<SEC-DOCUMENT>0001012477-22-000004.txt : 20220316
<SEC-HEADER>0001012477-22-000004.hdr.sgml : 20220316
<ACCEPTANCE-DATETIME>20220316160217
ACCESSION NUMBER:		0001012477-22-000004
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		140
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220316
DATE AS OF CHANGE:		20220316

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AVADEL PHARMACEUTICALS PLC
		CENTRAL INDEX KEY:			0001012477
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37977
		FILM NUMBER:		22744845

	BUSINESS ADDRESS:	
		STREET 1:		BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK
		STREET 2:		BALLYCOOLIN
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			15
		BUSINESS PHONE:		636-449-1830

	MAIL ADDRESS:	
		STREET 1:		16640 CHESTERFIELD GROVE ROAD
		STREET 2:		SUITE 200
		CITY:			CHESTERFIELD
		STATE:			MO
		ZIP:			63005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FLAMEL TECHNOLOGIES SA
		DATE OF NAME CHANGE:	19960422
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>avdl-20211231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:9768bc4a-d41b-4cde-8dab-4f8611fcf569,g:2327e6e7-350d-456e-9b47-ccea1e6c574d,d:56bb95bb4ed94f6abb9be4d186e21dfb--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:avdl="http://www.avadel.com/20211231" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>avdl-20211231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl80L2ZyYWc6MDliOTZkNWMzY2FkNGU0MWE2YjM3N2IxYjYwOTY2ZDQvdGFibGU6ZTA3YjAwYTYxZDRjNGYzMWE2YmM3ZDdiNDUxMTMxZTkvdGFibGVyYW5nZTplMDdiMDBhNjFkNGM0ZjMxYTZiYzdkN2I0NTExMzFlOV80LTEtMS0xLTIzNDU4_739c444b-a96f-4570-b728-a7bd003389ee">0001012477</ix:nonNumeric><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl80L2ZyYWc6MDliOTZkNWMzY2FkNGU0MWE2YjM3N2IxYjYwOTY2ZDQvdGFibGU6ZTA3YjAwYTYxZDRjNGYzMWE2YmM3ZDdiNDUxMTMxZTkvdGFibGVyYW5nZTplMDdiMDBhNjFkNGM0ZjMxYTZiYzdkN2I0NTExMzFlOV81LTEtMS0xLTIzNDU4_2ffbb74f-e386-4799-8da9-24a0a46fb1be">false</ix:nonNumeric><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl80L2ZyYWc6MDliOTZkNWMzY2FkNGU0MWE2YjM3N2IxYjYwOTY2ZDQvdGFibGU6ZTA3YjAwYTYxZDRjNGYzMWE2YmM3ZDdiNDUxMTMxZTkvdGFibGVyYW5nZTplMDdiMDBhNjFkNGM0ZjMxYTZiYzdkN2I0NTExMzFlOV82LTEtMS0xLTIzNDU4_e0416590-edc0-4873-99ae-58fd6a1be46d">FY</ix:nonNumeric><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl80L2ZyYWc6MDliOTZkNWMzY2FkNGU0MWE2YjM3N2IxYjYwOTY2ZDQvdGFibGU6ZTA3YjAwYTYxZDRjNGYzMWE2YmM3ZDdiNDUxMTMxZTkvdGFibGVyYW5nZTplMDdiMDBhNjFkNGM0ZjMxYTZiYzdkN2I0NTExMzFlOV83LTEtMS0xLTIzNDU4_c04c4da7-6c3a-4203-81ff-af7c5b6e45d5">2021</ix:nonNumeric><ix:nonNumeric contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMTktMC0xLTEtMzUzMDQ_f56fced8-8277-4fc5-853a-d6b09d65d5dd">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate202006Member</ix:nonNumeric><ix:nonNumeric contextRef="i6d1b0f4826d84816aa9460ece5298de4_D20200630-20200630" name="avdl:DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzQwNg_d7d1bf58-ccde-4c16-a6b6-573abd462bd2">P10M</ix:nonNumeric><ix:nonNumeric contextRef="i91742d6730614741949177cbcf4302d6_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90ZXh0cmVnaW9uOjIyMGM2MjEzZTI4YTQ4YTU5NDMyYzkzOTY1NjcxODAyXzY2OQ_ea03d613-a2cf-479a-bdb9-ee92938c3329">P2Y</ix:nonNumeric><ix:nonNumeric contextRef="i911b1d37c6734cba9182382fa4082eed_D20180216-20180216" name="avdl:DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzIzMjM_cdb5c14c-1181-4685-9a23-0a0887188621">P5D</ix:nonNumeric><ix:nonNumeric contextRef="i911b1d37c6734cba9182382fa4082eed_D20180216-20180216" name="avdl:DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzIzNjg_cdf18a29-792e-43e1-baa4-c68eb2cf6a76">P5D</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="ief750bd091b4462594bc83d332433361_D20210101-20211231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTQvZnJhZzo5OWYwMTc3ZjI0YWU0ZDZkOTgxZjA5OWNkNGNkZTY0ZS90ZXh0cmVnaW9uOjk5ZjAxNzdmMjRhZTRkNmQ5ODFmMDk5Y2Q0Y2RlNjRlXzEyNjQ0MzgzNzIwMTM3_4aef4419-c0e6-40b5-8d2b-bcc54c123d28">67</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i3e7e7087a91147f6a6c45f3da7e17949_D20210101-20211231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTQvZnJhZzo5OWYwMTc3ZjI0YWU0ZDZkOTgxZjA5OWNkNGNkZTY0ZS90ZXh0cmVnaW9uOjk5ZjAxNzdmMjRhZTRkNmQ5ODFmMDk5Y2Q0Y2RlNjRlXzEyNjQ0MzgzNzIwMTQ2_f728c597-c404-441b-a75d-65c390a30101">33</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i6def031541f3454daffd8bd55988af5e_D20210101-20211231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTQvZnJhZzo5OWYwMTc3ZjI0YWU0ZDZkOTgxZjA5OWNkNGNkZTY0ZS90ZXh0cmVnaW9uOjk5ZjAxNzdmMjRhZTRkNmQ5ODFmMDk5Y2Q0Y2RlNjRlXzEyNjQ0MzgzNzIwMTU1_1f474040-349b-4bdd-8b5f-15354086971f">25</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i97ce66e51f7346639c2f4447e25ce6b6_D20210101-20211231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTQvZnJhZzo5OWYwMTc3ZjI0YWU0ZDZkOTgxZjA5OWNkNGNkZTY0ZS90ZXh0cmVnaW9uOjk5ZjAxNzdmMjRhZTRkNmQ5ODFmMDk5Y2Q0Y2RlNjRlXzEyNjQ0MzgzNzIwMTY2_54032740-53b5-4848-8dfb-efc3e6bfc418">33</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="avdl-20211231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3840421dd70d40aba8c9dc8a0052f33e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">avdl:AmericanDepositarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i370907e69e7f449e958e11d58db5bf21_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">avdl:OrdinaryShareNominalValue001PerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia143361add2b4e9c93fd4b3b2019fefd_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ie534be6ccea84023a1ded40a74cfac08_I20220311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ib45086ff0e0a4835b7367935d02327f4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3742cf8102b48d39bc674ec35e7f8d0_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i812a792161364ad492b0f6fe55adf3f4_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fb14a7aef624d6b8b4c8f13072f3c9f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26cf650e64fc419d90c5273bbc7ac968_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6fbbd5528b2439293da3c165945acb2_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i394f53cfcde141e98500d79a19551b90_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie19b226220734349af34ea12f273148b_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62c97ced29404b4b822be5a8b268125c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie148f975b2854da787567794ba46c657_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8606a26085a4a74842150a8d122fa0d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e4d19794fda42f0b37baafb371b84eb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb598c0f14344aae992296441052f63c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i197afee9fd6b4ccaa43ec6478392822f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i899ea66e7b964d058e1797ec8ba84773_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54c88094c4ef4380afaf16c83eff800a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67e12346ebfb4c079f8ca4ba96c5d37c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7eb97deba3549d6b376ab774b0445a5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie73b28a1c0c648e5a6641e1c909996f0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cf266a805904fcb95e5e2c230b341cd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecf586fe05cc4a8796842f7e0739adcd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if771595121ea48de8b53daa551326307_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9de1c77df78b4ba98727acf8dec79f60_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i222f8cd80d79448189c83644ac3d2355_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0877df49af64182b24f4e10a6ba5e3e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic789417b0e004065ba225a51e910fb39_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00d4167fc12941e6afffad25855327d4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia20446b447fa4a8ab7a66e1764ce6493_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82fc7bbe97ac467ba08500fce8cb112e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaddacdf3080a4469857cc1c79a9583e3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i965ba5cfda524be99b22224e377b7879_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27057cf80d054326a72f1357eef1f0c2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdaa54a433dd430a83d91856c8287945_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia03de445d5514be7925f47534612a3c6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2aea8b8d433e4423879f52b4780b5b0f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1271ce9577746e28ccd19f9aebc5938_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71e818e3e9d648c6b90862da8ce42be5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcc16b22124640c1b74cb0fad033cc0d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c79a087deb04cc1aee09bf57361d370_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4880683abd4349769692521b4246f81c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f3ba7983a1d4e8d8ca3d4d571f7417f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic954e2aba16348f4beeb6795e6fad4fa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79b00d255f634de49f2fc2b349447e88_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10196011707944b18724021dfce2ca7e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic562d9c206fb48efa5bb76601ca9f47a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i0a1f89fa820b46799ce79a937450f547_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f8c561814cb4f708a96e8a38bb166f0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5309d5e8acaa431c9c274770bb06176c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99ac7af65eda496da535e06c493274b8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf9cbe9d47d34e1390ad1c335c52c141_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:AdvertisingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b913b3f3b0f4f44964bcbdf8ad62c1b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:AdvertisingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa9feaab286342789251faa80710001c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:AdvertisingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78886c225d1047eeaaea9dd1a3216a79_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">avdl:SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66c72f9a21ad431c99a6a9e5043d92a7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">avdl:LeaseholdImprovementsFurnitureFixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie09e5d490621464e9ce04e340e7c04df_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">avdl:LeaseholdImprovementsFurnitureFixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ffb01488f3a42119218fd36f48c1d40_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85c848bffc1542ceb9f02559b91119f8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">avdl:SpecialtyPharmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i394c910852974a2b9a5ecd7ffb761fce_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:BloxiverzVazculepAkovazandNouressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d1b0f4826d84816aa9460ece5298de4_D20200630-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:BloxiverzVazculepAkovazandNouressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-30</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0756957a1e1d4fce943a2b692ad6e709_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:BloxiverzVazculepAkovazandNouressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c9923703844411eb3e5ce7edba6c8ed_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:BloxiverzVazculepAkovazandNouressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic759888cdbc54a9a9b75a3bc35604e1c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:BloxiverzVazculepAkovazandNouressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d9561d07a174b4d928f303fd47bd68b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38080e480d2448d89a3f5285f946f2e5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibaeb39fd6c394110b9fd0a0d5423884f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib89e2680daf342f19590ad40660e7d7c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76d9d41ce856419e9dfc0d9e14013a83_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i452c804743a24cfe918d651e2bd94b98_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ead4e892b78440b941a75e56c9490b1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i116a6b04235e4b1c93dc94865613041c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0083fb6ccd404e979fe21e48af0fa1f5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id52d7d2aa62b4b4da464b12866a6c924_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83bc9cfa1af3440280eb8de38f8166dd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic01169ef9e0a4955a3206600ff07ada7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2b2742f57824ceda1edb68f0ff8c8f3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d1044cc5fce464b8bc7a7bfef8cde56_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18e72e8a73fd4634a6d3d9497623275a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3c0427547534f92a024aa31e44c88b7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i293bd7a5c8b64a69aac7ebd06bdbcd7d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5fb86d740e0439ca6608ab69d36eb11_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bfe961a6b074629ab468b545ec27937_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0630338310348249f7dc7b831142ee2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7eb59743d34e40129c556f867c6c573c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5f30bb744514756aea4f12be8815603_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5979606d5744565bf77ff486631a39e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6913fac34a90404fa88993860b66d7e2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic28f71d280c5400baa92f1e72d94daf9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id88486af4378447498d419d174a87a1f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa70138b99c048b89b45f15ed355b484_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie16c2dc1e48343529c36da1c15195964_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4b3eeee3d8446c7b5e89621aa4d248c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib17fcae9927b47b188df8b1fa2c25721_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68cd10c5610845ebabca121f25b49d60_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d79f4c0bc9b455887433f737f576ca8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a771a5f8997450bbbff5c44c4e92027_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b4d5f4b3fec4948b3a7c8a60e155623_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c7e425e645c4dc79f2d64d4e4939081_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id14aee310c1d455eba4dc5a754e72eee_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i440d19b8d2524ebdaf59efde284e3f22_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib15012d3c7954901bf95432b698ea122_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1789d52ed2dd4776b2edfab82bbba9d2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia43fd9d7d0184bf48d0ca7e30b92fe15_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26a649c3c54c4610811b4ccf08d404fc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2ad46fe0b3942418942545c861a553b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4de00269e1884c6ba19491a6f480f8c0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12fe5967822c4c7c815ef3f9bfcf263a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a1d5321937c496998a92b6d7b15b2ec_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0135ceeb3a74418aebc3bea16187547_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90001ac5605243f1919453ac916355e5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85699a651b9645bdaa89df0e755480d9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcf68fc36aa144f6aed0720b51cae4de_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e1399e88a8a4132b1ab0865edb594ab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e74df425db74915b7e617e549e87b1f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">avdl:SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79bb42f554984d2286d06ea284888cfd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">avdl:SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8c3aa61520d40aebe11479c3ccbff53_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82ff4d5bf5de4a8ba5b7fb4b53054871_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91742d6730614741949177cbcf4302d6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f6fe7015e8f450194b70a8556bf0935_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfaa054052d14e7a8ca1f2c58126ec2e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4dc9b8e4c33d47f78a2c32f6fc5be381_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b007cff8b974e868c3993f562d9feaf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd8ea8ce80304018bd5b1979eb26d074_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33e06b7a13eb4e85be3a4f81119b68c1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9ebe4ca9019413ebb51803e053e035d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf503e36fd6a429f84871178d6090bcd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d1ea1ea40054379a04b6e20ee96f982_I20180216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-02-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id653d0c0a8b74c299e04291165d88344_D20180216-20180216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-16</xbrli:startDate><xbrli:endDate>2018-02-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i483626a1ca994a1ab8f44a4dd0abd7f7_D20180216-20180216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-16</xbrli:startDate><xbrli:endDate>2018-02-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="rate"><xbrli:measure>utr:Rate</xbrli:measure></xbrli:unit><xbrli:context id="i911b1d37c6734cba9182382fa4082eed_D20180216-20180216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-16</xbrli:startDate><xbrli:endDate>2018-02-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cf2ba3d017445f7b369d02baa194a26_D20180216-20180216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-16</xbrli:startDate><xbrli:endDate>2018-02-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="day"><xbrli:measure>avdl:day</xbrli:measure></xbrli:unit><xbrli:context id="ic9d6fffe305c44aeb5282edb28b92265_D20180216-20180216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-16</xbrli:startDate><xbrli:endDate>2018-02-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74b20dd17dcf4f36b4f73cfd680e44c9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1798461a2fc34d85ace6dea31e0f8881_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08b7b375f4d048c9ab8e6d5fd7ea7ea5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie59a27f48eeb44b5bb24636fb8639702_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13a6499a4aea49bfbc0d46162aaf1ebe_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4590886cb1c49159327f4cd498c421f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i537c662c0452407d996503d13075eee0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3e2739e702347078b4ee9a8124ae398_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64421d34a1204f448424959b78e8a9d8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaf12fbafde84863931c23859cbdb5da_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">avdl:SpecialityPharamaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia27d598a536e49f8a6849f6207c5e949_I20190702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">avdl:SpecialityPharamaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cf4dc7580ba45efa635d0308b128ae0_I20191002"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">avdl:SpecialityPharamaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0729539c1221405f81e7676478827e0e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib32f28d9fbb54bab90164eb85e585915_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94f0c3f367384e14bdd26826dd6b02fd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">avdl:FscHoldingsLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8fc76361f664419bb4b6bec6e9f55d1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">avdl:U.S.HoldingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i965546c452da46f2b76a6fe33a65e75c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b27235b791c489ba62df9bcd96969e8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8aae7fedfa0841069d9766ab4280c0ce_D20180201-20180228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:FSCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:A2016MIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-01</xbrli:startDate><xbrli:endDate>2018-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie92e7a337b354b108b7bcc24805f0ef5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:A2016MIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5adac7e213d040e6be9c9156b4e7a03d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:CerecorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9dabd3a46c348c4af8ae3e2b161a78b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3109188b67084c50b94dbbece93b1abd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b6255d17e27499c84e9416e2247c6d2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">avdl:RetirementIndemnityObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5abec81499e34146bd019b20912a78d9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">avdl:RetirementIndemnityObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fe6439ac97147e2bef805733848150d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia076dc0709334bbeaf09ce17301fb2b2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c3cd06d5ae74e7ca62b8e96948d1fbe_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7cf514ecb0a4781b0ac7b4a71edab2e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5987a3d29dec46bbb4bf5192b6d19fa6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08f7c0e44e0a42769d59e55ba48a1a37_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice4e909fcef6444cab32b6676fcfd8a6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee22e31315ba4f7e8c83a112021555d6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27fed9afac844925a080e2a721c7438b_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateRestructuringObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91f93d16ae9742dd81fc60061f927f11_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateRestructuringObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7326c61f55a843b198262a29c6c921c5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateRestructuringObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba84066aae6641519638f5dc4a7827a7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateRestructuringObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18f1d74601ab46d1bf4daa3efd8b638b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateRestructuringObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic33e6a0dbfbb440fb29af7e8c03ab9d7_I20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-02-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2787db7d87db4fbbb4a9524ed6ef5ca7_D20200201-20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-02-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaf43fbfb3db4fd9b03a187560479d16_D20200221-20200221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-21</xbrli:startDate><xbrli:endDate>2020-02-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69fc50e94a814273a65f41128688da91_D20200221-20200221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sic:Z8880</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-21</xbrli:startDate><xbrli:endDate>2020-02-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72449ec228e943259a39bc04a30d454e_D20200221-20200221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-21</xbrli:startDate><xbrli:endDate>2020-02-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc5a6d80e8124b0a8bd28950f9fab4f6_I20200221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dd0849c19e5445a8e3c4ff75cf420fe_D20200221-20200221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-21</xbrli:startDate><xbrli:endDate>2020-02-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03c965967c7441e5b5bcfced0e7683c0_D20200221-20200221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-21</xbrli:startDate><xbrli:endDate>2020-02-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief992a6b46384fde9bd18e611b58d86a_D20200428-20200428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">avdl:AmericanDepositarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-28</xbrli:startDate><xbrli:endDate>2020-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0872a3688509439e8994fb7fcb662949_I20200428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">avdl:AmericanDepositarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd0f3157ccaf401eb75302e497df671d_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25009cefa3684002b043b7c8af74ee8a_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae6e5465f9294b758b40203ccdae2d14_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b077651731849bb9b0eddf0ad66d964_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebf3233476024b80bd208d93e82c7650_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c016d73d5464ed1853cdbc6f93adae3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d53c3a9d81648dfa5f09b49ada455d1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1229a210a7f49d4bbb9220069f8160e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d793592e3a9425abb3183a775c1d08e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i455e8146c8434385aa9ae98f6c5ed465_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaea59e16245b4fe5ba425b805b97b872_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i430f2e5a391247ff991d3a3d8de0d7d8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62b6ae12248b41dd9329f8af33aa447e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2880bd052c594c028d8ff7cb30be355f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">avdl:InducementPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17b0b84673264785a47fb9c2393d8d97_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12defb4ee11f4638be647bb1b2e8d3cd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3404683becd24bbaa99d0f9b831bc219_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80fe8f6ade7440249243d34649acec04_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc32436cac984c44acb451d8f53084cb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i542cb65bcac94725a2e85b1f9d50115f_D20170101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43f3e0d370bf48618c4b4ffce4f20c85_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avdl:RestrictedShareAwardsGrantedToEmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i543086e15a0649c38d2ae050067cfe92_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avdl:RestrictedShareAwardsGrantsBeginningIn2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9385e38dbc52477281fcde7e0e8243bf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avdl:FreeShareAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60cd02301b0744718ab6232fc8397080_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avdl:FreeShareAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa8fa276a1de4b9ea652bbce418a979a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avdl:FreeShareAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id51962221b6045adacaa762297fcce4c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avdl:FreeShareAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4e4adc9bd9a43e4b7a14bed4eafeaaa_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avdl:FreeShareAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ada9b293d7f49f393204ff4cdec742a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">avdl:VestUponTheAchievementOfCertainRegulatoryMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia69e39054ae948c9a9472b1618aee17c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">avdl:VestOneYearFollowingAchievementOfMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcd77640185c41ca9d2ac2883e957c10_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8244f7a6941e41b6b0fc0fa1f31f090c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">avdl:VestUponAchievementOfCertainCorporateObjectivesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i213dddfe6eca46e9b836e9ed09ef1520_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">avdl:VestOneYearFollowingAchievementOfCertainCorporateObjectivesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4518f66a522647cd984ba59be675f8ce_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">avdl:VestUponAchievementOfCertainCorporateObjectivesBeingMetAndExceededMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08ccab8f43964d778b6f1aa5700dd88f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7b206dec3ef4b5d9ee30dd96c6c7208_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice6e75c4e53f421694026f9bdc2f0a37_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ea3506d4ee445e483ed272a81e24e72_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief179786cb524ebfa29b22addb7be488_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">avdl:A2017AvadelEmployeeSharePurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdf6a4240ce9425b9403a1273967c137_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">avdl:A2017AvadelEmployeeSharePurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf6ce914e29a4f3d86cdf8ae44d7a965_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebe32eeb9dbe40dbb43d30c6ba5c778b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief750bd091b4462594bc83d332433361_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avdl:RestrictedShareAwardsGrantedFrom20172020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e7e7087a91147f6a6c45f3da7e17949_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avdl:RestrictedShareAwardsGrantedFrom20172020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6def031541f3454daffd8bd55988af5e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avdl:RestrictedShareAwardsGrantedToEmployeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97ce66e51f7346639c2f4447e25ce6b6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avdl:RestrictedShareAwardsGrantsBeginningIn2018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">avdl:SharebasedCompensationAwardTrancheFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8998385242564cbfaaaf6433c863849d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief47867d77194fa783312c489f06e3d5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79413685d8144e178e42b28c2e99365b_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieeed97785c574074863094742c31cea8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i474a662d5a374ab8b341858690d4bd8e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica4213e299f9427b901f343c8c2b93e9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6899b6aea474e37acddcb73ba8cdaef_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00f270d697454afeb8bada6c69682df2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a4d131f2ecc46778f5ed88f6d27c807_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56a9ae7f277b43dc8ec524cd0712a41c_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4eec0f5944eb41a387ea1b80154c9f6b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i575efbeda86d4caba5c559924eae6606_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5143455b68ee4952a8f2f5bd2395cc6b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7de80df209214ad6aec995ee651920e0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>avdl:segment</xbrli:measure></xbrli:unit><xbrli:context id="i7560f23c3ff844359638f73f581206cd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:BloxiverzMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic58ebe2ec1a34491b83d98083867b7c2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:BloxiverzMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15b58b8fae3c434ca88a14dfad44f1f9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:VazculepMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8c719f27eb049d5b2f929f14a52769d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:VazculepMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic69cf75cdcb0443f8394a9f9f2b8481e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:AkovazMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i633dae8062544ae688cd05721bcc4684_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:AkovazMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id56837453cdf432dba648aaa4d2c9cf8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:OtherProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fb31d32e89a42278408412283fc7bc7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:OtherProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i961305f8256144a0921c3dcb9f63da7a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">avdl:CustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia55f30e804be44cea8352288a384a9c3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">avdl:CustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94e3ccf5ec9740e58837d91fdc1f7e3f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">avdl:CustomerBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6393bb62733a46eeb7ef3712baca37c8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">avdl:CustomerBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6170920a302f4c30b265cb1c3c9b5e4c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">avdl:CustomerCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd0191dbbea742a0ad131c24b89d15dc_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">avdl:CustomerCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0359dc3ae57641d8a06f346eb996b112_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">avdl:CustomerDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5eca0785abb64ad4a7ba38ca114bffbd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">avdl:CustomerDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4efcd62648ae4318a25132f75b187f91_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">avdl:OtherCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i791518d5395c46a5a1dcb85211cb3fc0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">avdl:OtherCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i202d7516b2bd4304ad55b1aafeb6d3d5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27b63bdbcab14d6eb97ff7f6e4f0a10c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie28cee2136b144d498b35733e7331556_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bcaec4506f44e42ab5e37d5e0a7f18d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78d0a8066299410fae55ee22a1483399_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1133dde1f8446e48e8886c74d1845df_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica869e44a5d747338f8da7c47e19f318_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6708f8d915264e56880479e22149d123_I20220316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i360019dcf2b1493e9e2047d365cd0d6f_I20220316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-16</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_1"></div><div style="min-height:18pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDM2_763c8d76-e419-41a9-9626-4547e8caa7e5">10-K</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDM3_6fca0d8d-787b-4513-bb2d-4ad7325d9e67">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the fiscal year ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl8yMDE_418155ac-bb00-45dc-b6b3-184439c0c4c2"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl8yMDE_4e7639b6-d6f7-4d03-8778-1803cf241b2b">December&#160;31</ix:nonNumeric>, 2021</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">&#160;&#160;</span></div><div><span><br/></span></div><div style="padding-left:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:107%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDI5_fe4bd0ba-53a2-4e14-a8fb-e0bf5140487c">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:107%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:107%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the transition period ____________ to ____________&#160;&#160;&#160;</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission file number: <ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDMw_c665f155-bb53-406b-8d48-e999de70183b">001-37977</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDM4_fe2b1500-7aee-4896-811d-476d74541490">AVADEL PHARMACEUTICALS PLC</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.166%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.167%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6YzBhNzgyOTdjNjY2NDM0Mzk5NGIxZDMzOTk0ODNjNjEvdGFibGVyYW5nZTpjMGE3ODI5N2M2NjY0MzQzOTk0YjFkMzM5OTQ4M2M2MV8wLTAtMS0xLTIzNDU4_fce14099-05be-407a-9905-9a405aa497fe">Ireland</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6YzBhNzgyOTdjNjY2NDM0Mzk5NGIxZDMzOTk0ODNjNjEvdGFibGVyYW5nZTpjMGE3ODI5N2M2NjY0MzQzOTk0YjFkMzM5OTQ4M2M2MV8wLTItMS0xLTIzNDU4_df999b46-6d4c-47c5-ae3e-0e9ec8d52344">98-1341933</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">State or other jurisdiction of incorporation or organization</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6YzBhNzgyOTdjNjY2NDM0Mzk5NGIxZDMzOTk0ODNjNjEvdGFibGVyYW5nZTpjMGE3ODI5N2M2NjY0MzQzOTk0YjFkMzM5OTQ4M2M2MV8zLTAtMS0xLTIzNDU4L3RleHRyZWdpb246MTBlNTUyZmNmOWUzNGExOWFiZTM5MTY0NzRmNzFlNmJfNA_f91d6332-1096-4607-a2fd-062c59cd1e9f">10 Earlsfort Terrace</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6YzBhNzgyOTdjNjY2NDM0Mzk5NGIxZDMzOTk0ODNjNjEvdGFibGVyYW5nZTpjMGE3ODI5N2M2NjY0MzQzOTk0YjFkMzM5OTQ4M2M2MV8zLTAtMS0xLTIzNDU4L3RleHRyZWdpb246MTBlNTUyZmNmOWUzNGExOWFiZTM5MTY0NzRmNzFlNmJfNw_8d2452ec-ffc9-4480-81a4-6f2c120e1049">Dublin 2</ix:nonNumeric>, <ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6YzBhNzgyOTdjNjY2NDM0Mzk5NGIxZDMzOTk0ODNjNjEvdGFibGVyYW5nZTpjMGE3ODI5N2M2NjY0MzQzOTk0YjFkMzM5OTQ4M2M2MV8zLTAtMS0xLTIzNDU4L3RleHRyZWdpb246MTBlNTUyZmNmOWUzNGExOWFiZTM5MTY0NzRmNzFlNmJfMTE_b47aeb3c-c44f-4800-ad22-052de252da05">Ireland</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6YzBhNzgyOTdjNjY2NDM0Mzk5NGIxZDMzOTk0ODNjNjEvdGFibGVyYW5nZTpjMGE3ODI5N2M2NjY0MzQzOTk0YjFkMzM5OTQ4M2M2MV8zLTAtMS0xLTIzNDU4L3RleHRyZWdpb246MTBlNTUyZmNmOWUzNGExOWFiZTM5MTY0NzRmNzFlNmJfMTQ_d5b87581-67c2-4278-a59f-d93d6585d4be">D02 T380</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Not Applicable</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Registrant&#8217;s telephone number, including area code: +353-<ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6YzBhNzgyOTdjNjY2NDM0Mzk5NGIxZDMzOTk0ODNjNjEvdGFibGVyYW5nZTpjMGE3ODI5N2M2NjY0MzQzOTk0YjFkMzM5OTQ4M2M2MV82LTAtMS0xLTIzNDU4L3RleHRyZWdpb246MmQ3MjViNDVhNGVjNDNiZDllNGUwM2I4OWM2Mjk2NGFfNjE_c44a6b89-a880-4ffc-9dea-48c841e65ebf">1</ix:nonNumeric>-<ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6YzBhNzgyOTdjNjY2NDM0Mzk5NGIxZDMzOTk0ODNjNjEvdGFibGVyYW5nZTpjMGE3ODI5N2M2NjY0MzQzOTk0YjFkMzM5OTQ4M2M2MV82LTAtMS0xLTIzNDU4L3RleHRyZWdpb246MmQ3MjViNDVhNGVjNDNiZDllNGUwM2I4OWM2Mjk2NGFfNjQ_6129414b-ba1f-469c-bbf5-d1b84421cd0a">901-5201</ix:nonNumeric></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-bottom:4pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol (s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of exchange on which registered</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3840421dd70d40aba8c9dc8a0052f33e_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6OGI4ZWM3OWU3Njg1NGRmZGFjZDIzOTFkZDU3OTVkZDUvdGFibGVyYW5nZTo4YjhlYzc5ZTc2ODU0ZGZkYWNkMjM5MWRkNTc5NWRkNV8xLTAtMS0xLTIzNDU4_c0230a3e-bbb7-4ec0-baf0-795cd07a730f">American Depositary Shares*</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3840421dd70d40aba8c9dc8a0052f33e_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6OGI4ZWM3OWU3Njg1NGRmZGFjZDIzOTFkZDU3OTVkZDUvdGFibGVyYW5nZTo4YjhlYzc5ZTc2ODU0ZGZkYWNkMjM5MWRkNTc5NWRkNV8xLTEtMS0xLTIzNDU4_66d75bb5-17e5-437e-956a-c93da44a8704">AVDL</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3840421dd70d40aba8c9dc8a0052f33e_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6OGI4ZWM3OWU3Njg1NGRmZGFjZDIzOTFkZDU3OTVkZDUvdGFibGVyYW5nZTo4YjhlYzc5ZTc2ODU0ZGZkYWNkMjM5MWRkNTc5NWRkNV8xLTItMS0xLTIzNDU4_30c69c1b-e71e-438f-9b61-49113535d566">The Nasdaq Global Market</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i370907e69e7f449e958e11d58db5bf21_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6OGI4ZWM3OWU3Njg1NGRmZGFjZDIzOTFkZDU3OTVkZDUvdGFibGVyYW5nZTo4YjhlYzc5ZTc2ODU0ZGZkYWNkMjM5MWRkNTc5NWRkNV8yLTAtMS0xLTIzNDU4_72d14d56-6a7b-4550-b46a-f2a006a2c390">Ordinary Shares, nominal value $0.01 per share**</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i370907e69e7f449e958e11d58db5bf21_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6OGI4ZWM3OWU3Njg1NGRmZGFjZDIzOTFkZDU3OTVkZDUvdGFibGVyYW5nZTo4YjhlYzc5ZTc2ODU0ZGZkYWNkMjM5MWRkNTc5NWRkNV8yLTEtMS0xLTIzNDU4_287fd018-5636-44f8-b5f1-82e2f8afda8e">AVDL</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i370907e69e7f449e958e11d58db5bf21_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6OGI4ZWM3OWU3Njg1NGRmZGFjZDIzOTFkZDU3OTVkZDUvdGFibGVyYW5nZTo4YjhlYzc5ZTc2ODU0ZGZkYWNkMjM5MWRkNTc5NWRkNV8yLTItMS0xLTIzNDU4_b3ddd837-267c-45a2-bfde-976471fff22e">The Nasdaq Global Market</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:539.25pt"><tr><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:517.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">American Depositary Shares may be evidenced by American Depository Receipts. Each American Depositary Share represents one (1) Ordinary Share.</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:539.25pt"><tr><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:511.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Not for trading, but only in connection with the listing of American Depositary Shares. on The Nasdaq Global Market.</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act: None</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes&#160;&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDQz_0a99b907-3d16-439f-9676-b1d5bf54a3df">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#253;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act.&#160;&#160; Yes&#160;&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDM5_980bdedf-ba46-4a99-942b-1b04ca608500">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#253;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.<ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDQw_4674a3c5-6559-4519-a257-6bfc90fefb86">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#253;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;No&#160;&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#168;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted and pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDQ0_9bc9c3fe-7658-4d1f-85b8-0642706fd2f7">Yes</ix:nonNumeric>&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#253;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;No&#160;&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221;, and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Large accelerated filer </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDQ1_d5177634-d44b-4f71-a614-5a933e6cf1fb">Accelerated filer</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#253;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Non-accelerated filer </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;Smaller reporting company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDMx_1aaea427-3287-4a4e-87a7-d6086c452a3b">&#9744;</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDMy_21f2c496-6281-4516-b44d-0d220bf26e66">&#9744;</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDM0_7a4b251e-e3fd-4b4b-a0a9-97c31fa61884">&#253;</ix:nonNumeric> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes&#160;&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDMz_2a45192c-9bd4-45fa-9469-374221bc94f3">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#253;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The aggregate market value of voting stock held by non-affiliates of the registrant as of the last business day of the registrant&#8217;s most recently completed second fiscal quarter was $<ix:nonFraction unitRef="usd" contextRef="ia143361add2b4e9c93fd4b3b2019fefd_I20210630" decimals="0" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl8yOTk2_08fd7379-a736-4cf9-b5ce-9b0d70fcb8b1">390,167,685</ix:nonFraction> based on the closing sale price of the registrant&#8217;s American Depositary Shares as reported by the Nasdaq Global Market on June 30, 2021.  Such market value excludes 513,155 ordinary shares, $0.01 per share nominal value, which may be represented by the registrant&#8217;s American Depositary Shares, held by each officer and director and by shareholders that the registrant concluded were affiliates of the registrant on that date.  Exclusion of such shares should not be construed to indicate that any such person possesses the power, direct or indirect, to direct or cause the direction of the management or policies of the registrant or that such person is controlled by or under common control with the registrant.</span></div><div><span><br/></span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:18pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The number of the registrant&#8217;s ordinary shares, $0.01 per share nominal value, outstanding as of March&#160;11, 2022 was <ix:nonFraction unitRef="shares" contextRef="ie534be6ccea84023a1ded40a74cfac08_I20220311" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl8zNzQ0_b0aab1e8-fb6e-4d15-9453-22d2ba3487a3">59,032,237</ix:nonFraction>.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDM1_978a36cb-23a1-4808-bb00-07da830c63cb" escape="true">Portions of either (a)&#160;a definitive proxy statement involving the election of directors or (b)&#160;an amendment to this Form&#160;10-K, either of which will be filed within 120 days after December&#160;31, 2021, are incorporated by reference into Part&#160;III of this Form 10-K.</ix:nonNumeric></span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.175%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page #</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_10">Summary Of The Material Risks Associated With Our Business</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_10">4</a></span></div></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_13">Cautionary Disclosure Regarding Forward-Looking Statements</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_13">5</a></span></div></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_16">PART I</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_19">Business</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_19">7</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_22">Risk Factors</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_22">23</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1B.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_25">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_25">59</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_28">Properties</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_28">59</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_31">Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_31">59</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_34">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_34">59</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_37">PART II</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_40">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_40">60</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_43">Reserved</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_43">61</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_46">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_46">63</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7A.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_67">Quantitative and Qualitative Disclosures About Market Risks</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_67">73</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 8.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_70">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_70">74</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_175">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_175">109</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9A.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_178">Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_178">109</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9B.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_181">Other Information</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_181">110</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9C.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_1849">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_1849">110</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_184">PART III</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 10.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_187">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_187">111</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 11.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_190">Executive Compensation</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_190">111</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 12.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_193">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_193">111</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 13.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_196">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_196">111</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 14.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_199">Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_199">111</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_202">PART IV</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 15.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_205">Exhibits</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_205">112</a></span></div></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_208">SIGNATURES</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i56bb95bb4ed94f6abb9be4d186e21dfb_208">116</a></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-3-</span></div></div></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUMMARY OF THE MATERIAL RISKS ASSOCIATED WITH OUR BUSINESS</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is subject to numerous material and other risks and uncertainties, including those described in Part I, Item 1A. &#8220;Risk Factors&#8221; in this Annual Report on Form 10-K. The principal risks and uncertainties affecting our business include the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">We cannot be certain that our lead product candidate or future product candidates will receive marketing approval. Without marketing approval, we will not be able to commercialize our lead product candidate or future product candidates.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">Our business is significantly dependent on the successful development, regulatory approval and commercialization of FT218, our only product candidate.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">Our lead product candidate and future product candidates may not reach the commercial market for a number of reasons.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">If we are not able to use the 505(b)(2) regulatory approval pathway for the regulatory approval of FT218 or if the U.S. Food and Drug Administration (&#8220;FDA&#8221;) requires additional clinical or nonclinical data to support an New Drug Application under Section 505(b)(2) than we previously anticipated, it will likely take significantly longer, cost significantly more and be significantly more complicated to gain FDA approval for FT218, and in any case may not be successful.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">We incurred a net loss in 2021 and we will likely incur a net loss in 2022, and if we are not able to regain profitability in the future, the value of our shares may fall.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">We may require additional financing, which may not be available on favorable terms or at all, and which may result in dilution of the equity interest of the holders of American Depositary Shares (&#8220;ADSs&#8221;).</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">The distribution and sale of FT218, if approved, will be subject to significant regulatory restrictions, including the requirements of a Risk Evaluation and Mitigation Strategy (&#8220;REMS&#8221;) and safety reporting requirements, and these regulatory requirements will subject us to risks and uncertainties, any of which could negatively impact sales of FT218, if approved.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">Disruptions at the FDA, the U.S. Drug Enforcement Administration and other government agencies caused by funding shortages or global health concerns could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal business functions on which the operation of our business may rely, which could negatively impact our business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">FT218, if approved by the FDA, may not obtain desired regulatory exclusivities, including orphan drug exclusivity.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">We rely, and intend to continue to rely, on single source providers for the development, manufacture and supply of FT218, and if we experience problems with those suppliers, or they fail to comply with applicable regulatory requirements or to supply sufficient quantities at acceptable quality levels or prices, or at all, our business would materially and adversely affected.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">If we cannot adequately protect our intellectual property and proprietary information, we may be unable to effectively compete.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">If we are unable to establish effective sales, marketing and distribution capabilities, or enter into agreements with third parties to market, sell and distribute FT218, if approved, our business, results of operations, financial condition and prospects will be materially adversely affected.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">COVID-19 may materially and adversely affect our business and our financial results.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">We may become involved in lawsuits to protect or enforce our patents or other intellectual property, which could be expensive, time consuming and unsuccessful.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">The price of ADSs representing our ordinary shares has been volatile and may continue to be volatile.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-4-</span></div></div></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_13"></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Disclosure Regarding Forward-Looking Statements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form 10-K includes &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section&#160;21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). Any statements about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. These statements are often, but are not always, made through the use of words or phrases such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;predicts,&#8221; &#8220;projects,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; and similar expressions, or the negative of these terms, or similar expressions.  Accordingly, these statements involve estimates, assumptions, risks and uncertainties which could cause actual results to differ materially from those expressed in them. Any forward-looking statements are qualified in their entirety by reference to the factors discussed throughout this prospectus, and in particular those factors referenced in the section &#8220;Risk Factors&#8221; in Part I, Item 1A of this Annual Report on Form 10-K. </span></div><div style="margin-bottom:5pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form 10-K contains forward-looking statements that are based on our management&#8217;s belief and assumptions and on information currently available to our management. These statements relate to future events or our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements include, but are not limited to, statements about:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our reliance on a single lead product candidate, FT218;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to obtain regulatory approval of and successfully commercialize FT218, including any delays in approval;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The ability of FT218, if approved, to gain market acceptance;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to enter into strategic partnerships for the commercialization, manufacturing and distribution of FT218, if approved;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on a limited number of suppliers for the manufacturing of FT218 and certain raw materials in FT218 and any failure of such suppliers to deliver sufficient quantities of these raw materials, which could have a material adverse effect on our business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to finance our operations on acceptable terms, either through the raising of capital, the incurrence of convertible or other indebtedness or through strategic financing or commercialization partnerships;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our expectations about the potential market size and market participation for FT218; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to continue to service the our Exchangeable Senior Notes due February 2023 (the &#8220;February 2023 Notes&#8221;) and our Exchangeable Senior Notes due October 2023 (the &#8220;October 2023 Notes&#8221;, together with the February 2023 Notes, the &#8220;2023 Notes&#8221;), including making the ongoing interest payments on the 2023 Notes, settling exchanges of the 2023 Notes in cash or completing any required repurchases of the 2023 Notes; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential impact of COVID-19 on our business and future operating results;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to hire and retain key members of our leadership team and other personnel; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Competition existing today or that will likely arise in the future. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements are neither promises nor guarantees of future performance due to a variety of risks and uncertainties and other factors more fully discussed in the &#8220;Risk Factors&#8221; section in Part I, Item 1A of this Annual Report on Form 10-K and the risk factors and cautionary statements described in other documents that we file from time to time with the SEC. Given these uncertainties, readers should not place undue reliance on our forward-looking statements. These forward-looking statements speak only as of the date on which the statements were made and are not guarantees of future performance. Except as may be required by applicable law, we do not undertake to update any forward-looking statements after the date of this Annual Report or the respective dates of documents incorporated by reference herein or therein that include forward-looking statements. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to revise any forward-looking statements to reflect events or developments occurring after the date of this Annual Report, even if new information becomes available in the future. </span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTE REGARDING TRADEMARKS</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We own various trademark registrations and applications, and unregistered trademarks, including Avadel&#174;, Micropump&#174;, LiquiTime&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Medusa&#174;. All other trade names, trademarks and service marks of other companies appearing in this Annual Report are the property of their respective holders. Solely for convenience, the trademarks and trade names in this Annual Report may be referred to without the &#174; and &#8482; symbols, but such references should not be construed as any indicator that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto. We do not intend to use or </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-5-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">display other companies&#8217; trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may use our website, LinkedIn or our Twitter account (@AvadelPharma) to distribute material information. Our financial and other material information is routinely posted to and accessible on the Investors section of our website, available at www.avadel.com. Investors are encouraged to review the Investors section of our website because we may post material information on that site that is not otherwise disseminated by us. Information that is contained in and can be accessed through our website or our Twitter posts are not incorporated into, and does not form a part of, this Annual Report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-6-</span></div></div></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">PART I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_19"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Business.&#160;</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Dollar amounts in thousands, except per-share amounts and as otherwise noted)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Overview</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Avadel Pharmaceuticals plc (Nasdaq: AVDL) (&#8220;Avadel,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221;) is a biopharmaceutical company. Our lead product candidate, FT218, is an investigational once-nightly, extended-release formulation of sodium oxybate for the treatment of excessive daytime sleepiness (&#8220;EDS&#8221;) or cataplexy in adults with narcolepsy. We are primarily focused on the development and potential United States (&#8220;U.S.&#8221;) Food and Drug Administration (&#8220;FDA&#8221;) approval of FT218. In December 2020, we submitted a New Drug Application (&#8220;NDA&#8221;) to the FDA for FT218 to treat excessive daytime sleepiness or cataplexy in adults with narcolepsy. In February 2021, the NDA for FT218 was accepted by the FDA and was assigned a Prescription Drug User Fee Act (&#8220;PDUFA&#8221;) target action date of October 15, 2021. On October 15, 2021, we announced that the FDA informed us that the review of our NDA for FT218 was ongoing beyond its previously assigned target action date. As of the date of this Annual Report, the FDA&#8217;s review of our NDA for FT218 remains ongoing.   </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside of our lead product candidate, we continue to evaluate opportunities to expand our product portfolio. As of the date of this Annual Report, we do not have any approved or commercialized products in our portfolio.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FT218 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FT218 is a once-nightly formulation of sodium oxybate that uses our Micropump controlled release drug-delivery technology for the treatment of EDS or cataplexy in adults suffering from narcolepsy. Sodium oxybate is the sodium salt of gamma hydroxybutyrate, an endogenous compound and metabolite of the neurotransmitter gamma-aminobutyric acid. Immediate release sodium oxybate is approved in the U.S. for the treatment of EDS or cataplexy in patients with narcolepsy and is approved in Europe for the treatment of cataplexy in patients with narcolepsy. Since 2002, sodium oxybate has only been available as a formulation that must be taken twice nightly, first at bedtime, and then again 2.5 to 4 hours later. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 16, 2020, we announced the submission of our NDA to the FDA for FT218. On February 26, 2021, the FDA notified us of formal acceptance of the NDA and assigned a PDUFA target action date of October 15, 2021. On October 15, 2021, we announced that the FDA informed us that the review of our NDA for FT218 was ongoing beyond its previously assigned target action date. As of the date of this Annual Report, the FDA&#8217;s review of our NDA for FT218 remains ongoing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted a Phase 3 clinical trial of FT218, the REST-ON trial, which was a randomized, double-blind, placebo-controlled study that enrolled 212 patients who received at least one dose of FT218 or placebo, and was conducted in clinical sites in the U.S., Canada, Western Europe and Australia. The last patient, last visit was completed at the end of the first quarter of 2020, and positive top line data from the REST-ON trial was announced on April 27, 2020. Patients who received 9 g of once-nightly FT218, the highest dose administered in the trial, demonstrated statistically significant and clinically meaningful improvement compared to placebo across the three co-primary endpoints of the trial: maintenance of wakefulness test (&#8220;MWT&#8221;), clinical global impression-improvement (&#8220;CGI-I&#8221;), and mean weekly cataplexy attacks. The lower doses assessed, 6 g and 7.5 g also demonstrated statistically significant and clinically meaningful improvement on all three co-primary endpoints compared to placebo. We observed the 9 g dose of once-nightly FT218 to be generally well tolerated. Adverse reactions commonly associated with sodium oxybate were observed in a small number of patients (nausea 1.3%, vomiting 5.2%, decreased appetite 2.6%, dizziness 5.2%, somnolence 3.9%, tremor 1.3% and enuresis 9%), and 3.9% of the patients who received 9 g of FT218 discontinued the trial due to adverse reactions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2018, the FDA granted FT218 orphan drug designation for the treatment of narcolepsy, which makes FT218 potentially eligible for certain development and commercial incentives, including potential U.S. market exclusivity for up to seven years. Additionally, several FT218-related U.S. patents have been issued, and there are additional patent applications currently in development and/or pending at the U.S. Patent and Trademark Office (&#8220;USPTO&#8221;), as well as foreign patent offices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, we announced that the first patient was dosed in our open-label extension (&#8220;OLE&#8221;)/switch study of FT218 as a potential treatment for EDS or cataplexy in patients with narcolepsy. The OLE/switch study is examining the long-term safety and maintenance of efficacy of FT218 in patients with narcolepsy who participated in the REST-ON study, as well as dosing and preference data for patients switching from twice-nightly sodium oxybate to once-nightly FT218, regardless of whether they participated in REST-ON.  In May 2021, inclusion criteria were expanded to allow for oxybate na&#239;ve patients to enter the study. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-7-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New secondary endpoints from the REST-ON trial were presented at the American Academy of Neurology, beginning April 17, 2021. The first poster described FT218 improvements in disturbed nocturnal sleep (&#8220;DNS&#8221;), defined in REST-ON as the number of shifts from stages N1, N2, N3, and rapid eye movement (&#8220;REM&#8221;) sleep to wake and from stages N2, N3, and REM sleep to stage N1. FT218 also decreased the number of nocturnal arousals as measured on polysomnography. Improvements in DNS were further supported by post-hoc analyses demonstrating increased time in deep sleep (N3, also known as slow wave sleep), and less time in N1. A second poster described the statistically significant improvements in the Epworth Sleepiness Scale, both the quality of sleep and the refreshing nature of sleep, and a decrease in sleep paralysis. These clinically relevant improvements were observed for all doses, beginning at week 3, for the lowest 6 g dose, compared to placebo. FT218 did not demonstrate significant improvement for hypnagogic hallucinations compared to placebo.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional data supportive of the efficacy findings in REST-ON were presented at the 35th Annual Meeting of the Associated Professional Sleep Societies, a joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society, also known as SLEEP 2021, beginning June 10, 2021. New data included post-hoc analyses demonstrating endpoints improvements, regardless of concomitant stimulant use, in both narcolepsy Type 1 or Type 2. Additionally, a post-hoc analysis showed that FT218 was associated with decreased body mass index compared to placebo, which may be relevant as people with narcolepsy often have co-morbid obesity. In August 2021, the primary results from the REST-ON trial were published by Kushida et al. in the journal SLEEP. New data was presented at the American College of Chest Physicians annual meeting, beginning October 17, 2021, including additional post-hoc analyses from the REST-ON trial, demonstrating a greater proportion of patients receiving FT218 experienced reductions in weekly cataplexy attacks and improvement in mean sleep latency compared to placebo, as well as the results of a discrete choice experiment, indicating that the overall driver of patient preference between sodium oxybate treatments is a once-nightly, versus twice-nightly, formulation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe FT218 has the potential to demonstrate improved dosing compliance, safety and patient satisfaction over the current standards of care for EDS or cataplexy in patients with narcolepsy, which are twice-nightly oxybate formulations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Micropump Drug-Delivery Technology  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Micropump drug-delivery technology allows for the controlled delivery of small molecule drugs taken orally, which has the potential to improve dosing compliance, reduce toxicity and improve patient compliance. Beyond FT218, we believe there could be other product development opportunities for our Micropump drug-delivery technology, representing either life cycle opportunities, whereby additional intellectual property can be added to a pharmaceutical product to extend the commercial viability of a currently marketed product, or innovative formulation opportunities for new chemical entities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Previously Approved FDA Products </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On June 30, 2020 (&#8220;Closing Date&#8221;), we announced the sale of our portfolio of sterile injectable drugs used in the hospital setting (the &#8220;Hospital Products&#8221;), including our three FDA-approved commercial products, Akovaz, Bloxiverz and Vazculep, as well as Nouress, to Exela Sterile Medicines LLC (&#8220;Exela Buyer&#8221;).  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Our Drug Delivery Technologies&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own drug delivery technologies that address formulation challenges, potentially allowing the development of differentiated drug products for administration in various forms (e.g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;capsules, tablets, sachets or liquid suspensions for oral use; or injectables for subcutaneous administration) that could be applied to a broad range of drugs (novel, already-marketed, or off-patent).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A brief discussion of each of our drug delivery technologies is set forth below.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Micropump</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Micropump&#160;technology allows for the development of modified release solid, oral dosage formulations of drugs. Micropump-carvedilol and Micropump-aspirin formulations have been approved in the U.S.  Further, Micropump technology is being employed in our investigational FT218 product. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">LiquiTime</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LiquiTime&#160;technology allows for development of modified release oral products in a liquid suspension formulation, which may make such formulations particularly well suited for children and/or patients having issues swallowing tablets or capsules. Although we own this technology, we are currently not pursuing any commercial pharmaceutical drug development opportunities using it.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-8-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medusa. Our&#160;Medusa technology allows for the development of modified-release injectable dosage formulations of drugs (e.g., peptides, polypeptides, proteins, and small molecules).  Although we own this technology, we are currently not pursuing any commercial pharmaceutical drug development opportunities using it.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Competition and Market Opportunities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competition in the pharmaceutical and biotechnology industry is intense and is expected to increase. We compete with academic laboratories, research institutions, universities, joint ventures, and other pharmaceutical and biotechnology companies, including other companies developing brand or generic specialty pharmaceutical products or drug delivery platforms. Some of these competitors may also be our business partners. There can be no assurance that our competitors will not obtain patent protection or other intellectual property rights that would make it difficult or impossible for us to compete with their products. Furthermore, major technological changes can happen quickly in the pharmaceutical and biotechnology industries. Such rapid technological change, or the development by our competitors of technologically improved or differentiated products, could render our products, including our drug delivery technologies, obsolete or noncompetitive.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pharmaceutical industry has dramatically changed in recent years, largely as a function of the growing importance of generic drugs. The growth of generics (typically small molecules) and of large molecules (biosimilars) has been accelerated by the demand for less expensive pharmaceutical products. As a result, the pricing power of pharmaceutical companies will be more tightly controlled in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, consolidation has reduced our pool of potential partners and acquisition opportunities within the biopharmaceutical space.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Potential competition for FT218</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If FT218 receives FDA approval, it will compete with the currently approved twice-nightly oxybate formulations, as well as a number of daytime wake promoting agents including lisdexamfetamine, detroamphetamine, methylphenidate, amphetamine, modafinil, and armodafinil, which are widely prescribed, as well as solriamfetol and pitolisant, all of which may be prescribed concomitantly with sodium oxybate.  If approved, we anticipate FT218 may face competition from manufacturers of generic twice-nightly sodium oxybate formulations, who have reached settlement agreements with the current marketer, which allows for entry of an authorized generic in 2023.  In addition, there are other products in development that may be approved in the future that could have an impact on the narcolepsy treatment market, including, for example, reboxetine, orexin 2 receptor agonists, flecainide / modafinil combination, histamine H3 antagonists/inverse agonists, or GABA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:1.69pt;vertical-align:baseline">B</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> agonists.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an Irish public limited company. Our registered address is at 10 Earlsfort Terrace, Dublin 2, Ireland and our phone number is +353-1-901-5201. We file annual, quarterly and current reports, proxy statements and other documents with the SEC under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). Our website is www.avadel.com, where we make available free of charge our reports (and any exhibits and amendments thereto) on Forms 10-K, 10-Q and 8-K as soon as reasonably practicable after they are electronically filed with or furnished to the SEC. These filings are also available to the public at www.sec.gov.  We do not incorporate the information on or accessible through our website into this Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have five direct wholly-owned subsidiaries: (a) Avadel US Holdings, Inc., (b) Flamel Ireland Limited is an Irish limited company, which conducts business under the name Avadel Ireland, (c) Avadel Investment Company Limited, (d) Avadel Finance Ireland Designated Activity Company and (e) Avadel France Holding SAS. Avadel US Holdings, Inc., a Delaware corporation, is the holding entity of (i) Avadel Legacy Pharmaceuticals, LLC, (ii) Avadel Management Corporation, and (iii) Avadel CNS Pharmaceuticals LLC. Avadel Finance Ireland Designated Activity Company is the holding entity of Avadel Finance Cayman Limited. Avadel France Holding SAS is the holding entity of Avadel Research SAS. A complete list of our subsidiaries can be found in Exhibit 21.1 to this Annual Report on Form 10-K. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-9-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Parts of our product pipeline and strategic alliances utilize our drug delivery platforms and related products of which certain features are the subject of patents or patent applications. As a matter of policy, we seek patent protection of our inventions and also rely upon trade secrets, know-how, continuing technological innovations and licensing opportunities to maintain and develop competitive positions.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FT218 Patents. We have been awarded several FT218-related U.S. patents having expiry dates from mid-2037 to early-2040. We have a number of additional FT218-related patent applications pending at the USPTO as well as at non-U.S. patent offices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Drug Delivery Technology Patents. Our drug delivery technologies are the subject of certain patents, including: (i) for Micropump, patents relating to coating technologies that provide for controlled release of an active ingredient (expiring in 2025 in the U.S. and 2022 in non-U.S. jurisdictions); (ii) for LiquiTime, patents relating to film-coated microcapsules and a method comprising orally administering such microcapsules to a patient (expiring in 2023); and (iii) for Medusa, patents relating to an aqueous colloidal suspension of low viscosity based on submicronic particles of water-soluble biodegradable polymer PO (polyolefin) carrying hydrophobic groups (expiring in 2023).</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The patent positions of biopharmaceutical companies like us are generally uncertain and involve complex legal, scientific and factual questions. In addition, the coverage claimed in a patent application can be significantly reduced before the patent is issued, and patent scope can be reinterpreted by the courts after issuance. Moreover, many jurisdictions permit third parties to challenge issued patents in administrative proceedings, which may result in further narrowing or even cancellation of patent claims. We cannot predict whether the patent applications we are currently pursuing will issue as patents in any particular jurisdiction or whether the claims of any of our licensed or owned patents will provide sufficient protection from competitors. Any of our licensed or owned patents may be challenged, circumvented, or invalidated by third parties. For more information, please see the information set forth under the caption &#8220;Risks Related to Our Intellectual Property &#8211; If we cannot adequately protect our intellectual property and proprietary information, we may be unable to effectively compete&#8221; in the &#8220;Risk Factors&#8221; included in Part I, Item 1A of this Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplies and Manufacturing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We attempt to maintain multiple suppliers in order to mitigate the risk of shortfall and inability to supply market demand. Nevertheless, for FT218, we currently rely on one supplier for sourcing active pharmaceutical ingredients (&#8220;APIs&#8221;).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The API in FT218, sodium oxybate, is a Schedule I controlled substance in the U.S., and FT218, if approved by the FDA, will be a Schedule III controlled substance in the U.S. As a result, FT218 is subject to regulation by the U.S. Drug Enforcement Administration (&#8220;DEA&#8221;) under the Controlled Substances Act (&#8220;CSA&#8221;), and its manufacturing and distribution are highly restricted. Quotas from the DEA are required in order to manufacture and package sodium oxybate and FT218 in the U.S. Similar rules, restrictions and controls apply to FT218 in relevant jurisdictions outside of the U.S.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The API for FT218 is currently manufactured by a single source contract manufacturing organization (&#8220;CMO&#8221;) in the U.S. The drug product for commercial lots is manufactured outside of the U.S. by a single source CMO. We will continue to outsource the production of FT218 to current good manufacturing practices (&#8220;cGMP&#8221;) -compliant, DEA and FDA-audited CMOs pursuant to supply agreements and have no present plans to acquire manufacturing facilities. We are establishing, and may continue to establish, additional CMOs for the manufacture FT218, including drug product manufacturing in the U.S.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government authorities in the U.S. at the federal, state, and local level and in other countries extensively regulate, among other things, the research and clinical development, testing, manufacture, quality control, approval, labeling, packaging, storage, record-keeping, promotion, advertising, distribution, post-approval monitoring and reporting, marketing, pricing, and export and import of drug products, such as those we are developing. Generally, before a new drug can be marketed, considerable data demonstrating its quality, safety, and efficacy must be obtained, organized into a format specific to each regulatory authority, submitted for review, and approved by the regulatory authority.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Drugs are also subject to other federal, state, and local statutes and regulations. The process of obtaining regulatory approvals and the subsequent compliance with appropriate federal, state, local, and foreign statutes and regulations require the expenditure of substantial time and financial resources. Failure to comply with the applicable regulatory requirements at any time during the product development process, approval process, or after approval, may subject an applicant to administrative or judicial </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-10-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sanctions. These sanctions could include, among other actions, the regulatory authority's refusal to approve pending applications, withdrawal of an approval, clinical holds, untitled or warning letters, voluntary product recalls or withdrawals from the market, product seizures, total or partial suspension of production or distribution, injunctions, debarment, fines, refusals of government contracts, restitution, disgorgement, or civil or criminal penalties. Any agency or judicial enforcement action could have a material adverse effect on us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Drug Development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., the FDA regulates drugs under the Federal Food, Drug, and Cosmetic Act (&#8220;FDCA&#8221;) and its implementing regulations. Drugs are also subject to other federal, state, and local statutes and regulations. Our drug candidates must be approved by the FDA through the NDA process before they may be legally marketed in the U.S. The process required by the FDA before a drug may be marketed in the U.S. generally involves the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">completion of extensive preclinical, sometimes referred to as nonclinical, laboratory tests, animal studies, and formulation studies all performed in accordance with applicable regulations, including the FDA's good laboratory practice (&#8220;GLP&#8221;) regulations;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">submission to the FDA of an Investigational New Drug Application (&#8220;IND&#8221;), which must become effective before human clinical trials may begin and must be updated annually;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">performance of adequate and well-controlled human clinical trials in accordance with applicable IND and other clinical trial-related regulations, sometimes referred to as good clinical practices (&#8220;GCPs&#8221;) to establish the safety and efficacy of the proposed drug for its proposed indication;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">submission to the FDA of a NDA for a new drug;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a determination by the FDA within 60 days of its receipt of a NDA to file the NDA for review;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">satisfactory completion of an FDA pre-approval inspection of the manufacturing facility or facilities at which the active pharmaceutical ingredient (&#8220;API&#8221;) and finished drug product are produced to assess compliance with the FDA's current good manufacturing practice requirements (&#8220;cGMPs&#8221;);</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential FDA audit of the clinical trial sites that generated the data in support of the NDA;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">payment of user fees for FDA review of the NDA; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FDA review and approval of the NDA prior to any commercial marketing or sale of the drug in the U.S.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The data required to support a NDA are generated in two distinct development stages: preclinical and clinical. The preclinical development stage generally involves synthesizing the active component, developing the formulation, and determining the manufacturing process, as well as carrying out non-human toxicology, pharmacology, and drug metabolism studies in the laboratory, which support subsequent clinical testing. The conduct of the preclinical tests must comply with federal regulations, including GLPs. The sponsor must submit the results of the preclinical tests, together with manufacturing information, analytical data, any available clinical data or literature, and a proposed clinical protocol, to the FDA as part of the IND. An IND is a request for authorization from the FDA to administer an investigational drug product to humans. The central focus of an IND submission is on patient safety and the general investigational plan and the protocol(s) for human trials. The IND automatically becomes effective 30 days after receipt by the FDA, unless the FDA raises concerns or questions regarding the proposed clinical trials and places the IND on clinical hold within that 30-day time period. In such a case, the IND sponsor and the FDA must resolve any outstanding concerns or questions before the clinical trial can begin. The FDA also may impose a partial clinical hold that would limit a trial, for example, to certain doses or for a certain length of time or to a certain number of subjects. The FDA may also impose clinical holds on a drug candidate at any time before or during clinical trials due to safety concerns or non-compliance. Accordingly, we cannot be sure that submission of an IND will result in the FDA allowing clinical trials to begin, or that, once begun, issues will not arise that could cause the trial to be suspended or terminated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The clinical-stage of development involves the administration of the drug candidate to human subjects under the supervision of qualified investigators, generally physicians not employed by or under the trial sponsor's control, in accordance with GCPs, which include the requirement that all research subjects provide their informed consent for their participation in any clinical trial. Clinical trials are conducted under protocols detailing, among other things, the objectives of the clinical trial, dosing procedures, subject selection, and exclusion criteria, and the parameters to be used to monitor subject safety and assess efficacy. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-11-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each protocol, and any subsequent amendments to the protocol, must be submitted to the FDA as part of the IND. Further, each clinical trial must be reviewed and approved by an independent institutional review board (&#8220;IRB&#8221;) at or servicing each institution at which the clinical trial will be conducted. An IRB is charged with protecting the welfare and rights of trial participants and considers such items as whether the risks to individuals participating in the clinical trials are minimized and are reasonable in relation to anticipated benefits. The IRB also approves the informed consent form that must be provided to each clinical trial subject or his or her legal representative and must monitor the clinical trial until completed. There are also requirements governing the reporting of ongoing clinical trials and completed clinical trial results to public registries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trials are generally conducted in three sequential phases that may overlap or be combined, known as Phase 1, Phase 2, and Phase 3 trials. Phase 1 trials generally involve a small number of healthy volunteers who are initially exposed to a single dose and then multiple doses of the drug candidate. The primary purpose of these clinical trials is to assess the metabolism, pharmacologic action, side effects, tolerability, and safety of the drug. Phase 2 clinical trials typically involve studies in disease-affected patients to determine the dose required to produce the desired benefits. At the same time, safety and further pharmacokinetics (&#8220;PK&#8221;) and pharmacodynamics (&#8220;PD&#8221;) information is collected, as well as identification of possible adverse effects and safety risks and preliminary evaluation of efficacy. Phase 3 trials generally involve large numbers of patients at multiple sites (from several hundred to several thousand subjects) and are designed to provide the data necessary to demonstrate the efficacy of the drug for its intended use, its safety in use, and to establish the overall benefit/risk relationship of the drug and provide an adequate basis for physician labeling. The duration of treatment is often extended to mimic the actual use of a drug during marketing. Generally, two adequate and well-controlled Phase 3 trials are required by the FDA for approval of a NDA. Post-approval trials, sometimes referred to as Phase 4 clinical trials, may be conducted after initial marketing approval. These trials are used to gain additional experience from the treatment of patients in the intended therapeutic indication. In certain instances, the FDA may mandate the performance of Phase 4 clinical trials.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Progress reports detailing the results of the clinical trials must be submitted at least annually to the FDA and written IND safety reports must be submitted to the FDA and the investigators for serious and unexpected adverse reactions, any finding from other clinical studies, tests in laboratory animals, or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> testing that suggests a significant risk for human subjects, or any clinically important increase in the rate of a serious suspected adverse reaction over that listed in the protocol or investigator brochure. The sponsor must submit an IND safety report within 15 calendar days after the sponsor determines that the information qualifies for reporting. The sponsor also must notify the FDA of any unexpected fatal or life-threatening suspected adverse reaction within seven calendar days after the sponsor's initial receipt of the information. Phase 1, Phase 2, and Phase 3 trials may not be completed successfully within any specified period, if at all.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There also are requirements governing the reporting of ongoing clinical trials and completed clinical trial results to public registries. Information about certain clinical trials, including clinical trial results, must be submitted within specific timeframes for publication on the www.clinicaltrials.gov website.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA, the IRB, or the clinical trial sponsor may suspend or terminate a clinical trial at any time on various grounds, including a finding that the research subjects or patients are being exposed to an unacceptable health risk. Similarly, an IRB can suspend or terminate approval of a clinical trial at its institution if the clinical trial is not being conducted in accordance with the IRB's requirements or if the drug has been associated with unexpected serious harm to patients. Additionally, some clinical trials are overseen by an independent group of qualified experts organized by the clinical trial sponsor, known as a data safety monitoring board or committee. This group provides authorization for whether or not a trial may move forward at designated check points based on access to certain data from the trial. We may also suspend or terminate a clinical trial based on evolving business objectives and/or competitive climate. Concurrent with clinical trials, companies usually complete additional animal studies and must also develop additional information about the chemistry and physical characteristics of the drug as well as finalize a process for manufacturing the drug in commercial quantities in accordance with cGMP requirements. The manufacturing process must be capable of consistently producing quality batches of the drug candidate and, among other things, cGMPs impose extensive procedural, substantive, and recordkeeping requirements to ensure and preserve the long-term stability and quality of the final drug product. Additionally, appropriate packaging must be selected and tested, and stability studies must be conducted to demonstrate that the drug candidate does not undergo unacceptable deterioration over its shelf life.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">NDA and the FDA Review Process</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following trial completion, trial data are analyzed to assess safety and efficacy. The results of preclinical studies and clinical trials are then submitted to the FDA as part of a NDA, along with proposed labeling for the drug and information about the manufacturing process and facilities that will be used to ensure drug quality, results of analytical testing conducted on the chemistry of the drug, and other relevant information. The NDA is a request for approval to market the drug and must contain adequate evidence of safety and efficacy, which is demonstrated by extensive preclinical and clinical testing. Data may come from company-sponsored clinical trials intended to test the safety and efficacy of a use of a drug, or from a number of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-12-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">alternative sources, including studies initiated by investigators. To support marketing approval, the data submitted must be sufficient in quality and quantity to establish the safety and efficacy of the investigational drug product for a particular indication or indications to the satisfaction of the FDA. FDA approval of a NDA must be obtained before a drug may be offered for sale in the U.S.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the PDUFA, as amended, each NDA must be accompanied by a user fee. The FDA adjusts the PDUFA user fees on an annual basis. PDUFA also imposes an annual prescription drug product program fee for human drugs. Fee waivers or reductions are available in certain circumstances, including a waiver of the application fee for the first application filed by a small business. Additionally, no user fees are assessed on NDAs for products designated as orphan drugs, unless the product also includes a non-orphan indication.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within 60 days following submission of an original NDA, the FDA reviews the application to determine if it is substantially complete before the agency accepts it for filing. The FDA may refuse to file any NDA that it deems incomplete or not properly reviewable at the time of submission, including for failure to pay required fees, and may request additional information. In this event, the application must be resubmitted with the additional information. The resubmitted application also is subject to review before the FDA accepts it for filing. The FDA typically makes a decision on whether to accept a NDA for filing within 60 days of receipt. Once the submission is accepted for filing, the FDA begins an in-depth, substantive review of the NDA. Under the performance goals established under the PDUFA, the FDA has agreed to review 90% of standard NDAs for new molecular entities (&#8220;NMEs&#8221;) in ten months from the filing date and 90% of priority NME NDAs in six months from the filing date. The goals for reviewing standard and priority non-NME NDAs are ten months and six months, respectively, measured from the receipt date of the application. The FDA does not always meet its PDUFA goal dates for standard and priority NDAs, and the review process is often significantly extended by FDA requests for additional information or clarification.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the NDA submission is accepted for filing, the FDA reviews the NDA to determine, among other things, whether the proposed drug is safe and effective for its intended use, and whether the drug is being manufactured in accordance with cGMP to assure and preserve the drug's identity, strength, quality, and purity. The FDA may refer applications for novel drugs or drug candidates that present difficult questions of safety or efficacy to an advisory committee, typically a panel that includes clinicians and other experts, for review, evaluation, and a recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions. In the course of its review, the FDA may re-analyze the clinical trial data, which could result in extensive discussions between the FDA and the applicant during the review process. The review and evaluation of a NDA by the FDA is extensive and time consuming and may take longer than originally planned to complete, and we may not receive a timely approval, if at all.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before approving a NDA, the FDA typically conducts a pre-approval inspection of the manufacturing facilities for the new drug to determine whether they comply with cGMPs. The FDA will not approve the drug unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the drug within required specifications. In addition, before approving a NDA, the FDA may also audit data from clinical trials to ensure compliance with GCP requirements. After the FDA evaluates the application, manufacturing process, and manufacturing facilities where the drug product and/or its API will be produced, it may issue an approval letter or a Complete Response Letter. An approval letter authorizes commercial marketing of the drug with specific prescribing information for specific indications. A Complete Response Letter indicates that the review cycle of the application is complete and the application is not ready for approval. A Complete Response Letter usually describes all of the specific deficiencies in the NDA identified by the FDA. The Complete Response Letter may require additional clinical data and/or an additional pivotal clinical trial(s), and/or other significant, expensive and time-consuming requirements related to clinical trials, preclinical studies, or manufacturing. If a Complete Response Letter is issued, the applicant may either resubmit the NDA, addressing all of the deficiencies identified in the letter, challenge the determination set forth in the letter by requesting a hearing, or withdraw the application. Even if such data and information are submitted, the FDA may ultimately decide that the NDA does not satisfy the criteria for approval. Data obtained from clinical trials are not always conclusive and the FDA may interpret data differently than we interpret the same data.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no assurance that the FDA will ultimately approve a drug product for marketing in the U.S. If a drug receives marketing approval, the approval may be significantly limited to specific diseases, dosages, or patient subgroups, or the indications for use may otherwise be limited, which could restrict the commercial value of the drug. Further, the FDA may require that certain contraindications, warnings, precautions, or adverse events be included in the drug labeling or may condition the approval of the NDA on other changes to the proposed labeling, development of adequate controls and specifications, or a commitment to conduct post-marketing testing or clinical trials, and surveillance to monitor the effects of approved drugs. For example, the FDA may require Phase 4 testing which involves clinical trials designed to further assess a drug's safety and may require testing and surveillance programs to monitor the safety of approved drugs that have been </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-13-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">commercialized. The FDA may also place other conditions on approvals including the requirement for a Risk Evaluation and Mitigation Strategy (&#8220;REMS&#8221;) to assure the safe use of the drug. If the FDA concludes a REMS is needed, the sponsor of the NDA must submit a proposed REMS. The FDA will not approve the NDA without an approved REMS, if required. A REMS could include medication guides, physician communication plans, or elements to assure safe use, such as restricted distribution methods, patient registries, and other risk minimization tools. Any of these limitations on approval or marketing could restrict the commercial promotion, distribution, prescription, or dispensing of drugs. Drug approvals may be withdrawn for non-compliance with regulatory standards or if problems occur following initial marketing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pediatric Information and Exclusivity</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Pediatric Research Equity Act (&#8220;PREA&#8221;), as amended, a NDA or supplement to a NDA for a drug that includes a new active ingredient, new indication, new dosage form, new dosing regimen, or new route of administration must contain data to assess the safety and efficacy of the drug for the claimed indications in all relevant pediatric subpopulations and to support dosing and administration for each pediatric subpopulation for which the drug is safe and effective. The FDA may grant deferrals for submission of data or full or partial waivers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A sponsor who is planning to submit a marketing application for a drug subject to PREA must submit an initial Pediatric Study Plan (&#8220;PSP&#8221;) within 60 days of an end-of-Phase 2 meeting or as may be agreed between the sponsor and the FDA. The initial PSP must include an outline of the pediatric study or studies that the sponsor plans to conduct, including study objectives and design, age groups, relevant endpoints, and statistical approach, or a justification for not including such detailed information, and any request for a deferral of pediatric assessments or a full or partial waiver of the requirement to provide data from pediatric studies along with supporting information. The FDA and the sponsor must reach agreement on the PSP. A sponsor can submit amendments to an agreed-upon initial PSP at any time if changes to the pediatric plan need to be considered based on data collected from preclinical studies, early phase clinical trials, and/or other clinical development programs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A drug product can also obtain pediatric exclusivity in the U.S. is another type of regulatory market exclusivity in the U.S. Pediatric exclusivity, if granted, adds six months to existing exclusivity periods and patent terms. This six-month exclusivity, which runs from the end of other exclusivity protection or patent term, may be granted based on the voluntary completion of a pediatric trial in accordance with a FDA-issued "Written Request" for such a trial.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Orphan Drug Designation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA may grant orphan drug designation to drugs intended to treat a rare disease or condition that affects fewer than 200,000 individuals in the U.S., or if it affects 200,000 or more individuals in the U.S., there is no reasonable expectation that the cost of developing and marketing the drug for this type of disease or condition will be recovered from sales in the U.S. Orphan drug designation entitles a party to potential financial incentives such as opportunities for grant funding towards clinical trial costs, tax advantages, and user-fee waivers. In addition, if a product receives the first FDA approval for the indication for which it has orphan designation, the product is entitled to orphan drug exclusivity, which means the FDA may not approve any other application to market the same drug for the same indication for a period of seven years, except in limited circumstances, such as a showing of clinical superiority over the product with orphan exclusivity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Orphan drug exclusivity may be lost if the FDA determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantity of the drug to meet the needs of patients with the rare disease or condition. Orphan drug designation must be requested before submitting an application for marketing approval. Orphan drug designation does not convey any advantage in, or shorten the duration of, the regulatory review and approval process.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">505(b)(2) New Drug Applications</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an alternative path to FDA approval for modifications to formulations or uses of products previously approved by the FDA pursuant to an NDA, an applicant may submit an NDA under Section 505(b)(2) of the FDCA. Section 505(b)(2) was enacted as part of the Hatch-Waxman Amendments and permits the filing of an NDA where at least some of the information required for approval comes from studies not conducted by, or for, the applicant, and for which the applicant has not obtained a right of reference. In addition, if the 505(b)(2) applicant can establish that reliance on the FDA&#8217;s previous findings of safety and effectiveness is scientifically and legally appropriate, it may eliminate the need to conduct certain preclinical studies or clinical trials of the new product. The FDA may also require companies to perform additional bridging studies or measurements, including clinical trials, to support the change from the previously approved reference drug. The FDA may then approve the new drug candidate for all, or some, of the label indications for which the reference drug has been approved, as well as for any new indication sought by the 505(b)(2) applicant. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-14-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Post-Marketing Requirements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following approval of a new drug, a pharmaceutical company and the approved drug are subject to continuing regulation by the FDA, including, among other things, establishment registration and drug listing, monitoring and recordkeeping activities, reporting to the applicable regulatory authorities of adverse experiences with the drug, providing the regulatory authorities with updated safety and efficacy information, drug sampling and distribution requirements, and complying with promotion and advertising requirements, which include, among others, standards for direct-to-consumer advertising, restrictions on promoting drugs for uses or in patient populations that are not described in the drug's approved labeling (known as off-label promotion), limitations on industry-sponsored scientific and educational activities, and requirements for promotional activities involving the internet. Although physicians may prescribe legally available drugs for off-label uses, the FDA takes the position that manufacturers may not market or promote such off-label uses. Modifications or enhancements to the drug or its labeling or changes of the site or process of manufacture are often subject to the approval of the FDA and other regulators, which may or may not be received or may result in a lengthy review process.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prescription drug advertising is subject to federal, state, and foreign regulations. In the U.S., the FDA regulates prescription drug promotion, including direct-to-consumer advertising. Prescription drug promotional materials must be submitted to the FDA in conjunction with their first use. Any distribution of prescription drugs and pharmaceutical samples must comply with the U.S. Prescription Drug Marketing Act, a part of the FDCA. The Drug Supply Chain Security Act (&#8220;DSCSA&#8221;) was enacted in 2013 with the aim of building an electronic system to identify and trace certain prescription drugs distributed in the U.S. The DSCSA mandates phased-in and resource-intensive obligations for pharmaceutical manufacturers, wholesale distributors, and dispensers over a 10-year period that is expected to culminate in November 2023. The law&#8217;s requirements include the quarantine and prompt investigation of a suspect product to determine if it is illegitimate, and notifying trading partners and the FDA of any illegitimate product. Drug manufacturers and other parties involved in the supply chain for prescription drug products must also comply with product tracking and tracking requirements, such as placing a unique product identifier on prescription drug packages. This identifier consists of the National Drug Code, serial number, lot number, and expiration date, in the form of a 2-dimensional data matrix barcode that can be read by humans and machines.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., once a drug is approved, its manufacture is subject to comprehensive and continuing regulation by the FDA. FDA regulations require that drugs be manufactured in specific facilities per the NDA approval and in accordance with cGMP. We rely, and expect to continue to rely, on third parties for the production of clinical and commercial quantities of our approved drug and drug candidates in accordance with cGMP regulations. cGMP regulations require among other things, quality control and quality assurance as well as the corresponding maintenance of records and documentation and the obligation to investigate and correct any deviations from cGMP. Drug manufacturers and other entities involved in the manufacture and distribution of approved drugs are required to register their establishments with the FDA and certain state agencies and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with cGMP and other laws. Accordingly, manufacturers must continue to expend time, money, and effort in the area of production and quality control to maintain cGMP compliance. These regulations also impose certain organizational, procedural, and documentation requirements with respect to manufacturing and quality assurance activities. NDA holders using contract manufacturers, laboratories, or packagers are responsible for the selection and monitoring of qualified firms, and, in certain circumstances, qualified suppliers to these firms. These firms and, where applicable, their suppliers are subject to inspections by the FDA at any time, and the discovery of violative conditions, including failure to conform to cGMP, could result in enforcement actions that interrupt the operation of any such facilities or the ability to distribute drugs manufactured, processed, or tested by them. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA also may require post-approval testing, sometimes referred to as Phase 4 testing, risk minimization action plans, and post-marketing surveillance to monitor the effects of an approved drug or place conditions on an approval that could restrict the distribution or use of the drug. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA may issue enforcement letters or withdraw the approval of the product if compliance with regulatory requirements and standards is not maintained or if problems occur after the drug or biologic reaches the market. Corrective action could delay drug or biologic distribution and require significant time and financial expenditures. Later discovery of previously unknown problems with a drug or biologic, including AEs of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may require revisions to the approved labeling to add new safety information, including the addition of new warning and contraindications; imposition of post-market studies or clinical trials to assess new safety risks; or imposition of distribution or other restrictions under a REMS program. Other potential consequences include, among other things:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">mandated corrective advertising or communications with doctors;</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-15-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictions on the marketing or manufacturing of the drug or biologic, suspension of the approval, complete withdrawal of the drug from the market or product recalls;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fines, warning letters or holds on post-approval clinical trials;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refusal of the FDA to approve applications or supplements to approved applications, or suspension or revocation of drug or biologic approvals;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">drug or biologic seizure or detention, or refusal to permit the import or export of drugs; or</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">injunctions or the imposition of civil or criminal penalties.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Marketing Exclusivity</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing exclusivity provisions under the FDCA can delay the submission or the approval of certain marketing applications for competing products. The FDCA provides a five-year period of non-patent marketing exclusivity within the U.S. to the first applicant to obtain approval of a NDA for a new chemical entity. A drug is a new chemical entity if the FDA has not previously approved any other new drug containing the same active moiety, which is the molecule or ion responsible for the action of the drug substance. During the exclusivity period, the FDA may not accept for review an abbreviated new drug application (&#8220;ANDA&#8221;) or a 505(b)(2) NDA submitted by another company for another drug based on the same active moiety, regardless of whether the drug is intended for the same indication as the original innovator drug or for another indication. However, an application may be submitted after four years if it contains a certification of patent invalidity or non-infringement to one of the patents listed with the FDA by the innovator NDA holder. The FDCA also provides three years of marketing exclusivity for a NDA, or supplement to an existing NDA, if new clinical investigations, other than bioavailability studies, that were conducted or sponsored by the applicant are deemed by the FDA to be essential to the approval of the application, for example new indications, dosages, or strengths of an existing drug. This three-year exclusivity covers only the modification for which the drug received approval on the basis of the new clinical investigations and does not prohibit the FDA from approving ANDAs or 505(b)(2) applications for drugs containing the active agent for the original indication or condition of use. Five-year and three-year exclusivity will not delay the submission or approval of a full NDA. However, an applicant submitting a full NDA would be required to conduct or obtain a right of reference to all of the preclinical studies and adequate and well-controlled clinical trials necessary to demonstrate safety and effectiveness. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Regulatory Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturing, sales, promotion, and other activities following drug approval are also subject to regulation by numerous regulatory authorities in addition to the FDA, including, in the U.S., the Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;), other divisions of the U.S. Department of Health and Human Services (&#8220;HHS&#8221;), the Drug Enforcement Administration for controlled substances, the Consumer Product Safety Commission, the Federal Trade Commission, the Occupational Safety &amp; Health Administration, the Environmental Protection Agency, and state and local governments. In the U.S., sales, marketing, and scientific/educational programs must also comply with state and federal fraud and abuse laws. Pricing and rebate programs must comply with the Medicaid rebate requirements of the U.S. Omnibus Budget Reconciliation Act of 1990 and more recent requirements in the Patient Protection and Affordable Care Act as amended by the Health Care and Education Reconciliation Act of 2010 (or collectively, the ACA). If drugs are made available to authorized users of the Federal Supply Schedule of the General Services Administration, additional laws and requirements apply. The handling of any controlled substances must comply with the U.S. Controlled Substances Act and Controlled Substances Import and Export Act. Drugs must meet applicable child-resistant packaging requirements under the U.S. Poison Prevention Packaging Act. Manufacturing, sales, promotion, and other activities are also potentially subject to federal and state consumer protection and unfair competition laws.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to numerous foreign, federal, state, and local environmental, health, and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment, and disposal of hazardous materials and wastes. In addition, our leasing and operation of real property may subject us to liability pursuant to certain U.S. environmental laws and regulations, under which current or previous owners or operators of real property and entities that disposed or arranged for the disposal of hazardous substances may be held strictly, jointly, and severally liable for the cost of investigating or remediating contamination caused by hazardous substance releases, even if they did not know of and were not responsible for the releases.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The distribution of pharmaceutical drugs is subject to additional requirements and regulations, including extensive record-keeping, licensing, storage, and security requirements intended to prevent the unauthorized sale of pharmaceutical drugs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-16-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The failure to comply with regulatory requirements subjects firms to possible legal or regulatory action. Depending on the circumstances, failure to meet applicable regulatory requirements can result in criminal prosecution, fines, or other penalties, injunctions, voluntary recall or seizure of drugs, total or partial suspension of production, denial or withdrawal of product approvals, or refusal to allow a firm to enter into supply contracts, including government contracts. In addition, even if a firm complies with FDA and other requirements, new information regarding the safety or efficacy of a product could lead the FDA to modify or withdraw product approval. Prohibitions or restrictions on sales or withdrawal of our approved drug or any future products marketed by us could materially affect our business in an adverse way.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in regulations, statutes, or the interpretation of existing regulations could impact our business in the future by requiring, for example: (i) changes to our manufacturing arrangements; (ii) additions or modifications to product labeling; (iii) the recall or discontinuation of our product; or (iv) additional record-keeping requirements. If any such changes were to be imposed, they could adversely affect the operation of our business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Regulation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Controlled Substances Regulations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Narcotics and other APIs, such as sodium oxybate, are &#8220;controlled substances&#8221; under the U.S. federal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Controlled Substances Act (&#8220;CSA&#8221;). The CSA Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970, regulates the manufacture and distribution of narcotics and other controlled substances, including stimulants, depressants and hallucinogens in the U.S. The CSA is administered by the Drug Enforcement Administration (&#8220;DEA&#8221;), a division of the U.S. Department of Justice, and is intended to prevent the abuse or diversion of controlled substances into illicit channels of commerce. The DEA classifies controlled substances into five schedules. Schedule I substances by definition have a high potential for abuse, have no currently &#8220;accepted medical use&#8221; in the U.S., lack accepted safety for use under medical supervision, and may not be prescribed, marketed or sold in the U.S. Pharmaceutical products approved for use in the U.S. may be listed as Schedule II, III, IV or V, with Schedule II substances considered to present the highest potential for abuse or dependence and Schedule V substances the lowest relative risk of abuse. The API in FT218, sodium oxybate, is a Schedule I controlled substance in the U.S., and FT218, if approved by the FDA, will be a Schedule III controlled substance in the U.S</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For drugs manufactured in the U.S., the DEA establishes annually an aggregate quota for the amount of substances within Schedules I and II that may be manufactured or produced in the U.S. based on the DEA&#8217;s estimate of the quantity needed to meet legitimate medical, scientific, research and industrial needs. The quotas apply equally to the manufacturing of the active pharmaceutical ingredient and production of dosage forms. The DEA may adjust aggregate production quotas a few times per year, and individual manufacturing or procurement quotas from time to time during the year, although the DEA has substantial discretion in whether or not to make such adjustments for individual companies.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The DEA limits the quantity of certain Schedule I controlled substances that may be manufactured and procured in the U.S. in any given calendar year through a quota system and, as a result, quotas from the DEA are required in order to manufacture sodium oxybate and FT218 in the U.S. Accordingly, we require DEA quotas for sodium oxybate and FT218, until approved, if ever, by the FDA.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If approved by the FDA, FT218 will be a Schedule III controlled substance and subject to DEA import volume limits and state regulations relating to manufacturing, storage, distribution and physician prescription procedures, including limitations on prescription refills. In addition, the third parties who perform our clinical and commercial manufacturing, distribution, dispensing and clinical studies for FT218 are required to maintain necessary DEA registrations and state licenses. The DEA periodically inspects facilities for compliance with its rules and regulations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Any person or firm that manufactures, distributes, dispenses, imports, or exports any controlled substance (or proposes to do so) must register with the DEA. The applicant must register for a specific business activity related to controlled substances, including manufacturing or distributing, and may engage in only the activity or activities for which it is registered. The DEA conducts periodic inspections of registered establishments that handle controlled substances. Failure to comply with relevant DEA regulations, particularly as manifested in the loss or diversion of controlled substances, can result in regulatory action including civil penalties, refusal to renew necessary registrations, or proceedings to revoke those registrations. In certain circumstances, violations can lead to criminal prosecution. In addition to these federal statutory and regulatory obligations, there may be state and local laws and regulations relevant to the handling of controlled substances or listed chemicals. Governments outside of the U.S. have similar controlled substance laws, regulations and requirements in their respective jurisdictions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-17-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Healthcare Laws</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare providers and third-party payors in the United States and elsewhere play a primary role in the recommendation and prescription of pharmaceutical products. Arrangements with third-party payors and customers can expose pharmaceutical manufactures to broadly applicable fraud and abuse and other healthcare laws and regulations, including, without limitation, the federal Anti-Kickback Statute and the federal False Claims Act (&#8220;FCA&#8221;), which may constrain the business or financial arrangements and relationships through which companies research, sell, market and distribute pharmaceutical products. In addition, transparency laws and patient privacy laws can apply to the activities of pharmaceutical manufactures. The applicable federal, state and foreign healthcare laws and regulations that can affect a pharmaceutical company&#8217;s operations include without limitation:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The federal Anti-Kickback Statute, which prohibits, among other things, knowingly and willfully soliciting, receiving, offering or paying any remuneration (including any kickback, bribe, or rebate), directly or indirectly, overtly or covertly, in cash or in kind, to induce, or in return for, either the referral of an individual, or the purchase, lease, order or recommendation of any good, facility, item or service for which payment may be made, in whole or in part, under the Medicare and Medicaid programs, or other federal healthcare programs. A person or entity can be found guilty of violating the statute without actual knowledge of the statute or specific intent to violate it. In addition, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the FCA. The Anti-Kickback Statute has been interpreted to apply to arrangements between pharmaceutical manufacturers on the one hand and prescribers, purchasers, and formulary managers on the other. There are a number of statutory exceptions and regulatory safe harbors protecting some common activities from prosecution, but such exceptions and safe harbors are drawn narrowly and require strict compliance in order to offer protection;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The federal civil and criminal false claims laws, including the FCA, and civil monetary penalty laws, which prohibit any person or entity from, among other things, knowingly presenting, or causing to be presented, a false, fictitious or fraudulent claim for payment to, or approval by, the federal government or knowingly making, using or causing to be made or used a false record or statement, including providing inaccurate billing or coding information to customers or promoting a product off-label, material to a false or fraudulent claim to the federal government. As a result of a modification made by the Fraud Enforcement and Recovery Act of 2009, a claim includes &#8220;any request or demand&#8221; for money or property presented to the federal government. In addition, manufacturers can be held liable under the FCA even when they do not submit claims directly to government payors if they are deemed to &#8220;cause&#8221; the submission of false or fraudulent claims. The FCA also permits a private individual acting as a &#8220;whistleblower&#8221; to bring actions on behalf of the federal government alleging violations of the FCA and to share in any monetary recovery;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The federal Health Insurance Portability and Accountability Act of 1996 (HIPAA), which created federal criminal statutes that prohibit, among other things, knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program or obtain, by means of false or fraudulent pretenses, representations, or promises, any of the money or property owned by, or under the custody or control of, any healthcare benefit program, regardless of the payor (e.g., public or private) and knowingly and willfully falsifying, concealing or covering up by any trick or device a material fact or making any materially false statements in connection with the delivery of, or payment for, healthcare benefits, items or services relating to healthcare matters. Similar to the federal Anti-Kickback Statute, a person or entity can be found guilty of violating HIPAA without actual knowledge of the statute or specific intent to violate it;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009 (HITECH), and their respective implementing regulations, which impose, among other things, specified requirements relating to the privacy, security and transmission of individually identifiable health information held by covered entities and their business associates as well as their covered subcontractors. HITECH also created new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorneys&#8217; fees and costs associated with pursuing federal civil actions;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The federal legislation commonly referred to as the Physician Payments Sunshine Act, created under the ACA, and its implementing regulations, which requires certain manufacturers of drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program (with certain exceptions) to report annually to CMS, information related to payments or other transfers of value made to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members. Effective January 1, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-18-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022, covered manufacturers also are required to report information regarding their payments and other transfers of value to physician assistants, and nurse practitioners, clinical nurse specialists, anesthesiologist assistants, certified registered nurse anesthetists and certified nurse midwives during the previous year;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Federal government price reporting laws, which require us to calculate and report complex pricing metrics in an accurate and timely manner to government programs;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Federal consumer protection and unfair competition laws, which broadly regulate marketplace activities and activities that potentially harm consumers; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Analogous state laws and regulations, including: state anti-kickback and false claims laws, which may apply to our business practices, including, but not limited to, research, distribution, sales and marketing arrangements and claims involving healthcare items or services reimbursed by any third-party payor, including private insurers; state laws that require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the U.S. federal government, or otherwise restrict payments that may be made to healthcare providers and other potential referral sources; state and local laws that require drug manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures; state laws that require the reporting of information related to drug pricing; state and local laws requiring the registration of pharmaceutical sales representatives; and state laws governing the privacy and security of health information in some circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The distribution of pharmaceutical products is subject to additional requirements and regulations, including extensive record-keeping, licensing, storage and security requirements intended to prevent the unauthorized sale of pharmaceutical products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Coverage and Reimbursement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of any product depend, in part, on the extent to which such product will be covered by third-party payors, such as federal, state, and foreign government healthcare programs, commercial insurance and managed healthcare organizations, and the level of reimbursement for such product by third-party payors. Decisions regarding the extent of coverage and amount of reimbursement to be provided are made on a plan-by-plan basis. These third-party payors are increasingly reducing coverage and reimbursement for medical products, drugs and services. For products administered under the supervision of a physician, obtaining coverage and adequate reimbursement may be particularly difficult because of the higher prices often associated with such drugs. Additionally, separate reimbursement for the product itself or the treatment or procedure in which the product is used may not be available, which may impact physician utilization.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to secure coverage and reimbursement for any product that might be approved for sale, a company may need to conduct expensive pharmacoeconomic studies in order to demonstrate the medical necessity and cost-effectiveness of the product, in addition to the costs required to obtain FDA or other comparable regulatory approvals. Additionally, companies may also need to provide discounts to purchasers, private health plans or government healthcare programs. Nonetheless, product candidates may not be considered medically necessary or cost effective. A decision by a third-party payor not to cover a product could reduce physician utilization once the product is approved and have a material adverse effect on sales, our operations and financial condition. Factors that payors consider in determining reimbursement are based on whether the product is (i) a covered benefit under its health plan; (ii) safe, effective, and medically necessary; (iii) appropriate for the specific patient; (iv) cost-effective; and (v) neither experimental nor investigational. Additionally, a third-party payor&#8217;s decision to provide coverage for a product does not imply that an adequate reimbursement rate will be approved. Further, one payor&#8217;s determination to provide coverage for a product does not assure that other payors will also provide coverage and reimbursement for the product and the level of coverage and reimbursement can differ significantly from payor to payor.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The containment of healthcare costs has become a priority of federal, state and foreign governments and the prices of products have been a focus in this effort. Governments have shown significant interest in implementing cost-containment programs, including price controls, restrictions on reimbursement and requirements for substitution of generic products. Adoption of price controls and cost-containment measures and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit a company&#8217;s revenue generated from the sale of any approved products. Coverage policies and third-party payor reimbursement rates may change at any time. Even if favorable coverage and reimbursement status is attained for one or more products for which a company or its collaborators receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future. Decreases in third-party reimbursement for any product or a </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-19-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">decision by a third-party payor not to cover a product could reduce physician usage and patient demand for the product and also have a material adverse effect on sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Healthcare Reform</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In both the United States and certain foreign jurisdictions, there have been, and continue to be, a number of legislative and regulatory changes to the health care system. Among policy makers and payors in the United States and elsewhere, there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality and/or expanding access. In the United States, the pharmaceutical industry has been a particular focus of these efforts and has been significantly affected by major legislative initiatives. In particular, in 2010, the ACA was enacted, which, among other things, increased the minimum Medicaid rebates owed by most manufacturers under the Medicaid Drug Rebate Program, extended the Medicaid Drug Rebate Program to utilization of prescriptions of individuals enrolled in Medicaid managed care organizations, subjected manufacturers to new annual fees and taxes for certain branded prescription drugs, and provided incentives to programs that increase the federal government&#8217;s comparative effectiveness research.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since its enactment, there have been numerous judicial, administrative, executive, and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">legislative efforts to expand, repeal, replace or modify the ACA, some of which have been successful, in part, in modifying the law, as well as court challenges to the constitutionality of the law. On June 17, 2021, the U.S. Supreme Court dismissed the most recent judicial challenge to the ACA brought by several states without specifically ruling on the constitutionality of the ACA. Prior to the Supreme Court&#8217;s decision, President Biden issued an executive order to initiate a special enrollment period from February 15, 2021 through August 15, 2021 for purposes of obtaining health insurance coverage through the ACA marketplace. The executive order also instructed certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare, including among others, reexamining Medicaid demonstration projects and waiver programs that include work requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the ACA. It is unclear how other healthcare reform measures of the Biden administration or other efforts, if any, to challenge, repeal or replace the ACA will impact our business.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Biden administration, on October 13, 2017, former President Trump signed an Executive Order terminating the cost-sharing subsidies that reimburse insurers under the ACA. The former Trump administration concluded that cost-sharing reduction (&#8220; CSR&#8221;), payments to insurance companies required under the ACA have not received necessary appropriations from Congress and announced that it will discontinue these payments immediately until those appropriations are made. Several state attorneys general filed suit to stop the administration from terminating the subsidies, but their request for a restraining order was denied by a federal judge in California on October 25, 2017. On August 14, 2020, the U.S. Court of Appeals for the Federal Circuit ruled in two separate cases that the federal government is liable for the full amount of unpaid CSRs for the years preceding and including 2017. For CSR claims made by health insurance companies for years 2018 and later, further litigation will be required to determine the amounts due, if any. Further, on June 14, 2018, the U.S. Court of Appeals for the Federal Circuit ruled that the federal government was not required to pay more than $12 billion in ACA risk corridor payments to third-party payors who argued the payments were owed to them. On April 27, 2020, the United States Supreme Court reversed the U.S. Court of Appeals for the Federal Circuit's decision and remanded the case to the U.S. Court of Federal Claims, concluding the government has an obligation to pay these risk corridor payments under the relevant formula. It is unclear what impact these rulings will have on our business.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, other legislative and regulatory changes have been proposed and adopted in the United States since the ACA was enacted:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On August 2, 2011, the U.S. Budget Control Act of 2011, among other things, included aggregate reductions of Medicare payments to providers of 2% per fiscal year. These reductions went into effect on April 1, 2013 and, due to subsequent legislative amendments to the statute, will remain in effect through 2030, with the exception of a temporary suspension from May 1, 2020 through March 31, 2022 due to the COVID-19 pandemic. Following the temporary suspension, a 1% payment reduction will occur beginning April 1, 2022 through June 30, 2022, and the 2% payment reduction will resume on July 1, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On January 2, 2013, the U.S. American Taxpayer Relief Act of 2012 was signed into law, which, among other things, further reduced Medicare payments to several types of providers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On April 13, 2017, CMS published a final rule that gives states greater flexibility in setting benchmarks for insurers in the individual and small group marketplaces, which may have the effect of relaxing the essential health benefits required under the ACA for plans sold through such marketplaces.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-20-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On May 30, 2018, the Right to Try Act, was signed into law. The law, among other things, provides a federal framework for certain patients to access certain investigational new drug products that have completed a Phase 1 clinical trial and that are undergoing investigation for FDA approval. Under certain circumstances, eligible patients can seek treatment without enrolling in clinical trials and without obtaining FDA permission under the FDA expanded access program. There is no obligation for a pharmaceutical manufacturer to make its drug products available to eligible patients as a result of the Right to Try Act. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On&#8239;May 23, 2019, CMS published a final rule to allow Medicare Advantage Plans the option of using step therapy for Part B drugs beginning January 1, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On December 20, 2019, former President Trump signed into law the Further Consolidated Appropriations Act (H.R. 1865), which repealed the Cadillac tax, the health insurance provider tax, and the medical device excise tax.  It is impossible to determine whether similar taxes could be instated in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been heightened governmental scrutiny in the United States of pharmaceutical pricing practices in light of the rising cost of prescription drugs and biologics. At a federal level, President Biden signed an Executive Order on July 9, 2021 affirming the administration&#8217;s policy to (i) support legislative reforms that would lower the prices of prescription drug and biologics, including by allowing Medicare to negotiate drug prices, by imposing inflation caps, and, by supporting the development and market entry of lower-cost generic drugs and biosimilars; and (ii) support the enactment of a public health insurance option. Among other things, the Executive Order also directs HHS to provide a report on actions to combat excessive pricing of prescription drugs, enhance the domestic drug supply chain, reduce the price that the Federal government pays for drugs, and address price gouging in the industry; and directs the FDA to work with states and Indian Tribes that propose to develop section 804 Importation Programs in accordance with the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, and the FDA&#8217;s implementing regulations. FDA released such implementing regulations on September 24, 2020, which went into effect on November 30, 2020, providing guidance for states to build and submit importation plans for drugs from Canada. On September 25, 2020, CMS stated drugs imported by states under this rule will not be eligible for federal rebates under Section 1927 of the Social Security Act and manufacturers would not report these drugs for &#8220;best price&#8221; or Average Manufacturer Price purposes. Since these drugs are not considered covered outpatient drugs, CMS further stated it will not publish a National Average Drug Acquisition Cost for these drugs. If implemented, importation of drugs from Canada may materially and adversely affect the price we receive for any of our product candidates. Further, on November 20, 2020 CMS issued an Interim Final Rule implementing the Most Favored Nation (&#8220;MFN&#8221;) Model under which Medicare Part B reimbursement rates would have been be calculated for certain drugs and biologicals based on the lowest price drug manufacturers receive in Organization for Economic Cooperation and Development countries with a similar gross domestic product per capita.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, on December 29, 2021 CMS rescinded the Most Favored Nations rule. Additionally, on November 30, 2020, HHS published a regulation removing safe harbor protection for price reductions from pharmaceutical manufacturers to plan sponsors under Part D, either directly or through pharmacy benefit managers, unless the price reduction is required by law. The rule also creates a new safe harbor for price reductions reflected at the point-of-sale, as well as a safe harbor for certain fixed fee arrangements between pharmacy benefit managers and manufacturers. Pursuant to court order, the removal and addition of the aforementioned safe harbors were delayed and recent legislation imposed a moratorium on implementation of the rule until January 1, 2026. Although a number of these and other proposed measures may require authorization through additional legislation to become effective, and the Biden administration may reverse or otherwise change these measures, both the Biden administration and Congress have indicated that they will continue to seek new legislative measures to control drug costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been several changes to the 340B drug pricing program, which imposes ceilings on prices that drug manufacturers can charge for medications sold to certain health care facilities. On December 27, 2018, the District Court for the District of Columbia invalidated a reimbursement formula change under the 340B drug pricing program, and CMS subsequently altered the FYs 2019 and 2018 reimbursement formula on specified covered outpatient drugs (&#8220;SCODs&#8221;). The court ruled this change was not an &#8220;adjustment&#8221; which was within the secretary of HHS&#8217;s discretion to make but was instead a fundamental change in the reimbursement calculation. However, most recently, on July 31, 2020, the U.S. Court of Appeals for the District of Columbia Circuit overturned the district court&#8217;s decision and found that the changes were within the Secretary&#8217;s authority. On September 14, 2020, the plaintiffs-appellees filed a Petition for Rehearing En Banc (i.e., before the full court), but was denied on October 16, 2020. Plaintiffs-appellees filed a petition for a writ of certiorari at the Supreme Court on February 10, 2021. On Friday July 2, 2021, the Supreme Court granted the petition. It is unclear how these developments could affect covered hospitals who might purchase our future products and affect the rates we may charge such facilities for our approved products in the future, if any.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-21-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Individual states in the United States have also increasingly passed legislation and implemented regulations designed to control pharmaceutical product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital Resources </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At Avadel, the way we work is as important as the results we achieve. Our global organization fosters an entrepreneurial environment, where purpose, innovation, integrity, and collaboration come together to transform medicines to transform lives.  Our organization fosters our culture based on being relentless for patients, having confidence with humility, being courageous, taking insight to action and togetherness (the &#8220;Avadel Values&#8221;). In everything we do, we live the Avadel Values so we can be the best for our patients, our community, and each other. Success for us is defined through how we improve the lives of patients and how we achieve our objectives as one team.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to offering employees a rewarding and entrepreneurial work experience where patients are at the center of everything we do. Our people are our greatest competitive advantage, and our values serve as the foundation of our culture. We consider our relations with our employees to be good and are focused on maintaining a highly engaged and motivated workforce.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Demographics</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we had approximately 66 employees, all of which were full-time. None of our employees are subject to a union or other collective bargaining agreement. In addition to our employees, we contract with third parties in certain areas of the business such as clinical, regulatory, and manufacturing. We expect to continue to build and grow our organizational capabilities with a focus on talent attraction, development, engagement, and retention.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Diversity, Equity, and Inclusion</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Avadel is committed to fostering a diverse workforce and a culture of inclusion. Avadel pursues fair employment practices in every aspect of its business and is committed to a productive work environment for its employees. We strive to create a level of connectivity that goes beyond working together. Rooted in the trust we earn every day, our team is inclusive, valuing diverse perspectives and work every day to lift each other up in pursuit of improving the lives of the patients we serve.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation and Benefits </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At Avadel, we prioritize the well-being of our employees by offering a comprehensive benefits package. We know that benefits play an important role in helping to ensure the health and financial security of our employees. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commitment to our employees includes benefit and compensation programs that value the contributions our employees make. We strive to provide pay, benefits, and services that are competitive and create incentives to attract and retain employees. In addition to competitive pay, we offer bonus and share-based compensation packages for all levels of employees within the organization as well as a company match for employee retirement programs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health and Wellness</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our healthcare plans allow employees to choose what works best for them and their families. We offer competitive health, dental, vision and life insurance for all employees as well as competitive vacation packages along with time off for holidays and other forms of leave for all employees.  Further, we offer a variety of tools allowing employees to prioritize wellness, including retirement planning, employee stock purchase program, legal services, employee assistance programs, and more.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Career Growth and Development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are invested in the development of each of our employees. We provide opportunities to lead and participate in cross-functional teams, coaching, leadership development, and more. We provide reimbursement to our employees for seminars, conferences and educational and professional training. In alignment with our business strategy, it is our goal to empower all employees to take full advantage of their professional growth opportunities, to lead them to long-term job satisfaction and organizational success. Through professional development, our employees can broaden their skills for their current and future roles.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-22-</span></div></div></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.&#160;&#160;&#160;&#160;Risk Factors.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">An investment in Avadel involves a high degree of risk. You should carefully consider the risks described below, as well as the other information included or incorporated by reference in this Annual Report on Form 10-K, before making an investment decision. Avadel&#8217;s business, financial condition, results of operations and cash flows could be materially adversely affected by any of these risks. The market or trading price of Avadel&#8217;s securities could decline due to any of these risks. In addition, please read &#8220;Cautionary Disclosure Regarding Forward-Looking Statements&#8221; in this Annual Report on Form 10-K, where we describe additional uncertainties associated with Avadel&#8217;s business and with the forward-looking statements included or incorporated by reference in this Annual Report on Form 10-K. Please note that additional risks not presently known to us or that we currently deem immaterial may also impair Avadel&#8217;s business and operations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Lead Product Candidate, Future Product Candidates Clinical Development and Commercialization</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We cannot be certain that our lead product candidate or future product candidates will receive marketing approval. Without marketing approval, we will not be able to commercialize our lead product candidate or future product candidates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have devoted significant financial resources and business efforts to the development of our lead product candidate. We cannot be certain that our lead product candidate or future product candidates will receive marketing approval.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The development of a product candidate and issues relating to its approval and marketing are subject to extensive regulation by the FDA in the U.S. and by comparable regulatory authorities in other countries. We are not permitted to market our lead product candidate or future product candidates in the U.S. until we receive approval of a NDA by the FDA. The time required to obtain approval by the FDA and comparable foreign authorities is unpredictable but typically takes many years following the commencement of clinical trials and depends upon numerous factors, including the substantial discretion of regulatory authorities. In addition, approval policies, regulations, or the type and amount of clinical data necessary to gain approval may change during the course of a product candidate&#8217;s clinical development and may vary among jurisdictions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An NDA must include extensive preclinical and clinical data and supporting information to establish the product candidate&#8217;s safety and effectiveness for each desired indication. An NDA must also include significant information regarding the chemistry, manufacturing and controls for the product. Obtaining approval of an NDA is a lengthy, expensive and uncertain process, and we may not be successful in obtaining approval. For example, we submitted an NDA to the FDA for FT218 for the treatment of EDS or cataplexy in adults with narcolepsy to the FDA in December 2020 through the Section 505(b)(2) regulatory pathway. In February 2021, the FDA assigned FT218 a PDFUA target action date of October 15, 2021. In October, the FDA notified us that its review was still ongoing and action would not be taken by the PDUDFA date. Any delay or setback in the regulatory approval or commercialization of our lead product candidate will adversely affect our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has substantial discretion in the drug approval process, including the ability to delay, limit or deny approval of a product candidate for many reasons. For example, the FDA:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">could determine that we cannot rely on the Section 505(b)(2) regulatory pathway or other pathways we have selected, as applicable, for our lead product candidate;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">could determine that the information provided by us was inadequate, contained clinical deficiencies or otherwise failed to demonstrate the safety and effectiveness of our product candidate for any indication;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">may not find the data from bioequivalence studies and/or clinical trials sufficient to support the submission of an NDA or to obtain marketing approval in the U.S., including any findings that the clinical and other benefits of our product candidate outweigh their safety risks;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">may disagree with our trial design or our interpretation of data from preclinical studies, bioequivalence studies and/or clinical trials, or may change the requirements for approval even after it has reviewed and commented on the design for our trials;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">may determine that we have identified the wrong listed drug or drugs or that approval of our Section 505(b)(2) application for our product candidate is blocked by patent or non-patent exclusivity of the listed drug or drugs or of other previously approved drugs with the same conditions of approval as our product candidate, as applicable;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">may identify deficiencies in the manufacturing processes or facilities of third-party manufacturers with which we enter into agreements for the manufacturing of our product candidate;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-23-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">may audit some or all of our clinical research study sites to determine the integrity of our data and may reject any or all of such data;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">may approve our lead product candidate for fewer or more limited indications than we request, or may grant approval contingent on the performance of costly post-approval clinical trials;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">may change its approval policies or adopt new regulations; or</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">may not approve the labeling claims that we believe are necessary or desirable for the successful commercialization of our lead product candidate. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if a product is approved, the FDA may limit the indications for which the product may be marketed, require extensive warnings on the product labeling or require expensive and time-consuming clinical trials and/or reporting as conditions of approval. Regulators of other countries and jurisdictions have their own procedures for the approval of product candidates with which we must comply prior to marketing in those countries or jurisdictions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have submitted a NDA for FT218 in the U.S. and will evaluate filing potentially elsewhere. We have determined, following FDA consultation, that the 505(b)(2) approval pathway, which permits an NDA applicant to rely on the FDA&#8217;s previous findings of safety or effectiveness and data from studies that were not conducted by or for the applicant and for which the applicant has not obtained a right of reference, is the appropriate pathway for a FT218 NDA. There can be no assurances, however, that the 505(b)(2) approval pathway in the U.S., or similar approval pathways outside of the U.S., will be available for FT218 or that the FDA or other regulatory authorities will approve FT218 through an application based on such pathways.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Obtaining regulatory approval for marketing of a product candidate in one country does not ensure that we will be able to obtain regulatory approval in any other country. In addition, delays in approvals or rejections of marketing applications in the U.S. or other countries may be based upon many factors, including regulatory requests for additional analyses, reports, data, preclinical studies and clinical trials, regulatory questions regarding different interpretations of data and results, changes in regulatory policy during the period of product development and the emergence of new information regarding our product candidate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business is significantly dependent on the successful development, regulatory approval and commercialization of FT218, our only product candidate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have invested substantially all of our efforts and financial resources in the development of FT218, which has not yet been approved for sale or commercial use. Currently, FT218 is our only product candidate and we have not licensed, acquired, or invented any other product candidates for preclinical or clinical evaluation. This may make an investment in our company riskier than similar companies that have multiple product candidates in active development and that therefore may be able to better sustain a failure of a lead candidate. The success of our business, including our ability to finance our company and generate any revenue in the future, will, at this point, depend entirely on the regulatory approval and commercialization of FT218, which may never occur. Any failure to obtain regulatory approval of FT218 would have a material and adverse impact on our business. Even if we successfully obtain regulatory approvals to market FT218, our revenue will be dependent, in part, upon the size of the markets in the territories for which we gain regulatory approval. If the markets or patient subsets that we are targeting are not as significant as we estimate, we may not generate significant revenues from sales of FT218, even if approved.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The commercial success of FT218 will depend on a number of factors, including the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the timely receipt of necessary marketing approvals from the FDA and similar foreign regulatory authorities;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">our ability to raise any additional required capital to support the commercialization on acceptable terms, or at all;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">our ability to consistently manufacture FT218 on a timely basis;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our ability to secure and maintain from the U.S. DEA our annual quota for FT218 APIs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">our ability to successfully to develop and implement a REMS for the safe use of FT218;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the prevalence, duration and severity of potential side effects or other safety issues that patients may experience with FT218;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">achieving and maintaining, and, where applicable, ensuring that our third-party contractors achieve and maintain, compliance with our contractual obligations and with all regulatory requirements applicable to FT218;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-24-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the differentiation of FT218 from other available approved, or investigational, drugs and treatments of excessive daytime sleepiness or cataplexy in adults with narcolepsy, and the willingness of physicians, operators of hospitals and clinics and patients to adopt and utilize FT218&#8217;s once nightly formulation;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">our ability to successfully develop a commercial strategy and thereafter commercialize FT218 in the United States and internationally, if approved for marketing, sale and distribution in such countries and territories, whether alone or in collaboration with others;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the availability of coverage and adequate reimbursement from managed care plans, private insurers, government payors (such as Medicare and Medicaid and similar foreign authorities) and other third-party payors for FT218;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">patients&#8217; ability and willingness to pay out-of-pocket for FT218 in the absence of coverage and/or adequate reimbursement from third-party payor;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">acceptance by physicians, payors and patients of the benefits, safety and efficacy of FT218, if approved;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">patient demand for FT218, if approved;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">our ability to establish and enforce intellectual property rights in and to FT218; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">our ability to avoid third-party patent interference, intellectual property challenges or intellectual property infringement claims.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These factors, many of which are beyond our control, could cause us to experience significant delays or an inability to obtain regulatory approvals or commercialize FT218. Even if regulatory approvals are obtained, we may never be able to successfully commercialize FT218. Accordingly, we cannot provide assurances that we will be able to generate sufficient revenue through the sale of FT218 to continue our business or achieve profitability.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our lead product candidate and future product candidates may not reach the commercial market for a number of reasons.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Drug development is an inherently uncertain process with a high risk of failure at every stage of development. Successful research and development of pharmaceutical products is difficult, expensive and time consuming. Many product candidates fail to reach the market. Our success will depend on the development and the successful commercialization of new drugs and products that utilize our drug delivery technologies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if our product candidates and current drug delivery technologies appear promising during development, there may not be successful commercial applications developed for them for a number of reasons, including:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the FDA, the EMA, the competent authority of an EU Member State or an IRB, or an Ethics Committee (EU equivalent to IRB), or our partners may delay or halt applicable clinical trials;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">we or our partners may face slower than expected rate of patient recruitment and enrollment in clinical trials, or may devote insufficient funding to the clinical trials;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">our drug delivery technologies and drug products may be found to be ineffective or to cause harmful side effects, or may fail during any stage of pre-clinical testing or clinical trials;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">we or our partners may find that certain products cannot be manufactured on a commercial scale and, therefore, may not be economical or feasible to produce; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">we or our partners may face delays in completing our clinical trials due to circumstances outside of our control, including natural disasters, labor or civil unrest, global health concerns or pandemics or acts of war or terrorism; or</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">our lead product candidate and future product candidates could fail to obtain regulatory approval or, if approved, could fail to achieve market acceptance, could fail to be included within the pricing and reimbursement schemes of the U.S. or EU Member States, or could be precluded from commercialization by proprietary rights of third parties. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are not able to use the 505(b)(2) regulatory approval pathway for the regulatory approval of FT218 or if the FDA requires additional clinical or nonclinical data to support an NDA under Section 505(b)(2) than we previously anticipated, it will likely take significantly longer, cost significantly more and be significantly more complicated to gain FDA approval for FT218, and in any case may not be successful. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We submitted an NDA to the FDA for FT218 for the treatment of cataplexy or EDS in adults with narcolepsy in December 2020 through the Section 505(b)(2) regulatory pathway. The Drug Price Competition and Patent Term Restoration Act of 1984, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-25-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">also known as the Hatch-Waxman Amendments, added Section 505(b)(2) to the Federal Food, Drug, and Cosmetic Act, or the FDCA. In general, Section 505(b)(2) allows an applicant to rely on the FDA&#8217;s prior findings of safety or effectiveness for a listed drug only to the extent that the proposed product in the 505(b)(2) application shares common characteristics with the listed drug, or on published literature that the applicant believes supports the safety or efficacy of its proposed product but for which it does not have a right of reference for the underlying data. The 505(b)(2) application must include sufficient data to support differences between the listed drug and the proposed drug in the 505(b)(2) application. If the FDA does not agree that the 505(b)(2) regulatory pathway is appropriate or scientifically justified for FT218, we may need to conduct additional clinical trials, provide additional data and information and meet additional standards for regulatory approval. Specifically, the FDA may not agree that we have provided a scientific bridge, through, for example, comparative bioavailability data, to demonstrate that reliance on the prior findings of safety or efficacy for a listed drug is justified. Although the active ingredient in FT218, sodium oxybate, is approved for the treatment of cataplexy or excessive daytime sleepiness in patients 7 years of age and older with narcolepsy, it has not previously been approved or demonstrated to be safe for once nightly administration in these indications. If we are unable to establish a bridge between FT218 and the listed drug upon which we rely to demonstrate that such reliance is justified, we may be required to show safety and efficacy through one or more additional clinical trials. In addition, if we are unable to utilize the 505(b)(2) pathway, the time and financial resources required to obtain FDA approval for FT218 would likely increase substantially. Moreover, the inability to utilize the 505(b)(2) regulatory pathway could result in new competitive products reaching the market faster than FT218, which could materially adversely impact its competitive position and prospects. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we are successful in pursuing the 505(b)(2) regulatory pathway for FT218, we cannot assure you that we will receive the requisite or timely approval for commercialization of FT218. Although the Section 505(b)(2) pathway allows us to rely in part on the FDA&#8217;s prior findings of safety or efficacy for approved listed drugs or on published literature for which we do not have a right of reference, the FDA may determine that prior findings by the FDA or the published literature that we believe supports the safety or efficacy of FT218 is insufficient or not applicable to our application or that additional studies will need to be conducted. To the extent that we are relying on the 505(b)(2) regulatory pathway based on the approval of a listed drug for a similar indication, the FDA may require that we include in the labeling of FT218, if approved, some or all of the safety information that is included in the labeling of the approved listed drug. For example, the labels of current FDA-approved sodium oxybate products include a black box warning regarding risks of central nervous system depression and abuse and misuse. Moreover, even if FT218 is approved via the 505(b)(2) regulatory pathway, the approval may be subject to limitations on the indicated uses for which the product may be marketed or to other conditions of approval, or may contain requirements for costly post-marketing testing and surveillance to monitor the safety or efficacy of the product, such as a Risk Evaluation and Mitigation Strategy, or REMS, which is a risk mitigation plan which could include medication guides, physician communication plans, or elements to assure safe use, or ETASU, such as restricted distribution methods, patient registries and other risk minimization tools.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business depends heavily on our ability to successfully commercialize FT218 in the U.S. and in other jurisdictions where we may obtain marketing approval. There is no assurance that our commercialization efforts with respect to FT218, if approved, will be successful or that we will be able to generate revenues at the levels or on the timing we expect, or at levels or on the timing necessary to support our goals.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our business currently depends heavily on our ability to successfully commercialize FT218 for the treatment of cataplexy or EDS in adults with narcolepsy in the U.S. and in other jurisdictions where we may obtain marketing approval. Even if we obtain marketing approval for FT218, we may never be able to successfully commercialize our product or meet our expectations with respect to revenues. There is no guarantee that the infrastructure, systems, processes, policies, relationships, and materials we are building for the commercialization of FT218 in the U.S., or that we may build for other jurisdictions where we may obtain marketing approval, will be sufficient for us to achieve success at the levels we expect. If we are unable to establish adequate sales, marketing and distribution capabilities, whether independently or with third parties, or if we are unable to do so on commercially reasonable terms, our business, results of operations, financial condition and prospects will be materially adversely affected. We may encounter issues, delays or other challenges in launching or commercializing FT218, if approved. For example, our results may be negatively impacted if we have not adequately sized our field teams or if our targeting strategy is inadequate or if we encounter deficiencies or inefficiencies in our infrastructure or processes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may encounter issues and challenges in commercializing FT218, if approved, and generating sufficient revenues to result in a profit. We may also encounter challenges related to reimbursement of FT218, including potential limitations in the scope, breadth, availability, or amount of reimbursement covering FT218. Similarly, healthcare settings or patients may determine that the financial burdens of treatment are not acceptable. We may face other limitations or issues related to the price of FT218. Our results may also be negatively impacted if we have not adequately sized our field teams or our physician segmentation and targeting strategy is inadequate or if we encounter deficiencies or inefficiencies in our infrastructure or processes. Other factors </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-26-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that may hinder our ability to successfully commercialize FT218, if approved, and generate sufficient revenues to result in a profit, include:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the acceptance of FT218 by patients and the medical community;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of our third-party manufacturer(s) to manufacture commercial supplies of FT218 in sufficient quantities at acceptable costs, to remain in good standing with regulatory agencies, maintain applicable registrations and licenses, and to maintain commercially viable manufacturing processes that are, to the extent required, compliant with current Good Manufacturing Practices, or cGMP, regulations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to remain compliant with laws and regulations that apply to us and our commercial activities;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FDA- or other foreign regulatory agency-mandated package insert requirements and successful completion of any related FDA or other foreign regulatory agency post-marketing requirements, including a REMS;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the actual market size for FT218, which may be different than expected; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the length of time that patients who are prescribed our drug remain on treatment;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the sufficiency of our drug supply to meet commercial demand which could be negatively impacted if our projections regarding the potential number of patients are inaccurate, we are subject to unanticipated regulatory requirements, or our current drug supply is destroyed, or negatively impacted at our manufacturing sites, storage sites, or in transit; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to effectively complete with other therapies; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain, enforce, and defend third party challenges to our intellectual property rights in and to FT218.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of these issues could impair our ability to successfully commercialize our product, if approved, or to generate sufficient revenues to result in a profit or to meet our expectations with respect to the amount or timing of revenues or profits. Any issues or hurdles related to our commercialization efforts may materially adversely affect our business, results of operations, financial condition, and prospects. Even if approved, there is no guarantee that we will be successful in our commercialization efforts with respect to FT218. We may also experience significant fluctuations in sales of FT218 from period to period and, ultimately, we may never generate sufficient revenues from FT218 to reach or maintain profitability or sustain our anticipated levels of operations. Any inability on our part to successfully commercialize FT218 in the U.S. and any other international markets where it may be approved or any significant delay, could have a material adverse impact on our ability to execute upon our business strategy.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to establish adequate sales, marketing and distribution capabilities, whether independently or with third parties, or if we are unable to do so on commercially reasonable terms, our business, results of operations, financial condition and prospects will be materially adversely affected. We may encounter issues, delays or other challenges in launching or commercializing FT218, if approved. For example, our results may be negatively impacted if we have not adequately sized our field teams or if our targeting strategy is inadequate or if we encounter deficiencies or inefficiencies in our infrastructure or processes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clinical development of drugs is costly and time-consuming, and the outcomes are uncertain. A failure to prove that FT218 is safe and effective in clinical trials could materially and adversely affect our business, financial condition, results of operations and growth prospects.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Clinical trials are expensive and can take many years to complete, and the outcome is uncertain. Failure can occur at any time during the clinical trial process. The results of preclinical studies and early clinical trials of product candidates may not be predictive of the results of later-stage clinical trials. Product candidates in later stages of clinical trials may fail to show the desired safety and efficacy traits despite having progressed through preclinical studies and initial clinical testing. For example, we are currently conducting an open-label extension (&#8220;OLE&#8221;) switch study of FT218, RESTORE, to examine the long-term safety and maintenance of efficacy of FT218 in patients with narcolepsy who participated in our REST-ON trial, as well as dosing and preference data for patients switching from twice-nightly sodium oxybate to once-nightly FT218 regardless if they participated in REST-ON or not. In May 2021, inclusion criteria were expanded to allow for oxybate na&#239;ve patients to enter the study. If any participants in the OLE/switch study report any serious adverse events that are deemed to be related to FT218 or if FT218 is not observed to have long-term efficacy, our business, financial condition, results of operations and growth prospects could be material and adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to issues relating to the results generated in clinical trials, clinical trials can be delayed or halted for a variety of reasons, including delay or failure in:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtaining regulatory approval to commence a trial; </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-27-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reaching agreement on acceptable terms with prospective contract research organizations (&#8220;CROs&#8221;) and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and trial sites; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtaining institutional review board or ethics committee approval at each site; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">recruiting suitable patients to participate in a trial; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">having patients complete a trial or return for post-treatment follow-up; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">clinical sites dropping out of a trial; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adding new sites; or </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtaining clinical materials or manufacturing sufficient quantities of FT218 for use in clinical trials. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have limited experience as a commercial drug company targeting an orphan drug disease and the marketing and sale of FT218, if approved, may be unsuccessful or less successful than anticipated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have limited experience as a commercial drug company targeting an orphan disease and there is limited information about our ability to successfully overcome many of the risks and uncertainties encountered by companies commercializing drugs in the biopharmaceutical industry. To execute our business plan, in addition to successfully obtaining marketing approval and marketing and selling FT218, we will need to successfully:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">establish and maintain our relationships with healthcare providers who will be treating the patients who may receive our drug;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">obtain adequate pricing and reimbursement for FT218;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">develop and maintain successful strategic alliances; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">manage our spending as costs and expenses increase due to marketing approvals and commercialization in multiple jurisdictions, if approved.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unsuccessful in accomplishing these objectives, we may not be able to successfully commercialize FT218, raise capital, expand our business or continue our operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our relationships with healthcare providers, physicians, prescribers, purchasers, third-party payors, charitable organizations and patients will be subject to applicable anti-kickback, fraud and abuse and other healthcare laws and regulations, which could expose us to criminal sanctions, civil penalties, contractual damages, reputational harm and diminished profits and future earnings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare providers, physicians and third-party payors in the United States and elsewhere play a primary role in the recommendation and prescription of biotechnology and biopharmaceutical products. Arrangements with third-party payors and customers can expose biotechnology and biopharmaceutical manufacturers to broadly applicable fraud and abuse and other healthcare laws and regulations, including, without limitation, the federal Anti-Kickback Statute, or AKS, and the federal False Claims Act, or FCA, which may constrain the business or financial arrangements and relationships through which such companies sell, market and distribute biotechnology and biopharmaceutical products. In particular, the research of our product candidates, as well as the promotion, sales and marketing of healthcare items and services, as well as certain business arrangements in the healthcare industry, are subject to extensive laws designed to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, structuring and commission(s), certain customer incentive programs and other business arrangements generally. Activities subject to these laws also involve the improper use of information obtained in the course of patient recruitment for clinical trials.  See the section entitled, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business &#8212; Government Regulation &#8212; Healthcare laws</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The distribution of biopharmaceutical products is subject to additional requirements and regulations, including extensive record-keeping, licensing, storage and security requirements intended to prevent the unauthorized sale of biopharmaceutical products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scope and enforcement of each of these laws is uncertain and subject to rapid change in the current environment of healthcare reform, especially in light of the lack of applicable precedent and regulations. Federal and state enforcement bodies have recently increased their scrutiny of interactions between healthcare companies and healthcare providers, which has led to a number of investigations, prosecutions, convictions and settlements in the healthcare industry. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ensuring that our internal operations and future business arrangements with third parties comply with applicable healthcare laws and regulations will involve substantial costs. It is possible that governmental authorities will conclude that our business </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-28-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">practices do not comply with current or future statutes, regulations, agency guidance or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of the laws described above or any other governmental laws and regulations that may apply to us, we may be subject to significant penalties, including administrative, civil and criminal penalties, damages, fines, disgorgement, the exclusion from participation in federal and state healthcare programs, individual imprisonment, reputational harm,  and the curtailment or restructuring of our operations, as well as additional reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with these laws. Further, defending against any such actions can be costly and time consuming, and may require significant financial and personnel resources. Therefore, even if we are successful in defending against any such actions that may be brought against us, our business may be impaired. If any of the physicians or other providers or entities with whom we expect to do business are found to not be in compliance with applicable laws, they may be subject to criminal, civil or administrative sanctions, including exclusions from government funded healthcare programs and imprisonment. If any of the above occur, our ability to operate our business and our results of operations could be adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Coverage and reimbursement may be limited or unavailable in certain market segments for our product candidates, if approved, which could make it difficult for us to sell any product candidates profitably.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our product candidates, if approved, depends on the availability of coverage and adequate reimbursement from third-party payors. We cannot be sure that coverage and reimbursement will be available for, or accurately estimate the potential revenue from, our product candidates or assure that coverage and reimbursement will be available for any product that we may develop.  See the sections entitled, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business &#8212; Government Regulation &#8212; Coverage and Reimbursement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business &#8212; Government Regulation &#8212; Healthcare Laws</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patients who are provided medical treatment for their conditions generally rely on third-party payors to reimburse all or part of the costs associated with their treatment. Coverage and adequate reimbursement from governmental healthcare programs, such as Medicare and Medicaid, and commercial payors is critical to new product acceptance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government authorities and other third-party payors, such as private health insurers and health maintenance organizations, decide which drugs and treatments they will cover and the amount of reimbursement. Coverage and reimbursement by a third-party depends upon a number of factors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, no uniform policy of coverage and reimbursement for products exists among third- party payors. As a result, obtaining coverage and reimbursement approval of a product from a government or other third-party payor is a time-consuming and costly process that could require us to provide to each payor supporting scientific, clinical and cost-effectiveness data for the use of our products on a payor-by-payor basis, with no assurance that coverage and adequate reimbursement will be obtained. In the United States, the principal decisions about reimbursement for new medicines are typically made by the CMS. CMS decides whether and to what extent a new medicine will be covered and reimbursed under Medicare and private payors tend to follow CMS to a substantial degree. Even if we obtain coverage for a given product, the resulting reimbursement payment rates might not be adequate for us to achieve or sustain profitability or may require co-payments that patients find unacceptably high. Additionally, third-party payors may not cover, or provide adequate reimbursement for, long-term follow-up evaluations required following the use of product candidates, once approved. Patients are unlikely to use our product candidates, once approved, unless coverage is provided and reimbursement is adequate to cover a significant portion of their cost. There is significant uncertainty related to insurance coverage and reimbursement of newly approved products. It is difficult to predict at this time what third-party payors will decide with respect to the coverage and reimbursement for our product candidates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors and by any future relaxation of laws that presently restrict imports of drugs from countries where they may be sold at lower prices than in the United States. Increasingly, third-party payors are requiring that drug companies provide them with predetermined discounts from list prices and are challenging the prices charged for medical products. We cannot be sure that reimbursement will be available for any product candidate that we commercialize and, if reimbursement is available, the level of reimbursement. In addition, many pharmaceutical manufacturers must calculate and report certain price reporting metrics to the government, such as average sales price and best price. Penalties may apply in some cases when such metrics are not submitted accurately and timely. Further, these prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs. Payment methodologies may be subject to changes in healthcare legislation and regulatory initiatives. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, increasing efforts by governmental and other third-party payors in the United States and abroad to cap or reduce healthcare costs may cause such organizations to limit both coverage and the level of reimbursement for newly approved </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-29-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products and, as a result, they may not cover or provide adequate payment for our product candidates. There has been increasing legislative and enforcement interest in the United States with respect to specialty drug pricing practices. Specifically, there have been several recent U.S. Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer patient programs and reform government program reimbursement methodologies for drugs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that healthcare reform measures that may be adopted in the future may result in more rigorous coverage criteria and in additional downward pressure on the price that we receive for any approved product. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our products. Legislative and regulatory proposals have been made to expand post-approval requirements and restrict sales and promotional activities for pharmaceutical products. We cannot be sure whether additional legislative changes will be enacted, or whether the FDA regulations, guidance or interpretations will be changed, or what the impact of such changes on the marketing approvals or clearances of our product candidates, if any, may be. It is also possible that additional governmental action is taken in response to the COVID-19 pandemic.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in some foreign countries, the proposed pricing for a drug must be approved before it may be lawfully marketed. The requirements governing drug pricing vary widely from country to country. For example, the European Union provides options for its Member States to restrict the range of medicinal products for which their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. To obtain reimbursement or pricing approval, some of these countries may require the completion of clinical trials that compare the cost effectiveness of a particular product candidate to currently available therapies. A Member State may approve a specific price for the medicinal product or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the medicinal product on the market. There can be no assurance that any country that has price controls or reimbursement limitations for pharmaceutical products will allow favorable reimbursement and pricing arrangements for any of our product candidates. Historically, products launched in the European Union do not follow price structures of the U.S. and generally prices tend to be significantly lower.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ongoing healthcare legislative and regulatory reform measures may have a material adverse effect on our business and results of operations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in regulations, statutes or the interpretation of existing regulations could impact our business in the future by requiring, for example, changes to our manufacturing arrangements; additions or modifications to product labeling; the recall or discontinuation of our products; or additional record-keeping requirements. If any such changes were to be imposed, they could adversely affect the operation of our business. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we may have obtained, and we may not achieve or sustain profitability. See the section entitled, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business &#8212; Government Regulation &#8212; Healthcare Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, increasing efforts by governmental and third-party payors in the United States and abroad to cap or reduce healthcare costs may cause such organizations to limit both coverage and the level of reimbursement for newly approved products and, as a result, they may not cover or provide adequate payment for our product candidates. There has been increasing legislative and enforcement interest in the United States with respect to specialty drug pricing practices. Specifically, there have been several recent U.S. Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drugs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the state level, legislatures are increasingly passing legislation and implementing regulations designed to control pharmaceutical and biologic product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. Legally mandated price controls on payment amounts by third-party payors or other restrictions could harm our business, financial condition, results of operations and prospects. In addition, regional healthcare authorities and individual hospitals are increasingly using bidding procedures to determine what pharmaceutical products and which suppliers will be included in their prescription drug and other healthcare programs. This could reduce the ultimate demand for our drugs or put pressure on our drug pricing, which could negatively affect our business, financial condition, results of operations and prospects.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-30-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These laws, and future state and federal healthcare reform measures may be adopted in the future, any of which may result in additional reductions in Medicare and other healthcare funding and otherwise affect the prices we may obtain for any of our product candidates for which we may obtain regulatory approval or the frequency with which any such product candidate is prescribed or used. Additionally, we expect to experience pricing pressures in connection with the sale of any future approved product candidates due to the trend toward managed healthcare, the increasing influence of health maintenance organizations, cost containment initiatives and additional legislative changes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FT218, if successfully developed and approved, may cause undesirable side effects</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">that limit the commercial profile or result in other significant negative consequences for approved products; or delay or prevent further development or regulatory approval with respect to product candidates or new indications, or cause regulatory authorities to require labeling statements, such as boxed warnings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Undesirable side effects caused by FT218, if successfully developed and approved, could limit the commercial profile of FT218 or result in significant negative consequences such as a more restrictive label or other limitations or restrictions. Undesirable side effects caused by FT218 could cause us or regulatory authorities to interrupt, delay or halt non-clinical studies and clinical trials or could result in a more restrictive label or the delay or denial of regulatory approval by the FDA or other regulatory authorities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trials by their nature utilize a sample of the potential patient population. With a limited number of patients and limited duration of exposure, certain side effects of FT218 may only be uncovered with a significantly larger number of patients exposed to the drug, and those side effects could be serious or life-threatening. If we or others identify undesirable side effects caused by FT218 (or any other similar drugs), a number of potentially significant negative consequences could result, including:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory authorities may withdraw or limit their marketing approval of such drugs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory authorities may require the addition of labeling statements, such as a &#8220;boxed&#8221; warning or additions to an existing boxed warning, or a contraindication, including as a result of inclusion in a class of drugs for a particular disease;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory authorities may refuse to approve label expansions for additional indications for any approved drugs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be required to change the way such drugs are distributed or administered, conduct additional clinical trials or change the labeling of the drugs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory authorities may require a modification of an existing REMS to mitigate risks;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be subject to regulatory investigations and government enforcement actions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may decide to remove FT218 from the marketplace;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we could be sued and held liable for injury caused to individuals exposed to or taking FT218; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our reputation may suffer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of these events could prevent us from achieving or maintaining market acceptance of FT218, if approved, and could substantially increase the costs of commercializing FT218 and significantly impact our ability to successfully commercialize FT218 and generate revenues.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may incur significant liability if governmental authorities allege or determine that we are engaging in commercial activities or promoting FT218 in a way that violates applicable regulations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Physicians have the discretion to prescribe drug products for uses that are not described in the product&#8217;s labeling and that differ from those approved by the FDA or other applicable regulatory agencies. Off-label uses are common across medical specialties. Although the FDA and other regulatory agencies do not regulate a physician&#8217;s choice of treatments, the FDA and other regulatory agencies regulate a manufacturer&#8217;s communications regarding off-label use and prohibit off-label promotion, as well as the dissemination of false or misleading labeling or promotional materials. Manufacturers may not promote drugs for off-label uses. Accordingly, if FT218 is approved, we may not promote FT218 in the U.S. for any indications other than its FDA-approved indication. The FDA and other regulatory and enforcement authorities actively enforce laws and regulations prohibiting promotion of off-label uses and the promotion of products for which marketing approval has not been obtained. A company that is found to have improperly promoted off-label uses, including promoting unapproved dosing regimens, may be subject to significant liability, which may include civil and administrative remedies as well as criminal sanctions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding regulations related to product promotion, the FDA and other regulatory authorities allow companies to engage in truthful, non-misleading, and non-promotional scientific exchange concerning their products. We currently, and intend to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-31-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increasingly, engage in medical education activities and communicate with healthcare providers in compliance with all applicable laws and regulatory guidance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Obtaining and maintaining regulatory approval of FT218 in one jurisdiction does not mean that we will be successful in obtaining regulatory approval of FT218 in other jurisdictions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Obtaining and maintaining regulatory approval of FT218 in one jurisdiction does not guarantee that we will be able to obtain or maintain regulatory approval in any other jurisdiction, while a failure or delay in obtaining regulatory approval in one jurisdiction may have a negative effect on the regulatory approval process in others. For example, even if the FDA grants marketing approval of FT218, comparable regulatory authorities in foreign jurisdictions must also approve FT218 in those countries. Approval procedures vary among jurisdictions and can involve requirements and administrative review periods different from, and greater than, those in the U.S., including additional preclinical studies or clinical trials, as clinical trials conducted in one jurisdiction may not be accepted by regulatory authorities in other jurisdictions. In many jurisdictions outside the U.S., a product candidate must be approved for reimbursement before it can be approved for sale in that jurisdiction. In some cases, the price that we intend to charge for our products is also subject to approval. Obtaining foreign regulatory approvals and compliance with foreign regulatory requirements could result in significant delays, difficulties and costs for us and could delay or prevent the introduction of FT218 in certain countries. If we fail to comply with the regulatory requirements in international markets or receive applicable marketing approvals, our market will be reduced and our ability to realize the full market potential of FT218 will be harmed.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laws and regulations governing international operations we have and may expand in the future may preclude us from developing, manufacturing, and selling certain product candidates and products outside of the U.S. and require us to develop and implement costly compliance programs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we seek to expand our operations outside of the U.S., we must dedicate additional resources to comply with numerous laws and regulations in each jurisdiction in which we plan to operate. The Foreign Corrupt Practices Act (FCPA) prohibits any U.S. individual or business from paying, offering, authorizing payment, or offering anything of value, directly or indirectly, to any foreign official, political party, or candidate for the purpose of influencing any act or decision of such third party in order to assist the individual or business in obtaining or retaining business. The FCPA also obligates companies whose securities are listed in the U.S. to comply with certain accounting provisions requiring the company to maintain books and records that accurately and fairly reflect all transactions of the company, including international subsidiaries, and to devise and maintain an adequate system of internal accounting controls for international operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with the FCPA is expensive and difficult, particularly in countries in which corruption is a recognized problem. In addition, the FCPA presents particular challenges in the pharmaceutical industry, because, in many countries, hospitals are operated by the government, and doctors and other hospital employees are considered foreign officials. Certain payments to hospitals in connection with clinical trials and other work have been deemed to be improper payments to government officials and have led to FCPA enforcement actions. Similar laws in other countries, such as the U.K. Bribery Act 2010, may apply to our operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various laws, regulations, and executive orders also restrict the use and dissemination outside of the U.S., or the sharing with certain non-U.S. nationals, of information classified for national security purposes, as well as certain products and technical data relating to those products. As we expand our presence outside of the U.S. in key European markets, we must dedicate additional resources to comply with these laws, and such laws may preclude us from developing, manufacturing, or selling certain product candidates and products outside of the U.S., which could limit our growth potential and increase our development costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The failure to comply with laws governing international business practices may result in substantial civil and criminal penalties and suspension or debarment from government contracting. The SEC also may suspend or bar issuers from trading securities on U.S. exchanges for violations of the FCPA's accounting provisions.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Governments outside of the U.S. tend to impose strict price controls, which may adversely affect our revenues, if any.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In some countries, particularly the countries of Europe, the pricing of prescription pharmaceuticals is subject to governmental control. In these countries, pricing negotiations with governmental authorities can take considerable time after the receipt of marketing authorization for a product. To obtain reimbursement or pricing approval in some countries, we may be required to conduct a clinical trial that compares the cost-effectiveness of our product candidate to other available therapies. If we seek approval for our lead product candidate or future product candidates outside of the U.S. and reimbursement of our lead product </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-32-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">candidate or future product candidates is unavailable or limited in scope or amount, or if pricing is set at unsatisfactory levels, our business could be harmed.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Failure to comply with domestic and international privacy and security laws could result in the imposition of significant civil and criminal penalties.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The costs of compliance with privacy and security laws, including protecting electronically stored information from cyber-attacks, and potential liability associated with any compliance failures could adversely affect our business, financial condition and results of operations. We are subject to various domestic and international privacy and security regulations, including but not limited to HIPAA and the General Data Protection Regulation (&#8220;GDPR&#8221;), (Regulation EU 2016/679). HIPAA mandates, among other things, the adoption of uniform standards for the electronic exchange of information in common healthcare transactions, as well as standards relating to the privacy and security of individually identifiable health information, which require the adoption of administrative, physical and technical safeguards to protect such information. In addition, many U.S. states have enacted comparable laws addressing the privacy and security of health information, some of which are more stringent than HIPAA. GDPR requires Avadel to ensure personal data collected by Avadel is gathered legally and under strict conditions and to protect such personal data from misuse and exploitation. If Avadel fails to comply with HIPAA, GDPR or other similar laws, we will face significant fines and penalties that could adversely affect our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Risks Related to Our Financial Position and Capital Requirements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We incurred a net loss in 2021 and we will likely incur a net loss in 2022, and if we are not able to regain profitability in the future, the value of our shares may fall.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we reported a net income for the year ended December 31, 2020 due to the gain on the sale of our Hospital Products, we incurred a net loss of $77,329 for the year ended December 31, 2021. We do not expect to become profitable in the near future, and may never achieve profitability. The amount of our future net losses will depend, in part, on the rate of our future expenditures and our ability to recognize revenues from the commercialization of FT218, if approved. We have devoted significant financial resources to research and development, including our clinical development activities, and the pursuit of regulatory approval for FT218. If we obtain marketing approval, our future revenues will depend upon the size of any markets in which FT218 and any future products have received approval, and our ability to achieve sufficient market acceptance, reimbursement from third-party payors and adequate market share for our product and any future products in those markets. In addition, we are in the process of building a sales organization and supporting commercial infrastructure and, accordingly, we will incur significant expenses as we continue to develop a sales organization and commercial infrastructure in advance of generating any commercial product sales. Because of the numerous risks and uncertainties associated with developing pharmaceutical products, we are unable to predict the extent of any future losses or when we will become profitable, if at all. Our ability to operate profitably depends upon a number of factors, many of which are beyond our direct control. These factors include:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timely receipt of necessary approvals from the FDA for the commercialization of FT218;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain, build and expand manufacturing capacity, including capacity at third-party manufacturers;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effectiveness of our sales and marketing strategy;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the demand and market size for FT218;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the level of product and price competition for FT218;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to develop new partnerships and additional commercial applications for FT218 and any future product candidates;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to control our costs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the initiation of additional research, preclinical, clinical or other programs as we seek to identify and validate additional product candidates;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to acquire or in-license other product candidates and technologies;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain, protect and expand our intellectual property portfolio;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic conditions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if the FDA approves our NDA for FT218, we may never recognize revenue in amounts sufficient to achieve and maintain profitability. The net losses we incur may fluctuate significantly from quarter to quarter and year to year, such that a period-to-period comparison of our results of operations may not be a good indication of our future performance. In any particular quarter or quarters, our operating results could be below the expectations of securities analysts or investors, which could cause our stock price to decline.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-33-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may require additional financing, which may not be available on favorable terms or at all, and which may result in dilution of the equity interest of the holders of ADSs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may require additional financing to fund the development and possible acquisition of new products and businesses. We may consume available resources more rapidly than currently anticipated, resulting in the need for additional funding. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any additional fundraising efforts may divert our management from their day-to-day activities, which may adversely affect our ability to develop and commercialize FT218, if approved. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we cannot obtain financing when needed, or obtain it on favorable terms, we may be required to curtail our plans to continue to develop drug delivery technologies, develop new products, or acquire additional products and businesses. Other factors that will affect future capital requirements and may require us to seek additional financing include:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the development and acquisition of new products and drug delivery technologies;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the progress of our research and product development programs; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of, and amounts received from, future product sales, product development fees and licensing revenue and royalties. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If adequate funds are not available, we may be required to significantly reduce or refocus our product development efforts, resulting in loss of sales, increased costs and reduced revenues. Alternatively, to obtain needed funds for acquisitions or operations, we may seek to issue additional ADSs representing our ordinary shares, or issue equity-linked debt, or we may choose to issue preferred shares, in either case through public or private financings. Additional funds may not be available on terms that are favorable to us and, in the case of such equity financings, may result in dilution to the holders of ADSs. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We could also be required to seek funds through arrangements with collaborative partners and we may be required to relinquish rights to some of our product candidates or otherwise agree to terms unfavorable to us, any of which may have a material adverse effect on our business, operating results and prospects.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our net loss and use of cash in operating activities may limit our ability to fully pursue our business strategy.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reported net loss of $77,329 in 2021. We reported cash used in operating activities of $77,310. Cash and marketable securities as of December 31, 2021 totaled $157,221. Our business strategy is to primarily focus on the development and potential FDA approval of FT218 for the treatment of EDS or cataplexy in adults with narcolepsy. The successful pursuit of all components of our strategy will require substantial financial resources, and there can be no assurance that our existing cash and marketable securities assets and the cash generated by our operations will be adequate for these purposes. We will likely incur a net loss in 2022 and, if we use existing cash and marketable securities, there is no guarantee that we would be able to generate additional cash through our operations or through financing. Failure to implement any component of our strategy may prevent us from achieving profitability in the future or may otherwise have a material adverse effect on our financial condition and results of operation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Regulation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The distribution and sale of FT218, if approved, will be subject to significant regulatory restrictions, including the requirements of a REMS and safety reporting requirements, and these regulatory requirements will subject us to risks and uncertainties, any of which could negatively impact sales of FT218, if approved.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The active pharmaceutical ingredient, or API, of FT218 is a form of gamma-hydroxybutyric acid, or GHB, a central nervous system depressant known to be associated with facilitated sexual assault as well as with respiratory depression and other serious side effects. As a result, the FDA requires that sponsors of sodium oxybate products, such as FT218, if approved, maintain a REMS to help ensure that the benefits of the drug in treatment of EDS or cataplexy in adults with narcolepsy outweigh the serious risks of the drug. A REMS imposed on FT218, if approved, may impose extensive controls and restrictions on the sales and marketing of FT218 that we will be responsible for implementing.  Any failure to demonstrate our substantial compliance with any REMS obligations, including as a result of business or other interruptions resulting from the evolving effects of the COVID-19 pandemic, or a determination by the FDA that the REMS is not meeting its goals, could result in enforcement action by the FDA, lead to changes in our REMS obligations, negatively affect sales of FT218, result in additional costs and expenses for us or require us to invest a significant amount of resources, any of which could materially and adversely affect our business, financial condition, results of operations and growth prospects.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict whether the FDA will request, seek to require or ultimately require modifications to, or impose additional requirements on, the REMS for FT218, if approved. Any modifications approved, required or rejected by the FDA could change the safety profile of FT218, and have a significant negative impact in terms of product liability, public acceptance of FT218 for treatment of cataplexy or EDS in adults with narcolepsy, and prescribers&#8217; willingness to prescribe, and patients&#8217; </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-34-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">willingness to take, FT218, any of which could have a material adverse effect on our business. Modifications approved, required or rejected by the FDA could also make it more difficult or expensive for us to distribute FT218, make distribution easier for sodium oxybate competitors, disrupt continuity of care for FT218 patients or negatively affect sales of FT218.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceutical companies, including their agents and employees, are required to monitor adverse events occurring during the use of their products and report them to the FDA. As required by the FDA, and similarly for other regulatory agencies, the adverse event information that we collect for FT218, if approved, must be regularly reported to the FDA and could result in the FDA requiring changes to FT218&#8217;s labeling, including additional warnings or boxed warnings, or requiring us to take other actions that could have an adverse effect on patient and prescriber acceptance of FT218. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any failure to demonstrate our substantial compliance with a REMS required for FT218, if approved, or any other applicable regulatory requirements to the satisfaction of the FDA or another regulatory authority could result in such regulatory authorities taking actions in the future which could have a material adverse effect on sodium oxybate product sales and therefore on our business, financial condition, results of operations and growth prospects.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disruptions at the FDA, the DEA and other government agencies caused by funding shortages or global health concerns could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal business functions on which the operation of our business may rely, which could negatively impact our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory and policy changes. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding of the SEC and other government agencies on which our operations may rely, including those that fund research and development activities, is subject to the political process, which is inherently fluid and unpredictable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disruptions at the FDA, DEA and other agencies may also increase the time necessary for new product candidates to be reviewed or approved by necessary government agencies, which would adversely affect our business. For example, over the last several years the U.S. government has shut down several times and certain regulatory agencies, such as the FDA and the SEC, have had to furlough critical FDA, SEC and other government employees and stop critical activities. If a prolonged government shutdown occurs, it could significantly impact the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our business. Further, future government shutdowns could impact our ability to access the public markets and obtain necessary capital in order to properly capitalize and continue our operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of May 26, 2021, the FDA noted it was continuing to ensure timely reviews of applications for medical products during the ongoing COVID-19 pandemic in line with its user fee performance goals and conducting mission critical U.S. and non-U.S. inspections to ensure compliance of manufacturing facilities with FDA quality standards. However, the FDA may not be able to maintain its current pace and approval timelines could be extended due to the ongoing COVID-19 pandemic. Since March 2020 when foreign and domestic inspections of facilities were largely placed on hold, the FDA has been working to resume routine surveillance, bioresearch monitoring and pre-approval inspections on a prioritized basis. Since April 2021, the FDA has conducted limited inspections and employed remote interactive evaluations, using risk management methods, to meet user fee commitments and goal dates. Ongoing travel restrictions and other uncertainties continue to impact oversight operations both domestic and abroad and it is unclear when standard operational levels will resume. The FDA is continuing to complete mission-critical work, prioritize other higher-tiered inspectional needs (e.g., for-cause inspections), and carry out surveillance inspections using risk-based approaches for evaluating public health. Should the FDA determine that an inspection is necessary for approval and an inspection cannot be completed during the review cycle due to restrictions on travel, and the FDA does not determine a remote interactive evaluation to be adequate, the FDA has stated that it generally intends to issue, depending on the circumstances, or defer action on the application until an inspection can be completed. During the COVID-19 public health emergency, a number of companies announced receipt of complete response letters due to the FDA&#8217;s inability to complete required inspections for their applications. Regulatory authorities outside the U.S. may adopt similar restrictions or other policy measures in response to the COVID-19 pandemic and may experience delays in their regulatory activities. We cannot guarantee that the FDA, DEA and other agencies, as applicable, will be able to complete any required inspections or take other necessary actions in respect to our product candidate or future product candidates.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FT218, if approved by the FDA, may not obtain desired regulatory exclusivities, including orphan drug exclusivity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Orphan Drug Act, as amended, the FDA may designate a drug as an orphan drug if it is intended to treat a rare disease or condition, which is defined as a patient population of fewer than 200,000 individuals in the U.S., or a patient </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-35-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">population of 200,000 or more where there is no reasonable expectation that the cost of developing the drug for the rare disease or condition will be recovered from sales of the drug in the U.S. Generally, if a drug with orphan drug designation subsequently receives the first marketing approval for the disease or condition for which it has such designation, the drug is entitled to a period of marketing exclusivity, which precludes the FDA from approving another marketing application for the same drug for the same disease or condition for seven years, except in limited circumstances, such as if the FDA concludes that a subsequent same drug is clinically superior through greater safety, greater effectiveness, or a major contribution to patient care. In assessing whether a drug provides a &#8220;major contribution to patient care&#8221; over and above the currently approved drugs, which is evaluated by the FDA on a case-by-case basis, there is no one objective standard and the FDA may, in appropriate circumstances, consider such factors as convenience of treatment location, duration of treatment, patient comfort, reduced treatment burden, advances in ease and comfort of drug administration, longer periods between doses and potential for self-administration. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although FT218 obtained orphan drug designation for the treatment of narcolepsy from the FDA in January 2018, there is no guarantee that we will obtain approval or orphan drug exclusivity for FT218. Orphan drug designation does not give a product candidate any advantage in, or shorten the timeline for, the FDA regulatory review and approval process. In addition, because FT218 would not be the first sodium oxybate product to be approved for the treatment of narcolepsy, we must demonstrate that FT218 is clinically superior to any previously approved same drug in order to obtain orphan drug exclusivity for FT218, and we may be required to demonstrate clinical superiority for the approval and exclusivity of other product candidates in the future. However, such a demonstration may be difficult to establish and there can be no assurance that we will be successful in these efforts. Even if we obtain orphan drug exclusivity for FT218, that exclusivity may not effectively protect FT218 from competition because different drugs can be approved for the same condition. In addition, the FDA could determine that unexpired orphan drug exclusivity for an approved product that is determined to be the same drug could delay the approval of FT218 unless we are able to demonstrate that FT218 is clinically superior to such approved product. Moreover, any orphan drug exclusive marketing rights may be lost if the FDA later determines that the request for designation was materially defective or if we are unable to assure sufficient quantity of FT218 to meet the needs of patients with the particular rare disease or condition. The FDA may reevaluate its regulations and policies under the Orphan Drug Act. We do not know if, when or how the FDA may change the orphan drug regulations and policies in the future, and it is uncertain how any changes might affect our business. Depending on what changes, the FDA may make to its orphan drug regulations and policies, our business could be adversely impacted.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The API in FT218, sodium oxybate, is a controlled substance subject to U.S. federal and state controlled substance laws and regulations and applicable controlled substance legislation in other countries, and our failure, or the failure of third-parties on whom we rely, to comply with these laws and regulations, or the cost of compliance with these laws and regulations, could materially and adversely affect our business, results of operations, financial condition and growth prospects.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FT218 contains a controlled substance as defined in the CSA. Controlled substances are subject to a number of requirements and restrictions under the CSA and implementing regulations, including certain registration, security, recordkeeping, reporting, manufacturing and procurement quotas, import, export and other requirements administered by the DEA. The DEA classifies controlled substances into five schedules: Schedule I, II, III, IV or V. Schedule I substances by definition have a high potential for abuse, no currently &#8220;accepted medical use&#8221; in the U.S., lack accepted safety for use under medical supervision, and may not be prescribed, marketed or sold in the U.S. Pharmaceutical products approved for use in the U.S. which contain a controlled substance are listed as Schedule II, III, IV or V, with Schedule II substances considered to present the highest potential for abuse or dependence and Schedule V substances the lowest relative risk of abuse among such substances. Schedule I and II drugs are subject to the strictest controls under the CSA, including manufacturing and procurement quotas, heightened security requirements and additional criteria for importation. The API of FT218, oxybate salts, are regulated by the DEA as Schedule I controlled substances, and FDA-approved products containing oxybate salts, including sodium oxybate, are currently Schedule III. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Individual states have also established controlled substance laws and regulations. Although state-controlled substances laws often mirror federal law, they may separately schedule our product candidates. We or our partners may also be required to obtain separate state registrations, permits or licenses in order to be able to manufacture, research, distribute, import, export, administer or prescribe controlled substances for clinical trials or commercial sale, and failure to meet applicable regulatory requirements could lead to enforcement and sanctions by the states in addition to those from the DEA or otherwise arising under federal law.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. facilities conducting research, manufacturing, distributing, importing or exporting, or dispensing of controlled substances must be registered (licensed) to perform these activities and must comply with the security, control, recordkeeping and reporting obligations under the CSA, DEA regulations and corresponding state requirements. DEA and state regulatory bodies conduct periodic inspections of certain registered establishments that handle controlled substances. Obtaining and maintaining </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-36-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the necessary registrations, obtaining and maintaining quotas and complying with the regulatory obligations may result in delay of the importation, export, manufacturing, distribution or research of our lead product candidate and our commercial product, if approved, and any future products candidates or products. Furthermore, failure to maintain compliance with the CSA and DEA and state regulations by us or any of our contractors, distributors or pharmacies can result in regulatory action that could have a material adverse effect on our business, financial condition and results of operations. In addition, if we change any third-party upon whom we rely to conduct our research, manufacturing, distributing, importing, exporting, or dispensing activities, doing so will result in additional costs and expenses and may take a significant amount of time, and we may be unsuccessful in identifying a new, satisfactory third-party, any of which could materially and adversely affect our business, financial condition, and results of operations. DEA and state regulatory bodies may seek civil penalties, refuse to renew necessary registrations, or initiate proceedings to restrict, suspend or revoke those registrations. In certain circumstances, violations could lead to criminal penalties.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because FT218 contains sodium oxybate, to conduct clinical trials with FT218 in the U.S. prior to approval, each of our research sites must submit a research protocol to the DEA and obtain and maintain a DEA researcher registration that allows those sites to handle and dispense FT218 and to obtain the product candidate. If the DEA delays or denies the grant of a researcher registration to one or more research sites, the clinical trial could be significantly delayed, and we could lose clinical trial sites. In the event the product candidate would be made outside the U.S., the importer for the clinical trials must also obtain a Schedule I importer registration and an import permit for each import.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our manufacturing partners in the U.S. are subject to the DEA&#8217;s annual manufacturing and procurement quota requirements. Additionally, even though FT218, if approved, will be classified as Schedule III, the active ingredient in the final dosage form, sodium oxybate, is a Schedule I controlled substance and will continue be subject to such quotas as long as it remains classified as Schedule I. The annual quota allocated to us or our U.S. manufacturing partners for sodium oxybate may not be sufficient to complete clinical trials or meet commercial demand of FT218, if approved. Consequently, any delay or refusal by the DEA in establishing our, or U.S. manufacturing partner&#8217;s, procurement and/or production quota for controlled substances could delay or stop our clinical trials or commercial activities, if approved, which could have a material adverse effect on our business, financial position and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If approved, FT218 will be classified as a Schedule III substance and an importer can import it for commercial purposes if it obtains the appropriate registrations and licenses from the DEA, including an importer registration and files an application for an import permit for each import. The DEA provides annual assessments/estimates to the International Narcotics Control Board, which guides the DEA in the amounts of controlled substances that the DEA authorizes to be imported. To the extent an importer is utilized for commercial purposes, failure by any current importer or future importer that we identify as an importer, if any are available, to obtain and maintain the necessary import authority from the DEA and other applicable regulatory authorities, including specific quantities, could affect the availability of FT218 and have a material adverse effect on our business, results of operations and financial condition. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Governments outside of the U.S. have similar controlled substance laws, regulations and requirements in their respective jurisdictions, and our failure, or the failure of third parties upon whom we rely, to comply with applicable controlled substance laws, regulations and requirements or secure necessary authorizations would result in similar risks to those described above.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will need to obtain FDA approval of any proposed product names, and any failure or delay associated with such approval may adversely impact our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any name we intend to use for our product candidates will require approval from the FDA regardless of whether we have secured a trademark registration from the USPTO. The FDA typically conducts a review of proposed product names, including an evaluation of potential for confusion with other product names. The FDA may object to any product name we submit if it believes the name inappropriately implies medical claims. If the FDA objects to any of our proposed product names, we may be required to adopt an alternative name for our product candidates. If we adopt an alternative name, we would lose the benefit of any existing trademark applications for such product candidate and may be required to expend significant additional resources in an effort to identify a suitable product name that would qualify under applicable trademark laws, not infringe the existing rights of third parties and be acceptable to the FDA. We may be unable to build a successful brand identity for a new trademark in a timely manner or at all, which would limit our ability to commercialize our product candidates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to our Reliance on Third-Parties</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely, and intend to continue to rely on single source providers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">for the development, manufacture and supply of FT218, and if we experience problems with these suppliers, or they fail to comply with applicable regulatory requirements or to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-37-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">supply sufficient quantities at acceptable quality levels or prices, or at all, our business would be materially and adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, we use single source providers for the development, supply of clinical materials and supply of commercial batches for our lead product candidate, FT218. We do not own or operate manufacturing facilities for clinical or commercial manufacture of FT218. We have limited personnel with experience in drug manufacturing and we lack the capabilities to manufacture FT218 clinical or commercial scale. There can be no assurance that our clinical development or commercial product supplies will not be limited, interrupted, or of satisfactory quality or continue to be available at acceptable quantities or prices to meet commercial demand, if FT218 is approved. If the supplies of these products or materials were interrupted for any reason, including but not limited to, natural disasters, labor or civil unrest, global health concerns or pandemics or acts of war or terrorism, delays at the manufacturer, delays related to quality control, delays related to the supply chain and the manufacturing and supply of certain products could be delayed. If the supplies of these products or materials were interrupted for any reason, our manufacturing, clinical development or commercial activities, if approved, of FT218 could be delayed. These delays could be extensive and expensive, especially in situations where a substitution was not readily available or required variations of existing regulatory approvals and certifications or additional regulatory approval  For example, an alternative supplier may be required to pass an inspection by the FDA, EMA or the competent authorities of EU Member States for compliance with current cGMP requirements before supplying us with product or before we may incorporate that supplier&#8217;s ingredients into the manufacturing of FT218 by our contract development and manufacturing organizations (&#8220;CDMOs&#8221;).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, our third-party suppliers may not be required to, or may be unable to, provide us with any guaranteed minimum production levels or have sufficient dedicated capacity for our drug. Failure to obtain adequate supplies in a timely manner could have a material adverse effect on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We contract with third parties for the manufacture of FT218 for clinical testing and expect to continue to do so throughout commercialization. This reliance on third parties increases the risk that we will not have sufficient quantities of our product candidate or product or such quantities at an acceptable cost, which could delay, prevent or impair our development or commercialization efforts.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not currently own or operate, nor do we have any plans to establish in the future, any manufacturing facilities. We rely, and expect to continue to rely, on third parties for the manufacture of FT218 for clinical testing, as well as for the commercial manufacture of our product if FT218 receives marketing approval. This reliance on third parties increases the risk that we will not have sufficient quantities of our product candidate or product or such quantities at an acceptable cost or quality, which could delay, prevent or impair our development or commercialization efforts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The facilities used by CDMOs generally must be inspected by the FDA pursuant to pre-approval inspections conducted as a part of the FDA&#8217;s review of an NDA. We do not control the manufacturing process of, and will be completely dependent on, our CDMOs for compliance with cGMPs in connection with the manufacture of our product candidate. If our CDMOs cannot successfully manufacture material that conforms to our specifications and the strict regulatory requirements of the FDA or others, they will not be able to pass regulatory inspections and/or maintain regulatory compliance for their manufacturing facilities. In addition, we have no control over the ability of our CDMOs to maintain adequate quality control, quality assurance and qualified personnel. If the FDA or a comparable foreign regulatory authority finds deficiencies with or does not approve these facilities for the manufacture of our product candidate or if it finds deficiencies or withdraws any such approval in the future, we may need to find alternative manufacturing facilities, which would significantly impact our ability to develop, obtain regulatory approval for or market our product candidate, if approved. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CDMOs upon whom we rely are also required to comply with the CSA, DEA regulations and other applicable controlled substance laws, regulations and requirements in other countries, where applicable, including and those relating to licensing and registration requirements. The inability of our CDMOs to maintain compliance with applicable controlled substance laws, regulations and requirements and obtain and maintain the necessary licenses and registrations could have a material adverse effect on our business, including our clinical trials, commercial activities, if approved, financial position and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any CDMO with whom we contract fails to perform its obligations, we may be forced to enter into an agreement with a different CDMO, which we may not be able to do on reasonable terms, if at all. In such scenario, our clinical trials or commercial supply could be delayed significantly as we establish alternative supply sources. In some cases, the technical skills required to manufacture our product candidate or product, if approved, may be unique or proprietary to the original CDMO and we may have difficulty, or there may be contractual restrictions prohibiting us from, transferring such skills to a back-up or alternate supplier, or we may be unable to transfer such skills at all. In addition, if we are required to change CDMOs for any </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-38-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reason, we will be required to verify that the new CDMO maintains facilities and procedures that comply with quality standards and with all applicable regulations, including those relating to controlled substances. We will also need to verify, such as through a manufacturing comparability study, that any new manufacturing process will produce our product candidate or product according to the specifications previously submitted to or approved by the FDA or another regulatory authority. The delays associated with the verification of a new CDMO could negatively affect our ability to develop FT218 or commercialize our product, if approved, in a timely manner or within budget. Furthermore, a CDMO may possess technology related to the manufacture of our product candidate or product that such CDMO owns independently. This would increase our reliance on such CDMO or require us to obtain a license from such CDMO in order to have another CDMO manufacture our product candidate or product. In addition, in the case of CDMOs that supply our product candidate, changes in manufacturers often involve changes in manufacturing procedures and processes, which could require that we conduct bridging studies between our prior clinical supply used in our clinical trials and that of any new manufacturer. We may be unsuccessful in demonstrating the comparability of clinical supplies which could require the conduct of additional clinical trials.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, our failure, or the failure of our third party manufacturers, to comply with applicable regulations could result in sanctions being imposed on us, including clinical holds, fines, injunctions, civil penalties, delays, suspension or withdrawal of approvals, license revocation, seizures or recalls of product candidates or products, if approved, operating restrictions and criminal prosecutions, any of which could significantly and adversely affect our business and supplies of our product candidates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be unable to establish any agreements with third-party manufacturers or to do so on acceptable terms. Even if we are able to establish agreements with third-party manufacturers, reliance on third-party manufacturers entails additional risks, including: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reliance on the third party for regulatory compliance and quality assurance;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the possible breach of the manufacturing agreement by the third party; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the possible misappropriation of our proprietary information, including our trade secrets and know-how; and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the possible termination or nonrenewal of the agreement by the third party at a time that is costly or inconvenient for us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our product candidates and any products that we may develop may compete with other product candidates and approved products for access to manufacturing facilities. There are a limited number of manufacturers that operate under cGMP regulations and that might be capable of manufacturing for us. Any performance failure on the part of our existing or future manufacturers could delay clinical development or marketing approval. If our current CDMOs cannot perform as agreed, we may be required to replace such manufacturers. We may incur added costs and delays in identifying and qualifying any such replacement. Our current and anticipated future dependence upon others for the manufacture of our product candidates or products may adversely affect our future profit margins and our ability to commercialize any products that receive marketing approval on a timely and competitive basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We outsource important activities to consultants, advisors and outside contractors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We outsource many key functions of our business and therefore rely on a substantial number of consultants, advisors and outside contractors. If we are unable to effectively manage our outsourced activities or if the quality or accuracy of the services provided by such third parties is compromised for any reason, our development activities may be extended, delayed or terminated which would have an adverse effect on our development program and our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend on key personnel to execute our business plan. If we cannot attract and retain key personnel, we may not be able to successfully implement our business plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are highly dependent on the expertise of Gregory Divis, our Chief Executive Officer, Thomas S. McHugh, our Chief Financial Officer, and Richard Kim, our Chief Commercial Officer, as well as the other key members of our management, scientific, clinical and commercial team. Although we have entered into employment letter agreements with our executive officers, each of them may terminate their employment with us at any time. We do not maintain &#8220;key person&#8221; insurance for any of our executives or other employees. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recruiting and retaining qualified scientific, clinical, manufacturing and sales and marketing personnel will also be critical to our success. The loss of the services of our executive officers or other key employees could impede the achievement of our research, development and commercialization objectives and seriously harm our ability to successfully implement our business strategy. Furthermore, replacing executive officers and key employees may be difficult and may take an extended period of time because of the limited number of individuals in our industry with the breadth of skills and experience required to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-39-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">successfully develop, gain regulatory approval of and commercialize drugs. Competition to hire from this limited pool is intense, and we may be unable to hire, train, retain or motivate these key personnel on acceptable terms given the competition among numerous pharmaceutical and biotechnology companies for similar personnel. We also experience competition for the hiring of scientific and clinical personnel from universities and research institutions. Failure to obtain FDA approval for FT218 may make it more challenging to recruit and retain qualified personnel. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will need to expand our organization and we may experience difficulties in managing this growth, which could disrupt our operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently employ approximately 66 full-time employees. As we mature and commercialize FT218, if approved, we expect to expand our full-time employee base. Our management may need to divert a disproportionate amount of its attention away from our day-to-day activities and devote a substantial amount of time to managing these growth activities. We may not be able to effectively manage the expansion of our operations, which may result in weaknesses in our infrastructure, operational mistakes, loss of business opportunities, loss of employees and reduced productivity among remaining employees. Our expected growth could require significant capital expenditures and may divert financial resources from other projects, such as the development of additional product candidates. If our management is unable to effectively manage our growth, our expenses may increase more than expected, our ability to recognize and/or grow revenues could be reduced and we may not be able to implement our business strategy. Our future financial performance and our ability to commercialize FT218 and compete effectively will depend, in part, on our ability to effectively manage any future growth.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on third parties to conduct our clinical trials, and if they do not properly and successfully perform their contractual, legal and regulatory duties, we may not be able to obtain regulatory approvals for or commercialize FT218 and future product candidates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on CROs and other third parties to assist us in designing, managing, monitoring and otherwise carrying out our clinical trials, including with respect to site selection, contract negotiation and data management. We do not control these third parties and, as a result, they may not treat our clinical studies as a high priority, which could result in delays. We are responsible for confirming that each of our clinical trials is conducted in accordance with its general investigational plan and protocol, as well as the FDA&#8217;s and foreign regulatory agencies&#8217; requirements, commonly referred to as good clinical practices, for conducting, recording and reporting the results of clinical trials to ensure that the data and results are credible and accurate and that the trial participants are adequately protected. The FDA and foreign. regulatory agencies enforce good clinical practices through periodic inspections of trial sponsors, principal investigators and trial sites. If we, CROs or other third parties assisting us or our study sites fail to comply with applicable good clinical practices, the clinical data generated in our clinical trials may be deemed unreliable and the FDA or its non-U.S. counterparts may require us to perform additional clinical trials before approving our marketing applications. We cannot assure you that, upon inspection, the FDA or foreign regulatory agencies will determine that any of our clinical trials comply with good clinical practices. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If third parties do not successfully carry out their duties under their agreements with us, if the quality or accuracy of the data they obtain is compromised due to failure to adhere to our clinical protocols, including dosing requirements, or regulatory requirements, or if they otherwise fail to comply with clinical trial protocols or meet expected deadlines, our clinical trials may not meet regulatory requirements. If our clinical trials do not meet regulatory requirements or if these third parties need to be replaced, our clinical trials may be extended, delayed, suspended or terminated. If any of these events occur, we may not be able to obtain regulatory approval of our product candidate and future product candidates or succeed in our efforts to create approved line extensions for certain of our existing products or generate additional useful clinical data in support of these products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-40-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we or our partners fail to comply with these laws and regulations, the FDA, or other foreign regulatory agencies, may take actions that could significantly restrict or prohibit commercial distribution of FT218. If the FDA or other foreign regulatory authorities determine that we are not in compliance with these laws and regulations, they could, among other things:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issue warning letters;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impose fines;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seize products or request or order recalls;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issue injunctions to stop future sales of products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refuse to permit products to be imported into, or exported out of a particular country;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspend or limit our production;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">withdraw or vary approval of marketing applications;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"> withdraw  approval of marketing applications; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">initiate criminal prosecutions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may rely on collaborations with third parties to commercialize FT218 outside of the U.S., if approved, and certain of our future product candidates and such strategy involves risks that could impair our prospects for realizing profits from such products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that the commercialization of FT218 outside of the U.S., if approved, or future product candidates may require collaboration with third-party partners involving strategic alliances, licenses, product divestitures or other arrangements. We may not be successful in entering into such collaborations on favorable terms, if at all, or our collaboration partners may not adequately perform under such arrangements, and as a result our ability to commercialize these products will be negatively affected and our prospects will be impaired.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face significant competition in seeking appropriate collaborators. Whether we reach a definitive agreement for a collaboration will depend, among other things, upon our assessment of the collaborator&#8217;s resources and expertise, the terms and conditions of the proposed collaboration and the proposed collaborator&#8217;s own evaluation of a potential collaboration. Such factors a potential collaborator will use to evaluate a collaboration may include the design or results of clinical trials, the likelihood of approval by the FDA or comparable foreign regulatory authorities, the potential market for FT218 or future product candidates, the potential of competing products, the existence of uncertainty with respect to our ownership of our intellectual property, which can exist if there is a challenge to such ownership without regard to the merits of the challenge and industry and market conditions generally. The collaborator may also consider alternative product candidates or technologies for similar indications that may be available to collaborate on and whether such a collaboration could be more attractive than the one with us for FT218. The terms of any additional collaborations or other arrangements that we may establish may not be favorable to us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also be restricted under collaboration agreements from entering into future agreements on certain terms with potential collaborators. Collaborations are complex and time-consuming to negotiate and document. In addition, there have been a significant number of recent business combinations among large pharmaceutical companies that have resulted in a reduced number of potential future collaborators.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to negotiate additional collaborations on a timely basis, on acceptable terms, or at all. If we are unable to do so, we may have to curtail the development of our product candidates for which we are seeking to collaborate, reduce or delay its development program, delay its potential commercialization or reduce the scope of any sales or marketing activities, or increase our expenditures and undertake development or commercialization activities at our own expense. If we elect to increase our expenditures to fund development or commercialization activities on our own, we may need to obtain additional capital, which may not be available to us on acceptable terms or at all. If we do not have sufficient funds, we may not be able to further develop FT218 outside of the U.S., if approved, or future product candidates, or bring these products to market and generate product revenue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, any future collaborations that we enter into may not be successful. The success of our collaboration arrangements will depend heavily on the efforts and activities of our collaborators. Collaborators generally have significant discretion in determining the efforts and resources that they will apply to these collaborations. Disagreements between parties to a collaboration arrangement regarding clinical development and commercialization matters can lead to delays in the development process or commercializing the applicable product candidate and, in some cases, termination of the collaboration arrangement. These disagreements can be difficult to resolve if neither of the parties has final decision-making authority. Collaborations with pharmaceutical or biotechnology companies and other third parties often are terminated or allowed to expire by the other party. Any such termination or expiration would adversely affect us financially and could harm our business reputation.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-41-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Intellectual Property</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we cannot adequately protect our intellectual property and proprietary information, we may be unable to effectively compete.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends, in part, on our ability to obtain and enforce patents and other intellectual property rights for our product candidate and future product candidates and technology, including our drug delivery technologies, and to preserve our trade secrets and other proprietary information. If we cannot do so, our competitors may exploit our technologies and deprive us of the ability to realize revenues and profits from our product candidate and future product candidates and technologies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent any of our product candidate and future product candidates may benefit from protections afforded by patents, we face the risk that patent law relating to the scope of claims in the pharmaceutical and biotechnology fields is continually evolving and can be the subject of uncertainty and may change in a way that would limit protection. If challenged, a court or other body may determine that our patents may not be exclusive, valid or enforceable. For example, our patents may not protect us against challenges by companies that submit drug marketing applications to the FDA, or the competent authorities of EU Member States or other jurisdictions in which we may attempt to compete, in particular where such applications rely, at least in part, on safety and efficacy data from our product candidate and future product candidates. In addition, competitors may obtain patents that may have an adverse effect on our ability to conduct business, or they may discover ways to circumvent our patents. The scope of any patent protection may not be sufficiently broad to cover our product candidate and future product candidates or to exclude competing products. Any patent applications we have made or may make relating to our potential products or technologies may not result in patents being issued. Even after issuance, our patents may be challenged in the courts or patent offices in the U.S. and elsewhere. Such challenges may result in loss of exclusivity or in patent claims being narrowed, invalidated or held unenforceable, in whole or in part, which could limit our ability to stop others from using or commercializing similar or identical product candidates, or limit the duration of the patent protection of our product candidate and future product candidates. Further, patent protection once obtained is limited in time, after which competitors may use the covered product or technology without obtaining a license from us. Because of the time required to obtain regulatory marketing approval, the remaining period of effective patent protection for a marketed product is frequently substantially shorter than the full duration of the patent. While a patent term extension can be requested under certain circumstances, the grant of such a request is not guaranteed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our partnerships with third parties expose us to risks that they will claim intellectual property rights on our inventions or fail to keep our unpatented products or technology confidential.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to protect the confidentiality of our trade secrets, the value of our technology could be materially adversely affected and our business would be harmed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also rely on trademarks, copyrights, trade secrets and know-how to develop, maintain and strengthen our competitive position.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To protect our product candidate, trade secrets and proprietary technologies, we rely, in part, on confidentiality agreements with our employees, suppliers, consultants, advisors and partners. These agreements may not provide adequate protection for our trade secrets and other proprietary information in the event of any unauthorized use or disclosure, or if others lawfully develop the information. If these agreements are breached, we cannot be certain we will have adequate remedies. Further, we cannot guarantee that third parties will not know, discover or independently develop equivalent proprietary information or technologies, or that they will not gain access to our trade secrets or disclose our trade secrets to the public. Therefore, we cannot guarantee we can maintain and protect unpatented proprietary information and trade secrets. Misappropriation or other loss of our intellectual property would adversely affect our competitive position and may cause us to incur substantial litigation or other costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we and our partners do not adequately protect the trademarks and trade names for our products, then we and our partners may not be able to build name recognition in our markets of interest and our business may be adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competitors or other third parties may challenge, infringe or circumvent the trademarks or trade names for our products. We and our partners may not be able to protect these trademarks and trade names. In addition, if the trademarks or trade names for one of our products infringe the rights of others, we or our partners may be forced to stop using the trademarks or trade names, which we need for name recognition in our markets of interest. If we cannot establish name recognition based on our trademarks and trade names, we and our partners may not be able to compete effectively and our business may be adversely affected.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-42-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in U.S. or ex-U.S. patent laws could diminish the value of patents in general, thereby impairing our ability to protect our product candidate and future product candidates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in either the patent laws or interpretation thereof in the U.S. or in ex-U.S. jurisdictions could increase uncertainties and costs surrounding the prosecution of patent applications and the enforcement or defense of issued patents. For example, the Leahy-Smith America Invents Act of 2011 (&#8220;AIA&#8221;), changed the previous U.S. &#8220;first-to-invent&#8221; system to the current system that awards a patent to the &#8220;first-inventor-to-file&#8221; for an application for a patentable invention. This change alters the pool of available materials that can be used to challenge patents in the U.S. and limits the ability to rely on prior research to lay claim to patent rights. Under the current system, disputes are resolved through new derivation proceedings, and the AIA includes mechanisms to allow challenges to issued patents in reexamination, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review and post grant proceedings. The AIA also includes bases and procedures that may make it easier for competitors to challenge our patents, which could result in increased competition and have a material adverse effect on our business and results of operations. The AIA may also make it harder to challenge third-party patents and place greater importance on being the first inventor to file a patent application on an invention. The AIA amendments to patent filing and litigation procedures in the U.S. may result in litigation being more complex and expensive and divert the efforts of our technical and management personnel.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the patent positions of companies in the development and commercialization of pharmaceuticals may be particularly uncertain. Depending on future actions by the U.S. Congress, the U.S. federal courts, and the USPTO, or by similarly legislative, judicial, and regulatory authorities in other jurisdictions, the laws and regulations governing patents could change in unpredictable ways that could have a material adverse effect on our existing patent portfolio and our ability to protect and enforce our intellectual property in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Third parties may claim that our product candidate or future product candidates infringe their rights, and we may incur significant costs resolving these claims. Additionally, legal proceedings related to such claims could materially delay or otherwise adversely affect commercialization plans related to our product candidate, if approved. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third parties may claim infringement of their patents and other intellectual property rights by the manufacture, use, import, offer for sale or sale of our drug delivery technologies or our other products. For example, in connection with us seeking regulatory approval for a product candidate, a third party may allege that our product candidate infringes its patents or other intellectual property rights and file suit to delay/prevent regulatory approval and/or commercialization of such product. In response to any claim of infringement, we may choose or be forced to seek licenses, defend infringement actions or challenge the validity or enforceability of those patent rights in court or administrative proceedings. If we cannot obtain required licenses on commercially reasonably terms, or at all, are found liable for infringement or are not able to have such patent rights declared invalid or unenforceable, our business could be materially harmed. We may be subject to claims (and even held liable) for significant monetary damages (including enhanced damages and/or attorneys&#8217; fees), encounter significant delays in bringing products to market or be precluded from the manufacture, use, import, offer for sale or sale of products or methods of drug delivery covered by the patents of others. Even if a license is available, it may not be available on commercially reasonable terms or may be non-exclusive, which could result in our competitors gaining access to the same intellectual property. We may not have identified, or be able to identify in the future, U.S. or non-U.S. patents that pose a risk of potential infringement claims.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the possibility of intellectual property infringement claims, a third party could submit a citizen&#8217;s petition to the FDA requesting relief that, if granted, could materially adversely affect the NDA and/or underlying product candidate. For example, such a third-party petition could, if granted, materially adversely affect the likelihood and/or timing of NDA approval, content of final product labeling, and/or resulting regulatory exclusivity (if any) for such product.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Parties making claims against us may be able to sustain the costs of patent litigation more effectively than we can because they have substantially greater resources. In addition, any claims, with or without merit, that our product candidate, future product candidates or drug delivery technologies infringe proprietary rights of third parties could be time-consuming, result in costly litigation or divert the efforts of our technical and management personnel, any of which could disrupt our relationships with our partners and could significantly harm our financial positions and operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">An NDA submitted under Section 505(b)(2) subjects us to the risk that we may be subject to a patent infringement lawsuit that would delay or prevent the review or approval of our product candidates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FT218 was submitted under Section 505(b)(2) of the FDCA. Section 505(b)(2) permits the submission of an NDA where at least some of the information required for approval comes from preclinical studies or clinical trials that were not conducted by, or for, the applicant and for which the applicant has not obtained a right of reference. A 505(b)(2) NDA enables the applicant to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-43-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reference published literature for which the applicant does not have a right of reference and the FDA&#8217;s previous findings of safety and effectiveness for a previously approved drug.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 505(b)(2) NDAs, the patent certification and related provisions of the Hatch-Waxman Amendments apply. Accordingly, if the applicant relies for approval on the safety or effectiveness on information for a previously approved drug, referred to as a listed drug, the applicable is required to include patent certifications in our 505(b)(2) NDA regarding any applicable patents covering the listed drug. If there are applicable patents listed in the FDA publication Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book, for the listed drug, and the applicant seeks to obtain approval prior to the expiration of one or more of those patents, the applicant is required to submit a Paragraph IV certification indicating our belief that the relevant patents are invalid or unenforceable or will not be infringed by the manufacture, use or sale of the product that is the subject of the 505(b)(2) application. Otherwise, the 505(b)(2) NDA cannot be approved by the FDA until the expiration of any patents listed in the Orange Book for the listed drug. While we did not submit any Paragraph IV certifications in connection with our 505(b)(2) NDA for FT218, there can be no assurance that we will not be required to submit a Paragraph IV certification in respect of FT218 or any future product candidates for which we seek approval under Section 505(b)(2).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we submit any Paragraph IV certification that may be required, we will be required to provide notice of that certification to the NDA holder and patent owner. Under the Hatch-Waxman Amendments, the patent owner may file a patent infringement lawsuit after receiving such notice. If a patent infringement lawsuit is filed within 45 days of the patent owner&#8217;s or NDA holder&#8217;s receipt of notice (whichever is later), a one-time, automatic stay of the FDA&#8217;s ability to approve the 505(b)(2) NDA is triggered, which typically extends for 30 months unless patent litigation is resolved in favor of the Paragraph IV filer or the patent expires before that time. Accordingly, we may invest a significant amount of time and expense in the development of one or more product candidates only to be subject to significant delay and patent litigation before such product candidates may be commercialized, if at all.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, a 505(b)(2) NDA will not be approved until any applicable non-patent exclusivity listed in the Orange Book for the listed drug, or for any other drug with the same protected conditions of approval as our product, has expired. The FDA also may require us to perform one or more additional clinical trials or measurements to support the change from the listed drug, which could be time consuming and could substantially delay our achievement of regulatory approval. The FDA also may reject any future 505(b)(2) NDAs and require us to submit traditional NDAs under Section 505(b)(1), which would require extensive data to establish safety and effectiveness of the product for the proposed use and could cause delay and additional costs. In addition, the FDA could reject any future 505(b)(2) application and require us to submit a Section 505(b)(1) NDA or a Section 505(j) ANDA if, before the submission of our 505(b)(2) application, the FDA approves an application for a product that is pharmaceutically equivalent to ours and determines that our product is inappropriate for review through the 505(b)(2) pathway. These factors, among others, may limit our ability to commercialize our product candidates successfully. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we or our partners are required to obtain licenses from third parties, our revenues and royalties on any future commercialized products could be reduced.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The development of certain products based on our drug delivery technologies may require the use of raw materials (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> proprietary excipient), active ingredients, drugs (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> proprietary proteins) or technologies developed by third parties. The extent to which efforts by other researchers have resulted or will result in patents and the extent to which we or our partners are forced to obtain licenses from others, if available, on commercially reasonable terms is currently unknown. If we or our partners must obtain licenses from third parties, fees may be required for such licenses, which could reduce the net revenues and royalties we receive on any future commercialized products that incorporate our drug delivery technologies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Patent terms may be inadequate to protect our competitive position on our product candidate or future product candidates for an adequate amount of time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patents have a limited lifespan. In the U.S., if all maintenance fees are timely paid, the natural expiration of a patent is generally 20 years from its earliest U.S. non-provisional filing date. Various extensions may be available, but the life of a patent, and the protection it affords, is limited. Even if patents covering our product candidate and future product candidates are obtained, once the patent life has expired, we may be open to competition from competitive products, including generics or biosimilars. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, our owned and licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Obtaining and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-44-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">eliminated for non-compliance with these requirements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodic maintenance fees, renewal fees, annuity fees and various other governmental fees on patents and/or applications will be due to be paid to the USPTO and various governmental patent agencies outside of the U.S. in several stages over the lifetime of the patents and/or applications. We rely on our outside counsel to coordinate payment of these fees due to patent agencies. The USPTO and various non-U.S. governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. We employ reputable law firms and other professionals to help us comply, and in many cases, an inadvertent lapse can be cured by payment of a late fee or by other means in accordance with the applicable rules. However, there are situations in which non-compliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such an event, our competitors might be able to enter the market and this circumstance would have a material adverse effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to protect our intellectual property rights throughout the world.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filing, prosecuting and defending patents on our product candidate and future product candidates in all countries throughout the world would be prohibitively expensive, and intellectual property rights in some countries outside the U.S. can be less extensive than those in the U.S. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the U.S., or from selling or importing products made using our inventions in and into the U.S. or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and may also export infringing products to territories where we have patent protection, but enforcement is not as strong as that in the U.S. These products may compete with our product candidate and future product candidates and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many companies have encountered significant problems in protecting and defending intellectual property rights in non-U.S. jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets, and other intellectual property protection, which could make it difficult for us to stop the infringement of our patents or marketing of competing products in violation of our proprietary rights generally. Proceedings to enforce our patent rights in non-U.S. jurisdictions, whether or not successful, could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in any lawsuits we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property we develop or license.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Acceptance, Sales, Marketing and Competition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to establish effective sales, marketing and distribution capabilities for FT218, if approved, or enter into agreements with third parties to market, sell and distribute our product candidate, if approved, or if we are unable to achieve market acceptance for FT218, our business, results of operations, financial condition and prospects will be materially adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are continuing to build the systems, processes, policies, relationships and materials necessary for the launch of FT218 in the U.S. for the treatment of cataplexy or EDS in adults with narcolepsy. If we receive regulatory approval to market or sell FT218, but are unable to establish adequate sales, marketing and distribution capabilities, whether independently or with third parties, or if we are unable to do so on commercially reasonable terms, our business, results of operations, financial condition and prospects will be materially adversely affected. We may encounter issues, delays or other challenges in launching or commercializing FT218. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have limited experience in building and managing a commercial team, conducting a comprehensive market analysis, obtaining state licenses and reimbursement, or managing distributors and a sales force for our medicines. For example, our results may be negatively impacted if we have not adequately sized our field teams or if our targeting strategy is inadequate or if we encounter deficiencies or inefficiencies in our infrastructure or processes. We will be competing with many companies that currently have extensive and well-funded sales and marketing operations. As a result, our ability to successfully commercialize FT218 may involve more inherent risk, take longer, and cost more than it would if we were a company with substantial experience in launching medicines.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will have to compete with other pharmaceutical and biotechnology companies to recruit, hire, train and retain marketing and sales personnel. If we are unable to, or decide not to, further develop internal sales, marketing, and commercial distribution </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-45-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">capabilities for FT218 in any country or region, we will likely pursue collaborative arrangements regarding the sales and marketing of FT218. However, there can be no assurance that we will be able to establish or maintain such collaborative arrangements, or if we are able to do so, that they will have effective sales forces. Any revenue we receive will depend upon the efforts of such third parties. We would have little or no control over the marketing and sales efforts of such third parties, and our revenue from product sales may be lower than if we had commercialized FT218 ourselves. We also face competition in our search for third parties to assist us with the sales and marketing efforts for our medicines.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of these issues could impair our ability to successfully commercialize FT218 or to generate substantial revenues or profits or to meet our expectations with respect to the amount or timing of revenues or profits.  There is no guarantee that we will be successful in our launch or commercialization efforts with respect to FT218, if approved, or with respect to any other product candidate that may be approved in the future.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the market opportunities for FT218 are smaller than we believe they are, and if we are not able to successfully identify patients and achieve significant market share, our revenues may be adversely affected and our business may suffer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FT218 is an investigational formulation of sodium oxybate designed to be taken once at bedtime for the treatment of EDS or cataplexy in adults with narcolepsy. Our estimates of the market opportunities for FT218 are based on the estimated </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">market size for the twice-nightly administration of sodium oxybate, which is the current standard of care for EDS or cataplexy in patients with narcolepsy, and our expectations with regard to FT218&#8217;s potential to take a significant share of this market</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates have been derived from a variety of sources, including scientific literature, surveys of clinics, patient foundations, or market research, and may prove to be incorrect. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, new studies may change the estimated incidence or prevalence of these diseases. The potential target population for FT218 may turn out to be lower or more difficult to identify than expected. Even if we obtain significant market share for FT218 in this indication, because the potential target population for FT218 is small, we may never achieve profitability without obtaining marketing approval for additional indications. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of these factors may negatively affect our ability to recognize revenues from sales of FT218 and our ability to achieve and maintain profitability and, as a consequence, our business may suffer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FT218, if approved, may not gain market acceptance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FT218, if approved, may not gain market acceptance among physicians, patients, healthcare payor and medical communities. The degree of market acceptance of FT218, if approved, will depend on a number of factors, including, but not limited to:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the clinical indications for which FT218 is approved and any restrictions placed upon the product in connection with its approval, such as a REMS or equivalent obligation by other regulatory authorities, patient registry requirements or labeling restrictions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the prevalence of the disease or condition for which FT218 is approved and its diagnosis;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">scheduling classification of sodium oxybate as a controlled substance regulated by the DEA;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">demonstration of the clinical safety and efficacy of the product or technology;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the absence of evidence of undesirable side effects of the product or technology that delay or extend trials;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acceptance by physicians and patients of each product as a safe and effective treatment;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">availability of sufficient product inventory to meet demand;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">physicians&#8217; decisions relating to treatment practices based on availability;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">physician and patient assessment of the burdens associated with obtaining or maintaining the certifications required under the FT218 REMS, if approved;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the lack of regulatory delays or other regulatory actions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">its cost-effectiveness and related access to payor coverage;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">its potential advantage over alternative treatment methods;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the availability of third-party reimbursement or other assistance for patients who are uninsured or underinsured; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the marketing and distribution support it receives.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If FT218, if approved, fails to achieve market acceptance, our ability to generate revenue will be limited, which would have a material adverse effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-46-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FT218, if approved, will be subject to ongoing enforcement of post-marketing requirements and we could be subject to substantial penalties, including withdrawal of FT218 from the market, if we fail to comply with all regulatory requirements. In addition, the terms of the marketing approval of FT218, if approved, and ongoing regulation of our product, may limit how we manufacture and market FT218 and compliance with such requirements may involve substantial resources, which could materially impair our ability to generate revenue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If approved, FT218, along with the manufacturing processes, post-approval clinical data, labeling, advertising, and promotional activities for FT218, will be subject to continual requirements of and review by the FDA and other applicable regulatory authorities. These requirements include, but are not limited to, restrictions governing promotion of an approved product, submissions of safety and other post-marketing information and reports, registration and listing requirements, cGMP requirements relating to manufacturing, quality control, quality assurance and corresponding maintenance of records and documents, and requirements regarding drug distribution and the distribution of samples to physicians and recordkeeping.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., the FDA and other federal and state agencies, including the Department of Justice, closely regulate compliance with all requirements governing prescription drug products, including requirements pertaining to marketing and promotion of drugs in accordance with the provisions of the approved labeling and manufacturing of products in accordance with cGMP requirements. Violations of such requirements may lead to investigations alleging violations of the FDCA and other statutes, including the FDA and other federal and state healthcare fraud and abuse laws as well as state consumer protection laws. Our failure to comply with all regulatory requirements, and later discovery of previously unknown adverse events or other problems with our products, manufacturers, or manufacturing processes, may yield various results, including:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">litigation involving patients taking our products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictions on such products, manufacturers, or manufacturing processes;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictions on the labeling or marketing of a product;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictions on product distribution or use;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">requirements to conduct post-marketing studies or clinical trials;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">warning or untitled letters;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">withdrawal of the products from the market;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refusal to approve pending applications or supplements to approved applications that we submit;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">voluntary recall of products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fines, restitution, or disgorgement of profits or revenues;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspension or withdrawal of marketing approvals;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">damage to relationships with any potential collaborators;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unfavorable press coverage and damage to our reputation;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refusal to permit the import or export of our products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">product seizure; or</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">injunctions or the imposition of civil or criminal penalties.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-compliance by us or any future collaborator with regulatory requirements, including safety monitoring or pharmacovigilance, and with requirements related to the development of products for the pediatric population can also result in significant financial penalties. Similarly, failure to comply with applicable regulatory requirements regarding the protection of personal information can also lead to significant penalties and sanctions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we and our CDMOs will continue to expend time, money, and effort in all areas of regulatory compliance, including manufacturing, production, product surveillance, quality control and distribution. Under the DSCSA, for certain commercial prescription drug products, manufacturers and other parties involved in the supply chain must also meet chain of distribution requirements and build electronic, interoperable systems for product tracking and tracing and for notifying the FDA of counterfeit, diverted, stolen, and intentionally adulterated products or other products that are otherwise unfit for distribution in the U.S. In addition, the distribution of prescription pharmaceutical products, including samples, is subject to the PDMA, which regulations the distribution of drugs and drug samples at the federal level, and sets minimum standards for the registration and regulation of drug distributors by the states. Both the PDMA and state laws limit the distribution of prescription pharmaceutical product samples and impose requirements to ensure accountability in distribution. Prescription drug products must also meet applicable child-resistant packaging requirements under the U.S. Poison Prevention Packaging Act. We, our CDMOs and other third parties upon whom we rely will be subject to applicable controlled substances laws, regulations and requirements. If FT218 is approved and we are not able to comply with post-approval regulatory requirements, we could have the marketing approvals for FT218 withdrawn by regulatory authorities and our ability to market FT218 could be limited, which could adversely affect our ability to achieve or sustain profitability and we could be subject to substantial penalties. As a result, the cost of compliance with post-approval regulations may have a negative effect on our operating results and financial condition.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-47-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our competitors develop and market technologies or products that are safer or more effective than ours, or obtain regulatory approval and market such products before we do, our commercial opportunity will be diminished or eliminated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competition in the pharmaceutical and biotechnology industry is intense and is expected to increase. We compete with academic laboratories, research institutions, universities, joint ventures and other pharmaceutical and biotechnology companies, including companies developing drug delivery technologies or niche brand or generic specialty pharmaceutical products. Some of these competitors may also be our business partners.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the FDA approves a competitor&#8217;s application for a product candidate before our application for a similar product candidate, and grants such competitor a period of exclusivity, the FDA may take the position that it cannot approve our 505(b)(2) application for a similar product candidate until the exclusivity period expires. Additionally, even if our 505(b)(2) application for a product candidate is approved first, and we receive a period of statutory marketing exclusivity, we may still be subject to competition from other companies with approved products or approved 505(b)(2) NDAs for different conditions of use that would not be restricted by a grant of exclusivity to us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our competitors have substantially greater financial, technological, manufacturing, marketing, managerial and research and development resources and experience than we do. Furthermore, acquisitions of competing companies by large pharmaceutical companies could enhance our competitors&#8217; resources. Accordingly, our competitors may be able to develop, obtain regulatory approval and gain market share for their products more rapidly than us.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the FDA or other applicable regulatory authorities approve generic products that compete with any of our product candidates, the sales of our product candidates, if approved, could be adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once an NDA, including a 505(b)(2) NDA, is approved, the product covered becomes a &#8220;listed drug&#8221; which can be cited by potential competitors in support of approval of an ANDA or subsequent 505(b)(2) application. FDA regulations and other applicable regulations and policies provide incentives to manufacturers to create modified versions of a drug to facilitate the approval of an ANDA or other application for similar substitutes. If these manufacturers demonstrate that their product has the same active ingredient(s), dosage form, strength, route of administration, and conditions of use, or labeling, as our products or product candidates, they might only be required to conduct a relatively inexpensive study to show that their generic product is absorbed in the body at the same rate and to the same extent as, or is bioequivalent to, our products or product candidates. In some cases, even this limited bioequivalence testing can be waived by the FDA. Laws have also been enacted to facilitate the development of generic drugs based off recently approved NDAs. The Creating and Restoring Equal Access to Equivalent Samples Act (&#8220;CREATES Act&#8221;) was enacted in 2019 requiring sponsors of approved NDAs to provide sufficient quantities of product samples on commercially reasonable, market-based terms to entities developing generic drugs. The law establishes a private right of action allowing developers to sue listed drug holders that refuse to sell them product samples needed to support their applications. If we are required to provide product samples or allocate additional resources to responding to such requests or any legal challenges under this law, our business could be adversely impacted. Competition from generic equivalents to our products or product candidates could substantially limit our ability to generate revenues and therefore to obtain a return on the investments we have made in our products or product candidates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we cannot keep pace with the rapid technological change in our industry, we may lose business, and our product candidates, if approved, and technologies could become obsolete or noncompetitive.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success also depends, in part, on maintaining a competitive position in the development of products and technologies in a rapidly evolving field. Major technological changes can happen quickly in the biotechnology and pharmaceutical industries. If we cannot maintain competitive products and technologies, our competitors may succeed in developing competing technologies or obtaining regulatory approval for products before us, and the products of our competitors may gain market acceptance more rapidly than our product candidate and future product candidates. Such rapid technological change, or the development by our competitors of technologically improved or different products, could render our product candidate and future product candidates or technologies obsolete or noncompetitive.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business and Industry</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 may materially and adversely affect our business and our financial results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has spread globally. The continued spread of COVID-19 could adversely impact our operations, including our ability to fully enroll and complete RESTORE, our OLE/switch study of FT218, initiate and complete any future </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-48-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">clinical trials, manufacture sufficient supply of our FT218 at sufficient scale for commercialization, if approved. We submitted our 505(b)(2) NDA for FT218 in December 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, COVID-19 has resulted in significant governmental measures being implemented to control the spread of the virus, including quarantines, travel restrictions, social distancing and business shutdowns. We have taken temporary precautionary measures intended to help minimize the risk of the virus to our employees, including temporarily allowing employees to work remotely. We have suspended non-essential travel worldwide for our employees and are discouraging employee attendance at large gatherings. These measures could negatively affect our business. For instance, temporarily allowing employees to work remotely may induce absenteeism, disrupt our operations or increase the risk of a cybersecurity incident. COVID-19 has also caused volatility in the global financial markets and threatened a slowdown in the global economy, which may negatively affect our ability to raise additional capital on attractive terms or at all.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the beginning of the COVID-19 pandemic, three vaccines for COVID-19 have received Emergency Use Authorization by the FDA and two of those later received marketing approval. Additional vaccines may be authorized in the future. The resultant demand for vaccines and potential for manufacturing facilities and materials to be commandeered under the Defense Production Act of 1950, or equivalent foreign legislation, may make it more difficult to obtain materials or manufacturing slots for the products needed for our OLE/switch clinical trial and future commercialization of FT218, if approved, which could lead to delays in these activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which COVID-19 may impact our business will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the duration of the pandemic, the severity of COVID-19, the identification of new variations of the virus or the effectiveness of actions to contain and treat COVID-19, particularly in the geographies where we or our third party suppliers and CDMOs, or CROs operate.  We cannot presently predict the scope and severity of any potential business shutdowns or disruptions. If we or any of the third parties with whom we engage, however, were to experience shutdowns or other business disruptions, our ability to conduct our business in the manner and on the timelines presently planned could be materially and negatively affected, which could have a material adverse impact on our business and our results of operations and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we need to take further restructuring actions, necessary third-party consents may not be granted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2019, we announced a restructuring plan intended to achieve future cost savings through, among other actions, a reduction of our overall workforce by approximately 50 percent. Our management may determine we need to take further restructuring actions to achieve additional cost savings, to generate additional capital needed for our business strategy, or for other purposes. Certain restructuring scenarios that management consider could require obtaining the consent of third parties, such as holders of our Exchangeable Senior Notes due February 2023 (the &#8220;February 2023 Notes&#8221;). For example, the voluntary bankruptcy filing by Avadel Specialty Pharmaceuticals LLC (&#8220;Specialty Pharma&#8221;) required the consent of holders of a majority in principal amount of our February 2023 Notes in order to avoid a default under the Indenture governing such February 2023 Notes. While we were successful in obtaining that consent, there can be no assurance we will be successful in obtaining additional consents in the future from such holders or from other third parties whose consents may be required. Failure to obtain these third-party consents would prevent us from taking additional restructuring actions, which could have a material adverse effect on our cash flow, financial resources and ability to successfully pursue our business strategy.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Litigation and Legal Matters</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may become involved in lawsuits to protect or enforce our patents or other intellectual property, which could be expensive, time consuming and unsuccessful.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competitors may infringe our patents or other intellectual property. If we were to initiate legal proceedings against a third party to enforce a patent covering our product candidate or future product candidates, the defendant could counterclaim that the patent is invalid and/or unenforceable. In patent litigation in the U.S., defendant counterclaims alleging invalidity and/or unenforceability are commonplace. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of novelty, obviousness, written description or non-enablement. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the USPTO, or made a misleading statement, during prosecution. There is risk that a court could rule in favor of the defendant with respect to such a counterclaim of patent invalidity and/or unenforceability.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interference or derivation proceedings provoked by third parties or brought by us or declared by the USPTO may be necessary to determine the priority of inventions with respect to our patents or patent applications. An unfavorable outcome could require </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-49-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">us to cease using the related technology or to attempt to license rights to it from the prevailing party. Our business could be harmed if the prevailing party does not offer us a license on commercially reasonable terms or at all, or if a non-exclusive license is offered and our competitors gain access to the same technology. Our defense of litigation or interference or derivation proceedings may fail and, even if successful, may result in substantial costs and distract our management and other employees. In addition, the uncertainties associated with litigation could have a material adverse effect on our ability to raise the funds necessary to continue our clinical trials, continue our research programs, license necessary technology from third parties, or enter into development partnerships that would help us bring our product candidate and future product candidates to market.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the substantial amount of discovery that can occur in connection with intellectual property-related litigation and/or administrative proceedings, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation/proceeding. There could also be public announcements of the results of hearings, motions, or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of our common stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to claims that our employees, consultants or independent contractors have wrongfully used or disclosed confidential information of third parties or that our employees have wrongfully used or disclosed alleged trade secrets of their former employers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We employ or may employ individuals who were previously employed at universities or other biotechnology or pharmaceutical companies, including our competitors or potential competitors. Although we endeavor to ensure that our employees, consultants and independent contractors do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or our employees, consultants or independent contractors have inadvertently or otherwise used or disclosed intellectual property, including trade secrets or other proprietary information, of any of our employee&#8217;s former employer or other third parties. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying any awarded monetary damages, we may lose valuable intellectual property rights or personnel, which could adversely impact our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and/or be a distraction to management and other employees.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We and companies to which we have licensed, or will license our future products or drug delivery technologies and subcontractors we engage or may engage for services related to the development and manufacturing of our lead product candidate or future product candidates are subject to extensive regulation by the FDA and other regulatory authorities. Our and their failure to meet strict regulatory requirements could adversely affect our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, and companies to which we will license our future products or drug delivery technologies, as well as companies acting as subcontractors for our product developments, including but not limited to non-clinical, pre-clinical and clinical studies, and manufacturing, are subject to extensive regulation by the FDA, other U.S. authorities and equivalent non-U.S. regulatory authorities, particularly the European Commission and the competent authorities of EU Member States. Those regulatory authorities may conduct periodic audits or inspections of the applicable facilities to monitor compliance with regulatory standards and we remain responsible for the compliance of our subcontractors. If the FDA or another regulatory authority finds failure to comply with applicable regulations, the authority may institute a wide variety of enforcement actions, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">warning letters or untitled letters;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fines and civil penalties;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in clearing or approving, or refusal to clear or approve, products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">withdrawal, suspension or variation of approval of products; product recall or seizure;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">orders to the competent authorities of EU Member States to withdraw or vary national authorization;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">orders for physician notification or device repair, replacement or refund;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">interruption of production;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operating restrictions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">injunctions; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">criminal prosecution.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any adverse action by a competent regulatory agency could lead to unanticipated expenditures to address or defend such action and may impair our ability to produce and market applicable products, which could significantly impact our revenues and royalties that we would be eligible to receive from our potential customers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may face product liability claims related to clinical trials for our product candidate or future product candidates or their misuse.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-50-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The testing, including through clinical trials, manufacturing and marketing, and the use of our product candidate and future product candidates may expose us to potential product liability and other claims. If any such claims against us are successful, we may be required to make significant compensation payments. Any indemnification that we have obtained, or may obtain, from CROs or pharmaceutical and biotechnology companies or hospitals conducting human clinical trials on our behalf may not protect us from product liability claims or from the costs of related litigation. Insurance coverage is expensive and difficult to obtain, and we may be unable to obtain coverage in the future on acceptable terms, if at all. We currently maintain general liability insurance and product liability insurance. We cannot be certain that the coverage limits of our insurance policies or those of our strategic partners will be adequate. If we are unable to obtain sufficient insurance at an acceptable cost, a product liability claim or recall could adversely affect our financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similarly, any indemnification we have obtained, or may obtain, from pharmaceutical and biotechnology companies with whom we are developing, or will develop, our future products may not protect us from product liability claims from the consumers of those products or from the costs of related litigation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we use hazardous biological and/or chemical materials in a manner that causes injury, we may be liable for significant damages.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our R&amp;D activities involve the controlled use of potentially harmful biological and/or chemical materials, and are subject to U.S., state, EU, national and local laws and regulations governing the use, storage, handling and disposal of those materials and specified waste products. We cannot completely eliminate the risk of accidental contamination or injury from the use, storage, handling or disposal of these materials, including fires and/or explosions, storage tank leaks and ruptures and discharges or releases of toxic or hazardous substances. These operating risks can cause personal injury, property damage and environmental contamination, and may result in the shutdown of affected facilities and the imposition of civil or criminal penalties. The occurrence of any of these events may significantly reduce the productivity and profitability of a particular manufacturing facility and adversely affect our operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently maintain property, business interruption and casualty insurance with limits that we believe to be commercially reasonable but may be inadequate to cover any actual liability or damages.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Ownership of Our Securities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The price of ADSs representing our ordinary shares has been volatile and may continue to be volatile.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading price of ADSs has been, and is likely to continue to be, highly volatile. The market value of an investment in ADSs may fall sharply at any time due to this volatility. During the year ended December&#160;31, 2021, the closing sale price of ADSs as reported on the Nasdaq Global Market ranged from $6.49 to $11.18. During the year ended December&#160;31, 2020, the closing sale price of ADSs as reported on the Nasdaq Global Market ranged from $4.06 to $11.75. The market prices for securities of drug delivery, specialty pharma, biotechnology and pharmaceutical companies historically have been highly volatile. Factors that could adversely affect our share price include, among others:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fluctuations in our operating results;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements of technological partnerships, innovations or new products by us or our competitors;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actions with respect to the acquisition of new or complementary businesses;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">governmental regulations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments in patent or other proprietary rights owned by us or others;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">public concern as to the safety of drug delivery technologies developed by us or drugs developed by others using our platform;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the results of pre-clinical testing and clinical studies or trials by us or our competitors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adverse events related to our product candidate or future product candidates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lack of efficacy of our product candidate or future product candidates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">litigation;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decisions by our pharmaceutical and biotechnology company partners relating to the products that may incorporate our technologies;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the perception by the market of specialty pharma, biotechnology, and high technology companies generally; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general market conditions, including the impact of the current financial environment; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the dilutive impact of any new equity or convertible debt securities we may issue or have issued.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-51-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to the 2023 Notes</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Servicing our February 2023 Notes and our October 2023 Notes (as defined below) may require a significant amount of cash, and we may not have sufficient cash or the ability to raise the funds necessary to settle exchanges of the 2023 Notes in cash, repay the Notes at maturity, or repurchase the 2023 Notes as required following a fundamental change.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2018, we issued $143,750 aggregate principal amount of our February 2023 Notes. Prior to February 2023, the February 2023 Notes are convertible at the option of the holders only under certain conditions or upon the occurrence of certain events. On March 16, 2022, we executed an agreement to exchange $117,375 of the February 2023 Notes for a new series of Exchangeable Senior Notes due October 2, 2023 (the &#8220;October 2023 Notes&#8221;). We refer to the February 2023 Notes and the October 2023 Notes as the &#8220;2023 Notes&#8221;. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If holders of the 2023 Notes elect to exchange their 2023 Notes, unless we elect to deliver solely our ADSs to settle such exchanges, we will be required to make cash payments in respect of the 2023 Notes being exchanged.  Holders of the 2023 Notes also have the right to require us to repurchase all or a portion of their 2023 Notes upon the occurrence of a fundamental change (as defined in the applicable indenture governing the 2023 Notes) at a repurchase price equal to 100% of the principal amount of the 2023 Notes to be repurchased, plus accrued and unpaid interest. If the 2023 Notes have not previously been exchanged or repurchased, we will be required to repay the 2023 Notes in cash at maturity.  Our ability to make cash payments in connection with exchanges of the 2023 Notes, repurchase the 2023 Notes in the event of a fundamental change, or to repay or refinance the 2023 Notes at maturity will depend on market conditions and our future performance, which is subject to economic, financial, competitive, and other factors many of which are beyond our control. We had limited net income in 2020 and incurred a net loss in 2021. As a result, we may not have enough available cash or be able to obtain financing at the time we are required to repurchase or repay the 2023 Notes or in the event we elect to pay cash with respect to 2023 Notes being exchanged.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The conditional exchange feature of the 2023 Notes, if triggered, may adversely affect our financial condition and operating results.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event the conditional exchange feature of the 2023 Notes is triggered, holders of 2023 Notes will be entitled to exchange the 2023 Notes at any time during specified periods at their option. If one or more holders elect to exchange their 2023 Notes, unless we elect to satisfy our exchange obligation by causing to be delivered solely ADSs (other than paying cash in lieu of any fractional ADSs), we would be required to settle a portion or all of our exchange obligation through the payment of cash, which could adversely affect our liquidity. In addition, even if holders do not elect to exchange their 2023 Notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the 2023 Notes as a current rather than long-term liability, which would result in a material reduction of our net working capital.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The accounting method for convertible and exchangeable debt securities that may be settled in cash, such as the 2023 Notes, could have a material effect on our reported financial results.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 470, Debt, an entity must separately account for the liability and equity components of convertible debt instruments (such as the 2023 Notes) that may be settled entirely or partially in cash upon conversion in a manner that reflects the issuer&#8217;s economic interest cost. ASC 470-20 requires the value of the conversion option of the 2023 Notes, representing the equity component, to be recorded as additional paid-in capital within stockholders&#8217; equity in our consolidated balance sheets and as a discount to the 2023 Notes, which reduces their initial carrying value. In addition, under the treasury stock method, if the conversion value of the 2023 Notes exceeds their principal amount for a reporting period, then we will calculate our diluted earnings per share assuming that all the 2023 Notes were converted and that we issued shares of our common stock to settle the excess. However, if reflecting the 2023 Notes in diluted earnings per share in this manner is anti-dilutive, or if the conversion value of the 2023 Notes does not exceed their principal amount for a reporting period, then the shares of common stock underlying the 2023 Notes will not be reflected in our diluted earnings per share.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (&#8220;ASU 2020-06&#8221;), which eliminates the beneficial conversion and cash conversion accounting models for convertible instruments. This would reduce non-cash interest expense, and thereby decrease net loss (or increase net income). Additionally, the treasury stock method for calculating earnings per share will no longer be allowed for convertible debt instruments whose principal amount may be settled using shares and the if-converted method will be required.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-52-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We elected to early adopt ASU 2020-06 beginning with our fiscal year ending December 31, 2021, including any interim periods within that fiscal year. Under ASU 2020-06, the 2023 Notes will be subject to the &#8220;if-converted&#8221; method for calculating diluted earnings per share. Accordingly, under the &#8220;if-converted&#8221; method, diluted earnings per share will be calculated assuming that all of the Convertible Notes were converted solely into shares of common stock at the beginning of the reporting period, unless the result would be anti-dilutive. This new method of calculating earnings per share may adversely affect our reported financial condition and results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of the conditions to the convertibility of the 2023 Notes is satisfied, then we may be required under applicable accounting standards to reclassify the liability carrying value of the 2023 Notes as a current, rather than a long-term, liability. This reclassification could be required even if no noteholders convert their 2023 Notes and could materially reduce our reported working capital.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exchanges of the 2023 Notes will dilute the ownership interest of our existing shareholders and holders of the ADSs, including holders who may exchange their 2023 Notes and receive ADSs upon exchange, to the extent our exchange obligation includes ADSs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exchange of some or all of the 2023 Notes will dilute the ownership interests of our existing shareholders and holders of the ADSs to the extent our exchange obligation includes ADSs. Any sales in the public market of the ADSs issuable upon such exchange of the 2023 Notes could adversely affect prevailing market prices of the ADSs and, in turn, the price of the 2023 Notes. In addition, the existence of the 2023 Notes may encourage short selling by market participants because the exchange of the 2023 Notes could depress the price of the ADSs.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The fundamental change repurchase feature of the 2023 Notes may delay or prevent an otherwise beneficial takeover attempt of Avadel.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The indenture governing the 2023 Notes will require us to repurchase the 2023 Notes for cash upon the occurrence of a fundamental change and, in certain circumstances, to increase the exchange rate for a holder that exchanges its 2023 Notes in connection with a make-whole fundamental change. A takeover of Avadel may trigger the requirement that we repurchase the 2023 Notes and/or increase the exchange rate, which could make it more costly for a potential acquirer to engage in a combinatory transaction with us. Such additional costs may have the effect of delaying or preventing a takeover of Avadel that would otherwise be beneficial to investors.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we pay dividends, the dividends may be subject to Irish dividend withholding tax</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain circumstances, as an Irish tax resident company, we may be required to deduct Irish dividend withholding tax (currently at the rate of 20%) from dividends paid to its shareholders. Shareholders that are resident in the U.S., EU countries (other than Ireland) or other countries with which Ireland has signed a tax treaty (whether the treaty has been ratified or not) generally should not be subject to Irish withholding tax so long as the shareholder has provided its broker, for onward transmission to our qualifying intermediary or other designated agent (in the case of shares held beneficially), or us or our transfer agent (in the case of shares held directly), with all the necessary documentation by the appropriate due date prior to payment of the dividend. However, some shareholders may be subject to withholding tax, which could adversely affect the price of ordinary shares and the value of their 2023 Notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Risk Factors</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provisions of our articles of association could delay or prevent a third-party&#8217;s effort to acquire us.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our articles of association could delay, defer or prevent a third-party from acquiring us, even where such a transaction would be beneficial to the holders of ADSs, or could otherwise adversely affect the price of ADSs. For example, certain provisions of our articles of association:</span></div><div style="padding-left:40.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">permit our board of directors to issue preferred shares with such rights and preferences as they may designate, subject to applicable law;</span></div><div style="padding-left:40.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impose advance notice requirements for shareholder proposals and director nominations to be considered at annual shareholder meetings; and</span></div><div style="padding-left:40.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require the approval of a supermajority of the voting power of our shares entitled to vote at a general meeting of shareholders to amend or repeal any provisions of our articles of association.</span></div><div style="padding-left:40.5pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-53-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe these provisions, if implemented in compliance with applicable law, may provide some protection to holders of ADSs from coercive or otherwise unfair takeover tactics. These provisions are not intended to make us immune from takeovers. They will, however, apply even if some holders of ADSs consider an offer to be beneficial and could delay or prevent an acquisition that our Board of Directors determines is in the best interest of the holders of ADSs. Certain of these provisions may also prevent or discourage attempts to remove and replace incumbent directors.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, mandatory provisions of Irish law could prevent or delay an acquisition of the Company by a third party. For example, Irish law does not permit shareholders of an Irish public limited company to take action by written consent with less than unanimous consent. In addition, an effort to acquire us may be subject to various provisions of Irish law relating to mandatory bids, voluntary bids, requirements to make a cash offer and minimum price requirements, as well as substantial acquisition rules and rules requiring the disclosure of interests in ADSs in certain circumstances.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These provisions may discourage potential takeover attempts or bids for our ordinary shares at a premium over the market price or they may adversely affect the market price of, and the voting and other rights of the holders of, ADSs. These provisions could also discourage proxy contests and make it more difficult for holders of ADSs to elect directors other than the candidates nominated by our board of directors and could depress affect the market price of ADSs.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Irish law differs from the laws in effect in the U.S. and might afford less protection to the holders of ADSs.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of ADSs could have more difficulty protecting their interests than would the shareholders of a U.S. corporation.  As an Irish company, we are governed by Irish law, including the Irish Companies Act 2014 and the Irish Takeover Rules, which differs in some significant, and possibly material, respects from provisions set forth in various U.S. state laws applicable to U.S. corporations and their shareholders, including provisions relating to interested directors, mergers and acquisitions, takeovers, shareholder lawsuits and indemnification of directors.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The duties of directors and officers of an Irish company are generally owed to the company only. Therefore, under Irish law shareholders of Irish companies do not generally have a right to commence a legal action against directors or officers and may only do so in limited circumstances. Directors of an Irish company must act with due care and skill, honestly and in good faith with a view to the best interests of the company. Directors must not put themselves in a position in which their duties to the company and their personal interests conflict and must disclose any personal interest in any contract or arrangement with the company or any of our subsidiaries. A director or officer can be held personally liable to the company in respect of a breach of duty to the company.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Judgments of U.S. courts, including those predicated on the civil liability provisions of the federal securities laws of the U.S., may not be enforceable in Irish courts.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An investor in the U.S. may find it difficult to:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">effect service of process within the U.S. against us and our non-U.S. resident directors and officers;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enforce U.S. court judgments based upon the civil liability provisions of the U.S. federal securities laws against us and our non-U.S. resident directors and officers in Ireland; or</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">bring an original action in an Irish court to enforce liabilities based upon the U.S. federal securities laws against us and our non-U.S. resident directors and officers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Judgments of U.S. courts, including those predicated on the civil liability provisions of the federal securities laws of the United States, may not be enforceable in Cayman Islands courts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been advised by our Cayman Islands legal counsel, Maples and Calder, that the courts of the Cayman Islands are unlikely (i) to recognize or enforce against us or Avadel judgments of courts of the U.S. predicated upon the civil liability provisions of the securities laws of the U.S. or any State; and (ii) in original actions brought in the Cayman Islands, to impose liabilities against us or Avadel predicated upon the civil liability provisions of the securities laws of the U.S. or any State, so far as the liabilities imposed by those provisions are penal in nature. In those circumstances, although there is no statutory enforcement in the Cayman Islands of judgments obtained in the U.S., the courts of the Cayman Islands will recognize and enforce a foreign money judgment of a foreign court of competent jurisdiction without retrial on the merits based on the principle that a judgment of a competent foreign court imposes upon the judgment debtor an obligation to pay the sum for which judgment has been given provided certain conditions are met. For a foreign judgment to be enforced in the Cayman Islands, such judgment must be final and conclusive and for a liquidated sum, and must not be in respect of taxes or a fine or penalty, inconsistent with a Cayman Islands judgment in respect of the same matter, impeachable on the grounds of fraud or obtained in a manner, and or be of a kind the enforcement of which is, contrary to natural justice or the public policy of the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-54-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cayman Islands (awards of punitive or multiple damages may well be held to be contrary to public policy). A Cayman Islands Court may stay enforcement proceedings if concurrent proceedings are being brought elsewhere.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Holders of ADSs have fewer rights than shareholders and have to act through the Depositary to exercise those rights.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of ADSs do not have the same rights as shareholders and, accordingly, cannot exercise rights of shareholders against us. The Bank of New York Mellon, as depositary (the &#8220;Depositary&#8221;), is the registered shareholder of the deposited shares underlying the ADSs. Therefore, holders of ADSs will generally have to exercise the rights attached to those shares through the Depositary. We will use reasonable efforts to request that the Depositary notify the holders of ADSs of upcoming votes and ask for voting instructions from them. If a holder fails to return a voting instruction card to the Depositary by the date established by the Depositary for receipt of such voting instructions, or if the Depositary receives an improperly completed or blank voting instruction card, or if the voting instructions included in the voting instruction card are illegible or unclear, then such holder will be deemed to have instructed the Depositary to vote its shares, and the Depositary shall vote such shares in favor of any resolution proposed or approved by our Board of Directors and against any resolution not so proposed or approved.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Security breaches and other disruptions could compromise confidential information and expose us to liability and cause our business and reputation to suffer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we collect and store on our networks various intellectual property including our proprietary business information and that of former customers, suppliers and business partners. The secure maintenance and transmission of this information is critical to our operations and business strategy. Despite our security measures, our information systems and infrastructure may be vulnerable to disruptions such as computer hacking, phishing attacks, ransomware, dissemination of computer viruses, worms and other destructive or disruptive software, attacks by hackers or breached due to employee error, malfeasance or other disruptions. Any such breach could compromise our networks and the information stored there could be accessed, publicly disclosed, lost or stolen. Any such access, disclosure or other loss of information could result in legal claims or proceedings, investigations by regulatory authorities in the U.S. and EU Member States, disruption to our operations and damage to our reputation, any of which could adversely affect our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We could suffer financial loss or the loss of valuable confidential information. Although we develop and maintain systems and controls designed to prevent these events from occurring and we have a process to identify and mitigate threats, the development and maintenance of these systems, controls and processes is costly and requires ongoing monitoring and updating as technologies change and efforts to overcome security measures become increasingly sophisticated. Moreover, despite our efforts, the possibility of these events occurring cannot be eliminated entirely and there can be no assurance that any measures we take will prevent cyber-attacks or security breaches that could adversely affect our business. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have broad discretion in the use of our cash and may not use it effectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management has broad discretion in the use of our cash and may not apply our cash in ways that ultimately increases the value of any investment in our securities. We currently intend to use our cash to fund marketing activities for any future commercialized products, to fund certain clinical trials for product candidates, to fund research and development activities for potential new product candidates, and for working capital, capital expenditures and general corporate purposes. As in the past we expect to invest our excess cash in available-for-sale marketable securities, including corporate bonds, U.S. government securities, other fixed income securities and equities; and these investments may not yield a favorable return. If we do not invest or apply our cash effectively, our financial position and the price of ADSs may decline.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We currently do not intend to pay dividends and cannot assure the holders of our ADSs that we will make dividend payments in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never declared or paid a cash dividend on any of our ordinary shares or ADSs and do not anticipate declaring cash dividends in the foreseeable future. Declaration of dividends will depend upon, among other things, future earnings, if any, the operating and financial condition of our business, our capital requirements, general business conditions and such other factors as our Board of Directors deems relevant.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our effective tax rate could be highly volatile and could adversely affect our operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future effective tax rate may be adversely affected by a number of factors, many of which are outside of our control, including:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the jurisdictions in which profits are determined to be earned and taxed;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-55-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the valuation of our deferred tax assets and liabilities;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in share-based compensation expense;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in domestic or international tax laws or the interpretation of such tax laws;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in available tax credits;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adjustments to estimated taxes upon finalization of various tax returns; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the resolution of issues arising from tax audits with various tax authorities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any significant increase in our future effective tax rates could impact our results of operations for future periods adversely.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in tax law could adversely affect our business and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income and other taxes in the U.S. and foreign jurisdictions. Changes to applicable U.S. or foreign tax laws and regulations, or their interpretation and application (which changes may have retroactive application), including with respect to net operating losses and research and development tax credits, could adversely affect us or holders of our ordinary shares or ADSs. In recent years, many such changes have been made and changes are likely to continue to occur in the future. Future changes in tax laws could have a material adverse effect on our business, cash flow, financial condition or results of operations. We urge investors to consult with their legal and tax advisors regarding the implications of potential changes in tax laws on an investment in our ordinary shares or ADSs.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our ability to use our net operating loss carryforwards and certain other tax attributes may be limited</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we had $74,406 of net operating losses in the U.S. Of the $74,406 of net operating losses in the U.S., $10,365 were acquired due to the acquisition of FSC Therapeutics and FSC Laboratories, Inc., (collectively &#8220;FSC&#8221;) and $64,041 are due to the losses at Avadel US Holdings, Inc. The portion due to the acquisition of FSC will expire in 2034 through 2035. The U.S. net operating losses acquired as part of the acquisition of FSC are subject to an annual limitation under Internal Revenue Code Section 382 and $1,473 of the $10,365 will not be fully utilized before they expire. The remaining $64,041 of net operating losses do not have an expiration date. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under U.S. federal tax legislation enacted in 2017, informally titled the Tax Cuts and Jobs Act (&#8220;Tax Act&#8221;), U.S. federal net operating losses incurred in 2018 and in future years may be carried forward indefinitely, but the deductibility of such U.S. federal net operating losses is limited. Under Sections 382 and 383 of the U.S. Internal Revenue Code of 1986 (the &#8220;Code&#8221;) if a corporation undergoes an &#8220;ownership change&#8221; (generally defined as a greater than 50 percentage-point cumulative change (by value) in the equity ownership of certain shareholders over a rolling three-year period), the corporation&#8217;s ability to use its pre-change net operating losses and other pre-change tax attributes to offset its post-change taxable income or taxes may be limited. We may also experience ownership changes as a result of this offering or future issuances of our stock or as a result of subsequent shifts in our stock ownership, some of which are outside our control. We have completed an analysis to determine that no events have been triggered in the past. If any ownership changes are determined to be triggered in the future, our ability to use our current net operating losses to offset post-change taxable income or taxes would be subject to limitation. We will be unable to use our net operating losses if we do not attain profitability sufficient to offset our available net operating losses prior to their expiration.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we had approximately $124,720 of net operating losses in Ireland that do not have an expiration date. While these losses do not have an expiration date, substantial changes in the activities performed in these jurisdictions could have an impact on our ability to utilize these tax attributes in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-56-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Holders of ordinary shares or ADSs may suffer adverse U.S. tax consequences if we are classified as a passive foreign investment company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, if, for any taxable year, at least 75% of our gross income is passive income, or at least 50% of the value of our assets is attributable to assets that produce passive income or are held for the production of passive income, including cash, we would be characterized as a passive foreign investment company (&#8220;PFIC&#8221;) for U.S. federal income tax purposes. For purposes of these tests, passive income includes dividends, interest, and gains from the sale or exchange of investment property and rents and royalties other than rents and royalties that are received from unrelated parties in connection with the active conduct of a trade or business. Our status as a PFIC depends on the composition of our income and the composition and value of our assets (for which purpose the total value of our assets may be determined in part by the market value of the ordinary shares or ADSs, which are subject to change) from time to time. If we are characterized as a PFIC, U.S. Holders (as defined below under &#8220;Material U.S. Federal Income Tax Considerations for U.S. Holders&#8221;) of ordinary shares or ADSs may suffer materially adverse tax consequences, including having gains realized on the sale of ordinary shares or ADSs treated as ordinary income, rather than capital gain, the loss of the preferential rate applicable to dividends received on ordinary shares or ADSs by individuals who are U.S. Holders, and having interest charges apply to distributions by us and the proceeds of sales of ordinary shares or ADSs. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we were not a PFIC for the taxable year ending December 31, 2020 and, based on the expected value of our assets, including any goodwill, and the expected nature and composition of our income and assets, we expect that we will be a PFIC for our current taxable year. However, our status as a PFIC is a fact-intensive determination subject to various uncertainties, and we cannot provide any assurances regarding our PFIC status for the current, prior or future taxable years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain U.S. Holders that own 10 percent or more of the vote or value of ordinary shares or ADSs may suffer adverse U.S. tax consequences because our non-U.S. subsidiaries are expected to be classified as controlled foreign corporations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each &#8216;&#8216;Ten Percent Shareholder&#8217;&#8217; (as defined below) in a non-U.S. corporation that is classified as a &#8216;&#8216;controlled foreign corporation,&#8217;&#8217; or a CFC, for U.S. federal income tax purposes generally is required to include in income for U.S. federal tax purposes such Ten Percent Shareholder&#8217;s pro rata share of the CFC&#8217;s &#8216;&#8216;Subpart F income&#8217;&#8217; and investment of earnings in U.S. property, even if the CFC has made no distributions to its shareholders. Subpart F income generally includes dividends, interest, rents, royalties, &#8216;&#8216;global intangible low-taxed income,&#8217;&#8217; gains from the sale of securities and income from certain transactions with related parties. In addition, a Ten Percent Shareholder that realizes gain from the sale or exchange of shares in a CFC may be required to classify a portion of such gain as dividend income rather than capital gain. A non-U.S. corporation generally will be classified as a CFC for U.S. federal income tax purposes if Ten Percent Shareholders own, directly or indirectly, more than 50% of either the total combined voting power of all classes of stock of such corporation entitled to vote or of the total value of the stock of such corporation. A &#8216;&#8216;Ten Percent Shareholder&#8217;&#8217; is a U.S. person (as defined by the Code) who owns or is considered to own 10% or more of the total combined voting power of all classes of stock entitled to vote or 10% or more of the total value of all classes of stock of such corporation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we were not a CFC in the 2021 taxable year, but that our non-U.S. subsidiaries were CFCs in the 2021 taxable year. We anticipate that our non-U.S. subsidiaries will remain CFCs in the 2021 taxable year, and it is possible that we may become a CFC in the 2022 taxable year or in a subsequent taxable year. The determination of CFC status is complex and includes attribution rules, the application of which is not entirely certain. U.S. Holders should consult their own tax advisors with respect to the potential adverse U.S. tax consequences of becoming a Ten Percent Shareholder in a CFC, including the possibility and consequences of becoming a Ten Percent Shareholder in one or more of our non-U.S. subsidiaries that are anticipated to be treated as CFCs. If we are classified as both a CFC and a PFIC, we generally will not be treated as a PFIC with respect to those U.S. Holders that meet the definition of a Ten Percent Shareholder during the period in which we are a CFC, subject to certain exceptions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We incur significant costs as a result of operating as a public company, and our management is required to devote substantial time to compliance requirements, including establishing and maintaining internal controls over financial reporting. We have identified a material weakness in our internal control over financial reporting. We may be exposed to potential risks if we are unable to comply the requirements to maintain internal controls over financial reporting or if we identify additional material weaknesses. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public company in the United States organized, we are subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and the listing rules of the Nasdaq Stock Market ("Nasdaq"), and incur significant legal, accounting and other expenses to comply with applicable requirements. These rules impose various requirements on public companies, including requiring certain corporate governance practices. Our management and other </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-57-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">personnel devote a substantial amount of time to these requirements. Moreover, these rules and regulations increase our legal and financial compliance costs and make some activities more time-consuming and costly.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, the Sarbanes-Oxley Act of 2002 (the "Sarbanes-Oxley Act") requires, among other things, that we maintain effective internal controls for financial reporting and disclosure controls and procedures. In particular, we must perform system and process evaluations and testing of our internal controls over financial reporting to allow management to report on the effectiveness of our internal controls over financial reporting, as required by Section 404 of the Sarbanes-Oxley Act. Such compliance may require that we incur substantial accounting expenses and expend significant management efforts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the Company&#8217;s fiscal 2021 financial statement close process, management identified a deficiency in the design of internal control over financial reporting related to its February 2023 Notes indenture. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. Specifically, management did not have a control to identify that we were in technical default of the February 2023 Notes and owed 0.50% of additional interest on the February 2023 Notes due to not removing a restrictive legend from the February 2023 Notes 365 days following the original issuance of the February 2023 Notes on February 16, 2018.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once the material weakness was identified, we developed and implemented a remediation plan that includes the implementation of additional control procedures surrounding timely and period evaluation of all terms of our debt agreement and the associated calculation of interest expense in accordance with the terms of such debt agreement to ensure the completeness and accuracy of the calculation and timely payment of additional interest expense. Management is committed to maintaining a strong internal control environment and have fully implemented measures designed to help ensure that the control deficiency contributing to the material weakness is remediated. However, there cannot be any assurance that these remediation efforts will be successful or that our internal control over financial reporting will be effective as a result of these efforts. The material weakness will be fully remediated when, we have determined, through testing, these controls have operated effectively for a sufficient period of time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the future we may determine that we have additional material weaknesses. Our failure to remediate the material weaknesses or failure to identify and address any other material weaknesses or control deficiencies could result in inaccuracies in our financial statements and could also impair our ability to comply with applicable financial reporting requirements and related regulatory filings on a timely basis, which could cause investors to lose confidence in our reported financial information, which may result in volatility in and a decline in the market price of our ADSs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the periodic reporting requirements of the Exchange Act. We designed our disclosure controls and procedures to reasonably assure that information we must disclose in reports we file or submit under the Exchange Act is accumulated and communicated to management, and recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. We believe that any disclosure controls and procedures or internal controls and procedures, no matter how well-conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements due to error or fraud may occur and not be detected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If securities analysts do not publish research or reports about our business or if they publish negative evaluations of our stock, the price of our stock could decline.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for our common stock relies in part on the research and reports that industry or financial analysts publish about us or our business. We do not have control over these analysts. There can be no assurance that existing analysts will continue to provide research coverage or that new analysts will begin to provide research coverage. Although we have obtained analyst coverage, if one or more of the analysts covering our business downgrade their evaluations of our stock, the price of our stock could decline. If one or more of these analysts cease to cover our stock, we could lose visibility in the market for our stock, which in turn could cause our stock price to decline.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-58-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A transfer of ordinary shares may be subject to Irish stamp duty.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transfers of ordinary shares (as opposed to ADSs) could be subject to Irish stamp duty (currently at the rate of 1% of the higher of the price paid or the market value of the shares acquired). Payment of Irish stamp duty is generally a legal obligation of the transferee. Although transfers of ADSs are not subject to Irish stamp duty, the potential for stamp duty to arise on transfers of ordinary shares could adversely affect the price of our ordinary shares or ADSs.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_25"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1B.&#160;&#160;&#160;&#160;Unresolved Staff Comments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_28"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Properties.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have commercial and administrative activities located in Chesterfield, Missouri. Our current office space consists of 24,236 square feet, and the lease expires in 2025. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Part II, Item 7 of this Annual Report on Form 10-K for more information regarding our investment activities and principal capital expenditures over the last two years.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_31"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Legal Proceedings.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information regarding legal proceedings we are involved in, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 15: Contingent Liabilities and Commitments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our audited consolidated financial statements included in Part II, Item 8 of this Annual Report on Form 10-K. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_34"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Mine Safety Disclosures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-59-</span></div></div></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_37"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PART II</span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_40"></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock Data (per share):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal trading market for our securities in ADSs is the Nasdaq Global Market under the symbol &#8220;AVDL&#8221;. There is no foreign trading market for our ordinary shares, ADSs or any other equity security issued by us. Each ADS represents one ordinary share, nominal value $0.01. The Bank of New York Mellon is the Depositary for the ADSs.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;11, 2022, there were 59,032,237 ordinary shares outstanding, and our closing stock price was $7.22 per share.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reports the high and low trading prices of the ADSs on the Nasdaq Global Market for the periods indicated:&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:49.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.796%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021 Price Range</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020 Price Range</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">High</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Low</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">High</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Low</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First quarter &#160;</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second quarter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.05&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third quarter &#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth quarter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Holders</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;11, 2022, there were 78 holders of record of our ordinary shares and 61 accounts registered with The Bank of New York Mellon, the Depositary of our ADS program, as holders of ADSs, one of which ADS accounts is registered to the Depositary Trust Corporation (DTC).  Because our ADSs are generally held of record by brokers, nominees and other institutions as participants in DTC on behalf of the beneficial owners of such ADSs, we are unable to estimate the total number of beneficial owners of the ADSs held by these record holders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never declared or paid a cash dividend on any of our shares and do not anticipate declaring cash dividends in the foreseeable future.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Compensation Plan </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by Item 5 of Form 10-K regarding equity compensation plans is incorporated herein by reference to Item 12 of Part III of this Annual Report on Form 10-K. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not repurchase any of our equity securities during the year ended December&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Sales of Unregistered Securities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-60-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Performance Graph</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following graph compares the cumulative 5-year return provided to shareholders of Avadel&#8217;s ADSs relative to the cumulative total returns of the Nasdaq Composite Index and the Nasdaq Biotechnology Index. We believe these indices are the most appropriate indices against which the total shareholder return of Avadel should be measured. The Nasdaq Biotechnology Index has been selected because it is an index of U.S. quoted biotechnology and pharmaceutical companies. An investment of $100 (with reinvestment of all dividends) is assumed to have been made in our ADSs and in each of the indexes on January 1, 2017 and our relative performance is tracked through December&#160;31, 2021. The comparisons shown in the graph are based upon historical data and we caution that the stock price performance shown in the graph is not indicative of, or intended to forecast, the potential future performance of our stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><img src="avdl-20211231_g1.jpg" alt="avdl-20211231_g1.jpg" style="height:364px;margin-bottom:5pt;vertical-align:text-bottom;width:675px"/></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This performance graph shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Exchange Act.  Notwithstanding any statement to the contrary set forth in any of our filings under the Securities Act of 1933 or the Exchange Act that might incorporate future filings, including this Annual Report on Form 10-K, in whole or in part, this performance graph shall not be incorporated by reference into any such filings except as may be expressly set forth by specific reference in any such filing.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_43"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-61-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Reserved.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-62-</span></div></div></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_46"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_49"></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands, except per share data)&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">You should read the discussion and analysis of our financial condition and results of operations set forth in this Item 7 together with our consolidated financial statements and the related notes appearing elsewhere in this Annual Report on Form 10-K. Some of the information contained in this discussion and analysis or set forth elsewhere in this Annual Report on Form 10-K, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks and uncertainties, and reference is made to the &#8220;Cautionary Disclosure Regarding Forward-Looking Statements&#8221; set forth immediately following the Table of Content of this Annual Report on Form 10-K for further information on the forward looking statements herein. In addition, you should read the &#8220;Risk Factors&#8221; section of this Annual Report on Form 10-K for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis and elsewhere in this Annual Report on Form 10-K.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Information pertaining to fiscal year 2019 was included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, on pages 45 through 57, under Part II, Item 7, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; which was filed with the SEC on March 9, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-63-</span></div></div></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_52"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Avadel Pharmaceuticals plc (Nasdaq: AVDL) (&#8220;Avadel,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221;) is a biopharmaceutical company. Our lead product candidate, FT218, is an investigational once-nightly, extended-release formulation of sodium oxybate for the treatment of excessive daytime sleepiness (&#8220;EDS&#8221;) or cataplexy in adults with narcolepsy. We are primarily focused on the development and potential United States (&#8220;U.S.&#8221;) Food and Drug Administration (&#8220;FDA&#8221;) approval of FT218. In December 2020, we submitted a New Drug Application (&#8220;NDA&#8221;) to the FDA for FT218 to treat excessive daytime sleepiness or cataplexy in adults with narcolepsy. In February 2021, the NDA for FT218 was accepted by the FDA and was assigned a Prescription Drug User Fee Act (&#8220;PDUFA&#8221;) target action date of October 15, 2021. On October 15, 2021, we announced that the FDA informed us that the review of our NDA for FT218 was ongoing beyond its previously assigned target action date. As of the date of this Annual Report, the FDA&#8217;s review of our NDA for FT218 remains ongoing. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside of our lead product candidate, we continue to evaluate opportunities to expand our product portfolio. As of the date of this Annual Report, we do not have any approved or commercialized products in our portfolio.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FT218</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FT218 is a once-nightly formulation of sodium oxybate that uses our Micropump controlled release drug-delivery technology for the treatment of EDS or cataplexy in adults suffering from narcolepsy. Sodium oxybate is the sodium salt of gamma hydroxybutyrate, an endogenous compound and metabolite of the neurotransmitter gamma-aminobutyric acid. Immediate release sodium oxybate is approved in the U.S. for the treatment of EDS or cataplexy in patients with narcolepsy and is approved in Europe for the treatment of cataplexy in patients with narcolepsy. Since 2002, sodium oxybate has only been available as a formulation that must be taken twice nightly, first at bedtime, and then again 2.5 to 4 hours later.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 16, 2020, we announced the submission of our NDA to the FDA for FT218. On February 26, 2021, the FDA notified us of formal acceptance of the NDA and assigned a PDUFA target action date of October 15, 2021. On October 15, 2021, we announced that the FDA informed us that the review of our NDA for FT218 was ongoing beyond its previously assigned target action date. As of the date of this Annual Report, the FDA&#8217;s review of our NDA for FT218 remains ongoing.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted a Phase 3 clinical trial of FT218, the REST-ON trial, which was a randomized, double-blind, placebo-controlled study that enrolled 212 patients who received at least one dose of FT218 or placebo, and was conducted in clinical sites in the U.S., Canada, Western Europe and Australia. The last patient, last visit was completed at the end of the first quarter of 2020, and positive top line data from the REST-ON trial was announced on April 27, 2020. Patients who received 9 g of once-nightly FT218, the highest dose administered in the trial, demonstrated statistically significant and clinically meaningful improvement compared to placebo across the three co-primary endpoints of the trial: maintenance of wakefulness test (&#8220;MWT&#8221;), clinical global impression-improvement (&#8220;CGI-I&#8221;), and mean weekly cataplexy attacks. The lower doses assessed, 6 g and 7.5 g also demonstrated statistically significant and clinically meaningful improvement on all three co-primary endpoints compared to placebo. We observed the 9 g dose of once-nightly FT218 to be generally well tolerated. Adverse reactions commonly associated with sodium oxybate were observed in a small number of patients (nausea 1.3%, vomiting 5.2%, decreased appetite 2.6%, dizziness 5.2%, somnolence 3.9%, tremor 1.3% and enuresis 9%), and 3.9% of the patients who received 9 g of FT218 discontinued the trial due to adverse reactions.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2018, the FDA granted FT218 orphan drug designation for the treatment of narcolepsy, which makes FT218 potentially eligible for certain development and commercial incentives, including potential U.S. market exclusivity for up to seven years. Additionally, several FT218-related U.S. patents have been issued, and there are additional patent applications currently in development and/or pending at the U.S. Patent and Trademark Office (&#8220;USPTO&#8221;), as well as foreign patent offices.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, we announced that the first patient was dosed in our open-label extension (&#8220;OLE&#8221;)/switch study of FT218 as a potential treatment for EDS or cataplexy in patients with narcolepsy. The OLE/switch study is examining the long-term safety and maintenance of efficacy of FT218 in patients with narcolepsy who participated in the REST-ON study, as well as dosing and preference data for patients switching from twice-nightly sodium oxybate to once-nightly FT218, regardless of whether they participated in REST-ON.  In May 2021, inclusion criteria were expanded to allow for oxybate na&#239;ve patients to enter the study. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New secondary endpoints from the REST-ON trial were presented at the American Academy of Neurology, beginning April 17, 2021. The first poster described FT218 improvements in disturbed nocturnal sleep (&#8220;DNS&#8221;), defined in REST-ON as the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-64-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">number of shifts from stages N1, N2, N3, and rapid eye movement (&#8220;REM&#8221;) sleep to wake and from stages N2, N3, and REM sleep to stage N1. FT218 also decreased the number of nocturnal arousals as measured on polysomnography. Improvements in DNS were further supported by post-hoc analyses demonstrating increased time in deep sleep (N3, also known as slow wave sleep), and less time in N1. A second poster described the statistically significant improvements in the Epworth Sleepiness Scale, both the quality of sleep and the refreshing nature of sleep, and a decrease in sleep paralysis. These clinically relevant improvements were observed for all doses, beginning at week 3, for the lowest 6 g dose, compared to placebo. FT218 did not demonstrate significant improvement for hypnagogic hallucinations compared to placebo.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional data supportive of the efficacy findings in REST-ON were presented at the 35th Annual Meeting of the Associated Professional Sleep Societies, a joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society, also known as SLEEP 2021, beginning June 10, 2021. New data included post-hoc analyses demonstrating endpoints improvements, regardless of concomitant stimulant use, in both narcolepsy Type 1 or Type 2. Additionally, a post-hoc analysis showed that FT218 was associated with decreased body mass index compared to placebo, which may be relevant as people with narcolepsy often have co-morbid obesity. In August 2021, the primary results from the REST-ON trial were published by Kushida et al. in the journal SLEEP. New data was presented at the American College of Chest Physicians annual meeting, beginning October 17, 2021, including additional post-hoc analyses from the REST-ON trial, demonstrating a greater proportion of patients receiving FT218 experienced reductions in weekly cataplexy attacks and improvement in mean sleep latency compared to placebo, as well as the results of a discrete choice experiment, indicating that the overall driver of patient preference between sodium oxybate treatments is a once-nightly, versus twice-nightly, formulation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe FT218 has the potential to demonstrate improved dosing compliance, safety and patient satisfaction over the current standards of care for EDS or cataplexy in patients with narcolepsy, which are twice-nightly oxybate formulations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Micropump Drug-Delivery Technology  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Micropump drug-delivery technology allows for the controlled delivery of small molecule drugs taken orally, which has the potential to improve dosing compliance, reduce toxicity and improve patient compliance. Beyond FT218, we believe there could be other product development opportunities for our Micropump drug-delivery technology, representing either life cycle opportunities, whereby additional intellectual property can be added to a pharmaceutical product to extend the commercial viability of a currently marketed product, or innovative formulation opportunities for new chemical entities.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Previously Approved FDA Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On June 30, 2020 (&#8220;Closing Date&#8221;), we announced the sale of our portfolio of sterile injectable drugs used in the hospital setting (the &#8220;Hospital Products&#8221;), including our three FDA-approved commercial products, Akovaz, Bloxiverz and Vazculep, as well as Nouress, to Exela Sterile Medicines LLC (&#8220;Exela Buyer&#8221;). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Key Business Trends and Highlights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In operating our business and monitoring our performance, we consider a number of performance measures, as well as trends affecting our industry as a whole, which include the following:&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Healthcare and Regulatory Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Various health care reform laws in the U.S. may impact our ability to successfully commercialize our products and technologies. The success of our commercialization efforts may depend on the extent to which the government health administration authorities, the health insurance funds in the E.U. Member States, private health insurers and other third-party payers in the U.S. will reimburse consumers for the cost of healthcare products and services.</span></div><div style="padding-left:33.75pt;text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Competition and Technological Change</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competition in the pharmaceutical and biotechnology industry continues to be intense and is expected to increase. We compete with academic laboratories, research institutions, universities, joint ventures, and other pharmaceutical and biotechnology companies, including other companies developing niche branded or generic specialty pharmaceutical products or drug delivery platforms. Furthermore, major technological changes can happen quickly in the pharmaceutical and biotechnology industries. Such rapid technological change, or the development by our competitors of technologically improved or differentiated products, could render our products, product candidates, or drug delivery platforms obsolete or noncompetitive.</span></div><div style="padding-left:33.75pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-65-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Pricing Environment for Pharmaceuticals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The pricing environment continues to be in the political spotlight in the U.S. As a result, the need to obtain and maintain appropriate pricing for pharmaceutical products may become more challenging due to, among other things, the attention being paid to healthcare cost containment and other austerity measures in the U.S. and worldwide.</span></div><div style="padding-left:33.75pt;text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Generics Playing a Larger Role in Healthcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Generic pharmaceutical products will continue to play a large role in the U.S. healthcare system. As such, we expect to see generic competition for our products in the future.</span></div><div style="padding-left:33.75pt;text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Access to and Cost of Capital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The process of raising capital and associated cost of such capital for a company of our financial profile can be difficult and potentially expensive. If the need were to arise to raise additional capital, access to that capital may be difficult, expensive and/or dilutive and, as a result, could create liquidity challenges for the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Continuing Net Loss from Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sold our Hospital Products on June 30, 2020 and no longer generate revenue. We expect to continue to incur operating losses for the foreseeable future to continue our preparations for the commercial launch of FT218, if approved.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of COVID-19</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since early 2020, we have seen the profound impact that the ongoing coronavirus (&#8220;COVID-19&#8221;) pandemic is having on human health, the global economy and society at large. We have continued to actively monitor the COVID-19 pandemic and have taken measures to mitigate the potential impacts to our employees and business, such as continuing to offer a work from home policy. We believe the ongoing impact of COVID-19 and measures to prevent its spread could impact our business in a number of ways, including: i) possibly delaying  our ongoing RESTORE open-label extension/switch study, ii) disruptions to our supply chain and third parties; iii) requiring our employees to work from home for an extended period of time; and iv) hindering sales efforts for FT218, if approved. An extended period of global supply chain and economic disruption could materially affect our business, results of operations, access to sources of liquidity and financial condition.  Despite progress in vaccination efforts, future developments and impact on our operations remain uncertain and cannot be predicted with confidence, including the duration of the COVID-19 pandemic, new variants of the virus, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or we, may direct, which may result in extending continued business disruptions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Highlights</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Highlights of our consolidated results for the year ended December&#160;31, 2021 are as follows:&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenue was $0 for the year ended December&#160;31, 2021 compared to $22,334 in the same period last year. The year over year decrease was the result of the sale of the Hospital Products on June 30, 2020.</span></div><div style="padding-left:33.75pt;text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating loss was $85,546 for the year ended December&#160;31, 2021 compared to operating income of $5,815 for the year ended December&#160;31, 2020. Operating income for the year ended December&#160;31, 2020 was driven by the gain on sale of the Hospital Products on June 30, 2020 of $45,760. Selling, general &amp; administrative expenses increased in the current year by $36,090, driven by the Company&#8217;s continued commercial preparations and launch readiness activities for the potential approval of FT218.</span></div><div style="padding-left:33.75pt;text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net loss was $77,329 for the year ended December&#160;31, 2021 compared to net income of $7,028 in the same period last year.</span></div><div style="padding-left:33.75pt;text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Diluted net loss per share was $1.32 for the year ended December&#160;31, 2021 compared to diluted net income per share of $0.13 in the same period last year.</span></div><div style="padding-left:33.75pt;text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cash and marketable securities decreased by $64,181 to $157,221 at December&#160;31, 2021 from $221,402 at December&#160;31, 2020. This decrease was largely driven by $77,310 of cash used in operations during the year ended December 31, 2021, partially offset by cash proceeds from the disposition of the Hospital Products of $16,500.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-66-</span></div></div></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Critical Accounting Estimates</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to use judgment in making estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have identified certain policies and estimates as critical to our business operations and the understanding of our past or present results of operations. These policies and estimates are considered critical because they had a material impact, or they have the potential to have a material impact, on our consolidated financial statements and because they require us to make significant judgments, assumptions or estimates. We believe that the estimates, judgments and assumptions made when accounting for the items described below were reasonable, based on information available at the time they were made. However, actual results may differ from those estimates, and these differences may be material. For a complete list of significant accounting policies, see  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1: Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our audited consolidated financial statements included in Part II, Item 8 of this Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Sales. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to June 30, 2020, revenue included sales of pharmaceutical products. We sold our products primarily through wholesalers and considered these wholesalers to be our customers. Revenue from product sales is recognized when the customer obtains control of our product, which occurs typically upon receipt by the customer. Our gross product sales were subject to a variety of price adjustments in arriving at reported net product sales.    </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price adjustments contained estimates of product returns, chargebacks, payment discounts, rebates, and other sales allowances and were estimated based on analysis of historical data for the product or comparable products, future expectations for such products and other judgments and analysis.  The estimates were reviewed monthly and any adjustments were recognized as adjustments to product sales in the period the adjustments were identified.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any adjustments made were recognized as adjustments to product sales in the period that they were identified. We did not record any revenue from sales of pharmaceutical products in the year ended December 31, 2021 nor recognize any adjustments to product sales from prior periods. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development (&#8220;R&amp;D&#8221;). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expenses consist primarily of costs related to outside services, personnel expenses, clinical studies, and other R&amp;D expenses. Clinical studies and outside services costs relate primarily to services performed by clinical research organizations and related clinical or development manufacturing costs, materials and supplies, filing fees, regulatory support, and other third-party fees. Personnel expenses relate primarily to salaries, benefits and share-based compensation. Other R&amp;D expenses primarily include overhead allocations consisting of various support and facilities-related costs. R&amp;D expenditures are charged to operations as incurred. Raw materials used in the production of pre-clinical and clinical products are expensed as R&amp;D costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize refundable R&amp;D tax credits received for spending on innovative R&amp;D as an offset of R&amp;D expenses.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When estimating R&amp;D expense, we review open contracts and purchase orders, communicating with our personnel to identify services that have been performed on our behalf and estimating the level of service performed and the associated costs incurred for the services when we have not yet been invoiced or otherwise notified of the actual costs. The majority of our service providers invoice us in arrears for services performed and some require advanced payments. We make estimates of our accrued expenses at each balance sheet date in our financial statements based on facts and circumstances known to us at that time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the actual timing of the performance of services or the level of effort varies from our estimate, we adjust the accrual or amount of prepaid or accrued expenses accordingly. To date, we have not made any material adjustments to our prior estimates of accrued research and development expenses.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-based Compensation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for share-based compensation based on the estimated grant-date fair value. The fair value of stock options is estimated using Black-Scholes option-pricing valuation models (&#8220;Black-Scholes model&#8221;). We recognize compensation cost, net of an estimated forfeiture rate, using the accelerated method over the requisite service period of the award.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by the Black-Scholes model, estimates are made of the underlying volatility of Avadel stock, a risk-free rate determined by reference to the U.S. Treasury yield curve, and an expected term of the option. We estimate the expected term using a simplified method, as we do not have enough historical exercise data for a majority of such options upon which to estimate an expected term.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-67-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the estimates used to determine the fair value of share-based equity compensation instruments could result in changes to our share-based compensation expense. We have not made any material changes to our assumptions and estimates related to our share-based compensation during the periods presented. Individual assumptions are not sensitive to change. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our income tax benefit, deferred tax assets and liabilities, and liabilities for unrecognized tax benefits reflect management&#8217;s best estimate of current and future taxes to be paid. We are subject to income taxes in Ireland, France and the U.S. Significant judgments and estimates are required in the determination of the consolidated income tax benefit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes arise from temporary differences between the tax basis of assets and liabilities and their reported amounts in the financial statements, which will result in taxable or deductible amounts in the future. In evaluating our ability to recover our deferred tax assets in the jurisdiction from which they arise, we consider all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income or loss, tax-planning strategies, and results of recent operations. The assumptions about future taxable income or loss require the use of significant judgment and are consistent with the plans and estimates we are using to manage the underlying businesses. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations in a multitude of jurisdictions across our global operations. A tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, on the basis of the technical merits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record unrecognized tax benefits as liabilities and adjust these liabilities when our judgment changes as a result of the evaluation of new information not previously available. Because of the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from our current estimate of the unrecognized tax benefit liabilities. These differences will be reflected as increases or decreases to income tax expense in the period in which new information is available.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not recorded a deferred tax liability for any income or withholding taxes that may arise as the result of the distribution of unremitted earnings within our Company. As of December 31, 2021, we had unremitted earnings of $3,916 outside of Ireland as measured on a U.S. GAAP basis.  Based on our estimates that future domestic cash generation will be sufficient to meet future domestic cash needs along with our specific plans for reinvestment, we have not recorded a deferred tax liability for any income or withholding taxes that may arise from a distribution that would qualify as a dividend for tax purposes.  It is not practicable to estimate the amount of deferred tax liability on such remittances, if any. We believe that our estimates for deferred income taxes and the amount of benefits recognized for uncertain tax positions are appropriate based on current facts and circumstances. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Goodwill represents the excess of the acquisition consideration over the fair value of assets acquired and liabilities assumed. We have determined that we operate in a single segment and have a single reporting unit associated with the development and commercialization of pharmaceutical products. We can test for goodwill impairment by first performing a qualitative assessment to determine whether a quantitative goodwill test is necessary or we can elect to forgo the qualitative assessment and perform the quantitative test. We elected to perform a quantitative impairment assessment of goodwill in 2021 and 2020.  Upon performing the quantitative test, if the carrying value of the reporting unit exceeds its fair value, an impairment loss is recognized in an amount equal to that excess, not to exceed the carrying amount of goodwill.  We have elected to make November 30 the annual impairment assessment date for goodwill.  However, we could be required to evaluate the recoverability of goodwill outside of the required annual assessment if, among other things, we experience disruptions to the business, unexpected significant declines in operating results, divestiture of a significant component of the business or a sustained decline in market capitalization. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When performing the quantitative assessment of goodwill impairment, we estimate the fair value of our single reporting unit using the market approach, based on quoted market prices of our securities on the Nasdaq Global Market, adjusted for the effect of a control premium as contemplated by ASC 350. Based on the results of the annual quantitative evaluation for 2021, the fair value of our single reporting unit exceeded its respective carrying value and did not result in impairment for the reporting unit.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continuously monitors for events and circumstances that could negatively impact the key assumptions in determining fair value. While the Company believes the judgments and assumptions used in the goodwill impairment test is reasonable, different assumptions or changes in general industry, market and macro-economic conditions, including a more prolonged and/or severe COVID-19 pandemic, could change the estimated fair values and, therefore, future impairment charges could be required, which could be material to the consolidated financial statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-68-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_58"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Results of Operations</span></div><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our financial results (in thousands, except per share amounts):&#160;</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.069%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.747%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Increase / (Decrease)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Comparative Statements of (Loss) Income:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,334)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,742)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,338)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,090&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(406)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in fair value of contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,327)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on sale of Hospital Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45,760)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,546&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,519&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,027&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">417.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(85,546)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,815&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(91,361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,571.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment and other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,126&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(832)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,958&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">355.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,942)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,994)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain from release of certain liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,147)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense - changes in fair value of contingent consideration payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(435)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93,145)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,082)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(88,063)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,732.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,816)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,706)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77,329)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,028&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(84,357)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,200.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income per share - diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.32)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.45)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,115.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2020, we announced the sale of the Hospital Products, including our three FDA-approved commercial products, Akovaz, Bloxiverz and Vazculep, as well as Nouress, to the Exela Buyer. As a result of the sale, the Company recorded a gain on the sale of the Hospital Products of $45,760 and no longer recorded revenue, cost of products, intangible amortization and changes to the fair value of the contingent consideration related to these products subsequent to the Closing Date.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.607%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.747%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Research and Development Expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,338)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development (&#8220;R&amp;D&#8221;) expenses decreased by $3,338 or 16.3% during the year ended December&#160;31, 2021 as compared to the same period in 2020. This decrease was driven by lower clinical studies expense due to the completion of the FT218 clinical study during the year ended December 31, 2020, offset by higher pre-NDA approval activities and higher compensation expense.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-69-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.607%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.747%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Selling, General and Administrative Expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,090&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative (&#8220;SG&amp;A&#8221;) expenses increased by $36,090 or 111.4% during the year ended December&#160;31, 2021 as compared to the prior year.  This increase was driven primarily by the Company&#8217;s continued commercial preparations and launch readiness activities for potential approval of FT218. These activities included an increase in marketing and market research costs of approximately $12,700 and an increase in other launch planning and preparation activities totaling $5,000. Compensation costs increased by approximately $11,000 due to an increase in headcount, primarily in commercial and medical affairs. Legal, technology and insurance costs increased by approximately $7,200.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.607%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.747%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investment and Other Income (Expense), net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment and other income (expense), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(832)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">355.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment and other income, net was $2,126 for the year ended&#160;December&#160;31, 2021&#160;as compared to investment and other expense, net of $832 for the year ended December&#160;31, 2020. The increase in investment and other income (expense), net was driven by higher foreign currency gains of approximately $1,100, an $800 legal settlement related to a bankruptcy claim recognized in the prior period, higher interest income of approximately $600 and lower realized losses on our marketable securities of approximately $300.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.607%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.747%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,942)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,994)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Interest expense of $9,942 and $12,994 for the years ended December&#160;31, 2021 and 2020, respectively, is related to interest on the February 2023 Notes. Included in these amounts are coupon interest expense of $6,469 for each period and the amortization of debt issuance costs of $1,248 and $998 for the year ended December 31, 2021 and 2020, respectively. Current period interest expense also included $2,225 of additional interest expense owed as a result of not removing a restrictive legend from the February 2023 Notes 365 days following original issuance of the February 2023 Notes on February 16, 2018. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Note 1: Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> to our audited consolidated financial statements included in Part II, Item 8 of this Annual Report on Form 10-K for further details. Prior period interest expense also included amortization of a debt discount of $5,527, which is no longer recognized upon our adoption of ASU 2020-06.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Note 11: Long Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> to our audited consolidated financial statements included in Part II, Item 8 of this Annual Report on Form 10-K for further details for further details.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.607%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.747%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain from release of certain liabilities </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain from release of certain liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Subsequent to the finalization of the bankruptcy, we recognized non-cash gains of $217 and $3,364 for the years ended December&#160;31, 2021 and 2020, respectively, from the release of certain liabilities that had been retained following the deconsolidation of Avadel Specialty Pharmaceuticals, LLC in February 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.607%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.747%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income Taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,816)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,706)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Percentage of loss before income taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the income tax benefit increased by $3,706 when compared to the same period in 2020. The increase in the income tax benefit in 2021 was primarily driven by the additional tax benefit from an increase in the net operating losses in the U.S. in 2021, when compared to the same period in 2020. This was partially offset by the nonrecurring nature of tax benefits </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-70-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recognized in 2020 from the sale of the Company&#8217;s Hospital Products and passage of the Coronavirus Aid, Relief and Economic Security Act (the &#8220;CARES Act&#8221;) in the U.S.</span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_61"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Liquidity and Capital Resources&#160;</span></div><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Sources and Uses of Cash</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have had no revenue from product sales since the sale of our Hospital Products on June 30, 2020. We expect to continue to incur operating losses for the foreseeable future to further the clinical development of and continue our preparations for the commercial launch of FT218, if approved. As a result, we may need to raise additional capital to support commercial launch of FT218, if approved, and the continued growth of Avadel. At December 31, 2021, we held cash and marketable securities of $157,221 that will be used satisfy any cash requirements that we will have during the twelve months ended December 31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the 12 month period ending December 31, 2022, we project that our fixed commitments will include (i) capital commitments, (ii) interest on our 2023 Notes, and (iii) lease payments. We project that our long-term fixed commitments will include (i) capital commitments, (ii) interest on and repayment of principal of our 2023 Notes, and (iii) lease payments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capital Commitments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, we have one commitment with our primary contract manufacturer related to facility upgrades and the purchase and validation of equipment to be used in the manufacture of FT218. The total cost of this commitment is estimated to be approximately $5,500 and is expected to be completed during the year ending December 31, 2022. We incurred approximately $3,348 of this commitment during the year ended December 31, 2021. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have a commitment with another contract manufacturer that commences in the first quarter of 2022 and will continue until FDA approval of the contract manufacturer. The commitment will be approximately $3,000 per year.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the twelve month period ending December 31, 2022, we will pay interest on our 2023 Notes of $8,694. For the twelve month period ending December 31, 2023, we will pay interest on our 2023 Notes of $3,234 and principal, upon maturity, of $143,750. On March 16, 2022, Avadel Finance Cayman Limited, a Cayman Islands exempted company and an indirect wholly-owned subsidiary of the Company (the &#8220;Issuer&#8221;), executed an agreement to exchange $117,375 its 2023 Notes due February 1, 2023 for a new series of its Exchangeable Senior Notes due October 2, 2023 (the &#8220;October 2023 Notes&#8221;) (the &#8220;Exchange&#8221;). The remaining $26,375 aggregate principal amount of the February 2023 Notes will maintain a maturity date of February 1, 2023. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Note 11: Long-Term Debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Note 23: Subsequent Events </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">to our audited consolidated financial statements included in Part II, Item 8 of this Annual Report on Form 10-K for further details.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, we have leases for office space and a production suite. We have a current obligation of $974 due within one year and a long-term obligation of $1,833 due between January 1, 2023 and December 31, 2025. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 10: Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our audited consolidated financial statements included in Part II, Item 8 of this Annual Report on Form 10-K for further details for further details.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated Statement of Cash Flows</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash flows from operating, investing and financing activities, as reflected in the consolidated statements of cash flows, are summarized in the following table:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Increase / (Decrease)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Cash (Used In) Provided By</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77,310)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48,734)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28,576)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,929&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69,721)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126,650&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(179,420)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(99.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-71-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities of $77,310 for the year ended December&#160;31, 2021 increased from net cash used in operating activities of $48,734 in the prior year. Net cash used in operating activities for the year ended December 31, 2021 was driven by net loss of $77,329 and unfavorable non-cash adjustments of $3,676, offset by favorable changes in working capital of $3,695. For the year ended December 31, 2020, net cash used in operating activities was driven by net income of $7,028 and favorable non-cash adjustments of $4,322, offset by the $45,760 gain recorded for the sale of the Hospital Products and a $14,324 unfavorable change in working capital. The year over year change in working capital is driven by an increase in accounts payable and accrued expenses in 2021 as a result of the Company&#8217;s commercial preparations and launch readiness activities for potential approval of FT218.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by investing activities was $56,929 for the year ended December&#160;31, 2021 compared to cash used in investing activities of $69,721 in the same prior year period.  Net cash provided by investing activities for the year ended December 31, 2021 was driven by net proceeds from sales of marketable securities of $40,455 and proceeds of $16,500 received from the sale of the Hospital Products. Net cash used in investing activities for the year ended December 31, 2020 was driven by net purchases of marketable securities of $95,123, partially offset by proceeds from the disposition of the Hospital Products of $25,500.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash provided by financing activities was $263 for the year ended December&#160;31, 2021 compared to cash provided by financing activities of $179,683 for the same prior year period. Cash provided financing activities for the year ended December 31, 2021 related to proceeds from the issuance of ordinary shares related to employee equity awards. Cash provided by financing activities for the year ended December 31, 2020 was driven by the February private placement that resulted in net proceeds of $60,570, the May public offering that resulted in net proceeds of $116,924, and proceeds from the issuance of ordinary shares of $2,189 related to employee equity awards.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Management&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adequacy of our cash resources depends on the outcome of certain business conditions including the cost of our FT218 clinical development and commercial launch plans, our cost structure, and other factors set forth in &#8220;Risk Factors&#8221; within Part I, Item 1A of this Annual Report on Form 10-K.  To complete the FT218 clinical development and commercial launch plans we will need to commit substantial resources, which could result in future losses or otherwise limit our opportunities or affect our ability to operate our business. Our assumptions concerning the outcome of certain business conditions may prove to be wrong or other factors may adversely affect our business, and as a result we could exhaust or significantly decrease our available cash and marketable securities balances which could, among other things, force us to raise additional funds and/or force us to reduce our expenses, either of which could have a material adverse effect on our business. Additionally, we are unable to estimate the near or long term impact of COVID-19, which may have a material adverse impact on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If available to us, raising additional capital may be accomplished through one or more public or private debt or equity financings, royalty financings or collaborations or partnering arrangements. Any equity financing would be dilutive to our shareholders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalent and marketable security balances as of December 31, 2021 and unused financing sources are expected to provide us with the flexibility to meet our liquidity needs in 2022, including operating requirements related to the commercial launch of FT218.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_64"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Other Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">&#160;</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to potential liabilities generally incidental to our business arising out of present and future lawsuits and claims related to product liability, personal injury, contract, commercial, intellectual property, tax, employment, compliance and other matters that arise in the ordinary course of business. We accrue for potential liabilities when it is probable that future costs (including legal fees and expenses) will be incurred and such costs can be reasonably estimated. At December 31, 2021 and December 31, 2020, there were no contingent liabilities with respect to any litigation, arbitration or administrative or other proceeding that are reasonably likely to have a material adverse effect on our consolidated financial position, results of operations, cash flows or liquidity. For information regarding legal proceedings we are involved in, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 15: Contingent </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-72-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liabilities and Commitments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our audited consolidated financial statements included in Part II, Item 8 of this Annual Report on Form 10-K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_67"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;7A.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Interest Rate Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to interest rate risk as a result of our portfolio of marketable securities. The primary objectives of our investment policy are as follows: safety and preservation of principal and diversification of risk; liquidity of investments sufficient to meet cash flow requirements; and competitive yield. Although our investments are subject to market risk, our investment policy specifies credit quality standards for our investments and limits the amount of credit exposure from any single issue, issuer or certain types of investment. Our investment policy allows us to maintain a portfolio of cash equivalents and marketable securities in a variety of instruments, including U.S. federal government and federal agency securities, European Government bonds, corporate bonds or commercial paper issued by U.S. or European corporations, money market instruments, certain qualifying money market mutual funds, certain repurchase agreements, tax-exempt obligations of states, agencies, and municipalities in the U.S and Europe, and equities.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Foreign Exchange Risk</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to foreign currency exchange risk as the functional currency financial statements of a non-U.S. subsidiary is translated to U.S. dollars. The assets and liabilities of this non-U.S. subsidiary having a functional currency other than the U.S. dollar is translated into U.S. dollars at the exchange rate prevailing at the balance sheet date, and at the average exchange rate for the reporting period for revenue and expense accounts. The cumulative foreign currency translation adjustment is recorded as a component of accumulated other comprehensive loss in shareholders&#8217; equity. The reported results of this non-U.S. subsidiary will be influenced by their translation into U.S. dollars by currency movements against the U.S. dollar. Our primary currency translation exposure is related to one subsidiary that has functional currencies denominated in euro. A 10% strengthening/weakening in the rates used to translate the results of our non-U.S. subsidiaries that have functional currencies denominated in euro as of December&#160;31, 2021 would have had an immaterial impact on net loss for the year ended December&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transactional exposure arises where transactions occur in currencies other than the functional currency. Transactions in foreign currencies are recorded at the exchange rate prevailing at the date of the transaction. The resulting monetary assets and liabilities are translated into the appropriate functional currency at exchange rates prevailing at the balance sheet date and the resulting gains and losses are reported in investment and other income (expense), net in the consolidated statements of (loss) income.&#160; As of December&#160;31, 2021, our primary exposure is to transaction risk related to euro net monetary assets and liabilities held by subsidiaries with a U.S. dollar functional currency. Realized and unrealized foreign exchange gains resulting from transactional exposure were immaterial for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-73-</span></div></div></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;8. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial Statements and Supplementary Data.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_73"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF (LOSS) INCOME </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands, except per share data)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.747%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMy0yLTEtMS0yMzQ1OA_ce6ddac4-757d-4aee-8653-11d5445ef62f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMy00LTEtMS0yMzQ1OA_ffe5aad9-edf6-4690-a8ff-742d7d6f07bf">22,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMy02LTEtMS0yMzQ1OA_33532a69-b006-452f-98bd-6cd2c9dbc2a4">59,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of products </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfNy0yLTEtMS0yMzQ1OA_7adca47e-ca0c-4776-8920-85ab5617bbaa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfNy00LTEtMS0yMzQ1OA_40740739-f5cd-4056-b6fd-6619d1dc995b">5,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfNy02LTEtMS0yMzQ1OA_49702d03-62ee-40e3-8ee3-35f14dc62a70">12,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfOC0yLTEtMS0yMzQ1OA_6afcbe0c-a1d0-4283-9fba-79e40811b4ff">17,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfOC00LTEtMS0yMzQ1OA_4e2aec7c-7d62-44e5-b627-e53bfaf7f2fc">20,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfOC02LTEtMS0yMzQ1OA_820ce2d8-2319-4197-81ae-22ba52a554a4">32,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfOS0yLTEtMS0yMzQ1OA_4a34d226-fc16-4e3f-80e3-75a4adcc56c0">68,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfOS00LTEtMS0yMzQ1OA_b1407bc1-0a7a-4142-9ede-8c992832077d">32,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfOS02LTEtMS0yMzQ1OA_254f1f5d-d214-4964-898c-f3f432757d8e">30,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTAtMi0xLTEtMjM0NTg_80fcc84d-2729-4da2-8a13-aeb27235ca7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTAtNC0xLTEtMjM0NTg_3360190a-10d9-4377-96f0-73184268acd3">406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTAtNi0xLTEtMjM0NTg_eeddfe63-7dab-4537-95d9-c0a3ac94bcd2">816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in fair value of contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTEtMi0xLTEtMjM0NTg_e1fdd64d-e5b9-4edb-b794-5ee02b23a55e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTEtNC0xLTEtMjM0NTg_f2b5248c-a05d-4e10-9af4-312334ffcaec">3,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTEtNi0xLTEtMjM0NTg_4a650525-9436-413d-9d1b-2f1244342950">845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on sale of Hospital Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTItMi0xLTEtMjM0NTg_75deae66-5902-40e7-8211-f85aa3b2b35a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTItNC0xLTEtMjM0NTg_aed9c5f6-97b9-436f-abea-c70f22717781">45,760</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTItNi0xLTEtMjM0NTg_a70af2fc-5a0e-437d-8f56-84a0f888a2da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring (income) costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" sign="-" name="avdl:RestructuringCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTQtMi0xLTEtMjM0NTg_436f44ba-a482-4536-864c-c740dbad18a4">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" sign="-" name="avdl:RestructuringCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTQtNC0xLTEtMjM0NTg_1d72ade6-07d1-4338-8ad2-6c313867f52e">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="avdl:RestructuringCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTQtNi0xLTEtMjM0NTg_25a7882b-3fd3-49d1-890a-316a0874e1e6">6,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTUtMi0xLTEtMjM0NTg_6876690e-2e98-4ffa-b7f0-4cf89313009e">85,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTUtNC0xLTEtMjM0NTg_9f15243f-4362-4d77-b0f7-96c04763a59e">16,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTUtNi0xLTEtMjM0NTg_aa0bb5b5-f15a-4c3f-b4ff-3dfba559b37c">83,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTYtMi0xLTEtMjM0NTg_b38245f7-b0dd-4634-8479-9a81fac14932">85,546</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTYtNC0xLTEtMjM0NTg_946098b7-a0f3-4b88-ab8c-0959e3fdd008">5,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTYtNi0xLTEtMjM0NTg_434201af-7e25-42ff-8ef2-55b3d28bdb81">24,112</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment and other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:InvestmentIncomeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTctMi0xLTEtMjM0NTg_773ca4e0-eb6f-4cdd-a472-6a57946c6e4d">2,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:InvestmentIncomeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTctNC0xLTEtMjM0NTg_4fccb353-6615-47bc-8258-9dd85d7bb7f3">832</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:InvestmentIncomeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTctNi0xLTEtMjM0NTg_041558f7-51ec-414c-a915-bf651e4d85d5">1,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTgtMi0xLTEtMjM0NTg_846f874f-2f82-4390-8e0e-be7e08739a51">9,942</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTgtNC0xLTEtMjM0NTg_81417cfb-cf51-4ab5-b056-daef5495a492">12,994</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTgtNi0xLTEtMjM0NTg_3ad503ec-0695-4732-9749-9956d7210f83">12,483</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain from release of certain liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTktMi0xLTEtMjM0NTg_13afc7dc-7200-4499-9e99-20c42ae4c09f">217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTktNC0xLTEtMjM0NTg_f5d17358-3ec8-4f2e-b033-7a1561f49bfa">3,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTktNi0xLTEtMjM0NTg_56714497-8409-43c9-aaa1-2357ba17be3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on deconsolidation of subsidiary</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:DeconsolidationGainOrLossAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjAtMi0xLTEtMjM0NTg_6f866395-7888-4874-88e1-352c02bf4621">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:DeconsolidationGainOrLossAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjAtNC0xLTEtMjM0NTg_cb707196-398e-4f56-8c80-71d1a3cab185">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DeconsolidationGainOrLossAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjAtNi0xLTEtMjM0NTg_de073e68-da20-4bdb-9779-a0c4c78d0371">2,678</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense - changes in fair value of contingent consideration payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjEtMi0xLTEtMjM0NTg_0c5c5640-161c-4b6c-acbe-b4470d144ac4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjEtNC0xLTEtMjM0NTg_c4507cc6-c396-4664-9803-5ab80bd8ba59">435</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjEtNi0xLTEtMjM0NTg_aadfc264-8f17-42c3-ae2a-fe4adcaa45ee">378</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjItMi0xLTEtMjM0NTg_ac665b0a-be52-4e39-8eaf-cdbf1c10ecd0">93,145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjItNC0xLTEtMjM0NTg_728aeca4-8dda-45bb-b4eb-a0508c64cb34">5,082</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjItNi0xLTEtMjM0NTg_fb4821b0-ea0a-4221-8164-e82826983234">38,582</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjMtMi0xLTEtMjM0NTg_9c9e7f84-a770-40c3-a716-e14c8584458a">15,816</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjMtNC0xLTEtMjM0NTg_85aa433b-4220-4ddc-8ff4-63968b905370">12,110</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjMtNi0xLTEtMjM0NTg_f623a896-1d5b-492b-bf31-1cb72f8f39dd">5,356</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjYtMi0xLTEtMjM0NTg_dd26b39b-1540-4eae-b115-f67cd63ee33a">77,329</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjYtNC0xLTEtMjM0NTg_0f9fcf0d-8446-4cf1-bc54-2e8fde1f3da7">7,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjYtNi0xLTEtMjM0NTg_45f57a9f-0ae8-4a44-bb6e-e32e333683dd">33,226</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income per share - basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMzEtMi0xLTEtMjM0NTg_1c4adb6e-fa25-47b5-a3fa-6180e3d0f685">1.32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMzEtNC0xLTEtMjM0NTg_7e2d926c-8d3f-448d-9dd1-07e105f99428">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMzEtNi0xLTEtMjM0NTg_4fa46bda-3e09-45ae-a2a7-0e47919b8a80">0.89</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income per share - diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMzYtMi0xLTEtMjM0NTg_016f5f54-5669-4d64-8542-8a26bea8dfb4">1.32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMzYtNC0xLTEtMjM0NTg_bed05b4f-0b12-45f6-b24b-7c69a2c4e2ff">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMzYtNi0xLTEtMjM0NTg_fd935f7d-3d0a-43ea-bcf6-baca83bc3d0e">0.89</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of shares outstanding - basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMzgtMi0xLTEtMjM0NTg_e8f41144-ea9c-42a0-b62f-c4518d60c2cd">58,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMzgtNC0xLTEtMjM0NTg_cad0d07d-beb2-4319-a354-535f4ed7eeac">52,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMzgtNi0xLTEtMjM0NTg_411037d4-eb31-46d2-a8a8-021d35b42b65">37,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of shares outstanding - diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMzktMi0xLTEtMjM0NTg_61c2a76f-59ab-46d8-8c81-97a3976afeaf">58,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMzktNC0xLTEtMjM0NTg_0faa45a1-0703-404b-8f78-1337e98ce046">54,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMzktNi0xLTEtMjM0NTg_00ec8023-14f8-4c3d-8b45-2cc7551d593a">37,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-74-</span></div></div></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands)</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:61.161%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.796%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfMi0yLTEtMS0yMzQ1OA_b448c81c-8357-44f2-b591-87512d106943">77,329</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfMi00LTEtMS0yMzQ1OA_f7f059ff-d616-4d9b-84d5-1feb0d7ec0d6">7,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfMi02LTEtMS0yMzQ1OA_356ed94d-08cb-4707-ac16-f6d7c5c7e10b">33,226</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation (loss) gain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNC0yLTEtMS0yMzQ1OA_4e97cd06-b268-41e2-9185-2c0ca71b1197">1,228</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNC00LTEtMS0yMzQ1OA_30221201-bda0-4872-9e88-0db967e5c657">1,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNC02LTEtMS0yMzQ1OA_bf9018c7-025d-4490-afc6-4cc36019e953">117</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive (loss) income, net of income tax benefit (expense) of $<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNS0wLTEtMS0yMzQ1OC90ZXh0cmVnaW9uOmQzZmE2NzZjNzc4MTQyMzViZGVlODhlNjZhYWMzM2NkXzQz_356cbfd1-ecad-402e-8027-f15cd072ced3">214</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNS0wLTEtMS0yMzQ1OC90ZXh0cmVnaW9uOmQzZmE2NzZjNzc4MTQyMzViZGVlODhlNjZhYWMzM2NkXzQ3_b99f0d85-5126-478d-a598-f9e623f03aab">202</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNS0wLTEtMS0yMzQ1OC90ZXh0cmVnaW9uOmQzZmE2NzZjNzc4MTQyMzViZGVlODhlNjZhYWMzM2NkXzUx_eee60a6e-bed3-4cdf-aa34-b03e70b6349d">43</ix:nonFraction>), respectively</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNS0yLTEtMS0yMzQ1OA_00355a43-b136-4aa2-a97e-1fa0d0e174b4">1,661</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNS00LTEtMS0yMzQ1OA_d0f4d08a-ade7-44db-81ae-7a9f4c3098d4">644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNS02LTEtMS0yMzQ1OA_ffb721bf-4fa8-42b1-94ae-d97862624f2f">727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other comprehensive (loss) income, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNi0yLTEtMS0yMzQ1OA_39a120f9-8844-443e-aeb3-2b7aa5994539">2,889</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNi00LTEtMS0yMzQ1OA_0ecab2ce-9c0a-4974-a7ed-20dfe7650ce9">1,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNi02LTEtMS0yMzQ1OA_1ff8210f-0ca0-4cec-ae37-404ceee0e068">610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total comprehensive (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNy0yLTEtMS0yMzQ1OA_0ebceecf-8895-4678-9cf6-1dc7a7ff1c2f">80,218</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNy00LTEtMS0yMzQ1OA_009f2dc2-5c37-4c92-b23e-860af4a164f9">8,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNy02LTEtMS0yMzQ1OA_80a1546a-9011-4f97-af62-52bdb0a2bced">32,616</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-75-</span></div></div></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_79"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands, except per share data)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:75.116%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.168%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASSETS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfNC0yLTEtMS0yMzQ1OA_7fb436cf-fc08-4f7f-a9dd-0ef40a9898aa">50,708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfNC00LTEtMS0yMzQ1OA_59de3b20-306e-4d3b-ad0e-998bb04d4bea">71,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfNS0yLTEtMS0yMzQ1OA_0cbd972b-39d2-497d-95fa-7f385fa90d6d">106,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfNS00LTEtMS0yMzQ1OA_1d403aa8-7be5-4cac-9d5b-ba9a63caa039">149,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development tax credit receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="avdl:ResearchAndDevelopmentTaxCreditReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfOC0yLTEtMS0yMzQ1OA_a80069a1-c602-4aad-a763-4147c8d289cd">2,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="avdl:ResearchAndDevelopmentTaxCreditReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfOC00LTEtMS0yMzQ1OA_64ed633f-4531-496f-bd17-004de84b8ede">3,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfOS0yLTEtMS0yMzQ1OA_d9b2ce67-f8a4-4f01-a321-e13cad5c5e99">32,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfOS00LTEtMS0yMzQ1OA_36e2410b-59bf-43c1-9391-84a72a28ef63">38,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTAtMi0xLTEtMjM0NTg_29c97992-e664-4b27-81b9-aafe047390f7">192,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTAtNC0xLTEtMjM0NTg_a1d68f31-1efd-4c59-99a5-ebb130a649ca">263,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTEtMi0xLTEtMjM0NTg_96397f94-e6a1-4dbd-976f-8ec6f78e3e7f">285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTEtNC0xLTEtMjM0NTg_6fa776b4-dd2f-4247-bfbe-9be54e00b338">359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTItMi0xLTEtMjM0NTg_f2108093-7edc-49a1-b721-6d300d778f7e">2,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTItNC0xLTEtMjM0NTg_496ad562-1ba8-451b-9187-89ba7736e767">2,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTMtMi0xLTEtMjM0NTg_60ccc910-65f6-4295-8cd3-d73b18f5462a">16,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTMtNC0xLTEtMjM0NTg_a2c21d25-ed9c-4fb8-a114-04e394d6ebc4">16,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development tax credit receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="avdl:ResearchAndDevelopmentTaxCreditReceivableNonCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTUtMi0xLTEtMjM0NTg_d1c7e07f-0ee2-49be-80cf-74545c0b7a32">1,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="avdl:ResearchAndDevelopmentTaxCreditReceivableNonCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTUtNC0xLTEtMjM0NTg_fc274dbf-2056-4be0-bb7b-a114bd4b5bd4">3,445</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTYtMi0xLTEtMjM0NTg_88b32373-d378-48a9-b0e4-4236672c2f9b">33,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTYtNC0xLTEtMjM0NTg_9eed8edd-b106-4d12-bdf9-1d06f5690b9e">24,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTctMi0xLTEtMjM0NTg_8e4aca89-babf-4a45-8cab-18e05a38734b">247,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTctNC0xLTEtMjM0NTg_01363df4-93fa-4bde-969c-f31daa46362b">311,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMjMtMi0xLTEtMjM0NTg_25cfd72c-0710-440d-9ec1-7c00ad3e6128">900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMjMtNC0xLTEtMjM0NTg_35c2bad9-3f20-4f5f-821f-9b44bd06530e">474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMjQtMi0xLTEtMjM0NTg_4862be8c-39ae-4856-adaf-e0e95dbe6c95">7,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMjQtNC0xLTEtMjM0NTg_fe179210-e5bf-45a3-972d-65f94b4bf274">2,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMjUtMi0xLTEtMjM0NTg_7026adba-6ecb-4569-b022-73ba143dc61f">7,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMjUtNC0xLTEtMjM0NTg_11b7d5bc-6bd5-45a8-87ba-86992660313b">6,501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMjctMi0xLTEtMjM0NTg_3dc101b0-2490-404c-b2aa-cd791e356dae">5,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMjctNC0xLTEtMjM0NTg_afa0597d-2dcd-4a37-b21d-102c0bfe0877">5,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMjgtMi0xLTEtMjM0NTg_4871dc5e-8983-4f55-ab7e-fcbe63c4d904">21,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMjgtNC0xLTEtMjM0NTg_f900d332-e276-416a-b7b7-40bc279245db">15,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMjktMi0xLTEtMjM0NTg_180d1672-f9cb-4073-964d-3b4890e5a0c2">142,397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMjktNC0xLTEtMjM0NTg_a101ccab-d8d7-41aa-ac36-298df062f28f">128,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzEtMi0xLTEtMjM0NTg_55331d22-2b6c-4c10-9e85-0800a3be447e">1,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzEtNC0xLTEtMjM0NTg_20bad181-868b-49d4-b583-6789aa47df93">1,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzItMi0xLTEtMjM0NTg_25020244-e3e6-4142-baad-23bc1a803cfe">3,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzItNC0xLTEtMjM0NTg_6303ec4d-943a-4549-9c92-f8b9f37da2bf">4,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzMtMi0xLTEtMjM0NTg_86c6508e-8e94-48b5-a490-7838072034d8">169,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzMtNC0xLTEtMjM0NTg_2208c218-9973-4a60-bd04-8c2cc651e5d3">149,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred shares, nominal value of $<ix:nonFraction unitRef="usdPerShare" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzYtMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo4N2EwOTlkNmU0MGQ0NjkxOTc5OTczYzExZGNlZmU5Yl8zOQ_76d23339-9c73-41ba-8c72-2fd2c48ef5cb"><ix:nonFraction unitRef="usdPerShare" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzYtMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo4N2EwOTlkNmU0MGQ0NjkxOTc5OTczYzExZGNlZmU5Yl8zOQ_c4704952-904f-4f4b-9286-888cd4d16168">0.01</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction unitRef="shares" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzYtMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo4N2EwOTlkNmU0MGQ0NjkxOTc5OTczYzExZGNlZmU5Yl81Mw_2f82829e-4cd6-4316-9ede-7be8e4c334b4"><ix:nonFraction unitRef="shares" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzYtMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo4N2EwOTlkNmU0MGQ0NjkxOTc5OTczYzExZGNlZmU5Yl81Mw_8ed5a6ab-277d-499d-a2d3-342ffbea2b3a">50,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzYtMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo4N2EwOTlkNmU0MGQ0NjkxOTc5OTczYzExZGNlZmU5Yl83NQ_35d1f159-81be-4f1b-80b9-52818ff5f30f"><ix:nonFraction unitRef="shares" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzYtMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo4N2EwOTlkNmU0MGQ0NjkxOTc5OTczYzExZGNlZmU5Yl83NQ_54e90d3b-13bf-460e-9ba5-1c79a6cf535c"><ix:nonFraction unitRef="shares" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzYtMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo4N2EwOTlkNmU0MGQ0NjkxOTc5OTczYzExZGNlZmU5Yl83NQ_bfbff1c3-6010-47cd-a2ce-626b503f7516"><ix:nonFraction unitRef="shares" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzYtMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo4N2EwOTlkNmU0MGQ0NjkxOTc5OTczYzExZGNlZmU5Yl83NQ_c4b04cf3-eedf-4648-9862-bf5f567f016e">488</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding at December 31, 2021 and 2020, respectively</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzYtMi0xLTEtMjM0NTg_7893b29e-2989-442b-962a-820ef66f7db8">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzYtNC0xLTEtMjM0NTg_7e26b15c-8d28-4aca-a108-5ab9d1eba42a">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ordinary shares, nominal value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzctMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo5MTVhZDQyODE3ZmM0MWUxODMyMzBkNmRiMDkwZGQ2OF8zOA_7497b81e-2537-4ba4-bb1a-0316481773cb"><ix:nonFraction unitRef="usdPerShare" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzctMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo5MTVhZDQyODE3ZmM0MWUxODMyMzBkNmRiMDkwZGQ2OF8zOA_b0d9e9e9-f35c-4919-9413-4c54dcd87691">0.01</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction unitRef="shares" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzctMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo5MTVhZDQyODE3ZmM0MWUxODMyMzBkNmRiMDkwZGQ2OF81Mg_305646c4-e9b4-4646-afe0-9d7fff2bfad4"><ix:nonFraction unitRef="shares" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzctMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo5MTVhZDQyODE3ZmM0MWUxODMyMzBkNmRiMDkwZGQ2OF81Mg_85d9458f-da1d-4f99-b52a-81bcb01fe419">500,000</ix:nonFraction></ix:nonFraction> shares authorized;&#160;<ix:nonFraction unitRef="shares" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzctMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo5MTVhZDQyODE3ZmM0MWUxODMyMzBkNmRiMDkwZGQ2OF83NA_31e2ea49-3098-450d-93cd-2dfe381d3b81"><ix:nonFraction unitRef="shares" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzctMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo5MTVhZDQyODE3ZmM0MWUxODMyMzBkNmRiMDkwZGQ2OF83NA_6a8b3dec-1381-485e-924f-89d9488e311d">58,620</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzctMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo5MTVhZDQyODE3ZmM0MWUxODMyMzBkNmRiMDkwZGQ2OF8xMjY_1a17f8fe-aef1-46f0-800f-fefea375add0"><ix:nonFraction unitRef="shares" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzctMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo5MTVhZDQyODE3ZmM0MWUxODMyMzBkNmRiMDkwZGQ2OF8xMjY_ea5c1ae1-e8c0-4062-b987-9a2078a5ea69">58,396</ix:nonFraction></ix:nonFraction> issued and outstanding at December 31, 2021 and 2020, respectively</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzctMi0xLTEtMjM0NTg_16ebfa0f-1f16-43a5-ae0c-e14c541372e4">586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzctNC0xLTEtMjM0NTg_236772d7-5031-4927-aff8-397013135b7f">583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzktMi0xLTEtMjM0NTg_4b5dfae4-e5d5-4e99-b1af-836d378a007a">549,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzktNC0xLTEtMjM0NTg_2716d762-7a00-4317-9965-e8dac9bccd29">566,916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfNDAtMi0xLTEtMjM0NTg_c548942f-9f3e-4a0f-9aef-504ad0112abb">447,756</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfNDAtNC0xLTEtMjM0NTg_f844eb67-3141-48fe-8b68-b7a66f85e38a">384,187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfNDEtMi0xLTEtMjM0NTg_9ef2ad61-edd0-4ae0-b02c-5fb709411d27">23,940</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfNDEtNC0xLTEtMjM0NTg_277f4a7c-0747-4670-8e0d-4ebb08027a0b">21,051</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfNDItMi0xLTEtMjM0NTg_aaa7893b-7440-4732-8a93-6ba95d801727">78,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfNDItNC0xLTEtMjM0NTg_5c8ee24d-badf-4336-93b9-b3af274423b6">162,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfNDMtMi0xLTEtMjM0NTg_2d62ffee-4e6e-4d9d-83f1-9865c7d87c81">247,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfNDMtNC0xLTEtMjM0NTg_12d4c109-2efc-4659-9d19-bf253b69ff38">311,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-76-</span></div></div></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_82"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.045%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.462%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.462%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.462%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.462%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.754%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.754%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.462%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.462%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ordinary shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preferred shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>shareholders&#8217;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">paid-in capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance, December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib3742cf8102b48d39bc674ec35e7f8d0_I20181231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjEtMi0xLTEtMjM0NTg_cf77c001-a6f8-402d-80c3-05c992a8b6d8">42,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3742cf8102b48d39bc674ec35e7f8d0_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjEtNC0xLTEtMjM0NTg_da4210af-62e9-4e59-b926-7d8f2d40e5c2">427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i812a792161364ad492b0f6fe55adf3f4_I20181231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjEtNi0xLTEtMjM0NTg_fd63465b-1cf9-4e52-8cb8-d85ca27e4ed8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i812a792161364ad492b0f6fe55adf3f4_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjEtOC0xLTEtMjM0NTg_b88a71cc-412d-4510-9fb3-0d12ec795bc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fb14a7aef624d6b8b4c8f13072f3c9f_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjEtMTAtMS0xLTIzNDU4_f5f9c88d-7095-4186-a7ae-219385f2d788">433,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26cf650e64fc419d90c5273bbc7ac968_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjEtMTItMS0xLTIzNDU4_5f0659a6-00e5-4c22-98df-662f94dc5b1c">357,989</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6fbbd5528b2439293da3c165945acb2_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjEtMTQtMS0xLTIzNDU4_10bf4123-a516-49ce-aeff-b497abfc5e29">23,416</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i394f53cfcde141e98500d79a19551b90_I20181231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjEtMTYtMS0xLTIzNDU4_dac78ca4-f4b2-4a49-be5c-6c7824429de7">5,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394f53cfcde141e98500d79a19551b90_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjEtMTgtMS0xLTIzNDU4_f3daa9da-b619-4e6e-a93b-72bdbbc37527">49,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie19b226220734349af34ea12f273148b_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjEtMjAtMS0xLTIzNDU4_0e140469-f263-4166-8276-f2255e5ecc42">2,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62c97ced29404b4b822be5a8b268125c_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjItMTItMS0xLTIzNDU4_5b6bc122-44e1-407a-a04e-95a28690365c">33,226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjItMjAtMS0xLTIzNDU4_d0e72a95-95da-44ce-b40a-96910dfda636">33,226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie148f975b2854da787567794ba46c657_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjMtMTQtMS0xLTIzNDU4_ea3b4699-b824-4165-86ff-3afbe08f56fc">610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjMtMjAtMS0xLTIzNDU4_e426013b-62dd-476b-ac3f-6820d21ffc3d">610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia8606a26085a4a74842150a8d122fa0d_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjQtMi0xLTEtMjM0NTg_2a5c69db-612e-484f-8e17-72885ab22d64">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8606a26085a4a74842150a8d122fa0d_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjQtNC0xLTEtMjM0NTg_ff8b55ea-83e5-491e-a418-8f28000a52e3">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e4d19794fda42f0b37baafb371b84eb_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjQtMTAtMS0xLTIzNDU4_893e7650-f7a1-4e9b-9188-57ed1b5723b2">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjQtMjAtMS0xLTIzNDU4_53e8203d-49f1-41b1-be18-75aef580198d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee share purchase plan share issuance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia8606a26085a4a74842150a8d122fa0d_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjUtMi0xLTEtMjM0NTg_5f714701-25a2-4dc6-a40b-60de478fc2fd">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e4d19794fda42f0b37baafb371b84eb_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjUtMTAtMS0xLTIzNDU4_9682c2ea-eabf-4e17-9b06-212623301d3e">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjUtMjAtMS0xLTIzNDU4_c384e1a7-a938-4ce5-9f9e-b05da75f9a11">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e4d19794fda42f0b37baafb371b84eb_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjYtMTAtMS0xLTIzNDU4_5bbce8ef-4c54-414c-9e1b-bac4046ec811">519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjYtMjAtMS0xLTIzNDU4_b7130681-9afe-4b87-a5e0-515f6f29f5bb">519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb598c0f14344aae992296441052f63c_I20191231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjctMi0xLTEtMjM0NTg_4b895522-8f6b-48bc-b19e-c328190505ca">42,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb598c0f14344aae992296441052f63c_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjctNC0xLTEtMjM0NTg_dd85e058-0ceb-4c5a-b859-81d6ec450b89">429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i197afee9fd6b4ccaa43ec6478392822f_I20191231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjctNi0xLTEtMjM0NTg_397f806a-c902-4abd-9313-ac39938fa11b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i197afee9fd6b4ccaa43ec6478392822f_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjctOC0xLTEtMjM0NTg_61eb10cb-2910-409a-844a-8ad5ad5b55e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i899ea66e7b964d058e1797ec8ba84773_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjctMTAtMS0xLTIzNDU4_bcb8b4d1-a98c-4486-9631-ab135ab20de7">434,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54c88094c4ef4380afaf16c83eff800a_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjctMTItMS0xLTIzNDU4_6111f895-27fc-4790-8821-884e711587fd">391,215</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67e12346ebfb4c079f8ca4ba96c5d37c_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjctMTQtMS0xLTIzNDU4_1b839dc9-8f2c-4b6b-a90b-a85187eb6ede">22,806</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib7eb97deba3549d6b376ab774b0445a5_I20191231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjctMTYtMS0xLTIzNDU4_a9d6d88e-fd30-48f3-a7aa-b1b24fb9acd4">5,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7eb97deba3549d6b376ab774b0445a5_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjctMTgtMS0xLTIzNDU4_89429366-290c-43d6-af24-02eda645bc22">49,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie73b28a1c0c648e5a6641e1c909996f0_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjctMjAtMS0xLTIzNDU4_3973befe-ba91-4abb-806d-c70da01e6eeb">29,199</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cf266a805904fcb95e5e2c230b341cd_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjgtMTItMS0xLTIzNDU4_f1c178c6-dde6-48f6-b335-202cb8c7c378">7,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjgtMjAtMS0xLTIzNDU4_205f860f-42c9-4a0d-8dbf-802137fcb769">7,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecf586fe05cc4a8796842f7e0739adcd_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjktMTQtMS0xLTIzNDU4_3f7543d0-55cb-4f64-afda-1a9fc6a19f02">1,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjktMjAtMS0xLTIzNDU4_9ee41f16-d2a6-4162-b238-f053715c916a">1,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if771595121ea48de8b53daa551326307_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzAtMi0xLTEtMjM0NTg_ab88b597-71b2-4365-9d13-02f88dd4b53d">403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if771595121ea48de8b53daa551326307_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzAtNC0xLTEtMjM0NTg_b675826a-0dba-4e0c-9a62-ba4daac31671">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9de1c77df78b4ba98727acf8dec79f60_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzAtMTAtMS0xLTIzNDU4_ede1dfd2-022e-4b49-bbfb-72bd5b1ee002">2,041</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzAtMjAtMS0xLTIzNDU4_434129f6-4f4f-43d9-b486-4b74039e41e7">2,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">February 2020 private placement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if771595121ea48de8b53daa551326307_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzEtMi0xLTEtMjM0NTg_42253f97-dde7-48e3-895e-6200c3d19232">8,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if771595121ea48de8b53daa551326307_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzEtNC0xLTEtMjM0NTg_8ff04560-c6f5-4f7c-b495-285589274750">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i222f8cd80d79448189c83644ac3d2355_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzEtNi0xLTEtMjM0NTg_b021d85d-ba01-4229-a03b-62dd2db9b89a">488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i222f8cd80d79448189c83644ac3d2355_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzEtOC0xLTEtMjM0NTg_592efd99-1be1-4525-b24f-335b3620aa07">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9de1c77df78b4ba98727acf8dec79f60_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzEtMTAtMS0xLTIzNDU4_af47c164-6cc0-4e66-8dd4-47f25b6fff6d">60,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzEtMjAtMS0xLTIzNDU4_67dac234-ea55-409d-8211-08350f3efe21">60,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 2020 public offering</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if771595121ea48de8b53daa551326307_D20200101-20201231" decimals="-3" name="avdl:StockIssuedDuringPeriodSharesPublicOffering" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzItMi0xLTEtMjM0NTg_e1e522f4-cadc-482c-bf7b-99094d612bf4">11,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if771595121ea48de8b53daa551326307_D20200101-20201231" decimals="-3" name="avdl:StockIssuedDuringPeriodValuePublicOffering" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzItNC0xLTEtMjM0NTg_dd665211-52a2-4ce7-870f-b3236149149f">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9de1c77df78b4ba98727acf8dec79f60_D20200101-20201231" decimals="-3" name="avdl:StockIssuedDuringPeriodValuePublicOffering" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzItMTAtMS0xLTIzNDU4_b848fe7e-1450-49a9-a329-e075a00de473">116,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="avdl:StockIssuedDuringPeriodValuePublicOffering" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzItMjAtMS0xLTIzNDU4_20a72140-4281-4b6d-9862-c825cce68768">116,924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if771595121ea48de8b53daa551326307_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzMtMi0xLTEtMjM0NTg_ff51d3e7-726f-4741-90fa-66f26a9fed10">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if771595121ea48de8b53daa551326307_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzMtNC0xLTEtMjM0NTg_352de33c-dc80-40ad-a249-a19cd9f72b3a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9de1c77df78b4ba98727acf8dec79f60_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzMtMTAtMS0xLTIzNDU4_610a63ae-4e62-41fa-8822-eb9611561448">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzMtMjAtMS0xLTIzNDU4_b7522cb5-1f18-48d2-b1b6-890b27d5a8b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee share purchase plan share issuance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if771595121ea48de8b53daa551326307_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzQtMi0xLTEtMjM0NTg_2046ba69-fb87-41dc-b1d2-5280dbc1d32e">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9de1c77df78b4ba98727acf8dec79f60_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzQtMTAtMS0xLTIzNDU4_183178ad-a578-4924-83f6-274b837708dd">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzQtMjAtMS0xLTIzNDU4_3eafc07f-1d15-4898-b48a-eac8995daf69">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9de1c77df78b4ba98727acf8dec79f60_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzUtMTAtMS0xLTIzNDU4_8096d08b-9f19-4396-8cac-1105a997fcfd">2,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzUtMjAtMS0xLTIzNDU4_b65d5411-ea12-43ab-9cd0-5723f4ddd4c1">2,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retirement of treasury shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if771595121ea48de8b53daa551326307_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockSharesRetired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzYtMi0xLTEtMjM0NTg_6b1ae154-0454-4063-8f42-4c248c3146ef">5,407</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if771595121ea48de8b53daa551326307_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzYtNC0xLTEtMjM0NTg_1efb8ce2-6c88-46b6-9f3e-9f31f58514df">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9de1c77df78b4ba98727acf8dec79f60_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzYtMTAtMS0xLTIzNDU4_ad39ebc4-42f4-4e2c-94f5-27631e3e757e">49,944</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id0877df49af64182b24f4e10a6ba5e3e_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockSharesRetired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzYtMTYtMS0xLTIzNDU4_455d4a0d-62c0-4abb-9869-5aaf3c9beeb6">5,407</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0877df49af64182b24f4e10a6ba5e3e_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzYtMTgtMS0xLTIzNDU4_c7928ac5-74d5-4fae-9c27-5b170a8fdd8f">49,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzYtMjAtMS0xLTIzNDU4_dbfd6284-7096-4850-bf8a-aca783894f62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic789417b0e004065ba225a51e910fb39_I20201231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzctMi0xLTEtMjM0NTg_90729378-a0a5-4322-b90a-3dab00b090b3">58,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic789417b0e004065ba225a51e910fb39_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzctNC0xLTEtMjM0NTg_5bd5fc90-d64d-45d7-b300-31e5ed7c2fed">583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i00d4167fc12941e6afffad25855327d4_I20201231" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzctNi0xLTEtMjM0NTg_e6af9374-05c5-4d0e-95bf-1e0807faddc3">488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00d4167fc12941e6afffad25855327d4_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzctOC0xLTEtMjM0NTg_c1c80bfe-7769-4cfe-9a06-d2bf6a2fde74">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia20446b447fa4a8ab7a66e1764ce6493_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzctMTAtMS0xLTIzNDU4_586df6a8-9abe-46fc-8a4f-8456031f9e12">566,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i82fc7bbe97ac467ba08500fce8cb112e_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzctMTItMS0xLTIzNDU4_e61c25d5-1a3d-40c5-b0e9-295578c41703">384,187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaddacdf3080a4469857cc1c79a9583e3_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzctMTQtMS0xLTIzNDU4_1517edbe-9b91-4ba3-bc34-61bb911c9413">21,051</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i965ba5cfda524be99b22224e377b7879_I20201231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzctMTYtMS0xLTIzNDU4_05b13cb8-11ba-4b39-bd03-34b6c24e8680">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i965ba5cfda524be99b22224e377b7879_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzctMTgtMS0xLTIzNDU4_fa2ca4bb-c9d4-4dd5-9d01-fd6152eac32b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzctMjAtMS0xLTIzNDU4_6efddad6-6b19-4f1c-9266-8d1200d0372d">162,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMTktMC0xLTEtMzUzMDQ_f56fced8-8277-4fc5-853a-d6b09d65d5dd">Impact of the adoption of ASU 2020-06</span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27057cf80d054326a72f1357eef1f0c2_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMTktMTAtMS0xLTI0NTky_ae035a2a-2593-4fbe-823a-f4b9b6bc0c87">26,699</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdaa54a433dd430a83d91856c8287945_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMTktMTItMS0xLTI0NTky_9ee64294-ae39-499f-a30b-0289f49ff15f">13,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia03de445d5514be7925f47534612a3c6_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMTktMjAtMS0xLTM1MzAw_c49be4b6-614a-4b13-8248-010cbb75fa87">12,939</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2aea8b8d433e4423879f52b4780b5b0f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjAtMTItMS0xLTI0NTky_778106cc-e8f7-4bbe-888f-fc5aac11201d">77,329</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjAtMjAtMS0xLTM1Mjc5_4bf73bd0-f927-43ba-b7dc-83d933d62d89">77,329</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1271ce9577746e28ccd19f9aebc5938_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjEtMTQtMS0xLTI0NTky_852851b4-082b-4ba2-8148-d92bb676e1bc">2,889</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjEtMjAtMS0xLTM1Mjgx_11303af7-bf21-44b8-bc8b-c341f2820d4a">2,889</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i71e818e3e9d648c6b90862da8ce42be5_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjItMi0xLTEtMjQ1ODQ_e09f782b-8f5c-4b88-bfe3-6d8d225f632a">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71e818e3e9d648c6b90862da8ce42be5_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjItNC0xLTEtMjQ1ODQ_7566a8ab-33fd-41db-9d54-0e9cd3898347">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcc16b22124640c1b74cb0fad033cc0d_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjItMTAtMS0xLTI0NTky_ba5de53f-4ad8-4358-92ad-d4c2e607d968">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjItMjAtMS0xLTM1Mjg0_4c6091d5-9ea4-4092-8967-96985f3900d9">169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i71e818e3e9d648c6b90862da8ce42be5_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjMtMi0xLTEtMjQ1ODQ_8071e643-e25b-48d2-8bc7-64c06fbf4e88">159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71e818e3e9d648c6b90862da8ce42be5_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjMtNC0xLTEtMjQ1ODQ_d00209c5-df21-44b2-956a-766b22dc665f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcc16b22124640c1b74cb0fad033cc0d_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjMtMTAtMS0xLTI0NTky_d9993a88-d609-4ec7-a3eb-e6cef17234f3">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjMtMjAtMS0xLTM1Mjg3_688ec7a4-3375-4581-a6be-7085dbecccee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee share purchase plan share issuance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i71e818e3e9d648c6b90862da8ce42be5_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjQtMi0xLTEtMjQ1ODQ_d84f9906-2743-49a2-81f5-3f1e5e622580">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcc16b22124640c1b74cb0fad033cc0d_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjQtMTAtMS0xLTI0NTky_b859bb54-10d8-4481-8d6e-2e22a63b61a1">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjQtMjAtMS0xLTM1Mjky_5fece827-a3df-4f70-a27c-a1af6591010b">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcc16b22124640c1b74cb0fad033cc0d_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjUtMTAtMS0xLTI0NTky_02e43429-0ee9-4915-88e0-1c700d600ac1">8,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjUtMjAtMS0xLTM1Mjk1_bb84e222-2aec-431d-90d6-0c46f15f6a80">8,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5c79a087deb04cc1aee09bf57361d370_I20211231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjYtMi0xLTEtMzUyOTg_46cfd133-efa7-4811-9f8a-6df5b33232fb">58,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c79a087deb04cc1aee09bf57361d370_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjYtNC0xLTEtMzUyOTg_7305ec82-9c5c-4661-9b1a-28935311c2d5">586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4880683abd4349769692521b4246f81c_I20211231" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjYtNi0xLTEtMzUyOTg_c56575a0-28e2-41df-90fb-c49e2478ec53">488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4880683abd4349769692521b4246f81c_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjYtOC0xLTEtMzUyOTg_2d446223-26ff-44f0-8b1b-e9a6fa145eca">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f3ba7983a1d4e8d8ca3d4d571f7417f_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjYtMTAtMS0xLTM1Mjk4_f50d7d08-7755-42d1-ab0a-370f6dec9ff7">549,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic954e2aba16348f4beeb6795e6fad4fa_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjYtMTItMS0xLTM1Mjk4_c5c0992f-8dd3-4aae-8bdb-9179b0c0f09b">447,756</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79b00d255f634de49f2fc2b349447e88_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjYtMTQtMS0xLTM1Mjk4_642230ab-d177-447f-9de8-3f7f11e49771">23,940</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i10196011707944b18724021dfce2ca7e_I20211231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjYtMTYtMS0xLTM1Mjk4_c8b9819d-357e-46b6-bc7a-76b1e3728705">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10196011707944b18724021dfce2ca7e_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjYtMTgtMS0xLTM1Mjk4_f898261f-6f9e-4546-810b-a1583fb5e69c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjYtMjAtMS0xLTM1Mjk4_fe784ce4-79fd-48e2-acaf-cc35c3874042">78,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-77-</span></div></div></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_85"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:63.106%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.181%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.042%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.183%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMy0yLTEtMS0yMzQ1OA_7529f3ef-b65c-4bbc-8c1a-9cdb744ba979">77,329</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMy00LTEtMS0yMzQ1OA_b3645de4-d511-49a0-909c-4e8cd0ee1bac">7,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMy02LTEtMS0yMzQ1OA_614e1022-910a-4760-b50c-5b992ff2753c">33,226</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net (loss) income to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNS0yLTEtMS0yMzQ1OA_28b5d2a5-1844-4dd5-94aa-21269ce1a2e4">815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNS00LTEtMS0yMzQ1OA_d605a65d-dbe4-4991-9931-53a69884c88e">1,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNS02LTEtMS0yMzQ1OA_ed4acaae-3e25-4c88-9897-9f3c38150408">2,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Remeasurement of acquisition-related contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="avdl:AcquisitionRelatedContingentConsiderationRemeasurement" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNy0yLTEtMS0yMzQ1OA_5471299e-a347-4b27-bf12-332790b532bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="avdl:AcquisitionRelatedContingentConsiderationRemeasurement" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNy00LTEtMS0yMzQ1OA_20f73b7c-f07b-4ca5-af58-afa47450a5a8">3,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="avdl:AcquisitionRelatedContingentConsiderationRemeasurement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNy02LTEtMS0yMzQ1OA_77015d3d-9a8c-408f-b36c-34fa88bcef4d">845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Remeasurement of financing-related contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="avdl:FinancingRelatedContingentConsiderationRemeasurement" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfOC0yLTEtMS0yMzQ1OA_67042c5b-613c-4686-83be-8e0fcea01b21">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="avdl:FinancingRelatedContingentConsiderationRemeasurement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfOC00LTEtMS0yMzQ1OA_d30f0560-13d7-4c10-abb9-fc2c771316e1">435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="avdl:FinancingRelatedContingentConsiderationRemeasurement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfOC02LTEtMS0yMzQ1OA_b452cd1c-5f5f-459c-91b5-676782b16f81">378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of debt discount and debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfOS0yLTEtMS0yMzQ1OA_ab9e9c2a-f864-43f2-9d84-a3aa9728b420">1,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfOS00LTEtMS0yMzQ1OA_f2a8543d-088f-4431-abf3-27a305fbfc26">6,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfOS02LTEtMS0yMzQ1OA_72269872-3d61-410c-b58a-ad327dc33c51">5,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in deferred tax </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTAtMi0xLTEtMjM0NTg_157ff166-0262-4553-80e8-0d793f54cdd4">15,666</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTAtNC0xLTEtMjM0NTg_146d7a54-e2f3-4bbf-bea7-29d87a5fe365">7,431</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTAtNi0xLTEtMjM0NTg_8aae3329-ec61-46d7-b5cb-d11054c1aea0">6,334</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTEtMi0xLTEtMjM0NTg_5589d76c-c09e-4a9a-ab27-bc7edfb5bad9">8,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTEtNC0xLTEtMjM0NTg_8b8dec5e-0f38-4fd6-be02-1cffcd3af039">2,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTEtNi0xLTEtMjM0NTg_87ee0b92-b186-43f2-96e7-7a1680c88233">519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on the disposition of the Hospital Products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTItMi0xLTEtMjM0NTg_0b61f000-6c19-46ca-9969-d9fcd926f7e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTItNC0xLTEtMjM0NTg_6a27a9c2-5fb8-4078-a49a-d5c03af1ec23">45,760</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTItNi0xLTEtMjM0NTg_c76bf524-0e06-46d9-8869-5014c010cecf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on deconsolidation of subsidiary</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="avdl:NoncashGainLossDeconsolidationOfSubsidiary" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTMtMi0xLTEtMjM0NTg_ddba6c23-8bf8-44a9-8d60-b76f4ce34993">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="avdl:NoncashGainLossDeconsolidationOfSubsidiary" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTMtNC0xLTEtMjM0NTg_dd8c4fd8-337c-4b90-aa5a-26910743b3e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="avdl:NoncashGainLossDeconsolidationOfSubsidiary" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTMtNi0xLTEtMjM0NTg_f9dd2478-1ec4-4463-a67f-1a91647d6080">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain from the release of certain liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTQtMi0xLTEtMjM0NTg_2cf8e67e-d4ef-4a76-a2af-995c2c906772">217</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTQtNC0xLTEtMjM0NTg_bc6ce927-08ae-49e3-8b11-afe28c904668">3,364</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTQtNi0xLTEtMjM0NTg_a47de877-2d59-440f-ac9f-c975326af44f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTUtMi0xLTEtMjM0NTg_7c7ff703-914e-46b5-ab63-820b1f155281">1,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTUtNC0xLTEtMjM0NTg_3663981e-0b92-4012-ac05-411c566f63a6">142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTUtNi0xLTEtMjM0NTg_7cc963fb-9392-4b20-a38d-d22c63fa468d">254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net changes in assets and liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTctMi0xLTEtMjM0NTg_79356780-4ae9-4454-8119-6af3d0d8646f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTctNC0xLTEtMjM0NTg_824c522c-47ef-4a41-a2b9-d1b7eca34df8">8,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTctNi0xLTEtMjM0NTg_aee9dadd-9850-4b65-8b47-1a4a2a7b038e">2,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTgtMi0xLTEtMjM0NTg_2735c54a-23d4-439a-82b2-18adfc2ff19e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTgtNC0xLTEtMjM0NTg_11d065ff-cb36-4664-8d78-163c22296acd">1,352</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTgtNi0xLTEtMjM0NTg_14f8b4a9-82cd-400b-a65c-36a4f8832248">1,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTktMi0xLTEtMjM0NTg_9fca10fd-5e28-40a5-8f98-7edc15a3216b">439</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTktNC0xLTEtMjM0NTg_5f59a3ba-4371-47ee-9377-faf330a06b62">1,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTktNi0xLTEtMjM0NTg_9e009eb2-cade-486b-a0fe-89460c9dfcae">1,187</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development tax credit receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" sign="-" name="avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjAtMi0xLTEtMjM0NTg_e0858ddc-c06f-4479-852f-5ccdeabafb88">2,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" sign="-" name="avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjAtNC0xLTEtMjM0NTg_52135520-8ebf-4a56-bd2e-863230cbae8b">2,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjAtNi0xLTEtMjM0NTg_4c517845-bc71-4fad-821a-8fd9bcfb77ae">1,014</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable &amp; other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjEtMi0xLTEtMjM0NTg_b2531d71-2126-4111-b981-11d82e469395">4,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjEtNC0xLTEtMjM0NTg_f3dd659d-ac22-4108-a556-cf06047c57cb">2,788</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjEtNi0xLTEtMjM0NTg_e5f8bdd9-8170-4094-8a99-9a3a0f1862ba">4,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjItMi0xLTEtMjM0NTg_c3837345-1173-47e2-8a12-469110bffd1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjItNC0xLTEtMjM0NTg_f4dd7ff1-17c4-4a6d-8e17-d1d7b81048c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjItNi0xLTEtMjM0NTg_f6b752a4-4baa-484a-83aa-76f11b125933">114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjMtMi0xLTEtMjM0NTg_8b3f0931-a047-40fd-b1f3-a69d69b24455">895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjMtNC0xLTEtMjM0NTg_99086e70-79f2-49d1-8e67-1710193aea39">13,226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjMtNi0xLTEtMjM0NTg_cda934d9-a34a-4446-8f86-c84f08a17609">357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earn-out payments for contingent consideration in excess of acquisition-date fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="avdl:EarnOutPaymentInExcessOfAcquisitionDateFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjUtMi0xLTEtMjM0NTg_161eeb80-90ce-4ac1-b440-227f91ee1c74">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="avdl:EarnOutPaymentInExcessOfAcquisitionDateFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjUtNC0xLTEtMjM0NTg_b89ed304-3ed1-4fda-9edb-2c7f75728930">5,323</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="avdl:EarnOutPaymentInExcessOfAcquisitionDateFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjUtNi0xLTEtMjM0NTg_07269ef3-e151-49e0-97ea-b2087bf4cf0d">10,988</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Royalty payments for contingent consideration payable in excess of original fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsForRoyalties" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjYtMi0xLTEtMjM0NTg_f88c99d0-a5e9-4fe3-bcda-12a584f80499">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsForRoyalties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjYtNC0xLTEtMjM0NTg_a7edd175-f2b7-45c8-82ba-b30d29ef0502">866</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsForRoyalties" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjYtNi0xLTEtMjM0NTg_ca71c5cc-c247-409b-96d0-5152b5125eea">1,748</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets and liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjctMi0xLTEtMjM0NTg_e8cf5a56-cb18-4501-a3c7-34a5200f55c0">3,789</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjctNC0xLTEtMjM0NTg_d23e4586-0bea-4fbd-a611-ffa729dfe946">3,126</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjctNi0xLTEtMjM0NTg_1e296f14-c048-47ae-9d5a-71b6b2f82230">4,057</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjgtMi0xLTEtMjM0NTg_528b653f-7453-48ca-a5b5-0d8487f6f2dd">77,310</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjgtNC0xLTEtMjM0NTg_d51ae1e1-ba67-4f09-8d9b-d60766464e6e">48,734</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjgtNi0xLTEtMjM0NTg_3c13b621-9fe4-4a6c-a55d-50ba49bc769e">38,325</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzEtMi0xLTEtMjM0NTg_29caa413-473a-4895-bdfa-c6f5ac20c0fd">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzEtNC0xLTEtMjM0NTg_61624a7b-5d7f-4e6f-828f-11fedfa2212e">98</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzEtNi0xLTEtMjM0NTg_f4f8e1a3-1c09-4109-8b4b-deb5b187e180">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from disposal of property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzItMi0xLTEtMjM0NTg_f7d0156f-037f-4589-8ce6-8dcf29a34ec5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzItNC0xLTEtMjM0NTg_4cc96a27-cf4a-494b-836b-e3dcc7cfc430">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzItNi0xLTEtMjM0NTg_bba32e31-7ff2-4a01-a301-a27d6f7cf583">154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from the disposition of the Hospital Products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzMtMi0xLTEtMjM0NTg_281b5d9c-66af-4651-ae75-ac08ab143a5b">16,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzMtNC0xLTEtMjM0NTg_84d60592-e5ed-46bc-83c4-2fb33987ba4d">25,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzMtNi0xLTEtMjM0NTg_ad6e502a-aa96-4537-a6db-b9843b2be7c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sales of marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzUtMi0xLTEtMjM0NTg_20e40bbb-dc44-412f-9221-a25e4373b781">102,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzUtNC0xLTEtMjM0NTg_8eb0d6c1-845f-411b-b9a1-46aa000292ff">36,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzUtNi0xLTEtMjM0NTg_9564ec5f-a0a0-4d75-b4f5-fab13fdad236">63,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzYtMi0xLTEtMjM0NTg_6b055bd8-e2fe-48f6-a649-311d3f41dfd0">61,769</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzYtNC0xLTEtMjM0NTg_443d6f7c-81f7-4059-9c54-ec054e4f7c4e">131,407</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzYtNi0xLTEtMjM0NTg_59be688b-32c4-44ad-877a-9d638c9c0042">24,648</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzctMi0xLTEtMjM0NTg_6c5b0618-3a6d-4191-b30a-f214c4dd6d87">56,929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzctNC0xLTEtMjM0NTg_0b783e92-555c-490d-896c-9415461eba16">69,721</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzctNi0xLTEtMjM0NTg_022ff384-3b7f-4817-a775-adf3e6331afb">38,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from the February 2020 private placement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDQtMi0xLTEtMjM0NTg_c697e5da-5692-4f44-8a04-b5ff1552b48a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDQtNC0xLTEtMjM0NTg_9c35d3cc-51c9-4de9-a102-839a2a49e1cd">60,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDQtNi0xLTEtMjM0NTg_7c3db41a-a987-4e40-8df7-98563ac893b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from the May 2020 public offering</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDUtMi0xLTEtMjM0NTg_f791055e-29cb-477b-9cfb-f759ef687257">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDUtNC0xLTEtMjM0NTg_2e91e061-b6d7-4a44-a915-286b61c617b1">116,924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDUtNi0xLTEtMjM0NTg_ca2ee0c1-dd18-4948-ad95-cf48785af4f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of ordinary shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDYtMi0xLTEtMjM0NTg_58f9b0f2-246b-4005-9ffd-c00be0e31dbc">263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDYtNC0xLTEtMjM0NTg_69fd470b-a438-441f-ab35-4924db4fbb67">2,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDYtNi0xLTEtMjM0NTg_2764fd36-4c47-4f01-95f7-b0552d94877b">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other financing activities, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDgtMi0xLTEtMjM0NTg_2bc6452c-bdcb-4f1b-b86c-68d5b5d2434a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDgtNC0xLTEtMjM0NTg_a499681a-b183-48aa-94e9-50ffeb78c589">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDgtNi0xLTEtMjM0NTg_c87f879c-c232-46fa-a67c-525af893e26c">145</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDktMi0xLTEtMjM0NTg_4b98ad75-eb59-4663-ba8f-588a9745fbe6">263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDktNC0xLTEtMjM0NTg_791a6e03-d508-41f5-8597-ffaadbc95f40">179,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDktNi0xLTEtMjM0NTg_eff41dc0-ccca-45d9-8112-831ff268c142">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of foreign currency exchange rate changes on cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTAtMi0xLTEtMjM0NTg_97118263-501d-4f70-8590-32b0f132efc7">896</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTAtNC0xLTEtMjM0NTg_1b00ad80-772d-4e73-a57f-b63e5c2af31b">720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTAtNi0xLTEtMjM0NTg_755ee13e-0e73-4032-981c-8a7dc31ba41b">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net change in cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTEtMi0xLTEtMjM0NTg_93e320e1-487d-426d-9e85-252ce29c0e99">21,014</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTEtNC0xLTEtMjM0NTg_09395f47-c903-4493-a90f-a607600f2646">61,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTEtNi0xLTEtMjM0NTg_fc934aa3-20f0-43ed-942a-e6d3ded09b7a">449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents at January 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTItMi0xLTEtMjM0NTg_9435fab4-aa12-46a4-ac54-4b9abe1e3a9a">71,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73b28a1c0c648e5a6641e1c909996f0_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTItNC0xLTEtMjM0NTg_dbd2296a-f135-44f6-a687-0a36febe9966">9,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie19b226220734349af34ea12f273148b_I20181231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTItNi0xLTEtMjM0NTg_23c18a23-843e-4b72-b03f-19c6ea7ccd06">9,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents at December 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTMtMi0xLTEtMjM0NTg_adb29c19-1bec-419d-8269-f9f9822768bb">50,708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTMtNC0xLTEtMjM0NTg_ffb118a6-e97d-4c68-afe7-841ce767df75">71,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73b28a1c0c648e5a6641e1c909996f0_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTMtNi0xLTEtMjM0NTg_f828cec0-39fe-4741-bb51-e14708465891">9,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Supplemental disclosures of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income taxes paid (refund), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTYtMi0xLTEtMjM0NTg_3e9a9b3d-a871-4498-ab2b-02935385bd19">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTYtNC0xLTEtMjM0NTg_31eb9807-e3a5-4529-83c9-9fff03b71bcc">1,701</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTYtNi0xLTEtMjM0NTg_64cca4f4-cdec-4a17-9fde-9b7316ab3b67">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTctMi0xLTEtMjM0NTg_074f9d4d-15b7-44ce-956d-9a7e68be6a6f">6,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTctNC0xLTEtMjM0NTg_aa0a19c7-aec5-47cb-a6c3-bebf2bb3b34a">6,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTctNi0xLTEtMjM0NTg_20c80961-580b-43cf-bd10-ba030102cf8b">6,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-78-</span></div></div></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands, except per share data)</span></div><div><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyMjI_6dc75914-9f77-4b96-81ec-c6b9b1bb3f7f" continuedAt="ic2c94510a04f43ee8dc56f97d495b27f" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ic2c94510a04f43ee8dc56f97d495b27f" continuedAt="i132728ad66b34435b1b7a21a4a98dcc3"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="avdl:NatureOfBusinessPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyODg_2e27f442-605b-43e9-b120-31662a996db5" continuedAt="i3552f62be56a4eafbbc3c8c25f5d3030" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Avadel Pharmaceuticals plc (Nasdaq: AVDL) (&#8220;Avadel,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221;) is a biopharmaceutical company. The Company is registered as an Irish public limited company. The Company&#8217;s headquarters are in Dublin, Ireland with operations in St. Louis, Missouri, United States (&#8220;U.S&#8221;).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s lead product candidate, FT218, is an investigational once-nightly, extended-release formulation of sodium oxybate for the treatment of excessive daytime sleepiness (&#8220;EDS&#8221;) or cataplexy in adults with narcolepsy. The Company is primarily focused on the development and potential United States (&#8220;U.S.&#8221;) Food and Drug Administration (&#8220;FDA&#8221;) approval of FT218. In December 2020, the Company submitted a New Drug Application (&#8220;NDA&#8221;) to the FDA for FT218 to treat excessive daytime sleepiness or cataplexy in adults with narcolepsy. In February 2021, the NDA for FT218 was accepted by the FDA and was assigned a Prescription Drug User Fee Act (&#8220;PDUFA&#8221;) target action date of October 15, 2021. On October 15, 2021, the Company announced that the FDA informed us that the review of the Company&#8217;s NDA for FT218 was ongoing beyond its previously assigned target action date. As of the date of this Annual Report, the FDA&#8217;s review of the Company&#8217;s NDA for FT218 remains ongoing. </span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3552f62be56a4eafbbc3c8c25f5d3030">Outside of the Company&#8217;s lead product candidate, the Company continues to evaluate opportunities to expand its product portfolio. As of the date of this Annual Report, the Company does not have any approved or commercialized products in its portfolio.</ix:continuation> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyMTg_ed8c6693-5c90-4b21-ae40-60fe2ecf78ff" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (&#8220;U.S. GAAP&#8221;). The consolidated financial statements include the accounts of the Company and all subsidiaries. All intercompany accounts and transactions have been eliminated.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s results of operations for the period January 1, 2019 through February 6, 2019 include the results of Avadel Specialty Pharmaceuticals, LLC (&#8220;Specialty Pharma&#8221;) prior to its February 6, 2019 voluntary petition for reorganization under Chapter 11 of the U.S. Bankruptcy Code. See&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 3: Subsidiary Bankruptcy and Deconsolidation.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyNzY_8d1e7e9f-28db-419a-aa68-234252984277" continuedAt="i4a985d53413145b2a5a94be0508f7a56" escape="true">Reclassifications</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i4a985d53413145b2a5a94be0508f7a56" continuedAt="i8c30fa738f9340169d5f89d6c22428e5"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications are made to prior year amounts whenever necessary to conform with the current year presentation. Certain reclassifications have been made to the Consolidated Statements of Cash Flows for the fiscal year ended December 31, 2019 and balances within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 14: Other Assets and Liabilities </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8c30fa738f9340169d5f89d6c22428e5">for the year ended December 31, 2020 to condense line items of the same nature into a single line. This change does not affect previously reported net cash flows used in operating activities in the Consolidated Statements of Cash Flows.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Out of Period Adjustments </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the Company determined that <ix:nonFraction unitRef="number" contextRef="ic562d9c206fb48efa5bb76601ca9f47a_D20210101-20211231" decimals="4" name="avdl:DebtInstrumentAdditionalInterestExpensePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMTA0NDUzNjA1Mjc2ODc_8f3bcb5c-7576-4bf5-83dc-294ef33552e0">0.50</ix:nonFraction>% of additional interest expense (the &#8220;Additional Interest&#8221;), as defined in the indenture dated as of February 16, 2018 among Avadel Finance Cayman Ltd, Avadel Pharmaceuticals PLC, and The Bank of New York Mellon as trustee (the &#8220;Indenture&#8221;), was owed on its long term <ix:nonFraction unitRef="number" contextRef="i0a1f89fa820b46799ce79a937450f547_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMTA0NDUzNjA1Mjc2OTQ_6328c307-48ec-4c68-afb4-8003e0916c82">4.50</ix:nonFraction>% exchangeable unsecured senior notes due 2023 (the &#8220;2023 Notes&#8221;) from a period of February 17, 2019 through December 31, 2021, totaling $<ix:nonFraction unitRef="usd" contextRef="ic562d9c206fb48efa5bb76601ca9f47a_D20210101-20211231" decimals="-3" name="avdl:AdditionalInterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMTA0NDUzNjA1Mjc3MDE_77bb6140-0da3-49f7-ba89-1d73496e285f">817</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i1f8c561814cb4f708a96e8a38bb166f0_D20200101-20201231" decimals="-3" name="avdl:AdditionalInterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMTA0NDUzNjA1Mjc3MTA_8610802e-7eaf-4d79-b8ed-6aec9ad7f79b">773</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i5309d5e8acaa431c9c274770bb06176c_D20190101-20191231" decimals="-3" name="avdl:AdditionalInterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMTA0NDUzNjA1Mjc3MTk_4f9e8615-168c-4e41-9a50-8f33bb670584">635</ix:nonFraction> for the years ended December 31, 2021, 2020 and 2019, respectively. At December 31, 2020, the Company&#8217;s accrued interest was understated by $<ix:nonFraction unitRef="usd" contextRef="i99ac7af65eda496da535e06c493274b8_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjc0ODc3OTEzNDk0Nw_1fd3a4fa-6349-4d1a-b237-db0618749f6d">1,408</ix:nonFraction>. The Additional Interest resulted from not removing a restrictive legend from the 2023 Notes 365 days following their original issuance on February 16, 2018.  The restrictive legend was removed in March 2022 and the Additional Interest is no longer applicable following the date of removal of the restrictive legend. The Company identified and recorded an out of period adjustment for cumulative amount of the Additional Interest in 2021 of $<ix:nonFraction unitRef="usd" contextRef="i99ac7af65eda496da535e06c493274b8_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMTA0NDUzNjA1Mjc3Mjg_d016d7d1-7fd3-4df9-9816-ef1c3f191d1a">1,408</ix:nonFraction>. Management assessed the materiality of the impact of the out of period adjustment on its financial statements, both quantitatively and qualitatively, and determined that it was not material for any quarterly or annual period.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 Notes were issued on February 16, 2018 (the &#8220;Original Issuance&#8221;) with a restrictive legend which remained in place until March 14, 2022. Per the terms of the Indenture, if the restrictive legend on the 2023 Notes was not removed on the 365th day following the original issuance of the 2023 Notes, the Company owed Additional Interest, payable on each of the semi-annual interest payment dates of February 1 and August 1 beginning August 1, 2019 and each of the semi-annual payment dates thereafter until the restrictive legend was removed. The non-payment of the Additional Interest expense on the semi-annual </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-79-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i132728ad66b34435b1b7a21a4a98dcc3" continuedAt="i1d8499e260ad4512a65dbb81c216c8db"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payment dates, which was first due beginning August 1, 2019, is defined as an &#8220;Event of Default&#8221; in the Indenture, causing the Company to be in technical default of its 2023 Notes until the default was cured. The Additional Interest was paid to the trustee on March 10, 2022, which under the terms of the indenture, management believes cured the Event of Default for all periods. Additionally, on March 14, 2022, the restrictive legend on the 2023 Notes was removed and the Company is not subject to the Additional Interest after that date. Had the Company identified and been unable to cure the technical default prior to the issuance of its financial statements for fiscal years 2020 and 2019, it could have resulted in the reclassification of the long-term principal balance of 2023 Notes reported in those periods. As a result of curing the technical default, the Company classified the 2023 Notes as long-term at December 31, 2021 and 2020. The Indenture is included as Exhibit 4.2 to this Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEzMTM_15fbc60d-3e6d-4a8c-8a88-8242ecb30f33" continuedAt="i84271e28c3364286b18618be911d0dc1" escape="true"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to June 30, 2020, revenue included sales of pharmaceutical products, licensing fees, and, if any, milestone payments for research and development (&#8220;R&amp;D&#8221;) achievements.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine the appropriate revenue recognition, the Company performs the following five steps: (i) Identify the contract(s) with a customer&#894; (ii) Identify the performance obligations in the contract; (iii) Determine the transaction price&#894; (iv) Allocate the transaction price to the performance obligations in the contract&#894; and (v) Recognize revenue when (or as) the entity satisfies a performance obligation. The Company applies the five-step model to contracts only when the Company and its customer&#8217;s rights and obligations under the contract can be determined, the contract has commercial substance, and it is probable that the Company will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. The Company identifies the promised goods or services in the contract to determine if they are separate performance obligations or if they should be bundled with other goods and services into a single performance obligation. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Sales &#160;</span></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i84271e28c3364286b18618be911d0dc1">Prior to June 30, 2020, the Company sold products primarily through wholesalers and considered these wholesalers to be the Company&#8217;s customers. Revenue from product sales is recognized when the customer obtains control of the Company&#8217;s product, which occurs typically upon receipt by the customer. The Company&#8217;s gross product sales were subject to a variety of price adjustments in arriving at reported net product sales. These adjustments included estimates of product returns, chargebacks, payment discounts, rebates, and other sales allowances and are estimated based on analysis of historical data for the product or comparable products, future expectations for such products and other judgments and analysis.</ix:continuation>   &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyMDM_6bcd848e-e92a-45f2-aef8-4f524a599d8b" continuedAt="i654293830ebb4583b6e62ac217b3a19c" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development (&#8220;R&amp;D&#8221;). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> R&amp;D expenses consist primarily of costs related to outside services, personnel expenses, clinical studies and other R&amp;D expenses. Outside services and clinical studies costs relate primarily to services performed by clinical research organizations and related clinical or development manufacturing costs, materials and supplies, filing fees, regulatory support, and other third-party fees. Personnel expenses relate primarily to salaries, benefits and share-based compensation. Other R&amp;D expenses primarily include overhead allocations consisting of various support and facilities-related costs. R&amp;D expenditures are charged to operations as incurred. Raw materials used in the production of pre-clinical and clinical products are expensed as R&amp;D costs.  &#160;</span></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i654293830ebb4583b6e62ac217b3a19c">The Company recognizes refundable R&amp;D tax credits received for spending on innovative R&amp;D as an offset of R&amp;D expenses.</ix:continuation> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyMzE_4a698fb8-e20d-4e3c-8b03-c0c97c443b8a" continuedAt="i0b5268d26f784629afb9be34710c1605" escape="true">Advertising Expenses.  </ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0b5268d26f784629afb9be34710c1605">The Company expenses the costs of advertising as incurred. Branded advertising expenses were $<ix:nonFraction unitRef="usd" contextRef="iaf9cbe9d47d34e1390ad1c335c52c141_D20210101-20211231" decimals="-3" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfNzAyMw_4b92a0a9-2383-480c-b1da-457a1b16c271">0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i4b913b3f3b0f4f44964bcbdf8ad62c1b_D20200101-20201231" decimals="-3" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfNzAyNw_f034581a-0154-47f6-8823-0bf7ca7a62f3">312</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="iaa9feaab286342789251faa80710001c_D20190101-20191231" decimals="-3" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfNzAzNA_81014fdd-169d-44ca-8662-db04f2e28587">372</ix:nonFraction> for the years ended December&#160;31, 2021, 2020 and 2019, respectively.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyNTA_f4d116c5-a8e4-48ca-b8dd-9768b4a86f43" continuedAt="i532ce70015b8452eba203c6185ce12a4" escape="true">Share-based Compensation. </ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i532ce70015b8452eba203c6185ce12a4">The Company accounts for share-based compensation based on the estimated grant-date fair value. The fair value of stock options is estimated using Black-Scholes option-pricing valuation models (&#8220;Black-Scholes model&#8221;). As required by the Black-Scholes model, estimates are made of the underlying volatility of Avadel stock, a risk-free rate and an expected term of the option or warrant. The Company estimates the expected term using a simplified method, as the Company does not have enough historical exercise data for a majority of such options upon which to estimate an expected term. The Company recognizes compensation cost, net of an estimated forfeiture rate, using the accelerated method over the requisite service period of the award.</ix:continuation>  </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyMTU_53bd4a8a-7d07-4470-960c-9cce6811f88a" continuedAt="i9ab137e8f5d74f7db0777b7e08cf3312" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, the Company determines deferred tax assets and liabilities on the basis of the differences between the financial statement and tax bases of assets and liabilities by using enacted tax rates in effect for the year in which </span></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-80-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1d8499e260ad4512a65dbb81c216c8db" continuedAt="i9578ed9f699e4d4891389a0855b7daa8"><ix:continuation id="i9ab137e8f5d74f7db0777b7e08cf3312"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes deferred tax assets to the extent that the Company believes that these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the Company determines that it would be able to realize its deferred tax assets in the future in excess of their net recorded amount, the Company would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records uncertain tax positions on the basis of a two-step process in which (1) the Company determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes interest and penalties related to unrecognized tax benefits in the income tax expense line in the consolidated statements of (loss) income. Accrued interest and penalties are included on the related tax liability line in the consolidated balance sheets.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyMjE_2880bdaf-e1d0-47b7-b6f5-1c1085706135" continuedAt="i23a6024daf21409f83ca777d19956d7c" escape="true">Cash and Cash Equivalents.</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i23a6024daf21409f83ca777d19956d7c">  Cash and cash equivalents consist of cash on hand, cash on deposit and fixed term deposits which are highly liquid investments with original maturities of less than three months.</ix:continuation>  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:MarketableSecuritiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyOTk_a6e89a6a-261b-48c6-890b-b0601853d65a" continuedAt="i91f11d6179264c37a2e4b5e8286f3570" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Securities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s marketable securities are considered to be available for sale and are carried at fair value, with unrealized gains and losses, net of taxes, reported as a component of accumulated other comprehensive (loss) income (&#8220;AOCI&#8221;) in shareholders&#8217; equity, with the exception of unrealized gains and losses on equity instruments and allowances for expected credit losses, if any, which are reported in earnings in the current period. The cost of securities sold is based upon the specific identification method.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i91f11d6179264c37a2e4b5e8286f3570">For available-for-sale debt securities in an unrealized loss position, the Company assesses whether it intends to sell or if it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security&#8217;s amortized cost basis is written down to fair value. If the criteria are not met, the Company evaluates whether the decline in fair value has resulted from a credit loss or other factors. In making this assessment, management considers, among other factors, the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and adverse conditions specifically related to the security. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of the cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded for the credit loss, limited by the amount that the fair value is less than the amortized costs basis.</ix:continuation>  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyMTY_7382f6f4-2e8b-4ac6-aa22-96c42bb383a3" continuedAt="i56fbbd5d193f4455a677635fbb0f7020" escape="true">Allowance for Credit Losses.  </ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i56fbbd5d193f4455a677635fbb0f7020">Amounts owed to the Company are presented net of an allowance that includes as assessment of expected credit losses.  An allowance for credit losses is established based on expected losses. Expected losses are estimated by reviewing individual accounts, considering aging, financial condition of the debtor, payment history, current and forecast economic conditions and other relevant factors.  To the extent that the Company identifies that any individual customer's credit quality has deteriorated, the Company establishes allowances based on the individual risk characteristics of that customer. The Company makes concerted efforts to collect all outstanding balances due from customers; however, amounts are written off against the allowance when the related balances are no longer deemed collectible</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyMTI_51712042-c533-4d6f-82b6-e20fb688821a" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  <ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyOTM_9c5434b8-64f5-40c4-b957-ed5ba2310bf5" continuedAt="i1c79a14a97b54e0e894087c4fbdf13c6" escape="true">Property and equipment is stated at historical cost less accumulated depreciation. Depreciation and amortization are computed using the straight-line method over the following estimated useful lives:  </ix:nonNumeric></span></div><div style="text-align:justify"><ix:continuation id="i1c79a14a97b54e0e894087c4fbdf13c6" continuedAt="ifc168493d9dd41768075d27b3fc0c52d"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:77.639%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.161%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software, office and computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i78886c225d1047eeaaea9dd1a3216a79_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RhYmxlOmI4ODRmZDJmNGNhMTQ4Yzk4OGVmMDUyMTM4ZDI5YzcxL3RhYmxlcmFuZ2U6Yjg4NGZkMmY0Y2ExNDhjOTg4ZWYwNTIxMzhkMjljNzFfMS0xLTEtMS0yMzQ1OA_ed3ab7a3-cca1-4194-8a2e-59b629bbbec3">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements, furniture, fixtures and fittings</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i66c72f9a21ad431c99a6a9e5043d92a7_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RhYmxlOmI4ODRmZDJmNGNhMTQ4Yzk4OGVmMDUyMTM4ZDI5YzcxL3RhYmxlcmFuZ2U6Yjg4NGZkMmY0Y2ExNDhjOTg4ZWYwNTIxMzhkMjljNzFfMi0xLTEtMS0yMzQ1OC90ZXh0cmVnaW9uOmQyY2JmMzY2NjUwNTQ0ZGU5MGQ4ODVhZDU5ZDFmOTk1XzQ_a9854735-69fb-48d9-aed3-e47623351b19">5</ix:nonNumeric>-<ix:nonNumeric contextRef="ie09e5d490621464e9ce04e340e7c04df_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RhYmxlOmI4ODRmZDJmNGNhMTQ4Yzk4OGVmMDUyMTM4ZDI5YzcxL3RhYmxlcmFuZ2U6Yjg4NGZkMmY0Y2ExNDhjOTg4ZWYwNTIxMzhkMjljNzFfMi0xLTEtMS0yMzQ1OC90ZXh0cmVnaW9uOmQyY2JmMzY2NjUwNTQ0ZGU5MGQ4ODVhZDU5ZDFmOTk1Xzc_1347a9fd-e041-438c-82cb-edee4b9cf5b8">10</ix:nonNumeric> years</span></div></td></tr></table></ix:continuation></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyNDc_1be128e4-af83-4f9c-b90c-e91cb4f40a0f" continuedAt="i440f6ed1d1134772a0a121ad487f62f2" escape="true">Goodwill.</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i440f6ed1d1134772a0a121ad487f62f2">  Goodwill represents the excess of the acquisition consideration over the fair value of assets acquired and liabilities assumed. The Company has determined that it operates in a single segment and have a single reporting unit associated with the development and commercialization of pharmaceutical products.  The Company tests goodwill for impairment annually and when events or changes in circumstances indicate that the carrying value may not be recoverable. The Company determined that <ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="0" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjc0ODc3OTExNzkyOQ_1bf89cf3-cf81-44d8-b6b2-ffcdb97fb356"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="0" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjc0ODc3OTExNzkyOQ_d8a6a29f-cb96-4519-9ca8-3f19f1121f87">no</ix:nonFraction></ix:nonFraction> impairment of goodwill existed at December 31, 2021 and 2020.</ix:continuation> </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-81-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9578ed9f699e4d4891389a0855b7daa8" continuedAt="i580c200085a24a77b2e82d9de1c47762"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyNjA_a9395b5e-cf90-4508-b988-04417047c7bb" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Assets. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets include fixed assets and intangible assets. Prior to the sale of the Company&#8217;s portfolio of sterile injectable drugs used in the hospital setting (&#8220;Hospital Products&#8221;) on June 30, 2020, intangible assets consisted primarily of purchased licenses and intangible assets recognized as part of the &#201;clat Pharmaceuticals acquisition. Acquired in-process research and development (&#8220;IPR&amp;D&#8221;) had an indefinite life and was not amortized until completion and development of the project, at which time the IPR&amp;D became an amortizable asset, for which amortization of such intangible assets was computed using the straight-line method over the estimated useful life of the assets.  &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets are reviewed for impairment whenever conditions indicate that the carrying value of the assets may not be fully recoverable. Such impairment tests are based on a comparison of the pretax undiscounted cash flows expected to be generated by the asset to the recorded value of the asset or other market-based value approaches. If impairment is indicated, the asset value is written down to its market value if readily determinable or its estimated fair value based on discounted cash flows. Any significant changes in business or market conditions that vary from current expectations could have an impact on the fair value of these assets and any potential associated impairment.  On June 30, 2020, the Company transferred its remaining intangible asset to Exela Sterile Medicines LLC (&#8220;Exela Buyer&#8221;) as part of the disposition of the Hospital Products.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjExOTU_aa8873f3-530a-4dfc-a91e-4bb3e5bbc6ae" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lease Obligations. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if a contract is a lease at the inception of the arrangement. Right-of-use assets and operating lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. The Company reviews all options to extend, terminate, or purchase its right-of-use assets at the inception of the lease and will include these options in the lease term when they are reasonably certain of being exercised. Short term leases with an initial term of 12 months or less are not recorded on the balance sheet and the associated lease payments are recognized in the consolidated statements of (loss) income on a straight-line basis over the lease term. The Company&#8217;s lease contracts do not provide a readily determinable implicit rate. The Company&#8217;s estimated incremental borrowing rate is based on information available at the inception of the lease. The Company&#8217;s lease agreements may contain variable costs such as common area maintenance, insurance, real estate taxes or other costs. Variable lease costs are expensed as incurred on the consolidated statements of (loss) income.</span></ix:nonNumeric></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="i580c200085a24a77b2e82d9de1c47762" continuedAt="i8ff727edca8f4562b1dbc0f086681091"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyNjQ_cac652ec-8579-4324-a85d-59f4c14b7686" continuedAt="iba459785950b48e69500d5d7e6fdbf73" escape="true">Use of Estimates. </ix:nonNumeric></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8ff727edca8f4562b1dbc0f086681091"><ix:continuation id="iba459785950b48e69500d5d7e6fdbf73">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, including marketable securities and contingent liabilities at the date of the consolidated financial statements and the reported amounts of sales and expenses during the periods presented. These estimates and assumptions are based on the best information available to management at the balance sheet dates and depending on the nature of the estimate can require significant judgments. Changes to these estimates and judgments can have and have had a material impact on the Company&#8217;s consolidated statements of (loss) income and balance sheets.  Actual results could differ from those estimates under different assumptions or&#160;conditions.</ix:continuation></ix:continuation>  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_94"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2: <ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85NC9mcmFnOmE0MDc4MDQ4YTIyODQxMTE5YTc4OTRlOTk3ZDk0OTljL3RleHRyZWdpb246YTQwNzgwNDhhMjI4NDExMTlhNzg5NGU5OTdkOTQ5OWNfMzEwNQ_6eddb116-3adf-4821-ab1c-af7dd2c53021" continuedAt="i3904afdb18d9490aaa369e8af9e515b4" escape="true">Newly Issued Accounting Standards</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3904afdb18d9490aaa369e8af9e515b4" continuedAt="ic827473e6157474a8caed43848dd9573">&#160;</ix:continuation></span></div><ix:continuation id="ic827473e6157474a8caed43848dd9573" continuedAt="i3469fc7b4aab4244a432a6bfbc9441ec"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85NC9mcmFnOmE0MDc4MDQ4YTIyODQxMTE5YTc4OTRlOTk3ZDk0OTljL3RleHRyZWdpb246YTQwNzgwNDhhMjI4NDExMTlhNzg5NGU5OTdkOTQ5OWNfMzEwOA_48792386-6df4-4f36-89d6-f3df534a42d1" continuedAt="i5d184b38fbd2437bb97bf650d52196f0" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Guidance</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. The FASB&#8217;s amendments primarily impact ASC 740, Income Taxes, and may impact both interim and annual reporting periods. ASU 2019-12 is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years and early adoption is permitted. The Company adopted the provisions of ASU 2019-12 on January 1, 2021. Adoption of ASU 2019-12 did not have any impact on the Company&#8217;s consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging- Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to reduce the complexity associated with applying U.S. GAAP principles for certain financial instruments with characteristics of liabilities and equity. The amendments in this ASU reduce the number of accounting models for convertible instruments and expand the existing disclosure requirements over earnings per share as it relates to convertible instruments. Convertible debt will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The update also requires the if-converted method to be used for convertible instruments and the effect of potential share settlement be included in the diluted earnings per share calculation when an instrument may be settled in cash or shares. This ASU will be effective for the Company&#8217;s fiscal year beginning January 1, 2022 and interim periods therein. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The amendments may be adopted through either a modified retrospective method, or a fully retrospective method.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-82-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3469fc7b4aab4244a432a6bfbc9441ec"><ix:continuation id="i5d184b38fbd2437bb97bf650d52196f0">The Company elected to early adopt ASU 2020-06 as of January 1, 2021 using a modified retrospective method. The Company&#8217;s <ix:nonFraction unitRef="number" contextRef="i8ffb01488f3a42119218fd36f48c1d40_I20201231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85NC9mcmFnOmE0MDc4MDQ4YTIyODQxMTE5YTc4OTRlOTk3ZDk0OTljL3RleHRyZWdpb246YTQwNzgwNDhhMjI4NDExMTlhNzg5NGU5OTdkOTQ5OWNfMjc0ODc3OTA3ODgyNA_28a36894-385e-4787-a43d-2f549c541bf1">4.50</ix:nonFraction>% exchangeable senior notes due 2023 (the &#8220;2023 Notes&#8221;) are a convertible instrument with a cash-conversion feature that is accounted for within the scope of Subtopic 470-20. The Company calculated the cumulative-effect adjustment as of January 1, 2021 by comparing (i) the historical amortization schedule for the 2023 Notes through December 31, 2020 and (ii) an updated amortization schedule wherein the conversion feature within the 2023 Notes would not be separated as an equity component and subsequently recognized as non-cash interest expense under ASC 835-30. The adoption resulted in a $<ix:nonFraction unitRef="usd" contextRef="i27057cf80d054326a72f1357eef1f0c2_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85NC9mcmFnOmE0MDc4MDQ4YTIyODQxMTE5YTc4OTRlOTk3ZDk0OTljL3RleHRyZWdpb246YTQwNzgwNDhhMjI4NDExMTlhNzg5NGU5OTdkOTQ5OWNfMjc0ODc3OTA3ODgzMQ_5712682b-e2aa-43fb-991f-f3d231967eaa">26,699</ix:nonFraction> decrease in additional paid-in capital, a $<ix:nonFraction unitRef="usd" contextRef="ia03de445d5514be7925f47534612a3c6_I20201231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85NC9mcmFnOmE0MDc4MDQ4YTIyODQxMTE5YTc4OTRlOTk3ZDk0OTljL3RleHRyZWdpb246YTQwNzgwNDhhMjI4NDExMTlhNzg5NGU5OTdkOTQ5OWNfMjc0ODc3OTA3ODg0Mw_59fba576-a9f3-46ac-8de1-e88836cc7de1">12,939</ix:nonFraction> increase in long-term debt, and a $<ix:nonFraction unitRef="usd" contextRef="ifdaa54a433dd430a83d91856c8287945_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85NC9mcmFnOmE0MDc4MDQ4YTIyODQxMTE5YTc4OTRlOTk3ZDk0OTljL3RleHRyZWdpb246YTQwNzgwNDhhMjI4NDExMTlhNzg5NGU5OTdkOTQ5OWNfMjc0ODc3OTA3ODg1NQ_d8be8e18-f250-49ff-997a-8bb0bc3fdffb">13,760</ix:nonFraction> increase to the opening balance of retained earnings.</ix:continuation></ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_97"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3: <ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:ReorganizationUnderChapter11OfUSBankruptcyCodeDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85Ny9mcmFnOjY4NmZkNTA2OTY5NzRkNzFiZGM4N2JmYjk3NTZmOWQ1L3RleHRyZWdpb246Njg2ZmQ1MDY5Njk3NGQ3MWJkYzg3YmZiOTc1NmY5ZDVfNjE4Ng_887b2594-d0cd-4076-a6e1-0fa9c44c2ed3" continuedAt="id70aeabad51a41c9a7710efc59fe7d5d" escape="true">Subsidiary Bankruptcy and Deconsolidation</ix:nonNumeric></span></div><ix:continuation id="id70aeabad51a41c9a7710efc59fe7d5d" continuedAt="icb7adb4d19874729a9579fa98ec97923"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 6, 2019, the Company deconsolidated Specialty Pharma effective with the filing of the Chapter 11 bankruptcy and recorded a non-cash charge of approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="i85c848bffc1542ceb9f02559b91119f8_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DeconsolidationGainOrLossAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85Ny9mcmFnOjY4NmZkNTA2OTY5NzRkNzFiZGM4N2JmYjk3NTZmOWQ1L3RleHRyZWdpb246Njg2ZmQ1MDY5Njk3NGQ3MWJkYzg3YmZiOTc1NmY5ZDVfMTUwMw_85210919-872b-4a89-8758-0f8876133e9b">2,678</ix:nonFraction>&#160;for the&#160;year ended&#160;December 31, 2019. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized a non-cash gain of $<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85Ny9mcmFnOjY4NmZkNTA2OTY5NzRkNzFiZGM4N2JmYjk3NTZmOWQ1L3RleHRyZWdpb246Njg2ZmQ1MDY5Njk3NGQ3MWJkYzg3YmZiOTc1NmY5ZDVfMTY0OTI2NzQ0ODEzNg_13afc7dc-7200-4499-9e99-20c42ae4c09f">217</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85Ny9mcmFnOjY4NmZkNTA2OTY5NzRkNzFiZGM4N2JmYjk3NTZmOWQ1L3RleHRyZWdpb246Njg2ZmQ1MDY5Njk3NGQ3MWJkYzg3YmZiOTc1NmY5ZDVfNDk3MQ_2810091e-99f7-4a4f-b4bd-46372bf1d059">3,364</ix:nonFraction> from the release of certain liabilities that had been retained following the deconsolidation of Specialty Pharma. These gains are included in "Gain from release of certain liabilities" within non-operating (loss) income for the years ended December 31, 2021 and 2020.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icb7adb4d19874729a9579fa98ec97923">On October 26, 2021, the U.S. Bankruptcy Court for the District of Delaware issued the Final Decree and Order, dismissing the bankruptcy case and dissolving Specialty Pharma.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4: <ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4Xzc2MjA_7d688c82-d4bc-4534-b68b-e6bf9f5280b6" continuedAt="i7a15be1550bb47a59f01dd6dbd0002b4" escape="true">Disposition of the Hospital Products</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i7a15be1550bb47a59f01dd6dbd0002b4" continuedAt="i2c84322ad92b44d7b81cd4fa0b862877"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2020 (the &#8220;Closing Date&#8221;), the Company announced the sale of its Hospital Products, which included its three FDA-approved commercial products, Akovaz, Bloxiverz and Vazculep, as well as Nouress, to the Exela Buyer pursuant to an Asset Purchase Agreement (the &#8220;Transaction&#8221;).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Transaction, the Exela Buyer agreed to pay a total aggregate consideration amount of $<ix:nonFraction unitRef="usd" contextRef="i394c910852974a2b9a5ecd7ffb761fce_I20200630" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzMyMw_84e2c138-480a-45ec-a79d-aef59d4493d0">42,000</ix:nonFraction>, of which $<ix:nonFraction unitRef="usd" contextRef="i394c910852974a2b9a5ecd7ffb761fce_I20200630" decimals="-3" name="avdl:DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzMzNg_3b8ac63c-dcd7-495a-8bc0-3ed52795a51d">14,500</ix:nonFraction> was paid on the Closing Date and an additional $<ix:nonFraction unitRef="usd" contextRef="i394c910852974a2b9a5ecd7ffb761fce_I20200630" decimals="-3" name="avdl:DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzM4Ng_f25f95f3-6ada-4cf2-8d4f-c5b42184da52">27,500</ix:nonFraction> was paid in <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzQwNg_d7d1bf58-ccde-4c16-a6b6-573abd462bd2">ten</span> equal monthly installments following the Closing Date. During the year ended December 31, 2020, the Company collected four installment payments, totaling $<ix:nonFraction unitRef="usd" contextRef="i0756957a1e1d4fce943a2b692ad6e709_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzUyNw_02fb9dbf-cb73-4411-b80f-ecebb706a86a">11,000</ix:nonFraction>. The Company collected the remaining six installment payments, totaling $<ix:nonFraction unitRef="usd" contextRef="i1c9923703844411eb3e5ce7edba6c8ed_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzY1Mg_7c89975b-4ab3-4d4f-b29b-69152789ea73">16,500</ix:nonFraction> during 2021. In connection with the sale of the Hospital Products, the parties also agreed to cause the dismissal of the pending civil litigation related to Nouress in the District Court for the District of Delaware.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was party to a Membership Interest Purchase Agreement, dated March 13, 2012, by and among the Company, Avadel Legacy, Breaking Stick Holdings, LLC, Deerfield Private Design International II, L.P. (&#8220;Deerfield International&#8221;), Deerfield Private Design Fund II, L.P. (&#8220;Deerfield Fund&#8221;) and Horizon Sant&#233; FLML, Sarl (&#8220;Horizon&#8221;) (the &#8220;Deerfield MIPA&#8221;) and a Royalty Agreement, dated February 4, 2013, by and among the Company, Avadel Legacy, the Deerfield Fund and Horizon (the &#8220;Deerfield Royalty Agreement&#8221;). In connection with the closing of the sale of the Hospital Products, the Deerfield MIPA (with respect to certain sections thereof) and the Royalty Agreement were assigned to the Exela Buyer. Pursuant to the Purchase Agreement, the Exela Buyer assumed and will pay, perform, satisfy and discharge the liabilities and obligations of Avadel Legacy under the Deerfield Royalty Agreement for obligations that arise after the Closing Date.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was also party to a Royalty Agreement, dated December 3, 2013, by and between the Company, Avadel Legacy and Broadfin Healthcare Master Fund, Ltd. (the &#8220;Broadfin Royalty Agreement&#8221;). In connection with the closing of the sale of the Hospital Products, the Broadfin Royalty Agreement was assigned to the Exela Buyer and the Exela Buyer assumed and shall pay, perform, satisfy and discharge the liabilities and obligations of Avadel Legacy under the Broadfin Royalty Agreement for obligations that arise after the Closing Date.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a net gain on the sale of the Hospital Products of $<ix:nonFraction unitRef="usd" contextRef="i0756957a1e1d4fce943a2b692ad6e709_D20200101-20201231" decimals="-3" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzIzOTg_94f3abaa-e98b-4c46-9f06-a130c4a3f137">45,760</ix:nonFraction> during the year ended December 31, 2020 which has been recorded on the consolidated statements of (loss) income. <ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4Xzc2MjE_ab2dd2e5-5802-4e90-a6d9-8bd546681715" continuedAt="i1217ccf269c54bac9fc4cc6856d36454" escape="true">The $<ix:nonFraction unitRef="usd" contextRef="i0756957a1e1d4fce943a2b692ad6e709_D20200101-20201231" decimals="-3" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzI1MTc_2f5e86e4-cbed-4160-94cd-e26b368ffaa7">45,760</ix:nonFraction> gain represents the aggregate consideration of $<ix:nonFraction unitRef="usd" contextRef="ic759888cdbc54a9a9b75a3bc35604e1c_I20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzI1Njc_83556bc0-c3aa-4750-b123-06957409724a">42,000</ix:nonFraction>, less transaction fees of $<ix:nonFraction unitRef="usd" contextRef="i0756957a1e1d4fce943a2b692ad6e709_D20200101-20201231" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzI1OTY_a753398b-428c-4685-803e-5a37bf0b87d9">2,928</ix:nonFraction>, plus the assets and liabilities either transferred to the Exela Buyer or eliminated by the Company due to the sale of the Hospital Products, which are listed below.</ix:nonNumeric></span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-83-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2c84322ad92b44d7b81cd4fa0b862877" continuedAt="ia6260c4dea0c4cb6aaeacd6f7ec577b2"><div style="text-align:justify"><ix:continuation id="i1217ccf269c54bac9fc4cc6856d36454"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394c910852974a2b9a5ecd7ffb761fce_I20200630" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo4MTQyNzRlZWRjNTQ0NTM3OTgzMWY4YjI5MzZjMTNjNi90YWJsZXJhbmdlOjgxNDI3NGVlZGM1NDQ1Mzc5ODMxZjhiMjkzNmMxM2M2XzEtMi0xLTEtMjM0NTg_9ff507bf-570b-4a8e-a3d2-fe10bb09b0f5">134</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394c910852974a2b9a5ecd7ffb761fce_I20200630" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo4MTQyNzRlZWRjNTQ0NTM3OTgzMWY4YjI5MzZjMTNjNi90YWJsZXJhbmdlOjgxNDI3NGVlZGM1NDQ1Mzc5ODMxZjhiMjkzNmMxM2M2XzItMi0xLTEtMjM0NTg_aca67ac0-028e-4bab-b5f4-bb7000329e74">4,922</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394c910852974a2b9a5ecd7ffb761fce_I20200630" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo4MTQyNzRlZWRjNTQ0NTM3OTgzMWY4YjI5MzZjMTNjNi90YWJsZXJhbmdlOjgxNDI3NGVlZGM1NDQ1Mzc5ODMxZjhiMjkzNmMxM2M2XzMtMi0xLTEtMjM0NTg_8208bd27-a68e-44fb-8293-cb985d6bf0b4">1,654</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394c910852974a2b9a5ecd7ffb761fce_I20200630" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo4MTQyNzRlZWRjNTQ0NTM3OTgzMWY4YjI5MzZjMTNjNi90YWJsZXJhbmdlOjgxNDI3NGVlZGM1NDQ1Mzc5ODMxZjhiMjkzNmMxM2M2XzQtMi0xLTEtMjM0NTg_1796a0a7-651d-403d-96f4-2ffbe01016ec">407</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i394c910852974a2b9a5ecd7ffb761fce_I20200630" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo4MTQyNzRlZWRjNTQ0NTM3OTgzMWY4YjI5MzZjMTNjNi90YWJsZXJhbmdlOjgxNDI3NGVlZGM1NDQ1Mzc5ODMxZjhiMjkzNmMxM2M2XzUtMi0xLTEtMjM0NTg_ddc2a379-c563-4787-b1e9-a6b47916ee1c">1,095</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term contingent consideration payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394c910852974a2b9a5ecd7ffb761fce_I20200630" decimals="-3" name="us-gaap:DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo4MTQyNzRlZWRjNTQ0NTM3OTgzMWY4YjI5MzZjMTNjNi90YWJsZXJhbmdlOjgxNDI3NGVlZGM1NDQ1Mzc5ODMxZjhiMjkzNmMxM2M2XzYtMi0xLTEtMjM0NTg_89f61009-d996-48ca-a284-ab21a235ad8a">14,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net liabilities disposed of</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394c910852974a2b9a5ecd7ffb761fce_I20200630" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo4MTQyNzRlZWRjNTQ0NTM3OTgzMWY4YjI5MzZjMTNjNi90YWJsZXJhbmdlOjgxNDI3NGVlZGM1NDQ1Mzc5ODMxZjhiMjkzNmMxM2M2XzctMi0xLTEtMjM0NTg_db152de5-d190-436d-8d91-129295eaa880">6,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aggregate consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394c910852974a2b9a5ecd7ffb761fce_I20200630" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo4MTQyNzRlZWRjNTQ0NTM3OTgzMWY4YjI5MzZjMTNjNi90YWJsZXJhbmdlOjgxNDI3NGVlZGM1NDQ1Mzc5ODMxZjhiMjkzNmMxM2M2XzgtMi0xLTEtMjM0NTg_c6224b40-7109-49b6-b78a-9e580b3fe47a">42,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less transaction fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d1b0f4826d84816aa9460ece5298de4_D20200630-20200630" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo4MTQyNzRlZWRjNTQ0NTM3OTgzMWY4YjI5MzZjMTNjNi90YWJsZXJhbmdlOjgxNDI3NGVlZGM1NDQ1Mzc5ODMxZjhiMjkzNmMxM2M2XzktMi0xLTEtMjM0NTg_bb2765cc-41e3-48b9-8b27-c7792844eab0">2,928</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net gain on the sale of the Hospital Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d1b0f4826d84816aa9460ece5298de4_D20200630-20200630" decimals="-3" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo4MTQyNzRlZWRjNTQ0NTM3OTgzMWY4YjI5MzZjMTNjNi90YWJsZXJhbmdlOjgxNDI3NGVlZGM1NDQ1Mzc5ODMxZjhiMjkzNmMxM2M2XzEwLTItMS0xLTIzNDU4_e726f84e-a30f-46be-840e-1fa37993f389">45,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the disposition of the Hospital Products, the Company entered into a separate and distinct agreement with the Exela Buyer, whereby the Exela Buyer assumed all future returns of the Hospital Products in exchange for cash consideration paid by the Company. The Company recorded a $<ix:nonFraction unitRef="usd" contextRef="i9d9561d07a174b4d928f303fd47bd68b_D20200101-20201231" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzI3NDg3NzkwODYwNzM_f1205975-9a69-42f2-b46b-5f2468fb214e">518</ix:nonFraction> gain from this transaction, which is recorded in &#8220;Selling, general and administrative expenses&#8221; for the year ended December 31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated various qualitative and quantitative factors related to the disposition of the Hospital Products and determined that it did not meet the criteria for presentation as a discontinued operation.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4Xzc2MjI_938eca30-6ada-4d34-938a-bf86181835eb" continuedAt="if08f17087ea34b6d8e27a6405b1dbb71" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma condensed combined statements of (loss) income for the years ended December 31, 2020 and 2019 included below is being provided for information purposes only and are not necessarily indicative of the results of operations that would have resulted if the Transaction had actually occurred on the date indicated. The pro forma adjustments are based on available information and assumptions that the Company believes are attributable to the sale.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:39.575%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Pro Forma Condensed Combined Statement of (Loss) Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pro Forma Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notes</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pro Forma</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38080e480d2448d89a3f5285f946f2e5_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo2OTllZmVkNDY2YTQ0YzA1YTI5ODJjMDU3MmE4NzkyZi90YWJsZXJhbmdlOjY5OWVmZWQ0NjZhNDRjMDVhMjk4MmMwNTcyYTg3OTJmXzUtMi0xLTEtMjM0NTg_a57bc86f-155f-475a-9388-8f2072404cf3">22,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibaeb39fd6c394110b9fd0a0d5423884f_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo2OTllZmVkNDY2YTQ0YzA1YTI5ODJjMDU3MmE4NzkyZi90YWJsZXJhbmdlOjY5OWVmZWQ0NjZhNDRjMDVhMjk4MmMwNTcyYTg3OTJmXzUtNC0xLTEtMjM0NTg_bb524c65-2041-4ac5-a816-03566b5dc5da">22,175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib89e2680daf342f19590ad40660e7d7c_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo2OTllZmVkNDY2YTQ0YzA1YTI5ODJjMDU3MmE4NzkyZi90YWJsZXJhbmdlOjY5OWVmZWQ0NjZhNDRjMDVhMjk4MmMwNTcyYTg3OTJmXzUtOC0xLTEtMjM0NTg_b9f1cfd3-00fd-4ce4-9e43-eab3edfc9c0a">159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38080e480d2448d89a3f5285f946f2e5_D20200101-20201231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo2OTllZmVkNDY2YTQ0YzA1YTI5ODJjMDU3MmE4NzkyZi90YWJsZXJhbmdlOjY5OWVmZWQ0NjZhNDRjMDVhMjk4MmMwNTcyYTg3OTJmXzYtMi0xLTEtMjM0NTg_f3e36680-98c6-4012-8a22-5aa8bd6a22c5">16,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibaeb39fd6c394110b9fd0a0d5423884f_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo2OTllZmVkNDY2YTQ0YzA1YTI5ODJjMDU3MmE4NzkyZi90YWJsZXJhbmdlOjY5OWVmZWQ0NjZhNDRjMDVhMjk4MmMwNTcyYTg3OTJmXzYtNC0xLTEtMjM0NTg_71125783-a68f-46b6-887b-6a4e9e69a9e1">8,392</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib89e2680daf342f19590ad40660e7d7c_D20200101-20201231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo2OTllZmVkNDY2YTQ0YzA1YTI5ODJjMDU3MmE4NzkyZi90YWJsZXJhbmdlOjY5OWVmZWQ0NjZhNDRjMDVhMjk4MmMwNTcyYTg3OTJmXzYtOC0xLTEtMjM0NTg_a27b15e5-66fc-42bd-8fcd-2d9f0c8027ae">8,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38080e480d2448d89a3f5285f946f2e5_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo2OTllZmVkNDY2YTQ0YzA1YTI5ODJjMDU3MmE4NzkyZi90YWJsZXJhbmdlOjY5OWVmZWQ0NjZhNDRjMDVhMjk4MmMwNTcyYTg3OTJmXzctMi0xLTEtMjM0NTg_7f44b87d-0a91-4261-b949-b64a3806adbd">5,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibaeb39fd6c394110b9fd0a0d5423884f_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo2OTllZmVkNDY2YTQ0YzA1YTI5ODJjMDU3MmE4NzkyZi90YWJsZXJhbmdlOjY5OWVmZWQ0NjZhNDRjMDVhMjk4MmMwNTcyYTg3OTJmXzctNC0xLTEtMjM0NTg_5d9967c5-48d8-4350-b4e5-f13252595f37">13,783</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib89e2680daf342f19590ad40660e7d7c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo2OTllZmVkNDY2YTQ0YzA1YTI5ODJjMDU3MmE4NzkyZi90YWJsZXJhbmdlOjY5OWVmZWQ0NjZhNDRjMDVhMjk4MmMwNTcyYTg3OTJmXzctOC0xLTEtMjM0NTg_7b79ed3b-a7ac-4acb-b863-61d77736b6f4">7,968</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i38080e480d2448d89a3f5285f946f2e5_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo2OTllZmVkNDY2YTQ0YzA1YTI5ODJjMDU3MmE4NzkyZi90YWJsZXJhbmdlOjY5OWVmZWQ0NjZhNDRjMDVhMjk4MmMwNTcyYTg3OTJmXzgtMi0xLTEtMjM0NTg_b0d0e2a7-3e6d-4e4e-8df0-e89ae8108a2f">5,082</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibaeb39fd6c394110b9fd0a0d5423884f_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo2OTllZmVkNDY2YTQ0YzA1YTI5ODJjMDU3MmE4NzkyZi90YWJsZXJhbmdlOjY5OWVmZWQ0NjZhNDRjMDVhMjk4MmMwNTcyYTg3OTJmXzgtNC0xLTEtMjM0NTg_ba621074-7536-4880-a4cc-718d4becb94e">13,348</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib89e2680daf342f19590ad40660e7d7c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo2OTllZmVkNDY2YTQ0YzA1YTI5ODJjMDU3MmE4NzkyZi90YWJsZXJhbmdlOjY5OWVmZWQ0NjZhNDRjMDVhMjk4MmMwNTcyYTg3OTJmXzgtOC0xLTEtMjM0NTg_56cc471e-bafc-4542-a848-b63c59843a7f">18,430</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:39.575%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Pro Forma Condensed Combined Statement of (Loss) Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pro Forma Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notes</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pro Forma</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76d9d41ce856419e9dfc0d9e14013a83_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTplMjc5YTY2NmIzNGQ0MjRkOTY3ZWU4YmQ0YWQ2MGE3ZC90YWJsZXJhbmdlOmUyNzlhNjY2YjM0ZDQyNGQ5NjdlZThiZDRhZDYwYTdkXzUtMi0xLTEtMjM0NTg_23154092-f5c6-4378-8042-a5ac1e0e1447">59,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i452c804743a24cfe918d651e2bd94b98_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTplMjc5YTY2NmIzNGQ0MjRkOTY3ZWU4YmQ0YWQ2MGE3ZC90YWJsZXJhbmdlOmUyNzlhNjY2YjM0ZDQyNGQ5NjdlZThiZDRhZDYwYTdkXzUtNC0xLTEtMjM0NTg_36c62c2d-b7d9-4736-a600-671cd62794dd">59,273</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ead4e892b78440b941a75e56c9490b1_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTplMjc5YTY2NmIzNGQ0MjRkOTY3ZWU4YmQ0YWQ2MGE3ZC90YWJsZXJhbmdlOmUyNzlhNjY2YjM0ZDQyNGQ5NjdlZThiZDRhZDYwYTdkXzUtOC0xLTEtMjM0NTg_f5b1c4e9-cc84-4cf2-bece-d190fd3af35b">58</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76d9d41ce856419e9dfc0d9e14013a83_D20190101-20191231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTplMjc5YTY2NmIzNGQ0MjRkOTY3ZWU4YmQ0YWQ2MGE3ZC90YWJsZXJhbmdlOmUyNzlhNjY2YjM0ZDQyNGQ5NjdlZThiZDRhZDYwYTdkXzYtMi0xLTEtMjM0NTg_2ebd0221-897a-4e33-90f7-a24e9859e528">83,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i452c804743a24cfe918d651e2bd94b98_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTplMjc5YTY2NmIzNGQ0MjRkOTY3ZWU4YmQ0YWQ2MGE3ZC90YWJsZXJhbmdlOmUyNzlhNjY2YjM0ZDQyNGQ5NjdlZThiZDRhZDYwYTdkXzYtNC0xLTEtMjM0NTg_3bfb671d-ee1d-4d0c-90c6-d994aea90cc0">16,092</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ead4e892b78440b941a75e56c9490b1_D20190101-20191231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTplMjc5YTY2NmIzNGQ0MjRkOTY3ZWU4YmQ0YWQ2MGE3ZC90YWJsZXJhbmdlOmUyNzlhNjY2YjM0ZDQyNGQ5NjdlZThiZDRhZDYwYTdkXzYtOC0xLTEtMjM0NTg_1816a4ca-391a-4e62-9272-d7835ca27df9">67,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76d9d41ce856419e9dfc0d9e14013a83_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTplMjc5YTY2NmIzNGQ0MjRkOTY3ZWU4YmQ0YWQ2MGE3ZC90YWJsZXJhbmdlOmUyNzlhNjY2YjM0ZDQyNGQ5NjdlZThiZDRhZDYwYTdkXzctMi0xLTEtMjM0NTg_bf315316-8d03-4f6d-b070-ee686bf154a3">24,112</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i452c804743a24cfe918d651e2bd94b98_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTplMjc5YTY2NmIzNGQ0MjRkOTY3ZWU4YmQ0YWQ2MGE3ZC90YWJsZXJhbmdlOmUyNzlhNjY2YjM0ZDQyNGQ5NjdlZThiZDRhZDYwYTdkXzctNC0xLTEtMjM0NTg_0fa32a5a-c1e3-4df9-a852-af5a2b18def4">43,181</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ead4e892b78440b941a75e56c9490b1_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTplMjc5YTY2NmIzNGQ0MjRkOTY3ZWU4YmQ0YWQ2MGE3ZC90YWJsZXJhbmdlOmUyNzlhNjY2YjM0ZDQyNGQ5NjdlZThiZDRhZDYwYTdkXzctOC0xLTEtMjM0NTg_6032cc34-465d-46fc-8268-724a53d19083">67,293</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76d9d41ce856419e9dfc0d9e14013a83_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTplMjc5YTY2NmIzNGQ0MjRkOTY3ZWU4YmQ0YWQ2MGE3ZC90YWJsZXJhbmdlOmUyNzlhNjY2YjM0ZDQyNGQ5NjdlZThiZDRhZDYwYTdkXzgtMi0xLTEtMjM0NTg_e652864e-dcc8-495c-8afe-d77b65ece15b">38,582</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i452c804743a24cfe918d651e2bd94b98_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTplMjc5YTY2NmIzNGQ0MjRkOTY3ZWU4YmQ0YWQ2MGE3ZC90YWJsZXJhbmdlOmUyNzlhNjY2YjM0ZDQyNGQ5NjdlZThiZDRhZDYwYTdkXzgtNC0xLTEtMjM0NTg_5c8ae484-e78b-44bb-9feb-cbb14aa4f2ee">42,803</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(e)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ead4e892b78440b941a75e56c9490b1_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTplMjc5YTY2NmIzNGQ0MjRkOTY3ZWU4YmQ0YWQ2MGE3ZC90YWJsZXJhbmdlOmUyNzlhNjY2YjM0ZDQyNGQ5NjdlZThiZDRhZDYwYTdkXzgtOC0xLTEtMjM0NTg_52299e48-8ec6-455c-aeff-c56725c4ca8c">81,385</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjustments to the pro forma unaudited condensed combined statements of (loss) income</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) This adjustment reflects Product sales attributable to the Hospital Products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) This adjustment reflects the following estimated expenses attributable to the Hospital Products:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cost of products of $<ix:nonFraction unitRef="usd" contextRef="i116a6b04235e4b1c93dc94865613041c_D20200101-20201231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzY0MDU_b5dbff94-7265-4633-88f0-3fb77a90c63b">3,540</ix:nonFraction>.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">R&amp;D expenses of $<ix:nonFraction unitRef="usd" contextRef="i116a6b04235e4b1c93dc94865613041c_D20200101-20201231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzY0MjU_db0f5a7e-432d-455e-861b-b59a4c7de368">322</ix:nonFraction>.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Selling, general and administrative expenses of $<ix:nonFraction unitRef="usd" contextRef="i116a6b04235e4b1c93dc94865613041c_D20200101-20201231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzY0Nzc_3e81876e-5281-43df-8835-0564ba4c5673">797</ix:nonFraction>.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Intangible asset amortization on acquired development technology for Vazculep of $<ix:nonFraction unitRef="usd" contextRef="i116a6b04235e4b1c93dc94865613041c_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzY1NjI_49b65ee7-789d-4122-91ce-e424ff9c5b66">406</ix:nonFraction>.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-84-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia6260c4dea0c4cb6aaeacd6f7ec577b2"><ix:continuation id="if08f17087ea34b6d8e27a6405b1dbb71"><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in fair value of related party contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="i116a6b04235e4b1c93dc94865613041c_D20200101-20201231" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzY2MzM_9f5f1c3d-a05d-4755-8326-eb5ac0baba84">3,327</ix:nonFraction>. The Company will no longer be responsible for these payments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) This amount reflects the adjustments noted in (a) and (b) above, as well as estimated Changes in fair value of related party payable of $<ix:nonFraction unitRef="usd" contextRef="i116a6b04235e4b1c93dc94865613041c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzY4NDA_30393194-74a3-460a-a380-486af0ebd5be">435</ix:nonFraction> attributable to the Hospital Products. The Company will no longer be responsible for these payments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) This adjustment reflects the following estimated expenses attributable to the Hospital Products:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cost of products of $<ix:nonFraction unitRef="usd" contextRef="i0083fb6ccd404e979fe21e48af0fa1f5_D20190101-20191231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzcwNjc_bf92b0a4-7f99-4bcb-92dc-1feade9dc882">11,368</ix:nonFraction>.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">R&amp;D expenses of $<ix:nonFraction unitRef="usd" contextRef="i0083fb6ccd404e979fe21e48af0fa1f5_D20190101-20191231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzcwODc_bfb3a7f0-1965-4622-8e02-714c84b42b0a">1,960</ix:nonFraction>.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Selling, general and administrative expenses of $<ix:nonFraction unitRef="usd" contextRef="i0083fb6ccd404e979fe21e48af0fa1f5_D20190101-20191231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzcxMzk_4e963aff-0033-4dcb-af99-a7676ac8274c">1,102</ix:nonFraction>.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Intangible asset amortization on acquired development technology for Vazculep of $<ix:nonFraction unitRef="usd" contextRef="i0083fb6ccd404e979fe21e48af0fa1f5_D20190101-20191231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzcyMjQ_07ca2c8e-153d-4c3a-8be8-1011bfb79afc">816</ix:nonFraction>.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in fair value of related party contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="i0083fb6ccd404e979fe21e48af0fa1f5_D20190101-20191231" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzcyOTU_b6553579-6db9-4318-8c20-d18a71d7a4cf">845</ix:nonFraction>. The Company will no longer be responsible for these payments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) This amount reflects the adjustments noted in (a) and (d) above, as well as the reversal of estimated Changes in fair value of related party payable of $<ix:nonFraction unitRef="usd" contextRef="i0083fb6ccd404e979fe21e48af0fa1f5_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4Xzc1MTg_9e8d6495-cd09-405b-8dcc-d082bf5c1ddf">378</ix:nonFraction> attributable to the Hospital Products. The Company will no longer be responsible for these payments.</span></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_103"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5: <ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDMvZnJhZzo4NWM2YTdhYjQxZWE0ODRmYTgyNWEwM2MxNGRjOTVhMi90ZXh0cmVnaW9uOjg1YzZhN2FiNDFlYTQ4NGZhODI1YTAzYzE0ZGM5NWEyXzc1NjY_95507b19-43a9-4e09-8927-b9b463dfb4cd" continuedAt="idf8dbc642f2c4767a0d845d18dc38956" escape="true">Revenue Recognition </ix:nonNumeric></span></div><ix:continuation id="idf8dbc642f2c4767a0d845d18dc38956" continuedAt="i68c4f0f13dff40b593cc895ca91a9d26"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to June 30, 2020, the Company generated revenue primarily from the sale of pharmaceutical products to customers. On June 30, 2020, the Company sold the Hospital Products. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4: Disposition of the Hospital Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Sales and Services</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to June 30, 2020, the Company sold products primarily through wholesalers and considered these wholesalers to be its customers. Revenue from product sales was recognized when the customer obtained control of the Company&#8217;s product and its performance obligations were met, which occurred typically upon receipt of delivery to the customer. As is customary in the pharmaceutical industry, the Company&#8217;s gross product sales were subject to a variety of price adjustments in arriving at reported net product sales. These adjustments included estimates for product returns, chargebacks, payment discounts, rebates, and other sales allowances and are estimated when the product is delivered based on analysis of historical data for the product or comparable products, as well as future expectations for such products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reserves to reduce Gross Revenues to Net Revenues</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from product sales were recorded at the net selling price, which included estimated reserves to reduce gross product sales to net product sales resulting from product returns, chargebacks, payment discounts, rebates, and other sales allowances that are offered within contracts between the Company and its customers and end users. These reserves were based on the amounts earned or to be claimed on the related sales and were classified as reductions of accounts receivable if the amount was payable to the customer, except in the case of the estimated reserve for future expired product returns, which were classified as a liability. The reserves were classified as a liability if the amount is payable to a party other than a customer. Where appropriate, these estimated reserves took into consideration relevant factors such as the Company&#8217;s historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns. Overall, these reserves reflected the Company&#8217;s best estimates to reduce gross selling price to net selling price to which it expected to be entitled based on the terms of its contracts. The actual selling price ultimately received may differ from the Company&#8217;s estimates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Returns</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with industry practice, the Company maintained a returns policy that generally offered customers a right of return for product that has been purchased from the Company. The Company estimated the amount of product returns and records this estimate as a reduction of revenue in the period the related product revenue was recognized. The Company estimated product return liabilities based on analysis of historical data for the product or comparable products, as well as future expectations for such products and other judgments and analysis.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-85-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i68c4f0f13dff40b593cc895ca91a9d26"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chargebacks, Discounts and Rebates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chargebacks, discounts and rebates represent the estimated obligations resulting from contractual commitments to sell products to its customers or end users at prices lower than the list prices charged to the Company&#8217;s wholesale customers. Customers charged the Company for the difference between the gross selling price they pay for the product and the ultimate contractual price agreed to between the Company and these end users. These reserves were established in the same period that the related revenue was recognized, resulting in a reduction of product revenue and accounts receivable. Chargebacks, discounts and rebates were estimated at the time of sale to the customer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s primary source of revenue was from the sale of pharmaceutical products, which are equally affected by the same economic factors as it relates to the nature, amount, timing, and uncertainty of revenue and cash flows. For further detail about the Company&#8217;s revenues by product, see&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note&#160;21: Company Operations by Product, Customer and Geography.  </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not recognize revenue in advance of invoicing its customers and therefore has no related contract assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A receivable is recognized in the period the Company sells its products and when the Company&#8217;s right to consideration is unconditional. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no material deferred contract costs at&#160;December&#160;31, 2021 and 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transaction Price Allocated to the Remaining Performance Obligation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For product sales, the Company generally satisfies its performance obligations within the same period the product is delivered. Product sales recognized in 2020 and 2019 from performance obligations satisfied (or partially satisfied) in previous periods were immaterial. No product sales were recognized in 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected certain of the practical expedients from the disclosure requirement for remaining performance obligations for specific situations in which an entity need not estimate variable consideration to recognize revenue. Accordingly, the Company applies the practical expedient in ASC 606 to its stand-alone contracts and does not disclose information about variable consideration from remaining performance obligations for which it recognizes revenue.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_106"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> NOTE 6: <ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90ZXh0cmVnaW9uOjdkMjY0YTc1ZjA0NDQxZTc5YjM3Mjk5YzVjYWIyZmY4XzM1MjU_a6e98840-f226-4aad-be9e-abb5693c0d0e" continuedAt="i4e574790de794ab394abc9ceccb7175c" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="i4e574790de794ab394abc9ceccb7175c" continuedAt="i274929171623404d8fbb88cc200a287f"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to measure certain assets and liabilities at fair value, either upon initial recognition or for subsequent accounting or reporting. For example, the Company uses fair value extensively when accounting for and reporting certain financial instruments, when measuring certain contingent consideration liabilities and in the initial recognition of net assets acquired in a business combination. Fair value is estimated by applying the hierarchy described below, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;defines fair value as a market-based measurement that should be determined based on the assumptions that marketplace participants would use in pricing an asset or liability. When estimating fair value, depending on the nature and complexity of the asset or liability, the Company may generally use one or each of the following techniques:&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Income approach, which is based on the present value of a future stream of net cash flows. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a basis for considering the assumptions used in these techniques, the standard establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value as follows: &#160;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 - Quoted prices for identical assets or liabilities in active markets. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-86-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i274929171623404d8fbb88cc200a287f"><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 - Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are directly or indirectly observable, or inputs that are derived principally from, or corroborated by, observable market data by correlation or other means. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 - Unobservable inputs that reflect estimates and assumptions. </span></div><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90ZXh0cmVnaW9uOjdkMjY0YTc1ZjA0NDQxZTc5YjM3Mjk5YzVjYWIyZmY4XzM1Mjg_9aa0553e-a1b2-4da2-898f-e271870c457b" escape="true"><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial instruments measured at fair value on a recurring basis classified in the fair value hierarchy (Level 1, 2 or 3) based on the inputs used for valuation in the accompanying consolidated balance sheets:</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.649%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id52d7d2aa62b4b4da464b12866a6c924_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzUtMi0xLTEtMjM0NTg_5d3ae8b0-dc1e-4273-b2f6-286bc992fb8c">78,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83bc9cfa1af3440280eb8de38f8166dd_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzQtNC0xLTEtMzU0MDk_9566bb4f-ead7-4d6d-82b0-1ecdc366dbdb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic01169ef9e0a4955a3206600ff07ada7_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzQtNi0xLTEtMzU0MTE_7021f1e9-54c9-4f37-a7c6-e0c1e53f6940">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2b2742f57824ceda1edb68f0ff8c8f3_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzUtOC0xLTEtMjM0NTg_8e97e13e-dad4-414c-b7ef-360c44acf58d">104,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d1044cc5fce464b8bc7a7bfef8cde56_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzQtMTAtMS0xLTM1NDEz_70d57282-824e-47c7-8ca5-d1c829451ec8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18e72e8a73fd4634a6d3d9497623275a_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzQtMTItMS0xLTM1NDEz_c0496971-c298-4d82-852c-b9f9d8100d7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c0427547534f92a024aa31e44c88b7_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzUtMi0xLTEtMzU0MDc_30437142-ade8-488c-87ab-90488949ad32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i293bd7a5c8b64a69aac7ebd06bdbcd7d_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzYtNC0xLTEtMjM0NTg_b4993319-f8a6-4c3f-a3cd-fc522d944504">16,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fb86d740e0439ca6608ab69d36eb11_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzUtNi0xLTEtMzU0MDM_4c722301-8f6c-4e09-8614-a6a5a9b716e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bfe961a6b074629ab468b545ec27937_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzUtOC0xLTEtMzU0MTM_1c703845-881c-4f7a-a593-0c785ff8d625">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0630338310348249f7dc7b831142ee2_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzYtMTAtMS0xLTIzNDU4_1732a93c-1e92-4381-935b-6b0b2fbbcef5">22,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7eb59743d34e40129c556f867c6c573c_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzUtMTItMS0xLTM1NDEz_54cd5dcc-ac6b-4d3d-aaa9-4193820824f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f30bb744514756aea4f12be8815603_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzYtMi0xLTEtMzU0MDc_5f4ef673-225b-4339-a20a-4af84926cbfb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5979606d5744565bf77ff486631a39e_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzctNC0xLTEtMjM0NTg_30f31629-d69c-4401-8132-11800a93f919">9,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6913fac34a90404fa88993860b66d7e2_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzYtNi0xLTEtMzU0MDM_44a5ad52-6f1f-4a39-9f5f-1080a79ab7df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic28f71d280c5400baa92f1e72d94daf9_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzYtOC0xLTEtMzU0MTM_6c2ae31a-fed7-4980-b4d1-d83bf6478b0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id88486af4378447498d419d174a87a1f_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzctMTAtMS0xLTIzNDU4_055c928c-322d-40b7-b59b-2a82443d5d62">18,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa70138b99c048b89b45f15ed355b484_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzYtMTItMS0xLTM1NDEz_250f9838-3325-46c8-bf0e-3583bfd971ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie16c2dc1e48343529c36da1c15195964_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzctMi0xLTEtMzU0MDc_cc5a56a0-0741-4850-b602-a7df95e5d57e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4b3eeee3d8446c7b5e89621aa4d248c_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzktNC0xLTEtMjM0NTg_eb4f7099-c3c5-4ac7-a391-b79a78748a0a">2,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17fcae9927b47b188df8b1fa2c25721_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzctNi0xLTEtMzU0MDM_c8caefac-9470-4bd0-960d-94e8f65dcf63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68cd10c5610845ebabca121f25b49d60_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzctOC0xLTEtMzU0MTM_c93bbe2e-8ebe-4c23-8d5c-efc22b2178be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d79f4c0bc9b455887433f737f576ca8_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzktMTAtMS0xLTIzNDU4_ed85794b-eaf4-45e5-8ddc-786873c96f9e">3,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a771a5f8997450bbbff5c44c4e92027_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzctMTItMS0xLTM1NDEz_d41257ac-0940-46e0-91bd-974429acd332">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b4d5f4b3fec4948b3a7c8a60e155623_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzEwLTItMS0xLTIzNDU4_baa7ca7b-99ad-4ab2-bd30-aa3ebd881a7f">78,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c7e425e645c4dc79f2d64d4e4939081_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzEwLTQtMS0xLTIzNDU4_5010315e-3ad2-4fc9-b665-a47e88b9e8f8">28,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id14aee310c1d455eba4dc5a754e72eee_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzgtNi0xLTEtMzU0MDM_5a468e6e-22e2-4078-a391-30b017289452">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i440d19b8d2524ebdaf59efde284e3f22_I20201231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzEwLTgtMS0xLTIzNDU4_6637d2b0-1594-4c48-80b1-fb8d96c7217e">104,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib15012d3c7954901bf95432b698ea122_I20201231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzEwLTEwLTEtMS0yMzQ1OA_eeeca103-cfc3-4d67-b389-05c3f553a68e">45,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1789d52ed2dd4776b2edfab82bbba9d2_I20201231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzgtMTItMS0xLTM1NDEz_6abb1c69-4261-4f55-b32d-5456d8348792">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A review of fair value hierarchy classifications is conducted on a quarterly basis.&#160; Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. During the fiscal year ended December&#160;31, 2021, there were no transfers in and out of&#160;Level&#160;1, 2, or 3. During the&#160;twelve months ended December&#160;31, 2021, 2020 and 2019, the Company did not recognize any allowances for credit losses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s financial instruments, such as cash and cash equivalents and accounts payable, are reflected in the balance sheet at carrying value, which approximates fair value due to their short-term nature.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the fair value of its&#160;$<ix:nonFraction unitRef="usd" contextRef="ia43fd9d7d0184bf48d0ca7e30b92fe15_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90ZXh0cmVnaW9uOjdkMjY0YTc1ZjA0NDQxZTc5YjM3Mjk5YzVjYWIyZmY4XzMwMjY_343af6f3-79c4-4b99-a4b6-80d6f3f3cace">143,750</ix:nonFraction>&#160;aggregate principal amount of&#160;the 2023 Notes based on interest rates that would be currently available to the Company for issuance of similar types of debt instruments with similar terms and remaining maturities or recent trading prices obtained from brokers (a Level 2 input). The estimated fair value of the 2023 Notes at&#160;December&#160;31, 2021 is&#160;$<ix:nonFraction unitRef="usd" contextRef="i26a649c3c54c4610811b4ccf08d404fc_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90ZXh0cmVnaW9uOjdkMjY0YTc1ZjA0NDQxZTc5YjM3Mjk5YzVjYWIyZmY4XzEwOTk1MTE2MzE4Nzk_5d01a518-1d90-4d6d-9206-05d1394b872c">153,273</ix:nonFraction>. See&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note&#160;11:&#160;Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;for additional information regarding the Company&#8217;s debt obligations.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_109"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90ZXh0cmVnaW9uOmY1MmNhOTdkN2UxNTQ5OTZiOGNmNGEyZGU0NDU5MTIzXzIyOTU_b912afa5-a5da-48bd-a98b-d8e6a9ddfaf9" continuedAt="icfaf6aee1dca45b78de18394f23e688a" escape="true">Marketable Securities&#160;</ix:nonNumeric></span></div><ix:continuation id="icfaf6aee1dca45b78de18394f23e688a" continuedAt="i6b8bada0e19b4f2fa1b6a7f0a491c24e"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in available-for-sale debt securities that are recorded at fair market value. The change in the fair value of available-for-sale debt investments is recorded as accumulated other comprehensive loss in shareholders&#8217; equity, net of income tax effects. As of December&#160;31, 2021, the Company considered any decreases in fair value on its marketable securities to be driven by factors other than credit risk, including market risk.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90ZXh0cmVnaW9uOmY1MmNhOTdkN2UxNTQ5OTZiOGNmNGEyZGU0NDU5MTIzXzIyOTc_75c14b07-733a-4c3d-89ee-6892c73ad50b" continuedAt="iff433e043ab14526a600707f682a008a" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the Company&#8217;s available-for-sale securities&#8217; adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category as of&#160;December&#160;31, 2021 and 2020, respectively:</span></div><div style="margin-bottom:15pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:44.861%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Securities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2ad46fe0b3942418942545c861a553b_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzQtMi0xLTEtMjM0NTg_68e96d05-e350-4da9-b1dd-11409f5b61dd">78,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2ad46fe0b3942418942545c861a553b_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzQtNC0xLTEtMjM0NTg_59149036-cd8c-4c36-a44d-cc6db01ec605">813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2ad46fe0b3942418942545c861a553b_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzQtNi0xLTEtMjM0NTg_94e11361-3f3a-4b8b-bb8d-af6419d22daf">1,046</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2ad46fe0b3942418942545c861a553b_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzQtOC0xLTEtMjM0NTg_258c3902-85b6-484f-82ee-2f02b85acad4">78,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de00269e1884c6ba19491a6f480f8c0_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzUtMi0xLTEtMjM0NTg_dd14cb5f-3d20-40b2-8616-8482b22eb342">16,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de00269e1884c6ba19491a6f480f8c0_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzUtNC0xLTEtMjM0NTg_664f2c3e-5283-479d-b377-83753d3351e2">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de00269e1884c6ba19491a6f480f8c0_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzUtNi0xLTEtMjM0NTg_ff30de67-c2f9-4e0a-b6c1-020837934541">93</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de00269e1884c6ba19491a6f480f8c0_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzUtOC0xLTEtMjM0NTg_e1457d03-74fa-4b7b-b9e2-0eeb67eccc87">16,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fe5967822c4c7c815ef3f9bfcf263a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzYtMi0xLTEtMjM0NTg_91b9da36-73cb-4ffe-9928-0e101ab12790">9,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fe5967822c4c7c815ef3f9bfcf263a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzYtNC0xLTEtMjM0NTg_97b6a0d5-e82e-41b1-a0d7-ff9181fabc18">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12fe5967822c4c7c815ef3f9bfcf263a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzYtNi0xLTEtMjM0NTg_d109318a-5305-42bf-ba4f-f827117bd537">98</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fe5967822c4c7c815ef3f9bfcf263a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzYtOC0xLTEtMjM0NTg_42154716-5578-49ab-a8c5-f36b26822c96">9,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a1d5321937c496998a92b6d7b15b2ec_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzgtMi0xLTEtMjM0NTg_b8519e7b-3c01-4123-b6b7-585e34dc6a75">2,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a1d5321937c496998a92b6d7b15b2ec_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzgtNC0xLTEtMjM0NTg_f96508f2-d041-45ab-a07c-2dab01ae1ed0">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a1d5321937c496998a92b6d7b15b2ec_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzgtNi0xLTEtMjM0NTg_a0da1600-7eeb-46ae-beb4-65ee5c0f02c0">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a1d5321937c496998a92b6d7b15b2ec_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzgtOC0xLTEtMjM0NTg_5110762c-9c2f-4088-b70a-c5a9bc256eba">2,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzExLTItMS0xLTIzNDU4_22d28f20-0f54-4fab-91b7-03509ce6e0b6">106,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzExLTQtMS0xLTIzNDU4_b21f22e1-78c2-46fc-b089-c3e30b8240ef">948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzExLTYtMS0xLTIzNDU4_66ae2c1e-cfc3-42f8-a9d1-0082829c1519">1,247</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzExLTgtMS0xLTIzNDU4_89b91537-3220-4311-a7a3-6e2ea3dab657">106,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-87-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6b8bada0e19b4f2fa1b6a7f0a491c24e" continuedAt="iba0393bd190546608e8e61aee1487189"><div style="text-align:justify"><ix:continuation id="iff433e043ab14526a600707f682a008a"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:44.861%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Securities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0135ceeb3a74418aebc3bea16187547_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzQtMi0xLTEtMjM0NTg_7abf2d3f-4618-4718-8435-fee3c12cfc58">103,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0135ceeb3a74418aebc3bea16187547_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzQtNC0xLTEtMjM0NTg_cf3e4ee7-c056-42c4-bb00-4763e60ac260">1,288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0135ceeb3a74418aebc3bea16187547_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzQtNi0xLTEtMjM0NTg_0a4e97a7-6d98-4303-8ca1-4feda2fcb9bb">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0135ceeb3a74418aebc3bea16187547_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzQtOC0xLTEtMjM0NTg_0a17840a-eaf2-472a-a13d-7c6599f2b95e">104,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90001ac5605243f1919453ac916355e5_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzUtMi0xLTEtMjM0NTg_68970d14-dd91-434d-a81b-b1257f43b6db">21,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90001ac5605243f1919453ac916355e5_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzUtNC0xLTEtMjM0NTg_d05663e1-3ac0-461d-ad4d-bde885b83592">350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90001ac5605243f1919453ac916355e5_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzUtNi0xLTEtMjM0NTg_cd96191e-9292-42a3-b6d8-5a4c6f3d434b">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90001ac5605243f1919453ac916355e5_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzUtOC0xLTEtMjM0NTg_faa25d20-b092-4fc9-bf5a-c97b8401238a">22,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85699a651b9645bdaa89df0e755480d9_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzYtMi0xLTEtMjM0NTg_256a89af-d5c6-4b78-9dd6-15f7fd70e41e">18,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85699a651b9645bdaa89df0e755480d9_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzYtNC0xLTEtMjM0NTg_2706ae39-82f3-4cd3-a518-07e9f29aa846">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85699a651b9645bdaa89df0e755480d9_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzYtNi0xLTEtMjM0NTg_90933001-aeb0-4dea-a051-8dd855ed6385">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85699a651b9645bdaa89df0e755480d9_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzYtOC0xLTEtMjM0NTg_ada2d680-ab05-472d-bde8-29dedf36e989">18,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcf68fc36aa144f6aed0720b51cae4de_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzgtMi0xLTEtMjM0NTg_1380c7b6-426c-43af-9caf-76d81bcff33d">3,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcf68fc36aa144f6aed0720b51cae4de_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzgtNC0xLTEtMjM0NTg_bff8bafe-d821-4946-86ba-d2163e15a2ac">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idcf68fc36aa144f6aed0720b51cae4de_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzgtNi0xLTEtMjM0NTg_deed5f24-bd30-4f65-a278-a6c5b4cde5b0">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcf68fc36aa144f6aed0720b51cae4de_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzgtOC0xLTEtMjM0NTg_3d84773f-68c8-4ab8-929a-601c76498c4e">3,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzEwLTItMS0xLTIzNDU4_d500fa14-2b51-424b-b10a-dbe1e1c379d8">147,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzEwLTQtMS0xLTIzNDU4_304503b0-0833-46f2-b27f-4cf618771724">1,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzEwLTYtMS0xLTIzNDU4_75ff4704-a603-46a8-a6b1-19788e7f56f9">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzEwLTgtMS0xLTIzNDU4_0253bd0a-2c45-4c76-bbbc-11c363da2eb7">149,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines realized gains or losses on the sale of marketable securities on a specific identification method. The Company reflects these gains and losses as a component of investment and other income in the accompanying consolidated statements of (loss) income.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized gross realized gains of&#160;$<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="avdl:MarketableSecuritiesRealizedGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90ZXh0cmVnaW9uOmY1MmNhOTdkN2UxNTQ5OTZiOGNmNGEyZGU0NDU5MTIzXzExMzU_392c231a-414e-44b2-9a0b-445d97f41597">174</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="avdl:MarketableSecuritiesRealizedGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90ZXh0cmVnaW9uOmY1MmNhOTdkN2UxNTQ5OTZiOGNmNGEyZGU0NDU5MTIzXzExMzk_415e1be3-5e65-429e-a572-0e9dbad0dd31">474</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="avdl:MarketableSecuritiesRealizedGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90ZXh0cmVnaW9uOmY1MmNhOTdkN2UxNTQ5OTZiOGNmNGEyZGU0NDU5MTIzXzExNDc_dc39741c-4420-4a69-9a16-43aac1de91d4">483</ix:nonFraction> for the&#160;twelve months ended December&#160;31, 2021, 2020 and 2019, respectively. These realized gains were offset by realized losses of $<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="avdl:MarketableSecuritiesRealizedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90ZXh0cmVnaW9uOmY1MmNhOTdkN2UxNTQ5OTZiOGNmNGEyZGU0NDU5MTIzXzEyNjM_28ee4e87-c87d-4531-a394-88c4a3cb3ed2">275</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="avdl:MarketableSecuritiesRealizedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90ZXh0cmVnaW9uOmY1MmNhOTdkN2UxNTQ5OTZiOGNmNGEyZGU0NDU5MTIzXzEyNjc_b54f02d5-f2d9-4947-938f-79a13781309d">912</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="avdl:MarketableSecuritiesRealizedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90ZXh0cmVnaW9uOmY1MmNhOTdkN2UxNTQ5OTZiOGNmNGEyZGU0NDU5MTIzXzEyNzU_76fefd71-c990-4be9-bb07-4378b15837d4">151</ix:nonFraction>&#160;for the twelve-months ended December&#160;31, 2021, 2020 and 2019, respectively. </span></div><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90ZXh0cmVnaW9uOmY1MmNhOTdkN2UxNTQ5OTZiOGNmNGEyZGU0NDU5MTIzXzIyOTg_84d0e660-46cd-489e-941d-d7cf2dc93eda" escape="true"><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated fair value of the Company&#8217;s investments in marketable debt securities, accounted for as available-for-sale securities and classified by the contractual maturity date of the securities as of December&#160;31, 2021:</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:33.554%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.240%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Debt Securities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 1 Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1-5 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5-10 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 10 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de00269e1884c6ba19491a6f480f8c0_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzUtMi0xLTEtMjM0NTg_df79ba26-b1cd-4fc3-acf4-a04233d74279">5,288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de00269e1884c6ba19491a6f480f8c0_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzUtNC0xLTEtMjM0NTg_e5f86828-7d85-4178-bc32-898d308d4608">10,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de00269e1884c6ba19491a6f480f8c0_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzUtNi0xLTEtMjM0NTg_f7981bf0-a470-43b5-a7a2-d518ae7aab74">318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de00269e1884c6ba19491a6f480f8c0_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzUtOC0xLTEtMjM0NTg_917146df-b60b-4532-8df1-9a849caca7a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i293bd7a5c8b64a69aac7ebd06bdbcd7d_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzUtMTAtMS0xLTIzNDU4_b4993319-f8a6-4c3f-a3cd-fc522d944504">16,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fe5967822c4c7c815ef3f9bfcf263a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzYtMi0xLTEtMjM0NTg_8aabfe0c-fc5a-489d-899b-73bfd8245d58">1,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fe5967822c4c7c815ef3f9bfcf263a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzYtNC0xLTEtMjM0NTg_bd9eba6b-f31d-43fa-afc8-aff0cc26b73f">5,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fe5967822c4c7c815ef3f9bfcf263a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzYtNi0xLTEtMjM0NTg_e04629c7-ab37-4049-a78f-5c684a94465e">807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12fe5967822c4c7c815ef3f9bfcf263a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzYtOC0xLTEtMjM0NTg_6ccb2e91-974b-459b-ba41-7b28404b5dd9">1,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5979606d5744565bf77ff486631a39e_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzYtMTAtMS0xLTIzNDU4_30f31629-d69c-4401-8132-11800a93f919">9,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a1d5321937c496998a92b6d7b15b2ec_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzgtMi0xLTEtMjM0NTg_fcd73689-3f42-456b-a6aa-c9738c0f57a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a1d5321937c496998a92b6d7b15b2ec_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzgtNC0xLTEtMjM0NTg_f2bb54b5-12a2-4520-a862-8f0c355a2ca7">1,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a1d5321937c496998a92b6d7b15b2ec_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzgtNi0xLTEtMjM0NTg_48af3f45-4768-43e2-a635-deea3b3b4a29">605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a1d5321937c496998a92b6d7b15b2ec_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzgtOC0xLTEtMjM0NTg_59fec777-6090-45be-a8c1-68ae9700274b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4b3eeee3d8446c7b5e89621aa4d248c_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzgtMTAtMS0xLTIzNDU4_eb4f7099-c3c5-4ac7-a391-b79a78748a0a">2,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e1399e88a8a4132b1ab0865edb594ab_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzExLTItMS0xLTIzNDU4_59be3d81-f1b4-42ef-8893-957e8831f87c">6,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e1399e88a8a4132b1ab0865edb594ab_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzExLTQtMS0xLTIzNDU4_0b24974e-388b-44f2-84c8-ffaed7925649">18,671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e1399e88a8a4132b1ab0865edb594ab_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzExLTYtMS0xLTIzNDU4_5d68bdd7-b6b0-4559-93e1-b2abcd996a35">1,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e1399e88a8a4132b1ab0865edb594ab_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzExLTgtMS0xLTIzNDU4_dea83521-96a9-44b2-bf40-76aa187867db">1,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e1399e88a8a4132b1ab0865edb594ab_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzExLTEwLTEtMS0yMzQ1OA_db3742f0-9966-46e6-adba-37bffbcb94dc">28,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified its investment in available-for-sale marketable securities as current assets in the consolidated balance sheets as the securities need to be available for use, if required, to fund current operations. There are no restrictions on the sale of any securities in the Company&#8217;s investment portfolio. </span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iba0393bd190546608e8e61aee1487189">Total gross unrealized losses of the Company&#8217;s available-for-sale debt securities at December&#160;31, 2021 were immaterial and have been in an unrealized loss position for less than one year. The unrealized losses are driven by factors other than credit risk. The Company does not intend to sell the investments and it is not more likely than not that it will be required to sell the investments before recovery of their amortized cost bases.</ix:continuation>  </span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_115"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTUvZnJhZzpjZmQ4ZDM1ZjU0MWY0NjA2OWNmZTA2NDM4YzQ2YTM5My90ZXh0cmVnaW9uOmNmZDhkMzVmNTQxZjQ2MDY5Y2ZlMDY0MzhjNDZhMzkzXzIzNw_e6a35345-5256-4a66-962b-65d9a166b511" continuedAt="if61b5d6c15dc4e90a0aa3ba230cc567d" escape="true">Property and Equipment, net</ix:nonNumeric></span></div><ix:continuation id="ifc168493d9dd41768075d27b3fc0c52d"><ix:continuation id="if61b5d6c15dc4e90a0aa3ba230cc567d" continuedAt="i9ad73bc063544187b2e71facfb9379e2"><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal categories of property and equipment, net at December&#160;31, 2021 and 2020, respectively, are as&#160;follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.103%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Property and Equipment, net:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Software, office and computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e74df425db74915b7e617e549e87b1f_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTUvZnJhZzpjZmQ4ZDM1ZjU0MWY0NjA2OWNmZTA2NDM4YzQ2YTM5My90YWJsZTo4NzA4ZWVhNzgyNDE0NzlmOGNkNTg3N2ZkN2QzMjU2MC90YWJsZXJhbmdlOjg3MDhlZWE3ODI0MTQ3OWY4Y2Q1ODc3ZmQ3ZDMyNTYwXzMtMi0xLTEtMjM0NTg_168153a5-276b-4e3d-aa0f-2c01f00368e1">448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79bb42f554984d2286d06ea284888cfd_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTUvZnJhZzpjZmQ4ZDM1ZjU0MWY0NjA2OWNmZTA2NDM4YzQ2YTM5My90YWJsZTo4NzA4ZWVhNzgyNDE0NzlmOGNkNTg3N2ZkN2QzMjU2MC90YWJsZXJhbmdlOjg3MDhlZWE3ODI0MTQ3OWY4Y2Q1ODc3ZmQ3ZDMyNTYwXzMtNC0xLTEtMjM0NTg_4e2f6a8a-bd86-44c2-a301-73a6b4486995">1,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Furniture, fixtures and fittings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8c3aa61520d40aebe11479c3ccbff53_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTUvZnJhZzpjZmQ4ZDM1ZjU0MWY0NjA2OWNmZTA2NDM4YzQ2YTM5My90YWJsZTo4NzA4ZWVhNzgyNDE0NzlmOGNkNTg3N2ZkN2QzMjU2MC90YWJsZXJhbmdlOjg3MDhlZWE3ODI0MTQ3OWY4Y2Q1ODc3ZmQ3ZDMyNTYwXzQtMi0xLTEtMjM0NTg_675a6c05-e094-4231-b3db-76444beb67d8">302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82ff4d5bf5de4a8ba5b7fb4b53054871_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTUvZnJhZzpjZmQ4ZDM1ZjU0MWY0NjA2OWNmZTA2NDM4YzQ2YTM5My90YWJsZTo4NzA4ZWVhNzgyNDE0NzlmOGNkNTg3N2ZkN2QzMjU2MC90YWJsZXJhbmdlOjg3MDhlZWE3ODI0MTQ3OWY4Y2Q1ODc3ZmQ3ZDMyNTYwXzQtNC0xLTEtMjM0NTg_ef73df3c-706b-4234-a02c-a03c5e80afa7">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less - accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTUvZnJhZzpjZmQ4ZDM1ZjU0MWY0NjA2OWNmZTA2NDM4YzQ2YTM5My90YWJsZTo4NzA4ZWVhNzgyNDE0NzlmOGNkNTg3N2ZkN2QzMjU2MC90YWJsZXJhbmdlOjg3MDhlZWE3ODI0MTQ3OWY4Y2Q1ODc3ZmQ3ZDMyNTYwXzUtMi0xLTEtMjM0NTg_e035fa2b-61a1-44b2-8e02-de9fb11702c4">465</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTUvZnJhZzpjZmQ4ZDM1ZjU0MWY0NjA2OWNmZTA2NDM4YzQ2YTM5My90YWJsZTo4NzA4ZWVhNzgyNDE0NzlmOGNkNTg3N2ZkN2QzMjU2MC90YWJsZXJhbmdlOjg3MDhlZWE3ODI0MTQ3OWY4Y2Q1ODc3ZmQ3ZDMyNTYwXzUtNC0xLTEtMjM0NTg_7757eb1f-9734-440e-8366-091587fe8f2c">1,384</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTUvZnJhZzpjZmQ4ZDM1ZjU0MWY0NjA2OWNmZTA2NDM4YzQ2YTM5My90YWJsZTo4NzA4ZWVhNzgyNDE0NzlmOGNkNTg3N2ZkN2QzMjU2MC90YWJsZXJhbmdlOjg3MDhlZWE3ODI0MTQ3OWY4Y2Q1ODc3ZmQ3ZDMyNTYwXzYtMi0xLTEtMjM0NTg_a0aa8e81-7de7-4937-935e-98d35db555c0">285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTUvZnJhZzpjZmQ4ZDM1ZjU0MWY0NjA2OWNmZTA2NDM4YzQ2YTM5My90YWJsZTo4NzA4ZWVhNzgyNDE0NzlmOGNkNTg3N2ZkN2QzMjU2MC90YWJsZXJhbmdlOjg3MDhlZWE3ODI0MTQ3OWY4Y2Q1ODc3ZmQ3ZDMyNTYwXzYtNC0xLTEtMjM0NTg_7479778c-c27e-497c-8afe-e39aaebca726">359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9ad73bc063544187b2e71facfb9379e2">Depreciation expense for the years ended December&#160;31, 2021, 2020 and 2019 was $<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTUvZnJhZzpjZmQ4ZDM1ZjU0MWY0NjA2OWNmZTA2NDM4YzQ2YTM5My90ZXh0cmVnaW9uOmNmZDhkMzVmNTQxZjQ2MDY5Y2ZlMDY0MzhjNDZhMzkzXzIwNg_2420bd66-1dd2-4db2-a6b9-78d1b34ef77d">97</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTUvZnJhZzpjZmQ4ZDM1ZjU0MWY0NjA2OWNmZTA2NDM4YzQ2YTM5My90ZXh0cmVnaW9uOmNmZDhkMzVmNTQxZjQ2MDY5Y2ZlMDY0MzhjNDZhMzkzXzIxMA_7caaf042-6997-41b6-b9f6-e2a0cee5bf14">287</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTUvZnJhZzpjZmQ4ZDM1ZjU0MWY0NjA2OWNmZTA2NDM4YzQ2YTM5My90ZXh0cmVnaW9uOmNmZDhkMzVmNTQxZjQ2MDY5Y2ZlMDY0MzhjNDZhMzkzXzIxNw_61796f57-08ef-485c-af60-2f6c1c3d44b5">459</ix:nonFraction>, respectively.</ix:continuation>&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-88-</span></div></div></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTgvZnJhZzozMjJhMmZjMTRkOWE0YjRiOTZhMjY0NzU1ODdiOGY3NC90ZXh0cmVnaW9uOjMyMmEyZmMxNGQ5YTRiNGI5NmEyNjQ3NTU4N2I4Zjc0XzEwMDA_7ea73267-8ea4-4f63-b767-01c78458b330" continuedAt="i75ffeb03769b4f8cb4deb255a9302356" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill and Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></ix:nonNumeric></div><ix:continuation id="i75ffeb03769b4f8cb4deb255a9302356"><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s goodwill is $<ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTgvZnJhZzozMjJhMmZjMTRkOWE0YjRiOTZhMjY0NzU1ODdiOGY3NC90ZXh0cmVnaW9uOjMyMmEyZmMxNGQ5YTRiNGI5NmEyNjQ3NTU4N2I4Zjc0XzEwOTk1MTE2MzEyMDM_328c75d0-5af3-42e8-bb96-531582c3125c"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTgvZnJhZzozMjJhMmZjMTRkOWE0YjRiOTZhMjY0NzU1ODdiOGY3NC90ZXh0cmVnaW9uOjMyMmEyZmMxNGQ5YTRiNGI5NmEyNjQ3NTU4N2I4Zjc0XzEwOTk1MTE2MzEyMDM_a082465c-723c-4cc8-ad27-1ddb79afca47">16,836</ix:nonFraction></ix:nonFraction> at December&#160;31, 2021 and 2020.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded amortization expense related to an amortizable intangible asset that was assumed by the Exela Buyer as part of the disposition of the Hospital Products on June 30, 2020 of $<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTgvZnJhZzozMjJhMmZjMTRkOWE0YjRiOTZhMjY0NzU1ODdiOGY3NC90ZXh0cmVnaW9uOjMyMmEyZmMxNGQ5YTRiNGI5NmEyNjQ3NTU4N2I4Zjc0XzEwOTk1MTE2MzEwMTU_3360190a-10d9-4377-96f0-73184268acd3">406</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTgvZnJhZzozMjJhMmZjMTRkOWE0YjRiOTZhMjY0NzU1ODdiOGY3NC90ZXh0cmVnaW9uOjMyMmEyZmMxNGQ5YTRiNGI5NmEyNjQ3NTU4N2I4Zjc0XzI3NDg3NzkwNzI4MDc_c8954a32-7c7d-4848-9483-20aa75d4f9fe">816</ix:nonFraction> for the years ended December&#160;31, 2020 and 2019, respectively. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4: Disposition of the Hospital Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. There was no amortization expense recorded during the year ended December&#160;31, 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="INF" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTgvZnJhZzozMjJhMmZjMTRkOWE0YjRiOTZhMjY0NzU1ODdiOGY3NC90ZXh0cmVnaW9uOjMyMmEyZmMxNGQ5YTRiNGI5NmEyNjQ3NTU4N2I4Zjc0Xzg3MA_02e4adb8-9e37-4a1e-835a-0af79eba848c"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="INF" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTgvZnJhZzozMjJhMmZjMTRkOWE0YjRiOTZhMjY0NzU1ODdiOGY3NC90ZXh0cmVnaW9uOjMyMmEyZmMxNGQ5YTRiNGI5NmEyNjQ3NTU4N2I4Zjc0Xzg3MA_4014854c-243b-4f05-ab28-ecf6d18d3a71">No</ix:nonFraction></ix:nonFraction> impairment loss related to goodwill or intangible assets was recognized during the years ended December&#160;31, 2021 or 2020.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_121"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10: <ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90ZXh0cmVnaW9uOjIyMGM2MjEzZTI4YTQ4YTU5NDMyYzkzOTY1NjcxODAyXzI0OTI_39b2119a-4c2d-446e-bd25-4be61b01919c" continuedAt="i860f59faaefa46b09312a0a0bf9577dc" escape="true">Leases</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i860f59faaefa46b09312a0a0bf9577dc"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases office space and a production suite. All leased facilities are classified as operating leases with remaining lease terms between&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90ZXh0cmVnaW9uOjIyMGM2MjEzZTI4YTQ4YTU5NDMyYzkzOTY1NjcxODAyXzY2OQ_ea03d613-a2cf-479a-bdb9-ee92938c3329">two</span>&#160;and&#160;<ix:nonNumeric contextRef="i8f6fe7015e8f450194b70a8556bf0935_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90ZXh0cmVnaW9uOjIyMGM2MjEzZTI4YTQ4YTU5NDMyYzkzOTY1NjcxODAyXzY3Ng_bfc293fa-9e4f-413e-8072-1bf2b1c02d29">four years</ix:nonNumeric>. The Company determines if a contract is a lease at the inception of the arrangement. The Company reviews all options to extend, terminate, or purchase its right-of-use assets at the inception of the lease and will include these options in the lease term when they are reasonably certain of being exercised. The Company&#8217;s lease agreements do not contain any material residual value guarantees or material variable lease payments. For the Company&#8217;s leased production suite, contract consideration was allocated to lease and non-lease components on the basis of relative standalone price. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90ZXh0cmVnaW9uOjIyMGM2MjEzZTI4YTQ4YTU5NDMyYzkzOTY1NjcxODAyXzI0ODk_2afd4db6-8ca4-4d39-8546-c5020be4e7ee" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease costs, which are included in selling, general and administrative expenses in the consolidated statements of (loss) income of years ended December&#160;31, 2021, 2020 and 2019 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.886%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Lease cost:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTowNTJjNmZmZTNiMjc0NjQ1YTAxYjFkNTdkZmRmYmVhYy90YWJsZXJhbmdlOjA1MmM2ZmZlM2IyNzQ2NDVhMDFiMWQ1N2RmZGZiZWFjXzItNC0xLTEtMjM0NTg_2ce2fe79-9352-42c6-8f09-423411c00b16">821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTowNTJjNmZmZTNiMjc0NjQ1YTAxYjFkNTdkZmRmYmVhYy90YWJsZXJhbmdlOjA1MmM2ZmZlM2IyNzQ2NDVhMDFiMWQ1N2RmZGZiZWFjXzItNi0xLTEtMjM0NTg_21115ecc-d373-401f-a9b8-a5ad27505403">1,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTowNTJjNmZmZTNiMjc0NjQ1YTAxYjFkNTdkZmRmYmVhYy90YWJsZXJhbmdlOjA1MmM2ZmZlM2IyNzQ2NDVhMDFiMWQ1N2RmZGZiZWFjXzItOC0xLTEtMzU0MzA_ec46aee8-5290-464e-b823-88485124f300">1,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sublease income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTowNTJjNmZmZTNiMjc0NjQ1YTAxYjFkNTdkZmRmYmVhYy90YWJsZXJhbmdlOjA1MmM2ZmZlM2IyNzQ2NDVhMDFiMWQ1N2RmZGZiZWFjXzUtNC0xLTEtMjM0NTg_178d987e-2bb9-46f6-b344-674a3e2f7095">110</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTowNTJjNmZmZTNiMjc0NjQ1YTAxYjFkNTdkZmRmYmVhYy90YWJsZXJhbmdlOjA1MmM2ZmZlM2IyNzQ2NDVhMDFiMWQ1N2RmZGZiZWFjXzUtNi0xLTEtMjM0NTg_0180d9c5-5c59-4c77-a43d-f1647ce61c97">336</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTowNTJjNmZmZTNiMjc0NjQ1YTAxYjFkNTdkZmRmYmVhYy90YWJsZXJhbmdlOjA1MmM2ZmZlM2IyNzQ2NDVhMDFiMWQ1N2RmZGZiZWFjXzUtOC0xLTEtMzU0MzA_b0a04e42-3a57-4b1c-a19a-a9d0dad9151b">276</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTowNTJjNmZmZTNiMjc0NjQ1YTAxYjFkNTdkZmRmYmVhYy90YWJsZXJhbmdlOjA1MmM2ZmZlM2IyNzQ2NDVhMDFiMWQ1N2RmZGZiZWFjXzYtNC0xLTEtMjM0NTg_712146c3-ac22-4312-8339-fba551d32504">711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTowNTJjNmZmZTNiMjc0NjQ1YTAxYjFkNTdkZmRmYmVhYy90YWJsZXJhbmdlOjA1MmM2ZmZlM2IyNzQ2NDVhMDFiMWQ1N2RmZGZiZWFjXzYtNi0xLTEtMjM0NTg_37544d6a-5597-4850-b504-0c38c3194a73">797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTowNTJjNmZmZTNiMjc0NjQ1YTAxYjFkNTdkZmRmYmVhYy90YWJsZXJhbmdlOjA1MmM2ZmZlM2IyNzQ2NDVhMDFiMWQ1N2RmZGZiZWFjXzYtOC0xLTEtMzU0MzA_3d6ffc71-fd48-479e-b902-e9835ef55435">1,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable lease costs were immaterial for the years ended December&#160;31, 2021, 2020 and 2019.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Represents sublease income received for office subleases.</span></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2021 and 2020, the Company reduced its operating lease liabilities by $<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90ZXh0cmVnaW9uOjIyMGM2MjEzZTI4YTQ4YTU5NDMyYzkzOTY1NjcxODAyXzE1ODU_cceb753e-b088-474b-b7ce-7b54e5378cf0">578</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90ZXh0cmVnaW9uOjIyMGM2MjEzZTI4YTQ4YTU5NDMyYzkzOTY1NjcxODAyXzE1OTI_bf1a09c1-ede5-4d10-a623-3a10c86524e7">769</ix:nonFraction> for cash paid. During the year ended December&#160;31, 2021, the Company remeasured its production suite lease liability. During the year ended December&#160;31, 2021, the Company did not enter into any new operating or finance leases.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company&#8217;s operating leases have a weighted-average remaining lease term of <ix:nonNumeric contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90ZXh0cmVnaW9uOjIyMGM2MjEzZTI4YTQ4YTU5NDMyYzkzOTY1NjcxODAyXzIxNzQ_2da67e4d-ebdb-4ceb-8c28-18d2de309b60">2.9</ix:nonNumeric> years and a weighted-average discount rate of <ix:nonFraction unitRef="number" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90ZXh0cmVnaW9uOjIyMGM2MjEzZTI4YTQ4YTU5NDMyYzkzOTY1NjcxODAyXzIyMTc_ad557ecb-00d7-4d02-bf0f-16515d51d118">4.9</ix:nonFraction>%. The Company&#8217;s lease contracts do not provide a readily determinable implicit rate. The Company&#8217;s estimated incremental borrowing rate is based on information available at the inception of the lease.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90ZXh0cmVnaW9uOjIyMGM2MjEzZTI4YTQ4YTU5NDMyYzkzOTY1NjcxODAyXzI0OTA_6c9d33c9-1aef-4331-b00f-7c527924fadb" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of the Company&#8217;s operating lease liabilities were as follows:</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:80.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTo5NDIxYTM4YjUyMWQ0MDU1YTJiNzhlMDk0NzYxZDEzZi90YWJsZXJhbmdlOjk0MjFhMzhiNTIxZDQwNTVhMmI3OGUwOTQ3NjFkMTNmXzItMi0xLTEtMjM0NTg_3452e3aa-5854-4d0f-a91d-0b2ada64d8f0">974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTo5NDIxYTM4YjUyMWQ0MDU1YTJiNzhlMDk0NzYxZDEzZi90YWJsZXJhbmdlOjk0MjFhMzhiNTIxZDQwNTVhMmI3OGUwOTQ3NjFkMTNmXzMtMi0xLTEtMjM0NTg_0b011777-73e5-4213-aa68-0aab7132f45d">1,013</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTo5NDIxYTM4YjUyMWQ0MDU1YTJiNzhlMDk0NzYxZDEzZi90YWJsZXJhbmdlOjk0MjFhMzhiNTIxZDQwNTVhMmI3OGUwOTQ3NjFkMTNmXzQtMi0xLTEtMjM0NTg_7e4087f3-f210-4dcf-a5d0-112ca7999811">614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTo5NDIxYTM4YjUyMWQ0MDU1YTJiNzhlMDk0NzYxZDEzZi90YWJsZXJhbmdlOjk0MjFhMzhiNTIxZDQwNTVhMmI3OGUwOTQ3NjFkMTNmXzUtMi0xLTEtMjM0NTg_12f3f871-4db3-47e4-a6c9-7660f9bb549a">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTo5NDIxYTM4YjUyMWQ0MDU1YTJiNzhlMDk0NzYxZDEzZi90YWJsZXJhbmdlOjk0MjFhMzhiNTIxZDQwNTVhMmI3OGUwOTQ3NjFkMTNmXzYtMi0xLTEtMjM0NTg_41cab1ff-566e-453f-ab6f-6d7c6b0d80ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTo5NDIxYTM4YjUyMWQ0MDU1YTJiNzhlMDk0NzYxZDEzZi90YWJsZXJhbmdlOjk0MjFhMzhiNTIxZDQwNTVhMmI3OGUwOTQ3NjFkMTNmXzctMi0xLTEtMjM0NTg_71610252-49ee-4b56-9a16-96c3b9ced333">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTo5NDIxYTM4YjUyMWQ0MDU1YTJiNzhlMDk0NzYxZDEzZi90YWJsZXJhbmdlOjk0MjFhMzhiNTIxZDQwNTVhMmI3OGUwOTQ3NjFkMTNmXzgtMi0xLTEtMjM0NTg_41dd560b-74c4-47a3-9c9e-9aa096cbb33c">2,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTo5NDIxYTM4YjUyMWQ0MDU1YTJiNzhlMDk0NzYxZDEzZi90YWJsZXJhbmdlOjk0MjFhMzhiNTIxZDQwNTVhMmI3OGUwOTQ3NjFkMTNmXzktMi0xLTEtMjM0NTg_a6035422-5373-456a-8aa0-0bd79cc12d0e">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTo5NDIxYTM4YjUyMWQ0MDU1YTJiNzhlMDk0NzYxZDEzZi90YWJsZXJhbmdlOjk0MjFhMzhiNTIxZDQwNTVhMmI3OGUwOTQ3NjFkMTNmXzEwLTItMS0xLTIzNDU4_3f919674-bf7e-42e5-af87-bc8e37c5c928">2,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-89-</span></div></div></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzY2NTY_40b37fa1-14e6-46aa-89cf-e3c9a553bf38" continuedAt="i89fa1d743c834be6a097a48334004772" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></ix:nonNumeric></div><ix:continuation id="i89fa1d743c834be6a097a48334004772" continuedAt="id10f24c0ce634634ba12b672cabbeb96"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzY2NTk_2f8595f7-702b-4585-9e44-3465cd0c2351" escape="true"><div style="margin-bottom:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt is summarized as follows:</span></div><div style="margin-bottom:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:58.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.487%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.490%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of <ix:nonFraction unitRef="number" contextRef="i0a1f89fa820b46799ce79a937450f547_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90YWJsZTpkZTE0ODFlODlhYzQ0OTk4ODk5MTBkOGUwMWM5NWUzYi90YWJsZXJhbmdlOmRlMTQ4MWU4OWFjNDQ5OTg4OTkxMGQ4ZTAxYzk1ZTNiXzEtMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo1YzEyM2RhN2U1M2U0NWNiYjVhOTgzOTg5ZGM2MmZjNF8yNA_2d1025a5-30cd-485e-a94f-933327a9806b">4.50</ix:nonFraction>% exchangeable senior notes due 2023 </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia43fd9d7d0184bf48d0ca7e30b92fe15_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90YWJsZTpkZTE0ODFlODlhYzQ0OTk4ODk5MTBkOGUwMWM5NWUzYi90YWJsZXJhbmdlOmRlMTQ4MWU4OWFjNDQ5OTg4OTkxMGQ4ZTAxYzk1ZTNiXzEtMi0xLTEtMjM0NTg_ba03a3e0-2254-4f5e-ac12-215a4f593078">143,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfaa054052d14e7a8ca1f2c58126ec2e_I20201231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90YWJsZTpkZTE0ODFlODlhYzQ0OTk4ODk5MTBkOGUwMWM5NWUzYi90YWJsZXJhbmdlOmRlMTQ4MWU4OWFjNDQ5OTg4OTkxMGQ4ZTAxYzk1ZTNiXzEtNC0xLTEtMjM0NTg_5410f60f-df2b-4882-8fbc-eb3c8c63c84f">143,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: unamortized debt discount and issuance costs, net </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4dc9b8e4c33d47f78a2c32f6fc5be381_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90YWJsZTpkZTE0ODFlODlhYzQ0OTk4ODk5MTBkOGUwMWM5NWUzYi90YWJsZXJhbmdlOmRlMTQ4MWU4OWFjNDQ5OTg4OTkxMGQ4ZTAxYzk1ZTNiXzItMi0xLTEtMjM0NTg_aa6e38a1-42a8-46fa-9f94-cf5a5de0f351">1,353</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b007cff8b974e868c3993f562d9feaf_I20201231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90YWJsZTpkZTE0ODFlODlhYzQ0OTk4ODk5MTBkOGUwMWM5NWUzYi90YWJsZXJhbmdlOmRlMTQ4MWU4OWFjNDQ5OTg4OTkxMGQ4ZTAxYzk1ZTNiXzItNC0xLTEtMjM0NTg_00513137-ccc2-4f83-b619-b5afb77ad7e6">15,540</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dc9b8e4c33d47f78a2c32f6fc5be381_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90YWJsZTpkZTE0ODFlODlhYzQ0OTk4ODk5MTBkOGUwMWM5NWUzYi90YWJsZXJhbmdlOmRlMTQ4MWU4OWFjNDQ5OTg4OTkxMGQ4ZTAxYzk1ZTNiXzMtMi0xLTEtMjM0NTg_88571dd3-282b-4535-8bc2-4a20f2bf7927">142,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b007cff8b974e868c3993f562d9feaf_I20201231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90YWJsZTpkZTE0ODFlODlhYzQ0OTk4ODk5MTBkOGUwMWM5NWUzYi90YWJsZXJhbmdlOmRlMTQ4MWU4OWFjNDQ5OTg4OTkxMGQ4ZTAxYzk1ZTNiXzMtNC0xLTEtMjM0NTg_08cc14dc-a90c-4651-9e96-768b6a3b130d">128,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: current maturities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90YWJsZTpkZTE0ODFlODlhYzQ0OTk4ODk5MTBkOGUwMWM5NWUzYi90YWJsZXJhbmdlOmRlMTQ4MWU4OWFjNDQ5OTg4OTkxMGQ4ZTAxYzk1ZTNiXzQtMi0xLTEtMjM0NTg_ed7b67ca-ae93-4b04-98d4-e8aaa4db984a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90YWJsZTpkZTE0ODFlODlhYzQ0OTk4ODk5MTBkOGUwMWM5NWUzYi90YWJsZXJhbmdlOmRlMTQ4MWU4OWFjNDQ5OTg4OTkxMGQ4ZTAxYzk1ZTNiXzQtNC0xLTEtMjM0NTg_da2895a6-6efe-45d8-85ac-9914d890bca9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90YWJsZTpkZTE0ODFlODlhYzQ0OTk4ODk5MTBkOGUwMWM5NWUzYi90YWJsZXJhbmdlOmRlMTQ4MWU4OWFjNDQ5OTg4OTkxMGQ4ZTAxYzk1ZTNiXzUtMi0xLTEtMjM0NTg_f25b6cb7-30bf-4491-9a32-a2b9144bb376">142,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90YWJsZTpkZTE0ODFlODlhYzQ0OTk4ODk5MTBkOGUwMWM5NWUzYi90YWJsZXJhbmdlOmRlMTQ4MWU4OWFjNDQ5OTg4OTkxMGQ4ZTAxYzk1ZTNiXzUtNC0xLTEtMjM0NTg_e55cef84-5e25-4cff-8a74-866ed0ba8f6e">128,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity component:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity component of exchangeable notes, net of issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dc9b8e4c33d47f78a2c32f6fc5be381_I20211231" decimals="-3" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90YWJsZTpkZTE0ODFlODlhYzQ0OTk4ODk5MTBkOGUwMWM5NWUzYi90YWJsZXJhbmdlOmRlMTQ4MWU4OWFjNDQ5OTg4OTkxMGQ4ZTAxYzk1ZTNiXzgtMi0xLTEtMjM0NTg_92e819a0-aa67-4a81-bb16-b5db3a824e46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b007cff8b974e868c3993f562d9feaf_I20201231" decimals="-3" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90YWJsZTpkZTE0ODFlODlhYzQ0OTk4ODk5MTBkOGUwMWM5NWUzYi90YWJsZXJhbmdlOmRlMTQ4MWU4OWFjNDQ5OTg4OTkxMGQ4ZTAxYzk1ZTNiXzgtNC0xLTEtMjM0NTg_ef50000d-e57d-43fe-9f6b-4a48961da6e9">26,699</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2021, 2020 and 2019, the total interest expense was $<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzEwOTk1MTE2Mzc3Nzk_97222a18-451b-4425-ad56-9dbcc32f6b59">9,942</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzEwOTk1MTE2Mzc3OTY_5cb22e30-48d5-4d6f-9c99-7fd46524049d">12,994</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzEwOTk1MTE2Mzc4MTE_5864a938-2b4e-4dba-8de9-acdfad611ed5">12,464</ix:nonFraction>, respectively, with coupon interest expense of $<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="avdl:CouponInterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzEwOTk1MTE2Mzc4MjI_2caaa098-ea9e-48c4-90c5-4a1753c26cc8"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="avdl:CouponInterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzEwOTk1MTE2Mzc4MjI_db5784c0-eb27-49a8-9a30-c42a3e42acfc"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="avdl:CouponInterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzEwOTk1MTE2Mzc4MjI_e0dd0764-46d8-413b-af5a-b3b281cf37bd">6,469</ix:nonFraction></ix:nonFraction></ix:nonFraction> for each period and the amortization of debt issuance costs and debt discount of $<ix:nonFraction unitRef="usd" contextRef="ifd8ea8ce80304018bd5b1979eb26d074_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzEwOTk1MTE2Mzc4Mzg_9dd596d8-87b8-4060-96ac-6bbf0f71d37d">1,248</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i33e06b7a13eb4e85be3a4f81119b68c1_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzEwOTk1MTE2Mzc4NDc_adc9d5b5-c7a6-45d0-b9c4-d4e3798bb241">6,525</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="id9ebe4ca9019413ebb51803e053e035d_D20190101-20191231" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzEwOTk1MTE2Mzc4NTc_45ba64e8-1e21-42f7-b4d5-4acd79e01dc1">5,995</ix:nonFraction>, respectively. Current period interest expense also included $<ix:nonFraction unitRef="usd" contextRef="ibf503e36fd6a429f84871178d6090bcd_D20210101-20211231" decimals="-3" name="avdl:AdditionalInterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzI3NDg3NzkwODI3NjA_c0870ca2-a2e8-46aa-b693-c34b87b2c346">2,225</ix:nonFraction> of additional interest expense owed as a result of not removing a restrictive legend from the 2023 Notes 365 days following original issuance of the 2023 Notes on February 16, 2018. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1: Background and Basis of Presentation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further details.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 2: Newly Issued Accounting Standards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company elected to early adopt ASU 2020-06 as of January 1, 2021 using a modified retrospective method. The adoption resulted in a $<ix:nonFraction unitRef="usd" contextRef="ia03de445d5514be7925f47534612a3c6_I20201231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzI3NDg3NzkwODE3NjU_7d24d454-3cfb-4d74-ae58-b583c7237599">12,939</ix:nonFraction> increase in long-term debt and a $<ix:nonFraction unitRef="usd" contextRef="i27057cf80d054326a72f1357eef1f0c2_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzI3NDg3NzkwODE3Nzc_569dd9b4-b13e-4f6f-9572-71e4e7f1711e">26,699</ix:nonFraction> decrease in the equity component of the 2023 Notes.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 16, 2018, Avadel Finance Cayman Limited, a Cayman Islands exempted company and an indirect wholly-owned subsidiary of the Company (the &#8220;Issuer&#8221;), issued $<ix:nonFraction unitRef="usd" contextRef="i7d1ea1ea40054379a04b6e20ee96f982_I20180216" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzI1Mg_0a9468c0-fc52-45a2-8522-8c5c513cc876">125,000</ix:nonFraction> aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i7d1ea1ea40054379a04b6e20ee96f982_I20180216" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzI4NQ_7e45c9b4-c2d8-40f2-9672-a04142947eef">4.50</ix:nonFraction>% exchangeable senior notes due 2023 (the &#8220;2023 Notes&#8221;) in a private placement (the &#8220;Offering&#8221;) to qualified institutional buyers pursuant to Rule 144A under the Securities Act. In connection with the Offering, the Issuer granted the initial purchasers of the 2023 Notes a 30-day option to purchase up to an additional $<ix:nonFraction unitRef="usd" contextRef="i7d1ea1ea40054379a04b6e20ee96f982_I20180216" decimals="-3" name="avdl:DebtInstrumentOptiontoIncreaseFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzYwNQ_ddc14f86-6b4a-43b4-8326-d6ae69b8d32c">18,750</ix:nonFraction> aggregate principal amount of the 2023 Notes, which was fully exercised on February 16, 2018. Net proceeds received by the Company, after issuance costs and discounts, were approximately $<ix:nonFraction unitRef="usd" contextRef="id653d0c0a8b74c299e04291165d88344_D20180216-20180216" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzc5NQ_e1add4b4-e311-41c9-ac23-daa197a0c10c">137,560</ix:nonFraction>.  The 2023 Notes are the Company&#8217;s senior unsecured obligations and rank equally in right of payment with all of the Company&#8217;s existing and future senior unsecured indebtedness and effectively junior to any of the Company&#8217;s existing and future secured indebtedness, to the extent of the value of the assets securing such indebtedness.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 Notes will be exchangeable at the option of the holders at an initial exchange rate of <ix:nonFraction unitRef="rate" contextRef="i483626a1ca994a1ab8f44a4dd0abd7f7_D20180216-20180216" decimals="INF" name="avdl:AmericanDepositorySharesConversionRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzEyMzA_863fb765-23db-4f66-8666-aab8d3c9b5f8">92.6956</ix:nonFraction> ADSs per $1 principal amount of 2023 Notes, which is equivalent to an initial exchange price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i7d1ea1ea40054379a04b6e20ee96f982_I20180216" decimals="2" name="avdl:AmericanDepositarySharesOptionPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzEzNDM_f673fbf6-f752-4def-b29e-7a1bb1e4b78c">10.79</ix:nonFraction> per ADS. Such initial exchange price represents a premium of approximately <ix:nonFraction unitRef="number" contextRef="i7d1ea1ea40054379a04b6e20ee96f982_I20180216" decimals="4" name="avdl:AmericanDepositarySharesPremiumPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzE0MjE_b369ec26-2cc1-4f49-adbb-a7e3c6d0a42c">20</ix:nonFraction>% to the $<ix:nonFraction unitRef="usdPerShare" contextRef="i7d1ea1ea40054379a04b6e20ee96f982_I20180216" decimals="2" name="avdl:AmericanDepositarySharesPurchasedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzE0MzE_18ba0084-811f-4102-9cd8-4489186d0c5f">8.99</ix:nonFraction> per ADS closing price on The Nasdaq Global Market on February 13, 2018.  Upon the exchange of any 2023 Notes, the Issuer will pay or cause to be delivered, as the case may be, cash, ADSs or a combination of cash and ADSs, at the Issuer&#8217;s election. Holders of the 2023 Notes may convert their 2023 Notes, at their option, only under the following circumstances prior to the close of business on the business day immediately preceding August 1, 2022, under the circumstances and during the periods set forth below and regardless of the conditions described below, on or after August 1, 2022 and prior to the close of business on the business day immediately preceding the maturity date:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prior to the close of business on the business day immediately preceding August 1, 2022, a holder of the 2023 Notes may surrender all or any portion of its 2023 Notes for exchange at any time during the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzIzMjM_cdb5c14c-1181-4685-9a23-0a0887188621">five</span> business day period immediately after any <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzIzNjg_cdf18a29-792e-43e1-baa4-c68eb2cf6a76">five</span> consecutive trading day period (the &#8220;Measurement Period&#8221;) in which the trading price per $1 principal amount of 2023 Notes, as determined following a request by a holder of the 2023 Notes, for each trading day of the measurement period was less than <ix:nonFraction unitRef="number" contextRef="i911b1d37c6734cba9182382fa4082eed_D20180216-20180216" decimals="2" name="avdl:DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzI2MjE_fe25cbc8-3904-4edf-96b5-179455e1fc44">98</ix:nonFraction>% of the product of the last reported sale price of the ADSs and the exchange rate on each such trading day.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If a transaction or event that constitutes a fundamental change or a make-whole fundamental change occurs prior to the close of business on the business day immediately preceding August 1, 2022, regardless of whether a holder of the 2023 Notes has the right to require the Company to repurchase the 2023 Notes, or if Avadel is a party to a merger </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-90-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id10f24c0ce634634ba12b672cabbeb96" continuedAt="i23e875e5a3024baa8b86c4cfc66482bb"><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">event that occurs prior to the close of business on the business day immediately preceding August 1, 2022, all or any portion of a the holder&#8217;s 2023 Notes may be surrendered for exchange at any time from or after the date that is <ix:nonNumeric contextRef="i0cf2ba3d017445f7b369d02baa194a26_D20180216-20180216" name="avdl:DebtInstrumentConvertibleScheduledThresholdTradingDays" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzMzMDk_3d3c6b13-a8c3-442a-bec2-36709bbd01f1">95</ix:nonNumeric> scheduled trading days prior to the anticipated effective date of the transaction (or, if later, the earlier of (x) the business day after the Company gives notice of such transaction and (y) the actual effective date of such transaction) until <ix:nonFraction unitRef="day" contextRef="i0cf2ba3d017445f7b369d02baa194a26_D20180216-20180216" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzM1NTc_7f8db574-9470-4302-aac7-1b20ea74b468">35</ix:nonFraction> trading days after the actual effective date of such transaction or, if such transaction also constitutes a fundamental change, until the related fundamental change repurchase date. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prior to the close of business on the business day immediately preceding August 1, 2022, a holder of the 2023 Notes may surrender all or any portion of its 2023 Notes for exchange at any time during any calendar quarter commencing after the calendar quarter ending on June 30, 2018 (and only during such calendar quarter), if the last reported sale price of the ADSs for at least <ix:nonFraction unitRef="day" contextRef="ic9d6fffe305c44aeb5282edb28b92265_D20180216-20180216" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzQxMjQ_3c67bd76-0bd2-467d-ae53-a426c9ce49f3">20</ix:nonFraction> trading days (whether or not consecutive) during the period of <ix:nonFraction unitRef="day" contextRef="ic9d6fffe305c44aeb5282edb28b92265_D20180216-20180216" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzQxOTA_9c49ea99-64d5-43ca-87e7-c9296bd69e70">30</ix:nonFraction> consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to <ix:nonFraction unitRef="number" contextRef="ic9d6fffe305c44aeb5282edb28b92265_D20180216-20180216" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzQzMzk_00f79741-b968-4513-bce5-36b978422080">130</ix:nonFraction>% of the exchange price on each applicable trading day. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If the Company calls the 2023 Notes for redemption pursuant to Article 16 to the Indenture prior to the close of business on the business day immediately preceding August 1, 2022, then a holder of the 2023 Notes may surrender all or any portion of its 2023 Notes for exchange at any time prior to the close of business on the second business day prior to the redemption date, even if the 2023 Notes are not otherwise exchangeable at such time. After that time, the right to exchange shall expire, unless the Company defaults in the payment of the redemption price, in which case a holder of the 2023 Notes may exchange its 2023 Notes until the redemption price has been paid or duly provided for.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i23e875e5a3024baa8b86c4cfc66482bb" continuedAt="ibbdaeef2be7a46709bee97b27e54d85d"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considered the guidance in ASC 815-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Embedded Derivatives</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to determine if this instrument contains an embedded feature that should be separately accounted for as a derivative. ASC 815 provides for an exception to this rule when convertible notes, as host instruments, are deemed to be conventional, as defined by ASC 815-40. The Company determined that this exception applies due, in part, to its ability to settle the 2023 Notes in cash, ADSs or a combination of cash and ADSs, at the Company&#8217;s option. The Company have therefore applied the guidance provided by ASC 470-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and Other Options, </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibbdaeef2be7a46709bee97b27e54d85d">as amended by ASU 2020-06.</ix:continuation> </span></div><div><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_127"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 12:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="avdl:LongTermContingentConsideraionPayableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjcvZnJhZzpmNWUxYzhmMWZkOGI0YWU4YmUxZGQ5YTk3N2M0MTVhMy90ZXh0cmVnaW9uOmY1ZTFjOGYxZmQ4YjRhZThiZTFkZDlhOTc3YzQxNWEzXzUyNTY_b540913b-3a7e-47e7-889b-d127c2fbe99c" continuedAt="iea0494ae19d1402fbe673385eef8f492" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Consideration Payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></ix:nonNumeric></div><ix:continuation id="iea0494ae19d1402fbe673385eef8f492" continuedAt="ie53d9ab710424af681493a7da489c2f9"><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the sale of the Hospital Products on June 30, 2020, the Company computed the fair value of the contingent consideration using several significant assumptions and when those assumptions changed, due to underlying market conditions, the fair value of these liabilities changed as well. Prior to the sale of the Hospital Products, these changes had a material impact on the Company&#8217;s consolidated statements of (loss) income and balance sheets. As part of the sale of the Hospital Products on June 30, 2020, the Exela Buyer assumed and will pay, perform, satisfy and discharge the liabilities and obligations of Avadel Legacy and the Company under the Deerfield Royalty Agreement and the Broadfin Royalty Agreement. As of December&#160;31, 2021 and 2020, the balance of the contingent consideration payable is $<ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="0" name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjcvZnJhZzpmNWUxYzhmMWZkOGI0YWU4YmUxZGQ5YTk3N2M0MTVhMy90ZXh0cmVnaW9uOmY1ZTFjOGYxZmQ4YjRhZThiZTFkZDlhOTc3YzQxNWEzXzI3NDg3NzkwODYwMjk_bbf4ead9-13e8-4919-a518-6daad028b557"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-6" name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjcvZnJhZzpmNWUxYzhmMWZkOGI0YWU4YmUxZGQ5YTk3N2M0MTVhMy90ZXh0cmVnaW9uOmY1ZTFjOGYxZmQ4YjRhZThiZTFkZDlhOTc3YzQxNWEzXzI3NDg3NzkwODYwMjk_d5acf9c3-4993-41d1-bc1b-18dd1d38c527">0</ix:nonFraction></ix:nonFraction>.</span></div><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjcvZnJhZzpmNWUxYzhmMWZkOGI0YWU4YmUxZGQ5YTk3N2M0MTVhMy90ZXh0cmVnaW9uOmY1ZTFjOGYxZmQ4YjRhZThiZTFkZDlhOTc3YzQxNWEzXzUyNjU_67a8b4cd-6208-4893-8db6-426401a9f314" continuedAt="i32d2173dc05846f08619221e344e8984" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes to the contingent consideration payables, a recurring Level 3 measurement, for the twelve-month periods ended&#160;December 31, 2020&#160;and&#160;2019:</span></div><div><span><br/></span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:78.665%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent Consideration Payable:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie19b226220734349af34ea12f273148b_I20181231" decimals="-3" name="us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjcvZnJhZzpmNWUxYzhmMWZkOGI0YWU4YmUxZGQ5YTk3N2M0MTVhMy90YWJsZTplY2Q5ODIxYTcyYjc0ZDRiOTViYjRlZGIyYTYzYTRiNi90YWJsZXJhbmdlOmVjZDk4MjFhNzJiNzRkNGI5NWJiNGVkYjJhNjNhNGI2XzctMi0xLTEtMjM0NTg_dfc3aabc-b218-45d5-aa95-efdff39f152b">28,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of related party payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjcvZnJhZzpmNWUxYzhmMWZkOGI0YWU4YmUxZGQ5YTk3N2M0MTVhMy90YWJsZTplY2Q5ODIxYTcyYjc0ZDRiOTViYjRlZGIyYTYzYTRiNi90YWJsZXJhbmdlOmVjZDk4MjFhNzJiNzRkNGI5NWJiNGVkYjJhNjNhNGI2XzgtMi0xLTEtMjM0NTg_77d61aa3-a186-4b68-87d2-ea2b708db3e2">12,736</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:LiabilitiesFairValueAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjcvZnJhZzpmNWUxYzhmMWZkOGI0YWU4YmUxZGQ5YTk3N2M0MTVhMy90YWJsZTplY2Q5ODIxYTcyYjc0ZDRiOTViYjRlZGIyYTYzYTRiNi90YWJsZXJhbmdlOmVjZDk4MjFhNzJiNzRkNGI5NWJiNGVkYjJhNjNhNGI2XzktMi0xLTEtMjM0NTg_c7c607e9-67ba-419d-bf25-9ab8fcf64065">1,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73b28a1c0c648e5a6641e1c909996f0_I20191231" decimals="-3" name="us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjcvZnJhZzpmNWUxYzhmMWZkOGI0YWU4YmUxZGQ5YTk3N2M0MTVhMy90YWJsZTplY2Q5ODIxYTcyYjc0ZDRiOTViYjRlZGIyYTYzYTRiNi90YWJsZXJhbmdlOmVjZDk4MjFhNzJiNzRkNGI5NWJiNGVkYjJhNjNhNGI2XzEwLTItMS0xLTIzNDU4_281f893b-0a00-45b7-a335-a14768939f5b">17,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of contingent consideration payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjcvZnJhZzpmNWUxYzhmMWZkOGI0YWU4YmUxZGQ5YTk3N2M0MTVhMy90YWJsZTplY2Q5ODIxYTcyYjc0ZDRiOTViYjRlZGIyYTYzYTRiNi90YWJsZXJhbmdlOmVjZDk4MjFhNzJiNzRkNGI5NWJiNGVkYjJhNjNhNGI2XzExLTItMS0xLTIzNDU4_f57eef26-974d-4def-bdfd-04eb4e2154aa">6,189</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:LiabilitiesFairValueAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjcvZnJhZzpmNWUxYzhmMWZkOGI0YWU4YmUxZGQ5YTk3N2M0MTVhMy90YWJsZTplY2Q5ODIxYTcyYjc0ZDRiOTViYjRlZGIyYTYzYTRiNi90YWJsZXJhbmdlOmVjZDk4MjFhNzJiNzRkNGI5NWJiNGVkYjJhNjNhNGI2XzEyLTItMS0xLTIzNDU4_8cd4b2ea-8b5e-4eb2-97a3-97f078a91cc4">3,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Disposition of the Hospital Products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjcvZnJhZzpmNWUxYzhmMWZkOGI0YWU4YmUxZGQ5YTk3N2M0MTVhMy90YWJsZTplY2Q5ODIxYTcyYjc0ZDRiOTViYjRlZGIyYTYzYTRiNi90YWJsZXJhbmdlOmVjZDk4MjFhNzJiNzRkNGI5NWJiNGVkYjJhNjNhNGI2XzEzLTItMS0xLTIzNDU4_ac7d6249-96f3-432b-a0c0-17954a7d2fb6">14,900</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjcvZnJhZzpmNWUxYzhmMWZkOGI0YWU4YmUxZGQ5YTk3N2M0MTVhMy90YWJsZTplY2Q5ODIxYTcyYjc0ZDRiOTViYjRlZGIyYTYzYTRiNi90YWJsZXJhbmdlOmVjZDk4MjFhNzJiNzRkNGI5NWJiNGVkYjJhNjNhNGI2XzE0LTItMS0xLTIzNDU4_ad2b70d5-6069-4005-8e95-80ccba699bd4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"><ix:continuation id="ie53d9ab710424af681493a7da489c2f9" continuedAt="ia7f478575b374ade9e59ec26c9c3c0bb"><ix:continuation id="i32d2173dc05846f08619221e344e8984" continuedAt="i10cbea2104cc4bb3b5612cc7cbe2d44d">(1) </ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia7f478575b374ade9e59ec26c9c3c0bb"><ix:continuation id="i10cbea2104cc4bb3b5612cc7cbe2d44d">Fair value adjustments are reported as changes in fair value of contingent consideration and other expense - changes in fair value of contingent consideration payable in the consolidated statements of (loss) income.</ix:continuation></ix:continuation> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-91-</span></div></div></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 13:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzk2NTk_54a8239a-6937-480b-a87f-34b995a5ac8e" continuedAt="ibc9d3b3cb9bb48b08b679ed6588bcd06" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="ibc9d3b3cb9bb48b08b679ed6588bcd06" continuedAt="ia0852a47f5c447c6b1a7379b63df437b"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="avdl:ScheduleOfComponentsOfIncomeBeforeIncomeTaxTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzk2NjQ_79dfd548-d73b-4d51-a193-e36fc53b609d" escape="true"><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of loss before income taxes for the years ended twelve months ended December 31, are as follows:&#160;</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:48.679%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.909%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Loss Before Income Taxes:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74b20dd17dcf4f36b4f73cfd680e44c9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmMGNjY2E5MDlmZWI0NDY0YmU3NmRjODZlNGZlYWU1NC90YWJsZXJhbmdlOmYwY2NjYTkwOWZlYjQ0NjRiZTc2ZGM4NmU0ZmVhZTU0XzItMi0xLTEtMjM0NTg_eb8ed09a-00bb-40a9-aa27-2b9f7696d985">36,631</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1798461a2fc34d85ace6dea31e0f8881_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmMGNjY2E5MDlmZWI0NDY0YmU3NmRjODZlNGZlYWU1NC90YWJsZXJhbmdlOmYwY2NjYTkwOWZlYjQ0NjRiZTc2ZGM4NmU0ZmVhZTU0XzItNC0xLTEtMjM0NTg_a52e9510-9596-4e0f-8750-7735eacbb47e">27,205</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08b7b375f4d048c9ab8e6d5fd7ea7ea5_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmMGNjY2E5MDlmZWI0NDY0YmU3NmRjODZlNGZlYWU1NC90YWJsZXJhbmdlOmYwY2NjYTkwOWZlYjQ0NjRiZTc2ZGM4NmU0ZmVhZTU0XzItNi0xLTEtMjM0NTg_0da6217c-8bbe-46ef-8bb7-8c71b4327fd3">50,134</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie59a27f48eeb44b5bb24636fb8639702_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmMGNjY2E5MDlmZWI0NDY0YmU3NmRjODZlNGZlYWU1NC90YWJsZXJhbmdlOmYwY2NjYTkwOWZlYjQ0NjRiZTc2ZGM4NmU0ZmVhZTU0XzMtMi0xLTEtMjM0NTg_c9f2f103-05f9-4f5f-b935-7da5b500f29b">56,687</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13a6499a4aea49bfbc0d46162aaf1ebe_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmMGNjY2E5MDlmZWI0NDY0YmU3NmRjODZlNGZlYWU1NC90YWJsZXJhbmdlOmYwY2NjYTkwOWZlYjQ0NjRiZTc2ZGM4NmU0ZmVhZTU0XzMtNC0xLTEtMjM0NTg_423be182-f373-44eb-9a37-6ae7e608cdd3">22,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4590886cb1c49159327f4cd498c421f_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmMGNjY2E5MDlmZWI0NDY0YmU3NmRjODZlNGZlYWU1NC90YWJsZXJhbmdlOmYwY2NjYTkwOWZlYjQ0NjRiZTc2ZGM4NmU0ZmVhZTU0XzMtNi0xLTEtMjM0NTg_eaa1c740-3a80-4117-bf13-018e3ac189ea">10,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i537c662c0452407d996503d13075eee0_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmMGNjY2E5MDlmZWI0NDY0YmU3NmRjODZlNGZlYWU1NC90YWJsZXJhbmdlOmYwY2NjYTkwOWZlYjQ0NjRiZTc2ZGM4NmU0ZmVhZTU0XzQtMi0xLTEtMjM0NTg_831316d5-4397-4935-8bfd-6199845d6ee1">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3e2739e702347078b4ee9a8124ae398_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmMGNjY2E5MDlmZWI0NDY0YmU3NmRjODZlNGZlYWU1NC90YWJsZXJhbmdlOmYwY2NjYTkwOWZlYjQ0NjRiZTc2ZGM4NmU0ZmVhZTU0XzQtNC0xLTEtMjM0NTg_526e4709-9948-4401-a8a9-521b2e589c53">212</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64421d34a1204f448424959b78e8a9d8_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmMGNjY2E5MDlmZWI0NDY0YmU3NmRjODZlNGZlYWU1NC90YWJsZXJhbmdlOmYwY2NjYTkwOWZlYjQ0NjRiZTc2ZGM4NmU0ZmVhZTU0XzQtNi0xLTEtMjM0NTg_a557dcee-b23b-461c-9d5e-b942169601be">1,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total loss before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmMGNjY2E5MDlmZWI0NDY0YmU3NmRjODZlNGZlYWU1NC90YWJsZXJhbmdlOmYwY2NjYTkwOWZlYjQ0NjRiZTc2ZGM4NmU0ZmVhZTU0XzUtMi0xLTEtMjM0NTg_f338323e-cc49-4c96-b5d3-a62cffa1a720">93,145</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmMGNjY2E5MDlmZWI0NDY0YmU3NmRjODZlNGZlYWU1NC90YWJsZXJhbmdlOmYwY2NjYTkwOWZlYjQ0NjRiZTc2ZGM4NmU0ZmVhZTU0XzUtNC0xLTEtMjM0NTg_3df1b8a9-9723-4844-93fb-21c428b378e0">5,082</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmMGNjY2E5MDlmZWI0NDY0YmU3NmRjODZlNGZlYWU1NC90YWJsZXJhbmdlOmYwY2NjYTkwOWZlYjQ0NjRiZTc2ZGM4NmU0ZmVhZTU0XzUtNi0xLTEtMjM0NTg_50b3e3a7-c7df-49ca-97e7-45206328c69a">38,582</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="avdl:ScheduleOfIncomeTaxPaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzk2Njc_dfdb8586-a903-4cb6-b197-1bb97c8f67d2" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax benefit consists of the following for the years ended December 31:&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:48.679%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.909%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Income Tax Benefit:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. - Federal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzMtMi0xLTEtMjM0NTg_858e5c04-66da-4ca4-93f6-b75e10063d73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzMtNC0xLTEtMjM0NTg_caea17cb-e44f-4819-ae3d-9df4525fa8f7">12,810</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzMtNi0xLTEtMjM0NTg_0f6b0a25-4579-4439-b2f1-71742d028198">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. - State</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzQtMi0xLTEtMjM0NTg_f0aa2a6b-c5bb-4cd9-9c22-4a53898ac96b">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzQtNC0xLTEtMjM0NTg_1fdecbc1-4465-4fbf-9d1e-5cac9e8ad1d9">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzQtNi0xLTEtMjM0NTg_569813cd-e6a0-401b-8351-a57da88c440b">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzYtMi0xLTEtMjM0NTg_c860094b-c44e-463a-a7ce-5f0009edbd09">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzYtNC0xLTEtMjM0NTg_e853cf8a-dcb3-4fd6-86f7-e1266fac0beb">12,790</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzYtNi0xLTEtMjM0NTg_be445f21-0b07-4bea-8b52-84de95b001c1">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzktMi0xLTEtMjM0NTg_152373fc-c353-491c-87ee-0ccda8c283d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzktNC0xLTEtMjM0NTg_969c04a6-f6d4-4a20-9571-d0e1a6dcf899">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzktNi0xLTEtMjM0NTg_98f27f90-575f-4bb6-ad31-86a31629f25e">1,256</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. - Federal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzEwLTItMS0xLTIzNDU4_64b70ae8-eadf-4f63-b215-385493a51beb">15,876</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzEwLTQtMS0xLTIzNDU4_444e5730-8e17-4bee-9385-d18658141668">680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzEwLTYtMS0xLTIzNDU4_2d3f94e4-c369-454a-80c5-a437afcdd654">4,093</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. - State</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzExLTItMS0xLTIzNDU4_cd30d3fb-cd81-488b-8887-aad71ad939a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzExLTQtMS0xLTIzNDU4_93aa1492-b66a-494c-93fc-015c41c0de25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzExLTYtMS0xLTIzNDU4_7a30fe29-02e5-4e12-bd57-e3b2196dc42a">104</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzEzLTItMS0xLTIzNDU4_093b25f4-40f0-4186-86a8-1a3339ea7ef6">15,876</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzEzLTQtMS0xLTIzNDU4_49e15acd-478d-4f3e-a686-7a07b64c3c8d">680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzEzLTYtMS0xLTIzNDU4_4e1bf8e7-95ff-4a53-8b21-d65273eac532">5,453</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzE1LTItMS0xLTIzNDU4_a4cdf218-96a1-4b41-b82a-1d7720ba6625">15,816</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzE1LTQtMS0xLTIzNDU4_da36ab78-b73d-41c8-b917-6364d139fbc9">12,110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzE1LTYtMS0xLTIzNDU4_13263a2f-a707-4285-bf91-1c628703b302">5,356</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;<ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzk2Nzc_54d7b0e8-39fa-4e1b-a907-3b610cf074a2" continuedAt="i6f605b17d06a45fcb2cebc4172605cf7" escape="true">The reconciliation between income taxes at the statutory rate and the Company&#8217;s benefit for income taxes is as follows for the years ended December 31:&#160;</ix:nonNumeric></span></div><div style="margin-bottom:4pt;text-align:justify"><ix:continuation id="i6f605b17d06a45fcb2cebc4172605cf7"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:48.679%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.909%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Reconciliation to Effective Income Tax Rate:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit - at statutory tax rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzE3LTItMS0xLTIzNDU4_a962862e-fdc2-403f-9560-f2da7a413a1f">11,642</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzE3LTQtMS0xLTIzNDU4_23b9864b-11b6-4388-b344-b98d93849de0">636</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzE3LTYtMS0xLTIzNDU4_46f9982f-c4bd-41f6-940e-b9b368b9bd2f">4,823</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Differences in international tax rates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzE4LTItMS0xLTIzNDU4_e5bcde47-2c71-4b89-bb6f-fcec7f1c7f6d">8,950</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzE4LTQtMS0xLTIzNDU4_9e8f62ea-4ebb-43ba-8904-7fa862b90ec8">1,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzE4LTYtMS0xLTIzNDU4_bd2ab610-04a8-454e-a7ab-edaec4628662">1,218</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nondeductible changes in fair value of contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzE5LTItMS0xLTIzNDU4_240321fd-152d-40f4-9593-68f343e2d3df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzE5LTQtMS0xLTIzNDU4_45ef7a7b-4683-4527-ae21-8270de6bbd22">988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzE5LTYtMS0xLTIzNDU4_1ac9caac-822d-4d68-9bfc-bba02ca37c40">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intercompany asset transfer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="avdl:EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzIwLTItMS0xLTIzNDU4_fa93fd8b-59ba-4730-9274-c482e4a3054a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="avdl:EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzIwLTQtMS0xLTIzNDU4_ad3f1a4e-8056-4a45-b952-c42124407862">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="avdl:EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzIwLTYtMS0xLTIzNDU4_763c8ead-702d-4308-825a-29711434880b">8,190</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in valuation allowances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzIxLTItMS0xLTIzNDU4_380137d8-7294-4008-b468-4d3317b1a022">4,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzIxLTQtMS0xLTIzNDU4_de6a00f8-ca75-4b43-b8a7-265b97882b1c">4,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzIxLTYtMS0xLTIzNDU4_2c78f2be-d206-42b8-872a-0e61b9ef4c4d">7,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nondeductible share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzIyLTItMS0xLTIzNDU4_0f58dcc1-2c27-4f16-96d5-f1da84444d4d">645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzIyLTQtMS0xLTIzNDU4_aa3283a8-c038-4aa5-9fa0-1f58d70435f9">1,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzIyLTYtMS0xLTIzNDU4_7c1ffa1a-c542-4d2f-ad41-b4ced4e2c08e">1,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hospital Products sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzIzLTItMS0xLTIzNDU4_47ed4a70-7435-43d7-9ded-74c68dbd306d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzIzLTQtMS0xLTIzNDU4_0e793610-7954-487c-92fb-c540a09d1dd8">9,328</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzIzLTYtMS0xLTIzNDU4_fec715e2-621c-492b-8fb8-6bb1f9b6fef7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized tax benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI0LTItMS0xLTIzNDU4_9dde6212-16c8-4342-802a-940142841fbd">239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI0LTQtMS0xLTIzNDU4_f5b67a15-69ba-4454-9c9d-384adc10abcf">274</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI0LTYtMS0xLTIzNDU4_e5cb07fc-74f0-4f2a-b326-b44588a71616">261</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State and local taxes (net of federal)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI1LTItMS0xLTIzNDU4_72b9dff1-efb9-4446-95d7-0f82c262dd79">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI1LTQtMS0xLTIzNDU4_c690732d-22c5-4faa-a9c9-f31870336ede">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI1LTYtMS0xLTIzNDU4_f4f92c2a-88aa-4a60-a4b9-c1532d0a9686">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in U.S. tax law</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI2LTItMS0xLTIzNDU4_61955442-abe0-4903-b41f-0b4b9d736f65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI2LTQtMS0xLTIzNDU4_82011bf7-5efd-4f22-b7f3-afaaa78a4283">9,124</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI2LTYtMS0xLTIzNDU4_fd054c73-0a17-472c-bd4f-09b5d8fdd650">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nondeductible interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="avdl:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI3LTItMS0xLTIzNDU4_bc19b7ef-c9c8-4eb8-a187-f17cbfd2ba5f">2,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="avdl:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI3LTQtMS0xLTIzNDU4_2a11e517-0c61-4820-9aac-03db064c5133">1,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="avdl:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI3LTYtMS0xLTIzNDU4_422a1cbf-4782-4839-92e9-9670298e821d">982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Orphan drug and R&amp;D tax credit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="avdl:EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI4LTItMS0xLTIzNDU4_6f9d65f5-0e8c-440c-83c3-8d27094cb151">1,524</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="avdl:EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI4LTQtMS0xLTIzNDU4_c92d3f59-9537-4320-8279-03884e3f51c3">2,793</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="avdl:EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI4LTYtMS0xLTIzNDU4_b60b16c2-850d-4a36-b311-1f46fbcd383c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI5LTItMS0xLTIzNDU4_2308ce82-5b63-4dab-9a44-b8d8730ec07c">1,113</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI5LTQtMS0xLTIzNDU4_68187f8e-291e-44e1-836a-fd387cc0e71d">263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI5LTYtMS0xLTIzNDU4_00e386d8-752b-4875-be08-7262e5cd6234">378</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit - at effective income tax rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzMwLTItMS0xLTIzNDU4_5db7dd14-dd07-46d8-b711-3a4f33832c3f">15,816</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzMwLTQtMS0xLTIzNDU4_179228d0-6960-443d-a0b4-af46ef628394">12,110</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzMwLTYtMS0xLTIzNDU4_5b8a4f41-96de-400e-8382-5354c5b00a84">5,356</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the income tax benefit increased by $<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="avdl:IncreaseDecreaseInIncomeTaxBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzI3NDg3NzkwODgxMTM_96894e1e-3eec-4aa7-b503-539119b56bef">3,706</ix:nonFraction> when compared to the same period in 2020. The increase in the income tax benefit in 2021 was primarily driven by the additional tax benefit from an increase in the net operating losses in the U.S. in 2021, when compared to the same period in 2020. This was partially offset by the nonrecurring nature of tax benefits recognized in 2020 from the sale of the Company&#8217;s Hospital Products and passage of the Coronavirus Aid, Relief and Economic Security Act (the &#8220;CARES Act&#8221;) in the U.S.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-92-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ia0852a47f5c447c6b1a7379b63df437b" continuedAt="id90b8da6d3ae479dbe880d31622f5b92"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the income tax benefit increased by $<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="avdl:IncreaseDecreaseInIncomeTaxBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzQ1NQ_ebc45505-f911-4843-bb3a-6b6114bdbe79">6,754</ix:nonFraction> when compared to the same period in 2019. The increase in the income tax benefit in 2020 was primarily driven by the tax benefits from the sale of the Company&#8217;s Hospital Products and passage of the CARES Act in the U.S. The Company recorded additional tax benefit in 2020 from the Orphan Drug and R&amp;D tax credit in the U.S. Tax benefit from the intercompany asset transfer recorded in 2019 did not recur, resulting in a partial offset of tax benefits described above.  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unrecognized Tax Benefits</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company or one of its subsidiaries files income tax returns in Ireland, France, U.S. and various states. The Company is no longer subject to Irish, French, U.S. Federal, and state and local examinations for years before 2017. During 2020, the Company completed the 2015 through 2017 U.S. Federal Tax Audit. Completion of the audit resulted in an assessment of $<ix:nonFraction unitRef="usd" contextRef="idaf12fbafde84863931c23859cbdb5da_I20201231" decimals="-3" name="us-gaap:BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzIzMTM_0ae7d7f8-3e2b-4de2-9a31-0103511d61b6">1,937</ix:nonFraction> for the 2015 through 2017 U.S. Federal Tax Returns compared to the IRS Claims of $<ix:nonFraction unitRef="usd" contextRef="ia27d598a536e49f8a6849f6207c5e949_I20190702" decimals="-3" name="us-gaap:BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzIzOTc_f3547371-4aa8-4250-807a-a3ebf684b9fb">50,695</ix:nonFraction> made on July 2, 2019 and the updated IRS Claims of $<ix:nonFraction unitRef="usd" contextRef="i7cf4dc7580ba45efa635d0308b128ae0_I20191002" decimals="-3" name="us-gaap:BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzI0NTE_3f148bad-4825-46fb-812b-dfa01ca7eece">9,302</ix:nonFraction> on October 2, 2019 made as part of the Specialty Pharma bankruptcy proceedings, which at this time does not include interest and penalties.  </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzk2Njg_f909a677-fe43-4b27-82a2-cf062fd0238e" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the Company&#8217;s unrecognized tax benefits for the twelve months ended </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:48.679%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.909%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Unrecognized Tax Benefit Activity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at January 1: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzItMi0xLTEtMjM0NTg_d3343f3c-acdb-4820-8d3b-dc61edef6951">3,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73b28a1c0c648e5a6641e1c909996f0_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzItNC0xLTEtMjM0NTg_12391580-c3e8-446f-8997-c7dd4b46bb38">6,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie19b226220734349af34ea12f273148b_I20181231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzItNi0xLTEtMjM0NTg_a9793635-ed03-4085-93d2-2c07433e7622">5,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increases for tax positions of prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzQtMi0xLTEtMjM0NTg_f51f9660-b920-437a-85e3-29f7a60c8207">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzQtNC0xLTEtMjM0NTg_11f9cc77-e59f-49b6-9647-c71e61fab413">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzQtNi0xLTEtMjM0NTg_2745f4d3-1560-4f7f-80e7-c813959e35b2">2,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Statute of limitations expiration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzUtMi0xLTEtMjM0NTg_d6c03053-c801-44e4-aff5-5b9ee636ec45">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzUtNC0xLTEtMjM0NTg_b4969714-2464-4253-be85-bc3fb0b1163a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzUtNi0xLTEtMjM0NTg_f5d16c0a-2ebf-46e2-b115-ed6afc640bb6">1,266</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzYtMi0xLTEtMjM0NTg_1d8d363d-a9c3-4d90-98aa-7b4561c686d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzYtNC0xLTEtMjM0NTg_c47e1742-9685-4dc3-8941-2e530077a200">3,322</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzYtNi0xLTEtMjM0NTg_404739db-8ea9-43ff-8cc6-02a08473297e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzctMi0xLTEtMjM0NTg_c98d8b21-05b4-419b-88de-a70a88e61747">3,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzctNC0xLTEtMjM0NTg_dbd8d282-e97f-4dd0-ad81-7225d2883e5a">3,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73b28a1c0c648e5a6641e1c909996f0_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzctNi0xLTEtMjM0NTg_77d06cca-546d-44b3-8b18-a10aae2767c5">6,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects that within the next twelve months the unrecognized tax benefits could decrease by an immaterial amount and the interest could increase by an immaterial amount.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021, 2020 and 2019, there are $<ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzMxMjU_b99711b8-d6f5-435a-beab-d2f50980d622">2,483</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzMxMjk_9c2cd5a8-6509-479d-b904-7376642286b6">2,483</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ie73b28a1c0c648e5a6641e1c909996f0_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzMxMzY_a9432cf4-1213-4d3f-9001-4c080c103e2c">3,806</ix:nonFraction> of unrecognized tax benefits that if recognized would affect the annual effective tax rate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes interest and penalties accrued related to unrecognized tax benefits in income tax expense.  During the years ended December&#160;31, 2021, 2020 and 2019, the Company recognized approximately $<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzM0MjY_a7870a2a-9003-414d-bf7f-ec2e4794ce65">239</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzM0MzA_b1f7288f-6105-4a83-99f4-6878ef0a6620">203</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzM0Mzc_105805ee-7b43-4901-8753-8afab4d5f176">555</ix:nonFraction> in interest and penalties. The Company had approximately $<ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzM0OTg_e42a465f-0070-406d-bb17-731200e84b25">1,777</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzM1MDU_3b7cb2c6-d5ac-436f-977f-dd19235972ce">1,475</ix:nonFraction> for the payment of interest and penalties accrued at December&#160;31, 2021 and 2020, respectively. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-93-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="id90b8da6d3ae479dbe880d31622f5b92" continuedAt="i8d97d01058204b2b9d9bd991d0e59bb3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Tax Assets (Liabilities)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income tax provisions reflect the effect of temporary differences between consolidated financial statement and tax reporting of income and expense items.  <ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzk2NzA_6b7a8011-70a2-427a-b994-624f54aa7f5c" continuedAt="ife6748305951495e8fa6748287f6f777" escape="true">The net deferred tax assets (liabilities) at December&#160;31, 2021 and 2020 resulted from the following temporary differences:&#160;</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="ife6748305951495e8fa6748287f6f777"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.353%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Net Deferred Tax Assets and Liabilities: </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzMtMi0xLTEtMjM0NTg_fc51cdb7-8406-4958-9621-d240e83b3e68">35,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzMtNC0xLTEtMjM0NTg_83c89ac4-fade-430a-bb90-411b917104a2">31,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Orphan drug and R&amp;D tax credit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="avdl:DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzQtMi0xLTEtMjM0NTg_695aff11-0eda-488b-a122-473e345074bb">4,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="avdl:DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzQtNC0xLTEtMjM0NTg_b0545bb0-801f-4d8c-9465-6b9733690188">2,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzUtMi0xLTEtMjM0NTg_8c17ad9f-7682-497e-9509-f0854f99ed60">4,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzUtNC0xLTEtMjM0NTg_76512127-a8bc-4732-8cc9-52948affd19b">2,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="avdl:DeferredTaxAssetsAmortizationofIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzYtMi0xLTEtMjM0NTg_f868f16c-6ee9-4b31-9fcc-9bb9affd6661">3,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="avdl:DeferredTaxAssetsAmortizationofIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzYtNC0xLTEtMjM0NTg_1ca50cb7-34e3-41b8-80e0-48987dc833ff">3,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzktMi0xLTEtMjM0NTg_40e82c63-ff2c-457e-9d29-75ef067c85c8">662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzktNC0xLTEtMjM0NTg_9d127948-fdfa-420d-b8e0-ec0a7d97b5d8">423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzEwLTItMS0xLTIzNDU4_b82966c9-1bd0-442d-95a2-bb4af705d400">49,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzEwLTQtMS0xLTIzNDU4_65f58952-b4b9-4c9a-a0a5-3078aa75be88">40,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzEzLTItMS0xLTIzNDU4_f880c218-c808-441f-adb5-917969cdd638">925</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzEzLTQtMS0xLTIzNDU4_91206e64-4136-4cd8-a2da-4b919f02c5d3">890</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPrepaidExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzE0LTItMS0xLTIzNDU4_372a6a76-2270-411c-a9bf-7c9f1900f3b1">75</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPrepaidExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzE0LTQtMS0xLTIzNDU4_932fc991-9a72-4328-afdf-e97183943bcf">75</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzE2LTItMS0xLTIzNDU4_8d8c78d6-713a-4313-be04-9ef9940e7729">1,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzE2LTQtMS0xLTIzNDU4_f44ea2a8-98fe-420e-a237-a42477625f24">965</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: valuation allowances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzE4LTItMS0xLTIzNDU4_833edfff-a927-4340-94d2-79b2bea5c961">24,025</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzE4LTQtMS0xLTIzNDU4_73ef55b0-d69d-4ce0-a78c-7c07f1683d6d">21,624</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred tax assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzIwLTItMS0xLTIzNDU4_3d267d72-5314-4569-8ab5-3288e65710ef">24,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzIwLTQtMS0xLTIzNDU4_970cf692-6b2d-4777-80f2-c1e5160a7f1d">18,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At December 31, 2021, the Company had $<ix:nonFraction unitRef="usd" contextRef="i0729539c1221405f81e7676478827e0e_I20211231" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzM5NDU_cc70dd95-7d3e-42b9-be80-43d422b4ea20">124,720</ix:nonFraction> of net operating losses in Ireland that do not have an expiration date and $<ix:nonFraction unitRef="usd" contextRef="ib32f28d9fbb54bab90164eb85e585915_I20211231" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzQwMjM_d0b9dd13-7e6c-4602-b489-6f4dc17793a1">74,406</ix:nonFraction> of net operating losses in the U.S.  Of the $<ix:nonFraction unitRef="usd" contextRef="ib32f28d9fbb54bab90164eb85e585915_I20211231" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzQwNzA_aa24cb80-8d84-4d20-8871-05fb7c53383d">74,406</ix:nonFraction> of net operating losses in the U.S., $<ix:nonFraction unitRef="usd" contextRef="i94f0c3f367384e14bdd26826dd6b02fd_I20211231" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzQxMTA_2473f84e-bc75-43b8-a67b-838395ece606">10,365</ix:nonFraction> were acquired due to the acquisition of FSC Therapeutics and FSC Laboratories, Inc., (collectively &#8220;FSC&#8221;) and $<ix:nonFraction unitRef="usd" contextRef="if8fc76361f664419bb4b6bec6e9f55d1_I20211231" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzQxNjE_c6f5e162-e8c9-4968-8396-05f77ead22d0">64,041</ix:nonFraction> are due to the losses at US Holdings.&#160;The portion due to the acquisition of FSC will expire in 2034 through 2035. A valuation allowance is recorded if, based on the weight of available evidence, it is more likely than not that a deferred tax asset will not be realized. This assessment is based on an evaluation of the level of historical taxable income and projections for future taxable income.  For the year ended December 31, 2021, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="i0729539c1221405f81e7676478827e0e_I20211231" decimals="-3" name="us-gaap:OperatingLossCarryforwardsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzQ3NDI_eb2606a4-b19f-4068-8fd4-17123903de68">4,045</ix:nonFraction> of valuation allowances related to Irish net operating losses. The U.S. net operating losses are subject to an annual limitation as a result of the FSC acquisition under Internal Revenue Code Section 382 and will not be fully utilized before they expire.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a valuation allowance against all of its net operating losses in Ireland and France as of December 31, 2021 and 2020. The Company intends to continue maintaining a full valuation allowance on the Irish net operating losses until there is sufficient evidence to support the reversal of all or some portion of these allowances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company believes it is more likely than not that it will be able to realize the deferred tax assets in the U.S., the Company continues to monitor any unfavorable changes that could ultimately impact its assessment of the realizability of the Company&#8217;s U.S. deferred tax assets.  If the Company experiences an ownership change under Internal Revenue Code Section 382, the U.S. net operating losses could also be limited in their utilization.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, the Company has unremitted earnings of $<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:UndistributedEarnings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzYxNjg_1ff0d9e0-ce27-4e07-a16a-c0765deb46d0">3,916</ix:nonFraction> outside of Ireland as measured on a U.S. GAAP basis.  Whereas the measure of earnings for purposes of taxation of a distribution may be different for tax purposes, these earnings, which are considered to be invested indefinitely, would become subject to income tax if they were remitted as dividends or if the Company were to sell its stock in the subsidiaries, net of any prior income taxes paid. It is not practicable to estimate the amount of deferred tax liability on such earnings, if any.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">R&amp;D Tax Credits Receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The French and Irish governments provide tax credits to companies for spending on innovative R&amp;D.  These credits are recorded as an offset of R&amp;D expenses and are credited against income taxes payable in years after being incurred or, if not so utilized, are recoverable in cash after a specified period of time, which may differ depending on the tax credit regime.  As of December 31, 2021, the Company&#8217;s net research tax credit receivable amounts to $<ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzcxMjk_e7159647-0fe9-4802-8289-20e852236d6f">3,668</ix:nonFraction> and represents a French gross research </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-94-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8d97d01058204b2b9d9bd991d0e59bb3"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tax credit of $<ix:nonFraction unitRef="usd" contextRef="i537c662c0452407d996503d13075eee0_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzcxODU_91de440f-f225-4288-a180-2feb4bada006">3,139</ix:nonFraction> and an Irish gross research tax credit of $<ix:nonFraction unitRef="usd" contextRef="i74b20dd17dcf4f36b4f73cfd680e44c9_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzcyMzA_8ba80bba-47a3-45fc-a51f-4a2c28bdaf86">529</ix:nonFraction>.  As of December 31, 2020, the Company&#8217;s net research tax credit receivable amounts to $<ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzczMTA_68301e87-fdfa-4b11-98b7-56c1d355a6cb">6,771</ix:nonFraction> and represents a French gross research tax credit of $<ix:nonFraction unitRef="usd" contextRef="ia3e2739e702347078b4ee9a8124ae398_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzczNjY_aff7cb81-c5ad-421c-b0ba-64c87b32598e">6,396</ix:nonFraction> and an Irish gross research tax credit of $<ix:nonFraction unitRef="usd" contextRef="i1798461a2fc34d85ace6dea31e0f8881_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzc0MTE_5c1dfd2b-5764-452e-9532-877e60b24798">375</ix:nonFraction>. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 CARES Act</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CARES Act, enacted on March 27, 2020, includes significant business tax provisions. In particular, the CARES Act modified the rules associated with net operating losses. Under the temporary provisions of the CARES Act, net operating loss carryforwards and carrybacks may offset 100% of taxable income for taxable years beginning before 2021. In addition, net operating losses arising in 2018, 2019 and 2020 taxable years may be carried back to each of the preceding five years to generate a refund. During the twelve months ended December 31, 2020, the income tax benefit includes a discrete tax benefit of $<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="avdl:CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzgzNjM_8f9ca21a-d201-4875-8964-ed7250831aee">9,124</ix:nonFraction> as a result of the Company&#8217;s ability under the CARES Act to carry back net operating losses incurred to periods when the statutory U.S. Federal tax rate was 35% versus the Company&#8217;s current U.S. Federal tax rate of 21%. During the twelve months ended December 31, 2020, the Company received $<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="avdl:CARESActProceedsFromIncomeTaxRefunds" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzg2MjE_00c4536c-4dd0-46aa-b5a9-3ca642ba5751">3,351</ix:nonFraction> in cash tax refunds from carryback claims related to the CARES Act from the carryback of 2018 tax losses. The Company filed refund claims for $<ix:nonFraction unitRef="usd" contextRef="i965546c452da46f2b76a6fe33a65e75c_D20200101-20201231" decimals="-3" name="avdl:CARESActCashRefundClaims" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzg3Njc_70926fed-941e-4ca0-9d12-41f3e6102e49">18,753</ix:nonFraction> associated with the carryback of 2019 tax losses and a $<ix:nonFraction unitRef="usd" contextRef="i8b27235b791c489ba62df9bcd96969e8_D20200101-20201231" decimals="-3" name="avdl:CARESActCashRefundClaims" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzI3NDg3NzkwODgxMjQ_8309e2b6-ecf3-48b1-a6bc-a4f91e53288f">10,273</ix:nonFraction> refund claim associated with the carryback of 2020 tax losses.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_136"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 14:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:OtherLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90ZXh0cmVnaW9uOjAzOTBjZmU3ZTJmMTQ4ZTRiNTJjMTdmNjVhMjI3MjUzXzE3Nw_3cc87812-daf2-4a1c-b114-b4fb0732c4ac" continuedAt="i85479a30bc9a41c19880c26e62aa72b5" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Assets and Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></ix:nonNumeric></div><ix:continuation id="i85479a30bc9a41c19880c26e62aa72b5" continuedAt="i5b517c3dcaa0491d82979ff7244954de"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90ZXh0cmVnaW9uOjAzOTBjZmU3ZTJmMTQ4ZTRiNTJjMTdmNjVhMjI3MjUzXzE3Mg_563e9443-b77a-4a0b-ab2f-e86295e8f5d4" escape="true"><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various other assets and liabilities are summarized for the years ended December 31, as follows:&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prepaid Expenses and Other Current Assets: </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax receivable (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzItMi0xLTEtMjM0NTg_08ba54cf-6172-40d1-ae1d-74416d9012bb">29,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzItNC0xLTEtMjM0NTg_b1a8969f-2ce7-4baf-930a-cf0c5ca2d779">18,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid and other expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzMtMi0xLTEtMjM0NTg_582af7e3-282d-4d5d-a117-69c756a7f134">3,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:PrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzMtNC0xLTEtMjM0NTg_5fa58070-e1ce-4f8a-9539-94fa7b496ba9">1,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee from Armistice</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="avdl:GuaranteeCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzQtMi0xLTEtMzY1NjA_8f238f80-9c4b-49df-8e4c-808330c803bc">279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="avdl:GuaranteeCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzQtNC0xLTEtMzY1NjA_3d8351c5-7031-4353-baa2-97646413c1ee">318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzQtMi0xLTEtMjc5OTc_07127373-710e-4b64-bcaa-100f47d936cf">271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzQtNC0xLTEtMjc5OTc_d41d1dba-c063-49cd-a044-47b97f638802">798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivable from Exela (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="avdl:ShortTermNoteReceivable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzYtMi0xLTEtMjM0NTg_75e516a8-540a-4a83-a42c-6aac634972cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="avdl:ShortTermNoteReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzYtNC0xLTEtMjM0NTg_89183f91-748c-48f2-bfbe-7959a2b79930">16,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term deposit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzctMi0xLTEtMjM0NTg_9e17fced-0ca2-4cd9-ada3-c7f0c9dfa8ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzctNC0xLTEtMjM0NTg_65701f63-c518-4744-89d8-0510a436f50b">1,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzktMi0xLTEtMjM0NTg_7b37e79f-b82e-455e-b8c6-8391256cfec2">32,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzktNC0xLTEtMjM0NTg_c9c1c1dc-0b93-4c87-bcb1-4b7cc251cee1">38,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:14pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90ZXh0cmVnaW9uOjAzOTBjZmU3ZTJmMTQ4ZTRiNTJjMTdmNjVhMjI3MjUzXzE4MA_9e6514c3-2efa-4917-91d0-6642f1bb665c" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Non-Current Assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTo5YjE3NmUxMzM4MzM0ZjUzOWJjNWNmZDM0NjcwOTIxOS90YWJsZXJhbmdlOjliMTc2ZTEzMzgzMzRmNTM5YmM1Y2ZkMzQ2NzA5MjE5XzItMi0xLTEtMjM0NTg_d162d295-a0a8-40b8-bb5c-39e12fae0d17">24,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTo5YjE3NmUxMzM4MzM0ZjUzOWJjNWNmZDM0NjcwOTIxOS90YWJsZXJhbmdlOjliMTc2ZTEzMzgzMzRmNTM5YmM1Y2ZkMzQ2NzA5MjE5XzItNC0xLTEtMjM0NTg_0e06bfbc-afcf-4b83-946d-82ba65d800dc">18,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use assets at contract manufacturing organizations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTo5YjE3NmUxMzM4MzM0ZjUzOWJjNWNmZDM0NjcwOTIxOS90YWJsZXJhbmdlOjliMTc2ZTEzMzgzMzRmNTM5YmM1Y2ZkMzQ2NzA5MjE5XzMtMi0xLTEtMjgwMTk_346b8c5c-1d42-428e-b69b-8be990400d22">8,549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTo5YjE3NmUxMzM4MzM0ZjUzOWJjNWNmZDM0NjcwOTIxOS90YWJsZXJhbmdlOjliMTc2ZTEzMzgzMzRmNTM5YmM1Y2ZkMzQ2NzA5MjE5XzMtNC0xLTEtMjgwMTk_6ffa2e10-ac72-4b96-9841-f52cb37f6872">5,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee from Armistice</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="avdl:GuaranteeNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTo5YjE3NmUxMzM4MzM0ZjUzOWJjNWNmZDM0NjcwOTIxOS90YWJsZXJhbmdlOjliMTc2ZTEzMzgzMzRmNTM5YmM1Y2ZkMzQ2NzA5MjE5XzQtMi0xLTEtMjM0NTg_8c9a05db-a98d-4090-9836-dc67a252991c">771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="avdl:GuaranteeNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTo5YjE3NmUxMzM4MzM0ZjUzOWJjNWNmZDM0NjcwOTIxOS90YWJsZXJhbmdlOjliMTc2ZTEzMzgzMzRmNTM5YmM1Y2ZkMzQ2NzA5MjE5XzQtNC0xLTEtMjM0NTg_65755ec6-1e1d-441d-aeac-4f59ff02f5de">1,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="avdl:OtherNoncurrentReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTo5YjE3NmUxMzM4MzM0ZjUzOWJjNWNmZDM0NjcwOTIxOS90YWJsZXJhbmdlOjliMTc2ZTEzMzgzMzRmNTM5YmM1Y2ZkMzQ2NzA5MjE5XzYtMi0xLTEtMjM0NTg_d7448485-85da-456f-a591-16db7680c099">329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="avdl:OtherNoncurrentReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTo5YjE3NmUxMzM4MzM0ZjUzOWJjNWNmZDM0NjcwOTIxOS90YWJsZXJhbmdlOjliMTc2ZTEzMzgzMzRmNTM5YmM1Y2ZkMzQ2NzA5MjE5XzYtNC0xLTEtMjM0NTg_3a6b5660-495c-4644-91c6-7f7a6c2461ce">432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTo5YjE3NmUxMzM4MzM0ZjUzOWJjNWNmZDM0NjcwOTIxOS90YWJsZXJhbmdlOjliMTc2ZTEzMzgzMzRmNTM5YmM1Y2ZkMzQ2NzA5MjE5XzctMi0xLTEtMjM0NTg_6387fe30-e86f-47ef-8454-3ee88d291266">33,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTo5YjE3NmUxMzM4MzM0ZjUzOWJjNWNmZDM0NjcwOTIxOS90YWJsZXJhbmdlOjliMTc2ZTEzMzgzMzRmNTM5YmM1Y2ZkMzQ2NzA5MjE5XzctNC0xLTEtMjM0NTg_0f653f6e-2118-49f1-abc8-e17bba05fc48">24,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90ZXh0cmVnaW9uOjAzOTBjZmU3ZTJmMTQ4ZTRiNTJjMTdmNjVhMjI3MjUzXzE4Ng_c703ddec-93af-4b90-b451-5e9dac07d7b2" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued Expenses:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:AccruedSalariesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpmZWU3NTAxM2MzNzc0ZjI4YmVmOTU1ZjdjMWU5NmYyMy90YWJsZXJhbmdlOmZlZTc1MDEzYzM3NzRmMjhiZWY5NTVmN2MxZTk2ZjIzXzQtMi0xLTEtMjgxMTI_2d4567de-3887-4052-bb6a-a59facf97ec2">3,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:AccruedSalariesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpmZWU3NTAxM2MzNzc0ZjI4YmVmOTU1ZjdjMWU5NmYyMy90YWJsZXJhbmdlOmZlZTc1MDEzYzM3NzRmMjhiZWY5NTVmN2MxZTk2ZjIzXzQtNC0xLTEtMjgxMTI_a3506c95-cc22-4f37-8a60-7150225ecdb0">1,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpmZWU3NTAxM2MzNzc0ZjI4YmVmOTU1ZjdjMWU5NmYyMy90YWJsZXJhbmdlOmZlZTc1MDEzYzM3NzRmMjhiZWY5NTVmN2MxZTk2ZjIzXzQtMi0xLTEtMjgyMDI_73c3eec8-0ffc-4604-89ce-812dbd90dffd">2,678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpmZWU3NTAxM2MzNzc0ZjI4YmVmOTU1ZjdjMWU5NmYyMy90YWJsZXJhbmdlOmZlZTc1MDEzYzM3NzRmMjhiZWY5NTVmN2MxZTk2ZjIzXzQtNC0xLTEtMjgyMDI_b4944020-46fd-43c6-9e0c-71d35d3e5000">2,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued outsourced contract costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="avdl:AccruedOutsourceContractCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpmZWU3NTAxM2MzNzc0ZjI4YmVmOTU1ZjdjMWU5NmYyMy90YWJsZXJhbmdlOmZlZTc1MDEzYzM3NzRmMjhiZWY5NTVmN2MxZTk2ZjIzXzQtMi0xLTEtMjgyMTQ_d699ff64-03e4-447a-be2a-701d769b0a20">1,048</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="avdl:AccruedOutsourceContractCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpmZWU3NTAxM2MzNzc0ZjI4YmVmOTU1ZjdjMWU5NmYyMy90YWJsZXJhbmdlOmZlZTc1MDEzYzM3NzRmMjhiZWY5NTVmN2MxZTk2ZjIzXzQtNC0xLTEtMjgyMTQ_40f4f5be-0b6e-4a0e-8770-7f538e987b8f">473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer allowances</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="avdl:AccruedTradeDiscountsAndRebates" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpmZWU3NTAxM2MzNzc0ZjI4YmVmOTU1ZjdjMWU5NmYyMy90YWJsZXJhbmdlOmZlZTc1MDEzYzM3NzRmMjhiZWY5NTVmN2MxZTk2ZjIzXzQtMi0xLTEtMjgxODk_39822c3c-bbfe-4070-bd7f-f238b3fc36b6">217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="avdl:AccruedTradeDiscountsAndRebates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpmZWU3NTAxM2MzNzc0ZjI4YmVmOTU1ZjdjMWU5NmYyMy90YWJsZXJhbmdlOmZlZTc1MDEzYzM3NzRmMjhiZWY5NTVmN2MxZTk2ZjIzXzQtNC0xLTEtMjgxODk_87ef3d72-3208-4528-a17f-88f51bfa41fd">1,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued restructuring (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:RestructuringReserveCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpmZWU3NTAxM2MzNzc0ZjI4YmVmOTU1ZjdjMWU5NmYyMy90YWJsZXJhbmdlOmZlZTc1MDEzYzM3NzRmMjhiZWY5NTVmN2MxZTk2ZjIzXzctMi0xLTEtMjgxMjM_0272ab0f-e66c-4620-99ab-c90652f835ac">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:RestructuringReserveCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpmZWU3NTAxM2MzNzc0ZjI4YmVmOTU1ZjdjMWU5NmYyMy90YWJsZXJhbmdlOmZlZTc1MDEzYzM3NzRmMjhiZWY5NTVmN2MxZTk2ZjIzXzctNC0xLTEtMjgxMjM_8c1b9502-29c9-4d9a-b712-d1f88d7521f8">520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpmZWU3NTAxM2MzNzc0ZjI4YmVmOTU1ZjdjMWU5NmYyMy90YWJsZXJhbmdlOmZlZTc1MDEzYzM3NzRmMjhiZWY5NTVmN2MxZTk2ZjIzXzktMi0xLTEtMjM0NTg_2ee73a12-d984-49de-b280-2ebfd72ec7b3">7,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpmZWU3NTAxM2MzNzc0ZjI4YmVmOTU1ZjdjMWU5NmYyMy90YWJsZXJhbmdlOmZlZTc1MDEzYzM3NzRmMjhiZWY5NTVmN2MxZTk2ZjIzXzktNC0xLTEtMjM0NTg_07b36073-ec78-45ac-914e-60176078c056">6,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-95-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5b517c3dcaa0491d82979ff7244954de"><div style="margin-bottom:1pt;margin-top:3pt;text-align:justify"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90ZXh0cmVnaW9uOjAzOTBjZmU3ZTJmMTQ4ZTRiNTJjMTdmNjVhMjI3MjUzXzE4NQ_49d89d49-ffd3-478c-9bb1-83fd513dfaff" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:61.895%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.667%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Current Liabilities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="avdl:AccruedInterestCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpkMDc3MjUyMGMzMjM0ODQxOWM5M2QxMjg0MjA3ZTkyOS90YWJsZXJhbmdlOmQwNzcyNTIwYzMyMzQ4NDE5YzkzZDEyODQyMDdlOTI5XzItMi0xLTEtMjM0NTg_f1012d09-77ab-4243-ab0f-67afc904d332">4,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="avdl:AccruedInterestCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpkMDc3MjUyMGMzMjM0ODQxOWM5M2QxMjg0MjA3ZTkyOS90YWJsZXJhbmdlOmQwNzcyNTIwYzMyMzQ4NDE5YzkzZDEyODQyMDdlOTI5XzItNC0xLTEtMjM0NTg_4b322d8b-82c2-4c99-bf84-c43a38206c10">2,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee to Deerfield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="avdl:OtherGuarantorObligationsCurrentCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpkMDc3MjUyMGMzMjM0ODQxOWM5M2QxMjg0MjA3ZTkyOS90YWJsZXJhbmdlOmQwNzcyNTIwYzMyMzQ4NDE5YzkzZDEyODQyMDdlOTI5XzQtMi0xLTEtMjM0NTg_5006a3f4-ab5a-4ad5-887c-7ecb4f58e00d">280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="avdl:OtherGuarantorObligationsCurrentCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpkMDc3MjUyMGMzMjM0ODQxOWM5M2QxMjg0MjA3ZTkyOS90YWJsZXJhbmdlOmQwNzcyNTIwYzMyMzQ4NDE5YzkzZDEyODQyMDdlOTI5XzQtNC0xLTEtMjM0NTg_a5fcf8a4-f5f5-40e1-9419-1196a039f9ec">319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="avdl:OtherLiabilitiesMiscellaneousCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpkMDc3MjUyMGMzMjM0ODQxOWM5M2QxMjg0MjA3ZTkyOS90YWJsZXJhbmdlOmQwNzcyNTIwYzMyMzQ4NDE5YzkzZDEyODQyMDdlOTI5XzUtMi0xLTEtMjM0NTg_04285021-e69c-4121-8349-fc7e0ab580c1">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="avdl:OtherLiabilitiesMiscellaneousCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpkMDc3MjUyMGMzMjM0ODQxOWM5M2QxMjg0MjA3ZTkyOS90YWJsZXJhbmdlOmQwNzcyNTIwYzMyMzQ4NDE5YzkzZDEyODQyMDdlOTI5XzUtNC0xLTEtMjM0NTg_35a6671f-3e50-4fa3-8f93-6fe544380b2d">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due to Exela</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:DueToAffiliateCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpkMDc3MjUyMGMzMjM0ODQxOWM5M2QxMjg0MjA3ZTkyOS90YWJsZXJhbmdlOmQwNzcyNTIwYzMyMzQ4NDE5YzkzZDEyODQyMDdlOTI5XzYtMi0xLTEtMjgwMzA_5639cc57-71a4-473e-86e7-3748448a1b31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpkMDc3MjUyMGMzMjM0ODQxOWM5M2QxMjg0MjA3ZTkyOS90YWJsZXJhbmdlOmQwNzcyNTIwYzMyMzQ4NDE5YzkzZDEyODQyMDdlOTI5XzYtNC0xLTEtMjgwMzA_643843de-a8a3-4cba-9ff2-0b85133ab4a3">2,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpkMDc3MjUyMGMzMjM0ODQxOWM5M2QxMjg0MjA3ZTkyOS90YWJsZXJhbmdlOmQwNzcyNTIwYzMyMzQ4NDE5YzkzZDEyODQyMDdlOTI5XzYtMi0xLTEtMjM0NTg_19591353-4490-4bbb-b9ee-a7ba1ed6e7e0">5,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpkMDc3MjUyMGMzMjM0ODQxOWM5M2QxMjg0MjA3ZTkyOS90YWJsZXJhbmdlOmQwNzcyNTIwYzMyMzQ4NDE5YzkzZDEyODQyMDdlOTI5XzYtNC0xLTEtMjM0NTg_4d43dc4b-ec60-4195-b73f-681e4e5734f5">5,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:4pt;text-align:justify"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90ZXh0cmVnaW9uOjAzOTBjZmU3ZTJmMTQ4ZTRiNTJjMTdmNjVhMjI3MjUzXzE4Nw_c02ee994-d9e9-47c9-8c88-f073416540ab" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:61.895%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.667%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Non-Current Liabilities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax liabilities and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="avdl:TaxLiabilitiesAndOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZToyNjY2YWI5YjdiN2I0NThmOTM3ZGJjYWU1YWUzNGVlNC90YWJsZXJhbmdlOjI2NjZhYjliN2I3YjQ1OGY5MzdkYmNhZTVhZTM0ZWU0XzQtMi0xLTEtMjM0NTg_7db8b6db-9336-4c2d-a7d5-2ed0c7c76e53">3,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="avdl:TaxLiabilitiesAndOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZToyNjY2YWI5YjdiN2I0NThmOTM3ZGJjYWU1YWUzNGVlNC90YWJsZXJhbmdlOjI2NjZhYjliN2I3YjQ1OGY5MzdkYmNhZTVhZTM0ZWU0XzQtNC0xLTEtMjM0NTg_5d5e7772-fb88-4134-8811-2cb9290e14cb">3,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee to Deerfield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:GuarantyLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZToyNjY2YWI5YjdiN2I0NThmOTM3ZGJjYWU1YWUzNGVlNC90YWJsZXJhbmdlOjI2NjZhYjliN2I3YjQ1OGY5MzdkYmNhZTVhZTM0ZWU0XzUtMi0xLTEtMjM0NTg_a0a94eb0-d455-4356-b35f-fc8cc6d35a64">774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:GuarantyLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZToyNjY2YWI5YjdiN2I0NThmOTM3ZGJjYWU1YWUzNGVlNC90YWJsZXJhbmdlOjI2NjZhYjliN2I3YjQ1OGY5MzdkYmNhZTVhZTM0ZWU0XzUtNC0xLTEtMjM0NTg_ea451530-3bcf-43fd-bbbc-66c1adae91bc">1,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZToyNjY2YWI5YjdiN2I0NThmOTM3ZGJjYWU1YWUzNGVlNC90YWJsZXJhbmdlOjI2NjZhYjliN2I3YjQ1OGY5MzdkYmNhZTVhZTM0ZWU0XzctMi0xLTEtMjM0NTg_fd4ec3f6-85e0-427c-a3a7-a9aa85ba1fdc">3,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZToyNjY2YWI5YjdiN2I0NThmOTM3ZGJjYWU1YWUzNGVlNC90YWJsZXJhbmdlOjI2NjZhYjliN2I3YjQ1OGY5MzdkYmNhZTVhZTM0ZWU0XzctNC0xLTEtMjM0NTg_7cfbb992-2ae7-4a2a-b431-9548a6545167">4,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_139"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 15:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzkvZnJhZzplMGJkMGJiMTkwN2M0M2M5YmU3NjdjMWVhNDI0YmNlYi90ZXh0cmVnaW9uOmUwYmQwYmIxOTA3YzQzYzliZTc2N2MxZWE0MjRiY2ViXzE5NzA_3e26e529-a84f-47f5-a7a7-6c997de057b9" continuedAt="i5e0690317ff94a8cba7ae2b5d6073f55" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Liabilities and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></ix:nonNumeric></div><ix:continuation id="i5e0690317ff94a8cba7ae2b5d6073f55" continuedAt="i9fbe5dd4409c47b4b9a4f22a0bfb3952"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to potential liabilities generally incidental to its business arising out of present and future lawsuits and claims related to product liability, personal injury, contract, commercial, intellectual property, tax, employment, compliance and other matters that arise in the ordinary course of business. The Company accrues for potential liabilities when it is probable that future costs (including legal fees and expenses) will be incurred and such costs can be reasonably estimated. At December 31, 2021, there were no contingent liabilities with respect to any litigation, arbitration or administrative or other proceeding that are reasonably likely to have a material adverse effect on the Company&#8217;s consolidated financial position, results of operations, cash flows or liquidity. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">First Complaint</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 12, 2021, Jazz Pharmaceuticals, Inc. (&#8220;Jazz&#8221;) filed a formal complaint (the &#8220;First Complaint&#8221;) initiating a lawsuit in the United States District Court for the District of Delaware (the &#8220;Court&#8221;) against Avadel Pharmaceuticals plc, Avadel US Holdings, Inc., Avadel Management Corporation, Avadel Legacy Pharmaceuticals, LLC, Avadel Specialty Pharmaceuticals, LLC, and Avadel CNS Pharmaceuticals, LLC (collectively, the &#8220;Avadel Parties&#8221;). In the First Complaint, Jazz alleges the sodium oxybate product (&#8220;Proposed Product&#8221;) described in the NDA owned by Avadel CNS Pharmaceuticals, LLC will infringe at least one claim of US Patent No. 8731963, 10758488, 10813885, 10959956 and/or 10966931 (collectively, the &#8220;patents-in-suit&#8221;). The First Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 3, 2021, the Avadel Parties timely filed their Answer and Counterclaims (the &#8220;Avadel Answer&#8221;) with the Court in response to the First Complaint. The Avadel Answer generally denies the allegations set forth in the First Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patents-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of each patent-in-suit, and ii) a declaratory judgment of invalidity of each patent-in-suit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 18, 2021, Jazz filed its Answer (&#8220;Jazz Answer&#8221;) with the Court in response to the Avadel Answer. The Jazz Answer generally denies the allegations set forth in the Avadel Answer and sets forth a single affirmative defense asserting that Avadel has failed to state a claim for which relief can be granted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 21, 2021, the Court issued an oral order requiring the parties to i) confer regarding proposed dates to be included in the Court&#8217;s scheduling order for the case, and ii) submit a proposed order, including a proposal for the length and timing of trial, to the Court by no later than July 21, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 30, 2021, the Court issued a scheduling order establishing timing for litigation events including i) a claim construction hearing date of August 2, 2022, and ii) a trial date of October 30, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 18, 2021, consistent with the scheduling order, Jazz filed a status update with the Court indicating that Jazz did not intend to file a preliminary injunction with the Court at this time. Jazz further indicated that it would provide the Court with an </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-96-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9fbe5dd4409c47b4b9a4f22a0bfb3952" continuedAt="i4d6dc924985f4832ae118086c9621107"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">update regarding whether preliminary injunction proceedings may be necessary after receiving further information regarding the FDA&#8217;s action on Avadel&#8217;s NDA.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2022, the Court entered an agreed order dismissing this case with respect to Avadel Pharmaceuticals plc, Avadel US Holdings, Inc., Avadel Specialty Pharmaceuticals, LLC, Avadel Legacy Pharmaceuticals, LLC, and Avadel Management Corporation.  A corresponding order was entered in the two below cases on the same day.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Second Complaint</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 4, 2021, Jazz filed another formal complaint (the &#8220;Second Complaint&#8221;) initiating a lawsuit in the Court against the Avadel Parties. In the Second Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS Pharmaceuticals, LLC will infringe at least one claim of US Patent No. 11077079. The Second Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 9, 2021, the Avadel Parties timely filed their Answer and Counterclaims (the &#8220;Second Avadel Answer&#8221;) with the Court in response to the Second Complaint. The Second Avadel Answer generally denies the allegations set forth in the Second Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patent-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of the patent-in-suit, and ii) a declaratory judgment of invalidity of the patent-in-suit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 22, 2021, the Court issued an oral order stating that this case should proceed on the same schedule as the case filed on May 12, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Third Complaint</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 10, 2021, Jazz filed another formal complaint (the &#8220;Third Complaint&#8221;) initiating a lawsuit in the Court against the Avadel Parties. In the Third Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS Pharmaceuticals, LLC will infringe at least one claim of US Patent No. 11147782. The Third Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses.  This case will proceed on the same schedule as the cases associated with the First and Second Complaints above.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 7, 2022, Avadel CNS Pharmaceuticals LLC timely filed its Answer and Counterclaims (the &#8220;Third Avadel Answer&#8221;) with the Court in response to the Third Complaint. The Third Avadel Answer generally denies the allegations set forth in the Third Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patent-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of the patent-in-suit, and ii) a declaratory judgment of invalidity/unenforceability of the patent-in-suit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2021, the Court entered a revised schedule for the First, Second and Third Complaints, setting a new claim construction date of August 31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Material Commitments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, the Company has one commitment with its primary contract manufacturer related to facility upgrades and the purchase and validation of equipment to be used in the manufacture of FT218. The total cost of this commitment is estimated to be approximately $<ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:PurchaseObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzkvZnJhZzplMGJkMGJiMTkwN2M0M2M5YmU3NjdjMWVhNDI0YmNlYi90ZXh0cmVnaW9uOmUwYmQwYmIxOTA3YzQzYzliZTc2N2MxZWE0MjRiY2ViXzE0Mjc_c6cbbd41-d9ce-4cf2-8ee7-693fbecc10f9">5,500</ix:nonFraction> and is expected to be completed during the year ending December 31, 2022. The Company has incurred approximately $<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="avdl:CostsIncurredPurchaseObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzkvZnJhZzplMGJkMGJiMTkwN2M0M2M5YmU3NjdjMWVhNDI0YmNlYi90ZXh0cmVnaW9uOmUwYmQwYmIxOTA3YzQzYzliZTc2N2MxZWE0MjRiY2ViXzEwOTk1MTE2NDU4Mjc_68272543-67a2-4e9d-9dbc-00837820018c">3,348</ix:nonFraction> of this commitment during the year ended December 31, 2021. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has a commitment with another contract manufacturer that commences in the first quarter of 2022 and will continue until FDA approval of the contract manufacturer. The commitment will be approximately $<ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="avdl:ContractualObligationAnnualAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzkvZnJhZzplMGJkMGJiMTkwN2M0M2M5YmU3NjdjMWVhNDI0YmNlYi90ZXh0cmVnaW9uOmUwYmQwYmIxOTA3YzQzYzliZTc2N2MxZWE0MjRiY2ViXzI3NDg3NzkwOTc2OTk_80a65fc6-20e5-467a-812e-be8866474b8e">3,000</ix:nonFraction> per year.   </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deerfield Guarantee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company&#8217;s February 2018 divestiture of its pediatric assets, including four pediatric commercial stage assets &#8211; Karbinal&#8482; ER, Cefaclor, Flexichamber&#8482; and AcipHex&#174; Sprinkle&#8482; (&#8220;FSC products&#8221;), to Cerecor, Inc. (&#8220;Cerecor&#8221;), the Company guaranteed to Deerfield a quarterly royalty payment of <ix:nonFraction unitRef="number" contextRef="i8aae7fedfa0841069d9766ab4280c0ce_D20180201-20180228" decimals="2" name="avdl:PercentageOfRoyaltyPayableOnNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzkvZnJhZzplMGJkMGJiMTkwN2M0M2M5YmU3NjdjMWVhNDI0YmNlYi90ZXh0cmVnaW9uOmUwYmQwYmIxOTA3YzQzYzliZTc2N2MxZWE0MjRiY2ViXzEwNDQ1MzYwNDkxNTY2_debeac1e-543c-4484-bc6a-9a05dd871da7">15</ix:nonFraction>% on net sales of the FSC products through February 6, 2026 (&#8220;FSC Product Royalties&#8221;), in an aggregate amount of up to approximately $<ix:nonFraction unitRef="usd" contextRef="i8aae7fedfa0841069d9766ab4280c0ce_D20180201-20180228" decimals="-3" name="avdl:RoyaltyPayableonNetSalesMaximum" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzkvZnJhZzplMGJkMGJiMTkwN2M0M2M5YmU3NjdjMWVhNDI0YmNlYi90ZXh0cmVnaW9uOmUwYmQwYmIxOTA3YzQzYzliZTc2N2MxZWE0MjRiY2ViXzEwNDQ1MzYwNDkxNTcx_21bf3e38-af02-4bd8-b30e-beae9faf7d59">10,300</ix:nonFraction>. Given the Company&#8217;s explicit </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-97-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4d6dc924985f4832ae118086c9621107"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">guarantee to Deerfield, the Company recorded the guarantee in accordance with ASC 460. The balance of this guarantee liability was $<ix:nonFraction unitRef="usd" contextRef="ie92e7a337b354b108b7bcc24805f0ef5_I20211231" decimals="-3" name="us-gaap:GuarantyLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzkvZnJhZzplMGJkMGJiMTkwN2M0M2M5YmU3NjdjMWVhNDI0YmNlYi90ZXh0cmVnaW9uOmUwYmQwYmIxOTA3YzQzYzliZTc2N2MxZWE0MjRiY2ViXzE2NDkyNjc0NTk0MzQ_6bbaa099-e372-4a42-b155-72b12897e008">1,054</ix:nonFraction> at December&#160;31, 2021. This liability is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Armistice Guarantee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company&#8217;s February 2018 divestiture of the pediatric assets, Armistice Capital Master Fund, Ltd., the majority shareholder of Cerecor, guaranteed to the Company the FSC Product Royalties. The Company recorded the guarantee in accordance with ASC 460. The balance of this guarantee asset was $<ix:nonFraction unitRef="usd" contextRef="i5adac7e213d040e6be9c9156b4e7a03d_I20211231" decimals="-3" name="us-gaap:GuarantyAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzkvZnJhZzplMGJkMGJiMTkwN2M0M2M5YmU3NjdjMWVhNDI0YmNlYi90ZXh0cmVnaW9uOmUwYmQwYmIxOTA3YzQzYzliZTc2N2MxZWE0MjRiY2ViXzE2NDkyNjc0NTk0MjM_c8eff4e3-ef13-477a-88cd-9ad7a16e4c33">1,050</ix:nonFraction> at December&#160;31, 2021. This asset is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s guarantee to Deerfield and the guarantee received by the Company from Armistice largely offset and when combined are not material.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_145"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 16: <ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzI4ODE_f1eab408-aa21-41d6-9fb4-8951da353c23" continuedAt="ie39bdfcf727f46a4b1201eefe973b9ca" escape="true">Restructuring Costs</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie39bdfcf727f46a4b1201eefe973b9ca" continuedAt="i5a8c150641504d59980a4af1f057f467">&#160;</ix:continuation></span></div><div><span><br/></span></div><ix:continuation id="i5a8c150641504d59980a4af1f057f467" continuedAt="i16142c30b8294697bb8d0af4b6f482a0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019 French Restructuring</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2019, the Company initiated a plan to discontinue all French R&amp;D activities, which resulted in the redundancy and reduction of its entire workforce at its V&#233;nissieux, France site (&#8220;2019 French Restructuring&#8221;). This reduction was part of an effort to align the Company&#8217;s cost structure with its ongoing and future planned projects. The discontinuation of R&amp;D activities and elimination of the workforce in France was completed during the year ended December 31, 2020.  Restructuring charges associated with this plan recognized during the years ended December 31, 2021 and 2020 were immaterial. Restructuring charges associated with this plan of $<ix:nonFraction unitRef="usd" contextRef="ia9dabd3a46c348c4af8ae3e2b161a78b_D20190101-20191231" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc1OTU1_4715d3bb-ce6a-4ae6-bc9a-d8ad89180282">4,855</ix:nonFraction> of were recognized during the year ended December 31, 2019.  Included in the 2019 French Restructuring charges of $<ix:nonFraction unitRef="usd" contextRef="ia9dabd3a46c348c4af8ae3e2b161a78b_D20190101-20191231" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc1OTY2_36f61b8c-aab5-4edc-a4ae-18c66f7a02fa">4,855</ix:nonFraction> were charges for employee severance, benefits and other costs of $<ix:nonFraction unitRef="usd" contextRef="i3109188b67084c50b94dbbece93b1abd_D20190101-20191231" decimals="-3" name="avdl:RestructuringChargesBeforeGainLossDuetoCurtailment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc2MDk5_ccadf170-9390-457a-bb61-4b0d613c5fc8">4,339</ix:nonFraction>, charges related to fixed asset impairment of $<ix:nonFraction unitRef="usd" contextRef="ia9dabd3a46c348c4af8ae3e2b161a78b_D20190101-20191231" decimals="-3" name="us-gaap:OperatingLeaseImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc1OTc3_ca9ef2aa-482e-41ba-9fa4-2fb08be3486c">629</ix:nonFraction>, charges related to the early termination penalty related to the office and copier lease terminations of $<ix:nonFraction unitRef="usd" contextRef="ia9dabd3a46c348c4af8ae3e2b161a78b_D20190101-20191231" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc1OTg2_4393bfe1-783b-445e-94e7-1ff98cb4ceed">887</ix:nonFraction>, partially offset by a benefit of $<ix:nonFraction unitRef="usd" contextRef="i5b6255d17e27499c84e9416e2247c6d2_D20190101-20191231" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc1OTk1_b2e9ee1e-2cb5-42dd-82cd-60611db298ce">1,000</ix:nonFraction> related to the reversal of the French retirement indemnity obligation. At December 31, 2021, there are <ix:nonFraction unitRef="usd" contextRef="i5abec81499e34146bd019b20912a78d9_D20210101-20211231" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc2MTEz_ef26da72-b6a2-4029-8975-6fc80d926ac4">no</ix:nonFraction> future expected retirement indemnity benefits to be paid. The Company does not expect to incur any additional expenses related to the 2019 French Restructuring. <ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzI4Nzk_e5a32d62-06ef-4610-a928-dfc00197a6c3" continuedAt="i9eec3701752d4c8bb7d02d6cd771b326" escape="true">The following table sets forth activities for the Company&#8217;s cost reduction plan obligations for the years ended&#160;December&#160;31, 2021 and 2020:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><ix:continuation id="i9eec3701752d4c8bb7d02d6cd771b326"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.915%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019 French Restructuring Obligation:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of restructuring accrual at January 1,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fe6439ac97147e2bef805733848150d_I20201231" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90YWJsZTo2MjQ2ZWFjYjAxMDk0ZDZiOTkyYWFiMDk3NTE3NzExNi90YWJsZXJhbmdlOjYyNDZlYWNiMDEwOTRkNmI5OTJhYWIwOTc1MTc3MTE2XzItMi0xLTEtMjM0NTg_1e48e679-3692-4fb9-a165-3c8c5d7e34a7">248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia076dc0709334bbeaf09ce17301fb2b2_I20191231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90YWJsZTo2MjQ2ZWFjYjAxMDk0ZDZiOTkyYWFiMDk3NTE3NzExNi90YWJsZXJhbmdlOjYyNDZlYWNiMDEwOTRkNmI5OTJhYWIwOTc1MTc3MTE2XzItNC0xLTEtMjM0NTg_a8d2ad95-3fa4-4ed7-ba76-433a6cfcf34f">1,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Benefit) charges for employee severance, benefits and other costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c3cd06d5ae74e7ca62b8e96948d1fbe_D20210101-20211231" decimals="-3" sign="-" name="avdl:RestructuringChargesBeforeGainLossDuetoCurtailment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90YWJsZTo2MjQ2ZWFjYjAxMDk0ZDZiOTkyYWFiMDk3NTE3NzExNi90YWJsZXJhbmdlOjYyNDZlYWNiMDEwOTRkNmI5OTJhYWIwOTc1MTc3MTE2XzMtMi0xLTEtMjM0NTg_c0a890d6-e234-4541-b5db-048bafc91b45">122</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7cf514ecb0a4781b0ac7b4a71edab2e_D20200101-20201231" decimals="-3" name="avdl:RestructuringChargesBeforeGainLossDuetoCurtailment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90YWJsZTo2MjQ2ZWFjYjAxMDk0ZDZiOTkyYWFiMDk3NTE3NzExNi90YWJsZXJhbmdlOjYyNDZlYWNiMDEwOTRkNmI5OTJhYWIwOTc1MTc3MTE2XzMtNC0xLTEtMjM0NTg_31a36dcd-8b66-4865-b6e8-0b5c1b4abf5d">172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5987a3d29dec46bbb4bf5192b6d19fa6_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsForRestructuring" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90YWJsZTo2MjQ2ZWFjYjAxMDk0ZDZiOTkyYWFiMDk3NTE3NzExNi90YWJsZXJhbmdlOjYyNDZlYWNiMDEwOTRkNmI5OTJhYWIwOTc1MTc3MTE2XzQtMi0xLTEtMjM0NTg_789547ba-ebbf-4701-906a-6cbe4dd1bf33">77</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08f7c0e44e0a42769d59e55ba48a1a37_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90YWJsZTo2MjQ2ZWFjYjAxMDk0ZDZiOTkyYWFiMDk3NTE3NzExNi90YWJsZXJhbmdlOjYyNDZlYWNiMDEwOTRkNmI5OTJhYWIwOTc1MTc3MTE2XzQtNC0xLTEtMjM0NTg_5f9f6f2b-d4d5-489a-a525-377408530278">1,813</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency impact</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5987a3d29dec46bbb4bf5192b6d19fa6_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90YWJsZTo2MjQ2ZWFjYjAxMDk0ZDZiOTkyYWFiMDk3NTE3NzExNi90YWJsZXJhbmdlOjYyNDZlYWNiMDEwOTRkNmI5OTJhYWIwOTc1MTc3MTE2XzUtMi0xLTEtMjM0NTg_dcb0f12d-9e3c-47d1-8c3e-b950f425b553">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08f7c0e44e0a42769d59e55ba48a1a37_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90YWJsZTo2MjQ2ZWFjYjAxMDk0ZDZiOTkyYWFiMDk3NTE3NzExNi90YWJsZXJhbmdlOjYyNDZlYWNiMDEwOTRkNmI5OTJhYWIwOTc1MTc3MTE2XzUtNC0xLTEtMjM0NTg_7133b87a-870b-49a4-bb15-b129253c2c68">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of restructuring accrual at December 31, </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice4e909fcef6444cab32b6676fcfd8a6_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90YWJsZTo2MjQ2ZWFjYjAxMDk0ZDZiOTkyYWFiMDk3NTE3NzExNi90YWJsZXJhbmdlOjYyNDZlYWNiMDEwOTRkNmI5OTJhYWIwOTc1MTc3MTE2XzYtMi0xLTEtMjM0NTg_4371099d-0748-4f0d-aa83-038945c9426d">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fe6439ac97147e2bef805733848150d_I20201231" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90YWJsZTo2MjQ2ZWFjYjAxMDk0ZDZiOTkyYWFiMDk3NTE3NzExNi90YWJsZXJhbmdlOjYyNDZlYWNiMDEwOTRkNmI5OTJhYWIwOTc1MTc3MTE2XzYtNC0xLTEtMjM0NTg_0916ef36-66c5-4acd-b0ed-5e1110dfc7fd">248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2019 French Restructuring liability of&#160;$<ix:nonFraction unitRef="usd" contextRef="iee22e31315ba4f7e8c83a112021555d6_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzExNjE_59f43a4c-17ba-456a-9edf-f4bfc6e8a28a">41</ix:nonFraction> is included in the consolidated balance sheet in accrued expenses at&#160;December 31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019 Corporate Restructuring</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2019, the Company announced a plan to reduce its corporate workforce by more than&#160;<ix:nonFraction unitRef="number" contextRef="i27fed9afac844925a080e2a721c7438b_I20190331" decimals="2" name="avdl:RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEzOTM_d1c12ea1-0e15-4ca2-8ad7-12bf82696c8e">50</ix:nonFraction>%&#160;(the &#8220;2019 Corporate Restructuring&#8221;). The reduction in workforce is primarily a result of the exit of Noctiva during the first quarter of 2019 (see&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note&#160;3: Subsidiary Bankruptcy and Deconsolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), as well as an effort to better align the Company&#8217;s remaining cost structure at its U.S. and Ireland locations with its ongoing and future planned projects. The reduction in workforce was completed during the year ended December 31, 2020.  Restructuring income associated with this plan for the years ended December 31, 2021 and 2020 were immaterial. Restructuring charges associated with this plan of $<ix:nonFraction unitRef="usd" contextRef="i91f93d16ae9742dd81fc60061f927f11_D20190101-20191231" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc2MDA2_343a285c-9305-44e5-9b74-af8efca4cba2">1,755</ix:nonFraction> were recognized during the year ended December 31, 2019. Included in the 2019 Corporate Restructuring charges of $<ix:nonFraction unitRef="usd" contextRef="i91f93d16ae9742dd81fc60061f927f11_D20190101-20191231" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc2MDE3_f445598b-c398-4855-9678-77eaa979b6fb">1,755</ix:nonFraction> for the year ended December 31, 2019 were charges for employee severance, benefit and other costs of $<ix:nonFraction unitRef="usd" contextRef="i7326c61f55a843b198262a29c6c921c5_D20190101-20191231" decimals="-3" name="avdl:RestructuringChargesBeforeGainLossDuetoCurtailment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc2MDI4_03e11b63-68e6-45be-8afc-523f4ad027dd">3,406</ix:nonFraction>, charges related to the early termination penalty related to the office lease termination of $<ix:nonFraction unitRef="usd" contextRef="i91f93d16ae9742dd81fc60061f927f11_D20190101-20191231" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc2MDM5_65e203b3-f109-413e-8159-fe9500b31c47">288</ix:nonFraction>, the write-off of $<ix:nonFraction unitRef="usd" contextRef="i91f93d16ae9742dd81fc60061f927f11_D20190101-20191231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentDisposals" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc2MDQ4_25ebdc99-fadc-4204-9a47-9fa02e5e3248">125</ix:nonFraction> of property, plant and equipment, net, partially offset by a benefit of $<ix:nonFraction unitRef="usd" contextRef="i91f93d16ae9742dd81fc60061f927f11_D20190101-20191231" decimals="-3" name="us-gaap:EmployeeBenefitsAndShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc2MDU3_8186bd7d-86f9-4e37-8659-20b93a874d50">2,064</ix:nonFraction> related to share based compensation forfeitures related to the employees affected by the global reduction in workforce. The Company does not expect to incur any additional expenses related to the 2019 Corporate Restructuring.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-98-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i16142c30b8294697bb8d0af4b6f482a0">During the years ended December 31, 2021, 2020 and 2019, the Company paid $<ix:nonFraction unitRef="usd" contextRef="iba84066aae6641519638f5dc4a7827a7_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsForRestructuring" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc2MDY4_27bc6480-ae65-4af8-b3c5-33ed058310b1">272</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i18f1d74601ab46d1bf4daa3efd8b638b_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc2MDc3_f1fd6d4a-4e73-461c-b279-11bec8c93e32">1,014</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i7326c61f55a843b198262a29c6c921c5_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc2MDg4_75e93bfc-203a-4b31-a1ed-b2bfd381dfc9">2,326</ix:nonFraction> respectively, and has no remaining obligation for the 2019 Corporate Restructuring plan as of December 31, 2021.</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_148"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 17: <ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="avdl:EquityTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzQ3MTA_f0eb216d-ac55-4c61-8481-60a0de3d3fe3" continuedAt="icf98b50b540c4e0fbb8f3c8bf61f89bf" escape="true">Equity Instruments and Transactions</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="icf98b50b540c4e0fbb8f3c8bf61f89bf" continuedAt="ief8a84127b474b6fb611a2f5de846ee3"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capital Shares</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="shares" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzc1_59b156cf-041d-455c-bf13-5afdecef47c7">500,000</ix:nonFraction> shares of authorized ordinary shares with a nominal value of $<ix:nonFraction unitRef="usdPerShare" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzEzOQ_915677c9-a5a6-4758-8a6f-f9a658dce9e2">0.01</ix:nonFraction> per ordinary share. As of December&#160;31, 2021, the Company had <ix:nonFraction unitRef="shares" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzE3OQ_31e2ea49-3098-450d-93cd-2dfe381d3b81"><ix:nonFraction unitRef="shares" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzE3OQ_6a8b3dec-1381-485e-924f-89d9488e311d">58,620</ix:nonFraction></ix:nonFraction> ordinary shares issued and outstanding, respectively. The Board of Directors is authorized to issue preferred shares in series, and with respect to each series, to fix its designation, relative rights (including voting, dividend, conversion, sinking fund, and redemption rights), preferences (including dividends and liquidation) and limitations. The Company has <ix:nonFraction unitRef="shares" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzUzNw_7dbb3441-14d9-44a2-b02e-ca286d940f63">50,000</ix:nonFraction> shares of authorized preferred shares, $<ix:nonFraction unitRef="usdPerShare" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzU3OQ_6de77cd7-c0e2-42f8-bcb4-8d2193a8f284">0.01</ix:nonFraction> nominal value, of which <ix:nonFraction unitRef="shares" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzYwNg_947d22a4-8bbe-4548-b985-624a85cdabb1"><ix:nonFraction unitRef="shares" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzYwNg_b1c6f3c6-e5b4-4657-bf58-f811a098cd35">488</ix:nonFraction></ix:nonFraction> are currently issued and outstanding as of December 31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shelf Registration Statement on Form S-3</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the Company filed with the SEC a new shelf registration statement on Form S-3 (the 2020 Shelf Registration Statement) (File No. 333-236258) that allows issuance and sale by the Company, from time to time, of:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">up to $<ix:nonFraction unitRef="usd" contextRef="ic33e6a0dbfbb440fb29af7e8c03ab9d7_I20200229" decimals="0" name="avdl:MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzkzMA_a9a9c775-753d-42cf-8c8e-47766cf0ab42">250,000</ix:nonFraction> in aggregate of ordinary shares, nominal value US$<ix:nonFraction unitRef="usdPerShare" contextRef="ic33e6a0dbfbb440fb29af7e8c03ab9d7_I20200229" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzk4Mg_12b29ace-7248-4ee4-9369-a5c31b597740">0.01</ix:nonFraction> per share (the &#8220;Ordinary Shares&#8221;), each of which may be represented by American Depositary Shares (&#8220;ADSs&#8221;), preferred shares, nominal value US$<ix:nonFraction unitRef="usdPerShare" contextRef="ic33e6a0dbfbb440fb29af7e8c03ab9d7_I20200229" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzExMjc_0e103f71-993e-4fdc-af7e-f0b431ca5020">0.01</ix:nonFraction> per share (the &#8220;Preferred Shares&#8221;), debt securities (the &#8220;Debt Securities&#8221;), warrants to purchase Ordinary Shares, ADSs, Preferred Shares and/or Debt Securities (the &#8220;Warrants&#8221;), and/or units consisting of Ordinary Shares, ADSs, Preferred Shares, one or more Debt Securities or Warrants in one or more series, in any combination, pursuant to the terms of the 2020 Shelf Registration Statement, the base prospectus contained in the 2020 Shelf Registration Statement (the &#8220;Base Prospectus&#8221;), and any amendments or supplements thereto (together, the &#8220;Securities&#8221;); including</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">up to $<ix:nonFraction unitRef="usd" contextRef="ic33e6a0dbfbb440fb29af7e8c03ab9d7_I20200229" decimals="0" name="avdl:MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzE3MDk_2161e23d-9104-4bfc-9fe5-b8019944ed61">50,000</ix:nonFraction> of ADSs that may be issued and sold from time to time pursuant to the terms of an Open Market Sale Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">SM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, entered into with Jefferies LLC on February 4, 2020 (the &#8220;Sales Agreement&#8221;), the 2020 Shelf Registration Statement, the Base Prospectus and the terms of the sales agreement prospectus contained in the 2020 Shelf Registration Statement.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transactions costs associated with the 2020 Shelf Registration Statement totaled $<ix:nonFraction unitRef="usd" contextRef="i2787db7d87db4fbbb4a9524ed6ef5ca7_D20200201-20200229" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzIxNDY_193a62ef-b770-404f-b12e-a173b6340917">428</ix:nonFraction> of which $<ix:nonFraction unitRef="usd" contextRef="i9de1c77df78b4ba98727acf8dec79f60_D20200101-20201231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzIxNTg_3eeaadc6-caa9-439a-8df5-7ada8194e58d">214</ix:nonFraction> was charged against additional paid-in capital during the twelve months ended December 31, 2020 as a result of the May 2020 Public Offering, discussed below. The remaining costs of $<ix:nonFraction unitRef="usd" contextRef="i5f3ba7983a1d4e8d8ca3d4d571f7417f_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzIzNDI_f094cddd-f3b4-4694-9799-db4c63fc8a2a">214</ix:nonFraction> are recorded as a prepaid asset at December 31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">February 2020 Private Placement</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 21, 2020, the Company announced that it entered into a definitive agreement for the sale of its ADSs and Series A Non-Voting Convertible Preferred Shares (&#8220;Series A Preferred&#8221;) in a private placement to a group of institutional accredited investors. The private placement resulted in gross proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="idaf43fbfb3db4fd9b03a187560479d16_D20200221-20200221" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzI3NTI_deaefb59-e834-40b6-a4c7-6e6394d8ab16">65,000</ix:nonFraction> before deducting placement agent and other offering expenses, which resulted in net proceeds of $<ix:nonFraction unitRef="usd" contextRef="idaf43fbfb3db4fd9b03a187560479d16_D20200221-20200221" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzI4NTE_ed869973-e15c-4613-9a5c-4827edbf8389">60,570</ix:nonFraction>.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the private placement, the Company issued <ix:nonFraction unitRef="shares" contextRef="i69fc50e94a814273a65f41128688da91_D20200221-20200221" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzI5MTQ_b7444824-b913-4cd7-89fc-5df55b1a60b6">8,680</ix:nonFraction> ADSs and <ix:nonFraction unitRef="shares" contextRef="i72449ec228e943259a39bc04a30d454e_D20200221-20200221" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzI5MjY_114e07e0-f638-4d9a-bf72-d79e53768bcd">488</ix:nonFraction> shares of Series A Preferred at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ifc5a6d80e8124b0a8bd28950f9fab4f6_I20200221" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzI5NzI_ee711576-42a4-4ec9-9bd5-de65d087e56b">7.09</ix:nonFraction> per share, priced at-the-market under Nasdaq rules. Each share of non-voting Series A Preferred is convertible into one ADS, provided that conversion will be prohibited if, as a result, the holder and its affiliates would own more than <ix:nonFraction unitRef="number" contextRef="i0dd0849c19e5445a8e3c4ff75cf420fe_D20200221-20200221" decimals="4" name="avdl:MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzMyMTE_abeaaa70-3db6-4be8-8461-3478cc48f54f">9.99</ix:nonFraction>% of the total number of Avadel ADSs outstanding. The closing of the private placement occurred on February 25, 2020.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i03c965967c7441e5b5bcfced0e7683c0_D20200221-20200221" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzMzNDk_3c6a1677-9631-42cc-aa6e-94dafe49e99b">4,430</ix:nonFraction> have been recorded as a reduction of additional paid-in capital.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">May 2020 Public Offering</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the shelf registration statement described above, on April 28, 2020, the Company announced the pricing of an underwritten public offering of <ix:nonFraction unitRef="shares" contextRef="ief992a6b46384fde9bd18e611b58d86a_D20200428-20200428" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzM1OTU_f42b1a8f-2e8f-40a8-a139-7a41fd582d8d">11,630</ix:nonFraction> Ordinary Shares, in the form of ADSs at a price to the public of $<ix:nonFraction unitRef="usdPerShare" contextRef="i0872a3688509439e8994fb7fcb662949_I20200428" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzM2NjM_c87f5643-8d28-493e-bb97-535cc6079351">10.75</ix:nonFraction> per ADS. Each ADS represents the right to receive one Ordinary Share. All of the ADSs were offered by the Company and the gross proceeds to the Company from the offering were approximately $<ix:nonFraction unitRef="usd" contextRef="ief992a6b46384fde9bd18e611b58d86a_D20200428-20200428" decimals="-3" name="avdl:SaleOfStockConsiderationReceivedOnTransactionGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzM4Mzc_dea70cc7-99dc-4fe3-98c7-0c7c895fd7c4">125,000</ix:nonFraction>, before deducting underwriting discounts and commissions and offering expenses, which resulted in net proceeds of $<ix:nonFraction unitRef="usd" contextRef="ief992a6b46384fde9bd18e611b58d86a_D20200428-20200428" decimals="-3" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzM5NTQ_aa875c87-c9ed-43b1-bfd0-1a59b468792d">116,924</ix:nonFraction>. The offering closed on May 1, 2020.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-99-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ief8a84127b474b6fb611a2f5de846ee3"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Retirement of Treasury Shares</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company retired all of its <ix:nonFraction unitRef="shares" contextRef="icd0f3157ccaf401eb75302e497df671d_D20200801-20200831" decimals="-3" name="us-gaap:TreasuryStockSharesRetired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzQwNzM_ea91e8fa-931e-46be-96ea-93010fee10ec">5,407</ix:nonFraction> treasury shares, or $<ix:nonFraction unitRef="usd" contextRef="i25009cefa3684002b043b7c8af74ee8a_D20200801-20200831" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzQwOTY_3a2f9e72-f617-4faa-9412-a1c4af67b195">49,998</ix:nonFraction> previously repurchased ordinary shares. As a result, the Company reduced additional paid-in capital by $<ix:nonFraction unitRef="usd" contextRef="iae6e5465f9294b758b40203ccdae2d14_D20200801-20200831" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzQxOTM_a9002138-4346-4f67-93c4-a760261cb185">49,944</ix:nonFraction> and ordinary shares by $<ix:nonFraction unitRef="usd" contextRef="i5b077651731849bb9b0eddf0ad66d964_D20200801-20200831" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzQyMTk_67028ac7-c9ee-4251-8a19-192fa7dae170">54</ix:nonFraction> during the twelve months ended December 31, 2020. The portion allocated to additional paid-in capital is determined pro rata by applying a percentage, determined by dividing the number of shares to be retired by the number of shares issued and outstanding as of the retirement date, to the balance of additional paid-in capital as of the retirement date. Based on this calculation, the entirety of the excess of repurchase price over par of $<ix:nonFraction unitRef="usd" contextRef="iae6e5465f9294b758b40203ccdae2d14_D20200801-20200831" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzQ2NjM_d3a3a672-1141-400e-959d-d0cdc9a3aa6c">49,944</ix:nonFraction> was allocated to additional paid-in capital.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_151"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 18: <ix:nonNumeric contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzY3MTI_6d7d1af5-3b10-4d7c-92e3-47d8d19f3585" continuedAt="i0ffba93455e64ef2b12bbf2eb11f8f66" escape="true">Share-Based Compensation</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0ffba93455e64ef2b12bbf2eb11f8f66" continuedAt="i7b659f3e6f6e40e9a9b9dc60b55c983d">&#160;</ix:continuation></span></div><ix:continuation id="i7b659f3e6f6e40e9a9b9dc60b55c983d" continuedAt="id07f65e80fa54096b509f32c7d5bb1a4"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzY3MTM_e737449b-b507-4a2b-8871-fe7440c72474" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense included in the Company&#8217;s consolidated statements of (loss) income for all share-based compensation arrangements was as follows for the periods ended December&#160;31, 2021, 2020 and 2019, respectively:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:48.679%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.909%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-based Compensation Expense:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebf3233476024b80bd208d93e82c7650_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpiNmZhMDc4NzQ2OTI0ZTM0ODZiOGI4MDhhM2YzM2VhYy90YWJsZXJhbmdlOmI2ZmEwNzg3NDY5MjRlMzQ4NmI4YjgwOGEzZjMzZWFjXzMtMi0xLTEtMjM0NTg_ef9d4cff-9621-4b69-8b08-ab00b245262b">758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c016d73d5464ed1853cdbc6f93adae3_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpiNmZhMDc4NzQ2OTI0ZTM0ODZiOGI4MDhhM2YzM2VhYy90YWJsZXJhbmdlOmI2ZmEwNzg3NDY5MjRlMzQ4NmI4YjgwOGEzZjMzZWFjXzMtNC0xLTEtMjM0NTg_22509fa8-39b8-4d48-bcc9-319f2030b591">139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d53c3a9d81648dfa5f09b49ada455d1_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpiNmZhMDc4NzQ2OTI0ZTM0ODZiOGI4MDhhM2YzM2VhYy90YWJsZXJhbmdlOmI2ZmEwNzg3NDY5MjRlMzQ4NmI4YjgwOGEzZjMzZWFjXzMtNi0xLTEtMjM0NTg_49882d5a-4aeb-4b33-9527-6f4aaf13cc0f">429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1229a210a7f49d4bbb9220069f8160e_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpiNmZhMDc4NzQ2OTI0ZTM0ODZiOGI4MDhhM2YzM2VhYy90YWJsZXJhbmdlOmI2ZmEwNzg3NDY5MjRlMzQ4NmI4YjgwOGEzZjMzZWFjXzQtMi0xLTEtMjM0NTg_d648dc40-354a-4fe7-ae8f-4ff9d3cf26cd">8,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d9561d07a174b4d928f303fd47bd68b_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpiNmZhMDc4NzQ2OTI0ZTM0ODZiOGI4MDhhM2YzM2VhYy90YWJsZXJhbmdlOmI2ZmEwNzg3NDY5MjRlMzQ4NmI4YjgwOGEzZjMzZWFjXzQtNC0xLTEtMjM0NTg_8d7c341b-5877-4c52-91d4-b5aa71f8c945">3,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d793592e3a9425abb3183a775c1d08e_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpiNmZhMDc4NzQ2OTI0ZTM0ODZiOGI4MDhhM2YzM2VhYy90YWJsZXJhbmdlOmI2ZmEwNzg3NDY5MjRlMzQ4NmI4YjgwOGEzZjMzZWFjXzQtNi0xLTEtMjM0NTg_2893c087-ebff-4059-943e-4816102bd3f6">2,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i455e8146c8434385aa9ae98f6c5ed465_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpiNmZhMDc4NzQ2OTI0ZTM0ODZiOGI4MDhhM2YzM2VhYy90YWJsZXJhbmdlOmI2ZmEwNzg3NDY5MjRlMzQ4NmI4YjgwOGEzZjMzZWFjXzUtMi0xLTEtMjM0NTg_180a2b8c-2dfd-40d9-9caa-264b4913d748">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaea59e16245b4fe5ba425b805b97b872_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpiNmZhMDc4NzQ2OTI0ZTM0ODZiOGI4MDhhM2YzM2VhYy90YWJsZXJhbmdlOmI2ZmEwNzg3NDY5MjRlMzQ4NmI4YjgwOGEzZjMzZWFjXzUtNC0xLTEtMjM0NTg_031874ca-82e7-4047-b371-5428e117592f">421</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i430f2e5a391247ff991d3a3d8de0d7d8_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpiNmZhMDc4NzQ2OTI0ZTM0ODZiOGI4MDhhM2YzM2VhYy90YWJsZXJhbmdlOmI2ZmEwNzg3NDY5MjRlMzQ4NmI4YjgwOGEzZjMzZWFjXzUtNi0xLTEtMjM0NTg_ccea8c75-bda1-402f-ae46-2725683cd29a">2,064</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpiNmZhMDc4NzQ2OTI0ZTM0ODZiOGI4MDhhM2YzM2VhYy90YWJsZXJhbmdlOmI2ZmEwNzg3NDY5MjRlMzQ4NmI4YjgwOGEzZjMzZWFjXzYtMi0xLTEtMjM0NTg_5f2fee78-e485-4d15-8dae-47025519530a">8,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpiNmZhMDc4NzQ2OTI0ZTM0ODZiOGI4MDhhM2YzM2VhYy90YWJsZXJhbmdlOmI2ZmEwNzg3NDY5MjRlMzQ4NmI4YjgwOGEzZjMzZWFjXzYtNC0xLTEtMjM0NTg_569f1a22-acb6-4464-a2bd-9b8790425606">2,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpiNmZhMDc4NzQ2OTI0ZTM0ODZiOGI4MDhhM2YzM2VhYy90YWJsZXJhbmdlOmI2ZmEwNzg3NDY5MjRlMzQ4NmI4YjgwOGEzZjMzZWFjXzYtNi0xLTEtMjM0NTg_654864b6-4a8f-4967-b062-79cfb435330d">519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company expects $<ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI5Mw_4e225793-0c5b-41c1-8f48-dce502a019fc">18,429</ix:nonFraction> of unrecognized expense related to granted, but non-vested share-based compensation arrangements to be incurred in future periods. This expense is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzUwMw_36155214-fd9c-42ca-8f41-1dac7399e22b">3.2</ix:nonNumeric> years.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The excess tax benefit related to share-based compensation recorded by the Company was not material for the years ended December&#160;31, 2021, 2020 and 2019. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon exercise of stock options, or upon the issuance of restricted share awards or performance share unit awards, the Company issues new shares.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021, there were <ix:nonFraction unitRef="shares" contextRef="i62b6ae12248b41dd9329f8af33aa447e_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzgxNg_503a8afa-3268-42a5-ab22-1debf9c83058">1,336</ix:nonFraction> shares authorized for stock option grants, restricted share award grants, and performance share unit award grants in subsequent periods.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inducement Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Board of Directors approved the Avadel Pharmaceuticals plc 2021 Inducement Plan (the &#8220;Inducement Plan&#8221;), which allows the Company to grant equity awards to induce highly-qualified prospective officers and employees who are not currently employed by the Company to accept employment and provide them with a proprietary interest in the Company. The maximum number of shares reserved and available for issuance under the Plan is <ix:nonFraction unitRef="shares" contextRef="i2880bd052c594c028d8ff7cb30be355f_I20211231" decimals="-3" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI3NDg3NzkwODEwMzc_ac04c126-3f17-445f-beab-6612cfebff1a">1,500</ix:nonFraction> shares. As of December 31, 2021, the Company had not issued any shares under this Inducement Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Determining the Fair Value of Stock Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the total fair value of stock options on the grant date using the Black-Scholes option-pricing model and recognizes each grant&#8217;s fair value as compensation expense over the period that the option vests. Options are granted to employees of the Company and become exercisable ratably over <ix:nonNumeric contextRef="i17b0b84673264785a47fb9c2393d8d97_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzEzMTI_46cfb4bf-5ceb-4273-9a8b-aeae92173448">four years</ix:nonNumeric> following the grant date and expire <ix:nonNumeric contextRef="i17b0b84673264785a47fb9c2393d8d97_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzEzNTE_b59fa27e-5032-47f8-a710-5bc0c6b41592">ten years</ix:nonNumeric> after the grant date. Prior to 2021, the Company issued stock options to its Board of Directors as compensation for services rendered that are exercisable ratably over <ix:nonNumeric contextRef="i12defb4ee11f4638be647bb1b2e8d3cd_D20200101-20201231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzE1MTk_19a67a67-e9ac-4cad-9969-e53c8072fd7b">three years</ix:nonNumeric> following the grant date, and expire <ix:nonNumeric contextRef="i12defb4ee11f4638be647bb1b2e8d3cd_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzE1NTk_a335fdfd-5ffa-4464-9173-c8445e8ff6c4">ten years</ix:nonNumeric> after the grant date. In 2021, the Company issued stock options to its Board of Directors as compensation for services rendered and are exercisable one year following the grant date and expire ten years after the grant date.  </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-100-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id07f65e80fa54096b509f32c7d5bb1a4" continuedAt="i511833720b0949a1b3da8fc97d51aa78"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="avdl:ScheduleOfShareBasedPaymentAwardStockOptionsAndWarrantGrantsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzY3MDc_0209e136-7e0b-44e8-b810-7ca48caaf229" escape="true"><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions under the Black-Scholes option-pricing model for stock option grants as of December&#160;31, 2021, 2020 and 2019, are as follows: &#160;&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:48.679%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.909%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Option Assumptions: </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock option grants:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3404683becd24bbaa99d0f9b831bc219_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTphYjk3OTNhMjRjZDY0YzQ1ODUwODFmZjE5ZjlhZGE0Mi90YWJsZXJhbmdlOmFiOTc5M2EyNGNkNjRjNDU4NTA4MWZmMTlmOWFkYTQyXzMtMi0xLTEtMjM0NTg_28b08c1c-2d92-4779-beab-6e5c024cca67">6.20</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i80fe8f6ade7440249243d34649acec04_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTphYjk3OTNhMjRjZDY0YzQ1ODUwODFmZjE5ZjlhZGE0Mi90YWJsZXJhbmdlOmFiOTc5M2EyNGNkNjRjNDU4NTA4MWZmMTlmOWFkYTQyXzMtNC0xLTEtMjM0NTg_2471c7bc-fa49-40c6-82a8-1554f34a2441">6.08</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibc32436cac984c44acb451d8f53084cb_D20190101-20191231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTphYjk3OTNhMjRjZDY0YzQ1ODUwODFmZjE5ZjlhZGE0Mi90YWJsZXJhbmdlOmFiOTc5M2EyNGNkNjRjNDU4NTA4MWZmMTlmOWFkYTQyXzMtNi0xLTEtMjM0NTg_96caf1a3-1c6a-4d9e-ba19-4207919acd2c">6.25</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3404683becd24bbaa99d0f9b831bc219_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTphYjk3OTNhMjRjZDY0YzQ1ODUwODFmZjE5ZjlhZGE0Mi90YWJsZXJhbmdlOmFiOTc5M2EyNGNkNjRjNDU4NTA4MWZmMTlmOWFkYTQyXzQtMi0xLTEtMjM0NTg_2065d0c3-8dc4-4334-831c-937604c95c7c">73.91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i80fe8f6ade7440249243d34649acec04_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTphYjk3OTNhMjRjZDY0YzQ1ODUwODFmZjE5ZjlhZGE0Mi90YWJsZXJhbmdlOmFiOTc5M2EyNGNkNjRjNDU4NTA4MWZmMTlmOWFkYTQyXzQtNC0xLTEtMjM0NTg_dccf0fda-74d2-42ff-837d-eb4a3a4b8d9c">75.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibc32436cac984c44acb451d8f53084cb_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTphYjk3OTNhMjRjZDY0YzQ1ODUwODFmZjE5ZjlhZGE0Mi90YWJsZXJhbmdlOmFiOTc5M2EyNGNkNjRjNDU4NTA4MWZmMTlmOWFkYTQyXzQtNi0xLTEtMjM0NTg_9f76281e-1d5c-4ec3-b17d-e73ed6c6fce4">56.48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3404683becd24bbaa99d0f9b831bc219_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTphYjk3OTNhMjRjZDY0YzQ1ODUwODFmZjE5ZjlhZGE0Mi90YWJsZXJhbmdlOmFiOTc5M2EyNGNkNjRjNDU4NTA4MWZmMTlmOWFkYTQyXzUtMi0xLTEtMjM0NTg_ea6b7a90-078f-4264-ab15-110e33c804b7">1.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i80fe8f6ade7440249243d34649acec04_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTphYjk3OTNhMjRjZDY0YzQ1ODUwODFmZjE5ZjlhZGE0Mi90YWJsZXJhbmdlOmFiOTc5M2EyNGNkNjRjNDU4NTA4MWZmMTlmOWFkYTQyXzUtNC0xLTEtMjM0NTg_691ba2a2-41f4-4b47-97c3-4bab81ebb7ac">0.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibc32436cac984c44acb451d8f53084cb_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTphYjk3OTNhMjRjZDY0YzQ1ODUwODFmZjE5ZjlhZGE0Mi90YWJsZXJhbmdlOmFiOTc5M2EyNGNkNjRjNDU4NTA4MWZmMTlmOWFkYTQyXzUtNi0xLTEtMjM0NTg_98456917-bb26-4e7c-925f-f12ff941e5d4">2.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3404683becd24bbaa99d0f9b831bc219_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTphYjk3OTNhMjRjZDY0YzQ1ODUwODFmZjE5ZjlhZGE0Mi90YWJsZXJhbmdlOmFiOTc5M2EyNGNkNjRjNDU4NTA4MWZmMTlmOWFkYTQyXzYtMi0xLTEtMjM0NTg_787eadb0-09bb-4e9a-a150-835114521f82">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i80fe8f6ade7440249243d34649acec04_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTphYjk3OTNhMjRjZDY0YzQ1ODUwODFmZjE5ZjlhZGE0Mi90YWJsZXJhbmdlOmFiOTc5M2EyNGNkNjRjNDU4NTA4MWZmMTlmOWFkYTQyXzYtNC0xLTEtMjM0NTg_bf1ef104-63b5-4efe-96b0-b98f910ae7e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibc32436cac984c44acb451d8f53084cb_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTphYjk3OTNhMjRjZDY0YzQ1ODUwODFmZjE5ZjlhZGE0Mi90YWJsZXJhbmdlOmFiOTc5M2EyNGNkNjRjNDU4NTA4MWZmMTlmOWFkYTQyXzYtNi0xLTEtMjM0NTg_c91ea152-4a88-443e-aadc-cf5532666fd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected term</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The expected term of the options represents the period of time between the grant date and the time the options are either exercised or forfeited, including an estimate of future forfeitures for outstanding options. Given the limited historical data, the simplified method has been used to calculate the expected life.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The expected volatility is calculated based on an average of the historical volatility of the Company&#8217;s stock price for a period approximating the expected term.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-free interest rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant and a maturity that approximates the expected term.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected dividend yield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The Company has not distributed any dividends since its inception and have no plan to distribute dividends in the foreseeable future.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzY3MTg_6f003fb4-e020-4829-a0ca-16e3713ce719" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the combined stock option activity and other data for the Company&#8217;s stock option plans for the year ended December&#160;31, 2021 is as follows: &#160;&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:34.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.194%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.194%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.194%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.196%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Stock Option Activity and Other Data: </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number&#160;of Stock<br/>Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options outstanding, January 1, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzItMi0xLTEtMjM0NTg_7695dcd5-89ec-4fdb-838b-b0680ddd1018">5,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzItNC0xLTEtMjM0NTg_1147b6e4-5949-4df0-8593-c052d6190c26">7.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzMtMi0xLTEtMjM0NTg_0e5907e1-d5e5-40b3-9ee1-d1a1ff3e8ffa">2,857</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzMtNC0xLTEtMjM0NTg_e164a6bf-4922-49de-b2f4-e8b41ea70b09">8.20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzQtMi0xLTEtMjM0NTg_4b18d396-1ddb-4434-9389-7702b30d2fd8">48</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzQtNC0xLTEtMjM0NTg_8832665b-1a3b-4523-acf4-ddb234604b79">3.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzUtMi0xLTEtMjM0NTg_842cf09f-758a-4a38-b684-778d38a88002">234</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzUtNC0xLTEtMjM0NTg_54de7362-6ec1-4cb2-b10e-c80fc7346ac9">7.13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzYtMi0xLTEtMjM0NTg_9c309d8b-74dd-49dc-85f2-9e5c2e14891e">70</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzYtNC0xLTEtMjM0NTg_952b000d-0f8f-425c-82a3-6bd438ed911f">12.62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options outstanding, December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzctMi0xLTEtMjM0NTg_8e715c7b-2e0a-45a0-94c4-abe6ff0b8bc4">8,403</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzctNC0xLTEtMjM0NTg_10ccc2ba-3797-4cb5-ae8d-9103d9e5b99b">7.39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzctNi0xLTEtMjM0NTg_48796160-93b6-4aa8-97f2-12ab4b209066">7.83</ix:nonNumeric> years</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzctOC0xLTEtMjM0NTg_18c295ac-5249-4bcf-a181-ed466ff75a81">12,204</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options exercisable, December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzgtMi0xLTEtMjM0NTg_5a33f89e-bbd4-467e-a12b-f2041fc7826d">3,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzgtNC0xLTEtMjM0NTg_40b2981c-a6d3-4423-b99b-693e9ae62b42">7.88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzgtNi0xLTEtMjM0NTg_44e341ff-c2e9-40cc-ba2a-2147390139de">5.88</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzgtOC0xLTEtMjM0NTg_c530deac-1cf6-4183-9102-b56874422494">6,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value of options exercisable at December&#160;31, 2021, 2020 and 2019 was $<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI4MTM_0ca6e638-5be1-47bb-b23a-c19ee85f6c93">6,291</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI4MTc_24092a61-9446-493f-85e8-4752db8b559e">1,841</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI4MjU_618dd3ff-6c8e-4633-a79a-0c23d2fea425">572</ix:nonFraction>, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average grant date fair value of options granted during the years ended December&#160;31, 2021, 2020 and 2019 was $<ix:nonFraction unitRef="usdPerShare" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI5NDg_3b50a7af-bac7-415f-94b3-f1571e7584c1">5.36</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI5NTI_7c5147f5-dad3-4ce8-95c7-16965eab9fd4">4.63</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI5NTk_0a8e8b4d-29d1-4105-a78e-b72033aa122a">1.24</ix:nonFraction> per share, respectively.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Share Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted share awards represent Company shares issued free of charge to employees of the Company as compensation for services rendered. The Company measures the total fair value of restricted share awards on the grant date using the Company&#8217;s stock price at the time of the grant. Restricted share awards granted from 2017-2020 vest over a <ix:nonNumeric contextRef="i542cb65bcac94725a2e85b1f9d50115f_D20170101-20201231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzY3MTA_fc1deddf-878d-4dd8-980b-e3c0be50c5a7">three-year</ix:nonNumeric> period; two-thirds (2/3) vesting on the second anniversary of the grant date and the remaining one-third (1/3) vesting on the third anniversary of the grant date.&#160; In 2021, restricted share awards granted to employees vest over a <ix:nonNumeric contextRef="i43f3e0d370bf48618c4b4ffce4f20c85_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI3NDg3NzkwODEwMjA_86b05f2f-f184-494a-a6b8-21aa555999fd">four-year</ix:nonNumeric> period; one-fourth (1/4) on each anniversary of the grant date. In 2018, the Company issued restricted share awards to its Board of Directors vesting over a <ix:nonNumeric contextRef="i543086e15a0649c38d2ae050067cfe92_D20180101-20181231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI3NDg3NzkwODEwMzU_e00f91ab-d904-4bd5-a0ff-f32f402d2c87">three-year</ix:nonNumeric> period; one-third (1/3) vesting on each of the three anniversaries of the grant date. Compensation expense for such awards granted during and after 2017 is recognized over the applicable vesting period.&#160; </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzY3Mjg_8248d45c-f15d-4e8c-b7e8-e535abb9a8e9" continuedAt="i78a87cedd0694dc78b867ed1c069ae1b" escape="true">A summary of the Company&#8217;s restricted share awards as of December&#160;31, 2021, and changes during the year then ended, is reflected in the table below.&#160;</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-101-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i511833720b0949a1b3da8fc97d51aa78" continuedAt="i795de145a23d47c1b9ae3b12ee81ec00"><div style="text-align:justify"><ix:continuation id="i78a87cedd0694dc78b867ed1c069ae1b" continuedAt="i7e72605571be4d219239c324b7c253fd"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.353%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Share Activity and Other Data: </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Restricted Share Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date<br/>Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested restricted share awards outstanding, January 1, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9385e38dbc52477281fcde7e0e8243bf_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4NDVjN2U0ZmQ2ZWE0MTczOTczYWQ0MmQzM2YwODgwZi90YWJsZXJhbmdlOjg0NWM3ZTRmZDZlYTQxNzM5NzNhZDQyZDMzZjA4ODBmXzItMi0xLTEtMjM0NTg_e981d79f-9f89-48fe-bb86-2473a87f157c">347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9385e38dbc52477281fcde7e0e8243bf_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4NDVjN2U0ZmQ2ZWE0MTczOTczYWQ0MmQzM2YwODgwZi90YWJsZXJhbmdlOjg0NWM3ZTRmZDZlYTQxNzM5NzNhZDQyZDMzZjA4ODBmXzItNC0xLTEtMjM0NTg_dbae645c-c3a7-4569-b4dd-7467247af10d">5.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i60cd02301b0744718ab6232fc8397080_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4NDVjN2U0ZmQ2ZWE0MTczOTczYWQ0MmQzM2YwODgwZi90YWJsZXJhbmdlOjg0NWM3ZTRmZDZlYTQxNzM5NzNhZDQyZDMzZjA4ODBmXzMtMi0xLTEtMjM0NTg_86079eb5-0d78-448a-9cb4-35458aeb061d">99</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i60cd02301b0744718ab6232fc8397080_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4NDVjN2U0ZmQ2ZWE0MTczOTczYWQ0MmQzM2YwODgwZi90YWJsZXJhbmdlOjg0NWM3ZTRmZDZlYTQxNzM5NzNhZDQyZDMzZjA4ODBmXzMtNC0xLTEtMjM0NTg_93a94a5f-ea8d-4fc9-af53-99821e71ff3a">8.22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i60cd02301b0744718ab6232fc8397080_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4NDVjN2U0ZmQ2ZWE0MTczOTczYWQ0MmQzM2YwODgwZi90YWJsZXJhbmdlOjg0NWM3ZTRmZDZlYTQxNzM5NzNhZDQyZDMzZjA4ODBmXzQtMi0xLTEtMjM0NTg_e6828f88-3dd2-4d2e-a4fd-71406f4b5ed0">160</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i60cd02301b0744718ab6232fc8397080_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4NDVjN2U0ZmQ2ZWE0MTczOTczYWQ0MmQzM2YwODgwZi90YWJsZXJhbmdlOjg0NWM3ZTRmZDZlYTQxNzM5NzNhZDQyZDMzZjA4ODBmXzQtNC0xLTEtMjM0NTg_22220313-22d3-45f3-9dbe-db69c980a6ff">5.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i60cd02301b0744718ab6232fc8397080_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4NDVjN2U0ZmQ2ZWE0MTczOTczYWQ0MmQzM2YwODgwZi90YWJsZXJhbmdlOjg0NWM3ZTRmZDZlYTQxNzM5NzNhZDQyZDMzZjA4ODBmXzUtMi0xLTEtMjM0NTg_215429c5-73e5-44dc-853d-f0b6affdb606">12</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i60cd02301b0744718ab6232fc8397080_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4NDVjN2U0ZmQ2ZWE0MTczOTczYWQ0MmQzM2YwODgwZi90YWJsZXJhbmdlOjg0NWM3ZTRmZDZlYTQxNzM5NzNhZDQyZDMzZjA4ODBmXzUtNC0xLTEtMjM0NTg_9f77f3dd-74fe-4221-a90f-e76fea095baf">7.08</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested restricted share awards outstanding, December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifa8fa276a1de4b9ea652bbce418a979a_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4NDVjN2U0ZmQ2ZWE0MTczOTczYWQ0MmQzM2YwODgwZi90YWJsZXJhbmdlOjg0NWM3ZTRmZDZlYTQxNzM5NzNhZDQyZDMzZjA4ODBmXzYtMi0xLTEtMjM0NTg_0740ea53-1b15-44c7-b648-0bde3d58c677">274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifa8fa276a1de4b9ea652bbce418a979a_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4NDVjN2U0ZmQ2ZWE0MTczOTczYWQ0MmQzM2YwODgwZi90YWJsZXJhbmdlOjg0NWM3ZTRmZDZlYTQxNzM5NzNhZDQyZDMzZjA4ODBmXzYtNC0xLTEtMjM0NTg_4872316c-a51f-4565-b3ed-37942e80c7c8">7.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average grant date fair value of restricted share awards granted during the years ended December&#160;31, 2021, 2020 and 2019 was $<ix:nonFraction unitRef="usdPerShare" contextRef="i60cd02301b0744718ab6232fc8397080_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzQ1MDM_2225d828-b4fd-4388-ae12-cd9734716a3f">8.22</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="id51962221b6045adacaa762297fcce4c_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzQ1MDc_835a7201-c86f-4ee4-a255-b5eebda0d908">7.69</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="ie4e4adc9bd9a43e4b7a14bed4eafeaaa_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzQ1MTQ_a668a760-83cf-4488-ad1c-be1343eecfff">2.47</ix:nonFraction>, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Share Units Awards</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance share units awards (&#8220;PSUs&#8221;) represent Company shares issued free of charge to employees of the Company as compensation for achieving various results. The Company measures the total fair value of performance share unit awards on the grant date using the Company&#8217;s stock price at the time of the grant. In 2020, the Company granted performance share awards, of which <ix:nonFraction unitRef="number" contextRef="i8ada9b293d7f49f393204ff4cdec742a_D20210101-20211231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzQ5NDE_24f3192b-7267-4367-a5d3-b4774437b5a2">50</ix:nonFraction>% vest upon the achievement of certain regulatory milestones related to FT218 and the other <ix:nonFraction unitRef="number" contextRef="ia69e39054ae948c9a9472b1618aee17c_D20210101-20211231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzUwMzQ_8a50ac3a-e47f-4975-9a98-670047a78eb0">50</ix:nonFraction>% vest <ix:nonNumeric contextRef="ia69e39054ae948c9a9472b1618aee17c_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzUwNDI_fb25ab9f-0ec6-46c6-aafe-6fa2c417a902">one year</ix:nonNumeric> following achievement of those milestones (&#8220;2020 PSU awards&#8221;). The Company has not yet recognized any share-based compensation expense related to the 2020 PSU awards as the regulatory milestones have not yet been met; however, in the event the performance conditions are met before a certain date, approximately <ix:nonFraction unitRef="number" contextRef="ibcd77640185c41ca9d2ac2883e957c10_D20210101-20211231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzUzMTg_752b0169-876a-4474-8ef3-7e90e369fce2">100</ix:nonFraction>% of the outstanding shares, or $<ix:nonFraction unitRef="usd" contextRef="ibcd77640185c41ca9d2ac2883e957c10_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzUzNTE_3f30315b-3786-4855-a9b3-94152c50b7e7">1,786</ix:nonFraction> of compensation expense will be recognized by the Company for the 2020 PSU awards outstanding as of December&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the Company granted performance share awards of which <ix:nonFraction unitRef="number" contextRef="i8244f7a6941e41b6b0fc0fa1f31f090c_D20210101-20211231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI3NDg3NzkwODA5NjQ_50fc8e9e-7302-4e30-b28e-4953c17aa872">50</ix:nonFraction>% vest upon achievement of certain corporate objectives and the second <ix:nonFraction unitRef="number" contextRef="i213dddfe6eca46e9b836e9ed09ef1520_D20210101-20211231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI3NDg3NzkwODA5Njk_e2dabece-d91d-460b-afd9-894faaea0a77">50</ix:nonFraction>% vests <ix:nonNumeric contextRef="i213dddfe6eca46e9b836e9ed09ef1520_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI3NDg3NzkwODA5ODU_eb23ac4a-00c4-45b8-aee7-fc2b25254ad6">one year</ix:nonNumeric> following achievement of those objectives (&#8220;2021 PSU awards&#8221;).  The Company has not yet recognized any share-based compensation expense related to the 2021 PSU awards as the objectives have not yet been met; however, in the event the performance conditions are met and exceeded, approximately <ix:nonFraction unitRef="number" contextRef="i4518f66a522647cd984ba59be675f8ce_D20210101-20211231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI3NDg3NzkwODA5OTE_a9676c57-89ad-42a4-8f4c-c73164962bc3">150</ix:nonFraction>% of the outstanding shares, or $<ix:nonFraction unitRef="usd" contextRef="i8244f7a6941e41b6b0fc0fa1f31f090c_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI3NDg3NzkwODA5OTc_8fe7b038-0658-4c76-8575-330017246331">3,509</ix:nonFraction> of compensation expense will be recognized by the Company for the 2021 PSU awards outstanding as of December&#160;31, 2021.</span></div><div><span><br/></span></div><ix:continuation id="i7e72605571be4d219239c324b7c253fd"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company&#8217;s performance share units awards as of December&#160;31, 2021, and changes during the year then ended, is reflected in the table below. </span></div><div><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.353%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Performance Unit Share Activity and Other Data</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Performance Share Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date<br/>Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested performance share awards outstanding, January 1, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i08ccab8f43964d778b6f1aa5700dd88f_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4ODA1OTVjMGU2MGQ0MGJmYmQ5ZjgzYmUwZjM0NjA2Zi90YWJsZXJhbmdlOjg4MDU5NWMwZTYwZDQwYmZiZDlmODNiZTBmMzQ2MDZmXzItMi0xLTEtMjM0NTg_c6e2f256-eb1e-4dfc-b4ee-e914e511db43">257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i08ccab8f43964d778b6f1aa5700dd88f_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4ODA1OTVjMGU2MGQ0MGJmYmQ5ZjgzYmUwZjM0NjA2Zi90YWJsZXJhbmdlOjg4MDU5NWMwZTYwZDQwYmZiZDlmODNiZTBmMzQ2MDZmXzItNC0xLTEtMjM0NTg_e2660426-bafb-46a7-847b-12d742d7f5eb">7.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibcd77640185c41ca9d2ac2883e957c10_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4ODA1OTVjMGU2MGQ0MGJmYmQ5ZjgzYmUwZjM0NjA2Zi90YWJsZXJhbmdlOjg4MDU5NWMwZTYwZDQwYmZiZDlmODNiZTBmMzQ2MDZmXzMtMi0xLTEtMjM0NTg_7a4fc997-6286-46eb-b616-95a0da42c9f1">285</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibcd77640185c41ca9d2ac2883e957c10_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4ODA1OTVjMGU2MGQ0MGJmYmQ5ZjgzYmUwZjM0NjA2Zi90YWJsZXJhbmdlOjg4MDU5NWMwZTYwZDQwYmZiZDlmODNiZTBmMzQ2MDZmXzMtNC0xLTEtMjM0NTg_c82d73c9-c50c-441b-9804-ccf4af00571b">8.20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibcd77640185c41ca9d2ac2883e957c10_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4ODA1OTVjMGU2MGQ0MGJmYmQ5ZjgzYmUwZjM0NjA2Zi90YWJsZXJhbmdlOjg4MDU5NWMwZTYwZDQwYmZiZDlmODNiZTBmMzQ2MDZmXzQtMi0xLTEtMjM0NTg_5150a4a4-05eb-4d7d-9f82-b06367820390">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibcd77640185c41ca9d2ac2883e957c10_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4ODA1OTVjMGU2MGQ0MGJmYmQ5ZjgzYmUwZjM0NjA2Zi90YWJsZXJhbmdlOjg4MDU5NWMwZTYwZDQwYmZiZDlmODNiZTBmMzQ2MDZmXzQtNC0xLTEtMjM0NTg_f5071bc0-9f64-47e7-afa6-effcf34022d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibcd77640185c41ca9d2ac2883e957c10_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4ODA1OTVjMGU2MGQ0MGJmYmQ5ZjgzYmUwZjM0NjA2Zi90YWJsZXJhbmdlOjg4MDU5NWMwZTYwZDQwYmZiZDlmODNiZTBmMzQ2MDZmXzUtMi0xLTEtMjM0NTg_a463089a-d338-42e9-ae00-f45c1004dacd">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibcd77640185c41ca9d2ac2883e957c10_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4ODA1OTVjMGU2MGQ0MGJmYmQ5ZjgzYmUwZjM0NjA2Zi90YWJsZXJhbmdlOjg4MDU5NWMwZTYwZDQwYmZiZDlmODNiZTBmMzQ2MDZmXzUtNC0xLTEtMjM0NTg_b6bb62a9-bbaa-4381-a480-e645854e768c">5.36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested performance share awards outstanding, December 31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7b206dec3ef4b5d9ee30dd96c6c7208_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4ODA1OTVjMGU2MGQ0MGJmYmQ5ZjgzYmUwZjM0NjA2Zi90YWJsZXJhbmdlOjg4MDU5NWMwZTYwZDQwYmZiZDlmODNiZTBmMzQ2MDZmXzYtMi0xLTEtMjM0NTg_da94160f-8b54-45ee-864f-0fec98d4600e">535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie7b206dec3ef4b5d9ee30dd96c6c7208_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4ODA1OTVjMGU2MGQ0MGJmYmQ5ZjgzYmUwZjM0NjA2Zi90YWJsZXJhbmdlOjg4MDU5NWMwZTYwZDQwYmZiZDlmODNiZTBmMzQ2MDZmXzYtNC0xLTEtMjM0NTg_4ae95a6a-db3a-4eec-b081-cd04e1e9d7eb">7.71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average grant date fair value of performance share awards granted during the years ended December 31, 2021 and 2020 was $<ix:nonFraction unitRef="usdPerShare" contextRef="ibcd77640185c41ca9d2ac2883e957c10_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzEwNDQ1MzYwNDc1Mzgx_0583ece1-4228-49ea-a0fe-7ff236e380f3">8.20</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="ice6e75c4e53f421694026f9bdc2f0a37_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzU3MzI_845069c6-d43c-4bb6-a1a2-6f60c554784d">7.09</ix:nonFraction> per share, respectively. There were <ix:nonFraction unitRef="usdPerShare" contextRef="i1ea3506d4ee445e483ed272a81e24e72_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzEwNDQ1MzYwNDc1Mzkx_8f0ba6e7-e74a-4934-8362-d5d969de4399">no</ix:nonFraction> performance share awards granted during the year ended December 31, 2019. </span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-102-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i795de145a23d47c1b9ae3b12ee81ec00"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Share Purchase Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, the Board of Directors approved the Avadel Pharmaceuticals plc 2017 Avadel Employee Share Purchase Plan (&#8220;ESPP&#8221;).  The total number of Company ordinary shares, nominal value $<ix:nonFraction unitRef="usdPerShare" contextRef="ief179786cb524ebfa29b22addb7be488_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzU5NjQ_7efabbeb-ee89-4d1c-95c2-171ffe989fda">0.01</ix:nonFraction> per share, or ADSs representing such ordinary shares (collectively, &#8220;Shares&#8221;) which may be issued under the ESPP is <ix:nonFraction unitRef="shares" contextRef="ief179786cb524ebfa29b22addb7be488_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzYwODM_afde9817-fe69-41a8-bb03-fd8abc1058b3">1,000</ix:nonFraction>. The purchase price at which a share will be issued or sold for a given offering period will be established by the Compensation Committee of the Board (&#8220;Committee&#8221;) (and may differ among participants, as determined by the Committee in its sole discretion) but will in no event be less than <ix:nonFraction unitRef="number" contextRef="ifdf6a4240ce9425b9403a1273967c137_D20210101-20211231" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzYzNzc_0f2900bb-a059-4747-836a-49d071a695aa">85</ix:nonFraction>% of the lesser of: (a) the fair market value of a Share on the offering date; or (b) the fair market value of a Share on the purchase date.  During the years ended December&#160;31, 2021 and 2020, the Company issued <ix:nonFraction unitRef="shares" contextRef="icf6ce914e29a4f3d86cdf8ae44d7a965_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzY1NzM_e55c5424-bcb1-4f36-a1e9-483a83f09d2c">17</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="iebe32eeb9dbe40dbb43d30c6ba5c778b_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzY1ODA_350667d7-8de7-404e-8711-984d02090820">49</ix:nonFraction> ordinary shares to employees, respectively.  Expense related to the ESPP for the years ended December&#160;31, 2021, 2020 and 2019 was immaterial.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_157"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 19:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90ZXh0cmVnaW9uOjc4NDIyM2U0ZmE3YjQ5YzY5NWQ5ZTAyZjRlOTIzMTk3XzIxNzk_e4e786ef-5713-4efb-8a67-5f640b2acb43" continuedAt="idfdf7dca2cf74345817c6ec16b37f5ee" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net (Loss) Income Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></ix:nonNumeric></div><ix:continuation id="idfdf7dca2cf74345817c6ec16b37f5ee" continuedAt="i69ffa06719d1446dabfb25da1156bfd7"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net (loss) income per share is calculated by dividing net (loss) income by the weighted average number of shares outstanding during each period. Diluted net (loss) income per share is calculated by dividing net (loss) income - diluted by the diluted number of shares outstanding during each period. Except where the result would be anti-dilutive to net (loss) income, diluted net (loss) income per share would be calculated assuming the impact of the conversion of the 2023 Notes, the conversion of the Company&#8217;s preferred shares, the exercise of outstanding equity compensation awards, and ordinary shares expected to be issued under the Company&#8217;s ESPP.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a choice to settle the conversion obligation under the 2023 Notes in cash, shares or any combination of the two. The Company utilizes the if-converted method to reflect the impact of the conversion of the 2023 Notes, unless the result is anti-dilutive. This method assumes the conversion of the 2023 Notes into shares of the Company&#8217;s ordinary shares and reflects the elimination of the interest expense related to the 2023 Notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dilutive effect of the stock options, restricted stock units, preferred shares and ordinary shares expected to be issued under the Company&#8217;s ESPP has been calculated using the treasury stock method. The dilutive effect of the PSUs will be calculated using the treasury stock method, if and when the contingent vesting condition is achieved.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90ZXh0cmVnaW9uOjc4NDIyM2U0ZmE3YjQ5YzY5NWQ5ZTAyZjRlOTIzMTk3XzIxODQ_0d526f14-c0c8-4f78-b24d-fc2876591322" escape="true"><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted net (loss) income per share, together with the related shares outstanding in thousands for the years ended December&#160;31, 2021, 2020 and 2019, is as follows: &#160;&#160;</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.832%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net (Loss) Income Per Share: </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2aea8b8d433e4423879f52b4780b5b0f_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzUtMi0xLTEtMjM0NTg_778106cc-e8f7-4bbe-888f-fc5aac11201d">77,329</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzUtNC0xLTEtMjM0NTg_b3645de4-d511-49a0-909c-4e8cd0ee1bac">7,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzUtNi0xLTEtMjM0NTg_614e1022-910a-4760-b50c-5b992ff2753c">33,226</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzgtMi0xLTEtMjM0NTg_e8f41144-ea9c-42a0-b62f-c4518d60c2cd">58,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzgtNC0xLTEtMjM0NTg_cad0d07d-beb2-4319-a354-535f4ed7eeac">52,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzgtNi0xLTEtMjM0NTg_411037d4-eb31-46d2-a8a8-021d35b42b65">37,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive securities&#8212;employee and director equity awards outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzktMi0xLTEtMjM0NTg_68b81a78-4fb8-4f72-b3ef-229dc18f875d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzktNC0xLTEtMjM0NTg_8f0aa73f-e614-4644-9100-e2baa0f97eb5">1,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzktNi0xLTEtMjM0NTg_dd650455-01fc-4008-b9c2-e13273dab3f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzEwLTItMS0xLTIzNDU4_61c2a76f-59ab-46d8-8c81-97a3976afeaf">58,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzEwLTQtMS0xLTIzNDU4_0faa45a1-0703-404b-8f78-1337e98ce046">54,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzEwLTYtMS0xLTIzNDU4_00ec8023-14f8-4c3d-8b45-2cc7551d593a">37,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income per share - basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzE1LTItMS0xLTIzNDU4_07f2d98c-c8d3-4aed-b152-b3c4062c5d66">1.32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzE1LTQtMS0xLTIzNDU4_d6b19ec2-df0c-47a2-aafa-a215f9c8d221">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzE1LTYtMS0xLTIzNDU4_8c3e9d9f-6d98-4901-aea8-19150bea09d9">0.89</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income per share - diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzIwLTItMS0xLTIzNDU4_21a64914-e97c-4e0c-8716-bb6ba21be68b">1.32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzIwLTQtMS0xLTIzNDU4_ce3253ce-128e-4f92-9a66-a7197df1241e">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzIwLTYtMS0xLTIzNDU4_b959136c-29d4-4d13-9c6e-56430f5de7a3">0.89</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i69ffa06719d1446dabfb25da1156bfd7">Potential ordinary shares of <ix:nonFraction unitRef="shares" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90ZXh0cmVnaW9uOjc4NDIyM2U0ZmE3YjQ5YzY5NWQ5ZTAyZjRlOTIzMTk3XzE2ODA_e8e9eddf-80cd-40c5-a85e-3bf13ed27424">15,327</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90ZXh0cmVnaW9uOjc4NDIyM2U0ZmE3YjQ5YzY5NWQ5ZTAyZjRlOTIzMTk3XzE2ODQ_4da1c54e-72c7-49ed-aa21-d04661d167bf">14,915</ix:nonFraction>, and <ix:nonFraction unitRef="shares" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90ZXh0cmVnaW9uOjc4NDIyM2U0ZmE3YjQ5YzY5NWQ5ZTAyZjRlOTIzMTk3XzE2OTI_5eb3deee-5128-4dea-8a65-6a3253bfaa7d">16,740</ix:nonFraction> were excluded from the calculation of weighted average shares for the years ended December&#160;31, 2021, 2020 and 2019, respectively, because either their effect was considered to be anti-dilutive or they were related to shares from PSUs for which the contingent vesting condition had not been achieved. For the years ended December&#160;31, 2021 and 2019, the effects of dilutive securities were entirely excluded from the calculation of net (loss) income per share as a net loss was reported in these periods.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-103-</span></div></div></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_160"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 20:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90ZXh0cmVnaW9uOmZkZGMxYmUwNjBhOTQ2OWM4MjNkMjFhYWNjYjYzMmYzXzE4Ng_dbbd60b8-84b0-4ddf-b162-044ee1eda6a3" continuedAt="iba462f0ea47e4296a6dcec13662b1bce" escape="true">Comprehensive Loss</ix:nonNumeric></span></div><ix:continuation id="iba462f0ea47e4296a6dcec13662b1bce"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90ZXh0cmVnaW9uOmZkZGMxYmUwNjBhOTQ2OWM4MjNkMjFhYWNjYjYzMmYzXzE4MQ_c07edcac-5dfc-476e-8b4f-c073b27288a0" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of accumulated other comprehensive loss for the year ended December 31, net of immaterial tax effects:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:49.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8998385242564cbfaaaf6433c863849d_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzMtMi0xLTEtMjM0NTg_14ac88f1-bc2e-4eb4-9637-6d9fb5c059d3">22,627</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief47867d77194fa783312c489f06e3d5_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzMtNC0xLTEtMjM0NTg_a216b64e-5675-413e-b1b0-6843d7500feb">23,738</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79413685d8144e178e42b28c2e99365b_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzMtNi0xLTEtMjM0NTg_a785d45b-1d11-4b77-9499-e106f8f6ded2">23,621</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive (loss) income </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieeed97785c574074863094742c31cea8_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzQtMi0xLTEtMjM0NTg_acf59f55-f6d6-4436-95a2-a27b854289a9">1,228</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i474a662d5a374ab8b341858690d4bd8e_D20200101-20201231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzQtNC0xLTEtMjM0NTg_f914cbe7-dbcf-49e0-8ac7-f2cc4e60ccc1">1,111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica4213e299f9427b901f343c8c2b93e9_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzQtNi0xLTEtMjM0NTg_92252c4d-9c2e-435d-abba-c58019ea878a">117</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6899b6aea474e37acddcb73ba8cdaef_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzUtMi0xLTEtMjM0NTg_4416f9ac-f091-43e1-ae38-0b15126b2c53">23,855</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8998385242564cbfaaaf6433c863849d_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzUtNC0xLTEtMjM0NTg_8bb55b2a-5f3f-41b8-8dd7-f58da50ea1f4">22,627</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief47867d77194fa783312c489f06e3d5_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzUtNi0xLTEtMjM0NTg_757e3d7b-023f-41b3-80a5-0b1a0fc16b4f">23,738</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized (loss) gain on marketable securities, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00f270d697454afeb8bada6c69682df2_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzgtMi0xLTEtMjM0NTg_f4513820-95f4-4073-9cfc-a98a40250f81">1,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a4d131f2ecc46778f5ed88f6d27c807_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzgtNC0xLTEtMjM0NTg_7a61893b-424b-4205-bfb3-7f2698dd3e7c">932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a9ae7f277b43dc8ec524cd0712a41c_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzgtNi0xLTEtMjM0NTg_ca70ad19-aa66-4980-8457-08ffab9b6cfe">205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive (loss) income, net of income tax benefit (expense) of  $<ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzktMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo3NjU4ZWU2OTZkNjc0OTc4YWY3ZmRjYWVhMGJhNjNhZl80Mw_5ca0fd2f-6a4b-4d79-816f-0efb1c5d33be">214</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzktMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo3NjU4ZWU2OTZkNjc0OTc4YWY3ZmRjYWVhMGJhNjNhZl80Nw_0b070220-c250-427b-a428-3f5fd9823323">202</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzktMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo3NjU4ZWU2OTZkNjc0OTc4YWY3ZmRjYWVhMGJhNjNhZl81MQ_b1092bf9-89a4-45e5-807a-886247dc7a36">43</ix:nonFraction>),  respectively</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4eec0f5944eb41a387ea1b80154c9f6b_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzktMi0xLTEtMjM0NTg_9a895574-dc29-4200-88ab-3f4d5462b1b2">1,661</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i575efbeda86d4caba5c559924eae6606_D20200101-20201231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzktNC0xLTEtMjM0NTg_a9f10c7f-d08d-405c-9130-29555b70f714">644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5143455b68ee4952a8f2f5bd2395cc6b_D20190101-20191231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzktNi0xLTEtMjM0NTg_a2321b31-bd68-4694-b3f7-3a0051c1c850">727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7de80df209214ad6aec995ee651920e0_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzEwLTItMS0xLTIzNDU4_4a83e10d-5af5-4622-9ac9-ec666e03466f">85</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00f270d697454afeb8bada6c69682df2_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzEwLTQtMS0xLTIzNDU4_b860751d-bb3e-4a3e-9517-97f395892b02">1,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a4d131f2ecc46778f5ed88f6d27c807_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzEwLTYtMS0xLTIzNDU4_59f64b20-3a8a-497f-bffb-f5448df1de6b">932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss at December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79b00d255f634de49f2fc2b349447e88_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzExLTItMS0xLTIzNDU4_74ce3037-b911-4f1b-b8fc-73b917822de9">23,940</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaddacdf3080a4469857cc1c79a9583e3_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzExLTQtMS0xLTIzNDU4_559ddac1-95ab-4b2a-a841-1fec65766993">21,051</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67e12346ebfb4c079f8ca4ba96c5d37c_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzExLTYtMS0xLTIzNDU4_f6539c0b-e473-4b6d-b39b-f607b2c32a18">22,806</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_163"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 21:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90ZXh0cmVnaW9uOjhmYTZlOTI4OTY0NjQ3NGM4MjI5NmVjYjA4ZGFmMDU1XzE5NjI_23a32fa0-ef73-4a1c-86bf-a9c970b1be9e" continuedAt="id9331167a9ec406ba36d5961bfdc12f7" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Operations by Product, Customer and Geographic Area</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></ix:nonNumeric></div><ix:continuation id="id9331167a9ec406ba36d5961bfdc12f7" continuedAt="ib9602fc8d5be43769c1964131312c91e"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that it operates in <ix:nonFraction unitRef="segment" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90ZXh0cmVnaW9uOjhmYTZlOTI4OTY0NjQ3NGM4MjI5NmVjYjA4ZGFmMDU1XzExMw_92f1435e-8c78-4936-a864-9fbfb23effec"><ix:nonFraction unitRef="segment" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90ZXh0cmVnaW9uOjhmYTZlOTI4OTY0NjQ3NGM4MjI5NmVjYjA4ZGFmMDU1XzExMw_d9f993c8-4982-4477-9383-2a42d9899f1d">one</ix:nonFraction></ix:nonFraction> segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer based technology. The Company&#8217;s Chief Operating Decision Maker is the CEO. The CEO reviews profit and loss information on a consolidated basis to assess performance and make overall operating decisions as well as resource allocations. All products are included in <ix:nonFraction unitRef="segment" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90ZXh0cmVnaW9uOjhmYTZlOTI4OTY0NjQ3NGM4MjI5NmVjYjA4ZGFmMDU1XzUzOA_39ce0faf-4675-4867-8e37-3613a01e7e70"><ix:nonFraction unitRef="segment" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90ZXh0cmVnaW9uOjhmYTZlOTI4OTY0NjQ3NGM4MjI5NmVjYjA4ZGFmMDU1XzUzOA_98c7e6ca-b7a2-4ce1-adec-5cbb6cf107b5">one</ix:nonFraction></ix:nonFraction> segment because the Company&#8217;s products have similar economic and other characteristics, including the nature of the products and production processes, type of customers, distribution methods and regulatory environment.&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2020, the Company sold the Hospital Products. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4: Disposition of the Hospital Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company had <ix:nonFraction unitRef="usd" contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90ZXh0cmVnaW9uOjhmYTZlOTI4OTY0NjQ3NGM4MjI5NmVjYjA4ZGFmMDU1XzI3NDg3NzkwNzI4OTM_dbbda1a3-ee3b-4834-a2d7-527a4dbe175e">no</ix:nonFraction> revenue during the twelve months ended December&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90ZXh0cmVnaW9uOjhmYTZlOTI4OTY0NjQ3NGM4MjI5NmVjYjA4ZGFmMDU1XzE5NTk_530a8348-5978-453b-a0fe-7467e4321848" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of total revenues by product for the twelve months ended December 31, 2020 and 2019:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.566%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.839%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Revenue by Product: </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bloxiverz</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7560f23c3ff844359638f73f581206cd_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZToxNGE0Y2JhZGE1NjM0NmEwODEzMTI0ZWU4NTJhNzc0ZC90YWJsZXJhbmdlOjE0YTRjYmFkYTU2MzQ2YTA4MTMxMjRlZTg1MmE3NzRkXzItNC0xLTEtMjM0NTg_d5e60891-82d2-41f6-9349-e840ecbc629b">2,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic58ebe2ec1a34491b83d98083867b7c2_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZToxNGE0Y2JhZGE1NjM0NmEwODEzMTI0ZWU4NTJhNzc0ZC90YWJsZXJhbmdlOjE0YTRjYmFkYTU2MzQ2YTA4MTMxMjRlZTg1MmE3NzRkXzItNi0xLTEtMjM0NTg_f56667a0-eb3e-40c9-8669-873e31fbc1fc">7,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vazculep</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15b58b8fae3c434ca88a14dfad44f1f9_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZToxNGE0Y2JhZGE1NjM0NmEwODEzMTI0ZWU4NTJhNzc0ZC90YWJsZXJhbmdlOjE0YTRjYmFkYTU2MzQ2YTA4MTMxMjRlZTg1MmE3NzRkXzMtNC0xLTEtMjM0NTg_b780c621-798d-42f6-a93f-1358435413c7">10,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8c719f27eb049d5b2f929f14a52769d_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZToxNGE0Y2JhZGE1NjM0NmEwODEzMTI0ZWU4NTJhNzc0ZC90YWJsZXJhbmdlOjE0YTRjYmFkYTU2MzQ2YTA4MTMxMjRlZTg1MmE3NzRkXzMtNi0xLTEtMjM0NTg_b6624df3-5712-4cae-aa02-132181795c93">33,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Akovaz</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cf75cdcb0443f8394a9f9f2b8481e_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZToxNGE0Y2JhZGE1NjM0NmEwODEzMTI0ZWU4NTJhNzc0ZC90YWJsZXJhbmdlOjE0YTRjYmFkYTU2MzQ2YTA4MTMxMjRlZTg1MmE3NzRkXzQtNC0xLTEtMjM0NTg_a6651dd4-0b38-441e-887a-d215b7d5eb0d">9,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i633dae8062544ae688cd05721bcc4684_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZToxNGE0Y2JhZGE1NjM0NmEwODEzMTI0ZWU4NTJhNzc0ZC90YWJsZXJhbmdlOjE0YTRjYmFkYTU2MzQ2YTA4MTMxMjRlZTg1MmE3NzRkXzQtNi0xLTEtMjM0NTg_b1887aa5-597b-48d8-ab1a-0489bbb2e298">18,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id56837453cdf432dba648aaa4d2c9cf8_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZToxNGE0Y2JhZGE1NjM0NmEwODEzMTI0ZWU4NTJhNzc0ZC90YWJsZXJhbmdlOjE0YTRjYmFkYTU2MzQ2YTA4MTMxMjRlZTg1MmE3NzRkXzUtNC0xLTEtMjM0NTg_7e74e2ce-c3a4-4cc8-bf49-b72aa646abcc">159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fb31d32e89a42278408412283fc7bc7_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZToxNGE0Y2JhZGE1NjM0NmEwODEzMTI0ZWU4NTJhNzc0ZC90YWJsZXJhbmdlOjE0YTRjYmFkYTU2MzQ2YTA4MTMxMjRlZTg1MmE3NzRkXzUtNi0xLTEtMjM0NTg_4efa9266-9187-43ae-a573-79dc17cd38de">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZToxNGE0Y2JhZGE1NjM0NmEwODEzMTI0ZWU4NTJhNzc0ZC90YWJsZXJhbmdlOjE0YTRjYmFkYTU2MzQ2YTA4MTMxMjRlZTg1MmE3NzRkXzYtNC0xLTEtMjM0NTg_b08d8037-2b33-4b31-aca3-ec744c9a61f5">22,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZToxNGE0Y2JhZGE1NjM0NmEwODEzMTI0ZWU4NTJhNzc0ZC90YWJsZXJhbmdlOjE0YTRjYmFkYTU2MzQ2YTA4MTMxMjRlZTg1MmE3NzRkXzYtNi0xLTEtMjM0NTg_8ccde1e1-eadd-4010-b2ca-0aa952f54dae">59,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90ZXh0cmVnaW9uOjhmYTZlOTI4OTY0NjQ3NGM4MjI5NmVjYjA4ZGFmMDU1XzE5NjQ_23b2a950-c65d-473b-af61-4b05f2b7dc70" escape="true"><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of total revenues by significant customer for the twelve months ended December 31, 2020 and 2019:&#160;</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.566%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.839%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue by Significant Customer:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">McKesson Corporation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961305f8256144a0921c3dcb9f63da7a_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTpkOTM3ZTk5MDRmZTk0OGE1YmJhZDc5N2QyODViNDE4Yi90YWJsZXJhbmdlOmQ5MzdlOTkwNGZlOTQ4YTViYmFkNzk3ZDI4NWI0MThiXzItNC0xLTEtMjM0NTg_8175f3de-98c9-478a-b638-5272142ca4d0">5,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia55f30e804be44cea8352288a384a9c3_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTpkOTM3ZTk5MDRmZTk0OGE1YmJhZDc5N2QyODViNDE4Yi90YWJsZXJhbmdlOmQ5MzdlOTkwNGZlOTQ4YTViYmFkNzk3ZDI4NWI0MThiXzItNi0xLTEtMjM0NTg_d8e84c4e-7fd4-47e2-9c44-0d7f3506e3cd">14,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cardinal Health</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3ccf5ec9740e58837d91fdc1f7e3f_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTpkOTM3ZTk5MDRmZTk0OGE1YmJhZDc5N2QyODViNDE4Yi90YWJsZXJhbmdlOmQ5MzdlOTkwNGZlOTQ4YTViYmFkNzk3ZDI4NWI0MThiXzMtNC0xLTEtMjM0NTg_3044e1b4-619d-4d37-8fda-d6045d676724">5,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6393bb62733a46eeb7ef3712baca37c8_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTpkOTM3ZTk5MDRmZTk0OGE1YmJhZDc5N2QyODViNDE4Yi90YWJsZXJhbmdlOmQ5MzdlOTkwNGZlOTQ4YTViYmFkNzk3ZDI4NWI0MThiXzMtNi0xLTEtMjM0NTg_8109c318-ed2c-4f94-8194-c7e5c8957640">15,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AmerisourceBergen </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6170920a302f4c30b265cb1c3c9b5e4c_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTpkOTM3ZTk5MDRmZTk0OGE1YmJhZDc5N2QyODViNDE4Yi90YWJsZXJhbmdlOmQ5MzdlOTkwNGZlOTQ4YTViYmFkNzk3ZDI4NWI0MThiXzQtNC0xLTEtMjM0NTg_1cd155d1-7ddd-4fe3-a1e6-16b332ab5f59">3,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd0191dbbea742a0ad131c24b89d15dc_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTpkOTM3ZTk5MDRmZTk0OGE1YmJhZDc5N2QyODViNDE4Yi90YWJsZXJhbmdlOmQ5MzdlOTkwNGZlOTQ4YTViYmFkNzk3ZDI4NWI0MThiXzQtNi0xLTEtMjM0NTg_161d7c20-09fb-4eb3-b638-d98b73e56766">12,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">QuVa Pharma</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0359dc3ae57641d8a06f346eb996b112_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTpkOTM3ZTk5MDRmZTk0OGE1YmJhZDc5N2QyODViNDE4Yi90YWJsZXJhbmdlOmQ5MzdlOTkwNGZlOTQ4YTViYmFkNzk3ZDI4NWI0MThiXzUtNC0xLTEtMjM0NTg_f653dc10-2e1e-4c23-9533-a2879b1a5966">3,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eca0785abb64ad4a7ba38ca114bffbd_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTpkOTM3ZTk5MDRmZTk0OGE1YmJhZDc5N2QyODViNDE4Yi90YWJsZXJhbmdlOmQ5MzdlOTkwNGZlOTQ4YTViYmFkNzk3ZDI4NWI0MThiXzUtNi0xLTEtMjM0NTg_597102ea-796f-45f1-82c5-2ce9ab3bc30a">3,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Others</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4efcd62648ae4318a25132f75b187f91_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTpkOTM3ZTk5MDRmZTk0OGE1YmJhZDc5N2QyODViNDE4Yi90YWJsZXJhbmdlOmQ5MzdlOTkwNGZlOTQ4YTViYmFkNzk3ZDI4NWI0MThiXzYtNC0xLTEtMjM0NTg_eab71262-ff12-48e1-9dfa-48af3352172e">5,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i791518d5395c46a5a1dcb85211cb3fc0_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTpkOTM3ZTk5MDRmZTk0OGE1YmJhZDc5N2QyODViNDE4Yi90YWJsZXJhbmdlOmQ5MzdlOTkwNGZlOTQ4YTViYmFkNzk3ZDI4NWI0MThiXzYtNi0xLTEtMjM0NTg_df41f641-5ca9-4bf1-aabc-b8d2317fc46f">13,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTpkOTM3ZTk5MDRmZTk0OGE1YmJhZDc5N2QyODViNDE4Yi90YWJsZXJhbmdlOmQ5MzdlOTkwNGZlOTQ4YTViYmFkNzk3ZDI4NWI0MThiXzctNC0xLTEtMjM0NTg_a3a7af8c-9a6a-4091-8828-46ef921876b9">22,334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTpkOTM3ZTk5MDRmZTk0OGE1YmJhZDc5N2QyODViNDE4Yi90YWJsZXJhbmdlOmQ5MzdlOTkwNGZlOTQ4YTViYmFkNzk3ZDI4NWI0MThiXzctNi0xLTEtMjM0NTg_06253144-2dfe-4c75-82eb-7583623e51b8">59,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90ZXh0cmVnaW9uOjhmYTZlOTI4OTY0NjQ3NGM4MjI5NmVjYjA4ZGFmMDU1XzE5NjY_5077a918-932d-4514-acdf-86d963841b60" continuedAt="ibf23147c01f1413d80d80aba5fecc2e7" escape="true">All revenue earned during the years ended December 31, 2020 and 2019 was generated in the U.S.</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-104-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ib9602fc8d5be43769c1964131312c91e"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibf23147c01f1413d80d80aba5fecc2e7">Concentration of credit risk with respect to accounts receivable was limited due to the high credit quality comprising a significant portion of the Company&#8217;s customers. Management periodically monitors the creditworthiness of the Company&#8217;s customers and believes that it has adequately provided for any exposure to potential credit loss.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, the Company is working with contract manufacturing organizations for the manufacture of FT218. Additionally, the Company purchases raw materials used in FT218 from a limited number of suppliers, including a single supplier for certain key ingredients.</span></div><div><span><br/></span></div><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-monetary long-lived assets primarily consist of property and equipment, goodwill, intangible assets and operating right-of use-assets.&#160;<ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90ZXh0cmVnaW9uOjhmYTZlOTI4OTY0NjQ3NGM4MjI5NmVjYjA4ZGFmMDU1XzE5NTY_b99d48ac-97ae-409b-bb13-2a2e1b411bfb" continuedAt="ibae77284e1dd4a7b87e80b72583dd862" escape="true">The following table summarizes non-monetary long-lived assets by geographic region as of December&#160;31, 2021, 2020, and 2019:</ix:nonNumeric></span></div><div style="margin-bottom:4pt;text-align:justify"><ix:continuation id="ibae77284e1dd4a7b87e80b72583dd862"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:48.679%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.909%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-lived Assets by Geographic Region: </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib32f28d9fbb54bab90164eb85e585915_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTo2ZGYzOTdkMWZjZGY0YjU0ODRkNmJkZTRhNmI0ZDM0ZS90YWJsZXJhbmdlOjZkZjM5N2QxZmNkZjRiNTQ4NGQ2YmRlNGE2YjRkMzRlXzItMi0xLTEtMjM0NTg_e7f09211-67bd-4293-a1fd-74feb554e4f0">19,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i202d7516b2bd4304ad55b1aafeb6d3d5_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTo2ZGYzOTdkMWZjZGY0YjU0ODRkNmJkZTRhNmI0ZDM0ZS90YWJsZXJhbmdlOjZkZjM5N2QxZmNkZjRiNTQ4NGQ2YmRlNGE2YjRkMzRlXzItNC0xLTEtMjM0NTg_dc2ff938-b6d2-407c-82ba-833d1b3e8f6d">20,424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b63bdbcab14d6eb97ff7f6e4f0a10c_I20191231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTo2ZGYzOTdkMWZjZGY0YjU0ODRkNmJkZTRhNmI0ZDM0ZS90YWJsZXJhbmdlOjZkZjM5N2QxZmNkZjRiNTQ4NGQ2YmRlNGE2YjRkMzRlXzItNi0xLTEtMjM0NTg_7ded04a6-7805-44d5-8e23-36fb82b49cb3">22,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie28cee2136b144d498b35733e7331556_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTo2ZGYzOTdkMWZjZGY0YjU0ODRkNmJkZTRhNmI0ZDM0ZS90YWJsZXJhbmdlOjZkZjM5N2QxZmNkZjRiNTQ4NGQ2YmRlNGE2YjRkMzRlXzMtMi0xLTEtMjM0NTg_8f7b18ea-1821-4862-bf56-372f9a559780">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bcaec4506f44e42ab5e37d5e0a7f18d_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTo2ZGYzOTdkMWZjZGY0YjU0ODRkNmJkZTRhNmI0ZDM0ZS90YWJsZXJhbmdlOjZkZjM5N2QxZmNkZjRiNTQ4NGQ2YmRlNGE2YjRkMzRlXzMtNC0xLTEtMjM0NTg_b0101290-dbe2-48a9-91a6-768dabbb7394">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78d0a8066299410fae55ee22a1483399_I20191231" decimals="-3" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTo2ZGYzOTdkMWZjZGY0YjU0ODRkNmJkZTRhNmI0ZDM0ZS90YWJsZXJhbmdlOjZkZjM5N2QxZmNkZjRiNTQ4NGQ2YmRlNGE2YjRkMzRlXzMtNi0xLTEtMjM0NTg_fd2efca5-303f-4a9d-8476-452e2686bf72">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0729539c1221405f81e7676478827e0e_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTo2ZGYzOTdkMWZjZGY0YjU0ODRkNmJkZTRhNmI0ZDM0ZS90YWJsZXJhbmdlOjZkZjM5N2QxZmNkZjRiNTQ4NGQ2YmRlNGE2YjRkMzRlXzQtMi0xLTEtMjM0NTg_95396a0d-9e39-4521-9eae-25b5a27bf80b">9,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1133dde1f8446e48e8886c74d1845df_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTo2ZGYzOTdkMWZjZGY0YjU0ODRkNmJkZTRhNmI0ZDM0ZS90YWJsZXJhbmdlOjZkZjM5N2QxZmNkZjRiNTQ4NGQ2YmRlNGE2YjRkMzRlXzQtNC0xLTEtMjM0NTg_d80106c8-384b-44e9-8dd7-5d7464cc379e">6,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica869e44a5d747338f8da7c47e19f318_I20191231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTo2ZGYzOTdkMWZjZGY0YjU0ODRkNmJkZTRhNmI0ZDM0ZS90YWJsZXJhbmdlOjZkZjM5N2QxZmNkZjRiNTQ4NGQ2YmRlNGE2YjRkMzRlXzQtNi0xLTEtMjM0NTg_bed57d4a-a6b3-4cf3-8387-fcaf20321c83">7,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTo2ZGYzOTdkMWZjZGY0YjU0ODRkNmJkZTRhNmI0ZDM0ZS90YWJsZXJhbmdlOjZkZjM5N2QxZmNkZjRiNTQ4NGQ2YmRlNGE2YjRkMzRlXzUtMi0xLTEtMjM0NTg_cb5d4bdc-8ddc-44d3-9fad-85663769d658">29,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTo2ZGYzOTdkMWZjZGY0YjU0ODRkNmJkZTRhNmI0ZDM0ZS90YWJsZXJhbmdlOjZkZjM5N2QxZmNkZjRiNTQ4NGQ2YmRlNGE2YjRkMzRlXzUtNC0xLTEtMjM0NTg_26c8938b-4875-411c-a256-dd295bd6ceb6">26,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73b28a1c0c648e5a6641e1c909996f0_I20191231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTo2ZGYzOTdkMWZjZGY0YjU0ODRkNmJkZTRhNmI0ZDM0ZS90YWJsZXJhbmdlOjZkZjM5N2QxZmNkZjRiNTQ4NGQ2YmRlNGE2YjRkMzRlXzUtNi0xLTEtMjM0NTg_190e4dd4-7514-414e-b4e1-64b566896aff">29,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_166"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 22:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjYvZnJhZzpjMmEwNGI3YjJjNzE0NjZkODNkODU0M2NkOTI3N2ZiZi90ZXh0cmVnaW9uOmMyYTA0YjdiMmM3MTQ2NmQ4M2Q4NTQzY2Q5Mjc3ZmJmXzIyNDA_41c950de-327b-45f3-9cc2-ac5046ccd55a" continuedAt="i0846063b8eb74d859194b93b30f780cd" escape="true">Related Party Transactions</ix:nonNumeric></span></div><ix:continuation id="i0846063b8eb74d859194b93b30f780cd" continuedAt="ibb27b3b4633d44b6b097b8e8ead2ee37"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4: Disposition of the Hospital Products, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prior to June 30, 2020,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company was party to a Membership Interest Purchase Agreement by and among the Company, Avadel Legacy, Breaking Stick Holdings, LLC, Deerfield Private Design International II, L.P. (&#8220;Deerfield International&#8221;), Deerfield Private Design Fund II, L.P. (&#8220;Deerfield Fund&#8221;) and Horizon Sant&#233; FLML, Sarl (&#8220;Horizon&#8221;) (the &#8220;Deerfield MIPA&#8221;) and a Royalty Agreement by and among the Company, Avadel Legacy, the Deerfield Fund and Horizon (the &#8220;Deerfield Royalty Agreement&#8221;). In connection with the closing of the sale of the Hospital Products, the Deerfield MIPA (with respect to certain sections thereof) and the Royalty Agreement were assigned to the Exela Buyer. Pursuant to the Purchase Agreement, the Exela Buyer assumed and will pay, perform, satisfy and discharge the liabilities and obligations of Avadel Legacy under the Deerfield Royalty Agreement for obligations that arise after the Closing Date.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to June 30, 2020, the Company was also party to a Royalty Agreement by and between itself, Avadel Legacy and Broadfin Healthcare Master Fund, Ltd. (the &#8220;Broadfin Royalty Agreement&#8221;). In connection with the closing of the sale of the Hospital Products, the Broadfin Royalty Agreement was assigned to the Exela Buyer and the Exela Buyer assumed and shall pay, perform, satisfy and discharge the liabilities and obligations of Avadel Legacy under the Broadfin Royalty Agreement for obligations that arise after the Closing Date.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="ibb27b3b4633d44b6b097b8e8ead2ee37" continuedAt="i7d3d99f19bc84257842158a69cdf9694"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 12: Contingent Consideration Payable </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7d3d99f19bc84257842158a69cdf9694">for a summary of payments made for and changes to the fair value of the related party payable for the year ended December 31, 2019. Deerfield and Broadfin disposed of their 2023 Notes and ordinary shares in the Company during the year ended December 31, 2020 and are no longer considered related parties for the years ended December 31, 2021 and 2020.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_169"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 23:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjkvZnJhZzo4MGUzNzJjYzEzNGQ0YWQxYWRhNzE4NGVmOWMyZWE5MS90ZXh0cmVnaW9uOjgwZTM3MmNjMTM0ZDRhZDFhZGE3MTg0ZWY5YzJlYTkxXzQy_695ee507-1bf1-4f6e-8166-aa18ee6e3cdf" continuedAt="i848bab5ea1b646b4af6f7d3422d55b42" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subsequent Events</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i848bab5ea1b646b4af6f7d3422d55b42">On March 16, 2022, Avadel Finance Cayman Limited, a Cayman Islands exempted company and an indirect wholly-owned subsidiary of the Company (the &#8220;Issuer&#8221;), executed an agreement to exchange $<ix:nonFraction unitRef="usd" contextRef="i6708f8d915264e56880479e22149d123_I20220316" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjkvZnJhZzo4MGUzNzJjYzEzNGQ0YWQxYWRhNzE4NGVmOWMyZWE5MS90ZXh0cmVnaW9uOjgwZTM3MmNjMTM0ZDRhZDFhZGE3MTg0ZWY5YzJlYTkxXzI3NDg3NzkwNzYxNTI_40aab02a-f8b8-4c72-918b-9d019ca30e05">117,375</ix:nonFraction> of its 2023 Notes due February 1, 2023  (the &#8220;February 2023 Notes&#8221;) for a new series of its Exchangeable Senior Notes due October 2, 2023 (the &#8220;October 2023 Notes&#8221;) (the &#8220;Exchange&#8221;). The remaining $<ix:nonFraction unitRef="usd" contextRef="i360019dcf2b1493e9e2047d365cd0d6f_I20220316" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjkvZnJhZzo4MGUzNzJjYzEzNGQ0YWQxYWRhNzE4NGVmOWMyZWE5MS90ZXh0cmVnaW9uOjgwZTM3MmNjMTM0ZDRhZDFhZGE3MTg0ZWY5YzJlYTkxXzI3NDg3NzkwNzYxNjU_a5890e0c-80c7-4fb5-84df-67f439e9a3b6">26,375</ix:nonFraction> aggregate principal amount of the February 2023 Notes will maintain a maturity date of February 1, 2023. Taking into consideration the Exchange and the maturity date of the October 2023 Notes and based on the Company&#8217;s current plans, the Company has sufficient cash on hand and available liquidity to satisfy its obligations and fund working capital needs for at least twelve months following the date of issuance of the Consolidated Financial Statements. The Company has a recent history of generating losses from operations including during 2021 and expects to continue generating losses over the next twelve months. Similar to other businesses in the Company&#8217;s industry and at its stage of development, the Company will continue in the medium term to rely on external sources of capital to fund its business.</ix:continuation></span></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-105-</span></div></div></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_172"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the shareholders and the Board of Directors of Avadel Pharmaceuticals plc</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Avadel Pharmaceuticals plc (the "Company") as of December 31, 2021 and 2020, the related consolidated statements of (loss) income, comprehensive (loss) income, shareholders&#8217; equity, and cash flows, for each of the three years in the period ended December 31, 2021, and the related notes and the schedule listed in the Index at Item 15 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2021, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8212; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated March 16, 2022 expressed an adverse opinion on the Company's internal control over financial reporting</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Critical audit matters are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.  </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Deloitte and Touche LLP</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">St. Louis, Missouri&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 16, 2022&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company's auditor since 2016.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-106-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the shareholders and the Board of Directors of Avadel Pharmaceuticals plc </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the internal control over financial reporting of Avadel Pharmaceuticals plc (the &#8220;Company&#8221;) as of December 31, 2021, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8212; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, because of the effect of the material weakness identified below on the achievement of the objectives of the control criteria, the Company has not maintained effective internal control over financial reporting as of December 31, 2021, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8212; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by COSO.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2021, of the Company and our report dated March 16, 2022, expressed an unqualified opinion on those financial statements. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Report on Internal Control over Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Material Weakness</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material weakness of the Company&#8217;s annual or interim financial statements will not be prevented or detected on a timely basis. The following material weakness has been identified and included in management&#8217;s assessment: Management did not have a control to identify that they were in technical default of its 2023 convertible notes and owed 0.50% of additional interest due to the failure to remove a restrictive legend from the 2023 convertible notes. This material weakness was considered in determining the nature, timing, and extent of audit tests applied in our audit of the consolidated financial statements as of and for the year ended December 31, 2021, of the Company, and this report does not affect our report on such financial statements. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-107-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Deloitte and Touche LLP</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">St. Louis, Missouri</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 16, 2022</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-108-</span></div></div></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_175"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None. </span></div><div style="padding-left:4.5pt;text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_178"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Controls and Procedures.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Evaluation of Disclosure Controls and Procedures</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by Rule 15d -15(b) of the Exchange Act, our management has evaluated, under the supervision and with the participation of our principal executive officer and principal financial officer, the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this Annual Report. Based on that evaluation, our principal executive officer and principal financial officer concluded that as of the end of the period covered by this Annual Report our disclosure controls and procedures were not effective due to the material weakness in our internal control over financial reporting described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Management&#8217;s Report on Internal Control over Financial Reporting</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with U.S. generally accepted accounting principles.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect all misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assessed the effectiveness of our internal control over financial reporting as of December&#160;31, 2021. In making this assessment, our management used the criteria set forth in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Based on this assessment, management concluded that, as of December&#160;31, 2021, the Company&#8217;s internal control over financial reporting was not effective.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company&#8217;s annual or interim financial statements will not be prevented or detected on a timely basis.</span></div><div style="margin-bottom:9pt;padding-right:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Material Weakness in Internal Control Over Financial Reporting</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the Company&#8217;s fiscal 2021 financial statement close process, management identified a deficiency in the design of internal control over financial reporting related to its February 2023 Notes indenture. Specifically, management did not have a control to identify that we were in technical default of the February 2023 Notes and owed 0.50% of additional interest on the February 2023 Notes due to not removing a restrictive legend from the February 2023 Notes 365 days following the original issuance of the February 2023 Notes on February 16, 2018. The Company cured the default through payment of the additional interest in March 2022. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effectiveness of our internal control over financial reporting as of December 31, 2021 has been audited by Deloitte &amp; Touche LLP, an independent registered public accounting firm, as stated in their report included in this Annual Report. This report contains an adverse opinion on the effectiveness of our internal control over financial reporting.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;padding-right:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Remediation of Material Weakness</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Once the material weakness was identified, we developed and implemented a remediation plan that includes the implementation of additional control procedures surrounding timely and periodic evaluation of all terms of our debt agreement and the associated calculation of interest expense in accordance with the terms of such debt agreement to ensure the completeness and accuracy of the calculation and timely payment of interest expense, classification of debt and compliance with terms of the debt agreement. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are committed to maintaining a strong internal control environment and have fully implemented measures designed to help ensure that the control deficiency contributing to the material weakness is remediated. However, there cannot be any assurance that these remediation efforts will be successful or that our internal control over financial reporting will be effective as a result of these efforts. The material weakness will be fully remediated when, we have determined, through testing, these controls have operated effectively for a sufficient period of time.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-109-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Other Changes in Internal Control Over Financial Reporting</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Except as noted above, there have been no changes in our internal control over financial reporting identified in management&#8217;s evaluation pursuant to Rules 13a-15(d) or 15d-15(d) of the Exchange Act during the quarter ended December&#160;31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.  </span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_181"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9B. &#160;&#160;&#160;&#160;Other Information.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_1849"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9C. &#160;&#160;&#160;&#160;Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-110-</span></div></div></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_184"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PART III</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information required by Part III is omitted from this Annual Report on Form 10-K because we intend to file our definitive proxy statement for our 2022 annual general meeting of shareholders pursuant to Regulation 14A of the Securities Exchange Act of 1934 (our &#8220;Definitive 2022 Proxy Statement&#8221;), not later than 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K, and certain information to be included in our Definitive 2022 Proxy Statement is incorporated herein by reference.&#160;</span></div><div><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_187"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;10. &#160;&#160;&#160;&#160;Directors, Executive Officers and Corporate Governance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding Directors, Executive Officers and Corporate Governance is hereby incorporated by reference to our Definitive 2022 Proxy Statement, which we intend to file with the SEC within 120 days after December&#160;31, 2021.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_190"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;11. &#160;&#160;&#160;&#160;Executive Compensation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding Executive Compensation is hereby incorporated by reference to our Definitive 2022 Proxy Statement, which we intend to file with the SEC within 120 days after December&#160;31, 2021.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_193"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;12. &#160;&#160;&#160;&#160;Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters is hereby incorporated by reference to our Definitive 2022 Proxy Statement, which we intend to file with the SEC within 120 days after December&#160;31, 2021.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_196"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;13. &#160;&#160;&#160;&#160;Certain Relationships and Related Transactions, and Director Independence.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding Certain Relationships and Related Transactions, and Director Independence is hereby incorporated by reference to our Definitive 2022 Proxy Statement, which we intend to file with the SEC within 120 days after December&#160;31, 2021.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_199"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;14. &#160;&#160;&#160;&#160;Principal Accountant Fees and Services.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent public accounting firm is <ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xOTkvZnJhZzozMzcwMmJkMmM1N2Q0OTFlYWI2YzNjZWE1ZmVlMzFlYS90ZXh0cmVnaW9uOjMzNzAyYmQyYzU3ZDQ5MWVhYjZjM2NlYTVmZWUzMWVhXzI3NDg3NzkwNzAxMzM_8bf666ae-7148-4fff-8af8-5ee02ae00339">Deloitte and Touche LLP</ix:nonNumeric>, <ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xOTkvZnJhZzozMzcwMmJkMmM1N2Q0OTFlYWI2YzNjZWE1ZmVlMzFlYS90ZXh0cmVnaW9uOjMzNzAyYmQyYzU3ZDQ5MWVhYjZjM2NlYTVmZWUzMWVhXzI3NDg3NzkwNzAxMzQ_97f1c227-5c83-41b3-8335-7814d073bb4a">St. Louis, Missouri</ix:nonNumeric> (PCAOB Auditor ID: <ix:nonNumeric contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xOTkvZnJhZzozMzcwMmJkMmM1N2Q0OTFlYWI2YzNjZWE1ZmVlMzFlYS90ZXh0cmVnaW9uOjMzNzAyYmQyYzU3ZDQ5MWVhYjZjM2NlYTVmZWUzMWVhXzI3NDg3NzkwNzAxMzY_02ae8c73-7b35-4ecf-93fd-c31f6661b8c2">34</ix:nonNumeric>). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding Principal Accountant Fees and Services is hereby incorporated by reference to our Definitive 2022 Proxy Statement, which we intend to file with the SEC within 120 days after December&#160;31, 2021.&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-111-</span></div></div></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_202"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PART IV</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_205"></div><div style="-sec-extract:summary;margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;15. &#160;&#160;&#160;&#160;Exhibits and Financial Statement Schedules</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.34pt">Documents filed as part of this report:</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Item 8 - Financial Statements and Supplementary Data of Part II of this Report. </span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.&#160;&#160;&#160;&#160;Financial Statement Schedules</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See below for Schedule II: Valuation and Qualifying Accounts. All other schedules are omitted as they are not applicable, not required or the information is included in the consolidated financial statements or related notes to the consolidated financial statements. </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule II</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Valuation and Qualifying Accounts</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands)&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:26.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.961%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.024%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.561%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Deferred Tax Asset Valuation Allowance:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance, <br/>Beginning of Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additions<br/>(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Deductions<br/>(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Changes<br/>(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance, <br/>End of Period</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,783)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,762)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,896)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Additions to the deferred tax asset valuation allowance relate to movements on certain French, Irish and U.S. deferred tax assets where we continue to maintain a valuation allowance until sufficient positive evidence exists to support reversal.</span></div><div style="margin-bottom:9pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Deductions to the deferred tax asset valuation allowance include movements relating to utilization of net operating losses and tax credit carryforwards, release in valuation allowance and other movements including adjustments following finalization of tax returns.</span></div><div style="margin-bottom:9pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Other changes to the deferred tax asset valuation allowance including currency translation adjustments recorded directly in equity, account method changes and the impact of corporate restructuring.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">3.     Exhibits required by Item&#160;601 of Regulation S-K</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exhibits required by Item 601 of Regulation S-K and Item 15(b) of this Annual Report on Form 10-K are listed in the Exhibit Index immediately preceding the signature page of this Annual Report on Form 10-K. The exhibits listed in the Exhibit Index are incorporated by reference herein.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;16. &#160;&#160;&#160;&#160;Form 10-K Summary</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected not to include summary information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">Index to Exhibits</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Description</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000114420416111245/v443435_ex2-1.htm">Constitution (containing the Memorandum and Articles of Association) of Avadel Pharmaceuticals plc (incorporated by reference to Appendix 15 of Exhibit 2.1 to the registrant&#8217;s current report on Form 8-K, filed on July 1, 2016)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000110465920024077/tm209736d1_ex3-1.htm">Certificate of Designation of Series A Non-Voting Convertible Preferred Shares of Avadel Pharmaceuticals plc, dated February 20, 2020 (incorporated by reference to Exhibit 3.1 to the registrant&#8217;s current report on Form 8-K, filed on February 24, 2020)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-112-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000114420417000976/v456368_ex1-1.htm">Deposit Agreement dated as of January 3, 2017 among Avadel Pharmaceuticals plc, The Bank of New York, as Depositary, and holders from time to time of American Depositary Shares issued thereunder (including as an exhibit the form of American Depositary Receipt) (incorporated by reference to Exhibit 1.1 to the registrant&#8217;s current report on Form 8-K12B, filed on January 4, 2017 and amended January 6, 2017)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000114420418009543/tv486339_ex4-1.htm">Indenture, dated as of February 16, 2018, by and between Avadel Finance Cayman Limited, Avadel Pharmaceuticals plc, and The Bank of New York Mellon, as Trustee (including an as exhibit the Form of 4.50% Exchangeable Senior Note due 2023) (incorporated by reference to Exhibit 4.1 to the registrant&#8217;s current report on Form 8-K, filed on February 16, 2018)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000114420419005584/tv512742_ex4-1.htm">First Supplemental Indenture, dated as of February 6, 2019, by and among Avadel Finance Cayman Limited, Avadel Pharmaceuticals plc, and The Bank of New York Mellon, as Trustee (incorporated by reference to Exhibit 4.1 to the registrant&#8217;s current report on Form 8-K, filed on February 7, 2019)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247720000007/a123119ex-46.htm">Description of Securities (incorporated by reference to Exhibit 4.6 to the registrants annual report on Form 10-K, filed on March 16, 2020)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001012477/000101247721000004/a123120ex-101.htm">Exclusive License Agreement by and between Perrigo Pharma International DAC (f/k/a Elan Pharma International Limited) and Flamel Ireland Limited dated September 30, 2015, as amended by the First Amendment to Exclusive License Agreement dated December 21, 2018 (incorporated by reference to Exhibit 10.1 to the registrant&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020, filed on March 9, 2021)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001012477/000101247721000004/a123120ex-102.htm">Office Lease Agreement by and between Grove II LLC and Eclat Pharmaceuticals LLC dated October 5, 2015, as amended (</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001012477/000101247721000004/a123120ex-102.htm">incorporated by reference to Exhibit 10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001012477/000101247721000004/a123120ex-102.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001012477/000101247721000004/a123120ex-102.htm"> to the registrant&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020, filed on March 9, 2021</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001012477/000101247721000004/a123120ex-102.htm">)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.3&#8225;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000114420416088149/v433294_ex10-25.htm">December 2015 Stock Option Rules (incorporated by reference to Exhibit 10.25 to the registrant&#8217;s Annual Report on Form 10-K for the year ended December 31, 2015, filed on March 15, 2016)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.4&#8225;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000114420416088149/v433294_ex10-26.htm">Form of Stock Option Grant Letter (incorporated by reference to Exhibit 10.26 to the registrant&#8217;s Annual Report on Form 10-K for the year ended December 31, 2015, filed on March 15, 2016)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.5&#8225;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000114420416119757/v445278_ex99-1.htm">Rules Governing the Free Share Plan - August 2016 (incorporated by reference to Exhibit 99.1 to the registrant&#8217;s Registration Statement (No. 333-213154) on Form S-8, filed on August 16, 2016)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.6&#8225;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000114420416119757/v445278_ex99-2.htm">August 2016 Stock Option Rules (incorporated by reference to Exhibit 99.2 to the registrant&#8217;s Registration Statement (No. 333-213154) on Form S-8, filed on August 16, 2016)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.7&#8225;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000114420416119757/v445278_ex99-3.htm">August 2016 Stock Warrant Rules (incorporated by reference to Exhibit 99.3 to the registrant&#8217;s Registration Statement (No. 333-213154) on Form S-8, filed on August 16, 2016)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8225;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247717000021/avdlex-1031.htm">Form of stock option grant letter for 2016 Stock Option Rules (incorporated by reference to Exhibit 10.31 to the registrant's Annual Report on Form 10-K for the year ended December 31, 2016, filed on March 28, 2017)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.9&#8225;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000091068019000040/ex10_1-f8k05302019.htm">Amended Employment Agreement dated as of June 3, 2019 between Avadel Management Corporation and Gregory J. Divis (incorporated by reference to Exhibit 10.1 to the registrant&#8217;s current report on Form 8-K, filed on June 5, 2019)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.10&#8225;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247720000013/exhibit102q22020.htm">Employment Agreement dated as of May 15, 2020 between Avadel Management Corporation and Thomas S. McHugh (incorporated by reference to Exhibit 10.2 to the registrant&#8217;s current report on Form 10-Q, filed on August 10, 2020)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-113-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.11*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247718000008/avdlex-1043.htm">Asset Purchase Agreement by and among Cerecor, Inc. and Avadel Pharmaceuticals (USA), Inc., Avadel Pediatrics, Inc., FSC Therapeutics, LLC, Avadel US Holdings, Inc. and Avadel Pharmaceuticals plc dated as of February 12, 2018 </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247718000008/avdlex-1043.htm">(incorporated by reference to Exhibit 10.43 to the registrant&#8217;s Annual Report on Form 10-K for the year ended December 31, 2017, filed on March 16, 2018)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.12*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247718000008/avdlex-1045.htm">Guarantee by Avadel US Holdings, Inc. and Avadel Pharmaceuticals plc in favor of Deerfield CSF, LLC, Peter Steelman and James Flynn dated as of February 16, 2018 (incorporated by reference to Exhibit 10.45 to the registrant&#8217;s Annual Report on Form 10-K for the year ended December 31, 2017, filed on March 16, 2018)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.13*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247718000008/avdlex-1046.htm">Guarantee by Armistice Capital Master Fund, Ltd. in favor of Avadel US Holdings, Inc. dated as of February 16, 2018 (incorporated by reference to Exhibit 10.46 to the registrant&#8217;s Annual Report on Form 10-K for the year ended December 31, 2017, filed on March 16, 2018)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.14#<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000110465920024077/tm209736d1_ex10-1.htm">Securities Purchase Agreement, dated February 20, 2020, by and among Avadel Pharmaceuticals plc and the Investors named therein (incorporated by reference to Exhibit 10.1 to the registrant&#8217;s current report on Form 8-K, filed on February 24, 2020)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.15</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247720000007/a123119ex-1040.htm">Registration Rights Agreement, dated February 25, 2020, by and among Avadel Pharmaceuticals plc and the Investors named therein incorporated by reference to Exhibit 10.40 to the registrant&#8217;s annual report on Form 10-K, filed on March 16, 2020)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.16*#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000110465920080648/tm2023976d1_ex10-1.htm">Asset Purchase Agreement, dated as of June 30, 2020, by and between Avadel Seller, Seller Parent, Exela Buyer and Buyer Parent (incorporated by reference to Exhibit 10.1 to the registrant&#8217;s current report on Form 8-K, filed on July 2, 2020)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.17&#8225;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001012477/000101247721000004/a123120ex-1018.htm">Avadel Pharmaceuticals plc 2017 Omnibus Incentive Compensation Plan and related equity award agreements (</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001012477/000101247721000004/a123120ex-1018.htm">incorporated by reference to Exhibit 10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001012477/000101247721000004/a123120ex-1018.htm">18</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001012477/000101247721000004/a123120ex-1018.htm"> to the registrant&#8217;s Annual Report on Form 10-K for the year ended December 31, 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001012477/000101247721000004/a123120ex-1018.htm">20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001012477/000101247721000004/a123120ex-1018.htm">, filed on March </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001012477/000101247721000004/a123120ex-1018.htm">9</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001012477/000101247721000004/a123120ex-1018.htm">, 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001012477/000101247721000004/a123120ex-1018.htm">21</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001012477/000101247721000004/a123120ex-1018.htm">)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.18&#8225;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001012477/000101247721000004/a123120ex-1019.htm">Avadel Pharmaceuticals plc 2020 Omnibus Incentive Compensation Plan (</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001012477/000101247721000004/a123120ex-1019.htm">incorporated by reference to Exhibit 10.1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001012477/000101247721000004/a123120ex-1019.htm">9</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001012477/000101247721000004/a123120ex-1019.htm"> to the registrant&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020, filed on March 9, 2021</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001012477/000101247721000004/a123120ex-1019.htm">)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.19&#8225;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247721000008/exhibit101q12021.htm">Employment Agreement dated as of</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247721000008/exhibit101q12021.htm"> February</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247721000008/exhibit101q12021.htm"> 1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247721000008/exhibit101q12021.htm">5</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247721000008/exhibit101q12021.htm">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247721000008/exhibit101q12021.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247721000008/exhibit101q12021.htm"> between Avadel Management Corporation and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247721000008/exhibit101q12021.htm">Richard Kim</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247721000008/exhibit101q12021.htm"> (incorporated by reference to Exhibit 10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247721000008/exhibit101q12021.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247721000008/exhibit101q12021.htm"> to the registrant&#8217;s </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247721000008/exhibit101q12021.htm">Quarterly</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247721000008/exhibit101q12021.htm"> report on Form 10-Q, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247721000008/exhibit101q12021.htm">for the qu</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247721000008/exhibit101q12021.htm">arter ended March 31, 2021, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247721000008/exhibit101q12021.htm">filed on </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247721000008/exhibit101q12021.htm">May</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247721000008/exhibit101q12021.htm"> 10, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247721000008/exhibit101q12021.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000101247721000008/exhibit101q12021.htm">)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a123121ex-1020.htm">Avadel Pharmaceuticals plc 2021 Inducement Plan and related equity award agreements (filed herewith)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.21&#8225;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="a123121ex-1021.htm">Employment Agreement dated as of February 1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="a123121ex-1021.htm">4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="a123121ex-1021.htm">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="a123121ex-1021.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="a123121ex-1021.htm"> between Avadel Management Corporation and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="a123121ex-1021.htm">Douglas Williamson</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="a123121ex-1021.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="a123121ex-1021.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="a123121ex-1021.htm">filed herewith</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="a123121ex-1021.htm">)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.22</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex1022avadel-formofexchang.htm">Form of Exchange Agreement between Avadel Finance Cayman Limited, Avadel Pharmaceuticals plc and certain holders of its February 2023 Notes</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex1022avadel-formofexchang.htm"> (filed herewith)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex1022avadel-formofexchang.htm"> </a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001012477/000101247721000004/a123120ex-141.htm">Code of Business Conduct and Ethics (</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001012477/000101247721000004/a123120ex-141.htm">incorporated by reference to Exhibit </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001012477/000101247721000004/a123120ex-141.htm">14.1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001012477/000101247721000004/a123120ex-141.htm"> to the registrant&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020, filed on March 9, 2021</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0001012477/000101247721000004/a123120ex-141.htm">)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1012477/000091068017000027/ex14_2.htm">Financial Integrity Policy (incorporated by reference to Exhibit 14.2 to the registrant&#8217;s current report on Form 8-K, filed on March 7, 2017)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a123121ex-211.htm">List of Subsidiaries (filed herewith)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-114-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a123121ex-231.htm">Consent of Deloitte &amp; Touche LLP (filed herewith)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a123121ex-311.htm">Certification of the Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a123121ex-312.htm">Certification of the Principal Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a123121ex-321.htm">Certification of the Chief Executive Officer pursuant to USC Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a123121ex-322.htm">Certification of the Principal Financial Officer pursuant to USC Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instant Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Labels Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101.*) </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(filed herewith)</span></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">*  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Confidential treatment has been requested for the redacted portions of this agreement. A complete copy of the agreement, including the redacted portions, has been filed separately with the Securities and Exchange Commission.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"># The representations and warranties contained in this agreement were made only for purposes of the transactions contemplated by the agreement as of specific dates and may have been qualified by certain disclosures between the parties and a contractual standard of materiality different from those generally applicable under securities laws, among other limitations. The representations and warranties were made for purposes of allocating contractual risk between the parties to the agreement and should not be relied upon as a disclosure of factual information relating to the Company, the Investors or the transaction described in the Current Report on Form 8-K.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#8225; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Management contract or compensatory plan or arrangement filed pursuant to Item 15(b) of Form 10-K.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) This certification accompanies the Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the registrant under the Securities Act of 1933 or the Securities Exchange Act of 1934 (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing. </span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-115-</span></div></div></div><div id="i56bb95bb4ed94f6abb9be4d186e21dfb_208"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:43.995%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.095%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Avadel Pharmaceuticals plc</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: March 16, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Gregory J. Divis</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:&#160;&#160;&#160;Gregory J. Divis</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:&#160;&#160;&#160;&#160;Chief Executive Officer</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POWER OF ATTORNEY</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">KNOW ALL PERSONS BY THESE PRESENTS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that each of Geoffrey M. Glass, Eric J. Ende, Mark A. McCamish, MD, Ph.D., Linda S. Palczuk, and Peter J. Thornton, by their respective signatures below, irrevocably constitutes and appoints Gregory J. Divis and Thomas S. McHugh, and each of them individually acting alone without the other, his true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments to this report, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or either of them, or their or his substitutes or substitute, may lawfully do or cause to be done by virtue hereof.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:29.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.990%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Gregory J. Divis</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director, Chief Executive Officer and Principal Executive Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 16, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gregory J. Divis</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;Thomas S. McHugh</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer and Principal Financial and Accounting Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 16, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas S. McHugh</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;Geoffrey M. Glass</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Executive Chairman of the Board and Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 16, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Geoffrey M. Glass</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;Dr. Eric J. Ende</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 16, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Eric J. Ende</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;Mark A. McCamish, MD, Ph.D.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 16, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark A. McCamish, MD, Ph.D.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;Linda S. Palczuk</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 16, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Linda S. Palczuk</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;Peter J. Thornton</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 16, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter J. Thornton</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-116-</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.20
<SEQUENCE>2
<FILENAME>a123121ex-1020.htm
<DESCRIPTION>EX-10.20
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i8f0256af6f8d464c90ff49b283308964_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">AVADEL PHARMACEUTICALS PLC</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">2021 INDUCEMENT PLAN</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.36pt;text-decoration:underline">GENERAL PURPOSE OF THE PLAN&#59; DEFINITIONS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The name of the plan is the Avadel Pharmaceuticals plc 2021 Inducement Plan (the &#8220;Plan&#8221;).  The purpose of the Plan is to enable Avadel Pharmaceuticals plc, an Irish public limited company (the &#8220;Company&#8221;) to grant equity awards to induce highly-qualified prospective officers and employees who are not currently employed by the Company and its Affiliates to accept employment and provide them with a proprietary interest in the Company.  It is anticipated that providing such persons with a direct stake in the Company&#8217;s welfare will assure a closer identification of their interests with those of the Company and its shareholders, thereby stimulating their efforts on the Company&#8217;s behalf and strengthening their desire to remain with the Company. The Company intends that the Plan be reserved for persons to whom the Company may issue securities without shareholder approval as an inducement pursuant to Rule 5635(c)(4) of the Marketplace Rules of NASDAQ Stock Market, Inc.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The following terms shall be defined as set forth below&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Act&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> means the United States Securities Act of 1933, as amended, and the rules and regulations thereunder.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Administrator&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> means either the Board or the compensation committee of the Board or a similar committee of the Board performing the functions of the compensation committee and which is comprised of not less than two Non-Employee Directors who are independent.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;ADS&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> means an American Depositary Share representing one Ordinary Share, registered with the SEC and listed for trading on the Nasdaq Global Market under the trading symbol &#8220;AVDL&#8221;&#59; an ADS may be represented by a physical certificate referred to as an American Depositary Receipt, or &#8220;ADR.&#8221;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at the time of determination, any &#8220;parent&#8221; or &#8220;subsidiary&#8221; of the Company as such terms are defined in Rule 405 of the Act. The Board will have the authority to determine the time or times at which &#8220;parent&#8221; or &#8220;subsidiary&#8221; status is determined within the foregoing definition. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Award&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Awards,&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> except where referring to a particular category of grant under the Plan, shall include Non-Qualified Options, Share Appreciation Rights, Restricted Share Units, Restricted Share Awards, Unrestricted Share Awards, and Dividend Equivalent Rights.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Award Certificate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> means a written or electronic document setting forth the terms and provisions applicable to an Award granted under the Plan.  Each Award Certificate is subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Board&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> means the Board of Directors of the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Code&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> means the United States Internal Revenue Code of 1986, as amended, and any successor Code, and related rules, regulations and interpretations.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Companies Act&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> means the Companies Act 2014 of Ireland (as amended).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:27.884%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ACTIVE&#47;113395993.5 </font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Consultant&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> means a consultant or adviser who provides </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">bona fide</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> services to the Company or an Affiliate as an independent contractor and who qualifies as a consultant or advisor under Instruction A.1.(a)(1) of Form S-8 under the Act. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"> &#8220;Dividend Equivalent Right&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> means an Award entitling the grantee to receive credits based on cash dividends that would have been paid on the Shares specified in the Dividend Equivalent Right (or other award to which it relates) if such shares had been issued to and held by the grantee.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Effective Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> means the date on which the Plan becomes effective as set forth in Section&#160;18.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Exchange Act&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> means the United States Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Fair Market Value&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of a Share (represented by ADSs) on any given date means the fair market value of a Share determined in good faith by the Administrator&#59; provided, however, that if the Shares or ADSs are listed on the NASDAQ, The NASDAQ Global Market, The NASDAQ Global Select Market, The New York Stock Exchange or another securities exchange or traded on any established market, the determination shall be made by reference to market quotations.  If there are no market quotations for such date, the determination shall be made by reference to the last date preceding such date for which there are market quotations.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Non-Employee Director&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> means a member of the Board who is not also an employee of the Company or any Subsidiary.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Non-Qualified Option&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> means any Option that is not an &#8220;incentive stock option&#8221; under Section 422 of the Code.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Option&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> means any option to purchase Shares granted pursuant to Section&#160;5.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Ordinary Share&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means an ordinary share, par value $0.01, in the capital of the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Restricted Shares&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> means the Shares underlying a Restricted Share Award that remain subject to a risk of forfeiture or the Company&#8217;s right of repurchase.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Restricted Share Award&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> means an Award of Restricted Shares subject to such restrictions and conditions as the Administrator may determine at the time of grant.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Restricted Share Units&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> means an Award of share units subject to such restrictions and conditions as the Administrator may determine at the time of grant.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Sale Event&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> means (i) the sale of all or substantially all of the assets of the Company on a consolidated basis to an unrelated person or entity, (ii) the following individuals cease for any reason to constitute a majority of the number of directors then serving on the Board&#58; individuals who, on the Effective Date, constitute the Board and any new director (other than a director whose initial assumption of office is in connection with an actual or threatened election contest, including, but not limited to, a consent solicitation relating to the election of directors of the Company) whose appointment or election by the Board or nomination for election by the Company&#8217;s shareholders was approved or recommended by a vote of at least a majority of the directors then still in office who either were members of the Board on the Effective Date or whose appointment, election or nomination for election was previously so approved (the &#8220;Incumbent Directors&#8221;)&#59;  (iii) a merger, reorganization or consolidation with any other </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;2</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.948%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ACTIVE&#47;113395993.5 </font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">corporation or other entity, other than (A) a merger, reorganization or consolidation pursuant to which the holders of the Company&#8217;s outstanding voting power and outstanding Shares immediately prior to such transaction continue to own a majority of the outstanding voting power and outstanding Shares or other equity interests of the resulting or successor entity (or its ultimate parent, if applicable) immediately upon completion of such transaction and (B) the Incumbent Directors continuing immediately thereafter to represent at least a majority of the board of directors of the resulting or successor entity (or its ultimate parent, if applicable), (iv) the sale of all of the Shares of the Company to an unrelated person, entity or group thereof acting in concert, or (v) any other transaction in which the owners of the Company&#8217;s outstanding voting power immediately prior to such transaction do not own at least a majority of the outstanding voting power of the Company or any successor entity immediately upon completion of the transaction other than as a result of the acquisition of securities directly from the Company.  For the avoidance of doubt, any one or more of the above events may be effective pursuant to (a) a compromise or arrangement sanctioned by the court under Chapter 1 of Part 9 of the Companies Act, (b) an acquisition pursuant to Chapter 2 of Part 9 of the Companies Act, or (c) a merger pursuant to the European Communities (Cross-Border Mergers) Regulations 2008.   Notwithstanding the foregoing, in the case of any Award that constitutes deferred compensation within the meaning of Section 409A of the Code, there shall not be a Sale Event unless there is a change in the ownership or effective control of the Company, or in a substantial portion of the assets of the Company, within the meaning of Section 409A of the Code where necessary for such Award to comply with Section 409A of the Code.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Sale Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the value as determined by the Administrator of the consideration payable, or otherwise to be received by shareholders, per Share pursuant to a Sale Event.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Section 409A&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> means Section 409A of the Code and the regulations and other guidance promulgated thereunder.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Service Relationship&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means any relationship as an employee, director or Consultant of the Company or any Affiliate (e.g., a Service Relationship shall be deemed to continue without interruption in the event an individual&#8217;s status changes from full-time employee to part-time employee or Consultant).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Share&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means an Ordinary Share, subject to adjustment pursuant to Section 3&#59; unless the context otherwise requires, references herein to &#8220;Shares&#8221; shall include references to ADSs.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"> &#8220;Share Appreciation Right&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> means an Award entitling the recipient to receive Shares (or cash, to the extent explicitly provided for in the applicable Award Certificate) having a value equal to the excess of the Fair Market Value of the Share on the date of exercise over the exercise price of the Share Appreciation Right multiplied by the number of Shares with respect to which the Share Appreciation Right shall have been exercised.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Subsidiary&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> means any corporation or other entity (other than the Company) in which the Company has at least a 50 percent interest, either directly or indirectly.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Unrestricted Share Award&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> means an Award of Shares free of any restrictions.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.36pt;text-decoration:underline">ADMINISTRATION OF PLAN&#59; ADMINISTRATOR AUTHORITY TO SELECT GRANTEES AND DETERMINE AWARDS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Administration of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Plan shall be administered by the Administrator.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Powers of Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Administrator shall have the power and authority to grant Awards consistent with the terms of the Plan, including the power and authority&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;3</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.948%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ACTIVE&#47;113395993.5 </font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">to select the individuals to whom Awards may from time to time be granted&#59;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">to determine the time or times of grant, and the extent, if any, of Non-Qualified Options, Share Appreciation Rights, Restricted Share Awards, Restricted Share Units, Unrestricted Share Awards, and Dividend Equivalent Rights, or any combination of the foregoing, granted to any one or more grantees&#59;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">to determine the number of Shares to be covered by any Award and to determine whether any Award shall pertain to Shares or ADSs&#59;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">to determine and modify from time to time the terms and conditions, including restrictions, not inconsistent with the terms of the Plan, of any Award, which terms and conditions may differ among individual Awards and grantees, and to approve the forms of Award Certificates&#59;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">to accelerate at any time the exercisability or vesting of all or any portion of any Award&#59;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">subject to the provisions of Section&#160;5(c), to extend at any time the period in which Options may be exercised&#59; and</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15.36pt">at any time to adopt, alter and repeal such rules, guidelines and practices for administration of the Plan and for its own acts and proceedings as it shall deem advisable&#59; to interpret the terms and provisions of the Plan and any Award (including related written instruments)&#59; to make all determinations it deems advisable for the administration of the Plan&#59; to decide all disputes arising in connection with the Plan&#59; and to otherwise supervise the administration of the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">All decisions and interpretations of the Administrator shall be binding on all persons, including the Company and Plan grantees.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Award Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Awards under the Plan shall be evidenced by Award Certificates that set forth the terms, conditions and limitations for each Award which may include, without limitation, the term of an Award and the provisions applicable in the event employment or service terminates.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Reserved</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Neither the Board nor the Administrator, nor any member of either or any delegate thereof, shall be liable for any act, omission, interpretation, construction or determination made in good faith in connection with the Plan, and the members of the Board and the Administrator (and any delegate thereof) shall be entitled in all cases to indemnification and reimbursement by the Company in respect of any claim, loss, damage or expense (including, without limitation, reasonable attorneys&#8217; fees) arising or resulting therefrom to the fullest extent permitted by law and&#47;or under the Company&#8217;s constitution or any directors&#8217; and officers&#8217; liability insurance coverage which may be in effect from time to time and&#47;or any indemnification agreement between such individual and the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Non-U.S. Award Recipients</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding any provision of the Plan to the contrary, in order to comply with the laws of countries other than the U.S. in which the Company and its Subsidiaries operate or have employees or other individuals eligible for Awards, the Administrator, in its sole discretion, shall have the power and authority to&#58;  (i) determine which Subsidiaries shall be covered by the Plan&#59; (ii) determine which individuals outside the United </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;4</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.948%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ACTIVE&#47;113395993.5 </font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">States are eligible to participate in the Plan&#59; (iii) modify the terms and conditions of any Award granted to individuals outside the United States to comply with applicable foreign laws&#59; (iv) establish subplans and modify exercise procedures and other terms and procedures, to the extent the Administrator determines such actions to be necessary or advisable (and such subplans and&#47;or modifications shall be attached to this Plan as appendices)&#59; provided, however, that no such subplans and&#47;or modifications shall increase the share limitations contained in Section 3(a) hereof&#59; and (v) take any action, before or after</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">an Award is made, that the Administrator determines to be necessary or advisable to obtain approval or comply with any local governmental regulatory exemptions or approvals.  Notwithstanding the foregoing, the Administrator may not take any actions hereunder, and no Awards shall be granted, that would violate the Exchange Act or any other applicable United States securities law, the Code, any other applicable United States governing statute or law, or any applicable Irish law.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.36pt;text-decoration:underline">STOCK ISSUABLE UNDER THE PLAN&#59; MERGERS&#59; SUBSTITUTION</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Stock Issuable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The maximum number of Shares reserved and available for issuance under the Plan shall be 1,500,000 Shares, subject to adjustment as provided in this Section&#160;3.  For purposes of this limitation, the Shares underlying any awards under the Plan that are forfeited, canceled or otherwise terminated (other than by exercise) shall be added back to the Shares available for issuance under the Plan.  Notwithstanding the foregoing, the following Shares shall not be added to the Shares authorized for grant under the Plan&#58;  (i) Shares tendered or held back upon exercise of an Option or settlement of an Award to cover the exercise price or tax withholding, and (ii) Shares subject to a Share Appreciation Right that are not issued in connection with the share settlement of the Share Appreciation Right upon exercise thereof. In the event the Company repurchases Shares on the open market, such Shares shall not be added to the Shares available for issuance under the Plan.  Subject to such overall limitations, Shares may be issued up to such maximum number pursuant to any type or types of Award.  The Shares available for issuance under the Plan may be authorized but unissued Shares or Shares reacquired by the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Changes in Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to Section&#160;3(c) hereof, if, as a result of any reorganization, recapitalization, reclassification, share dividend, share split, reverse share split or other similar change in the Company&#8217;s capital, the outstanding Shares are increased or decreased or are exchanged for a different number or kind of shares or other securities of the Company, or additional shares or new or different shares or other securities of the Company or other non-cash assets are distributed with respect to such Shares or other securities, or, if, as a result of any Sale Event, or sale of all or substantially all of the assets of the Company, the outstanding Shares are converted into or exchanged for securities of the Company or any successor entity (or a parent or subsidiary thereof), the Administrator shall make an appropriate or proportionate adjustment in (i) the maximum number of Shares reserved for issuance under the Plan, (ii) the number and kind of Shares or other securities subject to any then outstanding Awards under the Plan, (iii) the repurchase price, if any, per Share subject to each outstanding Restricted Share Award, and (iv)&#160;the exercise price for each Share subject to any then outstanding Options and Share Appreciation Rights under the Plan, without changing the aggregate exercise price (i.e., the exercise price multiplied by the number of shares subject to Options and Share Appreciation Rights) as to which such Options and Share Appreciation Rights remain exercisable.  The Administrator shall also make equitable or proportionate adjustments in the number of shares subject to outstanding Awards and the exercise price and the terms of outstanding Awards to take into consideration cash dividends paid other than in the ordinary course or any other extraordinary corporate event.  The adjustment by the Administrator shall be final, binding and conclusive.  No fractional Shares shall be issued under the Plan resulting from any such adjustment, but the Administrator in its discretion may make a cash payment in lieu of fractional Shares.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;5</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.948%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ACTIVE&#47;113395993.5 </font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Sale Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In the case of and subject to the consummation of a Sale Event, the parties thereto may cause the assumption or continuation of Awards theretofore granted by the successor entity, or the substitution of such Awards with new Awards of the successor entity or parent thereof, with appropriate adjustment as to the number and kind of shares and, if appropriate, the per share exercise prices, as such parties shall agree.  To the extent the parties to such Sale Event do not provide for the assumption, continuation or substitution of Awards, upon the effective time of the Sale Event, the Plan and all outstanding Awards granted hereunder shall terminate.  In the event of such termination, (i) the Company shall have the option (in its sole discretion) to make or provide for a payment, in cash or in kind, to the grantees holding Options and Share Appreciation Rights, in exchange for the cancellation thereof, in an amount equal to the difference between (A) the Sale Price multiplied by the number of Shares subject to outstanding Options and Share Appreciation Rights (to the extent then vested and exercisable at prices not in excess of the Sale Price) and (B) the aggregate exercise price of all such outstanding Options and Share Appreciation Rights (provided that, in the case of an Option or Share Appreciation Right with an exercise price equal to or greater than the Sale Price, such Option or Share Appreciation Right shall be cancelled for no consideration)&#59; or (ii) each grantee shall be permitted, within a specified period of time prior to the consummation of the Sale Event as determined by the Administrator, to exercise all outstanding Options and Share Appreciation Rights (to the extent then vested and exercisable) held by such grantee.  The Company shall also have the option (in its sole discretion) to make or provide for a payment, in cash or in kind, to the grantees holding other Awards in an amount equal to the Sale Price multiplied by the number of vested Shares under such Awards.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.36pt;text-decoration:underline">ELIGIBILITY</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Grantees under the Plan will be such employees of the Company and its Affiliates as to whom the Company may issue securities without shareholder approval in accordance with Rule 5635(c)(4) of the Marketplace Rules of NASDAQ Stock Market, Inc. as selected from time to time by the Administrator in its sole discretion&#59; provided that Awards may not be granted to employees who are providing services only to any &#8220;parent&#8221; of the Company, as such term is defined in Rule 405 of the Act, unless (i) the stock underlying the Awards is treated as &#8220;service recipient stock&#8221; under Section 409A or (ii) the Company has determined that such Awards are exempt from or otherwise comply with Section 409A.  </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.36pt;text-decoration:underline">OPTIONS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Award of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Administrator may grant Options under the Plan.  Any Option granted under the Plan shall be a Non-Qualified Option, and shall be in such form as the Administrator may from time to time approve.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Options granted pursuant to this Section&#160;5 shall be subject to the following terms and conditions and shall contain such additional terms and conditions, not inconsistent with the terms of the Plan, as the Administrator shall deem desirable.  .</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The exercise price per Share covered by an Option granted pursuant to this Section&#160;5 shall be determined by the Administrator at the time of grant but shall not be less than 100 percent of the Fair Market Value on the date of grant.  Notwithstanding the foregoing, Options may be granted with an exercise price per Share that is less than 100 percent of the Fair Market Value on the date of grant (i) to individuals who are not subject to U.S. income tax on the date of grant or (ii) if the Option is otherwise compliant with Section 409A.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Option Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The term of each Option shall be fixed by the Administrator, but no Option shall be exercisable more than ten years after the date the Option is granted.  Where an Option is granted with an exercise price per share that is less than 100 percent of the Fair Market </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;6</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.948%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ACTIVE&#47;113395993.5 </font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Value on the date of grant to an individual who is tax resident in Ireland, the Option shall lapse if not exercised within 7 years of the date of grant.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Exercisability&#59; Rights of a Shareholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Options shall become exercisable at such time or times, whether or not in installments, as shall be determined by the Administrator at or after the grant date.  The Administrator may at any time accelerate the exercisability of all or any portion of any Option.  An optionee shall have the rights of a shareholder only as to Shares acquired upon the exercise of an Option and not as to unexercised Options.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Method of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Options may be exercised in whole or in part, by giving written or electronic notice of exercise to the Company, specifying the number of Shares to be purchased.  Payment of the purchase price may be made by one or more of the following methods except to the extent otherwise provided in the Award Certificate&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">In cash, by certified or bank check or other instrument acceptable to the Administrator&#59;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">Through the delivery (or attestation to the ownership following such procedures as the Company may prescribe) of Shares that are not then subject to restrictions under any Company plan.  Such surrendered Shares shall be valued at Fair Market Value on the exercise date&#59; </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">By the optionee delivering to the Company a properly executed exercise notice together with irrevocable instructions to a broker to promptly deliver to the Company cash or a check payable and acceptable to the Company for the purchase price&#59; provided that in the event the optionee chooses to pay the purchase price as so provided, the optionee and the broker shall comply with such procedures and enter into such agreements of indemnity and other agreements as the Company shall prescribe as a condition of such payment procedure&#59; or </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">By a &#8220;net exercise&#8221; arrangement pursuant to which the Company will reduce the number of Shares issuable upon exercise by the largest whole number of Shares with a Fair Market Value that does not exceed the aggregate exercise price. Where newly issued Shares are to be delivered in this way, the Affiliate which employs the grantee, if so agreed with the Company, shall pay to the Company such price as is at least equal to the aggregate nominal value of the Shares issued.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Payment instruments will be received subject to collection.  The transfer to the optionee on the records of the Company or of the transfer agent of the Shares to be purchased pursuant to the exercise of an Option will be contingent upon receipt from the optionee (or a purchaser acting in his or her stead in accordance with the provisions of the Option) by the Company of the full purchase price for such shares and the fulfillment of any other requirements contained in the Award Certificate or applicable provisions of laws (including the satisfaction of any withholding taxes that the Company is obligated to withhold with respect to the optionee).  In the event an optionee chooses to pay the purchase price by previously-owned Shares through the attestation method, the number of Shares transferred to the optionee upon the exercise of the Option shall be net of the number of attested Shares.  In the event that the Company establishes, for itself or using the services of a third party, an automated system for the exercise of Options, such as a system using an internet website or interactive voice response, then the paperless exercise of Options may be permitted through the use of such an automated system.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.36pt;text-decoration:underline">SHARE APPRECIATION RIGHTS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Award of Share Appreciation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Administrator may grant Share Appreciation Rights under the Plan.  A Share Appreciation Right is an Award entitling the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.948%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ACTIVE&#47;113395993.5 </font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">recipient to receive Shares (or cash, to the extent explicitly provided for in the applicable Award Certificate) having a value equal to the excess of the Fair Market Value of a Share on the date of exercise over the exercise price of the Share Appreciation Right multiplied by the number of Shares with respect to which the Share Appreciation Right shall have been exercised.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Exercise Price of Share Appreciation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The exercise price of a Share Appreciation Right shall not be less than 100 percent of the Fair Market Value of a Share on the date of grant.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Grant and Exercise of Share Appreciation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Share Appreciation Rights may be granted by the Administrator independently of any Option granted pursuant to Section&#160;5 of the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Terms and Conditions of Share Appreciation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Share Appreciation Rights shall be subject to such terms and conditions as shall be determined on the date of grant by the Administrator.  The term of a Share Appreciation Right may not exceed ten years.  The terms and conditions of each such Award shall be determined by the Administrator, and such terms and conditions may differ among individual Awards and grantees.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 7.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.36pt;text-decoration:underline">RESTRICTED SHARE AWARDS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Nature of Restricted Share Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Administrator may grant Restricted Share Awards under the Plan.  A Restricted Share Award is any Award of Restricted Shares subject to such restrictions and conditions as the Administrator may determine at the time of grant.  Conditions may be based on continuing employment (or other Service Relationship) and&#47;or achievement of pre-established performance goals and objectives.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Rights as a Shareholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Upon the grant of the Restricted Share Award and payment of any applicable purchase price, a grantee shall have the rights of a shareholder with respect to the voting of the Restricted Shares and receipt of dividends&#59; provided that any dividends paid by the Company during the vesting period shall accrue and shall not be paid to the grantee until and to the extent the Restricted Shares vest.  Unless the Administrator shall otherwise determine, (i) uncertificated Restricted Shares shall be accompanied by a notation on the records of the Company or the transfer agent to the effect that they are subject to forfeiture until such Restricted Shares are vested as provided in Section 7(d) below, and (ii) certificated Restricted Shares shall remain in the possession of the Company until such Restricted Shares are vested as provided in Section&#160;7(d) below, and the grantee shall be required, as a condition of the grant, to deliver to the Company such instruments of transfer as the Administrator may prescribe.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Restricted Shares may not be sold, assigned, transferred, pledged or otherwise encumbered or disposed of except as specifically provided herein or in the Restricted Share Award Certificate.  Except as may otherwise be provided by the Administrator either in the Award Certificate or, subject to Section 15 below, in writing after the Award is issued, if a grantee&#8217;s employment (or other Service Relationship) with the Company and its Subsidiaries terminates for any reason, any Restricted Shares that have not vested at the time of termination shall automatically and without any requirement of notice to such grantee from or other action by or on behalf of, the Company be deemed to have been reacquired by the Company at its original purchase price (if any) from such grantee or such grantee&#8217;s legal representative simultaneously with such termination of employment (or other Service Relationship), and thereafter shall cease to represent any ownership of the Company by the grantee or rights of the grantee as a shareholder.  Following such deemed reacquisition of Restricted Shares that are represented by physical certificates, a grantee shall surrender such certificates to the Company upon request without consideration.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;8</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.948%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ACTIVE&#47;113395993.5 </font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Vesting and payment of Restricted Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Administrator at the time of grant shall specify the date or dates and&#47;or the attainment of pre-established performance goals, objectives and other conditions on which the non-transferability of the Restricted Shares and the Company&#8217;s right of repurchase or forfeiture shall lapse.  Subsequent to such date or dates and&#47;or the attainment of such pre-established performance goals, objectives and other conditions, the Shares on which all restrictions have lapsed shall no longer be Restricted Shares and shall be deemed &#8220;vested.&#8221; Where newly issued Shares are to be delivered on the vesting of a Restricted Share Award, the Affiliate which employs the grantee, if so agreed with the Company, shall pay to the Company such price as is at least equal to the aggregate nominal value of the Shares the subject of the Restricted Share Award.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 8.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.36pt;text-decoration:underline">RESTRICTED SHARE UNITS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Nature of Restricted Share Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Administrator may grant Restricted Share Units under the Plan.  A Restricted Share Unit is an Award of stock units that may be settled in Shares (or cash, to the extent explicitly provided for in the Award Certificate) upon the satisfaction of such restrictions and conditions at the time of grant.  Conditions may be based on continuing employment (or other Service Relationship) and&#47;or achievement of pre-established performance goals and objectives.  The terms and conditions of each such Award shall be determined by the Administrator, and such terms and conditions may differ among individual Awards and grantees.  Except in the case of Restricted Share Units with a deferred settlement date that complies with Section 409A, at the end of the vesting period, the Restricted Share Units, to the extent vested, shall be settled in the form of Shares.  Restricted Share Units with deferred settlement dates are subject to Section 409A and shall contain such additional terms and conditions as the Administrator shall determine in its sole discretion in order to comply with the requirements of Section 409A.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Rights as a Shareholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  A grantee shall have the rights as a shareholder only as to Shares acquired by the grantee upon settlement of Restricted Share Units&#59; provided, however, that the grantee may be credited with Dividend Equivalent Rights with respect to the stock units underlying his or her Restricted Share Units, subject to the provisions of Section 10 and such terms and conditions as the Administrator may determine.  Where newly issued Shares are to be delivered on the vesting of a Restricted Share Unit, the Affiliate which employs the grantee, if so agreed with the Company, shall pay to the Company such price as is at least equal to the aggregate nominal value of the Shares the subject of the Restricted Share Unit.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as may otherwise be provided by the Administrator either in the Award Certificate or, subject to Section&#160;15 below, in writing after the Award is issued, a grantee&#8217;s right in all Restricted Share Units that have not vested shall automatically terminate upon the grantee&#8217;s termination of employment (or cessation of Service Relationship) with the Company and its Subsidiaries for any reason.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:3.36pt;text-decoration:underline">UNRESTRICTED SHARE AWARDS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant or Sale of Unrestricted Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Administrator may grant (or sell at par value or such higher purchase price determined by the Administrator) an Unrestricted Share Award under the Plan.  An Unrestricted Share Award is an Award pursuant to which the grantee may receive Shares free of any restrictions under the Plan.  Unrestricted Share Awards may be granted in respect of past services or other valid consideration, or in lieu of cash compensation due to such grantee.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;9</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.948%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ACTIVE&#47;113395993.5 </font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:33.36pt;text-decoration:underline">DIVIDEND EQUIVALENT RIGHTS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Dividend Equivalent Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Administrator may grant Dividend Equivalent Rights under the Plan.  A Dividend Equivalent Right is an Award entitling the grantee to receive credits based on cash dividends that would have been paid on the Shares specified in the Dividend Equivalent Right (or other Award to which it relates) if such shares had been issued to the grantee.  A Dividend Equivalent Right may be granted hereunder to any grantee as a component of an award of Restricted Share Units or as a freestanding award.  The terms and conditions of Dividend Equivalent Rights shall be specified in the Award Certificate.  Dividend equivalents credited to the holder of a Dividend Equivalent Right may be paid currently or may be deemed to be reinvested in additional Shares, which may thereafter accrue additional equivalents.  Any such reinvestment shall be at Fair Market Value on the date of reinvestment or such other price as may then apply under a dividend reinvestment plan sponsored by the Company, if any.  Dividend Equivalent Rights may be settled in cash or Shares or a combination thereof, in a single installment or installments.  A Dividend Equivalent Right granted as a component of an Award of Restricted Share Units shall provide that such Dividend Equivalent Right shall be settled only upon settlement or payment of, or lapse of restrictions on, such other Award, and that such Dividend Equivalent Right shall expire or be forfeited or annulled under the same conditions as such other Award.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as may otherwise be provided by the Administrator either in the Award Certificate or, subject to Section&#160;15 below, in writing after the Award is issued, a grantee&#8217;s rights in all Dividend Equivalent Rights shall automatically terminate upon the grantee&#8217;s termination of employment (or cessation of Service Relationship) with the Company and its Subsidiaries for any reason.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 11.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:33.36pt;text-decoration:underline">TRANSFERABILITY OF AWARDS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Transferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as provided in Section&#160;11(b) below, during a grantee&#8217;s lifetime, his or her Awards shall be exercisable only by the grantee, or by the grantee&#8217;s legal representative or guardian in the event of the grantee&#8217;s incapacity.  No Awards shall be sold, assigned, transferred or otherwise encumbered or disposed of by a grantee other than by will or by the laws of descent and distribution or pursuant to a domestic relations order.  No Awards shall be subject, in whole or in part, to attachment, execution, or levy of any kind, and any purported transfer in violation hereof shall be null and void.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Administrator Action</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding Section&#160;11(a), the Administrator, in its discretion, may provide either in the Award Certificate regarding a given Award or by subsequent written approval that the grantee (who is an employee or director) may transfer his or her Non-Qualified Options to his or her immediate family members, to trusts for the benefit of such family members, or to partnerships in which such family members are the only partners, provided that the transferee agrees in writing with the Company to be bound by all of the terms and conditions of this Plan and the applicable Award.  In no event may an Award be transferred by a grantee for value.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Family Member</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  For purposes of Section&#160;11(b), &#8220;family member&#8221; shall mean a grantee&#8217;s child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships, any person sharing the grantee&#8217;s household (other than a tenant of the grantee), a trust in which these persons (or the grantee) have more than 50 percent of the beneficial interest, a foundation in which these persons (or the grantee) control the management of assets, and any other entity in which these persons (or the grantee) own more than 50 percent of the voting interests.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;10</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.948%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ACTIVE&#47;113395993.5 </font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Designation of Beneficiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  To the extent permitted by the Company, each grantee to whom an Award has been made under the Plan may designate a beneficiary or beneficiaries to exercise any Award or receive any payment under any Award payable on or after the grantee&#8217;s death.  Any such designation shall be on a form provided for that purpose by the Administrator and shall not be effective until received by the Administrator.  If no beneficiary has been designated by a deceased grantee, or if the designated beneficiaries have predeceased the grantee, the beneficiary shall be the grantee&#8217;s estate.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 12.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:33.36pt;text-decoration:underline">TAX WITHHOLDING</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Payment by Grantee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Each grantee shall, no later than the date as of which the value of an Award or of any Share or other amount received thereunder first becomes includable in the gross income of the grantee for income tax purposes, pay to the Company, or make arrangements satisfactory to the Administrator regarding payment of, any Federal, state, or local taxes of any kind required by law to be withheld by the Company with respect to such income.  The Company and its Subsidiaries shall, to the extent permitted by law, have the right to deduct any such taxes from any payment of any kind otherwise due to the grantee.  The Company&#8217;s obligation to deliver evidence of book entry (or stock certificates) to any grantee is subject to and conditioned on tax withholding obligations being satisfied by the grantee.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Payment in Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Administrator may require the Company&#8217;s tax withholding obligation to be satisfied, in whole or in part, by the Company withholding from Shares to be issued pursuant to any Award a number of Shares with an aggregate Fair Market Value (as of the date the withholding is effected) that would satisfy the withholding amount due&#59; provided, however, that the amount withheld does not exceed the maximum statutory tax rate or such lesser amount as is necessary to avoid liability accounting treatment.  For purposes of share withholding, the Fair Market Value of withheld shares shall be determined in the same manner as the value of Shares includible in income of the grantees.  The Administrator may also require the Company&#8217;s tax withholding obligation to be satisfied, in whole or in part, by an arrangement whereby a certain number of Shares issued pursuant to any Award are immediately sold and proceeds from such sale are remitted to the Company in an amount that would satisfy the withholding amount due.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 13.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:33.36pt;text-decoration:underline">SECTION 409A AWARDS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Awards are intended to be exempt from Section 409A to the greatest extent possible and to otherwise comply with Section 409A.  The Plan and all Awards shall be interpreted in accordance with such intent.  To the extent that any Award is determined to constitute &#8220;nonqualified deferred compensation&#8221; within the meaning of Section 409A (a &#8220;409A Award&#8221;), the Award shall be subject to such additional rules and requirements as specified by the Administrator from time to time in order to comply with Section 409A.  In this regard, if any amount under a 409A Award is payable upon a &#8220;separation from service&#8221; (within the meaning of Section 409A) to a grantee who is then considered a &#8220;specified employee&#8221; (within the meaning of Section 409A), then no such payment shall be made prior to the date that is the earlier of (i) six months and one day after the grantee&#8217;s separation from service, or (ii) the grantee&#8217;s death, but only to the extent such delay is necessary to prevent such payment from being subject to interest, penalties and&#47;or additional tax imposed pursuant to Section 409A.  Further, the settlement of any 409A Award may not be accelerated except to the extent permitted by Section 409A.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;11</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.948%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ACTIVE&#47;113395993.5 </font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:76.5pt;text-indent:-76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 14.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:1.86pt;text-decoration:underline">TERMINATION OF SERVICE RELATIONSHIP, TRANSFER, LEAVE OF ABSENCE, ETC.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Termination of Service Relationship</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the grantee&#8217;s Service Relationship is with an Affiliate and such Affiliate  ceases to be an Affiliate, the grantee shall be deemed to have terminated his or her Service Relationship for purposes of the Plan.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">For purposes of the Plan, the following events shall not be deemed a termination of a Service Relationship&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">a transfer to the employment of the Company from an Affiliate or from the Company to an Affiliate, or from one Affiliate to another&#59; or</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">an approved leave of absence for military service or sickness, or for any other purpose approved by the Company, if the employee&#8217;s right to re-employment is guaranteed either by a statute or by contract or under the policy pursuant to which the leave of absence was granted or if the Administrator otherwise so provides in writing.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 15.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:33.36pt;text-decoration:underline">AMENDMENTS AND TERMINATION</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Board may, at any time, amend or discontinue the Plan and the Administrator may, at any time, amend or cancel any outstanding Award for the purpose of satisfying changes in law or for any other lawful purpose, but no such action shall materially and adversely affect rights under any outstanding Award without the holder&#8217;s consent.  Except as provided in Section 3(b) or 3(c), without prior shareholder approval, in no event may the Administrator exercise its discretion to reduce the exercise price of outstanding Options or Share Appreciation Rights or effect repricing through cancellation and re-grants or cancellation of Options or Share Appreciation Rights in exchange for cash or other Awards.  Nothing in this Section&#160;15 shall limit the Administrator&#8217;s authority to take any action permitted pursuant to Section&#160;3(b) or 3(c).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 16.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:33.36pt;text-decoration:underline">STATUS OF PLAN</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">With respect to the portion of any Award that has not been exercised and any payments in cash, Shares or other consideration not received by a grantee, a grantee shall have no rights greater than those of a general creditor of the Company unless the Administrator shall otherwise expressly determine in connection with any Award or Awards.  In its sole discretion, the Administrator may authorize the creation of trusts or other arrangements to meet the Company&#8217;s obligations to deliver Shares or make payments with respect to Awards hereunder, provided that the existence of such trusts or other arrangements is consistent with the foregoing sentence.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 17.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:33.36pt;text-decoration:underline">GENERAL PROVISIONS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">No Distribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Administrator may require each person acquiring Shares pursuant to an Award to represent to and agree with the Company in writing that such person is acquiring the shares without a view to distribution thereof.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Issuance of Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  To the extent certificated, stock certificates to grantees under this Plan shall be deemed delivered for all purposes when the Company or a stock transfer agent of the Company shall have mailed such certificates, addressed to the grantee, at the grantee&#8217;s last known address on file with the Company.  Uncertificated Shares shall be deemed delivered for all purposes when the Company or a Share transfer agent of the Company shall have given to the grantee by electronic mail (with proof of receipt) or by United States mail, addressed to the grantee, at the grantee&#8217;s last known address on file with the Company, notice of issuance and recorded the issuance in its records (which may include electronic &#8220;book entry&#8221; records).  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;12</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.948%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ACTIVE&#47;113395993.5 </font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding anything herein to the contrary, the Company shall not be required to issue or deliver any evidence of book entry or certificates evidencing Shares pursuant to the exercise or settlement of any Award, unless and until the Administrator has determined, with advice of counsel (to the extent the Administrator deems such advice necessary or advisable), that the issuance and delivery is in compliance with all applicable laws, regulations of governmental authorities and, if applicable, the requirements of any exchange on which the Shares are listed, quoted or traded.  Any Shares issued pursuant to the Plan shall be subject to any stop-transfer orders and other restrictions as the Administrator deems necessary or advisable to comply with Federal, state or foreign jurisdiction, securities or other laws, rules and quotation system on which the Shares are listed, quoted or traded.  The Administrator may place legends on any Share certificate or notations on any book entry to reference restrictions applicable to the Shares.  In addition to the terms and conditions provided herein, the Administrator may require that an individual make such reasonable covenants, agreements, and representations as the Administrator, in its discretion, deems necessary or advisable in order to comply with any such laws, regulations, or requirements.  The Administrator shall have the right to require any individual to comply with any timing or other restrictions with respect to the settlement or exercise of any Award, including a window-period limitation, as may be imposed in the discretion of the Administrator.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Shareholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Until Shares are deemed delivered in accordance with Section 17(b), no right to vote or receive dividends or any other rights of a shareholder will exist with respect to Shares to be issued in connection with an Award, notwithstanding the exercise of an Option or any other action by the grantee with respect to an Award.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Other Compensation Arrangements&#59; No Employment Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Nothing contained in this Plan shall prevent the Board from adopting other or additional compensation arrangements, including trusts, and such arrangements may be either generally applicable or applicable only in specific cases.  The adoption of this Plan and the grant of Awards do not confer upon any employee any right to continued employment with the Company or any Subsidiary.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Payment of Nominal Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding any other provision of this Plan, no Shares in the authorized but unissued share capital of the Company shall be issued in settlement of an Award unless they are paid-up, on issuance, to at least their nominal value. If the Board determines that an Award is to be settled by the issuance of authorized but unissued Shares, the Board may decide that the Shares so issued will be&#58; (1) paid-up from the exercise price (if any)&#59; (2) otherwise paid-up by the grantee&#59; (3) subject to applicable law, paid-up by the Company from distributable profits or other reserves which may be applied for that purpose&#59; or (4) subject to applicable law, paid-up by a subsidiary of the Company or by another person.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Trading Policy Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Option exercises and other Awards under the Plan shall be subject to the Company&#8217;s insider trading policies and procedures, as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Clawback Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Awards under the Plan shall be subject to the Company&#8217;s clawback policy, as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Concert-Party Restrictions under the Irish Takeover Rules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In the event that any individual who is eligible to receive an Award is, or is presumed to be, a &#8220;person acting in concert&#8221; for the purposes of the Irish Takeover Rules, and the grant, exercise, vesting, settlement or any other action in relation to an Award to such individual may, in the reasonable opinion of the Administrator, result in the individual and&#47;or any person acting, or presumed to be acting, in concert with such individual (&#8220;Participant&#8221;) becoming obliged under the Irish Takeover Rules to make an offer for the Company under Rule 9 of the Irish Takeover Rules (&#8220;a Concert-Party </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;13</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.948%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ACTIVE&#47;113395993.5 </font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Offer&#8221;), the Administrator may decide that either (i) such grant, exercise, vesting, settlement or other action in relation to such individual or Participant shall not take effect unless the Company is in receipt of a confirmation, direction or ruling from the Irish Takeover Panel that satisfies the Board that such grant, exercise, vesting, settlement or other action would not result in an obligation to make a Concert-Party Offer&#59; or the Shares which are to be delivered on the vesting or settlement of the relevant Award shall not have any voting rights. If the Administrator determines that the exercise or settlement of any such Award by way of the issuance of Shares is not possible or desirable, it may determine that such Award shall be settled in cash, on such conditions as the Administrator may determine.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 18.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:33.36pt;text-decoration:underline">EFFECTIVE DATE OF PLAN</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Plan shall become effective immediately upon approval by the Board.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 19.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:33.36pt;text-decoration:underline">GOVERNING LAW</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Plan and all Awards and actions taken thereunder shall be governed by, and construed in accordance with, the General Corporation Law of the State of Delaware as to matters within the scope thereof, and as to all other matters shall be governed by and construed in accordance with the internal laws of the State of Delaware, applied without regard to conflict of law principles.</font></div><div style="margin-bottom:12pt;margin-top:30pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">DATE APPROVED BY BOARD OF DIRECTORS&#58; November 23, 2021</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;14</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.948%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ACTIVE&#47;113395993.5 </font></div><div><font><br></font></div></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.21
<SEQUENCE>3
<FILENAME>a123121ex-1021.htm
<DESCRIPTION>EX-10.21
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>a123121ex-1021</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- a123121ex-1021001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="a123121ex-1021001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- a123121ex-1021002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="a123121ex-1021002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- a123121ex-1021003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="a123121ex-1021003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- a123121ex-1021004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="a123121ex-1021004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- a123121ex-1021005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="a123121ex-1021005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- a123121ex-1021006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="a123121ex-1021006.jpg" title="slide6" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- a123121ex-1021007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="a123121ex-1021007.jpg" title="slide7" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- a123121ex-1021008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="a123121ex-1021008.jpg" title="slide8" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- a123121ex-1021009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="a123121ex-1021009.jpg" title="slide9" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- a123121ex-1021010.jpg -->
<DIV style="padding-top:2em;">
<IMG src="a123121ex-1021010.jpg" title="slide10" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- a123121ex-1021011.jpg -->
<DIV style="padding-top:2em;">
<IMG src="a123121ex-1021011.jpg" title="slide11" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- a123121ex-1021012.jpg -->
<DIV style="padding-top:2em;">
<IMG src="a123121ex-1021012.jpg" title="slide12" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- a123121ex-1021013.jpg -->
<DIV style="padding-top:2em;">
<IMG src="a123121ex-1021013.jpg" title="slide13" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- a123121ex-1021014.jpg -->
<DIV style="padding-top:2em;">
<IMG src="a123121ex-1021014.jpg" title="slide14" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- a123121ex-1021015.jpg -->
<DIV style="padding-top:2em;">
<IMG src="a123121ex-1021015.jpg" title="slide15" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- a123121ex-1021016.jpg -->
<DIV style="padding-top:2em;">
<IMG src="a123121ex-1021016.jpg" title="slide16" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- a123121ex-1021017.jpg -->
<DIV style="padding-top:2em;">
<IMG src="a123121ex-1021017.jpg" title="slide17" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- a123121ex-1021018.jpg -->
<DIV style="padding-top:2em;">
<IMG src="a123121ex-1021018.jpg" title="slide18" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- a123121ex-1021019.jpg -->
<DIV style="padding-top:2em;">
<IMG src="a123121ex-1021019.jpg" title="slide19" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.22
<SEQUENCE>4
<FILENAME>ex1022avadel-formofexchang.htm
<DESCRIPTION>EX-10.22
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i735c57d4239642d99bcdbef395970f69_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTION VERSION</font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 16, 2022</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Avadel Finance Cayman Limited</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c&#47;o Avadel Pharmaceuticals plc</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 Earlsfort Terrace</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dublin 2, Ireland</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">D02 T380 </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Attention&#58; General Counsel</font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Re&#58;&#160;&#160;&#160;&#160;Exchange for Avadel Finance Cayman Limited Exchangeable Senior Notes due 2023</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ladies and Gentlemen&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Avadel Finance Cayman Limited, a Cayman Islands exempted company limited by shares (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), is offering a new series of its Exchangeable Senior Notes due 2023 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">New Notes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;). The New Notes will be fully and unconditionally guaranteed on a senior unsecured basis (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Guarantee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) by Avadel Pharmaceuticals plc, a public limited company incorporated under the laws of Ireland and the parent company of the Company (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Parent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;). The New Notes will be exchangeable into cash, American Depositary Shares (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ADSs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), each representing, as of the date hereof, one ordinary share of Parent, nominal value $0.01 per share (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ordinary Shares</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; and such ADSs into which the New Notes are exchangeable, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Underlying ADSs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), or a combination of cash and Underlying ADSs, at the Company&#8217;s election.  Any ADSs to be issued upon conversion of the New Notes are to be issued pursuant to, and in accordance with the applicable procedures of, the Deposit Agreement, dated as of January 3, 2017, among Parent, The Bank of New York Mellon, as depositary (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depositary</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), and the holders and beneficial owners of the ADSs issued under such agreement, as supplemented by a letter agreement, dated as of February 16, 2018, between Parent and the Depositary and as further supplemented by a letter agreement to be dated the Closing Date (as defined below), between Parent and the Depositary (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deposit Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;).  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The undersigned (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), for itself and, on behalf of the accounts (if any) listed on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> hereto, for whom the Investor has been duly authorized to enter into the Exchange (as defined below) (each, including the Investor if it is listed on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exchanging Holder</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), shall exchange 4.50% Convertible Senior Notes due 2023 (CUSIP&#58; 05337YAA6 or 05337YAB4) of the Company (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Old Notes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) for an amount of (i) New Notes and (ii) cash, each as set forth herein (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exchange</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), pursuant and subject to the terms and conditions set forth in this agreement (this &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exchange Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;). Reference is made to the Indenture (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Old Notes Indenture</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), dated February 16, 2018, by and among the Company, Parent and The Bank of New York Mellon, as Trustee (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Old Notes Trustee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), which governs the Old Notes.  </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Exchanging Holders (including the Investor, as applicable) are referred to collectively as the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchasers,</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; and each Purchaser (other than the Investor) is referred to herein as an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Account</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.&#8221; </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Investor and each Account understands that the Exchange is being made without registration under the Securities Act of 1933, as amended (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Securities Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), or any securities laws of any state of the United States or of any other jurisdiction, and that the Exchange is only being made to investors who are &#8220;qualified institutional buyers&#8221; (as defined in Rule 144A under the Securities Act) in reliance upon an exemption from registration under the Securities Act. The Exchange is described in, and is being made pursuant to, the draft Indenture relating to the New Notes (the</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> &#8220;Indenture</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) to be entered into as of the Closing Date (as defined below) among the Company, Parent and The Bank of New York Mellon, as Trustee (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">New Notes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trustee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), as supplemented by the Pricing Term Sheet, dated as of the date hereof (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pricing Term Sheet</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; and, together with the Indenture and the Guarantee, the</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> &#8220;Transaction Documents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;).  </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt;text-decoration:underline">The Exchange</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. On the basis of the representations, warranties and agreements contained in this Exchange Agreement and subject to the terms and conditions of this Exchange Agreement, each of the Exchanging Holders hereby agrees to deliver, assign and transfer to the Company all right, title and interest in the aggregate principal amount of Old Notes for such Exchanging Holder set forth in column 2 of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> hereto (such aggregate principal amount of Old Notes, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exchanged Old Notes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) in exchange for (i) New Notes having an aggregate principal amount, for each Exchanging Holder, as set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (such aggregate principal amount of New Notes, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exchanged New Notes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) and (ii) an amount of cash as set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (such aggregate principal amount of cash, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Consideration</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; and the Cash Consideration, </font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:27.884%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">ACTIVE&#47;115855038.2 </font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">together with the Exchanged New Notes, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exchange Consideration</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), and the Company agrees to issue such Exchanged New Notes and deliver such Cash Consideration to the Exchanging Holders in exchange for such Exchanged Old Notes. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the avoidance of doubt, Exchanged New Notes will be issued in denominations of $200,000 principal amount and integral multiples of $1,000 in excess thereof, and the Company will not make any separate cash payment in respect of rounded amounts, interest (including Additional Interest (as defined in the Old Notes Indenture)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> accrued and unpaid to the Closing Date (as defined below) or Defaulted Amounts for the Exchanged Old Notes. Instead, such amounts will be deemed to be paid in full rather than cancelled, extinguished or forfeited upon exchange of the Exchanged Old Notes for the Exchange Consideration. Subject to the terms and conditions of this Exchange Agreement, the Investor, on behalf of itself and each Exchanging Holder, hereby (a)&#160;waives any and all other rights with respect to such Exchanged Old Notes, and (b)&#160;releases and discharges the Company and Parent from any and all claims the Investor and any other Exchanging Holder may now have, or may have in the future, arising out of, or related to, such Exchanged Old Notes, including, without limitation, any claim to &#8220;Defaulted Amounts&#8221; or &#8220;Additional Interest,&#8221; in respect of such Exchanged Old Notes, in each case, arising under and defined in, the Old Notes Indenture. The Old Notes Trustee may rely on the immediately preceding sentence with the same force and effect as if such representation or warranty were made directly to the Old Notes Trustee. The Old Notes Trustee shall be a third party beneficiary to this Exchange Agreement to the extent provided in the immediately preceding sentence.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt;text-decoration:underline">&#91;Reserved&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt;text-decoration:underline">The Closing</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The closing of the Exchange (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Closing</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) shall take place at the offices of Goodwin Procter LLP, 100 Northern Avenue, Boston, MA 02210, at 10&#58;00 a.m., New York City time, on April 4, 2022 or at such other time and place as the Company may designate by notice to the Investor (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Closing Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;).  </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt;text-decoration:underline">Closing Mechanics</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">The Depository Trust Company (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DTC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) will act as securities depositary for the New Notes. </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">At or prior to the times set forth in the Exchange Procedures set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> hereto (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exchange Procedures</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), the Investor, on behalf of itself and&#47;or any other Account, shall  deliver and&#47;or cause the Exchanging Holders to deliver the Exchanged Old Notes, by book entry transfer through the facilities of DTC, to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Bank Of New York Mellon, in its capacity as trustee of the Old Notes (in such capacity, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Old Notes Trustee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), for the account&#47;benefit of the Company for cancellation as instructed in the Exchange Procedures. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.23pt">On the Closing Date, subject to satisfaction of the conditions precedent specified in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> hereof, and the prior receipt by the Old Notes Trustee from each Exchanging Holder of the Exchanged Old Notes pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">clause (b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> above&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:94.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:4.62pt">the Company and Parent shall execute and deliver the Indenture, dated as of the Closing Date, among the Company, Parent and the New Notes Trustee&#59; </font></div><div style="padding-left:94.5pt;text-align:justify;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:94.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:2.4pt">the Company shall execute, cause the New Notes Trustee to authenticate and cause to be delivered to the DTC account(s) specified by the Investor or the relevant Account in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> hereto, the Exchanged New Notes&#59; and</font></div><div style="padding-left:94.5pt;text-align:justify"><font><br></font></div><div style="padding-left:94.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:0.18pt">the Company shall deliver or cause to be delivered the Cash Consideration pursuant to the wire instructions specified by the Investor or the relevant Account in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> hereto.</font></div><div style="padding-left:94.5pt;text-align:justify;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All questions as to the form of all documents and the validity and acceptance of the Old Notes and the New Notes will be determined by the Company, in its sole discretion, which determination shall be final and binding. </font></div><div style="text-align:justify"><font><br></font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:83%"> </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.948%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">ACTIVE&#47;115855038.2 </font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt;text-decoration:underline">Representations and Warranties and Covenants of the Company and Parent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Each of the Company and Parent, jointly and severally, represent and warrant to and covenant with the Investor (and each Account, as applicable) that&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:9.67pt">Organization</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The Company is duly incorporated and is validly existing under the laws of the Cayman Islands. Parent is duly organized and is validly existing under the laws of Ireland.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:9.67pt">Due Authorization</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. This Exchange Agreement has been duly authorized, executed and delivered by each of the Company and Parent.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:10.23pt">New Notes and the Guarantee. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The New Notes have been duly authorized by the Company and, when duly executed by the Company in accordance with the terms of the Indenture, assuming due authentication of the New Notes by the New Notes Trustee, upon delivery to the Purchasers in accordance with the terms of the Exchange, will be validly issued and delivered and will constitute valid and binding obligations of the Company entitled to the benefits of the Indenture, enforceable against the Company in accordance with their terms, except as such enforceability may be limited by bankruptcy, fraudulent conveyance, insolvency, reorganization, moratorium, and other laws relating to or affecting creditors&#8217; rights generally and by general equitable principles (regardless of whether such enforceability is considered in a proceeding in equity or at law) (collectively, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Enforceability Exceptions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;). The register of the New Notes will at all times be maintained outside of the Republic of Ireland. The Guarantee has been duly authorized by Parent and, when the New Notes are duly executed by the Company in accordance with the terms of the Indenture, assuming due authentication of the New Notes by the New Notes Trustee, upon delivery to the Purchasers in accordance with the terms of the Exchange, the Guarantee will constitute a valid and binding obligation of Parent, enforceable against Parent in accordance with its terms, subject to the Enforceability Exceptions.  The maximum number of Underlying ADSs (including the Ordinary Shares represented thereby) initially issuable upon exchange of the New Notes (assuming settlement solely in ADSs and taking into account the maximum make-whole adjustment under the Indenture) have been duly and validly authorized and reserved for by Parent and, when issued upon exchange of the New Notes in accordance with the terms of the New Notes and the Deposit Agreement, will be validly issued, fully paid and non-assessable, and the issuance of any Underlying ADSs (including the Ordinary Shares represented thereby) will not be subject to any preemptive, participation, rights of first refusal or similar rights.         </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:9.67pt">Indenture.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Each of the Company and Parent has all requisite organizational power and authority to perform its obligations under the Indenture.  The Indenture has been duly authorized by the Company and Parent, and will have been duly executed and delivered by the Company and Parent on or prior to the Closing. Assuming due authorization, execution and delivery by the New Notes Trustee thereto, the Indenture, upon execution and delivery thereof by the Company and Parent, will constitute the valid and binding agreement of the Company and Parent, enforceable against the Company and Parent in accordance with its terms, subject to the Enforceability Exceptions. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">e.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:9.67pt">Exemption from Registration. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assuming the accuracy of the representations and warranties of the Investor and each other investor executing an Exchange Agreement, (i) the issuance of the Exchanged New Notes, pursuant to this Exchange Agreement is exempt from the registration requirements of the Securities Act&#59; (ii)&#160;the Indenture is not required to be qualified under the Trust Indenture Act of 1939, as amended&#59; (iii) the Exchanged New Notes will, at the Closing, be free of any restrictions on resale by such Holder pursuant to Rule 144 promulgated under the Securities Act&#59; and (iv) will be issued in compliance with all applicable U.S. state and federal laws concerning the issuance of the Exchanged New Notes. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">f.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:12.46pt">New Class. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The New Notes, when issued, will not be of the same class as securities listed on a national securities exchange registered under Section&#160;6 of the Securities Exchange Act of 1934, as amended (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exchange Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), or quoted in a U.S. automated inter-dealer quotation system, within the meaning of Rule 144A(d)(3)(i) under the Securities Act. </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:83%"> </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.948%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">ACTIVE&#47;115855038.2 </font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">g.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:9.67pt">Listing</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. At the Closing, the Underlying ADSs are listed on the Nasdaq Global Market (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nasdaq</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), and the Company has taken no action designed to, or likely to have the effect of, delisting the Underlying ADSs from the Nasdaq nor has the Company received any notification that the Nasdaq is contemplating terminating such listing. </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">h.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:9.67pt">No Conflicts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The issue of the New Notes pursuant to the Exchange Agreements, the execution, delivery and performance, as applicable, by the Company and Parent of their respective obligations under the New Notes, the Indenture, the Guarantee, each Exchange Agreement, and the consummation of the transactions contemplated hereby and thereby, as the case may be, will not (i) conflict with or result in a breach or violation of any of the terms or provisions of, impose any lien, charge or encumbrance upon any property or assets of Parent or its subsidiaries, or constitute a default under, any indenture, mortgage, deed of trust, loan agreement, license, lease or other agreement or instrument to which Parent or any of its subsidiaries is a party or by which Parent or any of its subsidiaries is bound or to which any of the property or assets of Parent or any of its subsidiaries is subject, (ii) result in any violation of the provisions of the memorandum and articles of association, charter or by-laws or similar organizational document of Parent or any of its subsidiaries or (iii) result in any violation of any statute or any judgment, order, decree, rule or regulation of any court or arbitrator or U.S. federal, state, local or non-U.S. governmental agency or regulatory authority having jurisdiction over the properties or assets of Parent or any of its subsidiaries or any of their properties or assets, except, with respect to clauses (i) and (iii), conflicts, breaches, violations, impositions or defaults that would not reasonably be expected to have a material adverse effect on the condition (financial or otherwise), results of operations, stockholders&#8217; equity, properties, business or prospects of Parent and its subsidiaries taken as a whole or a material adverse effect on the performance by Parent or the Company of their respective obligations under any Exchange Agreement, the Old Notes Indenture, the Indenture, the Guarantee or the New Notes or the consummation of any of the transactions contemplated hereby or thereby.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:13.01pt">Exchange</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Parent and the Company each acknowledge that the terms of the Exchange have been mutually negotiated between the parties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">j.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:13.01pt">Deposit Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The Company and Parent shall (i) have taken all actions necessary to permit the deposit of the Ordinary Shares and the issuance of the ADSs representing such Ordinary Shares in accordance with the Deposit Agreement and (ii) do and perform, or cause to be done and performed, all such acts and things (including to execute and deliver any documents and provide any consent or confirmation and to satisfy any other procedural or substantive requirements under the Deposit Agreement)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to effect the issuance of ADSs, and otherwise comply with the terms of the Deposit Agreement, including without limitation, the covenants set forth in the Deposit Agreement.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">k.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:10.23pt">No Rights of Immunity</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Except as provided by laws or statutes generally applicable to transactions of the type described in this Exchange Agreement, neither the Company nor any of its subsidiaries or any of their respective properties, assets or revenues has any right of immunity under Irish, French, Cayman Islands, New York or United States law, from any legal action, suit or proceeding, from the giving of any relief in any such legal action, suit or proceeding, from set-off or counterclaim, from the jurisdiction of any Irish, French, Cayman Islands, New York or United States federal court, from service of process, attachment upon or prior judgment, or attachment in aid of execution of judgment, or from execution of a judgment, or other legal process or proceeding for the giving of any relief or for the enforcement of a judgment, in any such court, with respect to its obligations, liabilities or any other matter under or arising out of or in connection with this Exchange Agreement or the Deposit Agreement. To the extent that the Company or any of its subsidiaries or any of their respective properties, assets or revenues may have or may hereafter become entitled to any such right of immunity in any such court in which proceedings may at any time be commenced each of the Company and each subsidiary, the Company waives or will waive such right to the extent permitted by law and has consented to such relief and enforcement as provided in Section 15 of this Agreement.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">l.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:13.01pt">Enforceability of Judgments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Any final judgment for a fixed or readily calculable sum of money rendered by a New York Court having jurisdiction under its own domestic laws and recognized by the Irish courts as having jurisdiction (according to Irish conflicts of laws principles and rules of Irish private international law at the time when proceedings </font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:83%"> </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.948%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">ACTIVE&#47;115855038.2 </font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">were initiated) to give such final judgment in respect of any suit, action or proceeding against the Company based upon this Exchange Agreement or the Deposit Agreement and any instruments or agreements entered into for the consummation of the transactions contemplated herein and therein would be declared enforceable against the Company, without re-examination or review of the merits of the cause of action in respect of which the original judgment was given or re-litigation of the matters adjudicated upon, by the courts of Ireland.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt;text-decoration:underline">Representations and Warranties and Covenants of the Investor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The Investor hereby represents and warrants to and covenants with the Company and Parent, on behalf of itself and each Account, as applicable, that&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">The Investor is a corporation, limited partnership, limited liability company or other entity, as the case may be, duly formed, validly existing and in good standing under the laws of the jurisdiction of its formation. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">If the Investor is participating in the Exchange, the Investor has full power and authority to deliver, assign and transfer the Exchanged Old Notes in exchange for the Exchange Consideration pursuant to this Exchange Agreement and to enter into this Exchange Agreement and perform all obligations required to be performed by the Investor hereunder. If the Investor is executing this Exchange Agreement on behalf of an Account, (i) the Investor has all requisite authority to enter into this Exchange Agreement on behalf of, and, bind, each Account to the terms of this Exchange Agreement and (ii) </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> hereto is a true, correct and complete list of (A) the name of each Exchanging Holder, and (B) the principal amount of each Exchanging Holder's Exchanged Old Notes. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.23pt">Each Exchanging Holder participating in the Exchange is the current beneficial owner of the Exchanged Old Notes. When the Exchanged Old Notes are exchanged, the Company will acquire good, marketable and unencumbered title thereto, free and clear of all liens, restrictions, charges, encumbrances, adverse claims, rights or proxies. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">Participation in the Exchange will not contravene (1)&#160;any law, rule or regulation binding on the Investor or any investment guideline or restriction applicable to the Investor (or, if applicable, any Account) and (2)&#160;the charter or bylaws or similar organizational documents of the Investor (or, if applicable, any Account). </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">e.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">The Investor (or applicable Account) is a resident of the jurisdiction set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> and, unless otherwise set out in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> hereto, is not acquiring the Exchanged New Notes as a nominee or agent or otherwise for any other person. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">f.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:12.46pt">The Investor and each Account will comply with all applicable laws and regulations in effect in any jurisdiction in which the Investor or such Account purchases or acquires pursuant to the Exchange or sells New Notes and will obtain any consent, approval or permission required for such purchases, acquisitions or sales under the laws and regulations of any jurisdiction to which the Investor or such Account is subject or in which the Investor or such Account makes such purchases, acquisitions or sales, and Parent and the Company shall not have any responsibility therefor. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">g.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">The Investor and each Account has received a copy of the Transaction Documents. The Investor acknowledges that&#58; (1) no person has been authorized to give any information or to make any representation concerning the Exchange, Parent or any of its subsidiaries, including the Company, other than as contained in this Exchange Agreement or the Transaction Documents or in the information given by Parent&#8217;s or the Company&#8217;s duly authorized officers and employees in connection with the Investor&#8217;s examination of Parent and its subsidiaries and the terms of the Exchange&#59; and (2) Parent and its subsidiaries do not take any responsibility for, and cannot provide any assurance as to the reliability of, any other information that may have been provided to the Investor. The Investor hereby acknowledges that J. Wood Capital Advisors LLC (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Placement Agent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) does not take any responsibility for, and can provide no assurance as to the reliability of, the information set forth in the Transaction Documents or any such other information provided or deemed provided to the Investor by Parent or the Company. </font></div><div style="text-align:justify"><font><br></font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:83%"> </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.948%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">ACTIVE&#47;115855038.2 </font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">h.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">The Investor and each Account understands and accepts that acquiring the New Notes in the Exchange involves risks. The Investor and each Account has such knowledge, skill and experience in business, financial and investment matters that the Investor and each Account is capable of evaluating the merits and risks of the Exchange and an investment in the New Notes. With the assistance of its own professional advisors (to the extent the Investor and each Account has deemed appropriate), the Investor and each Account has made its own legal, tax, accounting and financial evaluation of the merits and risks of an investment in the New Notes and the consequences of the Exchange and this Exchange Agreement. The Investor and each Account has considered the suitability of the New Notes as an investment in light of its own circumstances and financial condition, and the Investor and each Account is able to bear the risks associated with an investment in the New Notes. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.01pt">The Investor confirms that neither it nor any Account is relying on any communication (written or oral) of Parent, the Company or the Placement Agent or any of their respective agents (including authorized officers and employees) or affiliates as investment advice or as a recommendation to participate in the Exchange and receive the Exchange Consideration pursuant to the terms hereof. It is understood that information provided in the Transaction Documents, or by Parent, the Company or the Placement Agent or any of their respective agents or affiliates, shall not be considered investment advice or a recommendation with respect to the Exchange, and that none of Parent, the Company, the Placement Agent or any of their respective agents or affiliates is acting or has acted as an advisor to the Investor or any Account in deciding whether to participate in the Exchange. The Investor and each Account acknowledges and the Investor agrees that the Placement Agent has not acted as a financial advisor or fiduciary to the Investor or any Account and that the Placement Agent, its affiliates and its or their directors, officers, employees, representatives and controlling persons have no responsibility for making, and have not made, any independent investigation of the information contained herein or in Parents filings with the Securities and Exchange Commission and make no representation or warranty to the Investor or any Account, express or implied, with respect to Parent, the Company, the Exchanged Old Notes or the ADSs or the accuracy, completeness or adequacy of the information provided to the Investor or any Account or any other publicly available information, nor shall any of the foregoing persons be liable for any loss or damages of any kind in connection with the Exchange.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">j.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.01pt">The Investor confirms, for itself and for each Account, that none of Parent, the Company or the Placement Agent has (1)&#160;given any guarantee or representation as to the potential success, return, effect or benefit (either legal, regulatory, tax, financial, accounting or otherwise) of an investment in the New Notes (except for the Guarantee provided by Parent pursuant to the Indenture)&#59; or (2)&#160;made any representation to the Investor regarding the legality of an investment in the New Notes under applicable investment guidelines, laws or regulations. In deciding to participate in the Exchange, neither the Investor nor any Account is relying on the advice or recommendations of Parent, the Company or the Placement Agent, and the Investor and each Account has made its own independent decision that the investment in the New Notes is suitable and appropriate for the Investor or such Account. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">k.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.23pt">The Investor and each Account is a sophisticated participant in the transactions contemplated hereby and has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of an investment in the New Notes, is experienced in investing in capital markets and is able to bear the economic risk of an investment in the New Notes. The Investor and each Account is familiar with the business and financial condition and operations of the Company and its subsidiaries, including the Company, and has conducted its own investigation of Parent and its subsidiaries and the New Notes and has consulted with its own advisors concerning such matters and shall be responsible for making its own independent investigation and appraisal of the transactions contemplated hereby. The Investor and each Account has had access to Parent&#8217;s filings with the Securities and Exchange Commission and such other information concerning Parent and its subsidiaries and the New Notes as it deems necessary to enable it to make an informed investment decision concerning the Exchange. The Investor and each Account has been offered the opportunity to ask questions of Parent, the Company and their respective representatives and has received answers thereto as the Investor or such Account deems necessary to enable it to make its own informed investment decision concerning the Exchange and the New Notes. The </font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:83%"> </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.948%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">ACTIVE&#47;115855038.2 </font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investor and each Account acknowledges and understands that at the time of the Closing, Parent and the Company may be in possession of material non-public information not known to the Investor or any Account that may impact the value of the New Notes, the Exchanged Old Notes, and the ADSs (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) that the Company has not disclosed to the Investor or any Account. The Investor and each Account acknowledges that they have not relied upon the non-disclosure of any such Information for purposes of making their decision to participate in the Exchange. The Investor and each Account understands, based on its experience, the disadvantage to which the Investor and each Account is subject due</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to the disparity of information between Parent and the Company, on the one hand, and the Investor and each Account, on the other hand. Notwithstanding this, the Investor and each Account has deemed it appropriate to participate in the Exchange. The Investor agrees that Parent and the Company and their directors, officers, employees, agents, stockholders and affiliates shall have no liability to the Investor or any Account or their respective beneficiaries whatsoever due to or in connection with Parent or the Company&#8217;s use or non-disclosure of the Information or otherwise as a result of the Exchange, and the Investor hereby irrevocably waives any claim that it or any Account might have based on the failure of Parent or the Company to disclose the Information.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">l.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.01pt">The Investor and each Account understands that no U.S. federal, state, local or non-U.S. agency has passed upon the merits or risks of an investment in the New Notes or made any finding or determination concerning the fairness or advisability of such investment. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">m.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.9pt">The Investor and each Account is a &#8220;qualified institutional buyer&#8221; as defined in Rule 144A under the Securities Act. The Investor, for itself and on behalf of each Account, agrees to furnish any additional information reasonably requested by the Company or any of its affiliates to assure compliance with applicable U.S. federal and state securities laws in connection with the Exchange. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">The Investor and each Account is not directly, or indirectly through one or more intermediaries, controlling or controlled by, or under direct or indirect common control with, Parent or the Company and is not, and has not been for the immediately preceding three months, an &#8220;affiliate&#8221; (within the meaning of Rule 144 under the Securities Act) of Parent or the Company. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">The Investor and each Account is acquiring the New Notes solely for the Investor&#8217;s or such Account&#8217;s own beneficial account, or for an account with respect to which the Investor or such Account exercises sole investment discretion, for investment purposes, and not with a view to, or for resale in connection with, any distribution of the New Notes. The Investor and each Account understands that the offer and sale of the New Notes have not been registered under the Securities Act or any state securities laws by reason of specific exemptions under the provisions thereof that depend in part upon the investment intent of the Investor or each Account and the accuracy of the other representations made by the Investor and each Account in this Exchange Agreement. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">p.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">The Investor and each Account understands that each of Parent and the Company is relying upon the representations and agreements contained in this Exchange Agreement (and any supplemental information) for the purpose of determining whether the Investor&#8217;s and such Account&#8217;s participation in the Exchange meets the requirements for the exemptions referenced in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">clause 6(o)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;above. In addition, the Investor and each Account acknowledges and agrees that any hedging transactions engaged in by the Investor or such Account after the confidential information (as described in the confirmatory email received by the Investor from the Placement Agent (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Wall Cross Email</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;)) was made available to the Investor and prior to the Closing in connection with the issuance and sale of the New Notes have been and will be conducted in compliance with the Securities Act and the rules and regulations promulgated thereunder. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">q.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">The Investor and each Account acknowledges that the New Notes have not been registered under the Securities Act. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">r.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:11.9pt">The Investor and each Account acknowledges that the terms of the Exchange have been mutually negotiated between the Investor (for itself and on behalf of each Account), and </font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:83%"> </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.948%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">ACTIVE&#47;115855038.2 </font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the Company. The Investor was given a meaningful opportunity to negotiate the terms of the Exchange on behalf of itself and each Account. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">s.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.23pt">The Investor and each Account acknowledges the Company intends to pay an advisory fee to the Placement Agent. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">t.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:12.46pt">The Investor will, for itself and on behalf of each Account, upon request, execute and deliver any additional documents, information or certifications reasonably requested by the Company, the Old Notes Trustee or the New Notes Trustee to complete the Exchange. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">u.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt">The Investor and each Account understands that, unless the Investor notifies the Company in writing to the contrary before the Closing, each of the Investor&#8217;s representations and warranties contained in this Exchange Agreement will be deemed to have been reaffirmed and confirmed as of the Closing, taking into account all information received by the Investor. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">v.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.23pt">The participation in the Exchange by any Exchanging Holder was not conditioned by the Company on such Exchanging Holders&#8217; exchange of a minimum principal amount of Exchanged Old Notes. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">w.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:8.01pt">The Investor acknowledges that it and each Account had a sufficient amount of time to consider whether to participate in the Exchange and that neither the Company nor the Placement Agent has placed any pressure on the Investor or any Account to respond to the opportunity to participate in the Exchange. The Investor acknowledges that neither it nor any Account did become aware of the Exchange through any form of general solicitation or advertising within the meaning of Rule 502 under the Securities Act. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">x.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.23pt">The operations of the Investor and each Account have been conducted in material compliance with the rules and regulations administered or conducted by the U.S. Department of Treasury Office of Foreign Assets Control (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OFAC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) applicable to the Investor. The Investor has performed due diligence necessary to reasonably determine that its (or, where applicable, any Account&#8217;s) beneficial owners are not named on the lists of denied parties or blocked persons administered by OFAC, resident in or organized under the laws of a country that is the subject of comprehensive economic sanctions and embargoes administered or conducted by OFAC (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sanctions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), or otherwise the subject of Sanctions. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt;text-decoration:underline">Conditions to Obligations of the Investor and the Company and Parent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The obligations of the Investor to deliver, or to cause the Accounts to deliver, the Exchanged Old Notes, and of the Company to deliver the Exchange Consideration are subject to the satisfaction at or prior to the Closing of the condition precedent that the representations and warranties of the Company and Parent on the one hand, and of the Investor on the other contained in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, respectively, shall be true and correct as of the Closing in all material respects with the same effect as though such representations and warranties had been made as of the Closing.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt;text-decoration:underline">Covenants and Acknowledgment of the Company and Parent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Parent hereby agrees to publicly disclose at or before 9&#58;00 a.m., New York City time (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Release Time</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), on the first business day after the date hereof, the Exchange as contemplated by this Exchange Agreement in a press release or a Current Report on Form 8-K filed with the Securities and Exchange Commission.  Parent hereby acknowledges and agrees that, as of the Release Time, Parent will disclose all confidential information to the extent Parent believes such confidential information constitutes material non-public information, if any, with respect to the Exchange or that was otherwise communicated by the Company and&#47;or Parent to the Investor or any Account in connection with the Exchange.  For the avoidance of doubt, each of Parent and the Company may be aware of material non-public information regarding Parent and&#47;or the Company at the time of Closing that has not been communicated to the Investor or any Account.  Parent will, within two (2) business days after the Closing, file a Current Report on Form 8-K publicly disclosing the closing of the Exchange as contemplated by this Exchange Agreement.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.67pt;text-decoration:underline">Covenant of the Investor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. No later than one (1) business day after the date hereof, the Investor agrees to deliver settlement instructions for each Purchaser to the Company substantially in the form of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> hereto.</font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:83%"> </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.948%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">ACTIVE&#47;115855038.2 </font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:4.11pt;text-decoration:underline">Waiver, Amendment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Neither this Exchange Agreement nor any provisions hereof shall be modified, changed, discharged or terminated except by an instrument in writing, signed by the party against whom any waiver, change, discharge or termination is sought. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:4.11pt;text-decoration:underline">Assignability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Neither this Exchange Agreement nor any right, remedy, obligation or liability arising hereunder or by reason hereof shall be assignable by Parent, the Company or the Investor without the prior written consent of the other parties. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:4.11pt;text-decoration:underline">Reserved</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  </font></div><div style="padding-left:90pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:4.11pt;text-decoration:underline">Waiver of Jury Trial</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. EACH OF PARENT, THE COMPANY AND THE INVESTOR (FOR ITSELF AND, IF APPLICABLE, ON BEHALF OF EACH ACCOUNT) IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY WITH RESPECT TO ANY LEGAL PROCEEDING ARISING OUT OF THE TRANSACTIONS CONTEMPLATED BY THIS EXCHANGE AGREEMENT. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:4.11pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. THIS EXCHANGE AGREEMENT SHALL BE GOVERNED BY THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAW PRINCIPLES THAT WOULD RESULT IN THE APPLICATION OF ANY LAW OTHER THAN THE LAW OF THE STATE OF NEW YORK. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:4.11pt;text-decoration:underline">Submission to Jurisdiction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Each of Parent, the Company and the Investor (for itself and, if applicable, on behalf of each Account) (a)&#160;agrees that any legal suit, action or proceeding arising out of or relating to this Exchange Agreement or the transactions contemplated hereby shall be instituted exclusively in the courts of the State of New York located in the City and County of New York or in the United States District Court for the Southern District of New York&#59; (b)&#160;waives any objection that it may now or hereafter have to the venue of any such suit, action or proceeding&#59; and (c)&#160;irrevocably consents to the jurisdiction of the aforesaid courts in any such suit, action or proceeding. Each of Parent, the Company and the Investor (for itself and, if applicable, on behalf of each Account) agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:4.11pt;text-decoration:underline">Venue</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Each of Parent, the Company and the Investor (for itself and, if applicable, on behalf of each Account) irrevocably and unconditionally waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Exchange Agreement in any court referred to in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;15</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Each of Parent, the Company and the Investor (for itself and, if applicable, on behalf of each Account) irrevocably waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:4.11pt;text-decoration:underline">Service of Process</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Each of Parent, the Company and the Investor (for itself and, if applicable, on behalf of each Account) irrevocably consents to service of process in the manner provided for notices in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;20</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Nothing in this Exchange Agreement will affect the right of any party to this Exchange Agreement to serve process in any other manner permitted by law. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:4.11pt;text-decoration:underline">Section and Other Headings</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The section and other headings contained in this Exchange Agreement are for reference purposes only and shall not affect the meaning or interpretation of this Exchange Agreement. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:4.11pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. This Exchange Agreement may be executed, either manually or by way of a digital signature provided by DocuSign (or similar digital signature provider), by one or more of the parties hereto in any number of separate counterparts (including by facsimile or other electronic means, including telecopy, email or otherwise), and all of said counterparts taken together shall be deemed to constitute one and the same instrument. Delivery of an executed signature page of this Exchange Agreement (whether executed manually or by way of a digital signature as described herein this Section 19) by facsimile or other transmission (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, &#8220;pdf&#8221; or &#8220;tif&#8221; format) shall be effective as delivery of a manually executed counterpart hereof. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:4.11pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. All notices and other communications to the Company provided for herein shall be in writing and shall be deemed to have been duly given if delivered personally or sent by registered or certified mail, return receipt requested, postage prepaid to the following addresses, or, in the </font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:83%"> </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.948%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">ACTIVE&#47;115855038.2 </font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">case of the Investor or any Account, the address provided in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (or such other address as either party shall have specified by notice in writing to the other)&#58; </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.594%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If to the Company&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Avadel Finance Cayman Limited</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c&#47;o Avadel Pharmaceuticals plc</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 Earlsfort Terrace</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dublin 2, Ireland</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">D02 T380 </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Attention&#58; General Counsel&#59; Christopher McLaughlin</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In each case, with a copy to <br>(which shall not constitute notice)&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwin Procter LLP</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 Northern Avenue, Boston, MA 02210<br>Attention&#58; Jim Barri</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:4.11pt;text-decoration:underline">Binding Effect</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The provisions of this Exchange Agreement shall be binding upon and accrue to the benefit of the parties hereto and their respective heirs, legal representatives, successors and permitted assigns. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:4.11pt;text-decoration:underline">Notification of Changes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The Investor (for itself and, if applicable, on behalf of each Account) hereby covenants and agrees to notify the Company upon the occurrence of any event prior to the Closing that would cause any representation, warranty, or covenant of the Investor (and&#47;or such Account) contained in this Exchange Agreement to be false or incorrect in any material respect. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:4.11pt;text-decoration:underline">Reliance by Placement Agent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The Placement Agent may rely on each representation and warranty of the Company, the Parent and the Investor made herein or pursuant to the terms hereof with the same force and effect as if such representation or warranty were made directly to the Placement Agent. The Placement Agent shall be a third party beneficiary to this Exchange Agreement to the extent provided in this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;23</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:4.11pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. If any term or provision (in whole or in part) of this Exchange Agreement is invalid, illegal or unenforceable in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other term or provision of this Exchange Agreement or invalidate or render unenforceable such term or provision in any other jurisdiction. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Signature Pages Follow</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#93; </font></div><div><font><br></font></div><div><font><br></font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:83%"> </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.948%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">ACTIVE&#47;115855038.2 </font></div><div><font><br></font></div></td></tr></table></div></div></div><div id="i735c57d4239642d99bcdbef395970f69_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the Investor (for itself and, if applicable, on behalf of each Account) has executed this Exchange Agreement as of the date first written above. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:7.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.476%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.094%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Legal Name of Executing Investor&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal Name&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt"><font><br></font></div><div style="height:91.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:30pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to Exchange Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#93; </font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ACCEPTED AND AGREED&#58; </font></div><div><font><br></font></div><div style="padding-left:234pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.102%"><tr><td style="width:1.0%"></td><td style="width:9.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.835%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AVADEL FINANCE CAYMAN LIMITED,</font></div><div style="margin-bottom:0.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">as the Company</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;text-indent:-12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#160;&#160;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;text-indent:-12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;text-indent:-12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:12pt;text-indent:-12pt"><font><br></font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:12pt;text-indent:-12pt"><font><br></font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:12pt;text-indent:-12pt"><font><br></font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:234pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.102%"><tr><td style="width:1.0%"></td><td style="width:9.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.835%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AVADEL PHARMACEUTICALS PLC,</font></div><div style="margin-bottom:0.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">as Parent</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;text-indent:-12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#160;&#160;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;text-indent:-12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt;text-indent:-12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:12pt;text-indent:-12pt"><font><br></font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:12pt;text-indent:-12pt"><font><br></font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:12pt;text-indent:-12pt"><font><br></font></div></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="height:91.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:30pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to Exchange Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#93; </font></div><div><font><br></font></div></div></div><div id="i735c57d4239642d99bcdbef395970f69_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXHIBIT A TO THE EXCHANGE AGREEMENT</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:4.92pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:24.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.411%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:12pt;padding-left:3.5pt;padding-right:3.5pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Name of<br>Exchanging Holder (i.e., Beneficial Owner)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Aggregate Principal Amount of Exchanged Old Notes</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Aggregate Principal Amount of Exchanged New Notes</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Aggregate Amount of Cash Consideration</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td></tr><tr style="height:24pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total&#58;</font></td><td colspan="3" style="border-bottom:4pt double #000000;border-left:0.5pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="6" style="border-bottom:4pt double #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:30pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to Exchange Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#93; </font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:30pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to Exchange Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#93; </font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXHIBIT B TO THE EXCHANGE AGREEMENT</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">NOTICE OF EXCHANGE PROCEDURES</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Attached are Exchange Procedures for the settlement of the Avadel Finance Cayman Limited (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) exchange of its Exchangeable Senior Notes due 2023 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">New Notes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) pursuant to the Exchange Agreement, dated as of March 16, 2022, between you, the Company and Avadel Pharmaceuticals plc, which is expected to occur on or about April 4, 2022. To ensure timely settlement, please follow the instructions for exchanging your Avadel Finance Cayman Limited 4.50% Exchangeable Senior Notes due 2023 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Old Notes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) as set forth on the following page.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">These instructions supersede any prior instructions you received. Your failure to comply with the attached instructions may delay your receipt of the Exchange Consideration.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If you have any questions, please contact &#91;NAME&#93; at &#91;TELEPHONE&#93;.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thank you.</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:30pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to Exchange Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#93; </font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><img alt="image_0.jpg" src="image_0.jpg" style="height:170px;margin-bottom:5pt;vertical-align:text-bottom;width:638px"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Note that the DWAC instruction should specify the principal amount, not the number, of Exchanged Old Notes.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Note that the DWAC instruction should specify the principal amount, not the number, of Exchanged New Notes.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br></font></div><div style="text-align:center"><img alt="image_1.jpg" src="image_1.jpg" style="height:171px;margin-bottom:5pt;vertical-align:text-bottom;width:638px"></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:30pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to Exchange Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#93; </font></div><div><font><br></font></div></div></div><div id="i735c57d4239642d99bcdbef395970f69_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXHIBIT C TO THE EXCHANGE AGREEMENT</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><br>Purchaser Settlement Details</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">These settlement instructions are to be delivered to the Company for each Purchaser no later than one (1) business day after the date of the Exchange Agreement. </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of Purchaser&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchaser Address&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Telephone&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Email Address&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Country of Residence&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxpayer Identification Number&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exchanged Old Notes<br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DTC Participant Number&#58; &#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DTC Participant Name&#58; &#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DTC Participant Phone Number&#58; &#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DTC Participant Contact Email&#58; &#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FFC Account #&#58; &#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Account # at Bank&#47;Broker&#58; &#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exchanged New Notes (if different from Exchanged Old Notes)<br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DTC Participant Number&#58;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DTC Participant Name&#58;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DTC Participant Phone Number&#58; &#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DTC Participant Contact Email&#58; &#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FFC Account #&#58;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Account # at Bank&#47;Broker&#58;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wire instructions for Cash Consideration&#58;</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank Name&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank Address&#58; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABA Routing #&#58; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Account Name&#58; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Account Number&#58; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contact Person&#58; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:11pt"><font><br></font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:83%"> </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:14.583%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">ACTIVE&#47;115855038.2 </font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:83%"> </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:14.583%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">ACTIVE&#47;115855038.2 </font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div><font><br></font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:83%"> </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:14.583%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:143%">ACTIVE&#47;115855038.2 </font></div><div><font><br></font></div></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>5
<FILENAME>a123121ex-211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i2822947a46b548c9bf579856f1717bfb_1"></div><div style="min-height:54pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 21.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">List of Subsidiaries</font></div><div style="margin-top:5pt;padding-left:4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.958%"><tr><td style="width:1.0%"></td><td style="width:72.433%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.616%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction</font></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Avadel Pharmaceuticals plc (the Registrant)&#58; </font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ireland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1) Avadel US Holdings, Inc. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(f&#47;k&#47;a Flamel US Holdings, Inc.)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States (Delaware)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B. Avadel Legacy Pharmaceuticals, LLC </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(f&#47;k&#47;a &#201;clat Pharmaceuticals LLC)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States (Delaware)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C. Avadel Management Corporation</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States (Delaware)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D. Avadel CNS Pharmaceuticals, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States (Delaware)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2) Flamel Ireland Ltd. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(d&#47;b&#47;a Avadel Ireland)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ireland</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3) Avadel Investment Company, Ltd. </font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cayman Islands</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4) Avadel France Holding SAS</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">France</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A. Avadel Research SAS </font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">France</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5) Avadel Finance Ireland Designated Activity Company</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ireland</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A. Avadel Finance Cayman Ltd.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cayman Islands</font></td></tr></table></div><div><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>6
<FILENAME>a123121ex-231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ibafd3c57de77453aa8010b074b820053_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in Registration Statement Nos. 333-213154, 333-212585, 333-177591, 333-219016, and 333-252956 on Form S-8, and 333-183961, 333-236258 and 333-237962 on Form S-3 of our reports dated March&#160;16, 2022, relating to the consolidated financial statements of Avadel Pharmaceuticals plc (the &#34;Company&#34;) and the effectiveness of the Company&#8217;s internal control over financial reporting, appearing in this Annual Report on Form 10-K of Avadel Pharmaceuticals plc for the year ended December&#160;31, 2021. </font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Deloitte and Touche LLP</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">St. Louis, Missouri </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;16, 2022 </font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>7
<FILENAME>a123121ex-311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i7d09b586ad9c46208a08e017d49ba37c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CERTIFICATION </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Gregory J. Divis, certify that&#58;</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Annual Report on Form 10-K of Avadel Pharmaceuticals plc&#59;&#160;</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;&#160;</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;&#160;</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;&#160;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;&#160;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;&#160;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59;&#160;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and&#160;</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;&#160;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and&#160;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; March&#160;16, 2022</font></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:63.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Gregory J. Divis</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gregory J. Divis</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>8
<FILENAME>a123121ex-312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i296a5125ee37404e857b3a1e1402df71_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CERTIFICATION </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Thomas S. McHugh, certify that&#58;&#160;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Annual Report on Form 10-K of Avadel Pharmaceuticals plc&#59;&#160;</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;&#160;</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;&#160;</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;&#160;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;&#160;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;&#160;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59;&#160;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and&#160;</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;&#160;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and&#160;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.&#160;</font></div><div style="margin-bottom:9pt;text-align:justify"><font><br></font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; March&#160;16, 2022</font></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Thomas S. McHugh</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas S. McHugh</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Chief Financial Officer</font></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>9
<FILENAME>a123121ex-321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i384843d81fb44f7683771fa0a73222be_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the annual report of Avadel Pharmaceuticals plc (the &#8220;Company&#8221;) on Form 10-K for the period ending December&#160;31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I,&#160;Gregory J. Divis, Chief Executive Officer of the Company, certify, to the best of my knowledge, pursuant to 18 U.S.C. &#167;1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:43.995%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.805%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Gregory J. Divis</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gregory J. Divis</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Avadel Pharmaceuticals plc</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March&#160;16, 2022</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>10
<FILENAME>a123121ex-322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ib700bad51db241d987c68daf75971616_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the annual report of Avadel Pharmaceuticals plc (the &#8220;Company&#8221;) on Form 10-K for the period ending December&#160;31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Thomas S. McHugh, Senior Vice President and Chief Financial Officer of the Company, certify, to the best of my knowledge, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:43.995%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.805%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Thomas S. McHugh</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas S. McHugh</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Chief Financial Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Avadel Pharmaceuticals plc</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March&#160;16, 2022</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>avdl-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9768bc4a-d41b-4cde-8dab-4f8611fcf569,g:2327e6e7-350d-456e-9b47-ccea1e6c574d-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:avdl="http://www.avadel.com/20211231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.avadel.com/20211231">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="avdl-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="avdl-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="avdl-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="avdl-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.avadel.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.avadel.com/role/AuditInformation">
        <link:definition>0002002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofLossIncome" roleURI="http://www.avadel.com/role/ConsolidatedStatementsofLossIncome">
        <link:definition>1001003 - Statement - Consolidated Statements of (Loss) Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveLossIncome" roleURI="http://www.avadel.com/role/ConsolidatedStatementsofComprehensiveLossIncome">
        <link:definition>1002004 - Statement - Consolidated Statements of Comprehensive (Loss) Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveLossIncomeParenthetical" roleURI="http://www.avadel.com/role/ConsolidatedStatementsofComprehensiveLossIncomeParenthetical">
        <link:definition>1003005 - Statement - Consolidated Statements of Comprehensive (Loss) Income (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.avadel.com/role/ConsolidatedBalanceSheets">
        <link:definition>1004006 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.avadel.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>1005007 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofShareholdersEquity" roleURI="http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity">
        <link:definition>1006008 - Statement - Consolidated Statements of Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.avadel.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>1007009 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>2303301 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2404401 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails" roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails">
        <link:definition>2405402 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment Useful Lives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewlyIssuedAccountingStandards" roleURI="http://www.avadel.com/role/NewlyIssuedAccountingStandards">
        <link:definition>2106102 - Disclosure - Newly Issued Accounting Standards</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewlyIssuedAccountingStandardsDetails" roleURI="http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails">
        <link:definition>2407403 - Disclosure - Newly Issued Accounting Standards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsidiaryBankruptcyandDeconsolidation" roleURI="http://www.avadel.com/role/SubsidiaryBankruptcyandDeconsolidation">
        <link:definition>2108103 - Disclosure - Subsidiary Bankruptcy and Deconsolidation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsidiaryBankruptcyandDeconsolidationDetails" roleURI="http://www.avadel.com/role/SubsidiaryBankruptcyandDeconsolidationDetails">
        <link:definition>2409404 - Disclosure - Subsidiary Bankruptcy and Deconsolidation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionoftheHospitalProducts" roleURI="http://www.avadel.com/role/DispositionoftheHospitalProducts">
        <link:definition>2110104 - Disclosure - Disposition of the Hospital Products</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionoftheHospitalBusinessTables" roleURI="http://www.avadel.com/role/DispositionoftheHospitalBusinessTables">
        <link:definition>2311302 - Disclosure - Disposition of the Hospital Business - (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionoftheHospitalBusinessNarrativeDetails" roleURI="http://www.avadel.com/role/DispositionoftheHospitalBusinessNarrativeDetails">
        <link:definition>2412405 - Disclosure - Disposition of the Hospital Business Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails" roleURI="http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails">
        <link:definition>2413406 - Disclosure - Disposition of the Hospital Business Components of Consideration and Assets and Liabilities Either Transferred or Eliminated (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails" roleURI="http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails">
        <link:definition>2414407 - Disclosure - Disposition of the Hospital Business - Unaudited Pro Forma Condensed Combined Statement of Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://www.avadel.com/role/RevenueRecognition">
        <link:definition>2115105 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.avadel.com/role/FairValueMeasurements">
        <link:definition>2116106 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.avadel.com/role/FairValueMeasurementsTables">
        <link:definition>2317303 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsMeasuredonRecurringBasisDetails" roleURI="http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails">
        <link:definition>2418408 - Disclosure - Fair Value Measurements - Measured on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.avadel.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>2419409 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecurities" roleURI="http://www.avadel.com/role/MarketableSecurities">
        <link:definition>2120107 - Disclosure - Marketable Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesTables" roleURI="http://www.avadel.com/role/MarketableSecuritiesTables">
        <link:definition>2321304 - Disclosure - Marketable Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesNarrativeDetails" roleURI="http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails">
        <link:definition>2422410 - Disclosure - Marketable Securities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesSummaryofMarketableSecuritiesDetails" roleURI="http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails">
        <link:definition>2423411 - Disclosure - Marketable Securities - Summary of Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesScheduleofMaturitiesDetails" roleURI="http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails">
        <link:definition>2424412 - Disclosure - Marketable Securities - Schedule of Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentnet" roleURI="http://www.avadel.com/role/PropertyandEquipmentnet">
        <link:definition>2125108 - Disclosure - Property and Equipment, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentnetTables" roleURI="http://www.avadel.com/role/PropertyandEquipmentnetTables">
        <link:definition>2326305 - Disclosure - Property and Equipment, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentnetDetails" roleURI="http://www.avadel.com/role/PropertyandEquipmentnetDetails">
        <link:definition>2427413 - Disclosure - Property and Equipment, net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssets" roleURI="http://www.avadel.com/role/GoodwillandIntangibleAssets">
        <link:definition>2128109 - Disclosure - Goodwill and Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNarrativeDetails" roleURI="http://www.avadel.com/role/GoodwillandIntangibleAssetsNarrativeDetails">
        <link:definition>2429414 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.avadel.com/role/Leases">
        <link:definition>2130110 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.avadel.com/role/LeasesTables">
        <link:definition>2331306 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.avadel.com/role/LeasesNarrativeDetails">
        <link:definition>2432415 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesComponentsofleasecostsDetails" roleURI="http://www.avadel.com/role/LeasesComponentsofleasecostsDetails">
        <link:definition>2433416 - Disclosure - Leases - Components of lease costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofoperatingleaseliabilitiesDetails" roleURI="http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails">
        <link:definition>2434417 - Disclosure - Leases - Maturities of operating lease liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofoperatingleaseliabilitiesDetails_1" roleURI="http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails_1">
        <link:definition>2434417 - Disclosure - Leases - Maturities of operating lease liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://www.avadel.com/role/LongTermDebt">
        <link:definition>2135111 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://www.avadel.com/role/LongTermDebtTables">
        <link:definition>2336307 - Disclosure - Long-Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtScheduleofLongTermDebtInstrumentsDetails" roleURI="http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails">
        <link:definition>2437418 - Disclosure - Long-Term Debt - Schedule of Long-Term Debt Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtScheduleofLongTermDebtInstrumentsDetails_1" roleURI="http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails_1">
        <link:definition>2437418 - Disclosure - Long-Term Debt - Schedule of Long-Term Debt Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNarrativeDetails" roleURI="http://www.avadel.com/role/LongTermDebtNarrativeDetails">
        <link:definition>2438419 - Disclosure - Long-Term Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingentConsiderationPayable" roleURI="http://www.avadel.com/role/ContingentConsiderationPayable">
        <link:definition>2139112 - Disclosure - Contingent Consideration Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingentConsiderationPayableTables" roleURI="http://www.avadel.com/role/ContingentConsiderationPayableTables">
        <link:definition>2340308 - Disclosure - Contingent Consideration Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingentConsiderationPayableNarrativeDetails" roleURI="http://www.avadel.com/role/ContingentConsiderationPayableNarrativeDetails">
        <link:definition>2441420 - Disclosure - Contingent Consideration Payable - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingentConsiderationPayablePayableBalanceDetails" roleURI="http://www.avadel.com/role/ContingentConsiderationPayablePayableBalanceDetails">
        <link:definition>2442421 - Disclosure - Contingent Consideration Payable - Payable Balance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.avadel.com/role/IncomeTaxes">
        <link:definition>2143113 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.avadel.com/role/IncomeTaxesTables">
        <link:definition>2344309 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeLossBeforeIncomeTaxesDetails" roleURI="http://www.avadel.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails">
        <link:definition>2445422 - Disclosure - Income Taxes - Income (Loss) Before Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeTaxProvisionBenefitDetails" roleURI="http://www.avadel.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails">
        <link:definition>2446423 - Disclosure - Income Taxes - Income Tax Provision (Benefit) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofTaxRateDetails" roleURI="http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails">
        <link:definition>2447424 - Disclosure - Income Taxes - Reconciliation of Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesAdditionalInformationDetails" roleURI="http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails">
        <link:definition>2448425 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesUnrecognizedTaxBenefitDetails" roleURI="http://www.avadel.com/role/IncomeTaxesUnrecognizedTaxBenefitDetails">
        <link:definition>2449426 - Disclosure - Income Taxes - Unrecognized Tax Benefit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredTaxesDetails" roleURI="http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails">
        <link:definition>2450427 - Disclosure - Income Taxes - Deferred Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilities" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilities">
        <link:definition>2151114 - Disclosure - Other Assets and Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesTables" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesTables">
        <link:definition>2352310 - Disclosure - Other Assets and Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails">
        <link:definition>2453428 - Disclosure - Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails">
        <link:definition>2454429 - Disclosure - Other Assets and Liabilities - Other Non-Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesAccruedExpensesDetails" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails">
        <link:definition>2455430 - Disclosure - Other Assets and Liabilities - Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails">
        <link:definition>2456431 - Disclosure - Other Assets and Liabilities - Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails">
        <link:definition>2457432 - Disclosure - Other Assets and Liabilities - Other Non-Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingentLiabilitiesandCommitments" roleURI="http://www.avadel.com/role/ContingentLiabilitiesandCommitments">
        <link:definition>2158115 - Disclosure - Contingent Liabilities and Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingentLiabilitiesandCommitmentsNarrativeDetails" roleURI="http://www.avadel.com/role/ContingentLiabilitiesandCommitmentsNarrativeDetails">
        <link:definition>2459433 - Disclosure - Contingent Liabilities and Commitments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCosts" roleURI="http://www.avadel.com/role/RestructuringCosts">
        <link:definition>2160116 - Disclosure - Restructuring Costs</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCostsTables" roleURI="http://www.avadel.com/role/RestructuringCostsTables">
        <link:definition>2361311 - Disclosure - Restructuring Costs (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCostsNarrativeDetails" roleURI="http://www.avadel.com/role/RestructuringCostsNarrativeDetails">
        <link:definition>2462434 - Disclosure - Restructuring Costs - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCostsSeveranceObligationDetails" roleURI="http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails">
        <link:definition>2463435 - Disclosure - Restructuring Costs - Severance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityInstrumentsandTransactions" roleURI="http://www.avadel.com/role/EquityInstrumentsandTransactions">
        <link:definition>2164117 - Disclosure - Equity Instruments and Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityInstrumentsandTransactionsDetails" roleURI="http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails">
        <link:definition>2465436 - Disclosure - Equity Instruments and Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://www.avadel.com/role/ShareBasedCompensation">
        <link:definition>2166118 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://www.avadel.com/role/ShareBasedCompensationTables">
        <link:definition>2367312 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationStockbasedCompensationExpenseDetails" roleURI="http://www.avadel.com/role/ShareBasedCompensationStockbasedCompensationExpenseDetails">
        <link:definition>2468437 - Disclosure - Share-Based Compensation - Stock-based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationNarrativeDetails" roleURI="http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails">
        <link:definition>2469438 - Disclosure - Share-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationFairValueAssumptionsDetails" roleURI="http://www.avadel.com/role/ShareBasedCompensationFairValueAssumptionsDetails">
        <link:definition>2470439 - Disclosure - Share-Based Compensation - Fair Value Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationStockOptionsDetails" roleURI="http://www.avadel.com/role/ShareBasedCompensationStockOptionsDetails">
        <link:definition>2471440 - Disclosure - Share-Based Compensation - Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails" roleURI="http://www.avadel.com/role/ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails">
        <link:definition>2472441 - Disclosure - Share-Based Compensation - Restricted Stock and Performance Unit Share Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossIncomePerShare" roleURI="http://www.avadel.com/role/NetLossIncomePerShare">
        <link:definition>2173119 - Disclosure - Net (Loss) Income Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossIncomePerShareTables" roleURI="http://www.avadel.com/role/NetLossIncomePerShareTables">
        <link:definition>2374313 - Disclosure - Net (Loss) Income Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossIncomePerShareReconciliationofbasicanddilutedEPSDetails" roleURI="http://www.avadel.com/role/NetLossIncomePerShareReconciliationofbasicanddilutedEPSDetails">
        <link:definition>2475442 - Disclosure - Net (Loss) Income Per Share - Reconciliation of basic and diluted EPS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossIncomePerShareNarrativeDetails" roleURI="http://www.avadel.com/role/NetLossIncomePerShareNarrativeDetails">
        <link:definition>2476443 - Disclosure - Net (Loss) Income Per Share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveLoss" roleURI="http://www.avadel.com/role/ComprehensiveLoss">
        <link:definition>2177120 - Disclosure - Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveLossTables" roleURI="http://www.avadel.com/role/ComprehensiveLossTables">
        <link:definition>2378314 - Disclosure - Comprehensive Loss (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveLossDetails" roleURI="http://www.avadel.com/role/ComprehensiveLossDetails">
        <link:definition>2479444 - Disclosure - Comprehensive Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompanyOperationsbyProductCustomerandGeographicArea" roleURI="http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicArea">
        <link:definition>2180121 - Disclosure - Company Operations by Product, Customer and Geographic Area</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompanyOperationsbyProductCustomerandGeographicAreaTables" roleURI="http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaTables">
        <link:definition>2381315 - Disclosure - Company Operations by Product, Customer and Geographic Area (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompanyOperationsbyProductCustomerandGeographicAreaRevenuebyProductDetails" roleURI="http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebyProductDetails">
        <link:definition>2482445 - Disclosure - Company Operations by Product, Customer and Geographic Area - Revenue by Product (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompanyOperationsbyProductCustomerandGeographicAreaRevenuebySignificantCustomerDetails" roleURI="http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebySignificantCustomerDetails">
        <link:definition>2483446 - Disclosure - Company Operations by Product, Customer and Geographic Area - Revenue by Significant Customer (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompanyOperationsbyProductCustomerandGeographicAreaDatabyGeographicRegionDetails" roleURI="http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaDatabyGeographicRegionDetails">
        <link:definition>2484447 - Disclosure - Company Operations by Product, Customer and Geographic Area - Data by Geographic Region (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://www.avadel.com/role/RelatedPartyTransactions">
        <link:definition>2185122 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.avadel.com/role/SubsequentEvents">
        <link:definition>2186123 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.avadel.com/role/SubsequentEventsDetails">
        <link:definition>2487448 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" abstract="false" name="ResearchAndDevelopmentTaxCreditReceivableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" abstract="false" name="OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" abstract="false" name="RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="avdl_MarketableSecuritiesRealizedLoss" abstract="false" name="MarketableSecuritiesRealizedLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_CustomerDMember" abstract="true" name="CustomerDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_DeferredTaxAssetsAmortizationofIntangibleAssets" abstract="false" name="DeferredTaxAssetsAmortizationofIntangibleAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_GuaranteeCurrent" abstract="false" name="GuaranteeCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_VestOneYearFollowingAchievementOfMilestonesMember" abstract="true" name="VestOneYearFollowingAchievementOfMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_CustomerBMember" abstract="true" name="CustomerBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_CouponInterestExpense" abstract="false" name="CouponInterestExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_ScheduleOfComponentsOfIncomeBeforeIncomeTaxTableTextBlock" abstract="false" name="ScheduleOfComponentsOfIncomeBeforeIncomeTaxTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="avdl_SpecialtyPharmaMember" abstract="true" name="SpecialtyPharmaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_RestrictedShareAwardsGrantedFrom20172020Member" abstract="true" name="RestrictedShareAwardsGrantedFrom20172020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" abstract="false" name="DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="avdl_MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock" abstract="false" name="MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="avdl_FreeShareAwardMember" abstract="true" name="FreeShareAwardMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" abstract="false" name="DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="avdl_RestrictedShareAwardsGrantsBeginningIn2018Member" abstract="true" name="RestrictedShareAwardsGrantsBeginningIn2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_AccruedInterestCurrent" abstract="false" name="AccruedInterestCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_AmericanDepositarySharesOptionPricePerShare" abstract="false" name="AmericanDepositarySharesOptionPricePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="avdl_RestrictedShareAwardsGrantedToEmployeesMember" abstract="true" name="RestrictedShareAwardsGrantedToEmployeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_CARESActProceedsFromIncomeTaxRefunds" abstract="false" name="CARESActProceedsFromIncomeTaxRefunds" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_AmericanDepositorySharesConversionRatio" abstract="false" name="AmericanDepositorySharesConversionRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="avdl_CerecorMember" abstract="true" name="CerecorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_AdditionalInterestExpenseDebt" abstract="false" name="AdditionalInterestExpenseDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_A2016MIPAMember" abstract="true" name="A2016MIPAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_PercentageOfRoyaltyPayableOnNetSales" abstract="false" name="PercentageOfRoyaltyPayableOnNetSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays" abstract="false" name="DebtInstrumentConvertibleScheduledThresholdTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="avdl_AmericanDepositarySharesPurchasedPricePerShare" abstract="false" name="AmericanDepositarySharesPurchasedPricePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember" abstract="true" name="SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" abstract="false" name="ResearchAndDevelopmentTaxCreditReceivableNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_RestructuringCostsNet" abstract="false" name="RestructuringCostsNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_RoyaltyPayableonNetSalesMaximum" abstract="false" name="RoyaltyPayableonNetSalesMaximum" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_OtherLiabilitiesMiscellaneousCurrent" abstract="false" name="OtherLiabilitiesMiscellaneousCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_IncomeTaxesTable" abstract="true" name="IncomeTaxesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="avdl_SharebasedCompensationAwardTrancheFourMember" abstract="true" name="SharebasedCompensationAwardTrancheFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" abstract="false" name="DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" abstract="false" name="ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities" abstract="false" name="TaxLiabilitiesAndOtherNoncurrentLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="avdl_CustomerCMember" abstract="true" name="CustomerCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_LeaseholdImprovementsFurnitureFixturesAndFittingsMember" abstract="true" name="LeaseholdImprovementsFurnitureFixturesAndFittingsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_IncomeTaxesLineItems" abstract="true" name="IncomeTaxesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="avdl_DebtInstrumentAdditionalInterestExpensePercentage" abstract="false" name="DebtInstrumentAdditionalInterestExpensePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="avdl_CustomerMember" abstract="true" name="CustomerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch" abstract="false" name="DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_BloxiverzVazculepAkovazandNouressMember" abstract="true" name="BloxiverzVazculepAkovazandNouressMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_OtherProductsMember" abstract="true" name="OtherProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_IncreaseDecreaseInIncomeTaxBenefit" abstract="false" name="IncreaseDecreaseInIncomeTaxBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_BloxiverzMember" abstract="true" name="BloxiverzMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="avdl_FscHoldingsLlcMember" abstract="true" name="FscHoldingsLlcMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_A450PercentExchangeableSeniorNotesDue2023Member" abstract="true" name="A450PercentExchangeableSeniorNotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_AkovazMember" abstract="true" name="AkovazMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue" abstract="false" name="EarnOutPaymentInExcessOfAcquisitionDateFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_CostsIncurredPurchaseObligation" abstract="false" name="CostsIncurredPurchaseObligation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member" abstract="true" name="FourPointFiftyPercentExchangeableSeniorNotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_MarketableSecuritiesRealizedGain" abstract="false" name="MarketableSecuritiesRealizedGain" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_StockIssuedDuringPeriodSharesPublicOffering" abstract="false" name="StockIssuedDuringPeriodSharesPublicOffering" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="avdl_EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit" abstract="false" name="EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_A2017AvadelEmployeeSharePurchasePlanMember" abstract="true" name="A2017AvadelEmployeeSharePurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_CARESActCashRefundClaims" abstract="false" name="CARESActCashRefundClaims" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit" abstract="false" name="CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_SpecialityPharamaMember" abstract="true" name="SpecialityPharamaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_OtherCustomersMember" abstract="true" name="OtherCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_InducementPlanMember" abstract="true" name="InducementPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_StockIssuedDuringPeriodValuePublicOffering" abstract="false" name="StockIssuedDuringPeriodValuePublicOffering" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_ContractualObligationAnnualAmount" abstract="false" name="ContractualObligationAnnualAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_ShortTermNoteReceivable" abstract="false" name="ShortTermNoteReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_OtherGuarantorObligationsCurrentCarryingValue" abstract="false" name="OtherGuarantorObligationsCurrentCarryingValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_LongTermContingentConsideraionPayableTextBlock" abstract="false" name="LongTermContingentConsideraionPayableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="avdl_FinancingRelatedContingentConsiderationRemeasurement" abstract="false" name="FinancingRelatedContingentConsiderationRemeasurement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_OtherNoncurrentReceivables" abstract="false" name="OtherNoncurrentReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member" abstract="true" name="A450PercentExchangeableSeniorNotesDueOctober22023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" abstract="false" name="MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_AmericanDepositarySharesPremiumPercentage" abstract="false" name="AmericanDepositarySharesPremiumPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="avdl_PublicOfferingMember" abstract="true" name="PublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward" abstract="true" name="BusinessCombinationChangesinRelatedPartyPayableRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="avdl_NatureOfBusinessPolicyPolicyTextBlock" abstract="false" name="NatureOfBusinessPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="avdl_FSCMember" abstract="true" name="FSCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_OrdinaryShareNominalValue001PerShareMember" abstract="true" name="OrdinaryShareNominalValue001PerShareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_VestUponTheAchievementOfCertainRegulatoryMilestonesMember" abstract="true" name="VestUponTheAchievementOfCertainRegulatoryMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_RetirementIndemnityObligationMember" abstract="true" name="RetirementIndemnityObligationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_SaleOfStockConsiderationReceivedOnTransactionGross" abstract="false" name="SaleOfStockConsiderationReceivedOnTransactionGross" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_RestructuringChargesBeforeGainLossDuetoCurtailment" abstract="false" name="RestructuringChargesBeforeGainLossDuetoCurtailment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_ScheduleOfShareBasedPaymentAwardStockOptionsAndWarrantGrantsValuationAssumptionsTableTextBlock" abstract="false" name="ScheduleOfShareBasedPaymentAwardStockOptionsAndWarrantGrantsValuationAssumptionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" abstract="false" name="IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_ScheduleOfIncomeTaxPaymentsTableTextBlock" abstract="false" name="ScheduleOfIncomeTaxPaymentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="avdl_AccruedOutsourceContractCosts" abstract="false" name="AccruedOutsourceContractCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_U.S.HoldingsMember" abstract="true" name="U.S.HoldingsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_NoncashGainLossDeconsolidationOfSubsidiary" abstract="false" name="NoncashGainLossDeconsolidationOfSubsidiary" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_AmericanDepositarySharesMember" abstract="true" name="AmericanDepositarySharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_VestOneYearFollowingAchievementOfCertainCorporateObjectivesMember" abstract="true" name="VestOneYearFollowingAchievementOfCertainCorporateObjectivesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_EquityTransactionsDisclosureTextBlock" abstract="false" name="EquityTransactionsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="avdl_TwoThousandNineteenCorporateRestructuringObligationsMember" abstract="true" name="TwoThousandNineteenCorporateRestructuringObligationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_VazculepMember" abstract="true" name="VazculepMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember" abstract="true" name="TwoThousandNineteenCorporateFrenchRestructuringObligationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_AccruedTradeDiscountsAndRebates" abstract="false" name="AccruedTradeDiscountsAndRebates" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_VestUponAchievementOfCertainCorporateObjectivesMember" abstract="true" name="VestUponAchievementOfCertainCorporateObjectivesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_AcquisitionRelatedContingentConsiderationRemeasurement" abstract="false" name="AcquisitionRelatedContingentConsiderationRemeasurement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_VestUponAchievementOfCertainCorporateObjectivesBeingMetAndExceededMember" abstract="true" name="VestUponAchievementOfCertainCorporateObjectivesBeingMetAndExceededMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_DebtInstrumentOptiontoIncreaseFaceAmount" abstract="false" name="DebtInstrumentOptiontoIncreaseFaceAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration" abstract="false" name="MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_GuaranteeNoncurrent" abstract="false" name="GuaranteeNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>12
<FILENAME>avdl-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9768bc4a-d41b-4cde-8dab-4f8611fcf569,g:2327e6e7-350d-456e-9b47-ccea1e6c574d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.avadel.com/role/ConsolidatedStatementsofLossIncome" xlink:type="simple" xlink:href="avdl-20211231.xsd#ConsolidatedStatementsofLossIncome"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/ConsolidatedStatementsofLossIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_68bdceb5-8289-425f-a313-f11012f0df2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9ae3f8f0-9ee3-46e1-81cc-77f2a897266c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_68bdceb5-8289-425f-a313-f11012f0df2f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9ae3f8f0-9ee3-46e1-81cc-77f2a897266c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_be7cb9dd-60ba-4465-b8d2-76fabcd12cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_68bdceb5-8289-425f-a313-f11012f0df2f" xlink:to="loc_us-gaap_CostsAndExpenses_be7cb9dd-60ba-4465-b8d2-76fabcd12cc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_e0269f8a-4002-486c-8176-e9ada6ca3d30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_3dd14cf1-b4c7-4002-bd6c-b1bca0fbc425" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_e0269f8a-4002-486c-8176-e9ada6ca3d30" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_3dd14cf1-b4c7-4002-bd6c-b1bca0fbc425" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_ebbb4625-4db9-478d-b7b6-b730b4d0484d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_e0269f8a-4002-486c-8176-e9ada6ca3d30" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_ebbb4625-4db9-478d-b7b6-b730b4d0484d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ef3a99a2-8092-4c1b-9fed-ff7d3449537d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_e0269f8a-4002-486c-8176-e9ada6ca3d30" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ef3a99a2-8092-4c1b-9fed-ff7d3449537d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_a3094476-707a-4810-9cd1-13becc14a4be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_e0269f8a-4002-486c-8176-e9ada6ca3d30" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_a3094476-707a-4810-9cd1-13becc14a4be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_dd857c4e-0ae5-438b-9060-2d4aeed5883f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_e0269f8a-4002-486c-8176-e9ada6ca3d30" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_dd857c4e-0ae5-438b-9060-2d4aeed5883f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_c0dd4ff1-649d-4788-9911-f29f157039ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_e0269f8a-4002-486c-8176-e9ada6ca3d30" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_c0dd4ff1-649d-4788-9911-f29f157039ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestructuringCostsNet_f083ee32-3b01-4685-99f6-f7e8892d022f" xlink:href="avdl-20211231.xsd#avdl_RestructuringCostsNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_e0269f8a-4002-486c-8176-e9ada6ca3d30" xlink:to="loc_avdl_RestructuringCostsNet_f083ee32-3b01-4685-99f6-f7e8892d022f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_44540320-69eb-454c-84f8-e41fe864c91d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationGainOrLossAmount_f30b1c99-8345-4391-9b2b-630333d76b74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeconsolidationGainOrLossAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_44540320-69eb-454c-84f8-e41fe864c91d" xlink:to="loc_us-gaap_DeconsolidationGainOrLossAmount_f30b1c99-8345-4391-9b2b-630333d76b74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_2b66a4b7-ef88-4811-b8e6-7ebb701d869f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_44540320-69eb-454c-84f8-e41fe864c91d" xlink:to="loc_us-gaap_InterestExpense_2b66a4b7-ef88-4811-b8e6-7ebb701d869f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_eab5b7f1-06c4-4680-8bad-d1cfa28b2339" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_44540320-69eb-454c-84f8-e41fe864c91d" xlink:to="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_eab5b7f1-06c4-4680-8bad-d1cfa28b2339" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_5e0d1428-4899-42d2-bd59-53e75ca42d53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_44540320-69eb-454c-84f8-e41fe864c91d" xlink:to="loc_us-gaap_InvestmentIncomeNet_5e0d1428-4899-42d2-bd59-53e75ca42d53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f1bca3ef-5c57-47df-bf6f-849683ce4bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_44540320-69eb-454c-84f8-e41fe864c91d" xlink:to="loc_us-gaap_OperatingIncomeLoss_f1bca3ef-5c57-47df-bf6f-849683ce4bbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_65e630a0-7d6b-40e0-a864-0def4a7bc6fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_44540320-69eb-454c-84f8-e41fe864c91d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_65e630a0-7d6b-40e0-a864-0def4a7bc6fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_77ce6107-acf6-4372-8a02-af86b447c184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6663ffd8-430b-4c80-abf0-5610c4d255c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_77ce6107-acf6-4372-8a02-af86b447c184" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6663ffd8-430b-4c80-abf0-5610c4d255c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2953a6d3-70cd-4e88-915e-74171857a18f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_77ce6107-acf6-4372-8a02-af86b447c184" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2953a6d3-70cd-4e88-915e-74171857a18f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ConsolidatedStatementsofComprehensiveLossIncome" xlink:type="simple" xlink:href="avdl-20211231.xsd#ConsolidatedStatementsofComprehensiveLossIncome"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/ConsolidatedStatementsofComprehensiveLossIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f0833ee4-5805-4388-b6c9-eb690a2c853b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_2eedf6b0-c9d0-44ea-9bc7-c3490daf5413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f0833ee4-5805-4388-b6c9-eb690a2c853b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_2eedf6b0-c9d0-44ea-9bc7-c3490daf5413" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_d1b1406c-017c-4fca-bf8c-b2730f2430d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f0833ee4-5805-4388-b6c9-eb690a2c853b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_d1b1406c-017c-4fca-bf8c-b2730f2430d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_c7ca9525-758d-48c2-bb3b-90a3ceef3292" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fbe5177e-9e2d-4891-b1b7-5326e3182174" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_c7ca9525-758d-48c2-bb3b-90a3ceef3292" xlink:to="loc_us-gaap_NetIncomeLoss_fbe5177e-9e2d-4891-b1b7-5326e3182174" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bbb428b1-1422-4e80-80a5-3700cb2ef28a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_c7ca9525-758d-48c2-bb3b-90a3ceef3292" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bbb428b1-1422-4e80-80a5-3700cb2ef28a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="avdl-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_02e97e4b-94eb-4644-82f5-c3628b7dd6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_683175ba-5d58-49f1-a513-eb96b1f5d221" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_02e97e4b-94eb-4644-82f5-c3628b7dd6c8" xlink:to="loc_us-gaap_Liabilities_683175ba-5d58-49f1-a513-eb96b1f5d221" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3852ccf1-4ade-48b9-9c1d-b245db06c87b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_02e97e4b-94eb-4644-82f5-c3628b7dd6c8" xlink:to="loc_us-gaap_StockholdersEquity_3852ccf1-4ade-48b9-9c1d-b245db06c87b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4ac05ce0-238c-4700-a42e-6f0638e5d7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_47147950-e18a-4471-955f-b7b0d7afb727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4ac05ce0-238c-4700-a42e-6f0638e5d7cc" xlink:to="loc_us-gaap_LiabilitiesCurrent_47147950-e18a-4471-955f-b7b0d7afb727" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_33ae3e0f-7f5a-478a-ac31-adf0c1a74254" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4ac05ce0-238c-4700-a42e-6f0638e5d7cc" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_33ae3e0f-7f5a-478a-ac31-adf0c1a74254" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e92440d9-ea37-42de-b29c-8ae443668fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4ac05ce0-238c-4700-a42e-6f0638e5d7cc" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e92440d9-ea37-42de-b29c-8ae443668fb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_cd511793-6f89-4725-b5c2-09a136b5d973" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4ac05ce0-238c-4700-a42e-6f0638e5d7cc" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_cd511793-6f89-4725-b5c2-09a136b5d973" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e111b981-6a32-4543-8df5-b257cd99f17e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f32ddfa8-61b8-444b-87f8-1ee582880405" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e111b981-6a32-4543-8df5-b257cd99f17e" xlink:to="loc_us-gaap_AssetsCurrent_f32ddfa8-61b8-444b-87f8-1ee582880405" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_09cb66d9-8b2b-4a26-95fc-42015d3b8518" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e111b981-6a32-4543-8df5-b257cd99f17e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_09cb66d9-8b2b-4a26-95fc-42015d3b8518" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_600341c0-1e02-4daf-baa8-1cce9747a298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e111b981-6a32-4543-8df5-b257cd99f17e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_600341c0-1e02-4daf-baa8-1cce9747a298" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8ee78392-3595-4053-9cef-356b3c02e191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e111b981-6a32-4543-8df5-b257cd99f17e" xlink:to="loc_us-gaap_Goodwill_8ee78392-3595-4053-9cef-356b3c02e191" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_8ce862ed-6382-4866-9d0c-29a5822b4414" xlink:href="avdl-20211231.xsd#avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e111b981-6a32-4543-8df5-b257cd99f17e" xlink:to="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_8ce862ed-6382-4866-9d0c-29a5822b4414" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_7ed176dd-59a3-4250-997e-51d150a6c013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e111b981-6a32-4543-8df5-b257cd99f17e" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_7ed176dd-59a3-4250-997e-51d150a6c013" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0d160115-f8f5-4dee-b807-57c1c895b096" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8a1322a4-6ea5-4ce9-ad01-cbf64a47aaf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0d160115-f8f5-4dee-b807-57c1c895b096" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8a1322a4-6ea5-4ce9-ad01-cbf64a47aaf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_0c24c7f6-ae10-4b18-a978-226672928bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0d160115-f8f5-4dee-b807-57c1c895b096" xlink:to="loc_us-gaap_AccountsPayableCurrent_0c24c7f6-ae10-4b18-a978-226672928bd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_3cfb6b21-d533-4f61-be0c-4dcb8c6a4251" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0d160115-f8f5-4dee-b807-57c1c895b096" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_3cfb6b21-d533-4f61-be0c-4dcb8c6a4251" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_6a930e73-15c8-42de-a7f5-2251bc4d4935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0d160115-f8f5-4dee-b807-57c1c895b096" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_6a930e73-15c8-42de-a7f5-2251bc4d4935" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1d5a4f41-1390-43e9-8ba7-15571ab1bf60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9c453270-885e-4688-b775-d4c0f2a8065b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1d5a4f41-1390-43e9-8ba7-15571ab1bf60" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9c453270-885e-4688-b775-d4c0f2a8065b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_0152b4b9-6a77-4d6a-a302-7667dfe74264" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1d5a4f41-1390-43e9-8ba7-15571ab1bf60" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_0152b4b9-6a77-4d6a-a302-7667dfe74264" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_d1927b65-e47a-4670-8856-64bb06004fc7" xlink:href="avdl-20211231.xsd#avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1d5a4f41-1390-43e9-8ba7-15571ab1bf60" xlink:to="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_d1927b65-e47a-4670-8856-64bb06004fc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b28dc710-8e9a-4d8e-85fe-fd527b96d94b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1d5a4f41-1390-43e9-8ba7-15571ab1bf60" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b28dc710-8e9a-4d8e-85fe-fd527b96d94b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_506363b5-038f-43d2-b9fd-6cf77f8f7111" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_9c8e52ed-bb0f-46f7-b515-c3e904a070b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_506363b5-038f-43d2-b9fd-6cf77f8f7111" xlink:to="loc_us-gaap_PreferredStockValue_9c8e52ed-bb0f-46f7-b515-c3e904a070b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_23b40976-50b4-4b8b-8fc0-c1274f4d9b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_506363b5-038f-43d2-b9fd-6cf77f8f7111" xlink:to="loc_us-gaap_CommonStockValue_23b40976-50b4-4b8b-8fc0-c1274f4d9b1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ab5725c8-4e0e-4f3a-83fd-7fe9f7ed0354" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_506363b5-038f-43d2-b9fd-6cf77f8f7111" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ab5725c8-4e0e-4f3a-83fd-7fe9f7ed0354" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7c48e243-1d1a-4d2f-b5ef-31678e1ccca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_506363b5-038f-43d2-b9fd-6cf77f8f7111" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7c48e243-1d1a-4d2f-b5ef-31678e1ccca9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_161b874a-ac3e-4c52-9937-bd515271a4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_506363b5-038f-43d2-b9fd-6cf77f8f7111" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_161b874a-ac3e-4c52-9937-bd515271a4e4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="avdl-20211231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b0f68656-d0bb-4cf2-b279-7231235e9435" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e3333086-8a4b-4a35-8252-12249b0fb086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b0f68656-d0bb-4cf2-b279-7231235e9435" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e3333086-8a4b-4a35-8252-12249b0fb086" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_1f8fabce-7979-4c47-8f9e-1b6a034fb017" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b0f68656-d0bb-4cf2-b279-7231235e9435" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_1f8fabce-7979-4c47-8f9e-1b6a034fb017" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7397da9d-c8ad-4d51-ab47-9798918f9507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b0f68656-d0bb-4cf2-b279-7231235e9435" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7397da9d-c8ad-4d51-ab47-9798918f9507" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_67ed8ad0-77b7-4131-9590-86b6eec2e45b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b0f68656-d0bb-4cf2-b279-7231235e9435" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_67ed8ad0-77b7-4131-9590-86b6eec2e45b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_509665a3-60ee-464b-b069-5ce9145fb10d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b0f68656-d0bb-4cf2-b279-7231235e9435" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_509665a3-60ee-464b-b069-5ce9145fb10d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_edfe8d2c-5c1f-46bc-b978-1b17bbd4767b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_59b56bc7-56b6-4042-b9a9-2c60a14f0426" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_edfe8d2c-5c1f-46bc-b978-1b17bbd4767b" xlink:to="loc_us-gaap_NetIncomeLoss_59b56bc7-56b6-4042-b9a9-2c60a14f0426" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_3c65328b-142d-4dee-9c42-bc18b50327c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_edfe8d2c-5c1f-46bc-b978-1b17bbd4767b" xlink:to="loc_us-gaap_DepreciationAndAmortization_3c65328b-142d-4dee-9c42-bc18b50327c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AcquisitionRelatedContingentConsiderationRemeasurement_f3f234c7-5d68-4d23-adc4-e1306ed11b0d" xlink:href="avdl-20211231.xsd#avdl_AcquisitionRelatedContingentConsiderationRemeasurement"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_edfe8d2c-5c1f-46bc-b978-1b17bbd4767b" xlink:to="loc_avdl_AcquisitionRelatedContingentConsiderationRemeasurement_f3f234c7-5d68-4d23-adc4-e1306ed11b0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FinancingRelatedContingentConsiderationRemeasurement_9b220614-5a36-45c9-987b-9a38f29ee0cc" xlink:href="avdl-20211231.xsd#avdl_FinancingRelatedContingentConsiderationRemeasurement"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_edfe8d2c-5c1f-46bc-b978-1b17bbd4767b" xlink:to="loc_avdl_FinancingRelatedContingentConsiderationRemeasurement_9b220614-5a36-45c9-987b-9a38f29ee0cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_c243a4b9-9452-42bc-a273-e0a30a58a97f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_edfe8d2c-5c1f-46bc-b978-1b17bbd4767b" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_c243a4b9-9452-42bc-a273-e0a30a58a97f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_916b1ad5-d0cf-432a-8d34-e9696e30eab4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_edfe8d2c-5c1f-46bc-b978-1b17bbd4767b" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_916b1ad5-d0cf-432a-8d34-e9696e30eab4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_292212ab-e648-46cb-9f3c-16e5dad546ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_edfe8d2c-5c1f-46bc-b978-1b17bbd4767b" xlink:to="loc_us-gaap_ShareBasedCompensation_292212ab-e648-46cb-9f3c-16e5dad546ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_2e18ccca-34fb-4815-b226-c673485f5b43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_edfe8d2c-5c1f-46bc-b978-1b17bbd4767b" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_2e18ccca-34fb-4815-b226-c673485f5b43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0fe42108-4a5f-4ed0-bc79-bf59ff24c70e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_edfe8d2c-5c1f-46bc-b978-1b17bbd4767b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0fe42108-4a5f-4ed0-bc79-bf59ff24c70e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_8a842707-4766-4213-a4ae-793f08b1e475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_edfe8d2c-5c1f-46bc-b978-1b17bbd4767b" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_8a842707-4766-4213-a4ae-793f08b1e475" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_13625694-def7-4482-840c-91fd494188d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_edfe8d2c-5c1f-46bc-b978-1b17bbd4767b" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_13625694-def7-4482-840c-91fd494188d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_357e810c-d22d-467e-a988-1773168f34ad" xlink:href="avdl-20211231.xsd#avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_edfe8d2c-5c1f-46bc-b978-1b17bbd4767b" xlink:to="loc_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_357e810c-d22d-467e-a988-1773168f34ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c7d9bcea-c3d4-43b3-8aa3-cf4b577beb26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_edfe8d2c-5c1f-46bc-b978-1b17bbd4767b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c7d9bcea-c3d4-43b3-8aa3-cf4b577beb26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_a02df339-d62c-4818-901a-44df0491a2ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_edfe8d2c-5c1f-46bc-b978-1b17bbd4767b" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_a02df339-d62c-4818-901a-44df0491a2ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_a3874286-4ff4-4d12-b999-998a83b8f028" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_edfe8d2c-5c1f-46bc-b978-1b17bbd4767b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_a3874286-4ff4-4d12-b999-998a83b8f028" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue_2d011de9-98ae-4150-b16d-0b9c36950255" xlink:href="avdl-20211231.xsd#avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_edfe8d2c-5c1f-46bc-b978-1b17bbd4767b" xlink:to="loc_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue_2d011de9-98ae-4150-b16d-0b9c36950255" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_c0d48484-b15e-4981-8ef8-b88007ddf8f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_edfe8d2c-5c1f-46bc-b978-1b17bbd4767b" xlink:to="loc_us-gaap_PaymentsForRoyalties_c0d48484-b15e-4981-8ef8-b88007ddf8f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_88e81dc2-ef70-48d3-b6b3-2e177e29d38d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:calculationArc order="18" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_edfe8d2c-5c1f-46bc-b978-1b17bbd4767b" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_88e81dc2-ef70-48d3-b6b3-2e177e29d38d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_NoncashGainLossDeconsolidationOfSubsidiary_31a55b29-dc67-4ef4-a153-79ca05e6a4ca" xlink:href="avdl-20211231.xsd#avdl_NoncashGainLossDeconsolidationOfSubsidiary"/>
    <link:calculationArc order="19" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_edfe8d2c-5c1f-46bc-b978-1b17bbd4767b" xlink:to="loc_avdl_NoncashGainLossDeconsolidationOfSubsidiary_31a55b29-dc67-4ef4-a153-79ca05e6a4ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_c39d2d71-617d-4330-9c67-029c602cefa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount"/>
    <link:calculationArc order="20" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_edfe8d2c-5c1f-46bc-b978-1b17bbd4767b" xlink:to="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_c39d2d71-617d-4330-9c67-029c602cefa1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_7a423b71-f6b8-41cc-9095-e4b260b14c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="21" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_edfe8d2c-5c1f-46bc-b978-1b17bbd4767b" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_7a423b71-f6b8-41cc-9095-e4b260b14c6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_590870bf-100f-4e7b-8184-fb565e95293d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5eb476fd-80ef-4d03-8d24-1074f4423e40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_590870bf-100f-4e7b-8184-fb565e95293d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5eb476fd-80ef-4d03-8d24-1074f4423e40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a8f0c126-e30b-4569-8a77-c769f1a26765" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_590870bf-100f-4e7b-8184-fb565e95293d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a8f0c126-e30b-4569-8a77-c769f1a26765" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3d9cea84-6880-4df7-8090-2b4edc26d1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_590870bf-100f-4e7b-8184-fb565e95293d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3d9cea84-6880-4df7-8090-2b4edc26d1f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5dd4b229-5949-4a7d-bf85-ba9da775ab78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_590870bf-100f-4e7b-8184-fb565e95293d" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5dd4b229-5949-4a7d-bf85-ba9da775ab78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_071e96fc-b39b-4484-9daa-efc449b04fab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_88d5f3cd-a38d-4c95-83b1-f0ab2b46ef14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_071e96fc-b39b-4484-9daa-efc449b04fab" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_88d5f3cd-a38d-4c95-83b1-f0ab2b46ef14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_ab58bd21-1cf3-451d-a6c4-3d5d4742f846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_071e96fc-b39b-4484-9daa-efc449b04fab" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_ab58bd21-1cf3-451d-a6c4-3d5d4742f846" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_9b8d2921-662b-4cf0-b628-123210538066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_071e96fc-b39b-4484-9daa-efc449b04fab" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_9b8d2921-662b-4cf0-b628-123210538066" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_651fc057-f019-4cda-b5e6-cd9fe202faf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_071e96fc-b39b-4484-9daa-efc449b04fab" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_651fc057-f019-4cda-b5e6-cd9fe202faf3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_d664695c-d870-4906-b639-57aa197d74e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_d776e02a-93df-4d3a-acc7-f91364fa20cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_d664695c-d870-4906-b639-57aa197d74e1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_d776e02a-93df-4d3a-acc7-f91364fa20cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_226798b8-9a8f-45df-bfcc-0ffa9558e70d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_d664695c-d870-4906-b639-57aa197d74e1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_226798b8-9a8f-45df-bfcc-0ffa9558e70d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_d0a4e5c8-04b2-450c-99cc-4b7adb6d7572" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_d664695c-d870-4906-b639-57aa197d74e1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_d0a4e5c8-04b2-450c-99cc-4b7adb6d7572" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_3625226f-d9d0-4257-9ebb-c3fab9a74581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_d664695c-d870-4906-b639-57aa197d74e1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_3625226f-d9d0-4257-9ebb-c3fab9a74581" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_ac0d0766-338c-478e-a9cb-c17db6a5dd23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_d664695c-d870-4906-b639-57aa197d74e1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_ac0d0766-338c-478e-a9cb-c17db6a5dd23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_400d6e1f-477d-48d9-818e-e7a102429966" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_d664695c-d870-4906-b639-57aa197d74e1" xlink:to="loc_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_400d6e1f-477d-48d9-818e-e7a102429966" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#FairValueMeasurementsMeasuredonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_45733cc9-8ca1-4f34-8fae-7072815e12c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_192fac4d-0321-4e48-bbe7-f98d7632c260" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_45733cc9-8ca1-4f34-8fae-7072815e12c9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_192fac4d-0321-4e48-bbe7-f98d7632c260" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#MarketableSecuritiesSummaryofMarketableSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_701501d2-f753-4755-be6a-e9eb7c10485b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_2f318d74-7cb2-4ce3-b171-ba8b27b5d349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_701501d2-f753-4755-be6a-e9eb7c10485b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_2f318d74-7cb2-4ce3-b171-ba8b27b5d349" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4bf4d52b-a34a-4dd8-a7eb-89b0c3890fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_701501d2-f753-4755-be6a-e9eb7c10485b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4bf4d52b-a34a-4dd8-a7eb-89b0c3890fbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3725a986-bf9e-4526-be7a-78c5f03f5ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_701501d2-f753-4755-be6a-e9eb7c10485b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3725a986-bf9e-4526-be7a-78c5f03f5ac2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/PropertyandEquipmentnetDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#PropertyandEquipmentnetDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/PropertyandEquipmentnetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_255ad5c8-4da4-4469-aabb-8305fd093f25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_fd522e20-b4ee-4124-90ab-e1c12cbcab69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_255ad5c8-4da4-4469-aabb-8305fd093f25" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_fd522e20-b4ee-4124-90ab-e1c12cbcab69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b6042481-0fe6-4578-afcb-bf2011ed367c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_255ad5c8-4da4-4469-aabb-8305fd093f25" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b6042481-0fe6-4578-afcb-bf2011ed367c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LeasesComponentsofleasecostsDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#LeasesComponentsofleasecostsDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/LeasesComponentsofleasecostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_e1df2bf1-7688-4f90-bdd3-9d4bb89f333e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_c4b07e5c-cadc-4448-97dd-0935bc6be1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_e1df2bf1-7688-4f90-bdd3-9d4bb89f333e" xlink:to="loc_us-gaap_OperatingLeaseCost_c4b07e5c-cadc-4448-97dd-0935bc6be1d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_e233966e-a66a-4b97-ae1c-27783a6cb15e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_e1df2bf1-7688-4f90-bdd3-9d4bb89f333e" xlink:to="loc_us-gaap_SubleaseIncome_e233966e-a66a-4b97-ae1c-27783a6cb15e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#LeasesMaturitiesofoperatingleaseliabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5cbff476-f173-470d-b16d-f6b3c8bdf7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0bfaa8cd-88ef-4cc3-a47f-d8d7cc29437a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5cbff476-f173-470d-b16d-f6b3c8bdf7e0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0bfaa8cd-88ef-4cc3-a47f-d8d7cc29437a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_adf54d92-f544-4fd1-a4c9-e98108548d73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5cbff476-f173-470d-b16d-f6b3c8bdf7e0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_adf54d92-f544-4fd1-a4c9-e98108548d73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1e184394-a7b5-4664-9d3b-b6cc7b402357" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5cbff476-f173-470d-b16d-f6b3c8bdf7e0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1e184394-a7b5-4664-9d3b-b6cc7b402357" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2364fb66-5052-40a3-962e-23d45cdc6125" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5cbff476-f173-470d-b16d-f6b3c8bdf7e0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2364fb66-5052-40a3-962e-23d45cdc6125" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_d9fa20c7-0f08-4c04-bd6a-201713dc2e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5cbff476-f173-470d-b16d-f6b3c8bdf7e0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_d9fa20c7-0f08-4c04-bd6a-201713dc2e7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_6cbf233c-55dd-4141-8fcc-6a6f6842ad62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5cbff476-f173-470d-b16d-f6b3c8bdf7e0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_6cbf233c-55dd-4141-8fcc-6a6f6842ad62" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails_1" xlink:type="simple" xlink:href="avdl-20211231.xsd#LeasesMaturitiesofoperatingleaseliabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1a051bd0-d3cd-497c-b878-ed4ebc404e37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_e6f756bf-00ac-4bfe-895d-6f2a191e33e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1a051bd0-d3cd-497c-b878-ed4ebc404e37" xlink:to="loc_us-gaap_OperatingLeaseLiability_e6f756bf-00ac-4bfe-895d-6f2a191e33e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_6cb21ab6-8c5e-40c8-89d3-4037fbb137ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1a051bd0-d3cd-497c-b878-ed4ebc404e37" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_6cb21ab6-8c5e-40c8-89d3-4037fbb137ce" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#LongTermDebtScheduleofLongTermDebtInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_8c6f7c29-ded1-4824-a875-f51396d14a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_dc552896-2b8f-4dfe-aac8-71544739eef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_8c6f7c29-ded1-4824-a875-f51396d14a7f" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_dc552896-2b8f-4dfe-aac8-71544739eef8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c28924d2-28df-4e07-98f6-0d0a7a44bf25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_8c6f7c29-ded1-4824-a875-f51396d14a7f" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c28924d2-28df-4e07-98f6-0d0a7a44bf25" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails_1" xlink:type="simple" xlink:href="avdl-20211231.xsd#LongTermDebtScheduleofLongTermDebtInstrumentsDetails_1"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6e3d8bb2-c084-49dc-8349-995920bad5c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_7bfa81ad-5fec-4521-8638-3b54060a2446" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_6e3d8bb2-c084-49dc-8349-995920bad5c7" xlink:to="loc_us-gaap_LongTermDebtCurrent_7bfa81ad-5fec-4521-8638-3b54060a2446" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_33236240-53a6-4283-908a-8ab5c6b08542" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_6e3d8bb2-c084-49dc-8349-995920bad5c7" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_33236240-53a6-4283-908a-8ab5c6b08542" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#IncomeTaxesIncomeTaxProvisionBenefitDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_87efbc7b-fb3c-45b6-9307-521d516099c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ae37afc7-90a4-4f4c-a037-ae211884d4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_87efbc7b-fb3c-45b6-9307-521d516099c2" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_ae37afc7-90a4-4f4c-a037-ae211884d4c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d3f93033-c6d3-4c42-9797-56af492c2b09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_87efbc7b-fb3c-45b6-9307-521d516099c2" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d3f93033-c6d3-4c42-9797-56af492c2b09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f22c205b-c2d7-46be-a3d0-3884f76dea2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_306f4862-7a7e-4837-9127-9c91798c257b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f22c205b-c2d7-46be-a3d0-3884f76dea2f" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_306f4862-7a7e-4837-9127-9c91798c257b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_da4e4855-b5ab-4fec-92bc-a116ffdae9c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f22c205b-c2d7-46be-a3d0-3884f76dea2f" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_da4e4855-b5ab-4fec-92bc-a116ffdae9c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_430ef28d-a948-461c-8ec9-bbd668a9d33d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f22c205b-c2d7-46be-a3d0-3884f76dea2f" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_430ef28d-a948-461c-8ec9-bbd668a9d33d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_02e90a5c-916b-4749-a205-b10e41da07a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_8c551404-ac2d-46ec-9965-61fd0895f394" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_02e90a5c-916b-4749-a205-b10e41da07a5" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_8c551404-ac2d-46ec-9965-61fd0895f394" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_4f68a33e-005d-42e9-93dd-721cb299238d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_02e90a5c-916b-4749-a205-b10e41da07a5" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_4f68a33e-005d-42e9-93dd-721cb299238d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#IncomeTaxesReconciliationofTaxRateDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3acf8ba0-e26a-48b4-b628-385856568c38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_5aa428e2-f563-4428-9e97-191c189402a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3acf8ba0-e26a-48b4-b628-385856568c38" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_5aa428e2-f563-4428-9e97-191c189402a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_02b0b47b-a755-477c-941d-6b74ad902f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3acf8ba0-e26a-48b4-b628-385856568c38" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_02b0b47b-a755-477c-941d-6b74ad902f0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_8de53cc3-ec4d-4742-876d-5d5a6b221f11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3acf8ba0-e26a-48b4-b628-385856568c38" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_8de53cc3-ec4d-4742-876d-5d5a6b221f11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount_f42dabe5-c802-45f1-acb1-3c81c131a92e" xlink:href="avdl-20211231.xsd#avdl_EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3acf8ba0-e26a-48b4-b628-385856568c38" xlink:to="loc_avdl_EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount_f42dabe5-c802-45f1-acb1-3c81c131a92e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c97bd1c7-e197-454a-9f17-6f41701bf7da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3acf8ba0-e26a-48b4-b628-385856568c38" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c97bd1c7-e197-454a-9f17-6f41701bf7da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_1e49727c-d0d2-4d38-8d72-64f3331be49f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3acf8ba0-e26a-48b4-b628-385856568c38" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_1e49727c-d0d2-4d38-8d72-64f3331be49f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_9a390035-5751-43a2-81f9-688448d75262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3acf8ba0-e26a-48b4-b628-385856568c38" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_9a390035-5751-43a2-81f9-688448d75262" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_c693a067-809c-4d88-86c4-4f8afd184c79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3acf8ba0-e26a-48b4-b628-385856568c38" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_c693a067-809c-4d88-86c4-4f8afd184c79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_1f283d8a-beae-4515-bcd5-600aca5bacdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3acf8ba0-e26a-48b4-b628-385856568c38" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_1f283d8a-beae-4515-bcd5-600aca5bacdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount_90b849ed-fd79-417b-b471-c6ade3500722" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3acf8ba0-e26a-48b4-b628-385856568c38" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount_90b849ed-fd79-417b-b471-c6ade3500722" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount_caded07e-d5da-4946-8c9a-d8891528f77b" xlink:href="avdl-20211231.xsd#avdl_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3acf8ba0-e26a-48b4-b628-385856568c38" xlink:to="loc_avdl_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount_caded07e-d5da-4946-8c9a-d8891528f77b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit_49e84a12-85f9-4be1-af18-c2ebe054fe64" xlink:href="avdl-20211231.xsd#avdl_EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3acf8ba0-e26a-48b4-b628-385856568c38" xlink:to="loc_avdl_EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit_49e84a12-85f9-4be1-af18-c2ebe054fe64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_d518550b-3b55-4b60-82cf-7de5c1317902" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3acf8ba0-e26a-48b4-b628-385856568c38" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_d518550b-3b55-4b60-82cf-7de5c1317902" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#IncomeTaxesDeferredTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_14b0cd36-f6ae-4e11-823d-037f9595435e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_861e2992-2835-4b4c-bb54-81380ae74946" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_14b0cd36-f6ae-4e11-823d-037f9595435e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_861e2992-2835-4b4c-bb54-81380ae74946" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_57c5572b-3992-4adb-8d9c-f8e04ffe477e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_14b0cd36-f6ae-4e11-823d-037f9595435e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_57c5572b-3992-4adb-8d9c-f8e04ffe477e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_24a983a2-d9c6-4afd-9f8f-683ecff541b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_01a3bfd8-3acc-4e33-a97e-799a19d4289d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_24a983a2-d9c6-4afd-9f8f-683ecff541b1" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_01a3bfd8-3acc-4e33-a97e-799a19d4289d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_e73612db-3781-4b19-9429-5564475e7804" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_24a983a2-d9c6-4afd-9f8f-683ecff541b1" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_e73612db-3781-4b19-9429-5564475e7804" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_fc3f2b20-db74-46a0-9ae8-afdde5bea0f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_24a983a2-d9c6-4afd-9f8f-683ecff541b1" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_fc3f2b20-db74-46a0-9ae8-afdde5bea0f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_b2391a0c-b3e1-48c0-a782-c7a50df8f434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_0979b869-f756-494c-8273-5bbf3693c3db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_b2391a0c-b3e1-48c0-a782-c7a50df8f434" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_0979b869-f756-494c-8273-5bbf3693c3db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DeferredTaxAssetsAmortizationofIntangibleAssets_ad222e34-1b36-4494-ac2c-dd7f211e74cc" xlink:href="avdl-20211231.xsd#avdl_DeferredTaxAssetsAmortizationofIntangibleAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_b2391a0c-b3e1-48c0-a782-c7a50df8f434" xlink:to="loc_avdl_DeferredTaxAssetsAmortizationofIntangibleAssets_ad222e34-1b36-4494-ac2c-dd7f211e74cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_b18dc9e8-531e-4bb4-b16a-386cc8f1ffe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_b2391a0c-b3e1-48c0-a782-c7a50df8f434" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_b18dc9e8-531e-4bb4-b16a-386cc8f1ffe9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_50658c4a-849b-44be-8db2-9c1bb08109f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_b2391a0c-b3e1-48c0-a782-c7a50df8f434" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_50658c4a-849b-44be-8db2-9c1bb08109f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch_447744b8-e026-4079-8f48-400f0c6c5675" xlink:href="avdl-20211231.xsd#avdl_DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_b2391a0c-b3e1-48c0-a782-c7a50df8f434" xlink:to="loc_avdl_DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch_447744b8-e026-4079-8f48-400f0c6c5675" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3bfff485-838a-46f7-89e1-21a4325da178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_80a290c8-31b4-487e-927a-30807010d2dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3bfff485-838a-46f7-89e1-21a4325da178" xlink:to="loc_us-gaap_IncomeTaxesReceivable_80a290c8-31b4-487e-927a-30807010d2dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_093e2bdb-1104-4a38-bff2-c8408948dc39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3bfff485-838a-46f7-89e1-21a4325da178" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_093e2bdb-1104-4a38-bff2-c8408948dc39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_defa36d5-738a-4a82-924c-d3b72873d0ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3bfff485-838a-46f7-89e1-21a4325da178" xlink:to="loc_us-gaap_OtherAssetsCurrent_defa36d5-738a-4a82-924c-d3b72873d0ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeCurrent_8e4456d2-4fb8-4c97-8d37-ad250cb6d908" xlink:href="avdl-20211231.xsd#avdl_GuaranteeCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3bfff485-838a-46f7-89e1-21a4325da178" xlink:to="loc_avdl_GuaranteeCurrent_8e4456d2-4fb8-4c97-8d37-ad250cb6d908" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ShortTermNoteReceivable_c5b10283-96e4-4232-b789-813630ad4536" xlink:href="avdl-20211231.xsd#avdl_ShortTermNoteReceivable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3bfff485-838a-46f7-89e1-21a4325da178" xlink:to="loc_avdl_ShortTermNoteReceivable_c5b10283-96e4-4232-b789-813630ad4536" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_5401e714-4f37-4005-957e-6179a36560cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3bfff485-838a-46f7-89e1-21a4325da178" xlink:to="loc_us-gaap_ShortTermInvestments_5401e714-4f37-4005-957e-6179a36560cb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c82fcefa-7db9-44fc-8946-8ac58cdf2d29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_9d6300b6-42b3-4728-91ac-baf41bd63df9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_c82fcefa-7db9-44fc-8946-8ac58cdf2d29" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_9d6300b6-42b3-4728-91ac-baf41bd63df9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_8d5d7727-22a5-454f-9981-939779b92734" xlink:href="avdl-20211231.xsd#avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_c82fcefa-7db9-44fc-8946-8ac58cdf2d29" xlink:to="loc_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_8d5d7727-22a5-454f-9981-939779b92734" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeNoncurrent_d2779340-2453-4e94-9381-c42147095446" xlink:href="avdl-20211231.xsd#avdl_GuaranteeNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_c82fcefa-7db9-44fc-8946-8ac58cdf2d29" xlink:to="loc_avdl_GuaranteeNoncurrent_d2779340-2453-4e94-9381-c42147095446" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherNoncurrentReceivables_3f9ab655-b318-4443-84c8-a6f1635fbdbc" xlink:href="avdl-20211231.xsd#avdl_OtherNoncurrentReceivables"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_c82fcefa-7db9-44fc-8946-8ac58cdf2d29" xlink:to="loc_avdl_OtherNoncurrentReceivables_3f9ab655-b318-4443-84c8-a6f1635fbdbc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#OtherAssetsandLiabilitiesAccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_53bf1c1b-1337-4e0d-b310-2ab4df4b2ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_a13568c2-2a53-4c84-a1f0-85ac7d50467d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_53bf1c1b-1337-4e0d-b310-2ab4df4b2ee8" xlink:to="loc_us-gaap_AccruedSalariesCurrent_a13568c2-2a53-4c84-a1f0-85ac7d50467d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_d8d2e33b-d5e1-4a9f-bde0-23ca85a73a13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_53bf1c1b-1337-4e0d-b310-2ab4df4b2ee8" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_d8d2e33b-d5e1-4a9f-bde0-23ca85a73a13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedOutsourceContractCosts_3c2f28e4-318c-4e84-8b78-5c17f18aaeb9" xlink:href="avdl-20211231.xsd#avdl_AccruedOutsourceContractCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_53bf1c1b-1337-4e0d-b310-2ab4df4b2ee8" xlink:to="loc_avdl_AccruedOutsourceContractCosts_3c2f28e4-318c-4e84-8b78-5c17f18aaeb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedTradeDiscountsAndRebates_5839f4f9-04c8-4896-9089-37c6d4943559" xlink:href="avdl-20211231.xsd#avdl_AccruedTradeDiscountsAndRebates"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_53bf1c1b-1337-4e0d-b310-2ab4df4b2ee8" xlink:to="loc_avdl_AccruedTradeDiscountsAndRebates_5839f4f9-04c8-4896-9089-37c6d4943559" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_7e05e866-4c48-4f87-b145-eae877b3d816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_53bf1c1b-1337-4e0d-b310-2ab4df4b2ee8" xlink:to="loc_us-gaap_RestructuringReserveCurrent_7e05e866-4c48-4f87-b145-eae877b3d816" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_4c6a6711-ec0e-4f61-88f5-a69afeba396e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedInterestCurrent_ddafae30-04ac-4513-b357-e1e363aa9ffd" xlink:href="avdl-20211231.xsd#avdl_AccruedInterestCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_4c6a6711-ec0e-4f61-88f5-a69afeba396e" xlink:to="loc_avdl_AccruedInterestCurrent_ddafae30-04ac-4513-b357-e1e363aa9ffd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherGuarantorObligationsCurrentCarryingValue_9cc291ab-7ff8-4d52-bda9-31ed1ff2ded3" xlink:href="avdl-20211231.xsd#avdl_OtherGuarantorObligationsCurrentCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_4c6a6711-ec0e-4f61-88f5-a69afeba396e" xlink:to="loc_avdl_OtherGuarantorObligationsCurrentCarryingValue_9cc291ab-7ff8-4d52-bda9-31ed1ff2ded3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherLiabilitiesMiscellaneousCurrent_1b8c3031-c01d-401d-8dbf-64bffceb5baf" xlink:href="avdl-20211231.xsd#avdl_OtherLiabilitiesMiscellaneousCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_4c6a6711-ec0e-4f61-88f5-a69afeba396e" xlink:to="loc_avdl_OtherLiabilitiesMiscellaneousCurrent_1b8c3031-c01d-401d-8dbf-64bffceb5baf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_146f3cbc-421b-4df7-92af-87f1c9e0514a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_4c6a6711-ec0e-4f61-88f5-a69afeba396e" xlink:to="loc_us-gaap_DueToAffiliateCurrent_146f3cbc-421b-4df7-92af-87f1c9e0514a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_0cf96363-aecf-4067-9de2-ac35ecf0ebf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities_4403607d-1065-4445-866c-3d454497eb60" xlink:href="avdl-20211231.xsd#avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_0cf96363-aecf-4067-9de2-ac35ecf0ebf9" xlink:to="loc_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities_4403607d-1065-4445-866c-3d454497eb60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyLiabilities_dbfcc47c-32da-44b3-90bd-b3efe48e41fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuarantyLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_0cf96363-aecf-4067-9de2-ac35ecf0ebf9" xlink:to="loc_us-gaap_GuarantyLiabilities_dbfcc47c-32da-44b3-90bd-b3efe48e41fe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/NetLossIncomePerShareReconciliationofbasicanddilutedEPSDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#NetLossIncomePerShareReconciliationofbasicanddilutedEPSDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/NetLossIncomePerShareReconciliationofbasicanddilutedEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_992f1375-1d7f-4f72-8679-7a5ae57730d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_362ec959-c52d-4895-8711-7dcf282f08f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_992f1375-1d7f-4f72-8679-7a5ae57730d1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_362ec959-c52d-4895-8711-7dcf282f08f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_3f0e04fe-a7b7-4e2b-9290-1a1fc1aaf0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_992f1375-1d7f-4f72-8679-7a5ae57730d1" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_3f0e04fe-a7b7-4e2b-9290-1a1fc1aaf0d0" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>13
<FILENAME>avdl-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9768bc4a-d41b-4cde-8dab-4f8611fcf569,g:2327e6e7-350d-456e-9b47-ccea1e6c574d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.avadel.com/role/CoverPage" xlink:type="simple" xlink:href="avdl-20211231.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/CoverPage" xlink:type="extended" id="i379a198316b54ab695630ef81bf35488_CoverPage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_cd216f6b-0a58-4005-b6f8-29514d913347" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_DocumentType_cd216f6b-0a58-4005-b6f8-29514d913347" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_0cd64f09-185f-4ef9-b432-3538cf2884c2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_DocumentAnnualReport_0cd64f09-185f-4ef9-b432-3538cf2884c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_53e7c8d9-e468-428f-9e6e-4f27406ddf94" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_DocumentPeriodEndDate_53e7c8d9-e468-428f-9e6e-4f27406ddf94" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_66432f2e-cd9e-432a-b282-933a57419b52" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_CurrentFiscalYearEndDate_66432f2e-cd9e-432a-b282-933a57419b52" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_ab6a7f43-a64f-44b6-b111-29935609dc35" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_DocumentTransitionReport_ab6a7f43-a64f-44b6-b111-29935609dc35" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_31547a69-736a-4b77-af8f-2f117e34fb0f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityFileNumber_31547a69-736a-4b77-af8f-2f117e34fb0f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_b4f5a4e9-fa11-4fe2-ba88-4d3276a00800" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityRegistrantName_b4f5a4e9-fa11-4fe2-ba88-4d3276a00800" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_62d9f61f-e3de-42b2-acf4-78a8a4b8e6ce" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityIncorporationStateCountryCode_62d9f61f-e3de-42b2-acf4-78a8a4b8e6ce" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_94fead48-2c1f-414d-b570-46bcc61fa518" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityTaxIdentificationNumber_94fead48-2c1f-414d-b570-46bcc61fa518" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_e71798c8-4299-4bac-9162-9250042fdc5f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityAddressAddressLine1_e71798c8-4299-4bac-9162-9250042fdc5f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_18d02e05-5871-4442-86bd-9567b0f8d522" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityAddressCityOrTown_18d02e05-5871-4442-86bd-9567b0f8d522" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_59382d51-dff8-401f-be07-e83bc37d8392" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityAddressCountry_59382d51-dff8-401f-be07-e83bc37d8392" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_aea9b85e-8b77-4e77-a62e-10d2ddeb95ae" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityAddressPostalZipCode_aea9b85e-8b77-4e77-a62e-10d2ddeb95ae" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_f597d78a-a53a-464f-8a6f-a24c21609fe8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_CityAreaCode_f597d78a-a53a-464f-8a6f-a24c21609fe8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_994a42b2-69db-4960-9b3f-44c0affd2a7a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_LocalPhoneNumber_994a42b2-69db-4960-9b3f-44c0affd2a7a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_449fda5c-954a-4d5d-83d2-56f5fbf65136" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_Security12bTitle_449fda5c-954a-4d5d-83d2-56f5fbf65136" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_e9e758e7-9c3c-4d9e-a994-007e1822f051" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_TradingSymbol_e9e758e7-9c3c-4d9e-a994-007e1822f051" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_460895de-5ad0-4eaf-84a4-f80236565c9f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_SecurityExchangeName_460895de-5ad0-4eaf-84a4-f80236565c9f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_5bd0f444-aae5-4e55-8ccc-a0a0f5cbcb41" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_5bd0f444-aae5-4e55-8ccc-a0a0f5cbcb41" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_e27c39fa-d5b4-425c-8e2e-fbdc290405f8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityVoluntaryFilers_e27c39fa-d5b4-425c-8e2e-fbdc290405f8" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_5c69c686-a30c-459f-b70a-a35039b47fc9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityCurrentReportingStatus_5c69c686-a30c-459f-b70a-a35039b47fc9" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_0bd4bbee-0bff-43b5-8926-599318949a58" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityInteractiveDataCurrent_0bd4bbee-0bff-43b5-8926-599318949a58" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_37f00008-5e40-4f87-8944-34530fd4d5e1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityFilerCategory_37f00008-5e40-4f87-8944-34530fd4d5e1" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_03906c28-6f4b-48ea-9adc-e523ae4bfef1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntitySmallBusiness_03906c28-6f4b-48ea-9adc-e523ae4bfef1" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3a606a90-bfa0-4ad7-aed8-87a3b6d0d1d1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityEmergingGrowthCompany_3a606a90-bfa0-4ad7-aed8-87a3b6d0d1d1" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_318ad054-abba-410f-a45e-cb4cb96cd1a6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_IcfrAuditorAttestationFlag_318ad054-abba-410f-a45e-cb4cb96cd1a6" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_f8829275-60b4-42b3-ab52-54af52970caa" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityShellCompany_f8829275-60b4-42b3-ab52-54af52970caa" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_8c31d859-46c3-4bd6-b49a-6747ce89341e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityPublicFloat_8c31d859-46c3-4bd6-b49a-6747ce89341e" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_fd9bdd30-d53e-480d-964f-3c6a0d9cfca5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_fd9bdd30-d53e-480d-964f-3c6a0d9cfca5" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_5f8cb761-e51c-4822-adab-7d665cf664b1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_5f8cb761-e51c-4822-adab-7d665cf664b1" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_6a27343e-0e4c-4b1a-97c3-c2000453d59b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityCentralIndexKey_6a27343e-0e4c-4b1a-97c3-c2000453d59b" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_7f57cc4f-4e13-4b9a-b57d-af15d6940dd0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_AmendmentFlag_7f57cc4f-4e13-4b9a-b57d-af15d6940dd0" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_cfe6182f-0978-4a24-8f8e-fdc34088e17d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_DocumentFiscalPeriodFocus_cfe6182f-0978-4a24-8f8e-fdc34088e17d" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_deb00fd4-c2ca-4cd1-ad28-38e654dbd219" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_DocumentFiscalYearFocus_deb00fd4-c2ca-4cd1-ad28-38e654dbd219" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_645a1ca8-2ebe-4374-ace9-3a07e50a7537" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntitiesTable_645a1ca8-2ebe-4374-ace9-3a07e50a7537" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_69a19b49-3eef-4995-a9fa-14497e506baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_645a1ca8-2ebe-4374-ace9-3a07e50a7537" xlink:to="loc_us-gaap_StatementClassOfStockAxis_69a19b49-3eef-4995-a9fa-14497e506baf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_69a19b49-3eef-4995-a9fa-14497e506baf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_69a19b49-3eef-4995-a9fa-14497e506baf" xlink:to="loc_us-gaap_ClassOfStockDomain_69a19b49-3eef-4995-a9fa-14497e506baf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_359e1d8d-bd18-4aee-8068-088d05829db3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_69a19b49-3eef-4995-a9fa-14497e506baf" xlink:to="loc_us-gaap_ClassOfStockDomain_359e1d8d-bd18-4aee-8068-088d05829db3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesMember_ebef1942-b48b-45f7-bab2-9649a289693c" xlink:href="avdl-20211231.xsd#avdl_AmericanDepositarySharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_359e1d8d-bd18-4aee-8068-088d05829db3" xlink:to="loc_avdl_AmericanDepositarySharesMember_ebef1942-b48b-45f7-bab2-9649a289693c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OrdinaryShareNominalValue001PerShareMember_7df0b619-4556-4646-91f4-803a14f1efbe" xlink:href="avdl-20211231.xsd#avdl_OrdinaryShareNominalValue001PerShareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_359e1d8d-bd18-4aee-8068-088d05829db3" xlink:to="loc_avdl_OrdinaryShareNominalValue001PerShareMember_7df0b619-4556-4646-91f4-803a14f1efbe" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="avdl-20211231.xsd#ConsolidatedStatementsofShareholdersEquity"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="extended" id="i798b58af612741e5ba24051c896958c1_ConsolidatedStatementsofShareholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5a9c27fb-1cd9-4e00-b0d6-0c51b7981a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5a9c27fb-1cd9-4e00-b0d6-0c51b7981a7c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_b53ebfab-c4af-4812-b6fc-2ef15380a5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_SharesOutstanding_b53ebfab-c4af-4812-b6fc-2ef15380a5c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1f13310a-595e-4df7-ad8f-0114c891ace8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_StockholdersEquity_1f13310a-595e-4df7-ad8f-0114c891ace8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_3dfb1a43-bd3c-4270-a6d9-f3cbad26cf50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_3dfb1a43-bd3c-4270-a6d9-f3cbad26cf50" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_df14a4d2-0088-49ee-90e8-c20decc41860" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_NetIncomeLoss_df14a4d2-0088-49ee-90e8-c20decc41860" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_72c7d422-c348-4fd2-9a98-2eb09b4e14d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_72c7d422-c348-4fd2-9a98-2eb09b4e14d6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2f0b1910-56b5-4630-883c-5eaa560ff6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2f0b1910-56b5-4630-883c-5eaa560ff6b4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_93230352-42aa-420c-a428-5fc44ddb8efd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_93230352-42aa-420c-a428-5fc44ddb8efd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e89bbeea-fb40-42cd-beb8-1c8f5635976e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e89bbeea-fb40-42cd-beb8-1c8f5635976e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_05587923-2b95-46a3-a352-fe80535a40dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_05587923-2b95-46a3-a352-fe80535a40dd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_StockIssuedDuringPeriodSharesPublicOffering_2c86d787-f177-4792-987d-a0b23c217c9e" xlink:href="avdl-20211231.xsd#avdl_StockIssuedDuringPeriodSharesPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_avdl_StockIssuedDuringPeriodSharesPublicOffering_2c86d787-f177-4792-987d-a0b23c217c9e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_StockIssuedDuringPeriodValuePublicOffering_2ca257a5-d049-48e8-ab35-15e025401bc5" xlink:href="avdl-20211231.xsd#avdl_StockIssuedDuringPeriodValuePublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_avdl_StockIssuedDuringPeriodValuePublicOffering_2ca257a5-d049-48e8-ab35-15e025401bc5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther_7531f3eb-a982-41ea-aea1-ade85d15ca3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesOther_7531f3eb-a982-41ea-aea1-ade85d15ca3d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther_9e2ad49d-1886-40e0-8777-85460b0fb5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueOther_9e2ad49d-1886-40e0-8777-85460b0fb5e7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_e7f51836-a6e2-4257-950e-b9d9d58f7516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_e7f51836-a6e2-4257-950e-b9d9d58f7516" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_d5ef94da-3525-4eba-8000-ab7f21856ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_d5ef94da-3525-4eba-8000-ab7f21856ad4" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_269abd9d-c7ea-43e8-b7e1-70342ad0b3dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_269abd9d-c7ea-43e8-b7e1-70342ad0b3dd" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_cc11123c-9ecf-461f-b4ab-75faeeb79548" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_cc11123c-9ecf-461f-b4ab-75faeeb79548" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_f7472237-b508-483b-a7de-8f2f067a055d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_f7472237-b508-483b-a7de-8f2f067a055d" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_ba380a09-a80d-43ac-802f-9fd3fd9027d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6712c4ba-0f10-4696-9990-3b72aec09a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6b842141-0732-4fd6-9084-cec7feffc635" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5a9c27fb-1cd9-4e00-b0d6-0c51b7981a7c" xlink:to="loc_us-gaap_StatementTable_6b842141-0732-4fd6-9084-cec7feffc635" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2a147d86-1cb5-4aad-a7f4-5e7d05ee0826" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6b842141-0732-4fd6-9084-cec7feffc635" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2a147d86-1cb5-4aad-a7f4-5e7d05ee0826" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2a147d86-1cb5-4aad-a7f4-5e7d05ee0826_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2a147d86-1cb5-4aad-a7f4-5e7d05ee0826" xlink:to="loc_us-gaap_EquityComponentDomain_2a147d86-1cb5-4aad-a7f4-5e7d05ee0826_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7bbb659f-fbb3-4be6-ae63-0fa652037b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2a147d86-1cb5-4aad-a7f4-5e7d05ee0826" xlink:to="loc_us-gaap_EquityComponentDomain_7bbb659f-fbb3-4be6-ae63-0fa652037b0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_bbcf7bb9-f7e7-4022-a1bc-13d25ac1fb31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7bbb659f-fbb3-4be6-ae63-0fa652037b0f" xlink:to="loc_us-gaap_CommonStockMember_bbcf7bb9-f7e7-4022-a1bc-13d25ac1fb31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_9a10ec45-9177-4949-9af6-f28bf7738e44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7bbb659f-fbb3-4be6-ae63-0fa652037b0f" xlink:to="loc_us-gaap_PreferredStockMember_9a10ec45-9177-4949-9af6-f28bf7738e44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_194e397a-fef4-4557-bf22-7dfa0bdb0b18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7bbb659f-fbb3-4be6-ae63-0fa652037b0f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_194e397a-fef4-4557-bf22-7dfa0bdb0b18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9d5c4d80-c49a-4027-87cd-7fedd19d586b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7bbb659f-fbb3-4be6-ae63-0fa652037b0f" xlink:to="loc_us-gaap_RetainedEarningsMember_9d5c4d80-c49a-4027-87cd-7fedd19d586b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_55eec7fb-7c5f-4bf6-b748-48851b92eb20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7bbb659f-fbb3-4be6-ae63-0fa652037b0f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_55eec7fb-7c5f-4bf6-b748-48851b92eb20" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_e462b1f4-c6fa-47e1-a81e-881c500fdefe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7bbb659f-fbb3-4be6-ae63-0fa652037b0f" xlink:to="loc_us-gaap_TreasuryStockMember_e462b1f4-c6fa-47e1-a81e-881c500fdefe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3803f7b9-4d2b-4a9f-9685-64f59dc2ff77" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6b842141-0732-4fd6-9084-cec7feffc635" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3803f7b9-4d2b-4a9f-9685-64f59dc2ff77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3803f7b9-4d2b-4a9f-9685-64f59dc2ff77_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3803f7b9-4d2b-4a9f-9685-64f59dc2ff77" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3803f7b9-4d2b-4a9f-9685-64f59dc2ff77_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_14c2cf91-42bd-4650-8631-01005495346e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3803f7b9-4d2b-4a9f-9685-64f59dc2ff77" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_14c2cf91-42bd-4650-8631-01005495346e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_9669aade-eb4b-41cc-ab85-103aaad3d8f1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_14c2cf91-42bd-4650-8631-01005495346e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_9669aade-eb4b-41cc-ab85-103aaad3d8f1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i2fce6e608ece48ac8b21749e007daada_SummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_53a6d2f5-5c02-4b5e-99cf-97eeae11210e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentAdditionalInterestExpensePercentage_802ebe29-d7fa-41b8-bd23-2e3a40dbd347" xlink:href="avdl-20211231.xsd#avdl_DebtInstrumentAdditionalInterestExpensePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_53a6d2f5-5c02-4b5e-99cf-97eeae11210e" xlink:to="loc_avdl_DebtInstrumentAdditionalInterestExpensePercentage_802ebe29-d7fa-41b8-bd23-2e3a40dbd347" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_bcc31ff8-600c-49ea-b327-27dfe88a6e11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_53a6d2f5-5c02-4b5e-99cf-97eeae11210e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_bcc31ff8-600c-49ea-b327-27dfe88a6e11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AdditionalInterestExpenseDebt_e5a8937b-f503-43bf-977a-33860336e78d" xlink:href="avdl-20211231.xsd#avdl_AdditionalInterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_53a6d2f5-5c02-4b5e-99cf-97eeae11210e" xlink:to="loc_avdl_AdditionalInterestExpenseDebt_e5a8937b-f503-43bf-977a-33860336e78d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_9c917040-b121-4109-a32b-5e607b97febb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_53a6d2f5-5c02-4b5e-99cf-97eeae11210e" xlink:to="loc_us-gaap_InterestExpenseDebt_9c917040-b121-4109-a32b-5e607b97febb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_db951cd3-fafd-491a-a16e-854ef4392fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_53a6d2f5-5c02-4b5e-99cf-97eeae11210e" xlink:to="loc_us-gaap_CostsAndExpenses_db951cd3-fafd-491a-a16e-854ef4392fd4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_ad00a04d-e341-4894-9b0f-d14d3d2973a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_53a6d2f5-5c02-4b5e-99cf-97eeae11210e" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_ad00a04d-e341-4894-9b0f-d14d3d2973a5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_f91d16b3-2d88-4edb-b8d6-49608ed2021d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_53a6d2f5-5c02-4b5e-99cf-97eeae11210e" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_f91d16b3-2d88-4edb-b8d6-49608ed2021d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9d8e7b3f-21fb-4e2a-9726-4c219e382ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f91d16b3-2d88-4edb-b8d6-49608ed2021d" xlink:to="loc_us-gaap_DebtInstrumentAxis_9d8e7b3f-21fb-4e2a-9726-4c219e382ca5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9d8e7b3f-21fb-4e2a-9726-4c219e382ca5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_9d8e7b3f-21fb-4e2a-9726-4c219e382ca5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9d8e7b3f-21fb-4e2a-9726-4c219e382ca5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_54638255-d73f-404b-97b7-2e39b4696382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_9d8e7b3f-21fb-4e2a-9726-4c219e382ca5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_54638255-d73f-404b-97b7-2e39b4696382" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_200bd564-9b94-4f57-9c42-c050cdd21d22" xlink:href="avdl-20211231.xsd#avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_54638255-d73f-404b-97b7-2e39b4696382" xlink:to="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_200bd564-9b94-4f57-9c42-c050cdd21d22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_944c1e7c-dd6f-45e5-bd39-f3d1c7653e33" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f91d16b3-2d88-4edb-b8d6-49608ed2021d" xlink:to="loc_srt_RestatementAxis_944c1e7c-dd6f-45e5-bd39-f3d1c7653e33" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_944c1e7c-dd6f-45e5-bd39-f3d1c7653e33_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_944c1e7c-dd6f-45e5-bd39-f3d1c7653e33" xlink:to="loc_srt_RestatementDomain_944c1e7c-dd6f-45e5-bd39-f3d1c7653e33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_cb92baca-43d8-490d-9bd1-1897f9c13b6a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_944c1e7c-dd6f-45e5-bd39-f3d1c7653e33" xlink:to="loc_srt_RestatementDomain_cb92baca-43d8-490d-9bd1-1897f9c13b6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_3e3548a3-2f5c-4de6-bf4e-d1f6e7fb6838" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_cb92baca-43d8-490d-9bd1-1897f9c13b6a" xlink:to="loc_srt_RestatementAdjustmentMember_3e3548a3-2f5c-4de6-bf4e-d1f6e7fb6838" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0796e916-7fdc-42c9-bacc-4a3cad88f137" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f91d16b3-2d88-4edb-b8d6-49608ed2021d" xlink:to="loc_srt_ProductOrServiceAxis_0796e916-7fdc-42c9-bacc-4a3cad88f137" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0796e916-7fdc-42c9-bacc-4a3cad88f137_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_0796e916-7fdc-42c9-bacc-4a3cad88f137" xlink:to="loc_srt_ProductsAndServicesDomain_0796e916-7fdc-42c9-bacc-4a3cad88f137_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9d4c6cb4-1532-4e95-8668-1055cfe1ef7a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_0796e916-7fdc-42c9-bacc-4a3cad88f137" xlink:to="loc_srt_ProductsAndServicesDomain_9d4c6cb4-1532-4e95-8668-1055cfe1ef7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingMember_d4104e98-5fb7-4add-af33-a390ca6c876c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9d4c6cb4-1532-4e95-8668-1055cfe1ef7a" xlink:to="loc_us-gaap_AdvertisingMember_d4104e98-5fb7-4add-af33-a390ca6c876c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#SummaryofSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails" xlink:type="extended" id="i672bee9653a54a80ad21109961ba7fa8_SummaryofSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_22ad24fe-bb4f-4a38-bfc6-20754c4b1b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_887ca881-f536-431a-a657-e073fe3e9a34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_22ad24fe-bb4f-4a38-bfc6-20754c4b1b9d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_887ca881-f536-431a-a657-e073fe3e9a34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e53784bb-cd90-4296-b74b-a78ef77bd60e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_22ad24fe-bb4f-4a38-bfc6-20754c4b1b9d" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e53784bb-cd90-4296-b74b-a78ef77bd60e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0cdea5de-4a98-4a61-825a-b866780a4f32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e53784bb-cd90-4296-b74b-a78ef77bd60e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0cdea5de-4a98-4a61-825a-b866780a4f32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0cdea5de-4a98-4a61-825a-b866780a4f32_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0cdea5de-4a98-4a61-825a-b866780a4f32" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0cdea5de-4a98-4a61-825a-b866780a4f32_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ef62cce3-9b72-4d18-827c-24057a0bf764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0cdea5de-4a98-4a61-825a-b866780a4f32" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ef62cce3-9b72-4d18-827c-24057a0bf764" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember_9c5d7974-1520-4688-8373-46493522c67a" xlink:href="avdl-20211231.xsd#avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ef62cce3-9b72-4d18-827c-24057a0bf764" xlink:to="loc_avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember_9c5d7974-1520-4688-8373-46493522c67a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_LeaseholdImprovementsFurnitureFixturesAndFittingsMember_3f2d994f-1f93-444c-94a8-721a687430a1" xlink:href="avdl-20211231.xsd#avdl_LeaseholdImprovementsFurnitureFixturesAndFittingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ef62cce3-9b72-4d18-827c-24057a0bf764" xlink:to="loc_avdl_LeaseholdImprovementsFurnitureFixturesAndFittingsMember_3f2d994f-1f93-444c-94a8-721a687430a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7b6c8e9f-a0ea-4aa6-bb6f-ea04617edfdd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e53784bb-cd90-4296-b74b-a78ef77bd60e" xlink:to="loc_srt_RangeAxis_7b6c8e9f-a0ea-4aa6-bb6f-ea04617edfdd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7b6c8e9f-a0ea-4aa6-bb6f-ea04617edfdd_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7b6c8e9f-a0ea-4aa6-bb6f-ea04617edfdd" xlink:to="loc_srt_RangeMember_7b6c8e9f-a0ea-4aa6-bb6f-ea04617edfdd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7e38e11a-11cf-44c6-9c86-cd32b723023f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7b6c8e9f-a0ea-4aa6-bb6f-ea04617edfdd" xlink:to="loc_srt_RangeMember_7e38e11a-11cf-44c6-9c86-cd32b723023f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_412bb2e7-974d-47af-9bd9-45193ba86f28" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7e38e11a-11cf-44c6-9c86-cd32b723023f" xlink:to="loc_srt_MinimumMember_412bb2e7-974d-47af-9bd9-45193ba86f28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ccb04c44-d888-4de4-b8cd-24c96c66b958" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7e38e11a-11cf-44c6-9c86-cd32b723023f" xlink:to="loc_srt_MaximumMember_ccb04c44-d888-4de4-b8cd-24c96c66b958" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#NewlyIssuedAccountingStandardsDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails" xlink:type="extended" id="icf7e7750b660453bb8c12bdfca8d8c81_NewlyIssuedAccountingStandardsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_92651b13-9c1d-4564-9b1c-488a5e84f821" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6fcf6c8a-c9a6-4ec3-ac52-6f3aa1de451f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_92651b13-9c1d-4564-9b1c-488a5e84f821" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6fcf6c8a-c9a6-4ec3-ac52-6f3aa1de451f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_079b3a72-45a3-4f0b-ba73-6e0c845fffc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_92651b13-9c1d-4564-9b1c-488a5e84f821" xlink:to="loc_us-gaap_StockholdersEquity_079b3a72-45a3-4f0b-ba73-6e0c845fffc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_3198c187-702d-47cb-be59-02130c6e5ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_92651b13-9c1d-4564-9b1c-488a5e84f821" xlink:to="loc_us-gaap_LongTermDebt_3198c187-702d-47cb-be59-02130c6e5ac9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_afbf3bf2-1af0-4fe0-b2da-0c51c3e4a1f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_92651b13-9c1d-4564-9b1c-488a5e84f821" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_afbf3bf2-1af0-4fe0-b2da-0c51c3e4a1f5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0b9745b5-735a-400c-a55d-976eac7e4914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_afbf3bf2-1af0-4fe0-b2da-0c51c3e4a1f5" xlink:to="loc_us-gaap_DebtInstrumentAxis_0b9745b5-735a-400c-a55d-976eac7e4914" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0b9745b5-735a-400c-a55d-976eac7e4914_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0b9745b5-735a-400c-a55d-976eac7e4914" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0b9745b5-735a-400c-a55d-976eac7e4914_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6ad93177-a1b1-44fe-a406-03292dffc544" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0b9745b5-735a-400c-a55d-976eac7e4914" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6ad93177-a1b1-44fe-a406-03292dffc544" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_a3dca7d8-99e8-45e4-99bc-f0a65fc7c48f" xlink:href="avdl-20211231.xsd#avdl_A450PercentExchangeableSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6ad93177-a1b1-44fe-a406-03292dffc544" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_a3dca7d8-99e8-45e4-99bc-f0a65fc7c48f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7c57df5c-7fa6-443a-874e-62f415a531c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_afbf3bf2-1af0-4fe0-b2da-0c51c3e4a1f5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7c57df5c-7fa6-443a-874e-62f415a531c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7c57df5c-7fa6-443a-874e-62f415a531c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7c57df5c-7fa6-443a-874e-62f415a531c8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7c57df5c-7fa6-443a-874e-62f415a531c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b10e35ba-be7d-4a46-805d-f5e425413b17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7c57df5c-7fa6-443a-874e-62f415a531c8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b10e35ba-be7d-4a46-805d-f5e425413b17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_4a3042e4-08a3-4866-8657-21a6a9137c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b10e35ba-be7d-4a46-805d-f5e425413b17" xlink:to="loc_us-gaap_SeniorNotesMember_4a3042e4-08a3-4866-8657-21a6a9137c3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9633d2ef-a7a3-4638-bfb2-81b61042d21f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_afbf3bf2-1af0-4fe0-b2da-0c51c3e4a1f5" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9633d2ef-a7a3-4638-bfb2-81b61042d21f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_9633d2ef-a7a3-4638-bfb2-81b61042d21f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9633d2ef-a7a3-4638-bfb2-81b61042d21f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_9633d2ef-a7a3-4638-bfb2-81b61042d21f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_df4d9e83-a170-4a2b-a296-d0385e952efc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9633d2ef-a7a3-4638-bfb2-81b61042d21f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_df4d9e83-a170-4a2b-a296-d0385e952efc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2ae17367-1881-42c2-a755-9f2de34a1073" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_df4d9e83-a170-4a2b-a296-d0385e952efc" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2ae17367-1881-42c2-a755-9f2de34a1073" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2c453924-5fc9-4562-9315-505144dfc70e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_afbf3bf2-1af0-4fe0-b2da-0c51c3e4a1f5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2c453924-5fc9-4562-9315-505144dfc70e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2c453924-5fc9-4562-9315-505144dfc70e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2c453924-5fc9-4562-9315-505144dfc70e" xlink:to="loc_us-gaap_EquityComponentDomain_2c453924-5fc9-4562-9315-505144dfc70e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_90552977-6d0a-4a69-82fa-b0eab6792f70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2c453924-5fc9-4562-9315-505144dfc70e" xlink:to="loc_us-gaap_EquityComponentDomain_90552977-6d0a-4a69-82fa-b0eab6792f70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_95c208b1-2b64-4890-94d4-7ab93267c164" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_90552977-6d0a-4a69-82fa-b0eab6792f70" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_95c208b1-2b64-4890-94d4-7ab93267c164" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_184a8e3c-8074-40f5-8e31-e90e3c07c32d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_90552977-6d0a-4a69-82fa-b0eab6792f70" xlink:to="loc_us-gaap_RetainedEarningsMember_184a8e3c-8074-40f5-8e31-e90e3c07c32d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SubsidiaryBankruptcyandDeconsolidationDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#SubsidiaryBankruptcyandDeconsolidationDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/SubsidiaryBankruptcyandDeconsolidationDetails" xlink:type="extended" id="i7988023cd6244d029ff99c76eb2a9146_SubsidiaryBankruptcyandDeconsolidationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_c5531247-2ab1-45bb-ba4b-ca140761e3e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationGainOrLossAmount_478ee2aa-e47b-46ec-8a4d-990490628239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeconsolidationGainOrLossAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_c5531247-2ab1-45bb-ba4b-ca140761e3e3" xlink:to="loc_us-gaap_DeconsolidationGainOrLossAmount_478ee2aa-e47b-46ec-8a4d-990490628239" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_7299e66c-8472-4463-8e10-c944bf8c0559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_c5531247-2ab1-45bb-ba4b-ca140761e3e3" xlink:to="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_7299e66c-8472-4463-8e10-c944bf8c0559" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_2ed5a5fd-5345-4298-9b85-7815c5652d04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_c5531247-2ab1-45bb-ba4b-ca140761e3e3" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_2ed5a5fd-5345-4298-9b85-7815c5652d04" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3b08a7fd-ff2e-4818-a1a2-7c990a58c06e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_2ed5a5fd-5345-4298-9b85-7815c5652d04" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3b08a7fd-ff2e-4818-a1a2-7c990a58c06e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3b08a7fd-ff2e-4818-a1a2-7c990a58c06e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3b08a7fd-ff2e-4818-a1a2-7c990a58c06e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3b08a7fd-ff2e-4818-a1a2-7c990a58c06e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3ddfece4-8148-4770-8773-7d2dc5d49c0a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3b08a7fd-ff2e-4818-a1a2-7c990a58c06e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3ddfece4-8148-4770-8773-7d2dc5d49c0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_SpecialtyPharmaMember_32ef6ba6-0aa8-43be-9210-f3a252b91f79" xlink:href="avdl-20211231.xsd#avdl_SpecialtyPharmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_3ddfece4-8148-4770-8773-7d2dc5d49c0a" xlink:to="loc_avdl_SpecialtyPharmaMember_32ef6ba6-0aa8-43be-9210-f3a252b91f79" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/DispositionoftheHospitalBusinessNarrativeDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#DispositionoftheHospitalBusinessNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/DispositionoftheHospitalBusinessNarrativeDetails" xlink:type="extended" id="ibee1c8f911cf40a7b3a296ec92ba635e_DispositionoftheHospitalBusinessNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7490a89e-0039-46cf-bb7e-0868837625f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_525bfdbb-ab6c-4e52-b801-0aac1135b10a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7490a89e-0039-46cf-bb7e-0868837625f1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_525bfdbb-ab6c-4e52-b801-0aac1135b10a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration_beb2e87d-bbe7-43c3-b00d-677c761b899e" xlink:href="avdl-20211231.xsd#avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7490a89e-0039-46cf-bb7e-0868837625f1" xlink:to="loc_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration_beb2e87d-bbe7-43c3-b00d-677c761b899e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments_bfd9d20f-bc56-46b7-8650-7826032ac571" xlink:href="avdl-20211231.xsd#avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7490a89e-0039-46cf-bb7e-0868837625f1" xlink:to="loc_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments_bfd9d20f-bc56-46b7-8650-7826032ac571" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm_d4fb96e4-c379-43d4-9227-b497bf1ee2a3" xlink:href="avdl-20211231.xsd#avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7490a89e-0039-46cf-bb7e-0868837625f1" xlink:to="loc_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm_d4fb96e4-c379-43d4-9227-b497bf1ee2a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7f242fa0-fb17-43ea-b1c3-2cf9e8b0197f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7490a89e-0039-46cf-bb7e-0868837625f1" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7f242fa0-fb17-43ea-b1c3-2cf9e8b0197f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_ec35d150-4c4d-45dc-9dd6-4ebe113e3ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7490a89e-0039-46cf-bb7e-0868837625f1" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_ec35d150-4c4d-45dc-9dd6-4ebe113e3ccc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_c9531aed-a2a1-4543-81ca-92385341ec7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7490a89e-0039-46cf-bb7e-0868837625f1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_c9531aed-a2a1-4543-81ca-92385341ec7b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_6f9bb035-2214-4870-a8d9-c29e3cbe31fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7490a89e-0039-46cf-bb7e-0868837625f1" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_6f9bb035-2214-4870-a8d9-c29e3cbe31fe" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fdac9dbf-c8a0-4eaa-a5a7-70a8970e7fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7490a89e-0039-46cf-bb7e-0868837625f1" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fdac9dbf-c8a0-4eaa-a5a7-70a8970e7fa6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1f489d8c-d963-449c-b88f-03e31590929e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fdac9dbf-c8a0-4eaa-a5a7-70a8970e7fa6" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1f489d8c-d963-449c-b88f-03e31590929e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1f489d8c-d963-449c-b88f-03e31590929e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1f489d8c-d963-449c-b88f-03e31590929e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1f489d8c-d963-449c-b88f-03e31590929e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0331ced3-1807-4bf8-9c73-1bacd01b54b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1f489d8c-d963-449c-b88f-03e31590929e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0331ced3-1807-4bf8-9c73-1bacd01b54b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_BloxiverzVazculepAkovazandNouressMember_aaf0f7a9-80c8-4500-984e-d5cb7215815e" xlink:href="avdl-20211231.xsd#avdl_BloxiverzVazculepAkovazandNouressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0331ced3-1807-4bf8-9c73-1bacd01b54b8" xlink:to="loc_avdl_BloxiverzVazculepAkovazandNouressMember_aaf0f7a9-80c8-4500-984e-d5cb7215815e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_acdd33c2-6c40-44d5-a8b3-783465303a30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fdac9dbf-c8a0-4eaa-a5a7-70a8970e7fa6" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_acdd33c2-6c40-44d5-a8b3-783465303a30" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_acdd33c2-6c40-44d5-a8b3-783465303a30_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_acdd33c2-6c40-44d5-a8b3-783465303a30" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_acdd33c2-6c40-44d5-a8b3-783465303a30_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_512a5ec8-4fcd-4a1e-b3d9-7280ea564a94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_acdd33c2-6c40-44d5-a8b3-783465303a30" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_512a5ec8-4fcd-4a1e-b3d9-7280ea564a94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_03d59fd0-b5f9-45e2-981b-9bce0c44747a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_512a5ec8-4fcd-4a1e-b3d9-7280ea564a94" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_03d59fd0-b5f9-45e2-981b-9bce0c44747a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_92a0f2bc-fef5-4e97-9f24-06360f583964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fdac9dbf-c8a0-4eaa-a5a7-70a8970e7fa6" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_92a0f2bc-fef5-4e97-9f24-06360f583964" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_92a0f2bc-fef5-4e97-9f24-06360f583964_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_92a0f2bc-fef5-4e97-9f24-06360f583964" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_92a0f2bc-fef5-4e97-9f24-06360f583964_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3de024de-8127-44ed-9ed6-ee3f2319eeb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_92a0f2bc-fef5-4e97-9f24-06360f583964" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3de024de-8127-44ed-9ed6-ee3f2319eeb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_ffa963bd-e178-4efa-98a1-a990249c19e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3de024de-8127-44ed-9ed6-ee3f2319eeb7" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_ffa963bd-e178-4efa-98a1-a990249c19e2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails" xlink:type="extended" id="i1638feaa8ef64e398d375af46773789c_DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_db9068d0-a31f-42f4-b6da-60ea1fa884b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_39cfba6b-1ee9-4298-a430-023917a39fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_db9068d0-a31f-42f4-b6da-60ea1fa884b2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_39cfba6b-1ee9-4298-a430-023917a39fc1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_6170ab1d-6b0b-4de9-855b-0ea411f18045" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_db9068d0-a31f-42f4-b6da-60ea1fa884b2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_6170ab1d-6b0b-4de9-855b-0ea411f18045" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_d274d822-fed4-4749-96a6-6f84b2a4df02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_db9068d0-a31f-42f4-b6da-60ea1fa884b2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_d274d822-fed4-4749-96a6-6f84b2a4df02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_83d3b2d0-84ba-485f-b320-19be38eafa63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_db9068d0-a31f-42f4-b6da-60ea1fa884b2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_83d3b2d0-84ba-485f-b320-19be38eafa63" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_60eb0f2b-55b4-4aec-936c-3c6ab4c5e88f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_db9068d0-a31f-42f4-b6da-60ea1fa884b2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_60eb0f2b-55b4-4aec-936c-3c6ab4c5e88f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_1bc5bad8-b14b-487b-90e0-90725d372479" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_db9068d0-a31f-42f4-b6da-60ea1fa884b2" xlink:to="loc_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_1bc5bad8-b14b-487b-90e0-90725d372479" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_a2814c0a-9a76-44dd-85ef-16b6afc2cdb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_db9068d0-a31f-42f4-b6da-60ea1fa884b2" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_a2814c0a-9a76-44dd-85ef-16b6afc2cdb9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_32173f1d-e505-498b-afc5-40758e6fd346" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_db9068d0-a31f-42f4-b6da-60ea1fa884b2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_32173f1d-e505-498b-afc5-40758e6fd346" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_d1e959b9-3182-4522-ba32-480dda75ac2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_db9068d0-a31f-42f4-b6da-60ea1fa884b2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_d1e959b9-3182-4522-ba32-480dda75ac2a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_2ab905e0-8439-425d-9e9f-94b3303310d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_db9068d0-a31f-42f4-b6da-60ea1fa884b2" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_2ab905e0-8439-425d-9e9f-94b3303310d8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_760e4bcf-75cd-4541-bf8f-461ad6e6b898" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_db9068d0-a31f-42f4-b6da-60ea1fa884b2" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_760e4bcf-75cd-4541-bf8f-461ad6e6b898" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b076af7d-d20f-4736-ab88-45078294a6ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_760e4bcf-75cd-4541-bf8f-461ad6e6b898" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b076af7d-d20f-4736-ab88-45078294a6ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b076af7d-d20f-4736-ab88-45078294a6ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b076af7d-d20f-4736-ab88-45078294a6ad" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b076af7d-d20f-4736-ab88-45078294a6ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0bc0d503-263a-4b6e-b1e2-d0a9740386d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b076af7d-d20f-4736-ab88-45078294a6ad" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0bc0d503-263a-4b6e-b1e2-d0a9740386d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_BloxiverzVazculepAkovazandNouressMember_29c799f6-bb97-4797-8296-4f53cba0a5fc" xlink:href="avdl-20211231.xsd#avdl_BloxiverzVazculepAkovazandNouressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0bc0d503-263a-4b6e-b1e2-d0a9740386d3" xlink:to="loc_avdl_BloxiverzVazculepAkovazandNouressMember_29c799f6-bb97-4797-8296-4f53cba0a5fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_9da48a09-7f36-4f26-9128-923ddbe22576" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_760e4bcf-75cd-4541-bf8f-461ad6e6b898" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_9da48a09-7f36-4f26-9128-923ddbe22576" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_9da48a09-7f36-4f26-9128-923ddbe22576_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_9da48a09-7f36-4f26-9128-923ddbe22576" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_9da48a09-7f36-4f26-9128-923ddbe22576_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_106ee6dc-bb40-404a-9d5d-3633b707c450" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_9da48a09-7f36-4f26-9128-923ddbe22576" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_106ee6dc-bb40-404a-9d5d-3633b707c450" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_0c0dabc3-2973-45e2-8ea4-74d8c9115062" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_106ee6dc-bb40-404a-9d5d-3633b707c450" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_0c0dabc3-2973-45e2-8ea4-74d8c9115062" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails" xlink:type="extended" id="i24a7590668d3451a84a963cbf773dfbe_DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_c96ef880-b303-48b5-9d61-c54b1fe3397c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_25bd05ce-2003-4611-9579-a713b678633c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_c96ef880-b303-48b5-9d61-c54b1fe3397c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_25bd05ce-2003-4611-9579-a713b678633c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_d83a12e1-42c6-485c-8346-174b168a9a93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_c96ef880-b303-48b5-9d61-c54b1fe3397c" xlink:to="loc_us-gaap_CostsAndExpenses_d83a12e1-42c6-485c-8346-174b168a9a93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ebec9ee5-2bda-44af-871b-20c2a52b143f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_c96ef880-b303-48b5-9d61-c54b1fe3397c" xlink:to="loc_us-gaap_OperatingIncomeLoss_ebec9ee5-2bda-44af-871b-20c2a52b143f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4afc3598-a867-4a7c-b318-7b9fafa71345" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_c96ef880-b303-48b5-9d61-c54b1fe3397c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4afc3598-a867-4a7c-b318-7b9fafa71345" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ad7c0e27-41cb-47ea-bce6-595edc09bbbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_c96ef880-b303-48b5-9d61-c54b1fe3397c" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ad7c0e27-41cb-47ea-bce6-595edc09bbbc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_c993e3f3-0255-4f63-add9-e76a0c8c3522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_c96ef880-b303-48b5-9d61-c54b1fe3397c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_c993e3f3-0255-4f63-add9-e76a0c8c3522" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_da842caf-ad3b-433d-acfa-3dcfae82c9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_c96ef880-b303-48b5-9d61-c54b1fe3397c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_da842caf-ad3b-433d-acfa-3dcfae82c9a4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_4b0c6d0d-a79a-4c12-aed4-561453b42413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_c96ef880-b303-48b5-9d61-c54b1fe3397c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_4b0c6d0d-a79a-4c12-aed4-561453b42413" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_607ccd18-d92b-40d2-9b87-a3bbbf1a32fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_c96ef880-b303-48b5-9d61-c54b1fe3397c" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_607ccd18-d92b-40d2-9b87-a3bbbf1a32fc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a30f128e-f9bc-4fd7-b4c5-28edf1ab0597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_c96ef880-b303-48b5-9d61-c54b1fe3397c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a30f128e-f9bc-4fd7-b4c5-28edf1ab0597" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_23250518-d19b-4a33-9c29-fc12b57ce7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_c96ef880-b303-48b5-9d61-c54b1fe3397c" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_23250518-d19b-4a33-9c29-fc12b57ce7b1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_a696b20e-ab97-4f56-a237-219d08c3284f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_23250518-d19b-4a33-9c29-fc12b57ce7b1" xlink:to="loc_srt_RestatementAxis_a696b20e-ab97-4f56-a237-219d08c3284f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_a696b20e-ab97-4f56-a237-219d08c3284f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_a696b20e-ab97-4f56-a237-219d08c3284f" xlink:to="loc_srt_RestatementDomain_a696b20e-ab97-4f56-a237-219d08c3284f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_5a4de5bc-85f5-49f6-bdfb-f4a7a6e5167e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_a696b20e-ab97-4f56-a237-219d08c3284f" xlink:to="loc_srt_RestatementDomain_5a4de5bc-85f5-49f6-bdfb-f4a7a6e5167e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_54c4ad6d-83d7-405e-af0c-5cb73012e985" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_5a4de5bc-85f5-49f6-bdfb-f4a7a6e5167e" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_54c4ad6d-83d7-405e-af0c-5cb73012e985" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_86ac6ff8-4f8c-44a7-9c8f-7c5c46adee17" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_5a4de5bc-85f5-49f6-bdfb-f4a7a6e5167e" xlink:to="loc_srt_RestatementAdjustmentMember_86ac6ff8-4f8c-44a7-9c8f-7c5c46adee17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_9fee9c52-4779-411f-8752-6cc5d738474c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_23250518-d19b-4a33-9c29-fc12b57ce7b1" xlink:to="loc_srt_StatementScenarioAxis_9fee9c52-4779-411f-8752-6cc5d738474c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_9fee9c52-4779-411f-8752-6cc5d738474c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_9fee9c52-4779-411f-8752-6cc5d738474c" xlink:to="loc_srt_ScenarioUnspecifiedDomain_9fee9c52-4779-411f-8752-6cc5d738474c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_70a7df7b-9de5-4a92-a9b1-735eb31de8e8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_9fee9c52-4779-411f-8752-6cc5d738474c" xlink:to="loc_srt_ScenarioUnspecifiedDomain_70a7df7b-9de5-4a92-a9b1-735eb31de8e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProFormaMember_e76c5f5a-ca1b-4fd6-8160-328e16291fe3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProFormaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_70a7df7b-9de5-4a92-a9b1-735eb31de8e8" xlink:to="loc_srt_ProFormaMember_e76c5f5a-ca1b-4fd6-8160-328e16291fe3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_dd0b4dff-0268-4836-88df-4fec8bf603fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_23250518-d19b-4a33-9c29-fc12b57ce7b1" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_dd0b4dff-0268-4836-88df-4fec8bf603fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_dd0b4dff-0268-4836-88df-4fec8bf603fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_dd0b4dff-0268-4836-88df-4fec8bf603fa" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_dd0b4dff-0268-4836-88df-4fec8bf603fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_f60ab128-fb13-40aa-b787-714381e4d34a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_dd0b4dff-0268-4836-88df-4fec8bf603fa" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_f60ab128-fb13-40aa-b787-714381e4d34a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_ae6ed015-c18f-4ff6-a1cf-2f589d503dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_f60ab128-fb13-40aa-b787-714381e4d34a" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_ae6ed015-c18f-4ff6-a1cf-2f589d503dc6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#FairValueMeasurementsMeasuredonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails" xlink:type="extended" id="ie7fdd23695ef45e4a068daa9f2e3555c_FairValueMeasurementsMeasuredonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7e94774b-757c-4057-b18b-16717b760895" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eaf3dbc4-216d-4645-b1a7-8ee2e82103a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7e94774b-757c-4057-b18b-16717b760895" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eaf3dbc4-216d-4645-b1a7-8ee2e82103a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_facf01a7-17be-44ad-929e-048ada6b0bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7e94774b-757c-4057-b18b-16717b760895" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_facf01a7-17be-44ad-929e-048ada6b0bb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_59c7ca19-94b8-434b-ba51-e91819dd535b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7e94774b-757c-4057-b18b-16717b760895" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_59c7ca19-94b8-434b-ba51-e91819dd535b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_10ab6d8c-109d-421f-8078-3e889cfb3f12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_59c7ca19-94b8-434b-ba51-e91819dd535b" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_10ab6d8c-109d-421f-8078-3e889cfb3f12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_10ab6d8c-109d-421f-8078-3e889cfb3f12_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_10ab6d8c-109d-421f-8078-3e889cfb3f12" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_10ab6d8c-109d-421f-8078-3e889cfb3f12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d9f7e302-a951-4f67-987f-9aea76e77ada" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_10ab6d8c-109d-421f-8078-3e889cfb3f12" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d9f7e302-a951-4f67-987f-9aea76e77ada" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_6d782dfc-b486-4055-aa80-2b6a88dddd7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_d9f7e302-a951-4f67-987f-9aea76e77ada" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_6d782dfc-b486-4055-aa80-2b6a88dddd7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cf3be795-47c4-4bf8-8ad0-bc114475117d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_59c7ca19-94b8-434b-ba51-e91819dd535b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cf3be795-47c4-4bf8-8ad0-bc114475117d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cf3be795-47c4-4bf8-8ad0-bc114475117d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cf3be795-47c4-4bf8-8ad0-bc114475117d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cf3be795-47c4-4bf8-8ad0-bc114475117d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_56a394bc-d4bf-4706-8b95-cf90212604fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cf3be795-47c4-4bf8-8ad0-bc114475117d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_56a394bc-d4bf-4706-8b95-cf90212604fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1f6555a3-7873-4236-b7a2-9b9fd8c8ef57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_56a394bc-d4bf-4706-8b95-cf90212604fd" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1f6555a3-7873-4236-b7a2-9b9fd8c8ef57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_e3720699-a8fb-4a34-a728-095463f19c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_56a394bc-d4bf-4706-8b95-cf90212604fd" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_e3720699-a8fb-4a34-a728-095463f19c3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ba7bc223-25bb-46d6-8c8a-63a24ab25d73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_56a394bc-d4bf-4706-8b95-cf90212604fd" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ba7bc223-25bb-46d6-8c8a-63a24ab25d73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d24f39fe-6197-4038-a890-fb7dad12e657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_59c7ca19-94b8-434b-ba51-e91819dd535b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d24f39fe-6197-4038-a890-fb7dad12e657" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d24f39fe-6197-4038-a890-fb7dad12e657_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d24f39fe-6197-4038-a890-fb7dad12e657" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d24f39fe-6197-4038-a890-fb7dad12e657_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ba3592b0-a4e2-4018-af9c-ab185640f017" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d24f39fe-6197-4038-a890-fb7dad12e657" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ba3592b0-a4e2-4018-af9c-ab185640f017" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_38048200-a717-48c5-9e1a-13b14e6ae377" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ba3592b0-a4e2-4018-af9c-ab185640f017" xlink:to="loc_us-gaap_MoneyMarketFundsMember_38048200-a717-48c5-9e1a-13b14e6ae377" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_721bcff5-e5f5-40f3-b2af-f99744aa82b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ba3592b0-a4e2-4018-af9c-ab185640f017" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_721bcff5-e5f5-40f3-b2af-f99744aa82b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4d9cc38a-5db3-41ec-939d-bc1c76198808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ba3592b0-a4e2-4018-af9c-ab185640f017" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4d9cc38a-5db3-41ec-939d-bc1c76198808" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_af81245d-3614-431b-80f0-4a4cc7cbab9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ba3592b0-a4e2-4018-af9c-ab185640f017" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_af81245d-3614-431b-80f0-4a4cc7cbab9c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended" id="i4849f600620f4c65ad7736043dce21d5_FairValueMeasurementsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_44d9d761-85da-4570-afaa-02d7db519c11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_8bb3f5d1-a802-4ed8-972a-2240cdab803f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_44d9d761-85da-4570-afaa-02d7db519c11" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_8bb3f5d1-a802-4ed8-972a-2240cdab803f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_e79eb96c-1a45-43c3-8f5c-332b6e92a67c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_44d9d761-85da-4570-afaa-02d7db519c11" xlink:to="loc_us-gaap_LongTermDebt_e79eb96c-1a45-43c3-8f5c-332b6e92a67c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f2e9c348-5bf2-4f03-83fb-67a2815e80be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_44d9d761-85da-4570-afaa-02d7db519c11" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f2e9c348-5bf2-4f03-83fb-67a2815e80be" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b2ad247a-da83-49a5-b780-24b04405c7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f2e9c348-5bf2-4f03-83fb-67a2815e80be" xlink:to="loc_us-gaap_DebtInstrumentAxis_b2ad247a-da83-49a5-b780-24b04405c7cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b2ad247a-da83-49a5-b780-24b04405c7cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b2ad247a-da83-49a5-b780-24b04405c7cf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b2ad247a-da83-49a5-b780-24b04405c7cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_056f6099-7071-420e-805b-56493c1a9b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b2ad247a-da83-49a5-b780-24b04405c7cf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_056f6099-7071-420e-805b-56493c1a9b1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_d94a0bd3-4552-4dd3-9c4f-fda8861d405f" xlink:href="avdl-20211231.xsd#avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_056f6099-7071-420e-805b-56493c1a9b1b" xlink:to="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_d94a0bd3-4552-4dd3-9c4f-fda8861d405f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3ec9b603-c535-4ad4-a358-c2f12ba17918" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f2e9c348-5bf2-4f03-83fb-67a2815e80be" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3ec9b603-c535-4ad4-a358-c2f12ba17918" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3ec9b603-c535-4ad4-a358-c2f12ba17918_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3ec9b603-c535-4ad4-a358-c2f12ba17918" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3ec9b603-c535-4ad4-a358-c2f12ba17918_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_47d8ae6d-d3df-4306-81ba-33082e1e785a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3ec9b603-c535-4ad4-a358-c2f12ba17918" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_47d8ae6d-d3df-4306-81ba-33082e1e785a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_64868e26-d348-4a36-9985-343770e4e5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_47d8ae6d-d3df-4306-81ba-33082e1e785a" xlink:to="loc_us-gaap_SeniorNotesMember_64868e26-d348-4a36-9985-343770e4e5f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_fbe84488-5c96-4d60-9f54-82b29cf82e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f2e9c348-5bf2-4f03-83fb-67a2815e80be" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_fbe84488-5c96-4d60-9f54-82b29cf82e0e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_fbe84488-5c96-4d60-9f54-82b29cf82e0e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_fbe84488-5c96-4d60-9f54-82b29cf82e0e" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_fbe84488-5c96-4d60-9f54-82b29cf82e0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_71f10e70-253e-4f80-8df5-e35d8d583b01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_fbe84488-5c96-4d60-9f54-82b29cf82e0e" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_71f10e70-253e-4f80-8df5-e35d8d583b01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_5a2501a5-69a8-47b3-909f-d784f26c2f76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_71f10e70-253e-4f80-8df5-e35d8d583b01" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_5a2501a5-69a8-47b3-909f-d784f26c2f76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_7c71b766-dc5d-414c-81b1-4aea0eb19561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_5a2501a5-69a8-47b3-909f-d784f26c2f76" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_7c71b766-dc5d-414c-81b1-4aea0eb19561" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#MarketableSecuritiesSummaryofMarketableSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails" xlink:type="extended" id="i90cf024ce15142edbbbf18aa299c13e2_MarketableSecuritiesSummaryofMarketableSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_13922fa8-ca5a-4b7a-b70d-09d5a98d92a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_caa8f046-2811-41fe-aa7e-c62871d0dca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_13922fa8-ca5a-4b7a-b70d-09d5a98d92a5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_caa8f046-2811-41fe-aa7e-c62871d0dca1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f956a612-966b-478b-8592-f687aa92f554" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_caa8f046-2811-41fe-aa7e-c62871d0dca1" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f956a612-966b-478b-8592-f687aa92f554" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_12dd8bdd-98f4-44b2-98a2-620e977a0482" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_caa8f046-2811-41fe-aa7e-c62871d0dca1" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_12dd8bdd-98f4-44b2-98a2-620e977a0482" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_bc40141f-7daf-43b2-bd67-c7257ae6766f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_caa8f046-2811-41fe-aa7e-c62871d0dca1" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_bc40141f-7daf-43b2-bd67-c7257ae6766f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_018a8991-7241-4e67-8351-cabdd7ac18ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_caa8f046-2811-41fe-aa7e-c62871d0dca1" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_018a8991-7241-4e67-8351-cabdd7ac18ed" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_924b87d2-65e2-409c-8010-862a8aaf906a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_13922fa8-ca5a-4b7a-b70d-09d5a98d92a5" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_924b87d2-65e2-409c-8010-862a8aaf906a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_3c33e954-dc04-4ab7-ab91-e6d86618985a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_924b87d2-65e2-409c-8010-862a8aaf906a" xlink:to="loc_us-gaap_FinancialInstrumentAxis_3c33e954-dc04-4ab7-ab91-e6d86618985a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3c33e954-dc04-4ab7-ab91-e6d86618985a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3c33e954-dc04-4ab7-ab91-e6d86618985a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3c33e954-dc04-4ab7-ab91-e6d86618985a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b42e325-93a9-412c-9fb7-c277228fb67e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3c33e954-dc04-4ab7-ab91-e6d86618985a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b42e325-93a9-412c-9fb7-c277228fb67e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_99974193-3d5d-4d42-9af2-80a930cfe1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b42e325-93a9-412c-9fb7-c277228fb67e" xlink:to="loc_us-gaap_MoneyMarketFundsMember_99974193-3d5d-4d42-9af2-80a930cfe1cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_2513cdf0-1ea7-48a4-bec1-e286bd8418a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b42e325-93a9-412c-9fb7-c277228fb67e" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_2513cdf0-1ea7-48a4-bec1-e286bd8418a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_5d02b74b-f750-4da4-908c-c1fd16f98af2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b42e325-93a9-412c-9fb7-c277228fb67e" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_5d02b74b-f750-4da4-908c-c1fd16f98af2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_36ab63da-6d8c-49c5-8ddc-d54be4467a93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b42e325-93a9-412c-9fb7-c277228fb67e" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_36ab63da-6d8c-49c5-8ddc-d54be4467a93" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#MarketableSecuritiesScheduleofMaturitiesDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails" xlink:type="extended" id="i03f9d193a04f409db7a6ec49c6ca9b2b_MarketableSecuritiesScheduleofMaturitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_12884434-0b36-4c5d-aef4-620fafc16d77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_67f6a8c7-f351-468f-b57a-56846e7b3103" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_12884434-0b36-4c5d-aef4-620fafc16d77" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_67f6a8c7-f351-468f-b57a-56846e7b3103" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_78b3bfa8-1d6d-4f10-8ca3-373f9e9727f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_12884434-0b36-4c5d-aef4-620fafc16d77" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_78b3bfa8-1d6d-4f10-8ca3-373f9e9727f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_b651a39c-d4c0-4a00-9e57-7e3ae29db184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_12884434-0b36-4c5d-aef4-620fafc16d77" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_b651a39c-d4c0-4a00-9e57-7e3ae29db184" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_b838c179-dd93-4f65-924e-5ebe6490869a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_12884434-0b36-4c5d-aef4-620fafc16d77" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_b838c179-dd93-4f65-924e-5ebe6490869a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ac3c426c-8144-44ba-90fa-3db27e472e40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_12884434-0b36-4c5d-aef4-620fafc16d77" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ac3c426c-8144-44ba-90fa-3db27e472e40" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e626ee46-e986-4457-afe2-8c9de9c873b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_12884434-0b36-4c5d-aef4-620fafc16d77" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e626ee46-e986-4457-afe2-8c9de9c873b3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_7e46cfb5-dda1-40ae-b9eb-670af9fe53fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e626ee46-e986-4457-afe2-8c9de9c873b3" xlink:to="loc_us-gaap_FinancialInstrumentAxis_7e46cfb5-dda1-40ae-b9eb-670af9fe53fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7e46cfb5-dda1-40ae-b9eb-670af9fe53fb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7e46cfb5-dda1-40ae-b9eb-670af9fe53fb" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7e46cfb5-dda1-40ae-b9eb-670af9fe53fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dfe326ca-6ada-44c2-b5ab-e8b8fb99041c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7e46cfb5-dda1-40ae-b9eb-670af9fe53fb" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dfe326ca-6ada-44c2-b5ab-e8b8fb99041c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_49708395-c0ea-4df3-834f-6033676fe6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dfe326ca-6ada-44c2-b5ab-e8b8fb99041c" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_49708395-c0ea-4df3-834f-6033676fe6fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_80ba5fb4-3fc9-458d-aea5-9e39028307b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dfe326ca-6ada-44c2-b5ab-e8b8fb99041c" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_80ba5fb4-3fc9-458d-aea5-9e39028307b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_7128e044-6ff1-48d4-9269-03a92397dc6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dfe326ca-6ada-44c2-b5ab-e8b8fb99041c" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_7128e044-6ff1-48d4-9269-03a92397dc6b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_3c566bee-fb6b-4a1d-aefa-38d1d0cd1e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dfe326ca-6ada-44c2-b5ab-e8b8fb99041c" xlink:to="loc_us-gaap_DebtSecuritiesMember_3c566bee-fb6b-4a1d-aefa-38d1d0cd1e8d" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/PropertyandEquipmentnetDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#PropertyandEquipmentnetDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/PropertyandEquipmentnetDetails" xlink:type="extended" id="i0ed6cddf8c7d468a897b9b38875b0ba2_PropertyandEquipmentnetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ef9a59d6-6a04-4627-8a1a-94b7b26d7b76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_7a4d48bf-1c1d-4f1f-acea-544436f7d480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ef9a59d6-6a04-4627-8a1a-94b7b26d7b76" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_7a4d48bf-1c1d-4f1f-acea-544436f7d480" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_00611e3e-0cce-4cc1-a0e1-e8e9be61050f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ef9a59d6-6a04-4627-8a1a-94b7b26d7b76" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_00611e3e-0cce-4cc1-a0e1-e8e9be61050f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_09e08b08-12f6-4547-b9d5-62c45e62e073" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ef9a59d6-6a04-4627-8a1a-94b7b26d7b76" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_09e08b08-12f6-4547-b9d5-62c45e62e073" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_a496cc7c-63b6-4a2a-83ab-a0f6b3951eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ef9a59d6-6a04-4627-8a1a-94b7b26d7b76" xlink:to="loc_us-gaap_Depreciation_a496cc7c-63b6-4a2a-83ab-a0f6b3951eb9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_979444d3-b189-4db2-aba4-eef75cfa09a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ef9a59d6-6a04-4627-8a1a-94b7b26d7b76" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_979444d3-b189-4db2-aba4-eef75cfa09a1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_60b9868a-7a50-4fff-b122-5b97a96012d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_979444d3-b189-4db2-aba4-eef75cfa09a1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_60b9868a-7a50-4fff-b122-5b97a96012d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_60b9868a-7a50-4fff-b122-5b97a96012d6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_60b9868a-7a50-4fff-b122-5b97a96012d6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_60b9868a-7a50-4fff-b122-5b97a96012d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3aecc9f5-4039-43d6-a7db-aec78278756f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_60b9868a-7a50-4fff-b122-5b97a96012d6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3aecc9f5-4039-43d6-a7db-aec78278756f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember_eaf526eb-bf7a-4aa1-a8cd-1aa619cea861" xlink:href="avdl-20211231.xsd#avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3aecc9f5-4039-43d6-a7db-aec78278756f" xlink:to="loc_avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember_eaf526eb-bf7a-4aa1-a8cd-1aa619cea861" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_ba86c7bb-3c1b-430a-a15a-a214ee7ccf76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3aecc9f5-4039-43d6-a7db-aec78278756f" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_ba86c7bb-3c1b-430a-a15a-a214ee7ccf76" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i21d5b8ee80704a6a876d414cd81bf04c_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_a58dc91e-c9d5-4cb8-965b-6b7be8413967" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_ea5f2f8e-ee66-4824-909c-1cd99f5e076c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a58dc91e-c9d5-4cb8-965b-6b7be8413967" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_ea5f2f8e-ee66-4824-909c-1cd99f5e076c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_9620912e-ef8b-4f1b-9d7a-5a2606114038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a58dc91e-c9d5-4cb8-965b-6b7be8413967" xlink:to="loc_us-gaap_OperatingLeasePayments_9620912e-ef8b-4f1b-9d7a-5a2606114038" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_c558e649-6bec-4dc4-b19e-16da35e058b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a58dc91e-c9d5-4cb8-965b-6b7be8413967" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_c558e649-6bec-4dc4-b19e-16da35e058b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_ad144270-9ca1-4f39-8165-c9d40bb64cde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a58dc91e-c9d5-4cb8-965b-6b7be8413967" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_ad144270-9ca1-4f39-8165-c9d40bb64cde" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_faa2b239-594c-45d6-b94a-37eef0e18203" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a58dc91e-c9d5-4cb8-965b-6b7be8413967" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_faa2b239-594c-45d6-b94a-37eef0e18203" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1631bee2-bb7c-438e-a31d-09408a1607f1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_faa2b239-594c-45d6-b94a-37eef0e18203" xlink:to="loc_srt_RangeAxis_1631bee2-bb7c-438e-a31d-09408a1607f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1631bee2-bb7c-438e-a31d-09408a1607f1_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1631bee2-bb7c-438e-a31d-09408a1607f1" xlink:to="loc_srt_RangeMember_1631bee2-bb7c-438e-a31d-09408a1607f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_703ec2bc-3890-4841-9795-3e6fc15e36a9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1631bee2-bb7c-438e-a31d-09408a1607f1" xlink:to="loc_srt_RangeMember_703ec2bc-3890-4841-9795-3e6fc15e36a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_740d6d81-8815-404e-8a32-a8b3ebfd3086" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_703ec2bc-3890-4841-9795-3e6fc15e36a9" xlink:to="loc_srt_MinimumMember_740d6d81-8815-404e-8a32-a8b3ebfd3086" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_61b40edd-a88d-4164-ab5a-a1fcaf2540dc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_703ec2bc-3890-4841-9795-3e6fc15e36a9" xlink:to="loc_srt_MaximumMember_61b40edd-a88d-4164-ab5a-a1fcaf2540dc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#LongTermDebtScheduleofLongTermDebtInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails" xlink:type="extended" id="i733e134158a94f8c82745d116ef856c6_LongTermDebtScheduleofLongTermDebtInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ad5f25b1-5f35-48b9-bfd3-e443061b4c25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_4ef3862b-f8bd-4605-a492-c5898783fffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ad5f25b1-5f35-48b9-bfd3-e443061b4c25" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_4ef3862b-f8bd-4605-a492-c5898783fffc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_7c5478cd-94a4-442e-a4b5-6762f1070783" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ad5f25b1-5f35-48b9-bfd3-e443061b4c25" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_7c5478cd-94a4-442e-a4b5-6762f1070783" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_9c1a1be4-e3c9-4501-a2a5-7d9cd962e893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ad5f25b1-5f35-48b9-bfd3-e443061b4c25" xlink:to="loc_us-gaap_LongTermDebt_9c1a1be4-e3c9-4501-a2a5-7d9cd962e893" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_f1003eb4-3c50-4700-9991-4ed178c7c7f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ad5f25b1-5f35-48b9-bfd3-e443061b4c25" xlink:to="loc_us-gaap_LongTermDebtCurrent_f1003eb4-3c50-4700-9991-4ed178c7c7f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_a00ead14-de56-4c11-a2ee-085d3c0a5703" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ad5f25b1-5f35-48b9-bfd3-e443061b4c25" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_a00ead14-de56-4c11-a2ee-085d3c0a5703" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_292a8ded-a522-41d2-90bc-220ed1f069ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ad5f25b1-5f35-48b9-bfd3-e443061b4c25" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_292a8ded-a522-41d2-90bc-220ed1f069ab" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_16608ad3-60a3-41e0-be8c-5b72a3001731" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ad5f25b1-5f35-48b9-bfd3-e443061b4c25" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_16608ad3-60a3-41e0-be8c-5b72a3001731" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b391198f-df83-43cd-847a-5aa6552811e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ad5f25b1-5f35-48b9-bfd3-e443061b4c25" xlink:to="loc_us-gaap_DebtInstrumentTable_b391198f-df83-43cd-847a-5aa6552811e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_726266f2-2010-4a9c-adcf-647b1315fe3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b391198f-df83-43cd-847a-5aa6552811e7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_726266f2-2010-4a9c-adcf-647b1315fe3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_726266f2-2010-4a9c-adcf-647b1315fe3c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_726266f2-2010-4a9c-adcf-647b1315fe3c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_726266f2-2010-4a9c-adcf-647b1315fe3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_60660a38-566e-4aea-82c9-752f984cb92e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_726266f2-2010-4a9c-adcf-647b1315fe3c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_60660a38-566e-4aea-82c9-752f984cb92e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_be424304-cb69-4092-86f1-1daa32bd0671" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_60660a38-566e-4aea-82c9-752f984cb92e" xlink:to="loc_us-gaap_SeniorNotesMember_be424304-cb69-4092-86f1-1daa32bd0671" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0c881f2a-4297-40b2-a0e2-45476e6798ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b391198f-df83-43cd-847a-5aa6552811e7" xlink:to="loc_us-gaap_DebtInstrumentAxis_0c881f2a-4297-40b2-a0e2-45476e6798ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0c881f2a-4297-40b2-a0e2-45476e6798ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0c881f2a-4297-40b2-a0e2-45476e6798ab" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0c881f2a-4297-40b2-a0e2-45476e6798ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a39b7ba8-6596-488d-9969-d06c29d48932" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0c881f2a-4297-40b2-a0e2-45476e6798ab" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a39b7ba8-6596-488d-9969-d06c29d48932" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_568b653d-3c29-4101-88b9-6face4424c62" xlink:href="avdl-20211231.xsd#avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a39b7ba8-6596-488d-9969-d06c29d48932" xlink:to="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_568b653d-3c29-4101-88b9-6face4424c62" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#LongTermDebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/LongTermDebtNarrativeDetails" xlink:type="extended" id="i13b557765c734d6a84b1f0360c1115d5_LongTermDebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_d118ec9a-7bf8-4dce-aaad-6fcbcdd29676" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_us-gaap_InterestExpenseDebt_d118ec9a-7bf8-4dce-aaad-6fcbcdd29676" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CouponInterestExpense_dd138400-cb40-4a35-a996-4a5b836fc878" xlink:href="avdl-20211231.xsd#avdl_CouponInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_avdl_CouponInterestExpense_dd138400-cb40-4a35-a996-4a5b836fc878" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_2ea687dd-9df4-4262-ae5a-a76de2aeed78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_2ea687dd-9df4-4262-ae5a-a76de2aeed78" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AdditionalInterestExpenseDebt_62fd21df-28ea-46bb-99c3-0f03fba72bb0" xlink:href="avdl-20211231.xsd#avdl_AdditionalInterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_avdl_AdditionalInterestExpenseDebt_62fd21df-28ea-46bb-99c3-0f03fba72bb0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_468eabc4-fd14-44d6-bb3a-c420fe11c619" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_us-gaap_LongTermDebt_468eabc4-fd14-44d6-bb3a-c420fe11c619" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_20a117e9-e9af-473a-8e43-f08a05471db3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_us-gaap_StockholdersEquity_20a117e9-e9af-473a-8e43-f08a05471db3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_a0e9ce8f-27df-4711-ad39-119796305f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_a0e9ce8f-27df-4711-ad39-119796305f5d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_57208dd5-dbdb-47eb-b739-6667e3fb8893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_57208dd5-dbdb-47eb-b739-6667e3fb8893" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_61cef879-e857-43ea-93e1-0d01718d1241" xlink:href="avdl-20211231.xsd#avdl_DebtInstrumentOptiontoIncreaseFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_61cef879-e857-43ea-93e1-0d01718d1241" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_9b8e83cd-5def-4283-9bc6-c7eac8602d98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_9b8e83cd-5def-4283-9bc6-c7eac8602d98" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositorySharesConversionRatio_b5eb94c6-f3ab-475a-9121-68d5695edd74" xlink:href="avdl-20211231.xsd#avdl_AmericanDepositorySharesConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_avdl_AmericanDepositorySharesConversionRatio_b5eb94c6-f3ab-475a-9121-68d5695edd74" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesOptionPricePerShare_8f319b12-bc1a-4deb-b623-65bb12a1a96c" xlink:href="avdl-20211231.xsd#avdl_AmericanDepositarySharesOptionPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_avdl_AmericanDepositarySharesOptionPricePerShare_8f319b12-bc1a-4deb-b623-65bb12a1a96c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesPremiumPercentage_ed0d9155-87f2-49de-b2fd-88eeea87a81b" xlink:href="avdl-20211231.xsd#avdl_AmericanDepositarySharesPremiumPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_avdl_AmericanDepositarySharesPremiumPercentage_ed0d9155-87f2-49de-b2fd-88eeea87a81b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesPurchasedPricePerShare_fdfd66bf-7f36-47ae-85ba-9dbdc119374a" xlink:href="avdl-20211231.xsd#avdl_AmericanDepositarySharesPurchasedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_avdl_AmericanDepositarySharesPurchasedPricePerShare_fdfd66bf-7f36-47ae-85ba-9dbdc119374a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted_e261d0c4-e7a6-4ec0-b6fe-38b80e37bffe" xlink:href="avdl-20211231.xsd#avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted_e261d0c4-e7a6-4ec0-b6fe-38b80e37bffe" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays_122539ba-a58b-4bad-8e91-f8d0347e73d7" xlink:href="avdl-20211231.xsd#avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays_122539ba-a58b-4bad-8e91-f8d0347e73d7" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay_17114140-0001-421a-9780-4f130926cd46" xlink:href="avdl-20211231.xsd#avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay_17114140-0001-421a-9780-4f130926cd46" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays_c725e4d0-b85f-4a4a-8ffc-a7eecd499342" xlink:href="avdl-20211231.xsd#avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays_c725e4d0-b85f-4a4a-8ffc-a7eecd499342" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_87b81d1b-9ba2-466c-9fcd-448a7afead06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_87b81d1b-9ba2-466c-9fcd-448a7afead06" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_51ef96ea-644b-4357-b734-184f0f160db1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_51ef96ea-644b-4357-b734-184f0f160db1" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_37d91be6-983a-47ba-a5e8-f2cacb565309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_37d91be6-983a-47ba-a5e8-f2cacb565309" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_ab438aa2-2133-41f1-aa80-753eecf013df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCapitalizationLongtermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_ab438aa2-2133-41f1-aa80-753eecf013df" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_941ee372-1d6d-4aaa-8f51-27c677e521bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_ab438aa2-2133-41f1-aa80-753eecf013df" xlink:to="loc_us-gaap_DebtInstrumentAxis_941ee372-1d6d-4aaa-8f51-27c677e521bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_941ee372-1d6d-4aaa-8f51-27c677e521bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_941ee372-1d6d-4aaa-8f51-27c677e521bd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_941ee372-1d6d-4aaa-8f51-27c677e521bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e10c5414-b562-4284-896a-6396078d2851" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_941ee372-1d6d-4aaa-8f51-27c677e521bd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e10c5414-b562-4284-896a-6396078d2851" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_d611a6c0-9a33-4440-be46-613cc8a61082" xlink:href="avdl-20211231.xsd#avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e10c5414-b562-4284-896a-6396078d2851" xlink:to="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_d611a6c0-9a33-4440-be46-613cc8a61082" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c6af80fd-2dc1-4ca0-aaba-444424caf5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_ab438aa2-2133-41f1-aa80-753eecf013df" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c6af80fd-2dc1-4ca0-aaba-444424caf5e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c6af80fd-2dc1-4ca0-aaba-444424caf5e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c6af80fd-2dc1-4ca0-aaba-444424caf5e3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c6af80fd-2dc1-4ca0-aaba-444424caf5e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8f836d7b-a28d-489d-80cd-918b840152c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c6af80fd-2dc1-4ca0-aaba-444424caf5e3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8f836d7b-a28d-489d-80cd-918b840152c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_1868ef2e-caf4-4e39-b075-ddcf4435d252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8f836d7b-a28d-489d-80cd-918b840152c9" xlink:to="loc_us-gaap_ConvertibleDebtMember_1868ef2e-caf4-4e39-b075-ddcf4435d252" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_199bb480-99b0-4351-9054-d4a8ebebe796" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8f836d7b-a28d-489d-80cd-918b840152c9" xlink:to="loc_us-gaap_SeniorNotesMember_199bb480-99b0-4351-9054-d4a8ebebe796" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d269c0bd-27d6-4dc3-baba-54cbef55b849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_ab438aa2-2133-41f1-aa80-753eecf013df" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d269c0bd-27d6-4dc3-baba-54cbef55b849" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_d269c0bd-27d6-4dc3-baba-54cbef55b849_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d269c0bd-27d6-4dc3-baba-54cbef55b849" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_d269c0bd-27d6-4dc3-baba-54cbef55b849_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_074dde0f-b83b-4834-a43a-fac056c43e05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d269c0bd-27d6-4dc3-baba-54cbef55b849" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_074dde0f-b83b-4834-a43a-fac056c43e05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_1eeea341-4b4a-48c1-8c9f-b56b9ea8a34c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_074dde0f-b83b-4834-a43a-fac056c43e05" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_1eeea341-4b4a-48c1-8c9f-b56b9ea8a34c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_d20d877f-2841-42c8-b37b-09a954e0e7ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_074dde0f-b83b-4834-a43a-fac056c43e05" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_d20d877f-2841-42c8-b37b-09a954e0e7ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_57630db9-ed9a-4e9c-a49f-677eafd8d41b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_074dde0f-b83b-4834-a43a-fac056c43e05" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_57630db9-ed9a-4e9c-a49f-677eafd8d41b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_23a4372b-50a9-415f-bde0-bc5b6e3775ff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_ab438aa2-2133-41f1-aa80-753eecf013df" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_23a4372b-50a9-415f-bde0-bc5b6e3775ff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_23a4372b-50a9-415f-bde0-bc5b6e3775ff_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_23a4372b-50a9-415f-bde0-bc5b6e3775ff" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_23a4372b-50a9-415f-bde0-bc5b6e3775ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8ce04482-f450-40f2-8f42-c168bc439332" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_23a4372b-50a9-415f-bde0-bc5b6e3775ff" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8ce04482-f450-40f2-8f42-c168bc439332" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_6251de46-426a-44c6-8b97-77223506ec6a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8ce04482-f450-40f2-8f42-c168bc439332" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_6251de46-426a-44c6-8b97-77223506ec6a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9f5b4d9b-c2a7-4e67-a8ff-1d366fe971d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_ab438aa2-2133-41f1-aa80-753eecf013df" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9f5b4d9b-c2a7-4e67-a8ff-1d366fe971d2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9f5b4d9b-c2a7-4e67-a8ff-1d366fe971d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9f5b4d9b-c2a7-4e67-a8ff-1d366fe971d2" xlink:to="loc_us-gaap_EquityComponentDomain_9f5b4d9b-c2a7-4e67-a8ff-1d366fe971d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_41ae5b1a-0959-45a2-ab3d-7bb916fde9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9f5b4d9b-c2a7-4e67-a8ff-1d366fe971d2" xlink:to="loc_us-gaap_EquityComponentDomain_41ae5b1a-0959-45a2-ab3d-7bb916fde9ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9689def0-846a-4bef-a3a6-3030a3e07d12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_41ae5b1a-0959-45a2-ab3d-7bb916fde9ee" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9689def0-846a-4bef-a3a6-3030a3e07d12" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#IncomeTaxesIncomeLossBeforeIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails" xlink:type="extended" id="ib1c71b5d591649e4a0b1a2ae065bb911_IncomeTaxesIncomeLossBeforeIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_avdl_IncomeTaxesLineItems_d4749386-8e4a-471d-9fea-94b01d2f5066" xlink:href="avdl-20211231.xsd#avdl_IncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d9611a87-182f-4c8c-a33a-60dd4c88af68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avdl_IncomeTaxesLineItems_d4749386-8e4a-471d-9fea-94b01d2f5066" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d9611a87-182f-4c8c-a33a-60dd4c88af68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_IncomeTaxesTable_964a0f7f-c3da-4b74-99b4-b4937fc1d6e0" xlink:href="avdl-20211231.xsd#avdl_IncomeTaxesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_avdl_IncomeTaxesLineItems_d4749386-8e4a-471d-9fea-94b01d2f5066" xlink:to="loc_avdl_IncomeTaxesTable_964a0f7f-c3da-4b74-99b4-b4937fc1d6e0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a0da3947-2ff5-4c1b-9017-89372de3fdc9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_avdl_IncomeTaxesTable_964a0f7f-c3da-4b74-99b4-b4937fc1d6e0" xlink:to="loc_srt_StatementGeographicalAxis_a0da3947-2ff5-4c1b-9017-89372de3fdc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a0da3947-2ff5-4c1b-9017-89372de3fdc9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_a0da3947-2ff5-4c1b-9017-89372de3fdc9" xlink:to="loc_srt_SegmentGeographicalDomain_a0da3947-2ff5-4c1b-9017-89372de3fdc9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c6b2d88e-3277-4d9e-b898-a297ad657bc5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_a0da3947-2ff5-4c1b-9017-89372de3fdc9" xlink:to="loc_srt_SegmentGeographicalDomain_c6b2d88e-3277-4d9e-b898-a297ad657bc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_980e1157-3cca-452d-83a0-3738d819f521" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c6b2d88e-3277-4d9e-b898-a297ad657bc5" xlink:to="loc_country_IE_980e1157-3cca-452d-83a0-3738d819f521" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_32bb3d88-4a0d-411c-ae1d-c56bc6168faf" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c6b2d88e-3277-4d9e-b898-a297ad657bc5" xlink:to="loc_country_US_32bb3d88-4a0d-411c-ae1d-c56bc6168faf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_d2cb67c6-2c87-464a-8234-5937b56c270b" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c6b2d88e-3277-4d9e-b898-a297ad657bc5" xlink:to="loc_country_FR_d2cb67c6-2c87-464a-8234-5937b56c270b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#IncomeTaxesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="extended" id="i5b4390477fcb4b0d81ff722da4c25c23_IncomeTaxesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:href="avdl-20211231.xsd#avdl_IncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_IncreaseDecreaseInIncomeTaxBenefit_219c5a63-9227-46ca-be8f-240eaeec795d" xlink:href="avdl-20211231.xsd#avdl_IncreaseDecreaseInIncomeTaxBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_avdl_IncreaseDecreaseInIncomeTaxBenefit_219c5a63-9227-46ca-be8f-240eaeec795d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DeferredTaxAssetsAmortizationofIntangibleAssets_0321ced1-bb30-4c77-923c-cef4299e3ee4" xlink:href="avdl-20211231.xsd#avdl_DeferredTaxAssetsAmortizationofIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_avdl_DeferredTaxAssetsAmortizationofIntangibleAssets_0321ced1-bb30-4c77-923c-cef4299e3ee4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f93d29da-54d9-4ac9-ba10-73a5c0d509a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f93d29da-54d9-4ac9-ba10-73a5c0d509a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied_0b1be4ec-ed14-4269-bdd8-719ece92f4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_us-gaap_BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied_0b1be4ec-ed14-4269-bdd8-719ece92f4e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_bbc5214a-f1d4-495a-abd8-6404b31ce113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_bbc5214a-f1d4-495a-abd8-6404b31ce113" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_f9a5cc86-5aa5-4dd8-8c49-e3a464dced69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_f9a5cc86-5aa5-4dd8-8c49-e3a464dced69" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_b66c8e5f-6fa8-4904-b378-9fe58f0c24dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_b66c8e5f-6fa8-4904-b378-9fe58f0c24dd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_c9906e3d-1958-4b9b-bcdb-a550951d6f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_us-gaap_OperatingLossCarryforwards_c9906e3d-1958-4b9b-bcdb-a550951d6f6c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_da8facc8-9f1e-45f5-8043-a769bcd6e438" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_da8facc8-9f1e-45f5-8043-a769bcd6e438" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarnings_09e1349a-4f38-447d-b745-3b79cb6dd975" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_us-gaap_UndistributedEarnings_09e1349a-4f38-447d-b745-3b79cb6dd975" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_440038f4-df59-4104-b0a0-5ef32334d7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_440038f4-df59-4104-b0a0-5ef32334d7cf" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_53049683-9e4b-4dc9-bfd6-459a316ac689" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_53049683-9e4b-4dc9-bfd6-459a316ac689" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit_e95f2171-a29a-4816-a54f-a917e574e868" xlink:href="avdl-20211231.xsd#avdl_CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_avdl_CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit_e95f2171-a29a-4816-a54f-a917e574e868" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CARESActProceedsFromIncomeTaxRefunds_a348062e-f2a8-4739-9883-9c33e03795aa" xlink:href="avdl-20211231.xsd#avdl_CARESActProceedsFromIncomeTaxRefunds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_avdl_CARESActProceedsFromIncomeTaxRefunds_a348062e-f2a8-4739-9883-9c33e03795aa" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CARESActCashRefundClaims_d0bb305a-0bc9-46da-9269-50e54dca1483" xlink:href="avdl-20211231.xsd#avdl_CARESActCashRefundClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_avdl_CARESActCashRefundClaims_d0bb305a-0bc9-46da-9269-50e54dca1483" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_IncomeTaxesTable_71cd469b-77d7-42dd-9e43-684d25569f4b" xlink:href="avdl-20211231.xsd#avdl_IncomeTaxesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_avdl_IncomeTaxesTable_71cd469b-77d7-42dd-9e43-684d25569f4b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c81e53df-df58-4f90-b788-80694d1bc71c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_avdl_IncomeTaxesTable_71cd469b-77d7-42dd-9e43-684d25569f4b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c81e53df-df58-4f90-b788-80694d1bc71c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c81e53df-df58-4f90-b788-80694d1bc71c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c81e53df-df58-4f90-b788-80694d1bc71c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c81e53df-df58-4f90-b788-80694d1bc71c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cac26ed1-0060-421f-a5ac-3d0de2c1f227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c81e53df-df58-4f90-b788-80694d1bc71c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cac26ed1-0060-421f-a5ac-3d0de2c1f227" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FscHoldingsLlcMember_08176a0a-6c8d-4bb1-8c55-fb911c2c983b" xlink:href="avdl-20211231.xsd#avdl_FscHoldingsLlcMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cac26ed1-0060-421f-a5ac-3d0de2c1f227" xlink:to="loc_avdl_FscHoldingsLlcMember_08176a0a-6c8d-4bb1-8c55-fb911c2c983b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_U.S.HoldingsMember_9660d9f6-133f-40d0-8b06-fa0ec24b4856" xlink:href="avdl-20211231.xsd#avdl_U.S.HoldingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cac26ed1-0060-421f-a5ac-3d0de2c1f227" xlink:to="loc_avdl_U.S.HoldingsMember_9660d9f6-133f-40d0-8b06-fa0ec24b4856" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_3c8f333f-044f-4c9b-ac4d-ef241b6f0736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_avdl_IncomeTaxesTable_71cd469b-77d7-42dd-9e43-684d25569f4b" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_3c8f333f-044f-4c9b-ac4d-ef241b6f0736" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_3c8f333f-044f-4c9b-ac4d-ef241b6f0736_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_3c8f333f-044f-4c9b-ac4d-ef241b6f0736" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_3c8f333f-044f-4c9b-ac4d-ef241b6f0736_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_81ee1a9b-0bf2-4434-b71b-c3f188bb7b60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_3c8f333f-044f-4c9b-ac4d-ef241b6f0736" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_81ee1a9b-0bf2-4434-b71b-c3f188bb7b60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_17b1ffae-48ed-46d7-9903-b295afa34e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_81ee1a9b-0bf2-4434-b71b-c3f188bb7b60" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_17b1ffae-48ed-46d7-9903-b295afa34e0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_830ace39-d9f4-4f68-9514-90ddfd6d45b9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_avdl_IncomeTaxesTable_71cd469b-77d7-42dd-9e43-684d25569f4b" xlink:to="loc_dei_LegalEntityAxis_830ace39-d9f4-4f68-9514-90ddfd6d45b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_830ace39-d9f4-4f68-9514-90ddfd6d45b9_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_830ace39-d9f4-4f68-9514-90ddfd6d45b9" xlink:to="loc_dei_EntityDomain_830ace39-d9f4-4f68-9514-90ddfd6d45b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_1307d3a0-4330-4908-bcdf-ef012d23bea4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_830ace39-d9f4-4f68-9514-90ddfd6d45b9" xlink:to="loc_dei_EntityDomain_1307d3a0-4330-4908-bcdf-ef012d23bea4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_SpecialityPharamaMember_f30c1847-285c-4bf0-8a1d-a2cb08b94df1" xlink:href="avdl-20211231.xsd#avdl_SpecialityPharamaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_1307d3a0-4330-4908-bcdf-ef012d23bea4" xlink:to="loc_avdl_SpecialityPharamaMember_f30c1847-285c-4bf0-8a1d-a2cb08b94df1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_60596f6d-49dd-42ec-acce-791c883cf3f2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_avdl_IncomeTaxesTable_71cd469b-77d7-42dd-9e43-684d25569f4b" xlink:to="loc_srt_StatementGeographicalAxis_60596f6d-49dd-42ec-acce-791c883cf3f2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_60596f6d-49dd-42ec-acce-791c883cf3f2_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_60596f6d-49dd-42ec-acce-791c883cf3f2" xlink:to="loc_srt_SegmentGeographicalDomain_60596f6d-49dd-42ec-acce-791c883cf3f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e271daf1-b7a2-4438-8988-75bb8878f6ba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_60596f6d-49dd-42ec-acce-791c883cf3f2" xlink:to="loc_srt_SegmentGeographicalDomain_e271daf1-b7a2-4438-8988-75bb8878f6ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_4971c876-8877-4502-bcd5-988335d89cf4" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e271daf1-b7a2-4438-8988-75bb8878f6ba" xlink:to="loc_country_IE_4971c876-8877-4502-bcd5-988335d89cf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_cebfc145-1a7e-4036-add5-6669d94fcd0a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e271daf1-b7a2-4438-8988-75bb8878f6ba" xlink:to="loc_country_US_cebfc145-1a7e-4036-add5-6669d94fcd0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_20f8f3ad-50c4-4881-83fb-01607c65e682" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e271daf1-b7a2-4438-8988-75bb8878f6ba" xlink:to="loc_country_FR_20f8f3ad-50c4-4881-83fb-01607c65e682" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_7bf3723c-bf12-4aa8-b085-4e32f5a90535" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_avdl_IncomeTaxesTable_71cd469b-77d7-42dd-9e43-684d25569f4b" xlink:to="loc_us-gaap_TaxPeriodAxis_7bf3723c-bf12-4aa8-b085-4e32f5a90535" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_7bf3723c-bf12-4aa8-b085-4e32f5a90535_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_7bf3723c-bf12-4aa8-b085-4e32f5a90535" xlink:to="loc_us-gaap_TaxPeriodDomain_7bf3723c-bf12-4aa8-b085-4e32f5a90535_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_c96e14c2-a71c-4727-9e4a-888170e7e77f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_7bf3723c-bf12-4aa8-b085-4e32f5a90535" xlink:to="loc_us-gaap_TaxPeriodDomain_c96e14c2-a71c-4727-9e4a-888170e7e77f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxYear2019Member_07ca820d-27ae-4ed7-b74e-fa612848c0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxYear2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_c96e14c2-a71c-4727-9e4a-888170e7e77f" xlink:to="loc_us-gaap_TaxYear2019Member_07ca820d-27ae-4ed7-b74e-fa612848c0b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxYear2020Member_416bf86a-be5d-4bff-b8ef-6b8ce1e20888" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxYear2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_c96e14c2-a71c-4727-9e4a-888170e7e77f" xlink:to="loc_us-gaap_TaxYear2020Member_416bf86a-be5d-4bff-b8ef-6b8ce1e20888" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ContingentLiabilitiesandCommitmentsNarrativeDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#ContingentLiabilitiesandCommitmentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/ContingentLiabilitiesandCommitmentsNarrativeDetails" xlink:type="extended" id="i609084f52a084eb9907caeefdefa3ea4_ContingentLiabilitiesandCommitmentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_320c771c-09c8-46cd-a9e9-1a01b2a160bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PercentageOfRoyaltyPayableOnNetSales_17452147-567e-4af1-9ca8-035de2d3061d" xlink:href="avdl-20211231.xsd#avdl_PercentageOfRoyaltyPayableOnNetSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_320c771c-09c8-46cd-a9e9-1a01b2a160bc" xlink:to="loc_avdl_PercentageOfRoyaltyPayableOnNetSales_17452147-567e-4af1-9ca8-035de2d3061d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RoyaltyPayableonNetSalesMaximum_69e1bccd-f6b0-4d7d-8856-5ab045fa00fb" xlink:href="avdl-20211231.xsd#avdl_RoyaltyPayableonNetSalesMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_320c771c-09c8-46cd-a9e9-1a01b2a160bc" xlink:to="loc_avdl_RoyaltyPayableonNetSalesMaximum_69e1bccd-f6b0-4d7d-8856-5ab045fa00fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyLiabilities_10ea9c03-75d7-430f-bad5-48513fae1888" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuarantyLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_320c771c-09c8-46cd-a9e9-1a01b2a160bc" xlink:to="loc_us-gaap_GuarantyLiabilities_10ea9c03-75d7-430f-bad5-48513fae1888" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyAssets_1fc3ed3e-d699-453c-bf81-4909ee249d85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuarantyAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_320c771c-09c8-46cd-a9e9-1a01b2a160bc" xlink:to="loc_us-gaap_GuarantyAssets_1fc3ed3e-d699-453c-bf81-4909ee249d85" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CostsIncurredPurchaseObligation_420c2d98-0eb6-4484-90b0-e8a8fc3276e3" xlink:href="avdl-20211231.xsd#avdl_CostsIncurredPurchaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_320c771c-09c8-46cd-a9e9-1a01b2a160bc" xlink:to="loc_avdl_CostsIncurredPurchaseObligation_420c2d98-0eb6-4484-90b0-e8a8fc3276e3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ef1556df-73c6-4724-9a84-4669df841e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_320c771c-09c8-46cd-a9e9-1a01b2a160bc" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ef1556df-73c6-4724-9a84-4669df841e8d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0bcbf7f3-3e3d-4ca5-952f-18995df9816c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ef1556df-73c6-4724-9a84-4669df841e8d" xlink:to="loc_srt_ProductOrServiceAxis_0bcbf7f3-3e3d-4ca5-952f-18995df9816c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0bcbf7f3-3e3d-4ca5-952f-18995df9816c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_0bcbf7f3-3e3d-4ca5-952f-18995df9816c" xlink:to="loc_srt_ProductsAndServicesDomain_0bcbf7f3-3e3d-4ca5-952f-18995df9816c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0208d6f1-a752-4b71-b093-e3960641231d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_0bcbf7f3-3e3d-4ca5-952f-18995df9816c" xlink:to="loc_srt_ProductsAndServicesDomain_0208d6f1-a752-4b71-b093-e3960641231d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FSCMember_158bd9b6-7871-4433-b2fc-3a2d4c6a48f5" xlink:href="avdl-20211231.xsd#avdl_FSCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0208d6f1-a752-4b71-b093-e3960641231d" xlink:to="loc_avdl_FSCMember_158bd9b6-7871-4433-b2fc-3a2d4c6a48f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_2649b78c-8682-46f5-aecd-53a7f0cb17d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ef1556df-73c6-4724-9a84-4669df841e8d" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_2649b78c-8682-46f5-aecd-53a7f0cb17d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_2649b78c-8682-46f5-aecd-53a7f0cb17d1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_2649b78c-8682-46f5-aecd-53a7f0cb17d1" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_2649b78c-8682-46f5-aecd-53a7f0cb17d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_0f3ca91e-4ee8-4adc-886c-1ec5de7a39ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_2649b78c-8682-46f5-aecd-53a7f0cb17d1" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_0f3ca91e-4ee8-4adc-886c-1ec5de7a39ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_3ccc30bc-ef92-46a8-a284-193d740e14d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_0f3ca91e-4ee8-4adc-886c-1ec5de7a39ec" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_3ccc30bc-ef92-46a8-a284-193d740e14d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1c9c3b33-7027-4355-bc27-83b5b0b93ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ef1556df-73c6-4724-9a84-4669df841e8d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1c9c3b33-7027-4355-bc27-83b5b0b93ec0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1c9c3b33-7027-4355-bc27-83b5b0b93ec0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1c9c3b33-7027-4355-bc27-83b5b0b93ec0" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1c9c3b33-7027-4355-bc27-83b5b0b93ec0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_05b5dea2-c34d-4961-b652-c47549e12215" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1c9c3b33-7027-4355-bc27-83b5b0b93ec0" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_05b5dea2-c34d-4961-b652-c47549e12215" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A2016MIPAMember_b83330d0-6512-431c-8f29-88ad45758887" xlink:href="avdl-20211231.xsd#avdl_A2016MIPAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_05b5dea2-c34d-4961-b652-c47549e12215" xlink:to="loc_avdl_A2016MIPAMember_b83330d0-6512-431c-8f29-88ad45758887" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CerecorMember_3da215c3-2d76-433f-bef0-3319423bd1ca" xlink:href="avdl-20211231.xsd#avdl_CerecorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_05b5dea2-c34d-4961-b652-c47549e12215" xlink:to="loc_avdl_CerecorMember_3da215c3-2d76-433f-bef0-3319423bd1ca" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RestructuringCostsNarrativeDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#RestructuringCostsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/RestructuringCostsNarrativeDetails" xlink:type="extended" id="i3084d97032df4acba9dcc08d09864817_RestructuringCostsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_67a8b509-bd21-42b7-b08e-756fdf30d798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_c6926d31-3a7f-494c-ac1d-7a48a33e0e70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_67a8b509-bd21-42b7-b08e-756fdf30d798" xlink:to="loc_us-gaap_RestructuringCharges_c6926d31-3a7f-494c-ac1d-7a48a33e0e70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment_c6ded0f0-5993-4c3a-8f2c-f8e2031d060b" xlink:href="avdl-20211231.xsd#avdl_RestructuringChargesBeforeGainLossDuetoCurtailment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_67a8b509-bd21-42b7-b08e-756fdf30d798" xlink:to="loc_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment_c6ded0f0-5993-4c3a-8f2c-f8e2031d060b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_8e3c827d-db54-48ae-a78b-3cab02e652f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_67a8b509-bd21-42b7-b08e-756fdf30d798" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_8e3c827d-db54-48ae-a78b-3cab02e652f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_6864712b-4851-4fb5-8f10-a7554819ccb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_67a8b509-bd21-42b7-b08e-756fdf30d798" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_6864712b-4851-4fb5-8f10-a7554819ccb0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_9b52d28b-d5be-4ab4-a5ce-03aaf9103475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_67a8b509-bd21-42b7-b08e-756fdf30d798" xlink:to="loc_us-gaap_RestructuringReserve_9b52d28b-d5be-4ab4-a5ce-03aaf9103475" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent_6a6965a8-25af-4de3-80dd-f3f11a94d0bd" xlink:href="avdl-20211231.xsd#avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_67a8b509-bd21-42b7-b08e-756fdf30d798" xlink:to="loc_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent_6a6965a8-25af-4de3-80dd-f3f11a94d0bd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisposals_5f824d39-ba2c-4efe-8927-c70e614e8b66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisposals"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_67a8b509-bd21-42b7-b08e-756fdf30d798" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisposals_5f824d39-ba2c-4efe-8927-c70e614e8b66" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_955e2570-b1aa-4213-a2ad-66a09bbfb506" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_67a8b509-bd21-42b7-b08e-756fdf30d798" xlink:to="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_955e2570-b1aa-4213-a2ad-66a09bbfb506" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_a2232436-38a5-4be9-9d69-b59c8109ce61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_67a8b509-bd21-42b7-b08e-756fdf30d798" xlink:to="loc_us-gaap_PaymentsForRestructuring_a2232436-38a5-4be9-9d69-b59c8109ce61" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b7648897-2d67-4288-84aa-a41ee12a13b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_67a8b509-bd21-42b7-b08e-756fdf30d798" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b7648897-2d67-4288-84aa-a41ee12a13b6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_d68ab349-96f1-4f16-b1ff-8f8306c66762" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b7648897-2d67-4288-84aa-a41ee12a13b6" xlink:to="loc_us-gaap_RestructuringPlanAxis_d68ab349-96f1-4f16-b1ff-8f8306c66762" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_d68ab349-96f1-4f16-b1ff-8f8306c66762_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_d68ab349-96f1-4f16-b1ff-8f8306c66762" xlink:to="loc_us-gaap_RestructuringPlanDomain_d68ab349-96f1-4f16-b1ff-8f8306c66762_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_8770030b-11fe-4830-99c8-90ceafa3cd9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_d68ab349-96f1-4f16-b1ff-8f8306c66762" xlink:to="loc_us-gaap_RestructuringPlanDomain_8770030b-11fe-4830-99c8-90ceafa3cd9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember_33dc9806-1a6d-4dc6-a392-252a41349c04" xlink:href="avdl-20211231.xsd#avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_8770030b-11fe-4830-99c8-90ceafa3cd9c" xlink:to="loc_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember_33dc9806-1a6d-4dc6-a392-252a41349c04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember_92dcfde2-b0d5-4be9-a522-920e3db17a94" xlink:href="avdl-20211231.xsd#avdl_TwoThousandNineteenCorporateRestructuringObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_8770030b-11fe-4830-99c8-90ceafa3cd9c" xlink:to="loc_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember_92dcfde2-b0d5-4be9-a522-920e3db17a94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_383c34da-4a62-4ed6-91b1-d39f4f7ece74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b7648897-2d67-4288-84aa-a41ee12a13b6" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_383c34da-4a62-4ed6-91b1-d39f4f7ece74" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_383c34da-4a62-4ed6-91b1-d39f4f7ece74_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_383c34da-4a62-4ed6-91b1-d39f4f7ece74" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_383c34da-4a62-4ed6-91b1-d39f4f7ece74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_19dd7fa4-fc84-472d-adef-454aab43ca05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_383c34da-4a62-4ed6-91b1-d39f4f7ece74" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_19dd7fa4-fc84-472d-adef-454aab43ca05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_5aadf034-3cd4-48f3-9b39-85e3f4dbad90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_19dd7fa4-fc84-472d-adef-454aab43ca05" xlink:to="loc_us-gaap_EmployeeSeveranceMember_5aadf034-3cd4-48f3-9b39-85e3f4dbad90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RetirementIndemnityObligationMember_44f061c7-fade-4619-ba9a-46999c9123a2" xlink:href="avdl-20211231.xsd#avdl_RetirementIndemnityObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_19dd7fa4-fc84-472d-adef-454aab43ca05" xlink:to="loc_avdl_RetirementIndemnityObligationMember_44f061c7-fade-4619-ba9a-46999c9123a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_50575c0e-9cfc-4f11-8ab5-5339d0cdb13d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b7648897-2d67-4288-84aa-a41ee12a13b6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_50575c0e-9cfc-4f11-8ab5-5339d0cdb13d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_50575c0e-9cfc-4f11-8ab5-5339d0cdb13d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_50575c0e-9cfc-4f11-8ab5-5339d0cdb13d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_50575c0e-9cfc-4f11-8ab5-5339d0cdb13d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7e8d6eed-fcde-4488-81c4-9b0dec8ef6de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_50575c0e-9cfc-4f11-8ab5-5339d0cdb13d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7e8d6eed-fcde-4488-81c4-9b0dec8ef6de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_85cce7f7-eaf7-4ec8-a0c6-bdb6721a52ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7e8d6eed-fcde-4488-81c4-9b0dec8ef6de" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_85cce7f7-eaf7-4ec8-a0c6-bdb6721a52ca" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#RestructuringCostsSeveranceObligationDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails" xlink:type="extended" id="icf55678a15ae4fdabe3c27ae7aed280e_RestructuringCostsSeveranceObligationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_4e336f76-d88e-4f0a-b1e0-2fe13e937d87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_8423de96-5408-403c-b1fc-500e01b85b50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4e336f76-d88e-4f0a-b1e0-2fe13e937d87" xlink:to="loc_us-gaap_RestructuringReserveRollForward_8423de96-5408-403c-b1fc-500e01b85b50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_debb927e-9180-4611-bd91-de8280a8eab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8423de96-5408-403c-b1fc-500e01b85b50" xlink:to="loc_us-gaap_RestructuringReserve_debb927e-9180-4611-bd91-de8280a8eab9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment_c338498e-ff02-4c41-a02c-dd531492e6f5" xlink:href="avdl-20211231.xsd#avdl_RestructuringChargesBeforeGainLossDuetoCurtailment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8423de96-5408-403c-b1fc-500e01b85b50" xlink:to="loc_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment_c338498e-ff02-4c41-a02c-dd531492e6f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_25d94fe7-ab72-4ff4-9128-5dcbc058fffb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8423de96-5408-403c-b1fc-500e01b85b50" xlink:to="loc_us-gaap_PaymentsForRestructuring_25d94fe7-ab72-4ff4-9128-5dcbc058fffb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment_8a78ce95-6a81-4a72-9378-557f3574f571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8423de96-5408-403c-b1fc-500e01b85b50" xlink:to="loc_us-gaap_RestructuringReserveTranslationAdjustment_8a78ce95-6a81-4a72-9378-557f3574f571" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_327a912a-23d1-4a76-945f-901e87da4216" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6cea4c94-c7e1-45e9-93f9-1b914eed76ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4e336f76-d88e-4f0a-b1e0-2fe13e937d87" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6cea4c94-c7e1-45e9-93f9-1b914eed76ae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_e2d430b8-ae97-4cfb-8322-c99692e685cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6cea4c94-c7e1-45e9-93f9-1b914eed76ae" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_e2d430b8-ae97-4cfb-8322-c99692e685cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_e2d430b8-ae97-4cfb-8322-c99692e685cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_e2d430b8-ae97-4cfb-8322-c99692e685cf" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_e2d430b8-ae97-4cfb-8322-c99692e685cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_30f37fef-fbaa-4d98-87ab-5853dcb01581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_e2d430b8-ae97-4cfb-8322-c99692e685cf" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_30f37fef-fbaa-4d98-87ab-5853dcb01581" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_c8504c03-9ec5-4c38-ae94-3dea199001e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_30f37fef-fbaa-4d98-87ab-5853dcb01581" xlink:to="loc_us-gaap_EmployeeSeveranceMember_c8504c03-9ec5-4c38-ae94-3dea199001e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_df42e681-d72c-4c12-845f-7f871548943e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6cea4c94-c7e1-45e9-93f9-1b914eed76ae" xlink:to="loc_us-gaap_RestructuringPlanAxis_df42e681-d72c-4c12-845f-7f871548943e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_df42e681-d72c-4c12-845f-7f871548943e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_df42e681-d72c-4c12-845f-7f871548943e" xlink:to="loc_us-gaap_RestructuringPlanDomain_df42e681-d72c-4c12-845f-7f871548943e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_9fd0bd4f-0dd4-4c03-91af-213422d34f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_df42e681-d72c-4c12-845f-7f871548943e" xlink:to="loc_us-gaap_RestructuringPlanDomain_9fd0bd4f-0dd4-4c03-91af-213422d34f8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember_6c251e71-e6e5-4037-9573-37a0d20e1d58" xlink:href="avdl-20211231.xsd#avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_9fd0bd4f-0dd4-4c03-91af-213422d34f8c" xlink:to="loc_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember_6c251e71-e6e5-4037-9573-37a0d20e1d58" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#EquityInstrumentsandTransactionsDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails" xlink:type="extended" id="i760a891c926f46708bec5fd0ea5676ff_EquityInstrumentsandTransactionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_4d2aad50-7373-4b20-996b-def403bdaa04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_4d2aad50-7373-4b20-996b-def403bdaa04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_ce43c6a6-fa39-49c1-a424-d315bd817eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_ce43c6a6-fa39-49c1-a424-d315bd817eb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_691b9f70-736a-4061-9458-cc2e2951a3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_CommonStockSharesIssued_691b9f70-736a-4061-9458-cc2e2951a3d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_dc33c1e6-0529-4794-8a07-60e5bdde4932" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_dc33c1e6-0529-4794-8a07-60e5bdde4932" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_58f1cc02-2035-4062-9f0f-1886b243d778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_58f1cc02-2035-4062-9f0f-1886b243d778" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_05c7406c-7de0-45b0-90fc-678f65e179c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_05c7406c-7de0-45b0-90fc-678f65e179c4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_c139462f-f13e-43dc-83d5-dbcb11d4f35f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_PreferredStockSharesIssued_c139462f-f13e-43dc-83d5-dbcb11d4f35f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_722ed398-b02b-4a98-89d9-9bdd8ae7d994" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_722ed398-b02b-4a98-89d9-9bdd8ae7d994" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration_7aa65cd5-3678-4c50-a430-e2c0a0748e85" xlink:href="avdl-20211231.xsd#avdl_MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_avdl_MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration_7aa65cd5-3678-4c50-a430-e2c0a0748e85" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration_030f78b3-203a-4094-b5f2-59cd2d8da40f" xlink:href="avdl-20211231.xsd#avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration_030f78b3-203a-4094-b5f2-59cd2d8da40f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_13a52116-3991-4755-b3ee-688448b987ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_13a52116-3991-4755-b3ee-688448b987ef" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_ec3ef066-b00f-4332-a5d8-7c14165e30db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_ec3ef066-b00f-4332-a5d8-7c14165e30db" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2aa8cb8b-bf88-4760-80aa-2afc7441bf3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2aa8cb8b-bf88-4760-80aa-2afc7441bf3a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_f0d9ac6d-dd2e-4b6e-a6fa-79ac5cebbfea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_f0d9ac6d-dd2e-4b6e-a6fa-79ac5cebbfea" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_ff00b6a8-fc25-4c0a-a3bb-3d8837535180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_ff00b6a8-fc25-4c0a-a3bb-3d8837535180" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b566a1f8-be90-45e1-add6-5a7fe921a061" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b566a1f8-be90-45e1-add6-5a7fe921a061" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_c244418d-207c-4014-8e32-e8590200e08a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_c244418d-207c-4014-8e32-e8590200e08a" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock_1ea199e7-7dbe-44d4-8b59-f234e141cbaf" xlink:href="avdl-20211231.xsd#avdl_MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_avdl_MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock_1ea199e7-7dbe-44d4-8b59-f234e141cbaf" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_46fcd900-d0fd-4b62-a5b5-9e944c7b2616" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_46fcd900-d0fd-4b62-a5b5-9e944c7b2616" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_b33efe9e-0c78-4225-9b1a-fbad2f9b028d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_b33efe9e-0c78-4225-9b1a-fbad2f9b028d" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_00d23f5c-1d5c-41b9-8163-9519805538de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_00d23f5c-1d5c-41b9-8163-9519805538de" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_SaleOfStockConsiderationReceivedOnTransactionGross_950a83df-f3c8-4ee0-a323-eca7d89c05f1" xlink:href="avdl-20211231.xsd#avdl_SaleOfStockConsiderationReceivedOnTransactionGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_avdl_SaleOfStockConsiderationReceivedOnTransactionGross_950a83df-f3c8-4ee0-a323-eca7d89c05f1" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_728db23d-b5fa-4738-8f8b-f90b47481f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_728db23d-b5fa-4738-8f8b-f90b47481f2d" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_ef03f958-9aff-4b1a-a780-7b1a8ed8a3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_ef03f958-9aff-4b1a-a780-7b1a8ed8a3e4" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_48c495da-dba3-41e8-a855-c72c96ea2bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_48c495da-dba3-41e8-a855-c72c96ea2bbd" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_b7a64243-83cb-4e6b-a78a-5c3c9108a553" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_b7a64243-83cb-4e6b-a78a-5c3c9108a553" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d8e8ac8a-5906-4f17-943b-130e80bbc205" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b7a64243-83cb-4e6b-a78a-5c3c9108a553" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d8e8ac8a-5906-4f17-943b-130e80bbc205" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d8e8ac8a-5906-4f17-943b-130e80bbc205_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d8e8ac8a-5906-4f17-943b-130e80bbc205" xlink:to="loc_us-gaap_EquityComponentDomain_d8e8ac8a-5906-4f17-943b-130e80bbc205_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1564ab5b-167c-4ca6-a634-babbdeee1044" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d8e8ac8a-5906-4f17-943b-130e80bbc205" xlink:to="loc_us-gaap_EquityComponentDomain_1564ab5b-167c-4ca6-a634-babbdeee1044" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_a26d6cbd-68d2-43d4-b14b-312633f9ec02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1564ab5b-167c-4ca6-a634-babbdeee1044" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_a26d6cbd-68d2-43d4-b14b-312633f9ec02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_d20b662e-7b08-416f-a100-9dc84fffeaf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1564ab5b-167c-4ca6-a634-babbdeee1044" xlink:to="loc_us-gaap_TreasuryStockMember_d20b662e-7b08-416f-a100-9dc84fffeaf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_38fcfb73-c2d5-44bf-b092-3d0754207154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1564ab5b-167c-4ca6-a634-babbdeee1044" xlink:to="loc_us-gaap_CommonStockMember_38fcfb73-c2d5-44bf-b092-3d0754207154" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_1c234503-18e3-4956-9f57-f03d4f806018" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b7a64243-83cb-4e6b-a78a-5c3c9108a553" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_1c234503-18e3-4956-9f57-f03d4f806018" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1c234503-18e3-4956-9f57-f03d4f806018_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_1c234503-18e3-4956-9f57-f03d4f806018" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1c234503-18e3-4956-9f57-f03d4f806018_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e42ffcce-502b-4492-bcc2-242b1426f223" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_1c234503-18e3-4956-9f57-f03d4f806018" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e42ffcce-502b-4492-bcc2-242b1426f223" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_a2ec29dc-837d-41e5-807a-f120abd04658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e42ffcce-502b-4492-bcc2-242b1426f223" xlink:to="loc_us-gaap_PrivatePlacementMember_a2ec29dc-837d-41e5-807a-f120abd04658" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PublicOfferingMember_061b67b1-d846-43c5-b3b9-8f97c132ab1a" xlink:href="avdl-20211231.xsd#avdl_PublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e42ffcce-502b-4492-bcc2-242b1426f223" xlink:to="loc_avdl_PublicOfferingMember_061b67b1-d846-43c5-b3b9-8f97c132ab1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_74b6e3b8-07e5-424d-9d8d-7d1f67ec14d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b7a64243-83cb-4e6b-a78a-5c3c9108a553" xlink:to="loc_us-gaap_StatementClassOfStockAxis_74b6e3b8-07e5-424d-9d8d-7d1f67ec14d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_74b6e3b8-07e5-424d-9d8d-7d1f67ec14d4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_74b6e3b8-07e5-424d-9d8d-7d1f67ec14d4" xlink:to="loc_us-gaap_ClassOfStockDomain_74b6e3b8-07e5-424d-9d8d-7d1f67ec14d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f525d4c2-ae53-466e-b626-d44bf1fa7217" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_74b6e3b8-07e5-424d-9d8d-7d1f67ec14d4" xlink:to="loc_us-gaap_ClassOfStockDomain_f525d4c2-ae53-466e-b626-d44bf1fa7217" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sic_Z8880_f23e5b1a-5dfa-42e0-a84d-f27a41227123" xlink:href="https://xbrl.sec.gov/sic/2021/sic-2021.xsd#sic_Z8880"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_f525d4c2-ae53-466e-b626-d44bf1fa7217" xlink:to="loc_sic_Z8880_f23e5b1a-5dfa-42e0-a84d-f27a41227123" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_b3c3d2af-ff32-4373-aa72-86ebec2e4095" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_f525d4c2-ae53-466e-b626-d44bf1fa7217" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_b3c3d2af-ff32-4373-aa72-86ebec2e4095" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesMember_835843c5-c421-4878-bb2c-976572653073" xlink:href="avdl-20211231.xsd#avdl_AmericanDepositarySharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_f525d4c2-ae53-466e-b626-d44bf1fa7217" xlink:to="loc_avdl_AmericanDepositarySharesMember_835843c5-c421-4878-bb2c-976572653073" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ShareBasedCompensationStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#ShareBasedCompensationStockbasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/ShareBasedCompensationStockbasedCompensationExpenseDetails" xlink:type="extended" id="i388303475b2c4787bed47af9e18fa9e9_ShareBasedCompensationStockbasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad6134b2-01c6-430c-a448-d6541ee648b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2246750f-9625-4b1e-af86-724fb9ca807f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad6134b2-01c6-430c-a448-d6541ee648b6" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2246750f-9625-4b1e-af86-724fb9ca807f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_396ff8d7-8c64-4f01-bc1a-076fe8add83a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad6134b2-01c6-430c-a448-d6541ee648b6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_396ff8d7-8c64-4f01-bc1a-076fe8add83a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_26eb631d-7d50-4ecc-8931-88e2e2ae287d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_396ff8d7-8c64-4f01-bc1a-076fe8add83a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_26eb631d-7d50-4ecc-8931-88e2e2ae287d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_26eb631d-7d50-4ecc-8931-88e2e2ae287d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_26eb631d-7d50-4ecc-8931-88e2e2ae287d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_26eb631d-7d50-4ecc-8931-88e2e2ae287d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b00c2fc9-c221-44dc-941d-41a96c919915" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_26eb631d-7d50-4ecc-8931-88e2e2ae287d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b00c2fc9-c221-44dc-941d-41a96c919915" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_52ae9bd9-3d8b-4c0d-b7b5-ab2bf9337bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b00c2fc9-c221-44dc-941d-41a96c919915" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_52ae9bd9-3d8b-4c0d-b7b5-ab2bf9337bc8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_37dcd5ca-1089-44ef-b34c-0f781532c730" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b00c2fc9-c221-44dc-941d-41a96c919915" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_37dcd5ca-1089-44ef-b34c-0f781532c730" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_b545def9-97d9-40f2-b72a-7920b2a45fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b00c2fc9-c221-44dc-941d-41a96c919915" xlink:to="loc_us-gaap_RestructuringChargesMember_b545def9-97d9-40f2-b72a-7920b2a45fb8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended" id="ib77b4f06ebc6461c9f01c29787894892_ShareBasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_ed6e1310-0158-40b6-85c1-8788ca9862a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_ed6e1310-0158-40b6-85c1-8788ca9862a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a84c151d-390c-405d-b752-2318beb8b3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a84c151d-390c-405d-b752-2318beb8b3f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_003b6e26-1af2-45d3-8798-1dec1a15e8d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_003b6e26-1af2-45d3-8798-1dec1a15e8d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_5bd267c6-e42a-4c5d-9eae-b73395e23c46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_5bd267c6-e42a-4c5d-9eae-b73395e23c46" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2cb7c335-faeb-482a-963b-1aeb0e44b8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2cb7c335-faeb-482a-963b-1aeb0e44b8a4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7ce2831b-1bee-4cfe-a9f8-9920382ba464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7ce2831b-1bee-4cfe-a9f8-9920382ba464" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_410d929c-33ad-4256-964a-41a8a1a5f38e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_410d929c-33ad-4256-964a-41a8a1a5f38e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_30476116-a398-43a7-b91d-f6cc518e1a90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_30476116-a398-43a7-b91d-f6cc518e1a90" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_47e196f0-5f8f-4932-b3c2-ed6365cb3b67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_47e196f0-5f8f-4932-b3c2-ed6365cb3b67" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_aaff3ee5-9646-46ad-b1b7-96e4b2b72fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_aaff3ee5-9646-46ad-b1b7-96e4b2b72fa4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ef882a51-32ed-496c-9da0-f83bb8632084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ef882a51-32ed-496c-9da0-f83bb8632084" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_2c47a9f2-416b-49b7-8562-0871069e274e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_2c47a9f2-416b-49b7-8562-0871069e274e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_9e1eb3db-2b33-46c4-908d-17c264dc03f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_9e1eb3db-2b33-46c4-908d-17c264dc03f4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_9c3a229a-2236-4031-97a9-2271e8c927af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_9c3a229a-2236-4031-97a9-2271e8c927af" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_0bba5c70-392d-455c-8bea-c7e52e562455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_0bba5c70-392d-455c-8bea-c7e52e562455" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_9728e4a6-f4f5-4889-a20e-f3df975d030a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_9728e4a6-f4f5-4889-a20e-f3df975d030a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_021baf13-cf32-4c6c-ab3e-dcd0a55fffb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_021baf13-cf32-4c6c-ab3e-dcd0a55fffb9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_2d65ce30-43be-40db-9500-e98ab28af0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_021baf13-cf32-4c6c-ab3e-dcd0a55fffb9" xlink:to="loc_us-gaap_VestingAxis_2d65ce30-43be-40db-9500-e98ab28af0bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_2d65ce30-43be-40db-9500-e98ab28af0bc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_2d65ce30-43be-40db-9500-e98ab28af0bc" xlink:to="loc_us-gaap_VestingDomain_2d65ce30-43be-40db-9500-e98ab28af0bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_a83f5081-e485-4fa0-a388-e274730a1b66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_2d65ce30-43be-40db-9500-e98ab28af0bc" xlink:to="loc_us-gaap_VestingDomain_a83f5081-e485-4fa0-a388-e274730a1b66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_6f7ccb23-7125-487c-a2e1-4cd237eb2951" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_a83f5081-e485-4fa0-a388-e274730a1b66" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_6f7ccb23-7125-487c-a2e1-4cd237eb2951" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_b946aff8-2dbf-4972-88e9-541d6d22a234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_a83f5081-e485-4fa0-a388-e274730a1b66" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_b946aff8-2dbf-4972-88e9-541d6d22a234" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_cc46114a-45f3-499a-98b7-3f6857e02a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_a83f5081-e485-4fa0-a388-e274730a1b66" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_cc46114a-45f3-499a-98b7-3f6857e02a8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_SharebasedCompensationAwardTrancheFourMember_24b18bb1-c98a-49d4-a527-64b94de37edd" xlink:href="avdl-20211231.xsd#avdl_SharebasedCompensationAwardTrancheFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_a83f5081-e485-4fa0-a388-e274730a1b66" xlink:to="loc_avdl_SharebasedCompensationAwardTrancheFourMember_24b18bb1-c98a-49d4-a527-64b94de37edd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_VestOneYearFollowingAchievementOfMilestonesMember_a378e45c-16d0-46ea-a96c-2951b1bd496d" xlink:href="avdl-20211231.xsd#avdl_VestOneYearFollowingAchievementOfMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_a83f5081-e485-4fa0-a388-e274730a1b66" xlink:to="loc_avdl_VestOneYearFollowingAchievementOfMilestonesMember_a378e45c-16d0-46ea-a96c-2951b1bd496d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_VestUponTheAchievementOfCertainRegulatoryMilestonesMember_5ea92ed2-70e1-4641-a747-364ed1f5aed4" xlink:href="avdl-20211231.xsd#avdl_VestUponTheAchievementOfCertainRegulatoryMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_a83f5081-e485-4fa0-a388-e274730a1b66" xlink:to="loc_avdl_VestUponTheAchievementOfCertainRegulatoryMilestonesMember_5ea92ed2-70e1-4641-a747-364ed1f5aed4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_VestUponAchievementOfCertainCorporateObjectivesMember_518caac9-c2fb-4841-86be-876023e24514" xlink:href="avdl-20211231.xsd#avdl_VestUponAchievementOfCertainCorporateObjectivesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_a83f5081-e485-4fa0-a388-e274730a1b66" xlink:to="loc_avdl_VestUponAchievementOfCertainCorporateObjectivesMember_518caac9-c2fb-4841-86be-876023e24514" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_VestOneYearFollowingAchievementOfCertainCorporateObjectivesMember_f274cf0a-0ae2-49ab-8d19-301522564711" xlink:href="avdl-20211231.xsd#avdl_VestOneYearFollowingAchievementOfCertainCorporateObjectivesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_a83f5081-e485-4fa0-a388-e274730a1b66" xlink:to="loc_avdl_VestOneYearFollowingAchievementOfCertainCorporateObjectivesMember_f274cf0a-0ae2-49ab-8d19-301522564711" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_VestUponAchievementOfCertainCorporateObjectivesBeingMetAndExceededMember_0479265e-c4c8-4b11-876a-33708ded30ef" xlink:href="avdl-20211231.xsd#avdl_VestUponAchievementOfCertainCorporateObjectivesBeingMetAndExceededMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_a83f5081-e485-4fa0-a388-e274730a1b66" xlink:to="loc_avdl_VestUponAchievementOfCertainCorporateObjectivesBeingMetAndExceededMember_0479265e-c4c8-4b11-876a-33708ded30ef" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_e9e487f1-17b6-40ff-8a97-154b3a1efe26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_021baf13-cf32-4c6c-ab3e-dcd0a55fffb9" xlink:to="loc_us-gaap_PlanNameAxis_e9e487f1-17b6-40ff-8a97-154b3a1efe26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_e9e487f1-17b6-40ff-8a97-154b3a1efe26_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_e9e487f1-17b6-40ff-8a97-154b3a1efe26" xlink:to="loc_us-gaap_PlanNameDomain_e9e487f1-17b6-40ff-8a97-154b3a1efe26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_c0644d44-c60d-4ddd-a419-60b0c18aaffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_e9e487f1-17b6-40ff-8a97-154b3a1efe26" xlink:to="loc_us-gaap_PlanNameDomain_c0644d44-c60d-4ddd-a419-60b0c18aaffc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A2017AvadelEmployeeSharePurchasePlanMember_49c5c53d-d92d-4049-a05e-855823dcf5eb" xlink:href="avdl-20211231.xsd#avdl_A2017AvadelEmployeeSharePurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_c0644d44-c60d-4ddd-a419-60b0c18aaffc" xlink:to="loc_avdl_A2017AvadelEmployeeSharePurchasePlanMember_49c5c53d-d92d-4049-a05e-855823dcf5eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_InducementPlanMember_03e1dd9b-9ead-47c0-99ec-77ddffadcdb0" xlink:href="avdl-20211231.xsd#avdl_InducementPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_c0644d44-c60d-4ddd-a419-60b0c18aaffc" xlink:to="loc_avdl_InducementPlanMember_03e1dd9b-9ead-47c0-99ec-77ddffadcdb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3e05a4eb-c6c7-41b5-b5d7-18bcd9958236" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_021baf13-cf32-4c6c-ab3e-dcd0a55fffb9" xlink:to="loc_us-gaap_AwardTypeAxis_3e05a4eb-c6c7-41b5-b5d7-18bcd9958236" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3e05a4eb-c6c7-41b5-b5d7-18bcd9958236_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_3e05a4eb-c6c7-41b5-b5d7-18bcd9958236" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3e05a4eb-c6c7-41b5-b5d7-18bcd9958236_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9ef3847-9332-4920-8a3c-4ee87954c9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_3e05a4eb-c6c7-41b5-b5d7-18bcd9958236" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9ef3847-9332-4920-8a3c-4ee87954c9b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_b33be09f-d031-4e63-b750-5f400b92655f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9ef3847-9332-4920-8a3c-4ee87954c9b8" xlink:to="loc_us-gaap_RestrictedStockMember_b33be09f-d031-4e63-b750-5f400b92655f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestrictedShareAwardsGrantedFrom20172020Member_5bd3d0b8-f0fd-4012-ac22-72e12c3c09f3" xlink:href="avdl-20211231.xsd#avdl_RestrictedShareAwardsGrantedFrom20172020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedStockMember_b33be09f-d031-4e63-b750-5f400b92655f" xlink:to="loc_avdl_RestrictedShareAwardsGrantedFrom20172020Member_5bd3d0b8-f0fd-4012-ac22-72e12c3c09f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestrictedShareAwardsGrantedToEmployeesMember_0504e549-504c-4178-bac7-ef45d26e83b9" xlink:href="avdl-20211231.xsd#avdl_RestrictedShareAwardsGrantedToEmployeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedStockMember_b33be09f-d031-4e63-b750-5f400b92655f" xlink:to="loc_avdl_RestrictedShareAwardsGrantedToEmployeesMember_0504e549-504c-4178-bac7-ef45d26e83b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestrictedShareAwardsGrantsBeginningIn2018Member_a607baeb-b7af-47da-b44c-c4c56a641092" xlink:href="avdl-20211231.xsd#avdl_RestrictedShareAwardsGrantsBeginningIn2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedStockMember_b33be09f-d031-4e63-b750-5f400b92655f" xlink:to="loc_avdl_RestrictedShareAwardsGrantsBeginningIn2018Member_a607baeb-b7af-47da-b44c-c4c56a641092" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d6671d82-0059-4236-bdca-deee155f3101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9ef3847-9332-4920-8a3c-4ee87954c9b8" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d6671d82-0059-4236-bdca-deee155f3101" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_3200472b-e4c8-42cc-957c-6871df7a5043" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9ef3847-9332-4920-8a3c-4ee87954c9b8" xlink:to="loc_us-gaap_PerformanceSharesMember_3200472b-e4c8-42cc-957c-6871df7a5043" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0cb87438-6eae-4ffa-8005-4f7953e39ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_021baf13-cf32-4c6c-ab3e-dcd0a55fffb9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0cb87438-6eae-4ffa-8005-4f7953e39ac4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0cb87438-6eae-4ffa-8005-4f7953e39ac4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0cb87438-6eae-4ffa-8005-4f7953e39ac4" xlink:to="loc_us-gaap_EquityComponentDomain_0cb87438-6eae-4ffa-8005-4f7953e39ac4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a59db8be-26f8-4e63-b0df-f036b78a5ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0cb87438-6eae-4ffa-8005-4f7953e39ac4" xlink:to="loc_us-gaap_EquityComponentDomain_a59db8be-26f8-4e63-b0df-f036b78a5ba1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6c8844b9-a279-480d-96c1-5bc6d58c795c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a59db8be-26f8-4e63-b0df-f036b78a5ba1" xlink:to="loc_us-gaap_CommonStockMember_6c8844b9-a279-480d-96c1-5bc6d58c795c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_51e4b30e-8a3d-44f7-86cc-52b7d3cf9c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_021baf13-cf32-4c6c-ab3e-dcd0a55fffb9" xlink:to="loc_us-gaap_GranteeStatusAxis_51e4b30e-8a3d-44f7-86cc-52b7d3cf9c5c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_51e4b30e-8a3d-44f7-86cc-52b7d3cf9c5c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GranteeStatusAxis_51e4b30e-8a3d-44f7-86cc-52b7d3cf9c5c" xlink:to="loc_us-gaap_GranteeStatusDomain_51e4b30e-8a3d-44f7-86cc-52b7d3cf9c5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_d1fcc5dd-3586-4fb3-9486-369afb9411d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GranteeStatusAxis_51e4b30e-8a3d-44f7-86cc-52b7d3cf9c5c" xlink:to="loc_us-gaap_GranteeStatusDomain_d1fcc5dd-3586-4fb3-9486-369afb9411d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_a725f63a-6662-4116-842a-90ce3bcdc9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_d1fcc5dd-3586-4fb3-9486-369afb9411d5" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_a725f63a-6662-4116-842a-90ce3bcdc9c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_931794b8-5f82-45c7-a9fc-41d9662237fd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_021baf13-cf32-4c6c-ab3e-dcd0a55fffb9" xlink:to="loc_srt_TitleOfIndividualAxis_931794b8-5f82-45c7-a9fc-41d9662237fd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_931794b8-5f82-45c7-a9fc-41d9662237fd_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_931794b8-5f82-45c7-a9fc-41d9662237fd" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_931794b8-5f82-45c7-a9fc-41d9662237fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a56e4a47-d18b-4787-84fd-891dd6869eed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_931794b8-5f82-45c7-a9fc-41d9662237fd" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a56e4a47-d18b-4787-84fd-891dd6869eed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_504a9412-1ad6-4bdb-a69b-bb9dbb78aa1a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a56e4a47-d18b-4787-84fd-891dd6869eed" xlink:to="loc_srt_DirectorMember_504a9412-1ad6-4bdb-a69b-bb9dbb78aa1a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ShareBasedCompensationFairValueAssumptionsDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#ShareBasedCompensationFairValueAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/ShareBasedCompensationFairValueAssumptionsDetails" xlink:type="extended" id="i51548cf389134969bc7d5a0d67c34156_ShareBasedCompensationFairValueAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fec54133-4fe6-482c-9b8b-79d0950764e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6fadfed2-11d5-43c4-ba06-b6b10c92c439" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fec54133-4fe6-482c-9b8b-79d0950764e6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6fadfed2-11d5-43c4-ba06-b6b10c92c439" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_a4100216-1aa7-46e7-8b24-ee4a997aaee0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fec54133-4fe6-482c-9b8b-79d0950764e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_a4100216-1aa7-46e7-8b24-ee4a997aaee0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_74ced4a4-82d4-4c3c-a7e1-9fcc1a7ecf78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fec54133-4fe6-482c-9b8b-79d0950764e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_74ced4a4-82d4-4c3c-a7e1-9fcc1a7ecf78" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_8cb46e96-7b7a-4430-8729-8f8f89bd241c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fec54133-4fe6-482c-9b8b-79d0950764e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_8cb46e96-7b7a-4430-8729-8f8f89bd241c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5a05894d-dffa-4cbc-b442-5de56499b38a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fec54133-4fe6-482c-9b8b-79d0950764e6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5a05894d-dffa-4cbc-b442-5de56499b38a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_cde413d1-50bd-45d9-a57b-d5fb2e66fb57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5a05894d-dffa-4cbc-b442-5de56499b38a" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_cde413d1-50bd-45d9-a57b-d5fb2e66fb57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_cde413d1-50bd-45d9-a57b-d5fb2e66fb57_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_cde413d1-50bd-45d9-a57b-d5fb2e66fb57" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_cde413d1-50bd-45d9-a57b-d5fb2e66fb57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_d5676d36-c3ce-41e5-932f-667981bee7f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_cde413d1-50bd-45d9-a57b-d5fb2e66fb57" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_d5676d36-c3ce-41e5-932f-667981bee7f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_60672d30-8ce5-4b22-a59c-c57eeb973a44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_d5676d36-c3ce-41e5-932f-667981bee7f7" xlink:to="loc_us-gaap_EmployeeStockOptionMember_60672d30-8ce5-4b22-a59c-c57eeb973a44" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails" xlink:type="extended" id="i5d9fbd9307b44ce1b978d3612d6a1e62_ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3f502545-e8ff-45f0-b88c-ae07ea3d98d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d6dbdb63-4e72-4da7-9472-9ba2a181bb7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3f502545-e8ff-45f0-b88c-ae07ea3d98d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d6dbdb63-4e72-4da7-9472-9ba2a181bb7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0d5ef764-43da-4705-9061-aaed10697bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d6dbdb63-4e72-4da7-9472-9ba2a181bb7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0d5ef764-43da-4705-9061-aaed10697bc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6db8948d-b6ae-4709-aef2-e8c33ec0d4f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d6dbdb63-4e72-4da7-9472-9ba2a181bb7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6db8948d-b6ae-4709-aef2-e8c33ec0d4f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_fe3abbd0-168d-4d64-82ce-da9f047d4ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d6dbdb63-4e72-4da7-9472-9ba2a181bb7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_fe3abbd0-168d-4d64-82ce-da9f047d4ee8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_cdab7abf-fd41-4aaa-b844-58b3b2841fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d6dbdb63-4e72-4da7-9472-9ba2a181bb7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_cdab7abf-fd41-4aaa-b844-58b3b2841fcd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e4fead5d-f698-4db4-9b02-39cad572cc1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4f8177ba-7ad3-4a4b-880e-8d72b3ac9418" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3f502545-e8ff-45f0-b88c-ae07ea3d98d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4f8177ba-7ad3-4a4b-880e-8d72b3ac9418" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b1cb5c1e-2e43-4d70-a182-454e3933b4ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4f8177ba-7ad3-4a4b-880e-8d72b3ac9418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b1cb5c1e-2e43-4d70-a182-454e3933b4ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b256637b-dea5-4fd7-8ab0-b65fbc9447cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4f8177ba-7ad3-4a4b-880e-8d72b3ac9418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b256637b-dea5-4fd7-8ab0-b65fbc9447cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_56ab20fa-2b9d-4239-8cb8-c0660ad770ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4f8177ba-7ad3-4a4b-880e-8d72b3ac9418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_56ab20fa-2b9d-4239-8cb8-c0660ad770ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_160fa6e0-37e1-4059-988b-2199afc06289" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4f8177ba-7ad3-4a4b-880e-8d72b3ac9418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_160fa6e0-37e1-4059-988b-2199afc06289" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c397aa5e-8847-43bf-bca3-440df72e2250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_88f68449-4a1a-44ff-add2-83b9180292ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3f502545-e8ff-45f0-b88c-ae07ea3d98d8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_88f68449-4a1a-44ff-add2-83b9180292ff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_15395463-769e-4cb0-a10a-82250b290c29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_88f68449-4a1a-44ff-add2-83b9180292ff" xlink:to="loc_us-gaap_AwardTypeAxis_15395463-769e-4cb0-a10a-82250b290c29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_15395463-769e-4cb0-a10a-82250b290c29_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_15395463-769e-4cb0-a10a-82250b290c29" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_15395463-769e-4cb0-a10a-82250b290c29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b694360c-0a5e-455f-82ac-57a573c0ba2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_15395463-769e-4cb0-a10a-82250b290c29" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b694360c-0a5e-455f-82ac-57a573c0ba2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FreeShareAwardMember_7c9721ce-ceb5-4d2e-8d26-2c32b9da2c9f" xlink:href="avdl-20211231.xsd#avdl_FreeShareAwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b694360c-0a5e-455f-82ac-57a573c0ba2a" xlink:to="loc_avdl_FreeShareAwardMember_7c9721ce-ceb5-4d2e-8d26-2c32b9da2c9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_22bc3524-8c6e-466c-a972-72f4ec81dd26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b694360c-0a5e-455f-82ac-57a573c0ba2a" xlink:to="loc_us-gaap_PerformanceSharesMember_22bc3524-8c6e-466c-a972-72f4ec81dd26" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ComprehensiveLossDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#ComprehensiveLossDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/ComprehensiveLossDetails" xlink:type="extended" id="ic2031edb0a9d4dd38538202db9132e0c_ComprehensiveLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7463f7ad-47cc-4731-a4d3-56636509c9d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0d81aa86-415d-4e29-b5fe-40a61c16df40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7463f7ad-47cc-4731-a4d3-56636509c9d4" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0d81aa86-415d-4e29-b5fe-40a61c16df40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_fca896b7-51d7-479d-9925-bae5ff90c7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0d81aa86-415d-4e29-b5fe-40a61c16df40" xlink:to="loc_us-gaap_StockholdersEquity_fca896b7-51d7-479d-9925-bae5ff90c7f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_1908c2c2-7c82-4114-a0f3-d1f231b2cb8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0d81aa86-415d-4e29-b5fe-40a61c16df40" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_1908c2c2-7c82-4114-a0f3-d1f231b2cb8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_99eb492a-6678-4e17-bd2e-46d77020871f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_040a923e-541a-4c1b-a1f8-480d7f65abf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7463f7ad-47cc-4731-a4d3-56636509c9d4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_040a923e-541a-4c1b-a1f8-480d7f65abf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_fa1e08a4-7ae5-45ed-a4bc-410bb32ae5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7463f7ad-47cc-4731-a4d3-56636509c9d4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_fa1e08a4-7ae5-45ed-a4bc-410bb32ae5d6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9df02b9f-757d-42f3-8e6c-2c3f5ce57334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_fa1e08a4-7ae5-45ed-a4bc-410bb32ae5d6" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9df02b9f-757d-42f3-8e6c-2c3f5ce57334" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9df02b9f-757d-42f3-8e6c-2c3f5ce57334_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9df02b9f-757d-42f3-8e6c-2c3f5ce57334" xlink:to="loc_us-gaap_EquityComponentDomain_9df02b9f-757d-42f3-8e6c-2c3f5ce57334_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b87588e0-d365-48ec-8b9d-f24a053ba40d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9df02b9f-757d-42f3-8e6c-2c3f5ce57334" xlink:to="loc_us-gaap_EquityComponentDomain_b87588e0-d365-48ec-8b9d-f24a053ba40d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_a5043a00-31e9-4340-93e1-fd8fb773c165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b87588e0-d365-48ec-8b9d-f24a053ba40d" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_a5043a00-31e9-4340-93e1-fd8fb773c165" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_d6ffc616-a92e-4357-8ceb-0835b6650cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b87588e0-d365-48ec-8b9d-f24a053ba40d" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_d6ffc616-a92e-4357-8ceb-0835b6650cdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ab1294dd-f72c-45b3-8151-3bdbcb620343" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b87588e0-d365-48ec-8b9d-f24a053ba40d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ab1294dd-f72c-45b3-8151-3bdbcb620343" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebyProductDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#CompanyOperationsbyProductCustomerandGeographicAreaRevenuebyProductDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebyProductDetails" xlink:type="extended" id="ia355592f72e049e3bc792b76fa0e9cc1_CompanyOperationsbyProductCustomerandGeographicAreaRevenuebyProductDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_461f3a10-1606-4ab6-8f9f-cba7612a6a66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c4da0816-6556-4661-b347-487b348cbc04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_461f3a10-1606-4ab6-8f9f-cba7612a6a66" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c4da0816-6556-4661-b347-487b348cbc04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d89bc54b-33ad-4e03-887f-27242a0e47b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_461f3a10-1606-4ab6-8f9f-cba7612a6a66" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d89bc54b-33ad-4e03-887f-27242a0e47b4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_cedb9534-3c13-4257-95f7-e404c6266a06" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d89bc54b-33ad-4e03-887f-27242a0e47b4" xlink:to="loc_srt_ProductOrServiceAxis_cedb9534-3c13-4257-95f7-e404c6266a06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_cedb9534-3c13-4257-95f7-e404c6266a06_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_cedb9534-3c13-4257-95f7-e404c6266a06" xlink:to="loc_srt_ProductsAndServicesDomain_cedb9534-3c13-4257-95f7-e404c6266a06_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7638fe43-6df6-47c5-b82b-9a36c4942a54" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_cedb9534-3c13-4257-95f7-e404c6266a06" xlink:to="loc_srt_ProductsAndServicesDomain_7638fe43-6df6-47c5-b82b-9a36c4942a54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_BloxiverzMember_5de34f33-4b2d-409d-b3b7-6439daa4872a" xlink:href="avdl-20211231.xsd#avdl_BloxiverzMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7638fe43-6df6-47c5-b82b-9a36c4942a54" xlink:to="loc_avdl_BloxiverzMember_5de34f33-4b2d-409d-b3b7-6439daa4872a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_VazculepMember_8186be2f-d1e7-4863-9bf2-a1f1bf198cd0" xlink:href="avdl-20211231.xsd#avdl_VazculepMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7638fe43-6df6-47c5-b82b-9a36c4942a54" xlink:to="loc_avdl_VazculepMember_8186be2f-d1e7-4863-9bf2-a1f1bf198cd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AkovazMember_ea001a46-dd42-4a2e-86a1-21b3bba83f1c" xlink:href="avdl-20211231.xsd#avdl_AkovazMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7638fe43-6df6-47c5-b82b-9a36c4942a54" xlink:to="loc_avdl_AkovazMember_ea001a46-dd42-4a2e-86a1-21b3bba83f1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherProductsMember_7f38983c-3f81-4e74-b03b-e575afeeff88" xlink:href="avdl-20211231.xsd#avdl_OtherProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7638fe43-6df6-47c5-b82b-9a36c4942a54" xlink:to="loc_avdl_OtherProductsMember_7f38983c-3f81-4e74-b03b-e575afeeff88" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebySignificantCustomerDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#CompanyOperationsbyProductCustomerandGeographicAreaRevenuebySignificantCustomerDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebySignificantCustomerDetails" xlink:type="extended" id="if7a790f684f14f93b21959a4dc7df324_CompanyOperationsbyProductCustomerandGeographicAreaRevenuebySignificantCustomerDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_e0da23db-c333-466b-85b1-3d23ccf406a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c04f0a61-cc3e-47f5-b81f-94dfe67faf6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e0da23db-c333-466b-85b1-3d23ccf406a5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c04f0a61-cc3e-47f5-b81f-94dfe67faf6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2cfbfe58-4d05-4a3c-82cc-38674bfeb417" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e0da23db-c333-466b-85b1-3d23ccf406a5" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2cfbfe58-4d05-4a3c-82cc-38674bfeb417" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_c6a1527a-b261-4dd7-a4d9-0f0cdb4b554c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2cfbfe58-4d05-4a3c-82cc-38674bfeb417" xlink:to="loc_srt_MajorCustomersAxis_c6a1527a-b261-4dd7-a4d9-0f0cdb4b554c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_c6a1527a-b261-4dd7-a4d9-0f0cdb4b554c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_c6a1527a-b261-4dd7-a4d9-0f0cdb4b554c" xlink:to="loc_srt_NameOfMajorCustomerDomain_c6a1527a-b261-4dd7-a4d9-0f0cdb4b554c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_79b31894-f945-4015-8dff-639b7f5dc96f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_c6a1527a-b261-4dd7-a4d9-0f0cdb4b554c" xlink:to="loc_srt_NameOfMajorCustomerDomain_79b31894-f945-4015-8dff-639b7f5dc96f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CustomerMember_addae4f1-b999-495f-896e-22e12011e083" xlink:href="avdl-20211231.xsd#avdl_CustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_79b31894-f945-4015-8dff-639b7f5dc96f" xlink:to="loc_avdl_CustomerMember_addae4f1-b999-495f-896e-22e12011e083" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CustomerBMember_96f7443d-e0bf-430f-ad15-07afef69f991" xlink:href="avdl-20211231.xsd#avdl_CustomerBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_79b31894-f945-4015-8dff-639b7f5dc96f" xlink:to="loc_avdl_CustomerBMember_96f7443d-e0bf-430f-ad15-07afef69f991" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CustomerCMember_6596d7a7-7964-43f4-98ca-c02018e293c5" xlink:href="avdl-20211231.xsd#avdl_CustomerCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_79b31894-f945-4015-8dff-639b7f5dc96f" xlink:to="loc_avdl_CustomerCMember_6596d7a7-7964-43f4-98ca-c02018e293c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CustomerDMember_1efa4778-2864-4908-aea0-c393df815681" xlink:href="avdl-20211231.xsd#avdl_CustomerDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_79b31894-f945-4015-8dff-639b7f5dc96f" xlink:to="loc_avdl_CustomerDMember_1efa4778-2864-4908-aea0-c393df815681" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherCustomersMember_cb22308b-e29f-408d-8c55-b6049d7fc0b6" xlink:href="avdl-20211231.xsd#avdl_OtherCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_79b31894-f945-4015-8dff-639b7f5dc96f" xlink:to="loc_avdl_OtherCustomersMember_cb22308b-e29f-408d-8c55-b6049d7fc0b6" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaDatabyGeographicRegionDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#CompanyOperationsbyProductCustomerandGeographicAreaDatabyGeographicRegionDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaDatabyGeographicRegionDetails" xlink:type="extended" id="i6c76cc1d1fef4ba2b4e2a82e4069aae9_CompanyOperationsbyProductCustomerandGeographicAreaDatabyGeographicRegionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_210268c9-ce19-467d-832b-9699f7c662a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicAreasLongLivedAssetsAbstract_e075efbf-0368-4b3c-99a4-bae93fccb555" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicAreasLongLivedAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_210268c9-ce19-467d-832b-9699f7c662a6" xlink:to="loc_us-gaap_GeographicAreasLongLivedAssetsAbstract_e075efbf-0368-4b3c-99a4-bae93fccb555" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_31b4ea9c-f764-45c9-bb67-eb9ddd0af492" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicAreasLongLivedAssetsAbstract_e075efbf-0368-4b3c-99a4-bae93fccb555" xlink:to="loc_us-gaap_NoncurrentAssets_31b4ea9c-f764-45c9-bb67-eb9ddd0af492" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_73aba17b-5a66-4506-bd75-274392638231" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_210268c9-ce19-467d-832b-9699f7c662a6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_73aba17b-5a66-4506-bd75-274392638231" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_34f97739-52ca-4ee6-9e8f-e9cafeec732d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_73aba17b-5a66-4506-bd75-274392638231" xlink:to="loc_srt_StatementGeographicalAxis_34f97739-52ca-4ee6-9e8f-e9cafeec732d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_34f97739-52ca-4ee6-9e8f-e9cafeec732d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_34f97739-52ca-4ee6-9e8f-e9cafeec732d" xlink:to="loc_srt_SegmentGeographicalDomain_34f97739-52ca-4ee6-9e8f-e9cafeec732d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_13c49693-98b4-47f7-8845-8f6a208849fa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_34f97739-52ca-4ee6-9e8f-e9cafeec732d" xlink:to="loc_srt_SegmentGeographicalDomain_13c49693-98b4-47f7-8845-8f6a208849fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_7029177f-a8e7-47e8-945e-92d6534a777a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_13c49693-98b4-47f7-8845-8f6a208849fa" xlink:to="loc_country_US_7029177f-a8e7-47e8-945e-92d6534a777a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_00570f11-c135-49c1-8961-8aadee30f1fc" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_13c49693-98b4-47f7-8845-8f6a208849fa" xlink:to="loc_country_FR_00570f11-c135-49c1-8961-8aadee30f1fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_15192a9f-ac4d-49ad-90ec-07b287614f9b" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_13c49693-98b4-47f7-8845-8f6a208849fa" xlink:to="loc_country_IE_15192a9f-ac4d-49ad-90ec-07b287614f9b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/SubsequentEventsDetails" xlink:type="extended" id="if2efccde3c0f4f2e90f57964fcd3696b_SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_256c3cb6-8002-46e1-8f3b-35a6522d262c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_479e6402-d839-47c4-81d0-3128f27c9f89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_256c3cb6-8002-46e1-8f3b-35a6522d262c" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_479e6402-d839-47c4-81d0-3128f27c9f89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_f541bf58-6f94-4eb7-88d6-a85a89003fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_256c3cb6-8002-46e1-8f3b-35a6522d262c" xlink:to="loc_us-gaap_SubsequentEventTable_f541bf58-6f94-4eb7-88d6-a85a89003fd7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5fe1cd98-fe92-40e1-bcbd-611035fd2adb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_f541bf58-6f94-4eb7-88d6-a85a89003fd7" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5fe1cd98-fe92-40e1-bcbd-611035fd2adb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5fe1cd98-fe92-40e1-bcbd-611035fd2adb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5fe1cd98-fe92-40e1-bcbd-611035fd2adb" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5fe1cd98-fe92-40e1-bcbd-611035fd2adb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_22dc7d09-ec3b-4023-b707-3db403f6d3bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5fe1cd98-fe92-40e1-bcbd-611035fd2adb" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_22dc7d09-ec3b-4023-b707-3db403f6d3bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e24175a7-b92b-40ea-b40a-9a9d4fd8c492" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_22dc7d09-ec3b-4023-b707-3db403f6d3bf" xlink:to="loc_us-gaap_SubsequentEventMember_e24175a7-b92b-40ea-b40a-9a9d4fd8c492" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c68f8185-9ac6-40fe-9ed5-28539de19fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_f541bf58-6f94-4eb7-88d6-a85a89003fd7" xlink:to="loc_us-gaap_DebtInstrumentAxis_c68f8185-9ac6-40fe-9ed5-28539de19fc8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c68f8185-9ac6-40fe-9ed5-28539de19fc8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c68f8185-9ac6-40fe-9ed5-28539de19fc8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c68f8185-9ac6-40fe-9ed5-28539de19fc8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_da029098-30b6-4bb1-b882-026bb6c4ab2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c68f8185-9ac6-40fe-9ed5-28539de19fc8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_da029098-30b6-4bb1-b882-026bb6c4ab2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_d75913e5-0a7b-4aab-9a0c-c31d3b9e19e0" xlink:href="avdl-20211231.xsd#avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_da029098-30b6-4bb1-b882-026bb6c4ab2a" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_d75913e5-0a7b-4aab-9a0c-c31d3b9e19e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_f554b27a-7d51-48e1-9c1a-df9d6fc55b74" xlink:href="avdl-20211231.xsd#avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_da029098-30b6-4bb1-b882-026bb6c4ab2a" xlink:to="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_f554b27a-7d51-48e1-9c1a-df9d6fc55b74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ecc742cd-e665-434a-80bc-a447a76ad2a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_f541bf58-6f94-4eb7-88d6-a85a89003fd7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ecc742cd-e665-434a-80bc-a447a76ad2a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ecc742cd-e665-434a-80bc-a447a76ad2a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ecc742cd-e665-434a-80bc-a447a76ad2a0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ecc742cd-e665-434a-80bc-a447a76ad2a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_39190dfa-e97d-4e46-84e3-20aa6f90ca00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ecc742cd-e665-434a-80bc-a447a76ad2a0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_39190dfa-e97d-4e46-84e3-20aa6f90ca00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_ec5c371a-ff18-41f4-90e9-a02a68a3eded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_39190dfa-e97d-4e46-84e3-20aa6f90ca00" xlink:to="loc_us-gaap_ConvertibleDebtMember_ec5c371a-ff18-41f4-90e9-a02a68a3eded" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>avdl-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9768bc4a-d41b-4cde-8dab-4f8611fcf569,g:2327e6e7-350d-456e-9b47-ccea1e6c574d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_20a4eadb-c9a5-4229-8152-9def38ee09e3_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosures of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_bcac7cfc-0e9d-4058-9e40-de01fcfac6c8_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_c765ff31-4d2d-46b3-963e-0599d86ca4b6_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on marketable securities, net</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_822ff921-5d9d-4f6b-b997-098ea424e6f1_negatedLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_c988d832-a1a8-411b-9e6d-369ffe89c1f9_terseLabel_en-US" xlink:label="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50% Exchangeable Senior Notes Due October 2, 2023</link:label>
    <link:label id="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_label_en-US" xlink:label="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50 Percent Exchangeable Senior Notes Due October 2 2023 [Member]</link:label>
    <link:label id="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_documentation_en-US" xlink:label="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50 Percent Exchangeable Senior Notes Due October 2 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member" xlink:href="avdl-20211231.xsd#avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member" xlink:to="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_02f71535-443c-425d-927c-39b6b64f9e8b_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4618aee9-7e71-440e-8317-e2d65748d22f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_a6ac082f-9487-4747-9985-cfe9028f8550_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. - State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0f298e47-8b62-447f-81ff-2ca8efe372ba_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_108b28df-960f-40e3-b3bc-c92a8bb991c1_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_60030811-9f2c-4ca6-9000-b10529487fb6_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_54d80810-9e20-4917-b5c0-a1a797bde36b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_4d8fe6a2-ae9f-4146-87e4-e70ecfad459b_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_5acd2d9e-20bc-4840-b6fd-cb742899ced7_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AmericanDepositorySharesConversionRatio_f3390f7f-6f7a-4d86-89b4-255bed83ae5f_terseLabel_en-US" xlink:label="lab_avdl_AmericanDepositorySharesConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ADSs, conversion ratio</link:label>
    <link:label id="lab_avdl_AmericanDepositorySharesConversionRatio_label_en-US" xlink:label="lab_avdl_AmericanDepositorySharesConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depository Shares, Conversion Ratio</link:label>
    <link:label id="lab_avdl_AmericanDepositorySharesConversionRatio_documentation_en-US" xlink:label="lab_avdl_AmericanDepositorySharesConversionRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depository Shares, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositorySharesConversionRatio" xlink:href="avdl-20211231.xsd#avdl_AmericanDepositorySharesConversionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AmericanDepositorySharesConversionRatio" xlink:to="lab_avdl_AmericanDepositorySharesConversionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_1fe91da8-d696-4e6d-8ab7-6176a91215b6_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_933430aa-d82c-4750-819b-06d92385d7ff_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_43200955-bc57-4eb1-9a97-56078d275aa7_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_0f755dba-696b-467a-ab8f-9a225000419e_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities_f4cb891c-83eb-4ab2-8975-ab0c139bd5c3_terseLabel_en-US" xlink:label="lab_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax liabilities and other</link:label>
    <link:label id="lab_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Liabilities And Other Noncurrent Liabilities</link:label>
    <link:label id="lab_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities_documentation_en-US" xlink:label="lab_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Liabilities And Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities" xlink:href="avdl-20211231.xsd#avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities" xlink:to="lab_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_3215ea8c-2446-4bbb-9d16-35acf80a3ca4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Prepaid and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_b7d2903e-a2a0-4e78-9937-6436334cf826_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_085fa9e0-fe1c-435a-b0f4-f3ee2e3fd3db_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate consideration</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_01c6a1d1-fd76-4991-a1e1-883bb7de3eed_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_78ac11d7-8b8b-4a5c-9b75-b2c05791e98b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from disposal of property and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_583ea255-d168-45c9-ae9b-4302a1487236_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_34cb4a1b-0049-4fb2-8d29-4f2c013cb2af_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarnings_9755e1d1-1555-4cab-8958-d80da03728fd_terseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unremitted earnings</link:label>
    <link:label id="lab_us-gaap_UndistributedEarnings_label_en-US" xlink:label="lab_us-gaap_UndistributedEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarnings" xlink:to="lab_us-gaap_UndistributedEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_f04f137d-9936-4df9-8414-ee9e5d080869_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_e52c79fe-f2f8-44ce-acda-36ac7b82eb01_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_5e96440c-8d46-4078-88d2-00e7855b5e12_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_3c696b1e-6588-4806-8cbd-fd55067f59bc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, weighted average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_95099db3-f3c2-4455-bfd6-87e4d181dca5_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_0473936a-eb55-4bba-8a38-0fa1c40e3342_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_0f23ce2b-93fe-47e1-9df8-6863466a03ce_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6f57d5e0-f89a-4df3-a670-81fa93360f43_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a7e31b9c-65d6-41b0-8e6b-6758dc59f7ab_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_64eb4398-2d57-4f92-aacc-4c6aa2f1739d_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_029f8786-7f1a-4889-aa94-1bb6b47c1d85_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for issuance under ESPP</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_ShortTermNoteReceivable_f467063c-66f7-4f2a-9737-3dcb1941525d_terseLabel_en-US" xlink:label="lab_avdl_ShortTermNoteReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable from Exela (see Note 4)</link:label>
    <link:label id="lab_avdl_ShortTermNoteReceivable_label_en-US" xlink:label="lab_avdl_ShortTermNoteReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term Note Receivable</link:label>
    <link:label id="lab_avdl_ShortTermNoteReceivable_documentation_en-US" xlink:label="lab_avdl_ShortTermNoteReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term Note Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ShortTermNoteReceivable" xlink:href="avdl-20211231.xsd#avdl_ShortTermNoteReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_ShortTermNoteReceivable" xlink:to="lab_avdl_ShortTermNoteReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_edf345a7-4592-4c0b-9a6e-0ca0c83e76dd_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_aca86e0f-8d71-4464-981f-6d029ee40f02_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_835e92be-6fcc-45de-a033-d0811fab17be_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuarantyLiabilities_ec602cce-8159-45d9-95af-da9845b6f263_terseLabel_en-US" xlink:label="lab_us-gaap_GuarantyLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee to Deerfield</link:label>
    <link:label id="lab_us-gaap_GuarantyLiabilities_label_en-US" xlink:label="lab_us-gaap_GuarantyLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guaranty Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuarantyLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuarantyLiabilities" xlink:to="lab_us-gaap_GuarantyLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a94129a1-c571-4e44-bee5-9a30370d3b27_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_5eefb6b1-a184-44f5-b333-d1a39515c056_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_31a7ac56-395a-4a00-8bbd-8fdbabae9aff_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_aa7d627c-b589-42f4-a4a2-513266bab463_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on disposition of assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_72dd2563-6907-427d-8f89-c49f63f1eb25_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposition of the Hospital Products</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_b62e91b0-40fc-4b82-84c3-728ef557b145_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_0c0a2ebf-a6d6-43f8-b74a-e60431f7eaa1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_4f7a1ce4-dd0f-4bb6-9b78-1c43ee4b089f_periodStartLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party payable, beginning balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_17de4bde-7c36-4f91-941f-540ef4823b27_periodEndLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party payable, ending balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Liabilities Arising from Contingencies, Amount Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:to="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_SharebasedCompensationAwardTrancheFourMember_585919d5-2834-4fff-8869-44d808cfc8cc_terseLabel_en-US" xlink:label="lab_avdl_SharebasedCompensationAwardTrancheFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1/3 vesting at third anniversary of grant date</link:label>
    <link:label id="lab_avdl_SharebasedCompensationAwardTrancheFourMember_label_en-US" xlink:label="lab_avdl_SharebasedCompensationAwardTrancheFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Award, Tranche Four [Member]</link:label>
    <link:label id="lab_avdl_SharebasedCompensationAwardTrancheFourMember_documentation_en-US" xlink:label="lab_avdl_SharebasedCompensationAwardTrancheFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Award, Tranche Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_SharebasedCompensationAwardTrancheFourMember" xlink:href="avdl-20211231.xsd#avdl_SharebasedCompensationAwardTrancheFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_SharebasedCompensationAwardTrancheFourMember" xlink:to="lab_avdl_SharebasedCompensationAwardTrancheFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_d9e555bb-3cce-43e8-bb1f-60ca6c72a84d_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset amortization</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember_0a9347e8-f957-4e2f-96fe-551dead0c6a6_terseLabel_en-US" xlink:label="lab_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 French Restructuring Obligation</link:label>
    <link:label id="lab_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember_label_en-US" xlink:label="lab_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Nineteen Corporate French Restructuring Obligation [Member]</link:label>
    <link:label id="lab_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember_documentation_en-US" xlink:label="lab_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Nineteen Corporate French Restructuring Obligation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember" xlink:href="avdl-20211231.xsd#avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember" xlink:to="lab_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_494d484d-af03-429f-b2b8-866650adb07c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_9ca47fee-732a-442f-9a56-678b1d235f1e_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_02b82b66-142a-4a1c-99dc-97252e561089_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets (see Note 13)</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e7d7a530-bab1-4e0d-a5cb-8e9b5e73d22b_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_ffc53a89-1836-4382-9df6-b8e9dc4cab7b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, weighted average discount rate, percent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_3314a0bf-4e01-4eb7-92b2-27fe049ac23d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction fees</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_94ff7878-7427-45b1-9112-71fc937ef1e6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less transaction fees</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Costs of Goods Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_52377484-6ef9-444a-ba94-c28b7b5571a2_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_f227058b-3575-43e4-a030-79f6d6d40c3d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_c19148f2-00b5-416a-91bf-ebf21371f582_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_46b3602f-1465-4cc6-b5b3-ee48a9bef95c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrivatePlacementMember_d216f97e-a67b-41b2-9297-8d56b0580ae7_terseLabel_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Purchase Agreement</link:label>
    <link:label id="lab_us-gaap_PrivatePlacementMember_label_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Placement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivatePlacementMember" xlink:to="lab_us-gaap_PrivatePlacementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8c7749d0-eba8-44f4-9d75-3690ef230e71_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant fair value of free share awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7efdb263-bc70-4862-b76b-a82369f580b9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_8886d5d7-23f7-45d8-9deb-ae2795e9b711_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_548f28c4-9f8f-4fc7-9307-eb0f6109b7ea_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Relationship to Entity [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_cf47f927-f88d-41eb-ab58-09ce7d7c3b4c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net other comprehensive (loss) income, net of income tax benefit (expense) of $214, $(202), $(43), respectively</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d1ba243b-3fad-4f8f-8b6e-03d297c7a27a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_cf388106-6fce-4548-9315-581cbe2035f3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d52f43ed-99e8-4976-be68-0bb4d3c6313b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_VestUponAchievementOfCertainCorporateObjectivesBeingMetAndExceededMember_c68529b9-1c24-4128-8fb7-633fb2e919c8_terseLabel_en-US" xlink:label="lab_avdl_VestUponAchievementOfCertainCorporateObjectivesBeingMetAndExceededMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vest Upon Achievement Of Certain Corporate Objectives Being Met And Exceeded</link:label>
    <link:label id="lab_avdl_VestUponAchievementOfCertainCorporateObjectivesBeingMetAndExceededMember_label_en-US" xlink:label="lab_avdl_VestUponAchievementOfCertainCorporateObjectivesBeingMetAndExceededMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vest Upon Achievement Of Certain Corporate Objectives Being Met And Exceeded [Member]</link:label>
    <link:label id="lab_avdl_VestUponAchievementOfCertainCorporateObjectivesBeingMetAndExceededMember_documentation_en-US" xlink:label="lab_avdl_VestUponAchievementOfCertainCorporateObjectivesBeingMetAndExceededMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vest Upon Achievement Of Certain Corporate Objectives Being Met And Exceeded</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_VestUponAchievementOfCertainCorporateObjectivesBeingMetAndExceededMember" xlink:href="avdl-20211231.xsd#avdl_VestUponAchievementOfCertainCorporateObjectivesBeingMetAndExceededMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_VestUponAchievementOfCertainCorporateObjectivesBeingMetAndExceededMember" xlink:to="lab_avdl_VestUponAchievementOfCertainCorporateObjectivesBeingMetAndExceededMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_b4fbb213-7025-470b-b314-9bab91c94c3b_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_b4405e79-964e-410e-905e-bd0d60a4eee9_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_36368d9c-009f-436a-abf2-4ac6fd51683c_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_fabaffac-1471-44f4-b806-c261c47f57c9_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_BloxiverzMember_fbbe718e-7dde-42db-b43f-9d79059fcf78_terseLabel_en-US" xlink:label="lab_avdl_BloxiverzMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bloxiverz</link:label>
    <link:label id="lab_avdl_BloxiverzMember_label_en-US" xlink:label="lab_avdl_BloxiverzMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bloxiverz [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_BloxiverzMember" xlink:href="avdl-20211231.xsd#avdl_BloxiverzMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_BloxiverzMember" xlink:to="lab_avdl_BloxiverzMember" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_VestOneYearFollowingAchievementOfCertainCorporateObjectivesMember_23bfa8e3-c3dc-436f-ab01-03d55ee5cda7_terseLabel_en-US" xlink:label="lab_avdl_VestOneYearFollowingAchievementOfCertainCorporateObjectivesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vest One Year Following Achievement Of Certain Corporate Objectives</link:label>
    <link:label id="lab_avdl_VestOneYearFollowingAchievementOfCertainCorporateObjectivesMember_label_en-US" xlink:label="lab_avdl_VestOneYearFollowingAchievementOfCertainCorporateObjectivesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vest One Year Following Achievement Of Certain Corporate Objectives [Member]</link:label>
    <link:label id="lab_avdl_VestOneYearFollowingAchievementOfCertainCorporateObjectivesMember_documentation_en-US" xlink:label="lab_avdl_VestOneYearFollowingAchievementOfCertainCorporateObjectivesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vest One Year Following Achievement Of Certain Corporate Objectives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_VestOneYearFollowingAchievementOfCertainCorporateObjectivesMember" xlink:href="avdl-20211231.xsd#avdl_VestOneYearFollowingAchievementOfCertainCorporateObjectivesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_VestOneYearFollowingAchievementOfCertainCorporateObjectivesMember" xlink:to="lab_avdl_VestOneYearFollowingAchievementOfCertainCorporateObjectivesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_LongTermContingentConsideraionPayableTextBlock_4dab26c7-7819-48c1-8963-ecb205aefa21_terseLabel_en-US" xlink:label="lab_avdl_LongTermContingentConsideraionPayableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Payable</link:label>
    <link:label id="lab_avdl_LongTermContingentConsideraionPayableTextBlock_label_en-US" xlink:label="lab_avdl_LongTermContingentConsideraionPayableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Contingent Consideraion Payable [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_LongTermContingentConsideraionPayableTextBlock" xlink:href="avdl-20211231.xsd#avdl_LongTermContingentConsideraionPayableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_LongTermContingentConsideraionPayableTextBlock" xlink:to="lab_avdl_LongTermContingentConsideraionPayableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_1f6b5922-99e3-4bce-aa2f-55c6e22477e5_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_96e0d742-c22e-47bb-974c-3a94d949b6e3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_ContractualObligationAnnualAmount_169677a7-2716-47b3-b059-533f954d4740_terseLabel_en-US" xlink:label="lab_avdl_ContractualObligationAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual obligation, annual amount</link:label>
    <link:label id="lab_avdl_ContractualObligationAnnualAmount_label_en-US" xlink:label="lab_avdl_ContractualObligationAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, Annual Amount</link:label>
    <link:label id="lab_avdl_ContractualObligationAnnualAmount_documentation_en-US" xlink:label="lab_avdl_ContractualObligationAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ContractualObligationAnnualAmount" xlink:href="avdl-20211231.xsd#avdl_ContractualObligationAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_ContractualObligationAnnualAmount" xlink:to="lab_avdl_ContractualObligationAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c9cadd4a-1f3b-43ad-bd1d-151d2e56a146_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_9fa0350b-d6e8-40e8-894d-f7d3edc5874d_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_01df3234-cca3-4354-9773-12f5b24c9444_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, nominal value of $0.01 per share; 50,000 shares authorized; 488 issued and outstanding at December 31, 2021 and 2020, respectively</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_6d182887-86f4-4931-b385-ea51ce2b3c69_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_6edfed79-8a96-433b-a1f2-3517bb934d22_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of ordinary shares</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_898a3f3f-6356-4fc0-9b5d-8bf0d2c4623d_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9784c55a-b4a5-49c7-8664-a30162596f50_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_06227a71-dd9f-49a7-a17d-3755ece0e51d_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_ff9560bb-4a62-4796-85c7-fd0764f0db18_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued, price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_0396d0ee-131c-40a9-8993-54f58e04511d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consecutive trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_f9e9610c-2df1-4ca0-87d3-6195286548f3_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_0085f7bd-1b1a-424b-a8bc-c0327d5f6a23_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c02c013b-75f9-47ec-bfd0-80a019448a26_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_d3ddc8a7-b618-46d8-970d-e877fe748cfd_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expenses</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_3a98b3f1-cc95-41f8-878a-69a466118fd2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1946a5d9-f2aa-4070-af67-e5b3be776b98_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Liabilities and Commitments</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AmericanDepositarySharesOptionPricePerShare_49c3bc2e-2735-406e-b49f-e89245c5f5fe_terseLabel_en-US" xlink:label="lab_avdl_AmericanDepositarySharesOptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ADS, option price per share (in dollars per share)</link:label>
    <link:label id="lab_avdl_AmericanDepositarySharesOptionPricePerShare_label_en-US" xlink:label="lab_avdl_AmericanDepositarySharesOptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares, Option Price Per Share</link:label>
    <link:label id="lab_avdl_AmericanDepositarySharesOptionPricePerShare_documentation_en-US" xlink:label="lab_avdl_AmericanDepositarySharesOptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares, Option Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesOptionPricePerShare" xlink:href="avdl-20211231.xsd#avdl_AmericanDepositarySharesOptionPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AmericanDepositarySharesOptionPricePerShare" xlink:to="lab_avdl_AmericanDepositarySharesOptionPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted_fdcaca80-e2af-4fb4-b0db-696d639686e7_terseLabel_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of business days</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted_label_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Business Day Period During Which Debt Can Be Converted</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted_documentation_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Business Day Period During Which Debt Can Be Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" xlink:href="avdl-20211231.xsd#avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" xlink:to="lab_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_5b84cde8-c0a4-4db1-ab3b-53c2690030e9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesMember" xlink:to="lab_us-gaap_DebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DeferredTaxAssetsAmortizationofIntangibleAssets_06d4f02f-1f15-46ee-b17e-80e3dcb00e03_terseLabel_en-US" xlink:label="lab_avdl_DeferredTaxAssetsAmortizationofIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_avdl_DeferredTaxAssetsAmortizationofIntangibleAssets_label_en-US" xlink:label="lab_avdl_DeferredTaxAssetsAmortizationofIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Amortization of Intangible Assets</link:label>
    <link:label id="lab_avdl_DeferredTaxAssetsAmortizationofIntangibleAssets_documentation_en-US" xlink:label="lab_avdl_DeferredTaxAssetsAmortizationofIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DeferredTaxAssetsAmortizationofIntangibleAssets" xlink:href="avdl-20211231.xsd#avdl_DeferredTaxAssetsAmortizationofIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DeferredTaxAssetsAmortizationofIntangibleAssets" xlink:to="lab_avdl_DeferredTaxAssetsAmortizationofIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_c5b002cc-5db4-4ac9-a12d-e5f10dacc180_terseLabel_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived Assets by Geographic Areas</link:label>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived Assets by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_24bce77b-73cb-425a-a2b8-9f79d0eea0e9_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeconsolidationGainOrLossAmount_337d358b-09f0-4b34-8ac6-7bb745fc4e5b_terseLabel_en-US" xlink:label="lab_us-gaap_DeconsolidationGainOrLossAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on deconsolidation of subsidiary</link:label>
    <link:label id="lab_us-gaap_DeconsolidationGainOrLossAmount_9249f090-cd7e-4c01-aea1-b3a8f4960ef2_negatedLabel_en-US" xlink:label="lab_us-gaap_DeconsolidationGainOrLossAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge for deconsolidation of subsidiary</link:label>
    <link:label id="lab_us-gaap_DeconsolidationGainOrLossAmount_label_en-US" xlink:label="lab_us-gaap_DeconsolidationGainOrLossAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deconsolidation, Gain (Loss), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationGainOrLossAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeconsolidationGainOrLossAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeconsolidationGainOrLossAmount" xlink:to="lab_us-gaap_DeconsolidationGainOrLossAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember_8b2630e4-ea9a-43c2-bc16-93336bc7047c_terseLabel_en-US" xlink:label="lab_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Corporate Restructuring Obligations</link:label>
    <link:label id="lab_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember_label_en-US" xlink:label="lab_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Nineteen Corporate Restructuring Obligations [Member]</link:label>
    <link:label id="lab_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember_documentation_en-US" xlink:label="lab_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Nineteen Corporate Restructuring Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember" xlink:href="avdl-20211231.xsd#avdl_TwoThousandNineteenCorporateRestructuringObligationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember" xlink:to="lab_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_VazculepMember_3283ec1f-29b7-426a-938d-cdd837c4d288_terseLabel_en-US" xlink:label="lab_avdl_VazculepMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vazculep</link:label>
    <link:label id="lab_avdl_VazculepMember_label_en-US" xlink:label="lab_avdl_VazculepMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vazculep [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_VazculepMember" xlink:href="avdl-20211231.xsd#avdl_VazculepMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_VazculepMember" xlink:to="lab_avdl_VazculepMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_ed561ed3-9a8f-4ac5-a089-fb89532ab89f_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_dbd96dc9-5be8-4b16-976c-e435ade95514_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_13b0ade6-698f-4f49-a513-b4aec0a87a22_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_883bd2f9-80db-45a9-b3d9-f6e0d56bca4a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_d1a64875-fed9-4b4a-a814-6b98ccb157ef_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nondeductible changes in fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7d6cd1d5-a00b-47a5-ae31-125c3a2b2851_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7d1f3568-9495-41e8-8c45-d3229a908582_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_b65398d0-872f-41cc-b780-c76a180f10df_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Non-Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodDomain_bd2a5914-9fe0-4f05-8964-256b99fe458a_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain" xlink:to="lab_us-gaap_TaxPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_20ea5243-ce00-48b7-8fe6-47263e11afbe_terseLabel_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration payable</link:label>
    <link:label id="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_5e449191-ca6f-46e7-95d2-312e1365e824_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_357e6721-2b78-432e-b786-88ae1794aab6_verboseLabel_en-US" xlink:label="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development tax credit receivable</link:label>
    <link:label id="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_label_en-US" xlink:label="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Tax Credit Receivable, Current</link:label>
    <link:label id="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_documentation_en-US" xlink:label="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Tax Credit Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" xlink:href="avdl-20211231.xsd#avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" xlink:to="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_b3b141f7-b2d0-48e1-8a0f-0223fd82900f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per share - basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_b31f3f2e-ae2f-480a-b462-e2679dbc8be2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of Hospital Products</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_b8a35eec-f359-47e9-a5bd-3b96e8db72aa_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_838ee624-6fd8-4116-bcf2-51b8ba39923c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_3278198b-e8c4-49a4-8233-89e37faa7fc1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_SaleOfStockConsiderationReceivedOnTransactionGross_c4130708-dd3b-4fdc-902e-08e74bde19bd_terseLabel_en-US" xlink:label="lab_avdl_SaleOfStockConsiderationReceivedOnTransactionGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public offering, proceeds</link:label>
    <link:label id="lab_avdl_SaleOfStockConsiderationReceivedOnTransactionGross_label_en-US" xlink:label="lab_avdl_SaleOfStockConsiderationReceivedOnTransactionGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Consideration Received On Transaction, Gross</link:label>
    <link:label id="lab_avdl_SaleOfStockConsiderationReceivedOnTransactionGross_documentation_en-US" xlink:label="lab_avdl_SaleOfStockConsiderationReceivedOnTransactionGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Consideration Received On Transaction, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_SaleOfStockConsiderationReceivedOnTransactionGross" xlink:href="avdl-20211231.xsd#avdl_SaleOfStockConsiderationReceivedOnTransactionGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_SaleOfStockConsiderationReceivedOnTransactionGross" xlink:to="lab_avdl_SaleOfStockConsiderationReceivedOnTransactionGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6344fea1-1caf-41d5-b9b4-d1226bc409c0_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8415ab00-57d1-417b-a964-68d770ce18e3_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAdjustment_156d4871-2ebb-435b-a586-89cd7aaec756_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency impact</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_028655d7-3319-449d-bf77-792f38080587_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and other expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_42f863c6-1f3c-46b2-9006-aaddebf822b8_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, debt</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch_438567a6-e2b2-4fcf-bf72-64e335067792_terseLabel_en-US" xlink:label="lab_avdl_DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orphan drug and R&amp;D tax credit</link:label>
    <link:label id="lab_avdl_DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch_label_en-US" xlink:label="lab_avdl_DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Orphan Drug And Research</link:label>
    <link:label id="lab_avdl_DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch_documentation_en-US" xlink:label="lab_avdl_DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Orphan Drug And Research</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch" xlink:href="avdl-20211231.xsd#avdl_DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch" xlink:to="lab_avdl_DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember_21d25711-6192-49ad-8d8a-7ed9e788a63c_terseLabel_en-US" xlink:label="lab_avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software, office and computer equipment</link:label>
    <link:label id="lab_avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember_label_en-US" xlink:label="lab_avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs, Office Equipment, and Computer Equipment [Member]</link:label>
    <link:label id="lab_avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember_documentation_en-US" xlink:label="lab_avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs, Office Equipment, and Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember" xlink:href="avdl-20211231.xsd#avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember" xlink:to="lab_avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_37532497-bc78-4d7b-aca3-e8f40db6ccbd_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Share Activity and Other Data, Nonvested [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_FscHoldingsLlcMember_e776c594-8403-4310-b498-941ec755548c_terseLabel_en-US" xlink:label="lab_avdl_FscHoldingsLlcMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FSC</link:label>
    <link:label id="lab_avdl_FscHoldingsLlcMember_label_en-US" xlink:label="lab_avdl_FscHoldingsLlcMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FSC Holdings, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FscHoldingsLlcMember" xlink:href="avdl-20211231.xsd#avdl_FscHoldingsLlcMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_FscHoldingsLlcMember" xlink:to="lab_avdl_FscHoldingsLlcMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_704c5f27-bde6-46d5-b879-88f813c1a9af_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_FreeShareAwardMember_3da660e5-e3d1-408e-a6ca-90b2000b2d93_terseLabel_en-US" xlink:label="lab_avdl_FreeShareAwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Share Award</link:label>
    <link:label id="lab_avdl_FreeShareAwardMember_label_en-US" xlink:label="lab_avdl_FreeShareAwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Share Award [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FreeShareAwardMember" xlink:href="avdl-20211231.xsd#avdl_FreeShareAwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_FreeShareAwardMember" xlink:to="lab_avdl_FreeShareAwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b49939d9-d4fe-48ab-b657-586abe164c47_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_39e9cb0e-82b7-426e-bb2d-f21c0a5dc7d5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_88e397bd-dc1c-4b0d-87b8-1db1d01a14d5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_LeaseholdImprovementsFurnitureFixturesAndFittingsMember_ef3b77a7-5d38-4703-8519-32fe6f735455_terseLabel_en-US" xlink:label="lab_avdl_LeaseholdImprovementsFurnitureFixturesAndFittingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements, furniture, fixtures and fittings</link:label>
    <link:label id="lab_avdl_LeaseholdImprovementsFurnitureFixturesAndFittingsMember_label_en-US" xlink:label="lab_avdl_LeaseholdImprovementsFurnitureFixturesAndFittingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements, Furniture, Fixtures And Fittings [Member]</link:label>
    <link:label id="lab_avdl_LeaseholdImprovementsFurnitureFixturesAndFittingsMember_documentation_en-US" xlink:label="lab_avdl_LeaseholdImprovementsFurnitureFixturesAndFittingsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements, Furniture, Fixtures And Fittings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_LeaseholdImprovementsFurnitureFixturesAndFittingsMember" xlink:href="avdl-20211231.xsd#avdl_LeaseholdImprovementsFurnitureFixturesAndFittingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_LeaseholdImprovementsFurnitureFixturesAndFittingsMember" xlink:to="lab_avdl_LeaseholdImprovementsFurnitureFixturesAndFittingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation_48583f44-d3d1-4e02-8f54-a2e16de1a834_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation forfeitures related to the employees affected by the global reduction in workforce</link:label>
    <link:label id="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefits and Share-based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:to="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_19c22a4a-286a-4fb9-ab4a-1a7e5aa8f39b_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development (&#8220;R&amp;D&#8221;)</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock_dfaaf949-4fe2-4dab-bb32-99060015027d_terseLabel_en-US" xlink:label="lab_avdl_MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum threshold percentage for trigger of convertible preferred stock</link:label>
    <link:label id="lab_avdl_MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock_label_en-US" xlink:label="lab_avdl_MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Threshold Percentage For Trigger Of Convertible Preferred Stock</link:label>
    <link:label id="lab_avdl_MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock_documentation_en-US" xlink:label="lab_avdl_MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Threshold Percentage For Trigger Of Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock" xlink:href="avdl-20211231.xsd#avdl_MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock" xlink:to="lab_avdl_MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c9bbb8c2-147f-4ca2-a423-f8de03ea41bc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicAreasLongLivedAssetsAbstract_6e30f620-060c-4d8e-a1ba-913204a07d31_verboseLabel_en-US" xlink:label="lab_us-gaap_GeographicAreasLongLivedAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived Assets by Geographic Region:</link:label>
    <link:label id="lab_us-gaap_GeographicAreasLongLivedAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_GeographicAreasLongLivedAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Areas, Long-Lived Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicAreasLongLivedAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicAreasLongLivedAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicAreasLongLivedAssetsAbstract" xlink:to="lab_us-gaap_GeographicAreasLongLivedAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_5a4e0722-4fbf-445d-ae95-8c0d38b315e0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, gross</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_81e58836-581d-443e-888f-eb331b802cc5_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal amount of 4.50% exchangeable senior notes due 2023</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_00e0ad26-5a58-459e-9b75-356120ce40dd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_bbef8470-cbe8-45e4-bd98-6a9c7700b9ba_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_7ff01410-4b08-4322-b649-0544c62e2a43_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_a72e5406-e7f6-45e7-bb2c-585264c08d51_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_d37d46ec-0c2a-4691-8504-e49e454c56d9_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_397917e4-25b8-4a4c-987e-0b69bdfdfb7f_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_26247192-adac-4a7d-aba8-1c4d0b4fa2e8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_35ca39f2-89b2-4883-8afd-57e9449a2d34_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6d6ffba4-6019-49ea-9945-834ba12b8a69_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefit Activity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_929ec483-1a15-4320-9052-af656b6c7f42_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_6c8a7a62-ef3b-4a90-bb20-c964f7950126_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_a72cac3f-e68b-49dc-a15b-3168ac06f1f2_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of shares outstanding</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_f1e4e741-3f0f-493d-bba6-fd867c335921_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_01681da2-955a-4b14-8fc5-b4b8fb6efe19_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local taxes (net of federal)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_a6b0e007-b3e9-4eec-ae91-7711c35df847_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_ScheduleOfIncomeTaxPaymentsTableTextBlock_755eb949-e85a-4c13-ad1e-f0a819bd0527_terseLabel_en-US" xlink:label="lab_avdl_ScheduleOfIncomeTaxPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Income Tax (Benefit) Provision</link:label>
    <link:label id="lab_avdl_ScheduleOfIncomeTaxPaymentsTableTextBlock_label_en-US" xlink:label="lab_avdl_ScheduleOfIncomeTaxPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Income Tax Payments [Table Text Block]</link:label>
    <link:label id="lab_avdl_ScheduleOfIncomeTaxPaymentsTableTextBlock_documentation_en-US" xlink:label="lab_avdl_ScheduleOfIncomeTaxPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of scheduled payments of income tax.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ScheduleOfIncomeTaxPaymentsTableTextBlock" xlink:href="avdl-20211231.xsd#avdl_ScheduleOfIncomeTaxPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_ScheduleOfIncomeTaxPaymentsTableTextBlock" xlink:to="lab_avdl_ScheduleOfIncomeTaxPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_9bcff3a9-d816-4fab-9d30-bc0caf2705c3_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_71d844a5-7ba4-494f-8af1-2d103d230094_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued professional fees</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_A450PercentExchangeableSeniorNotesDue2023Member_41309dd5-0d4c-45ee-bf54-03d544fffe40_terseLabel_en-US" xlink:label="lab_avdl_A450PercentExchangeableSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50 Percent Exchangeable Senior Notes Due 2023</link:label>
    <link:label id="lab_avdl_A450PercentExchangeableSeniorNotesDue2023Member_label_en-US" xlink:label="lab_avdl_A450PercentExchangeableSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50 Percent Exchangeable Senior Notes Due 2023 [Member]</link:label>
    <link:label id="lab_avdl_A450PercentExchangeableSeniorNotesDue2023Member_documentation_en-US" xlink:label="lab_avdl_A450PercentExchangeableSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Fifty Percent Exchangeable Senior Notes Due 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member" xlink:href="avdl-20211231.xsd#avdl_A450PercentExchangeableSeniorNotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member" xlink:to="lab_avdl_A450PercentExchangeableSeniorNotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_b27ca49f-76e5-4eaf-a5a7-b4feeca36111_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuarantyAssets_fb4d631d-45cf-4fd8-99ca-68ba3a864e98_terseLabel_en-US" xlink:label="lab_us-gaap_GuarantyAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guaranty assets</link:label>
    <link:label id="lab_us-gaap_GuarantyAssets_label_en-US" xlink:label="lab_us-gaap_GuarantyAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guaranty Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuarantyAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuarantyAssets" xlink:to="lab_us-gaap_GuarantyAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_1f40d8cb-93b9-4f40-bc75-168601ecf1c5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2/3 vesting at second anniversary of grant date</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_CostsIncurredPurchaseObligation_13411624-aad2-4529-8bc5-ee3217910779_terseLabel_en-US" xlink:label="lab_avdl_CostsIncurredPurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs incurred, purchase obligation</link:label>
    <link:label id="lab_avdl_CostsIncurredPurchaseObligation_label_en-US" xlink:label="lab_avdl_CostsIncurredPurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs Incurred, Purchase Obligation</link:label>
    <link:label id="lab_avdl_CostsIncurredPurchaseObligation_documentation_en-US" xlink:label="lab_avdl_CostsIncurredPurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs Incurred, Purchase Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CostsIncurredPurchaseObligation" xlink:href="avdl-20211231.xsd#avdl_CostsIncurredPurchaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_CostsIncurredPurchaseObligation" xlink:to="lab_avdl_CostsIncurredPurchaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_StockIssuedDuringPeriodSharesPublicOffering_a5925535-0966-4efd-8d7a-43afd6293af8_terseLabel_en-US" xlink:label="lab_avdl_StockIssuedDuringPeriodSharesPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2020 public offering (in shares)</link:label>
    <link:label id="lab_avdl_StockIssuedDuringPeriodSharesPublicOffering_label_en-US" xlink:label="lab_avdl_StockIssuedDuringPeriodSharesPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Public Offering</link:label>
    <link:label id="lab_avdl_StockIssuedDuringPeriodSharesPublicOffering_documentation_en-US" xlink:label="lab_avdl_StockIssuedDuringPeriodSharesPublicOffering" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_StockIssuedDuringPeriodSharesPublicOffering" xlink:href="avdl-20211231.xsd#avdl_StockIssuedDuringPeriodSharesPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_StockIssuedDuringPeriodSharesPublicOffering" xlink:to="lab_avdl_StockIssuedDuringPeriodSharesPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_1ddc87f0-2fed-4dd2-a206-1988783b3346_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_f6eb3ee4-235e-4298-b987-32826af924f4_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_8e98d010-9c5b-4618-8967-523df5785575_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_71fa43ac-971c-41d9-b542-953ce2c3dade_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government securities - U.S.</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied_359ad8b9-e9f2-4d0e-af31-29843be21f08_terseLabel_en-US" xlink:label="lab_us-gaap_BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bankruptcy claims, amount of filed claims likely to be denied</link:label>
    <link:label id="lab_us-gaap_BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied_label_en-US" xlink:label="lab_us-gaap_BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bankruptcy Claims, Amount of Filed Claims Likely to be Denied</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied" xlink:to="lab_us-gaap_BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_a01d4966-fb61-4c60-8e7a-acebc93167a0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRoyalties_70794898-cf44-41a8-b75c-5dc1a59cd47a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRoyalties" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty payments for contingent consideration payable in excess of original fair value</link:label>
    <link:label id="lab_us-gaap_PaymentsForRoyalties_label_en-US" xlink:label="lab_us-gaap_PaymentsForRoyalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRoyalties" xlink:to="lab_us-gaap_PaymentsForRoyalties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8d404218-0144-4819-b398-2c6edd323f8c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_3311e632-6fd9-4f9e-995b-7dae3fe52eb4_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_0f246de0-4261-43b9-9ef4-593f617503e3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the May 2020 public offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_2318f9e8-d136-449d-b610-6326025139f1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable &amp; other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_e23993d3-c0ea-4bb8-94b7-cce2f75f01c2_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_bf3ca62d-340d-49a7-97c3-263cd6cf713f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_69350962-7d28-4fe9-a535-25db83b4566e_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (Loss) Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_15ae3a1f-8efb-4572-9dd5-30140af241e6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, impairment loss</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:to="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_90a8553b-e483-459c-8d36-611eb0e1cc25_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_6df8fae9-5a0f-4d6c-a419-0b845353a66a_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_97ac0a43-3e74-4778-9771-9404bfe25386_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_b4a30f11-df87-4848-a2b2-bf42424929b8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_43357676-3428-4848-a37f-18634d0a18af_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_b574945b-66a5-4d1e-9a0c-c0e30af8ce6d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_2f7e2145-fae1-4ca9-b2cc-16425ee4987d_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_b104b41f-0997-4434-b0be-ff09d05e9acb_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivable (see Note 13)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_9180fe13-3af9-44be-bc48-8a217e11ee88_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity component of exchangeable notes, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Carrying Amount of Equity Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:to="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_1baa9016-433f-4546-8efe-5ae6bb956bf7_verboseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_fe0f917a-b9ff-4610-8318-8d796402b98b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f3c1c206-b8eb-466c-bb52-793343506313_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign currency exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AdditionalInterestExpenseDebt_755fd24c-00c3-4129-b90e-d2943659731d_terseLabel_en-US" xlink:label="lab_avdl_AdditionalInterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional interest expense</link:label>
    <link:label id="lab_avdl_AdditionalInterestExpenseDebt_label_en-US" xlink:label="lab_avdl_AdditionalInterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Interest Expense, Debt</link:label>
    <link:label id="lab_avdl_AdditionalInterestExpenseDebt_documentation_en-US" xlink:label="lab_avdl_AdditionalInterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AdditionalInterestExpenseDebt" xlink:href="avdl-20211231.xsd#avdl_AdditionalInterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AdditionalInterestExpenseDebt" xlink:to="lab_avdl_AdditionalInterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_b104b82b-8b0b-4711-9a43-7d00794ec365_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d1c27e9d-addd-4362-8fbf-63cf8ec0779b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_cdf2455d-7432-43c8-8351-2c9c94b31ca7_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_CustomerBMember_afcce041-01a2-4b74-83a8-72ef6ab0013b_terseLabel_en-US" xlink:label="lab_avdl_CustomerBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardinal Health</link:label>
    <link:label id="lab_avdl_CustomerBMember_label_en-US" xlink:label="lab_avdl_CustomerBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer B [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CustomerBMember" xlink:href="avdl-20211231.xsd#avdl_CustomerBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_CustomerBMember" xlink:to="lab_avdl_CustomerBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_4a73810f-adfc-421b-ba5a-d89e79fa418f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income, net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_4afca483-acd8-4089-b3ef-0221ed28fd49_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_180eb643-d7d4-4dfa-9d81-d61733f86af5_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_bd129fe8-81b4-43b8-980b-547046a54156_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_ed8e8b2b-e9cd-45aa-9c74-9149b1289cab_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_939598da-4a44-490e-850a-79ced78bf2e1_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_c56c0eb1-d90a-4251-8fce-86d4aa4a89dc_terseLabel_en-US" xlink:label="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to increase aggregate principal amount</link:label>
    <link:label id="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_label_en-US" xlink:label="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Option to Increase Face Amount</link:label>
    <link:label id="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_documentation_en-US" xlink:label="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Option to Increase Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentOptiontoIncreaseFaceAmount" xlink:href="avdl-20211231.xsd#avdl_DebtInstrumentOptiontoIncreaseFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtInstrumentOptiontoIncreaseFaceAmount" xlink:to="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_f448bf64-06a8-4403-a00e-092b0e03efac_terseLabel_en-US" xlink:label="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use assets at contract manufacturing organizations</link:label>
    <link:label id="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_label_en-US" xlink:label="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset, Contract Manufacturing, Noncurrent</link:label>
    <link:label id="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_documentation_en-US" xlink:label="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset, Contract Manufacturing, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" xlink:href="avdl-20211231.xsd#avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" xlink:to="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_FR_880acfd4-ed5f-4311-bb68-9d2868c7cd80_terseLabel_en-US" xlink:label="lab_country_FR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">France</link:label>
    <link:label id="lab_country_FR_label_en-US" xlink:label="lab_country_FR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FRANCE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_FR" xlink:to="lab_country_FR" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_8c0b9a64-ae34-4e1a-97b8-2df15455de5c_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_175ac3ed-500a-48e1-b6b0-cdceb6b13894_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_64ca8f90-27ec-4599-865f-6bf132ca65db_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than 10 Years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_eed094a6-37c1-4041-8dfe-f58137da6857_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_460e89e9-c49d-4a13-a173-387f31712beb_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_1b77e448-cd38-412f-bb88-b9e25d8cced6_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance of accrued costs</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_b4f45220-090e-4bce-bd8a-7acb19b91fb9_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance of accrued costs</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AmericanDepositarySharesMember_9929d29a-c67d-434a-8a2d-df44a964d121_terseLabel_en-US" xlink:label="lab_avdl_AmericanDepositarySharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares</link:label>
    <link:label id="lab_avdl_AmericanDepositarySharesMember_label_en-US" xlink:label="lab_avdl_AmericanDepositarySharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares [Member]</link:label>
    <link:label id="lab_avdl_AmericanDepositarySharesMember_documentation_en-US" xlink:label="lab_avdl_AmericanDepositarySharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesMember" xlink:href="avdl-20211231.xsd#avdl_AmericanDepositarySharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AmericanDepositarySharesMember" xlink:to="lab_avdl_AmericanDepositarySharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_fc1ac2a5-d4db-4088-bdba-bae4eded6b84_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_654d6a37-c663-40cc-8501-8473c950586b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2020 private placement</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance_dd0bba28-c87d-4662-98b7-49fec5332705_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, valuation allowance (decrease)</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:to="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_0de2d5ec-226d-45a7-86c8-7a4bde37eb3b_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_10e5136a-366d-49c3-8373-2f7c8fadcec4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_adc0ac35-2609-4098-8176-089729a3af99_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_b3a3ce07-c3ae-41ac-8f34-d99713650e42_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_bf16d828-514c-4282-b59f-cda0d206905f_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_d3fc3b43-d7b1-4f84-8a05-fcd9835ff432_verboseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_0b9a7aa4-5bcf-4e56-9344-4a378c0c0e47_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_e8345cc6-9170-44a1-9db4-572adb0cc874_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_47c829f4-65b1-4101-bd52-1bea3d61dc46_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Obligations</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_CustomerCMember_41869bdd-acc3-47e0-8cf1-9b6048f8efc4_terseLabel_en-US" xlink:label="lab_avdl_CustomerCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AmerisourceBergen</link:label>
    <link:label id="lab_avdl_CustomerCMember_label_en-US" xlink:label="lab_avdl_CustomerCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer C [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CustomerCMember" xlink:href="avdl-20211231.xsd#avdl_CustomerCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_CustomerCMember" xlink:to="lab_avdl_CustomerCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_662d4b57-10ca-4370-9c4f-1bdf11684310_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax penalties and interest accrued</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_fcd777e3-165d-4fa4-9105-0ec810865ce7_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_727e9867-c6e0-4b73-a269-24694a587007_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_80d318fe-b5b5-404b-949c-398edc74a691_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2020 private placement (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_789f087d-e94b-4974-82d4-51ccaf4d6def_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued during period, new issues (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_d22e1746-4fc8-4cfb-a8e8-9fcda01443a2_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_ea269a8d-3ce2-4dd9-bb92-255501cd0514_verboseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Marketable Securities [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_2be5c409-f9b3-4fd9-8a33-47b81c3265d6_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. - Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_3381f21c-8014-4ccf-8710-c6e7c9283edb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_ab535c99-f135-47d0-971b-d296ffe40879_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Product and Services</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration_5da0a3dc-af6d-4c44-a7b9-05798bea1836_terseLabel_en-US" xlink:label="lab_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum aggregate offering price of ADSs under shelf registration</link:label>
    <link:label id="lab_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration_label_en-US" xlink:label="lab_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Aggregate Offering Price of American Depositary Shares Under Shelf Registration</link:label>
    <link:label id="lab_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration_documentation_en-US" xlink:label="lab_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Aggregate Offering Price of American Depositary Shares Under Shelf Registration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" xlink:href="avdl-20211231.xsd#avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" xlink:to="lab_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_61eb4626-bb3c-4bcd-b70b-e60e0c4328c1_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment_350d25e2-8da2-4744-9e8d-2144dec30737_terseLabel_en-US" xlink:label="lab_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Benefit) charges for employee severance, benefits and other costs</link:label>
    <link:label id="lab_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment_label_en-US" xlink:label="lab_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges Before Gain (Loss) Due to Curtailment</link:label>
    <link:label id="lab_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment_documentation_en-US" xlink:label="lab_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges Before Gain (Loss) Due to Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment" xlink:href="avdl-20211231.xsd#avdl_RestructuringChargesBeforeGainLossDuetoCurtailment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment" xlink:to="lab_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_71af0040-72dc-48ea-bd50-cc8a3209d83e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_fb177dc5-1158-45f6-91bf-cd4eb113fd91_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, nominal value of $0.01 per share; 500,000 shares authorized;&#160;58,620 and 58,396 issued and outstanding at December 31, 2021 and 2020, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_460f8157-d6ea-4981-89c1-aa3bfae1c5b4_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net liabilities disposed of</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_cafb148b-4e65-4969-8ebc-fba324e03a3a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested free share award, beginning balance (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_79c63ebb-5c1d-49af-8df8-5e31822c8a88_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested free share award, ending balance (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_06382bd1-5bd1-4de5-b57d-b959997256a9_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_8a708f13-f39c-43aa-b4de-c61a59ed0b54_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_aacc66c2-28c5-4a18-8588-e955c4f54d29_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_c32c65d3-101d-49c1-a65d-aee5cbe6ae98_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_146c003e-812d-42ca-b6bd-5076731fbbce_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_f4e368cd-099b-49ae-b87c-7ed3339a164b_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AkovazMember_c5615979-f24f-412c-ba11-6b77349cce36_terseLabel_en-US" xlink:label="lab_avdl_AkovazMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Akovaz</link:label>
    <link:label id="lab_avdl_AkovazMember_label_en-US" xlink:label="lab_avdl_AkovazMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Akovaz [Member]</link:label>
    <link:label id="lab_avdl_AkovazMember_documentation_en-US" xlink:label="lab_avdl_AkovazMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Akovaz [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AkovazMember" xlink:href="avdl-20211231.xsd#avdl_AkovazMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AkovazMember" xlink:to="lab_avdl_AkovazMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_861ea313-1e30-4ee8-b765-9f8a80e188a4_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_7608fd87-8f90-4c41-8938-ac34f2372b55_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_A2017AvadelEmployeeSharePurchasePlanMember_2e9d0197-61f3-41d7-9d71-69e0d5f9df42_terseLabel_en-US" xlink:label="lab_avdl_A2017AvadelEmployeeSharePurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Avadel Employee Share Purchase Plan</link:label>
    <link:label id="lab_avdl_A2017AvadelEmployeeSharePurchasePlanMember_label_en-US" xlink:label="lab_avdl_A2017AvadelEmployeeSharePurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Avadel Employee Share Purchase Plan [Member]</link:label>
    <link:label id="lab_avdl_A2017AvadelEmployeeSharePurchasePlanMember_documentation_en-US" xlink:label="lab_avdl_A2017AvadelEmployeeSharePurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Avadel Employee Share Purchase Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A2017AvadelEmployeeSharePurchasePlanMember" xlink:href="avdl-20211231.xsd#avdl_A2017AvadelEmployeeSharePurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_A2017AvadelEmployeeSharePurchasePlanMember" xlink:to="lab_avdl_A2017AvadelEmployeeSharePurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_b59ad5dd-447f-4173-ba09-1025539c875d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Non-Current Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets, Noncurrent [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_447cb809-d4fe-422a-b979-a038f0b20c7b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_df260a7b-a053-4e4f-8280-0399d4ba6432_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ireland</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_7a9e25a0-ab80-4bb3-b9c9-23379ff0058e_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_5270d19d-8a4e-4dd9-9c66-955ebd076af4_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_692a3d96-2045-4c0e-a955-871616770f04_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_3ff1cdc3-9a3d-4f10-81bc-bfdf2815234b_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_7a8b7e9f-f74c-45e4-b94d-c779f5a49fca_verboseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expense</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_26946b1e-259a-492a-a167-994dceb8631c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_d542b3e9-7515-4172-93c7-777c83fbecca_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_368a9fd0-1d05-47d4-8315-f454b541b1ae_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_c19a24fd-8421-4894-aaac-8aa08e4ef143_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term contingent consideration payable</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Amounts of Material Contingent Liabilities Remaining</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining" xlink:to="lab_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_5b4d2182-f109-40e3-a319-cb7c8c9dfed7_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_e89b8d18-9ad5-490d-a3f3-d48e1c685b06_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_42f57b1e-7f54-4699-b8c0-a301ab2e71d2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_ScheduleOfShareBasedPaymentAwardStockOptionsAndWarrantGrantsValuationAssumptionsTableTextBlock_fd699e7b-ba11-4c86-b26c-2feaa632e4e8_terseLabel_en-US" xlink:label="lab_avdl_ScheduleOfShareBasedPaymentAwardStockOptionsAndWarrantGrantsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share Based Payment Award Stock Options and Warrant Grants Valuation Assumptions</link:label>
    <link:label id="lab_avdl_ScheduleOfShareBasedPaymentAwardStockOptionsAndWarrantGrantsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_avdl_ScheduleOfShareBasedPaymentAwardStockOptionsAndWarrantGrantsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Payment Award Stock Options And Warrant Grants Valuation Assumptions [Table Text Block]</link:label>
    <link:label id="lab_avdl_ScheduleOfShareBasedPaymentAwardStockOptionsAndWarrantGrantsValuationAssumptionsTableTextBlock_documentation_en-US" xlink:label="lab_avdl_ScheduleOfShareBasedPaymentAwardStockOptionsAndWarrantGrantsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options and Warrants grants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ScheduleOfShareBasedPaymentAwardStockOptionsAndWarrantGrantsValuationAssumptionsTableTextBlock" xlink:href="avdl-20211231.xsd#avdl_ScheduleOfShareBasedPaymentAwardStockOptionsAndWarrantGrantsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_ScheduleOfShareBasedPaymentAwardStockOptionsAndWarrantGrantsValuationAssumptionsTableTextBlock" xlink:to="lab_avdl_ScheduleOfShareBasedPaymentAwardStockOptionsAndWarrantGrantsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_7228b61b-c2ab-4cd9-98f4-e02ea122d375_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from public offering</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AccruedInterestCurrent_63dc4de4-ccb6-4e11-9de2-1e8d58ae5737_terseLabel_en-US" xlink:label="lab_avdl_AccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_avdl_AccruedInterestCurrent_label_en-US" xlink:label="lab_avdl_AccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest, Current</link:label>
    <link:label id="lab_avdl_AccruedInterestCurrent_documentation_en-US" xlink:label="lab_avdl_AccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedInterestCurrent" xlink:href="avdl-20211231.xsd#avdl_AccruedInterestCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AccruedInterestCurrent" xlink:to="lab_avdl_AccruedInterestCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d9e85526-842c-41a7-a289-e101d545ef15_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_68b841a0-0f27-4b4a-956f-3eadc1a9e03f_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_b949e078-3e8b-447b-ae82-d8e9a1b9523c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on marketable securities, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_6e983546-98f7-40bf-8e1d-bd1ee70397e3_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_31559e16-c364-48d9-9fe4-4c7c03feb6d6_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_284e7b69-4d82-4343-bf6d-2695587975b3_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_28ca20cb-59a6-43eb-b003-84ebe526d8db_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_a708a45a-343c-4102-909f-f7bfdfde5864_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cfb70bfb-08bf-40ad-8861-e98f86a22324_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_61febaf3-cea1-4ff6-85e9-a10ec5488a97_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_40f51e21-e7dd-4f27-8af8-f88b408e26dd_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_5a872904-d6c1-4336-8c61-10b9194aad13_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the February 2020 private placement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Private Placement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount_6060a452-33d4-4ae3-bbf7-9ad343ab13d7_terseLabel_en-US" xlink:label="lab_avdl_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nondeductible interest expense</link:label>
    <link:label id="lab_avdl_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount_label_en-US" xlink:label="lab_avdl_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Interest Expense, Amount</link:label>
    <link:label id="lab_avdl_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount_documentation_en-US" xlink:label="lab_avdl_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Interest Expense, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount" xlink:href="avdl-20211231.xsd#avdl_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount" xlink:to="lab_avdl_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_bb01ff2c-ef78-4ad8-84f2-1538606e829e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_55bd7255-0bf5-427c-aa3c-829355fc0466_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance costs recorded as a reduction to additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_b17e7e2c-c0a1-48e2-8491-2e7e67e26ea8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_CARESActCashRefundClaims_6b35d488-4f8f-4bc5-849b-b150da294b6d_terseLabel_en-US" xlink:label="lab_avdl_CARESActCashRefundClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act, cash refund claims</link:label>
    <link:label id="lab_avdl_CARESActCashRefundClaims_label_en-US" xlink:label="lab_avdl_CARESActCashRefundClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act, Cash Refund Claims</link:label>
    <link:label id="lab_avdl_CARESActCashRefundClaims_documentation_en-US" xlink:label="lab_avdl_CARESActCashRefundClaims" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act, Cash Refund Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CARESActCashRefundClaims" xlink:href="avdl-20211231.xsd#avdl_CARESActCashRefundClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_CARESActCashRefundClaims" xlink:to="lab_avdl_CARESActCashRefundClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_6493f7f2-4a8a-4515-ae7d-9deb62a649a3_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for restructuring</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_4e5ca5c5-4b73-4eed-84d2-6243ff6155f7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReorganizationsAbstract_5a94d5b2-8daa-489f-ae18-82f823bb7759_terseLabel_en-US" xlink:label="lab_us-gaap_ReorganizationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reorganizations [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReorganizationsAbstract_label_en-US" xlink:label="lab_us-gaap_ReorganizationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reorganizations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReorganizationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReorganizationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReorganizationsAbstract" xlink:to="lab_us-gaap_ReorganizationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_db58bcb1-8e09-4798-aca1-f12902d22c7e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_0d9ffe35-8b10-453d-841c-5b8e93fafdce_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_71ac73d8-4dcc-40e5-a149-2272a3df2287_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm_148abb00-9464-43ec-a3ef-5d4bbdb73ba4_terseLabel_en-US" xlink:label="lab_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment installment term (in months)</link:label>
    <link:label id="lab_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm_label_en-US" xlink:label="lab_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Payment Installment Term</link:label>
    <link:label id="lab_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm_documentation_en-US" xlink:label="lab_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Payment Installment Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm" xlink:href="avdl-20211231.xsd#avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm" xlink:to="lab_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_e3e6e853-3b1c-4a2e-86c7-70eb80d43f41_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Operations by Product, Customer and Geographic Area</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_3ab91d67-0961-4545-8210-51ad083c902c_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating (loss) income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_2518690b-8a7b-4e06-8b18-49991528a028_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtInstrumentAdditionalInterestExpensePercentage_e58858d1-f242-4c10-a65f-34bdd5c351bb_terseLabel_en-US" xlink:label="lab_avdl_DebtInstrumentAdditionalInterestExpensePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, additional interest expense, percentage</link:label>
    <link:label id="lab_avdl_DebtInstrumentAdditionalInterestExpensePercentage_label_en-US" xlink:label="lab_avdl_DebtInstrumentAdditionalInterestExpensePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Additional Interest Expense, Percentage</link:label>
    <link:label id="lab_avdl_DebtInstrumentAdditionalInterestExpensePercentage_documentation_en-US" xlink:label="lab_avdl_DebtInstrumentAdditionalInterestExpensePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Additional Interest Expense, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentAdditionalInterestExpensePercentage" xlink:href="avdl-20211231.xsd#avdl_DebtInstrumentAdditionalInterestExpensePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtInstrumentAdditionalInterestExpensePercentage" xlink:to="lab_avdl_DebtInstrumentAdditionalInterestExpensePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_40e9ee14-ba1d-4fc7-8bf5-269546fe4104_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_IncomeTaxesTable_1e069709-beb7-4809-8981-001df2c7c7c3_terseLabel_en-US" xlink:label="lab_avdl_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:label id="lab_avdl_IncomeTaxesTable_label_en-US" xlink:label="lab_avdl_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_IncomeTaxesTable" xlink:href="avdl-20211231.xsd#avdl_IncomeTaxesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_IncomeTaxesTable" xlink:to="lab_avdl_IncomeTaxesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3bbde94e-b737-478b-9edc-b67816fc6e09_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock_4a7ba58f-a357-4919-8583-f9ee9079261b_terseLabel_en-US" xlink:label="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations</link:label>
    <link:label id="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock_label_en-US" xlink:label="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature Of Business Policy [Policy Text Block]</link:label>
    <link:label id="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for nature of business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_NatureOfBusinessPolicyPolicyTextBlock" xlink:href="avdl-20211231.xsd#avdl_NatureOfBusinessPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_NatureOfBusinessPolicyPolicyTextBlock" xlink:to="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_fe21a9e9-ad44-4d2c-8722-179dff9cabee_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_CustomerDMember_2efff168-3fdf-4f83-8d98-f62f334b2967_terseLabel_en-US" xlink:label="lab_avdl_CustomerDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">QuVa Pharma</link:label>
    <link:label id="lab_avdl_CustomerDMember_label_en-US" xlink:label="lab_avdl_CustomerDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer D [Member]</link:label>
    <link:label id="lab_avdl_CustomerDMember_documentation_en-US" xlink:label="lab_avdl_CustomerDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer D</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CustomerDMember" xlink:href="avdl-20211231.xsd#avdl_CustomerDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_CustomerDMember" xlink:to="lab_avdl_CustomerDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_dc4b31a2-ea1c-4861-b989-c781e9fab27e_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1-5 Years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_f024b79f-8e1c-42d0-885e-2d1e6ec31d5f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_03c54fd8-938a-4358-af89-eab0795f9f67_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_1d473a9e-cf27-4130-b87d-aef61a12964a_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_42761744-09f7-44bc-abab-e86f2c309d90_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_62bd1466-a7de-443b-9926-bd4e39faea61_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_bb43f92c-8d6b-4ae1-b5e3-092764c0f7f4_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_202028ee-86b2-4fa7-ba58-31e5882281f2_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_e0212c82-a827-4dbf-9ccc-31cadf67abd2_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_8621f1ff-5dfc-494c-8f6e-c22369f02444_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_4b82e13e-2432-418d-b64b-a94c828e690c_verboseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_GuaranteeNoncurrent_3f043612-9682-432c-a214-42faa1b212bd_terseLabel_en-US" xlink:label="lab_avdl_GuaranteeNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee from Armistice</link:label>
    <link:label id="lab_avdl_GuaranteeNoncurrent_label_en-US" xlink:label="lab_avdl_GuaranteeNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee, Noncurrent</link:label>
    <link:label id="lab_avdl_GuaranteeNoncurrent_documentation_en-US" xlink:label="lab_avdl_GuaranteeNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeNoncurrent" xlink:href="avdl-20211231.xsd#avdl_GuaranteeNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_GuaranteeNoncurrent" xlink:to="lab_avdl_GuaranteeNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent_570e0b40-f8ee-49f6-b635-97f377d3f569_terseLabel_en-US" xlink:label="lab_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent reduction in workforce</link:label>
    <link:label id="lab_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent_label_en-US" xlink:label="lab_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Related Costs, Expected Number Of Positions Eliminated, Percent</link:label>
    <link:label id="lab_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent_documentation_en-US" xlink:label="lab_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Related Costs, Expected Number Of Positions Eliminated, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" xlink:href="avdl-20211231.xsd#avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" xlink:to="lab_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_3ea30d50-5d96-4bd2-822c-fd942375d361_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_063e3c6b-f7b1-4846-843d-e8a274762c10_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in deferred tax</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_1e369d7c-35c0-491c-8959-e386517e2d06_terseLabel_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">As Reported</link:label>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_label_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioPreviouslyReportedMember" xlink:to="lab_srt_ScenarioPreviouslyReportedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_a6a84f64-3b15-43ac-81c8-af147c2d982f_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration_a93b339b-227c-4276-b362-5ea4d3072ba2_terseLabel_en-US" xlink:label="lab_avdl_MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum aggregate offering price of securities under shelf registration</link:label>
    <link:label id="lab_avdl_MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration_label_en-US" xlink:label="lab_avdl_MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Aggregate Offering Price of Securities Under Shelf Registration</link:label>
    <link:label id="lab_avdl_MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration_documentation_en-US" xlink:label="lab_avdl_MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Aggregate Offering Price of Securities Under Shelf Registration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration" xlink:href="avdl-20211231.xsd#avdl_MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration" xlink:to="lab_avdl_MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_6d2a65b6-6ccb-43ac-9388-89dc6a0aca9d_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_A2016MIPAMember_9687c01a-4934-4357-bd12-dfa6a7d32546_terseLabel_en-US" xlink:label="lab_avdl_A2016MIPAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 MIPA</link:label>
    <link:label id="lab_avdl_A2016MIPAMember_label_en-US" xlink:label="lab_avdl_A2016MIPAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 MIPA [Member]</link:label>
    <link:label id="lab_avdl_A2016MIPAMember_documentation_en-US" xlink:label="lab_avdl_A2016MIPAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 MIPA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A2016MIPAMember" xlink:href="avdl-20211231.xsd#avdl_A2016MIPAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_A2016MIPAMember" xlink:to="lab_avdl_A2016MIPAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_ea30aaa6-2d99-4a04-82f7-68e714911b8f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment loss related to goodwill or intangible assets</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_8dcc624e-4c85-41d1-9596-908f29b5a21e_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_2a66d92f-6096-4f21-b12a-4b84612f5dce_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nondeductible share-based compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_dd5adb4b-ce98-48af-b54c-5042fc8a8e9c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense - changes in fair value of contingent consideration payable</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_660429e0-1942-402b-94f0-5d16641d456e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense - changes in fair value of contingent consideration payable</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e2293355-2199-462d-ba7c-2429b7b19343_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_b6ee774e-3274-4bfe-998b-1f2c072a6fc5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_aafcd647-dfa5-45ab-a6fb-87e0bceb3eb0_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_669f20fe-7556-4ac2-b8bd-c4939e74d1bd_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_aceaa8f6-615f-46b2-847e-830515a77676_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1e43a8d8-23fd-4b7c-8198-70df685031fb_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_b0dae6d6-3fb3-400b-8950-7f3c1f55f77c_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_InducementPlanMember_cede4bf1-e845-4ef1-9ffc-9fc319127208_terseLabel_en-US" xlink:label="lab_avdl_InducementPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inducement Plan</link:label>
    <link:label id="lab_avdl_InducementPlanMember_label_en-US" xlink:label="lab_avdl_InducementPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inducement Plan [Member]</link:label>
    <link:label id="lab_avdl_InducementPlanMember_documentation_en-US" xlink:label="lab_avdl_InducementPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inducement Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_InducementPlanMember" xlink:href="avdl-20211231.xsd#avdl_InducementPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_InducementPlanMember" xlink:to="lab_avdl_InducementPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_cd92b47b-08e4-4540-9d3f-319d41889b5a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_f83d938a-0148-40ff-a032-80080fa0decd_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_b5a270c1-23a2-4e0f-8876-6fbe7e0b489c_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringChargesMember_3c3a752a-bb1a-4e3e-8d20-34aae1d374b8_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringChargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring costs</link:label>
    <link:label id="lab_us-gaap_RestructuringChargesMember_label_en-US" xlink:label="lab_us-gaap_RestructuringChargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringChargesMember" xlink:to="lab_us-gaap_RestructuringChargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_dab2d8f7-64fc-4b74-99a0-8b8c215f6533_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_cad1702d-491c-44fc-9b9c-3a73724dfb42_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_493cfdd8-d940-4bc5-af8a-aa72c30ed955_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options outstanding, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_eedf5889-b56c-4cf5-9740-07055064db98_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options exercisable (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_f59e8df8-5f01-47ab-82a8-8f4afc7ea7d6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_VestOneYearFollowingAchievementOfMilestonesMember_447c1db6-fa18-46bc-a6ab-2efaeb23aee9_terseLabel_en-US" xlink:label="lab_avdl_VestOneYearFollowingAchievementOfMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vest One Year Following Achievement Of Milestones</link:label>
    <link:label id="lab_avdl_VestOneYearFollowingAchievementOfMilestonesMember_label_en-US" xlink:label="lab_avdl_VestOneYearFollowingAchievementOfMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vest One Year Following Achievement Of Milestones [Member]</link:label>
    <link:label id="lab_avdl_VestOneYearFollowingAchievementOfMilestonesMember_documentation_en-US" xlink:label="lab_avdl_VestOneYearFollowingAchievementOfMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vest One Year Following Achievement Of Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_VestOneYearFollowingAchievementOfMilestonesMember" xlink:href="avdl-20211231.xsd#avdl_VestOneYearFollowingAchievementOfMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_VestOneYearFollowingAchievementOfMilestonesMember" xlink:to="lab_avdl_VestOneYearFollowingAchievementOfMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_de032a4f-814c-4c8d-bc91-c1f84047648c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Capitalization, Long-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Capitalization, Long-term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCapitalizationLongtermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable" xlink:to="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_421c3b15-f15d-41c5-ad7c-4023ad399869_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Operating Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_1b5eba1c-a7f6-4304-b2d2-4acce162c012_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers by Reporting Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_3f3d6f99-3811-4ffa-98a1-4e9b23cb36f4_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_d82b77a0-ebf4-4caa-a5b2-e6246cc8e5be_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_f46d3363-b046-431e-a1cf-ef5971640293_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_e7b5d458-0454-4bf8-800d-a2b306a8f8b0_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; (deficit) equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_589f3af6-d42a-495d-899b-f62052a82a2f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_6782b19b-2ccf-47b4-8bf4-c9476734bbc2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_99c99fe0-ac86-4e32-8d87-92a85c80bbc9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_fc7a15fb-61a6-4502-88b1-8e6665071d12_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_e26fde9b-bc74-46e7-94d0-41be8bac9789_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options exercisable, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_EquityTransactionsDisclosureTextBlock_d54604af-0f47-46ca-8c4a-c86323d55078_terseLabel_en-US" xlink:label="lab_avdl_EquityTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Instruments and Transactions</link:label>
    <link:label id="lab_avdl_EquityTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_avdl_EquityTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Transactions Disclosure [Text Block]</link:label>
    <link:label id="lab_avdl_EquityTransactionsDisclosureTextBlock_documentation_en-US" xlink:label="lab_avdl_EquityTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Transactions Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_EquityTransactionsDisclosureTextBlock" xlink:href="avdl-20211231.xsd#avdl_EquityTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_EquityTransactionsDisclosureTextBlock" xlink:to="lab_avdl_EquityTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e16023fb-3cff-4021-83fe-49e070db90f7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_country_IE_7e329e5c-fb63-4f6f-b01e-7bdd636a4e1d_terseLabel_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ireland</link:label>
    <link:label id="lab_country_IE_label_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IRELAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IE" xlink:to="lab_country_IE" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_5e1f200a-29f6-4279-b0ef-9a6418c1d5bf_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_RestrictedShareAwardsGrantsBeginningIn2018Member_068b5b01-be1e-4ba2-95cd-5650f4ea5fa5_terseLabel_en-US" xlink:label="lab_avdl_RestrictedShareAwardsGrantsBeginningIn2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Awards, Grants Beginning In 2018</link:label>
    <link:label id="lab_avdl_RestrictedShareAwardsGrantsBeginningIn2018Member_label_en-US" xlink:label="lab_avdl_RestrictedShareAwardsGrantsBeginningIn2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Awards, Grants Beginning In 2018 [Member]</link:label>
    <link:label id="lab_avdl_RestrictedShareAwardsGrantsBeginningIn2018Member_documentation_en-US" xlink:label="lab_avdl_RestrictedShareAwardsGrantsBeginningIn2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Awards, Grants Beginning In 2018</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestrictedShareAwardsGrantsBeginningIn2018Member" xlink:href="avdl-20211231.xsd#avdl_RestrictedShareAwardsGrantsBeginningIn2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_RestrictedShareAwardsGrantsBeginningIn2018Member" xlink:to="lab_avdl_RestrictedShareAwardsGrantsBeginningIn2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_48fb7967-e6f1-481b-b1da-4dd74b9e4ccb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, useful life (in years)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_71a633b4-c8bf-4244-848c-511e87f41bf5_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_ad9f7178-a1d9-4cfc-9f1c-1432a372de4a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_BloxiverzVazculepAkovazandNouressMember_8d2de8a0-3112-4eff-abe6-e978a9598f87_terseLabel_en-US" xlink:label="lab_avdl_BloxiverzVazculepAkovazandNouressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Business</link:label>
    <link:label id="lab_avdl_BloxiverzVazculepAkovazandNouressMember_label_en-US" xlink:label="lab_avdl_BloxiverzVazculepAkovazandNouressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bloxiverz, Vazculep, Akovaz and Nouress [Member]</link:label>
    <link:label id="lab_avdl_BloxiverzVazculepAkovazandNouressMember_documentation_en-US" xlink:label="lab_avdl_BloxiverzVazculepAkovazandNouressMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bloxiverz, Vazculep, Akovaz and Nouress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_BloxiverzVazculepAkovazandNouressMember" xlink:href="avdl-20211231.xsd#avdl_BloxiverzVazculepAkovazandNouressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_BloxiverzVazculepAkovazandNouressMember" xlink:to="lab_avdl_BloxiverzVazculepAkovazandNouressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_3481358d-0db2-4ca2-bb52-bb6fc6c4a96d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain on the sale of the Hospital Products</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue_cb558276-6288-48bc-9370-8c6df3fb8eb6_negatedTerseLabel_en-US" xlink:label="lab_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-out payments for contingent consideration in excess of acquisition-date fair value</link:label>
    <link:label id="lab_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue_label_en-US" xlink:label="lab_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn Out Payment In Excess Of Acquisition Date Fair Value</link:label>
    <link:label id="lab_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue_documentation_en-US" xlink:label="lab_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the Earn Out Payment In Excess Of Acquisition Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue" xlink:href="avdl-20211231.xsd#avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue" xlink:to="lab_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_bb2cf88a-fe1b-400a-9bef-6665bfe5230b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_f25eb487-f62e-4445-9bd9-3a8a11aa5a5d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_153f517e-405a-40ef-9c43-1d23b6759362_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_ed1a02b1-98ed-4c20-a8ec-c7f63641b308_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_6f5a8016-4460-46ce-a936-f9fe107f0c48_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment and other income (expense), net</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNet" xlink:to="lab_us-gaap_InvestmentIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AccruedTradeDiscountsAndRebates_0ceff6b4-fe4f-45b9-a8d0-57348278efcf_terseLabel_en-US" xlink:label="lab_avdl_AccruedTradeDiscountsAndRebates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer allowances</link:label>
    <link:label id="lab_avdl_AccruedTradeDiscountsAndRebates_label_en-US" xlink:label="lab_avdl_AccruedTradeDiscountsAndRebates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued trade discounts and rebates</link:label>
    <link:label id="lab_avdl_AccruedTradeDiscountsAndRebates_documentation_en-US" xlink:label="lab_avdl_AccruedTradeDiscountsAndRebates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred through that date and payable for accrued discounts and rebates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedTradeDiscountsAndRebates" xlink:href="avdl-20211231.xsd#avdl_AccruedTradeDiscountsAndRebates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AccruedTradeDiscountsAndRebates" xlink:to="lab_avdl_AccruedTradeDiscountsAndRebates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_1ace37a2-8597-4897-89df-8521d1749a01_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_bbdd68f5-817a-4f88-bb95-6ac5238129f9_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_74fb5535-7974-40de-911c-448510ca8de2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_768cc14b-0efb-40c9-82fd-3763f5f80634_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_e09e638d-f839-4505-af2e-6ee0d0017d5e_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_9d94703b-22d0-4389-87fb-a3fa39021723_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisposals_88930301-c725-474f-99ee-acaee3426617_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisposals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-off of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisposals_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisposals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Disposals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisposals" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisposals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisposals" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisposals" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_60ccf1ea-8cad-4bcc-8b23-ab45c70a7848_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_RestructuringCostsNet_bae316c6-08cd-4c07-84fc-a257b0d1d0a9_terseLabel_en-US" xlink:label="lab_avdl_RestructuringCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring (income) costs</link:label>
    <link:label id="lab_avdl_RestructuringCostsNet_label_en-US" xlink:label="lab_avdl_RestructuringCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs, Net</link:label>
    <link:label id="lab_avdl_RestructuringCostsNet_documentation_en-US" xlink:label="lab_avdl_RestructuringCostsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestructuringCostsNet" xlink:href="avdl-20211231.xsd#avdl_RestructuringCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_RestructuringCostsNet" xlink:to="lab_avdl_RestructuringCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_OtherProductsMember_789f0b4a-1c01-4c56-baa6-cfa00fc6627d_terseLabel_en-US" xlink:label="lab_avdl_OtherProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_avdl_OtherProductsMember_label_en-US" xlink:label="lab_avdl_OtherProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherProductsMember" xlink:href="avdl-20211231.xsd#avdl_OtherProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_OtherProductsMember" xlink:to="lab_avdl_OtherProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_180da2c4-c6b4-4678-bcee-edf507c23609_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_VestUponAchievementOfCertainCorporateObjectivesMember_0459b823-57bc-41dc-986d-d4dbd6856c4d_terseLabel_en-US" xlink:label="lab_avdl_VestUponAchievementOfCertainCorporateObjectivesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vest Upon Achievement Of Certain Corporate Objectives</link:label>
    <link:label id="lab_avdl_VestUponAchievementOfCertainCorporateObjectivesMember_label_en-US" xlink:label="lab_avdl_VestUponAchievementOfCertainCorporateObjectivesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vest Upon Achievement Of Certain Corporate Objectives [Member]</link:label>
    <link:label id="lab_avdl_VestUponAchievementOfCertainCorporateObjectivesMember_documentation_en-US" xlink:label="lab_avdl_VestUponAchievementOfCertainCorporateObjectivesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vest Upon Achievement Of Certain Corporate Objectives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_VestUponAchievementOfCertainCorporateObjectivesMember" xlink:href="avdl-20211231.xsd#avdl_VestUponAchievementOfCertainCorporateObjectivesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_VestUponAchievementOfCertainCorporateObjectivesMember" xlink:to="lab_avdl_VestUponAchievementOfCertainCorporateObjectivesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_b71a82ea-f777-4e4c-ba9b-ece34735ee0f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c483f265-f146-4bb1-a4af-ef14376c5d79_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration period (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_2c9ded5f-2fec-47d3-a94b-a064d3534a97_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_d8f51ecf-34e0-4af2-99d2-c20f77e37843_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_95b68449-a9a9-4a8f-addf-be1674788533_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_74ec3ddb-c313-4f0b-84c2-ff316a2599ea_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1e8d13dd-83fb-41de-a0d2-84a96da9c492_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_cd11d372-a65c-46bf-83e3-7a73cd8126cf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1/3 vesting at third anniversary of grant date</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AmericanDepositarySharesPremiumPercentage_69fc6594-6686-4211-a4d8-74349bd29076_terseLabel_en-US" xlink:label="lab_avdl_AmericanDepositarySharesPremiumPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ADS premium percentage</link:label>
    <link:label id="lab_avdl_AmericanDepositarySharesPremiumPercentage_label_en-US" xlink:label="lab_avdl_AmericanDepositarySharesPremiumPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares, Premium Percentage</link:label>
    <link:label id="lab_avdl_AmericanDepositarySharesPremiumPercentage_documentation_en-US" xlink:label="lab_avdl_AmericanDepositarySharesPremiumPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares, Premium Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesPremiumPercentage" xlink:href="avdl-20211231.xsd#avdl_AmericanDepositarySharesPremiumPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AmericanDepositarySharesPremiumPercentage" xlink:to="lab_avdl_AmericanDepositarySharesPremiumPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_b77b2d3c-df87-4b8a-824a-58959e80bbff_terseLabel_en-US" xlink:label="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development tax credit receivable</link:label>
    <link:label id="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_label_en-US" xlink:label="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Tax Credit Receivable Non Current</link:label>
    <link:label id="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_documentation_en-US" xlink:label="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The non current portion of tax credit receivable on research and development as on the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" xlink:href="avdl-20211231.xsd#avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" xlink:to="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_78525d12-8a06-4608-9ab8-83f33295e0ed_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_9e2e48d0-5fd4-43e6-99ef-dd0ee777243e_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_e4d75102-8471-471d-a0c4-8ef3a927deae_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_OtherLiabilitiesMiscellaneousCurrent_8f3a0fa8-3009-4072-bccf-ee44c60be6cd_terseLabel_en-US" xlink:label="lab_avdl_OtherLiabilitiesMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_avdl_OtherLiabilitiesMiscellaneousCurrent_label_en-US" xlink:label="lab_avdl_OtherLiabilitiesMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Miscellaneous, Current</link:label>
    <link:label id="lab_avdl_OtherLiabilitiesMiscellaneousCurrent_documentation_en-US" xlink:label="lab_avdl_OtherLiabilitiesMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Miscellaneous, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherLiabilitiesMiscellaneousCurrent" xlink:href="avdl-20211231.xsd#avdl_OtherLiabilitiesMiscellaneousCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_OtherLiabilitiesMiscellaneousCurrent" xlink:to="lab_avdl_OtherLiabilitiesMiscellaneousCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_CARESActProceedsFromIncomeTaxRefunds_8e9de950-8d58-456c-aa78-ff61a5ae83a1_terseLabel_en-US" xlink:label="lab_avdl_CARESActProceedsFromIncomeTaxRefunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act, cash tax refunds</link:label>
    <link:label id="lab_avdl_CARESActProceedsFromIncomeTaxRefunds_label_en-US" xlink:label="lab_avdl_CARESActProceedsFromIncomeTaxRefunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act, Proceeds From Income Tax Refunds</link:label>
    <link:label id="lab_avdl_CARESActProceedsFromIncomeTaxRefunds_documentation_en-US" xlink:label="lab_avdl_CARESActProceedsFromIncomeTaxRefunds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act, Proceeds From Income Tax Refunds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CARESActProceedsFromIncomeTaxRefunds" xlink:href="avdl-20211231.xsd#avdl_CARESActProceedsFromIncomeTaxRefunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_CARESActProceedsFromIncomeTaxRefunds" xlink:to="lab_avdl_CARESActProceedsFromIncomeTaxRefunds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_d224aa7d-d376-4dc3-be9a-dbf9b5bfe033_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Newly Issued Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_65c5df3f-c1ca-4521-b55d-75911e6bf99b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term deposit</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_U.S.HoldingsMember_cc6cf741-f2a1-4bc0-985a-4943faa3965d_terseLabel_en-US" xlink:label="lab_avdl_U.S.HoldingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Holdings</link:label>
    <link:label id="lab_avdl_U.S.HoldingsMember_label_en-US" xlink:label="lab_avdl_U.S.HoldingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Holdings [Member]</link:label>
    <link:label id="lab_avdl_U.S.HoldingsMember_documentation_en-US" xlink:label="lab_avdl_U.S.HoldingsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Holdings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_U.S.HoldingsMember" xlink:href="avdl-20211231.xsd#avdl_U.S.HoldingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_U.S.HoldingsMember" xlink:to="lab_avdl_U.S.HoldingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_fbf5d566-73ed-448b-a252-c285a01e77ab_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_387c73b5-e99d-4d76-b5b1-636d02972923_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hospital Products sale</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_cdbdf192-91e2-48f7-9179-a6dcee718f02_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_001b6f9d-9015-4402-b10b-17cd3a158cda_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_OrdinaryShareNominalValue001PerShareMember_59c4d2d4-ea64-42ab-96a8-7eb934781664_terseLabel_en-US" xlink:label="lab_avdl_OrdinaryShareNominalValue001PerShareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary Share, Nominal Value $0.01 Per Share</link:label>
    <link:label id="lab_avdl_OrdinaryShareNominalValue001PerShareMember_label_en-US" xlink:label="lab_avdl_OrdinaryShareNominalValue001PerShareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary Share, Nominal Value $0.01 Per Share [Member]</link:label>
    <link:label id="lab_avdl_OrdinaryShareNominalValue001PerShareMember_documentation_en-US" xlink:label="lab_avdl_OrdinaryShareNominalValue001PerShareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary Share, Nominal Value $0.01 Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OrdinaryShareNominalValue001PerShareMember" xlink:href="avdl-20211231.xsd#avdl_OrdinaryShareNominalValue001PerShareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_OrdinaryShareNominalValue001PerShareMember" xlink:to="lab_avdl_OrdinaryShareNominalValue001PerShareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_03c718f1-20f4-4590-924e-7e39b19b7c98_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee share purchase plan share issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Ownership Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_9309d42a-b23a-4a8f-ba34-c11f1cf48228_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_96d0b7af-0293-4b45-be42-6a0535b9ed00_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from loans or conditional grants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_3b4b0eee-dae5-490a-a7af-29e31f89f102_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_88e314da-6770-4c75-a2d5-cb1215298754_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_2713c879-6ea0-477e-b3b6-3da09aff0ba1_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_4c503e30-9b18-4c48-8cba-3cba2636b503_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_0b91f5a2-afe4-4ff8-bad9-2f23715d5c42_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_0efb42e4-f6f2-4ce0-9ae8-068940c601af_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_25c95d1d-5cdb-4094-b2f3-9d1b44640315_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_40f4b740-20ea-4170-b347-25a548235065_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_ef3f2958-86e3-4adc-821c-40a77935238e_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_d03f931a-4788-4b8c-a4a9-52baab34f84a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowances</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_a749ca08-9b2f-4b8e-bb6d-4304ab27b9a9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_a82c5268-77c0-4960-aef1-24620539d891_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_c15b19f3-f434-44a0-b75d-79b3c7565922_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. - Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3b975ad1-7579-4866-8c16-3f5347d5cd8e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_b65382d7-ce5c-404d-bfcb-d47c6a414c26_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_95754da6-4c5d-4ef2-af54-feb06a31b263_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_a390be4b-266f-4d27-8ac2-144d86544c78_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation (loss) gain</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_2d9ed290-dcf2-42e9-a04c-05e7fd11f113_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_295800f8-8c1e-4646-a1bb-6fe8fc31f064_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_6a0d4ffe-80f3-459e-a8cd-9814f5e4574d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount_fd387238-21e5-4f80-bd31-ee9732b8bd0b_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in U.S. tax law</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_22ad349f-fc6e-48bd-b68d-ffc8cf1e4d3a_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_f99c1d4f-d407-4d18-beab-85e74a35b525_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_CouponInterestExpense_931cb2c4-e1b8-49d2-8b6c-95875e5c5a7e_terseLabel_en-US" xlink:label="lab_avdl_CouponInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coupon interest expense</link:label>
    <link:label id="lab_avdl_CouponInterestExpense_label_en-US" xlink:label="lab_avdl_CouponInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coupon Interest Expense</link:label>
    <link:label id="lab_avdl_CouponInterestExpense_documentation_en-US" xlink:label="lab_avdl_CouponInterestExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coupon Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CouponInterestExpense" xlink:href="avdl-20211231.xsd#avdl_CouponInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_CouponInterestExpense" xlink:to="lab_avdl_CouponInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusAxis_e71ee44e-fc51-4bdb-a23f-ed1a8f00ffec_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusAxis_label_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusAxis" xlink:to="lab_us-gaap_GranteeStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_9364b16a-9b5b-4ae5-be0d-d78f900bb1ec_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_2771275d-f48e-4848-80cd-83f7fb9489ae_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, nominal value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_b4d514a4-79ae-4980-b687-0ebe3d00baf2_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_8206df02-d6ce-4983-926c-072d729ce741_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_CustomerMember_22d3c41d-596e-4823-a9f9-67ae655c92f3_terseLabel_en-US" xlink:label="lab_avdl_CustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Corporation</link:label>
    <link:label id="lab_avdl_CustomerMember_label_en-US" xlink:label="lab_avdl_CustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CustomerMember" xlink:href="avdl-20211231.xsd#avdl_CustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_CustomerMember" xlink:to="lab_avdl_CustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_577679b9-35ac-4d8b-a4cb-947a57226cc5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant date fair value of options granted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_a4c64a61-c27b-4d09-b449-f130f1f0b3cd_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_4027e35e-28d2-4402-ac94-c4fa913fae63_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Prepaid Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_c2e6c65e-aad1-44dd-a41e-b466a3b1c397_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Three</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_ebe192bb-46b0-4820-a164-8cef1c718268_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Sale</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:to="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_608575d3-9955-4e21-bf66-381a6a8ae4e5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ce1cb53d-9537-415e-ac14-979842141322_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AmericanDepositarySharesPurchasedPricePerShare_38ca9b74-5e1f-4f85-8f01-882b8aba7f2a_verboseLabel_en-US" xlink:label="lab_avdl_AmericanDepositarySharesPurchasedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ADS purchased, price per share (in dollars per share)</link:label>
    <link:label id="lab_avdl_AmericanDepositarySharesPurchasedPricePerShare_label_en-US" xlink:label="lab_avdl_AmericanDepositarySharesPurchasedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares Purchased, Price Per Share</link:label>
    <link:label id="lab_avdl_AmericanDepositarySharesPurchasedPricePerShare_documentation_en-US" xlink:label="lab_avdl_AmericanDepositarySharesPurchasedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares Purchased, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesPurchasedPricePerShare" xlink:href="avdl-20211231.xsd#avdl_AmericanDepositarySharesPurchasedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AmericanDepositarySharesPurchasedPricePerShare" xlink:to="lab_avdl_AmericanDepositarySharesPurchasedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_929cdcf7-95d8-4606-abb7-95815a8f725a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_MarketableSecuritiesRealizedLoss_73a4b3f3-2a81-47b2-8c5b-60bd78b504fb_terseLabel_en-US" xlink:label="lab_avdl_MarketableSecuritiesRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities, realized loss</link:label>
    <link:label id="lab_avdl_MarketableSecuritiesRealizedLoss_label_en-US" xlink:label="lab_avdl_MarketableSecuritiesRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Realized Loss</link:label>
    <link:label id="lab_avdl_MarketableSecuritiesRealizedLoss_documentation_en-US" xlink:label="lab_avdl_MarketableSecuritiesRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Realized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MarketableSecuritiesRealizedLoss" xlink:href="avdl-20211231.xsd#avdl_MarketableSecuritiesRealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_MarketableSecuritiesRealizedLoss" xlink:to="lab_avdl_MarketableSecuritiesRealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_d9ce3c6a-f04a-465a-b5de-8f8aa632225f_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_3d547726-938d-45a2-90ba-0c50267ec9bb_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed asset impairment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusDomain_271f99a6-5f75-44c9-8b8d-c7123f89c6f1_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusDomain_label_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusDomain" xlink:to="lab_us-gaap_GranteeStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_63c4ce98-e377-4ff0-8fc8-590302147c6c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_baba6e73-196a-448c-9d36-dc80f80077d1_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_52316a7e-8083-47a7-8189-0cd1b271148a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_PercentageOfRoyaltyPayableOnNetSales_df587947-f0dc-4197-8182-d7e693aeb265_terseLabel_en-US" xlink:label="lab_avdl_PercentageOfRoyaltyPayableOnNetSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of royalty payable on net sales</link:label>
    <link:label id="lab_avdl_PercentageOfRoyaltyPayableOnNetSales_label_en-US" xlink:label="lab_avdl_PercentageOfRoyaltyPayableOnNetSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Royalty Payable On Net Sales</link:label>
    <link:label id="lab_avdl_PercentageOfRoyaltyPayableOnNetSales_documentation_en-US" xlink:label="lab_avdl_PercentageOfRoyaltyPayableOnNetSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percentage of royalty that has to be paid by the company as per the royalty agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PercentageOfRoyaltyPayableOnNetSales" xlink:href="avdl-20211231.xsd#avdl_PercentageOfRoyaltyPayableOnNetSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_PercentageOfRoyaltyPayableOnNetSales" xlink:to="lab_avdl_PercentageOfRoyaltyPayableOnNetSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_104b744e-352b-46d1-9767-b52bc63eeb2f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement of treasury shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_87f52bbc-05e2-406e-a11f-deb35b304bc4_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement of treasury shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_label_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Retired, Cost Method, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:to="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_d6189d4d-10b5-4e50-86fc-da9a47677c60_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount_2b767b22-0a18-4a14-866e-231f33fa6ae2_verboseLabel_en-US" xlink:label="lab_avdl_EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intercompany asset transfer</link:label>
    <link:label id="lab_avdl_EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount_label_en-US" xlink:label="lab_avdl_EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Intercompany Asset Transfer, Amount</link:label>
    <link:label id="lab_avdl_EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount_documentation_en-US" xlink:label="lab_avdl_EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Intercompany Asset Transfer, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount" xlink:href="avdl-20211231.xsd#avdl_EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount" xlink:to="lab_avdl_EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_bb70ef6d-5b6d-41dd-9bb3-b265a66336dd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToAffiliateCurrent_a359b3a1-593f-488e-a7fa-645d31a67040_terseLabel_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Exela</link:label>
    <link:label id="lab_us-gaap_DueToAffiliateCurrent_label_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Affiliate, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToAffiliateCurrent" xlink:to="lab_us-gaap_DueToAffiliateCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_b0e74a67-9e09-4a33-94eb-38ebd1359e58_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodAxis_ef313d1c-2d70-46b3-9a6a-5cda780ef45d_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis" xlink:to="lab_us-gaap_TaxPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_97d26cc4-7546-4630-9ba0-636b47bad309_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_7638fa62-cc7f-4c40-b426-e1839cd76643_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price of common stock, percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_RestrictedShareAwardsGrantedToEmployeesMember_85bbb2a4-e121-48a1-bab8-297264948212_terseLabel_en-US" xlink:label="lab_avdl_RestrictedShareAwardsGrantedToEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Awards Granted To Employees</link:label>
    <link:label id="lab_avdl_RestrictedShareAwardsGrantedToEmployeesMember_label_en-US" xlink:label="lab_avdl_RestrictedShareAwardsGrantedToEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Awards Granted To Employees [Member]</link:label>
    <link:label id="lab_avdl_RestrictedShareAwardsGrantedToEmployeesMember_documentation_en-US" xlink:label="lab_avdl_RestrictedShareAwardsGrantedToEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Awards Granted To Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestrictedShareAwardsGrantedToEmployeesMember" xlink:href="avdl-20211231.xsd#avdl_RestrictedShareAwardsGrantedToEmployeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_RestrictedShareAwardsGrantedToEmployeesMember" xlink:to="lab_avdl_RestrictedShareAwardsGrantedToEmployeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_17e665d5-6acc-4225-be41-b4c1d502566f_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9d3596e8-2f60-47d3-8695-436f719d2368_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_2a36a5e6-b535-4b84-961a-615715f62a87_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_PublicOfferingMember_0a6bc8f0-00a1-4ed6-bba7-6907a3e1a392_terseLabel_en-US" xlink:label="lab_avdl_PublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Offering</link:label>
    <link:label id="lab_avdl_PublicOfferingMember_label_en-US" xlink:label="lab_avdl_PublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Offering [Member]</link:label>
    <link:label id="lab_avdl_PublicOfferingMember_documentation_en-US" xlink:label="lab_avdl_PublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Offering [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PublicOfferingMember" xlink:href="avdl-20211231.xsd#avdl_PublicOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_PublicOfferingMember" xlink:to="lab_avdl_PublicOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_46269b4c-4951-466f-8c83-5e565ba3925d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross research tax credit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_77afe2f3-5c16-4480-add8-dc99ad0f7f81_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9940ace0-fa11-4b62-9097-1aec206c5cd7_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_93206a79-3a75-45ab-bb27-e8f77fffa1f9_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: valuation allowances</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_8ce802cc-b2fb-417b-ba35-4a52c4eed00a_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_255bf59f-c7c5-41c2-983c-cf75814955b0_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_43ff989d-81ba-4036-808c-3be5abe4db47_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit_0d482bf7-634b-4fa7-a682-e34877b75b2f_negatedTerseLabel_en-US" xlink:label="lab_avdl_EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orphan drug and R&amp;D tax credit</link:label>
    <link:label id="lab_avdl_EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit_label_en-US" xlink:label="lab_avdl_EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Amount, Orphan Drug and Research And Development Tax Credit</link:label>
    <link:label id="lab_avdl_EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit_documentation_en-US" xlink:label="lab_avdl_EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Amount, Orphan Drug and Research And Development Tax Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit" xlink:href="avdl-20211231.xsd#avdl_EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit" xlink:to="lab_avdl_EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4a8e06a6-cfe1-43a2-9395-d5d73bd503bd_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_841824f4-88fa-4e48-bc17-2ebce607cfe0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Capitalization, Long-term Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Capitalization, Long-term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems" xlink:to="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_8d80030d-9dee-4a7e-a8c0-6c1857e46035_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_80bd1433-6d08-4910-84f7-ca65994ef3ac_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_VestUponTheAchievementOfCertainRegulatoryMilestonesMember_bdeef282-9baf-49c8-9137-aabe563dcec1_terseLabel_en-US" xlink:label="lab_avdl_VestUponTheAchievementOfCertainRegulatoryMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vest Upon The Achievement Of Certain Regulatory Milestones</link:label>
    <link:label id="lab_avdl_VestUponTheAchievementOfCertainRegulatoryMilestonesMember_label_en-US" xlink:label="lab_avdl_VestUponTheAchievementOfCertainRegulatoryMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vest Upon The Achievement Of Certain Regulatory Milestones [Member]</link:label>
    <link:label id="lab_avdl_VestUponTheAchievementOfCertainRegulatoryMilestonesMember_documentation_en-US" xlink:label="lab_avdl_VestUponTheAchievementOfCertainRegulatoryMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vest Upon The Achievement Of Certain Regulatory Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_VestUponTheAchievementOfCertainRegulatoryMilestonesMember" xlink:href="avdl-20211231.xsd#avdl_VestUponTheAchievementOfCertainRegulatoryMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_VestUponTheAchievementOfCertainRegulatoryMilestonesMember" xlink:to="lab_avdl_VestUponTheAchievementOfCertainRegulatoryMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_49231a61-948b-4aaf-94ff-27293cb4daa9_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_176bbadf-6297-4e3e-aea9-6a04949b493d_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c9f33917-3c0e-4818-b68f-7d63f6e76979_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_3bdf66ce-1379-4675-9585-23048fe3ad42_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_5051e9e7-b868-482b-9062-b3184ad8bfc8_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_b74e7b7b-3258-4ae6-955f-2479464150f8_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive (loss) income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_61bcd83e-a8ac-47f4-b463-a0af9827a347_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_f434c2ca-a7dc-449e-8477-b5b09892b282_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_5f29f319-faad-4bfe-bf17-98c621a0c0ad_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxYear2020Member_6c153ee0-df78-4b79-9313-6238768b588d_terseLabel_en-US" xlink:label="lab_us-gaap_TaxYear2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2020</link:label>
    <link:label id="lab_us-gaap_TaxYear2020Member_label_en-US" xlink:label="lab_us-gaap_TaxYear2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxYear2020Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxYear2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxYear2020Member" xlink:to="lab_us-gaap_TaxYear2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_06ac93ee-2643-41b0-b122-9fb7e198bfce_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_a093d66e-73c7-4dab-8e9f-fed715c082a6_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_50809b4d-bf5b-481c-9c3c-5f9733412914_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_0e03a9ea-a9b4-4633-9041-cf6b36e163db_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_74fdfa48-7ee3-48b7-be09-a230443de43d_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAdjustmentMember_c0f66eee-016b-4dae-a16b-7a85eb09395e_terseLabel_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustments</link:label>
    <link:label id="lab_srt_RestatementAdjustmentMember_label_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAdjustmentMember" xlink:to="lab_srt_RestatementAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_05e57771-8d07-4716-b052-e894a4a5a008_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board of Directors</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_837e8377-26c0-48a5-9293-c7fa89b562b5_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_SpecialtyPharmaMember_f42bd01c-bf7f-4100-ad32-f86de12ebdc3_terseLabel_en-US" xlink:label="lab_avdl_SpecialtyPharmaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Pharma</link:label>
    <link:label id="lab_avdl_SpecialtyPharmaMember_label_en-US" xlink:label="lab_avdl_SpecialtyPharmaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Pharma [Member]</link:label>
    <link:label id="lab_avdl_SpecialtyPharmaMember_documentation_en-US" xlink:label="lab_avdl_SpecialtyPharmaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Pharma [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_SpecialtyPharmaMember" xlink:href="avdl-20211231.xsd#avdl_SpecialtyPharmaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_SpecialtyPharmaMember" xlink:to="lab_avdl_SpecialtyPharmaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_f71b7dec-ef9a-4b1e-a857-fc50e864a763_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_c1e86930-449c-42be-ac85-2d53dd90bb8e_terseLabel_en-US" xlink:label="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Prepaid Expenses and Other Current Assets</link:label>
    <link:label id="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Prepaid Expenses and Other Current Assets [Table Text Block]</link:label>
    <link:label id="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_documentation_en-US" xlink:label="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the carrying amounts of prepaid expenses and other current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:href="avdl-20211231.xsd#avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:to="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AccruedOutsourceContractCosts_47b9bf7a-b61b-4597-8518-f99edb39b437_terseLabel_en-US" xlink:label="lab_avdl_AccruedOutsourceContractCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued outsourced contract costs</link:label>
    <link:label id="lab_avdl_AccruedOutsourceContractCosts_label_en-US" xlink:label="lab_avdl_AccruedOutsourceContractCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Outsource Contract Costs</link:label>
    <link:label id="lab_avdl_AccruedOutsourceContractCosts_documentation_en-US" xlink:label="lab_avdl_AccruedOutsourceContractCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Outsource Contract Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedOutsourceContractCosts" xlink:href="avdl-20211231.xsd#avdl_AccruedOutsourceContractCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AccruedOutsourceContractCosts" xlink:to="lab_avdl_AccruedOutsourceContractCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_59469c04-098e-4b51-9c38-b2b271eaef17_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_63077738-2982-4041-aff6-68dfbfa18754_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_7be33663-0c63-4dc2-b178-11d8b516e3a9_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_14a7e9d4-e9fa-429e-9cd7-cccc3cbb4c0b_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_c838fd42-17fc-4335-b7e7-937f2a956fa0_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_60190ff9-1064-488d-9487-f63f338d1268_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_7ea0fec9-2fb9-4544-8915-01d1e55e6288_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_c7d3e371-4317-441d-a7d5-f776c3993ea7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposition of the Hospital Products</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:to="lab_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_053c2273-b81c-42f7-be85-fb63e259ef96_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_ScheduleOfComponentsOfIncomeBeforeIncomeTaxTableTextBlock_96151f91-6e52-4733-a537-cc3d110407e2_verboseLabel_en-US" xlink:label="lab_avdl_ScheduleOfComponentsOfIncomeBeforeIncomeTaxTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Components Of Loss Before Income Tax</link:label>
    <link:label id="lab_avdl_ScheduleOfComponentsOfIncomeBeforeIncomeTaxTableTextBlock_label_en-US" xlink:label="lab_avdl_ScheduleOfComponentsOfIncomeBeforeIncomeTaxTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Components Of Income Before Income Tax [Table Text Block]</link:label>
    <link:label id="lab_avdl_ScheduleOfComponentsOfIncomeBeforeIncomeTaxTableTextBlock_documentation_en-US" xlink:label="lab_avdl_ScheduleOfComponentsOfIncomeBeforeIncomeTaxTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of components of income before income tax.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ScheduleOfComponentsOfIncomeBeforeIncomeTaxTableTextBlock" xlink:href="avdl-20211231.xsd#avdl_ScheduleOfComponentsOfIncomeBeforeIncomeTaxTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_ScheduleOfComponentsOfIncomeBeforeIncomeTaxTableTextBlock" xlink:to="lab_avdl_ScheduleOfComponentsOfIncomeBeforeIncomeTaxTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReorganizationUnderChapter11OfUSBankruptcyCodeDisclosureTextBlock_5e057c46-94e1-4d39-abdf-98544a39f0b3_terseLabel_en-US" xlink:label="lab_us-gaap_ReorganizationUnderChapter11OfUSBankruptcyCodeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary Bankruptcy and Deconsolidation</link:label>
    <link:label id="lab_us-gaap_ReorganizationUnderChapter11OfUSBankruptcyCodeDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ReorganizationUnderChapter11OfUSBankruptcyCodeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reorganization under Chapter 11 of US Bankruptcy Code Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReorganizationUnderChapter11OfUSBankruptcyCodeDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReorganizationUnderChapter11OfUSBankruptcyCodeDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReorganizationUnderChapter11OfUSBankruptcyCodeDisclosureTextBlock" xlink:to="lab_us-gaap_ReorganizationUnderChapter11OfUSBankruptcyCodeDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxYear2019Member_5837476a-ad1c-4698-a066-b9c34ffa0787_terseLabel_en-US" xlink:label="lab_us-gaap_TaxYear2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2019</link:label>
    <link:label id="lab_us-gaap_TaxYear2019Member_label_en-US" xlink:label="lab_us-gaap_TaxYear2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2019 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxYear2019Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxYear2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxYear2019Member" xlink:to="lab_us-gaap_TaxYear2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_24f6c034-932c-40e2-a29c-f287556d58e3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_4066f218-2903-4c2a-962f-a9be12074330_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increases for tax positions of prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_a69a30e7-15a5-43dc-9e20-d4effc30deec_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_3616351f-e5f5-46c8-8c0e-3dd79d06352b_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_8c3ed9ee-94d7-47cc-afba-696e92fba60b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_cc43e1b7-578c-4269-a2f6-813e62a08b07_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_StockIssuedDuringPeriodValuePublicOffering_b38fb721-02fa-4096-8df8-c0716b5d9dcc_terseLabel_en-US" xlink:label="lab_avdl_StockIssuedDuringPeriodValuePublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 2020 public offering</link:label>
    <link:label id="lab_avdl_StockIssuedDuringPeriodValuePublicOffering_label_en-US" xlink:label="lab_avdl_StockIssuedDuringPeriodValuePublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value Public Offering</link:label>
    <link:label id="lab_avdl_StockIssuedDuringPeriodValuePublicOffering_documentation_en-US" xlink:label="lab_avdl_StockIssuedDuringPeriodValuePublicOffering" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_StockIssuedDuringPeriodValuePublicOffering" xlink:href="avdl-20211231.xsd#avdl_StockIssuedDuringPeriodValuePublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_StockIssuedDuringPeriodValuePublicOffering" xlink:to="lab_avdl_StockIssuedDuringPeriodValuePublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_cb66a067-6506-424b-ab56-636bbe2a557e_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture, fixtures and fittings</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f6286fac-ec7c-427c-b3a5-14cd7ab251f8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_87e0d668-db73-4bbc-a456-e1daa8e40869_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_9ac11da3-fc11-4fb5-b28f-7bfdbad4928c_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Lease Costs</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_4f01e892-95cc-4acb-b5cf-6cad7c4de5ab_terseLabel_en-US" xlink:label="lab_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50% Exchangeable Senior Notes Due 2023</link:label>
    <link:label id="lab_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_label_en-US" xlink:label="lab_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Fifty Percent Exchangeable Senior Notes Due 2023 [Member]</link:label>
    <link:label id="lab_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_documentation_en-US" xlink:label="lab_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Fifty Percent Exchangeable Senior Notes Due 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member" xlink:href="avdl-20211231.xsd#avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member" xlink:to="lab_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_4a86f088-02e2-458d-ad9e-c1dc7131205d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_09c96a53-332e-4f06-94b5-e8a1f25f1f0d_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit_18e16bfc-b05e-4a87-b01c-4c4b63d18cc0_terseLabel_en-US" xlink:label="lab_avdl_CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act, change in tax rate, deferred tax liability, income tax benefit</link:label>
    <link:label id="lab_avdl_CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit_label_en-US" xlink:label="lab_avdl_CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronavirus Aid, Relief And Economic Security Act (CARES Act), Change in Tax Rate, Deferred Tax Liability, Income Tax Benefit</link:label>
    <link:label id="lab_avdl_CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit_documentation_en-US" xlink:label="lab_avdl_CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronavirus Aid, Relief And Economic Security Act (CARES Act), Change in Tax Rate, Deferred Tax Liability, Income Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit" xlink:href="avdl-20211231.xsd#avdl_CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit" xlink:to="lab_avdl_CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6f6e0d25-fed5-4996-88ce-d891cea7f57d_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of shares outstanding - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6f275dfd-cb0b-4d07-b058-04b6158f5c97_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_e65a1a19-0553-402a-af21-2f3b4a7f525a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per share - diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue_337acd8b-a277-464b-8887-a83055857505_terseLabel_en-US" xlink:label="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee to Deerfield</link:label>
    <link:label id="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue_label_en-US" xlink:label="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Guarantor Obligations, Current Carrying Value</link:label>
    <link:label id="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue_documentation_en-US" xlink:label="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Guarantor Obligations, Current Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherGuarantorObligationsCurrentCarryingValue" xlink:href="avdl-20211231.xsd#avdl_OtherGuarantorObligationsCurrentCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_OtherGuarantorObligationsCurrentCarryingValue" xlink:to="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_a2b494ad-d201-4fa4-a077-c73586890b8f_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount and debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_4b7dc3fa-106c-4f49-9d2e-99fd2ddd84f1_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public offering, price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_c5147d2a-1938-4e2c-9e20-1a7960bb4a42_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold percentage of stock price trigger</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_69adc61e-30e4-4139-884f-b8d8ac51735d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities&#8212;employee and director equity awards outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_1aef15a6-f614-4cbc-9020-ba5d61acddc1_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_add4015d-f571-49c7-9821-3357221faeb2_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid (refund), net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_FinancingRelatedContingentConsiderationRemeasurement_e377933f-1944-4f19-a017-731927f54116_terseLabel_en-US" xlink:label="lab_avdl_FinancingRelatedContingentConsiderationRemeasurement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement of financing-related contingent consideration</link:label>
    <link:label id="lab_avdl_FinancingRelatedContingentConsiderationRemeasurement_label_en-US" xlink:label="lab_avdl_FinancingRelatedContingentConsiderationRemeasurement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Related Contingent Consideration Remeasurement</link:label>
    <link:label id="lab_avdl_FinancingRelatedContingentConsiderationRemeasurement_documentation_en-US" xlink:label="lab_avdl_FinancingRelatedContingentConsiderationRemeasurement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the remeasurement of financing related contingent considerations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FinancingRelatedContingentConsiderationRemeasurement" xlink:href="avdl-20211231.xsd#avdl_FinancingRelatedContingentConsiderationRemeasurement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_FinancingRelatedContingentConsiderationRemeasurement" xlink:to="lab_avdl_FinancingRelatedContingentConsiderationRemeasurement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_7f939531-71da-41a4-a2cb-5fdccaf4da10_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_NoncashGainLossDeconsolidationOfSubsidiary_c1cfbda4-1894-45f0-8e53-5b861b7d81ed_negatedTerseLabel_en-US" xlink:label="lab_avdl_NoncashGainLossDeconsolidationOfSubsidiary" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on deconsolidation of subsidiary</link:label>
    <link:label id="lab_avdl_NoncashGainLossDeconsolidationOfSubsidiary_label_en-US" xlink:label="lab_avdl_NoncashGainLossDeconsolidationOfSubsidiary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Gain (Loss) Deconsolidation Of Subsidiary</link:label>
    <link:label id="lab_avdl_NoncashGainLossDeconsolidationOfSubsidiary_documentation_en-US" xlink:label="lab_avdl_NoncashGainLossDeconsolidationOfSubsidiary" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Gain (Loss) Deconsolidation Of Subsidiary</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_NoncashGainLossDeconsolidationOfSubsidiary" xlink:href="avdl-20211231.xsd#avdl_NoncashGainLossDeconsolidationOfSubsidiary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_NoncashGainLossDeconsolidationOfSubsidiary" xlink:to="lab_avdl_NoncashGainLossDeconsolidationOfSubsidiary" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_e77c48ed-1d46-4e04-bda8-08b26580438c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_163aa3cb-4a2c-4eeb-85ed-387ed3fcbd77_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Differences in international tax rates</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_931cad48-844f-4b69-b772-2242c927c023_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_6bca05ff-31b8-4366-9211-3ff2f8ef6637_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_4abcfcfd-30c9-47e1-9eb8-a6c9acf0f057_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_d92a9094-db52-4f03-8940-f5a20cffcc6c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_64bffbcc-7e8b-4c29-ad14-8cb913cce395_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued restructuring (see Note 16)</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveCurrent" xlink:to="lab_us-gaap_RestructuringReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_83fb8185-51c5-4cba-8193-3d863597b1c5_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_721af092-c4d9-4c78-927c-50717a04cb1c_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a3394cf7-f1fc-4033-bbd7-4469b4a2bdab_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_3a7ea407-bc54-4d9d-b535-fc0ae1a4c1da_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax penalties and interest expense</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_e43ff0f7-9a67-4e17-af52-55ff3f937602_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_3c5baad0-6dd0-42c2-9db0-2127b2675453_negatedLabel_en-US" xlink:label="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development tax credit receivable</link:label>
    <link:label id="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_label_en-US" xlink:label="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Research and Development Tax Credit Receivable</link:label>
    <link:label id="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_documentation_en-US" xlink:label="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The increase (decrease) during the reporting period in research and development tax credit receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" xlink:href="avdl-20211231.xsd#avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" xlink:to="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_OtherNoncurrentReceivables_b8eea39c-776e-4ec0-9803-89b4f1c38dc2_terseLabel_en-US" xlink:label="lab_avdl_OtherNoncurrentReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_avdl_OtherNoncurrentReceivables_label_en-US" xlink:label="lab_avdl_OtherNoncurrentReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Receivables</link:label>
    <link:label id="lab_avdl_OtherNoncurrentReceivables_documentation_en-US" xlink:label="lab_avdl_OtherNoncurrentReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The carrying amount of other noncurrent receivables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherNoncurrentReceivables" xlink:href="avdl-20211231.xsd#avdl_OtherNoncurrentReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_OtherNoncurrentReceivables" xlink:to="lab_avdl_OtherNoncurrentReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_6f1001a0-0dbb-43a5-994d-342340a09ff9_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_46d5cdab-b615-41da-9088-25dcff166f01_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_91d7c509-973e-455b-93d2-aa7e9a06efe7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_fde5350f-6395-4ae8-a1af-80c6b3bf2b64_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring costs</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_59a3d068-2e2b-48e8-81e9-b75feb610994_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_8f8df80f-8993-454c-880a-e0d47d418e5a_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Salaries, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalariesCurrent" xlink:to="lab_us-gaap_AccruedSalariesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_8b2c3ff5-ccb3-447d-bffc-c7eecf3ede90_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_591822c2-4680-44f2-b790-2176111e2f95_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_SpecialityPharamaMember_90e7b24e-7071-428c-947e-9cf985a344fb_terseLabel_en-US" xlink:label="lab_avdl_SpecialityPharamaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Speciality Pharama</link:label>
    <link:label id="lab_avdl_SpecialityPharamaMember_label_en-US" xlink:label="lab_avdl_SpecialityPharamaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Speciality Pharama [Member]</link:label>
    <link:label id="lab_avdl_SpecialityPharamaMember_documentation_en-US" xlink:label="lab_avdl_SpecialityPharamaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Speciality Pharama [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_SpecialityPharamaMember" xlink:href="avdl-20211231.xsd#avdl_SpecialityPharamaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_SpecialityPharamaMember" xlink:to="lab_avdl_SpecialityPharamaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_01047865-e0ef-456c-8a24-6e3612d0af70_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_e73eda76-d4ff-4710-92ec-f5d6ce57786b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_eb9677d7-989f-4261-8620-591cf18d8d52_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a3c801b1-f9dd-4d0d-8563-aab7cbcf88b8_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_1569e440-e760-44b3-949e-4cce8ef0c438_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5-10 Years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_ae6a9f51-396c-4985-8228-e39dfd16f0c2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement of treasury shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_c33d2ee8-639b-40bc-8c66-f0e05c3b02a6_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement of treasury shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Retired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesRetired" xlink:to="lab_us-gaap_TreasuryStockSharesRetired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_7485d848-1394-4f60-8ac9-d033dcd5f66e_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_534277b2-aea9-4f49-8856-4140b69903b7_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract_673c1261-4f64-4007-83c4-90c82f1f2d73_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay_cbc85064-f4f9-4b0e-bdd3-d3fbb31f3f55_terseLabel_en-US" xlink:label="lab_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of product of the last reported sale price of the American Depositary Shares and the exchange rate on each such trading day</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay_label_en-US" xlink:label="lab_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Percentage of Product Of The Last Reported Sale Price Of The American Depositary Shares And The Exchange Rate On Each Such Trading Day</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay_documentation_en-US" xlink:label="lab_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Percentage of Product Of The Last Reported Sale Price Of The American Depositary Shares And The Exchange Rate On Each Such Trading Day</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" xlink:href="avdl-20211231.xsd#avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" xlink:to="lab_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_2372ba68-95c5-4de2-83a5-f616028dc4f9_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_ea13d963-16c8-4d45-9880-d8daa90820c5_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_2683d419-d95a-4207-a8e9-24d474a7090a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the disposition of the Hospital Products</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_c683d40e-c163-4ce2-bc1f-373a54ab435f_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_sic_Z8880_5fc8047a-bb7f-4400-87fe-6112ebeebce5_terseLabel_en-US" xlink:label="lab_sic_Z8880" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Receipts</link:label>
    <link:label id="lab_sic_Z8880_label_en-US" xlink:label="lab_sic_Z8880" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">8880 American Depositary Receipts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sic_Z8880" xlink:href="https://xbrl.sec.gov/sic/2021/sic-2021.xsd#sic_Z8880"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sic_Z8880" xlink:to="lab_sic_Z8880" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FixedIncomeSecuritiesMember_7dfed6d2-aedd-4a33-bae5-85a69e67fd62_terseLabel_en-US" xlink:label="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other fixed-income securities</link:label>
    <link:label id="lab_us-gaap_FixedIncomeSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FixedIncomeSecuritiesMember" xlink:to="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_84d2a914-edfe-4473-b12b-3bf007cad659_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_1e1f88e0-5b53-4f79-aa4a-1ff858192003_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. - State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_62272ba8-5031-4f13-9e0a-1509ed4b3aa6_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_be39f7eb-0080-43e7-8f9e-bd9b6289c029_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_f30fc956-3fb9-4b4d-ae18-bf3743f5a973_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment Useful Life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_8a6da41e-520f-445e-a7ec-20192cb45771_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_e160e329-6dc5-400a-baed-2bbee159171b_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, tax credit carryforwards, research</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_9b447cc6-eff4-4892-ab0b-04a77fa077dc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_56b0d7ff-0742-493d-8159-82a7a628b5c9_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal, State and Local, Tax Expense (Benefit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_75b4ce89-4ca0-4cbd-ad00-5baf41a3e411_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_80911941-1f77-435e-879e-f248680e73f2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_e807a434-f8cb-4e3b-a8db-0fde6facc6dd_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_69f0d060-128a-4086-9bbc-2d32c04e8661_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_ac55a860-71a1-48b4-8f5f-8ed75d06b826_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_6e9f7773-0a3d-4028-82b2-1ff5e31d22fb_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProFormaMember_f93dcf77-fa83-461d-8760-1e3bf4be7c40_terseLabel_en-US" xlink:label="lab_srt_ProFormaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma</link:label>
    <link:label id="lab_srt_ProFormaMember_label_en-US" xlink:label="lab_srt_ProFormaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProFormaMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProFormaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProFormaMember" xlink:to="lab_srt_ProFormaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember_ee141b53-1ddb-4cc2-adeb-adb18c36f107_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Employee</link:label>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Employee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:to="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_4ee99acf-5852-4453-a417-1c056e79cfe0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_f9be4b67-70d0-4950-9ea2-7ac29e629373_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_12013f19-ca0c-4bcb-8414-17510eefe8b3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_2c491ce5-41f0-4cce-b991-8f28f3447bcf_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_4f132738-4e1a-44f0-bca7-3dc9fc07af45_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_dfd3104b-aba5-4372-92e4-49f720f14cfb_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_ef1d6fda-43b9-4cd7-bbda-cee44c4dc7ba_terseLabel_en-US" xlink:label="lab_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from release of certain liabilities</link:label>
    <link:label id="lab_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_83bcc925-1d9b-4fdd-89e2-d8e3ac8286a4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from release of certain liabilities</link:label>
    <link:label id="lab_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_label_en-US" xlink:label="lab_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deconsolidation, Revaluation of Retained Investment, Gain (Loss), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" xlink:to="lab_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_a828e4e6-a78b-4470-bc61-075b1a487d30_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_FSCMember_91afc58a-e4a3-4c76-9fb3-2e791399e280_terseLabel_en-US" xlink:label="lab_avdl_FSCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FSC</link:label>
    <link:label id="lab_avdl_FSCMember_label_en-US" xlink:label="lab_avdl_FSCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FSC [Member]</link:label>
    <link:label id="lab_avdl_FSCMember_documentation_en-US" xlink:label="lab_avdl_FSCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FSC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FSCMember" xlink:href="avdl-20211231.xsd#avdl_FSCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_FSCMember" xlink:to="lab_avdl_FSCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_fa853078-0437-4838-85c9-1e1cf14f97cf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1/4 vesting at each anniversary of grant date</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_554d6b3c-4c14-444c-8774-a0d2a665e39f_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1a7d9036-0f73-421f-ac6c-701a8ed5b675_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options outstanding, beginning balance (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_bd926a4e-b3d6-4972-824f-7eddc8d212e4_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options outstanding, ending balance (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_bcc2ea67-f20a-483b-a829-f988b9da72c9_verboseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_4418e610-f3a2-4d34-a179-ecd03d38644a_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueOther_727fccb4-2820-4969-a9cc-46f1275fb7f3_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueOther" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueOther_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_80a0b4e6-9a49-492a-89aa-c7fdc2aa92a3_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_d4fac542-28b3-4f5f-a272-3bf0ff287834_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options exercisable, Weighted Average Remaining Contractual Life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_96b5281c-ec91-45dc-a5f4-981a9da4f032_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7465b756-1fa2-44b2-89fb-63343c3bd4bb_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Free Share Activity and Other Data, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueAdjustment_bc2537da-22da-497f-bf25-10470efa1623_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustments</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueAdjustment_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueAdjustment" xlink:to="lab_us-gaap_LiabilitiesFairValueAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_0c4a87c7-a6cf-43e5-8d98-dfa176527e6c_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesAPreferredStockMember" xlink:to="lab_us-gaap_SeriesAPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_cef9cc65-9adf-4d48-ae53-6d8952879e5a_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges against additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_84dc05ad-059f-42ab-936a-4146d4174b34_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesOther_28b531c1-2ce7-4fc3-8b8f-11565f4f07f0_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesOther_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7163df85-16e6-46b7-88cb-de69adc7fefa_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at January 1</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_07576f12-ec67-4f94-a017-674bad62ce29_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at December 31</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_d7cc6658-7272-4434-9e6c-4097e6ac1c01_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public offering, shares issued</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_04b568c1-9dcd-463d-bd73-d9135795a7e6_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_7e75648f-044b-4228-95d9-77d0db8a7688_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, nominal value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_5e609877-6d9a-4c34-b922-f3260396b9e7_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, nominal value (in usd or euro per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_b70210c5-86a6-45ee-89ee-9bbb4cc4508f_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f8454c24-37f9-45e4-a36d-02fc3b1cf1a3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_f00a0755-3468-4147-93c4-b8d09b5a8311_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing activities, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_IncreaseDecreaseInIncomeTaxBenefit_ca25c0ce-ee5a-4dfc-b859-cb262872c5dd_terseLabel_en-US" xlink:label="lab_avdl_IncreaseDecreaseInIncomeTaxBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in income tax benefit</link:label>
    <link:label id="lab_avdl_IncreaseDecreaseInIncomeTaxBenefit_label_en-US" xlink:label="lab_avdl_IncreaseDecreaseInIncomeTaxBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Income Tax Benefit</link:label>
    <link:label id="lab_avdl_IncreaseDecreaseInIncomeTaxBenefit_documentation_en-US" xlink:label="lab_avdl_IncreaseDecreaseInIncomeTaxBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Income Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_IncreaseDecreaseInIncomeTaxBenefit" xlink:href="avdl-20211231.xsd#avdl_IncreaseDecreaseInIncomeTaxBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_IncreaseDecreaseInIncomeTaxBenefit" xlink:to="lab_avdl_IncreaseDecreaseInIncomeTaxBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_a2c618f5-f35f-45dc-be39-3e7d6d9630b3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_329a191a-f3a0-43ce-b195-5708b554c9f1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares reserved and available for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments_01d5fe84-e1cf-443e-a8db-7e50f4b90b1c_terseLabel_en-US" xlink:label="lab_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional consideration paid in monthly installments</link:label>
    <link:label id="lab_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments_label_en-US" xlink:label="lab_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Additional Consideration Paid In Monthly Installments</link:label>
    <link:label id="lab_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments_documentation_en-US" xlink:label="lab_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Additional Consideration Paid In Monthly Installments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments" xlink:href="avdl-20211231.xsd#avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments" xlink:to="lab_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_5ab5f546-b7fa-44f1-b4bd-1d400a5d9c78_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_15107a23-0160-446d-9b3b-c39997eb9ef0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_3ecc238f-b536-4b5f-aaf1-2c9701d20af9_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_f798cb54-15c7-49d1-9a59-e02c1f84098f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_a82139ac-5a85-4482-89e0-845f0f46ea73_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS)</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_IncomeTaxesLineItems_5cfb20ec-ab8d-47b2-bde0-27cc99db6503_terseLabel_en-US" xlink:label="lab_avdl_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_avdl_IncomeTaxesLineItems_label_en-US" xlink:label="lab_avdl_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_IncomeTaxesLineItems" xlink:href="avdl-20211231.xsd#avdl_IncomeTaxesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_IncomeTaxesLineItems" xlink:to="lab_avdl_IncomeTaxesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis_3ceef256-99a6-402f-af4a-9d6d960a2624_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity [Axis]</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_d1594adb-e044-4396-b9bf-506a36dc67db_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_3ecf2d71-d7b8-4e8e-8148-1d5f57deb0e1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_CerecorMember_3d391af3-c71c-4516-97e8-c089ed2c09ef_terseLabel_en-US" xlink:label="lab_avdl_CerecorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cerecor</link:label>
    <link:label id="lab_avdl_CerecorMember_label_en-US" xlink:label="lab_avdl_CerecorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cerecor [Member]</link:label>
    <link:label id="lab_avdl_CerecorMember_documentation_en-US" xlink:label="lab_avdl_CerecorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cerecor [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CerecorMember" xlink:href="avdl-20211231.xsd#avdl_CerecorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_CerecorMember" xlink:to="lab_avdl_CerecorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_c81b7805-9e57-43db-99a6-52239b729322_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_37c845a2-65db-4590-b8d6-3747516c60b2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4bba4068-7428-484b-b7b1-deb23d96178b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_18e44af3-c34b-4c7a-98a3-a65b944005d9_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of shares outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0c72a389-45bc-44c3-9905-30ad78e3993b_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e7cdfac0-d21b-4b56-bcc8-166c69e141ba_terseLabel_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Corrections and Prior Period Adjustments Restatement [Line Items]</link:label>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_label_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Corrections and Prior Period Adjustments Restatement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_32eef5cd-406b-4ae3-8ee6-d69252c38221_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_d51c0760-cffa-49de-8be2-f2f529465647_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_eef228b2-67e6-4158-9fce-852ef75bfc19_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_729c8c96-1b5f-4aae-85ca-60b043148a97_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation, Stock Options, Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_060e1c33-80d7-4e60-8ff7-b48c7ac12adf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities either Transferred Or Eliminated Representing the Aggregate Consideration of Disposal Group</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_c8a520e2-9c44-4fc0-8084-17d91d5be363_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statute of limitations expiration</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_dd9c9d3f-f93d-4125-bbca-0433414ac055_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_5e6df3b4-c438-499b-902f-2f4d9ce507c1_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_bf7d1953-849e-4e48-b244-d8e43e4357f5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_dd9954b6-de96-4325-87ce-9970c3a61889_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0af079da-b5c7-4c4a-8ca0-84f729336af7_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_RoyaltyPayableonNetSalesMaximum_fe916f4d-2919-4a45-afb3-d86d80136242_terseLabel_en-US" xlink:label="lab_avdl_RoyaltyPayableonNetSalesMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty payable on net sales, maximum</link:label>
    <link:label id="lab_avdl_RoyaltyPayableonNetSalesMaximum_label_en-US" xlink:label="lab_avdl_RoyaltyPayableonNetSalesMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Payable on Net Sales, Maximum</link:label>
    <link:label id="lab_avdl_RoyaltyPayableonNetSalesMaximum_documentation_en-US" xlink:label="lab_avdl_RoyaltyPayableonNetSalesMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Payable on Net Sales, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RoyaltyPayableonNetSalesMaximum" xlink:href="avdl-20211231.xsd#avdl_RoyaltyPayableonNetSalesMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_RoyaltyPayableonNetSalesMaximum" xlink:to="lab_avdl_RoyaltyPayableonNetSalesMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_746e4350-088c-417e-a9ab-e12f150a9359_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligation_a199bb94-1bf2-481f-9783-10b47875d7fe_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase obligation</link:label>
    <link:label id="lab_us-gaap_PurchaseObligation_label_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligation" xlink:to="lab_us-gaap_PurchaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_873191a9-9d90-4cdd-95fb-bf10fe8cdd3a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays_d97e0652-fc7b-4e00-9b77-a285b4b2e973_terseLabel_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consecutive business days</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays_label_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Business Days</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays_documentation_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Business Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" xlink:href="avdl-20211231.xsd#avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" xlink:to="lab_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_694dd22d-29ad-4452-b076-1a1e101fd1c7_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_7afd1b16-0d85-4b6e-91a0-2674d9f974f5_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2eef5191-c86d-48c8-bca9-77debbfc3169_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net changes in assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ce8dae4d-9973-4345-828c-cfc32f122d5a_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less - accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_624fb0c7-015d-411c-8f98-c6b8f69b5bda_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee share purchase plan share issuance</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts_d38e21b3-560b-4864-9c26-0e12b198807c_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Losses, Policy for Uncollectible Amounts [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" xlink:to="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9780a57c-3cda-4226-8478-6626a22ec1f8_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a3e117f5-27b1-4002-8eb4-18cced6b28f6_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_3672258b-9462-4885-b317-1e5f4a4facb7_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_512bc41e-c4b0-4e0b-a462-92c0459b65b7_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average period for unrecognized expense (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_11879662-a959-4d0b-b5d2-13b7b2b0b601_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_4d692a81-6ce4-4590-acad-c48cf1cf9211_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_3a4723ab-3ff8-409e-90d9-642fcb10abf7_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_7a1039eb-2e0d-4b01-b72a-4fce703dbaab_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of related party payable</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_GuaranteeCurrent_43b65f76-a5e6-4c25-8579-4fb3fa015dbb_verboseLabel_en-US" xlink:label="lab_avdl_GuaranteeCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee from Armistice</link:label>
    <link:label id="lab_avdl_GuaranteeCurrent_label_en-US" xlink:label="lab_avdl_GuaranteeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee, Current</link:label>
    <link:label id="lab_avdl_GuaranteeCurrent_documentation_en-US" xlink:label="lab_avdl_GuaranteeCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeCurrent" xlink:href="avdl-20211231.xsd#avdl_GuaranteeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_GuaranteeCurrent" xlink:to="lab_avdl_GuaranteeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AcquisitionRelatedContingentConsiderationRemeasurement_41df1f1f-c9e9-4393-a7b7-f202bfd6dbf5_verboseLabel_en-US" xlink:label="lab_avdl_AcquisitionRelatedContingentConsiderationRemeasurement" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement of acquisition-related contingent consideration</link:label>
    <link:label id="lab_avdl_AcquisitionRelatedContingentConsiderationRemeasurement_label_en-US" xlink:label="lab_avdl_AcquisitionRelatedContingentConsiderationRemeasurement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Related Contingent Consideration Remeasurement</link:label>
    <link:label id="lab_avdl_AcquisitionRelatedContingentConsiderationRemeasurement_documentation_en-US" xlink:label="lab_avdl_AcquisitionRelatedContingentConsiderationRemeasurement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the remeasurement of acquisition related contingent considerations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AcquisitionRelatedContingentConsiderationRemeasurement" xlink:href="avdl-20211231.xsd#avdl_AcquisitionRelatedContingentConsiderationRemeasurement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AcquisitionRelatedContingentConsiderationRemeasurement" xlink:to="lab_avdl_AcquisitionRelatedContingentConsiderationRemeasurement" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_MarketableSecuritiesRealizedGain_68c9c7c9-9b5f-4b40-9f71-03cd3a76c1eb_terseLabel_en-US" xlink:label="lab_avdl_MarketableSecuritiesRealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities, realized gains</link:label>
    <link:label id="lab_avdl_MarketableSecuritiesRealizedGain_label_en-US" xlink:label="lab_avdl_MarketableSecuritiesRealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Realized Gain</link:label>
    <link:label id="lab_avdl_MarketableSecuritiesRealizedGain_documentation_en-US" xlink:label="lab_avdl_MarketableSecuritiesRealizedGain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Realized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MarketableSecuritiesRealizedGain" xlink:href="avdl-20211231.xsd#avdl_MarketableSecuritiesRealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_MarketableSecuritiesRealizedGain" xlink:to="lab_avdl_MarketableSecuritiesRealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_4b24dc66-72af-491f-aae1-5057d15c4ef1_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual and money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_1395df5d-f1ca-4746-908b-420a2666c9ef_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_9ab62ef7-dbeb-4fda-9ea0-eb1895b670b1_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_66c2b092-5ce2-44d7-8b2b-4334f5d86130_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: unamortized debt discount and issuance costs, net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AuditInformationAbstract_label_en-US" xlink:label="lab_avdl_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_avdl_AuditInformationAbstract_documentation_en-US" xlink:label="lab_avdl_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AuditInformationAbstract" xlink:href="avdl-20211231.xsd#avdl_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AuditInformationAbstract" xlink:to="lab_avdl_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_c8b0cb59-96a1-4200-b8d8-5d31ca8cb0ab_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_63b09ffc-92fa-4750-96bf-1d7d0ab915ac_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration_5f3586c2-6c7d-49b9-a74e-ed11b87012fe_terseLabel_en-US" xlink:label="lab_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial cash consideration</link:label>
    <link:label id="lab_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration_label_en-US" xlink:label="lab_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Initial Cash Consideration</link:label>
    <link:label id="lab_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration_documentation_en-US" xlink:label="lab_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Initial Cash Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration" xlink:href="avdl-20211231.xsd#avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration" xlink:to="lab_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_82180c22-14b1-4557-a80b-b978cb95b1e3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_9d1f7468-3fe9-4932-bd3e-8e2a4b9ad11d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_39d7efc2-d8ef-41cb-9914-d8cca74d3027_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Guidance</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_d2682f98-538c-42fc-b596-365c29aa7338_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_53f844bc-9562-473e-82fe-8724bb906f31_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_532dc119-6aaf-4640-977b-b92b100d44b2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_a7c0ef07-63f8-45ba-8b06-fc7d90bd60fe_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_431ef3e7-fb17-4bf7-b35d-08c8d8ba361e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_8a884c0b-c46a-4da9-b0e9-222dab0e825e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_9dd36be8-4a9e-4657-a5aa-72efc1fc8f22_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit - at statutory tax rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays_d1117471-e0f2-4be8-82c5-bbac9233a063_terseLabel_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled threshold trading days</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays_label_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Scheduled Threshold Trading Days</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays_documentation_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Scheduled Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays" xlink:href="avdl-20211231.xsd#avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays" xlink:to="lab_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_077bb582-1627-4ba2-b5ad-a2f126add6c5_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockMember_23e9cabe-567b-4055-92d3-b062879e036b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares</link:label>
    <link:label id="lab_us-gaap_PreferredStockMember_label_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockMember" xlink:to="lab_us-gaap_PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_10c5e386-c72e-4718-acb1-bbbb0eb05b0c_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_d6c44bec-bcf5-4f14-a36a-41fb6bfd5504_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingMember_d6aaa14f-5371-412c-aa6a-bf6075b3477a_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising</link:label>
    <link:label id="lab_us-gaap_AdvertisingMember_label_en-US" xlink:label="lab_us-gaap_AdvertisingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingMember" xlink:to="lab_us-gaap_AdvertisingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_OtherCustomersMember_dedd2af1-b2da-45dd-8f31-e2e9542a3e79_terseLabel_en-US" xlink:label="lab_avdl_OtherCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Others</link:label>
    <link:label id="lab_avdl_OtherCustomersMember_label_en-US" xlink:label="lab_avdl_OtherCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherCustomersMember" xlink:href="avdl-20211231.xsd#avdl_OtherCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_OtherCustomersMember" xlink:to="lab_avdl_OtherCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_2eb15781-e18e-4951-beeb-4494f6e78421_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0ee8a5d3-8c47-44f8-b405-64ef3147d341_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net (loss) income to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_RetirementIndemnityObligationMember_80c2cadc-efa8-4b25-9af4-cfb0be6a1b96_terseLabel_en-US" xlink:label="lab_avdl_RetirementIndemnityObligationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Indemnity Obligation</link:label>
    <link:label id="lab_avdl_RetirementIndemnityObligationMember_label_en-US" xlink:label="lab_avdl_RetirementIndemnityObligationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Indemnity Obligation [Member]</link:label>
    <link:label id="lab_avdl_RetirementIndemnityObligationMember_documentation_en-US" xlink:label="lab_avdl_RetirementIndemnityObligationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Indemnity Obligation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RetirementIndemnityObligationMember" xlink:href="avdl-20211231.xsd#avdl_RetirementIndemnityObligationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_RetirementIndemnityObligationMember" xlink:to="lab_avdl_RetirementIndemnityObligationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_d8a140cc-6192-4d44-8aec-6d433d613433_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_656c6101-cb70-41eb-ac7f-32dbd6c03e2f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than 1 Year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_f06de838-c9a6-4e22-9e38-d542921840d8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease costs</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_4064111a-a2f1-4530-b471-52c9f82bb106_verboseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_20f4d4ec-ad97-4ef0-9ac2-0ba13f6a882d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward_610d2bfa-ac8f-4c73-b683-075073651693_terseLabel_en-US" xlink:label="lab_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Changes in Related Party Payable [Roll Forward]</link:label>
    <link:label id="lab_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward_label_en-US" xlink:label="lab_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Changes in Related Party Payable [Roll Forward]</link:label>
    <link:label id="lab_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward_documentation_en-US" xlink:label="lab_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Changes in Related Party Payable [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward" xlink:href="avdl-20211231.xsd#avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward" xlink:to="lab_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_RestrictedShareAwardsGrantedFrom20172020Member_6d73e774-7d92-457c-bf74-72bfe5721001_terseLabel_en-US" xlink:label="lab_avdl_RestrictedShareAwardsGrantedFrom20172020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Awards Granted From 2017-2020</link:label>
    <link:label id="lab_avdl_RestrictedShareAwardsGrantedFrom20172020Member_label_en-US" xlink:label="lab_avdl_RestrictedShareAwardsGrantedFrom20172020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Awards Granted From 2017-2020 [Member]</link:label>
    <link:label id="lab_avdl_RestrictedShareAwardsGrantedFrom20172020Member_documentation_en-US" xlink:label="lab_avdl_RestrictedShareAwardsGrantedFrom20172020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Share Awards Granted From 2017-2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestrictedShareAwardsGrantedFrom20172020Member" xlink:href="avdl-20211231.xsd#avdl_RestrictedShareAwardsGrantedFrom20172020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_RestrictedShareAwardsGrantedFrom20172020Member" xlink:to="lab_avdl_RestrictedShareAwardsGrantedFrom20172020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_be9d4a6a-aff6-4113-9473-18597e4c3b80_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized tax benefits</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_8c7ff293-ecd8-4698-8bfd-a73ca810660b_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_14d44594-77a4-4a53-94e3-a56a091b028b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_f44914e1-edbe-4fff-bb08-be8fad69b298_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_ec5e88d3-b7a0-4f07-bc5f-bde65b37f535_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options outstanding, Weighted Average Remaining Contractual Life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>avdl-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9768bc4a-d41b-4cde-8dab-4f8611fcf569,g:2327e6e7-350d-456e-9b47-ccea1e6c574d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.avadel.com/role/CoverPage" xlink:type="simple" xlink:href="avdl-20211231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_037509ac-3b38-4655-9ac7-a801d442bb27" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_645a1ca8-2ebe-4374-ace9-3a07e50a7537" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_037509ac-3b38-4655-9ac7-a801d442bb27" xlink:to="loc_dei_EntitiesTable_645a1ca8-2ebe-4374-ace9-3a07e50a7537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_69a19b49-3eef-4995-a9fa-14497e506baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_645a1ca8-2ebe-4374-ace9-3a07e50a7537" xlink:to="loc_us-gaap_StatementClassOfStockAxis_69a19b49-3eef-4995-a9fa-14497e506baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_359e1d8d-bd18-4aee-8068-088d05829db3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_69a19b49-3eef-4995-a9fa-14497e506baf" xlink:to="loc_us-gaap_ClassOfStockDomain_359e1d8d-bd18-4aee-8068-088d05829db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesMember_ebef1942-b48b-45f7-bab2-9649a289693c" xlink:href="avdl-20211231.xsd#avdl_AmericanDepositarySharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_359e1d8d-bd18-4aee-8068-088d05829db3" xlink:to="loc_avdl_AmericanDepositarySharesMember_ebef1942-b48b-45f7-bab2-9649a289693c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OrdinaryShareNominalValue001PerShareMember_7df0b619-4556-4646-91f4-803a14f1efbe" xlink:href="avdl-20211231.xsd#avdl_OrdinaryShareNominalValue001PerShareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_359e1d8d-bd18-4aee-8068-088d05829db3" xlink:to="loc_avdl_OrdinaryShareNominalValue001PerShareMember_7df0b619-4556-4646-91f4-803a14f1efbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_645a1ca8-2ebe-4374-ace9-3a07e50a7537" xlink:to="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_cd216f6b-0a58-4005-b6f8-29514d913347" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_DocumentType_cd216f6b-0a58-4005-b6f8-29514d913347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_0cd64f09-185f-4ef9-b432-3538cf2884c2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_DocumentAnnualReport_0cd64f09-185f-4ef9-b432-3538cf2884c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_53e7c8d9-e468-428f-9e6e-4f27406ddf94" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_DocumentPeriodEndDate_53e7c8d9-e468-428f-9e6e-4f27406ddf94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_66432f2e-cd9e-432a-b282-933a57419b52" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_CurrentFiscalYearEndDate_66432f2e-cd9e-432a-b282-933a57419b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_ab6a7f43-a64f-44b6-b111-29935609dc35" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_DocumentTransitionReport_ab6a7f43-a64f-44b6-b111-29935609dc35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_31547a69-736a-4b77-af8f-2f117e34fb0f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityFileNumber_31547a69-736a-4b77-af8f-2f117e34fb0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_b4f5a4e9-fa11-4fe2-ba88-4d3276a00800" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityRegistrantName_b4f5a4e9-fa11-4fe2-ba88-4d3276a00800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_62d9f61f-e3de-42b2-acf4-78a8a4b8e6ce" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityIncorporationStateCountryCode_62d9f61f-e3de-42b2-acf4-78a8a4b8e6ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_94fead48-2c1f-414d-b570-46bcc61fa518" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityTaxIdentificationNumber_94fead48-2c1f-414d-b570-46bcc61fa518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_e71798c8-4299-4bac-9162-9250042fdc5f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityAddressAddressLine1_e71798c8-4299-4bac-9162-9250042fdc5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_18d02e05-5871-4442-86bd-9567b0f8d522" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityAddressCityOrTown_18d02e05-5871-4442-86bd-9567b0f8d522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_59382d51-dff8-401f-be07-e83bc37d8392" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityAddressCountry_59382d51-dff8-401f-be07-e83bc37d8392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_aea9b85e-8b77-4e77-a62e-10d2ddeb95ae" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityAddressPostalZipCode_aea9b85e-8b77-4e77-a62e-10d2ddeb95ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_f597d78a-a53a-464f-8a6f-a24c21609fe8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_CityAreaCode_f597d78a-a53a-464f-8a6f-a24c21609fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_994a42b2-69db-4960-9b3f-44c0affd2a7a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_LocalPhoneNumber_994a42b2-69db-4960-9b3f-44c0affd2a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_449fda5c-954a-4d5d-83d2-56f5fbf65136" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_Security12bTitle_449fda5c-954a-4d5d-83d2-56f5fbf65136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_e9e758e7-9c3c-4d9e-a994-007e1822f051" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_TradingSymbol_e9e758e7-9c3c-4d9e-a994-007e1822f051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_460895de-5ad0-4eaf-84a4-f80236565c9f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_SecurityExchangeName_460895de-5ad0-4eaf-84a4-f80236565c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_5bd0f444-aae5-4e55-8ccc-a0a0f5cbcb41" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_5bd0f444-aae5-4e55-8ccc-a0a0f5cbcb41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_e27c39fa-d5b4-425c-8e2e-fbdc290405f8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityVoluntaryFilers_e27c39fa-d5b4-425c-8e2e-fbdc290405f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_5c69c686-a30c-459f-b70a-a35039b47fc9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityCurrentReportingStatus_5c69c686-a30c-459f-b70a-a35039b47fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_0bd4bbee-0bff-43b5-8926-599318949a58" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityInteractiveDataCurrent_0bd4bbee-0bff-43b5-8926-599318949a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_37f00008-5e40-4f87-8944-34530fd4d5e1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityFilerCategory_37f00008-5e40-4f87-8944-34530fd4d5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_03906c28-6f4b-48ea-9adc-e523ae4bfef1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntitySmallBusiness_03906c28-6f4b-48ea-9adc-e523ae4bfef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3a606a90-bfa0-4ad7-aed8-87a3b6d0d1d1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityEmergingGrowthCompany_3a606a90-bfa0-4ad7-aed8-87a3b6d0d1d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_318ad054-abba-410f-a45e-cb4cb96cd1a6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_IcfrAuditorAttestationFlag_318ad054-abba-410f-a45e-cb4cb96cd1a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_f8829275-60b4-42b3-ab52-54af52970caa" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityShellCompany_f8829275-60b4-42b3-ab52-54af52970caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_8c31d859-46c3-4bd6-b49a-6747ce89341e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityPublicFloat_8c31d859-46c3-4bd6-b49a-6747ce89341e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_fd9bdd30-d53e-480d-964f-3c6a0d9cfca5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_fd9bdd30-d53e-480d-964f-3c6a0d9cfca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_5f8cb761-e51c-4822-adab-7d665cf664b1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_5f8cb761-e51c-4822-adab-7d665cf664b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_6a27343e-0e4c-4b1a-97c3-c2000453d59b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_EntityCentralIndexKey_6a27343e-0e4c-4b1a-97c3-c2000453d59b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_7f57cc4f-4e13-4b9a-b57d-af15d6940dd0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_AmendmentFlag_7f57cc4f-4e13-4b9a-b57d-af15d6940dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_cfe6182f-0978-4a24-8f8e-fdc34088e17d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_DocumentFiscalPeriodFocus_cfe6182f-0978-4a24-8f8e-fdc34088e17d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_deb00fd4-c2ca-4cd1-ad28-38e654dbd219" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_79e4b955-991a-4414-b88a-f5c2241977ba" xlink:to="loc_dei_DocumentFiscalYearFocus_deb00fd4-c2ca-4cd1-ad28-38e654dbd219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/AuditInformation" xlink:type="simple" xlink:href="avdl-20211231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AuditInformationAbstract_785a7d0f-a9f1-4c09-aafa-689142eb7e63" xlink:href="avdl-20211231.xsd#avdl_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_ebd2b72a-7bcd-42be-b631-bb980a01699a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_AuditInformationAbstract_785a7d0f-a9f1-4c09-aafa-689142eb7e63" xlink:to="loc_dei_AuditorName_ebd2b72a-7bcd-42be-b631-bb980a01699a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_b2916e9f-f57f-401d-89be-e27508db0a85" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_AuditInformationAbstract_785a7d0f-a9f1-4c09-aafa-689142eb7e63" xlink:to="loc_dei_AuditorLocation_b2916e9f-f57f-401d-89be-e27508db0a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_0a325fca-2905-4ddd-a96a-9c7438286f30" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_AuditInformationAbstract_785a7d0f-a9f1-4c09-aafa-689142eb7e63" xlink:to="loc_dei_AuditorFirmId_0a325fca-2905-4ddd-a96a-9c7438286f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ConsolidatedStatementsofLossIncome" xlink:type="simple" xlink:href="avdl-20211231.xsd#ConsolidatedStatementsofLossIncome"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ConsolidatedStatementsofLossIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_3507a243-9807-4a03-81a8-1fc27ff98444" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_f58223af-e7da-4769-9025-da62bc4b941e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3507a243-9807-4a03-81a8-1fc27ff98444" xlink:to="loc_us-gaap_RevenuesAbstract_f58223af-e7da-4769-9025-da62bc4b941e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_eba64fb4-8d3c-4f85-8e0b-656ef6f1421e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_f58223af-e7da-4769-9025-da62bc4b941e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_eba64fb4-8d3c-4f85-8e0b-656ef6f1421e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_ede48bc1-5806-48f5-be7a-f06369efdf44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3507a243-9807-4a03-81a8-1fc27ff98444" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_ede48bc1-5806-48f5-be7a-f06369efdf44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_89e8187d-bd45-4ba2-8028-f4e1d03af8eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_ede48bc1-5806-48f5-be7a-f06369efdf44" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_89e8187d-bd45-4ba2-8028-f4e1d03af8eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_60c56973-d86f-4c87-9759-a6b27bb44ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_ede48bc1-5806-48f5-be7a-f06369efdf44" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_60c56973-d86f-4c87-9759-a6b27bb44ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_da3864e4-2b15-4bbc-aedc-d0edf0ce00db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_ede48bc1-5806-48f5-be7a-f06369efdf44" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_da3864e4-2b15-4bbc-aedc-d0edf0ce00db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9fe6eea1-1ede-44ca-8061-fbdf76c28a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_ede48bc1-5806-48f5-be7a-f06369efdf44" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9fe6eea1-1ede-44ca-8061-fbdf76c28a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_ba6fb698-f4b9-4d1d-921c-3cdcf77dbb54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_ede48bc1-5806-48f5-be7a-f06369efdf44" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_ba6fb698-f4b9-4d1d-921c-3cdcf77dbb54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_4265ff55-a661-4d78-a466-b139b001ebcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_ede48bc1-5806-48f5-be7a-f06369efdf44" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_4265ff55-a661-4d78-a466-b139b001ebcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestructuringCostsNet_1fe88819-81c8-4bae-82a8-1356b55f7136" xlink:href="avdl-20211231.xsd#avdl_RestructuringCostsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_ede48bc1-5806-48f5-be7a-f06369efdf44" xlink:to="loc_avdl_RestructuringCostsNet_1fe88819-81c8-4bae-82a8-1356b55f7136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_6befebc3-c785-4d08-b841-cdaf95c89d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_ede48bc1-5806-48f5-be7a-f06369efdf44" xlink:to="loc_us-gaap_CostsAndExpenses_6befebc3-c785-4d08-b841-cdaf95c89d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a49eac84-168d-47db-a864-a29366ce9c42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3507a243-9807-4a03-81a8-1fc27ff98444" xlink:to="loc_us-gaap_OperatingIncomeLoss_a49eac84-168d-47db-a864-a29366ce9c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_9b685321-ea6b-4613-8ecb-00a7bb4ff043" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3507a243-9807-4a03-81a8-1fc27ff98444" xlink:to="loc_us-gaap_InvestmentIncomeNet_9b685321-ea6b-4613-8ecb-00a7bb4ff043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c43913ff-cd07-4d3f-b3e2-4689a03c42c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3507a243-9807-4a03-81a8-1fc27ff98444" xlink:to="loc_us-gaap_InterestExpense_c43913ff-cd07-4d3f-b3e2-4689a03c42c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_93ed3543-5c61-42f7-9a93-9ccc5af93375" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3507a243-9807-4a03-81a8-1fc27ff98444" xlink:to="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_93ed3543-5c61-42f7-9a93-9ccc5af93375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationGainOrLossAmount_76df13fc-1740-4653-b36c-9beee939ba48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeconsolidationGainOrLossAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3507a243-9807-4a03-81a8-1fc27ff98444" xlink:to="loc_us-gaap_DeconsolidationGainOrLossAmount_76df13fc-1740-4653-b36c-9beee939ba48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6367df7f-5a73-43d5-ad58-ce6fe055eb9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3507a243-9807-4a03-81a8-1fc27ff98444" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6367df7f-5a73-43d5-ad58-ce6fe055eb9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ddb1721b-e5ce-456f-aa00-beb945e081cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3507a243-9807-4a03-81a8-1fc27ff98444" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ddb1721b-e5ce-456f-aa00-beb945e081cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f6eeee23-0dfb-435d-9367-fab709c9bfda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3507a243-9807-4a03-81a8-1fc27ff98444" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f6eeee23-0dfb-435d-9367-fab709c9bfda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6bba9da9-a186-4f8f-ae1c-43ba524f7e78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3507a243-9807-4a03-81a8-1fc27ff98444" xlink:to="loc_us-gaap_NetIncomeLoss_6bba9da9-a186-4f8f-ae1c-43ba524f7e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f34840c9-cd1a-4d4d-a89e-e2268fcc9802" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3507a243-9807-4a03-81a8-1fc27ff98444" xlink:to="loc_us-gaap_EarningsPerShareAbstract_f34840c9-cd1a-4d4d-a89e-e2268fcc9802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_4427b710-0634-4159-9fc6-fb204e4b1dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f34840c9-cd1a-4d4d-a89e-e2268fcc9802" xlink:to="loc_us-gaap_EarningsPerShareBasic_4427b710-0634-4159-9fc6-fb204e4b1dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_e6c3e2a9-8472-49f2-bd89-a38f6134d644" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f34840c9-cd1a-4d4d-a89e-e2268fcc9802" xlink:to="loc_us-gaap_EarningsPerShareDiluted_e6c3e2a9-8472-49f2-bd89-a38f6134d644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_565575b7-d858-4d9b-b36a-baa6e2df0426" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3507a243-9807-4a03-81a8-1fc27ff98444" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_565575b7-d858-4d9b-b36a-baa6e2df0426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_38db08bc-e2c6-488f-9e79-d2678f7afbcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_565575b7-d858-4d9b-b36a-baa6e2df0426" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_38db08bc-e2c6-488f-9e79-d2678f7afbcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_58cd0b0e-e735-42ef-bc96-52e2ada791b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_565575b7-d858-4d9b-b36a-baa6e2df0426" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_58cd0b0e-e735-42ef-bc96-52e2ada791b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ConsolidatedStatementsofComprehensiveLossIncome" xlink:type="simple" xlink:href="avdl-20211231.xsd#ConsolidatedStatementsofComprehensiveLossIncome"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ConsolidatedStatementsofComprehensiveLossIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_989e6b03-b085-43a7-95a7-55f372488a78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c3a7a106-ce76-45bc-9347-6d6595902baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_989e6b03-b085-43a7-95a7-55f372488a78" xlink:to="loc_us-gaap_NetIncomeLoss_c3a7a106-ce76-45bc-9347-6d6595902baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_e4ccd3b2-b3c8-4307-9cf7-617e84fe13b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_989e6b03-b085-43a7-95a7-55f372488a78" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_e4ccd3b2-b3c8-4307-9cf7-617e84fe13b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_236e2f24-9e3e-4900-9ad2-1bfb5557637e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_e4ccd3b2-b3c8-4307-9cf7-617e84fe13b2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_236e2f24-9e3e-4900-9ad2-1bfb5557637e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_49f8b315-9f74-4b98-a4aa-b3ec4a8e42a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_e4ccd3b2-b3c8-4307-9cf7-617e84fe13b2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_49f8b315-9f74-4b98-a4aa-b3ec4a8e42a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_27545c0d-5a13-4ce4-bac4-57447279346f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_e4ccd3b2-b3c8-4307-9cf7-617e84fe13b2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_27545c0d-5a13-4ce4-bac4-57447279346f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_ab96a8ba-2a54-47a1-8f4e-b7e267d64f87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_989e6b03-b085-43a7-95a7-55f372488a78" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_ab96a8ba-2a54-47a1-8f4e-b7e267d64f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ConsolidatedStatementsofComprehensiveLossIncomeParenthetical" xlink:type="simple" xlink:href="avdl-20211231.xsd#ConsolidatedStatementsofComprehensiveLossIncomeParenthetical"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ConsolidatedStatementsofComprehensiveLossIncomeParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_867c9efd-a8e8-497c-959a-ad1e72810337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_084bc9a9-11fc-4dd4-bcf1-7244cbfcb77d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_867c9efd-a8e8-497c-959a-ad1e72810337" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_084bc9a9-11fc-4dd4-bcf1-7244cbfcb77d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="avdl-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e7e4dc4f-3d22-4bfc-a995-f1d336de8c84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_5d4c4f1f-c5e2-4a01-a836-0d241932f30e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e7e4dc4f-3d22-4bfc-a995-f1d336de8c84" xlink:to="loc_us-gaap_AssetsAbstract_5d4c4f1f-c5e2-4a01-a836-0d241932f30e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_cfa7a737-789e-492b-826a-174187d1db90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5d4c4f1f-c5e2-4a01-a836-0d241932f30e" xlink:to="loc_us-gaap_AssetsCurrentAbstract_cfa7a737-789e-492b-826a-174187d1db90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_476dc8fd-1873-4054-9373-4e82e21280b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cfa7a737-789e-492b-826a-174187d1db90" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_476dc8fd-1873-4054-9373-4e82e21280b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_ec633893-f100-4906-88b6-f1c197ad2469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cfa7a737-789e-492b-826a-174187d1db90" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_ec633893-f100-4906-88b6-f1c197ad2469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_ca40a2be-dcae-480e-ad3f-085cfe7bf3c2" xlink:href="avdl-20211231.xsd#avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cfa7a737-789e-492b-826a-174187d1db90" xlink:to="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_ca40a2be-dcae-480e-ad3f-085cfe7bf3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0a6283c2-a9a8-4f59-b4cd-e1ff7043ea64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cfa7a737-789e-492b-826a-174187d1db90" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0a6283c2-a9a8-4f59-b4cd-e1ff7043ea64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_cbf8bc19-26bd-49f0-8bf4-2634df7d9a50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cfa7a737-789e-492b-826a-174187d1db90" xlink:to="loc_us-gaap_AssetsCurrent_cbf8bc19-26bd-49f0-8bf4-2634df7d9a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f219f5c4-4907-466e-906f-1407b67b9688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5d4c4f1f-c5e2-4a01-a836-0d241932f30e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f219f5c4-4907-466e-906f-1407b67b9688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_147b068e-dde5-429e-a907-03f1b5a589e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5d4c4f1f-c5e2-4a01-a836-0d241932f30e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_147b068e-dde5-429e-a907-03f1b5a589e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5ba45d34-281a-41d5-85e9-560a2ec06eed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5d4c4f1f-c5e2-4a01-a836-0d241932f30e" xlink:to="loc_us-gaap_Goodwill_5ba45d34-281a-41d5-85e9-560a2ec06eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_5c82fa49-354e-40c2-bb1d-eb560fc02025" xlink:href="avdl-20211231.xsd#avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5d4c4f1f-c5e2-4a01-a836-0d241932f30e" xlink:to="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_5c82fa49-354e-40c2-bb1d-eb560fc02025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_28c2dffc-97f9-4614-b399-d83c5b84c8de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5d4c4f1f-c5e2-4a01-a836-0d241932f30e" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_28c2dffc-97f9-4614-b399-d83c5b84c8de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_27f8796c-2354-4a46-9ae0-2089651fd426" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5d4c4f1f-c5e2-4a01-a836-0d241932f30e" xlink:to="loc_us-gaap_Assets_27f8796c-2354-4a46-9ae0-2089651fd426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9fa8ba9d-342a-4673-93dc-3b2d6b258b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e7e4dc4f-3d22-4bfc-a995-f1d336de8c84" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9fa8ba9d-342a-4673-93dc-3b2d6b258b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_7f798cf8-236d-48d6-8f54-817cdc852da3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9fa8ba9d-342a-4673-93dc-3b2d6b258b30" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_7f798cf8-236d-48d6-8f54-817cdc852da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_73c6cb3c-2827-432b-a09c-40541311ead6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7f798cf8-236d-48d6-8f54-817cdc852da3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_73c6cb3c-2827-432b-a09c-40541311ead6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_754fbe69-929c-450b-a556-0145bafa18a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7f798cf8-236d-48d6-8f54-817cdc852da3" xlink:to="loc_us-gaap_AccountsPayableCurrent_754fbe69-929c-450b-a556-0145bafa18a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_c3832ec7-2b79-411f-947d-962e72a430d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7f798cf8-236d-48d6-8f54-817cdc852da3" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_c3832ec7-2b79-411f-947d-962e72a430d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_edfcf1cf-e529-4570-b1c5-769f9ab3b89c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7f798cf8-236d-48d6-8f54-817cdc852da3" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_edfcf1cf-e529-4570-b1c5-769f9ab3b89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c337b71e-dc60-438e-9e47-455e9e31b1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7f798cf8-236d-48d6-8f54-817cdc852da3" xlink:to="loc_us-gaap_LiabilitiesCurrent_c337b71e-dc60-438e-9e47-455e9e31b1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_f05da492-ed5f-4729-a6dd-e5f546eed885" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9fa8ba9d-342a-4673-93dc-3b2d6b258b30" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_f05da492-ed5f-4729-a6dd-e5f546eed885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_256696a9-e0ac-4b52-b585-e3fee8548a29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9fa8ba9d-342a-4673-93dc-3b2d6b258b30" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_256696a9-e0ac-4b52-b585-e3fee8548a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_20443ba0-ff7f-442f-a96e-5f12de3ea9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9fa8ba9d-342a-4673-93dc-3b2d6b258b30" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_20443ba0-ff7f-442f-a96e-5f12de3ea9dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_371ddd38-7838-4e79-bc74-2927b7231c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9fa8ba9d-342a-4673-93dc-3b2d6b258b30" xlink:to="loc_us-gaap_Liabilities_371ddd38-7838-4e79-bc74-2927b7231c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_b43d5f0f-0afb-4187-bb67-e903039ac746" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9fa8ba9d-342a-4673-93dc-3b2d6b258b30" xlink:to="loc_us-gaap_StockholdersEquityAbstract_b43d5f0f-0afb-4187-bb67-e903039ac746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_18fb301a-c378-44e5-8bfa-1064f9932a96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b43d5f0f-0afb-4187-bb67-e903039ac746" xlink:to="loc_us-gaap_PreferredStockValue_18fb301a-c378-44e5-8bfa-1064f9932a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c1367eb7-25ff-486e-83e8-f036fa61c3b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b43d5f0f-0afb-4187-bb67-e903039ac746" xlink:to="loc_us-gaap_CommonStockValue_c1367eb7-25ff-486e-83e8-f036fa61c3b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_8804110e-d682-4aa9-b33f-33c0b9df8232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b43d5f0f-0afb-4187-bb67-e903039ac746" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_8804110e-d682-4aa9-b33f-33c0b9df8232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5c4e6312-5f9f-4e24-a818-b9a17ce53c50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b43d5f0f-0afb-4187-bb67-e903039ac746" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5c4e6312-5f9f-4e24-a818-b9a17ce53c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_728976c6-8fbf-4a38-afa3-dad5724c2850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b43d5f0f-0afb-4187-bb67-e903039ac746" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_728976c6-8fbf-4a38-afa3-dad5724c2850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b09c08e5-3c92-4b22-8a66-13a0dc874c1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b43d5f0f-0afb-4187-bb67-e903039ac746" xlink:to="loc_us-gaap_StockholdersEquity_b09c08e5-3c92-4b22-8a66-13a0dc874c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_6e42ea03-96e2-492c-8358-d9c3676a477a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9fa8ba9d-342a-4673-93dc-3b2d6b258b30" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_6e42ea03-96e2-492c-8358-d9c3676a477a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="avdl-20211231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d052a4a1-4816-45a2-9a8c-e244136c3cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_299625b2-28ec-42e7-903a-b3311fb10f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d052a4a1-4816-45a2-9a8c-e244136c3cc2" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_299625b2-28ec-42e7-903a-b3311fb10f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_f850c080-f136-42bd-8392-576d34b1c862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d052a4a1-4816-45a2-9a8c-e244136c3cc2" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_f850c080-f136-42bd-8392-576d34b1c862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_1c53c938-dcf7-4f07-b84f-ccb9d075b641" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d052a4a1-4816-45a2-9a8c-e244136c3cc2" xlink:to="loc_us-gaap_PreferredStockSharesIssued_1c53c938-dcf7-4f07-b84f-ccb9d075b641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_77f42c0a-7891-4dc9-a4a2-fe42576229a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d052a4a1-4816-45a2-9a8c-e244136c3cc2" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_77f42c0a-7891-4dc9-a4a2-fe42576229a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_386c3d10-519f-45b4-b135-13c2711f94f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d052a4a1-4816-45a2-9a8c-e244136c3cc2" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_386c3d10-519f-45b4-b135-13c2711f94f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_ea26b252-3985-465c-891f-8111de93f285" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d052a4a1-4816-45a2-9a8c-e244136c3cc2" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_ea26b252-3985-465c-891f-8111de93f285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_71213027-122a-4283-be36-ef898d7f348a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d052a4a1-4816-45a2-9a8c-e244136c3cc2" xlink:to="loc_us-gaap_CommonStockSharesIssued_71213027-122a-4283-be36-ef898d7f348a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_b7a9f686-61dc-4ac0-9433-567056b8b0da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d052a4a1-4816-45a2-9a8c-e244136c3cc2" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_b7a9f686-61dc-4ac0-9433-567056b8b0da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="avdl-20211231.xsd#ConsolidatedStatementsofShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_139965ef-558e-4d61-959c-1dfed7a06199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6b842141-0732-4fd6-9084-cec7feffc635" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_139965ef-558e-4d61-959c-1dfed7a06199" xlink:to="loc_us-gaap_StatementTable_6b842141-0732-4fd6-9084-cec7feffc635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2a147d86-1cb5-4aad-a7f4-5e7d05ee0826" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6b842141-0732-4fd6-9084-cec7feffc635" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2a147d86-1cb5-4aad-a7f4-5e7d05ee0826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7bbb659f-fbb3-4be6-ae63-0fa652037b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2a147d86-1cb5-4aad-a7f4-5e7d05ee0826" xlink:to="loc_us-gaap_EquityComponentDomain_7bbb659f-fbb3-4be6-ae63-0fa652037b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_bbcf7bb9-f7e7-4022-a1bc-13d25ac1fb31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7bbb659f-fbb3-4be6-ae63-0fa652037b0f" xlink:to="loc_us-gaap_CommonStockMember_bbcf7bb9-f7e7-4022-a1bc-13d25ac1fb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_9a10ec45-9177-4949-9af6-f28bf7738e44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7bbb659f-fbb3-4be6-ae63-0fa652037b0f" xlink:to="loc_us-gaap_PreferredStockMember_9a10ec45-9177-4949-9af6-f28bf7738e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_194e397a-fef4-4557-bf22-7dfa0bdb0b18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7bbb659f-fbb3-4be6-ae63-0fa652037b0f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_194e397a-fef4-4557-bf22-7dfa0bdb0b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9d5c4d80-c49a-4027-87cd-7fedd19d586b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7bbb659f-fbb3-4be6-ae63-0fa652037b0f" xlink:to="loc_us-gaap_RetainedEarningsMember_9d5c4d80-c49a-4027-87cd-7fedd19d586b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_55eec7fb-7c5f-4bf6-b748-48851b92eb20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7bbb659f-fbb3-4be6-ae63-0fa652037b0f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_55eec7fb-7c5f-4bf6-b748-48851b92eb20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_e462b1f4-c6fa-47e1-a81e-881c500fdefe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7bbb659f-fbb3-4be6-ae63-0fa652037b0f" xlink:to="loc_us-gaap_TreasuryStockMember_e462b1f4-c6fa-47e1-a81e-881c500fdefe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3803f7b9-4d2b-4a9f-9685-64f59dc2ff77" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6b842141-0732-4fd6-9084-cec7feffc635" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3803f7b9-4d2b-4a9f-9685-64f59dc2ff77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_14c2cf91-42bd-4650-8631-01005495346e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3803f7b9-4d2b-4a9f-9685-64f59dc2ff77" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_14c2cf91-42bd-4650-8631-01005495346e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_9669aade-eb4b-41cc-ab85-103aaad3d8f1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_14c2cf91-42bd-4650-8631-01005495346e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_9669aade-eb4b-41cc-ab85-103aaad3d8f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5a9c27fb-1cd9-4e00-b0d6-0c51b7981a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6b842141-0732-4fd6-9084-cec7feffc635" xlink:to="loc_us-gaap_StatementLineItems_5a9c27fb-1cd9-4e00-b0d6-0c51b7981a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5a9c27fb-1cd9-4e00-b0d6-0c51b7981a7c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_b53ebfab-c4af-4812-b6fc-2ef15380a5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_SharesOutstanding_b53ebfab-c4af-4812-b6fc-2ef15380a5c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1f13310a-595e-4df7-ad8f-0114c891ace8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_StockholdersEquity_1f13310a-595e-4df7-ad8f-0114c891ace8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_3dfb1a43-bd3c-4270-a6d9-f3cbad26cf50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_3dfb1a43-bd3c-4270-a6d9-f3cbad26cf50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_df14a4d2-0088-49ee-90e8-c20decc41860" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_NetIncomeLoss_df14a4d2-0088-49ee-90e8-c20decc41860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_72c7d422-c348-4fd2-9a98-2eb09b4e14d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_72c7d422-c348-4fd2-9a98-2eb09b4e14d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2f0b1910-56b5-4630-883c-5eaa560ff6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2f0b1910-56b5-4630-883c-5eaa560ff6b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_93230352-42aa-420c-a428-5fc44ddb8efd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_93230352-42aa-420c-a428-5fc44ddb8efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e89bbeea-fb40-42cd-beb8-1c8f5635976e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e89bbeea-fb40-42cd-beb8-1c8f5635976e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_05587923-2b95-46a3-a352-fe80535a40dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_05587923-2b95-46a3-a352-fe80535a40dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_StockIssuedDuringPeriodSharesPublicOffering_2c86d787-f177-4792-987d-a0b23c217c9e" xlink:href="avdl-20211231.xsd#avdl_StockIssuedDuringPeriodSharesPublicOffering"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_avdl_StockIssuedDuringPeriodSharesPublicOffering_2c86d787-f177-4792-987d-a0b23c217c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_StockIssuedDuringPeriodValuePublicOffering_2ca257a5-d049-48e8-ab35-15e025401bc5" xlink:href="avdl-20211231.xsd#avdl_StockIssuedDuringPeriodValuePublicOffering"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_avdl_StockIssuedDuringPeriodValuePublicOffering_2ca257a5-d049-48e8-ab35-15e025401bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther_7531f3eb-a982-41ea-aea1-ade85d15ca3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesOther_7531f3eb-a982-41ea-aea1-ade85d15ca3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther_9e2ad49d-1886-40e0-8777-85460b0fb5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueOther_9e2ad49d-1886-40e0-8777-85460b0fb5e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_e7f51836-a6e2-4257-950e-b9d9d58f7516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_e7f51836-a6e2-4257-950e-b9d9d58f7516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_d5ef94da-3525-4eba-8000-ab7f21856ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_d5ef94da-3525-4eba-8000-ab7f21856ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_269abd9d-c7ea-43e8-b7e1-70342ad0b3dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_269abd9d-c7ea-43e8-b7e1-70342ad0b3dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_cc11123c-9ecf-461f-b4ab-75faeeb79548" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_cc11123c-9ecf-461f-b4ab-75faeeb79548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_f7472237-b508-483b-a7de-8f2f067a055d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_f7472237-b508-483b-a7de-8f2f067a055d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_ba380a09-a80d-43ac-802f-9fd3fd9027d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_SharesOutstanding_ba380a09-a80d-43ac-802f-9fd3fd9027d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6712c4ba-0f10-4696-9990-3b72aec09a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b056cbb-acb3-4831-b469-22d3174a7629" xlink:to="loc_us-gaap_StockholdersEquity_6712c4ba-0f10-4696-9990-3b72aec09a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="avdl-20211231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_54a6ab38-755e-434a-b13d-e0706fa72309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2c126380-6d91-403c-90b9-f86d1c5a9dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_54a6ab38-755e-434a-b13d-e0706fa72309" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2c126380-6d91-403c-90b9-f86d1c5a9dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_41d26aa2-668a-44dc-802a-79c63af48e56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2c126380-6d91-403c-90b9-f86d1c5a9dc3" xlink:to="loc_us-gaap_NetIncomeLoss_41d26aa2-668a-44dc-802a-79c63af48e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ace75f93-d661-4057-a313-e25c5db9b571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_54a6ab38-755e-434a-b13d-e0706fa72309" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ace75f93-d661-4057-a313-e25c5db9b571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_9d234fe7-e3c7-4e4f-b178-245a498105f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ace75f93-d661-4057-a313-e25c5db9b571" xlink:to="loc_us-gaap_DepreciationAndAmortization_9d234fe7-e3c7-4e4f-b178-245a498105f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AcquisitionRelatedContingentConsiderationRemeasurement_c96a084e-68f7-4506-a561-017c6ede763e" xlink:href="avdl-20211231.xsd#avdl_AcquisitionRelatedContingentConsiderationRemeasurement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ace75f93-d661-4057-a313-e25c5db9b571" xlink:to="loc_avdl_AcquisitionRelatedContingentConsiderationRemeasurement_c96a084e-68f7-4506-a561-017c6ede763e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FinancingRelatedContingentConsiderationRemeasurement_d9acb2da-c931-4461-a0e3-8c9c0698d65d" xlink:href="avdl-20211231.xsd#avdl_FinancingRelatedContingentConsiderationRemeasurement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ace75f93-d661-4057-a313-e25c5db9b571" xlink:to="loc_avdl_FinancingRelatedContingentConsiderationRemeasurement_d9acb2da-c931-4461-a0e3-8c9c0698d65d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_afac7127-3367-43c7-85d6-85bea5a8d175" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ace75f93-d661-4057-a313-e25c5db9b571" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_afac7127-3367-43c7-85d6-85bea5a8d175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_c9b17742-7613-488e-ac19-89689d5a5d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ace75f93-d661-4057-a313-e25c5db9b571" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_c9b17742-7613-488e-ac19-89689d5a5d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f2e1a86a-ef36-498b-be62-a95127a6b3ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ace75f93-d661-4057-a313-e25c5db9b571" xlink:to="loc_us-gaap_ShareBasedCompensation_f2e1a86a-ef36-498b-be62-a95127a6b3ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_9188794e-e66a-4f1c-98ad-cf4777c30ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ace75f93-d661-4057-a313-e25c5db9b571" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_9188794e-e66a-4f1c-98ad-cf4777c30ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_NoncashGainLossDeconsolidationOfSubsidiary_ac6bcb06-ac52-41cd-90d1-e51750518b1a" xlink:href="avdl-20211231.xsd#avdl_NoncashGainLossDeconsolidationOfSubsidiary"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ace75f93-d661-4057-a313-e25c5db9b571" xlink:to="loc_avdl_NoncashGainLossDeconsolidationOfSubsidiary_ac6bcb06-ac52-41cd-90d1-e51750518b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_5e2f0af6-24a4-4c4b-be5c-5d6866d6224c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ace75f93-d661-4057-a313-e25c5db9b571" xlink:to="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_5e2f0af6-24a4-4c4b-be5c-5d6866d6224c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_02160dae-4620-4591-941e-473fbe40fd1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ace75f93-d661-4057-a313-e25c5db9b571" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_02160dae-4620-4591-941e-473fbe40fd1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_af3b673c-6367-4280-8a7f-bf322a51b53b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ace75f93-d661-4057-a313-e25c5db9b571" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_af3b673c-6367-4280-8a7f-bf322a51b53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_699f8b28-5021-4437-87ca-6fc255f6fe48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_af3b673c-6367-4280-8a7f-bf322a51b53b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_699f8b28-5021-4437-87ca-6fc255f6fe48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_b1127912-79ce-4618-aa27-2d1d7a987347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_af3b673c-6367-4280-8a7f-bf322a51b53b" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_b1127912-79ce-4618-aa27-2d1d7a987347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_91b216f1-8f65-4a0f-baea-2cf5b49a5598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_af3b673c-6367-4280-8a7f-bf322a51b53b" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_91b216f1-8f65-4a0f-baea-2cf5b49a5598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_4d2b72f9-8491-42dd-acc5-44d51e2f464f" xlink:href="avdl-20211231.xsd#avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_af3b673c-6367-4280-8a7f-bf322a51b53b" xlink:to="loc_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_4d2b72f9-8491-42dd-acc5-44d51e2f464f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_94b48bee-5cba-4850-b39a-c3120eca5046" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_af3b673c-6367-4280-8a7f-bf322a51b53b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_94b48bee-5cba-4850-b39a-c3120eca5046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_0286ccc6-9969-4adf-85a6-a42b17240d51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_af3b673c-6367-4280-8a7f-bf322a51b53b" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_0286ccc6-9969-4adf-85a6-a42b17240d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_da1222cd-bf8a-4605-97e1-6baa940c43e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_af3b673c-6367-4280-8a7f-bf322a51b53b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_da1222cd-bf8a-4605-97e1-6baa940c43e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue_21beddf1-ff59-4695-a42c-011301b972d3" xlink:href="avdl-20211231.xsd#avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_af3b673c-6367-4280-8a7f-bf322a51b53b" xlink:to="loc_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue_21beddf1-ff59-4695-a42c-011301b972d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRoyalties_b4792a6a-3a68-459b-a6bc-695dabca1c66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRoyalties"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_af3b673c-6367-4280-8a7f-bf322a51b53b" xlink:to="loc_us-gaap_PaymentsForRoyalties_b4792a6a-3a68-459b-a6bc-695dabca1c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_f4862801-dee9-45d3-bc66-6b605ad07eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_af3b673c-6367-4280-8a7f-bf322a51b53b" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_f4862801-dee9-45d3-bc66-6b605ad07eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_80bf7a10-03d6-411e-b159-c879989e9efb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_af3b673c-6367-4280-8a7f-bf322a51b53b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_80bf7a10-03d6-411e-b159-c879989e9efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d9da5abb-a4bf-4a2c-9700-4e21fb15a420" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_54a6ab38-755e-434a-b13d-e0706fa72309" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d9da5abb-a4bf-4a2c-9700-4e21fb15a420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_29775a13-0a6c-4ca5-803e-0f09371fc378" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d9da5abb-a4bf-4a2c-9700-4e21fb15a420" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_29775a13-0a6c-4ca5-803e-0f09371fc378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_976be8c0-cd02-4f02-9659-905e749483dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d9da5abb-a4bf-4a2c-9700-4e21fb15a420" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_976be8c0-cd02-4f02-9659-905e749483dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_b380e880-9ac9-4a69-a4cb-1ddfef785d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d9da5abb-a4bf-4a2c-9700-4e21fb15a420" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_b380e880-9ac9-4a69-a4cb-1ddfef785d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_7e15ec36-e9cd-463f-8405-7276b9170b91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d9da5abb-a4bf-4a2c-9700-4e21fb15a420" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_7e15ec36-e9cd-463f-8405-7276b9170b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_6936767e-e0a0-4824-8fca-6a729e0f900e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d9da5abb-a4bf-4a2c-9700-4e21fb15a420" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_6936767e-e0a0-4824-8fca-6a729e0f900e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_879371b1-8505-46a2-8d92-81fe3ee479ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d9da5abb-a4bf-4a2c-9700-4e21fb15a420" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_879371b1-8505-46a2-8d92-81fe3ee479ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_37d948f7-f8f2-4deb-a0d7-540627924e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_54a6ab38-755e-434a-b13d-e0706fa72309" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_37d948f7-f8f2-4deb-a0d7-540627924e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_d610f9e9-ddc4-485e-b2e7-9d51a9d5fab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_37d948f7-f8f2-4deb-a0d7-540627924e9e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_d610f9e9-ddc4-485e-b2e7-9d51a9d5fab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_095efb30-dc63-4942-948b-8d521de3a74b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_37d948f7-f8f2-4deb-a0d7-540627924e9e" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_095efb30-dc63-4942-948b-8d521de3a74b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_f648d53f-91f4-4dae-ae3d-d4258db0f196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_37d948f7-f8f2-4deb-a0d7-540627924e9e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_f648d53f-91f4-4dae-ae3d-d4258db0f196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_5fa7d30e-6c39-4a5a-8f6a-46bef577d5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_37d948f7-f8f2-4deb-a0d7-540627924e9e" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_5fa7d30e-6c39-4a5a-8f6a-46bef577d5ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5d66eb0e-9b4d-41c5-bd54-6d9ab9070274" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_37d948f7-f8f2-4deb-a0d7-540627924e9e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5d66eb0e-9b4d-41c5-bd54-6d9ab9070274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_60db9aea-0eaf-41b8-afb7-445f965d31c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_54a6ab38-755e-434a-b13d-e0706fa72309" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_60db9aea-0eaf-41b8-afb7-445f965d31c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c8d0826c-8e8f-4ce2-8539-284fff8d8bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_54a6ab38-755e-434a-b13d-e0706fa72309" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c8d0826c-8e8f-4ce2-8539-284fff8d8bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b096bf35-d660-4475-9e80-ec90b1ca4eac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_54a6ab38-755e-434a-b13d-e0706fa72309" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b096bf35-d660-4475-9e80-ec90b1ca4eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b2fa0041-3721-40cf-9614-dae192cf4594" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_54a6ab38-755e-434a-b13d-e0706fa72309" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b2fa0041-3721-40cf-9614-dae192cf4594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_cfedd6f9-308e-4252-bc04-d3b269be304e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_54a6ab38-755e-434a-b13d-e0706fa72309" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_cfedd6f9-308e-4252-bc04-d3b269be304e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_222e737d-fc18-43f6-b737-cca9dd99caa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_cfedd6f9-308e-4252-bc04-d3b269be304e" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_222e737d-fc18-43f6-b737-cca9dd99caa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_782a841c-3985-4db5-b7b1-0df7ee78da81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_cfedd6f9-308e-4252-bc04-d3b269be304e" xlink:to="loc_us-gaap_InterestPaidNet_782a841c-3985-4db5-b7b1-0df7ee78da81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="avdl-20211231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d16e349a-c30c-484e-a1d2-30604b7405b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_76d95dd3-712a-4e0b-a1a4-7c81c6dc90bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d16e349a-c30c-484e-a1d2-30604b7405b9" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_76d95dd3-712a-4e0b-a1a4-7c81c6dc90bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="avdl-20211231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e725f916-0482-42c7-afb5-47ddfa7aae55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_NatureOfBusinessPolicyPolicyTextBlock_2314bdce-973b-419e-80e9-4c649ac3cfe1" xlink:href="avdl-20211231.xsd#avdl_NatureOfBusinessPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e725f916-0482-42c7-afb5-47ddfa7aae55" xlink:to="loc_avdl_NatureOfBusinessPolicyPolicyTextBlock_2314bdce-973b-419e-80e9-4c649ac3cfe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_cc727331-d46f-4ecb-a7e9-2f449045747c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e725f916-0482-42c7-afb5-47ddfa7aae55" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_cc727331-d46f-4ecb-a7e9-2f449045747c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_23f350c7-f5a2-4995-9a32-7749ae2e8135" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e725f916-0482-42c7-afb5-47ddfa7aae55" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_23f350c7-f5a2-4995-9a32-7749ae2e8135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_a5da7e3a-f1ad-422a-a78b-57823bca596c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e725f916-0482-42c7-afb5-47ddfa7aae55" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_a5da7e3a-f1ad-422a-a78b-57823bca596c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_bf04b87a-37d4-43ef-b669-ed8c6394b57a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e725f916-0482-42c7-afb5-47ddfa7aae55" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_bf04b87a-37d4-43ef-b669-ed8c6394b57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_43d9bf96-85d2-4f84-8f1f-ef1156a1f2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e725f916-0482-42c7-afb5-47ddfa7aae55" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_43d9bf96-85d2-4f84-8f1f-ef1156a1f2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_fa3654b0-e7a3-4b3d-b94d-bc5748f42fec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e725f916-0482-42c7-afb5-47ddfa7aae55" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_fa3654b0-e7a3-4b3d-b94d-bc5748f42fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_9662345f-8a1a-4c62-9458-59bc31af0807" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e725f916-0482-42c7-afb5-47ddfa7aae55" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_9662345f-8a1a-4c62-9458-59bc31af0807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_59e495ed-4486-4ff4-98aa-1c3af478ca70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e725f916-0482-42c7-afb5-47ddfa7aae55" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_59e495ed-4486-4ff4-98aa-1c3af478ca70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_bec5bdf2-5f39-437f-aae8-db49e8e3f6d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e725f916-0482-42c7-afb5-47ddfa7aae55" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_bec5bdf2-5f39-437f-aae8-db49e8e3f6d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts_ccc8aecc-1e1d-4313-841f-f81a1453310b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e725f916-0482-42c7-afb5-47ddfa7aae55" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts_ccc8aecc-1e1d-4313-841f-f81a1453310b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_d0db01d6-ee43-4c01-9131-f60dacb4dc1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e725f916-0482-42c7-afb5-47ddfa7aae55" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_d0db01d6-ee43-4c01-9131-f60dacb4dc1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_009df6a9-d154-48f3-8e7b-d415829e94be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e725f916-0482-42c7-afb5-47ddfa7aae55" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_009df6a9-d154-48f3-8e7b-d415829e94be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_4762dcf0-026e-4e63-97b9-ac7dc9851dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e725f916-0482-42c7-afb5-47ddfa7aae55" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_4762dcf0-026e-4e63-97b9-ac7dc9851dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_4fccbecb-2289-46c8-a4a0-4ff819ba92e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e725f916-0482-42c7-afb5-47ddfa7aae55" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_4fccbecb-2289-46c8-a4a0-4ff819ba92e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_a62b9630-d108-4af8-b80d-264e74670156" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e725f916-0482-42c7-afb5-47ddfa7aae55" xlink:to="loc_us-gaap_UseOfEstimates_a62b9630-d108-4af8-b80d-264e74670156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3c9c7b6c-12a5-44df-a5d6-d6094f5a5bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e725f916-0482-42c7-afb5-47ddfa7aae55" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3c9c7b6c-12a5-44df-a5d6-d6094f5a5bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="avdl-20211231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_64594d03-45dc-47b5-b94c-2b70d4ad1212" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_62928ac1-6a8a-48a5-8cb5-8596be51d0a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_64594d03-45dc-47b5-b94c-2b70d4ad1212" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_62928ac1-6a8a-48a5-8cb5-8596be51d0a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_46f97b06-dfff-4d5c-b26d-eeb07f6f867a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_f91d16b3-2d88-4edb-b8d6-49608ed2021d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_46f97b06-dfff-4d5c-b26d-eeb07f6f867a" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_f91d16b3-2d88-4edb-b8d6-49608ed2021d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9d8e7b3f-21fb-4e2a-9726-4c219e382ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f91d16b3-2d88-4edb-b8d6-49608ed2021d" xlink:to="loc_us-gaap_DebtInstrumentAxis_9d8e7b3f-21fb-4e2a-9726-4c219e382ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_54638255-d73f-404b-97b7-2e39b4696382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_9d8e7b3f-21fb-4e2a-9726-4c219e382ca5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_54638255-d73f-404b-97b7-2e39b4696382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_200bd564-9b94-4f57-9c42-c050cdd21d22" xlink:href="avdl-20211231.xsd#avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_54638255-d73f-404b-97b7-2e39b4696382" xlink:to="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_200bd564-9b94-4f57-9c42-c050cdd21d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_944c1e7c-dd6f-45e5-bd39-f3d1c7653e33" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f91d16b3-2d88-4edb-b8d6-49608ed2021d" xlink:to="loc_srt_RestatementAxis_944c1e7c-dd6f-45e5-bd39-f3d1c7653e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_cb92baca-43d8-490d-9bd1-1897f9c13b6a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_944c1e7c-dd6f-45e5-bd39-f3d1c7653e33" xlink:to="loc_srt_RestatementDomain_cb92baca-43d8-490d-9bd1-1897f9c13b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_3e3548a3-2f5c-4de6-bf4e-d1f6e7fb6838" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_cb92baca-43d8-490d-9bd1-1897f9c13b6a" xlink:to="loc_srt_RestatementAdjustmentMember_3e3548a3-2f5c-4de6-bf4e-d1f6e7fb6838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0796e916-7fdc-42c9-bacc-4a3cad88f137" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f91d16b3-2d88-4edb-b8d6-49608ed2021d" xlink:to="loc_srt_ProductOrServiceAxis_0796e916-7fdc-42c9-bacc-4a3cad88f137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9d4c6cb4-1532-4e95-8668-1055cfe1ef7a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_0796e916-7fdc-42c9-bacc-4a3cad88f137" xlink:to="loc_srt_ProductsAndServicesDomain_9d4c6cb4-1532-4e95-8668-1055cfe1ef7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingMember_d4104e98-5fb7-4add-af33-a390ca6c876c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9d4c6cb4-1532-4e95-8668-1055cfe1ef7a" xlink:to="loc_us-gaap_AdvertisingMember_d4104e98-5fb7-4add-af33-a390ca6c876c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_53a6d2f5-5c02-4b5e-99cf-97eeae11210e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f91d16b3-2d88-4edb-b8d6-49608ed2021d" xlink:to="loc_us-gaap_ClassOfStockLineItems_53a6d2f5-5c02-4b5e-99cf-97eeae11210e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentAdditionalInterestExpensePercentage_802ebe29-d7fa-41b8-bd23-2e3a40dbd347" xlink:href="avdl-20211231.xsd#avdl_DebtInstrumentAdditionalInterestExpensePercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_53a6d2f5-5c02-4b5e-99cf-97eeae11210e" xlink:to="loc_avdl_DebtInstrumentAdditionalInterestExpensePercentage_802ebe29-d7fa-41b8-bd23-2e3a40dbd347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_bcc31ff8-600c-49ea-b327-27dfe88a6e11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_53a6d2f5-5c02-4b5e-99cf-97eeae11210e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_bcc31ff8-600c-49ea-b327-27dfe88a6e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AdditionalInterestExpenseDebt_e5a8937b-f503-43bf-977a-33860336e78d" xlink:href="avdl-20211231.xsd#avdl_AdditionalInterestExpenseDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_53a6d2f5-5c02-4b5e-99cf-97eeae11210e" xlink:to="loc_avdl_AdditionalInterestExpenseDebt_e5a8937b-f503-43bf-977a-33860336e78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_9c917040-b121-4109-a32b-5e607b97febb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_53a6d2f5-5c02-4b5e-99cf-97eeae11210e" xlink:to="loc_us-gaap_InterestExpenseDebt_9c917040-b121-4109-a32b-5e607b97febb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_db951cd3-fafd-491a-a16e-854ef4392fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_53a6d2f5-5c02-4b5e-99cf-97eeae11210e" xlink:to="loc_us-gaap_CostsAndExpenses_db951cd3-fafd-491a-a16e-854ef4392fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_ad00a04d-e341-4894-9b0f-d14d3d2973a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_53a6d2f5-5c02-4b5e-99cf-97eeae11210e" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_ad00a04d-e341-4894-9b0f-d14d3d2973a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#SummaryofSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5c2ccfdf-ee8e-496a-b191-c59ee0bf9bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e53784bb-cd90-4296-b74b-a78ef77bd60e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5c2ccfdf-ee8e-496a-b191-c59ee0bf9bc5" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e53784bb-cd90-4296-b74b-a78ef77bd60e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0cdea5de-4a98-4a61-825a-b866780a4f32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e53784bb-cd90-4296-b74b-a78ef77bd60e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0cdea5de-4a98-4a61-825a-b866780a4f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ef62cce3-9b72-4d18-827c-24057a0bf764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0cdea5de-4a98-4a61-825a-b866780a4f32" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ef62cce3-9b72-4d18-827c-24057a0bf764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember_9c5d7974-1520-4688-8373-46493522c67a" xlink:href="avdl-20211231.xsd#avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ef62cce3-9b72-4d18-827c-24057a0bf764" xlink:to="loc_avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember_9c5d7974-1520-4688-8373-46493522c67a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_LeaseholdImprovementsFurnitureFixturesAndFittingsMember_3f2d994f-1f93-444c-94a8-721a687430a1" xlink:href="avdl-20211231.xsd#avdl_LeaseholdImprovementsFurnitureFixturesAndFittingsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ef62cce3-9b72-4d18-827c-24057a0bf764" xlink:to="loc_avdl_LeaseholdImprovementsFurnitureFixturesAndFittingsMember_3f2d994f-1f93-444c-94a8-721a687430a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7b6c8e9f-a0ea-4aa6-bb6f-ea04617edfdd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e53784bb-cd90-4296-b74b-a78ef77bd60e" xlink:to="loc_srt_RangeAxis_7b6c8e9f-a0ea-4aa6-bb6f-ea04617edfdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7e38e11a-11cf-44c6-9c86-cd32b723023f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7b6c8e9f-a0ea-4aa6-bb6f-ea04617edfdd" xlink:to="loc_srt_RangeMember_7e38e11a-11cf-44c6-9c86-cd32b723023f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_412bb2e7-974d-47af-9bd9-45193ba86f28" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7e38e11a-11cf-44c6-9c86-cd32b723023f" xlink:to="loc_srt_MinimumMember_412bb2e7-974d-47af-9bd9-45193ba86f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ccb04c44-d888-4de4-b8cd-24c96c66b958" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7e38e11a-11cf-44c6-9c86-cd32b723023f" xlink:to="loc_srt_MaximumMember_ccb04c44-d888-4de4-b8cd-24c96c66b958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_22ad24fe-bb4f-4a38-bfc6-20754c4b1b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e53784bb-cd90-4296-b74b-a78ef77bd60e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_22ad24fe-bb4f-4a38-bfc6-20754c4b1b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_887ca881-f536-431a-a657-e073fe3e9a34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_22ad24fe-bb4f-4a38-bfc6-20754c4b1b9d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_887ca881-f536-431a-a657-e073fe3e9a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/NewlyIssuedAccountingStandards" xlink:type="simple" xlink:href="avdl-20211231.xsd#NewlyIssuedAccountingStandards"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/NewlyIssuedAccountingStandards" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_1dfeac42-8643-4b82-b400-451a3994c3a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_c3d83059-60f1-42d4-afe0-fedf5d75a303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_1dfeac42-8643-4b82-b400-451a3994c3a0" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_c3d83059-60f1-42d4-afe0-fedf5d75a303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#NewlyIssuedAccountingStandardsDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_bc70d2dc-23a2-4f32-afe0-a1adfb8e67f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_afbf3bf2-1af0-4fe0-b2da-0c51c3e4a1f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_bc70d2dc-23a2-4f32-afe0-a1adfb8e67f0" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_afbf3bf2-1af0-4fe0-b2da-0c51c3e4a1f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0b9745b5-735a-400c-a55d-976eac7e4914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_afbf3bf2-1af0-4fe0-b2da-0c51c3e4a1f5" xlink:to="loc_us-gaap_DebtInstrumentAxis_0b9745b5-735a-400c-a55d-976eac7e4914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6ad93177-a1b1-44fe-a406-03292dffc544" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_0b9745b5-735a-400c-a55d-976eac7e4914" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6ad93177-a1b1-44fe-a406-03292dffc544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_a3dca7d8-99e8-45e4-99bc-f0a65fc7c48f" xlink:href="avdl-20211231.xsd#avdl_A450PercentExchangeableSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6ad93177-a1b1-44fe-a406-03292dffc544" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDue2023Member_a3dca7d8-99e8-45e4-99bc-f0a65fc7c48f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7c57df5c-7fa6-443a-874e-62f415a531c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_afbf3bf2-1af0-4fe0-b2da-0c51c3e4a1f5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7c57df5c-7fa6-443a-874e-62f415a531c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b10e35ba-be7d-4a46-805d-f5e425413b17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7c57df5c-7fa6-443a-874e-62f415a531c8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b10e35ba-be7d-4a46-805d-f5e425413b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_4a3042e4-08a3-4866-8657-21a6a9137c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b10e35ba-be7d-4a46-805d-f5e425413b17" xlink:to="loc_us-gaap_SeniorNotesMember_4a3042e4-08a3-4866-8657-21a6a9137c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9633d2ef-a7a3-4638-bfb2-81b61042d21f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_afbf3bf2-1af0-4fe0-b2da-0c51c3e4a1f5" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9633d2ef-a7a3-4638-bfb2-81b61042d21f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_df4d9e83-a170-4a2b-a296-d0385e952efc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9633d2ef-a7a3-4638-bfb2-81b61042d21f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_df4d9e83-a170-4a2b-a296-d0385e952efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2ae17367-1881-42c2-a755-9f2de34a1073" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_df4d9e83-a170-4a2b-a296-d0385e952efc" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2ae17367-1881-42c2-a755-9f2de34a1073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2c453924-5fc9-4562-9315-505144dfc70e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_afbf3bf2-1af0-4fe0-b2da-0c51c3e4a1f5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2c453924-5fc9-4562-9315-505144dfc70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_90552977-6d0a-4a69-82fa-b0eab6792f70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2c453924-5fc9-4562-9315-505144dfc70e" xlink:to="loc_us-gaap_EquityComponentDomain_90552977-6d0a-4a69-82fa-b0eab6792f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_95c208b1-2b64-4890-94d4-7ab93267c164" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_90552977-6d0a-4a69-82fa-b0eab6792f70" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_95c208b1-2b64-4890-94d4-7ab93267c164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_184a8e3c-8074-40f5-8e31-e90e3c07c32d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_90552977-6d0a-4a69-82fa-b0eab6792f70" xlink:to="loc_us-gaap_RetainedEarningsMember_184a8e3c-8074-40f5-8e31-e90e3c07c32d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_92651b13-9c1d-4564-9b1c-488a5e84f821" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_afbf3bf2-1af0-4fe0-b2da-0c51c3e4a1f5" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_92651b13-9c1d-4564-9b1c-488a5e84f821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6fcf6c8a-c9a6-4ec3-ac52-6f3aa1de451f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_92651b13-9c1d-4564-9b1c-488a5e84f821" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6fcf6c8a-c9a6-4ec3-ac52-6f3aa1de451f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_079b3a72-45a3-4f0b-ba73-6e0c845fffc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_92651b13-9c1d-4564-9b1c-488a5e84f821" xlink:to="loc_us-gaap_StockholdersEquity_079b3a72-45a3-4f0b-ba73-6e0c845fffc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_3198c187-702d-47cb-be59-02130c6e5ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_92651b13-9c1d-4564-9b1c-488a5e84f821" xlink:to="loc_us-gaap_LongTermDebt_3198c187-702d-47cb-be59-02130c6e5ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SubsidiaryBankruptcyandDeconsolidation" xlink:type="simple" xlink:href="avdl-20211231.xsd#SubsidiaryBankruptcyandDeconsolidation"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/SubsidiaryBankruptcyandDeconsolidation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReorganizationsAbstract_3c85792f-5732-4a96-aec5-1238784f4ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReorganizationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReorganizationUnderChapter11OfUSBankruptcyCodeDisclosureTextBlock_ecf74fe7-1da0-407c-bc5e-8ee9866d2fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReorganizationUnderChapter11OfUSBankruptcyCodeDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReorganizationsAbstract_3c85792f-5732-4a96-aec5-1238784f4ef6" xlink:to="loc_us-gaap_ReorganizationUnderChapter11OfUSBankruptcyCodeDisclosureTextBlock_ecf74fe7-1da0-407c-bc5e-8ee9866d2fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SubsidiaryBankruptcyandDeconsolidationDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#SubsidiaryBankruptcyandDeconsolidationDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/SubsidiaryBankruptcyandDeconsolidationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReorganizationsAbstract_470cdde3-3c8a-4b5b-91f3-b6d899502553" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReorganizationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_2ed5a5fd-5345-4298-9b85-7815c5652d04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReorganizationsAbstract_470cdde3-3c8a-4b5b-91f3-b6d899502553" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_2ed5a5fd-5345-4298-9b85-7815c5652d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3b08a7fd-ff2e-4818-a1a2-7c990a58c06e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_2ed5a5fd-5345-4298-9b85-7815c5652d04" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3b08a7fd-ff2e-4818-a1a2-7c990a58c06e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3ddfece4-8148-4770-8773-7d2dc5d49c0a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3b08a7fd-ff2e-4818-a1a2-7c990a58c06e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3ddfece4-8148-4770-8773-7d2dc5d49c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_SpecialtyPharmaMember_32ef6ba6-0aa8-43be-9210-f3a252b91f79" xlink:href="avdl-20211231.xsd#avdl_SpecialtyPharmaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_3ddfece4-8148-4770-8773-7d2dc5d49c0a" xlink:to="loc_avdl_SpecialtyPharmaMember_32ef6ba6-0aa8-43be-9210-f3a252b91f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_c5531247-2ab1-45bb-ba4b-ca140761e3e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_2ed5a5fd-5345-4298-9b85-7815c5652d04" xlink:to="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_c5531247-2ab1-45bb-ba4b-ca140761e3e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationGainOrLossAmount_478ee2aa-e47b-46ec-8a4d-990490628239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeconsolidationGainOrLossAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_c5531247-2ab1-45bb-ba4b-ca140761e3e3" xlink:to="loc_us-gaap_DeconsolidationGainOrLossAmount_478ee2aa-e47b-46ec-8a4d-990490628239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_7299e66c-8472-4463-8e10-c944bf8c0559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_c5531247-2ab1-45bb-ba4b-ca140761e3e3" xlink:to="loc_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount_7299e66c-8472-4463-8e10-c944bf8c0559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/DispositionoftheHospitalProducts" xlink:type="simple" xlink:href="avdl-20211231.xsd#DispositionoftheHospitalProducts"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/DispositionoftheHospitalProducts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_13a51c9e-c60b-478e-a592-1b5afed655ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_e1fa8f0b-99c7-49aa-89ec-1699f18ff510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_13a51c9e-c60b-478e-a592-1b5afed655ef" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_e1fa8f0b-99c7-49aa-89ec-1699f18ff510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/DispositionoftheHospitalBusinessTables" xlink:type="simple" xlink:href="avdl-20211231.xsd#DispositionoftheHospitalBusinessTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/DispositionoftheHospitalBusinessTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_28b00e86-3695-48a0-b55c-aa9359a61fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_7bc280fe-d355-42a9-8d41-dd57d4780d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_28b00e86-3695-48a0-b55c-aa9359a61fcd" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_7bc280fe-d355-42a9-8d41-dd57d4780d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_58d220d0-35fe-489a-b721-ad2b8f4bcd73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_28b00e86-3695-48a0-b55c-aa9359a61fcd" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_58d220d0-35fe-489a-b721-ad2b8f4bcd73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/DispositionoftheHospitalBusinessNarrativeDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#DispositionoftheHospitalBusinessNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/DispositionoftheHospitalBusinessNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_e6bba666-f073-479b-82e3-9be0ce95ef80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fdac9dbf-c8a0-4eaa-a5a7-70a8970e7fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_e6bba666-f073-479b-82e3-9be0ce95ef80" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fdac9dbf-c8a0-4eaa-a5a7-70a8970e7fa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1f489d8c-d963-449c-b88f-03e31590929e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fdac9dbf-c8a0-4eaa-a5a7-70a8970e7fa6" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1f489d8c-d963-449c-b88f-03e31590929e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0331ced3-1807-4bf8-9c73-1bacd01b54b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1f489d8c-d963-449c-b88f-03e31590929e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0331ced3-1807-4bf8-9c73-1bacd01b54b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_BloxiverzVazculepAkovazandNouressMember_aaf0f7a9-80c8-4500-984e-d5cb7215815e" xlink:href="avdl-20211231.xsd#avdl_BloxiverzVazculepAkovazandNouressMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0331ced3-1807-4bf8-9c73-1bacd01b54b8" xlink:to="loc_avdl_BloxiverzVazculepAkovazandNouressMember_aaf0f7a9-80c8-4500-984e-d5cb7215815e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_acdd33c2-6c40-44d5-a8b3-783465303a30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fdac9dbf-c8a0-4eaa-a5a7-70a8970e7fa6" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_acdd33c2-6c40-44d5-a8b3-783465303a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_512a5ec8-4fcd-4a1e-b3d9-7280ea564a94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_acdd33c2-6c40-44d5-a8b3-783465303a30" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_512a5ec8-4fcd-4a1e-b3d9-7280ea564a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_03d59fd0-b5f9-45e2-981b-9bce0c44747a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_512a5ec8-4fcd-4a1e-b3d9-7280ea564a94" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_03d59fd0-b5f9-45e2-981b-9bce0c44747a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_92a0f2bc-fef5-4e97-9f24-06360f583964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fdac9dbf-c8a0-4eaa-a5a7-70a8970e7fa6" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_92a0f2bc-fef5-4e97-9f24-06360f583964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3de024de-8127-44ed-9ed6-ee3f2319eeb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_92a0f2bc-fef5-4e97-9f24-06360f583964" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3de024de-8127-44ed-9ed6-ee3f2319eeb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_ffa963bd-e178-4efa-98a1-a990249c19e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3de024de-8127-44ed-9ed6-ee3f2319eeb7" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_ffa963bd-e178-4efa-98a1-a990249c19e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7490a89e-0039-46cf-bb7e-0868837625f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fdac9dbf-c8a0-4eaa-a5a7-70a8970e7fa6" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7490a89e-0039-46cf-bb7e-0868837625f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_525bfdbb-ab6c-4e52-b801-0aac1135b10a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7490a89e-0039-46cf-bb7e-0868837625f1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_525bfdbb-ab6c-4e52-b801-0aac1135b10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration_beb2e87d-bbe7-43c3-b00d-677c761b899e" xlink:href="avdl-20211231.xsd#avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7490a89e-0039-46cf-bb7e-0868837625f1" xlink:to="loc_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration_beb2e87d-bbe7-43c3-b00d-677c761b899e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments_bfd9d20f-bc56-46b7-8650-7826032ac571" xlink:href="avdl-20211231.xsd#avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7490a89e-0039-46cf-bb7e-0868837625f1" xlink:to="loc_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments_bfd9d20f-bc56-46b7-8650-7826032ac571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm_d4fb96e4-c379-43d4-9227-b497bf1ee2a3" xlink:href="avdl-20211231.xsd#avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7490a89e-0039-46cf-bb7e-0868837625f1" xlink:to="loc_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm_d4fb96e4-c379-43d4-9227-b497bf1ee2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7f242fa0-fb17-43ea-b1c3-2cf9e8b0197f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7490a89e-0039-46cf-bb7e-0868837625f1" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7f242fa0-fb17-43ea-b1c3-2cf9e8b0197f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_ec35d150-4c4d-45dc-9dd6-4ebe113e3ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7490a89e-0039-46cf-bb7e-0868837625f1" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_ec35d150-4c4d-45dc-9dd6-4ebe113e3ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_c9531aed-a2a1-4543-81ca-92385341ec7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7490a89e-0039-46cf-bb7e-0868837625f1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_c9531aed-a2a1-4543-81ca-92385341ec7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_6f9bb035-2214-4870-a8d9-c29e3cbe31fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7490a89e-0039-46cf-bb7e-0868837625f1" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_6f9bb035-2214-4870-a8d9-c29e3cbe31fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_fb66d158-1fd3-496f-9732-bd957fe69d65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_760e4bcf-75cd-4541-bf8f-461ad6e6b898" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_fb66d158-1fd3-496f-9732-bd957fe69d65" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_760e4bcf-75cd-4541-bf8f-461ad6e6b898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b076af7d-d20f-4736-ab88-45078294a6ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_760e4bcf-75cd-4541-bf8f-461ad6e6b898" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b076af7d-d20f-4736-ab88-45078294a6ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0bc0d503-263a-4b6e-b1e2-d0a9740386d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b076af7d-d20f-4736-ab88-45078294a6ad" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0bc0d503-263a-4b6e-b1e2-d0a9740386d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_BloxiverzVazculepAkovazandNouressMember_29c799f6-bb97-4797-8296-4f53cba0a5fc" xlink:href="avdl-20211231.xsd#avdl_BloxiverzVazculepAkovazandNouressMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0bc0d503-263a-4b6e-b1e2-d0a9740386d3" xlink:to="loc_avdl_BloxiverzVazculepAkovazandNouressMember_29c799f6-bb97-4797-8296-4f53cba0a5fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_9da48a09-7f36-4f26-9128-923ddbe22576" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_760e4bcf-75cd-4541-bf8f-461ad6e6b898" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_9da48a09-7f36-4f26-9128-923ddbe22576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_106ee6dc-bb40-404a-9d5d-3633b707c450" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_9da48a09-7f36-4f26-9128-923ddbe22576" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_106ee6dc-bb40-404a-9d5d-3633b707c450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_0c0dabc3-2973-45e2-8ea4-74d8c9115062" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_106ee6dc-bb40-404a-9d5d-3633b707c450" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_0c0dabc3-2973-45e2-8ea4-74d8c9115062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_db9068d0-a31f-42f4-b6da-60ea1fa884b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_760e4bcf-75cd-4541-bf8f-461ad6e6b898" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_db9068d0-a31f-42f4-b6da-60ea1fa884b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_39cfba6b-1ee9-4298-a430-023917a39fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_db9068d0-a31f-42f4-b6da-60ea1fa884b2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_39cfba6b-1ee9-4298-a430-023917a39fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_6170ab1d-6b0b-4de9-855b-0ea411f18045" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_db9068d0-a31f-42f4-b6da-60ea1fa884b2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_6170ab1d-6b0b-4de9-855b-0ea411f18045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_d274d822-fed4-4749-96a6-6f84b2a4df02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_db9068d0-a31f-42f4-b6da-60ea1fa884b2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_d274d822-fed4-4749-96a6-6f84b2a4df02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_83d3b2d0-84ba-485f-b320-19be38eafa63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_db9068d0-a31f-42f4-b6da-60ea1fa884b2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_83d3b2d0-84ba-485f-b320-19be38eafa63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_60eb0f2b-55b4-4aec-936c-3c6ab4c5e88f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_db9068d0-a31f-42f4-b6da-60ea1fa884b2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_60eb0f2b-55b4-4aec-936c-3c6ab4c5e88f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_1bc5bad8-b14b-487b-90e0-90725d372479" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_db9068d0-a31f-42f4-b6da-60ea1fa884b2" xlink:to="loc_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining_1bc5bad8-b14b-487b-90e0-90725d372479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_a2814c0a-9a76-44dd-85ef-16b6afc2cdb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_db9068d0-a31f-42f4-b6da-60ea1fa884b2" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_a2814c0a-9a76-44dd-85ef-16b6afc2cdb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_32173f1d-e505-498b-afc5-40758e6fd346" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_db9068d0-a31f-42f4-b6da-60ea1fa884b2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_32173f1d-e505-498b-afc5-40758e6fd346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_d1e959b9-3182-4522-ba32-480dda75ac2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_db9068d0-a31f-42f4-b6da-60ea1fa884b2" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_d1e959b9-3182-4522-ba32-480dda75ac2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_2ab905e0-8439-425d-9e9f-94b3303310d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_db9068d0-a31f-42f4-b6da-60ea1fa884b2" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_2ab905e0-8439-425d-9e9f-94b3303310d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_30eceab4-cc6f-4584-919c-69d5bc4500a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_23250518-d19b-4a33-9c29-fc12b57ce7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_30eceab4-cc6f-4584-919c-69d5bc4500a5" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_23250518-d19b-4a33-9c29-fc12b57ce7b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_a696b20e-ab97-4f56-a237-219d08c3284f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_23250518-d19b-4a33-9c29-fc12b57ce7b1" xlink:to="loc_srt_RestatementAxis_a696b20e-ab97-4f56-a237-219d08c3284f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_5a4de5bc-85f5-49f6-bdfb-f4a7a6e5167e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_a696b20e-ab97-4f56-a237-219d08c3284f" xlink:to="loc_srt_RestatementDomain_5a4de5bc-85f5-49f6-bdfb-f4a7a6e5167e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_54c4ad6d-83d7-405e-af0c-5cb73012e985" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_5a4de5bc-85f5-49f6-bdfb-f4a7a6e5167e" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_54c4ad6d-83d7-405e-af0c-5cb73012e985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_86ac6ff8-4f8c-44a7-9c8f-7c5c46adee17" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_5a4de5bc-85f5-49f6-bdfb-f4a7a6e5167e" xlink:to="loc_srt_RestatementAdjustmentMember_86ac6ff8-4f8c-44a7-9c8f-7c5c46adee17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_9fee9c52-4779-411f-8752-6cc5d738474c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_23250518-d19b-4a33-9c29-fc12b57ce7b1" xlink:to="loc_srt_StatementScenarioAxis_9fee9c52-4779-411f-8752-6cc5d738474c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_70a7df7b-9de5-4a92-a9b1-735eb31de8e8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_9fee9c52-4779-411f-8752-6cc5d738474c" xlink:to="loc_srt_ScenarioUnspecifiedDomain_70a7df7b-9de5-4a92-a9b1-735eb31de8e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProFormaMember_e76c5f5a-ca1b-4fd6-8160-328e16291fe3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProFormaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_70a7df7b-9de5-4a92-a9b1-735eb31de8e8" xlink:to="loc_srt_ProFormaMember_e76c5f5a-ca1b-4fd6-8160-328e16291fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_dd0b4dff-0268-4836-88df-4fec8bf603fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_23250518-d19b-4a33-9c29-fc12b57ce7b1" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_dd0b4dff-0268-4836-88df-4fec8bf603fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_f60ab128-fb13-40aa-b787-714381e4d34a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_dd0b4dff-0268-4836-88df-4fec8bf603fa" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_f60ab128-fb13-40aa-b787-714381e4d34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_ae6ed015-c18f-4ff6-a1cf-2f589d503dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_f60ab128-fb13-40aa-b787-714381e4d34a" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_ae6ed015-c18f-4ff6-a1cf-2f589d503dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_c96ef880-b303-48b5-9d61-c54b1fe3397c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_23250518-d19b-4a33-9c29-fc12b57ce7b1" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_c96ef880-b303-48b5-9d61-c54b1fe3397c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_25bd05ce-2003-4611-9579-a713b678633c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_c96ef880-b303-48b5-9d61-c54b1fe3397c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_25bd05ce-2003-4611-9579-a713b678633c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_d83a12e1-42c6-485c-8346-174b168a9a93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_c96ef880-b303-48b5-9d61-c54b1fe3397c" xlink:to="loc_us-gaap_CostsAndExpenses_d83a12e1-42c6-485c-8346-174b168a9a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ebec9ee5-2bda-44af-871b-20c2a52b143f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_c96ef880-b303-48b5-9d61-c54b1fe3397c" xlink:to="loc_us-gaap_OperatingIncomeLoss_ebec9ee5-2bda-44af-871b-20c2a52b143f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4afc3598-a867-4a7c-b318-7b9fafa71345" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_c96ef880-b303-48b5-9d61-c54b1fe3397c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4afc3598-a867-4a7c-b318-7b9fafa71345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ad7c0e27-41cb-47ea-bce6-595edc09bbbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_c96ef880-b303-48b5-9d61-c54b1fe3397c" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ad7c0e27-41cb-47ea-bce6-595edc09bbbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_c993e3f3-0255-4f63-add9-e76a0c8c3522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_c96ef880-b303-48b5-9d61-c54b1fe3397c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_c993e3f3-0255-4f63-add9-e76a0c8c3522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_da842caf-ad3b-433d-acfa-3dcfae82c9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_c96ef880-b303-48b5-9d61-c54b1fe3397c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_da842caf-ad3b-433d-acfa-3dcfae82c9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_4b0c6d0d-a79a-4c12-aed4-561453b42413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_c96ef880-b303-48b5-9d61-c54b1fe3397c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_4b0c6d0d-a79a-4c12-aed4-561453b42413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_607ccd18-d92b-40d2-9b87-a3bbbf1a32fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_c96ef880-b303-48b5-9d61-c54b1fe3397c" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_607ccd18-d92b-40d2-9b87-a3bbbf1a32fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a30f128e-f9bc-4fd7-b4c5-28edf1ab0597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_c96ef880-b303-48b5-9d61-c54b1fe3397c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a30f128e-f9bc-4fd7-b4c5-28edf1ab0597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RevenueRecognition" xlink:type="simple" xlink:href="avdl-20211231.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7c798367-c37f-4ae3-b6b6-9cb1d60f5f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_775cceaf-b719-44d6-a2a8-9d58130aca3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7c798367-c37f-4ae3-b6b6-9cb1d60f5f67" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_775cceaf-b719-44d6-a2a8-9d58130aca3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="avdl-20211231.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_da9c4b10-b255-456f-870a-88a3c61f3735" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_770d76b2-9461-43ea-ab8a-84d01579dbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_da9c4b10-b255-456f-870a-88a3c61f3735" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_770d76b2-9461-43ea-ab8a-84d01579dbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="avdl-20211231.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_efdf4dc5-ffed-416c-bba5-90ad837bdeeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_941706ac-5491-4404-9fb6-3835c41b0621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_efdf4dc5-ffed-416c-bba5-90ad837bdeeb" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_941706ac-5491-4404-9fb6-3835c41b0621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#FairValueMeasurementsMeasuredonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_29bf9817-7091-4bf3-8b58-9b9f3167c15a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_59c7ca19-94b8-434b-ba51-e91819dd535b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_29bf9817-7091-4bf3-8b58-9b9f3167c15a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_59c7ca19-94b8-434b-ba51-e91819dd535b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_10ab6d8c-109d-421f-8078-3e889cfb3f12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_59c7ca19-94b8-434b-ba51-e91819dd535b" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_10ab6d8c-109d-421f-8078-3e889cfb3f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d9f7e302-a951-4f67-987f-9aea76e77ada" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_10ab6d8c-109d-421f-8078-3e889cfb3f12" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d9f7e302-a951-4f67-987f-9aea76e77ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_6d782dfc-b486-4055-aa80-2b6a88dddd7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_d9f7e302-a951-4f67-987f-9aea76e77ada" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_6d782dfc-b486-4055-aa80-2b6a88dddd7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cf3be795-47c4-4bf8-8ad0-bc114475117d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_59c7ca19-94b8-434b-ba51-e91819dd535b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cf3be795-47c4-4bf8-8ad0-bc114475117d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_56a394bc-d4bf-4706-8b95-cf90212604fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cf3be795-47c4-4bf8-8ad0-bc114475117d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_56a394bc-d4bf-4706-8b95-cf90212604fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1f6555a3-7873-4236-b7a2-9b9fd8c8ef57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_56a394bc-d4bf-4706-8b95-cf90212604fd" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1f6555a3-7873-4236-b7a2-9b9fd8c8ef57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_e3720699-a8fb-4a34-a728-095463f19c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_56a394bc-d4bf-4706-8b95-cf90212604fd" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_e3720699-a8fb-4a34-a728-095463f19c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ba7bc223-25bb-46d6-8c8a-63a24ab25d73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_56a394bc-d4bf-4706-8b95-cf90212604fd" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ba7bc223-25bb-46d6-8c8a-63a24ab25d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d24f39fe-6197-4038-a890-fb7dad12e657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_59c7ca19-94b8-434b-ba51-e91819dd535b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d24f39fe-6197-4038-a890-fb7dad12e657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ba3592b0-a4e2-4018-af9c-ab185640f017" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d24f39fe-6197-4038-a890-fb7dad12e657" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ba3592b0-a4e2-4018-af9c-ab185640f017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_38048200-a717-48c5-9e1a-13b14e6ae377" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ba3592b0-a4e2-4018-af9c-ab185640f017" xlink:to="loc_us-gaap_MoneyMarketFundsMember_38048200-a717-48c5-9e1a-13b14e6ae377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_721bcff5-e5f5-40f3-b2af-f99744aa82b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ba3592b0-a4e2-4018-af9c-ab185640f017" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_721bcff5-e5f5-40f3-b2af-f99744aa82b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4d9cc38a-5db3-41ec-939d-bc1c76198808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ba3592b0-a4e2-4018-af9c-ab185640f017" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4d9cc38a-5db3-41ec-939d-bc1c76198808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_af81245d-3614-431b-80f0-4a4cc7cbab9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ba3592b0-a4e2-4018-af9c-ab185640f017" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_af81245d-3614-431b-80f0-4a4cc7cbab9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7e94774b-757c-4057-b18b-16717b760895" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_59c7ca19-94b8-434b-ba51-e91819dd535b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7e94774b-757c-4057-b18b-16717b760895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eaf3dbc4-216d-4645-b1a7-8ee2e82103a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7e94774b-757c-4057-b18b-16717b760895" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eaf3dbc4-216d-4645-b1a7-8ee2e82103a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_facf01a7-17be-44ad-929e-048ada6b0bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7e94774b-757c-4057-b18b-16717b760895" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_facf01a7-17be-44ad-929e-048ada6b0bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_707ff61a-8ec1-46c1-9eca-bc368f2f2eea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f2e9c348-5bf2-4f03-83fb-67a2815e80be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_707ff61a-8ec1-46c1-9eca-bc368f2f2eea" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f2e9c348-5bf2-4f03-83fb-67a2815e80be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b2ad247a-da83-49a5-b780-24b04405c7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f2e9c348-5bf2-4f03-83fb-67a2815e80be" xlink:to="loc_us-gaap_DebtInstrumentAxis_b2ad247a-da83-49a5-b780-24b04405c7cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_056f6099-7071-420e-805b-56493c1a9b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b2ad247a-da83-49a5-b780-24b04405c7cf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_056f6099-7071-420e-805b-56493c1a9b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_d94a0bd3-4552-4dd3-9c4f-fda8861d405f" xlink:href="avdl-20211231.xsd#avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_056f6099-7071-420e-805b-56493c1a9b1b" xlink:to="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_d94a0bd3-4552-4dd3-9c4f-fda8861d405f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3ec9b603-c535-4ad4-a358-c2f12ba17918" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f2e9c348-5bf2-4f03-83fb-67a2815e80be" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3ec9b603-c535-4ad4-a358-c2f12ba17918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_47d8ae6d-d3df-4306-81ba-33082e1e785a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3ec9b603-c535-4ad4-a358-c2f12ba17918" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_47d8ae6d-d3df-4306-81ba-33082e1e785a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_64868e26-d348-4a36-9985-343770e4e5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_47d8ae6d-d3df-4306-81ba-33082e1e785a" xlink:to="loc_us-gaap_SeniorNotesMember_64868e26-d348-4a36-9985-343770e4e5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_fbe84488-5c96-4d60-9f54-82b29cf82e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f2e9c348-5bf2-4f03-83fb-67a2815e80be" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_fbe84488-5c96-4d60-9f54-82b29cf82e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_71f10e70-253e-4f80-8df5-e35d8d583b01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_fbe84488-5c96-4d60-9f54-82b29cf82e0e" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_71f10e70-253e-4f80-8df5-e35d8d583b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_5a2501a5-69a8-47b3-909f-d784f26c2f76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_71f10e70-253e-4f80-8df5-e35d8d583b01" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_5a2501a5-69a8-47b3-909f-d784f26c2f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_7c71b766-dc5d-414c-81b1-4aea0eb19561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_5a2501a5-69a8-47b3-909f-d784f26c2f76" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_7c71b766-dc5d-414c-81b1-4aea0eb19561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_44d9d761-85da-4570-afaa-02d7db519c11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f2e9c348-5bf2-4f03-83fb-67a2815e80be" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_44d9d761-85da-4570-afaa-02d7db519c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_8bb3f5d1-a802-4ed8-972a-2240cdab803f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_44d9d761-85da-4570-afaa-02d7db519c11" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_8bb3f5d1-a802-4ed8-972a-2240cdab803f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_e79eb96c-1a45-43c3-8f5c-332b6e92a67c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_44d9d761-85da-4570-afaa-02d7db519c11" xlink:to="loc_us-gaap_LongTermDebt_e79eb96c-1a45-43c3-8f5c-332b6e92a67c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecurities" xlink:type="simple" xlink:href="avdl-20211231.xsd#MarketableSecurities"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/MarketableSecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_baa67303-80a0-4c51-a34b-54432ef096c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_265a2dc2-420c-4b53-a6cd-5f870482f4d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_baa67303-80a0-4c51-a34b-54432ef096c4" xlink:to="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_265a2dc2-420c-4b53-a6cd-5f870482f4d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesTables" xlink:type="simple" xlink:href="avdl-20211231.xsd#MarketableSecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c5e600f6-ab4c-499a-85aa-95aefa2f0ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_020c7436-878d-4f08-975c-758a63a1c7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c5e600f6-ab4c-499a-85aa-95aefa2f0ab3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_020c7436-878d-4f08-975c-758a63a1c7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_aec11d63-33e1-405c-87b4-579b73eee1ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c5e600f6-ab4c-499a-85aa-95aefa2f0ab3" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_aec11d63-33e1-405c-87b4-579b73eee1ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#MarketableSecuritiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6bd95756-fccb-48f0-8563-3f196ce174b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MarketableSecuritiesRealizedGain_098805fc-1f69-4315-b429-4fcd1f4d198a" xlink:href="avdl-20211231.xsd#avdl_MarketableSecuritiesRealizedGain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6bd95756-fccb-48f0-8563-3f196ce174b7" xlink:to="loc_avdl_MarketableSecuritiesRealizedGain_098805fc-1f69-4315-b429-4fcd1f4d198a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MarketableSecuritiesRealizedLoss_56c5fc52-9a65-4d9a-9811-66e11f7ca49f" xlink:href="avdl-20211231.xsd#avdl_MarketableSecuritiesRealizedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6bd95756-fccb-48f0-8563-3f196ce174b7" xlink:to="loc_avdl_MarketableSecuritiesRealizedLoss_56c5fc52-9a65-4d9a-9811-66e11f7ca49f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#MarketableSecuritiesSummaryofMarketableSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8f9531f9-eb37-4ff4-95af-a04ff10259f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_924b87d2-65e2-409c-8010-862a8aaf906a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8f9531f9-eb37-4ff4-95af-a04ff10259f4" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_924b87d2-65e2-409c-8010-862a8aaf906a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_3c33e954-dc04-4ab7-ab91-e6d86618985a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_924b87d2-65e2-409c-8010-862a8aaf906a" xlink:to="loc_us-gaap_FinancialInstrumentAxis_3c33e954-dc04-4ab7-ab91-e6d86618985a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b42e325-93a9-412c-9fb7-c277228fb67e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3c33e954-dc04-4ab7-ab91-e6d86618985a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b42e325-93a9-412c-9fb7-c277228fb67e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_99974193-3d5d-4d42-9af2-80a930cfe1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b42e325-93a9-412c-9fb7-c277228fb67e" xlink:to="loc_us-gaap_MoneyMarketFundsMember_99974193-3d5d-4d42-9af2-80a930cfe1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_2513cdf0-1ea7-48a4-bec1-e286bd8418a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b42e325-93a9-412c-9fb7-c277228fb67e" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_2513cdf0-1ea7-48a4-bec1-e286bd8418a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_5d02b74b-f750-4da4-908c-c1fd16f98af2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b42e325-93a9-412c-9fb7-c277228fb67e" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_5d02b74b-f750-4da4-908c-c1fd16f98af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_36ab63da-6d8c-49c5-8ddc-d54be4467a93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b42e325-93a9-412c-9fb7-c277228fb67e" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_36ab63da-6d8c-49c5-8ddc-d54be4467a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_13922fa8-ca5a-4b7a-b70d-09d5a98d92a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_924b87d2-65e2-409c-8010-862a8aaf906a" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_13922fa8-ca5a-4b7a-b70d-09d5a98d92a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_caa8f046-2811-41fe-aa7e-c62871d0dca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_13922fa8-ca5a-4b7a-b70d-09d5a98d92a5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_caa8f046-2811-41fe-aa7e-c62871d0dca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f956a612-966b-478b-8592-f687aa92f554" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_caa8f046-2811-41fe-aa7e-c62871d0dca1" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f956a612-966b-478b-8592-f687aa92f554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_12dd8bdd-98f4-44b2-98a2-620e977a0482" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_caa8f046-2811-41fe-aa7e-c62871d0dca1" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_12dd8bdd-98f4-44b2-98a2-620e977a0482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_bc40141f-7daf-43b2-bd67-c7257ae6766f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_caa8f046-2811-41fe-aa7e-c62871d0dca1" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_bc40141f-7daf-43b2-bd67-c7257ae6766f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_018a8991-7241-4e67-8351-cabdd7ac18ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_caa8f046-2811-41fe-aa7e-c62871d0dca1" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_018a8991-7241-4e67-8351-cabdd7ac18ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#MarketableSecuritiesScheduleofMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0bca2e09-dc72-40fc-93b9-ba1f6c7e3bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e626ee46-e986-4457-afe2-8c9de9c873b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0bca2e09-dc72-40fc-93b9-ba1f6c7e3bd7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e626ee46-e986-4457-afe2-8c9de9c873b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_7e46cfb5-dda1-40ae-b9eb-670af9fe53fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e626ee46-e986-4457-afe2-8c9de9c873b3" xlink:to="loc_us-gaap_FinancialInstrumentAxis_7e46cfb5-dda1-40ae-b9eb-670af9fe53fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dfe326ca-6ada-44c2-b5ab-e8b8fb99041c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7e46cfb5-dda1-40ae-b9eb-670af9fe53fb" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dfe326ca-6ada-44c2-b5ab-e8b8fb99041c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_49708395-c0ea-4df3-834f-6033676fe6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dfe326ca-6ada-44c2-b5ab-e8b8fb99041c" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_49708395-c0ea-4df3-834f-6033676fe6fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_80ba5fb4-3fc9-458d-aea5-9e39028307b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dfe326ca-6ada-44c2-b5ab-e8b8fb99041c" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_80ba5fb4-3fc9-458d-aea5-9e39028307b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_7128e044-6ff1-48d4-9269-03a92397dc6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dfe326ca-6ada-44c2-b5ab-e8b8fb99041c" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_7128e044-6ff1-48d4-9269-03a92397dc6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_3c566bee-fb6b-4a1d-aefa-38d1d0cd1e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dfe326ca-6ada-44c2-b5ab-e8b8fb99041c" xlink:to="loc_us-gaap_DebtSecuritiesMember_3c566bee-fb6b-4a1d-aefa-38d1d0cd1e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_12884434-0b36-4c5d-aef4-620fafc16d77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e626ee46-e986-4457-afe2-8c9de9c873b3" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_12884434-0b36-4c5d-aef4-620fafc16d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_67f6a8c7-f351-468f-b57a-56846e7b3103" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_12884434-0b36-4c5d-aef4-620fafc16d77" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_67f6a8c7-f351-468f-b57a-56846e7b3103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_78b3bfa8-1d6d-4f10-8ca3-373f9e9727f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_12884434-0b36-4c5d-aef4-620fafc16d77" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_78b3bfa8-1d6d-4f10-8ca3-373f9e9727f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_b651a39c-d4c0-4a00-9e57-7e3ae29db184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_12884434-0b36-4c5d-aef4-620fafc16d77" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_b651a39c-d4c0-4a00-9e57-7e3ae29db184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_b838c179-dd93-4f65-924e-5ebe6490869a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_12884434-0b36-4c5d-aef4-620fafc16d77" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_b838c179-dd93-4f65-924e-5ebe6490869a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ac3c426c-8144-44ba-90fa-3db27e472e40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_12884434-0b36-4c5d-aef4-620fafc16d77" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ac3c426c-8144-44ba-90fa-3db27e472e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/PropertyandEquipmentnet" xlink:type="simple" xlink:href="avdl-20211231.xsd#PropertyandEquipmentnet"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/PropertyandEquipmentnet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ab69f7cf-ae4a-478c-8ede-4b348ac4d938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_578e06f8-213b-4d1e-99be-d0bcac8acdd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ab69f7cf-ae4a-478c-8ede-4b348ac4d938" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_578e06f8-213b-4d1e-99be-d0bcac8acdd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/PropertyandEquipmentnetTables" xlink:type="simple" xlink:href="avdl-20211231.xsd#PropertyandEquipmentnetTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/PropertyandEquipmentnetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_17352873-46e4-47d1-91e6-101d7e285a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_9ddbd060-4644-444e-8bc6-5ac007e813bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_17352873-46e4-47d1-91e6-101d7e285a9e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_9ddbd060-4644-444e-8bc6-5ac007e813bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/PropertyandEquipmentnetDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#PropertyandEquipmentnetDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/PropertyandEquipmentnetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_445b3bc7-7a8b-4f99-98c2-84d5be2393b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_979444d3-b189-4db2-aba4-eef75cfa09a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_445b3bc7-7a8b-4f99-98c2-84d5be2393b0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_979444d3-b189-4db2-aba4-eef75cfa09a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_60b9868a-7a50-4fff-b122-5b97a96012d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_979444d3-b189-4db2-aba4-eef75cfa09a1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_60b9868a-7a50-4fff-b122-5b97a96012d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3aecc9f5-4039-43d6-a7db-aec78278756f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_60b9868a-7a50-4fff-b122-5b97a96012d6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3aecc9f5-4039-43d6-a7db-aec78278756f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember_eaf526eb-bf7a-4aa1-a8cd-1aa619cea861" xlink:href="avdl-20211231.xsd#avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3aecc9f5-4039-43d6-a7db-aec78278756f" xlink:to="loc_avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember_eaf526eb-bf7a-4aa1-a8cd-1aa619cea861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_ba86c7bb-3c1b-430a-a15a-a214ee7ccf76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3aecc9f5-4039-43d6-a7db-aec78278756f" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_ba86c7bb-3c1b-430a-a15a-a214ee7ccf76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ef9a59d6-6a04-4627-8a1a-94b7b26d7b76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_979444d3-b189-4db2-aba4-eef75cfa09a1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ef9a59d6-6a04-4627-8a1a-94b7b26d7b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_7a4d48bf-1c1d-4f1f-acea-544436f7d480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ef9a59d6-6a04-4627-8a1a-94b7b26d7b76" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_7a4d48bf-1c1d-4f1f-acea-544436f7d480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_00611e3e-0cce-4cc1-a0e1-e8e9be61050f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ef9a59d6-6a04-4627-8a1a-94b7b26d7b76" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_00611e3e-0cce-4cc1-a0e1-e8e9be61050f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_09e08b08-12f6-4547-b9d5-62c45e62e073" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ef9a59d6-6a04-4627-8a1a-94b7b26d7b76" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_09e08b08-12f6-4547-b9d5-62c45e62e073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_a496cc7c-63b6-4a2a-83ab-a0f6b3951eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ef9a59d6-6a04-4627-8a1a-94b7b26d7b76" xlink:to="loc_us-gaap_Depreciation_a496cc7c-63b6-4a2a-83ab-a0f6b3951eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="avdl-20211231.xsd#GoodwillandIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/GoodwillandIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7ad0be80-8077-4215-bf4e-f236cc031763" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_18b1670a-039f-4a84-b046-89c9b472d771" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7ad0be80-8077-4215-bf4e-f236cc031763" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_18b1670a-039f-4a84-b046-89c9b472d771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#GoodwillandIntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_68fbc43b-6160-476b-a99e-faa18d07e4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_465b95df-62f7-4919-9b16-642595a81b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_68fbc43b-6160-476b-a99e-faa18d07e4e1" xlink:to="loc_us-gaap_Goodwill_465b95df-62f7-4919-9b16-642595a81b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_afda9da0-a7ac-486f-9073-d9b51a8879c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_68fbc43b-6160-476b-a99e-faa18d07e4e1" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_afda9da0-a7ac-486f-9073-d9b51a8879c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_49c6ea29-78e3-41a8-95b1-6a1ad9cb72e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_68fbc43b-6160-476b-a99e-faa18d07e4e1" xlink:to="loc_us-gaap_AssetImpairmentCharges_49c6ea29-78e3-41a8-95b1-6a1ad9cb72e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/Leases" xlink:type="simple" xlink:href="avdl-20211231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_37262d00-d0b1-4abe-8057-aae22826ccdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_818b7842-1266-4cf5-bc87-1a472461f0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_37262d00-d0b1-4abe-8057-aae22826ccdb" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_818b7842-1266-4cf5-bc87-1a472461f0c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LeasesTables" xlink:type="simple" xlink:href="avdl-20211231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f1304182-73be-4559-92f9-d69e032bc626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_011df7f8-fd7d-40ca-aab3-17bc10afc1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f1304182-73be-4559-92f9-d69e032bc626" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_011df7f8-fd7d-40ca-aab3-17bc10afc1c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_b13d47bb-4d52-453a-ba3c-a2c5e61e8cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f1304182-73be-4559-92f9-d69e032bc626" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_b13d47bb-4d52-453a-ba3c-a2c5e61e8cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ad75fb3e-641d-4763-916f-aff967208dce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_faa2b239-594c-45d6-b94a-37eef0e18203" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ad75fb3e-641d-4763-916f-aff967208dce" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_faa2b239-594c-45d6-b94a-37eef0e18203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1631bee2-bb7c-438e-a31d-09408a1607f1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_faa2b239-594c-45d6-b94a-37eef0e18203" xlink:to="loc_srt_RangeAxis_1631bee2-bb7c-438e-a31d-09408a1607f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_703ec2bc-3890-4841-9795-3e6fc15e36a9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1631bee2-bb7c-438e-a31d-09408a1607f1" xlink:to="loc_srt_RangeMember_703ec2bc-3890-4841-9795-3e6fc15e36a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_740d6d81-8815-404e-8a32-a8b3ebfd3086" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_703ec2bc-3890-4841-9795-3e6fc15e36a9" xlink:to="loc_srt_MinimumMember_740d6d81-8815-404e-8a32-a8b3ebfd3086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_61b40edd-a88d-4164-ab5a-a1fcaf2540dc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_703ec2bc-3890-4841-9795-3e6fc15e36a9" xlink:to="loc_srt_MaximumMember_61b40edd-a88d-4164-ab5a-a1fcaf2540dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_a58dc91e-c9d5-4cb8-965b-6b7be8413967" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_faa2b239-594c-45d6-b94a-37eef0e18203" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_a58dc91e-c9d5-4cb8-965b-6b7be8413967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_ea5f2f8e-ee66-4824-909c-1cd99f5e076c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a58dc91e-c9d5-4cb8-965b-6b7be8413967" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_ea5f2f8e-ee66-4824-909c-1cd99f5e076c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_9620912e-ef8b-4f1b-9d7a-5a2606114038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a58dc91e-c9d5-4cb8-965b-6b7be8413967" xlink:to="loc_us-gaap_OperatingLeasePayments_9620912e-ef8b-4f1b-9d7a-5a2606114038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_c558e649-6bec-4dc4-b19e-16da35e058b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a58dc91e-c9d5-4cb8-965b-6b7be8413967" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_c558e649-6bec-4dc4-b19e-16da35e058b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_ad144270-9ca1-4f39-8165-c9d40bb64cde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a58dc91e-c9d5-4cb8-965b-6b7be8413967" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_ad144270-9ca1-4f39-8165-c9d40bb64cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LeasesComponentsofleasecostsDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#LeasesComponentsofleasecostsDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/LeasesComponentsofleasecostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_aa12bb91-133c-4147-9861-afbc209a7552" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_c64054a7-459c-4c87-b272-b7ddb2ba9925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_aa12bb91-133c-4147-9861-afbc209a7552" xlink:to="loc_us-gaap_OperatingLeaseCost_c64054a7-459c-4c87-b272-b7ddb2ba9925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_36688c63-079c-4a80-af99-6f1bba7fc79e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_aa12bb91-133c-4147-9861-afbc209a7552" xlink:to="loc_us-gaap_SubleaseIncome_36688c63-079c-4a80-af99-6f1bba7fc79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_15aef400-39d2-491b-a309-ee7492ffb9cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_aa12bb91-133c-4147-9861-afbc209a7552" xlink:to="loc_us-gaap_LeaseCost_15aef400-39d2-491b-a309-ee7492ffb9cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#LeasesMaturitiesofoperatingleaseliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_45a07b29-5a29-462b-b8c2-72146bb68000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0da61701-b8f8-4093-9242-8adf3a75d0fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_45a07b29-5a29-462b-b8c2-72146bb68000" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0da61701-b8f8-4093-9242-8adf3a75d0fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_978b0ec4-a1bd-4847-8daf-ff703f52e124" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_45a07b29-5a29-462b-b8c2-72146bb68000" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_978b0ec4-a1bd-4847-8daf-ff703f52e124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_bdc2710c-8342-4837-8bfc-0dae447ae99c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_45a07b29-5a29-462b-b8c2-72146bb68000" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_bdc2710c-8342-4837-8bfc-0dae447ae99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_cadf02a7-da32-44f9-bfff-2ce1381228be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_45a07b29-5a29-462b-b8c2-72146bb68000" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_cadf02a7-da32-44f9-bfff-2ce1381228be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_1aea0a3d-6e4a-4233-84c0-c66b3538a14b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_45a07b29-5a29-462b-b8c2-72146bb68000" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_1aea0a3d-6e4a-4233-84c0-c66b3538a14b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_ab4396a8-a9ed-43e7-8b58-f0b51317bf29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_45a07b29-5a29-462b-b8c2-72146bb68000" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_ab4396a8-a9ed-43e7-8b58-f0b51317bf29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b6bf9676-9a38-433b-af84-90e4f8b28003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_45a07b29-5a29-462b-b8c2-72146bb68000" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b6bf9676-9a38-433b-af84-90e4f8b28003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_c24105d1-adc4-4690-a459-9ec7a99f2cea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_45a07b29-5a29-462b-b8c2-72146bb68000" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_c24105d1-adc4-4690-a459-9ec7a99f2cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_888b9bf0-7ee8-4071-aebb-2af107f59ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_45a07b29-5a29-462b-b8c2-72146bb68000" xlink:to="loc_us-gaap_OperatingLeaseLiability_888b9bf0-7ee8-4071-aebb-2af107f59ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails_1" xlink:type="simple" xlink:href="avdl-20211231.xsd#LeasesMaturitiesofoperatingleaseliabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebt" xlink:type="simple" xlink:href="avdl-20211231.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8a0748da-3fa8-497f-a3b6-077e885148fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_fd510be3-395e-44b9-abcd-70bc81959801" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8a0748da-3fa8-497f-a3b6-077e885148fb" xlink:to="loc_us-gaap_LongTermDebtTextBlock_fd510be3-395e-44b9-abcd-70bc81959801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="avdl-20211231.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5bfb996e-fda4-4022-a040-4cf7e29b0bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_945a6b37-3e50-496e-83fa-b9b10d2dfd20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5bfb996e-fda4-4022-a040-4cf7e29b0bd1" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_945a6b37-3e50-496e-83fa-b9b10d2dfd20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#LongTermDebtScheduleofLongTermDebtInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_17389489-31e7-4e87-b576-c07a2961982c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b391198f-df83-43cd-847a-5aa6552811e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_17389489-31e7-4e87-b576-c07a2961982c" xlink:to="loc_us-gaap_DebtInstrumentTable_b391198f-df83-43cd-847a-5aa6552811e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_726266f2-2010-4a9c-adcf-647b1315fe3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b391198f-df83-43cd-847a-5aa6552811e7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_726266f2-2010-4a9c-adcf-647b1315fe3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_60660a38-566e-4aea-82c9-752f984cb92e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_726266f2-2010-4a9c-adcf-647b1315fe3c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_60660a38-566e-4aea-82c9-752f984cb92e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_be424304-cb69-4092-86f1-1daa32bd0671" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_60660a38-566e-4aea-82c9-752f984cb92e" xlink:to="loc_us-gaap_SeniorNotesMember_be424304-cb69-4092-86f1-1daa32bd0671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0c881f2a-4297-40b2-a0e2-45476e6798ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b391198f-df83-43cd-847a-5aa6552811e7" xlink:to="loc_us-gaap_DebtInstrumentAxis_0c881f2a-4297-40b2-a0e2-45476e6798ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a39b7ba8-6596-488d-9969-d06c29d48932" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_0c881f2a-4297-40b2-a0e2-45476e6798ab" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a39b7ba8-6596-488d-9969-d06c29d48932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_568b653d-3c29-4101-88b9-6face4424c62" xlink:href="avdl-20211231.xsd#avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a39b7ba8-6596-488d-9969-d06c29d48932" xlink:to="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_568b653d-3c29-4101-88b9-6face4424c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ad5f25b1-5f35-48b9-bfd3-e443061b4c25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b391198f-df83-43cd-847a-5aa6552811e7" xlink:to="loc_us-gaap_DebtInstrumentLineItems_ad5f25b1-5f35-48b9-bfd3-e443061b4c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_4ef3862b-f8bd-4605-a492-c5898783fffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ad5f25b1-5f35-48b9-bfd3-e443061b4c25" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_4ef3862b-f8bd-4605-a492-c5898783fffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_7c5478cd-94a4-442e-a4b5-6762f1070783" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ad5f25b1-5f35-48b9-bfd3-e443061b4c25" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_7c5478cd-94a4-442e-a4b5-6762f1070783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_9c1a1be4-e3c9-4501-a2a5-7d9cd962e893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ad5f25b1-5f35-48b9-bfd3-e443061b4c25" xlink:to="loc_us-gaap_LongTermDebt_9c1a1be4-e3c9-4501-a2a5-7d9cd962e893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_f1003eb4-3c50-4700-9991-4ed178c7c7f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ad5f25b1-5f35-48b9-bfd3-e443061b4c25" xlink:to="loc_us-gaap_LongTermDebtCurrent_f1003eb4-3c50-4700-9991-4ed178c7c7f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_a00ead14-de56-4c11-a2ee-085d3c0a5703" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ad5f25b1-5f35-48b9-bfd3-e443061b4c25" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_a00ead14-de56-4c11-a2ee-085d3c0a5703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_292a8ded-a522-41d2-90bc-220ed1f069ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ad5f25b1-5f35-48b9-bfd3-e443061b4c25" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_292a8ded-a522-41d2-90bc-220ed1f069ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_16608ad3-60a3-41e0-be8c-5b72a3001731" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ad5f25b1-5f35-48b9-bfd3-e443061b4c25" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_16608ad3-60a3-41e0-be8c-5b72a3001731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails_1" xlink:type="simple" xlink:href="avdl-20211231.xsd#LongTermDebtScheduleofLongTermDebtInstrumentsDetails_1"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#LongTermDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/LongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_84e48bc0-4a76-4754-a3a8-7288bd9b8fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_ab438aa2-2133-41f1-aa80-753eecf013df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCapitalizationLongtermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_84e48bc0-4a76-4754-a3a8-7288bd9b8fa3" xlink:to="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_ab438aa2-2133-41f1-aa80-753eecf013df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_941ee372-1d6d-4aaa-8f51-27c677e521bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_ab438aa2-2133-41f1-aa80-753eecf013df" xlink:to="loc_us-gaap_DebtInstrumentAxis_941ee372-1d6d-4aaa-8f51-27c677e521bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e10c5414-b562-4284-896a-6396078d2851" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_941ee372-1d6d-4aaa-8f51-27c677e521bd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e10c5414-b562-4284-896a-6396078d2851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_d611a6c0-9a33-4440-be46-613cc8a61082" xlink:href="avdl-20211231.xsd#avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e10c5414-b562-4284-896a-6396078d2851" xlink:to="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_d611a6c0-9a33-4440-be46-613cc8a61082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c6af80fd-2dc1-4ca0-aaba-444424caf5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_ab438aa2-2133-41f1-aa80-753eecf013df" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c6af80fd-2dc1-4ca0-aaba-444424caf5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8f836d7b-a28d-489d-80cd-918b840152c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c6af80fd-2dc1-4ca0-aaba-444424caf5e3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8f836d7b-a28d-489d-80cd-918b840152c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_1868ef2e-caf4-4e39-b075-ddcf4435d252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8f836d7b-a28d-489d-80cd-918b840152c9" xlink:to="loc_us-gaap_ConvertibleDebtMember_1868ef2e-caf4-4e39-b075-ddcf4435d252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_199bb480-99b0-4351-9054-d4a8ebebe796" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8f836d7b-a28d-489d-80cd-918b840152c9" xlink:to="loc_us-gaap_SeniorNotesMember_199bb480-99b0-4351-9054-d4a8ebebe796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d269c0bd-27d6-4dc3-baba-54cbef55b849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_ab438aa2-2133-41f1-aa80-753eecf013df" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d269c0bd-27d6-4dc3-baba-54cbef55b849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_074dde0f-b83b-4834-a43a-fac056c43e05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_d269c0bd-27d6-4dc3-baba-54cbef55b849" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_074dde0f-b83b-4834-a43a-fac056c43e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_1eeea341-4b4a-48c1-8c9f-b56b9ea8a34c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_074dde0f-b83b-4834-a43a-fac056c43e05" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_1eeea341-4b4a-48c1-8c9f-b56b9ea8a34c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_d20d877f-2841-42c8-b37b-09a954e0e7ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_074dde0f-b83b-4834-a43a-fac056c43e05" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_d20d877f-2841-42c8-b37b-09a954e0e7ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_57630db9-ed9a-4e9c-a49f-677eafd8d41b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_074dde0f-b83b-4834-a43a-fac056c43e05" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_57630db9-ed9a-4e9c-a49f-677eafd8d41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_23a4372b-50a9-415f-bde0-bc5b6e3775ff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_ab438aa2-2133-41f1-aa80-753eecf013df" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_23a4372b-50a9-415f-bde0-bc5b6e3775ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8ce04482-f450-40f2-8f42-c168bc439332" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_23a4372b-50a9-415f-bde0-bc5b6e3775ff" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8ce04482-f450-40f2-8f42-c168bc439332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_6251de46-426a-44c6-8b97-77223506ec6a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8ce04482-f450-40f2-8f42-c168bc439332" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_6251de46-426a-44c6-8b97-77223506ec6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9f5b4d9b-c2a7-4e67-a8ff-1d366fe971d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_ab438aa2-2133-41f1-aa80-753eecf013df" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9f5b4d9b-c2a7-4e67-a8ff-1d366fe971d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_41ae5b1a-0959-45a2-ab3d-7bb916fde9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9f5b4d9b-c2a7-4e67-a8ff-1d366fe971d2" xlink:to="loc_us-gaap_EquityComponentDomain_41ae5b1a-0959-45a2-ab3d-7bb916fde9ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9689def0-846a-4bef-a3a6-3030a3e07d12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_41ae5b1a-0959-45a2-ab3d-7bb916fde9ee" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9689def0-846a-4bef-a3a6-3030a3e07d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_ab438aa2-2133-41f1-aa80-753eecf013df" xlink:to="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_d118ec9a-7bf8-4dce-aaad-6fcbcdd29676" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_us-gaap_InterestExpenseDebt_d118ec9a-7bf8-4dce-aaad-6fcbcdd29676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CouponInterestExpense_dd138400-cb40-4a35-a996-4a5b836fc878" xlink:href="avdl-20211231.xsd#avdl_CouponInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_avdl_CouponInterestExpense_dd138400-cb40-4a35-a996-4a5b836fc878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_2ea687dd-9df4-4262-ae5a-a76de2aeed78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_2ea687dd-9df4-4262-ae5a-a76de2aeed78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AdditionalInterestExpenseDebt_62fd21df-28ea-46bb-99c3-0f03fba72bb0" xlink:href="avdl-20211231.xsd#avdl_AdditionalInterestExpenseDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_avdl_AdditionalInterestExpenseDebt_62fd21df-28ea-46bb-99c3-0f03fba72bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_468eabc4-fd14-44d6-bb3a-c420fe11c619" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_us-gaap_LongTermDebt_468eabc4-fd14-44d6-bb3a-c420fe11c619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_20a117e9-e9af-473a-8e43-f08a05471db3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_us-gaap_StockholdersEquity_20a117e9-e9af-473a-8e43-f08a05471db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_a0e9ce8f-27df-4711-ad39-119796305f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_a0e9ce8f-27df-4711-ad39-119796305f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_57208dd5-dbdb-47eb-b739-6667e3fb8893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_57208dd5-dbdb-47eb-b739-6667e3fb8893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_61cef879-e857-43ea-93e1-0d01718d1241" xlink:href="avdl-20211231.xsd#avdl_DebtInstrumentOptiontoIncreaseFaceAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_61cef879-e857-43ea-93e1-0d01718d1241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_9b8e83cd-5def-4283-9bc6-c7eac8602d98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_9b8e83cd-5def-4283-9bc6-c7eac8602d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositorySharesConversionRatio_b5eb94c6-f3ab-475a-9121-68d5695edd74" xlink:href="avdl-20211231.xsd#avdl_AmericanDepositorySharesConversionRatio"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_avdl_AmericanDepositorySharesConversionRatio_b5eb94c6-f3ab-475a-9121-68d5695edd74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesOptionPricePerShare_8f319b12-bc1a-4deb-b623-65bb12a1a96c" xlink:href="avdl-20211231.xsd#avdl_AmericanDepositarySharesOptionPricePerShare"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_avdl_AmericanDepositarySharesOptionPricePerShare_8f319b12-bc1a-4deb-b623-65bb12a1a96c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesPremiumPercentage_ed0d9155-87f2-49de-b2fd-88eeea87a81b" xlink:href="avdl-20211231.xsd#avdl_AmericanDepositarySharesPremiumPercentage"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_avdl_AmericanDepositarySharesPremiumPercentage_ed0d9155-87f2-49de-b2fd-88eeea87a81b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesPurchasedPricePerShare_fdfd66bf-7f36-47ae-85ba-9dbdc119374a" xlink:href="avdl-20211231.xsd#avdl_AmericanDepositarySharesPurchasedPricePerShare"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_avdl_AmericanDepositarySharesPurchasedPricePerShare_fdfd66bf-7f36-47ae-85ba-9dbdc119374a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted_e261d0c4-e7a6-4ec0-b6fe-38b80e37bffe" xlink:href="avdl-20211231.xsd#avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted_e261d0c4-e7a6-4ec0-b6fe-38b80e37bffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays_122539ba-a58b-4bad-8e91-f8d0347e73d7" xlink:href="avdl-20211231.xsd#avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays_122539ba-a58b-4bad-8e91-f8d0347e73d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay_17114140-0001-421a-9780-4f130926cd46" xlink:href="avdl-20211231.xsd#avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay_17114140-0001-421a-9780-4f130926cd46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays_c725e4d0-b85f-4a4a-8ffc-a7eecd499342" xlink:href="avdl-20211231.xsd#avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays_c725e4d0-b85f-4a4a-8ffc-a7eecd499342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_87b81d1b-9ba2-466c-9fcd-448a7afead06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_87b81d1b-9ba2-466c-9fcd-448a7afead06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_51ef96ea-644b-4357-b734-184f0f160db1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_51ef96ea-644b-4357-b734-184f0f160db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_37d91be6-983a-47ba-a5e8-f2cacb565309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_42439047-089e-46d6-b77a-205c53c690aa" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_37d91be6-983a-47ba-a5e8-f2cacb565309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ContingentConsiderationPayable" xlink:type="simple" xlink:href="avdl-20211231.xsd#ContingentConsiderationPayable"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ContingentConsiderationPayable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e30347c6-ba52-4528-b333-a47656a62c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_LongTermContingentConsideraionPayableTextBlock_402a50c0-8fe5-4fac-8f89-b1b5d6805e24" xlink:href="avdl-20211231.xsd#avdl_LongTermContingentConsideraionPayableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e30347c6-ba52-4528-b333-a47656a62c0b" xlink:to="loc_avdl_LongTermContingentConsideraionPayableTextBlock_402a50c0-8fe5-4fac-8f89-b1b5d6805e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ContingentConsiderationPayableTables" xlink:type="simple" xlink:href="avdl-20211231.xsd#ContingentConsiderationPayableTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ContingentConsiderationPayableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_94d90e4f-2f25-47ba-8156-5778be13d0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_3f73c6f0-1b9c-441b-96cc-77697d5fffa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_94d90e4f-2f25-47ba-8156-5778be13d0e0" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_3f73c6f0-1b9c-441b-96cc-77697d5fffa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ContingentConsiderationPayableNarrativeDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#ContingentConsiderationPayableNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ContingentConsiderationPayableNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3a32bcd7-ed75-4f6c-8f6d-d41e787fa41a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_7a49d92c-e5a5-4440-aa73-a55a3b923923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3a32bcd7-ed75-4f6c-8f6d-d41e787fa41a" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_7a49d92c-e5a5-4440-aa73-a55a3b923923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ContingentConsiderationPayablePayableBalanceDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#ContingentConsiderationPayablePayableBalanceDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ContingentConsiderationPayablePayableBalanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0a18690d-74b6-4d9c-bd26-338afc82aa96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward_df5b0c5d-4942-497a-bdb8-8037fe1e71d6" xlink:href="avdl-20211231.xsd#avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0a18690d-74b6-4d9c-bd26-338afc82aa96" xlink:to="loc_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward_df5b0c5d-4942-497a-bdb8-8037fe1e71d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_43380eee-8cd5-4988-9f8b-186d33b2d737" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward_df5b0c5d-4942-497a-bdb8-8037fe1e71d6" xlink:to="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_43380eee-8cd5-4988-9f8b-186d33b2d737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_a6bf6156-bcba-441c-b060-4fd767b71445" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward_df5b0c5d-4942-497a-bdb8-8037fe1e71d6" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_a6bf6156-bcba-441c-b060-4fd767b71445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueAdjustment_a9fd29e3-9dea-4a44-ad7a-76340d9e66e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueAdjustment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward_df5b0c5d-4942-497a-bdb8-8037fe1e71d6" xlink:to="loc_us-gaap_LiabilitiesFairValueAdjustment_a9fd29e3-9dea-4a44-ad7a-76340d9e66e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_251494cd-a802-44b1-ac4e-f12d4fae8a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward_df5b0c5d-4942-497a-bdb8-8037fe1e71d6" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_251494cd-a802-44b1-ac4e-f12d4fae8a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_b95226e2-9490-4f32-ab8f-cf89ff39b3de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward_df5b0c5d-4942-497a-bdb8-8037fe1e71d6" xlink:to="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_b95226e2-9490-4f32-ab8f-cf89ff39b3de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/IncomeTaxes" xlink:type="simple" xlink:href="avdl-20211231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8db7eaea-1d49-4571-bde7-854c84933802" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_8dc68bc1-bb84-4d40-a047-67d204a61962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8db7eaea-1d49-4571-bde7-854c84933802" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_8dc68bc1-bb84-4d40-a047-67d204a61962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="avdl-20211231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c488483a-81fd-4ff2-932a-22505f5abad3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ScheduleOfComponentsOfIncomeBeforeIncomeTaxTableTextBlock_6e445803-cea6-417c-8ae3-41414c73fe31" xlink:href="avdl-20211231.xsd#avdl_ScheduleOfComponentsOfIncomeBeforeIncomeTaxTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c488483a-81fd-4ff2-932a-22505f5abad3" xlink:to="loc_avdl_ScheduleOfComponentsOfIncomeBeforeIncomeTaxTableTextBlock_6e445803-cea6-417c-8ae3-41414c73fe31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ScheduleOfIncomeTaxPaymentsTableTextBlock_e4064289-983f-4a3d-88c4-c95c5c680316" xlink:href="avdl-20211231.xsd#avdl_ScheduleOfIncomeTaxPaymentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c488483a-81fd-4ff2-932a-22505f5abad3" xlink:to="loc_avdl_ScheduleOfIncomeTaxPaymentsTableTextBlock_e4064289-983f-4a3d-88c4-c95c5c680316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_e6a19ecc-41b9-43d1-a7c3-691f97720b76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c488483a-81fd-4ff2-932a-22505f5abad3" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_e6a19ecc-41b9-43d1-a7c3-691f97720b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_18696a66-a9a9-4c78-a380-ab26985bee95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c488483a-81fd-4ff2-932a-22505f5abad3" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_18696a66-a9a9-4c78-a380-ab26985bee95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_d4ebb034-1d4e-4cf9-8629-50647653332b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c488483a-81fd-4ff2-932a-22505f5abad3" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_d4ebb034-1d4e-4cf9-8629-50647653332b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#IncomeTaxesIncomeLossBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_05920e4f-ea4c-4d66-8e08-65342159de93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_IncomeTaxesTable_964a0f7f-c3da-4b74-99b4-b4937fc1d6e0" xlink:href="avdl-20211231.xsd#avdl_IncomeTaxesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_05920e4f-ea4c-4d66-8e08-65342159de93" xlink:to="loc_avdl_IncomeTaxesTable_964a0f7f-c3da-4b74-99b4-b4937fc1d6e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a0da3947-2ff5-4c1b-9017-89372de3fdc9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_IncomeTaxesTable_964a0f7f-c3da-4b74-99b4-b4937fc1d6e0" xlink:to="loc_srt_StatementGeographicalAxis_a0da3947-2ff5-4c1b-9017-89372de3fdc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c6b2d88e-3277-4d9e-b898-a297ad657bc5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_a0da3947-2ff5-4c1b-9017-89372de3fdc9" xlink:to="loc_srt_SegmentGeographicalDomain_c6b2d88e-3277-4d9e-b898-a297ad657bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_980e1157-3cca-452d-83a0-3738d819f521" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c6b2d88e-3277-4d9e-b898-a297ad657bc5" xlink:to="loc_country_IE_980e1157-3cca-452d-83a0-3738d819f521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_32bb3d88-4a0d-411c-ae1d-c56bc6168faf" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c6b2d88e-3277-4d9e-b898-a297ad657bc5" xlink:to="loc_country_US_32bb3d88-4a0d-411c-ae1d-c56bc6168faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_d2cb67c6-2c87-464a-8234-5937b56c270b" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c6b2d88e-3277-4d9e-b898-a297ad657bc5" xlink:to="loc_country_FR_d2cb67c6-2c87-464a-8234-5937b56c270b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_IncomeTaxesLineItems_d4749386-8e4a-471d-9fea-94b01d2f5066" xlink:href="avdl-20211231.xsd#avdl_IncomeTaxesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_IncomeTaxesTable_964a0f7f-c3da-4b74-99b4-b4937fc1d6e0" xlink:to="loc_avdl_IncomeTaxesLineItems_d4749386-8e4a-471d-9fea-94b01d2f5066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d9611a87-182f-4c8c-a33a-60dd4c88af68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_IncomeTaxesLineItems_d4749386-8e4a-471d-9fea-94b01d2f5066" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d9611a87-182f-4c8c-a33a-60dd4c88af68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#IncomeTaxesIncomeTaxProvisionBenefitDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2fc9db2f-8932-454f-b8f9-1539b2656170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_4f538e00-fb2f-4562-b68b-a5cfc0a39ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2fc9db2f-8932-454f-b8f9-1539b2656170" xlink:to="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_4f538e00-fb2f-4562-b68b-a5cfc0a39ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_b15eaa20-8c77-4645-97c1-d530dfa42b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_4f538e00-fb2f-4562-b68b-a5cfc0a39ad8" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_b15eaa20-8c77-4645-97c1-d530dfa42b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_cbdf4054-b8f5-4dd1-8bbd-6baf678fdd11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_4f538e00-fb2f-4562-b68b-a5cfc0a39ad8" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_cbdf4054-b8f5-4dd1-8bbd-6baf678fdd11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_bd56fdfa-c4fe-40f4-843e-d529a4c8ae60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_4f538e00-fb2f-4562-b68b-a5cfc0a39ad8" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_bd56fdfa-c4fe-40f4-843e-d529a4c8ae60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_98014947-4fad-456c-b348-d976c8245507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2fc9db2f-8932-454f-b8f9-1539b2656170" xlink:to="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_98014947-4fad-456c-b348-d976c8245507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_8c09939c-e39f-432b-ab92-6b0d859ede25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_98014947-4fad-456c-b348-d976c8245507" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_8c09939c-e39f-432b-ab92-6b0d859ede25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_d935510a-438f-4d46-99ec-06467590b4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_98014947-4fad-456c-b348-d976c8245507" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_d935510a-438f-4d46-99ec-06467590b4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_338f43d9-cba1-45dc-aed5-9e1737bcf7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_98014947-4fad-456c-b348-d976c8245507" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_338f43d9-cba1-45dc-aed5-9e1737bcf7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_44768aee-6760-46fa-96a1-f30138964ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_98014947-4fad-456c-b348-d976c8245507" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_44768aee-6760-46fa-96a1-f30138964ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b0c2cf15-b4a7-4038-83a4-b36ee50edded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2fc9db2f-8932-454f-b8f9-1539b2656170" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b0c2cf15-b4a7-4038-83a4-b36ee50edded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#IncomeTaxesReconciliationofTaxRateDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_7cc33406-3897-4b57-bdf7-443cf76d8052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5163e616-22b6-4c07-9ac2-cfc194166ced" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7cc33406-3897-4b57-bdf7-443cf76d8052" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5163e616-22b6-4c07-9ac2-cfc194166ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_4d968123-b3e1-4a3a-aec1-11885184d3f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5163e616-22b6-4c07-9ac2-cfc194166ced" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_4d968123-b3e1-4a3a-aec1-11885184d3f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_5d00e76e-1801-4bdf-a17e-f19b369e17da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5163e616-22b6-4c07-9ac2-cfc194166ced" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_5d00e76e-1801-4bdf-a17e-f19b369e17da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_2c89ce1e-8cd5-40c0-8c93-102b6c1dd425" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5163e616-22b6-4c07-9ac2-cfc194166ced" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_2c89ce1e-8cd5-40c0-8c93-102b6c1dd425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount_08815903-7057-4901-82f2-4bf6abdee00f" xlink:href="avdl-20211231.xsd#avdl_EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5163e616-22b6-4c07-9ac2-cfc194166ced" xlink:to="loc_avdl_EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount_08815903-7057-4901-82f2-4bf6abdee00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_46b11a4f-542c-4cf3-a07b-e3905c4b6358" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5163e616-22b6-4c07-9ac2-cfc194166ced" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_46b11a4f-542c-4cf3-a07b-e3905c4b6358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_5ebf9495-f8df-441a-b87c-27f08e676510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5163e616-22b6-4c07-9ac2-cfc194166ced" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_5ebf9495-f8df-441a-b87c-27f08e676510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_8c8a9ead-e102-4d89-9fd0-0258b5bc457b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5163e616-22b6-4c07-9ac2-cfc194166ced" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_8c8a9ead-e102-4d89-9fd0-0258b5bc457b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_fad210f7-2c88-42d2-ac9c-70ecbd19056f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5163e616-22b6-4c07-9ac2-cfc194166ced" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_fad210f7-2c88-42d2-ac9c-70ecbd19056f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_47aaa7f9-aaf6-47f4-9b2e-4a4a2d392e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5163e616-22b6-4c07-9ac2-cfc194166ced" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_47aaa7f9-aaf6-47f4-9b2e-4a4a2d392e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount_c159c30e-b80c-4b28-9603-012c52ea1a60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5163e616-22b6-4c07-9ac2-cfc194166ced" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount_c159c30e-b80c-4b28-9603-012c52ea1a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount_ba0dd3a8-622a-4ccb-9aa0-33fc1e4b0275" xlink:href="avdl-20211231.xsd#avdl_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5163e616-22b6-4c07-9ac2-cfc194166ced" xlink:to="loc_avdl_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount_ba0dd3a8-622a-4ccb-9aa0-33fc1e4b0275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit_a955bce3-e114-4818-a8f0-083e0f191de3" xlink:href="avdl-20211231.xsd#avdl_EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5163e616-22b6-4c07-9ac2-cfc194166ced" xlink:to="loc_avdl_EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit_a955bce3-e114-4818-a8f0-083e0f191de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_428c5769-7394-4d3a-81a2-6b06641d2200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5163e616-22b6-4c07-9ac2-cfc194166ced" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_428c5769-7394-4d3a-81a2-6b06641d2200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_19e488e3-ead2-4cf7-9ad7-f39822a2ffc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_5163e616-22b6-4c07-9ac2-cfc194166ced" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_19e488e3-ead2-4cf7-9ad7-f39822a2ffc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#IncomeTaxesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_7c5f3fc8-2bf9-463b-97f4-828b3f7b65e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_IncomeTaxesTable_71cd469b-77d7-42dd-9e43-684d25569f4b" xlink:href="avdl-20211231.xsd#avdl_IncomeTaxesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7c5f3fc8-2bf9-463b-97f4-828b3f7b65e3" xlink:to="loc_avdl_IncomeTaxesTable_71cd469b-77d7-42dd-9e43-684d25569f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c81e53df-df58-4f90-b788-80694d1bc71c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_IncomeTaxesTable_71cd469b-77d7-42dd-9e43-684d25569f4b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c81e53df-df58-4f90-b788-80694d1bc71c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cac26ed1-0060-421f-a5ac-3d0de2c1f227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c81e53df-df58-4f90-b788-80694d1bc71c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cac26ed1-0060-421f-a5ac-3d0de2c1f227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FscHoldingsLlcMember_08176a0a-6c8d-4bb1-8c55-fb911c2c983b" xlink:href="avdl-20211231.xsd#avdl_FscHoldingsLlcMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cac26ed1-0060-421f-a5ac-3d0de2c1f227" xlink:to="loc_avdl_FscHoldingsLlcMember_08176a0a-6c8d-4bb1-8c55-fb911c2c983b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_U.S.HoldingsMember_9660d9f6-133f-40d0-8b06-fa0ec24b4856" xlink:href="avdl-20211231.xsd#avdl_U.S.HoldingsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cac26ed1-0060-421f-a5ac-3d0de2c1f227" xlink:to="loc_avdl_U.S.HoldingsMember_9660d9f6-133f-40d0-8b06-fa0ec24b4856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_3c8f333f-044f-4c9b-ac4d-ef241b6f0736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_IncomeTaxesTable_71cd469b-77d7-42dd-9e43-684d25569f4b" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_3c8f333f-044f-4c9b-ac4d-ef241b6f0736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_81ee1a9b-0bf2-4434-b71b-c3f188bb7b60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_3c8f333f-044f-4c9b-ac4d-ef241b6f0736" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_81ee1a9b-0bf2-4434-b71b-c3f188bb7b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_17b1ffae-48ed-46d7-9903-b295afa34e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_81ee1a9b-0bf2-4434-b71b-c3f188bb7b60" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_17b1ffae-48ed-46d7-9903-b295afa34e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_830ace39-d9f4-4f68-9514-90ddfd6d45b9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_IncomeTaxesTable_71cd469b-77d7-42dd-9e43-684d25569f4b" xlink:to="loc_dei_LegalEntityAxis_830ace39-d9f4-4f68-9514-90ddfd6d45b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_1307d3a0-4330-4908-bcdf-ef012d23bea4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_830ace39-d9f4-4f68-9514-90ddfd6d45b9" xlink:to="loc_dei_EntityDomain_1307d3a0-4330-4908-bcdf-ef012d23bea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_SpecialityPharamaMember_f30c1847-285c-4bf0-8a1d-a2cb08b94df1" xlink:href="avdl-20211231.xsd#avdl_SpecialityPharamaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1307d3a0-4330-4908-bcdf-ef012d23bea4" xlink:to="loc_avdl_SpecialityPharamaMember_f30c1847-285c-4bf0-8a1d-a2cb08b94df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_60596f6d-49dd-42ec-acce-791c883cf3f2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_IncomeTaxesTable_71cd469b-77d7-42dd-9e43-684d25569f4b" xlink:to="loc_srt_StatementGeographicalAxis_60596f6d-49dd-42ec-acce-791c883cf3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e271daf1-b7a2-4438-8988-75bb8878f6ba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_60596f6d-49dd-42ec-acce-791c883cf3f2" xlink:to="loc_srt_SegmentGeographicalDomain_e271daf1-b7a2-4438-8988-75bb8878f6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_4971c876-8877-4502-bcd5-988335d89cf4" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e271daf1-b7a2-4438-8988-75bb8878f6ba" xlink:to="loc_country_IE_4971c876-8877-4502-bcd5-988335d89cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_cebfc145-1a7e-4036-add5-6669d94fcd0a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e271daf1-b7a2-4438-8988-75bb8878f6ba" xlink:to="loc_country_US_cebfc145-1a7e-4036-add5-6669d94fcd0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_20f8f3ad-50c4-4881-83fb-01607c65e682" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e271daf1-b7a2-4438-8988-75bb8878f6ba" xlink:to="loc_country_FR_20f8f3ad-50c4-4881-83fb-01607c65e682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_7bf3723c-bf12-4aa8-b085-4e32f5a90535" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_IncomeTaxesTable_71cd469b-77d7-42dd-9e43-684d25569f4b" xlink:to="loc_us-gaap_TaxPeriodAxis_7bf3723c-bf12-4aa8-b085-4e32f5a90535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_c96e14c2-a71c-4727-9e4a-888170e7e77f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_7bf3723c-bf12-4aa8-b085-4e32f5a90535" xlink:to="loc_us-gaap_TaxPeriodDomain_c96e14c2-a71c-4727-9e4a-888170e7e77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxYear2019Member_07ca820d-27ae-4ed7-b74e-fa612848c0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxYear2019Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_c96e14c2-a71c-4727-9e4a-888170e7e77f" xlink:to="loc_us-gaap_TaxYear2019Member_07ca820d-27ae-4ed7-b74e-fa612848c0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxYear2020Member_416bf86a-be5d-4bff-b8ef-6b8ce1e20888" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxYear2020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_c96e14c2-a71c-4727-9e4a-888170e7e77f" xlink:to="loc_us-gaap_TaxYear2020Member_416bf86a-be5d-4bff-b8ef-6b8ce1e20888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:href="avdl-20211231.xsd#avdl_IncomeTaxesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_IncomeTaxesTable_71cd469b-77d7-42dd-9e43-684d25569f4b" xlink:to="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_IncreaseDecreaseInIncomeTaxBenefit_219c5a63-9227-46ca-be8f-240eaeec795d" xlink:href="avdl-20211231.xsd#avdl_IncreaseDecreaseInIncomeTaxBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_avdl_IncreaseDecreaseInIncomeTaxBenefit_219c5a63-9227-46ca-be8f-240eaeec795d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DeferredTaxAssetsAmortizationofIntangibleAssets_0321ced1-bb30-4c77-923c-cef4299e3ee4" xlink:href="avdl-20211231.xsd#avdl_DeferredTaxAssetsAmortizationofIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_avdl_DeferredTaxAssetsAmortizationofIntangibleAssets_0321ced1-bb30-4c77-923c-cef4299e3ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f93d29da-54d9-4ac9-ba10-73a5c0d509a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f93d29da-54d9-4ac9-ba10-73a5c0d509a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied_0b1be4ec-ed14-4269-bdd8-719ece92f4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_us-gaap_BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied_0b1be4ec-ed14-4269-bdd8-719ece92f4e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_bbc5214a-f1d4-495a-abd8-6404b31ce113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_bbc5214a-f1d4-495a-abd8-6404b31ce113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_f9a5cc86-5aa5-4dd8-8c49-e3a464dced69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_f9a5cc86-5aa5-4dd8-8c49-e3a464dced69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_b66c8e5f-6fa8-4904-b378-9fe58f0c24dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_b66c8e5f-6fa8-4904-b378-9fe58f0c24dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_c9906e3d-1958-4b9b-bcdb-a550951d6f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_us-gaap_OperatingLossCarryforwards_c9906e3d-1958-4b9b-bcdb-a550951d6f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_da8facc8-9f1e-45f5-8043-a769bcd6e438" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_da8facc8-9f1e-45f5-8043-a769bcd6e438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarnings_09e1349a-4f38-447d-b745-3b79cb6dd975" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarnings"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_us-gaap_UndistributedEarnings_09e1349a-4f38-447d-b745-3b79cb6dd975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_440038f4-df59-4104-b0a0-5ef32334d7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_440038f4-df59-4104-b0a0-5ef32334d7cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_53049683-9e4b-4dc9-bfd6-459a316ac689" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_53049683-9e4b-4dc9-bfd6-459a316ac689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit_e95f2171-a29a-4816-a54f-a917e574e868" xlink:href="avdl-20211231.xsd#avdl_CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_avdl_CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit_e95f2171-a29a-4816-a54f-a917e574e868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CARESActProceedsFromIncomeTaxRefunds_a348062e-f2a8-4739-9883-9c33e03795aa" xlink:href="avdl-20211231.xsd#avdl_CARESActProceedsFromIncomeTaxRefunds"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_avdl_CARESActProceedsFromIncomeTaxRefunds_a348062e-f2a8-4739-9883-9c33e03795aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CARESActCashRefundClaims_d0bb305a-0bc9-46da-9269-50e54dca1483" xlink:href="avdl-20211231.xsd#avdl_CARESActCashRefundClaims"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_IncomeTaxesLineItems_6b723075-ac82-4008-a6e3-247b77f7f029" xlink:to="loc_avdl_CARESActCashRefundClaims_d0bb305a-0bc9-46da-9269-50e54dca1483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/IncomeTaxesUnrecognizedTaxBenefitDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#IncomeTaxesUnrecognizedTaxBenefitDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/IncomeTaxesUnrecognizedTaxBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9d475e90-b46f-48dd-a4a4-eaf6bf7556a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b63f269e-3907-4721-a481-e488af6ad8fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9d475e90-b46f-48dd-a4a4-eaf6bf7556a9" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b63f269e-3907-4721-a481-e488af6ad8fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_9ee165da-031f-4ed3-a256-8a7af7337974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b63f269e-3907-4721-a481-e488af6ad8fa" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_9ee165da-031f-4ed3-a256-8a7af7337974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_7507c3d9-47a4-4bdf-8524-10df1e779423" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b63f269e-3907-4721-a481-e488af6ad8fa" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_7507c3d9-47a4-4bdf-8524-10df1e779423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_4ddcfd99-5aca-44b2-acf8-88072c1bc5fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b63f269e-3907-4721-a481-e488af6ad8fa" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_4ddcfd99-5aca-44b2-acf8-88072c1bc5fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_2eab2aa0-28df-496e-94b5-f916e680e25f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b63f269e-3907-4721-a481-e488af6ad8fa" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_2eab2aa0-28df-496e-94b5-f916e680e25f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_8b720428-860d-452d-84c6-b8387051a5ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b63f269e-3907-4721-a481-e488af6ad8fa" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_8b720428-860d-452d-84c6-b8387051a5ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#IncomeTaxesDeferredTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_71edaa00-1e6e-4870-a229-175430f10885" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_e3eefd43-e325-4713-bf22-04030c794ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_71edaa00-1e6e-4870-a229-175430f10885" xlink:to="loc_us-gaap_DeferredTaxAssetsNetAbstract_e3eefd43-e325-4713-bf22-04030c794ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_c1e59742-7964-4787-9aa8-a89aed15c0bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_e3eefd43-e325-4713-bf22-04030c794ab0" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_c1e59742-7964-4787-9aa8-a89aed15c0bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch_4ce5cdc1-3f3b-4bd0-8b13-eb109974c021" xlink:href="avdl-20211231.xsd#avdl_DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_e3eefd43-e325-4713-bf22-04030c794ab0" xlink:to="loc_avdl_DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch_4ce5cdc1-3f3b-4bd0-8b13-eb109974c021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_c9c5ce4c-44db-435f-afd2-2546da36ae51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_e3eefd43-e325-4713-bf22-04030c794ab0" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_c9c5ce4c-44db-435f-afd2-2546da36ae51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DeferredTaxAssetsAmortizationofIntangibleAssets_f2f177c8-3537-4ad0-aa59-40e4fa8cfbc5" xlink:href="avdl-20211231.xsd#avdl_DeferredTaxAssetsAmortizationofIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_e3eefd43-e325-4713-bf22-04030c794ab0" xlink:to="loc_avdl_DeferredTaxAssetsAmortizationofIntangibleAssets_f2f177c8-3537-4ad0-aa59-40e4fa8cfbc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_db9593af-d7e8-41f1-a18f-db372e866386" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_e3eefd43-e325-4713-bf22-04030c794ab0" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_db9593af-d7e8-41f1-a18f-db372e866386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_da7871f8-ded6-4c8d-9806-ef2a86e291ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_e3eefd43-e325-4713-bf22-04030c794ab0" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_da7871f8-ded6-4c8d-9806-ef2a86e291ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_a4004185-3911-4a21-9a17-98735ed0d71f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_71edaa00-1e6e-4870-a229-175430f10885" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_a4004185-3911-4a21-9a17-98735ed0d71f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_b98d5c16-d17a-4bae-86f0-9f7e585e2cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_a4004185-3911-4a21-9a17-98735ed0d71f" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_b98d5c16-d17a-4bae-86f0-9f7e585e2cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_da16d707-2418-462d-b05a-d8756c8c9626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_a4004185-3911-4a21-9a17-98735ed0d71f" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_da16d707-2418-462d-b05a-d8756c8c9626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_4bae327e-e3b2-4b8a-b8a6-f1b20eae69e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_a4004185-3911-4a21-9a17-98735ed0d71f" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_4bae327e-e3b2-4b8a-b8a6-f1b20eae69e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_02149eba-4421-487c-b2f4-d1d459a34fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_71edaa00-1e6e-4870-a229-175430f10885" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_02149eba-4421-487c-b2f4-d1d459a34fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_125a1ead-769f-45de-94b7-95b4915fc110" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_71edaa00-1e6e-4870-a229-175430f10885" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_125a1ead-769f-45de-94b7-95b4915fc110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilities" xlink:type="simple" xlink:href="avdl-20211231.xsd#OtherAssetsandLiabilities"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_77fa38ee-835e-49dc-a2d0-27ba232e52aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_065d38e3-26f0-403b-9750-fd9c04884902" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_77fa38ee-835e-49dc-a2d0-27ba232e52aa" xlink:to="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_065d38e3-26f0-403b-9750-fd9c04884902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesTables" xlink:type="simple" xlink:href="avdl-20211231.xsd#OtherAssetsandLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_af848a9a-dcdb-4f0c-a45e-29eccecaedc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_571f7008-cc87-4264-9473-f2ed9f69b345" xlink:href="avdl-20211231.xsd#avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_af848a9a-dcdb-4f0c-a45e-29eccecaedc4" xlink:to="loc_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_571f7008-cc87-4264-9473-f2ed9f69b345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_d34cbe47-d652-45d8-83a2-dda29312cfdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_af848a9a-dcdb-4f0c-a45e-29eccecaedc4" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_d34cbe47-d652-45d8-83a2-dda29312cfdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_eb117b8a-163e-4850-8b20-ed8911bf27a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_af848a9a-dcdb-4f0c-a45e-29eccecaedc4" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_eb117b8a-163e-4850-8b20-ed8911bf27a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_0611ed4c-e8ce-420b-9228-f5eba103d06a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_af848a9a-dcdb-4f0c-a45e-29eccecaedc4" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_0611ed4c-e8ce-420b-9228-f5eba103d06a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_5e629fd1-fbf6-4453-af72-fbd0e1be4015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_af848a9a-dcdb-4f0c-a45e-29eccecaedc4" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_5e629fd1-fbf6-4453-af72-fbd0e1be4015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_640a3e86-8187-48a7-a486-3cdf3d4fd74b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_1bf7be20-c90e-464d-9f83-2a97cabbceba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_640a3e86-8187-48a7-a486-3cdf3d4fd74b" xlink:to="loc_us-gaap_IncomeTaxesReceivable_1bf7be20-c90e-464d-9f83-2a97cabbceba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_0501a5f9-50de-44b1-8a9d-f4f4e276a504" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_640a3e86-8187-48a7-a486-3cdf3d4fd74b" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_0501a5f9-50de-44b1-8a9d-f4f4e276a504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeCurrent_75249bf1-a23b-46ec-a947-d1d4efcd0192" xlink:href="avdl-20211231.xsd#avdl_GuaranteeCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_640a3e86-8187-48a7-a486-3cdf3d4fd74b" xlink:to="loc_avdl_GuaranteeCurrent_75249bf1-a23b-46ec-a947-d1d4efcd0192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_72f7216e-f310-4aab-9bf7-251e5bfed572" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_640a3e86-8187-48a7-a486-3cdf3d4fd74b" xlink:to="loc_us-gaap_OtherAssetsCurrent_72f7216e-f310-4aab-9bf7-251e5bfed572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ShortTermNoteReceivable_bc0d300e-1f1f-4663-a2af-d4f0b2157ed2" xlink:href="avdl-20211231.xsd#avdl_ShortTermNoteReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_640a3e86-8187-48a7-a486-3cdf3d4fd74b" xlink:to="loc_avdl_ShortTermNoteReceivable_bc0d300e-1f1f-4663-a2af-d4f0b2157ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_7199c736-638a-4965-9ccb-6c389742310e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_640a3e86-8187-48a7-a486-3cdf3d4fd74b" xlink:to="loc_us-gaap_ShortTermInvestments_7199c736-638a-4965-9ccb-6c389742310e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0341373d-1be4-495f-a572-c6119a00802e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_640a3e86-8187-48a7-a486-3cdf3d4fd74b" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0341373d-1be4-495f-a572-c6119a00802e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_17876a97-7968-40b1-90c8-b840eb053c33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_19693bbd-6f1c-4544-817e-420695c286ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_17876a97-7968-40b1-90c8-b840eb053c33" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_19693bbd-6f1c-4544-817e-420695c286ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_002752e9-6ddc-4bd3-899f-b6346ebccdc3" xlink:href="avdl-20211231.xsd#avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_17876a97-7968-40b1-90c8-b840eb053c33" xlink:to="loc_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_002752e9-6ddc-4bd3-899f-b6346ebccdc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeNoncurrent_4cd36c8d-8a9b-46f9-89a4-b6e9277ab706" xlink:href="avdl-20211231.xsd#avdl_GuaranteeNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_17876a97-7968-40b1-90c8-b840eb053c33" xlink:to="loc_avdl_GuaranteeNoncurrent_4cd36c8d-8a9b-46f9-89a4-b6e9277ab706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherNoncurrentReceivables_00d6ba2a-81ef-4809-8a94-597d403bd01e" xlink:href="avdl-20211231.xsd#avdl_OtherNoncurrentReceivables"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_17876a97-7968-40b1-90c8-b840eb053c33" xlink:to="loc_avdl_OtherNoncurrentReceivables_00d6ba2a-81ef-4809-8a94-597d403bd01e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_a2bebbdb-9b34-4d15-8e17-43e7120794c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_17876a97-7968-40b1-90c8-b840eb053c33" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_a2bebbdb-9b34-4d15-8e17-43e7120794c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#OtherAssetsandLiabilitiesAccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_fb751332-8b53-4f22-8eea-14df50211a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_aea41fae-3c16-4ec2-a813-2bc0dfde8081" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_fb751332-8b53-4f22-8eea-14df50211a1f" xlink:to="loc_us-gaap_AccruedSalariesCurrent_aea41fae-3c16-4ec2-a813-2bc0dfde8081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_2e409250-1f8c-412f-9a77-ce7a546fbc22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_fb751332-8b53-4f22-8eea-14df50211a1f" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_2e409250-1f8c-412f-9a77-ce7a546fbc22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedOutsourceContractCosts_d1ca4bb1-c382-40e5-9073-35c95f918808" xlink:href="avdl-20211231.xsd#avdl_AccruedOutsourceContractCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_fb751332-8b53-4f22-8eea-14df50211a1f" xlink:to="loc_avdl_AccruedOutsourceContractCosts_d1ca4bb1-c382-40e5-9073-35c95f918808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedTradeDiscountsAndRebates_8c8490e5-3700-4e80-ae3a-4f70db003232" xlink:href="avdl-20211231.xsd#avdl_AccruedTradeDiscountsAndRebates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_fb751332-8b53-4f22-8eea-14df50211a1f" xlink:to="loc_avdl_AccruedTradeDiscountsAndRebates_8c8490e5-3700-4e80-ae3a-4f70db003232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_cacea005-901d-40df-8d1c-b8621540090e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_fb751332-8b53-4f22-8eea-14df50211a1f" xlink:to="loc_us-gaap_RestructuringReserveCurrent_cacea005-901d-40df-8d1c-b8621540090e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_dd088a7d-3394-48d0-98ee-fe89a84cd413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_fb751332-8b53-4f22-8eea-14df50211a1f" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_dd088a7d-3394-48d0-98ee-fe89a84cd413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5305bce4-abd3-4f13-a11e-50fae59f0bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedInterestCurrent_6d1df41f-d3ab-41a9-9796-608bf8a9ad80" xlink:href="avdl-20211231.xsd#avdl_AccruedInterestCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5305bce4-abd3-4f13-a11e-50fae59f0bd7" xlink:to="loc_avdl_AccruedInterestCurrent_6d1df41f-d3ab-41a9-9796-608bf8a9ad80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherGuarantorObligationsCurrentCarryingValue_c520ce56-5487-4db1-835a-92673f279932" xlink:href="avdl-20211231.xsd#avdl_OtherGuarantorObligationsCurrentCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5305bce4-abd3-4f13-a11e-50fae59f0bd7" xlink:to="loc_avdl_OtherGuarantorObligationsCurrentCarryingValue_c520ce56-5487-4db1-835a-92673f279932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherLiabilitiesMiscellaneousCurrent_d0667e27-d2cd-4049-aae2-828fc372bf91" xlink:href="avdl-20211231.xsd#avdl_OtherLiabilitiesMiscellaneousCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5305bce4-abd3-4f13-a11e-50fae59f0bd7" xlink:to="loc_avdl_OtherLiabilitiesMiscellaneousCurrent_d0667e27-d2cd-4049-aae2-828fc372bf91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_7c3b639a-e1ca-46d3-b1ea-7de77ba09807" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5305bce4-abd3-4f13-a11e-50fae59f0bd7" xlink:to="loc_us-gaap_DueToAffiliateCurrent_7c3b639a-e1ca-46d3-b1ea-7de77ba09807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_b9507f82-a056-4fc8-bc4c-199c95cb585b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5305bce4-abd3-4f13-a11e-50fae59f0bd7" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_b9507f82-a056-4fc8-bc4c-199c95cb585b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_efd05342-5ce8-427b-957b-03333d48d6cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities_59eba93e-429e-4cf5-a204-1171fd3e7be4" xlink:href="avdl-20211231.xsd#avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_efd05342-5ce8-427b-957b-03333d48d6cc" xlink:to="loc_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities_59eba93e-429e-4cf5-a204-1171fd3e7be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyLiabilities_96de3f89-8044-47de-ada2-57fc27acddd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuarantyLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_efd05342-5ce8-427b-957b-03333d48d6cc" xlink:to="loc_us-gaap_GuarantyLiabilities_96de3f89-8044-47de-ada2-57fc27acddd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_bcf4ae9b-a2f7-4f00-bbfe-7fc257a2cf76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_efd05342-5ce8-427b-957b-03333d48d6cc" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_bcf4ae9b-a2f7-4f00-bbfe-7fc257a2cf76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ContingentLiabilitiesandCommitments" xlink:type="simple" xlink:href="avdl-20211231.xsd#ContingentLiabilitiesandCommitments"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ContingentLiabilitiesandCommitments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a6bdb839-0ce5-4bd6-947f-e6184b4fce45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_18f499e0-7ca5-48f1-9b11-6dc43e7547e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a6bdb839-0ce5-4bd6-947f-e6184b4fce45" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_18f499e0-7ca5-48f1-9b11-6dc43e7547e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ContingentLiabilitiesandCommitmentsNarrativeDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#ContingentLiabilitiesandCommitmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ContingentLiabilitiesandCommitmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2bd438a0-9ed2-4eba-b39f-bb7345a8e87f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_9d673493-6182-4291-8cba-b96aed3f4b31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2bd438a0-9ed2-4eba-b39f-bb7345a8e87f" xlink:to="loc_us-gaap_PurchaseObligation_9d673493-6182-4291-8cba-b96aed3f4b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CostsIncurredPurchaseObligation_45ba93ed-90f1-403f-a5ad-2d831061e6db" xlink:href="avdl-20211231.xsd#avdl_CostsIncurredPurchaseObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2bd438a0-9ed2-4eba-b39f-bb7345a8e87f" xlink:to="loc_avdl_CostsIncurredPurchaseObligation_45ba93ed-90f1-403f-a5ad-2d831061e6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ContractualObligationAnnualAmount_b715528a-5ff5-4475-a9a9-673ddfbdff4d" xlink:href="avdl-20211231.xsd#avdl_ContractualObligationAnnualAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2bd438a0-9ed2-4eba-b39f-bb7345a8e87f" xlink:to="loc_avdl_ContractualObligationAnnualAmount_b715528a-5ff5-4475-a9a9-673ddfbdff4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ef1556df-73c6-4724-9a84-4669df841e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2bd438a0-9ed2-4eba-b39f-bb7345a8e87f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ef1556df-73c6-4724-9a84-4669df841e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0bcbf7f3-3e3d-4ca5-952f-18995df9816c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ef1556df-73c6-4724-9a84-4669df841e8d" xlink:to="loc_srt_ProductOrServiceAxis_0bcbf7f3-3e3d-4ca5-952f-18995df9816c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0208d6f1-a752-4b71-b093-e3960641231d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_0bcbf7f3-3e3d-4ca5-952f-18995df9816c" xlink:to="loc_srt_ProductsAndServicesDomain_0208d6f1-a752-4b71-b093-e3960641231d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FSCMember_158bd9b6-7871-4433-b2fc-3a2d4c6a48f5" xlink:href="avdl-20211231.xsd#avdl_FSCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0208d6f1-a752-4b71-b093-e3960641231d" xlink:to="loc_avdl_FSCMember_158bd9b6-7871-4433-b2fc-3a2d4c6a48f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_2649b78c-8682-46f5-aecd-53a7f0cb17d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ef1556df-73c6-4724-9a84-4669df841e8d" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_2649b78c-8682-46f5-aecd-53a7f0cb17d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_0f3ca91e-4ee8-4adc-886c-1ec5de7a39ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_2649b78c-8682-46f5-aecd-53a7f0cb17d1" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_0f3ca91e-4ee8-4adc-886c-1ec5de7a39ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_3ccc30bc-ef92-46a8-a284-193d740e14d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_0f3ca91e-4ee8-4adc-886c-1ec5de7a39ec" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_3ccc30bc-ef92-46a8-a284-193d740e14d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1c9c3b33-7027-4355-bc27-83b5b0b93ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ef1556df-73c6-4724-9a84-4669df841e8d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1c9c3b33-7027-4355-bc27-83b5b0b93ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_05b5dea2-c34d-4961-b652-c47549e12215" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1c9c3b33-7027-4355-bc27-83b5b0b93ec0" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_05b5dea2-c34d-4961-b652-c47549e12215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A2016MIPAMember_b83330d0-6512-431c-8f29-88ad45758887" xlink:href="avdl-20211231.xsd#avdl_A2016MIPAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_05b5dea2-c34d-4961-b652-c47549e12215" xlink:to="loc_avdl_A2016MIPAMember_b83330d0-6512-431c-8f29-88ad45758887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CerecorMember_3da215c3-2d76-433f-bef0-3319423bd1ca" xlink:href="avdl-20211231.xsd#avdl_CerecorMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_05b5dea2-c34d-4961-b652-c47549e12215" xlink:to="loc_avdl_CerecorMember_3da215c3-2d76-433f-bef0-3319423bd1ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_320c771c-09c8-46cd-a9e9-1a01b2a160bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ef1556df-73c6-4724-9a84-4669df841e8d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_320c771c-09c8-46cd-a9e9-1a01b2a160bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PercentageOfRoyaltyPayableOnNetSales_17452147-567e-4af1-9ca8-035de2d3061d" xlink:href="avdl-20211231.xsd#avdl_PercentageOfRoyaltyPayableOnNetSales"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_320c771c-09c8-46cd-a9e9-1a01b2a160bc" xlink:to="loc_avdl_PercentageOfRoyaltyPayableOnNetSales_17452147-567e-4af1-9ca8-035de2d3061d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RoyaltyPayableonNetSalesMaximum_69e1bccd-f6b0-4d7d-8856-5ab045fa00fb" xlink:href="avdl-20211231.xsd#avdl_RoyaltyPayableonNetSalesMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_320c771c-09c8-46cd-a9e9-1a01b2a160bc" xlink:to="loc_avdl_RoyaltyPayableonNetSalesMaximum_69e1bccd-f6b0-4d7d-8856-5ab045fa00fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyLiabilities_10ea9c03-75d7-430f-bad5-48513fae1888" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuarantyLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_320c771c-09c8-46cd-a9e9-1a01b2a160bc" xlink:to="loc_us-gaap_GuarantyLiabilities_10ea9c03-75d7-430f-bad5-48513fae1888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyAssets_1fc3ed3e-d699-453c-bf81-4909ee249d85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuarantyAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_320c771c-09c8-46cd-a9e9-1a01b2a160bc" xlink:to="loc_us-gaap_GuarantyAssets_1fc3ed3e-d699-453c-bf81-4909ee249d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CostsIncurredPurchaseObligation_420c2d98-0eb6-4484-90b0-e8a8fc3276e3" xlink:href="avdl-20211231.xsd#avdl_CostsIncurredPurchaseObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_320c771c-09c8-46cd-a9e9-1a01b2a160bc" xlink:to="loc_avdl_CostsIncurredPurchaseObligation_420c2d98-0eb6-4484-90b0-e8a8fc3276e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RestructuringCosts" xlink:type="simple" xlink:href="avdl-20211231.xsd#RestructuringCosts"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/RestructuringCosts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_1a2596cc-56f5-462b-a193-98a581dbe0f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_2929020c-e218-4a60-b0c2-14382a7bdfa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_1a2596cc-56f5-462b-a193-98a581dbe0f4" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_2929020c-e218-4a60-b0c2-14382a7bdfa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RestructuringCostsTables" xlink:type="simple" xlink:href="avdl-20211231.xsd#RestructuringCostsTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/RestructuringCostsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_ac154531-9096-4304-8259-9383db0110e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_98778a1d-a116-46e3-8130-b6939c7bf129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_ac154531-9096-4304-8259-9383db0110e8" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_98778a1d-a116-46e3-8130-b6939c7bf129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RestructuringCostsNarrativeDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#RestructuringCostsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/RestructuringCostsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4d13c860-db6c-48ea-9ee5-41e1d033ba95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b7648897-2d67-4288-84aa-a41ee12a13b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4d13c860-db6c-48ea-9ee5-41e1d033ba95" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b7648897-2d67-4288-84aa-a41ee12a13b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_d68ab349-96f1-4f16-b1ff-8f8306c66762" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b7648897-2d67-4288-84aa-a41ee12a13b6" xlink:to="loc_us-gaap_RestructuringPlanAxis_d68ab349-96f1-4f16-b1ff-8f8306c66762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_8770030b-11fe-4830-99c8-90ceafa3cd9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_d68ab349-96f1-4f16-b1ff-8f8306c66762" xlink:to="loc_us-gaap_RestructuringPlanDomain_8770030b-11fe-4830-99c8-90ceafa3cd9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember_33dc9806-1a6d-4dc6-a392-252a41349c04" xlink:href="avdl-20211231.xsd#avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_8770030b-11fe-4830-99c8-90ceafa3cd9c" xlink:to="loc_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember_33dc9806-1a6d-4dc6-a392-252a41349c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember_92dcfde2-b0d5-4be9-a522-920e3db17a94" xlink:href="avdl-20211231.xsd#avdl_TwoThousandNineteenCorporateRestructuringObligationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_8770030b-11fe-4830-99c8-90ceafa3cd9c" xlink:to="loc_avdl_TwoThousandNineteenCorporateRestructuringObligationsMember_92dcfde2-b0d5-4be9-a522-920e3db17a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_383c34da-4a62-4ed6-91b1-d39f4f7ece74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b7648897-2d67-4288-84aa-a41ee12a13b6" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_383c34da-4a62-4ed6-91b1-d39f4f7ece74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_19dd7fa4-fc84-472d-adef-454aab43ca05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_383c34da-4a62-4ed6-91b1-d39f4f7ece74" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_19dd7fa4-fc84-472d-adef-454aab43ca05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_5aadf034-3cd4-48f3-9b39-85e3f4dbad90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_19dd7fa4-fc84-472d-adef-454aab43ca05" xlink:to="loc_us-gaap_EmployeeSeveranceMember_5aadf034-3cd4-48f3-9b39-85e3f4dbad90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RetirementIndemnityObligationMember_44f061c7-fade-4619-ba9a-46999c9123a2" xlink:href="avdl-20211231.xsd#avdl_RetirementIndemnityObligationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_19dd7fa4-fc84-472d-adef-454aab43ca05" xlink:to="loc_avdl_RetirementIndemnityObligationMember_44f061c7-fade-4619-ba9a-46999c9123a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_50575c0e-9cfc-4f11-8ab5-5339d0cdb13d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b7648897-2d67-4288-84aa-a41ee12a13b6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_50575c0e-9cfc-4f11-8ab5-5339d0cdb13d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7e8d6eed-fcde-4488-81c4-9b0dec8ef6de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_50575c0e-9cfc-4f11-8ab5-5339d0cdb13d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7e8d6eed-fcde-4488-81c4-9b0dec8ef6de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_85cce7f7-eaf7-4ec8-a0c6-bdb6721a52ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7e8d6eed-fcde-4488-81c4-9b0dec8ef6de" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_85cce7f7-eaf7-4ec8-a0c6-bdb6721a52ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_67a8b509-bd21-42b7-b08e-756fdf30d798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b7648897-2d67-4288-84aa-a41ee12a13b6" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_67a8b509-bd21-42b7-b08e-756fdf30d798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_c6926d31-3a7f-494c-ac1d-7a48a33e0e70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_67a8b509-bd21-42b7-b08e-756fdf30d798" xlink:to="loc_us-gaap_RestructuringCharges_c6926d31-3a7f-494c-ac1d-7a48a33e0e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment_c6ded0f0-5993-4c3a-8f2c-f8e2031d060b" xlink:href="avdl-20211231.xsd#avdl_RestructuringChargesBeforeGainLossDuetoCurtailment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_67a8b509-bd21-42b7-b08e-756fdf30d798" xlink:to="loc_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment_c6ded0f0-5993-4c3a-8f2c-f8e2031d060b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_8e3c827d-db54-48ae-a78b-3cab02e652f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_67a8b509-bd21-42b7-b08e-756fdf30d798" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_8e3c827d-db54-48ae-a78b-3cab02e652f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_6864712b-4851-4fb5-8f10-a7554819ccb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_67a8b509-bd21-42b7-b08e-756fdf30d798" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_6864712b-4851-4fb5-8f10-a7554819ccb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_9b52d28b-d5be-4ab4-a5ce-03aaf9103475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_67a8b509-bd21-42b7-b08e-756fdf30d798" xlink:to="loc_us-gaap_RestructuringReserve_9b52d28b-d5be-4ab4-a5ce-03aaf9103475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent_6a6965a8-25af-4de3-80dd-f3f11a94d0bd" xlink:href="avdl-20211231.xsd#avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_67a8b509-bd21-42b7-b08e-756fdf30d798" xlink:to="loc_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent_6a6965a8-25af-4de3-80dd-f3f11a94d0bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisposals_5f824d39-ba2c-4efe-8927-c70e614e8b66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisposals"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_67a8b509-bd21-42b7-b08e-756fdf30d798" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisposals_5f824d39-ba2c-4efe-8927-c70e614e8b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_955e2570-b1aa-4213-a2ad-66a09bbfb506" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_67a8b509-bd21-42b7-b08e-756fdf30d798" xlink:to="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_955e2570-b1aa-4213-a2ad-66a09bbfb506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_a2232436-38a5-4be9-9d69-b59c8109ce61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_67a8b509-bd21-42b7-b08e-756fdf30d798" xlink:to="loc_us-gaap_PaymentsForRestructuring_a2232436-38a5-4be9-9d69-b59c8109ce61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#RestructuringCostsSeveranceObligationDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_76388d51-25bc-41d5-8bce-82df2851ab95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6cea4c94-c7e1-45e9-93f9-1b914eed76ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_76388d51-25bc-41d5-8bce-82df2851ab95" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6cea4c94-c7e1-45e9-93f9-1b914eed76ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_e2d430b8-ae97-4cfb-8322-c99692e685cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6cea4c94-c7e1-45e9-93f9-1b914eed76ae" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_e2d430b8-ae97-4cfb-8322-c99692e685cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_30f37fef-fbaa-4d98-87ab-5853dcb01581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_e2d430b8-ae97-4cfb-8322-c99692e685cf" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_30f37fef-fbaa-4d98-87ab-5853dcb01581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_c8504c03-9ec5-4c38-ae94-3dea199001e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_30f37fef-fbaa-4d98-87ab-5853dcb01581" xlink:to="loc_us-gaap_EmployeeSeveranceMember_c8504c03-9ec5-4c38-ae94-3dea199001e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_df42e681-d72c-4c12-845f-7f871548943e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6cea4c94-c7e1-45e9-93f9-1b914eed76ae" xlink:to="loc_us-gaap_RestructuringPlanAxis_df42e681-d72c-4c12-845f-7f871548943e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_9fd0bd4f-0dd4-4c03-91af-213422d34f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_df42e681-d72c-4c12-845f-7f871548943e" xlink:to="loc_us-gaap_RestructuringPlanDomain_9fd0bd4f-0dd4-4c03-91af-213422d34f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember_6c251e71-e6e5-4037-9573-37a0d20e1d58" xlink:href="avdl-20211231.xsd#avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_9fd0bd4f-0dd4-4c03-91af-213422d34f8c" xlink:to="loc_avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember_6c251e71-e6e5-4037-9573-37a0d20e1d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_4e336f76-d88e-4f0a-b1e0-2fe13e937d87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6cea4c94-c7e1-45e9-93f9-1b914eed76ae" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_4e336f76-d88e-4f0a-b1e0-2fe13e937d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_8423de96-5408-403c-b1fc-500e01b85b50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4e336f76-d88e-4f0a-b1e0-2fe13e937d87" xlink:to="loc_us-gaap_RestructuringReserveRollForward_8423de96-5408-403c-b1fc-500e01b85b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_debb927e-9180-4611-bd91-de8280a8eab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8423de96-5408-403c-b1fc-500e01b85b50" xlink:to="loc_us-gaap_RestructuringReserve_debb927e-9180-4611-bd91-de8280a8eab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment_c338498e-ff02-4c41-a02c-dd531492e6f5" xlink:href="avdl-20211231.xsd#avdl_RestructuringChargesBeforeGainLossDuetoCurtailment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8423de96-5408-403c-b1fc-500e01b85b50" xlink:to="loc_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment_c338498e-ff02-4c41-a02c-dd531492e6f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_25d94fe7-ab72-4ff4-9128-5dcbc058fffb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8423de96-5408-403c-b1fc-500e01b85b50" xlink:to="loc_us-gaap_PaymentsForRestructuring_25d94fe7-ab72-4ff4-9128-5dcbc058fffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment_8a78ce95-6a81-4a72-9378-557f3574f571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8423de96-5408-403c-b1fc-500e01b85b50" xlink:to="loc_us-gaap_RestructuringReserveTranslationAdjustment_8a78ce95-6a81-4a72-9378-557f3574f571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_327a912a-23d1-4a76-945f-901e87da4216" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8423de96-5408-403c-b1fc-500e01b85b50" xlink:to="loc_us-gaap_RestructuringReserve_327a912a-23d1-4a76-945f-901e87da4216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/EquityInstrumentsandTransactions" xlink:type="simple" xlink:href="avdl-20211231.xsd#EquityInstrumentsandTransactions"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/EquityInstrumentsandTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_84b51538-cea2-4b16-b7bf-cb1e453e72bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_EquityTransactionsDisclosureTextBlock_3cbb92e2-65ed-424b-a84f-7b403cb6a764" xlink:href="avdl-20211231.xsd#avdl_EquityTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_84b51538-cea2-4b16-b7bf-cb1e453e72bd" xlink:to="loc_avdl_EquityTransactionsDisclosureTextBlock_3cbb92e2-65ed-424b-a84f-7b403cb6a764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#EquityInstrumentsandTransactionsDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_9a17aa61-a47f-48df-93ad-ed7780900463" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_b7a64243-83cb-4e6b-a78a-5c3c9108a553" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9a17aa61-a47f-48df-93ad-ed7780900463" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_b7a64243-83cb-4e6b-a78a-5c3c9108a553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d8e8ac8a-5906-4f17-943b-130e80bbc205" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b7a64243-83cb-4e6b-a78a-5c3c9108a553" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d8e8ac8a-5906-4f17-943b-130e80bbc205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1564ab5b-167c-4ca6-a634-babbdeee1044" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d8e8ac8a-5906-4f17-943b-130e80bbc205" xlink:to="loc_us-gaap_EquityComponentDomain_1564ab5b-167c-4ca6-a634-babbdeee1044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_a26d6cbd-68d2-43d4-b14b-312633f9ec02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1564ab5b-167c-4ca6-a634-babbdeee1044" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_a26d6cbd-68d2-43d4-b14b-312633f9ec02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_d20b662e-7b08-416f-a100-9dc84fffeaf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1564ab5b-167c-4ca6-a634-babbdeee1044" xlink:to="loc_us-gaap_TreasuryStockMember_d20b662e-7b08-416f-a100-9dc84fffeaf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_38fcfb73-c2d5-44bf-b092-3d0754207154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1564ab5b-167c-4ca6-a634-babbdeee1044" xlink:to="loc_us-gaap_CommonStockMember_38fcfb73-c2d5-44bf-b092-3d0754207154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_1c234503-18e3-4956-9f57-f03d4f806018" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b7a64243-83cb-4e6b-a78a-5c3c9108a553" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_1c234503-18e3-4956-9f57-f03d4f806018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e42ffcce-502b-4492-bcc2-242b1426f223" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_1c234503-18e3-4956-9f57-f03d4f806018" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e42ffcce-502b-4492-bcc2-242b1426f223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_a2ec29dc-837d-41e5-807a-f120abd04658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e42ffcce-502b-4492-bcc2-242b1426f223" xlink:to="loc_us-gaap_PrivatePlacementMember_a2ec29dc-837d-41e5-807a-f120abd04658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PublicOfferingMember_061b67b1-d846-43c5-b3b9-8f97c132ab1a" xlink:href="avdl-20211231.xsd#avdl_PublicOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e42ffcce-502b-4492-bcc2-242b1426f223" xlink:to="loc_avdl_PublicOfferingMember_061b67b1-d846-43c5-b3b9-8f97c132ab1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_74b6e3b8-07e5-424d-9d8d-7d1f67ec14d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b7a64243-83cb-4e6b-a78a-5c3c9108a553" xlink:to="loc_us-gaap_StatementClassOfStockAxis_74b6e3b8-07e5-424d-9d8d-7d1f67ec14d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f525d4c2-ae53-466e-b626-d44bf1fa7217" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_74b6e3b8-07e5-424d-9d8d-7d1f67ec14d4" xlink:to="loc_us-gaap_ClassOfStockDomain_f525d4c2-ae53-466e-b626-d44bf1fa7217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sic_Z8880_f23e5b1a-5dfa-42e0-a84d-f27a41227123" xlink:href="https://xbrl.sec.gov/sic/2021/sic-2021.xsd#sic_Z8880"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_f525d4c2-ae53-466e-b626-d44bf1fa7217" xlink:to="loc_sic_Z8880_f23e5b1a-5dfa-42e0-a84d-f27a41227123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_b3c3d2af-ff32-4373-aa72-86ebec2e4095" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_f525d4c2-ae53-466e-b626-d44bf1fa7217" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_b3c3d2af-ff32-4373-aa72-86ebec2e4095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesMember_835843c5-c421-4878-bb2c-976572653073" xlink:href="avdl-20211231.xsd#avdl_AmericanDepositarySharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_f525d4c2-ae53-466e-b626-d44bf1fa7217" xlink:to="loc_avdl_AmericanDepositarySharesMember_835843c5-c421-4878-bb2c-976572653073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b7a64243-83cb-4e6b-a78a-5c3c9108a553" xlink:to="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_4d2aad50-7373-4b20-996b-def403bdaa04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_4d2aad50-7373-4b20-996b-def403bdaa04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_ce43c6a6-fa39-49c1-a424-d315bd817eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_ce43c6a6-fa39-49c1-a424-d315bd817eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_691b9f70-736a-4061-9458-cc2e2951a3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_CommonStockSharesIssued_691b9f70-736a-4061-9458-cc2e2951a3d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_dc33c1e6-0529-4794-8a07-60e5bdde4932" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_dc33c1e6-0529-4794-8a07-60e5bdde4932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_58f1cc02-2035-4062-9f0f-1886b243d778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_58f1cc02-2035-4062-9f0f-1886b243d778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_05c7406c-7de0-45b0-90fc-678f65e179c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_05c7406c-7de0-45b0-90fc-678f65e179c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_c139462f-f13e-43dc-83d5-dbcb11d4f35f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_PreferredStockSharesIssued_c139462f-f13e-43dc-83d5-dbcb11d4f35f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_722ed398-b02b-4a98-89d9-9bdd8ae7d994" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_722ed398-b02b-4a98-89d9-9bdd8ae7d994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration_7aa65cd5-3678-4c50-a430-e2c0a0748e85" xlink:href="avdl-20211231.xsd#avdl_MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_avdl_MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration_7aa65cd5-3678-4c50-a430-e2c0a0748e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration_030f78b3-203a-4094-b5f2-59cd2d8da40f" xlink:href="avdl-20211231.xsd#avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration_030f78b3-203a-4094-b5f2-59cd2d8da40f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_13a52116-3991-4755-b3ee-688448b987ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_13a52116-3991-4755-b3ee-688448b987ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_ec3ef066-b00f-4332-a5d8-7c14165e30db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_ec3ef066-b00f-4332-a5d8-7c14165e30db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2aa8cb8b-bf88-4760-80aa-2afc7441bf3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2aa8cb8b-bf88-4760-80aa-2afc7441bf3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_f0d9ac6d-dd2e-4b6e-a6fa-79ac5cebbfea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_f0d9ac6d-dd2e-4b6e-a6fa-79ac5cebbfea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_ff00b6a8-fc25-4c0a-a3bb-3d8837535180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_ff00b6a8-fc25-4c0a-a3bb-3d8837535180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b566a1f8-be90-45e1-add6-5a7fe921a061" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b566a1f8-be90-45e1-add6-5a7fe921a061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_c244418d-207c-4014-8e32-e8590200e08a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_c244418d-207c-4014-8e32-e8590200e08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock_1ea199e7-7dbe-44d4-8b59-f234e141cbaf" xlink:href="avdl-20211231.xsd#avdl_MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_avdl_MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock_1ea199e7-7dbe-44d4-8b59-f234e141cbaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_46fcd900-d0fd-4b62-a5b5-9e944c7b2616" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_46fcd900-d0fd-4b62-a5b5-9e944c7b2616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_b33efe9e-0c78-4225-9b1a-fbad2f9b028d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_b33efe9e-0c78-4225-9b1a-fbad2f9b028d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_00d23f5c-1d5c-41b9-8163-9519805538de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_00d23f5c-1d5c-41b9-8163-9519805538de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_SaleOfStockConsiderationReceivedOnTransactionGross_950a83df-f3c8-4ee0-a323-eca7d89c05f1" xlink:href="avdl-20211231.xsd#avdl_SaleOfStockConsiderationReceivedOnTransactionGross"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_avdl_SaleOfStockConsiderationReceivedOnTransactionGross_950a83df-f3c8-4ee0-a323-eca7d89c05f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_728db23d-b5fa-4738-8f8b-f90b47481f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_728db23d-b5fa-4738-8f8b-f90b47481f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_ef03f958-9aff-4b1a-a780-7b1a8ed8a3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_ef03f958-9aff-4b1a-a780-7b1a8ed8a3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_48c495da-dba3-41e8-a855-c72c96ea2bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_52bd6be8-7492-4324-92ac-2da949a2fd0c" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_48c495da-dba3-41e8-a855-c72c96ea2bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="avdl-20211231.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ae6dc468-844f-4d0b-ad78-63033d4478f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_23fcec0f-5e63-4256-b946-b116dcf81aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ae6dc468-844f-4d0b-ad78-63033d4478f7" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_23fcec0f-5e63-4256-b946-b116dcf81aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="avdl-20211231.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_32528313-2c30-4966-8337-e86313d6669e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_d070488c-80e2-439a-b168-a0aca563dd4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_32528313-2c30-4966-8337-e86313d6669e" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_d070488c-80e2-439a-b168-a0aca563dd4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ScheduleOfShareBasedPaymentAwardStockOptionsAndWarrantGrantsValuationAssumptionsTableTextBlock_1a48deaa-b127-44fe-8321-d623ab1ba7d7" xlink:href="avdl-20211231.xsd#avdl_ScheduleOfShareBasedPaymentAwardStockOptionsAndWarrantGrantsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_32528313-2c30-4966-8337-e86313d6669e" xlink:to="loc_avdl_ScheduleOfShareBasedPaymentAwardStockOptionsAndWarrantGrantsValuationAssumptionsTableTextBlock_1a48deaa-b127-44fe-8321-d623ab1ba7d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_74d51f18-d1fd-420a-ae37-f0ef5a9a27bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_32528313-2c30-4966-8337-e86313d6669e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_74d51f18-d1fd-420a-ae37-f0ef5a9a27bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_8b8dbc5f-3f9f-482a-b8a5-2046f1f48fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_32528313-2c30-4966-8337-e86313d6669e" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_8b8dbc5f-3f9f-482a-b8a5-2046f1f48fd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ShareBasedCompensationStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#ShareBasedCompensationStockbasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ShareBasedCompensationStockbasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_725daae5-846e-4f44-a5ac-2f59798cdf03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_396ff8d7-8c64-4f01-bc1a-076fe8add83a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_725daae5-846e-4f44-a5ac-2f59798cdf03" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_396ff8d7-8c64-4f01-bc1a-076fe8add83a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_26eb631d-7d50-4ecc-8931-88e2e2ae287d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_396ff8d7-8c64-4f01-bc1a-076fe8add83a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_26eb631d-7d50-4ecc-8931-88e2e2ae287d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b00c2fc9-c221-44dc-941d-41a96c919915" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_26eb631d-7d50-4ecc-8931-88e2e2ae287d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b00c2fc9-c221-44dc-941d-41a96c919915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_52ae9bd9-3d8b-4c0d-b7b5-ab2bf9337bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b00c2fc9-c221-44dc-941d-41a96c919915" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_52ae9bd9-3d8b-4c0d-b7b5-ab2bf9337bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_37dcd5ca-1089-44ef-b34c-0f781532c730" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b00c2fc9-c221-44dc-941d-41a96c919915" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_37dcd5ca-1089-44ef-b34c-0f781532c730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_b545def9-97d9-40f2-b72a-7920b2a45fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b00c2fc9-c221-44dc-941d-41a96c919915" xlink:to="loc_us-gaap_RestructuringChargesMember_b545def9-97d9-40f2-b72a-7920b2a45fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad6134b2-01c6-430c-a448-d6541ee648b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_396ff8d7-8c64-4f01-bc1a-076fe8add83a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad6134b2-01c6-430c-a448-d6541ee648b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2246750f-9625-4b1e-af86-724fb9ca807f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad6134b2-01c6-430c-a448-d6541ee648b6" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2246750f-9625-4b1e-af86-724fb9ca807f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9ce12054-883c-4505-9b71-6a44edc1ff7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_021baf13-cf32-4c6c-ab3e-dcd0a55fffb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9ce12054-883c-4505-9b71-6a44edc1ff7f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_021baf13-cf32-4c6c-ab3e-dcd0a55fffb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_2d65ce30-43be-40db-9500-e98ab28af0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_021baf13-cf32-4c6c-ab3e-dcd0a55fffb9" xlink:to="loc_us-gaap_VestingAxis_2d65ce30-43be-40db-9500-e98ab28af0bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_a83f5081-e485-4fa0-a388-e274730a1b66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_2d65ce30-43be-40db-9500-e98ab28af0bc" xlink:to="loc_us-gaap_VestingDomain_a83f5081-e485-4fa0-a388-e274730a1b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_6f7ccb23-7125-487c-a2e1-4cd237eb2951" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_a83f5081-e485-4fa0-a388-e274730a1b66" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_6f7ccb23-7125-487c-a2e1-4cd237eb2951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_b946aff8-2dbf-4972-88e9-541d6d22a234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_a83f5081-e485-4fa0-a388-e274730a1b66" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_b946aff8-2dbf-4972-88e9-541d6d22a234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_cc46114a-45f3-499a-98b7-3f6857e02a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_a83f5081-e485-4fa0-a388-e274730a1b66" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_cc46114a-45f3-499a-98b7-3f6857e02a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_SharebasedCompensationAwardTrancheFourMember_24b18bb1-c98a-49d4-a527-64b94de37edd" xlink:href="avdl-20211231.xsd#avdl_SharebasedCompensationAwardTrancheFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_a83f5081-e485-4fa0-a388-e274730a1b66" xlink:to="loc_avdl_SharebasedCompensationAwardTrancheFourMember_24b18bb1-c98a-49d4-a527-64b94de37edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_VestOneYearFollowingAchievementOfMilestonesMember_a378e45c-16d0-46ea-a96c-2951b1bd496d" xlink:href="avdl-20211231.xsd#avdl_VestOneYearFollowingAchievementOfMilestonesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_a83f5081-e485-4fa0-a388-e274730a1b66" xlink:to="loc_avdl_VestOneYearFollowingAchievementOfMilestonesMember_a378e45c-16d0-46ea-a96c-2951b1bd496d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_VestUponTheAchievementOfCertainRegulatoryMilestonesMember_5ea92ed2-70e1-4641-a747-364ed1f5aed4" xlink:href="avdl-20211231.xsd#avdl_VestUponTheAchievementOfCertainRegulatoryMilestonesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_a83f5081-e485-4fa0-a388-e274730a1b66" xlink:to="loc_avdl_VestUponTheAchievementOfCertainRegulatoryMilestonesMember_5ea92ed2-70e1-4641-a747-364ed1f5aed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_VestUponAchievementOfCertainCorporateObjectivesMember_518caac9-c2fb-4841-86be-876023e24514" xlink:href="avdl-20211231.xsd#avdl_VestUponAchievementOfCertainCorporateObjectivesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_a83f5081-e485-4fa0-a388-e274730a1b66" xlink:to="loc_avdl_VestUponAchievementOfCertainCorporateObjectivesMember_518caac9-c2fb-4841-86be-876023e24514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_VestOneYearFollowingAchievementOfCertainCorporateObjectivesMember_f274cf0a-0ae2-49ab-8d19-301522564711" xlink:href="avdl-20211231.xsd#avdl_VestOneYearFollowingAchievementOfCertainCorporateObjectivesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_a83f5081-e485-4fa0-a388-e274730a1b66" xlink:to="loc_avdl_VestOneYearFollowingAchievementOfCertainCorporateObjectivesMember_f274cf0a-0ae2-49ab-8d19-301522564711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_VestUponAchievementOfCertainCorporateObjectivesBeingMetAndExceededMember_0479265e-c4c8-4b11-876a-33708ded30ef" xlink:href="avdl-20211231.xsd#avdl_VestUponAchievementOfCertainCorporateObjectivesBeingMetAndExceededMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_a83f5081-e485-4fa0-a388-e274730a1b66" xlink:to="loc_avdl_VestUponAchievementOfCertainCorporateObjectivesBeingMetAndExceededMember_0479265e-c4c8-4b11-876a-33708ded30ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_e9e487f1-17b6-40ff-8a97-154b3a1efe26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_021baf13-cf32-4c6c-ab3e-dcd0a55fffb9" xlink:to="loc_us-gaap_PlanNameAxis_e9e487f1-17b6-40ff-8a97-154b3a1efe26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_c0644d44-c60d-4ddd-a419-60b0c18aaffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_e9e487f1-17b6-40ff-8a97-154b3a1efe26" xlink:to="loc_us-gaap_PlanNameDomain_c0644d44-c60d-4ddd-a419-60b0c18aaffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A2017AvadelEmployeeSharePurchasePlanMember_49c5c53d-d92d-4049-a05e-855823dcf5eb" xlink:href="avdl-20211231.xsd#avdl_A2017AvadelEmployeeSharePurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_c0644d44-c60d-4ddd-a419-60b0c18aaffc" xlink:to="loc_avdl_A2017AvadelEmployeeSharePurchasePlanMember_49c5c53d-d92d-4049-a05e-855823dcf5eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_InducementPlanMember_03e1dd9b-9ead-47c0-99ec-77ddffadcdb0" xlink:href="avdl-20211231.xsd#avdl_InducementPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_c0644d44-c60d-4ddd-a419-60b0c18aaffc" xlink:to="loc_avdl_InducementPlanMember_03e1dd9b-9ead-47c0-99ec-77ddffadcdb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3e05a4eb-c6c7-41b5-b5d7-18bcd9958236" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_021baf13-cf32-4c6c-ab3e-dcd0a55fffb9" xlink:to="loc_us-gaap_AwardTypeAxis_3e05a4eb-c6c7-41b5-b5d7-18bcd9958236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9ef3847-9332-4920-8a3c-4ee87954c9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_3e05a4eb-c6c7-41b5-b5d7-18bcd9958236" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9ef3847-9332-4920-8a3c-4ee87954c9b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_b33be09f-d031-4e63-b750-5f400b92655f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9ef3847-9332-4920-8a3c-4ee87954c9b8" xlink:to="loc_us-gaap_RestrictedStockMember_b33be09f-d031-4e63-b750-5f400b92655f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestrictedShareAwardsGrantedFrom20172020Member_5bd3d0b8-f0fd-4012-ac22-72e12c3c09f3" xlink:href="avdl-20211231.xsd#avdl_RestrictedShareAwardsGrantedFrom20172020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedStockMember_b33be09f-d031-4e63-b750-5f400b92655f" xlink:to="loc_avdl_RestrictedShareAwardsGrantedFrom20172020Member_5bd3d0b8-f0fd-4012-ac22-72e12c3c09f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestrictedShareAwardsGrantedToEmployeesMember_0504e549-504c-4178-bac7-ef45d26e83b9" xlink:href="avdl-20211231.xsd#avdl_RestrictedShareAwardsGrantedToEmployeesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedStockMember_b33be09f-d031-4e63-b750-5f400b92655f" xlink:to="loc_avdl_RestrictedShareAwardsGrantedToEmployeesMember_0504e549-504c-4178-bac7-ef45d26e83b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestrictedShareAwardsGrantsBeginningIn2018Member_a607baeb-b7af-47da-b44c-c4c56a641092" xlink:href="avdl-20211231.xsd#avdl_RestrictedShareAwardsGrantsBeginningIn2018Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedStockMember_b33be09f-d031-4e63-b750-5f400b92655f" xlink:to="loc_avdl_RestrictedShareAwardsGrantsBeginningIn2018Member_a607baeb-b7af-47da-b44c-c4c56a641092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d6671d82-0059-4236-bdca-deee155f3101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9ef3847-9332-4920-8a3c-4ee87954c9b8" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d6671d82-0059-4236-bdca-deee155f3101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_3200472b-e4c8-42cc-957c-6871df7a5043" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9ef3847-9332-4920-8a3c-4ee87954c9b8" xlink:to="loc_us-gaap_PerformanceSharesMember_3200472b-e4c8-42cc-957c-6871df7a5043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0cb87438-6eae-4ffa-8005-4f7953e39ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_021baf13-cf32-4c6c-ab3e-dcd0a55fffb9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0cb87438-6eae-4ffa-8005-4f7953e39ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a59db8be-26f8-4e63-b0df-f036b78a5ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0cb87438-6eae-4ffa-8005-4f7953e39ac4" xlink:to="loc_us-gaap_EquityComponentDomain_a59db8be-26f8-4e63-b0df-f036b78a5ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6c8844b9-a279-480d-96c1-5bc6d58c795c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a59db8be-26f8-4e63-b0df-f036b78a5ba1" xlink:to="loc_us-gaap_CommonStockMember_6c8844b9-a279-480d-96c1-5bc6d58c795c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_51e4b30e-8a3d-44f7-86cc-52b7d3cf9c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_021baf13-cf32-4c6c-ab3e-dcd0a55fffb9" xlink:to="loc_us-gaap_GranteeStatusAxis_51e4b30e-8a3d-44f7-86cc-52b7d3cf9c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_d1fcc5dd-3586-4fb3-9486-369afb9411d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_51e4b30e-8a3d-44f7-86cc-52b7d3cf9c5c" xlink:to="loc_us-gaap_GranteeStatusDomain_d1fcc5dd-3586-4fb3-9486-369afb9411d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_a725f63a-6662-4116-842a-90ce3bcdc9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_d1fcc5dd-3586-4fb3-9486-369afb9411d5" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_a725f63a-6662-4116-842a-90ce3bcdc9c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_931794b8-5f82-45c7-a9fc-41d9662237fd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_021baf13-cf32-4c6c-ab3e-dcd0a55fffb9" xlink:to="loc_srt_TitleOfIndividualAxis_931794b8-5f82-45c7-a9fc-41d9662237fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a56e4a47-d18b-4787-84fd-891dd6869eed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_931794b8-5f82-45c7-a9fc-41d9662237fd" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a56e4a47-d18b-4787-84fd-891dd6869eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_504a9412-1ad6-4bdb-a69b-bb9dbb78aa1a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a56e4a47-d18b-4787-84fd-891dd6869eed" xlink:to="loc_srt_DirectorMember_504a9412-1ad6-4bdb-a69b-bb9dbb78aa1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_021baf13-cf32-4c6c-ab3e-dcd0a55fffb9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_ed6e1310-0158-40b6-85c1-8788ca9862a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_ed6e1310-0158-40b6-85c1-8788ca9862a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a84c151d-390c-405d-b752-2318beb8b3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a84c151d-390c-405d-b752-2318beb8b3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_003b6e26-1af2-45d3-8798-1dec1a15e8d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_003b6e26-1af2-45d3-8798-1dec1a15e8d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_5bd267c6-e42a-4c5d-9eae-b73395e23c46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_5bd267c6-e42a-4c5d-9eae-b73395e23c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2cb7c335-faeb-482a-963b-1aeb0e44b8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2cb7c335-faeb-482a-963b-1aeb0e44b8a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7ce2831b-1bee-4cfe-a9f8-9920382ba464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7ce2831b-1bee-4cfe-a9f8-9920382ba464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_410d929c-33ad-4256-964a-41a8a1a5f38e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_410d929c-33ad-4256-964a-41a8a1a5f38e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_30476116-a398-43a7-b91d-f6cc518e1a90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_30476116-a398-43a7-b91d-f6cc518e1a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_47e196f0-5f8f-4932-b3c2-ed6365cb3b67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_47e196f0-5f8f-4932-b3c2-ed6365cb3b67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_aaff3ee5-9646-46ad-b1b7-96e4b2b72fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_aaff3ee5-9646-46ad-b1b7-96e4b2b72fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ef882a51-32ed-496c-9da0-f83bb8632084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ef882a51-32ed-496c-9da0-f83bb8632084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_2c47a9f2-416b-49b7-8562-0871069e274e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_2c47a9f2-416b-49b7-8562-0871069e274e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_9e1eb3db-2b33-46c4-908d-17c264dc03f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_9e1eb3db-2b33-46c4-908d-17c264dc03f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_9c3a229a-2236-4031-97a9-2271e8c927af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_9c3a229a-2236-4031-97a9-2271e8c927af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_0bba5c70-392d-455c-8bea-c7e52e562455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_0bba5c70-392d-455c-8bea-c7e52e562455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_9728e4a6-f4f5-4889-a20e-f3df975d030a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cd902218-2b84-476d-97e8-c983979efa64" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_9728e4a6-f4f5-4889-a20e-f3df975d030a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ShareBasedCompensationFairValueAssumptionsDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#ShareBasedCompensationFairValueAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ShareBasedCompensationFairValueAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d3ce7d2e-0683-422c-9202-970e71b372a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5a05894d-dffa-4cbc-b442-5de56499b38a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d3ce7d2e-0683-422c-9202-970e71b372a3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5a05894d-dffa-4cbc-b442-5de56499b38a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_cde413d1-50bd-45d9-a57b-d5fb2e66fb57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5a05894d-dffa-4cbc-b442-5de56499b38a" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_cde413d1-50bd-45d9-a57b-d5fb2e66fb57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_d5676d36-c3ce-41e5-932f-667981bee7f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_cde413d1-50bd-45d9-a57b-d5fb2e66fb57" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_d5676d36-c3ce-41e5-932f-667981bee7f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_60672d30-8ce5-4b22-a59c-c57eeb973a44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_d5676d36-c3ce-41e5-932f-667981bee7f7" xlink:to="loc_us-gaap_EmployeeStockOptionMember_60672d30-8ce5-4b22-a59c-c57eeb973a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fec54133-4fe6-482c-9b8b-79d0950764e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5a05894d-dffa-4cbc-b442-5de56499b38a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fec54133-4fe6-482c-9b8b-79d0950764e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6fadfed2-11d5-43c4-ba06-b6b10c92c439" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fec54133-4fe6-482c-9b8b-79d0950764e6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6fadfed2-11d5-43c4-ba06-b6b10c92c439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_a4100216-1aa7-46e7-8b24-ee4a997aaee0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fec54133-4fe6-482c-9b8b-79d0950764e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_a4100216-1aa7-46e7-8b24-ee4a997aaee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_74ced4a4-82d4-4c3c-a7e1-9fcc1a7ecf78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fec54133-4fe6-482c-9b8b-79d0950764e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_74ced4a4-82d4-4c3c-a7e1-9fcc1a7ecf78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_8cb46e96-7b7a-4430-8729-8f8f89bd241c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fec54133-4fe6-482c-9b8b-79d0950764e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_8cb46e96-7b7a-4430-8729-8f8f89bd241c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ShareBasedCompensationStockOptionsDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#ShareBasedCompensationStockOptionsDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ShareBasedCompensationStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d32cba04-3507-4782-abc7-ce132decce41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2bdafbad-7df3-4e94-a3fe-5a763250edbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d32cba04-3507-4782-abc7-ce132decce41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2bdafbad-7df3-4e94-a3fe-5a763250edbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c4a56918-6e7e-4397-a8ad-26d90338fa49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2bdafbad-7df3-4e94-a3fe-5a763250edbc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c4a56918-6e7e-4397-a8ad-26d90338fa49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_445611b1-7cea-4303-a7a6-c187ecd058a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2bdafbad-7df3-4e94-a3fe-5a763250edbc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_445611b1-7cea-4303-a7a6-c187ecd058a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_292d2551-eb6a-41ca-b11a-7abd6c2fc7d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2bdafbad-7df3-4e94-a3fe-5a763250edbc" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_292d2551-eb6a-41ca-b11a-7abd6c2fc7d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4eed9b3b-72c1-4543-80be-4c5809d964a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2bdafbad-7df3-4e94-a3fe-5a763250edbc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4eed9b3b-72c1-4543-80be-4c5809d964a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_ffc6fab1-1f76-49ec-8d69-ecb2eeb67be8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2bdafbad-7df3-4e94-a3fe-5a763250edbc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_ffc6fab1-1f76-49ec-8d69-ecb2eeb67be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5a4f62bb-b8aa-43c4-a785-87cb06e8b422" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2bdafbad-7df3-4e94-a3fe-5a763250edbc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5a4f62bb-b8aa-43c4-a785-87cb06e8b422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_35e1a7e0-ac82-43e8-b5a8-f4e27b9029ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2bdafbad-7df3-4e94-a3fe-5a763250edbc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_35e1a7e0-ac82-43e8-b5a8-f4e27b9029ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_28f32f82-886f-46c6-9431-cec5f694d497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d32cba04-3507-4782-abc7-ce132decce41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_28f32f82-886f-46c6-9431-cec5f694d497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8b56573e-2513-4734-8561-47d84881c4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_28f32f82-886f-46c6-9431-cec5f694d497" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8b56573e-2513-4734-8561-47d84881c4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_062dd33c-1c4c-4b5f-a91a-9c0d5c5ac4d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_28f32f82-886f-46c6-9431-cec5f694d497" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_062dd33c-1c4c-4b5f-a91a-9c0d5c5ac4d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0d852871-ff72-49e1-8666-f04d7a1aa072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_28f32f82-886f-46c6-9431-cec5f694d497" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0d852871-ff72-49e1-8666-f04d7a1aa072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_5ed1125b-bbbd-401b-8033-ea51c1f9f995" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_28f32f82-886f-46c6-9431-cec5f694d497" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_5ed1125b-bbbd-401b-8033-ea51c1f9f995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_08313934-21a3-43b5-a2a0-81a4d2249c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_28f32f82-886f-46c6-9431-cec5f694d497" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_08313934-21a3-43b5-a2a0-81a4d2249c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_dab49d24-635a-4eab-a375-65651c20ae91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_28f32f82-886f-46c6-9431-cec5f694d497" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_dab49d24-635a-4eab-a375-65651c20ae91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_eeba07f0-9ccf-408a-acc7-41c01f50e312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_28f32f82-886f-46c6-9431-cec5f694d497" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_eeba07f0-9ccf-408a-acc7-41c01f50e312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_08c3e73d-aea6-44dd-a1f7-e6a1a893a1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d32cba04-3507-4782-abc7-ce132decce41" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_08c3e73d-aea6-44dd-a1f7-e6a1a893a1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_497f4a43-cc21-41fc-8a59-f1527a72a9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d32cba04-3507-4782-abc7-ce132decce41" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_497f4a43-cc21-41fc-8a59-f1527a72a9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_7631fa10-f997-4017-9aa6-84e9508f9e83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d32cba04-3507-4782-abc7-ce132decce41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_7631fa10-f997-4017-9aa6-84e9508f9e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_ef5e0537-b719-46ff-8f04-af272753b25d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d32cba04-3507-4782-abc7-ce132decce41" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_ef5e0537-b719-46ff-8f04-af272753b25d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_707ac416-7ede-41c1-b265-96cf5b9bae52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_88f68449-4a1a-44ff-add2-83b9180292ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_707ac416-7ede-41c1-b265-96cf5b9bae52" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_88f68449-4a1a-44ff-add2-83b9180292ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_15395463-769e-4cb0-a10a-82250b290c29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_88f68449-4a1a-44ff-add2-83b9180292ff" xlink:to="loc_us-gaap_AwardTypeAxis_15395463-769e-4cb0-a10a-82250b290c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b694360c-0a5e-455f-82ac-57a573c0ba2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_15395463-769e-4cb0-a10a-82250b290c29" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b694360c-0a5e-455f-82ac-57a573c0ba2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FreeShareAwardMember_7c9721ce-ceb5-4d2e-8d26-2c32b9da2c9f" xlink:href="avdl-20211231.xsd#avdl_FreeShareAwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b694360c-0a5e-455f-82ac-57a573c0ba2a" xlink:to="loc_avdl_FreeShareAwardMember_7c9721ce-ceb5-4d2e-8d26-2c32b9da2c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_22bc3524-8c6e-466c-a972-72f4ec81dd26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b694360c-0a5e-455f-82ac-57a573c0ba2a" xlink:to="loc_us-gaap_PerformanceSharesMember_22bc3524-8c6e-466c-a972-72f4ec81dd26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3f502545-e8ff-45f0-b88c-ae07ea3d98d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_88f68449-4a1a-44ff-add2-83b9180292ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3f502545-e8ff-45f0-b88c-ae07ea3d98d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d6dbdb63-4e72-4da7-9472-9ba2a181bb7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3f502545-e8ff-45f0-b88c-ae07ea3d98d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d6dbdb63-4e72-4da7-9472-9ba2a181bb7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0d5ef764-43da-4705-9061-aaed10697bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d6dbdb63-4e72-4da7-9472-9ba2a181bb7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0d5ef764-43da-4705-9061-aaed10697bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6db8948d-b6ae-4709-aef2-e8c33ec0d4f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d6dbdb63-4e72-4da7-9472-9ba2a181bb7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6db8948d-b6ae-4709-aef2-e8c33ec0d4f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_fe3abbd0-168d-4d64-82ce-da9f047d4ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d6dbdb63-4e72-4da7-9472-9ba2a181bb7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_fe3abbd0-168d-4d64-82ce-da9f047d4ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_cdab7abf-fd41-4aaa-b844-58b3b2841fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d6dbdb63-4e72-4da7-9472-9ba2a181bb7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_cdab7abf-fd41-4aaa-b844-58b3b2841fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e4fead5d-f698-4db4-9b02-39cad572cc1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d6dbdb63-4e72-4da7-9472-9ba2a181bb7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e4fead5d-f698-4db4-9b02-39cad572cc1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4f8177ba-7ad3-4a4b-880e-8d72b3ac9418" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3f502545-e8ff-45f0-b88c-ae07ea3d98d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4f8177ba-7ad3-4a4b-880e-8d72b3ac9418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b1cb5c1e-2e43-4d70-a182-454e3933b4ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4f8177ba-7ad3-4a4b-880e-8d72b3ac9418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b1cb5c1e-2e43-4d70-a182-454e3933b4ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b256637b-dea5-4fd7-8ab0-b65fbc9447cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4f8177ba-7ad3-4a4b-880e-8d72b3ac9418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b256637b-dea5-4fd7-8ab0-b65fbc9447cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_56ab20fa-2b9d-4239-8cb8-c0660ad770ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4f8177ba-7ad3-4a4b-880e-8d72b3ac9418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_56ab20fa-2b9d-4239-8cb8-c0660ad770ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_160fa6e0-37e1-4059-988b-2199afc06289" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4f8177ba-7ad3-4a4b-880e-8d72b3ac9418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_160fa6e0-37e1-4059-988b-2199afc06289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c397aa5e-8847-43bf-bca3-440df72e2250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4f8177ba-7ad3-4a4b-880e-8d72b3ac9418" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c397aa5e-8847-43bf-bca3-440df72e2250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/NetLossIncomePerShare" xlink:type="simple" xlink:href="avdl-20211231.xsd#NetLossIncomePerShare"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/NetLossIncomePerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_bdd1237d-8ff3-4bf7-a29a-bac46b8360b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_8b9f8a89-223f-48c9-bcf8-f5ab5ec88008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bdd1237d-8ff3-4bf7-a29a-bac46b8360b9" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_8b9f8a89-223f-48c9-bcf8-f5ab5ec88008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/NetLossIncomePerShareTables" xlink:type="simple" xlink:href="avdl-20211231.xsd#NetLossIncomePerShareTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/NetLossIncomePerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_989fdde9-d3fd-43e4-af12-9d3d13f72088" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_71f44762-1a0a-4876-b7a8-392ab2d0aba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_989fdde9-d3fd-43e4-af12-9d3d13f72088" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_71f44762-1a0a-4876-b7a8-392ab2d0aba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/NetLossIncomePerShareReconciliationofbasicanddilutedEPSDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#NetLossIncomePerShareReconciliationofbasicanddilutedEPSDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/NetLossIncomePerShareReconciliationofbasicanddilutedEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f48780a9-5fa8-47e2-9a84-3fa5243ea648" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_28f9158f-3235-4f63-a04e-08030e7641e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f48780a9-5fa8-47e2-9a84-3fa5243ea648" xlink:to="loc_us-gaap_NetIncomeLoss_28f9158f-3235-4f63-a04e-08030e7641e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_808d80ea-761d-4a6c-834b-602edc362d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f48780a9-5fa8-47e2-9a84-3fa5243ea648" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_808d80ea-761d-4a6c-834b-602edc362d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7cfe28be-156f-49e4-bfa4-74cbfb87c4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_808d80ea-761d-4a6c-834b-602edc362d6b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7cfe28be-156f-49e4-bfa4-74cbfb87c4ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_6ab5cee5-70b7-4937-9361-9bb36c71fb3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_808d80ea-761d-4a6c-834b-602edc362d6b" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_6ab5cee5-70b7-4937-9361-9bb36c71fb3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_68345740-f597-4eca-a768-8b4920b20ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f48780a9-5fa8-47e2-9a84-3fa5243ea648" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_68345740-f597-4eca-a768-8b4920b20ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_dabeb510-c4fb-44ba-8e95-3b806a0d43a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f48780a9-5fa8-47e2-9a84-3fa5243ea648" xlink:to="loc_us-gaap_EarningsPerShareBasic_dabeb510-c4fb-44ba-8e95-3b806a0d43a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_0e9cf16c-0656-48d0-a3e7-84b918c9252c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f48780a9-5fa8-47e2-9a84-3fa5243ea648" xlink:to="loc_us-gaap_EarningsPerShareDiluted_0e9cf16c-0656-48d0-a3e7-84b918c9252c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/NetLossIncomePerShareNarrativeDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#NetLossIncomePerShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/NetLossIncomePerShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_467366e7-41b5-47fb-a1f1-f08f9c194db3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_15ccee4c-f1d5-4957-a6e2-dc02d493a165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_467366e7-41b5-47fb-a1f1-f08f9c194db3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_15ccee4c-f1d5-4957-a6e2-dc02d493a165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ComprehensiveLoss" xlink:type="simple" xlink:href="avdl-20211231.xsd#ComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_2a2f5e40-138b-4dfa-b8b0-43a9c8bd05c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_13e1a333-44fd-4f4c-a7ff-304260e0561d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_2a2f5e40-138b-4dfa-b8b0-43a9c8bd05c3" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_13e1a333-44fd-4f4c-a7ff-304260e0561d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ComprehensiveLossTables" xlink:type="simple" xlink:href="avdl-20211231.xsd#ComprehensiveLossTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ComprehensiveLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_11513cb5-0e20-40ef-b74d-ae0e2ede6c38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_f4d94c58-d410-469f-988a-cfcc23c995b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_11513cb5-0e20-40ef-b74d-ae0e2ede6c38" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_f4d94c58-d410-469f-988a-cfcc23c995b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ComprehensiveLossDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#ComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_c084b54a-902a-4a4d-a78b-8768619f4d04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_fa1e08a4-7ae5-45ed-a4bc-410bb32ae5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_c084b54a-902a-4a4d-a78b-8768619f4d04" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_fa1e08a4-7ae5-45ed-a4bc-410bb32ae5d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9df02b9f-757d-42f3-8e6c-2c3f5ce57334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_fa1e08a4-7ae5-45ed-a4bc-410bb32ae5d6" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9df02b9f-757d-42f3-8e6c-2c3f5ce57334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b87588e0-d365-48ec-8b9d-f24a053ba40d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9df02b9f-757d-42f3-8e6c-2c3f5ce57334" xlink:to="loc_us-gaap_EquityComponentDomain_b87588e0-d365-48ec-8b9d-f24a053ba40d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_a5043a00-31e9-4340-93e1-fd8fb773c165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b87588e0-d365-48ec-8b9d-f24a053ba40d" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_a5043a00-31e9-4340-93e1-fd8fb773c165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_d6ffc616-a92e-4357-8ceb-0835b6650cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b87588e0-d365-48ec-8b9d-f24a053ba40d" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_d6ffc616-a92e-4357-8ceb-0835b6650cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ab1294dd-f72c-45b3-8151-3bdbcb620343" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b87588e0-d365-48ec-8b9d-f24a053ba40d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ab1294dd-f72c-45b3-8151-3bdbcb620343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7463f7ad-47cc-4731-a4d3-56636509c9d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_fa1e08a4-7ae5-45ed-a4bc-410bb32ae5d6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7463f7ad-47cc-4731-a4d3-56636509c9d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0d81aa86-415d-4e29-b5fe-40a61c16df40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7463f7ad-47cc-4731-a4d3-56636509c9d4" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0d81aa86-415d-4e29-b5fe-40a61c16df40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_fca896b7-51d7-479d-9925-bae5ff90c7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0d81aa86-415d-4e29-b5fe-40a61c16df40" xlink:to="loc_us-gaap_StockholdersEquity_fca896b7-51d7-479d-9925-bae5ff90c7f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_1908c2c2-7c82-4114-a0f3-d1f231b2cb8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0d81aa86-415d-4e29-b5fe-40a61c16df40" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_1908c2c2-7c82-4114-a0f3-d1f231b2cb8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_99eb492a-6678-4e17-bd2e-46d77020871f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0d81aa86-415d-4e29-b5fe-40a61c16df40" xlink:to="loc_us-gaap_StockholdersEquity_99eb492a-6678-4e17-bd2e-46d77020871f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_040a923e-541a-4c1b-a1f8-480d7f65abf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7463f7ad-47cc-4731-a4d3-56636509c9d4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_040a923e-541a-4c1b-a1f8-480d7f65abf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicArea" xlink:type="simple" xlink:href="avdl-20211231.xsd#CompanyOperationsbyProductCustomerandGeographicArea"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicArea" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e01938c3-57b6-49e6-a69b-a5be08faace6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_b3ec2903-98a1-4991-a570-9a2899e76039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e01938c3-57b6-49e6-a69b-a5be08faace6" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_b3ec2903-98a1-4991-a570-9a2899e76039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaTables" xlink:type="simple" xlink:href="avdl-20211231.xsd#CompanyOperationsbyProductCustomerandGeographicAreaTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bbdf0198-d1b4-4e83-8f3f-e750435cc1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_388b6ff9-a9cf-4df9-8afb-958eba589bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bbdf0198-d1b4-4e83-8f3f-e750435cc1d4" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_388b6ff9-a9cf-4df9-8afb-958eba589bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_5e3fed62-0649-4119-829b-acb74672684f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bbdf0198-d1b4-4e83-8f3f-e750435cc1d4" xlink:to="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_5e3fed62-0649-4119-829b-acb74672684f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_10e05858-d45f-467a-ab7e-e5bc484dab0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bbdf0198-d1b4-4e83-8f3f-e750435cc1d4" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_10e05858-d45f-467a-ab7e-e5bc484dab0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_638d663b-1621-487a-a25a-700c59cc299b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bbdf0198-d1b4-4e83-8f3f-e750435cc1d4" xlink:to="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_638d663b-1621-487a-a25a-700c59cc299b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebyProductDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#CompanyOperationsbyProductCustomerandGeographicAreaRevenuebyProductDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebyProductDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a227b69b-d169-4f3a-89eb-9fff4748504d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_155fd105-8cd2-43d3-bd4b-6df764d5ae9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a227b69b-d169-4f3a-89eb-9fff4748504d" xlink:to="loc_us-gaap_NumberOfReportableSegments_155fd105-8cd2-43d3-bd4b-6df764d5ae9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_41048e27-6987-4682-bc94-5f6c52a550d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a227b69b-d169-4f3a-89eb-9fff4748504d" xlink:to="loc_us-gaap_NumberOfOperatingSegments_41048e27-6987-4682-bc94-5f6c52a550d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_46f4ea6e-d826-4e95-9c39-b92da4365a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a227b69b-d169-4f3a-89eb-9fff4748504d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_46f4ea6e-d826-4e95-9c39-b92da4365a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d89bc54b-33ad-4e03-887f-27242a0e47b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a227b69b-d169-4f3a-89eb-9fff4748504d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d89bc54b-33ad-4e03-887f-27242a0e47b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_cedb9534-3c13-4257-95f7-e404c6266a06" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d89bc54b-33ad-4e03-887f-27242a0e47b4" xlink:to="loc_srt_ProductOrServiceAxis_cedb9534-3c13-4257-95f7-e404c6266a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7638fe43-6df6-47c5-b82b-9a36c4942a54" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_cedb9534-3c13-4257-95f7-e404c6266a06" xlink:to="loc_srt_ProductsAndServicesDomain_7638fe43-6df6-47c5-b82b-9a36c4942a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_BloxiverzMember_5de34f33-4b2d-409d-b3b7-6439daa4872a" xlink:href="avdl-20211231.xsd#avdl_BloxiverzMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7638fe43-6df6-47c5-b82b-9a36c4942a54" xlink:to="loc_avdl_BloxiverzMember_5de34f33-4b2d-409d-b3b7-6439daa4872a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_VazculepMember_8186be2f-d1e7-4863-9bf2-a1f1bf198cd0" xlink:href="avdl-20211231.xsd#avdl_VazculepMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7638fe43-6df6-47c5-b82b-9a36c4942a54" xlink:to="loc_avdl_VazculepMember_8186be2f-d1e7-4863-9bf2-a1f1bf198cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AkovazMember_ea001a46-dd42-4a2e-86a1-21b3bba83f1c" xlink:href="avdl-20211231.xsd#avdl_AkovazMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7638fe43-6df6-47c5-b82b-9a36c4942a54" xlink:to="loc_avdl_AkovazMember_ea001a46-dd42-4a2e-86a1-21b3bba83f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherProductsMember_7f38983c-3f81-4e74-b03b-e575afeeff88" xlink:href="avdl-20211231.xsd#avdl_OtherProductsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7638fe43-6df6-47c5-b82b-9a36c4942a54" xlink:to="loc_avdl_OtherProductsMember_7f38983c-3f81-4e74-b03b-e575afeeff88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_461f3a10-1606-4ab6-8f9f-cba7612a6a66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d89bc54b-33ad-4e03-887f-27242a0e47b4" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_461f3a10-1606-4ab6-8f9f-cba7612a6a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c4da0816-6556-4661-b347-487b348cbc04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_461f3a10-1606-4ab6-8f9f-cba7612a6a66" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c4da0816-6556-4661-b347-487b348cbc04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebySignificantCustomerDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#CompanyOperationsbyProductCustomerandGeographicAreaRevenuebySignificantCustomerDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebySignificantCustomerDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_467f5a0c-d631-4bb3-88f1-f73e4f205468" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2cfbfe58-4d05-4a3c-82cc-38674bfeb417" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_467f5a0c-d631-4bb3-88f1-f73e4f205468" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2cfbfe58-4d05-4a3c-82cc-38674bfeb417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_c6a1527a-b261-4dd7-a4d9-0f0cdb4b554c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2cfbfe58-4d05-4a3c-82cc-38674bfeb417" xlink:to="loc_srt_MajorCustomersAxis_c6a1527a-b261-4dd7-a4d9-0f0cdb4b554c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_79b31894-f945-4015-8dff-639b7f5dc96f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_c6a1527a-b261-4dd7-a4d9-0f0cdb4b554c" xlink:to="loc_srt_NameOfMajorCustomerDomain_79b31894-f945-4015-8dff-639b7f5dc96f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CustomerMember_addae4f1-b999-495f-896e-22e12011e083" xlink:href="avdl-20211231.xsd#avdl_CustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_79b31894-f945-4015-8dff-639b7f5dc96f" xlink:to="loc_avdl_CustomerMember_addae4f1-b999-495f-896e-22e12011e083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CustomerBMember_96f7443d-e0bf-430f-ad15-07afef69f991" xlink:href="avdl-20211231.xsd#avdl_CustomerBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_79b31894-f945-4015-8dff-639b7f5dc96f" xlink:to="loc_avdl_CustomerBMember_96f7443d-e0bf-430f-ad15-07afef69f991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CustomerCMember_6596d7a7-7964-43f4-98ca-c02018e293c5" xlink:href="avdl-20211231.xsd#avdl_CustomerCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_79b31894-f945-4015-8dff-639b7f5dc96f" xlink:to="loc_avdl_CustomerCMember_6596d7a7-7964-43f4-98ca-c02018e293c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CustomerDMember_1efa4778-2864-4908-aea0-c393df815681" xlink:href="avdl-20211231.xsd#avdl_CustomerDMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_79b31894-f945-4015-8dff-639b7f5dc96f" xlink:to="loc_avdl_CustomerDMember_1efa4778-2864-4908-aea0-c393df815681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherCustomersMember_cb22308b-e29f-408d-8c55-b6049d7fc0b6" xlink:href="avdl-20211231.xsd#avdl_OtherCustomersMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_79b31894-f945-4015-8dff-639b7f5dc96f" xlink:to="loc_avdl_OtherCustomersMember_cb22308b-e29f-408d-8c55-b6049d7fc0b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_e0da23db-c333-466b-85b1-3d23ccf406a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2cfbfe58-4d05-4a3c-82cc-38674bfeb417" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_e0da23db-c333-466b-85b1-3d23ccf406a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c04f0a61-cc3e-47f5-b81f-94dfe67faf6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e0da23db-c333-466b-85b1-3d23ccf406a5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c04f0a61-cc3e-47f5-b81f-94dfe67faf6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaDatabyGeographicRegionDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#CompanyOperationsbyProductCustomerandGeographicAreaDatabyGeographicRegionDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaDatabyGeographicRegionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5e4bf355-65b4-4b05-95e3-b93f20ed126c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_73aba17b-5a66-4506-bd75-274392638231" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5e4bf355-65b4-4b05-95e3-b93f20ed126c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_73aba17b-5a66-4506-bd75-274392638231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_34f97739-52ca-4ee6-9e8f-e9cafeec732d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_73aba17b-5a66-4506-bd75-274392638231" xlink:to="loc_srt_StatementGeographicalAxis_34f97739-52ca-4ee6-9e8f-e9cafeec732d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_13c49693-98b4-47f7-8845-8f6a208849fa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_34f97739-52ca-4ee6-9e8f-e9cafeec732d" xlink:to="loc_srt_SegmentGeographicalDomain_13c49693-98b4-47f7-8845-8f6a208849fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_7029177f-a8e7-47e8-945e-92d6534a777a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_13c49693-98b4-47f7-8845-8f6a208849fa" xlink:to="loc_country_US_7029177f-a8e7-47e8-945e-92d6534a777a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_00570f11-c135-49c1-8961-8aadee30f1fc" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_FR"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_13c49693-98b4-47f7-8845-8f6a208849fa" xlink:to="loc_country_FR_00570f11-c135-49c1-8961-8aadee30f1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_15192a9f-ac4d-49ad-90ec-07b287614f9b" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IE"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_13c49693-98b4-47f7-8845-8f6a208849fa" xlink:to="loc_country_IE_15192a9f-ac4d-49ad-90ec-07b287614f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_210268c9-ce19-467d-832b-9699f7c662a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_73aba17b-5a66-4506-bd75-274392638231" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_210268c9-ce19-467d-832b-9699f7c662a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicAreasLongLivedAssetsAbstract_e075efbf-0368-4b3c-99a4-bae93fccb555" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicAreasLongLivedAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_210268c9-ce19-467d-832b-9699f7c662a6" xlink:to="loc_us-gaap_GeographicAreasLongLivedAssetsAbstract_e075efbf-0368-4b3c-99a4-bae93fccb555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_31b4ea9c-f764-45c9-bb67-eb9ddd0af492" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicAreasLongLivedAssetsAbstract_e075efbf-0368-4b3c-99a4-bae93fccb555" xlink:to="loc_us-gaap_NoncurrentAssets_31b4ea9c-f764-45c9-bb67-eb9ddd0af492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="avdl-20211231.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_8199f9da-f45e-4d03-9097-eac2244cffea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_b6f7d9f5-7681-4c37-b373-ac69a9a3cdaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_8199f9da-f45e-4d03-9097-eac2244cffea" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_b6f7d9f5-7681-4c37-b373-ac69a9a3cdaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SubsequentEvents" xlink:type="simple" xlink:href="avdl-20211231.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_157dcd87-4ecd-413e-a9da-a8a0b6eaf035" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_9a2e99e1-ad7d-4c03-a533-04fdb0251abe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_157dcd87-4ecd-413e-a9da-a8a0b6eaf035" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_9a2e99e1-ad7d-4c03-a533-04fdb0251abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="avdl-20211231.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_1f85a93b-6f9f-44ca-9516-41f84fb99c26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_f541bf58-6f94-4eb7-88d6-a85a89003fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_1f85a93b-6f9f-44ca-9516-41f84fb99c26" xlink:to="loc_us-gaap_SubsequentEventTable_f541bf58-6f94-4eb7-88d6-a85a89003fd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5fe1cd98-fe92-40e1-bcbd-611035fd2adb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_f541bf58-6f94-4eb7-88d6-a85a89003fd7" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5fe1cd98-fe92-40e1-bcbd-611035fd2adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_22dc7d09-ec3b-4023-b707-3db403f6d3bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5fe1cd98-fe92-40e1-bcbd-611035fd2adb" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_22dc7d09-ec3b-4023-b707-3db403f6d3bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e24175a7-b92b-40ea-b40a-9a9d4fd8c492" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_22dc7d09-ec3b-4023-b707-3db403f6d3bf" xlink:to="loc_us-gaap_SubsequentEventMember_e24175a7-b92b-40ea-b40a-9a9d4fd8c492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c68f8185-9ac6-40fe-9ed5-28539de19fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_f541bf58-6f94-4eb7-88d6-a85a89003fd7" xlink:to="loc_us-gaap_DebtInstrumentAxis_c68f8185-9ac6-40fe-9ed5-28539de19fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_da029098-30b6-4bb1-b882-026bb6c4ab2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c68f8185-9ac6-40fe-9ed5-28539de19fc8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_da029098-30b6-4bb1-b882-026bb6c4ab2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_d75913e5-0a7b-4aab-9a0c-c31d3b9e19e0" xlink:href="avdl-20211231.xsd#avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_da029098-30b6-4bb1-b882-026bb6c4ab2a" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_d75913e5-0a7b-4aab-9a0c-c31d3b9e19e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_f554b27a-7d51-48e1-9c1a-df9d6fc55b74" xlink:href="avdl-20211231.xsd#avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_da029098-30b6-4bb1-b882-026bb6c4ab2a" xlink:to="loc_avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member_f554b27a-7d51-48e1-9c1a-df9d6fc55b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ecc742cd-e665-434a-80bc-a447a76ad2a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_f541bf58-6f94-4eb7-88d6-a85a89003fd7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ecc742cd-e665-434a-80bc-a447a76ad2a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_39190dfa-e97d-4e46-84e3-20aa6f90ca00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ecc742cd-e665-434a-80bc-a447a76ad2a0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_39190dfa-e97d-4e46-84e3-20aa6f90ca00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_ec5c371a-ff18-41f4-90e9-a02a68a3eded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_39190dfa-e97d-4e46-84e3-20aa6f90ca00" xlink:to="loc_us-gaap_ConvertibleDebtMember_ec5c371a-ff18-41f4-90e9-a02a68a3eded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_256c3cb6-8002-46e1-8f3b-35a6522d262c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_f541bf58-6f94-4eb7-88d6-a85a89003fd7" xlink:to="loc_us-gaap_SubsequentEventLineItems_256c3cb6-8002-46e1-8f3b-35a6522d262c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_479e6402-d839-47c4-81d0-3128f27c9f89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_256c3cb6-8002-46e1-8f3b-35a6522d262c" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_479e6402-d839-47c4-81d0-3128f27c9f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>a123121ex-1021001.jpg
<TEXT>
begin 644 a123121ex-1021001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHI,\T +1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %':BB@!!FEHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI,
MTH.: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ,"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT2(SLBNI9<;@#R/K0 ZBD9U1"[L%4#)). *SHO$.BW#A(=8T^1R0 J7*$\D
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+[&Y?[1-&L"S2. =[,KE_P "2:Z8^#!<^-['Q/<O&LT=L!/!'RC3 8# D9(
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M2EEQACW Y].O>J>EZ1XP\*6ATG24TW4--1V^RR7,C))"I.<. ,-R2>/_ *P
M*WA.T@@\7>+O#!BCDTA6CE2V9/D7S%RR@= .1^0K%A;5O!6MW?@G3XTFAU8^
M9ITTA&( _#EAG)  ;ZE1QSBNZ\*>&)-$:^U"_G2XU;49/,NI8Q\B]<*F>=HS
MWK#U_P /^(KWXC:9KUK96K6E@!&-UQAI%.[)QC@_,>/:@"'QKX;L=%^%W]DV
MD:(BS0*T@0!G8NH+GW--\(^(GT#PIK.E7S>;?^'W:)4/'FJ21%@GJ">/H170
M^/-+U36O#ZV.E00RRM/'(YEDV!0C;OQR0!52Y\$C4?&NG^);AEAVP*;JU#9#
M3+@IR!\P![G^ZOX &#\-])-OXN\5#43#<WI6!IG"Y :4,\BX/OQ^%9/@O4;?
M3M#UB(^$[K5%6_G(DAMT>-1M7Y"2<CIT /!KJ] TCQ+I?BSQ#JDNGVC6^I'>
MB_:?F!3.P=.^>:S_  MIGCGPQ87-K'I.F7'VBZ>Y9FNRN"P ( QTXH J^+-&
MM-4\&^$;.VMET];Z]BVJ!N,'FJ[E1T. 6Z>U4=3\17-UX$UOPWXBC(UW3D1@
M\@R)D\Q '!]<'\0<^N.AO-&\87T.C274-I-<V^J&_FS<86-02%C7CH%/O5[X
M@^!(_%UI%/;>7%JD&!'*YP&3/*M@=.21[_6@"/Q3X1T2R\->(]1CL(&N9;5G
M5GB4^3MC"J(^/E V@_6G>#?#.DW'AKPUJ@LXHKVV@2431(JLY*D$,<<CYB?K
M6WXOM=0U#PS>V&FV\<T]W&T)\R78$5@06Z<_2CP?97^F>%K'3]1ACBN+6,1$
M1R;PP'0Y_I0!K7=U%96<]U<.$AAC:21CV4#)/Y5Y1X:UF;3O'EK?7M[%.OB:
M'+HDJGR) ?W:$!CT4J.<?>..A%=MXTT_5M8L;?3;"VADM)ID-ZSR!6\I6!*J
M"",G'6LOQEX#MKS1$7PYI%A:ZFDZ21S1(L)3').0.?I^/:@"IXFW>(_B9I?A
MBZ8C2X(#>7$/F8$Y&=H([X(''IFF^/\ 1?!NFZ5"MWIGV R2 QW5A9#*$'H2
M,#D9X-7=:\-ZY?7>C>)=/BL[?Q!9(4GAE;,<RD$$;A]3CIPWM5?Q'8>*?&6F
M0Z3/HD.FJEQ')+<O=K(I SDHJ\X^N.U &)XFN_#]I\5;2]UBRC>QGT@2NDEI
MO)?+D%DQG.!C)''?%:_P[M'N-9US5;"V:U\,WQ M+9U"J[# 9@N< <$>^?;%
M:-[HFKR_$V#7$L89-.6S^QR!IAN8$L2P7TYZ'WJ+0] USPAK]Y!IMO'>>'KI
M_-2(S!9+=CU !P,>WTYX- '$^#)_#EC!JZZMX<>^87\BQR)IPG55'\(/.,>F
M!U[]M3Q;'H]S\&EOM+L!;VTMR)HHW )B9I"& ].XX[5>\(0>+?"T.HP2>$Y;
MD75VUPK)J$2@9XQ@MCMUXSWZ"CQ'I_C'Q%X+OK.XT55N;B^#06T<\0$$"@$9
M.[!)(/?OVZ4 11S>#-3U+1=*MO#$UK/+<*RW!M/LQ4HI;.[&7SC!'OG-4/$5
MS#X<^)L_B2S4"UM98;?44C0YS*K$M[G !^N.]=;=ZGXPO+1+6U\*?8[@E52[
MGNX95@SP7V@Y) )JK#X;O]4U;Q=:ZKI<D5CJJQ^3<^=&1NC7:#@$D$G##CMS
M0!G_ !6O)=4TVYTRV=UMK*V6^N7"\,2X6-/QRS?\!%9?B[3-)M/#W@6X;3X0
MAE@6<10_-)&0&=<#ELDDX]2?6M:;PAK>G_#"YTB*V;4-9OV47#B=<*JD!?F<
MC@(J@#U]J-=TSQ%>:;X1BM?#UP\FE20S3J]S"O,>!M!WGKMSGT([Y  )=#@\
M%ZCXNMX]-T&[LKV))+D.\!AC<?<*E2>1\^< 8X_"N;T6_O?!.M:MJL*EO#7]
ML7%E<VT2D^1M/R.!T'W@/?&/2N_75?%5[J-FO_"+&QA$G[^XDNH96$?4JH!X
M)( _PZB+PCI%X;#Q#::YI,EM%J-_/<A))4</'+_#E&)!&.>G48]@#)/A/2_$
M?B?Q(H1(8+ZULYXKB!0&9'9F<CW<QX)/-9UQX.\/I\6[325TN$6#Z69F@RV"
M^]AGKGH!71>!O"%UX3UO7$9VDTZ80_8Y&DW$*"Y*D=B-P[8Y^M,GL-:D^+-O
MK*Z--_9L=I]C,_G1?WF._;NSCGIU]NU '3Z!H=OX=TTZ?:,YMQ*\D:L<[ QS
MM'L*U*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M .SK^$R":S:0M%\FY=^>!GI]?UW==UJ+0[!9WC:::618;>!3\TLC' 4>GU-
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MV\SR-$TV+S$,;^7:HNY#U4X'(/I5JQTRPTR)HM/LK:TC9MS);Q+&"?4@ <T
M<C\.=1U'5%UNYU:W%O?"\6.:,*1@K$B]#ZXS^-5=$N8&^-/B-5FC+-:1* &&
M255,CZCO7?1P0Q22R1Q1H\I#2,J@%R!C)/<X 'X54BT/2(+\W\6E6,=Z69S<
M);H)"S9W'=C.3DY]<T 7Z\XN$UCQ?XEO[_1+S3A8V*OIJBX4R*Y8 R,-I[Y"
MY]!7HY&1@]*J6.EZ?I:.FGV%K:*YRRV\*QACZG &: /+=$MKN?P=XE\ 37*G
M4K#<;<Q/CS$R' 'L3P?9\'%=/X!UO2[_ ,$65B]W'%<6T'V:XA>79(A QGJ"
M,]0?\*ZB'1M+MKY[Z#3;.*\<DO<) JR,3URP&3GO5/4?"/A[5IS/?:/9S3,<
MM*8P&8].2.3T[T >;:!,[^ _'4TVI7%U AFMH'GN3(-H4[<$]SN'/?BL]M/^
MP:3X3UG56O-2\.&!%N;8RDI _.UL# V@GOZ$5[$V@:0VER:9_9EHMC)RUND*
MJA/K@#K[T0:#I-MI#:5%I]N+!L[K<H"C9.>0>O- '"_$V2RU!O"<,=XHAN-2
MCQ)!* 0A(!92.F,]>W%:%GI6B>&/$ME?+KE[>7%VILHK>:Y$[$LP.X=P!CGZ
MC\=J7P)X6FBBB?0K/9$"$"IMZ^I'7\:=9>"/#.G7:75KHUK'.F=K[2<=N] '
MG_AK0M/UK7/%LEUJ][9XU695%M>>4K@LW)'>M:>ZL--\-Z3I=K=+>IIFL6]I
M),ZX1R3DX.2#@/@\\$5T9^'GA(DDZ%:Y/U_QJ=_!'AF2RALVT:V^SPNSI& 0
M S8R>O).!U]!0!YW8:;>VFKZA\.621;*[NA>1S]56U!W,O&#\VU5X.,DUI^%
M3&(?B(D>T*+NXVJO0##XQ[5Z0EA:1SBX2VA$XB$ EV#?Y8.0N[KC/.*Q8_ G
MAB%95CT>!1*NV3!;YAD'!Y]0* /._!_AFTUSX=Q!M>O+&X8RJD:W8$0.[JR#
M&0<<@FNTN;K3]8UGPP89Q=6DRWD6]SGS0$V,??)!Y[U;_P"%=^$?^@%:_P#C
MW^-71X2T%9+*1=,A1[$!;8IE?*&2W&#ZDG\: /*?$^F:AX+WZ(@$N@ZC>1S6
MC<DP.KJ2AS[?GP?6O1?B40/AYK&2!F-1_P"/K70W^G6>J6WV>]@2>$.K[&Z;
M@<@_G4>JZ-I^N6RVVI6JW,"MO$;DXSZ\&@"+PW_R*^D?]>4/_H KF_&+C_A.
M/!4<C2"!KF=B$'5PJ[,_B3^!-==I^GVFEV4=G8PK#;QYV1KG R<]_K6?XDT1
MM:T^,6\H@O[65;BTG(^Y(I[^Q&0?8T <M>VD+_'"Q>:WC96THNI= 075VY&?
MX@,>XKD)=%T^]T[XB:A<6X>[M=0F:"7<08R'8Y&#7K%WX<T[6I;"^UC3X9+Z
MV0$ .65&(Y7MN&<]1^%0#P3X?6UU*V6PQ#J3*UTHE?YR#D=^.>>* ..BNI+W
MQY\/[N1F\RYTMY)!N)!)A8_U-588H]"\3VLNMV-OJ%G=ZF9++6[:7#B5CPKX
M/(!&,=!@]:[W_A#=#^TZ7<?9I#+I:*EH3/(?+5>@Z\_C38/!6A6UVMQ':RY2
MX-RL;7$AB67^^$+;0??% &W<6T%W T%S#'-$WWHY%#*?J#48L;))X[@6MNLL
M2;$D\L!D3T![#VJS69X@MKF]T.ZM+2W@N))T\LQSRM&I4\-EE!(XSTH \VU.
M#5_&-KK=Y::$E]:WI,%E=B]2,Q1Q,0,(02<N"3R,Y[5K)KVH>(?@]=7=E,L.
MH0P-#<,S;2-GW\'/!*\Y]ZN:1I_BW0M+33=/TC1(K5"Q5#?3MC)R<$KGJ:YB
MX\(^(-.T?4K2R\*Z>8+IT^T)#J$DC2JOS94.>#U&?O9Z T 7O#'A^TO?%VGZ
ME9:5JNGV5M8_O5N \0,_0#DY;Y2<GH>*SK71X++0?%FOQ3W?]HZ7J-W%:R-<
M.=H& "1GD_,>3UHT_2]?L[ZVU#P_X'N]/F@<^8)]7++,A4C:5<CC.#^%7=,L
M_&&D1WT=IX%L_*OB6N(Y=2$B.3G/RLY'.3GUH =X=\-7%E?Z!KXU33(8A %/
ME/(6O"R8Y#-@MDY./KVK,T'2;_6-+T[Q3)JVGVTL=T;FXNA))YS#<<QL,E>G
M &.F*FTGP_XDT344O[#X?V<=Q'N\MFU/>$R,' ,A XI(/#>NP:D=17X=6?VD
M.)4QJ8\L/GJ4+X/?\>: )Y])MM6\7^.HKU[J2.T@2>%!<R*JOY9;. W//0'@
M5EQ0_9?"?@SQ&DMP^IRZA' \LEP[ QAG&W:3@#"CH/YFNE2TUU;O4KO_ (0"
M;[1J49CNW&OJ/,!]!GY?08Z#@5!)H^J2:39Z6WP\G^QV<IE@0>(0-CGG((.>
MYQZ9.* ,R/0]3\:WNNZ@+ZV@N;>_>%)9)ID>U5"-NT*P7&!G)'4FM*2P7Q%\
M2$TO4;^>YL_[%25OLURR1ROD#=\IP02<_E46H^'K[5-3;4+GX</YTAS*$UV-
M5E/JP'7^O?-7TM]>BUW^V(O $L=U]G%J-FN1JBQ@8P% P.WY ]: .=B=-<^'
MWAF/4"\H@U^.S9WD.6C+'J>WRD#\*]@CTRRBFDF2W42R0K SG)8HN<+GTY->
M9)H.JIX=_L/_ (0*Y:U^T?:0QUV+>)/[P..../\ Z_->E:,;DZ1;?:[1[2<)
MAH)+CSV3ZR?Q'WH P/'EE;P?#;4K6&,1PV]NOE(A(V;"I7'TP*W-!FFNO#FF
M3W"LD\MI$\@.<AB@)Z\]:S/%>FZEKHMM&@B6/3)V#WUT9,'8K ^6J@YRV,9Z
M 9KH/)06WD)E$";!L."HQC@]J /)='.OZG\.M7CL;NXN;R/667]Y<E9)(UV$
MHKYR,^@([^M==X U"RO[&_\ LJZI#)'.%GM=0E:1H&VCA2W..,\]^PJ>T\!:
M98Z2^G6]WJ*1M="\$@G'F+*!C(;'?O6KH^A6VC/=RQ37$\]W())I;A]S,0H4
M= !T'I0!PNK2ZQXD\;ZYI%J'$=A;1K %U&2U",PSYGR*=YR0,'CBFW5IK8D\
M'Z3J>MS"Z::XM[F2QN"-RJF0&..6Q@9(_7FNLUGP/I.LZNFK/)>VM^J[//L[
M@Q,0./\ .*63P3I1;23 ]W;+I;,ULL,Y RQR2V<DY[^Q- 'G-V]R/"/CW2YK
MVZN;?3KJ-;<SREG +X(+=2.!QTK2O([V[N_#?AS2IIX;)M,%\8CJ#0R.3_#Y
MNUB<9SC&,9Z8&.P_X0323%K43R7<B:PVZZ#2C[P)(*X'&":BN/AYHUS96$$D
MU_YUB?\ 1[L7)\]%SD+O]!V';'% '&ZXOB7P_P"!K*UOM:/VZ/58XA);3EG$
M; L [$ DY&>>WK6AK>GZM;Z_I_AFRU:[GAN5GO9O/OO(EE.1A%D"L0%QG '3
M=72W/@#2+O2DT^6:^*BY%T\QGW2RR@8#.S YP*M:WX0T_7I;&>ZGO(KNR!$5
MU;2^5+SC.6 ]NWJ?6@#BY1XFT;2-,T#4]7C#7VJ+;FXBG+2QP$9V;R =QY .
M,\UJZ-I,.C_%BZMX)KF5&T57S<3-*P_>XQEB3CC./<UKR> M&ETLV;F[:0W"
MW7VUIRUSYHP WF'G.!BG:=X*L=/UV+63?ZI=7D41A5[JZ+_(<\'CD<D\]^:
M*WC^XO;2PTJ>SO9;?_B9P)*J?\M%+=":Q=075-<^)&JZ$-=O[*QCL%G5+9E4
MY.T$9QGN?>NL\3>&U\2VUI!)?7%JMO<+<?N<?.5Z9S4"^$D7Q9<Z^-1N1+<6
MOV9XP%  P!D''7(S]: . BO)O$?@_P $3WES<F<:PEM)()-I?!;!R.X"CGKU
M]:Z5O/\ %'C?5=&EU&^L[/2(X?+2UGV-([#.]FQD]<8S4\7PXMH?#%IHT6JW
MD9M+O[9!<H%#H_/3CW-7=2\%K=ZA#J5EJU[I^H)!]GEN8B&:9!@C=GC.1UH
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M[=:DVH3:3;O<L07."%<@YRR@[6.?4&I]6\,:+KL]M/J>G0W,EM_JB^>!D'!
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MV.\*7&K/"9/LT@ )*JP^5CO./;UKK+GPMKD&OW^I:1K5O''?%6D@N[7S0A
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MGR20QZ2VUY4F*$QA>1M Y+$<G(ZGK0!I^-)A;^#]1D.I/IHV*/M4:%V3+ 8
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M!)V]#R<]*J6FJWGB?4?#6A7D]Y;Q3:0M]<O%+Y<D[XP"2O;*[N/49]*Z75/
MUGJNLW>HOJ.HVYNX5AGAMYMB2 # SQGI57_A6^G+INF6T&HZC!<:<6\B\BD
ME 8Y*YQTYZ4 <1;ZC=^'H?&@L)9#<2:M%:I-)+\Z[F8;BQ!YQW/KFNO\*VGB
MG3O$]PFIE4TN=&,<4U_Y[^8#]Y"1NYYR.,5:B^&VC+9ZI;SSWMU_:3!Y9)Y=
MS*XZ../O9).?>I-+\!6NF)=/_:NIW-W-"T*75Q-O>!6Z[,C /O0 [X;?\D_T
MOZ2_^C7KJZR/#>@1>&M&CTR"YGN(8V9D:<@L,G.. .,Y_.M>@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /(X=3OO#
M'Q4N ]S/+HEU=BRVS7)<12.B/G#'@ MU],^E:'Q9U^_MM,>PTFZ,+0JL][)&
M^UU1F"HH(Y!).>W"^_-*;3$\77GCFW%E=I+(8)[,SP/&?,CC*@\CC)[=2#57
M7].U%?A5<7FI174^M:I)"\X$#9C5" JL,?+A1SG'+&@#O5UBT\-6NEZ,!J&H
MWLD!=(T(EF90,L[%B._O[#I3+CX@:#:Z/8:I+)<_9[YBD6VW8L&!P5('0@\8
M]N,UAZOKMS#X@T*5M.U=]/EL"WEVEG^_,A/W&)P5  R0".@S7(Q//#X<\(6<
MFFZC%+9ZXSR+):O]T2;N#CGAL?4'TH ]-TGQWHNKZ=J-ZC7%NFGKON$N8MC*
MN"0<<YS@X[U9TKQ=I>L:BUA;FXCN!;K<JL\)CWQGHRYZBN+O;R]M/&'CJYM;
M:27&G1%(I("R2,J@9P?O8R?8@FJNEZI%/XXTR_FM=6D%UI#6LUU)9F-7D !.
MU<84  ],@9'N: .MN/B3X<MMIDEN_+>1HHY1:2%)&4X(5L8;GTJ]JWC+1]&>
M1;I[AO*19)FAMWD$(;IO('R$^AP:\ET._P!),&DV^H:E-:Z-I]\;NUC:R?S.
M7)3?(/DQR"2/I6O=1:9IWBKQ#%XBT_5+V#4I5N+2:R,FV>,@XC^1@#C('?\
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M94KY:88Y(VCDT>3%N#>6F5X!VCBN?U'QYX:TK4GT^\U-8[A" X$3LJ$]BP!
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M')7TR:L-K>DI??87U2R6[W!/(-P@DW'H-N<YI\VK:;;S-#/J%I%*I4,CS*K
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M->I$\J]B%(R/US0!MV?A'3K+7-0U=9+J6XOT,<ZS2[T*G'&,9P ,#G@54M_
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M&C;&,J01CK3+#PSI&FZ5/IMO9I]FN 1.')9ILC!+,>3Q0!RGC/\ TGQ!X%6
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MZ##,L,]U<S3N'FN;N7S)9"!@9;T Z"M:@ HHHH **** "BBB@ HHHH ****
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M<!@8[^U<=XBL+70-/\%Z7-*C.NKQ22NPXD;YB[?]]/\ J*PM4634/$7Q&M;
M^;<O;0E8XS\S!-N\ =^XQ[XH ]'L?&?A[4;B""VU)#)<9\D21O&)<'&%+ !C
M["L?3[[5YM2\:V,NIN39[#:2>6N80\;.,#'...OI6%XBU[2_%MCX7AT.1)+\
MZA#*MO$V'MU4'=N&. /P['H*MZ;K>F+XD\?RM>1! D;9SV2(HV/7#<4 ;FC>
M+K*U\+Z#/KNI)'>:A"NUG7F1SC)X&!U'H*WDUBP?69-(6XS?1Q"9X@K<(>AS
MC'ZUP$.G)XD^#&GFPD5KVP@6:!U."DT74>QX(_$?6M[P)))K,%SXIN;=H9]2
M"(B,V[;%&-HQ[%M[?B* -[5]>TO08$FU2]CMD<X3=DECWP!R>HZ54'C+P\='
M?5AJL!L4<1O(,G:QZ KC(/X5SWB.^BT;XEZ'J.J2*NG/:S0Q328"6\O4G/J1
M@=NM9MAI5MXH\0>-CI\D#Z1?010B6, H]QMW;AZX8DGW- '=KXCTAM7M]*6^
MC-]<1>=#%@_.F"<@XQT!/7M48\5:#]G,YU:U2(7#6V]Y H\U>J\]^E>4C4-5
MCL=(\93V#(V@%=-FB<Y>?AHW8MVY8#ZEN:UO&VG0Z-X5\.PW;)YTVL)=7C2$
M?.[!FD)]AG'T H ]'T_7](U59FL-2M;E81F0Q2AM@]3Z=#3+#Q)HFJ7/V>PU
M6TN9BI81Q2AF(]<5Y=X@5H/%_C"QT7RX2=%7,, "@D%"W [["WOS4^C/H%Y<
M:->:?KE[=ZVEDT-I9)MVP,(3D$;1A<YZG!)[T ='\0O&<>CZ%<+I&KVJ:K#*
MJM""KO@\$8/0C(/X5W$+%X(W;J5!/Y5X5>:SIK?!9M+:ZB75Q<DW%NS8E9_-
MR6(ZGC'/M7M,<UO=Z LXD)MI;;=O4?PE>H_"@"&T\3:'?W!@M-6LYI0I8HDH
M)P.IQ[4K>(]%6R@O6U2T%K<.4AF,HVNP., ]SP:\[\+7LND:WI&B&YL=>TJZ
MCD6QN(57SK5,98,.H!!&<^GU%<W=:OIG_"K=*TQ;R 7=OJQ>2WW89%WR'./3
M!'- 'HMIXLFL?&^OZ=K>J6,6GVB1/ 9,1,-^"!R?FP#@GUQTS747&MZ7:6,=
M]<:C;1VDI CF:4;6)[ ]^AKS^'^QKCXM>(O[5-D]M)8P[#<E=IRB=-WMZ5CZ
M1I$O_",Z2L.KPZ9?KJ5Q<Z.MQGRY8L 8Y&#G.0>>&XZT >BZMJS7.FV-[HNM
MZ=#"]VBO+,P9)4S@HIY^;-7]8UFRTN#9<:E9V=Q*K>0;EA@L!UQD$C\:\SU'
M6;+5? FF:A/I]KI\T6N(K;  C.&S(Z'T/.?H?2MJUU#2X?B7XE36Y(4G6&'[
M(]UM"B()\P4GW8_7)H NZ-KNLZKX%T;4FU+3[6\N;@"5[A=JR)YC+M4=F( Q
MQ_C767NK:=IO_'[?VUN< XEE53C.,X)]:\@LKFPN/A%H+S^4LUGJD<<;,XR&
M\TL?_'2>/09K2\9ZGILNN^)H(Q917,6D^5--<L2\N1N5(ER #RI)YYQQQ0!Z
M;<:MIMH%-QJ%K"'3>OF3*NY?49/(IEGKFE:A<?9[+4;6XF\L2[(I0QVGO@=J
M\KTZ#2-<U'P!%>_9[L'3YHY5=@V651M5OH=W!K9\5PQ>!/$&F>)=-L4^RO$=
M.FMX4 Z_,A ^HQVZ"@#T.TO;6_B,MI<13QARA>)PP# X(R.XJO?:YI6F31PW
MVHVMM)(0$2655)STX)JEX0T8Z#X7LK)T"S[/,G _YZ-\S#\"<?A7)^'4TZ]\
M6^,;;Q!#:2W8N=ZBY12?LP4A2">P7&<=,T ='XN\4)H.C6UQ:S6K3WDT<-NT
MKY3#$9?@C< .>#Z<U<\-G53ISMJM_97[&1C#<68PK1]L]LYSTKRZ*$+\-M.%
MZL?V4>($-GYA!'D;^V>WW_PKV:&"&VA6*"*.*)?NHBA5'T H YGQSXO;PGIT
M$EO;BYNII.(L$[8UY=SCL!QGU(KHHKVUFL$ODGC-J\8E$I.%VD9SD]!BO/I8
M=8\7:UJ^H:2VCW.FJC:7&+QI#\N 9&38,<DXS_LBIOAQ=>?H^I>#]6$4L^F.
M]NZ;\B2(DCCO@'(_$4 =U_:-CY$<_P!LM_)E;9')YJ[7;T!SR>#1)J-C#<K;
M2WENEPV-L32J&.>F!G->6^&;*:35E\%36H:WT746O)9F"E6BQF(9QG<68'Z#
M'3(K)\7WVE7.F^*;BQAA2X348Q]HFE!G>164'8,95!CU[T >S:C?0V-J[/<V
MT$K*?*^T2!%+8XZFL?PAXBEUKP?;:QJC6T$CF02%#MC&UV4=2>P]:Y[3?[(U
M?Q_KD>LBTN)X[>V6S68AL1&+<VW/');)[\]:X^U^SW/A7P9IEQ>Q6VGRWEYY
MCR1B6,2*Y\L,"<?Q'KZYH ]3\4:[/I_A&\UC1I+.X>!=X:0EXV .&^Z>OXUK
M:7<S7FD6=U.BQS30)(Z+G"L5!(&>>IKS&32;'1?!/C&UL=:744:)9GCBB"Q0
M,Q/"X)'(QP.@ ]:])T$./#NF"283.+2+=*.CG8/F_'K0!PND^,/&&K:WKMM;
M66CRQZ1,T;PDR(\O+@!6R1GY.X'X=I;3XF2:F?#LMI8Q)!J-ZUI<K(Y+Q,,?
M=P,='4Y^HQWK#\,Z;J&L>-/&T>G:N^DJ+[$IAA$AD^>4=6/'<\=SVQ5KQ-X8
MTS1+KP3HMM$6M#J#"7>?FE)V;BQ'K0!ZL&4@D,#CT- 96Z,#]#7D%O'IN@:G
M\0[(++;:7%;1?NK=L$%DQ\N<X)+8_&K/A^"/3_'6AV=K9QV=KJ&AGS8HWRSK
MEB&9@!E^!DCWH ]5WI_>'YT!U)P&&?K7C^E^%-(/PIN==,$AU#[!= 2&9L ;
MG XSCM^I]:@A\,:8=.\"W,2FVN=0D1+J?SG!E39DI][C(&WC'6@#V@,K#(((
M]C0&5NC _0UY/ FF>'-:\=Z1&EQ:Z2EE#+MMI#OC^0 [,GJ2_?T':H;=;?0-
M8,^FVD&FN_AF>9(TG$C,ZX*L^."V!G(SGF@#U[<N[;N&?3-&Y<XW#/IFO.O#
M_A_P]?:'X>\0)<E-1B\N26YCF_>3SLHW1R,>3ECC'IQTKF=)T2;Q5ILOB6XU
M.PT_4(KUI);J7>98"&X0Y?:!R !MZ8H ]KW#GD<=?:JEYJMCI\MK%=74<3W<
MGE0!C]]L9P*\[@Q/XH^(T3_/"UFC;#]T_N3SBL""W@O-!^&RW4*3K)=20N)1
MN!3S,8/M0!Z]#=Z@^O7-I)8!-/CB5XKOS03(YZKMZC'K6AN7=MR,^F:\ROKR
MZT_XD^*I[0R/+%H1EC3<2-XVXP#D>OYGUJ;PMX?T2]TCP_XD-\T6JF1'FNA<
M9:XE;AHFR><],"@#T?<N<9&?3-<[%XFF?Q_/X::S58H[,72W'F9+<@8VXXZG
MOVKSGQ5+$D6M>(+"":XGM=3CQJ<SE&C*L 88@,DJ.A)P.3UP*Z5&:3XS7+*X
MB9M"R'/13N'/X4 >AA@20",CM2UY/X/6'2?$FEVNMZ=-:ZO*DH@U&*??#J (
MSESGYB 1CKU'3BMKXMF6'PM;W4%S<03)=H@:&9DR&SG.#STH [J:1HX)7C4.
MZ*2%SC) Z9[5B^#_ !'_ ,)5X=AU4VWV<R.Z^7OW8VDCKBN5@TL>%_B;IUCI
MTUV]EJ%I,]VDTS2 $ _/SWR%&:Y_2;]K;P7X=TZUGE@T^_UF2":>-RI\K><+
MNZC=^!X- 'M%%8&BZ#;:)K5_]EU"9H[A$<6,DK/Y/)RXW,3\QS^5;] !17CV
MK:B(+--<TO4K^YF.OK"+N20B.1"&S&J!B-HP!D@9J_=Z;-JWC7QA9R:EJ<<-
MM;QS0".X<)'(8@<\'L2<+Z4 >I5REOXPN)_'$_ADZ04DA7S6G-P-IBXPP&WG
M[PX^OI5WP5>7&H>"])NKN5I9Y+<%Y&ZL?4USH3S/C=<H&92VB8W+U'SCD4 =
MU=RR06<\T,!GECC9DA4@&1@,A03TSTJ+3+N>^TRWNKFSDLYI4#-;R'+1^Q]Z
M\UT+2[L^![_Q%+KNJR7L,%_Y8:X.T8W 9'<@J6SQRWL*EW:U>?#OPO>0P76I
M11'?>P13NDTR88## @G'ISV]#0!V7B3Q,GAN33!)9RSI?72VV]& \LGH3GK_
M /6-;U>0:U?65WX5\,3:1?7KQ?VZ@S<.3- QW$QDG^[NP.O&.375^&$FL/''
MB'2Q?7=Q:1QP3HMS*9"K.#NP3SVH [2BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **X6?XE(%OFM?#NKSK83>7=-Y:J(E'4]3R,=/3G(K3M
MO&UG>:YIVFP6L[+J%E]L@FRHR.3M(SP>#SZ_G0!T]%>4^*_$</B7P/>7YM+J
MSGTK4HX7B\W.2'4$<<-U_,5U>D>-K?5]:.C76EZAIMS,C26ZW<>SSHP.2,=#
MU_+K0!U=<SX9\*3>'M2U2[;5&NEU&8SR1F (%D)))!!/J1BN$\/7>GV_PDU!
MM9:_:Q7461OLC_O -RX )/3/7ZUZ)=^);6QN(K&&UO;ZY^SB<Q6ZJS)'T#,6
M8#]<F@#=HK-T'7+7Q%H\.IV2RK#*6 65=K J2"",GN*X[3V>V^+^O0&XNY+<
MZ9YQB\UFP2R9VC/'4X Z9XH [76+&;4]*GL[>^GL99 -MS ?G0@@\?E@^Q-0
MZ#HJ:%I[6XN9[J:20RS7$[9>5S@9)^@ ^@%<MH?BK0- \!PZE'-JEQIWVEH5
MDN%\R7)8]>>%';_&KY^(6GC4)M/&E:T;V-=ZVXLCOD3^\HST^N* .NHKA]>\
M3:)JW@>/5Y+K5;2R-PJE[12DT;AN5;' '&#VZ=\5>'BN4^/HO#<5D[P?8_M#
M3_Q9)&#R1\O8]3DB@#JJ*Y23X@Z-'<Q*8K[['+-]G34/(_T8R9(QOSZ@\XQ4
M'BSQ3;#3]9TNRCU&:Z@M9/.GLXSMMFV$C<^1C\,GK0!V5%<YX"N)KOP+I$]Q
M*\LK0?,[MEC@D<DU7U+XA:-IDLV^*^FMH)O(GO((-T$4G'RLV>O(Z9H ZK R
M3@9/4TFQ< ;1@=!CI7/ZEXSTS3[S[)%%=W\ZQB65;&'S?*C/1F(X _7VID_C
MWP[;Z19:HUZQM+R3RXF2)F.X=00!D$4 =(5!() )'0T%%.,J#CIQTKD%^)GA
MIMZB:[\U,$Q?9)-^#WQCI5JY\?\ AVTTS3]0EO'%O?Y^SD0N2V#@\8XP>* .
ME"J"2% )ZG%&U=V[:-WKCFN<T[QWH&IQW[PW,B?88O.N%EA9&5,9S@C)J73/
M&.D:K=);0-<1RR6YN8Q/;O'YD8_B7(Y'TH WBJE@2H)'0XH*J2"5!(Z'%<E!
M\3/"]P\"I>2@32>6':W=45LXP6(P*V(?$FFS^))M 223^T(8_-9&B8#;QR">
M#U% &M2;1C&!CTJCI&L6FMVCW5D9#"LK1;G0KEE.#C/49XS[&LY_&FBQW.JV
MYFG,NEKONE$#DJ,XR..>H_GTH WRJMC<H..F10$4,6"@$]3BL6W\6:1=6FEW
M,<[^5JDC16I,3?,PSG/''0]:PHO%=CHGA76-:75;C6XH[UU0LFW8Q"XB'&-H
MR.<8YH [2.W@B=WCAC1W.695 +'&,GUX IWEIS\B\]>.M>>>)/%$R7G@[5([
M^XT[3[N;-S$\9 92%.&R,D<XSTYS78Z+XBTOQ!'.VFW/F^0^R52A5D/.,@@'
MG% %#Q#H>K7\5M::-JD6EV6&2Y1( 69",?+Z'K^?M6Y96<&GV4%G;1B."% B
M*.P%4]1\0Z5I5VEK>76RX>)IEC6-G;8O5L*#P,'\C5K3]0M-5L8KVQF6:VE&
M4D7.".G>@"6:"&YB:*>))8VX*.H8'\#1!!#;1+%!$D4:]$C4*!^ KG[OQ_X6
ML;J>VN=9@2>"0QR)M8E6&<C@=L&K%WXQ\/6$%I-=:K!%'>1&:!FS\Z8SGIQ]
M#WXZT ;+Q1R(4=%9#R589!J*ZL;.^"B[M8+@(<J)8P^WZ9KG;76+/4_&%K-9
M>)$EMY+ L-.1<AN<^83VXP,'GCZU+'\0?"<LT4*:Y;,\K[$'/7..3CC\: -Y
M;*U2Z>Z2VA6XD&'E$8#L/0GJ>@_*FP:?96LKRV]I;PR/]]XXPI;ZD#FJ.K>*
M-$T*=8-2U"."9D\P1X9FV?WB%!P.#S[51O=:MYM4\/SVOB&V@M+MFVV^P,;S
M(^4*>JX/Z\4 :TNB:3-*TLNEV4DCG+.]NA)/J3BKVQ2FS:-N,;<<8]*Y^\\=
M>%[!Y$N-;M%>-_+=%;<RMW&!D]JMWGB;1K"SM;NXU"(077^H9,OYG&?E"@D\
M4 6[;2M.LY?-M;"U@DQC?%"JG'ID"D_LC3=TC?V=:;I3F0^2N7.<Y/'//-<Q
MXQU^?_A$+?6/#VJ(J&ZB!E1 XD4ML*\CCD_7C%=F,XYZT 4+S1-*U&>.:]TZ
MUN)8_N/+$K$?B14UQIUC=K&MS96\RQ#$8DB5@GTR..@_*LD^-O#2ZK_9AUFV
M%V'\LIDXW>F[&,]NO7BL#Q=XDGC\66>@6VNQ:.K6S3R7#1JQ+GA$^;C!ZX'-
M '7W&AZ5=VL5M<:;:200MNCB:%=J'U QQ27F@Z1J,T,UYIEI<20@"-I(58J!
MT R.GM7"R>(-3U3Q&^A6GBBTLKFS@@4/Y*L+R<\R<'G&!T7UZUU7A^^,'A^6
MZU/7[/45BD<R7D85(T /W3@XXH O7'A_1[JWBMY]+LWAB?S(XS"NU6]0,=:)
M_#^CW5TEU<:79RSHGEJ[PJ2%[#D=*?I^N:5JRRMI^HVMT(L&0PRAMGUQTZ&H
M[#Q'HNJ7)MK#5;.YG +>7%,K-@=3@&@!L7AG0H9K>:+2+));<YA=8%!0^H.*
MR-1TK7];\0Q6]^MBF@6TZW*&/<9)ROW4<$]CR>W ZTGQ'UC4M!\(2ZAI<Z0S
MQS1@LR!LJ3@@9]\?K6U>:_I>EQVYU/4;6T>9-RB:4)NZ9QGZT :=9VH:!I&K
M2K+J&FVMS(@VJ\L08@>F?2IDU33WTW^TEO;<V.TM]H$@V8'4[NE166NZ3J4,
MLUEJ5K<10_ZQXI58)]3VH 2^T#2-3A@AOM-M9XK<$0I)$"(QQP!VZ#\JNF")
MK<VYC4PE-A3'&W&,?3%9]KXDT6^AN);/5+6Y2V0R3>3*'V+SR0/H:ATGQ7H^
ML:$VLP7:1V:$B1IF"F+!_BYX['Z$4 7M.TJPTBW:WTZSAM86<N4A0*"V ,X'
M? 'Y5#;^'](M-2?4;?3K:.]<DM.L8#DGKD^]3V.JZ?J5LUQ8WMO<PKUDBD#*
M/J17+7OC!G\;:)IVEW]A<V%TTL5R(V#R*ZJ3U!X[=O6@#KDM+>.ZEND@C6XE
M4+)(%^9@.@)]LFLV;PGX>N;B>XGT:QDFGR97>%27R<G)K6DD2*,R2.J(.K,<
M ?C5&XUS2[:PNKZ2^@^SVHS,Z.&V>QQWY''O0!7N?"N@79B-QH]E(8HQ'&6A
M'RJ.@'M2_P#"+Z#_ &:VG?V19BS9_,,(B 7=_>^OO5S3-2M=8TV"_LY-\$Z!
MU/<9&<'T-<'KWB/QIH.C7^N3QZ:MHET8H;62)_,$>_:K$@]3QQZ'/M0!UY\*
M:"=)ETL:7;I8RL&DAC78&(Z$XP<UI6MK!96D5K;1B.") D:+T51T K!TN]\3
M?VZ(=4M[%M-DM?-2YM0R[7!'RL&)ZY/Y5OPW5O<;O(GBEV_>V.&Q]<4 96E>
M$M"T._EOM-L%@N905=Q([9!.3P21UJ?5/#^EZS<6L^H6@GEM'WP,78;&R#G@
MCT'6K:7UG(ZHEU S/]T"0$GZ4FH&\%A,=/, NPN8_M )3/O@@],T 9TGA+0I
MI=1EET]7?41MNRTCGS!G([\8('3'2JB?#[PJAB9=&A#1 A&#OGGU.>?QZ=JY
M_P .^)?'/B?1TU.QM/#Z0.S*!,TP;(.#P,UVNGWEPND6T^LK;V=VZCS4$@V*
MWH": *MOX2T.UT2XT:&Q"Z?<-ND@\UR">.Y.1T'0U&_@OP_)#80OI^4T\DVH
M\Z3,63G@[L]0.O2MKSX=B/YJ;9" C;AAB>F/6N>U3Q%=VGB;0K*TCMIM/U!Y
M(I9PV61U7< ,'% %M_"6A276H7+Z>C3:@ACNF+L?,4XXQGCH.F*KVO@3PQ97
M%M/;:1#'+;$F-PS$C/J2?F_'-;AN[99_(-Q$)O\ GF7&[\JY#5?%FJOXHNM"
MT"WL);BS@6207<A7S68C")@@ @'.3F@#6L?!7AS3-2&HV>E11708L'#,0I/4
MA2<#\!Q4;> O"[Z@U\VCPFX:3S6.YMI;.<[<[>OM6Y'=1LR0R21)<E06A$@+
M XR1BI7=(T+NRJHZLQP!0!BZEX.\/ZOJ7]H7^F1SW6 I=F8;@.F0#@_B*CE\
M$>&YM+MM-DTN,VEJ[/#&'<;&/4Y!SS]:U+75;*]O;RSMYUDGLV59U'\)(R!6
M+KVI^)8]:BT_0M.LWC^SF>2ZO681YW8V#;SGO[Y]C0!HIX:TB/6)-56T_P!-
MDC\IY#(Q#)@#:5)QC ':J=CX%\,Z;J"7UII,4=Q&Q=&WL0K>H4G _+BN7T3Q
MKXMUC1+?6ETK2_L/VE89@LC^8P+A257H,9[D_2O1S+&LBQEU#MDJI/)QUP*
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M_P!E21B4RVMTLCJAYW%"!QB@"Z_PR\-/%)$8KL1/+YPC6Z<*CYZJH.!UJ_\
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MD]K,EL0Q65R[')Z!<OUZ<?2N\T#PU_8%U?S)J=Y=+>RF>2.?9CS#C+#"@YP
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M:TB'Q!+KL=F!J4J[7FWL<\8Z9P#@8SBM&ZMHKRUEMIU+12H4<!B,@C!Y'(H
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MJ[:I+I:-=/()6/F.$9AW*9VGGGI0!Q%]I-[XO\1>)K#[58[K,Q0QR77F&6!
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M+J^TB_LKN:2XDTV^EM!<2ON>50<@M[\X_"LK5K-?^%S:3&)[Q8[BR>215NI
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M9X')A<CY2!C)&,+D9&,CMB@#K?"_B)!<>*;N^U.XDT^UNU,;W<91H@5'R;"
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M,&/2_"FA&>)K5;GQ(M_! 5.Y;<-U(Z\#'YBMZWUZR\->)_$MAXC@D6/4)A-
M_P!G:5;B-EV[,*#P,8Y]3TH VB-:U#Q0MYINL2'0KO3FD4K K+&Q&$*D\EB3
MNZ=L'J,41J'B#0/!^GZSJ-S+<_9)'%]$\.UYH'DVJ^.JLHPV/3()[UV6F%3I
M=J4LOL2&)2MMM"^4,<+@<#'I6)\0Y$B\ :R78 &#:/<D@ ?B2* .DCD26))(
MV#(X#*1W!IU<QH.K0:='H?ABZ\[^U/[,CD8;"5 5<'+>N0:Z>@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML3J1/]*@F^'ETR_N?&GB5#N)RUZS<=AV_.NXHH X'_A7.H_]#SXB_P# EO\
M&HH?AOK$.LRWZ>-M1#2Q")F\O,A4#@%BV.#ST[GU)KT.B@#C8_!FLQKM7QMJ
MY''WE1CTQW'M3_\ A$-:_P"AUU7_ +]Q_P"%=?10!1TFQN-.T]+:YU">_E4D
MF>8 ,<GIP.U5]5T"'6;VREN[B<VUJ_F"T5@(Y7!R"_\ >QC@>M:U% ";5+!L
M#<!@''./\@4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '
MG,+ZA8_$^^T:_P!<O_LNHV326.91A6)Y"C&-PPV/0#OFD\ ZW+''XFL=5UFX
MO)M-G8F=VW8B (W*3WRIX^E3_%+3-0DL]*UC1ED_M*PN@$:-=Q"OQZ'C(7KQ
MR<UBZYX(GT[6/#MKIQD$%[ -.U)T+;7089B?3(#=^<>M '8^ ;74HO#,-WJF
MHW5Y<7F)P)VSY2G[H&>>F"?>L?7)-3?XLZ1IT&LWMM9SVIG>&-AM^7=QC'?'
M?-=_'&D,211J%1%"JHZ #H*\UU_6=/L_C7HOGW*+Y=H8'[['?=M!],[A^= '
M8^)]-U/5;"WM=+U"2P9KA3//$V&$0#9 ]\[:XBRL]>NO&FO>'5\5ZH([:TC>
M&4E-V2JXR=O'7DK@GO7J5>:^'=4L;KXS^(O(N8W\RV2.,J<AV0(& /?&#^5
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M%% !33&A;<44MZXYIU% !31&BL6"*&/4@<TZB@ (!&",@TU45/NJ%^@Q3J*
M$P 2<<GK2-&CG+(K'U(S3J* &"*-3E8T!]0*<RJPPP!'H12T4 116T$!8PPQ
MQEB68HH&2>I.*D(##! (/8TM% $$5E:03230VL,<LG+ND8#-]2.M3,H888 C
MT-+10!2FTC3+G9Y^G6DNP;5WP*VT>@R.*M111P1)%%&L<:#:J(,!1Z 4^B@"
MM<:?97DB27-G;SR1_<:6)6*_0D<59 P,#I110!5DTVPFNENI;*V>X7!65HE+
MC'3!QFB73+":Z6ZEL;:2X7!65XE+C'3!QFK5% !1110 4444 %%%% !1110
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M>ZO>Z7!.'O+((9X\?=W#(P>_OCI5;7O$UAX=^S)=K<2S7+,(8+:(R2/M&6(
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MH+*]MM1LXKNSF6:WE&Y)%Z,*9#J5E<7]Q8PW,;W5L%,T2G)0-TS]: +5%%%
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MBK_A![(Z<='-B&FPMQY@D/S'N.!SD_2O1KG3-VAMIEC.;("$0Q2(@;RU P,
M\=.*R?#GA27PYX8FT:#5II-Q<PS&)08=P[#G/.3SZT <-X=_Y(#J7^Y/_P"A
M5M>&U\:?V#X=:&32_P"R?+M=ZQ!O/$&%SDM\O3KCGTJS:?#F6S\'W?AR/Q!<
M_9KB0/N\E?E7^)1SG!('?U]30/ 6LC25TM?&=\MDL0A$:6R+A ,!<CGIQUH
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MLGV>>UE8@.HSM8-ST(&1U)K('@[7K[P]J5M<?9K.^.K'5+-XYBZARV<-\H(
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M"*[>>/B0Y&-@). 5/)QT^F777CN[6[U>WL?#-[=-I38N&,T<8"X)W#DDY R
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M?"7VBW6W)^TF5&1P6()9!\Q^E=)XNU[4?!;Z5-:VUK_PCRE;>9%C/F1^FWD
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M\/7VF,%)GB*H6Z!^JG\" :O6MM#96D-K;1B."%%CC0=%4# 'Y5+0!Y=)\/\
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M2R,Z%?M$C<MM49QC<H&/:@":_P#$.J&\\12Z;-:M8:9IPE0LA.Z<H7ZYY 4
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M^#D9&.<4 ><:Z\@V:WH>H:==36^CQQZAI]T05DMRI<$>N03QGIC\7RWL-_\
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M* /*M!T31(;3PYK:>(H895EA41VUJHFFD8@&-RIW-DY!]LUW?Q%C23P!K&]
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M29FPC&(OD#..#TSTKL;7P#X7LM2_M"#1X5N0YD!+NRJV<Y"D[1STP..U6?\
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M+?B?_P!??- &Q1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6YUS2+*6**ZU2R@DF4-$LLZJ7!Z$ GD5YM#HYL_$-_X$6!_[-O[Q-21PH*)
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M?B'5Y&O6NW0-)&S;5R N2!@#ZUW8\1Z6?$(T(7)_M$Q>:(O+;!7&<AL8Z>]
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M^&-$DTB/27TRW:PC;>D!7*J<DY'IR3^=6H-6TVZN6MK?4+26=<YBCF5F&.O
M.:0:QIAO/L8U&T-UNV^3YZ[\^FW.<T .T[2['2;46VGVD-M"#G9$@4$^I]35
M75/#6BZW,DVI:9;7,L8VJ\B98#TSZ52\<ZW>>'?"-WJM@(3/ T>!,A92&<*>
MA'K6GIVJ6U]%$BW5N]T85DDB20%ER ?NYR!S0 EWH6E7]G#:7-A;O;P$&&/8
M (\<?+CI^%0?\(MH?]F/IO\ 9EO]CDD\UXMO#/ZGU-7AJ-B;PV8O+<W0Y,/F
MKO\ ^^<YI7OK2-]CW4"MO$>TR '<>B_7VH J+X=TA;NTNA81>?9Q^5;O@YC3
MD8'YFH[+POHFG2PR6FG0Q- Q:+&<(2,$@$X!([U>&H61O?L8O+<W0&?(\U=^
M/]W.:K6.O6&HZMJ&FVTNZYL"JSCL"PSQZXZ'WH 9%X:T6&UO+6/3H!!>G=<H
M1D2GU.>_O5>T\&>';&Y@N;?2;=)H#F)R"2GTR:TX=2L;FX>""]MI9HSAXTE5
MF7Z@'(JU0!A#P9X<74_[2&CVHN]X?S-G1@<YQTSD]<5;M=!TRSUF[U:WMME]
M=@":7>QW =."<#IV%&H2ZJFIZ<MDMH;-W879F8AP,#;L]3US5YIX5)#2Q@C@
M@L.* .>D\ >%94N$?1H")W\QSN;.[U!SE?PQ5\>&='&KG55LPMZ8O),JNP^7
M!'0'&<$C.,U+>:YIUAJ-C87-RB7-Z6$*$]=HR2?0=O<FKS2QHP5I$5CT!8 F
M@#%@\&^'[?0GT2/34.G._F-"[LWS<<Y))!X'>ET[PAH6E1W*6ECM^TQF*5WE
M=W9#U7<Q) ]@:V6EC0D-(JD#)R<<4HD0IO#KLZ[L\4 8'_"$>'O[+M--^PM]
MDM)O/@C^T2?(_KG=D]3UI]MX9@MO&=WXA0A'GM5@*+GYSGEFSWP% QZ&J=KX
MIN[KQSJ>@):V[16UF+B&02G,C';P3C &6/KTK8T6YU";1X9]8BMK>[;.](9=
MZ#GCGU_$T &LZ!IFOQ0QZG;><L+^9'B1D*MC'52#4/\ PB^D#4KW41;R+=7L
M)@N)%GD&], 8QNP. ,$8(K661')".K$<'!SBD$L9D\L2(7_NYYH YZ3P%X:E
MTFUTQ]-S:VKM) OG2;HV8Y.&W;N3VSCI6II&B:;H5LUOIMJL$;MN?DLS'IDL
M22?Q-7)IHK:"2>:18XHU+.[' 4#J345CJ%KJ6GQ7]I,LEM*F]).@(]>: *0\
M-:4/$/\ ;WV=_P"TMNSSO/?&W&,;=VW'MCWJC=^ O#-[J4VH3Z6K7$S;I2LK
MJLA]64,%.>^1S71)(D@RCJPZ94YKF_$?B:ZT37M!T^.TBDAU.X\EI6<Y3D9P
MN/<<Y_"@"QJG@OP_K%VEW>:>#.L8C#Q2O$2HZ [",X]Z74O!OA_5H[-+O3U*
MV:>7;^5(\7EKZ#81QQ6Z"#T-(K*V=K X.#@]#0!SEYX%T*[T:+21!-;VL<PG
M403,&+CN2223[GFN;O='GU#XM7)>/5K:T?3!;K>VRR1@/D' D Q]W/7(S[BN
MF\:^))O"GA_^TX;1;D+,D;AGV[%/\7OV&/?VKH4;>BL.A&: .>NO!&B76@PZ
M,(98+6&<7"&&4A_,&?F+')).3R?\*V3I]L^FMI\B-);-$8661V<LA&""Q.3Q
MW)S5FB@#C8/AEH-O':JLNI$VDQEMV-ZX,0)R54 X4''.!GWJT? >DG3]9LA-
M>K'J\_GW)$WS!MV["G' /0YSD5T-Y++;V-Q-!#Y\T<;.D6[;O8#(7/;)XS7%
M2?$@+X$M?$R:46$UQY#6YGQM.2,[MO/3TH UK[P-IEZ+)_M.HV]U:6Z6RW=O
M=-'*\:CA6(X/J>.M7?#OAG3_  Q:SP:>9RL\IED,TI<ECWYX'\S@9S6S10 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %!Z444 >4^&=%O8/$VEW
MVFZ1JFD+(7;5;63Y;8<8&P$\\XX_PK,N]'UN#P-JGA*V\.Z@_E7C2PW/RE'C
M$@([C)QV /K7M"NKC*L&'J#FEH \]O;?41\3/#NHC2KQK:*Q$$TBH"L3/N')
M!QQD9J?2;>]B^+6MWLFG7B6=U D45PT?R$HJYY]#M.*[NB@#QV#0-=GT?77M
M]-N8;N'7!JMLDT>WSE!) 7/?OCZ>M=W:Z]J6J6MX\F@7UC!%;ME9T!EE<CA4
M4'D=<D^H]ZZ>B@#Q]='U+_A$?"=]+H<MRNBO*MYI\\ +R(^.51AAN.?_ -7%
M_7(6U;X>:Z=+\(OI2RI!LC%LL<TY$BL?D09P!C&?4^E>H A@"""#T(I2<#)Z
M4 >::AIE_J/BCPB8K:ZAB&ERQS2M$0(2T+ !O0YQQGTI_A75=;TK3;'PQ/X8
MO);RT?RVN7 %NJ[B0^[O@>G7'O7I%% 'FWCO1KH^*],ETN18GUI'TZ]&X9>/
M );'J%!Y]A^/HEM;QVEK#;0KMBA01HOHH&!6)IGA5+'7)]6N=1O;^=F?[.MS
M)N6V5B"0@[=,9].*Z"@#RW2[B\T?P9J_A2^TV_\ MQ^T0VAAM7>.82[MI#@;
M0,L>I'%1:AI=SH5YX LY8+B<Z;O:ZD@MW=4W;>Z@]P?RS7J]% #719$9&&58
M8(]17D,O@[69=.UO1E25+;1YWNM'=&(9F;#JH..< $?[S^W'L%% 'G&L6.IC
MX5:M=M:NVLZKLGN(8XRS#>R+L Z_*G&.W)J.?S7\<>!KQ;6Z-O%9LDK_ &=\
M1LR% &X^7GUZ5Z710!Y'-#J&I^'_ !+]ATZZ-Q'KG]I11SPLGFQC;]W/4_(>
M![5U1\1IKNGZB\&A:C 4L)1)-=6Q1QE>(T&"7).>!Z?2NRHH \;NI7M/A7X1
MCLH[I;E-0CD ,+%E<,Y;MZMQZBO2?%UU/9^$M2N+:T2\E6'Y8'C\Q7R0.5[C
MG./:MNB@#RK1-:BG\=Z-J BU*2&?2FM6GDM&1/-#;B%4# &%[<=*@TV.?4_@
MCJ-G803-=1S/OB"LK./.#D#')RG'Z5ZY10!YMX-N?#6HZO8R:5X<OHKVW0B6
MYF#A+;Y"",LQR23MQ[Y[5;^+^3X'VA68FZBX4$^M=]10!Y3XJ6?5O']Q#IQ=
MVN/#<D8"Y&22[*#[\J<?2G>&9_#6KSZ"L.F:I)JUB%4K*\Q2UP!N9BQVXXX
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MFD6T5RK%E=0<*3U*CH#]!3M.\-6VG>)M4UJ,();X(NU%VX ')//))YS@?S-
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MDL]3CDD@1_,"I*R<XQS@\]:HZOX&T#7+R"[OK1VN(8Q&LB3,K%1T!(//X^M
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 0365M<SP33V\<DMNQ:%W4$H2,$CT.*G
MHHH **** "BBB@ KG=<\(6VOZC#<W>H:BL"*%:SBGVPR '/S+CO@9Y[5T5%
M     , =!1110!SWB'PL-;OK'4;?4KG3]0L=WD31 ,!NP#E6X/&1^/.:GTC0
M)-/NWOK[4KC4M0>/RC/,JH%3.=JJH 49 )]<5M44 %%%% !1110 4444 %%%
M% !1110 =Z*** "DP,YP,TM% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%9VN:Y9>'=*EU+4&D6WCP"8T+')Z#C^9XJ_
M&XDC5UZ, 1GWH =1110 4444 %%8?B;Q5I_A.SBN]1CN6BED\L&&/=@X)YY'
MI5*'QU9O>VMM<:1K=G]JF6".6[L6C3>W09)[T =316/9^*-)OM=N=$AN'&HV
MP)DADB9#CCD$C!'(/'8U+KFOZ;X<L!>ZI<>1 7" A2Q+'M@ GL: -.BN?O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@""\O;:P@\^[GCABW!=SG R3@#ZDU/7'7#/J?Q3M[250UIIM@;E4
M8\><[;0V/4#(]LU#XE\1ZYI$>M7<3Z?'#8")H;<@RR3(<;F;:<H.<#(QP>U
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M=.)[67.R0 C.#@\'!ZB@"Y1110!P'Q+:UNX]-L6UG3;"YM[E+T+>NPW!=P7
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MXB\/1Z=ID$<DC3K(S22A H7^><TE]?\ C6^@>SM-#MM/D?:IO6O5D" ]2J@
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M<8R1QG->8:U#XJO]+U:UN=!U&]G755N(9GD3RTB5OE$:YST!'R@_>)->NT4
M>9^(]/N]2N[C5=+TK6-+\1QF)8I8B#'<CY>'(RN "0<G^'GTKT.YCEETV:/&
MZ5H67 [L15FB@#R.[TK6;SX8:)I8T6]2[LKZ,2(R#)5=Q+#!SCFMKQ)I&H:Q
MXHUJVM[.<176B"UCN63$?FARX7/OD#\Z]"HH \\\+QL;O3(V\!)87L*A;F_D
MAC14VI@E"/F))P /?KQFMGX@^&IO%'A:2UM IO(9%G@#' 9AP1GMD$BNJHH
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M(R3UZ<"O1** //96F\:^.=$O[""9-&TE6G^URQ-'YSN!@(& )&%4YQW/M3?
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M@H N_%95/PVU4D E3"1D=#YJ5#IOBO4=/U#1=-UC2H[6SOXEBM+B.<2$N%7
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M4M0M6*W$:*L;#^$LP4'\-V:Q/#^F^,]&TN#0!%IXMX'*)J?FY81;L\18Y;'
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MM@L84YR(T7MPI^[USSSSU/AFTNX_B3XJNY;.YBMK@1"&62)E63:-IVDC!YH
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MFV?27A,DENR!&\S=@Y ],?4BM3QO9Z??Q:=!>37EI.;@M:WML,_9I I(9O\
M9/3^HZT 4/$_B:.30=+UBSO;JSMH]7BANE*E&VJY$BNN,\8/%;^G>+=%U.XO
M8+>[*RV:[YEEC:,A/[XW 97W_P 17!W^IZC-X1LO[<#W;6GB".-9EMC_ *3!
M&X_>8 P0>?8UIZMJ!M?B-J<T%L]U(/#Q"1B/<'8.6QV!&".] '4Z=XNT35KF
MWM[.\9Y;E&D@#02()%7@E2R@''/Y5RJ7NIKX(\:.^J73W5G?7*0W ;#(JJA
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M499F. !ZFN3T?Q3JT\/B"#4=+C.I:1@^39N7$VY"RA<C.3C]>E13>)[F6_\
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MD_,3D\Y[8V].^3^'.:+KD_AR7QC+!HT]W:6VIR32R+,JA%VC(^8Y)&,\=B*
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MU\=07?A.UUU+"4?:KI;6*V,J[F<OL&#G\<=?PYH ZVBJ>K30V^CWLURLS0)
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MT_3]1A2&YMT*,J2!^,G'(XK#M[36]#UOQ(MIH]Q>IJ<QGMYVGCV*=F,-N8'
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MXT&RO@LH0S7MUYG[ULGY09#DD=_J*[*B@ HHHH **** "BBB@ HHHH ****
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M$\.V%QINA6MI<WINVCC55D,83"A0 ,#TQ]:P9_ GF^%]5TU;\&_U602WEZ\
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M7>JO8R6MOB1X5)PF75R W<C'3TJ?4M?\5'7/$%GIZZ7'!ID$<ZO.'9BI5CC
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MB*+*7 *R*^!O4D D L!T]?2G7NO1OXG?PO<6&]+BQ:?S2V49.5*E2/KZ\8H
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M47\D1E4>6=I7&?O=.QK7H X^]\#O<>%=1TJ+4BMWJ4WGW=V\0/F/P<!00%'
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MNSN()9-RW$13=N=F!7/48;\Z36(KJU^)6CZC'IMW<V[VCVKRP)N$9+C!<YX
M'/\ C7944 >2QZ=J:^'_ (@PG2K\2WMZ\ELGV=LRJ[G!7U]3CH*IQZ--9ZGH
M^HZKX6O]7L9-'AM7@%MNDMI8P%/R'_=[XX8U[-10!B>%87AT?!TF/2H6E9H;
M-0 R)Q]_!(W$Y/'8BMNBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV@>N0>IQQUIVB>+=/UV_N+"WBNXKNV!\^*> J8CG&">5R>W/2O-K03Z9\-=
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M-+64H%8*"7?&"^2>AXQ^=9FHV5S/\3/#-I<:C+]H_LIUENK8A69@'R02#C-
M'I]-\Q!((]Z^806"YY('4X].1^=<;\.M1N[NTUFSN[F:Y^P:E+;Q2SN7<H.@
M)[TRWM=WQBOI3<7'RZ7&X02$+]_&,>G&<>I- '2Z1J[:JUZ&T^[M!;7#0@W$
M>T2@?QKZ@UI5YG8:WJ\NB^.S/J\JRZ=<RI;3E5S&%W8 &,<X _&JLM]KD/\
MPA#)X@OM^MH/M)8(0,HA^4;>/O'GGUH ]6HKR:_\6ZQX?D\5Z6+R2\DMI($L
M[BX*AHS*!U. ,#U/>NJT>T\3V7B]UN9IIM#>UX:YN$=EESVPH/3VQCOGB@#K
MF95QN(&3@9/>L>#Q-8S^*+GP\$N$OH(A,2\>$=#CE3W^\!^?I7-_$<&74_"5
MLMQ<0F754&8FQCIS]1GCCUJK?6&I7_Q7N[>PU*>P3^RH_-N(HU8_?.!\PXSS
MT]* /1Z*\JL_%/B#4-&\-V,<TTMY?R71FGA,<<CI"Q 5=PV@D8YKK?!9\2);
MWL'B*)UV2YM7FFC>5HS_ 'MG'!'^<<@"ZWXYT_0M:CTF:PU.XNI$WQBVMMX<
M8R=O/.,<XZ4_2/&=EJ^JKIOV#5+*Y>-I$%[:F(.!C..?>N=\6F]7XK^%SIZ0
M/=?9Y]@G8A/N-G)'/3-=!I3^))]2U&+61:6H:WC^Q/;#>$<A]^"PRS#"G'3&
M/>@#IJ*\K\,:OX@O/&4OA>_UIBVFS2SR3KL+7*?(%CP5[98GZ^U+J6J>--=U
M/5I?#RW2)I]ZUG#'&\ B9D(W%]Y#'.<XQ@9 SUH ]3HKA/[1USQ'X@O=#M]3
M_LE[&SA:X,,*R,9W&2,GHHXZ?G4<VJ^(M.\1^#=,U&]B:>[$XOA"HV2$#Y>W
M88Z8YH [\D 9/ K-U37+/2)[&&Y$Q:]F$,7EQE@&/=B.@Z?G7F^LZ[K%]X?\
M?6D]^Q33YDB@*1JA$;.05R!SD8%;.K:QK.B6/@J.WOGVWL\%O=">%3(X;;D$
M]N,CU]_4 ]!HKB+[7=2T7QW-:ZEJ &D7%A+<6N8578Z8++NQR0 3R>X]JH/K
MOB=(M!TN26X;4;JVEO;J6VM8FD5!]U-K$*",@'OD #K0!Z-17.>#;[7+W2YO
M[>M)89XIV2.26-8VFCZABH/!['M5'4M4U>Q^(5II\E^D6E:A:2_9QY2Y29%R
M><=A\W)QVH [&LM?$&GFXU2#?('TQ0US^[. "NX$>O&>GI7$:!XLUK6?#]E!
M%>)+K#ZK]GE<1( 85&]GV]EV=\9SQUK<T76[V^\=^)M)N3$UK9I"80L8!^9<
MG)[]: -)O&&BIX=@UY[IETV9MB2F)NNXKR,9 R#R:W 0RA@<@C(->,7O_)NM
MG_OC_P!'M7L<&?LL>,9V#&?I0!+17D)\;>+'\&S^*/MM@D5M=^0;5;0_O1D#
MEBW'7L.W6NGM-<UJS\>P:1J%Y!=P7]DUS!'';^5Y3#.%SDDC .2<\XX% ';U
M1T_6+#59KV*SG$KV4YMYQ@C8XZCW_P#K5Q\/BC7(K[0EO7L2=0OI;:>V@7>(
M<9P/-#$;@-N1]?0UA^']3FMO$WBK1-)O+5=8O-6>6%IE)C5 2SYXY(&5QUZG
MM0!ZU17$:IXAUA==.AZ?/&;FTL!/=3"PDF$DIP%0*K?)GDY)(YQVK=\*ZEJ.
MK>';:ZU6R>SOCN66)D*\@D9 /(!ZT :MS<PV=M+<W$@CAB4N[GHH'4TRQO[7
M4[*.\LITGMI,E)$.0V#@_J#7!VLNJ3:YX\6ZOEDMH(=B1%,D*8F9 #G@ $Y&
M.2<YK"\->(-<\.>#O"UQBR?2+FZ^RF,*QF^:23+9Z#H: /8:9++'!"\LKA(T
M4LS,<!0.237G&K>.-=E.I7&B6_F16=T;6& :?-,UP5QO;>ORIC)X/I7H,$@O
M],CDFB:(3PAGC?AEW+R#Z$9H 33]1L]5LDO+"X2XMI,[9$.0<'!_4&K5>.^'
M-6\1^'/A]::I9PV,VC6LTGF0?-YS)YK;FST&/Q]:V==\=ZVVIW]OH-H"M@$#
M*]G-,UP[#)53&"JX']XC.: /2:*\_P!3\9ZE]MT>U62VT1[VQ-RS:E"2HEZ"
M/.Y<=^3ZCBI;N^\0'X@>'+)K^WMXY+!I;F! 6220?? Y&>VT]L$^Q .[HKG_
M !OK5UX>\'W^JV0C-Q!Y>P2+E?FD53D?0FJUYXBOX-=\,P+%!]DU9'\W.=Z,
M$W\'IB@#J:*XG0_$^I:WKCQPW&G>3#>30W%B<B>.-<JK@D_-R,GC^*LZ3XA:
MI.HU'3--%[IXN&A^SQ6\[3,H(&_<$V#C)Q[^H(H ]'HK/UG5X-$T*ZU6X#>5
M;Q&0KCECV7VR2!^-<G+XPUS2;;2=4U>RL3I>I2QIFWD;?;AU!7.1\W<G'TH
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M7@$4<F[S_LAR5W%P,;^N3U].W>NVBCECLTC+H9EC"EPI"EL=<9Z9[9_&IJ*
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MKB&[L_L>KP@;'C8R(XCV#G.-O4GO60_@'56\'Z#H@N[(2:9>_:6EPQ# ,Q
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MX5UN\\2Z7J-Y8:;:7=K<F6YU*SE*FY09^4QX'7@$DG^E&D^'?&N@F71M.O\
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MV63!5BI'RGH1R*OTC*KJ58 J1@@]"* /#[B 6?P$LKJ&2999+E9"3*Q"L)7
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MQ+Y+JYOWDBC,?SR*TBG(&>P';/MF@#M;+Q<EWKMIILFF7ELE] 9[.XDV%)E
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M!.X8R0<' Z#TH ];HKS-[GQ'XCU_2(8=<DTNVU'1%NRMN@;$G&[&>1RPYSG
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MS;X]QVDC.#VXR/QK%UW7O$TOB#Q+IVG7]O9VVE62W2R"VWN?D#[<DXYY&<4
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M$NC+@!U_AVX)]/\ OH>]0-XODCM]8G.F23)8WHLX1;/O\]S@<G VX+ 'T/%
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MMX4AAC2.)!A410 H] !TI] '&)INA>$O",NDZS?0!;\S/,[@)YSL"6VCGH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MLO#<NHP,]Y'#:F9&'S&4!<@\=<UP/AVV\6:C)HWB$:BZVTS+)>+/J+/')&<
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M:=5T>;SHG\I<NP;*Y^G3WSS6E8>%CIWBF^UF#5+H17IWS69"^66Q@'IG\L4
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MJVJ6VBZ7<:C>,PMX%W.44L>N!@#W(KA[;5/%.E:KK.B:CJ5O>31:4^H6UT(
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M4VMEM(GW-/,VWG/J<_D..PH ]"K#TCPM::+K&I:G!=7LDNH-OFCFE#(#G((
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKY1C_NXVYQGYNO6MNN6UWQBVF:Q_9.GZ1<ZK>I;_ &F:.!U'EIG Z]3[#U%
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M.WRMFW!PP).">]=WI\UM<Z;:SV6W[))"CP[5VC80"N!V&,<58H YOPEH&H:
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MC!^?[O4ENE=MHOAO1_#T<B:3816HD^^5R6;TR223UJVVHV27Z6#7<(O)%+)
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MTW^KN8FC)],C@_G7$II%YXA\"0>&GDCLM8TEH4D65-R$1_<;_:5E&<],@C%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %1W#3);R-;QI),%)1'?8&/8
M$X./K@U)2'H: .1\$>/[+QE%,@A%G>Q')MC+O+)Q\P.!D9X/''XU>\.>(+S6
MK[5H+BPAMDL+DVVZ.X,A=@ 3P5''/7].]>?:7H-]<^ M \4Z(2FMV$3 I$H!
MNHED8;#CJ<#WS]<5#9Z_)=>!_%&K1F:Q2[U=/.VG+QQOL#C..N"1G% 'M%5+
M'4K/4A.;.X2=8)3#(R'(#@#(S^-<!JVE67AGQ1X2N=!BDC%W<?9IE21F$L1
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MIS:4\\$L;*@EGSTR0<D#^'_&MWX?2ZS<^$;:ZUR>>6[F+,%FC",BY(7H 3D
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MZ>RG):.>)HI#T)##!_G7'CX>2KX?M-(3Q#>"&TN4N(&,293;T4>V>?K7<44
M<M>>#1J/B&\U*]OVD@N[ V,EL(@ %R#D-DXYR?J:BT+P5<:5-;B[\0ZAJ%K:
MD&VMI#M5"!QG!RV.<#ITXXKKJS;/68KW6+_34M[E'LMF^5X\1ON&?E/?&>:
M*GBW0;CQ-H,NE0WZV:3$>:YA\S<H(..HQR*P7\%^*9=+73'\:D68C$)2+3D1
MM@&,;@V>G%=W10!QUUX!@U#^T([Z[6>"6S2SLD:W&;-%'!4DDDYP<\=*ANO
M=[=:3I*'Q#*FKZ7N6#4$@Q\AXVE-W/  SGM6\?$U@OBI?#K"=;UX3,A:,A&
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MR+)%(I5T89# ]010!P.F>'O#=O9Z+KU@Z_VE';,8?*G!-Y(4)*OU+G)/OVZ
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MJR@\B'?.6&W!'.>23D]3W]A0!P,XGT/4/$OA);B9[G53$^F-)*V2';:1N/\
M=Y/OM/>NG^SR:9\1=#L(+V\:T&E21^3),2IV8 8CNQ[GV%=/<:-8W.LVFK2P
M[KRT1TADR?E##!X_/\S52X\,VMSXJM_$+7-VMW!#Y*1K(!'MR2<C&3G/KZ4
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M"@#D_$WB;7M&_M2^BU*Q865U&JZ?'&)#Y+=&D;JI/X8KMM=_Y%[4O^O67_T
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M2NTDT&\2O)]Y\9Z]A[51;X<Z^NCZEI\>LV++>7PO2[6[!BX(//. ,CH!V]Z
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M/G2"*/>V-SGHH]S5B@#CQI?C+^RYIIM3L+C4I'C'V=D(M?*'WD(P3DY.3C.
M.E2>$O#$^B:EJE_-#:6@O2FVSLW9HH]H.3R!R<]@*ZRB@#C=8\/:Y;^+_P#A
M(O#KV#33VWV>YAOBX7 ((*[1[#\O>L2T^'^O1^';^"6^LTU-M3&IVLD);:)!
MQ\W&0"/0<>]>D7-Q#:6TMS<2K%#$I=W<X"J.I-1V%_::I8Q7MC.L]M+DI(O1
ML'!_4&@#FK70M9U+Q18ZUKRV$7]GPLEO#:.S[G<89B648XZ ?G3_ !]X?U+Q
M)I5G:Z;]F#PW:7#&>0J,*#P,*?6M_4]5L-&LS=ZC=1VUN&"[Y#QD]!5M2&4,
M#D$9!H XB^\&7NK>,]3U"]:V73;O2S8J$8F12=IW$$8X.<<]A59_"WB?4/#M
MMX7U&73!I43)&]U$S^<\,9!0!"NT-\HR<_GW]!JC+K&G0ZM#I4EW$M_.A>.W
MS\S*,G./P/Y4 <[HWAK5-%\;ZI?V[63:3J.QG4[A*A12%"@<8R>YZ"I?B!X?
MU'Q-H$>G:=]F#^>LKM/(5 "YZ84YZUU=% '*?V/K7_">MKFVR^R/IHLR@E;>
M&SOS]W'WN/IVKEO^$$\10^"+#3S]CGO[#5!>J%G.)EY)!9E&#EC^5>J44 <!
M+H_C#3/%-UJVC)ILJ:I'&;J&YE;9#(JXR" "1VS[]!2WOA_Q+<>*/"FHS_9K
MLV <WDWF! "Y^8*H'( Z=SCGUKO))$AC:25U2-!EF8X 'J345G>VNHVJ75E<
M17%N^=LL3!E;!P<$>X- '(:EH^MS?%#3=:@L8GT^VM_L[R&< X;=D[>O&[IW
MJCIFB>,O#=S<:/HJZ>^CRSO+#=W+$O &Y(V@\D?3!/U->B44 <5I>B:S9?$O
M4]6EMXWT^\MHXOM'F@-E$49V^Y!^E9VEZ1XXT"2XTC3X-*GTV2YDECN[@G**
MQSRH.20?8\]\5Z-5>\O[/3HA+>W<%M&6VAYY @)],D]: )HU98D5WWN% 9L8
MW'UQ3J** "BBJ=OJVFW=Y)9VVH6DUU%DR01S*SI@X.5!R,$@4 7**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV-O.FK:JNHRO*621;<0A%P/EP">^:YG4_AT=0\.2Z<-687EU=B[O+V2#>9G
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MI]S&(;H3&..U(*@Q(,_-U.>,<C\;^HV$_B'XH/I-QJ^J6]F=+2XV6MR8QNW
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M)"(Y (LC<HZX/K0!Z;6)J/B:VTWQ'IFBRV\[3:B&,4J@;!M&3DYS^G>N!O\
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MO4'V53(AW!<'=WSU_*@#N:*\H7Q%XDU+X80Z[::A)'>:=.XNRL:'[1&IY/3
MP"/R-=;I&K7&N>*FGL[UVTB&PB+Q;4*M-)\PYZ@A<9'N* .CO+RVT^SEN[N9
M(;>%2[R.<  4ZVN([NVBN(MWER*&7>A4X/J#@C\:X[QI<)=>)?"^@SQ[[6[N
MFGF4GY7\M<JI'<9(..G%2:C?:GK'C"Y\/:;JG]FQ6EFLTDL42N[.S<#YN  ,
M?G0!V54]5U.VT?2[C4;LN+>W3>Y12QQ]!7&W>I^(H[K0/#-SJ,,&K7S3M<WE
MO$&Q$@8J5!&,L!^&*9=7VK6L'BCP[JETM\L6D275O=E CLC*RE6 XSD&@#3G
MUWPE_P 2?7;BTA,VI.J6ERUEND#= "V,KCIU^F<5UU>.:A(TOPX\!,YR1J-N
MO3' W ?H*U]7\6>);N\UD:%!>,EE<FT@$%FLJ,Z8W[R3D<DXQQ@"@#TRBN)A
MU?Q#KFMG3()8])DM;"*>Y#1"5C-(#A1GC:,?6LO5E\3R7W@VVU#48[34)+F8
M3-:KN0[5R"0>"=N1Z<T =S!KFGW.MW6CQ3%KVUC625-APH;ISTST_.M&N+CU
M?5&^)FH:&);983IHGAD\CYT;( W'/S#))Q]/QQ[+Q7X@N-!NK%KB/_A(H=66
MP!$(P5)SNVXZ;5<Y([4 >F5FS:]IMOKMMHLMP5U"Y0O%%Y;?,H!).[&.@/>N
M%U3Q=XAO+S6$T$7$GV"86\*P6(G25@ 7+OGY3SC Z8JQ<&[NOB%X&U&]M_LU
MQ<6=P)+<]8W$1)'T^;Z^M 'HE%><IXLU;29/%=EK5XAOK*'SM/VPJJNK A"/
M[QW% 1_]>NZTD7@TBS_M&027IB4SL%VC>1S@?7B@"Y6>VMZ<NN)HQN!_:#Q&
M80[6^X.^<8_6N6^+%W>6?@LO9W4EN7N8XY#&<%E.>,]1V_E4&O6^KKXY\/16
M%W;&_-E<I)=3P9&W*\[01ST[XY- 'H%%>:-XUUVRT&Z@G$-SJT>K_P!EQS10
M$ACC=OV C)QD #OBM7P;K?B6[U>\T_7+*X,"1B2"]DLS;[NQ4C)&?3Z&@#KI
MK^UM[NWM99T6XN"?*C)^9\#)P/:EM[NUODE^SRQS(CM$^TY 8=5-9.I^&EU'
MQ)INM+J-W;2V0*^7$WRRJ3DJ0>QQSZ\>@J/0M%M_!FC7H?4;B>T5Y+DFX;/E
M+C+ >W4_4F@"71=-\.Z1J-Y9Z1#;07@57N(HS\P!SM)';_\ 5[5N5X=I?B&V
MM/%^D^)SJL,L^L220ZC;>8&^SHS8CXZ@ !>O]WWKT7QGK^J^&WTV^MUM6TAK
MA(KYY(V9XE9@-PP>F,]CSCUH ZRBN1EUW6IKGQ#+ID=I<6MA&D=LK_)OGP&?
M+E@-H!_ESZYMCXXN[36Y[+5[BPN8%TQK\36494 JQ#)DNP/W3R.] '9:AK.G
M:5);I?W<=NUR_EPAS]]N.!^8J]7CWB>^UK6-(\+:MJ)L$M;K5(9(((8V\Q%;
M)7<Y;!XZ@ <UJZ[\0-:AU34X=&M()8]/F$'DO:3RO.P^_AT^5<9Z'Z^U 'H#
MZM8)JL>EM=QB^D3S%@S\Q7GG]#5RO/Y&:\^)OA;5'B> W6ERY@D7#1D L0?^
M^\?A4_Q6O[JS\()%:W!MS>7<=M)(#@A&#$\_AS[9H W)?&GAJ&\^R/K=D)MP
M7;YH(R>G/3O6M9WEOJ%I'=6DR302#*2(<AA6)-HVCZ%X7>*'1([NVMX"&ABC
M0NZX^;EB,D\GKDURFG^)ETGP/H+>%M-8VMU?_8D&H-@AF<\Y4\Y;/(Z4 >FT
M5P\OB/Q+]NL_#R1:6GB"6"2YF=_,-ND8<A<8Y)('X54O/'>KV.AZQY]E:KJV
MCW$$=P/F\F5)&VAD[\\]>GOTH ]#HKFKO7=2M_'$6C);V\EK-8/<1')#F13C
M:3T _#O[5RZ_$'Q1_P ([)KSZ!9"PMY3'/BY.\8?:2!Z9./_ *U 'IM%16MQ
M'>6D-S%GRYHUD7(P<$9%2T %%%% !1110 4444 %%%% !1110 4444 %%%%
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MEXZ\CB@"BOAO2%UXZXMC&-2(P;@$Y/&WIG'3CI4FKZ'INNVR6^IVB7$<;B1
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M^\:V\HQ$?Q\#?G_=&,5,WC'1D\.VVNM-)]@N9!'&_E,26+%>1VY!ZUO Y&:
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MZQ+(SC#/P"/3C-:GB?5_!OBC0;C2[GQ%8QB3#)(LZY1QT/\ ];TKI_[!T?\
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MVVN<X!YY ZULVH,[_#6^D9FG9&C+9X*^5Z?A4S>$?$SS:E*VD>%M^I+LN_\
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M'0],EMK!=&$HEDE,S-*Z+*Q*[-N 2>.I&*]9    Z"@ HHHH **** "BBB@
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MH9-0BM[K3I])#64ETH,1._+;0W!.*Y/5H(X/#/C^VLU4Z3;W=L;15.Z..0R
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M*SJ"-^=W(YQGD$=>M6)[!M F\&ZS8WM^]]JD]O%>O-<O)YRNH)R">V>/3 H
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M1=0L^XY;&,'CO6[J%OK,_P /IH;_ %T66O62-+--%.$'WF*;MO164#!_^N*
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M\<8^]C/2K-% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH9_"^K0Z!I$/]HZBR>8R%4+8D#DDL0.QX]Z[>B@#G_#.@66G65O='1XK'43
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M$6HES'-QC<_J??\ E6Y110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445SF
MN>---T'58=-N+>^GNI8_-1+:W,F5R?\  T ='16?HVMV&OV/VS3I_-AWE#E2
MI5AU!! (-:% !1110 45#=7,5E:RW,[%8HE+.0I. /8<UF>'_%6D>)UN&TFX
M:9+=E5V,;(,D9&-P'H: -FBBH;R[M["SEN[N9(8(E+/(YP% H FHK,T;7K+7
MHIY++SML$GE/YT+1G. >C '&#5;3?%^AZQJ\VEV%\)[N%2SJL;8 ! /S$8/4
M=Z -RBN<7QSX?;4FL5O':19Q;F00N8O-)P%WXVY_&NCH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH+B"6699XV <O)]\DXQSZ8QP/2@"#P1?W6J^$+:>[F9Y]TD1E/+$*[*"?4X
MIG@"[N;WPC;S7ES+<3>;,IDE;<Q D8#)^@K3L-"M=,CABM'FB@AA,2QB0X.2
M26/JV2>:/#^B0>'M*73[>::6-'9@TQ!;YCDC( [F@#4HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
4B@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>a123121ex-1021002.jpg
<TEXT>
begin 644 a123121ex-1021002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM3-Y@C<]0#DC'TH V:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MYP,UWE% '%>!K>[,_B,7^D3VD-Y?//&LZ *Z,,8Q^'/'>J7A/P=?6.HZFFH
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MJ/A;49]1\DQ">T"-!*<$!BQ(VY]"*Y=_!FO6/PTT[2EL'N+[^TQ>211,O[M
M",$D@9Z=* .NG\>S6\444VA30ZE(\F+.>ZCB(C3 W[F(&"3@8SG!QTI]M\0K
M2[\+0ZS%83M+->"QCM=ZY,Q. -W3'?-9_B/2=3B\9V7B6RT-=5@EL_L]Q:2,
M@>/G<",\9[=^_P!:J>+&NYO"%K#=:'':W-WJ<0L[&TD"S18R=VX?*7P#VP,C
M.<4 ;=IX^C.IZK8:GI5Q82Z9"9YW,B.FP $$'()SD8P._:D;QU/:V^GWVI:#
M<VNFWS(L=SYR/LW_ '=Z\%<C\JYG3+<ZJ-;T>ZTW6++5]8M6"7FJ%6\P1@#:
M"JJ !D= >OTJ?4+3Q!XH\,6'A:ZT2[M+J%X1<WLI3R-J Y92#DDXZ <$T =#
M+XYG;Q!>Z-9>';Z[GLYDCE99(P K='Z].A^G7'2F0>/P_AK6-6GTF:WETN?R
M);5Y5+ELJ.O;[WIVJ/P]8:E;?$CQ)?W&G3Q6=Z(U@G8KM;8 O8YYZCCIUQ5'
M4_#9E^*-N+:XVV=]$M[?VXP=S0L I^A)4?@WX 'H,#R26\4DL1BD9 6C)!V$
MCD9'!Q7G7A?2[&'XP>*9([9%:!(VB(_@,B@N1]23^=>@WTMQ#87$MI )[A(V
M:*(MM#L!P,]LUQO@_3M9;Q5KWB#4]--@+Y(42W:57;*J >1QCB@#NJ\GU30=
M$U+XUM9:C9++%=:?YNP%E#2C^(X(_A4UZ-H5]J&H:=YVIZ8=.N1(R^29 ^5'
M1LCUKA-8M?$%O\4T\06.@7=W:06WV<A98T\SAN1ENG(ZCM0 _4[1O 'B70GT
M66<:7J5R+.XLI92\:$D;60'D'D]^WO6GH^HVUE)XMETC0;EKJVO2\\;3<W+G
MDE<].,L!WS[TUM(UCQ=KVF:AK-C_ &7IVFOY\5J9@\DLN>"V. !C/?K[FI_"
M,&J0^)?$DM]I4UK;7EPLT$DCJ=P VX(!.#@ _G0!:M?&2WVCZ'?VM@\K:K<>
M0L(E&8N&))..P0FJ6F:KI>DGQC>VVEW$#65R\UT'?)G;;NW*#T!ZCZY]JB\*
M^#KC1O%>J3W'.G0RO)IB@C;'YW^LXZY 55ZXZ^M5[>/6Q>>+I'\,R2QWS(\,
M4\J;9E4+&RG!ZE<L!T[9H Z?0];N]6?]_I;6L+0)/%,LPD20,3QD <C&2/<5
MMUY[X8T>_P!#U;5+K2=)OK32C9YBTZ\G4E[G<2-A#-A<<9)ZFNVTJXN[O2[>
M>_L_L=TZYDM]X?8?3(ZT 7**** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH CD@BE>
M)Y(U9HFWQDC)4X(R/0X)'XU)110 4444 %%%% !1110 51UC2;;7-+FTZ[,H
M@F #^5(4)&<XR.WM5ZB@#/T;1;'0=/6RT^+RX@Q=B3N9V/5F)Y)/K6A110 4
M444 %9&O>&]/\1Q0+>B59+=R\,T,A1XR1@X(_P \5KT4 86A^%+#0Y//26ZN
M[LH(S<7<QE<#OC/W<GDXK=HHH 1U#HRG.&&#@X/YUA>&_!^C>%%G_LNW='G(
M\QY'+,0.@Y[=?SK>HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HJMJ%ZFG:?<7DD4TJ0H7*0IN=@.P'<U%HVJ1ZUHUIJ4*,D=S&)%5^H!]:
M+U%8>N^)%T>Y@M+?3KO4;V92XM[5<E4'\3$\ 9X]Z?X;\1VWB2PDN((I8)89
M6AGMYAB2)QU#"@#9HHHH **S/$&KG0=%N-3-I+=);C=(D1 8+W//I7,Q?$A?
M[/34KKPYJ\&F.H?[6$5U"GH3@YQ[T =S15;3M0M=5T^"^LIEFMIUW(Z]Q_CV
MJS0 444R:6.WADFF=8XHU+N[' 4 9))H ?161J6M26L>F2V-A+J,-[.D9DMS
ME8XV&?,) .5_SFM>@ HHHH ***QO$?B#_A'[:UD6PN+Z6ZN!;QPV^-Q8JS=_
M930!LT5PL'Q%N+F^N[&+PKJKW=HJM/""FY <8XS[YK4TCQE%J^KV=@EA/#]J
MT_[<LDC#@;@NW'K0!TU%%% !116+X;\0#Q#;WLHLY;5K2\DM'CE8%MR 9/'U
M_2@#:HHHH ***R[W6DCT2[U#3(O[4>WW*(+9P2[@X*Y&<$4 :E%16TKSVL,T
MD30O(BLT;=4)&<'W'2I: "BBB@ HHKDK3QE=ZEJXAT_0+FXTL736LFH"4 *R
M\,P3'*\CG/KZ4 =;14,EU;Q7$,$DR+--GRXRWS/@9.![5CZ%XD;6M6UFP>P>
MU;3)EB)=\F3<"<XQP.,CDY!H WJ*** "BN+O/&^I1>*Y_#MGX;DN;N.+SD8W
M:QJZ9^]DC@?UXK7T'6M2U*\O;34]$?3)K81LO[\2I*'W=&  XV\T ;M%%% !
M1110 45#<W4%E 9KF58HP0NYCQDD #\R*JS7]W%KEM9+ITLEI+$SO>!QMC8=
M%(Z\^M &A1110 45B^(_$2>'+:VN9;*YN899UA=H #Y6XX!/MGCZUM4 %%%%
M !1110 445AZIX@DTSQ#I.EFP>2/469!<^8 L9"DXQC)/'M0!N4444 %%%%
M!1110 445$ES!)<2VZ2HTT04R(#DIG.,^F<&@"6BBB@ HHHH **** "BBB@
MHHHH **** "BN?E\2R1>-H/#K:;+MFMVG2[\P;2!U^7Z\=>N..:Z"@ HHHH
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M-<F[6:68&6*4]61L<?CG-:7A[PGIWAI'-JUQ//(-KW%U+YDA&<XST ^@'04
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MM'\2)K,*QF02W=Q-?S;70NVY&C;Y!CH ,#T]:]6M[.WM;"*QAB"VT40A2/J
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M'PYTG^Q=/THWFI-;V%S]IA)G&0WI]W&.O0 \GGDUIQ^%+"'Q3+X@BFNX[J9
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M$%M1F6XR>8EY&,]SGIZ]*DTSP)I6FZC9ZCY^H7=[9HT<4UU=LY"GC&.!@ D
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M4\P8P=N<=ATH ]0HKR;PQX>UVWN-$\0_VU9QVTP4W+27DLGVD28^7:0%#9.
M >OKBNB^+#21> [BXAFEBEAFB='C<J0=VWM[$T =O17#>4J?$W3V^TS(;S27
M:1/..'<%0" >^,GCTSZUPUU9W6G^ 8_$<&J:DU_%J;)&S7+LL2"5EQM)P<D9
MYZYH ]LNI98+2:6& SRHA9(@P7>0.!D\"LCPAXD'BOP_'JHM3:AW9/+,F_&T
MXZX%<W%&GB[QMXBL]3:?[-I21Q6T44[Q@%PQ9CM(R>!U]*X;PW>ZA/H/AG0+
M81K;7MQ</+YLSQ)*5R50NO(YP<#J<4 >]45Y)JFDZIH'@/Q#8WFL+YB/%=V\
M-K=.[Q(S[2&9@#M)''N#7HFA^'X=!%R(;V_NC<.'<WDYE((&,C/3/4__ *J
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MFW,,Y)X/';U-:OPJL+6S\!V-S$I62Z#/*2Y()#L!@$X''I0!V]%%% !1110
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MGC-=10!R:?#K08]&ETE?MGV*5U=HS<L1E<XQZ#)SQ6@GA33DURVUG?=->VT
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M[["FC*?+CNG&2"%R<DY['W(R<UE6&@WOC ZW<C4(K*YL[YH(GFDE\ZSC3&
M'"@8!!)'4&O0M.\(VT.H:?K-Y+<2ZQ!9QV\LPG;;(0H!)&><G)QTYSC-0WWP
MZ\-ZCK;:K/9OYTC;Y8TD*QRMZLHZ_P!>^<F@#D/L5YXW\0:O82WEK-'8P0)
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MU** QH#<-AAC&,$X_IDYZ\T ><-;_P!CW&M> %B?=J=U%)8RL6)\IB-Q_P"
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M6/=GY01@X!&<'U-:GBG3K7P9H>K3Z+J=S +R:V\Z&*;+6T98Y9.<C=R ?;%
M'J-%<%J6AZ=X5AU/6=$OFMIAI4GEV:S;D<J"1+@DDD<?Y-9'ASP_=07OA_78
M-6T^VBE18YO*EE<WN[DA@QQNS^OT% 'JE%>1>'I%TCQ98QZ[9R2W5W=R-9ZW
M;W!,5WOS@, 2,'(P!TXX]5\/.='\5V$.O6$DEU=74ALM9MKDM'<[L\/@X(Y_
MEQQ0!Z1HUYJ=V;[^TM/6T$5T\=OA]WFQ#H_XUJ5Y?X3TH:_H7C'3)YI7+ZG-
M'%))(S,C #8<YR<$ ]><55\,NNOP:/:2QXN/#,<[WBD, )0V(AD8SRA8]?NC
MWH ]:HKQ31='N]9T&R\2/K6GVL\=V;JYOWED,H(8DHPSMZ8PO<8]:]3\3%9O
M!VK,CMM:QE=61BI^X2.10!L45XO9:7!I_@_PKXCM)[B/5I+R&,N9V;S%9F4J
M%)(QCT%.MM*U'Q;:ZCJJZI86MY;ZD[?;))I%D@5#A5QG:%QC'^- 'LU9NFW6
MISZAJ45]8I;VT,H6TE63<9DQR2.W/\\=J\[?1;/Q)\5-1L[Z>>6WDTF.8-#,
M\8+?NP& SP.<XY%2WMU=Z4?B-+I\LXFA%L8V+L[)F/YB"3G@$G/;'M0!ZC6=
MKVHSZ3H-[J-O;+<R6T32^4TFP$ 9/.#T&3^%>;:KI<&@^'/"NNZ)'+'J<D]L
MC,DC-Y_F)E@PS\V2/U-2"PL/$GA_QEJFI9N=1MI;J-"9&'DI&I\L* < <?C0
M!Z9IEX=0TFSO2FPW$"2E <[=R@XS^-6J\IU>'4'T?PWJ$5C'K%C;Z6HN],67
M#*"H E7N3P1G'&#Z\=]X5GLKGPMITNG>>+,P@1"X;<X4<<G)]* -<NH<*6 9
MLX&>3BN?\2>(;C2KK3M,TZVBN-3U)G6W$TFR--B[B6(Y^@'6N(M-,T_7O!_B
M#7;J:9]<MYKDFZ,C*]N\9RBIC  VA.GK2&S@\1:K\/;K6+837-[:3K<;V/[Q
M4B+(3SW)+?C0!Z7H\^HW.F0R:K9I:7N,21)('7/J".QZX[5<61&=D5U++]X
M\CZUA>+[FYTGP3J<^FH1-!:D1[7VE!T+ G^Z,GWQ7#ZUIUCHWA;1/$GAY774
M6GMR9(9F+7>[[R,23NR?7- 'J]%>-7^CZ?JEW\0KV0W3-IY+VX,[*$DV,6.
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MGA339],$HLS"%C$IRXV_*03W.0>:\KL+.RM_ 'CV4PD$7TD*E3R &78/H&-
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M7QS$^H,5@O['R;1R/E4@+D9^JM_WT*]#N+FVM_+6XFAC,C!8UD<+O;L!GJ:
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M<\_,3SR:M6FE6-A-=S6ULD<EW)YDY ^^V,9/^?6K896&58$>QH5U;[K _0T
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M(LH/7*L2/8>@X%-\(:]-XC\,VFJW,$=O)<;\1H^X8#$9Y^E;A95(!8#/3)H
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M2\0ZKIJZ?>WWEHEOY@=DB51C<1QDG/8$8%=3N7;NW#;ZYH!!S@@XXH YR]\
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M"= TR]CO(+-WN(CF-YYWE,9]5W$X_P#U5T#.J_>8#ZFC<N =PYZ<]: .;O?
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MI&95^\P'U-4=5UFRT:VBGO)=J33)!&!R6=C@ ?S^@- %^B@$$9'(HH ****
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M/$-M/KFG1W4-WJAELM<M9-SEVR DG\6,=NGUP:[KQUH(\1>$+ZR5-UP$\V#
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M!%N!?(Q$K3&0!]Q/WN<]?P]_8ZYQ/ GAV/4!>)88(;S!#YC>4'SG=LSMS^%
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M-LXK.S@2"WB&$C08"CK5B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** .9L_$EW/\0[_P .2P0"V@LUN8I5)WG)4$'M_$>GI70I<P23R0)/
M&TT>-\:N"RYZ9':O,=7NI['XD>*;JU)$\/AUGC(ZAAL(JOX:\.Z>4\.ZY'XC
MM(Y@\>X0P[);AF(!C<[\L2>.1ZT >MT5XQ?K92:;-K6DQQF-==C;^T+BXS.Y
M,G.P+P$&1@$\C)]*U?$<+Z%K.IZIJNFPZMH5Y<122W43 36A7: OJ1P.F,T
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M;#!;>%K2VMM2.HPP%X4N2NW<%<C ]AC /?%;U !1110 4444 %%%% !1110
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M78&8G!7T8 X8?7-:PN8&D$:S1F0C<%##)'KBA;JW:8PK/$91U0.-WY4 >?\
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ML]F_[7!LSC=Y@QGTI[W,$84O/&H<94LX&X>HH J:3H>FZ&DZ:;:K;K<2F:0
MDY8_4\?3I5;5_"NB:[=0W.I:?'//#C:^2IP.QP1D>QXJ/Q1K,VF>$M1U33'M
MY9K>/<I8[DZC/0]<&K&F:Q'-X7T_5M1F@MA/:132N[A$4L@)Y)X'- %>?P9X
M<N-.33WTFW%HD_VA8D!0>9C&>,=N/>FIX(\-11W<<>CVRI=H$F500&4$$#VY
M /'<9K8%Y:M;BX%S"83TD$@VG\>E/-Q"!&3-&/,^Y\P^;Z>M &%=>!O#=[I=
MMIL^EQ-;6W^J&Y@R^OS [N>_/-7'\,Z*]C;67]G0+:VLPN(8D7:J2 Y##'U-
M7OMMID#[5#DG:!Y@Y/I]:>EQ#)*T231M(OWD# D?44 25CZQX6T;7KNUNM3L
M_/EM3F$F1E"\@] 0#R.]: O[-KHVHNX#< 9,(D&_\NO8TZ2[MH6*R7$2$'!#
M.!B@!MW8VM_:M:WEO'/ V,QR*&4XZ<&J.L^&='U^-$U.QCG,8PCY*N@R#@,I
M!'3UJ34-?TW2[^QLKRY2*>]9A"">#@9))[#H/J:3Q#?76F^'-0O[%(7GMX&F
M42D[2%&3T]@: (6\)Z$V@'0SIT7]G-@F(9!+?WMV<[N.N<U;&C:=_9<>F&SA
M:QC"A8&7<HVG(X/N,U5\.:O_ &IH.F7%U+;B\N;:.5XXW!Y*@\#J/7';WZUH
M27]G#<I;2W<"3O\ =B:0!F^@SD]1^= "_8K;[=]N\B/[5Y?E>=M^;9G.W/IG
MFL^+PSH\.ORZY'9@:C*NUYM[<CZ9QV]*T9+NVB<I)<1(PY(9P"*&O+9+A;=[
MB%9VZ1EP&/X=>XH Q)? OAF:QGLVTB 03R^:ZKE3NYY!!R.IX'K5EO"NB/J-
MM?MI\9N;:(PQ/D\)C&,9P>"1SZUIM<VZEPT\0,>-^7'RY]?2D^U6^Q'^T1;7
MX0[QAOIZT 9&D>#M"T*[6ZT^S*3*AC1GF>38I.2%#$[<GTJ)? OAI=-NM/&E
M1?9KJ022KN;)89P0<Y&,G&,8R:WHIX9U+0RI(H."48$?I7(^*/%USI>LZ#:Z
M=)8S6][?);7)W[Y%W$#  Z<'.3[<4 7CX!\*Y<KHMLA>(Q-L!7Y3UZ'K[]:L
M_P#"(:%LTQ/[/7&EG=9_.W[L]?7GD \YYK5:[MDF\EKB)9<@;"X#9/3BB2[M
MHF99+B)&7&X,X!&?6@#%N? _AJ\U.74+C2+>2XESYA.=KG.<E<[2<]\9J>3P
MIH<ESI]P=-A$FGC%KLRHC^@''OSWYK7:1$C,C.JH!DL3@8^M1K>6SL56YA+!
M=Q <9QUS]* ,D>$-!#:B?[.0_P!I#%UEF(D[^O'//&.:XWQCX4NCJ%@MIX9B
MU?1[6S-M#:+=&)HF+ EL]>@ ZFO2H[B&6,R1S1NB]65@0/QIB7EK(KLES"RH
M,L5<$*/?TH YCP+X=N-!AO6DL(M.BN"ACLX[II_+*@@DLW<Y' ]*V[_P]I.I
MZC;7][80SW5M_JI'&2O.1]>>>:L_VG8?8OMOVZV^R''[_P U=G/ ^;.*I^)K
MZ^TSPW?ZAIRV[3VT+38GSM*J,MT[X!Q[T 5_^$+\.C3[VQ72XEMKUP]PBDC>
M0<CD'(Q[>M27OA'0-1ALXKO2[>6.S 6 ,/N*!C;[CV/%/\.ZJ^I:'I\U[);K
M?3P+))%$XZD9X&?3FKTFHV,-W':2WMNES*<1PM*H=_HN<GJ* )+6U@LK6.VM
M84A@B7:D:+A5'H!4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% '!2Z9IEQ\9G\^RM96;1A,1)&K?O1, &Y_B"@#/7%<]H&DZ7K
MGP[UR[UJWM_[62:X:XN9 !+#(!E?F/( XXSBO2_^$>TG^V_[9^Q1_P!H_P#/
MQD[ON[?7TXJ"Z\(Z!>W4MS<:5;O+,0TIP0)".[ <'\: /,XM.B\1^*_"$&MQ
M-/\ :M%+7&\E6D(#8+$8)/ YI6T*'Q!J'B6ROM5TS3A:3K!&+FW$DD$"*-AC
M=G7:N!S@>N2<UZE+X>TJ;58=4>R3[;" L<P)!4#H!@]/:H-1\(^'M6O3>7^D
M6L]R<;I&3EL=,XZ^G- '!ZJUM%KGAN2\C'B.Q&EO&%;;N8@@>=Y;G'/ SG\>
M.<ZXT=]!\"Z!:7,444%YK2-J $H9-A<X5B#C&T#(Z<5O^*_#FI7OBEKAO"]O
MK>F"R6WMXQ=K;F$Y))YYSZ8[8K6\,>#;:VT*\L=2TN"*TNYA*NG-,;A8 % Q
MO/4Y!/'3- &7<Z=:Z1\6-'@TBUCM;:^LIA?1VR[49 IVD@<+SMYX_6N.NVMA
M\&KZWMHRBPZTT3G=G?R"#G_=*C\*]BM/#6C6(F^S:?"AGC,4C<EF0_P[CSCV
MJNG@WP['ILNG)I4 LY9!(\/.TL.AZT <C9:98Z!\8;2RTB%;:UGT<O(B$D.=
M[<G/7[H_*N8TCP\OB#1])L5L+874&J,USJIDC/VF(,V2#NWN2>!QC@<\UZQ<
M>'+!)3J%G9QKJD-L8;:=B24PI51SVY[UYO:^!+ZZTNVTZ7P5;Z?=I&JG5O[2
M!*N!@R;$Y)ZG;G&: /6TO;62[DM$N86N8U#/"L@+J#T)7J!7&>.K:PF\4>$C
MJ$5N\)NI8W^T %""G0@\=<?C6];^&H8/&=UXC611)/:+;&)(\9P02S-GYCPH
MZ#@=ZN:MH6EZ[#'#JEE%=)&VY!(/NGIQ0!YR-%TS6/B3XR2_M([A(;6%H@W1
M3Y2\C%9-O))=^!? 5U/.N8=82+#-C*B0@<=#@*.:]63PQHL=S<W,>G0I-<Q>
M3,R9&], 8./8"JY\%^'#;06QTF#R;=S)$F3A&.,D<^PH X+Q5:G2O$FJ:W>:
M;::WHTLT27#J^)[%E"]"!D#D' _'%>L":/R/.+@1;=^YN !C.363=>%-"O;Q
M[NYTR"2:1P[E@<.PQ@D=#T'45IW5I;WMG+:7,0DMY5*/&>C+Z4 >676C^(O&
M5GK=Y!;Z9-8ZI($M9+F9Q)%%$Q"%0H(&3ENO.X^M7(]8F\3?!W4(A<QVFH6<
M0MKEI7VX9"N<^FY1CZG%>AZ?IMGI5BEE8P+!;)G;&N<#)R:Y3Q'X.B@\+7]E
MX:TFU\Z[>/SX6; E16R1DG /O[^N* .>\+Z!;ZEXTT[58-(2QL[334$BGRUW
MW /WP$8YZ@[O:LK3='TV#X>:]KEC 'U2SN;F..568F)20IP <8"'/?&<UT.B
M>$Y6\0V=Z/"*^'A;N'>>'5/,,B@'Y-B\8)QG/;BNVTWPYH^D6T]M8:?##!<?
MZV,#*OQCD'VH \XT?0;*SDTG7-/\0V/G+:/':6UI8K%)<-Y;</AV+,".<@\C
M%9/A_1+#4=%TS6KGQ+9VES!=^;+BS'VMIM^2A?>2Q/;Y>G:O5],\(^']'NOM
M.GZ3:P3@8$@3++]">GX4D7@_P[!J8U*+1[1;P/Y@E"=&Z[@.@.>: .#U+P_H
MUYK7Q!GGMDFFMK5)H2SD[',+,S 9Z[@/I65:Z-I]IX8\#ZS;;8M1FU*%)9 Y
MWR@N01G/08Z>]>JMX7T1IKZ8Z=%YE^-MTW.91G.#SZU&?!^@&UM;4Z9%Y%JY
MD@3+8C8D$D<\<C- 'E\6DKXH&O-K&N:9IE_'J#F7SX ]Q;JC#;MD,@P@Q@8&
M*W+O2=*UOQ_X<BOIO[223126:4E?- ^ZY7J,Y8__ *J[2\\(>'M0U#[?=Z1:
MRW1(8R,G+$=">Q_&K4VA:9/JT&J26<9OH$\N*<9#(O/ QV^8_G0!XPXMY/ F
MF6GE#R+3Q.;=@_S+LY.#GMA@.:]OWVECIN^,1Q6<$6X")?E5 .P'; [5GKX3
MT%-)ETL:7!]AEE\YX2"07X^;USP*TX[2WBLULXX(UMEC\I8@HVA,8VX],<4
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MAI5K<7"@#S'3D@=,^OXT .\.+;GP[IP@NGO8HX@B7,JD-)CC=SSSCKW%>?\
MBRV-GKVO:P]I9:[IABC@U"T9]L]HNT$%3C('?CZ]LCU2**.&)8HD6.-!M5%&
M H] *R;SPIH6H7<MU=Z9!+-+M,C,#\^.FX9P>G>@"674+1O#+:C(6CLVM/..
M3@JA3/YXKS#3%TVVUGP-=Z<+>QBD\Y3"LVZ5T920TC #)Z<=B>IKU]H8F@,#
M1H8BNPQE1MV],8]*P8_ OA:%D9-"L@R2"13Y?(8>_I[=* .9\%1_9],UUM$M
MM,.KKJMP@68[#Y8<<$J"V .@Z5>\2Z-J_B'P7J,6LVFGI?0#S[,VK-)RHSCY
M@.3@K^-=-9^'M(T_4Y]1M-.@AO)\^9,BX+9.3^9YK3(!&",@T >)_P!O&WU7
M3_'EMI;-:36PTZ:)5*EYQ']X<8V[L)G_ &3Q6EXIT"/0O#'@ZV:-/M,6J1>8
MR@ ;WRSX XQD#\A7IJZ/IJ6L=JMC;K;Q2^='$(P%1]V[<!V.>:CU70M,UOR?
M[2LTN?(8M'O)^4GN,'VH Y2Q7R_C;JA9E^?24*@,"?O(.?3H:;\)B#H>LD$$
M'6)\$?[J5U3>'-'?59=4:PB-]*A1YSG<05VD>W'%/TG0=+T**2/2[..U24AG
M5,X)'?F@#S35K:TUGXB^([/6=4M;-4M8X[7[="C*J% 6:,N1@@Y.1[TZYTC2
M;EO FGO>#5+6.:XM_/.4695!Z#/*Y  ()SCJ:]$U7PQHFN2I+J>F6US*@P'=
M/FQZ9'.*6?PUHEPUD9=,MC]A_P"/90F%BY!X XZ@4 >=0>"O#TNL>-K-;:(+
M:PH;4LQ(MR\18D#/9L?EBLQK2UU.+X:"^47"W"2PS>8Q.]5*X4_3)KU0^$]!
M,M[+_9< DO05N6 (,@)R0?J:Y/Q/X.>;6?#%OIFAB31M.DD>=$F1  [*2 &8
M'(*D_C0!SU_9QZ:_Q"L-+58](ALX?W2/E$E(&<<\'[V?ISVK0M4MKG6O =KK
M$4,FG/HB_9TG7<CSF-<@@C:3C&,]\=\5Z"OAK1ETF;2UT^$64S;I8@#ASG.2
M>I.12S>&]&N-.M]/FTZ"2UML>0C+GRL?W3U'3L: .%L?#]K?>*?%WAVUCB&B
M2P1NZ(1M@N3R-H!&,$$X'H.E,\#R2>(KO2[._L@K>%XW@D+H=K3?<3&>X5<\
M\@X/T[.[L9O#NAS#PMHUO+<M('\@R",.2?F8L>IQZG_"CPOH]QIMG=7%_P"7
M_:&H7#75R(P,(6  C![A0 ,_7UH \BM]%TN7X:^*=2:TB-]:ZBZ0RCAHUW1X
M ]!R:V7TV#2/$G@N?1+=(;N\L97D*,<32>2"-W//)KT2/P7X<BLY[1-)@6"X
M96E09^<CIGGWJ=?"^B)-8S+IT*R6"A;4C(\H YXY]30!Y)HMAH]UHFFZK?>)
MK.PU.VO'N;E%MT:Z9]Y^7@[SGL,'K6UJF@Z-?ZO\0;J>TCEGM;598"Q/R.;<
ML6QGKN%=\OA#PZNIG4AHUG]K+[_,\L?>_O8Z9[Y]>:?_ ,(OH?VB]G.F0&6^
M4I<N5R9 >2#0!YAN@NS\,Y[Y8)O-2:.9YD5@RKLP#GTYQZ5Z=XK*CP=K1R /
ML$__ *+--D\):!+IEOITFE6SV=NQ>&)ER$).3CZDUI7=C;7]E)974*RVTB['
MC/0CTH \:M;*RTS1OA]JEI:PQW]Q>QQRR@?-(I8@Y]>O\JK1:38Z_!JQU?Q1
M8Z9?IJ4QN%NK6)IOE(QL<L' &",#CMCU]<;PEH#6]E VEP-%8L6MD8$B,D@G
M'/J!1=>$/#M[J'V^YT:SENB=S.T0^8^I'0GW- '"P:-I>L_%O48;^VCO(_[+
MBE3S1@N_R?,1QSBN=L=/L]?T^XO=7\36&DZBE_+-=1O;Q?: P(("/D/CT R,
MU[(F@:4FM-K"V,7]HL,&XYW8QC^7%03^$_#]UJAU.?2+26\)#&5X\Y([D=":
M .(1+=/%WC9+F>(B\TR*1%N,(6'ED<JV.<XSQQFL&VBT^^\%> +>Y"R@ZDT4
M@\P;0ID.Y6'7D%?\D5ZQJ'A?0M6O4O+_ $JTN+A,8DDC!)QT!]?QS3)?">@3
M6]O;MI-J(;>0RQ1HFT(QQD@#'/ _*@#S6^,GAZ_\?Z9H4/V:".R@E1(5)*95
M0Y'IPS'/;KVIVMV?A^W3P'=:1;V<3/?VY=XMN\@E2=Y'4Y]>^:]/AT#2H+^Z
MOH["$75VI6>0C)D4]0<]O:J$'@3PM;RK+%H5F'5@X)3."/K0!Y:-,LM=CU>?
M6O$6GZ/J*:E,\\<L,;SIM(VB-]P; P0,9SQ73?\ ".Z!XA^(<XO(3=QS:-!/
MF5W1F;.T,1D$':%XKL[KPCX>O=2_M"YT>TENR=QD:,'<?4CH3]:L#P_I2ZU_
M;"V,0U'&WSQG=C;MQZ=.* ,CX@6\7_"N]7AV#RTMOE7TVD$?E@5Y_?:#I$5M
M\.BMC GVX1"[8#!F#)&3N/?J?SKV#4-/M-4L9+*^A6:VEQOC;HV#G^8K/?PG
MH4B62OIL3+8_\>P)/[KG/'/K0!YPYT_2-2^(=K);NFE1QP'[+:MY7+ #@C[H
M)//;&>#TK0\/6NF_\)Y]DECTM([S0@CVELX=/O@!"V?G;8!SZ?G7</X5T.2:
M]FDTV%Y+Y=MR6R?-&0>>?4 _A55O"NDZ3 ;S1="L1J5M&YM?E"Y8@\%O?ID]
M* ."TS2_)U&3X=SPL\":D+_>4RCV@&[!.<@E@J^G)_'T;Q: /!>N # &G7'_
M *+:L[POIFK-J=]K^O6\%K?W2) MM"P<1QIGJV3DDGMZ"NHDC26-HY$5T<%6
M5AD$'J"* /&+?1["R\)>"M6TVVBCUB?4+=#*'(,@);<&P>G !]JK6FGZ?K]C
MJ5SKGB2TTO5DU"1YHY+>'S496Z*3^\(P,  _@>_K6G^%="TJ=)[+3+>*5,[&
M"Y*9Z[<_=S[4DWA+P]<:G_:,VCV<EV3N,C1 Y/J1T)]SS0!JVY!MHB'9P4!W
ML,%N.IJ2BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*,/B-GRX0<$>K=P!GH* .G\9>*Y]#%@-,EL9I)+V.WN8Y&W/&K]"%!&.G?\
M*NOZ5XA=VVC?\*W\+:A9I9)<C48/M4P $K-\VX,W4\\\]AGIBO7=?EMHO#FI
M2W;2BU6UD,I@.'V;3G:?7'2@"U%?V<[ND5W!(R LRI("5 )!)].01^%5=%U_
M3?$%O+/IER)XXI6B8@8Y']/0UYUHBV</BKP6UK%9VUO-8W 6*)E9RNWCS&'#
M,?I][=6M\(8XE\+W3!$$OVZ520!NQ\O'TH [FZOK2Q56N[J"W5CA3-($!/MF
MI'N((U1GFC57^X2P&[C/'KQS7GOBRYTL^-UMI$B:^_LR3+ZA*/LT2'(^5#U<
MGCJ.*P+>VL-5\-?#I+H1W ^UM"T;G(*\[@1W&54?IWH ]<34+*2T:[2\MVME
MZS"52@_X%G%.^VV@CAD^TP[)R!$WF#$A/3:>_P"%><^&]'L+WQ!X[\.-;QII
MKR18AC4 (6#<KZ8(!'8$53\&BYU;4-+\.ZA:*I\,22O<'RP%9Q\L6#^+-[[<
M\T >EZQJ]GH6ES:C?R^7;PC)/<GL .Y-5[Z\OUU32A926!L)V87#2O\ O&^7
M*^7S@]#GKQ6)\5$1_ASJA=58KY3*2,X/FH,C\"?SK*\;P6D7B/P,]FD2*NH!
M$\G 4(2G  XQ0!W]Q>VMI&9+FYAA13@M)(% _$T?;;47*6YN8?/==R1>8-S#
MU ZD5Y>/#^EWOC/Q[-=6MM,L-NIC60;BCO%N9UST.1U'(JAH]CI\/@GP3K#0
M01WQU>-)+O 5V3S)!AFZD84#GH!0!Z])?6<-REM+=0)._*1-( S?0=35@D 9
M)P*\6BT?1]?;Q&VM:Y;V5U'J4ID,L,?G*BGY2KM\V,#HOI7JTL<-SX7>(N\\
M$MD5W2 JTBE.I&!@D=>!0!<:^M%N([=KJ 329V1F0;F^@ZF@WMJ'F0W,(:!=
MTJF09C'7+>@^M>)66D:./@JNJ-;PIJRS%H+A /.,GG;5 /4C QCL,FNATJ2S
MM_B9KRZLUM$MQI< E6XVJLC%$W @\$DYS0!Z<+JW:..19XC'*,QL'&'XSP>_
M%5WUC3(X(YWU&T6&3.R1IU"OCK@YYKRFWMM+U'P1X"^UK#-&NH""3>W !WEE
M/XJM:OB3PU'HFH"YT"QTZZ@MM.:*ZTBX;!\EG9C("3UR#SU^7 H ](6[MGG$
M"W$33%/,$8<%BG]['I[T)=VTL+S1W$3Q(2'=7!52.N3VQ7FEE>Z<_CKPUKT1
MBL=.NM'>*..8[-A1CP2>/X@ >^*Q[.\TBP\,^)8;KRKR&;7]L,<4FV.0DAEW
M'& GRG/8@$4 >PP7UG=0-/;W4$L*]9(Y RC\11'?V<TRPQ7<#RLGF!%D!8K_
M 'L9Z>]>.(T$MY\0K=GLO+?34F$=FW[DNL8.5 ZX;OZ_6K^BZ9I>G6GP^OX+
M>"WN9Y2LLR_*TFZ-N&/?G&,_04 >E:?KVG:I?7MG:7"R3V4GERKGG. 3CU S
MC/K3=3\0Z;I%]865Y<!+B^D\N!.Y/J?0=!^-<_X.AL8?$WBL1QVR7)U#HJJ'
MVE%/UQDD_7-4O'JP_P#";^"6F";#=2ABX&#]S .: .WNM2L+%U2[O;:W9AE5
MEE5"1[9-6@01D'(-><Z%9V&K^*O&5MKT%O<7'GJJ+,-V+?!V;<].QX[_ (5K
M?#(S'P-:+(\DD:R2+ [K@M$&.T_3% %9_$7B75O$VK6&@KI*0::RQNMZ)!)*
MV,DC&,#L#C'?)S6_X=U:YO?#%OJ.L)%9W.'%PN=J(5=E/4\#Y?6N2U70])\4
MWM[K6BZD^C^(+*9X99!*%P8SM.]0>A Z^G7/2N;NO$%YXCTOP;-K4L-O:3W$
MZ7$\L2O&[K\J,R-\I'/<8!R>* /9H+JWN8!/;SQ2Q'I)&X93^(JJ^N:4EG<7
M?]HVK6]LNZ9TE#!![XKRK6[&R\/Z'<Q:5JZ7EI=:I;/J*0HJPPQ'=D83Y0"0
MH(]  >M;>O6OA(VNN76D3V[7\^B2CR+0@Q>6HX8A1@-]T#)SQP.* .INM<GO
M]$T_4O#T]B\=S/&&:\8HOEDX8#OOS@8K7N]1L; H+R\M[??G;YTJINQUQDUY
M'K:VS?"'PI)&L19;NW!90,@X;=^/'/TK?LK.PU3XG^);7Q!9VUTZPP&S6X0.
MJQ8.[;NZ$DC..^: /01<P&%)A/&8I,%'#C:V>F#WS3;:]M+S?]ENH9]AP_E2
M!MI]#CI7BLMA"^CVMC,5?2XO%?V>Q1I"P>#>589/5>G3U-=9X8M+;3/BWXCL
MK&&.VM?LD+^1$-J;L*<[1QW/YF@#K=>N-;1(+?0K6WDN)22T]T3Y4*C'4#DD
MYX ]">U4O!NO:AK=KJ$>J6T45W87CVDCP9\J1EZE<\_Y'T&OJGV6>V-C<7[6
MCW(*(T<_E2G_ '#US]*XOP)')H.I>)M/-XTNAV,X:.ZN) 2KE0T@+=..,\=?
MK0!U?BC5+O1?#E[J-E;13RV\32;9'V@  DGISCTXSZBG^'-2EUCPWIVHSHB2
MW,"2.J= 2.<52\7SQ7/@#6)X94DBDL)&1T.0P*G!!I? O_(B:)_UYQ_RH I:
MAXGN]/\ B'9:)*;2/39[-[AY7R'4KNZDG 'R^E=.+NV:U^U"XB-OMW>:'&S'
MKGIBO/O$5A9ZE\9-#MKZVBN8#I[L8I5#*2"^,@\&N+>8Q:%<VKRI;Z/%XI9)
ML1*R1IU *=&7CIR..G:@#W*+4+*>V>YAO+>2!,EY4E4JN.N2#@4B:E8R+(R7
MMLRQH'<K*I"J1D$\\ CG->;/HV@:=IOBAK36;>[DNM+=Y+:VC2.%-B_(V(_E
M!R>,]<GWK,U+2=(L?"7@^Z@BM[6*^:V6_N1"LBM\F?G#94C<3G/IST& #U^V
MO;2]B,MK<PSQJ<%XI P!],BF6^IV%W,T-M?6TTJ\E(Y59A^ ->4ZQI6GZ%X7
M\5'1-86]N;JWB>:"UB18HT\P*2 @VJ=I;C(XR<5>U^&PM[/P1>Z'!:B]-Y"L
M;6RKEHRAW\#J/7T_&@#2O/%6N:IXMU'1?#]UI<+6+1 += EK@GEP"&_A'4 9
MX/(KT"N \++"/B?XNC$$ $9@=&$8W*2F#@]0*[:QU"SU*W^T6-S%<0[BOF1,
M&&1U&10!9KD?%?C>+PSK>DV4L8,%R_\ I4I!/DH>%/'J<_@IKK'=8T9W8*BC
M)9C@ >M>52Z1XC\;6.KW]F^C'3=6?9#]H$GFK'$Q5"I P.03SZ_A0!Z/K.M6
M.@Z5+J6H2^7;1@9*C<23T  ZDU;M[B&[MX[BWD22*095T(((^HKR#4]:D\3_
M  2N#*5DOK"2..X^8$_*X ?UY'ZYKUC2WM9-,@:R:%H-HP82"N>_3CK0!SVK
M>,[=O#NMW>@SVUS>Z9D-')DCY2-QP#DC&>?45KZ%K46IZ1IDL]Q;B^NK.*X>
M!' /S*"2%SG&<UYKIYMSH7Q)M]EKYB75T51L(VW+=QS@$#';/%-&G66FW?PS
MGL+2"">YBWS21H%:5C'&?F/4\L>OJ: /63J%DMX+,WEN+H](3*N_IG[N<]*?
M=74-E:375PXCAA0R2.>R@9)KQ31=+TO6-#N;K7=<M]/U.WO9)+D>3&+E)%;/
M#GYV^@)].U>N:X8[KPIJ+-'F.2RD;9(O8H3R* 'Z?K^F:EH\>JPW<2VCJ"7D
M<+L)QPW/!Y''O5E-0LI;5KJ.\MWMESNF652@QUR<XKR"6:TD\->!;;S[.#2I
M&*W<IB21%G\O $BD8SR>OU[9J?6=%T72O!GBN/3]6COWE6&>2**-!%"3)@%=
MHV@]> >@Z4 >L+J%DP8K>6Y"N(SB5>&/\/7K[4W^U-/,4LHOK;RXFVR/YRX0
M^A.>#7E'C#0=(L_A]H$UM86\4EW=6AF=$ +YB(//;..<=^>M:<.@Z*/C%/I_
M]E6'V(:2)/LYMT\O?O'S;<8S@GGK0!VFN7UY_9=M=:+>:<NZXC#2W,G[MHR<
M'!!Z]/UK4FO;2V+">ZAB*KO8/(%POJ<]J\/BVS?"*U,CH%M-<'EY(&U2W('_
M 'T3_P#JKJ[O2=,U7XV2Q7UG;W,1TD2E9%#*S9"AB.YVG^7H* /1&O[-+,7C
M7< M3@B8R#9UQ][.*I7WB31]/T>?59K^!K.$X:2)P_S=E&.IY'%>9V]QI\/@
M30+:8!RNL2) KW&R&-EE<KYO7*@8X]Q65JMS VA_$.TB-HR+=6T\1MP I!D
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MVS0!TFH>&]&U:^@O;_3;>YN8!B-Y%S@?3H?QZ56/@SPWMMU&CVJK;2F6(*N
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M44GA7P_*9VDT6Q=KAMTI:!27.<Y)Q0!BZ==V[?%#5U6>,EM-MV4!AR S9/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM)+N!+E_NPM( Y^@SFIV8*I9B H&23T% "T50&MZ2T32C5+(QJ0&<7"8!.<
MG/L?RJ2VU33[UREK?VL[@9*Q3*Q _ T 6Z*H2:YI,,KQ2ZI9)(A*LK7" J1U
M!&:>-7TUK5KD:A:&W5MAE$R[ WIG.,T 7**C:>%+<W#2QB$+O,A8!0OKGIBH
M$U33Y+5[I+ZV:W0X>59E**?<YP* +=%5+;5=.O93%:W]K/(!N*13*QQZX!JQ
M+-% H:61(U+!078 $DX ^I- #Z*9--%;PM+/*D42C+.[!0/J35'_ (2#1?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4 ]* %HI"P498@#U-<^-?O!X];0);.)+4V)NH[CS,L^&"GCMR2._3- '0T4
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MH=U1=SL%'J3B@!U% ((!!R#WIJNKYVL&P<'!S@T .HI-R[]FX;L9QGG%)YB
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M2Z(9<C[N0#TY[GJ:[72="T_1GO)+*W\I[V8SS_,6RYZ]>U &E7 ^./\ D>O
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MU/JWAKP#!=33%6U)[=F68AF3<%Z@Y'RDCZ4 >X"6,D .I)Z<]:4,K$@,"1U
M/2O+_$GAG3O!5YX>\0:=;.+/3IS%=#<SL(W)^;GL"S?F*ZOP591K87>L>6%F
MU>Y>Z)VD'RR3Y8.?]G!_$T =(SHGWV5<^IQ65XEU^#PWX?N=6G4R)$HVHI^^
MQ. ,_4UR@L;#Q)\2M>T_78#=1VMO#]BAE.$5&7YV4=SN/7M^%<EJ9E;X5>(K
M.92UOIVKF&S:3+%4$@& 3Z D?C0!ZMH5]K-ZUP=3L;6WA4(;>6WG,@ER,GJ
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M":UNKP3#<,\KD,WYX_X#63\-X)=-U[0S=/+B_P!$D$"D95<3%\ _[OS?\"H
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MXA^)DEMK$!=Y]"CFE#,PQ+\@S@'MZ=*Z[X8/(_P]TSS)&<IYJ L<\+*X _
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MBBB@ I.<TM% !^-%&,=** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,8(P<>G'%6: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN)O/$^M7_B?4-'\/+II;3UB9_M1;]\6Y*@CI@?7I6YX3CMX/#5G:VM\]]%;
MP"Y92/,*D@D9ZKV!!(P.":Y3PQ96H^*WBTBVA!B\AXR$'R,R?,1Z$Y.3WR:
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M<S6NG(JQQHHVY78"JMS@$]R?>LK1)H8_&/@AK>*WM8;C3)$9(I Y,?EL5$C
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M-CJMY'#*9A\ZJXR  #@'&?TKJ(;NVN5=H+B*548JY1PP4CJ#CH:\LO+>RN?
MW@&VG$?D2WUJ)@#C/[LYR1^%0>(;>/29_'MMI48MHC8VK^3 -JC)PY"C@?+G
M/U- 'JUMJ5C>S2PVM[;3RPG$J12JS(?1@#Q^-6J\T\.Z5X;@\1:1J=AK\4UU
M)"8HK:UMXTWKM).]47(^K8/ %>ET %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MUM/'-$>CQN&4_B* ):*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ!(I5P1\W7'&,52\/:[J/AW2O%6I6UC;W-I;ZQ*T_F3%'P6 ^4!2#CCJ1UH
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M32%X5N8A((WZKFL'1/%M[KVH,MG:6K6L5W);W$;3E;B!5X#LA&.3V!/4<]<
M'36M_:7QF%I<Q3F%_+D\MPVQL9P<=^:L5Y%HFKZAX?;QS?V%A;3P6NJ2/*LD
MQ0[=S#"@*<D<=2*[>?Q%J-P+.72M.1[.:P-\]Y<N4B48R$! ^]TZXXY[&@#>
MNK^TL?*%W<Q0F9Q''YC@;V/0#U-"7UI)?/9)<Q-=1H'>$."RJ>Y%>9>+=97Q
M'X.\(ZQY B>?5H<KUVD;P0#Z97^5:VGJJ_''5L #.DJ3@=3NCH [F:ZM[9XD
MGGCC:5MD8=@"[>@]34U<#\5A#'HVD7,EJEPT6J0X1CMW ALKNZC.!5F'QO>:
M?J=U8>)--BL)([)[V%HK@2"1%SE>WS<<#V- ':T5Q&G>-K^;4]'@N[&T>WU1
M28WLIFD:$[0P$@*@#@GH3T/I6YXG\0Q^'M/AEQ$US<SI;VZ2OM4NQQEB 2%
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M%J5NT2GC+;N!GMGI^-3+XPO--U^;3O$-A#9Q?9I+F"XAE,BNB9W9R!@XY_\
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MBCSH+);[29S#!#'*6$A/RH#SDDMQV.3C&15H:OM^(UMI<VEV@O9-+$QO%.7
MW'*=/NY![T =/?7]IIEH]W?7$=O;IC=)(V ,G JP"" 1T->3:C>ZGJ_P<UNX
MUIHI;B.Y905'W"LX! ]AT'M72Z=XMU)=?T?3M3LK.*WU6U,MK)!,SL"%W8;*
MCL>WYT =I1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!3U22_BTRX?3(8IKX)^YCE;:A;W/I7%>'K;QS9:
MIFYTK1HH;J<27MR)'>1AW/+^G '0>E>@T4 <]=7'BH:;JI@LK'[8LNVP E.U
MH^/F<GN.3CCT]ZQO"MMXSLM06*_TS1[:RE<RW5Q&[O-*V.N=QR2<=> /RKNJ
M* "BBD9@JEF("@9))X H CN9UM;6:=RH6-"Y+L%' SR3P/K7E?A_4M5\):3J
M($.C2"[O7NDEEU:-54.  #Z_='UR:]'@U+1M=CN;.WO;*_7:5GBCE63"GC#
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M.V?AH@6.22.N6/X ?ATUOH^JQ?$^ZUIX8SITMB+9'$@W*<JW*]>H(_&NMHH
MY;Q]H%[XAT*W@L/+,]O>1W(1VV[PN00#V//Z5GZCX1NO%.J7>HZM;0VF=.>R
MM8?,\PJ[9/F-CCC/ _\ K5W-% '%>'K;QO!%IVGWZ:7;V=D0DL\;EWGC484*
M,8'3DG'48QS5_P :^'[W6]/M)M+ECCU+3[E+JW$I(1RO53CU'^'&<UTU,26.
M4N(Y%8HVUPISM. <'T."/SH Y7[-XKU70]4CU2+3X))[%X(+6W<G,C+@LSGI
MST SP>3QFL"[\'Z_)X*\,:9%;VQN]-O$FF#3X&%+8YQ[]NGO7H\5U;SS3113
MQR20D+*BL"4)&0".W%4)/$NA17ILY-9T]+H/Y9A:Y0.&Z;<9SGVH XG6K>^U
M?Q]J1LM,MM2BM;)+.5!?/:NN_P"<AB/O#!Z=.?7-/N[;4M?\&V=GH^C6UJ^G
MZDJO;"Y5H]L1SE''7G .1G.:V?$7ACP3<:C]NUZ&TBNK@A=\MVT)D(X' 8 F
MM^R;2[&.VTZR>UB4QEH((F RG<J.X]Z ,";3-;T_QQ>:S8VL%Y:WMHD)C:81
MF-T/!)(/&">E8FJ^!]8?PC:6%N+::^;53J%UB4K&I)8D)D9(Y'7FO14N(7GD
M@2:-I8\;T# LN>F1VJ2@#@Y-(\6Z'XGU&ZT"+3KG3]3D$SQW4K PR[<%N.V>
M>,\#'%=GI\5W#80QWUPMQ=!?WLJIM#-[#L.U6:S[S7-)TZY2VO=3L[:=P"L<
MTZHQ!X& 30!RMEX8U.]'BZTU."&VM]6D+0RQS>81QM!Q@>@/;KBF_P!@Z]J7
MAFP\+:A9V\%G!Y45Q=QS[O-BB(*[5QD%MJ]>G/TKO*@6]M7O7LUN8FND0.\(
M<;U4]"1U H Y?PWH>IZ;XU\2ZA=01BTU%XWAD64$_)D8(ZC.[]*G\=Z/JFM:
M)!;Z68V:.Y26:!WV">,9RF??(_*NHHH XKPUH.N6'C/5M7OK:QBM]1BB^6"X
M9S$5& HR@STYZ#TS5'QF\Z?$GP>UM$DLP%P51WV!OE&><''%=A>^(M$TVY-M
M?:O8VTX )CFN$1@#TX)K,*^$O$NN6MY'?6E[J5FNZ V]\=R#/)VHV._/'UH
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MOU% '::KX:TO6[ZRO+^!Y)K)BT!$K+M)(.< CT%:U0R3"ULWGN74"*,O(PX
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M+I_VG3X+HV_D"SF>2=5.&=7"[%!Z 'D8Y%>FQMOC5]K+N .UA@CV- #J***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#D?$NA:E/XJT3Q!IL45
MRVGB5'MGE\O<'4C(;!Z9Z8K,U3P7JNHZ7X@O898[/6-6:,F))-RI&B@"/=@<
MG!R>G2O0:JW^HV6EVINK^ZBMH <%Y6"C/I0!PUEX=\36WBB77!9Z5&9]+:S6
MV61C'"5 * C R"5 ..U1KX%NM2GU222SM]&COM/,$UO;R[XY)]V1+@8  P..
M^3[D^CU6M-0L[YIUM;F.9K>0Q2A&SL<=5/O0!S&A6?C PP:?K,EA'9VZ&*2>
M(EY;I<%1UX7L2>I]N:YV;PGXP_X1.3PK&FGO9P.&MKQI2'95D#J"N.M>I44
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M4]R2Y"C:I!V\9QDGWZ5:BT;5H?B%>:TIMOL$]BL"KN.[>#D9X]<_@?PKJ**
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M&XC P>@P"3T'O6J^A:LWC;2]5::UEL[2R:WD9F*S.[=6VA=O4+QD=_I0!7\
M*J'Q0J@!1K]R  .G"5:\1:MKEC?K%IUM:):+:R3O=766#2*"1$JA@<\9^GTI
MWA31-2T:?6VOI+9H[[4)+R)8&9BN_J"2!Z"J6M>'_$,OC.'7-)NM-V+:?90E
MZKDPY;)9 O!)]R/2@#.E\?W<OA[PU?Q&PLY-6D>.66[1VCC9<@X"L#@L."3P
M.M=KI$M]-I4$FI+;"[8'?]F8F,\G!4GG!&#^-<AHWA77+#PM8^'[^#1;ZPC\
MU;F)I)!O4MN0JVW@@D]O2MWP?H,WAO0%TZ:99-LKNB(Q98E9LA 3@D#UP.IX
MH YS1M2U76M8\:V&I3PS:?;!H%A"E2H*N.#GN!S[],5F>%M?\0:)X7\+M+9Z
M<VCW4R68*R.9\NS -_= ]N:Z&R\,:SIFO>)KJVEL)+75E+Q^:SATEVG:" ,;
M<L<\YQ^54SX/U]?!OA_24FTW[5IEXEQ(S-)L8(S%0#MR3R,\"@"#6_B%J=M<
M7[:7:V\T=E=FV-N]M.\DVT@.5=1L7&3P<\#/H#Z!9W)O+""Z$3Q&:)9/+D&&
M7(S@CL:XY= \7:1J>J#0[_2CI]_<O<_Z8CF2!W.7VA1@^V3V'OGL;.&2WL;>
M&:9IY8XU5Y6ZNP&"Q^O6@#SA?'/BT>'IO$3Z9I/]G6MPT4\*O(9BH<*2O;C/
M4^F<"I]:^(MU]JODT$V<JVD:_)-;3RM-(1DJ#'\JX''S=\]*S?#FFZ]K_@W5
M-(M7L(;"XU&9'N'D8RHF\%@$"X)//)8=?H:Z!O#?B71?$-_>>&)M)%A>K&7M
M[[S/D=5"Y&P9Z#N>YH ;J/B_Q ]YH5MH^EVQ?5;1I@MYO#1.HR0P7H!D?7/;
MK4*PZO>?$>RBU)-.9SHF;F'RV= IE D"Y/4],],<'-:%UX=U^7Q-X=U'[=;3
M)I\;I=R.QC>;?]["JI&!@8YY_6KD^CZNWQ!M];A:S&GK9FTE5G;S6!;=D#;C
M[V._2@#)M_$&NZCI>HW_ (<@TE=.L9)(8+>5&+RB,<D,K!5![<>E)/XUUB^N
MM!CT*QLG75[.29#=R,/+D09(.WL/USVQ4UCX;U[0(-5T_2#IDVGWDKRP&YD>
M-X"XY&U4(8#C'(IMMX,OM)UCPR^FO9M8:3!)%+YI99)&D^^P !'OU]: &?\
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M5ECD+G$9.22.=V>>WO5.Y?4[7XEZ%<:Z+ %+"Y8SVB,!@*2P.XDG'7\34?\
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M64"1D5T)QM&<XQMZ]23R*R(/&_BNX\-ZOJ<=GI32:1</#<(JRGS0I^8J,_*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%E0-R3U&&''^'(!VU!.!D]*XWX:ZAJ&J>&Y;O4;\7<K74H^YM:/#=">F.A
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M!)SD=Z .RU'2[#5K;[-J%I#=0YW;)4# 'U'H:LQQI%&L<:A$4!551@ #H!7
M:)XJ\37>JZ3]ITV6:SODW3^7I\D2VN1E3YC'#CI^M3>$]?\ $_B+4KB24Z:F
MGV=[-;7"I&PD;:!MVDG'4T =W1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@:'2[&&U1SEA&O+'W/4UH4 </X>T'Q=I4EMI4^IV)T2T("211D3R(#D*>P[
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M?V56\V<*, ,3T'3..N,=,UV=% '*>/O#VH>)-&M;33FMUDANTN"9V('RY&.
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M-WNOEM_+2YE4<R;<!V'3KR15VB@#B[;PE?G7[76K@:=!?6]K)%(]IN474C#
M,@P.!R>YSCT%4U\$ZTG@73M 6\L1<65XLZRD.5*JQ8#&.N3^5=EJ6KV.D"V-
M]<+"+F98(B0?F=N@_2KU 'GFI^!-<O9/$4$6J60LM7D\TF2%FE4@@JN<_=&,
M=\#H*O:1X<\0V.O6.HW$^FNEMIHT]DCW@NH.X-R.#D#/XUVM9][K>G:=?V5C
M=7*QW-ZY2WC/5R!_D?4CUH S?!VAWV@Z;=6]_-;S2SW<ESN@! ^?!(Y]\UGW
M/AS7+/QG?Z]HTU@POXHXI$N]_P"[VJ!D;>OW1^==E10!YZ?AS=:9;://H&HP
MP:I8-(99Y8CMN YR0P&3@= /0FNKT*RU:VBFEUK4$NKJ5A\L*;8HE&<!0>>_
M)/\ 2M>B@#B&\+>(]+\0ZG?^']3L(K;47$LL%U"3MD[D;?7^OXU--X3U)O%V
M@ZO_ &A%/'IL#12-.#YLI<,&/' ^]P*[&CI0!P,'@K6(=-\5VQNK$OK<KRH<
M/B/>QW9_ \>]8Y@UBQ^*&BVJRV4NHQ:$(V>7<(WPSC(P,]@<?7ZUZ-I6MZ=K
M:3R:==)<)!*8I&3H&P#^/7K39_#^DW.LPZO-8Q/J$( CG(^9<9Q_,T <G<^!
MM2?1+I(;JR75;[45OKF5E;RQM;<JJ.N!QU]36F_A_6+'Q%=:SH\]D'OX4%Y!
M=;RGF(,!E(]N.E=710!Y]=:?HGA?P9J&F:_?6QNM3\^XFVC'F2-S\B\GCY0/
M<59L_!)NOAG#H-Q<R0W<J+/)/DLPER&&?7& /PKK[C3;&\GBFNK*WGEB.8WE
MB5F0YSP2..:LT <E!X?\0ZCIUW8>(]4M)K>6U:W5;6$@LS#'F-GN,9&,#D^U
M8<O@?Q3=0:'9W&K:8;?1YXY('6%]Y"8"Y'0\#V^M>DUGKKFFMKC:*+I3J"Q>
M:8<'(7CG/3N* (?$VBCQ#X<OM*+JAN(\*[+D*P((./J!6/;^'=8O+G2/[<N+
M VNE,)HUM5<&215VJ6+= ,D\5O7NMZ=I]_:6-S<JEU=MM@BP27/^%:!&1@T
M>>M!I/B?XDZ;J>F74=Q%;6K27;0L2K,KXB#=LY+$9Y^4'H!7;:M9R:AH]Y91
M3&&2>%XUD'5200#4EGI]EI\;1V5I!;1L=Q6&,("?7 %6* /.M.\#^([67P^9
M=3TSRM'D81QQV[#*,,,2<\L>?0=ZZ3QGH5]XAT-;&PG@@E^T1RLTP)&%.<<=
M\@?K6B^N:<FN1Z*URHU"2(RK#@Y*COGI_P#J-:% ',G0]4;QQ!KYGM?)2P-J
M\(W;B2=QP<=-V/PK!7P)KJVJW*:G9PZQ!J,U]!-'&Q3][CS$8'MQ^E>B44 <
M;J?AKQ!K7A34M/U'5;22\O/+5 D&V&%5;)QG))([GH<8Z4Z3PMJ4GBKP[K!G
MM NF6ODS)\V7+*58KQTYXS7844 <!?>!M3U6S\1PW=U9*^IW,=S;LBL?*9"
M <_[( R/4_2K]QX1O-?U+[9XCDLF$=K+;016B-A3(,,Y+'KC@#WKL** .-\/
M^'?%&FK96-YKML^F61&Q8("LLJK]U&)X ]<9/&*N>"_#=WX<M=26\G@EEO+U
M[K]R#A=P''/TKIJ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>*[3PWIWB?4$TL:7*T?GPHK^:$9MN\'D>AQS79>)]=.@^')M2AB$TGR)"K'
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MKZ%J4<E]:?VIJ5Y'<3R!&6-51=JHHY/'J>N: -;1M6U]/&-QHFM_8'5K/[9
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M:]LGTAY][2JK><T>X-M(Z G&,@\5J+X:U31O$-]J/A^6Q%O?JOGVUTK *ZC
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M:%/?:>9;Z\%RLB(P RX=@?3E1C _^L 1ZEXN\0ZI?ZA%X?CDA&G)$=@L_/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"&[O+>PM)+J[F
M2&WB&YY)#@*/K7.0_$CPA/*T:ZW &7J9$=%_ L #^%8_C1/[4\>^%=#N78Z?
M*\EQ)$IP'9%)7/J.,?B:[#6=$L==T>;2[R/_ $>5=HV8!3T*\<$4 :-%<0=3
M\4:[K.KQ:)<V-G:Z9/\ 9U6> NT[A06R=W SP,=C6?'X\UK5++PZVEPZ<EQJ
M%Q):W2SI(PBD3!)7##C&3U/4#UH ]'HKSY=5\:W%QKNF)=:0MSI@63SU@?\
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M(-9&F7),;%".2' SQG:0>>QZ9%78]9\93^*]0\,I>Z2+F.V%VES]E?"@E1L
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M>&0!CC(.<XY?JVO>*O#VGV]WJ]Y8+:W5Q$K7-K:N_P!D0J2Q(/7G '7OZ@
M]$HK)\-W,]YH<-Q<7]M?N[.5N;881UW';QV.,9'KFN8M==\0^(K#6M3T:[MX
M4L;J2"VM7MMWG", DL<YRP. ![4 =;J^MZ?H5O'/J,YB26011XC9RSG)  4$
MD\&C1=9LM?TN+4=/E,EO)D E2""#@@CUKS^]O[SQ9>> M2M;A;*:Y:=CF$.$
M=$.\@$\@[2!GV/6O38D\N)5)!8#YB!C)[G'N>: (+G4;2TNK6VGG6.>[8I A
MZN0,D#\*M5XGXS\0:;J&O7^HIJHBU+1)HQIL# E)"AS)G QR>!R#\M>@:UKF
MHW7P_&O>'I$$_DK<A3&'W+CYUP>XY_[YH ZRBN4LM;U#5M9L#I\L<EB=,%U<
M H,&1_\ 5KN!."<$D>@[UB6GB[5K'4M _M6^M;J'5#<I-%:1J5MWCQ@*X/.,
MX/7I0!VVKZWIV@VB76IW(MX'D$2N59OF.<#@'T-7P0RAE(((R".]>7:_J&KZ
M]\/Y-;EGBAL;FYB,=EY0)6(3J%._/WB0">,8)&*MZ[XOU^74]9L]#MKG?IS)
M'$(K SB9R 6#L#\OMQ_]8 [>?7-.MM;MM&EN=NH72,\,.QCN4 DG.,#A3U/:
MM"O-)[JYO?B5X'NKVU:UNI;&9Y8&&"C&)\C\_7GUYK?^(?B#4?#7AI=0TSR/
M-^T)&WG(6&TYZ8(]/RS]: .J=UCC9W.%4$D^@JEI&LZ?KVGK?:9<>?;,Q4/L
M9>1UX8 UR\6K^)-)\7Z?IFN2V=U:ZHD@B:TA*>3(HSC)/(Q]36%X5U&YT+PI
MIVB:>,WM[JD]K%)*H(B56.]R,X) '3/7UH ]4JKJ&I6>E6WVB^N$@BW! SGJ
MQZ >I]JSM#C\10WU_%K$UM<6BLIM)XUV.PQR&4<#%8EU<C4?BU::9.I:WL-/
M:[C0G*F4L%#8]0#QZ4 =?>WEOI]E/>74GEV\"&21\$[5').!S3=/U"UU6PAO
MK*7S;:9=T;[2-P^AP:\[274[A?B+]JU"2:UABFC2)H0%!\DX(;V  (^A/6L_
MP]K>O:!HO@]GN;272]0F2T%NL!#J&)&XL3R<GMZ4 >NTR::.W@DFE<)'&I=V
M/0 #)->7R>-?%5X9[_2K"ZN(%O&CBM%TXLDD2MM),H/7@Y]#Q7HFI:=%KFB3
MV%XKQQW46R158;ER.QZ9%  -:T\QV[BX_P"/F W$2[&WM&!N+;<9Z$=L]NM8
M0^)?A$Y/]K$ .$+-;3 !O0DI@=#U]*FL?!=O8WVD7B:GJ+S:; ;<;Y01,AR<
M.,=LC&/0>@KA?!M_KEMX9\21Z9H4>H1?;YB"\P 9B%#*4ZL ,'MG.* /6K2\
MM[^TCNK29)K>4;DD0Y##VJ:O(_"WB,:5\/-#T[1KE)-3O[PVH:<$K;NQRQ('
M8!EP.^<]*ZI=5U[2?%<6CW]S;7T-[:R36TWE>48WC&2& ."#Q0!V5%>?:7XH
MU5/%&AV5]J=E=PZG#+YBV\64BE3^%'!(;!&.?QZBJ.E>,?$]UX8NO$L\NG&R
MLVG5[=8&#R$#Y.=V, D#MQGJ: ._O=<T[3]2LM/NKGR[J])%O'L8[R.O(&!U
M[XK-_P"$[\,_9C<'5HQ$+C[*69'&)/3!&?QZ>]<SK$.MKX@\&SZI?V\XEO2S
M10P[%C<ID!3U(QD<\]*ZH^$-)?3[VQDC:2&]N_M<P(4$MD' P!@ *!QSCOGF
M@#9ANH)Y)HXI5=X6V2*#RIQG!_ BEN+>"[@>"XACFA<8:.10RL/<&N.UN<:/
M\3/#]S&VU=5AFL[A0/O; &0_7<V,^F:[6@".""*VA2&")(HD&%1%"@#V J2N
M(\3:YK.F7.LS0WUG%%9VBSVMLH$DDI!&\R+]X+SCC'4'/6JE[XE\1WGBG2](
MTV>PM4U#35NU>2!I#&2,D?>&?ND#CH: /0J*\TN/%/B<_#JZU:"6U&H:=>20
MW+"'<LB*VTE1VZCMT':NFL-8N]6\4JEE<1/I$5A'-,0HRTLF2@!Z@;>: -2\
MUW3=/U.STVZN?+N[TD6\>QCOQUY P/QK1KSKXA+=-XU\%K9211W)FN/+>52R
M@XCY(!!/YU!)XYU?0WU[2]6FL[G4K,P+:2I&460RXZKGG;D' ZX- 'IE%<9>
MZKK?AS7M&M[^_M[VSU*0VS,T(B:*7'RD8/()XQ7,GQ?XRM_#"^(Y+C3Y;:*]
M-O) EL067?MR6SQSP,>HH ]9HKE;35M4G\6>)-+,\7E6MO%):'R_N%U/WO7D
M5SO_  F^I1^$_#.J7MV+6&^>5;R[2U\P1X)"<= #CT)XH ],HK/T.>:YT2UF
MN+RUO)73+7%K_JY.3RO^>M:% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!SWBSPLGB2VMWBN#::E9R":TNE&?+8'/([CBJD5CXYG=8+O5](M[=6
M!-Q:V[F:11U!#':N?;-=910!QTGAO7M*UW4+[P[>V AU.19+F._1V,3C(+1[
M2,]>AJHG@6]T]/#4>FW%H!IEP]Q=O*K!IG;[Q&,]1D<]./2N\HH Y2+0=:BU
MSQ+>I<6(CU2)$M_E?<C(A52W;N>F<^W2N2N-*U30K[P#I OK%-1MC<C=N81L
MIVG;ZG(R.V37K%4+O1-,O[^"^N[&":ZM\>5+(@+)@Y&/QYH Y&Y\!ZAJMKJ5
MUJ&I01:U>36\Z2VL;"*!H1A< G)ZMR?8U8E\-^*-3T'4;+6-;M9Y;BV:&%(H
M2D:L?XF(Y/Y=Z[6B@#ASX+U)V\'^9>6FW0@!+M5@9,  ;?\ OE>N.I/M4I\)
M:EJ.JZ5?ZO/8FZT^Z:7[5:HR2S1C.Q#V Z9'/ P#W/9T4 >9P?#SQ%;:;96$
M>NV(AL+X7MNQM269QN.7.>?O?_7K7'A37+>X\3I:ZC:+9ZOODB#1MYD<C+M)
MR#@ ?CG Z5VM9EUK^FV6M6FD3W&V^NP6ABVD[@,]^@Z&@#EAX)U:VTOP[+97
MUG'K.C1M&&:-C#,I&-IP=V.G/U.!3-3\$ZQK&FZO<WEW8'6]0@CMAY:NMO#$
MK!B!G+9)!.3^5=_10!R'_",ZLNI^%)DNK-8-'MVAF&UMSY0(=O;!"CKC'O6K
MXH\-VOBG1GL+EVB8,)(9D^]$XZ$>OH1Z'L>:V'=8T9V.%49)]!5'1]:T_7['
M[;IMP)[?>T>\ CD'G@\^_P!"* .>AT_Q\L*V3ZSHYA"A?MWV=S<?7:3LS3[O
MPYKEGJW]L:'J=O)>RVJ6]TFH(?+G*8P_R8VMUZ#'-==10!YU?_#W4[C2H8HK
M^R-Z^KG5+J5XF"LYZ!0"3@ ]#^8K:C\-:G#\0;[Q$ES:>1/9"VCC9&+ \$$\
MXQE1WZ'&!UKJZ* /.;3X?:M8:!I&F0:C9DZ?J0O_ #&C;YB.@QVZG]*Z*+0]
M4C\:7VM"[MA;7%HMNL00[U*Y()/0\D_@?;GI** /.(_A[K":7HMB=3L2NEWI
MO%?R7S(Q?=@C=TR3^GXZG_"&7J:]XDN(K^%;#6[?RY$:,M(C[&7(.0,#<3WS
MT]ZZ*[UW3K'5[/2[B?9>7F?(CV$[L9SSC':M&@#@6\#:P-)T)8=9@BU31F9;
M>Z6 D-$5 VL">>!CTQ4]_P"#=9UG36_M774DU*&XCN+&:* +';LG^S_%GG.?
M;Z5V]% &%H>FZ[;7<USK>L)>$QB.**"'RHTYR6(SRQX&>P'O5'5_#>I_\)0O
MB/0;RU@O3:FVFANXBT<PSD$E2"#G'/L/QW-1UFPTJ>SAO)O+>\E\J ;2=S>F
M1P/QJ_0!P]]X(O[WP_KD#7]NVJ:S(CW$QC81*J?=5%SD8  R<UU6CVDUAHUG
M9W#QO+;PK$7C!"MM& <'V%7))%BC>1SA4!8G&>!6"WC;0%T%=;-]_P 2]I3"
M)?+;[V<8QC/;K0!C1>"=2M;;Q+8VVH6@LM8:5U5X6+Q,_!YW<C&>W7%6Y/"^
MJO#X83^T+56T=U,C>43YH"[,#GCY<_CBNHGNH;>TDNI7VPQH9&;!.% SG YJ
M#2=6LM<TR+4-/F\VVESL?:1G!(/!]P: .3TSP=XAT?S+"Q\1)%H[SM((OL^9
M8T8Y*J^>#R>?QKJ=;L9M1T*]L+:2..2Y@:$/("P4,,$\<G@FM"B@#SY/!?B4
M>%(_#1UK3ET\(8G=;1C(R$Y(R6QW]!6A-X*EL8M%FT&\6&]TF%H(_M*EHID8
M?,' (/)YX/'ITKL:* . U;X?7NNV.HSWNHV\>L7_ )2/)!$PA6)""$ )SR1D
MDGL..*9)X)\2/K-WJW]N6#7=Y8FSGW6C!0IXRH#=> ?KGBNR.LV2Z\NB&1OM
MS6_VD)L./+W%<YZ=0:36M=T[P]9"\U.?R8"XC#;"WS'IT'UH YZ;P9>3^#-*
MTC^T(HK_ $N6.6VND0[=R9 )7/H3WZTZS\-^(/\ A,+77M1U6QD\FV-J\4%L
MR[T)SW8X.[!_#I7844 <]XC\.3:K?Z9JEA=K;:CISLT32J7C96&&5E!!YP.]
M9[>$;Z]&K7^HW5HVL7]D;%7AB80PQD<X!.XDDDYSZ<5V-% &-X5TBXT#PY::
M7<S13/;*4$D:E0RYR.#WYK&U+POK<_C=?$EAJ%A$T5M]FCAF@=P4Y)+88<Y)
MZ8[5T&DZ]INN?:O[/N/-^RRF&4%"NUO3D"M*@#D[#PE>3:W;ZSXBU-=1N[12
M+6..$110D]6QU)Z=>GY8RIO .J7&@^(--DU&S!UB]%VS+"V(SO#$#G)^Z.I]
M?6O0:Y7_ (6)X<+SQQW%S++!*8I(X[25F4CN1MX% %?6O!M[J5IH4]KJ4=IK
M&D@!+A8R8V&T!AM)[X'ZU'?^#-7UC3 =2UU6U>"Y6XL[F* *EN5'0+GG/4D^
MWI72:)KMAX@LY+K3Y':..4PN)(V1E< $@@@'H16E0!QUUX6UW5] U33]8UZ.
M>2[C6.'RK<)'%@ALD=220!UJ ^"]60Z)?PZI:IJ^EQ?9Q)]G)BEAQ@*R[LY]
MP1U/M7<44 </>>"=2U&TUN:\U*V?5-4B2W\Q8F$4,*_PJN[.3R<DG^>=>XTK
M6Y;33(_MUE)Y,;1WL,MN3%=*0!TSE2,'U'/3M70T4 8'A'PTGA?2I[170F>Z
MDN"L8(1-V %4'G   Y)K)B\):WI!U6#0M7M(++4)GGV3VQ9X'?[VPJP[8QD'
MI^?2Z3K-EK45S)8R,ZV]P]M(60KAUQD<_45H4 <:?!EW93>&TTF\MX;;10V!
M-&SO*7&')YP,@GZ$UU=]'<2V%Q':2I%<M&RQ2.NX(Q'!([XJ>B@#(\/Z1+HW
MAFUTN9XIY88V1G"D+(22<D'/7//OFL[P7X8O/#6CW&F7MY#=V[R%X@L97:&^
M\IR>1_\ 7KJ** .4T;P3#HGAG5='MKD@WWG!9MIS&K@A1U_A!]N<UA6OPYUA
M&T%;K6[:6#2)#Y42VQ7,;8W@G/4@8]J[_4;^WTK3I[^[<I;P(7D8*6( ]AS1
MIVH6VJZ?!?V<GF6\Z!XVP1D?0T <(_@#6TT"X\/6VO0+I)E$EN);;=+&!)O"
M[L@'GV[=A5]_".NV.LW6HZ+KT4#WR(;Q9[;>KRJ,;U&?ESZ<_7ICM:* .1D\
M'W7_  D^A:LFHB0:9$Z2&=2SSEPP9LC !^8UG_&'_D13_P!?<77\:[ZJFHZ7
M8ZM;?9M0M(;J'(;9*@8 CO0!ST7A[5;W7K?6]4O=/FFM+=TLDMK=E17?^-MS
M$GCT(K)7X>:@WA^"WDUB,:K9WS7MK>QP\!F.6W*3@\\\>@]\]9=ZSI6AW>FZ
M7,PMWO&\JUC2([<C'' P.HK6H Q]#T_5[7SIM9U47L[X55BC\N-%'HO]XYY/
MTK&UNS;1O&UGXJ\LM9-;&RO2JEFB!;*R8_N@@ GL.WIV-% '$-X*U%=5\37%
MMJENMKKD#(\;P%F1BI4'.X=-S5!+X#U)]$\-6"ZC:A]&N//+F%L2%6RHQNXX
MSG^E=GJ>I6VD:=/?W9<6\*[G*(7('K@<TFEZI9ZUIL.H6$PFMIAE' Q[$$=B
M#Q0!R,/@O7M-GO[;2/$:VFDW<S2B%K??)#N^\$;/'^>^37;Q1B*)(U)*HH4$
MG)XK)/BG1_\ A(QH"W1?4L9,21LVWC/) P.*V: *]_<K9Z=<W+2)&L4;.7=2
MRK@=2!R1]*\9T?5X]"MKRWT_Q[I4<=U.T[9L)&VNPP=N?PZYZ#WS[=10!XM"
M?!=GX:MM.M?%:+J<%V+];]H'(,PXY'IC _#-7;S7-"UJXFNM8\7V(N%LI;6U
M^QVLJ+'Y@(9VW9)/3N!Q7I6CZ[I^NI<OI\K2+;3&"7<C+AQC(P0/6M*@#PV&
M\L(9]%N?^$YTMIM'!2V0Z?($V$ $-C!/2M/0]2\):?X-OO#FH>)K>>*\D<^;
M;P2*4# 'G(/0BO4(=;TRXU>;28;V%[^%-\D"G+*..OYC\ZS]?\::#X9F2'5+
MWRIG4,(U1G;:<\\#VH \T.L07$NDF\\?V<_]G3H\)33W+M_#SZ\?UKVE&#HK
MK]UAD<8JMIVH6^JZ=!?VK,UO.@>,LI4D'H<&K5 '(2VY\0>/K2[BW?8]#25#
M(4^5KAP%*C/7:!D^AQ5WP@VN&TODURX:X:.[9+>5[?R6>, <[?3.0..U:&JZ
M]8:,8ENGD:64,4AAC:21@HRS;5!.!W/2K&FZA;:MIUO?V;E[>= \;%2I(/L>
M: ./U/P-JEWJNO36FM0V]GK$82:)K7>PPFW ;(XZT[2_!>KVGB+1M5O-5M;@
MZ?9FS*K;E"R?-CG=C/(YQVZ=ZZB[UNPL=6L=,GF*W=]N\A I.[:,GGH*T* .
M'LH['P+X?N[;Q/JMM+%?W,L@ B(W[QEEP,D]_P Q5SX<:(^B>#[9)E(N+DF>
M0$Y(!X0?@@48^M=-<6EM>(J75O%.JL'594# ,.A&>]34 <UXH\-7.M7^CZC8
MW<5O>Z9,TD9FC+HP8#((!!_A%4Y? YU"QUIM2O%.I:MY9>>V38D1BQY>T$DX
M! )R>?:NQK.UK7+#P]IQO]2E:*W#JA8(6Y/3H* ,6'P[K-YJ6EW6N:C9SIIN
MYX4MX&0R2E=H9R6/3DX&.366_@'4I/ TOAYM5@$DEZ;GS5B(7:6W;2,Y/S<]
M?2N]CD66-9$.4<!E/J#3J ./O_"FLOXEFUC2];CLVO+=(+I&M_,&5XW("?RS
M[^M1Z;X3UK1] L](M]5L[FVBCEBGANK4E)%=LCH001DCKWKM*S/[?T[_ (2$
MZ%YQ_M#R?/\ +*'!3ZXQ0!!X4T$>&O#MOI?G>:T99F< @98DX ).!S6U110
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MB,Q%Y8]PVL,,/;(/7FLJY\&#5CX>N=8N4FOM)8.\D46T3$8('7@;@#^!X&:
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M?#?B32!J,&-5NVN(F\H_)D@X;GV ]O>NQTFTEL-'LK.:19)(($B9U& Q4 9
M_"@#CK9MGQONT4*%?1PQ^49SO'?\:;XF\,:_;ZKJ'B;1=8C\XQ*6LY[965DC
M&=@8YZG/3'7K6Q;^&;N/X@W'B22\A:&2T^S)"L9# 9!Y.?;K^@IEQHOBFZO;
MZ!_$4*Z5< J@%HOGQJ>J@C Z$C<<]!Q0!IZ#K2ZKX6M-8:'R5EM_-:-3G;@<
M@?E7%C6O$^K>%)O&&GZLD$$:RR)IGV165D1V!W.3NSM&>,=*]!L-.M=-TR#3
MK:(+;0QB-$//'OGK7(1^!M3M;*ZT2TUQ4T&Z9RT36^9H@QR41@0,'GDCOTH
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M$W=@,GTS^- &_1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MPL+N5DN+]RENH1B&(QGD# ZCK6E7CVJ+J$D/PU,5_P";>2Y>.XN(\XRL9&X
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MQ(IUF'_B==A:G$&05) +G.5P/PKH]'.G/I-M+I,<,=C*@>(0QA%P1Z8&*O4
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M (A-PU]8M976+14+*1U7!PN" >AZ5T]UXBTZS\06>B3R2+>W:%X1Y9*D#/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$N](E^SVGB2\31Q.918")>!G.P2') ]<=>?6@#$U'4[_ ,3:%XQO#J,MO86
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M$EU")S=W 1'*RJHP@W949)]/3!K,@U_Q%_PK37M4?68[FYM;IHH+C[.F"B.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+M8RH*A,^85 )Y...V23TK&FD:_^&OB'Q%=0K!<:K:NX4GE(PFQ%SQZ$_P#
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MH?4>U-M[.UM=WV>VAAW?>\M N?KBLK3O%_A_5;:YN++58)(K5=\[$E=B^I!
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M=  LA*# (&YC]X__ *JU]=URSN] L-0L?$D>GP3W*&.Y$>_S@"04"GG].,4
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M.%0+C!"L3Q\N2.?ZUE72+'H.MZU'#)%IEQX@BN(696.Z-6RT@&!\IY(X]NU
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MQ'IGB&.5M/G+-"VV2.1"CIZ94\X]ZJ:QXLM-&\0Z9H\T$\DM]N(:-&8(!P.
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M-';G<LT$\@D1E(().1UH V[[Q?;6/C&U\.M:7$DL\/G&6-"P3)P. "<<')X
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M6WG@,7EN2!P&4-TY_&M?Q1XLA\,SZ7%+;33?;I_++1H6V*,9.!DD\C 'OZ4
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M%X7C9!%C.<[@,_=/3/2@#2%M L'D"&,0_P#/,*-OY4Z.&**+RHXT2/\ NJH
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MGJ%S@ 8R<'IU .J"(KLX50S8W$#DX]:545,[5"Y.3@8R?6N8T?QOI^H>%/\
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MC?\ ,<9R21SNJ#QG=1:WKNF>#HKYK:2X<W%PZ(6(5%+HO3'++G![+[BNZHH
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MY31KS3"ZDQAEB=EPAC'4G^(_EW&*@O?$/AKP1I^L:A=2W,MH2;R"90&EB=\
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M,&I>)M9TDVDT,>F8#7$@.TGYMQ)Z*..,GGDT1^/="D> F6XCMYY#'%=R6[K
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M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Q]>T*76TA5-7O\
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MRW^TVLC.[>6%&2,]2#CFNZ^'9/\ P@6DHR2(R1%661"IR&/K_.NHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S?C?PS/XMT%=,@O$M0
M9ED=VCWY !XZC')!_"MZU%PMK&+MXWN H\QHE*J3[ DD#\34U% !1110 444
M4 %%%% !1110 4444 %5=1T^WU2R:TN@YA<@NJN5W '."1V..1WJU10   #
MX%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'B[Q1X6BB-O:JMJ-4>-XRVQ@2O(W D'C'INSS7H>K7$&DZ#?711%BMX))"H
M . 3C'3G^M $>E>(M(UQ9FTR_BN1!@RE"<+G.,Y^AJMIOC+P_K&I-I]CJ,<U
MR,X4*P#XY.TD8;&.U>?^&]"U&?X-:J]DF[4-59Y@H7!9 P!4?4*V/]ZJ>A/)
MJGC'PEHUK:SVHT*VW7HD3;LEV_/Q[D*/^!=.* /::*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!^=7J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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$H __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>a123121ex-1021003.jpg
<TEXT>
begin 644 a123121ex-1021003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M51@"H;:2&(P>>.#0!LT444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YIXT\<:,^I
MOX=O9;N*RC/^G&.$[I>A$:GLI[GTX'7-=-9^,M)>PT>6*"[B@U&8V]J# >-N
M0"0.@../8YZ9QTM% 'D/C7PWKFC^"M0,VNQ7EM+<K++&;("21FD&"7W$G'';
MH *]0T:*\@TBVCO[F.XN GS21P^4".WRY..,"KU% !1110!YI\2-7L+7Q5X4
MCFN C6MZMQ.-I^2/*_,>/8_E4<>I:=<>-/&L\+1A1I2YDP/GPGS$'OU4?A71
M:YX.U#5M5EO(/%FKV$;@ 6]O(51,#' !'7K6=_PKS5O^A[U[_O\ -_\ %4 <
MK926%QX*\)RW.N/I.KVR3FSN60F,A7P4;';&W\,]:N2^))YK#P9XBUVV6W2*
M]F62:&,E63:5#[1D@$]N^"1VKI(/ FLVY)3QSK1SG_6$/U&/XB:;!X"UBWF6
M5/'6MEEY D;>OXJQ(/XB@#!76]-O_P#A8EW&LBV\]G$8C);LN_\ =,@;!'&6
M((SSSFK=_J>GVGPPT&^M+:SDBWVT,D\MJ7%N5R&DVC!)5MWXGOGG<7PAKR74
MEP/&^I[W !!AC*#'HI&T?@*F_P"$9\0_]#K??^ </_Q- 'GMSKFFW8\?20W\
MLZW=E;M#).A4R[1M) (&!N90!@=:N7%W:G_A5XBFC^1 &V_PMMC7GWW CZUV
MW_",^(?^AUOO_ .'_P")H_X1GQ#_ -#K??\ @'#_ /$T <EX+UO2K32F\+Z[
M:R76KQZ@_P#HKVID\QR^=XR,#')R<<"LY)-!AU+Q'I/B^]U5)Y=1DE6&(RB*
MY0[=A")D9^48SVV\\<=]_P (SXA_Z'6^_P# .'_XFC_A&?$/_0ZWW_@'#_\
M$T ;&E,+?PW:M'8S0+'; K:EM[J O"Y[FO%D\2Z?<KX5F,D-LMKJGGSVD%LR
M16:%\CYL?-G!;K] ,5ZC_P (SXA_Z'6^_P# .'_XFC_A&?$/_0ZWW_@'#_\
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MT)_"TVB0Z7K;:Q)K4-TP.G1SRG?-NQO7^!3R<DD=#7I$?A77H8UCB\97:(O
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;&=IP2=V> > !^!KDO#&M:SX<\):WJ&FV>G/I]KJLOG+*SB1L[!\H' QE?\
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M'  SC)SR#4>J^,]:_MZPTO1--M)WOM/%Y";F4J?7!QQT![]QR,4 =V2 "2<
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M45A>SG>3=B2/&,J.1GD9[>AKT.\U*QT]H5O+N"W:9PD0ED"EV) P >O45:H
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M(+;4 C6-M,@LY%A*9!!)7G[V/E&>F<_05M?\.ZQ)XFMO$.@7MM%>);FUEAO
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M^ -2F\0Z;IVG6FJ7&F+I=LJSP(B>9<D]&&Y3A!ZCDY/3@U6'B+QCXBMKO4=
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M^O;?3;&>]NG*6\"%Y&"EL*.IP 34>E:G:ZSI=OJ-FS-;W";T++@X]Q5;Q/\
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ME52U75K'1-.DO]1N!!:QXW.5)QDX' !)Y-<I_;.M?\(?=W]CK6D7[><OE7K
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MYE]9^7K2D1*J-^Z8J5R?P/Z \=*[6B@#S^3P9KY\$:1H<-]8175C<)*9P'(
M5MRE<CDC/<8..U:,WAV_L_'!\3Q:A:Q6TEHL5\DJ'("D$E.P!"]^G/7MU]!
M(((R#VH \YAM=*\4?%.UUK3+A+JVL[,-<O'S&9,GRP>.6&<^VT5T#2ZVOQ#C
MA6XWZ,]D7:$18\M\X!+XY).> >W3O6[8Z=9:9!Y%C:PVT18L4B0*"3U/%6:
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MVOXIU8QET7!9<#./0<?K5F]\-^)D?2-5L]4M;K6;02I/]I0K%*DAR0,#*@8
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MD@PSWD\+.D@Y&T1D\'I_^J@#OJ*YKQE=S6UK8)'JPTV*:[5)I(UW3.N"=L0
M.6) '2L'2;K7M6T;Q7I=OJ-V+NQN"EC<3(HFQC<%;@#G&.0,!J /0Z*\^\.:
MUJ/B&Y\.>1?SH+6R:354(7YY/]6H;C()97/T'8UDV>O:Q;W_ (>NAKDNH?;M
M2>TO%5,VHR>!&=HS@'J">1CL: .^3Q+9R7&KP^1>*=+7=,S0$*XP3\A_BZ?Y
M'-6-"UFV\0:-;ZI9K(MO.&*"4 -PQ4Y )[@UQT&K:G<>(_'&F7=X9K6UM T"
M; HC#1DXX^N/?%96B75[;?"_PM':ZH-/CN+MHIY$0O*ZF23Y8P%;+$CT_K0!
MZ!XB\1V/AC3?M^H+.8-X0F&(O@D]^P'UK5#JT8D7)4C(P.U>.^)-1O;OX<>)
MK2]N9KC[!JJV\4DZ@2% RD;L<$\UOV]WKWASQEH5A>:T^IV>KHX,<D"Q^254
M'*D>YZ>GKUH [#0?$%GXBM[B:R2X1;>=K=Q/$4.Y>N ?_P!?J!6K7DMIJE_H
MOA?5Y-,9S>7_ (DEM(\D'RRS8RH;C/'<XR<UTO@]/&%MJ]U#K:3OI;1AH9;J
M6%I5?C(_=DY!YZ^@H [0D @$@9X'O56+2]/@OI+Z*PM8[N3AYTA42-]6QDUQ
M/CT3MXS\&Q17MS DMU("(F  (VX."""?F(YSQ1!-K/C'7==2TURXTF#2[@VD
M4=O&K;V&<NQ/7)'3CB@#T&BN;\#:S?:[X6ANM251>I(\$Q7&&9&(S@<#\.*X
MI]6\<Z_>7FIZ EUY,%XT$$)>!8"B8!W!B&))SS^O% 'K) (P>13418UPBA1Z
M 8KS;QQK>O>'=4LKU-2:&SU*%K<6TGE@6DI48;/.X G)/MUP15SQ!J6NZ5!H
M7AVPNI[[4+Y9#+>QB-9&5!DE=QV@\CD]AZT =_17FT>M>,-&T"2VU6/R[RXU
M&&RL+NX\MB%D_B94)!*X_$GV-:MU!XKT2TUNXEUM+RT2P>>"9X$66*903@*!
MM*G'?_'(!VE0W%W#;6\\\C_) A>3:-Q4 9Z#GI7#OK&L^3X$O&U$_P#$Q*+=
MQK$H67?'NS[8YZ<=QBHO"+7]QX@\:W,&I.[1WLD4<<T8*;P"%S_%A<;< C(%
M ';Z5J4&L:7;:A;"00W"!U$B[6'L1ZU<KS6\UOQ(_P *]/\ $5AJ(CNXH_,N
M4%LC"52^W@8PNT<\=LU:U;Q=/!<:CK]C>>=HUEI<1$  P]S*V4SW&%*$_7ZT
M >@45YMX9UGQK/KNG"\@O+C3)X?W\EQ:QQ!&*[@RE.<9XY__ %)X/\67^K:U
M':ZGK9MK]995GTF>T5..=H1P 3CCJ<\'\0#TJBN9\8ZW<:9%IEC8W M[[4[V
M.VCE,>_RU)^9L'@D<#!]?:LR&_UCPYXOT[0[[53J-IJ<,AAFGB DBE7G'RXR
MIR.OYC'(!W-%<)X$N_%.N6MIJ^HZM;O8EIHVMTM55I"K%58L.G.>!CA1UR34
MGBCQ+?Q^)[3P_I37$<A@:YN);:W6:15Z* K\8SU/)Z=* .WHKRW4O%7C#2_A
M_)>7T0M-2CO5@6>6!098SR&V9(!['C'IS5MK_P 81>-SX:;7[0M=67VM;C^S
MQ^X^9AM1=W/3JQ- 'H],FF2W@DFD)$<:EV(!. !D\"O*I/'?B"+X=7&I+<0-
MJ%IJILGF:$8E48.=HP%/('?CWY&[!J>OZ'XQL-)UK58=1@U2&0Q>7:B(PR+S
MC@\C'<T =7HVM:?K^G+?Z9/YULS%0^QEY'7A@#6A7CGA#7;K2OAUHUCI[QQW
M^J:B]K#+(NX0@MR^.AQD<'U]JZP:CKNC>+;;0[[5H[V'5+>0VMP]NJ/!(@Z%
M5X8'CKC].0#MZ*\QL?$WB*Z\*W%G_:"?\)(FK"P!\A?E!.<E<8QM5SGVIFH^
M)_%&K7VIGP[/<"/3YC;)%%IZRK.ZXW%G8@ISD8 Z"@#U&BO,=6\3^+-1U6>Q
MTF*XL9K*RBEFBBM$N"T\B!Q&Q8C:!R,@=CQTJ75?%>NV5IX;_M:6301=K*+Z
MZ%NLH611A!@YV@GGIW]C0!Z315'1GGDT:T>YNX;R9H@3<PKA)?1@/<8-<+'K
M'BK7M.U;7=-U:VL;6PFFCBL3:K)YJQ\Y=RV5)Z8QZ$=<T =QJ^MZ?H=ND^H7
M'E+(^R,!&=G;T"J"2?H*?I6K66MZ>E]I\IEMW) 8HRG(.#PP!'(KSO4=1NO%
M.I> ]5M;A;,73S$(8A)Y;JIW')Z]"!Q[UW^L>?;^&[\VLP@N$MI&25$&%?:3
MN ^O- $6OZSHVE6L<>M2((+M_(6-XC(LA/8@ \?7BI;#P[HNE3M/8:59VTS9
MS)%"JMSU&0.!QTZ5Y9KXO?\ A4/AAIKH7$\E[ Z.ZGC*N0#SSC.,\5OR^,=7
M\-^(-:L-:N+:^BMM/-_"\4)APV0HCP"W!8XR<GOGT /1J;)(D,;22NJ(HRS,
M< #W->?Z)K/C&77-.DNH)[C3[Q<W"/8BW6TR 05;<Q89SU]/?B3XNW<\'A"*
MWC=HH;N[CAGD! PG)QSZX'Y<]: -9OB'X664I_:>5!P95@D,?_?87;^M=!87
M]MJ=C#>V<HEMIEW1N <$?C4%GI=A;Z)%ID4$+V(A$?E[04=<<Y'0YZ^^:Y.1
M-2LM8L_!?AN]73H+:P-T]U-")WVF0J% ) ZYY^E '=T5YI>>.M:TG0_$<%Q]
MEGU;0Y(5\XQ$1SQNRJ&*@_*V#D@'%2/KWBVT\2:)837VFRKK5N60"T8+;,J[
MB0-V6_$\^U 'H]%>:OXN\16'@_7;EY;.ZU#1K\VSS20E5F3(&=JD 'YNWI^-
M7K36/%FE^*-*M-<DT^YM-7W*HMD*?9V5-V 3R<^^?J.E '>45YJGC36K?4]$
M^WSV+?;+]K*XL[5 XBRP"$RAB-PXR,]#R,TR_P#$_BV[O?%,.G7.FVT&A?O"
MS0,9)%VLV!DD=$(Z=^U 'IM%<#J_BO5;-?!^K>;%#IFI"-;Y/*W!6D52/FZ@
M<G'3ISGI6[X=U.^U35M?,LR/8VUY]FM@L84J44>8"<Y/)[^_T !T-4=+UBPU
MJ":;3[@3QPS- [ $8=>HY^HJ]7F<'C?5(OAUK>NQV]@EU8Z@8%1(6$;KNC7)
M&[.?G/.>U 'IE%<+IOB'7;;Q7IMCK=Q8/;ZO;M+;I;Q,#$R@'&3UR">OIVK5
M\8>))M!BT^WLU5K[4+E8(=\;2!1D;F*@@G (XSWH Z6BN"T3Q'XIN++75FTW
MSY;,;K*XN;=K-9\D\%7Z8^O3&3WIMCXXNDUFZM[FZL+^S@TA]0:6SB9/F0X9
M02Q##(;!% '?UGZ3K>FZY#++IMW'<I%(8W*9X8?6N?T^_P#&5PFCWS0:9<6E
MZ0]S#$IC:VB;D,'+G><'H%'/YUQ>EZGK6AP>,M0TA--6VL]4G>9)T<N_S<!<
M, ,"@#V2BL^+5K=O#R:S(V+8V@NF8 \)LW$XZ]*YC3M9\7:KI>F:S8Q:=-:W
MDP,EKY95XH22"V\O@D8Z;: .WHKSWQ1XOUS0FU&X6;24CMKB..&R<&2:6-L#
M>2K_ "=3C*]OIFQK7BS4[;Q==:+!>:98E;>.2T%]"Q^U.V<J'WJ%YXZ&@#NJ
M*\_UWQIJ\>KZO8:1;?O--1 JFPFN?M#LN[&Z,@1\>N<^U=CHE]/J>B6=[=6D
MEI<31AI() 0R-W&#S0!?HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*ZM
MTN[2:VD)"31M&Q7K@C!Q4M% '$O\.8I-#T[2Y-<U&1+"X6>)G*MC:,*H!' '
M;K^6 +UWX(M;WQ!JFJS7US_Q,;)K*2%=H"H0 =IQ_LY^IKJ** .*L_AVEK?Z
M/>R:_JEQ+IG$2R.NW9_= QP,8!Y.0*UO#GA:'PT]Z+6\N'M[B9I5MWQLB).3
MC S^M;]% '+:WX(@UC7TUA-3OK&X^SFVE^RN%,D9SQD@XZ_R]*SHOAC:P6FF
M6L>LZAY&GW?VJ&-PA .[./N_YR>*[JB@#D]?\"P:SK U:UU2_P!+OB@BEELI
M-AD4=CCG/3OV%;>B:+;:%8&TMY)I=TC2R33OODE=NK.W<]!GT K'L?&T.I:;
MK%U:Z7?M+I;F.6V*KYCL.H !]OK71VEP+NR@N1%)$)8U?RY5VNN1G!'8T >0
M76HV\?C'7KF^\1ZQH][]I:"&WAMWE$L*X"E?E(Y(.!QU]ZZ>/P9=^(M(TC4M
M0U6_L==B@,;7=L?+D>(LQ56 Z'!&??/6N^HH X^;P! ]AI]M%JU\DEI>?;GN
M'*R2SS8P&8D<D#@>U3MX'M)=<UO4)[R>2/5[?[//;X4!1A0"#CJ ./K7322Q
MPIOED5$R!N8X'/ I] ''Z'X"71KN.5M>U6\A@!^S6UQ,3%"<$ [>A(!XXJ32
MO EMIWAC4-!DO[B>UO69F;"HR%L9P1]!UKK*C:>)7:/>IE5-_E@Y;;ZXH XJ
MV^'#6]_IU]_PD>I-<V">5$Y6/B/& @&.G7USFIX? DD6AZOI3ZY<2QZG*997
M>%=RLQRY'^]Q^5;7AKQ':>*=*:_LXIHD65HF290&#+]"?45L4 >?^)+JRT?P
MS#X(,5WJ%]<6(@M0L6 W\*%FZ#&,GZ9.*[#0]+CT70[+38ONVT*QYSU(')_$
MY-:%,CFBE+B.1',;;'"L#M;K@^AY'YT 8&H^%?[0\7Z=X@.H2QO8J4C@5 5(
M.0V2>Y#8_ 50'@/;#X@C&KS_ /$[;,[>4N5Y.0OU!(KL:* .+;X>_O[.:'7]
M2@>"R6QD9&!,D0/3G.W.!T]*AC^&D4.F:=;0:Y?Q3Z=,\EK<H%#(K\LG3D9Y
M_$UW5% '%0?#FV:WU>+4]6OM1.IJ@E:4@$,GW6&.X[=O:M#1?"D^FWL-S>Z[
MJ&I&W0K!'.0%3(P3@=3CC)]3ZUTM% '.^)_"H\1SZ=<+J-S8W%A(TD4D(!Y.
M.Q^G\ZC\.^#SX?U:^OQK-]=_;,-+'<%2&?\ O9 Z]N,<?2NFHH P=(\):?HP
MU@6Y?&J3/+)T78&'W5QT R<?6N:M_A:T$.GQ_P#"27Q&G3>;:+Y2;8CN)Z=^
MWZUU>J^(K;2-4TRPFM[EWU"7RHY$3Y%/^T<_IUK8H Y.+P9+'K.O:B=68OJ\
M(A91  (P!C(YYP./YYJ@GPZDC\.Z-IT>N2Q7.E3O+#=1P*.&))&TD\\\')KN
MZ* .%;X;++I.KZ?<:W=SQZE*D[.\:[ED4@EN.N<#CBM&P\)7(U>SU36=6_M&
MZLHWCM0+98HX]PP6P"23CWKJ:* .%3X<F70+[3+[6997N+XW\<\,7E&&4]P,
MG(YK6\/>&K_2KHW>J:_=ZM<",Q)YBA$0$Y)"@GDX')/:GV_C"RNI-<BBM;TS
M:/\ ZZ/ROFDR"1L .3G:?3M6I8:G%>Z;:7CI):BZ52D5R-C@G^$CU]J ,KQ-
MX7;7[W2KV"_:SNM-F,D3B(2 AL9!![_*,']#5.7P=?6VIWEYHFNMI_V\AKQ#
M;+('<9RZ<C83DYZ\UN0:S%/K]UI"V]RLMM$DK2M'B-@W96[D?YZ5I4 9VA:+
M:^']'@TVSW&*('+ORSL3DL3ZDURDGPZNHM2O&TOQ->Z?IE[(99[*%!]YOO;6
MS\N>.V>*[RB@#D]0\$KJ=SJ;7=ZLEO<60L[.%H<_8Q@9923R20#G@\#FLZ3X
M=WDVC:9;R>(YAJ6EN?L=\D&"B$ ;"-QST]>G%=[6;?Z[8Z=J5CITKN]Y>OMB
MAB0LV.['T4>IH YZX\ OJ7A^?3]6UV]O;N5XY%NV 'E,F=NQ>@^\W?//6I=-
M\&WD<%ZNM>(KS5)+FU>T4LHC6)'&&(7)^;IR?2MO1M<@UO[;Y$-Q%]CN7MG\
MY-NYEZD>HK3H X2U\ :E''HT=UXEDGBTB=)+9%M0OR+QM)W$GC ![#/'IIV_
MA>_L=7UJ]L-82&/4B7$+6@;RY-H&[.X9[G''6NHK(LO$EA?^(+[1(A,+RR4-
M*'3"X.,8/?J* (?#GAY]%\+QZ'=W:WL2*T8<1>7E#_"1D^IYJCIG@2PT_P %
M7/AEI#+!<;S)*44,2QX;'/*X7!_V175U5U+4(=*TVXO[A96A@0NXB0NV/8"@
M#E-&\$ZM875NU]XMO[VUM>8+<((P" 0-QR=P /0^E2V7@V_&J:1?:KK$-[+I
M@;RY5L_+FERNW]XY=L\>PK2@\7Z7<V6D7<)N'BU67RK?;"?O9(.[T P:WJ ,
M3Q1X=3Q)IB6XNI+2YAE6>VN8OO12+T/OUZ9%5+7PS?OK4.K:MJL5Y=6UNT-J
M([7RDC+?><@LV6.!W KIJ* ,'PAX?N/#.B#3)[]+Q4D9XW6#RR QW$'YCGDG
M\ZK^(O"MQJVK66K:9JSZ7J%JIC,BQ>8LJ$@[67(R,C_/%=-61KWB33O#D=M)
MJ+2JES*(49(F8 GU(X'\SVSB@#GM7\!WVLZ ]A=>());F:Y6XFN)8-P^7.U$
M0, BC/J>]:;>&+F3QS;^)6U"+]U:?93;BW/S#DYW;^/F.>G3CWK3;6[5?$2Z
M)MF-VUO]HR$^0)DCEO7(K2H \<\9>&Y/"GPYO+2;48KHW>J+<J1#Y>&8<C&X
MY'RBN^@T"_N=9BUF_P!4M+J6&V>*T$%H8T0OC+G,C%N@[BK6H76BZAK:>']0
MLDNI_L_VM5GMQ)&%W%>I! .14GAOQ!IGB/3&NM)+?9HI##AHRF" #@#TP10!
MS-G\-WM?"EOHYU?_ $BSO/MEI>1V^TQO[KN.X=>XK3CTFYM=27Q+XEU*W=]/
MMY%C%M"T<4:'.YVRS%B5 ] /?K6T^M6D>OQ:*WF_:Y8#<+B,E=H..6['CO6=
M'XOT:\T;5;]?.DM-/D:&X#0')(QD!3R>O?\ &@#G/#-OI?B+XAZCXJTN7SK)
M(4B5BC*#.1AB P'(4 ?\"K0?P3JEIK&I7FA^(SIUOJ#;Y;;[() KD<LOS  G
MUQGZUU6GM;26$$]I$L4$Z+*BA O##/0=\5:H XR7P3J5MKK:MH_B*2UGEM8[
M>X-Q;BX,VP !R2P^; 'Z^M6I?#VLB.VMEUB&[M6BECO$U" RB5F)8.!D="0-
MN0 *ZFB@#&\+>'T\,>'[?2DN9+CRLDR.,9).3@=A[<USS>#M;TU]2LM"U&QB
MTK5)7EF2ZA9I("XPWEX(!XZ9]!7=44 <5<>"[VUF\,)HUW;16FC,Q(N$)=]W
M#'C@Y!/'')ZUUUY;+>6-Q:LQ59HVC+#J 1C/ZU/6?K6M67A_3'U#4'9+=&52
M50L<DX' H XB?P#K]QX.LM"DU6Q;[!=K-;N8GR44M@,<]<-T P, 9[U?U'P-
M=:OXNO=1OKJV;3[O3?L3QHC"0'@Y&20,,-P//88[UVT;K)&LB'*L 0?4&G4
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M'9KL)2,[7RC891D=AACT)[?2N[K)U[Q)IOAR!)=0DD!D#&..*)I&?:,M@ <
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M:W'VHR0NN^6;_GHQ(.3GFK>M^$+;6;ZVOUOKVQOX(S%]JLY CNA_A;@C&>:
M//M)-QIGASXB&UO;E)[:^?9<[_WI*L>2V.IQR?<ULSW.J:FW@&!=:OK7^T[-
MS=/ P!<B%7)Y'4\\]NHYK9M/AW96ND:QIXU349/[68-<32.K/G.21\N,G)R<
M58_X0BW$F@R+JE^K:*FRW(9/F7@$-\O=1MXQQ0!R=GJ_B"'PQXVMK2]NKRZT
MR[:&UEF;?*J;L,<\9(4$_7\JG\+W-YJ/C6S_ +.UO4;O2DTU)KSS)C(@G)^Y
MEAP>AP.>OTJ;Q/X;?P[X6U^;3KC4[J;5KB-Y_+ 9H\R9=E"@'D$C&>]1^&?M
MS>*;+^S=:\0WE@H;[5%J<!5$38<'<P&3OVX &<9H TOBHBR:%I:,9@6U6 !H
MCC'WN2?3&<>^*20W&I>/7\.?VI?VUG8:<)1Y-RRRS.S ;F;&3@'N>N/>NG\0
M:%;^(M*:PN99HEWK(LD+8=&4Y!&:R;[P4+B6RO+36+ZUU6UA\@7P*N\R_P#3
M0$8;]/TH K>!=2OI;[Q!H][>37G]F78CAGFQO9"#@$@<D;>OO5&QM1/\:M7E
M\RZC\FQA;:),))PHZ=U]O4$UU>@Z#!H-O.D<\UQ/<S-/<7$Q!:1SW., <8&
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M-)/#+:9CG1^=IYR,,6.?<>E:OA+PY_PC.GW=MYD3?:+R2Y"PQ[$C#8PBC)X
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M1AM(KB-["<V\PF0+EAGIR>..^*XWPSK.HZU:^&; 7]\+^WN)CJN_AU$8/R2
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M4G'S>N#D^PP.M5+CQKJ+>%/#&JW-W/8P7C.E]=6UNDFPK\JD[E(4$@GIGTH
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MH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K+\1SI;>&M3E
M<.5%LXPB%B200.!SU-:E% 'G7@;PY9ZGX;T:[NKO4KA+/#"RNSB..9<C(4C)
M W<<^E=/I'A6UT?7-4U6&ZN9)=18-+'(RE ?4  >_P"=;U% '()\.]+A$EO!
M=W\6ERN7ETY9OW+G.<=,@<#@&N3\8JB>++U]0M_$UK;)#!;V<^D@E'&"S9/
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MM9<G@"9_#FN:0-<EQJMX;HRF $QY8$@X(+9V@$Y'TZY[5&WHK8(R,X(P12T
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MNK+[(8#:[MO'#;MW.&.<8'''O73U1UC5[/0M)N-2OI-EO NYL=6/8#U)/ H
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MMKB^N7?4+S[;YRA5:*7).5XZ<T 9.E0>/;73M=CEBN4W6NZP6YO(KF99>X#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %->-)4*2(KHW!5AD&G44 1PP0VZ;(8DC4
MG.U% &?PJ2BB@ IKQ1R%2Z*VT[EW#.#ZCWIU% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%<O/J4^J>-QHMK
M=>3;:=$ES>&,_/(Y/R1^RXY/<Y Z5R/A7QQ9Z%)KT&M7M],(]3E6-V1Y0B @
M#+=!0!ZM17*:]J\NC7.G:_!=//I-TT=O<Q9W(B/]R9/0Y(!]01WKJZ "BBB@
M HKS[XHKJFGZ?!KNGZG?P16\B1W5O!,45HRQ^;CHV2!GW'I5_P 7WLNI66A6
M>D:A<6T^IW2%);>0JPA"DNQ]@"./4B@#LJ*YV]\6:5HDTMA,]Y/+90+)<-'"
MTIC3'WG8#T&:LWGBC3+-;/+3SO>1>=!%;P-([1X!+8 X'(ZT ;-%<XOCC0I-
M*M=1BN)9HKJ;R(4CA9I&D[KM SFJ>K?$#3[+PVVKV<,MR1>"S,+*49),G(8'
MD8 - '7T5RUU>V4WC+P^S:C?V]S-!,8K QLJ2C;DF0'H1@]>X'XRZAXXT73I
M;Q)&NI%LB%N9(;9W2%B<89@,9H Z2BN<U'QUH.F36L4]S([7=N+F#R87?S$/
M0C [X-:>BZU9:_IJ7^GNSP,S+\Z%2"#@@@T :%%86J^+]*TB_DLIVGEN8H#<
M2I;P-(8X_P"\V!P*CO\ QOX?TU;%KB^RM]'YMN8XV?>O;H._2@#H:*PK+QAH
M=]HD^L1WH2SMV*3-*I4QL.Q4\YY''O7-IXB?4OB5H@LKS4$LKFTE9[2:)HD.
M =K@$#=GG_OF@#T&BN-^*-W>:?X(GO+"\GM)X9HR'A?:2"VT@GTY_05@:O/K
M7@D^'[B#7=0U0WURD4]K=E7$F0,[.-R]?4\D?B >HT5ST_C71(+YK5IY3LN!
M:R3+"QBCE)QL9\8!I+2ZLY/'-]#'K5Q+<):+OTXY\J+D9<<8S]W\SZ\ '145
MYGXX\;6TNC+/H^I:A!]GO8TDFMX2J2 D[@&88)&#QG''>N[UZTOK[1;FUTVZ
M^R7<H"I.#@H-PW$>^,T :-%>57FDZG;?$'3O#R^*]>-M=6CSO(;D;PPW<#C&
M/E':MF**[T.71;#6_%D_VIK]_LX4%FO(R0%1^..3SG/7@^@!WE%<YJ?COP[I
M-W<VES?$W5L,RPQPN[*.#V&._K21^/?#<UY9VT.I+(]XP2)D1BFX]%+8P&.>
MG6@#I**Y[5?&V@Z+?&SO;QED4@2E(F98LXQO8# SFMZ.:.6%9HW5XG4.KJ<@
M@\@B@!]%>=:'<:M\0Q>ZC_;%UI6EPW#06L5@=CR8 .]G(Y&#T'?Z5>T37M0T
MKQ+?>&=<N?M1AM_M=I>&/#2Q=PP'4CGD=<&@#MZ*\>T3Q+>WFCWOBN;7M0^T
MVXFDDTT1,UOC!$8!VX'..<]NW-=1\/&N=1M$UB77]0OFFMU%Q;7"8CCE.#E#
M@# '&!GKUZ4 =S117/ZMI.M:CKD<EKK<^G:?';X*P*C,\I8\_,IX Q0!T%%>
M7^$7\6>(M"CU./Q)-Y\5_P"5)%)#%Y;Q*R[NBYS@GOS[5)X9\<VNF:AX@L_$
M>N,3!J4D-N9U).Q21_"N!T]AU]Z /3**R-3\4:-I!C%[?+&9(_-4*C/\G]X[
M0<#W-7[&^MM2L8;VSF6:VF7?'(O1A0!8HKRV&_UV]^(NNZ&WBBYL[*SA\Z.0
MQPG:3LP"2O0%_KP.:Z'2=3;0K/4K[6_$\>I:='*D4=R(AF-P#N5@B^I'K^%
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M"!TK9H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"[NVAN_)'VHLSVSIM#IL7.1Z@UFZ#?P>$M/\2Z-K=I<O(]W-/$@MW9;N-U
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MGLKB=8(C%"Q=G+;<!2,]<_EQGBH]1\<:+IEU)#</=>7%)Y4]REL[0PR<85G
MP#\PXY]\5R'A_2KF+Q[=^' G_$FTJ[.I1@,V%,B?)'Z8!)8#U!Z\UD6QTO29
M]:T#Q/HNIW]Y<ZA)<0")'87"M]TC!'.0>>>I]* /4+WQ3I-A?/92SN]S';FY
MDC@A>4I&/XCM!Q5>^\;^'].AL)KF^(COXS);%87;S%&/0>XXKDM<UB2V\3WF
MF2VLULKZ/Y<%O:67FR7+E&^0R!2VU><8P.#DUAZ%JMJMG\/DN6E\RVN+A)&D
MA?"YRJC)&".5Z=* /7++5[+4-'35;64R6;QF17"$$J,YX(SV/:L<^/O#HTF+
M5/M<ILY9C;I(MM(<R 9VXVY!_G72HBQH$10J@8  P!7DD_A/5[FYU[PK#&]O
MIHG.J6MTHX+,/DB'H-P/3D;?>@#M?%&MP'3-8TVTO)[?5(-.>\#1QL"B@$@[
ML8&2,8SGK5?PSXVT>\MM)TV34GEU*>W3YI(V D?8"P#X"DYXX-9-M/<W'PXU
MSQ!J\0BO=0LGCV*I)50AC0=SRQ+?\"JA<ZC8+IOPZD@1BBW"KB.$Y!50C\8_
MOD?7KS0!U.C:C8Q:UXGN&\0374=O(IG@G0JED%#9"GH0<'I_=[GDW;3Q9H^J
M7R:;;W<T-W<1&2 2V[Q&1<'YDWJ W&3QGI7F]Y;7&JW?Q*L[ 2-<RM T:1J=
MT@C8[U&.OICWKLO#?B?3M;?3(;739I+RV@V7,LL!0V0V<C<PY+,N,*?4GI0!
ME>$?'EA8:0T'B#6IIKO[9)$))86(0!MJAF5<#UY/?TKT>21(HGDD=41 69F.
M  .I->*F\LY?@SK,<2DS/J.2HB(8EIE8'I_<'7VQ7KUY/!-H-Q<21O);O:L[
M1]&9"N2/8XH SK3Q-INO)]DL+B\AEN;=I()FM)(\KP-R,ZA3C(]:YKP/X\T]
MO#VEV^LZO)+J5R[(7EB; 8N0JEP-N< =3WK/\(ZJVEZQ!IVG:Q)JN@?8Y)RL
M]N1+9*H'RDXY'3C\AZY5KJ6GV_P>TB%CMN(M03S$$1W!EEWDXQ_<QS[@4 >F
M:GXQT32;J>WNKF3?;JK3F*"2180W3>R@A<^^*R+[5;U?BIHME#=R?V=<V+RF
M(8V,P#8/\JX[QAK2WDWB[33%-;3,D0A@@M<FZV@,9)'"DX"XQR!C\:U;/5[*
M3Q1X#42LICTYXVWQLN&=%51R.Y4@?AZB@#I/"%Q>RZQXE@N]1ENDM[_RX8Y,
M?NEV[N,<X^;'_ ?K69XF\13Z%\2-$6XU*6+29;:5IH F5+!6QP!DDG;4G@B_
MMKGQ9XM2&<OONUE3"#:R[=I8-WY&/3ICJ:@\831:5\2?#&LWY\K3HXIXWG*D
MJC%6QG'3EA_D4 =/:>+]"O=(N-4BU",6EL^R=Y%*&-LXP5(!!)(QQS3M%\5:
M-X@GFM]/NB\\*AGBDC:-PI[X8 D>_N*\PUNS;4;?Q1K=AI\UUI$U_:2[(RR_
M:$CSYK+WQENHZ<GM76>%I?#5]XD^VZ%9:A<7!@9;B_NI)R(QQA,RDY)]!T -
M '5:OKNG:&D!OIF5KB3RH8XXVD>1O154$G\JKQ>+=#FT5]76_06<<AB=G4JR
MR#^ J1NW=.,9YK \?:S%I6IZ )R+6-IW=M0^S><T&%Z(.?F;.WD'&<]JX:+4
M(H=/FN8(KR:"Q\3C4)XI(F\SR&4!6.?<$8^G2@#UBR\6:+?1WSQWGE?8.;I;
MB-H6B'JRN 0*CT_QGH.IWAM;:]/G>49E66%X]Z#.64L!N'!Z9Z5R'BN^L/%G
MA'79O#EK+).(XC<7(M60RA6SLY +$#GZ8K6TKQ=X;UN2VFBL9))[6T<S326V
MT6J;?F4LPQSC&!UYH N-\2?"@#%=4WA8S(QCAD8!0<'HOJ:U9/$ND17VG6;W
M8$^HIYEJNQL2+C.<XP/QKSC28(M1^!%ZEE'&]Q&DV\  ,H$Q<@_\!P<55;7;
M'Q!J_@*VTJX=Y[%&BG;RG41.8T Y(P>5/3TH ])/C/P^-3&GG44$Q?RPVUO+
M+YQMWXVYSQC-5/%/BRPTVRU"RM]1\O58[621!%$93&P4L-W!"YQ_%7G_ (=_
MX1B/2K?0M>@U2;7(+A_] \RXVM)O.UE4'8,YZ_6KG]K6VC7/C_3-6G\J_OFF
MDM0RD^:C(VP @=<%>* .^\$7USJ?@O2KR\E,UQ+#EY&ZL02,G\J-0\:^'],O
MGL[J_ FC.)-D;NL1_P!ME!"_B:I_#:9)? &E!=V8XS&P*D88,<]:Y/1;^RT/
M1/%NBZ_*L5_-=7$HCF/S7"NH"E"0=V3]>N?6@#O]1\5:%I1A%]JMM#YT9DBW
M/G>OJ,=O3UJ_9:A:ZCI\-_:S+):S)O20< C\>E>0V\)TO6/AU9:R42:*&82Q
MS')0.2$# ].P_#':O3_$UM/-X1U6VL(V\]K.1(DBX.=IP!B@".R\8:#J&I#3
M[;48WN6)$:E6 EP,G8Q&&_ FIE\3Z*]R+<:A%O,_V8'!VF7^YNQC=[9KSGPG
M<^#]1_X1Z%8]2FUVRV*L#23,(6'WB<_(%'WN,< #VK!UCQ)!=Z( '2PN8]>$
M_P!AAB*-$ 6S([<G<21W'3I0!Z]>>,O#EA>R65UK%K%<QL%>-FY!/:H9?'GA
M6&5HI-<LPZN4(W]".O\ ^OI7+Z!<:=??&'Q RM!*LMK"T(8#YB$0D@&N<26Q
M?PQ\1YF:!V_M"0H_#'#.0I!]">AH ]7U3Q-H^CB/[=?1QF1=ZA07.S.-V%!P
MO/7IU]*6X\2Z-:Z;;ZA+J$(M;D?N'4[O-XSA0.2?:O,)=2TBR\52W7B&:_AT
MW4=*M393P2RHI38,KB/GDY./KD<U:BETKP]K7A34%MKJ#P['%<10W%WN.UVZ
M2D$<;^,<#@]L8H Z'P9KMWK'BSQ+&VK+>V$$J?94$80Q@Y.,8Z#[N3R2N:ZG
M4]<TS1MG]H7L4!D!*JQRQ ZG YP/6N&\$:A97_Q*\67%E,DL$Z0O&Z#AP!@G
M\S^M1>*GM[#XBFYUV^N[+3;O3?L]K=6Y91&^_+*2 1TR>0>H]!@ [E_$NBQZ
M7!J3:E!]CG8)%*&R'8]@!R3P>/:G6_B'1[G3Y[^+4;?[);L4FE9MHC/'#9Q@
M\C\Z\XEU+0M$\.^'8M+18M/DOY3#J6HPEVAQUD5<#DDX&>!C)%<[=7<EW:>*
MY+.ZDN+:/68+N4#^.'+@MMP!UV?D* /6I_$ECJVGZE;Z'JL0U&&V:13LR8SC
M@E6'(Z5F>#O&VG7VBZ3;:AK5O-K%Q& R9 8L2< XX!Q21>(O#&M/J>H:7$)9
MH].D^T7XMV41H%R$9B!SWQ_L^U<?'<Z1%X#\#2HUJLZZK 790-XVL3)GOQE<
M_44 >P7=W;V%I+=W<R0V\2EY)'. H%8B>._"KS+$-?L=S+N!,H QC/)/ /M^
M'6IO&$D<?@O6VE("_89AD^I0@?J17FQFT:S\._#N25[>2-KD&5V0 <##;L]E
M9@"3Z9H ]/T[Q+HNJVMQ=6.I6\T%O_KI V G&>2>E167BW0=0NX;6UU.%YYA
MNB0Y4N.ORY S^%><^)%BENO']CI4:F<V]E(8(%VEE1LR\#V//UK1\0:AIGB=
M/"$?A^>UDO%OHI!%"X\R")5)8'NH&!UQTH Z^?QSX7MW9)=<LPZR&-E$F2&'
M7@?SZ4Z\\6:?9^)[#07\PW%Y&9%<*=@'\//?)ST].:\UC;3I-.^)CO\ 9I )
MF,1PK8R6"D?\"QSZUI17MM:>.O!M_/*J6DVBK#'*>C/@C:/?YA^= &QH?C6"
MRU'6[7Q'K]J&@U%X+5)$6-@@QS\O;G&3Z'GT[U65U#*P96&00<@BO(0^D3:%
M\1YG-O)<?:IL%AD@8PA /3YR>?6NV\.^)=,&E^'=.EGV7M[8QO#%M8[@J\\X
MP.AZT =37GWBEO&6GV6M:U#KR6=I:L6MK06<4F]  ,ESR,DGKFO0:Y7XCSPP
M> =6$TL<9DBV('8#<Q.<#/4\'CVH S-%C\:2VNE:E)X@CO+2]LVEF1K*-/L[
M-#N0\$%\,0,<?X7/"/C;3M1T728M0UFT?5[F/YX]ZABV3P0. ?;BKOAJ^M?^
M%<Z;="=#!#IJ>9(#D+LCPV?H00?I7GGFZ3#\+?"MP!;)*NHP[Y @#95R7R<9
MZ=: /3=0\6^']*O_ +#?:M;07/&8W;D9Z9]/QK9!! (((/0BO%GA\/W&L>*+
M#Q3J]_9ROJ4DBPAQB6+(,>W*L<X X!Z8%>O:3C^Q[,"&:$"%0(YS^\48Z-[T
M 7**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBH+VTAOK*:UG!,4
MJ%'"L5.#[CD4 3T5X3X3'A!_"/V_Q'J=R+U7?=&EW)O*YP,*I]Z]!3Q!9>"=
M(T&PF74+NTN@J1W\I7"ECD!R2,8!_(>U ':T5SR^+K4:)=ZO/:W,-G#*8XG8
M*?M)W;08P"<@G@$XSFJ>F?$#3;R_N;*]M;O2[B"W-R5O%"[HQG<1@GH!F@#K
M:*Y6R\<6]YJ%A;MI6I6\.H!C:7$L8"2X&>QRN0,C('K4)^(>G?\ ")R^(A97
M9M8;G[/+'A-ZG(&?O8(Y'0]Z .PHKE#XJOG\=QZ);Z6\MF;-;AY@RAEW$ -R
MP^4<@CKGH*I:=KVD:7;>*M2L;?5+EK6]+7<3\MNSSY8)X4?,>?0^U '<45S]
MKXMM;RPT2\@M;EH]7E\N(87,9PQ)89Z *W3/2LQOB7I"WZ0FVO39R7/V5+]4
M!A:3., @Y(X/.* .SHJGJNIVVC:7<ZC>,5M[="[D#)QZ#W[5RNM:[+J_@_74
M;3=0T]DTUKF.1V4!P5)&UD8CMR/>@#MJ*X#P9XR@&F^'M)N[?4!-=6P2.[FB
M/ERNHY4,>3]>E;,WCC3(&D9H;HVT5\+"6Y"+Y:2G\<XSWQ0!TU%<5 DS?%V_
M19Y?(;249X_,. 2^ 5';IVQ47PIN+BY\+737%Q-.ZZA,H>:0NV/E/4^Y)_&@
M#NJS->TNXU?2VM+;4KC3I2ZL)[?[PP<X^AJMJOBFRTF^ELY(+J::&T-Y*((P
MP2($C<22/0\"N7\2:L+WQ+X$OM.O)_LE[.S;5D95=<+C*],X8CGU(H [+0]&
MBT+3%LXI9)V+M)+/*<O+(QRS,?4FM"2..:)XI45XW!5D89# ]016%/XNLH+F
M>);:]G6"Z2SDE@B#HLK $#@Y_B )QP>*JZCXYL[&_N[6'3]1OOL1 NY;6'<D
M&1GDYYX]/2@#<TO3(-(L5L[9Y3 C$QK(^[8"<[0?[H[#L*NU4TO4K76-,M]1
MLGWV]P@=&(P<>A]QTKSG0_%UKX5NO$=KJ<VJ7JP:B^)-CS>7'@ ;F/ Z8Z]J
M /4:S].T:TTVYN[F(/)=7<ADFGE.YV]%S_=4< =JSKWQCIMK#:O!'=7S7, N
M4CM(M["'CYV]!SWK3T?5[+7=+@U'3Y?,MIAE21@@@X(([$&@"]17,ZMXZTK1
MI;H3Q7LD5HRI//# 6CC8X^4MGKR/SHU3QWH^E7EG:N+NXDO(/M$'V:W:3>F"
M1C'4\?AWQ0!TK@LC*&*DC 8=1[US_A[PS+I%S->ZAJL^JZA(GE"XF0+LB!R$
M &>_)/?CTK.U/X@6L/AJTUG3;2>Z2YO%M-C(5:,Y.[(]>"![D59DN+!OB)8[
MKN_2_DTUBMGTAV;B=S#^]D$8]AZ4 =33)E=X9%BD\N0J0KE=VTXX..]<)I_B
MV?Q;X?\ $:);WE@;<3I!<QJ4VA54@%L\29)X':KN@>(H--\%>'C=FYNKRZMD
M$<,*F663"Y)QZ =2: -/PCX>N/#&B_V;/J/VY5D9XW\GR]@8Y*XW'OD_C6]7
M.1>.=$E\/3:UYTJ6\4I@>)XR)?,_N;>['_/>L#2M;N=1^+,D0;4K>T.E[_L=
MV"BAMZC<$SCIW^M 'H55=2MI[S3;BVMKM[2>1"J7"+DQGL<=ZQ?%WBH^&$TW
M9927+WMVD "<X!(S@=2V.@]:FU+Q;8:;??8?(O+N[6+SI(;2 R-$G8N!TSGI
M0 _PWX?;0K:<W-_+J%_<R>9<7<J[6?  4 <X  Z9/>MNJ&C:S9:]IJ7UA+OB
M8E2",,C#JK#L1Z5CVWBAM0\5:MX?%E=0K:QJ%NE3(W,K$DGHHX&W/4@T =/1
M7EO@/Q_!;>&+"'6I=1N+B6X:+[4\+N@W-A0TAZ]?>NMUCQSH^B7TMI<+>2O
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MFZ(XPRY SR0* .A9%?&Y0V#D9&<'UIU8K>+-'0Z2'N'4ZJJ-9YA?$F[&!D#
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M'A=7BSTRA&[GZ4 ;*P0K*TJQ()&X9@HR?J:;%:V\#%H;>*-B,$H@!Q^%4/\
MA(]*^QZ==BZS!J3K':L$8[V8$@=.. >N*AA\7:)<:HFG17;-.\K0HPA?RV=0
M25$F-A/!XSVQ0!J"SM0' MH0'^^-@^;Z^M/^SPD1CR8\1_<^4?+]/2I*Y[4;
MORO&6EV_]OI;B2-\Z9Y8+7!PV&W=0!@_E0!M_8[8!P+>'$GW_D'S?7UIRP0J
M4*Q("@PA"CY1Z#TK N/'OA>UF>&;6;=9$F\EUY.UO? X'OTJ[K/B;1] B634
MKZ.'<,J@!=R/4*H)Q[XH UJ9+#%.FR:-)%SG#J",_C7'>(O$,DUIX:U+0]3!
MLKS58+>38H(E1F((R1D8VD?_ *JZ(>(-+:34HQ=KNTP W8P?W0(R,\<\ ]/0
MT 7E@B2'R5B18L$; H P>O%1_8;/:%^RP;0<@>6, _Y K/?Q3H<6BPZP^HPK
M8SKF*0DY?V"]2>#QC-<UH/B.75M4\7!=>22PMXXFM;@QA%MMRR$^F<8')ZXH
M [B2VMY9!))!$[KT9D!(_&I:Y^SU_3=,\.Z?/J?B"UN!*FT7KE46=AU( J[I
MGB+2-8BN9;"_AG2V8K,P.-F,\G/;@\]* -.BL2'QCX<N)XH8M:LGEE8+&HE&
M6)Z 5MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %07MP;2RFN!!+.8T
M+"*%=SO[ >M3T4 >5>#;J30/!JZ+J_AK5YIY&E_=)9E@X/.,YXZ5=U'^U?%>
MB:=X?O=&FT];YF>61;<E+.)&(1>?XSM7GC@^]>D44 >3W5CK^I> IM"N-)NW
MN='N$,1*;([^)'( QCGY>W? /-6FT==?T74K33/!?]AW,EFRFXFA2(LY((1<
M<D'!!/&...:].HH XCPKKFLR6VD:1<>%[VU:WC6.>YN,+&JHFW*GJ2>./<UP
MS:=KJ>!=8\++X=U*2Z:]:<3K&/**AU/!)R<[>,"O<** . B;4-.^(]G=OI=V
MUG>:3';LZ1;S&X<$AL'"XSS5GP9'=R:_XN>]LIHHY[[]VTD159$ *C&>O &?
MK7;44 >?^#O"VH:5XBOH[M,:9ISRKI6X9^64@DY]@H'XFN;\-6#:7:IHEYX!
M^V:S!(WEWCVZB)UW\.TA].>G4 8KV2B@#)\3O&GAK4#-82W\)B*R6T7WY%/!
MQCO@D_A7GEM;WD&D>);#2WU.YT!M*<V\5W;R"2*=ACRTR,D8)SQZ>Y/K-% '
MD;6M[)I/PWB&GW@:WND,VZ%AY05E!+>GKSVJKXA;5-0TW6(+S2M9N+VVU030
M[(2(%A#_ "D 8#$J3S@GIV%>S44 <)87DLGQ3N+DZ?>Q6TVDHOFRP,H5@=^W
MIUP<?4&CX4P3V_AB[CN+>>!S?RN%EB9"5(7!&0*[NB@#S;Q7?:ROBC4[-[#4
M)K*;3'BLEL[?<)9&0@^8W7 );C(Z XK M4O(K/X?B32]11M/NI4N ;9OERR<
M].G/7V->T44 >5ZNMU#XEN-1\/QZI9:R]^(;BT,+M;W4:D#S2=NT KSUS_,Z
MUAJ<GA;6?$EKJ6FWDEO<W3WUK-;V[2K/N508^!P>!UP.M=]10!ROPZT:[T+P
M596=\K)<DM(\;=8]Q)"_EC\36!;7@TZ7QE876F7D\][>2-;P"U=DN Z!0-V"
MH'KFO2:* /'9]%;PQJVFOK6@W.K63:3':,UK&9#'(K98$ ],?G^=>A^#[>*V
MT(+;Z,VD0-*S1VSGY]IQ\S\G!/IGIBM^B@#QY[&QM/$&N6&N^#KW47N+^6[M
M;BW1F$@<DJI(( X/KZYZ5LW5O/#\1?!C'3WMXK:RD21(8V>.WW1LJIN QP>*
M](HH \7L[.]A\"7[-I]Z6C\2+=&,6[[S'E/F (R>E=?->F]^)N@SQV5ZL1T^
M3<[V[*L9<;@K'H#A>?<@5W-% 'EGA::?2- \7:9>:=?I/]HN9U*V[,KAE5%"
MD=23Z=N:S7TZ1+#P;JE_I6HW>GV]F]K=6T4;B2%LXW;1@\GZ9 %>RT4 >27U
MD(=,TW5-#\.7]EIECJ\=S-;88RW"@+^\"$YXY&/Q]:T-&U!]8^+AU2'3M1AM
M'TPP>9<6S1@,&!YS7I=% '"?$N&XV^'KV&UGN(K/5(YIA!&78*.<X'/:DL[]
MM'\<ZKJ5]97D5CJ]K;2P2BW=RI1,%'502K?-W]*[RB@#D? >FW-I#K-[,LD4
M.HZE+=6\+KM*QL?E)7^$D=O0"J>FJ='^(WB/[1'=F/4(8IH91 [)\BMN7< 1
MQV]?KBNZHH \,-E>_P#"DHK'[#>?:QJ.##]G?=U+9QCICOTK9N+/3;+Q+KT6
MO^'-1U 7ES]IM9[5)'66-@,(<$ 8([^I]J]:HH S-)M(_P#A&[6TDL1:1-;A
M&M-Q/EJ1]S/7@'%<!X/U,^ ([[0O$%I<V]JERTMO?) SQ.IZ9(SCH/SQVKU*
MB@#@O%5U<>+?"=^NDZ??$6=Q%(GFQ^7]J"D,P4-\V /89.,9Z57U748/&>M>
M&ET5I_,LKW[1=.UNZ"!5 +(S$ 9/3 KT6B@#QNW8R>%?B/*L4Q2:^E:/]TV6
M!<XXQGZ^G?%:L-REOJGPR1TEWQV3JZB-OE+0*@SQZ@Y],5Z?0<XXZT >3V6N
M:;;:7XVTFX26>[N-5O/)MDA9S*6&!C QQM)/IQZU5U"^O=&O+31+NSNXO+\/
MI;EK*V$DEQ($(VE\9\M23P.X]Z[WPCX=U#P\-2%[J$-Y]MNFN\I"4*R-][N<
M@X%=+0!XAILN_2/AW;B.82VVHR"53"PVXD!/4<\'M[^AKL?#?V+5O%WCFSDC
M+07$D4;HRD;E"%'_ %S7?5GZU9WU_I<MOIVHMI]TV"EPL8?;CM@^M '!^ ]-
MU!M>FL[Z3S+3PV\MK:-S\[.>I_W4P/;=]*[[63 -"U W4#SVXMI/-AC^](NT
MY4>Y'%0Z#HJ:'IQM_/>YN))&FN+EQAII&.2Q_08]!6I0!Y=X%OKJV\2PZ5I>
MIS:KH$MJ9OWR8:R/.U"?7MC\1TK2^*+-;IX=U!HI&MK/5(IIW1"VQ0>IQ7?T
M4 >3"XL]0\6>+]5N+*\N-&GTN,Y6%D,J8497./0D?2IM"N=06;4] L=0;7-(
M_LEV@N1'AH6P56(M_$<=NO(Z5ZG10!Y"NOVFH:)X'LK2*[EN=/O+872+;/\
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MA5&.@ Z?KFK;VT$DT<TD,;2QYV.R LN>N#VH \>OI[*7P;\0?+:+S/[4) P
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MDXJ'57&NZWKFLZ?:7!LHM FM3.UNZF65LD*H(R<#KZ4 ;G_"S_#0M&NC+>"
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M(RO;PEU3CD]!GV'4^U9%EXP:/P;INJZA8SF]O%C2*VB"E[F1@#E #PIY/."
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MT(FV 'Y<C(7)'S'(QVJ;5?&5GI5W=6QL;^Z>TMA=7/V:-6$2'URPY[X&>.:
M.CHK@+[4G?XE^'+R.XN$TNYTV6;YF81M\K-DCID J3^%;<7C.S;1WU2>PU&U
MM]R) )X0KW+,<*L:AB6)[9QP<],D '245R]OX\TN5=66:VOK6XTN+SKBWGB
MDVXSE0"0>W?O3-.^(.DZEJ.GV:VNHV_]H)NMI[FV\N*0@9*AB>3VXR,]#R*
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M-I'=R,[0B@MNQVQFL[5O$VE:EX/OKVVUN;38HY?(:[6!M\,BD$J4(!SVQ[T
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MVH W:*Q-,\7:%J^H_8+&_66X,?FJI5EWKZJ2!N_"MN@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ JCK1N1HMZ;2U2[N/)8);N<"0X^Z?K5ZB@#RFQ\*:
MD+S5++1[>_L=&O\ 395>VOV^2&=\@! "?;GT[FND\.:OXED73],NO#3V8A0)
M<W4LP*;5&/D Y)/'T]Z[*B@#R6#1-9;P3XQM#I%VMQJ%\9K>-E&75F!]>V.:
MECT;5-'UDWEYX9_MZVU"RMO-5EC9X)HX@A!WYR>.N1U[XKU6FJZN,HP8=,@Y
MH \]N+37]+UG1O$%MX?A9$M)+2?3K-E!A5F++CL>V<>_K69'HFOWT?CFXDT6
M:V.K0(;>.21"Q90?EX/7G],5ZO2*RMG:P.#@X/>@#SJ.3Q#JOB?PI>3>&;BS
M@T_SDF>6=#C?&%)XYP.WKTK.U;PYK&N:9XQ1-.N();B\BN+5)2H$ZIP1U] 3
MCZ5ZO10!YU!IMSKNFW=C%X,M] FFLW1[PI&I#D<*FT9()ZD]!6-J5MXBO_"?
MAW2!X9ODNM+NH6D.Y"CK&I7(;/?/X8ZUZ]10!A^,=)N-<\):EIMIM^T3Q8CW
M' )!!QGWQBN*U5_$.OW?A.63PS>6\VGWB2W7*B,8*_=.>G!/M7J--,B!PA=0
MQZ GDT >3:Q9Z^J>+]$@\.WEPNJ7)N(+I&7R]O'KW^7IG//2M"UT_4X/&G@^
MYFTN[6*VTD6]PRIN6)]I7#$<=Q_D&O21(A<H'4N.JYYIU '"&VOA\8)-173K
MIK-=+,(G\O"%P=V ?T^OYURTVEZM<_"JQL5T?4!>1:KYKP- 0VTNYSCT^8<_
MTYKV2B@#R3Q9<7D?CF[N=*L-:622QCAN9-,C65FW9.'X.Q@,#UX!&.">Z\%3
MZ;)X:AM=+CNHH+)C;-'=H4E5UY;<.QYS^-4K_P $0W.J76HV>NZIIQO6!N4M
MIP%D/ XX^4\=?>NATG2[?1[!+.W:5U!+-),Y=Y&/)9F/4DT <%XIUN^OO$/]
MFW7A+6;W2;24,%AA)CNG'0L<8V \@9Y[^E6-0;4_[6T'QG_8%T)5BDM;VSC!
MDGCC+'8P48SCDXQGYO:O020" 2 3P/>EH \ZL&U"'6/$'C>71K]_,A2VL;%H
MBL[H"-V4&2,L >03BF^$=9U"76\W/A75TOKUR;K4+R(HD2 $A$R.%' "]\DF
MO1Z* /+K[Q/J=UXE%U=^#=>GAL786<*0-Y9?IYK';UQP.2 .:T_B$'U32/#N
MFRK]GOK[4(&, .\I@'?Z9"[NM=]5)=*M!J[ZH49[MHQ$'=BP1?10>%SWQUH
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M#*1G(.>@]?7BG6WCO3;O1[&_M[>[D>]N?LL=LJ#S!*.JMS@8ZY)K"AU5M/\
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M,8HMWV=G &]L<X/'TV>] %3PKXF;^W?&MUJ-_<_V=9212(+E6!A4A\@+C(Z
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MA5VC\#0!UM%1P3"XMXIE5U$B!PKC##(S@CL:DH **** "BBB@ HHHH ****
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M* "BBB@ HHHH **** "BBB@ HHHH **** "BL[4M:MM-N;.U=)9KJ\?9#!"
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 A (P0"/>EHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ%LTT>PAB!@@. >HS^%<_P"!/&]IJ/AW3DUC6+8ZO<,Z^6SJKM^\8*,#V H
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M7+Q3PV\BQL5FG^XAQP6Y' KG?^$NM-%\/:/<ZMJ,%Y)>RK!]IM0!$S$X9\]
MJ]_IT[4 =7165J'B71-*N5MK_5;2VF90RI)( 2#T-:H((!!R#0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 <E#(+;XJW:2@K]KTR,P$]'V.VX?4;A4>@7*'XB^*
M8]DH\T6YC=HV"ML3:V"1@X)%=!JFC6VJM;2NTD-S;2"2"XA($D9[@$@@@C@@
M\&KTT9E@DC$CQEU*ATQN7(ZC/<4 <7X+MF;Q?XPU-&5K:>\2%&!ZM&IW?JP'
MX&NWJGI6EVFC:=%86,?EP1 X!))))R22>I))-7* "BBB@"O?WD.GV,UW<%A%
M$NYMJEC^ ')-</\ !R5&\"I$,[TGD+ J1P3P1Z_A7H%% 'C]AJEOI7PXO?!V
MHV\L6N+%/#%:BW=C,6)*L"!@CD<Y[5Z7X:L[C3_#&F6=VS-<0VT:2;NH(4<?
MAT_"M6B@#PZ]OX!\%[_26\Q+VSO2D\;QL-K&<L!G&,X[9K:\1?\ $P\>:+!:
MR;9;G0IHXB<KAGCD"^XY(KU?%% 'CO@ZY\,SV^DZ5-HU]/K]I(FZ(^9MB<-_
MK.6V@ ?-_3M7I7BR:.#P?K,DC;5^Q3#..Y0@?J:V** /(->NHYOA5X/U",,U
MO8W-J;A@/N!%*MQ]>/QK4TC4[:[^)VKZ]%YW]E'1PRW3PNJL 4)(R,GH?RKT
MO%% 'AM[=P2_L_V$:2 O'=>6XP>&\QFQ^1!K8U>]TK1_'>MR>(([TV6K6\/V
M2:W:0!EV!2N%(R>I[_K7K6!Z44 >4ZE'H=G!HWV*^N/"]];6CR64MRN5DB+G
M*OW)/W]O;?T]*MQJ\\MUX!\0:M:_9(5:=)6BA;8,\(0H&?F R!CO7L&,T4 <
MI\1+:[O_  '?QV"22.51V1"0SH&!8>O3/%8.BZUX1U77K#5+*.]EO+2U=IY9
MY)"ME&$;)?<2"?X<+GJ3VKTFC ]* /'+;4[31/%L7C66WMTT/5[B6&,JI:2$
M]/.QV+E23CG!/?BN@EO8?^$\\3:8"QN]3TR+[(H4XDVQR9YZ#KWKT/ ]** /
M'O#]WX=U6ST.RN(-6N->TYTC%@))"(G3"E^?E5?ER?3I38[FV^Q?%!I'4JTA
MVY&>3O"_^/$5['BC H \HCO;>S\7^!]4GDVV<^D"VCD",<R;<8P!GJPKK/B5
M_P D\UC_ *Y+_P"AK75XK$\7:/<:_P"%K[2[62*.:X0*K2YVC!!YQD]J . F
MN+3Q+;^"+#0;R%[ZS:*2<Q@Y@1$&_=QQR,8[FLKP\?#4VDP:-K4VLMJMM=$'
M38VD*M('.&5/NCKSG'>O8-$L[C3]$LK.Z>)YK>%8BT0(4[1@'GGH!5_% '!:
M!<:=-\4_%EL?*:9TM61"G)*+\Q''9BOXX-<G!>6S>&_B6PG0AKZ1E.>H9R%/
MXG@5[3BC ]* /'[J^M5/PM8SQ@)&NXYZ?+&O\P1^%7GN[2[MOB7'9R(YP3M0
M=2(MK''^\&Y[UZE@>E&!0!Y+KVM:?>:?X$UF&X4V%K?1QSRD8\M@JY!'7^$U
M3NKC1++Q=XGM_$^HZE:Q7S+-"T$L@CN(2O"D <X!QSQP1VY]FP/2C /:@#RJ
MVO--\,^.=)O+L2VFCS:.MO8RW0;,9W [3_=)'7/KVK1^%%W!=Q^)'@?>CZK)
M*K8(!5ONG]*]$Q1TH \VU#4;'2/C.]SJ=S%;6SZ0$#S'"L=XXY^AJ+1/#3:W
MX(\16]NP2TO;^:XTH!-@0*^8V7N <#MTKTJ6"&?;YT22;&#KO4':PZ$9[UD^
M([+7;ZVACT/5(=/</^^=XMY92,<>A'7\N10!@?#^6\UX2^(-5MQ'=)$FGQDD
MDD1Y\Q_^!.3T_NX[9+_'FKV>DZGX=:[@MTWW+[;^="PM  ,D =SGC/ QG'''
M4Z1ID.C:3;:? 69(4VEV^\[=2Q]R<D_6K;QI)MWHK;3N7<,X/J* /#)KZWO/
M!OQ 5;@3)_:J7$8;^ZTZC?CMD"NROY=)OO'?AA=#-O));QRO.;; "0>6 H;'
M;)&!6_XUT"[\0>&+O3=-^R1W%T\?F//E055@W503GY1^M:]M#<1:9\T%I'>M
M'F18<B(R;<=<9QP!G&<"@#Q33+C2IO@O-IQ:VDU66Y*V\ 4-*TA=<8'7.*ZS
M2&^R_%^."[N$:X304BD8MG,@VEN3[ GFMWP#X7OO#6C+8ZHEA+)"[-!/ S,V
M&^\#N48[=.M=5]F@%R;D0Q^>5VF78-V/3/7% 'C?VRW3P--=Q?OK"U\4>?=)
M#@@P!\].A!^7CZ5T^H^)_".J:9KVI:=;1:C<1V&+DF)T5TSA58D#O^/'6N]A
MMH+??Y,,<6]MS[$"[CZG'4TL5O!##Y,4,<<7/R(H"\]>* /*['7--N?%FE&*
M_MW,F@O:K%;(PA27Y3Y:9&1P#P3V'0\5AVBZ;>?!FWTV(6KZY+=^3!%@><)#
M.#CU'R=SVKVU+.UC,)2VA7R01%A /+SUV^F?:DCL+.&X:XBM($G8DM(L8#'/
M7)QF@#S^YE+>/]0M$N!-?+X8,!$;98RAB<#OGD'\:Q/#E]X3O+;PM"][JD^K
MV+QK%IZYPLO1CR NT'YOO9P/PKUT6EL+DW(MXOM!&#+L&['IGK0EI;1W#W"6
M\2SN,-*$ 9A[GJ>@H P_'<\4'@76C+(J!K21%+'&6(P!]2:Y9_$FD6-]X+^T
MK;1YT\2"_N0V(TV %5Y #$CJ<X].:](FABN(FBGB26-NJ.H8'\#49LK0B$&U
MA(@YB'EC]W_N^GX4 >/:)8V^L_"C5K;3Y1/<Z??O>0#^+Y3E21_M*&XJ>34=
M4;5[;Q/;6)6+Q-!_9Z0' :)L!4D8X^;HQ_W<<^GKL<$,)<Q1(AD;<Y50-Q]3
MZFG"- $ 10$^Z /N\8X].* ,4:EH?A<:5H4EREL\JB&TB*GY\8'4# ))'7N:
MI_$96?X?:R%V9$.?G7(P&'Z^E:^I:-:ZK=:?<7():QG\^( #EL8&21G'?@CD
M#TJ^Z)+&T<BJZ,"&5AD$>A% 'EVM:A8ZEKGPYGMKB*: R/A@>,@1COWW CZB
MN?UW>#X^B@S]BBO[-YXH2!\FYMV." <A>W:O:CI]D1"#9VY$!S$/*7]W_N\<
M=.U/BM+:"25XK>*-Y3F1D0 N?4^O4_G0!PWAQ_#5]XT74M.UJ^U/4I;,[@Q!
M2*+((W848(R!CKZ^M,^)-E+;:AX?\3+$\L&E70:Y5.JQDJ=V,=L?J*[NVL[6
MS5EM;:& ,<D1(%S^53T <[+X[\,0V:71UFV=)!F-8SN=_8*.<\CC%8FC7T&F
M_$'Q+;ZQ<1127HAFM6F*J'A"D;1D]NA'L3WKM(M.L89S/%96\<QR3(L2AN>O
M.,TMS86=X5-U:03E?NF6,-CZ9H \9$<%OX6TQ;L1?V:_BH/:HRE@;;<=V >J
MGVZUU,5MHJ?%O4+.>RM-ATI6"F)-JX;+<=C@@_05WLUC9W$213VL$L<?W$>,
M,%^@/2C[#9_:#<?98//(P9/+&XC&,9Z].* /%X(].N/AWX3N)S&8K77?*EW@
M; C2LS Y'3;M/I6WK$^E6/B[6+_38(I[&#0V6_AMV58I&8D(IV]R.OMC%=+X
MQ\.7NH6VD6VC6=C]GM]0CNIX9,1JP7V"GCKGO[&NG@L+2"!XHK.WB20?O(XX
MP%;COQS0!YAHFMZ5/XW\-E+VQ;.DM;>7; [(SP5C^;+9 X^;TZ#.*P+J.Q@^
M$R7MFEO'<#6&V31@!QAR1@]>@'X8KVY=.L4$02RMU$1)CQ$HV$]2..*;_96G
M>1Y'V"U\G=O\OR5V[L8SC&,X[T <)X[W>&_$&F>,K& 3,P-E<(HSO# ["/?/
M&?I6_IUQIW@O0=,LM7O8H+FY;#.P_P!;.QW.>!QR>IXZ5'?:#K>K>(XOMUS8
MCP[;2I/!;1(3*SH/E#9& ,Y/!["MG6M$M=>M(K:\R8HYDFP%4[BISCD' ]<8
M..] #];6&30=06<(T)MI-P?&TC:>M>00W*-X(^'UXZQ0P6VKJLS+PJ8E/+>A
M(!8_B:]KEABGA:&:))(FX*.H(/X&H#IE@;86YL;;R VX1>4NW/KC&,T >=^*
M)6T[6M;US2KFPU&%8(5U;3+I2<Q[?E*'T*L/;/KTKT>RG%S8V\XA>$2Q*_E2
M##)D9VD>HZ5$^E:=)()'T^U9P  QA4GC@<X[8%7* "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#EAX]T
MI]9FTJ*VU&:X@NA:RF.V)2-B2-S-V7@\^Q/2EB\>Z3+JD-FT-]##<2^3;WLM
MN5MYGY&$?//(/:L?0X[F^U;QY9QV]U;2W$I6&:2,JI/EE 5;ZC/T(-87A&UT
MZT6PTJZ\$7TFN6LJB6Z>W B0[\B0R9Z #(XYQ@=: .VU/QYI&ER7'F1WTT-K
M+Y-S<V]LSPPO_=9^F<D#'7)%2:OXTT[1YY(VMK^Z$*J]Q):6YD2!2"=SMT P
M,^N#7'Z%>7'A236/#U_X;U'49+S4);B$PVX>&:-@H&XDX XYX.,\U#=V]IH7
MBS78]>\/:GK$.IW"S6LL$'FAA_<(W#[I. /8<#- '8W^I:1)XJ\/LVH7BW%Q
M'(;2.#/DSJ0"2YQ@X XY[U8MO&&GW4NM11P7GF:0";A&APS  GY!G)Z''2N5
MU.WD3QEX$":7)9I"DN^"-2ZP94 +N Q5CQ1H=Z/&EO)80LUIKL/V+4F"G"*I
M!+9'0E R@G\_0 WY?&FG165E.+:_DFO+?[5':0VYDF$?'S,JYP.1SG%-E\>:
M!%I%CJAN)&M;R7R8BL1+;^X(Z@URGBJ"VT/QLE_J&@7.H:--IRVJ_98R_E%6
M)VD9"XX'!].*@UVWB^Q^%&T_0;C3;<ZTDXMO).]4! W. #M)QTR>,?@ >DZ/
MJL&M:;'?V\<\<4A8!9X]C\$CD?A3M3U.TT>P>\O9-D2D#@$EF)P% '))/&*I
M:CXEM-+U[3])N8+H27^1#.L>8MP_A+9Z_AW%8WQ%T^_NM,TV]L(9;EM.OXKJ
M2WCY+JIYX'7'L#0!KZ?XIT[4-1.G[;JTO"GF)#>0-"TB\Y*ANN,=JK:/XYT3
M7K^.ST^2XEDD5V5C;L$PIP?FQCT_,>M8]S=P^(O&N@:CIL$\EOIT-S+<SM;.
MH >/:J<C);.3MH^$>Y/!*P2020RQ7$@9'C9<9.1C/7@B@#8\0WFG1Z[H-M=Z
MG>6EP]R6MXX.$F;&-LG!X.<8]Z;IOBT7OB77-,ELYK>#2T5C.Z':>I8D]LC!
M4=P"?88WQ )/B;P?M21A%J DD*H6"KE>3@5'#=K8^+_&\-S87TJW$$<R"&$D
M2HD.&"MTSS@>] '5:1XFL=9G6&WCND9X!<H9H&0/&3C()X/452\5^+5\,W&D
MP?8YKE[^Y$7[M"VU<C=C');D87OS7.^"WN]/\3#2],O[G4?#IM6D47$3(UF<
MC"[F49ST !]\<<V_B.LD-_X7U#R97MK/4EDG:)"Y1>#G Y[&@#7U3Q[H&CZC
M-87EQ*MS"B.Z+"S8#8QT'N/SJ5?&NC/H]_JB23O;6$QAN,0-N1@0#\N,XYK(
ML+R*7XKW;^5.JSZ7$J,\+*"V=^"2.#M(Z_3K7)SL^E:1XWT*>VNWOKV[EF@6
M&UD=71@&!W!<=/Y4 >CWGBW3+2.UD'VFX6YMC=Q_9X&D_=  [SCH.:IW7C>U
MBU?P]96]I/<)K,?G)(JG*(5RIVCD^_3 R>U<9>VZ#2-$F@N=0T77]/TB+9,]
MHWES@(08CQR<KT([C .:MR3:C_;_ (#\0:O;3HY@FBN1';L2CLA"DJH.-VX<
M?7TH Z^[\;:-97QMII+@*+C[,UP(&,*R_P!POC&1W':I=5\7:7H\\L5S]I<0
M!3<20V[R)!GIO8#"]<UYQIMMI%E#J&D^(/#^JW.H#47EBMX?.,=SN8;6X8)Q
M[]AWZ5.]GH^G>(/$6G^)M)U2?[;>/=P/:M.8IXV(*H50@%@<\D=<\\"@#UF"
M>*YMXYX)%DBD4,CJ>"#T-8EKXPTJ\U.&QB%T6G=XX9C;L(I2F=VU\8.,&K^B
M1B'0K*,6/V%5A4"UW;O*&/NY]J\[\*SS:9K.C0Z)=7;Z-J#2^;IEU"2UA@%O
MO=0,Y^OO0!<\,>.;/2K"ZM=?U2XGN(M2EM_/>-F"*& 4LW11^-=;JOBO3-(O
M%M)C/+.8&N2EO"TI6,=6.WH*\Z:X63X7^*H5BG\Z;4I3'&86#,'D5E(&,] ?
MR-;&J:N\?B,1M%=0VEQHZ[)+:P9Y;AF#84L%)4+G...: -'Q1K%U/<^$KG0]
M186U[?JK^61LFC/)SD>@/'N>^,/TG4KZ7XJZ]ITMW+)9PVL3Q0L?E0D)G _$
MUQH;S?"G@&+RIP]MJ2><#"P,>UN2<C@?,.?>NHT;=_PN3Q#(4D$;VD2JY0A6
M*A,@'&* -SQ;?V^GP:?+<ZW)I:F\CY5 1.,\HWH,=3D8'K3M7\::'HEW-:7E
MT_VJ*,2-#'$SMM/?@>G/TK/^(EQ'!IFEEP[%=3MY2J(7.Q&RQP!V%9]NQC^,
M&JW,B,+=M( 241G:V"K'D#DXS0!U#^*=(30(];^U!K*7B)E4EI&SC:J]2V0>
M/:L'0O$$EYXV\0>=<W46GV]K!(L5XAB$&02W! QZY-<1X=F?3?#/A/5+VUGF
MM-.U&Y6X'EES#N4@,5P2,'GZCUK2U:5O$6J^+TT=;B4W>F0B!Q"ZB78<LH..
MX./?- '=Z1XST;6]0-C:2RB<J7C$T31B51U*$_>]>.U5Y?B'X7CC$@U(/'YH
MB9TB<JA/]XXP!7/>&YO#.HZMH[6&C:J=0@4DFXEN&2Q&SD9=MI'10!ZBL8W<
M$WPJ\7I&2Q_M*8XV'HTBD'\@?RH ]%L/&&BZGK1TJUNB]SL\Q,H0LJ]RC'AO
MP]*JGX@^&/-B1-2#B280;UC;8KGLS$8%8U_J5HWC[P;)YFU&LIV#,I PZ +^
M.0>.U<0LOE_!34X_G64ZKA?E(.=ZGC\C^5 'K1GB/C98!K3^:MF6.E[/EQN'
M[W/Z=ZY.WURXUC7]:O)-;O\ 3[/2+X((TMR8C%&#Y@? ZL0>2<CT[5H?VA;-
M\3='0S R-I#KGDY9F1AS[@?YS57X<W$$OB#QI )%9SJLC[<]5+,,_2@#I6\8
MZ,N@6^M^>YL9Y%C1Q$V=S'&".O6MZO+_  QIMY:>,;KPNT.-*TR\;4XG#'HX
MQ%'QQP26QW*FNZL_$>G7VO7NBPR2"^LQNDC>-ERO'S GJ/F _P#K<T 2ZMKV
MFZ(L7V^Y6)IB1%& 6=R.3A1R:Y#PCXJ::]\6W6IZHSZ;97*F&290HC0[AC&
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M,5I#X<LHM/BN(K-$Q"MP,.4R<$_7J,\X(X%:U !1110 4444 %%%% !1110
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MLE$+*Q5=R]#CD4ABC*;#&I7.<8XSUK$E\9:)!H2ZU/<2Q6#2")9)+=U+$],
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MD D8SQG( (Y^@J_7$^-_%]I9:+JUE87\T>IV\0)D@A9UA8G@,X!52<$<G/-
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M+95A9O.9>(^/O$'TZXH D>UMY(EB>")HU((1D! /7.*!:VXF$P@B$H& X09
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M.<@%\@#&._2M#Q9;O:ZI?:KH:ZM9:[;)"NR&!Y(+Q<+QP"#@''7^'\:].HH
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M[FF"&)96E6-!(PP7"C)_&@#QCP[JMMI?PSM9IH[9U_MT+YLR%UMSU\S:.20
M>_>I=6OK6^B^(4-G++</<16UQ%^[/SHH7<1P/E&>/;GGK7L'V:#RC%Y$?EDY
M*;!C/TI^Q,D[5RPP>.HH \VOSI^LZGX,B\.M;--;S)<2&$ F&!5&X.1G!(XP
M3G-5[+4+!M-^)30S1"/S)>G ):-ES^+ \]Z]0BABA4K%&D8)R0B@4@@A7S-L
M48\S[^%'S?7UH \EUJ[M7\-?#5UFC.VXM<MGIL5 _/;!X-;_ (=D@TSXI^*+
M&XF47%^()X$P?F4*Q8?49KN_L\.U%\F/:AR@VC"GV]*;<0L\4I@*17+1E$E*
M [3V^H!YQ0!YC:Z1=6WC.;P85+Z-)<+K ;><I&"3Y>/0R!1SZ9ZFO0_$#*OA
MS5&8@ 6DN23_ +!K/\-Z)J5C+<7^N7\-]J<ZK&98HMBI&N2%'KR2<X'6N@(#
M @@$'@@T >'S2P-\+/!09X_DU90VXC@!Y,_AR*V_$@FF\3^*M+TA1]JGT6-E
MCA7D[7^8#'0E6Z8YSVKU+[/!L5/)CV(<JNT8!]J7RH_-\W8OF8QNQSCTS0!P
M?A?Q+X:UG^PK."VDN=5LH%C!-LP-L0F')8C '&.O4BO/Y+^U@^$NIZ++,JZF
MNHEFM3]\ .O./P->^)#%$6,<:(6.6*J!D^])]GAW,WDQ[G^\=HRWUH \Y@6T
MG^-!@G$$F[150QN <MD'&#WV\_2H-"A6]\5_$.*U,!O/D^RDX.R0+( 1UQAM
MOT.*]-\B'SO.\I/-_O[1N_.A((8W9TB17;[S*H!/UH \A\-W/AC4=$\.V>H7
M.H/J]C<A$LD9MPDW=2O]WH2>.A'L8X-7M+'P=XTTC5[I(M8FN[E_)E^_)E1M
M(]1D'&*]B$$*RF58D$AZN%&3^-(]M!(Y=X(V<C!8H"<4 8?@=@_@31=AY%FB
M_0@8/ZBN*TK4=/M/ 7B'1]?N8H]2CEN1/%)A'E=\E61>I!R,8%>K    # ':
MHGMK>23S'@C9_P"\4!/YT >3Z3;K%X[\'V-^D9E30A')%+@X;#G!![^U>MQQ
MI%&L<:*B( JJHP !T %-,$)E$IB0R#HY49'XU)0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/*SRY>1BS']XW<UIKXKM#?:Q:&UNU;2HQ).?+'S*02"O.3P#^59WPRL+S3/
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M_P 3=-]H_EG:W (!]#R/SK@H[;4Y-'\0^'].O+W5],_LQ7M'N(662-R3B++
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M&$O'"1YS,,A"".58<Y]@?KK:OXNTS1;J6WNDNW,,:RS/#;LZ1*Q(!9AP.AH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?1[X7MM$"&EQ@[R=S @\KRW0]L56U;PCK%QX@N]4TGQ$;$7@B2>&2S28!4!
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MYTU;97LX?,VR"5FP?3@CDURSPZE;_#ZTBET;41.-=\YH5@+.J!R^[ [=L^M
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M[=K>61 S1,02I^H)'ZUSEWX[ABBU"YL=)OM0LM/=H[FZ@V;5=?O  L"V.#D
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MK>S/;X^T-;VKR)#D9^9@,#CF@#HJ*Y?4?&MG;7N@Q6B/>6^K.VV>%&<! .H
M&2<XX[#/I6YJVHQZ1I%YJ,JETMH6E*CJ=HSB@"Y17GNK^)Y;CP[X4U\SW.GQ
MSZC"+F)-P5D8,2#QEEXXQP<_EU5EXIT;4);R*"\*R6:>9<)/$\)C7&=Q#@<8
MYS0!L45A:=XPT75-373[>>87,B>9$LUO)'YJ8SN4LHR/\#6[0 4444 %%%%
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M5S<6ZR6VH6MO=,J6UY=6QC@F)!("L?IWQFM/Q'I]QK'A34+"%_*N+BV9%/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M 95DS[C''UJ_XAF\47NHZW9C1[VXLKS3O(LQ&5"1,R9<ODC+9X[],#K7I-%
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M?>V]\_I5G5/'4>GZS-IEOHVHWTT4"W!:W0;=A[\GI7.M8:^W@&7P9-H]R]Z
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M7:)I_P#8M^;RSU!#+"(QNVJY<L.>F"!]:])UM7?0=12*-Y)&MI%5$&68E2
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MX&O3J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<M;":,SJNXQ!QN ]<=<5+7E^E3W5G\6M<N]0M;>.YCT8RR+;.61\&/!!(!Z
M#D=JZGPGX@U77X8;NXL[(6$\'F1SVMP7V." 8W4@$'D],CB@#IZ*R]7U.ZL)
M;&"ST^2[DNIO++9VQQ #)9VP<< XXKGH/B KZ+=7#V!-_!J(TP6\<GRR3$X&
M&(&!U.3Z4 =B9X1.(#*GG%=PCW#<1ZXZXKF;KX>Z%=:C<7V+R&6XD,LH@NG1
M68\DD ]ZQ+$:C_PMF&?4;"UM[N31F+?9YBZOB08R2!@C@5?@\;WL_A34[_\
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MSI+R[2UB4OL&YL\DX.!P: -C.**\_P#'<LEWX1AOK_2I(+JSU&%HXE<2,?G
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA<PF[5-Y@#C>%]=O7% ''V%KXDO_ !Q9:[>:1#9VJV+6KQM<AG4EMQ/ YY
M'%3'P;+_ ,+$?6EE TZ54GEA! +7" JAZ9QAF/4<^O2NRHH \YUS0O%-_K'B
M.%8([BTU&T6&TE>Z*I HY(VX/)/M^.,U/I.B:W9:]X6DN-/7R;'3&M)Y(YPP
M5L 9QQZ \>OM7?U"MY;->/9K<1&Y1!(T(<;U4\ D=<4 >6V?@_Q)'H-VEO;1
M0W]KX@.I6HF<%)EP%[=!WKHKVU\3>+O".J6FH:?::6]Q"%MX#*9'WALDLPX
M.  ,$]37;4V21(HVDD=411EF8X 'J30!Q5D_C#Q!:2Z;K.F6VG6[02P7%PLV
MYIB4*@HH^Z,G/7M7/W>A^+;SPE:>%SHT(?3IHV6\^U 13HF<8'7/(SG_ /5Z
MI#-%<1++#(DD;='1@0?Q%/H YNW\0W[^.'T"XL(HX19+=+.DNXYR 01CIDD#
MI]W/?B?QCHC>(/"UY8Q?\?!7S(#G&)%Y7GZC'XUM"*-97E6-1(X 9P.6 SC)
M[XR?SI] 'G/_  @FI7%]HM_-,B7$P/\ ;A7 \X95PN,<C*A3[?C6AXMTW4]0
M\:>%I[33Y);6QF:6><,H"[BHQ@G/&W/XUVQ( ))P!U)J*WN8+J$36\T<T1)
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MXKFDTR6"WO+(6]K,[+MD*@KG@Y&=V1[#G'2NZIAFB6983(@E8$JA8;B!W H
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M8+5%>XFCB5F"!I&"@L> .>YJ6O.]7\8V&H^#=(UF]T 74,]^(_L\DXQ#*I8
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M[??#J-X8;F-V4,A7K&<]#U.1V7WKN+FX^RV,UR\4C^5&TACC&YFP,X [GTH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY1@#)YQNKF+;1M<AT/P/"-)D\S3[O-VK2*#$N2N[KR,$GCT]ZM^.-".I>,-
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MR]T_XL1SK87<E@-)6T6ZVY0$%3DL3[8]?;O7?T %%%% !1110 4444 %%%%
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M7BWY1$A%X8R%48!Y7&< 9_2K<?\ PG,\.J7S6=G:W+1+#9V0GW)DMEI68?Q
M?3./S[>B@#@-,\(:GX=\3$:5MDT2_@VWRRW#%DEQS(,]2?\ 'IQ2>'])\;:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+HFN:'8+9I-#J5QY#2^;@QG@=,<]0>M<1)JE[I5[\29[>>Y=X/),/SEC&7W
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MD&P<XZYQUIT5W;3S210W$4DL9Q(B."4/N!TH FHJO!?V=S,T,%W!+*H)9(Y
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M?O?YR?6MQKJW6.61IX@D1Q(Q<80]<$]NH_.EAGBN(5E@E26)NCHP8'\10!P
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M&@V.I2V_V=KJ!9?*W;MH89'/TYK-TSQ)=:AK>OZ:VF&)],V>5NDYN-P;:>F
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MTNKZ;;6FFZ7<22VS)(':<XPAQVP,GZXH W=(M;'P]I>FZ,LL,;K&(XTR%,K
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MU=Q:7*[K.X6"&,G[^,$E^W; _3DK39K'@WP&FI2OY;Z@]LY$K+N3+*%)![X
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MBS^;<,QE<(&#$MGGMZ=/2NI'PX\+"*>)=.=8[A4255N90'"X(S\WJ <UH?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MPXP#]:<;B$*C&:/;(<(=PPQ]O6O/= \+:1'>ZYI$VKVNH?VG"LDUI96WE10
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!G'0-(;
M4Y-2;3K8WLJ&-YC&"S*1@@_AQ].*@7PGX?2P-BNCV7V4R^:8O)&"^>O]/IQT
MJ]<ZE8V<BQW5[;0.WW5EE52?H":=)?V<-REM+=P)/( 4B:0!F'L.IZ&@#/N?
M"F@7=VUU/I-J\K;0Y,?#XZ;AT;'N#4M]X<T;4M0BO[[3+6XNHAM226,,0/QZ
M]>,]*LQZE8S6KW4=[;/;QG#RK*I13[G.!U%.M;^SO59K2[@N%3AC%(' ^N*
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MBNCHH :J(D8C55" 8"@< >F*P8_!'AR+3+K3ETR/[)=2>9)&68@-VV\_+CG
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MSCBNBU0OJ/A?2+.\T:RO4"[+RS:]B$D6U"%:-]P&<]P<X./6M?\ X5YX2_Z
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M &EIE[J5U?ZG%>Z<+:W@F"VLHD#>>F.6QV_^OCM6I3(HD@A2&-=L:*%4>@'
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MXV\ZZFMEB?=@86/"@D')R>F*[ND!# $$$'N*6@ HHHH **** "BBB@ HHHH
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MB[7-1'@FXTX06QU.1V>)I&VLR_+M8@?<^;/?G'I716UY/_PG>I6?]D6,-_\
MV8DR7@<DS\[0&P,A0V1Z_*/:N>;P;XBM]%\)&WCLI+_19)&>)I2$8,01\V/;
M]:Z*QT_76\>MK%Y:VD5HVGK:'RYBS;@V_.,#^(D?0"@#.LO'.J7/AC5KI]-M
MQK%C?K9+9*YP[%D4<_BW_?-5-;^)<^FWU_!;1:?)_9[+%+')(X>:3'SB/"D8
M!XY]*V#X/D'Q$_MM'4:<\8FEA+9+72AE5L>@5L_4?2JB:-XKT#Q!JTNA)876
MGZE.;K%W*RM%*WWN!U'],<\4 =CIM\FIZ;;7T<<D:3QB14E7:P!'0CUK(\9>
M)&\+Z-'>I LC2W"0!I"1'%NS\[D G:,=NY%5FU#Q!8>(]#TEEMKRVGMV:[N#
MQ('7[S # "Y*CISFM#Q-:WUYI\,%G8V=]$\X%U;71PLD6ULX.#AL[2#[4 86
MJ>+M9T?PXFI7%A8S&2]C@C>VF+Q/$P^^#U'/'-6+_7Y+CQ9J/A:YLX)+4Z:U
MRLA.21T*LI&.N?TK 7P%J\7A36]/M!##]HOH[BRM'F+I"BL&P6QU/]*OV/A[
MQ-=>-&UW5(=/@673GM'2"5FVG/!Y'KC\* .=\)>*]5\.>!M)O'T>V;05D,,M
MPDY\Q29""Y7'KV[^V:ZEM?L['XC:C%)I<,072_M;7Z-F26-<'D#MU'K\M8VG
M^$=?D\&P^#[^Q@@M(YQ)-?\ VD,'3S#(0J 9ST'.*LWVG?VC\5;VSB^6&3P\
MT!=>0@9BHH 31OB;<ZCX@TZTEL[/['J#$(8)6>6'C*[QC&>@./?TJZOC76KZ
MT?5]'T6*]TA;GR $D;[0Z@X+A<8 S4_AFT\9V%KI^DWT.EI8VJK$US'(S2-&
MHP %QC)  S^-4- T#QEX;M)-#T_^S/[/$[-%>R,QD1"<DE<8)QQZ9H T="UO
M6+SXA>(-+N'M396?EE$&[>H*Y4CMSGGWZ5+X[U36--_L)=(:)6NM2C@?S#@-
MG)"GC[IP<D<\5#I^AZWIWQ+U354@MGTK45C#RF7#IL3  7N=P_*KGC?2M4U*
MRTR;2(8I[JPU"*[$4K[ X4,,9_$?K0!#<>(]=N=8N=)T;3;.>YL(HS>2SS,D
M8D=<A4XR>.<FM+PMXC3Q'ITLAA,%W:RM;W4.<A)5Z@'N/>L)=-\1Z+XDO=>M
M-/BOQJ5O%]ILH[H1F.9 %RK, "N,]>?ZZ?@KP_<Z#87KWK)]LO[N2[ECC.5C
M+=%![X]: ,JX\9^(9O$VK:'IGAZWDGL4$@:6[ W+U!P!U8$8&>.]5F^)=R^A
MZ)>VFC+//J%RUG)$USL$4P( &<'(.<^P'O55+O4K/XN^)'TS3!J$QM( 8S.L
M6!M3G)X-+!X-UO1]-\-0VEK#=7%MJ3WMX1,%5-W&!GD\'''<=.: +6J?$+4=
M,2"QN+'3[?6?*,UU#-='RXAG"J"H.6(YQGCWS4J_$<7'AC3-1BLX[:YOKO[)
MB[<K%$XY+%L9*X[CU]C3M9T;Q%I7C2?Q'X>M;?4/ML"P3VTTHC*%<88$XXP!
M[U8U33]?U#2;>'6-)L-6BGED-W:PL%>!2 $\IW(&5YR2<\\4 0ZUXYO]"LK&
M"]LK*'5[N20*KW)\@1KG]YN )PW  Z\\],53C^*?_%'SZTVD[[BVNEMI8%FV
MJ<CAU8KT//&,UFV/A'Q;HEMI6J64<=U>V$DR1Z?/*IVV[@87?G&5YZ'Z9QSI
M>*M'\7>(_!4]O=65L;^6[C>.UMY5"Q1J.<LQ&23G]* -6Q\6:N_BB;0=2TBW
ML[I[(W=H%N?-#8XVL0H[AN>.G?.:S_"WB[6I_ 1UJ[M(]0N'N"D,=N[!CNDQ
MA^#M"YZC/&,U;FTG69_BCI^MG3E2Q33OL\LGGJ=C$L3QU/) Z8]ZYN#PGXNL
M_A]+X?@LX?,AO0[;;H#[9%DDJ.FT9V]2"1F@#?G\;7LFG^*K=+>VBU31XO,7
MRY3)&R%<YW8'(YXXYJMK&LBW\$>'M0\0:);ZE+++ %S-PK,F1(25ZGNH!'O5
M&W\)^(O[3\2L-)LK2UU;3S!$D5P-L+!-JK@#VYX[U-KVB^)M6\ :/IPT5%O;
M.XAWQ+=H<I&I7=DX'/IDT =!?^)M6N-?O-(\/:9;7<E@L;74MQ<;%!<$A5 !
MR<#K6;/\2I%T33KR#0WDN[N]:P>T>X$9BF!QMW%><\=A3SIFO^'O&&J:QI>E
M)J5GJJ1M+ +E8GBD4=<MP1RW3U]JQK_P;KBV^FW<5@D]\^N-JEY%'<*%C!;(
M4%B,\>E '6>&_%=SJ^LZAH^IZ5_9NHV:I(8A.)@R-T.X#&1D?G5CQ#XBETR^
ML=)T^V2ZU6_WF".638BJBEBS'!].!WK-TW2-3M_BCK&K2V3#3[JUCBCG$B$;
ME"]5SN['M3O%.CZJ?$VB^(M)MEO)+ 21RVAF$9D5QC()XXR3SZ"@"%/%^H7-
MIKFF7&G)9Z]86K3",7&Z.1-O^L5MO'7."/3GDXH?"G2;=O#EEJTNE6T5V$=(
M[U'S),I=MVX8&".G).15Q](UB]OM<U^;33#=3Z>VGVE@9HRS+G.YF!V@DGUX
MQ]*TOA_I]_I'@VSTW4K-K6YMBZE6='# L6!!4GCYL<\\&@!NN>*[W2;G4E@T
M;S[>PM1<R3RSF)7ZG:GR-D@#/442>,C<_P!E0Z-IQOKO4;;[6(GF$*Q1=V9B
M#W., <U@^)= \1W^O:V5TY-1LKNR\FQ>2Z55M&*88A&_B)[@?CUJOI>@^)M#
MET+5[;1DGN;?3SI]W9-=(K8#9#JV=O.!Q_\ K !#X4UN+PKHWB6ZN[);>3^V
M6ACM%D 42,!A=Q& OOC@#IVK;TSXEVEU=ZK!?6T,']GVYN#);70N%D .& .U
M>0<#WS^>*_A;Q1?:5K,SV$%K?-JT>J6<+3*X=E'*D@X].N,GVK7GTSQ'XAT7
M4[.YT6QT99K,QA5=9'FE."#E>%3@]>>?:@">+QSJ2OH<EYX?2WM-8D5(91?A
MF4,,J678.H/3/ZU-+XWFCT[Q+=?V3\^B3^5Y;7&/.7/WL[?E^7G'-<MK5SK4
MTG@ZW\1:4MDT.IPJ9EN5?SG X(50=H)Q_P#6ZU<U;1/$WG^+;&TT5+BUUA@\
M-U]J1 N$Q@J3GMCM^7- '3-XIOYK/1)-.T*2ZFU2W%P0TVR* ; V&DVGGD <
M#-<YK/C[4Y_"^DZCIUDMK/<ZF+2:-Y@VTJQ^4-CD-MP3CCWIYTGQ3;1>$@-+
M^UV]A:>7=62WJQH)  $9N<-C /<=:QT\'^)AX42T;2(5N[36Q?I'#-&!.A!S
MR3QCISSC''% '5Z_X_71KRXLH+&"YN;2W6>Z62^6$)G^!202[8YX XQWXKHO
M#^LP^(=!L]5@0I'<INV-U4@D$>^"",UQ4ND:_I_C*[UR'PW!J,&IV\9FMVN8
MPT$J@# 9L CCL#FNVT.*_BTB%=22VCNLL6CM1B- 6)"CUP,<T 8FF^,+K6-5
MN(-/TA9K.WO#:33?:U$D>."YC*_=SG^+)_2H!X\>3P[KFJ0:2TCZ3=O;O#Y_
MWU4C+@[3C@YQCMUK'E\-ZI/XGM-4L]#FTN]74-UU=0748@GMPQY9 ^[<1C(Q
MSDYZTU]$\3:;;>*M*TW0TF@U6>:6&Z>[0*%=<$;2=V>N.@S[4 5]1OYC\3/#
M^KZ?I;3W5[I!F-M'*J%R5; +-@8''/MT[5OQ_$2)O#>J:C+I<L%[ILJ07%E+
M* 5=F"CYL?=YZX[&LR;2M:TK6O"^N-I$UTMCIOV.YM[5U>1'QM'4@$?-U&<8
M-3Q>']2A&NZA/H8O#K=VBSZ<\\8:.W4,-V[.W?DYP#QQSWH F\2>*M>LO!6K
MZ@=*2PN(&CCBE6Y$RLKD#S$.T9P6 Q_A6C)XHU.%-%LX]&^TZE?P&9Q]HV11
MJJY)+[3R>.,=ZY'_ (0C6QX5\4:19VMS%9W1MY-.M;JYC9E*L&D&58@= !D\
MX%:]Y;>*9)] N3H4D]O:0,LVGKJ$:KYHP$=CD!N!D#G% %N;XD01>&M-UA=+
MN)3>7?V1H(Y%)23D'!Z-T..F?:GP>-[Z>37;&?1#9:IIUH;F*"2Y602K@D'(
M&!_#W/7K7)_\(OXG'AG3--/A\K+9ZQ]M;R[F'88\DX7YACK@#VK?ET;5;CXB
M:[=C3Y4M+O1S;13NR[2Y P.#Z@C]>A!H KWVOBZ^'.D:QXETJ2<M<0N##,%&
M<_+*2,;1_L\]0/<;VO\ B^ZTFYNHK/1C>1VEG]LN)9+@0JJ<X"_*VX\&N:DL
M-?O/AK8Z/)X:F-Q:SP1F)IHB)4C89)R> <8[\<].:L>(+'Q)>>)KM3H;ZA83
MV'E6<?VH1Q6Y9<.7&<%LMCCMTZ4 :4_C&_N->\,PZ58K-9:I;M<.7D"-@#D<
MCC;D'WZ4RRUC1=.\:>*I&L)K6XMK=)[NY>3(E4#^%>W!&/7/;OEV&E^(M-?P
M=<OH<K/IL4UG<0I-&S ,H <'=C''<\=/3*W7AW4M7\:>,(WL9X+;4-/6&"Y?
M C+JJ8YYXR.W8'I0!J)\0+N 6-YJGAV:RTB_=$MKW[7'(3OY0L@Y4$<GDX]Z
M2^^(-S#?:Y:V/AVXO/['(,\GVA$4)@DMSD]C@ '(';I66MOK^M>'-+\)SZ!/
M9M:M EW>3%3$(XB.8R#\S':.@[GZTZ'2]7BU+XANVDW.V_@Q:L-I$OR.HV\\
MYW X_ X/% 'H6G7T6IZ9:7\ 817,*3(&&"%8 C/OS65XTEM(?"&HO?6,U[:"
M/,L,+;6*Y'.<C '7^E8=EKVJ>'M"\)65QH4N)TBLYLR+YD;!,#Y??&[V (.#
M6YXTBN;CP=JMO9VLMU/-;M&D<6-W(QGDC./;F@"AJ/BZ/19M%TRSTFZO)M0@
MS:HCHO 7@$L>.V3TQZTRQ\?V\VC:C=WNGSVMYI]P+:>R5UD8R,<*%/ .3].A
MK)N[#6)O$O@>_.C7(2TA9+D!D;RB4V\G/MG].O%8\OA;7-0D\52P:=+%=?VK
M%>V0G8(DVQGXSG!X/KCIR* .O&O7NJ?VKH^K>'[C3F-E)+&S3+*DD?(.67A6
MY'&3WK!\$>)%T/X?^%8Y;:6<:A>M9AU;B/=*X!/Z<>F?2NAL-5\1ZO97GV[P
M^=/B2VD0HTH:2:7&!L' "]>3UR,'K7)6>CZW;?"_0$&D7+7FEZHMV]H?EDD1
M9';@=?XA^IH [;_A+(X=>UG3KRT>WBTVU6[^T;MPDCQDG:!QCIWS@]*XCQ-K
MEYK=_P"$+V31[BQM9-5A>UG>=&\Z-BIY53E2>.N>.]7[K1M;\2:UKTLVDRV%
MMJ&CK# TTB95P<A6 )Y)S]!C.":SIK?Q'JFG^%M/_P"$9O8KC0[J'SG=T6-Q
M&,95B><A.O3D>HR =;::GI6GZWXNN8+"\6[LTBFO<L")@$8J4!;C@'T[55L_
MB3%<W.F/+HE]::9J#^5%?3E0I<YV@ 9R#@\Y_"LV:TUE_%GC:XBTV_2"[TTP
MP,!@2R+'M!7GD]<=^:S9M+UB?P)X1LQHM\+BQU%&FC,8RJJ3\V,\ YZGT[<9
M .LUCQX-.U._M+/29[]-,19=0E65(Q"I&?E#<N<=ABNAT/5DUW1K;4X[>:".
MX7>B38W;>QX)Z]:\QU>-;SQIXB:#2M>ELYE6SN9-)9'69PH+!PP(!P0."",>
MYKT7PM>6-YX=M3IUM-;6\(, MYE(>(I\I4Y[C% &-!\0%NM8N+&WT._,5G<&
M&]N7*JENHS\YP22./;C/TJ#3_B7:7FM6=G+8-#;7[!+.X6XCE+D]-Z*28\DC
M&?TK/T;2;[4;7QQ9RZ9<V,VIS2-#-<)@.K A1QQP<GC^]3_"CZY$FG:3<^#(
MK>6R*)-J$NP(%7@LF!RQ'&5)Y.>E &K/\0;:.*6\@TF_N=+ANOLTM[$%*@]"
M0N=Q .!G'^!CUKXC6FE7]U!'8M<Q63*+N7[1'&4R,_(C'<Y&1D 5C^&I?%WA
M>!O#:>'FNPMP[6]\90L*QLV<G_QXXSGG%02:?J>@^(=6MYO"0\16^H7'VBVN
M) K["PPRNS @#H.V .IH Z%]:T+4/'/A]TANY;RXM'EL[E6Q#Y;*Q((SR<#T
MX./2HW^)5OC47BT+5YHM.E>*YD2-,1[>I/S>Q_*LV2QU6'Q]X3N)-'?R[2S:
M*X:RAVV\+.K#"\XPN?T_"L;2+VY_XKW2[32KV\N+W4+B&-H4'EJ7++\S$X7&
M<\]J .OC\9RWOCC2M,T^(3Z;>:=]L,@P&^9N"<D8 V\CD\].*NZ;XQ35KI5M
M-)OI+0W3VOVM3&4#+GEEW;E''4@=17+V'AW4O#'B[PY.MA/>VZ:4+&5[?!$<
MNXEBQ.,+\W'L*K6VEWJ^+K#4M%TK6-+NY[T_VE&X(M'CR2SY/KUQ[C'(H ]7
MKSKQ[=S7'B[P[HLFG2WEE,TLCP)(J_:"$(V\L.F<\D?C72Z'XEDU?6M5TR;2
MKBRDL&4;I6#"0-G!XZ<#/?K6'XK@O3\1/"]]!IUY<VUH)/.DAB+*F_Y1D^W4
M^U %FUURWT-9=#\/Z+>ZA!I0 N3%*O[G<&;:-QR[>P_/C%/E^(VDKI^DWL-M
M>W$>IR&&)8HQN60'&Q@2.<\?KTJGI[:GX4\2:_\ :-+OKVPU&X-W;2V<8DPQ
M'S*PSD'IUXXKG8O"^HZ-IGA*WGTZ\N9(=4-]=+;+N$/(P"1D<<$CO@X/>@#T
M[2=3;5='BOQ8W-LT@8BWN%"R#!(Y&<#./UKS36O$VI>(OA%JFI75K)9R)<*(
MIHI %D'G 8 !S\HX.>">1[>MUXU;:7KT'PPU[0/[#ODO!<AU;RP5E#2+D)S\
MW"DY'&.] ';:)XUM;B^T_1[FPO[2>XM1)!)<Q@+,%7)(P21P"><=*8?B1IB3
MVK2V=[%I]W-Y,%^ZKY3GL<9W ''4BLS4K:\U77_"833M2@CCL9X[BY6(H8#+
M%L W=F4@_3(/-97AVPN++3[?1Y? $$FK02&,:A<6J>0<$D2-)C)_#KQ@T >M
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45P%EXR\
M0RR:K=W.FV*Z5I5U<PW+I(WF 1IN  S@G.WGWZ#%1Z-X[UJ]US3H+C3(I+&^
M'WK:"<-;$XQO9U"D?3COGU /0Z*X#4O&^K:/JML+^#3XK6XU'[(MKO8W(BR0
M)C@XP<9QCN*E?QAJUUXDO]+TY=+6:SNEB^QW3,LT\> 6=&R!WX&#0!W5%<4W
MB3Q#J^H:JOARUTU[7393 YNV<O-(!DA-O [#FJ+_ !#O[JT\-2:=ID/GZQ-+
M"\5Q(0(V0A>H'3)STZ"@#T.H[BXAM+>2XN)4BAC4L\CG 4#N37':-XMUFZC\
M1VEWIUO/JVD$;8;,L%FR"5QNR><'_"FV'B6XU'7E\.:Q;V-PM[IYN<VX)1>6
M5HW#$Y(VGGCZ4 =C:7EM?VL=U:3I/!(,I)&<JP]C4<>I64VH2Z?'=PO>0J'D
M@5P70'H2.W4?G7EV@>)M?\,_#_1]1DTJUGT2-2DK)*?. +X#8Q@<G&.?PK46
MZ@TSXPZ]?3 +%#HGG2$8&0"A/Z"@#T>BO.=)^(&KZAJ>F%M-ADT_4'5,013&
M2W!QAG=E"$?3^G/0^/[Z^TWP1J=WI\HBN(XQB3D%06 )7'?!XH Z6BN)U;Q5
MK>C3:#IB:?:7VH:E"_S+,8T#J >X/'([^M2ZCXEU_3;*66ZTRRM_LUBMQ++-
M.1')-R3%'ZG"G')ZB@#K+FWBO+6:VG0/#,C1R*3]Y2,$?E67H7A71O#8D.EV
MGDO*H5W+LQ8#.!R??M6!?^.+N!/#>HV]M:MI.K.D4TCLV^%V[=,8'//?';K3
M]0\:W6F#6;B6V@EM;>\CL;+RRQ:68CY@_7 &>P[$<T =E+-%;Q-+-(D<:#+.
M[  #W)IEI>6]_:QW5I.D\$@RDD9RK#V-<?H/B"\\276J:+K6FQM;F'*3PP3)
M#*A&"I\P @C/7COZ<W?AO_R3W1O^N)_]":@#J:*HZSJMOHFCW>IW3 0V\9<\
MXR>P^I.!^-<=HGC[4+W7-/L[[3HQ#J*DQ&VCFW0$ '#EU 8>Z\#]: ._HKS*
MY^(WB&WTZ?5I/#MM'IEK>&WG<W6YSAMI"CCG..>G'XUJ#Q#JO_"TGTTR0C2E
MTT7)1B<A<C+<#[V>,=,=^U &_;^%M-MO$DVOQ_:/M\P*R,9F*L,8QMZ8&!CT
MQ6U7F,?Q3N)+NSN4M+:33+JX6 1HLOGH&8@.3MV'H?E!)]ZU1XO\0W_B/4](
MTK0[27^S[B..6:2Z*@(V?FQC/0=LX]Z .YHKSWPMXG\177@J_P!5ELXM2NH[
MED@BA<[W)DP0PQ\H4'(QV';J=;3/%5[=Z[J6C3V5HUS:6@G'V:ZWJ7Z&-B1\
MI!X_6@#IK6ZM[VW2XM9HYH7^[)&V5/;@U-7F=EX[33? .DZCI>@0QK<WOV-;
M..7: ?FY!QU)'?UK;T_QAJ37.LV6J:1#;WVG6HNA%%=!Q(I!.,XXZ#\Z .QH
MKS1?B3KIT.PUK_A&(VL+N40AENQN+%BO QP.,9/>M>/QK?V6H:E:Z]I"6/V6
MP:_C,=P)!(@;;C..#D@4 =I17G>B?$TZGXATS2Y+:S87R$[K6X,AA;&X*X*@
M9QZ$U!<_$K6;?3+W4SX<C%E97C6LTANN<A@ORC'/6@#TNBN'?7=7F^*<&EVS
MQ?8/[.$[1.2."PRW .6'0#@5W% $+7EJEVEHUS"MRXW+"7 =ASR%ZGH?RJ:O
M/]>C1?C/X4E"@.UM<!F[D".3'\S^=6#XSUBZTN^UG2]%M[G3+65T!-R1+*J$
MAG50N.V<9H [BH;6\M;V,R6ES#/&#M+1.& /ID?45S)\8/J>HV6G:#:Q7%Q<
M62WTAN93&D43 ;<X!.XDCC'>N.\%>((_"?P\US49K4%H]7DC6W1L#<5C&W..
M@_I0!Z[45O=6]W&9+:>*9 =NZ-PPSZ9%<I8>+-6E\87'AR[T>#SX8!<-+;W6
M5V8'9E!)R0.U8NG^-+32/AU-KFFZ#'!#'?-$]LLV!DMR^<>X&/Z"@#TJBN4T
M7Q5J-[XC.CZIHWV"22U^UP,LXDRFX##8Z'FLAOB'JOV*SU.+0(YM.O;QK.#%
MUB7?N*KN!&!D@]STH Z77/"ECX@O;*YO+B\4V<@EB2*;:NX="1CK[C!K=J"Z
MN&MK":Y\AY7BB:3R8^68@9VCU)Z5RFF^,K^;7-(T_4=)2U&K0236X6;=)&%!
M;$BD#!(';O\ C0!V5'2O-F^)NI'2[O5XO#F=-LKHV]Q*UVH8'*@8&/5A^=;V
MI^)+FYUIM#T?2HM2/V99KEY9O+C6-\@+G!R2.?H: .G@N(;F/S()HY4R5W1L
M&&1U&14E<3\*E*>"PAB\DK=SCR\YV?.>,]\=*N:AXFU:36[O2] T>.^>Q"?:
M9)KD1*K.,A1QSQ0!U51BX@:X:W$T9G5=S1AAN ]2.N*\ZU+XA7=Y:Z'_ &/;
M^5>7.I_9;JWF8 HRD9C)QP#D<U'=7%UI_P 7;V33M'6]U&XTI&*_:-BJ00"<
MD<CY5'2@#TVBN&D^(]NGA73=4-JD=W?M)'';S7"QHK(2&)<\;00/?D55M?BG
M#-X9U35&TXO/IDR1SQ0SAD8.VT.KXY&0>U 'H=,2:)Y'C21&=,;U# E<],CM
M6/X<U?4]8MYIM1T9]-7*F#=,LGF(1G/'0_XUP>DZE>Z+X\\9MIFA3:ENGB>1
M89$CV<.23GJ22>@]: /5Z*X^R\>V]_+X=:*W5;76/,0RM+S#*H^YC'//&>.H
MJ&;X@BS?Q+'>:8Z2:*4.$E!$JN0%.<#'7/T- ':2RQPQ-+*ZQQH,L[' 4>I-
M".DD:R1LKHPRK*<@CU%<A<:Y=3^$]8N=:T:*6S2U$BBUN=\=S$R_-AL#&.<_
MIGC-1_&<.AZ!X:73=!EECU.-4MK=)P/+.!A-S=3S0!WE%<79^/PFF:S<:UI<
MNFW&E,BR0-(&W[\[ #TR>/;G.:KZ;\2[>XU>[TZ^M(H'@MI+D2072SH51=Q4
ME1PV 3^% '>45RNF>,)[[2_[4FTAH=/-D]X+B.X651MZHV "&QV]CZ59T#Q)
M<ZXMG.-*,=G=VWGI<QW"R*ASC8W (;\^_H: -UX(9)HI7B1I(LF-RN2F1@X/
M;(J2L#Q-XHB\.FQA\E9KF]D,<4;S+$N%&68NW  X_.LFQ\?MJ'AW4M2M-)>>
MXTV8QW%O%.I! ZNCXPPZG\* .UHKE] \8-XC66XLM+F-C' )//,@^:0J"8E'
M0L.A.<"L*W^*4]QHW]LCPQ>#3$<)-<^>NU/F R!C+#D=O:@#T6BN&UGXE66G
M378L[>&]BM8T>5_MB1DEAD!%/+<<\>M27GQ!V7VEVFF:-<:C+J5F+N%4E5"
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MH=%\1^&M;U.;0[:ROK#4IA,4N)C$T,A'S,<+@J?;G^N=)X#U/39_"W]FK;7
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M;Z[I=TT<L3SR1@HX7:=V1]>W3ZFM9M'UK_A8/AS5)+!#!#IY@N7@*K'"YW\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ+L51L 'S?-\O/X#N>&6VA^(M/;Q;91Z.)X]:NIFAN1=1JB+)N 9@3NX#9(
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MM7&M:8^GWVFA2UL9@_G;CA=C8&<\53^)$DL/B'P=)# T\JW[%8E8*7/R<9/
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN1?7I;C6O!K:AH=M]JOXY)!/N+?9R4SA3CJ1C/\ DU)I]M OB7Q["L,8B>.
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M)QR^.%_VL46_CZ(:=K<VH:>UM=Z3,L,MM%,)=[.<)M; ^\>.1Q0!V!=0P4L
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1]?T/3=:TR)VG>XN-/EM[O?%"V"[93ID# !K0\.>#;S3-8E:\T&QN'^WM/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
#?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>a123121ex-1021004.jpg
<TEXT>
begin 644 a123121ex-1021004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *#THH/2@ '(HH' HH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M51I,'CY1^5 '=45EZGXCT;1IXX=2U*VM99!E4D?!(]:TU974,K!E(R"#D$4
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M1[NV2.U %NBJMI<2"PM6OG@2Y>-3)Y;_ "%\#.TGJ,U/'+'*NZ.177.,J<T
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M4.@:/;6TUM!I5E'!/_K8TMU"R?[PQS2KH6D(8RNEV0,<9B3$"_*AZJ..![4
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M3KM+,&_3->J7&AZ5=ZG#J5QI]M+>PX\N=HP77'3GV[>E+9Z)I>GRW$MGIUK
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MD9(7VC,:G&0/3H* /.;G0M,U/XOOIM[:)-9QZ,NV(Y"C:X Z8Z5S=N4E^$,
MGF8&VUI4MUSVWCY?I@L?PKV$Z!I;:P^KFT7[>Z>6T^YLE<8QUQTJB?!'ALZ?
M]@.E1&T\WSO*WMC?C&>OI0!R;)I.L^/_ !-9^*7M@D$,45C'<RJ!'&R$NZ9.
M W"G/44V^TC1[K5O >E0RO>Z4$O8T9Y#F15C'4C&1D8XX(]J[74_">@:S/'-
MJ.E6]Q+&H579><#H"1U'UJ2X\-:-=7-C<2Z?$9; *MJ5ROE!>@4#C P.* .;
M^'UM!I^I>*-.LW/V.VU'$,>_<L>5R5'I@\?AS56^MK63XY67FV\+G^RA*"Z
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M=*U34'OIA<QSRQB*8P7#QB9/[K@'D>U %[1KBUO]!L9[0-]EEMT,8?).TJ,
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;3O;^:QR7"XP2>YYQ^%<_P")EM] \<ZAK.O>'!JFC7D,*I<^2LWV8J-IRK#
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M#;R7;QQVM@EQ&3&@;<[E\A22?Y=* .7FBTK7(/#^F^%]):/7+7[/-<W45O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M45C:[X@717LK>.RGO;V^D:.WMX2H+%5+$EF(  QR:QH_B##_ &3JFH7&BZC
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M6H=8T?6?%7A>[DMO#4&D21SQ74%LX427+IN#;\8QP0 #@\>AKU&D) ZD#ZT
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M3A&;' /M7&^&/#%WI?BU]2@TK^R;*>U87%NMT)$:7<,%5'08S],X% &OXO\
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M3YDL;N.)8Y9%&R3:H4CKSGG\.N* +J>-1-I_A^Z@TR24ZR^Q8UG3='CDGWP
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M?O\  SA/FYXK-N%O+KPAK\UIX+.F/>6WDI#&@\^9CE<E5 PH!^O6I9UOFO/
M;C2-1*VJG[1^X_U.8Q'\WISSSVH UK?XAZ7+H^J:A-:WMJ=-D$4UM.@67<?N
M@#.,DY')[5-9^.;&XO=0L;BQOK.\L;8W4D$R*6:,#)*[&()Y'&>]<'J/AC5=
M2E\6B'3+K=_:45];+*FQ+@(7#*">#PQQ^%=!I$DLS7UU:^!VTA?L<WGR/$!-
M*V/ECC'!.>#Z=J -+3_B1IE_<::AT_4K>#46$<%S/"%B9SD;<YY.1CC(YJQX
M?\37VK>*]>TV;3Y([2QE$<4XQC(ZAN>IX(QVZX[\:^G:HWA;P+'_ &1?B2PO
MT>Y3R#NC56Y8@<X]*Z+PW#J&F_$3Q+'<:?>_9=0ECE@N53]R JMG+$]3E1QG
MI[4 =%K?B&#19[*V-K<W=Y>LRV]O;*"S[1ECEB  !CJ:YK7OB&UOX.FU?3;&
M9;F.^^Q217*@&&0'Y@P!]..#U(J[XUN-6M]1T-K*VU*?3Q-(UZNG+F4@ ;!G
MJ 3G/(SCK7#7>BZU/X)U^QCT"^@?^VA>Q1%=Q:-SC"X)W%<#./7ZT >R03&6
MUCFDB>%G0,T<F-R9&<'!(R/8FN7M/']C>7%@$T[4$L[^X-O:WSQJ(I&&<?Q;
MAG!QD5TEG=M>Z?'=?9I[9I%W"&X4+(OLP!.#[9KR,/XBGL]&N+_P_K=SJ%CJ
MHNKEWC&T)D_)$OITZ#''7I0!V-]\2=/L[S4[>/2M5NO[-<K<RV\ 9$QU))88
M'!Z^E:5QXQL;;5]'T]K:[;^UHP]O.$ CY&<$DYSC'&.XKCHM.U%+7XBHVF7N
MZ^=C:CR&/G9W@;?7J.G:K6KZ?=2_"33KR7S+75-(ACN4:=2KJ\?!!SSR.GKQ
M0!VVF:U%J>H:G9QV\\;:?,(7=]NUR1GY2">V,YP1D5C3^+[F/X@KX;BTJ66(
M6XE>9&7/S%1NP2,(,G/4YZ#UT?"EC+9:!"]R"+R[)N[G.?\ 62'<1SZ9 _"N
M?OK>^TSXKQ:P=-O+JRNK 6HDM8]_EOO'+]-HQSF@"?2-8TFPU+Q?<Q3:G*UG
M*LMY',"RI\I_U0ZX^4_@!VQ2#XF:6?[/=M-U=;>_P(9S:_(SGH@YRQSQP".:
MQ;>QOTO?B,S:;>A;^$K:G[.W[XA9%^7CGEA^'-4I].U)?"G@2+^RK]I;&]66
MYC6V8M$J/R2,<>WK0!VMGXXTZ>#59;RVO=-&F*C3K>1;&VOG:0 2><4FD>.K
M'5=:CTE[&_L;J:,RVZWD03SE&3E>3V!-<=XGT#5];\3^*HK6SN1#<V$*Q,\;
M+'-)&\;8!/!. P!]S6QX:^S2ZOITEOX$FTNY17:YNIK81B(;" (SU8DD#'H3
M0!Z#7-R>,K6/7-5T@6%\]UIUJ;I@D:D2KA>$YR3\WMT-6?#'B)?$EA<7'V*>
MSDM[E[:2&?[RLH!Y_!A7/>--'U9?$6E:QH$9%U-NL;IT0DK&XXD./[O)R>^*
M -BU\9V=WHFEZI'9WGE:E="UACV+O#'=R1GI\AK-MM=L+!?&%_I_]H7<]C(7
MGAG;Y58*3B,$\+D,3].,\52\)^$M0TCQ-<6D^YM%TZ5[BP9^KO*H')[[0&'U
M:J]I:2S77Q$MK73[Y3>Q-Y FA*B1_*8$ ].68$#T(H J^)?$=[=:?X,UB:"^
ML&DU",S6\;']ZGRDD*IRP.. >>?>NYT3Q39:Y?7MC'#=6UY9D>9!=1>6^T_=
M8#T/Y\CUKS_5+R?4-!\"7(TR_B^R:A LJ-;L2-FT9&!R#CCU_"M[1%E'QA\1
M2M;SI%-:1>7(\1"MM" \GW!_*@#I->\36F@R6UN\%U=WMUN\BTM(]\D@7EB!
MTP!SSZ&J<'CK2)-(O[^9;JV.GE5N[>6$B6$L<#*C/YCT-9OBI;O2O&FC>)/L
MCW&FV\$D%RT2%WB#9PVT<XZ<CW'>N9UBWGU9/%_B:WM+M+&ZT^.UMUD@*O,V
M5RP7K@8ZX[GT- 'H>@>*;'Q&T_V&&[6.-482SP-&L@8<%2>M;=8O@\D^"]$#
M1R1LMC"A612I!" '@_2MJ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGO2UPVJ:I8W%UX.DUK3[M;ZXG#VYBD&R.0@?>P>0<J<?_7!UK7Q;'<^*-3T
MV$\5U8PF<,[*$E7C!![9W#]?2@#HZ*XVX^(-O#8:9(NF7,EY?QM,EF'0.L8.
M-Q)('/4>O/I6QX7\367BO2!J%FKH YCDBDQN1AV./J#0!M45RNH^-1;ZM=Z;
MIFC7VJSV07[4;;;MC+#*CD\G@_E7/>,_&*ZGX MKS2(Y3!?W2VLQ8A'CP?F0
MC/!;&/3!/J* /2Z*P?"^A6VBVMP]O92V374IDDMI)A((ST 4CMCG%6]>URV\
M/Z4]_<K)( RI'%$NYY'8X55'J30!IT5RNF^-DN=7&E:AI%]IEZ\+30QSA3YJ
MKR0I!Y/!X]J3PUXYB\430BTTC4HK>0/FZEC B!7'&X$\G/\ .@#JZYO6_!EK
MK^KPWMY?W_D(JJ]DDV(),'/S+]?Y57\0>)[_ $OQCH.CVMFLT-_YAD8L 3@=
M!Z8Z^_2N<L-:/AGQ=XQCM]*U'4 )HIRL #! 4+-DDYZL<  ]* /3P !@<"BN
M3OO'MA;6FG26MI<WL^H0?:(;>/:K"/CYF).!UQ[FM/PSXEL?%6E?;[$.JJYC
MDCDQN1AU!P3ZT ;-%>/^)++P\?BY.NOS-%8/8"9@9G4-+G Y!R.!T&.E;_AI
M_#6FQ:UJWA2WO[Q+9%BD@BD9UE(^;*;B23@X_#@<\@'H-%<EH'CN#Q'<645C
MIEVRS(S3OE<6V"0-_/<J<>O/I52^^)^EV-Y(&LKN2PBG-O)>IMV;P2#@9RPS
MW^M '6Z=IMII-K]FLH1%$7:0C).68Y))//4U;KE]6\;6VGW%Q#9Z?>ZF;55D
MNGM%#)"A7<"23R<<X%2V_C*PNM7T[3H8+EI-0L?ML+%0/EYPIR>#P?:@#HZ*
MX#5/B3M\)WNK:9IDYEMKX631SX!4]V."?ICU-7K[4=(F\8^'&O;?4X=3GA=K
M6,_+&F0=PDYP3QT&>V>U '8T5S5MXSM;F_UNR^PWD4^DQF61)%53(H&05Y[]
MNV,>M,G\<6=O865PUA>O-=6PNC;QJN^&/CYGRP Z\>M '445QFLLWCKP;!=^
M';V[B>216C,4HB*G.&$GL.>!GVS6OJ/B.WT>_M=+-M?7MY+ TH6!%8E4X).2
M!D^U &Y15>QNTU#3[:]C1TCN(EE59!A@& (!'8\U8H **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#AIOA^+O7]9>XEC?1[^,RQVI!(BNF7:
MTH'KC/.?XNV!5W1O#^HZ/X#N-/E,=WJTT4GF-YF%D<C:HW$= H4<CM765335
MM/EU632X[N%[Z*/S9(%;+(O')';J/S% ' R^%/$#^%?">RVM_P"TM%N$D>U:
M;"NH/'SC(!X&?QQZ'8@T?6_^%D/KLEI:K9MIPMSB?<=_WL#Y<_>X^F#UXKLJ
M* /*M)\!Z]8:587216::OI^I37,4<DI*21. "N1T)V@CC\N16VGA[6M>O]3U
MC5;>+3IY],DT^VLQ.)MF[.79@ .N.!VKNJ* /,[/P]XSGM_#]K>6^EP0Z)=1
M[7$S,TT:#;N  (Y7IG!]<5T6CZ5K&F>,M9G,%L^EZA(D_G^:0ZD(5VA<<\@>
M@P>_0;&J^(-(T/9_:>H06IDY42-R1ZXZX]ZO03Q75O'<02+)#*H='4Y#*1D$
M&@"2N=\:>&#XKT(64=R;:YAF6>WFY^5UR.Q]"?IUKHJ* ./MK_QT(5L9]#T\
MW"I@ZD;X>2Q]?+"[OPXY'I63KGA_Q5=>([:[:WL=4C.GO; R2>5';3,/FD"\
MD^V,G'I7>)J5C+J$FGQWD#WD:[Y(%D!=%XY*]1U'YBK5 'EUAX7\4Z5X=\/A
M=/M;B[T6\E=;=;D*9XW)YW$84\D_3'?BM!-*\6P7/B/4)--TRZDU)8-MKYV5
M95^5D)8 ?<)&3C)[5Z#10!Y5'X"U*XL]=@M+)M%L[F.)[:RDNA,//1@V[@D*
M#C%=-H$WC>\N87UNTL["&WC8,L;J[7+E<#.,[5!YX(/3M77T4 9VA/JLFD1-
MK<4$5^2WF) V5 W'&#],5HT44 %(2%!)( '))I::Z))&T<BJZ,"&5AD$'L10
M!Y5#J'_"(:]J=YH>IZ+JVG:C-YS6C:K%"\3G))!8D8_7IQQFKE]XMU+6-"U+
M9J6AZ1.UN4MX$U:*25W)'S>8"%3C('?)SD8KJCX?\'Q7<=BVDZ&MTZED@:WB
M\QAZ@$9(ZTR3X?\ A.61I&T&S#,<G:FT?@!P* /.M,N5_P"$GT&^G31;2SM+
M5[.=%UJ!VP0<R'!ZDL3@9/7)%9\INF\'V_AN,Z(([&]^T1W)UN#]\-[' 7/'
M#=2>W3/%>I_\*\\(_P#0"M?U_P :/^%>>$?^@%:_K_C0!P7BR6SUO4)Y8?[(
M348YT:RU:WU:"/:OR_ZP%MS;<'L3Z8JQ_:+>'O%>H:K8WF@ZW!J:1F96U.&%
MHY%&,_,<8))Z?I7:_P#"O/"/_0"M?U_QH_X5YX1_Z 5K^O\ C0!I>'KMKS1(
M)9+RRNIN1+)9.&B#9SM4CT! K4JEI>D:?HEH;73;2*U@+%RD8P"QZD^_ _*K
MM 'G\.AZU'XJ\8WQTUOL^HVGEVK>='^\94V@8SD9Z\X]ZQI/"_B0^ /#VD+H
MSF[T[4/M$J_:(L% 7;@[N^_'X&O6:* /.[#3?%/AV^U6UL=#M=1M;VZ:Y@NI
MKI$$!?J&7!) /I4.N:+XMO=<N@^G07]I+IOV:!_M8BBMY6CVO)L.23DL!QT(
MYKOQJNG-J!T\7]J;T=;<3+Y@XS]W.>G-6R0 23@"@#S31=&\26#^#A-H?&EI
M/%<D7<?RK(0H;KS@#=@9].M6;6PUF)?%\UUX<\^&]NHWBMI)D8SQ<*_0X!"#
M<.>IQVKOH+B&ZA6:WFCFB;[KQL&4_0BI* /.?"^E:SX:M/$<^F:7<):N4?3M
M/NYP6W '?T)P.F.<G KO[*2XFL+>2[@$%R\:M+"&#"-R.5R.N#QFIZ* .&\#
MQ'0-0\0Z#.,W O7OK==P#3PN  5!QT*X)Z9X[4G@EK[P]X5U>?7K26SBBNYK
ME Y4_NS@X&#USNZ^HQ782Z=93WT%]):Q-=P B*<J-Z@@@C/7')XZ4M[I]IJ,
M217D"S1HXD"/]W<.F1W^AH YOX::1/HW@:Q@N>)9=TY7&-H8Y /OC%8MC:^*
M/"&NZM!IV@IJEAJ5VUS#*+H1^4S==^0>.G;\:]'HH \_N[#7/#_C4^(K?3I-
M4BOK)(;R*U904F4 ;@&YV_+^O/:L;7_#^O7WAVXN5TF;[7?ZTE[]D5U9HHU3
M:-QSC)QGVSS7K-% '$1Z?J1^+S:FVG3+8'31 +C*E=V0WK^'_P!;FH[?P?=P
M?$BXOU8_V+)B^,7 4W6"O0<G'+9]2/2NW@N(;J%9K>:.:)ONO&P93]"*DH \
MVO\ PYJ.L^/?$.ZSG@L;W2_LB7; !=XV'(YR1D5?\+W?BVWAL-!N?#T=I#8I
M'%+?O<AD=$ 'R*!R2!CKQG\*[JB@#S72M)U;2-"\6Z*^BSW<<\UQ-#,'15G#
MJJJH&<YX)_\ K\4R#2]>T[3/!^KP:3+-/I<$EM=6.Y5DVL-NX9.#TSCW'X>E
MM(B,BLZJSG"@G!8XSQZTZ@#S/4=)U?6$\1>('T:XM[FYTW^S[2R:13(X)^9R
M!TQV'L?6DFL-8DU?P%=C1;L)81>5= [?W60J9.#[;OI[\5Z;10!S?CK09_$/
MAB6UL]OVR&1;BW#' 9U.0.H'(R.>.:PYHM8\9:KH?V[0KG2H=-N1=SRS2*0S
M*.%0#DY;OQ@?6O0*165QE6!'L: .-\'+J">(O$LMYI5S:17=T)H))<8=0-OY
MG /XU8\<0:@4T6\T[3Y+][+44GDAC8!BH5AW^HKJZ9'+'+N\N17VL5;:<X(Z
M@^] '#6MGJ4/Q0U35I=+NA:3:8(T<!6!<!"5&#UX(^M<AIOA36[+PYH5\WA]
M[N[TN\G$UA.5'FQN 0PSG//L>>W%>UT4 <OX.6_,=S-/X=M- M7V^5:0A2[-
MSN=BH ] !C/%8?C :L?'>A:A9Z#?7=OI@D+O'MQ)O&/EY[>^*]$HH XZ#Q#K
MEYJD;)X4N[.%(W>YFF"%Y%525C3!ZECQD\>G)-<_%I_B/1]9M?%L&FS3W6I.
MZZEIT2J#''GY,?[0 &3W/UKU&B@#RI-)OM)\0:VESX+@UR&]NGNK2Y:&+Y#(
M2=CLP) !..O&#ZUI%?$/AKQ7<ZG%H)U"UU.U@66.R< V\D2;< 'MDG'M],5Z
M'10!P6O'7_[2\*Z__8<EQ+:&X-Q:6T@+1"1 JKD]2!G) QD=LBL"3P[KU_X<
M\;VYT::UEU&Z2[MXY)%;?\X<J,$\X'TR<5ZWN&[;D;L9QWI: /--5M]8U*3P
M5.-#O8OL-R&N$.TF-5*#)P>^"?I6CXX\,W^J:UI-]I>5D??97C+P1;N#N;/;
M SCW(KNJ* ///%.AW%KXITK4H/#L>LZ7#8FSDM=J.8\$E2 WX<_7UKI_"Z3+
MI\S/HD&C0O+F&TC500N!\S;>,DYX[5N4$@ DG '>@#@(I=4\)>,-<FDTF_U'
M3M4DCF@DLHP_ER8(*L,\9]<XX'K7-WGA?6;#X:Z=9?V?<3WDFJK>200IN,2G
M( .#UY'TR<],U[&"",CD44 <[J?BEM.U[0]-_LR=X]5R//+;?*(&<%<<GUY&
M/>J?Q#T>^U70[6;3HC/=6%Y%=I /^6NTX(_(Y_"NGDL[::[@NI;>-[BW#"&1
ME!:/< &VGMD#%39!)&>1UH X8W5[XE\2:7J46B:A9VVDI</*;R+RWE=XR@1%
MSSUSGI4GPKM+S3_!D=G?6=Q:SQ32$I/&5R"<@CV_SZ5VU% '">,+74$\<>%M
M5MM-N;VWMFE246Z@E2RX&<D #KR<#CK4-D]_!KOCJ5M(OMLZH;?$1Q,5C*84
M]#G@UZ#2;ASR..OM0!X^FG7UE;>&]7N_"DVJVL.E?8KBSEMPTD3A\A]A!Z]N
M.A/2O0_"BG^SII/[ AT2.28F.V1%5BH &YPO&2<_ABMX$$9'(HH \QU6\N=+
M^+,NJ/H.K7EC_9XMC);6C2 MG=D=B.U:-OXGN?[3O+S3O"FJ062VYENC+:%)
M;B7A8U1>^ #DC/X8Y[PLH(!8 GH">M+0!Y;X=M=9\)>)+28Z?=W-EK\?VB\B
M@ML"SN&.<>RKNV\D<9/;%4M.M;C19;O2+[X?+JEZUQ*]O>FW1XG5B2NZ0C@#
MZ].PKU^B@#S2WEUCP=XJUG.@7NIVVJ21R0R6B[E0A<%#_= S@9[ 5/K2ZG8>
M-O#_ (CGT>[G'V)K:XM["/SO(<Y(&>,CYL9X'%>B4 Y&1TH \7GT#6IO /BF
MU_LB\2XFU7[7'$R#<\9(/R@$Y( YQFMW5KB[O_&W@S4(]%U5((=ZRE[4_NM_
MR#=C(7U.>@/X5Z710!P/BOPU?3^+;.\TQ&%OJL9L=6V@_P"IX.[CH2H9<]N/
M6LWQ7ITFF>./[6N?#,VO:9<VJ0JD4?FM Z$'[N#P<#KUR?I7J%% &%X2A,6B
M _V+%HZ22LZ6B !E7H"^/XB!GV&!VKG?'$$=UK<(-GK-M=VUJ9;35M-BDEPQ
M)!B95'< =3_%V[]]D9QGGTI: ,CPO)JDWAG3Y-:0IJ+19F! !SGC('0XQGWK
M7HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "F2LZPNT:!W"DJ
MI. 3V&>U/I#T- 'ET/Q&\23>&!XD_L6P_LN*0).1.3)C=MR%..Y'K5Z"XAM?
MBWJ.JN0MI)H NEDZ;D#IS_XZ>M<YX/TG6/$7PQ30[>*VCL+FZ/G7;RG>B!PQ
M 3'+94<YQ@UU\GA?4IO&D\S06YT1])_LM2TF7"<'.W'/.1S0!D:;\2M5NM0T
MR2?3HOL%_*(]D-O.9(0<X)<J%?U^7/ -:NN>-=5T*WOKZ\T^U@MK>[6&*"6;
M]]<19 :1<' Z@CCO[<PZ!HWCK3([319+O3(])M6"BZC5C.\8;.T Y )''(X'
MO6-JG@;Q5>6.OV,<6F,FH7OVG[5)*QF= V53.. ,#KTYH ]-O]2@T_1Y]2F.
M((83,<G&0!G'U/2N+E\7>)=,TVRU_4['36T:Z,6Z.WD?S8%DQAB2,'J./>NI
METR75?"CZ9J20I-/:F*4)\ZHQ7&1GK@\_A7*'PSXEU#PU9^&-36P-G!+&);Q
M)"6DA1@0JIMX;@#)XXH K9OM5^+>K6C6VFW-K'911O'<@LIA+*Q(&""W/TX%
M=7XNUF3PIX3GU&RLX9!:^6HB)V*JE@O 'ID<5F:?H6K6?Q,U#6?LUN-,N[=8
M 1+\Z!57!VX]5QCWH^)[1S>#9].-Y96TMXZ*INYA&"%8,<'N>!^= #-,\8:L
M-;AM-<TVVM+:XL7O89;>4R$*N"0WX>WI5&;QIXFM?#Z^*9M*L?[%=D80>8PN
M$B9L!R?NG.1P/6L^75=*N/$NBS2ZSHYT^#2VL[HB\&X,RD';ZCA>?<UF1W=N
MW@Y_!UQKVBM9&4*M^+X;EA#A\;,<MP1UQ0!U%NUO;_%R[U(2@V]QX?%T6"$8
M42*,^IX7-$OC3Q GAM?$XT>S.D%@_E&9A<"'=C=TVYZ'&>]98U71V\<2W3:U
MI*:-_9/]F(RW@\S;PV<>N<BLZVU0VO@N;PB-=T%H6#0IJ O<8B8Y.4()S@D=
M?\: /4[G6K.U\/OK;L?L:V_VG(&"5VY& >Y]*P=-U_Q+<MIEW=:/:)IEZ"[/
M%,S26\94LK/QCD8Z56OM8\'WOA&3P^?$5AY1M!;*[3KD84!6_ @&L+P[XJNK
M:&STO5-?\-C3K5?*>:*YW231A=H7'0=N>* -I?&6NWFA3^(M.TNQETF)Y"$:
M=O/:)"0S?=VCH3BG7/C?5+K6[+3]!T:.Z6\TY;Z.6XF\H 'UX/3@$#N>U<O:
M:M%H_AB^\,66L:%/:3-)'!=R7H7RXI/O;DQDD;F[U9TZ[T/1O&MA>6FN:7)I
M=MI0L06NU5@PYW8QSD@9^N: +NJ^+]8O_"6B7ELL%C>7FJI:RQ^8W)64C 8<
MX)7GKP35W7O'\^E7LFG1C3/MEI;++<^=,X5Y",[(\#)Z'KCJ*YB&>W?P6L#Z
MKH)OK'5Q>VZF[!&POOP6]22PX["MB2:_TKQ)/K6CWWAZ4ZC;QB^MY;X*%F4'
ME3Z<_P#UNE &DOCS4;VQ\/2Z9HL<TVK>8ICFN/+\MT!W#IR.,Y[@8QDT6WQ"
MDAT76Y]3L$74=*N!;M;P2$K*S<*%8CN0>QZ?A5*\N;^;4/#E])J^AW5S9SR3
M71%VD:*L@VE$&<G"DX)/6LNZT**]_P"$L0ZWID!U"Z2[L9DODR'0L0&[CKU%
M %R^BU:;XG>%9M9M=.MYBDS!K60DG"]&+#G&>![FG7'Q89+Z*2"SM9=.:X\D
MA9F-QMW$;]NW '&<>XJK<MJFO>)M$O\ 6+GP[%;V)=9A#J .]'&&X^G3FI-!
MGUW0=._L&VU;PX+%)'$-Z;L%XD9B<[,\GDXS0!NS>+_$$GB34-+L/#T,L-C)
M%YT\EV%Q$PSNZ=UYQR1@\&L=?BV)-5MBEG VE3W'DAED)G1<XWLH&,9YQZ5H
MZ7=QQ>,?$,]U>Z8NFZA%$J3B_C+DHFS[N>,@D^W'6LG1+W7]!LX= M=1\.FQ
MA<^7J+WB%A&7SC9GEL$^WO0!W7B[4;K2/"6IW]EL^T00%D+] ?7\.M8-KXIU
M.R\&Z))<1V]UK&IK#'9Q^:0)=R*2\A(&",DG'L.];_B2P;7O"6H6=G(C-=6Q
M$+@@JQ(R.?0^M<D?#?B"[\+^'9#8V]MK.A/&(8GN RRH %;) P,@#N>E &UH
MOBC47\2MX>U[3H;2^:W^TP/;RF2.1,X(Z9!R#_G&>LKC(;/6[[7V\2WUA%I[
M6=@\-M9RW*ON<DDL[J,!< "MCPEJUYKGAFSU&_MEM[B4'<J?=;!(#+R>#C(H
M P=>\=:CHCWES+HBKIMI>);-+)/MDE!&2Z+MZ<KW_KCMI3((G,*J\@!VJ[;0
M3VR0#C\C7DFI^$_%][!XBMI=*L;J:]G$D=_+."[1@Y6.,$_+C'? Y/M7JD,M
MW_9J2W%L/M8CW/!$X(WXY4,<#KZXH \D\)ZC8Z=X9O\ Q5J^E6DMW#?R&WNM
M^)9)7."GW>%&>O/&>.*Z;1?&S>(Y-4T:_M;4R?8WE5[5S)$Z8P5;<!SR/KFL
M6Q\#Z[<_#NYTBXM!9ZA!J'VVUWS(RR''0[2<=QSWQ74:?<>-=0CF.K:7:64"
MV\H\B*97DGD*X49SM4=>_IVH Y_P7KTFB?#+0H[6U6ZO[ZYEM[:%GV*6,CDE
MFQP !^-=!;>+]4MK^YTO6M&C@U%+-[JV$%QNCNMH)*C(R#T]>YKF].\'>(+;
MP=H++81QZSHE[)-'!).I$T;-N8!@2 3P.?2MR?2M7UGQ.==NM(:T6PL)8K.W
MDN$,DTKJ0>58J!R1R>^: *^G_$:^NI]%GNO#YLM*U27R([EKI7)<],* #C(Q
MD]?Y[-MXLFD\2ZOH]UI\5J=/@-PDK76[SD[-@+\HQR>3CWKE#X9\0OX5\(61
MTDK<:7?K+<)]HC.$5L[L[L'.>@YXK1^(&B#4M>T"2RNY+>^N9FL9C"?F:W*L
MSY]@ ?8;J .K\,:G>ZSX=L]1O[1+6:X3S!&C[AL/*GVR,'%8%SXSU><ZA>:+
MH<=[I6GN\<TTESY;S,HRWEC!X'J>O:NT1%C1410J*,*JC  ]!7G]EIGB30+/
M6M%ATG^T;.[DEDM;E+F--GF<%75B#QR> ?\   O77CYR^D#2M$GU'^U+62XA
M"SHA!4<J<YZ=SV[9/%=)%J1BT$:GJ<!L2D'G3Q,^XQ8&2"1UQ7%6'A;5]!UG
MPC%;6?VNSTVWECNKD2HH#2GYL*2"0#STZ'UKM]9T_P#M;1+[3M^S[5 \.[TW
M C/ZT <]8>,=2OI-,N/^$;G&EZB^V*Z2X5W0'[K.@'R@XSU./KQ4&D^-=1U^
M[N;:'PO*;6"ZDM+F;[8AV;1_=QDD\\#CIR<U'X53QI8VMAHE]I=M!;6I"-?B
MX5]\2] $R3N/3)QQZ4_P1IFKZ+'XBDO=+DC>YO9+NW3SHR90V<+D,0#P.N!S
M]: *NE>*+30?AC;:MIVA3+;+.8A9K/N*9E*DER/7VZD#WJR_CC6H]:&DOX/N
M5NYHFFM4^VQ?O%!ZL>B?F3GBL9-"\2K\+)-"&AL-0%V&5#=18*>=YN[.[';;
MCKSFMZXM=<G\>Z%JO]DD6B6+173^?'F%WY(QNR=I Y&1SQ0 R/XB1CP\]_=:
M:;:]74#IWV1YQ@3#J#)C &.2<=N]7?"_C2+Q#J=_I<MLEM?6?S%8K@3QR(<?
M,K@#/7ICT^@Y:3PSXF?3K^>'3HH[V+Q ^JVT,LR,)T88VY!P#]<5UWAW^VI;
MR6>_T6STBV$>P01NKR2/P=Q9> HY '7F@"KXIU'3['Q5X92\TIKJ:>X:.WN=
M^! QP,X[]1],9JEJ7C_4;2^UN"T\,2W4.D'-Q,UXL8";=V[!!/0< 9X_*I?&
M6EZOJ?B;PU+8Z8\]KI]T+B><31J -PR &8$D!<_B*J7.BZY++X[QI;;=5B5+
M,B>/]X0AC]>/7G% &MJ/C&6QNO#^S2FELM8:-!<F<+Y+/C@KM.>#GJ,X-,O/
M&YTY]8:ZTY1;6$Z6T4D5R&:XE?!"!<#:<,,Y/'/I5.7PM?:A\*K71IK<0:K;
M0(8E=E;9+&>#D$CGUST;GTI-8\'7U[X BL(S')K"3K?.SMA9+C.7R?Q('L!0
M!HQ^++RTUZQTO7-'73S?AA:S170G5W&,J0%!7J.>E<MX4OY/#NG^.;FRL3=)
M8:I*4M5DV (&.<$@XPH)Z=JWKRPU;Q/K.B2:AHLEA:Z=)]KD:2>-S)*!\JJ$
M8\9YR<4G@G1=1L[KQ,VK:<UO#J5\]Q$KR1ON1RV0=K'! //UH T(O%KW#>&1
M;Z<)1K<1E8K./]' 16;/'S8R1VY'J<5A:7XCT[1M(\7:AI^B3I)8W[FX@,X/
MFN2 Q!Y"@'/ SP/PJ]X)\*7N@7^I&\9FM89'ATQ"X;9 S%ST[DD#G^[Z5AQ>
M'/$']@^-X3I#K/JUTTMK&T\7S*[G.2&(! .>?PH Z'3/&]Q=^(K'2K_0Y=/&
MH6YGM)'N%D,F%W$%5^[QGJ>W3FJ>H?$6>W@U"_L=":]TFPN1:S7:W2JV[C<0
MFTY W 9SSD?A&^D:W+XP\(ZFVDR);V%F8KL^?$?*9D9,?>YQP<CL?7BN8>.\
MN)M3N/[ U:\T2_U!Y?)TV\4V\H3"EBH4MR5)SE0>!VH ]AM)GN+2*:2"2W>1
M QBDQN3/8X)&:X9_B3=+IESJB^%[PZ?:7+07$QN(P4 (&0O4G)Z=/>NSTS4H
MM5TBVU*W23RKB(2HC !L$9QUQG\:\Y;1]>/PV\1:?)HDZ7=U>R311++&Y*LX
M8GANVTCU.1C- '56GB^>3Q)#I5]HMQ81W4+36L\LR-Y@4 MN52=O'J?RK,/Q
M#NVL6UB'PU/)X?5B#??:H]P4-M+>5UP"#WZ<T[4;'5;_ ,6^&YVTJ:.U2RFB
MN)?,0^2TB8(.#VQUZ'-85OI?B&Q\$S^!VT*>6:0ND-]'(OV?RV<MN9LY!&3Q
MC)XH Z34O'K6^M2Z3INB7>IW"V\=U&89%598V(RP)YP-P[<G/0<T7WCN2R2\
MNVT6X_LZRN8[:YG>4(ZLV,E4Q\P&Y._.3Z<T]$TG4-(^(,<2Z?-)IT.CPV7V
MYMH7*#J.>^,8'.>V.:YW7])\3ZC#XGLY=!NKZ5KSSK2[FN%*Q0!PR+"I[E0<
MA3GG!YX(!T$D20_'. QJ$\W2"SX_B.]AD_D*U/'OB._\.:=I[Z= LL]W>QV_
MS$#@\X&>YQC/;-9UO:ZM>?%.QUB?2KBWMAI CD=RNU'))VY!ZY.,=?PYJY\1
MM,NK_0[*>RM)KN>QOX;D0P_>8 D'C\: -6+Q"[^*9=">PD29+ 7JN9%(8%MI
M7 Z<]_K[$Y#_ ! %OX336[C1[D-]L-I+;0NLAC8,5)W<9Z8^I ]ZJ:M)KVG^
M.K+7;/P]/>176FBS>%95#0OYA?YF&5'4<YQUYK(O;#7[+P3):2Z!<R73:S]I
M2.W=9<IYGF9)4\#J.GY4 ;]Q\0VLY;2"Z\,:S%<7DC)!%L0E\8_VO0C]?2HY
M/%UGK?A[7;36=%O+>>S@WWFG[P7,1YW*W';D],>]+XSNI(/$G@VX6TFE?[5)
MF!,%^8\'VR,D_A5&ZMM4U&V\4Z^^D7L37NG_ &"SLF0><1M(+LN>/F8^^!T]
M0"[J7B>ZTBY\&6&D62O9ZDH&V5AO$85, '/4!LGUQ6DOC.)I_$T2V,K?V$JN
M^'&905+'&>F-I_SQ7,W]CK,L/@+4TT6[=M-S'<VR[?,0E44'D@ '83DXQD9I
MVH:?J]AX@\6P6>@7=U'K]JBP31R($1Q$P;>2<+RQ_+CK0!O#QU'-I&C3VFFS
M7.I:M&SV]BDB@_*,MESP /4]?2N>\,:G:>'9O&FM7L-W;117D:-;2,'9/11@
MD<L_7.,8[4RQTCQ!X<C\+ZJ=(GN#I]K+:7MI R/* S':RX;#<D'CH!S5"Y\+
M^(==B\4W?]DRVK7MQ;7=E#</&=Y3.589(!*L.O&1@]#0!VFA^.H=7UFYTF:Q
M:WO(XVFB5+B.<2QCI\R' ;_9SQZUMZ#JK:WH\%^]E<6329S!<+AEP<5@>&;J
M^U'4/MLO@^'1PD1CDGE"B:3H0J@ $+GGGC\:U?"OB%O$VE27KV$MDR3O"8I&
M#'*XR0?J<?4&@#+^U/X@\?W.G.SC3M&CCD=%8@2W#\KNXY51V]<'Z4[*]T&X
MB\9^58:D/+D8:BN_+2'# F,;N. ?3M5G2%ETWXG:[;SG;%J<$5U;D@8;8-C
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MOX]-B_M.2-KQOGD6(81"?X5]ATR>35ZHKFZM[.W>XNIXH($&7DE<*JCW)X%
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M2ZTV+3IS=SO<A"2P'RHA!R03UX'04[X:V6HV-IK(U'3[BS>XU![F-9<<JX'
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M$KN&& RH*G\017IU !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM!9QBWBA?YVD0A8R@/.2<#\37H=4KG1]-O+Z&]N;"WFNH/\ 53/&"Z=^#VH
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M5)Q_L#\Z]$HH X3Q:SW7PZO(?$KV-OJGDO-%%!-U=.5*;N2<]AZXK3TNVO\
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M+O)3=GA <YP2!G %=[<W5O9Q>;=7$4$><;Y7"C/U-5/^$@T7_H+V'_@2G^-
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M,N/8<Y[ &NTL+*'3=/M[*W0)#!&$50,< 5EP>#]%M_$TGB".V;^T9,DNTC$
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MM;RQ%_HXECD>2-RCQOG@#.21D^F<]JO-X,NKOQ+KM[J%U"]CJMFMLT<(967
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M3TMQ+M0R$_>SR=O(_/\ &LVU;4;;XN7MQ>060OQHC2$6[MY;L",$DC(Z =\
M#K4-AX$\1P>%[>();0ZGI^JF_MD:;*3# RI(Z=,=OPK8LM \2WGC<Z[J5K86
ML4VG-:2)%<,[)GD'[HR<X[XQW[4 1S_$2^3X?Z?XGCT^W)GG\F:%I&&#N*Y7
MC_9/7IGO6S<>)M2NKS58-!T^WO!I>$F\Z8HTDF"2B *<X]\<\5QX\#>*Y_!:
M>%C%IL,%K<^:ER\[$S#>QX !V]>];9T'Q7H'B/4;KPZNF3VFJRB>8799?(DY
MW'@Y(.<]_H.X [_A(=;NOB)HFGHJVD$^DBZN;6;.59B<C_>4J!^=7_B<BO\
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M\%D:6)E( QSC=^-/\.V/C?3;2RT6>WTY;6UD5/M_F[G:!6'RA/4J, G&!]*
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M'V'Q=KNR9GT[3IVBLH3C;$TBJ\FWTP,+^)H ZWQ'KL/AS1Y+^:,RL&6.*%6
M,KL<!03_ )P#63%XMU"TN;]->T-[""VM6NQ<1S"5"@.-A. -YYP*D\>^'KOQ
M'X=6WL'1;RVN$N80YPK,N1@_@3^.*SY+7Q/XPT+4=.UG3K?2()8"B 3>8[RY
M!5N. HQSW.: $'CO4K-+"^UC0?LFE7\L<<,\=RLCH7Y4NOICGBFWGQ"O(K[6
MK:S\-SW2Z0W^DRBY10$P3NP>>BG &:I3V/B?6=!TSPW=:(+06\L(N+TSHT?E
MQE>4 .2QQT/I[\$>B:U#=_$!AI<K#58MMF?,0"3Y77^]Q]\'GT[4 7+[Q;J,
M_BGPE;Z9#FVU.U:ZDA=PNX,F0"V#C;R>.O2K4/CB\N_$-_I-GX<N9S8W*0S3
M"= %5B0'(ZXXS@9XZXK(_L76[2Z\$ZK#I$D]QIUFUI=V_GHOE_NP@;/XL3C/
M05H^%=.U6R\:^*KNZTV6"WOY5:VF+H58)N&3@Y&<@CCUH MQ^-)_-L#<Z+-;
MV]]?M8Q,\O[P$9PQ0@<'![_TS"WCF]D\1ZAHUCX;NKN2QE1)76X10%;HV#V[
M_3KBN-F\/^,KG3[""ZT5KBZM-6^URW37BL91NZ*"?E7'\AQ77^&=-U2W^('B
M74;O3I;>UO?+\B1G1@VSY>QR,]>E #[3QZ]QHVN7LFD-#/I,HADM3< L[9Q@
M<<>W')KK[>1YK:*22(Q2.@9HR<E"1R,^U<'J>A&7XI6XMF'V6\MUNM1B ')B
M;]VQ^K8'OM/X>@4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%(X)1@
M#M..#Z4 +17D?AGQ/J.F?#%;]KI9K^^U(P6YF7*H[OR3@\_Q'M71/JFO^%_$
MNDV>L:I%JECJDK0K(+587BDXVC"DY7GOZF@#NJS)-?TZ+Q!#H;SD:A-$94CV
M'!4>^,=C^58/Q+^W?\(M%]AN_LQ-[ LC;0Q92^ .?]HJ?PQWK&\007[?%CP_
M#:WL:7?]G2#[1+#O'\>3L!'/XT =LGAK0XKW[;'I%BMSQ^]$"@_R]JU*\N@\
M?ZRFASVTJI-JZ:O_ &9'-#!N#@'YGV9 SC/&0.G2N@\':KXDN=3U"QURUN3!
M JM;WDUH(#)GJ"%)4_@>W- '8T5QOC#7=9TSQ!X?T[3);6)-2E>)WFB+E2-O
M.,C^]TK&B\1>+);GQ/9C4-/#Z&GF^=]C.9P5+!<;\+]T\\]: /2Z*XFT\1:Q
MK.E>&[J"YT^PCU!&^T2S$%S( 0%C0D9R1GJ3C]>=N=?UCQ%X6\-7*WJVMS-K
MBVTDB0_*Y#,58J2.!@?*>OJ* /6**\^UCQ3KIUC5-.TH2E]+@CWM%IS7'VB5
MDW8X8;!TQU[U#=>*O%#MX4LXX8+"_P!5CF%PEU ?D=,8.W.1GKCW% ';?VYI
M_P#;_P#8AGQJ'D^>(BIY3..O3\*T:XB'6M;L_'FC:)J36,QN;!Y)I882IWC<
M>"3T^451F\7:Y87^G-=7&G3"YU3[%/96Y#FV5CA-S@GYN^".?:@#MK+6M.U*
M^O+*SNDFN+)@MPB@_(3G SC!Z'IZ5?KC] _Y*5XO_P"N=E_Z+:G^,=8U[3-2
MT2WT@V(2^N/L[FY5B0V,CH>F ?>@#K:*\XG\9Z_X<.O6NNPVMU<65K'<VLL"
M%%D#N(QD$] Q_0^U7;W6?$?ABYT:;6;RQN[.^G6UG2.W,;PR,,@J0QW $'T_
M7( .EB\2Z/-!J,\5\CQ::66[8*V(BN<]N>AZ9J[87UOJ=A!>VC[[>=!)&V",
M@^QKBK -8ZA\0'LHH?,1UE5)1E&<P;CN'<$DD_6GV?B/5[_2_#-E9?9+>_U2
MV:>29HRT<4: 9VH",DY'&<=: .MU75K'1+![[4;@06R$!I""<$G Z FKBL'4
M,IR",@UP6NZIXIT;P/JUWJ<%A<75O<*('$>4>'<N'9<\'VH\3>*M9AU:/3-&
MC82QVBW$S+8R7.XMD!0$^Z..I]?:@#OJ*\VG\<:U'H^A-J,!T*>[EDCNKJ[M
M69(]@X^4D8W=L^A[<UW&A27LVBVTNH7-I<W+@DS69S$XR<%?PQ0!HU6O]0M-
M+LWN[V=88$P"S>I.  !R23V%<:NN>)]<.IW^A3:7'I]C<2P1QRJTC7!CZG<"
M  W;'8UA>)/$EWXD\.>$;ZTDCM4O=3B62,Q;]LJMC.<C*@CIQGUH ]*TG6=/
MURT-UIMTMQ"KF-F4$;6'4$$ @\C\ZO57M(#;6^UA#YI)=S#%Y:LQY)QD\GZF
MN"MO&6N6VJ:&FI-ISIJ5T]M/:6_,EHQP4#,&(R RY&!Q0!Z+17FEWXI\:R66
MNWMK#H\=OHUR\<G#EI0@RP&3_=(/;VK6U#Q3J=KK_AJ0"VCT35U ;>I\Q'9<
M@$YQW&/QH [6J.JZ-INN6GV74[.*ZAY(60?=.,9!Z@\]15#PYJ%_J<FJS71C
M-I'>R0V>V,J2B'!))Z\Y''H:R]3UWQ%_PG \/Z;#IT<36?VI9[E78D [3PI'
M<B@#H-*T#2=#C*:9I]O:@@ F-,,P'J>I_&M&O*/^$_\ $[>#O^$B$.F+!:77
MV>X3:Y:;D#(YPOWAQGU/M6MKWC36/[6O+'0K7>UC%%+(!9RW#2LZE@GR<(,8
M&3WSZ4 >@T5P>H^,M=A;PO##I=O;7&L;DEBO-X:%QCL,$#G//)]NM5(?%7BR
MX.OZ>D>DB\T4B26X._;*A!8*$['"GG/X=Z .[EU;3X-4@TR6\A6^N%+Q6Y;Y
MV49R<>G!_(^E7*\IU/4;W6/%7@C6=+6Q:]NK*9DBEF.Q7,3;@=H+8!R.G48X
MK1F^(>IZ;::O9ZEIL/\ ;5C)%&@M]S02>;]P_P![\!R: /1:*X6Q\5>($O\
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MSC+KAL?WL#'0>U3:EX@U+6=0UK2-$BT]H-/MQ]JEO-[>89%)"JJ]  #DG\J
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MF#O.X-D@].-U<Y!\._$%MIMII\>MV/V>SOUO8@;0[I'#$Y=L]>1Q^O%>F44
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M9/9P7EP(I+V80P*03O<]N.GXT 8EQH.LW%K:6]W>66I0$2&^ANX<)*S8*[,
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7F25YC; !""-WR@]\8]L"M#6/"-]JMCHT@U9;?5]+.Z.[2#Y&S@'*$]PH[T
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MUB[T_1I(-82?5].NS=&>[5O+E).2,#E0,  #C% &;KWB'6!I/CRUEN(P=/\
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M+CE$<(G69IGD7:3E>   />CX=:/JFAZ7J-MJ=F+=I;Z2XC(E5]RL!_=SCI0
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M\:QM)Y1>I%YLEM- \;QKQUW#'\0[]ZYCX6I%<_\ "1:G+MDU"35)8Y)3C=L
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MU*2)W;!81C!7W )S[?*/2NA\3-9^'K74/%J6H?48+,P Y(#J6! 8?[V.>N*
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MY)BK07"DB;8.-Q7;G.3@].:K>$?%NK^(Y)IKB*SM[6QCVWJ>4XE$WS95<M@
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M&5157')]21B@#K:*XI/%^K+K?ABQN],CM#JT<IGAD),D+("1@].>#@CO5/\
MX3W4K?3_ !5<7%C:/)HEPL2+&[*)%+;>2<\_E0!U^L:!I6OQ11ZI9I=)"V]%
M<D '\#5^**."%(HD5(T4*BJ,!0. !7"GQKK5MI]G+J%A86]QJ<JBQC65W C*
M;B[[03UP.!WYZ9K5\(>)+_7&OK?4; P36K*%G2&1(IU.>5W@$8(Z'VH ZBBN
M7U[Q1)IGB"WTB,V43W%H\T4MW(55I P"I^.?TJ2/7M17Q7I^CW5K;QBYTXW,
MFURS1R@@,N>A7GK0!TE0W5W;V-L]S=3QP01C+R2,%5?J37%-X]NH-%O;B>R@
M:^BUAM*@A20A)'! R2><<GM5C59]7U'3]>TK6]'@2S73GE2Z@E+QNV"0HR <
MC&?;'N* .O@GBN8(YX)%DBD4,CH<A@>A!J2O-_#GB75-)T;PA:W&EQ?V?J"1
MVJ3K,2ZMC"DC&.>O7IGO76^+[NYL?"&JW5IL\Z*V=AO)&!CDC'?'2@"[:ZSI
ME]=O:VFH6L\Z)O:.*4,0N<9XJQ=75O8VLES=3)#!$NYY)&PJCW-<!X:_M#3O
M!^AZA::%975_-'#:QRQ$AE@8;BTC;>!D<CID]:MW/BDZGX?\4PW>CP7<FD.T
M<]L9/W<J#G=DCMM)Q[4 =A+J=C"UJLEW K79Q;@N,RG&?E]:M5YMXJ>UF;X?
M7;6BHK7L'EQH<>6&"D 'T!V_7;6S'XSN)6\6QK8Q"305WKF4XF7:S<\<'"?K
M0!V%%<#/\0;\V_AIK31HYI=;B<HC7&T+(N.,XZ9(YHU+X@7.FS-9W%M86M];
MV8N;J.YN6"AC]V-"%.YL8_,>] '?45D^&==B\2>'[358HGB$ZG,;?PL#@C/<
M9'6M:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGTKNZI/K&G1ZM%I3WL(OY4+I;[OG*CJ<?YS@^AH S?&NC7/B#PE?:;9L@N)
MC1[S@$JZMC\=N/QK)O=%\1#6;'Q/;16#ZHEHUM=61F=8W7)8;7QU!/<8]ZZG
M3]6L=5%P;&Y6<6TS02[<_*Z]1S_/I5R@#F?"VA7EE?:IK.JI;IJ.IR*SQP,6
M6)%4!5R>I]3ZUE:EX=\2:9XRN==\-/82KJ*)'=07I8!"HP&!')&!V]>A[=W1
M0!PNN^'O$4MWX?UJW-I>ZIIK2F>)G,4;A^R<=!G )/8=:S9?!'B!]%\6QR-I
M[W.M2I+&D4K *0Q8@DK^ _I7IE% '#ZMX8UBXT3P[=6!M(M<T94(60DI( @#
M)NQG!Q_]<=:V?#L?B9Y9KOQ%+9QED5(K2SR43DDLQ/)8\#@XP*WZJG4K!=17
M3S>VXO67>+<R#S"OKMZXX- '*>,-&U36KJ6U;1;#4M.>WQ \DWE2V\QZL&QT
MZ=/2J,GAKQ-I-UX;O]/:#4;G3[)K2Z268H'R.S$9(!_'Y1ZUZ'5+4]8T[1;;
M[1J5[!:Q<X:5PNX@9P!U)]AS0!P,W@+7)]&U%9;FQ%^=7.K68B+%-YZJV0,9
M_&MJ.#QGJ&B:G_:J:;%/+:20V]I;YPSL,;G8DX] !Z\UU=I=V]_:175I,DT$
MJ[DD0Y##V-1'5+%=672S<QB^:+SQ!GYBF<9_.@#AV\/^(SH7@^S^P6WF:5<Q
MRW'^D]!'\HQQSD$G\*ZOQ5976I>%=3L;*-9+BXMVB16;:,MQG/MG-7[/4;+4
M5D:RO+>Y$;;',,@?:WH<=#5F@#SN?P[XCE\#:%IXL[8W&FW$9GLWG&RYC08&
M6Z8]5/\ 056M_#/BNUC\6J;+3I#K<3%?+NCA&;*[1E1G 8GG'05Z;10!Y]K'
MA[7;W3?!R1V4)FTN>*:Z7SP /+VC /?(!J*_\->(K;6O%(TNSM+BSUZ)4,T]
MSL,)\ME/ !SRY_2O1J* /,X/"6OP'P0KVMNPT<N;EDG& '8=,CD@#)QWX'K6
MMJFE^)=,\8W.M:%!:7UM?0)'<6\\GEE6084@_B?U]C7;44 4='CU&/3H_P"U
M989+QB7D$*[43/\ "O<@=,GK5ZF/+'$4$DB(7;:NYL;CZ#U-/H **@-Y:B]%
MD;F$73)Y@@+C>5SC=MZXSWJ5'21 Z,K(PR&4Y!% #J*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *;(K/$ZJYC8@@.H!*GU&>*=10!Y#?\ BOQ19>%-2A.J
M2_V_I^I^4^;6+,D.PD;5VXQ@%\X)P#SBNM77KW5+_5KW2KU#I-KI@,1$:NC7
M+ OG/7(7:"N>_:M!O"-@_C"?Q P4O/9_9GAV<,<\N3GKMPN,=*31_"<6A^#Y
M- L[DY>.13<.F3N?/S%<]LCC/:@#AY[[4O$'@?P3>W6I3I=76L)%)+"%3/SR
M!6V@;<KL&.,>H-6[ZSU*?XP?9K'5#:W(T8!KMH%D8X;KMX7).">,=<8K77X>
MSIX/TW0X]<=)M.O!=VUVML/E(+$#;NYY8GK5ZV\(WD/B^'Q#-K1FF6S%K*GV
M55\SC[V0>/F^; 'M0!S1\4^(Q\/9[V6\B74K+519S3"%3O4.%/&-H.6Z@=!6
MAJ]_XBO/B.^@:9KG]GVYT\7()M(Y<-NP>HSS]3]*?_PKN[/A>[T8^(6)N;[[
M:TYM 3G.2,;N<L <Y[5IQ^$[M?&"^(I-75Y19"T:,6H&>.6SNX^;YL8]O>@!
M? &LW>N>%(KF_N%N+R.:2&9U0+DJQQP !TQ69XNU;6+&XUE[77(;86E@)[:T
M@B620G/S/+O0[1G@ $9_"MGP=X7?PGI4UBU^;SS)VFWF$1X) SQD^E9>K> K
MJ^U?5;RS\0SV4.JQ".Z@%NLA;"D##$Y4<]![\^@!TVA7[ZKX?T[4)%"27-M'
M,RCH"R@G^=><:5XH\2)H&J^([_6TFMM*NIK9K/[&B_:#@!,L.5&YUZ=AR37H
M?A[29M#T*UTV:^:\-N@C64Q!/E'"C ]!@=S6'HW@1+#P[J^C7U^+V#4Y7F=A
M (RC, "1RW0@$>A% &;X?U3Q=/KFEO/'J-QIES ?M1NK:")8W(R&0IEBO;!_
M_5$_B#6+74=,F&O0WR7.L"RGMH(4:WC1\[0L@4,7  SR>>O3G7T7P;J5A)8K
MJ/B>ZU"TL2&M[?R!$ P! W,"68#/ )K)7X8W\>D6^F1^++A;:SN1<V:BS3]R
MX).2<Y8_,>X'M0 'Q%J2>-[C3-0UR73,7R&U@FM8_(N;?C*ARN[<>><]_P K
M.GZAX@\4/K\UCJ[:?]ANGM;6".")U8IW?<"W/L1BK][X0U'5K06>JZZEY;"[
M2X&ZR59%"MDH&#8&>F<<"F_\(9?V5_JDVBZZ+&VU)C)+;O9B8+(1RRG<,9H
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M6L=8N5MVMH8"&CSP#N+>O-:T?@W4TN?%DPO;0'78]B81OW7#*,^ORL?QJ!_
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M* 03O/W>O<?XTS2G_MKXCWNLVDD<FGV5E_9_FIR'E+AV /?'J..: .SHHHH
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M:XA#.J=-W0X]LC.*Y*;7?%DX\4O!>:;"FBR$QJ+5F,J@;\$E^/E '0]3TZT
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M.#GN* ._HKA]*\6:GK%CX6:V-K]HU)I'O/W3%4CC^_MYX.2HY/4UM>,]6O\
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M7>I7T7S30V$._8?]IN #_A5C0_%MAK^H7=A;P7D%S: &6.YA\LC/3O0!D2^
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MDVGV:X5(G7<-S$[1D_WAR3^%=I5'2]8L-9AFET^?SDAF:"0[&7:ZXR.0/44
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6HA%C]DEA56W'G<2#_O?I1X-T"]\.Z9=6U]>174DUT]P'C3;][!.?QS71T4
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MOE\L#^Z._K6MI][>^,_$!M;C4;FQ@LK"UN1'9S>6TLLJ!R3QDJ.F/<>M:H\
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MDUXVW>L<;'(7/&XY '':KNKW'B?PIIUY&=1-['>W\%MITTA5IH@^=V[("D\
M#.!WJ[;_  YMXO#6F:6VI3I<Z;.T]M>PJ%="S9(P<\?X"K-UX"AU'1[NRU/5
M[^\FN)(Y!<R, T13[NP 8'4YXYS0!%X0@\5V>K7<.K_:9=+9 T$EW+$\JOQD
M?(3QUJGXY$W_  F_@U%O;B&*6YD!2/!&X!<-@\$_-CG.!6YH/AFZTVY6[U/6
M[O5+J-&CB,N%2-2>RCJ< 9)-+XG\+MK]SI=Y;W[6=YITQEBD$8<8.,@@]^!C
M^1H Q$EU7QAKNMV]KKEUI=MI<XMHDMXU!=\?,S$\D9' XXK6\!Z[=Z_X<,NH
M%&OK:XDMKAD&%9E/4<>A'2F7/A2_BU^XU;1M<DLGO%47<4L(E20J-H91QM;
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MD3)!W=/F8;5P2..>N: *6HZSXB\+#2]0U74+2]L[Z[C@GA6U\LV^\$Y1@26
MP>HR<=LT6VL>)_$MG>ZIX?O+&."WNWBM[66#/GJN =TF[C/)&!Z<U/%X3UF]
M_LNRUR^L;G3--E66-8H6$DY083?DX&.IQG-,M_!NNZ5?30Z)XA2ST>XG>:2
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MJMOK>E0:C:K*L,P)42H488)'(/TKB?#EQXIU*WO=2N/$"&&QN;J$V_V1<2%
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MTTOQ#I&DO:2R'4BZK,& 5"HS@T &E>%[?2-=U+5HKV]EEU @RQRR H"#Q@
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MHIA.=L08LP^[U(QC)_.E\6IJ%SX>DTK3XGEO;]/LXEVXCC!X=W/\(VYXY)/
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M[ETVB'E0(^.N,CGN6JYIOB_0=7U(Z?8:BD]SL,@548!E&.0Q&#U'0T ;=%9
M\3Z*US';KJ$3/).;="H)4R_W-P&-WMFH--\56FHZYK.FA&B&EE0\SY"MD?-R
M1@8/'7GKTH WJ*Q+#Q=H.IZE_9]IJ"R71&Y8RC+O&,Y4D ,,<\$TOBGQ);>%
MM&.HW,;2*95B5%SR6/K@XX!/X4 ;5%<#JOBF33?B-I<<NI^5HMS8/*\<B!1N
M&[!Y&[.0*ZBW\3:-<Z.^K1:A%]A1MC2L"N&_ND$ YY'&,T :U%96C>(])\0+
M*VEWBS^20)%*,C+GIE6 ./>N9^)=]JFG1:-+INJS60N+U;64(JD$/_%R.HQ^
MM '=T5R&F:9JMGK]IN\8/J,05WGM)D0%DQ@,-O/#%:T4\9^'Y()YDU%62"X6
MVDVQ.2LC=%QC//KTH WJ*R]6\2:1H;(NI7T<#N,A2"S8SC. "<>_2GSZ]I-K
M8P7LVHVR6TXS%(9!B3_=]: -&BL<>*M!-DMX-4MC;-.+<2!LCS#R%/H:GN-=
MTRVNKBUENXQ<V\!N)(<_,(P,EL>E &C17(2^)K;7?!L>JVNKKHJ2RJ//G3.,
M/]WG R0.V<<_6NA;6-.34X--:]A%Y.GF10[OF=<$Y'J, _E0!>HK+;Q)HRQ7
M<K:C J6DWV>=B<!)/[ON?I43ZQ;ZMHU^^AZE"T\4; 2(OF>6^W(RO4_3'- &
MS17/Z+J]Q;>%],N?$LL=O?W "LI7:6<D[5"_WL8X'?-;%E?6NH0&:TF66,,4
M++V8'!'U% %BBLK4/$NBZ3.8+_4[>WE"ABKOR >F?2G7?B'1K!X4N]3M86FC
M\V(/*!O3U'K_ %H TZ*P_P#A,_#7D+-_;ECY;' /G#KTY';\:L7_ (ET32Y$
MCOM5M+=W3>JO* 2OK]/YT :E%<IXE\0K-X#U/5O#VIPL\*96>+#A2",C'8XS
M^>:UFUVPL--LI]3OH('GB5AYC %S@$X% &K164?$VB#2SJ?]J6IL@^PS"0%0
MWH?0U8DU?3XKJTMGO(EGNU+6Z%N9 !DD?A0!=HK%7QAX<=XT76[!FD?RT G4
MDMG&*LV6OZ1J-]-96>HVT]U#GS(HY 67!P>* -&BLNW\1Z+=:A]@@U.UDN\L
M!$L@R2.H'KCVJ&Y\7>';29XI]:L4D1_+93,N0WH: -JBLF\\2:;8:Y8:1<3;
M+F^1FAX^4XQ@9]3SCZ?3-V_U"TTNSDO+ZXCM[:/&^20X R<#]2* +-%4!K>F
M->6MFM] UQ=Q^;;QAP3(F"=P]1@$UF:YK*2Z/=/I6NV%E-;7 AFGGPRQL#\R
M$'^+&?\ /( .BHK*F\1:=;^(X-"EFV7LT!G0,, C=M SZGGCV^E<[H'C**&;
M6+?Q%K%G'-;ZG);0!V6,[ !CCCCKR: .WHI-Z[-^X;,9W9XQZUPNL>.1?> M
M4UKPY<!)K.41DS("<;P,@'U!XS0!W=%9NGZWIU](+6'4;2>\6)7DCBD!/(ZX
MSTIL7B31)M3.FQ:K:/>@X,*R@MGT^OM0!J4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 444C=* %HIB2(\CA3RO!I] !1110 4444
M%%%% !1110 4444 </KL'V?XK>&;^1B(YK>>V'R\!PI(Y]]WZ5%?ZK:^'OB?
M->:GYT-M=Z?'!!*L#NKR!R=@V@\^U=;K6C6NO:8]C=&1$8AEDB;:\; Y#*>Q
M!J]&ACB1"[.54 LW5O<^] ' :+9_V-\-->FO+4V\%R;NYCMY<JRQN"$5NX)
M'OS6_P"!+2:R\"Z/!<(4E%N&*GJ-V6 /O@UI:KH]OK,<$5VTIMXY!(T*MA)L
M= X[KGG'M6@    , =J "BBB@ KSOX37*/9:] %?<-5EDW%"%(8*!@^OR\CM
MD>M>B44 >=6MU /$GQ$)#[A!&<^4V<+ 0>WK^?45SEM?0Z1;^$];U&VO9-(&
MDM:O+ 74PR;^IQ@X/3W]\5[110!S_A!--72Y3I.E3:?9-*2BS(R-(<#+;6Y
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M'E"0JN>6"GJ1UZ&N)2ZG?QKJ>H_V?K$EM<Z$\$<TUDRM(P"DD@*!SCL,9(H
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M\/)\/[;4XW:9KBXE\K828Q(N%SGI@D$^G/I7J^IP/=:3>6\0!DE@=%!..2I
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M"ZS,0#)&>O;(/\\5;\/ZIIN@77BS3/$ES%$\M])<8N2 +B)UXVY/S<#&/<4
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M,U7XQ:#<:?>0W,)T]TW0MNVL=YP<=#CL:Z/XCSQ0^ -6\V1$\R+8FXXW,2,
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M $- ';T4 @@$'(-% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>QZ'KVH Q8O"GBB"(10^-FCC&<(FE0 <\G@5':>#/$5A&T=GXP6V1CN*PZ/
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M5SB/=H5PXU-]W(^TC*[?S;?CV'/!%8C6#Z-XCUR+4?!!UQ+R\>ZM;I+=).&
M)0LW0#^>>M '8:AITVN:WX>UG3+^46<.Z60QS8CDC(&!M[DG] >^*FN?%D46
MK7>GV^FWMXUDT*7,D"J1&9.G!(8X')(!K7TU)(],MDFMX;:01*&AA^Y&<?='
ML*\XUZ*XD\17^H:':ZOI_B&&X1 JQ2/;7\8P 6.-H&!Z]NYZ 'I5[=PV%C/>
M7!*PP1M)(0I)"@9/ ZUAZ?XSL-0O[2R%K>037EJ;JW$R*/-C'IAB<]>#CI5_
M7I-1C\,WSZ?%YFHBW;RD7!^?'8'.?IWZ5YYI37TOB?PCJ#Z-K#>3;R6UU<3Q
M'(=@>W\**2<'@8.!TH ZT^.[(>%K;Q!]BO#:S3^0RA5W1G?LRW/3([4X>)KB
M;Q_<>'$L)6MX;59'G0@8+8^;)(^4 XXR<UPOEZJ?A[/X:30=3;4+>]\Q\0_(
M5\[?E6SAN..,_E73Q)+IOQ9GO&L+YH-3L(U\Y(BR1R+U!(Z<*/QH S/"7C&T
MT3PW<-J U6>.+49HY[MHS*D1+C&6SG^('N<D^HKK]4\50:?J3Z;;V%_J%Y'&
MLLD=I%N$:L<#<20 >IQ[5Y^\5_+\(M=L!I-XMS_:)$<8MG#RJ9DDWXQGU'X"
MN@L9+CP_XUU/5+ZQOFL-8@AD6:*%YO(D53F-E4%AU/./Y\ &U)X[T1- AUD/
M<26TLXMBD<):2.4_PNO4$?X8SD5GW?B'1=2U+P[/>1:O97#W;I:1RP-%E\ ?
M.#V.1C_]=<Q>:??6/A":1]*ND:_\0C4(K6"$R-'#E3\P4?+PO0^N*Z+QU!<7
M.O\ @^6"VN)8XM0$DK1PLP1<KRV!Q^- %[3O&+7FL^)+5[&8V^CXP\8#%\ [
MAC/4D' ]N:L?\)KI[^&K378+>\GMKJ<01QQQ@R;BQ7D9]1Z]Q65X9@ETKX@^
M)[:2TNS'?2QW$-QY)\HC:2WS=.K8K-T7P_<6WQ"O=)V)_8=G.-5A3!XE==JC
MT !#D#V'X 'I0.0#C'L:RM9\0VFB2VL$L5Q<75TQ6&WMH]\C8&2<>@]:;9>(
M(;SQ%?:+]EN89[5%D#RIA)5/&5/<9XKGO$KW>C^/-+U_^S;B\L!:/:2M;1F1
MXF+;@=HY]L_6@"CX?\4KI</BW5=3EU1K*TO458;HEI(@Q VA2< ;F]>F*ZNY
M\56%IJFE6,\=PK:HN;:78"A.,[2<Y!Y';'(]Z\_N+>ZUS1O'<:Z5J4:WC1W5
ML9+<H9-H4A0",YRHX]*LSW%UK^M>")+?2-3B2PE*W+7%JR!#L3N>WRGF@#:7
MQ;!KOAKQ,VHP7NFVME+):M/"I+XX'&.=V3R,8 (YZFM6WU_3M+T+1XX7O+]K
MBV0VT<:;YY4" [R..W4GN:X_RKN+PUX\THZ=J!GFO;FXA;[.Q65'*A=IQ\Q.
M">.W-5&TZ:UF\):U=Z5?7NGQZ2MA<P10N)(' (+%>#U/MTR#TH [J'QSH]QH
M<6J1&X99;G[(EN(OWQFS]S;ZXYZ]*UM*U1-6MGF2VNK8QR&-H[F+8X(]O3GM
M7#W=CH]UX8@MT\/ZKIEI+J8:&6!&$\3[,BX*C+ 9&WGG]*W? T^KO87UOJLD
MUPEK=-%:W4\31R3QCHQ!Z_7O0!=U'Q79Z?>S6<=I?WT]N@>=+*#S/)!Y&[D<
MD9( R:KR^//#\.DV.IO=N;:\E\E"D3,ROC)5E )!'3'N*Q=+>7PMXW\1/J-O
M>/::DZ7%O<PVTDR\ Y0A%)!&[]*YBXTB_M+'0KJ2RO LWB%M1,"P,QMX2P()
M"@XX&<4 >J:'K=KX@TT7UHDZ1%V3$\91L@XZ&L6T^(N@WMY]GA-Y@2R1/,UL
MPC38"26;L" ?<8Y KJ]PV[NV,UYOI<%UK'A#QC86]I=P75U>74\*W$+1>8LA
MRN"0 <X(]L\T =+IWCC2-2U6#3T6[ADNHS+:O<0%$N$&?F0GM@$\@<4[3?&>
MGZI?PVUO;7_ESO(D%TUN1#*4!)VMGT!(R!G%<MX9CTF2?1PG@^_CU.! LLMS
M%(L=OA3N*EL@\C@#U'2H?#T5UI>MZ6WA]]432KZ=_M>E7MJR"URI8D,5  !Z
M8//3GF@#H)?B;X=2)YHOM]Q!%)Y<TL5E)LAZ<N2!CK]?:M74/%>GV,T5O$ES
M?W$L/V@0V41E81?WSV [=<GTKS?PWJUO!X*\4:9]FN;J\N[^Z2&"*VD<2%D4
M ;E&T=R<GH,UK:+'+X"U@3ZY#)'82:5;PF[BC:5$DCX*L%!(Z]3Q0!U<GCKP
M_#HL>K27C+;-.+=AY+EXY.ZLH&5(P>OIQG(S+I7B_2]6O[NRB^T03VR>:5NH
M&B+Q_P!]0W./J!UK@;ZQNK31=6U!K6\\C5-=AFMX5@8E8U?.\H!E<X[C/"^M
M:UPQ7XL7=XUG=S6KZ(R#RX'^<Y#;0<=<?KQUH Z73?%VGZQ,T$,-]"CV[3Q3
MR0%4EC!P60\YZ@\C/M7#:UK#6GP]TW4-(\2:E=*-5"-=3.5=AELJV>2HP.#_
M /6&CX7COM#\1V=CIMQ?W'ARXMY)F@NK5PUF1R%W$>O&/KQT-<REGJ-Q\)XD
M^R73&UUKS3'Y+;EBR<D+C)&6/Z^E 'J&G>+M)U?4;K38)+F&ZAC+E9X&B+)Q
M\Z[ATY'7\JY'6=1%O\)=3O=&\27]^\5PNV]>1DD4F5 4S@' !_7TK1CEB\2_
M$#2]=TN6673-/M9UEG$+JCL<KL!(&[KGC(^6N5FGFN/@GKUN]M+&T-^RH&C8
M%E\]7)((XQE@?3;0!WZWULVN>'4N-8N8KV:T9DLE!\NYRF2S8&,C!(R?_KMT
M_P 50:Y:Z_&\5U8)I\DL#3F-B0%498$#[P.3M'.,5B7=U"WC#X?827/V:9MW
ME-T:  #IZ]1V[XJ'1+TVQ\>://!.MRUU=7<:B%V+I(N 1@8YP,=SF@#H=/\
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M;9,JINF8G):1OF<D]^2: -6BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HKA])\1:'86_BK4K2SU+-I=L]\L@W,[]#L7=P!COC ^E6].^(&GZAJ]C
MIQT_4[5KY2UM-<V^Q)<+DXYS^F* .MHK/US6;;0-(GU*Z25XHL?)"FYF).
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M;9W4HC\N0XXZ.2,\8! /- '545R</CVRN-8ETV'2M7DDANC:R2K;91&]20>
M<'W]JS_#GB#0=&\%SZCIR:E-:&_>/RI@&F:5W P!D#'(ZGZ\T =Y17(ZEX@@
MUC0/%%C]FN[.]TZU<RQS85AF-F1E9&(P<>O:K/P^EDG\!:1)+(TDC0DEG.2?
MF/>@#I:*Y/\ X3^R;7KC2(M+U6:>WN5MI7CMP40L<!R<\+P>?3FE'C[3C<66
MZSODL;VX-O;Z@RH()&&>^[< <<$CF@#JZ*YS_A,+=[^6"WT[4+F"&\%C+=0H
MI1)>,@C=OP,C)"XJE>?$73K:XOX(M+UB[DL&VW @M#B,8SN.2,#CO_*@#J+Z
MV:\L+BU6>6W::-D$T+8>,D8W*>Q%9WAWP\N@6TRM?7=_<SL'FN;M]SL0, 9[
M 8X'-59_&>GK9V=Q8V]YJ37<!N(H+.+=)Y8(!8@D8P2!]:AM_'VCW>@PZI;K
M=2F:?[,EHD>9S+_<VYQG'.<X]Z .ACL;:*^FO4B N9U5)),DDJN<#V')Z58K
MA]6^(D=MX;UB^M=/N(K_ $V1(9+6]3:59SA2=I(*]>AYQ[@UV-E.]S8P3R1-
M"\B!FC;&5)'3@D?K0!/17)W'C^QA:[DATW5+NRLY3%<7MO"&B1AG=U8$@8Y(
M!'3U%3ZKXYTC2I+%"MS=-?0-<6PM8C)YBA=W'U'_ -?% '2T5GOJJ#P^=72"
M8I]F^T"%AM?&W=@@]#7 :]XENM4^&VE:_=13V#B_A=UB<@.@8@D ')4CL>_X
M&@#T^BN>TSQC8:CJMWISVU[97%M!]H87L'E;H^A89[ \<XJK8?$#2[[5;2P:
MUU"U-Z,VDUS;[(Y^,_*<Y].W>@#JZ*Y?Q_XANO#?AEKFQ0->3S+;P%AD*S9Y
M/X _CBJD7@)I+83W?B#6VU5D^:Z2\*;6(Y"J. N<\>E '9T5R%MKDWAC1--T
MW5$OM4UHPEGAM%,\K*&P7.3TY')-6E\<Z-_8-YJTIGA2R94NK>2/$T#%@H#)
M]3]* .EHKD?^%BZ1_:$5D;35%EGB$ML#9/FX'/W!U/ SG&*FC\>Z.WAJ?795
MNX+>WG^S3120GS(Y,@;2!]1W_7B@!_@_PQ<^%X;^&6_CNHKJY:Y 6 H49L \
M[CD<"NEKF-*\>Z-J^J0:="+N*XG1GB%Q 8PX R<$]>*?!XYT>YDM/+-R8+RY
M-K;W!A/ERR#L#UQ[XQU]#0!TE%<A=_$G0;.YO+=UOV>SD,<Y2T<A",Y)/8<=
MZTKGQ;IEK?:5:O\ :&;5 IM76$[&W=,GMU!Q[T ;M%8&IWG]L6^N:/8M?0WM
MI$O[ZW(0[V7>H1B>IXSTZ]14=MJ<GAS0M&M=;FFNM2N-MN/+3<TDN,]>G'<D
M^] '1T54TW48M4LQ<PQS1KO9"DR%'5E8J00?<&LG4?&6E:;<:A"XN93IT:27
M;0Q;EA#=,GN>_&?T- '0T5AW_BO3[&Y2W$=U<RM;?:]EM"9"(LXW$=<9/^<4
MR^\8:;83K T=W-*;,7I2" N5A)QN/XT ;]%<K?ZAI5QXN\/K)JE]!=R0O+;V
ML8813JP_CXP< 'C/_P!=VI>/=&TN:\25;V5+)Q'<306S/'&Q_A+=,\T =117
M,W_CS0]/:S5WNI7O(/M$"0VSLS)V.,9'?\J>/'&B?\(S+KYEF6RBD\EPT)#J
M^0,;?Q% '1T5R"_$KPXUP81)>[S'YD0^Q2YF&/X1MR?KP*O6_C71;C0Y=66:
M58(IO(>-HF\T2YP$V=<DD?Y!H Z&BN=MO&NDW$.INPNH'TR,27,,]NR2*I!(
M.WJ>E0Z9X_T'5M1M+*VEN!)=J3 TMNR(Y R0&(P2* .HHKG/#GBQ/$&IZK9I
M8W4(L;AHA+)&0C;< @GLV2>/3!H\2^*U\.ZAI-J;&YN3?S,A\F,L54#L!U.2
M./3- '1USWB[P]=^([6RAM;Z*T-K=+=;G@\S+*#M&-PXY.:=J?B_3=+N[BV>
M.\N);5!)<?9;9I!"I&06(&!QS6KINHVFKZ?#?V,PFMIEW1N 1D9QW]P: +(S
M@9QGOBEKCH_%!\0MXDTFW@OK)[)9(DNU0C!"\G=V;=G ZXP?I0\&^/=-DT71
M+&_O+J2_N5$1GFB<JTN2-I<C!/;O0!Z!17-:CXZT32M2>RNI+@&)PDLZV[-%
M&QQP7 QGD?G7031K<VLD8D=5E0KOB;# $=5(Z'T- $M%>/>$X%U;3;^XUCQQ
MK5I);7DL*J-3"9C4 AB&!.>3^5=I9Z_8^&M&T6UU+4KF^-\=L%Z8V<2AVRFY
MOHP_+I0!UM%8EKXLTB[TV_U%)Y$L[&1HYII(F5<KUV\?-^'-1Z1XQTG69KB&
M)I[>6"+SG2[A,1\OH6&>P[F@#?HKG+'QOHFHZI;6$$LX>Z0O;220,B3@==A8
M#/?\J1_'6A)X>;7?/E:P2?[.SK"Q(;..1CI[^_KQ0!TE%<XWC"V7QFOAT6MR
MSFW$WG)$S+R1CH.!SRW0'TJGIWB+2M-T_7]0DUJ[U"WM;US-OC8_9R6_U:<9
M*@G'IQV% '7T5C#Q1ICC2#&\SC5B?LI$+?-@9).1P,>M4SX\\/C5ET\W4@=I
M3 )C XB,H)&S>1@G(^GO0!TM<KHOAO4=.\;:[K4\]J]MJ.P1I&&WJ%&!G/ _
M,Y]JZ:>>*V@DGGD6.*-2SNYP% ZDFL'3_&^AZE?I913S132G$'VBW>(3?[A8
M 'Z=: .BHKS4ZA/XH\:ZIIS:UJ^F+931Q6BV<;HK'!+^9D$'.#C=@8 QW![[
M4=3L]'L_M-]/Y46X(#M+%F/  5022?0"@"Y32B&19"JEU! ;'(!QD9_ ?E7"
M:-XL6Z\:>(';4IY-'M+%)]LT!C\G'+84J&/'/3)]\"ND;Q7HBP:9.;W]UJ;B
M.S?RGQ(Q( '3Y>3WQ0!K[$\SS-J[\;=V.<>F:=UKG++Q5!J.O:]I(5X!IBIF
MY*DKRI+$G&!C'<\\^AJ/2-<TS3?"-O?7.NR:A:F0Q+>R1,7E8N0%"@9//' Z
M#- '2"&)1&!$@$7^K 4?)QCCTXXH6&)96E6-!(X 9PHRP'3)K&@\8Z!<Z;>:
MA%J*FVLFVW):-U:,],%2-W7CI5S3M:L-5EGBM)9#)!M\U)(7C9=PR.' /(H
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M/VN\LQX>MY$FBM(XOWC.@X#$\8#<\'L!BNIHHH **** "BBB@ HHHH ****
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M3VWMY+?)NB8#=QQUY]*YW4XI8_"/Q&:2":-9=41T,D;*&4SCD9'->VUB^*]
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MC)X<MM%9_M]MJ,,]Q$L+!K5 IW;B0, ' KTRB@#A_"5]:W'CWQC'%,KN9H"
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MCI((R#U.>>. *EUL'_A%)9=/\*W=E!<:C;RI!#;YFDVMO:1T7[HPN![_ %H
MT]1\3:+JVI:%]HBUNUE74O*MU\DQ*\@P/GS_  _,/?KQ6SJOC2PTB;44FM+Z
M5-.$9NI88U*Q[\%>K G@@G XK"\=&>[U;P?=6]E>RQ17JW,OEVSL8TRI^8 <
M'V/H:QO%,^NZB?%.F3:7JUPS +9""'%OY0*MN)_B?CW/;% &YJ,[_P#"X] $
M<TODRZ?*Q3>=IX;^'IV'Y"DT+53H]UXVO+EKV[@M+\R;%^=U4C)V@D?*,_D*
MH0SW>H?$3PMJ;:5J,$2Z<T<WF6K@1.0XPQQ@<^O8BK_@6*>ZU/Q>NH6-VD%W
M?,\9NH&02Q-N4 ;@,_*!Q[B@#H%\663VVBS);7C_ -L-BV144L!C=EOFX ')
MZ\4SQR]@G@[4/[2ENXK0JH=[09D'S#&.W7 .>,&N7\!:1<0^(=1L[DB2ST">
M6#3BW)42_,>?90!_P(UTGC\R'P1J<,-M<7$T\7E1QV\1D8D^P[>] !?^+],T
M,:5:RQWTTE]$#;K%"978!1C..K'VS_6EM?'&D7.CW^I/]HMUL)/+N+>>/;,C
M=ALR>N<#WSZ5ARW,\NK> YAIFH;8D?SS]F;$):+R\/\ W<-USVYKEKC2-6O9
MO%-Q::?>[DU:&_ABDA:,7*(SY )'/4&@#T:S\::?<7]U97-M>Z?-;6OVR07D
M80"+C+<$^HXJ)?'6GAK-KFRU&SM+Q]D%Y<P!(6)^[DYR,]L@9K.OKV]\;Z%J
M>GVNB:AIXELF43WJ>2QER"(P#R5/.3TK)U+[5XF\"V/AB/3-0MM3_<Q2&:U=
M8HO+(W-YA&TC"\8/.10!T5[\0M*LK[4;06>IW$NGG_2/L]J6"KC);.< #'4X
M]LUH77BJR@33C!;W=[)J$+3P1VJ!FV  DG)&/O#\:Y247 N?'Z_8+_$]G'#;
MG[*Y\XK"8_EP.?F(Z=N:R(-+AO/#/A^VNK+6]/U6RLW>"^M[23]VX<_NW 7/
M.,CV/7F@#L-0UC3K^\\+737>IVK7<[&WMT78)#@968>@_P <9J_/XOLH=4EL
M8[2^N##/';SS0Q QQ.Y 4,20>XR0".:Y.XGUN?3O!%WK%E=RWJWOG7/DVS,8
MTP0"X ^4X9<CZ^E0:];7*:_=ZOX=BUBQUI;I(9+8VSM;7HWA1(6'RA=O.2>/
M8G- '6:;XM^W>*]<TJ2V\FVTM$)N">,D$L6/88Z?0Y/2I+#QKIFH:I;6207\
M(NU+6EQ/;&.*XP-WR,>O'/3^E<A+H^HR^)/'&FBSN4;5X$-I<>4?).U3P7Z
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MLI+I@ -S<%@O4J#CGW&* .JHKG+SQ88-5U&PMM*NKMM/$1G,17/[S&-JYR<
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MY_.@#J:H:SIG]L:3/8?:[FT\T#]_;/LD3!!X/X8^E,T'6K;Q#HMOJ=HLBQ3
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MV[,_C6_0 @      Z 4I&1@T44 -"(-N%4;1A>.@]J%C169E10S?>(')IU%
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M289)V@=50EC(!DC&>!Q[^M=I10!RGCP3)9Z-=16MQ<K::M!<2I;Q&1PBALG
MY[BLBSDDF^+KZG]CO4M)-(""22UD4!LJ^TG'7';UXZ\5Z%10!X3IFE7\&BZ+
M>7.B7MS;6>IW'VJV,$BR!)0F)%48)QM/3OQ7IG@]=-,^HS:9H%WIL3F,--=*
MR-<, W\+'/RYZ]\^U=510!P6OAQ\7_"TOE2F-;><%UC8@95AU ]2/ID9K,TV
M_P#[#\-ZMX8U:SN4U&>:Z6SA2V>07*N-P*L 5ZMSSP.M>H44 >4:&M]X"U>!
M]5LK^\MKG2[>'SX86E,,@./*X[9.!_P&M;5]<GT^]\*NFBRV-E+)*66.R$LL
M0[( !\FY?F..>/8UZ#10!XO<K-<>#7DDLKV!],\1"Z>)[9MTB/(<8_[[]^GN
M*Z[4-0ANOB;X7:-+@*UG<,"\#K]Y1@$$9!XYSTR/6NZHH \IL;Y=*\%:IX-U
M"VN#K;K=1V\*6SO]IWEBL@8 KC+=2>,5)864VF_$GPK8SM--+::,4E=E8X/S
M]_0$@9^E>I44 <=\/;E+BVU[8DJC^V;EP9(RF0S9'7GZCM6;_:D/@[X@:[=:
MV\L=CJL<,EO=^6S*#&I!C^4'GDX^@]:]#HH \:U9'LOAMXCN9TFBAU;63/9Q
M/$5(C,JL&(QD953U]!7L,$T=S;QSQ$M'(H=201D$9'!Y%244 >5MJ$":%\1-
M*<2K=K<75QM,38*.JJISC')'Y<]*JS2[=/\ A@1O!65,X4],(#7KU% 'B^F-
MI-O97/A;7M$U.]UA;J1Q#&\A6Y.[(?.[ !]>F.:]F0811MV\=/2G44 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!XI
M+8>%[7XB^*(-6TF6YMQY30PV\,CE690S$;>G)]1Z"NLT;4=-\/>";G6?#.C7
MLUE)<O++:.^UX=H",1G)(^0'&2>3Z8%&S;Q)I7CK7]9C\*W=Q;W^Q(P+B-2
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M49A8H1A\' Z^OTS4OP[M-2T:36M*O=,N(U_M"6X2[( BD5MH&W)R?NYZ=^U
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MMY:7&DQ>;<02JI8KCC:58J>H'7O7#S>'_$$_A^:-K6^U*STO58I[*"]4I-/
MH.]2IZC[N..?FX[5OV@MGTK46A\ W-I9S0K'<P^2J33DL 0J@Y(4%CGOQC%
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M6YV$9.P<D#COR :DO)CXP\6^&+W3[:[CMM.,MQ=27%NT83(7"<]6)7H,]<T
M:/\ PLS0/LLMWLU#[+#+Y,L_V-]D;9 ^8]NO3K6CIOC'2]4U5=.@6[29XC-$
M9K9XUE08Y4D<]0:\R2&Y_P"%0^)+86=V9KG5MT2>0V64M$V<8Z84UU%S=S0^
M-O"&RWN_+33G$["V9@ RC /'!RGUZ>M &FWQ.\.+;-<[KXVZ2^3)*+1]L;>C
M''&>N.M:-AXSTK4=26Q@2\662%IX3+;-&)D&.4W8)X.:X*2=[KX2:_!'97HF
MDOI"D;6[!B'F#@@8YXZ^E=)>77VCXA>$YH[:Z\HV4Q+F%@$WK\H;T/RG@^U
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MA_9FX7>\A/*#@; N<=>^* .E,T8C>0R($3.YBPPN.N3VQ3P00"#D&O.(];T
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M'S%*G!!4@C^5 '445Q6E>-!#/HVFWVCW]G%>PI';74X7;))M'RD G&>V>>G
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M:+>,DF0?*<;4)W \X'6MY_%FDZ_HNO6LL>I636=LWVN*2'RYT1E)RHR><=*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"$FB7<1TCY+HDH0H 1 P^;_9)KN/%]A<:GX1U2RM(_,N)K=EC3(&X^G-;5%
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M=_*"@ XQU! ]<&MG1?$QT[P=H:?V+JTTJK#8R1BU*E'50I)W8^7/&>E=M10
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB#5GT/0[K4DLWN_L\9D:-'5. ,DY/;Z9/L:=H.K#7-$M=36WDMUN4#K'(02
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M<A ?C)''0$=36S::C/K^E^$EO-8OXKFZMW:2WT_<DDY'RB1W! 51C)SU)_(
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MMU;ZS+%'/;&W5$3S%W#;CG(&><]16[\33(OP]U5HYI(BJ+GRR!N!< J?8@T
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MS4-3^V1+"\E[,'=45MP"D 8^;GZ@5U%% '/:+X0MM%GCE_M+5+[R8O*A2\N
MZQ*0 =H '8 <YK%'PKTL63V U?65L?-\V.V2X4)&<YR!MZYSS_\ KKNZ1F5$
M9W8*JC)). !0!A/X87_A*I->@U.\MY)H1%-!'LV/M^[U4].?SZ]07>&?#O\
MPC=I<P?VA<7GGW#SDS!1M+')P /S]^PJUJ&JO:+8M;6-Q>I=3)'OMQD1H?\
MEHQ_NUI4 8NC^%M+T.QO;.TA8V]Y,\LJ2'(^88*CT&.*R-,^'MMITZH=7U.?
M389%DM]/DF_=(0=V#_> ;! XZ<YKL:* ,[7=$L_$6CSZ9?JYMY@,E&PRD'((
M/J#6%8^!%AU#3=0O]=U.^N]/#+"7**FUL@J1MR<@X///Z5UU9'B#Q#:^';2"
M6>.6:6XF6WMX(L;Y9&/ &2!^)- &!#\-;.">6--8U4:5*YE;3A,%C+%LD' ^
M[T&.O'6K=UX(%^;VVN]8O)M+N[G[4;1@F5?>&P'()"9'08/OUSL:%JESJUB\
MUWI=SILR2M&T-Q@DXQ\RD=5.>OL:J^(_%%KX>T"?5_*>\BAD\IU@(.UMVTY/
M;!X/O0!&OA;;XDU36%U2Z1K^W6W,484", 8# X/(ZCTR>M5;7P)9)X('A>]N
MIKJV!)67:J,AW;AMX.,$]\]3VXKIK:=;FUBG0$+*@< ]0",U+0!QECX!DALI
MXM0\0ZE?RM"\,$DCE1;AEV[E7)^;'<FKVE^%)K;5K74]3U:74KJT@,%NS0K'
MM4]2V,EC[D^O%=+6)J'B>UT[Q-IVA36]R9[]6:*55'EC&<@G.<\=AW% $?BG
MPPGB6WLP+R2SNK*X6XMYT4-M<>JG@U3U#P9--JW]K:9KEUI^HO L%Q,L22"<
M*."RD ;N!R/3I75TP2QM*T0=3(@!90>0#TR/?!_*@"CHFC6^A:?]D@DEE+2/
M-+-,07ED8Y9F( Y)K-TGPH=*\3ZOK U&25-2(,EL8U !'3GJ< D=NO.:Z.HY
MYXK:!YYY4BBC&YW<X"CU)H XNS^&T-A>2+;ZWJ2:0\AD;3%<",D]03W7MC'3
MO5B^\#-J<TD-[K$TVEO>F]^R-"I96))VAS_#DGC'3CWK7N?$EG:>*;+P_)'/
M]JO(FEBD"?N\*"2"<]<*>W\ZV: .1O=#N=)O_$/B2*\N;J2YLBBV<<85E*CY
M=K#)R.<<=^^*XCPUJ-Q'8Z;;:+XONKNXW1L^FC3@< L-X9R.@R<L37LC,J(6
M9@JJ,DDX %"LKHKHP96&00<@B@#DY/!,DL_B21]8FVZW'L=!"N(N-H^N%X[?
MG6WX?TIM#T&TTQKDW/V9/+64ILRH/'&3T&!6E10!R6G^#;BPU?7=03668ZNC
M!XS;J C<A&Z\[03QQG-&D^!8++P?<>&;Z]>^L9<[/W0C:/)W<=<D-\P)[UUM
M9'B#Q%:^'(;26[AN)%NKE+9?)3=M9NA/MQ]?:@#,M/!\PNM-?5-9FU"'3&W6
ML30*F&Q@%V'+$#Z<TR#P7/ WB)AKD['6<YS"N(<Y&<=SM(';I^76T4 <6W@6
M\>TT"V?Q!*8]&D62+%LHW[?NYY[+\O>NA\0:-%X@T&\TJ:1HTN4V[U&2I!!!
MQWY K3HH Y)/!ESYGAZ277)9&T9F()MU'F@X&..GRC;W]:BN/ $6H?V^NHZC
M)-'J\B2$1Q!#"4^[@Y.<# YKH=3U=-,N+"%[6ZF-Y.(%:&/<L9/\3GL*T: .
M>T'P[?Z7=&XU#Q!=ZFRQ>5$DB+&B#C)P.K<#DU9\1^&[+Q-8);7ADC>)Q+!/
M"VUXG'1@:V** .33PUXAEV6]]XMGFLP1O6.U2*24<Y4N.@Z<CFG7/A*Z@UR[
MU;0M6.GS7JHMRCP"5'*_Q<GAL9KJJS]8U>/1])FU!K>XNDB(4QVJ;W)+!>!G
ML3S]#0!S-W\.XYM&TG3[;4W@^PW/VQY3 &,\W7<>1CG/'N/2M%/"DL?B_4/$
M":D1)=VWV80^0"$&!@YSS@C-=&C;T5@"-PSAA@CZBG4 >/\ B?P]'X3\,>'=
M&.JAA_;2RQSO$ 8UP<G;GD G/7O79R^#3J2:I<WVKR7-WJ-H;1)HX@J0PGG"
MKDYR><YY_6NENK"SO@@N[2"X"'*^;&'V_3/2K% '#6?@/4[75=,U!O%$\\E@
MAAC62U0*(BN-H /7CK]/2H8OAW=P>"CX?BU>,-]N%UYQM^P.=N-WL#G\*[^L
M[4-8ATZ_T^TD@N9'OI3$CQ1EE0@$Y8]AQ_D9H X[QG-HWBR\L?#",UUJ$5]&
M9Q&C P1C_6,3C'*\?4BMWQ=!K)M=,_L*XEAF2]B#HB;E:,\'>>R@9)_QQ5BV
M\1:9-X@U;3HX)EO;&%)+A_)Y=<$@#'+8!X_WN*NZ)K-IX@TJ+4K$N;>4L%+K
MM/RL5/'U% "ZW82:KH=]I\4PA>Y@>$2%=P7<,=/QKFG\':J^D^&K0:S$)-&F
M5RXM_P#6JHVJ.O&%R/?-;UEXCT^_U^^T6 R_;+)0TH9"!SZ'OV_.M:@#@U\
M:G:7MY#IGB>YLM&NY&EDM$B5F4L?F"N>@]^OUKND18XUC4850 .<\"G44 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y1 3H?BE3XCLIG6
M?43):ZY;2L0Q)^6)\=%[%>GMQFJ#:;#>3_$:[DDN%FLI3/ 8IF0)(H=@V >3
MP.M>@0^!=)AN%<S7TD"7)NDM)+EC"LF<Y"_7L>*6/P-H\4.LQ*;O9J__ !\Y
MG8GJ3P?Q/7/ITH PM/N%\0-X>,]U?27DNCM(;6.3;'DX7SI'R#G/'0G)SC@Y
MYO5Y[BY^#OAZ2ZFDFF_M,*SR.68XDE Y/7@ 5WA^'VAL=-)^V?\ $OA,$6+E
MAN3).UB.HY/IZ=*A;X:>'SIJV ^VI;I<FY5%NFPK'T'3''IGWYH HK_R7)O^
MP-_[/2_%EYX?#=E-;W=S;O\ ;HXR8)63*L#G..O2NC/ABP_X2E/$6^X^W+#Y
M./-.PKC&"/U^O-<]\5[6YOO#-I;VMG=73F^C=EMHF<A0&R?E''6@#)?1I/#'
MCZWL=-O-1EMM2T^X:Z,T[.4*J<.#V.0HR?6N?M%NK;X4OXJ6_P!2EU-E:U,C
MW1*Q1M-M) /.?QZG->G:9X6TM(+B\0W\EQ?V_EM<7<K&=(V'W1NY3&>F,YZ]
M*DTKP?I.D^'KC0HUFGT^<L7CGDW?> ! (Q@<9X[Y- ',:OI,'A75O#VJ: ]R
MPN[Y;>XA^T.ZW0D4G>2S$9&"?QK%?11?>&_&E]-J&HFXTW4;@6K?:W_=B(!A
MQG'?T^F*[S2?!&DZ/>07,3WD[VV?LRW-RTBP9&#L!X'''X5&O@/2ET_5+(7&
MH>5J4OFW'^DGEB<G';GH>N10!SJ:>VD^)?!]_!?WSS:DC1W?GSF02CRR_(/3
MD]O\:PM)T:35=%\5WEQKVK13:==7$<,AO6"@(,C<._OTKT-_!&F2/I#M<:@6
MTH 6Y^U-ZY^;U].,<<=,5Q?@[PTFLS^(8=5M];M(;B^:<1,)+>*>)B< @@9/
MJ.N,4 2:!$FK>-?#-]J =KM]!6<OYC*6D5P 3@\\9R.A[U8\/:=_:VO?$&R$
MTL#2W4866)RC(WSD$$=.:ZR_\&:1J&HZ?>NMQ%+81"&$03M&-@Z*<<X_&JIT
M>T\'#5M=L+;4K^XNV$DUM&WF%V+=57';)]>* .2\.7=QXB&@:#/<W4=_H]S)
M-J.9&)/E,-@)[ABPZ_W3[5W7C2;4+?P;JLVEMLNXX"RMG!51]XCW"[L>^*J>
M$-/E-QJFOW5@UE<ZK*K^1(,.D:KA=PZ9)W'\>?8^(4=]-X,O8+&Q>\>;:DD<
M>=XCS\Q4#EC[4 <QX8MSJGBC2;_2YM8338[ -=^=-+Y9GS]T[R<GGD#C&,=Z
MN:%IUSKGA[Q7ISZC>>?'K-S';W'GLKH5";1D=!GJ.G)JKX;T\OK]A)I47BZT
MB@8_:/[5XA,>TX4*QY.0!QTSGTKM-#\-6?A^:^DLYKI_MLOG2K-+N&\YR0.Q
M.>?H* .(\-ZQ<Z_'HT)6\-QH-O*U_$)F!EE0;$5L?>)(W?@?QJ:-;^(==TS1
M/$J:C!; 3F>]N9;V4!U$C*4,7W -H'I7IFGZ-9:7<7\]K$$DOI_/G/JV /Z9
M^I/K6#!\./#]M>F>-+H0^<)_LGVEO(W\'.SOR.] %SQU EQX$UM'S@6DC\''
M*C</U KA-=TZ%-,^'EM#)/$)[J%F=9F+J65,E22<>V.!7JE_90:EI]S8W*EH
M+B-HI #@E6&#S7-CX>Z2+>PA-UJ;?8)O/MV:Z+%&XP!G@ ;1C% '$ZEK5[X0
MN?%^E65Y=2K%%;-!/=W#2-"9-JL0?^!Y_ 5TWAW1M<TWQ+;W4M];II4]OY?D
M_;I;AKAP"0XW@;3CDX[ UL2^!](N-4U._N?M$\FI1&&X227*%>,8&.,8&/2C
M0O!&E>'[I+BVDO)I(D,</VFX,BP@]=@Z#/% '-_%5GCOO"DTQ T]-24W&X9&
M<KC/M@/7H_RNG9E8?4$54U32K'6K"2RU&VCN+=^J.._J#U!]Q7-+\.[)$%LN
ML:U_9P&#9?;#L/;&>N,<8S0!7-G;ZQXZOM&GN9[>TTVPA%K:6L[0CYL[GPI!
M.WY .PXXKEKF_P!7;PGJ&E_VG?(VGZ^MA#>AR'>/=C:QZL1UZ]Q7?7_@G3;J
MXM;JUENM.NK:$6Z3V<FQC&,84YSG@8_&FWW@72;[0$T9FN8[<7 N9'23]Y-)
MGEG8@Y)_P]* .5ET>>#XEKX?77M8^PWFG&YE#79+E]S# ;''3/;O5,WE]+X!
M:&'7;];C3]:^QM*LF)&3S0H#-CG@YKT-O#5F_B:+Q TUR;Z.'R!EQLV<\8QZ
MDGCO7%>,- T[PQX/GM+:34)!J&H132-S(^X,"[;@.#@9Y[CB@!Y>7PE\08]/
M36+Q["\TZ6XG>^F\P1,NX[QGIC;^IJMI-]+IWBKPIY-SJ$\&J6\JSRW$K;;E
M@,B0(Q.P9P>W!Z"NOM?!VE2)<7$\M]>O>VGV9I+R9F=86'*CH5SGGO5&W^&6
MB6UQ93K=:H7LGW0;KQCLZ<#T'';% '"ZB-1A\'ZKKQUW59+O3M7>"%6N3L*B
M11R!UZUU?B"XGT#QEHGB2XOKA=)NQ]GNHFE(AA8I\K8Z8ZG\*TG^'6FR:#>Z
M.U]J!M+JY^TL#*"0_?G'()YY]!5#Q2#K$2^"(]*U*49MA_:,L6Z)44AF8OZ[
M5(]R2* -OP5#-_8LE_/--(=1N9+R-9)6D$<3G]VJYZ#;@_C7,:_*- \=7K:A
MJ=[!I>K:;((G$Y413*1D)G@' &.G+8KTB&%+>".&)=L<:A%'H ,"L[6/#]AK
MLE@]]'O-E<">/@<D C!]NAQ["@#SSPK=WVJ:?I'AV>[OH=5L-2DDU#,^9%CC
M!//.=K,Z*.HZ^E6_#EG?ZYXQ\0&XU[5$CTO45,,23 (P^8;6&,8P *[JVT'3
M[37+S6(8<7MXJI+)GJ%&!C\AGZ"J.C^%(=%U?5=1@O[MWU)M\J/LVJV201A>
MHR: /-M:N9;GX2ZS%<:C<WD]IJS0EYG)8 2  'UX.>_6NGO]*A7Q]X.B\^[*
MI9SCFX;)VJ",G.>=W/X#I6C;?#K3H?#NIZ-+>WEQ%J$WGR2RE=ZR<?,#CKD#
MK5FY\$6MRFD%M4U-;C3 RQW"SXD=6^\&..^,<=J .->W\6^+;K4=0T^_2W>T
MOY+> _;GB2-4(&#&J$'([EN]:-[%J6M>.[G2I==O;56TA;A+>SFVH9"-IVMC
M[N><GDYK5O?AII5WJMQ>QWVI6L=TQ:YMK>X*1S$]<]^<_J:T%\'6L?B6;6X;
MRZBE>T^QI$FW9$F !MR,C&,_6@"+X=7]YJ7@BQN+^9IKD&2-Y&.2VUV49/?I
M7.SPZIK?Q&U_1SX@U.TLX;:.5$MY N,JN0..!R>G-=GX9\/0^%]'73;>YGN(
MED9U:<@L-W)' '&<G\:JKX1@CU_5=9CO[Q+G4;?R' 9<1C  *\9!& 1S0!QM
MGKNI:Y%X*T::_N8!J5O+)=W$#[9) BMM&[MG;SZYHUP7NEIXG\-/?W=Q8_V+
M]OMI)IMTL>T[2A;'()!X]/K73I\/]/30K#31>WHET]V>TO%<":$GJ 0,8]L5
M:3P;9LNJ/>W-S>W>I0?9Y[F4J&$>,!5"@!1]!0!RFNM<^'?"'A)=+U.[2.2]
M@C?][G>CKG;GT&, >]6X/[2\7>(O%%O'K5_IPT^1+>U6WDVJIP<LP_BR1Z]#
M6A)\.[>30K#26UC46AL;D7,+L49E(&%'*X"CGCW-2:K\/;#4]=EU:/4=3L9I
MRIN%M+C8)<  9XXX% &3J*^(=2U]M 342S6>F([O%<FU,TK$C>V%8D<=!CK7
M5>%(];AT"&'Q!)#)J$9VLT3;LKQC<?[WK6;JW@#3]1NK2ZM;R^TVYMH1;K+9
MR[6:,= Q.<X__76_I&DV^BZ<EE;&5D4EFDE<N[L3DLS'J: .%LEOO%I\1:B^
MM7]D]C=2V]K#:3%4B"+C+#'S$]>M8ES=W'BOP_X$O;U[AKF74##(T$FPDJ2/
M,] PVYS]:[R3P7$FH:A=:=JE]IZZA_Q\PP;"CDC!8!E.TGU'-+J'@FQNX=%@
MM;FYL8M(??;I 1@GC!;<#GH?KN/K0!O>0(M.^S^;*X2+9YCN=[8&,EASGWKQ
M6S@*? '5;LS3/)/<*S!Y"R@B=!D#MGOZU[E7&_\ "NK'^PM4T<:EJ'V/4)A,
M4+J1$0^_"#'&3C/T% &1#>:AH/B.P+:K?WT-SH\MW)#<ON7S%4-Q@?*.O\JH
MZ)_PF>J6VAZS;7<TB32^==O)?*8&C+D%?*Q\I ]"?SZ=DW@VUDUS2M4GO+F5
M].M#:K$VW9("K*2PQU(;M@<"J&G?#:PTV:-8M5U1K".?STL&G'D[@<C(QDCC
MO0!H>/->N/#?A"\U&T"FX7;'&6&0I8XSCOC-<EJ6F-IWQ&\&;M0OKQI1,2UU
M+OP=@Z<<9S7H.MZ-::_H]QIEZI,$ZX)4X*GJ"/<&N<M?AY%#K&G:E<:_JUY+
MI[9@6>52 .A'3.#WH YO6=9OM-5-7M=?O;YEUM;>0(=EMY9R3$!C!( P6'\Z
MLB1M$\7^/M92:XDDLK:"1(MV4<O&Q 8=P"!CT&:O-\*-/-F]F-:U9;7S_M$<
M(D7;')G[P&WKCBMS_A#K8Z[>:FU_>,+Z 07=N67RYP(R@+#'7!/XF@#F/#4?
MC"YO]"U4O=M8W$7F7OVF\1XY Z@AD0 %,$Y ^@]:U_BM#YOP_O&\QT\N6%L*
M<;LR*N#[?-GZ@5/HG@*#19;;&LZK<VUJVZ&UEG_=*>W  SCTK:\0Z);^(]#N
M=*NI)(X9]N7B(# JP88S[@4 <'XBTN3_ (61X3TV#4;R%A:7""[W!Y@-CGJP
M(SCC.*BLM:OT\-^(K&X\03P/I^L?91?S_/*8=P&U<#._ ;''?MVZR+P7&FKZ
M1J<NK7\]SID;1QM,4;S V0=QVY/#8JL_P[L9++4H&U"]$E_>K?-,I4,DH)/R
MX&,<F@#F[N\U!;/QMI4E[J#6MOIZ7%N;J3,R[D)(SU .,8/OZUVG@:,)X)T@
MK+/*'MD?,[[F&0.,^@["J%O\/K6*74I)M7U.Y;4;3[+<&>16+#& V=O4=OK6
MSX<T%/#FE+I\=[=74:'Y#<,"47  48 P!B@#C+C5KJR\;S0Z_J&IZ=&]ZAL)
M$_X])81C]VV.YYR3ZT6VIZK+;_$.*74;L?V>7DM&W8:+"NPVG' ^4?A]:Z2]
M\')J$<]O<:I>-9RW@O#!A,*P;=M5MN0N?\]:BU3P-;ZGJU_>_P!K:E;)?HJ7
M5O;R!4E 38,\9Z4 <YHFKZIXE;P_HTNIWEMOTMKVYN8<+),0X15#8X ZDCK1
MXMTW6=.\)Z39W>K->7O]NP_9[ID^90=VS(P<D=>A_&MMOAS8"QTN&WU+4;:Y
MTU&CANX9 )2C$G:3CH,\5)J'@*"_T6#3WU2]+I=K=R7,I$DDSC@;B1V' QC'
MO0 W01J.F^.=0TBYU>YU&V>R2\0W(7=&Q=E(& !CCH .U.\<2ZM'=:!%I>JR
M6'VJ^^S2E(U;<&4G/(/3:?S]JTH_#CIXO/B!M2G9FMA;&WV*$V@Y'(YZDG\?
M3BD\1>''U^73W74[BR-E.)T\E%.6 QG)'H3[<\@T <3>/XD.N?\ "*6>J:A>
MM96HGFN8YHX)I'9N,LV<J 0..<GD]*L:M?>*M,\-:&VM_:T6.=UU.?3B#((P
M,(Q89QUR?7%=+KW@R/5]635K/4[S2]0$0A>:U8#S$SG##\^?IUQ0WA2[MXK,
MZ=K]Y#/#O\Z2X G%R'()WJ2!G@8(Q@4 <WK6NWMGX7\+W>D>()KN&XU!+>2X
M>,!YT+$X;(R"-NT^M/\ %FL31>)M1L[WQ!-HL$%@L]CY3A1,^3DG(^;D8VYK
M3N?AW#+H>F:9#J4D(LKS[:S^2I\V0DG[O 4<G '&.QKD_$6J1?\ "?ZE-=Z_
M=Z%);)'%"OV4S+<JHW9QTZM]W_\ 50!H:AJ_B:V\/>#PVL30WNJW217,IMXP
MP$A&!M*XX!_&M+3;W5["X\9Z8^LB=M.CBFMKN_ Q&9(V8[L#[HP.WX=J2R\/
M:MXKTW1=0U?59$EL;XW4.;54::,,"A9>-I('Y$9&:U+OP/'>WOB*>;4IRFM1
M1Q/&J*/*V# /O_\ 7/6@#)M]0U ZV=/;5;ZYM;K0GN/.EC6/,@(7?'@ KU)Y
M]JQ=/U74-)^!0U:PO[A+I7^5Y-K[<S[6 R.AR>N:ZNW\#W*:K8:A<^(KVYEM
M[=K64-&@$L9&-O'3U).23CFH!\.RO@V[\,#6IC92R!H=T"?N5$F_'&"Q)ZDG
MZ 4 1W%WJ7B#Q/;Z#'JEWIT$>E)>32VRJKRNS <,1P![>XK$U'Q1KVEZ'XHT
M[^U6EU#1YX/*O# NYXI&4 $=,C/7%=9?^#9)[O3M0L=8FLM4LK46OVD0HXE3
M'\2'CKD^V:@O? 7VSPW?Z8^KS&ZU"X6XN[UX5+2%<$ *,!5!48 Z4 9^CW.O
M:3\2DT/4M;DU2&XT[[02\*QA&#$?*!_N_CFMCQ]=:EIN@+JFG7TULMI*C7*Q
M1HQDB+ -]X'!'44\>$IO^$OL?$+:L[26UH+62,PC]Z/FR2<\9)ST[5T%Y:17
M]E/:3KNAGC:-QZ@C!H \[/C&:R\<7R7&LO+H<FG/<6W[M $DVJ^T,!DD*<X/
M]X<5)>:KXBT2T\$I<ZB99[Z\2*]$D*Y<2,#@G'&T-C@#I6N/ASH_]AZ5I3;V
MCT^Y%P),#?*><@GL#QT_NBKOB7PO)XAO])N5U#[,NG7"W*)Y&_<ZD$<Y''%
M&)H?_)9?%/\ UZV__H"5?^&'_(@V/_76?_T<]6;?PK/:^*M7UZ+4P)M0@$2H
M;<$1$ !6SN^;&.G&:M>%/#\GAC1%TQKYKQ$=G1S$$VACDC )SR2?QH XO[#J
M5_\ %OQ)%IFK'391;0%I5@64L-B<8;@5'IWC;6]5T[2-,4R?VA<7L]K-=6RQ
M[V6%58LJO\H)W#.>.#CJ*ZVX\*7*^*;K7]+U;['<7<*Q3QR6XE5MH !'((X
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MO! \+W5]<SP* $F.T.F#E<8&,#WIVA^,&UV]MUM]%OH["YC=X;YRA1MK%2"
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MBFXBU*;[06.DE3%+G.Y<#UQQ[40LSZGIM]J-QXNO7T]W\I6T;:"C?>5N.<C
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M$ TP,S-M,R@L<G E<#]!7&^(A_9/B6_U35-/75]&DO(Q]MAFQ-9.I7]WP<@
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MPI!QVP?SQ7/:WH%M#XMT_P +V<B1V5S'+?/%=RRNL\I^7!(8'@*6'/7.<\4
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M7&FZKX7\87\]S#87MN(KZ(NWEQ.T?RML'KS^E 'IU5WO8!<26L<B27:1>;Y
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M5\#)P!GBO./"VHSZ\^@Z*\MW%>:/+,VI'SWW9C^55;GD,S=_[I%=;X_MUN?
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M=Y)>6YB"I/+]]\<?-[\8/N*X71(K_P 8>'M3\03:SJ5I>I+.MLEO<%8H0JC
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MXY/S;LD$]B<5LZ?/<-I=O+J+6Z7+1AY?*)"#C)QGG JTDB2H'C=70]&4Y!H
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M4M4BTZXD:2;3XY]L+ECDC &0.G /:I]3\$PZE=7CKJE_:VUY"D$]K 4$;(H
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M5+34EMG%W:1>3#()W^5,$8Z\]3UJ;1O#^F: DZ:9;&!9Y#)(/,9@6_$G'X4
M<G:V4,OQIU&6ZM(=R:=%);.R\GD N/?[PS[5PBZ9:-\-_$^L&-AJ%IK#?9Y@
M[ Q_/$,@ X!^8\_3T%>RW?AS2;[6K?6+FT$E];IY<<I9N%R2.,X/)/6J2>!O
M#R:+<Z.MBPL;F;SY8O/DY?CG.[(Z#I0!P%QI\GC+Q3J-OJFK6EN8;.W\A+JW
M+?*T8+.GSJ =S'D9[5Z5X8@^R^'+.V_M,:GY*M']K QYFUB/4],8ZGI534_
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M=&XCN;)B8I;>9HVP>JDCG'TP?>@#B-$T:V\;KK^I:U+.FJ6U]+;P,L[H;1%
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M5&\*0Y(!ZXZ55@T33]*TOP#J]DLD5]<W5K%-,)F)='0EEZXQGC [<4 >MF1
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M34-&9KG$SEW;>PW;B<YX'>N5&AZ>/A5'XMMKJ\?6K9D*S-,Q"OYH4J >,8-
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M4*"]BMRMQ=VL/FM;JWS<@[0?3.TUYHD4_C'6O#:ZA?ZE;K>:*TDR6\YC#."
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M[@D>6!T  ..*H7W@G2)=*UFULK2&WFU1?WTC;G!?)(;&>Q.1C'-7V\2:4GB
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M,<J <\?7]* -ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO"?AZXN9KF;1;&2:;/F.T"DMGKF@#D--6P;XFZ4\XMR[>'(6A9\9,GF<%?\
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M3O#/@;6+4/'J,NH6R/-O.YU<_,I]@  !V%>C3^#/#]S?7U[-IJ-<7R%+A][
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M*F^)>J:1JMA!(MI900Z7#<8D5857G:&)R>0>YX- 'HTEY;1(CR7,**XRC,X
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MG^+' KS]M&T^Y\(>.-4FM4>]M]3D6*8DY0;UZ=NYH ]SFGAMTWS2I&N<;G8
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M$UI$C.TBN,# [^E<QX,UO7/$LL.JMJFF'3Y%<S:=''F6WY(0;LYSQDD^^!W
M!U6IZ)I>LK&-2T^WNO+.4\V,,5^AI;G1=,N]-&G3Z?;262C"P&(;%^@[?A3[
MG5-/LY#'=7]K!(%WE99E4[<XS@GIFHIM=TFWNHK:;4[2.>491&F4$CJ._?/'
MK0!'!X;T6VTJ72X=,MH[*;_6PK&,/]?4^]-;PSHC1V,;:9;E+ YM1L_U1SGC
M\0#5R[U.PL&5;R^MK8N,J)I53/TR:CO-:TS3]/6_NK^WBM&QMF,@VMGT/?\
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MI?CB&YT35K_4[&73Y=*D:*[@W"3!'3:P W9_SQS3+/QG=_:-+_M?1?[.M-4
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M].G.,Y[=>*A\*V5S?ZU?^)]1TIM-NKF-+>*"0@NL:]6)P,9../11774 </\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=[<1P6\8RTDAP!6+%XYT":WNIDNI?]%A%Q(C6TB/Y9_B"E06'N.* .BHK@_
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M: ]<#N?>K5% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU.$Z?J3=TB)!WX]0H89/J*SO%=M:6GCO24EEU.QL8-+:%+C3T<&,Y.T94'C
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
$* /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>a123121ex-1021005.jpg
<TEXT>
begin 644 a123121ex-1021005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#WZBBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1G^= '1T5R5KXRO4UK3])UCPY=:=<WQ81/Y\<T?R@D_,IZ\=,=ZZV@ HHHH
M**Q_[?'_  EW]@-9S*QM3<K<$C8P! P!U[^W2H_%7B1?"ND?VE-8SW5NKA9#
M"5'EYX!.2.,D#CUH W**X^U\?PF\LX=3T?4=+BO&"6]Q<H/+=ST7()QFNPH
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M=3*]I+(L4@"C(P%QD9!&3CJ._6NPNM!T>^DADN]+LIWA4+$TL"L4 Z 9' H
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ME98X[<D[5)!RF[KQV)'!KH/"FD:GH?BJ]BO-1LEM[R'SHM-AGDE*$%07!<#
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MTU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%!Y% '&3_ !*TR$R3+IVJ
MRZ=%+Y4FHQVX-NIW;2=V<XS[5H:OXSL=,N5M;>TOM3N3$)VBT^'S2D9Z,QR
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MT35+6PO]+TTHUE<KB*XMLYV9/!Y'OVSB@#T>&:.X@CFA</%(H=&4\,",@BJ
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M_M2/2+5;W=N\T)T;).0.@//7K6U10!AZAX.\/:IJ/V^]TJ":Z(PSG(W\8^8
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M<=OH!5_4/B/INGW;;K.\DTZ.;[/)J$: Q+)T('.6P>X%84[W3^&O $8TR_\
M-MKJV,J>0<H$0J2>PSU'M6=IMJ=%NM1T?4? B:MJ!N))K2Z%K&Z2(QRNYVZ
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ME^SR6\8$@4Y^]ZDJ ,]CG'2LO74U(>#/ KM>1W-W+>6LENTT>U4S&NU6P<L
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M/B%QI,%U?0ZDEW+>-=@R7.W( YZ*,_AZ=:]GBE2:))8G5XW4,K*<A@>A!IU
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M#GBJGA V,L^EVJ> I;?4[=D6ZO)K81QQ%1RX;DECC@8')ZUZK10!XO%#<_\
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MS:U\@?O%965CNSQG=TQ571?A_<:1/%"?$M_/I$#AX;#:% (;< S Y(SS@ 4
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MDW@CQ&UGX@M9-;L;B/5\.Q:V*%7X!(P3@;1COT!XYJU+X,U223P@WVNS T%
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MUK9%+A]H_=,Z,N#SU!//]:U_!,5]#+X@^VZ?/:"?4Y+F(RX^=7 '&/3;^HH
M%\3WS_$B7P]'9K):0V@F>16 8$E?F.3T&<8'/.:XOPAXH_X1>Q\0O+IE_=64
M&JR&6X1@5B7(4#+-EC[>X]:ZBZM+W2_BH-4M],N[RVO[%;>66/&V%MXY)..
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M3210($0S/N;:.@S[#BKE% !1110 4444 %%%% !1110 4444 %%%% !1110
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M07MLEQ;3)-"XRKH<@_0T 2T45AKXEC;QF_ALVDZRK:_:1.1\C#(&!^O/J,4
M;E%%9NOZNN@Z)=:F]M-<I;IO:.+&['KR>@[T :5%<W?>,;:RN_#\#6D[+K1
MCDX CR 0#[_,./K71LRHI9F"J!DDG  H 6BF12I-$DL3AXW4,K*<@@\@BGT
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6'C"QF'FV]SJ4VX8(RC]"/?@^XI_P_M]2NM4>WU([H_#GF6,#$Y\QF;[WMA
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M:^OVNEN1=B^,H\[S< 9SC&, <8["NLHH YA?!-J^EZG9WFH7][+J,8CEN9Y
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM;+7]=0W^K+%/(;YMQ5P2>F!U&>G<]:C/AS[9XI\2:,NJZJMC#:1SQ0_;)&
ME=3\Q.2QP1G'.2>_%=AK'A"SUQ--6[O=0']GLKQ%)\%V&,,V0<GCKP>32?\
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M9>ZM<ZC%>ZG8276/M,=C<^4DQ'=@!SG//-='9VD%A906=L@C@@01QJ.R@8%
M$]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN?$_B2S\*Z.=1O%=D,BQ(J#)9C_(8!/X5AZGXJDL_&6B$ZE;1^'[VTEE+M@
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MI;)1BN6()SR>,'-:'AM?"^K>%+Q/$$L$>I?;Y);QG8)<&02%EQ_%TP, >HH
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MKZ&ZTI=/L/MEM=S;9YE? ACVY#^__P!;'4BO(]37?X,^(,;O(Z6VKJ(0SD[
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M9;H3WZUJ:WK5M<:%I^HZ?XAM["WFN8RMRR;Q,I)!CP>Y[^F#G% '2A550JJ
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M%DKJLK8D#@%@W/(XZ=*ZH^#]):[U>X=9Y/[6C\NZC>4LA&,9 /0^GIVQ55_
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MGG2=8T[[??\ EZK<?:)VWKN#9S@';TS5BY\&I/N6+6-2@CEM4M;B-'5A,BC
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "HYY&BMY)$C:1D4L$7JQ
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M=[Q;I%.3RW. N>!@XY JSIDT^E>.O%<MQINH-!<+#/%-%;LZ.(XL$ CJV3@
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M.:))8G62-P&5T.0P/0@]Q7E&A6T%A>?$:\M+:"*YLO,-K(D2[H3LD^YQQT'
MH ]4CNK>65HH[B)Y%ZHK@D?A3WFBC(#RHI)"@%@.3T%>2ZOI.EZ=\.=*\0Z'
M"(]44VSK<PN0\KLPW*QZG+$Y^GI6MIWAW3-;^(OB4ZC;-*;5K*>)3,X"2%"Q
MX!]1TH ]'I P;."#@X.#WKEO'\UFFAV\%VUPQN+V&.*""81M.VX?(22/E/?T
MZU1\'QR6OC;Q3:M#%;)MM95MX9"T:%E;<1G&.>N .U '<45P/C/0[;5?''AB
M.YENA%=&>*:..=D5E1"XZ=#GJ1SBN2UPOH%[X@T/3;^6+37N+)6#S%UA#YW@
ML6W $ 9Y!Q[4 >UU2U>>^MM)N9M,M%N[U%S% S[0YSZ_K^%<2/#ZZ-=Z[)'K
M*-!>:9+LL;;>NQE'+CYVQCIG(Y;\\;2-'@D^$-QKIN+W^T9--F1I?M3GY5<D
M  D@?< X[9]: /5[9Y9+6&2>+RIF12\>[=L8CD9[X-2UYNC1ZIXD\+:-J4DC
M63:*MRL(=@)9L ?-CKA0Q'O6'JU_>^'+[Q=I%A<SQ:9']E"%Y&;[-YI7?L8G
MY<AF/X>U 'HU]XAFL?&&E:&UANAU".5ENO-QM**6(VXY[=^];U>;7&B6>B_%
M/PF+&+R[:2WN%!,A8LPC.2<DG."O/>MGXBWLMOH]C:B:6WMKV_AMKJXC<)Y<
M3'YLL>F1WH ["N0@\7ZGJ&ISQZ7X>-WI]O?FQENOM:JRLN-S;,<J,^O/M6;>
MV*>&/B#X<BT83)!J:S175L)F*LJ*"'PQ.",D\>GN:A^$MA;#3M5O1'_I U*>
M+?N.=F$..O/- '3^(_$LFC75CI]EISZAJ5\6\FW$HC&%&268]*IV_CNV72M7
MN-2LY+*]T@ W=F9%<@D?+M8<,#G -1^)= U:3Q3I?B/1/(>YM4:">">4HLD9
MR>O..2>WIZ5YIKBWFJZ7XXULPI&CW-M"ZQ2%U!0@-AB%R!QV[T >EZ;XVNI=
M1T^VUG0Y-+CU//V*9KA9!(<9 8  J2"./7BNPKSOXAE+D>$ELW_XF$NH1M:R
MJWRA<#<<CC^YS6K\2-6NM*\,1BTD>*2\NH[4S1MM:-6R20>QPN/QH T+CQ.+
M?QM:>&VLWS<VS3K<;Q@8SQM_ _I6_7F+:79Z'\8=&BMFF$)T^:1C/</+@_/D
MY<G'KZ=36;#JUS:/X8O+/5-2OHKO6&@DN[B5D2X5FVD"+<0%';/<=LT >P45
MYAJFK77A'Q-KUE=75[>QZM;>=IL;S.2LI9E\I"#E>6XV\X"]Q4FMV>KZ##H3
MSC5M0TNTLFBOOLETZRK(<?O"%;+ <XY. .OJ >EUF:7J=U?WFI0W&F3VB6L_
ME12R'BX7&=Z\=/S_ )@'AVYMKOPYITUI=R7<!MT5;B7.^3 P2V?XL@Y]\UYU
M;7NHC2?B*AU6_9K*9OL\C3G?&!N.%/\ #TQQB@#UBBO*]"_M*RU3P7?'7-2N
M5UB%Q=07,V],B+<-H[<_C[UZI0 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 444R9WC@D>./S)%4E4SC<<<#/:@!Q(49) 'J:6O&_%&N7WB3X.1ZK?V_D
M3&\#1NCC:XWL 0 <@#ISSQGWKOK7QG!)XA.C7VGW>GW'V8W2M<;-K1COE6..
MAZ^AH Z:BN.A^(VF27.G*]M<16FI2F*UNG9-KD'&2H;<H)]0.M=%K6JPZ'HU
MUJ<\<DD5NFYDC&6;G&!^= %^BN?TWQ5%>ZE<:?=6%S8W$%LMT5F9&!C)(R"C
M'TZ5D-\2K9(=.N3HNI_8]1G\FUG C(D.['W=V1GMD<T =O17+ZOXVMM,NM1@
M@TZ\O_[-C22\:VV8A#=."P)X&3@''>JTWQ%L(K+2+@:9J;MJJL;>)81N)';K
MSGC&.Q!H [&BN1N/'L,-JDJ:/J4LHM1=3P!5#VZ%B%W L.3@G R<#/2K4GC.
MR;3-(N[*VN;U]6.VU@A"[B0,MDDA1MP<\T =)17)V'Q TV\TO4;^6RU&U33N
M+E9H.5;.-HP>6Z<=LBEMO'$,YU"%]+O+>]L[+[=]EE*;Y(\9&-I.#T&#TS0!
MU=%<AIWC8_\ "$V6NZG8S)/<L(X[>$ M,Y)"[!GOC/-7_#?BZQ\2O=P0Q3VU
MY:,%GMKA0KKG.#P3GI0!T%%<IKUQI$'C30%O+C4DOW++;1P,PA;/!W]C^'X\
M8JM>_$[1+*[O[8VNI2M8RM%<-%;;D0@D$DYX'!ZT 6]4\)7FKZRL]UKDS:8)
MHIQIY@4@/&<C#]@>XQSZUU-0V=U#?64%W;MNAGC62-O52,C^=<__ ,)UI/VD
M(([SR#=_8A=^3B'S>F-V>F>,XH Z:FRQB6)XR6 =2I*L01GT(Z&N7U+X@:+I
M>JWFFR)?375HJM*EO;,^ 0#G([ $9)]:GG\;Z1;KHSG[2\>KD"U=(21DD##>
MAY_G0!LZ;IUMI.G0V-G'LMX1A%)R>N22>Y)).:M5EVVNVUUK]YHT<-R+BTC6
M221H\1X;& &]3G]#Z56\9R7D'@[5;BPNVM;F"W:5954$_*,D<^H!&>V: -VB
MN,UG5-6L?A3'J.G,\E^+&!S(?F895=S\]3@DUA>%]:\[Q5"=%U2^U'2?[-\[
M4!=S/*8I!G !;[K$]AQC/H* /4**\F2;7;SP1<>.6UJ_AOT+306BR;;81!\;
M3'@[LKNY/J/2O3=(OQJNBV.H!"@NK>.;:>VY0<?K0!:DC25"DB*Z'JK#(-!C
M1DV,BE!CY2...E<AXP\5Z=:V6HZ7'?W<-\EN7::SA:3[.>JAF (4G&/ISQP:
MGT;Q+9V/ACPZNI74TE[>6,;JHC>:24B,,S$*"?4Y- '545SLOCKP[#I%IJK7
MS&RNW,<,BP2-N8'&" N0>._6M236+*/6HM':5OMTL)G6,1L1L!P26 P.1CDT
M 7JB2UMXU=8X(E5^'"H &^OK69J_BG1=!NH+;4[^.WFG!,:L"<@=^!Q^-1:9
MXRT#6+6[N++4%:.S4O/O1D*+C.<, <>] &P;6W(C!@BQ'R@V#Y?IZ4J00QL[
M)$BM)RY50"WU]:QM+\8:'K-U);6=X3/'&)6CEA>)MG7< X&1[CU%4)O&V@ZK
MI]U#IFOQ07!M7F6X$9/D@<;B",<$C@\T =/%:V\#%H8(HR1@E$ S^5!M;<N[
MF"(LXPYV#+#W]:Q(_$>FZ5X;TJZU+5!,;F"/RYA$V^Y)5?F6,#=SD' '&:GT
MSQ7H>L6-Q>V>HQ-!;#,S/F,QCU8, 0.#0!JO!#)(LCQ(SI]UF4$K]#1+!%.H
M6:))%!R Z@C/XUPK>,8]4\>^'[;2-69["X$XGMC;E-^U'(<,P!(R,<<?*?>N
M^H C:WA:$0M#&8AT0J-OY4AMH#!Y)@C\H?P;!M_*I:* (/L5IS_HL/*[3^['
M(]/IQ2P6=K:JRV]M#"K?>$:!0?KCZFIJ* *MMIFGV<\D]K8VT$TO^LDBA56?
MZD#)J,:-I8BN8AIMF([H[IU$"XE.<Y88^;GUJ]10!5?3+"1[=WLK9GMAB!FB
M4F(8QA>/EX]*B;0])>S-FVEV36I?S/)-NA3=_>VXQGWJ_10!4CTO3XK!K".P
MM4LV!#6ZPJ(SGKE<8IK:-I;V"6#Z;9M9(<K;F!3&ISGA<8')-7:* (K:UM[.
M!8+6"*"%?NQQ(%4?0"H+C2=.N[I+JYT^UFN4&$FDA5G4>@)&1U-7** ,]]!T
M>2T2T?2;%K9&++"ULA16/4A<8!J9M,L'L18M8VS68&!;F)3&!Z;<8JU10!5M
M]-L+.U-K;65M!;GK%%$JH?P Q4=EHNE::[/8:99VK,,,T$"H2/? J]10!FKX
M=T18)8%T?3Q%*09(Q;)M<CH2,<TXZ#HY-N3I-B3;C$!^S)^Z&<_+QQSSQ6A1
M0!E?\(UH?V:YMAI%DL-U_KT6!5$GIG I?^$<T4/8N-,M0UA_QZD1@>5]/QY^
MO-:E% &1=^%M!OM1&H76D6<UV/\ EH\0)/N?7\:EU7P]I&M^2=3T^WNC#_JS
M(N2O_P!;VK2HH QF\)>'GL'L3HUD+5Y/-:-80 6]>/R^G'2D3PCX=B,ICT6Q
MC\V$P/LA5=R'J./Y]:VJ* ,%O!7AIX((3HMH(X&+1A4V[2<9.1U/ Y/I5B_\
M,:)J=VUU>:;!)<,NUI,89AZ$CK^-:U% &7<^'-'NVLS-IT#?8O\ CV 7:(NG
MW0.!T%5K_P *:9/9:NEO96T=SJ43+-(ZDAVY(+?0G-;M% %'1=-71M$LM-20
MR+:PK%O(QNP,9J&Q\.Z3IMS<7-I9)'-<@B9LD^9GD[LGG\:U** .>MO _AVT
MU$7L.G(LBN)(X]Q\N-AR&5,[5.>>!5VR\.Z9IVL7NJVT#)>7N//?S&(;'L3B
MM2B@#.UK0].\0:>UCJ5N)H"=P&2"I]01R#573O".B:3JO]I6-F(;KR?)+ACR
MN>I&>3[]:VZ* .(\8V5QJ/BOPZHTS4)[.U>1YY[5MFS>NU<,"""" 3CM6U%X
M/T.'2+G3/L0>WNCNG,C%GD/8LY.21VYXK=HH YK2_ ?A[1K2\M[&S:(7<9BE
MD\UC(4/50V<@?2ID\':0GAIO#ZI<#36.3']H?/7.,YSC/;I6_10!@W?@[1KR
MPT^TE@D"Z=@6LL<S++'@8X<'=Z=^PJ1/"FD)I-YIK0/+#>9-P\TK222'L2Y.
M<CMSQBMJB@#E++X<^&['4K>_CMIWN+=@T32W+N%(Z<$UOZKI5EK6G2V&H0":
MVE'S*3CIR"".A!JY10!AZ5X4T[2;MKM)+NZN=I2.:\N&F:)"?NH6^Z.W'/'-
M.\.^%]/\,17$6GO<E)Y#*ZS3%QN/<9_ 9ZG SFMJB@#*US08=>BAAN+R^@A1
MB7CM9S&)0?X7QR1[<5+_ &'I@T1]&2SB33WC,9@08&T]?Q]ZT** .:TGP/I>
MDZC%?">_O)H%*6WVVX,HMU/!" ]..*UM9T>RU[2IM-U",R6\P&X X((.00>Q
MXJ_10!R-E\.M'M-0M;Z2ZU*\N+92D;7=T7PIXVX]!SP..3[557X5Z%''%'%=
MZK&D-Q]H@5;L[86SGY1C ^O7CK7<44 <(=WC#Q5IWF:/>6MKH<\DC3WD0!E<
M8"!#SD9&XG_9'X;VJ^%H-4U,Z@-1U&SN&M_LSFTF"!DR3SE3SDGD5NT4 4]+
MTRUT;2[?3K)-EO;IL0$Y/U)]2>:PHO >G16VM0"]U KK!S=%I5SG))V_+QG)
M'?BNIHH YJ/P1I\9T,B\O_\ B39^S?OA\P/9OEYXXXQQQ72T44 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %!Z&BB@#Q>XTS7KCX/QZ"?#]^EY:W(7&T
M'S!O9RP .<#(&:Z/7=+O]4^(]M<1V-XEG/HSVIN-A"QN^\C<1]W&1FO1:* /
M*_#EIJ=L+#29/ \*7]HR1OJLZJT>U3@N#@%CM/ ![UVGC:768?"EXV@)(^H_
M*(_+7+ %AN('KC-=!10!Y9IUO?'QP=8O=$O[;3FT9H)I;QE)) R2[;CU QSS
M[8K'T"<Z;%HIUW3_ ! NG6D_G6JO;+Y,!8\%G^\R@'T']*]@U33;;6-,N-.O
M$+V]PFQP#@X]C7/6/@2&UDB%SKFM7]O%MVVMU=9B.T@C( &<8Z'B@#C=>DNH
MO&'B1K.PU=;"XCCM[UM/MDF$Q"G=R3\AVL!QD]<BKER/[4N? =QHVFZ@UAI\
MK1RAXCN@"E$P_N"IS]*Z6?P% VI7=Y9ZYK6GBZF,\L%I<A(RYZG&">?K726%
MA!IME':VRL(TR<LQ9F).223R2222: /.M;TMK#Q[J%]?>%;CQ!87L$9C=8UF
M,#+D%0#T!_PZU'XA>\L=.\,O;:5)8WUO+/<K:Z;$LKVT)##!C/!SN4$\#.<=
M:]2KE_$7@Q-<U2/5;;5[_3-0C@^SK+:O@%-Q;!'4]3W'Z4 <C8:S<KX,UR'0
M8M1?Q TGVNY%[;!)"9#@LJ#(/RJ./QINGK=S^+7N(="UM(KW1)+19[WYG=^"
M&<D_+TQ^(XQ7H&@^'HM$21FO+N_NY@!)=7<F^1@.BCT49/'O6Q0!XY/:ZA<>
M"?#<TOARYN!HDVR\LIX<^<G*DJ/X@ /3@D=<&NS\&+:3W5U>6'A0Z);M&JB2
M:(123'.<!1_",#\37844 <!XS$T_C_P>D-K=2+;3O)+*D+,BAMH&6 Q_"?I6
M1<_:9[#XBPBPO0\TO[D&W8B4 ;,J0.>1GZ'->K44 8?@XO\ \(7HRO%)%)'9
MQQLDBE6#*H4Y!]Q7F.JZEJ^HZ9.+_2M8EO+;64N?*BM-L,42L?ND?>)R>N><
M?6O:J* /,;03?\)?XZN7M+N..XL%,1>W<;\1 $#CDY/0?A4=AH4FI?!&"TDB
MDM[ZQ62XB\U&1HY$=V!YP>AZ^]>I5S?B/PM<>(;N%AKM_96BIY<]K;MA9E)Y
MR>N2.._^(!'X%@FFT=]<O8T34-787,VT$87&$7GL% _/\:L>.)Q#X*U==DLC
MS6LD*)%&78LRD#@?SK?1%C1410J*,*H& !Z4M '#:G-J7_"I;<Z0ER;I;."-
MUBCQ*% 42  C.<;JPM+L]+E\6:>_@CS([6:"6#5 89!$JA1MSD ;\D]^H]^?
M5J* /'XM2:R^&D_@VYCN&\0?/:QVA@;+J9.&! *E0I)SGL:["'PGK4.GZ=;V
MWBFZLDMK2&!X8X(W7<BA202,X.*["B@#RR+5H?#LOC33-3@GCN[ZYGN+1D@=
MS<(Z' ! Z*!^&33=/\11:<_@N&ZL9K:'^S@CWC69>0L 4\I>"0"5!.!D@KTS
M7JM% 'E'A#2(/$7POU3P^(IH9XKB4(+F,JT;YW)DD8ST!Q[^HK>^',M]KEH_
MB?4VS/<Q);1#GA(^&;_@3[CQZ5O>)-*U?5;>"/2=;?2V5CYK+$'+J1TYZ'WK
M0TO3;?1]*MM.M%*P6\8C3/4X[GW/6@#A_B3-#:ZYX.N9W6..+4PSR-P%4%22
M3Z5SGBRWN?$NJ>(-6T037&G16,,$K1 A;AED5F"G^+"CKBN_\4>'=1UK5=%O
M+&[M8!IUQYQ$T1?<?P/M^N<\5TXSCGK0!YCI5UX5O[Y=2TY=2NKV.RE\V>[D
MD86<80\,7XYZ #/<]JA\*&TA^!UW),L:R+;743,5^8,Q;:/7G*_I7JE% 'DT
M&H)83?#W6;ALZ3!8-;2S$,5@E,00D^G(QD]@?2J/B59=;F\9ZIHSM<Z<UI:Q
M$P*Q6602(Q(P,-M4-D^C5[*Z+(C(ZAD8$,K#((]#1'&D4:QQHJ(@"JJC  '8
M"@#SF]\5Z%J_B[P=<V-VCA9)@X5#F/?$456XX^8X_7IS7;:3KEGK1O/LGF_Z
M)<-;R>9&4^8 'C/;FKT,$-NA2&)(U)+;44 9/4\4\*JDX &3DX'4T +1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 9NL:Y9:)%"UTSM)/((H88EW22L>RKWK
M/USQA9Z'??8C8ZC?3K!]HD2QA$AB3.,MR,?_ %JH"%KWXLO)*^8]/TQ3#&1T
M:1B"W7@X7'XU4M[&5_C%J$G]H7*J-.BDV+MP1OQLZ?=XSZ\GF@#K='UBTURP
M%W:%P,E9(I%VR1,.JNO8CTJ_7$6UU):_&*]L8RP@N],2XD3<<>8K;0V.@.W
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M<YW*Z9.!TP>_-5?%7BJ_MM>BT/1FVW2V_P!JGD%I)=87=M"[(P2#W)/'3UH
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MI5DY2:\B9,?+]XJI.6 '.: .RHKD;[X@6-O=Z;;65A>ZC)J5L;BV%L@^88R
M<D8Z'/IBM?PWX@A\1Z:]U%;S6TD4SV\\$PPT4B]5/YB@#7HJ.>1HK>61(S(Z
M(65 <;B!TR>E>4:WXANO%?P<OM7O(&MGCNE,?E2?*Z^<HQP<G ..>X!H ];H
MKF-+\907VKIILVF7]AYEM]H@ENU $J#&>03TR#UJC%\2]*DUBUM&MKF.TO)/
M*MKUMH21LX!QG<%/8D=Q0!VM%%% !1110 4444 %%%% !1110 4444 %%%%
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M<'S P<''H" /7 [5V-% '+Z+H_B>&ZLWUK78+B"T5L1V\)0SDJ5!D)/.,Y
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MG&"HY]_:O29IX;:)I9Y4BC499W8*!]2:D!! (.0>] 'F<^E^(/$FFZ)X?O\
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M?V)>#Q19:QHMAJ>DW,U^!J%NQ7[/)""=S\9&6 'XGMUIFB6VL>&?#VL^'9-
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M%O<;(W 7:,C'..N,X_#BGVG@33[._P!(O%O]1>328C%;"21"-ASD'Y>>#CZ
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M$V^8X]JQG&4 QWQU.?I0!C>&_P#D6?B)_P!?=[_Z U=UX/\ ^1*T+_L'P?\
MHM:Q[;P')9V&OVD&MSJNL2F1V,*DQ[B=^/7(./PXKHM"TO\ L30[/3/M#W M
MHQ&)'&"0.GY#C\* .!M9/%&N>)/%6FP^))+4Z?(K6VR!-OS!B%.03@8'\Z?I
MGB2_US2O#<EUK4MBUTLB2QVT&;BYD7(#*-K )W)P!FJVCVDNK^./&*:=XA^P
M-+,D;"&)79U"D95CTP<CC_"NCN/ $2W>ES:5JUWIHT^V-L@C <LA.3][@$Y.
M3C^5 ',)KOBC4/A9!KD=],E[8W#"Z$2*K2PJ<-G(.&'7..QXKK])U:XUSQA<
M3V=T[:-;V,2E %*O.YWYSUR$*Y'N/QS(H=,^&^@/IU_>7=_:WLD@AA$&6Y4D
MKE>N>!D]S]<:W@'P\?#7A"TLI45;I\S7&!U=O7Z# _"@#.\;0W%QXJ\(Q17T
M]LC7<F1%CJ$SGD$9QD=/XC4<$^L>*O$&N6UMKDVEP:7,MO'' B.SG!R[[AW(
MXQ[UN^)/#LNMS:;<VNH-8W=A/YL<HC$@((PP(/M6?<^$-0MM8N-3T'6_L$UZ
M$^V+);+*LK+QO X"D]Z +'@76[W7?#IEU% M[;SR6TQ QN9#UQVZ]*YWP]Y\
MOC?QVTEY<.L0C41L05(*/CMQC'&,>^:[70-#MO#VDQV%J68!B\DC?>D=CEF/
MU-8J>#[NU\0ZWJ=EJWE1:K%AX6@#8D"%5;=GH"V<=^E '(Z!?Z_HGA#PA=PW
M\3V-U=I:RVQA7A'<X(;&<XSG\*T+_7O%6K2Z_/H?VE!I5V;:WAAAB=9F7A]^
MX[B><C;[5?/@/4_^$9T72%UR)?[,NA<"3[+]_:<H,;NV3]:DN/ FI0:_>W^B
M>))],@OY?.N8%A5\OW()/&22>G>@#K].EN)]-M9KN'R+EX4:6+.=CD#(_ UY
M;X'N?$L.CZTN@Z?8W _M:X+/<SE3NVIP% ^G)/?M7J4-J;334M+:1MT40CCD
MF)<Y P"WK[^M</HW@CQ3H$%Q#I_BJVC2XG:XD#:>&R[  GEO84 2ZU?^)=.\
M$V.MVHALYK>,3ZA8BW #Y(+XSDJ1\Q_&FCQ;J<'@:]\3LR3F[D_XEUIM4^2&
M;:@<K]XY()'X5<C\&ZE)!90W^M+>1K>F\OA);_\ 'RPQM7[WRJ !QTXJL/AW
M)]AUO2CJ,:Z/?EI+>T6#_CUDW @J2>G'(P/PH IV/B;Q587E[/J5G=W.DP6+
MW#2W%FMNR2*N=HP<,"?QY'H<Z>D_\)G=1Z/J;:E8RV]UMENK4P;%CB8 @(PR
MQ(SW]JFTWPIJYB-MK_B%]2LQ;-;B!(?*#!AM)<@Y8XZ9]<TS0_">N:7]DM+C
MQ+)/I5H08H(X!&[ 'Y59P<E?4=\8H R!XF\02>!O$6H"_MEO=-OI8T=80?D0
M@;2IZ9['FK/V[4+OXMV5J+QD@BTCSC'MRK%F&[CWP.?:HIOAUJPCUJTM?$4<
M.GZK/)-+"UF&;+<XW;OY5K'PKJ<.OZ)JUMJ%MY]K9BSOGE@^:X7C)&#P21QZ
M9[]" 0:9J>OZFOBRSCDM(+^SN2EI(D7R_=RNX'J2 .3TS[8JMHWBO4=9TKPP
M(KE%O[J>07V8#@1Q*WF9&/E.=@^K5M>'-!U'2=:UV\O+JWFBU&X$T:QH0R8&
M #GCI@?AFC0O!]IH>OZSJL3[VU&3>$*X\H$Y8 ^YY_ >E ''0^-_%FIS)JNE
M:?-<:<UP4%JEB2K1!B-XEW9+8[8 KT+Q'?RZ7X:U._@QYUO;22IGID*2*Y/3
M_!7B/1IY=.TKQ!%:Z \K2+&(0TZ!NJJQ''L<^^*[+6-.75]%O=.=RBW4#PEA
MVW C- '&1:G)X/\ AKI,L*Q/J5^8D5YMS"2>7YB[D<GC)Y/;%78]6\0:)XET
M[2]8N;6^@U,2B&>&W,1AD49"D;B"N/QJG8Z)_P )#X$B\.73M9:MI)C4NR;S
M%(GW'7/WE8>G8D5I1Z!KFH:UIFHZU<V)_LU',45J'Q+*RXW,3]T8[#- %'P-
MX@\3^)E6_N_[,734EDAD6)'$I91P1DD8Y%=W7'^%/#FJ^&/"6H6#7-K]L9Y9
MH)8PS*K,O&01DX(]#6MX2N=5N_#-G<:VH6_D#&0!-G&X[<KV.,4 <YXB\3>(
M-&EU*[,NEQV=I/"L5NZ[Y98W95+$A_DY)ZKVJOKD.KW/Q5TS['>6(A?3Y##Y
MT!D55X#Y 8;B>.<CC]8-1^'_ (ANQXCMHM3TX6FKW7VG,L3M(,.&52>@ P!T
M-;J>'M;'BG0]5:>P,5G8"UN4 8%F/WRG&,9"XS[T <[IWBG4M,E\9ZI=W22Z
M=IEV\$5J8SD$-LC52#A5S@'CGKFKGAGQCXCU'Q+:65]9QRV-U"S^?!93Q+"V
MTL S28!Z8R..1S5J7P%<3-XHLVN+8:;K3^>IPQEBESNZ="-W/6KWA[2?%UH]
ME%J^K6$EG9KM"6T3;Y_E*@.QP,#(/ YQ0!G^$?$/BSQ%.MQ+'I*Z?!>2VUUY
M>_S/E P5YP.2.M6_&=UK$7B'PO::7>I;+<73^8'4D/M3.&P1D8)X]<'M5CP-
MX<U#PU8ZA;WTEM(;F\:Z4P,QQN !!R!TVC\ZD\5:)J>HW^B:AI4EN)].N3(4
MG)"NK#!Y /;V[T <A#+J]O\ $CQD^C)9"988'=[K=M $8)PJ\DGZBKC_ !+G
MN]!T9[*&*/4]121V#PR2I&$)4G;&"QR5X_'-:UGX9U6W\6^(M49K1H-3M4C0
M;V!#A O/' SG]*P-/\!^(])T?1+FPET]-9THSH$DRT<T<C$X+#!R,GCWZT =
M?X,UW4-=TF634[)K:Z@F:(MY3QK*.H=5?D @]ZY7QK<"R^*/ANY&G2WY%M-F
MW@0,\GRL. >N,Y_"NXT.WUF*"637+NWFNI&&$M4*Q1J!T&>23U)/]*YKQ'HO
MB.?QWINNZ9:64L-A"Z(LUP4+EU8'/R\8S0!+H>HMJVK:M):>&AI>I6MO$D+7
MJ;#(KECA@O;*]LU%X;\6ZYKFJ)IDEG;0W=C-(NK JVU%!Q&(SGDMR?HOO5R,
M>-;K44N;FWL+6"WAD*6\-RS"XE(PH<E>%'7ZUEP^$M<TC5]*UO3'CEU&:,C6
MA<7!"3,=I)7 ['=C X '% $6H_$74%.IW>EV5O<V&GW/V=E*RF6;&-Q4J-H
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M;21898I##=/G:SVKC$B@_3('^\: ,R3X@WD6BZ4TEM8PZGJ$#7(6>9DA2,,
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M9XF>1-KR!M^T\\<G;^&>E9F@>'+_ $_Q5I]]IFDW6C64L;G4K5[A'A+8^78
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^.]/U/5+:P:QU&R>[C:6VDO(1&DP R=OS$GCGI0!U-%<WIOC*TU6YMTMM/U
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M1/$-CK]M-<68G5(7V/Y\1C(. >A]B*U001D'(H X:X\"WLTOBUQJ%N!KBHJ
MQ']UMSUYYX/]?:GCP9J)G\).VH0!-"CV.$1@9> O!SQE5'ZUVU4M6U2UT72Y
M]1O79+:!=SLJEB.0.@]S0!Q=YX$UR5->LK77H8--U:XDN6C^SY<.^"1NST.
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M*":1<3*,':"I(R<=R.E>N44 <3=V.I>(_%&FZE+I=WIUOI,,SQ^;*@DGED
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MDG."#UQT'%4M(TLZ7ILNC7W@!M0UB*1UAN_LBFWE!.59Y6(]?T ZU[#10 B
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MK_\ 9NH& V%V+>VQ?O"L. #DQJAWYYY)JQ?2ZS<^-?#NB7&N3QI<::7NFL9
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MAC.?E(QC !P*N^&/"$?AJ[U"Z&I7=[-?,KRM/MY89YX'7F@#/O[^[UGXA_\
M".17UU8VMI8_:Y3;,%:9BR@ MC( #=N]<;XGO-3C\)>*=%U/4)KK^R[VVV7
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M(]@RS%L!<G &<=:YFZ^'5YY6K6>F^(FL]+U.1I9;1K-9 K-C=M;((Z8^GYT
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MM[B/1R#<2O=K&-NTMG&">@! &:YN/P]XS6#3GN=#@N;ZSU1;V6\:]0O< 9X
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MH^ /#VJZK-J5S:R_:9\>:8YW0/@8Y ..@KIJ* ,4^%=)_MNTU=89([JTB\F
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M21F(VJQVY XYS75K(CLRJZL5X8 YQ]: ,9?".AK<:=.+'$NG(([5O-?Y%!R
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M/OVK=\.^([#Q1ISWVG>;Y*2M"?-3:=PP>GIR*UZ ,'3O#KPZ]+KFI7B7NHF
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M6** /.QI'BBTMO$NC0Z9;SVNJ7,\D%X;A56-9L[MR_>) /8=:M2>&]0LM?\
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M^'L'GZI-?ZK=WTNI6@MKAY JGC&&&.G0<>U6=!\(76C2VQG\17]]!:(5MX)
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M6W_LQ?,TNZBDNP+A,QA&'X'@9XSCIS0!Z=1110 4444 %%%% !1110 4444
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M5<:Q>VD%II4,@BM9S&\SR#YG8CKC@8]Q5N='LG\.:/>>(;ZZNA++O6UW"2[
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M]:=%%'!$L4,:QQJ,*B#  ]A67X;OCJ6E&[&IP:C%)*YAFA7;\F?E##CY@.O
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MW\EBLH-S'&)'C'55)(!/UP: .>\5>']4U75=$U#2Y;$2:=)(S1WJ,R-NV_,
M/XEVG'3KU%<X? _BH:#K.GG4-,F?4-02\5G\Q57YM[\ '!+!..>,\],>A7.H
MV=G<VMM<7$<4UTQ2!&.#(0,D"K5 '%7OA#4-5\93:I>RVJ64NE-I["%V\S+
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !6;XAACG\-ZG'*@=&M9,J>A^4UI5
M1UF.>;1+Z&VB\Z>2!T2/<%W$@@<G@=: /&8]%M(?A/H6KV%G$NN->((9UX=G
M\Y@!GOP!^5;/BVYTF>P\;^1;VZW :))9IKC=+)*I7A(SRJ@9Y[G/8<=+X"\)
M0Z=X;TUM5TB*/5+?<=TF'9<L6!'4 \_45NW'A/P_=7<]U<:-92SW (ED>($M
MG^O'6@#D/$LD.EZGX:\='RFCPL%_+;JS*4D3AQ_L@Y'(SR!6?XAT.WM?A@\U
MU;^7<W^I)>R(6((:27A>W(1L?G73:EI.LWMTOA^#3+&V\,HT1\X29<HI#% G
M;)&/IGZ5TFI:-IVKVZ6^H6D5Q"C;EC<94'UQ0!P;^%- B^)L&F1:="MG+I32
MRVZD['82  LN>?Q^M<I;D#P7I^FO?11Z:?$,L#RR1[HO+ RN5./ER<X)%>R'
M0M,.KKJOV-/MRQ^4L^3N"8QCK5=/"6@)ITNGC2K8VDLOG/$5R"_][GO0!YY<
MZ!8:#X8\6QVNN6]Z]S9K*]M;1"-(=IP&&&(&?3OCO3]"TG3]+UKX=W%C D%Q
M>V<S73(QS+_HX;+<\\DG_P#57H">$] BTRYTZ+2;:.TN@!-'&FW?CD9(YX/3
MGBG?\(QHWVC39_L*^9IB[+1M[?NAC&.O/XYH \Z\.:.+[P'XNLS<0Z?<SZM+
M ;B8;<<QX1CUP22N/]HUT?@.[B&I:GIL_A]=(U:!(C="%LQ2C&%90.!T[?F:
MW)/!OA^5M09].0G4#NNCYCC>=P;/7Y>0#QCD5?L-'L-,DDEM8-LLH59)7=I'
M8*, %F))_.@#E_%<$7_"?>#KC)\XS31XW?P[,]/K7%3Z'IVJW'Q&N[V RSV+
MO);MYC*$;:YS@$ ]!US7J]_X=TK5-3LM2O+4RW=DVZWD\QUV'.>@(!Y'<5$O
MA314&J!;,@:IG[9^^?\ >]?]KCJ>F* &^#[N2^\':/<RG,CVD>XYSD@8S^E>
M?^&;.VC\/_$.X2!%F6:]A#@8(0(2%^F:]3L+&VTRP@L;./RK:! D:;B=H';)
MYK(;P5X>:74)/[/PVH@BZVS2 29()X#8'([8H X*'2+30]4\ W]A++%=WZJE
MT6F=FF0QH<<G 4=,#'4>E6[""[O->^(UE:WK02N(A%))*<(S*_<]!V]ACTKM
M7\(:(\FFR-:R%M, %F3<R_NL'/\ >YZ#KG@8Z4K>$-#?^T]UD6.J,K7A,TA,
MA4[A_%\N">-N* .9\ ):V6L7>GSZ$^D:S%:1^<B/NAG0,1YBXXR3WY],]:V?
M%>DZ3XCN;72+B[EM=51&N;.>$E7CP0&(/?MD?CVK6L=!T[3KU[VWBE-R\2PM
M+-/)*VQ>0N78X%1:QX9TK79X;B]@D-S I6&>*9XGCSZ%2/UH X>Q\1>(-&?Q
M!HFJF&\U/3=->ZMK]%^9T &T,,<G)S^!Z]:3PQX5N_M>C>)HM9M5:55-S.KR
ML]X& ^1M[$9R,< <CIQ7;:5X5TC1WFE@MWEN9XQ'/<7,K322J!C#%B>#CH,#
MVJII?@+PYH^H"]L[%EF5R\6Z9V6+(QA5)QZGUY- '-^';"S\6>';+Q->:E-;
MZJMRTLEQ'<G$($A'E;2=JJ5VC&.>#S5_PSIUJOQ$\92JC+(KVX#*YXWQEF[^
MO/M6I'X \-1:PVIII^)R_FE/-?R]^<[MF<9_3CI5V/PQIL7B*ZUQ!.MY=($E
MVSL$;"[<[0<9QQ[8R,'F@#R[3M:U23P/IEO+?7C)=>(!:3W)F8.L602N_J,\
M\Y'2NIN-,3PIXLTRTTB>X@T^_M+H26C3.Z*\:[PZ[F."2W;T]ZW+/P)H5IH$
MNB&&6>SDF,Y$TI+*_'*L,$$8[58L?"=C9/+*]Q>W=P\!MQ/=7!=TC/55/&/K
MU]Z /+=-ENK7P/X>\2OJFK2W;ZHD,J?:W97C\QLKM)P20,5[?7)GX>Z,= LM
M%$MZ+2TN#<1XF^8ODGGC&.3VKIKNV6\LYK9WDC65"A>)RK+D8R".AH XGQ%:
MZE9>/?#NKRWT5Q:/=&SAM6AV^3YB-N8-GDX7K7>5S^E>$;'2YH)3=ZA>-;DM
M;B\N3((B002HX&<''.<=L5=T_0K33=2U"_@>X,U\X>423,R@C^Z#T_R.G% &
M%X9_Y'SQG_UVM?\ T33/ ,1FBU^]FG\V>ZU2=9#T950[%7(YX X],UL:1X9M
M=&U2_P!0@N[R6:^(:<3R!U)'0CC(P.!STJIIFD7&B>)=32WA;^S=4/V@21%?
M]'F PV0?[W!'49&,4 97PRL8(=.U2:.29V&IW,89IW8,H88.,X)XZXS2_#*9
MOLNOV@X@M=6GCA0=$7.<#VK7TW0!X/T.[AT-+B\D=_,CM[B50-YP"=V!@=S]
M*L>%=$?0=%6WG=9+R:1[BZD7HTKG+8]NP^E '.>([NX74_$:P:M<R26VE^='
M:6Y,8M6 W!V;."3C('<9_&K<W>JZK-X%M_[9O+8:M82-=-;E5+.(%?=TZY/X
M=L5T&H>!K'4=8O\ 4'OM0A^WPK#<PP3;$D 7:,\9Z?U]:6U\$6=I+H4B7]^[
M:,KK!OD!W!A@@\=,8''8 4 <@VG^(M:O]4TC3=4D T<Q6\$TVH/$X;;GS'"(
M?,R?4@<8KT;1EOX=#M8]3FAGOHXMD\L))5V'!/('ISP.<UAZMX!T_4]:?5HK
M[4=/N9@HN#93F,3 =,^_3\JZ2RLX;"QALX%(BB0(NXY)]R>Y/4GO0!P7AR#6
M_%?AF+7(?$=Q;W]Q<F14!#0Q(KX\LH, \#OUS5^QCO/%%YXA9]9O;-[.]>SM
MX[60*L:JH(<K_$26/7TQ3K3X;:=8ZJ;FUU+5(+0R^<;".X*PELYQ@=N,8]*O
M7/@V,ZQ>:EIVJWNFR7P NTM]A67C&<,IVMUY'/)H X!M<N_$5G\/K^^R;DZJ
M8Y'P!YA5E&[ XYKI]4U7^P_%OBC4PF]K;1X75?5MSX_#.*U+KP)I\L.AP6MQ
M<6D6C2>;;K'M;<V0<MN!SR/U-6F\*6\NNZGJ4]W/-'J-L+::U<+L" 8XXS_>
M[_Q&@#G-!B\6'5M(U&2>XDTN6U\V]:>Z61'+(&!1  5()QC&./3JNB0ZYXNT
M!-<@U^ZM+J6[9HHEQY,<22%=A4#YL@=36OHG@>/1;BW8:UJMS;6I)M[6:;]V
MG7'  SC/&:@M_AY:6EU)]GUC58=/DF,SV$<^V(DG)' S@^GI0!#H%M(/B5XQ
M87,N[R[7&<$#<A(X]L<?C5.VDU_5_A7<7%OJ=TVL12SNLT0 >79*PVX'0$#
M ]JZB/PTD/B:]UN"_NHGO8ECG@7;L8JNU6Y&01UX/^%/\,^'D\-:4VGQWEQ=
MH96E#3XR-W)' Z9R?Q- '(+XJGNHH=>MKJ=['3M%^T7,2,"CW#@A4;D9(PQ/
MX>HJ'PVWCB[O]&U=I+J:QNU1[M;B>'RC&RCE$4 KC.1WXY[Y[/2/"NF:-I=[
MIMM$3:WDTDLB$]GXVCT & /I65HO@&/1I+95US59[*V?S([.24",$'*YP 2
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MO6C,EW-&#M5&W!50$ #.>_>K/B#PA-KFG:/:+J8M_P"S94FWFWW^8Z# XW#
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MA]I]KIVAV^$$NF7'V@S*#N8Y+%5.>%W$=<\#UYKL:** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 (6"XR0,G SWI:\^^(&FZ+:VMWK6NWVH,S*([*."1
ME$+A3@*%XR3DY;Z5U'A*66;PEI4DUT+J5K9"TX).\XZY/- &S17"^*_#43:3
MK6M:CJ5Y]JCBDDMC#<O&D(5?D4*#CJ!G/4DUT7A6:_N/"FES:GG[:]LC2DC!
M)QU/OC&??- &Q1110 45P_Q'NI+*+2+FX2[?14N2-16VD9#M(PA;;S@-SCH2
M .XIWABUT?3Y+O7](U@SZ%):_O!-.\AA=#DGYN1\IY!YX'KP =M17(V7Q L;
MK6K/3Y["^LEO@39SW*!4GZ8QSD9R.M2VWCBTN+/7YS8W<;Z(6%Q$^W<P )R.
M<?PF@#J:*YC4/&L%DD,<>F7]U>O;K<R6D* O#&>[G.!^=))X^T-+/2KI'N)D
MU3>+9886=BRX#*0.<Y.* .HHKFO^$WT\1Y:TOUF2S^VS0F##PQ9()8''/!X&
M31=^.M%M++2KMFN98]45FMA#"79L 9&!SGD#% '2T5SEMXWT:?2=0U%WN+>'
M3V"7"W$#(Z$XVC;UYR *EL?%NG7M_/9-'=VEQ#;?:G2[@,?[K.-W/:@#>HKG
M[/QEI=YJ%I9%+NWEO$9[4W$!C$P'/RY]CGFN@H ***\Z\'WEW;:WXT\^]O[V
M/39,01SSM)A?G. ">OR@4 >BT5Y_\.VO=;M;?7KW4-7^T,)#+#(Y^RRAG8+M
M4C'  ^[@=/>N@'B4/XW?PV+28;;3SS<;3MR3P,]AC/)[C% '045Y?X.\<6VE
MZ3J7]N:A>W!CU25//:.298H_E"[FP=HSG ]^E=IK'BS3-%<),+F=_+$S+:V[
M2[(SG#L0, ?*>_:@#<HJKIVHVFK:?#?V,PFM9EW1R $9'3H>1R*\VWR7WCOQ
M)IFH^+=2TZQM?)>'R[Q(<;@"1DCH"V./;.: /4Z*X_1+VP\/Z'?ZE<>)[G5-
M(6;;'/.#,\./E8%E&6&[OC &/K6_::YI]]>+:VTS22F!+GB)POEM]TEB, GT
MSGVH T:*PK;QCH5WJ%O8Q7C^?<EA 'MY467'7:S*%/X&C4?&6@Z5--%>7K(8
M&"RNMO(Z1L>@9U4J#R.">] &[168/$.EM>WMFMUNN+*$3SQJC$JA&X$<?-QZ
M9K'U'Q_H]GI^E7UO(]U;:C<"&*2.)S@ X8XQG(].I[=* .KHKG/ML,GCB&)-
M=8$V&\Z5Y9Y^;(D)['!QCKP*L6OBW1+S2+S58+PM96;%;B0PR+L( )&TKGC(
MZ"@#;HK#U#Q?H6EKNN[[:/+65MD+R;$;[I;:IV@]LXK7M[B&[MH[BWE26&50
MZ.AR&!Z$&@"6BN=T'QEIVNIJLJ+);PZ=,T<DDX*@J!RV2.._!Y&.>M3:3XP\
M/ZY/<0Z=J<4\D"EY%VLN%'4C<!D>XS0!N45@P^-?#=P\BPZQ:R>5"9W*MD*@
M."2>G7MUI@\=>%FG\D:[9[RGF??XQC/7IGVZT =#16 _B#3-;\/ZC/I.N0PK
M"C(]X!D0-_>(;&?Z]JD37],TO2=,;5-:MF:X@4I<N0BW!"@EP.V<@X]Z -NB
MLVS\0Z/J%C/?6FI6TUK;Y\Z57&V/ R<^G%,M_$NC78F-OJ$,IAA^T.JDDB/K
MNQU(]Q0!JT5A:/XLTS5_#AUP2BWLU9P[3'&P!B!GZC!Q[XJU9>(M'U&TN+JS
MU*VFM[?F:19!B,8SSZ<4 :=%4--UK3=7\T:?>17!AQY@0YVYZ9^N*JZEXGTW
M2M<T[2+J7;<W^?+]!C@9^IX'O0!LT5PFE>,_(\4^)K37=3MH+.SN(HK3S J8
MW!R1GJ?NCK70W]Y*=4T5[35[*&UG9]\,F&-VI4%?+.>W7CU'7H0#:HK*G\2Z
M);:DNG3:K:)>,P40F4;LGH/8^U:M !17(:]XT_L?Q;IFE")&LYG$=W.P/[IW
M!\M0<XR=I)SVKK)IHK>%YII$CB0;F=V 51ZDGI0 ^BJ5IK&F7\QAL]1L[B4#
M<4AG5R!ZX!Z<TD&LZ7<S>3;ZC:2R>69=L<RL=@."W!Z \4 7J*IV>K:=J#LE
MEJ%K<NHRRPS*Y ]3@TL.J:?<W;VD%_:RW,>=\,<RLZX.#D Y&#0!;HJE-K.E
MVY83ZE9Q%'\M@\ZKAL9VG)ZX[5*+^S-Z;(7<!N@-Q@$@W@>NWKB@"Q15235=
M.AO%LY;^U2Z8@"!IE#DGI\N<\T^>_LK7S/M%W!#Y:AW\R0+M4G )R> 2,9H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MRP_:(%,\>UH\G)8Y^7H1@9Y_.HXOB'92^'X=1^RF.XEO?L(M9)E!67/.6Z
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M7D_K0!Z*=5TY6VM?VH;<4P9ESN'4=>M96H:O?VGC;1M,5;<V%]#.S$@^8'C
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MA(Y%</\ \)=8^'? UMJ4%]<:Y')=?9TE?AV8LV0>,C !QQD\=C4.J^*QI?Q
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M:7)>VEFMY&;B\A\^W3!_>)C.10!:FL;2YB6*>U@EC7&U)(PP&.F :F    &
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M<$*0PQK'%&H5$08"@<  =A6.W@[PX^IG46T:S-T6WE_+X+?WB.A.><XZ\]:
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MM8].1(;:4SP*CL/+D_O @Y!K2L;"UTRT6ULH$A@4DA%]2<D^Y)/6@"S1110
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M%% !1110 4444 %4M5TC3]<L6LM2M4N;=B&V/V(Z$$<@^XJ[10!@:'X+\/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO" T]S#D_*@ /SGCID_D:DU --\;?)@U-K&5M+""2-48D[L[<,".1SZUO2>
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MDW1DY^7=PI]\'M61'\/=1@\-VNCQ>(\"UO\ [9%*]F&/!W!3\W)W$G/?.,4
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M>2UMC*=V!G=MZ9S0!V%%>?&\NO&?B[4-*CU/5-*LK*TA<+;'R)7=P&RQ(R,
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M 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<UU=% 'GLG@SQ ? VCZ)'=:<+JPNTF9CO\MD0DJ.F<Y(STKL/$&FRZQX?O\
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M)]:6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]?7$M[JTD$]Y.S*+M"VTD1[B O) X'2NZ^(NJW>C^";VZLIS!-N2,2J.4#,
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MK 8VCMP!QBI+WP-!>:A+>?VQJD+3VRV]RL4P43A5*AFXY//TH Y?7+R;4/\
MA6E[<MOGN)XI9&QC+,L9)Q]:GL99(/'_ (_FAD,<L=I$Z. "5(BR#SQ6W_PK
M^ PZ)$VL:@ZZ.^^VW>63P00#\O0  ?2K<?@V"+5]:U(:A=&75H3%,I";4&,
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0ZOI4&M:>]C<R3+!(1Y@B?:74')4G^Z>A'<&K4$$5M!'!!&D<4:A41!@*!T
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M)8A>K,>I)ZDGU-6Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/.2U@W2--T\MB!N4# /!'6@#:OO'<$;>''T^SGO(=8D;:53Y@BCG SU!*^V
M>:NZMXUTK1IKA+E+QXK4JMS/#;L\4+-C 9AWY4X]Q7FUA_:<6C^";N72+]$T
MB]FAN%2%B^#M(.WK@\CTX(J]+9:=INO>(-.U_P -:AJ!O;YKRVEM(W995;E4
M)!'(.>O&?H* /0-3\4Z?97,%DHNKNZN(3.D=E$97$?3?QT&>AK&^&-U=WF@7
MDMS?7MV@OI4A-YN,B(,  L>I]?0\5D6]Q-X0\7&]O-!N8K&\TV&&-;*,S^0R
M=8SC^?L/PT?ADMTL.OFYM+NW674Y)HA<1%,JWIGW!S0 [4;_ %'Q)XYN?#5E
M?7.GZ=8VZR7L]L0DS.V"JJQR0,$<@=C535Y-0^'UYI=TFKZEJ6E75R(+J*_<
M3,A8<,KX!'3IWQ4NH1W/A/XB7&O?9+NZTO5(%2Y:WB\PPR+@*<#G;@?J:@\0
M72_$"^TK2M'2XDTR*Y6ZN[[RBD8"Y&Q2P&6Z_P#U^: -[4/B#H&G7E]9R274
MES9']]'#:N^!@$G(& !GJ2.E+;>/]"O-1LK.![IOMI @G-LZQ,Q&0NX@<_Y]
M:Y.U$@U+XE.;>X"W-OB F!_WA"2*=O'/+ ?C6=<)+'X-\ (UO<!K?4$>9?(?
M,85\$D8XZCZ]J .YO?B/X=LIKZ%IKJ66QE,5PL5K(VPC@DG&,9!'7MQ2ZKJF
MFOXE\.M_;]W;M< M!:P*3%=JPX+\8QTZ^O&.M<E?.&LOB4@AE#LX*L8B P"@
M<''.#_,'O3+I\?\ "L#Y<V(442?NF^4[$'/'^RWX#/2@#2L?&-OX8\0>)+37
M]4O+GR[N/R/W3N(XV7(Z#:N,@'IG&<5UZ>*]'DU33]/CN2\NH0&>V8(=CK[-
MZ\'CKZURHUC3M+\2^,;/43();PHT$"QN6G7R IVX![Y&?KZ5@1"X\%GP%-JT
M300PQ7$=TYC+"+S#N .!P>>WH: /1(/&FA3V5_=_:G2.PE$-P)('5T8G &S&
MXY/3BK^FZW8:N]S'9RNTELP2:.2%XF0D9&5< \BO+[=+*XMO&TVLV][;Z;=Z
MA"T<X@9'3+-MDY )"G!Q^G-=1X!U?4[RZU33KJ^75+*R,8MM25 HE!&2IQU(
MX&?8YH A\9:AJ5IXT\/6-MK<]A9Z@76?:(\+MQ@J64X)SCG/;BF:/K6I6WCZ
M#0EUQ-<L9[5IY)=B;H",XY3C' Z^M9WQ&O-''CSPQ%JK1/:0+,]TDB%U56 V
MY !ZD?I5:P72;GXD:3<>"(98[4(PU*2&)DMRG&%Y'WO7_@..<T >A/XKT2.Q
MU&]:]'D:=,8+MEB<F)PVT@J!D\]P"*+WQ7HMA#923WI(OD\RV$43RM(N,[@J
MJ3C'?%>67.H6VFV?Q!TB[9X[^]O)I;>'RV8R(26!& 1C'/-:^FZM#X8UGPY>
MZO%+#8W'AVWMEN60E8Y5^8J0 2#C% &[X+\2^=H&MZIJVK--9VFHRQ1W$\8C
MQ$H7;D!0<G=TQG)QBMO3?&6@:MJ L+2_S=LNY8989(F88)R ZC/ )XKS5[^S
MOO 'CU=\R1'5VN$E$)PP>5-F <=U&>X!K4T?4H/$.NWUZ^LZ=<ZP^CO906UF
MDB[B,L7#2!>22>!T'>@#L;/QUX9O]6&EVVJQR7;,45=CA6([*Q&T_@>:DT/Q
M79:[J^JZ=;QRI+I\OEL74@..A(R..<C'MGO7G'AAO"]UIFAVMZ-6GUFSE54T
M_?)^ZDW8+ '"JO0GGBNI\%:E!'XN\5Z1+E+IM0>Y16!^=" "1QVP/SH ;\1]
M2URQOM M]%U%K1[ZY-NP"*022N#E@>F34<6M:UH7Q TWP[<ZJ-7MKV)G=GA5
M982 W.5P,?+_ #K/^,$UF+GPW'=_O(ENB\T2OM8Q_*"<]N_-1:=!:?#CQC^^
MBCET753NM]3< O QYVE^Z^_OGUH [G5/&?A[1=233M0U.."Z?;\A1F"YZ;F
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M5Y7"CUZGZ55O-;L[?0KS589XKB"VA>0F*0,"57.,YQG_ !KDO%3(OQ,\-'5
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M+2^NHTU*>U1S#(P61CM&X[?K6/\ $6;3HO#4::DL[PRW<4:QQ2B,.V20KL>
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M6H)XFB642H8VP P88.3@<_6@"2BF1313J6BD20 X)1@<'TI] !1110 4444
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M,(K?,W7K@8JE_P *TTA;JXN(;_6('G<N_E7S+DDD_4]3UIW_  KNP_Z#.O\
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M&5X)YZ?6I-.U#2H?&_B1;6WU-]2BMTEN$=LI(%' C4GJ<C'UXQ6':6.K:2?
MMW)H]Y*+*WFMKF., O&74 $C/3@_UQ6GH<%V?BUX@OGL+N*TEM8HTFDB*HS*
M%!P3UZ'I0!?A\>6L_A:SUM+"Z;[7="TCMEP7#EBO/IT)J/6?B+IFD7EQ"EK=
M7L=HVV\FMPI6!O3D@DCOCI^>*6B^%KRR\>7H>W5= @E-]9KM 7SY%"G S_#\
M_&,#(/'%8J6DFB^)M;MM1\#'6EO;Z2ZM;M+5)/E?DJ688 'IGKF@#LIK"XU3
MQ;H>NV-[.=.2UD+A9<12*R_*-O4DE@V3Q\@[])1XOLWOY[:"ROIT@O%LI;B&
M-6C24XX/S;L D G&,ULV$9BTZVC:WBMF6)08(L;(^/NKCL.E>8SVUROB3^TO
M#]EK.EZM+J)CO+5H7:VN8]QW2[R-@R#GK]/4@'H'B?6/[ \,ZAJ@3>UO$61?
M5CPN?;)%<QX?\*G7M$LM9US5-5GU&YB$RLMR\ MRP_Y9HI 4XQ]?2NG\3Z/_
M &_X9U#2P^QKB(JC>C#E<^V0*Y7PYXGO]#T.VTG6_#VM"\LT$)>WMFN$D4#@
MAEXZ=LGI0!G:E=:]X5T_3O#7]K23:CJVHM'#?2R-(\<!90/O \\_AVK5\0^%
M[C1=#N=6T/6=2AU"T0W$C3W;RI<A%YWJQ(SM&!Q[57\4:;K.O6VB>([?1GBO
M],N_.6Q>4%WBR#D] &^4?+R>>O:IM?\ %=QK6AW6DZ+H>J2:A=QFW=;BT:)(
M PP2['C.TY'/<4 8?B/7%U&Y\%:F^IWVFVFJ!A>^5>/"F%V>C8');GKCK6EH
M.HF+X@P:5HFN7>LZ6;9WO#/<>>(&_A(<]<G P">IK/UW2/[)OO ^G_8+V^M]
M)W-=M%9R3(-VSG(7!Y#' Y&!4MO:SZG\3--U'0=$O=)L84;[?-+:FV6;.3@K
MQNSQ^)![4 16B07GC7Q3;ZKXHU.PM;*6,P*-4:)0&SN^\>F=OTSBND^&FKZM
MJ^A73ZF\DZ1731VUU( #-'@8.,<_7OGVKF(O"]OXE\6>+[74-.NHA>,C6-]+
M9.%1DR&*L0.^.,_,!70>%O$.I:=HMQIFN:3J"WFEH8XY(K1W2Z1>%VE5QGH/
MU]< %;QIXKU'2]?M)K %M,TN6/\ M1E8X_>Y 4@>@P?JRUZ$CK(BNC!D895E
M.01ZBO--(\$_V_X6FU&_UK68[C5HVGN85D(CR3P#&RY. JCW XX-;?PTU2]O
M?"D5IJ4%W%>V1,+FXA="R@_+R1@D#@]^.: -#6/'&@Z%J#6%]<S"\">8(8[>
M1RPQQ@@8_6H8?B%X<DT ZR]W+%:+,()-\#[HY,9VL #V[]/>L#Q)?V^F?&#1
M[NZ,@ACTR4L4C9R!^\[*":YS5;5X_#/B359;:X%KJNKPO:PO 0SQJVXMMZ@$
M9Z@=/>@#T,>/=%>P%U M].SR-'%;16CF:8KR2B$ D8(.>@SS@\5(OCOP\= .
MM/>F.S600R;HFWQR?W64 D']*Y;QLL%MXNT;6[_2[F\T46;0MY*-F%R<@D#&
M."!S_2J7B-=+_P"%;WIT[0[NQL[J^A94DC827'(9FV\D# (!/7'N* .T;Q[X
M>2X%NUS<"9E#QQFRFW2J>Z#9EAWR,\<U4UCQ+H>L>"[J_M]?N;&R\T0O>6\;
MB2-\CY<;=PSD=N]59;^T/Q0T@*DVT:6Z)F!_E+$,HSC@[0W\JX[4+N*7X=^,
M[:&.?S+G7'DA3[.XW(TB,#TXX1OR]Q0!ZM#KNG)J=MHQO#+?R6HN$!1OGCZ;
MLXQS@\537QQX>.B3ZQ]N9;&"?[/([02 K)Q\NTKGN.U<O>ZG:Z1XJ\+:K=I,
M+-M):,S1P,^"0I .T$__ *ZYE$D3X3>)X);6Y2:;6-\226[@D%X^F1Z(V?3'
M- 'H_P#PL7PMYSQ?VGB1!N"F"3+C_9^7YNG;-6X/&.A7.C/JT-Z9+1)1"Q6)
MRXD) "[,;LY(XQ6%J=_8_P#"S/#IVL ;.55;R&P/,QY8SCCHWT]LU@POIMS8
M>*[.]EO+2*XUPF*Y@A?]PV,I(<#IN0\_3ID&@#TC2=;L=:2=K)Y3]GD\J598
M7B9&P#@JX!Z$5ROC'7VB\3Z1H*WE]:17"R2SR6<#M(<+A N%.1G.<=,<XJ7X
M>:AJMW%JD&HSB]BMK@);WXA,?VD8Y)R!G&!S[]3577;Q8?B]X>\V1_)2UDCP
M(R55WR!R!WX'X4 :EMXCT_PY:?V9JNL7.H7EFFZYN19R-M!Y!<HI"X!'4U=O
M_&GAW38+2:YU.-8[Q#);LJLXD4#M@'Z8]>.M<;H^JV_ARX\6:;K\LD-S=7<L
M\!E1F$\;+\H4X.XX&,5AVEK<:='\.+?4T=)(IIY)%E4_NT9U*;L]./RH ]BL
M-1M=4TZ'4+.42VLR;T?!&1]#R*S++QAHFH3^5;W4A)B>9&:WD1)$3[S(Q4!@
M/8FM2ZD@T_3)YC&5@@B9V2)>=H!)P/6O-/"%S)I6NV&C:7JL>LZ+<P2R*'3]
M_I^%)VMW&3@8..>PQR =FWC?PZNBV^KMJ&+"XD\J.7RGP6SC!&,C\:GU?Q9H
M>AS"'4+](Y>"R*K.R ]V"@[1[G KQ1-3MI?A,- 3SFU2WO@\MN('R@W'DG&!
M7;1:W8>'?&GBFV\3F18]2>,V[&W=UFBVD;1M!Z X^H- &MK/B46?C7P],-92
M/1+RUE<J "DA RISU.<C ]O>NKTO6=.UNV:XTV\BNHE;8S1G.&]#^=</=W&F
MIX]\%0_9A:(+2;R;66/#19 "#'8_*?Q%7?AY/9R7OBI+-HC&-6=E6,<!2  1
MCMD'\J .FU+Q#I&CR"/4-0@@D*[]C-EMO][ YQ[]*;/XDT6VL;:]EU*W%M<G
M$#AL^8?;'7^E<;<:UIOA[XE:V?$$?E6]];0K:W,JET*!,/'T. 3D_A[U!+=:
M5H_B_P ,ZC]D^Q>'I+.:&U:93''#*SYW;?X2PQR<9!SVH [:/Q3H4NG7&H1Z
MG UK;,%GD!_U9)P PZCFI_[?TK_B7_Z=#_Q,1FTP?]=P#Q^8KC-&TV#6_&7B
M^6%8I="OX(H3)%@QS2;/F*D<$@ELD=S4/@>VO+^Y^R:C RGPN9;.W<L3YKMD
M;L'IM0*!_O9'I0!V?_"4Z$-5&F?VK:_;2YC\KS!G>.JYZ9]NM.F\3Z%;WQL9
MM6LTNA(L1A:8;MQZ#%>1Z!;^&Y]$M[;6]5UB/5K>[+2Z<K@2-/OZ@;-W.<YW
M>O(Q73>'8--O?BGXO6:&UN?+,,B*ZJ^'4?,1GN&ZGL: .T'BC0VU$:>-3MS=
M&7R0@;^/^[GIGVI^I>(]&T>=8-0U&"WD8 A7;& 3@$^@^M>,7WB6PO\ 1=->
MW%K81QZZEP;.,,9(5RVZ21R><D] !C^6UXCO;6#Q7XFLH[_3'CU>VAC=KJ;R
MS;N4P"IVG< ,-@$=1S0!Z;=^)=$L;"*^N=5M$M921%+YH*R8.#MQUQ[5<LK^
MTU*T2ZL;F*XMW^[)$X93^(KR?5(=,TK6_#%I>ZM)#H\>E-%#>VS(R&8'YB"5
M88( YQW'O7:> +/1++1[F/0+N[NK'[2Q\VX.59L#.S@<?AUS0!<O-:N9_%$.
MA:9Y0EB1;F]EE7(2+. JC/+-S[#K[5H-KND)=?96U6Q%QYGE>4;A-^_^[C.<
M^U<OX7+I\2_&4=RRF=_LKQ<<F,(V/RRH-<%K^MZ1?:'<R64=K92GQ"LQB,I,
M[?>W2OGD DC@<+TH ];M?%&F7GB6\T&.=?MEJBLRL<;B<DJH/4J "<?WOK6G
M=WEK86[7%Y<PV\"X!DF<(HSTY/%<5H%WIL/Q1\3H9[5);F.T:W&Y09?W9+%?
M7J"<4WXC7<=GJWA:74 /[&6]9KHLFY P4;-W!XY;\J .QMM8TR\MY;BUU&TG
M@AYEDBG5E3C/S$' X]:;9ZYI&HS&&QU2RNI0NXI!<(Y ]< ]*\U\;G07\*:S
M<>&?+9I9X&U"2T!,17/<CY<YP2!SSSUK2\0C2W\6>#KC0A;FXDN2"UGM^:WP
M"V[';!_4T =Q%KFD36<MY%JEE):PG$DRW"%$/NV<#J.M+=:UI5C'%)=ZG96Z
M3+NC:6=4#CU!)Y%>:W=A+I_B[5?",%K_ *%X@DCNE< !8HP<S# ]@0.G;ZU6
MU32]*U+QWK^GZQJL&F1)!#%:"XABV^3L&?+:0?+@D_=P?RH ]7N-3L+0*;F^
MMH0ZEU,DJKE0,DC)Z8YS44^N:3:K UQJEE"LXW0F2X11(/5<GGKVKRVZT[1Y
M/$7@*S24:E8F.>+S;N,9E09VY! RN<[?P(SUJ7Q/+H%GJVN:1;6=C;26NC&+
MS+N0$?=+K'"A_B)8<Y[#CU /4[G4+*RMA<W=Y;P0'&)99553GIR3BEM]0LKR
M SVUW!/$!N,D4@90/7(/L:\B^UH/#?P_OI9;2[BM_.CDM;BY1!)\N.KD+\@&
M.3QN [XJ&YTDZ)X%U>[W1VEIJFJQ-*MFR2F&T+9"EE)!ZXQG';O0![%9ZC8Z
M@KM97EO<JC;7,,JN%/H<'@U9KSSPGI&@Z=XK^U:;XCAO;FZMV#6UI%$D>U=O
M+"(84C(ZXSS[UZ'0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 -$D;2-&'4R* 64'D ]"1^!_*G5PT#66B?$3Q+J$G[J'^S8;JX8 GH6!.![
M**33?B3#>ZUIME/8Q0P:D&-O-'>I*P/82( -A/ID\\<\T =U17&VWCJ66P\0
MRSZ3Y-WHK8>V-R#Y@YP0=HQG''!JOK/Q&.E.MJFD"74([1;J[@DO8XA "N2H
M9OOL/0#F@#N2R@@$@$] 3UI:\J\5:O9>([/P3KMG&R-+JL: L,,GS?,N>_*_
MI75S^+KM]<N]/TO1C?+92QQ7+_:1&Z%^ZIM.Y0.<Y'?TS0!U5("&&5((]14-
MX0ME.3"\X$;9BC^\_'0<CD_6N'TSQ;H_ASX?Z+>V>F7OV&ZF:WMX$97=6+.<
M$DC.2#0!W]%<UX=\6G6]6OM,N=+N--N[95D6*X8%GC/1L#ISVYZCFIO$OBJ#
MPZ;:'R#<WEWO\B'S4B4[1DEG<@*.G/OTH WZ0.K$A6!(ZX/2O/M3\>#5?AYK
M=_IL$D5Y:@VTT?F*3"QX+AE/(Y."/3.*Y75[1-%\!V.HV&E75C<ZF;:"ZE%P
M/WRX#[OE<\N<]>V<@9H ]K5E894@CV-+7!VFIZ/X/DN+/3M&NTN)(C>7=HD\
M1^S 8 R6DVY/HI.:TX?'NEW>BZ?J%E%<W,M_*88+2-1YI<?>!R0!M')).,4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]<GZ#/IGT?(SC(SZ4M 'C_B/2M3U[5O&*V5A>$^99S1I)$46Y$2L&7G[V<Y
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M<8NK--S)'N&X ]G/0#KD$5T'AK3Y+&SF=K_4+J*XE,L27X(DA4_P\\]?7_\
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M]%O);._U2.*YB*[X]C$C< 0>!SP0:CT35M.>^\07">(6OHH'$DT3C"62@-D
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>;P5%%837HT^XFFNV@*[4,CJ<#)'3GDUZK3$ECD+A)%8H=K!3G:<9P?0X(H
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M%?PM>WLL<%IY$Z>=*P50VUN,GIRR_F*Q(C8RZI\3WF^SNWV;,;/M)^X_3/\
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MIVD0W%_I$MO?SSO!#9/.BEBH)+;VPNW Z^XZYJ7PEXRMO%/VR(6YM;RS?9+
M95DX/1@R\$<'\J .DR,@9&3VI:Y37;O2H?'7AR&ZM+B34)!,+69'PD8V_-N&
M>>@_.LW4?B?#:3ZC%:Z!JET-.E,=U*$"I&!GYB>3V[@4 =[2$@=2!GBN2UKQ
M[;:;]C2SLVO9[JV%T(S.D(2(XP26/4YX ]#7,>-]?L_$O@71]8L?-CQJL2A6
M.&C8;L@X.,\ T >JY&<9YHKE4O=*?XFR6@@O1JJ:?DREL0F+<#@#/7)ZX[&J
M>H?$NRL+62^.D:I-IZW#6ZW<:)L=P<'&6!QD$9QVH [;(SC//I1G-<=]NTNZ
M^(MO#+;:C%JLFEY7<VR-(B22, YW9[CN.O%<WX5\:6_AOPXT=]9:K-;17TR2
M7HB+QQYDXW,3R>>V>M 'JM%<#-<$_&FP$4[FWFT<R[1(2C$LPR!TZ*OY5?\
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MI<Y80R.%62-AAQD]#P,5FRZ3KFN:G=>(;C3?[/N8--EM+&U,RO(96W?.2#M
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MN;S7=;TV#5+C5-#MTC%O>S/N?<5&5W\9QS^5 '>PPI;P1PQ*%CC4(J@8  &
M*?7B.@"=M#UN_P!6\9:K9WFGW,L,)^WED8JO]QLE^>PKTGP!J=_J_@K3KW4B
M6NG5E9F7:6"L5!/N0!S0!TM%><IXPOQ\3$CD5TT"YD?38I')"FXCY+ >I8[,
M]#^!KT:@ J/R(MJ+Y2;8SE!M&%/MZ5R=]\3O"UA-<0/>3R7%NY22*.VDR"#@
M\D ?K5N[\?>&K&PL;Z?42+>^5FMV6&1BX!P> N1SQS0!TM%<L_Q!T(6T$L#7
M=U)/'YJV]M:N\@7=MRP ^7D=_P ,U/<^.O#MIH]OJLU^197#%$D6%VPPZJP
M)4^QQ0!T5%8UYXCTN"^DTR6[>&Z^RM<D^2^$B .7W8V\8]:S-!US3-*\#6=_
M=:]+J%KN:,7TT;AYFWL,!>6)SP.O2@#K**X'0_$;WWQ!UK&J7!TF"R6;R+B
MPB$\9X8 ]!G/^U6[I?CCP[K.I+I]AJ(EN6W;%,3J'P,G:2 #P,\4 =#17.VO
MCKPW>ZI%IMOJ:27<LKQ+&(W^\O49Q@>WKVKHJ "BBB@ HHHH **** "BBB@
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MX.!N565<'UP<'\C7HM(%5<[0!DY.!WI: "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@#B?"4J:YXJ\1:Q/MEDM;K[!:[E_P!3&@^;;_O$DFL^
M+6KW7?!'C&,065C/9R7,+&",E7 7+$@G[Q&1G\<5?T<GPUXWU73+HHL.LR_;
M+!PI 9\?.AXZ\ _3ZU2TWPCXEL?#?B:R,FE_;-7G>1&61]BB3AP<ID<=.O6@
M#H?!5K<Q>&M.FO6M99FM(A'+%#L<1; 0K')SC\![5E>(O%&O:3<:S)'%ID-K
M80I-"DY,DMR#U("N"H!P.1WKI/#EI?6'AZQLM1^S_:;>)86-NS%"%& 1D YP
M!GWKC]4\%>(+K4_$IM;C2Q::Q&%$DZNTR84 (,<!<_7Z4 69O%OB"\US2K+2
M+/33!J6GB\BEN7?Y?E!.X#T)Z=\CD<UEWOQ'UO3M U5KJPL!J^FWJ6\L89O+
M*.,JP&<G.#W']*C%KK>D>*_"6GQ'39=1M=*EA=&E=8W1>!@[2<X /3L:I^.]
M"NM+\#:K?ZB]N^I:EJ,4TWD ^6@'"H">3@=SZT =9:^(?$EEXLT[2-=L;#R-
M11S#-9E_D95+%6W=3@=O6N0T&\&E_#3Q9<K8VEW'%JTNZWN!^[*_NP.!UP<<
M<=*[6+1_$&H>)+'5=8.GQ1Z=%)]GM[25V$DKJ5+,648&#TYK M_ _B.+P5KF
MB,=+,VIWAN XN)-J!L%A_J^HV#'U/IR ;(\4WU_=V6CZ!;V*7S:<E]+]J+B*
M)#M 0!1DGYO88I#XB\4#0K&:?1K>RO);HPW,L[?N8(P?]81N!P>W/X\BJ?\
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M%YI[V,<HF#$=,.5Z\XZ>] ',:I=7NN?!:VU35HXKNZ%TKP/DEF_?%2#QQW7
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M>R12J'$9C!8C<>O? Q[UN:99ZN/B3J6NS:-=0VLVG")-SQDF1=IQP_?! /\
M*I?!FAWTG@:]TG7[%K22YFG#H'!RLG.X8)QRQ'X4 ;3>(7/B#3M*BL?-^UVI
MNI)EF&(4&!TZGD@9XSGZU%XQ\42>$M)74O[.:\@WA)=LH3R\]#R#G)XK!^%>
MF3PZ/-J%Y*9IF;[' _;R(B0N!_O%OT]Z[#7-*BUS0[W3)CA+F)H]V,[2>A_
MX/X4 9MYXA9=4N=-.ER7$,>GF[DDCF7.#D!-IQR<'G-8N@^)]*TSP+I$NCZ3
M=;;N1X;.P5]SM)N;=ECP!D$Y/;M4_A/1=4TOP9=MJB2SZM/$R&/*[@B*4CC!
MSCH,]?XOK6#I?AWQ#IO@OPXR:>PU#1KYYI;1F4M+&S-G80<9VMW]_P 0#HK;
MQ6-8?5-!U+2KC3-12S>4P22!P\9&,AU^M8_@/7DT;X;:#YEO<74MW=/:PQQ
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M9LJS+PDJX]../8?A3;/PIJ\'B:/3;G+Z=JZ1ZEJ;D$@7$;%G1>P!<IU[#VY
M/4XI!+$DB@@.H8!A@\^HIU%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<N+BT#CR4BW*JA4Q\N,YR/0U[+0 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
,0 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>a123121ex-1021006.jpg
<TEXT>
begin 644 a123121ex-1021006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BN;\1:U=PZGI^@Z6RIJ.H;F\]E#"WB4?,^W/)]!T/-/
MBNB/&D\$GB"%TCLP?[-" ,AR"9&/Y?G0!T-%8,?C7PS+-#%'K=D\DS;8U64$
ML<XQ^=6=1\2Z+I,_D7^I6\$H7>4=N0OJ1V% &K17):EK%V/&OA:.ROT?2M22
M?=&B A]D98-N].1T]/>M9O%&AK9W%VVJ6XM[>7R9GW<1OZ'TH UZ*S;OQ!I%
MC;6]Q<ZA;QQ7(S Q;/F#&<KCJ,5Q^F>(KV_\)ZY<3^);6!K?47M[?4G@4)L
M0CY??)]30!Z%161<>(])TN*V34]7LXYI8?-#%PHD '+*,G@]N3^-6+76]+O=
M-?4;:_MY+) 2\ZR#:N.N3VH OT5CV/BK0=2NA:V>K6LMPPRL8D 9OH#UK8H
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MZ@!\;G/)Z_=V_ABNK'B#0M$\6>*K?Q*WEKJ!B,+/$TGG0&/&T%0>/RZUZ/\
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M1],;3O[.;3[4V0_Y=S"OE_\ ?.,4D.BZ7;V$EA#IMI'9R9WVZ0J$;/7*XP:
M//O%G]FMK'@%[!K8QB^58S R[=NY,XQQC/ZU+X:MM.U#4/&,/B6&VDO%O',I
MNE&];;:-A#'HH XP>./:NU/AC02D*'1=/*P9\H?9DPG.>...>:74/#>B:K<+
M<:AI5G<S+C$DL*LWI@GN/8T >1VUJE];?#BVU"/[1 ]S=C9-\P:/>NT'/48
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M>U &C%;00VRVT4,:0*NQ8E4!0OICIBO)XEM;7X):RUJ+6*4RS1RD* 3^_P
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M^S;D_P!*M;ACR< =01^6.G%(;;3+G2?B1<2I#+<I<2X9P#M 4["#V.[/3TH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML+B)=D<HB7>BXQ@'&0,$C'O0!Y+X8;PA/!X=+:GJ5QK%OY:QV4;X\N4X#X&
M O!)YZ"O0_'<T4/@;6C+*D8:TD1=[ 98J0 /<UKQ:;8P7;W<5E;1W+_>F2)0
M[?4XR:?=6=K?0^3>6T-Q%G.R:,.N?7!H \DT71? 0\*:9J%YJD-OJ$,4=Q+M
MO]SAUPQ'EECZ8P!FK'C>:#Q,NFW>C6\G]JQ6;7MS'YHB<6A4;HWP<Y.X8]L^
MM>C?\(UH/_0$TW_P%3_"K@L;02R2BU@\R5-DC^6,NOH3W'M0!Y5XJU;3M7B\
M):A#>S6>@;G262V/_'K-M&S<,'!'/;IG%9>JPZ+9^$-3DT'4[G4X9-0MI=1G
ME0;=N7.!P.X&>.XKV5=)TU+-K-=/M%M6.YH1"H0GU*XQ4D-A9VUJ;:"T@BMS
MG,21A4YZ\#B@#A+[4?"6LVNNW6B*EQJ3:/.DDL,3 *@7@-P!DG&._'M6!;:W
MI<VG?#I!/:_:X;A(GCA(9T&W9\P'(R=I.>IYKUFTT^RL$9+.SM[9'.66&)4#
M'WP*CAT?2[<@PZ;9QD.)!L@488=&X'7WH XKP_>:3;>)O&=I=SV<4DER7\J9
ME7>ACRQP>HX)/ZUB>%]!7Q)\%'LD5&NDDED@8@$K(K[@!Z9''T->IMIE@\TL
MSV-LTLR[)7,2EG7&,,<<C'K3[2QM+"(Q6=K!;1EMQ2&,("?7 [\"@#RU9]4\
M2>"]<\5K"L6H/IZV40QSY:',S#'())? _P!D4W0(O#EU=>&-0CUZ[NK^+;#!
M:0Q1*Z<?,) J@[!SDD],^]>KQ00P1>5%$D<?/R(H Y.3Q]2:KVVDZ=93M/:Z
M?:P3,"&DBA56(/J0* .>^)H7_A7>K[L9")C/KO6N?N;BSM;_ , SWWE_V8;9
ME+MCRUF,:A2>P.<\]J]&N[*TOXA%>6L-Q&#N"31AQGUP:C;2]/:R6R:PM3:*
M<B PKY8YS]W&.M 'FFL01+XD\7BQ2 :8=!9K@1!?+\_!*$XXW=3ZUTWPYTS3
M8/".F7]K;1+<S6H668(%=\$\''7FNCAT?3+>Q:QBT^U2T8 -"(EV-]1CG\:L
M6UK;V<"P6L$4$*YVQQ(%49Y. * .)CGT^U^,=V+A[>*:?38A$9, N^\C )ZG
M 'OQ7"6]AILGPJ\57D\, NTU)U2<J/,&&C(4'&0"<_F:]MFTZQN;A+B>SMY9
MX_N221*S+]"1D53?PUH;V<]F=)LQ;SG=)&L( 8\X)Q]3],T >:W,>F:AXPGM
M=:U1+&.72;;[-+/'"R,FT[@K2 [3DY!7'0\\5WO@BWL+7PQ#;Z9=W%W9122)
M%-..6 8YV\#*YS@UH7'A_1[N.WCN=,M)4ME580\0.Q1T ]O;I5^&&*WA2&&-
M(XD&U410%4>@ Z4 ><Z*=-&G^/K+9"LZWETS+M"GRS'\H^F0W';\:Y>[2WF^
M$_@M)A&RG5 K!L?=+R;A].F:]?E\/://<75Q+IEJ\UTNR=VC!+C&,$U _A+0
M'T^VL'TFV:UMG,D,17A6/4T <1#HNBGXS75F=/LOLO\ 97F>3Y:[-^Y1G;TS
M@FN3TBXDFT7PQ;7U[]ET9-0N8VE:.-XT; *!@X((^9NH(&?:O:QH.E#5GU06
M$'VYX_+:;;R5QC'Y<?2HH?#&B6^E2Z9%IEL+*5BSPE,J21C//?WH Q?!-AHV
MFW>J0Z1K!U$2LDTPCV>3$QW#Y=@"@G'('H*S=?TC1+[XJZ9'JEK!()]/D(60
M<22*1C/KA=W7T^E=OIVF6.DVBVFGVL5M O(2-<#/K[FN0U_0;[5_'UC=7&A1
M7FD0P&W>1YU!^?DN%R"-O3\\=J .)O?)TY[ZTMKC[)X?/B!$DD2,2PHH3)&"
M"N V..G3CBM&^TW1=/\ #OB^.QUQ-3-S:I.Z0QH(8L-A>8QM#$]ACIT[UZ<=
M TEM'_L@Z?;_ -GX"_9PF%X_K[]:@C\*:#%I,VE1Z7;K8S$&6$+@.0<C)ZG!
M% 'F7B30M,LOA!IVH6UK!!=3Q63S2 ?-(=O\_F)^E=.4T^_^+%_::O%'<*-/
MB:Q2Y :/!/S[ >"2<<@=C73S^%]$NM)@TJ?3HGL;=MT4!SM4\].?<TZ^\,Z)
MJ4%O!>:;;RQVP A!7!0#@ $<X]J /(/.^PW#V6(AX67Q*%+%MT00<E3SC9T/
MID5U>EKIUI\:YX[$6L,+Z3A%@"JK-O4G '!. 3^%=P=!THZ.-(-A =/"[1;E
M?E _Q]^M1:=X8T/29DFL-+M8)478LB1C<!DGKU[F@#6HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH R=2\2:7I-VMI=33?
M:&C,OEPVTDS! <;B$4X'UJG>^.?#FGRV\=SJ!5[B!;B)1!(Q:,C(/"G\NM<M
MXYGL+7Q&]W#K$VBZS!9ADE:(R0W<>3\A&"#@C_Q[H<50GUM;;QYX0U36PE@6
MTEO-4J56-B' &.W]* .\@\9Z!<Z/-JL6H!K.&7R7;RG#!^,+L(W$\CM4EGXL
MT2]6^:.\,?V%0UR+B)X6B!&02' /:O*=2LKF:YU'Q5:0W%QHK:S!<".))$,D
M<:MND &" "?O<<BM&XMM&U3PUKT_A'2[Z65X(GFN9VD.\K(CF)=Y)8[0V<>@
M'<4 >AV/B[1-2OX["WO'%U-&98DE@DB\Q/[R%U 8<$\9Z5S">)$T?X8W^IV6
MO3ZS+!(T<=Y+"<B0D  @]AD<GCGZ"KVB>,M$\026E[#IDAGMX&-Q<O;86R4*
M2PWGL<8PN>M<.-2M;GX+>(((3@KJ!5%QC<&F1U('IC/Y&@#?BD$2:;J4GC76
M;1;R>*(P7=LY623"EE7<HPIS]X?+[FNQU7QEH6BW4MM?7;I)"JO+LMY)!&&Z
M;BJD#..]<)XUU>PN?"/A!HKE6'VRWFZ$'8BLK''L>*JW+Z+IOBWQ+8>*(M10
M7TPG@^SRS;;J,\*A5#AL<XSQU&>* /2;[Q1H]DMLLEZQDNX]\"V\3S.ZD?>"
MHK''N1BN?^&>L7NL6.KM>7TUXL-^\4,DJ[6V #'&!CZ5AVFJ6_A/QA;7VJV5
MQIND7&D)!:>8KRF$@J3'\N2/4\=<>]:/PINHKI/$DL)8QRZI),C%"H96Y!Y'
MMTZCO0!UFJ^*='T:Z-M>W+B<1&=DB@DE*1CJS;%.T>YQ7.ZYXB_LOQ=H&H/K
M)&A7UM,3"J94E4RK# R2=XX]JQ?%VO!/%VM:8Z?9=VDO#&8K0RRWS-&2J[@I
M*J"3T]#D^E/1=4L+&P^']_>R^5:6\=Y%+-)&VU'(  )QZ]_:@#T>S\5Z'?Z3
M<:I;ZA&UG;DB9V5E,9'9E(!'Y4RQ\7Z)J-]%9074BW,R>9%'/;R0F1?5=ZC=
M^%>9:S9S:K:>+=:TA9CI<E[:S H&Q<"+/FLH[@,0WI\OM71:UJNG^,-:\+#0
M;H7%Q;WHN)62,EH(@N6W$_=S@#!/7U- '41^-?#\NFW^H)?,;6P<1W+F"0&-
MB< 8VY//H*=J7C+0=)$!O;XQF:,2HJPR.P0]"5525'UQ7(ZIHDZ^/KC1([?&
MC>($2[NG7C:\3;G Y_BPH/'\?L:H:Q/IFD_$?6CXGFU&VLK^",VTT$TRHZA0
MI0B/D\YXY'YT >J6EW;W]I%=6DRS02KN21#D,/6IJY+1M:T30])T/3X+2[LK
M:_D:*RBE1F;EL@MG)&2V1GUKK: .!\::[>6WBO2M%_M?^QM/NH7DDO0JY+@G
M"[FX'0?]]5I:1<:IH7]L3>(M6^V:9;QQ2VUX80N4PV[A1R1QZYX/>JGBC5_#
M<^L3:!XJ@A2U,"36\\JL 22P8!A]TC [CK7.^&DN5\/>,K"PNKC4-"CMI4L)
MY,DEC&V43U'/;OCCF@#T63Q%I45UIUL]V!+J2[K0;&Q*, \'&!P1U]:K7WC/
MP]IM\;*ZU.-)P^QE"LP1N.&(!"]1U(KSY/%6C:J/ L%I.[SV5S#%.# X\LF/
M9C=C')'8_P J70->T/2]'U;PYXBMWN=4>_E,EL87D-XY<%3NQC).,$D=CWH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MV\C*)&QA2X7:#R.];%Q/%:VTMQ.XCAB0O(YZ*H&2?RH (H(K="D,21J3G"*
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M>@6&C:K;7.GW1D6YCC4,0R@]^N#QCZ9KNKFY@L[:2XN94AAC4L\CMA5'J30
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M4[^#EDB5FB@NXI;A5&<Q@G/'<9VG\*ZRWTK3K1U>VL+6%UR5:.%5(SP<8'?
MJT0&4JP!!&"#WH \^UR?3M6\;^$[O2)([BX0RR3R6[J0MMM&?,(Z#YL#ZM7$
M11Z?_P *E\0SLEN9TUC]R^!N WQ\*>OW=WX9KV^VTVPLA(+2RMH!(,.(HE7=
M]<#GJ?SJ,:-I:V[6XTVS$+,&:,0+M)'0D8QF@"99HKW3A/&0\,T6]<\AE(R/
MT->+27NF7?P5TJQ^VPH\=[&ER 06CS(YR5Z].:]OCC2&)(HD5(T 5448"@=
M!V%4VT72FC:-M,LRC/O93 N"WJ1CKR>: /.M?2WB\;:W;:2D27$_AEPB6X +
M2;R>W?:!^&*K^&8_"MRWAN\37+ZXU.%D2*R0Q!D<C#;@J!BH .22>!U/?U*/
M3K&*Z-S'9VZ7!&WS5B4/C&,9QGH!1!IUC:SO/;V5O#,^=\D<2JS9.3D@9/-
M''_%K2;G5O \GV5"[VLZW#(HR64!@<?3=G\*U=*\;^'+W1H[U=6MHD6,&1)I
M KQGI@KG.:Z2LQO#NB->?:VTFQ-Q_P ]# N>N<].N>] '$76H6-U\3=+U'4B
MATB[TQUL7ND"IYF[+?>Z$C^8]:Q=7M+9(OB%+8K -&>&W*%.8VGX)*'ID,3G
M'<BO7+VPM-1MS;WMM#<0GJDJ!ATQT/U-1?V1IW]E_P!F?8;?[!MV_9_+&S'T
MZ>] 'GMQ8Z(/$OP]\JVM/(FMI>"@^<>2OEYSUY/&>]8>N1V<?A?XAPVHB"1Z
ME"0J?PDR)G'ISN'YBO6CH&CF>UF.F6GFV@Q WDKF,?[/'%<[XT\(QWOA;4K3
M0M*M5O[YH][H%C) =6))_P" ]* .>N['34\1^"%T-+2.[0&2X^S$!A#Y89MV
M.Q!;KUW>]8D&L:*;/PR]G-9V=M'K@F^Q^9YD\:$G+R,3GMTQT(Y->J>&M&M]
M.TZ"9M(M;#4'B5+@0A221Q]X#D' -6!X<T0"4#2+'][)YKY@4[G]3QUH \N:
MQL/+^)C3Q6KRQL6C8@$ID,1@]CG'XUHZDDQ^'_AGQ?:A'O\ 2(8I&PH(>+ 5
MU/?_  YKT'_A']'VWB_V9:8O?^/D>4/WO^]ZU@ZYH&LW9AT/2?L-CX<DMS'<
M;4^=06&54>XR/Q/?% %GP/!(^EW.L3ILFU>X:\VXY6,\1J?^ @?G5+QW8S7U
MWHO]GZA;6^KP2R36D%UGR[C  8>F1D8^IKLHXTAB2*-0J(H55 X '052U/1-
M+UI8UU.PM[L1$E/.0-MSUQ^0H RO VJ)JOAP2"QALI89Y(9X8,>7YH;+E<=B
M23^/?K725#:6=M86L=K:01P01C"1QJ%51]!4U !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#EM:\)WMYKO
M]M:1KTVF7K0B"3,*S(R#.!M)&#DUIZ'H2Z-'.SWEQ>W5RP:>YN"-SD# X'
M'%:U% !1110 4444 <PGA:ZB\>S>)DU.,)- +=K4VV3L&#P^[KE0<X]O>NGH
MHH S==T^^U/2WMM/U233;@LI%PD8<@ \C!(Z_6ET/1XM#TQ;..5YFWM)+-)]
MZ5V.68^^36C10 4444 %%%% !1110 4444 %! .,CITHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BLW6M>T_P /VT%QJ,WE133+ K8S\S?TX)-6[RZ2RLI[J179(8VD
M8(,L0!DX'K0!/17+CQWII\/:9K?V:\-KJ$PA3$8)C8L5^?G &0:ZB@ HHHH
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M'J#5R@ HHJ&ZNH;*TENKF01P0H7=SV Y)H FHJKIVHVFK:?#?V,PFMIUW1R
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M=@US$+N1#(L.[YBHZG'I0!9HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQHNBO=PVUC:1R 6ETD#,7 ()+ Y4 @8%,U=?%VG> +34;W4)H]1TF;-U';S
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MUCQ'K'B Z9?7HAET9G&H*(D(NMS?N\8Y&!GIZ#KF@#T2BO*;OQAXJU.:^O\
M0+:YEMK*]:VBMXK-9$F P"9&W;P><C"_CZ=&-7\0ZUK>IV.F2VE@-/@C#+/%
MYI>=UW8X(PHR!G% '9UFW_A[1M4N4N+_ $NTN9D^[)+$&;\ZY<>(/$>G^(O"
M^F:H+02:E%*+N.-,['3)!5L^FW(Z<&N>\0^)-6O?"WC2RN+M%.G7,=O'+''M
M:1&8@J<>H'7ZT >D3ZKIFE:AI^D,RPS789;:%(\*0HR1P,"M.N,OK_5]+U3P
MEIYGM;H73NEQ/)!ASM7/R@'"G;D9]?RJ)O$NJ:3XNU33-7N+8VHL)+VRD2/:
M=JY)#<\D 'IUQF@#N*S]:U73-'TU[G5YXH;1CY;&0;@V?X<8.<\\?6N0D\3:
M]$-&TN;*ZI<V;WMU+!9&81KGY5"!@>^"?4#UXNZ.NH^,_!US8>)M/FLIG?RW
M)BV>8H((95;)'I_*@#:TK0?#]J\>HZ7IEE$\J;TGAB )5AU!]P:V*XKQ?XCF
M\-7^CV,4T>GZ;,CK)>/ 9EC*@!5P",?7_P"O74:/--<Z/:37%Q;W,KQ!FFMO
M]6Y]5]J +M%>=:5XD\3W^HZU(T^GBQT>_>.>,0L'>)2<[3GKA>,_G4.D^,/%
M5]<:1=KITUS97LG^D1)8.@@0D8992<,,<YH ]+HKB5U7Q5K5IJ-_HCV*);W3
MV]M:RQ$M,$;:Q9RP"GKC%9NK>--=N=7U2ST* DZ9B-D%E)/Y\F"2,KP@R,<]
M>M '=76L6%EJ-GI]Q<K'=7F[[/&027V\GMC\ZO5PT_B74AXB\(6]S86\)U*)
MVG26(^;"X3D*2>.H]ZH)XC\9:EJWB2TL6TJ+^QW!"O&S&52"57.>.%))]3Z4
M >BM%&\B2/&C/&248J"5)&#CTXXIQ56*DJ"5.02.AZ?U->5VOBC5/$?BOP9+
M;WBVL5W;322PHA:/>H<,",C/W<#T]Z[SQ7KC>'/#%[JJ1"62%5"(>A9F"C/M
MDB@#9K%U/Q=H.C7@M-0U**"<[<H0QVYZ9(&!GWKG[C7/$?AN]TJ77KBQN+'4
M)Q;,D$+1O [#*]SN'!!J/PUI]W<>-O%+7<MG-"MY%YB&VR7_ '>4 )/&,J>_
M([9H [ZJ46L:=/JTVE17D3WT""26!3ED4XY/YC\QZUS?CRXU*"?PXFGW8MQ/
MJL44F5)W9R1G!&1P<CO6%(NK'XP:LFE/:+>'24S)<*VP<IR%'OCOQ[T >G4C
M*&4JP!!&"#WKS*U^)&H7V@:6L5M&-6O9IH&:.%Y501C)<1KR>HXSZFNI\(:O
MK.IQ7D>LV#V[V\@6*=H&A%PIS\P1N0>/U% &IJFLZ5X<L$GU&YBL[8$1ID<>
MP  ]/2GV=YIOB#2X[JV>&\LIN5)7*M@^A'8C]*X?QXE^_CSP@D%S;JC22F%)
MHV*B0!<EL'G(( Z8YYYJ];ZGK6I7^JV7AK^RK6UTJ80['A)\Z7&77Y2 HW<9
MY/6@#N**\TG^(NK2Z'HMQ865A]MO+YM/N4F9RD4P( QCL<Y[X!'6GW_B_P 3
MVMXVBM#9C4X;833S6MM-<)N9L(F!@KD=2<CGB@#TBBN _P"$\U*30O#LRZ?'
M;7^K77V9OM"-Y<>#@MC(//&!GU]*8OCG6+.'Q1)J5M8'^QRL4?D[E\V1C\N0
M6/R]#US0!Z%5.SU2QO[F[M[6Y26:TD\N=%ZQMZ'_ #V-<O<Z]X@\.ZEI:ZZ=
M/GLM1N!;F2V5HS;N1\H^8G<O7G@_RJC9^*;N&#QM<PZ9IT5SI4I8&,$>=C=R
MYZDX7V_K0!Z%17G^C^,/$=QJ'A\ZCI^G)IVLJ?+>W=RZ$)NYSP,XZ<_6H]3\
M<ZW]BUW4-)MM/:VTBY,$D5P'\Q@!R_!'<],=CS0!Z)6-<>+?#MI<R6]QK=A%
M-&Q5XWG4%2.H(SUK1L)+F:P@DNXXH[AD!=(G+*#[$@$_E7D,D$/A&?4],\5Z
M&+G2]0N)I$UB- [H'X&3@D'@'KD$]Z /8XI8YX4FB=7C=0R.IR&!Y!!]*?7
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MM &E_LHVH'[H.029=V=P49_#UKHI?"]VGCQM?M;JW%M<VHMKN":,LQ4?W""
M,X4<^_6LR#P3K5IH-UX:@U>V_L:=V"R/"S311,<F,#.#Z9/J3Z4 =5?WLA\,
MW-_;,8I/L;31D@':=FX<=#7DNH-?7'P(%U>W:W FF5XQY6UD/G-NRV3NR>>@
MQ7LCV4#Z>UB5_P!',7D[<G[N,8SUZ5P+_#_6I/A_)X6DU2R=$F5K>3R6&$#%
MB&YZY/IQ[]@"1?%FK^'M<EL=?DL[B#^S)+Z$6D;*PV9^3)]@>?:HM,\6>)[C
M4]%9K.:ZM;\AKF--,EB%JK %3YK':X&<Y'I6IJ?@NXUGQ-;:A>SP?9$TU[*6
M)-VYBRL"0?3YJCT+POXITV*RTZZ\0PMI=G('7R82)I54Y6-F)X7CG'...E #
M?BUJ=UIG@6;[(Q0W,RV\C#J$8$G\\8_&NDTC1-.T_0K6PM[6,6Z0A<%1ELCD
MD]R>2?K4FN:+9^(-'N-,OD+03+@E3@J>S#W!YKG]/TCQGI6G)IT&KZ5<0PH(
MX;BXMW\P*.FX!L$@<?XT 5@TWA_4M-\%>')(8&:.6[>>Y4R>5&7)VA01DY)'
M4<"JT_C/6M,L/$=E>QV<FL:5$MQ$ZY6.:)B/FVY)! /3/<5H7_A/5DOM+UNR
MU2.YUJQB>*5KF+8ETK9.TA,;<$G'4#CTYCO?!NH:EI^NSW$]DFKZM%' 65&,
M<,:XRH/WB2,Y/3(7CB@"M)KGC.+5-&MB-'(U>%O* $F(65-[$GOQGBH;CQCX
M@T[P_P")/M26,FI:-+&IE0,(Y%DQC"]<C([UKW'A_79M1\-7:W&GJ=)0K*"'
M/F%EV,5]!MY'N>^.>>\7Z)J6G>'?&>HW<MJ\.I>2ZI%NW1['50#D<\?K0!HQ
M>*O$%CK&@-JR6#V&MX2*.V#;X&*J023U'--7Q7KMOK5H+V331#<ZI]@^PQ'=
M+&I'RR%PQQZ[2!P14^E^'M1UD>&+_4IK);3385FAC@5B[L44+N)X&, \=Q69
M'X!\3V^G0V4&L:;MMM0%_%*]NYD>3GESG!Z^A^O% $MUXN\3W-QXH.FIIL=O
MH<A8F8,6=%4DJ,<9.TG/X5>U[Q7JVF/X:U-!:Q:-J+0I=!U+-$S\_>XXQG\J
M6/P=JENGBX1W-H_]N*WE@AAY98,.?P8_CBJWB$V6G_#4:!XAO+5M4^P$0Q)A
MF>11B/:,9SG:.GK[F@#H]%U2^U'Q!KL3M$VFVDL<-NRQD,7VYD!).#@D#BJV
MLZKK,_B$:%H1LX9TM1=37%VK,-I8J%51WX.36AX5TI]&\-6-G*2UP(]]PQ.2
MTK?,Y)[_ #$\UFZYH>K)XDB\1Z'+"]TMM]EEM+EBL<J;L@@CH02>N?PH YK6
M/$.I:OX$\5:=>);P:II>(KDQDLDJ'^)?[N0#Z_X=OX<LGATJTGNA:O>/;1JT
MT,&P[ HPI.23@Y].O05S%YX-U9_#?B/RS9R:SK<JF7!98HT& %!/)(&[GU/Y
M]GI4-S;Z19P7GE_:8X523RB2I8#!(S0!Q/B7QAK>BSZA<N+"UM;*9!%:RG=-
M>QDC<RX;Y ,]<'KZBN^MYX[JVBN(6W12H'1L8RI&0:\XU7P/XBOI/$L$4VF"
M#5)!*EQ*KM.5!!6+.?E4;1Z_X=YH=M=66A6%K>-&US# D<AB!"Y QQF@"_11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8+UH[282EH0#AF"G);!&>" /2LEY=?M/$_CFYT-[6,0>3,ZR0&1Y&$6=JX8
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M5X 8<^] 'I-%<7I?B#Q!%XO&AZVNEL9[%KNW^R;U)(; 0ENIQD].U06/B?Q
MNK:)!J)TDIJ$TL,T%L2[V[*"P&\,5)P!GZT =M<W,-G:375PXC@A1I)'/\*@
M9)_(5'87]MJEA!?6<HEMIT#QN 1D'V/(KSOP[K.L/H_C74;F:WO([6XN-L$Z
MM@[%&1U("[1C;CKWK0LO%&H2Z#X5M--MK""_U='*@QD001QC+80'/3&!F@#O
M:*X2X\5Z[I=SK>FWZ:;+?VFGF_M)(@R)*@SD,I).1@]#5:Q\8^)(]3\,#5;?
M3/L>NQY1;;?YB?(IR23C^(<<_6@#T2BL/Q;XA3PQX>GU(IYD@*QPQGHSL< '
MT'<_2LF77/$6A^(-)M=:&GW-CJ,GV<36D3QM%,>@.YB"#_CZ4 ;EQXGT2TU0
M:9/J=O'>EE3R6;G<W0?4UK5YEX,M;N^\:^*6NFL[BWBU(-(LT!=MR[@A0EL+
MC'H?;%>FT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1W$"75M+;R@F.
M5"C ''!&#4E% ',6'@BQLYK)YK_4;]+*-XK:&[E5DC##:> H)^7(Y)X-5;#X
M::%I]XLT<VH20))YB6<EQF!&!R/EQDX]R:T/$GBN'0O#;:W;VYU"W20(WDR
M!?F*DD\]&&/K70T >6^'-';5?&'C%)+W4[*&>XQMA4(LZ?,&R60^HZ$'YJZJ
M[\":7<7&G3PW%]9-86_V:(6D_E[H_P"ZQQGUZ$=:ZBB@#BH_AEI4-@EC!J6K
M16\=V+R-4G7Y)!T(RG;\ZTM6\&6&K:O%JC7=_;7B0^0\EK/Y9ECSG:W'3Z8Z
MUT=% '&K\--'31(-+2]U-8K>Y%U!()QOA?G[ORX R<],Y[UI)X1M4\1V>N-?
MZA+=6MN+=%DE4HR;2#N^7)))+$YZ_E7044 <HG@#38HKNUAOM1CTZ[E,LUBD
MJ^2Q)&1]W< <= U78_"=G!XCFUR"YNHKF6V^R[$*>6J #&!MSD8!ZT@\3?\
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M86_V&[N/MDWE;X$W+%WW.<\#&?RH PM&\$W&FR1R7GB'4-0:W7%HDQQ'"V"
MVW/S$ D#)Z?ABBWPXDD\(S^'Y=>GDCGN_M+S/ "Q[D=>[<YS7>44 <K=^"DU
M#Q!9ZI>7OG+!9&S>W: ;9592&.<\9W&JNC> )-*:"W?7[VYTJVF$T-BRJJA@
MVY<MU(!YQP,UNZ'XAMM?:_%O#/$;*Y:VD$RA26 &2.>G-:] ''-X&E?3?$%D
M=9E9-8G\YF:$$Q9/('//  ]L4X^")D?0Y;;7+FWGTNV%H9(XE_?1<<$'(' ]
M^Q[5UDDL<*AI9%0%@H+'&23@#ZDT^@#$\5^'(?%6A2:9+.T&YUD655R5*G/3
MOQD?C6/;^ /^)Q+J&I:U<Z@;FS-I=1S1(!*I],#Y0.#@<Y'7M79T4 <KH/A"
M\T::V2;Q%>7EC:*5M[5T50O!498<L "0!TZ>E5=(^'[Z.ZVT>OW[Z0DWG)88
M &<Y +CG&1T&,UVE% '&-X!EAO[Y],\07NGV-_*9;FUA13EC]XJYR5)_2N=D
MMF@^,":?INJ)8O'I"PH[HLI;!!VX8_>(&?7BO5:K26EDUXMR]M UTBY60Q@R
M #T.,]_UH Y6?P I\/P:?;:G)'=QZBNHO>-$&+S9))V\ =>![4W4/ EU>:M?
M7T6OSV_]HV@MKU%@0B7";,C/3N<?K70:!K]IXCT][RS29$29X669-K!E.#Q^
M5:M '!#X>WMI;:#)IVM)%J.D1R1)/);;E=7SQMSVR1^-6Y_ LDF@ZS;#4@=2
MU<@W=XT P0.BA0>!CW/4_AV). 3C/L*Y>+Q]I,UU=VL-OJ<D]IG[1&ED[&/Z
MX'L: ,Z_\!ZA-_9%[8Z\UIK%A9BS>Z$.Y9D [J3UY/KUKI]"TF32+%X9[Z:^
MN)96EFN)N"[' X X   &!Z4:)KMGK]K+<67G!8I3"ZS1&-E8 '&#ST85IT <
MH/!TJ>+M2U>/4=MGJ<(CNK4Q EL+MX;/ QSZUFP^ -273$T"77_-\/K(#]G-
MN!,R!MVPN#TS[5WM% %34=/AU+2;G3I<B&XA:%L'D C%<3<_#_5;KPC8:'+K
MD+?8KE)8G^RX&Q5(52 V3U/.:]!I&95QN8#)P,GJ: .1OO!4NJ>)-3U"]OPU
MG?:?]B-O&A4KT.[.><')''>HM#\&:O87=K_:?B>YOK&R8&UMA&$Y (&\]6P#
MTKI(]7MY==GT@1SBXAA69G,1\LAB0 &Z9X_S@XT* ,_6]%L_$&D3Z9?HS6\P
M .TX92#D$'U!%<Y:>&?%=A#'8VWBQ!8Q+Y<?F6*M*J 8 W9Y('>NSHH Y*\\
M'W:ZCINJZ9J[QZG9V_V:26[4S+<IU.\9!SDD\'O[54O/ 5Q>Z)J\4NH0MJNK
MNANKLP$*$0C:J*#QP!U)[UW%% '&R>#KZ35_#-\=0M\:-"(F7R&_>Y&UB/FX
MX Q[^M<]XJ\/3^'_  MXRO[J_@E75I$D5%C*%6\S@9).>#^E>IUA0:AH7BUM
M0TUH4NUL91'<17$/RA^<8W#GH>: ,S3=$U'5;O2M5U/6+6[MK2+?:I90^6&=
MEQO9BS9X)X&!6/%\.=:@L+2PB\10"ULKT7ENALA]X,6RQW9/6O0[>V@M(%@M
MH8X8E^ZD:A5'X"J&E^(-.UB]O[.SE9Y["01W"M&R[2<XZCD<'\J .=C\%:A'
M<>*I?[3M_P#B>IL&(#^Z^\!_%S\K'/O5+Q'-IFD^!4\':E>BYU-[%8;:&*([
MI6!VQ8&"!\RCJ>U>AU#)9VTT\<\MO"\T?W)&0%E^AZB@"CX=TH:)X>L-.R"\
M$*K(P_B?&6/XG->?>/Y8]1\81V,VJZ=9)96?F)'JD :*21SU4GV ^F. ><=]
MK/B;2=!:.._N@L\O^J@C4O(_T5<FLM-;\)^*+^WL+J".2^8%X;>^LV63 R<C
M<O3@G\#0!@:;I=]XQ\-26-S>V2OIMU')I^HZ:N(6<+G&W SMW8.,#GU!K?L_
M#FJW?B.TUKQ!=V,LMBDB6L5G"RJ"W!9BQ)SCL.G\^HBBCAB6*)%CC085$& !
MZ 4^@#FQX0MAX[/B<28<P>680O!DZ;R?]WBLN7P?KMCXAU"^\/ZY#8VNHN))
MX9;?S"KXY*Y]3GTZ]\5W%% '&'PCJB>,](UA=1AF@L+3[.YG#-+*3G<3SCG<
M2#GCT-.B\*ZI'XO\0:T+NT\O4;000)L8E2% !;GH,<XZ^U=C10!YQ)X#UYO#
M_AG3UO\ 3_.TBZ\]G97*L P*@8ZXYSTSQR*U)?">JR^*]=U0W=J+;4; VD:
M-N4X !8=#CGG/>NSHH \?UW2KC2O#7AKP?=:CI:7?G22E[E6\@J-Q4%B.N6]
M.?Y]'X$O+ZWU.?0W&B2VD%OYQFTA&"+(6 VO_#N(YX]*['4=)T[5X5BU&RM[
MJ-3E5FC# 'VS3[#3K+2[86UA:PVT )/EPH%&?7 H YWQ/X:U'5-?T76-+NK6
M&XTYG!6Y1F4JXP3A2"2/3(^M5XO#FOPZAXIN4N=/']K(!;G#Y1E78N[CTZXS
MS79U'/-';023S-LCC4L['L!U- 'GD/@7Q%I]MI-[I>I6%OK-I:&QF8H6BEB#
M$J>03NQMSQ^7?MM&LKZRL=NI7[7MX[%Y)=NU1V 5>P  _')[T_2=8T_7+%;W
M3;E;BW+%0Z@CD=1@\U;FECMX))I6VQQJ79O0 9)H XZZ\(:C-XPU?4([NU&F
M:M:"VN8G5C)@)L^7! ''<YZ]*AT+PQXNTYK6PNO$<+Z/:,GEB*+$SHI!"$XX
M' !Y/'%==I>J66LZ?'?Z?.)[63.R0 C."0>" >H-7* .2\,>&]3T2?Q%-</9
MNVI73W4(C=L*6+':V5''(Y&>]<\WP\UH_#F'PT+FP^T1WGG^;O?9LY/]W.<G
M\J].)P"3VKDV^)G@]6*MK488'!!ADR/_ !V@"&Z\.:[)X]M?$<,NG;(K'[*\
M;L^6/S$D8''S'U/%8]SX&\17G@>[T*>YTOSY[XW/F(T@55+;R/NDYW=/:N[T
M?6]-U^R-YI=TES;ARA=01AAC(P0#W'YU?H XV[\*ZI>^,[76I+BTC@ATYK3:
MA8N'96R1Q@C+>U8UAX&\56EKH< U#1XETFZ\U/*A?<ZG[Q8]"2"1C ^M>ET4
M <);^#M7L(?$]A:W-BVGZL)GB\W?YJR2*%.X@8VCGH"3Q42^!]8BT'PV(;RS
M75]#D<QL=_DR(QY4\9^Z!V]:] HH XN\\*ZIJ<FL:C=MIZ:G=V!T^V6,LT<4
M9SN)8@$L2QZ# P.M5#X/UZ1_"#R2Z;G0@4DVR/\ O%PJC'R]=J#\:[*UU:PO
MK^\L;:Y66YLBHN$4']V6!(R>G8]*NT 8GBOP]%XH\/3Z8\AB=B'BEZ['!R#C
MN.Q]C66-#\0:M?Z0^NR:>L&F2BX_T5G9IY@N%)R!M')..:Z^J,VLZ;;ZM!I4
MMY$E_.I>* GYF SS^A_(T 8/A3P]J>BZUKM[>M:&/4Y_/402,Q0Y/!RHSP>O
MM76444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN:&>0R+#,X*0Y))"  8R6J.;PO#-XPA\2&]N5N8H/LXB4)L*<G!RN>I)ZYH
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MM8L;?[,]PL 9)D)R05.>F3C^E=9HNF3:7:RK<W\M]=32F6:XD4+N; 7A1P
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MVB:O9>--<U:ZDLS9Z@L058BV\>6NT$@C X)SR>M%AX-@L/'%]XBCE 2XC^6
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MK?:R9!(2H^]C('/08%4K;6]:U/X?^'M2_P")C?0P7+IJ:VDC)/(@W!2&3#$
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M7'XTM;Z^^UO=1:9)9-LEN[B&66*8+PR;<YSR<$8_+D ]$HKR71[GQA??#_\
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M1^$]!U8^:MN=3.2_V6W\R9<]2VT$C/OZUT5C!/;644-S=O=S*,-.Z*I?GT4
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M9SDGO7)>'=#&J^+_ !?'?Q:M;07%Q\A1I(8Y5^8')'!Z\>Q- #-'U"]U31O
M-U?LS7!OI%+L#EE5) I.>I( Y[U/ING6_B]_$UYJES>&[M+R6WA$4[QK B?=
MV '&>,GBNLNO!FCW3Z8QCFC&F "T2*9E6/!R#CN>._6FWG@K2;S5;C40UY;3
MW2[;D6UPT:SC&,.!U_2@#SV6YU2Z\">&?&$K7$LVF3!;H&5AYL ?;N/=CP,G
MW).:LZWJ]RNC>(?%>FW31QW]S%8V<X=L)$N%>0 =,D'GKQD>_5>(Y;JSTX>%
M](\.7,]O<6AMHYT(\F 'Y1N/)X&3SZ#KGC8B\,Z>/"<7AVXB$UDL"PL#QNQC
MYN.AR,Y]: .#;1->\%VVI:Q#?VL5L+"0+:K=2S!I.H<!^X_D/<U;\)^&]9M-
M7TS6SJ=N+.XA)N(Q>RRM<ED)!^?C(//YUTNF> ] TDR&"VDDWQ&#$\S2!4/!
M"@GC/'2HM)^'GA_1YVE@BN)!M942:=F6,,NUMH[9!;GK\QH X_PH3IOB>PLO
M$UKJ5KK9:3R[P7+/!>ELG#<XX'0#CCGFO600>AS6!8>#]/L9=/<SWMS_ &<&
M%HMQ-N$6<Y(P!G@XYSP!4?A+PX_AY=34L5BNKMIH83*9/+3H/F/4G&?;('.,
MT <_-:)XM^(^M:7J<ET+/3;>'R(X;AXQN8;BQ (R><?A7*ZO/<3?"_Q#8W,\
MTZZ5JOV>WD>8LQ3S%P&.<-@'OT]L5ZCJ_A6SU:^6_6ZOK"]">4;BQG\MV3.=
MIX((S[56O/ FCW?AK^P0;F"S,OG.8I?GD?.26)!W9/K0!R7CC2+>W3P@L<EW
MB34XE;==2-][!)&6X/H1R*Z"7S]+^(%I#%?7LMM_8\C&":X9T+1LH#$'JQ[D
MY)K1U;P;8ZS%ID=S=WX&G.KPE)\$L.A8XY/'7K4UQX6M+KQ1:Z_)=WOVFVC,
M<<0D'E;2"#E<9YSZ^E '*Z#I#^)=%TSQ/)KM[#J+SB:0K<MY07S.8=F< $ #
M _'-8TFF>(_&=[KUU;:@MM/9:A);VX>]EC:V"8^ZJ97D<%L]<^E=E9_#C0+'
M66U&%;KF7SEMFF/DJ^<[@OU /)/04FH_#?0=2U674'^V0O.Q:>*WN"D<K'J6
M YS]"* .<U*"^UKQ]IFBW.MWJ6MSHBRS_P!GW)6.1PS99>,8..N.13M0OY]#
M\3O#XANM7AL9+F+[!J%K=-Y051CRY5^[DX);(R<GMBNP3PC81>)K;78IKI)[
M>W%M'"'7RA& 0%P1GOGKUJ&Z\$V-Y/*9[V_:UENOM;V?F+Y1DZY^[NQD9QNQ
M0!TM<3XEO)[WQWH?AP7-U:VDT,MS,]K.T3R$ A5W+S@8)]\BM+2M!NK/QGK&
MK//-]ENHT6.)YMX9NI8#'R@8P!D]3[ 6=>\+6/B":TN)YKJVNK0L8+BUEV21
MYQG!Y'./2@#S_18);)/B5'9WES%);_-'.9"THVK(?O'G)QC/6KFNW-_<GX?V
MB:K?VRZA"5N9+><H\F8X^2>YY/)SUKH[;X?Z;:VNJP)?ZH6U10MS,USEV'UQ
MCGGJ#U-/?P+82/HC/J&I,=&_X]LRKSR#\QVY/  XQP* .7GM]:N]?U'P]:7]
M[<C2[.)87.IO;RO)(NXR.5&7P<#!X''K4ZS:Y&_A3PKJVJ3>==FX^V75I*1(
MPC!9$$O7/ #=SZ\UT>M^!-*UO6$U9I[VROU7:T]E,(V<=!G(/0"F7OP^T.]T
M6STQOM4:6;M)#/'-^]5F.6.XYZGK0!S'B_P_+8>')+.XUR^O(I]8@:-99V9X
M(V.W:6))/<C/&0#C-:<HEU3XB?\ ".-?ZE#I^GZ6L@$-VZ/+(64;G<'<W!'4
M]1GO6M<^ M)O-!GTJXFO91<2K--=/-NG=UZ$L1CIQC&*EG\&VTU[97ZZGJ<6
MH6EO]F%VDRF25,DX?<I#<DGI0!YWK.MZYH_AKQ!IT>LW3RZ3J4*0W9EW2O&X
M)VNW?&/Z=.*WO$VFZGX=M[25=1\0:GI[7KS7IBN6$T<97  *X.T')P,#Z<5N
MW7P^TF\T*;2I;F^*3W7VNXG\Q3+-)_M$KC'3@ =/KG5O= ^V7=G=+JFH6]Q:
MQ-$)(70>:#C.\%2#RH/04 )X6FM[CPQ82VM_<7\+1Y6YN#F1^3][W!X_"JOC
MC6KG0/"ES?6;1I.&2-9)!D)N8+NQ[9S6;?>#'M[;P[::-=7L*:?=;GD\\#]V
MQ+.6&,,2>!QCGTKIM7TFRUS2YM.OXO-MYAAES@@]B#V(/- ',/HU]X:2ZUJV
M\0W]W;P:=*[6U[,9A+(%+!@2<*.!P!6#=->Z;X#LO&L6OZI<7RK#<31/<;H)
M-[*KIY?"@#<<8YS^G8:7X,L=.E626]U'4=D1AB6^G\Q8E(PP4 #&1Q]*IP?#
M^V@2.R_M6_;1HI!*FFL4*;@^_!;;N9<_PGTZT <WJ$FJZQJ'BX_V_J5K;V%E
M%=VL5LXCV[HF<*Q SVP<'G/L*H75Q<:V/AM<WES/YUP[K(Z2,I)4J W7[WJ?
M>N^D\'02:GK=Y_:-ZJZO L,\8*84 %<J2IQP< ?7KVI#X>VBZ7HEHNI7BRZ1
M(7@N%V[OF^\,$8QD#&0<>] %&XM-4UOQ_K&G#Q#J-G:6T5O/'';,JX)SD9QT
MX/USSG%8NH:Y>V4MIJ5MKE[>R'7%M)B 4M7C;=^[52,':%&2.Y/)XKN;#PN+
M'Q5?Z[_:5U,UY$L30/MV@#IT';''U/7-8(^%5@EB+.+6-42WBNEN;:+S%*0L
M/8CD\GGW'OD K6D>I>-Y_$%Q!K>H:=+97;6ME%!+LC0J%^9P/OY([]B:LK8S
M#XKZ6+B_N))8M$WNR/A9&#A3QZ'J1Z@>E:-WX!M)M9N=0M=5U2P%X^^[@M9]
MBS''TR.IS]>,5<F\)PMXBTS5K:]N+7[#;?9?(CP5DC!R%).>/7^G6@#C;9=5
MUOP?>^+H_$FI6^H0?:)4MXY1]G18V;"&/&#E1U/J#5B+4-:\3^(-.M%UBZTZ
MTOM%6[*VZ!660, 2,C(!/OTK8;X>I$+FUL=;O[32;MW>XL8PFUMWW@K8RH(P
M,<U>3P@D/B^WUVWOY8DAM1:+:+&NSRP.!GL,X/X=: .6O]7N+#QM)#X@O]7L
M+<747]G7,+$6TBX&Y'4<'<>YY&>V*[[7))8M"OI(+R&SE6!BEQ-]R(X^\?I_
MG-<_=^!Y[Z2X@N-=N9-+GO?MC6;1*2#OW[5?J%SZ5T&N:3%KNAWFES2/''<Q
ME"Z'E?0__6[T <?IFJ:B/%&D6B:M=7=C>Z0UP998U7?(#]]05!';@C&,=>:Y
MG3]>\0MX.TWQ/=>([C_D()!) T:",IOP2Q STKM+3P');:GIFH2>(M1GGL86
M@^<)AD(P !CCWSN)P*IGX9J?!D?AO^V9?(2[^T>8(!DC'W<9]><T .>34?%?
MB/Q!90ZM=Z?#I6R*W2U/E[Y&1LM(2"2,\8''0CL:O?"__DG&D?[LG_HUZDU#
MP7Y_B&;6-.UB\TR6Z14O%@"GS@. 06SM..,__7SI>&/#\?AC0X=+ANI[A(R2
M&E(X).3@#H,Y./>@#EM*.I>,KW6[I=;U"P^P7TEM9PV[*D8VKC+@@[\D]_PK
MFHM9O_%&K^!Y+JZN()VENHY7APH+IQO4$$<@XSCU%=[-X/GBU>^OM(UJXTT7
M_P UU$D2R!G_ +ZEONG%17O@"S>VT=--O;C3Y]*+>1.@5V(;[^01@DGG/UH
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M=RVA)*2KE"6W.<_*1W[=* -FY\?SV]GK4_\ PCMZ[Z5<"*5 X&4(+>9DC@8
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M^YMW[H_P[>-QX_\ KUS]MJ?B"_\ %'B6$Z\;:QT>Y28HMLK%HB&8IGZ+UZT
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MZ _XT =?;-(]K"\WE^:R OY9RN<<X/<5R?Q'FU2PT"+5-,O+B#[',KW"0_\
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MHB\MY""/7//4UVQ\%1)K>L:E;:G=VXU6$QSPQXVYV%0V2,Y&21@CD^G%56\
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MJ,@D@$9'45Y+=+-;Z[XLT33XTM(9-$6Y$*2';%(H4<'H.&.3CG IYTO2-,\
MZ7?SOJ3W>KBS1UBN6+7#XW!,L<*O!^@'TH ]3NKF&RM9;JXD$<,*%W<]  ,D
MUG76HW\T6E7&C6D5W:W4J-/(\FPQPL,[P#C)P>G7V]/-[EG,_P 1=+=%CLXK
M))TME<LD4GE[LKTQSCIZ>U6?$L2Z=X$\%O8L]M_IEIGR7*@[HR23CJ<CK]:
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M&D,)D W-N)R.IY]2*Z*P\.:WX<EU*[_M**.PFL9?]&6[EE;S@F?,0OT/'Y4
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MJ)@$8!E'S#'/7IT]J /::*\RM[[4-*\6^%YY-5U&\CUNT9[BWED!16$88;%
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M7GB>$23S[VB1A@A.,#ZXS755G76J_P#$MO[C3(A?W%H6C,$; $R*.4R>AY%
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M:/"LL,GFQLS,Y5NQ&XGIV'0'FDE^'WA2:2ZDDT6W9[H[I3ENOJO/R?\  <4
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MB@"7Q%;0S^%M3@D0-$;20;<^BG'\J\SUZQ@@^&7@F&!3$LUY:.Y1B#N>-BS
M]CDUZ[/!'<V\MO,NZ*5"CKG&01@BN6_X5SH']CV^ED7AMH+C[0@-RV=V,?@/
MICJ?4T <;JEY<>%?%7BN'2Y9Q#'I"SI$\K.$D+1KO!))X#$UJ^&O#MW;WGAW
M7K?5XH[>>V5;M#-(S7;%"1]XD$Y[<8P:[ ^%M+?7[K69(Y)+FZM_L\JO(3&R
M<<;>G8<=*H:)\//#F@:D+^RM9/M"D^6TDS,(\@@@#..A[Y- %#XN?\D[O?\
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M2[74]'GTN="+::(Q%4.,#&./I7,V?PXLK*]TN\36-7>?3?E@:2=6 3&-F-N
MN.,#L: .&@N-<E\!Z[KA\3:N+C3;]XHD$PV, 8Q\W&3]X\9Q[=:WK6\U32?%
MOA9I-:O[V+6+5Y+F&X8,BD1AOD50,<UO1_#VRC\/:CHBZE?_ &34+C[1+GR]
MP;()P=G0X7\N,<U;?P9;/J.AWK:A>>9H\0B@'[O#C&#N^7N,#C'MB@#E0=4U
M'X?S^+DUS48-059;H1)+^X 1V 3R^FW"_7-6?#VOW^L>/XXY+FX2TN]"2Y-M
MG"I(2H)4=NI_.MG_ (0&S2UN["#4K^#2KN4R2V$9C\LYQE0Q4NH..@85-J?@
M>RO]4M]0MKZ^TRXAMQ; V,@CW1@Y"G@F@#SQ?$6N_P#"LK6Z36+I;LZU]F\\
MMN<IR0"3U&?\.E=#"+VR\7:]X<NM:U&]@N=(:='G<$QL<ABN  O7C _E6F?A
MGI@T)=(CU'44MEO/MH.]"P?& .5/ _\ UUL?\(K:MXGGUZ2YN'N)K3[(8R5"
M!.,XP,YR,]>] '"6::Q8?"/1Y]*>^N$,@GNUAF(F6+)RL1 ^4<?S]Z[3P1?6
M=_HTTMEJUWJ,7VAN;S/FP<#]V2>N/7W]JCL?!*Z;9V=K:ZYJJ1V<OF0#>AVC
MGY"-N"OS'KS[\"M/0_#]KH(O3;O))+>W+W4\DF,L[')Z <#L* ..N4U76?B?
MJNB#Q!J-G8I9).J6S*I!RO ...6)SU/3.*I:-K6I:IX7M+:[UJ>&2'6'LI)8
MR?M%W&JY"K@$[B2N3D<#)/K)_P ??QLU2V@U6>PF:P1 T*(6<@(2OSJPZ<\>
MG6NAD^'NGG3-.M+?4-1M9+&62:.ZAF E9W^\22._L!0!@QMKNI>#O$MK::IJ
M"7>E:A*EM(7S,Z( VQF!YSD\Y]*T= UN;Q)JVAW-KJ$WV6UTTRZ@NX!7E;Y0
MK#U!5S^7K5F*UL/AU!<WDMWJ]_'J%ROF*5$S"0@Y?@ ]!R>>@I_@30(K'P[=
MNUL;<:K/)<>25VM'&W"*1V(7MVS0!A:1J>I)JWAV;^VKK4$O[NYBN''_ !ZM
M@$XC! ;Y2, XQPU9FA:5J=[I_BNXTC7+JR>UU2XECCC10)7"YP_7C.!UQUR#
MGCJ;3X<16<>G)'K^J[=.G,ULI9,1@]5^[R,<<^_ S5N?P7-)>ZF8=>N[>PU-
MF:ZM(X8CN++M.'920, =/SH Y6[U2;6M4^&>HW(43SM,TFWH6Q&"?QQFF)<^
M./$<LFM:/+(BI>.D$(NT6 1J=NUXRN2QQU)[\ 5V-YX*MY]4T"ZM[R2VM]%&
M(+54#*1P/O'GD*,DY_GG.?X:6PO;HV^MZI;:?=R-+<6$,@6-RQY'3A<<8].]
M '3:U).OAB_E#M!<+:.^Z-N48(3P?K7G$NO:Q_P@W@K4!J=R+BXU!(9V#?ZY
M2S#YO7A?UYS7JDUI#/926;H/(DC,3(./E(QC\JXJW^&4265G8W&O:C-9V%R+
MBSA"QJ(B"3R=IW=?YX S0!D:A=>(-5\1^+K&#Q#<V5KID:3Q+%&N3\A;;NX(
M&:LKK>H^('\*Z+_:=S9RW^GF\N[BUPLC87@ XXR0<XKH(_!@CU3Q#?#4YMVL
MQ>4P\I?W7&!CUP#Z?GUJJ?  72]&BMM9NH-0TD,MO?*@)*$\J4/!&,#\* .-
MLM2O/#\7CN2SF>6\.HQ6\<TF-P9V9=QXQGGTQ73Z=:^+--UK4VGN;V72&LGD
M26]FB>1)L=5"# '!XZ=_:K$/PWLS:ZU#?ZG=WAU9E>9RJ(5=3G<H P#G/;IQ
M4FF>!)K%9WNO$.H7]P;:2WMGN,,MN'7&Y5.<M^/3B@"M\.&UG5])M?$&IZY/
M<B>*2+[*8U5 1(0&R._'IW]J=JMG)<_%S1V_M&>%(K"298E(PV& *].A!R>O
MW>W6M_PKX?'ACP_#I*W1N4A9BCLFTX9BV,9/<FJ^L^%?[4\1Z9K<.HS6=S8J
MZ9CC5]ZMU'S @<$]CUH XN9-7B?QY?Z5J4MI):70F5(D0[RJ MNW \8],=.]
M;$GB#57U3P$PNQ'#JMLTEU$L0(=O*1OJ.6_#WJ__ ,(._P!E\26YUB<KK<ID
M)\H9AR3D YY&"%^@H'@>3[3X<E;692-#C\N)?(4>9P!R>WRA1WZ4 8]KK]W_
M ,)E<Z9J^MW>G70U(FTMGA3R+BVR-JAL9W$9YSU/KQ7H]<B_@J>Y\B&^UN:Z
MLX+W[8B20CS VXL!YF>F3Z=/2NNH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBF2OY<3R!&<JI.U>K8[#WH \_A\7>*]8T6^UO0['2GLH)72.
MWF\PSLJ=2<$#/?'H?S[>WOT_LRUNKR2*W:6-&;>VT!BN2.?QKS+5M%M;72YO
M''@O638@Q_:)K<ONCF/WF4C)PW;;Z\<4NJ7[^(?%&AIJL]KIL-SH_GQPWUNL
ML7GN^",-CYMH&.<^G7D ]4-Q (//,T8AQGS-PVX^O2J5_KVF:;I4^I7%Y%]D
M@'SNC!N>P&.Y]*\NDTZUT)/#>AW.L#4M"_M*07$K_NX0P4%8S@D$;B3R2,YS
M6IXMT?P]9^#?%1T-K9I)?)EN88I R1$-\N /ND\G% ';75[J#ZAI#Z<UBVFS
MLQN'E<[R-N5\OL??_P#76E->6UNZI/<PQ,W17<*3^=<!XBT[2&N_ [QK!# E
M\%1H6"("5W8XXR75??\ .J^AV&GZW?>-/[>M;6:\CNW7]Z 7CA"X0KSE1CN,
M4 >EM(B%0[JI;A03C/&>/PIL-Q#<H7@FCE4'!9&##/IQ7AUK;#5=/^'4>IHT
MZRW%Q"?,R"\2NNT?3%=IX#@BT_QKXPTRTC6&R@E@:.%!@*2K9Q^0H Z;7;W7
M8YH;30;""6=P7DN+QBL$:CM\O)8^@IOA'79_$.@I>75NEO<K(\,R(V5WH<$C
MVJ[J]NNH63Z>NHRV4TZX1X'"R<?W<_TKD_A]<0Z)X:U.TO[^);+3-4FM8KB=
MA&I0%<$DG'+,: -#6M>\1-J<^G^&='AN6M=OVBXNW*1@L,[%Y&3@J2<\9Z<U
M?\(^)$\5^'H=42W:W+LR-&6W88'L>X_ 4OB#7(]/@6TM)X!J=XA%JLD@"CC_
M %C9_A'XYZ &JOAF+1/"WAF"P35+,QV[!)IC.H!F;D@G/!.>!UQB@#I))$AC
M:21U2- 69F.  .I)JMI^IV>JV"7UE<)-;/G;(IX."0?Y4:FD<VDWB2*KQO X
M*L,@C::\;MI=GPK\,J8DAL+K4UCU%HQLWQB0CYR.>0.3[4 >U07,%RI:":.5
M0<$QN& /X55U36;#1HX'O[A8A/,L$0/5G8X '\SZ"N/&C:=X=^)6B+HJ):I>
MVMPMU;Q'Y2J@%6([9/&?]GZU'\4X()Y/"ZW$:/&VK1H^\<;#]X'V/>@#I(]=
MNO\ A-[O1IX88K.&P6[2;=\S9;:2>P P1CVSGFMW>NS?N&S&=V>,>M>?ZCX=
MTK5_BK#;7MO&UM;:*ACM_NH?WCKC [ 'I7&VUVMSHFC:%)=I;:<-8N[>62Z0
MR1J4 :)3\PROS]R.?IR >XQ2QS1B2*19$/1D.0?QHDECA4-+(J*2 "QP,GM7
M'>!]!@\.WFHVMOK\%\D^+C[)!$$6$DD;AAFP#C&/]FL3Q':0Z_\ $.^TK4;^
MU@2/3D-F+N'>JEB-[)\RC=QWS^E 'IQ8+C) R<#-07%]:VMI/=33QI! "97+
M#"8ZY]*\SU/0K*+X>V5O%J4>IZG8W)CTR=!AI)/,SY8&[YAU!YP /:H88[*^
M^$7B":SAV:K('?5$;AQ,K[FR"> !G _KF@#U.SNX;^R@O+=MT,\:R(?52,BI
MZ\?O[1;E_!>A1R6=CIES8_:6:2,-'+.(QG<-R[C^/5N]+K.C)HW@'4M'76_M
MC6VHPRA;?*>0'<#8>3_M'&>.#0!Z^2 "2< 54T[4K35K,7=E,)H"[(''0E6*
MG]0:\XM=*M-#^(^I:+IZ/'I]SHC230O(SAVR1DEB3T)_,UJ_""SMH? EM=1P
MHL\[R>;(!R^UV S]!0!V?]I67]I_V;]IC^V^5YWD;OFV9QG'UJU7"/863_&D
MS2PQM(-&6=2_.)!*5W#WVC%<=<26,%GI.OZ,DWF2^(=GVV=_WLRMN+ @?P9)
M')R<>] 'ME%>/^-K:RTOQJTL<K_V9J"QIKB1[F$(,@8,2#\I;;^'/]ZNH\0V
MFCW?B+PUHTJR7,161H[%'_=; N!(YSD@ $ =\GTH UO$7B=]!U;1+(67GIJ=
MR+<R^;M\HD@9Q@YZ^W2MR\G:VLKB=(_,>*-G5,XW$#.,]LUXC;F36/#G@R"1
M9UB@UI[1IHY&# %P5PP^Z<' _P!WBNMM=+C\->.;[2]+EE33;G2'N9+9G9PL
M@;:&RQ)R1F@#K/"7B ^*/#=MJYMA;&8N/*#[\;6*]<#T]*VZ\.TJ2>Z\$>#=
M$69(K;4+JZ$P=G59"KG;&Q0@X)8]^PKT#P=HDOA>;5+:XU*V:U_=RQVD<CE;
M4'=GER2 W7KVH [&CM320T9*L,$9#=OK7EGA:.'1_$>FV^N::\>I2O)]FUB"
M<O%?E@?OXX.0<C/<#I0!W7A77W\1Z0][)9FT99Y(3'Y@?[IQG.!6W7A(L;<_
M#O7-<22[74=-U=_L\@N'"QDR1_=0';T;KC.:W_%KV6KWFK721W5S=6^CK<IN
MDV1V!(+ J0<ES\IZ=NO.  =MJGB9M,\6:/HC66]-25\7'F8V%1G&W'/;OWJ;
M2=?DU/Q!K6EO9F'^S7C42^8&\P.NX'&../K7"I-<7^L?#6_N'WO)!('<MR6\
ML<^O;K6WX;FD'Q4\80;OW96V<C'<1@?UH V=5\3-I?BO1M%:R\Q-2#XG\S&P
MJ,XVXY[=QUKH:\[\<6RW?Q"\'6[O*B.UP&,3E&QM7HPY'X<UR^K:EJ?A"?Q'
MH6FW%U)IT;VRI--(Q-H)!EOGZ@'IU'J.<Y /;**X/PSX7G\->)5G&I6-O9WL
M106$4LC^<X^;>OF,22!UQGBF?$QK@3^&XX+Z\M1<:BMM+]FG:/<CD9SCOQQZ
M<T =_17EDL<GA7Q7J>BP:Q?PZ5<:2][-/,QF:WD+L#("><G'XD^N*N:)/J$'
MCO1H?-O4L+K1B?*N9_,:1E8_.PR0K$;3P>^,]: .UT2^OM0L#-J.F/ITXD9/
M):0/E1T;(]:HS^)O(\;VOAM[)O\ 2+9ITN/,&.,\;<>QKSBT\0ZI!X'N8GO[
MJ1I_$1L#<O,?,BA(4G#=1W^F:W#I5KI'QDT6"T\_RVT^5L37$DI!^?H78D#V
M% 'I=%<9X_U&YMY= TZ*>6WM]0U!(;F:)RC!,CY0P^[G/7KQ56&Q'AGQWIVC
MZ5<31:;J-G-NMFG>3RI%^;>N\G&<_CS0!WM%>?\ PUTVXN='M-<N]8U.YG8S
M1F*:Y9HR!(5'RGOQG\:LZE*=8^(Z:%=7]Q;VD%A]H2&WG>%II&;&2RD$[0,X
MH [>BO,]66ZT630/#QUZ\N[2[U1TN;DS[)$7Y66%G!W G<#U!/TP!H"VN-$\
M<IHUA?72:9>Z9(XBDF>4Q2(<!D9R2.".,XXH [RBO%X(-2_X0#0M=3Q#K"WU
MS=I Q-TQ4(TC*?E/!/?)S756%E=:9\0-0T:#5]0EM[C1OM*FZF,IBE,A0,N>
MF.O^10!WU%>,VMKJ3_#K1]?7Q%K"WTMRD1/VHE=K3%,;3UZYR<UIZC>ZMX/\
M1:W!:7EY=P'1FO8A=S><5D#A2PST R21[4 >IT5YQH6E>(OM^A:TE^D=C)"I
MO%FU.6;[274'(1EVJ<GH#[#%<X3JUUX;\3ZLFO:FMUI&I2+!_I+;-BLO!7H>
M/7B@#VJBN$C\WQ-XPUG3+O4;J"*QM+?[/%;7#0G=(A9I#L(+$' P>.>E9>IQ
MZTFK:+X0CU.ZO&2TDGDNFNFM#.0V /,4.25 /'?/)H ]/J,7$)N6MA-&9U0.
MT08;@I) )'7!(//L:Y_P7I^LZ7I,UEK=]'=SI.6C99FE9(R!A69E!)SGD^M<
M_' EI\2?%6JJTKSVFG1R1J9&V\H<@@=1\HX/UZT >B55U*]_L[3+F]\F2<01
MM(8X\;F &>,D"O+9%O1\+H_%\>NZF=64"=I!<MY;$N$*>6?EP/IUKT2\NOMW
M@RXO-FSS]/:79G.W='G&?QH FT#5TU[0K35(X)8$N4WB.4?,!DC\CC(]B*TJ
M\4TY=4T3X<:/XHLM9U!I8G$9LF;?$\9E*[ OX=>O/TK2B_X2GQI<:M=Z?=FU
M>TOF@MO^)@\2P[".&C6,A\_[1[],4 >LT54MA/<:1$LMPOVAX KS0$$!\8++
MD8ZYQQ7C]B^NWW@.]\3MXGU-;S3II0D>_P#=N!MX8=^IH ]KK/N=3DM]:LM/
M&GW4L=RKEKI$S%"5&0'/;/;\*X+4M9U&^T_4;ZWU&Z%VNBP7:VEL&5;-V7>Q
MD;."QYP#V[=#5^WU74IM<\!2O?2^7J=C(]U ,!'80!]WKG+?H* .LU[5H= T
M6ZU::WFG2W3<R0J"Y&0/R&<D]@":FTG48M7TBTU&%'2*YB655?J 1G!KS:=K
MGQ'X+\4:[=ZG=;D^TP0VD,V(H43HK*.I..2>QKMO!'/@71/^O*/_ -!% &_3
M97\J)Y-K/M4MM09)QV ]:\?OM0U6TTKQ+H9UG4#K%IJ"RV)64F2:-AD*.Y 4
M,QQTKJM OIO$VM0ZC8ZE<"RM]+2)E#[T-R^2=WJR@#.1W'3N =-IFKK?Z1;W
M]S;3Z<9FV>1>+Y;JV[: 0?4XQZY%5X_$MK)XNE\-BWN%NHK?[09& \ME^4<'
M.?XO0=*\YN;B?5_A[X1N]3U"<S/KB1RW'F;#M\V0;L]B HP>U;5YIIN/C"(;
M?4I[=FT;]XT6/, #@ ;CGO@YZ\8[T =KK>J/H^FF[2QN+U@Z((;==S'<P&?H
M,UH*=R@X(R,X/6O*;O6_$-K\*]4N9=5D&IZ9J+6QN$ )D"R*N"2.GS=>#P/>
MM?4GUK4_&.D:?!KUS8VUUI9FE$$:Y+ \D$C@G(^F..M 'H%9&N^)+#P]%$;H
MRRS3-MAMK=-\LI_V5_KTK&^&^KWVK^';DZA<-<36M[+;"5\;G5<$$X[_ #5@
M'3M0UWXKZW+#J3:==:=:Q1VDGV=)?E9>2 XZ9)Z>O6@#LKGQ/#IVA1ZEJ=E=
M6LDK^7'9D*\TCDD*J@'!) SC-.T?Q/::QJ%UIWV>ZL[^V =[:[15<J>C#!((
MY'>O,QKM]K]QX/EU B2ZM-<DM)9E4*)"NPAL#@9!_0UUE^9%^->E",N$;2G\
MS;G!&Y\9_''Z4 =W63I6OV^K:CJ=C%;W4,VG2+'*)T"[MP)!7DY! SDXZBLG
MQ+=WT_B?0]"M;N2SAN_-FN)82 [+& =H..,D]:P[..?2;_QVL>L^1+']F*W]
MZ=_E@QYR?4@' _#K0!Z117GNBWE[)XO.D)J>IRV%WHYN%ENAMD#[]N],@%>I
M/(]*S+#6]7;3KCPM-J5V_B :NMMYXQO6#.XR#_9V(WYT >JT5YOJVK75EXKN
M;/6-5U/2K=Y(AIUY&H-L5 &X.2,%B<Y)X&?3%>C@@@$$$'H10 M%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 <\O@7PNB[%T2UV;MVW
M:=N?7&<5H:IH6E:U#'%J5A!<I$<H)%SM[<5:6]M'N/LZ74+3X)\L2 MQUXZ]
MQ^=<=J?B36[OQ7?Z)H$VE126-NDC?;-Q,KM_",$8P"/7J* .DD\.:++I*:4^
MF6K6$9RD!C&U3SR/0\GGKR:(/#FBVNF3:;!IEK'9S#$L*Q@!_KZTNB^(-,U^
MRDN].NEEACD:-FZ8(^O8]1[5:MM0LKV-WM;RWG2,X=HI58*??!XH S5\(>'U
MCMHUTN!4M7+P!<@1MG.X<]<]_:GWWA;0M2NY+N[TRWEN)%VO(1@L/0XZUI1W
MEK-*(HKF%Y"GF!5<$E?[V/3WJI-KFGP:Y!HSW"B]GB:58\C[H('/N<G'T- #
M9O#NCW$EE))IT!:RP+;"X\K&"-H'3H*DM-$TVPU"YO[6SCBNKDDS2J.7R<\_
MC6%X4\4W.K76MV^J?9(&T^^-JAC8@-@X_B//(_6NFN+RULX?.N;F&"+^_*X5
M?S/U% &?JOAG1M;NH+K4;%)IX/\ 5R;F4@<\9!&1R>#Q4EQH&DW6DG2IM/@-
MAU\@)A0<YR,=#GO6B"& *D$'D$5PT?B/Q/J'BK6=!L(-)1M/"GSYO,P0P!7@
M=\'GZ4 =!?\ A'P_JEP)[[2;:>54"!F7HHZ >U4=6\#Z5>>&9M$L;*TM(99!
M)N\O.QNA<8/WL9 Y^O'%7M'O-::6]37+>RMTB91#+;R$K)D$G[W(QQ^=:XFB
M9@JR(6(R &&30 D<*1VR08W(J!,-SD8QS63!X1T"VTJXTR+3(197#;I8CDAC
MG/<Y&#TQT[5K^=%OV>:F_IMW#-(\\4;;7E13Z,P% &9H_AC1] 9VTZS$3N-K
M2,[2/CTW,2<>U3ZQHFG:_9"SU.V6X@#API8KAAT((((J]YL>2-ZY49(ST%4-
M3US3='MH;B]NHXXYI5AC.<[F8X _J3V H AB\+Z-!K$6K16>R]BA$"2"1\",
M# &W.#Q[557P-X;71Y=)_LQ#92SFX:-I'/[P@#<"3D' QP15UI]4_P"$CACC
M2T;2'MBS2;_WOFYXP.ZXQ^M:(FC*LPD0A?O'<./K0!GZ)X=TGP[:M;Z391VT
M;'+8)9F/NQ))_.J^N^$="\2O&^K:>EQ)&,+)N9& YXRI!(Y/%;#31(H9I$"M
MT)88-87BG7;[0XM.FLK*.[CN+N."7+D,JL< J!U/^<>@!97PQHR3:;+'8I&V
MF[OL@C9E6/=][Y0<'/OFF1^$M$BNM2N$LL2:DK+=YE<K*&Z_+G ZGH*UWECC
MQYDB)GIN.*?0!SDG@3PU+H\6DOIH:SA<R1H97W*QZD-NW?K3F\#^'&T8Z0=.
M LC*)V197!9Q_$6!W$_4TWQAXAN/#NEI=VD5M,PGCCE25R"%8XR .IR170O+
M''C>ZKGIN.,T 9?_  C>E'7$UG[,WV](O($GG/@IC&TKG:1SW'7GK3M'\.:3
MH#7!TNT%O]H;=(JNQ7/)X!)"CD\# J:ZUBPL]2L].GN%2[O-WD1<Y;:,GZ<#
MO5QI8T8*SJK'H"<9H S;KP[I5[K=MK-Q:![^V39%-O887DX(!P>IZBLC_A6W
MA+R#"-)Q&7\P#[1+\K>WS<?A75TSS8_,\OS$W_W<\_E0!C?\(?H9MM2MS9LT
M>I,K78:>0F0J<CDMD?ABH)_ GARYBL8YK!F%BACMS]HDW*I.=I.[)'L<XJ'7
M?$>IP:_'H>AV5M<7WV0WDAN9=BA-VT*,=6)_SSQL-JG]GZ -2UH1V;10B2Y5
M6WK&<<@$=>?2@#.C\#>'(;$V<6GF.'[1]J4)/(K)+_>5@V5Z=B*NVWAS3+2.
MY6*&4O<QF*6:2XDDE9.?E\QF+ <GH>*TA-'Y2R[U$; $,3@8-/H YX^!_#IT
M2/1SI^;&*7SHXS-(2C^JMNW#\#5:\\#:0GAG5-*TVR6,WR ,TDSDEA]TEB2Q
M"GG'3MW-=2&##*D$=.*,C&<C'2@"GI5A_9NBV6GF0R?9K=(2Y_BVJ!G]*HV7
MA/1M/>R:WMY?]"W?9A)<R2"+<,':&8@<?E5J^GU6+4].CLK**>SD9Q>2O)M,
M( &T@=\G/;MVZUH$@#).!0!SL7@;0(M$N='^S3/8W,YN)HVN9/G?.>3NSV'Y
M#.3S2W/@7PY=W;W4VGDRO$(7*SR*'0+M 8!L'@#KZ5T55+[4[/3?L_VN81_:
M)E@B!YW.W04 9*>"=$BN=)FBBN$.E;OLJBY<A<]CDDD>WX=.*M6'AO3M-UN^
MU>W6;[7>@"8O,S X]B?I],<8J:.YU-M?EMGT]%TM8 T=WYH+-)D979U P3S[
M>]:&1NVY&<9Q0!D:]X:L/$*P&Z:>&>W8M!<VTICEC)ZX8>M10^#M#BTRZL)+
M0W$=YC[3)<2-)),0, LY.<CMC&.V*W:* .=\/^"M&\.3&XM$GEN""!-<2F1E
M4_PKV _#-8?Q-M)[P^'EAL[ZXCBU%99S:0R.R1C&XY09!YX[^G2N^HH YV+P
M?I,MI?"87-Q)J,7ESSW,C&;8>0H)^Z!Z8[<YJK9_#S1;.\L+M)M1>YL5*1RR
M7KDE<$!3SP!GHN!ZYKK** .8M? .AVV@WVC%+B>TO)C/()I2S*_'*GL>!SU]
M<TFF^ M(TW4[34?.O[J[M$*12W5TTA4'MCI@#( Z<GOBNHK-UV[U&QTJ2?2M
M/%_=AE"P&0)D$@$Y]A0 NMZ)9>(-,>POXRT3$,K*<-&PZ,I[$51L/"5C97$E
MT]U?W=XT!MUNKFX+21QG^%2,8]<XSGO6Z"WEY*_-C.W/?TK#\*>(9O$=A<W$
M^GFR>WNGMF3SA("5QDY '>@"QX=\/6GAG3/[/LI;F2'>SC[1)O()Z@<# SS^
M)JKXC\&:3XGE@GO1/%<P<1W%M)L<#TSTQ^%=!7.:QXHDT?Q1HVD2:>7@U,LB
MW(E VLO4;<<]5YR.M #YO!>BS:&NE"!XXDD$R3)(?.67KY@<\[N.OX=*6V\(
M6$ NGEN;ZZNKF V[75Q<%I5C/\*D8 '?IR>N:WZPKKQ$]MXRL- %@[I=V[S_
M &H2#";<\%>O8<^X]Z *#_#[2G\.VFA_:]16UM)O/B9;C#[LD]<8P"<CCBM"
M7PM9RZ_+K/VJ]6ZDM3:$+-\H3VXSG//7KS6Y10!R;_#_ $QO#=KH*WVI)96T
MQF39. V[.1D[>@)) ]>:O7/A'3;O7SK%PUQ),UJ;1XF<>6\9!!##'/7UZUO4
M4 <II?P^T?2;R&>.:_GBMV+V]K<7!DAA;.054]QV)SZ]>:;'\/=+CTK4].%Y
MJ)@U*433YF&=V<G!V]^_7.!76T4 <QJ'@;3M0N+:Z^V:E:WD, MVN;6Y\N29
M!C&\@<]/;K]*74_ ND:E!IT9DO+:33P1!<6TY64 ]<MR3D\Y]2?4UTU% &;H
MVB6FAVK0VS32/(V^6>XD,DLK=,LQZ\<55;PO:GQ8?$"SW"3O;^1-"K#RY1T&
MX$=OZ#\=RH+F\M[/ROM$JQ^=(L4>[^)VZ 4 <LOPZTU%^R+?ZB-(W^9_9@F_
M<D[MV.F=OMG\:ZN:WBGM9+:1 89$,;*.,J1@CCVK&M?$RW/C6]\.&S='MK9;
MCSRX(<$@8 [?>'Z\>N]0!R&E_#^STWR8)-1OKO3K=_,@L)W!B1LD@D ?-@G/
M/>G7WP_L+O6)M0@U#4[ 7!W7,%G<F-)F]3COZUT]W>6UA:R75W.D,$8R\DC8
M J8$$9!R#0!!''!862QQH([>"/"JH^ZH%>4?#K0X?$'AZ>UN-3ODMTO&DN-/
M7"I*IP5W$KG!VG(!YQVKTK3M5FNX]0>\T^:Q6TG:-3*<^:@ .\8['-4-#\3W
M6NW<3Q:)<Q:5/$9(+YY4(;!Q@H#E<]N_M0!3U+X?66HZK?W@U+4+:*_A6*XM
MK>0*CA1@=0>,=OK38?A_##)H3_VSJ+G1\^0'*$$$]/N\#  ^@%=7]K@^U/:B
M5#<I&)3$#\VTD@''ID$5F^&O$$7B72C?PVL]LHE>(I,!G*G!Z$\9X_"@#%N?
MAW9RRZ@EMJNHV=C?EWGLH)%$9=NI (. ?2NETC3(=%TFVTVW>5X;=-B-*P+8
M[ D =.E7:* ,EO#NGOXH3Q T>;U+?R!P,8S][IG=CC/I3--\-V>B:/<Z?I)>
MS\]GD\Y<,RNW<9&.. !CL*J:IXP@L]9_L73[*XU/5-N]X+? 6(8X+N3A>WYU
M/J7B5+#4;32XK&XO-3N(S+]F@*_NT'5F9B% SQUH QS\.+5O"</A]]4O6B@N
MOM4,N%W(W/ XZ98GZFM"V\'K;>)HM<.KW\TZ6OV7;*5.5]2<=<\_6M#0-?M?
M$.GO=6R21M%*T,T,F-\4BGE3CBM6@#B3\.HF\,WNAOK5])!>7(N99'"LQ.<D
M9([L 2>O%:D?A0)X@TW5SJ5RTMC9_9!'A0L@P06/'4D@\<<"K.E>(H=5UK5]
M+6UGAFTQT61I0,/OW$%<'IA<_B*V: ,+PMX8B\+6EU;0WDUPEQ<-<'S54%6(
M /0#T%1:IX36]U^/6['4KG3=0$)@DD@56$J=@RL"#C_#T%=%10!RJ> ]-C\-
MQ:3'-<))%/\ :DO%;$HGS_K/3/;Z5=T;PRFF:K=:K<WT]_J-R@C:>8*NU!CY
M0J@ #(STK=HH PO$7A>W\0/:7'VJXLKZT8M!=6S8= >H]"#Q64OP\MGMM8BN
M]7U&Z?5(HXYI)77(*8PV,8SP/PXKLJS['5#>ZCJ%H;*Z@^QNJ^;,F%FR,Y0]
MQ0!S</@J/1M0M]?EUW5[J>P@99-[!_-B SLV@9_#N:@\,0VOB+QE>^+X;&:*
MW-LEO;/<1!&=\L'8<]@%7/N1V-=W5#6M5CT31KK4I8)IH[="[)"N6(_SR?:@
M##U/P0NJQZC;7&JW7V&_N4N);?8IVE<<*Q&0#@9^GUSU*(L4:QHH5% 50.P%
M5]-ODU/2K._B5DCNH$F56Z@,H(!]^:M4 %%%% !1110 4444 %%%% !1110
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MH-1WWA?1M2NI[F[L]\UQ$(9F$KKYB#HI (!'%:D,,=O!'#"BI%&H1$48"@#
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MNYHRMH+7[,JKLV#&!TSC@<>O?M3;?P=;1ZUK6H7%Y<70U:+R9H9-H4)MVXX
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MDMK;7OQ6TN[E@S(VA^>"QR0V\ '@XR 3[4 =_5>^O[73+*6\O9T@MHAEY'.
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MBL/";W#V%P;:8+?H/G!(.,@9''ZBND\/ZM>:O:3R7VE2Z;/#.83#(X?. IW
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M3N9Y+:Q>YGNUF-JTYW;5^<!R< ],<GDF@#M=;U2;2;!;F#3KB_<RI'Y-N,L
M3@M^%:5>5:S?>*/#OP\VW^I,-2AU-(UE282/Y1^90S=R>>HY%;GB>XN= \:Z
M)K$VIW::-<.UM<V_F$Q(Y0A&V^A/7Z9H [FBO+;S5=:M-'TN!;J\:X\0ZFSQ
M[Y\-%;%LJBOCY"5*]CC)Z&NE\'67B.QO-376&E-E(RO:+/=_:)$X^8%N..E
M'6T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#)&&5<<# -26&FV.EV_V>PM(+6'.=D*!1G\*R]7\01CPUJ=_HEY9W=Q:0/(
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MDG+'OU/YU%J^AZ9KML+?5+**YC&=N\<KGN".0?H:BTN>_,NIMJ-U8/%'<-Y
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MP,]C-Y>]%& IX/;BC4_ >EZC;Z<B7%]:7&G@B"ZMY\38/)RQSG)Y_/UKJ:*
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M= NKB.XN-(M)I8XQ$K21AL(!@#GT%)'X2T"$6GEZ3:I]D<O 53!C8G.1^(%
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M$V2MYCJ''3) (&??&?>I;?PGHEI>V%Y!9;+BPA-O;.)7^2/!&,9P?O'KD\T
M>7Z5=EO!D&F7ES(NEMXC:QE^<C;;[=P3=U W?SKJ]*TO3=&^+D]MIMO%;1OH
M@=HT/&_SO3Z 5T*>"_#Z:1=:4-.!LKJ7SI8VE=LOQ\P);(/ Z$4FE^"O#VC:
MBNH6.GB.[5"BRM,\A /7[S'GMGKCB@#G?BQ"LNGZ!N+C.K11G:[+P0V>AZ\=
M>H[5G7&GV?@_QA>6>F"ZM-)GT26XO/)F9FBVD@2)N).[@ ?[U;7Q,TN^U;3M
M)@LK*XNO*U!)Y1 <%44$'G((//&*WK7POHT-M=HEF["_CV7#7$TDDCH1C:6=
MBP&.V: .(T**VT[Q=X3.GPBSM[_3)#*GFDO,0,J9.Q/.<^I(Z 5B1:E=:;X(
M\21VLLT:'7VMI)O-.8XF(W')S],]><UZ19^ /#&GW-K<6VEA)K5]\+F:1BI_
M%CD>QXJQ;>#]!M+*^LH['-M?/ON8Y)GD$C>OS,<'W% '&KHVFZ)\7] M]+MH
MX(6T^1B$.=QPXR3W.!UK:^*P(^'>HR*[JR-$04<KUD52#@\C!/!XK3L? WAS
M3;VWO+73MMS;DF*1II'*Y_WF.?QZ5I:QHMAK^GFPU.%IK5F#-&)63)'3)4@G
MZ4 >>:U80:IX[\(:?>&9[2YTV19HEG=%8",M_"1CD#..N!GI6S\-3#;1^(M*
M@#K%8ZQ.D2LQ8)'P%4$DG^$_G70#PIHPO].OA:N+G3H5@M7^T2?NT ( QNP>
M#@DYSWJ?2M!TW1'NWT^W,37<IFG9I7<NYZGYB?6@#B_%D&F:MXNO;6=)[N:T
MT624PNV(8#R0X&>7.0.G3!S6]\.KJ>\\ :1-<RM+*8F4NW4A791^@%6M2\&>
M']7U3^TK[3Q+=E0A?S74,HZ J& /XBKVCZ+I^@:>+'3(#!;!BP0R,^">O+$F
M@#@;\9;XG=>(8CP<=(#6?.6-I\,+K>_GF6.,OO.2IV9!KTBW\,Z3:WM_>1VS
M&?4%VW323.XE'H0S$>W X'%9UM\/?"]I+#)!IA5X)%EB8W$I*,O3&6X'MTH
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M;CB@#O[;5-/O9&2UOK:=U&YEBF5B!ZG!Z41:KIT]PMO%?VLDSYVQI,I8XSG
MSGC!S]*\RTC5+67Q]X76*:R$<VC&"6.%PRH.66,DDG<,*#GD\^M6_A1I^E1^
M'[C5YK>W2YMKJX7[20 4CPN>?3 _#GU- 'IM%06=Y;:A:1W=I,DUO*,I(AR&
M'M4] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUU-% $4]M!=6SVT\,<L#KM:)U!5AZ$>E5+;0M)L[.>TMM,M(;:<$311PJJR
MC!W #!XK0HH S8O#VBP-;M%I-BAMB3 5@4>7GKMXXJ2VT;2[.UGM;73[6&WG
MSYT4<2JLF1@[@!SD<5>HH BM;6WLK:.VM88X((QA(XU"JH]@*EHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BHI[F"UC\RXFCA3.-TC!1GZF
MGQR)-&LD3JZ,,JRG((]C0 ZBH;BZM[10US<10J3@&1PH)_&I$=)(UDC971AE
M64Y!'J#0 ZBBB@ HHJI)JNG12-')?VJ.IPRM,H(/N,T 6Z*C6XA=U19HV=D\
MQ5# DKZCV]ZDH **** "BBB@ HHHH **9++'!$TLTB1QKU9V  _$T1317$2R
MPR))&W1T8$'\10 ^BH9[RUM61;BYAB9_NB1PI;Z9ZU-0 4444 %%%% !1135
MD1RP5U8H=K '.#C.#^!'YT .HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MAD26XMU4R1*PW+N!*@^F<4 6**S]%O[K4M+CNKS3I-/G<L&MI6W,N&('.!U
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M%Q*A1@RXSP?8C\Z -6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/%&]RVV,@Y 4#  Y^OO6N?#%E_PDDVN)/=Q7,T0CE2.<K&^!@,5'4@?AQTH
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MJ*69@JJ,DDX %"L&4,I!!&01WKR?4'N9?"?CO2+K4[R[73Y$,4D[ OMPK8+
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M/^W21>2<RG8%P!@+T X_.KVJ:=!J^F7&GW)D$%PFQ_+?:V.XS5NLX7FH?\)
M;,Z=C3A;^8+WS1R^<;-F,].<T 9D_@?2+C1M/THM>);6#^9!Y=PP8-G()/<C
MMZ=JZ-1M4#).!C)K!UOQ1#IWA>\UNPB&H);,59$?:,JVULG'8Y_*MR&3S8(Y
M,8WJ&QZ9% '.-X#T5M*O]-/VO[)>R"22/[2Q"D-OPHS@#//O5D^$]-;5=,U)
MVN7N--@\BW)E.-N".1W)!Y]:W:* .5M/AYX>L;M9K>"X6)9A.MK]I<PB08PV
MS.">!UK;UG2+?7-,ET^Z>98)>'\F0H6'IGTJ>\O[33XDDO+B.!'D6)3(V-S,
M< #WJ<D*I)( '))H Y)?AWI26J6J7^L+;HNQ8EOW"A?3'I6G:^$]*L[R&YB2
M3=#9?8$0N=HBSG&/7CK6/%XTU+61+-X9\/OJ-G'(8_M,URMNKD==@()(K3\.
M>)9=<N]2M+C2Y]/N;!T22.5PV=P)!!';CKWS0!5'P]T :"-&:.X>T2;SX@T[
M;H7_ -@]N_'O4Z>!M#&EWMA+#-<+>[?M$L\[/*Y7[IW$Y^7M71T4 <]I?@O1
M])BFCC2>X$L'V8_:IFDVQ$8*+G[JGT'M52U^'6@6KVS 7LBVLRS6\<MV[)$R
MG(VKG%=910!CP^&[*WU:^U&WDNHIKX8G5)CL8XQNV]CCO4VAZ)9^']*CTVQ\
MW[-&25$C[B,G)Y]*TJ* ,NP\.Z9IVB/H]O; 6+AP\3'.X.3D?K69I/@+1='G
MMY(?M<JVQW017%PSQQ-_>5#P#R>?<UT]8'BGQ*?#4>GR?8FN4N[M+9F#A?++
M=SQSW_*@#6U"QAU/3KFPN0Q@N(VBD"G!VD8.#5"T\-V=K?6MZ\MS<SVD)@MV
MN)-WEJ<9QP,DX')R:V** ,;Q!X8TWQ+';+?I*'MI/,AEAD*.C>Q'T'Y"J,O@
M32GT2]TQ);Q1?%3<W#3EY90OW06;/ Z8KIZ* ,.;PO:3:CHM[]HNA)I*E(1Y
MF0P*[3N]21C)[XKD?''AF/2?!GB::UFO+JXU:>&4QM\^&$BD[0!Z9_  5Z51
M0!R_A_P_:NNFZQ/<WMU/%;A;87+$" % IVK@<\'D\G-36G@W3X-/U:QN)KF\
MM]4G::=9WZ,<=,8P> <^P]*Z*B@#F=/\'V]AJ$>H7>HZCJ<ML&-JMU+O$&1@
M[0.IQQDYK/TP+XJ\8VVOG2+VRATZWD@1KV(1O+(S8X&3PHW<^K>U=M10!A2^
M&(Y?&$/B,W]T)HH3 L *^7M.<CIGJ<]>M9B?#VTCT/5M*34[X1:G<>?*^5W
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MVVF_$;2H9)8[*R:*6WC61AY;-DG!SG'RCCI7HLG@O0Y7TIGMI"VE "T/GO\
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MP_\ V ^BI9O'8M/]HV+*V1)Z@YR.E;]M;I:6L5O&TC)&H4&1R[$#U8\D^YH
MX_X4W-O-\/=/BAE1Y(?,655/*,78@'\"#5WQG<V,6C21O?SVLLUQ#$S6(S.Y
M)R$&"""0#R3TI+GX?Z'+?R7ML+S3[B5MTKV-R\/F=R" <8)],4^;P#X=GTB;
M37LW\J:43R2><QD:09PQ<DDD9/7UH Y+73<PV/C^QMKB[9+>.UDAC,SNT89
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M\%:?/J%Y>V]UJ%C->@"Y^R7&P2^Y!!P?<8J5_"&EF^TBZB,\']DJ4M8H9,(
M1@Y&.<CKSSWH YCP;J^H6%MXEM!'?ZN-/U1X+=#('F*9(Y9B.!MS^)J+QQJ^
MI7FBZ--Y&I:++)J\=NR><%=D*DD_(2,?7TKLM&\-6>A7VHW5I+<LVH3&:997
M#+O)))'&>]-\2>%[+Q1;VT-]-=1I;R^<GV>0(=^, YP>G/YT <=>V&H)XCC\
M+6EQ?W$%O9/>(]QJ3PO,[.%_UB@DA03@$8ZU%>V&OZ?X9T"QU37)TO/[9CMV
MFM;DD^4X) 9B 21CO78^(?!VF>)+FUNKIKF"[MN(KBUE\MP.N,_7FJUWX!T>
M[T>WTPR7D<$,_P!I++-EY)?[[,P.30!R%W?:KX.O?%EK;ZC=7,$%A%<6INY3
M*Z,Y"$Y/H2QQTX%:V@Z-XEMM:TZ^:[B&GRP;;K?J4MQ]H++G>@884YZ8-=&_
MA#3)=;O]5F-Q++?VWV6XB>3]VR8 Z8ZX7KGN:JZ-X"TG1+J">&>_N!;DF"*Y
MN"\<1.1E5Z \GF@#@]1N]0M- U_PU_:%^^M66H":S*W3&:>$@OUZX$:L2!WQ
MZC/4Z5JW]O\ F:U:ZA-;6-EI 1I2Q=$G9=S%EZ,8QMS[G%=2=!TYM?.M& &]
M:W^SECT*9ST]>WTJ"#PKI-MX>N=#@MS%8W/F>8JG!^<G)S[=![ 4 <3HEQ=6
MWB;P?]GO]1GM-0MKE)I+N1L7)52X<(Q.T9((/7&!70> 2,^*!GD:_=<?]\T6
MGPXTFRN["ZBO]6,]B?W#/=EMJX V $8"X&,#'!/M6SHGARST&:_EM9)WDOYS
M<3-,P.7.<XP!ZT <[?3RZ_\ $B3P]<W%U;V%G8BY5;:=HFFD) RS+@X /0'J
M*YW5)KRW\'^-]$OKR>]BTQXA;RR2'S-KX*AF_BQQ]>:[_6/"]IJ^I6VI?:+J
MSO[9&CCN+5PK;3V.0<CV]S4$W@K3)M"U#2S)<?\ $P?S+JY+ RRMG().,<8'
M % %OPM;+;^&=.VO*^^UB8^9(7Q\@X&>@]JXWPLA?Q%X_E>69V24H-TA(QM?
M''M@ >@KT*PLTT_3[>RC=WC@C6-6D.6( P,UBCPA:IKVIZI#>W<!U&+RYX(F
M58R=NW?C'WN^?6@#S[1VN=+\'>#M7M]<O-LE_':2PF0" 1M(VX%<=MN,D_E7
M30:CK$_Q!\5Z9;7CN(;!&LXI&^1)61<?J:NM\/-.;PQ8:";V\^S65Q]H1@5W
M%LDX/R]/F/YU=?P=9OK6KZHUW=>=J=K]EE4,H"KMVY&!UP!B@##\$ZPD^JK8
M:C<ZI;Z[%;>5<V=V[-'*RGF1"<CWXQP>XKK?$&K+HFAW5^P+-&N(T R7D)PB
M@=\L0*H:;X42TU2VU*\OY]0NK6#[/;/,B+Y:GK]T#)([GW]:E\1^&H_$8L5E
MO;FW6TN!.%A(P[#IN!!SCM]: /.8FF\(:]H>M2:=J$ N%^QZK+<HBK(\C;C)
MN5CSN)//90,UV'B_4IK/Q!H=M<7EU9:5<F599[?Y3YNWY%9AR!U/X>E;7B?P
M[;^*=$DTNYFDAC=E??&!N!!SW%</XMVZ7XAT2VO-3UBSM+.R<PZA GF&24D+
MM8!<<*.N.XH KR7VMVGPKU;4Y-:OEN!=YM9YSAFC#A5VY .&'-:>HC5=,U31
M]!AUF_N7U6:6YFGDF6.0*J#Y$;&%&>< 4MCH=QXOT/5=.U#4M4FTN26%[6ZN
MH!%*V!EL*5'RYQR1ZXKHM<\(6VOZ796US>727-D0T-[$P64,!@G(&.?:@#C]
M1N_%GA_3X]-O;MY)-1U>*"SF$^Z186/S*7V\'[HS@]6]JV["T\4Z<VOQW%Z3
M:-:,^GO/.)I4D"D$DX' ."1C'(]ZMOX T^;P])I5S>ZA<R/(LPO)IRTRR*,*
M0>P&3Q[FG6'@B.SM+R.76=3N[FYMVMEN;B;<T*,,'9Q@$X&3WP* .+&IZ[!H
M_@O44U^^,^J7*6TZOL9-K-C(4KU /4YJS?\ B;5O#6I>,+);VXO4M+>&6U>Y
M(9HGDVKGH!@%\_\  :Z67P!;2Z/HFG?VG=JND3>=!(JIN8@Y&>.U6+CP/97>
MMZMJ,]U<.NJ6_P!GG@PH4*  "#C((P#0!G:-I_BFS\2V4KWDT^D2VI%P;F[6
M4B3!(*  =\>O&:Y%M6\0V'A"#Q)+XAO+B2'4S ;?"K&Z!R"#QDYP?IFN]T/P
M/%HUU!,VL:G>K:JRVL5Q*"D.01D#')P<#T%57^'-K)X5.@2:I>/";LW7FD)N
MR>W3&,Y/XT 5M-MT;XQZV[7EP'2SA=81(0K C!R.X&1@>K5;^),,LWA^S\J?
MR=NHVV2$#$Y< 8STP2#^&.]:$GA.(^+E\10ZA=0W!B6*:--NV95_O9'? Z8Z
M5>\0:)%X@THV,L\L'[Q)5EBQN5E8$'D8ZB@#F(1K.C^-8=%GUJYO;/5;25TE
MEVB2WD3DE<#&,$<8_ESCZ1J>L7FB2^'9M7N5UY-7%L\V?G6(?,6'MM5OQ(]:
M[&/1H=)NI_$&I7=UJ5W!;E%D:)<QQCDA%11R?S-9'AF*T\1>+[KQA;V4]O";
M9;6(SQ;&E;/S/U/0!5S]: -_Q8&'@S62DLD;I8S,'1L-D(3U_"O._LTO_"LO
M!B17<JRS:M:E)7P_E$E@, \8'7!KU:_LXM1TZYLI\^5<1/"^#@[6!!_0URR^
M (UT33M+_MF^,6GW2W,#$)E2OW1]WH#D_C0!D7.JZQX2O?$-N^J3:FD&F+?0
M&Z S&Y<ICCJ.,X__ %U/H5OXOC\0Z;=%KR72IH!]L%[=1N-Q7.Y O(YQQCVZ
M<UO7W@^VU+6-1OKJ[N'CO[06<EOA0JH.FTXR#G)^IJ+2/!O]ES6OFZUJ-[;6
MG-O;3N-B$# / !. 3@'B@#J**** "BBB@ HHHH **** "BBB@ HHHH ****
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M6V@2:9V9H$ \SY8\$D=?J:[/QK8R:GX2OK*&YBMY9O+5&E.%9MZX0_[WW?\
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M]:0RAXY# T<CJ#@;^,]@2,XKQ-=-MK;PYX%U*!9(KV\O8H)YTE<.\98@KG/
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M*QBN"D"JV&^7(!(SU)YH ]&HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$GE2RZ^86FS@1*P4$D]O3(Y&:]"TWPGINF3V\ZFYN)+9/+MS=3M)Y*XQ\@/
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MX?\ T 5I54TO3H=)TRWL+=I6A@38AE<NV/J:MT %%%% !1110 4444 %%%%
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MI&^/>HYD#8!&>_:N<T72X_$?AM]1U+Q!96-];7DD]Q*;8-<1.K$_?+Y(QC
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M0PBUMGT+SFMD(VJX4#MQG#'IUK+CT>'2/#'A#Q!ITT\>IRSVT;*9I'$RN,%
MN2!QS@8& : /9**\QTO2+'Q-9^*[K5A++J$=Y-$"S,K0(@^0)Z#O[UE31WEW
M\.O#GBZZ6:2_TJ9'EY8&:W64]<]> IS[F@#V.BO)M<EW:%=:_:2""'7M5@@,
MC;@!;#*Y.#P&*DG&,@_ETGA[09= \5WEP=3LDL;V#=%90!E'R;1Y@!)QP>3D
M_>H [6BFHZR('1@RGH5.0:\C\9MI]S8>+=3M)+JXO+&:WC^TR/@6[B508XAU
M ZY/J: /7J*\UN=)M?$WQ&6._,_DSZ#'<O%'<.BE_,QV/3H<>HS6!87U[_PB
M7AG1+BZDDM;S5Y+2Y<2$%XE?&P-U .?TH ]&M/$\ESX[OO#;60C6VM1<+<>9
MDODJ,;<<?>/?M71UYOH&G6FE_&?5K>RA6&'^RU;8I. 2T><5/\2$>?6?"=JM
MS<P1W%_Y4GD3,A(.T=N^">?>@#T&BO'[BZE\*7?CK3-'\R.&"T@FAW2.[1LR
MJ&().<_.3GV'I5S6M.M/#>C^'=?\/M<->S74$32&5W-TD@+,'!/))_$?@* /
M2K74;.]N+F"VN$EDM7$<RJ<[&QG!]ZM5YCX3T2/4KKQ[!(CQ7$]_/"L@)5@K
M$D?AT-<RNK.FC:#,EO<37GABX<:F@9@$3S O.<9)ZCTP<]* /9M7NKRRTJ>X
MT^Q-]=( 8[<2!-_([GIQD_A3QJ,"26=O<R1P7ETI,=NSC<2%W,!ZX&:\]OXW
MNO _BWQ!%=7:+J#^;;,)67$,9 0@=@V"?<$"DU&WBNOB9X(>=/,9[%V9F)R2
ML;,#GV/- '8Z'XA?5]9UO3WLS;_V9.L09FR9 03NQCCIQUX-;M>5OI4&M:SX
M^GEEO8'MBAB$<SQ898CAB <-RH(SGBDU%]0O/#/AC5KFPDUFQBL=U];I*1)E
M@H$@4=2/FY^O3K0!Z?)=V\-S!;23(L\^?*C)^9\#)P/85-7F,46E:MXO\%7=
MI)<3VS6-P(Y)I&\P[!QN/J"6SZU5\5W1CTCQ3J&FZKJ$ES;7L0\QY2D<!! ,
M2#=\W7GC!!'6@#UBBO-+JU;7/BG+I=Y>WPL9=(69X(KEXU+9 Z ^_2J.F:I?
M7'A'PIIL]W=-%J5_-;W,_F$.T:.V$WYR,X X[ \B@#NK3Q%+<^+=1T*33WA-
MK;K/',SY$P)QD#'3M]0?2M'2+N[O=+@N+^Q:QNG'[RW9P^PY]1UK@-!TV*Q^
M)GBC3[:6X2)=.C5':9GD3*KT9B3QGCTK'M;W4[_X4Z+,VK7T=P^K)"TR3'>R
MERN">IQG]* /9:*\XT(7^D^/==T"SU"ZN84TU9X/MTYE*R\8Y/0?-S7.:%:Z
MGJ__  C+6UWKGVDW$G]JRM/,(MJMD88_+TX^6@#VJBLGQ/<0VOAG49;B^>QB
M$#*;F-2S19X# #DG)%<5IEU-;>/-(T^UFOTL[_1BS"ZF9GW#=B0@D@-\OZT
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M(3DJ&4-C]: +=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
MC*&4JP!4C!!Z&EHH \.TK3] _P"%>^+Y[RUL!=0WMQ';NZ+YB':OEJIZCYLX
M ]_>M_3M,LKSXA:9::[!:7ES_P ([&9$FB#9F#]U(^\$]>U:_@?PA)IGVZ36
M](LC=/>/=03_ "RL@< ;0<9&,?K78-I6GMJ(U%K&V-Z!M%P8E\P#TW8S0!Y]
MX5ATHZAXPL-=BM!-%<LS"95&VUV;5VYZ*J@=.!D>M9ZZ5=3_  ?T[4T4?;=(
MD:\LGW?,(ED)Y)_V1D#T"_2O3;W1-)U*9)K[3+.YE3[KS0*[+]"15WRT\KRM
MB^7MV[<<8],>E 'GJ+#J7@?Q+XEOK>&%M6M7=%DQ\L:1[8@3DC)(S]2*KS0-
M=Z3X1GT2]L!JNGZ?Y\=K<#,<R%%5\D< @C'USZ5Z%/IMC=6 L+BSMY;,!5$#
MQAD '0;3QQ@8JK+X:T*>"&"71M/DA@!$2-;(50$Y.!CCF@#S#5]1L]2\->!]
M0BLHK%$U=4\L,"L8#_-AO[I*Y_*NDT?^S[OXA^*;+5X();H^5Y N55MT&SE5
M![9Y/UKKYM!T>Y@MH)]+LI8K88@1X%*Q#C[H(XZ#IZ4M_HFE:JZ/J.FV=VR#
M"M/ KE1[9% 'D.FZ?!+X=T2/4H(FL6\3,EMYV"IMRAX!/\)9?QP/:NN\(+'8
M_$7Q;IEG##;V48MW2&*,*JL4&< =*[*?1],NEMEN-.M)5M?^/</"K"+I]W(^
M7H.GH*=;:786=U/=6ME;PW%P<S2QQ!6D.<Y8@9/)[T <5\0D3_A)_!4A5=XU
M-1NQSC<G%8]YI>BW^L_$62YALVD@@1HY6C#F$^22S*.H.X<D<YKTN\T?3-0N
M(KB]TZUN9HO]7)-"KLG.>"1QS2#1M+#W;C3K0/> K<MY*YF!ZA^/F_&@#,\"
M,6\":(223]D3DGVKSG7=1TF70]:%K%8V4D>LJP62</<RR+* \G)RJ^F,X&:]
MAM+.VL+5+:SMXK>W3.R*) JKDY. ..I-49/#>A2RSR2:-I[R3\RLULA,G.?F
M..>: .,O-+TG4_B;K+7-I:W>W1TD_>*' ?. <'H=NW\*R-*TB37?@M8W$9+7
M^F/)<VAVYY21CMQW! QCUQ7IRZ%I"2O*NEV8D>'R'<0+EH\ ;"<?=P ,=,"L
M?6=.U:PL8;#PAI^E6T,S.+DR)L6,$ ;E5<9/7UZ"@"OX+F;Q#-<>*[BW,;7,
M<=M;*Z#*QH,L0>N#(S]>RCVJ'Q=<:,OB[P]%J(B\]1-)&]W*%MT7 R6!^\W'
MRC(YY["NIT?3(M&T:STV YCMH5B#8 W8')..Y//XTFH:-I>JF,ZCIUI=F/.P
MSPJ^W/7&1Q0!XQ";"]^'<T4R6Q@M/$82/! "Q,P)/7H0S#TP/:NJUK2=*TWQ
MD(])M(;?SM%NS=Q6Z[4*8 0LHXZ@_4BM/QOX;>70DM=!T"WG>:]CGN8XO+A#
MA222V<!L]/QK=?0[*ST._32M(MK2>YMF4Q01)&68J<*2..I]<4 >3C2-/C^#
MFE:E:6MO'KCW*B"X7"RL_GD 9[\#\,5Z!I\D,OQ+U:VEDC:4Z5 LD>X9SEMP
MQ]&'YCUJ/P#X2BTSP_8?VOH=K#JUJ7 F8)(_+$AMPS@X..O:NF.@:0=0FOSI
MMK]KF0QRR^4-SJ>H/KGI0!XYHEQ#:>"=*2\7.D/X@9+M"<(5P-H?U4'!(/!Q
M75:RW@K3-.\27EC/Y@N;2-;JWT^0"+EBJX*J55F)(.<GJ<<G/;6WAS1;/3'T
MR#3+5;*1MSP&,,K'.<D'KV_*B'PYHT&DRZ5%IELEC+GS( @VMGN??WZT <!I
M<L,'Q#FM[);2*";P^KR1VF/+W#E<>N%(Y[BL-- TV'X.6>L6D8.MJZ&WN(W(
ME$C3@;%P>3@GCZFO6+/PMH.GW%O<6FD6<,UNA2*1(@&4$8//?OR>>3ZFFVGA
M30;"[-S;:5;QR[S(#MR%<]64'A3[C% '':W<WT7C75);7RSJ,7A8Y5&P%D\T
MDXYXQG(Y]*S?#&DZ"R^'-33Q):Q7J>5B"VABCFE=L I(5^=LG@Y]R>YKTM=!
MTM-:;6%LHQJ#+L:<9R1C&/2H;+POH6FZB^H66E6L%V_66., CUQZ9[XZT <_
M\4KJ>W\,VR))Y5M<7T45W)L#!8CDDD'@C(&0>M<[>65CH%CXBU/0=?M+FZET
M]A]CL8XT2-=Z@R;8SC*AN">>3DFO4[JUM[ZUEM;J%)H)5*O&XR&![&LW3?"N
M@Z1'/'8:5;0K.I27Y-Q=3U4DYX]NE 'FU_I^DV,WPZN-.M[6&YGN(3+)" &D
MR$R6(Y/)/7UJ];QZ<ND?$B*58 1<3-L?& ?+)0X/&=V<=\U8U_P2++Q#H$WA
MOPV@@M;M;FZFBDC4D!A\HWL"> 3Z5V5UX2\/WNI/J-SI-K+=NI5I'3.X$8Y'
M0G'>@#AKN.T,_P ,YXF3?P@V8P1Y:9Y]C_,U<\,:=8WGC7QU:SVEN4ED1"P
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M9P 1G%=@G@O04L]4M!99AU-]]R&<G<>H(R>,'D>]16G@+PU8R0R0::@>*!H
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M=N,#H!C@$U'/X TV>#2$%[J<,VEQ^5!<PW&R4IC&TL!TQQQCB@#AX]6U>_\
M *K_ &O?0S1:^+);B.9O,,9(X9B<G&[U["NB\-&]TWXFZMHCZMJ%]9I8I.HO
M9_,(8E>G  ^\>@JV/ACI*:?)8QZGJ\<#W8O,+<K\L@!QC*_3D\\#FMF#PK9V
M_BN7Q$EU>&[EA$#QM(/+*@ =,9[ ]>M &[1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB.^0OX#TKNKBW@NX&@N88YHF^]'(H93]0:BM=.L;&-X[2SM[>-_OK%$J!OJ
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MI6VFA+@2&1?WCE Q[A,[1[<<5-_PAVB8U0?9Y<:J<WG^D2?O.<^O'4],<<4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MT??!.@=#WP1G!]Z\IFMK:SO/B5IMM;PQ626:2I"B *K>7G(';GFO1_"8MO\
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M/]XOTYX7G&<51L]%D\6QZUJM[K%GI]W!J,B^?/$YGM%1@557,BA5'3[OKSZ
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M_<_-R>G/7BO3H+B"ZA$UO-'-$>CQL&!_$4DUS!;J6GFCB !8EV"X ZGGMR*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M>*O>QO\ #S5K.,S&XT_63/=0QY$BQ>=G</\ /!%;=K=>$;J[U#4-+NK^^OSI
MDWG7,\KE88PO1RV.<\#&>AKTQ(HXV=D15,C;G(&-QP!D^IP /PIRJJ#"J%&2
M< 8Y)R: /)]%?3?^%"W$DGV<R):7$3-@%@YD8HI[YR5/Y&BZN=/&J?#28W,
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M,2?;&?P%>T>5'Y7E;%\O;MV8XQZ8]*J6FCZ;8"46FGVL FSY@CB5=^?7 YH
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M03UXH \TT&#1]3\&>*/[0BAFU%)[IKEI_P#6 C)0Y/( P,>X-4=)TBSU+4?
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M-$'_ +'"OVW,/F//?"D?E[5R>G7EG:_"WPM)(Z!H]<1GP,L LC,>GL0<>XH
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M/QR[6[M#X OA+<PRPQ>)E<\[@(B5.<?W3\W;GF@#V.XU_1[2S@O+G4[2*VG
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M/L[!<@8)]3GIZ5XW>:)I)^'GB+4K>&U2^M]6D5)MWS(@D7"KZ<'@5V-N8?\
MA=$4LI3YM%4QN^.6+ <'UZT =SJ^IV^BZ1=:E=$B&WC,C8ZG'0#W)X_&L>V\
M5+9Z;ILWB%H+*ZU.7%O;HV=JDC:&8G&0",G@9.*S?BH+@^$8C"6$2WT!N,'
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MXUCU6V2_M-'>P>4I(]JTGF(N"0V&XZ@#OUK$^*\MO:Z'HUL',!;4XV00G8P
M#;BIQ@$;A^=7X=*TOPUXBAU677[R=[@?8E@NI_.+22.N"OIRN#Q_*@#K/M]G
MM9OM<&U2 3Y@P"?Q]C5:37=-BUJ/2'NXQ?21&819_AR!U]R>!WYKRO6-/TG2
MO'9E%H3X8FNXEOL(IA6Z"OM'<X&\D@<9)':NKU*VMO\ A:EG*]O:,YTES"9
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MG;:O'?(\BS^3$@5;?=D8'S'@XZ9XQ[T =71110 4444 %%%% !1110 4444
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M QQ2G2=-,<T9T^T*3MNE7R5Q(<YRPQR<^M7** *<ND:9/!%!-IUI)#",1QO
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MY10!C?\ ")Z +&YLAI5N+:YD$LT87 =@<@FII?#VD3SV,TNGP/+8 +;.5YB
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MW)Z\]ZT_'MS9)JO@N>$HD#:BESN5< IE"6/YBMK_ (1#6_\ H=M4_P"_4?\
MA1_PB&M_]#MJG_?J/_"@#)T?5K/PMXC\36GB&5;7[9=_:K>69>)XV!&!@8XQ
MTZ\]*YK1(;OPK-X7U?6#/%I0DNP(S W^C>9G;D 9 ;@_GQ7<2>"]7E"B3QEJ
M3A6##=#&<$=#TZT__A$-;_Z';5/^_4?^% &+X#U.TOOB'XNDMI3)'<M$\+A&
MPZKD$YQZD?7M7I-<WI?AS5;#48KFY\47][$F=UO*B!7R".<#/!.?PKH95=X7
M6.3RW92%?&=I['!ZT <#'<)8?$SQ)K<TA_L^RTV-)V3+8?A@,#J0%/TR/6NY
ML;V'4;"WO;8EH+B-98R1@E6&1Q5/1M#M]&M)HE=IY;F5IKF:7&Z:1NI/8#MC
ML*TP JA5  '  [4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MUQ;3F)7,+1"9< AMK<CK^M<OXNN;BR^+&ASVFG-J$PL9,6Z.J%OOC.3QQUH
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M!=W(QQU%5]1^(>I16NL:AIVC0W6GZ9=&VE=KAED)&,MMVXV@GUH ]!)"@DD
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MP /[H]3V&3BM_P ,Z0=!\-:?IC/O>WA"NPZ%NIQ[9)K5(!() R.E+0 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MTN4PO]J9B]S(%)*J%^Z.5Y/_ .J7Q7H&I7VNZ%K.DBW>YT^1PT=PY52CKC/
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MR<#)QD^E.KS3XDW%QJUR='L+R*WETRW.J2!S@R,GW$7U. Q_+\.MTOQ-!?\
M@I/$14^6MJT\J+U!0'</S!H WJ*\]MO'^L"_T5+O0X#;:WS9F"Z!95R,[\C&
M0I!Q^'7BKL7C'5KC7-0MDT-$T[3;EH[N\>Z7]W&%SNVY!Z<]\ T =K17FVE_
M%-KS6+"*>Q@%EJ#%8C!,9)H3Q@R*!QG/]>U-NOBNL=V)[>UMI=,$QA8?:/\
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M3;*;3O$VC7=_*RO]B%F&GD=V&Y6<?-GDY;%=_I7A:[LO&.KZY<7L$T.I($>
M1$%0H 4;LX(P,'CFM^VTRPLI#):V-M Y&TM%$JDCTR![5:H X&P\!:SI<_V6
MP\57%MHOG&1;2.$!U!.XJ')R*DE\#:M::W?W6A>(WTVSOY1-/;B$.0Q/S%2>
MA//YUW5% ')7'A"X;Q7H>K07R"WTF P)%*A=Y 5*DE]W7!].OK5*/P)?IIOB
MBU.IVY;7)C*&%NV(BS$MQNYX/'OZUW5% ' KX"U6RN-+OM*UR*TO[2Q6QG?[
M-N2=%^Z2I/7&,\]ATJS?>"=0NY="E.LB673KG[5++<1%FFD)!.,$!5XP!VKM
M:* .1/@^ZDN?%+S:BACUR+RU58<&'"E%).>< ^U;'AS3M0TG1H;'4+Z*\>$!
M(WCA\O"   $9.3QUK6HH YW5_"<&K>*=(UMYF0V&[=&N?WO.Y,G/0-S[T>&_
M"<'AR]U>ZAD#OJ%P95&,"->2%_,D_EZ5T5% '"V7@2]@T/Q'IT^I6[G6)&F#
MI 5\IV/S=6.1TQ4D_@_6KV\\/75[K-K++I$K/D6I7S 2O'#<<+C-=M10!PEQ
MX$OYI_%,@U.W UP*H!MV_=!3Q_%S\I(^N#[4^?P3J,@\*!-1M0=" !)@;][C
M:/[W'"C\<GVKI=/\0:=JFJ:AIUI*SW&GLJW *%0I.> 3UZ&M.@#!T;0[S3O$
M.M:E/>12Q:C(CK"D14Q[1M&22<_*!^-1:]H>I7NOZ3JVEWEM!+9B2.1;B(NK
M(X&< $<_*.X^OKT=% '"1>"M5C'B]3?6>-<SY1$;?)G<#N&?1L<9]?:JB> =
M<L8-&O-+U:UM=8L;7[),WEDQ2Q[LCJ,\#U') Z5Z-6?J^MV&A6T5QJ$QBBEF
M6%6VEOF;IT^AH ;HMA>V-HPU'47O[N1]\DA78@[ (H^Z,#\\FLB/0-8M/&NI
M:Q9WMF+._BC$L4L3,X:-=JXP0,<DD_IWKJ:* /.(?A_JZ?#G4O#;7=B;F[NA
M,)07V ;D8YXSGY?2M6?PYKL^K^%;W[3IZC2(RLX ?+EE"/MXZ;1QG%=E10!Y
MS<?#_5[TZ[)/J-M'<7-^E]831[B874D ,,#C80.,_C72^'=.\203/<>(=7AN
MGV%(X+:+9&N2#N)P"3QCVR:V+W4+33HXWNYEB$LBQ1Y!)9V.  !R3575_$&E
MZ&(_[0NUB>4XBB +/(?15&2: .2^(8GD\0^$8[.:WCNQ>N\?GN50D '!QS@X
MQ^-/N_ VI:S;:U<:G?V\.IWWE>0UH&\N$1'*#)Y//4_E6KX@G\)2)876OV]N
M[W VVRW-LSR'/. F"PZ^GI6G9^)=&U#3DU"UU&&2U>40B3) #DX"G/()..OJ
M* ,"ST3QH\5P^J:Y9S2BWDBMX(D98B[#&Z0@ G'/&.^:?9^'M=MOAP_AYI[!
M[[R&M4E)?R_+;CGC.0I(Z=0*[&J]]?6NF6,U[>S+#;0KNDD;HHH XZ7PCK21
M^'M0M+K3TUK28#;.75S#-'C:!ZC SVZFFW?@:^U==>NM0N[>*_U-(4B^SAF2
MW$3!ARV-V2JD\"NRL+^UU2PAO;*42VTR[HW (W#\>:LT >>1>%?&-UXJT;6=
M3U'2"VG*4+0)(6D5@0V0<#)!/(P!G..U=?KUMJ5U8)'I;VJS"56=;H$QR(/O
M*< ]:U** /,I/AC<RZ=J7DRV=A=37D5W:16[.T,#(,=P.I+=N*W3H7BC5-+U
M2WUO5+(M<V;VT$5I&PB4L!\[9Y)X_#)]>.IO;VVTZSEN[R9(;>)=SR.<!15/
M1_$&E:^DSZ7>+<"!MDH"LI0^X8 __JH J>$-+U31?#UOIVJ36DKVZB.(VRL!
ML XR6ZGKV%9R>&]3;XB3>()OL364EH;/RA(Q?9G(8C;C/&,9_&NBU75[#1+%
MKW4KE;>W4A2[ GD]!QS4+^(M)CO[&Q:^C^TWR>9;1@$^8N,Y! P!]: .5@\(
M^(=.\/7OAO3[S3SID[NL<\V[S8H9#\Z[0-I/+8.1U[5<L_"=]I_CJ'5X&M3I
MT.GI8+&TC>8%7'S?=QG(Z9KL:* .*M?"^M6'B;Q'J%M<V#6NK1_*L@?>D@4A
M,XXVY8YZG%4CX0\2)X/T31H9]*$VG72SM([2%6"-N3 Q[G/TXZ\>A5GKK>FO
MK3Z,MY&=12/S&@YW!?7T].* ':S;W%YHM[:V@B,\T+1IYK%5&X8R2 3W]*XB
MW\&^((/#'A?3T?3Q-I5Y]JEWNY!P6( ('^T0?PKT6B@#F=-T75+?QYJVL7#6
MOV&[MXXHE0L9 4Z9R,?WL_4>],\5:#J>HZKHNIZ0;(76G2NQ^U%@"K+C'RC-
M=34=Q<0VEM)<7$JQ0Q*7>1S@*!U)- '&V7AG6K?Q-XCU61K KJ=LL<:B1^'5
M HS\O /.>OXUBZ=X!\0Z-INB7FG75DFL::DT;1RLS131NS, 2 ,$%O\ Z_%>
MCZ?J%IJMA%?6,ZSVTH)21>AP<?S!JS0!E:%#K45K(VNW5M-=2/N"6J%8XUQP
MHSR?7GUK(N[+Q3IWB/4-1TH6-[97@C_T6XE:-HF5=I(.",''/X?CUE4=3UC3
MM&A274;N*V21MB%S]YO0#N: .%A^'NIR>&]526]@M]6OK\:C'Y&1'!(#D+G&
M2.3R.G'6M 0>,9-)U&Y\0W6GQ01V$ZBVLT)\QBI^9F/3&.WK7<5#>6D%_9RV
MERA>"92CJ&*Y!ZC(YH \H\-:%K'BKP#HNE316<&C+)YS7 E9I7"R-E0N  23
MUSTK1U;P5XDO+CQ1%!)IS0:LR.D\[/YH52"(^.@&,?YX[[2='L-#LOL>FP>1
M;ABPCWLP!/7&XG'TJ]0!Q6DZ7XF3QG;:IJ5MIXMUTT6;F"8Y!R'R!M'<8QP.
M:P]2\%>)[B'Q/9PKIDD6J7(G6YE<B0J#D)C:<8P!VQS7J-9NL>(-)T")9-5O
MX;57SL#GEL=< <GJ.E ',0>'_$$'C6QU_P NP<OIR6EVGFLHC8$%BO!STXK+
MMO &J76B^(;"_P#L]O)<ZA_:%C-'*7"R9/WN.F,=NYXXKTFWN(;NWCN+>198
M9%#(Z'(8'H14E '$?V+XB\0:CI$OB"VL+>#3)?M'^CS,S3R@?+V^50>3U]*R
M9?"'B.Z\%>)-*F@LENM2U'[9&4G.WYG5F'3C&WCZ^W/IM% %&V@NDT&&WRL%
MV+8)G[P1]N/Q ->9VO@KQ;##HBO;Z:TFF7[732&Y;=<%F!+-\OL/?VKUJJMU
MJ-E93V\-U=10RW+[(4=@#(WH/4\B@#A(O"VNK8>,XC:VHDUEV:W_ '^>&R"&
M..P.:DB\.^(=(U?3]:TVTL9[DZ8EE>02SE0&7;AE;'^R.W;WKT&B@#C_  #H
M6JZ'!JW]JQV\;WEZUTBPR%\;AR#P/2HM5T36[CXE:;K=O:VS6%M#]GD+S?,R
MMG<P7';=T[X]Z[6JS7]HFH)8-<Q"\=#(L!8;V4<9 ]* .*L?">K^'?$UVFD>
M7+X<U 9FMGFVF!F.&9!@]!G [\#M3-!T?QMH6G?V#"^G-9QR%8+]Y"7CBW9/
MR8Y.,X],^@KT&B@#S^\\':EJ7BGQ-<3+%%8ZK9"VBE67+(RJH!*XZ96K_AV#
MQK;PV&GZDNG);VHVR722%Y)D4$*NW'!/&3GL:[&B@#R=O!_BUM.,#V>F2W/]
MI+?273W#>9/AB0O(.T#ZUI^(O"FJ:_>_:DTFSL=2CND:#4H;KYA&,??7;\Q]
MOY=_09YXK:"2>>18XHU+.[G 4#J2:K:;J^G:Q$\NFWUO=HC;6:&0-M/H<4 <
M58:1XL\+ZUJL.CV-C=Z=J-T]S')-,4\AB.=PZD=.!Z=LUW<"W$5E&LSB>Y6,
M;VQM#MCGZ FB\O;73[5[F\N(K>!.6DE8*H_$U)%+'/"DL3AXW4,K*<A@>010
M!Q'AKPN-3AO[_P 6Z!:MJ5Q=NX,^V4^7@!0#S@ # ^E9FBVNJ^$--\5Q76E1
MQ:%&DMS:":<-DE2/+X_A. .Q'OFO3:IZK'I\^F3P:H8?L4J[)1,^U2#VSVH
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M@#&>E %GQ]/=:1X OY-(=+1X455*#;L0L 0N.AP:S]1\7W^B_P!DZ3<3V/\
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M>_MM3"&:WGG\IHY%R-P."",?C^5 '->+?$5UXK^&T$MO&EO))J"6=]"[GY9
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M;2_B#J.JVUK%/8ZE#'YSM/M:-T4C"KCG.!^=/\$Z3J=EI.I6>M6,<'VF[EF
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZD3JA)ZD_+G/89]ZU-$T^\TRSDAOM3DU&1IF=99$VE5/1>ISCUK2HH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBN ^)E[+')X?T^#4[C3VO+W$DT-P8<1# <
MEL@<;AUH [^BO.?">J"T\4>( FL7%WX=MH(W2ZNK@RHCX&X!S_P+CVKH=.\;
MZ7J>KVVFPP7Z2W4;2V\DUL425!D[@3V..X';UH Z6BN6/Q T/[6D(-TT+77V
M,72P,83-_<#=2?H,?A5K6/&6B:))-%=W+M) %,R0Q-)Y08@#<0,+U[XSVH W
MZ*S]<U>WT'1;K5+D$Q6Z;BHZL>@'XD@5P'@S7+KQ7KBSZUJEW:W/^OL],@5X
M8FC&/F9L?O ?3)Z'M0!Z?15'5M8L-$LC=ZA.(8=P0'!8LQZ  9)/L*Q)?'FE
M1V6IRM'=Q7&G1B2:VF@99 &^Z<>AR._&>: .IHKB_ ,=UJ.G0>(;O4-2>XNH
MW\VWG8B+)?(9%/ &, %>"*S=8O;V[^,.DZ39ZI>+;Q1_:+J!),1KA2=I QG.
M%^]G[W'6@#T:BO(-5UN_U;6/%T]WJ=[96.AQ-%;P6LY@9I"Q56.#\P)4]3W&
M*]!\%7]UJG@S2KR]#?:)(!O+9R^. QSZ@ _C0!O4444 %%%% !1110 4444
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M<#YP2,>O H T**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 >7ZIHVNZI;77B>".:WU"*\6:VL6M?WA
M6/Y%&[[V""21TK5BGU#0O%NIZJVA7]W9:M%#(AMHE:6%U0 HZ[ACO^-=W10!
MQ/C0:AX@^'ER+72[V*YF=-MJZCS2H<<D*3VYQ1XPTZ]OO^$5:VM)I/L^H0R3
M!5SY:C&2WIBNVHH X77/"^H7'C2&>Q&S2]25!J>UL9\HY&?]X8'Y].M0:YI_
MF^.[RXO-.U:6QETU8%ELE;[^XGJI[>_&:]!HH XGPK;75[K?VVZTN[L;73;1
M+*Q%Y_K9!_$[>^ H[]3S5SP7;W4$6OM<VD]M]HU:>>(3+M+(P7!_2NJHH \]
MT:WMK/X=:3IOB#0[RX!D>)H?LQ9HV+.5;'49S@$>M0SZ/JEO\/\ 1].-G<RS
M+J,;K$%W-#$)"PWX)Z#'Y@5Z110!P/C&PM=8OIX+'2+P>((1$UM?B(K']X'.
M_."!@]1]*GU6&?5_%&F36$=ZM]I=T(IFFC(MS&5R[#U)R ,8/X<UV]% 'GFD
M:3X@TOQBFH:K%;RPQ:=,99K1';>3(6V_,<E^G XQQCI63J6@:EJTVMZCID6H
MFTNA;3^7=+AYF1R2%##.U5Z#Z 9Z5ZS10!QVC-<)XFUW6);"[BMKY[:&%982
MKDJI4L5[+ENM6-&M[B/Q]XCN'MIEM[B.V\J9D(1RBD, ?J:ZFB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
; **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>a123121ex-1021007.jpg
<TEXT>
begin 644 a123121ex-1021007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#WZBBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*ZE61QU5@>A&:S=4\;:;IM[<6BVVH7LUL ;D65L9!#D9&X\#D<\9Z4 =)17
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MG6Z;5UN/)$3,RI\W& #SR#MZ\].#7M3HEW:,A+".9",XP<$>_2N5_P"$"/\
MT-WBK_P8C_XFC_A C_T-WBK_ ,&(_P#B: ,#PKK<?P_T^70/$R7%JD$[FUN_
M):2*5&.< J#SU./?M5GQI=7'BOPG+-I%C>/;V5S#<AWB,?VE "6V*V&( (/(
MY[9Q6M_P@1_Z&[Q5_P"#$?\ Q-'_  @1_P"AN\5?^#$?_$T 9-WK.G>-/$_A
MR30_,NCIT[7%U*8G18(RHX)8#)8@8 S]TUR,-W"GPC\31,^)'UD;5VG/+QL/
MT5ORKT3_ (0(_P#0W>*O_!B/_B:/^$"/_0W>*O\ P8C_ .)H QX[^WTWXPW%
MW=&1(-1TM!:NL3/YG*D\*"1@*Q.<8Q61X:M7UOX7^*+72IB]Y->32JHCPV"%
M^49_O*I&>/O'TKK_ /A C_T-WBK_ ,&(_P#B:/\ A C_ -#=XJ_\&(_^)H Y
M;5]:M/%OA/0](TQF.M"X@)A$9+VQ08=CD#&/7O6MX7GB?XM>+E5P2R0X'KM4
M*WY$XJU/\/KUMOV?QMXCCZYWW1?/ITQ47_"O-6_Z'O7O^_S?_%4 5OB_?VUO
MHVE6\DN)FU".8)M).Q =QX]-P_.F^+O%=AXIT.Z\/>'$GU2^NRL9\F)@D0W
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:JF(@>@)=ERQ'.!DUGO\1M&&CZ;J<4%]/#?SFWC2*'+JXZ@C/\LY[5422_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR.HX]L5T=%% '->(?"MSK^H1.^N7<&G@!9["-1LF .3D^_3O72*JHH50 H&
M . *6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8@*(RNTC(())7N?7/U;%X U2'PAK>AKJ5H3J%X;A',+#:"5)!YZ_*/7'/7/
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MUS/.EM!'(^U2[G )/7 Z\5BZ!H7B^P@M=*O-7LAIEIL5)K>(^?(B]$R?E X
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG#5=-U+S+HW.GP^1 ?-XV<C#>O6J(^'ND1V<]K!<:C!')="[C\JY(\B3U3C
M_')KK** .;'@K3FL=4M[BYOKF74XUCN;F64>:P487&  ,?3GOFMRPLX].T^V
MLH2[16\2Q(7.6(48&3W/%6** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC=^5ST_F*P?B?<V5MI.E&ZDA20:E \>_&X*K?,1WP!U^M4+>XLO^%R:W)+)
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M"P^8XZ8W#'H3QWQ73>'-.T'3/$SSZ=X@AO)[FS?S(;2&%(@BX.YA& %//U-
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M<F]E #.0!GCUY/% '8^.O%<_A?2$N[%;2>83K')%,QR%(/( .<YQ73RW,$!
MFFCC)Z;V S^=>&ZI!ID_PBLM3*6LNL7%V'N+D[6G9B[9RWWN@'%;>K:0GBCQ
MWXCL[W5;*V988HK9;NV\QA$5#%HB77:0V>1GK0!W>L:[?:=XJT+38[>%K/46
MD225B=ZLJ[L ?_KKH:\W(B@O_A_"FIC45BEN(UNB-OFA4*Y'/3C .3GU->D4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC\,4 ==1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN]0CCFW!6&"0A(R Q' )]_6C4/%WA_2KM[2^U:V@N$4,T;MR >G\P?I0!M$
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+W=LT(7IA 6'S-D<XXP>M<7-::M;?#F_\)#0=6EO(;LN)X[5C%(@D'(/4_0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8C8C&3;P,>W7KS7(?;[6[^$R>%E#OKGR6HL3E9!*) <_[H^]GI@=:TOM2O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%<KXU\37OAU=)2QM$GDOKU+<[VP "1P/<],]!0!U5%<UJGBN>UU-M,TS1+K
M4[V*-9;A(W6-85;. 6;@DXZ"H%^(.E-X<36%AN3ONOL8M<*)?.S]S!.,XYZ]
M* .LHKD]/\=0W%]J%E?Z5>Z=-I\!N+DS;&1$ZCYE/)(Y_ ^E1Z/\0;35-<@T
MN:QFLWNHA+:O))&_FC;NP0I.TXY /;TH [ D 9/ HKRC4O$UYXK^%OB&ZN;6
M2W$,I6*6-@%=?,&%X.20#@\ &NIT+Q?:RW&F:0^G:C:>?:"2VGNE7;*BJ"3D
M,3G'//\ 6@#KJY[Q?X7/BO3(+(WS6BQ3B;<L8<D@$#J?>J/_  L/3A/9%K.\
M6QO;C[/;WS!!$[9QG[VX#(ZD4\>/;.37I](@TO5)IX+M;65XX 40MG#DYX7@
M\^@S0!T]M'+%:PQSS&>5$"O*5"[V Y; Z9ZXJ6L7Q-XD@\+Z:M_<VES/ 9!&
MQ@"G9GH3DCC/'XTP>*;;_A+SX;:UNDNO(\]964>6R^QSGKD=.U &O=VL-[:2
MVMRF^&9"CKDC<".1D<TZ""*VMXX(4"11J$11T '05QE]X@TS56\-WLT6J0>9
MJ;16Z+A0TBY3,F#@KG/OU]ZL6WB>;6/%NM>&I--GCM[:,(;B.0!AN!Y)!R 0
M1C'/KCL =?17F'@;QM;V/A31X;^+5)S/,T,E\\;/$CESM!<GZ=,UZ+J-V;#3
M+J\6%YC!$T@B099\#.!0!:HKRKQ1XEO=2^'NA:X!<Z?</?Q;Q&S(&&&R0 22
MO'&:[.P\9Z;>W]_9R1W5E+91&>07<1CS$!G> ><4 =%17-:;XWT[4=2M[(VU
M[:_;%W64US"42Z &XE#]"#SCJ*U]7U>ST2P:\O798@RHH12S.Q. J@<DF@"]
M17-:?XSM+V66UFL+^QOUB::.SNX=DDZJ,DIS@]#QG-<?XD\57FN_"Q=<A-SI
MDXNUVA&9!(-Y "D?>&,$G@94_2@#U6BL&P\7Z3J&I/IZO/!<K#YX2Y@:+='_
M 'AN R*BL_'&C7MW96Z-<I]N)%K++;ND<V/[K$8- '1T5S-OX]T&ZUC^RX9Y
MWN/M!MCBW?:).>"V,=C^1K7U76+/1X8I+IGS-((HHXHR[R.>RJ.3T- %^BL*
MV\8:+<:??7IN6@BL&V7*W"&-XSZ%3SSV]:CM/&>EW>J6FG".]AN;M&D@6>U=
M-ZA2Q(R/0&@#H:*YT^-]$_L"?6Q-,;&"?[/*PA;*/D#!&,]Q^8J.74K,^.=/
MA&MSB6>R9X]."'RY!R1)GUP#Q_L]J .FHKC=)^(=EJ&DZKJ=S97=M:V$YC+>
M2SY4;1DX& V6Y7L.:V/^$JTOR]'<22D:N0+3$9.[@'GTX/>@#:KBKWPEKZZY
MJ5]I>NV\<&HLC30W=H)=NT$ #M@>G\^^SXNNK>T\,W<ESJDNEH0JB[B4LZ'(
MQ@#GGI^-17'B[0](CL;>\U-FGN+=)(<Q,SS*> V%7J<=* +GA_15T/33;>=Y
MTTDC332;0H:1NI"CA1Z"I]4TFTUB&&"]5GABF6;RPV Y7H&]1G!QZ@5SU_\
M$+2H?!\_B*P62\ACD$/EX*$.3C#9' YS6IJ/BO2]*@@>Z>?S)XS*D$<#O)M&
M,DJ!D 9')Q0!MTQX8I8S')$CQDY*LH()SGI]>:Q9?&7AZ#2K34Y=3B2RNV*0
MS%6PS#.1TXQ@]:A?QWX?%E;W4=W).MP':%(8'=W56VL=H&0 >YH Z Q1F42F
M-3(!@/CD#TS0(HUE:01J)& #,!R<=,FLP>)M'>ULKF.]66.])6V\I&=I"!D@
M*H)X YXX[UE:IX^TJQM=+N+8O=Q:A=>0C1HWR@'#DKC.1Z8R: .I5%0L54 L
M<L0.IZ9/Y"FS017$>R:))$SG:Z@C]:R-1\7:%I-P\%]?>5+&BO(OE.VP-PN[
M"G;GWK4O(YI;&>.WF,$S1L(Y0 =C8X.#UQ0 YK:W> 0-!$T(QB,H"H_"I%54
M4*H"J!@ #  K@_!?C[3+S0M*MM6UJ%]9N-P=6&"6WL%!P-H.,<<=O6NCU+Q9
MH>CW#P7VH+%)'M\SY&8)NZ;B 0N?>@#6,$)E,IBC,A7:7VC)'IGTJ(Z?9&(1
M&SMS&#N">6, ^N,5RMYK5\OQ1TC38+TMIMU8/,T2A2K$;L$'&>P[U'X[\6V]
MAH6H1Z=J[6VI6Q',4!D&[^XS%2H)SZYZ4 =E):V\LB2201.Z?<9D!*_0]JEJ
ME8F>?1+8O=*]Q);+FYC489BH^<#IC/.*X_PGXZT\:5!;:[KMN^J27,L0#+M;
M D(7=CA>,8SC^M ';SVMO<[?M$$4NWIYB!L?G3TABCA\E(D6+&-@4!<?2J)U
MW3!K@T7[6G]HF/S/( .=N,YSC'3WI^FZQI^L+.VGW*W"P2F&0J#A7'4<]?J*
M +$-I;6Q8P6\41;KY:!<_E3!I]DL;1K9VXC8@LHC&#CID8JA=^*M#L=3&FW.
MH1I=[D4IM8[2_"AB!A2?<U,WB#2EGU&%KV-9-.0/=J01Y2D9!/'/'I0!:^PV
MJ[&2TM]T8_=_(!M[\'''-<=X)\*WNFRZI)K>GV):XO&NX75A(RENHY7C'K[U
MTI\1Z,-%BUAM1@33Y?N3NVU6/(QSWX/'7BN9\7^+@_@>75_#.K0EHYXT,J@,
M!N(!4[ON]0>10!V,VG65Q=)=36D$EQ&"J2O&"R@X. ?P'Y5&-'TQ9(9!I]J'
M@<O$1$N48]2..#S4&F>(=)U69K6RU.UN;F-<R)%(&(]3QVS61\0]5U30O"LV
MJZ5<QPR6[IO5X@^]68+CGIR0: -'4].N;.RO+GPW:6$6JSNKL\R860Y&=Q')
M.,TOAO1[C2;&8WT\=Q?W<[7%S+&NU2Y &%'H  !7)S^(_$/AW6/#R:G?6VHV
MFL.L15;<1/$QV<C!Y&7_ "'J:[$>)-$;4O[-&JV9O=_E^0)1OW>F/6@"]=6M
MO?6LEM=0QS02##QR*&5A[@U430=(CEM)4TVU62S7;;L(AF(>B^E12>)]"AO&
MLY-7LEN5D$1B,R[@YZ+C/6GV_B+1;K4#86^JV<MX"1Y*3*6R.HQ0 #P[HH@N
MH/[+M/*NV#W">4,2L#G+>IS3DT#2(Y!(FF6BOY)@W"%0?+/5>G2HF\4:"E_]
MA;6+$76\1^5YZ[MQ[8SUJ6^U_1],G,%]J=I;2A/,*2RA3MSC.#[T 4=0\'Z3
M>Z?9Z?':PVMI;W27/EPQ*-Q7)Q[9/4CG&1WK?J&TO+:_M8[JTGCG@D&4DC8,
MK?0BIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ KBOB)IU]=PZ)=V5G-=BPU&.XFC@&Y]@/.T=Z[6B@#SY!J/AGQCJ
M&LIHNHWNGZQ!%)(L$:O-;S+GY"H;&,$Y/(SCGUP=:TR]A\)2B?2[G[=JOB![
MZVMHF7SX!C=D 9RVU#TZ;O:O7ZQ?$/AJV\0K:M)<W5I<VCF2"XM9-CH2,'VY
M% '"_88=9M=;TSR]=BUO5;8&.?6(%C$@BP0B[. /7CO5[PG]LDO-,@E\#)83
M6:"*;4)E52,(02F "22!SR.:ZK1O#$.DW9O9=0O]0O#&81/>3ERJ$@D # '(
M'.,\5N4 >06VEZO9_#/Q!X?DT:_:\^TDQLD64E#.N"ASDC"DGCIBMAK/4)=8
M\&(NFW@CATR2"XE:(A86>(+AO0@J>/<5Z/10!Y-X>TZYM+*ST>Y\!K/J=I(4
M%]-&H@V[LB0OU)YZ#K70^$;2\M_'GBZXGLKF&"ZEB,$LD159 FX'!/7J/J*[
MBB@#)\3:0->\-:AIGR[IX2(RW0..5)_X$!7GPT+Q9/IFF>(S$5\20LMF(W'"
MVY4IEQGD[F+D_I7J]% '"^)M-;3K3PI8Z?874\.GZA#*XMH&;;&@(+''?)SU
MR>:CTZ*\TKXG>(;F?3;U[6_BB,-Q%"7C^1.02.AXP/>N^HH \AELM67X,6>E
M0Z7J*:I%.,1"V?<")2^[ITP1SZUZ?>1&\T&>)ED8RVS*5Y5B2O3U!J_10!XW
MJTMQ=?"O0;5=,U!9K&\A296MF&"FY21ZC.!5[Q+IEUK7Q"UBUMH)@T^@F*-V
MC(5GR& STYZ9]:]6HH \S\)G3Y)--M8?!$UOJMIY:7-U-;JD<+ ?,P<DDD]A
MUYK=^(.G7UWIVG7MC#-<OIU]%=/;1=954\CZBNOHH \_6]C\6^.=%U'3+2X%
MOID5P;BXG@:/.]-JH,CDY.?IFN0N;F2;X+0Z4+"^6ZM+E8Y UJV,^8S<''H?
M\YKV^B@#R[Q)#+J?Q)C6V$\?VO0'@BE\M@ [>80,XP.#5;PB='=M%LIO"VI-
MKEBRQNTB.L<!!&Z7D[1Z],Y_ UZU10!Y_P##1O+NO$MK+%(DW]J2S#?&0"A.
M 02,'H:3XDVKQZCX?U>6"ZN=/M)V2YAMBP8!P &&T@\8_7&>:]!HH \BU;3[
M.\\+:G<^&=#O;>W%S;SSRR*Y:\5&8L%5SGY2<Y[UK2^([+Q!\1?"36<-VBQ"
M\RT\#1@YBZ#/7&.?J*]'KF-1\/:I?>.-*UG[? MAIZOLM_*._+KM;GOGCZ4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR7^FW"SVSD@. 1R.""#R#]: +;Q1R.CO&C,G*L5R5^GI3?LMN/,Q!%^\^_\
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MJ/,E.TCE^-J_-TP>G6NXHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI6+::'>:7>Z+J=]X4GU:U?2DM)[:2!9'@E1NH1AQP!CZFO8C(@;:74'T)IU
M&-X9BGCTUS)I5OI4+R%H+.)%4QI@??V\;B<GCID#J*X>33)M&\5ZTVH^#AKM
MM?S_ &BVN(K>.4QYX*L6''Y\8]Z]1HH \[!UG0/%\.IMX<FGM[K3([=H=."L
M()%;.WJ  ,_3TK)AM;W4OAQK@M;*62X&N23&W7!<!959AP<$@ ]*]8E5GB=4
M<QN5(5P 2I]<'BL'PKX:?PU;WD3ZE->FZN&N&,B! K-][ 'J: .:TLZI?_$Q
M-?DT'4+2QETUH,SJH92K9Y /&<8 Z\YZ<US*Z-J,WPLUV%].OH[E-7^U10M
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7GOQDA@?P1YLD*-*EP@CD(^:/)YQ]0,5Z%7%?$_2]2UKPLNGZ7
M8RW4[SJ_R,H"!?7<1Z]LT <OXXU+0+KX<&PMK69I;2.#[+*UC)&BDLH8ABH
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M%24F^@A$[Q[3@*3CKT[C\ZXKQ[:/<_#_ $G3;6R-M--<6\5O9EMS)@'"$^H
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M?;SQB2-B,94C(XJQ0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR""&,O,[]T"#G([UEZC\1[.'P[<:C965W+<07"6TMK-$4DA=O[Z]0."/<\4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ KA_B'9WE[/H#6<,4IM+Y;J0/<1Q':I' W$9SS^5=Q67JWAS1]=:)]4TZ
M"Z:($(TB\J#UH X34M'GU?QGK\S2VMO8:AIOV..Y-S&V&&TY*ALX^4BB^74?
M$V@6/AS4;6ULU@DA^TWGVZ-D94ZE #DDCMQC/)KJO^%?>$_^@%:?]\G_ !JF
MGA3P#)J#:>ECI+7J_>MUD!D'&>5SGI0!2\0Z';ZGXOL]0MM0M4L[F$VVJKYZ
MCS8@0RKZ\D8..WZQ>&- CTI-9M;K5;;[,PDM=-_>JPBMW)8XYSG<W.?[@Y/%
M;W_"OO"?_0"M/^^3_C1_PK[PG_T K3_OD_XT <KX?NO$NFZ5::"]II<:PMY0
MU4WL3;8@W7RNI.W@?AGO6AXOT.+6M>TV_L-3M858&TU';,JM);$AB,Y]B/7Y
MO05JQ>"/!<\DL<.D:?(\+;9%0Y*'&<$ \'!!YH?P/X,CFCADTBP267/EHQPS
MX&3@9YXH Q-=>_TKQDNO:/#8ZI:R60MIK;[7'&RE6R""<^O;W]JJ>*)=2U2V
M\.W+6=M]H@U-;F6UM[J-A"BD8!<D D]<XQSCMST\7@;P9.9!#H]A(8V*/L.=
MK#J#@\'VI)O _@NW,8GTBPB,KB./>=N]CT49/)]J )M1\33VGB#0[*"R6XL]
M2+HTZ2 M&P&>@SD  Y/^%)\0-+N]9\#:G86,?FW,BH43NVV16('O@&M33M!T
MG28XTL=/@@$;,T>U.4+ !L$\C.!G'I6C0!YRMAK-SXQ\':C+HUQ##:6CQW!+
MH?+)1E&>?H<>_<\5F#3/%,-OXMNK'3[NWFOM0CDC1)%222'<V[:W8X(Y'/->
MLT4 >7VNCZQ?:QKX;P[-I]GJVE^2CM.C%652!NYZDG'//'Y=9X%6^@\*6=EJ
M&G2V4UH@@VRL#OP!\PQT%=$KJZ[D8,/4'-.H X;['J$?Q@?4O[.N6L'L!:BX
M4+L#9#9ZYQV^M96D6NM>&?#VM^'CH%U>O+),;6YB"-#*)%P-P+# '&1SWKTZ
MB@#S'3_#>J:3XK\'*UE--!IMD\5S<Q@>6KNK\#G) +=<5W'BC_D4M9_Z\9__
M $6U:U4]2LTU72KRP,S(MQ$\+O'@E<C!Z_6@#RNQM;[Q1\.-!\/VVEWJ*94:
M2\D"+"$5F)(.XD^W'6KU]::QI-_XMTRP\/WEVFLLTT-RNTQJ63YLYX^\QXZX
MKN_#6A+X;T6+3$O)KJ.(G8TP *@_PC Z?XUKT >50:;JMKJGP_>;2;P?88'B
MN=D>\1$C:"Q' Z9_^O5F?4_[)^,6K7/V&]O -*0>79Q>8_WDYVYKTO(! )&3
MT%<_%X5$7C2;Q(NHSB6:(0O!L384 '&<9Z@'U_"@#A+?PWK&CKI_B4:7<S3)
MJEQ>3V$;YD6.08&%Z%@!T'K]<:EZ;G6=?N_$0\/ZHUE:Z4]K]DGC,,EVSMRH
M7J1M)[=1Q7I%% 'D-GH.IRVNM:-HT>K#1;C32\<.I0-'Y5P3D1H7QGOG'&3^
M-:7ADO-)9P-\/%M+VSC"37DT"Q)PN"4.W+$E<#KC/7'7TRB@#RW0;6\M/$^E
M/H-GJ^FV=VSR:II]U;R"V@.W)V,R@9)X&WK@=!Q71?$32;O4=&LKFRA>XET^
M^BNS;QC+RJIP0OOSG\*["B@#B6,GB#QUH>HVVEWL%OIT4SS7-U;O"270J(PK
M $D9SD9%0_"Z.XM=.U:WN[*\M9'U&6X07%L\89&"@$%@ ?NGCJ*[RB@#B?%+
MW=CXY\.:G%IE[>VL23Q3-:PF0Q[PH!./\]:RYX+Z=OB*?[-OE-W$J6P-NY\[
M;&4^3CYLG'3UKTJB@#RVS>_CL/ $7]BZIYEK+MN UJP$(P8LL<?*,G=SV&:9
MJEGJ$7B&;6?#L6M6.I2WR175G);.T%RN['F;\;=N.<D\9/2O5:* ,CQ1L_X1
MN\673IM1B=0DEM!G>ZLP!(QSD D\>E>?Q:1K*:+XBT.UGU.^TK^S ]G]MM)(
MV1\D^4NX98[0. .N!@5ZO10!X]!<WVIW'@40:!K"KHK"WNWDM=JAMJ*<<] 4
M.2<8^O%7=/O&TBX\9Z3=Z?>_;-2N[B2S2*T=S.KAL$,!C'N3QS7JE% 'D>HZ
M;'H]GI$#W=[IGB"PTM3#?11M+'-RV8",8X/K_>'6J]W#/::Y;:_XP\/W%]#>
MZ=&D@MXBYAG!'#+D;20,_C@9P:]DHH \JU /H]YX;U^P\+WEMI5H]P)+1(-T
MT:N!\Y3^ \$\GC\:L^(]3;7O!.HZC::#=6D(N[>4&2+;-<!67<Y4=@, ')SC
MMBO3** /-M?U&'4/B#X,NH8KD0@2,S26[IM#C:N<CC)%,T741X5T_P 0Z)J\
M-W]H\^:>WD$+.+M9!QM(&"V>#[GZX],HH \AT?2[S1/%/@.&^24O%9S"0E"?
M+9P^%.!QC<!6AX6UB'P^GC;5[NWNGMEU5Y1Y<1W.C.0"N< CG)YZ5Z=4%[9P
M:C8S6=RK-!.A2158KE3U&00: $L;R'4=/MKZW),-S$LL988.U@",CZ&O(KJ8
MGX2Z_I/D7(O8[XYC:W<9S<!@ <8)P">*]BBB2"%(HE"1HH55'0 < 4^@#S;4
M)!=:]X<MX$D9[C19X X0A4+H-I8]AE6]ZQ/#T6@-I>F:=?:!K,NMV4RH+5GN
M/+60-S(.=BK_ !'@=^O6O9** ,#QO))#X+U1XK-+QQ#Q \9=6Y'4#KCK^%>>
MO=MJNO2K ]_=R7'AR>SBGFLVA668Y.U1M  X(_#J37L-% '">&O$6F:E9:)I
MLFDW;:G:*J&.:T8?9F5=K2%B, <=CGD5R2:Q:Z9\+M7\/WT%Q:ZHAF#(]N^'
M)DR#NQCH0.O0>E>T5A^+=)OM=\/7.F6,]O"UR-DCS*3A>^,=Z .*O;Z'0/B)
MHFK:B)8[*;1EMXY$B9]T@).T!03G!%8(;[+\(O$<=U'+!+)K&42:)D8_/$>A
M'7"G\J]DL;5H=.LX;KRI)X(D5G5>-X4 E<]*LO&DJ%)$5U/56&10!YEXNOK0
M^('U?2M?_LW6;6P79%<H/)O86RX5<]3\W3!.<<=PV\U&2^\=> )[V,6]Y):R
M231%2NPLG Y]P>*]-DMX975Y(HW9?NEE!(^E*T4;2+(T:EU^ZQ'(^AH \CTN
M>*U\)?$#3IW\N[%Q=2F)A@A2H /IR>E2V%Y!80?#_6;E<Z;#:26\MSMRD,A4
M*"Q[<@C/UKU<PQ'?F-/WGW_E'S?7UI/(A\GR?*3RO[FT;?RH \KUN6UO=1\8
M:U;20S:.='^S/,B!DEN3PFTX^8@XY'3CGBF75S8#5OAE]FD@1?+;(0A>JQJ,
MCW8,/<@UZN((1#Y(BC\K^YM&W\J;]DM\H?L\64^X=@^7Z>E $U%%% !1110
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MO5M[@1PW\,>P7*[1SZ$CH?R[5UM !1110 4444 %%%% !1110 4444 %%%%
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MV%I>-]J:W$ZH8F1O+/1QN49'(K,^'=Y=7_@BRN+RYEN)V>8-+*VYFQ*P&3]
M* .IHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+U22Y"&)0MIN28LO&T@XQSWQUKF(_#E]X2LO"&KRPRW$FE^9'?1Q@RE$ESR
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %<OXZU[5O#>AC4],MK:=(I +@3[B
M54G ( ([GGFNHJMJ%C#J>G7-C<KNAN(VC<>Q&/SH P+[Q4]EJM^_EPRZ19:8
MEW+*A/F>8S-M7TP57/3N*SKCQ9K^C0V.J:U8Z<-(O'1#]FE;S;;?DJ6+?*P
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MW;0=>L);/R[?[/NG<'.!E7&#P%.,9]* .C&MA_$<>DQ6[2*UJ+HW*."J@D@
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M,"KJ4ME1E=2I!7@\'W!H Z&BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>\9>&&\6Z*NG"_-F!,LI<1"3=C/&,CU]>U0VGCC3KZ:Q\BVNS:WMP]K#=M&
MC2*,XQG=@X.#CM7'^'_%R^'=0\4B]BU2]ACU5UW1HTPA0$C+,3QPOZ4 >J0H
MZ0(DLGFNJ@,Y &X^N!TI]<+K5Q%>^,O!6I6=W(]M=--M"L0CKY>X';Z\U>U/
MX@:7IDDS26UY+8P3>1/>Q1@Q))Q\O7+=>< T =1-"EQ!)#("4D4JP#$'!]QR
M*2VMH;.UBMK:)8H8E"(BC 4#H*YC6-0?1=>TG58[POI>IRK:7$;R9168$QR)
MGA>A!QP1BM_5M3AT;2KG4;A)7AMTWN(EW-CN<>W6@"[17-+XWTQO[&*V]Z4U
M? MG$0VYSC#'/![_ $JGXDU[2+[0-?MKN74;:WT]XXKB>V7:VXL" A[\XSTX
M- '8T5P^L2%?''@HQ7UU';W$<X9#+@2;8P5W#H22<&D\'7-S)XZ\96TMU<2P
M0SPF*.65G6/=O)"@G@>P]!0!W-%8>N^+-*\.7-I!J+SJ]T2(O+@9P2/H.N<#
M YY%0:;XVT?4M/U&]W7%K'IQQ<K=1%&3(XX]^F.N: .CHKGK7QA83ZI:Z;<6
MU]8W5VNZW6[@V"48R<$$C/'0XI/"GB=O$JZBS6,UL+6Z>!2ZX# >^?O#N* .
MBHKSKQ)KLFB?%33#+<W[V3V#LUI &D#O\X&(UZG@<G]*Z.S\;Z)>Z')JT<TP
M@CE$+QM"WF"0XPFT#))R.F>M '145B:#XJT[Q#-<V]LMS!=6VTRV]U"8I%#=
M#@]O_K>HK;H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]/HH \\\9:%+<>,](:SG\O\ M96L[Z/@^9"F') /'0$9]QZUZ$JJB!54*JC
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!F2:V^QJPBB*<CD_,<GJ>W%6%T36-7US3;_7DTV./32TD,=H[R>9*PQEMZC
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MN56W=G"YR2,D#UJEK^@>(;CQ@^I6,=E=VLM@UK&MW(5%JQZN!M.2?4#N0>*
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MR'U!'(J#0/"6B>&0YTNS$4DBA9)6<N[ >Y/'K@8%;=% !1110 4444 %%%%
M!1110 4444 %%%% ##%&95E,:F105#XY /49_ ?E3Z** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2<3HC74G[MAG&WGY1\QZ?CS5R7PII<^OR:S,DLES);&U=&D)C:,C!!7OGWH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVM'$!BFWJ%DV[1L!]>!P0!^%1:G&;R/X96\TLWE7,"B95E9=X\N+K@^YY]Z
M/6%=77<C!AZ@YH5U8D*P)!P<'I7EUO:RZ9H'CW3M(G^R16LV;<-(0L0* L%.
M>"1G'OCK4WAK1C<>+M+U2STR_L+*/3P]T9"8DEGQ@-C/SD@G).0>/Q /3-ZE
MMNX9Z8S2UY;H]S'I7BJRM=<TX&2XNI)-/UFWF+K=,_ #8//RD#GI@<=Z]2H
MYC7_ !7=:/XBTO1X-*6[?4<B)_M/E[2OWLC:> #FNG'3GK7!>+/^2G>"_K<?
M^@BL.\L8M5U+Q[=-J.I.--C+P)]I9%201,3P,9 9<#VH ]9HKROP]J=UXEU7
MP_IFKRRO:MHYN<>:4\^4/MR2I!)"@]_4UW?AK28]$TZ6QCU&:^1)W(:9]S1Y
MP=A/M_6@#9HK'\5WUQIOA/5;RT#?:(;9VC*]5..OX=?PK@]5M?[)^'>D^*K2
M[N(]62.VG>22YD;[0TFW>&!;!SN)^F: /5*ANKJWLK=KBZGCAA7[TDC!5'XF
MO.K733XB^(_BBTN]0U&**U-L\(M[ID"_*#TZ=O3N>]6_C%&K^!@S#E;N(CGZ
MB@#I+GQ"]MXPLM!:Q;9=P/,EUYG&5SE=N/IW[UN5P/B'2+>X\=^%].$MS!;K
M:W(_<3LC[0J\;LYQ^-8(O;_3M&O])M[^8Q#Q(NGQR7%PP*0D;BOF#D#(Z^A-
M 'KE8OB/Q-9>&K2*6Y62:>=Q';VT(W23-Z*/Q'Z>M8WA/0-4T#6[M;K48#:7
M,0:&R%S)*R,N 6!?G'//U%9WB9HH?B[X7EO0WV9X'2$G[OG9.,>_*?F* -"Y
M\:ZSIMO]JU7PA=VMKO1/-2[BEP68 ;@.1UKM*9+%'/$T4T:R1L,,K#((]Q7G
MVDV8\7:CXEGU#4;Q9K+4);:V2WN'B%NJ8"L #C)VYZ=0?6@#T2BO'8/$&KZU
M;^"(I=3NH6NKFXMKF2VF*F8(4 )(Z]^?>K@LI9-9\9Z6NLZK]DL+83PH+IP5
MD9"QRQ)+<]LXYZ=* /5J*\DAN=9\0:3X%C&M:A;/?^='<O;3;6=8\G<2>2V%
MZG/TJR;S4-#U;Q-H<WB*_P#L,%@ES'?W7[Z2W8E1@' SG)P..G% 'J5%>=17
M%[8^([ZVBO=2-HWAUKJ);NX+N) 0-^#RK=<^_IT&/H;:HN@^$M>D\0ZO-->Z
ME';302W&Z$H7<'Y<9)PHZD_RP >NT5Y]J&LS>%/']VU]?3R:;?V#SVT4LK,J
M2IR44'C)QP!Z@5U'A6RO;#P[:QZE<SSWKCS)FFE+E6;G:">PZ?A0!LTA. 3C
M/TKS#4[O4=-U+Q=I,VIZ@;BZ2.YTC;,V\DL<I'SP Q P.<#GBM#PQJ=SXEE\
M.>7J%PITVS9M3C$K9EEXC42>IW([<_K0!TWAGQ+;>*-.FO+6">%8IVMW28 ,
M&4 GH3ZBK+:HZ^(ETK[!<F-K;SQ=A?W0.[&PGL>_XUXYIT=[8^!=<UZQUC4+
M6:SU9E2"&11"^YXE)9<98X;UQP/?/;ZIK5]IOQ0:$74TEBNC/=&U+83<I;IQ
M_LCGW- '>UBZ)XDM]<U#5;.*WFADTV?R93)C#'GD8)XXKF]#TW5=?T;1_$$/
MB2[BNYI/M%P@8M ZY.8A'G QC&?8_ASUU'/=:A\0=1L=4O\ 3_L3*PCM75/,
M=$/+'!.,J>A'6@#U^BLCPM?3ZGX4TJ]N6#3S6R.[#N<<FN,TW^U?%>@:QK?]
ML:A8WD5Q*MI%'(8XX1'R%9!PV>ASF@#TJBO.=%UG4/&EW864][<6,*:8EW.;
M.3RWFD9MO+=0HVDX&.3Z<5)++K=CJ'A[PA<:Y,UQ=_:'GOH5'FF) 3&,L#\Q
MQ@GV[]: /0!&BNSJBAVQN8#DXZ9IU>9^+%U_PEX.G*Z_<W).H1"VF?\ UJQ=
M=K-_%R/Q'UQ6K=:EJ,?Q6_LM+^864NE&?R?E(1P6 (X]L\YH [>BO+O"<_BC
M5_!=QKXUNZN;S[//'!:") "X/RMG')XXS71>#=?M-;NKKR=2O6GCC19M.O5
MD@8?>;.!G)(!]".V: .OHKD]8N[V^\:VGA^#4Y-.@^Q->/)!M\V5MVT("P(
M'7I7*:AXBUW2].\8Z9_:TLUSI+0RV]VT2;]CE<J>,=^N/6@#U>BO/].O]<TO
MXAV.CW^L/J,%]8M.P>)8Q&XS]T#M\OZUZ!0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-Z1J&D0:5=68EL8-OEPEVP,# YSDX]Z;/X8T:YL[2UFL@T5G_P >YWMNB'3
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MX]WW>0N/O'!XZ9KJ6\#Z;-I>I6=S/>7$VI "YO)9 9F"D%0#C  QP ,5TU%
M'(+\/-.6YBN3J>K/<);/:M(]UN,B,"/FR.V> ,#IQ3AX L%T;2]+CU+4XX--
MG-Q"R2J&+YR,_+C@DXQCJ:ZVB@#A-2EA\:Z_::2=)OHH=*OOM%Q<W$ 5&V9
M53DY#'';H*[NN8T?Q;-K=XOV71;AM.:XD@%\)4*@IGYBN<[3C@C-=&T\*31P
MO*BRR E$+ %L=<#OC(H S[WP_I^H:UI^K7$1:ZL-_DGC'S#'/KCJ/0TNE:#8
M:*]\]C&8VO9VN)3G^(^GH*AT3Q FM7NK6R6LL#:=<FW8R?QD?Q >A[>U;- '
M()\/-.3PS>:"-0U VMW<_:97+1[RW!Z[,8RH/3M5\^$;1_$\.O27EY)<16WV
M7RG9#&\>""&&W)R23UZ^W%=!7*WGC*>W\33Z%!X>O[JYC@\]#&\8#KG&<LP
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M7&%"] O'3]37744 <Z?"H;Q-IFN/?R-/8VGV8KL&)>#EB>W7M71444 %%%%
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M+;XAZ#I<=YJ'V/4K21[N,WDG[UE5FSG.1D@=,5@:O<%_ GB+39'NI5T_7S%
M[R%RB;\ $G)P,'\2*]7D\,:=+K>GZNWGFZL(C%"?.;&T@CD=^#^/>JI\#Z*V
MGZK9,DYAU2?[1<9E.=^[=D'J.: .8U*.Y\'^,K0Z=J5U<17UG=S7-O=2F7YH
MXV=7YZ M@<>AJ+0=)UNYL/#_ (AM-2M(Y)&$U_/+>2N)U<\IL/R!N2,#&&Z5
MW%EX;L+2=IY//O+AHC#YMY*96$9ZH,\ 'OQSWK-TWX?:!I5ZES;17&(YC/%
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M<_\ ?1H Z*"+R+>.+>\FQ0N^1LLV!U)[FI*** "BBB@ HHHH **** "BBB@
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M\#GXRZ41-YV="'[W&-_S/\WX]: /1*B:7='+Y!225 <)OQ\W8$\XKA?C O\
MQ1*RJSJ\=W&5*L1UR#T]C4)T6W\-_$W0TT2 PQWMM,MY&)"0RJ!ACGOG'UH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %5KS3K+48UCOK.WND4[E6>)7 /J
M15FN<\7^*#X;M+5;>U^UZA>S""U@WA0S'')/8<_J.E &I:Z)I-C-YMGI=E;R
MXQOAMT0X^H%27&EZ?=W,=S<V-K-/'CRY9(59DP<C!(R.:Y2^@\?6&G3ZA%JN
MG7DZQ;_L(LB%SC)"-NR3Z9ZUT$FOZ?I]E:2:M?6UG/-&C%)7"')'/!YQF@"]
M#86=M<37$%I!%/,<RR1QA6D/^T0,G\:ABT;2X+S[7#IMG'<Y)\Y(%#Y/7Y@,
MU(^IV$=M%<O?6RP3$+%*TJA7)Z!3G!Z=JB&N:01*1JMCB'_6?Z0GR<XYYXYH
M )-$TF6\^V2:79/=;@WG-;H7R.AW8SFGR:5I\NHQZC)96[WL:[4G:,%U'L?\
M]Z5]4T^*VBN9+ZU2WE.(Y6F4*Y]CG!I;34["_+BSO;:X\O[_ ),JOM^N#Q0!
M4/AG1#JQU0Z7:F^(YF,8S]?3/OUJ<:-IJZPVK"RA_M!D"&XV_-CIU^G'TI]K
MJFGWTACM+ZUN' R5BF5R!G&< ^M1G7-)680G5+(2ER@0W"9+9QC&>N>,4 -A
MT#2+>Y>YBTRU6=YC.9/*!;S#U8'L>.U7Y(HYHFBE19(W&&1AD$>A%0B_LVO3
M9"[@-VHW& 2#>!USMZTZ"ZM[KS/L]Q%-Y;E'\MPVUAU!QT/M0!G:;X7T32+D
MW-AIL$$Q! =025!ZA<_=Z]L5/8:'IFF7EU=V5G'!/='=,R9^<YSTZ=S5:YUB
M5_$<&C6"(TBH+B\E;D0QYP!CNS8('H.>:O\ ]IZ?]J^R_;K;[1NV>5YJ[]V,
MXQG.<<T 0ZIH>F:T(!J5G'<B!]\8?.%;UQ4NI:79:O8O97]NL]L^-T;$@'!R
M.E%QJNG6EPMO<W]K#.V-L<DRJQSTP"<U;)P,F@"E::1I]EI7]EV]JB6.UD\C
MDKM;.1SV.32W>DV%_IATVZM(I;(J$\DK\H Z >F,"IHKNVG8K#<12,!DA'!.
M.F>/H:8^H643HDEY;H\C;45I5!8^@YY- &?9>$] TZ:.:STFUAD2-H@RISM/
M4'US[U53P#X6CF29-%MPZ/YB\M@-G.<9QV%;TUU;VZLT\\404;F+N%P/4YKF
MO&_B>Y\.^'H=4TY+:X5KA(V+L2"I/;'TQ^- %V]\%^'-0U!K^[TBVENF8,TA
M!^8CN1G!JW_8&F?VXNM?90-06/RA,&(^7&,8SC]*'FU,>(HXE%I_99MR6)<^
M=YN>PZ;<?SJ\9XA)Y9E0/TV[AG\J ..^*6GWNJ^$!9Z?9S74[W,9V1+D@#))
M/M6YIOA?1].:>:VL3'+<QE)6DD9WVGJN23@?0UJM/$C[&E16_NE@#7/VGB*Z
ME\;ZIHEQ;PQVEK;QS).).26QP0?7)Z=-OO0!-;>#-!M=#FT5+$-82OYC12.S
M_-QR"3D=.U5U\#Z+9>&M0TC3;"*-+N-@QD9CN;^'<V=V <4>,_$L_AO3+*\M
M8(9Q<7D=NQ=CP&R<C'7@&NCDFBBQYDB)GIN8#- %+0M+71="LM-61I1;1"/>
MW\1'4_G4>D^'].T2:\EL8I$>\D\V<O*S[FYY^8G'6H]6UIM'OK(W,*_V;<N(
M6N0^#%*3\NX'C:>F>Q^M:YS@X )[9H QX_"VDQ>)7\0+ XU)UVM+YK8(QM^[
MG'05>_LRS_M<ZKY ^VF 6_FY.?+!+8].IJ'2;O4)[&275K6"TF25T"QS>8I0
M' ;/&,^G\N@OI(DB[HW5QTRIS0!SNH> O#FJZG<:A>V!EN+D 2GS7 ;  !P#
MC(P*9<_#_P -W5M90/8L%LXS%"R3.K!2<X+ Y(R2>?4UTK.BYW,HP,\GMZT-
M(B,JLZAFZ GDT <]_P ('X<_L6;2?[.!LYIOM#*9&)\S^\&SD<<<=J?:^"M"
ML]*O-.@MI%@O5"SDSN7<#H-Q.<=>/>M]F"J68@ <DGM6%XMU^?P[H:ZC;6J7
M1,T<90OMX8XR/4YQ^= &EI6EVNC:;#I]DKK;0@B-7<N0,YQDG/>J.K^%=*UN
M\BO+J*5+N)=D=Q!,\3J/3*D>M;()(!(P?3TI: ,C2?#>G:-#.ENDLLEP )Y[
MB4R22\8^9CSZ\=.:R!\-_#P@>U47RV;_ 'K07LHB)SG.W=["NMW#;NR-N,YS
MQBEH 9%$D$*11*%C10JJ.@ X K*T_P ,:;IFL76JVRSB\N\^>[SNP?G/()QQ
MV].U5[WQ%/:^-M,T!;)7AO())FN/,Y3:#_#CIP!U_B]N>@H Q;+PKI5AK-UJ
MT,<IO;M2L[O,S!P<<$$X["LZ'X>:%!.I0WOV5'$B6/VI_LZL#G(3/KZ\5?BU
M^1_&L_A][38D=D+M)_,SO!8+C;CCG/Y5N4 8Z>&=/7Q'<ZX?->ZN8!;R*[YC
M*<<;?? ZUC'X9>'&C>!TO6M&D\U+7[9((HF]54'CJ?6NQK,TR^U&[O\ 4X;S
M33:P6\P2VE+AO/7'WL=O_KX[&@"%?#-BGB9M?62X%XUO]FQYGR;..V,YX]:S
M5^'VCIX=;0Q+>_9&N?M1(GP^_P"H'3BNKHH \LUZ ?\ "8ZA-J%GXI@!6.*V
MFTAF994 Y+$=#D]/ZYKHM%\,W%U8:?=:C>ZI%<V<\LEF99%,T<3@#9(<,&.!
MWY&<=J[&B@#CM:\#1W.A"PTV::*X?4!>R7+3%6+L?G<X')QD # SCTKK+F'[
M1;20B62+>I7S(R RY[C(/-2T4 <C#\.M)@\-SZ"EYJ7V":42E3.,@CL/EZ'@
MD>U:3^%;%]<L-7>:Z:ZLK?[,A:0$.F"#OR,DG)YK<J&2[MXKF&VDF19Y]WE(
M3R^T9./I0!S5A\/M(TZ^2>"XU'R$E\Y+)KHFW5LY!V>QYY]*V['1[?3]1U"]
MBDG:2^=7D620LJE00-N>@YZ5H44 8^K^&[/6+RTO7DGMKVU)\JYMG"2 'JI)
M!!'L1_6JLW@W3Y](U*P>>Z:34L?:;MG!FDQ]T$XQ@#C&.F:Z*L'3_$R7WBW4
M] -G)%)8QI(96<$.&QT Z<$?_6H UK&T6PL+>S2221((UC5Y3EB ,#)[GWK.
M7PW;IXFGUQ+J[2:>)8I85<>4X (&1CMGCG^=;-% ''_\*ZTW_A$8_#GVR[^R
MI<?: ^5W9SG'3I_GVJ35/ 5CJ&M2:I#J.IZ?+/C[2ME<&,38& 3[UUE4+35[
M:^U&ZL[;?)]EP)9E'[L.?X W=@,$CMD4 6+.S@T^RAM+9-D$*!$7). /<]:G
MK&T;Q';:WJ6JV4$,R-ILPAD:1<!B<]!UQQWK$O?B1861-P^EZF^EK*8CJ*PC
MR202,CG)&1UH [2BL\ZQ;IK$6FR)+')/&9()&7Y)<=0#_>'7![5H4 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7 ?$
MN.ZLI] \100-/#I-T7N%5<D(VW)Z_P"SC\:[^B@##/C+PV+'[9_;=CY.W=Q,
M"V/]W[V?;%<Q8/:/\4]=35S RSV<$MDMT@_U07YL;AQ@[B1]?0UV,7A[18+I
MKJ+2;%+ANLBVZAC^./85+J&CZ;JJHNHV%K=A#E?/B5]OTR* /([B"RC\"SQE
MA)IG_"2C[$T^-IARH.W( V_ZSIQUKHXM)TK_ (7)=0S06,D<FD[DMS&N%;<H
M/!&,E<GCL:[JZTK3KVWBM[JQMIH(6#QQR1*RH1P" 1@=32'1],;46U Z?:F]
M9=IN#$N\C&,;L9Z<4 >)W<%FWPYAAB*3Q6_B-H8F;#$1G/'L" #[UT^K65AH
MGQ"D.G6$<5A%H<\NH06H$89,-@'&,$X&#UK7\:>#WO-#M=/\.Z591*+U;J95
M*PJ=H(Z8Y)S^E=;9Z1IMC:R6]KIUK;Q3#][%%$JJV1SD <T >:Z-J.G/XJ\%
M26LUA K64\36MLP8Q9&55FZDDGH>X)[U@6=AIZ?"35]6>QMWOH-1&R<QCS /
M-CX#8R."?SKV2'PYHEOY/DZ18QF!]\16W4;&]1QP:0^&]$-FUF=(L3;-)YK1
M>0NTO_>(QU]Z ./\5S'1=:T3QS%;$V_E?9[]4&6$;CY3[X)Q^0KI_"6E#2]"
MC,D*1WEV3=76U<9D?YB#],X_"J.IZ7K>KZN-+GM]-7PNK1.W!,TFS#!,9VXW
MJ!T'%=70!P_A]9E^*GBOSB<-#;&/)S\NWMZ<YKC=1OM*ET=9+/[)9F+Q DF)
M9U>YD^<AW8]5&<8Z\#FO4+O0R?$EKKEDT<=RL?V:Y5P<30D@XR.C \CUZ>XD
MD\+>'YGE>31-/=I6W2%K9"7/J>.: .%\1*^AZWK&OBSL-:TB66/[;&&59K.1
M H&&ZGH#CW^IKOM;N+>/PU?W-R95MQ:N\GE-M<+M).".AILGAK0Y97EDT>Q:
M20@NQMURQ'3/'.*T9(HYH6AEC5XG4JR,,@CT(]* /+](_L^/Q5X*:SCM+>*?
M3IT,<<BN[?+P'< ;C[8X(;\,ZT\-:$?A]XHN9K2))[2]NA!<;<R)L/R 'KC/
M'XYKTF#PAX=M# ]OH=DKV[^9$RPKN##H<]<].OH*YWP9X5_T:ZF\1Z##'?\
M]H27<;R;'!W<@C#'I[].U '/66C6VO?$/3K?7[07$C>'H99TER"91M!)QCGK
M6-J8:#X?Z[90@?V;:^(C%9D/NPH)^4<].A_$UW&H^'+F_P#BB=0N]&DN=*:Q
M%L)A(@VN3G</F#  $C(&>O:NIN?#.BW>E1:7-IL!L86#1P*-JJ?48QZF@#FM
M7ADA^+%E=P8>=]'F5$8X&58D<^Y:L#PO;^$]7\)Z7>ZI?6\.LI<B:2X611<O
M()#M4Y!8@Y48%>D/H&E/K4.L-9QG4($\N.?)RJX(QC..C'\Z@B\)Z!!K']K1
M:5;)?9+>:J8^8]3CIGWQF@#SGQ4NFSZ=XPOK6+9=VU["IN[F8-)YBD?+$."@
M'8G.>?3C4;2='\0_%K5(-0@%W$=,BEC ?Y",KSP>>HQVZ^U=;<^"O#5Y=7-U
M<Z-:2SW)S*[IDD^H]#[C%22^$M"F,!.G(C01"&-HF:,A!T7*D$CCO0!YE<P?
M\6OBB:X<P6>O;+,N0=\8D*@ ]Q@L>/2M2^TY_%GBWQ1IM_+I\,\"1I;+=Q&9
MHH2IS)'AUVG)5B>>H!]*[R]\,:+J%C;V5SI\36ML=T,2DHJ'U 4BF:IX2T#6
MKF.YU'2X+B9%"AVR#@= <'G\: .9\0BU_P"%/SK_ &A]N6W@"QW; IYDB/@$
M?B..N?>NZ@'FV<8?)W1C=SUR*PM:T"356T_2HXH;;1+=DGE$?!<HV5B"XP%[
MD_@*Z)E#J5;H1@T >1>&[&[U/X=ZK9VLT)F&ML8X;I_W<^THWE-GJ&P>._XF
MNN\ W5E+#J=O#HHT>]@N MY:HV4#[1RN.,$#M^M:D?@[0(;![&/3E6V>83L@
MD?\ U@Z-G.<UH6.EV>FM.UK#L>X?S)G+%F=L8R222>!0!P6NZ;;ZO\7X=.O/
M->UGT8^9&LK*#\[>A]A^58UKH-QXOFUS[7?V5G>6-XT2M,'DFM8T"[2K"0*%
M^4\E3SN.?3U)]#TZ36X]9>V!U"-/+28NV57GC&<8Y/;O5"^\$^&M2U![^\TB
MWEN7(9W.1N([D X- ',C1[36/'T$%_=3:A:S:&L[ RLD<CAPF[:".",G'/6N
M<U3S+7X<>(;'[7*UI8ZT(;64DL4C#KPISS@Y[UU>HZ.VI?$Z$W&EWHTZ+33;
MQW,#%$#$D\D$8&"5P,\XKH[WPGHM]H@T>6S"V*N)!&C%?FSG)/4GDYS0!S>N
M)!?:YJUK#]LGOQH99&>0"& D-M8#.=Y..1TK%\.WT^O:IX;TO5YIGM&T=IT7
MSRGGR[\9.T@DA5/7W-=W>^#]#U#44OKJT,DZP?9SF5L.G'##/S=._J<U7N?
M?AZ[T.UTB>R+VUJ&$!,AWQ[CDX;W_I0!RNMV<.D76@>&+/5,Z=>W=R)%N9'D
M56"KY<)V,IV@L/E)ZXS46L65YX3T'4+:7Q"#'?WEL)%A5P;.)V8.5R[-@A<=
M?X37:W7@O0+O0$T1]/1;&-MZ)&2I5O[P/7/)HLO!>@6&A3:-%IZ&RG(,R.23
M(1C!)ZY&!0!R^H:=::=\7O"L=I%Y:FVN,_,3GY'ZDFM?X@WC066DVAN)+>VO
M]2BMKF2)BK^6<D@$<C. /I5W3O VA:;>6MW%!-)<VN?*EFN'=ES]3^'XFM75
M]'L=<TZ2PU&!9K=\$J>"".A![&@#C;71[.P^*-Y:6R2)#-H.6!E9CDS8."22
M.!6(MS*?A'X:O);J59$U",M*92"1YS@[CGD8]:[O3/!>BZ5J,6H00S/=Q1-$
MLLTS2-M)YZGZC\:ICX;^&A'/%]DE,$SA_)\YMB'=GY5S@?X4 8%QIBZW\6=7
MTNZO+];0Z>DWEPW3H X* ' ..YX]Z2=[BW_X6.B7MUFWCCDA;SB&C/E%L*1T
M&>/I7:1>&;"+Q-+X@1KC[=+'Y;_O3L*X QMZ8X!^O-0'P=I)EUB0BX)U==MU
M^^/(]O3K0!Q&EQI8+X%U9[^],]^XBG::[=U?,9PN"<#YB*=KUO?ZAJGBFTDM
M]3DU)!&^E2P/+Y87 ^4;?E4YY.>N?:NQ_P"$(TCR-(@8W31Z3();56G) 8,&
M&?7&,#T'%<)>:/)=:OJ\NI:-XK6ZN+QF273)%$?EC 7&6QR!W% 'J&C6MQ9:
M)8VUW,\]U' BS2NY<N^/F.3R><UYS-<F"VCU2/4+^3;XB13?S2[(Y$9RCHJ[
ML;%4;<D8ZXP.!Z!X=M;VR\/6-MJ,S37D<>)7=]Y)]SW/:L23X:>')4NHVBNA
M'<R^<T8N6"J^<Y49P#V^E &+J6FO?^(_&*W&IZF8;2RBFA@6[=(U9D9NBXX!
M08'N:HW%YJ%S\/\ PSXN>:ZEGTV1&NHXY&Q-$KE2S#/+?*"3[GMT[L>%+ 76
MHW/G7AEU" 07!:<G*@8& >X&>?<^M9%[9?\ ".>&5\+Z1I6I:@L\$D4<IVO'
M&6R/WC$C R<\"@"SX48ZKJNL>(8[B1[.[D6&T3)VF.,8+@'^\V>F.E4M>LHI
M_BGX:D<R!OLUQ]V1E^Z 1T/^T<^M=5I&FQ:/H]IIT'^KMHEC!]<#K^-4M9\,
M6.N7^GWUQ)<Q7%BS-%);RF,X(P02.<?3!H XG62^D^(?$VGW=]>E=8M%ET_;
M(VXR9V^6G.,Y(XXXZ\4_PSJ\VLVFC1,UP+G0X)I+\%R?WB QHCDCG=RW?&VN
M]O-$L+_4K#4+F /<V)9H&)^Z6&#]:6QT6PTZZO[BV@"27\GFW!/.YL8_+KQ[
MF@#SG0[#Q)KNFZ9XEM]:2*0OYUQ)+>2E'0.=T9C "JHQC ]*U-,A%Q\7?%<)
M>1!)8PIOC;:RY1!D'L?>KUI\,M"LM2-U%+?^1O\ ,%DT_P"XW9!^[C)Z="2*
MV;3PS:6?BB^\01SW+75Y&L<D;,OE@  # QG^$=Z .$TR_O\ 4/+\&W5[>-J5
MGJQ\ZX%P3));(3)N+9S@\#\J>L?B/Q,GB.XTW49H+ZUU22W@4W[QK$D9&!Y0
M!4Y&<DG!YKT.+1K*#7+G6(XL7EQ"D,C#H54G'X\@9]%%8%]\/-*O-7N-0CN]
M2L_M1W7$%I<>7',V<DL,9R3R>: -Y[J:/P^UVK1W4ZVID#0\K*P3.5QV)Z?6
ML'X8J!\/M,DY+R^9)(Q.2S&1LDUU44$4%NEO$@2)$"*@Z!0, 5SWA33;KP_]
MJT1X7;3X9&ELKG<"/+8Y\MAU#*<]L$&@"KX8_P"1X\9?]=[;_P!%4_Q;8_VA
MI,7A73;;8MT8UF,:82V@#9+>F?EP!WY]*T-'\,0:-K&I:G'?WT\NH,&F2=U*
M@CI@!01@<#GI6-<?#>UN+J\N/^$A\01F[<O*D=VH4\YQC;T':@!_Q$0V_AZQ
MNXG9)[+4+>2)ACKNVX/MACQ795R.J:%-J4VDZ D4XTFP:.XN;F5^9]GW(Q_>
M)/+'';UKKJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ JM>:A9:=&DE[=P6R.P16FD"AF/0#/>K-<3\3%T]M*TD7_D;
M/[4M_P#6D ;=WS]>VW.?:@#?'BKP^8I)1K>G>7$<.WVE,*??FK4FL:;%IJZE
M)?VRV+ %;@R@1G/ ^;I7'&WTH?&"XCDBM,'1 9%95QN\SG(]=F/PKD-&O;&S
MT7PS<N$DT:WURX67)RD9(/E,V?0-NY_K0!Z[:Z[I%];37%IJ=G/#""99(YE9
M4 &<D@\4RV\1Z)>74=K:ZM933R#<D<<ZLS#&> #Z5PNKK%<_$'5+RP:"2S_X
M1Z1;V6,JR%B6VACTW8"^^!67%#I,7AGX=W,$4$=R^HP@R*NTL 3YF3W^;'6@
M#O3XIMM1EU[3-,F\O4M-C(W2J-I;:>0,Y(!X/ H\+^*+35='TL7>HV9U2Z@$
MC0+(H8G'.%SGM7,^')HK7Q+X_AN)4BE>7S%21@I*[7.0#VP0<^]8Z6NDVO@'
MP1>PQVR2?VI;&2<8W9W,7RW7@CGTQ0!Z_--%;PO+-(D<:#+.YP /<U3@US2;
MJ\6SM]3LY;EEWK%',K,1ZX!JIXO@BN/!NLI-&LBBRF8!AG!"$@_4$ UP,EEI
M3^'? 1L(K;^U#<6;?N<"0KMS*3CME3G/H: /29-<TJ+45T^34K1+UN%MVF4.
M?^ YS4ESJFGV1875];0E<;A)*JD9.!G)[DBO(;"W\/:EIM['KFOW-K?P:A,\
MEJBPI,9!(Q&TE#(Q.>F>O%;L-AINJ_&/6+:\M8)XGTV-C%(H/S@QGIZT =OI
MEQ>FYU,WUY82P1SGR/LY.Z),?=DST88_G]!-8ZYI.IRO%8ZE:7,B?>2&96(_
M &O--<Q%I7Q'2PX;[1 SK#R=I">:2!]7S^-:'B>+2I9?"-]X<@LS=OJ,?D>1
M@%HMI+Y"]0,#/I0!TGC/Q(=%\/7\VGWMB-2@0,L,S@G&1GY<CG!R/Y&MG3+J
M:^T.SNVV+//;)*>#M#,H/3TR:\EAN-/O/AGXF.IO:V^NO/,]RK >:'WAE7GG
M&0 .OZ5ZEX8ECG\*Z3)%(LB&TB&Y3D9"@']0: ,3P+XLDUW0_/U:XM([PW4D
M2(I";@",8!.3UQ75FZMQ<BV,\0G(R(MXW$>N.M>(Z=H6DO\ "O6[Z\M%74[>
MZD1)@G[U'#+M7J.YQ^)X-=/XBBD\/'PQXRN$D,]K%':ZB,;G*LF"?J"6'OD4
M >D17$,[2+#-'(8VVN$8':?0XZ&JVJ7R65E*PN;6&X:-O(^TOM1G XSWQG&<
M5E^#-.>Q\/I<7"!;W4)'O;GY=IWR$M@CL0"!CVKF;.73[WQ[XMBU_P"RLT<<
M,-LEV%&(MK$[=WJ3DX]10!HZ'XGUW7?"6F:K%#IMO/-=^7<"X+*GE9(RG.=Q
MXP,FNPEN[>#=YUQ%'L 9M[@;03@$Y[$\5XMI*P2?"G068J9(]=CV?-R"7.?T
M-= ^@Z7K/QDUBWU"RCN(O[/CFVMD?.#'SD?E]* /1WOK2.Y%N]U L[8 B:0!
MCGIQUIUQ>6MH%-S<PPAN%,KA<_3->,:=IMOXGTN\O=5\1V.GWD-_)/-F!#-$
MP/!#[@2, 8P.U=)9C1=9U[QA:>)'A699Q$AN'5"EN%^79GD=SD>H- '=-K%B
MNM1:09U^VRPM.L8/\ (&3^?'T/I4\E]:0W"V\MU DS8VQM( QSTP.M<'96VD
M#XE:(EJL<ELNA9M&DY)Q)\I!;DG;G\*S?#^E6/B#P5XBNM:CA;4UNK@S7+_?
M@=%^4YSP%[#.,4 >J.ZQHSNP5%!+,QP /4U%)>6L,D<<MS#'))]Q6D +?0=Z
M\CLK"W\1^*/"T7B.&6YDN=%9F#_*78,Q!;&#]WG(YSBK^N6,.@:G?WYTVRU;
MPXJVUO/%'(6N+ 1*H&#UQWQGZXYR >J=*8LL;HCI(K+)RC Y#<9X]>.:@GAM
MM7TMX94\RVNH<,K<95A_@:\5NO/;P_#I M_.U+PG>O-*VTJ&MT88P<=6R"!Z
M(3Z9 /6?%.L7&C>&M2U#3XHKB[M(P_E.W &1DGD'A<G'?%:EG.;JQM[@J%,L
M:N0.V1FO/KJ:UU7P7XK\4HC1+J-LT4!D."8D38N1D@$OO_#%0G2;31?%G@V[
MT[-O+>P/%<JK$F8"(,"V3SS_ "'H* /3=R[MN1NQG&><4M>/V6DZ1J/PHO==
MN(8SKD:3S378)65)P[$9/8_=X]Z75EOI+6T\0:II=OK%G+I,,6HPAL36HY8N
MO/&>N?;MUH ]?HKRR:Q@\9^,-5M99[/REL(/L,=W;L[JCQABZ8=0"">3SV]*
M[GPI&\'AJT@DU--2>$-$;I.CE6(QU.<8Q^% &U17CNO1Z?+I][XATIS]HBU^
M,K?3RAI)B"04C &-BY&!W4$GI6FN@:7K_P 5?$=CJD$MQ EO!*B&X=5!VC/
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M+,!FJ&JW%\+6WDTJ:RW-.@<W#':T>?F"D?Q>E !?^'M(U.]M;R]T^&>XM?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA7I<UC9W%N+>:U@D@!!$3Q@J".AP>*7[':BZ6Z^S0_:%3RUEV#>%_N@]<>U
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MHOA;5M'AM[>^^UVJ)+:JH:96&&4D?>R,D_2I_#5G:O\ %KQ9(UM"SQ>0T;%
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M"];4#*+P"^F,\J+=.$$A.2P7.,Y]0>M7[+PCIFGZ\NL0-="Z%NMMAIV92@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU;0]4UG#0NN);6Y+88IQR!UZ= /J>H^(\-S/X U9+1'>78A*IU*!U+_^.AJ
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MHW#DCK7"Q%C\;KE-[[&T8$C><??7IZ?A7"Z=IUL?AT=;(D_M*VU<"&X\UMR
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MWB"VFN4OH=0"I_I#B/&\\; <<XYKJ;FQU7Q;KWB2&&_BAN;.Y$-NDL\T9MD
MXD4+P=W7GT^F0#U2BJ6D/))H]F\MU%=R&%=UQ%]R0XY8>QJ[0 4444 %%%%
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MXCG\.>&[N^L?LDEW;B-S#.2?D9PF=H(/4^W]*W;.X-U8V]PP"F6)7(STR,T
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M]O%:6T5O!&(X8E"(B]% & *DHHH ***@O+RWT^RFO+J416\"&21S_"H&2>*
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M=0L!/-&-+M7$SVH4YEE7[F3G[HZX[]ZUKEYH[69[>,2S*C&.,G&YL<#/;)H
M\7CT'0$^$%_J,EE;QZ@LTJK+G=(L@FPB@_0 8].>];-II-CK7Q6O+?6;6.Y(
MTF%]DPY$@$>3]>M;7@?PB+*R$NNZ#91:G#</*EP"LC-N);.1TQG ^@KJHM#T
MN#59-4BL($OY 0]P%^=L]<G\* /*M3:2&]^)4>DP(9BD+,T?7#8\WOCH7/KG
M-:FM6.F_V-X,U#1(HH[TW=NL#VZ %U*_.#[<<Y]/>O0++0-)TZ]FO++3K>"Y
MF!$DD: %@3DY_&HK'POH.FWGVNRTBS@N.<2)$ 1GT]* .0\(:!HU]XH\27UQ
M:127UIK#-$Q/,0 RI 'N6_$>U6?BJ\4.BZ1/)##*(]5A)69<J1AL@^W'-=;8
MZ)IFF7-Q<V5C!;S7!S,\:X+G.>?Q)J34=+L=7M?LVH6D5S!N#;)5W#(Z&@#B
MK=(-1^+.IPZE%;SP?V;$+%955@T9P6*^O):K/PSC$&FZQ;0,&L(-4F2U(Z!.
M,@<] :Z&[\,:%?P00W6DV<L=N@2)6B'R*.@'M[5H6EI;6%JEM:01P01C"QQJ
M%4?@* .#T=(%^-/B1F6,,MI"RD@9'R)DC\^?K7)S:1HX^%5SK4=O!_:@OR5N
ME;]X&^TX !S_ '.WX^]>O3Z%I5UJ2ZC/I]O+>(NQ9G0%@,$8S^)JL/"6@"P-
M@-)M1:&3S3#L^0OC&['KB@#SK4M'M?$_B[Q);:IK%G92Q2(D/VFW5G$6T8*,
M2,#.>GK7H_AQ(8?"]A':WSWT4< 2.Y=<&0#@''IQQ[8Y/4I>^%- U&=9KS2+
M2>54"!WC!.T=!^%:T<4<,211(L<:*%5%& H'0 =A0!XO>II]_P#!6_U6989=
M8EF5[F9P#*)?/ QD\CY>,>E;E^='O]1EMYX/.O+;PY\QN'7RHU*Y!1<9+G(R
M>@ %==-X&\+SW<EU+H=F\TGWR4X)R3G'3//6I;KP?X=O)X9[C1[222",1QYC
MX"CH,=#CMGI0!YOIKB_N/AI=31@PB.: F0@@LHVCK[KD4V/1K;Q1>^)3J^K6
M-C>)J+)NGB5I8D7[NQBXPN!Z=C[UZ-)X*\.36%M82:3"UK;2M-%%EL*S=>_(
M/H>*??\ @WP[JFHI?WNDV\UTF!O8$9P,#< <-^.: +8EF7PWYMK.+F86>Z*8
MC:)6V9#8P<9.#T[UY;_9.BW'PB'B 11_VO"GFF\W$2^>K]R>I]OI[5[&
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M=$71]0TL)<_9K^;SYP9V)+Y!X/X5#JGPY\-ZP;4W=K*SVT2PHZS,"R+T#>M
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K.UG7=.T"T6YU&X$2,VQ %+,[>B@<DUHUQ7C=F
ML/$'AC6YH#)IUA/,+J3&1$)%"JY R>#SG':@#8T_QCH6IV=U=07RI':KOG$R
MF-HU]2& .*=I'B[0]>OGL],OEN)DB\XA48#;G&<D>N/SKAKV^M-:\6:OKNF3
M>9I4.@O!<7"QL%>0EL+R.3C:?PKK_ ,EG/X'T:6T6/ M4C<JN#O48;/_  ('
MZ]: +FL^*]&T"9(-0N_+F==XC1&=@F<;B%!P,YY/I7/^*->N1JO@^XTG46^P
M7]ZJ2>5@I*I(ZG&>A/']17/Z\VG:5\1=6E\3M?II]_;1+:RP/*JL  #&=AYY
MR<?XT[6Y;&QA\!P6$$UEIHU3S8H)B2^W>,,0<GG<2,]FH [K4O&6@:3>M9WN
MHI'.A42*%9O+R,C<0,+^/J*L:EXET;26B6]OXHWE3S$498LO]["@G'OTKS%)
MM!TW5O$6D^+FU 37E\TRK&TVRXB/*G"'G'^>G&O'K>F>%/'%VFJPR6]C=Z?;
MI8RR(S^7&J8,1X/4Y)Z]/>@#IKOQOI<%WHD4'FW46K,XBFB0E0%[],GD@8[=
M?K9L;F&3Q9JB+KPN&2*,'3@!BVQU;/4DG\LC/:N3U34M*TK6/!.H063V6E%K
MI$5H=@3>%"DCMDY/K5.YB>^^(7C>TLIE%S/I"I$%P2S;$R!_+VS0!W,'C#P_
M<7\=E%J<33R2&-!A@'89X#8P>GKS27_C3PYI=U-;7NKVT,\! DC))8$].!U_
MI7!7^IZ;K7PLTW0[.19-:46MK':8Q+',C(')'51@-\QXK2=].F\8>.8T6%K@
M::A'R<@A&W\X]2F?PH ]#M[B&[MHKFWD62&5 \;J<AE(R"/PJ6N"^'^NZ?8>
M!?#=M=706:\>2"%<%LN';@XZ=NOJ*[V@#A/'M_K=EK?A^WTK6'LH]1N/LLBB
M".0 Y'S_ ##.>>F>U7K/3O$>GZS;-=^+X[ZV4,]Q;2VD<3&/!^8%>>#CVK$^
M)<MC+XC\(V5W)$5-\&EC=L#RR5&3Z#K5KQ5X+LK+0]9U'0[5XK^2P, CA8X*
M;@S8'J0,4 ='I_B_P_JM^ME8ZI!-<,"41<_.!UVDC!_"GW7BO0;&Y:VN=6M8
MYUE6%HS)EE=N@([=*\_UJ_L-7\*^$;31;FW?5!=6NR.)@98<*=Q('*@'KFM;
MPU#I5[\2?%X,$$KI);.@E568.JMO9<YQ\V.1[4 =Q?ZG8Z5 )]0O(+6(MM#S
MR! 3Z9-4[/Q1H5^]PMIJ]G,;=/,E*2@A5 R6STP.Y[5B_$^.!O =X]PB,L<L
M#989V_O4!(_ D?C63=6^C?\ "Q/#JZ#%:KLM;EKM;0  1F/Y-X'J3WYZ4 =F
M?$6C"UM;DZG:B&[8);N9!B4D@87U.33KK7]'L99(KO5+."2+;YB2SJI7/3()
MXS7C6FZII]O\+M(M9;N!;F+6$D>'>"Z*)"2Q7J!CO7<65CI-_P#%;Q EU;6=
MQ(MK;E4E17(./F.#W^[G\* .FE\6>'8)FAEUW34D0[61KE 0?0\U:O\ 6=+T
MM(WU#4;6U67_ %9FF5 _TR>:\VM[;PVNE^.OMUO8B>&]N I:-0Z(4&P*>H^;
M=C'>G>$94LO%&GV^O*JR2Z) +)[H@@$#YU4GH3_2@#T8ZYI0TP:D=2M/L)./
MM/G+Y><X^]G'7BD37-)>PDOTU.T:SB;;).)EV*?0G. >17EL6E?:K;7[>WO8
M=-MVUY7TJ8@"(S*&)&1VP,>F146IZU)<:19R:G;PV?V/7U74KBP12KR*N5DY
M!S[]<X_"@#U>VUW2;RTGN[74[2:W@&998YE98^,_,0>.*=IVLZ7J_F?V=J%K
M=^5CS/(E5]N<XS@\9P?RKSM]-\,L-?5?$TMQ-J,,2W%TFSR8F9]L>[8 N2>W
MH#G%:_@B^U!->U+2=7L+)-1BMX9&O;, +<)R%+8[\\=._% '8W^I6.EP">_O
M(+6(G:'FD"#/IDU5F\0::NA7.KV]Y;W%I C,9(Y5*D@?=W=,YP/QKF-?DBC^
M*?A_^T50V36DRP-(/D6;J2<\9P !WYK+:&VM-7\<FW6W&AFP5I OS)]H*'[H
M' /K[[: .@\'ZMK6N);ZA-J.EW5A+;AI8[9")()C@[#\QZ \YP<]JUQXCL9]
M;O=#MYT_M&VA$A5\;<D<#KDXX)]B*K^!Q;?\(1HIMA%M-G%O,>,;]HW9QWSG
M/OFL+1RL7Q5\4BY,*.]O \(.T$J%Y/\ C0!>\#^+_P"W?#ME<ZK<6D-_<RR1
MQQJP0R;3_"I.3Q6W'-J'_"2S0//9?V?]G#1Q GS]^>21_=KQFUAM;7X+P:LE
MM;_VA;Z@&BG9!OR).F>N.O%=I&8A\9;QY&$0DT/<[KP?O+D_7 _2@#M[?6]*
MN[Y[&VU*TFNTSNACF5G&.N0#FKDLT4*[I9$C7.,NP KS'PH\VB>(M'TF^M;&
M\MIH9CI6IVR?O-G4[P.F0>2>_<\UTGCNPEU"'2UL[VW@U&*[$UI#<C,=PZ@_
M*??&2* .@BUC3)X(9XM0M7BGD\J)UE4AW_N@YY/!XJOK.KK9:5JDMG-;R7ME
M:M<&%FS@ $C< <@':17G-]JD=WI&F_;-,@TV]LO$L"WHCQY>\DEF#9[@#-:.
MLR63^+O%(M9(&EF\.-O$; EW&_T[[=OX8H ZSPIKIUKPWIM[=R0)=W$09XT.
M.<D<#.>U;+W5O')Y;SQ*_P#=9P#^5>,7&A:=_P *IT/5+.W2/6O.B6":)?WD
MCF0C:2/;)Y]*V-?D;1]>U/67M]/U?09+R(785AY]I,NU!MYX(..GJ0<4 >GO
M<P12".2:-'/168 G\*66>&  S2I&#TWL!G\Z\K.FZ9XCN?%UIJFKP6MVFH-M
MDF1#)#$FTJ59L$+D$8!Q],U:T]]-U#QM?Z?KL\5U!_9L"6+7Q ,B%?F=00-K
M'OCGB@#O+S7M.L+[3[.>X437[E8 #G=@$D_3MGU(IMI+JK:]?Q77V3^SU2,V
MOEL?-S@[MX^O2O/KK3]+LO$?@)-/E$^D0M<K'-*P8$\GKWYS@^PK0U!GL?%7
MC.?3BPO&T>.5=AW-Y@# 8'X+Q0!Z MU;O+Y23Q-)_=#@G\J5YX8]WF2HFW&[
M<P&,],UY)K5AI0^%&EZKHMM$FHHUN8KB+'FF8L P+#DG)/!-69=*LM8^(OBR
M+5;=)UCTV)P'_@;RUY'H>M 'JW6L0ZY+<>)_[(L+=)DME#WT[/@0[@2J@8Y8
MX!]A5;X?R/)X"T9I'9V^S@98Y/!(%9/@$RMKGC+S]V[^UG W==O.W\,8Q[4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXR3T ]30!,((0% B0!3E<*.#[5)6+9^+M!OM.N;^#4HA;6Q G>56C\O/3(8
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MXR2/8<C/J#0!9T[3K/2;&.RL(%@MH\[(US@9.3U]S6:FBSV7BF34[%XEM;Y
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M:'PZNE,MG->@\R;F.3QP2-I'3@C&.E>ISV=K<LK7%M#*R\ R(&Q^=.GMH+E
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M0/\ 7 YZU6_X1?0#:BU_L33OLX?S!%]F3;NQC.,8SCO0!S'CN*/0]:T7QFD
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M@CM76Z7HVG:+#+%IMI';1RR&1U3/+'O^E1ZEX?TG5YHIKZQBEFB&$EY5U'/
M88..3QF@#RFYMT3X>>-+2.*)]+LM1QI[%M^P[EW!22<  C_OINO->H^%[6WM
M/"^F1VT$4*-;1N5C0*"Q4$GCN33I_#>C7.D)I,FG0?V>A#+;JNU01WXQ5^UM
M8;*UBM;=!'#$H1$!)V@=!S0!QOB6ZU34_%5I9:);VMX-*Q<W44\A1!(V1&"1
MW RV/<&LWP#<7>@^*=5\+:E#% \Y-_;+')N0!L;D7V]L#H:[NST33=/U"[OK
M2T2*ZNSF>0$Y<YSS^=0W7AK1[W5XM6N+%'OX=OESY(9=IR.AH \[N+,Z+XCU
MGP;;P9L]?V2VVV/(AW'$IZ=  2/3 Z5<\2V>AR7^J:<EJ]S-IF@N%$[J8;0!
M/DV*1GS#\O/H*]%EL;::]M[R2%'N+=76&0CE V-V/K@5GZCX4T'5[Y;W4-*M
MKBY V^8Z9)'OZ_C0!Y[HDD6LW'@K3]89;FT;3995@FY2213@;AT;"@XS[UGZ
MB(],T?Q?;:7,+*S.LPQ2/ "5AC.-WW>@!XP,>E>ER^"/#4VGP6,FD6[6UNS/
M$G/REOO'.<\X'Y"I;/PAX?L+*ZL[;2K=+>[ $\>W(D Z9SZ9XH YKPYX8A\-
M^)))H]9M +ZU;;I]G R(P7'[SEWZ>OO5_P"%T4<?P[TLHH!<2,V.Y\QO\*UM
M.\):#I*3K8:9#;^>ACD:/(9E/4;LY ^AJ[I>D6&BV?V/3K<6]N&+"-22 3UQ
MDT <.OA[3]:^(GB2SU(3W-L;:"01/.X5"PYP >/NCZ5D:3-/+X0\+I+.\\4/
MB2.&WE=2-\2EPI&><=?IT[5KQ>'EU'XD:X^IZ+="RN4B$-PK,L;E%&[)![]/
MP[5U=[X3T:^M;"VDM2D%@X>WCAD:,(1[ _\ UZ .5MK?3?%^K>*K36)R+FUN
M?)@VRLIMXE VNH)P#N!)/K['%=SI[1)86<*W?V@^0I21FRTJ@#Y_?.0<^]9.
MJ^"/#NM:FFH7^G1RW((W/DCS,# ##OQC\J+[PK;WGBO2M9 CB%A$R 1@AG/
M4<'&T?-QB@#H:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-^=I7 &>,8Z>_-<YJ7B'4M-\%>&;J74KE?[2>$WFHF.,F!74,0!@ <\ E3@
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MI%SXAT:SNGMKG5;.&="H:.2958%NF03WIOB#Q!8>&M+;4-1=UA#! $7<68]
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MR:]I46G0:@]_ +2<JL4N[*N2<#'^>.:Y[QEXF9/A_>ZUX>U*/="Z*)HU#_\
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M-,BTZV2QDSOMUC 1L^H[]!^5<OXF\4S1>*[;PU9:I;:;)+;-(]U,BOM<G"(
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ+B.6QGT]65]IVN @4]?]H@>^:]>,49C$9C38/X=HQ^5(+>%00(8P#U 4<T
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MU!VGH.,5[9]DMC"D/V>+RDQM38-JXZ8':D>QM)8Y(Y+6!TE.9%:,$/\ 4=Z
M*NG.TGANT>V9&9K1#&V<J3L&#QVKSKP9K/A:7PMI>C:NJOJT-R2;=X&,OG>:
M2&X&<\C.??->J@!0   !P *@6QLUNVNUM8!<L,-,(QO(]"W6@#SOPY=Z39S^
M,+/Q)-:1W#WTKR+.0C20LO&W."1C/3U]ZQ-.M2FH?#BUOXN=ER?*G&3M))3(
M/MC%>O3Z=8W4\<]Q9V\TL?*221*S+]"1Q3I;*UFN(KB6VADGA_U<C1@LGT/4
M4 >1W3VJ^#OB':VJQJD.H;E6, *JEE QC_=-:?BBYTO5_%/@'RI;6[MY&EW*
M"KJ5(0#(^H(Y[@CM7HXTZQ47 6RMP+G_ %X$2_O?][CYNIZTS^R=-Q;C^S[3
M%L<P?N5_='.?EX^7GGB@#C-.DT_3_B?K=A>Q6\$<UG!]A60*J>6JG>JCI]XD
MX]C7$ZQ"UMX%UP)L33W\1L;)5&%* D97U7@8QQP:]LN].L=0"B]L[>Y"\J)H
ME?'TR*;-I6G7-M%;3V%K+!%_JXGA5E3C' (P* %U SMI=T;0C[087\D\8W;3
MMZ\=<5Y"#IEU\"HX5,+:C'(%14 ,PG,_  ZY(/UP:]G5510J@*H&  , "J@T
MG31>?;!I]H+K.?.\E=^<8^]C/2@#AU+I\8M-AN-C3-H2K+N 8[PS$\^O':NX
MU74[;1]+N=0NI%2&",N=QQG X ]STIYT^R-\+XV=N;L# G,2^8.,?>QGIQ3[
MJSMKZ'R;NWAN(LYV2H'7/T- 'DUUX=\37_@J\OY+G2E6Z;^U\JA$J/C>,-TS
MC ^E=)<"'XB_"W>/+DNW@W@*<F.X0=/49(_(UVOV2V%I]D^SQ?9MFSR=@V;?
M3;TQ[4VTL+.PC:.SM(+9&.XK#&$!/K@4 <-X;U.WUG2;OQA?VKK]ET\VI0
ME44O*5Y[G@=.E<U:ZK:B[\ MHHM;>0_:HS;I*)&0-M #D\Y/J<<YQ7L*6T$4
M!@C@C2$YS&J *<G)X]R3GZU5CT/28=GE:79)L<2)MMT&UAT8<<'WH \>N;FP
MG^"NH-<R6S:R]X6N-Q7SC*9\\YYSMS^&?>M-I+#4/&4L.L:Q'90+IEJ;%YXH
M6B>,H"Q!E4C.X]1UP1GBO2I/#FB37DMW-I-E+<38\QY(%8MC/J.O-.OM TC4
MQ"+W3;6?R<>7OB!VXZ >WMTH \T\16MCI_A7PK9:??RWMK%K<:Q32D98 MG:
M0 "H/0CBO2/$D$5SX8U2*:-9(S:R$JPR.%)'Z@5)=:%I5ZEJESIUM*EH<VZM
M&,1\8X'ITXZ<"DU]+J7P_?PV5M]HN986CCBWA,EACJ>!C.?PH \HFT72;7P)
MX3O],@ACUF>ZM]DL>2\CDG<"1R0#G([8Q5C5);F/7?B3)99,PM(!E3R!M 8C
MW S^5=EX,\*6NEZ182WNC6]OJUO%Y3ON$AR#]X$< GKZ]JWK30],L=0NK^VL
MHH[JZ_U\H'+\YY_&@#C_  ]!X,N#X;N[>>S_ +5AA"QQVLBAV=H_F\Q5Y.,'
MD_UKN+6^L[Y9&L[J"X$;E',,@?:P[''0^U5-/\/:/I5W-=6&FVUO/-]^2.,
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MNETOPIH.BW!N-.TJVMYB,>8JY8?0GI5C2]$TW1$E33;1+99FWR!"<,WKR>M
M&A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+M L+J2VN=4@CEB.)%R3L/HQ' _&J\/CGP[=7<%I9:BEY<SN$2*V4NWN3@<
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M3)&!<6LC;MQ ZX SDXZ9Z=#U'Q#N[*S\)R-?V:W<3S1H(WD,:;B>"Q'.!WH
MW(]9TN:&:6+4K-XH &E=9U(C!Z%CG@?6H(/$VA75\EE;ZQ8S7,@RD<<ZL6^F
M#U]NM>:ZC?Z?/J_CA(;ZTN!-HZ>5Y)7:Q1#D+CKC@]\?A4,EAIY\'>"SI%O8
MQZY<74#"6&-1*VT'>2P&< XSF@#U*;Q'H=O,\,VLZ='*AVLCW2!E/H03Q6)X
MCU^_T[Q;X7L[2:(V>I22+,I0'(4+@AO^!?I7+:7IGAU[WQY<:G;V+M#=.!Y\
M2_NE(;!4D<$DGISD"LZP-U;1_#%+^1E<S7!Q(<?*67R^OL0!]: /4=-FO&UK
M5DN=2LKB!&C,-O#CS+<$'(D^O!&?>K%MK>DWMS]FM=4LIY^?W45PC-QUX!S7
MF^JR-!J'Q*&FNHG-M;,0AR<;&\PC'<9.?3-;>A7?@J[E\/2VDEL=4BM66V2'
M(=?W7SAPOH ?O?AUH ZZ/6=+FNA:Q:E9O<%B@B6=2Y8=1C.<CN*Y;PSXR\^_
MUZVU[4K"#[%?O;0%V6'<JY'<\],_C7$_V]IL>D>'+RR%A;JNM^=]D%P9)8T;
M<"TC,<CWXQTYK2TS2-,N/^%@S:I86KS17EPT4EQ$NY 0S J3R,\$8]J .VUK
M6=1L/%WA^R@-N=/U!I4ERI+[E7<"#G&.E;$NL:7!>BSFU*SCNB0! \ZAR3T&
MTG/->;Z<TULOPVBU&7;=9F)61L,%*$("#ST*CZUDQV&DZS#KJ:WXD33YHM2E
MDDBE@B$H(/RLC$;SP ,#Z4 >IWNLMIFNV=G=Q_Z+?GRX)P.$E SL;_>'0^Q%
M+XHO+[3O#.H7VFF'[5;0M,OG E2%Y;I[ XKE_B!Y\GAGP[]C:X:9M2M?*9OE
ME)VM@GIAOZUT_BS_ )$W7/\ L'S_ /HMJ %T77K+4;*R5K^T:_EMHY9($E7>
M"R@GY<Y'6KD>J:?+]J\N_M7^R9^T;9E/DXSG?S\O0]?0UYG?:+ID&@^"[W0[
M6SBU1[NU EA #."N7W[>6&1SGISZU+XB@F\-^+]0MK.W1H/%D!@0*@(2X'RE
MF'I^\+'Z^U 'IT%Q!=0)/;S1S0N,K)&P96'L1P:Y/4_&]M/X7UR_T&XAENM-
M)4K+T.",M@')7D@'C)%=)I.FPZ1H]GIL/,5M"L0. -V!C)]SU/UKR315MU^%
M?C'"Q"=;N=3@#<%PF!ZXR#0!ZGH^L07]I:QR7=HVHM;I+-!#*"5) SQG.,FK
M1U*P%Z+(WML+HC(@\U=Y'^[G-><6&G:=I&H_#ZYMH+2WGN+619IH5"^<QMN,
MD8W$L>,\DFN<T33-&U?0X=3U7Q,MGJB7;32H((_M7G;SC!QYC]1QSSVXH ]T
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHK)UK7X='FLK;[-/=W=[(T<%O!MW-M&6/S$  #J<T :U%8'
M_"66L>G6MU<65]!+<W1M([5X?WIEYXP#C'RDYSBHY?&^D0Z'>:M+]I2"SN3:
MSH83O24$ @C\1SG% '1T5R*_$71_ML=J]KJ<<D\8DM=UF_\ I.>R #/YX%7+
M/QII=YHMQJ12ZA%M-]GEMY82)5EX 3:.K$D=* .BHK!T+Q99:Y>3V*P7=G?0
M('>VNXMCA2>".N1T_.N>^)4US!<^'%@U*\L4N=06WG:VN&BS&Q&<X.,CU/2@
M#OZ*\[M=0FT+XD1:-!K5Q>Z9+:23W2WD_G&V903]\\J.!P3WKH+/QQH]YJ5I
M9*+N)KW<;26:W9([@#NC'KD=/P]: .DHKE;?XA>'[C46L4EN5D266)V>W<(A
MC4LQ9L8 P#^1SBK>F>+].U2YCACAO85E@-Q%+<6[1QR1C'S!CQC!!H ?XHT"
M7Q!96J6]^UC<VMRES#,$W@,N>JY&1SZTS3-"U*/48K_6-8^WS0*RPK';B%%#
M8R2 22>/7O52+X@Z'+-;+_IB6]U,8(+M[=A#(V<</[D4FH?$3P_IM]>V4LET
M]S9_ZY(K5VVCN<XQ@<<^_&: .KJII^FVNF1S+;(1YTS32,S%B[L<DDG\OH*D
ML[RWU"SAO+642V\R!XW'1E/0UA-XXT=(]7?%V1I+!;K%NQP22./;@_AS0!TE
M%8J>*=,>;2(E:8R:LADME\H\J%R2WIU%<K-J4:?#OQ%>:1XEOM0DC>1A<2Y5
MX&X^09 ( ![>O&* /1*0J"02 2#D>U>?W6HZE+:_#ZX&HW"&\:+[4$; G+1!
MCN]>0>/?Z5W&H7]MI=A-?7DOE6T"[Y'VEMH^@R: +-1QP11,[1Q(A<[G*J!N
M/J?6L'2_'?AO6=4CTZPU(37,B;XU\IU#<;B 2 ,@<X_^O3-0\>Z!IMW)!/<3
M%86*3SQ6[R10N/X690<'.!CWYH Z&."*)W>.)$9SERJ@%CZGUI9(HYHS'*BN
MC=589!_"N;O?&MC:^*-+T:-7G%]!YXFA0R*%)(0C;G@D')Z#BCX@W=[I_@J_
MO=/O)+6X@"N'C )(W $<CW[4 =%]F@\\3^3'YP&!)M&X#TS2"TME@: 6\0A8
MY:,(-I^HK#T;QOX>UN]33['4UFO#'OV>6ZYP.<$@ _@:<OC;P\VHK8#4/W[S
MFV7,$@0R@XVA]NW.?>@#>CC2*,1QHJ(O 51@#\*<0""",@]145Q<0VEO)<7,
MJ10QJ6>1VPJ@=R:R--\8:#JU[]CL[\-<&/S522)XBR?WEWJ-P[\=J -6"SM;
M9BT%M#$Q&"8T"D_E2RV=M-*LLMO#)(N,.R D?C6''XZ\-27*0#4P#)(8DD>&
M18F89! D*[#T/?FG:EXX\-:1=36U]JT4<\./,C"L[+G..%!].?3C/44 ;<EM
M!+*DLD,;R)]QV4$K]#VIILK4^9FVA/F_ZS]V/G^OK5"Y\2Z/:Z?:W\EZK6]U
M_J&B1I#)QGY54$G !SQQWK)U7Q!:WEIH=_I_B..QM;J["J7@)-T,[2@##*\]
M\4 1:SX>U*Z\8Z->V=GIITRRCD1XYF(R'QNPH7 /IU]ZZS[+;_9_L_D1>1_S
MSV#;Z].E8?B7Q-I^E6US9G4H[?4FMI'A4+O92%)#$8( X_BP*S?#?B^"'X?:
M9K/B+44228.&D9>7(=APJC). .@H ZLV%F1@VD&-NS_5C[OI]/:@V%F4C0VD
M!6/)1?+&%SUQQQ5"'Q1H<^D+JR:I;"P9MGGN^P!O[IS@@^QYJ%_&7AR/37U$
MZQ;&U20Q&1&W98<X ')..>!0!5TW1==D\0#4-?OK.XBM#)]A2U1DQOX+.#W"
MC Y/WFYKIZS(?$6CSZ+_ &Q'J$!T\#)G+84>QSR#['FN6T[Q>^K?$J*QT[4X
M[K1YM.\\(B ;'ST)QD'O@],]* .E@T)+37;J_MI$2WO4_P!*M3$"))!P'!['
M&0<YSQ5J/1],A1$BTZT18VWH%A4!6]1QP>:DOK^STVV-S?7,5O " 9)7"C)Z
M#)I++4K+4EE-E=0W B<QR>6P.QAU!]#0 RVT?3+.=I[73K2"9B29(H55B3U.
M0*GNK2WO;=H+NWBGA;AHY4#*?J#7+^)O$FHQ:_8^&M"2+^T[M#,\\ZEHX(N?
MFP.IR#C_ .O46I6WC/2Q:7%GJJ:FGVA!=0/:*K!"P!*X[#\\?2@#1\0^'+>Y
M\/7\&EZ;9K?2VC6L+!%C*JW&-P' &<XIG@[0?[(T2T2]TRSM]1@B$#S1;6:1
M0."6P#SSQ65HGC9%USQ%:Z]J=G;PV=X(;7S"L>5^;WYZ"NKO-<TK3UA:\U"V
M@692T1>0#>H&21ZC'- '+>'?"LZZYK5UKNC:;+'=79NK:5@LKH<].1QQ@\=#
MGUKJ[G2--O+N&ZN=/M9KF#'E2R0JSQX.1M)&1@\\4DVM:7;6MO=3ZA:QV]P0
M(97E 60GI@]Z-/UK3-5CE?3]0MKI8CB0Q2!@GUQTH ?#I>GVUW/=06-M%<3_
M .NE2)5>3_>(&3^-,LM%TK3I7EL=,L[:23[[PP*A;ZD#FH(/$VA75W]D@UBQ
MDN,[1&LZDDYQ@<\\T^;Q!H\&HKI\NJ6B7C$*L#3*')/08SUH 9_PC&@>6T?]
MB:;L9M[+]E3!;U/'6GW/A_1;R[-W=:183W)(/G2VZ,_'3DC-:594/B70[F^-
MC#J]E)=!BGDK.I;<#C&,]: +,^D:;=7T5]<:?:RW<./+GDA5G3!R,,1D8))J
M.;0M(N+X7T^EV4EX"&$[VZF0$=#N(SQ7)ZOXHU"]\8W/AW1M2L[*2VM0XEG4
M.)9RZ@1^W#=AG-=)K>N+X;\,RZIJ*H\D$:[TB. \AP,+GL3^E $4VB7-_P")
MXM2OYXFL[+)LK9%/#D#,CD]QR !P!SUK;DC26-HY$5T<%65AD$'J"*XNR_X3
M[4;*/4_M>DVC2)YD=@]NS#!&5#ONR#TSC_ZU:6B^(Y%\+6NH^*&MM+NI&=72
M3,2@AR!@,<\@ _C0!H:?X:T32;I[G3]*L[:=\YDBB"D9Z@'L..@XK&L],U_4
M_$D%[X@AL([33C(UHELS,9';Y0S9]%!Q[M[5T<6I6,]D;R*]MWM0,F99 4'U
M/2F6VL:9>3O!;:A:S2QKO=(YE8A?7@]* +M8TGA/0)3?%])M6:^.;EBG,G(;
MD_[P!X[C--TCQ7H^M6=W=VUVBP6LYAD>5@@!!X;D]#G@GK6@-5TXQ32B_MC'
M VV5_-7"'T)SP>: *W_"-Z+Y]E.-,M1+8C;;,(P/*'8#Z=1Z'FHU\*>'UU,Z
MD-'L_MA.[S?*&=V<[@.@.>_6K,.J6VI:=-<:1>6MRP1MC*^] V#C=CMFL7P1
MXEEUOPA:ZIJDT$<TDCQLP^12=Q  SWH ZFBBJJZG8-=?95OK8W&=OE"5=^?3
M&<T 6J*@EO+6 L);F&,K@,'<#&>F?KVJ>@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *XOX@P:?>QZ;9ZA;WZK)([1:
MA9HS-:. ,$@ DALX_#\1VE% 'E":QXJA\/Z*U_#J,D'VV6.:ZM[8-=-"% C8
M!A\N[+ G&<#KD\Y-W_:#^$_'%BVE:FC76HK<0(\#DX:53R>1G '_ ->O;:*
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M/RYKM6,5N1DESMQDXR ,CKGL:J>!M3TZ[\5>*X[.]2X,MTLZ$8^9=H!(P "
MQQGZ=<Y/;W%K;WD7E7,$4\><[)4##/K@TJV\*3O.L,:S2 !Y H#,!T!/>@#S
MOQ J^&OBG8^)+M7&F7=O]EEN.JPR<@9XX! 7]:ZM_&7A_P RWBAU."ZFN&"Q
M16S>:[Y.,X7MP>3Z5N.BR(R.H96&"I&01Z55M=+T^QD,EI8VMNY&TM%"J$CT
MR!0!Y/&EG-#\3I)5@=T=S&S $KPXX/UQ5W3]>L(Y_#1OGL+9Y-"(EO[ACG9]
MT1HN=N[<,G(/ (KTLZ9I[&<M8VQ,_P#KLPK^\YS\W'//K2G3;$F FRMR;?\
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M_P"(#(.1W !)_"NJ71=+34CJ*Z?:B]((\\1#?SUY_K5Z@#GM(\8Z%?Z'!?\
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M0017,Y9]/E@4HD(<J5#XW$X7KQU[50:'7G\6^-Y=$U."R:+[.Y\RW$AD80Y
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M-<1G81YG)"@YZXXS0!Z'17F\7CK6%T"V6XAA.J3ZJ^G&6"%I$3:>7$8.6X[
MBMOP?KVLZG>:E9ZK92B.W8&WO3:26ZSJ<_P/R#Q[]?S .MHKE]6U75[CQ7!H
M&CO!;%;4W=S=3Q>:%4L5557<N3D'O7/3^,/$4.A^(XE%E)J^ASIO9(VV2PMW
M"D\' )Z]OS /2:*X2#QA>?\ ":Z1I\UU9?V=J.G"Z3"'?NV$]<X ."1],5#+
MXJ\1IH>B7<4=@\FJZCY$9<,%$3$^6>/4 G/N.* /0:*\[@\<:II2>*(-:CMK
MFZT9(Y$:V4HDF\# .23U(Y^M2>'_ !/XFG\1PV-_9-=65Q$6^U16$]NL+C)
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M'G.1R#U% '244A=0X0L-Q!(7/) ZG]1^=96A>(K+Q"EX]D)@+2X:WD\U-IW
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MI-3U?3K=G1=TD[.T? '5B",X ZFH? _B.^\2:7<S7]IY,L%P8@ZQLB2K@$,
MW(]Q]*AO-=U+4_$>IZ'I"Z>4L;96N&O$=M[OG"  CC&,GWZ4 ;^C2Z7+I<7]
MC/;-8IE(_LQ&P8/(&..M7Z\L\ 7FJV?PYTS^RK>W=I+V1)YKEL1P1Y.6(W G
MG P*77O'.J/X.\1".6&#4=-O5M3/:@@%2V-RY)P>&'6@#U*BN%U3QE>:1=V.
MC23V/]HM:FXN+EX9&C SA5"(2V3U))P/QQ6SX,\07/B30%O;RS-K<+(T;H%8
M*<=QNYP<T ;\LL<,3RRNJ1HI9F8X"@=234%CJ%GJ=J+FPNH;F D@21.&7(ZC
M(KC]-U'5+OXK:WITT\;:?;VD8\@J<;2 1WQG+')/:N9\*:WKGAWP1;7UOI=@
MVD+>LD[M*PFD#2[=P &!@G;U/3I0!Z_17'^)?$FMZ//J$T-G9I864"RJUPQW
MW9ZL(\'C:.I(/;BJ?]O:OJ/C;PY]ADCCTV]TO[6\,A.?FP3D#J0"H'U- '>4
M5GZY>W>G:-<W=A8/?W4:@QVR'!<Y _0$G\*YFT\9:@FHZOIE[;6L]Y8V'VU&
MM6*HXP,H<DX()ZT =M17G&E?$75KN[T*2\T6"WTW5Y6AAE2XWON!QG&!@9_S
MZZMGXQO$U_Q!INK6MM:C3H/M,!$A_>Q<_,2>W3D#C.* .RHK,\.WU[J?A^QO
MM0@B@N;B(2-'$Q*@'D=?;%:= !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5F:[H.G^(]-:QU&+?$2&5E.'1AT*GL:TZ
MYWQ?XLC\(V$%Y-87%U%+)Y9,. $..,Y]: *:>";IU6WO/%.L7-@HP(#(J%P>
MH=U&YATP.,<^M6+_ ,(>9KK:SI6JW.EWLD:Q3&)%D251ZJP(SC S[4S3O'%M
M<ZQ!I&HZ;?:5?SJ6B2[0!),=E8'D_P#ZJZF@#C;KX=V<VAZ?I<&HW4*6EW]L
M,I"N\LF3ECD=>3[>QK17PJ$\877B./4;A)KBV^SF((A51QT)'J ?K[<5T-%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*)/LXV@OM+<%CD 9 ]>M=$G@:5-,U^R.M3-_;,ADD<Q#]V3][ SW''TJ>_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>9(R[4VKD$*"Q)Z'C'2LJVFU#1-*^($\%_(UY;709+ET4L?E&,C&,XXSCWH
M],L;M+_3[:\C1T2>)9560890PS@CL>:L5YQ>ZSKMRW@6.VU9K5M7M2;EE@5\
MMY2L6Q@\_,?8?2FZ7XFUV#PWXO!D.HWNCW4D4$KJJLR@XR0, [0"V._2@#TF
MBO--"U36+KQ=I=E:>)CJ-E-8+=W8:)'*$'!7*J N3@=21^5=/XRU:]TVRL+?
M3Y%BN=1OHK-9F&?*W9);!ZG /YT =)17!&^UKP[XQTW1KK5WU*WU6*01R31*
MKPR(,@C: ".1ZUS:^)?%D'AC2/$EQK*2)-J/V9K5;=55TW,#N.,YRAZ=B* /
M8:R=<\1Z=X>@MI[]Y!'<3+"C1H6 8^N.@H\4/)'X3UB2*5XI$LIF5T.&4A">
M#VKRV_%S:_![PS,ETTDOV^&2/S$4K&<N0,8Y'US0![156TTVQL&E:SLK>V:9
MMTIAB5"Y]3@<GGO7 W?BC5O"FOZK8ZE?'4U&E_;H"85CV."5*\=B1G_/,OAR
MZ\<2ZGI=W=0W$^FW40:[%Q]G0197(:/:V[&3T(SC] #T.LL^(=/'B0: 9'_M
M PF?88SMV_[W0]_R-9WC;7KC0M'M_L95+R]NH[2&1EW+&6/+$=\ '\<5S%M9
MW=A\9+&&[U&2_E&D,1-+&J'&]^#MX]: /3*0$$D CCK7G4'BS5+6]\-+<ZI;
MWW]HW4EO=I:QJT2-D!0C@ \$C.2>]8^D^(+[0]"\9:])>2W$J:B\$44BJ5,G
MRJK$XSP,# P,"@#UZBN#\-:OXLN?$L-O?6MT^F/;%I9KFT6'9)_LE200>/S]
MJUO%>N7.GWVBZ58RI#=:I<F/S7CW[(U&6('3/*]?7H: .FKGH/&NB76NII%O
M/++<.[Q!UA;R]Z?>7?C!(]N*S4U75[#Q<WAN_P!1287]HTEA=B *\<B@Y!4<
M'H2,^F.]1_#"VO(O"T;SWQFC,LZB+RE 5A*V6R.3DYX]Z .WK-TG7],UQKI=
M.N?/-I*89OD9=K>G(&?J*Y+5)M0N/C%IUE!J,MO!'IIF\M0&5B78,"#Z@#GK
MQ7,Z?<:_8R^.]1TF^M;:&TU&>:19(/,>0@L<#)P!^&: /9:S7\.Z))=?:GT?
M3VN-V[SFM4+Y]<XSFN"OO'&NZK=6UOH4<L2_V?%=S/%8_:'WOR$QNP%QW]:[
M3PG?ZKJ7AZWN-:LC:7^662,H4S@\'!Z9&* -NBO-[SQ!XKNO$?B?3K"^L+>'
M2HEF1GMBS$%=P7KCD=2<^PJ"U\9>(AI7A_Q'?75@NEW]RMM/;1V[!DR67?NR
M2?NDX'MUH ]/HK@8=7\3>*+W5Y=!O[2RM=/N&M4AFM_,:=U&22Q/R@GBLYOB
M+<W>D:!<27$>EB\EG@O+E8?,6&1,!1SP%;<"3S@=^#0!Z?17FNMW^M#7? \9
MU>"3[3))YKVH)BE=0!NX(R"&Z=.M=QKUW=:=X<U"]M?*:YMK=Y5\T'82HR<@
M'/;UH TJ*\RA\8^*;;PF/$E\-,D@NTCCM+>"*3<LC/C+<Y(V[N >H&.]26_C
M;7](CUF37+.26UL[43073V;6^]RP54()/!) '?CF@#TFBN.M-1\76SV]_J2:
M;=:4]FT\_P!E4QO"P4L -S'=G@?X=^<L?B#XCO-4TN6+3GFL;V11)"EA(/)C
M+8!$I.&..IP!Q0!ZI17F=QXP\623>)WLET<6VAR-N\Z.3>Z@,1C#8SA?:K5]
MJ^L:GXE\'MIM[;PPWMI)<R1LA9"P0;LX(SPV!Z'- 'H#QI*A21%=#P589!IV
M,# HHH *;)'',A25%=#U5AD&G44 %%%% !1110 4444 %%%% !1110 4444
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MM$\5KLMQ&D6[&6QW/%8K?#G4'\'6N@MK41^SWWVM)?LW0<G;C=ZL3^->AT4
M5KZS34-,N;&<DI<0M"Y'!PRD'^=<-+\.]2F\(V.A2:\CK9W*S1L;7@*,X7@Y
M/6O0J* .-U+P,VL>*+C5-0OUDMI[!K(P1Q;&4'N&R>Y)YH\/>#]9TF:WBO?$
M\]WIMIM%O:+"$&%^Z&;J0../:NRHH P_%?AR/Q/HWV,SFWGCD6:WN%7)B=3P
M1^&1^-8,7@?5Y]=35]3\0K/<BRDLV,=H$RC9QWZ@L3FNZHH \VM/AKJUO#HD
M3^(8GCTBY\ZWC%H ,%MQR<Y)S6BWP^:9=?LY=03^S-5D:=(%MP&AE)!#[L\X
MQT[UW%% ')Z)X8UNUO+676?$<FH0V@/D0I"(P6P1N<@Y; )J]XG\.MKT-G+;
M79L[^QG$]M.%W!6[@CN".U;U% '+VOAS5#JUQK.HZG;SZD+4VUF8K<I%!GJQ
M4L2Q)QW]?6I_!V@WWAO1VT^\OX[P"5I(W2+81N)9@>3GDD_C70T4 <QK7AF]
MO/$]CKNF:A#9W$$)@D\RW\SS$+9QU'O^=9D'@;48=.\3VW]IVI.MRM)N^SM^
MZ+$[OXN>"<>_KTKNJ* .!C\ :CIMQIU[HNMI:7L%BEE<,]N)$F5>AP3QT'Y#
MWKJ]"TVYTS3O*O;^2^NY':2:=Q@%CV4?PJ!@ 59BU*SFU&;3TG'VN% [Q$$-
MM/1AGJ.V1QFK5 '&Q>$=2C\0^)M1-]:^7J]OY4:^4Q,9"[03SV'7U]JRI?A_
MK,G@S1M _M"QQ8W?VAW\M^1DD <\GYF[#/'3'/H]% '$#POXBT76-0N?#=_I
MRVFHR^=+!>QN?*D/4IM]??VZTZ'PEJFE:-9Z7I\VGWED(9$N[>]C*K,[G=O!
M4$CDXQZ5VM% 'G8^'FHV>G>&DT_4+7[7HT\LFZ>)O+82-N. #GC' SSZBNQU
MRRO-1\-WMA;20"ZN+=H=\@(3+#!/&3T)Q6G10!PY\$WUQ\.K7P]->107UHRO
M#<0DE=RL2I.0#W_#WIT7A;Q'J^DZA8>*=9MKF&X@\J.*VBVA7!#+(3@$D$=.
ME=5J>JV6C6?VN_G$,.X(#M+$L3@   DGZ5#HFNV'B'3_ +;ITIDB#F-@RE65
MAU!!Z'D?G0!SNC>'?%(A-EKNO02Z>L)A6*TA :0%2OS,5XP#GCOCGUK:#X5\
M7Z5Y.FR>(K?^QK=L((XOW[(#D+DCY>..IQ7>T4 < G@S6TC\7J+C3Q_;A)BY
M<[,D@[N/[K'IGFAO!WB"U@\,3:=?:>E[H\#P2><KF-PP XQST'M7?T4 (,[1
MNQG'.*6H+R\M]/LY;N[F6&WB7<\C=%%3 AE# Y!&0: %HHHH **"0!D]*HZ5
MK.G:W;R7&F7<=S#'(8F>/.-P )&>_!'(XH O457OKZUTVREO+V=(+>(;GD<X
M"BG6EW!?V<-W:RK+!,@>-UZ,IZ&@":BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=?U._N+ GRA*XV;2,;=IR0,<'GFEA^'%M!>.L6L:BFDM+YQTP2?N2V[<0?\
M9X''ZT <LEC>W7BSQ]-9ZQ=:>;=8Y#]G"YD(5F&21D ;3TQG->@>"M5N-;\&
MZ9J%T<W$L6)&_O,I*EOQQG\:HP>"F@U'Q%=KJ\^=:0HRB%/W74 CCG )';@\
MY/-:WAG0QX<\/VNDK<-<+;A@)&7:3EB>GXT >=VTGBK5;GQ0J^++F$:+,WE!
M;>/]Y@,1G ''R].:BM_$WB?QE%:V.GBX@DCT\33O;7"0N\I;:&)8'Y>,X&.O
M6G^&;9O$/B3QC:V6NFSAN+LF2.*-&DEBRP8KNY7KC..XKI]1^'-O)-9W&C:I
M>:/<VUN+7S(#DO&.@;D$GISGMTH PKS5_&-I8^%+2^NC8:A>7K6UPP1)-ZY4
M*Q'3//0&I=9U36?#5Y;V&KZW?QV+6K!-6BMD8&=G)'F+M/ 7 P/_ -6[>^!?
MM)T9H]6G$FFW!N3+/&)7GD)!RQR/3'TQZ5=UGPW?:I<7IBU@0VMY L,EM+:K
M,HQGYAD\'G]!0!E?:=2UOQ!'H<>MS6]O#ID-R]U9J@>X=CC=D@X!ZX'K6!J/
MBO7=/\->)[4:D9-1T.[A O#"N98Y'P 1T!'/:NJ7P,EA<Z==Z+J+V%S9VOV1
MG:(3":/.<,">N><@U!>_#Y;SPY?:8VK3?:=1N1<7MVT0)F(.0 N<* 0O3TH
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M&CND<O 77#%2.O0<'_\ 7*O@F\L;KPTNG7D L=%#$QS*=TKOG>V1TX)P.QH
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MM;000;DA7<>78XR3CIQ_.N@\+:==Z1X7T_3KXPFXMHA$QA)*D X&"0#TQ^-
M&O1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC86]A>PS6#%)O."  Y(QPQYR&]N.M/T7QA:ZYK-YI<&G:C#/9G%P9XU54/.
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M (]P*[3PM<SWFBB>?58-4#RN8KJ%0NZ//RA@  &'>@#:HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ K@_B3;/=S>'4^Q:A<01WXFG:RB=FC11R<H"0>>,<\'%=Y10!
MSEOX.TZ.UO0;B^EN;^/RYKV:;=/L)SM!(PH]@,>M5G^'>B2^&[;0Y'O&@M93
M+;S&7][$2<G:P&,=>,?K@UUE% '&7O@6WM?!>H:1HQG-U<8<3RW)5W<$8W.!
M]T#^'&/Q.:ZBTLVMM)@L3.[-% L)F7AB0N-PZX/?O5NN?M_$QG\<7?ALV>W[
M/:"Y%QYN=V2HQMQQ][KGM0!9\/>';;PW9S6MK<74Z2S-,S7+AVW-C/( ZXS5
M?2/"5GHVN7^K6]W?/-?$M/')*#&23G. !R.0/8FKVC7]YJ%K++?:;)I\BS-&
ML4D@<LHZ-D<<_C]:T: ,VUT.QL]<OM7A0B[O4C24GD80$#'IGC/K@5S]]\--
M$OY=0:6YU)4OIC<21)=$1K(6W%@N,9Z]<]>,<5UEW.UM93W"QF5HHV<1@@%B
M!G&3P,UE>$_$'_"4>'+;5_LOV;SBX\KS-^-K%>N!Z>E &?=^ -.N;E+J/4-5
ML[GR$@EFM+KRVG"C +X')_*H1\-=#70K?2EEOE2VN#<0W"S 31N>NUL<#@<
M=1GK6C_PDX7QS_PC3V3J6M/M*7/F AAD@C;VZ'G/;ICFN@H Y2Y\!6%SX>N]
M(DOM1D^U,K2W4T_F3-M.5!8C[H(Z5T=C:+86$%HDDDBPQB-7D(+$ 8Y(QS53
M3]:@OM0O-/:.2"]M"-\,F,E#]UP02"I_/U J[<W5O9QK)<S1Q(SJ@9VP"Q.
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M>#535]=U%=3G\S5X3#(OEIB/C"D<=AQSU[UU%% '%#X>(-+T>Q&M7FS2IS-
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M P ,"@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#S^X\ W5WHUS<S2P_\
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M:5?Z?XC\1W-S$BVM[<)+;N'R6PN#D=N@_.NDHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
2*** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>a123121ex-1021008.jpg
<TEXT>
begin 644 a123121ex-1021008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHJKJ5]'I>F7-_+'))';QM*ZQC+$ 9.* +5%<-
M'\3K$KI\TFCZK';7XVP3&)2KR=-@P>3GBM/3O&MK>)JQNK"]T^32T$D\=R@!
M*$$@C![X- '345S&D^,XM2U""TFTV\LS=6IN[5I=K":/VV$D'!S@\UA:GXZL
M_$?A;55TRUU6-#83RB\,1C1&0?=W@]3['VH ]$HKA?"WBI8M'\/:7]DOK^ZF
MLHVEDA4.(01@;V)XZ=^U6KKXCZ/:7SQO#=M91S?9Y+]$!B63."#SG ]<=N]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;P6ZNL$,<8=VD8(H&YF.23[D\DUG_P#",: $"#1-.VB3S,?9DQO_ +W3K[T
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M1K18;LJTT:IA6*YVD#MC)Z8ZTFG>"O#>DW8NK'2+>*<*5#\L0",'J3U&1^-
M'!>'O#41C\.>*?[=LK5\Q"1H(7,ER[[5,<C&1MS9R#@#J>/3K/"'_(S>+_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5D>4):,!RY+-M &,@8YXXKIOB;X=NO$?A,PV*F2YMIA<)&#R^ 00..3AC@4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^UW<9CGD(SYBGJ".G/?UXIFD^%M#T*>2?3-,@MI9,[G0<X)R1D]!QT'%:]%
M',O\//"<ES+</HENTDK;G)+8SG/ S@<^G6KR^%M$35VU46"?;&C\DR%F(*8V
M[=N=N,<=*V** .77X<^$438-#M\;_,R68G/USG'MT]JT(_"NAQ:C?7Z:=']I
MOD:.Y8EB)5;!(*DXYP.U;%% &!I7@KP[HDDLFG:9'!)(A1I [%@IZ@,22OX8
MJI/IW_"%Z.W_  B>@&[DFG!DMA<L/X3E\N3Z ?C7544 8?A/1Y=&T017.W[7
M<2O=7 0Y59'.XJ/8<#\*W*** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MYU!F$M]=7DAN93C=N&, GTP<X_VCZT ;8^(7AQK&]NA=S8LE5KB,VLBO&6.
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M;P,K0+(."&)YQP.?6H[KQ=XKEU3Q/#I\6C"WT3]XQN$EWNFUFP,-@G"^P_H
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MPV0H&2V,#GI7IU% '-^"K?6;;29TUFZN;A_M4GD-<J!)Y0.!NP3UY/TQ3?\
MA%)8O&MQXBM=4>'[5 (IX/*5MV  I!/3H#_^OCIJ* //[GX>7UQX+;P\VM1/
MB[-PDS6V#RQ;!PWJ2?TJU<^!]2C\03:IHWB.;3OM@!O46!7$C@?>4'@9_P >
M>:[.:40P22E78(I8JBEF.!T '4^U9V@:_:>)-.:^LEF6$2O$/-3:25.,X]*
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M#D/!$=U%?^)3<V-U;+-J;SQ-/'M$B,  1Z_=_45U]%% !1110 4444 %%%%
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M8)+,2>@ Y)KI=!UR?5WOH;K2[C3[BSE$;I*P8-D9!5AU'_UJXF#1/$=AX?\
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M8+>3^:%PZ<@GG/- 'J-Q?6EHZ)<W4$+2'""20*6// SUZ'\JP?$WB"_T?4M
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M-RSAHB^ N"2 -IZ"NBL-*L/&5OXAFU6_D2^AU"6&.<3D&UC1AMVC. .N?7-
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)WO+J6\A\BXNKFY=YI$_N[\Y YZ#%7=!T.V\.Z1%IMG).\$6=IGDWMS^@'L
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M*RMKUGEO!^Y_=,%)_NDXP#[>XH Z>BN<L?&%I>>(-7TIK:YA_LT;I)Y(SL(
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6KZ@+#^SDN$CM[DK'N^3D+T(YS_6NJ^'-S-=^ -(FN)7ED,;*7<Y) =@.?H
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M5IIUN/W-M$L2D@9( QDX[GJ?>K= !1110 4444 %%%% !1110 4444 %%%%
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M*1C/O7/:EX'UT>%_)AM8[B_O-8_M&YCCF4+".?E!;&[K0!T$?C#6(WUZRO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %<I+X#L_[2O+ZSU;6-/>\D,L\=G=!$9S
MU."I_G75T4 5=.TZWTJQ2TM581(2<LQ9F)))))Y)))-6J** "BBB@ HHHH *
M*** .6UCPA/>Z^=:TS7+O3+QX1#+L19$=1T^5NG^>G.=C2-'328I<W,]W<SM
MOFN+A@7<XP.@  '8#@5HT4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML\LD\UK*A??L)4],?,0HYQSCWS4-IX<\5:5X@U?7+:;2;FXU%EW12F1%15X
M! YP,#IVJ<:-XQN]/OEU#4K+SKV>-&BB+A(+89WA#@'<P/7]>F "'PYXRO\
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MHD+ [W/E(Z[=Q>1BN$P.P#<XQUXHV7ASQ WBF^OI-%M;&UOM(-FJ1W:NL#8
M .%!)^4=!CGJ:CAT+Q6/#_AZ4:3;IJ&@S%5M7N5(N8B@4D,.%/;!^OM0!HVO
MQ-MYM(U>ZDLXQ<:=,D16*Y$D,FYMJL)0OW<YR<=*ZG1M0U"^^T?;M/BMA&R^
M5)!<^=',"N<J=JGC..E84I\17^B7IOO#-DPE=(UTO[0C%TS\[-)PN?3TQ1X)
MT&^T.^U91!+9:/)(IL[*:42NAV_,V0Q !/;G].0":_UW5X_B+IVB6L5L;%[1
MKB8N^'8;MN1QU'8#KDY([<Q8ZW<>%]4\97-MH[W=I#J FN)/M 38&&6P#DL<
MG./?M6]KFE:H/B1HFMVED;JUCMWMY=L@4QD[OF.>V&[9/!]LYJZ9K)T_QZDN
MC/(]],_V1=ZXF4J5##)[ !OT'- &EJ>M:-=:[X0GN--GGFO5:6PN-^U8=ZJ3
MD9Y."O4<5>L_%LNIZC<V]AI;SQ6E^UE<OYZAX\9S)L_NY&.H[^F*YB72=:DN
M_A[G2+@)ID*K=/N0B,[47GGC&W/X^H-)J&B7]YXKCOM/T:]TW5$U$B6]BD M
M[BV#=7^;J5'3'7CZ 'IU>6^*]8U%?$\/B*TR=(T*\%E<*I.6+ >:Q [#<J\]
MZ]!UZ[O;'0[NXTZS>[O%3$,*'EF) !^@SGZ"N&L/AOI4W@TSWVE3G6IK5GE$
MD[[C,03G ;;UQ_7O0!VVNZY!H6D-J$D<DXW(D<<6"9&8@*!VY)ZUDV?C*6;7
M[G2+O0[RUEMK<W$DFY715QD<@]^0/<5R4LVKCX5Q:5K6F7*:BMQ#:6N9%620
M[@49.>64#]/K5O2+^6VO;R"_TC73J]_9,B3W00B81JQ"J%PH//U/?K0!J:?\
M2K>]TR75)=&O[;3TB9EN) NV5PX01J<\DD_H?2K&F_$*QNM3NK"_M9=/FM[8
MW7[R175D RV"IZ@<X]CZ5S5OX:U:X^#D.D-ITRZE9SF7[-+\HEQ*7QUPP*MT
M/<>N*O\ ]ESZ]I.H65KX,M]"DELW1YW2-&9R,JBE1D@L.2>U &GI7Q%L]1U>
MRL)-.NK5;_)M)I&0K( ,C(!RN01^)J%_B9;+;7]RFA:L\%A<&&XD$:XCP<$G
MYLY'I^HJEX/MKF%=+M)_ <%G=VZJLVHR)&  HP7! W%C@?B3S64FGZHGA?QX
MC:3?^9?7TCV\0@)9U9L@@#J,=<9H [+3_&\%]KEEISZ7?VJ7\32V=Q<(%68*
MNXX )QQSS[=,U3G^)>EP7\:-:77V!YO(%_\ +Y>_)&<9SMX^]5+4&O9/$'@>
M<:5?[(;>5;@B!B(#)$J88CI@YS6%X;M+G2K5-!O?A\E[J$+LB7TELGE.-W#-
M(5/3/J3@4 =CJ?Q"L-.U._T]=,U:[GL-IG-K;;U4%=V20>!CUQ4>J>-)8[KP
MP=-L9KFVU=BY( #[-F=H!( /(/7HI]:QX+6]3QAX[=M.O?*N[,>1+]G;9(5C
MVD*<<G)X ]#6?IMOJ.EZ#X%NI='U*4V$UP+B&*V8RINW!<J<8'/4X% 'J=Y>
M06%E->73^7!"ADD8_P *@9-8.F^-M/U&_@LC:7]K/<6INX%N(@#+&,] "3G@
MG!J]XAN-2A\,7EQI5J9-0$.Z*%P&.>,C&<$@9X[X[UY_I5U?3^,/#5_<Z)KB
M_9[*2WNKNYM6RSD$]!G"@DX/&<].* .@M_BCHMPEM*MCJRVT\P@^TO:XBC<M
MC#-G'OQGC\JT?$/B:WM1?:9;VVH7=VELS3&PC#&V!4[2Q)&">H')XZ5Y[9V6
MI6_PIDM&T?4VNCJROY M'W[0RONVD9QA2,^N!6[)/?>'/%?BB6?1]8OX-7CB
M:WFM+8RA<(PVMSQ@MC\.E &W\+[F>[^'^G37,TDTK-+EY&+,?WC#J:P[/Q,G
MA[QIXN6Y;4M1B#0RQQ6L3S>2,,7Z\(!D=P./:MOX7V]U9^ [.UO+.XM9X9)5
M*7$91CERP(!YQSW]#6)8V]U!KOQ!,EC>JMY%_HS_ &63;+M1P=IQ@\L/KVH
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M_"#>'/$J7TL2(\,FHI!&O[R-B S<_P O]KVH ])HKF-$OKK5O%FKW<5Z[Z/
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M0,*,]LKR?7VH ZB@'(R.E<E=^)8=3L=>TJ2VN;'4+6P:9HI'7=M9"004)Z'
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MN30!RC^!E=?#H_M6?.AC$)\M3OZ=?P4"LOQ3H,&A:9XMU^;49';4[1HC$T8
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MEN,^E8FJZ%JT'A'0HETNYDN/[8.HRV\$>\P(69MIQW 8?K7K5% #4<21JX#
M, 0&&"/J#TKQJWM=4L?A3KNASZ+J*W@N"1B$E6#.G*D=>G:O9Z"0!DG % '#
M7EY-<>-?"<PTW4%BBM9S(YMVPA=%&T^A&WGZCK6';3K+X8UZUU7P]JDMC=:U
M(SJL3K((Y'+"0#&3M*C('J/Q]5HH XKX?C4(?[3LWEO9]&@=!IL][$R2LI!W
M+\V"0N !D#V]!VM%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M.:AJ2(7>V@9U4#.6QQ^&:X+4Y==\/>$[+Q;_ ,)'?7,SK!)<VLRH875\955
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MCBT62YFM!=13,)51!N((89))X/3'K[5G3?$;5T\"W&LK96/VRUU(V,JG>8V
M .Y1G/<#D^OTKH)O#VJ2?$FV\0YM/L45E]E9?,;S"?F;(&W'WCCKT_*N$\0^
M'-4T#X=:C::BUENN]72Y1H96*C?@$,648 P.?<T =Q!XCURP\766BZ]!IHCU
M!)&MI+-GRK+SM;=UX]A7*^"->?1? EO#:K"]_?ZL]K;+,Q"!FQ\S8YVCOCU%
M==%H>L7_ (CBUO6(].62Q@=+&"WD=QO;JSLRCTQP.]8.G?#W5K?PE'927%E%
MJUGJ!OK*>,LZ9X^5LJ" 2.P/0?2@#:'B+6M/\4P:#JL=@SWUN[V5S KHGF*#
ME7#$_H?3UXS[3QKK=QX7GF:TLDUQ-373Q;,KA-Q(Z\YZ$G(/09K331M2O/$=
MIKWB V%O'ID,GDQVTC.,L/F=F95P !_]>LG2=-M=0^*VH:K8S++8);13/Y3!
MHVN&4A3QQD)D_P# O>@"Y=^*]<D\4ZKH>FV6GEK"U2=I[B1P,E03P!D]?;IU
MK+_X6+K/_",:?XE;3+*/39+@03IYK-*WS$%D'  X/4FM>W\.ZQ'XZ\0ZNR6O
MV6^LQ##^].XL% &1MX^[S]1C-<\_@GQ(WPP@\/&WL_M5O=^:N+@_,FXG^[C/
MS>O3WXH T]7^(-]%JFH6^D6<%Q'ITGE2H\<SR3N.H0HI5<=/F-6]0\9:W_:^
MEV&E:"LSZA8B[ N9_*,9YW*PQU'R_B:KIHGB[0-:OY= 73+BTU2<W,PNW<?9
MY3][&,94YZ]>.@[WVT?7!X]T?49/*N;*VTYK>>X)",93DEMON0OTR: ,'4_&
MVLZIX$2^TQ(K/45U-;"=<[@&S_"3ZY7\,UZ3;F<V\9N5C6?:-XC8E0>^"0"1
M^%>8V_@SQ'#X/OK);:U%Z=9&H0H9\JZC;P3CCI_/IW]*L'O)+&)[^&*&Z(S)
M'$Y=5.>@) SQCM0!PT_Q#U"W\)ZAJ[Z5;B>QOS:36YG(V@<9R1R<D<#L:W9_
M$<LNIRV=M8QW=HNEF]DD$N 2<[8^F/F Z^E9EQX"2[\8:A=SMG1[R)99;7C:
M]P 5W$>P.?J?:K7AGPYJ&A^#[JUNG2ZU.6-UR'X(5=L:;B.@ ';N: .=7Q%=
MQ?#WPY=^&K*WT\76I+;BV+;EYD<;<D=&(Y/7FDN[C4[3XP&2RTR*[OY-'421
MK,(T#9&6W$9(R .F>E26_A+Q#;?#S1M-BM;<ZEIFI+=B-YAMD579AR/]X<>Q
MK4L]*U\_$1?$%UIL,<#Z:+9PER&VO@-QQDC(V_K0!M^$?$8\3Z*;UH!;SQ3/
M!-$&W!77T/<8(/XUF6VK:G?_ !%U70[@6C:5#9J3"3\S!OXL8YZX(Z 8[]7?
M#S1-3T'2;^VU.W2&2:]>X39*'R& XX],5''I&K6GQ3N]8CLTEL+NR6$S><%\
MLC;U'4GY>WKUH Y;PWXHN?"7A2)_[(WZ0FH2PO<>> PRYQM7!) ]_2MWQ)\2
MET;5;RSM+6UN%L0OVAIKM8R6(SM1<98@#\^*P;KPWXCNOAG)I+:-(M^-3,PC
M$T9#(26W [NG.*V!IWB?PYXGU2\TG1;?4;75Y$F8/<!# ^#N!)ZC)/2@#NM+
MU"'5M*M=0MPPAN8EE0,,$ C/->>>!]+@\:K?^(O$4"WTK73Q6T4QW1PQ@#A5
MZ=_T%>A:4+X:7;_VF8OMI3,PA&$5CS@>PZ?A7":-I?B7P%<WMG8:4-9TFXF,
MT'EW CDB)QPV[CH.WU[XH OMHFD?#Z]U/Q';H8[2:!(A91(23+NX"\]S@8Z"
MK@\8W=IJVG66M:')IR:@WEP3?:%E7S.R-@<$YJCKEEXG\5>'+^*73[;3V'E2
MV=NTOF2,Z,&(=A\H!Q@#\S27MEJWBS4/#K7NCW.FC3[D7=R\DD;*67!"IM8D
MY(ZD# H BD^)<XAU.XA\,WCV^FSM#=2&XC7R\<'(SUSV&?K6AI_CI[S6=+M)
M]$N;.VU6-I+.YFFC/F ('^ZI.."._<5SD&@:V?#GC>!M(N$FU.[::UC9X\NK
ML?\ :P,#D_IFKDVAZO+<_#\C39@NE1!;PED_=G:B_P![G[A/';% %H_$BX>&
M^N+?PMJ,MK83M#=2;T!CVXS\O))'.1VP.?36OO&2Q-&-.TVXOT:P_M$RAA&B
MPD$CENYQTQG'Y5RND7>IG3O&.G:?HMQ>27.L7D:3"2-8E+$*=Q+;A@<\ YI;
M[3?$VGZI9:>FE3ZIIEOI26D"QW'EQ&4)M9Y!GGJ>#CC&.10!O3_$2SCTS0[V
M'3;RY_MABD,46W<&!P0<D<YXJ2/QRSZ1K5T^B7B7>DN%GLRREL$9#9'&,<G&
M<>]<;I^CZXNF^!H)M$O8CIE^_GDJ#A2X(; .0.O4=OIGL?#]I/\ \)=XM^V:
M?.EK=R1>6\J?)*H3:<'O_@: +D?BZ.:'PZ\5A.YUKE5!'[E=NXEO7&?\]*E\
M:75A:>$K^75(;F:R*A9DMCAR"P'7(P/7FN7^'^C36^N:I'+(TMCHUQ+::?N_
MAWG<_P"( 4?B:W?B)!<W?@?4+2SM)[J><(B1P)N/W@<D>G% #QXHM+,:7IUG
M97=W/<6'VJ*%67>L2J,9+,,L>G!)X-;NGW@U#3[>\$,T FC#^5,NUTSV([&O
M.M;TU=2TG1[>XTC5X;RUTU&MK^SA;S(I0-IC8 =. ?SZ9KM_"ZZBGAC3UU??
M_:"P@3^806W>Y'4T :]%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% &?#KFGW&MW&CQ7"M?6\:R2QC^$-T'UQSCW%6TN;>29H4G
MB:5/O(K@L/J*\Q,DMKX[\>W-LJB_CL$>U) W;A$.5S]*S_"?AW39D\/:XOB2
MPAN%F0F-;<+--(3@QNWF$DGD=/>@#V!IHE=4:5 [':JEADGKBF_:;?<B^?%N
M<D(-XRQ'7'KBO-?"'AC0=:UCQ%>W-H;B2WU>589'D<%>.> 1W)KE)-$L;?X0
M2:U':B+4HKP^5=+*2X'F[>,?=XR,>V>] 'NRSQR-(D4B.\?#*&&5/H?2J>BR
MZK-IROK-O!;WF]@4@;<NW/RG\JXS3-(L-*^)-I#86XMX[K16DF6-B [;P,GG
MK[UR5I$)/@W?J7D&S6 %(<@CYT7KWX)ZT >WA@20""0<'VI:\OT[3K#PO\5+
MFTL6>UL3HS3S%I6;D-RQ+$]A6;9K:6.J^"+W2$FC2]O+D-/,P:6Y0E1N?' S
MD\=OK0!ZM8ZI9:F]TMG<),;68P2[3G:X )'Z_P _2KE>.N1HOA#QUJ&F(L%\
MNLRV_GI@/'$7C&![?,PX]<]JT+?1)_"-Q>Z[;:CIRJ^ER^1:62MBX*KN$GS%
MO0'(R/SH Z_Q=XFE\,PZ=+'9K<+=WB6K%I-NS=GGIST-:6O:D^CZ!?ZE' )V
MM86E$9;;NP,GFO(]4TFQC\$^$]86/?J-YJ4#W%T[EGD+!RP)^H'Y5ZCXR_Y$
MG7/^O";_ - - %KP_JC:WX?L=3:(1-<PK(8P<A<]LUI5XLND)H?A/PCXDTHW
M1U22>"%U\YW697R=FW/3C  QUK1U>6+P3XQUL,D\D.N63-:AF9@;@G!3KZMG
MU .![@'K%8FL^(X=.\/ZIJ=J@NVT\LDD8;;\XQD$GTR#5CP[I*Z'X>L=-#%C
M!$%=B<Y;JQ_,FO-[?3+6R^'_ (XDAA\N07EU"0)&8!588'/IZ]: /3M(OQJN
MBV.HB/RQ=6Z3;,YV[E!Q^M7:\JTB Z/?_#^:UGNC_:%FXN8WN6*/B!2/E)P,
M9X QT%4=-L?$GB+1;;Q#:ZI903M.9Y[E]0F C 8Y1H^8P,;>.,8Z\\ 'L,DB
M11M)(RHB LS,<  =2:Y*S\;7&KQS7.B>';Z^LD)5+DR)$)2" =H8Y(YZ^Q]*
MM?$!;MO 6LBR_P!=]G.>GW,C?U_V=U+X FBG\!:,T3JP6V5#CLPX(_,4 6_#
M.OCQ'I;7GV&>S9)6B:&<?,&7K6S7#^+;@_VWH6AVTDEM9ZI=R&\EMFV%BH!V
M;ARI)QG&#5&5+K0/&-SH5C>WQL+_ $R6X&^0RM:R+D!E=LD#C'/<B@#T:BO(
MDMKZV\,>$M:BUW5/MMY=06TA>8,H24L#A2",CL3FM.1;O0M9\4Z?;:K?O"NC
MF^C,TV]HY?FY4D<=.E 'I5%>. ZGIO@G0O%L.MWSWS21QS17%P#')&7(VA3U
M/ Z<XR>U:GBG6;RSM_%=]8ZY=R7&GRV_DI&I6*WRRJR'^%R<G/7I0!Z?17FN
MH76K:O\ $'3]-CUJ]L;6YTA;MDM65=KY;@9!XX[\U1M;_P 2ZQ\(AJEMJ-RN
MJ6<LCLZ'#2QJ3N4^I Y_X#0!ZQ6?K6L6N@Z7)?W8E:-"%"1)N=V)P%4=R2:Y
MW1-9D\2^,6O=/OI&T>WT^,/$C HUPY)P?=5P#TYI/B79K<^'K5S--&8KZ# C
M?:"6D"Y/KC/'O0!NZ%K4FLI=&72[S3WMYO**7*@%N 01@X/!%:U<-<75[=>/
MX?"ZZE>065OIWVEY(W'FS/N &YMN<8/0=:P-8UWQ!H/ASQ18MJDDMUIEU;_9
M[PX+F*4@A3QU [^] 'K%8&M^,-+T.[2R<7-Y?N RV=E$992/7 Z?B:G\/6.H
M65I(^HZO+J4D[+(KR1+'Y8VC*@+QC.3VZUR'@4R3?$;QM+=J/M*3I'&3U$>Y
MP,>V GZ4 ='I/C2RU75DTMM/U2QO7C:58KZV,1*#'/4\<G\C7250U*U@_P"0
MF?*CNK."7R9YF(2,,!DM@XQ\HS]*XG2=<UG^WO"D,VKO>PZE%.+EOLZI$[(A
M8-&=JG'3G'/\@#T6BO(T\1ZX?ACX@U(:M<"\L-5,<4N$)*;HQM/'3YR?TZ<5
MIZSXGU;3]0@%]J5QINGW>G1&UO8[:.2(7!Y8R94D=>@P,?G0!Z317GM[K6N:
MQJVIZ=HUW< Z;:1,LUHD!6XF9=X8A\G8>.%/K76^&I=5G\.64FMQB/4BG[]0
M .<G!P. 2,$X[T :M%<#:7_B+Q#8:YJ=GK)L!:W$L%I:K;1LO[OO(74M\WMC
M%4AXG\1>(+GPP-+U"UT]-4M)FE!A$I61,Y.&'3ICGKG.<4 >ET53L8[ZWTB&
M.]N8[F^2+$DVS8KOCK@=!_GBN"LO$FLVVM>&Q=:RE_%JEQ<0W,4$2"&-EQM$
M;A0S!2P!.3G!H ])HKSK0/$NH:EXF:POM;>ROX;R19-,GMD5)(0&VB-MNXGH
M<[O4X(K6^)\ES#\/]1DMKAH6'EJ^T9+JSJI7V^]^GO0!MW7B'3;/7K319YF6
M^NT+PIL)# 9[XQV/Y5J5YKXM@OQX\\&017J&]VSK]IEA!&=HRVP$#IGC-0)X
M[UC3M,U/3[@_VAK%MJBZ?#/';@>9OR0Q0$ D!6X&.W/4T >HT5Q?@_4?%,FK
MW=EK<%U+9B(20WEQ:I V[."A5&(^GTYZU9\6:GKMEJVBVFCRV<:W\DD+M<1E
ML,%W*>.W!_2@#JZ*\VOO$WBFWU&XT>!C<W>G6JO<SVFG&;S)7!905W#:, <C
M.3GCT=>^,-=M=)\,RZALT9KXRI?7%S:,PA91\F5R-N[D\G^5 'H]5M0U"UTN
MPFOKV98;:$;I)&SA1T[5Q]UXDU?3]5\(VSW=C=Q:JTB3R0)E'QC#(V>F&'Y=
MZR]8US5-1TCQ_IU\(C;Z>H6WDCC*_*V3M)[D#;0!Z/:74-]9PW=M()()XUDC
M< C<I&0>?:H-2TC3M8B2+4;*&ZC1MRK,@8 ^N#7 !]8:R^'EII>IK9BXM06W
M0[P2EODY&1D;21CCG!SP,=UKFK)H/A^[U2X D^S1%RH^4.W8#KC)P._6@"]#
M#';0)#"@2*-0J*O10.@%96L>+-"T"=(=3U&.WE9=X0JS';G&3M!P,^M<O/XB
M\3:'I.F:_JD^GW.FW)C^U0QQ&-K=9"-I5LG=C/.1_C3=.CGU+XH>(HGN;6>W
M2&W62*6UW Q_>"#YASSG<<]>G&* .^EBAN[5XI466"9"KHPR&4C!!'H16;9/
MH.C7L>AV/V.TN9%:5;2$!6('4D#^O7!]#7/_ !1O[_3O#-K_ &=<?9WGO8H6
M8 @X.2,$'@949]JR]<&II\6- %NUI)?_ -G2 O(K)%GY\G:"3T[9_&@#TNBN
M _X3Z]AT7%Q;6QU<ZH^F!80[Q;E/+[1EB,=NI]NVEX3\3:KJ^K:CI^J:?Y)M
MDCDCG2WDB5@PZ$2<AO\ Z_I0!NWVO:/IDX@O]5L;24KO$<]PB,5Z9P3TX/Y4
MRT\1Z'?W*6UGK.GW%P^=L4-RCLV!DX .3P":XOXD2>3XK\&RBS:[*W,I\A "
MS_ZO@9XK1T>X@U#Q2$?P<VEW5M;R7,%S*JKN).PCY!@Y#'.2<>E ';45Y[8>
M,?$MUX@E\.RZ?81ZK!< NQ$@B:VVDEQWSG;CUW=.*7Q/X\U'3]6O['2(;%CI
MZ*9ENA*7E9EW!8P@QT]3U- 'H-%<4OC+4-5GTW3M&L+=-1NK(7LPO78);ID#
M! &XG/3IV-1S>,M9L8-!&I:1';75]J7V&XC9CC&=HD0^G.><Y_6@#N:@NKVU
MLD1[NYA@61Q&AE<*&8]%&>I/I7&7GB_55U/Q9IJV]K%)I5C]IMI06?/R;OFS
MC)P1].G/6LZ;Q(\?PZ\/:GK6FQ:L\]S&,R2!=K_-M<_+UX/&/QH ]+HKG+OQ
M+<V7C6PT&?3T6VOD=H;SSSR57)7;MZY]^A!]JS?^$[EBLH7N+.VBN;R_EMK-
M9+@QQ21Q]92Y7(';[O.1ZT =F[I&C/(RJBC)9C@ 4H(8 @@@\@BN(TO7[?X@
M:=KNBW.GP![9S"P$[20RX/RL' 4XW+GCG&*L7>HQ^ M#T+2(42XDE<6J/<W!
MCC!QDLSX.!GH,=^.E '857^W6?G>3]J@\W.W9Y@W9],>M1:5=7=Y8+->VB6L
MY9@8TE\U2 2 P; R".>@ZUPFJZ98M\;-(W6<!$EB\S@H,,X+X8^IXZT >D45
MYZ_Q+NA9ZC?1^')7L=.NS;W,INE!4!L9"XY//3IR.:W]2\2W,>K?V5I&FB^O
M%M?M4@DG\I$3HHSALL3T&,>] '1T'I7+Q>*[V;2-*N%T&Z2^OYFA^RRDKY)4
MG<SMMR%^4G.*HR_$6&#P[=ZH^F3/)97K65S!#(K^6P. V[NIX ..M &UX;\,
MP^&DO4@O;NY6[G,[BX93ASU(P!UXS]*W*Y'2_&TUUKT6DZEH5YIDMS$TEL9F
M!\S:,L,#H<9_*DL_'D<\ND?:M+N;2+5I7BMGD(+!E./F7J,_C0!U]9FN:7%K
MFG2Z:]Y<6K-M?S+639(N#_(XQ6+=>-S':W%_::-=WNFV\_D/<Q.N200&*H>2
M 3C/M2"\TR/X@ZJEIITTFM1Z8)'D,I"2*",(!G )RO..WY@'0:1I-KHFFQV-
MFK"),G<[;F=B<EF/<DU>K@K'QY?P^ 4\2:EI#R+OPWD.N"I=EW8Z@ @#GUS7
M1'Q$O]KZ3IT=H\KZA;M<%T<%84 ')(Z@E@ 10!MT45S%YXP*ZM?:;I>D76IS
M6"*UT86150L,JHR<LW7CVH Z>BN/N_B+IMOIVD7D5G?7(U*4PI'$@W1R @%&
MR1ALG '?!K?T?5'U;2DO7T^[LG8L/L]U'LD&#CI[T :-%>5ZYXANO$WPHUG4
M+NWET]HKC;$ROP0) H7@Y)Y*G(QGGZ=1HGC&VGO+'2+JSOK2>:T$D$MW&$6?
M ^;;SG/?GGZ4 =917'Q?$72Y+VSC-I>QV=[+Y-M?.JB*1MQ'][(&1P2/PXKL
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#/;1-,?6!JS64+:@%
MV"X*Y8#&,?EQ52R\(>'M.OEO;/1[2&Y4DK(J<J3Z>E<[=Z]XJN/']WX=TR32
MXXH;87(DGA<G:<#!PW7+"MW1)_$<>HWD&NFP>VCC1HKBU4H-Q)RI#$\C /XB
M@"W8^&M(TU;Q;2S$0O23<8=B9"<YR2?<_G53_A"/#O\ 8G]C?V</[/\ -\[R
MO-?[_KG.?UK8COK.5XDCNH':9#)$%D!+IQ\R^HY'(]14IFB#[#(@?IMW#- &
M5+X6T>;5HM4>T8WD4/D)()G&$P5QC..A-5/^$$\.?V*VC_V>?L#3_:#%Y\GW
M\8SG=G\,XKH'FBC.'D12>S,!2[UW;=PSC.,]J ,G_A%M'.IC46M"]U]F^REG
ME=@8L8VE2<$8]16;%\./"D+Q/%I01XI?.C99Y 5;V.[IQTZ5N:EK.G:19"\O
MKN.&W+K&')SEF. !CK_0 GM44]UJ2ZY906]I#)ILL;M/<&4!D8#Y=J_Q9XH
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M;[^RE .HO"%A.&_UF\C+<'..<G]/6*** "BBB@ HHHH **** "BBB@ HHHH
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M-4&I_96:$W(7&XACQU/3IU[5P,MA8:YX7\8:O?2/<ZG!)=1!FD/[A4SL50.
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MP#&^KZA:_;[>X2Y:VG*F3RX_O'U8XZG.,\5V$7@FPAN-<F2\OMVM*RW69%.
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M75M-"JKAQG,>/NXP<#/I39M<\17FI^,H8=76VAT5!+ JVR,6^5FVDGM\N/\
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M()&653W &!GG/KP:;K?AF\O_ !=HNNV5W#"]B'CD2:,L&1@1Q@CGD]3[]L$
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MQJ%[X=\>Z;?S/.-.CE2&61 KLC(Q&0 !V].]5=?:1M%^'!E0(_VVTR <]EH
M]4HK-\0W5Q8^&]3O+1T2XM[626-G7< 54GI^%<-I.N^*HI?"][J.IVEU9ZP^
MQH(X%0IN0D?,.N._3IB@#TNC-<#9ZEXA\31:UJ.D:O';0V=W+;6ML;96678H
MP68\C<3^%9:Z[J'B#Q=X)N8KN2R%Y:32M"BATW -NX..H7'.<<8]: /1M4U6
MRT73Y+_4)_)MH\;Y-I;&3@< $]35F*5)X4FC;='(H93Z@\BL3QM_R(VN?]>4
MO_H)KFH-4\3Z#/X=>^N;&ZTW47BM##%"4,!9!M(8G+=#G/OQTP >AT5Y@OC#
MQ5J"P:OI-E<75G-<LL5FEG\KP!BNXRD\-P>WX8KN/$NLMH'AF]U;R?,>WBW+
M&3P6)  /MDT :]%>?>&]<\83>([:+4K2:?3KF$M(YL3 +9\9 !)^8=L]\UF6
M_C;Q1<^'!XA+Z:EK#J(MY+=86WR(6"_>+''WAV[=>U 'H=KH.E6.J7.IVUC%
M%>W/^NF4<M_AGOCK4FFZO8:Q%/)87"SI!,T$C*" '7&1R.>HY'%<G8WFHW'Q
M>U:U6^_T.VLHO]'920,[3QR,'))SSUQ61K7B#4I/AQXIN8Q;V-W::F]HSV:E
M-X$B*S9SG<=QR?2@#T*ZUG3K'4+2PN;N..ZNR1!$>KD?_JJS<6\-W;26]Q$D
ML,JE7C<9# ]017G7B%IW\0_#I[F19)VD<NZ@@$E8^>2?YU)<^.]<N8M4O=#L
M(KJTLKO[.D1M)G>8+C>V]3M7KD C.,4 =Q8Z?IN@::8+."*TLX@7(48 XY)/
M?IU-26&HV6JVHNK"YBN8"2!)$V02.O-<V_B#4-9\07VC:6EI MG;1O<M>PLY
M+2#.P*K+T'4Y-4?A!_R3^W_Z[R_^A4 =Y17G^GZYJ$7Q#\4F]O8_[-TZWC8Q
ME2 J;2PV\X!YY)Z^U%SXO\16GANV\3O:Z=)I4KH\EO&LGG1PL< ELX+#(S\M
M 'H%%07$[QV$MQ!"T[K$72)>"YQD*,]STKD=.\6ZH^MZ+IVHVMFDNIQ3.T,;
M$26S(-P5^3VX['.>!TH [6LF?PWIUQXC@UZ1)OM\">7&PF8*%YXVYQW-<3_P
ML377T*[UY=*L%TZQO1;7"F=S(PRH)7@ ?>')_*NDG\3W,'C?3M)>*W73=0MF
MEM[@EM[N!G;Z#Z>X^E '45B>*#H$FD/:>(;BWBLYSC$TNS)'H>N14?A/6;[7
M+"[O+R&&*,7<L5MY08;HU. QSWR#Z=.E<MK,-Q?_ !DL[.:*SN+9=,++#<99
M=A<ACC!&[C\@.: .ZT>VTZTTFVATE(DL=FZ$1'*E3SD'OG/6KU>?V_C9[;P=
MK6H6FE6T4>C79M([=7*JR*5&1@<?>Z58U'QOJ<>IZ1INEZ-%=W6H6 O,/<;
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MU2_O3G/][C/?&,CCI0W@W0G@TV%K23R],;=:#[3+^Z.<]=W/('7..G2@#/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ J.:"&YB:*>))8VX*.H8'\#4E
M% $5O:V]I$(K:"*&,  )&@4 #IP*EHHH **** "BBB@ HHHH **** "BBB@
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M6-M;SQK:AXB2H.\D ("<#Y1D^@H ](HK)N_$VD6<-K++=[ENHO.A$,3REX\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BFO(D4;22.J(HRS,< #U)J.TN[>_M8[JTF2>"0922-LJP]C0!-112$@ DG
M'4F@!:*I?VQIG_01L_\ O^O^-689XKB(2P2I+&>C(P8'\10!)1110 4444 %
M%%,CFBE+B.1'*-M<*P.T^A]#0!CZ_K6HZ.]J;/0;G4XI6(E:W<!HNF/E/7//
MH..O-9FC:??6NH>(?$<FF-!<WBKY%B9%+GRTQ\Q4E<L?KBNNHH X#5+?6)-4
M\.^,%T:=[F"!XKS3XW4NBL#@J#C)Y/&?3WK2\*V5Z_B+7]=N;)[*+4&A2"&4
M .5C4C<P!XSGH>:ZVB@ HHHH Y7XCVEUJ'@34+.RMIKFXF\M4CB7<3B16/Z
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M1CT P1W%,T47FF?"+6M'GTO4/ML7FP[%MV(9G;:-IQR!G)([5UO_  KG2?\
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M5Z\T4<DN\(G8_4\D_AZ9(!T5%%% !1110 4444 %%%% !1110 4444 %%%%
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M7J-CXG\5W-[9/!#>72R0.S AU&_I@^XH MVOB]KZP\-W%M9B5M7?:ZK)GR0
M2YSCG:1[5F7OQ/L;219Q;))IQNC:F<7*;]P."WE@D[1@G/?CUJ;PWX.DTS7-
M5>Z^:P1W73$#?ZI)?FEQZ<@#\#Z\Y.@6?BCP_I[^&$\/P721SL;;49)5\I%)
M+!B",DJ3G'X4 >B7EVMIIT][L:5(8FEVQC+. ,X'J36'I7BI[_4K2RNM,DLV
MN[+[;$S2AODXR&'!4_,*T/$ U'_A&[]=+.=1^SL(2O!+X[>A]*\_TG3M:@\0
M>&-3OM!EBCL[62"[N)[@,RL0=TK'=P,D\'(P3TXP ;EQ\1A#!'>IH-]<:9+=
M-:Q7,+(S.P.WA,YY.0,D9Q5K5/'+V&N2Z1;:!J-[=1VJW)6$+G!(R.O;/;//
M'O7!V4LEA$MU>Z'X@FT4W\FI1):E'@4!MROTW[0,'E@#R:[+3XK^;XI3:N;.
MY;2[C35@@N"!M'*OZY Z]NIH 9J7Q0L-/N)3_9UQ+9V\XM[BX$L8*2<;@$W;
MFQGJ.,@X]:N:WX_L]*NIX;>SDOEM8UEN9(IXE"*PW#&YLL<<X [CUKGM,TW6
M-!;4-.D\'P:H\EW)+:WK>7LVN<C?GG //XT'3-2\.>+M8GF\,?V];:G(DL4L
M4:GRVP<@[L[1U_3GG% '4R>-()C9QZ78SWMQ=V7VY(]RQ_NNG?JV?X1GH>:Z
M&TG-U9PW!AEA,J!_*E&'3(SAAV->?>+=/:[@LHY]#OH-2@M#):7>D(SK!-DC
MRC@ ;>AR<#KTKM?#RZ@OAW3UU4DWX@7SRV,[\<YQWH P-$\:O<:/K&J:Q:-9
MV]C=21 H0V0I "8!R6R?3'-6X/&*)J%G9:KI-]ICWSLEJ\YC9)",8!*,2K'/
M0C\:X[^RM9OO#'B?18M*NXKM=3>]MY9H]L<X\T, I)Y.%^GO6MJ/VSQI>^'4
M33-0L6L;M;RZ>\MFC5=F/E!/#$GICMSQ0!V&NZS;>']%N=5NTE>"W +K"NYC
MD@< D=S6+;^/M/N+-KD:=JL:,85MQ+;A#=&3.T19;!Z<DX'O4WC];B3P1J<%
MI9SW<\\8B2*!"S<D#.!V'6N?\3V%YJ'AWPQJ<.DW5TNG2))<:;)&5D<;0#E,
M'D$?K0!MIX_THZ;J]Y-!>6[:3(([JWE1/-#$X& &(.3QG-/U+7K>X\.ZRVH6
M&K6$5M#MF 5?-VL/O(49AQUSGCO7/I!IDFA:FL7@/4+;3;AH8I8A#LN)1N.6
M\L$G"<$<\Y]JIP66M6?AKQ7I:_VG?:7]FV:<L]L_G%I!C: 1N8#(!/3@GB@#
MK8?$NFZ9X<T66,WMX+Y4BM(SAIYB1WR0,^I)Q3(/'NE366JW+V]_"=+'^EPR
M0?/&<D8X)!/'8]*XO5Y6T[P?X*$EKJ$&I6K;U$=N6EB\M</F(E<@\=QQ^LFG
MW>GS^#?%\MJFI3ZM>PO+=)/:>4S;@RJ50$C:,G/)/7Z4 =GI?CG3-6U:VTZ*
MVU"&2ZA,T$EQ;&-)5 R=I/7CVQ735YE/;W3^(/AW(+.["P6S+-F!AY9\M1AN
M..0>M=GH?B2#7+W5+-+:XMYM.G\F19EQN!SM8>QP?TH =J'B;3].U,:<_G37
MGD-<-#!&798UZL?3V]:@?QCI(M=,GB-Q/_::NUK'# S.X49;CV%8GB#5[ZU\
M9/:/8WLEC+IKI$;2SWM-*?X3)U  YX( SDUREJ+*^\)^&K.]&L:3?V:3?9]0
M2W;;$X(R"!R0>/RQW- 'K>GW\.IV$5Y )!')G D0JPP2""#R#D&LY/%.GRWT
MEK$MS)Y=V+)YDB)C6;'W2WZ>QXIO@VZU*]\+6<VK _:R&!<IL,BAB%<CMD '
M\:X<7$UCXBDOO#LU]!+<ZJ8K[2+N'<LA9B&E4]AQG(/MG'! .TOO&6EV-Q=0
MF.^N/LG%Q);6CR)$<9(9@, @<FI;SQ9I-I#8R)+)=_;@6MDLXFF:10,D@+S@
M5RGAZ^C\'CQ'IFLPW+.][+=PL(&D%S&X &,9&?EZ$]ZS- M;WP;>^&+S5;:;
M[-)ITEG+LB9_LTC2M("<="00#Q_": .W7QQH3:1>:D;F1(K)_+N8WA821,3@
M KC(S3]*\::'K.J#3K.XD-PT?FQB2%HQ(OJNX#->?ZW:W%Y8^.]8ACG-G?\
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MMD5Y$R._8<\D<9],BO-_#4GA:_\ !DUEXFEA346OWEN8&EQ</,&XPH^8\'
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M(D_D7,I9D=2PRP).&QC.#UKF;'_DWR7_ *^5_P#2E: /: <J"002.A[4M%%
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M^<YQCK[^U '7Q2QSPI+$ZR1NH9'4Y# \@@]Q4<=[:RW<MI'<PO<P@&6%7!=
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MP6(50N6.2<>IIU%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MVIGP?='\&S!64D7LN0#TZ5W<=O!$K+'#&@;[P50,_6EBABA4K%&D8)R0B@4
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MQ%=!H_AC1= >1]+TZ&V>4 .RY)(],GM5G5=(T_6[+['J5K'<V^X/L?L1T/%
M'+R6T,/Q8TU[=5"-I,@P'(4*'4#:HX_#TY["N+?P_IK^#_&E^\1>[L]4N%MY
M"YW1!&7;@^M>I1>%]%@OK2]BL$2XLXQ%;NK,#&@!&!SZ$_7-1?\ "'Z#]@OK
M);!5M[]@UR@D;YV!SGKP<^E ')'3+32O&?@Z[L49)[VUN?M,GF,QGQ &!8D_
M,<G//>N=T+08M8\.V?B*X\2VMC>13M--<?9RTZN'/RLQDY!R#C:.HKU,^%M(
M^UZ9<BU(DTQ2EIB1L1J1C&,\_C5)/ 'AB/63JJZ5']J+^9]YMH?.=P7. <T
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M@$8XQU.>M$7C/Q ^E:%JK:58"VU.=;<0_:&#AG)"'.W &!GOUJ;PIX9UC0_
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M:^FLM/CCTN-X)4CG.XAE*M(>.6.2W&>>M !;:SJE[\.=>O\ 7;2TU6&.>0)
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M;5;34K.VW6>I62LX<G.8B!_];KU]>FT>/4+CPK:QZHQ%_):A9R1R'*\Y [T
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MU>/502VX J \A/T[9_"KMM?>'()_$FC>++NZBGGU)YC"I<K,IP4(V+Z8[^E
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MXG>XBMC; J;:YMIMZ3J1R1Z8/% &I1110 4444 %%%% !1110 4444 %%%%
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MS2#:K%(R*F  !@'V'Y5L44 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO)YYKKEC1(A$J*(U7:% X ]*=10!C>&_#5GX8LKBULR2LUP\Y) &-QX4>P
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !5#6-5BT?3VN9%,DA.R&%<EII#]U!CN?TY/:K]87B'PV^NSV4R:M>V#VA8H
M;4@9+#&3D'MD?B: .>\#W.H3>-?%T6HW)FDB>W&T$[$X?A1G@=![XKJ_$<DL
M/AC59897BECLY71T."I"$@BN,\)Z!JNA^*/$E[<W&JW$,>#$'VD7IV$Y]V'
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M.BD66))%SM=0PR,'!]J=6=#K=E<:[=:-&TGVRVB660%"%"MTP>AK1H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^FZI8ZO;&YT^Y2XA#M&73IN'44 7**** "BBB@ HHHH **** "BBB@ HHHH
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MGAA &-JX5L8^K&NPK!\(:"WA_0$MIRC7DLC7%TZ=&E8Y./8<#\*WJ "BBB@
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M?79Y(]-LO[4L#:_9[/<8Q)@_O#D#N>@'OU- '0>$);R?PCI,]_.L\\MI$YD
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M PR",=/\]*W:\@G@-EKGQ%CM;BZBDAL8GCF$Q+C$8;&X\^V<]*Z&YNKS^TO
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M;1B[:)I\?.8E*KGV!)/ZUY?H^K>(= \-:I>Z;I>GRZ79:A<LZ/*RR,@D.=H
MPH SUSTZ4 >K45R+^++M/%.AVCP01Z5J]MYL,K9\P2;=VP\X[K^=:/A;5[[6
M[*ZN[N&&.'[5)':M%G]Y$IP'.?7!Z4 3:9X?T;PW]KN+&'[*LV9+AFG=E.,D
ML=S$#OS5^ROK74;5+JRN8KBW?.V6)PRG!P<$>]<?IVIZK=_%+7-)FN(WTV"V
MC/D%3P"H((]_FY]:YSPQKNN>'O =G>0Z=8R:1#>/%(3,WG%6F*Y5<8&&..I^
M@H ];HKS[Q%X]U&SU+4+72+6TE_L\A9%G69GF8@'"!%P,9QR>:[73K[^T-'M
MK\0R0F>%9?*D4AD)&<$>U #=0UK2])*C4-1M;4MT$TRH3U]3['\JDL]2L=13
M?97EO<K@-F&0-P>AXK@/AOI=KXATNZ\2:U;PWVH7UPXWSH'$:+@!0#P.0>G;
M%:VIVVD^ /[5\36\"QI<11Q?8XD"*TH8X(/;.1GCL3[4 =G17(KXDUK3-9TZ
MT\06%E%!J<ABMY+29G,4F,A)-P .>F1Z5F2_$+5%TW6=1CT.W-II5VUO-NNR
MKMA@,J-GN#R>_>@#T&BN.M/&=X=<T:QO],BMX-8A:6UDCN#(PPH;:XVC!P1T
M)'-9D7Q"URZM-4O+7PQ');Z9-)'<L;Y05"<G V\\9Z4 >B45R,WC"]GM%O=*
MT@S60TXW[W-S+Y:=,^6" P+\'/0"JUS\062S\-S6>D27,FM[PD7G!"A7'&2,
M'D]>.!0!V]%<9:^,M3N-"URY;0PFIZ3+LDM!< JRX!)#X[#<>G8>M6X/%LEW
M;^&9+2S29M9Y<+-Q  FY^<<[>1VY&* .HHK.US5'T?2WNX[.:\D#*BPPCEBQ
M Z]ASU-9$OC$6TVO07-B5GTBV%RXCF#K(I4G . 0>.XH ZBFNZ1QM)(RJB@E
MF8X  [DUQNF^.KF^U+1HYM#EMK'5T8V]PTZLVX+NY4=!COU]JS?&NMR:[X7U
MR"RT22^TZV#QR7?G!-DJ$$D)]XA3U/L>W- '60>&X(?%-QXA6]O&GGA$+0LZ
M^4%&,8&W/;/7N:B\1^'K'7;G2WO+^>UDL[@36ZQ.B[Y!@C[RG.,=!ZFKGAS_
M )%C2?\ KRA_] %><6D$.L>-O%5YXAT>.XM;)DS-YXS:K$C,-N,,=V!TQ[]Z
M /6J*XX^.I(+.SU.^T.YM='NV79>-,CE%?[C,BY(!X^F:DNO&T\6MW^F6OAW
M4KQ[)XED>+;C#]&P3G'I]#G% '6T5FZ_K,>@:-/J4EO/<+%M B@7<S$D ?0<
M]:I:'XE?5=3O=,NM,GL+VT5)'1W5U*N."&4]>O% &_17/>(?%UOX=OK&SET[
M4+N:])6$6L2L"P[<L.>:HVOC^U-IJTFI:==Z?<:8%:6VEVEG#<+L.<$D\>G/
M6@#KZ*X_1/B!:ZKJ-SI]Q836=W# UR$,B2!T'7!4_>]JJ-XYT[Q%H%XS:)K?
M]DR6<SS7'D!5VJ"&4,&Y/!Z'Z]\ '=T5R%CXGTO3/#.@IIMC?W"WL9CL;1=K
M3%47))RV, #DYXR*M6OC;39(-3:\BN=/N-,0/=6UR@\Q5(!##:2"#GM_6@#I
M:*\SU#7;G4O'OA*2&VUC3(;CS"RW& DZ;01\JN1GDYR!C(]*[[5]7LM#TV74
M-0E\JWCQDX))).  !U.: )K6QMK(SFWB"&XE,TIR3N<X!//L /PJQ7.6OC&U
MEU:WTV]T[4=,N;H9MQ>1*%E/< JS#/L<=17+:--=>*/&VLB[DU2$6%\BP&WG
MV1Q(F[Y'4-@[L>A/N* /3**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH Y(_#7PS]GD@2TF2-IA.@6X<>4PQ]SGY
M<XY[\]>F-"+PGI\&K7FI12WBSW=M]FD_TEB O&",\AAC@Y]:SKGQ/K-SK&H6
M>@:3:7\>G2I%.TEWY;,S+DA>,#!ZY/8C%=!H]Q?W6E03:G9K9WC ^9 K[PG)
M Y[\8/XT 5_#OAVQ\,:9_9^GF8P;R_[U]QR:9<>&-/N/$L.OL;A+V*,1_NYB
MJ.H)(W =>O3IZULT4 <LO@'21H^I:9YU\8-1F\^X8S_,6SGCC R>O'-7)_"M
ME<7VDW<EQ>^9I:!+<"? / !+=R2 ,^M:U[>V^G64UY=S+#;PJ7D=CP *R+OQ
M,+/PW'J\FGW*O,ZI!:,5$DA9L)WXR.?89STH A?P/H\IUKSQ/,-88-<B23."
MI)4IQQC/'T%16_@'28+6YA:?4+AIX3!YMQ<EWB0XR$)X7H.U2:'KNOW\5Z^J
M>&GT_P A T2_: YF/.0.!CI^M;6F:G:ZOIT5]9N6AE'&1@J1P01V(.010!1L
M/#5I8ZA'?O<7=Y=0P^1%+=2!C&F<D# &2?4Y/%-\0>%[/Q#]FDEEN+6[M26@
MNK5]DB9&",^GM6W10!S%GX%TJTDU21YKZYDU.$P7+W$^XLI&/0<X[U7L?A[8
MVLNFS3ZGJ=W-IKAK9I9^$ Q\N .G !KKZ* .?T+PJFA3:I+%J5Y.=0E,K^:5
M^1SGD8 YY'Y"LM/AQ9Q^%7T!=4OA ]T+II,IOW>G3ID _45VE% '+7GAL6>L
MS>)XKJ]N;Z'3V@$ "GS0%) X7.XM@\=_;BO/]!FNFTZWBTK7O$;:V2)'LWMR
M8A(6&_<6&-O)Y)]_:O::S=>UNU\/Z3+J%V244A512-TCDX"C/?\ ID]J +=[
M:1W]A<6<V[RKB)HGVG!PP(./SKDF^'<#Z#::3)K6HR1V=TMS;R.49HRJD!1E
M?N\YQ6]I&M/J+3Q7>GW&G3QRF)8[@K^]P 2R$'YASU%:U '.WOA"VU#7KS4[
MJ[N'%U9&QDM^ @B/) .,@YYZU5T3P-'H\MKOUG4[VWM>8+:XE'EHW8X &<9.
M.WY5UE-DD2&-I)'5(T!9F8X  [DT 8OBOP\_B?1)-,&H2V22$%VC0-O YP0>
MW?@CI6!)X%\03:4-*E\:W'V'RA"8DL(U)0#&W<#GIQ7=T4 <M=^"+;4%U=+R
MX\Y+VW2WMU:/_CT5!QMP?[V&[=*I7?@">[TS2D/B&[35--#K%J*1@.R,?NL,
MY.!P.?7UKMJ* .,N?A]%>Z(;2\UB_GU 3+<)J#M^\1U&!@=EZ\#GGK5ZT\+7
M3:??VVLZY<ZH]W;FV#O&L:QH0>B#@MDYW'G@5J:EK$&EW-A!-#<2->S>3&8D
MW!3ZL>PK1H X:Q^'UU#=:++?>(I[R/1V!M8?LR1JJA0-N1R>B\DGI[YJ[:^#
MKJRNM=:#6Y!::L9I#;/;J1%+)U?.<G'3'';TKK*1F5%W,P4>I.* ,3P]X;31
M/"T>@S3_ &R!%="Q39N5B201D^I[U4L_!&GVG@J7PQYDKV\JL'F/#DDY#>F1
MQ[<5KW6L06FL66F/%<-->*[1ND99%VXSN/;K6A0!RFA^%=5TVXMOM_B:YOK2
MS&+>V$2Q#&W:-Y'+8]#Z5O:M:7-_I5Q;6=Z]E<2+B.X1<E#D'./TJ[10!S6F
M>&)[?Q.VO7MS;/=&T%L1;0>6'/!+MR<G(Q]*C\4^%;W6-0L]5TG5Y--U*T1H
MT?8'1U8\@C_]==34%Y>6]A9S7=U*L4$*%Y';H * .-UCP1JVL^%#IMYKWVF^
MDG2:2YEAPH"CA552 ![XYS6B_AJ]?QW9^(VNX"L5C]EDB$9!)^8Y!SZG\JTM
M%\2:=K[3I8M-O@VF19H'C(#9P<,!UP:N:CJ%MI6GS7UY(8[>%=TCA2V!]!S0
M!Y+XM\.77ACX;:A;75U!.;K55N5,:E<%A@CD_P"S7?)X?OK[6[?6=4GLI;BS
MA=+-+>)@BL_5VR23T XQWK5,.E^)=)MIIK:*\LYU2XB$T>1R,J<'H<&KT44<
M$2Q11K'&@PJ(, #T H X/3_AY<VO@R+19-0B^U6EX+RSN8T8!'!R-PSSU(^A
MK4?1;M]>M?$'B&]L!%ID$GE"&-D52V-SLS,> !73SS1VT$D\I(CC4LQ )P!U
MX'-<JWQ'\*31[1>O-&Y9&VVTC*,<'=\O _I0!FZ3#IVO_$J?7-*NA/906J&8
MQG]V]P0RJ<=R$SSVS6W!HFJ1>/+W6S+:FTGLUMT3YMZE3D9['G/YUI:!<:1>
M:1%=Z&D"V,Q++Y,7E@G.#Q@<Y&/PK3H \]'@W7H_A])X=2>P>8W?FJYW!?+\
MT2>G7(S^GO5FX\-^*-/\27>HZ#J5BD&I%7NX[F-F$;@ ;D Z]^X_&NYHH XM
M_"NK?\)=X:U1[N*ZCTVWDCN9I6(DD=U8$@ 8QD],UE3^!-:O_"VOZ==36:7-
MYJ;:A;M&S%221E6XX&!VS7I-% %73C?'3X3J0@6\*_O1;YV ^V>:XF/PSXF3
M2M6T('318:A<S.+HR.9(XY"21LVX)Y/\7>NTL=4L=3:X6RNHYS;2F&8(?N..
MQJY0!Y]X[MM,E\.6F@6M_$NLVKP+8QK(//5LA00 01QDY]LUW&G646FZ;;64
M Q%!&L:_0#%1#1=,&K'518VXORNTW&P;R,8Z_3BGC4[%M4;3!=1&^6+S3 &^
M8)G&<4 <U'X?U>R^(E_KMH;.2ROK=(Y%E9@Z,J@#  P1E1^9K'7PEXF3X=_\
M(Z$TW[3]J\SS#,^W9YGF_P!WKNX^E>D44 <*-%\7:3X@U*^T=M*FM]1V2RQW
M3.#'*%PVW:.1]:[&QAN(;"*&\N?M-P%Q)+L"[SWX'059HH X'3]!\1>"KB\A
M\/VUIJ6D3R^<EM--Y,L3G@@-C!7 '^>MG6?#VO>+?#^H6>KM96;.4>SA@9I-
MC+S\[D#.3D8 X]Z[6B@#BQ8>(O$.H:2-;L+>Q@TV<73213B3[1*H(7:,?*O)
M)S]*QY/#7B*Y\,>+K*33X4N-3O//MU6X7# L,_3 4=<9S7HL5]:3W,UM#=02
M7$./-B20%H\]-P'(_&IZ //I] UQ]:\%72Z>#'I4 CNOWZ?*2H4XYYQC/'6L
M'PX-8N]/\7Z7IFF).MYJ5Q"]S).J+$'^4DKU. <\5Z_63HOAO3/#[73:=%)&
M;I_,FWS.^YN>?F)P>>?7CTH XZ;PMKNEWEM:Z=96VI:?'I@LT^TW)2.*3G?(
M4YSGV]<9JM9^%O$4:>#%ETZ-3HMQ*L^VX4@QL4PX_P#'N.O'O7J%% '(>'-(
MU#3_ !1XIU#48EAL;Z:-H-TJL&"[@21GC(V]:S_ GAT:?KNKSQW'G6%I-):V
M VKM16(>3!'7#?+^!^@[#6-&L=>TY[#483+;.02H8J<@Y'((-2:9IEGH^GQ6
M-A L-O$,*@_4D]2?<T 8WC>WUBY\.F/15>2?SD:2-)/+:2,'+*&R,9P.G-<K
M/H7B">]\1NN@);0:EI?V>)4N48HZ(0H..I/3VXKTZB@#S$Z#KCV7@"(Z9(AT
MZ96NSYBGR@"HYY[@9XI7LO$^DZ9XCT&#03?17[W$L%W'.JJ!*#D$'G(].Y_.
MO3:BCN()I)8XIHW>([9%5@2AQG!'8XH H>'(KR#PYI\%_;K;W,,"Q/&KAP-H
MQU'J!G\:XK2?#^I:C?\ CA;W39K.'6$ MGF(QD!P"=ISU93CZUZ,\L<94.ZJ
M6.%W'&3Z"GT ><3Z?K6K^!K+PC/H]S;3KY-M-=[D,*1Q,/G4[LDD(,# Y-;6
MA6FH6WCK799K"9+*:"W2&Y=P0YB!'UR=V?P-=;30Z%V0,I9<94'D4 <[XZ36
MY/"T\>@([7KLJD(0&V$_-M)Z&N?\.6>M+\1)M6N="N;*QN;!;=?,G60QE2,;
MCG)SM]SS7HE% '#>.;B6T\4^#YH8'G<7D@,:+EBI4!B![ D_A6'XA\.ZIXI;
M6M:M]*G@F,-O':078"O*$?>^5S@9X&#Z5V^N^&$US4],OSJ%U:RZ>YDB$.W!
M)QG.0>PQ^-;B.LB!D<.IZ,#D&@#@M&N+R^6=H_!"Z.@M)1+,T*K)(VWA$  /
M)]?2JWANUOK;X,7FG3:9?1WJ6US"(&@(=V<MM*KU(^<?D:](HH \GL-*U33+
M7P7KJZ9>R_V=%+;7EJ(3YJ!LJ&"<$]3^E6O$&D:EXK?Q%?66GW-NILH+:W2Y
MB,3W#)+YK$*<$#&%YZUZ=10!Y?J.H:EXA\4>$;J/PYK%M]AE=KKSK4HB[@F<
M,3C VGKBND^(NDWVK^$I(].B\ZZ@FCN$BV@E]IY !X)QSCOC%=910!P>I23^
M*]:\-&WT>_MOL=T+NXFN[9HA$H'W 6'S$G'3TI_@:UN[?Q-XMEN+.Z@CN;T2
MPO-"R+(N6Y!(YKN:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** /-/ >DV<OB3QC)Y926._DACD1B&16+ X_Q
MJK8Z-)X@^!=HBR2?:X$EN(6$A!++))P?7()'Y5W5AX4TG3?[0^RQW"G4,_:2
MUS(Q<G.3DMP>3R.:MZ+HEAX?TY;#38FBME8L$+EL$]>22: //I=<DUC2M1\9
MV<4HEL=*6" KG:)F&9& /]S<!W'7\'>&O#=_'>Z!XBBU'3H('B43E9)&:Z,@
M&0VYB"^<]._;C%=[9:!I>G:.^DVUG&M@X<-">0P8G<#GKU_*LW2? 7AW1;Z.
M\L;)EFBSY>^9W5">X!) /)Y]Z ,OXJSR1>$H40?+-?01R<?PY+?S45T>O>'-
M+\2V26FJ0&6*-]Z!79"K8QG(/O3O$.C1Z_H5UILCE#*N4D'\#@Y5OP(%9DWA
MY_$FEZ<^M_:K'4K,MB2RNMIW="P([-M!&>1G'K0!D^"8KC1?%.O^&A<W%U86
M@BFMWF;<8MXSLS_GH:M>"QY.O^+;6-R8$U+S%4G(5G4%L?C_ "K<ATR+0M/N
MGTNS:YNW&\^;-F2X<# W2.<_GTJ+PQH/]AV4[3M')?WL[W5W*@P&D8YP/8=!
M^>.: ,#Q1(_AWQMI'B.6:0:9,K6=WND.R(D95MO0#(Y^GK61_P 3&+3- LFO
M)$_M_4)+J;S+B2-A'MW)%OR67("CCOQZYW/%;3^(KS_A$SHMV()7CE?4'0&%
M45@QPP/WC@KV/-;OB'PQIGB:PCM-0C?$3AXI(FVO&?\ 9/:@#DS8ZQX<T7Q+
M_:&O+:6#KYMI()7N9K<'@@%\$],#GKSQ5>WEO;+Q1K6F1SZA#9RZ#]IC6XG+
MRQR* NX$D[6Y.<=ZZ1_ .B3:7=V5T+JZ:[VF:ZN)R\[%?N_.?3L.E,C\ :9%
M?/>B^U5KJ2V:VEEDO&=I$88^8MG/8@=,@<4 <EH=AKE]\-!K5GJVI7.I7-N8
MOL[W!VE5F(.SN'*C&<YYKI_ NHZ;=_;XK274XKE67SK#4IF>2 @=5W$G!^OY
M5?M_!UA:^&H]!@NKY+6*42Q2+*!)&P;>-K <<\_C5S3?#]IIFI7NHJ\T][>;
M1+/.5+848"C   H P_$SQW7B:SL6U6Z7%I-)]AM&9&SCB5W4C"XR #WQC-<3
MKM_+KGPB\/ZA=S327(OEC=V?&XAG!) X/3BO1=7\%Z=K&M+JTEUJ%M=B$0,U
MI<&+>F<[3CG%46^'.F'PU!H2WMZMK!=_:D)<$@Y^[TZ8S^))H JZE8)_PM;0
MF^T76(]/F('G'G:>_KG=SZX'I7/6#>+/%MJ=>TN\:"1+N3RC+?%(DC#?<:$)
MZ8Y+'UKT'4?#46H:[INK_;;J"XL05_=, )5/56XZ$XK%E^&M@U]<-#JFJ6VG
MW3-)/I\-P5BD=NI/L1@8]NM &=>'5==^)%_H0UR\LK)+&.Y5;5EX8,G )&<9
M/X_3BM?XGP^;\/=4/F2)Y:HXV-C/S 8/J.>E7[3PK!9^+[CQ!%=2AIK86WV?
M:H1%&W&..GRCBK^O:/#K^AW>E3R/''<IM+IU7D$'\Q0!S>I27Z^)=-\,V-U=
M+!%8-<R2BY"S288( 696SCDD=\^W.%JMWXUT7P(QO[]8K]=22-;A61V,#<#/
M'/S$>^*Z._\  HO8],G&MW\6JV"&-=15@9)%.20W8]?\<TS5/A]#J6CQV#:M
M>A_M(NI[F0B22:0+@$D] !P .,4 9VJV?B72K_0[%/%=Q(M[?.CR-;)N";,@
M>AQM;_OKVJ"WMO$4^L^(M'_X2R]6+3(XI8I?)CWLSH6 8XZ#'08S[5U>J>&I
M-4O-%NGU2>.33)!(=J+^_; !+>F1D<?WC4,7A.6'5-<U!=6F\[5HA$P\M<18
M&%(]2 2* .6N/%&M-X<\$7ZWI26_O8X;L*BXE!;'/'' /3'7Z59O+GQ#JWC_
M %W1+/79+&WMK-)8E2)#\Q (Y() RW/<CBM!_A\'TC1=._MB<)I,_GPN(5RQ
M!!4'Z<_7-7D\)2Q^*-6UN/5'634+;[.$$0S%@8# YYQ@=J ,>QU_4;WPWX5N
M[G5TM6O"5N1'$&GN".%V+M(ZX+''3TKG;K5=2U[X?A+J_G\ZUU]+,S+M#2J&
M7:2 ,<;@?JH-=-#\.IK:#0C;Z]-%>:0'2.<0*0ROU&T\#J1SGK21_#8PZ!?Z
M7%K4X^T7RWT4K1 F)P!U&?FY ].@H M:UK&JZ;X\\-:7%>AK&]603(T2[W90
M3DMCW'  Z'UXHQ7OB#6M(U;7+/6GM3:SW"VUI]G0QE8^,.2-QS@^F,UK7GA&
M[O?$>AZO-K+2-IBL&1[=<RELY.5(VY&!T/3ZU7?P5?6\^JII6N?9+#4W,D\#
M6PD9&;[Q1MPQGW!H Q7\3^(-<USP[9:;J$6F+J>F?:9,VZS!7&XG&<'MZUT'
M@+6[_6+#4H=2G%Q=6%]):M.(P@D"]#M' HA\$K:>)M'U2UO!';Z99_9$MC%D
ML,$9W9]_2K7A7PQ)X;.J&2^%U]NNVNN(MFPMU'4YH SIM5U75O'M]H-EJ!T^
MWL+19&=($D:1VP1]X'  /:N7\1ZQJ>I_#;Q)9:K(!>Z7>1V\TL485;A?,7!Q
MVSG/&.WO7:ZAX7NSXF;7M(U..RNI81!.DML)4E Z$@,ISTYSVK-O/A])<^%K
M_24U11<ZE<_:;Z[>WR9&W!L*H8!1D#N>* .GT&%X-#LDDN7N6\E?WKHJL1C(
M&%XX'%</X?%[/9^.Y+J^GGA2ZNX1$\:[257&X'KG  QP.E>@V%N]IIUM;2R"
M22&)8V=5VAB  3C)Q],UR\'@[4;0^(8[;6U6VU>2681M;;C"\G4@[L$8XZ#/
M'I0!@Z3?^(M&TSP9.^H6LNFW_P!FL_L:V^"BLG#;\Y+8'L/:H9O%GB_4+N6_
MT6VN9K2*Z:$6:V*F-T5B"3+NW;OH,5T<G@_4)-)\,V/]IVX_L::.5G^SD^88
MP0H'S<<<>_7CI56+P3KUA?7L.E>)VLM'NI&F\D0!Y(V8_,%8GCUR#U[=Z .Z
M4ED5BI4D9*G&1[<5Y'X U+7[+P;<C2- COU^U3GS7NE3!PO5,9;\#7JSQ2QV
M+16K@3+'MB>8E_F X+'.3[\YK@O#_A7QIX:TYK&QU/13"TK2GS89&.YNOIZ4
M 7?$6KZQH'A.PUK3K6S@@0)+?VC0$$;R"VW!&""3G/K2W'B^]TSP.WB"[^SW
M$EW(!8P1+C:'/R*Q!.X@<G&.A%.7PEK-W;Z=::SJT5_:+.]SJ$<BL?.8YV(O
M. @XX]1GVJG!\/+L:!J>@SZC$=/:?[1IA5"7M6R2 <]N@X]3SS0!+;>)]>TR
M\OVUFV,^FV]@UT+H6;6W[Q3_ *O#%LDU:TN]\77IT74E;3YM-OU$UQ"L11[>
M-E#+ABWSD9YX'3IS4EGH'B*^LKFS\2:O:W5M+;/!Y=O;[=Q;^-B>X[ #'>H_
M#?A[Q/I)M+*^UZWFTNSXB2&#;)(H&%5B>BC@]SVS0!C'QUK+_#[6M=06JW6G
MZ@;=08B5=-R#D9Z_/U]JOQ7VM7WQ*L8H;^.&S.CI=RVYC+*0SX8#G[V1PW8<
M8]<^[^'FN-IFLZ+9ZGI\6D:A=-=!7B=I5)96"YSC'R 9Y_6MV3PSJUOXLT[5
M].O[588;".PN8YHR2Z*^XE<="?Z=Z *&DZYK-\GB^VL;73XM0T^Y_<^7$0LK
M<Y+<Y+$)U]_:GZ=XNU'5K'PO/:26A^V!Y-29EP(DCQO(Y^7GC)]16EX7\.7N
MBZQKU[=RV\@U.X$ZB(M\GWN#D>].T#PDNC:IK,[S":UO9"8+<Y*PHW+K@\<L
M>P["@#E8OB#K]W=6]_9::USI<MP4,$-A.T@C#$;_ #,;"<#H/7ZUW1T&V?Q0
MFOG N%M?LZJ$ ZMDL3U)Q@#TY]:YC1_"?BO1;4Z3:Z]9II(D8HX@/GQH3DA?
MX0>O7.,UW@& !DG'<T <3X;\77_B#4519-.C,<\L=QI[AH[B- <*_).X\<@#
M'/6MSQ5X@3PWHIO"@>:258($(.#(QXS@$X')./3 YKFH_".L7_B#3-2U.#3[
M>[LYS+-J%JY\RZ4<*K)M 'N<GCBNA\8^'YO$>A"UM+G[->0S)<6TIZ+(IXSC
MV)_'% &%HOBOQ#=:CJ=A=::)9$MWGM)TM98(RP!Q&WF =3T/^11'C[Q%#I&B
MZO/I>FO::G,+=(HYG5]QS@DD$ 9!['I[\;>G6OCA[>XEU6\TSSD@=+>"!6"2
M2$<-(Q[ ]@.YK$G\&:_)X-\.Z6$L3<Z7>K/)^_8*RJ3@ [>IS^'O0!IVWB_5
MXM3US2=1LK(W^GV1O(6MW;RY% Z'/(/(_6LJ'X@^((="T[Q%J&F:>-&N91'(
M897,JY8KNP>.HZ<_X:&I:#J4'BGQ%KSI!]AN-)DMUQ*=^0H.2,>JD=:P_#.B
M:EXG^'F@Z9+!:PZ4DWG23F8O)*JR.=NS:,9/&=QXH OZ;?Q:1\0O'>H3(S16
MUO#,ZH.2!'DX]ZO3>+M>TO3]/UK5K"Q72+ME#B"1C+ K_<)S\I[9^M.C\(7]
MQXC\5SWGDQV.LVX@C>.0LZ87:"5P.HR>OM[U'/X9U_5O#5AX;U*.R2T@:,3W
M:3L[2QQ] $VC!.%_B..: +L/BR]3Q5K6DW\%K##9VAN[:4,?WL?J23C [U5_
MX336H=,\-22Z)#+=ZR[*4$YC2,=4Y(/53G\#ZU6\8:=9ZWXFT.+3KV/[69)+
M.[2&0,1;;<R*P&<<<?\  JVO$>CZG?:[X;EL(8#96%R99]\FT@8P-HQV&?Q(
M]S0!F-XS\0'^W+9="M%O-( EG+71,9C(+KM^7+,5!'89Y]J6]^(1;3-(?3[>
MVCN]2MFN0+V5ECA"D9!*C+'.0.G3/M4]KI>N0^)/&%Z;&+R[^&);-C.,2%$9
M1D=1UYSCVS6'9^&_%>CZ?X=U*QL;>74-.M9+6>PDF4;U9C@A_N^AZ]NIH UA
M\1'/A6+6%T6:24WPLI(!*%^8_P 2DCY@<C' ZU/'XTO9+_6]*N-)6RO["Q:[
MCS<"5' '&< 8ZCUJMXCTWQ7JGAFW+VEM<:B-0BN?LL,JHD,:<[=S8W'(Y.>_
M'3F:XT+5+SQSJUZ;&.&SN='-DEP)%.^0D') Y[XSCHHH UO!%_J&I^#].O=3
M*-<S1[BZG.\9X)XP#CM_^H02>*[I/%&I:&-)/F6MD;NWD:? N<8^4#;QR2,\
M]*3P#:ZQIWA6UT_6;);:6U7RT(G60NN3U"\# P.IJ#QAX6N]:U32;_3I$AFB
M=K>Z<]6MG&&'\\?[W:@"2Q\9/?Z!HNI0:;NEU.[^S?9Q/DQ#+Y8G;S@)G&!U
MK/BU:"Q?QQ<:7I'V:^L?WLLDLIQ<,$8[\8X& 2 .N>V:L>&_!CZ'XGU"[\P?
MV:K,VGVZ_=B,@'F$#M]T >Q/K5:+2=<O+KQN;G3/LZZK!Y5HYF1@^V-HUS@D
MC.0>10!F>);J\OO"_A'6=0L =034[5HTBD#-(&&?0 %B!QT''-=7H/BF35=>
MU/1KS36L+RR5'V&82[T;D'*C /(XR>M<[<Z?XGOO#?AJVET$13Z;J%O)-&MU
M&Q,<0&&!SCGGC)/%;5AINH1_$O5-3?33#836:0I<^8A\QU(.2H.[IQR/X: %
M\3Z_J>F>)?#FFV$4#)J$L@F\UMNY4 . >QYS[D 5C1WMUHGCWQ8^G://J#/!
M;3R!)@H4A6[MZYX !Z&M#QKI>IW'B#PQJFGV+WB:?<2&:.-U5L,%P?F(&/E-
M.LX]5M_%_BB\_L>=HI[6 6Y\Q )616&T$GONZ]L<]J $G^(U@NE:7=VUN7FU
M*-WBAGN(X H7(.YV. ,C ZYK5\)>*;?Q9I3WD,7DR12F&:'>'VL,=".H.>#7
M :?HOB+1M'\-:K#H;7<UA%-;7-A(5#E'<D,.OJ.Q/MBO0_#DNK7%O//JFFPZ
M:'<>3:(P=D7 R68<$D]L#&* .6ND?QC\2+W1[UYUTC2($9H8Y2@FE;!&[')&
M"?\ OGWYU#X"TK3]<T[5]+'V$6CLTT0D;RW0JPZ'H02#^=4=4TK6?#_C>;Q-
MH]DVHVE[$L=]:))B0$8 =0>#C _,^N:U+;6=:UV4V8\.7.GVKHRSW-[(H*@J
M0 B#)8Y^@X^E %-_B)$ND?VTNC7SZ/YQB^V*4/ ;:7VYW8R*M:CXZM[/7%TF
MTTR^U&X>U%TGV558,IZ=3T]_I7+6MCKL'P]F\&R^'KA[WYH4G 0V[*S[@^X,
M,$ _7(YYXK2TO2;_ $SXE1S-97,EE;Z,EF+I8_D=U"GCGOC'UH G7XH63Z5'
MJ:Z-J7V$2>7<3E%"0-N"X)SSU'2M#4/'=K9ZV^D6^EZE>W@A6:,6\(*R*1G(
M)/3MGUXKAH=$UH?"+4]'.CWHOIKX,D7EC)4LK9Z],*1]2*VTU6XTOXA6I_LJ
M]N!)H,*RQPQ;I(B'8\C.!SP>: -^V\=V-YHMM?VUE>237%U]C6T" 2+,!DJV
M3@8'.30?'NF1:)J6IW$%U&--NC:W4(56='W!>QP1D]<UR4ECK^DZ4U]%I]^H
MU76I+N\ALG(N(X6^ZG3@Y)RP(QQZ\9VIV.JOH?C2RC\-ZE U_=1740QYH(WJ
MS?,"<DX)P,XSCM0!Z%I/C.WU76(]..FZC9O-;_:+=[J(*)5'7')]1447CRRE
MT#5]6-C>1)I<IBFAE"JY88XQGCJ.OZUB7 OY/&O@J:.QU".&.S9;A_);:FY,
M;7(Z'*C(/M2:GX>G_P"%DK:6K!=-U54O;^-<_>A;T!X#$KGUR: /0X)?/MXY
M=C)O4-M<8*Y&<'WJ2L63Q%'#XMA\/O9W DF@,T=Q@>6P'4?4?U'K6U0 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '+
M^(/&,-AX2O=<TD17PM9?*<,Q0 APC=N<$]JZ"PN3>:?;7# *TL22%0>F0#7C
MQTVRM/@WXCFM[:*.5KQHVD"_,56X4*N>N .U:$\2>&O$?A&YTV-S->6,OVC<
M[.9]L0(!R3WZ?6@#UC(SC(SZ57U&YFL]-N;FWMQ<2Q1LZPE]F\@9QN/2O*/#
M/A^ZUG1--\32:]:VMT)C--=")S.X#L#&[&3:0>.-H[=>_K%__P @ZZ_ZY/\
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MQN#+C/3ZTT>([<^+CX<\F7[2+7[29#C9MR!CKG//Z5D_#W_D':S_ -AFZ_\
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MO9=[(@)(4'L.>?>M^B@" V5L;\7QA4W0B\D2D<A,YP/09_D/2IZ** "BBB@
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M.=X_!X@5&9+J[A@EP2,(6R<_7:!^-7;OPY<?\)9H-[82RP65A;O#*@E.TH
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MDECA4-)(J G +''->*:II6G)X#UO7DCVZC'K$IAN5)8@B8 8YP/K6CJ>D_\
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MU+4KYX%NP$D<6ZA3NX^7?\V,X[9ZU)H-M):?&3589;N:Z9=*0>;,%W$9CZX
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MK>V%JTT<UNSB"0;">&8 @@]: .L?Q!HL;RI)J]@CQ?ZQ6N4!3G'//')K1!!
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M0>&# 9XZ<CM^63J/@K6KG0;Q8VT\ZKJ6H1W=V^65%1.513@DX('7U/K7HM%
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M32Q7QN[A+/;MMQ@A8^N"0'Y;@?+^2:7;ZMI_CKQ=?G1KMX+J%6MW!4"4HN,
MY_BSQ^M>@T4 >1VVA:U!X:\%S/I-T9-(O7:YMU ,FTON# 9Y''K5O6O"^L^)
MAK^K16+VDUPMNMG:73*3*(B"2ZYVC., -[]C7J-% ' V$FH7D=S<?\(9'IDB
M6D@GE\M/.G=E/R1X R"V"235_P"&=K>Z?X*MM/U"QGM+BV>12LH W!G+ CV^
M;'X5U]% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+6SD\RVLKB</#$W8@8R=O;).*L67A*UL?%%UX@COKYKJZ&V6.1T,97' QMR
M,#'/:@#G/C$)_P#A%;0C/V,7L9NL _=YQG';/]*[RS>WEL8'M2K6S1J8BO0I
MCC'X4E]8VVIV,UE>0K-;S*4=&'!%<K'\.;.!!!;Z]XA@M!P+6._(B"]UQC.#
M]: (+^-;CQU8^&(;NXT[3H-.:[2*QF,)E<N5P2O.  3]:YO5]:U72M!\7Z.F
MK7KS:3+#);79?][Y<K+\C.3DX#=>#_*NZO/!>FW$NFS6TUW87&G1^5;SVL@#
M[,?=;<&##ZCN:9=>"-/O-#OM+GNKUQ?S":ZN2ZF:9@00"=N !@     4 <?=
MP:I:^)?#5K%XEUDIK<#?:2\ZG9A5;]V-N%/OC-5_[7UC3O#OC6UAUB]=](NH
MQ;7,\GF2[2V"I8]1QZ=S7=R>#;2;4]&OWO[\RZ3&(X!NCVL.A+?)R2, XQTX
MQ7,>-= L?#OA'Q->QWET\VK.A=)2K*7WY&W:H(X)ZF@"66+5?#?BCPW)_;FI
M:C'JC^1=07#!DSL^^@& H&<X]N]4VU748XM'U2WUZXOFGUS[',T:LEN8G<C8
M%8#. /O#.#D9]>HT/0;.\@TS6)M2O=2*6@%N;AE 0.H#$!5!R0.I)-9R_#*V
M338=/CUW5DMK>[%U;H'3$39SQ\N<\GGU.<=<@&'?7.MZMJ?C>--?O;.#1U6:
M".W(7)",V">N/E]>]:TFMZG/#X$OH[^1$OV2.\B$842L4!)Y&1R#['/'OKIX
M)ACF\12+J5UG6XQ'*2J93@C(XY^\?\\U%_P@V(/#L7]LW9&B/NCRJD2\C /I
M@#:/0&@#E!J'B_Q*NJZKH4UV&MM0:"VMQ/$D6Q=N0R,.20<_>J_XFUV^T_Q"
M8-7U+4-)M)[6%;6ZLXU:!9>=Y?.3UP,<<#\:U;WX=17&K7=W::]JVGV][(9;
MFUM9RJR.WWC^/N#_ $J[JOA"74;>]LTU>:&PNX8X6MC$KA-H RI/0G H Z(J
M9+(J)R2T>/.3 /(^\.WO7DVAZEJ.B?#31I[;496N-8OQ;[[A@RVP9WW,G'4X
MSR3R:]9M;:.TLH;6+(CBC6-<^@&!7(6WPXMH_#CZ'/JMY/:I,LUHV%5[5P2<
MJ<>I_P#U4 ))/JWAOQGI%BVI7&HZ;JGF1L+O87B=5W J5 Z^F*K_ !::4>&;
M%8[B6)9-1AC<1G&X$,>?H0#6W;>%G.N6FK:IJ<FH7%E&R6X:%(PA;[S' Y.*
ML>*?#</BC24L9;B2W,<RSQRQ@$JRY['KU- ',:K87\WQ+T^SL]4D@D&BNLET
MZ*\A7S,9Z8W9P<X'>J$7BKQ!%X?M;))S<ZA)K$NG?:5C3S&1,G(#$+N/N0!7
M7+X;NO\ A*+/7'U4R2P69M70P "3)SDX/'//X5C?\*X\W0VLKC5YOM:ZBVH0
MW<484QR$^GY'Z]* +W@T^*XKJ]MM?@E:R4!K2YN'B,IYY5A&Q'?]*@\3ZIK5
MSXB&@:0+F(+9"[DFM1$9#ERH4>8R@#Y>V2<]JUO#V@W^FRRW>JZS/J=[+&L>
MYE"1QJ"3\JCCG/)Z\"J?B7PE=ZIJ]OK.CZO)IFIPQ& R!-Z/'DG!4^F3_D4
M95[>>-+?X?G4+EEL=6L26FC81R"X0%3NR"0O&>.^#Z@T^+7-1U/X=:YX@6_8
M+-%</91HBHUNB[@H)'5^/7TJ\_@V[DM+&TFUB2Y@%V;O41.N3=ME2JC'W5!4
M?*..!45AX&FLY=?M3J6=%U42E;-(MOD,_=3G& ,C ]J ,?3M:U>S\->$=*L9
M9)+J^@,TDRPJ[1PHN2 "0">0,D_G2ZGXG\6Z+X/UJ[O[<17-M=I':7$L2@R1
MLV"2JDC(]>G/M5UOA]J#:%I4 UP1:II+G['=Q6X 5" -A'4]/7O4^I^"-3UG
MPS?6&H:Z;B^O)8W:9HL1QJAR%5 >!U_.@!MAK6O6GC:UT/5KZVN5O[!KB,P6
MWEB%QG@98DC /7VI_P +5O&\(+<W=\]R)YY6177E/WC!OFZG)R>?6KDGA>^E
M\9Z7K[WMOML[3[.\0A;+Y!W$'=QR>*D\'^&]0\,VTUE/JB75B'9K>(0A3'N8
ML<G//6@#-U36O$-Q\0'\.:5=6=K%_9_VCS9H#(0=V..1[=>,9K%M/B)J<_AC
M2DVHVL7UY+:&1("X 3!+J@(W'#*,$CGL:ZQO#5V/'K^)([N$1M9_9?(:,D^N
M<Y_O8_"N=M_AE>V^B06R:Q%'?VE\;RTNHX"-A;&Y2"3D' _+G- $D7BOQ1IN
MCZB=1T[SKH7$-OILLT'V<7#R$CYEW$#;]1V^M7=0U;Q+X56]U#5YK:^TJ*R$
MGF)$(V6X+!1&H!R5)(Y/;OQS-?>#M2UW0+ZQUW6OM-Q,4,#PPB-(2A)!V]R2
M2#[8Z=:!X4UK5;&]L_$NN)>6\]N8$CMX!&%.X,)#ZL-HQZ9- %'0=<\6S:[9
MB[M);K3+N,O))]B^SBW.,KM)<[E[<\_U/"GBC4]>U"/S=3LH[A7D6\TB6W*2
M0JO0HV<L?NYSQR>F*NZ%X>\56TEM#JWB"*2PL]HACM4*O*%&%\QNN.A(YSCK
M5.#P=K=[KFD:CK<NE--ISEVNK5&6:YP,*'X &.O7'48YH E\,^+M2U^\@A:;
M3H+B.>5+[3Y(W2>%1G;M);#G@9.*B;Q;KUKJ&G0WJZ6K76IBTDM(MTCPQL2%
M)=6*[N"<$#Z=</@\(ZW=Z[H^HZQ-IIETYRSW=JK+-=<8 ?@ #U&2.HQS67#X
M#\66^FVUE#J.CHEG?B^A;R7+RODG,C=\9]#Z9X% &RVM>+KWQ/J^EZ9#HXAL
M)8?WD_F%BCKNZ \G'/;&,<U5A\9ZQ%I/B2*_73UUK2I%6*%%98Y%;&P_,W.3
MGH1VK9T?2-8T_P 6ZWJEY+8&QOPA C+B1?+7:N<C&-N<\]:PY;/1O$_Q+T[4
M=,N([M;6 R7S12!H]RD>3G'5L[C]%% '<(]TFCK)=M$EXMN#*8P=BR;?FQU.
M,Y_"N!\/^)M8M_AS%J<UQ%J%_>WAM[0R!@-[RE1O.?NCJ  N  />O1Y$66-H
MW&58%2/4&N A\!ZJ/!]QH#7UK"+>Z^TZ9-;[PRD.SCS"?K_#T]Z -$>(-:T;
MQ5INDZ\+&:WU-66WN+2-T*R* 2K*S-D<@ ^_UQ<\9Z_J'AW3;:ZT^RANGEN$
M@*2R%<%N%Q^/O5=?#^JZMX@TS4]?-@BZ8':".R9VWR, "6+ 8 P" .]5OB@\
MD?ABU>'R_-74+<IYAPN[=QGVH 3_ (2O6=$UFYM/$MK9"V^QR7=O-8EFXC^\
MK!N2>1S@?X9VA>/-<U#7=/M[C38I;*^ RUM;SJ;;C/S,ZA6'NO'O6M?^%=2\
M07]S<:O/;0)]AEL[>.T9FP9/O,Q91Z+P/2HO#>F>-[$V6G:C>:8--L]JF6$,
MTTZ@<+EN .@)P#@<4 1Z!XJ\2^(M3F6WTW3HK&TO9+:YD:9BWRXY48'_ -?V
MKF?"&HC2_ ]YK]S8V=Y=)?N+=W3$GG.P4DMC@?-V]378>#="U;0+77?M,-N9
MKJ^ENK=5F)!W#@$XXZ5BZ3X&U?\ X5Y>Z!>-!:WC77VFWE23>NX$,,\<#(]Z
M -=O$FOZ+K6FV?B&TTXVVHS&&*XLI&_=N?NJP;K]15;3/&7B'5-1U**#1;(V
MNG7<MO<2?:B"-@.,97GIC.._2K#Z+KOB'4M%EURVL[6'3)!<-Y,I=IYATP,#
M:HQGG)IOAC0-7TQ/%+W=M"KZE<RW-NBS;L[MWRDXXZCGWH R$^)6LKX>LO$,
MVAVPTN:?RF*7),GWBO"X]CU/Y5T&E>*=3D\8/X?UC38+69[;[5 T$YD^7<1A
MC@<\?I[US$G@KQ WPQLO#@MK?[9!=F1F\\;2FXMGI_M8Q[5TKZ)JDGQ.MM>-
MO$MBEA]F<^;E@WS-G&.>3C]: ,SXKJ1:>'IHXEDG35HA&"<9R"<9[ D#\JNV
M?BV]EOM<TG6M*MDN+*R-T(892ZRQXY4DC'<#\>E3^/-#U+7(=(73H8I#:7R7
M4GF2[.%!X''?/Z53NO#FKR>-==U1+>(VM[IC6<1\T;BVU<$C' R,4 06?C*W
ML/!_AU].TVTLO[2D>&"*:8I# %9LEFQD]/S-=CH]QJ5S8EM4M(K:Y$C+B&7S
M$=1T8'T/H>:XJT\.ZI;>!-)T+4-!AU&&-I%NX%G42 %B4>-B0 1DYYK>\":+
M?Z%H#VM\\@!G=X+=Y YMXB?E0D9&>_!(YH Z>BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<8G4LY'! &<G&*=?:OINF%1?ZA:6A?[OGS+'GZ9- $5YH&D:A;0VUWIMM-!
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M+EF82 ]05)Q^E7H[NVF<I%<1.XZJK@FE%U;F?R!/%YO_ #SWC=^5 &/9^#=
ML+N*YMM.5)(69XE,CLD9/4JA.T?@*>/"6AAM2;[",ZGG[9^]?][DY/?CKVQ5
M/PKXCN]=U#7K:ZA@C_LV]:V0Q9^8 D9.>_'M7017=M.Q6&XBD8#)"."<?A0!
MC'P5X?,<$8LG000FWC*7,JL(R2VPD-DC)/!S6O8V-KIEC#964*06T*[8XTZ
M4_[5;^?Y'GQ>;_SSWC=^5!N(%F$)FC$IZ(6&X_A0!FV_A?1;2\O;N'3XUEO@
M1<Y)99,\G*DXY^E1V'A'1=-N8I[:U?=#_J5DG>1(N,?*K$@?A6W10!0UG1[7
M7=+FTZ]\WR)1AO*D*'\Q_(\4]],MI-(.ENKM:F#R"ID.XIC;C=G/3O5RB@#)
M\/\ AVP\-:9_9^G^=Y&XM^]E+G)_0?@!3X/#^DVVBR:/#8QII\@8- ,X(;K[
MUIUQ%YXPUY?%UWX?T_0;:[F@B$X<WFS,9( )RO7D<4 6M.^'/A_2[NPNX$NS
M/8L3$[W+'@Y^4CI@9/ QU.<TR3X9>&Y#<*8KI;:9]YM5N6$2MD?,%SUX_7Z8
MN>%_%J>(9KZRFLY++4;!PEQ;NP8 ^H(ZC(-=)0!RNJ?#SP_JMU!<R030R11B
M+,$I3S$   8]3P,9ZXJS/X+TB>ZTJ95GA32B&M8(I,1J0V[)'<D]3WKH:K6F
MHV=]+<QVMPDS6TGE3!#G8^ <?7!% &=XOE,7@[6"L,TS-:2QA(D+,2RD=!V&
M<GVK%\)>%[%])T34KB749Y;>!6BAO9&V0N5 )5"!COCVZ5TFM7=]8Z:\^G:>
M;^Y#*%@$@3() )R?0<U?4DJ"1@XY'I0!SUOX+TN"75I)&N+G^UEQ=B=P0_7&
M, 8QDXQ46A>!=+T"[CN+>>^G,((@2XN"Z0Y&#M7H#@G\S6]=7]I926\=S.D;
MW,HBA4]7<C.!^56: ,7Q%X9L_$D5J+B6X@FM)1+#/;OM=#WP<=ZQ9_AII<T&
MJ0C4-25=2"?: 9@VYE8-NY!^8E<Y]S7:'I6#X3\3)XJT^ZNTM)+7[/=-;-'(
MP)RJJ3T_WL?A0!#+X-M9M7T74FOKSS=)B$42[EVN,8)88ZD<'&.@K.N?AIIL
MZ7=O'J6IV]A=/YC64,P$(8D$D#'3CI5SQ!XS_L#7+#2FTJ>XDOV"6[I*@#-D
M#!R>.2.M=30!#:6R6=G#;1L[)$@16D8LQ &.2>IKD?\ A6]A_P (_>Z+_:>H
MFRN91*$9U(B(;=\OR\<UT.N:U'HEK!(T$D\MS<);01(0"\CG@9/ '!YI=#U*
MYU2R>:[TV?3YDE:,PS<DX_B!'!!SU% &7+X,MYM=T[5I-0O&ELK86RH=N)$P
M0V[C.3DYP?I5+3OAS9Z;+$D>KZJ^GQ3><M@\P\G.<@$ 9(SV[]Z[.B@"*YMH
M;RVDMKF))895*O&XR&![&N4MO ]UIG^C:3XGU*STXY_T7:DA3/9&8$J/SKL*
M* .6NO ]G-8Z?'!?7D%[82-+!?[@\NYB2V[(PP)/(J-/! >PU47FJ2W>IZE;
M_9I;YX54K'C "HN !_.NJEEC@3?+(D:9"[G8 9)P!^)('XU0DU?R_$,.D?8K
ML^9;F?[4(_W*X.-I;^]_B/6@# F\!^;9>&[8:K(G]B.'1Q",RX(QWXZ>]4?$
MWAI=+MO%_B%]28C4-/>-K<H%52$"K\W4GC Z=>]=_2,H8$, 0>QH \^\&Z(-
M:\-^';NYU3[1962+)%9I&H595&/G;DDJ<X'&*?<_#-Y[74+-?$=]'9W5T;M(
M!&I"2$YR2>6YQW'3O7?*BH,*H4>@&*3>N_9N&_&=N><>M '*VO@R>UU^_P!7
M_MF26:\LA:N)(%ZA%4.2",GY<X '6LJ230?A]X5A\,ZQ=37J7*2B-%MSF0,>
M5XZ'+<<_E7H--9%8@LH)'3(Z4 8/@G0QX?\ "5A9&+RYS&)+@=_,8 MGZ=/P
MI?$?AV?6Y].NK/5)-.N[%W:*9(ED^^NTC#<=*WZ* .#/PYD_LW7K4ZY+*^L%
M&EDE@7AE.2<*1U/Y#L:OR>#9WUCPW>_VBI71H3%L,&/-^7;G[W' '_UZZVB@
M#S\_#K4%TB^T*'Q&R:-<MO2%[8.\?S;BH;(XSC_ZU6K[P5JPUA=3T?Q))8W$
ML,4-X3 '$VP ;]IX!P/\YKMJ* ..E\%W;:EX<N5U;SETEI'D-S'O>9G(+'.>
M.G'I772QK-"\39VNI4X]#3Z* //_ /A7VH#P1>^%UU>#[(\H:W8VYW(GF;R&
M.[DDX_+WK4;PSJ@\0:3JD=_:C[#8&U:-H6(=B.6'S<#(7\C7644 <1HG@_6]
M"T.XL[;5K7[3-?\ VPR& [&! #(RYY!Q6AX6\*-H.I:KJ$LMN)+]D/D6D1CA
MC"C'"DGDDDUT]% '/7^A7U_XNT[5'NK<V%DCA;9HB6+,N"V<XSTQQ5'Q/X0O
M-6U[2-7TN]M[*XT\L?GB+>9DC@X(XZC\:Z+5-5M-&L6O+V1DA4A?E0L68G
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA8KH1(VKQ(5,0<;B#AN?3!X[Y]JMSZU?6?Q'TS0LP/:W-D\TC^5B0L-W?/\
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MR!MVX\G@8'3/T/;I4?BK0]3?7M*\2:)%%/>V(>.6VDDV>?$W\(8\*1EOS]J
M,W4/&FL6^D>(;*ZLH;/6M-M5F62)R\4BMQO7*]L]#GGZ&J6KW-U<VOP]U:6V
M2XU*6:+)#X+AXP22<<?WB,<5;N/#.O>((O$.H7]K!876H6*6EM:>>)=@4DDN
MX&.3TQV/-1MI7BAK3P9$VB1#^RI$^T!;Q"0JHJ!CP.OS' W=!S0!IKX_%I!K
MS:SI;V4ND-&K)'+YHF\PD(5)5>"1Z=*32_B"M]XA;19;.V^U&V,\9M+T3HS
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MHO$[ *G*JF2!^&,4 >YY!&<\>M-\V/&=ZXZ9S3$AA6V6".-%@";%1!A0N,8
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MWMS+(0,D*JY/Z"N/G\8Z]9:':^(KS2K%-&F>-W"3L9HH78!6(Q@G!!P/7MV
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M05QZKZUTFX XR,^F: .4OOAQX<U&]N[J>WGW7;F29$G949CWV@XSGGZU9N/
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M.J:;JU_I=S=@+=?9V4K*!WPP.&Z?,.GXFMC7-4&B:)=ZFUO)<+;1F1HXR Q
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M=#D,#T(- $E%5[6^M+Y7:TN89U1MC&)PP#8S@X[\BK% !1110 4444 %%%%
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MJ,_GW%I?2VOG%0ID"[2"0!@?>Q^%3Q^#H[;Q-I>K6E[)#!I]E]B2TV;@R88
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<1IY:R11!2!^'?WZU+J>@Z7K,D$FHV4=P]N28B^?D)QT_(5HT4 9?_".:/\
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MJ**+L7JR"XPZR[=NX''<=<UUE% &7I&A6VC27<L4MQ//=R"2:6XDW,Q"A1V
MX ILN@6TOB.'7&GNOM,,1B2/S!Y84]<+CC/K["M:B@# U[PC8>(K^RO;N>[B
MGLLF!K>4(4)(.<XSG@?E7G.M/<_\)7J_VY_%EG<SW"I:_P!E*S))"B8&.1N)
M))XZ9/J:]EHH XK3/"][J=CH=[J^IZBE[82R2H&*AF5F;;O&,;MNT'KW%:&N
M^#+/6M3BU*.]OM/OE41O/9S&-I(\YV''\ZZ6B@#DM4^'VF:A8V44-S>6EU9%
MFAO8IB9MS'+EF/)).3]2:9>?#^UN_#CZ0VJ:@6FD26YNI)?,DG*]-Q;/ P,
M=,5V%% '.OX5,GBBPUUM6NVFM+;[/Y9"[9!@Y)XZDD$_2LF+X9V0T2ZTV;4K
MR7SKO[:DPVJ\4V,;EQ7<44 <@O@*$Z;J$-SJ]_=7E] +9[V=@SI%G.Q1T /?
MUZT]?!&+[0+N35[F1]&3RXMT:?O >N[C^[A?PSUKK** .3M? R6+ZS]CUB_M
MX]39WV1,%\EV.2RGKGC'6NDL;9K*PM[9IY;AHHPAEE.7? ZD^M6** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BJO\
M:5AYR0_;;;S78HJ>:NYF!P0!GDYJ>6:*",R32)&@(!9V ')P.3[F@!]%%% !
M1110 444UI$4X9U!]S0 ZBD5U?[K _0TM !139)$B0O(ZH@&2S' %-AGAN(U
MD@ECE1AD,C!@1]10!)1129&<9&?2@!:*0D*,D@#U-+0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MT8<2( ^T\'#*>AQZ]*R-1U6RM/&_A74[F2-M.N+&6&"Z+CRXY" <Y[$CY?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%]*>9X6E6X_>Q;<_,Z$# )'&"3R* '_\*V\(_P#0'7_O_+_\51_PK;PC_P!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*WAD\&I*\2-(EU&%<J,@'.<&M#4O$][I?BF'POI&APS.UIY\1\\1(HR1R-O
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M58T618[81!'3&QAR>F,4 .\.W?C#_A(4348KJ?2IHBSR74$$)@?D@*(V)(/
MYY_KI>-]!N_$.B1V^GW,<%]!<)=0&0X!9,\9'(Z]:;H&@:_8W,<FL^)'U"&
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MXD(4$,H/!&#_ -]?G'IWA#Q)HR:Q);:GIMS+J%T+ETGMR$D)SO5N3A3GM^=
M&_X4OKW4;*XN;G4M/U&V:7_19[,%24QT=?X6]NU<KK@U$_&BR&EM:K<'2.3<
MJQ4+O?LI!STKH?"/A5O#MUJ]RQ@3[?.'2VM\^7"@S@#/<YYX%,N?#VIR?$RT
M\0QM:_8([(VLBL[>8?OG(&,=2O?IF@#G;;XD:B?#-N[VD4FKR:B^GD1QNZ-L
M 9I B_,>& P*ETKQOK\WA_7YY[*%Y],A$\-Q);R11SJ>2"IYS@'I[?6H+?X=
M:U#H[;+FRAU6WU9]1LY0[,GS!058%?\ 9'8ULR:)XNU'PYJUMJM_I\E[=6YM
MX(X=RPH"?F9CC);'3CC'N: *5QXS\1Z=IEA/J%GIHEU1HQ9+;B60HI&YC(HY
M. 1PI[U'8^,]2UC0O$?VO2;:86-N9HGDMY(X)E )(8/DY&.G?U'6M#4O"VMW
MGA_0&MKJTMM<T?'E\LT#X&T@G&>5 [>H]ZFN-)\7W_A_4X;Z\TU[V[MC:QP1
M[D@C5AAG+8+%B.G&!0!'JGB;5[&Q\++I5A8N^JJJ,LK,B1DHK #'0=?7@>],
MTKQ=K=S:^([:XTZUFU?1RN(K5F\N7<"0 6YS\II'\->(I8/" >33M^D2YNP'
M?#J,*I3Y>NS=P<<XJE=^"=?G;QB8+BS@.M-&8'69\JJ,<AOEXW*3G&<=.>M
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0*%^Z /H*6B@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MV]C:  1L23ND(^\_/7U_ 5Z%110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
; %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>a123121ex-1021009.jpg
<TEXT>
begin 644 a123121ex-1021009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP6-%DR6). /SH WJ*0D $DX ZDUCV_BS0+N[CM8-6M7FD8HBA_OMTP#T)^E
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MC7<"25!YYZ=:KP2[_BAK.IFPO);"32/+#-:2!96&PE.5ZD \?A6S_P ("?\
MH;O%7_@Q'_Q-'_" G_H;O%7_ (,1_P#$T <>DYL?@YH=O<6]RDHOHU93 ^5Q
M.6.1CT_,D"MK6-170_B)9>);T7/]BW.FFW\_R7Q;MNW#<N-PSQP0.OL:UO\
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MY1]H;8ZD&,2'Y5/OD_K7>?\ " G_ *&[Q5_X,1_\31_P@)_Z&[Q5_P"#$?\
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MVQDFH_MMM'X7^')BGC22/45#E3@J XW@GMU&?K7M=->-)-N]%;:=RY&<'U%
M'F?BVQO=)\8'^S$81>)X?L,^U@H248'F=#SL+?K7H]G:PZ?86]G -L%O$L2
MGHJC _05A:=X<U"/Q!_:FK:S_:'DB06D7V=8Q#OQD]3DX &>.I]:Z2@#Q.WU
M*RD\.?$G9=1-YMY))'AOO*SD*P]020/Q%:VG7.D6^J?#?RVM8[IK-O-9% 8[
MH-@R1_MY'US7J'V2V"RK]GBVRG,@V##GU/K2&SM2T3&VA+0@",^6/D Z8]*
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MH **** "BBB@ HHK"\1^*+;P\;2%H_.N[MF6&+S5C!"C+,6;@ #^= &[45S
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M%YMO&ELS,P]..,Y[9].W-$7Q#T-]+U"^E%W;_P!GL$N;>: B6,DX&5&>IXH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6!#>9G'W0.G?-7]'M;C1_B?=LUE?R6EOHR6J7 MFV2LBHWRGIR%/?KQ7I-%
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MXZ5:UC7++0[=)+HR-)*2L,$$9DEF8#.%4<GC\!WKD=+F#_&S5]OF!#IB#E"
M3E#W'H:E\<K)I_B;PWXBE21M-L)9%NF12WE!P &('./H* -:/QWHKZ1?Z@YN
M838*&N;6:$I/'G[N4/KD8.<<]:N/XHTQ-0TNR,DIEU./S+8B)MK+MW<G& <=
MNM<#=P?\)5JOB;7-%5[G3Y=&:T0B)D,T_7 5@"2,#G'<4ZV\1VNJW/@>&PM[
MVX%G*L=TZVK[87\K9M)(QWSP> ": .JTCQWI^I?VU)/'+:V^F2NK2O&^TH@&
M23C ;.?ESGIQ5N[\2:7=:;J<:7]Q9O#9F625[:1&A1E.V0!E!./;N*X71Y;"
MQL/&^C:VL\;/=S7$J)&25A?: X;&W/S @9SQTJ/3-0O+?2O$^EKJPUC1(=(?
MR+UHR&C8J0L1/<\],^F,9- '<Z9KNFZ5X1TNYN]8DO8Y46**Z>)S+<MTX3!<
MG\"?6LOP[X@$WBCQ3/<:K<MIEHD#HMW&81!N#EAM901C&/?WXKF-.OET_0/
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM(N[EX$O!Y>8G578#DA<@]@<\=,T[0](CT+2(--AN;FXA@&V-KA@S!>RY '
MZ"O-]9O=3U'QCX+O-2TN"R\RZ=H"DPD9HR$(#<<$9^G-:EU\5;:WE>Z6SCET
MI+IK4RI<KYS,#]\1]=N,^_2@#T$31&8PB1#*%#%-PW 'H<>G!I]>?Z;&B?''
M5RJA2VE*S8'4[H^3^56/B3J-_%:Z3H^G3O;S:M>+;M.C;65.,@'MG(_ 'UH
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M_/<7&K6M[<Q2K;V90K&PQ\WFKCKT/7C )JS8^,],O_[:V1W49T<%KI98MIP
MQX'?[K4 =%17.2>-M*2WM)$BO9I+JW^U1P0VS/((?[[ =!_C6IHVLV.OZ7#J
M.GR^9;R@X)&""."".Q!H OT5SM]XSTVQN+N$6]_<BSXN9;:U9TB.,D%NF0,$
M_6N7\3>)EM?&/A;4[/4;R72KJ&5GAM69DE"@X/ECJ<MCGT'3% 'I5%<9??$.
MQ_X134]8TR":>:Q81R6\T91HV8X!8'D+S^E:$GC*RMK;3C<6FH+=WZL8K,6K
M&8[?O':.@'UZ&@#HZ*XK6_$NC:IX7L-335[^QMI;U$1[4%96<$@QL.PZYSZ
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M@@#C'OBK^BZU9>(-,34-/=GMW9E!9"IR#@\&@#0HHHH **** "BBB@ HHHH
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MIE<HRQXP<=_E)JKI$.K>)/AII7ARWTF>&"<H)K^5D\M8UDWEE ;<3\H&"/\
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M(V)@Y_V24!7/Z9Z^BT4 >7>)["VTOQW)>ZKHUW?Z/>626Z-:1N3;LI^[\I!
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MI;V[DO+=Q.KJ68[@IQT *C/L:NW&G>(]?70;._TR*QALKF.YNIA<*X<Q_="
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MVS4WCJYTVWTRQ_M2XO[>)KZ+8]GP=^> Q_NXS^7%4)H5O_C+;2Q-D:;IA\[
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M0-433[B3REN $*E\D8'//0UJV7C@7$VHV]SH>I6MS96WVHP.JL\B9(^4 ]:
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M[$4 =-17G%UJA7QQH.N"#4W6^TR1A8*I=D/R]%SA3@\]!\OJ:MZIXHT/Q%X
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MZ56T;3O$&@64WAQ?!=MJ?ES.8+^=XQ&R[LJS CG'7&0?H17K--9U7[S ?4T
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M["MO[-@NC!*WVGYR,@#:,=>>IKH)=-US6=?TK4K^TM[.'3%DD6&.X\QII67
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M[:T:PCE9KF:!YMRQ-CG') &!VKB_"&BP?$"UNO$7B4/=B:=H[6U,K"*&->F
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M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***YWQ+X@N-,O\
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M(&GZI=7EM&)72VMM^5..1SZ$<G _&M3P_P"(+'Q-I*:C8%_*+%&20 .C#J&
M)P>A_$4 :E%<W=^,[2"ZOX+;3M1OQI_%U):1*RQMC.WYF!) '. :YWQQXI6]
M\+:)<:2T\EIJ=]$CM$=CE <F/.00Q(Q^!YH ]&HK#\*:-:Z)HQ@M(;R"*65I
MO(NW#/$3@;>"1CC/4]:W* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YG
MQ3X=N=4O-+U;3)8DU/3)2\2S$B.16P&5L XR!UQ734R6:.")I9I$CC099W8
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MRM;F<:6EA=V<D^S80=V5?H?FX_#WXO\ @#0-5\/6&I0ZF+8&YO7N4$+E\;@
M<D@?W1CZ\UT&GZUI>JEAI^HVEV5 9E@F5RH/J >*O4 <3>:1K>G?$.Y\0V%A
M'?V]S8"W\OSQ&R,"IYW=1\HZ>M9MWX+UZVM[?5[&:VEUR/4I+^6%C^Z?>-I0
M-@=% &<#//2O2*JW^I6.E6_VC4+R"UA)VAYI @)P3@9ZG /'M0!E>&_^$EE,
M]SXA6SMRX58K6UY"XSEF8Y))X[XP*R=7TC7M-\:-XAT*TMKU+JU%O<VTDHB.
M5/#;C^ KJ+#6=+U1F73]1M+MD +""=7*@^N#Q4EUJ-E8M$MW>6]NTS;8A-*J
M%V]!D\GZ4 >8?\(EXP/A75K+[-9QW%YJ@NV2*XQYJ$DNI)' R%QSG&<^]J/P
MWXE.LZ]>R:19PQZGI1M4B@N@1$VP*J\@>GT]S7IU% 'F$_A77_\ A%O"-DFG
MJUQI5V)[A//0<*V1@YYR#5O5/#GB&X\7^(-1L81 EWIAM;:<3A2'&T@\<C."
M*]$J!KVT2\2S>YA6ZD4LD)D =E'4A>I% 'F>F>%_$5KXA\-:G+HVGVEMID30
M3+%<Y;:0P:1B1S]XG&2>O/-8MA;7S6TWB&/PX;W2'O'O52+4?+B^1B-_E'N-
MI/)Y]*]K=%D1D=0R,,,I&01Z5QUKX"\$1ZFT,%I"]U!B1[;[6[[ >A:,MT^H
MQ0!"UEJFH_$/3/$<6FG^S([#RU=I563YU+9VYZ_-MQ6)=>%?$EYX"U;2&TV-
M+R[U,W2 7"%=C-N/.>V,?B*])OM5T[3 AU"_M;0/G9]HF6/=CKC)&:FM[F"[
MMTN+::.:%QE)(V#*P]B.#0!Y=XFM]4O_ !7OTS1YI[BQTZ**Y-I?B&0&3)V,
M>0< 'CWSZ5V7@F>$Z%]ABTB;2OL+^0]M*V[:V Q(;^+.[K3-;\!>'M=U!M0O
M;>47+%3))%.R;PHP 0#C&._7WJ_X>;P_#:&PT"YLI(H>6CMIUD*D]VP2<G'4
M^E &!)HFK'QKX@!LDDTC6K-(GN1* 8BL93IU[G]/>LJ#2?$P\&-X,ET>,$H8
M5U$3J8?+WYW$?>W8S@8]*],HH R]2M;V/PU/::2X%XMMY5N\AQ\P& 2?6O.-
M(\.^)[76_#.HOH*1BQ\R.Z)O%9Y6<,'E8GUZ]3V'2O6Z* /)[3P[K\?PV\1Z
M8VD2B]O=0::*(R)RA,9SG/;::W?'EM>7OAW2=4@S8ZY;W,+6R%MVV1R%*< A
MNOIV^HKNZYVY\,>'H?$:>(;Q56^=U5&FG(3S,;5*J3C=C 'T]: -71]-CTC1
M[33XL;8(PF0,;CW/XG)_&N9B@U>'XF:CJ(TJ8Z>VGB%9=Z?O'4[@!\W&<D<_
MI79T4 >3C1O$2_"I-'_L.8WR7V]8O-3E/,\W<3G\*T+FS\2:-XDU66S\-V^K
MVFJ2),K2RJHA;9M8-GJ.<?3ZUZ144UU;VQC$\\41E<1QB1PN]CT49ZGVH X6
M;2M;?QWX4U"XL=Z6=HZ7<MN%$4;NK#:H)S@$C\/RK,AT+6AH?CN$Z5<"74[I
MY;1"R9D5V/\ M<8')S^M>I44 >::?I&JZ5K'AG6&T>\F%MHXL+J&-H]\;KT.
M"P!!)/?IBH-2\*Z_>QWFO1V,0O7U6&^CTZ5AEHHD*@$Y(W'/(Z<?A7I\LL<*
M;Y9$C7.,NP I] 'GLMMJ^H>'];BB\)V^E":Q:!(8_+\Z>5@!U7 "#GJ<G/M7
M3^#[6YLO!^E6EW \%Q!;K')&Y&01QV)'O6W3?,3S?*WKYF-VW/./7% '%O:Z
MOH?Q"U'58=.N;_3=2MXPPMF3=%(@"C*LPSP.N>]<_J_AO6[OP-K4::4PO]6U
M+[2MI$5_<H",;CG&2%SQGDUZM10!7L69["W9XGA<QKNCDQN4XZ'!(_6O.FTC
M71HOC31SH\I%]=W%U:3B1-L@=AA<9R#@9KTVFF1!((RZAR,A<\D?2@#SZ;3=
M5%CX$A71IG;3C&UV^4W0[4"$=>03D\'^$52TC2M5T<7VFS>#+74)6NY&MK^3
MRBA5FR"^?FP,]N<5ZA10!6N9Y;/3);@P-<2Q1%S# .78#HH/KVKA_#OA&S\0
M:)/J6NV6HV^HZE)(UU&]Q+$<;B%!0$ @+@#(KT&DWKO";AN(R%SSB@#@OAF-
M1AT:^T+5--NXK>SE9+>2Y@V"2)B>/?G/3(YZT_P'X6U#1+V\_M DP6;26VF@
M@?ZEGWLW'J<#\/I7=T4 >.O#K]QIFGM>Z#J]UJEGK<=Q/,X!5D#D@1\\#!&2
M!M'.3Z:LC:QI5IXIT)]!O[K^TY;J>SGMHPT9$JDD.V<*1Z=Z]-HH \A?3]4T
MJ?P[K%YX6FU&&/24L+FS6%97C9,[6QR>>#[5<\96NHWW@'RX/#CV;37\<D5E
M:0%W5 O+2!!@$X_EWKU*B@"O/#'J&GRP.'6.XB*,",, PQ^!YK@/#=_K/@?2
M_P"Q-6T+4;ZW@D86ESIL(F#H23\P!!7KW]?:O1LC(&1D\XI: /(K/1M3?3O'
M6LOI=Y"FJQNMI;/ ?/;);J@R1R1_/I5N]TC4]8^$VC06FGW*7VF2PR/:W$31
M.YC!!"@_[V0?ZUZE2!@2<$'!P<=J .'#S^*_%NB7\6DWME;Z8))9I;ZV,3EF
M7:(USU[D]N!S7*,FLQ> ?^$9'AO57O;.\\UY%A'E,OG%\JV?FZXX!KV2B@#S
M^?5TTKXIW\LMG?3^9I40VVELTQ4[R>0N<?7I6MX"TZZL=%NY[NV-J^H7TUZM
MLPPT*.1M4CL<#IVJY#X9,/C&?Q"-2N2TT(A:VVKLVCH.F>N#]<]CBMZ@#SC1
M9;OPEXC\3PWVD:C<07]TUY;36EJ\RN&+'82HX/(Z^_3C.'J&B:GIG@_PW9/I
M=VUS'JOVZ:"UMWF$$>YC@E01D9'%>QT4 -C<21JX# , <,,$?4=J=110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !7G?Q,EDNM5\+Z'(LGV"_OU%SM. X
M#* I_P"^B?P]J]$KG/&/A5/%6G01)=-:7EK*)[:X49V,/4>G^ ^E %[4/#FE
M:CHDND26<,=H\?EA8XPNST*\<$=17,I?ZW=:G<Z#X6GL(;;1(8H)9;Q6=I'*
M\  8QC:0?>K0@\>S1K827.DP*  VI1JS.PXR1&> WZ<=L\,F\/Z[HWB*ZU;0
M)+.Y6^CC2Z@NLQYD48\S*C&3WXZDT 9Y\>ZK/X=LKJWL[1-1.JC3+J&5SM1R
M< C'.#_CUJS'K'C!O$&HZ#_Q*6NDMUNX)P'"HA)&W;_$<]\CI[\17O@K5(=!
MT^TL);2:]&JC4KN>7*!I-Q;@#/'..W3WK4CTC6X_B!>:R([,V<U@+>/,K!E8
M'<,C'/S9_#Z<@&(_C_6H_#.A7:Z=:-?7]XUC*))"$60,5!&!T)![\>]7;#Q5
MX@L]>OM$UK3[6;4/LIO;*.R<[9%R1LRW0\'D^A]JY/6M+UG1=#\-V5^EI]J7
MQ )(6C<E'WL6!;CCYB?PKJKOPKK>M76IZS>/;66I2Z>UC9Q6\C,(@6+;FDXR
M3DC@#@T 7;'Q3J#^)+#2+F*QD>[L#=$P.P\J0=4/7([9X/MZ\TGQ(\0-X;M?
M$LFG:>FE"Y$4ZI*QE89(.T$8';N>GO6CIGAKQ1;:OX?O9(M)BBL+5K22")GX
M4CKGU.!].>M9:^ O$!^%S>'&2S%X+WS5(F.TQ\'.<=<Y&* .QDU*&T\>7%O+
MI]I&!I3737RKF9E5P"IXSCOC)Z"N;T_X@ZK?:QILT=BTVE7TGE>7%:3;X020
MKF0KM;H<A?0\\5N7.BZQ>>.3?RP6JZ9)IK6,C+.?, 8[B0-O7=Q].:S=$T'Q
MMI\=OHC7]C%HULV%NHE)N7C#9"\\ D<=.!ZT 6],\7WVK:W<V5N-/1[6_:WE
MLIG:.<P@X\T$]?H!^(KM:\YO_"6M:UJUI-=V5C;SVVH&==4@FVS- ')"% G)
MQ@9)/3W-=GIPUC^TM2.H&V^Q&1?L0B!WA<?-N_'^OM0!H2R>5"\F"=BEL#OB
MO,_AE;0^)+G6?$^J11W-Y)>&.'SU#&!5 ("Y^[]X#C^[7I]<!!X6\0>%M;U"
M\\-/9W5CJ$GFR6=V2GE/R<JP[<_D?;- %K7K72/ [WOBZUM4CG-L+7[+$H1)
M79P0QP.OJ?058E\1:UI&O:79:W96?V346\E+FU9R(YNRL"._K_@:@U+P]K_B
MSP_?6.NRV%H90AMH[96D\IU;.XL2,YZ8QP#0VE>(M>U'13K5O:VEMILHNI&@
MG\QKB91A>-HVC))[^GO0!CK\1/$$VB:IK$>AV"V6FW)AF+7;%FP5!50%ZC<.
M3@<].#2^+KVYU/Q=X,%FL#6]VDLT<5TN5)*?Q@=MIZ?6H[;P=XAC\"^(-%>V
MM!<ZC>&XC(N<JH8J2#\O;8/KGMCG1N/#>N/J_@^\6UMBFD6_EW ^T<DE0IV_
M+S@#/OG''6@!='U;3-'\2>)K5-%LM.BTNV266:U7F5<%N0 ,<'I^IKG_ !I?
M:MJOAG1-4U33[&*SEU"&2..*1C,$8$@%B,#(ZX]JZ$>$M3NO$_BN>Y2&*QUF
MU^SQR)+N=,($!*X[\GKQ[UCZGX;\<:MX=TW1)[72A'8R1,LXN&W-L! R,8Z&
M@"_J_P 2;BWU#4$TRULKBWL)?*=997$LS#&X(%4@<Y')[5I7/B_5Y]4L+#2-
M$BE-]IXO8Y+JY\O8..&4 GC('N3V -4H-"\6>'=:U9]!CTV>PU"7[0%N793%
M*1\QXY(S[_E6@-+U^+QKIU_+'#>V\&G-;S7)D$1:1F!)" =,J,#T/4D<@&-=
M^,M9U/P?IVH:>EM;7S:JEG=1>82%8/C;G'0_+GV-:M_J,4'Q+T"RN=%M7O+F
MTDQJ ?+1D*Y*J,9QP>3_ '_KG"LO"'B.S\(75O\ 9+8WZ:RNIPPBX!$@!7Y<
MX 'W>O\ *MJ^TC7;[Q_X=UIM/@CMK.&1;C;=!MK.I! ^4$XW>G.#TH BN_'.
MJ6%QY]YI4%K8G4!9)%/*5N)%)QYJ@C&WO^!Y[TS341/CCJY554MI2EL#&3NC
MY-8-_P"#/%EQ:ZA;I8Z;),VH&ZCOI9<S2@-N4#(("\_=.!D'CG)Z?2=)UL?$
MV^UN]TZ."SFL! KI<+(-P*'V/8]J (?B_%&_@"YD>-&>.:(HQ4$J2P'![<$B
MHQXEU+0[3PSH^DZ E\UYIJO&!<+"-RH"W48XSGWS6A\2=*U;7?"SZ9I-DMS)
M+(C,3,J;0I!XW<'\Q5&#2O$*Z[X/N6TJ-8=/LVM[IA<J=A90IXXSC:#QGK[<
M@%/4_&%]K/PQU^Y%I':7]J[V5U&)=P3HK%3MP?O$8_6I-'F30=+T(:?X>L5U
MS5K=8X_*E*H\:1AC)(P3KD@D8)YZU0'A?Q(GA+Q7IXTE6GU/4#- OVI.49LD
M]<<8'4@G/M6M=:+XB_LKPIJ5I9(NIZ,ACEL6N%'FH552 _3)"#\_:@"U;^-;
MZVGU?3M8TN*'4]/LVO56&?,=Q& 3\I(ROIR#52/X@:R_AN?Q WA7;IZ0+-&W
MVY29,OM/1<C')Y';WJ.70=<UB[UO7KW2A97L^E/I]M8K=)*7+9RQ?@#J./K2
MIHOB!?@^VA#2U&I^5]G$)N$.5+\MNSCH3QF@"R_CC7(]6TVP?PLN_4XC):8O
MQ@X!)#'9@87!.,]>Y.*FTSQO?7NBZS.VAO)J>EW7V9[.VDW^8VX*,-CC'.>#
MP,^PJ2:/KTOBWPAJ9TS;!8VACNA]I0^4S(4/?YL9!X'-8]SH'C&2S\5)!8/$
M^HWZ3Q%;N-6DB#$%,@_+\NWDD9&1S0!TI\8WKRZ[IQL+:'5-/L3=1+'=><DG
M'J57&#C\ZR3JDD_P^\/:AX@TM=2D>ZMRCK<$;23A96XX/."O(.>M1Z=X=UYO
M%6H7\FA0:?:WND-9I''=(XB; P#@ G[O88YZT2Z9XJ?X?:;H_P#PCJ_:K2:
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MAH K7OB/1M-U"*PO-2MX+J7&R)WP3DX%:E>6Z+/+8S>+]4UFWTZYL[/4))9
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MA2)6Z?,W4GT% '2$X&335=7^ZP;'H<UYSXJ\8KJWPNU*]L89H)B_V2XB<@/
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MI;ZRU&RB@CE:<1B HFP!LY)Z=AW%>DT4 >4VOAWQ/I'A+PL+?3!-?:7?/-+
MLR9:-BQ/)X!PQ'?'6O1]0^W3^'[H6J^3J#VK^4 P.R4H<<].&QS5^B@#RG1]
M%\20:GX5O'\.>4=/,L5U))>*\DGF+AI#[#D@9/7'%0+X:\1)\-==T<:1+]MN
M]3\Z)?-3E"R-NSN_V,?C7K,]Q#:PM-<31PQ+U>1@JCMU-/5@RAE(*D9!'>@#
M@/B!87!\,Z;J=O,8==L)(E@<,"[-(51EYX/7/X5V6CZ9%HVC6FG0\I;Q!-V.
M6/=C[DY)]S6<?!NB-XG'B%[9WU$'(=I&*@XQD+G'2M^@#AX-.U2#XHZMJYTV
M9K&33Q!'*'3YW&TX W9YP1SWKE1X7\0CX0MH']C3_P!H&\SL\R/&W.[=G=T[
M>N:]BHH \SBT[7M!U_4KB#PPFK6.H[;E%>6-9()2HW*2??TSVYZUI2V>MKXN
M\*W4VEB1+:UE2ZEMBHCB>0 8 .#@8'X'VKNJ* /.X[?6?[-\;Q?V%=AM0=VM
M073,F^,)_>[8!_''451DL-9TK4/!FL/HEY<)IVGFUN8+;;)(C^64'&>ASFO4
MJ* /*;WP9JE[]N\1IIW_ !,9-3BO8=/FD7+Q(,;6ZJ&.X\9X]36[%/K.H:+J
M<A\*IIB&REC$*[6GG=A@!<8 4<]>3QBNV26.4N(Y%<HVUMISM/H?0\BGT 8O
MA%9XO"&DP75K-;3PVD<3Q2@!@54#/![XSZ^N*YV[@U'POXZU'6[?2+K4M/U*
MWC$@M &DCE7@?*2.,?Y]>\HH \FU+0-5'@GQ)='2;F34-=O!*MF@#- @?*E@
M.^,YQZCWKU&QE::PMY6ADA9XU8QR##)QT(]:L44 >8V6GZEIMEXYT==&OG2[
M-S/:W 4%9=Z;0H]3SGCW[]:+Z;JS>'? -N-'O_-LKU9+E?*YB5' RWIG.1GL
M*]<HH \KT2VUKPW)<>'QX/74,W,C6VHN%$91B2K.<'IW&<]O2O48@ZPH)-@<
M* VS[N>^/:GT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M535-0BTG2;O4)_\ 56T32L/4 9Q5NL'Q5HU_KEK:6MG=0P0I<I-<K(I/FHI!
M"\=.1^@H \K\/>)--TKQOINIQZMY[:PKC5$^8+#(S93DCH,@=^A]:]&\4:YJ
M6@:[HTS36ZZ)<SBWN=T9+HY!VG=TP?TQ5GQGX:D\2^'7TVU>"WF:1'$KK]S:
M<Y&._;\:;J'AR\USP2^C:O=QR7QC %S"I4;U.4;'X#/XT 49=;UZ32]?U"RD
MLFBM[HP6AF78J(A D=B2,X.[_OFLU?'MUI3>(XM0FM[W^S;:&XMI8HC$)A(
M #R>,LF"/6M;7?!LNH^"K+0;&\2WDM6B;S&4[9"O7<!ZDY^M9)^'NJ:CJ.L7
M.L:G:3#4[,6\GDP%=KKM*, 3V*B@#-U<ZP_B;P)=:Q=VLSSW#2*L$)01Y"'&
M23N'(["I_P#A._$>HDZGHE@]W8+<-&ELEA(QDC#$;O-!P#C!QVJ\G@SQ/=ZC
MH,^J:MI[QZ1+NC\J!@SK\H(/;.%_6I=/\(>)M'N;JQTO6[:WT2XF>51Y.9H0
MQY5.PX[_ *4 -TXY^-VJ'!&=(0X/7[T=)\49WD30-(:816FH:@B7+$D90$<'
MVY_05J6GAO4;;XD76OF2W^P2V2VP4NS2\;3DY&.J]<FM#Q5X8M?%>D"QN)9(
M'CD$T,T9YC< @'WZGB@"'Q+'8:1X.O571UN+**!@]M"$0*F,D\],=> 3FN5C
M\4:A9:7X1TSPU8VT2ZG!(L2ZBS,8PF,99.N1D]/3I6E?:7X]U'2KC2+FZT)[
M>XA:&2[VR"4@C!.T?+GM3;CP5J4&I>$WTZ>U>WT2-DD:X9@SY !P /0>M $Z
MZEXJU'4)](M)]-MKO3[>%KV=HFD5IG!.U!D?+C!SBLN/Q_JTUAIA-K;1W?\
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M4/E5&"A/!Y4=_P"?%#7/"&OZOH&O2_9(EU'6+R%Q;+.,0Q1C"Y8\%CCG'J*
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MQR".<;?;=GM0![%17,:OXJN[+55TFQTE;W4A:"[:$W0B!7=MVHQ4[FR"<8'
M_"NC@D::WBE>-HF= QC;JI(Z'W% $E%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2@E2R]C]3CUZ5TU% 'GL?A/Q#JOB6?5=7-A;+=Z9)82I;LSE V0",]3T-6M
MTCQE96UIH]U=Z?'IUFZJMU$&,TL2$;4P3A<@8)]":[BJ8U6P;5&TP7<1OEC$
MC0;OF"^N* .?U[P:NL^+=+U8R!;>%3'>0Y(\]5.^,'L0' .#Z"J^K:)XBLO%
M\NO>'VLYUN[=8;BVNV* ;?NL"/\ /7UX[2B@#AM?T+Q/?Z7HI2:UN=2M=06^
MF8MY2+M!PB#!XYQD^F>]3)HNMZ!XDU?4-%M+.\MM4*RO'/<-$T4@'7.UL@Y)
MQQ]:[.B@#Q[6-!G\+6O@BRC2.XOAJ9F==Y1'E9E.,G.!T&<=LXKI;GPQJ^I7
M&O:Q=6UK%J%[IQT^UMDN"RHC##,S[1DY.>G;'O73:OX;TW6[NQNKZ*1IK)_,
M@9)60J>#V(]!5N?4[&TO;>RGNXDNKCB&%F^9\ ]!^!YH X%_!^NMH/A"R\FU
M\W2+L3W'[_@A6R-OR\Y&?I[U9U;P?J^K:AXK.ZWMX-42V-M()"S!X2",C' .
M#7H%% ')Z:OC639_::Z;''!"P,<$A)NGV$ ,Q!V#/.1_^OEK7PAXFM/AW8:2
MEE;&]MM36Y*&<8*!MV<].O;/0>O%>JU%<7,%I T]S-'#"GWI)&"J.<<D^] '
M(6.B:UIGQ(U/4X;>WFTS4TC,DK2[6B*+C 7G)S^'N*I_%@NNF:"T:!Y!J\)5
M2V 3M; SVKO()HKF".>&19(I%#HZG(92,@BL/5](T+QD#:74QN#I\_SQPSE3
M')C^+!ZX/\_>@#+BTG6+WQ=)XGO=.2WDLK1[>RLUN%9ISECN9L84'/ ]_:L$
M>'/%8\#:+IZ6$8ELKUI+FQ>Y7%S&7+#+#C'S$$9]Z]/BC$,*1!F8(H4%V+,<
M>I/)/O3Z /))/"7BD:;XMMQH]F/[7:.2)8;M0$(?.T @9P">3CI[\;_]E^(8
M]8\(RII<;0Z;8O%.QN%&R1T"G//(&P'@=Z[RB@#S32_#FLOXJTO5CH":+<JS
MMJ<T%VIBN5/81J2>3SS^O%=7X6UR_P!:;54OK.*!K*\:V5X9-ROMZ_B._P#3
M%=!2*BH"%4*"23@8Y/)- 'GGB+1?$USXPOKFTT^*^L+C3S:P-/=!$MV8?,VW
MDD]1P/XNM4+;P[XNTQ= UNUTVVEU2RL3IT]F\ZA3&I.Q@V<9P>>?_K>IT4 >
M?>)]%\4ZYX=T^::UMI=2M]2CN_L<,@14C5<;-['DYR<^^.U32:;KUW\2-&UR
M72!#:Q6)AN"+E&$;,&) [M@D#I7=T4 <9JGA&>Z\?6.KV[+'I[H&OXQQYKQG
M,9///)'_ 'SSFEU#2-4F^*>EZQ%9%M.M[1H))_-08+;OX<Y[CM795%)<P0R1
MQRS1H\IVQJS %SZ =Z //=/T?Q#IGASQ)H2:'YD5R;EK2X%ZA\SS?E (/(P#
MG)/.*:^A>([2+PQJ=MI$-U<6%C]@N].EFC&Y0  P<Y'50>.1[\UZ*L\3S/"L
MJ&5 "Z!AN4'H2.V<&I* .'O[/6M1T:.#4/"UC<6UQ.3-IL,RJ\"!>&\S(!?=
MSP!QQ5WP+HVJ:)9:A;7[R_9C>.;&&:42/'#T4$@D=,<9]?6NF2Y@DGD@2:-I
MHL&2-6!9,],CJ,U+0!YGXBT3Q7?>(==,6FB]L[RS-K9RO>K&MNI7YOD[DMZC
M\<4RP\/>(DU7P5+/HYCCTF!HKEA<QMC(*9ZY/ #<9ZXKT^HEN8'N'MTGC:>,
M O&'!90>A(ZB@#RZ7P7KEQI6JA;"."YCUS^U+.+SE*3CIMR#\O'/..M:EM9^
M)-4^(NE:]>:!]@M8+1K>7?=QN03N.0!R>2!TKT*B@#DOB)::C?>&X[;3;"2\
ME:ZB=E1@"JJV[//7H!^.>U4?%>G:U#XFTWQ)IFDIJ:1VC6]S8NR*P!.X8)SD
MY/8'[O<&NWCN(9998HYHWDB($B*P)3/(R.U24 <#J<.JZCH,4&L>$H9;2YN\
M26-JX:6VCV\2!P0&;.>@'''>L>/0/$UKX-D2.WN+G[%J\=UI]I=2*9?(1L@$
MCN?3M@XKU..:*8,8I$D"MM;:P.#Z'WIQ8+C) R<<T <+ID/B&\\;3:[>Z$;.
MTFTO[,BFY1W!#;P",]3S].,US^G>']?@^%MG9_V1*;ZSU);G[,SJK2(K;LCG
M\/7VKUNB@#S?Q7976NEI;GPI?17B6H:QOK293-'+R=C$$8 )]^^*[?0(;ZW\
M/Z?#J3E[Y+=%G9FW$N!SD]_K6@SJOWF [\FFK-$Q 61"3V#"@!]%&1G&>:*
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M^G-8RI!$Z;1CY2N3SSUZ?2J=SX(\3W?P_'AF:_TMMCQK&X1QB-23R>YSM[=
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M2_LT+&CM$\G4, NYB-N3CJ<5=CT+Q#_;_AF]D^PK'I]FT%WLD;YBP (4%?\
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MK%%% %::PM;B\M[R6!'N+<,(9&&2F[KC\JLT44 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>4,6!'S'(YQV[^O&C'X2NKS5K2_U_5EU(VD#Q01):B!<N-KNP#')(XXP!Z4
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M$:OH\4$;P2B,KLD(&4W?Q'&2>N..F:B\8:3JVJW&B/ID=JZV5\EW+YTA7[O
M P#ZF@"BEXEA\1=/TI]&TI+FZLVN);V"+$F_YLX.,X..^:Q9/B#XF;2=5U6'
M2],^RZ7>-;W"F9][ $#Y>,=^OZ5T6H:!JD_Q*TS7H5M_L-O:M!)ND._G=R!C
MW'>L%?!>OKX3\3Z4([/SM3OC<0MYQ(VLP)!^7@C:/KF@#I=9US6+2XE^R6ME
M%:16+79N+J0X=@,E%"\C &2?TK%G\>:M);>%FL=.LS-KB2?+-*P5'7'<#IS[
M_P!:EO?#GB2;Q)_:,+:<4FTL6;BX+L(&(^;8!U!/YUGV7@WQ'#_PAPG2Q8:+
M++YNR8C*,RXQQR0 3^G% &A_PGMY8:1J\FJ6-J+^PO([-(X)F\N5WP1R1D8!
M)Z=JOSZ_K^BO>SZWIMJVG6]F;@7-FYP7'\!#<Y/T]ZP[OP%J^JMXH%S-;P_;
M;R*[T]E8L$9"PRPXY*X'?K[5KKH_BCQ!I5Y8>(KJSM89;4P!+-=_F.1_K&)Z
M8(^Z,9R>>E %+2?'FI7FMZ/:36,,D.HQ[Y/L\<N^U)7< Y88(]2/<_6UX;\7
M:EK^J>6L>FK;I<S0W$"S'[1 JAMK%3U!( X'?ZX7P[8^-;:*QT_4Y[!;.TP&
MN(F9I9E4853D8';)ZX'O5&#PGK%[XHTC5K^RL;&ZLV+75[97!W7>!P"FT 9/
M7D\9% 'H5<#JHU&V^*F_1+*TENY]'_>-<2F-% E W' )/0# ]?:MOPKJ>MZA
M-JT>KP6Z+:W1A@E@! D '/4\XR!GIG([5#JNG:U!XRAUS2[6UNX_L!M)(IK@
MQ$?/OR"%;^5 &))\1[N+P]!?/IL2W<>J#3KR R'"-@DE3CV__76I<>,;JQ\7
M:KI-S91-;6>G/?QO"Y+NJX^4@C&3S^G6LC5/ >J77A>2..>"35Y]4&IS*QQ%
MNY&P'&< $<XYQ5FTT'Q0WBJ[\17<6FI=2:7);111R,R"7=E-V1R#CF@#0T+Q
M'J6LV9O#%I=W8O9M*?LLQ+1R8!$3J<]03SCL>.E8L/C8:3\.-+UC3="MX8[B
M[-NEDLNU4^=^AQU.T_B<^U7=(\,:E8>*I-:MM.L],B:Q:.6SMI]R7$V<@D;0
M%'N!G]:R9O!?B&;X?:;HGV>T%W:Z@URY-Q\I7<[#!V]]WZ?A0!T%OXPO[&_U
M:V\1:?!:_8K,7R-:S>9NC)(V\@?-D8[#/M6=H_Q U&^US3;:XT^V:TU G:;9
MI#);<942;E"]\'!]3VP;FK>%]3UOQ%J4DZP6^GWNE"R,BR%W5P2X.W X#$CK
MR!VSQ+H-OXUMDL-/OO[,CL[5%22Y1WDEE51@#!X!.!D_6@!?#GBS4/$6HL8(
M+'["EQ+!-&)C]H@"@[78'@AB ..F[O@TGA_Q;J'B'46-K;V+64=S)!/$)\7$
M"KG#D'@@D=O7V-9UOX4U2?Q%I>K/IMEI=];SL;VZLY?DNDVGI'_M$X))R.>O
M%0Q>%M7O/$.EZI+H]IIE]:W6^\N[6X"I=Q^R#GG ^]CJ>O8 ZSQ;K\WAGP]-
MJL5C]L$++OC\WR\*3C.<'N16-9>,=9C\0:=I^NZ"EC#J8/V62.X$A1@,E7X
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MOE)/!XP.M/O_  WJ>I^*;2^_L..RNK;4O,.IV]PBK/;!\@.@.XL5 '3K['%
M'HM%<_HVM:G?>)-9TV\L(8;>R*>3-')NWALXSZ' !QVS[@UT% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC0+W3;>Y^S27,1C\W;NV@]>,CJ,C\:YR?P7J<NE^&K5-9B2319 _F?9LB4*
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MC5(L/'(^W.6SRN%QCN":J:;X)URTUO1M2GUBSD.G6[6PB6V(7R\8&!GKSR:
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M-/IQCTMS+;K8AP99.,,^[IC&<#O[4 8$WC?Q5+H>MZQ -)B@TB],#1&*0M,
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MU?2;O3K@ Q7,31MQTR.OX=:X$_#"XDT+3(9=1)U6&X#7-UYC',)788T.,X"
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M;'?7 N)Q>QYE"A=R[/ER  ,[<9]Z .VHKB==AU"7XF^'UM]3>W@^RS,8A$K
M[2-W7^\"H]MO'6J9OO%>L6NK:U8:U!8VME-/'!9&T602B+.=[GD9(/3M0!Z%
M16+X;U]=<\*6FM21^2)8B\B]=I4D-CVRIQ7*Z1J7C'Q%IEIXBTV_M!;S7)7^
MS6MU"B(2%2QD)W9 &>!0!Z)17G\?B36);CQ["MVJ_P!DQB2S8Q*3'\CL1[_=
M'7/X]*H2>,M230O"UU?ZE)I]O?P2?:M0CM4D'FCA 1C"]SG'/TS@ ]/HKSK4
M7U.Z\3>!@NMQR^>MRYG@A4QR%8\[@/=6Q[=15I=1\1^)]3U@Z/JL6E6NE7#6
MJQO;+,;F1?O%B>5&<#CL: .[HKR\^/\ 6=2TOPO/IPMK>;5+A[6<2QEU#J0-
MPYZ<YQ5A/$'BN34?$6E+?Z?YVCH)_M!M#^^4INV[=WR]^>>: /2**\TC\>ZG
MJEGX>ALE,-W>V\ES=R1VC7'EHA9,J@()RRGISTI\_BSQ7;>!WU"XL$MM1BU!
M;?-U"T8DC)P&"]N2!Z=: /2**\]U?Q!XA\.RZ7;ZUJ5C;QW<DHDOXK1GCCP!
MY:D$]SDGIP#Z9KHD/B"XT_1Y+6^TV5C*&O9E!*2Q9_Y9X[D4 ;D\$5S;RV\Z
M!XI4*.AZ,I&"/RKGK:[\)>%K6]%I+96<,,JK="$Y".<@!L9P>*O>*=2DT?PM
MJ>H1?ZV"W=D]FQ@'\R*Y.\M8H/@C/*B_O;K3ENIY#RTDL@5F9CW))ZT 7K/6
M_A]<:^-1M[W31JC$D7#'8Q)&WJV!D@XKK)K^TMY[:&6XC22Y)$(8_P"L(&<#
MWQS6!HND6.L?#K2+.^MXI89--@!W*.#Y8Y'H1ZUR/A6.36OA%J=I=S&4V$LR
MVMP&)*^4 Z,ISV/ P>@Q0!ZM16/X5U9M=\+:=J;D>9/""Y P-XX;CZ@UQ-QX
MP\167A[Q*T]U9?VGH]VB &V*AXFP 0,]\Y'T]P: /36941G=@JJ,DDX %5M.
MU*SU:QCO;"X2>VDR$D3H<$@_J#7.Z?KNI:IJ^GPV<EM+:'2EN[EB.LC\(."<
M<@G'H*XF^\1:Q-\,]-O+1[?2VFU4VY2R0(NS<Q['CD'/0G\>0#U8ZM8#5AI1
MNH_MYB\X09^;9G&:N5YUK9U&+XJZ?'IK6:WUQH[QM-,AV@AB=V <D_+TR:D3
MQKJJ>'XH9H[8ZY+JK:2KHK&+>&P9,=< =J /0:*XN#6_$&EZ[#HFLO97$U];
MRRV=S#$Z+YB#)1AZ8&>/7Z5 ?%VJ_P#"&>'=:5;;S+RXAAN4*'D,VTE>>.F:
M .[HKB-"U#4KSXH>)+=[PFRM(X46W8$CE<Y7G .2<G!S^%:OBOQ!<:/_ &=9
M6$4<FH:G<"W@,N=D?J[8'('''O0!J6VLZ;>:C<Z?;7L,MW;?ZZ)&R4[<U>KR
MVQFU33O'/BJ69=-;4X](697C5@'90.<=<'C//9:W_P#A*=4_L7PGJ CMBNJS
MPP70(.5+C.5_(]?:@#LZJ7>J6-A<6MO=7<4,UV_EP1NV&D;T []1^8]:Y(>(
MO%UWKNLZ;8:5I?\ Q+G7YYYW&]6&Y0 H/)&#VQ6%K&N1>(K;P%K,]D%DEU4(
MT>[[C!]IP>N-R@X[X&: /2H-4L;K4+JP@N8WNK7;Y\0/*;AD9JW7#-XM73?%
M/BJ*?3K2-=.M$N&FBXDN/E!4,V/]K ],U=TS6O$M[)HMT^F6;Z;J*>;(87;?
M;(4W)N+8!/(S@=C[4 =92.RHC.[!549)/0"N'N?&>JZ=<6<VH:?;16MSJ7V$
M0*Y:=%.=KL<XYQG'I4NA7FO3^*/%*7%S;W%I;2A(86!7;E-R $< 8(!."<\T
M =78:A::I91WEC<1W%O(,I(AR#5FO.M$\;?\4;HKV6F6=M=:A>&RM[9&*Q(=
MQR^!S@<9 [GKS6S_ ,))JVG^(!HVIV5M+-<6KSV<EHQ"R,@)*-NZ'IR,]: .
MLHKSBU\>ZXNEZ/K6H6&FQ:5?W2VS>7+(TJ$LPW8QC VGC)_7CT>@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *\]^+;J-'T5=[*PU2*0E5R555;+=#TR*]"HH Y
M>W\)I,;R_EUJ[N[V]MO(BO2$!AB/.$4#:,]<XI8_!-F?!R^&KJ\NKBV0@QRD
MA9(\'*X(';\:Z>N:TKQ@NL:A%%:Z1?M9RR21QWV%\H[,@GKD#*G&10 ZR\*%
M-1M[[4]5NM4DM8FBMQ<)&HC# !C\JC)( &36))\+K=K"338_$&K1Z:S[TM!(
MNQ#N!].F1T]>:ZV753%K\&E_8KIQ+"TOVE4_=)@XVL>QJ\DL<I<1R(Y1MK;3
MG:?0^AY% ',7_@B.YUI=5M-7O["X,"6\[0,N9E7H6)!YQ@9]A51?AMI\6@V>
MFP7][#+8W#SVUW&P$L98\CIT_P !7:T4 <K+X'@O/#U]I6HZG?7KWC*S74[A
MG3;@J%&, #!Z#G)J5_#%\[HS>([Y_P#1FMIDDC1DF!9CN*XP&^8#(QPHKI:K
MWU];:;8S7MY*L5O"I>1VZ 4 5M"T:V\/Z):Z5:%S#;KM!<Y)))))^I)-<W+\
M/W5;ZST_7;JRTB_=WN+%(48'< "$<C*CV%=;977VVRAN1!- )5W".9=KJ/<9
MX/M5/1M?L-=-Z+&1F^QW#6\NY<?,.N/4>] %"'PA;6WB'3]5M;J:%+&U^R16
MJ@;#'SU/4]<\]Q6QJ=B=2TV>T6XDMVE7 FB^\ASD$>_%,CU>T?6)M*+,EW&@
MD".N!(A_B4]P#P?0U>H Y2X\"66HW5Y=:M<27L]U9+9LY14PH.=^ ,;L@'TX
MZ5#HG@:XTJ[M7N/$FH7UI9G-M:R8"+\I W?WL9R.G:NHU&^CTS3;F^F5VBMX
MVE<1C+;0,G ^E0Z+JT&N:/:ZG:JZPW";U#C##G'/Y4 4/"?AR3PSIDUF^H/>
M^9</.':,)M+=1@$_7ZDU+IOAJPTO7=3U>W4BYU J9.P7 YP!ZGD^];-% ')6
MW@@?VAX@FU'46O+76@!+;^3LV8X4ALGD#@<#H*9HW@>YT]Q'?>(]1U"PC0QP
MVC'RU52I7#$'+<'V%=A10!PFF_#NYT^:*W;Q-?2Z-#)OCT[9M& VX*S9Y&>O
M S5FZ\$7FI&*#4M<^TV,-^;R.,VQ$H^8L(_,WGY1G'3/IC KLJBGG2W@EE?)
M$2%V"C)P!GI^% &;XFT&+Q-X?N=*EGD@68#$B#)4@Y''<9'2N?M? FHPZ]%K
M$_B5[BY%HUI+OLD4.A!P!M(Q@X/<G'6NET'7+3Q'H\.J6(D%O*6"^8NUOE8J
M>/J*TJ .-LO $$7@23PK>WOVF$N6CG2'RVC);<"!N/(.>?0X^MK1/"VI6-];
M76K>)+K53:JRV\;1")5+#!9L$ECC(R3WKJ** /.OB](JZ3HB"Y2WD.J1LLC8
M.P!6RV#U R,UN1^$KB6[U+4K[55N=1O+,V<4JV^R."(CH$W'/)SDM^5=++!#
M. )HDD Z;U!Q^=/RJ!5X7L!TH Y1/!"/X"7PM>W[3J@Q'<I'Y;*0VY3C)S@^
M_-31>%[NYU+3;O6]3BO_ .SLM;I':>2/,( WM\S9(QQC S7344 8%YX4L[SQ
MC8^(W;$]I"T0C"C#$]&)]@6_,>G,%YX4EO?&]MXADU!?*MX&@6T-OG*L"&^?
M=_M'M7344 >=S_#2_;1+G0;;Q.\6BRR;TM7L5<H-^_&_<#UP:T)O ^I0ZG'J
M.C^)9=/N6M(K>Y;[*LHN"@P'*DX!QV X_$UVE% '(7W@V^>?3+^PU^:'5+)&
M1[B>(2B<.<ME<C'/0#H.!ZU;\.>&K_1=6U2_N]8%\=0<2/&+;RPC#@8.XG '
M&/:NAFE6&&25PQ5%+':I)P!G@#K5/1=8MM>TJ'4;195AESM$J;6&"1R/PH S
MM8T&]OO$>DZO8ZA';-9"2.1)(=XD1\9 Y&#P/\\'*F\'ZO:2ZI#HFK6UOI^J
M2/)/'/;&1X6<88QD, <]<&NRED6&%Y6W%44L=H).!Z =:I:+K%MKVE0ZC:+*
ML,N=HE3:PP2.1^% "Z7I%KI.B6^E0(/L\,0BP1][U)^IR3]:Y/2_ NL:.WV"
MR\53Q:'YAD%JMLGF %LE1)U ]Q[\5W=% '$:CX)U.76M;N--U:WM+/6H5CNH
MWM?,=<*5ROS#KEN?]KIP*EA\)ZIIVCV.EVUY87MI!;-!+#?6YV.=V0X )YP2
M*[*B@#A5\!7=G9^'AINJQPW>D2RN'>$E'$I^<!=V0 . ,U;'AC5]*U;4KO0;
MZR2+4F\V>*[A9MLO.64J1P<]#77T4 <'+\/'MK?PU;Z7>1)'H]P9W,\9+2L2
M"3P>.G3]:M+X1U"/Q#XEU%+RV,>KVWE(A1LQL%"J3STQG/X5V5% 'G-M\.]4
ML-/T22PU:WM]6TI9(EF\DLDL;L6VL#_O-^?:K>K^"M<UC0?L]WKL<^H-?)=F
M1XBL2*JD"-5!Z9.<]^]=W10!S>L:1K6H7-NR7&G36GV?R[FQNX"\3R9SO!Z^
MP_\ KUB-I'B+PKX5T/3-%NQ+<QWFV8);%T>-W+$$D'8H!ZY'2NP@UJQN=9NM
M(BE8WMJBO,FQ@%# $<XP>O8TNKZQ8Z%I[7^HS>3;(RJS[2V"3@< $]30 FMZ
M:NL:%?Z<V!]I@>(%AD D<'\#@UR%I;76O_#R3PM%+!:ZI9PI8W:2J2$"C (Q
MUW!<@].OI7>JP90P.01D&C R3@9/>@#BHO#OBX:';:*NMZ?9VL5LMN9[>W=I
MMJC ()8 $@ ?F14NJ6=KX4\$C0-&@:6ZNHVMK2#[SRNP^=S[ $L3P![<5V-(
M54L&*@L.AQR* *&A:4FAZ%9:9&P9;:)8]P&-Q[G\3DUC7?@FTN_&BZ[(RF!H
M0L]J02L\@X5F&<' /3'4 UU-% ',^%/"K>%-*N[>&X%S-+*SQF3("+_ F>N!
M_,G KFT^'.HCP(-%-Y;"\BU#[=$X!V$X^Z>_>O2JJ:CJ=GI-H;J^G$,(8+N(
M)R2<  #DDT <_P#V#J\GC2PUZ=[!Q#8M;2(H8'<3G*DYQU_+/K60O@75+O3)
MUNKFUM]0CUE]4LY8@SH"6SA@>W\J['1M<T[Q!9&\TVX\Z$.8V)4J58=000"*
MT: .2L]"UG4O$%OK/B![2)[&.2*TM[0LRY<89V)[XXQ6%!X*\4_\(];Z%+J&
MF_9K"Z2:UF,;%G53D!@, <D^IKTJB@#E+'P]J.G?$+4M8A>W.FZA"GG!R?,#
MJ, *.F/K4GC#P_?ZO_9M]I-S'#J.FSF:$39V29&"K8YYP/PS73T4 <+8^$];
MN/$FIZSJUS8Q-?Z<;-HK=6;82 .I(SC&??/:JMOX5\5/H^C:=/<:7%'I%Y%+
M"RJ[&54R 6YXX/3]:]$HH \[M+K6)?&WC#^P8K*?+VT;23RE?+<1[20 IW8P
M>..:2\\"ZG!9^%+#3WMYH-*O!=W$LTA5F;>&(4!>G+?I7:6.@Z7IM[/>6=G'
M#<7!)F="<N2<\_C6C0!P4W@W4-1\3>*+J\%O'9:K9BVA*2%F4J%"L1@?W<XS
M[<U:\-:5XPL8;73M0OM/CT^R C22WC+2SQJ-J@YX7&!D]3^M=G10!Y._@3Q7
M_95O:&339WM-4^W"=W<27)R?F<X]_<^]=98:3KNG^*-<NT2RDT_4 LJ@R,)!
M(L84+TQC(Z__ *JZJ21(HVDD8(B LS,<  =2:K:;JEEK%DMYI]REQ;L2!(G0
MD<&@#S[3/ 6L6O@S3[-GM(M6TJ_-Y;,&WI(.NTG&5SGWZ#\-F;0M:UK6&U74
MH;2SEM+.6&QB@G,A$D@P79RHQCC&!WZUV=% 'F,_@OQ!+X#T/0O*L_M%C>^?
M(YN#@J"Q&/EZG>?R]^/3NW-%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5R/C
M2[N/M^@:3%>R6<&I79CGEA?9(55<A5;^')P..:ZZLO6] LM?A@2Z\Q);>430
M3PMMDB<=U/- '*0&ZT/X@)X<34+ZYT[4[)YA]HG:22W<;AE'.3C Z>M3_"NS
M6#P;!.)IV:2292KREE&)6&0.@/KCK6[9>&HK6XFNY;Z\NK^2$P"[F9=\29SA
M,* .>>G)%2^'?#]MX9TS^S[2XN9H [.OVAPQ4GD@$ <9Y_$T 86IZG?P_%?1
M--2[D%E/9RO)!QM9@&P>F>PKG+*2Y\.>$O%^I65Y=272:M);(9YMP'[U4WX/
M&[#')QS@>E=U>^&(+WQ78>(&NKB.>SB:-8TV[6!]>,]SGZ]L54_X0BQ=-;MY
M[JZEL=6D,LEJ6&V-R0Q=>,YW#(H RM!T?Q1IVOM)/?3?V5-"P=+F_%S()>2&
M0F, #IQTZ_2N,_MKQ /AW:^+3X@OFOXKTQ+$2ODE3\N&0#YO7G->AZ'X%ATB
M2.:?5M0OYK=62T-Q)E;92NWY%.1G'&?TJB?AI ?!2>&O[5N!$ES]H\T1KD_[
M./3OUH 2PN+[1_BB=&EU.\OK:]T[[21<N#Y<@8C*@  #"]!ZT_XASL]WX8TQ
MAFVO=5C$X!^\JD?+].<_A6S)X823QG;>)#>RF6"T^R^247##+')/U;/^<4GC
M#1KC6-)A:Q(^WV-REY; G 9TS\I/N"10 GC;6)-&\+W,EL)&OKC_ $:T2/[S
M2N"!CW')_"N%\-SP^$_'-G:Q:=?V6GZM;I YNXRFZY7^(<D'.?S:NYGTEO$-
M_H>M-/>60LB9?L4D0!+$8.[/(.,CO[>M)XN\)1>*[6TC:]EM);6;SHY8T#$'
M'O\ AWH H^.MUM>>&M1@;9<1ZM%;A@!DI+E77/H0*W/$MS):>&]0GBO4L9$A
M8K<NNX1^^,'/TQ61J6FW.N^)M-M9[>86&D.MT]U*,"YEQ\JJ!CH>2?48Q6KX
MFT"'Q/H-QI4\SPI-M/F( 2""".#]* .%N=<NVU'6=(^UWEU93^'7N8S=(%;?
MM(+8V@C.>AQ^6*S[!]=T+X7Z;XBM=;D,5L(R;$Q((V0R[<$XR3\W7-=C8^!#
M:Z];ZO-KEY=7"6S6LPD1 )$(( &!\H!(/?I3;/P$T.G6VDW>M7%UH]NX=;,P
MHH?#;E5V'++GMWH J6%UJGBK6/$J1:S=Z>FG7!M;9(%3:"N<LP();)'J.*QO
M^$NUB?P9H'BG[7+'%;W2P:G$JC;*F[!?H2.W3UKK[CPC+'K5[J>D:O-ILE\H
M%RBPI(KL.C#=T/6KR^&-.B\*/X=@C,=BT#0]<GG.6SW.3F@#D]8\3:EIVF>(
M->MKPRV<DZ6FF*Q0QJPPK2 ]"N[.,D]#VK1T2+Q7:^*46Z^V2Z.\!21[V:!F
M$HY#((^<''0CO6G+X-TR;P8GAEPQM$B"*^!N##G?]<\_C5;1O!TVG30RWNOW
M^H-;1M':B3:HARNTG'.YL="<XH ZJN TRQD3QIXTD-]=,J+$WEE@58/$Q .1
MG"YXP170^$++5;#05BUBZFN+HRNP,[!G1"?E5B"<G'/XX[4QO##CQ'?:K#JD
MT45]&J7%J(U*N50HIR>1@'- 'F&BWVK^'_AUH.LV>K3"%K_R&LC&GEE3(^<G
M&><>O>NBN]:\4:_JVNQZ";M3IMS]F@6%H%B++G=YGF'<<D=NPK4?X;JWA"S\
M/#6)1#:W1N4D\A<D\D#&?5B?QJQ=>!)SK5[J6F>(;W36O@/M,<**0[ 8+#/0
M_3IDT =1IS7CZ5:M?(L=ZT*&=5((63:-P&..N:\K.L>+8O ]SXE?7R\EG?-'
MY'D($D3S%3GC/4],]*]8M;9;2RAM8W=EAC6-6D;<Q &,D]S7'CX>M_PB5YX?
M?6IFBNKK[2TODC(Y#%0,XQN /US0!#XJU'4H]6U*WM]:D@,&G-<6MK91AY-Z
M@DF7*G"\#'(SGUK&N-0O-9\1_#NZN+J1'NH7FD6+ 7>$R2 0>N<?3IBNGU'P
M5<7NK7E_%KMQ;&]MEMKE(X5^=0N,Y/0\GIZU77X?O'#H'EZU,MQHS,(I_)7+
M1M_#CIT&,\T 9T?B'5WMOB #>N&TQF-FP5<Q#:QP..1\HZTU]:\17EAX*6VU
M5;9]5C9;F7R5=F8)G.",>OXULZCX'EO=8U:YBUJ>VL]6A$=W;)$IW$*%!#'I
MQG\Z9_P@]S"?#:VVLLL>B[MHE@#&7/'8C'''T]Z ,:\N?%UQ?WVC:?>7D]QI
M4$*F>W$"":5T+;G\PY / PN>AKO-#DU*71;1M7A6'4-@$Z*P(W#OQQSUX]:Y
M[6/!5[<^))-;T;7Y]+GN$2.Z58Q(L@4  @$X!P!_DTMWH>KZ?)X:M=(U*Z,4
M%RYOGD^83*?F8N?4G( ]6]J +GCG7YO#OAM[JU*B[FE2W@9EW*K,>I'L 3]<
M5CW=YK7A'7-%2]UA]3L-2N/LTPFA56C<CY2FT=,]CGI^(ZGQ!HEOXAT2XTRY
M=XTE *R)]Y&!!5A]"!6-:>%=4EU'3KG6];6_CTWYK>-+;RRSX(WR')).#VP*
M ,[PU<^*M8O-2GGUNV6#3]0N+0P"T!\PJORDL". 2#^%9EMXVUN;X96>M/,B
MW4E\L$]T(EQ%'OP6(/'H.G>ND\->%-1\.Z;JUJ-6BF>]F>XBD^S8\J1A@DC=
M\W0<>U<IJ^C2>$?!&G^&I=92*.\OCYE\]O\ NHX\;BK@[LY( [ ]^ : .@T2
M^UZX\7:M8'68;VPM;9&CD-LO+NN1DI@<8SCN#^-8MKXP\27OPTL]8@N+4:@]
M^MO)))%PR%]HX'&<D?AGO6AX:OM5GU,V=IX@T[5+.6"1GEM;(1BW< !2<'!R
M3TZ\4L'P\O[7P5#X?@UJ)6BO!<^>;7.0#N"XW?WL'/MB@"WH&KZU;>-[OPYK
M-_'?L+-;J*6.W$07YL$8!YZBNUKF!X6N1XWF\1?VB@$EE]D$0AY7H=V[/J,]
M*G\&KK2^'U_MZ9Y;LS2;6D0*_EY^7<!P"1SCW% &%;ZKXC\3RZ[)HFI06@T^
MZ-K;PR6X82%1\Q=CDC)X&,8JU'J.O:QXHO-(AOH=/&FVL+7+Q0K)YDTBY^7?
M_ ,'WJ-O ^IV6L7]SH7B&33K/4)/-N+?R!(0Q^\48GY2>><?RJU<>$;VV\1+
MK6B:JMO</;+;W*W<1G$P4 *Q.X'=P,G/./K0!RE[X]\0VGAC4)/,M#J.EZJ+
M&:7R3MF4$C<!G@DJ<^QXQ6A+J'C)/&W_  C7]NV6ZXM/M:W L!^Z 8C:J[N>
MG4D_UJUJ7PYDO?#DNG1ZC$EU=WQOKRZ-N3YLA). N[Y0,],FM=O#%Y)X[M_$
MCW\.V*S^RM (#EAR<[MW'S'/3IQ[T <J/&/B*7P3!=VUW:-J":M_9\\LD! /
MS?*0!QT(S['UK0GUWQ'X7UJXAUN]MM1M'TZ>[A:* 1%&CP2"!VYQUK#\0Z!-
MX0\&&VN-5MWDN]:BN8Y?)V!&.-QP6.0-H/YUV2>%+G4]0FOM?U&&]W6CVL,5
MM!Y4:(_WSRS9)XZGM0!S]QXA\3Z=X/L/%LM_!=02F.6YLEM0JK&Y'"L#G(SU
M)JQ)XGU.X\77NEG5X=+G2:/[%:W-N#'<Q8!)\SKDY. ",?G4R>!=6ET:U\/W
M^MP3Z+ Z$HMJ5FD13D(6W8 Z<XS5O6_!M]K]M<65_J4$EH]TLUN?LW[VW0'E
M%;/IQGWH 3^U]6;QAXBTR1X88(-.$UK)'&-V2.&).<D'(QTXZ5RFG:YJND_!
M*/5TN4N)_/(47,8<(OFE<#UYYYSC\J[B+PQ=KXNOM8EOT:UNK06GV98L,JCH
M=^>3G/;O6 WP[U3_ (0"7PN-7M6C\\/"YMR-J;BQ!.[DDD'...1SV +U[K.M
M:UXI?0=%OX-/:TM$N+F>2W\TLSXPH!P  #G/O6-J'CGQ!I?A?4O/6U;5M-U)
M+-Y?+_=RH1D-M!X)'\^U=!?>%]9BU:VUO1M1M(M26S6UN4GA8PW&,<X!RN.2
M.O89K/U?X?WVI>'+RV^WVYU.]O5O+F9HV6,D<!5 R0 /KG'OP 7-)UO6[3QX
M_AW6KBVNQ/9"[ADMX3&(^2"N"3D<'UKM*Y8^&;Y_'\/B.2\@,4=C]E\I8R&S
MR<]<=23^GO4_@MM<?0F.OR>9<_:)!&YCV,T6?E)';/)^F* ,2YU/QEJ'BK6=
M%TVYTJT2T1)(I)(F=BK].<XSP<\517QQKE_9Z/90QQVFIW;W,=U*ELTXB,1P
M2B*<GG'J*DMIM6F^)GBE=)GL//6WMXP+A7POR\=.I'/'?(Y&*L7/@'4K:STF
M?1=72+5[!I6>>9/DG,IRY(&<<]!S_6@"*?Q7XJLO!K7UU8PV]_#?I;YN8603
MQ,0 X4'Y3DCOC@U!XNMO$@L]"&IZC8F4Z] (6MH#@9)V$@G^$YX[\<UJ:MX5
M\1ZGX5-C/K%M=:C)=QSO++&4C15P0JA?]H#ZY/2KWBW0M8UR'2/L%Q9QR65W
M'=R"8-M=TZ8QDXSF@"A+J>M7OBBX\-Z3>6-G+96R3W=R;0MOD8@X5<@ 8(YR
M>M9>I>/M;LM E;R+-=5L]5&GW&Z-O*<'<5=1G(R .N:Z*[\.:A;>+6\1:/+:
M^=<P""[M[DL$?&-K*P!((P!TK$U3X?ZI?:*\0O;1]1N=2&H74KAECR 0$0#)
MP,XR: )-4\0>,='U/1=.N/[%DN=3N)44HD@154+C)SGG=Z=J:=>\:+/KMDS:
M+Y^DQ).TOER8D1E+ !<\'"GOZ?6MCQ'X;U'6-?\ #FI6\]K&-,E:29)-QW!M
MN0N!Z*<9Q4<?AK6#KGB:[GNK-K;5K;R854,'C*J53/&,88YZ]J ([#Q+JNL:
M'X=U&W%E9Q7S,+R6=@1&1D ("RDEF&!UQFLA?'NLS^#(]2M8K)[]-5_L^4.C
M+&V3P0,Y'5>_K3K3P+XBT^#PZ;74-.\[25E3;,KO&=Y/S@<?-@^W0<U#%\/O
M$5MHD^FQ:AICA]574$=D<<CJ".<<A>.>_- &G8^,-3T_7M;TWQ$MHPT^R^W!
M[)&QL'5?F.2>1^M7=+O?&-TVDWTL6F2:?>8>>% R26Z,,J=Q8ANV<#_&H;SP
M9=7WC#5M1FG@_L_4=/-BR L)$! YZ8/(]:/#>@>+-*2ST^]UFR?2[0_*88CY
MTBC[J$G@+Z]^,9[T 8'_  L;7+EH[_3[ W-F]V8_LB6$QD\D$C>)1\A/'3'&
M:]+O)IH=/N)[> S3I$SQPD[=[ 9"Y[9/%<5I/A3Q7H<4FE6&M62:0TS.DCPL
MUQ$C')"_PYZ]>YS[5UVM6$NIZ#?:?!<>3+<0/$LI&=NX8S0!RFD^*-;3Q+I6
ME:NUA,=2M9)%^R(0()4R2C-N8'&T@X[UC1>/O$\FB7.O&TTO^SK*_-M/$"_F
MN"Z@;3T&-PY[^E7],\&^)K._\.SRWFD&+1TDB2&*)URKJ%))[L>IZ<\\YID/
M@'68_ NJ:";FP\^]OA=+(&?:HW*Q'W<YR@_.@#9OM8U?4_$6H:1HS6$<&GP*
MUU)<H9#(S@D( I&. <DY^E4_A#_R3VU_Z[2_^A&K!\-ZYI_B:]U;29].,>HQ
M(+R"<.,R*"-RL <=<U=\">';SPMX:32[V>":1)7=6A!P%/..>ISF@#I:***
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MMQ;RP(46568*-PSQRZ]/?K0!Z-17$ZCK6O\ AB]T>35KJSN[._N%M9Q'"8S
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MG )[D# S[4 <<EUXBFU?Q->2>(95L=%NC,MHEO'^]14+^66QD#&%SSW/6H-
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/#MK>^(K#6Y)[I;FR1DB1) (R&SG(QWSZ]A5$^"=.;3]9LGN;UX=6E\ZXW2
ME6SGY3MXZ <YZ"NEHH Y5_ &F/=VMR+W4XY(+1;/,5SY?F1+T#%0"?PQTIB_
M#K1H])L=/BFOXA8SM/;SI/B6,M]X!L< \<#TKK:S_M]W_;_V :;+]D^S^:;W
M>-F[.-F.N>] %2/PM8Q^([K6_-N7N+JW%O+$\F8V0 #IC.>/7N:SE^'VEK9?
MV<+S4?[+\T2FP,X,/!#8Z;MN1G&>M:GB;73X=T9M1^R/<JLD:,JN%VAF"Y)/
M;)'0'K^-;% &&/"UF-5U+4/M-V7U&W^S31[QY83&!M&.H&<$YZFK6@Z);>'=
M'ATNTDF>WAW;#,P+#))QD =R:TJ* .,N/AEHMPE[";O4X[:[E,SVT=UMB#D@
M[@N,9XQSFKH\$V<=_#?6VHZC;7<=JMHTT4B;I(UQC=E2,\#D8Z5TU% '/77@
MS2[G2;.PW7,1M)O/AN8I,3"0DEFWD'DDDFBT\(V<9NIK^XN-1O+JV-K+<W!&
M[RCG*J%  !S70T4 <58_#33;6.R2;4]4N5L;A9[9)+CY(BK$@!<8],_3M6Q8
M^&(-/\3:AK4%W<@WVTRV^1Y98 C=TSW_ ,]JT/BV6\U@6]AHUS=6"W+6DM\C
M ".1<;LH>=H)QGCH>O&>FH Y[Q-X1M/$CVMRUU<V5]:;OL]U;-M=,^OJ/RJI
M>>!+>[\-7>D/JE^[W;QO-=SR>;(^P@@<]N.E7_#OB:+Q#<:I"EK+;OI]R;:0
M2$'+#J>/<&MV@# G\,"?Q-INMMJ5UYMC 81'\N)<]2W'?O\ 08Q7+>,-&B\.
M^!/$@-[<7#ZI="95=,X=F7@;1Z+U/H/Q](K&A\10S>+;CP]]FG2XAMA<^:P&
MQU) XYSU/Z&@"MI.C6]U>6^NS:G<:F1&?L3RJJ")& R< #+'')(_ 52L_A[8
M0Z/JVEW=W<74&HW)N78X1D?.<@COD#V]JZR66.&,R2R+&@(!9C@<G Y^M/H
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %</\7/\ DG=[_P!=(O\ T,5W%8_B
M+PUI_BBQ2SU'SS"C[]L4I3)]\=: ,:VT?Q!8WMMJDGB&2[M(H9'DM'C$:_ZO
MY<!?O8/J:Y1[=)_A2_BF#4K_ /M?!N&N5N7!$F_:R8Z;1R,8_&O5K.UCLK.&
MUB+F.% BF1RS$ 8Y)Y-<\G@+0XY)!&MTEK)+YTEDMR_V=WR#DIG!&0#CI^%
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MN!SZ ^M4D\ S07>GW%OKD\;VUA_9\C>2I,D7; .0IQCG!Z#KS0!C?VU=>(/
M'A?4KW:;B36;97*C 8K,5S^E:%Q_R7*T_P"P,?\ T-JD@^'MS::'8Z3;Z])]
MFLKU;N(/;*2"&W!2<\C.3^/I6P_AF1_'L?B4WB[$LS;"#R^<9)ZY]230!#X[
MU;5-(T6VFTB6".YFO(H,S)N&')'X<X]:QX_$.M:!XBUVQUBZ2^M[;3/[1AD$
M0CZ84K@9XR#70^+O#]SXCTRWM;6]6T>*ZCG\PQ[_ +ISP/7//X5!/X5EN_%M
MUJUU>+):7.F_8'M_+P<$Y.#Z9R?7F@#G6UGQ%IWA6V\8RZF+JWF6&:XT_P"S
MJJQQL0"$;.<C(ZYJ]X7FN)OB'XJ274IY%C,!2!@,!&4L!TX W8P#[U-:^"[]
M=,CT&\U5+C0H75DC\G$SHI!$;MG:5S[= !Q5ZS\+36'C>]UVVO@MM?1()[<Q
M@DLHP,'L,?CF@"'Q]KVH>'M*L+G3WC5YKZ.!]Z;LJP;./3I5#4]8\1W/Q!G\
M/:5?6EK$M@+E&FMO,(.X CJ/7K^E:WC;PU<^*=)MK2UNXK9X+I+C?(A8$J"
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7367AG4+A+^.P=(3MN9!D1GH#C!R?0>N*YS2=7NK?Q]:Z0U_<W=G=:.ETIG
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %5-0U2RTJ&.6^N4@CDE6%"W\3L<
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M%!=.@W!B. #P/E''K63:7M_+X3T+29;RZ%I=ZO+9SW8F"R"-6.U-W7YL=?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&,9Z]",>E=+<>"M"NM ;1I;0FU:3S6;>3(TG]\N>2WOZ<=*Z"H;N9K>SGF1
M[1QLX5FP"0,XS@XH P!X"\/J]TZ6LJ-=6OV68BX?+)Q[]>!S_P#7JPWA'2'7
M1U,4W_$H.;0B9LKTSDYYZ#_]59VF>)]7U_P=8ZUI6EP-<SW&R2WDFX6,.58@
M\9.!^O?'/74 <;9)J'B3Q99ZCJ.AS:=;Z0)UB,[@F65\+D ?P@ G/0Y&.E=D
M1D8-%<_XG\1R^'Y=)"60N$OKQ+5V+E?*W' /0Y_2@"BOPS\+K#+"MG*(WG%P
M%$[@1N/[N#P,''Y>@JZ?!>DEM8)^U'^U\_:OW[<\YX].N/IQTK7U*Z>QTRZN
MTC61H(FD",VT-@9QG!QTJCX6UL^(_#5GJS0"W-P&/E!MVW#%>N!Z4 4[KP+H
M=WIFGV,D4X73U*VTJ3LLD8/4;LYQ5K0O"NE>'9KF;3HI5EN=OFM),SEL#W/U
M/XUM44 8.N^#])\07<%W=I-'=0J56>WE,;[3V)'4?XFJD/P]\/V^BWNDPPSI
M:WDBR3 3MDE3D<D\#^?>NIHH YW4_!.C:LMD9TG2:SB$45Q#,4EV 8P6')_'
MW]:LZ#X7TOPV;IM-BD1KI]\K22LY8\XZGW/OZUH7U_::9:-=7LZ00*0"[GC)
M. /Q)JS0!C/X8L)/$Z^(6:X^W+'Y0_?'8$P1C;Z<D_7FJ</@30X?#\NB^5,]
MI)/]H!>4ETDX^96Z@\=O4^M=+10!C:?X9L+"ZDNB]S=W+Q^5YMY.TS*G4J"W
M0'O3_#_AVQ\-6)LM/:X\@MN"RS,X7V4'@#J>/6HT\26TFK:A:)&WV;3H]UW>
M$XC1L9V#U8#D^E8EKX\NSJ5C#J7AJ^T^TU"58;6XD93EVZ!E_AS0!T^J:18Z
MU:K;:A LT*R+*%/9E.15?7_#MCXDLXK2_P#.\F*02J(GV'< 0#GVR:EM]7BF
MUFYTF1&BNX4$JJW26(\;U/?!X/H:DU>ZO++2KBXL+(WMTB@QVX?9O.1QGMQS
M0!GZCX3T_4-2741->6EZ(Q$\]I<-$TB#H&(ZU'>>"M&O=#@TAXY4M(9?/'ER
M$,TG/S,W4GDG-;L#R201O+'Y<C*"R9SM..1GOBI* .9U'P)H^IZK/J,SWB3W
M,'D3^5<L@E7 'S8Z\ >U,;P#I7V'2;5+G4(AI3.;:6.X*N-WW@6QT..V*ZFB
M@#D[WX=Z'>ZK-?DWD+7#E[B&"X9(YF/4L!^/3'4UTTEK#+9O:-&/(:,QE!P-
MI&,<=.*AU6^;3-)NKY;=K@V\32>4I + #)Y-&DZ@NJZ/9:BD9C6Z@28(3DJ&
M4''ZT <Q!\--(@%A_IVJR&PF$ML9+K(CP<[0,8 X[#/O5N3P)ITFFZU8M>7_
M )6KS^?.3*I*MG.%RO X'7)KJ** .$\2(ES8P^ X+#493+!"@OFB!BCC5AEF
M;U 7TZD5V\$,=M;QP1*%CC0(J@8  & *DHH Y?7/ 6E:YJPU-YKVTNB%65[2
M?R_-4= W'X<8/%37?@W39_[+:T>?3Y],!6UGM67>JD8*G<&# ^X/?U-=%10!
MS4G@G3Y=$U/37NKPMJ<@DN[O>HFD.0<9VX XQC&,$T__ (0ZT_M;1M2^VWIN
M-)@$$.60B1=I4E\KDD@\XQ7144 <A+\/-.FL]:M'O]0\G6)Q<7 #1\.'W_+\
MG'/KFKLO@^UFU+1;][Z],^D)LAY3#C&#O&WN..,?A7144 <JO@'2S'KD<]Q=
MW$>L/YEPLC)\K D@IA1@C/?/2KEGX6B@O[2\N]2O]1DLU*VPNV3$1(P6&Q%R
M<<9.:WJ* .0/P\TUO#=[H<E_J,EO>7/VF21Y%+A\@G!VXP2/2NJBA,5HD E=
MBB!/,.-QP,9Z8S^&*EHH XZ'X<Z;#H!TA=0U(1"[6]CE$B+)%*.ZD(/U!J]H
MG@^#0]8N-2BU34[F:YC6.<74RR"3:,!B=N<CGOW/:NCK$O/$D%GXLTWP^]O*
MTU]%)(DP(V+M!.#SGL?T_  JCP-HHT_6K+RI#%J\QFN"2,@DY 7C@ \CKR:W
M[6VBLK.&UMT"0PQK'&H[*!@#\JR]$\1)K6HZO9K:30-IMQY#-)C$AYY'MQGZ
M$5M4 <]J7A..\UW^V[+4;O3M1,(@>2W"%9$SGYE93D^_L/2JEUX"M;C24L4U
M.^C/VW[=-< H9)Y,YR_RX..,<8&!P<5UE% " 8 &<^]<3%\-;2VOI6M=;U:V
MT^64S/80S!8RQ;..!]WC&.OO7;T4 <W=^$R=8NM4TK5+C3;B\18[H1HKI)M!
M"M@CAAGJ/RZU O@2RMX=#@LKNX@BTFX-P!A6,['J7)'4\]/4^V-@:P3XE;1_
ML-R +;[1]KV_NC\V-N?6HO#_ (BM_$=O<RV]K=V_V:=K>1;F,(=Z]1P3TH S
M6\#VTUYXAFGOKAX];14EB  \O:" 0>>1GZ>QJ%_ LLFE:-9'7[W_ (E4RRQ.
M(XQD*H55X P  >Y^\<YXQT>KZG'HVDW.HRPSS1VZ&1T@4,Y4=2 2.@YZ]!1I
M&IPZSI%KJ5NDB0W,8D195PP!]10!D:IX3.H^)H]:AU>\LI/LOV25+<+^\CR6
MQD@XY/IVXQUK)'PSMUT"RTY-9OTGL)WEM+Q"%>$-U08[=_7/MQ70Z;XEM-4U
M[4]'BAN([C3BHE:10%;=TVX))_$"MF@#DKGP';WWAJ[TF^U.]NIKIE>2\F8,
M^Y?N@#IM'/'N?6I+_P (W-W/I5W'K]W#?:?&\?VGR8V:0/C.1MVCI@<?XUT[
MR)&NZ1U1>!EC@<\4Z@#B7^&UF=%O-.35+[-S>B^\Y]A991[!0"#R<?3TJ:V\
M#36^K:CJ7_"07DEU?VGV>9WABSG  ;A0.,=,?C784FX;@N1N(R!GG'^30!F^
M'M'_ + T&TTL7!N%ME*+(RA21DD<#ZU3TCPPND^)-7U>.\=_[3*M) 4 "E>A
M!Z]S^=6M U^U\164UU:1SQQQ3O 1,H5MR]3C)X^O-:M 'GFLZ2W@OPOXCOHM
M0NGFU.Y$KS11[3;L[_,PV\X&3^0'>L_PWK=W)KVGV6A^*5UFRW!)[9]-,7E)
MR6?>% '3C)Y)KU.B@#DH/!+P^'];TDZO,ZZK,TSS-$"R%\!AR><@ 5(/!\L>
MK:3J,&LW$,UC:)9R!(UVW$:G."#TS^/:NIHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ KBO'Q26^\-V5[DZ7=:@([E"/D<XRBL?3=V]O:NUJM?:?::G:
MM:WUM'<0,02DBY&1T- '#_8H='^*]G8:7:I;V-]ISO>0Q+A&P6 8@<#G S[^
M]6?A796</@Z*XAMX5N'FF6215&X@2-@$]>@'%=+IOA[2=(5Q8V21F1=CL279
ME]"S$G'MFGZ/HFG:!9FTTNV%O 7+E S-ECU.22: .7O[*SG^,.G-/!"[_P!E
M.Z;U!^=9.",]P,UQ+Z38WFF?$2]N+<27-KJ$S02$G,9WDY7G@\#ZUZ]>Z'IF
MHWUI?7=G'+=6AW02G.4/X=?QJLWA71&AU.$V0$>IOOO%$CCS6SG/7C\,4 >;
MVI3Q1JUO:Z_=VD:C0K9K8WT982-(H+RK\RC=GC(]/:O0_!UI%IWAR&PAU8:I
M':LT2W 4   _=X)Z=.M,OO _AO4[2SM;S3$EBLXQ% #(X*(.@W!LD?4UM6EG
M;6%K':VD$<$$8VI'&N !0!Y/XN&G7&B^+=1LXV>[L]1B7[9<OF1)%9 4B[A5
MYZ]<GT%:-UX?T[7_ (P:A;ZG;-/:2:4DZ#S'0.0R $%2,CK[5U=SX#\,7ES=
MW%QI,4DMVQ:9B[_,QZD#.%/N,5S</A7_ (N7,\FEW<>CIIZVMO-%,R!6&T\,
MK!L8W#ZT <?J5H(?#L=BLDKV%MXI^SVGS,H$1#9 .<G!SSU'//-=2-+MO#/Q
M";3=$B:*RN](EENX?.9P&!;:_P Q)SG _P"!&KWCGPTP\/Z/IN@Z2[PVVHI<
M/'!CA &W$DD$D[JZBT\.:5!!<F.VF#7D6R9Y9Y&E*D?=WLQ9>IX!&* /+(8G
MD^!>DNDA01:@KN!_$//9<?F0?PKIA9V?BKQWXFTW7HU=;2&)+*.1^8D93O=!
MZD[3GMQ73?\ "%^'_P"PTT7["W]GQR^<D/VB3Y7]0=V>YXSBG:KX.T#6KM+K
M4-/66X1=@D$KHQ7T)4C/XYH YAM*T.2]\-:,&N-;ACM)1"K2*8!&#M,KGN1G
M: ,_A@5S@(O/ V@6F9I8[?Q +64K.P\D"4[5SU/RE<8/'%>FZAX2T+5&M&N]
M.C;[(NR (S($7CY<*0".!P>*BB\$^'H+&>RATX1V\\ZW#HDTBXD4Y#*0V5(]
ML4 <?+80^&_&.L:3I,+QZ?=Z#)=3QF5G D#.H?+$GVZ]ZP]+:XO?#G@G17:!
M;"Y6XD<7(;RII%=]J/M(R.X&>2!UKU2'PSI,%M=VZ6\A6[79.[W$CR.N,8WE
MBP'L#W-5I/!'AV;1H-(DTT-8V[F2&,RR9C8]<-NW#KTSB@"GX+T.;PV=0TZ7
M4;>:,NLT-G"6/V56SP-Q+8..,GL?4UA>)--@U/XMZ5I]T]PUI<Z=)YT23NBN
M/FX.".#M7('7 S7<Z1H>FZ%;M!IMHL".<L<EF8^[,23^)KCO$.E3W_Q5TB9[
M&_DL%LFBEN+?>BHQWXRZD8ZCO0!C6:0V>@:SH5U/?S6,.N+96L$+@R2@XQ#E
MB %/?GIG\;BVXM(OB#IL3-:1PVT=S'##.W[MS"78J>O+ 9KLI/!V@RZ1_9<E
MANM/.^T%3*^XR?WB^[<3SUS4:^"/#R2W<BV+A[N'R+AA<RYD3C@_-[#GKU]3
M0!YKXI\-:?8^!=)U1#<RW>H36?VAIYV<-^[/8GW_  [8KJO&-G%X>\0>'O%,
M4;?9;*4VMUEV98XI!M#8[8W'ZY%=1=>&-)O/#PT*:W=M/4 (AF<E<'(PQ.>.
MW/MTK"\1VU[=VZ>$K'0YY-/N%17OYYMZ1IN!8\DL6&.,GK]* (M.\.VVL^%=
M7N+^Y>WBURY:\\V*0H4AR/+!)X/R@$\?Q>U=O&GDP+&I9MBA06.2<#N:R/$6
M@IK'A2ZT2$*B21+''DD!-I!4\<\8!]\5HZ?:#3]-M;,2O*+>)8O,<Y9MH R?
M<XH Y'X8*T_A">6ZB43W-[</<*W.YRV#G/7IC\*LZA#)XG\26)1O+TC1KC[1
M).<8GN ,!4/HN3D^O';B;2=%O-%UC4+"&$/H5\SW(D$VUX)6X9 .NT]01TR:
MIVOPM\,VIMR([N0PN7/F7+$2>S#I@>V/?- $GBA1'XX\(3IE9&GGB+ ]5,>2
M/T%6/B++-!X"U2>WGF@EC1662)RK#YU[BIUTBZU'Q4FK:BJQ0:?OCL85;=OW
M !I']#V '3O6EK6CVVO:1/IEX9!;S@!_+;:W!!Z_A0!PFKSZO#:Z+K1M[S4]
M._LA5O(+>Y*2(S 'SL Y)P#SVP>:[C1[NWN?#UG<V,LEU ;=?*=S\\F!CG/<
MXY]ZS[GP=8SK:B*\U&U:VM1:!K>XVEXAT#9!S_\ 7K9L+"VTRP@L;.(16\"!
M(T'84 >;Z=$?$'PYU+Q!<7]^FK*+F4O#>R*(F0L50(&V@8 &,=#3;5[[Q-K7
MA=;R_P!0M%O-'>2>.WG:/S"#@-QZYSGZ5U[^!]):]NYXY+V"*]8M=6L-PRPS
MDYR67WSS@BK$GA/37\0:?K*^?'-80^1;Q1OMB5,$8V@>C?H* )=2MA9^#[RU
M$DDHAL'C#RMN9L1D9)[FO/%TZZT3PGX5UVSUG4?.=K2.6&2<M$R/CY0G0 #C
MZ5ZM<01W5M+;S+NBE0HZYQD$8-8.E^#-.TQ;5#<7UY%:$-;17<Y=(2 0"J\#
M@$XSG';% '$VT'B#Q=INIZC8WT-O>QZC)&L[7\\2VZ)MPOEJ"AX[GUK:MXY?
M%7BCQ!87NISQ_888([9;.X:-59X]QE 4@MSTR2,5J7/P^T6YU>?4-][$;E@U
MQ;PW!2*8]]RCJ#W%2ZGX%T;4]16^_P!)LYO+$4GV*8PB5!C"MCJ,#'T_"@##
M1)Y_&6F^%KZ_NY[*VTHS&59FA:YE#!=Q96W' SQGK6/K%WJ>E:3XUTF#4;[R
MM/,$UK/YA+1K)@F/>26/7CZ'I7>7WA'2[S["T8GLY[%?+MY[239(B8QMSSD?
M7_&H)?!.ESZ%=Z3)+=M'>2^=<SF;][*V0?F;'L!C':@#G;G1KFT\6>'[6+7]
M8\O4K>87.ZY)W>6BD$9^[G/;TK*FU/4](T_5]'@OYYHQKD%C%)<SD.D4@W,/
M,P2/3/) )(YKT"7PO9S:CI-\]S>>;I<?EP#SN",8);CDD 9]<54D\":-<0ZO
M%<BXGCU2;SYA)+GRY 20R'&5QG'T '2@#&MM$\5:='KD<5];1_;+8_8+7[?+
M.T4H !*O(H.#G\"13O EW ^JW-K/%JUCJL5J@GL;V=Y4;#',J%B<Y) [#TK7
MM? VF6UC=VQNM1G-S%Y)FGN2\D:=<(3]T?A5_3_#UO8ZHVIO<W5U>&V6U$MP
MX)$8.['R@9YYR<GWH POB!<W5N^A@-=+IDEZ%OC:LRN5QD<I\V."3CT[5RW]
MKZUH'A?Q/J,4VH26AN1;:7)<NQV(2<R#?S@9')[_ $K;^)#.+W2GN8M733(%
MEDDNM,)WI(0%4'TZGGWQ1X6T>75-/U"POWUNYT2YMT5!JX"R;]S$E<'.,;3D
M]Z )M&T#Q!8ZY]HFU6./3;N!XVC_ +2DN7:0@E7C+HH!'MV!KE!=:IIWA#PY
MXF_MK4;B[DU'R9(I9R8G0NXP5_X!^IKO]%\"Z?HCEX[W4;AU1HX#<7!86ZD8
M_=CH#CC-5C\.M/;PU:Z&^H7[6]M<_:5;>NXMD^W Y/3U)H YV[M_$?B_5]=_
MLZ]%J]A>?9[<F_DA$04+R8U0ALX)R3W]!4VJ/K&H>,M#T)M?N(([K2V-S)8R
M#:[@,"RDCOCKCZ8K?U/X>Z;J.L2ZE'>ZC8S3@"X%G/Y8FP,<X'7UJRG@NQA\
M1:=J]M// ;"W^S16Z;?+V8([C/.>: .6U^]N=.@\0QVVNZC=76FV5OY8C)46
MY  +2-PK,YR<<\ TXW<NI?$'P%J$JD-=:9)*WIN:%F(_6M[4/A[IVH:CJET;
M_4($U-5%S!!*%1R.A.0?R]ZG@\$VT%[H-T-0OF;1H3#"A==K KMYX]...P H
M R]%M9[W4O'-M;7+VT\EVJQS(>4;RQ@UF>&]5OO$-MHFBW&H7*:G87<TNJ8F
M(DVQ$@*WJ"S(/HIKHETRV\%/K?B)[K4KU+IEDG@55<@YQE0 .F?7H/85'X)L
M(YKS6/$HLGM?[6G#0QR)M?R@HPQ'0%FW-^/4T :GC"Z-GX5OIEU+^S6" +=;
M2Q3YAT Y)(R./6N<TJ]N[CQUJV@+?7RV4FF)/$9G;SH7.T9!;D'YLX/<5U/B
M/P_9^)M&ETR],BQN0RO&<,C#H1_]>LS3/!$.F>((];&KZE<7GE&&9IW5A,O&
M ?EX P#QZ4 <[HNK:GJ5OI_AR?4;A-:LM2=;YDD)=[= S;B>,*=R*/\ (J#Q
M5KE[9:?KVJ66N3S3V5]"D:0ADAA4, 8C_"['//7M7?VV@:?:Z_>:U%"!>W<:
M1R/[+Z?7C/\ NBN9OOAAIUX-1B74]1AM;Z;[0]M'(OEB3();!'/3O0!;2^OC
M\3K>U:[<V4NCF<6XX57\P#/N:R;">2V\(^*I8M1&G,-:NA]IV;B@,H!"CNQ!
MP/<BNCMO"BV_B&TUEM3O)I[:T^R;9"N'7U. .<X/X54'@6W.A:II<VIWDJ:A
M<_:GE.T,DFX.2N!@9(':@#!N;N_AO?%NE2W-W)8?V$;F!;HY928R"03R.<Y!
M[BJ$9UKPSX2\-:]'K5Y=)(+6)[#8IC,3J,*J@#Y@,#.<GUKJ[3P%#!J4U[<Z
MQJ=ZUQ:-:7"7$@(E0@C!P,CKV(YJ73?!:V<-C;76KWM_8V)5K>UG6,(K+]TD
MA0QQG@$XZ>E '(2ZS)H'BGXAZI#&7E@AM_+ 7=\Q4*"1Z G)]@:V="M?%L7B
M#3;EY+F;2Y+?%VUQ=I(K,5W!T7 *G.!C%;,7@NV&J:W>W%]<W"ZO$8IX7"[5
M7HH7 SP.!^N34>A^"(]'DMO,UC4KZ"U.;>WN)1Y<9Y . .<9XSTH A^)$3R^
M'K4)<S0C^T+<,(FV[P7 P?S!^H%-N);K4_'!T'^U[FVM;.Q6=DB=4EG=F(W;
M@,X QD#C)%;WB#0XO$.DM833S0 R)(LL) 965@01GW%9][X2:ZU"RU./6+RW
MU.VMS;M=QK&3,AY^92I7KSP/Z4 5/!6HZC)>ZYHVI7#73Z7<A(KB3&]XV!*[
ML=P!UZ\U5@LS-\9+RX-S./(TR,J@;Y<,V",'MQG'KS71:!X?AT""Y5+B:YGN
MIVN+BXFQND<]\  #\!5>?PO')XMC\10W]S;W A$$D:!"DB YP=P)&>.G- '
M3R:SIGAKQ+K>FZK<1?8];N&6UCB0HW[X!BY()(P3QP.*NZIJWB7Q-K6H66B-
M>0K86\) MIXX@970ME]XR5SQ@'MGO71KX%4>&-5T1M7NW34)VG>9E7<K,P8]
MN<XYS[]*2[\""6^COK+7-0L+O[-';SRV^T&<(,!F&.N/3CIQ0!OZ%_:7]A60
MU@*-1$0%QM((+C@GCCGKQQS6A5/3--ATJPCM("[*N2SR,6>1CRS,3U).2:N4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M.",8QUSQGT/?%87Q1MTN/^$92:/?;MJ\22Y'R[3Q@_7FDUW3M-U3XH:-I=S
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MXOM=C(5EL&"J>F<+DMNY_O#GL=NP:SN_B5XBM7<O#=Z9#)MW':R$ ,WMP5H
MW/%GB9_#,&G2K9BY%W>):G,FS9N!.>ASTK:%Y;&^:R$R_:5C$IC[["2 ?S!K
MRNV*S?!G0'E(DD6_B*L_)!^TD<>^"?PK>@L=-?XS7LDL6;P:?'-"<MUR58^G
M3:* .]HKB_B+?SVMKHUFKM':7^HQ6]Y(&*_NB>5W=@1_*J_]D6WASXAZ3#I<
MDL-MJD$ZW-KYA9/W:@JPSR#DG\OK0!J6/B;4M4U62.PTB.73(KY[.6Z-SAU*
M#YFV;<%<\#GGBNHK@OAIIFF16^JWEE'D)J=S#!)O8_NMPQU// '/6KWB..WO
MO&6A6$\]W(IBG=K*)<1R*1MWNV1C&3@<\^G< Z^JVH7$MIIUS<PV[7$L43.D
M*G!<@9 'UKFOAO<2S>%/+EDD<6]U-!&7;<0BMA1GKP..:QHX4\4ZSXLEU-9T
M?32UM9Q&1PL0"G]X%7&2Q&<^A YH W],\4W^K^&M'U>ST8S&^GV31+./W$>Y
M@7R0,XVCCCK745XPMS<6OPL\%-;W$T)?5%1_+<KN4R2'!QUY K8\3YTKQ9=:
MEKMM>W.D,\+VUW9RL38,N,AE' #'D^O% 'I]86H>();+Q9I6B+8F1+^.5S/Y
M@&S8,D;>_;\^]<Q!80>-]5\2IJ-W,LMG-]FLUCD91;)MR) H(R2<G)],=*=<
M.ECXS\#1/?-?_P"BW$(N@0WFG8HW9SWQ[T >A45Y5HNG#QCX>U;Q#?7-S'K$
M4TZV\J7+HMOL7* *#@ =^.>:AN=1U&\TK1]=UJUN=1TN33RMTMD[1O;OD_OB
MJD Y&>>,<T >MT5P%A/#-XZ\/2V-]=3V5QH;!3+*27"D89O]OGD^HKGKE[FS
M^'/BPV]_>QR66OR)#*)VWA?,C7!;KC#$_6@#V"BO--6TZ>Q\1Z9X7MK^[N+?
M4!/=3&[OG5Y&"8"[T&0HQG:.O-=)X.TO4]%BOK'4=0BND$HDMT$S2/#&W16+
M<XXX^AH L6WB9;CQK>>&S:.C6UJMQYY<$."0,8[?>'Y&M^O,;G25UKXQZK:O
M>WMHO]EHQ>SF\MSADXSCI_A68IUS5_ 6K"'4+Y[O0M0DCAD2=UDGA3&58J1N
M.,^_% 'L-0SW=O:F(3S)&9G$<88\NQZ >]<GX>O3XF\2-K-O<R_V=:V<4*1+
M,=C3.N]BR@X)4,%Y[_2J_C[3[>_UWPDLXDP;]DRDC(0"N>"""#E1S0!OV7B6
M"]\5:AH"V\J3V4:2-(Q&U@P!&,'WK;KRJXTS^TOB=XKB^W7MH(["%]UI+Y;-
MA$(!.,XXJCI&OZSKFE^$]*:X=S<Q7#S$W;0/<>6Q")Y@!8'Y<D]30!['7+:U
MXR;2/$=MHB:-=W=S=1EX#$Z . "6ZD8Q@]:/!5AJ^EP7]GJ]TDQ%P9;=#<F>
M2*-NBLS $].#CUK"\6QW<OQ6\+)8W$4%R;>XV22Q&15^1LY4$9XR.M '3Z1X
MCN=1U0V-WH=[IS^2TRM<%"& 900-I//S"M^N6TVQ\0C5-4M]<U6*:SNH56T:
MV'DLIP=^U<D@C@YR?7Z<GX5^V/XS.@:CK5W)%I4DLMK)YS@WQW#AB3A@G0J.
M^>P- 'JM%>3;?%/BZ_U:^TZYEMY;.^:VMMNH&*.((1]^((=^>3DD=?05NHEY
MXI\2ZKI=_J4EJ-/M81'%8SM&3+)&&:3((+ '@ \=* .\IDLT5O"\TTB1Q("S
MN[ *H'4DGH*XN,:EIOBCPE9W.KRWCRVUW'<L#A)60*0=OJ"<9]NW-<MXAN+N
M/P;X\M9+VXGC@U&-8C+(6**SH2H/ISC% 'I]WJC6U_IUO'97%S%>LP-Q" 4A
MP,@L?0]C[5HUPFH27FF3>!X;2]G2VDF$,T;,6,H,8(R3R<8/Y^U5]3U:?PG\
M0;B2_O[B33-2L7>".1SM29.=J]LD<#I]X#TH ]#HKRMUUW[9H_@XW=V[_P!F
M?;+N07IBFDE+'Y?,*L=H(QQV^G/;>$K;7+/1WM]?N(I[E)F$;H^\^5@;0QP,
MMUYQTQ0!?BU,RZY/IOV*Z40PK(;IDQ$Q)^Z#W-7ZXRSU/4)?BOJNDO>2FR33
MEECBPN$<E!D<>YZYZUQMAK&OS^"H?$4FOWK7$.IK!Y1">6R%@O(V\\,: /9:
M*CN(C/;2Q+*\3.A42)C<A(QD9[BO-=/U/5[S3?\ A'+K5IQKT>KB&26-U\P0
M+ARX _AV\=,9(H [ZWU0W&M7NG?8KJ-;5$;[2Z8BD+#.%/<CO6A7GTGB'4[3
MQCXPA%RTEOIVF"XMX7 VJXB#9_$U5U.]UG2? FG^+8=<NYY]EO<7%O*$,4@D
MVAE"A1CEO7C% '8VGB6UN_%5[X?6"=+JTA$S.X&UE)'3G/<5M5YS83[_ (M:
M[<1RK!NT9'624<)PA!89Z#OS2Z-JM^-7\+QC6;K4([UKI+J9H]D,Q1"P,8(!
MP#C##@XH [J]OTL]/NKI(WN3;(S-% -SD@9V@>O3CWI=-O5U+3+:]6*2);B)
M9!'*,,N1G!'K7G/@DWJ^$/%M]'?3I=B\NMA?#!&5%(;!YSVY/85;@UO5-2A\
M&:9_:4EL^I6IN+JY0J))-J [5R" 230!Z+17F&I:WK6BZEXET,:K/.(-+;4+
M2YD5?,A((RI.,-G/7M4UA>>(]/U_PF]UJ\]Y;:O ?M"21H$1O+# +@ Y_P#K
MT >DT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %<5\2=&U'7=+TRVT_3C>^5?I<3)
MYB*-BJP(^<C.=U=K3)9HK>%YII$CB0%F=V "@=22>E &;I.@:5ID;O9Z;';/
M<(!*#\S8_NDY/ ] <51B\ ^%(6#1Z%:!@XD!*DD$=.O;VZ&MJUU&QOH7FM+V
MWN(D.'>*575>_)!XKF/#OB#6_$<\>H6BZ;_8K7$L3(=WGJB\*V=V,D]L# (Z
M]: -:\\):#?ZA)?76FQ2W,F/,=B?GP,#(S@\>HJQ>Z!I6HSV<UW91RO9$-;9
M) B((/ !QV'Y4^36K"+6X-':X7[=-$TJQ9YVC'7ZYX^A]*P_#?BUM3O-:M]2
M-I;"QU V4+AMHD.2!]X_>)'04 ;46@Z9!JMQJ<=HJWERNV:7<?W@]",X/056
MTSPCX?T:^-[I^E6]O<D%?,0'(!ZXST_"M.ZO+6QA\Z[N8;>+.-\KA%SZ9-3T
M 5K_ $^TU2RDL[ZWCN+:08>.09!JEIGAC1=&N6N=/T^.&=D\LR ECMSG ))P
M*TIKB"WC,DTT<: @%G8 9)P!S[D"GD@=2* ,)?!?AQ+.XLUTF!;>X8-+&N0K
M$'(XSQSV%6CX=TEK^TOC9J;FTC$4$A9B8T (P.<=S5U[VUBMTN)+F%(7QMD:
M0!6STP>ASD8J;< ,Y% &%:>"_#=AJ*ZA:Z/;172L760 _*3W S@5;TSP_IFC
MW5Y<V-MY,MY(9)R'8AV)SG!..Y_,U?DE"YC1D,VPLJ%L$X_IDC\ZJ:1)J+Z5
M"^L);17QSYBVY)0<G&"?;% ":QHFGZ_8_8M3MQ/!N#A=Q&&'0@CZFHD\-:3'
MJEIJ2V@%W:6XMH)-[?)'@C'7G@GD^M2:S-JL5DC:-!;3W!E4,+ARJB//S$8[
M^GUK0) ZD"@#GCX%\.MI1TUK$M:FZ^UE6E<GS>F[=G/3BH7^'?A=X;J(:9M2
MYQYH69QG!!]?4"NGR,9R,4 @]"#0!CMX5TAM3T[43;N;K3XO*MY#*QVK@C!Y
MYZGK5C6M#T[Q!8?8M3MQ-#N#@9(*L.A!'(/7IZUH @]"#6#XCUZYT2]T2.*U
M26'4+Y+21V;'E[NA []#^5 %;_A7?A<"Y"Z;M^TQB.7$K\@,&]>#D#GK6KIF
M@6&DW$MQ;K,]Q*H1IKB9YGVCHNYB2![5I @]#F@$'H0: ,76?"6BZ_>V]YJ-
MJTD]N-J.LK)QG.#@C(_QJ?1/#VE^'89H=+MO(CFD,CKO9N?Q/%:>0>A% (/0
M@T 95OX<TZV\07&N1),+^X79*YF<JPXP-N<<8':L^?X?^&;G59-1ETQ6GE??
M(N]A&[>I0'!YYZ=:Z7(SC(SZ5S>N^(KVTURUT32;2WN+^>W>XQ/*44*IQC@$
MY)SR>.* )[_P=H^I7-U-<I<_Z6RM<1)=2)'*5  W(&P> .W:DU7P7H.M:BE_
M?6.^X5 A9)&3<HZ!@I&1]:V+&2XEL;=[R)8;IHU,T2MN".1R >^#4Y..M '-
MR^!/#\NEVVF_99([2VF-Q%''.Z[9#_%D'.1GCTJU=>%-'O->M]:GMV:_MPJI
M()6'"G(R <'GUK:R",YXHR* *6K:18ZYI\ECJ, FMWP2I)'(Z$$<@U5L/#6G
M:=>F]C%Q+=&+REFN;AYF1.N%+D[1]*74-<2TU:STJW@-S?7'SF,-M$<(.&D8
M^@[#J36!XA\8:]HLLUU'X8>31[9\2W;W"JS+D L$^\!G/4<]: .@T/P[IWAR
M":#34ECBE?S&1YF<;NY ).,^U,U;PQI6MWUI>WT$C7%K_JI(YGC(Y!_A(SR*
M6^U^+3M0TZ&XA9;6_/EQW6>%E/*HP[;AG!]1BM>@#*T+P[IOANWF@TN%X8II
M/-9&E9QNQC(R3CH/RJM?>#M&O]2N-0>*XBNKF/RIWM[F2+S5]&"D9[=?2MZB
M@#FW\": ^D6>E_9IEM+.4S0HEQ(I5S_%D')/)QZ59O?">E:@U[]H2=DOG62Y
MB6X=4D*@ 94''11]<5MT4 <YJG@3P]J^H&^NK)OM#*%=HIGCW@<#<%(SQQS5
MBZ\*:9=:OI>I%98Y-,4I;1Q/MC4?[M;=8_BC6W\.^';O54MA<_9P"8S)LR"0
M.N#ZT 4KCP-I4]U<RQS7UK#=L7NK6VN6CAG)&"64>HZXQFGWW@W3[R9WCN+R
MS22U6SDAM90D;Q*" I4@C@$@8Q@&MC3;S^T-+M+W9L^T0)+LSG;N4'&?QJU0
M!SEYX*TF[_LLHUW:/ID?DV\EK<-&XCQC:6'.,?CUYJM/\.M"FTFZTU?M<4%U
M<BYEV3DL7'NV>*ZRB@#!USPAIGB&PMK6_-P6MA^ZN$E(E'&"=W?('.:L:!X<
MT[PW9M;Z?&_SD&265M\DA'3+'^7055T[Q)+>^+M2T&337@^Q1K*+CS0RR*V,
M< <9Y[]C704 8-_X3L[S7!K,5U>V5^8O)>6UE"^8GHP((/2JVHSP^#]*@M=.
MT&\U".XD8,ENN]B[<EI">3N]36_?SS6VGW$]M;&ZGCC9D@5MID('"@]LTFGW
M$]WIUO<7-JUK/)&&>!FW&,G^$GO0!E^#M$'A[PM96!C$<P7S)E&#^\;DC(ZX
MSCZ 5)XA\-67B2&U2[EN87M91-#+;2['1L=0:V:BDN8(9X89)5668D1J3RQ
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M4G\S1$V(2@;SA@ [L].!C\:ZJB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"0^?*L,08\N[' 4#UJJ+G5O^$F-J;*+^R/LN\7.[Y_-W8VX],>U>1Z?$FI>
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M.U&*$-@D@<$=NV:T]4T;4/"'@KQ'%'J\:QM''+;6ML[@VN9 "5+,6 //?UH
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M!)I]]G?:';C )))!.3G- '5T444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5'
M4]&TW6H4AU*RANHT;<JRKD XQD5>J*YNK>SMVN+J>*"%/O22N%4?4GB@#%B\
M$>%X)DECT*Q5T8,I\H<$=*OC0]*$5Y$-/M_+O6+7*^6,2GU;UJ2'5M-N+.2\
MAU"UDM8\[YTF4HN.N6!P*:NM:4T[0+J=F9E7>T8G7<%]2,].10!!-X9T2XTV
M'3I=+M7LX#NBA,8VH?;\ZD;0-(?2UTQM,M38K]V Q#:/<#U]ZEAU;3;BS>\A
MU"TDM8\AYDF4HN/5@<"BWU;3;JY:VM]0M)IU&3%',K,!] <T 1P:'I5MILFF
MPZ=;1V4@(>!8P%;/J.]1V7AO1--DADLM*M()(2QC>.( J6&&P?<<5D>$/$=]
MK%WX@@U$6Z_V;?/ C1 J-H)ZY/MUK>L]8TS479+'4;.Z91EE@G5R/K@T 5QX
M9T,17D0TJU"7AW7"B,#S3G//X\U;M]-LK73AIT%M''9A2@A5?EVG.1C\321:
MKIT]M-<PW]K)! 2)94F4K'CD[B#@8]Z>;ZT6(2FZ@$93S YD&-O][/I[T (^
MGV<FG_8'MHFM-@C\EE!3:.@Q5?3-!TG1=_\ 9NG6UJ7^\8HP"?QJ0ZOI@AAF
M.HV@BG;;$YG7;(?13GD_2I+O4+*P1'O+RWME<X4S2J@8^@R>: )I8HYX7AE1
M7CD4JZ,,A@>""*A.G69DM9#:Q;[0$6YV#]T",$+Z<<5*UQ"@4M-&NX97+ 9'
MJ*H7GB#2[+1)]7>\ADLH5),D4BN&(XV@@X)SQCUH EN-&TZZU&#4)[.*2\@_
MU4S#+)]/2H7\.:-)<7=P^FVQFNU*W#E!F0'J#5ZUNH;VUBN;>19(95#(ZL""
M#[BFG4+(),YNX-D'^M;S!B/O\W/'XT 4_P#A'-'VV2C3H +'/V4!<>3SGY?2
MH+CPAX?NKYKV?2;9[AV+NVW[Y/=AT/XUJF[MA+%#]HA$LREHD+C+@=2!W'TK
M"77WT+PY]O\ %%Q9K()C&6L\LARV% SSG'7Z4 :&K>'M(UP0?VG80W/D-NB+
MCE?R[<#CI4;^%M!>PN['^RK5;:[(:>.--@<CH>,8([8Z5G:EX@O[3QKI&FQ)
M:OIEY;R2/*7PZE.ISTQROYGTKIHY8YDWQNKKZJ<B@".UM+>QM([6UA2*",;4
MC4< 5A-X!\+-#)$=%MMDC^8W7.[V.<CZ"M-];TZ/6DT=KE!?/$9A%_LY Z_4
M\"L;PCXFN]:M=0?5([6V>VO7M4\MSM?;C/4^M &E_P (OHOGZC,+%1)J,?E7
M3!V'F+C&.O''IBKFFZ;::1I\5A8P^3;0C")N+8&<]22>]3RSPP8\V6.//3>P
M&:>K*ZAE(*D9!!R"* ,.]\&Z!J-]+>7.GAIIL>:5E=%EP<C>JD!NW4&K&H>'
M-)U22WENK7][;#;#)#(\31C&, H00/:L2?Q7J6I>(;O1O#=C;3FQ*K=W=W(5
MCC8D_* O+'@_B#3M/UWQ%%XPBT76;*P$,]O)-%/:,Y^Z0.=WUZ>XYH U7\*:
M))HDFC-8)]@E</)$'8%VR#N9@=Q.0.2<G%,D\(:%+)IKO8[FTT!;0^=)^Z .
M1_%ST[YK72YMY)/+2>-G'\*N"?RI7GACW;Y47;C.Y@,9Z4 >776@W-SXBU.?
M5O!5QJ$]Q=92Z@OS%&8P J<!AC@#.>^:ZVU\$:7/I6F1:Q:B\N;)"$DDE8LH
M))V%AC<HSCGTZ5TIEC$@C+J)",A<\D?2B2:*(9DE1!G&68#F@#!'@;PV-+ET
MT:8HLY)Q<-$)7'[P#&X'=D<>F!5D^%M&.K6NJ_8R+VUC6*&197&U , 8!P1@
MGJ*UF=% +,H!X&3UHWJ5#;AM;&#G@YH P[CP7X?N;B>:6P.9Y!+-&L\BQR,,
M'+1A@IZ=QS5Q] TQ]:@U@VN+^"'R(Y5D9=L?/R[0=I'S'M_(5?66-]VR1&V'
M#8.=I]Z3SXA%YIE3R_[^X8_.@"EH^AZ=H%K);:9;^1#)*9G!D9R7( )RQ)["
MH-0\+:/J>HC4+FU?[8$\OSX9Y(F*^A*,,_C2^*-5N-#\,W^IVL4<LUM'O5)2
M0IY&<X]LU/HFI?VMHEA?,JQRW-M'.T:MG;N4'\J *MWX3T.]T6'1Y[!3I\+[
MT@21T ///RD$]3UK7BC6&)(DSM10HW,6.!ZD\G\:&EC5U1G4.WW5)Y/TI] '
M.0^ _#-OJ0U"'2D2Y$OG B1]H?.<[-VW]*EO_!^C:CJ,E_+#/'<RX$SV]S)%
MYR@8"L%89'Z\"MZB@#%G\*:-<3Z9*UGL.F'-HL4C(L?X XZ@9]<<U&O@[1UE
MUB013YU?_C[ N'&[KP,'@<G\R.G%;U% '.W7@K1[SPQ;^'Y5N/L5OM,>)FW@
MCOGOW[8YXQ3]5\'Z5J]Y;WDOVJ&ZA01B>WN'C=HQ_ Q!Y'/U]ZWZ* .;?P%X
M:;13I T[;9^<9PHF<E9",;@Q.0<?A[4V+P%H,&@W6D102I#=JJSR^83*^T@C
MYCG'(Z#CD\5TU% '/GP=I1O]'O,W/FZ3%Y5M^^.-N,?-Z_U^E0+X#T9(=6A4
MW@CU0LTZ"Y8!2QR=H' S[YZ8Z5T]% '+R^ -$F@TJ,_:T;3%V02QW#+(4[J6
M'./IC&>,57D^&GA]M-N=/C^VPVUQ.L[HETV-P! '.>.<\\YQSP*["B@##D\*
MV$OB"PUIY;HW-C%Y4*F8E0,$'/<DYYYYJD^DVW@^'5-7TC3[Z]FN9/,>RAER
MN6;YBB=!Z]"> !Q74T4 <QX.TJ6U34M6N[06EYJMT;AX,#,2=%4^_4GW8U!\
M3(+B\\"WME:6ES=3W#Q*D=O$7/$BL2<=!A3S]*ZZB@#G=%\,V-K<0:GYVHW$
MXMQ'#]OD):!#U 4@;3Z_2ETOP?8:1I%_IEO=7[07H;S#+/N92P(8J<<$YYKH
M:* .93P)I$>@6VCAKLPVLIFMIO.Q+"V<_*P''4\>]/7P7IPM]122XOIIM0B\
MF>ZEGW2^7_<!QP/P[UT=% %#1=(M]"TBWTVU>5H( 0AE;<V"2<9_&JEWX8L+
MOQ';:Z7N(KV!/+S#)L$BYSA@.H]JVJ* .7D\!Z4[W2I/?PVEW*99[.*X*PR$
M\M\O8'N 1[8KI888[>"."&-8XHU"(BC 50,  >E/HH Y5O &DMHMYI!N+_['
M=S>=(GG]&SNP!C &<'IVJW+X0TZXU33;^XDN9I=/@,$*.XV%2"IW+CDD'GZ"
MM^B@#D[7X>:+97L<\,E\((YO.2R-R3;ALY'R>@//X5T.IZ;::QIL^GWT0EMI
MUVNI./U[&K=% ')6'@"QM+^PO)M2U.[ET]C]E$\^1&I&-O Z8_.J;?"[2393
M6:W^II;/<_:8HEG^6%_]D$>YY/-=S10!SQ\(V;:_?:J]U=LM]"L-S:EQY4H"
M%!N&,G@GOUJCI/P\T_2=0BN$U'4YX8'#V]I-<DPQ$9QA>^,\?2NOHH R/$OA
M^#Q/HDNE7,\T,4K*S-"0#\IR!R.F15.3P?;RZ_I.L&_N_M&F0>1&N5VN-I!+
M<=2"<XQ^%='10!R-KX"BM+"[MH]9U(O/>+>B8LI>.4=Q\N#GC.1V%:FB^'(=
M'O+V^>ZGO+Z]V^?<3! 6"C  "@ 5M44 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5POQ$N/L][X::>X>WL?M_[Z8(K+&=N%9MP*\$GK[GM7=5#=6EM?6S
MVUW;Q7$#_>CE0,K?4'@T >5:MINCZ?X3\7/IFLMJ4UU%'-<&,(8E;?Q@H H8
M\\5'<Z;I:ZY\.D6RLPES;$S@1+B4^6GWN/FYSUKT]="TA-/>P32K);-VW-;B
MW01L?4KC!/ _*D;0-'9[9VTFQ+6H MV-NF8@#D;>/EP>>* /++Q;<V/Q(TR.
M"!+2W:*>&.-0H5L=@.."HK9O].T6VUOP3-HL%LER9P"UIC+0^7\Q;;U'(Y/K
M6]XM\.H_AK58]"T2U?4;]/+=HA'"[[CDL6.,^N">:U=#T+3].LXI(]&L;&[>
M$)/]GB3/N-P W#- 'DU^UW_PCOQ :S+;?[9_?%.OE>8<_ATS[9[9KL];@TE_
M$GA"]T8V_P!J-SY:_9=N&MO+8MP/X0,?]]&NOMM#TBSAGBM=+LH([@;9DB@5
M1(.>& '/4]?6H]/\/:-I$\D^G:79VLTF=SQ0JIQQQD=!P.!Q0!YW?64VD>(-
M5\&62,MOXB*W%O(JC$()Q."3_L*V/JM7M0T_3W^,VF6<EK;O;C1]ODN@9>&?
M'!]@*Z32M*U6ZUU=:UV*SBN((#;V\5J[. &(+,20.3@#&/7UK7?1=,EU5-4>
MPMVOT7:MP8P7 ^O^>_K0!XY'86+> O'$AM+<RVVI2+"QC7=$N]>%./E'7I5V
M)+;6_$$T/B+5HK%&TFU%NUQ%$1*C1@NRM(" =Q/W<'\J].7POH*65U9II%FM
MO='=/&L0 <]B?IV].U+>>&=#OX;6&[TFSFCM<"!6B&(P.P]O;I0!YK>:?I9U
MSP%I\5T=2TZ.2ZB66?!$@4@ <<$ C [$#O4ES#80^&?B'I]M'"J07/F+"H&$
M!5<$#MR&_*O2[C0M)NI+)YM/MG:Q(-KF,?N<8QM].@_(>E1)X:T6,:@$TV!1
MJ/\ Q]@+Q+UZC\3^= %C2&M6TBT^QF$P")0GDD;<8'3'%>9ZWHZZ;XEUOP_;
MP((O$\*/:83(296^?.!P!DO^ Q7J%AIUGI5G'9V%M%;V\?W8XUP![_7WITME
M:SW=O=2V\;W%MN\F1ERT>X8;![9'% 'GG@$/K-W9M=V_ER>'+5M/)*#YIB=I
MP>H 1!^+'IWYC4TB3X,7"1[=B:PZJ <X'F''Z5[1!I]G;)<)#;11I<R-+,JJ
M )';[Q;U)[UGV_A/0;72KC3(=*MULKAMTL.W(<\8)SZ8&/2@#EO%5OIE_P#$
M/PC;W*I- 4N"D:@,C$ 8!']W@_E4OP]VV^O>+].@C2.UM]1W1(@P%W9! ]OE
M%=+'X4T&&>QFCTJV66Q7;;,%YC&2>/Q)//<DU8T_0],TJYNKFQLXX9KIM\[K
MG+G)/.?J: ..>&(_'$/<1H1_9(:%I%'W]X&5SWZ]*XUM*L;KP=XYOIK9'NK?
M59##*?O)\PZ?F:]CN]#TN_U*UU"ZL89;RU_U,S+\R<Y&/H>?:J@\(: MI=VJ
MZ7"MO>.))XQD!V!R">?4T >=HK^)/$<MGJ5]9P32:);?9#=VJRJ0Z!I&4%AA
MLD]/Z<]]X)MK>Q\+6UC:ZE_:,5JSP_:0NT,0QR!UX'3J>E2WG@WP[J$5M%=:
M1;2);1^7"-N-J^F1V_\ K^M:UK:6]C;1VUI!'!!&,)'&H55'L!0!YY\/671O
M$OB?1K^?;>O>>?&93M,Z,3AAD\]C^-=-XMU98?#^K1:?=(=4BLI)$CB(:15&
M 6P.1S_GBK^K>'-'UQXI-2T^"YDB^X[##+[ CG%+I?A[2-%$PT[3X+<S']ZR
MKEG^I/)'M0!YQKUCI=E\/]!UCP[:P"^2>W-O-$/G=S]Y6/5CGJ#39-$TW4O&
M_CM;RU69;>V2:(,3A7,>2>OK7?V?@WP[874=S:Z1;1RQMO0X)"-Z@'@'W%3C
MPQHHNKZZ%A'Y]\C1W+Y.95;J#S[4 >616FFZ=X6\$>(K=)6OGU"&*>X\QM[K
M\X9>3TRN/H*W;'PKH>L>,_&,&IV_FQQ20LF^9OW>^,LS#GCG\J[$^#] -C;6
M7]FQBWMI#+"@9AY;GJ1SUKD].\-IJOCSQ#=:UX>N?(G=%MYY'PFU%VD\,"=V
M > : ,KP[-I]W8^$;'5A+<W6VY:*.>0+"(=S*'8$?,=H^7U]:RK)8]2^'.BV
MMPW[J/Q$MJ"K$$1LQ)&?Q_05ZQJ'A+0-5^S_ &W2K:;[,@CA!7 11T48[>U0
M?\(/X9$+1+HULD;2B8J@*_..AX/;)QZ4 <[H^AZ=8?$77=)M(C%8W6EHTL"N
M=NYF*G\<?S-86C6XN/*^'=Y;L38:DTTC$D![9<R*3QSDD#''4>]>BWFDVUA>
M7?B"PTO[5K!@\O:)MAF QA<G@=!SCM5+PS9W]UJ%YXBU>Q%C>7:)!#:[PYAA
M7GYB,9)8D^W ]J )/'W_ "(6M?\ 7JU<#)H\.BZ/X&UW24E35+F6U@D;S&82
M*\9)!!/U QT''I7KL\$5S;R03('BD4HZGH0>"*Q]-\(Z+I4T$MM:N6M\^1YL
MSR"'.<[ Q(7J>GK0!YE::"/%%M?:S=^(+*QN8+^5FG> F6+8V1\WF  8QQMZ
M5O\ B0/=^)[])K&XU2TO=* L1;'<T#9SDC(VY.#GK\OUQT]SX"\,7>L'5+C2
M()+ICEMV=C'U*9VD_A7':]H4MUXXU*[U7PI?ZE#*(ELI[*YV!5"X.[##&3Z]
M,>G- %M-+T_1=/\ "&BZC'.^HO,9?LR2@QRR;?G,FX\@9XQZ8[US4KR2_#WQ
M'9F658;77O*@"O@QH9%& ?3D]>*[G3/ .GW6A6]MKED6>&=Y[>+[2SM:JQXC
M$@.6'&3VS^=7G^'OAAK6YMAINR&Y96E5)G7<1T[^HS0!C:1H]MX>^)Z6>GO.
M(+G26FE269I-SB0#.237?(Z2+N1E9?53D5EGPWI1UF#5C;L;V"#[.DAD8_)@
MC!&<'J>M3:-HMAH%A]BTV#R;?>S[=Q;D]>30!H4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4C,J*69@JJ,DDX
M %+7%^(YX]8\;:5X6GR;)H'O;J/M,!E44GTR"3ZXH Z\7,#7#6ZSQF=5W&(.
M-P'KCKBF_;;3[.]Q]JA\A#AI/,&U3TP3T%<W;7-JOQ-NK%=(2&Y_LM9!>[^9
M(PX 4*. ,]^OR^F*YJPUK1_^%8Z[/'X:6&RMKIX9;#SR0[?)R6ZCEATZ8XH
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M7\UYKV)VFR,*!M/;)Z^M5=&U'6O#,=SH-I9:3>VAN));>]DOXE506RI8=R"
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MC#;PXFVJWRCL0&Y.<CBLBXTO5Y/"_C:S_L+4XYK_ %!+BVC,!;<IEW8RN02
M.<9'O7M=% %/2MW]CV.Y'1OL\>4=2K*=HX(/0^U>>6L=[_PE?C:X.DZD(+^S
MQ;R&U<!V6/:0..I)X]<5Z?10!Y-;6>I6O@CP7"=)OVN+'5!-/"+=]R(K/DD8
MX'S#ZUT%M%=R_$K74:SO8K*]L4A6]$3*H=1SAB,?Q'!]17<T4 >6V<>I6GPY
MO?"5QH=_)?J);:%E@9HI=[$K)YF-H W9YQTJ_H^DWNG_ !.@:2UN&M8M$CM/
MM(A;RS(NTXW=.@_I7H=% '#6B74/C'QI*^GWODW5M"8)?(;;(8XBK!3W.6X
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M ++?7*M&9&R,(%8Y.,<GV'6NOHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *YOQAXH_X1NTM1%'$]U>2&*'SBPC7 )+-M!.!QP!SFNDKF/&&@ZE
MJQTN]T>>&*_TZY\Z-9\A'!&"#@9_^MF@#)T+QGKNN:7K"PZ;;-J=B082HD6"
M=3Z%@#G@\<9XJ]X2\5:CXI>.XCM;6/3XX56Y?<P<7!&2J@C! XS]?:I&_P"$
MW_LG4)I%TPW[(L=I;P,1&IS\SLS#).#P.G%4=$\*ZGX8\6!]+VOHMY"#>+-.
M2RS#JXSU)_QZ<4 9FA>/;VU\&:CKFM,EQMOGM[5$&TECT4\<*/7DXS[5<T;X
M@7MP^JQ7UI:N]I9/>0R6GF"-]H)*$NH(/3MWJC!X U@>$[[0VDMHI(M0-]8W
M2RD[V'0,N/E&.^3SVXYW8H/&6KZ5J%OK$.FVBRV<T,<,#%F>1E(4L3D*![>O
MM0!0T_Q[JUP^@WE[I5G;:7J\I@1UN2\BMSM)R  "1TYK2\-:IK%]XM\26]V8
M#96EPL405FR@VDC QCD8)]ZY]O"7B!_"_A"P^QP";3+T3W(-P/E56)';G(/;
MI[UTNCZ5JVE^,-:G:"WDTW49$G$WG$.A"[=NW'/0=QU[]* +?B'Q%_8EYI=J
M$MPU_*\8EN9O*CCVJ6Y.#R3@#ZUGWGBK4M)_X1N#4=/MQ=ZI=?9YQ%*2D?.
MRGOD$']*L>*K*\U&2WM&T*VU;2G5O/1I0DJ/QM9"2/?ISS7+GP1K=EX9T,6R
M17.H:5J1NXX)+CCRB<[-Q&,\+[=: -U_'*V>L>);6^M52WT:))1)&Q+2!@"!
M@C@\@59L=;UNYU2SL=3\/K#:7L#2>?#.95CP,[9/D 4G..OTS7/R>"]:U>Z\
M4W5]':69UFUC2*-+@R&)T"X#'8 1E>2/UZUM^'I/&IE$>M6NG0VUM%M!A;<]
MRP& <YPHR,]._3T .0\'^(=0\->";:X&B1/I7VYHI+@7&'.Z7;N"8YQG'7M7
MJM](8K"YD$7G%(F;R\XWX!XS[UYHGACQ(GPT&B?V5#]M^W^;M%RH^3?YFXGH
M3GY?IBO2;P2R:9.$BW3-"VV,,.6QTR>.O>@#@M-\9QZ7\/=&U+3O#X6"XNOL
MBVD,V=GS,,@D98DC\SUK?TCQ'JMYKEYH^HZ/'8W4=J+J'_21(KJ6*C<0..1[
MUR4'A;Q+:?#_ $32XM,C>^L-3%TZ-<( 55F<<YYSNQU[5T%QI6L/\2XM?33\
MV<6F&WQYZ N_S-@#/J<9/'>@#EO#=XFE:!>^)=6T>SN;E+^;[--&2]Q).[[=
MG*].O.>G;-=G%XHU*SUVPTS7=*@M!J (MYX+KS$W@$E&RJX/3&,Y)%<]!X0U
MR_\ A[>Z-<VR6.H"]-U;,;@,I)?=R5Y&,D?D:V)]*U;Q+K6AW>J::-.CTMS<
M/BX63S9<#"KMZ $9R>W% $.D>.=6U6-[H>&VCL8))TN)S<K\GEC/RC'S9Z>F
M?I5"/XFZE_9.EZM+X:*V%]-]G61;M2QD)8 *,=/EZG'>KGA31-9TWPEKUE>Z
M:L-U=2SS1(MPKB0R+@#.< C&.P_6LQ?#7B*+X=:+H@TF*2[M+T2RYG3Y460N
M"ISC)SCZ9]: .BL?%]XVI:I8:GH[6UU9VWVJ*""8323Q\\ #^+@<#/6FZ9XM
MU6;7=+TW5-%CLO[2MWFB*W!=TVC.'4J,'%9VJZ#X@N/'.IZK8V_DQS:0]G;W
M!F4%92-P.,Y SQTK/TSP[XEM]5\,WKZ#:0_V>7BNF-X)))1)C=*21U')QDGG
MM0!/I7BB[UKP)X@U'Q!90W.GQO*@CB?:S*,?)C'&,C#9)_*MNW\2-'I?A^RT
MC2D>[OK!)XK8S;(K>(*OWGP3@;L# ).*P]$T#Q'I'@W7]"?28IC.9OL\HNU'
MF>9\N<$< #YN3GMBK*Z-K^E1>%]5MK(2W&FV!LKZR612SQA1RAZ9RH/7T'/-
M %W_ (3R6WTK7)+W27BU/1PK3VB2AE96/RLKX&1CD\=JEL/&ES/XFT_2KW1W
MLH]1MVFM9&G5V;"[B&5>G&>]8]_X7U?5(_%&KFQ\J\U6UCMK:S,REE48!+-T
M!X!QGMZU8FTO5G\7^#+UM)=4L[62.Z=9%81,8RN"<XP#SG'.?P !U7B#7;?P
M]IGVR>.24M(L444>-TCL< #/%8EMXTN[6XU*'Q%H[:<+&T%V98Y?-C93QM#8
M W9X [D&K'CO0+S7M%MQIZQO>V=U'=0I(VU7*Y^4GZ$U4NK;Q#XOT34]/U/3
M(=)MI[7;"IG$SM+NR"2,848'&,\]: (X_'6H02V%QJOA][/2M0D2.WNEN%D8
M%^5WJ.@(]Z2_^($\3ZVEAH4UT-&?%U(TZ(H49R1W/ )Z=JIP6_B#6]"T[P[>
M:))8M9R0>?>22*8BL3 Y0#EB=H'X]:KQ:)K$:_$)6TV;&HJQM2"I\W*N !S_
M +0__70!T%SXS:6?2[32+.&YO-0M/MB)-<"-0F.FX Y;/& .QIE_XBUR+Q%X
M<L8]+2*/4$DDGCEF7>I5>5R,CC(/OT]:YFYT6XN/"^B:9JGAF^G$-AA9[7 G
MMYQD8/S?=(QQ_A5^/3_$VGIX-O;FQDU*[L5GANE210R>8%5222<X Y/M0!?&
ML:38>)_%<MKIDJ:M:60N)Y9'^6=53*@<G:.G:DT;QCJ'_"(:-JFIV0DDU"Z2
MWWQR*  [E0Q&...U0)H5_=>/_%,L]E,EC?Z<MNDV0%8[%4@'/UK,ATWQ"?AG
M8V2:+)'J&D7D4BPR.#]H"/NRN.W(_6@#L;KQ2+;6M1TIK*036FGM?I(7&R5!
MQCU'.1^%8NA^-[@>"--U75H1)>7]R8($C=5\TER ><!0 ".?3WHM]/U?6_%L
M^JW>DR6-C=Z.U@?,F4R(2Y.2H^O^>E8%CH7B"+P?H<D>C,-0\/W3M]EN"I%T
MC$EMO7G!&#]<<@4 =1!\1=.DT_6KB6VECETD*98ED20.&X7:RD@Y/'M70Z;J
M-Q>RS)/8/;"-49)#(KI(&!^Z1Z8P:YIWU+4="U2YO/",,4,T:1_8 X,]P-V&
M+$ 8PI^4=01FD\":5=:5J&JI!;7UGH;;#:VUZ071\?/CDG;T[T ;VIZ\]CJ]
MKID&G7%U//$\V]?EC15]6/&>V/<>M3>'];@\1:);ZI;(Z1S _(_52"5(_,&N
M=\3C6U\8Z7-;Z=>:AI:0,##;S"-/.+<&3U7&.#Q^M6/AQ9ZAIOA--/U*P:SF
MMIY5 9@=X+%LC';YL?A0 W2_%=[>^*?$MA)9@V>E*FQHV&XG#$@Y/);''88Y
MZU%I_P 0X[_37U)=!U5;%;<S"81A@Y#[=B@'DY^G0U6M=.U#2?&7BQUTRYGM
M-3@2:*X3;C<L;93&>I9L 52T:Q\1:;\'FL;2TNH-8A9@L? <J9=QVDY_@)H
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M,;E, QY)/WC[\"K_ (1M[ZRBTS3+GP/%'=VT@234G1 H53_K <;BV!Q[\YH
MW;[QY!:Q37=OI=[=Z=!<"WENX@N ^<':N=S 'OBG:GXZBL-9GTJ#1=5OKF&.
M.4_9X005?'/7.!D=NN?2L/0)_$WA/3IO#Z>'Y[YX[AQ:WBLH@VNV06[@ DD_
MEFM>SCOD^*E_/)I]P+5]/CA6ZV_NRP.[@_B1^'N* ([[XDV%C>A'L+IK(7/V
M5KP%-HDS@X7.2 0><=C5S3?$E_?^.M5T;^S\6-E%$?/#C(9@6!([AATQTQ[\
M<?HMCJ.@P3Z/<>"(]0NTN)/LVH-"AC92V0SL1G SGUQZ8KI=,34-.^).KF?3
M)WMM2@MF2ZA \I#&A5@23QR3[]..: -SQ!XBM?#J6+744KB\NDM4\L#Y6;/)
MR>G%5AXMM1XBU/1GM;A9=/M?M3/@$2)@$[><YY%9WQ(TZYO-#LKJTMIKJ73[
M^*Z,,(RSJ#@X'?KVK*T/^UKOQWJ?B.;0;ZUMKC2]L23 !BRE<+C/!.WI0!I6
MOQ*TZ[?3I!IFIPV5_/\ 9XKN>)4C\SL/O=.O/L?0T_Q3XFBDL]9TJSL;^\:"
MV=+N:TV@6Y9"1U()/TZ5Q<MEJ7_"MO"=L-'U$W%GJ@>6$6S;@H9SG'8?,.3B
MMII-5T#5/%6G/H=_>1:M))/:3VD.Y=SI@AFSQV_(^M &AH'B2VT+P5X>MG2X
MO;ZYL_,B@0KN8 9)+,0 !G'7\ZNCXCZ,/#D>LO%=B)KH6;PK&#)'+@G!&?:N
M)CT_4],A\,:O?>&+G48;?3WLKBS,(D=,,2K[??/0C@ _6K_BR*[O_!MG)9^%
MI[!3JD4RVEO;YE**AR[J@X.>![8H ]$T75QK5DUR+&]LP)"GEWD)C<X[X/:L
MJY\=:7:O,7@O&MX;T6$ERL0\M93P1R<D \$@5TL3^;$D@5E#*&VL,$9]1V->
M1ZY/KFJZ1K=I>Z#JLMY!J23P^5'^X6-7 &SH7)7=V.<YXQ0!V=]X_P!.LM9O
M-)73M7NKNT"F1;6T,G! .1STYZFDF^(FB1:3I^I)'>SPWTIAC6&W+,CCJK#L
M?89)YQFN8L==6Q^*6O7\NGZ@_G:?;MY$-N9)$)C0[65>A[>F>]4XM/O/#.A^
M'KB]MI6FN?$'VS[-&NZ1%>,@*1W8 9(_"@#KF\6V/B#2=<LH8=0L;VVLGD:*
MZC,$H!4X9<'/7'/N*YS3;VP/PX\(OK%WJ(=[Y3$UN26>02/@.3_#^.>..E:4
MPN-7UO7]=AT^]BM%T5K&,36S))-(27RJ$;B.0.G6N;GL[]?AQX0M?[,U W%K
MJ0EGB%I(6159R21C/\0QZT >C:IXOLM,N+R$6MY>-91B6[-K&K" $9&XEAS@
M9P,U&?&NGN;!+6VOKR:]M#>1PP1 LL0[MD@#GCKUKGH+J]\)>,O$+3Z+JFH6
MVIR)-!-:PF49 P4;T'./H*L:QJNKQ:[I0GTC4O[.FL=TMOI\(D/GDX\MY,#"
M@'VYH I^)_$=K=2^$->LKW44LIKPH\=N&W2#^XT8^\=PVD<]\5OP>)].\4Z9
MK-E;_;K.ZMH&$L4R&"9,J<,.<]OY9ZUPEC;ZG8^%O").CZ@'TS5W-S&;9V94
M+LQ8 <D;6Z],CO72QQ37OB77?$\=I?QV0TO[+'$]NR23OU.(R-QQP ?4T 7?
M"_B!++P/H#WAN;N]O(RL4: R2S,,D]3V ZDUM^'_ !+8>(X;EK,31RVLIAG@
MG3;)&P[$<^GK7F\NDW?_  C'@F]N=#N[RVTX317MF(7$P#X4$)P3C:3^78UV
MW@R.R4WTNG>'9M(M'*8-S&8Y9F^;<2IS@#C'/<T 4-8NKJ'XO>'(([N=;>XM
M9A) )#Y;;5<@[>F<X_(5ICQUI+/&1'>&UDN_L:W?D'RO-Z8SUQGC.,9K*UF&
MXE^+OAVXCM+EK>WMYEEG$#&-"R. "V,>G?O7+:E>:O>Z<(KW1M;DN[;6%N"L
M-D5@6)9&/RA<;B02<D')[T >AMXPL%O=9M/L]X9=(B\ZXQ$#N7&?DYYX^E);
M>,]-NK+1KJ*&[9-7F,-N!$"5()!+8. .">_'XU@^*M(U%O$UEJ6C0OLU> Z=
M?L4),<;8(D(Q\I !Y/H!1X+\-WVEZW<V=W&YTW2))!IDCYRXEP2<]\#CCC)-
M 'H%%96C:U_;#WR_8;NU^R7!@_TB/;YF/XE]JU: "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M% !1110 4444 %%%<WX@\:6/AK5;"RU&VN$CO6VQW0*>6#D [OFR -PR<=Z
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M@8YP>_:N<U>;4=#/C#1H-3NS:0V$=Y:,UPS2P9;E0YYP>>YXQSUH ]9HKEO
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M-U:I)8[!&(N0 !TP>HQCK5?0O"VC^&Q,-*M/),V-[-(SD@=!EB3CVK4EGA@
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MQL93%)=*Z!"0VW(!.3S5S2/%LVI:K:V,^AWEF+NV-S#,[HZ,@QW4G'WA^8H
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M<&:*S)'G_:4B>1FBBDY^9$SM4\^E13> O#,^L'5)-)A-R6WMUV,V<[BO0G-
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MC37KW3-<,R8VG?[8R!C'M3T\&Z68M22Z>YO7U&-8KB6YEW,5'0#  &.O ZT
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MOA!K\$!5HX-:=8\-G \Q0/TKK-*TO3=%^)FG0Z=;Q6J3Z*S,D? =@XY]S@4
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M-SXBLKR:ZLX[:2WNY+?:DH?.TXS[?C]:Z"O/OAM/%;6_BB6>5(HEUF;<[L%
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M1PV!E0;A$ 6;>>",'C'7MZUQ<MW<>)/!?A.ZU">Y-U#KL5HTJL4\P;R-_'?
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M''_UJ *\G@;3)/[>S/=C^V\?:/W@.W&<;<CCJ?SQ0G@BQ2ZT&X%Y?%M%B\J
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M?;?,\WSMO._KN^M '.^$TL1XZ\8@11"\6X1@VP;@C)S@^YSFL"T\.?\ "3?
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M]6%RS3LPD_=<<$X'/85W(^'GA97D==*5&DA,#E)I%W(>N<-U]^M65\&Z$O\
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MJ]U8&QN=5NS/Y#XW(@ "AL=R=Q/^]6OK>C6^OZ5+IUU).D$N-_DOL+ =L^E
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$1UP:CJ2W7V?[.%$XV!,8Z$>OS>F>:RT^&FC1Z4EBMWJ8,5T;N*X%P!+%(0
M=K!>,X!Z=:[.B@#D8_AQHB1ZG$\E]/%J07STFN"_S*<AP2,[L]R3U-%E\.]+
MM-2L[Z74-6O9K0$1"[NO,4*1C;C'3V'KSFNNKD'\9ZA/-<-I/ANXU&TAN7M?
M/CN%4ET'.5(R!G(S[>XR ):_#?1;2^$T4^H?91-YXT\W'^C;NWR8Y SZUT6L
M:7'K6DW.G33SPQ7"['>!@K[>X!(/!'!]B:QM1\7OI<&@-<Z5-'+JT\<#1/(
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M38Z)8)8Z=;+;VR$D(I)Y)R>3S0!YG%Y-O:?$FYNIIH[=KO8QMF'FCD],]CN
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MH(R<[3SG' JM<V\UYXATWPNFH0WL-CIAD@:>YDC%T[-MR6CR3M4' R:['6_
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MZ'JND_;;\PZG<?:)F,B[@V0>.,8X[B@#JXI5:V2;>I0H&WYXQC.<UY)#K5_
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MYEVLNUPD4;9(/)Q@$@G\:;87NF7*_$QFNK62"92\1\Q2K_*^TKSS\Q7&.Y%
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M]M-^S_;V\4\!G$JJZ>8H*DSL1NYXX!//85L:[!!I_BBX72HXH+B7PQ.8UM0
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M)J?BS6=$>S$(TT)^\\S<9-W(.,<<8K)\96%M>>-?!WGQ[\W$P/S$<!-PZ'U
MKG7T2TUKQ[XXBO#/Y<=O$ZK',R MY8P3@\XQT/'M0!ZU17B&FWVJ^)],\+:#
M--%*D]K/,_VJ215G*2.BJQC()P%!Z_7W]%\#:9>Z'87>DZAJD%Y-!-O2..0N
MT$3#Y5.?F R&QF@#JJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@COM2L[5V7<%GG5"1G&<$],T]M3L$OHK)[VV6[E7?' 95$CKSR%SDC@\^QH
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MQJEB+&\<'S+</NV\D#GW&#[9K0H **** "BBB@ HHHH **** "BBB@ HHHH
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M0M(T6GVJ-(V]RL*@LWJ>.30!Y_HMU;6GCOQY;WDT<,DZ(\:2L%WHL;EB,]0
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MH-$TJUFAFM],LHI8 1$\=NJM&#U"D#C.3T]:DO=-L-3C6._LK:Z1#N59XED
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M08KG/%?@^VT_X=:AH_AS2V::X>+Y8AN=R)%;+$\G !H SQI2>'/$?A&;1?M
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M?5-(U;42&LID_?VK,3N<#J .>2 /;G-,LYO#5GIWCR.X-F&:[G2*/*^8P*8
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M-0LH!:3VTCB*:/&&4[0<@DGCIR?44 >CWGB31[#2H]3N-0A6SE&8Y5.[S/\
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M#TO[=:!X$-U!ON!F%?,&9!UROK^%(-1L6O/L8O+<W7_/$2KOZ9^[G/2O-?"
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M2.?X5')-<UJWB^2WF\,R:=#'/9:Q<+$TK$Y0-C&,<9P3^57/'4:2>!=;5U#
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M48!.=O\ D5M2^.?#<+7JR:FJM8G;<@Q/^[.[;_=YY..* -N2TMIK86TMO$\
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M#URW'/XT >.&YL_[=*^)M:O;&SN=)M/LLD#'$J;!O5L*<Y;?U]:W;G0K"_\
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MDD$''L.PYKTZ+2-,AQY6G6D>'#C9 HPPZ'IU&3S0-'TQ;C[0NG6@F#;_ #!
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MMM?#LNK6=M9/I5]-K4&K,USJ2(4AFBWG?^]! .,=N0>G>O:X6MXBMI'*N^)
M/++[F"C@$Y.?Q->,V/@MY=/@LW\':E;ZJ =U^M_LB\SGYB,D!<X. M>DQ>$H
M(_&$&OF4M+%9_9V9B2\K]-S<X^Z.P'))H Q/BL6BTC1YXY)$D75(5!1RO!#$
MY .#RHJMKVG6=]\9]'BNK:*:-].=F5UR"07P?PQ79:WX<TOQ%%#%JENTZ0OO
MC F>/#>ORD9--F\,:3<:[#K4D$IU"$!8Y1<2#:!VVAL8ZY&.<\T :X&!BBBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU>.;77EGV6RQYN;<$_O94_U;$=#C)Z],#'MG:EX8UBX\;ZAJL>G:->V4]K'
MB7KE>G4X"-SG/X$5W=% ',^'-$U6SO\ 4M5UA[)[^Z5(HH[4MY442 [5!89Y
M))-5]$\/:I:^!]1T:]^R+=3_ &D1F*1F3$FX@DE01RQ[=,=^*ZZB@#E;.V\0
MZ5X=T72X-.L+MH[8071DN"J)M4 '[I+ CKQ68_@W5++P[X5TNS>WN&TJ_2ZG
M>1RF<%B=O!R/G/OP*[VB@#D-?TG6_$=XMA+9V5MIUO=Q7$=WYY>1E7D@)MX/
M;DCOUJ*]\.:AKWB."]O+:#319F5!=VLVZ6XC92JC[HVX!)YSSVKM** .#TOP
M9J7AO7+S4K&_N=01;%8;:&[N<&1@3\K$+PH&,?6JY\&:HLMSJ]G;6=E>F]@O
M(+*.7*#8A612P7 9]S<X/;FO1** .9T+3=2L&O+RX@B2XU*],\\*R;A"NT*H
M#<9/R@GZT>&M)U+3]?\ $=U>Q0K!>W2RVY23<64#'(QQP!^.:Z:B@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
=HH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>a123121ex-1021010.jpg
<TEXT>
begin 644 a123121ex-1021010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFDV^I6JRK!.NY!*FUL9QTKBO'OC2"/P[J<.CW5\E[;.$-S!;OY2.)%5D,FW
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M]U...XMU#21A'=E!]E!S[XZ=Z -^BN<U3QIIFGKHKQL;J/5I0D+0AF^3'+X
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M,U4H=1TZTNS'G9Y\*OMSZ9'%)=:)I5[916=UIUK+:Q,&CA>)2B$=P.@[_F:
M(-?BM[KPEJ48VM;R64FW8>"NPXP1VKSD:AHTGAOP OVRS:^M[RV# 2J7C3!W
M9&>!D+UKUKRT\OR]B[,;=N.,>F*Q;;P;X:M-WDZ'8@M)YA+0AL,.A&<XQ[4
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M=.IXKSOPU/X5U#3-"M[R?5;K5[.1$CL/,?,<@8 D#@!1C/7H*LZ?JF@Z;?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !16'>^*+.S\6:=X=*.]W>H\@*D8C4 D9^NTUHZGJ-OI.G37UT6$,0!.
MU=S$DX  [DD@ >IH MT5R>F>.4N];MM)O]'U#2[BZ0O;FZ4 28Z@8/7VKK*
M"BBB@ HHK#\5>)!X6TG^TI;">ZMU8+*82H\O) !.3W) XH W**IZ7>OJ6F6]
MX]M);&9 XBD(+*#TS@XZ5<H **** "BBHWGACECB>5%DESY:,P!? R<#O@4
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M/I,;1)<1B(.Z-@$'/ X&._'K0!T%]XCU+1Y_'$S7#7(T]+=K2-P (C(A]!R
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** $(!!!&0>H-"JJ*%50J@8  P *6B@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBH;NZBLK*>[F)$4$;2.0,X51D_H* )J
M*XW0]9>U\-77BW7;V=;:[Q-';E25MHBV$50!R3D<]\BM>+5;/7I+_2(WO+2[
MAC4N"IBD0,,JZG_/3D4 ;=%<YX/UNXU6QNK34&0ZIIMPUK=%< .1T< = 1^H
M-='0 4444 %%%8&OZ'J&LWMG]FUJ[TZUB23SA:R;7=CMV]B".&_3WH WZ*\?
M\+66O>)]+U=H/%NJQZC9W;0Q*\Q\HJ,8+8&>?FZ>W%;.G^+X="\3^*HM8U.\
MFMX+A##$8FD$*L"3@@<#G&#Z4 >CT5AWWB_1K"UM)Y+EY1>1B6W2")I'D3 .
MX*!G'(ZU=T?6+'7M,BU#3IA-;29 ;!!!'!!!Z&@"_17EVH&ZN/B?J&E3^*=1
MTVP%H+E-ER$ <E1M&[C').*V]'NK;08M7U*7Q1>:QIUL$20./.:%QR3E1R,,
M.G3O0!VU%8MEXJTO4;RRM;9YGDO;?[3#^Y8+Y?/).,#H:A/C;0!J"V9O2"S^
M6LWEMY)?.-HDQMSGWH Z"BN?U;QMH&BW4EO>7A$D143".)G$.[IO(&%_&K4'
MB72;G5(=.ANM]S/;"ZB 1L/$>C XP: -:BN2U3X@Z5:: -5L2][$;U;,A$8;
M7R"V<C/"\CCDX'>KC7<<GC.RV:VR"6P+KI9B(WC=GS3GD'M@\\?6@#H:*Q;/
MQ9H>H65[=VNH))!8KNN7V,/+&">01GL?RI+OQ?H-C;P3W.HI''/$)X_D8DQD
MX#$ 9 SQDT ;=%1V]Q#=6\=Q;R++#(H9'0Y# ]"#6,WC+P^EO?3MJ48BL)!%
M<ML;]VY) !XYY!Z4 ;M%9PUW3"U@HO$SJ",]KP?WBJ 21QQP1UKC-9UO4+'X
M::GJFG^)5U"Y@NL)=Q0H %\U5V8P1P#U[Y]* /1**XVYU34XO%GA");YOLFH
MV\WVB#RUPS)#N#9QGJ1P/2NKO+VUTZT>ZO;B*WMX\;Y96"JN3@9)]R!0!/16
M OC?PN]P8%UZP+A#)GSAMP.OS=,^V<U:LO$NB:AI\]_:ZG;26EN2)I=^%3ZY
MZ4 :M%8=QXBT^]TS4#I&JVDUW!:O,OENLA7Y<ABN>G2LGPMXPMV\&:/?^(-3
M@BN[W>H:0A/,*NPZ#CH!_DT =E163?>*-"TR[6UOM6M(+AB!Y;R@,,C(R.P]
MS6KN&W=D;<9S0 M%>:67BR\U[Q)J$MOXFLM/TW3+KFW>-#Y\"X#/N)S@GH?]
MH5WAUO2Q+:1'4+827BA[9?-&9E/0KZCZ4 7Z*XW0]8U>^\3^+--GN$V66S[&
M?* V;PY&?7''Y5I^"=6NM<\'Z?J5ZRM<SJY<JNT<.PZ?0"@#?HK-O?$.C:;=
MK:7NJ6=O<, 1%+,JL0>G!-2WNL:;IS[+V_MK9]ADVS2JIVCJ>3TH NT54BU.
MPGTX:A%>0/9$$BX$@V8!P?FZ=>*Y?3?%4VI_$5]-M+^SNM(:P-Q$;<AB'#!3
ME@?7/'TH [.BJ]U?6EBBO=W4-NKMM4RN%!/H,U!9:WI6I1S266HVMPD'^M:*
M56"?7!XZ'\J +]%9\.N:3<,XAU.SD,<8E?;,IVITW'G@4:=KNDZO(\>G:E:7
M;QC+K#*KE1ZG% &A16=-X@T:!U275;%&9]@#7"@EO3KUJ>/4["6^>RCO+=[M
M!N:%9 7 Z<CKVH M453_ +7TSS?*_M&T\S=MV>>N<^F,]:K2^(M.A\11:&\P
M%Y) 9@"0 !N  Y/4YX'L: -6BFNZ11M)(RHB@LS,<  =237+1^)[FX^($.C6
MK65QISV37#2PR;G4@@<]NO8=CF@#JZ*QM#O+_P#LRXEUR>Q$T5Q*I:WD^1$#
M< D]#CUYZ9YS6E%>VD]N\\-U#)"F=TB2 JN!DY(X'% $]%9E_JR+HE]>Z;-:
MW4EM"T@ ERN0"<$KGTJIX7\0'6/"%GK6H&"V,RL9,-M1<.5')/L.] &]14-O
M=6]W&9+:XBF0'!:-PP!],BHXM3L)TD>*^MI%C&YV252%'J>>* +5%0F[M@\2
M&XB#S#,2[QEQ_L^OX4\S1*P5I$#%M@!8<MC./KCF@!]%0B[MFN6MEN(C<*,M
M$'&X#U(Z]Q^=1ZEJ-II.GS7]],(K:%=SN1G% %JBH/MMJ+-;QKB);9E#B5F
M4@]#D^N14J.DL:R1NKHP#*RG((/0@T .HJE)JUE%K$.DM-_ILT33)$ ?N#@D
M^E9OAC7KS7#JBW=BEJ;*]>U&R3>&*@$_S'YT ;]%%% !17(W_C&\EUVYT;P]
MHYU.YM,?:9'G6**,D?=W<Y-+I7B779?$T6CZQX?6R$UN\R3QW E4[2 >P_O#
MWY'K0!UM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT#7M-U&YU^&=S]DW3;6?>2K !M@'/WL>M>T;5)!VC(Z''2C8N_?M&[&,XYH
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M1>98:)XDT/5-!MK+4X=&+_:;;_5W,:<!L=,Y/7KG/3%>EVGAC1;+3)=.@TZ
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MJ:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#D;[QVL%U>K9:)J&H6MBYCN;JW"E$90"P'.3@$5A^/-=&H_\ "+VUHDUQ
MI6IW2/*T+8\] 1^['(.>>AQVYJ/36U#P?#KVBS:'J%^U[=RSVDUM!YD4@D4
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MWVJV5M*J[C'+.JOC_=)S7DEDFCWVDZI8>*M;OK35&O9&EM<@L[9!4JNW)SP
M ?3%;4EII-]\7Y$U"SMGA&BJ\L5TB,488^]U&X+W]/:@#MM5\7:/I-E8WDUW
M&\%],L4+QNI4Y."V<XVCJ3VJ[/KND6VW[1JMC%OC$J^9<(N4/ 89/0^M>/\
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MT[]@#U<$$ @Y!Z$4V26.%-\KJBC^)C@5FZ=K6ESK96L,\<4\ULLT5JYVR"/
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MA'Y@\G.T@,O. "%)X]1R>M '=44BLKJ&4AE(R"#D$4M !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 @(
M)(!&1UI:X[3M7T:TU_Q4;:TOUOK4+/>!R6$N%X* MZ#CIV[57B^)UE+:V5X=
M$U=;2]D\F&?R4*L^2 HPV2?E- '<T5RL'CFU>'56NM,U&SFTV 7$T$T:[RAS
MR,$CMW-5K/XCV%TVGO-I>IVEG?N(X+R>)1$6/0$ACCGC/3OTH [.BN23Q]:3
M:O<Z=#I6IR26UT+:>18EV1YS\Y.[A>"?PIC?$*R2Q74VTS41H[3>4-0V)Y>,
MXW;=V_;GOMH ["BL.'Q/;R^*CH!M+I)C!]HCG8+Y4B<?=.<GKZ=JHGQW9#3Q
M<_8;TRR7DEI;VP53).R?>*_-C:.>21T^E '545Q\?Q%TEM"U/4Y+>\B;391%
M<VKH/-5B=HZ'&,\=>U(GQ%L'U"*R_LK5EFN8?.M%-N,W"XS\HSZ ]<=* .QH
MKEK7QWIL^@W6JRVUW;BVN?LCV\J 2F7C"@9QSN'?UHL_'>GS_P!HI=6EY8W%
MA;FZEM[A!O,0'+#!(/Y]Z .IHKDM,^(6F:I?:?;)9ZA"E^&%O//!M1V R5!S
MZ=^E+IGC(W$_B.2^LI+:STB9D\TXY"KR#SRQ.2 !T('6@#K**Q-'\1?VM>-;
M-IEY:-]G2Y1IMA5XV. 048\\=#@UMT !&1BJVGZ?;:780V-G'Y=O"NU%+$X'
MU/)KEI?B;H,<]W"L6I2M:.R3^7:,0F,\GT'!Z^E6;OX@:':1Z>X-U.-0A::W
M$$#.6 ZC YSQ0!U-%<P_CBPWP16]EJ%U.]LEU)#!!N:&-N07YX/L,FIH_&NC
M3Z/9ZE!)-,EY+Y,$,<1,KR#.5V]L8/)X]^E '0T5SMOXVT>YL;RY4W"-:3""
M:W>$B42,<*H7N2>E)!XWT:6+4WF>>U;3 &NHKB$JZ ]#CG.?:@#HZ*P$\7Z<
M(;R6ZBO+)+2$3R&YMRN4)P"",@\]NM%IXPTVY6[:6.[M%M;874AN8"G[HYPP
MZ^G3K0!OT5SVD>,]*UF\>TB6[MYEB,P6ZMVBWH.K+GJ!Q^=%AXRTS4;^SM8(
M[L"]\S[+,\)$<P098J?H.^* .AHHK"U7Q?I&CW-Q;W,D[2VT*SSK# [^6A8
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M8H LC1=*6\BO%TRS%U$H6.80+O0 8 #8R !Q3$T#1HK6:UCTFP2WF(:6%;9
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MD:1;6!(0[=6VJ!GVZ=*NTTNBG#,H/N:=0 4444 %%%% !1110 4444 %%%%
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MUT@*EMJ2@"YMB20#D?>R.1].E=CH/BG3)M/T*UF:"SO=0M1+!9QH0H '08&
M..,XZ5OSV5I<L&N+6&5@, R1AB!^-4[O0K2]U/3;Z0N&T\L8(TP$RR[<GC/
MZ $"@#FOB>YATC2KB9%?3H-4@DO 4+?NP3VZ$>H/M536;[P_KVC^(;GPVRW.
MJRZ9^^EMPP)C[*V<#=@'C[V!@^E>A.BR(R.H96&"I&014<%K;VJE;>"*($Y(
MC0+G\J /+M<O[#6_ WAJ/0Y+0:H+BV%M"FW? X^\,8R ".>,<4VQ6P?Q)\1S
M,MLQ2(,A<*<$(X8C/N1GWKTV#3+"UN9+FWLK>*>7[\B1@,W&.33_ +#9[I&^
MRP;I<B0^6,OGDY]: /%RUM;?#CP3<QF&*X&JJ6E7"O@/)G)Z\<?I6YI\&@Q?
M$?QE%JD=A';M%$ L^U1\R OC/KU.*](ETG3IXHHI;"V>.)_,C0Q#"MZ@8ZUR
M&F^$KJ;QOK>IZUIEC-97AC:'<XD*%. <%>IZ^U '$Z&9=+C\ :CJTZ06B-=!
M9)FVA$(RN?;_ !%++<6MYH?Q)EMI(I89+F*2-D(((WGD?XU[)?:3I^IVJVU]
M96]Q N-L<D88#'H.U/33[*."2!+2!(I%VNBQ@!AZ$=Z /,]?OM'N/&VB/=:L
M+;33I;)#<P^6\:R;N1EE95^4<\9Z5D>(;'0++P/#:Z+>3WMH=<CS)<,K*S%#
MN"$  KTS@=:];ET'2)]-CTZ73;5[*/[D#1 HOT':B\T'2-0M8K6[TVUFMXCN
MCB>(%5/J!VH L66GV6FV_D6%I!:PY+>7!&$7)[X%>0V&FZ')IWQ$DO;2Q,EM
M=W(@>1%W1??V!3U'S8 Q7LRJ%4*HP , "N#\->"_*UG6KO7M)LYOM-^]W:R,
M5D,>YB<=.#TH Y6STZ+4/$O@*SUFVBG>72I%FCF4$E-CF/=]!@CN#[UT?ANU
MTT^)?%6G:M:60:%XUABDC!5;14VIC=GC&,CUS7:S:+IEQJ$.H36%N]Y  L4S
M1@L@&< 'MU/YTS4O#VCZQ,DNHZ9:W4B+M5IH@Q ].: /)84,?@?PO=";[1#;
M:N[6]M=3K&+B(,<8+X P!WP/F-:<6CVH\->.-6:ST^ WD+F*WADCE:! I/+(
M2!E@&P#C('I73>+O#M]?W&D'3]-TZ]L++>'L;EBBDD84C QP,_GT](O#W@M(
M[V_NM2T32[*"ZA$)L[9VD5QN!)?/R]5&,#UH Y];+0=+^&NBWDNE6[SZ@;6-
MV,AA1I "5:5A_",$GU_#A#)ISQ?$.SDN-/97M4GCCMF"QDB$G*@'D[MN3W/U
MQ7I#Z!I$FE)I;Z;;-8(<K;F,;%.2<@?4G\ZK2>$/#DK,SZ'8,64(28%Y Q@=
M/8?E0!Y]=:#X?CB\ M'96:?:G59]H \\&,$A_P"_\V!SGKCO3_[%M#>^/M$M
MKV#3[5VLS%R$ACD;)VD#@ MA3QS7H+^%M"<6@;2K4BS.;<;.(N<_+Z<\_6G2
M>&=#E:Z:32K1VNSFX+1 ^;SN^;UY - ',>$M4BL-2U>RUG3K+3=3M((WN;FV
M(6&:%0=K'L"-Q_/VQ7<Q2QSPI-#(LD4BAD=3D,#T(-8C>$M)AT;4;"PLH+?[
M=$T<C%2VXX.TMDY.">!GZ5H:/I<&BZ-::9;Y,-M$(P6ZMCJ3[DY/XT >>6,2
MVP^(5Y8+;O?0S2>1-;Q ,A\L\#'0C)!]2":SKK3=-MOA;HFL:9%;PZRCP/'<
M0QYFEE+892PY.23UXXQ7I>E>%]%T.[N+K3;".WFN.)65F.X9ST)P.?2H+7P5
MX<LM6&J6VD6\5X#N61<X4^H7. ?H* .-TS0-*UKXJ^*5U&S2<6YMY8E+$ -M
M'. 1G\:R)?#NBW'AKQW<_9X%DM;Z;[/+U\L*%8!?3)XXZYQ7J=OX<TBUUN?6
M8+)$U"<$23!FRV<9XSCL.U5$\$^'([6]MDTR,0WS!KA=[_.0<COQSZ8H X6W
MT^TTGQ?X"FL(%AEO+60W+CEI28P26)ZG+'G\.@%0*E@GPI\56I$.+?4;@1HY
M!*$.-N,]\=.]>B#PAH*OISKIZJVG?\>A$CCR^<^O//KFF7'@CPU=7US>SZ1;
MO<7*E97.?FR,$XS@'W'- ''6[^=XW^'UR0J^;I+':N<#]R3CDD]^Y)K%UB?3
MH-,GU_2[%&,&OJ_VRY(,\[!B7 ( *Q] !Z9S7J/_  B>A_VC9WXT]%N;-%2W
M968"-1T 4''?TJE)\//"<K7#/HENS3MO=B6SG.>#GY?PQ0!P<NCGQ9=>*HKO
M4=+@GBU&2,RWEN6G@A1AL,;EAM7\._O7J&D7-N-+TV 7Z7,CVL;)(2 TR[1\
M^WKSU_&J%]X%\,ZE>+=WFD0RSJJJ&+,,A>F0#@_C3KGPO;S^+=+UQ?+B.GP/
M$JHGS/D%0"<XV@,V!C.3UH WZ*** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV/;FX +Q_P#/3.W@8YZ'C'-:G_"4$76CQ&R)2_M'NY95ERMNBA22>.1E@.U
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M,X!%34 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1K%AKNG1W^FSB>VD)"OM*\@X/! -5M&T"'2H+GS)FN[N\8O=W,B@&5L8Z#@
M#@ <59TC2;71-,AL+-2(HQU.-S$\ECCJ2>: //\ Q-I]]!XSO-*L8BUMXHM/
M+=V)V0R)P\F.AQ&,XSDG'XR> ;.^N;Z.VU*+$?AI9+.)F7_62LWW@>0-L84<
M'^+\_22BE@Q4%EZ''(H"*I8JH!8Y; ZGIS^5 'B[W6CW7PJ\420O;O.VH2.6
M.-Q+2@H1GU4<8]#Z&K$\VB3^+]:'B#4[NRM+^TMS:R;]J30F,97E3CD]..IK
MUG^S[+84^R6^TG)7RQC/KTITEI;3!1+;Q.$&%#(#M'M0!YO]HTK2/$'@R96F
MM-,BM;N.*2^^5L8 7.?7J/8CCM5&![-M4^)\DC0%_LW[MF(SCRY <'Z[1]<5
MZO-;07&SSH(Y/+.Y-Z [3TR,]*C&G6*F<BSMP9_]<1$O[S_>XY_&@#Q71I;>
M"Y\/3ZW?W%EI<NCM%!<(PV^8')9#\I[8ZXZ"KNMP^'K71O#MMILCSZ3_ &ZI
M,EX?D*_*7VYP/+Y(/&,[J]:?2M.DLDLI-/M6M8\;(&A4HN.F%Q@4EUI&F7T4
M<5YIUI<1Q',:30*X3Z CB@"2TLK6QM/(T^V@MH>2J0QA%R>^!Q7E.BW>CP_#
M37=-UJ6V74T>X-Q"X596D)RI ;!)SMP1Z"O7@   !@#H!5*XT32KJ\6[N-,L
MIKE<8FDMU9QCI\Q&: /.K6QL9/%7A&QUR&WFOQH[)<17860EN-@(;.3G?COU
MKO=<@M+;PEJ, BABM8[.11'M"HJ[#QCH!5J;2--N+Z.^GT^TENX\;)WA5I%Q
MR,,1D8JQ-!%<P/!/$DL,BE7CD4,K ]00>HH \/L8]/M])^'=\L%I;SO?$7$R
M*J,P60#+MU/'KZUU&@G3&LO&-GK,<"7YNYWG6[(#/&1F-N?X0.A_&NZ_X1W1
M/*BB_L;3_+B8O&GV5,(QQD@8X/ Y]J?=Z'I%_<"XO-+LKF8  236Z.PQ[D9H
M \O\.F/3!X!N=::&V/V:^!EN65/DX,8)/;#<#WKN/B$J2_#[6-P5U^S[AD9&
M000:W;G3+"]$(N[&VG$!W1>;$K>6?5<CCH.E9?C.PO-3\'ZE8:? )KF>+8D9
M<)GD9Y/'3- 'GC6.FQV7P\ET:&S349)H#.]OM$CC8#)N(Y/?.>E5-2UG2+BP
MFN(&L[(+XE6=HI)0\[#=\\IYRBGC@# P>3FO2/"7AVUTK1-->?1;&SU6*W6.
M:2.-"Y8+@DN!R3C)Y[]36B_AO0I#*7T73F,S;Y-UJAWMSR>.3R?SH \X:X,7
MBOX@_8YE2]ELD>T\M@'<B+)*=SZY%1>%M*\,M/X=O[;Q$OVM&58[2&VB65F(
M^99-B[B, Y9OSKU1=*TY+U;U+"U6Z5=@G$*APN,8W8SC'&*AMM T:SN?M-KI
M-A!/S^]BMD5N>O(&: /&(]-TM_ 'C.]^R6QNH-398)@@W1KO3 4]AR>E=VK6
MK?%VQED%MB31,P2;@3(WF#!'OC.,9XKIE\+:"EC<62:/9+:W#;I8EA4!CV/'
MIV].U3RZ'I4UU:74FG6K3VBA;>0Q#,0'0#TQV].U 'C]UJ^EO8Z?J=BEK!$G
MB))VA:0/=2?,Q9V.1L4@8"X/;GUZ7^QO#^K_ !'\6?VY';.8X[3R3-)MV@Q?
M,1S[+SVKL?\ A$/#A,I;0[!C-)YKEH%.6SGN/TZ=?6G:AX4T'5;U+R^TFUN+
MA  '=,Y Z CH?QH \H@,Z^$_ ?V@_(NN 0LS$DQB3@G/XX[8Q5A]-TW7O$'B
MF+Q#KEMITPOBB+<1PAS$/N%'?Y@, <*1^M>J7?AW1[]+-+G3K>2.R.;>/9A8
M^G11QV%-O_#.AZI?)>W^EVMS<H !)+&&.!T!]?QH 6R5D\*VZZ?<-<.MBHMY
MY@<R'8-K-WYX)KS"TT_0;SX-W5_<6UI_:D*2F6X90DRW <E06X;/*\=\U[$
M   , = *R&\)Z UZUXVD6AF9_,8^6,,W]XKT)]\9SS0!P6GZ'::YX]M$\06D
M<]R_A^&>>-W)'G;]N>O7;_C7J44200I%&H6-%"JH[ < 50/A_23K0UC[#%_:
M(&/M R&Z8_E6E0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!QMSXVOFMY[[2O#\FHZ=#<_9_-2XVR.P(5BL>T
M\ G')'X58N?%>H2ZQJ>GZ+HBZC_9JIY[M>"++L"0BC:<G ]N>*P]"TWQAX4B
MGT+3=*LKBQ\]GMK^2<!45CGYDSN)'M^?>K]IINL>&O%FNWMGI4FI6.J%9E\J
M:-'CD Y!WLORG<>1F@!C?$J"32]%N[/2;BYDU.<VXA\Q4\N4<;<MUY(YX&,G
MCI4\7CB^6/5H+SP]);:KI]N+E;+[4K^='W*L!VYX -<EK6G7VBQ^$#=V^^_F
MUM[N2VA=3AW<-L5B0/09)QGO7::7I-U<^,[WQ)J%BUB#:):012RH[$9)9CL)
M4=@.30 L/C)[K3/#UW::9Y[:Q,(S&MP/W P2Q)QSM /''2J=CX[NM7O9[2S\
M,7TT<%X;2YE\Y (P.IZ\GKQTZ<\XJCX(\//9>+-8(F273=.G=+%5Y5'EPSX/
MJHPOXGWJ_P"!],U;1YO$+7^F2PB[O9+N#][$V\-T7AC@_7 ]Z *OAKQ'I&D_
M#V^U33=+N(+6UNGC%L\NYW<NH'S'IDLN?3GKWT;+Q;=W7B<>&M7T V=Q/;F9
M2MTDZ&/Y@2W [C&.?RYKDAIE_H?PKU?3=5TTI=7E^HMH6F0F5I'3;M*,?F&"
M?P[BM#PC=&S\3QQ:EHVN0W]U%]DMKO49EE 6-6;8"%7'"DYYR>_/(!G>%/$\
MG@[PDB2Z1/-I<6HRP2WQF10N7P"$Y9O?@=*[*SU[5I_B+J6C-:)_9UM;QNL@
M< J2,[L=3DY&.VW/>N*_L+Q))\)+C2IM%D;49;_?M8H6*EPQ<#/R\Y'T.>G(
MZM;?68/'VIW<.F2B*_TY%BN"R;(I$!X;GU('&?RR0 )9?$%I[S2_M6C2VMAJ
MTK165PTP9V8' W1XRH/KD_UKG-$UR3P=/XEAM=#OK^R@U21YIT<;88PHSR>2
M0!TXX[UG0Z/XGECT"_NO#E[/J%EJ9EN[B6=#).-RX W'*J ,?W1C/>NA UG3
MKKQ3I<7A^]N)-5N99+:X"J8 '3:"[%A@<<CK0 NN7MOJ7CWP)J=HQ,=TDS*W
M0E=H(!_,U=OOBAIUG=,4M&FT^*X-O-=+<1AE88&5CSN9<]\ >F:S;C0]0T[Q
M'X&M8[&ZN(-+B*7%U''NC!8!>O8 COCBH-&L];T!KG0#X.BU#-Q));7\FP1[
M2V59S@],9QG/0#M0!ZFK!U#*<J1D'U%<OXOU_4M%O="@T^S%P+V\\J4;U4D8
MSM&[C)Y.?]GWJY!X@E/BU_#TVGR(5M1<)=*P*.. 1CMR2/PK-\=0WWG:!?66
MGSWWV+4%EEB@ +;=I&: .?35)M)^+6OR1:;>WI:SAS!;88KPI).2!CD_G731
M>.K"ZTG2[ZQL[R[?4I#%#!$@W!@/F#$D*N/<_P C658P7]M\3]=U.;2[U;6>
MP01NL>X,RJI*@@X)X(^M<UHUGXET?PAH-L=+UA;9+V9KZ"S/ESLO!3!!#!<Y
MSTSCZ4 =-K_Q!D@\%WNK:99O'=VU[]ADBN@/W4@(W9 .&X/8]_:NXMY))K>.
M26!X'906B<@E#Z$J2/R->.ZCHNNW/A/Q+I@\/75O+)JPU"*-0K!D<@;%*Y!*
MXR<?TKUW3KM[_3X;J2TGM&D&3!. '3GN 3CUH YZW\=V<]U;*=/O8[2YO6L8
M;MPFQI02,8#;AD@\D4/X[MAK=YI<.DZI/+:3QPRO%""J[^C=>G_ZZX5AXEG@
MTJ?4?#^LW&H6>KI=74I(,>T%OEB0' &,9(&,CJ=U==H<5Y+XN\6F;3KNVCOU
MB\B6:(A&V1[#\PR.IH D_P"%EZ0MY DEM>1V4\Y@BOV0>4[@D<8.<9&,XKJ=
M2U*TTC3YKZ^F6&WA7<[G^0]3[5YCH5C-IVGVVD77P]AN=6@D\K[<]I'Y#@-_
MK#(>?N\^Y_*NT\>:5>ZSX1NK73D62[#1RQHQQN*.&Q^E !8>,8+S5_[-FTS4
M;.9XFF@-Q$ )D7J1@G';KZU0L/B7H^HRGR[348[=!*9;F2V(CBV*6(8^I Z=
M<X'>I]*\3:EJDT<DOAJ]LX[>)VNI;I,$';]V(#)8EAZ#@>I%<]H$5YK?POUG
M28=.NX+PM/L2YC,8?>Y<8)X[X/O0!TVF>-[+4-8BTR6SO+*:XC,EJ;E !.H&
M25P3CCGG%+I_CG2=2FT]8DNDBU%WCM9I8PJ2,F<CKD=,#(YKG/"MS'*($L_
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M "BBB@"@VNZ0C%6U6Q5@<$&X0$'\ZLVUY;7L9DM;F&= =I:)PP!],BO)5M]
MM?B5XJ&IZ*;NV00LB169F$;,H+' '&2:Z'2M6@TWP+>ZYX7\/ND37,DTMG,_
MED!1M9E SV4?*/>@#H]>\+67B&[TZYNI[N*2PE\V'R) HW9!YX/IVQ5W6-'L
M]=TJ73;]&DMI<;@KE2<'(Y'TK!\/^-&UJVO=2DLU@T>UMUD-YYA^9]@:10I
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ME11E/O[5/+ >O>I-1\>PVT]C#I^DW^IF^M#=6[6Z !P.W/.1WXXR.N: .NI
M01D'(JC%>-=Z"+R:QN8WD@+O:8Q*#CE.W/;M7,:)XBTK2?!>DOIFGWC)=RR1
M6=CN#3,V]]V23C ())SP* .VH!!&0<BN6L?%RWDM[I^I:5>:=?P6K7#6[$.9
M(^<F-E/S'I^)K-TCQ;H6B>!])O;*RU$:=<7!MH8R/,D5B[9)Y/<'@'/H* .[
MH) &2<"N1M_'MO=QZS&NF7UM>Z9;&Y>WNT",ZX)XY..W7U%<QKVN7OB#X*W>
MHWMM+!/B(B0$*LF95!*A23C!(PU 'JM%<Q8^*(HM5TG0)K2Z-Q=6:S)<';Y;
M )D\[LD\8Z=_3FM'0M>CUY+MXK2X@2VN&MRTNW$C*<$KM)R,]Z -:BN</C&V
M_M_4]&73[YKJPM3='"KB51MX3YN2=W&<4RV\:V5WHND:G%9WABU2Z%K"FU=R
MMEAN;GI\AZ4 =-59=/M%U%]0$"_:WC$1E/)V YP/09/:N+M_$-EI-KXQOK%M
M2N[BQFWRPW;$JK$' 0=0F<Y]A]*RO%&O7=UIW@O6'6]L6FOXO.@5B ZG:3\J
MD[@<< \X- 'J5%8FA^)[37+R]LDM[JUN[,KYD%U'L?:WW6 ]#_44[7/$=MHC
M00FVNKR\G#&*UM(M\C!<;CCH ,]S0!LT5Q6H?$.VC\)ZIJUG:3?;-/98IK.Z
M78\3LP4;AZ<]O2J&N^(&M_$/@K5YOMT-O=QS>;9H"Q):,;1L'4Y<4 >B45SM
MCXUTB\TR\OI#/:"SD\J>*YB*2*Q^Z-O<MQ@#FFV/C73;M[Z&:"\LKFRA-Q-!
M<P%9/*'\0 SD=/S% &O9Z5:6%U>74$9$]Y())Y&8DN0,#KV X J[7*VOQ#\/
MWENT\4MUY2Q^8':V<!_F"!5./F8L0,"K;:@OB.VO[#3[B]T^_MMC;Y(C&R,?
MF7(/WE..1Z4 ;]%8OA77#X@T*.[EB\JY1V@N8L8V2H<,/IW_ !IM_P"+--T^
M_N+)ENYY[:,2SK;6[2^4I&1N('''- &Y17-S^.M M]+T_46NG:WU!]EN8X68
MLP."" ."#QBM71]8M-=TR/4+%G:W<LHWH5.5)!X//4&@"_17.?\ ";Z)_8%Q
MK0FF-E;3_9YF$+91\@<C&?XA^=/OO&NB:??+9RSS-<- +A(XK>1RR'H1@=Z
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MRS6THRDBYP><=_<&N=\8^+K#1].OK2'6+:UUA;=I(8W&XY W $= 2.!GU[T
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M'TWQ.&'KVH L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-\2^'_$.L)9>'[36=.U.Z:Y5Y9$3RRX^8-GMSCZ?4UZ337=8T9W8*JC)9C@
M4 0:?'<1:?;QW9A-PJ 2>0NU,_[(["N$\'V]WI7A#7O#UD6_M?3Y)UB#X4L6
M&8W'/0\<UZ$CI(@>-E9&&0RG(-1&RMC?K?>2OVI8C$)>^PD$CZ944 >666D>
M)WU;PI>W>@7&_3G=;N9[I'DE+XRYR>@Y.,_E3[?PCK5[X<\2VKV+6UU/JGV^
MT$[C;(-V0#M8\X&.>.1^'JDLT<$9DED2-!U9V 'YT12QSQB2*1)$/1D.0?QH
M XJ^MK_Q?J.A^?I%YIT>G70NKA[DH S*!A4VL2V2>O P*Q;[1]=O/ ?B73O[
M%N4O=0U1KF*/?&1L:17SG=V"$?B/P]/>6.(*9'5 Q"C<<9)Z#ZT^@#RR+0M5
MT37YK]?"ZZS;:A:0-)'*T0>VE5<%?F)'Y>W/%>B:*MTFD6XO+2WM)BN3;VX^
M2+)R%]R.Y'&:OT4 >;Z>NM>']*UG0)="OKU[J:X>SN+8(8BC@XWL6&TYSU]:
M-(T:_P##WB#PI8&PNY[:SLIHY;N-0R+)*=Q!] ,=??VKT431&8PB1#*!N*;A
MN ]<4^@ KR73=.U!O!GA36]-M7NYM+NYWDMX_O/&TKAMHS@G ^O->A:]H/\
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MY&#Q2>7&0!L7 Z#'2@#S_P <17NA^)=,\1Z5;K++<*VG3(,C<7!\MCVX;U]
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M' &!CGN?:L-+77M2U'P6S^';RVAT=A%/)(Z<_*@W 9SCY30!MVGB.YUC1/%
MUC3)ELK.2X@9K=UW%%X*CGE@,DGI1'XMLO#OP_TG5+/2[Z?36C5.7#-",X&\
MD]SQZ?3@56M8-6MM-\8Z4^BW9^U37L]O.I4K+YG"J.<YYS5_0/#\E]\+8=!U
M.V>WE:V>%TE4$HVXE6P#V.".>U &KJ'BJUTS5+FUN()1;VU@+Z6Z7!0 L5"_
M[QVG'K6;H?Q M-9UU-(EL;BRN)H3-!YKH1*O/]TG!P"<>QK$C\):U??#/4K>
M_5/[<O$C4[NNR$KL0X[X4GZM5_PI/)<:G;A/ L>CO$K+=7CVZ1\A>1'@ G+$
M<], T 7M'T]? ^EZY?7]Y.UCY[W$<<LWFE(P,#DXRS'MG^Z.N:U=#UV;6!^^
MTJZLPT*3QR2%6CD1AD88'KZCM4GB5]GAN_)TV34E,15[2,D-*IX(&.<X)/'I
M7*> K&\TW6+NWLWU7_A'OLX:*+4H&C>*8MG:F[D@#.<8&3WZT =#KWBNWT.Z
MCLEM+B\OI8C,L$.T80$#)+$ #)]ZHR?$318_#=OK@CO)+::X^S;(X@723G@C
M/MV)K$\76,VG>-XM<E\//KVGSV?V=X([<2M$X;(;!!ZCZ=_QSO$EK>7?@BT2
MT\+SZ<AU5)X[*W@9W$8!W.X4?*23T],"@#J_^%@68U";3CHVMB_CC\[[-]E!
M=T_O##8Q]2/3KQ23_$;1[?1=.U5K;46M[^5H8PEOEE93@AAG@YZ 9)QQ5'R[
MA?C%)?\ V*\-I_97E"86[["^0^W=C&<>_7CK7(VHO--\ Z:;^ROHGB\212K!
M+ PD*$[L*IZY.>!W- 'H5CXITWQ,;[1S%J.G7GD$F"Z3[/,4(/S)SGBL[PSX
MC@T?X=:#<7OVFYGN0(8HHAYDLK%CP 3S@>_:FGS+_P :W'B9+&^2RT_33 JO
M92)-<NQ8D(C ,0 1VZG\:Y^VLM5M?#'@S55TB^=]&GD2YM#;'SBKG&Y4/)Z?
M7G/&,T =M!XVL9IM0MI+#4K>\LK<W+VLT $DB#N@#$-^=+#XWTZXT+3]7BMK
MU[>^N1;1(L:EPY) R-W3([9K,M8I=:^)L6LP6%W!96FG&!I[JW>$R.S$A55P
M#@ DYQZ^U9OA_0I(/'EYHS"(Z/I<W]HVL04_))*,*/\ @/S$?_7X -V^^(FD
MV5[J-F+35+F;3S_I M[0N%'<YS@ >IQ[9I;?XAZ-=7>GPQ0:B8;]UC@NFM66
M%G)QMW'J<\'&<5E6GVH:_P"/&?3;Y([B%3!(;=L2[(BA"8'S9/3'6N=O%N4^
M%WA>TM=/U*&[@OXW9!;2[E(+9;..,EP1ZYXZ4 =QJ_Q!TC1KZ:WF@OY8K>18
MKBZ@@WP0N<?*SYX(R,CK^-3ZKXXTK2M173S%>W=VT'VA8K.W,I9.Q&/Q_*N$
MBTVUTJ^UFWUSP7J&J3RWDEQ;7%M;M)'(CG*AFS@?EQFMJSB>T^+D+-92P0KH
M:Q!8XV9$((.T-CD #&?PZ\4 :.I_$*VB\,Z?K.EV=Q=K>W26Z1^7\RG=AE(S
M][ ('J<=J[&&3SH(Y=CQ[U#;'&&7(Z$>M>*:=;W(^&\,@LKQQ:^(%N94CC=7
M$8ZD=_RZ5ZFOB,2:_9Z7'IM^5N;8W'VEH2B1CG ;=@@\=",\B@#;KS'QGHVJ
M:/X=\1:^^O7YNGF_T>.*8K''"TJ@+M]0">1[5Z=7&?%60#X?W]N [2W#1)$B
M(6+$2*QZ>RDT 51H&HVEI)K=MK^H%9M+=ITFFW$2^6"C)Q@8Y_(5)X2\;Z;)
MH^@V%W=7#7UU"L:RR1-LDD Y&\C!.>.O6M26^B/PX>Z5)G3^S2 HB;>3LQ]T
MC/6N'DEA_P"$<^';F&Y\VWO(MY$+815P'SQZXQ^- '<7?CO0K*[EAGFG5(IQ
M;R7'V=S"DG]TR8V@_C6_<0B[M)(A-)'YBX$D389?0@UX]:P:9I\&J:'X@T+5
MM0U#[=)/!%$)-MUN/RME#MS@<GL"?<5Z^)Q;Z=]HN4$(CAWRJI+!,#) XR<?
M2@#RSPOJ0U'PW+>:YXXO+"X%S(BYNHT)1 .BL,GKVKL8O$MAX=TG28]5U&>[
M^UJHBO\ R&*2[CE22!@$@@XK@/!=WX2MO#UQ;>(=-5[N2XD.Z337D?RSC&'"
M$COWXKH-1U*UU[P=8>';73I[1-2<6MDLR,WDPQL LKYZ'Y>!DYXYZT =I!XC
MTV>WU&X$S1P:?*\-Q+*A10R'#8)ZXQVJOIGB[2=4OY+&.2>"Z2(3&*[@:%BG
M]X!@,BO/B]]J7PRUCPHMG*VJ:3((BD2'%S&DH)921ST/ Y.!ZXJ=+;0]?@E?
M0-.U4ZP-.=1<W4D[BV!0CR\R$@DY*@#CDF@#LK7QYH%YJ$%E%<R[KB0QP2-
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M!922>89Y N]I%#'H<]2>]=!:^.--G@U(W$%Y:7.FQ>=<VLT/[Q5QG(QD'\Z
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M@Q:W+>>782C,<CQL"_7HI&X]#VI+#Q5HFIZ5/J=MJ$9LX"1+(X*;".Q# $4
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MA!N,8!!(XY&1R.>HH NWFDZ;J$L<M[I]I<R1_<>:%7*]^"1Q5M5"J%4  #
M[5ROCS5=2T;3].NK"=(8C?Q1W3,%_P!63SU]\=/6MG3O$.D:L]PMAJ-O<&W_
M -;L?.WW^G'6@"5M&TMXYXVTVS9+AMTRF!2)3URPQR?K2+HNE*;8KIEF#:_\
M>^(%_<\Y^3CY>?2J]CXGT34[\V-EJ=O/<@%O+1N2!U(]?PID/BS0+FZBM8-6
MM9)Y9&C2-'R2R]10!:?0](D:=GTNR9K@YF+6Z$RG_:XY_&I$TO3X[M+M+&V6
MY1!&DRPJ'50,;0V,@8[52M?$^BZA?-I]EJMM)>8;:@.>1UQZX]C7,^#/'<-W
M83)XAU:S2^-]+!$IQ'E5"XX[<D\F@#MKRPL]1A$-[:07,0.X)/&'4'UP>]5Y
M-"TB7S?,TJQ?S@!)NMT.\#D9XYQ3CK&G#5UTHWD7V]D\Q8-WS%?7]*DL]1L]
M0:X6TN(YC;2M!,%/*..JGWH A.A:.RVZG2K$K;?Z@&W3$7.?EX^7GGBM"BB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#C=2\&/J'CR/57=&TJ6V"WMJQR)W0Y3<O0C[IY_N^]1^%? S:3H&
MJZ9J,WG?:]]NC!L[;?!"+VY^9C^/M77WE[:Z=;/<WEQ%;P)]Z25@H'XFI8Y$
MFB26-@R.H96'0@]#0!YW;Z!XGG\(IX0O;&V2W4+$^HI<@@Q!\_*F,[L#'/%:
MNB:!J>G>/]9U66"+[!>QQQQL)LLNQ0H)&.^/PKL:* /)['P-XBM+N_UFU@@M
M=834WN+8M."DT+GYD?';H1GWX%>HV4ES+:1O=VZP3D?/&LF\ ^QP,U/37021
MLC9PP(.#0!Y!X/37+[P/J6DZ581LE[>SQ/>O.JK "%!RF,GC/2MBW\,^(_!N
MLR3^&[2VU&UN[>""59Y?+:-HUV[CGJ.IX]>G%=EX?\-:=X9MI;?35F2*1][)
M),S@'U )XK7H XB^TWQ'+XE\+7\UK%=BS,[W<D4BHL9D7;A02"0H^I.*LZG9
M:NWQ(TK48--,VFP6KPR3K,@*LYY.TG) P.@[FNFO+ZTTZW-Q>W,5O""%WRL%
M&2< 9-6* ."TS3?$7@^ZU2UTS2(]4L;V[:ZAE^U+$T18 $.&ZC@=/0^M9UIX
M.UK1)O!T-K:"Y@T]Y9;YDF50'DX)&X@G )Z#G%>G44 <C-8ZN?B=#J:Z=NTQ
M-/:V\\3(#N+;\[<YZC'3O7,7GAGQ'=_#_6M,_L@I>WFJM<QQ_:8S\C,'R3NQ
MQC'K[5ZK10!YPNB:]HOB:[U*QT"WU*TU.&$SPRSHKP2HN,98X(R3TS_C/<Z1
MXDL/$6E^(K73;>\N/LKVUY903+$D:D[EV%B.^,GOCISQZ!44UQ!;!3/-'$'8
M(I=@NYCT SWH X_P%I6L:??^(;K5=.%D-0O#<Q)YZ2'#%B1\I[9'-+K&E:K!
M\1;+Q%::>]]:I8&U>.*5%=6W,<_.RC'S=CVKM** .4T+091;:[<:W#'&^LSL
MTEON4B.+;M521P6QG)'_ ->LGX4Z3/;:/-?W=PUPS,;2V8DX$$;-C'L6+?I7
M6>(/#FG>)K!++4XWD@202A4D*?, 1V^IJ_:VL%C:16MK$L4$2A(T4<*!T% '
M)?$;2]1U6QT>+3[*2Y,.I13R;"HVJ,CN1_>_#!SBH+FWUH?$'5KF#2[B2QET
MH0A@4 DD&2H!+#U8?_6Q7=44 >-OH6N#X4Z-I?\ 8UV;N#4O,DC"C<%#.=V,
MYQ\W^>*ZO['J(^,#ZB--N#9?V9Y(GXV%L[L9S^&/Z<UV8N[8W7V47$1N N[R
MMXWX]<=<5-0!Q/POL+[3?#=U!J%E/:2M>R2!91@D$#_"H9K;49?C'#?KI=T+
M&'3C;&Y91Y9;YFR#GD?,!ZY[5WE% 'F/A73+RW\5V-[IVEZGI5M<12-JUK<*
M1 'VC;Y>>IW?CC\:WO'FDW]W_8VJZ=;-=3:5>+<-;J1N=."<9ZG@<5V%% '
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M:VUSX;DM[BXDE'S7 ,<:(,AF=5/)Z8ZUEM\2H?\ A%=-UR+2II1>W?V3R%E
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MS#<21V_RQX.,DDC SVZ^U8_AFU\M=,M3X"^S:K;R(LM[/;J(55<!I _4L<'
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MY[:.6\B+N\@).6P6QD8';D].:JV1G@\"^!5:QO&>#5E>1%@8D -)V_X$/UH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC1&E!18T4-YC.!P#G &.H-49/B)!%X<LM7.EW,@N+PV;11NK%'!(X.>0<<4
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M&+.^2"H7&<Y4C&.U9FLZU8WVC6]U8^)HM-C^V*GGA YD93S%M.""3C/L/0T
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M8T5$4*BC"JHP /04ZN$N?$6JKXF\&6Z706WU.V:2ZB$:X=A&&SDC(Y/8UW=
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MAC@CID]:V-;\3ZE%XH.@:3!;>?'8M>O+<[BK '&P 8QGU]^G',/B[P]K.O\
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MU77(+\6"V>6*^87"C=W'!8]<?+UKKM4U2'1=%GU*_P ".WCWR!.>?09]3P*
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MX"!7099<D<^N>.*ZBWU.:'P\-2UBW%C)'"9;B(.'$>,D\CKP* -*H+J^M+%
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MH5G;[KB#5D>1)XPQVJ!\OR@9.3P>F.]7Y?%6BPW+6\EYATN!:LWE.4$QZ(7
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MN>59.>IZ>]6KKPWK/B'0[^S\0W]HKW401(;*(F.%@<AP7^9B>,]..GK76T4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** ."\-^)]2U?77M;G4[.&>"\F
MCGTV2 QR^4 =C(2<L<X)]L^G.1#X[\47PM=5T_3+JYL9[HC[''ISG$ )&X3
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MI6NF1:=H99=6O=[0LN/D2(;W/(/)&%'NU:WAI%3P_:!-*&EH02MF.L8+$C/
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MMD7(4<#(! (;OZ5K:!XLU&V?PYI5YX?DM[2]MTCM[MKE6+%8@<E ./Q/3\J
M.^HK)\2:[%X<T.;4I8C*$*JJ!MN68@#)[#)Y-9-]XHUC3/#^I:I=Z!&/L@1T
M$5\'29#]XAMH(V^FWGM0!UE%<[=>)9[3Q1I&E2:>@MM2BD=+K[1RA1"[ IM^
MG.>_M6:WCB^EB.HV/AZ:]T07'DBZAG#2L VTN(@N2 0>_O0!V0=&9E5E++U
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M/7M3LY[/2YUN(S#&_FSN@(1G)/'7)QG-0_\ "):[_9WBJU%[8*=9F9XB%<[
MWRL&_P" X'&><UVUQ/':VTMQ,VV*)"[M@G  R3Q4&EZI9ZSIT6H:?,)K6;.R
M0*5S@D'@@'J#0!RK^&=?:/PLGVO3L:0RF;Y'&_ V?+_P#/7'/Y5S/ABQUC58
MO&%CIMU90P7.J313-,C,ZHQ(8K@X)(. "/QKUNJ%AHFEZ7+)+8:=:VLDO$C0
MQ!"W?G'6@#D7\"ZEIVL6EQH-Y916T-@+$B\B:1U&22RX(Y.>>15&Q\ ^(K#2
M]%L8]1TW;I=^UTKE'RRGL??E^..W->ET4 <3%X3UBWUCQ5>17-B5UF+9#N#Y
MC8 J-P],$YQWQ4#^"];BTWP_/9:G;0:UI$)M]Q5C!)%C&",9SC;^.?:N]JEI
MNK6.L0RRV%P)DBE:&0A2-KKU&"!ZT 8$VC>*)-/1I-2L;B^DN%>XBEC86S0A
M6'E!>3U;.>IP,] *?X-\+3>'&U.69[9/MTXE%M:!A##@8^7=SSG]!74T4 <G
M>>'=6M/%\^O:'-8C[7 L5U#=AL,R\*P*^V!^%8=Y\/-4E\.FUBO;3^T)]3_M
M*YE;>$W<X5.IP,]Z](HH 1=VT;L;L<XZ9KEM2\&Q:AXQM]:,Q2W\G9=VZD@7
M#+_J]P'! Z\^@K<TS6=.UE)VTZ[CN%@D,4A3/RL.<?K5Z@#F/"?A1O"]E?Q"
M<7$DTK>1N8XCA&?+CR<X )8\#JQZURW_  K[6_\ A68\-F6R-T+WS@P=MNS.
M>N.O7\*]0HH XV[\+7VH^-;^_N4M%TV\TDV#[&/F9)R2>!D^_H!4'AK1/&6D
MBTTJZO\ 3AI%F5"RQ1L9I4!SMYX [?3\ZZW3=5L-8MVGTZ[BNHD<QL\39 8
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MM+3O#^I:!K?@RV6QEN(;*UGCN;B,@I&\G)Y] ?T/>NGTSP]I_AK4-1U0:C<
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MC_;[?%S:,HPZR+R,=P3R*Z:B@#@-4TR\LOA9J:SP7%QJNHH;BYCB0NWG28R
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M.J1KL%S"LA3.=I[C/?!R/PKE8O">OZ7:ZOI.FW.GS:5J4DCAKEI!+;^9D,
M"& &".1SFNMT;2H=$T6TTRV),5M$(U9NK>I/U.30!Y1X?UO6/#G@[Q!JU@EC
M);6^LR>='<!R[;O+7Y2" .HZY[^G/;'75D^)-CIRV-HZ3Z8;B*\VGS@I)^7)
MZ#Y3Q[BL.+P'KZ^!=<T)Y=-^T:C>_:5=99-B@E"0?DSGY!CCO6O#X6U:+QQI
M6L[[(VEIIRV4B^8_F' .6 VXZGUZ4 8S>//$SZ)K&JQ6>D+#I-VT$Z,TA9\$
M#Y>GKU/Y5L6'BG6F\1Z+:ZA#IL=CK%N\]N(6<RQX0, Q. 3SV%9D'@?7U\)^
M)-+EDTT7&K7?VB-EFD*)N8%@3LSQ@8XY]JOR^$]:DU;PC=;[ )HT(CN!YKY<
MD!3L^3G@9&<<T 3?%%-W@J1Q&KR1W,#1[NS>8!U[=2/QJ2WU_P 06_BF/1M6
ML[!!>V[R64UN790Z#)5R>O8\ ?K6CXQT2Z\0>&YK"RDACN#)'(AFSLRKAL'&
M3VJI#IFK7&OVNM:^^GV\6FP2"%+65W&YQAV8LJX 4#CF@#)M?&VKS^$[Z9K:
MQ'B"WU$:>MJ-Q1G+JO3=GIN/7^'-=O*;H:<YC,/VP1':6!\OS,<9[[<_CBN#
MT[2].U;XJ7.KV%P)[..VBN)?+(,33D%4/!Y(0D].,Y[UZ&PW(1ZC% 'D^HWN
MHWWPFT74+MEO+U[^&2//!8^8< DGKVSQQ74-XNU'3-:U6QUFRM0EKIS:E$]K
M(S9C!V[3D=<@\X'TK%'A3Q4/ =EHABTS[387D;Q,)GVNBL3D_+ZD<>F>_%:V
MK^&-4UCQ7?7#BWAL;O1&T\RARS*Y8M]W SR?R]^* (-(\::Q<:QIL%]ID9M-
M00,LEI%,3;$C@2,R@<GTZ=_6N[9E1&=V"JHR23@ 5Q6@6/CJ-[*RU2?3(+"R
M*AIK?<TMRJC '/ !XSP#Z5L^,;;5;[PQ>66C1Q/=7*>43))LVHW#$''7'TH
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M=3OIGF>"+S!%B/<SY9CG& <>Y%-T?4O%>D:2FG7OA=[N:TC6**>TNHQ',!@
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M3Q3-]FTHP22*A,8<AN,XQVZY]*=97K7&@_$+-I=(\DLQ16@8%P\>Q<#ORIH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M12Q) /3 XXZT =E17G/_  F^LZ3:ZQ8:I!#/JUE=00PRPQ-Y<BS'Y24!W$@
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MF%H=.LH+6-FW,L,84$^IQ5RL?Q3JMSHGAB_U.TCBDGMH]ZI*3M/(SG'/3/\
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MNM.N;*QN[-;);>]CV2N!G<Q7G YP/6N6B\&^)H]",I??J&A7.W1HP-H:,/\
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M ;F0_,2", XZ$]N:]CHH \JU32TUGP7JR^'/"][I>6@D,<T(CDO-K$E0N3P
M00>YX%7[K5_[8\;>%]2M="U;;;&:.YE:R=?)+H4V,2,?*QY(/K7HU% '(_$/
M3+W4-#M9[%))GL+V*[:WB!+3*IY4 =3SG\*I370\3^+=!O\ 3[*Z6#3#-)=R
MSV[1E-R8$8R/F;)Z#/2N[HH X/X2))%X.DBFAEB=;R0XDC*YSCIGK7>444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !0>!
M110!P>B7GBKQ)H-GK]GJ4$'VBXW?86A4QB$.5*[\;MV 3G^7:[;W.M^(;O6S
M9:L-.6QNGLX(EMTD#,J@[V+#/);H,8 [U7TKP!<:1?-':^(KZ/1?-\Y;"/"D
M-D'&_KMXZ#&?Q-7CX6O['7K[4M%U9+1-0(:Y@FM_-7>,?,GS#!Z]<CGI0!R]
MEXQU_6]*\*O9WEO;7-_<36UTSVP=24&=P&?3G QR?2H=2US5KOP=XTTZ^U S
M76ERK&+F.(1>8C$#&!TZ'\#73_\ "#?9F\-QZ=?^1;:-(TA1X@[3EOO'.1@D
M;NW?VJ)O +21^*8Y=1!776##;#CR2"2._P W)'ITH CU&?Q!I<?A;3[35XR;
MMS!/<3VP=F.S<OR@@8&#WSTYZTV_NO$]CFUGUNU^TPZ;-<*MM K2W$JY(RI4
MA4 P.V3D5:/A+69$\/>?KZ2OI,QD9S:C,PX4#[W!V[AGG.<TNK^#;^]\1W6J
MV&NR60O+46UQ'Y(D.W&/D)/R^OUR: ,[2_%FJ^(AH&GVUS#9W=W9O=WDRP[B
MJJVT! >,DYZYP*C\36_B)/#<%OJ>JXF;6H8HKBU4(SPEQL+ # 8')P..!UJQ
M!\/[^RTW2!9:^8-3TP/''<K;Y1XF.2C)GGGOG^E:%WX1U"]\/FUN-=EEU,W<
M=V+N2(%%9""H6/. O'3UH S]8\0:S<:YJ&E:--=;].M4+M!:QR&29LXW;R,+
M@#H.Y]*?9Z]K^IWND:%,ATO47L6O+Z78KLH#% %4\?,1N[X!Q[U:OO".KMK$
M>KZ7XB:SOGMD@NV>V$B3E>C;,@ ]?I^=)?\ @F[>ZT[4M.UV>'5[2-H6N[B)
M9O.1BS$%>!U8X]!Q0!G?#M)8_%'C-)YA-*MZ@:0)MW'Y^<=JF\=VLUUXI\'H
MER8U^W%@!'N 90&!/Y8]N:T_"GA6\T#4=7OKS4TO)=2D65PD'EA6&?<^M3>(
M?#M]K.L:/?6VHQ6JZ=,9@K0%RY/!&=PP"..G>@#/CO\ 5M<\1:II>E:I'I\&
ME*B22+:+(TLS@DG#' 4$?4\\]ZQ&\<:_/HMMY'V&/48]9&E73-&S(23@,!G\
M^>U='?>&]5M_$%WK7A_4;>">]1%N8+N)GC<J  PP000*S[OP%>C3].M['4H1
M)#J?]I7<DT1_?2;LY !X [#]: .IT.#5K?31'K5Y#=WF]B9(8]B[<\#'^?ZU
MY[8R^(=)TCQ)?:$^GI:66KWCM;20DEU4\@$$  #&![=>U>J5Q/\ PBNO(-7T
MZ'4+%-+U2[FN)9/*8SHLGWD SMSVS^..U $3>*M57Q%X6F;RDT36K8$J8\M'
M*4W ;O<E?U],UN>%K_4=3@U"\O)(VM7O95L0J;3Y"G:"?7)!_P \#G/'":--
MX;C\(V=PAU2-K>*SME?]XA!4 GCH%R2?2NYT^RATW3K:QMQB&WB6)![ 8H X
M^UO+V;XS7UJUTWV6'2E*P_P\LIZ>N6//7'%<YI6KZ[X>\$WNK6"64EG:ZI-Y
MMO(AW-&9,$AMV <G&,'U]J[*7PSJ$?C_ /X2.RO;=(9K9;>XBEC+,5# _+@@
M#.!R>GH:Q1X'U\^ +SP^VHV/VFYNVE>4(VTQL0Q'3@[O;I0!/J?BO6[G5-=M
M=!6%O[)55"M:O,9Y",E<A@%Q@CODUV&D74]]H]G=75NUO/-"KR0L,%&(Y&*Y
MBZ\+Z_9Z]>ZGX?U.RMO[11/MB3P%E611C>@'?J<$]2<Y[=5IMM-9Z;;V]Q<M
M=31H!).XP9&[G':@#@/B/J6F7]]'X:U'4A8VWV9KJ63/+2=(D^F<L?H.G6MK
MP%KL_B#P)#)'+&+^"-K9BV6 =1A6;N<C:3SW/-7- T"ZM;K5;S6OL5U=7MP)
M%:./(1 H55^89X JCH7A;4]#\9ZKJ,$]DNDZ@VYK9%(=2!P1Q@<DY^M %&P\
M7:S?^'(%'V5/$']IFPF@\O*@ACNXW9 " G//W3Q5[Q-KVNZ3-J<\"V,-E96J
MSPK-\\ET<_-@!@5 Z=#U!JS9>#X[/QW?>(@Z&.XC79#S\DN,,_IDCC/7YF_'
M%U3P/KEYK'B">#4+$VNKPB(F=':2)0O"KC@#/7\\<8H TH_$]_K&JZ5I^E"W
M@^TZ:NI3S7$9?:C$ *J@CG/J>!7&^%?$-QX;\&:A)%#&]Y=>()+5!L9D5BB$
MG:HW$  X YZ5TUMX1\0:9=:-?V%[8&[L].&G7"3*_ER1JV5QCG/K]*I6OP]U
MFWT&2 :C9I?IJXU2V958HKX (;/)'X=O?@ M:1XBUC6-+\06>L6)40VCM%<K
M:2PQR@H<C$@SD?XUO>!?^1$T3_KT3^558=-\67&G:@=4OK"2>:U>""UMT9(@
MS?QLQRQ/; X_.M'PEIU[I'A;3].U#R3<VT7EDPDE2!TZCKC% '*^";.WUWQ%
MXCUO4HEN;J&_>T@\T;Q#&O90>G7_ #DU=FDT"/XF6$/]GW=OK"12>6\<*+%,
MA7[S$')P 0.XI]QX;UO1?$%[JWAF:U>*_.^ZLKPD*9/[RL!QU/'^06'A[7;W
MQ?:>(];:PA>UMGACMK5F;).>68CW/2@"AHWCK6K[2KO7;NPL8]'L_.64QR,9
M691\H Z#)('XU9N?$_B/1/[,OM;M=-73;Z:.*00.WF6Q=>,D\-SG./2F>'?!
M>HV_@;5_#^IO!&UY)*T4D+E@-P&"<@="*&\->(-7TS1M&UI;/[+I\\<DUTD[
M.UPL8(4;2!@D8R2?6@"0^.+Y](\5W4=G;^;HEV\,89FVR(K8Y]\ _I45UXWU
MF2^\.66F:99O-K%C]J!GG8!6V%BO Z#'7O[=:IWO@[Q&DGB>RTX:>;#696F\
MR>5O,5FY(  QU)JI?6E[HWC7P'9Q0Q7-Y:Z<\.PR[$8K$5/S8..YZ4 ==X6\
M2W>JWVIZ5JMK%;:II[J)$@8M&R,,JP)_E2ZCKNJR^(Y=%T.VM))K:W$]Q+=N
MRJNX_*H"\DG!.>E'AO0;JSUG6-;U%88[S4I$Q%"Y<1QHN "2!D]^E07^C:U9
M>-#KVCK;7,-U;+!=VL\AC.5/RLK '^7KZ\ '/>)/%%YK7PXU^'[/';:C8R"V
MU",2'"C=C*'N#TP<=_Q[3P[I8L[;[5/8:?;7LR(KFS7@HH^4$D#..?TKEK[P
M7JDOAC7HX5MSJFN7(EF4RGRX5#9"@XYP.^.IKN[#[0-/MQ=QI'<"-1(L;;E#
M8YP>XH \[\*64?B[Q;XAU77(([Q;*Y-G:12@/'&H)SA#WX7GW-='>Z#H/AV^
M;Q5':Q6@LK219$MX@H<'!!P,#=P1[[O:LU?#>L^%_$FH:MX>A@OK+4#YEQ8R
MR^6XDR3E&(QW/7U-:,EEK_B2RO[36+6TT_3[FV:);=)3+,KG&&+C"X'H : ,
MK_A-M?M+.PUG4M%M8]#O6C >&=GEA23&UW&,8Y_4"KEQXKUV;7]7TC2M"MYG
MT]$?SIKS:'##*\!>IYXR.G6L^+0_$VH>&+7PGJ>GVL5I"(4EU!;@.'CC8, L
M>,YPH'/'4UKZ;I6IV7BWQ+?"QB6UNX(%M,3 !S&A7& /E'/IQ[T 9\7CS4GL
M='U:31(XM)OY4A9_M.Z568X!V@8VY!'7)XX%%UXWUZ77]6TC1_#*74FG,N]Y
M+Q5RIY!VX[C..>.,^E4G\.>(A\/M TF/3HC=VEW').AN%X5'+ YZ<Y]_QJ/3
MKC4+?XF>,CI]@+R5HX %,H0*=@P3GMZXY]C0!OZ;XRN=<TS2+K2=(,[WV_SM
M\VR.VV?>W/M.3GH,<U!-X\N8_#,&K)HWFR-J!L9H4N1A#N*[@Q7D9 '0=:R[
M+PGKWAR#PU!96L.HQ69F>[C-QY2"5S\K\]=HR.A^G-5CX?\ %D7AJ72SI%M(
M?[8%T##<* T6_P PE0Q&.0 ,\X/2@#J=(\37>I:GJ&C:MHPL;N&W$RP"Z68R
MHV1V ]/UK+TKQ=8Z=X'TN[LM*ALS>7+V]M9>?M16\Q@2SXX'!)X[U:.D:M'\
M3;G7DL0]F=,\A#YR@M)D-C&<CIC/2L"R\,^*[3PEI'D6<$>J:3?R3QV[RJPF
MC<DD;@< _,10!L1_$JV2PUI[RT2.[TPJ#'#/YL<N[A2) HXSU../>NDT;4K[
M46G-S8PPP*$:WN(+D31SJPR2#@$8]QWK'E_X2:_TR]EN=!TY3*8E&GO*LC2H
M&_>;WX7)7[OIWJ#P/X<O=!U35B(+BRTB41&TLYIUEV-@ESP3CD^O/?H* )_$
M]Q)J'B;1/#2[Q:W7F7-XR'!,<8RJY]&;@^U.O?#FLRZOJ\UGJ5O;V=[8K;11
MF(LT;*,#'HO+<#UZ5%XCBFL/'/A[6RV+$"2RN3M^YO\ N$GL"^T9_P :[$'(
MR.E 'E6JK?W6O^%_ 6IW06![8RWC68V"8('V+[#$8R,=3]*Z34_AKX>NH(C8
MV$-E<PS)*DL0(^Z<D'V(S_.H?&.@7DVOZ9XCT.:U&K6 *-%<N%66,AN/8_,P
M_P"!>U7EU[7KJ2WBCT6WLMQ!FFN;Z-U0=PH0DL?3I0!%<^,;V2;4GT?1EU"S
MTUS'<S&Z$;%UY947:=V >Y&>U$OCR%H-"FL-,NKP:QN$01E4H5'*G)QD'\.#
M65IB:GX0U'68;2P74K34+MKFUEBN(P4=@21(&88' Y_QQ3+;0;W33X,MXUAN
M(]-DEDO)5N$ 0R9S@$@D L>G84 6AX_U,V>K?\4M,+W2B6NH6ND")'MW;M^.
M3@$X /3K5V[\?6\4&AO:Z;=7<FLH3;(C*OS#&5)8C&,]>E99L]3:7QR\MJN-
M4@*696XC._$;(.-W'4'FN=D6XTQ_AM!<6Y%S;O.)(1(FX<IWS@<<\F@#M++Q
MX)+351J&DW%KJ6F,@FLD<2,P<X4J>,CIST&?3FKG_"7"&]U>TO-.F@FTZS^V
MX#JXDCVY.".AR",>W6N5N;35YX_%'B.S@>TU"_2"*VMO/43")-HD.0<!F ..
MXQQS230:G<ZSJ4T>B&"*^T)K,,]Y&SB0!@I<YY)^4=2<8)[@ '0V'CQ;Z31Y
M#HUY#8ZHYBAN9&3&_L-H).#AN?;O5VW\6P3:MK6FO:30SZ7%YS>8R@2I@D,O
M/3&.O3-<2UOJEMX+\&PV]G+]LLKY))DRA,:C<"2,]PW^.*U?&NCM>^)=)O-/
MNT0WP.G7RAAAK?!=B>>. PSUY&* .RT'4WUK0;+4I+8VS7,0D\HMNVYZ<]_6
MO/O& TN+XKZ6=7F$5@U@TDP9R$9AOQG'T'Y5UNL>%_#VN74=Q>,V^.(1((;I
MHU"@D@84@=S7.:K9F+XFZ'-'8-<Z5#8_8Y)"5=%!W#YLDY !&<T ,^'YD7Q/
MK<NF2SGPKL4VS7!D*L_&2A?MD/G\*W(_B%I[/9226LL5A>S^1;W;21E6;) )
M4-N4$CJ1QWQ61HMKJ/AK5[SP\H:Y\/WH<V=PKJPM,@Y5N<XY_/ZFJ/AV2^LM
M/M- F\*6;7EK+L74)@GD;5)(ESU+<G&.I.<C.* -O1Y(=.\=^-[N5YO(MHK:
M5E#,P ,;.V%]>*T;#QI%>WMG9R:;<VL]]:-=6BS,O[U1SC@G!(&>>U8;2:O:
MZ]XVOK&U>*2ZMX38SR ;)6B0J=OJ>>/UK)T9-8N?%7A._ETC42MG;O;W4L\@
M=C(RD,YRQ(7+9Y[<#IB@#I]$\;RS>$/[:U>Q:"1[AH(8HB#YKERJHO/!XP2<
M=">E6K+QUI\T^J07T$VGS:=$)IEF*OF/^\I0D'M^8KCI?#^L7?@X69T6<W>C
MZDUTD,Q7R[Q3*[%0,_,,$?7/&:OWVDW'B7PYJUEIOA&+0FDMU DEC2.25Q(K
M[!M'W<*>2>I''% $'B#5KC5?$G@N^^P7UA%->#8)I% D0E2#L5C@\]QGFO4J
M\KOI-8UK4?!Y7PWJ=N=-N$:X,J *!\HX.>G!/.*]4H **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@#CC\1]+^W7=G'IVL33VCE)EAM"^T@X[&M_1]?TO7X'F
MTN\CN%0[7 !5E/NI (_$5S?@FY-WXH\92,,%=06/KG[BE?\ V6L36[U?#_Q3
MOK_3XP2NAR7-W&OW7==Q&['3HG/^- 'J-%><>'9_&T^LZ3>3&[GTRZBWW9N/
M($:AE#*8PAW=>.::=<UJP'BG1KO49&U5)$;3)"J[G24A4VC&#@D _7VH ])K
M-U+7+/2KW3K2Y\WS;^4PP[$R-P&>3VKB-:U#Q5=:K=Z1H\MZTNEV\(>6W$&)
MI60MN?S"" ?1<]#4VI2ZK.G@A];MT@U'^T@)D1@1D*PSQD<C!X]: /0Z*X>&
M36_$]_K4MCKS:?'87;VL%O'$CY9, M)D9*D@X'O6*WB[Q'>6OA2&*[AM+G4+
MF:UNI! KY:-PNX \>O H ]2HKS&?Q'KV@S^)](N-3%[=65B+ZUNGMU7:,C*D
M X/WAC\?I5JUU?Q/)-X6?^V+=DUN ET>S&(B(=Y(P02>O7C)Z8XH ]$HKS23
MQ3KF@6OB:RGN!J=Y97,$-G,\80EIER P!Q@?Y]M&VN?&&G:E?"[\Z[TO[))*
MEU/'#&T4H!(PJ,<KQCIW_, [JDR"2,C(ZBO+]'\1>*I])\-ZW=:K;2VVHWR6
MDEJ+0*<-(ZEMV>OR]@.WOG5TY=1@\<>,;J.[GN3;0PF*T(4+(3&S(F<9&#D#
M&.O- ';W-Q%:6LUS.VR&%&D=L$X4#).!STK'C\9>'YETYDU)"NI.4M#Y;@2,
M#@CIP<G'.*P?!OB&7Q%(BRZ[YDXMW6\TZ6V2.6*7(&5P/NCGKGMGVW;;PAI=
MK9Z3:HCF+3)3-$&"Y=R#\S<>IW<8Y [<4 7K0:5?7LFH6J6LMW&3;R3JH,B[
M3RA/48STK0KCP9--^*GE0\6^JV'FRID_ZV,XW8]U(%=A0 45P/BC7=;T^[UB
M:'5K2T2P@6:VLEA$SSJ "S/_ !(,MMSQCK[TNH>(]?O/%VF:+I4UG:)>Z4+M
MY)H3(48D\CD9(VC&>.3G/% '>UFQZ]IDNNRZ(ET&U&*/S7@"M\J\<YQCN.,]
MZXV/QIJR>'=/@D-JVM7>IMIBRE3Y8*L5,NT=>W''7\*CTJ"]M_C/)%?7BW<P
MT?\ UPB$9(WCJ <9Z],<8H ](JIJ>J66C:?+?ZA.(+:+&^0@G&3CH.:S_$FI
M7^F164EFUC'%)<!+F:\;"QQX)) W#<W' %<EJ.N7FL> /&$-\$,MC++;ATC*
M!UX(.T].M ';W.O:9::A8V,]VJ7-]DVT94_O,>^,#\<5HUYWXL_Y&OX?_P#7
M:3_T&.NUUN\GT[0;^]MEC::WMWE19,[254GG'/:@"_45S<PV=K+<W,JQ01*7
MD=C@*HZDUP__  EGB"'0-,U&Y@T[?JOD1VD<,<KE'<%BS 'D;1D <^]2C6-4
MO[#Q+I^M6""VM[1FCO!;O!%,ICY&R0DY!SW_ /K@'96EW!?V<-W:RB6"9 \;
MKT93T-35PVAW^HV7@GPHEC':K'/'&EQ<W3@)"NWLNX%F)X !K)U#Q9K>J>%)
MI;:>*SO;+6DLKB2)2%E7?@;1DD9)7(ST!YYH ]/HKB]5\5Z@FL7NEZ9Y!GL(
M(VFDDLIIE>5QD(!&?EXP<G/7VJ.#QEJE\F@:?'8QV>L:G&\DJW4;;8%3.3LW
M!CNQQS0!UEIJMA?W5S;6EW#--:L%G1&R8R<X!_(_E5RO/? @F'COQH+AHVF$
MMOO:-2JDX?H"20/Q-:?B'Q+K%CXNTW0=,M+*1[^%WCEN'8!"H).0.V!^/M0!
MU]9EYX>TJ_U6WU2YM ]];@+%,'960 D\8/N:Y:R\7^(+BVUJP&F6MQKNFW$<
M.("PA97. YR<X !)Y_+FH;KQAJAT?Q5$MS8276EV\<L-Y9J=C!P3]UBW(P><
MD<B@#T*BN!7Q=?:;X3\.+)+!<:MJ<"LKR1R, HCW;F1-SL>@..I)/ IL?CO6
M(/"NKZE>:.IN=/E50VR2"*=&. ZAQN_#Z4 >@45Q6F^*=='BZ#0M:T^SMWO+
M0W%OY#ES&0#E7).#T/3]>M8WA_QGJMK\/;_7K]A>R17C1KN!&T%U')'\(W=A
M0!Z=165HNHW.I+-*XM9+3Y3;75M)N68$?-QVP>*U#G!P 3VS0 M%>=CQQXHE
ML-2OX?#-O]FTZ:6*?=>98>6?F  '.!WK7NO%.I/I\>H:?I(^QG2O[1>:=R%R
M5W"(8_BP.?J* .MK'LO#.G6&N76L6XN!>79S,S3N5?TRI...WIVKEG\4ZMJN
MI^"IM.\FWMM4$TDT$I)R40[@2.P!)'OC-,UWXG+ISW\ME'8W%O97 MV22<K+
M,W&XH,8(&<=>Q/2@#T2BN-O?%NL-XB32=(T6&Y,NGI?(\MSY>%9L<\?ABLC6
MO&VJS>#],O;2!;&^GU5;&>-FW!"K-N 8=B5 /7@F@#TFBF1F00*957S=H+!#
MD9QSC-<;9^,-6-UI+:EI,-C:ZG<O;Q+),PF3 )4L"H')' ]Q0!VM%<*WC/Q%
M/_:WV'PNCC3)C'+YEZN6 &3@ <G&#^..:ED\=W4W_"/C3=%^TOK,#R1A[D1A
M&09922.<>O>@#J]12QDT^9-2$!LRO[T7&-F/?/%*EQ9P+:VZSPIYJXMT\P9<
M ?P^N!CI7GVM>(9]>\$^+--U731::AIL8\V,-O0@G<C*?^ Y_*IXKVST^+X>
MVEYI:75Q+;HD%P9>(&\M Q &0W4<^W% '3ZKX.\/:W>_;-1TN&XN"H4R$L"0
M.F<$51_X5OX0_P"@'!_WV_\ C5:?QEJER=1GT/0A?V6G7#032?: KRLN-PC4
M YQGKW[5>U'Q->V4UV(M%D>"UL!>2333>4I//[L?*06P/7']0"+_ (5OX0_Z
M <'_ 'V_^-,7X>^"GF>%=(M6EC +H)6++GID;N,UGW/C#4+O7?!RV*)%9ZM&
M\TL;GYC\F=I.#@#.>.I]*L6OB'2+'Q1XJ>73EM)K&*.2[O#)N,Z[?EX[<8&.
M] %O_A6_A#_H!P?]]O\ XU6N?A5X0N)XY/[-:()U2*9@K_7G^5._X3:\M;73
M[_5-!:TTV]9%%PER)3'O&5+*%S@\?G46I>/;RTU/6;.U\-W-V-)59)Y?M"1J
M$*EMW/L. ,YYZ4 7/^%;^$/^@'!_WV_^-'_"M_"'_0#@_P"^W_QI&\;PS/H\
M-A:K-<:I:M<Q)+.(@,#.S.#EB<C'L:Z+3KB>[TZ"XN;1[2:1 SP.P8QGT)'6
M@#GO^%;^$/\ H!P?]]O_ (U##\+O"$,TLG]E"3S#G:\KD)[*,\"M#QMK=SX=
M\'ZAJEHJ-<0J@3>,@%G5<_ANS^%4[[Q==Z;#H4/]C7%[>ZG#N"0R( '";F&3
MC\^!C)[8H =_PK?PA_T X/\ OM_\:/\ A6_A#_H!P?\ ?;_XTR;Q=JJ6HD3P
MM=>9':?:KE)IEC$0R?E#$?,V%SCL",\\5-+XRAEBTE-,LVO+W5(?/AMFD$6V
M,#)9F.<>G?)H C'PY\'-G;HMN<'!P[\'_OJJC?";P>SLW]G2#)S@7#@#]:P?
M#6M1^&W\9ZM?PR0PG4A'' 9 2TIW90'.,\CGICZ5T.C?$&+4I-0MKC3V@O;2
MV:Z$$-PEQYJ <X9/EW9P,'U% ##\*/"3(J-93E%SM4W4F!GKCFG1?"OPI 28
M;2YC)X)2[D&?UJ"/XD-)#IU[_P (YJ"Z9?R"&&Y+IN:0DA5" YY(ZG%:-AXT
M\ZXUFWU/2KC3I],@^U-&[K(9(L$[@5XSP.,GKUX- $7_  K3PW_SSO?_  -E
M_P#BJ0_#3PV 28[T =_MLO\ \55G3O&27FK6>GW&FW%E)?6GVJT\UU)D')*D
M _*< 'GWZ8K$?QDOB[0M3MX-#U&*S^SW$<MT[*JQ.B;MIP<^@_'ZX -,?#3P
MWP1'>D?]?LO_ ,576QHL4:QH,*H"@>@%<CX?URYBTCPW86^F7-[YFG0-/<1L
MH6#*+C<2>3WQUQV.:T8/$QN[Z>"TTN[GA@OC8RSH5PC@ EB,YVC(YQ0!OT52
MU?4X-&TFZU*Y#F&WC,C!%W$@>@K)L?%T5S>O9W&GW5G<"Q%\D<VTEX^^,$X(
MXR#ZT ='17$Z;\2K+4'TUCI.I06NH3>1#=2QCR_,)*A<@GN,?_J-6M>\312#
M5M(L+"]U":WMV%VUJRKY&Y3CDL,G&?NY/% '645R7PSGDN?A_IDLMS)<2$2;
MGD))_P!8W&3Z=/PKK: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ ILC^7$[[6;:"<*,D_0>M.HH \7L
MM1AMI]1O+/5O$-A)J4YGFC_L<,5;)/!R1WK5L=4\+VMGJ$=Q%K]]<ZC&8KF\
MN;-VE9",;0<<*.PKU(,&) (.#@X/0TM 'DFBZI8:3-:I+J_B:[L+0Y@M)-/8
M 8^[N8#+ 9Z=,@>F*T+S7_#5[XLL/$,EKK N+.)HU3^SGPV>A/';)_.O2ZR;
MCQ#9VWB.ST)TG-W=1M(C"/Y %!)RQ^G;- 'G6K:KI]UXAEUG2]2\0:7<3QK'
M.L>FLZR!>AP>^,"GS:OI+_V(J76NE-,N3<EI].>22=R23N;C'4]!7K%% 'DD
MFM6EGJ]_?:%>ZM8KJ,BR7,,FD/(N[G+)TP3G/UK&U?6](L;WPC;::=0C73[B
M2622ZM6WNSE26VG&XDYX'K7NE,:*-W1W169#E"1DJ<8X].#0!Y%<:CIMW8ZX
M;FYU:34]6C6%KC^R7"11J>%5>O3.>?3TJ5=9L8F\,^5<:FHT1"F#I$A\T%-G
MKQQ_C7K=9^GZS:ZE>7]I )1-8RB*99$*X)&1C/4$<YH \MOKG1-4F\1?;9-7
M:'5WB= FEN&@:,84Y[_I3M.UEHX9EU;7=>U!O)>*!3I;JB%E*[F Y<@$]37L
M%% 'BR7=I#X3T;18;W4XWTV[%TLPTB3YB&9@,$\$%C_A6I)XBM1X@UC4+6[U
M:W@U.W6-XUTJ3>CK&45E?/&,YZ5ZK10!Y9H>J6=UXUL-3U&>8W@A-K&\>E2P
M><Q& 9&+-G@'T Z]J]3J*YGCM;66XE)$<2&1R 20 ,G@=:QW\7:3'H5CK+22
MBSO95BA81DL68D#('/8T 9EG9W&M^,K[75\R"VM;7[%82,,B1CDO*%/49( ]
M<5I^$?[8_P"$?C&N2F6\$CCS&3870,=I*X&"16[10!P^J>!=1O+W77M-<2WM
M]84"9&M0[C"A=H;(^7VQTJQ8>#[ZW\3Z9K-SJ4$S6=@+(HEN4W@9^;.XX/-=
MA6<NMV3^('T-7?[<EO\ :6780NS<%Z]^2* .6;P#=R:,D#ZI"FH0:DVHVUS%
M;8".QR5*ECD9/J.@ZXJ[IWA75(O&2^(M0U2VFE^R?96C@MC&&&<YY8X.?2NM
MHH YKQ5X>O\ 6;K2+S3KR"&?3[CSA'<Q[XWSP20.<@9QR/PZC$G\%^(&T[Q-
M:+JEC,-7D\Q3+"R[20,Y(/ XP/O= ?45Z!10!R&J^%]3U+6O"UZ;FT":3EKC
MY6!=B%SL'/!*]SQ[UT&MV<^HZ#?V5L\:37%N\2-(#M!92.<<]ZOT4 <7+X0U
M2Y\$Z1ICW\,&JZ6T<D$\08Q[D!50>AQM."?TH_L+Q9=Z)J2:IJ5A<WUS;-;0
MP*&6V4,>6;C+-CI\OMWKM** //Y/!>NQV'A4VUYIYO=%!5TF5S"V1C<,<D@
M>F?;I4,7@/6X-$UJR%[I\DUWJ$=_;R%75=X8,P<<X&0,8)KT:B@#AKGP[XIM
M?$?]NZ-=:4MQ=VR)J%O<>9Y3R*,!EQD^PZ=.^:?J/A77C>:1K-CJ%G/K=DLD
M<KWB,L4JODX 3D!<D >G4UUFHZC::3I\U]?3"&VA&9)"I.T9QT'/>IX9H[B"
M.:%P\4BAT=3D,",@B@#DO"7AW6M*\0:YJNK2Z>3J;1MY=H7;:5W=V XP??/M
M65XK-VOQ8\+FQC@DN?LUQL6=RB'Y'SD@$],]J[K4]3LM'L)+[4+A;>VBQOD;
M/&3@=.356YT#2-2U2TUBXLTFO+=<P3$M\H[<9P>O<4 <E/X'UBXT_5[AI]/&
MJZE>Q7$D67-NT<9XB8XRP(R3QST]Z<WA+Q'?3:V=0ETE(]5L4MV%J9!Y;H"%
MP"/N\G/?IZ<^@44 ></X5\3-H.@7-NNGVNN:(/+A4N766((%PS8X)P>!Q@]0
M:O:OI'BW6_!>HVM\VGMJ%V(U2VA)6.)5;)^8Y)8]^W%=S10!QLVAZS<_$32-
M=EM[5;>WLFAF,<Y.'(;. 5!(R:S_  _X=\1^'_#FH:6+/3+Q/M1DB660XN$+
M#<"",+\HX]Z]"JM-J-E;WL-G-=P1W4^3%"\@#R8ZX'4T <)I^EZGX.TCQ/J]
MK96-@LI2>WLY)S)''M!WY(QUSP![#TKN-*N+FZTBSN+R)(;F6%'EC0G"L1DC
MGFKE(0&4@YP1C@XH \RTQ=>O=/\ %>EZ=IUL\%WJMY#]JEN-OE[FVL2F,G .
M1S5JX\):_9:G!'IT>G7MC%I0L(#>MM%N=N&;: <EN^!SG!X%==HGAG2/#OVC
M^RK0V_V@@R_O7?<1G!^8GU-:U 'FEAX9\46%CX4ECL[%KK1GN(VB:Y(#)(NT
M-D#MSP,]O7B[8Z-XK\,ZCJEMH=KIEQIM[=-=0R7$K*8&? (8#D@8'3\Z[ZB@
M#D;31M8@\?IJDWESVBZ4+)KAG =W#[RVT#CGBN<E\'^([KP?#;RV]JFI6^L'
M41&LWR2 DDC/\/+'UZ5Z5=WUII\(FO+F&WB+!0\KA1D]!D]ZGH J1?;9=*7S
MUB@OGB^94;<J.1V..0#[5YA'X/\ %[6&BQSV>GF33M16[DD^U$R7!!SELC'0
M =<\#C%>J7-W;6:*]U<10H[A%:1PH+'H!GN:FH \ZT^;6_[3\8VVE:;!<^;?
M%5EEGV!&,:@Y&,D 8/'O45[IMQX<UOX?Z?9QB]GM8[M""X3?^[7>03TZL0/8
M#WKL=&\,:?H5Y>W5FUR9+Q]\OFSLX)YYP>_/7K2ZAX:T_4];L=7N/.%W8_ZE
MHY2HZ]\=: .7O_#>M7NC^*[U[2(:EK"1Q16:3@A$C&T9<@ L<L?3ITJ.?PYK
M+R^ RMD"FD1JMV?-7*G8H/&>1\G;U%>B44 >>:9I7BSPG=:AI^D:?8WMC=W;
MW,5S//L,>X 8=1UQ@=.N#4^L:?XHDU^^$=E'J%G=:=]FB>2Y$<<+D?.VSGJ3
MZ=NM=Y5;^T;+[/-<?;(/)A)663S!M0CJ">W4?G0!YK!H'B:"/P9??V,CSZ2L
MD$UM]J13@C:K%N1C SQDU>?PC?ZKXD\8"\M7M[+5;>)()]ZD;D4=@<]1Z=J]
M$5E=0RL&5AD$'((I: /.[C3/$&N>&=/\-7FC&T\F2%+B\^T(8C'&1R@!W;CC
MH0/K4KZ1K3:IXY;^S&\G4K)8;-Q*G[PI$R 8)XSNSSCI7?U')<0Q21QR31H\
MAPBLP!;Z#O0!YN_ABZG\&:/HVI^'9KEX+1\3V\T8FM9LY &6 P1CH3TZ5J:=
MJ&N^&M&\*Z??VANYKI_L]U(\R[X23\HZ_-@9S_NUW%-:*-W1V169"2C$9*G&
M./3B@#G?'VDWFN>"=1TZPC$EU*$*(6 W;9%8C)XZ UE36^LS:CX.NQH=POV
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M2'R1CH/UZYKT&B@#E?AS:7]AX'L;/4K>:"YA+J4FQG:6)7OP,$#!QTKJJ**
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M;:*YNWM[^YCBWB,*64,.,#) Z@UV>@W$MUI$4TU_;7Y=G*W-L $==QV].^,
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M2>PCMO,U>,11)-OW!=XR3@8Y!%=/'XLUC^W]5T*[L+."]AL&O+62*9I(^
MY(!^\>P_Q.'>V.H>*?!L>F:9HUM93:3J47^C+=AXRH3<2),8)^?GKWZFMZ?P
M]JDOQ%N=7$4/V*;2FM0_F\AR0>1C/_UORH O^ KW4-1\&Z?=ZE(DL\J%O,4D
MEADXW9[TW6_$>I:9)JCQ:0&L]/MA.US<3>6LQ(SM3Y3G&#G..<<<BCP)9:OI
M?AFWT[5[2&W>U'EQF.;>77).3C@=?4_A6/J^A>);GQ'K[P6UG<6FH6'V:WGG
MG*_9QM(954 G))R>@X!SVH LW?CJ[^WZ%9:;HPN9=7LOM<7FW(CV_(6VG@]
M*K2_$.\M-&UNXN]#$5_I,\4<MM]IR&5V"A@VWIGVK 6+5]-\7>!;>XLH3J%K
MITT7V=9\!@D;*/FP1DJ,^F>^.:M^+]*OX/!?BG6=258[O4)+8+;A@WDQI*H1
M2PX)Y)/\S0!TD/BW4K?Q#8:;K6B)80Z@76VG%TLGS 9"L,#!/3C/) KD_"TE
MO:?#7Q9+<:>M];Q:E.S6I;:'4"/OVQU_"NJ.FZOKWB;2[S5M+AM+72@\J?OQ
M(9IF&!@#HHP",\YQ6+H_AO7[3P'XFTN7356\OYY9($^T(0PD"J>0<#&,\]:
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M"R*'6)",!CG&X]\9Q^E:PM-6N/B=INL2Z;<Q69TLQ/EU80RDLQ!P?8#(]1^
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M",% 4XPI.021GT%9WB?1M7MO#$-CJ&N7$XEUJ%8)D;$@A9QM#G RP/(]"!^
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M%N#;#CD9'7'K7EB:7XEE\#)X9C\/2_:+&Z#F=YT2.51*7^4GD_Y^E>K;T+E
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M,0ZG &W //-.\1:[J=CXX\-:7:&,6UX93,&."^U>F<' '7CJ?2K'P_T:_P!
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M$C&"1Z^@H [;P[H-AHT4\MGI:Z=)<D&6%9-RY7(&,<=STK;ID3M)"CM&\3,
M2CXROL<$C\C3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH ***#P* ,GQ)K\'AG1)=4N;>>>&(J&6$ D9. 3DC R16
MM7C^L27&O?!Z_P#$-YJ%T\]RX?R%EQ%&HG"A-HXX&#GKT-=89KK7/B!JFER7
MM_:6FGVL1C2WD\H2,_)<D<GT].#Q0!VE5M0NQ8:?<7AAFG$,9D,<*@NP S@
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MCDC//('O7:3:I=0^.=,TJ6"SD6:QDE:Y$9$@=3@A>3M4\<9/Z<@&O_8NE?\
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MZ^%-3T(:T^S4+S[4\OV8<<J2N,^JCG(KMX4=((TDD\QU4!GQC<<<G';-/HH
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MMYU>,OYD>[.!S@'D\^]9:^!K]-.\56HO[8G6YS*C>4P\O<Q)!&>>#Q[UW5%
M' CP'JNGWNF:CHFL0VM[;Z?'8W/F0ETF" #.,\=!Q[#WKL-(L[NRTY(;Z^:]
MNLLTDY7:"2<X"]@.F/:KU% '&6_AG7K'Q=JVNVE[IW_$P"J898G(4* %Y!'.
M!^M6'T?Q7,FI2/KMJEQ<1+%;+' 1';C)+-@GEL'&375T4 <A8>"1HWB!;O29
M8K?3I[80WUF0Q\X@'#@YX/O]?6JFD>$/$>AVZZ78^(8(](65BJ_9<S*C-D@-
MG&>3S[UW5% '#CP=KFG:QJMQH6NPVEKJ<QGF26V\QXW;.XJ<^_&?:I;_ ,*:
MPGBK3-<TN_MGEM[(64_VT,2ZC/S_ "]6R<]179T4 >=#X?:K:^$+C3+;4+62
M^?5!J"2R(R)D;>"!D_PYK?DT35I_&FEZS++9?9[:S>"95WAV=N25'3&0.IZ5
MTU% ',ZGX.M]1\9Z=XA,I1K5-LL0'$I!RA/T)S^ ]*S]6\+:];^*+C6_#&H6
M=N]\BI>1W:%A\N &7 /..W%=M10!4TRWNK73HH;V[-W<C)DFVA=Q))X Z 9P
M/8"N8\4>'=8\0-J%G+#I5UILL8^R&=WCEM9-N"PVH=W//4>E=E10!G'2A+X<
M_L>XF:16M/LLDO=LIM+?7O7,^'?#WBS1[2TTB;4]/_LNUD#">%6\]T!SY>"-
MH!Z$Y)Q7;T4 <6GAG6E'B]0VGA=8W?9OWCDKE2GS_+QQ@\9Y]:K_ /"'ZS!/
MX3O[66P-[HUM]EFCE=_+==FS*D+G.,GD#_'O** .,_X1?5D\0>*;]9;1X=5M
M1#;AY7#(P3: PVD <D\$_3FJB>!+^3X=6.@S7%M%J5A-Y]O/&2Z!PY8$Y4'H
MQ'2N^HH P=%A\4&Y$FNW&G+%''M6.Q#'S&./F8N!C&#P/7VI?$&EWFJSVUN;
M33;S2RK?:8+MF5MW&UD(4X(Y].M;M% 'FUIX US2/[&O].OK-]2L/-1H[EY#
M#Y3DX16P6PN?0=3SVK3U_1O%&L^%I+6Y.GRWTMY"XCA=DBBC5@3AB,MR,GCN
M<9P >VHH RM=TDZ]X:O-,G$:27,!7KN5),9!SC) ;';M63%X>OK#X>7.D1-%
M=ZG-:2)*[/M$DKK@G=CG X&1V'3MU=% 'FX\*>);"P\-ZCIB6*:GI5HUO-:/
M(=DJD>N/O9Y/.,]#5_5?#_BC5;"QU*2YL8]=L+LW,$,980["H!B+=3G!.3ZD
M=.:[FB@##\/'Q',LESX@6SMRRA8[2VRVS!.69CW/' XXJCXATW5;SQ=X;N[6
MU26QLI9'G?S0K+N7;T/4 <\5U5% '$76G>)]$\6ZCJ6BV5IJ-IJ@C:5)9?*:
M%T7:.>X[\#\J??Z7XCEU;PQ++'#>K9SO->3)(J;"P*X4'&54-QW.WGGKVE%
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M.N).,=B<?='_ 'T*:UCKTWA_P;"VA3))IEY!YZ>:A(2- N_KT.3Q[>]>D44
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M\]2:N4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !115#6M5AT/1;S4YP3';1ERH.-Q[#\3@4 7Z
M*\N\6:EK&E>&-%U>ZU>XBEO-2BEN$@;;'%$R$F,8Y*@+WSDY-=EI?BK2/$=Q
M>:=I]W/'>0J=RM"8Y%7@!U#CIR.H],B@#?HKGO"NM3:C'?:=?.'U+3)S!<,$
MVB0=4<?4?J#VQ70T %%%% !117.ZQI^N7&IR7%OK<MCIL5MD1011EWDYSEG4
MX'3M0!T5%><>#V\3^(/"UCK7_"1SM</<_O+=X8A&T2R89<A,@[0QSGT''6NG
MN?&_AVTFECFU(?NG\N21(G>-&SC#.JE0>1U/% '044QIHT@,S2*(@N\N3P%Q
MG.?2N:'Q&\(EXU_MRWS(Y1?E; (..3C"CW.!0!U%%8>K>,?#^A7#V^I:G%!.
MB*YC(9FP3@< '-)=>,O#]E>BTN-15)2ZQG]VY16;HI<#:I]B10!NT5C:QXJT
M7091%J5[Y3[/,*K$\A5<XRVT':,^M9NH:M=2^+O#$>G:BITV_CG=U1%99 BA
M@=W7OVH ZNBL;_A*]#&GW]]_:,?V:PD,5R^UOW;@XQC&3R<#'7M4E[XDT?3]
M/MKZZOXDM[H*;=AEC+NQC:H!+=1T% &K17#>#O%,MV?$LVJZG#)96-^R0W#[
M458\D#D<8X'YUTNB^(](\0PO+I5]'<JAPX4%67ZJ0"/RH U**JWNI6.G"(WM
MW#;^:^R/S'"[V]!GJ:A_M[2/[/2__M.T^QR/L2?SEV,V<8!SC- &A16;;>(=
M&O(;B:VU6SFBMEWSO',K"-?5L'@<&E&O:0=,.IC4[0V(;:;CSE\L'.,;LXZT
M :-%1R3PPP-/+*B0JNXR,P"@>N:SK?Q+H5U=QVEOK%C+<2@%(DG4LV1D8&?3
MF@#5HK+N?$NAV=Z;.YU>QAN5(4Q23JK GH,$^]27^NZ3I8B^WZE:6OFC,?G2
MJN\>HR>>M &A16==^(-'L(H);S5+.".==T323*HD'J,GD<U7NKRXEU726LM3
ML$L9M[21L<R7 VY7RSZ=S0!LT5QF@>+6;4]<M]=U+3H5M]0-K:J6$;$=<8)Y
M[<_6KFOZOJ=AXH\.VEH]O]BOY7CG#(2YPN[@^F* .GHK/N-<TFTOEL;G4K2&
MZ;[L,DRJY_ FKY(4$D@ <DF@!:*H_P!LZ7]CBO/[1M?LTK;(Y?-7:[9Q@'/)
MSQ3[C5-/M/,^TWUM"8AF022JI4>^3Q0!;HJ%[JWCMA<O<1+;D ^:7 7!Z'/3
MG--COK.:W>XBNH'@3.^19 57')R>@H L456BU&QGBDEBO+>2.,9D=)5(0>YS
MQ5#5/%&C:1ITM]<W\!BCVY$<@9CNZ8 //K]* -BBJKZE8QP13R7END4HS&[R
M !A[$]:JZM/J ALY-*FL0KW""5KECM:(]=A'5CQB@#4HJO-?6=NS+/=01% &
M8/(%P#P"<U4U+Q!I>DK9->7D4:WL@C@;<,,2,YSZ=.?<>M &G14"WEJ]Q]G2
MYA:;&[RQ("V.N<=<4Z&X@N59H)HY55BK&-@P!]..] $M%1SSQ6T$D\\BQQ1J
M6=V. H'4DUQ^O>-GM-+T'5-(6WN+/4;R.!S+G<JL,\ '@\'KT]* .THJ..>*
M8N(I4<HVUPK [3Z'T-)%<P3221Q31R/&<.JL"5/H?2@"6BN;\<>(;SPOX=;5
M;2""?RY461)21\I..,=_\^U9Z:EX[N;2TU&ULM">UF2.0P"24S%6P3@G:H.#
M_P#KH [2BC-% !111D4 %%%9<FKK>6&IG1'AO+VS+Q>63A?."Y"D\>HS@T :
ME%5=-DO)=,M9-0ACAO&C4S1H<JKXY /UJU0 445SGBCQ)-X?N]$ABMHYEU&]
M2U=F<@IN(&0,<]30!T=%%% !1110 445#=W=O86DMW=3)#;Q*6>1S@** )J*
M16#*&!R",BN5U3Q1J?\ ;5WI6@:0NH7%BD;W7F2^6!OY"J3P3CGDC]* .KHI
M%)*@D8)'(]*6@ HK,OM:@M].U*YM0+R33PWG0QN 0P4,1D].#FK&E7ZZIH]E
MJ"QF-;J!)PA.2H90V,_C0!;HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=+ATLZ7'86RV!SFW\L;#SGI]>: /.;W3=%M;;Q3>:9KBWTMWH[EX(ECV(H
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M6LYHIK?2@DD094/GR' 8$$<MR#D\=.3ZT <IX.B30/$]KI.KZ4R:Q,)O(U6
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MA@O#/8VLVE206\,P9W4EU*H>IS@=#TX%-\-:G8:'>^+-*\0SV\$SWTMSYER
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M%B-S-]WC&W/;N>:Y/18;*R\>G1IY)9-!^V33:>98R$^U  %-YZA1D#L3CJ:
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M3Q9H>CB$WNH(IG0/&L:M*S*>C80$X]^E._X2G0O[+34SJEL+)Y/*6<O\N_\
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M]'>W4+$\;&-E4=%RI''M6U)-%" 9943/3<P&:'ECC3>\BJG]YC@4 8FH>#-
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3L;X6/A#QI97%K>I/]HO7 ^RR;2KC"D-C'<'KTYZ5Z?10!Y]JVGIK'PDL;F
MO'=:?9Q7=O(5*,CQ("<9P>Q^O!]*VO T<]SHIUR]15O=687,F,\)@"->>VT
M_B:G\0^';S79XD36[FSL2ACN;:)!^^4YR-QY&1Q]*W8HDAB2*) D:*%50,
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M\^#^CVZ%UFL-0BCN%9"-A^<]<8/'/%>Y44 >3>)<ZA\2M3L[.8"YN/#\D$0
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MBH97S[@D _6NP6TMDN#<+;Q"9NL@0;C^/6B.TMHIGFCMXDE?.YU0!FSSR>]
M'FNA:7)!XGE\&O )-+TZ\.IJ[J.8R,QQ\=PYSSUVGC%93_V//?>)].\6Z_=V
M,SW[2/;PX"2Q[5V%=R,Q.!T!Z8P*]C\M!(9-B[R-I;')'IG\34<EI;2SK/);
MQ/*F-LC("RX]#0!YMI6K6&B>/[@:Q)]CMQIEO'IKW@VL(P!D$G@,3G(&.E+\
M/_$N@:)X4U!Y]1"6L6IR(KLC$E7_ -62 .X4GIV/2O2)[.UNBIN+:&8KT\Q
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M*<V@Z0^F_P!G-I=F;+=N^S^2NS=Z[<8S[T >=^*X-$L]#O)]#U!5M+W5;?\
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MFZW\0O%UAJGG2V<*1NBO</B,NH9F'..O(]*]+L-/M-+LH[.QMX[>WC&$C08
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M(S'O_NYK.M#-'\7=2OFLKS[/+I "OY#<D%3CIUX(^O%<G9V][!\'[*#[#?\
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M &_R-:\&:A+:7BPG3Y8F @9BC,J !@.G(H [O4-0M=*L)KZ]F$-M"NZ20@G
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M&EO(&;G#+(H4CT(!/YUS5KH^E:OX#U_6[Y/,UJ*6Z>2[<D2Q2QDE%!_AP G
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M(V]T\A<,WJ1CD^]6XXXX8DBB14C0!511@*!T '84DTT5O"\TTBQQ("S.YP%
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MV\<X'85T=UKNDV-PUO=ZE:P3+M+))*JD;NF0?7M0 J:)I::8^FIIUJMDXPT
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MO3;>PM4"001A$ ]!6=K6JM_9%W)I.I:=%<VTJQR/<OF.-LC*M@\'!_45;O\
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M5)(9@#\N?R/X"NC^(<4DW@#6$BC>1S"#M09. P)_05TVU=^_:-V,9QSBEZT
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M7LJNH!5W<$+]0N!^!K0\3)<V^H3:UI5Q87;VVEJ+_3KP9#0<L&0^^&&/\:]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MNYBQ^7G.S!]<8]JA\)7=QIOB/3="GN+'6+0V+2:??Q(JRP1# V'V.T#US].
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M HHHH **** "BBB@!H="<!E)]C3J\&T.P\(PZ+XAO-5G2WU&*]FBM!'*R.@
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MO+;[3;BU@W[UQG Y'/!^F.:T_#GB&W\2Z:]Y;P7%N(YFA>*X4*ZNO4$ GUH
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MNWB@NEV3JJ\R+Z$]<>V:V:* ,<^%=$,-C#_9\?E6#%K50S8B).<CGUK8HHH
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MO+2[N/L4L[7,%O%O>(2C@8SV[_C^/LE% 'DMI#J(TOX@W=QH^HVXU%"UO')
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M>TMI)))'MXF>1/+=B@)9/[I/<>U 'F-MJ-I_PLO0;O[3&L%SH*10RL<!W+,
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MS9R>#/&JZHUL-<^VS%EE"B7'RA=N><<-C%.MYM,EU?P\NIZI]AM3X:@6&?\
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MW\&Z/IJK*S>>&/E[#C"L,=?_ *U:^@Z4FBZ):Z>I#-$G[QP,;W/+-^+$G\:
M-&BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1\.ZXFG^"[;1]2\&Z]<2Q1-'(HTTE'Y)')Y].U7=9@U/QOI^E:)J6F7%DUQ
MU]/<"$[(6^81Q9(X;IG/..._ !TD7C&S/AZ#6+FTN[9+F416T$B#S9R3\FT9
M_B'/)'?MS4=KX\T:>+4VF::T?34$EQ',%+!2!@C:6!Z@<'.:Y"Z;7=>\"Z:]
M[H5PU_HM_%)<6LMN5^TQH",H#][(/('H?:DO=%D\2^%=4CT?PD^AR,H<&5!%
M)<L&!\L#@@'!//&<?4 '8KXUM5OA9W6EZI:3FU>Z19X5^9%&3T8X/L<4R3Q[
MI4>A:9K)AO#8ZA+Y*2"-?W;9(PPW9Z@],]*K:?KVK>*;>6U'AVZTT&V=)Y;]
M2@W,I"K'QEN<$G' 'KBN%-GK-SX!T?PW'X>U075AJ"M/*\&V/'F/C:2<L/F'
M.,"@#T2P\2WE]XKUC19=+FCMK(*%N8V!(W*6!(SGD=, ^]9FC>*M%T/P(-4M
MTUBYL([EXW,R[YE8L22<G&W)QG/?US4UG<W6F?$?75DTG4);?4$@>*ZBAW1#
MRXB""W0'/&.N:K^!]/?4?AW<Z-J-A=6I9YXF2YA:,D.Q8,,C_:_,4 =/-X@M
M8-5M=/:*??/;-=>:%&R.->I8YR.PX!ZUFQ>/-+DOK&WDMK^WAOR!:7<\&R&8
MGIM.<\]L@=1ZBN>\/^&=8D\&:M%J/FIJ9M'TVV7.,1Q[@N">S'OT( JEX:2R
M6VT>RE\!7HU>%HHWN9[39$I4C=+YA[X&[IR>* /1-?URU\.:-/JEXDSV\)7>
M(E!;YF"C@D=R*JOXJT]/$&G:,4N//U" SV\GE_NV&"<$YSG"YQCN*I?$:QNM
M2\ ZI:V<#SSLL;+'&N6;;(K' '4X!KE+"YNM:\8^$=1@T;5(;.RAEMII9[?:
M _ED9ZGC/&3CTZT =))\2] 2.255OY((9A!/,MH^R%B<?,3C'\_:M;5?$%K9
MWR:4(KVXNYHR[+9Q;VBCZ;V/;G\?05YC;)<1?"OQ9#)97B2SZF[HC6SAB&,>
M#@C_ &3GT[UT<6HOH/CFXU>]L]5DLM8M(%@D^S%V211S&R*,J3SQCKF@!OP^
M\1_9?!"W&IW%W=2O?200+M::5SC(4#J>YKHX_'.BMI%[J,KSVZ6+K'=0S0D2
MPL3@!E&?\@UY=I^G7]CH.BZO?Z5>SV6GZC.9[5XV#"-]N'5203@Y]LUM:I=:
M;>>!=?FT7PU-I]K+%'&)G@V23R>8. HSE1ZYZT =K!X]T&Z95MY;B1GE2&,"
MW<>8S@D;<CD?*<GM5?6_'4&FV&G75M:3S?:]0%FR/$RNF&P_RXR2,8 '4UC:
MTFEWW@7PS#?S7=KE(O)O+>,EK>5(^I&,XR,5BZG/J]SX7\/:AJ2374>G:T"U
MTD#;I8$;"RE>O.#SCGCUH ]#U#QAI.FSSPS-<-+;P">=8H&<PH>A? ^7Z&FZ
MAXUT'2Q8&ZO"!?Q>=;[(V?>N,@\ ]<\5QGB3Q!/>:KK%B;?44M[K2U%G':V!
M,ETS1EOG;;N 4D\# ^]GOFEHUVEUXF^'T@@N$2VL'MY3)"P"N(V3KC'WA^HH
M ]#LO&&AWVBW.KI>>796KF.=Y4*&-N."",]Q^=84.O/?_$C3HK:XU**UFL9'
MDM;F%HD.,;74$#.<GGGI7&F">\M?%[6]I+<[-;2],(C.9(5D8D@'KQVKHW\6
MV&J^.]$O+.UU*6**VGCEQ9OE"^W&1CIP>10!U5GXQTB_O;:VMWN&^U,Z6\WV
M=Q%*5SNVOC!Z&I/%GB)/"VA/J;V\EQB1(PB#NQQR>W^.!WKA_#-RNE>(=)M/
M#U_=7.C7S2>9874#;K+Y=W#$<#)QZ'WZUT'Q3CN)/ 5W]FCD>598F C4DC#C
MGB@#.UGQ2=.^(6B2SWUU;Z5<V+R/;.C [OFQE ,YZ?E736OC/0;O1)]82^"V
M<#^7*TB%61NFTJ1G)R/SKE9M62_^)/A2[S(+1[&78TL)0[VW+SD9Y('7\.M8
M@U:+3-'\7MIMI]J4:PKYG@\Q$#'F3!^]AE./P/2@#T$^--+-CJDZ"Y$FFPB6
M>"6!HY ",KPP'6KOAO6E\0Z!::FL$D!F0%HY%(P>^"?O#T/>O+K34$OO$_BA
MXVO+@ZAHCQ6TLMJR-<.D0#<!0!RI[5Z#X"U*VU'P9I:VY?=;6T5O*&0KAU4
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M%% !1110 4444 %%%% !1110 4A(4$D@ <DFEIKHDL;1R*KHP*LK#((/4$4
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M+O3+64Q27D13:<'!*KNR0/7'Y4 =E17)W_CRRMM3L["SL+W49KRR%Y;_ &5
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MV[?-,8WX],]<56_M[2_/O8/ML9FL5WW,8R6C7U(]*;_PD.C_ -E1ZG_:5O\
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M.?J*]@HH XCXA033>'+3Q!8^9#J.F3)<0*Z'<=Q"F,K[Y''MCO71^'-.;2]
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M3[8\+90S[_ESC@G8*B\;07,_B+3I]'U2TM]9LK:62.VN@-L\;<$ GO\ *?\
MZU '6PZWI=Q<6T$-_;O-<Q>= BR F1/[R^HX-.LM8TW41.;*_M[@6[;9C'(&
M\L^_IT/Y5Y3_ &W:W.I^ -<N+>#3;55N8Y,?+%'MRN >PR"0/>L^ZO(IX_B!
M<:?)YUM)<VCM]F;_ %D.YM^,=L'GZT >M-XAT^^M;^/2=3LY[R"%V"I('V,
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MRR/((8VD*1C+-@9P!W-<4OQ/M'TR#5_[%U-=)>4Q27;*F$.<*0H8EN>OI[T
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M;'IGKBDET^RGGCGFM())HL>7(\8+)@Y&"1QS6;8>+-#U2^2SLK]9IWW; (W
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MBWM]?\+ZIK26>DOJEIJ5VUW T<R)Y3N/F#[L'&0.F>!7:1W5O-/+!%/$\L)
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M)%G5ONEF)P!ZGG&3GI5_Q3=W;Z]K.DR:=J2VW]F!+.+3K5L3.4Q\[J,LJEL
M?=X.1Z^K44 >+1QV3>&/#[7#ZOI.KVEI(+2\2!]A8$Y1A@G'3\ZTUN=6TW6_
M#?BW6K.ZDCETTVUZT4&3"Q)*L57IG<O8?TKU:B@#QWQ1%)JFC^,=:L[:Z2RO
M5M(84:V*F=TD4L^,9P.@/ .3W K7-[(?'_@IH8Y_*?3")3Y+$!70[0>./F49
M]._%>ET4 9NBZU#KEM//!;74"PSM 1<1["Q7&67DY7GK[&M*BB@#S/Q7?V@^
M*OAR0)+FR#K=3"%BJ[E^09 YZ_\ CWUJY\29 -3\)C:[>7JD<S[4+;45ADG
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M:7]G%O\ V;9^0'\P1^0NT-C&[&,9QWJ]0 4444 %%%% !1110 4444 %%%%
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M>,R7UK+\%]61 YDDU(A?W+<L9E<=O[G^%>P27L0TMK[#>2(3-C'.W;GIZXH
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M#]UG4#Y01SUXH ZQ75_NL#CT-+7CGA;7[CPG9^)IK?0Y+O3K?5)?-E2X1!$
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M>PK$;LSMB( +P4';@ DFJR_$JQVV$S:3J?V74)&CM)D1'\UE;;@*&)!SZ@4
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M1WS6Y0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1UHJM?WD5A8S74\\$*1KGS+B01Q@]!N8]
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M"^9$H))7YCZ=#BN0UK2SK7A75E\/^$KG2MHB=A-;B&:Z*ODH$&25 ^;/<@
MUT]GKD_BNVN+1?#^H6$C6DD4MQ?0^6L;,N-J$\MSUZ=!GM0!:;QSI*:-I&JE
M+HVNJ3B"$B,91R2/F&>.0>F:CT[Q;-?>,]8T1K"1+?3T7]\HW,21DDX/0C&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %-=$E1DD171A@JPR"*=2.6",5 + < G S0!G_ /"/Z+_T!]/_
M / 9/\*/^$?T7_H#Z?\ ^ R?X5Y]I_CKQ-=Z+8>()(=.&GR7PM9+=0WF,&;
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M6%U?%)D8(Y$3E$8] 7 V@\CO3+E-</CFPDM;G=HC6K_:HB@PK<[2&[DDC@=
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M9N>> =P.23T_"LUO!FMZ=::&FGPV5Q-:WS:C>.\IC#RMU5>#P <9]AQ7I%%
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M/JEYI7AS3+:Y&F!([B:[F,89BN0% ';O]151_B.[>&8=3M=(:>Z%Z+&YM!,
MT4F<8''S9[8]?8U/_9^N^'?%&J7^FZ>-4M=6:)F3[0(C;R*,%B".5/MSQ63<
M>$-9L?#L36]M'>:Q=:O'J-YB8*BD/NP"0,@=^_)/M0!JCQ;XA_M>]T3_ (1^
M ZG'!]J@Q=?NC%G R2 2<\<?IBJY^)3MX:TC5[?17N3J$YM3$DX79+D@+R.<
MX)ST'K5N+3-93XF7VKM9EK&32Q!$[3+@,&!VXZC)![8YS7%+I6LZ#X)\,V=U
MIZK?Q^($:*!Y%(DR&(R0<#)R* .TT_QMJ U"]TS6M#>SU&&T:\AABE$OGH"<
M!<9YX_0U:LO&$\NKV.F7NDFVN;VS:ZBC6X#L,<[&! VD@=>G;UQC7&C^(]8U
M35/$7V)=,OETTV>GPM*'D#;BQ8E3@$Y('/&?:J.E:-XEMM;\-:@?#T,2V5L]
MM/F[4R$D'+NWIGD#GJ: +EM\3[J>S@U)_#DL6EM>"UDN?M2N48\?= SZ>W;-
M=)_PD[)XX'AN6Q,8>W,\-RTHQ* .0%QUSGO_  DUQ,^@^)3\,['2(M&=;R'4
M/,EB$T?[R,.SYSG'4J/7Y:V_B+ITMW!I-[83?9M8CNTMXF4Y;;+\K#'?'7V
M)H Z3PSKC^(M'746LGM%>1U1&?<653C=T'4@_E3?%\$5SX-UF.9 Z?8I6P?5
M5)!_ @&J&MZC+X+T;2H-,TU;FW\Z.T*>9M*@\ C^\2?\:U?$D-Q<^&-4M[2
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MFL\;VKB.6*XCV.I(R,C_ #TKS(:-=Z5#X/,ME.A.K27LL,<+M]FC9EPK8!Z
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M3E2N5&WG & ,C!H [JBBO-%\5^--1GUW^SK?1$AT>X=)!*9-[A<G ['(7VH
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M6>Y7AE/6-U8D]._%3>(O$5U8ZOI>AZ7' VIZ@S%&N=WE1H@+,3MY)XP!^HH
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MEN)@5>0G'#D8 ^]D]@IH [FBN"T+XD#4I=2MKBR@^TV=JUTHL[D3)*H'*AL
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ML8,^5;QK&I8Y) &,FK5%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:]DT:Q>Z9M[2M I8MZDXZT <CJ_A._OO%5OK5KIFGWMBU@ENEI>N8Q;\YQM
M(( )X/J?05W5K'/;:7#$R0M<10A2D(V1E@.BCG:N>G7 JU10!P?ASP_X@A\?
MZCXAUBWM52Z@\J,17!?R@"N!@CGA>O'?UJCJ7@;6[B\\06=M);KI^MW44TER
MTGSQ(I)9=F.3D\<UZ510!GV^E166@)I5I\L45OY$98_[. 37!P^&-17PUH_A
MS6!IVGZ7!<*;AQ<%VNVW%@B@@8W'D\_2O3*K7^G66J6WV:_M(;F#(;RYD#+D
M=#@T <I\/T6[?7==$85=0OV$3#/S11_*O7MG=^=1_$/0M>\36UMIVG06WV))
M5FF:6?:9",_+C' ]\UVEO;PVMO'!;Q)%#&-J1HN%4>@ J2@# UN'7)-(M[/1
M;2P221 LC7;EDMP ,87!W]_R'6H_!_A&U\)Z<\:-YM[<$/=7&,>8WL.RC)P/
M>NCHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ J*Y\_[++]E\O[1L/E^;G;N[9QSBI:*
M. ;X?26VE:-+IY@CURSGBGGN'GE,<C?\M2!_M'V&:M+X>\2:!J.H2>&9])>R
MOIS<O!?JZ^2Y !VE.H/OZ#WKM:* .1\4^&M5\0:)I%K]JM7N[2]BN9Y7!C5P
MH8': #@\CC]:M:KHNIW?C;1-6MWM!96,<JRK(S>82XP< #'8=QWKI** .8'A
M%5\=GQ DP6!HLO;#(#3@%1(1T/RLP_\ UUBOX/UF#Q+KNI0V6A7T6HNC1"^=
M\Q;0>PC/<]CVKT&B@#F="T+4K'2]3GU![2;6]09GEDB+"/A=J+DC(4#V[GK5
M1?"VI1?"[_A&DDM3?FW,.\NPBY;).=N>A].M=C10!RE]8^))-.M=)AM=*DM)
M+ 07,DLKYCDQM)4;?F7'3@$GKCNK>&;N'5O"WV62#^SM&C='\PMYK$Q%!CC'
MIU(KJJ* ./N='UW7M9LSJT%A;6FFWRW<$UO(SO,%!VI@CCJ,GVX'<5W\)W_B
M'4&OM:CATR7[-+:N=-F)><.0 68KT ' .>O;&*[BB@#@]*\):SX8OM<O[*Z;
M56N5A6WAO+G!D"C#&0[<9'1<=NM1#P;J%H\&K6=E8QWD>HF]^P12%8U0Q["H
M?'WN_0#.<5Z#10!S7AC2+_1;39.D9>\NIKNZ"OD1,Y)"J>,XX'YT[PEIFHZ8
MNL#4(H8Q<ZE-=1>7)ORKG// _P ^E='10 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
..%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>a123121ex-1021011.jpg
<TEXT>
begin 644 a123121ex-1021011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\.WOA35-;L;O1_[3U'5H8BN9YYS]G3:<[BYVXR<8&>3TKT9$2-=J*JKDG"C
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MVMO(TD%M#$[?>9$"D_4B@#EOBDC2?#?5U12QQ$< 9X$J$G\JYO6]1T?5KWP
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M9]+T[4HYY#;:A.+>!O);_6$XP>..1C/2H="O;-=6\1$>()+[R+C=-#*<+9
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MPZ5J$=S)!S(H5E('3(R!D>XXKR3Q'YMWJWCV&PS-"LMK)/# 1EE0CS".#R&
MR<<8.:['P_>^%;_Q19WVEW>I:GJ;0F)I)9&<6\>"WSEL #.1QGDT :_Q"\3O
MX6\+375NZK>S,(K?<N<,>I_ 9//_ -:CPSJ#0W:V5]XFBU:6^C%Q9#RE1O+'
M#<J,'GI]#[UF?&&>*/P#/$\B+)+-&(U)P6PP)P._%1ZWJ6F67COPGJEQ=6\5
MO)93K]I9@%(VC;\W3')_.@#2\3>*HG\$:OJGA[4HGFLSY9E10P5L@$<\'ANO
M(JK>:[K46H>"9([A?LFIJ%O$\M>7*!ASU&<GITQ7'_;;&?P'X_\ LDZR1MJ)
MD0\#<K,N",<<X/3TK8U2XLENOAK,]Y$K(JC:6&-K1H,D]N5 _'VH ]+N[RVL
M+5[J\GC@@C&7DE8*J]N2:YW6O$5I>Z3(=%\4:7:3121-)/)(CJJ$]",]Z=\1
M-G_"O]9W[<>1QN]<C'ZUQ7B*'2(_@A!=0)9K=7%E9Q>8@4-(R,FX9[D?/G\:
M /3;[6=-TJ&*34=0M;99>$:60('..V37+>-O&+6/A-=6\.:A9S[;E(I'7$HP
M<\<' /2LG7-2CTCQ'X4U-)K%S_9S(8[F81#85'S*YXSS_.L'7+&TL/A$Z075
MA<R2ZD)9GLI Z LQPN>^!@4 >LP^(='N/M0M]3M9VM4,DRPRARBCJ2!S47AS
MQ+I_BC3OMEA*" 2&B+#>GS$#<!TR!FN/F2SM_C1:0VRP1PRZ,P9(P KDLYP0
M.O&#6C\*]0LY_ VGV<-U#)=6Z/YT*N"T>9&(R.V: -AO%^E)XN'AMI@+SR?,
M+%@%W$C$?^\0<X]*M3>)M#M[XV,VKV4=T&"&%IU#!CT&,]>:XVYN5L_C3.7F
MCADGT<16YE. \A<;5&>IR.E8>EMHL_P>U*RU)H%U*%K@R1O@2_:=Q*''4G[@
M_2@#V.LR#Q%HMU<306^JV<LL*L\J),I**OWB>> *AL#]G\%VQU(F(1Z>OV@G
M@H!'\V<]QSUKS_PW<W>CW>G:+/\ 8M3L[RQG_LO4(.)$C"EV1AC/.%X]1W[
M'H[>(=&2VMKAM5LU@NF*P2&9=LA!P0ISSS6!8>*9K7Q3XALO$%]86MK:&%K0
MEA'E'W=23R?NY]_3->8SZEIQ^#.FZ:;NW_M&&]+-;EQYB#S'YV]1P17>-;>'
MKWXA^(EUM;"0&VM3#]I*\KM;=MS_ ,!Z>U &KXT\17VBQZ%<:;+;M!>7\<$N
MY=^]&Y&T@].#^E:\$U\?%-W#)?6+60@5HK53^_1N,LW^S^?;I7E%P/LWP_\
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M<?0&K5>6Z[::4FB^#=2T=8(KS[7;I UO'AI%(PXXZ^^?ZUZE0 4444 %%%%
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MK2RG3=2MKGRAF0(_*CU(Z@>]26FO:1?SQP6>IV=Q+(AD1(IE9F4'!( /3(-
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MR.#771QI&N$14SR0HQ0!YKK-]I7B&T\(+H,\#:A'>P/''%@O;Q 9DW*I^4#
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M;1]$7Q'\%8;>UV/>VSS2VQ!R4D65B /0D<?B*#+=>(/!OB'Q;]G:*XN-/%G
MJC+A$_UIX[%MWT"UZA:V=K8P^3:6T-O%G.R% BY]<"GPP0V\*PP11Q1+P$10
MJC\!0!Y=X?M/"T^K:#J5MKLUU>F+RH[6*&)6"[<,)@B@X /)8\XZFN;O=/TR
M'X5"]MHX#>-K#>9(H4O'\[ +D<@;54X]\]Z]MMM(TVS=WM=.M(&<;7,4*J6'
MH<#D5'_8&C" P?V38>26W&/[,FW=TSC'6@#B[.:UA^-NJ?:)(8_.T^,0^8P'
MF-\G"YZG@]/2N1LRJ_"[5_E9K-/$&ZZ2(]8<QYZ=NE>T/IFGR7,=R]C;-/$H
M6.5HE+(!T .,@<FH[71M,LHYH[73K6%)^)5CA50X]" .1[4 </KL=@GC'P>^
M@)9QR232"7[,JKN@V@D,!VQGKW]ZX_4--TNU^&&K7UC! MXFKLHFCP7C"RX4
M ]5^7'3%>RZ?H.DZ5+++8:;:VTDI)=HXP"<XR,^G XZ5!_PBF@?V=+I_]D6@
MM97\QXQ& "WK0!/%K.G'48=+^V1&_> 3+#N^8IZUHU633[..Y2Y2UA6>.+R4
MD" ,J?W0?3VJS0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %0W=K#>VDMM<H)(9%*NI.,BIJ@O)VMK.:=89)V1"PBB&6<^@
M]Z /(/ ?B&X\+?9?[3E8^'-7>1K2YE<GR'#%=K>F=HSVYSGK71:"VF>#;?Q;
MJEU&T*6VH-"B[R28PB,B*">^_P#7GI4WA7PV-4^&,7A_7-/FMGC\R,B5!N5B
MQ99$^F[K[&L@>!M=F^'VNZ-=227.H'4/.MY9) 3<*J1A3ECQPI')XQ0!U5MX
MSD35[+3M8T2[TIK\D6LDLB.CGLI*GY6/H:S=+\<ZDVCZ_JE_HT[P:==NB^2R
M?<4@%<9Y*]2>G/%-U&/4_%FK^&9!HUW8)870N[I[E5 3&"%4YRV2,<#WI_A"
MSU&.;Q#HFJZ/*EC<WEQ,EPP4QNDAQMZG.1STQZT :9\;0#5]#L387 76(1+!
M/N7:,KN*GG.1Q^=9GB;Q)IEYX7U.74]-OFLK._6V?[/, 796'S!E;IG'X\=>
MG.#P3XB;P[(Y#G4]#N FC?-M+QJ^XL03M.X$8_W .:V?%V@7T'POCT.RM+F^
MOIG1IFC^8^87\R1B?0MG\Z -2X\57J>/;#0K.RDGM6L?M$I$BAL,P 8[L<*
M>A).[IQ7)^'O$A\+7OBYO[,O[VU@U*3<\1!6% 6')8UT$]I>V'C;1M>@TB^N
M8Y]-%I.J;083N4C<"1C&3FLB'2-5&B^/XSI=V)-0N7DM5,?,H9B!C\\GVH Z
MV\\:V\=U:6VG6%QJ,]S9?;UCB9$(A/0C<1N/7@9/%5;KQAJ">.--T.#27:&X
MM!<R9=1( W'0D ;<'(ZGL/7GKS1Y;K0]&MY='UBVU.RTE!!J%F2'CF (,3 =
MLJ#G_:[5:2SU^#QQX:UF\TVYNF.DQVMV\>W,<I)W%N< #=GCWH VY/'UJETV
M-.NVT]+T6#WPV;%E./X<[L<CG%.U;QY!IFJ7^G1:1J=Y<6,2S2F"(;=A&<Y)
MZ8_KZ5P>O67B74-)U*RO="U>YN3J/VA9HY0(A$K8 11P#@GD GN>G'2I_:,_
MBOQ%=2:-?PQ7>D(L1:/.YPA.S(XS\Q'U7W% &V_CG3SH6FZC:V]Q=3:ED6UG
M#@RL1G=QGHN"":YS1+F,WGCZ348=2@MQ'&9H9G\R:-3&^X*<D8Z[>< 8[5E:
M-::UHFA^$M5&B7LYTL7<5S;+'B4"0DA@IY(Q6JDFJ7MSXTN1H.HQ6^IV"BW,
MD>&9EB*!=O7G=GVQ0!J1>--(T'POH$D5MJ<]M?*(K8;?,DR"!AB3UYX'?%:>
MD^,;748]5-S9W>GS:6OF7,-PGS*A4L&&,YR :X*:SU >#_ <0TJ_,MK?I).@
MMVW1JK\EAVSGC-;T[/;>(O'EQ=V,XL9=/CQ+("B2;(F!4-ZG=VH T++XB6]U
M?V-K)HFK0C42#92-$I69>N[AN  03Z"M;QEKLWAKPK>ZK! )I80H56. "S!0
M3[#/;_Z]><>$-22&\T&77H]=0V*+:V)GL@D"O(H3[P&2,8 S[5WGQ%L+K4_
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MR\F::XEAW/(W5CDUQN@:E9V_B;XB7$LX6(;&W8)R%#J<>N"0/QKIOAM/%/\
M#_2A&X8QQF-QW5@QR#0!8O\ QWX;TV\NK2ZU+9<6I F189'*Y&>RG/OCIWJ[
M=>)M(M+*RNY+O=%? &U$4;R/-D9^5%!8\>W%>>"^L8]?^)2&55DDL\)D#+%8
MW5@,?[14>M5_#M['I<7@O6+HXTR.TN+2:X.=MO*22-W'&<8_'VH [VX\<:,G
MA[4=7M9FN4L!^]B\MT<,3A5*L,C)(Y(]ZUM'U6#6M*@O[=9%CE4$!XV0@_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%IO7ROWA"C+ -G:<C\CVS6Q=^,XX[V_MK#2;_4AIV!=R6P3$9P3M 9@688Y
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M77?[&N;?[1IR6-I9M&/M$@W9+LH)Z$_7 Z<<^GT4 >=7HU^#X9:'%8Z??K/
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MU,/+;;K4C=A7^4^A.1@57EL]2;1O *_V/J._3KE6ND^S-F,(R@D_7J*];HH
MX+QIX<U&\\1Z??Z2O_'Y$VFWYV9"P/R6]B!G\<53\3Z&MGXSMM3N/#LFM:2]
MB+7R((!*\+J<J<'M@XKTFB@#RS6H+PZ%H<NG>&+G3[6/6DN'LH8<R>6IX=E
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MO)S\VPL!NQZ9!KLA9VH:!A;0@VX*PD(/W0(QA?08XXIRP0I-),D2++( '<*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%<P"YM98
M&9E65"A9#@C(QD>]9WAWP]:>&=-_L^QEN'MPQ95F<-MSR0.!QGFM:B@ HHHH
M R/$7ARQ\3Z>EE?F=8TD$JF&38P8 CK]":T+.S@T^RAL[6,1V\"".-!_"H&
M*GHH **** ,+5O"]MJ^N:;JTMU=17&G[C"(F7;SUR"#6[110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !114%Y=P:?937EU((X(4,DCGLH&30!/15+2=2&K:;
M%?);3P1R_-&LX 9E[-@$XR.>>:CUG5X]$M8[NXAD:U\P+/*@SY"D'YR.I7.
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M_,)(I8SS'(,X;WZ]*R++P3<1Z[:ZMJ'B&^OYX8'@9'1$1U;MA1T]>Y(!SVH
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MZ2P;V1, %5Y[\G/&#ZU';^$?$=KX:L]&:YT>]MXX'AEAN8FV DDJZD#)(SW
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M73VVF:SXFO\ PIXFS80"S5_.C&\!U8E<QC'0J,C)[B@#:\%:OJFIVFHV^L-
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MRY.>FU2,#NP[U+>V7B3Q9KVO-INH^3)87GV> ?V@\(@  P?+5#NS@\D]<^E
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MY'E+\K!]F0<9]^?RKE;;Q1KUQ\-8]6_M21;V#4Q \GE)^]0N%VD8Q_$.0.U
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ6NM7-E?Z9!]GCO($ +IZ$9_KW-;>@Z&OARRN9;G4+F_N)?WEQ=7!RS;5P
M.@ [<]:W** .#TG5;/Q'\28M4TJ87%I%HYCD<#&QS+D*0>0< \5$WPP;^R;K
M2$\0W::9+/\ :(X%A0%'W Y+=6Z>WK76:SK5AX=T>YU.>-W@@($@MT#-DD#I
M^/>KUE=1WUC;W<081SQ+*@88.&&1G\Z .8OO!,KZY/JFE:W<:;+=Q+%=HL2R
M+, , X;@-COSU^N>2\2:+#X2\.^']!DUFYBLVOGEEO9(-\28&X*R<@@L00IS
MW/:O6ZHZO?1:9I5Q?36TUS' N]HX4#/CN0"1T'/T% '":!+>ZZ;[2+3Q#%J>
MC36+PO<)IP@%NY&T*N %/!Z9Z#M6C/\ #Z6;P[HND#6-J:7/YZ2?9@2Y!RH(
MW<8R?K19_$G3[NU%Q8^'O$,UNV<20:?N0XX/(;':NOTZ^BU/3+6_@#"&YA29
M XPP5@",^_- '-7W@2+4O$&JZE=7Q:'4;/[(]N(1\B_+@AB3R"H/2ET7P??Z
M=)8B^\27=_;V&3;P&)8P#@CYCR6P#QD\5UM% '"3?#NYN?"ESH,^O&2.XN_M
M32_9%# D[B,!N[<_F/IJ_P#"*7*^*K?78=9EB<6Z6]S"L*E9U4Y[_=S^8YP:
MZ:B@#&\3>';?Q-I0LIY7A>.19H9DY,<B]#CN.3Q52R\/ZC)JL6IZWJ4-U<VB
MR)9B&#RTC#X!9AG+,0!QT&*Z+>N_9N&_&=N><>M9^BZW;Z[;33V\%S"L4S0L
MMQ$8V)7N!Z4 4?"F@WF@6U['>:@EX]S=R7)=8?+.YSDD\XYX.,#'/6H_$'AJ
MXU36](U>POH[.\T\R#<\/F;T<8(ZCH,_G7244 <5:^#-2M]2\4W7]IP$:S'L
M0>2<H<$ GGL"1QUZ^U4(OAQ?Z?9Z3<:1K?V36+"V-L9C$&CD5G9B"ISTWMCC
MTZ5U]GXBTZ_UV]T:&1_MMFH:5&0@8/<'OU'YBM6@#+T+29M)M)DNM0FO[F>8
MS2SRJ%RQ & HX4 *.!65JWA&637F\0:)J!T_5&C\N7=&)(IU'0.OX#D>E=31
M0!S=EHFM7+,WB#5X[F)HGB-I:P^7$P88);.2QQVZ"L,> ]:;2QX=FUZ.3P\K
M !3"1<&,$-LW9QC(QGT_*O0** .6C\.ZK#XQO]9BOK5;>>R%M#'Y1+)MY4GG
M!P<_6L4>!==7P%'X=75K,.MUYQD\DX9-V_:???@\ =,5Z'10!Y?:_P!JO\5_
M$<>FW-DEZ;*!6>=&9<[$R0 >H/UK2E^']Y9VVB/H^HP1WVG333R27,.Y9GE
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MV-FL<-FOD*0LF$WL&_BP6[YYSZ<Z_P#P@6EMJ^N7\A9QJT/E/&>!'D?.0?\
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M\0O')<1SQ"*02!V:+S8\;B ,GJ,]_P">U?SWFO\ CN?0$U2YTZTL;1+@_8Y
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX:@AOX8M."Q7T:QSKYC$$#!&,GKD YZYKI:J+J=F^JR:8DZM>QQ"9H@>0I.
M3Z4 8=]\/O#>HZ;:6-S9,T=JI6)_-;> >N6SSGWK:TO2;'1+!+'3K9;>V0DA
M%)/).3R>:Q_!/B:Y\4:7>75W:1VLMO>/;&.-RP^55/7ZL?RKI: ,3_A$]'_X
M2.77O(?[=* ';S6VM@;>5S@\#%58/ >@V\B^7!/]G6?[0MJ;A_)5^Q"9QQZ5
MTM% $5U;0WMI-:W$8DAF0QR(>C*1@BN:'P\T!=,AT\1W7V>&<7"#[2^0X&!S
MGH*ZJB@#%?PKI,NM76JRPO)<75O]FF#R%D:/ &-O3M531O ?A_0KQ+JSM',L
M6?*,LK.(L]=H)P"?6M26[U%-?M[2/3@^GO"SR7GF@>6X/"[>IS6C0!G:YH=A
MXBTQM/U&-I+=F#X5BI!!X.146G^';#3[Y[Y3/<7CQB+S[J9I75 2=H+=!DDU
MK'I7.^#?$TGBG3+JZELQ:R6]V]LT8DWC*A3G.!_>_2@#/7X7>%D3RQ:W'EAQ
M(J?:I,*0>PSQ6G<^#]+NC>+(;KR+R837%N)V\MWR#DKTYP,^M;]8_BCQ!!X8
M\/W.J3H9/+ "1@XWN> ,]J &'PKIIUVYUDFY^VW$)@D;SV *$8VXZ8X'XC-4
MO^$ T/\ L2/1]MU]BCG^T(GGME7QUSU]?SJ_H%_K5[]J76M(33WB91&8YQ*L
MH(YQCIC^M5_"GB9_$L>I&2S^RO97CVI7S-^=N.<X% $.H^ =!U35)-1GBN%N
M95"R-%<.F_ QR >>E3W?@_3[J>619[RWCFM$LY(+>79&\2YP",>A(^AJ_->Z
M@FO6UG'IIDL)(F:6\\P 1N.B[>ISC]16C0!S=QX*T^60&"[OK2$VB64D$$HV
M2PJ" K!E)Z$C((//6MK3M/MM*TVWT^SC\NW@0(B]>!Z^IJU10!QL7PQ\.Q:F
M]XJW?EM)YIM///D;\@YV]3R!P3BM6V\*VEKXKN?$2W5X]Y<1^4Z/(IC"\< ;
M<XX'>MVB@#F](\%:?I%SJDRW5[=?VF"+E+F0,K9SSPHYY(JK:?#S2[62U4WV
MJ3V5K()8;&>YW0(PR1\N,\$YZUUU8%EXF^U^,;_PZ]A+"]K")UG+@K(I('0=
M.OZ=J ':7X6MM(UW4-6@O+UY;]MT\4CJ8R>Q VYXY YZ&J,7@#3+>UO+:"\U
M&&"YG6X6-)P%@D#AP8QMP.0.N>E=710!C:5X<M]+U&[U$W5U>7MTJI)/<E2P
M5>BC:J@#\*-8\-VVKWUG?FYNK2]M-PBN+5PK;6ZJ<@@CV(K9HH YB[\#:9>Z
M'=Z7-<7N+R83W5P)%\V9@<C<=N,# X  &!70VEO]DLX;<222B*-4\R0@LV!C
M)P ,U-10!AZ=X7M=-\0ZCK4=U=R7&H "9)&4H,?=P H(P.!STZYK*LOAOH]@
MWEPWFIFQ\[SOL#7/[C=Q_"!DC@=378U#:7=O?6RW-I/'/ ^=LD;!E.#@X(]P
M: ,&Z\&VUY*_G:GJ)MGNA=FU#Q^7OW;_ .YNQGMFJ]U\/M,N-3O+V*^U.T%Z
M<W-O:W.R*7/7(QGGO@UUE<_X@\50:)I,&I0V[7]O-.L.^"1=JDG&2?3.1QWX
MH JW_@'2[[4'NQ=7]J)+5;22&UF$<<D0& I&,D8]^U0P?#O3[?\ LC9JFJ$:
M2[-:!I(SMW$$@_)R.!7844 <QJG@:PU/7)=8CO\ 4["]FC$4KV5P$\Q1@<Y!
M[ ?E3F\&6JZAH5U;7MW"-(#K&FX/Y@8$-N+ \G/)_EU'2UDGQ'IR^*%\/&7%
M\UOYX'8C)^7ZX!./2@"#0?#$6@ZCJ]ZEY<7#ZE<>>ZRD;4//0 >YY],#MS#K
M'@^#5O$-MK2ZC?6=Q%!Y#?99 OF)DD G![D_7\*Z.B@#B8?AS!:Z;IMC;ZQ?
M)%I]^;V$D(2/1>F..><=SQSQ;?P):7&L:]>W=W--#K$*Q2V^U0$   (/J,<?
MUKJZQO$GB*+PU9074UG<W,<LZ0GR%!V;CC)_SR<"@##MOAW&)-/:^U[4[Q=-
MF$EDC%%$8!& ?E);H!G(XZ8KI=<T6S\0:1/IE\K&WF !*'#*0<@@^H-7P<@'
MGGUK#U+Q-#IGB;2M$DM9F?40^R8$;%V@D@\YST_.@#+L_ ;QWUA>:AXAU.^E
ML=ZQ!RJKL; *D8).0,'GD8Z8J"Q^&T&GW;I#K>IKI!<N--67;'DD$@D=5]L9
M]Z[6:6.WADFE<)'&I=V/10!DFN5B\>1WHEETO0=9U"T3[MS! H23_=W,"WX"
M@#5U_P -:=XDCM$OXM_V6=9D]\'E3Z@C@U3\3^$(_$-Q:7L-_<:=J-IN$5U;
MGY@K#!7&1US5SPWXBMO$VG27=M!<0>5.UO+%<)M='7&00"?45L4 <9>> !=>
M&9](_MJ[,MW,DMY>3J)9)RH&!ST *J0.V/>K]]X5FGU*TU6SU::TU2&#[/+<
M>4KBXCZX=.!G//%=)10!Y=\0]&MM"^'-]'YQFO+Z\26>9@ T\I;)( X' / [
M"NHTGPZ\]W!KEWK+ZA<"U\NSD6-42%6'+  X8GCD^E=310!P2_#4+X,G\-G6
M9##-="X:7[.,]OEQGU .:T+SP3]O\16>JW.I-((+/[') 8!ME0J5?G/&=Q^E
M=;6-KOB*'0WMH3:75Y=7/F&*WME!=E1=SGD@< CC.3G@4 8^C^!)=+>&W?Q!
M?7.E6\HEAL7 4*0V4!8<D X.. 2/PJ)?A^RZ7XALCK$A_MJ?SI'$"@QDL6;
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MKD)<.3S*5XW9_$<5K_"1%CT'6$7.U=8G R<\;4[FNBUCP=HNMRVDUU;NDUH
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MW2ARV78C(D8< G _#%;'_",6I\42:\]Q<//):?9'B9@8V3.>1C].GM7/7_@
MVW@Z30]*OK^0M,C0F6ZVK!\Q.>!RHR21W..] '6:\@D\.ZDC9P;64'!(/W3W
M%>51VP'P%LO+=T>>Y0EMQ.#]HQD GCH.F*]@DMTGM7MILR(Z&-\\%@1@],?I
M7)?\*YL%\./H:ZIJ:VAG6:,><#Y6"2%7C&,G/U H Q;^ZU#P?XFU.."_OK^
MZ))>+'<2&4K*K!0W)Z=S[ U%X<TGQ0FH:+K@OXS:7"JUV9M1>42JZC'R%0%;
M/0 GD^U=A+X0M+GQ"VKW5W=3NUF;)X'9?+>,C!R  >>OUK/TKX<:3I5]#<+=
MZC<16\@DM[6>X+11,,X(7OC/>@#J[NZBL;*>[G;;#!&TCD#.%49/Z"O%)[B\
MCMHO&,6A:G%J=O>O>S7$D*I%);R' 0'=N("8' .,G/6O7/$>AIXCT:72YKNX
MMH9B/,:#:&8 YVY(/&<?E2W^AP:AX;DT2::40R0"!I!C?@ #/3&>/2@#FOB
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MUP))&7;Y[(A;<P[<D<=L5FWMW>R^%O']I=WTUTEI,T<)E&"B$9V_AG&>^,T
M>C:?J=OJ&FV%ZA\M;V))8DD(#'<N['N<9Z>AJX3@9/05Y*MN;W6OAM:_:;N
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M22TG%O+/=0VYGP,Q*S8+#/&<9ZUD^#?#\.H:)H&IW.JWMY':01O;VLFU8X9
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MRE@>21D8&-O'!^E 'L=8.@^)EUS5=9L!:- VF3B%F9PWF9W<\=/N_K7->'=
M6_T?0/$4NNW\=X\B7$[-<$I.SM_JRN< 9^4 >O>L-=4NM&7XDWUD66XCNHPC
MJ =F68;N?3- 'K]%>9ZS9GPO9^'=9T:^OYY);J"WE1[AI5NDD!)X)(R>Q ]*
MB2Y;1_&<D>NQZI;W$VHR2Z==17#-#=(Q.V%@20."HP!^7< ]1IKNL:,[L%10
M2S$X 'K7C>GV7B?Q#8_\)/#J$-I*ER\LCW&H2*L:QN<HT03:   .O3ZUZ?XC
M2.]\):F!(WER6<C!HVQD;21@T :=O/%=6\5Q!(LD,JAT=3D,I&00?2I*\H(>
MQ\*^!]&M;J>W@UEXFNY1,_F$%%RJM_"#G&!QP.G)K=L;:?P]\28=-M;V>33+
M^RDF^S3SM(8I%8<KGD#& .3W]J .UFN8+8Q">:.,RN(X][ ;F/0#U/M679Z^
M+OQ/J.B?9)8VLHHY/.<\2!_[H]!TS[&N5^(UO'/XE\&*^_#:CL.URO&4]#P?
M?K3KK0O[8^(^JP?VC>VL2:7"I%O,5+DE@"QSDXP?KF@#T&BO'++4]>U?0O"F
MD17[M)>"[\V1[EH6E$3%54NH)QCVYP.:[GP1I6MZ-:WEGK.H076)0]NB3-*\
M2'/#,P!(XXX['\ "[K_BFST&:VM3#<7>H76?L]I;)N>3'4^@ ]3Z&L^#QI=1
M:C8V&K^'+[3Y;V;RH7,D<D><9Y8'@]>,5CV+ ?';4Q<-('.G*+8'[I7";L9]
MPW3WKO[F&&5%>:))#"WF)N&=K#H1[T 345Y+I5MJ/B3P7>>+O[8U"'5U,TL(
M6Y*PQJA)";,8(P"/QJ]'?WWB'Q=X?MY-6O;6.]T-+NX@LY#&N\Y((//4_CA1
MZT >F45XK!=ZW+X!UG6V\2:K]ITJ^:"!1*-K*&3[_&6/SGJ>PK;O[C5-:\=:
M)9+K6H6-MJ.DK<R1VD@0(V"?ER#Z=\GWH ]/HKRVRU+4O[.U72+S7+Y%L]92
MTBO NZXN$.?W2D?Q\ Y]#4=[JFN:=HOCFW_M&[C?3IXFM)'??(D<AZ;CDX*X
M]Q0!ZM17G.BIJFG^)?"SRZ]J-[#JUE+)-!<N&566-&&, =V^O'7FLU]7U31I
M/$GAFZU6]EU.:6+^RI7ES(ZR,%&WD=,\X]#Z4 >L456M()+338+>2X>:2&%4
M::0Y9R!@L?<]:\ST_4=3AU7PU>V^MWVH6][>2V][+(2+>1B,@1(<?*/FP0/X
M: /5:*\@-SKM[8^,;S_A)=2B?1;V7[.B% K!,X#?+G&%Z X[XK=UV_U'3?$?
MA;6YM1N$TJ["P7<(DQ$KLAVDKZ$DY)STH ]"HKF_!KW5[9WFK3W4\L-_<O+:
MQRL2L<()";0>@(Y_$5S/C+4[FP\5-'J.I:KIFDRVR"UO;3/EQS9^;> /F'3@
M_P!: /2J*XRSGN[GQ_K-BNIW!M9=,BDB ?*Q,WR[D'0=,_4USNEZ[K&H>'/"
MNE'5I(;C59KE)[YF'F[(G(VJ2#\Q! !]J ._\2>(+;PQH[ZG>13R0(ZHPA7)
M&XXR?05IPRK/#'*ARCJ&7/H1FO+_ !GI.L:1\/?$4.H:O)J-F9+<V;3'=*@\
MQ=V]L#/)&/I^%7M,N]3T7QUHFF2ZI<7MKJMB9'CFP%A9$)&P <#C&/S)H ]%
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *BN;:&\MI+>XB66&1=KHXR&'H:EJ.X69[>1;>1(YBI".Z;P
MI]2,C/YT 4K/0=)TZUGMK/3K:""<8ECCC 5^,<COQ3;'P[HNFK,EEI=I LR[
M952( ./0CN*X?POK'COQ'87-Y%>Z.C6MR]N]O+ WS,H!(+ \ YZC-=+X6\7)
MKJ7MO>VXL=2TY]EW S@JO7Y@?3@_3]: -.P\.:+I<_G6&EVEO+C >.( @?6K
MOV2W-X+PP1_:0GEB7:-P7.=N?3-5K77-(OHYI+35+*XC@7=*T5PCB,>K$'@<
M'K2C6M*:Q6^&IV9LV;8LXG7RRV<8#9QG/:@"Q!:6UM"T,$$<<3,S,BK@$L26
M./<DFJ-AX;T32[G[38Z39V\^,>9%"JM^=6;C5=.L[F*VN;^UAGE_U<4DRJS_
M $!.37/WOB#4+7XDZ9H0\@V%W:/*?E.\,H8]<_[(H Z62TMI;J&YD@C>> ,(
MI&4%DW=<'MG%5-2T#2-8D234M-M;IT&U6FB#$#TR:?+K6E0WPLI=3LX[L]('
MG42'_@.<U-<W]G9Y^U7<$&%W'S9 N!Z\GIQ0!5F\/Z/<"U$NFVKBT_X]P8AB
M+G/RCMT%5+GPS;W7C&S\0.$$MI T:;5(9F.1ECG! !.!COUK4CU"REM%NX[R
MW>V?[LRR H?H<XH74+)A*5O+<^4<28E7Y#[\\4 ,U32K'6K"2QU&V2XMI/O(
MV?S!'(/N*JQ^&-$AU&WU"/3;=+JVC\J&15QL7T Z?X9/J:T%N[9[472W$36Y
M&1*'!0CUSTIMO?V=W;&YMKN":W R98Y RX^H.* ,Q/"'A^.RN;-=)MOLUS+Y
MTL;+D,_KST_"K6CZ!I6@6Q@TJQBM8VQNV#EL=,D\G\35N.\MII#'%<0R.!G:
MK@G'TJEIGB#3-7^V?8[I'^R2M%+E@,%<9/TYZ^U %37/!F@>([N.ZU6P^T31
MIL5O.D3 SGHK"H-.^'_A?2KQ;NSTL+.H*J[S22;<C!P&8@'WZUOP75O<[O(G
MBEV]?+<-C\JP_%GB&714L+:S^S?;;^X6"-KEL1QCJ78#DC _,T /F\%>';C0
MX-&ETU386[F2*+S'!5CDD[@=W<]Z-3\$^'-8EMY;_2XYI+= D;;F4[1T#8(W
M#ZYJ;1[V]@TQ!X@N]-%V22LEO+A)4[-AL8/L,CCKS6L)HBB.)$V/C:VX8;/3
M'K0!DZMX3T+6[."TU#38988 %A"Y0Q@=E*D$#VHG\*:%<:&NBR:;#_9Z$,L*
MY7:?4$'(/OG/-:T4T4\?F0RI(G]Y&!'YBN;U7Q=$?#FL:AH,MK>SZ:2)%=OD
M^4!FQCJ,'MW% %[3?"6@Z07-CI<$+20^0[8+%T[@DY)SWSUP/2J+?#WPN^F+
MIQTP_9%E,PC%Q*!O(QG(;)X_*MC2=174--LYG>(7$UM'.\2MRNY0>G7'-6FN
M8%G$#3QB9ND9<;C^% %>]TFQU'31I]W;B6U&W$9)&-I!7D'/! J/6M!TSQ#9
M"SU6T6X@#!PI8J01W!!!'YUHU&MQ"THB6:,R%=P4,,X]<>E %#1?#VD^'H'A
MTJR2W5SER"69NN,LQ)/4]35G4=.M-6T^:QOH1-;3#;)&21D9SU'/:IOM$/EO
M)YT>R,D.VX84CJ">U.WKA3N&&Z<]>] %0Z38'5(M3^S)]LBA,$<H_AC)SM Z
M54/A?2#KSZY]GD&I.A1IA<2#Y2NW& V!Q[=>>M:IFB$/G&5!%C=OW#;CUS2[
MUV;]PV8SNSQCUH YZ/P)X<ATNZTU+&06=U()9HOM4IWL.ASNS_CQGI6W86-O
MIMC#96JLL$*[8U9V<@>F6)/ZU+%-%/'OAD21.FY&!'Z4[(W%<C(&2* .2;X8
M^$':8OI(;S9/,(\^0;3[8;@=>/\  5>/@K0SJESJ!MY3/<VQM9LW$FUHR-I&
M,^@ ]L<<UO*Z,S*K*2IPP!Z'KS3J ,2P\):1IUU#<113R26Z-%!Y]S)*(488
M*J&) ''U]ZI0?#_P_;7S7$4$XB,GF_9//;[.'R#GR\XZC..GMTKID=)%W(RL
M,D94YY'!KD(/%&N:MK]Q;:/I5L^G6-]]DNYIYBKMC 9D& ..>YSQTH W/$RN
M_A75DBBDED>SE1(XD+,S%2  !R>37)^ /"]HVAZ5=W]IJ45[8Y46]XTJ(DF2
M=ZQMQT;&1QU[UZ#7/^'/$4VMZAK5K/9K;G3KLVZ[9-^\8Z]!Z9_'VH L:9X:
ML=*U?4-3MY+EKB_8M,))BR9SGA>GL/0<5GCP!H2W9E2.Y2 RB5K)9V%NS YY
MCZ8SSCI[5TTDB11M)(ZHB LS,<  =234&GW]MJEA#?6D@DMYEW1N.XH S3X5
MT[_A)I/$ :Y%])%Y+;9B%*XQC';UX[\UGK\/-#3P]/H8^U_8IYQ<,#.<[ACO
MZ<=*ZNB@#S6XT22X^*1C>+68K,:8EJE] )%!<8.#(!@Y'4DXS[UT]SX'T.YT
M&TT<P2QV]I()87CE(D1\DEMW7)).:Z.L_6+R_L;6*33M.^WRM,B-'YHCVJ>"
MV<'IQQ0!GIX2TVVUV#7(?M;7EM;B"-3<,RL@4J <]?Q/7GK65H:7/B+Q9_PD
M%]H=SIGV*W-K"MT,/(S$EB./N@< _P"T?>NUJAJUW>V5FLMAIYOI3*BF(2A"
M%)P6R1VZXH NNBR(R.H9&&&4C((]*XQ_A9X:D!C9;W[/YGF+;BZ81H<Y^5>W
M<5VM% '/CP=I@UFZU3?=?:+FV-K(#,2OE[0N,'Z _7FH]/\ !&E6%Y:W)DO+
MM[2)HK=;N<R+$K#! !]N*Z2B@#E=.^'F@:7?QW5O'=;8I?.BMWN7:*-^S!<]
M1[YJU9^#M)M+C59=LTXU0DW44\F]'R2>GXFN@K#O/$#VGB[3="^QEDO89)1<
M[\!2@SMVXY[=QUH @L?!.EV4]I(TU[=)9G-M#=7!DCA/0%5/<=O2F6O@72K6
M:R<S7T\=E,9[>&><LB.>X&/Q%=-39)$AB>61@J(I9F/0 =30!RI^'6@_VC/>
M 7:K/,9I;9;AA"[$Y.4'!&>W3MTKI[JVCN[.:UESY<T;1M@X.",&L#6O%\&E
M#0I(;<W=OJ]Q'#',C[0H?&UL$9.0<_A724 <N/ 6D-X=CT262\FMXI5FADDG
M)DB8  ;&[# Z>YJWHOA:UT:\DOFNKR^OY(Q"UU>2[WV YVCH ,_RK=HH P_$
MGA:R\3):?:I;F"6TE$L,UO)M=3W_ )#WJ.#PE;VVMWFJQZAJ'GW5NMO(#*",
M*N >1U[Y]<^IK9N+VVM9K>*>94DN7\N%3U=L$X'X UCZ7XF&I>*=7T,V;0OI
MP0F0N") PR..W&/SH RW^&FCOX>M=(-S??Z),TUO="4"6-F.2 <8QGVZ\UN:
M!X<LO#MO+';/<32S,&FGN9#))(0,#)/8>GO6O10!A>(?">F^(S#+=":&[@YA
MNK=]DL?T/IWQ4&G>#HK.^AN[O5]5U.2!BT(O+C<B$C&=H !/UKI** .3D\ 6
M)6^M[?4+^UT^^D\RYLHG7RW8G)QE2RYXR%(X&.E7#X1LQXJL]?BGGAEM+;[+
M';Q[1%Y>& &,9XW9Z]A7044 <;%\.K*+0=3T==3U#[-J,XGFR4)!SDX^7 S@
M9X["N?U&P>#XGZ!8VVH7D"VNF"V^V+"I(;YMH)9"F2,=N_K7J58\6O"3Q;-H
M#6<L;QVOVI9V8;9%W!>!UZGOZ4 9DG@+3GT1-/2\OHI5NQ?->I*//><9^<DC
M&>>PJM)\.+.2+58CK&JLFIJBW DE5R=I!!RRDYXQ]#6S8^(A/H]]J5]IUYIL
M5FS[ENDVLRJ,[@/2H=!\2W6LW:Q2Z#?64+VZW$=S(5:-P<8&1WP>GM0!%_PB
M,,5[HU^VI:@[:/ 8H4!7#KC!R O)( '&,X%9&E7-IXT\:6NM1:9>VT>DP.F^
M\BV&21SA0!D@A0&/KEA[5WM97B#78?#^F"[EADG>25((8(_O2R,<!1^I_"@"
M_=VL5[9SVDZEH9XVCD )&588/(]C7&0?#*UMXK)$U[6O]!E$EMF92L1]EVX_
M2NDT/5KG5H;AKK2;O3I(9?+V7 'S\ [E(ZCWK5H Y#_A7UF;#7+,ZG?E-8E$
MUP04!5M^X[<+T/0CIBL_Q3)#?:>/ L5MJ%W>.D""Z-NIC5002[-P 0H/0=P*
M[^B@"*UM8;*TAM;:,1P0H$C0?PJ!@"N?U+PDVIR:HDFL7BV6I*!-;;4<(0 ,
MH6!V\#GWYXQ72T4 <=J/@"*ZUBWO[+6+_31';+:21VSX,D:_=&[M^M,/PWT]
M?#]KI<.H7T<ME.T]I=[QYD+-R0, <9YQ^M;&N^)[?0=0TJTN+:XD.I7 MXY(
MP-J,2 ,Y.>I'X9K<H XNY^'J77AN_P!,FUF]GN;]HFN+VXQ([",@A0.RYSQG
MO5UO"&[Q)HNLMJ4K/IEM]G$9B7$F5*EB1T)S^G&*Z>B@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *1
MB%0LQ  &232TR6&*XA>&:-)(G&UD=00P]"#UH \Y^%FK:/8>!C)/>V=FINY2
MPFG52,D8#$XR<8KE]8,VIP>*_$D EBTF]N[: 2K&3YD2$!GP1]W@'ICG'->M
M?\(KX=_Z &E_^ <?^%:4EK;S6S6TL$3V[+M:)D!4CT(Z8H \^\,:/X:A\3-/
M8Z]%J5Q>6;Q/;VT,2Q^5\I)<1* G8<X))Q[5F>'M)>'7KGP3-9L;*SU'^TUE
MDC!5H0!L7G/); SQP&'J*]+T[1=+TD/_ &=I]K:[_O&&(*6YSR1UJR+:!;EK
ME8(Q<.H1I0@W,HZ GKCF@#Q<V&C:[>>)!XC\0K87*:A(&2>.$2&-3\FQF&_&
M!C"G\.:Z&\)7XF^%UMY9)771Y-CR+AV.Q\%@>A/H17<77AK0[Z^%[=:1937(
M_P"6LD*DGZ\<_CTJ5]$TN354U1["W:^1=JSF,;P/K0!Y;HMEH=_\*]3GU:.S
M.L 7+333!1.)@21\QYS]VF6>EV.I>./#4&LVT<JOX;ADF6X&"S@-RV><@#OZ
M5Z9<>%/#]UJ)U"XT>RENB<F1X@=Q]2.A/N:YC6?#5[J?Q,M;^;1([K1ELA9R
M.\J #)8E@N<\;L?G0!Q&OV\%KX.\50:>I&EIK<:VX'W P'SA?8' _ 5TUSH.
MC)\9;"QCTVS%J=*,CP")=A<,X!*]"<8ZUW<OAG1)M)CTM]+MC8QL&6 )A0P[
M\=_>I1H6EC5EU46,(OE3RUGV_,%QC _#B@#Q2UN /#MG937"6^CIXFEB>0HK
MHBA0R!@>"N2QYR./;%='+I&A6'AWQ>]CK]MJ"7-B)'BMQ&D<3J#M.8_E!+8P
MO'T.:[^'PEX?@TZ73X](M!:3-O>(Q@@MC&>>^*?#X8T.WTR;3H=*M8[2< 2Q
MI&!YF#D;CU./>@#SBRTVQT7Q-\/YM,MXX'O;5_M#IR928ESDGW)JSH]AIM[X
M.\5Z:MU9V,]QJDT'F$ $?O (U('.,G ^M=^OAK1EFL9AIT'F6*A+4X_U0'I3
M&\*: QO"VDVI-X0UP?+YD.=V3^//UH YWP3<F#7M1TF_T6WT_6(K:(S2VK@Q
M7$:Y"-@?=//U]<8 IWCRTLKC6_"@NK>WEWZB(V\U%;<FTY4YZC..*ZC3=#TS
M2&E>PLHH'EQYCJ/F;'3)/--U+P_I.L3P3ZA8Q7$L'^J9\Y3G/'Y4 <7I>GV&
MI?$3Q%I^L6%K)';VT$5A!+"N$@ ;.P=ADCI7'WMK&/"UK9[VN+.#Q6UK:.[;
M@;?;T5O[I(/3C(KV/4?#VD:M<)<7UA#-.B[%E(PP7TR.<>WO45QX5T*ZLK6S
MFTRW:VM>8(]N A]1COQUH LZ1HUAH5@++3;<06P9G"!BV"3D]2:\L\-16</P
MY\<LD<"3">[CR  P38-J^N,DX'3K7L58[>%="9[USI=N6OABY.W_ %@SGG\0
M#0!P5KI&E:/J?@&[T^%+>XNU(GD1SF4&$'GGGDUC:;H-KKND#6[SQ/9:??0W
M4DL\OV;_ $B-Q(V 6WCU! "^@[5ZQ_PC&B[K%O[/B)L/^/7))\GG/R\\<_R%
M0GP9X;;4&OFT6S:Y9S(7:/.6/?'2@!?%<:3>"M863]X/L,K@GC)"$@_F :\J
M.BVFG^!?"6N:=!LUE[V)1(KG,NYFX//(X KUOQ-'--X6U6"WADFFFM)(HXXQ
MDLS*5'\ZYOP'X1L[30M/NM1T8P:K -I\]MV&!.&49(!P>N ?TH QMNG0VGQ'
MM;AH%1Y9)%CE<<N8]P(R>N_D>^*HZG!;:G:?#"UGQ-;2Q!)%#<-A(@0<>X(K
MT&]\%>&]2U1]1O-)MYKIQAW;.&XQDC."??&:?/X0T*X&G![$!=.)-HJ2N@B)
M()P 1W ZT <%<^$=#3XK6.B_8RVG'23)Y#S.PW;G7.2<] *S[5A!9V&B74\S
M^'SXDGM0<Y5XE"F-"Q."A<MGGL?2NLU31)M4^**376F7C::=-^R_:HIVB"ON
M9^J$'!!VX]ZZ<^&-%;11HYTZ'[ #N$6#PV<[L]=V>^<T <9<Z18^'/'BP:3<
M1:;;7FD3FXB#[4B*GY96)/R\GKQ]T\\FL.UO;CPQI5[87.AK9:[%I4J6FH6\
MF4NHUPS/D<%@ &R>>,<9P?2;+P?H6GVEW:P6/[N[C,4YDE=V=",;=S$D#V!I
M=.\):+I<GF6]J['R#;@7$\DP6,]4 =B /84 <1X9T"RL+WPYK=MKEC"TD"Q3
MP1*=]RSKT;+MEL^PZ9^G1?$B[>UT"R4SR0VMQJ$$%VT?!,#$[QGJ <?T[UH:
M3X'\.:)?F^T_2XX;DDD2;V;;G.<9)QU[5K:CIMGJUC)97]NEQ;28W1N.#CD4
M <)?Z3:>&?'WAO\ L.S,46I">&[AC+&-T 4[BOMN)S[4OPWT_38=9\3O!8I%
M<6NJ3P+*&/\ JRQPH'0 8KK--\+Z3I5R;FV@E,_E^4LDUQ)*R)_=4NQVCZ8I
M=$\,Z5X=:Y.F6[PFY8/+NF=]S#//S$X/)H YKQ)LU3XC:/H6I9.EM:/<"(R;
M5GF!( (&"< 9Q[UQ'GG2-%\96MC*EI$VN+;$@D".(NP/0Y P,?3->NZWX:TC
MQ"(?[3M!,8"3$X=D9,]<%2#V%5+7P-X;L[.]M(M,3R;T*+A7=GW[>ARQ)!&2
M<CG/- '*1^&6T:XUF0ZCIZ65_ITNW3;8N0^$XD 9CC@'D>M9"6ZP>$O!6EV/
MV:&VU27S;L32,$FD"@[7P<X)P,9Z@<5Z+I7@W0-%$WV'3PIFB\EV>1Y#L_N@
ML20/85$O@/PVNC?V1_9V;(3>>J--(2KX RK%LC@=C0!Q&JZ-/X<\$^*[-]3C
M8N([B*UM9) +96?!')S@^G?%5O$VAVNE^ =/O+::\$^JW-FURQN6;+;"2><G
MJ2?KCTQ7H:>"?#\>D7.EI8L+6Z8-.//DW2$=,ONW$#TSBIK[PKH^I:3::7=V
M\DEG:%3"GVB0%2HP#N#9.!ZF@#A(O#.FCXGWGA_%U_9<^FBYF@^V2_O9-_WF
M.[)ZGJ<5E6ES=3?!T8NID%IJHB7:YRT?F ;6.>1\YX]A7JG_  C>E_VZVM>3
M+_:#1>29?M$GW,8QC=CWZ=>>O-4/^$!\.?V0=*^Q2_83/]H,7VJ7_68QG.[-
M '-:KIL6M_%Z33+V>[-DVD[VACN'16.[&#@CCOCU%8>J3W-O\&K1H[NY#P:D
M8D?SFW;4F<*,Y[;5QZ8%>G)X7TI-:76%BF^WK#Y E^TR?<V[<8W8/KTZ\]>:
MICP)X?\ [%;2'M9GLFN#<E&N9,F0]\[L_P"<]>: .9UW38=7^,%OIMW+=&RF
MTDO+"EPZ*YW,,':1QP#@=2*SXY-0_P"%2F.WENIEM]1:%E28B1[=92"@.<GC
MC KT/_A&=,_X2"/7"DQOXH1 DAG<@)@C&,X/7OWYZ\UQOC'PI_9OA6'3=%TR
M[NK%]0^UWJPS%Y\=?DW9R>@[].A))H M^#='%OXNU>[L;74[/1MJ"V@N/,B1
MI2!O81O@]@,D?2I_B782-I%GKD'FM+I%RERT<;$;X\C=T(QC .?8UG> =(N[
M?4UNK>VUZPL!&_FPZI<!A(QP 53 P1@Y)'I7H=U;0WMI-:W,8D@F0QR(>C*1
M@B@#R"'Q&+#Q;KFH0VT]Q::] 4TPAR3/*N$*KUP"Q/I@#@=JV]2\/0IXF\%:
M++/<>5!9W".T<K1L^U%R-RD$ ^QKM!X:T=8]-C%C'MTP[K09/[HXQ^/XYYYZ
MTV_\-V.HZ]I^LSM<?:;$,(0DI5.?4?YSWS0!YO=SW&BZ-J6DV=[)%9KXABLD
M,\[XB@90Q7?G<J^I!Z9K0/A:;0-&\26\VH6@L;O3998=-BED;:R+]]=[%L9Q
MGZC/:NJ/@30Y+?4[>XBGN8M1F$\JSSL^UP, H3R#R>>O;H *-*\":)I%E=6\
M*7$S74#6\TT\Q=VC;.0.PZ]@.@H X36;&*/P?\/((FDC$UW:NS+(2P9T4DJ3
MG')SQP*76M9O?".I^+K#3+FX\I+."XA:XG:4PNTB(Q!8D\B3//H*[)OAWHS:
M;IUB9]1,5A,)HB;MMVX=.?X1Q_#C':KL_@W2;K6-0U*Y269[^W%M/%(^8RF0
M>!U!^4=Z ,#P[X:U'2M<L-0BU2WCT^ZA;SX%NI9?M4K)GS!O/WB1NR.P_&H_
MAWI$UU8KJE[K6K7,\%U-$J27;&,JI*C<O?N>?Z5MZ'X T30+EKBV%U++@K&T
M\Y;R01@A.F.#C/7'>K_AKPS9^%M/>RL9KJ6)Y#)_I$N\@GKC@ #O^- '/^-=
M/MK[QCX/$ZN<W$PRDC(>$W#!!!'(%8<>FIJ'Q%\:;KJ\@\FWB=3;7#1$MY0P
M25.3CTZ5WFO^&+'Q&;)KN2YBDLY?-BDMI3&P/<9'X=.?>JZ^#K&/5M5U**ZO
MHY]3A\F<+*, 8 !7(R" ..3U- 'GNC:]J_B3_A%]-DNFVO8S32)]LDMVNG1W
MC4&1 6_AS^?M6Q<Z%XF@^'NJVDVM2OJ=K.US ;2Z=Y%0#/ELQPQX)P/IUK;?
MX;:&VD:=IZR7L1T]V>WN8I@LR[F+$;@.F3Z=JEN5C\#:/_Q+M*U36);F;]Z5
M8S2NVW&YV.>, #IB@"EX:U4^+/$$&JVLUP-/LK!$9!,P1[B098,O1B@XYSR1
MZ<6O%UW._B'PWHJWLEI:ZC-,;AXG*.XC0$(&!!&XG'!S5SP/H<GA_P *VMG/
M&([EBTTZ@@X=CG&1UP,#\*L>(O"^G^)HK9;QIXI;63S()[:39)&>^#CV'Y"@
M#B6ANK/Q5XLTV#5+\6,.D>=&DE\[O')@$%"Q+=CR/49ZBGWEY<K:?#FY&I7:
MSW36Z3H)GQ.I12Q?G!.?7D[O:IO#5C:)X[\1:9Y&H7$,MC#$;N\$C.1@AU+N
M,C=G(Q@?+QT%:MK\--&M38G[9JLWV&99K<2WA(CQ_"    >,X /'6@#D?%^J
M3VD.KZCI^KZG/=6^HQJMQ&[1VT _YX!=VUV'4G:1@C//7M3_ ,E97_L!'_T>
M*K7/PPT*Y%XCW&I+!=2F8VZ7)6))"0=RKC&>,<YX_"M*'PA;P:['K"ZGJ9NH
M[<6PWS*RE ,<@KSS\W/?F@#B-/GO-1^'7C:*_P!0NKEK:YN$21Y#NPB@@?0X
MY'3DU>UO3KVP^&NE:GI5YJ2S64<%U*J7+MOCVKO!&<8 YQC  /')KH8/ =A;
M:'JFDQ7VH>3J4AEG<R)O+'[V#MZ' R*34KU/">AVFCQ6&J:MOA>&+;#YN<*<
M*Y  ]!] 3VH 9X>NCK_BG4-<M;^632D@CMH(A(QC=R [MCID9"^N<]*K?$FT
M6YM_#VZ69/\ B<V\?[N0KPQ//'<8X/:MWPEH@\/>&+'33M\R--TFT<;V.YOU
M--\2^&H_$L5G'+?75JMK<+<+]G*C<PZ'D'!';Z]Z .<F-QX@\?7OAUM0U"ST
M_3;1' MKDJ\KM@Y9_O<!L8SV]ZYS5]=U_2O#.MVHU>X,^G:PD$-SN!=HF&0K
M''/&/Q]J[[6O!\.JZC!J=OJ%YI^I11^4;FV8 R)Z,,8/?\_IBKJ/P_L+_P .
MMI'VNZC$EU]KGN,AI)I.Y8D?RQTH V]#TJ;2+.6"XU.ZU!Y)FE\VY(+#./E&
M.@R#Q[UQ5OK-[;^+VTWQ%/J5G/)J.^QN(R1:S18&V''3GGGKD\FO1HUV1JFY
MFV@#<W4^YKD5\ Q-/ MUJ]]=6-O>?;8;2780LF21\V-VWD\9QS0!BK=ZB?"7
MCG.J7?G6-]<?9YO,.Y%558*#V'4?C5BUOM0U[Q'I^D'5KBTABT:.ZE\E@LDT
MKX&[.#P._N:T;SX?6]W>:G(FKZC;VFI%GN+2*0!&<C!;U]\=^G3BEU/X>V=]
M%IQMM4U&QNK& 6R74$N)'C'9CWH Y;Q9I^I6UKX2L+W6C>7@UH(+Q%&Y,L-N
M0<@L,]_I6_X6O=2M_'NN^'[K4I[ZUM8(98GN,%PS*I/('3GI5RY\ 64MKI,$
M%]=P_P!FW/VM7.V1I9<[B[EADG-7[/PM'9^,+_Q$M[.\MY$(W@8+L  4#&!G
MC;^M &_1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ_-AO,29D!+L>"')XSST%<]X=L?L7A+P?KEO=WB7DNK):N/M#&,Q-*X*["<
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M,+1N26A'W2W^T?0>N* $E\):%/J=SJ,FGQM=749CF?<?G4C:>,XR1QFJ=O\
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M.[!54$DDX %<IH/B76M=FLKV#2;?^Q+MI0LXG_>1JI(5F4@=2.@S0!>'@W2
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 51UI2^A:BJ@DFVD  '7Y35ZB@#Q"ROXT\ >"Y_
M/1K"QU4?V@H(/EGS&9=X^A)_$5VLZVD_Q5TNXTEH&E-E,U_)$-P*9 3<0<9R
M#C/I]*[&/3[*&W>WBL[=(),[XUB4*V>.1C!I;6QL[+=]DM8(-WWO*C"Y^N*
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MWUC>R7=[:W-F6\N2UEV':WW@3COB@#.^'-U>7'ARX2]GFFDM[Z:!3,^]@JG
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MF7E6YSDDXZ_W:R/"7AS3;B/P[KK>(["&Y69&,4<(6::0G!C9O,RQ/(Z=R<4
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M^NZ7:7=IKE_%=L)=UN%F:5XXR.%9F4$].N/6@#IJ*** "BBB@ HHHH ****
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MY]/0'VZT 2_\(_HNUU_LBPVN@1A]F3#*,8!XY P./85(NCZ8C6[+IMF&MO\
M4$0+F+G/R\?+^%7:Q=8\4Z7H>I:?87LQ6>^?;&,<*/[S$\ 9P/QH UIX(;J!
MX+B*.:%QAXY%#*P]"#UJI!HFDVL4T5OI=E#',NV5([=%$B^C #D?6L"W\22V
M_CK6M.U2_M(+"""&2V$C*F-PYR3U.?Z5K:E=7$CZ5-IVJ6$5O+<J)/-(/VB,
MC[L;9^]Z8Z_S 'GPSH1L8;%M(LFM8&WQQ-"I53Z_CW]:AU31;15N]3L=(MIM
M7-NT<;?+&SY7&-W;CC)[<5?GU?3;:Y^SSZA:13Y \J295;)Z<$YYJQ<2^1;2
MS;=WEH6QG&<#- '(>!O"D.FZ'9-JFA6=MJML"GF (['G(?<,\G/U_"NEAT;3
M;?4Y]2BLH4O9UVRS*OS...OY"N(LO$'BS5?#$7B#3;K2KH,<RV$=LY>)=QR
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M'3+/[)9-B1[UF5IR!N.P#C'.,^N:W?#VKC7O#]CJ@A,/VF(.8R<[3T(SWY%
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M@9QP .GUSM:'H%IH,$J02W,\TS!IKBZE,DLA' RQ[ < 5JT4 %%%% !1110
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M-C.Y;:%8]P&-Q Y/XG)KQ_Q1XBM+K0_%<$)M[.X34T*0(#YLS(X#2-DGT'
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M,FD_LK3_ .T?[0^PV_VW;M^T>4-^/3=UH 9;:UI]WJ,NGQ7*&]BC626W)^=
M>F1ZUQOQ DBM_&'@NXF=(HTNY-\CD*%'R=2>E=5#X>M(_$]SKS!7NY8EA3]V
MHV*!SR.23QR>PQ5^\L+34(EBO;6&XC5PZK*@8!AT.#WH X:WCTB_^*.OF[%K
M,!IL6TN00$(^<@]N"O/H:YNPN;5/ 7@"266(/%K*Y9F&54/)GZ#[OZ5ZPVC:
M8UU+=-I]J;B:/R9)#$NYTZ;2<<C@<57_ .$9T+R(8/['L?)@8O$GV==J,>I
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M5U234;VP66XDC\N0[V <=!N ."0.]<MJ_A]+/Q1X6TZPTG4/[(L1.7GMV?\
M=F48'S@Y&&&3SP#0!SNO6B:%H/C?2M/NI_L=HUE+"OG$F)W<!QG/L.#6JNBQ
M>&?$WA"YT7[09M2)2[CDE:0.FP%FP3Q@$G\*V/&7AF.S^'6I:5H=A<33W4L;
ME5+2N[;U)9B3GHM;.@>&M/M5LM4-M.M\+..$?:)&9H%VC*J&)V]^!0!QGA#1
M3K_@'Q+IZ2-',^JW#0NK$;7"H5Z=LU=\)7B^*M2T62194FT"T9+H$,N+@_NP
MI]?E5C^(]ZWO[*A\#:7=7'A_1[K4);B56F@%P2Q//S?-GUYQ_2K/@_29].T^
MZN;VW2WOM0NI+J>)6W",L>%R.#@8Z=\T 9/Q5M5NO"< =%9$OX"P)(X)V\8_
MWJ9=P6FK_$@Z'J&XV=KIBR6ULCLB%BV&8[2,D# 'M76:QHUEKVFR:?J$1DMW
M()"L5.0<@@BJ-SX/T>Y^PL89HYK&/R[>XBG=)47'3>#D]3UH P_ #36FJ^)M
M$#3/8:?=K]F>5BQ <$LF3Z8!_P"!5F^,(=/U#6]>C\R\N+VSTAI=GG;(K4A=
MRD8.2QZXP:[[2]*M-'M3;V<956<R.SL6=V/5F8\D^YK)U+P-H&K:M+J=Y:2/
M<S($D(F=5< ;1D XZ?RH XZ>R.L7OP[AN;V\\F\TV19Q%.R%BL"L22#G)S@^
MHIFA:1+K?AWQAX<AN)4%GJDJV3M(Q9"I^49)Z?+C\37;67@G1=/FTR6VBG1]
M-#BV/GL=H<DL#SSG)ZU7FT^'P99W^H:+I5[J-U>SAYH$F9B[$DEN<XZG/'I0
M!@>#[\^*-6T6[VM&^CV#1W0RY_?G,>TDG!X5FYR1N')J[\6II[?P8LUO<302
M+=Q8:*0IGKP<=1_@*V/!NCR:9IEQ<W-LEO>ZC=27D\2G/EEVR$SWVC ^N:OZ
M]X?T_P 26"V6I)(\"R"3:DA3)&<9QUZT <GK&D1:M\4ELKK4;Y+672C*;>.Z
M:-7._:5 !'&!DCOBLFVTF\UOX5ZG8)=W$MSIU[.+5VE(8B,X"D]^"W7U'I7?
M?\(UIW]NV^M-Y[WT$/DQR/,S )C&,$X[D_7FI-"\/:?X<M9K?3HY$CEE,KAY
M"^6( )Y^E 'G\_B"XO\ 2[[QGIY9/L6DI:HN\[1.Y!<[>AV!AUR,_3B3POX?
MU:&^T;Q#_:UI';SJOVG-Y+(;K>  "'RN[/8=_I7>V/A_2]-TN?3+:U5;.=I&
MEB/(;?\ >'T[8]*RM'^'WA_0[];NT@F+QMNB269G2(XZJI[]>>O)H \]U&QE
ML_!VMZV-5U62\TS67BMS)>N5"K,J<C..0QR:ZVPL[>Z^*SW[B19I-'AN,+*P
M&XL5/&>1@#CIWK3D\ Z7+HFH:2]SJ!MKZX^TS9GW-OW;N"0>^,]SCK5MO"&G
M'5].U19;Q+JQMQ;*Z3D>;&.@?NW//;/?- 'GMQXCU6P\+>,/*O[V6XAUIK6.
M9WW&",OC*GMP".P!(Q6UJNE#P5K.@7FC7-\\5W?+:W-M)</*LP<'YL$_>&"<
M_P"3T5IX&T:UL]6M)!<74&J2^=<)<2;LMG.0< ]><\G@5)IW@^RT^YLYVO+^
M[^PJ5M$NI@ZP9&.  ,G!QDYP* /.KVTU&#PMXCU>3Q!J[WFD:K)';@71$> T
M8Y4Y/1CQG'ZY]<TVZ:]TNTNW4*T\*2%1T!90<?K7/+X TM=&U32OM>H-;:E,
M)Y@TP)#9S\OR\9P,]>@KI+*U2QL;>TB9VC@C6-2YR2 ,#- $]%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5#=W45E9S
M74Q(BA0NY R< 9-352U>-YM%OXHU+.]O(JJ.I)4X% '$ZWXSDU#P1IOB'2KB
M73XS?QI<+(HSLW%64D\8Z'(]*ZK2O%F@ZW/<0Z=J<%Q);KNE"DC"^N2,$>XX
MKRR'5-//P7T>.2XC/V?48TG0C.T^:SD$=_EY^E=7J%]9P?%2Z?$4N?#CYCZB
M0B0O@_51^5 '5V7B;1M1N8;>SOXY9)U9H@ <2!20VTXP<8[5#X=\3V?B3[=]
ME5E-I<M P8$$@?Q<@8SZ5YG8Z[I=Y?\ @.Y6:WBDAFEB>"UB9(K?<H 3G)SG
M'.><DUU_P[U"U,FO:9YH%['JMS*T)X;86&#]* .KO]8T_3)H8;RZ2*68,8T(
M)+!1EB /05-8W]IJ=G'=V5Q'<6\@RDD9R#VKDO$>NZ;I/CG2TODMK4O9RXU"
M56+ $X\M<< YYR<^G>F_"FZ@G\$QQ13>9)!<3+(",$$N6&?J"#0!N:KXO\/Z
M)=K::EJL$%PQ'[LY)&>A. <#W-.U3Q9H.BVMO<W^IP117"[X2,OYB^H"@DCD
M<UPMCKFA:-K'BS2_%2""2\O7<&6-W-Q V=@&T'@#I]?:K&GWUKHOQ'$][FPT
MV^TF&+3EN/E5%&W]WSPI!SQ[^] ':#Q1H9L;:]74[=K:YF6"*16R&D/(7CH?
MK4_]N:8-3N-.-Y&+NVA\^:(Y!2/^\3T__77E.J>5;Z1K^IP1,NE-K\$T3J/E
M8*1YC*/3=WZ&MVUU?1;[XIZA>0W,$UD="(FE7YD;$@W?7Y1CCTH Z2[\>^&[
M>RN+B+5;:Y:&%IO+A?<6 XQQ[X%;.E:G;ZQI=O?VI)AG0.N>HR,X_"O++""V
MN/@#/);11/=1V\B2NB@NH$V\@GKTP:]%\(WEM>^$]+DM9TF1+:.-BAR RH 1
M]0: "7Q?X=@N7MY=:L4F1_+9&F *MZ&I?^$FT0V$=^-4M3:2R>4DPD&TO_=S
MZUQO@B*RN?'GC(R1P2S1WJ/&64,RX+Y(/;G%<C'KNGQ_"N?2IIXHKZ'4LF'^
M,J)@Q8CMW'X"@#T<:WJ'_"U6T0S+_9XTW[0(P@!W[@,D]3W_ #K97Q+HCZI_
M9BZK:&^WF/R!*-^X=1CUKB[^02?%V86MS&+B?072' )*ODE>/ISCTK#\,_\
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MC<>3E6..FW)_ 4 >P^(_$-CHME-')J-K:W[P.ULD[#YF ..,\C-8-CXOO?\
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M4'!8>P]:+2_L[]6:SNX+A5.&,,@< ^^*\6T^PAL_@NNL6EG$E[*Q@N;L#YQ
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MQ^:B8*ETSC<N0,C/I0!?BM+:&:2:*WBCED^^ZH S?4]Z9_9UB7E?[';[Y?\
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MQ\WKP.]1:GHNG:QI3:9?6RRV3;08@Q4?*01@J01C J>.^M)9!''=0.Y) 59
M22.O'M2Q7EM<.T<%S#)(HY5'#$?4"@#+O?"&@:BMBMWID,JV"A+8$G"*,87
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M2JE<ASD@@^@P6.?;'>NVAM;>W),,$49/78@&?RI98(KA-DT22)G.UU!&?QH
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M>^#Z<=I+H>DSW4MU-IEG)/,NV21X%+..F"2.>*2+0M(@N(;B'2[*.:%2L3I
MJE >P(''4_F?6@#RU=,T.?PW\0;E[:U=XKR?RIG +H0 5PQY'SY^O2K*VMEI
M_B;X=R64,%N;BV?S7B4*928U^\1UY/?UKT1?#6B):W=LFE6BP7;;IXQ$ )#Z
MD?YQ3SH&D,]DYTVVWV( M6\L9B Z;?2@#S[19VT;7;"&1+/6-&OK^1]/OH.9
MH)FW%@X R3R02>@[CH-OXM@?\*^NW*J6CFA92R@X.\#//U/YUU%IH6DV$OFV
MFF6D,F\N'2%003U(../PJU=VEO?VLEK=PI-!(NUXW&0PH \_NFM=0^).C1ZH
MMI<:;)ICBS60*T;39&[ Z9P*O^"HH[;Q5XLM[# TI+B(Q(B@1K*4)D"X_P"
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MJ&5P<A@1P:?2*H10J@!0, #L*6@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *ANKJ*RM)KJ=BL,*%W(4L0!R>!S4U(0&!!
M(/!!H YYO'&@+9:==F[D\C47*6S"!_G8-MQTXY]:J^+M;W:)KUGI=]+;ZIIU
MJ+EV5"-J_>X8C!R >E<1+X=UJ6SU3P[;QR10Z#<OJ&GRK\PE)^:*/!]C)T/4
MC@XYZ&>2=_ACKVMW]O)'>:M \C1;<M&I7RXT]< 8/_ CWS0!K^&/&FD:K%IN
MFC4#-J<EHCN&C8;V"C=\Q&"<YJ;1]6LH(=<NI]?:\@MKM_->5-BVH '[L>N/
M4=ZYF>6W%U\-R -P7&X)T'E*N,]OF(&*RKU9+S1?'%O80O//'JR7/DH.7C#+
MDCU^XW2@#O(O%^E:N+FQL+J>*]-H\\?F6SQG;CAUWJ 1T-8'@7QY93>'=)M]
M:U0OJET[Q@LA))WD*"0, GC&:T;7Q5H6O^=/96<CSPV4C2W,EJ4^SKMSL+D=
MSG@>AK@8II+;X/\ A[RLBYBU<.J[<D%7<\C\0?QH ]EU._CTO2[J_F5VCMXF
ME8(,D@#-<5JOBN?4O"FA:]974NG127\"743K@%68;AN('RC^\."/TZWQ(C2>
M%]71%+.UE,%51DD[#P*\XDUJTN/AGX725U#0WUI#*NTD)Y;<[N./E )^M '?
MZ3XMT/6YKJ&QOE>2U&Z4.I3"_P![Y@,CW'%,TGQEH6MZ@]C87OF7"J6"M&R;
MP.I4L!N_"N$\:I)?^,-=MM*)-XWA\1L(U.7<3AF7@<DQ\5<\)2^%+[5M'DLQ
MJMUJ\$.,SM.RVX\LAB=YV@?P\=R* .E^(=U?V/@J_O-.O7M)X K[T4$L-P!'
M/3KU'I6%:Z?J<FG:7J"^.;E+NY\AE@N&0QNS $I@#)R,UK_$Z>*'X>ZHLDBJ
M9%5$!/WFW X'X _E7)6T_P .;/1].U8M:?VM9PPS[+:0K(\R*/EVCCD]>/<T
M =]=^,="L+J\M;F_"7%E#YTZ>6V57(&>G/)'3U%2W?BG1K'1[?5+B[V6MP 8
M3L8L^1GA0-WZ5P?C0?VUJ*:MIMG')=:##'/J,4DHPZ'Y_((&0Q 5B?ZTWQ!K
MNGR^)?#'BJ:>YCT-[62,30E@893G(('X#WQ[4 >@1^)M%ET9M7348#8*=IF)
MP >F/7/M4$7C+P]/:W=S'JD+0V@4W#8;]V&.!GCN:\[U.30[31].U;1K.^ET
M6'64N+MY?,Q*=O+@-R0#[8R*VM8U7P_XD\+^)K_0;=IKIK+;/<BW9-X&<+D@
M$G@G@=AGM0!VW]NZ8;ZSLA>(;B]C\VV0 _O5P3D'&.@)K&MO%5IXBTC739WI
MTXV,CP&[D3(0 ?ZS!P/7C.>*YB+Q%INJ^(_ $EI/YGE1S),%4GRW>!5"L1QG
M/Y4_0KO3[?1/'>FW-Q&TJ7][*T<N,^7M50Q&,8S0!U]OXATW3=*TA=2U:.26
M[AC$5P4(%PQ ^8<<9)SCWK0;6M-34)[%[R)+FWA\^9&.-D?]XD\ <UQ4NE?\
M)#\'-,^PL&O+2SAGMG10Q$L2C*CWR"OUK(UK[;K7PTU'Q*EHT=UJ1B:=$/(M
MH_E(''0D,WT;N!0!Z+I7B;1=;N'@TW4(KB9$\QD7((7UP1TY'YU8U/6-.T:!
M9M2O8;6-FVJ9&QN/MZUQ6@3^%]2\866IZ;J&H:AJ$UNRA6?*6L87HX &WT )
M/)I?B\\*^'--$C(&_M*(@,1G #9_#IF@#HU\;>&6BN)!K=F4MR!(?,Z$G''K
MT[9JY_PD6C_V.FK?VC!]@<X2?=PQR1@=R>#QUXKBE2P'QMDC*VWE_P!D?=PN
M-VX'IZXY^E<WHFOPZ;X L!/%!*#KI2"6<9CM>0WF$ C.-S$<]Z /55\4Z&^D
MS:HNIP&R@8++*#]PD[0".HY/I4KZ_I4=M8W+7T0AOV5+5^2)6;H!7G_A9M/\
M0>*/'&G_ &F.6UU!8VCVX(8%6#.H/H2IS]*?X+BO]1U6STC4HWQX4>6,RD#9
M,Q&R+ QQM3<?R- '5>/M5O\ 1/!M[J6FS)#<P&/#-&'X+JIX/'>K^E^(=+U.
M=K*VU.TNKV&,-,L#Y'09(]1FL/XJNB_#C5 S ;C" ">I\U#@?@#65--9VWQ+
M\)"Q@B1+G395*C&X)L++G'7[I'YT =C#XGT2?5/[-BU.W>[)*B-6SDCJ >A/
MMFIH]=TN:[O;6.]B>>Q7=<HIR8AC/->1P:[I1\.^&)1)96B1:\DIM(F+/;H"
M^XN2<DDD'/3&/2NB\86]UHGBQ;G3H25\16YTZ4A1A)C@(_OP3U]#^ !V=QXH
MT.UTN'4Y]4MX[.<9BE+??[<#J:TK>XAN[=)[>5)H7&5>-@RL/8BO+M7M+#1?
M'EA:ZG?SZ=ID>DK!:7"E N5;YE.5(R< ]OUKL?!%KI%GH<D&AS7$]B+ARLTQ
M!$C'&2IP,KGC..N: -'4?$>BZ1<1P:AJ=K;S2$*J22 'GID=A[GBK$VK:;;6
M\5Q/J%I%!,,QR23*JOWX).#^%<;HMWIB>,O%ECJPMTN&G297N2H+P^6!@$\X
M !/MFN,TRU@.@>$(=5CB:V?6Y1 DV"#">PS_  EL?7CVH ]JL[RVU"U2YL[B
M.>!^5DC8,#^(J&/5],ENOLL>HVCW!8IY2SJ7W#J,9SD>E36]I:V%IY%K;100
M*"1%"@11W. .*\?M=5T0V/A.YMWL;&*/6'D^S+*'>*-@?FD8\@Y ST!R/2@#
MUBYUO2;*<P76J64$PQF.6X16'X$U)>:KIVGLJWM_:VS.,J)IE0D>V37FFCWO
MAV2S\2Z9XODBCOY-1E:X6=L2.GR[-A S@8& "?;@U=MKG0XO&WB>RUYH88Y;
M>W2V%V0H, CY"[O<GWH [Z75=.@6-I;^UC$B&1"\RC<@Y+#GD>])#J^F7*RM
M!J-I*(DWR%)U;8O7)P>![UYKJEMH]UXH\ 06MNDNEO#*(H[A-VZ/:-N0W7\:
MTX+O2O#WQ-O;"5;6RLI-)BVEV6-!M8C;@]<@_I0!VYU73A8B^.H6HM"<"?SE
M\LG.,;LXZU-:W=M>P">TN(IX22!)$X93CW%>(Z7?6\.D>#&N+M[?3([N\665
M%5DCE+'9N# CHWIT->C>#;/2+/4=:_LG4YKX2R)+,WR^2CG=PFT!=W<X_P!F
M@#6N[F_3Q/IT$5Y8)8R1R>=!(W[^1@,C8.^.I]L^U66UO25D$;:I9!S(8@IN
M$R7&,KC/7D<>]<;KJQ+\:/"[A4#M;3AF &3\CXS7+7NF:.W@GQW=O;VZW4.L
MS+%,L8+Q@2)L53U4$DCCU- 'M55DU&QDN?LR7ENUQDCREE4MD $\9SP"/SIF
MFR&31K21V+EK=&+9R3\HYS7D5KJ6ESVGA6>Q^PV<0UP,+?S_ #+A%.<M(Y.1
MD@Y&,<KS0!ZY/J^F6N[[1J-I#L?RV\R=5PV,[3D]<<XJ62^LXKB&"2Z@2:;_
M %4;2 -)_NCJ?PKR:;2M.EE^)<\L-O=3P@O%*\8)C)1F.W/0@\9'I5VZM&7X
M?^%O%469+O1HHIG_ (C)#P'7\N<]L&@#TZ*[MIIY8(KB*2:$@2QJX+)GID=O
MQKG/$GBFYL=6L]!T6UCN]8NAOVRMB.&/G+L?PZ?_ %LN\&VOFP7VOR0F*;6)
M_M"JWWEA Q&#[[1G\:P-9N1X?^+]CJE[B/3[ZQ-I]H?A$?)."W0'('X&@"]<
MWOCK2;C3WO/[(N[6>\B@F%K%('16;!;DUUDVKZ9;W2VL^HVD5PQ $3SJKG/3
M@G-,N=:TVTDMHYKV$27,@CA0-N9V/H!_/M7FFD1:7=_#OQ*VIV]N=8BDNVNG
MN%7S?.&XH<]1C( ]\^M 'JLMS! RK-/'&S9VAW )QZ9JM_;6E"U%U_:=G]F+
M;1-YZ["?3.<9KS.VMHM5O_ANNL0QW$TMI<>:DXW%U6/,98'KZ\]:J7.CZ0FE
M?$(PV=LWV:<^1\@;R25R0G]WG(XQTQVH ]A>>&/'F2HN1D;F S38+RUNK?[1
M;W,,T!S^\C<,OYCBO)%LK/5/%/P[%_$ERDVDCS1-\P<K$6&<]?FJ!QIFBW?C
M2P%M(VB-+:P1P6\H13*0"1O.=O(.3V% 'LBSPNK,LJ,J]2&! IBWEJ\ZP+<P
MM,P++&) 6('4@>G(KS&1X'\;>,=/(MOL]QHOF.L!P%94 QD=3\QYX[5EVNFV
M6E1?#K4-/MT@N[N=%N)4ZR!MH(/YF@#V2.ZMY9)(XYXG>(XD57!*'KR.U+!/
M#<PK-;RQRQ-]UXV#*?H17F.O--X.\6ZBME:$V_B2W,<'E1@[+O[HS[$MN(]_
M:NF-CX@\/V-EIGAO3]+DLH( K-<2LC%_XC@#OU^I- %;4/$VOCQZ?#>F6FGN
MAMA<^=.SC:O0YQ_M<<>H]ZM^&O%-YJ6N:EH6JV45OJ-@ [- Y:.13T(SR.HK
MG];6>\^)6G6T6J/INJ7&D2+B$"0))][;DK]W@G/&=O:H/!5TNFV?B*T>!E\8
M0I(TWG2,[7956,;+D\CGH/8]Q0!Z:)X6D\L2H7Z;0PS^5<WH7B.]U'QAK^C7
M4,"1:<8_*>/.6#9(SGOC'XYKB/#^F:5?Z!H&N2ZS:V=]:7(:9X84\Z21WQL<
MCYB3GOZFKT4UM!XP^(DMWYWV9+6(R>0VU]OE\[3V- 'IJW$+YV31M@9.&!P*
MIZ5K>GZU9O=V-PLD"2/&S]!E203]..#7 :.+.#Q7X:D@MK6QBN=)FB\B*<2;
M@"&4,PP&)SGIUSU[<QI3I;?"73V0110W&K(FH3",,1$&)&_D9&0!@\8)H ]T
M26.4$QNK@<94YKF]=\17VF^(=%L;*VM;FWOIS#*3-B2,CDD#I@*"??&*Y#4+
M&3PQI_B/4=-UJR>6[LA)%96-N(T1 RKYH 8]%)YX]:MSV/A^PU3P1>:9':QK
M),5^T+@-(#$<;SW)..O.30!W&OWUSIF@7U_:1Q22VT#S!920I"@D]/85R6F>
M*/&=[HL.MKH>F7%C)&9?*AN628K[;AC/?'>NH\5_\B=KG_8/G_\ 1;5D^!KR
MVLOAOI-Q=3QQ0I;99W8 #!- &QX?\067B/18M4LV*Q-D.KX#1L.JMZ$?RP:T
MA-$T9D65"@ZL&&!^->%6J3'1O,WI8:5K>O,56Y5O+\G!*[N5)7) ZC.*[/0?
M!%E9IKFBS:M:W$>IP*YL[:,H(,$@. 7;OC\O:@#T/S$PIWKAONG/7Z4>8GF>
M7O7?UVYY_*O+_!ZG6SI.FW=JRR^%VF6<E-JF4?+'CU.,D^XR>O.1X9T#^V--
MT[Q-/KUC;7<5UYUQ+Y3&<L'/R.QDQSD<;>XH ]$T;Q)<ZCXQUW19K>%(M.\L
MQNA)9PPSSFNB66-G*+(A<=5##(KRV2YGL_%/Q(N;9V2>*QC9&7J"(N"*K:MH
M^F:5X!TKQ-H,#QZL3;.LZ2-OF9L!E;)YR2>* /76=4&78*/4G%+7E\/A'3-:
M\3>+(-2DNC' \,R!KEPL;/$78X!&<$\9Z"LVT2;5?#G@!=0N;EM]])$S"5D,
MB!FVYYYX5<'K@\=: /8-Z;2VY=HX)SQ2D@ DD #J37EMOX7TN;7/&VEE9DLK
M6&"2"(3OLB=XF9G S@G//.:R[-[C7I?!VE7\\7V5M*DD'VAF*3/RN"%922%4
M8R?6@#V>D9@JEF(  R2>U>1ZII4VF^"8-)D\0-=S0ZU$GG6TK PH_ 4\]0,M
M@DXS[9K1&DQZ)XMU[2]/>Y:WN/#[SF*25I29-S+P3D__ *Z /0M-U&TU?3X;
M^QF$UM,"4< C.#CO[@U:KR;2=-OY_A'H?]C"(W"W!N9;5WVB["L^4///0<>U
M=5X#U33;W3[\6MK<V$L=VPN;2YD+>3(0/E7/1?;CG/% '7T444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD#(X! *MG(X)Z>M3_P#"&:*VE3Z<\$LD%Q<"YF,D[L\D@(.XL3GL*WZ*
M #H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BJL.HV<^H7%A#<(]U;JKS1KR4#9
MVY]S@\=?S%-U35K#1;)KS4KN*VMUXWR'&3Z =2>.@YH N45FZ-K^E^(;5KG2
MKQ+F)&V,5!!4^A! (K2H **** "BBJ-SK6F6>H0V%S?V\-W.,Q0R2 ,_.. ?
M<T 7J*S=7\0:5H*V[:I>I:K</Y<9<'!;Z@<#W/%:*L&4,I!!&01WH 6BBB@
MHHK!D\;>&(KTVDFNV"S $G,PVC!P06Z ^V<T ;U%16]S!=V\=Q;3)-#(-R21
ML&5AZ@CK4M !1110 4444 %%-DD2*-I)&"(@+,S'  '4FHK2\MK^U2ZL[B*X
MMY,[)8F#*V#@X(]P: )Z*KG4+-;]; W4(O&3S! 9!O*^NWKBK% !1110 445
M5OM2L=,B$M_>6]K&>C32! ?S^H_.@"U13(IHIXEEAD22-NCHP(/XBGT %%%%
M !114%K>VMZ)#:W,,XC;8YB<-M;T..AH GHHHH **** "BBB@ HHHH ****
M"BBB@ HHJO/?V=K(([B[@A<C(620*2/7!- %BBD5@PRI!&2.#W%+0 445#/=
MVUJ4%Q<11%^%$CA=WTSUZT 344U)$D!*.K $J2ISR#@C\Z0S1"983(@E8;@A
M8;B/7% #Z*** "BBFK(CLZHZLR'# '.TXS@^G!% #J**165P2K!@"1P<\C@T
M +1110 444BL&&5((R1P>XH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*2UL]65A!/\ :%<AP">5QT('7]*R4TY?$7Q0\06>K6EK=6L%M!&(I)3E%(#
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M5?8/ER<D@*3T':FS:;JDFJ^/7&F3[-1LDBM&!7$I6)DXY]6!_.@!GC;7A?\
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M;) P-O(X/<<@_6MBS\7W;>(KK1=1T8VEVMJ;NV1;A9#,F2,$@ *W'J1UY[D
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MC\?:]/KW@Y+Y-*>'3S>1_8[LSC<XR<L4'0''')]>*]:<LL;%%W, 2%SC)]*
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ME;PK,66*/&"6?:,DGGIV IEOX5UJRL?"UW;FU.H:-$T$MNTA\N5&&#A]O!P
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M%L8^7D*..P/3-;DF@:A9?#FZTFU6.YU2XMG69G? DED!WMD]^3C/H.@KK**
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ JCK.I)H^BWNHR#<MM"TF/7
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M=&NK.V@_L]+M'FMR^TE@,,<]^><=.V>:Z[5KB]M-#N[FTC@DO(H&=%E;;&6
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MS3F:*[GW&2$-U&T'YB,<=O7T$NH^'_$%OXUO]4TB"QF@U*S6"=KF9DV,!C.
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M+B14(!)X W<'KUS7IUO<"XLHKD*5$D8DQZ9&: &F]MAJ"V'G+]J:(S"+/S;
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M2Y?%5@MOJ-Y]LM9D27S$?(;YAC&!@#@GU]J]F^R6W_/O%_WP*/LEM_S[Q?\
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M=6L=W:B)1*H8HP3@>X./UJ^=%UR?Q3I&KW5Q8%+2U>*=(U<%G<\E<]N$Z^]
M'/\ _"P[N'PQ^^-O)K;:B^GJ(H79 RM][8,L>,<#DY%26'C#Q*-%\03WNGH9
M=/@$]O</:RP1S#&6&'P<C%0Q_#?41I5P3?VT6K_VH=2M9XU8I&QQE2".G'Z"
MMV71?$^HZ!JMGJFI6$D]U;FWA6&)EC0'AF;/).#].* +7A:[\1ZA%]MUA=.2
MTN((Y;=;7=N&Y03NS]:W;J5H+.>9$+M'&S!1_$0,XKE=777]#^']O'87-NNI
MVB1192(R+*!A0JC'!/';_&NGN5NY-,F2WD2*\:%A&[#*I(5X)'< T <;X:\1
MW_B33I;J2_TR>WDM)#/:Q1E)K:3LI!8[EQGGCI7,^#M<UC0/!'A^[46']CR7
MAMY_,9A(-\K#=GH .OX5U<?@Z]DUZUUF9;"WNXK26&X:T9E%T[+@%QMP .3W
M.<>E9,G@#6G^&UEX:$UD)X;KS7<NQ!7>3QQU^;I[4 ;7B3Q+K&C0ZS<K#90P
M6*1R6ZSY9[D$@.?E;Y0"0,XZGG%,U;Q+X@.NZ9IFC6=@3?V!N0]RS?(P!)!Q
MVY4=.YJGJO@_Q'>W_B);>\TX66K(JAYU=I8P!]T8Z#CZ?-GM5RU\/^($\2>'
M]1N'T]H[&Q:VN=C,"Q/'RY'H%/YT 8VH>.O$RW-S!86$4TFGE8I_+LYY5N)@
M 75&484#..?K1J$]]??$#POJ=E!#;ZC=:;)NM;S(\G )^;')^\1T'2M23PYX
MJTGQ#J%UX=O[ 66HS>?+'>AF\M\<E0/7^@]*LOX8U7_A-]$UIKN&YCM+)K>Y
MDD&UW8[OF"@8Y+>O% &?9>/-2N-$E)M+5M575QI2<L(6<_Q'N!@']*NV>OZ]
MIGBNRT/Q$+"5-1C=K:XM RX91DJ0?;O[UEQ> ];_ +-U6,75I;W;ZN-3L7C)
M90PSPW ['MWK8@T+6=4\2Z;K6N1V,)TV%UAAMI&??(X +$D# ]!S0!S'@;6V
MT+X?[X81+<W6L-:6ZL<)YCX"ECUVCOBM-)=0T_XE_;M<%@BQZ--(7LU;E%=2
M=V[DD5#IW@'6H?!O]FR75I!?V^IC4+5TRZ;AT#9 [Y[5H)X<\2:MK\5_KK:9
M';/8S64\%J7+;']">^<?AF@"K8>.];N[[2)AIB2Z;J4VS$-O-YD"DG:S,1L/
M&"<=@:T=-\0^)M4\1ZC90Z?IJV=A>F&6225Q(8SRI  (SMY_&JOA[0O&ND"V
MTI]0TT:/:N LBJQG>,-G;TP../I6IX:T?5]-U_Q%=7HM?LU_<^=;M&Y+ #(
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MW22=KIR-[NNY$0 ^@/)[_KF:1X<\7^&OMFFZ//I)TV>X::&:<.7@#'IM_BX
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M^UVGVFV,$YE/'56. ,\'TQCOFB/QE?QW&DG4-&6SMM3NWMH_,G(E3&=I9"H
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M.]MXQMYZ#'^+KZZ\7)'X.LKG4?[/O;MY(;THB2$D#(/IG:.W<T >CDA5))
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MPDR263VZ*DB"0H5)'.>.M:%Q?KI?Q9U_4&7<MMH!F(]=K(?Z4 >E45Y=/?\
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M3R4!SP%;@$9X'7DZVFZUXG@.LQ7\'VB*VM7N+6^ELVMT=QSL*Y)QTQT. <T
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MCJNF:I=S2.]BU@9G4@D("0O/RA>,C%>V5!-=Q0Q3OGS&@3>\<>"^,9Z>^.*
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ML7?BGP[KEQ>V3RZ?'(ER$B90VY2/D&3ZGJ1ZX[5O:KK^FZ+/90W\YBDO91#
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MY1DC!RRANV>E=)10!YM'I?B=O$'B"_D\/P0Q:CIGDQJETC%7"[0N>.N3GC'
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M! 4DNI0E\\GKCG'UVD^'T<?A.W\/IK-ZL$%T+A) J;A@EMN,8QDY^OY4Z\\
MK+KMQJECKFHZ<UW@W<=LP42D#&?8^OU/2@"AJT_B"]\6:7H2ZZVEM<Z69I_)
MC1LS#A@N1GU/!Z"M[Q/J\WA;P1<WKS&>ZMX%C64J!OE.%#$=.ISBF?\ "&V\
M?B?3-8@NI(DT^V-M%;!05VX(Z]>YSU_QVM3TZWU;3+G3[I2T%Q&8W .#@^E
M'.Z?I&N:?=6NIMXBN;VV:W+WEO=*N&;9\ICVJ-@SV_G7-F;79O C^-(?$5]'
M>F-KC[(P1K<(&(V!-OH,9SFNET'P1_8]S$USK5_J%O;+LM+:=L)"-I3H."=I
M(^AZ527X=RQ03:9!XANXM FD9WTY84Z$Y*B3J!GT[?7- $'A_P 2ZAKGC>:W
M-T\=E-HD5U'$JK^[=MAW#(//S'KG\:QXO$/B.X\!^%KR#6U2]O\ 4A:S3/"C
M?*6< 'CMM],G-=AJ?A![OQ#:ZO8:O<::T5J+.2.&-6#PABVT$_=//7GH*SF^
M&\,6@Z9I-EJ]S!'87OVQ9&169F[=,8QD_GWH H+<>(H)O%NB7>M-?R6^F":V
MG\E865F5O[OTK/FU+5=#^&/A.73=3EBENKB"%F>-' 1E8[0"O08'O[UVW_"+
M$^)-6U5]1D:+4;06K6_E@;,  ,&_[ZXQ_%[5BR?#JYE\,Z?HTGB&5Q872W$$
MCVRG:%!"KC.<#)ZDT 1ZU/XB\(S:3J%[KTVH:;]J\J^!MHX]JMPIX&0 <YY]
M*Z#PU=WFH7FLW<EV\MA]L,-HC*HV!.'(( R"V0,Y^[UK-\>ZM8C2)_#DR3SZ
MCJ5L5MHHH6;>^< Y'3#8)]JZ31M-31]%LM.C.5MH5BR.Y Y/XF@#%U.^U.U\
M?Z%:)>*--O8I]]N(QG<B9R6Z]QTQTKC;G7/%%U%XNU"W\0-;0Z->2QQ6ZVL;
M!U!( +$9'3WKNM1\.W5_XJTS61JK116 8):B '=N&'^;.>1@=.,5E)X!D33O
M$EH-88C6YO-9S;C,1+$M_%SD'';'6@#J-(O?[2T2QO@?^/FWCESC'WE!Z?C7
MF%YXF\0V/A;7;>37';7-+U,1HRV\>Z:$@8&W:1C =_4;>M>GZ18MI>CV=@]P
MUPUM"L7FL,%]HQDBLN7PC8S>,O\ A(Y#NE^RFW,++E23QNY_V25Q_D@&/)JM
MUKES?W-C?&30DT,LRA5^:X<,<$XSD)@D C&17*>&;_6- \)^$K\:R!IMW?"T
M>S-LN$5I)"S;_O$\?K7?:+X.@T'PI=Z'97)'VGS29VC!(+C .,\X&!UYQ65+
M\.I7\*Z3H:ZT573;HW,<OV4$L<D@$;NVX]^: *]QXRU'3-?\9K<R)-;:5;Q2
M6L7EX 9E& 2.3DL,\_E6EHMKXIN'T;57UV.>SN81+>6LD"H%W#<OEE5SQD#D
M]B>^ \^!HYM:U^]N[\S0:S!Y,D A"^6  %(;)Y 'IUYHT'PAJFD36:7'BF[O
M+&S!$5J85C!XP-S DL!Z'VH XNWG\0Z7X:\1ZSINKQVUO9ZO.XMOLZOYO[P
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MLHI]*D+DJQ'G[4.2YQR<(<<=\>]27?A34M0US3M2N+;2H;NTO_.>]@D<2RP
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M-9NH_+O%0VHP(F1K@J5(')Y).2?:M>[D\4>(;_Q)_95[+%+87(M[2..Y$2#
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M*74T[C;& 2N$4D;F8C@=J .VHKS.?Q_K$7@S4-1C2S:\T_4S92O(A5'7=@,
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M0)XFN]=MK^\MI[N()-'&R[&(&T-R">!CCU%=#10!QP^'\*^$H/#R:O?+;P7
MG20!-PP2P7[O3<=WU%)?_#NSO-8EU*WU;5+![@JUREI<%!,P_B/O794A.%)
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M>%IHO$L6NW]Y;S7D=J;?-O;>3YA)R6?YFR?3I72$@ DD #J367J?B+3])O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&BQJXQO&>%[?J: /3:*X"P_M'6_$5_H9\1:C%%HT$"230+&DEQ,VXEF)4\8
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M=<\NKZU?:;X[AN[BVBFTV$H+FRB,4CLH8@DY)QA<>V376MX&TN/4I+^PGO\
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M\6:+K=K>VMQ+:VAMKEKE2N[.27 7UW'CC'O7:T %%%% !1110 4444 %%%%
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MK:S;>!O!UY;:O<QW-Y+;Q3RX5B_F)G)R.<8_'OF@#U"BO,K>VU:;QYJGA?\
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MO0NBRF6/)7]Z2<X;CIU ] 3]:ZVB@#@#/9^.O%NEO#IUW'#HTLDLT]Q!LR_
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M):/S$D7:5*LN1D<YZ]0#6I10!S_A;PPOAQ-0=IUFN+^Y:YE:./RT4G^%5R<
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MVJPPF*+4[UY;0'_GVR3'\O;[S''O5>/X=72^#=5\/MK$)&H78NFF%H1LY4D
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA@57VX'UQFNZKSKP+I&LV?C/Q++>W\LD0G02%K54%TQ4D,"/NX!' ]1FO1:
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M7JZW9F,KD1^8/-],>7][/MBN<M]4L[#XGZE<:Y/#;PWMC"UA)=+Y8" 9926
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M'N.* ,6/PSXPB7:GC>-1[:/%S_X]0GAKQA'G9XVB7/7;HT0_]FKL68*I9B
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MG\J .57P5XC6[^U+XKLQ<G_EL-"@W^G7.:DN_"'BB_C$=YXOMKA <A9M$A<
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@".XF%O;RS,CN(U+%8U+,<#H
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M#!<K"3$K*CY!?( YP.O>H/"\=O<R:/&W@BX@U:VVK-<7$3)#"J8!=2W!8@9
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MHF"QDMNP3C@\8QZFJ/\ 8-Q'\29M)C6+^Q;ITUB:/!SYB_+C@]"^&P?[H_$
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M_CCRQ?.M]IL$EO)<0L#*$7#'H.[#T%7)+L))\+C&[H5B"L=I& 4C0C\>1_\
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M]KIT.?1?"<FD26OV]+RT\E;7;YF"!N! Y''KCI0!ZA++'!$TLTBQQH,L[G
M]235:WU73KOSOL]];3>2,R^7*K;!C.3@\5C>/[FQM?!=^^HV[W-N0BF)6*[C
MN&/F .!GG\*X>*6TC\8:QG4=-G^V>'F"QV9Q&&4#"#D[B%7/;CL* /3X]:TN
M:ZBMHM1M'GE4M'&LRDN!U(&>:DCU*QEN9;:.\MVGA!,D:R LF.N1VKQW2;;1
M;#P5X,U8PVL5X=7C$]PJCS"H>3()')Q\OZ5O^+7N/"/C%M:L+1I$UFT:S(4
M@77_ "S)'H<#/KS0!Z3;W$-W L]O*DL3\JZ-D'Z&I*H:)IJZ/H=EIRG(MXE0
MGU/<_GFK] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 45'<2^1;R3>7))L4MLC&6; Z =S7#'XH6RZ=8:H^B:C'I=U*8C=L
M%PK<@84$ENA].G>@#O:*YBS\9H^IW]EJ6F76F-:VIO UP5(>%3AF^4D#&1QD
MU4TSXAVM]K=II\^GSVB7X)LYGE1A+QGY@I)0G(X/K0!V5%</=?$NTBM[ZXM]
M%U2>WT^X\B[EVHJQ\X)'S$GZ8[\D5?L_&=O?ZS9Z<^G7MO;ZC 9+2ZG 59L#
M) &<C@@\_P"% '4T5Y5X8\3Q>$;'6+*XLM5OXK35+@3W<4.]40<!F8GKD=,]
M^OKU.J^/+*S2!=.M9=2GFMENQ'&ZQXA;HQ+$<GLH!- '645R4GQ$T9;#2;N&
M&]N5U1G2"."(.X9<95AGKR.F:Z#2]0?4-)@OI[2:Q>12SP7 VO&02#G\ORH
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M&I7:Z<=-CEBL_)9OF)YPH&0< GGUKM=*U6SUO3(-1L)A+;3#*-C'L01V(/%
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M>RQQRK&$!08Q@>GZT ;UWHFE7UI%:W6G6LMO"VZ.)X@50^P[5>50JA5   P
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MJKY[B/[B*Y*\ <_*!S_6O<.M)L7;MVC;Z8XH \]M]4LS\8;F7S#Y;Z.AWF/
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M66="1M9@TRLO7K\H)QZ T9TNV\3:B/$VIWUK9ZI9V[6LUM*WES1>7RK$ Y[
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML;28M.DD[NLB%2/XB<$''ZU5U+2]8\.^/;CQ-IEC+J=GJ$(BNK:)PKQL H#
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M#N"#WXZZR8/86S#.#$I&1@]!V-><->?9-0^(&G3V]RDMS ]Q WD.5=/)*DY
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M]\L*J=-7<&88XC7=GZ=ZY_2'TN/X<^$IY6MDN8];0&0D!E F);)[84@\]B*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:9X0\5V_BW39;N&&2%HY61D=" !N.WG&"< 9QT- '0U%#;06Y8PP1Q[OO;$
MS]<5B7-W%_PG%A;#7/+D^RR%M,"Y\WIAR>V.?KCCO4$GQ$\)Q3K"VLP[S)Y7
MRHQ"MD#D@8 YZGCKZ&@#H3:6Q613;Q%9#N<;!ACZGUH^R6V]'^SQ;XP C;!E
M0.@'I4H960,&!4C((/&*P[3QEH%]J,=A;:@))Y698CY;A)"O4*Y&UB/8T ;
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M>=@SUY.WIZ'GD5<\$:!J.B:?<S:LIGOH%-G:[=N3:QY\M1CC))8\GTS79T4
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M_(/LUQ#N.YV)XR1S]<]R#7?>*9=3@\,:A)HR,^HB+]R%7<<Y&2!W(&2*V**
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M@FW=-\;H ,%6*\$#UKG-5\,:]<:-'<#2Y'O+O7AJ<MM&R9@C *@$EL%B,=*
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MB7>K7%F%-UY3K&L6X949;[Q(YP!4$GQ#TX:-9:E!8:C<)=7/V3R8H1YD<O\
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MOA.]9[[S[H2267E$"/!0%A)SZ8Z9Y%+=?$72[:\U*U33]5N9-.)%R;>V#!0
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M5W;3W[":T?9.J02/L/X*>..M26OCKPW>ZA;65OJ2O+<G$)\MPCGT#$8S[9H
MZ HA))53GKQUH\M <[%STSBN9N?B)X6M)YX9=3&^"3RY0D+ML/N0O3/&?6K]
MWXKT:S@M)6NS,MVAD@%M$\S.H&2P" G [F@#7\M-NW8NWTQQ3JPY/&&@0Z3:
M:I)J42V5V=L,I!^8^F,9!'?/3%16WBS1M:T_5&L-3,/V*,^?,\3*8,@X;#CG
MH3^% &_Y:;MVQ=W7..:=7-V.O:?I'A*PO=0UK[;%(H5+LQ$-<,<GA!DYX/'M
M5BW\7Z%=://JL5^IM+=PDQ*,&1B0 I4C=DD@#B@#6BM+:&626*WBCDDP7=$
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MJ[64JH'(_"O*]7MO%.JZ=-#=^']2>^CU87!G5OW2H"0!&F>!SU&<]237M=%
M'E]K:Z@-2^(4S:5?JM]:@VX,!_>'RW&T=B<MVS4K>'[B\^"MM:31/::A90_:
M8C,I1HG1BWL02N1^->EUSNO>$+3Q#J-O<WEY?+!&FR2TCG*Q3#<&&Y?J.?7
M]* &^![:[3PY'?ZB<ZAJ3?;+@XQRP 48[80*,=JR/%%O>2_$KPI/#87<MO;^
M;YL\<1:--XP,MT'3)S7=?*BCHJC@=@*6@#R>"WOULOB*[:5J(-^Q%LAM7W2[
M@Z@J,<]1G':L^VTZ\T:31]3O_",VL6DFE1VSPFUWR02J3_ P./Q'?KZ^T44
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M#A0"3U.?H*R+^SOM1N_&&NP6.H16]QIOV*VB:!UDN'QC<(\;N#P"1W->GT4
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M1XATC3CJ(M$DAN+97(<H^.5'KQU )Z?A3UI/$^OZ);:F=&6UN=/U&&]MK!I
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M4LKW4O"2V=A8W%W,]PC8A3=M R>:BN4O6^+-KJ2Z1>/9C2_L_GF(X5R6?KG
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M4-SHLL7GF)E$;.KX!;& >16>]Y>WOP^7P8^A:DFKJB6V3;GR1M8'?OZ8P,T
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M /"$^%_^A?TW_P !U_PH_P"$)\+_ /0OZ;_X#K_A6)'XWU8Z;;W4N@I&^HM
MFEQBZ#><9 6)<X^4 #/3O5R#Q3J=OXC;0]6TVVBNY;5I[,V]P62<KDE,LHP>
M/2@"_P#\(3X7_P"A?TW_ ,!U_P *@B\+^#9KN:UBT?2'N(,>;$L*%DSR,CMF
ML"T^(NIM:Z/J-]H4=MI>HSK;B9;G>VX[L$+CIQWK1BUJST[QGXE,NDI;K:6<
M=S<7ROEYE"\#;],C_@- &K_PA/A?_H7]-_\  =?\*/\ A"?"_P#T+^F_^ Z_
MX51L?$'B.>XTR6X\.HMA?G[\%SYDENI&0T@V@8QZ$_GQ6MXCUR/P]HTE\\1F
MDW+'#"I ,DC'"KD].>_IF@"O_P (3X7_ .A?TW_P'7_"C_A"?"__ $+^F_\
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M!OASPL^B7-Q=WFJW6JWDJB-9[G[T<8).T<GC)S^5;EW"UQ93P(P1I(V0,1D
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M[*LDOWAR1_=P,G'(Q7I-% 'D=A<S:[X.\,Z"MM<OJMK=Q&8/;,BV\<3'EF(
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MC=S\O![56?PU?^(M9?56LY_#LT]E+;W;I,DCS,VU5'RG!4*N<\'.!VS7H%%
M' Z!H&M^%]0\0WD@EU=9EMT@1?+B:<*NTG&0%VCC'<"J%IX1U'1;NUUJQL92
M(=2DFCTY)%WQV\J!6&2VW=D XS^->FT4 <IX2L-4T>V6*ZL?FU&ZN;RY991B
MU+$%4_VB?;I@U/X0L;RQCUD7EJ]N;C5;BYB#,IW(Y!!^4FNDHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
;"BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>a123121ex-1021012.jpg
<TEXT>
begin 644 a123121ex-1021012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX&<;>OOTK;?QOJ$2"*;PQ=PW]Q/Y-C:R3HIN/EW,Q;HH ^O48[X .RHKB?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5H3M5V ^4GL1C!^M=]10!Y;HEI=0^(["]T&TU;3OM-RQU;3+J-_L\8(.YPY
M!/'&,]N@X/:>*KW6=.M+.YT:S:\*72_:;=%!9X<'<!Z'..:WJ* /,&TJ'5_'
MFD:CH.BWNEFTF9[^>6U\A'7CC!^\3R./7-9ND:8VA7%[H^H>!FUB]>ZD>VO'
MMT9)$/W=TC X'KZ5[!D9QGFEH \VM;[6/"?B;6;1_#EWJ%MJ5Q]IMY+1<J"5
M *L3P .!SCH>N:M7*WVG_$S3-4GTZ\E2[TP6T@MH_,2"7<"06Z >YQ7?T4 >
M33Z3J7B"+Q_8P6MU&+J:&6U$]NT8E*-SM9L==@'X@UHSRW'BD>'--CT:^MKB
MPN89[J6Z@9$A$8^8*QP&R1CCZUZ110!Y##!>'P[\0O\ B77X>[O'>",VSAI%
M=R 5&.>O..@KTJQB>\\+6T*O/:22V:*&V[9(B4 S@]"*U** /*M;\$:MI\7A
M^UM=>U&Y@CU&)4 @4_9AAOWO [>IXYKLKI[F[>7PN?[25GL,MJZHJC=PO!Z;
MC[?_ %ZZ.B@#RO5O!FM6FK>&K:V\0:A-%'*Z),+=2+10G7@8Y''-=_KC_9O#
M-YYMI/J0%N4D@C'SS@C!''<@GI^%:M% 'F/AU;[2I=2M=.?5KS04TQYEAO;9
MTDAFYQ$A8#<2,] 1TJB\<Z>!O!,+:5J#7-MJ$<DBBV<M$D;G<2,<9R,9ZUZY
M10!X[XLFU?4K;Q7ITVEZHTKW""R2"V/DM&C@ERRCYB1SSGL.U;]O=._CGPW-
M]AU!8DTHQ22-:2!8W8 A6...G/IFO0Z* .!^'0E_M;Q3-+:7=NEUJ#7$/VBW
M>/<C%L'Y@/RZT:L][X>^)/\ ;LEC>WVG7=@+7-K$9&@8-NQM'8XSV^\?Q[ZB
M@#S#Q-'<7MUH&O2>'+MM.BEG6:SB1O."OPLA5<$$XS[=^M-U"5K#PQ>W'AGP
MK<VBSWD*L\ULTDK@98R")LD;3@ GN<]J]1HH \A@Q)XD\27-_HNM76GWVFQ1
MKYMHWFRX"*3TP&R"P^E,O-)UZXT36_#]A/?:CI<5M#/:M>0O'("&!,() W?*
M.G;  Q7L-% 'G?AE].N]:TJ:T\)7]I=I&YN+F[615MAL(PI<_-DG'';)J[\2
M+65H-"U"..66.PU2&:5(HR[E<]@*[>B@#@'UN/P[XTOM8U.&>WT?5K.!HKDP
M.Q5T'W&4 E20QX([?6KW@"PN;>/7+Z5)H;>_U.:>V@EC*%4)X;:>F?3'85V-
M% 'GTVN6'ASXDZO-JKRP1WEM;I;D02.)67.0-JG/4?G7,7.EOHNG>'M5U72[
M@:0EU=23VL>5:V64YC)"D8P/\/:O:** .6\%MI$\-W=Z+I$]E:SE&\^<%3<-
MSR Q)P,CGOGVK \3:QM\;7>FW$=U:Q?V:3$UG;%YKUB#\N]06"CGCCD9)KTB
MB@#Q"VU.UBM?AM<S,\<5J]RDS/&PVE2F3TY ]>G7T-7]41M2B\=>(K19!I5U
M911P2.A03,H7<P!P< @\X[_6NZ\1>&+O6?$&C:I;W\%O_9;,Z1R6Y?>S8SDA
MAQA1C\:O^*-'GU_P]=:7!=);&Y 1I6CWX7.3@9% '$7-W:>*-2\&VVC^8\E@
MT=S<RQQ$"VCV A6;&!NQC&><?2L.VU"UD\+_ !&D67Y9KYWCRI!(=FVG!Z9]
MZ]@TRWGL],MK:YF2::*-4:1$V!L#&<9./SJU0!X_;ZFN@7GA'Q)=+/+I T1+
M-GA7>(I0.<CMDX'X>U:VL^(K*/0].U*RT=;#3[K55<WLEHK-&-H)G5,'#GYE
M!(/W?<5Z510!X?++ ^C_ !"M;;[;([M#.OVF%A(RAAN=LJ,9)S@@'';@UUDU
M[IWB+QEX8N=&VW$>GI))=7**0D,93"JQ(P#G/%>B44 >%PQRZGX*\3-8&2;R
MM>^UR1P#+20YX([^^1_=KM/#$WAO4O$L&HZ)!J5]<^2R3WUS+,5@7&=A,GWC
MG P.F<UZ!10!P'Q-N?L$WAB_=WC@M]5C>:503M3OTYZ9X[U6TO6+7P_XZUV[
MUBX:&SUF*"YLKF96"NBJ?EY&01N'RG!&.G2O2** .-^&MJT'A^\F6!X;2[U"
M:YLT?((@;&S@^PKC?%.NP74OC+39VFLWVA8[2WM"7N&3:?.DD .%P ,9'R^]
M>R44 >4Z7J>GW_Q2T&XAG22(Z&L:L0?O@OD<]#C-6_#=C8>*OA[K>D0-'(3=
MW!0 8V,7+1L/;IS]:]+K%\1Z7JVJVL,>DZVVE2(^YW6$2;QCIR1B@#G_ (?_
M &S5O,UW5+9XKN.!-.3?R2(R=[ GGYGZCU7O7=52TG38M(TJVL(262! NX]6
M/4L?<G)/UJ[0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% &=KNI2:/H=WJ$-I+=R0)N6"(99SG'Y<Y/L#7/6?C.ZMM5
MU#3]>LX+>2ST_P#M!FM)3( @^\IS@[N1_G%;'BW3]0U3PM?V6E3>3>RH!&^\
MI_$"1D=,@$?C7$IX4UZXU:<-H]AIUC<Z-)IBK;W&X0 G(8\98Y_3Z4 =!IWB
M7Q#=7^E/<:#%'INI9*2QS&1XEVEE+X&!D5DV.N:GJ?A#Q3=:_86U[9VT\T8M
MT?:2J?>7/H.H.<]?:M7P]!XRM;;3]+O8-.AM[0*DMXDID::-> JI@8)&.2?7
MC-9=KHOB.WT7Q;H[:= \-Y+</:3+. 7,H]#V /MR,<]: )G\6SZ+X3\-7]AI
M$":7=".*8&0XM@V ,8!)'WN?IZUHZOK4T[^)K&YTF.[TS3[,._SE3*63<4YX
M&!D\>W>F67AF:_\ A?#X?U.W6&Y^R>7M+!MCCE#D>^#1:Z%J>G_#S4+.9%O=
M9O()3,8R%WR.NT<\#A=H_"@#$/BK4$L? L.C6\%I;:@=CP,Y("IM79N() P>
MO)Z?CTD7BB[3QXWAV\L(H(I+?S[:?S<F7'7 QZAO0\9KEF\,Z[:Z!X*GAT_S
MKW29CYUJ9%7ASG);..,#UZUH_$#3;C5H-&EM+A;76H[@6Y6%PQ03+B0=C@+D
MYQTS0!TGA36;S7M'.H7=K#;J\SB#RI-XDC' ;/N<_E6-+XRU6[N-0N-$TB&\
MTO3I&BN)I+@([N@RX0=P 1@GK7765I%86-O9P#$,$:Q(/]E1@?RK@M.T[Q%X
M2GU;3+'2%U*RU"YDN+>Y$RKY1< 8D!Z@8'3WH H^,]=7Q##X/DLK5;K3;^_5
M_*F.WS65MOEL", <D9Y']>YM;2#P[X<G-CI\5KY<;W!MED)0/C<1G'3/H,>@
MKA]1\*ZOI5MX,L+&PEU!-)N/M%Q-&ZJ,EPQ R0?7'MBO2KZW-WI]S;!@IFB:
M,,1TR",T >3ZOJ=[XB^$=MK.IVRO<17:20NC#,G[XK]T#CCCWQFNVM?&$G]L
MR:=JND3::5LVO1)).CCRU(SG;T/^%<A_8WB.+X7KX?&AR-=VEVH0B9,2J)6D
M+CG@=!Z\UMZKI>K:SXQ63^S9;>RN=%ELY+AW4B)Y 6Z Y.#@4 0V7Q2MKC6K
M*UFMH1:ZA(([=X;E99(R< >:H^[DD<9XY]*V_B);PW'@/5C-$DGE0F1-Z@[6
M'0CT/)YK!\-0^+8TL=*N_#VGVHLF16U)F4[D4@':H!.XJ,9R/6ND\<P7EWX/
MO[.PLI;NYN4\I4C*C&?XB21P* /.+'_A![WPQI&G7>@7:WDR00FZCM3$3*^%
M+>;T;DD\Y'M7<:MXQ3PIJ=KI=[IK163PO]GO&N%VMY:$[3QP20!_P(5F6&K>
M*=/\+VFF)X*GEGM;6.%'EN(RA=% #$9SC(!ZTWQ!X?U[QC';Z5J<)MX+:P%P
M;F,KMEO< 8QU"C+?F?:@#H;[Q8^F:583W^GBVO;Z410VDMRBXXR2SG &!U]\
M#O5"S^(^GW&FZI/-;/%=:?((FM4E60RLQPH1APV3Q61>6GBK5/#VAZG=:.DN
MKZ3<,)K.8KBZC9=I8')&<$=>^3Z4_6=%U[Q'X?G:#1;31Y;>>*XM+4,#)*Z9
MR7*X7&#P/44 ;C>,+RU;44U'P_<VK6=@U]N\T.CA<90,!C=S[]#3SXQ/]G^'
M[Y=,=K?6)8X=WG#]PS_=R,?-WZ>E0)+XC\3:=>V>HZ+%IEK+9R1.DDWF222,
M,#:5.%7DY)R:YJWM/%<F@>'-+/AIHCI5[!(\KW28<(3R .@]?ZT ;^B>)M4U
M?Q)XDL+C3U>QL7\H+%(-PX?M_$6QZC%4M,\3V?A[X:VNK:5H5Q_9\<KHUN9\
MO$/,8%B2.?F_+-6-'LM6T#QIXDF_LF:ZLM0<7$=Q&Z@95&;9@G.23M[#-6/!
MFB77_" 2Z-K%D]J\AGC=&8,2KL3D8_WOTH TKKQ9;VNH00-%NMFL6OI[E9 5
MAC XX YSVK&L_B9;7&K:=:SZ<]O;:BVVUN/M43YSC;N122F<C@]S]:JZ'X,U
M3_A!M6T[490-1NHC:1,Q!"Q1@K$..@ZGOP?PIWA:/7;:UTW3)_"-K:SVP2.3
M49&0J43@D!?F+%1QSU.>G% '0^.KVZT_P3JMS9JQF6 @,I * \%N?0$FN3T^
M;3O ^EZ7K!\.3075^L-CMM[A&W@J&#,,@;CS^7)&:ZWQO!<W7@S5+6SM9;FX
MFA,:1Q 9)/?DUR/B6#6M4\)>%HET.]-W;74$MQ&JK\FQ2I_BXR3D9[=<4 ="
M?&ERY@M(/#M\^K2J\AL7=(VCC5MN]F)Q@GIZ\TT?$&SCT34K^ZTZ^AGTR18[
MRTV O&6. 0<@%??-0:W!J6E>-;;Q1:Z?<WUH]A]CN;>W :9/F+@A2>><9 ]/
M>N=U71=4U#2/&&MC2;V.;5Q!';6;*#,%3:"S*.G3IDGKQ0!TZ>/'>_M+3_A'
M=3#WUOY]D-T1,PQD]'PO!!Y/X=,ZWAKQ$/$-O=%[*:RN;2X:WG@E(8JXYX(X
M/!KEXXM1C\1^"'_LB^,5M8-#<2>7\L3/&J_-Z8(YSBK7@:/4$\1^*I;JPO+6
MVN;L30?:(]H;[P)'KGY>E &UJ?B;[#K)TNWTRZO)TM6NI&0JJH@R!RQ&22,?
MC6?=_$/3[:QT:ZCT[4;D:NK&VC@C5GRN,J1NZ\]LU0\4'77\6>0FD7FIZ3+9
MF.**-U2)96R&9SW^4\ ^IQ6)I\.KQZ5X'M)= U%&L;UOM#>5G8H.T,?0'=GG
M'W3UH Z_3O'5C=:-J>HW]K<Z;_9K[+B&X7YU)QMP!W.0,>I_&N>GO[C4/BGX
M5N9]*O=.9XKE0)Y499(_+8K@*3@\\@^WI5#4/#^MZO+X[MHK*ZB6YF@FM/-&
MR.8QM\V#T.0!C\,XK5?4-8U[Q5X8U)?#&IVL5B\RW!N J8,D87(R<E1ZD#/U
MH [/7M;MO#VDR:C=)-)&A50D*;F9B<  ?7UK._X2U'?6;9=.NHK[3+83O#+L
M <%2PP0Q';%)XZFU>'PS(VBI<O<F5 XM1F7RR?FV\'!QWQQ7(Z;'?)K?B&XC
M\.:K;6M[I(6)ITW.S(A7#<DECGIDGCI0!BZ9>C1?!2>-ETFZ?6FWHU]),OE3
M%W8;F0/G"X Q@<X[<CT6_P#&<&FFQ@N-/NC>W4#3FW1X@8D7J6)<*,]L$YKB
MAI&K7WP0.CII=Y'?VK_-!+$59P)-^5!Z\'\P:GUNTNFURQ\1OX3O-2M+K3_L
ML]A+&/,B96R"5 .,@?KSCI0!TC_$C2!HFG:I%;7LT=_<&VCABC4R+(.Q&[K]
M,]171:/J9U?34O/L5W9[F8>3=($D&#CD GTKS76[:_;3O#,MMX5N+..VU079
MLK.$NT42D??QQO/)Q_@:]69R(2ZH6;;D)T)]J .=TOQE%J\MO]FTG4?LUS)+
M'%=,(_+8QALYP^Y<[2!D#G%5O^%A:<?"]SKXL;XVUK<&VN(\)OC;(&<;L$99
M>A/6N;\/V=[!XDT^ZT;2]8TF.YE9M4L;F,_9E7!Y0D=<],>HZ8-8UQI^M6O@
MWQ)X7'A_5)KFYU!KB*XBAS R!XSD,3DY"'@#N/>@#TF]\76]O<_9[33[[4)5
MMQ<RK:HO[E",KN+,!D@' &3Q7+:KXA@N->\(>*+0:C):W2W$?V.)2SN0C ?(
M#@G<?TSGBELO[3\'^)+F\;0M4U"TU.SMR3:J)'@D12"A'&!SZ_GSB]J5YJEQ
MKW@_4+G0KY&C:9[A($\T0"1"BAB,<C()].: .@\.>*+/Q*EV+>"ZMI[23RI[
M>ZCV.A[9P2.Q[]JSM3\57MG\0--T"&P:6WG@:61AMW'T9<L,!<'.>3V'2J_A
M"">'Q?XLE?3;JUM[FXCDADEC95DP"&()]3S^-5O$,5]:?%'1=7CTN]N[-+1H
M'>VBW[&9F'/H!N!^E %G2M=T:QG\6:A#_:CFSG#7B3#<%(!_U:]E^\>?Y8IJ
M_$_22+.633=7CMKOB&X>U^1WQ]Q<').>. 16#!9Z@L?Q#1M*U -J&\VO^C-^
M]^^OR\<\L#].:BO+/43X;\!QC2=1:2PNHY;E%MF+1K&P!R,<>H]10!V5AX[T
MR[CU4W-M>:?+ID8EGAO(PC[",@@9.>WYCUI=(\;6>J:O'I<NGZCI]U+&9(%O
M81'YRCKMY.>.:XCQ)X=U/6_$_B[R+"[$=Q:0M;R/"0DS1;"5!.!S@@5M>%8X
M)-4TYK7P(^DW$:EKJ[N+?RU0;",1GJQ)/<=,T =EKFMV^@:=]LN(YI=TBQ1Q
M0)N>1V. H'K]:R1X[TU-/U>YN[>ZM7TEU2YMY K2 M@+C8Q!R3CK47C^[UFU
MTJT&D07,B27*+=-:1AYDBSR4SP&]#CCVKC["VG-[XJ;4_"VLSV&II;.D4D9+
ME58 Y().\;@V.3\ISB@#T;2-=.J75Q:R:9?6,T"HY%TBX8-TP58C/J.HIFM^
M);?1;JULS:W=Y>70=HH+9 6*J,L<D@#\ZY[P+:ZOI^K:A8^;>3>'HXU>S>^B
M9) S8.U<\E0,@^_3O2^,M0U.S\2Z4JV&IW&E>6Y<Z:F97E[(3P57 SP1G\*
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MN+;59H/,FDWD*%3 SZ<GIQS78UQ7P\U&VOQXC>W<D/K$THRI'RL%P?T-=K0
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M>P_:F=[2*%6$=SD $2<=O3WK0E\6Z7%J$EEFX>2*YCM9'2%BB2/]T$_X=,T
M;M%<YI=U81>(/$)&K74\D/EO<PSDB*U&UL;,CH0#GZ5%;>/M'N)8=T=];VMP
MXCM[RXMF2"9CG 5S].^* .HHKE]0^(/A[3-0NK&YGN!<6K!952VD;;D9SP.F
M.]=!8WL&HV$%[:OOMYT$D;8QE2,C@T 6**Y?1O&<.I7FM1W-K-9P:9,Z&>5"
M(]J ;BS= ><X],&I;?QQHEQ=65N9+F!KXXM7N+9XTE)Z;68 '.1CZB@#HZ**
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#
M-U_1;?Q#H5WI5R2L=PFW<O52#D$?0@&N9T^3QSH6GP::VCV.K+ @1+I+WRBR
MC@!@PZ_3BNXHH \Q3P?X@TKX<VVB6]M;WEZ+Y;B0)/L555PXP6 S]T#\:WO$
MFB:M+K>D>)=(M[>6_LHVCFM99=HD1AR W0$9;G'?\*["B@#SJ\\(:MXE&M:G
MJEO!87]U8BSM8(YO-"@-N)9L <D <=!45OH7BR\U'PI)=Z98VMOHW[MLW(D9
MEVJ"V ,#[O '.?SKTJD(R"/7TH \JT==9N!XWT_3;);D7FIW$(=[E52#<2K$
MKG=T.>!SBO1-!TA-#\/V6E(VX6\(C+C^)NY_$Y-1:-X9TO0)[J;3XYDDNFWS
M%YWDWMDG)W$\\GFM>@#S.#P[XKL_"5YX16SM[BVD8Q6]^UR $B9LG<F,Y ]/
M7VYU)-!U.V^(^F:G;V1FTVUTY;%I3*@;JWS8SG@&NN74K!GN46]MB]MS.HE7
M,7^]S\O0]:EMKJWO+=+BUGBGA?[LD3AE;G'!'!YH H^(=$M_$6AW6EW)*I.N
M X )1AR",^]<SI,OC;0]+BTN30K74?LL8CBNDOEC$BC&,AAD8'ZBNQM[^SNY
M9HK:[@FDA.)4CD#%#Z, >/QJQ0!P]]HGB!]4T+Q(8+6XU6S$D5W;0OM5XG)P
M$9N,J#WZU6O?#^MZE=Z]K<NFI'>7.GG3K.T\]2=C=79L[1UZ>U>@TV66.&)Y
M976.-%+.[G 4#J2>PH \YU#0_$=YI'@^ Z2OG:7/')=!;A  (\*H'/)(&?\
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M)P>^T CC^\:YK1M-71].N=#U+P1<ZCJD<S)!<_9RT$^3\K,YX4<_EZ&O:**
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=X0,Y&>6/08!J?1+W4+[31-JFFG3KD,5:$RAQ@?Q CL: -*BN,3QW<:C-,=
M\.WFJV<3F,W:2I&CL.NW=U'3FM7PSXCE\0"_2?2KC3YK*;R9$E8,"V,X!'<9
M'YCUH WJ*** "BH;:ZM[VW6XM9HYH7^[)&P93VZBIJ "BBB@ HHHH **** "
MBBB@ HK!\4^*(O"UM9W$UI-<)<7*P$QD#9GN<_3I6U<7$5K;2W$[A(HD+NQZ
M*H&2?RH DHKA?^%EI'IIU:;P[JJZ2[ 0W:!&# G;EAN!49P!ZYKNJ "BBB@
MHHK'L_$$5YX@U'1Q:7,<ME&DA=U 60-GE>>1Q_.@#8HK.T35)=7TX7<NGW-B
M2[*(;@8? . <>_\ GUK1H **** "BBL'Q5XJMO"5C%>7EG=SP2/Y9:W53L/;
M.2.M &]17))\0;")U&JZ9JVD1NP5)K^U*1D^FX$X_&NL5E=%=&#*PR"#D$4
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M-XFT_5;3Q%8[;E#"EK86VQ;@$%N?WC?7/L*T_BY_R3R]_P"ND7_H8H F2_\
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M_P!JZ)8:ALV?:K=)MOIN4''ZUY;#_P @'XG?]?LW\VKT7P=_R).A?]>$'_H
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M)KBWN)8XU;S-@R&P1UQQ]>:]-TFSN;#2X+6\OGOKB,$/<NH4R')/0=.N/PH
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MCISZU'I?@;1=*LKJV6.>Y-W"8)Y;F8N[H<_+GL.>P%=&6 (!(&>E8WB;7_[
ML()([8W-U=7"6MM#NVAY&SC)QP.": ,N;X=Z3/HMAI4EYJC06,WG1,;L[LCH
M.F  .!@#';J<UM>6\\3:M!X>DT&X2PM[N.>>^GP4:->1L(.26Z>H!.170Z!=
MZU=VDK:YID5A<)(558IA(LB]F&.G?@UK4 &,# KF=3\$6.HZE-?17^J:?)<
M?:$L+HPI,1QEP!R<<5TU% '.77@K2[F]T>YC>YM1I&/LL,#@1CD$Y!!SG&">
MIK?GB,UO)$)'B+H5\R,X9<C&1GN*DHH XP?#72/^$>FT5K[4WM9;D71+3*7#
MXQP=O?OQ6H?"-@_B*/6YI[J>XCM?LFR5PT;1X(.X8R<Y).3U-;]% '%'X7:$
MT8@:YU1K-)A-%:&\;R8CDGY5[9R1GK[UIGP?9_\ "0W.MI?:@EU<6_V9@LP
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M1=) %K%;RJ$'J2"IR3T/J*O>&-<'B3P[::N+?[.+@,?*W[]N&*]<#/3TK7H
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5SGC]$D\!:TKJK
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "J>K:G;:-I5SJ5V2(+="[XZGV'N>E7*YGX@Z?<ZIX$U6TM$WS-&KJOKM
M=6(^N%- &?IE[XS\16=OJ]M)INF6DH$D-K+&TS2(>078$8S[=C6KH6NW;Z!)
M?>)8[;3)X9GCE!;:@"G@Y).<_6JO@GQ%I5[X3TY$O+:.:WMXX9H2P0QNJX(P
M>G2L3Q-JFFZOXG\)R-.EUHCW$RL_'D-,  N21@]\4 =U::MIU_9M>6E];S6R
MYW2QR@JN.N3VH35M-DE6)-0M6D89""922,9Z9].:\VUZTM+7Q!XMATY-EJ?#
MTC7,4: 1),"-G &-VT'WZUB3:1I*:)\/9A9VP-W=1K=/M'[T$J&#'O0![);:
MKIU['-):WUM,D!Q*T<JL$^I!XIT6IV%Q,L,-];22L,JB2J6(ZY !KS*\TS3M
M.\1^,=.LHH(K4Z"93;1C"JX!()&>O0_C62NFV-KX#\(ZCIUM;IK<U]$$E7AY
M#N;(/J.F: /8Y-2L8;D6TM[;).2 (FE4-D].,YYIT]_9VK%;B[@A8 ,1)(%.
M"< \GIFO'_%-SI]Q9>(Y+>*QMO(U=!))<2;[F:0. VS^XH^8CKQGI737.D:'
MK7Q2G:YM[>\CDT:.<!VWJS;R P&<?="_SH ZC6;V^^R6-QH]S8%'ND$LD\@V
M-$<@[2.ISBM"YU*QLY!'=7MM Y&X++*JDCUP37C>FE)/A'HLD[Y,.M1^66;[
MO[PC^1-7;NTM=>\1>+++6]6L].N1.%4W$".PME&5*,Q^7C!./7M0!ZS<W]G9
M%1=7<$!;[OFR!<_3-3HZR(KHP9&&593D$>HKRG4;7SOL.I:/-:>((K+2%BN+
M.^X<PDEA*N?NL0N/4 #KFO0_#=Q:77AK39["W-O:/;H8H2<[%QT]Z +/]JZ=
MY)F^WVOE*VPOYR[0WIG/7VJ22ZB$@@6>$7+H6CC9QEO?'4BO'M1T=8[GQ'X(
MM;-6N;RY74+!GSL5-N6/'0C!4<<YZ5U'@XP>*IDUZ>W5([;3UTX*5VX?&9<<
M\#D ?4_B ;D?B==+\-6VI>(IK**:67RB+1]Z9+X&#DYP.3Z8-(_B.XB\9QZ;
M)]C&DRV!NX[K?R2" <G.,<UYG>I!_P *;T@ (535RHSS@>9)Q^6*[75M,TC5
M/B+HUG<V]M/:II<K10G&S[R@8 X(QG _PH [F&:*XB66&1)(VY5T8$'Z$4PW
M=L)GA-Q$)8UWNA<;E7U([#WKD/AM'%;6.O64#Y@MM:N(H5W9V(-N /;K^M9O
MBXVWA;QG;>(Y;19++4+62QN@!DF3!9,#'5L!?H/S ._74+)X%G6[@:%FV"02
M J6],YQFN>T/Q1/=:QX@M-5%K:1:;<)%&Y)3<K D$ECW 'IUKA_"5E<%K;P)
MJ, $^G7_ -NNBA^4PA0R8/<F1E!Z<5>DTG2-<UWX@7%W;Q3F!(UCD8<QL(2#
MC/0@KU]J /3Y[B"UB,MQ-'#&.KR,% _$T0SPW,*S02I+$WW71@P/T(KRC28[
M34]3\&V.MHUS9S:,3!'+S&T^><YZ_*/SQ5+58O[.M_B#I5DI32[=;>6*-3\L
M4C;20O8=^/:@#V03PF<P"5#,J[C'N&X#UQZ40SPW$0D@E26,D@,C!AQP>17D
M4NAZ;!KG@".&T2-;ZV8W6PD&;]VA^8@Y(R3Q[FNA\!Q)9>,O&.GVRB*S@G@,
M4"<(A(;.!VS@?E0!V,^M:=;ZQ:Z3+=(+ZZ5FBA'+$*,DGTX!Z]<&L;0O%%QJ
M'B3Q#IE[';0Q:;-&D4BL?G#YQNSWX'3N<5B>(K2WE^,?A<R01OYEM/OW*#NV
MHY&?I6(^E6.HZ_\ $>2\MUF>VA62$L3\C"-R&'OD#F@#UFXN8+6+S;B:.&/.
M-TCA1GZFI:\;6WBU_5O#NGW]_;I /#<,J?:H_-4R$X8_>'S8'7/:O0_!=I;Z
M=H']G6VK-JBVDS0F<C[I&#L')Z9 X/M0!E/XI\03>,+WPW9Z9IXN((//6XFN
M7V%#C!("YSEAQ^M;6A7^O7-S=6^M:3#:>2%\N>&;>DV<YQQD=.A]:XN[TJ35
M_C)J,$6IWNGLNF(_FV;A6;E!M)(/'.?P%;-KH>FV%GK.A:UK3ZC]I#WQ^T,3
M+%$ J[B?4'D'CZ4 =O17DWP\>*&[O4OPS:O:V@.G-,FTO:@,591W)W<^V/>L
M[P]H[ZWHMEK\FN:?93QWOGW%T\9$_F;SE6._&#V&!P!QUH ]JHKS'3K'1_%\
MGB?^V;@IJ$5Z\8<RE7M84X0ID_*#@D]B:EM(+=OBN;43-<6<^@*)'=]WGKD+
MN8]R5 YH [Z_U.STQ(GO)UB$TJ0Q@]7=B  !WY-0/=:H/$<5JEBATLVY=[LR
M?,)<X";?IS^/MSY0UBEWX)\,HJI+:0^(#%(I;/RM,P ]^"*[.XM8K3XIZ)'
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MDM5E,R!9GW(Y&,@YS^'3VKI1(AD,8==X&2N>0/7%-,\0F$)E3S2,A-PW8^E
M&/H_A'1M"OI;ZPMY%NI4V22R7$DA8<==S'T%&L>%--US5++4+MKH3V9S%Y5P
MR <YZ \'W&#6X2 ,DX%)N7"G</FZ<]: *B:59QWEY>1P[+F[54FE5B&8*"!S
MVQD]*P+;X=>'[?1;O2FCN9[:ZD$L@EN&)WCHPQC!XZ]3WR*ZNB@#F+/X?^'K
M&_-[#;SF=H&@=I+F1]ZD8.<GTX_R*:?A[X>;03HSV\TEJ)#+'OF9FA8_W"?N
MCV_/-=!J&H6FE6,M[>SI#;Q+N9V/^<GVJPK!E#*001D$=Z .7B^'WA^'0;K1
MXH9T@NBIG<3,9'*G(R3_ "Z>U6=5\':9K&B66D7,ET+6SVF+9-ALJN 2>^!7
M044 <UJ/@30]5U9M2NH[GSY(?)F$=P\8E7&/FVD$\8[]A4,?P]T:*'384FU!
M4TZ4S0 73<,2#_3'&.,UU=9%EJ=Z$U6;6+2.QMK2=Q#*9,B2$#ASZ?Y]* -8
M@,"" 0>"#7)2?#C0Q/)+:2:A8+*Q9XK.[>-"22<X[=>@XJ;6_&*Z6?#\MM9B
M\M-8G2)9O.V>6'V[6QM.<@D]NGO744 <[+X'T"30X](6R,5K%+Y\9CD8.DG]
M\/G)/US4D7A'3XX+Y9)KRXGO83;RW4\Y>41_W5;L.2>.YK5N=0M+2YM;:>=$
MFNW,<*$\N0I8X_ ?R]:R]-\0RWWBG5M$DL?(^P+&ZS>;N\U7'!Q@8_,T 5/^
M$#TDV.EVAEO3'I<IEMB9_F4Y!QG'3CI4DG@;1Y-4U&^;[2&U%&2XB6<K&VY=
MI.T=\9Y]S7244 <C9?#?0;&[L;I#?//9.&A>2[<X Z+CIM]ACWR*=:?#O0;+
M4UO(5N@JS_:%MC.?)$G8[/;M5VS\1SW/C._\/R:=Y26L"SK<^=D2!L8^7 QU
M/<]*WZ .;F\$Z4^I:EJ*?:A<W\3I*JW+*A+(4)P.,X)ZYQG(%6?".C3^'_#-
MIIMS,)98MQ8ABP&YBVT$\D#.,\=*VZCG=X[>1XHC+(JDK&"!O..!D],T 8MG
MX2L;'Q)<Z[%<7C7=SN$HDFW(RG^'&.@XQZ8K/_X5WHX)A2>_33FD\UM.%P?(
M9\@Y*]<<=,XKHM*N[F^TNWN;RR:RN)%R]NS[C&<],X&:N4 8D7ABRA\42^((
MYKH7DL8B=?,&PI@#;C'3@'ZU?U73+;6=+N=.O%+6]PFQP#@_4>_>KE% '+#P
M'I^W2-U]J,C:4^^W9Y@V#QP<C&!M'%3OX+TF>YU6:Z^T71U10MPDTF5X^Z5
M P1V/:NBHH YS1O!.F:)?QWD,U]<30QF.'[5<&01 X!V@].!BN=^*C!9?#1)
MG"QZBLKO"A9D1<;F& >1D5Z+7+VGBJ^O]<>UM-"DETV.[>TEOA< %'3[Q,>,
MXSQG- $VG>$["&.^FGN;O4)=1A\F:>ZD)8Q'/R#&-HPW;%9=C\,=)M'M9)+_
M %6X>TE62V,MT<1 =%4 8 X'Y5VU% '.:7X9M_#EWK.II?W<HOF>XFCEVE5;
M))( 7/?%<+\.?#D.N>$XK2_O=16*VNFDFT\C9$^<%<_+DCC.,]<UZ[10!S&J
M>";:^UB75K/4M0TN\G4+.]G*%\T#ID$'TH_X0JWMUT[^S=2O[![(2;7B=6,I
M<Y8R!@0Q)'<5T]% ''3_  WT>XT6"P,]XLT$[7*7J2 3>8QRQSC'/'0=A6QX
M>\-VOAVWE2&>ZNIYL>;<74IDD?&<#/H,GCW-;-% &!JGA6&_UN'6;:^NM/U"
M./RC+;;?WB9SA@RD&J5]X"LKWPX^B_;KR.&:<W-U*NS?<R$[B7)7UP>,=!76
M57O[IK'3KF[6"2X:&)I!%$,L^!G ]Z %LK8V=C!;&9YO*0)YC@!FP,9. !^E
M3UG:%JT>NZ)::I%$T4=RF]4<Y(YQS^5:- !1110 445R^M^,AI>JS:=::1>Z
MG<00+/,MJ 2BL<#CJ3WX[4 =112*=R!L$9&<'M2T %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %8'C:*SG\':C#?WS6-K(BH]RJEM
MF6 &0.2,X!'H36_45Q;07EN]O<PQSPN,/'*@96'N#P: /%-6O=4M]%U_1)+>
MS:_MK")GU&P/^OME=5VL%Z'#'.>P;MBNHT&VT)?%6G:I;>(?[5O'MC D<$42
M".(*3ND" ;0.!R,\@?3N[/1M+T])$LM-L[9)1B188%0/]<#FFVFB:38+*MGI
M=E;"5=L@AMT3>/0X'(H \MANUD^"FNR3SVYEENY<F-L*S&4'Y<]CR1[5L:_+
M;3>// -S$T;"5)")!CYEVKMY].3CZFNU'AK01;&V&B::(&<2&+[*FTL 0&QC
M&<$C/O4O]AZ29+:3^R[+?:@"W;[.F80#D;#CY<'GB@#Q^]T^PN$^),C6UHTT
M$R-"[(NZ/YFW%2>F?;K6QJEY;V3^!+^62VNQ'8[393SQQCF(?O-SG:#D8Y/)
M  KT8^']%)N"=(T\FX_UY^S)^]YS\W'////>N0\3>&=4?6(9M-T31]0TN&S,
M$5C<*L8B8MEBG& >G],4 7OAQI%KINA3S0_8/-N[AYF%I(LHB4GY8RX)W;>>
M_4GZFCXFO=*3QN\-R;&UN1I3![Z^?*JC%P%2(X5VSR>>G%;'@[PTVA+=W$MI
M9V<MUL!MK,L40+GNQY)W'L.U;=SH^F7MVEU=:=:3W,8"I-+ K.H&3@$C(ZG\
MZ /';6.RO[#X;12);W(,TL4R,%?C<ORL/QZ'UK>\*Z)9:P/'&@RI&EH=1<11
M*HVPG+ ,J]!C Z>F*[V/PWH4+1M%HNG(8VWH5M4&UN.1QP>!S["J^HZ=/IUI
M/<>&=+TQ-3F=3(TD8C$@SDEBHR3U_.@#B_!$L_B2]TZUU6V=9O#<;I,LJ#!G
M+80CW55/XUJ?%^&.7X?W#N@9HIXG0G^$[MN?R)'XUT/AC1I]'T^4WLD4NH7<
MS7-U)&FU2[=A[ 8%9OQ'TG4=<\(2Z=I=H;FXFE3Y?,5-H!W$DL1Z8_&@#F[G
M2=+LO'WA.+1;>UAWV\WVQ8"!F/8.7_,\GK7.Z%I%LOPLUS5K&TC.J0RS1+.H
M)=8CM# 8_P!DM^&:]8T#0M/L+-9TT6VL+NXC'VE%56(..5W#@CZ<5;T[0]+T
MBTEM+"P@@MY26DC1>')&#GUXH \W\16^B1Z'X8U+PW;6,.I->6WD_9]J.P8<
MJVT\\@ YZ<^]4I5TZ^\(^,[G5;:Q_M^.[GW"0*TL0X"A2><#! (]*],L/"7A
M_2[TWMEI%I!<<XD2,97/IZ?A1?>$O#^IWS7M[I%K/<NNUI'3)88QS[X[]>GI
M0!YU836T?B?X<W1EA5#I1B>4L ,B$C:3[,<8]36'<W"0Z?XF$!B.F/XBC%UY
M>"OV?<QX [9"]*]BN_"N@WUE;6=SI-J]M;9\F/9@1YZXQZ]ZGAT#1X(+B"+2
M[-(;DYGC$"[9/]X8YH XK6+3PB--\07.@261OI-'F1XK!E,80=R$X#$D=>3C
MZU0M-,-_X(\(MHEQ8+?VS?:4M9<>7<R*OS@XXWCU/(R>E>A:9X=T?1[>:WT_
M3K>"*;_6JJYW\8P<]1[567P=X>2RCLTTFW2".4S(J@@JY&"<@YR0 /P'I0!0
M^'^HV=_X?D%II:Z8\%S)'<6JY*I+G+8..G/0=.G:L30]/TO7?%_BZWURUCN[
MJ*=4B%T Q2 @XV \J.^1ZBN\T_3K/2K06MC;I!""6V(.Y.23ZFJE_P"&M%U2
MZ^U7FG0R7&W:9<;6(]"1@D?6@#QS[*+OP[X5AO-UQ FO&U@>0,-]N67@9YVG
MG^7:O:]/TZQT/35M+*%;>TBW,$!)"Y)8]?<FJ]UX:T6]CM(Y].@:.S_X]T V
MB+I]T#&.@K490RE6 *D8(/0T >1:'!%X=U733+IMI?Q7,TQTO6[-@'9G5OED
M7JW!(YSCMGMDZ+H]GJ_AZ'5K[Q+9V-W#>M/<LUB/M8FW9V[]^XY[ +^%>N6'
MA30M,N(Y[/3((I(R3&0"=A/4J#P#UZ>M,'@_PZNJ?VF-'M/MGF>;YNS^/^]C
MIG/.?7F@#C-%T'2]=^)'B[^T[..Z^SS6[1"3/RG!_P !5&YTP:5XCUOP7:6B
M+!K_ )<]JVT%8DS^\XZ#: Y'I@>U>EVFA:98:E<ZC:V:17=SGSI5)R^3GGGU
MJT]G;/>1WCP1M<QH424J-RJ<9 /X4 <-?V$>F_$_2FTX1;UT>:.*S4X";,[>
M_ ;..WW367X6T[PSKGA:SU36KB!=8%VTUQ<&8)-YWF'"GV(V_+C'/ KT.30M
M,EUA-7>S1M01=JSY.X#&,=?<U5_X0_PZ-4_M(:/:"\W^9Y@3^+^]CIGOGUYH
M \O'AV'Q1=^(;S4->M-/NH-1D#M/;DRPHA^4JQD7"X'IVK4\5V+1ZE)KKZ?:
M^)--33HX+M/,"SQ<;O-& 2F00>.<'L.:[V\\(>'M1U W]YH]I-<D@M(\>=Q'
MJ.A_&G77A;1;R\GNI[(-+<1B.8AV42*   P! (P!0!;MS;:OH<1\MC:7=L/D
M?KL=>A_ UXK?Z>T.C7/A."S6;4M#OI+U9-NS=:A=Y;)[G*C'/;J!FO=(HHX(
M4AB14CC4*B*,!0.  *@_LVR%[/>?9H_M,\8BDEQ\S(.@SZ<T >;7SQ:[X3\4
M^+8X/*COK)(( P^;:@^8G_@9(^B#ZF&RT.PTJ#X?:M8)]GO+AXHYRK$F4219
M;.?Q_P"^J](?0M-?0VT7[*JZ<R>7Y",5&W.<9!S5.3P?H<J:6CV;%=+_ ./0
M><^(^GOST'7- '#:G/+H<'Q#NM-EDCN%G@(Q(QV>8%WL!G@_.QSV^@KH]&\/
M>%+36+#5-%N(DF>W9%2*7=YZD9W$9ZCU]^:V8/"FBVUYJ%TEGF345*76^1G6
M4'U!)%1Z1X,\/Z$9VT[38X7G4J[EF9MIZJ"22!["@#R'3[.VLOA+;^(DB8ZE
M9WZM%+YK#:!(/E'. #ST]<UZ_P"*M1NK#P7J5_9J?M,=JSH5/*$C[WX9S^%0
M_P#"">'3H(T0V+G3Q+YPB,\G#^H.[/X5O^1%]F^SL@>+9L*O\P*XQ@YZ_C0!
MY]HFA>'HK/0M<L+H1:DEKD+'-DW,C1\JP)R><G'UK T[2[#4?A;>>)KK_D/1
M^=,U\9&,J2JYVC@\<!>/>O1=*\$^'=$U![_3]+BAN6SA\EMF>NT$D+^%-?P1
MX?>\DN?L14R2B:2%9G6%W'0F,'8>_4=S0!P]I9+XC^(EC%K4<K>?X?AGN(-[
MQCS,KD%01W['N/6N?CL8O^%8:WJQDN#?:9J0ALI3<.3;H)(\!!G ^^W^17L,
MWAC2I]?37'@D&H)'Y:RK.ZX7!&, X[GM5-/ ?AZ/2+K2UM)?L=U*)IXS<R'>
MPZ$G=GT/X"@#C;S2[;7OB?IUKJ)GE@NM$2>9!.ZAGW'T(P. <#C/.*RK5YHX
M[7PY)>J-*_X2&YMPUT[%&CC52J'!!(W'/7&2*Z6Z\/O<?$JT+6&J)I=MIJV4
M=U#/)'A@21EU.XC!QUZ\FNHG\&>'[G0HM%ETV-K&)MZ)N(8-W;=G=D]SGF@#
MSS6= .D>#/%%M<:A8SH[1W<-E;DG[,2X7.2<X(X_"M;7M.AF\7Z5X;M39IIB
M:>\\%I.SB-Y"Y&05(.[!)'7'..M=;;^#/#]KH]UI4.G(MK=#$XW,7D[C+YW<
M=N>*CN_ WAZ]L+*RGL-T5EQ;L)7#H.N-X.XC/O0!!X#LI]+T6;3+C5X=1>UG
M* Q9(A!4$)D]>N?QKEO$D5IH7C;45NK>62SU[3V2-$+'=<@C"C'0L<?B:]%T
MK2+#1+%;/3;6.W@4YVH.I]2>I/N:+[2;'4IK26\MUF>TE$T!;^!P, _Y]J /
M,_!\8U@:)H%W;RPW6@3RSWJ;B,.&_=\_Q;BQ/!_@/8BII[6232/B3%&\DK><
MS@.^<#9O.,] .?P %>CVNEV5E>WEY;6Z1W%XRO.ZCERHP,_A_,GN:S[+PCHV
MGMJ!@@F/]HJRW7F7$C^:#G.=S'GD\]>: /.M7TRT@\(_#^&",Q+=7EI)*8W*
ML79%W,"#D'W%;WABV31?BCK6C6+2K8&QCN#%)(TG[S*_-EB3GYCW_E6X/A_X
M=%K;6PMKD16TOG0J+R;Y'P!D?-VVC'I6E#X=TVWU^;7(XI1J$R>7)(9W(*\<
M;2<8X':@#G/&6E6&I^,O"45]"LD<DMPK L1G;'N4<'^\!6=J.AQ:[XZ\4P2&
MX9ETZ'RXX[AHU=\';NP1G! Z\5VFM^&]+\1);KJ=NTOV=R\161D*GV*D&HQX
M6TI=3O-16*9;N\A\B>07#_,F ,8SQP!R.: /+K2\U#Q!IG@[0[IT>VN;:9V-
MQ.\:S.CLJJ2A!)4*,<\DBO0?!&D76@65YI=UJ,%UY<WF1Q1%F^SHW(0EN>Q(
M_/O4LO@+P[-I=IISV3FVLW9[<?:) T9/)PV[.,\XS6KI&BV&AVAMM/@\J-FW
ML2Q=F;U+,23P .?2@#B+_2+'7/BO?V%_+<")])1O*BF>,/A^Y4C.,C@\<US<
M-UJ?V+08))KB2+3O$XLH[AGY:,,  3^8KTO5?"&G:MJ\6JM-?6EZBB-I;.Y:
M(R1@YV,1V^F#[T^]\(:-?:"NC/;&.T1O,C\IRKI)S\X;J6Y)R<Y[YH Y"-+D
M_$/QO:64[022Z:AB/FE LK1C:V>QRW7MFD\'&WANKO1KW3K[1]<:P*3[9R4G
M R/-1LGY^2=P]^:Z6#X?^'+>.Y6.TE#7,'D2R-<2,S+D'J3UR!S[5;MO"FGV
MZJSRWEQ<+;?91<S7+&41^Q&-I]Q@T >>D7<GPH\-NNJWBO+J$0DDBF*N0SL-
MN1SQU^H%-OKZ[\&Z]XMM-*>ZFB33DNE269Y"LK,BM)DYY <L3_L]17:?\*\T
M4:#9Z.LE\MM:7'VB-EN"'+^I(X_(#';%7?\ A#]+.O7NKR^?-+>VWV::*63=
M&R8 Q@C/\([T <QX=\,:A8:OIFM)J5M;Q7,?^D(+F61KLLF1GS"1N!R>/>J'
MA7=I?BNQL]>MK^'6Y6E":@LQDBU!""1NYQP ,#M@=*ZW1O &AZ'?_:[9;F1U
M.85GG9U@X(P@^AQDY-2Z;X+L-.O+.?[7?W*V0;[)#<S!T@W<?+P#TX&2>* .
M.\*EM*\6VEKK]G?0:W,\PCOQ,98KY""<,<XX &,=,#I71_$'4[BRM='M8I9;
M>&^U*&"XN8I#&8XR>0&'W<^N>QJ[8>"K"PU"TNS>ZA<BRW_98;B<-'!NZ[1@
M'@<#)/%:NLZ-8Z]ILEAJ$7F0.0<!BI!'0@CH: ..:P3P?XWT.RTIKTV&J)/'
M-:&=Y$1E"GS!N)(//)]!4OPXT6TL%UF:%KC?'J=S;C=.Y4JK  E<[2W'WL9K
M;TCPA9:3<M=?;=2O;ORS$EQ>W)E>)#C(7/ Z9Z4_PUX5M?"T5S%:7E]/'</Y
MC+<RAPK<Y(P!@G//T% %#Q 8[GQ;I.GOJ5^OFPRM]ALV:/=Q_K))%8$*.@'/
M-<+-JNKS>!O#CR:E?PW#ZT;221+EMY3<PVLP^]C Y.:]&UCP?INM:U:ZM-)>
M07=NAC#VMPT1=#_"2.<<GH1U-9O_  K/1%L([.*XU&*&.\^VQA;C.Q\8 &01
M@?GZDT 4=%L;F/Q-XF\/?VUJ<L'V2%H))KEGEB+@Y*L>1SBLC0M2U/5X=$\-
M27E_%JNG:A(VIR"=M[11Y/S'()5BZJ,^G2NPO-&M-!U74_%T46HWU]) (VM8
MF#[E^481<9[ ]3WJ#PG8O=ZOJ?BFYT^2PGOPD4=O,@618U4?,W?+'MZ*/P -
M#QJ\\7@O5Y;:YEMYH[9Y$EB;:RE>>#VSC'XUQ3Z=J$%]X1V>)-:_XF\>VZW7
M1(P(@_R@\*>V>M>B:UI,6N:1<:;///##.NV1H&"L5[C)!X/0UC3>!K&>/1E?
M4=3W:1_Q[.)EW'D8W?+S@ #MQ0!R%_J.I^&;#Q=8V^K7=P+:XM([>>\G+O$)
ME&[YSTZ]>W7K6YX?T7Q'IWB%Y+K40FF7-N8U@EU)[M_- R&0NH]SC_(UI/ ^
ME7%SJ\UU)=W*ZJ!Y\4TN44C[I48R"O0'/%+I?@NTTIG<:EJMU,(C%!)=W/FF
MV!&"8\C"G&.<=A[T >:M)K,'@#2M?B\0:PUZ^HF!BUP6C5-[KRIX/*CKGKBN
MKLVO-&^)4NBC4[Z\M+C2S<N+R8R8DW,,KV4>PK4D^'>ER>';;0S>ZC]DMK@W
M$9\U-^\YZG;TR2>G>KZ^$K0>)8]?DO;Z6\2W^S8=UV,FW'("CJ26X(Y_*@#S
MJWM-1T7X8Z5XFL-;OUGM_+)MWES 4:39M\OH?O=3_A6C<)XF\6ZKKLNEWCVQ
MLKUK.W5=3>%8O+P"S1JAW[N3R1W'..>FL? %E9B*W?4M1N=-@D62&PGE!B5A
MDC/&2 3D#/;O4NI> ].U#5+G4(K_ %6PEN@!<)8W7E)*1QEA@Y.* ,/5+77=
M2\6Z/83Z[<6276E/YPL)2%\U3\S#CON7GKQVKHO$E]<^%O =W<V\SW%S:6ZH
MDTQW,S9"AF]3SGWI!X-M(O$5AJ]M>74'V*W%M';H5*>6.W()[G/.?<8K<OK*
MWU*QFLKN(2V\Z%)$/<&@#SG4+?4?#^B:-XDL];U.>666W^UV]W=&2*19,9 4
M\#DCIT%6-%LHW^,OB0F2X!B@@=<3N,DJAP<'YA['BMO3_ L%E+;)/JVHWMC:
M.LEM9W+J4C90<$D#+8SP.@JU8>$X[#Q=?^(5U"Z>6]4*\+;=F   .F>,#']:
M .AHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1&P?> -WWN^.O-9T%MH.JV6OV_B'Q!/8WXU*622!Q&"V",%<KN/ Q@,.G3U
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MJYFR\8^+=0CU@VFD:9++I4[031"9]SE<YV\8/3VKT2N!^'9!UWQGS_S%Y/\
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MP>U2ZN%C:ZE\J <G>W7''\Z\ZTZVTZ\\5:7H^L7T6J6-MHZ_8S+CR9Y-VUF
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MD.J30O)%'ADA,H& 1S@+N^E:_AWP[IFG:SINJ6FOV9>>W:-;:U@6,7(,9;+
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M\.[W4G>6XN;IHII Y0LH< =",'W'->A:AX&T?4+Z>[)N[9KG_CY2UN&B2?\
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M)96!EN4RO,@''?(Y./;%5M1LK+6OA9JWB.Z,<NLR7!:69Y"3'B8*$ S\HV
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MME%9V4"06\2A4C08 '^>]6** .6N?AUX6NY+EY=,_P"/AM\BK-(J[L@Y"AL
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,!N#;?\ :]*BN'AO/B+X2U2.+RY+O3YV;GG;L# 'Z;C0!W;,J(SNP55&22<
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M3'GUXX/M6O9:5IVF;_L%A:VF_&_R(5CW8Z9P.: +8SM&[&<<XI)"XC8QJ&<
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M/=:? N %N' RY(Y &, =,$_CZ510!P5WX-U#4_AO/I][('UVY(NY9&(P9QC
M)''W0$ST[TR[@USQ==Z-9ZEH,NGQV%VEU=3R3*R.44C:FTY.2>O:N[AN8+AI
M%AFCD,3;) C [&P#@XZ'!!Q[U+0!Y%<>'_$D&E^*?#MKH<ERFHWC7,-YYZ(F
MTLIZ$]>.GO[5O_8-8M_$_@]SI,KPV5DT%S,DBE8V9 I[]L?CGC-=O<WMK9('
MNKF&!20H:60*"2< <U."" 0<@]Z /(7T7Q'IOA+6O"4.@3W*3S/+!>QS)M9=
MP/(.,'"]/4UZ;X?BN+?P[IT%U"89XK:..2,L&VE5 ZCCM6C10!Y/INC:]:>$
M=3\(MHMP9[N[<+>!U$"QL1E\YSP!G&,FK4>DZUX&UV\.D^'_ .VM/O8854B4
M(8C&NW!R"<8]?SZUZ=10!G:+!>1:/%%?QVT4V"/)M5Q'"O\ "@]<# SQ7EUQ
MHGB2T\$ZMX-A\/SSH9S);WB3)M:,2JXR"<YP.GO7L5% 'GE]IVJR>+_!ER=*
MN?*L;<K=.I5EC9EVXR#SC&3CL>]7_#@U"W\7>*;NYTB\AM[IDD@=@O[SRUV8
M'/4]17:44 >7^'M*U:U^&.OZ1-H]Y%=2>=Y$;;29!(,#'/;O38M(U_3+'PGK
M=GI<UQ<Z9;-:7.GNX5\'(W+U']2,?AZB&5L[6!P<'!Z&EH X'Q3;ZWXG\&22
M/H+P7<-W%/;6IG!D95(R6QP#@L,<U'IB:U>?$>/7KCP[=6=L^G- Q>5&((;(
MX![XP![YZ5Z%10!Y-=Z#K5_\+&TU=*N([VWU$S""3 :1&D+97M_'Z]C7J=I.
M]S:13R6\EN\BAC%+C<GL<$C-34C,%!+$ #J30!Y))X=U_4/!&J>'VTB:">VO
M'NX)7==EP/,)VCG(."<=1P.F:W;EM3\8:WH#?V'>:;%IMU]INI;R,#YE PD9
MSE@2>O XSVKOZ1F51EF &<<F@#C/BE97NH^"Y;.PLI[N>6>/"0KN( .<GVX_
M6H;M-1E^)GAVY^P79L8["16?ROEBD8'(9N@/"CK]*[JB@#Q/_A&=7GT[49QH
MUQ+)9^(#?+;3Q;5NH3U"@_>Z#VP>]=7')J$_AS5[G1/"/]AW!M=L)\E$GE<G
MH% X &>O<C'2O0:"0.IQ0!Y=;RZB/%=MJY\*ZN\3Z,]O(9R"\CC#8;GY<].Q
M.>G&*=X5TVZLO$4?]AV^KV>C7,,CWMCJ%NR) ^W"",L.3GT[ 9->GT4 >0H-
M<F\%Z1H<?AG5/M6F7D3SO(@1&".3\A)^;/MQ[UU.D?:7^)7B-I-/O8K>:WBC
MBN)(&$3E!@X8C!^]Q]#7:T4 >/\ ARQNM)M%\/WO@!;V^BE8)?R0+Y+#=E6:
M0@\?0G@?A7L%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %5-3ENX-,N9;"!9[M8R88F<*&;' )/05;K*\2Z5-K?
MAR^TRWN?LTMQ'L67&<<C@^QZ?C0!S6D>)]9?Q7I^C7TNGW"WFF&[\VU0[8Y-
MQ!4'>0X&TCC&:PM/\=>+KK0+'7I$T@V,MZEK)&L<@DY;&1SBMFQ\)>*(=8T7
M4;C5=,)T^ VS11V[ &/&.N>2<#^Z!Z>M*'P!KMMX"AT"&]T];F*_%R)3O*[1
MR.W7=CMC% '0/XAOK'XA'1]1:TBTRYM&FLI K!RZ[=RLQ..@<_3%7_".H:EJ
MWAZ&_P!46W66=F>,0 @>7GY<Y)Y/7\17.>.X]'\37&GZ)%=K)JT=\B[('R\2
M'_6%L=%V9_'%=Y##';P1PQ($CC4(BJ,  #  H X/5=;U'Q#IOBM-/GM;?3].
MBFMG\R RO.PC8O@AU"#L.#Z^U,\+W>J6_@CPI!I[6<,-P&6>YNF!"#)VJJ;@
M69CG&#QBIKGP9K5K=ZU#HM_8Q:9K!9YX[F)V>-F4ABF"!SGOTX_&*#P1KUA;
M^'#9ZI8M/I*21LL\+&+Y\Y8 ')8 XY(Z#I0!"/'6M3_#N;7;:"S-[;7GV:8.
MK!"-X4,HW9_B7OZU8EUKQO!XCAT5X]#,UY \\,@\W;$%ZAN['I5*+P!XBM_"
M5[H,>HZ:T<]\MR'*."R@AB#UQRJ=/?FNDET36+CQWI^MR2V*V5M;-"T:[S(2
MRY)'&/O8Q[4 9UCXF\0WWAR]?RM-AU*QU-K&XF=\0*JX+288@]#C&:A7QS>V
MN@>*+FX6VN[C1IA%'+!&R)*6P%)4DD8)YP3D=/4P3>!O$#V%Y&M[IOG2ZT=4
M171FC;((*N".1]TXYZ55UJQU[PYHWB2^U&^TR=]8,42XA90';;&00> H3=US
MT!/I0!J6?B;Q!#XDTZQOYM+ELKRQ^W-/'$R-&@&6&W>WX$\?D167:_$/6M0G
MT^]LK/SK"ZNO+DM5L)C)%%NV[O-^XQXR<=,XYYQ5\/I<Z/KD-FMOX7NK:^(L
MW.GW+--Y9&3C<Q(4 $D<9Q]*W=!\+^+M @BTFVUG3_['BF)5S"QG6,MN*C^'
M)R>N>M $D7BS4KWQA=:3#<Z=:FUO$B-G<QL)9H>-TB/N SUPN/QKI_$&KIH.
M@7NJ21F06T1<(/XCT ]N2*YKQ%X1U+Q%/F=-+62*Z5[:]7>)XX0V2I &"?3G
M'X\UTOB#2$U_0+W2WD,0N8R@<#.T]0??D"@#(T^Y\7_VAIKWL-A-8W43/<+
MA1K5L95=Q<[^N,@>M9(\7ZY8ZAIDFK0V,-M?WYLVLTR9K;/^K+."02>N-HX(
M_#4T/2_%MND-KJVJV#VD$)C5K>-_-D.W:I=F].O')(%<O'\/O%2V&EV3ZCI+
M1:=>B\C;;)OD;<6)<]_\\T :G_"9ZK)H_C&X1+59M&NGCMR8R0R*W1ANY. >
M01UZ47GC>\">&X5GL-/DU6Q^TM<7,;/&'V@A,!AM!)ZDU'JG@WQ%/?\ B""P
MN]-CTS6?GD:5',BMMQ@8XY/?G^E3S^&]<71K#2)[+2M6T^+3UMWCE8QLDRY
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M.".[G $LRQ@.X]SU/05:K@;GQ+KNC^ ],OKEH[W5M3FBBAV0<(9 6'R@_-@
M].IQ56T\6^)](LM<N-:L)[FVM(!+:W<EK]F#MP-I7.<9/;T/M0!Z117)VG_"
M6V]_;37=[9W.G3VSR3LL.S[,^,J%YRRYP.<G@US<OC;6U^'6CZ\MQ ;J6_\
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MTNW@TN3Q(ATFVD5HQ%"5F=0V[86S\H[<9X_*NYHH Q_$_A^#Q/H%SI<[F,2
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MIVW6"WV4AWRF5*#>-O\ =P>,\YKH_#EA=:9X:T[3[TPM/;6Z0N822AVC QD
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M:^Z)-0:9@\<)8G!3'+8]..1SUK7MO#VIZ?XX6]M8+4Z7%I"V$1,I5AM.X @
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MJ[3M)/ (]_Z$<[K=M+:_\(_X9OM=TN.XTV!KB2;4H5\B49V1J-W4@;NX[?@
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M:D-/FM&GQL?!.0VWGH.U7]1TW4].\>C7]-TG[=%<6'V:<+<K&RN'!!PQQC
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ=A\P.IP1G.,=.U<EH.MZK+\(M2UF^:WU.7?(XBO$+*1O&X-DD$=2  ,8 H
M]1BD2:))8V#(ZAE([@]*=7$:SXBUC1E\,W2Q6::7>-##> 1L3$S8^Z01A<9
MX[>],U;QM>:0-7N'AAFMTOX]/L%5'W-)L!<MC.0#GH.<$4 =U5*XU?3[74;;
M3Y[R)+RYSY,!;YW SSCTX//M7,>#_$NMZIJUWI^K6>42(2Q7D5I+!&W(!3$@
M!SSG\#57QS%=#QEX1N+"&W:[\Z9$>=R%^[T( SC&30!WCHLB,C@%6!!![BJ6
MEZ+INB0/#IEE#:QNVYA$N-Q]ZY"+QEKD%KXBL[ZSLCK.D6ZW 6%F\N1"NXGG
MI@=L\TDWC+7M/T>"]U"RL@^I&%=/2 R28W)N<N I)QP0 ,\X[9H [^BN$T'Q
M7XCO=.UG[3I DN[) UJZPR01W).>T@!&,#_ZU6U\7W6GW^H6VKQVA%GIB:@S
M6K'@G(,9R3SGH<],'OP =AT&35/3M5L-7@>?3KR&ZA20QL\+AE##J,CZC\Q7
M-:3K?BN^;1[R32[!],U%1(Y@E;?;H5W MNX/!'0=L=Q7):5K6I^%/#GB:_TZ
MPLS8VFMS!TFE8N,E%"@*,<97G/.?;D ]>HK@-8\=7[WUQ::##;L]K:QW,HGB
MED9RXW"-1&#@XQR?7VIS?$"5K7PZ[Q6VGOJL<K.][NV1%. .H^\>A/8YH [M
MT62-D<!E8$$'N*H:1H.E:#%)%I=C%:K(=S^6.6/;)JQI\EU-I\$E['%'<L@,
MBQ-N0'V/<52\2ZXOAW0Y]1,#3LI5(XP<;G8[5!/89(R: -:BN-E\2Z[HVL:3
M;:[9Z>+74I/(66UD8F.4] 0W4=N/_P!<.@>+/$.NZS=6J:391VUC?/:W<GV@
MEE S@J,#/3&>^1P* .XHKF_&'B#4O#]O82Z?IL5[]HN5MV\R?R]I8@*!QWY&
M>WO64OB[7[+5;S3=7TFSBG%C)>6K0SLR/LZJQQG]!T]^ #N:*\\M?'VM-X;7
M7KG1[46EQ&J6:13EGEN"^P*<CY5X8_0#DFM*3Q-K>C^(-+L-=L['R-2)BBFL
MY&)27C"L&[<CGWH [&BO-QXY\6OH-UK*>'K$6MG+(DZFZ)?"-AL #''.3WQD
M"MA/%MYK>J&Q\-Q64OE6D=S-)=2, #(,J@"CKC!)SWH ["BO/)/B3*-!BN&L
MH;6__M'^S[@3NQAA8<EBRC./_K\\5<UCQI?Z!I%M_:-K9+J=W.\5OLF)@9%P
M?,) ) P0,=<T =O17GEG\29Y/#FM7US80_:-,:)=T3L89?,;:K D X'?Z5U7
MAZ_U+4(9I;X6+1;E^SSV4A=)5(R3SR,'CF@#9HKD=3U/6(_B3I>G6S1&PDLI
M)7C=RNX[L$Y /(XQ]3TZU6?Q;KMW:W^K:5I5G-I-E)(G[Z=EFG$9.]E &%Z<
M \T =N2 "2< =ZAMKNVO(C+:W$4\88J6B<, PX(R.XJKI6I6?B'1(+^!=]K=
MQYVR+VZ%2/S%>;Z%KFL>%_#=Y/9Z##/HUGJ%P)76YQ((]Y&53' 7ZG\!S0!Z
MQ17%7_C/5'UU=*T/14O7DL$OH9)9_*#*6'8CT/KUK*UCXIRV-_<"SL+:XM;6
M?R9%,[>=(1@,5 7  .1R><=J /2J*Y35/%M[:-++9Z,9[*/3OMYN9IS"K#&=
MB_(<M@9QQ447C6XU*'1TTC3$N+W4+1KIHIKGRU@48!RVT[OF.!@=L\4 =7-<
MP6[1K//'$96V1AW"[V]!GJ?:I:\Q\2W-WK6D:#JU]I$MEJ%CKD<*VY8'S/G
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M#3Z7'#IKWTNH7(MT43+&%8XQR>YS]..2* .@@MX+6(16\,<,8)(2-0HR3DG
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH+?[.>H]Z ,W1O!]EI$NNLIWKJT[2.H4+L0C[@Q[EOS'XY>E^"=7TV&'3?\
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M?*&088YZ?./?KSTQU-EX.U MI\.L:T+^RTV59;:/[,$<LH*KO;)S@']*K2^
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M["\=TGU!S'!A"5+9 P2.G45JUY;XE2[A@^'\<-Z3<M<(JW$T2OMW*H&5  .
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MSZ9LB 6U$GVB0C)))<;!TXP?Z4 >A455TR>XNM*M+B[@^SW,L*/+"?\ EFY
M)7\#Q7+_ !*:\7P[:K97KVK27\$;LJ@[@6QCZ9P??&.] '945QUWK.K7GC3_
M (1G3;R.U-M9?:9[J:W$ID)8  *" .H.?\FWX4UO4+^]UC2M46-KO2YUC,\:
M[1,K E6V\XX]Z .FHKD/%&KZOITNHO;WME;16^GO<V\;!7EG=<ELJ3G: .H'
M?VK)N_&.NW4OA2'3?L4#:W;,S--&S;'"Y)X/3GC]: /1:HSZQ86VKVNE37 6
M^NE9H8MIRX4$GG&!P#UK)\(:KJE^FIVFKFW>[T^[,#2P JL@VA@<'IUJ/5M4
MOK3Q_P"'M/6*W^Q7D=P&D*YDRJ;B >PX7ZT =15*XU:PM=3M--FN56\NPQ@A
MP27"C)/MQZUYS+XN\726_B.]@FTQ8=#NWC>)H&S*JG& <\< _G72W^M7H\6>
M$XHH;86VI13,^Y<R*1&'(#=AT^N* .KFACN('AF19(I%*NC#(8'J#4%AIMEI
M5M]GL+6&V@W%O+B0*N3WP*X6/Q9KL^@^+Y%DM4O-&NY%CD\HE6C7^'&>ORGG
MGK5[4-;\2R:SHVG:8^FQKJ&GF=I;A'9E=0"Q !QCYEP/KGM0!VU%>=67CG4Y
M?#YB98)-9.K_ -DI*8RL.\DD.0#G&T'\<5=UB3Q78:!XB%U>6TD<-CYMM>Q1
M>6V[!WKMW'! '!]Q0!T&O-H(-BFN1VTGFW*QVJSQ[\RGI@8//O6P    , 5P
M<NK:II7AOPA))]DO#=W-K!)+)$0R*ZC!'S'YL9^;]*N2ZCXBUK5M6@T6ZLK*
MWTY_('G0F1YI=H8YY 5><#O0!V%%>;Q>/M:U'2= FTVUL5N;V\:QNEG#E4D7
M!W+@CY<9/7T%;7@_7M4U#6->TC5F@EN--E0"6!"BLK@\8)/3'ZT ==17)^(-
M>U+_ (26T\,Z*UM#>SVYNI+FY4LJ("0 %'4D@]>@K&O?&^N:+I/B&&_M[.35
M-(\ATE16$,T<C*H)&<@\GV_+D ]%HK$\-SZ[=6TMSK0L%2;9);):,Q*J5Y#%
M@.>GYFL5M<U[7M>U6Q\/S6-K'I4BQ2-=1,YF<@YZ'Y0,8]>] ':U1MM8TZ\U
M&YT^VO(9;NV ,T2-DIGCG\OPK@6\5ZMX@E\*26$\=BUQ>2PWD+1EE\R-<GN"
M5QGC(ZCTJ+S-6@^*GBJ72?L7G1V4+N;H,5($:' "G/)[YX]Z /4:*\\@^(%Y
MK&FZ)'IL,4.HZE%-)*7A>98!&2N0J<G+ X],<TYO&OB&#P;=:E<:,D5_;7B6
M[>=')%$Z,X4.H;YCR0,=LY]J /0:*RM$_M[RY_[=&GA]^819,Y 7T8L!S]*Y
MK7_%FNZ-!JUZUOIT5O93QQPV\I+2W$;,JE\AAM'S CY3WH [JBN,U77_ !.?
M&<N@:/9Z7A;-;I9;QWY7=M.=OOQC'OGM61/\0]9@T2!VTZR&IC5CIES&SL$5
MNH*@9.".,D\$=#0!Z517"+XMU_3=5N](UNTTW[<;![RS>T:3RWV@Y5MW(Z'\
MO>J5MX\U\>&8/$-Y8Z6+*Z016\<<KB1YS)LYR,!<!C@9.!UH ](HKD6\0:UH
MWB#3;'7DT][7428HKBT#)Y<O96#L<@]!CO6*GC/Q=-H]]J\>DZ6;33KJ6.YC
M\US*R(1G:!QD#.23SZ<<@'I%58=1LKB^GLH;J*2ZMPIFB5@60'ID=JY&\\7:
MW>ZS!I_A_3[21;G3%OX)KUG4,"1D<#DX(&,CD\GM3M)UR=?%^OV!T6U2]@LX
MKF1K9OGN)-@.TD@?W@!Z8/)SP =M17$Z;XJUI?$FE:5K$&GJVIP2NB6NXO;N
M@W%'))!P 0<=Q69H_B_5[#P;?ZQJTEO<R/J#P6H&X!6+[<-UP@.2,9.!B@#T
MFBN*\+^+M3U3Q'=:3?VT$D21>;#>6D,J1MSR&W]#S_\ KJYXN\4S:%/96-DE
ML;V\#LCW6_RD5<9)"*6).<8% '4T5P>G^.]0G\-BYGTR/^U'U :?#&-T<,KM
MRK@L-P7'KZ5=C\1:W:>()M&U&WL'E739+Z.:W+JK$, %*DDCG.3F@#KZ@2]M
M9+V2R2YA:ZC4.\(<%U4]"1U K@'^(.J#P/H?B%;.SW7EY]GN(B6P!N893GC[
MO?.,]ZUWU%H_&NN6UOIEK%=Q:8LR7I8EI/0, .@/OGCWX .OJ&ZN[>QMGN;N
M>."",9>25PJK]2:XCPOXFUZZ^'UIJS61U6_GN3&%1MG!E*[FPO"K[ \55\3:
MY)J_ASQEI%[:VZR:;%&P>&7>K;OF7/'# K0!Z+')'-$DL3J\;J&5U.0P/0@U
M%;WMK>-*MM<PS&)MD@C<-L;&<''0UP>C>+M2TRV\.QZCHUO:Z-?Q0V]K-#<;
MV1BOR[@0, C'';!Y/2JNA:HGAR_^(&I743E;>]5_+ P6W%MOX'(Y]#F@#TVB
MN,T/QC?7?B--(U&SM\W$1G@FL6>1(Q_<D+*/F'J..0,"M'QCXFE\*Z=:W<=D
MMWY]TMOL,OED%@2#T/I0!T513W,%J@>XFCA0L%#2,%!)Z#GO7*7'C"_M+NTT
MR[TZSM=5N5>413WV(EB7H2X0_,3G QV/-<]KWB*+Q=\.?M[VGV>>WU.*-HBV
M[8XD R#@9^5O3N: /2_M=M]K^R?:(OM.SS/)WC?MSC..N,]ZFKFY[VUA\?QP
M2Z=&L_\ 9LDHO]_S; ZY3;CIT.36,OQ)0BRO#:6S:9=W7V='CN2TZ#<5#-'L
MP!D= QX]: .SN]2L;  WEY;VX.,>;($SDX'4^M600P!!!!Y!'>O-'MI-8^,6
MIV=]865W:IIZ(4F;[D6Y3E?EY;+'CCKUK:^(VL7_ (<\(+-I#)#)YT<(?O&O
M^R"".V.>Q- '945SEQXAOAJ\.B6=C:S:K]E^U7"O<LD,2YVX#A"6.?\ 9''-
M3^'?$+:U)J%I<V;6E_I\WE7$6[<O.2K*V!D$<]!0!N4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5/5;.34=)N[*&X^
MSR3Q-&)M@?9D8S@]:N44 <A+X$CN_!-IX=O-2FE>T8-!>*@1HRI.W R>@..M
M2V/A*_@L;Q+WQ'=WUY/;/;17$L8"PJW4A,X)R!R3V[5U5% '%OX%NVT#0]+7
M7F5M)N5N$F^R*=Y7.P8SQ@$COGO5F]\%?VGK>J7E]J3RV>H6BVK6BPA2@7!!
M#@YX;<>G\6.@KJZ16#*&4@@]"* .4T/P?>Z7)&E[XCO=0LH%*06K((U52-N&
M(.6P.G0#TK(G^&E])I;Z/#XJN8M'$GF0VC6RL8\-N WYW$#TKT.L[6-9M]$M
MX)KF.>19IT@401[VW-TX';B@#)/A*1O&H\0OJ.]/LGV1[8P<LF/[^[KNYZ>U
M4;#P%=6#&SC\1WG]A>86&F^6.$SG9YA);;R01QFNUHH Y*Y\&W5_.R7^LFYL
M1J/VZ.%K?]Y%R2$63<?ER1VZ#'&:V?$>B1>(_#]YI,TK1)<H!Y@&=I!!!QWY
M XK4HH XNX\#WUW%H N-?,LND3><LC6:CS,$;1@,, !<=\T7O@ 7]WXDN)M3
M(.M1I'A8,>2$QM_B^;H/2NTHH XRR\$ZC#KD&J7OB66\D2T>T=#:(@:,YP!C
M[N.#W/'6M+P?X:F\*Z/_ &8^HF\@1RT.81&8P221P3GDYKH:* .?F\.W4OC6
M#Q"NIA8XK<VWV7[.#E#R?GW9SG!Z=J9X5\+2>%S?0QZB9[&>=IHH&A"F(L>?
MFR2W  [=*Z.@G )]/2@#G-4\,RZAXQTC7H[U8AIZNAA,6XN&!!YSQP?2LU/
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M,#]:],70M+36&U=;*(:@PPUP!\Q&,8_*G:IHFFZTD2ZE9Q7*Q-NC$@SM/J*
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M6EX8T6[M=5UG6]0AC@NM3E0B!6#&)$&T L."3UXKIJ* "BBB@ HHHH ****
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MDXV]/F(+QKU.:OW&KZO8>./"^CW$UO,MW:2?:G$(#-(J$D@]@2!P!Z_A8@\
M:?#-X>E\Z1FT="O/2<GG+>GS?-^E6=5\,7.H>,](U^*_BB33T9?(:$L7W9#?
M-N&.#QQP?6@#E(DU ^&/B#)=ZBUS&L]U$(VC PPC7Y@<YQ@@;>@Q[U#HNLZY
MH=AX(5KR"73]2V6QM5@VE%( #%R22>0> !QCWKJ&\(7NSQ%:IJL8L=8,LGE-
M;Y>*1U"D[MW(XZ8]/QK2>!;M[#PQ;C5(0^ARB0/]G.)<$8&-W' ]Z *EGK7B
M3Q%I&K:YI.H0PQVT[I:69@5EE6/D[V;!!8>F,5+IWC"_U'Q7X;MUV)9ZEIAN
M9HM@R'PQR#U_AJ9?!^N:=+J5OHVLVT&FZC,\LD<UNS20;Q\WEG=@\^HXXI-0
M\"W<&H:'>^'M0CM9=+@^RXN8_,#1]S]>3Z=>HQ0!S6H^(=<U3P7KPFU!4FL]
M96T$D4(7='O"XQGU(/KQBO68%D2%%FD$D@&&<+MW'UQVKB#\/)5\.:UIJZIO
MGU"\%ZDS18"R AL$#MD=O6NQLH[Q+!([VXCENMN'EBCV*3ZA23_.@#B?"_BB
M]UGQ 8+C6(8)HKB>.XTJ: (VP9V&-NI/ )R?6LBUO-;TG1/&&IZ3<VD4=GKE
MS(T,L!8RX*;ANR-HQZ D^HKI1X0U&]U71[_5=0M)IM-F=Q-%:[99EZ*&;./3
M/'TJO_PAFKGPYXFTPZA:"35KR2YB=8FPF\C<&R>X&..GJ: )Y=:U?7M>_LC2
M+J+3%BL8KN:X>$3MN?H@4D#&.<_RK'N_&>OCP[J<B-:1ZAHNI"&^9(BRM!G&
MY5)ZY[9SQU&:VF\*:G9:E9:SI5Y:+J:626=VL\;>5,JXY&#E3Q[\8J_I'A:.
MTTO4X+]X[BYU6226\DCCVJ2XQM4')V@=,D\DGO0!FKXMD@^(D^E75]:G2WL/
MM$!1.58 ,=S=_EW'TQC\:\VO:Y;Z=X2N+J&VE?4;U8[EVB_U:NV4"\\';]>E
M!^%]A+X=TS2Y[EI);2X$TUQM^:=<89#SP"H51R<!16QXHT'4M8FT8:?=6UO#
M8W:7,BRH6+%/NXQ^/''6@##U3Q%XK34_$L5A_92VVCQK/NF1RS(8R^W@\G ]
MJ?<>,]0N-,\)M9K#!-K3;99YHBZ1$ 9X##J3QST!J^_AC4Y-0\5RO=6I@UFV
M\J(!6#1L(RB[O;!YQU]NE<KK%A-ING^&/"D^H:0D]JKW3M?1GR'VG"#)[_,W
M'?';C(!U?@[6]8U;4-<M]2>SDCT^Z-O%);QE?,QGD_,0.,<=B<=JGU+5=6G\
M61:#I3VMN$M/M=Q<W$9D^4L5554%><CG)[U4\%WM\US>:?)_8LMI BNDVD#;
M$KL3E2.A/?C\>M6M9\/ZE)XEM?$&C7D,5U' ;::"Y#&.:/)(SMY!!)- '.WO
MCK6[+0_$2O'8G5-%N(8V=5;RY(Y& #;<\'\?_K]GH?\ ;VVY.NFQW&0>0+3=
M@+CON[YX_"N6U'P'J%]H6M(+JT75=8N(Y;E\-Y2(C JJ]^W4^IKNK7[0+2'[
M48S<;!YIBSMW8YQGG&: .$;7_&.H>)=>TK2X]+1=-92C3HYWJRY"Y!QN/'IB
MJMOXZUW5M/\ #,FF0V"3ZF\T$_GA]J2(.HQVQSW]*99?VS)\1?&,>BW%FDK"
M ,+H.0O[O&X <9!]:UH? ]WIY\*PZ?=P&VT:1WF,RG?*7^]C''0MC/M0 ECK
M?B34];FT1+G3;:]T^U5[V3[.\B-*YRJK\R\;<$GGDUGR^,_$DG@K4=0M[2U&
MJ:3=M!>(8V9&5>K*,@CJ#SV!K=N_#NJVGBRXU[0Y[)3>0K'=072MABOW6#+S
MG&!CVJUX>\--INEW\.IRQW=SJ4TDUX54A&+C!4 ]L<4 5AKNH7>M2)9-:RZ?
M#I:W<FZ-@6D<,47=G@$#/0\5S2>-]2L_AKI&LV=CI\4EQ=_9VA6,K&HWL/E4
M'C.W]:ZCPYX6E\.^%+C3([A)[N42'SGSM)(VH#WP%"C\#7.O\/M8/@+3O#JW
M=AYMI>FX\P[]K+EB!TZY8T ;VC:SK@\3W^C:VEBS1VJWD,EIN VEBNT[NIR.
MOM[U@6_B_P 3W.GZ'J=O)I$D>K7;0+:F-P8?O8RX;G&.>!V]:W;VUOM*\27O
MBF\GM5T^+3/)DC0,9/ER^1GC[Q(^F*\]T>ZO] AMM6B'A6^9U6=TCDS=;WZJ
MB@D*WS8^4 =NU 'LVH33VVG7,]M#Y\\<3-'%D#>P' R:Y/1O$FKOX@L-/U";
M3[E+VS>XS:(1Y$B'E-VXAO3L?8=^EUW3GU;0+_3HI1%)<P/$KD<*2,9KD],\
M+>)K76-'O+BZT;R=/B>W\F"%T_=-MSC_ &N/8?GP 8]KX_\ $TWAVV\2S0:5
M%I?VL03)\YDVEL;NN!C-=1+X@U&T^($.E7C6<>DW=JTMK)M.]W7&023@=STZ
M8K%E\!:O-X N?#KSZ<DTUX9U>+<L:*6W$ 8]> /2I?'MM8:W;Z9H\5[$FNI=
M1)$L,F9(L@;R<<A=O.2!T% '2^$]2U#5]&-_?^3MFF<VQB0KNASA&()/) S^
M(K*\1>(];TE=6N(K>P2VL462))G)DNE^7>0 ?E W8S@\UUEK;16=I#;0*%BA
M0(BCL ,"N!U;P;XAN[WQ*EK<Z=]EU=4Q+.',J@#A!C@ <_G^% &M>Z]K6HZM
M=Z5X>BLDFLX(I;B6\W$!I!N5% QG@'GIS6;=:GXDFU[P9%.T5A<7?VDW5L06
M3*)WPW(P<@9X.#2?\(SXNL-;.L:9?:8+F\MXH;V*97,>Y!@.H'/0#\S5[4/#
MWB*:X\.:C'>V=QJ>FM,9S.I6-_-&#MV\X4<#\* ([;Q5JL]]XQM52UW:.H>U
M8HP!!5CAN>?N]L5/I7B76-:T+0+ZUL[:,W^_[5+(Q*0A<C@9!)8C@9X_6J$_
MA/Q!;^(-=GTVXT_[)K4(6=[@-NC8*1\H';YCWJ"U\%:]I,7AIK*XL+B72TEC
MDCG9Q'ERQ\Q<=P&QTH R/&&O2>)?A,NHSPQ1R?;Q'^[)*G:Q&1GD9%>KW5PE
MI:37,F?+A1I&P.< 9->:7?@7Q'-X)NM!:33Y9#J'VF*179 5)+-G(/<\"O2+
MJW^VZ?-;2G9Y\31L5.=NX8./SH \T\5:CJNN^#+35;BTL8K&:\@D@7YFF1#)
M@$GH"1CIV8^E=9KVM:WI\VHO:VEF+.RL3="2=B3,XR2@ (Q@ \\\US,OA'QC
M)X:B\-_:-):SM98VAN7+[W56R 5 P,<?E^-7=9\*^(;GQ#K5U:#3)8-3LOLH
MEN6??;CR]K! !P"<F@"74?'&HB?PPFEV=G*FN1DJ\TK81P!D<#H-W7O[54'C
M;Q.[:_!'IFEF;0P7N9#.^UUP2-JXSG"D\GVHM?!FN1?\(5YHLS_8IE^T%93R
M&(QM^7G@?G4T'A77(Y_&\I2SSK2[+7]Z>!AU&[CCY6!^M &P->UB]M=&FL+"
M!$OK+[5-/.Q*1,4#+& ""22<9[#GGI65%\09KKP?I6JP6D$5YJ%VMFJS.?*1
M\G))'..#CZU!'X7\3VUYX>NX?[,E;3].%F\4[-MC8#&\$#))7'Z^M85SI&K:
M/X8TSPG?Q:5)<WNH/)"&D9%*(/,8[P!L.[:HQV.* .AC\?W^GR^(X]:T^V T
M9$)DM9&Q(SD!% ([Y'/;TJ;0/'5UJ'B:/2+RWMV6>$R)):K*?*8<[)-RC'&>
M?;W%9=OIUSJ]OK7A*[T^QL;B\MQ>BZM+EI@[JZX+[LM]X#KZ''K72:)'XSDN
M;5=;?3H;> $R-:LS/<'! !R, =SCTH J?$C5M4TK3])&F3)$USJ$4+L20>N0
M..QVX/M5NX\0ZK=^(+C1=&@L&N+*W22[>YD?:';HBX&3QSD^O2D\>>']1\0:
M;8+IA@^T6=['=!9V*JP4'C(!]159-#US3?%<FOV-O9S&_M42_M6N"@$JC 9&
MVGC''2@#5\)>(9?$.FSO=VOV6^M+A[:YA!)"NOH?0@BLZ+4=8G^)M]IA:!]+
MCLHW\IR>C=6''+9R,'M6EX6T:YTJ"_GO6C^UZA>/=RI$<K'NP H)ZX '-56T
MK5;;Q]-K-O#;S65Q9I;N&F*.C*Q.0,'(H X/P7KVJ>'?!RW=OIUO/I:ZDT=R
MYEQ(NYD4;5Z<9_7MUK?\3_$FXTS5KVQTNUM9?L 43&X9PTCG^&,*.PZDGO5:
M#P5K\'PVO- $=H;V>]$ZL9LHJ[E;^[R<KC&.]:::+XKT/6[^\T8:==0:BL<D
ML5R[)Y4JK@[=HY!_P].0#KM(U%=6T>SU!(GB%S$LGEN""N1T/^/>KM5=.2\C
MTVW74)4EO!&/.=!A2_? ],]*M4 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %!( ))P!16%XT:9?!6L&W+B7[
M*^WR\[NG;% % ^/;6YGE32=*U/58H9?*DN+2$&,'OAB1G\*U/#OB2R\364UU
M8I.B0S&!UGCV,& !/&?]H53\ ):IX#T;[($$9ME+;.\G\>??=FJ/BF1].OM)
MTS3)AIO]M7[?:KF$*'/R<X)! 9L 9]A0!V5%><M>:GX8\33Z VLWM];76ERW
M%K+<[7E@D4,>6Q\PX;J/3TK!;7/$L'@#1?$B^(;EKFZN_(>)XHS'M+N,XVY)
M^7U_E0![)17GUO?:MIGCC4] ;5[F[A?2S=Q2W"H6AD'&1@ 8[XK#COO%5GX(
MT_Q8WB6:X+RQF2TD@385:3;C(&3V].] 'KM%>?>)]6U&TMO$UW::R[RV*0/!
M;6T1Q;@D;O,)&"3DDC.0.<"HM1U'7-5\=:9I-IK$NG076D)=/Y,2MA]S9QN^
M@'6@#T:BO*8];\2ZC\-=2O+349O[2TG4)(FE6-2T\:XSD8P,!\_\!]ZZO1=6
MF\1>*)+ZQOF.BP64:&)=I5YWRQR?55*@C/7]0#JF17QN4-@Y&1G!]:6L#Q+<
M3Q7&D0Q:FEE%-=A955"TLXQ]Q  <>Y[#O7"7OBCQ#:>!/$$AOY5O=,U0VL<[
M(N]X]PQNXQG#=0!VH ]:K*U_Q#9>'+.*ZOA,8Y9EA7RDW88],^@XKD;?5M6\
M.>([B'5-7DU*S.D/J)\R%4,95N@V]L5AZ^NL:C\/+37;O5YYA>74,LEH%188
MXV?Y57C=D';SNH ]?HJ"]CFFL;B.WE,4[Q,L<@'*,1P>?0UY))XPUJU\-Z-<
M3:A<F_M-2DAU6(*A8QJP+;AC@ 8&>.M 'K&HWT>F:=<7TR2/% AD=8EW,0.N
M!WIUE>1WUC;7:*Z)<1K(BR#:P!&<$=CCM7$ZGK.JBP\7ZO8Z@PL[:)(['Y%*
MAU4&1E/4\G'IG/7&*S=3N[S4KGX=33ZI=6[WB>9(\&T9D,2X;!&,G>5YXPQX
MH [JQ\0V6H:YJ&D0B875AM,V^/:IW=,'O6M7FFJ0:E+X[\32Z=JKV!@TV&1B
MD2NSX!(&3TZ'\ZDT?Q%K/B'2_"UG]N-I/J,4\MU=0QJ7*Q-MPH((!/!)Q^%
M'H]%>8WNN:YI4WBC0&U62>>ST\ZA:7SQKYBJ-N48  $\X!QZ_2M2?6=475_!
M#+?XAU*$BZ@VK^\;RPV[ID<GU]* .ZR#GGI2$@$ D9/0>M<#\.6N;C4?$]Q-
M>W$BC598Q$Y!7C&#R,YQQUQ@=*M^)H+N;X@^%4AU&:WB=;DE(U4C*("3R".0
MV.G% &_IOB*PU;5M2TVU,IGTYE2<M&5&3G@9Z_=//3TS6K7FTMGJ=QXW\9?V
M3J8T]T@M9"RPAB["-B!D]!D'/&>:8OBS7M7TKP[969=+W4;26XN;BWC3> F0
M-@<A<EL9],\4 >F45SO@R3Q"VCNGB2!H[N.4K&[,A,D>!@G82 >M8EW<>*]4
M\;:KI&GZW;6-K:P1RJ?L8<_/T')Z\'G/X4 =[17EUAXXU;6+;2=&2ZCMM5N+
MZ>TN;M(0P"Q+DE5/&3N7]>*U6U;Q)I&I:OHTLZ:E-%I37UC/Y(61F7"[65>#
M\U '>5GZMK-IHUM#/=>84FF2!/*0N2S'C@=N]</_ ,)!)K/@S7+RP\223-#I
MV]HS$L<]O* 2WW0.#C Z]^:-5U;5_#7P[\.W%G?^9),]O'(\T2D[&3.T<8P,
M=3D^] 'I%%<+J^I>)9O&.HZ5INI6MI;06"72L]MYC YP0.>2<'KQCMGFL]?'
M.K3^!/#^HJ(8KG4;Q;.>Z9,K$-Q4OCIDXSSQUH ]*HKB?"&KZW?>*?$&G7U_
M'=VFG.D22?9PA9CG/*G QCD<]NE7?$.K:G_PDFD^']*E6VDNUDFGNFC#^7&@
MZ!3P23@4 =3TK TOQEHNLZFMA87$LLCQ&5'\AU1P"0=K$#.,?3WZUS_]K:W!
M>^(O#FI7:SRQZ:]Y:7J0B,["-N"HXR#W^M6_A;!+%X%L':],\$B$Q1F(+Y7S
MMN&>K<YY- ':4A(4$GH.:XOQ3K.JV=UJBVFI6UJEGISW,,2!))97')+J0=J@
M<=LYZ]JZ+P[J3ZSX<T_4I$"27,"2,J] 2.<4 2:3K.GZ[9M=Z;<>? LAC+;&
M7##J,, >]/U#2=.U9$34;"VNUC.4$\0<*?;->8:;-XGL-"U[5=(O+1;6RU2Z
ME>T>#+3*'!?+D\  'H,]>>E=+!KVJ>)M=EL-*OHM-@M[*"Y=VA$DC/*NX+@G
M&T C) Z]Z .OM+.VL+9;>SMXK>!/NQQ(%4?@*GKR^^\=Z[9>&IMWV7^UK+5E
MT^XD,+;)%Y(<#(^]M_(\8XQK#Q)K'A_5=;M]<GM[Z*VT\:A";>+RL L5\O&3
MQD=22: .JU+7--T>6TBU"[2![N3RH P)WMZ<#CJ.OK6A7D7BE]9N]&\+:GJ5
M_#-'>ZG;3K;);A/(W L%# _, "0<]< \<Y]=H IV^DZ=:7LU[;V-O%=3Y\V9
M(PKODYY(Y/-7*** "BBB@ HHHH 1E5T*LH96&"",@BLJT\+Z!87BW=GHUC!<
M)]V2.!5*]1Q@<=36M10 4444 %4TTK3H]2?44L;=;Z0;7N!$!(PX&"W7L/RJ
MY10 4444 %%%% !1110 4444 %%%% !1110 5FZQX?TG7XHX]5L8;I8R2F\<
MKGK@CD9P/RK2HH SM(T'2M!A>'2[&&U1SEM@Y8^Y/)K1HHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "D95=2K ,I&""."*6B@#C+;P ^DLT>@^(=1TVSD?S'M
ME"2*#_LEAD?K5N\\#V=YI%I9/J.HFXM+C[5#?/*'G$GJ6(Z=./85U%% '.)X
M5:2:^N[W5)[B_NK1K,3A%00QGLB@>N#SGI6;)\.XI/!^G^'?[4G$5E<>>LOE
M+ECECC'_  (]Z[6B@#EM3\/0VVO7OBN6^D'EZ:\#Q%!M" $DY'/;/^<5S7@7
M0D\0^"-(2?6)IK"WDWR6:HH'F*Y8(S'DJ../IS7IU% '$W?PYCN;K6G77-0A
MMM5)>:V0KMWGN21DC/88XXSBK>G>"A8:_IVKOJMS<2V=B+(+(B_.HSR3^/Z=
M:ZNB@#A472?AKHUS#J%Q=7L6I7<DH06^[+,H!7CCG ')YSTZUL>!]!_X1WPI
M:V;1^7,^9I5_NLQSM]\# S[5T5% '.^(_"BZ_?Z;?QZA<6-Y8,QBEA56X88(
MP>,\=:QIOAI'+I&JZ:=<O6AU"X2Y=I41F#CDDD 9R<>F,"N[HH YP^%6?Q';
MZO+J,K>58_8GA$8"NI')SVR<'\*PI/AI<2:6NE'Q3J']FQ,&AMS&AV8;(!/4
MX_P],5Z!10 BC:H!).!C)ZFN:/@C3&U#7KLYW:Q#Y,B@#$8Q@D>Y/S<]Q734
M4 <\?"ENO@C_ (1B";RHC;B S!,D_P!YL9ZGD_C5.Y\#B>R\/1IJ<D=QH?$$
MWE*0XP!\R_11W]:ZVB@#FAX38:SK.H_VE(QU.U%NT;Q@B/"[00<_4XXZU0A^
M'ZVFD:1;6VINE[I$CO:W1A4\.22K+W'/K7:44 <M#X-$L&K2:G?O=:AJEM]E
MFN$B5!&FTC"+SCKGDGI5"R^']Q%>Z-=WOB&ZNI-)<^0HA15\O@!/7H "?Y=:
M[BB@#G- \+/X?U;4[F#4&DM+^9K@VS1CY')Y(;.:EU[P_/JNIZ5J%IJ+65SI
M[N0PC#AT< ,,'OP/UK>HH Y>#PK=6^L>(;]-5.=6B2-0T63"54J#G/.,G XK
M)'PYN(]&T6&VUV2WU/21*(;R. <AS]TC/0#CKW/K7?44 9&@:/<:1;3"\U.X
MU&ZGDWR3S<=@ JJ. !C]37((]W/\7-<BTS4K:WN?L$2E)XFD4]"3@,OS#(ZY
M^]TKT:H!9VJW1NEMH1<-P90@WG\>M '*/X CBTO3([+498=1TZ=[F*\9 V^1
MR2VY>.#Z ]!5D^&=4FN;[4I]81=6GMEMH)8+?;';H&#$!2Q)R1SD_2NIHH X
MUO!-Q>7>K7FH7ML+F_L6LLV=N8U ;.78%SN;D5#?^!]3U'PA8:)<:U"\MG.D
MB3FU(!5 0JX#>_6NXHH YL>&[L^+;[67OXS%=6(M! (<%<<YW9YYW?G[5Q>N
M::_A/PGH/A>?5[:.*>\=Y;J>VS#L4^9M=23GYBOIG\#7K%17%M;W<?EW,$4R
M9SMD0,,^N#0!Q7@[4;V769;.WU'2=3TP0^9)+8VWD^3)G !Q\IR/?/';C.QX
MA\,R:KJFFZO8WHL]3T\MY4C1^8CJPPRLN1VST(ZFMZ"WAMHA%!%'%&.B1J%
M_ 5)0!S">%[J6?5-0O;Z&75+VT-FDB0LL4,>.@4L2>>3SUJ[X3T.7PWX;M=)
MEN4N#;[@)%0ID%BW3)]:VJ* .'U7P+J-[K>M7MMK:06^K0"">)[;>0H3;A3N
MX]>G>NB\-:3/H?AZSTRXN4N6MD\L2)'LRHZ<9/.*UJ* .*7P9JD=AJNE1ZS
MFFZC<2S2;;9O.02'+*K;\>W(/4U9?PC<V/B&/5]"OH+5OLBVDL%Q;F1'5  I
MX93D  =>PKK** ."OOAY/>Z&;,ZG%]KGU$ZA=7)M_P#6/SA5&[A1GN36I?>$
MI=4U[4+R]O(VL[W3Q8M D1#HN<Y#9QG<2>1Z5U-% 'GEQX UR[TO2M,G\0VS
M6NF3I+ 19$/A!A03OP<#V[UV5I;:G%K-_/<WR2V$H3[- (\-$0,-D]\\&M&B
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+"9=VW.<@@'Y3T//8UU]IJVFWUQ-;VE_:W$T/$L<4RLR<XY /'->0:K+;R?
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MXW(Z.KD,"!'T([_,!QZU<\,Z-::I+XZ\/-#&EC]MQ%&J@"-B&P1QQC:N/3%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9/[W7D_6MF@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MUG7[+3+:UVZ/:+.WV@,3,Q7=@8( &/UK>\+:G=ZUX:L=2O8H8IKF/S-D))4
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MW6JP61O&MP&:(.5^7(!.<'H#GZ"L*'QEK$.J:5'JN@):6&J.L4$Z7(D*NP)
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MGN8+6/S+B:.)"<;I&"C/U-2 A@"""#R"*\YU56USXJG1M0L(+JP33"1$\A
M9US(..&],8/O5_2O&L2R7&G6NA7<>G:1(]K/<&562!(AC)Y)/"GU^IH [BBN
M+;QW=V]C;:K>^'KB#1KGR]MV)T<JKGAF0<@<K^=6[KQ?<IX@U#1[+0KJ[FLH
MEE=Q*B*0P!XS^/N<&@#J:*X:W^)$=SIUCJ:Z+=+IMS.ELUPTB#RY"<$;<Y('
MKQ7<T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q6
MII'X=^(<.OW#,MAJ-K]BFE/W89004+>S ;?K]:[6L_6M7T_0],>^U.3R[5&4
M$["W).!P!ZT 8.G:)=:)XL\0>)-0N[1;&\C#$+N!C5  "<\?=!S[T_P=92RW
M>K^(KF%H9-6G5HHW7:RPHNU,CJ">N/I75,H92K %3P01UI: $;=L;8 6QP"<
M#-<[X5TG5].35%UB2SE%U=O<)Y /1NH.1TX&/QKHZ* ./TWP#8Z;_P )%:Q%
M1IVKHH6'&3"<,#C/NV1Z?A5"'PGXCO-'MO#FL7.GOI$!CS<1;S-*J$%5P>!T
M SZ"N_HH XZS\+ZGI_BCQ#?6LMI]CU2)=JR!BZNJ, ., +D^_%<_+X!\0-\-
M;?PVLFGF>*\,N[>P!CR2.<=<D]NE>HT4 </<>&-9E\7ZUJRK9^3>Z6;.-3,V
M0Y"\GY>G!K,?P/KI\$>'M'!L3<Z;?"YD/FL%*AF( .WD_-7>OK.G175W;27D
M236D0FG5CC8AS@GVX_EZU-8WUKJ=G'>64Z3V\F2DB'(;!P?U!H \RU*&\USQ
MGK5U9P:%=00;;!XK^1HW&T!B<+U!+$9/7'M7=^%-1DU3P]!<2VT%N0S1!;=M
MT1",5RA_NG'%4KK1O!VN>(IX[BTL;G5K=5:9/XP.""P'7J.3ZBNECCCAB6*)
M%2- %5%& H'8"@#A7\,:_->^,6D%BL.LV_EP;96)#*A1=WR\ @\U7F\'ZY-H
M7A*SVV0ET>Y26?,S88(>-IV]Q^7O7HE% &7XDTI];\-ZAID<BQR7,+(KL,@'
MMFN43PWXE:P\)03+IH;1YU,VR1^8T547''+$;B>G.*[6PU*RU2%YK&YCN(D<
MQL\;9 8=1FK)( ))P!U)H XF7P[KKZKXNN2EEY6K6H@MP)6R"JE%+?+QPQ)Z
M\T)H6NKX<T/2KJPTF_@MH3#>6\SG:P4*(V1MIPP .?K^75Z=JMAJ\#SZ?=17
M,22&-GC.0&&"1^HJY0!S_@S1+KP]X;BT^[D1G1W951RZQJ3D*">3CI52W\.7
M%[XNU34M<L["ZLWCCALD<>:8U4G.0RX!).>*Z&_U*RTNW%Q?W,=O"6";Y&P,
MGH,U:H XB#POJFE_$:36-*BL(M)N85AN(=Q0X&,L% QG('Z^M<A +^1=1\20
M:9H5Y:W-T]R$N+IHSB-BH8QL=@/RDYZ\_A7LU<]'X%\+Q7OVM-$M/.W%\E<C
M)]CQ^E &98:3JEU\0(O%+00Q6$^FK#Y;2'S4) ?E=N.#QC/O[51TOP[XP\-2
M7VGZ+)I3Z9/<F:&2XW^9"&Z\#KCW/;WKT*B@#B)-#\4:/XCU*^T*33[BVU+8
M\J7C,ICD48)&T=_\]*GNM"UV77/"U^TMM<MIOG&\E=RI=I5VML7'0<X_"NPK
M-M/$&D7]^]C::C;372 EHDD!. <'ZT <[;:#K<%QXN8PVA3523:XF.<[2GS_
M "\<8/&>XJC;>%_%&E-HVI:?)IS:A:Z<NFW-O,S>4T:DE65@,YZ9KK[OQ%HM
MA.T%WJUE!,@+-').H8 8ZC/O2Z9XAT?679--U*VNG5=S)%("P'KCKB@#F]6T
M7Q/J=IHTLS6$MY:ZDM]*@8I'&JC C3C+=2<GO[4Z\\,:G?:]XFFE^SK9ZGIX
MM8&60[PP7'S#&.I/.>PKM*JW6IV-E<VUO<W<,,URVR&-W :0^@'>@#*\&V6I
MZ9X:M=.U6"WCEM4$2&&4N'4=">!@^W/]*Y_Q)X6U;Q ]XSV%A%>Q7*MI^I0S
M&.5(P1][ R2![_E7?T4 <3;^'=6A\:>(M4\J)H+RP2&W9I<;W" <C!(&5Z^_
M>L73?"_BC2-$\+0Q6=O</IUQ/)<VCW.U&WGY&)P1\N2>^#V->H5574K%M2;3
MENX3>HGF- '!=5XY([=1^= 'G%SX1\43>$?$^E/:V)DU'4!=PB*? ^9P[#D=
MMJ@9QW]L[MUHFKR>*?"-]'90&#3H'2Y<R@,I:/:1[@=L=\].M=I52]U33].*
M"^O[6UWYV>?,J;L=<9/- &7XX(7P-K9) 'V.0<_[IK$M;#6/$#^'/MNGI9:?
MIPBNS)YZNTLH3"J .@YY)_\ KUT5]::-XOT>2UDGCO;%G ?[/<<%EP<$H?H<
M?2KVFZ=;Z3IT-C:!Q;PKM0.Y<@9Z9))H XOP[X5U)-!\4Z9J,(M3J=S-)"XD
M5QMD7';TQW]:AET+Q'K?AJP\,:KI\$-O"\:W-ZEP")(HR,;%'.X@=P!7HE%
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M6*G# './K3J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MNK>:333&9UDLKME;S[1<J6 P.<[3W'7KTP ,OM=N)?%'B;1)+:V6*+2&F69
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M[>>VL9S#,K7!$TI&,F-0I& 3W/..U9TWA+Q#_P ('X:TM+"-KS3M0$\J?:%
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M (9%5-!\W_A:7C3R-GG>3!LWYV[O+&,X[9H ZGPW_8<^DQ7V@VMO#9SY*M#
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M$ I+D>NTCG\NIKJ: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOX&O0JHZ1I%CH6FQ:?IT AMX\X7)))/4DGJ:O4 %%%% !1110 4444 %%%%
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MLZR"MKB0YQM9?G.WC@@X&>2: (]/\9Z[=MH%[-IMA%I>K2K -LS-*&(8YZ
M?+TY_7C/U#XFWL+RW5E9VT]G'>&W6#9*9I$4X9P0-H[<<]15IO".O+X;\+:;
M UK'-I=TL\\HF/12>%^7G(8]<=/>I]-T#Q=X?DO-/TJYTV33)[EIH[BXW>;
M'ZX4?*<')'K^- $U_P"+-<E\5WFA:+IMG+)!9)=![N5HSSC(( Z_,!CCOSVK
M*U'QEJVI:7X-NM.:.SDU6\VS(<LIVMMP>^TG)]:VK?P]J]OX]U/7?]&>&;3Q
M;0EI#N9P%(+ +@ E3TK'B\$ZY;^%O#=LB6#ZEHU\9QNF81M'DMC.WJ3M[=J
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M1X+*6W:)9FD)=AD'@8 W <9.!GDT 6?"OBO4/$R1WJ6MDE@R2"5$G+302*>
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MN7>O#0UO5:PN!:VJV_D+&6'WC+YOS?\ ?..WUKHM=\&G6+K3=2BU.2SU>Q
MO(H@?,&.0R^F>V<<D=Z@N_ ]P-8N]1T?7[K2VO@/M:11*XD89^8%ONGD].E
M$-S)>3>+/!$FHPK!>M!=F>-&!"OY2YP1[UC^(O$&MZ8;V_MM;6:2VU1(6LX(
ME:"*!B0HD;;G><<@-QGW%=._A%QKFCWUOJDD-MI:,D=MY(;?N&')?.<MQGBL
M:7X:3O8W]A'XEO(K&YN3<K;B%"%?>&^8GYGZ#N.0#[4 6-(M[F?XK>(9FU&Z
M$=M!;*(,J48,C$ \=%.2,8.2>>N<&U\;ZTO@Z[EENTDU&77#IMO.T0Q&I"G.
MT<<?-C/MUKL+?PI<VOBHZY%K=P/.ACCNX#$A%P44J&S_  ]CP/7GGC-M?AO;
MIX;O]&N]2EG6ZN_MB3QQ"-X9>.1R?0?AGZT /GNM7\-^+=&M;G5Y=1T_4]\+
M"XB7?'(JY#+Y:C@G YZ ^V:X^V\5>)_^$)L_%-SKO[M+\12VZVJ8>/=SDXSG
MKTQQ7?6?AG4&U2#4M8U@7UQ9K(MF%@$:(6&"[ 'YCCCMU/X9'_"L_P#BB!X9
M_MEO)^U?:/.^SC.,?=QN]><Y]J *_B#Q#?VOBZ[T^\UBZT6!UC739A;H]O*Q
M'S&1BI/7CJ,>M>B)G8N6#' R1T-<MK/A/4-;AU"TN==_T&^\O?!]ESY6T+GR
MR6^7)&>0<9KHX[7[+IR6EFPB$40BA++O"8&!D9&<<=Z /(_ USXG3P=J4>C6
M&GW<)N9AB28K*&*CMT/;'(J[HOB%-'^'&@V>AS,+J[OA8M)<Q9\F1FRYQT."
MW'MUK9TCP!J_A^TGM-+\4>3%<R&25C9*7!(QE26XZ5>3X?64/A&/0[>]N(Y8
MK@7:7G!<3@YWXZ>V/3OGF@"LM]KGAKQ=INF:CJO]IV6J1RK%)+"J-%*@SSL'
MW3D?GGM4,?B+6+>?P[YNI6UXU_?R6UTMNBO"@&<!7 !W#CJ3G!],5J6_A2^N
M[Q;W7]6^VW4$,D-J8(O)6$2+M9L \L1Q[?RQ;7X<ZO;6%A:KXF&W3;KS[,?8
MUPH[[N<D\GOW/X $-CXDU^?5/$%]=ZK!%I6A7<J26Z6PW3*NX!=W)':J'B#^
MV[[PGX=U>^U$7"7E_:S20) B)"&Y&#][N!UKKM!\'2Z;)XA_M"\BNX=8F:5X
MXX2@7=NSU)_O?ABLJ3X>ZS/IMOI$GBEO[-LY$DM1]E!D7;]T,<X(';Z"@#T&
MN'\=2RKXA\(Q+>W%M'+J!5O)(Y; VY!X/)QSQ@GBM.TCUU?'MYYEU-)HHM%V
MI)"%429&-K#J?O$G&.0/3#O%?AB7Q"VF7%K>BTN].N1/$[1[U/3J./04 <TW
MVEOB+XI;1KJ*UGBL(6GDDA\PM(!D8YP!MP#Q4.G>.]7UNS\-VEL%CU#4%FDN
M'AB5L)&64$!R%Y*YZ\8KH+?PIJ4'B75]5;5(9%U"S6WV- ?E=5 #<'IG<<#U
MZUE6WPYU"QT'2X+/7?L^JZ;)*8+I(<H$D.64J<Y^M '1>$KO7KJSNUU^U,,T
M-RR0L553)'P0Q"DC/...*P+8+>_&R^%Z=WV*P0V2.!A=VW<R@]\D\BNE\.:+
M?:7'/-JFJR:E?W!7S)F78JJHX55' ZDY[YJKK_A5M1U6UUO3+W[!K%JK(LWE
MATD0C&UU[CDX^OTP 8GQ34V]GHVIVNW^T[;4(_LJ;<M*3U3CD@X&0*FCU;Q'
MXDM]:NM O;6#[%>-9VT#QAEFV;=SLYZ9#<8]!]:MP>$=0O\ 5;._\3:I'J'V
M%C):P0P>4BN<?,W.21@8J!?!FLV.KW\FD>(OL>FW\[3S6XMPS(S'YBC'H<#@
M_IQ0!*=2\1:SK.HZ=IUQ;6/]G6\8DD:'S!)<LN[;R>$ ([9]ZAE\0:_8>(?"
MFEZ@MHLNH),+U8@2NY1D%3V_EUJ6\\':C!XFEUO0=:^Q27421W4<\/G!]H #
M<GK@#]?6EUCP9?7<NBWECK3KJ.E[\7%W&)/,WCDD#'/IVQ0!BW'C+78--\9N
MDMLTNCW*I;N\/\#,000#R1QC]<U-%XE\3:=J?AN?5;BPGLM;*Q^1;P%#"S*I
M4@DDGDC/X\=*H^(_#%QX>\'^+[VZU1+MM2,<A'DB/Y@X]SZGBMK0-!O]4@\-
MZEJ=[926NGVZR6L-M RDDQ@ NQ8Y(XZ <T 4Y/%&NZ;J.E-?7MC<"\U/[%/9
MVRJP@#?=^<'.X9!.:MZ ^K#5_&4[ZBL\44[)##-'E5<1@@\'[N"!@=<=JHQ_
M#O7(;"TL8O$%L+:ROA>0(;/JP8MECNR>M;UOX;U:SU?69X-3MC9ZEOD\A[<D
MK*4"@[@W08Z?_KH Y[2_&FHW7A+PY%#]E@U/5[F2!'6']W$J.06"#C.-HQGO
MFKUSXCU[0M7U/2KZ2WO"NFR7]E<^24^X#E' .#T[>O7GAMG\/+JT\-Z59)J4
M*ZCI-T\]K=" E<,<E64GN?Y"K]QX4U/4YK^]U.^M'OI;![&V\B%UBB5\[F*E
MR2QR._:@#'TCQ-XHEC\,ZG>W&GRV.JRBV>". HZDAL/G)Y^4YZ#VJ?Q/XHUS
M18]4O1=V$:V=Q$L-B%\QY8BP!9R#\F=WMT'XV8?!>J0:+X=T]-2M0=(NO/,G
MD-^\ S@#YN.&;/X=*J:IX UJ]BUNS@UVW2PU2Z-TZ/:[G#;E8#=GH-H H FO
M/^2Y:?\ ]@8_^AR5O^,M#N/$/AJXL+29(KG<DL3.,J65@P!]CBJ47AG4F\:V
M?B*\O;61H;$6CQQQ,NX\DL,D]V/'I5_Q-HU]K%M9'3=0%C=VETMQ'(R;P<*R
ME2,C@AC0!RNC:Y#JWB;3[#Q7HYT_Q)9EFM)%&$E&T@A3DY!^8XY''!J35?%G
MB#24EO+@Z=Y<6JI;&TB&]C Q(#,P8[6.#C('(Z=JT+?PUKNH>*=/UGQ!=Z<1
MIPD%O%8QN-VX8W,6/!]AZ5BS?#SQ"VG:AIL6N6:VD]Z;U-UN3([Y##>1@#GT
M'8=.E $\QE_X73/YLL7DKHY+AXBP\O>,KC/7W_2L^U\:^)M0EMM0T;3Y)M*:
MY\I;1-.;;Y 8KN\P'&[ ' X!^G/31^&-4_X3P:_<7-E) ]B+26(1L&;H6(Y(
MZ_IQ[U1TKP=XCT5GTRQU^*+0?,9T7RLW"JS9*@XP/]X=SG% ":%=ZM>_$'Q>
MD5]&8K=(8XHY49E5MK;<<C !R3CKG\:J67BSQ#/X1OD>:W/B&#51IX"PY4'<
MH.0#TQOYQVZ=ZVX=$O=#\8:KKJ7MA!H]W'&UR)E8NIC4C.[( ZDY)/7I6;H^
MF:;K'Q.N_$6F2QS6=O;(&EADRDERP8$C'!Q&<'W:@#NKAYXK*5X466X6,E$S
MM#L!P/;)KC-/\7:LFMZ!8:H-/D_M6"0L+-2?)E7G&[>P(QQQWKJM:T]M6T.^
MT])O):Y@>(28SM)&,UPNE^!O$EM>>&Y[F]TDC1MT:I%')\T;#!)/=OP'KSW
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MF)XWMY/+FBGC*.C8SR#6O7E[>,V_X175M2TW2_L/B*2\CL[J-CD+,?E#<\=
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M4TO4=MZ@@'<P/!QR!QSWYKTZB@#B[OPE?7_C2;5;A[86-WI+6-P@9MP+==O
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MX(4$<:#LH& *X^ZT+Q#<_$BRU\1:>MC;1FV"^>QD:,ELMC;C=\W3/;K7;44
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M_E!7[V.,UJMHNLZKKUMKFI6MG;W&FPRK9017#2+)(V1N=MHPN,< =_PKL:*
M.>\$:7J&B^%K;3=2CA6> N 89"X8%BV>@QUZ>U=#110 4444 %%%% !1110
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M35Y"^R,,K*#N!!_!NU9\7@G5D\-OX5>_M'T5I,+-L87"Q;]^W'W2V<C/Z=J
M([/5KG_A-=6U66_QID>E070A>(96,AFVYSQSDD\]<=J@L?&7B*YOM&N$M/M-
MEJ,J^;!%83+]EC<X5C,1M; .3P.GXUN/X4G7Q%-/#+:?V1<V*65Q;R1EGV(&
M "G..XZ@_2JN@>&O%6CQ6VFOK]J^E6TBLA6V_?-&I_U9). I[GD^] $,'B'Q
M+X@L[G5_#BV4EK!=&%+*9"'G5<;F\PD!2<\ CCUJLFMZC;?$GQ')+<G^S]/T
MY)Y+4KNR%CW84Y !W,3G!ST^EK3O"'B'0Y;RRTG6K6+2+N<RX> F:WW'YA&<
MXSC R<].GK-<^#;V;Q;JFH)>0#3]5L_LETC*3*!LVY0],\ \Y[\4 9FE>,O$
M5UJFC2-8R75AJ/,T<6GRQ_9 V-A\T_*XP<Y&. >E5_$FJZSXB\%^(;^":SM]
M)A>6".%H2[SHC8+[MPV9[#:>E;VA^'_%&F0V>F3ZS:-I=HP"O%"WVB2-3E4)
M)V@8P#@=!CWK+G\#>(K?2]5T33=5L7TF^D>0"[C<RQ;N2 5..OM^'- '<Z7G
M^QK+'7[.F/\ OD5PS^+/$!^'$VO+)9"]M;IHY@824= ^S@9X.2#^%=MHMI=6
M&B65I>SI/<P0K')*BE0Q QG!_P GT'2N%F\"^)SH5_H,.KZ:--N+AIE+0/YO
M+AMI.< 9&>YH V-7U?Q*WB^70](33E4V NHY;G<2,/M.0/4\?K[5G67CO4-2
M\-:+]CBMWUK4KA[4E@1%$R9+,1U.!@X'J?I6\-%U9?&)ULSV3QC3OL83:RDM
MG?N[\;O?I7,:;X UK3_#^GK#=VL>K:=?R74).6B=6&"K< \@#IZ_D -34)_#
MGC7Q-J>K/;S/!I4,A>WB*"4\ 9&3@EN.O3%7/#WBWQ!=:U8Q7UFT]E?(26@L
M)XOLIP"NYG4!AR1D>F?J^7P9K&MZIJ5WK5Q8Q0:AIXM7AM@[%&!#*V3C.&R?
M0]*O:%I?B^$VMKJU_8_8;$@(UL'66X"KA0Y)P%YYXSP* (_#VL^*M:U$O)!I
M<.GVM[/:W05G,C%.!MXQU_.M?Q#J6HV5QIT-BMO'%<2D7%W<D;(% !Z9&2W(
M'O5?P;I6JZ3;:DFJBUWW%]+<JUNQ(.\Y/!' ]*A\6:'JNHZQH.I:6+*1].FD
M9XKO.PAPHW<=UP2/?% &%<_$#5+3P9=ZEY%I/=VFJ-I[.-RI(!_&%ZC.>F:V
M=.U_6E\6W7A_5$T\7#V0N[1H"VT<[=K9Y/()SZ"N=O\ P-XDNO#FLZ>SZ>\E
MUJ_]H1%69<[C\W7.!TP/8\]*Z&;1-17XD0^(YS:II\.G&"1_,P5.2Q.".F3^
M5 &=9^,=6D\'W3SO:#Q#%?BQ$"Q-M60N  1G/3<<]./:O0%W!1N(+8Y(&!FO
M/;#2-.U7XJW.KZ?<1W%E!;1SR&"4-&;H[E!XX)"9/X^]>AT %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 445QGCUKW3WT;6K>_N8+.RO(Q>PQ2E5DB9ER6
M'0XQCGL30!V=8TWB2TM_%=MX>>&<75Q 9HY-H\L@9R,YSG@]J\^7Q'/!J/BR
MRAU*_G^W1_\ $F=IF(9RQC/E'VD; P>B^U3:CI%P?B)X8TN;5+U;@:3(DEY%
M(/.8X?<0S ]>>>OOGF@#T;6-2.D:9+>BSN;OR\?N;90SG)QP"15U&W(K%2N1
MG!ZBO*;+5M87P%XK5-7N_/TF]EC@N9&#RLBG[K,?YC!':M3QI?75I=Z5=7D^
ML0Z,UHXFGTURICF.W#OM(X SUX_6@#T!I8UE2)I%$C@E5)Y;'7 [XR*R=)\2
MVFKZSJNEPPSQSZ:ZI*9% #9S@KSTX[UQ<[07?Q"\$R1ZE=7<<NGN8[A9"GFE
M4)W,O^U@[AQV!Z8JB^M3>'M;^(VJ6RJT\)M1&&Z!FRH)^F[- 'K$TAA@>01O
M(44ML099L=A[UE^&O$-IXHT:/4[..6.)V9-LH 8$''8D5RWAO3O%EOKMI>SW
M5Q+IUS$3=K=WRSC<5RK1*J@*,XX&1@UQ&A6VKV'PO'B/3M?N[9K&9V%HN/*<
M%E4Y'<\]\^V* /88_$%O)XIE\/\ D7"W,=M]I\QE C9=P'!SDG+>G8UK5PJZ
MFLGCJ'5?*(5O#+7/EYY \U6QFL59=;U'P#)XV@UW4HM1$<DHM4D3[,JK(P(\
MLKSA1U))H ]4HKSQ]6O8?%EE>W6I75OI>L:.7B7<"D$P4,< \!MN3DCD^HX&
M3X<U?5M6T#3=(&J7ZZO_ &MFY:1_WJVX'F$G/(4@J,'/ITXH ]9HKRI;WQ7X
MJ74-6T*ZND^SWLD5G&+B..$(NT?/&5RY(SU/!/%7]8O?$6I>-K30(-6;2Q<:
M.)Y1 BN%EW,#AB,]L9!H ]&HK \775[IG@G4;FTNVCN[>WW+/L!.1C)P>.>?
MSKCSK/B#1M.\+:[<ZY)>V^IRP17%H]N@ $B9RI&#D8/X_E0!Z?17G-O?^("/
M$&JSZ\_V/1[^8?9A;)^]2-0Q4G&0#D#CGK3)]1U^T^']MXN36YYKD)'<36DL
M<8@=6(!4 (&'4<[NU 'HDEK;RRI+)!$\B?==D!*_0]JHZMK<&CRV$<T-Q(;V
MY6V0Q)N"L>[>@KEK_P 0WN@>/8FU340NAWUB\L,;;%6.5 "1G@]!QSU;\F7M
M]X@TSP_X9GFU*0W-[J<"70DB3.R0_P"KX'  _'WH [^LV#6[:XU^[T9(YQ<6
ML22N[)A"&Z8/<_\ U_2N+U_Q!?:?XRGL;[6+O28)3$=.D6!)+>3IO#G;NR3Q
MU&/IS6A=:YJ=CXYUI)+H/IEGI'VQ+81C(8>_4GY3W[T =F\4<C(SQJQ0[E+#
M.T^H]*?7FL]_XD@\ 0>+;?7'N+K8MU+:&.,VY1CR@^4,-H/]XGY34CZMX@US
MQO>Z38ZO_9]J--CNX]MNKLI.TXR?=N3Z#M0!Z-17F1\5ZP_@;PWJ]S+=);3,
MZZE=6,*M*H7<JMA@0 2,L<?3' KMO#%VM[X>M9UU0:F&W$70387&XXRN!@@8
M!X'2@#7JAK&L6NB6/VN[,A0NL:)&A9W=C@*H'4URFFWFL>+[O77M=:FTV&RN
MVM+9((4.2H&6?<"3GT&*P[K5KKQ7X:\*WLEY);SKK<5M/Y"* 9 2 Z[@<$#G
MTRQXXH ]!TK7[35],FO[>*Y6.%W1TDA*R J,D;>M<_;_ !0T.\5FMK35IU4[
M6,5DS 'T.*["WB:"WCB>>2=D7!EEQN;W. !GZ 5Y-X N/%4'A*^;1;/3IXA>
M2[/.D99 V!DX P1T[B@#T_1=8M->TJ+4;%G,$I8#>A5@02""#[@U?KS"?6_%
M%_J:Z)9175M=V=C%/>&S2#<UQ(H9L^8P7;DG[O.<U?CU;Q3=OH7A^]9=,U2Z
MAEEO;B,)(RI&<+M&2N6.,^F>* .JTKQ'IVLZAJ-C:-*;C3W"3K)$R8)SC&>O
M0UK5Y!!JMUX9U+XAZA%(;FYMVM51Y5&26)4$@8'&[VSBNHT%O&4.ONFH1W4F
ME20,?-O!;AHI>HP(G.5Z#\: .WILLBPQ/*^=J*6. 2<#V')KSCP_J/C+4O"Q
M\22ZSI^Q[:4Q6\L(C12&QN9_;:3Z5LZ'K=_+XO&E2WWVVU;2Q=B<VXC#/O"D
MH1C*')]?K0!NZ#K]AXDTP7^G.[0[VC.]"I##J,'\*TZX+X0_\B9+_P!?TO\
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MCR[B^9DMDV,=Y&,C(&!U'7%7Z\JU(:E_PCGP\-M.DM\\T#)),G !CS\PR,@
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M10 4444 %%%% !1110 4444 %%%% !1110 53U73;;6-+N=.NU+6]Q&4<#J
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MU'P1=SG2[ZRUN6/6M/+D7D\8<2[_ +X*] .6P!T!Q[UV#ND<;.[!44$LS'
M'<U0O=9@L;[3K5H;B4WSLJ20Q[D3 SECV!R /K0!R\7PY$T&O+J>L374FLB,
MS-'"L>QD;<I'7H<<>E6]%\*ZS9LCZIXFN+XVZLMHGE!$3*E0S]W(!/4UUU%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 UX
MHY,;T5L=-PS3J** "BBB@ HHHH **** "BBB@"&.SMHKB2XCMX4FDQOD5 &;
M'3)ZFIJ** "BBB@ HHHH **** "BBB@"M=:?97NW[7:6\^TY7S8PV#[9%6%4
M*H50 !T I:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MIVRWV[9Y)?YMV,X^OM0!JT5P]AXP>P\4^(K+Q'J%M;6MK)%]CWJ$)1]Q^K<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7$;7LOC-YD\A,=]I)CM\GH5<%E'/H"WX_6NWK,UK0[;6XH!-+/
M!-;2B:"XMV"R1L.."01R"0010!QEC?6W_"Z]9<RA4CTORV9L@!E*$CGT'-+\
M)[V*V^&\LS;C]DFF:10,'@!L#/L17HM9NMZ+!K]@+&ZFN([<N&E2%]OFJ/X&
M.,[3WQ@\=: ,;X:0R6_P[T=)5VL8W<#/9G9A^A%6O'-S#:^!M9:9PH>TDB7C
M.692JC\2170*JHH50%4#  & !2T >?3Z!#XN\ Z+>:9/Y>IV-M&UI<)\I$B*
M 4)Z@9!'L>:P&BU.3X>Z)JEQ%,TEAK3WE_#&O( G<N=OL<_G7L%% 'G=W>6/
MBOQWHEUHC?:A9V=R]Q,H(55DC*QJ<]&R3P<&N22_MH_@AJ6A.Y74[.55GMV1
M@5)N<@9Q@\ ]">E>XT4 ><)J%E'X]\+,TJC.B,Q?:<;2NX'/3&$<_A[UR-[=
MVUW\'KU+9MWEZN25"D$*SEEX(Z$&O=:* /.);VSG^-&DS03(T+Z/M0KP"278
M#ZX(.*Y#3]2T7R8- DUBRM=)@U8W,1GMYOM 57.!DIM7/][(('7O7N-S$T]K
M+$DC1,Z%1(O521C(^E<';^ M;33(M'GUVSETN-&A"G3D,HC.<@,2<'WH [74
MYHH]&O)WD58A;NQ<G@#:>:\7,Z+\&O#R"0"5-6R0#@KAY#_(@_C7N$$$=M;Q
M01*%CB0(BCL , 5)0!XN6T&SU'Q%8>+;C5(YIKUYXX899BEU&W*<+\I/ '/M
MSQ6O8"Q3XMV=K)&(XUT..!(;E@[*W!"$Y(+;>O)S7J-)M&X-@9 P#0!XK;/H
M$5YXBTCQ7<ZJMP^I22+;0&817*D@IA$XSE1C/^SSQQU*W%C;?$GPW:(IM732
M&003-\\8.-J,<G+8![G]:]"IABC,JRF-3(HP'(Y ],T >'1S6_\ PJ3Q<-\9
ME.L97IDY>(C'X!OUKVJQN&ETJVN9V 9X%D=CP 2H)/M4AM;=HY(S;Q%)&W.I
M088^I'<\"IJ /'9]4T^Y^$OB9([F)V_M&7:,]2TP9<>N5YX]ZN7-Q;R^)OAJ
M!)&V+0GKZQJ!^H/XBO3ULK1(6A2UA6)SED$8"M]13C;0%HV,,>Z(8C.T90>W
MI0!Y-975E&GQ/,DT*QL7"[B "VV0#'ON('UI]Y?6-QK'PS\BY@DD2/#[6!(^
M5% /_ @P^H->JFTMB)0;>(B4YD&P?/\ 7UI!96BM&PMH0T0Q&1&,H/;TH \L
MT>;2U?X@Z7K$SPK+>S32(O#^46/SKGKU!_$>M;/@K4+V+Q"^BS7EEJ]O'8))
M!J5N!O$>XA4D.>?7OUR>M=X;: O(Y@C+R+M=M@RP]#ZBB"UM[92MO!%$#R1&
M@7/Y4 <-X\O!IOB[P;?22B"WBN9UEF;A5#*H()Z#(S61:7%I-XS^(+"6%P]@
MI4Y!RHBP?PR1FO498(IPHEB20*=R[U!P?4>])]EM_->7R(O,D&UWV#+#T)[T
M >':)?0Z9!X2OM6O;FVT?[!<0K+;,P,<QE?=G:">5*_S[5Z/\/HM!BTN^_X1
MZ2\FM&NBS3W(/[QRJDE<@' Z<CJ#UKJ39VK6XMS;0F$=(R@VC\.E2JJHH50%
M4#  & !0!Y/XQE\/:A\5]-M]9GMVL8;%EN/,D*JKY<@$@CGI6WH5_P"!M#O[
M^UT6:)H9[4W5T4E\R&-(\+@DGJ=YXY_E7:RZ=93R&26SMY';JSQ*2?QQ0NG6
M**ZI9VZJXPP$2@,/?CF@#R[P<R>&O%T?VV!K>PUN MI+33;O)4N6\KT!;>#@
M>H[DUE63:%<:1JNG>)]6U&TOXM0DFNK*$H#<RESM*@(2WX' Z\#!KVEK6W?R
MM]O$WE?ZO* [/IZ=!^5!L[5K@7#6T)F'_+0H-WY]: /--/UC0M*\1>*+'Q'N
MM1=K&8_M:-F6 1XVANIQZ>O3FK%Q?:+HWC'PO=833]*.F2K;&9=BKG!&2>A(
M]>>>>37H<]G:W+!I[:&5EZ&1 Q'YT3VMO<[?M%O%+M^[YB!L?3- 'C%W>0WO
MP[\:-9&-H?[=,^XJ0#$\B;2OOP/PS71>,]6TS4/$G@F>SO;:=3J&[?'(#\NY
M1GZ9!'X5Z088F616B0K)]\%1AN,<^O J(V%F1&#:0$1?ZL>6/D[\>E 'G?BN
MQNM%\9_:-+A9AXDMVL)3GY8YCC$F._RY/X-S5/58[?0?B)IMI>ZG/I>F)I M
M[6XC$8&0>02RD#..>!V]:]6:-'*ED5BIRI(S@],C\Z9/:V]T +B"*4+T$B!L
M?G0!SW@:VTBTT%X-#N;FYL%N'VS3X^=N-VW@97/?'7/6L/QCYG_"4+=Z+J-M
M#K5E8GSK6\7]U/;$EB <=<KSST]*]!5510J@*H&  , "H9[*UN6#7%M#*P&
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M*=VY01G@<=_3O7-(UIXF\)^*HM'OHK_6M1=+J2VA@,("HZ?=5N3P#GGDGWH
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M//;K7%V]QX4DEU74=*O[_4+M],F%Q=W$K%(DV@ ,6 R2< #GO67IUS80>"O
M#%HEE&K@LP7G =]V2/JGZ4 >FZAXOT#2KN2UO=12*6,J)!L9A&6Z!F (4GW-
M3IXCTB36QHZ7R-?LGF"%03E<;LYQCISUKS[0M=T?2XM=T#Q1$7OY=1DE-LT+
M2M=!MI3'4$G  Z#@5I>.(KC0[C2?%VDVFVX@VVL]K@ R1N,*I [AL#C^E ';
M:=JUCJJSM8S^<()6AD(4C:Z]1R.<>U4M4\6Z#HUTUM?ZC'%.J;WC"LY1>.6V
M@X'(Z^M/\,Z6VC^'K2UDR;@J9)V/5I7.YR3WY)_*N1TG6-.\/^,/%%GX@EAM
M9+J<7,$UP>)H2,!03QQZ>Y]* .NOO%&AZ;:VMS>:I;1078)@<OQ( ,DC';D<
M^XJYINIV>L6$=]I]PL]M+G9(N<'!P>ON*\8TU[>PT?P7_:K(J/J\L\*R+RD)
M. >1P-V#^1KVA[5(-.E@LX4B&QMB1*% )STQ[T 9:>-/#DFL#24U>W:]+^6(
MP206_N[L8SVZ]>*2^\;^&=-N)K>[UFVCF@?9)'DEE;TP!^?IWKRSP[_PBDVC
MZ?::O=ZJ^KVUU@::DK9,WF8RO  R3R=P[\UL64VG-XD^)!G>W)$'RE\' "L&
MZ^C;0??% '<ZKXRTO2=2TBSEDWC4LF.5/F55QE6X!SDX QZYJ&/55MO%6L?:
M/$$4UO;6HF.FK"-]N !EBPY/T_VA[5R<6KZ=9V7PWU&YN4CM(H)(Y)6!PK"#
M9C_OKBE>6"Y^*?B:.U>.22;0V15C()=\)QQU.* .HT[XA:#>>'$UJYN?L4#2
MF(K*"2&R<#@<D@9XSC\*W'U?3X]4M],>Y47MQ&98H<'+*.I]N_6O/O"%E8>+
M/A"-!2>-KF.)@X[PR&1V0G\ORK3^'\ESKKG6]2B=+JS@&F*&/4J<R-]2=HY_
MNT =CJ6J6.CV37FHW4=M;KP7D.!GT'J?852TSQ7H6L6UQ<6&J6\T5LI>8YV^
M6HYW$'! X/-<UX_G.GZ_X7U.\P=(M[MA<97<$=AA&/'0<]ZQM9O-.U+Q-KU[
MHT\$ULOAN=+N6%LH7.=@)!QG _2@#T+3_$>C:M=O::?J5M<SH@D9(GW?*>_O
M_3CUHUGQ)H_A]8VU74(K7S/N*V2S?0#)K#^&D%C_ ,(1IES;PVXG:$I++&@W
M$ACD,1S^=9KW4&E?%V\FUF6.&WN[&-+"2<C;P1N4$\ [L\>_O0!T.L^,M)TG
MPV-=687=J[JD?D,#O)., ].!D\^E9NH^*19>-M+235;:+0[K3WG!8J%9AR&W
MGJ",8^E>?:XBMX*\275H6;2YM?$ENW&PC)#,N.-N< 'T KL[Z^T?4?BAX<=9
M[6YB>QF,!!#J6R<$=OX6Q]#0!V4>M:7-ICZG'J%LUBF=UP)!L&.#STJ*V\1Z
M+>6$]];ZI:26L'^ME$HVQ_[Q[5Y++<Z<-(N&MYC%IEOXL\V8VPXB@* !L8X&
M1QQU%:5R?#<VF^+=1TS5[O49;G3F^T/*JK$K# 08VK\Q/3CL: /07\8>&TSN
MUW3AC&?](7N,CO5^/5M/FU)].CO8'O8T#O K@NJ\')'7'(_.N+NO#6GZO\+8
METRWMDN3913Q2P(H+2(H/+#WR/Q-<T-7U);^Q\=06)!U*+^RU@ &YY"GRO\
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MW4OE006R;WD;&3@$@8 ZDF@#5HKEG\?Z-%X>GUF1+M(;>Y-K-%Y0,D4@.,,
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MCD\T =C1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH?BVT58;*==47%M# P>4*XW22-C^+!;M@K[\]-INK6R?&*Z<W!2#4M,A:U#
M@3$[2I ^F[Z<UZ";: ^9F&/]Y]_Y1\WU]:7[/#YJR^3'YBC"OM&0/0&@#@_C
M$Z+X' =E!-W%M!/)ZGC\*KWEY8?\+MTL^=#Y<FDA$Y&"Q9RH^I&#^5>B2P0W
M"A9HDD4'(#J",_C2?9;?S1+Y$7F*,!]@R/QH \3T_6;2R\/ZI)LLIE?Q+\D\
MZ>:EJ",B;:.H^4@<C.373^$[G2]9\4^+]/>Y^U1Z@L3C<A7SHPFUV''3+8'X
M=:]#%C:+&T8M8 C8+*(Q@X]15'6;"^GTZ0:+<06.H858[AX5<!01E<$=,4 <
M'X#MM1N=7CTK48\P>&7EC20D?,['$>.^ F[\QZ5M?%I2WP\OL G$D1./]\5O
M>&]#?0["5;F[:\OKF4SW5P5QOD( X'8   5KNB2(4D574\%6&0: /-M65-;\
M3Z!-X9NK:2YL[.Y:>XMRLBQYC"HK$'&2Q(QUYS6%H9\.W^AZ59ZGJ&K3ZS:3
MXCTU9"KB?=GY<#@'KNW<<G(Q7LD-O#;@B&&.,'DA% S^5(+6W$_GB"(2_P#/
M38-WYT <U\1X;FX\ :I':1RRRE8SLB!+%1(I;IVV@Y]JI1ZQX;\0PJ^BJMQJ
MT6GR+;F%#OME*=,_PG) ]<UV]10VMO;DF&"*,GKL0#/Y4 >2W%[I5]\';;2(
MWMUUB-8XH[+<!.LPD )V=03R>G>K<7V2'Q7XJ2]EMVOX]#C660XY<1_.<G'?
M;S]*]+&G6*WOVT65N+O&WSQ$N_'7&[&:<UE:-,\S6T)E<;6<QC<P]">XH \>
MT/4;:QL? -_JLI^P0QW<;2N24CDR0F?3C@>U7KZ^T[6[CXAVUE=17!FM(;B(
MQDE7$48W$$<'YL#WKU&33[*:U:VEL[=[=NL31*4/X8Q3XK.V@SY-O#'D8.Q
M,CTXH \EFUO3=1UKX=+9W:3&U_=3[ ?W;E(P%/OD&K7AG6/#DFA3Z/XC17U=
M-1D>6WDC+2RS>82I7'?D#@^O8UZ;!I]E:H$M[.WB4,7 CB"@,>IX'7WI?L%G
M]J^U?9(/M&,>=Y8W_GUH \SEFN8/$WQ!M(+M$U6YMHFLT5OWC@1,2$'4L%(Z
M<_SJ'PK_ ,(OJ<'AUO[4OY]9LT1(K/=CRI H#<!1A!MZD]!7J)TZR-^+\V=O
M]L"[1<>4OF!?3=C.*2WTS3[2YEN;>QMH9Y?]9+'$JL_U(&30!XO<:C:#X1ZW
M87\T$6O&]+7%O(0LS.9T).#RW'?G@5[!HMQ#=^'+&:WD62)[9-K*<@_+BGSZ
M'I-U<O<W&EV4L\B[7EDMT9F'3!)&2*O(BQH$10J@8  P!0!X/I]IHS_!NXW6
M]FVMFX,4.$4W!?S!A1_%G&>/2NL\6K>>$[K0O%XC^T3PP+8W\:Y!EW+PQ./[
MWK_LUWT>AZ1%>F]CTNR2[+%C.MN@D)/4[L9S6+J&D:]K&NI!>RZ?_P (_#/'
M<*BQ$RRE>0C9)&-V"3CF@#0\*Z2='\/6UO)S<N#-<,0,M*YW,3CKR<?0"O./
M%FLV#GQM;+]CLI=L43F27?/>2#&-JD_*J@$<#O7L%4)=#TF>YEN9=+LI)YEV
MR2O;H6<=,$XR1QWH X!!H&O_ !,TV66.RNX9=%\Q!*=X=L@C*,, A=W'7KG&
M*H^&](_X27X7:WIB8:2WOYS9*N/D9<.H'H"21_P(UZ:FAZ3%.D\>EV231IY:
M2+;H&5,8V@XR!@XQZ5E:GIFI:9;PQ>#[+1[/S9?])\R#8-N.& 3&2* ,?P'/
M-XFG_P"$FOH6CF@MDT^-77!WKS*X^K' ]-I%6O'=G)=7&CO8ZG;V6K02R2V@
MN1^[E 7#J>W0C\,UT'A_2$T+0[73U<2/$G[R0*!YCGEFQ[DFI[[2M.U1474+
M"UNQ&24%Q"LFW/7&0<4 >5_VY::AH/AK4I["VTW['XA$=P8P!&IP69@>P.1G
MW'M2:MJ4%SJWCR70;J.25].A?S+=P0P7 D(/0X4XX_G7J3:-I3V"V#:;9FR4
M[EMS OE@^H7&*=:Z1IMDS-::?:0,R"-C%"J$J.BG Z>U ''^&W\'7\?AN:V:
MT?58+<+"MMD.AV?/O5>@SNY88R?4UQ=S:Z)<_#/Q)J9AM7O#JDODW&T>9DR*
M5 ;J,@DXKV*RT;2]-D>2PTVSM7<89H(%0L/0D"H_^$>T3[(;3^Q]/^S-)YIA
M^S)L+XQNQC&<<9H N6KK+9P2(P=&C5E93D$$=0:FIL<:0Q)%$BI&@"JJC 4#
MH .PIU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !65KWB"T\/VT$EPDLLMQ*(+>"%=SR
MR'HH']3Q6K7 ?%*1(+31)T@NGNXM01X'M0K.F!EL(?O<#Z9 R>Q -2P\?Z9>
M#41/:WUDVFQF2[%Q$,18[$@G)/8#K2V_CNS>[M([O3M0L;>]94M;FYC CE9A
ME0,$D9]Q7'QFVUW2/$FG6AU.3Q!JMNMRZW]MY&\1X 50...GXU9U:\NO&VD:
M1H4.F:A;7\5S#+=/<6QCBC" AR&)YY/ [T =C:^+K.[U+5[!;6[2XTM#)*KH
M!O&,_+SSGM58>.K)],L;J.QOI+B]@:XALT13+Y8.-QYP!R,<]ZR/&.@:E+XJ
ML+S2MXCU.,Z=J)"DJL)YW''?&X9/H*I>++"/1_&MMJ]UX;_MC2'L1:B**W$Q
MA93D':>.AQ^= '1-\0]"31['4V-R8;R<VZJL)9TD'56 Z'VY)[5$_P 2-&C:
MV1[75%EN _EQ&S;>=F<\=>W^.*Y'7X1!I'A^6R\-W.GVRZP+P6L4)>3RU"[G
M<+G#$\ $] /3CH/$ E/Q4\*726MR\"12AY%A;:F]649.,#D\^E &N/'NC'PY
M=:X1=K:VL_V>9&@(D23C@KV^\/\ ]=5?^%EZ$)EB>'4T>1"T :Q?,^.R#&3_
M "]ZX2[2ZF\-^/8!97WF7FHK+;QFV?YU,N<CC'05OWS/-XM\ RQVUT8X+<^:
MWV=\1[U"KN...0>O3J>* .H@\=:+-HEWJI:YCBM9?(EBD@*RB0XPH7N3D4^W
M\:Z5+)J$4RW5I-I\'VF>*YA*MY>,[@!G/_UZ\PU32KZ]N_$]S#IMQ<)!K$-[
MY+Q.GGQ+YBL%.!G[PZ<XY%='IDFFO'J5YI'A+4+0?V?+]IN;F-C*QV\11AR=
MQ/Y<"@#H=.^(VA:G>6=O"+V,7;;(9IK<I&S8^Z&/&>WUJ32_&(O=9UZTNK*:
MVMM+8YN&3Y-H7)+'UZD #IBN'NO/?PKX 3[%>A[6]C>=/LSDQK&P#$@#CV]:
MW;74;W3=:\96<>DW<MQ,S75H_D%HI3Y0&TGIV'?G..O4 Z'2?&^DZO?6EI"M
MU#)>1M+:F>+:)E7J5/X$\^E9/P]N;N74O%-O<WMU=):ZF\4)N)2Y506&!GIT
M[5RMAJD[:[X0U.\T[6Y);1)XKR:2Q( +)M"HJC[H+>G3UKH_APSMK'BR5K:Y
MBCN-1:XA>:%HPZ,S8(W '\/>@#I=8\56&BWT=E-'<SW4D+3^5;Q[RL:]6/(X
MZ_D:CG\8Z-#HMEJJS/-#?.$M4B0F25B<;0OJ.<_2L#Q7J4MEXSMTETV^EL6T
M]E,UC:!Y)'9F'EE\95<8. 1SBN-\]K;X?>%W>RO[?4=-U)E1GMBP7!,C,4X+
M#:1Z?=/I0!Z7I_CO0M1^W!99X)+"-I+I)X'4Q*IP<G&/PSGVHTKQWHNKZC]A
MA^U0S-$9HA<6[1B9!_$F>HQS7!VL]KXE\,>+8]/NGO-=U!5GEMQ:F$%8RH&Q
M<G/IU)SC\=3PX_AZ74].GMO">I6]]#&7EGG24); (<[=Q.[G@#'>@#=A^)OA
MJ=X0DUUY<LWD&8VSB-'SP&8C'/7Z=<5?UOQGI6A3R03K=SRQ('F6UMVD\I2"
M07(X7@$\FO+[1FA^$-PLEK<EQK"MCR&R '4YY'^R1]>*Z>#5&\*^*/$*:KI=
M[=6VJR+/;O;VOFAU*G*-]!Q@],'UH ZF/QKHTVI:98Q232/J47FVSK"2C+SU
M/;H?IWJ_I^MVFI:CJ%C;^;YU@ZQS;D(7)&1@]#7)>,K1V\%Z=KMM8)8WND-'
M=PV_01KD;HS@#@C&0,=,5T?A+3Y[#0(WO !?7;M=W6#D>9(=Q'IQP...* &Z
MUXNTW0[U+*:.[N+MD\TPVENTK*F2 QQT&1BHY?'7AV#1(M8EO]MG)+Y ;RG+
M+)@DJR@9!X[BL"XU6'PG\1=8OM7CEBT_4;: Q720O(H9!MVDJ#@GG\A7&:[:
MRQ>!M<U!H9HH-4UWSK2-XBI,>20Q'\(/OCI]* /8-!\0:?XDLI+S37D>&.5H
M27C*$D 'H><8(-9E_P"/] TV]>VN)KC;'*89ITMW,43_ -UGQC//;-=*CK)&
MLB,&1@"I'0@UXE;C0;%K_1?$7A[4I]5-W))#'$7(G!8LN,-CVS@T >DZQX_\
M.:'?3V%Y>O\ ;(5!:&.!W/(R!D#'0CO5?5_'^G:?INCZA:1R7MOJ=P(D,:MD
M*#AB%QDD'C;CFL33[R&U^,>I27"BW5-'52@!PI78Q5>/FP >GI7.6\\7_"%^
M#]5=G2UTK6&%R3&Q*@R%]P !)&,?B: /1DU"R;QM*JZO>-<+I^\Z88F$87(/
MF<C&[G&.O-4M(^(VEW?AV75]06>RBCG,;$VTC  LP0Y (/"\XZ'CTSG6]W#+
M\;%E4MLGT<",E&&22'P<CCY1GFF>!/L.N>!+OPS.)UG4W$<ZM$RA-TC$$,1C
M(R#C.>.E '8GQ)IGF:2@F=CJR%[/;$QWKM#9/'R\,#SBM:O-OAS#J4DL[ZJ?
MDT%)-+MRA8AL-ES[X"H!CL/I79>'_$NG>)K:>?3VEVP2F)UE38P. >A[<T 4
M([FT3XA3PMKMPUR;($:60?*1<YWYZ;OUY]*BA^)/A*XN(H(M6#/*XC3]Q)C<
M3@ G;@<^M8LU[;3?'.W5)0QBTMH'X/#@LY7Z[3FN-OKRTG^$-Q%;N-_]L,=F
MTJ>6+#C']W^7M0!ZYJOB[1-%NVM;V[99UB\YTB@DE*)_>;8IVCZUSNKZW+/X
M[\'2:=J,QT[4(Y6:-6(CD 7()7UY[^@K-MM<M/#'C7Q$NNQRO;ZOY<UI,L!D
M6:/:0$ 4'/4+^'/6C6+NU_X3?P%)%:-91&.3;;&+:80X"HI4<+SQ0!V+^,M"
M2TU"Y:\<1:=*(;H^1)F-B<<C;DC/<<5)<^+-%M+*RNY+PF.^&ZV$<3N\@QG(
M106Z>U><W.MPZ?\ \)]H=S'/]KO)I7M8XX'=I-Z8[#  &TY/8U-:ZQ#H?B3P
MYK6K">+3IM!2WC<P,WE2#!(.T$\X_6@"?0M?NKSP;XDFU'Q'<VD<%^T,5\\)
M,D<?&!M !!.?J,UVE]XR\/Z3%8F]U-5%W!YT#>6S>8F,[N!W[>M>9:;J-M-X
M"\=E';$]Y)+$61E#JY&W&1U/IUK=74;>77/AM-/(ID-G)YC;.-[0JH' P/G!
M&.QH [?3_%.BZII,^J6E_&]G;Y\Z1@4\O')R& (_*JEAX[\.:EJ$5A;W[?:I
M@&BCE@DC+@],;E&<UYW$]G/X:^)(GE?RFOWE4Q DG+DH>/X2P'/3&:TO!^LV
M&M^+M.N[O6=/-[:V'V6"UAAD0L>Y+2*.>ORC- 'HFM:]IGAVQ%YJMT+> N$#
M%2V6/8  GUJAI_C?PYJEY+:6>II)-$AD8%'4;1U() !'TK!^,) \",3T^U1?
MS-1:A?Z7K_CCP_=:3)'.NG0S3W5P@(2*(H0JD]CG/':@#?L_'OAB_N/(MM5C
M=_+>4GRW"A4SN)8C QBETKQWX;UK4$L;'4=]Q("41X73=CT+* 37GOA^RGU'
MX&W]M8H7O4>0%$7+E=ZL5]>0,X[UL:]J]CXIL_#%KH=Q =66]AF" 9:V54)?
M=Q\H'''?'2@#M+7Q5HU['JDEO=EUTO=]L_=./+QG/4<_=/3/2LYO$&GWGB#0
MYK?Q!Y<%W"YBL3 1]ISD!B3@K@@]?2N>\5:=J=EXS,>E+)]G\2P"UN2OW8F7
M :3TSY>['?.:O^(+G3].^(/@VV"QY1)X0B@90,J*F1V&0<?I0 _QSXRLK+2=
M4L;#59(-7MHPW[F%F"GCY6;:57.?4'./I5C3-4>]N?"33Z\(KJXT\3RZ>(LF
MZ+19W$C[N#D_A7")JMMI/@7Q3X>U69H];:XE<I(K%I]S+A@V/FSUSZ'-;5K?
MVD>J_#'?*J.MC)&P8$,"T"HN1UP6! /2@#KKOQ]X6LIGAGUFW$B2>4ZJ&8JV
M<<X![]^E7M8\3:-H,,<FI7T<(E&Z, %V<<<@*"2.:\L1[-M ^);N86<7TA5C
M@D!G(7!]S5F_U^+3;[P=J_VZV2\FTE8I1=!_("E1S\@.#NR#QVYZ4 >G:1K^
ME:]%)+I=['=)'@.4S\I/3.:K:_XETK1E6UO-42RNKA2(3Y9D*GH&( / /KQ6
M=\/;>PL_#7V6RU&RO769WG:S(V*['.T#K@# &?2L*UU>TT#XL:^VM7 M4O((
M?LDLWW655&0#VYSQ[4 :'@_Q? / $.K:YJ63'*\4D\B<LVXD  9+'&.@_E71
M:/XHT77HY7TV_CE\H;I%(*,@]2K $#BO)M#U,V^B>%=3N %TO3-3GBNBBYVE
MQE)&[_Q'MVK2\6$>)-=U:]\-7$4T<6ANEU-;\ASOSLW#J2H]^!CO0!Z#9>,_
M#NHWQLK35(99PA?:H/( ).#C!Q@]*E_X2G0O[/AO_P"TX#:32>3'*#\I?^[]
M:YC0?$WA#7)M%@L[,S:E:H%BB%LQ-H-N&)8C&!ZYZXKBX=9TJU^%ESI4\B0Z
MDFI M V3(2)E8MMQE<*"/P]Z /6]1\5:#I-T]K?ZK;6\Z(':-WY /2H3XV\,
MCR/^)W9?O_\ 5_O.O./P_&N7DGTV\^-,2LD$P?2!]\#ALEN0>^T@_2N.MS9'
MX0>)9U6!I1JP\M@!NVEXB,'KC /ZT >Q:GXET;1IUAU'48+>5EWA'/.WUIEY
MXJT'3_(^U:M:Q>?%YT6Y_OI_>'M7G5Q>Z1/XE\01:]K%[ID&IV\,T6R13'-
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MU>W'C.]TZV69-(U^W$E],A.8GCST.,#=\@[]37H<44<$*11(J1HH5$48"@=
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MJ<EO<26ML\XE:&)GVD@ # J#2-8M?">K>)+/7VN2UW=FY@<P,ZSHZ\(N,_,
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M-7@ !@  >@H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+'#"(0.0=YZ[FX&/QKKZ* .0T?PKKEJ+>WU3Q))>6%NN$@BA\HN,%0'8'+
M]/85B2_#?7#X>F\.Q>)HAI#.2D+V89U7?O W;L]0*]*HH K6=JUMIEO:22^8
MT<*QM)C&X@8SCM7!0_#O5X?!-[X9&LV[6\LZ20L;<Y50^X@G/.2%^F/>NE'C
M31FTW5+]))WATR7R;@+"VX-D#@=>IQ^!K;M;F.\M(;J+=Y<T:R)N4@X(R,@]
M* .:N_"U_J'B>RU.[U"%K:*Q>TGA2$J9-ZD,0<\9)!]L>]9^B^#?$6DQ6NG'
MQ/NT>WD#"*.WV2LH8MLWYR!T^H)%=W69KNOZ?X<L%O=2E:.%I%C!5"WS'Z=.
M] &-\2SCX=ZQ_P!<T_\ 0UK,T'P[J6LKX>U'5KZREL-.ACFLXK6-E9FV+@N2
M3]W';KCMTKMKZPL]3M6MKZVBN8&()CE0,I(Z<&G6=G;:?:I:V<$<%O'G9%&H
M55R<G 'N30!S?A7P_K.@V.L0W%[:2R75S)<6QC1ML;-G[V>V<<?7DUC6W@#5
MD\)6&GR:A:)J6F7IN[2:-6*$Y+8<''4D]!T]:]$HH XQ/#.NWEU<ZKJUWIKZ
MJMF]K8^1"PBA+9RY+9))Z?3/K6OX0TB]T'PS::9?RV\LMN"JM #MVYR.O>MR
MB@#C_$'A?6+WQ;9:[I.HVT#16S6SI<QEPH.?F4#OSZCH.O2L2U^'>MV/AVQL
M8-0TXW>F:C]KLY6A;!7G(?N,D@X'H/J/2Z* .$MO ^IR7GB*XU'4K5VUJT$,
MGV>!E\MP-H(RQX _//;', \'^)CHOA^R:^TO?I%VDRX1]K*@ 7/<GEL]!R*]
M"HH X*X\"7M_KWB6>[NK86&LP+&!&&\R-D"[#Z8X.>>>*F/A77=6ATS3_$%Y
M83Z?82K,7@#^=.R9";L\ 8//4FNWK-@U[2[G6I]'ANU;4+=-\D&U@0O'.2,'
MJ.GK0!D^'=%UK2M6UVYNY[*2"_G,\*1;@4;H-V1W 7/N*YVU\#>)[/P/?>'X
M-1TZ-[NX+M*OF?ZMA\RYQU. .G0FO2JH6^M:==:O<Z5#<A[ZU4--%M8; <8Y
MQ@]1T- '(3^%/$MWX>DT,7FEZ?8"S,$<=FCDN^5.6+#@$ @XY^8GFG:7X4\2
M6^OZ7?WEWI M[.T:T,-M$ZA4(XVYZG('H/:N\HH \V3P+XD_X5_=>%9M0TV2
M)F06[A7!51)O.XX]0,#'KS6H_A;6;+5['7-+FL1J"V2V=Y#,7\J4 #!4@9!!
M [=OSUM4\:^'M%U V.HZAY%R%#>689#P>X(4@U+H_BS0]?N9+;3+]9YHT\QD
M\MT(7.,_,!WH Y75_ >KZKH&J1/=V/\ :>JW<<]R_P XB1$&$5.,GH.2.YK;
M70=7_P"$YL]<::S%M'8?9)8E+;B2=Q(R,8W8].*ZFB@#G?%GA^[UN&PGTZ[%
MKJ%A<K<0,Y.QCT*MCG!'^>:S8/#VM:CK4VNZNFGQ7L=@]K:00N[(K,6^9R1[
M]NQ-=I10!RW@#1-4\/>&8],U3[+NBD<Q>0Q/RLQ;YL]\D].U1ZGX?U,_$+3?
M$&G_ &9H5MC:W2SL00FXG*@#KR:ZVJ=WJMC8WMG9W5RD5Q>,RVZ-G,A R<?F
M/SH X./P=KZZ%XOM"EEY^L7;30GSCM"LQ)_AXXZ5(/"OBO2-1M-3T6]L9+EM
M/@L[V.\9V5G0 %QC&>G?GD^M>B44 4=)BU"'3T&JW$4]XQ+2-"FU%R>%4'G
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M&Y>F1Q^0H V?"DNM3>';8^(+<0ZBN5D 93OP>&.W@$BN)\3:[K&DP:WJ47B
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MV5B\82X9?-N..?,;DY^G _"K&KZ+>7]_;W=IJKVOEQ/$\+1"6*0-CDJ2.>*
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M[=*EO_$FOWOBK2])TNXM+.+4=.%VCRP&1HR>>>0"?E(].>E,U'X=ZC>7.O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH 0J&Z@'ZTM%% !1110 8YSWHHHH **** "BBB@ HHHH **** "
MBBB@ I" <9 .*6B@ HHHH **** "BBB@ HHHH 9+#'/$T4T:21L,,CJ""/<&
MFV]M!:0B&VACAB'1(U"@?@*EHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR,&@"S<ZOIME.L%S?VT,SE0L;RJ&.3@8&<]:9J&O:3I4L45_J-M;22L%19)
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWUJJ6TVHQ)+<W8MVEBM4V!F.!DC)( SGC/UK:EUR]MM5\,V:R6=U!J2N)KE
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
$ '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>a123121ex-1021013.jpg
<TEXT>
begin 644 a123121ex-1021013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#WZBBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBNLRC^ZZ\'M^9]#0!US,JXW$#)P,GO2/(D2%Y'5%'=C@5YK=^(8]1\!Z-?\
MBC2;MUFNXMC03(H=\$J_RD$ \\8[?2CQH\NI?$71]%N=+DO[#[-)+]F694$K
M$'YCE@/EV]^>N,YH ]+!#*&4@@C(([TM<EX?UVRM;J_\.0Z;<68T:'<1-*K9
M3J"#DD@CGGUK<T+5AKFBVVIK:RVR7"[TCEQNVYX/'J.?QH T:*\OO_$.I>(/
M!GC%;[3V@AM)I(X95D'R%"GR$#YMP/S9QCG';%:7A7QE'%:>&]&O-.OK<W=I
M''!=S*!'*RQ@G'.2#Q@^XH [ZBN*N_B386DI<V%VVGK=&U:]#)L# X)V[MVW
MWQS72:_J8T;P_?ZB<9MH'D4-T+ <#\\4 :-%>=^&_"-OXGT&TUKQ)=7E]?7<
M?F?\?+HD:DG"JJD <8S[U<LTC^'6GW<,CSWJ7E_C3K2-B\K!E7Y1N/8@\_3N
M: .XHKF;+QE'->W=C>Z5?6%[;V[7(@E"L98UZE"#@FLJ+XHV#V5I?R:1JD>G
MW+^4+HQJ4#Y(QP<GH>E '=T5RUKXYM97U6.YTS4+.;3H?M+PS1#>\7/S*,X[
M>O\ 6J<'Q)L9A87$FE:E;Z=>.(UOIXPL2L20,G/3(ZT =K17*:GX[M-,O+Q&
ML+R6SL9(XKR\0+LA9R,#!.YNHZ ]:?JWC:VTS6I-(32]2O+M;?[0!;0A@R^N
M<].,9]>* .HHKC[OXB:;;^&]/UV.TNY[2\E\KY N8CDCY^<#D<5N?VTI\3'1
M!:3EQ;?:6N!M\M1G !YSG/M^G- &I17,>)?$]QHNN:'IUM827+:A,P?9C.U1
MR!D@9R0<D] :Y@:_/H?Q*\3GR-2OXDMHI%MH29-GRJQ/)PH&X_GQ0!Z=17.G
MQII36&E75N)[DZHVRUAA0%V(^]G) &#P<FLO7/'ZV?A^/4-.L)YIFU#["\,J
M;6CD!^8$#.3Q@8/?VQ0!VU%0V]P9[-+AH)82Z[O*E #K[$ G!KRS6?%=YXD^
M%6MZ@]M=6,D-PHB=245D,P4+D'YB 2&SQF@#UFBN4\/^-;#4;JTTF2*_@O'M
M]Z/=P&,3[0-Q4GD]STZ4L?Q T>2ZM8_*O4M[N<V]O>/#B"1P<<-GID=<4 =5
M169XBB,OAW4 LT\#K [K)!*8W4J"001SU%>6:/J6C-X0M+[6O&VM0ZB\;M)#
M#J3EL[V ^3GG '% 'LU%<S)XHLM"O--T2^-Y+<2VXV7;1_NY2J\DL3UXR?J*
MGC\7Z>?#Z:S-#>6\$L@CABE@(EF8_="*,YW=OSZ<T ;]%<W8^.-'NUU,S?:;
M%]- :YCNXMCJ#T( SG\/4>HHL_&NG7>I)8/;:A:SRP&XA%Q;%?.0 DE<9.<#
M.#@T =)17*_\+ T=M(T_5$BO9+2^F\A'6'/EOG&'YX_#/0U-#XJ:?QQ=>'1I
M]QL@@5S<JN5#$$\^@(P!ZG- '245PVB^)],TCPA>:G_:.K:O:V]Z\4DT\1,J
M'CC!P0HR.OKVZ5T/_"26)DTA EP?[40O ?+X50NXESVXH V**Y6#X@Z)/JMO
M8J+Q4N7,=O=R6[+!*WHK'KSQTK>U35+31M-FU"]=DMH1N=E0L1^ &: +E%<G
M'\1?#TES!'OO$BN$+07#V<BQS'^XF1EF]@#GIUJWI_C71[^QU&Z9Y[5=.P;J
M.ZA9'B!&02O7G!QWH Z&BL+2?%FG:O=S6J)=6T\4(GV74)C+1'HX]OUKCO%'
MC.+4CI)T>YU>W3^T84$RPO%!=(S<X?N!CIQG)X/8 ].HKG=9\;:-H=TT%TUR
M_E%1<2PP,\=ONQCS& P,Y'')]N16_'-'-"DT;AXW4,K \$'O0 ^BN?MO&V@7
MES90P7CM]M=X[>0P2+'(Z]5#%0,_Y]*K7WQ%\,Z?//!-?2&6WE\J94MI#Y9S
M@D_+C ]OPS0!U-%9$GB?28M5T_36NC]IU"+S;8"-B'7&0=V,#@'\OI4]AK-I
MJ5]J%G;&0RV$@BF+1D+N(SP>A]__ *XR :%%8^I^*-*TFYEMKF:8SQ1">2.&
MWDE*1DXW':I '^%/3Q)I4FIMIJ7+&\6 7/E>2^6C(SN7CYOH,GMUH U:*Q(/
M%VAW&DOJD5]NM%F\@MY3AO,X^0)C<6Y' %8OB/Q-;ZIX3UT:%JD]M?Z?")9,
MP/%(@ZX(=01D C(H [6BN:T/QIH>IRVFG1:D)=0DA#;3&X#D*"V&(VG\#72T
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\V:/*D[@3C.< L.V3Z5Z*SJB%W8*H&22< "D,L8D6,NHD8$JI/) ZD#\1^=
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M''&SEF8$ 84$]3UKS_PO>Z78^"K72M8\*ZG/<(CB4?V4S;LNQ'S8]"*]8HH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MYMTC90\JL6.2><8SZ>O2I-(EO]*\7^)HY=%OY(+N3[1%<Q(#&0L?3)(R20
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MA<SSVVU,#:,C!Z#'4@4 =?J'Q#TRPEN"++4;FSM9A#<7L$ ,,3YP022"<=\
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M8(Q&@/7 &.?4U8HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=RF]4?&1R1SCZ5HT %%%% !1110 444Q98WD>-9%9TQO4')7/3([4 /HHHH
M***S=3U@:9=Z=;FSNI_ML_D[X4W+%QU<]A_]?TH TJ*** "BBB@ HHHH ***
M* "BL[5]8AT=+5YK>ZF%Q<+;J+>/>59LX+>@XZUHT %%9.K>(;/1K[3;2YCG
M+ZA,((6C3*ALC[QSQUK6H **175U#(P93T(.0:6@ HI-REBH8;@,D9Y%+0 4
M444 %%%% !116;'K=O)X@ET58KC[1%")FD,1\O!.,!O7F@#2HHJO?7D6G6,U
MY/O\F%"[[$+' Z\#DT 6**PSXLTS^RM,U)?M#V^HRK%"5B)(+9^\.PXZUN4
M%%9VK:S;:,+3[2LS&[N%MHQ%&7.YLXSCMP:M7EW%864]W/N\J%#(^U2QP!DX
M Y- $]%4='U:TUS2H-2L69K:<$H67:3@D'CZ@U>H **;)(L43R-G:BEC@9X%
M9^AZ]I_B+3_MVFRM+;[S'N9"IW#KP?K0!I4444 %%%% !1110 4444 %%%%
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M-&A6.F1WE^C:?*9;2[\Q?.B)[ [<;?;'85)'X&T^:QO8M5GN-2N;V,137<Y
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M?DE+>7.VG^6I@VNX78#U& W7U'XUUQ\*-_PE5_JPU%_LNH1)'=V)A5EE"KM
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MZ_+<2ZO%&LCFW50KIC#8!Z< 8XXH 9X8\0:E/XL32[G4_P"TK6;31=K.;81
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MS1.03&2,E21QD=*P_'4UQ;>"-6GM;F:VGCAWI+"VUE((Z'MZ?C7*7#:CJC>
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MVVN 3)>6T8ABVR$(J $;=O3')_.MNB@!DT,=Q \,T:R12*5=&&0P/4&N;L?
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MA"S#EMHSQW_2K7A[PK)H6M:MJ!U-[D:E+YKQ&$+M;)(YSS@$CM5^XU^RMI+
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MY',ABD=GPQ[@DD@\=C0!RUUI-OHGQ*TNSTF(V]GJ-G.M[;PLRJ0JMAN/NG)
MR/ZUP^G6R0^#?#.M1M,-1;65M_.,SG$>6.T G 'T%>R6GA/1[*.X6*WE8W$)
MMY'EN))'\L_PAF8E1SVQ5(_#[PT=(CTLV#FSBG-PD?VB3Y7(P2#NST[=* -3
MQ'$DWAG58Y$,B-:2@J#C/RFO-(8;2V\)^!=/"F/3]3ND:]$1(\Y\# 8YZ$XR
M/;VKUR6-)HGBD4-&ZE64]"#U%<_'X%\.1:')HRZ>#8/-YYC:5V(? &X,3D'
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M0 ,8Q[F@#C=2N+F7X3>+K>YEFD%GJS6T0FD\QD19HL*6[XR>:]3TKC1+$_\
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MKR&062RJ8T.<\ CUK7F\&Q?VK;ZI8ZG?65]';BWDFC*MYZ@  N&4@GCKC^5
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M?*C41J!)Q@D\=Q@?A74444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBUO2K>QO_$?A&&V,EUK$L-WIH/ W$DL,DX&WYOP]>!6YX*NAXKO=,O'B:/\
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MRX(P&P3SRPQ]X\UZE8V<6GV$%E!O\J",1IO8L< 8&2>M8.G>"++3(=7BCO\
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M-S>9W)VC(/OC% 'JBLKJ&4AE(R"#D&N;M_$ERWCV^T">WABM8+(723[CN;D
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M<?:@;J4F7#;N3NSU_F13_P#A"= VZ:IM)"NF-NM ;B0B,[MW][GGUSZ5OE@
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MMGEF@78NV5E!7DX(!]35(?#GPZEO!;Q07,44%U]J14N7P'_$^P]_>NKZC(I
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M;?8FD\TP[>-_][ZUD:EI>N:UK$.E3V=I;>';6:.<2HP9I@A!6,IV&0,\8P*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:'!9*!?.9S&ZK\S;(RX7/7J#CW-:4?C%M;\ VES:';J6I2#3U"_\LYVR"3[
M M],4 =@-3T\I,XOK8I"<2L)5Q&>GS<\?C2Q:C8SV\EQ%>V\D,?WY$E4JO?D
MYP*\E\'Z-:0^!/&MK*BR&&:>#SO*#.0B?*<>QY'O2V.DW-S\%M);3=-6[?[7
M]IN[=>/M")(^0V,%NBC'7B@#UJWOK.\&;:Z@G!S_ *J0-TZ]/J/SI;J^M+)5
M:[NH(%8X!ED" _G7GOA1_"U]KBZUH2IIMW:VDD=[IHBVL1P>G X(ZCVSBHO
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!SFO>)+S3=4MM
M,TO2DU.]FB:9HC>)!L0$ 'Y@<Y)_2M31KC4;K3(YM5LDLKMF;= D@D"#<=OS
M#@\8K)\1^"=$\3R^?=H\=[&H5;F&0JZ8Y'M4?P^O[J^\%6,U_<&:<-)%YK]7
M"NRC/J< 4 6/$OB@^'KS28/[/>X74+I+;S?-"K&6('3DD]\8Q[UT-<%\2?\
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MA6R0>N",8'-=-J/A?0]6L8+.]TRWEMX!MA3;M\L<<*1@CH.E 'EOB'2K32?
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MFB%W@6>>5U,9ENI3*X3^Z">@]A5+_A7^@_V->:4L=PEG=2B5HUG;"8;< HZ
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ML;7CM=WYC>0LVS&]5SA0I.T<<YK1T_PQ=>(/#ZP:GJFLQQ0Z@;BREE=5G:,
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M):,5N+F>.U67C,>[.6'O@''N15FQ\*QV/B^_\0K?SM)>1K&T!5=@   YQGC
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M/D&<_P )).!][O0!T=%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO/F^;G@8Z8Q]:\RU/POHEEX5\,7R68\^]O;#[3)+(S[P5Y'S$X'/08_2MGQ
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ ILD:2QM'(BNC AE89!'H13J* ,&#P5X9MGB>'1+-'BD\Q&$?(;CG/X
M"GKX0\/I:7%HNDVRV]PX>6,+A789P2/;)K0@U73KJZ:UM[^UEN%!+11S*S@
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M6^K6VC.NL7<MS,9Y#$TR[9!'G"[O<XS^-;]%% !1110 4444 %%%% !1110
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M&T[4;"RO8;P3/INKP??=64LP<8RQ((Y/KWYK$L88/^&?]1.Q!*+@.V!@Y\U
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MO*T%NNU#*P+8SGD@#UH \NTYM16/Q;JSZWK$SZ)>W @@^TED< ,!O7N <'C
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MN[!U"LP/5MF3S]:P;73]#U.+Q38:QJ\>F31W[#8\40V1*0$V[ANQA0,*1VH
M]?NM2L;$H+R]MK<OROG2JF[Z9/-8_BOQ3!H/A2?5[62"X8@+;X<%7<G YSR!
MU..P-<QH]M:7/Q'GM]23[5$VD0?8#>*"70*NX[2/O9R3WZUSFHQ0VOPY\4PV
MC+/IUMK"_9,K\@&]-RK[ DC_ /70!Z9X8GUNY6XGU.]TV\M9-K6TED",==RG
MDC@X[GO705FP7>G:=;6%NSVUH;K @@7"!V(R0H_&M*@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:7>-ITFHZ9:7)DOK5"?F3;@,0.H')]/7C-1^%I/"\<UWXET*\6VTV.R,=W9
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MM77>"%>/P3H\<L4D4D=LJ.DB%&4C@@@\]J (9_&MA"+Z6.RU&YM;)VCGN8(
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M[L!;:C;7%O 9RES:/&SQYQN4$9//MFLOP[K^CZ9X-LKBVO=1U"":Y-O;^?\
M-/*Y8@* 2.@'Y"J-Z\O_  MR&^6VO#:#1VC:46[E=WS/MSCKCMZ\=>*P=#T^
MV;X766FZWIVK1G^T'&^WMG\VW;EA)C&=N.,@'K0!ZEI>IIJMO)*MM=6QCE,3
MQW,6Q@1@_B.1R.*K^)-2ETO0KB>V&Z\<"*U0#):9OE08^I%97@.76'TV]CU2
M>:XBANFBM)[B(QRRQC'S,#SCT)YZ^U4/$-N/%/C*UT.==3M;*RC-R+JW1D#7
M'&T"3&!A23GU.* +'PYU:]N](NM+U9V;4]+N&@G9W+,XSD,2>O<?A5W4?'.D
M:;<WD3K=3)8LBW<\$6^. MT#'.?K@''3K7+?V=)X'^(%G-9G5]1M-1A*7\DJ
M/.R'.$8N!STQCL,^HK&UZ^L;#7_$]JMUJ%K9ZA,L5T([ 3AF"@MLDWC:3N/!
M!QGI0!Z#=>.]%LUL&D%]B_1GMP+*7+@>@VY]/P(/0YJ.?Q_I,,"2I;:E<#R%
MN)A!:,YMD89!E_NY&3]!GI7-ZI<6NHZ]X!N-&BN;G3K8N/.2!V5%.Q%W''!R
MASGICFHKVSMM+\;:]-X@T&_U*VOS'):S6T+S *%(*G!X[#'MZ8H [:_\6Z99
M6]E)&MU?/>Q^=!#90&61X\ []HY Y')JN_CSP_%H<.KRW;I:RR^1_JF+I+C)
M1E )!%<=J=I;Z=K^F:G>^%[EM%DT\6\<$"&22V<.S#*J>,AA^)QVJ3Q ]C!X
M,LY+'0KG3[5]9AD6W,)WR@8)<KSC.",'K@>M '5?\)[I)NKBT%MJANX5#BV^
MP2^;(I[JF,X]SBK">,])ET*UU:$W$T=TQCA@AA+S.XR2FP9.1M-9 O(D^+TC
ME9MAT0*&$+$9$A?T]/UXZ\5Q,*%O#NCZG)IES>V-EJ]W]JA2-@^Q^0V,9P!S
M]>/7 !Z3#XZT.32+O4I9IK:*SD$5S%/"RRQ.3@!DQG_)]#1I/CC1M9U==,MC
M=).\7G0F>W:-9DQG*YY(_ >U<7K,^G3_  \U^71M N+"SN$AVS21D-</O'\/
M/ '\1/>M*VF7_A+_  ./*EXTIP7\HXYC  S_ ,!/7U'K0!TWA'Q,/%.F3WBV
MQA6.Y>)<Y(90>#GUQU%3:OXGL='NDLWBO+J]>/S5MK.W::39G&X@=!GUKF?A
M3(;71;W2)XIH[RVO)3*K1,%'('WL8)]@:DU*]_X1WXEMJFH0R+IEY8+ +I8F
M=8Y%?HQ ^7.: -G_ (3OP[_8_P#:IOR+43BW<^4^Y)#GAEQD=#U%7M$\0Z=X
MAAFETZ21TA?8Y>)DY]LCD5Y=JB&+1O%.M,DJV.KZA:&RS$P:0(^YFVXR 0#R
M1SCZ5[%!,ES;QSQ$F.10ZD@@X(R.#R* ,.Z\;:#9R72RWC;;698)Y$A=DCD/
M12P&,\<^G>FZKXXT#1=1ET^^NW2ZC4.R+ [\'IT!KSGQ1KOVW3/%>F36\R72
M:B##;VUFRJ8TD&97<#YMP_O=PN*Z6RU*SN?BI=W4$<R+-H:DEX64LV0_3'78
M5_+% '23^--#M]+L-2>YD:TOVV6[I [;VZ;< 9!X/!]#6BFK6CZU)I 9Q>)"
M)RIC8 IG&0V,'GC@UYQX1T0:_P#!R33Y%=;A))7@)&"DBG<I&?R_$UT7P\^T
M:GIC^)+[)N]01(P"<XCC&T?FP9OQ_$@'9T444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !114<\AA@DE$;2%%+!$ZM@=![
MT 245R%CXKU+^V-&L=3T^VMVU6.1DCCF+20E06PX('8=N]94/C[7;S1]3U6V
MT"U-MIL\D<X:\.[" %L#;SP?_K4 >B5#<W5O90F:ZN(H(@<%Y7"J/Q-<DWC/
M4;_4[*ST/2(KD7FGB^22>X\L*N0/F&T]"<<9ZCM7->+O$,_B'X8:Q]ML/L=]
M97J6\T6[< P=>0?H: /4C>6JW,=L;F$3R+N2(N-S#U ZD5-7'3:A:Q>//#]B
M^FQ/=2V#LMZQ^:-0I^4#\#^=)'XNUB^MO[3TO1%N]+^UFW&V4^>ZABK2!<8Q
MD="<T =E17(:WXMU+3&U>:/24^Q:6(V>6XE*&<-C/EC&#C..3UJO-XEU"Z^(
M6C:=I[1?8+C3?MDBNV-P8GG(!Y 7CMS0!V45S!/)+'%/'(\1VR*C@E#Z$=C4
MM<-;>(]-T5?%U^=(%HUC=#S_ "Y-QN6;A6]%+$C\^:NGQ/JNG:SIEGKFEP06
M^I-Y<4]O,9/*E()$;C'4\#(XH ZRBO/)?B/J+:1J.JVOA]7L].O#;SNUT 2!
M@948SGD?F.O..\CO+>6Q2]24?9GB$HD/ V$9SS[4 3U#<W=M90F:ZN(H(@<;
MY7"C\S7&2>.=0_L7_A(X-'CET$%LN+C$^T/LW;<8ZCIFL_79UUOXC^&H/(@N
M[";3Y9XXIB0K!U;)/RGL!C^E 'H\<L<T2RQ.KQN,JRG((]0:9+<P0/$DT\<;
MRMMC5W +GT&>IK!U]SX5\"WK:-%'#]CMSY*DDA/?G.>N>:Y?6)KFZMO .K7-
MND^I//'DQ./GW1Y// Y(!]NV: /29)$AB:65U2- 69F. !ZDTD4L<\22Q.LD
M;@,KH<A@>A![BN0?Q+_:%CXFL-6T3]YID&Z>V$P=9HV4L,,0.P--M/%=II^D
M>&(+33$M8]4C(@BGG$:0*JYY;!SG(QQSF@#8U;P?X?UR\^UZEI<-Q<;0GF$D
M$@=,X(SUJB?AOX/ R=$@ _WW_P :Z#3KBYNK".:\M/LD[9W0^8)-N"0/F'!R
M,'\:P_&DTT^F1:):R".YU9C;^8PR(H\9D<_0<?5A0!&/AQX/(!&B0$'OO?\
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M 'V_^-'_  K?PA_T X/^^W_QK/'CW52;^ ^$+L7E@HDN(C=Q;4C()#;N_0\
M'I5J7X@6)M=)>U2&2?48#<".:Y6)(E'7<Y!_B!7@=0: )O\ A6_A#_H!P?\
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M4L;?PW:ZQ97=XUW!<S2QJ(V?&=RGD@<]*]!:2VLH4#O%!$,(@8A5'H!_A4U
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M)7D<8)/IVYJ#1].U?PU/<:'_ ,(?%JP:X>2#4&V+'L;D;B5/3N,Y].U>IT4
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MZ0:@,6S072S2(V 0)5'W.N/K^-7])\8:GK&K26MOX=E%M;7LEI=7#3KB,KW
M[]LXHT$^,8TTZQO]-L(8;=52XO#<>8\JJ,?*H'#'CDGUI_@C3M3T^?Q =1M&
MMQ=:G)<Q?O0RLKX/&/Y]_P * -C7=9_L>&U"0&>YO+A;:WC+;5+D$_,>PP#V
M-8-MXXN(H-:;6-)^R'1TS<.EPK([G!14S@_,",9]<4SXDMYNGZ7906'V^]GO
M5>"%)O+D&Q6=F0^H QGG&[UQ6%'9W6NZ+K/AR71[O3-7OX!>&>\N!-YQC=
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M-K%YK=_IOAW3K.Z_LXH+F6XN2@+,"=B@#KQU)P#D4 =;37=8T9W8*BC)9C@
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M9KBXLHI;NU-I.P^> R!]AS_>'!JCXDUV/PWH4^J2V\MQ'#MW)'C/) SSVYH
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M (QQP?J:V/[$\6:-X@U2;0YM.FL-2E^T$7A8&"0\$@+U' ^O'I72?\)+HO\
M97]J?VG;_8-^S[1O^3=Z9JW+J=C!J$%A-=PI=S@M%"S@,X'7 H X^Y\.>)=*
M\2OK6AW%E=R7D$<=\MYE!(Z# =0H^7@=*=J^@>([R;PU<YL;RXT^X>XNC*Q1
M22>%3@\ $@$],"NXHH XN'0-:B\:^(-7\JV-M?6GDP+YYR650%W#;QG'OCWK
M#TOP+XCT*PT.\TZ6S.K6 FAFAED;RI(G=F'(&<C/\O3GU"JNH:E9:5;?:;^Z
MBMH-P7?*VT9/04 <?JOAOQ+K6F17ES=VL6L6MY'=6L$9;R$"C&TG[W.22?PI
MNGZ'XHN?B!:^(=6ATV&**T:U9+>5F)'S$$9'7+?E792:E90WMM9R742W-T&,
M$1;YI !DD#Z5:H Y;QIH^KZM'IC:4UM(+6Z$TUK=$B.8 <9(ST/;WSVKE)?!
M/BB72O$]FZ::S:S.EP'2=@$;>'(P5Z=17JE% '&ZOH>M:GXN\-:L(+58=/5C
M< SG.Y^&"C;R !D<\YQQ6%=^ -7OCXBF8VT-S=7\=]8,)"P5D+X#<#J&]Z]/
MHH Y6SB\7W,-P=5334*6KQQ0V\C8GD8#!8D?*!CL#][VK$N?".N2>&O"EHL5
MJ;K2+N.69?/.UE0\$';WX[<>]>BT4 >>R:!XFTX>(-,TVUL[G3M6>:2.6:Y*
M-"TB@-D;>>IQCTZU#!X;\5Z&NDZIIL=E<:A!8+I]U:M*0CHI^1E;CD#D_I7I
M%% '!:WX>\3ZI!I>KN]B^LZ==-/':)D0["%&S<>2?DSD_P![':I]"T77O^$^
MO/$6IVMG;17%F+<0Q7!D9""I'.T _=KMJ* .0\;Z)JFI7>@W^EV\=S)IUX)G
MA>41[AQW/T__ %U!;Z3K?A[Q;JFH:?I\=[8ZJ%DDC6X5&BF Y.6QE22>G//3
MC%=3?ZQINE!?[0O[:UW?=$TH4GG' /7DU<5E=%=&#*PR&!R"* ,'PAH4NAZ3
M*MT(A>W=Q)<W/E$E=SL3@$]0!@5D6>B:QIOBOQ-+;V,+Z;JB"1)3<8<2!""-
MN.[$]< ?I7;44 >5'P=KY^&6CZ)]A7[;;:AYTJ><F FYSG.<?Q#C-:4.E^,/
M#NLZG!HUC87FF7]TURLES-@Q%_O9'!(SZ UZ'10!GW%A->^'IM.NK@///:M!
M+,J[0S,FTL!VY.<5QWAZV\<Z9:6.AS:;I_V6U=%^WF8-F)3R G7=C@' KNKB
M\M;5HEN+F&%I6V1B1PI=O09ZGVJ>@#SSQ#X>\0ZO>7FMPP&#5=/G1-(2.X&V
M2(-\[/S@;@QR,@\ ?6]?6?B*;Q+X?UN/2H69+9X+V W('DER,D'OCVS_ %KJ
MSJ=@+1KLWUM]F5MK3>:NP'.,;LXSGBI6NK=+I+9IXEN'4LD1<!V ZD#J10!Y
MYH^B>*?"ZW6BZ?I&GWNGM,SVM[/,%\I6P<,G+-C'_P!?%:=IHNL67Q(N-9EM
MS=6LFF+;F=61"\@VD_+G(R5^@S7:T4 >71>%?$$?A/0MVF(VIZ/J9N([;[2B
MB2(N7.6Y .3C\*ZZ/7=4'C*VT>XT^%+::R-P9$F#,CC 8'I\N3@''/YXZ.DV
MKOW[1NQC=CG% '*^.-#OM631KFPB\^73]0BN6AW!2Z \X+$#-5)]"U77=4U7
M4;NU%COTN2PLX'D1V)<'<S%<@#. !D]^E=M10!Y5I^A>+OL?AC3IM#@MXM(N
MTE>=KQ'WKDY.T=, ^IYQ75:)8:MIGB_6WDL%:PU"=9DNEG7Y0$Q@KUSD"NFD
MN((I8XI)HTDE.(T9@"YQG@=^!4M '(^*M&U&3Q%H?B#2K5;NXT]W22W:4)NC
M=2"03QD9/?TK-U30=:UFZU_57T[R);C2O[-M;5I8R[9.XLQ!*]3Z]!TZ5WDE
MQ#%)'')-&CRG;&K, 7.,X [\ U)0!Y[;Z%K5N/ L;:<2NF[A=L)4_=$IM]>1
MU/'\ZT?"FCZAIGB3Q1=WUKY5K?W(E@D,BG<HW=0"2.HZUV-4M6TFTUO3I;"^
M1GMY,;@KE3P<]1S0!Q?@WPXECXQUIXKGS=/L)F2SC !6-Y55Y /3;@+^)]ZW
M/'^C7&O>#+^QM 6N"%DC0 9<JP;;R1UQ6OI&D6.AZ>ECI\(B@4EL9)))ZDD\
MD^YJ]TH X*XBUZ'4]"\2PZ+*SI:-:WUB)5,D:D@@J<X/(SZX'/MH>'-(O'\5
M:SXDOK22S-ZD4,%N[JS!%499MI."2!QVP:Z;[;:BV:X^TP^0I(:7S!M!!P03
MTZ\?6IP<C(Z4 <CK-KJ<?Q T74K73I+NU6VE@F='5?+W$')R?;_/2L"TT/5X
M]*\?1-IDX?49YGM5RO[P-N QS[YKTEKB!(FE::-8U.&<L  ?<U)0!Y>+3Q-H
MVI6VLQ>'(]36[TZ""XM2X5X)$&.^>,=\=_;GT'1OMATV-[^TAL[AR6-O"P81
M#/ W#ACCJ>.M7Z* /,-,M?$WAFZO]*@\*Q:I#-=R3P7KW"@!7Y&XL"3COG_Z
M]7_%>B:OXIDGT^:V>.+3K3S[6YB 47-WM& ,D[5'(Q^O%=\[K&NYV"KZDX%.
MH \WURW\0:YX?\.:E-I$PU#3M0CFNK1<!G"GEER<8.!W[TGV/6](\5ZC?+X5
M74[35=DRAGBWV\OEX*L3GC+$$],9(SR*])HH \_ETC5AXX\)ZA)IB1P6MM+'
M.MH!Y5N65@JCIP,@<>E8TWAW7+CPWXW@73)Q+?ZDMS:QN5!D7S@QQSUP*]9I
MGG1F/S/,39_>W#'YT <W-XIOK:YT.&YT"YA_M.4POF56:!L9&0N<\ D], 'Z
M4OQ M;R_\%WUE86DEU<3[$6./&1\P)//;BNB>"&2:.9XD:6//EN5!*9ZX/;-
M24 <%J>GZAK'BS1+DZ3+:P-IDT,\V%;R&D4@(W3.W_V;M6?X=L=3L+2STNX\
M$6KW]I((DU*18S&4#?ZS/WLXR<#J>>^*]-HH \]TI_$GA:;5M/C\/R:@+B^>
MXM;B*55BQ(<X<GD8^G^-4[C1KO2?&VLWMQX477+/4%CEC<)&YB<#E?GZ DG\
MA7IU% ' :YH::K8:?'=:#=V-Y;V[2V\NE,O^C2<XBR,?[/(XSGI5>ZT:ZU;0
M]&BU[3-2.IP69==1LW'G0RCHIQU) '/KZ=:]&)"@DD #DDTH.1D=* /.4/BN
M!O#$EY8ZA>+#:-]KB@D12TI.%\PDC(Q@D9Z]:P%T+7!X3TC3_P"P+N.:SUK[
M4\:[2!%DG@YY^]C\*]EHH Y3XB6"W7A&YNU(2ZTXB\MW/\+IS^HR*O>$;":R
M\/PRW@'V^\)NKIMI!,C\X.>>!A?PIVJ^&;35]2AO;N[OO+A50;1+@K ^UBP+
MIW.?Y"MI65U#(P93T(.10!QVII?6?Q/TW4(].N+FTFT][1I(0#Y;;]V3D\#I
MUQU]JP]%^V^%M'U3PO<:%?W<T\LYM7BC#PS(Z_+O?HOH<UZ=10!BZ#HLFE^$
M+31YI09([;RG<#@$CG\LUQ_A*YUSP[ID/A5_#=S/<V\QQ=E@+8HTA/F;O;).
M!SP.F>/2J* /*[B'4=.\2^-;(:1?7+:W;@6DL$>8_P#5N/F8X ^]^GTJ--)U
M*S/PZAFT^Y#V;R_:=L1819*XW$<"O6** /,]5MY=!\<ZG>WGAN76[+54C\EH
M;=93$R@*5.>@/7L/Z=YH:2QZ1 LMA#I[<D6D(&V($D@<<9QUQW)K0R,XSS10
M!Y;;6D\'C.VNM#M]5L)Y]1<:G9M&_P!F:(,<R!R O( .!S\W'3EMV^HVD'C/
M14T/49KG4[B::VD2+]TR,N,E^F< G'?@5ZI10!YAYFJ^%M<TO66T:_O+.;2(
M;.>*"(-)#(OL,GM[#GVJ_P"*;F^O-*T"X?1KJ%AK4-P;>*/S'CB0G)?;P"<Y
M_&O0** ..LC-_P +8U-C:7*PG3HXUG,1$;,&#$!NAX8?D?2JGQ'29KWPN\5K
M<SK!J:3RF"!I-B*1DG:#CK^-=Y10!P),\OB;QN@L;P+/IZ+%(T)"2%(V4A3W
M.7&,>]5M(\/S:S\&H-*DMYH;V*-VB25#&RRJ[,O4=^/P->CT4 <%$=;M_A]J
M6N"U8Z_?HLSP^3N*@84*$/H@)QZD\=JHZ+?RP^,K"^;2]<^RRZ2ULUQ=VY+;
MU<N2P'3@8' R<8%>ET4 >'K8W_\ PIBZL/[-OOM;:EQ#]F?<1D-G&.F >>G:
MNLDO)_#_ (^EU:>PU&ZL-2TZ)4>WMVD,++CY2H&1W///->B44 >(+8:C_P *
M9O;$Z7?BZDU+*0FV;<PRK9QC., \UW-Q</;>.="U V5Z]K<Z8;821V['RW9T
M(WC&4XZYZ?G7;44 >;>(=#N$\?Q6EJ4^P^)(P+]"O00$%B,=-RG;GU8UUUUX
MAMM.\2:?H+VEPIO(V,,RH/*!4$[?K@>G&14>C^&%TS4Y]1N-1N]0NG#+&URP
M/DH6+%4],D_D .@K5DTZVEU.'4'5FN(8VCC)<X4-U('3/'7K0!:HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$DTBJTI'8G 09'8_3&[H=_K5SX@UVUU".$V5M.JVLL:D<%0=ISU(!!)]2?P
M*^J^(=1E\2MX<T*.U^W):?:I9[LMLC&X  !>2>1^=9%SX]U+3]"UN2[TR)M3
MT>>**9(V;RY%?&''&0,9/Y5HZMH.J6GC"/Q-HBP7$CVXM;JTF?9O3(.5;G!X
M';M[UDZOX3U^_P!!\0RHMLNIZW-"7@$GR111@ #<1RV!R>!Z4 =AH=QK%S#-
M+J]K:V^YP8%MY2_R$#[Q('.:Q8/&%Q<-XL46D2G0P3&2Q/FX5FY]/N_K7460
ME6PMQ<(J3")1(JG(#8Y /?FN,U+P]K_]O>(/[-AT\V&MVZQR22R,K0L(RF<
M<YR3^5 $<OCW4&T_PQ+::9;R7.M^8!&\Q58V7&.<'CFI#X]N;+2-8FU.P@BO
MM/N8[58HIBRRN^,8)&>,DGV!JI%X,UBW3P2@%O)_8[R&Z(DP &*D8XYZ&B\\
M%ZSJ,GB4,]O;O<WL-[ILZN25=.,MCI\N/Q/M0!JV'BW4Y=<N]*N-*262.T-Q
M!);%Q'(P_@+.HP3P,]*S['QYJTEMHFHW^F65OIFJ3K;K(MR2ZL=V#C;C'R^M
M:>FGQM/')+J<>G0-#;.(H86+"XF(^4N<_*H]!ZG\,"?PAKTW@GPWI0MK<7.F
MWRS2@W'!52V"#CON_P#UT 2RK<ZE\9+VTGM[.YM8]+5&CN 2/)+J6P,'+98]
M>,=ZNIXNU9O#4WB#3M(LVT:#<8HVG*2O"AP6 VX'0X'M5NTT34XOB??:X\$8
MT^>R%LKB4;LC:<[<>H(K)LO#?B33/#=_X3CM[>XT^8O%;WSW&UHXI.I9,<D9
M/ Q0!=NO&VJ3ZG:VFAZ+'?"[TX7T3/<;"!GHW&!SQUZD<U-_PE>LWT6I2Z/I
M-O<?V:XAGB:<[Y)0 76/ P0,XR>N.E,L/#VIZ/XOTN2RMXGTJUTP:?)*\OSD
M9W;@O^\!Z]ZK6>A>*?#FLZJNC1:?/8:E<FX62=V#6[-U)'\7T]NU %G5?'4M
MM?/96UK;Q306:7-Q]MD91&S#(B^53\W(ZU9LO%.I:OI6C7>G:04-^S^<URQ"
M6X4XY(&26/W>F:HW>C>*=(\62:SHQM]0CO;:..\AN)/*!D10H<8Z=/U/M4FL
M:5XJNIM#O2EA>36DDDEQ:B1HHBQQL/.=VW'?O]> #G]<\0'Q-X4T35UL%^W6
MVNQ0B$/@%PQX#'H&^7D]*ZJR\4ZBOBM-!UK2HK22YC>2TDBN!(L@49(/ .<9
M[=C7/KX3\2C1;B%[6P^TQ:XNJ0I%,524;LE1D?*.F,]JWX-'U+5?%]GK^J64
M5D-/@>."%+CS2[/D$D@  8)% '):I/:WWP;U=[?2(M.B@O=D<*/O4$3H"P/X
MD=N_:NLU2_M+7XEZ):OI44EW=6TJI?%\/&JAF*[<=./7^(_C@+X4\1O\.=6T
M.6U@^UW5[YT(\\;5C+JYR<<G*G\ZW-3T75KSQ]X=UD6T?V6R@=;@B49#.K*0
M!W R#GO0!3\+^)=>U'1?$>H/!#>/:W<R6T08H245<(!CICG.<Y)JW:>-;B_T
M#P_?6EG!+<ZI=B!X!-CRP Q<Y([!?3OWXR[PKIM]X:O-<@N+6"#2);R6\BNF
MN1D A>"/3C.21WK,\):%'!X_\0S0NQT^QGQ:Q!OD265%:3 'ITQVS0!Z'6)J
MNLW]GJ2V5GIAF!M9+@W,LA2)"O\ #D*<D^G'%1:)K.I7_B'7-/O+."*"QD18
M98G+;@RY ;WQ@]L9''<YNM:=XA;QS::A:VT5[I@M3#Y4EQY:1.2<NR_Q<<=#
M0! WQ&!\/Z'JD&DO,VJW!MEA\\*4?=MZD<\CVJS;^-I+=?$(UJP2SET94D81
MS>8LBN"4 .!R< =.XKE+;PIXECT/PW82Z4@;3=7-PYCG3'E;]V<9[Y.!ST&<
M5M:EX4U+6M4\90S6RPVNIPVPM9VE!#/$..!R.?7]: ,S6[O4-0\8^"+W4--@
MLS+<.T0CG\QBA"$!OE&""3TSUKM/'&L7.@>#=1U*TV_:(D4(6Z LZKG\-V?P
MKE)-)\6:MJ7AB>ZT:WM?[&FVRO\ :U82K\@+*!R!A2<$YKJ_'&CW.O\ @W4=
M-L\&XE13&"<;BKJV/QVXH X[Q3+=27?@*_N;*.;4&G!*128+G"$?,0,#/)XK
MH3X\2UM-:?4].-K<Z7+'$T*SJXE9QE-K8&,^XX'Y51N+7Q+->>#[I=$6,V#L
MMRIN4;RT9 A/49.W)XSSZU3U/PMKNIW_ (I:.V6W:>YMKJQF:1665HAC!'49
MZ\B@#H-"\8MJOB*YT6XLXXIX8O-66WN/.B<9'&[:.0"/UJUXK\22^%[&"]^P
M"YMGF6*5O.V&+<<!ONG(_+M4.@7WBS4;W?K.E6VEVD8/R+*)7E;MR#A5')]<
M@>]:FOZ1%KV@WNF38"W$14,1G:W9OP.#0!GWOB.ZM=5U*&+2Y+JUL;-;AG@;
M=([L3M15[\ G-)8^(KBZUZ+1-0TM;::>Q-W@3^: -VTHPVCGGW%9=OH.O6/P
MXN[6*=Y/$5S'ODF\P!R_ "[B>H0!0<]JSM&T_P 20>*]+U*7PX+:VBT]K*4&
M]61UP=VXGN21P.?<B@#&\/7=C8?!_59=1L#?6,>H,'MA)LR-Z;>>PW8KO)O$
M4D5WIVDZ5I7VJXFM!<,C3B-((L87<V"3D\#BN)B\+^(4^%.J:(=(D^WW5\)$
MC\Z/[FY&R3NQ_#CKGFN@N+3Q%I6MZ;K>GZ0M\)-,CL[JT,ZQR0LI+9W$[3R<
M<9Z4 <_I,]A8?#CQ9+J6DE[./69 ]@LA7:=T0";O8XY]JZAO$6HKXTT32+.W
MA_L^XT\7+JTGSKSCKR?E 'IG)YXKGY_#OB6Z\"^*K"7252\U'5#=0Q).AR&D
M1CSD# V]\'VK8ETK5[;Q/X<UFVT<S&/3Q9W:F=$,.<=>3G&6Z9S0!IV?C'S7
M\0QWEB+231AN=3-N\U=I(8<# ( ]>M;FDWLFI:1:7LUL;9YXED,)<,4R,@9'
MM7&>*/#TEWX\TN2UD;RM1B,6I0\%7@C96R?J<+^(]\]#J>NW>G^*=(TM; 2V
MM^'#7 ?E&4$XVXZ8QS[T 4/B;$DOP\U;>N[8B,OL0Z\TFM^-(]#FCL(+6*YN
M4M!<2++=I  O0 %NK'DX]!5GQ[8WVI^#;ZPTVT:ZN;@*BH'5<#<"3EB!VK!U
M+2M<M_%-OKD/A^'5(9]/C@GM'EC5H9!S]YN#CID4 :<?Q M+CP[I6IVUH\DV
MI7(M8;9I N),D'<W. ,=<9P1Q19>.GG.NQ7.C7$5QHRYFCBD64/G.T*1@G."
M>G K"\7)?SZ/H5C+HT::E->M<6]KI\JQR6ZH-QVN05+<\G&,GI4-C)JLOA_7
M+#3=)U.Q\272K<-+>2)YEPN\*Q#X4 A<@<#KZT =9I_B-]3OI=&U/3!97,EB
M+H1-.) T;94J>!\PP<CGZUPF@SZ?;?!*.;4]/DOK5+LEHHY"G/F?*21T&<#\
M:U=-TOQ"/&>G:M-X=DMK2+339,OVR.5U(W$,3D9))'YYS5:V\-:_#\'I] ;2
M9?[1>Y&(A+']T2+)NSNQC@CUSVH ZJ[\1ZA%\2K+P_%!$UG)9&XD8G#9W$9'
MTV]/<^U);^.8Y+?Q$\^G2V\VB9+PO(I:5<$@CTSCWZCDU3U*PU>/XFZ9KL&E
M2W%FU@+:4I(@:)BS$Y!/.,CI^%5O$GAR2Z^(%E]FE3[+JD(&I6[+D/'"RL#^
M)VK_ /K- '<:;=2WNF6UU/;-:RS1J[0,<F,D9P34&N:NNB:8UXUM/<G>D:PP
M %W9B  ,_6J.I>(+G3_%FE:0-.:2VOT?_2@_W'4$D8QZ#]?:JOC\:X?#8_L
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M0N;%K<&-.6VYSDY )R?I0!W]%%% !1110 4444 %%%% !1110 4444 %%%%
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MZK;"3&UA,^,GN!COUKN;[Q%-'JMQINFZ9)?W%K$LMQB58PF[.T MU)P>GYT
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M '(%7-4\7267B$Z'::'?WUY]G\\&,HB%<@9W,1QU&?7 [T =-17)6_C^PN]
ML=1M[6>6YO;@VL-DI7>91U!)(&T<$MV!'TJ8>+9%NK_3KG3)+75(+1KJ"!I
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M5[B S17!*[&QG('.>Q_P[U9T;6EUA]0"0/&MG=O:[R<B0KC+#VYQ^% &I16
M?%4(\1:EHWV"[::QM1=;E"XE7 .$R02><>F0<D=ZEMXWM[KPYI6L16%P5U*\
M6TCAR-RL6923VP-I/^% '545S-SXVLK;[;(=/U![6SNEM)KD1H$#E@O&6#$
MD D#OQFK4/B>VF\5S>'6M+N*[CB\X22!!'(GJOS9/Y=CF@#<HK-T/6%URP:\
MCM;BWC\UXT$X +A3C<,$\'^AKB+#Q&OASQ1XJMSIVLZBOVQ9O]%A\X1AHP3D
MDC SV],>E 'I-%<ZOC*QN+/39["VN[YM0C>2&&$('"IPQ(=E P>.M6_#GB*Q
M\3Z9]NL1(BK(T;QR@!XV'9@"<=CU[T :]%<SJOC?3]*FU)&M;V==-$9NY(47
M;'OZ#YF&3R#QGK6/XTU;[7J/AO3XK:\N[#4&::1+:01F=0A*KDLI'4-R1T[T
M =]17E-QIMLWC*V\%FSU"?1;?3RRPQW&"K22 F1CN&0N<8Y]E-=*/&^DZ1!;
M6PM=1?3HYQIZ:AM5XBZC;R=VX]#SMYP<9H [&BN;U7QG9Z9/?QI8WUZ-.17O
M)+94*P[AD [F7)P,\9QWJNGC"6Y\5Z1IUI8.]CJ&GB]$Y # -TZD  #KU/(H
M ZRBN4NO'^F6C"1K6^>P^U?9/[01$\@29P>2P; .1NQC@XS2>(_$D#Q:OHUG
M;W]Q<PV;M/-:[56VRIQN8L.>^!DXH T?$OAQ?$5O: 7L]G<6DXN()HL':X!'
M*G@]:ATGPS/9ZA'?ZGK5WJES"K+ 955%B#8R0JCDG'4U7^'$TMQ\/])EFD>2
M1D?<[L23^\;N:ZF@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IKL%1F8
M@*!DD]!3J9+$DT3Q2*&C=2K*>A!ZB@#R?PEH>L^(?AK8:3Y]BFD3R,TTA=VF
M"B7.Q5P .5SG)Z]*[;3=$U2V\=:MK-Q+:&QNH(XH40L9!MQC=P!_>]>U;&F:
M1I^C6S6^FVD5K"SERD0P"V ,_D!5V@#A;?PEKND:=?Z'I%SIZ:1=,YCDF\SS
M[8/]X #A\=B2/?-:&N>#(=0\"IX=M'"-;H@MI9"?E=.C$CUY_.NAO[^UTRQE
MO;V98;:(9>1LX49QVJ6WGBNK:*XA</%*@=&'\2D9!_*@#E?$WA*?4? *^'-,
MDA1T6) \[$ A""2< \G'IWJ+Q!X>US5[!]/>+2+NTDLDB"SN\9@N #F1"$8D
M=."1T^N>SHH X8>$=9M[KP@;>\M7BT2,I.\K-O?<H5@HVD8VC S@U-9^'=?T
M"YU>'1)-->QOYS<Q_:6=6MG;AL*JD..!@9'2NSH/ S0!P=MX'O=.UOPK<6DU
MM)::/;O%-YCLKN7#!BH"D?Q9P3[5-I?A_P 2Z59ZDBG2+B2]U5[R2.5WV21.
MN&0_)\IX!Z$5U>FZG9:Q9)>:?<QW%NY($B'C(ZBK= ' )H&J^$-$\17VC?9(
M9KB19K>S0-*D:J,$+P,LW88]!S7;V,EQ+I]M)=QB*Y>)6E0=%<@9'X'-6*IP
MZI8W&I7&G0W*/>6RJTT0ZH&Z9H XNW\(^(#X2;PM<R:8M@TC9NHI9#)Y9DWD
M;"@&>2,[N*UFT36=+\47>JZ.UG/;7L,:3VUW*T95XQM5E94;(QG@^M=556/4
MK*;49]/CN8FO(%5Y80WS(IZ$C_/4>M '"WG@+5&T33A;75FVJ0:J=3F\TLL3
MN3DJ" 3@<#ISSTK<M=%UB/QQ>ZY,UE]GFL4MXT5V+(PP>?EP1NW<YSC'%=11
M0!S_ (-TC4-$T#[%J9M3.)Y9-UL[,I#L6_B (Y)&.>@YKS_Q#!=ZWXLU6^M(
M]$NXK=UT\Q7=S);M\GS-D!U#C+8).0<# X->P5R>O^'?!-M,-6URRL(7>7'F
MRDJ)';U .&/4\@XY/O0!A1:;K.NSZ5XGT"/3M/O+-9+%K>=V>"2)&8#:RCD9
MSC 'UXJ_XA\.^*M>\*M:7%UIK:B]W'*%3<L$*+_=RI+'/)W>I].>WBBC@A2&
M&-(XD 5410 H'0 #H*?0!R.J^&M0U?Q+<7$WV>*PN=(DT^1DE)D0L=Q(!7!P
M>.O3GVJ/P_IOC33A9:;>76D-IEKM0SQ>89Y(UZ#!&T<  ^W3GFNRHH XKPSX
M<UG2[/Q/#*T$$VH7,TUI-')OVEP<$C'8X_7CUQ=,\%>(XH/"WG0Z=$VC7$K.
MHG8F17()8_*>>.G.<]J]/HH X:WT#7DM_&0EM[/S-59OLH6<X(*%.3MX(&/J
M<]!S5Z+3H(?AY;Z)XEFM+?\ T(028F  "J ""W<8!],^U=767K'AW2-?:V.J
M6277V9BT6\D!2<9Z'GH.#Z4 9'P\TJ;3?"5M+>%FO;P"XF9Q\W( 4'Z*%%0^
M(-%UZY\::7JU@EG=65M"RFWNI2BI)\W[SA3S@@#@XP>F<UV-% 'DZ>"/$J>%
M[#26M; O9ZNMV&CN"%9/F)P"O Y '?VK<U'PEJ6H^,]<NR(HK#4-):Q2;?EE
M8[>=OX'_ !KO** /.AH_C*ZL="T^YL=,2/2;R&4S?:FS,L>0I "G;QUZG)'
MYKM]9BN;C1+Z&S2-[F2W=(ED.%+%2!GVJ]10!YH?".O/X;\(61MH!/I5ZLUP
M#.,!5;((..<C\O>NDTG2]3M?'>O:E-#&MA?1PB-M^6+1KMZ=AR?TKIZ* .-\
M1:%K*^,+#Q+HD-M<R0VYMI[:>4IO0DD;3@@=3^G6M>PL]3U#2[V+Q"+<&[RJ
MVUN=R0QE<8W$ LW7)Z>E;=% '%:'X-O;7P1J.BW]VCW=TCP"<#<%C"[(QT'
M SCWJUX>'BZ..RLM2LM.@AM@$EN(YB[3* 0 JX^4_=R2>QXYXZNB@#E_!EGJ
M.D:3>IK%M%:,UW+<AEF#KM<[CD]L=*R?#FB6Z?$'6;JTG\VP@<31JF-B7$JC
MS.?XOE /7 W=*[74-/M=5T^:QOH1-;3+MDC)(R/J.14.D:-I^@V L=,MA;VX
M8ML#%N3U))))H I>+] /B;PQ>:6L@CDE4-&[= ZG(SCMD5CW&FZ]KXT6UU'3
MX+**QNHKJ>5+@/O:,<!!C(R3W[5VE% ' R>'=;;0/%>D?9(<:A<SW-K,)QA_
M,8$*1C@@5'<>&-8E_P"$&Q:I_P 2= EV/.7CY47Y?7[I->A44 >?:!I?B_PW
M82Z):6&GS6RSO]FO9;C'EQL>,H%RQ'/>M73]*U.#XD:GJ<MNO]GSV<<23;E+
M,RX[=0/O9_"NLHH PO&O_(CZY_UY2_\ H)KBH=&U<:;X$UFQL#=G3K?$MOO"
M-AU R,_G7<:OX5TO7+U;J_6X=A"8"B7,D:.A.2"%(SS^?&<X%;"(D4:QQJJ(
MH"JJC  '0 4 >:7OA[Q&WACQ? ^G1&74[I;BWBAF#-R1NR3CH%'ZUJ>.M*U;
M6?".EQ6FGL]Y%<PS2P"1?EV@@C.>>37<T4 >;^-M%O-<U"=5\.SO>Q"/^SM3
MMI54(< D298<!MQR <<>]75L_$7A[Q3<ZE#8C5XM3M[>.8QNL3)-&NW<0?X3
MR>,]?:N[HH \KNM!\2?\*PN=&ET=)+N2_+Q)#*K%$,GF%B3[Y''8_GKWMKXC
MT#Q=>:QI.D)J-MJD<2S0FYV-%(N>22#\O)Z>M=[10!Q>L6^OK>^&-4?3TOKJ
MTFG-S%;.%5/,0J,%NH7.">^/>J\^BZCJ7C#Q/#-8RPZ?J.G+;QWFY<;@N.G7
M^(_]\UWE% 'G#6&N:SX/M/"5[I%S;RCRX;B^=T:$1H02RG);<0 !\O4]:GM=
M*U6R\6>,+X:9.\%U:(MJ=R_O66,+@<]S_D5Z!10!P.F:OK/ACPEX;M;C0)'=
MY%LYU$R[HOFVJ0/XB1SC/'<]ZZCQ+]I_L"Z6UTQ-2=P$:T=]HD0G##/KC-:4
MEO#-)')+#&[Q'=&S*"4.,9!['%24 >967A_4M/T[Q+!I.GWT.F75AY=MI]U*
M"PF<$-LY.  >YY/KUJW+IVK?8O 42Z5.?L#1_;.5S"414Y&>0<D\'H*]"HH
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M32H9IC)%;[0LFT@?-(!P&)SP,X&*VJ* /,O$\NNWUWXGTJ?1=3O+>>W5-/:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JC=:-IM[?VU_=64,UU
M;9\F5UR4SZ?YXJ]10 4444 %%%% !1110 4444 %%%% !1110 UT62-D=0R,
M"&5AD$'L:J:7H^G:+:?9=-LXK:'.2L:XR?4GJ?QJ[10 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-PMU9NYC<AE4J-PX/S9Q]* .EHIOF)M#;UVDX!SQG./YTK,JC+, ,@<GN>E
M"T450EFU$ZK9"VBMGTQT<SRESO!P-FT=".OKU[8Y +]%%% !17.>+_$<WANW
MTV2&".8W=]':MO)&U6R21COQ71T %%%<//\ $%=,\=R>'=7MHX(GV_9[F-RP
M);[H<8XST]C[<T =Q17/7^NWUGXRTO1EMK=K6^CD<2F1MZ[!EN,8[C'/K70T
M %%5&U.R754TLW"?;7B,PA')V @$GTY/>K= !12'.#CKVK&M=9GM-"6_\20P
MZ9+Y@1D63S%&6VKR/7(^E &U17/3>(+J'QW;: UFGV:>T:X6XWG)()!7&,>G
MYBNAH **K7VH6NF6WVB\F$46]4W$$_,Q  X]215F@ HHHH **P]2UV:Q\5Z)
MI MD:'41/F8ORIC3=@#\OSJ[IUSJ$\UZM]8K;1Q3E+9A*'\Z/LY Z?2@"_11
M10 4444 %%%% !1110 4444 %%%4--O+R[>\%WI[V8BG,<)9U;S4P,/QT[\4
M 7Z**BN;F&SMI;FXD6*&)2[NQP%4=2: ):*S-1U*\MWTXV&GF_ANIU261) !
M#&1GS/<?Y[UIT %%%% !1110 445"MW;O>/:+,AN(T#O&#\RJ<X)'X&@":BB
MB@ HHHH **HZ3?SZC:R37&GSV++,Z+'.1N90<!^.@([']1@F]0 4457ENU6W
MNGMQ]HEMP08D/)<*&"^Q((_.@"Q1533+J:^TRWNKBTDLYI4#/;R'+1GT-6Z
M"BBB@ HHKF[GQ8PUJ33M/T>\U 6\R0W<\)4)"6&>YRV._0#UH Z2BFO(D>W>
MZKN.U<G&3Z"LFW\1VMSXJN_#RPSK=6T G9V"[&4XZ'.<_,.U &Q16;K&K-I*
MV;"QN;L7%RL!$"Y,>[/S'VR/UK2H **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MUY]BFG,['>N_=G.,[>G _*M";PQ9SZ[I^L//<_:K"%H8L,NW!&"2,<G!/YT
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MXI_X24P)J U"19'D<+);Q*!LV$_= PW(].<T =U=:T;+Q%9Z9<P!8+Y&^SW
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M)TWQ'=QWTDUW::A$FR.ZMIBK*.2!CIU)]_>F> -1O=1\*QO?RM-/!-);^<P
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MZUN.-A>W,2PR,3QM7T';MGZ"M*B@#(L_#T%GXCOM;6YN7N+R-8WC=AL 7I@
M=NGY^M2PZ'8P:_<ZW'&1>W$*PR-GC:/0=N@_(5I5@:CXH33O%NE:"UG(YU!'
M9;@, J[03C'<\?J* *%[\/M.N]8GOX;_ %*R%RQ>Y@M+DQI*WJ0*Z6XLHI]-
MEL 6BADA,.8CM9%(Q\I[$#I6=XI\1Q>%M%;4Y[:6XB61498B 1GOR?7'YULH
MV]%8=",T <Y8>#X[>_MKR^U.\U&2U@:"W%P5PBL,-G !8D<9-9D7PPTJ.T2S
M?4-3DLXIQ/!;F<!(FZ\#'N:[>B@#DM3\ 6.H:S)J4.HZE8/<$&Y2SN#&LQ P
M"?>K_P#PBMJGB'3M6@N9X?L%J;2.V4CRRF"!G(SZ=_X16]69I.JSZE/J,<VF
MSV8M+EH(WEZ3J/XUXZ&@"OX<\.)X=2^5+VXNC>7+7+F?&0[?>/ '6MNBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *R/%)NQX5U4V(S=?9G\O
M&.N/>M>B@#R?PTOA6^M_#3-K%Y/J=J8O*LD*YCD& P(" [1@Y)/0=:J:Q/I]
MCX]?Q#;6BR^'TNH[:_D1U,9N0"0^T'D+N7.>-V>]>KP:3IUK>27EO86L5S)]
M^9(55V^I R:8-$TH6,EB-,LQ:2-O>#R%V,WJ5Q@F@#@M?M])OOBYH1NXK*>U
MN-/=F,JJR2_?VGG@]L5SE]#:P>#?'+0JHTE]0C6Q6'A-X89*]L?=Z>E=KJWA
M.>]\=Z7>#2;*;1+6U^S-"[+C!SR$(Q@9''M76RZ1IL^GK83:?:R6:8VV[0J8
MQCIA<8H \^U:TL-4^)_AF"ZAM[JVETMB4D4.K?*Y!]_454\2:GH\?_"9Z;!;
M6ME)#9PPEI)</.P7"+&IX"J!V]J],&D::MS!<C3[43VZ".&40KNC4# 53C(&
M.PIMQHFDW=R]S<Z99S3NGEM+) K,R^A)'2@#@]+U&T?Q%X/NK^Y@WW&A[?,E
M8#?+E.,_WL@_C6/=+<)>_$U--4"9EA.U!R0=WF8QWP6_$UZF=!TAEME.EV16
MUS]G!@7$6>?EXX_"I+?2=.L[R:\MK"VAN9\F6:.)5>3)R=Q R>>: . UDZ;/
MX<\)3Z2UN+];FV^S" *'*XPXQC.,=1[#-84FEZ5=:1\1;^^AM7EBOIA!*P'F
M1MDE<'J 6('!YY%>KVF@:-I]T;JSTJRM[@Y'FQ6ZJW/7D#-..AZ28+F#^S+/
MRKIM]PGD+ME;.<L,<G//- "Z*V_0M/;=NS;1G.<Y^45YIIJ:=<?"+5_MT4']
MK*+EKHRA1*;D,Q4^N?NXKU6WMX;2WCM[>)(88QM2.-0JJ/0 =*HR>'M%FOOM
MTND6+W>X/Y[6ZE]PZ'=C.>* //+/2[/5O&FAV^OV\%Q<R>'@9HY>29,\$@\[
MMN??J:[OQ)!%#X*U:".-4BCT^940#A0(S@ >U:#:;8MJ*Z@UG;F]5=BW!C'F
M!?0-UQR:L21I+&T<BJZ."K*PR"#U!% 'E6I7,?V;P&#J-O9:<;<@W/EK*J3B
M)0-P(*@Y)Y/0Y/:H]7TG1[#X?:]%:ZM%J:->P3L551'"[2)G9M^494G.WH.*
M]);P]HK6"V+:38FT1]ZP&W78&]0N,9I3X?T8Z>-/.E61LE?>+?R%\L-Z[<8S
M[T >?>.]!T2P'AJ*PT^TBAN=7BWK&@VR*0 ?J" /:G6GA[0Y?BKK%B^G6'V*
M/34<6WDC:&RN7 Q@$9//!^;ZUZ%<:+I=XENESIUI,MMQ )(581=/NY''0=/0
M4#1M+%Y->#3K47,ZE)9O)7?(IX(8XR1]: /&H9UN/A;X5>?[\&M+%$P'1=S$
MY)[?X"NIDTK3]6^,^IPZE:07,*:4KA)E# '*#//?!/-=L?#6A-9K:'1K VR.
M9%A-NFP,1@D#&,^]6#I.G->2WAL+8W4J>7),8EWNN,;2<9(]J /+M#NM._X0
M3P7%=A99_MDGD>9/LAC=6?F3UP",#KR!D9K,UDQ?\(3XUACD@?9K2N!" % +
M+R "<#J/SKUK_A%]".GQZ>VD6;6D<AE2%H@55B<D@'_...E+'X9T.**YCCTB
MR2.Y4),JP*!(!T!&* .8U^.S/B3P/<)*@D6=XT56&-ICYX^H _&LS1;+0M5A
M\6MK=K:RZC'?7 >2Z1?,2/'R%2>5&!P1BNY_X1?0MUD1I-HOV)M]MMB \HYS
MD8]^?KS3-1\)Z!J]VEU?Z3:SSJ<^8R<G_>Q][\<T >9:38QZL_P[AUN%97DB
MNPR2G)>)5W19&>1P/KTKK/ %I::?K7BRRL=JVT6H#8BG(3*\@>F#D?A75S:'
MI<]Y9W<MC"T]D,6S[<>4,8P/Z>E+8:+INF7-U<6-E%!-=L'G=%P7//)_,_F:
M .7U>.T_X6QH4DZ0[S83!6D R2#QC/?EOS-86F6&BZWX2\276L06\^IP7%R)
MI[A0)HBOW!N/*@ *!CCMZUZ'?:'I>IWEM=WUC!<3VQ)A>1<[,_Y_"JUWX2T"
M^O7N[G2K>2:0@R$K@2$'(W <-SZ@T 5O <UY<>!M(EORQN&@Y+')*Y.TD^I7
M%<+H?V>+P'X\MXHH(?*GO$4(,';MX&/0=!BO6U4*H50  , #M60WA707EOI&
MTJU+WR[;EMG,@R#^'(!X[@'K0!YW]C@TKQ#X#GTJVBAN+JQ<2M& /./E*1N/
M?D]35+1-(TW6/#-OJM]K=K9:E;WIGN9_)'VA7\P_*6#9P>W'IQ7JH\.:.'T]
MA81[M.&+0Y/[H>W/L.M5SX-\.'5#J1T:T-V7\PR%/XO[V.F<\YQUYH I?$6Z
MO;3P)J<M@#YOEA6(&2J$@,?R)K$T'PWI%OKVCZM9ZO8(LMJT2VEK$$^U H2=
MV&.[ Y.1U S7H,L4=Q"\,T:R12*5='&0P/!!'<5C:?X.\.Z7)+)9:1;122J4
M9@N3M(((!/0$'M0!YQIUKI.E?$%8GA#>'+B]+Z?*,>2EVJX(SW .0.V0/3CH
M!#90_$3Q1<100?VI%I\<UH=@+AO+8,5'<_=![\UU$WA#0+C2K?3)=+A:RMV+
MQ0\@*QSD\'W-3MX<T=]7AU5K"(W\*A(YSG<  0/KP<9- 'E_AW0K6XTK1->3
MQ+8VTD<XEFDAM<7,DKM\T3ONR>NW&.G.,5'/I-CJ)^(MW>0^9/93-);N7(\M
M@'P1@^PKTNV\%^&[/41J%OH]JET'WJX7[K9SD#H#].E3/X6T23^T-^GQD:@0
M;L;F_>D'(SSZ^E '">5'?_$+P=-?(MPCZ,'WSC<&D"ELY/5@2#ZUU'Q()'P]
MUC!Q^Z7_ -#6M23PQHLJ6"/IT++IXQ:@Y_=CC@>W X-7;^PM=4L9;*]A6:VE
M&'C;.&&<]OI0!YCI^E66B^)/!]U80B.ZO-+F:0LY)FD$2D9R>N2:S_#NB)K-
MA8^(Y_$5G:7Z77FW$SQG[1O#D;"QDQ@C  V],5ZDOAS2$N;&X%DGFV">7:L6
M8^4OH.:KQ^#/#<6IC4DT>U%V'\P2;>C==P'0'//3K0!R5GI^A>)1XI.MS0?;
MH]0FB\]V DMHD.(RN?N\+U'7'.:RKG2O^$M\5:UIUQJ5M''9Q11VBW<#/MB*
M</&0ZC)SDD@YXKT.]\&^'=0U$ZA=Z1;2W1(9I"OWB.Y'0_C3M4\(^']:N5N-
M1TJ">95"!R"#@=!P10!QNK:-?)::'=0FW\4PZ? \5Q:2D9F4G'F*"2,@KC/)
MX[U#J$::OHWA_6-%TU-1TRTLWC?1;AQYGE<IO7).6&W&<$FN^?P[I3>1BT$?
MD0F"+R7:/;&>J_*1Q4'_  B.B+):R0V?D&VA-O']GD>+]V<DJ=I&X9)//<YH
M YJUGT'5QX12WMYY;>2"7[/9RD%%10%9G+'YBI&!USG\:Y.^:4^!M(A-Q(I3
MQ(T'[F9L*NY^%.<X].]>H7/@_0;N.PCDL%"6 *VP1V78#U'!JNW@+PR;=H!I
MB)"TXN#&DCJN\< @ X'!(_&@#F/%/A?3O"4-AXDTFS<_V==B:XB:1GWQL<,>
M2<$'!'UKHO!\27\FI>)3'M?5)LPL5P?(0!(^.V0,_B*/%9U>^C;P_I^E>9;7
M]N8Y;]Y@$MP3M;*]2<'(Y[^QKH[2VBLK.&U@0)%"@1%'0 # H XV]L+.?XQ6
M,DT$;N-*:12XSAUDP"/< FL+2=*L?$NA^)-7UA3'J\-S<CS6F;=9[5^4  C
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MF>>[6X^9660@(1G & H  ':NKTCP#X:T/4AJ%CIP2Y4DH[2,VS.>@)XZTB>
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MD2ZU!(4LA8M"EP0LD0SC=CG(R1D$<&MNSLK?3[&&RMHQ';PH(XTSG"@8 YH
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MGY?EXQQ6KIND1:9-?2QW%S*;R<SN)I-RH3V0= /\YH T**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"*XN8+
M6/S+B>.%,XW2.%&?3)H@N8+J/S+>:.9,XW1N&&?J*XOQ[HNL:G=6-U9Z78:K
M:6B.39W+E69V_B'0' & ">K=#6IX%O=,O_#BRZ9IHTY!*R36H7&R48#?7MS0
M!T;NL:,[L%11EF8X 'J:$=)8UDC971@"K*<@CU!KBO&MW=:K9:MI-D[Q6MK9
M23WMU&W(8*2L/X]6_P!GZUN^$/\ D2]"_P"P?!_Z+6@#:HHHH AN+RULPIN;
MF& -PIE<+GZ9J2.1)HUDB=71AE64Y!'L:X#XQP12>!_->-6DCN8]C$<KG(.*
MT-3\43Z+XCMO#&D:!]ID:S\Z$+,L2* 2 .G &T_X4 =C17 :EXQUB?P9'J5E
M9QVMZ-26SG1I0ZQXDVG!QSDX'3C)/:KGB3QR^@WL=@MO8O>+;"><3WHA09X"
MH6&6.0>P[>M '9T5PC_$A&\.:+JMMI<DTFI7/V7[/YH4J_(P#T/.,9QP::?'
MFMQZG::3-X3=-2NHWDBA^V)C SR3C@<&@#O:*X5_B'+!HNJ7-SHKK?:7<1PW
M=HMPK8#G"LK=P3QTIU_X]O-*MD_M'0Q975Q*4M([B\1$=0@8LSGA<9QCU(H
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M)?W]REL+A3#L"LIQ@Y)Z=NF<]JSQ\2D.FV^J-H&I)II<1W-RX4"!]VTC&<L
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M=4N;MKF>.20I&ID;+!3W X SUZ^U=910!Q^N_#_1=2L]2NDTW.JW$+LK"YD
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ME#<6#6#1M:'48U2*=F.2_P#>^7 Z$<G%;?\ P@?A7_H V/\ W[H_X0/PK_T
M;'_OW0!P,&CZI;>$_#2FU@:_T34B_P!G%Y'^]B+%BV<\<X&/QKHIFNK_ ,=+
M<3VL<-C/I#6<TPNXV\LLVXXYYP>.GO6Y_P ('X5_Z -C_P!^Z/\ A _"O_0!
ML?\ OW0!P_V75XO!C^!TL(&4EHUU+[;'Y6PRE]Q'7..U;>FQ2Z7X]E>**-].
M328K6*Y-PF&9,$ \YYZ=.U;O_"!^%?\ H V/_?NC_A _"O\ T ;'_OW0!0^'
MI?3/",%IJ7DVMPDTI*-.C<,Y8'@^_P"E9UI+=>%O$^NS6UFM_I^IO]IA:"XC
MW)+CYE8,W )/7MZ=AT'_  @?A7_H V/_ '[H_P"$#\*_] &Q_P"_= '$W6FW
MND^%-(M;2VANKIM5&HWL<5RAV$-NV@EL=,+QQQ^?IIU*T$1<7$);;G9YJYSZ
M=<5D?\('X5_Z -C_ -^Z/^$#\*_] &Q_[]T <YH>C:=X@GOM9\4V,46HRW9\
MJ.2ZX2$*H1<*V".O4<G-5/#ID\,P>*-*GM(SH2":XLWENEPZXQY><D@$<Y^O
MK77?\('X5_Z -C_W[J.?X>^$[B!HFT.U4-U,8*,/H1R* .)\,QW>D1Z"^KZ)
MK1AM&"0S2S1O'"TN%R$ W8R1C/2M?0M/D&L>-8;YC9PZG*?)F\Y 2/G&1@Y!
MY!K1L?A9X9LIA(\5U=A<;4N9RR#\!@'\:G;X9>$6GEF.D*6E^\/-? YSP,X'
M3M0!S_AB[U*QMM-TFZ\.Z>);-UC.H27,6T1J?O+U;=@G'UJKIEIJ7A]+W18O
M#UEJ\9FDEL;V66+:JL<_.#S@%03CTKI'^%7@Z21G.E$%B20MQ( /H W%+_PJ
MSPAA0-,<;5*C%S(.,G_:]Z '6EMJ<?Q'OK]]/<VC:8D*SJPVNZD,0!U[D?A7
M/OI&MS_"2]TEM'N$U![PE(-RDE3,)=V<XQC(^HKH?^%8^%?^?*X_\#)O_BJ/
M^%9>%?\ GSN/_ R;_P"*H QKG3=2TOQ3J5Y_PBJZU8ZF(I]K&(M!*%(*_,/?
M_.35NXTW66\8^$K]M,\JUM895N(;5@8[8NI4#J,XR 2!V./2KW_"LO"O_/G<
M?^!DW_Q5'_"LO"O_ #YW'_@9-_\ %4 8MQHVL7GA7QG8KI<R2WE^US:AV4&5
M24X'/'W._J*[$:KJ3W6EHNB3K#=*QN7>10;4@< @9SD^E9'_  K+PK_SYW'_
M (&3?_%5OZ/HMCH-C]CT^-XX-Q;#R,YR?=B30!H4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!DZOK::;<6=E#
M;K4+QB(+<-MRH^^Q;& %'/\ *M:N,B:*3XP7 EF?SHM)401XX*F0[^W^[W[U
M@>*C;2V'C&]M+B^N+JU,2>=*^Q+9@1E(L<Y&>>.XY]0#OIM96TUV#3;J'RDN
ME)MK@N-LC#&4(ZAN<@=Q^(K4K@?B)<2)X6T.\MFWSKJ%L\3CYB3@GCUS^M=]
M0 4444 <WXS\4R^$M*CU%=.^VPF01R8G$93/0]#FKFN:O=Z-X;FU0:>MQ+!'
MYDUNMQM"J!EL,5YQ].:YKXP?\B%)_P!?,7\ZWO&\J1>!M;9V"@V<B@GN2N /
MQ)% &Q9RSS64,MU;BVG= 9(=X?8>XW#@X]:SO%&MOX<\/7.JK:&Z%OM+1"0)
MP2 3G!Z9]*YOQ7IW]I_$#P_9R7M[#;W%M<"2.WG,8.T ]O7.#[ 5S$5Q.WPO
M\9V4D\LL5E?200>:Y9E0.O&30!Z];2M/:0S/&8FD16,9()4D9QD<<5+7DX;4
M=:UW2M)CE@D2+0(9XX+B:6-7=MH+DISD"KM[I/B&P\):7#++%K=SIUVSW%M#
M<.#+$ <+DG+%<C@CIC@]P#TNBO+)VEU7PAHUWX<@O=1T^TNY'O+&><B?')*;
M@P)"[N!R?N^^>O\  U]I=]X<#:0]V;>.>162[R9(G)W%">^-PQUX[T =)4,U
MY;P7%O!+,B37#%84)Y<@%C@>P!-<%I=JOB[6_%2ZJUR/LEU]EMA'.Z>4@!PR
M@'&3@'.*P]!GF\1/X$O-4::2?S+J R>:REPD9*MD'.[('/?% '?Z3XG.I^*=
M8T1K%H&T[8?-,@;S PR#@#CCW/X5T%>5C1AK?Q"\:V_GW,3"& H()S'N;RQC
M=CJ,]JH6U]J^NZ!X-TH7>3>PW)E\RY>'S?+8JH9UR3QV[F@#V.BO*]6TO7=
M\ 7%O>:U*)X]1B:!K2Z<M'&S!0A9@#@9)'T!J;Q'H \&'3->M]1U2ZM[:^#7
M:7-X6&QS@D#C.#CZ]\T >G5GS7]W'KEK8QZ;++:RQL\EX' 6(CHI!ZY]ORKR
MVVUR6VU/Q-80W5Q-'KD0_L9I9G82%BT9*DY(Y/4XX0=N:Z*X:\TGXB^$=(BU
M"[:T^PR1RQ-,2LI2)@&8="> <XH ] HKR_3KE])\8)!XC348=0FO96MKZ.<M
M;7*L#MC(/0#@  <$#I6=I.F^*O$UA#XFM-9MX+AY6D,KWLH6- QS$8]I4**
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MX,>'+]\\C.,=\UZ'0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJ,A>,X901C(/K7,?\*]TS^P-/T;[;J/V:PN?M4+&1"V[DX)VXQR> !UKK:*
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M+B?;YMS>S>9(P7.T9P.!D\51UGP58ZQK"ZLM_J6GWWE>4TMA.(BZ]@W!S_\
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MJ!6#HFH3S^#=$TJXN95LI];:RF97(9XOO!"PYP2<?3B@#V9F5%+,0J@9))P
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M;(4$<<P9@RJ!@ '/H:NO?V<=S%;/=P+/+GRXFD 9\=<#.327.HV5FZI=7EO
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MNKQ1_*,/G=C'3.3TK*_X070#I5KIAM93:6LWGPQFXD^1_4'=G'MTKHBP49)
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MOJ-W9ZE;0B!;R,@L\><E7&-K<\]*LW?B!;3Q58:$;.5C>0O*LX8;5V]1CO\
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MI*TACC(&U26&>.?PQ7*>,99W\77EKJ4VI1V7]FF3319^8?WX(^;$8)SDXRW
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(SC4EF>">6*+RX6"LYWAMI)X (4Y]LT =+%<0SAS%-')Y;%'V,#M8=0?0^U
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M*WU#1V,J*^7D&&8,Q'\1P#[=*R+/0X?^%='Q&9Y3JEKJ>Z&<3L653.J%2"<
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M)<Q'3[^VE/E1 <E&0<8;!!R"?YT =EI/B>/5O$>KZ.+.6"332H9Y&'S[LX(
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MD?VM@2DNX*,8  'S=!Z5:T"#QC_;&CZC+/.^G2QC[89[Z.6.7>.&C4 ;>2"
M/;WR >E4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
MV2-)8VCD4,C@JRGH0>HIU(2%!)( '))[4 9'_"*:!_9_V#^R+3[()?.\GRQM
MWXQNQZXXJ6_\.Z-JERMQ?Z7:7$R]))(@6_.G#7]&,D48U>PWS';&OVE,N<XP
M!GDYXK%@\17A^)&H:).\"Z?;Z>+I6VX93E0<MGIR: -J]T#2-26!;W3;6=;?
MB$21 A!Z#T' I/\ A']'^PSV(TRT%K.^^6$1 *[<<D?@*?\ VYI @@G_ +5L
M?)G8I#)]H3;(W3"G."?I4ESJNG6;,MU?VL#+C<)9E4C/3.3WH K7?AO1;ZUM
M[:ZTNTF@MQMA1X@1&/0>E+/X<T:Y@M8)M,M7BM/^/=#&,1=/NCMT%3/K.EQW
MJV3ZE9K=N0%@:=0Y^BYS6$GB#4/^%F2^'W$!L?L N8R%.\'(')S]?TH ZEL[
M3MQNQQGI7DH\&:O/+-%J/A'3+Z[>>64ZDU\T08NY.2J?,0...OTKUNH+F]M+
M, W5U# "0 99 N<G Z^Y H R5\):1/IMA:ZG96^H2VEND FN(PS$*,=?U_&K
MKZ%I4DMG*VGVYDL@!;-Y8_= =-OITJU)=VT.WS;B*/<,KN<#(IMO?6EW:"[M
MKJ":V.2)HY R<=?F'% %6#P]H]L;KR=-MD^U@BXQ&/WH/7=Z]35>V\(>';*Y
MBN;;1K**:)MT;K$ 5/J*R8O%TEU\0K71K.:RN=,GLFN%F@;>=P)&-P./X3^=
M=5<W5O9Q>;=7$4$>0-\KA1D]!DT 9P\+:"NH_P!H#2+,7F_S/.\H;MWKGUJQ
M!HNF6VIRZE!8P1WLP(DG5,.V>N3^ JR]U LZVWGPBYD0O'$S@,P'4@=2.G-9
M^A7&H?V29=;N;![A9&W/:L?+"YX!)[T .MO#>BVDT4UOIEM')$Q>,J@^1CU(
M]"?6K&J:58ZU8/9:C;)<6SX)1_4="".0?<5/%<V\X8PSQ2;?O;'!Q]<40W,%
MQGR9HY-O78X./RH Q5\$^&D+E-'ME+PF!BH()0C!'7KCOU]ZF7PGH:Q:?&NG
MH%T]MUKAF_='V.>?QZUJRW$%OCSIHX]W3>P&?SH\^+SO)\U/-QG9N&['TH Q
M;SP5X;O[^6^N=(@DN)@1(W(#YZD@'!/OC-:UE96NG6D=I901P6\>=D<8PJY.
M3@?4FG17=M.Q6&XBD8#)"."<?A2BZMV95$\19B0H#C)(ZXH 9-8VEQ=074UM
M%)<6^?)D906CR,'![9JI=>'M*O=8MM6N+0/?6PQ#+O8;.O8''<]JO0W5O<$B
M&>*0CJ$<''Y4D5W;3.4BN(I''.U'!- &-)X)\-2ZM_:DFCV[7F[>7(."V<Y*
MYVDY[XI^J^#O#VMWJWFHZ5!/<+C]X<@MCINP1NZ=\UN44 ,AACMX4AAC6.)%
M"HB# 4#H *BEL+6>]M[R6!'N+;<(9".4W##8^HJQ10!C:SX3T/7[B*XU/3TG
MFB7:DF]D8#TRI&1]:2?PEH5Q)82/IZ*UA_QZ^4[1B+G/ 4@=:VJ* ,.^\'Z%
MJ5Y<W=S9LTURH6=DN)$$@ P P5@#Q3;OP7X=OKR*ZN=*ADEBC$2G) V 8 *@
MX( ]16]10!R6H?#_ $>XTVQL+.!;6"VNQ<C#.Q'0L%R>"< <Y YXKI;^PM=3
ML9K*]A6:VF7;)&W1A5BB@#F[;P#X8LYX)[?2ECE@8M'()9-RGZ[N?H:D'@GP
M\-).EC3S]B,PG,7GR?ZSINSNS7044 8.I^"_#VL7*W-_IRRSJ@C\P2.K%1TR
M5(S]35[1]$TW0+(V>EVJV]N7+E Q;+'&3DDGL*T** .>FT:YLO%HUO3D1TO$
M6WOH2=O )VR@]R.A'<>].B\&:+#:ZI;)#/Y>IG-SNN');CU)SZG\3VXK?HH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *;(JO&R
M.H96!!4C((IU-E+B)S&H9]IVJ3@$]AGM0!X/866EO\$[N7R+9M4:Y'E-@><6
M\U  O?IG@5W.G,A^+)@NO+-R?#Z1W 9@?,DWJ3G\.WH*=\.O!_\ 96AJFN:#
M91ZC#<%HYW6.60C@@AAG&#P.>U=FNDZ<FI-J2V-LM\PVM<B("0C&.6QGH *
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M L')?) 5 /7)')ZYK7M_%ERFMV6F:MHTNGM?(3;R^<)59P,E#@#!Q0!T])D
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M&RN,D#!XX]!6UK5W81>,- M[BZU".[D,OD10G$,GR\^9QSCMCUH Z6BN0O\
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M$@#!]@*Z*B@#RS3TNK&'XA6,^GWOFW4MU-"5MV975U;;A@,<Y'%)%,]KX8\
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M55F<<6SL)R90V[<!CIQ^ KVFB@"GI5P+K2;2<1S1[XE.R9=KCC^(=C5RBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&)",5 +
M < G&:6D?.QMH!;' )QDT >::?\ $/7KS2[+6WTBQ32IKT6L@6=C+\S8! QC
M SCW]!4_B'XBW=GK-_9:1!9R+I^!,+A92\SXR5CV @8QC+8Y]JS/^$&\1?\
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M]JQ[/0/%%CX1O?"*6=M+;N9(;>_>X 587R3N4#<6&3^)]!R :=[XRU5O$O\
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M>N*YU(KG4/ASXM>R@G>3^VFF"*A#JH*DDCJ,#KZ4 >M/XET^+Q(-"E\Z*[:
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M$L88UVJ OJ2&;_@5=5H6LVWB#1X-4LUE6"<$J)5VMP2.G/I0!HT444 %%%%
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MQ@DC;C)Z ?4]Z .X>:*-T1Y45G.%5F +?3UIL5S!-++%%/'))"0LB*X)0D9
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M=(ZHO3+' KSSXE:7>7^JZ"-*NS:ZE(THB?S64,47>J\<9SGGWK)UWQ';>+/
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M9PQ&0/N_J*S_ !7-JMW?>*=-FT[4IXI;1!8BUB_=L ,EF8'D[N,<\#I7J%%
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M] =PX]Q^HJ'PYX6:VMKN37[;3KS4+FZ>=YD3S 0V,#YQD8Q@#I@"L2TTK4O
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M9XE^VV;#_7R)D1L>.<9[_P!T?@OA#PM>^'='U"VEN@]S*[);R$E@D2@B(>H
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M2N"3@8/%;%SX.UFSU:T2PL["^LX=+%E%)>RG%N^"&8+SU[X'XB@#3N_&U_\
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M+*;3KZQNEM1=I%<(I,D73(VD]\#!P>:Y:^L]=EU;Q+XGTBTN[>=K&.VLTEA
MDD.Y2[!#Z!>,CG-0:0^IQ^.M.U1_#FM+"VFFUFFN3ND9P2VYN?48P<=0<=*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBD+*#@L!QGD]J %HI%8.H92"I&00>"* 0P!!!!Y!'>@!:*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&EB#)M;R5)$9/U'/X^]'C?PGJ/BZ""SAU2*TLD8.\;0;S(XZ$G(X'I[UUU%
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M1$57&T *HSQC YYI-!T:\TW6-<N[J2!X[^Y$L(BSD*!C#9[].E;]% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
=110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>a123121ex-1021014.jpg
<TEXT>
begin 644 a123121ex-1021014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB?/>3)LMM:MDC2<MQYZ<;/8E<8^GK7-ZEX*\57=KK]F(-.E6_N_/2ZFG8RE
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M(UMIOL\L4,ZNX7.UCNR.O7N*GD\&^(7T#0 E_81ZUHC;;=UW^4T6T+ACC.<
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MZ+K/B^U_X1_4;LZQ(S6LUNBF+!#@;G) 7K]: .BO?B!9166GS6-I)>37UO\
M:8X3-'%L3(!W%FP#DXP,]#Z5F:OXL\/ZYX4TG5KRRO9;=M115CB8*T4ZY'S$
M$9&,GCKQTK';PYJGA0Z%<'P^FNV\&G&UN8%42-'(9#(2H(]6QG!XS]:M>+++
M5[_P?8K%X;-K(-5CG6RLXPS)&%/+;>,DGVH Z36/&_\ 9OB"71+31+_4+V.W
M^T;8-H!7\3G].N!@YIR^.K)O"UAKB65TXO9Q:Q6RA=YE+%=O) ZJ>:REBOX_
MBW<:J=*OC9?V3Y8E$8P6X? .>O\ #CKGVYKFI([VV^%FF6,VE7\>J)JI:VB1
M2LP8.TGF*I'. 2* .^\/^+FUO5KK2I]%OK&\M$#7 E*LB;ONC<#R2.1QV-7-
M>\11:))9VRVEQ>WUZ76VMH -SE1DDDD  <9-<[X+O;9-=O89[+78M5OXQ/)/
MJL*Q^:L>% 7;Q\N[T'6G>+[/4;/QEH/B6TTVXU&WLDEBGAM@#( P*@@=_O'\
MJ ,?PAK,.F>(/&^HZDL]E;PO [Q7#[VC)W\9R<DD@#GN*Z?3/'5K?ZQ+I,NG
MW=K?" W$,$C1EIDQG VL0&Z\$].:XB;0]>UP>-#%HEU;+JJV\]O]KVH28W#;
M",GDC/TQ@XKH/"JM=ZY!<Q^ X]&9-S7%W-&$;E3Q&, Y+$>V,T :L7CZSN/#
M$NN1:=?&..Y^R^0P02E\@=-WJ<8Z^U&L_$#3=&N;R(VEW=+9X%Q)!Y>U&(SM
M^9P20.N <5EVWA:]@^(TZJ&30-ZZJB*GR?:<%-N?7J^!Z+6)<:3+I?B[6SJ?
M@J37(+VX-Q:W$,0?;N_A)(X&<9].3S0!OW%S;W?Q'\+:G9O*\5_8SMPYVE0H
M*G&<#KS]!5Z[^(%M;I>W$.CZI=6%E*T,]Y#&A167&[ +!B!W..U9]S#J%OXS
M\(NNBR)#;VLD<YM8RT-OY@P%W =L<].N:S](BO\ PQX6UWP]-HE_>3/)/]F>
M*V,D5PL@PN2.%'J#VH Z/4/B!IUGJ-K8V]CJ.H2W=L+F V<(<.G/3D'/'X4L
M/Q TJ72+B]-O>1W$%PMJ]A)&%N/-8X50N<9/)Z]CZ5Q4,,OA;QOX0MKF">XE
MM])9)$MHC(P)+YX') SV]*BU?PIJ=W/J7B:/29;I)=4BF739HL/+ @922IY&
M=W QGOB@#N[+Q[IEPNKBYM[NPETI ]S%<HN_;ZJ%8Y_^N/6N7U;7KC4/'OA"
MYALM5TZ.>1U/VDA$G3C&%#'U.<@'!%.N]&_MSPGK=KHGA!]&=X8BIN(EBDG=
M9 ^P+_=PO4D<GI45_?ZKKWB/PC<+X8UFW_LZ4FY,MKL0;@@RISC VGKCB@#T
M37=;M/#VCS:G>^88(L B-<L22  !]365:^-;.9M2CN;"^LI].MQ<S0SHI<QD
M$Y 5CG_Z]'CZ;68?"<_]APRRWC.BXB3>X3/S$#U[>V<^]<5:Q7[^*]:U%= U
MN&UO=&>"(W,1>0N /O').3M.!UZ<8H ZK3OB-IVH7NFVYT[4[:/4>+:XN(0D
M3MCH#NY/;CUJIXV\3QS:'KMA86FI7#6L++->6F%C@DQG#-N!..,@ \&L1['4
M9-,^'O\ Q*[\-I\Z_:D-NV8@I49/' XR/:H)(]4T#3O%GA]]!U2[DU2:>6UN
M+6#?&5=<#)SQCCUH ]!\%S2W'@K1III&DD>TC+.QR2<=S63I6OZ/9WGBN[23
M5&-E,LEY'<#*IP1^Z7L/E.?IGI6IX)BN(/!>DP75M-;3Q6ZQO%,N&!''(]\9
M_&N&LS,;KXE-]AO0+NW/D9MG&_"2+Z>K#\,^E '5:=\1-)U+4["SCM=0B34
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M-UJ4BF3[-'. %MPYYV@=\<=N.U=+6*/$UF_]B>7!<N=93S+<*@^5=@<E^>,
M]LUM4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !574K^'2]-N;^
MXW^3;QF1]B[C@>@JU00""",@]10!X=HEQ<Z/I]MK5K?^%[R^G*SM;$?Z4[.<
ME!@_*_.W@"O0AX9UG2?$&J:EH-]9"+4B))K>\C8A) /O*5/.<GBMVT\/:)87
M N+/1]/MYATDAMD1A^(&:MWMY!IUC/>W3^7;P1M)(^"=J@9)P.30!@6'@Z&R
M\$7'AU[AKDW$<HEN)!R\CY.[!)QSC\O6J@\!Q'X>+X7-T4EVAS<HO)EW;MQ[
MD9P/7 KJK*\@U"RAO+63S()T$D;X(RIZ'!YJK9Z[IM_JE[IEM<B2\LL>?'M8
M;,].2,'\* ,33]'\6^6RZKKEI.L=N\<4<,!42.5P&D/H/0#G/M5&Q\%ZI:?#
M:X\+&ZLS,^Y4GPVW:S;CD=<\G]*[JB@#ASX2U=;CP<RSV3)H:&.;(;YQM"Y7
M(/91Z<G-58O!.M)I7B^V:>Q\W6IVEA(+87<23NXXX.!UKT*B@#@6\':S(/!^
M^6QQH>%E"NWS@  $''HH_.DT[PEXJT59-(TO6[6'0_-+Q.T1:XB1FRR*>G S
M@^_:N_HH X>+PMK4?B;Q5J6^R\G5;7RK<;FR&"A5W#' QG.,U1_X0W7X=*\*
M26[Z>=5T5G1_,=_*:,\#&!DG 'IS7HU% &1X@TR[UCPO>Z;%<I#=7$!C\T*0
MN3UXZ@'D=\9[UQ5AX3\2:?JNAZQ>3:/#%I-L;>5(M^/) .YNGWB"?3FO3*1E
M#J58 J1@@C@B@#Q#2/MUKITGBE+/PW<AIWO$:6=TF#;C\H4';N[ ?UKKV\-^
M*],UV_O_  U<Z?%:ZJZSSQ7BL6AD/WL8'/4FNCMO!/AFSO!=P:'9),&W*WE
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MM)JETDT16X)WH"25)V\9#8_ ]N:2#P1XCDUB_EGM])M;>]TB2PQ:,Q6+@!<
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M2R@DEE 9G>69]SR.Q)9F/<DDUH4 %%%% !1110 4444 %%%% !1110 4444
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MX<UUM/\  D0TN3?I4RO>#SHOW84J/[W.0,\9H F\7ZY/KWAOQ#;VFA?:],M
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M^(4KZ/>I_:4.RU4H,R$*Z<8./X@?I0!M:;\0TO\ 5]*LYM%O;.WU1"UM<W!
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MV$:]6 89Q0!SVJZI=6GQ.T:\^PWKRS:4TDEC"X<E\. , [?3FM#6?$^C>(?
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MS-AMQ(&>#]/>@#UVBO+;WQWXFO+J[O-"T^2:SM+EH%M_L+R"<+@%C(#\IY.
M!QCG->C76I166CRZG<I)'%# 9Y%8?,H"Y((]: +E%>::+XV\37VHZ5-+IC2Z
M?J,BHP2RD00*>C"4L0P[DX[<8K0F\8ZK93^*[._2TCN=-@\^PVHP$R$':3EC
MN.=HXQSF@#NZ*\UUGQOKMG/#HMM'$^J164<UU+':O,!*V,(%4_+G(Y/KTJ6]
M\<>((M \-7D6F6MO=ZI=?99HKL. IW;00!R >3SG''6@#T6BO.+SQ-XB71/%
M]EJ/V&'4=+MXV2:R5]A612>-QSG Z]B?:NG\$&^;P;I3W\T4KO:Q-&T:L#L*
M+@-DG+=<GC/I0!O22)#$\LCA(T4LS,<  =2:ALK^TU*U6ZLKF*XMWSMDB8,I
MQP>17(:)J>J:C\0/$UG-=QRZ=:)%&(&0_+E6/';USD'/'I7,>$M?\0Z'X+T"
MY^R:>^BO/]F(+/\ :&+R,-X/W0,GIR>/?@ ]>HKB/$OB;7M(N=4FA72X+*PA
M26-+HLTMWG[Q4*PVC/R\@\^W2E/K>K7OQ)\-QVUPD-E=:?\ :3 P)RK#+!L$
M9;Y>#T'H: /1**R_$-YJ%AHLT^E6B75X"JQHYPH)(&YO89R?I6!I?BK4I-4U
MC2[G^S[RYLK,7<4MGN2-\KD(=Q;VY!Q@T =G17FD'C?Q6VD:)K$NF:4;/4;A
M;81+*ZR%V8A6SR%''O\ AVTO^$SU/2+W7+?Q!;60^PV@O(39NV&4MM"$MU.<
M#.!]* .YHK@/#GC/7+_Q!:V%_9VTMO=QLZ3V<$Z" A2VUS( #G&,CO\ 6LE_
MB7XA71FUHZ5IR6-M?FSN4\UVD8\'Y>@& 0,G.?04 >J.ZHC.[!549))P *@L
M;^TU*U6ZL;F*X@;(62)@RG'!Y%<U?Z_JM_XDN]!T.'3S]BC22\EO68@A\_(J
MKWQW/Y5Q7A+Q-<^&/AEI4UM91W3W6I/:A7E*8+9(/0^E 'L5%<';^*/%,WB?
M4?#?V#21?Q0?:(9O.D\I4. -W&YCEATV_A52/XFR3^&K">.V@35[R=[8(^]H
ME*#YI,*"Q7E>!SS^- 'H]%>>P^/M6A\*:MJ-YI*276FRHI:-7AAG1FQN7>-W
M'?/MZU:TWQ9KS>+8]$U?3K*V-Y:&XLS#*TF" >'/<'!Z 8QWS0!W%%>9^'_&
M>K6WP^U3Q#JAAO)(;LH@#%<9=5(/R\*-V1C)Q7;:%J=UJD$D\R6AMSM:WGM)
MS(DJD>X!!'I0!K45Q.K:OK*_%'2])L9;<VOV%IY89&9=V6()) /(VC''][UJ
M1_%VK7-CJ>J:9I$$^FV,KH#)<%99@GWV50I&.N,D'B@#LJCFGAMH6FGE2*)?
MO.[!0/J3571]5M];T:UU.U.8;B,.H/;U!]P<C\*\SU#4=:U?X7^)KC6!;,JW
M#I%L8ED*R@%3QC QP1UH ]81UD171@R,,JRG((]14<%W;71E%O<12F)]DGEN
M&VMZ''0\UPWA[Q9J%K<^'-&U'24MX+^S MIEN-['9&I^9<<9^M-L_%%KHFA>
M)]1AT-;1[346CDB63/FR':-[$ XZC.,T >@T5B^']5O]469[JVM%@"HT%S:7
M/G1S YR!D @J1SQWJ;Q'JZZ%X>O=2(!:&,[%) #.>%&3ZDB@#35U?.U@V#@X
M.<'TI:\R^'UU-H_B?4M!OKZ.Z>_5=1AF5@1)(P_>@8)'4$?\!-;FM^,KVSU^
M\TG2],BNI;*R^V7#33F,;>.%^4Y.#F@#L:*X63XA7)T#1=4MM"DD_M2Z^SQQ
M&<9'.!SCOANW:H;SXB7EDUO8W6FV=IJYB,T\%U?*D<:;L*-^#ECUQZ4 >@45
MP,GQ-MFT#2KVWMXA>:@7 AN9_*CBV?>+.1TSC'KD4U/B<A\'WVMG3"TMG<BV
MDB28%&)QAE;'*\^E 'H%%<3_ ,)MJJ:_!H\WAW;=WEOY]JJW:GC!SO...AZ9
MJ&#XEP?\(]+?7EC]GO(K[^SVMS,-HE]2YZ*.YQQB@#O*YKQ%X&TKQ+>QWUS+
M>6]XD8B$]K-L;8"3CD$=2>U8VG_$R.XL=8DN+!/M&EPB9A;7 DBE4G'ROCW'
M:K.E^/9KS5M)M;W0Y["WU:,O:7$DZ,'(0-T'0'( [\CB@#H-#\/:?X>MGAL4
MD)D8-)+,Y>1R!@98\\>G05JUQ_@W7M<UG4=<34+6%;6UOI+>.1'^X4P-F/XO
M7/'4_0;6L:O<Z==6-K::;)>S7;.HP^Q(PJ[B6;!QGH* -:J&LZ3!KFES6%S)
M/'')CYX)-CJ0<@@US,OQ$AB\,PZRNE7$I>^-D]O$X9D<$CKWZ#'3.12S^/)[
M6>VM;K1'M+VYED$<-U=QQCRU'^L9N0,G@#O@T =+HVC6>@Z9%86*%8DR2S'+
M.QZLQ[D^M7ZP?"?BBW\6:5)>00M"T4S0R1E@V&'HPX(P1S6=JOC:XL?$%[H]
MIX?O+Z:T@6=G2144J0"3D]AT]R#0!U]%<8_Q&L#H.CZC#;.TNJRF*&"658]I
M4X<LQX"@]_<4VS^)%C<6.HRR6D@NK*Z2U%O#*LIG=R0@1A@')!_(T =K7'I\
M.]/AN)FMM7URVMII6E>S@O2D)+=1@#.#]:LIXMEM9-0&M:1/I\=G:BZ,H<2H
MZGC ( ^;/&*S]*^(UO?:]::7=6!M#>1EX)1<I*#@9PVW[IP/SH [.WMX;2VB
MMK>-8X8D"1HHP%4#  _"I*YC1/%L^MO;30:1)_9MR9=EVLP;8$SRZX^7..!D
M]:31/%T^NFTN+;1IO[-NC)LNA*K% N>77^'..!DT =117&VOCWSYM,>72)X+
M'4KIK6VG>5=Y8$@%H^H&1Z\4U/'\ESK%YIUCX<U*[>SNQ;321[-J@Y^8\\<@
M^V.I'2@#M**XNV^(,=QX5U'6CI<R26-Q]F>U:5=[-E1CV/S=,=JZY97^QB:2
M%ED\O>T2G<0<9VCU/:@"8$$9!R**\[T3Q9HFA> 3JFFZ5J/V!+UHFA)#R*S'
MECDX R0,>I ]ZV]$\:+JVOR:/<Z5=Z;<?9UN85N<9EC/? Z?3/KW% '4U4U/
M3X-6TNZT^YW>1<QM$^PX.",<&JFOZ]%H-I#(UO-=7%Q*(+>WA W2N<D#G@#
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%9VOZG_8N@7^I"/S#;0M(%]2!Q6C5:_L8-3T^XL;I-\$Z&-U]0: .9TN#Q9-
M_8VHG6[>XMYT$E];O JJJL,@1%5W'&<<GW]JQHM7\1ZIX%N_%EMKGV8@2SQ6
M8MHVC6-"1L8D%LD*3G/>MK0/!^I:0UK%=^);F]L+/_CWM1"L0&!@!F!)8#C
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MT<TA@\IMB1@HN[)R06./4G'&:I^(?$NM6_AWQJCSPB;3Y8H;>6%"A5)2OO\
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MXBU2:PL_#D=N[@0SZQ<QI@1=_+'5FX !/2G^(=%FE3P_X4M]*N9]"0H+N=&
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT^VK$]Q--:Z?/<HJ9Q&H13G)(;))QTKH_!^K:GK/A^.ZU>P:RO-[(T;1M'N
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M:Y9Z/--MO+Q&>%,<$+UR>W?'K@UI4 <0GP_G2'Q#NUV62YUJ,)+*]N $([@
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MB.Y#&.1,Y[#/7_\ 770:'9ZA9Z=MU6^%Y>R.9)75=J*2!\J#LHQ^/)[UI44
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M=QAOM,I7RB4QNP!DC\1TKTRL>P\+:+IFJ3ZE96*P7<Y9I'5VPQ)R>,XZGTH
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M V2V[I]<#\ZY:S\!:];>%;>)1;)JFGZI]OME,N4E''RL<#'3_.:]4HH X/\
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MKD(XA##&Y>Y _D*AUOPAXFU"X\1P+:6-RE^0;>^N)R9$C!#")1CCD>PSGVH
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MY^M 'IU%>?>)KK5],3P]X<TS4;RXFOVD\R\+HLTB*-V%<C:"<]>O ]:I+?\
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M?4-5O[*[LKNY2&ZB2W*&(N.-A!^8#!///] #L=4U:QT6P>^U&X$%LA :0@D
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M#&P(PCJ5&#@]L]* .IHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "HYX([FWE@E7='*A1QG&01@U)10!Q:_#FV3PW%H:ZSJ7V:&X6XB;<F4(
MR0H^7&-QW?6M27PG;7/B!]7NKNXG>2R-C)"VT1O&>N0!GD\\=ZZ"B@#D=*\
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MAN#:H/)B! ) QAN>F1W/I4GBAK.W\76-E+X@&E#2K!1!)?VOVE9RV0Q&['S
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M;!]!42F=;!=]P#&7"D9VJ/H":W+/P5J]M/H#OXBADCT8%8D^P;2ZE=A!._\
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M?B*.*ZN+W2IX'MRTD5JC)+!+D?*P+'(QNYP.@KJ[Z\@TZQGO;E]D$$;2.WH
M,F@!8KRVFN9K:*>-YX-OFQJP+)GD9';-35XSX?\ $-O8>-].U0ZK!.VOJZZA
M$)586[YS$..1@;5Y]_P[_P 1Z]?V6NZ/HNG-:17&H>8WGW2LRJ$&=H4$$DY'
M?M0!T]%>;VWC?Q$_@_Q!J<MII[7.EW)@1D#B-]IPQP3GC(QSS[5+JWBWQ3HZ
M6T-W:Z6EWJ,@^Q^6)I5C0+ND+JHW-C(''J?2@#T.BO-H/B+J4.A73:EIZ1:B
M+Q;2UD\F5(9]Q(#A2-Y  R0.3QTS5K1O&&O3#68K^RMY7L[0W-O<1030PR8'
MS(?,&[/3MZT =_17F">/O$J:5H6L36.EO8ZG(ML(T>02"4DC<200%^4\<_6M
M.+QO?Z3<:_:^(X;+SM,MUN4^Q,V)5; "X;G.2!GWZ4 =Y17G_AWQIK=]KEG:
MW]E#+:WR%DEM+:=/LQQN D:0 -D<97O67_PL7Q$_AU?$BV&FQZ9%>>1/&6=I
M67<!E>@& <=_I0!ZI5>^O[33;8W-[<Q6\ (!DE;:H).!S7+V>HZM/\4+ZS,\
M1TR/3XY$B.[(W'KZ;L[N?3%3_$+5(]'\(W%Y+I]M?JDB#R;C[F2W!QCG!P>U
M '4@@@$'(-%<3KWBV_M=;CTG3VT^VF-I]I1K_<$G;_GFA! !]S^5=?:23R6$
M$MU$(KAHE:6-&W!6QR >^#Q0!/17$>$_%>J^)+PR[M,%L))4EM 66YMPN0K'
M).[) !X&,]ZIOX_U(^ +_P 01VEF+BQOC;RQ%F*E=ZCCISAA_/VH [J/4;*6
M_EL8[J%[N)0\D*N"ZJ>A([47M_9Z;;_:+VYBMX=P7?*P49/ &37G/FZM%\5+
MN]TG3[>XFO-'BF$<T_E@(64$D@')RN*EU;QQ%?> I-6N]"M[B6SOA!<V<TN1
M%(IZ@XYYQT]: /2LY&117#:_X^.FWMY;6:V9-A'&]Q]I:0;F<9")M4\].3QS
M5BR\:7&L_P!EVVEV,7VZ\LS>R+<R,D<2!MA&0I).[IQC'- '8T5YOK?BOQ&+
M#0,V TN^NM76VDAD8X=0PQ\V/NMGDX/M7?7<MQ!I4\R"(W,<#. 2=A<+GZXS
M0!:HKSC0O&NI1>!-.U"]%O>7^HW?V:T7S2N]FD(^?(X"].,\ 5O6OB>_@\70
M^'M8L;>&6Z@,MM-;3%U?;DLI!4$' - '4U"MW;/=-:K<1-<(NYH@X+J/4CKC
MFN1^(NLZII%KHPTR1(VN=1BA=B2"1U"].AQS[5G7K:A8_%:>72M-@N;R?14:
M96F\M ?-P6S@D\*!TH ]%HK@6^)2KX?T^Z>RC@U&\FD@$%Q,$CC:,_.6;&0.
MPXZFM;P=XP'BA;V*2V6&YLY-C^4YDB<'.&5L#(X- '44444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5#=V_VNSFMS))$)4*;XSAER,9!]:FHH XX_#K3SH&
MFZ-_:.H?9K"Y^TQ'<FXMDD _+T&3TQUJ34?A[INH:Q<:BE[J%G]K %U!:S[(
MY\'G<,9Y[X(KK:* .1U'X=Z1>7D-W9SWNE7$4(@\RPEV%D P <@]@/RJ6]\!
MZ9<VNG1V]Q>V,^G[A#=6TNV7#9+98@YR22?<GU-=310!QD7PUTE;75K>XO-1
MNAJ83SVFF!(93D.,#EL\\YJWIO@:SLA,MWJ.I:FDEN;8)>S[U2,]0H &,\<^
MW%:NIZI<V%[800Z5=7B7,NR2:'&V ?WFR>G^![X!TZ .$_X5=9,MG%)KVMR6
M]G(LEO"UPNV,KTV_+D?A736.AI8ZQ=ZBM[>RM<HB&&:8M&FT8RH]36K10 5S
MNF^$8=-\3WNO+J5[+<7@Q-'(4\MAQMX"CH ,<UT5% &+XF\.1>)=/AMVNY[2
M6WG6X@G@.&CD4$ _J:R$^'=E&NJL-5U*2XU.U%M<332AV8<#=R.3@8^F<8KL
M:9++'"H:5U0%@@+'&23@#ZDD"@#F)/!$$_@0>%KB_GEB50J3E5#+@Y7@=@1T
M/YTJ^#IO[6T;4I==O)9]-C>/+(G[T-UX P...F< <YYKJ:* .-/P]MIK?58K
MO5+V<WUTMXDF0KP2KT92!R>WI@#CO4UIX):+3+Z"\UR_O[NZMWMQ=7#;C"C=
M0BG(&>,^N.U=96#K_B4Z/<16=IIMSJ6H2Q-,EO 5'R*0"22??@ $G% &?J/A
MV_M/ARVA:?>W=Q=Q1+%!-&RQ.?F&!G/"@=><X%=+I\$]OIEK;W4YN+B.%4EF
M/_+1@,%OQ-5I]:@LO#W]LW\<MK"L"S2QR+\\>0/E(]03C%8UOX]M)=0TZTGT
MC6+/^T&"V\MS;JL;$C(Y#&@"G:_#6R@T"[T634;J6S>4RVJD*#:MG(92!DMS
MU)P?05J67A:4:U;ZKJ^IMJ=S:Q&.VW0+&L1;&YL#JQQC-='10!A^*?#4/BC3
M(K22XDMI(9UN(9D )1US@X/7@FJT'A6YC\366MRZU/-+;VGV5T:%!YHZDDCI
MDX/ [5T;2(A4,ZJ6.U03C)]!^54;;5DN=9O=-%I=QO:JC--)&!%)N&1L;//?
M/':@#EC\-HY-&FLIM7N&N#?F_@NUC"-#*<9( /-;VA^'Y=+FDNK[5;K4[UU\
MOSI\*J)Z*@X'09/4XK;HH Y;7O!K:KKD&M6&K7.EZA'%Y+2PJ&#IG."#[TT^
M#)3IEM9'6KF0?:UN[V250[7C K\K<X"X4#'H!^/5UE^(/$%AX9TF34M0=A$A
M ")@NY)QA02,G^@H R+/P4+'6-8NH-1>.RU56$UDD2A59AC<#Z\GMWJFWP^G
M?1=.LF\178NM-FWV=VD2JT2; NS /(XZGUK;U7Q58:5%99BNKJXO@6MK:UBW
MRR #<2!QT'/)J&'QOHLN@3:P\TL,$,ODRQ21D2I+TV%!D[N: *-WX'GU#0[Z
MROM>N;FZO J274D2_+&IR$5 0!SSGK5B/PE,FK:!>G5&*Z1;-;A/) \W*A22
M<\< ?E5G2?%UEJNIG3'M;[3[_P OS5M[Z'RW=,XW+@D$9SW[&M#5M8LM$LUN
MK^7RXFD6('&?F8X% &5X3\+2>%EO;>/4&GLIIFEA@:( Q9Z_-G)JGKO@FYU/
MQ,-:L=;ET^5[;[+,$A5]R9S@9Z9X_*NP!R,BB@#SRT^&][:6&C6::[NATR_:
M[C!M^HSD+D'/KG_>-:ZV2>%=:U_Q1JNK(+&\$09?((\K:=JY(R3]['3O71W]
M_!IUA<WDY8Q6\9DDV+N(4#).![5#IFH6?B#18+Z!"]I=Q[@DJ=0>""* .5\!
M:;:R:OXA\2VJYMM2NC]F<@C>@Y9@#R SD_\ ?/2MSQ?X=/BGP[-I:W36S.RN
ML@&1E3G!'<?_ %JW%544*BA5 P !@"EH X5?!&M/K4FJ77B-;B:;3WLI@UH
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M63!+A$S^[8YX)Z9^4_3%7Z /-)_!&N_\(;X;TB,V33Z;>BXE)E8+@,Q'\/\
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MJ+SW2&?S;B$E-Y &#]<8!]>?6K__  DNI67BKQL'G:>WTRR2>W@; 53Y>['
M]36S>>!;&XATE;>\O+272R[03QLK2$MRVXL#G)Y_&I8?!MFFMZMJ<]U<7/\
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MK7TGG3:A/ KY?@'" @ 8!P,\9[T <IJ-_<Z]\2_"OE:==V,UJDLLZ7(3<(R
M,X5B0#R,G'7C-1>/[[3M<UV?0[N*^E2SM6\I;>!WW7;@;/N]=JGH?[U=OHOA
MBWTB:YO&N9[O5+I0LU[.07('0 #A5'H/UJ+PIX;N/#L=^;O5&U&>]N#<22M"
M(_F( / )]* *OPZUQM<\'VK3%OM=I_HMP'QNW+W/U&.O?-=77'V/@Z]TG6];
MU.WUV81ZD'<V\=LN4<YVL"2<E<GL,]ZU?",&K6_ABSCUR9I=0PS2,YRV"Q*@
M^X! H Y+P[&\OBKQVLU]<3!&"O!(JF-E9&VGIG( *X&!C&<]L70]3U_0/#W@
MV>/54DL;^Y2U-D;9<*C,1G?]XG\J[9/!MS;>(=:U2SUEX(]5BVR6_P!F5MK[
M"JMN)R0"2<#&>A-43\/9SH6A:;_;>6TBZ^T1RFU&'P<JNW=QCUR: ,3_ (23
MQ?KL>J7N@?;6\G4&M[>!8;?R1&FW.]F^?<0<\<<]:VK^[\37GCI]&M=7CTZ
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M'IFM:@)C-.4601I&,[E7)&XY'!XZUG>+$\56_@V^AU;486*WT"P74" --&6
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M+VZTX-<:LME+IT(#M#&Q(4EP3@X&<$<C].T\/6%WI?A^RL+Z>.>>WC$1DC!
M8#A>OMBN&3X=^(H=)BTZ'7;%8;2^%[:_Z(=V\,3ECGWZ8/IT% %N^UOQ?<:_
MXDLM,ETV.+2HXY4$D3,[AD+!1R!DXYSTXJ"T\4^*I-/T'7)SIG]G:A<0V\EM
M&C[QO8KNW'OGG'\ZVX/#FL0:WXBU!;RT;^U;=(XU*,/+9%VJ3ZCDYK//@S7%
M\):-HL5_9++IUTL_G%&(<(VY!CZGGZ>_ !/%JOB;Q!=ZTVC3V-G;:?<O9Q+/
M"7::1,;B2#P.3C ]*K:)XSU36+WPN[116\.H-<PW<&P[EDB1CE23P.!P:LGP
MUXAT76=3N_#=WIYMM3E\Z:&]5\Q2'.YE*]>O0U7N? VJZ?I.B?V!J, U/3)9
M96ENE)69I1ASWQU/&/QSS0!7_P"$UUB#2O&4C_999M&N!';LR; REL?,,\G
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M!>6L%Y:2B5[<*I9HQG?Z9.>V,8KD[J[OM1^'6JV-[?W4S:;K2VL<YD_>2('
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MH&F6.JG3K?4M,%U)L@CD96VL>K#V'I5"#Q?K=CX2@M9+EKG59-9;2TN0B[B
MPRV&^4MV&>.1GI0!ZI17GUI<>,-+LO$BWKS?9K6S>>QN[M8GDW $X(0X/0G!
MSCCZ5L>#(]>N=/MM6U?6UO([VTBD2V6U6,1$@'.X'DX// _E0!U&X!@N1N(R
M!GG'^2*6N&:*Z;XQN3J$X@32!,L*XVX\S:5YSP2N<C!Z>E9$.L>)-5\'7GC&
MUUT6_E>9)'8"W1HA$A^ZQ(SN('7/?M0!Z+::7I]A+++9V%K;R2_ZQX850O\
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MM#=V\EO*7&W/0DXYY]*[&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX3L8O$L.N0SW<4T5N+98$D A\H#A=N,XSSUZC-;M% ''Q_#;1H_#8T,7%_\
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M_MB7%Q<7+30C?=2O$0S+SSCT[*HKJ? (CM-5\7173EKZ/4B\\SC:&C*Y0_\
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MU+7TG6XB_=7<J%3/MQDX XZC_P"O5O3O%NAZI9WMW;7R^19,5N&E4Q^7CU#
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M33Y[!K^&_M9+-02UPDRF, =<L#CBDL-5T[55=M/O[6[6,@.;>99 N>F<$XH
MN457O+^STZ#S[Z[@M8<X\R>0(OYFN3\(^+)]8UKQ';75W936>GRH;>Y@P$*-
MNZG)!Q@<Y]: .THJG8ZOINJ!SI^H6EV(_OFWF63;]<$XIMKK6E7MV]I::E9S
MW* EH8IU9U ZY .10!>HJC+K>E0N$EU.RC<OY85YU!+_ -WKU]J='JVFS7[V
M$6H6KWB#+VZS*9%'NN<CJ* +E%4_[7TW^T!I_P#:%I]M/2W\Y?,_[YSFJ'B;
M78M'T:^>*]M(]02UDF@BFD&7*J3PN<F@#;HK'\*:I/K7A;3=2N0@GN(0S[!@
M9Z<?E3])\1Z9K=Q?0V%R)6LI?*E(Z$XZCU';/J* -6BJ-KK.EWUP]O::E9W$
MR'#QQ3J[*>>" <CH?RJIXLU"]TGPKJ.H:>(C=6\)D7S<[<#KT[XSCWQ0!LT5
M0TW4[>]M[<"Z@>Y:!)'C1P6&X9SC.<=:L"\M6G\@7,)FSCRQ(-V?I0!/142W
M,#O(B31LT?WU# E?KZ4TWEJL"SFYA$+' D,@VD_7\#0!/13(I8YXQ)%(DB'H
MR'(/XT^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH XG2[8V'Q:UQIG .H6<,T ]
M0F$8?@1^M9=MJ46C:KXMTV]T^\DNM0N))K6%+1Y!<H8\<$ C&0<YX&?K7=W^
MD6NH7=E=RATN;.3S(98SM8?WE)[JPX(J_0!YCXCT>XT_X.V&@S$?;I7MX%0<
MYD:0':/IS^5>E01F&WBC)R40+GZ"JESH]K>:M:ZC<;Y)+52(8V.8T8_Q[?[V
M.,]JOT %%%% 'FWQ,GM&\1>%+>YB:6-+P2S(8&=3&2H.>"#T/%=#KGA334T/
M6'TG2[:"^GT^6V4P1!-P(SC"]>0.V:ZBB@#Q.WU./4M.\ P6MM>R/IUY&ESB
MUDVH1@XW8P> 3@'I76^!& \:^-5(92]XC*&4C(!<$\_6N_HH \.ENVG^#&I:
M6;:X2YLKW:ZM$PSF;=U(QGD\9SQ[UNZXQOO'WA_[/))%]IT62.*;RS\K/&X3
MKWR17JE% 'COAA]&EL-+TN^T;5Y_$&G2+LM6:=8T<-D2$9V*HR,DC\#6_P"#
MVAE^(WC,,NX-+"R;EZE-P)'T)%>AT4 8_A[Q+8>)8+F6Q$Z_9YC#(D\>Q@<
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MR9=9L?%FKWUG?_VC*\UMN'[SD%77Y">1CH><>AKH+-+%_BYJ*WJHT0T5"!>
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MM%;P)]V.)0JC\!5B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ IDTL<$+S2N$C12S,QP !U-/K-U_2SK7A^_TT2>6;F%HPY'0D4
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MN3"=DDA*GJ!C^$^V3CK70>-+JXLO!NJW%I:I=3+ <1.H92"0"2#U !)QWQ0
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MZ93L!C4ADSC@G)./;WJAHOAZ;7/!WB8D210:K>S7>GI(A4H-VY' [9('Y=Z
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MA_X12XP(_/%Y*'QC<!QC/>I;M;.[^+@MM6A26)=,W68G4% V[Y\9ZMC'X T
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M<2//9?;H9@H\MX\XP"3G//3%9@^(VD?\(P^OFUOQ:I=?93'Y2F3?] V,<^M
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M71O$>C^(//\ [*OX[KR&VR; 1M/XCD>XXJ35]<TS0;076J7D=M"3M#/DECZ
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MN)KKS9U+0+]BES,/]CY?F_"N/U81WB>-/$<"2C3+FP6TA)A*BXEX7> 1D@'
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M#T-7J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^PN1;7-Z%78CD@'@G<0"<9 _G4FK>.+;3-;N-'BTS4;Z]A@6<I:Q!LJ>O?C
MQ^= '4T5R,GC^Q30M(UA+&[>UU*;R00%_<MNV_/SQR#^5;$.O0S^*+G0D@F\
MVWMUGDFP-@W' 7KG/?\  T :U%8NM>(H])U"PT^.SN+R]OB_E0PE1PHRQ)8@
M#MWJJGC&W^V:':3V%Y;SZN)/+25 #$4ZAAGOVQ0!TE%<RGCG3 NN-/'/ -'E
M$4VY02Y8D+L /.2,8J!/%D6JW%YHL^F:EI]Q)9R2QM.NS>F",@J<J>?PH N^
M+_#'_"5Z5%9?;GM/*G6<.L8?)7U!QZGO6[$KI"BR/YCA0&?&-Q]<=J\U\#^,
M;;3?"WA^SN;;4Y%NI3 ;UTW1K*SMA=V<GGCVKT6^O(]/L+B\F5VB@C:1Q&NY
MB ,G H L45P\/Q1T>:>SS8:I%:W3B-+N6VVQ;B< 9SS^%7)_'^G1Z[+I$.GZ
MI<W,$ZPS&*U)2/)QN)]/?OVH ZRBN.F^(VGPHUV--U232E)5M12WS#D,5)'.
M2,CKBM8>*=/;7K32%6<RWD)GMY@G[J1<9X;//% &W17#>(/$>B:GHXDN9M6M
M8+?5%@$ELFTO*AZ9Z;>O7'3VK;U/Q99Z;J4UA]DOKJX@MQ<RK;0[]B$XSU&?
MPH WJ*Y>6_TL_$&PA>YOUU"2Q<Q0<^05)R3_ +WRG\A27/CW2K82S?9M1ELH
MIC"][%;%H 0<,=W< YY QQ0!U-%<SJOCK2-+OH+,I=WD\]L+J);. R[HR< C
M'T)_"M30==LO$>E1ZC8&0P.Q7$B[6!!P010!I45@:CXMLM/U2334M;Z]NHHA
M-*EG!YGEJ>F[D8)]*YWQCXRCN? <>H:%-<LEY<+;F6!")(QG# =-K=A]>/6@
M#T&BL'PMIBV%G/-'/JC174GF+;ZBY9X.Q R2>3SR>]<O>>*[KQ/X)\326D-Y
MITEB9/*N!F/*H0<;@<AL @CW% 'HU%<=X9\;:;>IH^E.UY]LGM%*S3P,J2LJ
M#=AF^\>^>A]:FT;6=*MK3Q!J(U>\NK:VNG:<W*G]P0HRB @?+Z<4 =7161HW
MB&WUJ:YACM;RVFMPC.EU#L)5\[2.N1P:T+Z\@TZQGO;J01P01F21CV &30!/
M17"^!O$FI7FJ7^EZ]F.\E O[16 '^CN!A1C^[Z=>3UQ6]K'BS2]#O4L[HW#W
M#1^<8[>W>4I'G&]MH.%R* -RBN;/CWPX-(M]5-\PLKB<V\<A@<9?TQC(^O2H
M_P#A/]$-A!=1?;)FN"XAMXK5VE?8<,=H' Y!R<4 =116'_PE^B'2;?4DO/,@
MN&V1+%&SR,W=0@!;([C'%11>-M!ET2YU?[6R6MK((I_,B97C?CY2N,YYH WR
MB,ZN54LN=I(Y&?2@QH=^47Y_O<?>[<^M<Y_PGWAO[0L!OG#NF^+-O)B8?[!V
M_.?0#.:LVGB_0[W1KG5H;T&SMF*3,R,K*W'&TC.3D #')Z4 ;/E1X0>6F$^X
M-H^7Z>E)Y$.''E)ASEQM'S?7UK'L?%VBW\MW%'<R1R6D7G3I<0/"R)UW8< X
MXJKIWC_PUJNH6UC9Z@7N+G/E PNH; )QDC&>.E '1&WA)0F&/*<(=H^7Z>E/
M95=2K*&4C!!&0:YO0?&%OKNN:KID=M/&UC,8@YC;#8X;)QA3NS@$Y(KI: (Q
M!""A$293A/E'R_3TI5BC4N5C0%_O$#[WU]:P)O'/AV#57TR345%VDZV[1B-C
MAVZ#.,8[9Z TMMXW\/7>J1Z=#?9GED:*(F)Q'(R]0KD;3^!H WHXHX5VQ1JB
M]<*,"DD@BF*F6)'*]-R@XKSR_P!9O=?\?7_AVWU2_P!,CM8D$+VT!.Z7AB7)
M7A>PY /J<UTL/C?P[)JD6EIJ:O<R-Y:-L;9(WH'QM)SQP>O% &]]G@WL_DQ[
MG&&;:,D>](;: Q"(PQ^6#D)M&/RK$?QOX=35SI9U)/M@N!;&,(QQ(>V<8]L^
MM)!XW\/7.L_V5%J"M=ES&HV,%9AV#XVD_0T ;I@B,7E&)#'_ '-HQ^5(;6W(
M(,$1! 4_(.@Z#Z<5@WWCSPSISW$=QJL8DMI?*E1%9V1AUR #TZ9K0U'Q!I>E
M6L%Q=70"W&/)6-3(\N?[JJ"6_ 4 71:VX96$$0*?=.P?+]*7[+;@./(B^?[W
MR#YOKZUD_P#"7:%_8:ZS_:$?V%R55\');&=H7&=W!XQFEM?%NAWFC3:M#?H;
M* [9792I0^A4C(/(XQWH U1;0#9B"/Y/N?(/E^GI7GT?@SQ)%<SVS2>'[RRD
MN'G^TWUD99@7;)XZ9 _#M79Z1K^GZY]H%E)(7MV"RI+"\3+D9&58 \BJESXK
ML;;Q=;>'&24W,T)EWA?E7T!^O/TH T=(TR'1])M=.MR3%;QA 3W]3^=2M8VC
MW"W#6L#3KG;(8P6&<9P>O8?D*Q[[QMX=T[4_[/NM21+@'#85F5#Z,P&%_$UO
M1R1S1)+$ZO&ZAE=3D,#T(/<4 ->WADD$CPQLZ]&*@D?C3W19%*NH93U!&0:R
MX_$NBS7PLH]3MFN3*T(CW\F1>J_4>E+XDO+^P\.WUUIELUS>QQ$Q1J,DGUQW
MQUQ[4 68=*TZWNVNX+"UBN6&&F2%5<CW8#-/GL+.ZFCFN+2":6+_ %;R1AF3
MZ$CBN4T_Q-JDVN:-;W.GWT-E<::9II9+;&)AG(<@?+PI( ZEAQ6CH7C/2];T
M*;6!(+:UAD9':8XQ@X!S[C!Q[T ;=S96EZJK=6L,ZJ<@2QAL'UYI)[&TNK=;
M>XM8)H5((CDC#*".AP>*I0>)M$N;6ZN8=3MG@M0#.X?B,'IGTJ*/Q?X=EMYY
MX]9LVB@"M*XE&$#=,_6@#2%A9B]-Z+2 79789Q&/,V^F[&<5'_9.G?;1>?V?
M:_:ATG\E=X_X%C-4!XQ\-,TJC7=/S$"7_?KP!^//X5'J>LVU]X5NK_2=<L[9
M=I6.]<AHT8=C_G\#0!JG3+ W<MV;*V-S*GER3>4N]UP!M+8R1@#CVI]I9VMA
M (+.VAMX021'"@103[#BLY_$&F:;:68U35[))IH!()-X19<*"649Z'J.?SJ>
M#7M)N=+DU.'4;9[&/.^=9!L7'7)[4 79[>&Z@>"XBCFA<8>.10RL/0@]:9<6
M-I=VOV6YM8)K?@>5)&&3CIP>.*SAXIT633;V_@U"&>"S3?,8VR5&,CCWQQ67
M>^(DU/PYINJZ9K-GIT,MQ"9FNB,E3@M%[-R/U^M '0)I6G16+V,>GVJ6C_>M
MUA41M]5QBIK6SM;& 06EM#;Q#I'$@11^ JGJ/B#2-(E6+4-1M[>1EW*DC@,1
MZX]/>EDU_1X;2"[DU2S2WN#B*5IE"N?8Y_\ U4 3V6F6&G!Q8V-M:B0@OY$2
MIN/O@<TV/2=-AOFOHM/M$NV)+3K"HD)/7+8SS69>ZY%J>@:E+X=U6S>ZMT/[
MW/F+&1R<@9SQG'!K,L]1\42:IX:686_V>ZLB^H1F,AU<#.[VY*C'N>/0 ZB]
MTVQU)%2^LK>Z1#E5GB5P#ZC(J!_#^BR"0/I%@PD8,X:V0[B,X)XY(R?SK1HH
M J)I6G1W,-PEA:K/!&(HI1"H:- ,!5.,@8)&!ZU6D\-Z%+*TLFB::\C,69VM
M4))/4DXZUJ44 8W_  CMM_PEBZ_D"9;7[.J*@'?)8D<DXP!GIBMFBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR@E3ZCTH \N\-:AIVC>%?$.B^(+F.&\%Q<>;'.2&G#@891U;/;%=GX'@GL_
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5#=Q//9SPQ2F*22-E60=4)& ?PJ:B@#A[+PUXE
MMX/"XEO=-9M*<K.JHP4QXV@IQ][9D=!UJ#1_'DZ>'M<UK6HH5M[.]D@A2&3+
M$C;A,$#N>I]>GKW]>51>#->;P]XAT1[-$DDU!M0L[KSE,<C97"[2">@/4#F@
M#H;+X@1RZS<:5>6,<%S':O<QF&[6=9-HR5RH^4X!//I],PV7Q"O+S09=;_X1
MB[73TM9)Q,+A&#%&(*XZXXZX['@]:EMI?%.K6TK:AH%K8.+.6.0B17DG8J=J
MI@_*N<$Y/4?C5/2=&UFT^#D^B-IKC4_L\T @:1/FWLQR""1T?OCD4 61\0;M
M'TTR^%M1$.I(#:,DD;,[D9VD9&!U.2>G..H#CXIBUS0/$EIJ6C7-M<:= ?M5
MF)E)9&0D8<<= ?\ Z]0SZ?K/D>"%32)&-@R&[_?)^YQ'Y?///4GC/2DN-+U=
MM:\;2C2Y3#J-BD-JXD3]XRQE,8SQDMGG'2@!Z>-[72_#7AF6QT6ZE@U$+;P0
M1N,Q;0%"Y/7VSC@$G%7=*\<+>P:T+W2;FTO-( :>U1A,S C(VD<$\'CZ<US]
MMHFNVV@>"K?^QYFETZ[,EVOFQYC4$C/WN<AL\>E6KO3?$T.L^,[O3=/,4E];
MPK93K*@WL@VDCG(;#$C..1UH U;#QE<W.IG2KO1FL]1EL/MUM$9Q()!R-I(
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MNVCN+>59895#(ZG(8'O7D=RVC:3XFUA/%4&H3P:F89+.6!I=DJ%,;/D89QG
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MUQ"K)'(1\RAL9 ^N!4]%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4]% $5Q;6]W%Y5S!%-'G.V1 PS]#44FF6$L444EC;/'%GRU:)2$SZ#'%6J*
M(;FSMKQ EU;PSJ#D+*@8 ^O-,?3;&2V2V>RMV@0Y6(Q*54^PQ@=35FB@"L-/
MLA<)<"SMQ,@ 601#<H Q@'&1QQ3K:RM;,,+6VA@#\MY487/UQ4]% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !4-WYWV*?[.JO/Y;>6K="V. ?;-344
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH SM1UB#3[FTM"CS7=VQ6&"/&6 Y9B3P !R36C7&:>S7/Q9U=IH74VFGPQ
MP,S<%6)9B!Z$\?\  :S++3[SQG%K-[+KM[97=KJ$MO:_9IBL<"Q\ E,X.><D
M^M ':KK-N-<;29DDAN"GF0%Q\LZX^;8>Y7N.O?I6C7%^.D:%?#-XDS"XBU:W
MC$BX&Y7R&_ @5VE !1110!S7BGQC#X6GL8I["YN?MKF.(PE,;\C@[B/4>U/B
M\37G]J6=E>>'-1M!=.429VB=%(4MR48XX!KFOBFV-0\**&AC)U$$22QEU4_+
MU4'D<\CVK1O7\7:'%JFIWNI6=Y:6^FS21+'!Y868$%<KDDC /.>YH [:BO,=
M1^VZ'X/TKQ1#KFJ7-P&MY;B%YS)'.'(W+LS@=>,8JW8V>I:WXW\0Q?\ "1:K
M:VUE/:R10QN-N&3<5((X'48_/- 'H=%<A\29KZV\*>?8:A/92I<Q O"<%@S!
M<9Z]\_A69/;ZCX8\7:?"->U._MM2MKH/'=R;_+=%#!EV@!>H[<<_@ >A45XV
M^O:P?A+H6J?VI>"].H^6TPE.YUWN,-_>' ZUT^JV.JZM\0+S2XO$6H6-JVFQ
MW*I;$#8V\K@?EDXP3G'04 =[17DVG1ZUJR^+#+XIU:/^Q[J1;;RW1=VP-C?A
M>1\HX&!UJYHFNWOC;6--T^>ZU"P@CTE;R7[.Y@>:;=L)W DE.<CIS0!Z;17E
MS7WB:#2/$FB6UU<W]UI5S$5N ^)Y+=AN*[L?? '7KR<=*BF\7QVOA>1O#^IW
MUW<WFHQ6NR_D/FV9=3E=SY&?D;!Y )[XH ]6HKSW2+'QQI=OK?FR23Q-:LU@
MMS=K<3+-MX&[: 03ZXQQ[U8\":I!?7D\;:GJOV^*W1+G3M2;+1N.KK['V]B:
M .ZIKNL<;2.<*H))] *X_P 4:A=7GBO1_"]K?7-@EW'+/<7%M@2;5!VJK'..
M0<\>E9$\NI:?_P )5X;NM1GOK6+1WNK:>=@9E!5@59L#/.?PH Z;1?%T.N7R
M0V^FWZ6LT;2P7DD6(I5!QUSP>O!P:Z'>NXKN&X#<5SSCZ5R?PT@,?@32Y#-*
MXDAR$<@A/F;[O%9M@KO\<-3W3RE8M+4JI;C!9?E^F23CUH ZGP[XAM?$VG27
MMG'-'$DSPXF3:V5[X_'^G45.=54:\NE"TNBQ@,QN!$?*7G&W=TS7E%F^LZ3\
M/M6UVSUF>#[/J4AAMD5#&RF95;=E<YR2>#_/CM9]7U&'XM6^D"Z)T^;3#-Y&
MT8#AF&<]<_+0!V5%>;>#/$-U>ZS!IVL:K?6^MPM+]JL+F-!%-G.WRR!_#P>O
M.#U'->AW=U#8V<UW<.$@A0R2,>R@9)H JKK=BVOMH@E/VY8!<%-O&S..M:%>
M$MX@BM-2T_Q<L5^M^UZS7[20OY9MI#A5!( .U ,<]?7BO1O'&MSV%EH[VU\U
MG97MY'%/>1*"4C()!!.0,^I!H ["BO,M+U77FL_&K1ZU)=6FG1N+&[D1&)95
M9FY4 $C '3&3^%(-3\2V6AZ+<OK$M[-KHMHHXT@C1H-R[G96)QNV^HQGF@#T
MZBO-/[=\7>&=%\07NJ6D\UI#L:PEO)(O-RSJFUA&2#C=GMT]^-#0&\8P^)D^
MVPWLFD2V_P"^:^>#=%, 3\@C)RN<#GU]J .[HKQ@^+/%3> (/%3:RN]+WR_L
MRVRA'7=T8]2/ICBNAOO$6K^%_&4EOJ.H?;[6;3);PQB(1K$R!CA0,G'R]R>M
M 'HU%>9Z#J7C74K_ $G5ECNI=/O"K744BP)!'&V/FCPY<XZ\C-5-5UKQ4=,\
M57\>MI!'I%]Y<*1VZY< @8)/088?4YH ]7HKS^.:YU;XCZ#<_;+B&%M&^V>0
MK IEB 1C'<$9/7@=*] H *R]7\0:=H3V::A*\9O)A##B-F!8]B0,#KW_ *&J
M6LWFH+XAL;&WU*ULX)K>5@K --+(HR H/\(')_'\.(\1ZI<:WX)\%ZC=[/M$
M^J0,^P8!/S#./PH ]&CUVQE\13:$CN;Z& 7$B[3M"D@=?7D5I5PMDS-\:]2#
M*0%T= I/<;UZ<>N?6K_CS6]2T/3].DTR:".6XOX[=C,FX%6!Z#COC\* -K4-
M:L],OM/L[DR"6_D,4 1"P+ 9YQT'O6C7#:KJVO\ AS4_#EE<:A;WHU#4&AE?
M[-L/EDC ^]U&3^E5]=\3ZPFH^)H[6_MK)=&MDFAAD@#M<97<3DGIG"\=\4 =
MA=ZYI]CJUEI=Q.5O+W=Y$>QCNP,GG&!6C7G&K-=75_X#FGN+<:U*[.9#"0 K
M19;Y-W;@=>OY53U37]8O?#?C72[F]Q<Z04"W4">69(VS\I';[I&1ZT >IT5Q
M.M:_-X9A\/P7M_/%8S0M'<:@(%<^8%79GLH/S$\'H/<UU.CSR7.CVD\MU!=/
M)$&,\ PDGN/\_ETH NT5Y?I/B2]TMO'6LW=VUQ!8WTD45O(<#(;:@#=AT&/>
MM74];UWP[I^E:Q>7]M>6=S+%'=0F 1>6)!]Y6!)X/KGB@#NZ*Q?%M_?:7X5U
M&_TYH5N;>$RJ9E)7 Y/ [XSCWKE)?$7B;1O^$>U/5;RRN-/U.6*&6""W*&(N
MF00Q))[F@#T6BO/-7\3Z]HQ-]/<6DL:ZJEJ]E"H8) P."S]0YQ^&>E:G_"0:
MAI_C^\TS5)85TQ[(W5F5CP<+C>"<]1AC].>* .OHKSK4/$WB?3M'\+.\EFMW
MJMX(I?-MS\JN1LX##H#ST)XZ<Y(=;\62:[K7A_\ M+3O/T^!+@7?V(Y8%0VT
M+OP.N,\]_P  #T6BO-/^$]U34]*\/QZ8@6^U"&26YEBM6F\H1G:=J9&<L,=>
M!27?C3Q1I7@::_O].2#4HKU8$:X@*)+&W1MN>#Q@T >F45QFG:IXA3Q3J&@:
MG=64KG3OML$]O"5$1+;-N"3D ^^>/>L#1_$6JZ/\*M+U*:[$@GN-CW,D)D-O
M&TC!G;YLL1CCCOT- 'J5%8OAB\N;_37N9M2M-1@DD)MKFW0INCP.'7LP.1Q[
M5E^(]>UO2KK4GMTTY+*TT]KF(SDM+-(,DJ%#@A0!R<?_ %@#KJ*X%O%WB&_N
M?#$&F0:;&=7M#/*UPKMY94 M@!AQ@\#//MUJ)/'&JZ;X;U1]6BM'U6TOQI\/
ME*WER2, 5+<YQ@DG&.!ZT =G)K>FQ:U%H[WD8U&5#(D'.XJ!DGTZ9_(^E&JZ
MWINAPQ2ZG>1VR2N(T+Y^9CVXKA;J/4H_B]X8&IW%K/*;6X(-O"T8'ROQ@LV:
MN?&#/_"%)C&?ML6,_C0!WU%</_PEFM:-XE;2_$,.G-'+:2W5M)8[\D1@L58-
MWVJ?0>YING^*]?N+K096LHKBRU3!D6*SFC-L&4,"9&)5P!GD 9QVS0!W5%>:
MWOC3Q9;:?K6I+9:-]BTF^:VEW-*7D *C"CIGYAR<=>G%:-YXTOK^_N+/P_#$
M9+:S2Y?[1;23%W==R1@1GY>.I)ZGIWH [*]O;;3K.2[O)T@MXQEY'. O..?S
MK,TOQ=X?UFY6VT[5;>XG;=B-20QQUX//:N'\;:MJ6I_#O0;V> 65Q=7\(F@9
M#P06(ZG(&5!QUZ<^O2-=SZ=XWT?3&L--_P!,MI9)KJ*#8YD4<[>3@<CKGK0!
MUU%>:Z!XEUFVT'Q;K%W/#?&RNY@D 1@59<#KDX3&#@9[\UU/A?5[O68YKF2[
MTZ[LBD9@FLT9#N.[>KJS,1C"XZ=30!T-%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%-D9EB=D3>X4E5SC)],T .HK$\):^WB;PW;
M:L]H;4S%AY9;<.&(R#W''H*VZ "BBB@ HHHH ***Q?$6O/H,5BZV;7 NKR*U
M)#[1'O;&X^OTH VJ*** "BBJNHW9L-,NKQ86F,$32^6IP7VC. ?PH QM2TNZ
MM/$\'B'3XI+AGB^RW=LKA=\><JZY(&Y3V/4&JEW\.-"N]9EU$M>1&X<O<6\,
MY6*<G^\.N.O (ZFM_1-436M$L]32)HEN8A($8Y*Y[5?H YK4M%GUKQ+IYN+9
M(M+TIA/&203/-CY< =%7WZGMCFNEK&;7POB]/#[6KAGM#=+/N&T@-M(QUI?#
MNN_V_:74QM'M7MKJ2U>-V#$,F,]/K0!L45A2>)HX_&L7AHVDGF26OVH3[AMQ
MDC&.O:MV@#G?$W@^T\4S6,MU>WD!LG\R(6Y0#=D<G<I]![5O7%O%=VTMO.@>
M&5"CH>C*1@BI*C>>&.:.%Y4667.Q"V"V.N!WQ0!S-EX$L[.WM;-M3U*XTZVF
M$T5E/(AC# Y4$A Q /(!..!6CIGARWTO7-3U:*ZNY)M196ECE<%%V\#: ,\#
MCDGBMFB@#B_BF<^")4 E+/<0JOE*2WWP>,>P-:EAX;MO[1&KW%_>ZC,]N8HC
M=,NV*-N3M"JO)XR3D\5T%1?:(?M7V;S4\_9YGE;ANVYQG'IGC- '%I\+=(6W
M6T.I:NUBDHFBM&N1Y4;;MW"[?<CGGD]^:Z"'PY!!XKN/$"W5U]HGA$#PEE,>
MT8Q@8R.1GKU)K9JKJ=^FEZ7=7\D4DL=M$TK)$ 6( R<9('3WH \V\(Z9_;6L
M>-+?^TKVV@DU202+;!0)%+/D;BI//?!!Z5V-[X/M)KVQO;"[NM+N;*W^RPO:
M[,>5V1@RD,!VK1T'5XM>T*TU2&)XDN4WA'QE><$<>XK1H YZ/PE!#;%8M2U"
M.Z>\%Y+=K(HDF<#&&^7:5QQMQCBH+OP+IE_#JJWD]U-+J4D<LDQ95:-XUPA3
M"@ @>QKJ** .1M_ 44=I<I<:YJUU=SPB$7<TX,D*[@Q\OCY<D#/7I6I9^'(K
M?7%UFXNY[J^%J+7<X15"YR<!0.2?4FKVJWTFFZ7<7D5G/>21+E;>!<O(>F *
MGMIC<6D,YBDB,B*YCD&&3(S@CL10!D>(?#46O265RMY<65]8N9+:X@(RI.,@
M@\,#@9'M]:A'A*)H-6>XO)9M0U.W-O-=E%!5-NT*J] .^.Y[UHZ[K$.@:-<:
MG<03S0P ,ZP %L9QGD@<?6I]-OHM4TNTU"%76*ZA29 X 8*R@C.._- %/PWH
M@\.Z%;Z6MW)<I "%>10I SG&!V^N355_"J?\)C_PD<%_<02O (9H452LJ@@C
MD@D=!T].HK>21)"P1U8H=K8.<'T/OR*=0!Q ^':KX2O_  __ &S<M%>W?VEY
M6B7(Y4[<?50>,5I?\(D6\5VVO/J<S36]D+,)L'S#G+$G/.2372%@" 2 3P!G
MK2T <K8>#IH;S2KC4=9FOSI8;[-OB56RPQ\S<EN/Z5I^)M$?Q%H<VEK?/9I.
M0)'1 Q9>Z\],\5KT4 96L:*-7\.7&CO<%%FA$1E,:L>W.#QGC\.U>?\ BJW'
MA[3_  YH>I:]<QV:2R/]O>W$@4(OR1LG(;D\9'\J]5HH \Y\/2ZEXFCUC3AX
MADU+29[0QQWWV$0^6S':5 ( ;C/3I6W=^!X;_P *Z=HUQ?S>=IVPVM[&NQXR
MG"G&<' P/UZUU=9TFL1Q^((M'-M=&26 SB<1_N0 <;2V?O>U &,W@K^T+*^M
M]>UB]U0W40AW,%B6-0P<;548W;@#DYZ =,Y?I/A2\L9;9[WQ!=:@MG&5M8Y(
MU18SM*;FV\N=I(Y/<]ZZ>B@#A!\-HO\ A"?^$9.JR& 7/GB;R1N'^SC/KSFM
M/4/!RZIXBM=7N[XL8K-K1XA" )58,&).>"=QZ5U%% '':/X'NM(2"T'B2^FT
MJ&3>MDR( 0#D*7Z[<XX& :9/X%N)=)\1V']JAEUB<S[G@YC;@]CR. *[2B@#
MD_\ A#[B+5=$U"VU5H9=/M!9RXB!$T0Z<$\'ZY[''%3^'(=<BU[Q"=1N99M/
M:Y4V(E7:5!!+!?\ 9&5 /?:?>NEI"< DYX]!0!S&K^%;J^\866O6>J-:F*W:
MVFC,8?<AR?ESP#D\GV%8_P#PKN]'AS3-(_MA9!IVH?:X7DA)^0'Y4^][G\^V
M*[/2M4AU>R^U01SQIO9-L\1C;*G&<'M5V@#GX_#]TOCN7Q"U\K0/9"T6W\O!
M4;MW7/KD_C47C+PS<>)[73XK>\CM3:7B7)9XRV=H(&.?>NEHH YOQ+X:N-=U
M70KR&ZBA73+K[0RO&6+\C@8(]*XB\U$WWB[6KH>(M$L!!.+:.'5+9#(H11DJ
M6P<%BV*]7N)XK6WDN)W$<42EW=NB@#)-<]I.NZ)XBU5O(T^4S1QK-%=7%GM$
MBYX*.1SV].O% &3;Z-K/B.?POXAN[FSBNK!I&E18GVRHS8! )!!*#//<].U2
M/X$N97\6F34(MNNA=FV(@Q%=V,\\]:[>B@#E9]$\0S6-O;R:G87(^S20744]
ML?*DW'A@ PY &.?ZUJ^&]$3P[H%KI<<K2B 'YSW)))QZ#FM6B@#C;7P,T-]X
M@CEO5ETG6F>66 IB1)&.<A@>@R<<>E$7A36+JVTS3]8U.UN-.L)4D'E0LLTQ
MC^X'8L1Z9P 3BNRHH Y_QS(D?@76V=@H-G(N2<<D8 _$D"L71_#^I:UIWAV;
M5[ZSEL+%(KF"*VA*L[A $WL200 3T S7:7=I;W]I):W<*302KM>-QD,/>EMK
M:"SMH[>VB2&&,;4C1<!1["@#SJX^'&LOI]WI\6OPK:R7WVU UM\S/NS\Y!&>
MW &,BI?&"Z;XLU;2- M[N.?5;:]'VL1 CRX0G[W)P1SD#'/)QV->BU#':6T,
M\DT5O$DLGWY%0!F^I[T <]XK\,W>O7.BRVEU!;KIMT+DK)&6WE2-H&",#@Y_
M"H(_"NH1^+-<UI;RVVZC:^1'&8FRA"@*2<\CCG^E==10!YU9?#G4--T[1FLM
M5AAU72GF$5P82R/'(22&4GJ-QZ>OY6]>\&ZWKGAA["YUB*XOI;J.=Y)$*1(J
MC&U%&<=S[G\Z[JB@#FQH-^?'+:\US;BV;3Q9F%5.[.[=G/3J:R]%\-^*=$\-
MVNE0:AI<@M9SM5X6VS0G=N5SZY8$8],'(KN** .>\+>&O^$=_M)S(A:^NFN#
M%"NV.+/0*/Z_3TK"UKP5K=[XBUF\L]1LA::K9BVD%S&SR1#&,)C&!U/7J>E=
M]10!P>F^$-=LK[PM,]WIY32+9X)PH?+AN/ESU^4#DXYSZ\1W/@+4=1L->M[V
M]M1)=Z@+^QEB#9C<# W@\=,# SW.?3T"B@#AK7PQXFN?%6CZ]K-]I9EL(GB9
M+:.3YPP(SDGK@D] !Z&M7QQX<G\4>&VT^UFCBN%E26,RYV$J>AQR.IKI** .
M1/A:\UO4SJ'B);%9$LY+2&.S+.%WY#/EP.<' &/Q-5="\/\ C+3VLM/O-:L3
MH]DRA#!&PGDC3[B-P !@#."?3FNUEEC@A>65U2-%+,S' 4#DDU6TO5;'6K%;
MW3KA;BV8D"100"1P>M '%R>#M=NO"_B?2[B;3A+JMX;J!HV?:I+*6#97CA!C
M />GIX3\1:/J,.I:!<Z8+F6SBM[Z&[#^4[1J%#*5&[MW_P#U=?9ZSIU_?7=E
M:7<<MS9L%GC4\QD^OY&KU '"^)/".NZQX>T^R2^M;B\BO1>7$UR[HI89PJ !
ML+ST[8K5U'1=4N_&^C:Q"]F+*RADCE5RWF$N,';@8QPO4CO72T4 <+I7ACQ)
MH3:_'I]SI30WUP]S;-.'+!V(R' &-N,],U=\.>%[K2O$^HZM)!86D5W;QH;>
MR=BID'+.054#GICU_/K:Q=1\7:!I-]]CO]5MX+@%0R,3\N[D;CT7(YYQQS0!
MM456T_4+/5;*.\L;A+BVDSMD0Y!P<']0:LT %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4AZ&EILD:RQ/&V=K J<$@X/N.10!XIIFE0V?P
MV\.:Y#-=+?C4$".+A]J*TK(5"YV@$=<#G-:EWH=WXTUSQ YU"UBNM/O3#;O)
M)()+5%"D,JJP S@\D'D'TKN_^$,T#^Q8M'%DRV$4WGI$MQ*,/SSN#9[^M,U#
MP-X;U34I=1O--$EU+CS'$TB[\# R%8 \#TH XR^@EUCQCX=T6\U>:[LKK2'%
MQ):SLD=P0'^;@X.<"H+71;[Q7<:VB71MKC3+P6UG-/<2[[9$4+D*K 98#.XC
MG)Z]O0CX6TG^VK+55@=+FRA\B )*P1$[#:#C@9'IR<YXQ1U3X?\ A[5]7_M.
MXMI%G8YF6*5D68]MX'7\,>^: ,NT61?B7IGF7AN6ET#][*K?)*0X^8 <<\G\
M:XZ/4;Y_A7-<-JUY'<+K?EI()FWLO V;LY P2?PKT_5/".E:K=V-TXGMYK)=
MD36LIB/E_P!PX_A^F*@N? N@3Z,^E):R06K7(NL12MD2>H))QZ8Z4 <I)-)X
M7^(.LP:?+,86T-KUDGF>7=*F<'+$GM4,MC')X+\-ZO+>7-W?7>H6<TTTER[+
MN:3) 3=M&"2. .E=V_A?3G\2G7G\]KLV_P!F*F0F,I[CO_+OUK*_X5IX<*M$
M\=X]MY@DBMC=R>5"0<G8H/&?Q]L4 8)MM4\8ZAXHCAOC:W-I=?9;7%W-&857
MHVQ,*0W/)SW]!EE]%>:MX]T;1;C6[LP2:()));&X:-99 S?O!@]\ UT^J?#_
M $'5M8;4YXKA)Y,>>L,[(LV,8W ?0=,5=/A/3/\ A(;'6HQ+#<65O]FACB8+
M&(_FP"N/]H_D* +&H6=Q'X9NK*QNI%N!:M'#/*^6#;2 2Q[Y[UPOAN^:2UU.
MQU&WU*QUFVTIUFM[F=Y(YU QYJ[B><X!Q_>[UZ+J-C%J>FW-A.7$-Q$T3E#A
M@",'!]:QH/!UC$EUYEYJ%S-<6ILS//<;I(XCU53CCGGOTH XC3+"73?#?@C5
M+?4K\2SWEO!+&9V,;1R$_+LZ  # X[_2CQA?O#8^(]3L=5U">[L[N!4E60QP
MVYW#,2J&^8X/)*]^M=E)X&TR31M+TO[3?K!ILOFP%9\-NR2,G'.,\>E07OPW
MT"^DOVD^VHE\_F2PQW++&),@EPO3)([YH A+F3XIZ9(WWFT1R?J9!5GP-_J_
M$/\ V';O_P!"%7K;PI96NM6FJI<7K7%K:BT023;E9/\ :R,DYYZ]A4N@^'+3
MPZEVMI-=2BZF,\GVB7?\YZD<=Z .,U_3EU7XS6-J]S<VZ'1R6:VD,;D;Y.-P
MY'_UJRH-7U5-/N_#XO;B2-?$7]G)<S7!1S#ACM\P D'*=>3\V*]$U;PM9:KJ
ML&J&>[M+Z&(PK/:R[&*$YVG(/&<_G4%WX(T6]\/G1Y8I?),WVAI@_P"]:7O(
M6[L>Y]Z *OA/2-;T?4[^/4K^)[.95>UM!>/</%CACN=5)&2*KZY81W'Q0\/2
MM+.I^R7'RI*RCY<$=/7<<^N!Z5N:'X:L]":62*>\NIY0%:>\G,KA1T4$]!G)
MQZFEU;PY::Q?V5]+/=P7-GN$<EM,8R0V,J?8X% '$Z>;W4_$_BBYFUC4/(T:
M]2>*V27:C[0Y*'K\IVX_I4>A67BK6K;2_$L>J6ZF27SI9'U"0QF+<VZ/R1'M
M&!Q][MU].YTGPS9:/J>I7\$MP\NHOOG61@5)R>@ &.IK-M?A[HMI>^?')??9
M_-,PLC<M]G#9S]SN,\X- ',^*-9EM-+\1:II^M7=U-;7L48,;F.*W 908@ <
M,>3DX/YUJ6P5?BEJ=^/,,G]C1S!3(VT'.,8Z8X_/FK5S\,]%NCJ"O<ZBD%]-
MY\MNEQB/S,YW8Q_//\L:1\(6G]NV^K+>7JS16RVKH)!MF0=-_'/?- ''>'+3
MQ5K5MH_B&+5(T668/=>;?R,LD6_E!$$VJ>HZ^E3/>77B%/'4MS>W:0:<LUK;
MV\<FQ %1LD@?>R1W[5O:?\.]*TR_6:"[U'[)')YL=@URWD(V2P^7N <$9[@=
M:=>^ ;&ZU.\O(-0U&R2_W?;(+:8+'-D8.00<=R?J: '_  X_Y)[HW_7$_P#H
M1KF]6U:ZALKO4K'7+N[E378X5\K*1+&6 \E0?D? ZGU[^O?:+I%MH.DP:;9F
M4P0 A/,?<W7/7\:Y:X^&.GW%C>67]JZFMM<3_:%A$HV1/D$D#'UZ^M %#Q%J
MM]I7B34UUB75+72+E(UL=0LV8QVK;?FWJ.Y.>N?IW'<ZK*PT*]F@E*L+9WCD
M0C@[2016'J?@O^U/M<,NN:BMC>%#<6OR,K;0HX)4E<[03@CFN@O+%+G2Y["-
MC;QR0F%3&H^0$8X!&.* /-=(;7;GX:7'B:3Q+?M<G3YML;!=J%'.&&!UPA&3
MD_-6CKNN7MII'A&2XN[BVT^\$8O[R)L/N,8*@G!(R<G(]*VX/!4-OX)D\+KJ
M5W]E8,HE 4.JEMQ7IC!.?SKF?%T":3-X>TRZO]7MM-M+=MM_;)O)E "J& !Y
MV[NW?ZT 5IH]4_X0CQD]YJ]Y?VD9>&U:X4891M.X'&>Y'7!ZU+HL]]HFH>!-
MVLWDMGJMELDM9 IC3$"; H X^9ASUXZ]:OZ+I5UXDTS5;1]>U.\T.[B5(Y[J
M )*'!.\+N'*\#/ Z\=#6U_PA-N9?#SR:A<N-#7; I5 'X ^; ]%4?A0!QWAE
M]8'P]\5W&C--)J;:I+L"G<W6/<5S_%M+>^0*Z[P7JEIJKW\MMJ.HR,I19;#4
M/]9:MSGD\X/_ ++20>!(K.VU:WL]7O[:+4+@7(2(J! X</E./]D#Z"M/2O#R
M:;J]]JLMU)=7EXL:.[HJ[50< !0.N>?PH Y?Q/$9_BSX5B:XN41H9F CEVA6
M56.<>XX/J*BLKW4?%&E^)-935[ZQ>RN98;2*%P$C6)%;)7'S$DG.:Z?6_"D6
MLZUIVK+?W5G>6&X1O!M.0>H(8'MD?C52;P0OVW4I;+6K^RM]28M<VT6QD8D8
M8C<I*D^H_H* +O@O5Y]=\'Z;J5R<SS1$2-@#<RL5)P/4C-<3I&IZ[<)XBUVX
MUVX:UT:\N=MB(UVR*JD@%N#CIQR./>O2M-T^WTG3;;3[12MO;QB- 3DX'J:P
M]%\&6VD6FK6DEY/>6^INTDZ3*H^9@0Q& .H[>U '+^'F\9F_T[6)Y[N72IH3
M->">>%U*E,@QJN"O/:K&@)XA\6:#:^(;;7YK:ZENV=;<J/($*N5V%1U.!G)^
MGO6SH?@5-%DMU.MZG=V=OGRK2>0>4#R.0!R!D\=*@M/AZMA<F.UU[4X=)+E_
M[.23"<G)7=UVGTZ^] &#?7_C/Q!JNK2Z')/%'87CVMND4T*QY0X8R*WS-G''
M89K9GUO7(/'_ (7TVXG6&"]LG>[M%16 E6-B?GQGJ!TQT]ZGN_ ).MW.H:7K
MM_I<=XYDNX+8C$C_ -X$_=)))/7KVJY)X/C/B?1M8COI5CTJV-O%;LN[<"I7
M)<G.<'WZ4 <U-KNLZ1+XJTB^OYY=0.R72FPH9TD;8H0 8X. ?Q/')J75;[Q)
M<ZX_AW3;JZ:2PL87EF@:%'FE/\3%_P"'CHO7//!KK+[PQ87_ (GT[7YMWVJQ
M1D10!M;(.,\9XR2/>LS7_!#:KKR:UI^LW6E7OE"&5X #YB YQU'/3GGH.* -
M7PN=;.@6X\0HJZDNY92K*0XSP?EX''I7&^*/$6LZ38Z_J-OK<,K6EY"D-K!&
MK)$A(!61BGWCSD \5WNE:<-+T]+4W,URX)9YYVR\C$Y))_STKBKSX7FZCU:V
M3Q!=16.HS_:3;>0C!9,YR6/)&>PV]* .[DDE-@\D2@S&(L@_VL<?K7GOA_QE
M--8W<]YJ=R=5T[3Y9+K2KNW2+?*HW;U( ..",>^<5VYTN9_#ATJ34)S,;;R#
M>*-LF=N-XQT/>L*#P1)/?QW6MZH-1,=E)9+MMA"S*XVLS,&)8[<C\<]: ,W1
M;KQI->:'>,9[BRNU+WJW"VZ1QJP#*8RGS\#/WO:F>';OQ-K_ (BUK'B#R++3
MM4E@^S_9(VWQ@G W8SQ@#UZ\UI:'X(OM(EMHY?$]]<Z=:MN@LP@C'7@,P.6
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MDK.'D<89R2 0 .@YZ]:ZF@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU%9^$+Z2;49M/4[%\^W&9!EUR%&1R1D=>,Y[4 ;5_=?8=.N;ORVE\B)I-BD
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MR,JC[5.<#MDG/M6??1:CI7@>T\:P:_J4NH&.WN)H990T$@D*AD"8PH^;MZ4
M>K45YMJO]I:KX@\36IUK4K2UM=/CNH887$91RN<$@9ZKTSW-=/X%U2YUCP3I
ME_>/ON)(V$C_ -XJQ7/XXH N>(_$=AX7TE]1U!F\L,%5$P6=CV /7UI-4\0V
MNER64+0W-S<WI/D06Z!G8 9)Y(  ^M>0^,O$VE^(=(U:ZFGNENV98+&W:V8*
MD2N"3NQC+D9SU  %==97<.I?%72+PR[K=]%+V88%#NW$-P0#TW=: .EC\::2
MVBWVIO\ :(5L93#<021XE63. NW/).1C![U-8>*+2]U8:7+:WEC>M%YL<5W&
M$\U>^T@D''<=:\\U[2-2USQCXMLM,0NR"SN%3=M1Y%"\$],X+<'^E:.HZC=^
M(/B'X3MSIT]C<V8EN9XY74D(0HYVDX^[WQU'K0!W>NZ]8>'=/%[J,ACA,J1
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVGF1VL5NSS!0,DL@Y&,@'/>N+\8Q:CJVI'6M.@2*X\- -MDA<FYD)!95Z90
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M:,9>(G&0%)YSVZU1T_XA:1J%F;Y;;48;!8FD>\FMBL*;3C:6S@MZ 9Z@=>*
M.LHKSC4M<?4O''A"2*#5+*.5Y3LGPL<JF/(. QY&>_K74>-/$$GACPK=ZI#$
MLLT>U45CQN8@ GV&: -^BL2?Q+!;"RA:TNIK^ZA\X6<"*TBICEF^; &>.O6I
MM%\0V6N_:4MQ+#<VLGEW%M.NV2(]LC)X..#WH U:*Y[5_&.G:/J\>DR07UQ?
M21&5(;6V:0L!Z8[\'\N<5%!X[T:;1-0U1_M,":>_EW,$T)66-B<!2OJ20/\
M"@#IJ*PV\5Z?&FJ&:.YB?38DFN(WB^;8RY4@#KT(QZBJ*_$'16MY9RE\L21P
MNK-;,/-\W[@0=6)_+WH ZJBLFW\2:;/>ZC:>:\<VG*'N5E0KM4C(;W&*S+;Q
M]I-S=V4'D:A&+_\ X\Y'M6VSC/5<9.._(''- '4T5S$/CS1[G6!IENE[+/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTYY!XZ&O(-"U2&Q@\(:IK-W<1Z9':W5JLL#-^YD$AZA02,H5Z<G /:KWB?\
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M6GMK_P <W5UI$D%Q VA3B_DMV1D/#; Q'5L@<=< =J ._.N:6IL0;^W!OO\
MCU^<?OO]WUZBH+KQ1H-C))'=:Q8Q21ML=&G7<I]",YKS6'Q%HD_A?P/:I?V[
M7=I?VOG1Y^:, ,&SZ#./TJ]?6>E7%_\ $DFWLY)8[170[%+*P@)8CT.\9/O[
MT =U>^*-)T_4].T^>Z037X+0G/RE0,@[NG/ 'KFM=W6-&=V"JHR6)P /6O*;
M#58+=OAQ>:G.BH;6YC\V0@!3M0+DG@=!S77?$1+N7X?ZN+'F3R0S8[Q@@O\
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M-2<V]LV_;L^4LSY'(PJL<^N.O2D\"ZXVO^%+6XG9C=PYM[H-U$J\'/N>#^-
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M(IH1.C+#(V$/1F 4E0>V<5<O?$>D:?;6UQ/>*8[H9@\I&E,@QG(5 21COC%
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MH'YFL_Q;:7UKXX\.^((=/NKVTLUFCF2T3?(NY2 =O<?-^AKN(XTBC6.-0J(
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M-AEOK/4!<36D,P^5#D !CP2 1D].M=5?6KZGHES:2 P/=6[1-T;RRRD?CC-
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M6.?GDP ,$=,%3^58?A:7PQ<Z1I.FZM<:DVK65RN+ %R%E$C$,% Q@Y&3G\J
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M@.X.3^*_I0![+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM0+C.23TP,>U=%8>-]&O;/4+F1Y[+^S@&NHKN$QR1J>AV\YSVQD_F* .CHK
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M9%M4D_LXIA;=1C+[NA)W ^O/THLO'OAC4&*VVJH^(GF),;J B?>))4 8].M
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MG1?%=[X,3P;>Z5&L:F.$ZFMRFSR58,"$^]N  &,<]?KLP:9JMM\2X[V/3/\
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MYA9?-4-G !^]D?R/M6[8):R6]\^F>!+C2F^P3"2::W$;LQ7 2,#)<D_3I^%
M%]?BAI+:<;_^S=7%L(#,)3:?(0&VXW9QUXSG'O5U/'NFO9-=-9:E&IEAAA22
MV*M.THR@3GG.#R<?K7+PZ?J(^!;Z4=,O1?A3%]G,#;R3-NR!UQ@]:U-;N=<L
M_!'AZ+3;'4-Y\B.\%O%FXBC"8<*I'#<<'M0!HZGK]MK/A?Q/;P?:+6\T^WE6
M:-F"R1L$8J<J3P<>OJ*M> 9I;CP)H\LTCR2- ,N[$DX)'4UQ-A'J0N/'DLVA
MZK"-5L]]MYD&22$9=I()&[YQQST/I7:^ (98/ FD131212+!ADD0J1R>QH X
M]M/@N_BGXAAO-7O[.WM[>.:.6.^:/RF=5!P2< ?,<#IVJ[X/\8S0>'[B34[B
MXU)5OWM=/:--\]TBJ#]T?>XY+>_-06VDVNL_%S7'U31)9[0PQI%)<6I,8=54
M9R1@9VG![U<^(6F>5=Z!J0T0ZGI=@\RW-G$@.%=0 0N.Q&?J!0!KP?$'1Y-"
MOM5ECO+=+"807,,L!\R)R< $#(Z^]9^I^*]#UFTM7FDUFRBCU&%()8XS%YSD
M$KUZH<'/T^E8.O!+KX;ZTND>%+C2[6X-OY2&#;+,WF*2Q1<X4 <'/>MGQB\O
M_"%Z"D5G=S/]IM698H&9D"X)R,9'3'UH Z+5O%=MIFH"PBL;_4+L*KRQ6,/F
M&%3T9N1C..G6FIXST>;1(=4MY9)XYY/*B@CC)F>3N@3KD?RYK#%U+X5\>:W=
MWUO=/IVJ)%)%-!;M(JNBE2K$=#P<5S%OHVJZ"]EXFFL;N6W&L7%W):QI^]2*
M0!58KUSQT]Z -32KR[UKQAXIMK:YUJT\RP1DAF;9+!(<'"!B0O7CIUX(X-;U
MEH.O07GAN275[UOLUNZZ@&FW1RGJ 03DL2Q&>>%[<9S/#$\UY\3]7U1-,U&*
MROK2+RYI[<QKE0HYSZX./I7HE '-:!JMPNO:KX=OG:26RVRVTS DRP/TR>Y4
M_*3W]SFNEKB(+H)\1/$NI+#++#I^FQ1R",99WYDVJ.YQQ]:ZS2[\:IIEO?+;
MSVZSH'$4Z[74'U':@!=2M1>Z=/;F:>#>G^MMY#&ZGKD,.E>>>"?%4.C_  _A
MUKQ!J-].;FZ:$R2L\VT@D#'7 P*]"U.]AT_39[J??Y<:\A$+L<\  #D\FO%X
M8YA\';6Q-O>+=1ZFK/&MNQ=1N+9 (YXYH ]6T3Q=I6OWUQ96AG2Y@4.T5Q"T
M;%2<;@#VZ?F*A\5^*CX9.F*MA/=M>W(AQ$,D#O@=V]!WK&L(Y%^,^I7#0RK#
M+IB*DAC8*3E#C..N :L_$-Y+>WT&^2UN+B.SU:&>98(R[! &R<#ZB@#)N_%+
MZ5\4)C=3ZDVGOI2R)9I&[[7++_RS'0XSDG\ZZE/&FC2Z':ZM#+-+#=2^3#%'
M"S2O)SE=@YSP?;\Q7.VDQD^,$FH>1<):RZ, LCP,!G*OCIUQG^76N%TS3Y[?
M0](U&\TN^NK.TU&X6YMHTD20+(%VN,$'C']* /9=!\2:?XBBN'L3*KV\GES1
M31E'0XR,@U'K?BG3M!D6*Y%Q-,4,C16T)E9$R!N8#H,D#FLOP3'I?VG4[C2=
M$O+"VE\K-Q=E]URPWYP').%SC/?)]*YGQ#:V^G_$B^O=<TJ_N]-OK:,0369E
M/EE5 *D(1U/;GJ/>@#LY?&^B1PZ/,LTLD.K2>5:R)$2"V0N&_N\G]#5N7Q+I
MMOJ&H6<[R1G3X5GN960^6BMTY]3Z>QKF;[0[75?A;);Z1IESIXB#75E;R%O-
M5U8LIQDG+<X'^UVJAJ>EZGJGPLU:^GMY'U75#%=R0 '*HK(50#KPBY^I/3H
M#JM-\;Z+JEW-:1O<PW,433&*XMG1FC'5E!'/TZ^U5;3XD>&KZXM(;>ZG<74O
MDI(;=U19#T4L0!DUB^'F\-W.K0WVG^'-3AO(8':6YN_-_P!'78<@;V.XDDC
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MOJ:G[)<W"*JR,.HP">.G/N.W- $O_" :;_T$=:_\&4O^-'_" :;_ -!'6O\
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MRPVB1O)L8,00J*#CA23^-;H\8Z1)HL&J6[SW$-Q(888XH6:2209RH3&<_*:
M-^BLK0O$-CXAMYY+,RJ]O*89X9D*21.!RK*>XZ?@:I^+->DTFP-O9 /J5Q'(
MT*_W%526D/LO'U) H Z&BO+(/$NJ2?#WPQ;)?2_VIK5S]F-VS?.B^8P9@<'G
M& /K[5JSWM[X3\8VU@VI7-[8W]E*Z+>2[V2:,%N#CH1CC_"@#OJ*\IEU#5M&
M\!:=XP&N7MW<LR23V\K@PR*[8*;?X<9ZCTKN_$VL-IGAV2>#_C\N0+>S3/+3
MR<(/S.?P- &W17*?#_6KG5?#YMM2=CJVGR-;7BO]X,"<$^N1W]0:TO%GG#PE
MJLEO<S6TT-L\R2PMM8%!N'/H<8/L30!K3"0PR"%E64J=A89 ..,^U8/@W0;W
MPWHS6%Y=PW1\UI%DCC*DECDYY]3VKE?#VB^(=5\(VFLVGBW4UU&:$ND<[*\.
M[)&"".G\NM;/AKQU%J'AEM0U9!!=0W36<D4",^^0<@*HR3D?R- '95S6M>'=
M2UK683-JX&A#8TVGB ?O2IS@MUP2!FF7?C.RE\*ZOJNEL\LUA&VZ%XV5T?'&
MY2,@=\^@/I6)X9UA=,T.'Q%K.N:G+%=01H;:XB)#3$!BT0QDC&?N\<'TX /0
MP,# HKG8?''A^?1;K54OL6UH0LX:-@Z$\ %2,Y-1?\+"\,")I6U+;&)%BW-"
MX!8KN&./2@#IZ*Y^V\;:!=V-M=Q7C%+EI$A3R7+N4^]A0,\<?G7/^./$C3>$
MM(U?0M1E2*XOXDWQ';N4[LJ>_48Q0!Z!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !4-W'+-93Q02>7,\;*C_W6(X/YU-2,RHI9B%4
M#)). !0!Y7!X-\6BV\.Q2V^EYTF\,[-]I<M-\V=S$J>N/?J.G0=)H_A[4I++
MQ18:M##!#JMS+*CPS;R!(@4\8'3'YY]B=M?%'A]V"KKNF,Q. !=QDD_G6J"&
M (((/((H XCPU8^-M.2STB[&EIIUF40W:LSRRQCG !X!(^4DXQU&:UO&OAZ7
MQ+X=>SMWC2ZCE2>!I,[=ZGOCL02/QKHJKR7UI#>0V<MS$ES."8HF<!G ZX'>
M@#EUL_$&N:YI%QJFG0:?;:<YG8K<"1I9"I7"@# 7G//-8%EX4\2V/@G7_#XL
M[23[1([6\HN<&3<5[8XP >IZ_G7I]!.!D]* .#UC0]=U;6?"4XLUAAL4)NW6
MX!*%U564>H&#R.N:K>'])\<:#$F@0QZ<VE12-Y=^[YD2,MGA>[#)QD8S[5WE
MGJ5CJ*NUC>V]T(SM<P2J^T^AP>*LT <;X=T;5M/\?>(]0N;5%L-0V-%,)03E
M. -O7D$GVQ45[X';4/&5]<7+*^AWL"R36^?O7"@H#CV4YSZXXXS78W5W;6-N
MUQ=W$5O"N-TDKA%&>!R>*E!! (((/0B@#C_!7A[4?"_ABX%THN]5;=M7S!RJ
M#;&@;L,#/MN-9FDZ#K5EX$TO0[[0K:^BCEE6[MFG7<4)9E96)P#D^N>*]$HH
M \JA\%>)+'2[6YL$B6XL=3>YL]/N)_,"0L,;"_3/&>#WZYKM] _MZ::6XU>T
ML]/B*A8[2W82-GNS/_(#UYK>HH XS6M-\06'C)?$&B6L%_'-:"UGM9)1$1AM
MP8,?K6(?"OB2\\):]9WUA8B\N-2^WVBI/GYS(&?D\ ;00#UY.<5Z=10!YK<^
M&?$'B7Q4=0U?38+"VFTN2Q<170E:,DL58X SRW0>G6KWAFW\865MINDW>C:=
M;P6H6.2^$P=FC48&$'.XX R?RKO** .>\<Z1=Z]X-U#3;%4:YF5-BNVT':ZM
MC/T!K&U33M<'B#1_%=OI(EO(;9K:]LA.NX+DD%#G!/)[]Q[UW5% '*^'-,U)
MO$6K>(-2MELVO4BBAMMX9D1!U<CC))[51\2:=JT'C[2?$5EIKW]M;VSP21Q2
M*KAFW8/S$<?-7<44 >8W?@C662?7;6*)=8DU5;\6C2_+Y8R/++=,X)SCU(R:
MZSP[<:]>3O/JFCVNE0!,+"DHDD=L]20   .WO7144 <CXML=4O/$/AB2RLVG
MM+6\,URX91LX !Y/3!;/X57L[?6;/QUXFU(Z5,UE<6T8APZ9E>-< #YN,\]?
M:NRCGBE:18Y4=HVVN%8$J?0^AH>>&*2..26-'D)"*S %L=<#O0!YEINE>*;'
M3O",1TVX:ULO-%W:17*HS,<["QW %>AQ]<]:S[;PEXCM=)-RFF%K_3]>>_A@
M:9=LT95<@'/JH_,U[#3!+&93$)%,@&2F>0/7% 'FO]AZYKWBW6+ZXTB6PM-2
MTA[,&:9"R,<8^Z3W7\C5_P ++XD2#3=*U'PS:V_V%E5[YG1EVJ, HHYW$9&>
MV<^U=]10!S7C^TO=0\%W]C86DEU<W 5%1"!CY@<G)''%8\&GZHOB#P7,=,G$
M-C8/%<R$K^Z9HPN#SV*]O45WM% '*>#X-1BU+Q%-J&G2V?VF^\Z'>RL'3:%&
M"#U^7/XCK576=.U"?XH^']2AL)I+*TAE2:<;=JEU8#OGC(SQ7:TV21(D+R.J
M(.K,< 4 >7C1M<'AKQQ FCR>?J-\\MJC%0TB.^,YSC@<X_QJYKNB/J]I )]"
MU*'4+2PC^QWUG*H</MYC?YN,-]1R<$5Z,"" 0<@]#34D23=L=6VG:<'.#Z4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBE7S8'4[NA.",G'''4_72\"V6KV0ULZKIALOMFI27L0,Z29$F/E^4GIM_'-
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M5)?"&JWFCZ@)[NX;[#AL>5G W/@X((PP]@?>L"7P=XEN+71-4>:5-9N?]#U
MALA+5DVX(SC@ DX_B;/! QTOBJSN8=1\*V^F:3<3VUA=*[>0HVQ1A=@')'K^
M0H O2>,7.KWME::+>W:64\<%Q-$R?(7Q@[<[B!GD@=C5;6OB%9:1/>[;*:[M
MK&18KJ>&6/$;G'R[2VXXR,D#&>.U8.OZ7J-WJUUJ&CZ5J>FZ^EUY<<]NP%O=
M1!@ \ASC[N3T]CFF'2[S1]=UJ&[\$PZ]#>WDEY:W(2-L;S]QBP.T#'X<\'-
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M,.K-Q@D9'(YQ]:Y/3/"FK7'B'Q3;7NI7EQ!+;1P^9<VX5;K*.%Y_V#@Y7\:
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MB3<UQ<,0 =W;)('/ H [DS1"983(@E8%@A8;B!U./Q%$LT4$9DFD2-!U9V
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MT'1KK5+I7:"W3<PC&6/. !^)H OT5@/XIAM;"_O]0L[BTL[6))EF8JRSJP.
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M+R\M]/LY;N[F2&WB7<\CG 45B:=XUTK4-1DL-EY;7*0&XV75NT9:,=QGKP:
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MJ]^T2[9MJE58E0"1R2#3]<\)^);W5_$3016$\.I0B*WN+B=MUNF!N15P<9_
M=.M>E44 >;Z=X6\16&N>'-3%K:.;/3%TZYC:XP%"LPW@XY^4@X]:DT#0_&/A
M>VNM%TV'2Y+$SL]M=S2-F)6Y.4 RWZ<^HKM(]=TF74VTR/4K5[Y20;=95+@@
M9(V]:T* //Y_#_B'2=?\07&D6=E>V.LJ&99K@QM&VT@]N>23P>];G@32-0T+
MPE::9J4<*30%P/*D+@@N6YXX//O6Y:W]I>F86MS%.8)#%+Y;AMCCJIQT-6*
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MTBA\PR-/YFP;@ <+UZ9/'O6AX5\2>(+S7I=-U6PDEMC%YD=_'92VZ!ACY2)
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4'D44CN$1G8X51D_2@#SS3? .JVW
MA4^%[F\L7TR2<232HK^:RAP^ .@SM SGC-79?"WB'3?$>J:EX>U2RBM]1P\L
M%W&SA).[+@]?TYQC@59A^)W@^XD$::P ?5[>55'U)4 5T]I>VM_;K<6EQ%/"
MW1XV##]* .:7PQJB^(] U&34TNH]-MGBE,RD22NX(9QC\.,]JQ%^'FJ?V9J,
M8U&VAOI=4&IVDT:DB-\G(.1TKT>L.?QCH-OK::/+?@7SR")8Q&Y&\XPNX#:#
MR.,]Q0!6MM-\32+<3:IJ5G++Y#0P6]LC1PDM_&^<DGT XZ^M81\&ZY_PK!O#
M$DEC-<JY5'=FV^7NW#MPPXQVKT*B@#C=0\,:O<>(?#>LP3V:SZ=&T,Z,&*D,
MI4LO0G@GCZ57O_"NK:SJ\$]_#I2RV=ZDT6HQ*RS/$&W>65]A@<DUW50W=W!8
MVDMU=2K%!$I9W;HH]: ,GQCHUQX@\)W^EVDB1SSJNUG)QPX;!QZ@8_&N83PK
MXI;7I-0D?1U6?26T]HXE>-(AV"@9SSS]./0UW6G:A:ZKI\%_93":VG7=&X!&
M1]#R*RKGQKX:L[J:VN-9M8YH6*2(S<J0<$&@#GK3P/J,_P ,(?#=Y<16M] Y
MDAEA<L P<NI)P/4]/;Z5K^'K7Q=)=0W'B*]LTCAC91;V:G]ZQP-SD^@SP,<F
MM^QO[34[1+JQN8[B!_NR1MD&K- '(^,] U36=2\/W.FK;G^S[P7$GG2%> 1Z
M YZ5!XBT#Q%'XGB\1>&Y[4W+6PMI[:Z)V,H)(/&.]=1JFKV&C6\<^H7*P122
MK"K,"<NW0<5=H X74/#WBEETC58;^UNM:L9YI'21=D+))@%%XR  .IYZFLC3
M=&O=4USQ]IEY+"MY>6]OS$244LC$#GG XKU&N?TBR\,V.OWL.EI;IJH0&Y5&
M)?:2#\V3]* .3M/"?BNXG\*F_73(HM#<(!&[,SH%4;CVS\H&/7FK%QX;\1S1
M>,(3:6>S6#FW87)XQA1GY?[O/U&._'HE% '!7OA/6K_X?:1IPEAM-9TIHY(&
MC<LA:,%5R<<9!S]:GFT+Q1XDT*_L_$%W8VOGP>5%#9H64/N5M[$GG[N !V8U
MVU5K_4+/2[-[N^N([>W3&Z20X S0!P,VA>--8O?#\NIPZ8G]EW"RM*LK,9<
M9)&.O';N:ZSQ?I-QKOA/4=,M2@GGCPF\X&00>?RK8AFCN((YX7#Q2*'1AT8$
M9!I] '!2Z)XH-_HOB!8K+^U+2)K6YLUG812Q'H0V.#WP01T]*U/#^@7L7B;5
M/$>I+%!<WR)$MK#)YBQJH R6P,DX'88KH;Z_M=,LY+N]G2"WCY>1S@"L/_A8
M'A/_ *#UG_WW0!2\1Z'JTOC/1/$&F6\%RMC%*CP2S^43N4@8.T_WO3M63<^
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MAE?7RZ.^BZC97T$EBS+!+/;,BR0Y^7!( R/3TQ[UW5% !1110 4444 %%%%
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MZYS0M(\;:)IT6@PG3?L4,I"7[.S2+"220$Z;N>.W\Z[Z7?Y+^5CS-IVY]>U
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MN_ADD47$>62,?>ZX&=Q_*M^SM=57XGW]_)IKIITEBD"W)D4@LIW= <]R/PH
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MIK<O;JW&6*Y7/Z5YI:'7[G4/"%]=^'=7>XL99$N[B=@2Q<8) )R%'7D #H*
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M26U"VMS=JRSR%#'Q@ 8RS?-C^&@#T.BO.[CXA:F=(\,7=EI4$LNL2-"Z2RE
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M9Q^% %^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0V-UJ%GG5;E;I&CC8"-PP)!![8 K<L_#VHW.LZ?J&N3V4G]FQLMK':QL!N8
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M,V5L;0P1V95/+XZ8/)) /&T#''% '&Q_\D;\8?\ 88;_ -&0U[%I'_(%L/\
MKWC_ /017#Q_#_55\$:QH#7MEYFHWOVGS0&P@RA(_P#'!^9KN],MYK32K2VN
M&1YHH4C=HP0I8  D9[4 >1>']0\2Z5X7UW4M%&GFSLM3G>>&5#YD@&TL0<XX
M7^5;FH?$&_U"[G@\/CFWLH[@A+&6Z,LCC<$^3 48(^8]_P!+5KX'UNST;5]$
MBU"R%EJ=U)-)/Y;&54?:& '3.U<?C5F7P=JVE^(VU7PU?V<"S6R6\\%W"65M
M@ 5LJ1S@#T_6@#H_#6H7FJ>';*\U"TDM+R1/WT,B%"K D'@\@'&1[&N._M_Q
MMJ3Z^=.32H1I=PT:HX9C)A<[0<CGODXZ^U=QH]E<Z?ID=O>7\E]<@LTEPZ[2
MY))X7)P!G  Z 5Y]HB:W>ZWXULM)N[&%)+XAFG4L\98$%@!P>!W[B@"T_C77
M=1U#0;+2(+))=4TQKD_:=V%DP?3L-I_.KUOJOBG6K^^L=/FTZT?3%CBGEEC,
M@GG* L  054'.#SG/Y%MX)N].\2Z%?VES ]II=G]DV2Y#N#N!;@8_BX%2S>'
M=;TGQ3J&L:!)921ZGY8N;>ZW#8RY&\$=>IX]Z ,6Z\>:[)X/M=?M+:WB^S7I
MMM2A="P ! W*<@@<\Y_O>U=*^K:G>^*+RTT[[++IUOIRRMYBGYIWW%%+>FT*
M3QT/O2Z1X22R\(W6BWMP;F6^\U[J<@G=))U89STXQ],T[PQX;F\,>&7L8YUN
MKYMS--*S;7;&U<]2 %"C ]* ,+2_%5X/"7A^*QTZQAU/5W=+:&,%88T7)9R
M.,#M[_6LVTU&?PSXJ\6:QKB6LMU;6%N2UJA42$_*!R"1N8+G\/2IK+P1XCM?
M#.BE+FV36M%N)7MU9RT3QOU4D $?X9]>+LG@G5];O=7N-;NK.*+5+)('@ME9
MC$Z$%&R<9P0?8T -T?Q?X@DURU34+)I--ND+/+'I\\*VG&1N=P 1[].*YWQE
MK.L^)/AU=ZPR6D6C3S*+>$@F8!9-H8GISCIVKL-(TGQC(8K+6]0T]=-M\(3;
MQ$R7:!2NUB3A0>^!FL&?P)XF/A>;PE'<V$FE+()(+J0L)0-X;:5''<F@#TJ-
MF33U=$WLL0(4'&XXZ5QUCXRU/^U]&L=2ATZ.74&=)+:"4M-;$+D;NWIGZUU-
MS97=QX>DL1<K!>26IB\^-3A'*XW >F>:X&Q\)^+;:V\/J8]&1M*NBYVEMTBM
MD,['N<$_4\T ;6C^+M0UK5)8+>&P58+][::V>0BX2)?^6N"1G/IC\ZV/%GB)
M/#.A/?>6)9FD6&",D@-(QXR0. .3^%<O)X5UW4]=T^]O;'3;6[M;P32ZG:RD
M231*3A"@ ZC R2>*Z;QAX>_X27P_)8HZI<)(LT#MG:LBGC..H(R/QH R_P#A
M(]:TCQ)IFDZ[!9-'J?F""XM6;Y''(4J>HY49]\UQM]>ZUJ/P>\17&L7$5Q_I
M@6)USN&)T!&.@&>@':NT31=7UW7M'U+7;6UM!I(=T2WG,OGR, ,]!M *@XY]
M*P9?!_BB3P=K?ATQZ>8)[@RVTHE8,V9@YW<8' /Y^U &GI/B?6+&_P!$T_5]
M,M;>QOK0F&:.X+F/9%O.\D = >G3/6J-M\3;FZ?3KF*RMGL[RZ$+01EVGB0D
MC>QVA>V<>X'O6G=Z'K5WJ7A<S6=H]I86Y2\_?D$L\9C<*,<@#GWZ<55T/0/&
M6BZ>GA^"ZL(]-BD/EWXR9EC+;B A&-W)Y/K0!;7Q/XEO?$FJZ7IVBV3QZ?<1
M1O)-=%3L<9S@#TY]NF":S;GXA:K:^%-4U.2PL_MFG:A]DFM]S@!>F[GDDDC'
MM6]H.E:M8^,?$%]=0VXLM09'B=)27&P;0"N.XR>O:J%[X COO&-Y?2LG]D7D
M :>U[27 #*'(Z< YSZ_G0!J2^(+B759;2VM(;FT32_MCR;\*7;.Q,X(PP!.<
M&N;T_P :1Z?X!T2^LM,L[!+V[-L%9B+>W^=@68@9YQG\3SQ6OX8\-:CX>\(W
MEI*R7FHR[E7,FU2H&R-=QS@!0#T[UFZ#X<UNP\#:;HM[HVGW:I/)]JM[B4-F
M-B6#*0" P)]^G4=@#0U/QE>:)I=L;^VLC?WERT-J8[@F!T R)20"P7GD8)SZ
M9JUX/\57/B)]0M[NSCAFLV4>; S&*8-G!7< >,5RO_"OM=L[*WNM/N(5N[#4
M9+G3[*5RR10L?]7N)[@ _GSS7<: _B&X$ESKT=M:DJJQVENV_:>I9F]>0,#C
M@]<\ &;KWBNYL/%%MH5F+&.::U-P);Z1D1SNPJ*1WX/6G7GB/63?V6CV&F6O
M]L26(O+E+BX(C@&=I7*@[CNR./2JGC/0[W7;W[*^AV^HV#VV(9S,(I;6?)^;
M.02I&W@9Z5G#PUXMT.[TG5=.FM]4O8=/^PW:7+[=XWE@0Q]-PYSDA??% %7Q
M5=ZCJFC>%[W4="$.IIK21?9'DP'^]_%@X#%0>AZ=ZW$\;W>GOK\>O:?#!)I<
M*7"_993(LBO]U<D YS@9Q^%1^(-.\47]CH,QL[:YO;;4TO)XXI0B1*H("@M]
M[KR>OM576/"NLZUKGBA6MX[>SO[&.&WG,H8M(A!7('(!YS^% $F@_$&[O]<@
ML;_3X4AN83,L]JTCB# )VR90<X'4<?G61XQU6_\ $/A2VU-M&MTTU[R%K6=K
MC,Z#S,;RFW&&&. W&>_;H-&C\;WJ0V.LP65C:11M'+-&XDDN/DV@XR0 2<GH
M>.U8$^@^-&\(Q>%CI=I*EI+&8[\W:J)$5PRC9C((XR3V'<T =8/%=P_BG7=&
MCL8W.FVB3QNTI7S"5!(/!QU'//3WXXWQ;KG_  E/PUT369+1()9-31=@;=MP
M74X.!UVY_P :W+[1_$-EXTOM7T[2H+R+5+)()]UV(Q"X &>1DC '0?E6+/X-
M\21_#/3M#2QBGO;34?.V1SJ 8P6.<M@<EOY4 =!XD^(8T?4[VPL;2WNI+&)9
M;AI;@IR>3&H"'+;1G.0!G\*G'CE]0ETBST?3DN+W4;3[64N)_*2&/OD[22<@
M@8'OTK,NM*\4Z'XFU+5-#TFVU"#6(XWN(9YU4PNH(*Y)&X<G_(YEU#1?$=AX
METKQ':6-OJES'9-:7-K'*MNJ9)8;"W8;L>O'O0 ?"V.&)/$D8MDM;E=6E62W
M1MRQ*,;5!P 0#N&0*] KSKP]I_BW1;'Q+>C1;7^T;V]^TV\)N@P?<WS G(
M!)!R"?3I7H41D,*&4*LA4;PIR >^* 'T444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5F6'A[1]+OI[V
MQTZ"WN)_]9)&N"W.?PYK3HH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2W$SA(HD+NS' 50,DFN:\,^(]7U^6&YDT:.#2;B%I8;E;@,P^; 5EQUZ].*
M.IHJF^I0&ZN;*!UEO8(1,T .#@YVY/09*FLWP?XA?Q1H"ZE):_96:5X_*W;L
M;3CG@<T ;U%%% !1110 4444 %%%% !1110 45!%>6TUW/:Q3(\]N%,J*<E-
MV<9^N#4] !1110 4451UF_DTO1[J_BM6NFMXS)Y*N%+ =>3Z#)_"@"]15#1-
M2_MG1++4OL[VXNHEE$3D$@$9'(]N?Q[5?H ***R=5U^VT[1M3U" "\.G@^=#
M$XRK  D$]B <T :U%4M(U$:MH]GJ*PO"+F)91&_5<C.#4&E:I=:A=7\5QI-S
M8I;2^7'),1B<<_,N.W'ZCWP :E%%% !16-H7B?3O$4VH16+LQL9S!(6QAC_>
M7U!P>?:MF@ HHHH **** "BBB@ HHHH **:LD;.Z*ZETQN4'E<],^E.H ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MYXLU*2+QM;:??:IJ&GZ9+8,\#V;%=\X8Y#$ DX4#BN@\6>$K7Q=9V]K>75S
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MOAF.S\376M0:A>J;K!FM=X\EF"A0<8SG '>MR@ HHHH **** "BBB@ HHHH
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M .%$_B(Q@ZVB/-)>K(PE6</GDYX/(X]ZT;;1[7Q!\0; ZW;%Y9?#T5U- [D
MS%MAR,]AV]LT >H&2,;,NHWG"\_>[\>M*2%4LQ  &23VKPU-$TZ7X::OJBBX
M^WZ9?/%;S&=B8E60;57G@8<GUR<^E>P^(;6>^\-ZG:VK%;B:UD2,@\[BI H
MYBU\7:[XENISX7TJT.GV\IC:\U"5E68CJ$"@G\>?PK9\.>(+[5[O4K/4=).G
M7-BZ*R^=YJN&!((.!Z?K6-\)[ZWG\#6UDAVW-D\D4\;<$-O+=/HP_*D^(FHP
MOINGVR31O8R:K!!J+1RCY(\Y*MCD9&#V_6@#MXIHITW12)(N<91@1FN=\9^)
MYO#&G6UU!;17!ENHX'5Y"NT-DYP!SP"/UYZ5RNN6">#?%=A<^&+/:US87?G6
MD3?*?+4,KXYYR1TZXQWKFM3T[3I/AIH>MI&DFIW-_']IN=Y9W8LY;<<]<XH
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5[\3G3KD6O\
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M@0&4G/[PMCD@$-G/IBJGBO4M-GT+Q?;PO9V<JZH UN[;Y[B174-("?NK@'
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MN5?>54#  ) _,_2@"_X*L3%I$NIS0"*\U6=[R8;<$!C\B_@N./4GUKI H!)
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MSG /)RHZUZ!X GEN/ 6C23.7?[.%R?0$@?H!5P^%M%,VH3&R!DU%2MVWF/\
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MAB*3!RS= /3/N:6UURXM?A=K/B:VN[FXU*[=C*C2NRVKF0J%13]W8K#Z[1V
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M9&*L.G5CQ[=*G;P/X>>74I#8N&U+/VO%S*/-RVX\!N.1VQW'0XKH:* .>N/
MWARZM+"UGTT20V (ME::0[ 3DC.[)'L<BE/@GP^;O[2;*3=Y_P!HV?:9?+\S
M=NW>7NV]>>E=!10!%=6L%[:2VMS&LL$R%)$;HRD8(K#/@;PZ=$71QIV+)9?.
M1?.<LC_W@Q;</SKH:* ,K1/#FG: LWV))3+/M\Z>:5I))-HP,LQ[9Z#BF:]X
M9TWQ&D'V])1+;L6@FAE,;QDXS@CUP*V** ,>'PMHT.CW&E?8A):7.?/$KL[2
MGU9R=Q/3!SQ@8Q4&@^#-!\-2O-IEEY<[KL:5Y&=L9Z#<3C\,9P*WZ* //_B7
M;-?W.@6XTS4[N**\$T[V43MLC'!&5_B].XP<=:Z"#P9H\6E7VGR1RW"7PQ<2
MW$I>5_3YCSQV]*Z"B@#D;/X;>'+&YMKF&*\%Q;C:LOVV4,1V&0PP!Z#%30>
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M08P",<5PTOAR#PWIFEIJVHWE_I5A<)Y-O#:_=<GY&?9RP4GTZD=:[ZB@#E/
M=E>1:;?:CJ$<D5SJ=Y)=>5)PR(>$!&!@[0*7Q;X/G\6&&.36)+:TA=9%@2!6
M!<9^8DGGKTKJJ* ,36=#O=7TZ"Q76)K./;LNC;Q*&G& " 3]SOT]?:KFCZ/8
MZ#ID6GZ?"(K>,<#NQ[L3W)]:OT4 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
40 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>a123121ex-1021015.jpg
<TEXT>
begin 644 a123121ex-1021015.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J6L:I;Z)I%UJ5UG
MR;:,NP7J?0#W)XKC[_/B/XEW'AZ^EN!IMKIHG6*&=HMTA=?F)4@GAL8Z5S&J
M3S7/@SQIH]S/<7$.C7:?99)9F+[2V K'^(#!ZYZ^PH ]&\/ZYJFK33+J'A^X
MTN-462%Y9E?S ?4 ?*<8R.U:%YJD5O9WTT"F[ELU)D@@8%\XSMY/!QS2Z59K
M8:;# HE7"@E))VF*' RH9N2!7%>%=.@BU'QI<HTP<7LT>WSFV$%0W*YP3DGG
M&10!V6AZHFMZ)9ZFD31+<Q"0(QR5SVS6A7C>GVNIZ/X?\%ZM:ZYJ+)<W<%O+
M:M-B 1N3\H0#GC/)S3HI_%WBZUU#4]*GFMV2_989?[2:*.*-/X##C:?4DG].
M* /8JR/$'B33O#5M;SZA(46>984QCJ3R?H!R:TX"QMXR[!G*C<1T)Q7E?C%K
MCQ+J^J0QZ#?ZA:6UNUG:30H"D=QNR[C..A"KQG[I^E 'K%%<%X<\1ZAJOPTN
M9+13)KEA"]L\;#YO-0<'&>I&#]<_2L#POJ-[JWB/PZ-,UG4[F%K,3:PKS.Z)
M( >/GR%RW&%[=,=: /7**\N@&LK_ ,)'KDWB+4)(]$O9_*LPP6.4(@;:^.JG
M(&/8]SFG>&;;QK<7ND:TUW+):7.U[Q9[]9(W1AUCC" (1G. 30!Z?17D5K/X
MT\31G7M)GFC873+''_:*"W$:MC:T.SKCN6SWQR*U;BZUK4_'VO:8FMW5E;6=
ME'.D=N$.',:]R#QDY]Z /2**\9@\0^(XO"&B^*I]>N)O-O4MY;/RT5&0.P.2
M!G)"]?>M&]U'QAKNH:^^BF\S:7AM+6.VN($C38<,T@?YCNY(Q0!ZK2,RHNYF
M"CU)Q7G%]>^)+_QQI.A?VL^F&71UN+H0(CXERP;!/N!S[5A7>HZEK_PYCBO-
M2G-S;:\MG)<* ID 88/'IN!^JT >RT5!';R16*VZW,K2+'L$\F&<G&-QX )[
M],5Y!>^)]=L/"$Z3:W=#6-.U@P3A8T9I(MI;H!@#"L>3V/M@ ]@O+I+*RGNI
M0YCAC:1@BEF( SP!U-85QXVTFTT;3=5N%NXK;4)1%'NMVW(22/F'8<?CVS6=
M_:M_J6HZ_>Z;J3+86NG*+<&(%?.9/,#X(!.%V\'^]7(Z[JEYK7PD\.ZA?R^;
M=3:FA=]H&</*!P..@% 'IJ>(=/D\2R>'U:3[?'!]H8&,A=N1T;OU'3^8-+K/
MB"PT'[(+UI UW.L$*QQEMS$@=N!US_+-<JG_ "7*3_L#?^SBK/Q+6=])T=;6
M18[AM8MA$[C(5LM@D=QF@#M:*\]E\0:_X5U>_M];OH=4MQIKWL#I (2K(P&W
M SP=PY)J#1-9\9S:MHKS1W=S972YO1+8I%'#N&1L8') ]3Z>_ !Z+/-%;023
MS.J11J6=V/  ZFN;C^(?AJ2XC@-[,DDK((EDM)E\S?\ =(RO0],TGQ%CFD\
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ML8 (P2/<@ ?_ *ZZ*B@#G=.\*1Z-X-D\/Z==%&:*1/M$J;CN?.6*@CUZ>PK
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MYKT99HGF>%94:5 "Z!@64'ID=J?0!YMJ-MXGT?Q!IOB6UT..Y+6+6EUI]G(
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M8-M4@X.1U[5K:Y-80>#X7L]$GL-/?6(98X7B8R2A2 [LO.,G  /)].:]:HH
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MI4U]]K\HL5;RP@4$Y('KR3U]: .3\,F^G\2^.'FU&22.&5D:$QC!^5@N#G@
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M'^C^5]Y6#E0#G@@DDGOP*V/"6B7?A_1WL;NZBN&-Q)*C1H5"ASNQR3W+?G4
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MZ>P\'7MWXBO)GFM[^6!O-;>Y8$ 1KZG/  IMS(FO^.=!O=,2XCM],@E>[N#
MR#:P 6/Y@"W1N/?ZURES#=ZCX5DU&*ROF@M_$;W\]F$:.5X6;((QSG![=,^U
M 'HVF^)=.\61WMCI]S>6=W"JE@\7ERQYY# ,",?4=_>E\'Z[-K.FW$5[M_M#
M3[A[.Z*X =TXW@=@?YYK-\)G1Y]:N+G1='OH2T(%S>7IE!8_PH/,)+$8Y/0#
M')S5+0M9ATO_ (3'7IK>XDLQJ>Q/*0,TA7$9VC/(S0!Z#138Y!+$DBYVNH89
M&#S3J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0@,"" 0>H-+10 U41!
MA%51[#%.HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD6.*2-PP;)QD$'E1U)[5;N=;TFR6)KK4[*!9EWQF6X50Z^HR>1]* +U%(""
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M+?P+X9M=6.IPZ1;K<[@ZG&51@2=RKT!R?T&.E 'G.KZ':W+?$._N$\QK>13
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M-3U2&&_96N;6&=1#(0 /NE21D* <'G%1:Q\.M"U?44OO])LIPBHQLI!$)%&
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M]J-_!<WC6HMO]'M?)##()9OF;+<#IB@#IZ*** "BBB@ HHHH **** "BBB@
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M,9KHD2UU#Q%X3TK5D$^G2:(LD4$HS&TX4<D="0N: /28IX9X5FAE22)AD.C
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M-K:Z;#%?!;YBMQ<VD#2-#$/O;<=&/ 'U)[4 :VE^*M-U>ZU:&V=@FEN$GF;
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M.A>"=,OGO=1N+*9VACFN4,DI8$YW8^A_*@#N**P-"\7Z=K^HWFGV\5W;W=H
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M( >#R0H7;@+AL]@,=.<U)XG\,CQ$NG.EXUI<6%TMU#*(]XW+V*DCOC\JWZ*
M.3E\"V^H0ZFVL79O;Z_A$!N1"L?E(.5"J,CKSGO2Z+X0OM/N[.74?$=WJ<-D
MI^SP21A%5L;=Q(.6(!(&?6NGGF%O;RS,K,(T+E4&2<#.![U0T#7+7Q'HT&J6
M:2I!,6"K,H##:Q4Y )[@T 4/&/AA_%FDQ6 OOLB),LK'RM^['0=1CK4)\*WC
M>-[?Q&VIH6CLQ:M%]GQN]2#NXY)/Z<UU%% 'G*_#2]AT/['#KB"YCU/^T89C
M:@@-C'()],'ZBK,WPZGO?[:2_P!;-PFJ+&Y;[,JM',G1Q@],#&/0]>]=[10!
MPD/@?6;C6M'U/5_$$=Z^GADV?9  ZD8()SR2.I-)8^!M;T^&32X/$[QZ&SDK
M D $J(2255\\=3S7>44 (!@ >E+110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!P\AU3PSXUU;4#IMYJ&E:FL3+]BC5WCE4!,$$@XP"<]!7*W'AC6+/P
MO8"32KF>>?Q"-1EMH2"T4>"NTG.,].>@[D5[%10 5XWH]W<'2/&FDVFEWUY<
M:AJ-U!&\$8,:,P(^=B?E ]Z]C8$J0&*DCJ.HKG_#/A2/PR]Z8=0NKE;R4S2+
M.$_UAZMD 'G\J .1L=#U#2/'7A*!K*YFALM,,$US''F)7(?/S=!R>_-6[2?4
M/!NMZY%<:)J>I6FHW)N;>>TC\[)(&4<<;0.@SV^E>@^;'M=MZ[4SN.>%QUSZ
M4\'(R.E 'GMEX.NG^$\NC7<7E7[B2YCC4AC%)O+HH[#L#CU/K4ME:7]I\-M4
MOM2M;F;6-3MF::.*)FE+,GEHNWJ,#&1V^8UWM% 'D&GV6J:7I?@O6_[+U&8:
M7YUO=626[^<N_<-X0CD<_P OP@U73=<\0S^*KFUT74(HKAK6Z@AO(M@E\M5R
MNW/+$>A[$'!XKV:B@#S6RM;?6[.Y@TOP;<Z/>2V<D4MW<P>3Y99" J$\MD_3
MCK7/ZC/J=UX0\.:$OAK7%O-,O(7F8V9,9"!E.UNAZCV]Z]JHH HZE/LT6YF,
M4QS Q\M(R[Y(Z;5R2?I7D=B\UM\,O"T3V%ZSP:VKR(MNQ.%D9CQWR#@>^17M
M5% ' :,6_P"%R^()/)F$<EE$%<Q,%R F>2*M^,=9O-)\2>'2()CIS22&>:WM
MA-)NVX50-I*YS@XY()QTKM** /"=/COK.V&H)I^H-%I6OO>7%N\!1FBD"A6P
M>K#:>.V[TKJ/$MZ_C?P5J\NBZ/?0.IA+M-;A)+H*Q)0 9+;>#7IU% '!R:]#
MXUTG4(-)T>\2]:PE07-Q"(_*9@0(PW4D^W&*YNZNXM7^&FF>%H;2Y.M;H;?R
M)H9(S"ZGER<8P #^!KV"B@#S_P .%7^+/BPE&V21P["R'#;%56P2,<&N3GUR
M"R^&FI>%I["]CU999(V MF*R$R[MVX<=./PKVRB@#RGQ!X@D;5;RP%K/'%<Z
M'M@,%EYDMVSQG"LV"54%NG'(K/TBXM99?AQ;3B1)+<W 99(V3#94+U'(R*]F
MP,YQS2%06!(!(Z''2@#Q;4EEU2Q\:#24=E@U>&>:&->9(ESD@#AOF7=]!FNH
MOM>T[QMI=_%X>LYYM12REC6Y: Q^3D#]WN/=NF!7H(5020 ">N!UH5%0$*H4
M$YX&* /(O!\GA/4;K0$@@U676K)5#Q%Y6CA?;AB=Q*JHP2 ,9X&.U>B^*]$3
MQ%X8OM,8?/+'F(C&0Z\K^H'X9K75$4DJJ@GJ0.M.H \474/$4B:1XZ-H3=1%
M=*:V,?,RY<-(23QER%^HK5\<6,&@>$?"]C-/']H35(IIW9^78AC(Y)Y(W-U]
MQ7JH50,  #TQ2/'')C>BMCID9H X"RU&WTOXMZRFHWT2?;[:#[&&)P0 <C.,
M#D,?QKA$>U_X4EJK*T/G-JF 01N)W*0/R!/T%>]&.,MN**6'?'-,:V@=-C0Q
MLF0VTH",CH: *I99O#Y:-A(CVN5*G(8%.WK7DT^MV1^"6G6<=Q TGGPP7$9(
M+1XE+\C/'W.IZC\Z]H    & .U5FT^R>%H7L[=HF;>R&)2I;.<D8ZYYS0!Y=
MXM\[_A84R:,0+AO#CB$08R3ESA<=]O3'MBHO#<OA*<>')!J>IW6KVGEB.Q#%
MO*<@*PP5 "COST%>L?8K7[6+O[-#]I5=@F\L;POINZXI(+"SM9I)K>T@BEE.
M9'CC"LY]20.>IH Y/XKM"OPYU(2% S-$(PQ&2WF+T]\9_#-<OXG@T[3?^$/F
M8KIVFS#S)[JU105F\L!'/RD'&3V[FO5KJSMKV+RKNWAN(\YV2H'&?7!IKV%G
M):"T>T@:V  $)C!0 =!MZ4 >/ZQ!I.G^'M1?1M1FU*VGU:W.K7#J#&$R20I4
M!2,XSC/45NF\TN]^,.A'2KFTGMTTZ1/]&=65>'X^7IQCBO0TL+..T-HEI ML
M0085C 0@]1MQBN0D\,7D7Q*T[5;'3K.WTJVM7B8QN$)9MW.P+UY_3KVH \\A
MU/3(OA5-875S:K=IJP9;=BOF!=ZDMMZ]-W/X5V\1MS\;Y2OE[7T89Z?-\PZ_
MAC\*[4Z+I1:1CIEEND.YSY"Y8YSD\<\\U*=.L3=F[-E;FY(VF8Q+O(QC&[&>
MG% 'CWAW3K23X5:[J$-K$VH6\ER(IT0>8BE0" 1SC:3^&:T_#&G^%Q?>&]1M
M==DGU!8UCALX%A5QE#N$@10V ,Y+'MU->G6VG6-G$\5K9V\$<GWTBB50WU '
M-,M=)TVQD,EII]I;N1@M%"J$CZ@4 >,W-MIUS\-/&>H1V4"SC6&\MR@+QH98
ML*#U Y/ZULW4$>F^-O";:/!#%<3:3,2L2@>:?)8KNQU^8=37H;>&=#?3Y[ Z
M7:BUN)/,EB$8 9LYSQ[T\>'-&6[L[I=-MEGLTV6[A #&O/ _,_G0!Y/X;LO#
MEUX:TJ]U#Q$T=];3^<;6)(1<F4.?EX7S7SGID]?;B[JFBZ3=ZA\1KJ:S@EN+
M:%'A8C)C8PDL1Z'=WKTJ+PYHT&K2:K'IMLM\_+3[/FSZ^QXZTQ_"VAR27TC:
M9 7OABY;!S*,YY_$9H \_P!/-I-J7P^EU+R'5M,E!:X"D$A%V]?3M75?$J>\
M@\ :G)8EMY15<KU$98!OTS6J_A309+:SMY-*MGALB3;HZ9$>3DXS[]JUBBLA
M1E!0C!4C@CTH \V\36.FPV7A._T""TBO7U"!8&@4+YB$?-NVC)7@9]*L^$K6
MUN/B1XREDL[<R0SVYC;RAE"0^6![$]2>]=3IWA30=)NUNK'2[>"=00KJ.5!Z
MX]*FM/#VDV&J3ZE:V,45[.6,LRYR^XY.?QH Y'XJQSPVFB:NL;RVNFZ@D]PB
M@'Y<CD_ECT^;Z5VHU;3CIPU#[?;"S*AO/,H"8(R.>G0U:DCCFB:*5%>-P596
M&0P/8BN>B\!>%X;T7::-;B0<A3DIG.<["=N??% '.F#3/$7Q1N;?5(TO+7^R
MXI;".508V4G)90>IYZ^F?2N71UMFNM$)$>@?\)1'!M9B$,9#%DW$_=&U#C/?
MWKU?6?#.C^($1=3LDF,8PCABCJ/0,I!QQ0?#&BG0_P"Q3IT/]G]?)QWZYSUS
M[YS0!YO>1Q>'_'GB@:1''9M#X?9X%A4#:PV'('KQFI-!T"R2[\-:_%XCL8W8
MH'6*'$EP[@ HQW$LQ.02>G)KO=.\&^'M*G6>STN%)E0Q^8Q+L5(P022<Y'K4
M6F>!?#6CZF=1L=+CBNLDJ^YF"Y_N@D@=>U %OQ))I7]EK9:RNZTOY5M,8.-S
MYVY/;D=>QQ7#PIJOP[\1:/I0O7U'0-1F\B&.8 R6[DCH?3GZ=>!W]!U;2+'7
M-.DL-1@\ZVD(+)N*\@Y'(((YK*TOP)X<T:_2]L]/Q<I]QY)GDV^XW$X- 'FU
MII5]XKLM4U:XOM.T^[AU!I+B>;>L]KL/"_>P% &,$=O49KHK&ST[Q?KOB:WU
MB[-Q);B.*W8N5\F,QY\Q%Z DC)/M72W/@#PS=ZM)J<^F*UU)()'(E<*S>I4'
M!]>E2:QX'\.Z]?"]U#3A)<;-A=)'C+#WVD9_&@#F1H^G?\)]X;M]XU"&'2G\
MNXE82%]C#:VX<'&36?J%U<Z,OQ$NK"YGEO8Y(MB-(7,:. 68+V"[VP>@"^U=
MWJ/A#0]5DL9+JRRUBH2W\N1H]BC&!\I'' IMEX-T*PN;ZX@LV,E^C)=>9,[B
M4,<G(8D4 </J>@V7ARQ\.ZYHDDMO>SW=NDW^DR.+A7'S#!8YYY_.LRXTN+4S
M\0+JZN+QY=,F:2T_TEP(V <@XS@] .>U>B:;X#T+2KR&X@AN'^SMNMHIKAY(
MX#ZHI. >^>:!X&T94UE%%T%U?_CY'VAO4GCTY)]?3IQ0!IZ3<2-X9L;F3?-*
M;..1N[.=@)_$UX]XEU:2[TJ"6_T?7(=0NM4AGGDGLMB!5#!8HSW(!X'<Y/>O
M:=-T^#2=-M["U#B"W01IO8L<#W-5]:T*Q\06L-O?H[1PSI<)L<J=Z].G;DT
M<AX=D>;XLZ[<O#+ +G3[>6..8;7"[5'([$$$8KEK'P[J>MZQXCO-,$6_3_$
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MJ-E=6(AL#]I5(H"0 Q*L0"V<GUX';D06,M_HM_X'CN=)N3<0V-S#);QX:10
M@W8_IGO0!N2_$NWM=$O;V\T:_@NK&:.&ZM"!NC+@E6SP"IQU^G'-6[+QRMSK
MUII%]HNH:<]ZK&WDN-H$F!GC!]/Z5Q/B[3]0_P"$1\5:[J-H]DVIW-KY5L[
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M4=-U&33Y%:[N4>/RB1_JU+'+9/'% '0'XC:2K6KM9:FMG=W'V>"\:W AD;.
M0<YQWZ5?_P"$OT\'7%,%X&T89N5\GEA@D%.>>!GG%>::QJSW'A#PCI<VEZE9
MW%G?6J2-=6S1H2JLORL>N>M;E]JDNB^+/%UI)I6HSR:M%&;,V\!<2;8=IY]
M2,GM0!T.HZWIE[+X7OAJM]:)>3!K:&)6 N2P&$DQQCD=:GO/'_AZRU2337N)
MWO(I1%)%';2-L).,DXQ@9SU^F:X6[:2#2_AM%/:W4,L-V@DCD@8,NUE!R,?D
M.XK:T"7[7\4/&9MBX9X(XT<JR_,J!3SCC!'^% '0#Q]H9U2&SWW(CFD,,5X8
M&%O)(#C8LG0G/?I[U)=^.O#]E>7EI-=R^?9?\?"QVLK^6,9R2JD8]^E><>&U
MT0VEIH>H>%;V?Q#;39:-O,"$[O\ 6,V>%PV>F/TK2M+Z*VU[XE;LAWM]T8>(
ME6VHX.<C'5E&#US0!VEGX^\-7][;6EOJ!:6Z($.8)%5B1D#<5QGVSUXJ?4?&
M.AZ5<2PWEVZ>2RI+(L$CQQLW0,ZJ54\C@FO,9[F%?!/P]W/CR]11GX/RA'^8
MGZ9%2JNC6&K>(=)\6P:K)/=7[SP)%)-LO$9AL^2,[2<CC/TXQB@#TC4O&>@:
M3=_9;N_"S^4)@D<3R$H>A&T'/6J.L^/M-TW1--U6TC>_M]0N%AB,888SU)^4
MG(P?EQDUC6]Y9P?%&'[1&+9HO#RQB-\MY3ABY4-CDA,\_6N'MI!'\*=!E8/L
MM->#SD(3Y8 8Y./8C\Z /=_M47V(W9WK$(_,.Z-@P&,_=(SGVQFO.M:\97>O
M_#:]US0I;C39;2<;LKRZ!MO#$8Y!!XZ$8SZ^AV5[!J-A#>6KEX)T#QL5*Y!Z
M<'D5X:M[&GP-N].DE9+N"\"20OD,F9,[<'Z,<>QH ]=T?Q;HNL70L+._6:\6
M(2,FUEW# Y!( (^E3VWB;1;RYBM[?4(9))G:.+&<2,OW@IZ$CV-<-?W]K#\5
MO#T\3(P&D,RA>-V5<J/Q%<P_B2UNH_"<D%]%;M%JBN]C:0&..U0M\V6(RS'<
M<G.#D\=: /5]#\6V&O:OJFG6P<26$OEDE6P^,!CTP,-D8SVSWI?$VN2:5%9V
M=F$?4M1F%O;*W13_ !2$=PHYQWX'>N?\"7$-CXB\3Z3/=*]\^I23JG))C*@Y
M^@R!4_B;S(/B7X.NI7/V4FYA VDA9&CP/SR/R- &KY\UOXGTNQG\1PF3[&WF
M630JLERX'^M&.G0G ]#[X71=5N4UJ^T#5)Q+>P 7%O+M"^=;L< D#C<I!!P,
M=*Y_6KBQ?XS^'$:ZB2>"UF!3J2S*P53Z$@DC/]14\R>?\;;=X@&^SZ,?.(8?
M+F1L CUY'YT ==J6JV&D6PN-0NXK:(L$#2-C<QZ >I]A51?%&AMI4FJ#5+;[
M#')Y;S;^%?CY3[\CBL#Q_J5EI]UX?%Y':HK7A=;NZ5F2W*KUVJ1DG.!DX!P3
MTXXJ[U72+GP+XVMTNHIW.JF>$L@Y5S&%8< <[6Z>GO0!ZM8>)=$U2YFM[#5+
M6XE@4O(L<@.U1P3GICWID7BG0I],GU*/4[=K*W;9+,&^56XX_45R$TME:_&/
M1(M/DMXH)-,92EN556!W,HP.#T4CZ"LP:1<VOBO4?!*Q%=+U2Y34%= -L< .
M9%QSC+*J^GMSB@#U074'V/[69D6W\OS?-8X4)C.XD]!CFLZT\4Z!?,XM=8LI
M2D1F?;,ORH#@L?0#WJWJABBT:\,A1(EMWW%L!0-IZ^U>+6MG GP8M+^SMHUG
M^U;-0N+=%\X0>:Q(9L$X^YQSQCC% 'K]CXBTG6;>Z.EZI;3- I+LK@B/@X)S
MVXZ^U5]&U:*V\-VUUK&OZ=<L69&OD=(XI&#$8!SCC&./2N5T6W\+-JUU=Z3K
M%WJEY)82QR[BACCCQG+X1<<X [\GC@XX^9X9/@)8#=&S1WY5AD$J=['!]."#
M]#0![(OB30GBDE36]-:./&]Q=(0N>!DYXS6'XN\1W=CINE:CHEW:2VDU]'!/
M(NV12C-C(;..H(/7KVQ6#=:1H\WQCL+3^SK"2R;1]XA\A#&2&;!VXQT Q[5R
M\3%_A]);.L1L$\4>5*&P%CAX.!Z#)_4T >SPZWI-PD[PZI92);@M,R7"$1@=
M2V#Q^-.&L:68K>4:E9F.Y;; _GKB4YQA3GYCGTK@-3T?3K?QQ-'H5JB%M$N%
MO(+2,",9_P!7D*,;F.>/]D'%<JU_8R_#;P;:)=VSWD.JHSPK(ID1=\G)7.0.
M1^E 'M4NK:;#/Y$NH6D<VX)Y;S*&W'H,9ZG!P/:FQZUI4U\;&+4[-[L$J8%G
M4R CJ-N<\5P.CZ1I>H_%CQ4MY8VTXB^SRQAXP=K[021]3U]>]4=*E;0-0TZ-
M;6RUK3[^[E?3M0B7_2(YFW?ZSN>I!)Z<YZ8H ]-.KZ8+_P"P'4;07F<?9_/7
MS/7[N<T^XU.PM"XN;ZVA,8#/YLJKM![G)XKQ7PYI^BZMH<-]JWB2&TU*"[::
M6,0Q"Y\P.2,/CS'SD="?3M71?V9IVH?%3Q7]LLK:X6/3XW031A@K;$R<'O[T
M >C?VOIGVB&W_M&T\Z89BC\]=SCU49R?PI;O5=.L)8XKR_M;:27_ %:33*A?
MZ GFO#A8V=K\'M*UJ&WB35%U %;H*/,XD8#YNN %''3BM5M.TWQ#KOBB+Q!X
M@@L9TOWBC2ZBA#B$'Y#&\GS 8'1<>O.: /89;NV@;;-<11MC.'< X_&J%_XC
MTC3=,CU&XOX/LDKJD<J.&5V/0 C@^OT!->>2Z1I&L_$;P]970;4K5=!1EEG8
M_O@"VUB.#GJ>?7VK$LXK?_A7=Q%.L9MK?Q.$59<%8T^3(YZ#!.?J: /<D=9$
M#HP92,@@Y!K)T6ZU.1-0;5UM8A%=.L)AD!'DC&TMSP:TK>&"WMXX;:...!%V
MHD2@*H'8 < 5Y'HNFR:EX-\7:;;7:6TLNLO%$96PKG*X0D^N,4 >NQ3Q3J6A
ME20 X)1@?Y5@^*/$CZ)-IMG;+;->7\_E)]HDVJ@ R6..<=!^-8WP_O(%O]4T
MN?1(=(UB 1FZAM_]5(,?*R@?*O!&<=<]ZJ>/;"SN?'O@P3VD$HGFF2421AO,
M4!,!L]0,G@^IH [/2[N\CTJ!M=:TM[X[@XBD^1L' *D^HP?QK2W+@'<,'ISU
MKSO3-#TOQ!XL\4VNL6PG:T>&&WAD7"V\)3Y3&.BYQV]!Z\\S90SZII/A6UU*
M2=H8M:EM(',A#26X'0G//*E?H,"@#VE'21 Z,K*>C*<@T@EC,IB$BF0#)3/(
M'TK*6QMO#'A>XATJ$116L$DD2,S-R 3R2<GFO.O#/A\WNE:1XE/B2S@N1*LL
M]R('\Z1BQ!BD=I,').W&WGCKW /6C+&N_,BC8,MD_=^OI3Z\>\61:=I'CIS'
M(YTB^,46M(J,R0$L&4%A]W=@9 Y SZBMCQ?I\$WCSPEIH>>.RGBFB>*&=T!5
M5R/ND>O7OWH ])HKQ:_FO-$OM:T*SNGCTDZK9P;[F=V$:R(6=<@AMIP >>E;
M;Z#J'AZ+Q).VKP0Q7.ES2PV%M*Y9&1/]8I8[@ 3V_O4 >G45X_HEC]EC\"ZN
ME[?/>7TYCN6DN782+M. 03C    ';UK0ECETSQFO_"06=X8KK5M]CJMO<DKR
M?W<+J.BC@8XZ>E 'J%(Q(4D#) Z>M>.V>DZSXIM+SQ FMV]M<PWTC?:'N)5^
MS(A_U>W.P+CGZ'FO67!NM*8&8@RP'][ =I&5^\I[>HH AT2^O-2TJ*ZO]-?3
MKAR=UL\@<K@X'( Z]>E:%>+V-SJ-U\)=(D75K^"XDU80F>*X97*LY4@G.2.<
MX]:T!<W/A3Q=XLM[&[NI88-'^UJMS,93YH"_-EL_WC^= 'K%%>?:#X>2:R\/
M>(?^$AO$NY CW,DMP[+>;N?*PS  9X  [=.]<]!J&H)\.?&,JZE?>=9ZFZP2
M_:7WQJ'3@-G..3^= 'L5%>8R6^IZ]XHTFQ'B#4[.*XT!+F7[-,5R^0,^QR02
M>O&.,TV#3[S4?B+K6DOK^N1VMA;6\D:P7C N=B9S]><XQR: /4*J:I?#2]*N
MK\PR3BWB:0QQ#+, ,X%>5Z8?%_BBRBUO3;B2&7[<TC.=4<1B-6(\HP;2HP .
M>IZG.:TIKJY\0#QI?2ZC?1#24E@M8+:Y>%$9$8EB%(W'<.I[=J .\T+5X]>T
M2TU2&)XH[E-ZHY&1SCG'TIVM:G_8VC76HFVFN1;IO,4 RS#OCZ=3[ UC_#O_
M ))_HW_7#_V8US-M)/XOT;Q1K,^HZA L#7-K;6L5P4B1%C&&*KC<QR>N1S0!
MZ!I&I)K&CV>I11M&EU$LJHW4 C.#5VO+-*U"\M]0^'-I#=31VUQ8.)HE<A9,
M1@C(Z'%4Y=7U:TT/Q^(]6O2]A>(MO(\NYHU+D$ GH,>F* /3M9U1])M(YX]/
MNKTO,L7EVR;F4'^(^PK1KS#58M=TCP1#JL7B>_DN[R:UDS(%*Q[P%*@8Z?,#
MC_9]S6AK<&LZE\01HMOXANK&TETOSW%NHW A]IP>Q.<Y% '?T5Y';>*-=/PF
MCO$N9WN8K_[-/>?>=(0V2Y)!Z9"YK:\'7.I7OC35EBUR\U#0K6./R9)=A$CN
MH.,[1TYZ8Z#/N >@/(D84R.J[F"C<<9)Z#ZUE6WB.RNO$UWH$:3B\M81,[,F
M$*G'0YR?O#M7._$"TDO-7\*0I>W-KOU J6@8 CY<YZ=1C ^IX-95[:7NH_%7
M4;:SU:6P:WTF,/-%&ID<!@<$GODYR.W% 'IU%>.V/C;Q!K.A^'M*MWN&U&^\
MXRW$!C65ECW8P7PH/')/8>IKN?!*^)(;6]@\1+*2LVZUDFDC>1HSV;82.,?K
M0!U-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5A7OA:"^\2
MVFNOJ&HQW%J-L<4<P$6.X*[>C=^>>/2LZ^\97L7BJZ\/Z?X>FOKF"!9]PNHX
MPRG;S\WNV/7V[U43XEV4VEV$\5F1>75R]JUM-.L0A=!EM[GH ".W>@#H?$OA
MRU\4Z2=-O9[B*W,BNWD,%+8Z Y!XSS^ J_:PI864%LUP\FP",23,-SGMG  )
M_"N,_P"%GV8\.WNIMIT[2V-PL%U!'*CA-Q(#!P<,..V>?;FJGB/7[:\TZTN_
M$/A?48(K?4HT@_TA1DGD/\IY&,],CCK0!Z/17-7?BFY.L7FFZ/H[ZE)9(#=.
M+A(EC9@2J#.2Q.#T&!W]JL?Q L[S1K&[T^QN+F\OIG@AL=RK)O3[VXDX4#CG
MW% '7!@20""1U&>E+7GG@B'_ (N#XMFEL)+*<^07B>7?@L&+$$<$$C(]O3I7
M3^(/$BZ+-9V=O9R7VI7K%;:TC<*7"C+$L>% 'K0!N4T.I8J&!(Z@&N07QG<7
M%EK-J=*EL]<T^W,WV.25&W+CAU;H0,\__7JA\-M!L?[-LM?:QGCU&6VVO=/<
M+(+C<Q9F^4]<_P!X9' Y(S0!WTB++&T;C*L"I'J#45G:VUC:1VMG#'#;Q#:D
M<8P%'I7.V_B/4IOB!?:&=.W6-O!&XG1UR"W.Y@3G'48 )X]^,G0_$N@Z-X6U
MG5;&RU/R;:]?[5'.=\ID)&3RW3D=3GCGF@#OZ*X<?$RU$]M"^@ZVCW<9>T!M
MUS/@ X7YN>#UJW%\0--.A7VIW-I>VOV*<6TEM-&!*9#C"@ ]3F@#K:*YOP_X
MSLM?U*YTW[)>6-_;H)&M[M K%3CD8)]1^=6M9\11Z1?65@EE<7MY>!S%# 4!
MP@R2=S =_P : -JBN5OO'VF:;!ISWEGJ4<M^A:*#[,2X(."I&>M-T_XA:/>Z
M?J5U<1W=@=-"FYBNHMKKN.%X&<Y/% $WB[PM<^)VTY$U*.U@L[A;DH;?S"[K
MTYW# P3^==-7,Z7XXT[4+ZYLKF"[TVY@B-PR7T8CS$.K@Y(Q_@:2R\<Z?>:M
M:V!LM1MQ>@FTGN+8I'/@9.WOTYY H Z>BN"M-=LK/PIXGU+1KC5+N2WGF9Q>
M<F*7'10<$(.#CJ.:YK3;?3(_"UAXCU+5_$UE/-)$DS).VVYD)W;@#G*\'G('
M% 'L5%8.L^+M.T2:2*:*\G:*'SYOLT!D$2'H6/;.#^5%SXOTJ"ST^YB::[&H
MY-K':Q&1Y !DG;VQW]* -ZBN'^'VHSZA?^)?-NKZ:*._*Q)>$[XA@DIM/W<'
MC ]*TM:U"RM?&.@0SZM>6\\AD6.SC!\J?*D OCT/3.><=.M '34A 8$, 0>Q
MKDKSXD^&K*:YB:XN9&M9O)N#':R%8CG&6;&,9XZ\]LUUB2)+$LD;!D8!E8<@
M@]Z '5&T$+QM&T2%'.64J,,?<5YWJWC.77?AUK>I:<;W3IK64HCA"A*[@/O$
M8S@\@'(/I70>&_&>D:K#I]B=0WZE+;*[*\3()& &[:Q 5N<_=)Z'TH Z0P1&
M593$AD485]HR!Z TGV:WQCR(L;_,QL'WO[WU]ZY7P_KNG6^EZYJ<WB)[^S@O
M)'>62-@+<<?NUR,L!VQQSQ6WI'B'3-=>X33YI'>WV^:LD$D17<"5X=1UP: -
M$0Q+,TJQH)&&&<*,D>YJAK>C0:W8B"5VBEC=9H)T^]#(O*L/\.XJU?7L&G6%
MQ>W+[(((VD=O0 9-<CX$\4ZEK5[JNGZU;FVO8'6>*)@ 1#)RHQ[#'YC- '61
M648$<L\<,MVJC=/Y0!9@.H]/IFJFCZ(FEM=7$D[W5]=OON+EQ@MCHH'\*CL.
MV34>L^*]%\/S)#J5X8I70R!$B>0A!U8A <#W-1/XU\-1V<%XVLVHMYY#%')N
MX+  D>V PSGIF@#:FMX;A0L\,<J@Y =0PS^-1FPLR&!M("&^]^['/UK&F\=>
M&K?3(M0DU6+[-*S+&51F9BIP<*!NP#WQ5N;Q/HL&BQZQ)J,(L)!\DP).\\\
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MCF98[V/B"( K\K=><9_,?6KFKZW=:)_9M_<RVTNES%(;J1!CRW;[LB\G*$D
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M$-SJ4-O/,)I;&*XVV[G.<% .5SVS3]3^'FF:CJ%[>)?ZK8F^4+<Q65SY<<P
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M < #)_.MJB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA70)+.&S?1[)K:%BT<1A&U">I [9J=="TE-0DOUTZV%W(NQYO+&YEQC!/<8
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 <5J/C/58O%MWH&F>'_MDUM"DVYKD
M)N0E02 1VW#\C63=_%VT@OC)%;V\NE+,(FE%TOGD="XBZD>GJ*V=/T_5X_BA
MJ>IRZ>J:;/9I#'.74L2I&.,Y&<'C_=K&T/2_%_A>WD\/6&CV-U;+(SP:E/,
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MM^QB9#<^7YAC!Y"YQD_C4U>;^'((M3^(_P#:UU"4O)=%MKI@KLH$C  \9Z8
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M)=2<!4^5MS'GCCZU3UOQ^VDR6=JFFPMJ$ULMS/;W5_';" 'C;O?AFSG@>F:
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MSU&YM)IIQIZ>9.BP.' P2, @$YP>E &CI>E6ND02Q6JMB:9YY&8Y9W<Y)/\
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M2Z:Y#R2+ PGN'+E3&[F3YBW(X6HFBM]9\&>-=7U*)9-6BNYXE,K$O;Q@KM0
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MLO#FH7;VEPD,LB%0H5OX^>W7'; SD5R0T7Q0L-E)/X;DN;ZTU9;V>[:\0O.
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MH ]!7Q?I?VW6+1_/CDTF/S;K=$<!<9RN.3QS69#\3/#UQ;23QF\,:0B7)MF
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MFN[HPQ3A1(<J=FT'DY/3%:5B3I^M?#:POIU%Y#:W DC=OFCWP@(I!Y']W\*
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MDVFD:K<W%K.D,[1P@I&&/WB=W XSSB@#JJ*R?$6OV_AG2'U.[M[J:!&"N+9
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MZ\X/!]#0!K7NF6.I6@M+VTAN+8$$12(&7CIQ563PUHDDUG,^EVIDL@%MF\L
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M F1+AE1B 1N(!Y/.>>,CZU:TWQ,]]XQU;0'L_*^P1HXE\S=O# 'ICC@BNAH
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M R.AQ0!X='J6FM\._!EK<W7EF#6!YX((*!6<L>1V#K^?L:NWAT.U\3^*=/\
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M \BMH+"XE^)LMQ%;2R1^88GD56*G9)RI/3G'3OBHXKH75S\+[B62-IR)$9N
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M^&[O6?[6GTF"2\SN+G.UCZE<[2?<BMFZM8KRSEM9E)AE0HX5BIP1@X(P1^%
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MOS@G([9_0XM:9XGN[[QGJNBR:7,EO9[%6X&" 2"V6YX##&,9Z>]<-#!J%O\
M#;PK9_V5JWVJUU,2S1Q6KB2-5=V)Y''#C!QCKZ5UVF375E\2-=CDTR^:WU!;
M=XKM8CY0V1X(+=!R?KQ0!NZYX@M-!CMS<1SS37,HA@M[=-TDC'T!(''<DU0M
M/&VFW#ZE%/;WME<:=#Y\\%S#A_+QG<H!.16=X[T^\.J^'-;M;6:[33+MC/#"
MA9]C[<L .3C;TQSFL[6%EUO5]7U2TTN^2&'1)[0/+9O&]Q))]U54@,V/IWH
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M"UTLCF,E8V:/"DD#/)Q^7UH W+/QEH-]IEUJ$%^/L]H0LY=&5D). "I&<D\
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MACMK:,CSUG# ' ZKWYX'O6]X;OX[7XK>)K&XGCCDN$MVC1R TC+&,X/?KTH
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MCH< FO4H6D:%&F18Y2 616W!3Z9P,_E0 ^BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH :8T:19"BEUSM
M8CD9]#2"*-96E$:"1AAG"C)^II]% $1M;=HA$8(C&#D(4& ?I3T1(T"1JJJ.
MBJ, 4ZB@"/R(?.,WE)YI&"^T;B/K38K6W@8M#;Q1L1@E$ ./PJ:B@".6"*=0
MLT22*#D!U!&?QH%O"LOFB&,2 8WA1G'IFI** (1:6PF\X6\0ESG?L&[/UIWD
M1&83>4GF@8W[1NQ]:DHH AN+6WNU5;FWBF53D"1 P!QCO[$TV2PLYK,V<MI
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)+?^8LC2HH  55P02!U/Y=JY.Y\+>-;K1WM+G2(Y[I=26]>[>_0M.%W *%Z
M 'U'':O9:* .%LM'U;2_$7BEH-*:6SU1/.BF^T(#YGEG*;2<\LQ /;]:YZ?P
MIX@C^&&C:-_9;-?VFI"5XUF0C9N<YSG'\8'X&O6Z* /.-<\+:GK?C?596LWC
ML;K1C:1W'F+M$F0PR,YQD8Z=OQJYX7;Q)$+'3;OPM:6<=FJ12WYG1MX5<91
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M/TR#2RQ9ELX0,1*3D XXR>IP!R?QK5HHH ***0L 0"0">![T +1110 4444
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M4WOA#P]J.I#4;S2;::[&,R,OWL>HZ'\:-4\):!K5['>:CID%Q<1J%5WST!R
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M@KJ/^$#T)=#O-*CBG2&\QYT@F8RMCD?,<\#TZ597PEIRZKI6HJ]RLVF0?9X
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M"T_P_I^F:KJ.I6T16YU!U>9CCL,8'H.I/J2:SHO ^EH-;626ZF3623=)*ZD
MY)!7"C!&>.O04 <C?Z7_ &9\0/!1.H7MZ\YGD=[J;S/F*@DK_='/0<<#\:MB
MOB_Q/$WB'3;Z6*3[6YB1M0VP)&K$;'AV<G'<GN#7667P]M[>[TVYN=9U.ZDT
MR0FS#NH")D?(?ER1@8Z]/2HA\,]/2\G\G4]2ATVX<R3:='-MB=B<G(Q]W'&/
MUH @E2^\3ZAKYDU:\L8M,80P06;A06\O<S/D'>"6X'3BM;X=?\D^T;_KA_[,
M:CO?!$4VL7.H6&JWFF_;5"7L5MMQ, ,#&1\IQGGWK6\.:#!X:T.#2[::::*+
M)#RD$Y)R>G09[4 <;I-N1\9_$+?:)_DM(Y,;A\V0ORGC[HS^@J&2[UJ[^'DO
MBZ'7KN&],1N/LZA# H#GY I7/3OG-=19>$VL_&5]XA_M260WB;'MVB7&T 8&
M>N!@>]4D^'Z06ESI=KJ]S%HES(7DL?+0X!.657ZJ#0!D_P!H:]XD\26MKI^M
MR:;!=Z#%J 58$;:[/CO_ (^U=7XIEN[#P7J4]M=R1W5M:-(LX W;E&<XZ<X_
M6HHO"OV?Q=%KD%^\<<=H+,68C&WRAR!GJ/FP?PK6U;3H]6TB\TZ5V2.ZA:)F
M7J PQD4 <E-J>I)J?@F1;^7R]0BVW4.%VR$1;MW3.<FL#4M4\3#3/%>IKXAE
MC&DWQB@AC@0*1E>"2,XPP_7UKH['P#/;7FD7%SXCOKO^RWS!&Z*%"[0NW\N_
M/'I4LG@4RZ3KU@^JR,FL7'GNQA&8SD$@<\] /PH K0:MJ?B+Q%8Z?%?R6%NN
MEQ7UQY"KOD=^@!8'"CZ5S=AKE]X?\,36UD[RWM[XCEM!*54L<L,L,X7<>V>.
M:ZT^!I8;[3M0L-:FM;ZTLELGE$"N)D7&,J>!TJLOPVC;0+S3+G6;N5Y[S[<D
MX4(8I>[ #UR?_K4 5K67QGIVE^(9+Z29;>&S:>RN+KR7E5U7+ B,D8//6MCP
M6FOW%A;:KJVL+=PWEG%(ENL"IY9(W9W#KP<=*9#X1U%M)OX-1\0SWUY<VKVT
M<TD0"PJP^;"CJ3QDDYXK;\/Z9+HV@6.FS7/VE[6)8O-V;<@<#C)Z# _"@#G#
M'</\8R/MTXA31Q*(AC;S+M*\CH2 <CGWKB-&U#6=#\#>(M:TW4$B2UU=\V[0
M*XD):-3ECR/O#IZ'UX]'U+PS>7/C&UU^QU4VC1VWV:>+R@_FIN+8Y/')K#3X
M=7J^$=8T$ZQ"5U&[%R9/LQ^3E21C=WVKWH UEUK5'\8Z+;&2%=/O]/><Q*GS
M"0 $\^GS#'XUE:)XFO[_ ,3/IUWJZ6UW#?2J^GSVX3S(,-L\ML9)Z'KTS6K%
MX7U-?$&C:E)JL)BTZT-LT*6V/,R,,02QQG"_E56/P9JMS>Z7)K&M07R:;<_:
M(Y?LFR=L9(5GW$;<D9&.U '9R2)%&TDC!44%F8] !7@]YXIL?[=MO%R7<[ZJ
MNH%7MS&X06?*@9Q@' SP3RU>P^*=(O-=T"?3+*^2S-P-DLC1>9F,@Y4#(QGU
M^M.U#1Y;SPG-HT<L$3R6OV;S/*RB_+M)"YXXSCGCB@#+\9>(;K2]+TR33)(T
M_M"[B@^ULH9(4?\ CYXZ=,\5DV7B#7X;KQ;;SZC9WD6C6IEAE6##.S(SJ"5.
M/EVX(QR3U%9?B.P;0?"6A^%=3UN!1+=%A>3V^8A%'\P1U).?F90.Q Y]Y/"D
M-[>VNJ:!!J.A7-E=6<H,VFV^P0NP"#<  #D%CCK\M #[7Q1XJA\)VFO7=Q9W
M"WPAM[:&&V)99&DVEF&1N.T'@$#.!@=:?:^,/$NB6.L7.N65Q<6MM LEO=36
MGV;=(6"["H)ZEAR/0_AKMX'N9/ =MX=?5!'<6<BR6]W#$5VE6RI(SUY/0CM3
MQX2U;5M(O;'Q/KAO5N(?*1+>(1I&=P8.?[S95?IR.] %#PUK?BZ?Q%;1:C:W
M$VG74;,\DEA]G6V;!8 ')+ ].?45EIXT\63^&-4UY'TI8M,O6@>'R'S* 5'7
M=Q]X?_6QSTNA>'_%%M/ FL>(4GLK3'DQ6T7EM)M&%\QNN/5><^M8\/@+6X?
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M/J.U7=(L@?BCXBN/M-R#'!;-Y?FG8VY7&".X&./2@#LI9HH(_,FD2-,@;G8
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MM(&'(^4-Q[C%9_BYT?6_ $Z1)'ONUPH4$*"$X'TH [V#4;*ZNI[6"ZAEN+?
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M9)$=9"1D!@I.PD$>O6I(/'=I=:U<:7;Z3JTTMO<_9II$@4QHV2,D[N!P?\*
M.JHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.U<_XS\27/A_19+K3DM+BYCEC5X9I""%9@,X'/<=<=<\]* )7\$>'G 'V%T
MMA:$17,L8,0_A(5AD<GKUK;MK>&TMHK:WC6.&) D:*.%4#  _"DDN8H(T:YE
MCA+8&'< 9] 3UJ8D $DX H YIO ?A]K34K4VL@AU&3S9T6=PN[.> #@<@'\!
MV  LR>$M(DU'2[XQ3";3(_*ML3O@+C !!//UZGOFMI'61%=&#(PRK*<@CUKF
M_$'B:YT;Q)H&F):1R0:G,T;RLY!7'8#_ ($#GZCW !5_X5CX6$+Q"RF"M/YZ
M[;AQY;>B@' ';U_(8V+3PQI=EK]UK5O'(EW<_P"M E8(3C&=N<9K8HH Q];\
M,Z?K]Q8SWOG^992>;"8I2N&X/([]!4*^$=,36]0U93="YOXC#/B=@"I ''H>
M./3M6E<:K96NHVFGRW"+=W6[R8L_,P4$D_3BKE '(GX;^'S86%FHO$2Q9V@=
M+EE==YRPR.QQV_J:B;3K+X>P2S:%HFI7YOI5#V]N[2"/ /S<YQUZFNJ74;-]
M2DTY+B-KR.,2O"#EE4G )]*LT 8'@S0W\/\ AFWLYD5+EF::8*0?G8DXSWP,
M#\*OZSHUKKMB+2[,JJLBRH\3E'1U.001WK0HH P+/PAIEM!=)<M<ZA+=PB"X
MGO9C([QC^'/89)/&.3]*K:%X#TO0;Q+J*XO[EHB?(6YN"Z0@C'RKP.!D9]":
MZBB@#)U[08M>M[:-[NZM)+:X6XBFMF 97 ([@C&">,5F3> M,N],U.TO+B\N
M9=2=9+FZ=P)"R?=(  48],8JYKWB)M#U'1[4V,DT>HW(MO.#8$3'IGU[_D:O
MZQJ2Z/HUYJ3Q-*MK"TK(A + #)ZT 9&G^"=/L-4@U)[S4+R[B@:#?=7!?>A[
M$=,>PXJC'X$L-,TO[,VHZG/I-M*;L:?\C(2#OQPFXC/\.>:Z31=336M%L]3C
MC:-+F(2!&.2H/:K] 'G6BX\4?$2YUN*TN%TPZ4+60741C)=FY3!Z\#G![BM3
M2_AUIVDSQ>5J6J26<,WGQV,DX,"N#D';CG!]:[&B@#CS\.M.6]NI8-1U2VM+
MJ4RSV$%QL@D)^\" ,X/UK4;PS#_PE1U^*_O89G14FMXY (I@H(&X8R<9]:?H
M?B%-;O=5MEM)K=].N/(?S<98XZC';T]JGOM5FL]6T^RCTV[N8[LL'N(ERD&!
MP7/;/^<T 0>)O#EMXGTU+.XFE@,4RSQ30XWHZ]",CWJA?>#I)M3BU:QUN[L]
M56W%M)<B*)_.0'.70KMS[C'05U%% &;HVBV^B6\T<,DDTD\K33SRD%Y7/4G
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M?I;*[O+;G=D*V1C;CC'/4FM*RT+Q5J<,UKXIU*QDLI+=X3%8JP,A88W,2!C
M)X Q79T4 <3X:T'Q=ID5GIE]JFG_ -EV; H]LC>?(J_=C;(P%]2.>V>:QKKP
M'XF6S\0:38W6E?V7JEPUP&G,GG*20<<# Y '>O3Z* .)7PSX@LM?T34K*?3G
M%KIR6%VLV\;E# DI@'G@=3VJUX6\/:IHWB'Q!?7ALS;ZG.)HQ#(S,N"V 05
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M=WY\K/,-P!B?<VT=A@ =L5Z&GA32(M3MM0C@D6>VMQ;)B=\&,= PS\V/?/\
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MV^S(.!D$[B#CGZ^M+;>&M6B\9>(-7D^RM#?V2PQ;7(.\(HY&.!D'N?QK$L?
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M]9>"]+M=2B:*[AB,;HP&5 8A1Q_LXKH* "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#+N?$>B6AQ<:M91D2>409UR']#SQ^/2K,^J:?;1Q27%];1
M)*,QM),JAQUX)/->8>';/PZVH^.3J]O8[(;Z3:94CWQKEA\F[IST]\4>&K^W
MTN+PI9:JEO;W<.G3S-<W\A41Q/(0JJ"<%B .#T H ].?5=.CA@F>_M5BG.(7
M,RA9#_LG//X5(U]:)<M;/=0+.J>8T1D 8)_>(ZX]Z\AT+3CK_P &%,15[[2)
MY+BUV@%E927VX]P3P?;TKH_#TB>)M(UKQ1J5NL45Y9_95#G:/*1#YA//0N7Y
M] * .U36M*EE2*/4[-Y)%W(BSJ2P]0,\BI;74;&]21[2\M[A8SAS%*KA3[X/
M%>/R:3H'_"O?!]Q]ELA+-J%NEQ+A=S@D^8&;J1Z@]*D\1VXT[7?&=IH"QPJ=
M)B::")-B+R-V N!G82?^!'WH ]9M=6TV^E:*TU"TN)$&62*97('J0#2?VQIG
MG)#_ &C:>;(Q5$\]=S,#@@#/)SQ7G^D6WAQ]>T#5H-;6[N&C,$%I;PQ+A&0@
MB15 .%![CBN2BL--'PM\2WIMK9;R#6"MO,$4.@WQ<*>N,%N/K0![*?$>F#Q)
M_8!G O\ R?.V'@8ST!/5N^!V%:M<!;)&OQKNY93$5N-(22W8L#N^=1D>_P K
M5VFGZG8ZM;M/I]W#=1*Y0O$X8!AU''U% $DUY:VZNT]S#$J#+%W"[1ZG/2G+
M<P/"DR31M$^-CA@0WT/>O.'TO2]0^-.J1:C:6TT/]E*^V9 1NRB[N>^"1FN2
MO[>$^%TMX07TQ?%/EV>>GE%6R%([9]Z /<'U*QCMC<O>VZP D&4RJ%!!P1G.
M.#Q4B7-O) )TGB:$\B17!4_C7G5UHFAZ=\1M%TE["%=,>SFD@@E7=$9R?F)W
M9R=JC]*2Q\/6]_J/C7P]9PPKH\@C,04Y6*Y*9^7''!P2.V * /23+&-N77Y_
MN\_>^E9FA7&JS6,SZU':PW"3R*HMWW+Y8/RDG/7'^17$>!9W\47.F/>V/EGP
MW;M;;F'!G)"\ ^B(#[%JRK@I8^"=6M$EDCT]O$[V]TZ$DK;[QG+=>< 9[YQW
MH [FX\2WD7CVPT.*VMI;&Z@>4SI*2Z%0<Y'3&<#\<^U=+YT7F>7YB;_[NX9_
M*O-=3BT[1/'VG/H-I:QSRZ3<B!+=!MED52R@A>O0\]_6L7PYH$.IZ7HVO?\
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M%D['YB.V<].,9-27$VH:UXD\%VTNL:C;QZGI/F7 M9_+RWE%B1CC)/\ ];%
M'J]%>3Q:A=V-MXGT6[UO4Q9V-[;QV]R,RW,@D;+1*W4L0, ]L^G%:5I]MM[O
MQI8Q7VH110V44]MYURTKPED<G!;E>@XYQZT >C45Y1837VC77@;49=8U.];5
ME6*XAGN,QX:,;<+CL6!R<DXZU-?:A>^%-8\3:?<7EY,+ZU$VD^9.S'>Q*;$)
M/!#,.!S@9H ]1HJGI-I+8:19VD\[W$T,*I)*[%B[ <G)Y/->27]Q?V6D>)-
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MR=+\\7A'[X#>%V@XZ9[9KEA\2]>.A2^(/[&LAI4%UY$G[]O-8;@/E'3H>IH
M]2HKC]8\5ZA'X@&CZ1:VSS)8-?2-=E@I4$85=O>K_@OQ#<^*/#<.JW-I';&5
MF55CD+;MI()Y''(/&30!T-037MK;310SW,,4LQVQ(\@4N?10>OX5S,WB'6]0
MU?4K/P_964D>G$1S27DC+OE/.U0N> .YKE]:UN'Q):^$]>L]/!U*'5UMG@=P
MI5P"60MSQD Y]^E 'J<DB11M)(ZHB@EF8X 'J34*:A926\5PEW;M!*P6.02
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MZDMM7TZ[TUM1M[V"2R4,S3JX* +UR?:N3B\:&_\ B-IVF:9J%I=Z5<6KLXB
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MKS58MEQ;Z,SI]AM;F82/'QECP2 "3ZYXYKLJ* "BBB@ HHHH **** "BBB@
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M>Z:'3;2-KL$7!6)1YH.<[O7J>M '+F3P1930ZQ:O L\>GRE!9'DPJN6)"\9
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MQ>VMYKIWBA;U52>V3BI(/!^EV\VL21FY_P")NK+=*9B0V[()&>AY./K0!YY
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M>J7=E#?32Q3" J,X"X/(()^8]<CI70:1X9MM'UK5=5BN;F6;4W#S+*5VKC.
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MJ"".A]?:HK;P=KNDW=Y#HVOQVNEW<[3-$UN&DA+'YMAZ#V^E23>$=8L-?O\
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M4J2,E3U'Y4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!P7A[QK
M;VL^L6OB/7[030:K+;6XE"QL(QC!('\.<\GWY].KU7Q!I&AP1S:EJ$%M'+_J
MR[<O] .37G5I=>'TM/'.GZO+:)=S:E<LD,Y >0%?D* \DYSC'//O69916^B:
MUI\?BFXO-,BDT2*&&16*C(/SQG /<YQ_B* /69->T>&UM[J75+)+>XXAE:=0
MLG^Z<X/X46&O:3J=O<7%CJ-M/#;DB61) 53 SR?3'?I7EVK1:':Q>"H-*DD?
M2EU<E&N3PZ[EW$;OX,D_K4&O"Y;5/B)::.56,Q6SR1P*/FP%\SH.O+Y_'- '
MJVG>(]%U>62+3]4M+F2+)=8I02 .^/3GKTKBK7Q!K'B7[??Z7XEL-.AM+B:,
MV\T2.AA4 "4D_,.3GL.1^)HU]X7U'Q1HU]9ZO=ZAJ4=NT"Q@#$:;"2S_ "K@
M#D9Y.2.M0>'I[&X^'WC)87@>(7-\ZJ,8"E?D..PXX^E '47/BZPT'3-&.K:C
M!<2WY6-;J !8FZ;I,YP%&1^?;MT4EU;Q6INI)XTMU3>968!0N,YSTQ7DEM<V
MEKX0^'EY=211Q0WN'E<C"#YLY/8<#/TKUI6MK^S#(8KBUGCR",,DB,/R((-
M%,^(-&$-M*=6L1'<L5@?SUQ*0<$*<\G)'3UK'\;^)9-&\-ZE<:5=VAU&R\II
M(G(=D5G Y7/&<]Z\VU"QU(:7=^'(+1VN/#-V]_!<R(2&M\Y1!C/)R6QT(3VK
M9U[%]\+O$/B2>V6WN-8DBDC4C#+"KQK&I]<A2V1UW4 >BZ5K=E?1V]O]NM7U
M!K=)9($D7>,@$G;G(&33-%NKV634_M]]I]PL-TRQ?96_U4> 0LF>C=S7!SV]
MG8>,/ $EC#!;"X@<2M H3S?W:_>(Z\^M4KN6&W\/>-HXG*P+K:_:%A)R(69
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ME75974,I#*>A!R#0!A6_@SP_;:9=Z='IR_9KL 3J\KL7 Z?,26&.V#Q5:T\
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M1=NU5P ".,Y! //>J&G^ 4TO3+"SLM;U"+[#<M<1N"O.X8*L,8(Z]?4UV-%
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M1QZ?+>D#:0Y/)/"L5V^G8&O1I+:WE??)!&[#^)D!--N;.UO4"75O%.H(8"1
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ME4[3POKUAIFF6EMX@A86=NUNZ3V>^*5<C;E0XY  '6@#/D\1:K*OA[3K*_\
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M'^F,\#GGI7::,FIKIRG5Y(7O'9F981\D8)X4'O@=S0!H4444 %%%% !1110
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MN0NI(3\7?"[*\>6TQ^01SE7Q7,S2VMS\/?$_S126\6O[XQL&$4RKR#[J3^%
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M6@CTW19;C8(H]9MB[/T5<G.?;%9<T-AJ7QK7SH[>ZA71MXW@.H^;KZ=&_(T
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M:;_9)N!;@'9;R%&.U1T&<[N/;TH ZCPUXBUC77MKM])ACTF[A:6*X2?+(0Q
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%0W5W;6-L]S=W$5O
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M_P!06^FVW5I=3?:-D>1E\XRO0_\ ?)]ZTOBU;W%YX-%O:VMQ<RO=1D)!$SG
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M;61[A RGT(SD5!>^*=,L=>T[1Y9?](OT9XV!&P* 2"3GOC ]:\YO[;3I-/\
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M9F75H7LYHHP,M/@>6<>Y !Z]#536=)BT36?AY82;3Y<LYF+8 +ML9SZ ;B:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(58 C/(/2LKQE+90>$[Z34;J\M;0!!)-9-B5074?*<'J2 ?8F@"C_P (,O\
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MB8LBLF<EV[YW'@# P/>N[HH XMM+UKQ)KND7FLZ;!IUOI4C3!5N/.:>3@+C
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M+8RN#CS 64C'&< UZ*S*BEF(50,DDX %".LB*Z,&5AD,#D$4 >?V.A:MX?\
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MRW)N5MXA.W!E"#<?QZT >0Q6EG)%\3G>W@::-Y#&2@+(,/T].:F6UTZV\/\
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M_+_P,5WZJJ($10JJ,  8 % 'FAUG4/$?@CQJ^H1P-;027$4&'!*;$4A<!<$
M\[LYR>E6/"'BB:PTGPKI=WI<D5O?0"*"Z,RG+*N>5[ ]N?2F6V@ZQ8:/XRT2
M'27-O>///9S^>A\PR*%"X)XZ9S4+^']8?3O $7]FS!M-G1KO++^Z *\GGV)X
MH T+SXHV%HK7(M5EL%N?L_FI=1^8<'!<1YSMZ_48-=5KNK)I'AV^U3*X@MVD
M3/1FQ\H_$X'XUQ.BQ>,] A/AR+0K6[M4F<VVH23!8T4N6#,O))!.<=>U=_>V
M2ZAI=S8SM\MQ"T+E?1E(./SH X/P=X1TOQ!X<BUO7X!J>HZBK/)+.Q.U22 J
M@?=P/2M&ULM/^'5O-%9I/<'5+Y5L[-6X5B -N3G '))/8"JOA^7Q+X1TM-$N
M= FU.*VWB"[LY4 =,DJ"K$$'M]/7O-K]IXDU6PT_51IL,5[IVH+<QV*S!WDB
M^Z06^[NY)],>] &K;>*W.KW&DW^ESVM_';FYAB5UD%P@SG:W SD8P<5B#XI0
MC2[?5I/#^I1Z7*_EM=$QX#9(&%W9/3V_&K#V5[K7BZV\0RZ3>6D.EVDJ1PSE
M/-GD<,,*%8C&#W(Y(KGM1T'7+GX0:;HJZ1/_ &A%.JM"&4D*I8[CSTH [+3O
M%S7>JWFFW>C7UE=06QNXXI"CM+$&VY&TD!L\8S^-94?Q-A?3[35'T'4XM)F?
M8]ZX39'SC. 22,@\\?C5MK346^*2ZDEE*NGG2?LSSL5 W;R^,9SW [5RF@QZ
MAKGPFT[P_:Z9<?Z6QC:[)411()BQ8\Y/<8 [4 =OJ7C.TTR75!+87SPZ9Y?V
MF=$38-^,;<L"W49P*9J/C:UL]6@TRVTW4-0N;BV^U1?940JR<\Y9AZ=O6N4\
M2+XJU(>+M+?2;VY@N!&+%T91$B+R<9/+''8$YXXK2T:UU*+QKH4DNE7<<,6@
MK:S2NHVQN"#@D$C/RXQ[T :)^(>FIX23Q"]E?>3Y_P!GEA5%\R%\D'=D@ 9Q
MSGN*V6UZ(>([71EMIWEGM3=&50-D:@X&3GN?3V_#F_"6CRZCX6UW3=7TZ>U6
M\O[AMDZX)5R"&'K@]_44GPOMKF70CJM_M>YD M8I-@4^1$2JC\]WUXZ\4 :_
MBSQ#=Z%-HT-G:&X>_OD@8#&0O4XYZ^_3@]*FO?%$=MJCZ;;:;?ZA=11+).EH
MJ'R0V=H8LP&3@G SQ6/\1;"^N4T*\LK*>\6PU*.XFCMUW/L![#O4%DEUX;\;
M:OJ,VF7\UCK,44R/;P-*T+H""CJH.#\Q]1QUZX .JT+7;+Q%IBWUBS[-Q22.
M08>)QU5AV(R*H:AXNALKZ\M(-+U+4'LU#7+6D:,L>1D Y89..<#-0^!].N[*
MQU.ZO;>2VEU'49KU8)#\T:.1@'!QGBLC2EN?"/B7Q&+C3=0N[;4)S>03VELT
MH).28R!T.3U/'':@#7N/'VBPZ?I5[&+JYBU.0QVX@BW-N'4%<YSGC SUK7T/
M5X]=TJ*_BM;JV20D".ZCV.,''3)KS"/P]JNG6W@V.32[D-#JDEW/%!$9%MD9
MU(!*Y' KV"@#S+1YDU[Q%K.J:M)JEJFEWQ:.4S>7#%''M/ENN3UY)XZ'K716
M_CVQENK..YTW4[&WO6VV]W=0JD,A/W>=V1G&1D#/XUSL6DZAK'A[QO8I8W5O
M/>WKSVPN86C$J_+C!/'.WU[BEO'E\2>%-(\.PZ7?1ZA;R6HG,]LZ);; -S%B
M #P#@ \YH Z>3QQI2:V^D1PWLUU%<QVTOE6Y98R^<,S= O'6I/&/B63PQI=O
M=0V9NI9[F.W5 <#YC_/ ./>L7P=!<0^/?&4LMK<1Q3S0F*1XF57VALX)'^T*
M?\5+2YNO"MNUM;RS>1?132"-2Q"#<"<#D]10!5\1:U/IWQ*\.2;KW[+-9S>9
M:1H7+':Q V#/S9V]/2NCM_&.DW.C2ZI&T_E17!MFB,+"7S>/D"=2W(XKG-3E
M>]^*WA.\BM;H6_V29B[P, NY' !XX/L>F>:Y>2TOY(=9O5TJZO(+3Q,UZ;1H
MV5GC.X$J,9SR,_2@#U'1_$VGZU>W-E MQ#=VP#2P7,)B< ]#@]JYOQAKMQHO
MCKPWF\N(["5)C<01 L'VKQ\H&2<FKOA:72]1UN?4]-\/W=F9+8+->W2&,NV0
M?+"DG)'.6_V0,GBJ/C,/:>._"FJR0S&QMVF6:6.-G"%EP,@ F@#>L?&FB7^E
M7>HQW+1Q6C;)TE0I(C=AM/.3T [TMCXPTJ^EO8C]IMIK*(3317,#1N$Z[@I&
M2/I7!:UI%_?CQ5K=M:7<UG<W-G)!$JLCS)'MWLHX8>QQ[BMK3WT"YFO-4TW1
M]32?[#*)[NZ\_P#=C /E@.3N.3T7@8^F0#:L_B#X=O[JR@ANI<WIVPR/"RH7
MSC;N(QNSQBI=3\<Z%I&I-8WEQ*KHP6658F:.(GD!F P#R/SKA) O_"&^ A'8
MRAK;483,1$P,.UOG)7'<\Y_'O0MGI-G?Z]I_B;1]4O+F6]>>#[.9VCNE;E
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MQU0Z?:):M8/<J\5UYI21>D;KM&"1D_@161I_CO5K7X<6WB/4=/2\DEN-F(9
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M!W8AS@8QS[9^M.\,>(-#B\.0>&-7TUKG6()VC?3S;>8TTH8G?EAMSR3DGL:
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M8W"M 8@<DGJORICZXKM?AYK%GJ?A2VMX L=U8H(+N'^)9!P6/KN(+9]SWS0
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M-)GOY#9PEHX75=ORH226(XZ] :Z1/B!83:)I-]!"6GU0LL,$DBQA2GW]SG@
M>O?B@#KZ*P/"WBF#Q/;7;I ;>:TN&@EB+AQD=PPX(//Y5!JWC%--\1IH4.DW
MU[>O;?:%$&P KDCJS#T.?ZT =-17"#XF1/HCZJF@Z@UO;3&&]8-'B!AC(SN^
M8_,.W?M6YJ7BN"QN?(M[*YOF^Q&^+V^S8(AT.XL.N.,9H WZ*\VUC4(=5\;>
M ]5MPZVURDT@,G&!LR,]L\FMJ[UV#6?#.MR:GHFI1:7#&XW 8:XC'\2#((Z9
MYXQWZT =?17)7GB_2_#>DZ!$MG?SI?P*MG#!&'DVJBX!YZ_,HXS5G3?&FGZC
MINJ7CV]W9G3 3<P74821<+NZ9/7'% '245Q]G\0[2[U73-/.CZK#)J<8EMGD
MCC*LA&=WRN>,#/M70:WK-GX?TB?4KYF$$(&0HRS$G  '<DF@#0HKF[3QC;RZ
MQ;:7>Z;J&FW-TI:W^V1J%DQDD JQ&>.AP:Y/2+:3Q?XTU>;5K34E2POE6SFC
MEV1P>7G*$!N2V03@'J>1F@#U"BLC7/$%OH9M(WM[FZN;R7RH+>V4%W(&3U(
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MMZ@28!0C.>@!/KFMI/$FFVMUHVF&2YDDU"$-;2M&2' 7.6;U('UYKS\W+_\
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MGQ'\+174ULVH2^= Y25!9S$HP."#A/4&MG1M=T[Q!:276F3M-%'(8G+1,A#
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M^FW,5O!-H]_$4C;RV,JSE24!^;&"=OZ^E=9I7]H_V=%_:QMC>X)D^S*1&.>
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MK[5UL=3T^R:TNI3>LRB6*/,<6!GYSVSVH RI/"3/J.@7O]IRA]'B\I!LXE!
M5BW.>0!56Y\ V]ZNL+=ZC<O_ &A<+=(4 0V\JY"LI'4XP.?2NO#J6*A@67J
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M6]C!*A8;9 S,[\*>!P!Z>]37&AZO>>(]%9].:.Q71WM+F<S1YA=T((V@Y."
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MX[UZ&SBG&_0O+23RR%>0,CA QP,D<=>_L:]7HH \U\,76FZC<Z4T?A&Z@U6
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MZ69#(MN" 1)M'4_*<>_K46I7AUF[\>#2YGG2:*UN%&QE,L2%=[#.,<8/3D=
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MRYU".[MXF/V;;#L**22<G)R2322Z!J#>.1X@2[@\A;,VBP,AR 3NSD'^]^E
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M.Y",DC)/'6@#537;"_\ %WA^2'2HY#J%B\T-^^!)&H!)0#\>>>]<[XQUN_\
M$O@'5[R'2[4:1'+MAGFE;S6"N%\Q5VXQG(Z^M;<?AO4]/\5>&?LEO'+I6E6;
MV[3F7#Y9<$E?P'3UK#G\->,+;PIJ/A.&RM+RQ=F-O>&X$;!"P?&S'7.>I[T
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M.\A8I!%L9@^"<COTX(ZCF@#TNVN(KNUBN8&WQ3()$;'52,@_E4M>;:7KFO\
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M5E)*#$K@Y';. ><>M=?10!QU_P##VUOI]3/]K:C#:ZDYDN+6)D",Y YY7/4
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MWE[?RR1P"T<,_F%<$*1G'!SZ8K=\<;KGX3I;".1+F[CM(XH)%VR%RZ':1V(
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M66D^$8]/LYK/3CK:RQK=*W*#.6.[) )((SVKU4@,,$ CT-#*K8W*#@Y&1T-
M'G_A:2,_%CQ@JNA)2 @ CG"C/ZT>-YH]/\>>$=3NV\JRA>=))F^ZI*\ _6N_
M"(&+!0&/4@<FAD1P ZJP!SR,T >96]S;?\+*\;RO(GEKIJ%BW8+&N[\JQ=*U
M"STZ+P3J>HSW,6F?89K83PNRK'-NP0V.0/\ #VKV?RT)8E%RPPQQU'O2&&(H
M$,:;!R%VC% ',>"(-&B@U*70X[PVL]T9#<7!8B9CU*$\E1Z]_4UU5( %
M'  I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC=Y@Z]CTSU[=:9XI\*ZOKL4T:Z?9?VA"\/V+5UF\N557:6+@#.<[\8/?MCD
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MHFL=*N-2D%K"?)A< @;4).3[GH,]:W_AII&JZ'X<GLM6LOLLWVIY%'FJ^Y6
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M:+<,#.ULH(&0><Y/0\XK3M+35M5^(%YK+Z->65K/H[V\?VG8"7W#@X8XS[T
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MZECGCN/+_=;1$H/S>N>,"JOQ$AN8]2\,:G':7%Q;6-]YD_D)O91\O\(Y/0T
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MJ51V8X4G"]!^8KK?$6HWZ^+M*\+Z8)_(6R-PZPW/D,X&54>9@G VDX&,\<T
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M2/P]IL,^ERQ0%/[,C:.U4-PH*A>?4XR.?[Q[UA:3$^F_$[6[2-A]FO;.*_\
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M)WNKF5EU.6'$DFX$ \,?]KMGTK7\5/=2Z_HEA'JT]I;7'F^9#9@B>5@HVD,
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M9&-TJ7(P =@SR/12<#/I0!./B+)9Z?XA;5;*"&]TB5(O*BF++*7SLPQ'MZ=
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M=@\3Z!X5T^U%D;N8WVQHYY1NM[4GC)SR0/RSTXH [FN?U3P?IFMZZFI:DAN
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MU<SJWC>STG5;C3VTW5;J6WB$LK6EN)$12"<DY&. :K^%E\3P:WJ4.K1RC2V
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M!'E22W98E!_RS(Q@)VP .IK=T/4+W4M-%QJ&F/IMQO93;O('( /!R ,YK2H
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MU'PW/;1K););7%O=J=KA  K KC#8'/&.M.M_"VKV%JS6]]97%S=W<EUJ$=Q
M1#/N7 4 $D!<#'KWKL*H#6K!M<;11.?[06'SS%L;[F<9W8QU[9S0!Q$/P[U*
MSTF(6&I6]K?PZDU] J(Q@B!&TH <G&/\/>M'5/"6M^(M"O;;6=6MC=.\<EH+
M:$K%;LF>>3N);)SGIVKM:* .%7POXGNO%NCZYJ-]I1;3U:,K#'(-ZL"&ZGK@
M_G^5:OA.]UJ[N-:359(9H8+UHK::)-@('WE P,A3QGGG/)Q72UGZ7KFFZT;D
M:==+/]FE\J;:"-K>G(Y_"@#!U3P]JK?$/3_$-@ULT*VAM9TF)!0;BVX8ZD[L
M>V*Y_P#X0?74\#>(M"46;27U_P#:(&\TC*[T//''"5Z=10!Y[)X9\4Z1J2:Q
MH,FFO=W%G%;7EM.K!-R #>I!!/3'/_ZNST>VO[73D34[Q;J\9F>21%VH"3D*
MH[*!@#-7Z* /)M0\!^)[JP\16*C3W74+W[2ES)*QE90V53..  ._K70:=H6O
MQ>/AKUW;6GDG35M2(YCD. &/!'3<"/IS7<T4 >5+X&\0?\*UO/#Q@M1=SWWG
M _:/E"9#9SMZY7&/?-;UMHFNZ'KUSJ^F6=I<#4[>(7=I)<>7Y,R*!D/M.X<M
MV%=?+?VD%PMO+<Q).R&01EAN*CJ<>E0VVLZ;=V]M/;WT$D5T2('#C$A'4#U/
MM0!PT_@G7(=&L;FUG@DUI-6;5;A&.V-G?[R@]A@ =.>>E3P:+XLDU77K^[M[
M!1J6G"#R8IS@2*-J\E<]&;\Z] HH \]ET'Q))HWA&R-E:"32;F*2=A<9&V,;
M5(X[CK[UH^'-#U;1?&/B":2"&33=2F%PEP)<,IY^79WZ]<CM]!V-% ')>*M'
MU5]>T?7]&@CN;FP\Q)+9Y!&9HV'0,1P?KZU2M](UFYO=8\2WND)#J<UE]DM;
M!;M6.WON?[N2<?E780:E975Y<6D%U%+<6^/.C1@2F>F?RJRS*BEF8*H&22<
M"@#GO ]OJ=CX3LK'5K'[)<VJ>3M$BN&4=&RI/:N:\<>']5UR\NUM_#JR3($-
MAJMO<QQ2(<#*OD@D [OP/'K7?#4+,W45L+J$SS1^;'&'&73^\/44D>I6,HD*
M7D#"*40N1(,*YQA3[\CB@#B+O3/%.G^)C>VVFQZLMSI<=E/.;E(,2#[SD'/'
M.< &LK3_  GXITCP[X>N+:S@?5=%N+@BU,ZXFCEZG=T!Y/&>G/7BO5J* ."\
M36GBGQ)X&U*TFT>"&ZN7B$%I'<*S(JN&9G<D*>F,"DGTG79/&_A74UTMA:65
MEY=TPGC&QW5E*[<\A>#QG/:N\DD2*-I)'5$499F. ![FHK6\M;V,R6ES#.@.
MTM$X< ^F10!SOQ!LM3U3PE<Z9I6GM=SW15#^]2,1@$-D[B,],8'K6<;[Q;!H
M5II]AX3(O(($C6YN+N'9$P7;O #'/?CC]:[>6:*")I9I$CC499W8  >Y-.1U
MD171@R,,JRG((]10!YWXJT'7_$4]S>QP36MUI!1M*"R1D7$F<NY].@ !Q_.G
M:C'XF34-'\7V^BM)>1VC6M[I@G4-M))!#<]\''4<<=:]#HH \Z\80^)]>\ W
M44VB&.]GN4,=K!(LC0QJ0<LV?F)(/0<9'I4/BO3KC4[B8CPUJ$>I6]M$=.U.
MS<;S)C)5R#@ '([]\=J]&6ZMVN&MUGB,RC<8PXW >N.M2T >7R6OB70==EU&
M?PXFO-J5E;+/M=08IHXPKYX(P22>!@\>E=]H,=S%I$2W=A;6$G)%I;8*PKV7
M(X) ZD<>E:5% '!_$NVU&^318M/TNZO#;WR7<AA4$!5SQUZG-:7CIM:E\.1#
M1(;EI99X_/$!VS+%U.T]FX'/:NJHH \RTB?6-+\5:QJW_")ZIY5Y:Q>6AE5V
M+(N!N8D\G@=SW-/T/2];\)^)%O/LLM[::TGG7Z00!3:S=>!G&,L1^=>DD@8R
M0,\"EH Q-'U^34]8U;3I].FM)+"155G.X2HV=K#C SCIDU@>)[S5[?QMIW_$
MOU&YT86Y!6Q&2TI/1R,$+@#C.#Q796UC:V<EQ);P)')<2>9,P'+MTR35B@#Q
M*"UU.+PYX4M9-$U-)--UHR3+]F9OD\S?N&!TYQGOBM?7='U?5M>\<VUK;7<<
M5W9VYB<QE5F>(+\JMT.1N&,]Z]6HH \FO;W4M8U;P;<P^'-61M,D9;I)+<J%
M)5!PQP"/E// KOO&%O-=^#M8M[>)Y9I+2141!DL<= *VZ* /+=3N+K5Y? ]U
M'I&J0K9W@%PLMHX,8 C!8X'3KS[&LW7M'U34-<\:FUTZYD\PVTL(D@<)<"(K
MO4' #?0'GM7LE% 'G_A<Z=<Z[93V7@^]L+D0L;FZNXW3R?EQL4M]_)./IVKT
M"BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *RO$M]<:;X9U*]M4+7$-N[Q@#/(%:M(RAE*L 5(P0>AH \\\.^'-)N-+\.
M>(7U.YAU B*2>?[6S&Y=O^6;;B?XB1@>XKGM5EA%A:ZUI=S>RS/XB1&O)7 W
MCYLJJ@D; 0!R!FN^TKX?>&M&U8ZG9Z>%N0Q9"SEEC)_N@\#K58_#'PJ4F06,
MJI))Y@5;AP(V]5 .!0!F:C>S:;XN\8WUN0)[?18Y8R1D!@&(J;0/#-A)8^'M
M=BU>[BN=J2S2&Y+"Z=P,HVXXZDC 'ZUOVG@[1[/5;C4(XIVFN(/L\BRSO(C1
MX VD,3D8'>JNE_#WP[I&I1WUI:2"2)R\2/*S)&Q[JI. : .*FBS\+?$^9Y]U
MEJD_D/YS;EVNJCG//!/%;-X<_%OPJ<YSIDG/_ 7K6N?AIX:NY[N66WN#]K<R
M2H+EPI<G);&<9S6E_P (EI0U;3]359TN+"%8+?;,P54 (QCOP>?6@#S35KKR
M-)'B.QN]0GNUUL*M]+(R),A9LQJ@;A  %Y [XXX'4>';!'^*?BNXFC=)H1;F
M(B5L89&!) .#GT/2KTGPO\+R"93;7&R5_,V"Y<*K9SD#/![5JQ^$]-AU==4A
M-S'=B%8699VPX52H+ G#$ ]3]: . L;VZ3P3IME<:I=*EYKSV=S=^<1*8]SD
M_/U!)4 _4UK+8MX9\>Z=HFG7>H?V?JMI,)8VG9_+=02)%)SM/0?E706W@31+
M;0+C11'/)9S3>>1),2ROQRK=0>!_DFI-.\(6=C<374M[J-_=2P-;^?>7&]TC
M/)5<  <\YZT >7V_VVR\'^%/$::QJDE]<ZFL+B6[9H]A9P5"^AV#ZY/MCU?Q
M=J5QH_A+5+^U!-Q# QC(&=IZ!OPSG\*RV^'>E/X=L=$-YJ/V6RN?M,3"9=^[
MGC.WI\QZ =:ZFZMH;VTFM;F,203(8Y$;HRD8(H \RO[&X\/^%M+\5V&J:B^H
M/]F>Y%Q<M*EP'V@JRDX[\=,5:T>Q1_C5KSF:Z4Q6\4H43L 257AAGE1G@'@<
M5T%GX$TZS6VA^VZC-8VLOG064TP,*,#D?P[B >@)(JS:^%+6U\5W/B)+V^-U
M<KLEB9T\HK@ # 7/&!CGM0!@?%I$;PWIYE:81_VE"KK%)M+*=V?QXX/8T:UI
M#7GCS2-/BU._M$32I5:>&7]\RAE&-[ G)X)/7BNH\1^';/Q/I?\ 9]\\R1B1
M95>%@KJR]""01Z]N]4T\(0IK-CJO]K:J]S9P>0I>96$B]3ORO)/?IT'I0!Q$
M&M:W#HG]C&]N+N;_ (2"33!<&?RYFB0!L>9@D$\C=UP:ZGP;I_B#2[_48-7N
MGELYB)+1+B]^T3)CAAN(!(Y7Z?B:5OAQI$NG7=G/=:A,+F[-Z9GE7S(YCU92
M%&"?H>E:NC>&K?1[F2Z-Y?7]VZ>7]HOIO,=4SG8"  !GGI_2@#,\3D7'B+1]
M/DU>\MXIMY^R6+.DLK= S.O1%R2<D=NM<.OB77W^&N@SC5+B&]DU864L_#.R
M9;[Q;))&!]<<YKT'7/!UMK6NV>L"_OK*[@C\EGM9-ADCY.W...3U],CW&0_P
MOLET>/2[;5[^*WAO5O(5;8_EL 1@?+[G_#U *%K;ZI)\0M4\,GQ)JWV%K$73
M2&1#,&)481MOR#YOX0*S]%\4:UJ7A_0=/DU)X9;O4Y+.2]&/-,2 '&2"-QSC
M./2NX7PIM\;3^)5U*='EMOLY@5%QCCN0>,C/U[XXK'M/AI;VV@G3FU2X::*[
M-Y:721JCV\F!TZY&0"?Z4 9E_>:KX7U;4=$75[^\M9-&FO+6:X8230R(&/+X
MY'!Z^PJ.;Q)K/_"/^![]=1E66_NXK>Z 5=LJEL'.1P<#J,=:ZVT\(J9KJYU?
M4)M3N[BU-FTCHL86$]0JKT)ZDUB6_P ,=EMIMO/XBU"6'3;@36L81%5 #G'0
MY.>Y/'I0!EW&H^)+W5O&B0>(9K:/1P)H(U@C((VNVTDC./EQ1+<7/B6_^'=T
MVH75M-<Q7#220[5.](AN8#!')!'/&#TKI%\$2)=>))UU9P=<0HX$ _=#D#'/
M.%8CMZU ?A_*FEZ%;VVNSV]UHYE\BY2%<E7Z@J3CIQ^= &5+XBU!/&=[INIZ
MS<Z1)]K7[ KP*;:>'(^4DKG<1GG<!DXKLO%EW=6'A/5+RRF\FY@MWEC?:&P5
M&>AX[8K(U+P3<ZRDEKJ>N2W6GO>?:A \ WJ,D^6'SPO..GTQ6_KVEMK6A7FF
M+<&W^U1F(RA V%/7CW&1^- 'GC:WXMM/"VF:G_:BWEQK3V]O!$L"(8&8,202
M0"2 !SQFM&QC\8?V?XBMM9:X6Q:S9K2YG,!F5MO*E8R1@\_Y-:EUX$CO?!ME
MH$^HR;[%U>VNXX]K(5SM)&>>"1UJ2V\*ZLMK>F^\1S7M[<6IMHY)(%5(0WWB
M$4@$GCD^E '(:/K-UH/P]\,VNDS3W%QJLWDI\B?N?G8R!-VT9R<#<2/I6[9W
MOC'3M)UZ34HW$%M9O/9W5T(3*7522K+$Q&.N/\BGVWP\=/!]EHT^J?Z783F>
MRO(8=K0MN+=R<\D^GZ583PCK4ND:C%J/B)KV_NK9K:.5X L<*,?FPH/)(QSU
MXH YFY\1>,;3P /%;:O9N)DCVVXLP-F7VDYSU/T_*M6[U?Q39ZEIVE-?)<W%
M\'NGDM;)<PP*OW0K-@DL0,D^G7-6KOP)>W7PYMO"O]J1!XG&Z?R>&0,6 QG@
M_=YSVJWKWA"\U9='O;75%L=9TU-JW,<.4?( 8;2<XZX&3U- &,?%GB73M%-O
MJEMY&IW.JK865Q-" I1B/G**<' SC!P>.N#E(K>[MOC79)>7QO)#I#$2&)8\
M#>_&!^/YUHWG@:_U/2G_ +0UZ2?5UN4NK>Z\H".!DZ!4].OY_F[3?".MIXSM
M_$6JZW;W4D-NUN4BM?+W(<D#KZMF@"/XGW=W;:5H\=I=26YN-5AB=D/4?,<'
MU&0#CVJS-JFL:IXMN]"TW4(;1-/M4>><PB1Y)'' P> !U/?FK_C#PU)XFTRV
M@@N5MKBVNDN8I63< RYZC//6J%UX8UFWU=-=TK4K5M5>T%M="[A;R9L$$, I
MRIX]_P"= %GP;K]WJR:E8:D8VU'2[DV\SQ+A9!SM?';.#Q[4Q=:U'_A94NB-
M%;BT.G?:(I/+.\G<!@MGD9)XK1\/:$-%ANI)95FO;V=KBZE5=JLY[*.< #MD
MUG-X;U ?$1_$<=Q:BV:Q-KY;*Q?.<@^F,@=_\: .0M/&GBVX\/#Q$\^FBTAO
MQ;26JV[!I%+ 9W$G&-W&/QS7I>LZG%HVC7FI3Y,=M$TA &2<#@?B>*X2'X?Z
MW!X%N- 2_L//DU 7*R[7V[ 0?SR!V([>]=UJ6F1ZQHEQIMZ<K<0F.1DXP2.H
M_'F@#F]&O?&-[)I.IN=.GTO4566:%$*-:QLFY<,6^8\@'CKTP*QO"ES>6A\?
MW&GQ12W<>IS-$DKA4+ MU)( 'XBMCPWX;\4Z7):V=]K\$FDV8588X(<22*HX
M5F(X XX!.0,<50'@/5WTWQ=9O?6D0UFY-Q;O'N)3+EBK\=",#C/4]: )T\9Z
ME;ZW+IERUC<L='-_'+;(0JR '*GYR&7CJ#563QUK"^$/#.LK%9>;J5Z+:X0Q
MM@ LP!7YN.%[YZU+8>#=?'B;3]4U&XTF2&&P-A-##'(H\O#8QG.3SSG QVK,
M7X?^+#H6FZ/)J&C_ &73;M;FW8))O8@L?F/3'S'@#\: -RX\4ZK)XQO]&MKO
M2;<VTD(BM[J-Q)<(P4L5;<%R,G P>E9^N^/M5@U?5;?1X89(]/98A')93RM<
M2?Q@,GRKCI\U:'B3PIJWB03VUTFE-'YX:UOLNMQ;QY!P %P2.?X@#FD?PQXF
MTKQ+JFH>'M0TY;34F$DL-ZCL8W[LNWJ>O4XYQCB@"OJ/C;51J.EV,)T_2YKW
M3UN0-3C<AI2<>7D,-O3J:[RV:9K2%KA46<HID5#E0V.0#Z9KDM9\,:IJ]J;*
M^_L[4[8VBH'NB8I8YP#F12JG@DCCCI70Z!ILFC^'[#3I91+);0)&SCH2!SCV
MH Y7P83?Z5J_BNY@CEOKV28)YF.(8\JL? X'RG/KUJ/2I/\ A*/A(9X[*WLY
MQ'++;Q6:B)8Y8W8H5_N_,H/XFG>$H+C2K/6_";8%Y!)++9^>Y"RPR9VL"!T!
MSG X)]Z;IUK>^#/A@VEWC1'4F66&T2W;>TDDA)0 $#)RWY#- '3>$M3EUGPG
MI>H7'^OFMU,A_O,."?Q()_&N8UWQQK.BK<W<VG6L5I;ZA]F$4I;SIX>GFKR!
MC.,=NU=1X5TJ31/"VFZ;,P:6"!5DQTW=2/P)Q7GNH^ O$]SI^N6"+ITBW>H_
M;4NY)2LLHYPI 7''U&,F@#HM3\5^(#XMO_#VC:;8RS6]LMPLMQ,P&#CJ!]>G
MZT0>.;J_T3P]+9V=O_:6LR.B12R$1H$W;F) SCCT[T6&AZ_#XYOM>N;:T*W&
MF+ %CF./- 4D<C.-RD9]*QK+P3XCLM#\/3PK8C5]%FEV1-(2DL3G)!..&Y/X
M4 6_!8NA\2_%OVU+=+G9 9!;DE,[>Q(!_P#KUK^+99-0\0:#X<(_T.^>2:[
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MUUM98GQ',AVXR._![]*S-=U?4I-2OM/O;347MIM("P_9+//G2-&2=[@9X)/
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MO3^)- M3J]E=VNIVINYE2W :(!>5&&X&> 3WS0!Z%-+';PR32N$CC4N['HH
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M>W5EHL<VFVEJER;FXF:+S0PR0GRD$@8XS3+[QK?"^T:UTG1EO3JEF;F)C<A
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M=0V!@9 8 \#TKHMPW;<C=C..]-,T0F$1D02D9";ADCUQ0 GD1?9OLZH$BV;
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M@  L2J[0-N>]=I3719$9'4,C##*1D$>E 'G4EAIFO_%.TOM*OXKB!+87%_\
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MV5U!%$;J)DO4(AV2@&92N3L(.3\O.1VYJGI.CZ1X5L#;6(%K:O*"%EG9AO;
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJFO@3PXNA_V/]@)LA-YZHTSDH_'*L3E>G8^OK0!G>"M!O/#>HZA8SZI;RP2
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M#&X$')/)/;GUJQ-X4OKZ;3K/5+Z*_P!'MXF^T1SJ3)<3%2-YZX SD 'C\!@
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MQF.H8CB\CY=PVR!B3STP/Y5>GM[J3Q_X2OUM)OLMM8E)Y#C$;,C  \]02,T
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M0*IP O)Y. .U '9RPQ7$+PS1I)$XVLCJ"&'H0>M97_")>&_^A>TG_P  H_\
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M>?ZDD#%0S^/;P:W?:3:^&KN>ZLX%GE!N(T"@@,<DG'0CIDGTH O?\*[\(_\
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MN2T9I,8=T."5P3QTZXH U:*Y0>(;N]\9:KX=-C(MI!9JQN4<!E9@3G.<@$$
M8Y!!/3IR'@'QO!H_@ZR34K;47C:Z>)[TQYB0LW&7)_\ U4 >M45R^N>.M/T.
M\FMWM+ZZ%L%-W);1;DMPW(W$D=N>*Z*TNH;VTANK=Q)!,@DC<=U(R#0!-111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@]ZMZ]E;M=+TF,0+C\<9["@#R[Q[H1T+P#>275X+G4-0U-)YYMNT%N<*JY.
M *ZY/"D^K:J=3U^]M+U39/:Q16L!CC"O]YLEF))!Q71:AI=AJUN(-0LX;J$-
MN"3(& /KS6-=^,]!TJZ?38WEFFML(\%E;-+Y/H#M&!]/:@#%M_!.N'0X?#=[
MK-K+H<>T,4@9;AT#9V9+$ =.<9_*M?3O#NH6/CC4=::[@:RNX$B6W5"&CV<+
M@],=?^^O:M+1?$FD^(4F;2[KS_(($HV,I0G. <@>AK5H X.U\#ZK:6'B>PCU
M*T-KJ[R/$&A8LA?J2<CMD8Y['VJ"?P/KLNC^%K,7VG!]&N%E=MCX;:1MQZ\
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M$;X&WGC(&"1R?7@5LSWESJGC30-"GN[I+)M(%Y((+AXFED.5^9E(8@8SUZT
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M8Z<TT.HWEC]JN9;:U2=Q@[1M5F5<$JQ/IQ]:[#P;=ZY>:&3XAMFAO8YFC!9
MAE0 8<J. 3D\#TH O:IKFD^'[=#?W<-LI&V*//S-CLJCD_A5+3?&N@ZK=0VD
M%X4NYB?+MYHFC=L9[$>Q_*N8T9$U#XU:]+>2++)8VJ):QNN=BD+DKZ8R1_P,
MUV.LZ?8,\.M7,!>XTM9)XF7 ;&P@KGT([>N* -:HKBXBM+:6XG<)#$I=V(Z
M<DUYS-K_ (M@\++XS-Y:?8F"RG26@'RQ%\#$HY+$8ZC'-:$FO:OXGN=3M](F
M@L;*SM(WD::$S23-+'O  ! 4 ''4\T =AIFJ6>LZ?'?6$PFMI,[) , X)!_4
M&K=>/^&?$MYI'@3PQIFGQN+J^EN"TPMGN/*C21MQ\M/F8\BNX\%ZUK.K07L>
MLZ?-;R6TNV.XDMV@%PISR$;D8P/S'O0!U%%<9XMUW6-,O)TM;JQL;>&QDN8V
MG DDNY%!/EHFX$8 Y//6LB37-:US4O \]G?+8C48+AY4\LNA=(^=R[AN'ID\
M=: /2JIWFK:?87-M;75W%%/=.(X(V;YI&]A6;XUO+S3_  9JEW83^1<PP[DD
MV[L<C/'KC(SVZUQ6K/J4OA3P'>22Q7NIR7UL\<DB;?O1D@,<DGMD\9QG% 'J
M=%<"/&.K:+_PD<.N1VUQ+ID,<\3VH*AA)PJD'T/>ET#Q/XEE\20V&I:;+/97
M*$_:HK">!;=N3M8R*,CC&>.H^E '>U3;5;!-532VNHA?21F5("?F91W'ZUS7
MQ!U#5M.M='?2[R"U\[48H9#-PK9R0&/9?EY]:6;5Y(/B5IFES:=9F:XT]F-X
MN?,&,DJ/1<K[T =A17F@\?>))=+UC4HM*TL6VE7,D,X:X?<VTC[ORX[]3CZ"
MM&T\;:HFJ:&-5L;&WT_6H7FMVAG=Y(P(PX#94 D[@./7VY .ZHKS.W^)]W<7
M-E.FGQ2V%U=-#Y<*RM/''G"R$;<'/7 ^G>NZ\0:S!X>T&[U6X4M';INV@X+$
MD!1^)(% &E5*\UC3-/FCAO=1M+:63[B33JC-VX!/-<M+XLUO29=)GUG3['^S
M]2D2$26LKEX7?E=P(^88],?XXVF6MQK7Q.\2V^H6MA=6T?V<21S*6VH!E=G'
M7GG- 'I]5Q?6C7ILA=0&[";S )!Y@7UV]<<CFN5^(>MZKHMEI+:7-%$]SJ$<
M#LZYX.2!]#CGO6;JLM_9?%NT?3=.AN;RYT<K*&F,:)^\SN9@I.!M Z<Y% 'H
ME%<+'\0V/AVUNWTY8]2GO6L3;R3;8TD4_,Q?!PH'/3/;WJUX+\;CQ3=7]E+!
M"EQ9;29;>1GBE!SRI*@CIT- '6/<0Q2QQ231I))G8C, 6QUP._45)7(^([^P
MM?&OAJ"[T=;B>Y:1;>\,F# 1C.%[]1UQC/'>LZ^^(>I6SZVT'AAYK?2)S'/,
MUXJ#;V8 KGGK@9X(H [MKB%)DA>:-99,[$+ ,V.N!WJ2N'U#6=-E\6^$+S^R
M)+B;4(7:UO!*5\E60$C9_%PW.>F:3P]XBU;7+WQ3!?V<$ME9326ZQ12?-\H(
MV#Y1NW8/S$CZ4 =O')'-&)(G5T/1E.0?QHDD2&,R2NJ(.K,< ?C7"Z+XDBL?
M 6D7&B^'[CR[FX^S6]IYQ8)EV^9I""0O!YQU.*AUG7(O$_@CQ99WEBD%UI8=
M)8UE,B[E&596VKW4]NWO0!Z"K!E#*05(R".AI:SO#_\ R+>E_P#7G%_Z *T:
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3FU&\E;?),XV*., (@X4?3K5C3-2M]6TRWU"U+>1.@9-Z[3]"/6K9( )/04
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MGAQ+"YL5TBW%M<OYDL8!PS=CUR,9XQTH Y:XT[2])\<^"7L;>WMI)X[@3-&
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MXZ8/04X?$>>VT36)-0LH(M4T^[6T$22$QN[9QSUQPQ/L*GF\-ZQ)K_@^]$$
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M_$Z3VK9QB13GKVXR/QKFX_AU<6^M:/<QW&])4_XG3D\W#AO-R?4&0 <=@.M
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M=9<JXR""OZ_45T-<5H.EZFGQ)\0:Q=6#V]G<Q1QP.[J=^P*N< DC.W/-=K0
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M@#NJP/"WB23Q'%J#2:=)9-9W;6I5W#990,].A&?_ *];]>/V7A[^UE\<7?\
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M&0SMYD3^JMV^G3VI;?P1I5E8ZA%']JGFO(# \UQ=.S[.RAOX1DYX'?O7344
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6Q\0F[2U2>*>TD$<\-Q'L="1QQZ'G\JY7QSHCVB>&]4@MXYK#0&+S0^8L;;
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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+ 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>a123121ex-1021016.jpg
<TEXT>
begin 644 a123121ex-1021016.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?S!$&V$^9GJ#S]W&.] 'H]%<%-XI\0ZCXNNM%T6/3T06"7<,ET&R =O4#O\
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MBEN+J,PXEDV!0W!.<=AVKF-.A\?:9X<@TFVTO2P8+<0I.;HY&!@-C'6O0J*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBD<,48(0&QP2,@'Z4 >7?$&_LM
M7UR71+N.[EM;.T9O]'A>0+=./D+;?[JG//\ >Z5=\.>-F3X53ZG(!+?Z7&8)
M8F7;\X.$R,],%<_0UTWA70;W0;>_%]J"WT]Y=M=-((MG+ #'4\84?2LM/A^A
MU77)YM3DDL=9#?:+,1 8)^ZP;)Y7L<4 ,TT>)X8-,UR?65O+&6V,]]:O"B;%
M*;QY6!G(Z<FHM.?Q;K&G:;K]GJL %S(LCZ<\2K$L)8_QX+;MN/UJQH?@G4=/
M\JVU#Q)=7VF6Z%(;01B,$$8^=@<D#)P,^GIBFZ=X"N=.9;*/Q%>#0DE\Q-/5
M%4_>W;/,^]MSZ8SS0!6@N?$7B%-8U&SUO[!'8W4UO!:K;HROY?0NQ!/)ZXJ'
M0?%NK:WJWA6Z:1(K+4K>Y2>W51S+%G+ ]0.F.?6M"7P;JEE?:BV@ZU'96>I2
MF6XAEMO-*LPPQ5B>_)YXZ4^_\$2QV6AQZ!J/]G3Z0'6.1XA('5P ^0>YQ^I]
MJ .=F\8:[:>'O&5TMXDDVE:D(;=I8E.(S*%QQ@=.^*NZ;K7B:S\;Z+8ZIJ5O
M=VNL6[S".* 1B':A88/)/3N:>_PUO/[!UW3_ .WA/+J\T<TLDMJ%PROO8@*W
M4G'MQTYK2_X1#4'U_P .:I+J4!;2;<PR*L!'FDJ5)'S<9!_F?8 '+>&=1U6P
M\#^+M8@U!Y+B"_FV+<*'7(V$MZY(..N!Z5LW.N^);JW\(#3KRTBFUBV)F,T&
MX!_*WEAC\<#UQVJ:#P%?6FD>(-*@U>/['J;R21H]ODQLY7)+ C/"X_'/M4\?
MA'5XO^$7V:G:K_8BE&_T<D2C&SCYN/DX^O- &?9^,-:@T#Q8+L17>HZ(Y5)8
MX]JN"#@E?8@D^U5]%\2Z_>^+M%L4UFUO;.]LQ>7&RW7,7R\IE3QR.I]:-<T>
M[\*Z3XJU.34N-9E10T$&/(W,06;)/&&(.*C\-7-YINJ:98:=KNA:I%(XCFAL
MK4*ZQ $ERR9QCCK@$F@#I_B1_P D]UG_ *Y#_P!#6L71[_Q4VDZ#:W.A6+Z5
M,L$+N)3(QB*<$J1@=!_+O73^+M%NO$/AVXTJTN8K8W! DDD0M\@.2!@CG('Z
MU;T&QNM,T*SL;R>*>:WC$7F1(5#*O"\$GG &: .0@\3ZVT_CB#=9^;I*^;;.
M(B!@JQ^;GD@*/Q]N!1N]>\::=X"D\2SW^F2));VTT2+;G<N]E!!YQT8>O?&.
M*T8?!.MQ-XEE.JV1FUQ CM]G;$8Y' W?W6(^N*M:AX/U+4/AW!X8;4K=98UC
MB><0G:T:'*C&>#\J\^Q]: ,:37/&4?B/2=*.I:86UB!YHW^QG%OA2V -V3TQ
MSFNE\$ZOJ.J6NJPZI/#-=V&HRVA>)-@95"X.,]R3^55Y/"=_)XE\/:L;VVQI
M5MY+QB)OWA*E6(.>!@\>GO5GPMX:N]!U'6[JYNX)QJ5R;D+'&5V$EB1R3D<B
M@#&\2>*K^S\6RZ,NI6^DHUJKV<US!F.>0YR&<_=' '%1ZG%K#_%6--*FLH;M
M]!'G32PEE \XY*J&'.0N,D\>M:WB?PUK&O"^M$O[ Z==(H6&ZMFD:%@,%D8,
M,'OWJ2W\,7]GXM@UB*^A>"+3EL/):,ABHYSG_>YH S+?Q%X@N?!BW1FTZ"^A
MOVM;N[E;;%'&C$-( >IX''OTJ@=>O=8\->.M/OY8KE=.AD6*=8POF*48@D#C
M^'/XU*_P^UIM(MH/[:MVN[?53J*,8#Y9)Y.5[D$DCM@D5*O@SQ(J>(S)J]A<
MR:U;"-V>!DPX7;V/ "DCOV].0"GKMQ+;:3\.I(7VO]JM4SC/#1A2/R)KN?$6
MKKH/AZ^U-E#&WB+*I. S?PC\\5R^H^#]<O\ 3_"UM]LL%;2)(Y96*N=[)C;M
MZ<8'?%=7K^D1:]H5YI<K[%N(R@< ':>QQ[&@#@=8CUS_ (27P5-J]Q:W'G7C
M/_H]N46%B =@8DDC'KR=M1S^-?%E[<7-]I&GS26<-R8H;5=/=Q.BMAB90< _
M>Z=,5JQ^$_%5S-HG]I:U8/'I-P)(S' Q>91@9<D_>VY' []Z+;P?XGTB[N[;
M1?$-O;Z5<SO/B2WWRPECR%SP?Q/X<T 16^M:@OQ/U)KBXE6RMM'%RUGC@#Y3
MC&<;@6//X52TOQCXPNM0TZ\.F2W.G7KKYD4>GR*(8VQAED)^8XY].OM6_/X/
MO#XU;5H;R)K&ZT_[%>)."TK#&,J1@ G"\GWXJEH/A+Q;I2VVF2^(H/[&MI%*
M"*(B9T!W;"?X1GCJ>/RH 9I>O^,=;\2:G8VK:+':Z7>"*8O'('D4[NG)'0>W
M.*R[CQKXRMO"]QK]PNC)%:7?V=[>.&0M(0VQ@27P!GD8]/SZ7PKX=UK1=<U^
M^OI;!X]2E\Y! 7RK G .1TP?>L2;P-XENO M[H-Q<:6US<WWVGS5>0* 6WMG
MY>N[H,8P: -G3M>UR+Q@NBZJ^G.+NQ-W;>0K)L8'&S))W="<]>OTK!M_'.JP
M_#:YUZWL=+BNHK[R&B6-EBVY SC=UR1SD5MW'AO7I/&>E:ZKZ:RV=C]G>,NZ
MDN0VXCY3QD\>U8@^'OB#_A7UWX=-SIGG3WPN ^^3:$X)&=O7<!VQC- &Q:>*
MM=T_7+FR\0P:;Y*Z;)J$;V&\G:AY!+'DX]!6;HWQ!UJ^U32UFTY9+2^?#I#9
M3*T"M]QO,)*N.>2 /6M>Z\*ZG?\ B:*]N9;,6#Z2VGSQJS&0%@=Q7@ C..3V
MSQ4'ASPWXPTF*VTRZUJR.DVK@HT,9,[QJ<A"2, 'H>IQQF@"]\2KN]L? >H3
MV,_D2@QJ7&=VUI%4@'L>?RS7-^(O[;C^(?A$(;&?5Q:SC+;D@+;6R>YP!D^^
M.U=GXST.?Q)X3OM)MI8XIIPFQY,[05=6YQS_  USW_"+>)GU[PYJTTVD-+I<
M30RHC2*K*P*_+D')VGJ<<]L4 1MX\U;3-$UEM7L+8ZI87:6J"VW&)RXRC8)+
M8QSCJ>!@&M#PIXIU35]?O=.OH8I+>.$2P7<%I- C<@,I$ASGD=/0UGWG@K7M
M3_M]KB[L+>2]NH;NT:$NWEO'PH?<.FT#IW]N*Z#1;+Q.=0%UK]_8E(XC&EM8
M*X1F./G<MR3U&.E #_$NI:O82Z>FF)9I%-*RW%W><QP +D9 93R>.O\ .N4?
MXBZI'X&U#5Q;6,E]87_V28*'$3#(&Y1G/<=_\*W/%WA[6M4UC1=2T>>Q#Z<T
MC^5>[]C,P !^49XY]*YN7X>>(I/#6MZ4UUI;-J-\MVL@:10O.6R-I]%P.>_-
M &J/$/C,^(#HGV30_M,]I]KMY-\OEH@8 A^['Z 4Q/'NH#PW"\MK:+K<VIG2
MT3YO(\P-C<>^T9]<UK'0]8'C/3]:7[#]GAT_[).AD?>23N)7Y<8R!U[9XK!/
M@/6Y=)EC>?3HK^+5SJEFZL[H"3DH^5'&<<@&@"^OB;Q+INLC1]:M]+-U=VDT
MUC/:"3RC(BEMKACG'':D'BW6I/#'AK64CL -0N8X+M&1^ [[08_FXQ@]<]JM
MQ:+K.MZW;:IK<5M9FQ@FBMX()C+EY%VLY.!@8XQS^'?GH/"'C==$L-'-SH@M
M=,NDF@9A)NEV-N&X@<#GT!X_&@#4U/Q/XI77];T_3=/TSR--MUG\^Y=SP06Y
M"G)) .!QC')YQ6=?>,=9U&S\%7FGO%9G5+HI-&065B#M(/?:<DXZ]/2MX:/K
MR>*?$5["+1+:_M$B@?SF#B15(4\+P/F.?PQWKGT\%>(8?#7A6.%+/[?HUVTK
M1/*=C*7W#Y@* ._UC58]$T.ZU.Z&Y;:(R,JG&XCL,^IX'UKCW\6>*-*M+'6=
M8LM).BW31[OLTCB6W5\;68L=IZ\XKKM9TI=<\/W>F7.U3<PE&*\A6QP1D=C@
M_A7(?\(]XGU/1[#PYK%OIO\ 9]L\7GW<<S,9DC((54*C!. "3QP?44 "6=WJ
M?Q/U:"\@TRZL#9092:-G/E[B1@'C.0Q/;[M7?B9JNHZ/X:MFTN98)9KR* N,
M@@')X(Z?=P?8FK6G:;K,'Q U+49[:V&FSVT<$+I+\P"<C*XZDL?3&.]/\>:!
M=>(?#GV:Q$9O(;B.XA$C;5)4\Y_ F@#F=<&HQ?%G0GMH+-]2?3I =S%(B?G&
M2<$X JY_PL=[?PW<RWEO;C6K>^.G-;QES&TH.-PX)VX!.!D\8[U=DT/7+KX@
M:/KMQ!:+#;6;0S^5.3ACNZ94$]17/GP!KL]OK%PQM;?43J_]IV+"0NI.6.T\
M# Y')'X"@#H_!WBV_P!<U&]TW4;:(3VT:RK<6T4L<4BL<?=E 8'M[X-9WQ4M
MX)(_#DKPQM)_:T4>XJ"=ISE<^AP./:MWP\OBZXO&N/$36%M"B%8[:R!.]CCY
MF+9Z=L$=3FE\:>')_$FD016<\<-[:7*7-NTH.S>O9L=L$T 4/BE!"_P[U#=$
MA\IH3'E1\A\U!QZ<$CZ&DU3Q-J>F^+(?#&C:/:2YLA/#OF\M0 2,8 P ,=*9
MJ%AXJ\4V::5JNG:?86+R1O=2)<F5I%5@VU5 &,D#DG@9JQ=:)J<GQ0M==2WC
M-A%8_968R@-G+-G'X@4 01^.YSX?M9WL(AJUU?/80VHE^0RJQ7.['W1WK!LK
MF72?BQJFH:O!:6S1Z,UQ/]C+,I 9<DY ); ]*E'@[Q#)HMK-]GM8M4L-7>_A
MC,^Y)$=MQ7..#G^7O4K^%O$FN^*;_4-1M;/3[>\TN2P?9/YQ7/0C@<YQ^&:
M)M*^)GVS7=+LYX;)[?4@?+:TF:22!C]U95P,'U_P%367CC7M3ENGL/#D4MM9
M74EO<L;P*5VC.1D<]_7M5C0;;QO;P6&EWJZ=!:VA57O(V+O+$F,*%Z L!@GT
M/0&F>%M%U31+'Q(-1MDC6\GFNHF24/PP/RGW% &=!\2-:?1[+7I?#\:Z-+,(
MI9EN,NGS;2V.PSQSW^HK6UWQCJ>F7&IRV^DQMIVF+$\T\\I0S!\?ZK () /<
M^GKBN3\,:;J_B+X6Z=HD%E"EA-<9GNY)N?+68LV$'.<C'7_ZVCK7A+Q%<7_B
M".WL+&ZMM0A2&UGFN"&MXU4?* 0>X'IR,DT =)=>++FV\7Z)IC6<:Z?JL)>.
MY=R&#!2VW'3/W1U_BK/O/B#<Z?HVJZI-I:R6]KJ36-N8Y<>: 2-YSVX[52\6
MV5R/AQ9?:O)M]>TPVYMQ;R;B)-PC& !_$,\8QD>U3^+?"5Z?AM:Z)I=O]JNH
M9(GDVL 9&SEW^8]V)- %F3QGKL?B%M"/AV,7\UN+BV7[6I4+R#O./4'IFF+\
M2K6/P^+JY@CBU'[8UB;<RX195ZDN1P@&#GGJ*FDTK5YOBA8ZX; )9+IQMY&,
MRDHV2>G?EL?@37+:?X0\2)!/J*6"P:A9ZR]_;P2R@K.C ;ER.G08/'>@#H--
M^)!N-*UJ>>QCEN=*1976SF$D<B''*O[<Y^E3:5X[O;O7],LM0T-]/MM4A,EG
M*\P=G(&[D#H,8ZXZTFH/XKUOPCJ_VK2(K66>U:""Q28.[LQP69L # Z#ZY[5
M3;2-9GUKP-=-I4R)I\#1W>70^4=@7GGGIGB@#8\#ZWK.M1ZD^J6\2I%>2Q1O
M&_"[2!LQUX]<\U%KWB'5K+Q_H.C6,4+V]U'(\JN^"X /?'&W:3QUJ;P=8ZKI
M%WK%A>6*K;->R74-VLH(D$AR%"XSQWS^M5_$NEZF/'?A[7K"R-[%;+)!-&KA
M"FX$!B3V^8_E0!B:;K%QX<UCQM-::+->6\-Y]HF=)0H7*Y;KR3U;CM^&>J;Q
M7/,=)%AI$UP-0L_MF]Y!&D*[00&;!YYQBL)=.UN-/'<9TB1AJ!;[&5E3][N0
MIZ\8&#S]*J)IGB51X9CN-%^U6-MIRP2V9N JI.HVAWSP1C!'!YSZ"@"U?^.K
M[4=&\.:EH-L%6_U!;>:*9@&R,_(#R,'!^;Z=*[+68GN?#M_%Y69)+20>6/F^
M8H>/?FO,M-\/^)=.\'Z-;_V([W6EZP+DP^<@,J88Y![#D"O4+I[M]#G<6@-V
MUNQ%OO# OM.%SQGGCM0!YOX+\8OH7@_P];W6C70L9YC;+>^8FTR,[D83.XCW
MXZ'\>HUCQM+I3:K(-$N);/3"@FG=Q'NW8^X"/F SUKCYM!\0CX?>&].70[AK
MS3M0\^2,21\HI8YSN[[\?@:FU_1/$FIW'BB*31);I[L 65RURH2*)2IV*I_B
M.!GIDC\P#K[WQ@Z:I)8:9IK:A)'9+>G9,%+(<X"#!W'IT]:Z2.;-JL\J&'*!
MW5R,IQD@XXXKR[5M&OM2TRV2;PGJ$6IV=A''9W]I<QAUD"8VN-P^7=]3C/2O
M2+:"XET.*WO7_P!*>V"3/U^<KAC^>: .8/C]SHKZ]'H=Q+HJR,OVE)DW[ VT
MOY?ID>M7;OQ@S7,\&C:5-JK6MNEQ<&.14V!UW(!GER5!/'\ZY>VTWQ##X'G\
M%SZ-<23'?!#?K(A@,9?.XDD,, \#'./RDTW1]=\"^(;S^S-'?5].O+:W3>LZ
MHZ-&FWG.!SDGIZ>] '2KXQ-R=.@L=*N9K^]@:X^S2LL1A13C+D],G@=?PJD_
MQ \FPTVZN=$O+<7E\;%TD8 Q/Q@C^\#SR/0U4U"U\4:?XFT[Q)%IL=_++8?9
M+VTMI GEG<7R"W4#./P]Z9XML/$>NZ!IEV=+C^U6VIQW0LHI!O6( X#,>"V>
MN..>^.0#</BV1-5URPDTJ8-I5O\ :-ZRJ1,I!( Z8) /Y'VSD_\ "R+@:(VL
MOX7U!=.$ F$_FQ[22VT#KG&?J>AQ@U4@M_$=WK/B74IM DMHK_3!%'"TR,YD
M52 ,@XYR?TI]UI>L77P:&C'2IEU(0I;_ &?<I/RN/FSG&,#- &D_CUHM.%S/
MHES;RSRK'9PSSQ)]H!3?N#%L  =?<@=>B67Q&L)]%U._N;2:"73YA!);HXE+
MNW"A67@Y.1^%9FO:%J\EAX3U2TTO[7<:7&$N-.F=1N!0*?;(P><^G6FZYHVL
M^)/#,QA\/V^ES6UW%<P6F]=\^P-NW%1M&=W'T/K0!!'<7EW\9='GOM+?3YGT
M]_W;3B4D8?GC@>F*[KQ!KB:!IR736L]R\DR0110C)9V.%!/89[UQD?\ ;VJ?
M$;1]=D\-WEK:PVS6TWFR1_*26RW7) S^-;OCX:RVBVZZ1;SSJ;I/M<5L^V1X
M.=RJ>V>F1S^M #(O'D M->DN].GAGT4K]IAC=7R&Z%3P#T/Y4ND^./[2U;3+
M.;1;VSBU2!IK.>9D(D"KN/"DXXYY]N.:XN33=;\GQC&GA:]MUU.T@,$:2+)M
M* J1G/)Y)P,XQ[C.G)8:J]S\.BFEWJBP@VW1V8\KY$4AN>/NGKZ^O% #?'OB
M4:QX1U=+?2;U]-@D\G^T4G1%\U7"\+G+)DXSCG)Z=1Z+I7_((LO^N$?_ *"*
M\S:WUK3?".L^$W\-WUW-*TS07,.'A97;(8L3D,/3!/ KTG13.=$LOM-NUM.(
M55X68$H0,8R.* +U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 45Y8WBC5M-CTR[FUTZCYFL?9+L6\"?9U0Y^16V@E@ #D$^_NS4[[Q7=7WC
M%XO$3V=MHW[R*"."-MRE2ZC=C(X ]>M 'JU%>;ZGXBU9=.\)>)GO);?39FC7
M48HE78-W\1)&<=O;C&#70>%I+Z^U;7-1EOIIM.DNO*LHV*E-J##,I';=D?AS
MDT =117!>,?$-]I/B"*">]N]+TF2U(COH(%E03EN-^5/  Z#'6KEKJ6HGQMI
M^G?VK]IL;C1O/W+$@#R!@/,!QWSG'2@#L:J:GJ5MI&FSZA>,RV\"[Y"JEB!]
M!7G\7B;6K;2&L9-366_FUZ32X[V:%5V(N!NVC W>F<\FM>_T[7[+3_$/V_5Q
MJ&EOIDGD^;&BRI)L.<[5 (Q_2@#J]/OH=3TVUO[?=Y-S$LJ;A@[6&1G\ZCU7
M5+?1M.EO[L2^1$,N8HRY4=R0.P]:\]T6;Q!I%AX,N6UE)M.OO(M6L1;*H16B
M)4[^6) 'MS[5V7C3_D2-<_Z\9O\ T T 2V&NZ;X@T&74+:*:XL2&4J]LV90!
MR%4CYAU''<$5'X7OM$U/3WO="M$AMG?:66U\D2$?@,XR1GZU!X!=)/ 6BF-E
M91:J"5/<<$?F#7!6.MZKH?PF\+2Z5<1127%\;9O,CW@AI)#^7RX/U[4 >P5E
MZMXAT[1;JQM[Z5TEOI1# %C+!F) Y(&!U'6N137]9\,77B*+6-2755LK&.[@
M8PK%\S%EVX7L3CGFL37X]5DB\%:AJ6JM=F\U.WF\GR%18BQ# *1S@ XYSG':
M@#UVBO*[SQ!XPUFXOKWPZUT8K:\-O%;);0M#($(!+2,V[)YZ#TYK1U'5O%%]
MXZ_L'3]0AT]9-,%S^\MQ(T39P1U.3G\,>O6@#T.BO-;&]\8:UK6NZ-%X@M[9
M]+$2B=+)29&()Z$D#ISU[=*;IWBG7/$.A:!<K?1:=%.\D-W<1HKS2.OW1'&0
M<YZG ..3QB@#TRBO+KGQ)XHN/AHNM6-U_IEC=.MRWV=<S1(Q4EE(^4]"<8Q@
M]*WYM<U"Z\0ZA-IEY&=+L]'$S(T8(,[[F0]C]T#/- '945Y,WB_Q6OAC0/$1
MOK(K?WOV9K7[+A>2P!+;L_P'ICK6E-XNU;PQXCUFQUBZCU""#3_M\+)"(BIR
M%$>!GC)ZDT >CT5YYX>UOQA<ZSIDMU:S3Z9J$0:4M;)&EN=N04978D'_ &L?
MA61=^+_&,'AO4=;>YTU8M/OS:O$D!+2;7"GDG '/I0!ZU17"VSZE=_%:0KJ3
MI:)ID<WV9DW*%9@"HY&#E<[OPK=\8ZK>Z)X3O]2T^-9+F!590R%@ 7 8D#T!
M)_"@"[K.M6&@:<U_J4WDVZD+NVEB2>@P*OJP90RG((R#7F/BC56UKX6ZY>)J
MMKJ-N7@\EH8O+9/WD9(=<G#<_E]:W+'5?$MGXTM-'UB;3YX+NTDG4V\3(492
M..3R* .SK(B\3Z/,=3"7J'^S,_:SM/[O )/;GH>GI7'0>+O$%G?:"FH7&G7!
MU&]:TGM[9,BW(('^L#$$X8'%6K0#^WOB(,#'EP_^DYH [:QOK;4[&*]LYA-;
MS+NCD7.&'XU7TW7--U>>[AL+M9Y+1_+G501L;)&#D>Q_*L[P)_R(FB?]>B?R
MKB-&_M]?%7C=]#EL8O+N@[FXC9RQ ?"@ C&>>?I0!ZQ17F:?$2_UBRTF+3(O
M(O[FW>>X(M'N0FQ]F B'/)!.3TP/6NK\&ZKJ^K:(9=;L'L[U)60AHFCWKV8*
MW(_^M0!T-%<!/K_BR^\::MH&F'2X!9PK-'),CL6! (!YZG<,^F.]58O'6O7^
MF:))8VMBMU<:A)I]X)=Q1)0,C&#G!&3WZ#UH ])HK@H-;\576L)X;\_3(=6@
MM3=75P(G>,@OA45<CG!!)_"L^\^(6KZ=X9U62:&RDU;3+];2;:&\MU/1P/4D
M'C/:@#TVBN!EU_Q9;>+K;P_*=):>]MC.DBQR!8,9R.N6^Z?3K6>WQ"UJW\%:
MCJ<EK9/?:;J'V.?[PC<=-RC.<Y(_"@#TZJ6J:M8:+9F[U*ZCMK<';OD/4^@]
M3P>*XV/Q3XEL=;BTS7(--B^WVLLMG-:LQ".B9P0W7Z>]8MM/>:Q\"[Z[U6=;
MMBDCQLZDN"LAY))YYZ8 P* /6%8.@93E6&0?:EKC]5U_4M&U[P[;%;7^R=0Q
M \C [UDP,#J!ST'X^U:7AS4=2U.XU>6Z,!LHKUX+,QH065"58GGGGC\#VQ0!
MO45Q&M>)O$D/C=/#NDV>F,9+7[2DER[\KD@YQT.1TY^M0Z=XQUV_T:[5-.LS
MJ]EJ'V*ZS)MAB7.#)R1D<$8!H [6_O[73+&6]O9EAMH5W/(W113[:YAO+6*Y
MMY!)#*@='7HRD9!KA!XOEU3P[XK\VVTV_P#[*^Z5R8)TV[N0<G(P?;..>]6+
M?Q?=W:>&M/TRVLH;W4K3[2ZRAC'#&%Z*%QU(('TH ZRRU73]1EN(K*\AN'MF
MV3+&X;RVYX.._!_*D.L:<-6&E?;8/MY7>+?>-^,9SCZ<UQ7PZ$R^)_&8N3&9
MOMJ;S$"%S\_0'G%5?% OX_B[H[Z1#:/?-I[[?M)*H?OY+%1GI0!Z917GQ\;:
M[_PC^MR#3[(ZSHLP%U K,T;1$$[UY!Z ]_X36Q:>(KW4=2T*&Q^R36UY9&[N
MI=CC8!@?+SQEB1@\C!H ZFJO]I6/]H_V=]K@^V[/,^S^8-^WUV]<5SWCR\U6
MST[33I5VEM)-J,$+LRYR&; 'TSU]1Q7-:M_:T/Q=LVT^&QEU)M&&_P UFCB+
M;F!/ )[<#T[T >H45YR/B9(OA:*ZEM[9=5DOGL1'E_)5UP2QP"VT KTR>:U/
M!?B^_P#$%]J%E?VD*/;!72XMED$4@/8;P#D'_P#5Q0!UT]Q#:P//<2I%"@RS
MNP55'N365#XM\.W$HCAUS3I'8@!5N4)))P._J17*>+H3KGQ)\/:!=$-IRPO=
MRPGI*PW<'U'R_J:Z'6?!.C:KIXMXK*ULY5D21)H;=0RE2#VQP>1^- '1U!>6
ML=]93VDI<1S(48QN58 C'!'2N-;Q7X@U6YU23P[8Z=+8Z=,T$ANY'661U&6V
M@# '89J!_B+=W%OX;DTW28I7UII$"S7!3RW0A6&=O3)SGVZ4 =7H'A^Q\-:=
M]@T_SA!N+A9)2^">N,]/PK5KSF/QSXFDAUV :+I_VS1?GNG^TMY93D_*,9)V
MJ>X_I5F^^(-\J>'FTW18[H:U%NB#W/EE9!C<A^7MD<]Z .EF\+:+<:^FN2V*
MOJ4>-LY=N,# XSCI[5L5Q-GXTU5K?5[2\T(C7=/1)%LK>4/YZ,< KCGC//7M
MZXIUOXWNCJ6KZ=<:;!]KT^P^V 07.]7X!*%B!@@G'>@#M**\[TSXA:U>2:)=
M7/A^&#2]5G%M',MUO8.20#C'3Y6XQ^-:5KXSNUUCQ'I^IV4%LVE0&YB(F/[V
M/&03D?3GMG':@#LJ*S?#]]=ZGX?L;Z^@C@N+B(2-'&Q*KGD=?;%<5H?C:_@L
MO%&JZR8GL;&\DCB"OAMPP%C4;>A]2<Y/2@#T>BN/?Q;JFFZCID.MZ/#;VNHR
M+#%-;77FE9&^ZK J/S&:V/$VO1>&]$EU!XQ*X98X8=X7S)&. ,G\S[ T ;%%
M<DGBO4K'Q%I^DZYI,%K_ &@K?9YK>Y\U2ZC)0Y48ZCGW%5_"_C35O$MY&%\/
M>38B>6"XN1<AO*=%R!MP"<Y4?C0!V<DB11M)(ZHBC+,QP /<U#9WUIJ$'GV5
MS#<19*[XG##(ZC(KB/BI=7L6GZ1:P11/!<ZC$D@=R-YSD(1@_*<<G]#5JTOI
MM*U(^'_#^@62W8B%Y?*+@QP1.V  &V$DG'H.!]: .UHKA)/B'.FAW%T-%8ZA
M:7R65U9_:%^1F. 0V.03P./Y5U&B7VI7UM,^J:7_ &=*DI1(_.$FY>,-D?YX
MH T7=(XVDD95102S,<  =R:2*6.>-9(I%DC895D.0?H:\ZFU?5M<T?QW!J-K
M;BPLTN(H</ED9(\@8QST#9)X)Q]*GA+Q??Z/H7A>RN]%VZ?>LMK#="X4LS%B
M =F.!^- 'J=!.!DUY[K7Q1@TO4;F**TMYK6TG\B9FO42;<" Q6+[Q )//L:[
M6X6UU;19 P$UK=6Y/IN1E_P- %J*6.>)98I%DC895D.0?H:?7D?@WQ?/X?\
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MR[HI4*.OJ",&I** .*T[P;K>C6?]EZ9XG:'2P6,8>T5Y8@6SM5LXYR>2.#C
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HK@_B)XJ
MFT:XTW3+;4QI;W99Y+QK?S1&J]!CW)].*WO"(O&T-+B\UU=9,YWI<)&J*%[
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M@BQJ2?X?E)_.@"II>M:7I?Q7\5R7^H6MLDD<"HTLH4,0BY SZ5;\9^+] O\
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MP4 8 % #/B(EN?$W@YIXX61KXI(945@4.W(.>W-1G0]*UCXFZZ-0@BG@BTZ
M)&^-H!'WA],=?>NXU/1M-UF)(]2L8+I(VW()4#;3[5$/#VCK<S7"Z? LTT7D
MR.%P73 &T^V /RH \CL";_2/ VGWUU!%930W/S7<?FQM('(4%21T' Y[UZ!X
M%TBST(:GI]IJXOP)EE=(XPL<!8$[5P3V&<9XX]>==_"N@RZ?%8/I%HUI$Y>.
M(QC:K'J1Z5=T_3+#2;;[/I]I#:PYSLB0*"?4XH \]O-$TW5_C3<V^H6JW$+:
M6)C&[':7!50<9]/\YK%9$MO 6N6=O*[Z?!KR16FX$ +YB$JN>H!S_.NAU;PP
M^L?%"2XU#1Y[C2)+(6_GAPH5\AMP(8,!VX]:ZN\\(Z%?Z3!I4^GI]AMY!)'#
M&Q0!N>?E(SU- '&>+Y+2Z\1Z[#%"+BYMM%<SFXD CMQM+*8UP27)*\Y K*T:
MYCUK5O"=EKY2:P_L=I$%PV$DD#,O.>&(51_.O1KSP;X>O[Y;V[TN":<1"'<^
M2"HQC(S@D8')YIESX)\.7>CPZ5-I<36<!)B7+!DR<G# Y&3[T <-K=EIVC_V
M'H.GZI'_ &1>:C.UP]P?.B1PJ[(R 0-H)'!/7!-=)X(T:UT#4M6LK;7(KWS&
M6X-I#$$2#=GD8)QG&,9Z 5N7'A30KK1$T:738#8)RD0&W:?4$<@\GGK4^BZ!
MI?AZS-KI5FEO$3N;&26/NQY/XT <?XS6U\/>+]+\3W*9L[B-]/O>"?E925.!
M^(/M7.Z!9S7!D\%7>G&%I+^._D3).RUP'PQ[D$*G/][VKUJ^TZTU.!(;R!)H
MTD655;H&4Y!_.G"QMAJ!OQ"OVHQ>29<<[,YQ],T >7G0]/UCX@>-%OH&E6W@
MADC E= &$7!^4C/XUCZ5?ZCK%EX,TVZN+<VLL-P2;W)BF9'955@""=H"XYZG
MVKU4>$M'74-0OE@F%SJ$;1W+BYD&]3[;L#IQC&.U02>!?#DNAPZ.^G!K*!R\
M2&5]R,3DD-G=^M 'G^K:1'I'@6_TAM;^U3P:G!(4MV95@$C8"#)/^T<9XX-:
M&NZ/;Z=XMTC0;2=8K.\,MTT=]))+'<3< *WS \8R.>3USQ782>!O#DNB+HYT
MY18K*)MBR.I+@$;BP.2<'N:L:KX4T76M/M++4;0SPV@ A+2N'7 Q]\'<>@SD
M\XYH S_!&COH,&HZ=)JD-VRW)D,,*D+;;AG8,DGWQG^=8UE;0S_'#5'EC5FA
MTZ-XR>JM\@R/P)'XUVFD:+I^A67V33;98(=VX@$DLWJ2>2>!UJO<>&-(NM?B
MUR:TSJ,2A%E#L.!G&0#@GGJ1Z>@H \?DT*VC^&FL^('#B_AU-FMI4F<;5\U$
M(QG'7=VSTYKM%NI)OB]ISK)(D=QH?G-'YA*AB3VZ=A^5;P\!>'ETB;2A:3?8
MIY1-+%]JEP[CN3NS[_4 ]JM1^$]'BU>WU18)?MEO"((Y#<2'" 8"X+8(Y[_6
M@#A?"\ TOQ)I5MK5@SWLK3/9ZQ;S;TOL@L2_?[IXS7H^LZI#HFC7>I7',5M$
M9",XW>@'N3@?C6;IW@K0M*N+6:UMI@UH6-N)+F218BPP=JLQ XJYX@\/V/B7
M3?[/U#S3!YBR$12%"2.QQU'/2@#R?4;3Q)HNF6'B"XT-(;C3[MKR:Z%VKF19
M6^=2G8<@<= /QKKO'UQ)J.A:!>6OFS:;/?0-<P0YWS1-_" .3Z8_R.OU'1K+
M5=);2[V-Y;1U563S&!8#&,L#GL.]<#XQ\)PV.G:58:?HM]=:);22S316<Y:9
M7( 7;N).,DGC/X4 06.BW%CHOC2[V7]CIIMG_LV*661"@"LS$(QXRVWKSU]>
M:-YI<6F^&_#SV]Y,DOB'[)'>RW,[LI&P-MX((#$X//3@$#-;7A?PG]JLKVUN
M+/5K+1;NU"?9KV[S)OW;MR@?=XZ@]SR.M=7-X/T6Z\.V^A75L]Q96X C\V1B
MZXZ$-G(_#C''3B@#SW5[#4/ 6@:X+;5H<W@B*6EN7'V92X5I 68L ?NY]2.>
M*W]#\,2Z)KB7R:M9Q6=];O&+.W>4BX;!;>I=V.[ SD=A6[IW@7P_IFF7>GQV
M9EANU"W!G<NT@&<<GI@G(QCGFFZ)X#T+0//-G#,9)D:,R22EF1",%5/\/U'/
MO0!Y.T4I^%=GXB-]?G54U#:EPUTY*KDK@ G Z?6NEUN2;P=XWNAI,LY-QHLM
MQ()Y6EW2J&P_)Z_(/UKJS\.="/AM=!S>?8EN/M _?G=OQCKTQ[8]^M7CX0TQ
MO$,6M.;E[F*#[.J/,639MVX(/7@G.3R: ..\+>'-08Z)XF&L6\7G!&N3OE9K
MO=@;7W/C=S@8 Y[5S=Q927_AGQ5KD^I:B;O3=3<6RBY;8F'7!V^HW'%>E:7\
M//#VD:O_ &E;6TAE5R\:/(3'$3_=7IWXSG%*O@#15TG4M-!O#!J,PFGS.<[@
M<\?YY[T 8L$%KJOQ0TB_DB8/)H2W2_O&!#;QC.#SP2,=#6]\06D3P)JTD,TL
M,D<0=9(G*L"&!ZBGR>"M)EO-+NRUVLVFQ+#"RW##<@Y"MZC_ !QTK0UW1+7Q
M#I4FFWCSK!(06\F0H3@]/<>QH X.XT,VWB3PA9QZMJPCU&WF%WF]<^;LC5AW
MXSG!QCCICK3+=SIFA>,K.;7-0M[:SO(XX[EF,TJ*0ORKDCELX[8SFNN;P5II
MN]'N1<7ZR:3&L=MBX.-H]1WR.#TR.*A?X?Z))#J\4INI%U61)9R\Q+!E8LI4
M]1C/OQ0!@:+:WW_":ZOH4KWMI87.EB6*&2[:61#N"!]V3M;J< XK/T9[S4;6
MP\(W5U<)JECJ;M>L+B02/ H+;MV>C;E4#\:Z<>$]-\+S2>(K2/5K^^MX"OE_
M:6D>8>A!^\<'ITX&!FG^$;26]U?5/$]UIDNGR7XCBB@G7$@1!@LPQQD_R'M0
M!UU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4<Z&2"1%D:-F4@.O
M5<CJ/>I*#T- 'E_@7X@V,'AJU37]3E:\FN'!ED1BJY;C<V, <UVFL>+=)T.9
MXKR2<M'&))?(@>41*>A<J#MSVS7F6BO&WPENO#;VTD^KSS/'%9!65]Y<8;.,
M +C=SQQS5FYM].T;Q;K%MXFM]4-K=6L"13VKS".8)$%=2(R-V3Z].^,T >MV
MMS!>VL5S;2I+!*H=)$.0P/<5@2^._#T.IK8R7C*[2^2)C$WDE^X\S&WCIUJQ
MH-JL?A&&VT^RETM?*<003,2\0);:6ZG)R&QVSBO+M%716\.)HNM:;K-YK-O<
M.BV!EN%BEDWDA@ =B#YN3CU.#GD ]*N_'.AV.H7MC<S3QW%E&99E-N_"Y R.
M.>6'2I[SQ=H^GZ7:ZA=32QQ70S!&T+>:X[X3&[N#T[UP'CE)-5UH:MIELA_X
M1KRFN,D_Z02X(C7 Y"[3D^]3Z_J5E?>)?#_B.Y@U$:/-9O"9[8RQO;RY.0=F
M&'I[\XSB@#O+7Q3HUYH7]LQ7T8L0=ID;Y2&SC:0><]..O(JI#XZT&>UOYQ<3
M1_8$$EQ'+;NDBJ>AV$9(Y'..]<->VVF66FZ?JF@Z%>G2;/5DN)WD#EIEVX,@
M5\M@$^G45M:WJ&E^(]!\1SZ+ILLLQT\K+?&U,1D(Z1Y8!F( SZ 8]J .H;Q5
MHZ76E6YN3OU5-]H=AVR C(YQQU'6JNB>,K#6?[78H]K%IL[QO)*"%**!ER<8
M'.>,YP,UY[;ZM:ZJ_P /8[(7$O\ 9KI#=L+>0+&^Q!MW%<$_*W3TIMTMU<>%
M?&6D0O)<:@FLR74\*(5:6#<@)&!ZC.!Z4 >F:/XNT;7;Z6RL;EC<QKO,<D3(
M2N<9&X#(S7*>+O'<3+IZ^'M4;>-2B@G9(LQR(<DX<C!Y7'![FH+67P]KHN[C
MPV-2N]<^P31+/<R3R"WRAPA:0D9W'  SW-<[J>MV$_P^\,:=&[B]TZ_A^UVQ
MB;?%L#AB1CU_G0!ZQXKGN+7PEJUS:SM!<0VDDD<B 94JI/?Z5A^$?'.EZAIV
ME6%YJT4NKS6Z&13U9_3(XW>U;/BD-=^"=7%NCR-+82[%53N;*' QUS[5YH9;
M+6O!/A+2-*EBDUE+F!F$*YD@"[MS,1RN.#^% 'I]GXGTF_NM0M;:Y+SZ?G[0
M@1LKCKCCG\*M:1JUGKFF0ZC82&2VFSL8J5)P<'@^XKS_ ,8VE_I'C.*[TL?\
MC%#_ &=,02/*?@"0'U"\\?W37HMA90Z;IUM8VZ[8;>)8D&<_*HP/Y4 43XGT
M47C6AU&'SEG%NPR<"4]$)Z;O;-0W_C+P[I=X]G>ZO:PW$?WXV;E?KBO(?$FO
M6]]X9UI%E@MIWUCS/L,$3;EP2#)(Y'4G'3 X]<BNM.HZ->^*_&$L=Q:2NVEQ
M^2^020$;=M/XIG\/2@#MIO%&B6Z63RZE JWH!MB2<2@],?F*N)J=E)JDFFI<
M(;V.,2O".JJ>A/YUYCI^E-K/P/T][1T^V:>7NX3P<.DCG'Y9Z^U=?X(+:I:W
M/B>X@$5QJK!D4@Y2% %5?Q(9O^!"@#:U76]-T6-'U"[2#S"1&IY9R!D@ <FL
M^[\6Z;_PC.I:QIUS%=K91.Q56QAP.%/&1DX[5B>(;V+2?B=HE]J6R/3Y+.2W
MCN)FPD4I.<YZ D8&3V/M6#=O;&7XA:G9R*=*N+(1B9&'E23^60=N.O)Z^I-
M'1^ [C4]7MXM9N/$+WD4T $UDULJB*7@Y5ACC';'?K6D?%MI<>)-1\.P,8[V
MWM]ZRM]TO@DCGT&TYZ')]*7P%=I>>!](=9TE9+=(W*L#M8#H<="..*YA-1AL
MOBOXFMIYQ']KL8A$A_Y:.(QC'X;J -#P3XYM+_0K"/6M9M&UBXD=-FY5+'>0
MHPO R,8]:Z74_$FBZ/*(M0U*WMY-NXHS<@=,D#H/K7C1:TB^"^C.IA28ZKEV
M! ;(9^O?IM_#%;EU+HZ>-O$EMXAU._T^+4!&T,J/MBN(0N,;L'(ZXQQUH ];
M66-X1,DB-$R[@X.5(ZYSZ5A/XY\+(ZH=>L<EBHQ*",@XZC^=6O#26J^&;".S
MCG6S$(6%;DDN8^BDY]1@X[ XKR72&T-?A[XJL;@6?VZ2_F6UM\*9F;""/8H^
M;[Q.,<#GWH ];U'Q+HVDS"&^U&"&0IYFPMD[/[Q Z#WIUYXBT73U@:[U2SA6
M="\3/,H#J!G(/<5YM<:O!IM]?:7>W-M97B:+'!/<RQ'S+IS&=J*OW0!GJ,YQ
M^6?9W.EWU_\ #B&2:TG2."2.>-RK!6P  P/0Y'&>] 'IFG>--$U776TJRO(Y
MI1 LRNK?*V?X1ZD#!_&ET'4BNCW5UJ6O6%ZD=PX-U$52.-<@!3V!'N>XY-8U
MC+IFE?$^]L]UK9B338$MXOEC!PS?*H_+@5Q-Q<6P\ :@(')LHO$I:Z%MCB#=
MD8QQC@8_"@#UNP\1Z-JD$\]CJ=K/' "TS+*/W8'=O0<'GIQ3M-U[2M8=TT^_
MAN'10S*C<[3T./3WZ5P$,/@VXFUBXM-<O[B2YTYTO+H.6CBC.U06V@<^@] <
MUH^#=0U*#Q =&U.2PU)ELA);:G9[23$" %?'KD$?3O0!>\6>(KW0_$_AN!+J
M&'3[V61;H2*/NJ!R6/0?-GMTKI+76--O;26[M=0M9K>(D22QRJRICKD@X%<5
MX]\B7QQX)AE\MQ]JD+(V#Q\F"1]1^E<7K\WS^.X+5\60OK1YEM\<+N.\_P#?
M0&??K0![)IOB'1]8\W^SM2MKDPY\P1R E1ZD>GOTI8-?T:Y=DM]6L966,RMY
M=PK80=6.#T]ZXK1E\*2^)3J-AK5QJ,TEF\5P'*F-8L9W2G:H XQ@]R/3CF(K
M&TB^",%_96L/VII-M[/#&IE,?FDE6/7& O!XZ4 >L0^)=$N+>ZGM]5M)X[5&
MDF,4RML5>I(!Z>]0Z/XKTG6=!&LQW44%KDJYGD53$0<8?G"D\'GL17!Z?;:#
M/J=[J&G^(KO5[R;3YX_+6( )'L)'F$ <= ,]\>E8]G=P#X?^#]\D#V%KJ8?4
MU^5_+!E;9YB]0",]?;VH ]AT[6=,U="VG:A;704 L(90Q7/3('(_&KU<!,+)
M/BY87.FO$ =-E>_:$KMV#A"<=3G'X 5VFFZI8ZQ9B[TZZCN8"2N^,Y&1U% &
M1-XLL)M2U71;.ZC35;2 L@E^ZS[6. .K;< G'8U1\$^,H=;\/6,VJ:A81:G<
M,X$ D5&;#E5PA.><5F6$UG:>/_&D4\MM%--#;M"C,JL_[IRVT<9XZ_K7(Z1!
MI%I\-O#FIRPV<5V-8CWW)11+M68DY;J0% _"@#V*\US2=/G$%[JEE;3$!O+F
MN$1L>N":O;EV;]PVXSG/&*\;DL]/U;6/%=GK_B)=.D:^;]W<1Q$M I_=E&<9
M& 3@+V^IKU#0%@G\+:?&OFS6S6J(IN5&Z5-N 6'/WASCWYH >/$&BED4:QIY
M:1BJ#[2F6(."!SR:EO=8TS3'1+_4;2T9QE1/.L98>V3S7D-OI?AH?"_6I)X+
M);Z.YG2%P%\X.'Q&H/WO3CT/XU<U75--V:]:W<<<&KPZ%'!<3WDV9)I#%D)&
M">N2,GJ2!QWH ]6FU&QMS&)[VWB,BED#RJNX=<C)Y%9UOXKT6[UQ=(MK^&:Y
M:$3*8Y%96'H"#R<<X].:\R$=CK.H?#A+Q8+I9;5XY@V&W;5&%;Z'/'KFNGT^
M'2-(^+-S:I':6F[2X4MTPJDG=C"^IP![\4 =-H5[?/97<NKWNFR-%.XW6;_)
M&@Q@,2>&]:OV6J:?J2.]C?VMTL?WS!,KA?K@\5XF#]F\'Z]#"\D-BWB3RKAH
M5W;8._MC@=>#T[UTECHOAJQN]6EM?%5N\M[ILL<JV\<:PQ(0%WL(@%!!(X."
M<GWH ]'L]5T[47D2QU"UNGC^^L$RN5^N#Q4MW>VMA 9[RYAMH0<&2:0(H/U/
M%<)X,EN=)UV#0-3L+1[I-/ M=3M"")[=3\H;_'_'-0>/_)G\9^'[/4;\6>G/
M%,P>:))(/- P-RR J>#C)Z9'2@#O9-7TV&R2]EU&T2U<@).TRA&STPV<&I([
M^SFN3;17<#SJH<Q+("P4]#C.<5YS8Z3X4T_PAK>GRZI_:6G-.#O5%*K.R\+#
MMX+_ '>%]0/6D^&T<:/J>E:U8B'7X85B?S H+6VT!53 X4<9QU)!/L >B_VG
MIXE2(WUMYDG")YJY;Z#/-/FO;6W;;/<PQ'CAY O7@=:\+TO1=)?X03:J+>,:
MRL^VWF5R)=XD4 +@\G!KL+/P[IFN>/[W^W+&&>Z&F6TDL;,<"4@A^ ?8#_\
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M6RE(62( QJ>"!Z4 >?\ A2X\&WF@>&89);0ZK;&-HHXEQ*)P"/F"C.,\G/'
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M^$D86\0D"PIN?,;/@_ZO"GCH0/Q'JFH:5I^JQHFH64%TL;;D$R!MI]1FHI-
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M&?0US5@MNWPJ\'_:1$81KD8D\S&W;YLF<Y[8ZUZ]_95A_9[Z>+.$6<F[? $
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M8FFC3XOL:3>>L/. ^[=GKZ_X=*-7\/6&M36D]UYR7%FS-!-!,T;IN #8(/?
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MU"WNFNB)(50#RU"[3_#G'(ZG..][QKK$7B3X-P:NHQ(9(F(!(V2!MC?S;\Z
M/4R0JEF(  R2>U-66-XA*KJT97<'!R".N<^E>87.A:;%\4='TZ.U"V=UIK27
M$(=MLK#=@L,_-T'7K63/+]CT./1X;J*UT\^)+BV?SLO&D2D[489^[GL3@]^]
M 'LL4T<\2RPR))&PRKHP(/T(K/UVXU:UT[S-&LHKN[\Q1Y4K[!MS\QSZXKS*
MY\/_ -@>&?%0_MJSN3=6@E%I9IL2+:P&X#)QUQ[_ (5)K&@:=I_P>&IV\<D=
MU=6EB\TGG.<G<F3R?]H\=.GI0!ZV,[1N !QR <TM>=F#3=;^)-UI>JO]IMX-
M-C^PPR.=K@C+N/5NG/I]*CU*RT:RMO#>A07%UK ^U2""U:Y79+C.?,;'W4[
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MWCA0DK&H09))P!CJ>34E% !1110 4444 %%%% !1110 4444 %%%% !1110
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M3M-\C[1<+L_?$@;<\].] ')7TVBZIXA\&C1#:SS6K&25[4KM@@"#(?'W1G&
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MZ"O0;BV@NX6AN88YHF&&21 RGZ@U!!I6G6MH]I;V%K#;/D/#'"JHV>N5 P:
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MCBO+I[3P]+\&H[ZW@M$U:)%/G#:MQYXDPW(^8GDG![8XZ5[-'&D4:QQHJ1H
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MJH[[XA>']/FV32W)12JS2I;.8X20" [8P#\PX&:P;2:.U^+UC;,GD*-$6".
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M<>U>L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&5I)KJS%["ZKE'C).#G\*SQ\0-"_L*?6'>YCM(+HVDFZ!MRR#G!'T(__ %T
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M[30X,XAA>00@C.7*@A>!0!S-CX)\1BV@TR^O]'_LZ$"/S(;,&>6,8 !+#"G
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MTZ\^F*L6'BW0]4O8K2ROA+-,&,0$3A9 OWBK$8('L: -=(8HG=XXD1G.7*J
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MB\.S:=X%:"\@\VSNH#,JG!A4 !]R@>H'_P!>O75MH$N'N%AC69P \@4!F Z
MGJ:;'8VD,DDD5K!&\AW.RQ@%CZD]Z &:A90:IIMQ97"J\-Q&8V!&1@BO&@-:
M&C6ET8/WG@RX992V,W(WC(7(R (P.>^[\O;Z888BLBF-")/OC:/FXQSZ\<4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %(Q*J2%+$#.!U-+10!QUKX_@NO"VI:U_9ERC6%R+9[0D&0N2@XQ[O\
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M ];U3Q%H^BR11ZEJ5M:O+]Q99 "??'I[]*EN=9TNSCBDNM2LX$F4M$TDZJ'
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXHGTK3KJ:&:XL+6:6#_5/)"K-'_NDCC\*??WL&FV%Q>W+[(((S([>@ S7,>
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M4# '/7 Z9IC^$?#TFGPV#Z/:&U@<R1QF/A6/4_C_ (>E;5% "*JHH50%4#
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MF5WL82[EMQ9M@SD^N<YK0^PVA61?LL&)#EQY8^8^_K4L<:1($C141> JC %
M'C5]J-E)\%=5L$NHC=PW1\R'<-ZYN\C(^G-;#O:V_P 2?!?V=H8DETY]_ED*
M'!C;&<=<D#'TKT@V5J1(#;0D2G,@\L?.<YY]>:7[';;T?[/#OC 5&V#*@= /
M2@#Q[0(-,U#X=:S9W>IK8+)KC>3<#)"/\A0G'\)P>3Q^5=CX&U6^NM2U?3M4
MCLIKZT,?F7]FHVW&0<;B.I XQ77"PLQ$8A:0",G)7RQ@GUQ4D,$-NA2")(E)
MSM10HS^% '&>.+IM5OM-\)V-]!!>7<GG2L_S;$C^< KD9R0.#V!K!NVO_!GQ
M!TO5-7U2SEBU5#:W310^2/E VNPW$$Y(^;L*]0-M;F<3F"(S#I(4&X?C236M
MO<D&>WBE*]-Z!L?G0!Y5XFG@M/&GB6,7^G$:EIJ6TBW5SY1@9DPI&0=P  ;
M]12>(+&PTO2O -E'<VMS'%J,0:9&4H^&7><]QG@_AFM;5?"/B.77=0EAM?#V
MH6E]<";?J,#,\050JK@=@.!C/ZUU>A>'+?2]%M;*YAM9WMWDD4I %1"[,Q"
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#+U_1(]?TX6<EY=V@$@D\RUDV/QGC/I
MS5G3--MM(TZ"PLTV00KM4$Y)]23W)/-6Z* "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **Q/$GB2/P]! 1975_=7#%8;:UC+N^!ECQV J;
MP_J\^MZ=]KGTN[TUMY40W:[7('?'7'UH U:*Y[5_%(T_4GTRSTR[U&^2$7#Q
M0  +&21G)/)R.@K2T;5[77=*@U&S+&&4'AUPRD'!4CU!!% %^BBB@ HK%\1^
M)K/PO:)=W\%TUNS;3)"@8*>P/(/-5E\:6":K;:=>V>HV$URP2!KJV*I(Q_A#
M D9YH Z.BJ"ZDS:X^FFRN@JP"8713]TQSC8&_O<YQ]:OT %%,ED$4+R%68(I
M;:BY)QV [FN<A\:6USX<MM:MM/OYXI[D6XB2+,@.XJ6(]./Z4 =-1110 444
M4 %%9VG:W8:K>7]K:3;YK&413KZ'&>/4=1]0:T: "BLK2O$-EK&H:E96RS";
M3I1%/YB;1DYQCU'!J74=8MM+N+&"=)V>]F\F+RHR^&QGYL=![T :%%)N!8KD
M9'44M !116=K6MVNA:4^HW2S20(RJ?(3>>3C^= &C1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<2^&[_19=$\5O%>77VIW-K%D-G)QSW- '7B34?$GB[4;)=4N=/LM.MX<+:.
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MV0*2"<@8]J -*BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** #'O2 YS[4OXT
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%<UK^HW5Q
MKECX;L)FMY+N)Y[FYC^_#"N!\N>C,3C/;K3M3\:Z+HM[+97<MR7ME0W#I;NZ
MPAL;2[ 8&<B@#HZ*Y;7=9;0=2TW5O/>72[]TM)D+C;&6Y25<].^[U&/2NIH
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MA<_G0!+13!+&8A*)%,; $-G@@].:(Y8Y=WER(^QBK;3G!'4'WH ?14;SPQL
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MOP7-<QXX\/W7AOP_IVKVFL74\FC3(;>.>.(!5X!&412>@ZD]Z]3*ANH!^M!
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M2VZ%%88Y.XD8SD 'C&35J:[@;QCIR_VS/#)+:N4TPQ,!*.27;(^4C'?'3ZT
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MHQP"#G'%6-&\-Z/X?\[^RK&.V\['F%23NQTZD^IK4HH **** "BBB@ HHHH
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MB0+ X=/F+C QT QSTKUF/68I?$4^BB"X$L-NMPTQ3]V03@ 'U_\ K^AK2HH
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M_$=Y+F)4%Y.=Q88PV\+S[G@5Z:--L0% LK<!7\P 1+P_][IU]Z4:?9#SL6D
M\_\ UW[L?O/][CGJ>M &5X*FCF\$:&\3AU%C$A(/=5 (_ @C\*XFTET.U^)'
MC)]9-DD CA8"Y"\_)EL ]3].:]0AABMXEB@B2*-?NHBA0/H!7(:=X3O(O&^M
M:MJ$&G7%A?[/+0DNZ%!A25*8Y&<\\4 <1I$5M:6WP]M=6,'FM)<2>7,@^6)\
M[ <^I(QGU]JZ73Y[/0_B=J]MJ,UM:6TEE"NGI)A$$0^\JGH/FSQ7>SV5K<NC
MSVT,KQ_<:2,,5^F>E%S96MX%%U;0SA?NB6,-CZ9H \9M);/3EM;V7GPR/$<S
MQLR[H]NPA6 '&T-G'':M?QG=Z'?Z)J-YH#&17O;5M7N+0'#Q_-W(*DCC. >H
MS7J!M+9K;[,;>(V^,>44&W'ICI21V5K#;M;Q6T*0-G=&L8"G/7(Z4 >47%IX
M>71_$%YH&N7>I:A-I;>8J[0J1<9R$10#CL>>O%6O#%GX6N-6T;4+'7;J\U5(
M6$5LBQKLS&=V\*@( R>2?3KFO38+*TM49+>UAA1_O+'&%!^N*;;:?96;E[6S
MMX&88)BB521^ H \=N=4T>3X*/9&>W74XY4,T+$"4S><-S8ZD[<\^E>KZQ-/
M/X8O9])999Y+1VMF1N&)7Y2"/TJ9]%TJ29YGTVS:1SEG:!26/N<>YJZJA5"J
M % P .@H \S\(ZAX/O\ P]X:M9'MFU2U9/)A12)5G[G YQGYB3QQFJ&C'0V\
M&^(K+7GL/[8CFN1<-,%61WY*LI//IC%>IPZ=8V\QFALK>*4YRZ1*K<]>0*@N
M="TB\NUN[G3+.:X7I+)"K-Z=2* /-M)@BN-<\!0ZM%;RW1TN7<LBY)7'[O(;
MOC/XYQ5?2+:*\\+:SIO]H0Z:8O$+BQ9U_=B1?G5&'3;\IZ\<#V%>L2:=92WL
M-[):0/=0*5BF9 70'J >HJH/#>B"WE@&D67DRR"61/(7#..C$8ZT >=:UJ U
M7X?^)[?6=.MK/4+&X42O;\1RS<88'NW8C)[>M:OB%YX[[^V]%NK.[EL]+!OM
M/N<E);9@6RAZ<[6Z>@SGH>T?0=(DL#8/IEHUF7\PP&%=F[.<XQC-,N_#FB7S
MQ/=Z393-$@2,R0*=JCH!QT'I0!Q-KJ%C-XU\)WPA@L5N=%801/A0A.-J+T[9
M ]1TZURNG0>'+[0;L>(M=>SU.'499IHXT02F0-U4E#(<_7K]*]FFT?3;B:UF
MFL+:22T_X]V:($Q=/N^G0=*C?0-'EU'^T9-+LVO<Y\]H5+YZ9SB@#@VTO0M7
M^(7BA=1M[=B-/AD!D4;HOD^9L'HP^7GMQ7/V\L9\-_#>>>1?(BOG661S\J8D
MX#$\#@=_2O7O[%TO[;/>?V?;?:KA#'--Y0W2*1@@GN, 5&?#NBMIRZ>VE69L
MD?>L!A78&]0,8SS0!;N;>VU/3Y;>8+-:W,91@#D,K#U^AKQ:=M2BT9+**TC-
MWX.NFFDG,9!:(,"@7J#D9)R.B@_7W!55$"(H55&  , "HA:6P:=A!$&G_P!<
M0HS)QCYO7CB@#S?752]^&OB3Q#Y91]7V2JI[1(RI'W/)4;O^!5)=G38M7^'D
MFHK (VL9%W3*"-WE1;,Y]SQ]:] NM-L;ZR^Q75I!-:\?N9$!3CIQTXJO-X>T
M:YM;>VGTNSD@MO\ 41O"I6/_ '1CB@#SW5-,TW4O$'Q%N;FU@N9;2PA,#NH8
MQ-]G?)'H<J/RKL/A_(\G@'16=BQ^S!<DYX!( _("M-M!TAI+J1M,M"]VNVX8
MQ#,H]&]:LV5C:Z=:I:V5O%;VZ9VQ1*%49.3@#W- 'F?ALVT5K\1B1 C1W=TH
M;"@JIWX&>N,CI4":;HVFZ1\/M0LH+:WNY[JW$L\9 :3,?[S<>_S<'TZ5Z0WA
MS17GN9VTJR,MT"L[F%<R G)W''.:4^']':"U@;3+0Q6C;K=#$N(CG.5';GTH
M \DM--TW7K'4Y=9\1P:?=0ZA)),LEO&)P5)VD,<.1C@ >F*]I@8/;Q.'9PR
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M#_LBXU26\,-M;3>1/YL;*\<F<;2N,YS[5E>/-8FTF?0RD'[F2[/FW0M_.:
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M0  ;03@!0<8 YSG-)-<QKI&DZSI.N6/]IV^@Q+=V5VP:.ZA53N7U+!E<$>N
M<4 >N0S17,$<\$B20R*'1T.592,@@]Q5(:]HYU'^SAJED;W=L^S^>OF;O3;G
M.:J:->RZGX+M+NSMEM)9K(-#"RX6-MOR@?[.<8]L5Y?H-SX<F\*:5::O?W_]
MIV%[Y@TZ,*)'G\PX !&3G/.3QSTH ];DUW28;PVDNIV:7(=8S$TRA@S#(7&<
MY(Z"JFG^*=-U'6=3TN*4+/I[A9-Y W<$G'?C!![5P6HWTWA_Q#=7VG7=GJ&F
M76K*MUI\X_?07&X LG?L"#]..]7[34+#2O$/C]+IDF=@LPM=P6291"68*!@]
M\9'U/- '<VNN:5?RB"RU2SGF="Z)',KD@<$X!Y -<WX1\8+=Z<Z>(-2L(-2%
MY);+&9%C+;2 , GGDUR&G:W:7'B7P$;6XLHE6.:-K:WE+>0K* D;$L26[<XR
M>U->'1;CP!XI2Y:U6_&I7'E':K3%_,&Q0/O<GC\30!W\FK:DGQ'AT<20_P!G
MR:>UR5*?.&#;>#]<5=TN_*VVHW%]J]A<0PW$A$D3 +!%G*JYSC(&,URMM=?9
M/B=H5K>R9NWT$0R?,"1)NW'/UVFL+2+2SO\ 1_'%DU['912:T!%,H!5&\X>7
MQ_=+ #Z4 =KXF\3[/!VHZIX;U"RNI[3:S,CK*H&X9!P>N,UKZ7KEAJ"PP1ZA
M:RWIA622&.52PR!D[0<@<UYW?:K=/X4\:Z?K$=B-1M(H?.N[4X2XWKA,@_Q8
M 'X@8J2ZLX+/Q;X-ET=K2![C3)U18P &/D$HS8Z@DC\J /1!KVCMJ/\ 9PU2
MR-[NV?9Q.OF;O3;G.:S_ !5X@BTC2+P6^HV$&J+ TD$5S*H+$#)^4D$\5YMX
M:@T'4/#&DKJWB&X6\L;K>NG*(A)YWF'  V>8V<C/)_3C4ANK+^R?'5KK%W:6
M^LS3W 8$X=HA&OE[0>2O7'UH ] \,W\^J^&-,O[DJ9[BW220J,#)&3@5S_@_
MQDU_#J$>NWMC!<PZA+;0C<(_,"@'@$\XS6IX$=)/ FB,C!@+1%R#GD#!'X$$
M5YK9VND-X2\<O?QVGVQ;VY\DS;1("!\NW//WCVH ]A?4["._CL'O;=;R1=R0
M&4!V'J%ZD<&G6U_9WDDT=K=0S/ VR58Y QC;T;'0UYMJL-WHGAWPIXM>$R7>
MF0Q17B@<M ZX([<C/YFNQ\'V<L.C&^ND"WFI2M>3#CC>?E7CT3:/PH MMXCT
MU?$@T$S_ .GF'SBN, #( &?4YSCT%8WA?Q4;N'4DUN^L8;JWU.:T10X0$+@
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MYGBU*0)(,%DQ(H4 ]AM[5L:K&ND?$2R_L2&&"6;09BBQ@*LCA7*9QUY5?RH
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MB3@<'IVQS1MK?Q#IOAS5)9+ZYN+JSNI9[4SJ"T\2#[C =F&X#&#G!QVH ['
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M6-L8OLB.BKC<,D# W-U&>OX5UEUXCT>SL+>]N-1@2WN0# ^[/F#&?E Y/X4
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MITKL_&%XMAX1U.Y>R6]5(2#;L,J^>.?89R?I3] T>?2X+B6^O!>ZC=2>9<7
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MR;7[8EN6A,@Z@,.3^ YKD-)N+J?QKX5OI+'53'#9-:S336;*%E(.1PH 4%@
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M@^S0"Z-UY,?V@IY9EVC=MSG&>N,]JEHH **** "BBB@ HHHH **** "BBB@
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M[-GGC.XKC&/3I6A10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\$6UUX/M?#]W?7,OV0JUO=*%22(K]TKQV''KCO1IW@L6NOV^N7NLW]_?PPF
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M1!@ #'05T%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 <UX@U2ZDUO3O#FG2M!<7BM-/<H,F&%>I'&,L?E!/3\JLZ
MEXLTG2;F:VN)9WEMT#W'DP/((5/0N5!"YZ\UBW,;6GQAL;B61O*O-+DAA!'
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M2FHL5M&SQ*1V'OVP>_'6N*AU?2]/^)^KR:RMK:^;IL#^9<.!L(QN09ZDY_\
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M0+)X+T0'#*=/@!'4']VN:\KMKN>T^$.M&RB6$#5FAFDB&UO*+*23CKUV_0T
M>S6]Y:W>[[-<PS;<;O+<-CZXJ>O/]7TS2M)\3>$K[1$AM)+B<P&.W 43P%"<
ME>^..?\ :^E7?B/>-:Z7I:22/%8SZE#'>.G'[KDD$]@2!G- '81S13 F*1'
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M-\TQ.&1\]<N2,5;^'<-FM]XJ:*)%NEUJX1F"\A-WR@>V<\4 =U1110 4444
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M3)!]JC@9R4,V-V1%C*DDGCJ">:[/PCJ=UJWAFSN+^WG@O57RYTFB9&WC@G!
MX/!_&MRB@#RGQ->ZB;KQ982:3J,ANHQ%:&TL,QR#8/F=P,L>,#KCFK&AO-'X
ME\&(]C?((M%,$KO;.JQO@ AB1QRF/Q7UKTZB@#SRTU!?#OQ"\12:PURL>H"
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MC)K/U;QWI&CZP^E3I>RWB()&2"V9^#WXZUG?#]F:_P#%#?8I[:.34VD021%
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MB&TMI+FXE6*&)2[NQP% ZDU@P>+]+U'48])C>\M[F[@:2V>2 Q^:N#\R%AZ
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[5IW_C#2--GOHIY)S]@"&Z9(&98M_P!W) [T ;U%<_J?C70])O$M+JYD\Z2
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M9T R6 4$XQWH TJ*XSQ7K+SZ;X=O]&U-UM[O5;>(O#TD1B00<CVZ?G21:GJ
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M!:Q^7;PQPIG.V-0HS]!6=?\ BC0M+$9OM5M8/,B\Z,-(,NGJ!WSVQUKE-/\
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M4EA<I++%&MI#;6>[[0H(S*[A<G &!DX&<5ZW10!YGH%W')XR\--Y-P%;P^(
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MVN- DAMI$5AF7.0 2/8_E6YX5\0^&]3TO0M*-GYNIV@11;?9R6MY%7YG)(
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M]M;VJ,EO!%"C,6*QH%!8]3QWJ6@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *6J:K:Z/9_:;MV"E@B
M(BEGD<]%51R2?2K$]PEO:27,@<1QQF1@%); &3P.2?:N1U M>_%G2;60MY-E
MI\MTBE?E+LVS/X U$;^]\1ZWK\4&I365KI"F!88E0F9RI)9\@_+D8 &.] &[
M8^+='U#3K"^CN&2"_D,4#21LH+@D;2<8!R#C)Y[9K;KS#PW&U_\  I_-?YX;
M>>2-\ E#&[,I'N"HYKOO#][+J7AS3+Z?;YUS:12OM&!N9 3C\Z -&BBB@ JE
M;ZO876J7>FP7*O>6@4SQ '*!AD<XP>/2G:GJ-OI.F7.H73;8+>,R.>_'8>YZ
M5X]INL1Z%KVB:[+-<B\U)F@UE9[:6.-2[;E(+#&5Z<$\+VH ]7U3Q#I^CZAI
MUE>-(LVH2^5!MC)4MQP3VY(I]IKVGWVM7VDP2.;RR"F=#&0!NY&"1SV_.N>\
M8/&GBSP<9!E?ML@'RYY*8'ZX^E5?#O\ R5SQ=_URMO\ T!: .]K'3Q1I;W>K
M6RS.9-*C$EW^[;"#!/'')P#TJEXDU.]&K:5H.GS_ &6?4?-+7.P,8T1<G:#_
M !$D8S[U@Z2FHV?B?QT([M9[^.UM3%-)& "PB<KD#CTH [C2]2MM8TRWU"T9
MFMYTWH64J<>XJW7G;>,M1@\(>&]8O7:.UNW(U&[@A#-$.0N%P0 3C)P>G0DU
M9U77-8B\/Z1?:3K%E=+<ZBL#7!@R'C=RJ<#'(&,]/PH [NBO,]5\5>(O#5_J
MFE7U[;7LXTPWUK<QVXCV$,1AER01P?TJ[<>*M7@C\#SB:)EUCRDNT:(8)95)
M(/;[QH [^BO---U+4/#^F^--:EOY;T6M_+$D$J@@N!&%;/4#D# ["M+3=5\5
MQZU;1S6=[>V<EN_FF:UCM_+E R,$,>#T_'OC@ [FBN#\%^*+OQ'>IYFJQ":%
M'%]ITMML>-\X4HPZJ.ASD^O7C0^(&OZEX=T>SN]-: 22WD<#^=&7&&R>Q'I^
MO:@#K*S]7US3M!MX[C4KCR(I)!$C>6S98]!\H/I7'7FOZY8:O!X=DOVN=0,<
MEU-<6>G[B(\A44(6QUR2>>PK*\1W>I:C\,XY?$T+VNI1ZE$L"^7L\T[A@D<X
M^4OZ<K^% 'JU%<=XLU?5;"]G2SU.TM(XM/DN8HS$)99I$R2"O9-H'/KFL.ZU
M?5=6\8^!WBOFM$OK%KEX47=&',3,<@GYN#CGIVH [ZVUG3[S5;S3()]]Y9A3
M/'L8;-PR.2,'CT)J_7(#7=0B\3^)[9EMO)L;*.XM]J<L2K'YSWY&/I6!I'BO
MQ1+8^&=7O+FPDL]5NQ9/;I;E6&2PW[L]?E/ P.G% 'IU%>=Z[XGUM-1\3K8W
M]I:IHD44B02P[O/!7<V23D>@Q[5V>@W-Y>Z!8W=_Y'VF>%97\A2J#<,@ $D\
M CO0!HT5Y;HGB>\TG2?&6M7MTUPEMJ$L<4,HR=XPJ '/"]!CT'%:6HZWXG\+
M#3=2U6]L;_3[R=(9XHK<Q- 7Y!0Y.X#GKZ#UX /0*S[O6]-L-2L].NKM([N\
M)$$1!R^/H./QK,\>S7-OX%U>6TG,$RP$AP,D#(W ?49&>V:Y#Q,NH?VG\/%$
M\$E\6?$KQD(3MCY*@Y/YC/M0!Z7>WEOIUE->7<HBMX5+R.03M ^E%G=P7]E!
M>6K^9;SQK+&^"-RL,@X/(X-<78>*-:N$\6:?<QZ?+?:.NZ.41LL4JD,0&3)/
M1?7O^)?=>,9=.T;PI=3&SLK?4X@;B=H6:. ^4&4*H(P"Q Y/ H [BHKFYAL[
M66YN9%B@B4O([=%4<DFJVD37-QI5O-=S6DTS@L9+3/E,"3M*Y)/3'?KFN6^(
M.J6.[3O#]]>I:6NHNS7<I?:RPJ,X![;FP/SXH [6.1)HDEC=7C<!E93D$'H1
M3JX7X6Z['J'AZ32VG$MQI<A@W@Y\R/)V,#Z8X_ 5E3>//$;^'YM<M4TQ(%U$
MV:VL\#B0#. 2PDZ\C("^OI0!Z?17#ZCXB\3'QJ_AS2H])\P62W0DNED !R P
M^4\^W2JEQXTUVXL;K4M(MH+FVMKLP>0+*9VF16"LZ2AMOK@$=!^% 'H=%<#J
MWC;4C=ZK%I$**VG1H#%<6$LS2RL"Q4-&P"@ #KWS3KKQ7XCDE\+V]EIUG%<:
MQ;R-(EYO7RY$3<>AR!WY!)Z<4 =Y17G2>)/',B:S$MIH(GT@_OW)EVR#9O 1
M<YSC')-27GQ N6BT:*U6""YO;#[;,TEK-<+&#PHVQX."V>><8Z<B@#T&BO-9
M/B#KL?A72M1?2(8+RYOQ92QW"NBY/(91UP0#US@^M7IO$WB&UMO$]GJ45C%>
MZ?8F[MYK,L5P0V,ANI!7V^E '>45SO@:>_NO!VFW&H7*W$LL*N'VD-@C^(DG
M<??CZ5E7WBW4F\:7F@6$FF0RVPA,<5V'W708;GVL& 4@8P"#F@#K(-4L+J_N
M+""[ADN[;!FA5@63/3(JW7ECRZO;?%?Q.^BQ6)E6RB=S=E@H 1#T7DG\JWM/
M\6ZIK/A[1-1LK.WC%Z[K=W$V?*M@A()(W \X('/_ -< ZO4-2LM)M&N]0NHK
M:!2 9)&P,GH*:^K:>E_;V+7L N[E2\,.\%G4 G('I@'GVKS?Q+KL_B'X2^(9
M;R.W\^ROA:F2#.R0I+'\Z@Y(R&]:V[N*/_A)_ 4NQ?,,4Z[\<X^SDXSZ4 =?
MJ&HV6E6C7=_<Q6T"D R2-@9/0581TEC62-E=& 964Y!!Z$&N4^)JJ?AYJQ90
MVU4(R.A\Q:S;#QCJNFWNDQ:YIMA9Z5J,0^R2VTI_=80, P/;! X Q[T =_17
MFT/Q'U*XN+2\@T^&XTNXG,0A@BF:X5=Q'F%MOEXP!QGOUX.._P!3ODTS2KR_
MD1G2U@>9E7JP52<#\J +5%<%;^,O$#:EX>AFTK3V@UD%T:"Y8F-!@MG(QD!@
M<?A0_C+7;W3M1UO1].L9M'LFD4>?*Z33JF-SKQ@#AC@\_B,4 =[17$S>.9Q>
M>&IH;.(Z3K6U/.=R'BD/52,8[@#UP:74/&\^G6U]-+;V^T:E_9UDQ+;9&'WF
M? ) '(X'530!VM%>?V/Q$N)5UY)[.VEDTRT-RDMK(YBE '(RR@CG^1]*@NO'
M_B&Q\+KKUUH-FMI.L)@*W9)8OGJ-OM[=1UYH ]'HKD;/Q9J%MJU]9>(;"WLE
MM[%K]7@F\T>6&VG)P.:R-+^)DM]K6E6DEI:&+4FPJ6\SO+;Y^Z9 5 Y![?7M
M0!W]U=VUC 9[NXBMX00#)*X103[FI000"""#R"*\K\9:Y?\ B7P-K%W;6%D=
M'AF\M)I9&,K;7 \Q!MQC/'7UKT+00LOAC3 R+L:SB!3J,%!QS0!>MKJWO(1-
M:SQ3Q$D!XG#*<'!Y'O4M>,^#/$.K^&_!4MY;Z-%=:5#>R&XE%QM=0=HX7'0?
MCUKO(_%=PWC:UT=[:$6%]:?:;2Y$F6E^4$C';O\ @* .JH) !). *Q?#.LW6
MN65S=SVT<,2W4D5N49CYB*V QR!C.#_]:LBWU35;WQ]KFDSQ0/I4%I&-I;IN
M!.<8.XG)!&0, ?B =9;W,%W L]M/'-"_W9(G#*?H1Q4M>->"_%5]X9\!:?<O
MID;Z5]K:*:Y:?# LQY5 #P/?KSQW/2>)?B6-(U6\LK*WM9C8X\_[1<;&<D9V
MQ@ Y(''U[4 >@U'%/#.',,J2;&*-L8':PZ@XZ'VJMI&HIJ^CV>HQH42YA64*
M>JY&<5Y_X'U Z/H/BV\BLY+IH-6FV6\(^9S\H 'IU_ 4 >FT5S-OXGO9-1U/
M3)]*2*^M+);N-$N/,67(.%)V@@Y&.A_QR8_B!<R:)X;U3^S8A!JEW]EN&,QQ
M V_:#R.>C'VQWZT =Y17(ZKXU;2F\0S/8K)::2($#K-@RR28RO0[0-R\_P"1
MM:/?:A?+,]Y:6\41VO;RV]QYJ2HRYZX!R/I@]J -2BN?UCQ%<6VKIHNDV O=
M3: W#+))Y<<<>=H8M@YR>,"L#5?%M[J/@_Q+'%8&PU;3HVCN(7G#;%(^^K ?
M-QDCI]: .X@O;6ZDECM[F&9X6VRK'(&*'T8#H?K4]<KX'T:WLM&MKTZ5:V=Y
M-:Q(SP2%S(@08)X&#[<_4UU5 !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 45BZYXHL-$T*;6&$EW:PR>6_V7:Y4[MISR!P>#S6U0 4457OKVWTV
MQGO;N01V\"%Y'/8"@"Q17&0_$:TDGL5FT/6[6&^E2*"YGME6-B_W>=W0UV(E
MC:5H@ZF10"R@\@'H2/P/Y4 .HHIJNK%@K E3A@#T.,X/X$4 .HHHH ***YNV
M\96MYK*:?!I^H/$\\ENMX(@8=Z?>!.<CGCD"@"OXDL9[+Q'IGBBWCEECM(WM
M[R*+)8PM_$%'WMIY(_PI;KP>TFL7NJZ5J\^G'4(@MS$D*NDAP0&P>C<_G]:N
MZSXOTK0=5L]/U%IHI+L@12%/W9YQRW;&1GZUL75S%96<]U.VV&&-I)&QG"@9
M)_(4 <5-H%QX?\&1^$M*EGN[B^,D:S2( D,;']XS$#  #' Y))X]NRT^RBTW
M3;6Q@SY-M$L*9.3M4 #^58-MXZTV]T"XUJTM-1GM(6"?);G=(2<?*,\X[UTJ
M,'17 (# $9'- #J*** ,/Q/H5UK]I:V\&H&TCCN$FE79N$H5@P4\CN :=XKT
M$>)?#MUI?F)$TH!61X]^P@Y! S^M;5% '&W7@R^O/^$9\_6!(=&D$CLT',S#
M&._L!^M7=,\,W%AXVU?7VO4>*_1$\A8\%=H !)S[?K7132K!!),P8JBEB%&2
M0!G@54T;58M;TBWU&"*:**=2RI.FUQ@D<C\* ,SQ+X;DUJ:QOK&]-EJ=@Y:W
MGV[UPPPRLO<' JA9>#]2MKS6-1DUUI;_ %*U$+'R L:N%P&VCKCM]:["B@#C
M]/\ #&N:3H&EZ?9ZM:,UFDL4JSVQ:&=&.1E0P.1ZY[FN<\0:-#X2\*V&G1W\
M:7M[K45T'9,1I)E<E5[(N!U/XUZG5>[MK2>/?=6T<ZQ@L \0<CUP,'T[4 <Z
MGA"2]OM3U#6[J&ZN[NU-E&(H=L<,)YP%))+9).2:R[;P%JC#05U#74ECT:96
M@2&V"_(J@ 9)/.5'7M75Z!KEAXATF._TW?\ 9BQ1=Z;2,<=*T)IH[>"2:5ML
M<:EW;T &2: .2'@F65_$5K=:EOTK5W:46ZQ@-%*VWYMW?&T<=.*31O"WB&VB
MA@U/Q1-/;V\3)"MNGEL6((!=LY; / ]0#VKHM&U>UUW28-3LBYMIP2A==IX)
M!X^H-7Z .0T_PIJ0\2:?K.J7ME/-9P/$9(+8QR3[@ "YR<X'IZU:\:^&KGQ1
MIEM9VUW#;>3<K<%I(R^2H.!P1ZUTM% '+:_X5O+[6;/7-(U)-/U6",PR2&+>
MDL9YP1GL?\\5GZSX(U76=!CM+C6DEOC=K=33R1';\H(5$0$!5&?QYKM9YH[:
MWDGE;;'$A=S@G  R>!5/1-:L_$&E1:E8,S6TA8*67:3M)!X^HH YO4?!FIWO
MB"_U"+68X(=1LQ:W4?V8.P 4@A"3\H)Y_&JD/@35[4^';F#5[8WVC1R0J\L#
M,DD;# !&[.0"1U],8Q77QZS9RZ[-HR,_VR&%9W!0A0I.!SWK0H Y#_A%M5;7
M]=U&34+5H]3M3;)$(2/+ !"$G/) )SZY[52B\#:G;^'O#VEQZC:YTF^%T9#"
MWS@%B !GK\Q_3\>\HH \7U>[_M3QAJ]ZFJ^'(A#<+!'!K40WJ(P 2N5) +9Z
M=:]3\-W]WJ>@6MW?1PI</NW>0"(V 8@,N>=I !'L:EN="TF]O$O+K3;6:Y3.
MV5X@6'&.M: &!@=* .$M_ -RJ>(].GO+=])U:1YT'EGSHY6.0<],# ^OMW4>
M%/$6IC3K#7]0TZ?2[":.96@B?SIR@X#[B5P>^.M=U10!F>(=*.N>'K_3%E$3
M7,)C#D9 /:N:NO">NWL_A2YN+S3S/H[DSE4<*X.T?+[X7VY.>.E=39ZS87^I
M7VGVTV^YL2HN%VD;"V<<]^AJ_0!PJ>$M<M]4\67<%QIVW68PD"R;R5(R/FQT
M^4MTSSCTYEAT#Q+!H6E::_\ 8EW!;6QM[BUN%?RI,8",#M)R%'/ Y)KJ-4U:
MQT6Q:]U&<06RD*TA4D G@= :8^N:9'J=IIK7:?:[Q#);Q@$^8H!.0>G0&@"G
MX1T!O#7AV#37E65T9W8IG8"S$X7/.![U!I6BZA'XFU;5-5%A,ESL2U,8)>.-
M<C:=PXSG)P>M='10!QK>'=4L?B%-XCMI[&'2Y8-EW%A@[@ G<0!@MG'.>E<9
MID]Y%:S:]:R^#9O.GDO$:\#"Z!+'"\'"L.@';/6O9:R+?PMH-K?"]@TBSCN@
MQ82K" P)[T 9-KH&I2>/U\32M;1VTFG+;M!N8R*W#'MCKWS^%9UIX3\4:%=7
MUKH&J:?!H]U,TJ+/&SRVY;KLXP<=MQ-=?=ZUIUAJ%I875TL=U>$B",@DN1UZ
M#^=7Z .&E\,>)M*\2WFJ>'M0T]H[]$^TQ:@KX,BC&X;/SZCK]*N7/AS6)-?\
M-7PO;>X33!*;B2?<))6E&&*@# &.@XQ[UUM% ''0^'M>CN?%;M+II35@WV;!
M?*';L7>,?W<9QWS6=;>#O$>F1Z+?:;=Z:FJV-F;"=93(8)H025Z '(S^=>A4
M4 <+XA\+^)-=T?3(YKS3WOK>^%Y+G>D2[00J)A2<<]3S5^3P[J5QXHUB]N/L
M#:??6 M1&2S/N X)!&,?,WKVK?OM6L=-FM(;RY2*2[E$,"G.9'/88JY0!SW@
M[3-8T;0HM-U9[%Q;*L<#6F_E /XMW?Z5B^*?!^I^)1>PSQ:5(IE5[*[9G2>W
M7C*G"G(X/?G-=?>ZM8:=/:PWEU'#)=2"*!7."['L*N4 <5!X8U:#QEKVJH;4
MV][8+!#OD;<7"!1N ' RO/UXS6+:>"?$UAH/ANWMGTYKG2[F:5X9Y',+[SE7
M.T DKS@>_P!17I]% 'F=UX+\33>%?$NER/IKR:G?B\C\MV !+AW'(X^ZH&??
M\=N?1M>DU[PG<+#9_9M-A;[2WFG(=H]C!>.1CI[]<5V-% &)XOT>?7_"FH:7
M;.B3SQ@(7Z9#!L'ZXQ7/VWAC5=8GT1=>M+*&QTJ$H(HY3(\SF,)D\8"]_7-=
MG?W]KIEC+>WLRPVT(W/(W11TJ6*5)HDEB=7C=0RLIR&!Z$4 <!HFA^-M%C30
M;6?2X]&AD/EWA5C.(RVX@#INY/48]ZZGQ7J$6E>$]4NYC'A+9PHD!*NQ!"J0
M.N20/QJ_::E8WTL\5I=P3R6[;)EC<,8V]#CH>#3KVRMM2LY;.\A2>WE&'C<9
M#"@#S#P]:WWAB;1)KW0;%P[):17,.H/(ZB4@;E1B0!SD[>V>U;%OX:UO1]*U
MKP_I]K:SZ;?M)]GN'G*M")1A@XP=VWMCK70:3X)\-Z'=BZT_288IQTD)9ROT
M+$XZ]JWZ .0U;P9Y_P /(_#MG*?M%K$AMYBQ7]ZISNSVR<_G^-0Z[X0OY/".
MEV>D7(75--ECN$E=R!-* =Y8]<L68UVM% '&7%CXMUS0=7@U1+"W:>S>"WM;
M=BP9R!\[.>GH /4YK/U?PGK.H?"W3M!6* :A;F(.OF_+A"1U^F*]#HH XK5_
M#VIZSXEGFD@C@L;K1GL)9/-!9&8[L@8YP<"E\.P>-K5+'3=0BTR.SM=J/=1N
M6>2-1@*%Z GCGCC/&:[2B@#RR;PGXLM/"^I^%;6WL[K3II&:VN7N"KHI<-@K
MC'8],<FO0]"MKFST'3[6\$8N(;=(W$;97*@#@_A6A5=;^T:^:Q6ZA-VB;V@#
MC>%]2.N* //-/\):_:>$]0\+M:VYAN[ES]N\_A8V8<[,9S@=,]ZN>.=(MT\/
MZ1;:;<K#JVG36\.GX<;QN*IC!YQ@$G_</I7?UCIX5T--?;7%T^/^TF.3/EB<
MXQG&<9QWQ0!H6%G%IVGV]E",101K&OT Q7.P:7JEK\0-2OUMHY-.O[6-#-YH
M#1L@(QM[Y_J*ZJD9E1"[L%51DDG  H \F'@OQ ?A3%H)L4%^E]YFSSEQLW9S
MG.._2MP:;XI\/>(]4N]%TZTO;/595G99KC8T#[3NSZ\^F>U=O:7EM?VXN+.X
MBGA8D"2)PRD@X/(J>@""R%TMC"+YHVNM@\TQ A-W?&>U>;6WAGQ1;^%O$]G;
MVYM[J[U%KF#;<*#-$2-R@@_*2!CDCK7J%% '#:)IFO+X[&L7VDVUM:S:<MN=
MDX=H&4@X_$YZ9' YJG<_#R>[F\00/(HLG+W&E(& \JXDPS,<#(PRJ![%L=:]
M%HH Y*WT?4=,\"FU>TAU?4YF66]BG*XN&9P9!DX!(7(!/]U?I4?@C0)M$O=7
M>.RN-/TV=HC:V<\ZR-&0&WGY68 $D=\\<UV-% '(ZOI^KV/CBV\0Z=9_;K=[
M/['<VZ2*D@ 8L&7<0#R?6L:;PYK,VE^+=2;32-1UM1%#9"=-T: ;06;.W/?@
MUZ/10!G: MQ'X?T^*[MFMKB.!(Y(F96*E1CJI(/3/XUHT44 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %,E3S(G3<R[E(RIP1]#3Z* /$-/0_P#"@=6G
M:65WEG!8.Y(!\Y.1]>]=BS:KX8\66Z3:W>:G!=6-Q/)%<A0 \8!!7:/E!ST
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M7:"0.I +#TYZ<9K0\1^'+?Q'9PQ2326]Q;RK/;7,6-\3CH1GJ/:@#G].76-
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MGV5W=6WX)! /0@$<5SMQX5U:QU'4O$5YJUI,TNER6]Q&EL4& N1M^8XY Y-
M&9#XP\40^%M,\67=S8OILDJQW%JD&U@N]D+;L]<@=*U#JWC'5-8\06.GS:;;
M+I[HT):)I&D5D+(OIR!DGJ":SO"'AZ^U[X?Z)97-[:KI"R>>RPQMYK[9&;86
M)P/FZX':I]'FUC4_&/C1-.GL;=O-CA8S([, J,BLN&'I^= #9=:/B2+P)J\M
MN(9Y-0='7'W6 96Q[$KG\JU4\3:C8>+M>TS5IH$MHK0W=@PCQE%!+<]R.X]C
M3V\$SV\7AJVT^\ACMM'F\Z3S(R6F8_>/7C.6]>OM6;XL32?%?BC0["QN8Y[Z
MTO76[6(G='"H_>*^", G"_4D#O0!UOA6?4[OPS8W.L%?MTT?F.%3;@-RHQZX
M(KFM)\4ZCJGBZ]L3JEA;&SU![<Z=+%M>6 9 =7SDL3SCI^==[T&!7%WG@^_U
M6:QFU&YLWNK2\$ZWL,128Q@Y$?''X_IWH HV_B[69=!\92EK?[9H]S*D#^7\
MNQ>V/7"GDGO5NP\4ZKKBZ7IUC]FM]0N=+74)[B5"R("=H"*#R=W//&/6JLG@
M?6DO_$5M::A9QZ5K>^61I(F>5';.0 "!CD\^_2ED\$ZYIJZ3>Z'JMLFI6-@+
M&031GRIXPV1ZD=2?P'2@"KXD?7&TGPK)J=M;?VQ'KD<8*'Y'QOPWL#@'%=)H
M6JZN_B74]&U8VDA@CCN(I;=67Y7)&T@^F*I:WX<\0WUCHVR_M+F]L]16]F>9
M3&G&<*@&< 9Q@_G5^TT?58?'U]J\CVITZXLTA"J3Y@93D9[8Y;OZ4 8WQ'_Y
M"G@__L,P_P#H0JUXB\4:OH\NM2I%8);6$,4L"S$L]SN^]@!@5 /'(J;QEX?U
M37;_ $&2P-JL=A>K=2-,[ _*1@  <]^XK&UKP3X@O-4\2/9W=@;;6(47S+@,
M98]@XC&. #Z\]!Q0!K2>*KW_ (273K-39+IVJV37%C.R.2SA VUCD#'.?I@=
M363I'CK5M6\,O-'_ &=_:QU5;*.(;MC*2#GKG&"W/HOK6AJ?@BYU?P9H>E37
M:6]]IPA!GA+8PJ[&"G@_=[^H[9JSI_@>UT[QB=9@.VV6W58K<'A90-A?'3[F
M!^)H Z+5)+R'2[J73XXI+M(RT22YVLP['%<.OQ!NOL/A6]_T%H-6F\BYPK@Q
M-N (7GMG'/U[UZ'7G\GPUC:W\1Q^>KK?%FL$?.VU)(?C'3YP.G91UYH L>(?
M$=[%H'B2\;3["[L+&=;>*.<-^]QMWEAC! =L#&/NFH+G4=8N/%?A".RN8;:U
MNK%IWMMA\O(0$]#Z, /3%7]8\)W3?#IO#6F/'),R*C2W$A&3N#,Q."22<_G5
M:Z\.>(TG\,7U@^G?:],M6M[A)F?8=RJI*X&3T]J .:T_4]:TC6O'E]I5O8R1
M6UT9IVNG8<*'.%51R3[D"NK@\7ZAJ\^C6>E6EO%=7UC]OE>Y)9(H^F %(+'=
MCTJI!X4UZT?QBT,EF#K!+6K>8P*$[AEOEXX;/&:2Q\)Z[I:Z!J%J;-]1T^T:
MQN+=IF$4L6200X7(.<'&/Y4 0ZE\0=5TC2M96[L;/^UM)FA6549O*ECE/RLO
M.[..N?4?2MJ\\37UMXVTK1$@MV@U&U>57;<&1U5FY[$<>E9.I> [W6],\0SW
MTMO%JNJF(JD3%HXA%]Q=Q4$YXR<>G'%2VOASQ-<^+]$US53I:+81RPO';,_W
M2A (W#DY/MTH T?A_?:KJ/AS[5JL\4SO/*%90=PQ(P(.>,#'&,<57U_Q5K=K
MXOC\/:+IMK=326)N0T\I3!W,/Q'R]/?J*O>#M)U?0[2XTZ_%FUJDTCVTD+L7
M8.[,=P(P.O:H9O#^HO\ $RW\0*+?[ EB;5P9#YF<LV0,8ZD#K[T 8.I_$358
M);LV%A:SK8S_ &>>W*S&660;0^PJI0 $GJ?X<^F=V[\3WUQK=KH^E16T-U+I
M_P!O8WP8#!. @48.[(.<] .AJC!H?B[1-8U;^Q9M+DT[4+MKH?:R^^)W^\0%
M'/L">PK(\2IJ]YXGM]/LH+34[K3=.4SS37#6TC.[<G*,G&%!QT^8^U &WHGB
M_6M;\+V6J6^BQM-=78M]JR,4C3H96^7. 0>!GZTP^/9X-(\2SSV,;W.ASB)E
M1R$E!; .3D@]?\GC,-EJ^O\ AZPLK#3-/LSI&H1B:Q^T;H)D"AOO+GCYN0<_
MB1R77A;Q-(GBU#9:9(FL1HT868C:X & ,=N3DXR0#W. #6?QEJUII<%W>Z5:
MI+J,UO%ID*W.?-,H&=QQQC/7'?\ $YFCB^'QGG.I1VB73:."_P!E+%&^=1GY
M@#VQ^ K1U;POJNI^%-!$8MX-9TAX9HXV<M$S( ,$@#K@']/>FZ7HOB67QZGB
M74+2PM8I+/[++ EPTCJ,YR/E SD#O0!;\=:UJ&E3>'X=/E$;7FIQ0R$C[R9Y
M7Z'//>IKO7]7O-<O=(T"WT^2:PCB:ZFNY7"AGR0BA1DG SG--\=:%?ZQ:Z7<
M:7%'+>Z??QW*1RR;%8 \C/Y?AFJ8TK7]%\57.MZ=I]O=1:G!']NM5N ACF4$
M95F RO)]SD\4 ;/A3Q(?$=E=--:_9+RSN7MKFW\P/L=?0CJ/\#69:ZAJMWX_
MU[3;AX'TNWM(ML1SD;@3G&,$GG.>V*O^$- FT6UOI[P1B_U&[DN[@1,2B%CD
M*">H'K[U1&F:Y:>/]1U"VM+>73KZUC1I'FVLC(IP,8/4G]>O:@#C/!WBF\\*
M_#>QOFTV.?3_ +:T4CB?$@W-U"[<8ZCK75ZSX]EL[K5X].L[6Z32@HF#W#*[
ML>2$4(0<=\D=ZYW_ (0KQ$?A7%H'V*,7T=]YNTSK@IG.<].IQCVK;;2_%>A>
M(]4NM$T^PN[/5&69XYIRODR[<,?<9)/'7VH [32[]-4TJTOXT9$N8EE"L.1D
M9Q5NJNFQW<6FVR7\D<EV(P)FC&%+=\#TJU0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%(X)1@&*DC@CJ* %HKQK3#KM]
M\-)_$W_"0Z@FI64LLJ*\H$9 /S*5QSP3@'O@<5KF;5?$_CR32SK=]86C:7%>
MA+4J,.=G )&<?-0!WMCJDE[J6H6C6%U;K:.JK-,N$GR,Y0]P/ZUHUY_)JNIV
MS_$"/^T)I/[/A62T9L9A+0L_&!V./RK$M[W5+)O ^KOK%]<RZK,L%S%-(/+*
ML1T4 =,]: /6ZSO[5/\ PD']E?8;O;]G\[[7Y?[G.<;-W][OBN-MK34_&$>J
M:A'KEU87ME?S6UHL+XA14( WI_%GN3^'I5V/4]2_X6M_9+7TAM#I(F\L ;1)
MN W#B@#MJQYO$$,/BNVT V\QFGMFN%FP-F 2,>YX_45YUI$OB75_ ^JZTGB>
M]2ZL99MB%4V,J ,<_+GD9K;LKZ74O&'A*_GQYUQHCS/@8&Y@I/\ .@#T*BO+
MM,?QAK6EZ;XETZ<R7<TY,MN]T! 822"H3;P1@<Y)X[U-=Z]>V'BZXT[6[[4-
M/,U^CZ?<PKNMY(<@"(@CJ><GU/H.0#TNBL/QCJUQH?A'4M2M-OVB"+,9<9 )
M(&<?C7,:W<:EX3B\/ZC%X@N]1AN;N*VN5E",DRN"=R8'R_=XY/7KZ@'0:MXO
M@TW49;*WTW4-1EM_+-S]CB\SR0^<9&<DX&< =.:Z)3N4,,C(SR,5PGAW3MWQ
M*\5SB\NU\F6V.P2?+(&BSAACD#MZ5I>*]8G@U?0M#MIY;9]3G8231 ;EC09(
M4GH22!TZ9H UO$&NVOAO2)-3O(YW@C(#"% S#)QG!(XK2CD$L22+G:ZAAGWK
MA?$NG:IIW@SQ0EYJ9OK-X-UKYH_>QC'S!B!@C.,?C4,<VL^'O$OAZ&?6YM0M
M]1MY_.AEB154QQ;P4VCCGZ_C0!Z%6<^L1)X@CT8VUT9I+<W F$?[H*"1@MGK
M[>XK@EOM9O/AY<>+HM?N8[SY[E($V-#&H;'EE2O/ QG/6M:RUW4+[Q;X=D%R
MRV5_HYN7M0H \S@[L_\  @,=L>] '<45P&@+XB\2Z%8>(+?7I+>>XN6D:V9%
M,*P!F7RP,<G ^\?_ *]4+O4O%OB*[U:?06O8197C6UN@:%(\J$)\Q7&XDY)]
M.0/6@#TZBJ$-U=6^@K=ZE$JW45OYD\<39&X+E@#7GJZGKO\ PK__ (31=<G-
MUDS&T*(;<IYFS9M R..^<YH ]1HKSR34/$/B3Q*;'3-;.EVDFEP7J@6R2,K.
M1QSS^M;_ (UUV?PYX8:XA<?;)72WA<KD!V_BQTX )Q[4 =)17&WJZYX6@U+5
MIM:;4;".R>3R;B)0RSC&TC:!\AYX[5B7][XATKP3;>,O[>FN)FB@GELY(D$!
M60J"H &1C<.<]C0!Z;5#5]7M-$L?M=XS!"ZQJJ+N9W8X"@>I-<1?:AXCU36-
M>2QUTV5A9V$=U$B6J%\NA8 DY/\ "<G/>L7Q+J=YX@\!^#M3FN'CFGU")) H
M7!<;U\SIURI..G/?% '=Z3XXTS5M8728[>^M[X[R8KF#9MV]<G./RS6KI^L6
M^I7E_;0QSJUE+Y4C21E59L9^4]Q_GTK"U!2GQ&\.JTC2$65T"[8R?N<G  _2
MN?/C35[*W\9-<7$<TEA=);668U18R[,H+'N!P>3VH ]-I 01D$$>U<F;'Q3;
M&5IM=CNK![%][M B2Q3;>&3:,$?7/XUSUK?ZMH7PJT6^M;RZE#RPM<2"%9'A
M@;._:,<X]3GK0!Z=16%X4U)-5TAKN+5QJ<3RMY<QC6-U7 ^5E &"#GMT(K,C
MU+4]>\7:SI=EJ;Z?;Z6D2YC@1VE=P22=X. ,8P.OK0!TNJ:G::-IL^H7TOEV
MT(R[8SU.!QW.2!571/$%IKZ7+6L5U$;>4Q2+<PF-L_0_Y]<5Y=XLUW4-7^'E
M];7T^+W3=5%E<O$N$N-IX;&..1G [C\*]@M8I8+:..:X>XD48:5U52WN0H _
M(4 4M*U[3]:FO8K&1W>RF,,X:-EVN,\<CVK3KS/PO+=0/\0);*:WAN5U&4QR
MW+;8T.6^9C@\#K5_2-8U>Z\176BIK/VQ)=(%Y;W;VJH4D+;<KA0&7G/(]O6@
M#O:*\CNO'&N6O@_2-1EU()>QZ@UKJ<1MXRVT,23@#C  ' 'WA[9Z;5-:UI[3
MQ->Z-.9H[2...TC6 ,?-P&D8'^+ 8<'/(/''(!VU%<KX+U@ZQ%<SC7TU2(K&
M4C:)(Y;<X.X.% [XQ]*S-?FO9OBSX?LH;Z6WA%I++M0 @GYLY!&.0,>OIB@#
MJM-U_3M6O]0LK.<O<:?(([A2A&UN?4<]#T]*TZ\CB.KP^)_']YI.I1V36ACG
MDW6PE,H5)"%&3A>G7!K0OO&6NZJ-'M=%$L4L^FI?74]K:K<$,QV[0CL  &5@
M3D]J /3**\RO/%GBVQ\'Z5)>6T=GJ\^I)9.T\7#J1D/M!XST./0XQ3]3UCQ=
M9:G#X?%\\U\+9KR2ZLM/24E3(55=C,H  ')Y/2@#TJHYX(KFWD@GC62&12CH
MXR&!Z@BN 7Q+XFETS0M+N8TTS7=2N)(GFEA#A412=X3.,G@8/H:NZ7JVN:=X
ML?PSK.H6]Y)<6AN+.\2W\LY!((9!QV)Z]O?@ T-,\1>&K748_#^FCR6\QXHU
MBMV6(NHRP# ;21WYK8M-%TRQO9[RUL+>&YN"3+*D8#/DY.37,?"^&8>"[26:
MZ68,\I11& 8_WC9&>ISR>?6NUH *KP6%G;3RS6]I!%+,=TDD<85G/7)(Z]3U
MJQ10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8
MFK^$="UVZ2YU'3HY9UQ^\!*L0.@)!&1ST/%;=% %>RL;33;5+6RMHK>!/NQQ
M*% _*K%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !39)%BB>1SA$4LQ] *=10!Y1X!
MT*W\2^$S;7UYJ"VZ7KR7%@[8$F2&7<VT,PXR>>3Z5W$'A:&#QG/XD6\G,LUN
M+<P8&P*-OX_PYQZUOT4 <J/!,;7NOW$NJ7<BZU%Y4T>% 08P,<=EX^E1MX#@
M:P\/6O\ :5R!HLHEB;:I,A!!&>.,8Q7744 <;<?#NREU6XNK?5-4L[6[9I+J
MSMKEDCF=NI/U[BM&7PP@\71>(AJ-Q'Y%OY'V<!2FSTZ9Z\_A70T4 >1> -#;
M7?#]_8R:M=V]LUX[7%DB*!(C8P=Q&0#@]/2NZD\(PGQ-IVL0WLT$5A!]GBLX
MU41A,$8Z=.1^0KHZ* .)M/AM:6=Q)'%J^IKI+R%_[,2<K%_N\'..>G?C/2I[
MWP.^H/)%=:W=2Z<]\;W[&\2%02V[:&(R%Y/'N:Z^B@"KJ6G6VK:;<:?>1[[>
MX0HZ^Q]/0]P:P+/P6(6L([W5KJ_LM.D$MI;3*H$;#A"6 RVT$@9KJ:* .?TK
MPS)IGB34]8_M.:;^T"#+ T:A05X7!Z\#BI?$OAJV\2V<,4L\UM/;RB:"X@.'
MC8=Q6W10!RDW@G[3H6H6%SK-]/<WX19[R3!8HIX4+T Y/YDU--X2:XU31+V;
M5)W.DQ>6J&-<2Y7:Y;_>'6NEHH XQ?A^L5G=Z9!K5Y#HUU(7>P5$*J"<E58@
ME1GTK2;PJG_"3Z?K"7LL<=C;&VBM%4;"A!')Z^A_X"*Z&B@#CM/\ )ID_E6F
MN:E'I7F^;_9ZN GKMW=0N1T'N.].N? K'6[[4=/U[4-.6^8/<0VY&UFQ@D$]
M">>?>NOHH JV>GV]EID.GQINMXHA$%D^;<H&.?7-<C_PKV1;.32(]>N4\/R.
M7;3_ "E) +;MJR'D+[5W%% '.P^%?(\:GQ"EZVS[(+06OEC"J,?Q9]1GI5[Q
M#H5KXDT6?3+PN(I0"&0X*,#D$?0UJ44 <OIOA":&.XCU?7+S58Y87MUCDPBH
MC<'@=6Q@9^N,9JC%X#O?L46D77B&6ZT&)D(LY+==Y5#N"&3.=N0.,= !7;44
M <K+X2NVU[6=136-L6I6GV8VYMP1'@84YR,XRW;OUK,E^'=PWA/2-$36E#:;
M=?:4F:UR&.6(&W<,#YCW-=[10!S=]X;O[SQ=IFMKJXCBLHS&;86X/F;OO_-N
MXS@=CC%9H^'J2MXD2]U 3V^M.)/+$ 4P."2K Y.2,^U=M10!RNA>%-3T\2C4
M_$UYJ:F)HHHV78B C&2,G<?<U3TWP9KNDZ-:6%KXLD_T6;?%OM R>7@YC8;L
ML.>YXP,8KMJ* ,/PUX>_L"*]+SQS3WEP;B5HH?*0,0!\JY..GKUJG?\ A6\_
MX2677=&U9;"YN(A%<I+;^>DH  4@;AM(QV_QSU%% '#ZE\/7OO"@T9-5"32W
M9O+NZ>WW&>4\D[0PV\X]>!7:6ZS);1+<2++,$ D=$VAFQR0,G SVR:DHH X0
M_#R>33O$EG-K"E=:G$Y9+;:8GW[O[YW#MCBK.F>#=5LO$5EK-QXB-S)!;?9)
M8Q9)&LD62548/RX)SGD\5V5% '*+X$L#JOB"]DE9AK$/E-&!CR@1\Y!SR20#
MVZ58@\+S:?X.M]"TO4Y+.:#:5NPFXE@VYLKGH>>,]#BNCHH YS1/"PTO7[_6
M99H'N;R)(V6WM_)3C[S$;CDD\_XTNN^'+K4=>TC6-/O8;.YL?,5V>W\SS$<#
MY>HZ8/\ WT3]>BHH XZ/P3=1W?BB<:M'_P 3U"FW[+_J1A@/X_FPK$=N>?:J
MD?P\NK%-(GTK7FL]1L+8VK7'V82++&22!L+8&"Q[FN\HH XC6?!>KZKH^GVT
MFNK<7MM?B]>XGA(#$< *H.% '8=?:K?B#PKJ=_K=MKFC:R-.U&*#[-(3#O26
M/=G!!..,D]#SCZUUE% '(ZCX1U._T_37;7F;6-/N3<1WKP *Q(Y0H" %/ [\
M58TKP_JL>JS:SJ^HVT^I-:_98?(MRL<*[BW=LMDX/;TKIJ* .)\/>$=:T'P=
M?Z1#JUNEY-(TEO<1Q'$9.,YSUZ>G'O78VJ2Q6D,<\OG3*BK))MV[V Y..V34
MM% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 <YX@U>Z&KV'A[391!>WRO(USM#?9XEZL%_O'H,\9JUJ'BC1M'F:WOK
M\))$JF3]VS; >A8J"%S[XK#N4:V^,-A-*[&.[TJ2*$8X#*X9A^7-<LS:+8Z]
MXHTCQ8U[%_:%T)[?RS(%N$[!53@G.!SU_"@#N-;UJ?1-2TW4/M*S:1?21VKQ
M\8C9LE)5;N#T(/L1735P7C &7X=:?:164EO)<3VL%O:D[F7#@JI/^ZO>N]H
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MBJ#($;VUL[?544#_ -"- '<T4R*:.>)989$DC895T8$'Z$4^@ HHHH ****
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MD,,5O$L4,:1QH,*B* %'L!5&;0-(N+R:\FTVV>YFC,4DK1C<Z$8()^G%:-%
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M=-0V)F\_RC(_^LZ;LYR/SJRGAG1X]4MM22R5;JUB\F%U=@$3G@+G'<]JUJ*
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M)($D,@=<CW'% $]%%% !1110 445 E[:27DMI'<PM<Q -)"L@+H#T)7J.HH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA>I=AT+)SD%L#' R !]#75#2-3A\:V6M7!LTL;?2C;3OYA!5L[B1D=,CJ>U
M&3#XWUEO"5[--:VJ:];ZBM@+<JP0LS +QG)X)/![9KNKF2XAT^:6&$3W*1,R
M1 [1(X'"Y/3)XKA+'2M/U7XK7NI6-V)K6WMXIYTA<&-KD[E0G!P2%W'IP3[\
M]MK-K/?:)?VEM((YY[>2.-VSA6*D \?6@#E[#QA?OK^BZ5?06@GU&&1I8X6)
M:VD1=VQCDC..O<>E8(^(OB9]&N];71].&G6%W]GN%,[%R<JN%X]77GZ\5/IO
MA;Q;;WWA>XEATB--(#1,D;MN977:[GCEB.>O4Y]:CB\%>(D^'VLZ(T5F;N^U
M'[2I$QVA,HQ[>J?K0!U%YKU_>^)+O0](ALF^QP+)=2W3L1E\X0*H],')]<8K
M+^#_ /R3^W_Z[R_^A5+=:'XAT_Q3-KFBQ6$IU&!([V"X=E".HQN5AU%7?A]X
M?U#PSX8_LW4G@:59W=/))(VG'4GOG/X8H S]+U+5M0^)OB#3)IH9-+MH8D:!
MU)&&7/ SC)R0<]>*Y7PCXDU/PYX'2\ATZP;3(K]H9F,K)(=S@;NF.^/PKLH-
M UO3?B!JFL6BV<MEJ4:!S*[*T;(F , <Y('/H:YL>!O$0^&MSX>\FT^US7_G
M;O/^79P<YQUR ,4 :GB#XC-876II8?8V33W6-A.)2T\A!)5-JX&/4^A[<UV^
ME7ZZII-I?HCQK<1+($=2I7(Z8-<:FA^+-!UV^ET'^SI['4&6:07C,##+MP2-
MO4=#] ![UV=E#=6VG1QW$_VJZ53OD(V!VZ].P[4 >0>'9K:W\3>-8W\-RZRI
MU$CR8X4D5%$DO4-T[?E[5UL>I2:+\/SKGAO0+>!)'>ZN+)F(V#.&(P!R-HXX
MP!Q6?H>B>,M U?6]0MM*TR1M4N3.RR7C?(-S,%X7G&X\UJ2:=XPU#2;RVO3:
MQ_VA=+'+'#+Q;VI $FPD<LWS=?K0!<T7Q9/?Z7>:[=PP0:)#&6BE&[S), 9.
M#VSN'OBL;3/B6][K&DP20V;6VHL5VP2,TMN3]P/D8/8''OZ4_2_!6H:8NM^'
ME6)O#=^&,#F8F2!BO<=QD#\OK5SPS8^-+&VT_2K\:;%86:A&N(F+221J,*H7
M&!VY]!ZT +;>*]?U/3X-8TO1(;C39KGRDC$I\YH@Q4R= !R#P>E65\3:E++X
MI@2TMO.T?:80SG$JE2_S>AP/SK.\/Z+XP\.VJ:#;MI\FFQS'R[YV/FI&3D_)
MT+<GVR:2^T/Q5!X@\12Z7#ILEGK"(-]Q*P:,K%LZ ?7]* (+OQ;K-Y?>"Q8^
M1#_:J/--$V=K$*,*3UQR?QQ6S:7^?'^MV4.DVT=VEE%*+HG#7'' )QPH/'_
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MC\*]<U.\;3]*N[U(3,UO"THC#!=VT9QD].E>5?\ "(>)?^%4Q:"=(/V^._\
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M(MO$JQX82A07YSR!D?GVQSC^*?%5[IOBJ#18KZRTV*>R,T=W=Q%E:;<P"9R
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M9F.  .I)J.TO+:_M8[JTGCG@D&4DC;*L/8UQ^@ZCK5YK_BV*[^SW5I;3&.&
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M0LM,N[P6^H)<RFW3=M5<\8SG)S]..M=Y10!YIK-AJ.D>.;W55\+G7+'4HHE
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MSQ#XHO-5\66]EJ-I:0:+'YJ'[-N=QM+!>21T4@G'>M#3/!&MZ3*]A9>)7@T
M2%TM5MU,NUCEEWD97OR*>O@S5$U3Q5<)J-J(M;A,:KY+%HS@A<\^C'/Y\=*
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ME7,$=Q872W BN,^7)C'7'ICT[]J ,*7XAWB>&?$%U']DFNM,O%MTEC1MC(S
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MY!)(PD/F<,0 I'  QSSS65!X<\2Q:=XKMBFF;M8DD>%A.^$WC:0WR_W>1[T
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MR,@.!'C)()ZYZ#O6//I/BH6_BKP];Z%'-;:C>3745ZUR$4"0@@8(Y/ ].<T
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJD_Q6T2S&KGRQI(G;RE!CE.Y@QVGCYL=1R!C% 'HM%>7Z]XM\0:%+=:C=7T
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M#*5/EAN<@+T7G'/3]0#TNBN:A\37%]J>@065G&]OJ-JUW/(9"3"@"XQQS\S
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MU>7Y7G;1OV9SMSZ9YQ4]% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU#K'AN_;Q /$&B7L,&H_9_L[Q749>&5<Y&<$%2.>>:Z>J&LZQ::%IKW]Z9!
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M..6_+DYKTNB@#C_#WA_6=%USQ%?2?894U*7SH0)7!5AG:&^7I\W)]N]96D>
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M23DDGN: .#D\.:K/XGL]3M=#DTJ]6_S=74%U&()[<$\L@?<6(QQCUS7I5%%
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MR8V$1D^Z&QQG /&: /+/#&J3>'OAMI-_)#83S32_9M.#1,K([R,&WMSD<9X
MX&*Z=-?\0:5XHT_2-933YX]1B?R)K2-T"2J,E6W$Y'O5&'P)J;_#^VT&XN+)
M;[3[@3V4\9=DW!BPW @?WF'0\5I1Z/K^JZ]I^I:R+&!-,$GDPV\C-YTC#;O)
M(&U<=N30!5\&>)?$GB=HKV:UTZ+2Q)+%-Y9?S0R_=QDXQR!^!/'2MSQ%?ZM:
M3V$&F"SB2=V\^\O,F.$ # P&!+,3@<]JI^ _#M_X8T2;3[][:0FX:9'@=CPV
M,@Y4>E1^*/#VLZEK^DZIIDU@ZV(<BVOU8QASC#C:,D_RP,=30!S-UXOUW6?"
M6BWUE-#9WDFLI93[5(1SN^7N3M/&1G/45T N]?/Q*6R-];"PATU)YHO+;#98
M@D<_>R#@]AQ@UC67@/7[+PX-.$^GO-:ZO'J%LV7"R8ZAO3\/0^QK>;1_$ \:
MV6L*;$P2V M;] S84ABWR<9/+<?3F@#)3Q?XHU#2+KQ'I5II<NCPO)MMW\S[
M1(B-@G(^4''-377C36KS7['3="L;)Q?:4M_$UT[ J6R1G'TQCWZBHK+PUXGT
M72KOPW8+I\FF7+2^5>/(RO;H^>"F#N/I@]^M6+3PIJFF^/-)O;=(9=+L=*2P
M\UY<.0N>=H'7]/>@"K<^,_%4U_K.GV.E:9%<:2@EF>:=G4J5W8  &3BI]0^(
M,WV/1HK"WACO]3M/M69UDDCA7W$:EFR<CCTYI8_#FNQ^(_%]\+>U,6IVPCMB
M9L;B%VC/''&?Q_.J$/A?Q;IEKH.IZ;]D_M2QLC8W%I+)^[DCW$KR.O8GGJ!0
M!->>.]?C\$2:U%H\4=S:W'E723K(%*\?.@(!P<]^GO6Y=>)KQ-8E^R0P7.FV
M^DF_F*9,A8Y**I'!R!T_6IXC.NAW$?B^^T^-KU64Q(0D<:%0"H+'YCU)/OZ5
MA_#_ $:^LOA_-*A_XF5[$Y@:?Y@%"E80>ORXP<?[72@#5\+:[?\ B*-;B<:;
M/IT]L&S;.Q:*3/S1N&]B/3H?45H>%O#T7AG1S8QLC;II)FV*54%CG"@DD #
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MBTU29IEB-NI$+,P9CG.6Z =0/:IF\#SR7_ARYEUC>NBP^4(_LH'G<8)SNXR
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/=;\/WNISZA!!;QSQR3A0RDXR!@=/F_2H?'T3S>+O!\'VV[@CFN90?L[A2K
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M[-'>PQ !X^F&3/I[^])??#^:ZTVP1-?NAJ-I>&\^VS()"\AQU7(P %4#GC%
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MU7PQKLMIX;U'36MXM7TB,1-!*Y,4BE0K?,![?K[5=GA\5WFD3_VEINCW9:9
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M"N<."J$CTQZ9[U-:ZKXCT7QEHUEJ>KC4(M1LY9IHO)5%C*1LP"$<]5ZGWXH
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MBJTTG4M8>VTG[#INHO:S(/,,DBB14^7L",]3U]!0!Z5)(D4;22,$1069F.
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M;S&12N2"#D#!XKJJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZE8Z@NIWVGW5HK(LEHX4E6ZCGH??_P"MBE9> Y-)MY(]*\0ZE;DW7VE?,V2
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M P,J2I/L#MS^-<;>^+=<NO"%]XK@N_LEM]H$>G6D<2/Y@#["9"02<G/ QC%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5J:=IUII-C%96,"06\2A511^I]3[U:HH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ ILJ>
M;$\99EW*5W*<$9[@]C3J* .=E\%Z7-X6A\/N]S]DB?S%<2?O-VXMG=CKDFDU
M'P;9WFI2ZA:WVH:9<S[?/:PG\L38SC<,')YZ]:Z.B@#$U'PM8:GI%MILTMV(
M;>99U<3$NS@DY9CG/))Y_I4NH>'K/4M9TO5)WE^T::7,(5@%;< #NXYZ5K44
M 9TNAV$NO0:T\ -]!$T*2?[)_KUY]S65=^"K:YUJ^U:+5-3M+J\C6.1K:94P
M%QC'RY["NFHH R-#\.67A^TN(+1YW:XD,DLTTFZ1CC'+>W:H;3PM:67A>?0(
M[FZ-O,)0TK./,_>$D\X]SVK=HH YT^$PECIMI;:UJMK'80^2ODS*/-7&/G&W
M!..X Q3KOP?IMS;Z-;QM/;1:1,LMNL+  E>F[(.?KUZ^M=!10!@7/A2"]U1K
MN]U"_N8#,LZV4LH,".OW2!C.!UQG&>M+#X5M?MYN[Z[N]2VO(\,5XRND._[P
M48'&.,'.!6]10!@R>$M.%W>W=D9+"YNK=;<RV@5#&H).5XX)SR?856E\$65Q
M8W$-Q>WLMW/-%.U\S()@\?"$$* ,#CIW/K73T4 8ECX;AL%A\N_OFD6X:YGD
M,H#7+D8_>8 ! XP!@<"I-(\/P:-?ZI>17-S-)J,_GR"9@0AYX7 '&#CG/ %:
M]% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
D4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>a123121ex-1021017.jpg
<TEXT>
begin 644 a123121ex-1021017.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#WZBBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>XN[G[/]E63(B(8J6=PIPHQG..]9&OZ^^O>!O%EM=Z>MK<:?F&1!,)58C!#
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M;!&&##N !^7O5'6/!6J7GA36;.*6U?4M7NA<7#EF5$"L"JKQS@*!DX[UWU%
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M1M4_X2/Q]+8:M-8_8@MR%CB1_,81L>=P/&%QQZ^W/?>$M4EUGPEIFHW',TT
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ&,<]NXZ]Z -VBL/2/$1U37M7TLV,D!TYU0RLX82;AD$ =.,'\:W* "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MGZ99VCN-K-;P+&6'H2!0!Y39:KH]O\(-&@N8+6]D>\6)XGFVK&YD=E:7'.,
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M &34;>31V3[)+/$@0%?]9ND(4[@<=>=IZUU/PXT2/1/"R*%MA+<2-,Y@D$H
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M"6\I&^!FY&T^G4\8'MD@UD7.C7_C#5_$%R^HV-G<VU^T*?:W826Z(!M*$,
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M35(;G]Y;#_CY:?S3V&"02WTQ]*N^&;BW7Q1X^M998Q++*2L3$9=0KYP.XYH
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M? S0!Z?<ZC8V3JEU>6\#,,J)954GZ9-<]XS\1W_ATZ1+:1VTD%W>I;2B4,6
M;/*X..QZU@:#IVGZWXN\6P>(K2"ZNX[D"%;E0Q2W^;84ST&/3N>:YN9F/P^\
M+Q^:\D47B 1P.W.8PSA>>XH ]FFO;6WFCAFN88Y9#A$>0 M] >M3UY#/INE^
M(]?\51:SJMK9W$=V8P;B&,NL(4;"C,<KT/3^M>F:/%!+X=M(4NVO;<VXC%P>
M#*N,;N/4=Z +KW5O')'&\\2O(<(K. 6/L.].$L9D>,2(70 LH894'ID=NE>$
MZ1X:T.X^%6KZS<P!=0@EE$-P&;((*[1@'').,X[UU>B_-\3E%]&GF7'AV)KK
MS!C<WRAMPZ'TY]* /2HYXIHEEBE1XVZ.K @_C2B6-AE74C)'![CK7AMS%:O\
M'M($>T_\3HJ^UNA+2<>WR[>E;OBWPEH5CXE\(Z9:V BM;NYF$RK*^6&$XR3W
MS0!ZN&#="#]*9'/#*6$<J.4.U@K [3Z'WY%>-:Y:Q>%;GQA9>'I)H;46%L\L
M<>X^2[2!2 QY^XQ/7N?2MS6]%T[1I?"&I>&;.**XDNXH%>/"^="R$G?@C<<#
M.30!Z9N4G&X9],T;E!QD9],UY'8VQ\/^);)M6TFTOK>\U%GLM:M7_>&5RV%D
M.<D<G(/''?%9>FZ3<>)?#\VN7FK:98W=M>M<W-R]L3<PNIX4MO\ N],+C]:
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MK>Z4[L>7S@8&",#M0!Z5;W4%VC/;S)*JN48HV0&!P1]14M>.:%$]A\&-5O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *J:I;37NE7=K!(D<LT31J\BEE7(QD@$5;ILDB0Q/)(P1$!9F8
MX  ZDT 87@W0KOPUX=BTFZNXKD0.WE/'&4PA.<').3DMS]*WZY:V\>Z5<3Q;
MK;4(+.=UCM[Z>V98)F;H%;_$"IKGQQHEKK$VE.]R;R&1(W1+9V +XV\@8QR.
M?>@#HZKWT,]Q83PVMRUK.Z%8YU4,8V['!X-<)X\\6PR>&M4BTJ?4HY[5PAN[
M6%A$'# %#)C'<_B.M='-XFL=)BAM;I[NZN8[59IC#;M*RKC[[[1@9P?UH D\
M.:'=Z2MQ<:EJ;ZCJ-SM\V=D"#:H(50HX &6/XUN5S=WX[\/6=EI]W+>,8M0!
M-MY<3,7QC(P!P<D#'J:UM+U>SUC2H]2M)&-K("0SJ4/!(.0?H: +U%<POC[0
M6C2;S+I;1Y?*6[:UD$!.<??(QCWIVK>/O#NB7TMG>WK+/%&LC*D3/PV,<@8[
M@_C0!TM%4[_5;+3-*DU.\F$5I&@=I&!X!Z<=<G(&/>J>E>)M-UB[>TMVGCN5
MB$_E3PM$S1G@. PY'O0!L5RWB;0=8U77M#OM.N;.&+3I&E<3AB6)&,  =,9'
M4=:TM;\3Z/X<\C^U;P6_GDB,E&8''7H#ZBJVG^-="U&*^>.Z>(V,?FW$<\31
MNB8SNVD9Q0!T SCGK17,V_C_ ,-W4$\\6H?N8(UD=S$X&&;: ,CDY&,"@^)+
M+Q#HNJQZ3J$MI>6T)9FEA,;P\9#%7'3B@#IJ0*H8L% 8]3CDUY[8ZH9O OAF
M[U+Q+/IT\TREIB-QN"&/R,?0^IXKJ;_Q;H6FZ@^GW6H(EXB;S J,SXQGH <G
M'./3GI0!L)&B%BB*I<[FP,9/J?R%-$$(G:<11B9AM,FT;B/3/I7.)\0O"TC6
MH358V%RP16"-M5CG 8XPIXZ'^53?:(#X[,7]OOYPL^=*Q\O7/F9]?;K^% &R
M+&S$2Q"U@$:-O5/+&%;U ]:XV[\,>)HM;U&XL)]#NK6]F\W.I6[/)"2 ,+CJ
M  , G'M6K%\0?"D]U%;1:U;M+*P1  W))P!G&.M7-2\6:'I-X]G>WZQW$<?F
MN@C=RB?WCM!P/K0!-H&D+HFD1V8='DW-)+(D80.[,68A1P!DX ] *NFTMRTK
M&WB+2C;(2@RX]#ZUF:CXMT#26@%]JEO"9XO.BR2=Z>HQZ]O7M2:7XMT+6KXV
M6G:C'<7 C\THJL/DXYY'^T/SH V5540(BA548  P *C2V@CF>9(8UE?[SJ@#
M-]3WJOIFKV&L0R36%P)DCD,3D*1M<=000*RK;4HQXIU<2>((9+>VMU=[':H^
MRX'S.S_AGVS]* -I[&SDG$\EI TP(/F-&"V1TYZT^>UM[I0MQ!%,H.0)$# '
M\:Q+;QQX9O+NWM;?6;62>X.(D5CR?0^A]CUH?4E7QF]N==MUBCL]TFF[ 7#
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MZ/ID4\5CIMK;I.NV58XPH<<\'UZFM*LQ?$>B/J L%U:R:\+;! )U+EO3&>M
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M"R$!M@56P>G!KT&B@#Q1]5?3OAA?>$+W3[U-7@W1[%@9U<&3?NW#C&#5N_\
ML6F^,;RZ\0Z3J$FG:M9P-#) 90R;8U5HW5&'?J.<<>IKV"B@#R._FMM/UOP0
M8M)GTVQ@DGD-L8V=HD9L(S=2">21DXKT[5[:6YT*_M;7"SRVTD<1!QABI Y[
M<FKU% 'D<&HV\_PK'A5[6Z.LE?L@M&MVR)?,R#G&  <'.>U:GAT^1\3KFRNP
MKM#I4-HDIBP)G0*S9. ">OX >E>D44 <[X[FEM_!6I2P6<=Y(J+B"6+S%8;U
MR2O? R?PKDO#6J6]U\3(ITFU"X6?2/LXN;JV,?F2K)N.   HPI].0:]/HH X
M+XE745G<>%IK@)Y$>K1R.=A9P .<8'3U'TK(UN[LM7N_$VNZ<C&QCT&6RDN3
M$RB69F! &1DX P3VKJ?&'AO4]=O=&N=.NK6!M.N/M $ZL0S C'3MP:ZK:NTK
MM&T]1CB@#R:Z:.;X1^'+N*VENX;*XMY+M("5<(F[<,C!'4<CUS5B*^\,7FE^
M(+S0;&[^?2IA<:A</*1G;A8\R$Y)QVZ8KU$* NT  >@%($14V!5"^@'% 'CC
M:MI\/PQ\&F2X3]UJ<)<8R0$=B_Y C\ZW3J%D/C?+(9X]L6D%7)[$'<?_ !WG
MZ5Z+Y4>T+Y:;1R!M&!2[$WE]B[CP3CF@#Q:74]+D^"^JI#)$)FU!E^[@NQG#
MCZ_)W]L5T,FK:?=?&JPG@NHGB_L<@L#P3\[_ /H)!^E>C^3%LV>6FW.<;1BE
M\N/<&V+N'0XYH \&O+O3Y?@_=&U:)7.L-@!=K<L67_QW'X#VKI/%7B.T?5O%
M&GNL-LSZ6%@ECA+27FY,CYN1M&<?CUKU3R8MNWRDVYSC:,9I?+CW;MBYQC..
MU 'CVCZEI5_JWP_AGNHI6CLI8I%?GYRH55.1W((K?\=6]SX:U73?%6C6J/)&
MOV":W4;0Z-]SH.QP/RKT'R8@5/EI\O3Y1Q7.2:#K%[XE%UJ&KQRZ/!.L]M8I
M %(=1\NYNIP>>IY Z4 :F@:8-'T.ULL[I$3=*^.7D/+,?J2:X6VNK9/BIXO+
M31!1IJ[LL,?*B;OR[UZ93/*CW%MBY/!..M 'B.F7&GVWPR\+2R-"DB:ZC2/M
MY&)&)R?]W;^&*[&\PWQMLRN#NT4G([_.]=K?6@FT^:*&*W,NTF$2QAD$@Y4D
M>QP?PKG= \/ZQ_PD)U[Q"]@UZMF+2-+16PH#LQ;)[\XXH \JAUG38_A9;Z+-
M<(NH0ZB))()(F;8H?DD8Z>V:[?[/H]S\6O$#Z@+22*'3$+QRQAO[I9OJ ![\
MUZ(EE:1O(Z6L*O*<R,L8!<^I]:1K"S:>2=K2 S2)Y;R&,;F7T)QDCVH \9T;
M4;73M&\!W^HJ'TJ!KJ.60Y*0S%R5) [XS_.M[Q#J'AJY\-:CJ.BJOE/J%I+=
MW*QL$D82#.,]< <@#O[UZ.FFV,=H;1+*W6V.<PK$H0YZ_+C%*;"S-G]C-I ;
M7&/),8V8_P!WI0!Q&J7^E7_Q)\)7$-S:S*\%R4=6!SD83GZAL?C67X8N-+MO
M"_B;3O$$MJMZEU<-=)-A68,!A@."03T(]L5Z3_9MAYT,WV*V\V%0L3^4NZ,#
MH%..!]*2;2].N;E;F>PM99UQB5X59ACIR1F@#R30[,R>*_!5IK$44K?V3)F*
M90PP?,* @YYQBNN^'5PAF\3V<(A6"WUB<QK'QA2QQQT XXQ77OIUE+=I=R6=
MN]RF-LS1*77'HV,BEM;"SL0XM+2"WWG+^5&$W'U..M '&WTMC%\9-,"M"ES)
MIT@DZ!F.?E!]3@'\!7 I:V+_  J\67I@MVO%U4JDQ4%POF18 /7'+?K7MSZ9
MI\EX+Q[&V:Z&")FB4OQP/FQFHUT72EMVMUTRR$#L&:,0+M8CH2,8S0!4N)[V
M?P:]Q9L)+Z2PWQM_><ID'CW]*XCPI>>#+OP_X6AFDMVU2WE011QC$HG[E@.<
M9Y)/'2O38HHX8DBB18XT 5448"@= !V%5XM+T^&Z-U%86L=P<YE2%0YSUYQF
M@#RRW\@VGQ17]WMW,0.,9Q)C]?UJI=VVGZ9X(\'7QLH%L)IX#JDRQY+JISA\
M?>&2W'/(KUDZ%I#+<@Z99D7)S./)7]Y_O<<U+'I6GPV'V".QMEM/^> B78?J
M,8H \Z\4#PO=>&_$UUX?$,UT]G%]H>UR8@H<8''RAL#H.<#ZU0GU/2[[7?AR
M+.[M9IX$$=QY3J60[(P%;'3G=P?>O58-,L+:"2"WL;:*&4$21QQ*JOD8Y &#
MQ5>T\/Z-8K&+72[.+RF+H5A7*L>I!QP: /(TL--FT#XC7#6UL\D5_+Y,A124
M&\[=I[#/I5]8+.POOAE<VD4,$\\7[^2,!6DS&@.XCKDLPY]37I2>&M$2WN[=
M-*M%AO"&N$$0 D(.1D>QYI5\-:(OV/;I5H/L1S;?NA^Z.<_+Z<\T >?6*G0=
M;LFDM[36='O-5=K2\4'[3;SOG((QEL8/\^P%%E=:1IOAGQ])=11DKJ=U&\<1
M"R&-BJJN<9"[CC/0<UZ!!X9T2UOC>P:5:1W.\R>8L0SN/4_6GCP_HXGNYQIE
MKYMXI6Y?RAF4'J&]<T >;Z2UO'\1M)B(LX;>70-CPP/E,;GPK'^(XQS@?2N=
MT_3;&U^'WAO5%BC_ +0EUE$6XB/SJ-S?*QZ]NGTKV)/"'AR,Q%-$L5,0(0B%
M01GK1_PB/A[[&+/^Q[/[.)/-$?EC ?&,_7% '%VR^'M2UWQ=9^)I;9;MK@HC
M7+!72W" J8RW0#DY'J":H36MK>>.'TF74;>#3ETF*/33>QB=948*2PW$8;KR
M,'CVKTF\\-Z+J-VEW>:7:7%P@ 622(,0!T%.U'P_H^K^7_:&FVMR8QA#)&"5
M'H/:@#SQM!=="\.Q:#JEEK3V+W316]XF$NDW .%!)&4/ _WLBNU\$WMGJ'A.
MSN;"P%A"Y?-LIR$<.0P'MNS5VZ\.:->PV\5SIEK)'; B%#& (P<9P!TS@5;L
MK&UTZT2ULK>."WCSMCC7"C)R>* . TZTAD^*_BVU=289M/02+N/.Y5S].IZ5
MRD6FV6F^"_!FK6<:IJ$^IQB2Y!^<@E\KGT]J]?'AW1Q>W%X-.@^TW*LDTNWY
MG5NH)]#4#>$?#[6L-JVD6A@A=GCC,?RHQQD@=LX% &AJ>GP:KIES87*AH;B,
MQL" >O?GN.M>)"26+0]/@CTT37OA"\>2]9^\7F9 7GG/)([;?S]WJH=,L2+L
M&TA(O/\ CYR@_>\;?F]>.* /.->@AN/AYXH\1  '6'26(D8/DJR+'GGJ0-W_
M  *KEKHUAH7C[PO'I\<<;S6$PN'CX\[:BX9AGGG)_P#U5VNHZ%INJZ.=)O+5
M7L<*HB!*@!<8P1@C&*@;PMHSZA97QLE^TV4?E6[AV&Q.F,9P?QH \C%Q+I_@
MGQ##;LZ6[>(?L\S!V&R'C.3GIP!SZUVFI^'_  YIEGK=[I$T<4TVC7$?V6W<
M>65"Y+X'?E1GWKI[#PGH>FV5Y9VVGQBVO'+SQ.2ZN3[,3C\*AL/!?A[2["\L
MK/3DBAO$,<^'8LZGJ-Q.0.>QH \QAL+:QT'X?:C:Q>5>3W\22S*QW.I;D'VX
MKU3Q9;F[\*ZC:K=QVKSQ>4DLK[%#,0%!/;)('XU5D\">'9-/L+!K)S;6#M);
MI]HD&QF.2?O<\^N<5KZII=GK6FS:?J$(FM9@ Z$D9P01R.1R!0!Y3*T-MX8\
M2Z5>:*VE:O'IL<DD:/NBF5'($JD=#N/\O2M5#;FZ^&UQ<.!/):X:0N0SG[."
M@)SDY<].Y..]=E8^$M$T]+E8K/S/M48BF:XD:9F0=%RY)Q[56L/ 7AG3)[>>
MUTM%EMY/-BD>1W96QCJ2>/;IGGK0!Q6@Z9I/BKP;<ZMK]VUKJ*7DDEQ=I+MD
MA*G(7GH,=%Q^M6VT>Q\4?$?Q7;7X=4M[6"-"LK*H)7(<@$9QZ'BNK?P'X9DU
M;^TSI4?VG?YAPS!"WJ4!VY_"K!\):,=0U&_^S2?:=1B,-S)Y[Y=#C('/'0=,
M4 4OAS++-X!TIYI6E<*Z[W.20LC ?H *X_2-%MM8\3^,KF\ENF>PO5E@59V5
M0R[B,@'G[N/89QBO2='T:QT'3EL-.B:*V1BRHTC/C/7!8DU7TWPSI6D:E=W]
ME#+'<7A+3DSNP<DYR5)(S^'% 'F/AWP_<:AI.E^+#K5K:2)-YUQ='S3))\^"
MCY?:?3  S75VB>;XQ\?1[W3=:VJ[D;#+F%^0>QK4LOA_X8T_45O[?3 LZN9%
MW2NRAO4*3M^G'%3Q>#M)@O=5NXQ=++J@(N2+EQD'TYX[X],D# XH \SLI+ZZ
M\*>"=&EO46'4YKEIO.9B)=K916*D-@[L8!'.*UM0\-'0O ?BK3[G4H+I=HNH
MK2(L/LN22.K$X)'&?[IZUUR^ /#W]@6^BRVLDUG;R&6+S)FW*QZD,",?0<5(
M/ VA)H%QHL,$L-K<$&9DF;>Y'3+$Y/T/'M0!8\(6L-MX3TLPVRVYEM89)$7/
MWC&H/7GL!^%<_;1S+X[\7Q0W3J[6$)C:64XB9E;H3]T9Y]JZ[2=+M]%TN#3[
M0RF"!0J>;(7;'U/\N@[5EOX+TB75-2U"87,LNHPF"=7G;;L(Y4 =!P/IVQ0!
MRO@5TTG7HM(U;2KBPUTVK(9E??%>*#DN3G[W'7W/TK?\<3QQKI4)N;WS9;H>
M796AVF[(&=C/D;5Z9.>G8]KVD^$=/TF\BNUFO+J>"+R8'NYS)Y2=PHZ#-3:_
MX9T[Q(ML+X3![63S(9(93&R'CH1]* /+=7O]3A\%>*0;NXMI;/60L:Q7;L8U
M. 4W'!V\_G]*WI=)?PQXI\,K8ZMJ,QU(R17,=Q<-)O78OS#L,9_4>E1>-_!%
MGI/A+4_["LK^>ZOYH@T2-)/]UMQ..3V/)]?>NIT'P[I]M]GUHR:I<W*6^V+[
M>[L\*X^8*A P3@=L\"@#S?3K&YO/AIJ>O2:WJXO;.:018O&VX4KU'?K70V=A
M=^)_$,$5YK&J6ZSZ!:W4B6UP8P)&X.!VY&?K5?X?^%(=0T::#6+?5H#%>><]
MI.)(H)AG*DJPPW0Y ]LUW:^%;!/%(\0K)<B\$?E!!)^[";<;=N.G?Z\T <AH
M.G#Q1IOB&[O;J^AO8+V>WMV^UR(;944!?E! SUSD<\UBVMYJ?B?5O!<%YJ]_
M"M_93?:/LTQCWE/,YX[D* 3_ "KT"\\#Z5=W]U=++>VOVP?Z5%:W!CCF]2P'
M<]S7+>*-)0?$+PM:6\&H6]A;6S1B:QC?]T,$* P![XS['GK0!CZE<:CINF>-
M='AU._>#37MY;65YR9%+E<J7ZD<]/:M77=,NO#VAZ5.^N:K]LO=1M?.BEG+A
MF(^9,CH/O'T/3TKK)_ ^DW.BW.F2R7C)=S">YG,Y,LS#IN8]1P..G%2:IX.T
M_5M,TZPN;B]\K3RK0LDV&W*, DXY(H Y3QK(ES?Z^;?4-1DN;#31((+><Q1V
MK==S$,-Q(QQ@\ ^HJG8S'6O'_@RYNO,+OHPF)$C EQN.21C/(Y'0]ZZ[4?A_
MHNIZK=:A.]\LEVH6X2*Y9$E 7:-P'7C\*6#P#I%L^E20S7R2Z8K)!(L^&*%B
MVUCC)')&..#0!PEE!XI\7VL_B"QU&.WF%RVTG4)$2!4/W#$$QT[YYSFO8HR3
M&I)!) R1T-<E/\-]!FU"YNU:]A6YD$D]O#<%(I#U(91U!Y_,U8MO#]S#\0KK
M6E9TLWLEA"F7(=\CHO\ " %_$L: .GHHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYJS_ ,(QI?\ ;DNL^7-]NEB,+R?:'P4(QMQG&.,_7GK6ON7 .X8/3GK0&!)
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M>A/<5'_9MCM5?L5MA#E1Y2\'VXH \Y\,6MO=^)?'7E16TEY'<^9:LR!S&^)
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MAY[9K=M%L3"TGFE/(7!?&-WUQ4MWX>T:_M[>"[TRUGBMQMA22,,(QZ#/3H*
M/([69+CP;J22R6TL-KXD0KE1M1&D'*^@.6_#(KMK]+'_ (6AX9FM/)S)97 W
M1$8*!?EZ<8Y;%=-_PCNB^1=0?V7:"*Z8-.@B&)".02.](GAK1([JWN4TNT6>
MV55AD$0W1@= #VQ0!YMH5GH^H_#?Q%)JL-N=2CEN7N99E4RI*,E#V(QV&>N?
M7%5M,T^+5O&'@V/6;5+AY-'+2I.@._;OV%AWXQUKTN]\'^'M1U(:A=Z1;2W8
M.XR%?O'U8=&Z=\U;ET/3)M6AU62RB:_A78D^/F ]/\^I]: .?^'4<$&DZM!:
M[1;0ZO=)"JME50-\H'MBN=UGP]I&J?&>.VOK-)8)],\^52Q4,X8J&X([ ?E7
MH6EZ)INB),FFV<=LL\AED"9^9CW_ /K=*Y#4O#SZW\2GFU3P^;C238BU6Y:4
M85AN;=@$$9W;: .,DTR)_"]_I[H6TJ'Q0(+/Y\X0L58*<],'KZD]\UTD^A:1
M8_$G2-!_LZ!-&-G+<1V\H+1R3G(8D,2&8*HZ]!^%=G>>#_#]_IUMI]QID+6E
MJ2T,2DH$)Z]"*LZMH&E:Y9)::G91W,"$%%;(*GV(Y'X4 >5:^PT.[\26%C</
M;Z(US9B:*#B.(2?ZU5 Z9 Y K?\ $5EH.E:5KFJ>&)K:+4&TTQ-;V,BA!'O7
M=)M3HP!ZYKM;3P]I%CH[:3;V$*V#YWP$;E;/7.<Y_&HM+\*Z'HMK<VVGZ;##
M#<C$RG+;QC&#N)XZ\4 >>Z'HUA8W>E:Y9>(-/$RVC*MM;V\:/*3%D!PIY(()
M)/IUJEX=T1-4TW0]<77]+M9X;A99IA;XN9)6=LH[ELL3R,$<XXXKTS2O!_A_
M1+QKO3M*@@N#G]X,DC/7&3P.>@IEKX*\.6>K'5+?28$O"Q<2<G#$YR 3@'Z"
M@#A5L])UOPWXTU+4TM[C58IKE!)*07A6,'R@N?NCCMC-$VS[?\+)HVRS6WEL
MRMV$<?'ZFNVU+P'X8U:^DO;[28I;F3EW#NNX^IP1S4H\'>'U;3RFFHATXYM=
MKL!&<[LX!Y)/)SG/>@#S35_#^FW,/Q U":)I+BUN=T!,C8C8KDL!GJ23U].*
MT]1C:YA\ WFI1RZG8-9#S[(+YCRN80=Y4GY\'!/ICWKMV\%^'G.HDZ<,ZBVZ
M[Q*X\T[M_/S<?-SQ7)>*?"K_ -LZ:D/A<:MHMK9&&*".Z\MXG+9Y8G)&,8'U
MH U/AGX=FT/1;F6ZMV@EN;AGCC9R2D/&P$9(!ZGUYYK'US0['5OC)!97RRS6
ML^F>=)"9F"E@S#L>!\JG XR,UO> - GT2UOF>RDT^WGD4PV<EQYS1@#!)/3)
M/I61KND2ZI\6;.:[T>_FTP60MS/'E4#[F;<65A@#./7VZ4 <J;&:UM+ZR@:8
M:=I7B6 6VYR=@)*D GZJ<>^:Z>Z2,?%G6EC.P2Z"S.8F*EFRHSD<YQWZUV<O
MA;19M!?16L4_L]CDQ G[V<[LYSG/.<U4L_ 7AFP'^C:5&C&!H"X=MS(WWLG/
M4YZ]: //_#/A:._^%ZZE9SF/5[N)[<--<,$D GXCZX&=H QCK[T/<:8W@_Q=
M8_V(='U>.!'N[,9,7!^5T'0?>[=>#S7H2^"M$3PR?#ZP2C3R_F;?-;<&W;L@
MYR.:FM?"FDVT=^K0R7#:@@CNI+B5I'D0#: 23P #V_I0!P5RB#6?AA=K_P ?
M$MJ%DDS\S 1QXS_WTWYU#)' 9+;5M/\ M,GF>(XE;4;J3;+*"^UE0#'[L  <
M]>>!C%=QIGP_\-Z3<6]S;6!-Q;MNBEDE=F3V'/3V^M5Y?AGX5F6X5K!_W\GF
ML1,_RM_L\\4 <SJGANSU/7O&J7=Q>R16UO%=Q1FY;8LC)(W3." 0,#M3+:"S
M\3'X=W&H0M*TL,\4K/*VYS'$<'((.=R[OQKM8_!.BQW6I7"Q3[]2B,5R#.Y#
M+QTYXZ5'+X#T&;2]/TYX)C;Z>Y>WQ.P923D\YSB@";QRH;P+K88 C['(>?4"
MN&MX8GT;P#HSQM'IVHJ9+O9*4\YA'D*Q!R<D_P AZ5ZG/:P7-G):2QAH)$,;
M(>A4C&/RKGU\!: NB+I/V>8VZ2^;&S3L9(VX&5;.5X&.* ,G2K/_ (1SXE?V
M-IGG#2KG3?M#6[2ED@97VAEW$]< 8'K[56\9V5O=_$WP@DR%A()@V'(R%&1T
M/J:[#2?#UCH]Q<W,'GR7-SM$LUQ*TCL%& ,GL*9KGAC2_$36SZA"YDMF+121
MR%'7/49'.#0!P%WI%OK'Q+\6QW,MRB0V<,RB&=H\L(EP3@\]3^=037=W_P (
M[\.+C[9<B1[V*-R)6^=2P!#<\\#'/8GUKOU\'Z2FHZE?*MP)]2A:"X/G-@J1
MC@=C@<'M4'_"!Z)]ATVS NA#ILIFM@+ALJY(.>O8CCTYH Y36,Z/XONM2UZV
MO)=.FO(7M=2LYR5MMA4>7(@XP2 #QDY.,GIZC7/7G@O2K^6Y-PUXT5S,)YK<
M7+")W&.2H./X1^5=#0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MAC%3ZUX5O/$=V\6J:NXT?<&6RM4\LOCM(YR3SZ8_K72Q1)#$D4:A8T4*JCH
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M)/X4 >TTCHLB,C#*L,$>HK'TDZK<:E=7TM[;3:/<QQO8QI$5D0$9);/KG_\
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MP31:CM)ACA*["O"\DG^'(-3>+/#]SX@L[);.]6SNK.\2[BD:/>-R@@ C/O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBV?Q&-%L].MC9K' D<L;LTASOD'ED@<';ZG\30!W8N(&E6(31F1E+*@89(&
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M]I4O,[-%)M_A;/&>?KM]JS;EFU#PW\.[3[==^3=S^7.R3L&;D C. >,D#T'
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB:Q@MYKB:WDMYUN(98L91UZ'!X/4UMT4 <W-X1 U1-5L=4N[743$(9Y]J/\
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M7I6'!?6T.AVLD'B72;?6=/U&:ZM\.S12)(/F4_+D9)(^GUKVC^S;'_GRM_\
MOTO^%']FV/\ SY6__?I?\* /*=0\3#7?"&J6FK>)M&^VW,:QPV]ON6),.&+,
MQ!))Q]!CWH;6M(DUKP==/KFEB/2+<QW)65LEB@7Y1MY' KU;^S;'_GRM_P#O
MTO\ A1_9MC_SY6__ 'Z7_"@#SCP3=7-KIFM:3X?U#2+R9)6N+',K%F#,,[Q@
M< 8Z=S7I=MY_V6'[44-QL7S3'G;NQSC/;--BLK2"7S8;6&.3&W>D8!QZ9%3T
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^A]Z\AU[3D\*>'M?FT;6(;F6]CB6>VM851((R=N\!2=N>1GW-=#HWAW2=/\
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M2N/,N_\ 6)SG8>,G&>IKE?&-Y?+<^))K;7KP/I]M#-;P6;[5MR>&$IQABQY
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M*AU""&>&.7.$N$V.,$CD?A7$63O%\4O&<D3E)%T^)E8 ':1&N#S5:+Q=K?\
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M29N@-55EN$%PP3YL;BHZ G Y_#IQ0?!FE%-%3-SLT=@UJIE)Y!!^;UZ5T-%
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M/K-Y#J5C!HZBQEG<;;IB2&D"],X4CG)^3.><TNI:79Z5J?@Q=,NVGT^SU.:
MR/,&\MFP?+SZ *P_"NZU#PMH6JK M[I5K,MNGEP@Q@;%_NC';VI+WPMHE_HJ
M://I\/V&/!CB4;=A'<$<@\GGWH \XO?)?6?B6B[&C-BC@#!!;R\Y^N><^M+J
MBBV^&_@=K?\ =%KVVW>6=N[<K$YQUR:]&MO"N@V2SK;:1:1">'R)0D8&^/\
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M[E\V2"1%8AE8CV P1CZT?#)-4U?2[?Q!J.N7UR["2'[,[#R\!NN.Y]ZW=/\
M!R6MQ/=W>K7]_?20-;QW,SC="AZ[ !@'/.>>@JWX5\-P^%-%&F6]S-<1B1I
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MUBST_P .&]U+Q+;7\/GLOVT[44$GA..XK.TO4[&T^)GB:RN;A(Y[I;4PQO\
M\M L1W8[<9%>?)) ?@IJL;2QJ6U;:F>QW(?Y GZ T >N#QCX;+2+_;ECF,98
M><.G]?PJU!KVDW6F/J4&HVTEE&=KSK(-JGC@GUY''N*X34_L/_"TO!BHUNZ&
MSDY7&&_=L$/X\8KE)+C[.^OW*2/_ &;:^)5FN4MV&?+#-M(XZ9 _*@#VC3=;
MTS6#*-.OH+DQ8\P1MDKGIG\JOUP>A77A:#7]1UFRU2ZO9#9^9=WDDF^*) PP
MIP!\QQTQG"]L\]EI^HVFK:?#?6$ZSVTR[HY%R 1G'?GJ* *<OBC0H+\V,NJV
MJ70D$1C,@R'/1?KS4C>(='6ZN[5M1MQ/9QF6XCWC,2#&2WH!D?G7D.C)H%SX
M6;3?$6JZE'J5O=/)/IJ2 /--N.",KDDY X;WXK>\?Q0ZAJ\E_I423RZ-"6U8
M+*4$L)(S"2."2H8GVX]J /0Y=:TR#3H]0EOX$LY0#',S@*^>F/6F1>(='FTZ
M34(]3M6LXB1)-YHVJ?0GL?:N%U?Q#ITGB3P=K<DL:Z T4PC<J=L4V,#=V&.
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ML2@E\':H@P?IAACZU3TC5M(CM_ \5PEH)Q9,RW=TY5(E'RNH_A+'!'7C'OR
M=WJGBO1])MK*XGO(FBO9UAA>-@RL2<$Y'&!W-;*.LB*Z,&5AD,#D$5XAHUQ9
MP^!O##/<QM!;^)4W2287:GSG+#/R@CG%>T27$$FGO<*ZS6YC+;HVR&7'8B@"
M.+5M-GN?L\.H6DDY)'E),I;(ZC .>*;+K6E02&.;4[.-PQ0J\Z@AO3!/7D?G
M7EEEJFBM)X(N+=["RCCNYA]F20.T:L" 78\@DXSGJ3[52BTS3KGPMX]O;BSM
MY+N#4)_*F>,%TY['J.] 'LS7]FEXEFUW MTXRL)D =AZA<Y/0_E3HKNVGGE@
MBN(I)H<"6-'!9,]-P[?C7GOB=3;:7X8\:P(+EM/6)KF2)=OF0.H!8*>>_'IN
M_$='X-LF6SO-8GC*7&KW#7>UAADB/$:GZ* ?J30!MW>I6.G[/MM[;6V_.WSI
M53=CKC)YI;C4;&T@2>YO;>&&3[DDDJJK<9X)//%<)XGU#16\7ZA;W,,2WL.C
M2 W%U* FTY*K&IZN2PY] 16)HMKJ.I^&/#.J:9=V-SJ-C:2QFPN\8EB#E>/0
M@!1^7/J >J2ZKIT%K'=2W]K';R_ZN5YE"/\ 0YP:>VH6268O&N[<6I&1,9!L
M(_WLXKS2.#^V-$\,:EX<AL+>6WBGDAT>\;<L@W8<J3W!S@_[58\EU8:_=>%D
M'D:/HLMM<-'#/$DD*3AVWC#\8Z8/;.!WP >KZAXBTG3+2VNKF^A6"YD6.%U<
M$.2<<8Z@=2>U6[G4+*S"&ZO+> /PAEE5=WTR>:\LGTS1-)\-Z59PZHFIV,/B
M*'SI9$'EID$LH/0KCK@D5J^+K">VU^ZUZSM;'5;.+3O(OK!W"O'#R2R'MQ_(
MT >CTP31%]@D0OTVAAFJEA=P2:%:WD41BMVMDE2/NJ[00/P%>5V4NG;O"%Y9
MV\5K!+JTC1O+,KW$@;.6<@#&3@8Y["@#U\S1*^PR(&_NEAFAY8XR \BKGIN.
M*\KTJT\(ZWI.IR^(;JWAU@WTIN)Y)1'/$5D.P)NY "@# &*L6D>B:SK_ (HM
M?%;V@E@F%M:F[F7?'" =I0MT)^]D=SS0!Z8TL:XW2*,C(R>HH$T1!(D0@#)P
MPX%>5ZOI&D:AXW\$V !N]-DT^2-6=CF6-8V*DD8/O^-6(-,TO2/$?B_3;:&*
M&W.CQ[82<[OD8'KU[4 =SK5SJT<5FVC16DY>Y19C-)C$>?F*^I_S@UJ-+&F=
MSJN.N3C%>)R*O_"K?!$H_P!8FK*H(/0&20G^0KH=6\.:?J_Q'UQ[R-98H]*2
M1H2S?-)R W![!>GO0!Z674)O+ +UR3Q0CI(,HRL/4'->.V[7U_\ "KPO(S-=
M01WZK<VO!:XB65@$ _BP%Z'TKI? 'A\6>MZYJR6+V=G<2A;&W<[3&G)?Y <#
M)Q^7I0!V%]K-AIMW96MW<".>]D\J!,$EV_#I]35QY8XR \BJ3TW'%<#XZ@MY
M/'?@KSK:*823S(PD7.1A,?D3D>]0:/IEEXL\0>+5\06T=S/;71MH/,^]#!SM
M*\_+GKD=R: /2*R+G7[8VFKG3Y(KFZTV-C+%NP X4D*3^'/I63\-KBZN/!5K
M]JG:<QO)%'*P^_&K$*?<8KF?"]K C?$2984$BW-S&KA>0OSG;GTXH [SPQK$
MNN^'+#4KB 6\US'O,0.<#)&1['@_C6J756"E@&/0$\FO(K#2;;3-!\!:I \H
MO9[Z&*2;S6YC?<Q3&<8X _"H_P"PCXK;6-3GUNQL;NWU"7,[*_FVR(<#'[P!
M1A1V]: /8)3(L3F)%>0 [59MH)[ G!Q^5<'H7B[Q5XET?[9INB:<I29HG:>Z
M8*V/10,CJ.IKN+-MUC;MYXGS&I\X#'F<?>_'K7DWP_T#5]4\+7,ECXDN;")K
MJ5/(2%&4GCG)YYH ]0T2\O;_ $J*?4;$V-V2RR0%MV"&(R#Z'&1[&M"O./&%
ME!<^!;(VVH>=J>EM';PM;.S^;. H:/ ZYQ^&/K5)=46#X3ZIKUA.5U.\DS>R
M'=^ZD>4!U SE0H<XQ]: /5**\SCT:[T&X3Q!INI6,=L-,F86L<DC_:F$;.K
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M*>-(FU65[G1[F6.VNG12^U.QXP<A>ON: /38I!+"D@5E#J& 88(SZBG!0"2
M 3U/K7"^(M=OM+.AW=S)?)I$UJPN[BU0,8Y"%VLW' ZUU6@3BXT"QE&H+J&Z
M%<W:KM$I[MCMSV[4 :-%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 1Q6\$$:1Q0QQHG**B@!?H.W4_G4;6%F\!@
M:T@,);<8S&-I/KCUKB_&WC&]T'6K!+.,O9VKI)J;XRJQN2JJ>^>K<>@_'M;J
M]MK*QDO;F=([:-/,>4G@+ZT 8%[H>M:EXC22ZU*W.@Q2QSI9"#YV91P&;TW?
M-^E=-6!I_C;P[J>H1V%KJ2M=2KNCC>)XRXZ\;E&>*;;>.?#-Y>"T@U>!Y\N-
MN&&-@RQ)(P!COT/:@#=^SP?:/M'DQ^?MV^9M&['IGKBHCIUB8# ;*W,);?Y9
MB7;N]<8QFL_3O%FAZMJ!L+*_62ZV>8(RC+N7U4D ,/<9ID'C'P_<:JNF1:G$
MUVS%%3:P#L#@A6(P>>.#VH U6L;1YTG:U@:9  LAC!9<=,'J*1;"S2.6-+2!
M4EYD41@!_J.]8UWXZ\,6-Q<07.LVT<UL_ERH<EE;.,8 YP>N.G>I8_&/AV74
MK;3XM6MY+JY ,21DMNR,CD<#(]30!IBPMH[.6VMX8[>.4$$0HJ\D8SC&,_44
MS2M,MM&TJVTZS39;VZ!$'<^I/N3DGW-4+_QAX?TO4TTV]U2"&[<@",Y.">F2
M!A?QQ1JOB_P_H=P]OJ6J06\Z*',9R6P>G !)H TS869NOM1M(/M'7S?+&_IC
MKUZ4X6=J/.Q;0_O_ /6_(/WG^]Z_C6%JWC32]+M-)NE?[3!J=PL4+Q<@*>K]
M.@].M= LJ-")0X\LKN#=L=<T 0?V;8?9_L_V*V\C=N\OREVY]<8QFGBRM5M3
M:BVA%N?^60C&SUZ=*RQXCT[4OM%EI6I0O?\ V9IHL+D8Z!@3P1G'>L+P5XVM
M;SP]IJ:WJML-6N7= C, SD2%5X'<\?6@#8\2Z&;OPCJ>FZ3:6\<US$55 !&I
M/')P*7PGH@TG0K!+G3[2WU&*W6&9X0"6VC&2V!G.,_C5N^\2:+IEP\%[J=M!
M*BAG220 J#T)],UEZQJE];^-_#%G!<J+"^%P98PHRY2(L.?3D?E0!T$5C:07
M<UU%:PI<38\V54 9\=,GJ:;>:;8ZB8C>V<%SY+;H_.C#;#ZC/2N:\,:SJ-]X
MS\4Z==W EM[*6+[.H0+L#!N/?H*Z2_U2PTP1&^NXK?S6V1B1L%SZ =Z (_[#
MTDS7<W]FVGF7:E+A_)7,JGJ&..1]:8_A_1I(;:&32K-HK7_4(T"D1?[HQQ3U
MUO2WTO\ M-=0MC8X)^T>8-G'7G\*+#6]+U2VEN;'4+:X@B.))(Y 0G&>3VXH
M 8_AW19+:2V?2;)H)'\QXS NUF]2,=>3^=7XX8HH5ACC1(E&T(J@*!Z8K/T[
MQ'HVK/(FGZG:W+1+O<1R [5]3[5 WB[PZN=VM6(Q'YA_?+]W.,T 2)X8T&-%
M1-%L%5)!(H%NO##OTZTX^'-$9+I#I-D4NV#W ,*XE8$D%N.3DD\^M6#JM@NH
MQ:>;R$7DJ>9'!O&]E]0/3@U%_;VD_P!K?V5_:-M]OZ?9_,&_IGI]* ,#7=+U
M^_N(]"LK;3H/#4D:1RR8/FH@ZHJYQT  XXS77(BQQJB*%10 J@8  [5!J-_;
MZ7IUQ?W3;8+>,R.1UP!V]ZJV'B#3=0T&/6H[F..R:,2,\C@>7D X;!P",X(S
M0 ^\T/2=0O$N[S3;2XN8U"I++"K,H!)P"1[G\ZA'A?052)!H]B%B#","!1L#
M?>QQQGO5O3M5L-6MS/I]Y#=1 X+Q.& -5=3\1Z7H^H6-E?7213WK%8@QP. 3
MDD]!G ^I% #V\/Z.R6R'3+3;:@K;CRA^Z!Z[?3/M27'AW1KO3X;"?2[22TA_
MU4)B&U/]T=NO:LJTU^Z'C;6M-OY[:*PM889("?E(WCG<3WR#71-=VR6XN'N(
ME@.")"X"G/3GI0!1E\.:+-I/]E/IEK]@W;Q;K&%4-G.<#O4;^%="DN!.VEV^
M\0B# 7"F,# 4J.",>HK5BFBGB66&1)(VZ.C @_B*YJ'Q!>1^.=1TJ^>RBT^"
MTCN(I.5;YFQ\Q)QUS^E '2B&-81"L:B(+L" < 8QC'I6"O@7PL@PNAV:_O1-
MPF#N'3\/;I[5N?:8/L_VCSX_(QGS-XVX]<]*2.\MI8#/'<PO"#@R*X*C\: ,
MF?P=X=N=5_M.;1[5[S=N,A3[S>I'0GGJ1FGZKX3T'7+J.ZU+2[>XG08$C @D
M>AQU'L:U$N8))WA2>-I4^\BN"R_4=J1;RV>X-NMQ"9UZQAQN'X=: *$OAO2)
MM1L[][)/M-D@2V=691$HZ  '&.?2H=2\(>']8U%;_4-+@N+D +O?/('3(S@_
MC6/J?B76;CQ5=Z'X?_LGS;2!'D%^S@R.V3M7:>RX/-:$?B"XT?0+K4?%3V-N
M89V0&R9G5AQM'/.[.>/Y4 3R^#O#\VG6VGMID0M+9S)%$K,H5O[W!Y/N:G7P
MWI":O/JJV:B^GC\J68.V77 &",XZ ?E6HK*Z!E8,K#((.01437=LEPMNUQ$)
MVY$9<;C^'6@#@?%7A4V\&D66D^&H]1T>WEEFGM%N-C;BN!AF.<<DX'<58\#>
M&Y=*U":[319M%MFB*FVDOO/\UR00V.BX QZ\^U:_B/7[VRU;3-%TI+5M0OQ(
MRO=$^6BHN>0I!Y/'Y]<8K1LKV]M= %YX@%K;7$2,]QY#$QJ 3R"?;% #]4T+
M3-9>W?4+19GMF+0MN*E"<9P01Z#\JIWO@[0[_4/MTMH4N2 'D@E>(R = VTC
M/_UA6;KGC&2RC\-76G10SV>L7,<3/(2&57Q@@#OR<YZ8Z>G7T 0VMK!96L5K
M:Q)%!$H1(T& H'85EGPGHYU"^O?LS"6^0I< 2L%<$8)V@XR1WZUM5S_C/7[O
MPSX=EU:UM(KD0NHE220IA6.W(P#DY*_K0 'P7H9T[3K VKFVTZ7SK=#,WRMG
M.3SSS4-[\/\ PQJ.KMJEUIB27+G<^78*[>I7.":A75O%_P!GM+H:+IL\$VQF
M$%VY=$;'.&09(!Z ]JZR@".6%)K=X&W!'4H=C%2 1C@CD?A7*0?#7P];1^7;
M_;XD)SMCOI5&?7 -=?10!@VG@[1+)=,6"U95TUWDMQYC'#OU8\_,?K2P^$-%
M@FU21;9F75"3=Q/(Q20DY)VYP#DGD5NT4 8&C^#-#T*X%Q96A\U5*QM+(TGE
MJ>H7<3M'TJ'3? ?A[2=06\M+-U=)#+&C2L8XW/\ $J$X!QP/2M;^U(;J+4$T
MR2*ZN[/=&T6[ $NW(4GMVY^OI4FES7EQIEO-J%JMK=NF98%?>$/IGO0!A7/P
M]\.7=W>7$UI*QO',D\8N'".Q.=VT'&<\U<E\(Z/*=,_<2)_9B[+;RYF7:O'!
MP>1P.M;E% &7I^@6&F:I?ZE;+(+F^8-.6D+!B.F >!UJ:VT>QL]5O-2@@"W=
MX$$\F2=VT8'TXJCX?UZ?6+K5K:YTZ2SDT^Z,'S-N$@QE2#ZXP<>XK<H Y>;X
M?>'9K^XO/LTR-</OFCCN'6.0]]R@X(/.1[FNDE@2:V>W;(C="AVG& 1CBL?5
M]=GTS7M%T]+,20ZC*\;SE\>657<!COG!_*MR@#EY? .B2:#;:,HNH[*WN!<1
MJL[$ALY[YX//YG&#6DGAVS3Q*=>\RX-X;<6Y#2DIM^G^>I-:DC,L;,J[V )"
MYQD^E4M&NKZ]TN*?4K#[!=L6WV_F!]N"0.1QR,'\: *_B'PUIOB:SCM]1C<^
M4^^*2-RKQMCJ"/\ / JI#X)T9- GT>6.:Y@N-K32SREI9&&,,6Z@C'; ]JZ*
MB@#GM+\(V^G7D5W/J.HZC/!&8X'O9@_D@]=N .3ZG)QQ5#_A76F'PI)X>:^U
M%K62?SVD:53(6SGNN,9]J["B@# 3PG:1^(Y-<6[O!=/:?9,;QM"\<CC.>,]:
MS?\ A6VCGP_;Z2]Q?,+69I[>Y,H$T+$Y.T@8QGGIUYKL:* .:'@;1WTBYL+K
M[3>-<LKS75Q,6F=ESM.[MC)QCCD^M+I_@JPLK.Z@FO-0OFN;=K5IKRX+ND3#
M!5> %_+L*Z2B@#C9?AS8S^&XM"EU?5I+2*82H7E1F7 P%&4P%'7 %:-_X2M[
MO54U6#4+ZQOQ#Y$D]JR S+QC>&4@GCL!_*MV>:*VMY)YG6.*)2[NQP%4#))_
M"G(ZR1JZ,&1@"I'0@T <G<?#S2IM(T_38[J]@CL[C[4)(W4O+-_?<LIR?ICK
M6M:^'H+3Q/>ZZMU=-/=Q+$\+,OE@+C& !G/!ZD]36Q10!2UC2[?6](NM,NMW
MD7,91BN,CW&01D'D5GIX3TQ+O1;@"3?H\316P! !!4+EACKQVQ6[10!@W7AB
M*Z\86?B(WDZ36L+0K"H78P.>O&?XC^G3O0/@*V%GKEG'J5XMKJK.YARI6)VP
M2PXR3D>O3\ZZVLOQ#K<7AW1+C5)K>>>.  LD(!;DXSR1@>IH R3X(A9_#;OJ
M-RS:$NV+Y4_>< <\<?= ^@]>:UO$6AP>)-!NM)N7>..X4#>G52"&!_,"M)'$
MD:N,X8 C-.H Y9/!:KJVA:E)JMU)<:5$T6YE7]\"".>.!R?P_.JO_" ;=/U^
MUCUFX3^V9S-*WE)\N22P]\@X[5T<^IF'7+33?L5RZW$3R?:57,<97'#'MG/\
MO7C0H Y>Y\*7CB,6NOW,(%BME,LD*2K*HS\V#P&^8YQ[5L:'I$&@Z)::7;%F
MBMH]@9NK'J2?J2322ZMY6OP:4+*Z<RPM,;A4_=)@@8)]?_K>M:- !135D1V=
M5=6*'# '.TXS@^G6G4 %%(2%!)( '))I0<C(Z4 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %5M0O[?2]/N+Z[?9;P(9)&P3@#V%6
M:",CF@#S#2/#%_XL\-7>H-XB=+?6V>>:V%JC@-G:JEV&[Y=JCCIM./6J.F>(
M(?$/P6U.VO;IEN+&$0ROM+'&X>63ZYP!^%>N@ # &*P_%&AW6MZ7%!87HLKB
M&X2X5BFY'*G(5U[CO]0* .3\)ZU8Z[XO@O[O6M+N-233S;)!:Q2*"=X8N&D
MYQV Z$]A6%X=LC?_  A\016< FOA<S;5C4&3^'('?E<\=^E=W8>'=8GU6TO?
M$&HV=R+)C);I;6OEG>5*Y9LYP 3P.IQGI74@ = !0!Y/8CPUKVV72+_5[[7T
ML)5A6:20FW/EM]XG@#)QP3R15#PG+X6O;'1+.[N-9EU:SN$VV&YV6*0/][;C
M:%SU].:]G"@= !0% .0!F@#RBUN+?^V?B>QECQ]GQG<.HCD4C\^/K6<UY%#X
M(^'S)<(CKJ29(< @!R&_+//UKVC:O/ YZ\4;5QC:/RH \3@?P[;0ZYIGBF]U
M6&]:_EDDLXY'VW.6!5@ ,$G Y)[ UTFGO9_\+CU,2[%CBT90RS,&,>-F0Q)/
M(7KS7HYCC,@D**7 (#$<@'KS^ _*D\F+SC-Y:>:5VE]HW$>F?3DT >)6L\5O
MX,^'M_+*B6MKJC">0MQ&?-+<_@":]@U2ZLQX>O+N>8FQ-J[O+%\V8]I)*^O'
M2K L+,6Z6XM(/(0[EC\L;5.<Y Z#FIV170HRAE(P5(R"* /+O#VH3:7>V^A+
M?V>KZ;/ITKV-U$JB:WC"YVN!T!XZ]_I7,EK?_A2^A$&+S5U;YCQD'<YY_#;^
M&*]PM]/LK176VM+>$/\ ?$<87=]<#FD_LZQ^S+;_ &*W\A&W+%Y2[5/J!C&:
M /*O%6M:>VH^-K<BSM)?L<46Z5R)KM]O&W+8V@=E'.035VPO[234OABJW4+,
MEE*K 2 E2;<* ??<"/J,5Z6UI;-<&=K>(S%=AD*#=M],]<>U,73K%6A9;*W#
M0_ZHB)?W?^[QQ^% '%^#9;:3X@>-/+D+3>?"#@@K@!AQWR#D'\*M>*-9T_3?
M&F@1WD=E$^R9Q>W<A40KC#!>VX],M_6NMAM+:WEEEAMXHY)3F1T0 N?4D=>I
MI)[.UNFC:XMH9FC.4,B!BI]L].E 'BNDZEIT.B>'[R\D\[2K37+@W)12%5R"
M8F*^G.>_&1STK;\;/H4^EWFI:&L-RC7ULVKSVY,B/$,\9!V]0N0/49ZUZ<;"
MS:&6%K2 Q2MOD0QC#MZD=SP.:=%9VT%N;>&WACA.<QH@"G/7@<4 <?-?>$=2
M?4KG2Y+6>_.CR!Y83E5@&,*W\(.<<$9P*Y&TL+ _ 26]6UMS=^0Z/,$&_BX)
M )Z^GZ5ZW%I]E!!)!#9V\<,GWXTB4*W;D <TL=C:0VS6T=K D#YW1+& ISUR
M.E 'GEUKFF:GXZ\+MI5_;7$ZV5RI,;@D,8QL4^^0>#7/>'[3PW=Z%I\NJZ_=
M1:E!>;GLHQ$)S<>9VPGF,"3ZGKVQQ[%!IFGVSJ]O8VT3KDJT<2J1G@XP*5=/
MLENC=+9VXN#R91$N_P#/&: ,;QXCR>!-:5%+-]E8X SP.37%7<\4_ASX>NSP
MRZ3')!'>GAD601J%#]NN[KWQ7JKHDD;1R*K(P(96&00>Q%4DT72X]-DTY-/M
MELI,[X!&-C9]10!R-HEM'\64_L81"T;2<W8ME419\P["<?Q?K@?6K?BQK2#Q
MGX0GNS#&@GN 9)<  ^4=O)_VL8]ZZ73=(T_1[<P:=9PVL1.2L2XR?>C4=(T[
M5TB34+.&Y6)]\8E7.UO44 <;#;Z5J7Q*\1B]2UN(DT^ $R8.Q2"6.>W&.?I7
M(Z'-:G3? 4-_>K!8E;S<9 K1^9O.W(8%<\\9]:]=&AZ6+^YOA8PBZNH_*GEV
M_-(F ,'VX'Y5"?#&AG2AI9TNV-B'\P0%/E#>OUH R_ ^GZ7I=GJ-KI6IO?PB
M\9F;"[$8@$JNT!>.^.,\<8K+GTC3-7^+-['J5G!=*FE1LB3*& .\Y.#7<6MK
M;V5M';6L*0P1C"1QK@*/I5#4O#6BZQ<K<:CIEO<S*NP/(F3CTH \EMC#!:Z'
M8W%P8=#_ +;O/+E=5>(!"!%DM\NW)?\ 6K_B+2['2O WBY+36A?RS26TTT44
M82* M*,;0OR@GO@YX&:]1N]%TR^TY=/N;"WDLU(*PE!M&.F!VJN?"^AMI2Z6
M=+MOL*OY@@V?+N]<>O- '!/:6^A>*-/DT6VB@NYO#\TGE0KCS9 N5RHZG.?K
M67X?T31[O1]$UAO$$$-U%-&[I#;)]H>8L,HS [CR?R.2/3U:/0-)BO;2\2P@
M6YM(A!;RA?FCC ("CVP2/QJ.W\+Z%::B=0@TJUCO"Q8S+&-V3R30!RGAZWMI
M_BOXK,EK;DPK;E#Y8R&*Y+?4D]:X.=%C^$VNQHH5%\0LJJ.@ "<5[7%H&E0Z
MC/J$=C$EY< K+,,[G!Z@FHHO"VAPZ9<Z;%ID"65SS-"H(5SZ_7@<^U &E;QP
M16Z);)&D.,HL8 7!YXQQ7DUGINC:K\+=8U:YM8FUB+[2\]TZXE68,67![<;1
M@8KU>SL[>PM([6TA2&WB&U(T& HK'O/!7AN_U0ZE=:3!+=-RSDMACZE<[2?<
MB@#D(K==0\3^!9-5M89+R739FG$JABQ$8VELYSU)Y[DUV7C)"W@K6E6%),64
MOR-P,!3S^'7\*GN_#>D7VKVNJW-F'OK7B&4.R[?P!P?Q%:%Q;Q7=M+;3H'AF
M0QR(>C*1@C\J /)=;L[1O!_P\@2*,0SW5KYHC^7<61=Q)'<G.3UJMK+R>&]:
M\<6^B(;:%;"!EAB!VIO,:LP'8A68Y[5Z,/ GAM;&ULETW;!:3&>%5GD!20XR
MV=V3T'4]JN?\(SHYU2\U(V2M=WD1AN'9V(D0C&"I..@]* ./T#0-+M_$FAZO
M8:O81;[8PM:6B;/M&8RP+ .<D<L3_LBM3XJ,!\-]5!(!/E 9[_O4K5T?P;X>
MT"[:ZTS3(X)VR/,W,Q /4#<3@>PJWK>@:9XBLEL]5MS<6ZN) GF,GS $9^4C
M/4T <DWAPP6.DZ[?>*-2%M8B&ZEBF9?)"*O0*BCGG&>3]:PO'6FV&G>*)+ZW
M1WM+E8UUZ./GRX6D0AO52Q7M]>]=<OPP\'*P8:/G!R ;F8C\B];/_"-Z3C5
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M=SW\LL4/V<R_;%<Y3G&/0#)XX]."WURT\*>-?$2^(DEB@U$0&U?[.71D"D;
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MJM\QW&<1C=GU'H?>M2B@#'3PKH4=\;U-+MA<&7SBX7^/KNQTSFFZ?X=M]/\
M$>IZS&RB2^"*8T3:%"CDGGYF)).>/ZUM44 9FI>'M'UBXAN-1TVVNI8>$:5
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML@4G\.O:@#0HJE8ZOINIC_0+^VN3M#XAE5B >Y /%7: "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **9%-%<1++#(DD;?==&!!_$4^@ HHHH *
M*:CI(@>-E93T93D&G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[H.K:G;V%M-.);E-T#2P,BR<9(4D<G_"E\+>*SXDO-6A^QR0I9730HQ7@@
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M=C;ZDL@N[L0[UC=1\@]!DY_(T >B45PNN>*+S1K/PZTVJ6_V:]=Q=:I#!OB
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M*!YDR$H#OY.T'/X9IMK\1K^X\,V)%NC:M=7<EF&CB>0#8 6D$:Y+<$<#U]*
M/3*KWE]::=;-<WMS#;0*0&DF<(HSP.37.^#=9UO43?6VLV4J-;,ODW;6KP+<
M*V>B,,@C'ZBL/6DCUOXPZ;I6H6_F65G9-<1QR#Y9'.?FQW' 'U6@#J+7QMX8
MO9?+@URQ+[@@5I0I8GH!G&?PK>K*UOP]8:_#;)>1\VTZ3Q.N RLI!QGT/0US
M@\1>(]2TW4-8TJ/3EL[.69$M[@/YDHCX)+ X!R#@?3F@#N**X*;QW?W5WX9C
MTJULS'K<+MNG=CY3J/F'R^GZ].*B7QAXF>T\0R"QTQ3H;.)9"9-LVT$D*.Q
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M17MKJ,<&QS<B/R6C39A@>2.^1^M='IVLZ;JS3C3[V&Y-NVR7RFSM/;_]=7J
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW$=MA$+<% F?NXXZUH6OAB_.J7NK:CJD5SJ$MH;2W,=N4B@4\D[=Q)R<$\T
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MGECU QZ=<UV]LLRVL2W#J\X0"1E& 6QR0/3-<3KO@W5]?D,-Y<V#1)?&>WO
M&6Y@BW9\M<#''3.?0]10 >)_$NO:+#K=XLFG1Q6)A:WMFP\DT;,JLS8?*C)X
MXJK?7L ^,.FWV\_9_P"PFFW8/W=TASCKTINJ> =?OCXBMTU6Q%GJ\WG[I87:
M488%$SGA1@#OP.GI>MO!VJGQ-IFIWT]A+#;Z;_9\\:;P7'S9(X_VL=: ,NT\
M>>(+N73KV&P::SN[@*UJFG3;HH22 _FYV$X&?QKMO$VNQ^&_#UWJLB>9Y"C;
M'NQO8G &?J:YG0_"GBS1+5-(AUZS&DQR$H_D$SK&3G:.PSSSSC/%=5K^C1:_
MH%WI4TC1I<)MW@9*G.0?S H YJ?7O$?A]M)NM;?3KBQOIH[>7[.C1M;N_0Y9
MB&4=SQ4EAK7BK5-=O+:"VTN.TL-1\B=W9RS18!^4?WL'.?4^W+Y/#6LZO;Z7
M8Z[-826EC-'.[0!B\[(,*"&& #GGK6AX=T?4=+U/6I[V2UDCO[HW$9A+!EX"
M@$$>@'?KF@#,^(>I:A8Q:'!I]V+9[O5(8F;!.1G.#C'&<9&1D<5+K>N^(;7Q
M%:Z'IEMITL]S8M,LTS.@$BG#<#/'3 ]^O%6_&7A^ZUZRL#8-;I>65['=1M/G
M;\N<CC\*CFT;6)O&VDZTQLS;P6303H&8,';DE>.1TQG'0T 4O$7B?7]#T[5-
M0>RLD@L5AV*Y+-.6*JQ&&X4%N"1SBEU#Q9JS>+;31-(L[-Q=:>+V.2Y=AC);
M@@?3&/?KVK.UOP5KVJ2>)8A<V+0:H(FAEDW>9&$;<(_9>!^><5>LO#.L1>-M
M)UBX%IY%KI0LY?+D.=XW'@$<CD#K[^U $#>/KR+PA;:M/:6\,[ZB;*=OF>*$
M!B"YQSCC\Z=XUN]1N/AEK$[3V39P%FM')22$LHSUX)!Z9(IVD>'_ !#I?AI[
M&2WTN[:74))9K:1CY<ENX)*Y*GYMQSTZ507P+JD'@S7]+M8[6&34K@/#:B<M
M';ID<;MN2>/Y4 :=SK,VCWMAI=E9Z>-7O;?[1<SB!Q'L7A<[ 6)[ D]O<"J4
M_P 1KR+P>NJ#2U%\-0%B\4F]$+<G<,@'&!^'?I5[5M"\1?VSI.OZ4UE]N@M1
M:W5K,[>6RDY.& SU]O2J_B7PUXFU_P -1PW$]E)?B_2Y$2DI%$BJ1M#8)8Y/
M)]Z .MT:75I;)FUFWMH+KS& 2W<NNSL<GOUKESXOUF^LM4U;2+&PFTS3YI(R
MLDS>;.(^792!@ CD9S7;KN*#< &QR!ZUPUAX?\0>'K75M*TJ&QEL;N9Y+::2
M=E>WWC!W+M.['&.>U &7XJUJ?6[GP--I\=OLOYC.J3DE0X5?E;'8;B#[BO0+
M:UATC2F2TLHHQ&K2>1;(%#-U(4>YZ5QUQX,U""?P;'9""2#1.;AWD*ER=NXJ
M,'T)Z]\5W%]%+/I]S#!)Y<TD3*CYQM8@@'CWH Y>Q\5:DVM:-9ZC96L*ZK'*
MRQ1RDRV[*"X#@@?PX!_VLU@I;0+X,^(:K!&%%]=X 0=HT(_(\BI-*\+>)+";
MPZYT_2472Y'\WR[AM\V]-K.25^\<D_A5Z/P[KW]C^+[*2&T']K322VH$Q.TR
M#:=QQV 4]/6@#;\"_P#(BZ)_UZ1_RK,D\5:Y>+J5[H^EVLVG:?,\3B69A+.4
M^_L &%]!G-;OA?3[C2?#&FZ?=!!/;0+&^QLC(XX-<S;Z3XD\/'5K"PL8-2M-
M1N)9XIWN1%]G+CD.N"2,^GZ4 32^/;B[DTJ'1=(^UR:I9O<6[27 15=0<HW'
M48&>1UKI?M]Q:>'FU'4K817$-LTT\$3[P"JDD ]^E<A8^%-2T76_"4=I:1S6
M.G6LT=S,)0N))!\QP>3SR,>_2NWU 7!TVZ%HD;W)A?R5D^ZSX.T'VSC- '/:
M;XJOM3TG^TX=+A>V>P>YC,-UYA$B_P#+)OE&&/MGH:BB\:7!\-Z!J[::KKJ<
MT<$H6;;Y+.VT$ @[AG/%9WA[PO<V^OS7\&C'1+>XL&CN+;[0KH\S$8*JI(
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M"^HG1RD=M'/]KQ<(1"9% QG@L1MYP.]<AK&@>--3L+VVN-&6XN1J0NEN_MB
M2QJ2%C12?E4!B1DCC/>@#>EC6+XZ0L@(,ND;GY^\=Q'\@*RO!VMR>'? 7B#5
M8[)KSR-7F+1*X3Y<("<X/3Z5O+INKS_%*UUN73)(K)=-%N\GFQL!(<L1C=D@
M$[<XZCTYH\!:%>Z?H6KV&M6!@2ZO990KR(P>-U48^4G'3]: -L>)(WU'1+.&
M#S3J<+3EEDSY*!-P;IR"2%[=:M:WK":+:13-;3W#33) D<*Y)9C@9]![UR/P
MRTB:U@OKBXN3<);3RZ?9'(*B!'))4^[$_P#?(]JV_&J:X^EVIT..:5TND:YB
M@F$4DD(SE58],G'2@#/U_78]5\+^+K!K62"YTZV995<A@2T992I%8IA23P?\
M/+AMQDCO[15.X]"#GC_@(J1].\0W#^-C+H4T*ZK:*UN/.C8EQ'LV\-UY)_#O
MQE\EAK47A7P59KHER\MG=P2W*JZ9B$>1SSW!SGMWYH ] OKR'3K"XO;EML%O
M&TLA SA5&37-KXX6.'3KJ_T>\LK'4)$CAN97C*@N,KN 8D ^I%:_B72/[>\-
M:AI8;:UQ"51LX ;JN?;(&?:N.DMM8U[PYI?AJXT6YLIK>2 7-S+M,2I%C+(P
M)W$X  ]S0!'=6R>)_B=K&D:K9_:K*VM(EC02;3$&*L7!SUR>W../KT/CG7+C
MPIX3%UIZ*9EEBAC\SY@!GG/KP"/QJCI-AJ$7Q8UZ_DL)TL;BUC2.X;&QBH08
M'//0_E4_Q,TB^UGP@\&GV[7$\<\<OE+]Y@#SCU/- &=KL\MK\4]!N4MKR::2
MPE#6]NXP2-V-V2%P-QY]<>E:T/CRPDT*349+6XAE2]-A]DDVK)Y^1\N2<#KG
M.>.:K2+J5U\0M!U%M(NH;<V,L<S.5(@8Y(#%21GY0/\ @0KF)]#UNXTW4[B/
M1I'>V\2-JD5M.H!N8CQ@ ^W/>@#O-"\5VNM:G?:88)+6_LMIDAD=6RI ((*D
M@]1FL+QKJMU<^*-$\)VEW/9"_)EN;B X?RQDA5/8G:>?I6KX<EN;W4IKY_#*
M:/$T(1I)0HGF;(P,+T4<]>N15'QGH&HR:WI/B;1K=+J]TTE7MF;:9HSG@'U&
M3^?M@@":E\-M.>R4:3-=6=VA7]Y]JD(=0P)#Y)SG^8%:-YXO2"2_%CI=YJ,.
MG';=2VY3"-C)4 D%B!R<"F#Q3JERT$-GX6U-9I2 [706*.+U);)SCGH.:QM%
MCU#P=J>O6LNC7U]:W=TUW;3VJ!PVX<JW/&#Q^?M0!L7/CW2H;+2+N&"]NX]5
M9EMQ;Q;CN'52,\')QCV/I53_ (6+!]FU!CH6KBYL,&YMS",QH1D,QS@# )_"
ML6UT+4]*M/!5B]A/,]K>27-TT*;D@#DX!/3C?V_NGVJ[-9:A)JWC]_[.N@E]
M9)%:OLR)66)DP,>I84 :]UX_TNUM](E%M?3_ -K1[[58(@Y8\94\]1D9IMK\
M0-.FTO4[RYL[ZTDTUT2YMI(P906.U< 'G)KAW2XTS_A6L5Y:7$4\$LZ20F,E
MQRG\(Y/K]*UM5M=;>7Q3XETRRO[>ZDBM[:TB:,>8ZJR^8X3GL./QH ZZ/Q=8
MF\U&SFM[J"YL+874L3JI8QXSD;2>?:J-E\0],OY].$=EJ4=MJ$GE074L&V,R
M9P%SGV//M7-2M?3^+]2ODT#5DBO]!>!7DC!9I .K '"DX"XZYP<<U%96E];^
M#O EN^FWIEM]4669! V8U#/RP[<,#^= '>6OBJRNM4UC3Q#<)-I:AYMZ@!E(
MR"O/MWQ6?<I=>+=-T'5],N+[3_WZS,ADV@Q9YWKR&S@8^OIFLCQSI-X/$NEW
M>F2B)M5!TN\"C!:-@6W9'<*&Y[8%=_;P1VMM%;PKMBB0(B^@ P!0!C7OBJUM
M+S4+5+2\NI-/B66Y^SHK; PR!@L"3CG '2MHR*L)E<[4"[B6XP/>O-?&-NPU
MV_O])AU6P\00K&D$UK \D5^I5>&(7:,'CD_PC\._GEO5T&240"2_%J6$*D8:
M7;G:"??CF@#)TSQKINIW.G0QPW</]I+(UI)-& LOE_>Q@G'KSU_&K%EXHM-0
MNX8;:VO'AGFE@CNO*'E%HP2W.<@<$ D<D5YQ'>ZKJ.H>"KF\TG5C+8W,HO)7
MLBJAG*XVA1]T8]!P.]:FEQ2V7BZSNO#\>J6UI>W,BZCIUQ;.(HADYD4D;0"<
M$8/?ZB@#L++Q;8ZA?Q6UM;WC1RSR01W7E#R6>,$L,YS_  G''.*K_P#"=Z2+
MF)6BO5M9;@VT=\8?W#29(P&STR",XQ7*Z9%-8^(K1O#_ /:UO:7UY(E]IMW:
MOY4?#9E5R, =.AYX],5F:!IEG:6$6BZEX*O+O6;:5D21HV%O*=Q(=GSMQ@]<
M'@4 =YI_B\7?B?6M+ELIX;?30";DI\@^7)W'/&>H]15_2/$MIK,T4=O!=1B:
MW^TPO+'M62/=MR#D]\<'!P0:YFVGDTWQAXOAO=)OIK:\C2:)H86=9E6+#("!
M@$\]2*C\*6]WI?B2ULM(N=1F\/S6SRO;WT#K]C((VJK,!U/8?7WH Z+Q/XG'
MAZ?2(%MGGEU"[6 *HZ+D;B/4\C J34_%ECIVH26"6][>W<4?FS164!D,2]BW
M89].OM6-\0;67[5X;U5(;B=+#4D:6."$R-L/); ]-OZTV+4/^$?\<:U<W]I=
M+8:I';RV]S';R2#*H$V,JJ2K$GO0!U6D:O8ZYIT=_I\XFMWR <$$$=00>0?:
MJ$_BS3X-1GLO+NI&@FB@EEBA+QH\F, L/JN?K]<9WP^TR\T_2K^:[22);Z^E
MNH8)!AHXV/&1V)QG'O6!K-M=6?B*]UCPY+J5K?\ VJ*.ZL6MG:*\&X#>#C;C
M!/(Z8/3- '9+XKTMI=:C#RYT<!KL^63@$$Y&.O0_E2#Q=I)TBPU+S)C'?+FW
MB2%GE? R<(H)X[GH*XR\C_LSQ'XXL3;7ADUFS4V12W=Q,_E,& *@@89P.>E4
M-.N+OPQ;^$]8N],OI+."PFM;A8X6WP,6SDJ0..E &KXZ\6QWG@Q[_0M1N()+
M;4(X)MJM$ZL.2K!@".WY$>HKL=+\4:5K&H36%I++]JBC$K1RP/&=A.-PW 9'
MN*X'QU?P:QX"EN[/2;FR6;4HR1-;^6\QQRY Y]LGTK;E>0_&NV:/S!$VC;7.
M" ?G8@']* .[HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***QO%>
MMMX<\,7VK)$)7MT&Q#T+,P49]LD4 ;-%<+X=_P"$QA\0P?;X[V73IH3]I-Z8
M!Y,F,@Q^6Q)!.1SV/M7-Z;XE\477AC3_ !++K"D'4EMWM!;J$=&8 Y/7C/%
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MP0/PH XR!M6\-_V/H<]C?2VZ:1("UK;^<SSN22C-C(1?08[9R*HZ%]HT_0/
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M9_$$L@TVY2:-S:H!M1=JI@$=!GDDGDY[8NWO@F+4=<UB^N[^1[;4[,6KVPC
M\O&,,&[D$$C([T 4-,/C.V\2::ERUY=:;+$PO#=+;*(WQP5,7.,]C6IXNU:]
MLY=)TW3ITMKG4[KR/M+J&\I0,D@'@MZ9XS4>B^$;W3KBV-]XCO=0MK/_ (];
M=D$:KQ@;R.7P.F>*O>)_#4/B6R@C-S):75M*)[:YB +1..A^G^% &=+%XET6
MPUB:YU^QG@$0-G<7R"(PMT._8H&/3@Y/I69:>(=5A\2WFF17DVI;M%%[:++"
MJYE&1V53ACC@COVK0NO!%UJ>@7VGZIXANKRYNM@^T/$JK&$;(VQCCGOSS4-O
MX$U"'6O[7E\33S7ALGLS(;5$P"#M*[<8VD@^IQUH S-"\82?V5=ZG=:[+<7-
ME8,]WI5S;)$Z3 #E2J@[<Y'?J*?H6K>,+O4M%O#'>W&G7J"2[$L,"11JZY4Q
M,I+D#/\ %SQ[\;2^#)+B_-WJFI)=2-ISV#M%:B)I W5V.3D\>@%1Z%X-U/1S
M:02^*;RYTZT(,5H(5CX'16;DLH]* +GC;7I]"T: VK*EU>74=I#(R[@A<\MC
MO@ \&J$=SKVA>,-+TV]U,ZGI^I)(HDEACC>*5%+'&P#(('ZUN>)?#\'B719-
M/FFD@)=9(YH_O1NIR"/\]ZJVOAV]?6;/4M6U5;V2RC9;=([;RE#,,%S\QR<<
M<8ZT 9'@&TO(KWQ&T^HO.%U>5'4Q(H=MJ?/P,@\CC..*VO$-WJ$-[I-O:7EO
M:0W-P4FED*F0\?*J*>I)Z\<#TZT>&] NM"?46N-16\^VW+73'[/Y95V !Z,<
MC %0^(_"]QK6J:7J5GJK6%UIY<HWD"4-NQG()'I^M $?@?6[K6-.OHKZ83W5
MA>RVKRA-F\*>&('&<>E9^I:MKUU\0I?#=AJ$%G;G3_M E-L)'0YQQDX)^O'M
M6KX3\+R>&1J(?43>?;;DW))A$95CUZ$@YX["D'AF<>/9/$GVU-C6?V58#$<C
MD'.<^O/3V]Z .&7QAXH/@C_A)&U. BPO1;S0"U4?:5# 9+9X^]V Z5LZEXDU
M_5]9U6ST%YH%TV*-E$5JLIGD9=VQBQ&T=!D>A.>E*OPZO1X"O?#AU*W\RYN_
MM'F^4V ,J<8S_LU<NO!.K0:L^I:#KXTV>Z2-+T?9ED20H,;E#9P>O'OUH BU
M#7/%377A>PB6UT^[U.&87 GCW[)$3<> >G<<]^:AU'Q!K]MKYT/^TK>">UT@
MW;S/:@_:I5SD("PXP#T[AN*U;CPKJ;Z[X?OTU=94TL2>9]HBW/,T@(=L@C&0
M>!T&*YKQ#=07WCV]=M8T2T-C ENL.K0 @ELLS)DC/7&10!=LO%VNW/A;P^SA
M/[3UF=U66*WW>5$F26V%AN.![<'U'*WGB3Q7IOA?7[FZME2;3Y5^S7<T&Q9X
MR0/N9X(R.>1SCJ*<FE:KXNT&SNXM0M[*_P!-NV-A>VD9\F:/ &X(>@ZKCD?+
MW!J_J7A/6M7T'4K6_P!9BFO+Y4CR(BD,$:MG"J#R2>2QY[=!0!MZ$FOA9Y-<
MFM&,FUH8K9"/*X^923UYXS[5/KVKQ:#H5YJDR%TMHR^P=6/0#\20*Q_$(\2V
M_A_3AIU\#J:31).T=KO6<'ALC!V#N3QC'45M:QI<6MZ)=Z9<G"7,1C9E&=I/
M<?0\_A0!S^FW7B@G3-3GN+2ZTN[A,US$L7EM; KN7:<G?CI63'XE\2W_ (3F
M\6V$]H;6-Y'&GM;G)B1B#\X.=V!GIBMC0?#FOV"6MGJ.NQW.G6BE8XXH-CRK
M@A5D.3E0#T'H.:I0^#-9L= N_#MCJUJNE3NX5G@;SHHW.64$'!ZGD^M $1\6
M:SK/B6UTS16M;6*[TE+]'N8B[(6([ ]<$>U11>.M0D\ SZHR(MW:WWV*ZG6$
MLD8##=*$!Y&TCCCFM6T\'W&G^,K?5[2XMULK?3UL([=E8L$4<'.>N0/P]ZC\
M/^$]5T'1KNR%W8SFYOFN9%>(E'1@ Z$'/H,'^= #&\1:I;Z':^3?Z9J5WJ&H
M"TL[N$$1!&7<&D4=&&&X&>WO4]KK6JZ9XPM_#NL3V]VE] \MM=1Q>4VY1RA7
M)'0$Y]ZI1_#V2&QO%M;N*SN6U)=0LUA#&*W8#&,9&<@L#T[8'%:=OX?U.[\3
M6^NZQ+8M-9P216L5LC !F)^=BQ/\/8>M '(Z!=OH'P>OIH[2VO1:W4JM%=K\
MKJ) .5YYZ<?K76W&OZE=^);/0+ 6MM=K:B\OS,#((UW*/+7!&X\GGCBLB+P7
MK2_#:_\ #\MU9O?7,SR>9A@I!8-SZ$D>F!FKEWX9UFRURRUO1#IPO?LBV5Y'
M/O$;(,'<F.1C:./2@#*\+7NIZ5X-U*2PL[6:[&LS1NK2>7#$"P#-R1\H]*T[
M[Q'J<EKXMTT3VD5_I=JLT,T2D;U:/>3M)/(Z9SC)%47\#ZZ/"\UD+NQFNVU;
M^T-C*RQ2#.2C=\$X/^<U=3PMK<NJ^([BZETXIJ^GB#?$C!DD$>P 9S\O<\\\
M=* $O-6N;/PWX1N+FTM=0DN[BUB>:=,F,N!\Z@DG?[^M:#:YK.I:QJUEHL-B
M$TTK&SW>\^;(5W8&TC:!P,\]:S+SP]XEN_"^@6++IHN]-O(96 D?84B&%YQR
M3WZ5>.B:WH_BG4M4T=;.YM=3"--!<2O&8I%&-P(#9SSD8':@#+C\?ZG=Z7HL
MUEI]F]Y=WSV%U#),RB.5?0@'C'/?''6MGPIXDO\ 5M3UC2M5M[:.]TR1%9K4
ML8V# D8W<YX-9/\ PA&H6$?A^/3VM)/LNHO?WTDA*%V8\[0,YP"1S_=%:V@>
M'[[3/&/B+5)S ;746B:+:Y+C:".1C'?UH FU?Q!<Q>)++P]IB6YOKB!KEY+C
M<4CC' X7DDD'N.E9-[XVU#2K#Q%'?6=LVHZ2D<B>46$4R2$!6YY&,\C/:M#7
MO#]])XET_P 2:.86OK:,V\L%PQ5)HCDXW ':03GI6-JOA'7=7TW7[B862:EJ
MJQ0+"DK>7#%&<@[MN68_04 =+X:U'6M3@EN=5LK6V@D6.2T,$I?<C+D[LXY&
M0.@[UE7?BZ^/BN]T6R2P62U,.V&ZD*276\9;RSD 8'UYKI-%MI[/0["UN0@G
M@MTC<(VY<JH'!P/2N,\4>$M9\0RWBRVVGO(LZOIU^LICEMX^,J0%^;^+OU/:
M@"_XF\3ZUHDFI7$-C:"PL(HY 9V;S+K)&[9C@!<@$G/-1WLT%[XV\&:HD>PW
M5I<N2W79Y2L ?IN/YFLS6O!GB2_O_$"I/8W%OJ<*1Q3SLPDA"X(0*!@ D8)^
MA]JT+;0/$']I^%GN[>P:VTNTDMYRDS9.Y0AP"O/"K^.: ,Z;XEWS7"75A86U
MWIK7)A$<8F-P5#%?,^YL XSC)//Y=[JFJ6^D:1<ZG<A_(MXC*P5?F('8 ]_K
M7%:/H/C/P_'-HFFR::-)\UVM[N7)EA1F)QMQ@L,YYX_E78:UI UGP]=Z5+<,
MOVB$Q&;:"0?7'2@#F)_%VNZ/:VFKZWI^GIH]TZ+BWF<SP!QE2X8!3CH<'Z5*
MWBS7KKQ9>Z+INA0316,T8GN'NL?NV .0"!S@],G\:SIO#GB+7-!L/#&K6D,-
MK:NGFZBER',J1C"[4QG<>^>G7GI6YX?L-8M/%WB*YO+2&.QO94D@E64,6VJ%
M&1VX&?8^O6@"#XE:WJ>@>%1>Z7+''+]H1'=ADA3GI[Y _#-2:YXHU?3->L-(
MLM$CO;B[MVE5OM0C7<OWEY'88.?>I/B#H%YXD\)S6%AL-R)$E17. VT],]JJ
M2V/B"]\9^'M5N--@B@M[>5;D)<AO*9\C'(!;@+T'<T 2:MXLU;2;&_O+C03'
M#8P122,\_P LCN1E8R!SMSR>.>W2HM2\;WL>L:7IVDZ,+V74;(7D8DN!$5!!
M.#P1T'K63K7AWQ7=ZIXECBL[*ZMM3A6.WN)[C'D(!]U5P>>_89&<U/I?A_7Q
MXL\-:E>:?###8Z:;6?;<!]I 8#MSQ@\<<]: +J>/V7PS_:=UIRV\XU'^SGC:
M?]W$^[!=GQPH[G%2^*-2U"7X=Z[<&*WC<1O'&\4WF))$< N#CN"W&.HZ]ZS-
M.T;7K;PWJ-I>^'K6]%WJKSO:27"X,+_,2&SC<"!BF1>%-7M?!7B/2;6U98KN
M4_V?9/<AC#&2,@L3@=SC)_.@"+1=1M?#.@:!-_9>FPZKJ=FD<4PG,<;0I&KL
M\S[/E/)) #<XY-74^)32>$M4UE--BEFTZZ6WDBBN=T; L%#J^WD$GL*CNO#>
MNP6'A+4K"R@DU/1K;[-/:33 "1"@0X;[O3)_'OC%3>(--\3:[X(U"S?2;*"[
MN98O+MH9Q\B*P8EG. 3E<8% '4:'?ZG?Q7#:GI!TYDDVQ*9EDWK@'/'3KBLN
M?Q-JES<ZHNBZ/%=PZ:YBEDFN3&99 H8I&H5LD9 YQS731,[0HTB;)"H+*#G:
M>XSWKCK:S\0>'M9UO[%I@U*QU"?[7"1<I$8Y&&'!SR>@_ ?6@#(\3Z^OB70?
M"UUI]LL]I?:I$DT$S@ L,_NWZ\9!Y]AZUW.BZ/9Z-:.EI8P6;3N9IHX&+)YA
M'."0../0?2N'/@[5M&\/^&--L+87TEAJ"WUTXE5 ",Y5=QY^\?R]Z]&G$K6T
M@A(64H=A/9L<?K0!RG_";313:4U[I$MG:ZE=-:1&9R)5?.%+)MX!/O\ IS5#
M3[6 >+OB##Y8,<L%L74\AMT+EOSR:PE\/>,KK2M%6[TXS7FFZI]KEEGOE)G&
M[/&<[0, ?D0.M=39:=JT?B3Q=?/IQ6*_@B6VS,G[QHXV7'!XR3U/2@"W\.E"
M_#_1L=X,_P#CQIE[XKU%M5O;+1-"?418,JW4AN%BP2-VU >6./IS4O@&RO\
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MFXU1+-X)W4DJ6/W3T^;& >U7]<\53:3<2P0:/<WAM[1KNY<.$2-!V#'[QX/
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MK:"POK!;6*17+.&5@P)7 XSG/-6="L?''VBUCUJ^TZ*RMMI/V56:2? (PQ/
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M9^YMP3C(Y]?:N\HH \_ATWQEX?UC5HM'M=/N['4KR6[CFGEV?9W89.X=2,X
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:26*-FP59F521QP?K6C8OJ.D_$.ST:?6;_4+74=/>5Q<./W;Y)RN ,<+C\:
M/08IHYE+12*ZABI*G."#@CZ@@BGUQ'PIM%M_!,$JR3,9I9<J\A95Q(P^4=NG
M/J:;XB35;[X@Z=I=IK=W86D]A))*L&W.5;&1D'GD<^@XH [FBO(6_MT^$O$E
M_P#\)1J?F:/J$T%N-R_,L9&=Y RV<CZ8XZFNGU6YN[V^CC35KA96T9[B.QM%
M96\W'$C,O;.  >] ';T5Y9-K.MR^!_#7BLZC.L=O(HU&-&VB6/S-I<\<G@<?
M[1KK?#5S/J>MZWJ27CS:8TJ06B^9N0[%^=E] 6./?!H NS>)+2#Q7;^'7AN/
MM5Q 9TD"CR]HSWSG/![5LUY_XKTZXO\ XD:!%;ZA+8M+9W"F:!%\P #)P3GK
MG\.<=:R+OQ'XCT;3]7T1[Q[B_BU.WLK6[D*!]DJEE).,9PO4_P![VH ]7HKB
M_"%IXJL=7N8]6-S)ICPAHVN[F.61)0>@*CH1_+WKM* "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBJFIZE;:1IL^H7CLEO NZ1E
M0L0/H.: +=%8(\8Z(9-)0W,BG51FT+0N ^>!U'&>.M2S>*M&MCJ/VB\$"Z<Z
M1W+2HRA6894#(^;CTS0!LT5A2>(--U#3]62WU![62SB;SY'A97M\J2'VL >G
M(JO!XBTO0_#NDRZAJ[727.V**\:-OWS'^(@9Q^- '2T5FRZ]IL&JRZ;+<A+J
M*V-U(K @+$#@L6Z57TKQ9HNM7LEG8WH>X0;MC(R%E]5W 9'TH VJ*\^\9>.;
M6/2V_L/62EY#=1QGRX-Z2Y;!7>1@< G(/;'>O0&8*I9B H&23T% "T5CV7BK
M1-1NH;:UOTDEGW>2-K 2;?O;21AL>U1>&_%-EXF%Z;,2+]EG:%@Z,,@=#R.,
M^G7UH W:*SM2UW3-(EBBOKM8I90S)&%+,P').%!.!ZU#)XIT*'3[._DU2V2T
MO&V02LV%<_TQCG/3O0!=?3-/ENQ=R6-L]RO29H5+C_@6,U-)!%,4,L2.8VWH
M64':WJ/0UDVWBW0;S3KN_MM3AEM;3'GR+D^7GID8SBI#XGT8:5;ZH;Y/L5Q(
M(HI=K8=B2  ,9[&@"[=:=8WS(UW9V]PT?W#-$KE?ID<4V[TO3]096O;"UN64
M84S0JY ]LBHM<UBVT#1KG4[O=Y,";B%&2Q[ ?4X%9%QXBMK^UT.]L-;@LX+R
MY4;)D^:X7H44$9!SCG]>10!O6FG66GJRV5G;VP?EA#$J9^N!5FL>]\5:!IT\
M\%YJ]G#- H:2-I1N7.>W4GCH.>GJ*1/%GA^2\M;2/5[1Y[H9A19 =WXC@?0T
M 9FNZ-XON]4>;2/$\5E9LHVP-9HY4XYY()/K5&S\.^-[2(0'Q%IDUN(_+$$F
MGJ$ SZ+CZ>GM71:GXKT'1KQ+/4=4M[>X?!$;'D9Z9QT_&M5]SPMY3A6*_*V,
M@'L<=Z .5ETWQK/$\4VK:))&X*LCV+$,#U!!;FJD7ACQ) \;PS^&XVB):,II
M>"A/4C#<4SP+XXAU+P[9MKNJVBZE/+(B*[+&7 /' P!Z=LUUG]MZ8=9_L@7T
M!U#9O^SALL!UY]\<XZXYH YRUT3Q=8HRVE_H%NKMN81:<R GU.&ZU)'IGC2'
M?Y6JZ(F]B[;;!AN8]S\W)KI++4K+43.+.YCG^SRF&78<[''4&LK_ (2NPN-7
MU31[68"_L8=YWC@M@G '&<8&?K0!BQ>&/$D%Z;V*?PXET3N,RZ80^3G)SNSG
MDU-8^'O$MEJ4EXEWH,<D[@W$D6GLKR#/.3NI_@;Q:FL>&-/GU;4;0:E<LZB,
MNJ,^'(&%SZ =*Z2]U;3=-9%O]0M+4N,J)YE3=],GF@"2SL+33TD2SMHH$DD:
M5Q&H4,YZD^]23PQ7,$D$\:R12*5=&&0P/4&G)(DL:R1NKHP#*RG((/<&J#:_
MHR'#:O8 [S'@W*??'5>O7D<4 6+#3[/2[1;2PMHK>W4DK'&N ,\FJ(\*Z"#=
MD:3:YO.+@^6/WO.[G\>:NWFIV&G;/MU];6N_.WSY53=CKC)YI)=5TZ!(7FO[
M6-)QNB9YE D&,Y7)YXYXH @;0=+6>VNH].MOM-G'Y=JVW'E@ X /8<G\ZQ=$
MT_7=1UN/6/$EI9VLUI&\-I#;OO\ OD;F)R>R@#ZFM2+Q1H]QK<6DPWL<MU-!
M]HCV'*.F<<-T)Z\#T-7HM3L)X9YH;ZVDBMR1,Z2J5C(Y.X@\8]Z +59)\,:&
MU^;TZ5:?:2XD,GEC)8?Q?7WK3BFBN(4FAD22)QN5T8$,/4$=:JG6-,%]]A.H
MV?VS./L_GKYF?3;G- #)M"TNXU6/5)K&%[Z+ 2=ERRXZ8/;J?SJW<6\-W;R6
M]Q$DL,BE71QD,#V(ILU[:6V?/N88L$ [Y N"3@=?4D?G4KR)$A>1U11U9C@"
M@#*7PMH206\*:5:K%;R&6%0G".<?,/?@?E4@\/:.+F[N?[-M_.O%*7#E 3*I
MZAO7I5V.ZMYGV13Q.WHK@FC[5;^;Y7VB+S,XV[QG/IB@"CIGAO1=&G:;3=,M
MK65EVL\48!(],U-JVC:?KEF+34[5+F .'",2,,.A!'/<U9:YMT<HT\:L" 5+
M@')Z5D#7H]7TO4VT&XMWN[5GA4SMA!(HZG'.WW[X_&@!-2\&^'=7D@DOM*@F
M>!56-N5(5>@.",CV.15BY\-:/=WUA>36*&XL !;,K,GECL  0"/8U:M9Y(]-
MMI-1EMTG,:^:R/\ NR^.=I/:I_M$'D^=YT?E?W]PQ^= &?\ \(YI/]NR:U]D
M_P")C)'Y3S>8W*X QMSCH!VJHO@GPZFCSZ2NFJ+">7SI(?-?!?CG.[(Z#H:W
M(Y8YEW12*Z],J<BFRW$$! EFCC)Z!V S0!BWG@KP_?2;[BQ8L85MVV7$J!HU
MX"L%8;NW7/2MR.)(8DBC0+&BA54#@ =!2F6-<9=1D$C)Z@=ZI:CK6GZ5I4NI
MW=RBVD6-TB_-R3@ 8ZG)H H1>"_#\$XDBT\(!*)O*65Q%O'\7E[MF>!VJTGA
M[2X]?DUQ+=AJ,B;'F\Y^5P!C;G;C@=O>DOKO4TU+3%L+>UFL)G87,SRX9!C(
MV#OW]?ZT'7(+MM5M=+=+G4-/7#Q'(&\J2JD_A@XZ4 7;ZPM=3LI;.]@2>WE&
M'C<<&LW1_"6A:"SOING1PNZ[&8LSG;_=RQ) XZ4WPGK<NN^%;35KR.*"28.7
M5#\J[79>_P!*VHY$E0/&ZNIZ,IR* ,2V\&Z#9R1/#9,%BD\V.)IY&B1LDY$9
M8J#DG''%2MX7T=I]2F-JWF:FFR[(FD'FKZ8#<?ACJ:J7/B*YB\::9H\<-L]C
M>Q2O]H67<^Y!DC:.G;GG.?:MG4-1M-*LGN[V=(8$QEF/<\ #U)H RYO!?AZ?
M2K73)=.#6EHQ:!3*^Z,DY.&W;A],TV'P1X>MX;^*.Q?;J"A;K=<RL90#GDEL
M]:WGECCC\QW54_O$X'YTX$$ @Y![T 8-WX.T6\T_3K%X)5@TYP]MLG<-'CL&
MSNQ^/88QBK,7AS3H/$$VMI')]LF@%NY,C%2@]OP'Y?6K;:C:)JD>FM.HO)(F
MF6(]2@(!/YG^=9OAK7+C6X]2-S:+;265]):;%DWYVA3G/_ J *UIX#T*RNQ-
M#%<"!3O2S:X<VZOG.X1DXSGUX]JL?\(EI7]JZEJ06X%QJ,/D7&V=@"N,9'/!
MQCZ8XQ6[10!RT/@+2[:QT^UM;G4+8V'F"&:&XVR8=MS G&",X[=A6WI.D6>B
M:>EE8QE(E)8EF+,[$Y+,3U)-9GAOQ+)KNH:U9S6/V:33;GR,B3>)!S@]!@\=
M/>NAH Y^\\':;>:M+J*R7=K-<*$N1:SF-;@#^^!UXXR,'FFZIX+TG5(-+A/V
MBUBTQMUJEK)L"'C!Z')&WK[GUKHJ*  @$$'H:Y!?AOHB:/=:4LM^MI<2+(T8
MN3A<'("C& ,\].PKKZY&3Q?J%UJ]Y:Z)HHU&WL;A;:YD%R(W5^=V%(P0,8SD
M<^W- &G)X6LI=?LM9:XO?M5G#Y,8\\["N"#D>ISSZX%4;?P#I5KI\MI#<ZBO
MF78O#,+DAQ*.^0,?F/Y"M2SU=ETFRN=9@73;FY<1?9VDW[78D*N0.2:U: ,O
M2=!MM(N;ZYCEGGN;UU>>:=P68J,#H   /:DDT&VE\1PZX\UR;F&(PI'YG[L*
M>OR^I_H/2L_Q-XOAT+PP=<M(!?P"81';)L ^8J3DCL1BNC1M\:N.C &@#$UW
MPG8^(=0T^]O)KI);!M]OY+A0K9!)Z9_A'Y5YYKT#3>+M2:^@\565W<S[;<Z2
M-T<\4:  CGDXY/IGM7L%% '&Z;X3DU*RT&]UJ[OS?:;(\L/F.H<*S959,#D[
M0@/T-7-:\#Z9K6L+JK3WMI>;/+>6SG,9=>P/Z?E7344 <GJGP]TC4(K/R);N
MPN+.,QPW-K,5DVDY.2>N26Y_VC2W?@'3KC1K;34O+^*.&Z^UM*)0TDLG]YV(
MY/\ @/2M/6]=.E2V=I!9O>7]ZSK;P*P0,44L26/ &!5K2+N[OM+@N+ZP>QN7
M'[RW=PQ0Y]1U% % >&(QXLF\0?VA>>?);_9Q$&78B\=!CU&>>]8T7PSTN+P^
M-+%[>[H[DW,%T'"RPN<9VD# !Q6]J.OIIVOZ7I4EI,QU$NL<ZD;%*C)!YSTK
M8H Y";X>Z?<>&KC1Y;Z_E-RZ/-=S2^9*VPY R> .O'N:O?\ ")0GQ%INMM?W
M37%C;"V53MPXP02W&<G)KH:8DL<C.J2*Q1MKA3G:<9P?0X(_.@#"\->%(?#
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M;F)HRJ>$;II;)SG=<88.03Z!,$8'<5J^,;>2R^$\\VH(3?ZC<K<S!0!MD<Y
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M "ST+2-/25+/2[.W652L@B@50X/8X'(HL]#TG3IEFLM,L[>54,8>*%5(7.<
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M,!C) ]LC\Z """.VMXX(5VQ1($1<] !@"I*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "J&M_\@#4?^O67_P!!-7ZHZQ93ZCHUW96UR+:6>)HUE*;]
MN>#Q]* /-A<Q>(?!?A+1K"WFFO8Y;5G+0.JP+&/F<L1C&..#SFM#PM!-<:SX
M\C2&53=RGR#)&R!^''!(]2*[3P]IL^C^'['3;BX2=[:)8O,1-@( P.,GMWK3
MH \I>X:[^%(\,R65RNM+&ML+4V[GYUD&#NV[<8&<YK2\5:5JND0^&];TR)KS
M4]-1;.6,+DS*Z[22>3U_]"KT2B@#S/XA6 TSP'H]@H9Y$OH2[!22S?-N8X[E
MC^M-\47 M/$.IZMX?U.>UUN".-;FQ> NMZN!L*C],CT/3OZ:0&&" >_-&U=V
M[ W8QG'- 'G,CN_QEC# QRSZ(8U^4X#YW$9[8K)_M2VMOAM=>$;V-UU\))"M
MF(79YWWDAU^7D'KGVKUS:-V[ W=,XI"B%PY5=PZ-CF@#SC2633OB1IMG?R;K
MN+PU'"S,O_+17+-S] >:M_!Y@? $0!R1<2@^W-=[L7?OVC=C&<<T*BH,*H4>
M@&* //-)U*U\*^-_%"Z]=I:"_ECN+628D++& W1CW&0,>W%<OJ\7]E_#_04N
M(GLHGU[[1!!.V&C@RY&02<8!&?K7M3QQR8WHK8Z9&:'C23&]%;'J,T ".LD:
MR(P9& *D="#7B.GZC:P?"3Q-IDLA2]BNGWQ,ARNYT SQC.0>/:O<*9Y,>&'E
MIAN3\HYH X*[U#3/^$T\#-#)$-]K,$*KC*M& @Z=,AL#M7.:;+I-[I7C]+Z^
M,5G+JRL9X2&*!IODD]UW8/T!KV'RTRIV+E>AQTI/)B ($:8;J-HYH XSP+J=
M[<:EK.G7EY:ZD;0PE=1MU \\,IP&(X)4 ?G1X[G35[K3/!T5VL%QJ<GFRMY8
M?9%&"X)!/=D 'T-=HD:1@A$5<^@Q040N'*J6'1L<T >3ZXE_X#\7Z3XBU+6/
M[12[S9W3&!86\OKG"GG'!Z?P@5)XHU>TT[QGJ;1ZGIPCU'3$BFCO!(J@$':R
MLBMNX.<8KU1XTDQO16QTR,UP>J^$->;Q#=WUA<:3=6][(A=-2M?,,"J, )V.
M,GT^M &/JHT6P\.>!+>&]MKJ"'4XL7(^X5&?,)ST^8C(/]*DU^31]'^(935)
MY]-TZ?30EO-:N8TSO8NN%'0YS]?K7<Z)X?@TO3([:=+>>43/.66 (BNQ.=B\
M[1@XK3N+2VNXQ'<V\4R YVR(&'Y&@#QV5M)TO4/#EU:3ZG9>%5:YC2X#N")#
MGYP>H5N@[X#<<Y,WB<Z#%\--;;0WN);>YO(G-U.Q(GE+ MM+<D@#GCU]Z]=F
MM;>Y@,$\$4L)ZQN@93^!XIDEA9S6@M);2![88Q"T8*#'3Y<8H \YOC8?\+4\
M&)%]GPMB_"[< >6VS_ZWZ5S;R1)IGC+9N:UA\01RW,=N1GR!*>0/3(&/I7M1
ML;1KB*<VL!FA&V.0QC<@] >HHAL+*W>9X;2"-YSF5DC ,A_VL#GJ>OK0!YZM
MQX2O[CQ#JECJLM_=R:4Z3M,#Y:(.G50 2=N![?6L8PV%G9_#6[L8[>%Y9HQ-
M-$ I<X4.&8=>2P.?>O6(M+T^"VDMHK"UCMY/OQ)"H5OJ,8-*-,T\1P(+&V"6
MYW0KY2XC.<Y7C@_2@#A_ ]S!#XZ\8VDLR)<RWH>.)CAG4;LD#N.1^=7/%DT5
MKXY\*7%\%%@'G7?(1L28J-A.>AX.*[!;.U6[:[6VA%RR[6F"#>1Z%NN*+FTM
MKV$PW5O%/$3DI*@9<_0T >7:Z=-FE\=W=J4DL7T^)97B8E#<\XZ<9^YG'X]Z
M[;P=INF6WAW3;NQM+:.6>RA$DL2 %_E'4CKSFM=-,T^.T>T2QMEMG.6A6%0C
M?5<8/2I;>W@M(5AMH8X8E^ZD:A5'T H X2PN+6V^*'B1-:%O&;BUA^RO.0$:
M$##*"W7)(R!QD&N=G2*U^&^NI^X73O[;_P")8=Q.4\]>4)ZC:&P1VW5ZQ=Z;
M8WY0WEE;7)3.WSHE?;GKC(XHFTRPN+:.VFL;:2"+'EQ/$I5,<# (P* +(92H
M8$%2,@CG(KQ.[U71;CPU$;1K.R2/Q D_V<S;Y<;R"[;L%<@?@!U]/:XXTBC6
M.-%2- %55&  .@ K/D\/:+*'#Z18'?R_^CI\W.>>/6@#SEK/3KSQMX\DNXK6
M?;8(\1D ;:/*'(ST[<CVIJV<NH?";P_KUO$/M^BXGB"#EDC<JR\^H4'\*]-7
M1],6:>8:?:B2X01S-Y2Y=  -IXY& ./:L/6M*UA+2'1O#=MIUGIDT;13RLI#
M0@\$JHX)P3U[T )X,ACOAJ'B<1M&^LRB1$=<,D2#8@/)Y(&[CCD5E>+-.TO4
M?B3X9M]1@@F22"X#))_%@ J"._.<?C7<VMK!96D-K;1B."% D:#HJ@8 JO<:
M/IMWJ,&H7%E!+>6XQ%,Z LG?@_B: .(L;6UT_P"-1MK6&*"(:,%2- %'##@?
M@/TKD[?18-9TF/2@-*9HM79Y-5^T1AI8]S;LJ3O)Y '8X_$^P3Z-8O?/JD5G
M -4\LHET4&\<8'->:67@;57TO^R;WPGI G96C?5C<@L,D_O H&21V''OB@#:
M?3M'U;XLZA;WUO!<+;:5&H249"$GG@_[+#GMFN2E^R?\(GX0#&%X(==>$^9A
MU6/S6^4YSQMQU[8KUQ?#^E"\-Z]A;R7C1>4\[1@LR[=I!/T&*C'A;05TTZ<-
M)M!9-)YI@\L;2^,;L>N * )]2DQX>O)+-AQ:NT+1?[AV[<?AC%>5WUIH<GP5
MLM0TR"W74+?R DL:@2_:=ZAQGJ3RQQZ8QQBO8888K>"."&-8XHU"(BC 4#@
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M7Z,T$A!RIPRD'((/8T </J"7O@_Q=:&RU&[NK>]L;J2>*[G:7#Q(7#X/W<G
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MUH Y"SDU?Q#X*U3Q'#JVHVE^)9I8(%EQ'$L9XCV].@YS7>>'-0EU;PWINH3
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M:;9O8PQ>((4%N\A/EDN2XR>HS@^WM6SI5MIVN^-O%EKK5M'<W$)CCB6X486
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MLVGB;1[Y]12WO59M-S]KRK+Y6,YSD<_=/3TH TD@BC.4B13ZJH%*(8E5E$:
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M&,#&, "NDM8/LUK#!YLDOEH$WR'+-@8R3W-2T4 %%%% !1110 4444 %%%%
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M:2>.PU/1X(XKB1=RQN "59@.,]<XZD]*PM4E5M!\7ZSEUTO5;^U%EE&'FE)
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M&'4X6<0OYD;HY1D/L1_G@547P+X<CL;ZTATY8HKY%2XV2-EPIR.<]<\Y[]Z
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MDO A\E)F*H6[9([5S?ACPE!9Z)'_ &QI&FR:N3(9IPBNTA9B22^W(SG'? H
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MN+:6XM8XRS) !N(5R%W'</0<'Z4 >K4C,$4L<X R<#-<IX'G\3O;WMOXDMY
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MG()SV]*]&\-?\BKH_P#UXP_^@"@#4HKSBZ\4:_INI:;+=7]E-'=:K]AEL;=
MP@4G !DZEAP31JNO^*3XC\2V-E?V%O!I=LMT@>#>[+LW8'/?N3G'% '?7NGV
M6I0""_L[>ZA!W>7/&'7/K@T^*TMH+1;2*WBCME78L*( @7TQTQ6;X5U:77?"
MVG:G.JK-/"&D"]-PX)'MD5S$>K^)]:TS5M;T[4+6SMK6>5+>UEM@_F)%U+-G
M()(/3I0!VG]E:=_SX6O_ 'Y7_"J*MX??6FT=8+0WZ0_:&A$ X3(&2<8ZD<9S
M7&S>-M=U.X\,+H[64":S;RY%Q"S;)4R&Y#=,CC]<]*W],U#6$\:1:3J@L';^
MR!<--;QD,7$BJPR?X<Y.,4 =#_96G?\ /A:_]^5_PJK;WFC0:Y)I-OY$6HB$
M3-$D6TF/.,YQ@\]LUY]=>-/%!TB#Q!8W6GO#=7YLXM.: N8^H7<P(.?ESCW'
MTKJ8M6U ?$G^R9K:T$1TSSQ,L1WL^X C<?X<YXH ZVBO)8O'7BZ;03XB<Z/'
MIMM>B":)4<2.-P4\DD ?-UKJO$7B'6=.N+]K4Z;#:V]E]H@-P&D>Z8 D@*K
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MJWNXV93(,X92I&.O/_UZH77@._71K"TL=4B-S#J?]IW$T\/RRRYSPHZ#/;-
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M5F)))+#)SGG_ "*X:;3]8\$?#G6;#4[JSDAN91#9!<LL?F'#;L@ #&3[<^M
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M#D <5T&DZ+JD'Q*UK69[9$L;J!(HG$H).T*,XZC.#0!5L?'=[J?A[3;ZUTZ
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M9WLI0A0W17+#.!C/_P"NO0+W39-1\,SZ9<&+S9[0PN8P50,5QD#J!F@#G_\
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M.:Z'BCQ2)].O+:*:[6:&6>$JL@QMX/0],_0T =G1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%<[XZU6ZT3P7J6H63;+F-%"-C[I9U7/X;
MJ .A<E49@I8@9"C&3[<UC>%?$<'BK1%U.W@D@C9V39(03Q]*YSPUH_BK3O$J
MSW=W,=*DB82PW6I?:F+\D,I\M<#IP/?GM7&:!K%_I_PYT/3]-9XY]2U5X&=)
M!&=F>0'(.TDD<X..: /<**\LGE\5>#?#NM75[=MY$GE):-<W9NI+=F8*S%MH
MR.<XQZ?COV_AG4M-F:\3Q-J%W92V<GVB"ZE+EY"IPR'C8.<X'I^0!V,4T4\8
MDAD21"2 R,"..#R*?7C&C/?Z9\%X=0T[4[JWN9+P'.X,J@RE" #T!SD^IK?N
MX-2M/$VE^%&\1:I)]O$MU<W895D"A" B''RC*D\>HH ](HKS62\UC0M0\0Z!
M'J]Y<Q0Z2U]9W-P!))"1G(9L#.<<9JGI^H:[IFI^#+NYUVZODUM,3V\JJ$4%
M%(QCN-_7OB@#T/3-7;4;_4;5K"ZMOL4PB$DR86;C.Y3W'^(K3KS"[\6:KI,G
MCN7[:UPVGR0BUBD0;81(<9!'7&>A_N^]=5IN@ZSI^L6L[>(KF]LA 5N(KD*2
M\G9EP!M'XF@#HI)8X@#(ZH"P4%CC))P!]2:?7#_$BU>[3PW$EU/;F3688]T+
M8(R&^8>XQQ46JVVO7?C==%LO$MQ9VYTGS@WD([;E<)DGC)).21CN.] '>T5Y
M;XGU#4K*UUVYM_%5W-=:<D(2&TA CBZ*WFG:1N)R< \>G8:FI2:UJ?CBRTVU
MUVXL+6XTK[2RQ0KG<&P>HX)R/IC% '?45Y/#XFUZY^&]O>1R7T\MOJ+0WUQ;
M[?.\E222/E(Z$<^U7M2UF]'PZGU+0/$\EV$O%'VF: >:L;,J^6<CJ"P.<#B@
M#TJL[6]9@T'2Y-0N8;B6-"H*6\>]CDXZ?XUPTA\20>/T\.?\)/</'=V'VEYS
M;1[D(++A!C"]!Z_UJC'XGU__ (5AJ]^NI,+W3-2-MY[1JS2H&08/8'Y^N.U
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MG1LTJLH=UCWF*,GYG"]R!SSQ7">+=1.J?"W5+A==CUB$W4/E2B)8W1<K\KJ
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MFX2/Q !;7-J+>>WNK03(2!C>HW#:3U[\U ?!5]!:M866NXTR2R2T>UN[;SP
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M6! QSCZ5M44 %%%% !13(9HKB)989$DC;[KHP(/T(I] !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !6;X@COY?#U^FEN4OVA80,"
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MF31E;3))_LK7'G_/EY&PP3'3/'6M^ST?7-,\?:_J$5C%/9:E"ICE\\+M9$P
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2W'C76=2U?P]::&ME$FKV;S!KI&8QL 2>A[;3CUH [K4M2L](L);Z_G6"UB
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M<Z8Y-G=IM5XDP!LXZCY:=>_#V/4=#N=/O-9OKB6YG2:6ZEPSD(,*H'0 ?XT
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M^U)K.:"UA0PQ@G"A9 H)(RIZ^O6K<GB/6=)U[Q/IFIZD)#'9&ZTQEMT!7.0
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MI6,UI*+EW D(^8''3!_G0!VM%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*!A-MR!T''\S0!UM%>=:/;ZC9>.Y[+74D>XOX9I+:]MKQ]FT8R/+)PI ( (
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MJJ,  = !3J* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7,_\*ST/[&]FMQJ:VKN7:!;Q@A8]217944 9$GAK39?# \/&-QIXB6+:KX;
M(/4=\C)]:35/#.GZOH]OI=R;@6]N4,9CF*L"@^4Y[UL44 8MWX7L+[4WO;F2
M[E60J9+9YV,#[?NYC/!P<'ZBI_[!LSX@DULF<WCVWV7_ %I"B/.< #ISS6G1
M0!SMEX/L[*UEB^VZC/*\+P)<SW!>2%&ZB,_P]NGH*MZ;X;L-.60MYM[/+L\V
MXO'\UWV_=R3Z>U:]% '/?\(?810-#8W-]I\;W+W,@LYS'O9AR"1V]!VIL_@G
M1YK>WBC%S;-#$\(FMYV21T8Y8,P^]D\G/<UT=% &9%HMK:P>1;M)%;BV^S+$
MA^5%]1[^]2:-I%KH6E0Z;9F4V\((3S'W$ DG&?QJ_10 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
5110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>a123121ex-1021018.jpg
<TEXT>
begin 644 a123121ex-1021018.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M FGG3/ ^D6[)L<VZR,N",%_F.<]_FKHJ "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#@OBO>1Q^';*PF=D@OKZ*.9@?NQ@[F/0^@K;URSU>Y.D77A^2R
M$=H[2F&=F5)5,950-H]&/MG'I7144 <7IF@:[/KFI:_J/V.SOKBP-G!#;L6"
MG.0[-CDY ]>/I60^FWNB_#S3O!LQMO[3U3S;>-Q_JHQDNQ8\DG'&0.I'IFO2
MZJ7^EZ?JL:1ZA8VUVB'<JSQ*X!]1D4 <!X;M+_[+X@T#[%96FNI;(AU&*0R+
M-N4A2Q.6!P.GXXJ[=>#-2BM/"EAIQL!;:5()K@S;L&08^8!<;N2Q[<XSWKL[
M#3+#2XFBT^RM[2-CDK!$$!/X"K5 'G0\)>(XK;Q791RVCQ:HTDL5RTC"5BPP
M$/'  R.3W]ZM?\(IK$<G@N.+[$(='5A=+EMA.U5W <9;AB#V)SR*[NB@#SZZ
M\*:[<7?C(JUN(M7B5;=VE;>=H("GL!R:L1^$]2N(O!UI>+;"STE-]W&CYW2J
M@$> 5YYR2?<^U=S10!Q/C3PQJ&K:YI.JV=K9:A'9K(DEC>G$;[@0&Y!!Q].P
MKIM%M[JVTR..\@LH)LDF*S4B-!G@#/4XZG K0HZB@#S/39=;U#QCXIU/1[*T
MDE$BZ=#<3S )$$'S$@ EN=IQ_A4MQX'U729?#LFBBWO3ISS2W NI2@DE?'SX
M'ISCZ#K7::-X>TO0%G73+7R!.P>3]XS;F]?F)K3H \]BM[WPGJ'BG7]:CMYH
MKUU6V*DN[Y)5(\'HO*CD]A63X-T:Y\/^(M*TKQ!I0:=DFDL+A;OS(XF'S.%C
MZ(<$<C]>WI]_I]IJEC+97T"3VTJ[7C<<'_ ^_:J.F^&-&TBZ-U9V06X*[/-D
M=I&5?0%B2!SVZT <;HOA75]+UB[BFT+2[WSKYKK^U[MU9MA).-@&=_7T&377
M>+-532O#&J3K,$N([5VC"D;@Q&U2 ?\ :(K;K*O_  UHVJ:G!J-[813W<("I
M(Q/0'(!&<'!YY!H XYO"=Y#X+\*16UA]IET^>*[N;/>D9D8@EN3QN4MZC./I
M6@-$UO4-5O\ Q'>0+;WR636VFV0G#>62I)9FQC<2<<<>YKMJ* /,9_"FO'X=
M:'H\>FVYG@O(Y+FV:92"@R3N8\9+'G&>#CG%;$^G:Q8>.KK7HM'.HBXL4@B$
M5RBB!P1N!WX.#Z@$^W-=M10!Y[<^"K]/ NO0 K<ZYJ[BXG"L%3?N!V*3V'/)
MI\OA/7I/$6C2_;F$":2;*_NU8>83U(7ODYX;MC/I7?T4 >?>+]-US58+W1[?
MP_YEG L+:5>03QQM%(HY+9<$ 9P,#MWR,2^/)9CX>T;P_/.LMWJ=W;VT[A#\
MP!!=@ >.0/P)^M=Y5(Z-IC:D-2;3K4WP_P"7DPKYG3'WL9Z<4 6XXUBC6-!M
M10%4>@%.HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *:VX$;0#GKDT
MZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@!DLJPPO*^=J*6./05QMC\3-)N[*VO9K'4;6TN9_L\=Q+"#&6^H)]_RK2\
M>ZK_ &/X)U2Y!8.T)A0KP0S_ "@^V,YKF-,\&:K-X?T:PUF>QAT>P"7;P6\;
M&5W +$,W3&6.<9S0!Z517E.H^)-:U'PM<^(+/5Y;9KJ]%MI%G B_O%\P+E\J
M26(#'J,8]\5K>(M7U.V\26VDR:E=6L":6;DM9P"26YF!*[1E3CL>GY4 >@45
MYJ?$WB#2].\/Z/=?:+C6[T&XNVC@5Y8H02<!,8W8XY&!S77>$EUE=##:ZS&\
M>5W"OMW+&3\H.WC.* (?$?C/2_"\]M!?I=M)<?ZL00%@><8STS[=:L:KXGLM
M)U"SL'ANKB\NU9XH+>/<VT=2>1@?X&N/\2,^N_%S0=*C#F+3%^US>F?O#V[*
M/QK)\9W&H:QXAO\ 6] Q;S^&$,<\LC#,F<D[5QC &_KUS0!Z=H>N6/B+3%O]
M/=FA+%"'7:RL.H(]:TJYOP1;Z?9>"[":SB:"":$7,F]LG<PRQ)KE[WQ5K%WX
M2U+Q1!?_ &.S$PCTVVCB5S+M?;ER03\Q!&!C% ':Z[XCLO#ZV_VE+B66X9A%
M#;Q[W;:NYCCT ZU+_;EFN@)K<GG)9M"L_,3%PI /*@$]ZXVS@N]:^*TMQ)=S
MHNE6<1\ORT*HTHRT8..XSSUZC-;_ ,0-4_LCP-JMP" [P^2G/.7.WCZ9)_"@
M"33?&FBZGX?NM<CF>+3[:0QR23)MY '0=\[@![TFB^--,UN_CLH8[N"XEM_M
M,2W,6SS(\D;AR?2N2N?!MY<?!RPTG3T!NB([J2.1]FXGYF7)X&,]^.*A\&WD
MWBGXC2ZW;VKP:;I]B+)=[!L$?PY'7DL<^E 'JM%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 )D9QD9ZXJ*XO+:T"FYN(80QVKYCA<GT&>]>;1Z[*/&EOXB6._\ [/NY
MOL&^2/$'DG C=6[Y?<?Q_/2T;2M-U_Q-XF;688[VYANO)BBN &\J'&5V@] <
MGD>E '<&Y@49::,#('+"G"6,XPZ\].>M>5^-/"GA_0_#%H^F6D+-)J$<3SLV
M]B,ME<_48(]N:W+W1-,T_P >^&+:TLH8H3%>'8%X^Z#_ #8_G0!W!FB6,R-(
M@C7JQ88'XT&:)3@R(#Z%A7ET6EQPW=YX!6$M%)?QWJL5(7[+PS<^H*A?QJ%=
M*;4O&?BU8-'TN]\IX%VWA(V @@E?3@$GD=!B@#UG<N0-PR>0,T!E*[@05]<U
MR&BQ6NI>)KV^M=K66EVZ:?9LC[E)QN<Y[\%!U/2LNT9D^!A9&*L+!\$'!^\:
M /0RZJNYF 'J31O7CYA\W3GK7$>)M$N]7\):=)#+;&"SMUN)+:X1BLV$'!*D
M$<9_.JKRV]W>> +NWM5MHY#)LA5LB-3%T% 'H!=%8*64$] 3UI0ZLQ4,"1U
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M Y9O[Q.<Y-/TO1[/29+U[57#7EPUS-N<G+MUQZ"M&B@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
5BB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>a123121ex-1021019.jpg
<TEXT>
begin 644 a123121ex-1021019.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#WZBB@9S0
M44QI5SC(&/>D\^/IO7/UH DHIK,%&2P"^II$D1\;&5OH: 'T5%')YB;BI3)Q
MBE,T:N$9U!]">: )**9O ;V]:1IE4]: )**A-S IPTBY]C0;F''WNE $U%5Q
M>Q$X&34HE5NAH ?13=U-\Y [)GYE )'U_P#U4 244PNN,D]LT+(K=&&* 'T4
MT2*S%0>1S2&3:: 'T5'YOM1YR^] $E%1^<OO1YR^] $E%1^:"<<TI=1G(/6@
M!]%,W_A]:"P4@'/)H ?13-XSQ2[J '44W=3J "BC.*,YH ***8TBKZT /HIN
M\>E*&XH 6BD+4A<#DT .HI X84NZ@ HHZT4 %%&<4FZ@!:*3<M&X4 +12;AG
M&1]*%.X4 +1110 44FX9(QT&: V0#0 M%&ZC=0 44;J-U !132_S8IWO0 44
M4;J "BDW<X[^E*"#WH **,@=Z,YH ***-U !11UI"P7&>_% "T4@9<X]*1I%
M7 ]>E #J*-U'6@ HHHH **** "BBB@ HHHH **** "BC.*,YH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBHQ(-[*>,>M $E%
M%-9MHSM)^G- #J*:K N5]*4-G/M0 M%%&Z@ HHZT4 %%%% !1110 4444 %%
M%% !112,0JY- "T4BD%<BEH **** "BBB@ HSSBBB@"LQ1G8",\=:3RHR?\
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M;AP#2X .<4M)GF@!:*** "D(I:* &#K3L#T- &#UI>?6@!,#T-&!Z4O/K10
MFT9SBEHHH #TIM./2FT +@8QBFL@8YS3Z3@G% "*@7OFG8%,4L78$8 Z4^@
MIFS_ &C3Z,"@!A5@5(8X'6D*'/)SW%244 1A!G.*<44D$J..E.HH 9@TNT_W
MB*=1B@!H4C^(FE -*.** "BBB@"*>(RH%65H\-G*]_:I:**  TF#2T9H 3!I
M:,T4 ,=26&#@4X# I:3'O0 TR .JX/-.+8'-&*1EW'.: $^<],8I0&[TH& !
MZ4M " 'O2T44 %%%% $;^9O785V_Q9J2BB@ HHHH 3YO:D(8]P*=FC'.: &X
M<#J#2?/[4['-+0 T''6C)[\4I7-&/4YH 8VY<L&R".!35,Q8\*!]:E*@T@7'
M>@!<\<]::8QR6Y'84[;[T;>G)XH 6DZG!QQ2T@4!B: &*,,3WIW3I2D9HQ0
MF?7OZ4A9?,"]S3L4;1G..?6@!1TI#1DCM1UH !UI:3%+0 4444 (>M+28YI:
M "F,^WL:?1B@"NUP$*DG(/7 /%2+*KJ2N2H]J?B@ #I0!$\YC<KY3%0N=PH2
MX1VP#V_&I2,]Z38N<[1GUQ0 T2YF:/:<!<YJ2C SG%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 (1FE[444 %%%% !1110 4444 %,VFGT4 (.E+110 4444
M %%%% !28YI:* "BBB@ HHHH **** "BBB@ HHHH *3%+10 48&<]Z** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHK!\1>+++PU-917=K>S&\?RXC;Q!QNR,*>1R
M<\"@#>HK"M/%NF7?B.XT F:#4(LD1SQ[?-&,Y0]QCGZ T[4O%%CI6OZ=H]Q%
M<FXO^(71 4ZXY.?Z4 ;=%4]6U*'1]*N=1G25XK=-[K$NYB/85@R?$+0H_#=M
MKS-<?8;B80 B$EE;G.1Z#!Z9]LT =516/K7B;3]!TNWU&\$YMIY$13'$6(W#
M()'854'C;2/^$AN]$;[2EW:QM)(6A(4JHR2#]/P.>,T ='17#CXJZ"&@,MKJ
ML,%P2(;B2T.R7''RX))_ 5<3XD>&FM'NOM<RPQS+#(S6T@\MFR1NXX'!_*@#
MK**H:GK-GI.DOJET[_9$4,SQH7X/0X';FL>]\?\ AW3[33[F>[D\N_3?;[('
M8L,XZ <')QB@#IZ*YK2_'>@ZOJL.FVL\XNY@QC26W=-V 2>2/0&HK_XB>&].
MO+BUFNY7>W;;*T,#NJ'N"P&* .JHK$U#Q=HFF:7::C<W@$%XJM;A4+/*&&1A
M0,]#3M!\4Z1XD^T#3;@N]N0)8W0HRYZ'!&<4 ;-%9.N>)-*\-Q6\NJW)@2>3
MRT;8S#.,\X' IK>*='76[72#=@WEU$)H5"DJZG)&&QCH": -BBLN?Q%IEMKB
MZ-+<%;UH3.$*'&P9R<XQV/Y4[2-?TO7;:2YTR\2XAB;8[J" IQGN!V- &E16
M';^,/#]W8WE[!JD#VUGC[0XS^[SP,C&>:I?\+(\($_\ (<@_[X?_  H ZFBN
M>OO'/AG3;MK6[UBW290"RC+8R,CD CI6K9ZKI^H:?]OM+R&:TV[C*CC: !DY
M],=P>E %RBN5_P"%D>$/^@Y!_P!\/_A6Z=7TY=*&J->P+8%!(+@N FT^] %V
MBL+3/&?AS6+D6UCJ]M+.>%C+%68^@#8R?I4^H>*-#TF^%EJ&IV]M<&/S DC8
M^7GG/3L>.IH UJ*IV.KZ;J9<6&H6EV4P7$$RR;<],X/%7* "BJNH:C9Z5927
ME_<);V\>-TCG &>!5E65T5T8,K#((.010 M%%% !1110 444R::*WA>:>1(H
MD!9W=@JJ!U))Z"@!]%,BECGA2:&19(I%#(Z'*L#R"".HI] !114*W=L]T]JM
MQ$UPBAGB#@NH/0D=0* )J*** "BBB@ HHHH **8)8VE:(2*9%&2H/(_"GT %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK0!E>-G^Q^(_!8@1%4:CY87;P%8!>!]#1\58F;PE'&D?[J:^@6YV@ E,GO\
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M1L6-BQ+,>"20.,\#WXH LW/Q$N;..WBO-"%GJ%PSF.VN[Y(1Y:X^=G887.2
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M6<OF75V^II<W4L<)/F2-O9V.!ZG ^E '2?\ "S_#&R3;<W+2(F]8?LSAY/\
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M74],9&:5;G3S$8YK?!(!7/+= >O<^F: /2)(TE0I(BNC<%6&0:<!@8'2O/\
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M<.RH?DVGG!) )QC!-9>JZ]JJ>#/"+:%%;Z6+^Z6,0P,< [OD7..A.=WK[Y-
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M34I#)/'<.&0$YSM  QG=@_05A1_";0(9LQW6J);E]QM1<CRC[$;<D?C7=T4
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MNGV$GFVME.5V*W\.[CYL=NF.V.E:VG^&$L/%.H:[_:%W-)>QA&AD(V( 01C
M'3&!Z GKFMZB@#%\4^'(/%.B/IEQ/)"C.KAXP"00?>J5OX1=/$UEKMWJ]Q=W
M-K;F "2-%# @Y/R@>IKIZ* .%/PRLGTBYLY=1N&N);TWR7:JJR12'&<8['_#
MTK7\.>$QH-S-=SZMJ&IW<J"/S;N4MM3.< ?7WKHZ* .9USP<FJ:U!K-GJ=WI
MFHQ1^4TT!!$B9R%93P>:QH_A="EHR?VU=M=F^6_%TR*7$@!Y(/!R3GFN_HH
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MOM76T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY95)W>;NST QWQ^&*]0T/24T/1K;3HYI)A"F#)(Q)=NI/).,G/':@#1HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC &%^4'L,#KSBN8\+_#^?2O"VJ>'M5O(;FRO6WCR$*LC$ $Y/^ZI'':N\HH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***IZKJ5MH^EW.HW;[8
M+="['^0'N3@?C0!SGCKQDWANUAL]/B%SK-X=MO !N*YXW%>I]O4UE>%OAQLN
MVUKQ6XU'5I&WA)&\Q(^.AS]XC\A@8JO\.-)EUO4+KQSJP#7=U(ZVJ8XB0?+D
M?AE?H#ZUZ90 BJ%4*H 4#  ' %+16!XL\66'A+2C=71WS/D06ZG#2M_0#N:
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M0/$=NRZG9*)#*<?,K= <<9Y'([?2N[I-J[BV!N(P3CG'^32T %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M00O(L*]7(&0!]:\O\->'=:\;>(QXE\4QO#:0/FWLI%(4D=@IZ*" 3ZFO7**
M"O$_BC>67B;Q+8Z1HL$MUK-NYB>2/.T#KM_ Y)/;^7H7C_5=7TKPV3HMI+/=
MW$@@#1IN,0;(W8]<X ]S5'X>^ XO"]I]MO,2:O.F)'R2(U/.T>_3)H D\/>$
M!X,T'4;NU+WVMRP/(TS@DR. 2% STW?B:X#PKX)\2>)9KZ76);G3[*ZDWW4C
M+MFN#S\HS_"#CKQZ9QQ[G10!Y3IGPFU)0FG:KK:R:'#.9DM;=2IE/J_''0>O
M?&.M7_B#+XD\,:7:S>&/*M](MH3'+%#""T1_O<@\=.?7)/6O1Z",C!Z4 ?.^
M@^"/%>K6&H:RCW%L[PNR.Y/FW9(.4'.<'U/7CK70:!\(-3GT>1-6U*2T64%Q
M90MD;P/E+GD=<= ?K7M%% 'DFA_!VX%ND.O:O(]JDOF"RMF.PGIDD]"?8?C7
M1ZO\+] N?#\MCIEG%9W8PT-SR7#CIECDX/>NXHH RO#=KJ=EX?M+?6+I;F_1
M,22KWYX&>Y P,]\5JT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MKQC)]*ZFWOK2[>9+:Z@F>%MDJQR!C&WHV.A]C4] '*_\)/KW_0EZA_X$P_\
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M1G=@JJ,EB< "H8;ZTN&=8+J"5D&6"2!BH]\=* .4A\?R-$#-X0\3QR=U2P+
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M_<U'_P  9/\ "NOHH Y#_A9.@_W-1_\  &3_  H_X63H/]S4?_ &3_"NOHH
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M4 8G_"R_!_\ T&XO^_4G_P 31_PLOP?_ -!N+_OU)_\ $UM_\(_HO_0(L/\
MP&3_  H_X1_1?^@18?\ @,G^% &)_P ++\'_ /0;B_[]2?\ Q-'_  LOP?\
M]!N+_OU)_P#$UM_\(_HO_0(L/_ 9/\*/^$?T7_H$6'_@,G^% &)_PLOP?_T&
MXO\ OU)_\35JU\>>%;P?NM=LA\VW$K^6<XS_ !8X]ZT?^$?T7_H$6'_@,G^%
M T#1@<C2+#_P&3_"@#1HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !2'I2T4 )S2T44 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M ZVTL<21LPZ%MI&<>]>O DJ"1@^GI2T4 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH KWE]::=;FXO;J"VA! ,D\@1<GH,GBL__A+?#7_0
MPZ3_ .!L?_Q5/\22VMOH5S<WFE_VE!"/,:W$:OD#OAN..M9&@6_@_P 2:.FI
M:=HFFNAX:,V<0=&'52,<&@#4_P"$M\-?]##I/_@;'_\ %4?\);X:_P"AATG_
M ,#8_P#XJL7PTGA?Q-#>/#X7LK9K2X-O(DUG%G<.O0&MS_A%O#W_ $ =+_\
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MF5@0>AX/2N27P]X%?Q&^@KHEO]N2#[0P\IMNW..OKS6I_P *_P#"?_0"M/\
MOD_XT ;WVNV_Y^(O^^Q1]KMO^?B+_OL5@_\ "O\ PG_T K3_ +Y/^-'_  K_
M ,)_] *T_P"^3_C0!LVVJZ=>PB:UO[6>(G >*967/U!J7[7;?\_$7_?8K!_X
M5_X3_P"@%:?]\G_&C_A7_A/_ * 5I_WR?\: -[[7;?\ /Q%_WV*/M=M_S\1?
M]]BL'_A7_A/_ * 5I_WR?\:IO\+_  B]Y]I_LH [@=@E8)Q_LYQB@#JOM=M_
MS\1?]]BC[7;?\_$7_?8KCC\)O!Y)/]GR_P#@0_\ C1_PJ7P?_P! ^7_P)?\
MQH ['[7;?\_$7_?8H^UVW_/Q%_WV*Y)_A7X0>"*+^S"!'G#+,X9L^ISS4?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 44'BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** &AF*Y*8/I3J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHI'&Y" <9'6@!:*11A ,Y]S2T %
M%%% !10>!29X'O0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 '6CKQ11C
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%'/:@"&*25V;='M4=#GK4U HH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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*1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>avdl-20211231_g1.jpg
<TEXT>
begin 644 avdl-20211231_g1.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %L J,# 2(  A$! Q$!_\0
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M:]5HH \J_P"%R>+O^B%?$#_P.\/?_+6C_A<GB[_HA7Q _P# [P]_\M:]5HH
M\J_X7)XN_P"B%?$#_P #O#W_ ,M:/^%R>+O^B%?$#_P.\/?_ "UKU6B@#RK_
M (7)XN_Z(5\0/_ [P]_\M:/^%R>+O^B%?$#_ ,#O#W_RUKU6B@#RK_A<GB[_
M *(5\0/_  .\/?\ RUH_X7)XN_Z(5\0/_ [P]_\ +6O5:* /*O\ A<GB[_HA
M7Q _\#O#W_RUH_X7)XN_Z(5\0/\ P.\/?_+6O5:* /*O^%R>+O\ HA7Q _\
M [P]_P#+6C_A<GB[_HA7Q _\#O#W_P M:]5HH \J_P"%R>+O^B%?$#_P.\/?
M_+6C_A<GB[_HA7Q _P# [P]_\M:]5HH \J_X7)XN_P"B%?$#_P #O#W_ ,M:
M/^%R>+O^B%?$#_P.\/?_ "UKU6B@#RK_ (7)XN_Z(5\0/_ [P]_\M:/^%R>+
MO^B%?$#_ ,#O#W_RUKU6B@#RK_A<GB[_ *(5\0/_  .\/?\ RUH_X7)XN_Z(
M5\0/_ [P]_\ +6O5:* /*O\ A<GB[_HA7Q _\#O#W_RUH_X7)XN_Z(5\0/\
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MK_A<GB[_ *(5\0/_  .\/?\ RUH_X7)XN_Z(5\0/_ [P]_\ +6O5:* /*O\
MA<GB[_HA7Q _\#O#W_RUH_X7)XN_Z(5\0/\ P.\/?_+6O5:* /*O^%R>+O\
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MCDD#D#J16#HW[2?A>^\/^(]7UBQUSP?'X?2&2^M?$6GFUN%64L(MJ MNW%"
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M!L_A']A73KB^#'5M=U:'6KUW&&9YRS*3[^6$_'- 'UI\-_B]_P +&U"[M?\
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M53DCJ >U6[7PMHMCK#:O;Z186^JM +5KZ*V19S",8C,@&[8-J_+G' ]*U**
M,ZW\-Z3:ZY<ZS#I=E#K%U&L4^H1VZ+<2H,85Y -S 8& 3V%4M4\ ^&-<O[B^
MU+PYI.H7MQ!]EFN;JQBEDDASGRV9E)*<#Y3Q6]10!BW_ ()\/:KIVGZ?>Z#I
MEY8:<4:RM;BSC>*V*#:AC4KA-HX&W&!TJ-O /AAH-2@;PYI)AU.8W%]&;&+;
M=RDDF24;?G;)/+9/-;U% &3X=\(Z%X0M7MM"T73]$MW.YH=.M8[=&/J0@ )Y
M-9T/PO\ !EOJXU6+PCH46J!_,^W)IL(GW?WMX7=GWS73T4 9\OA_2I]:@UF3
M3+.35X(C!%J#0(;B.,DDHLF-P4DG@''-0P>$=#M?$$^NPZ+I\6N3IY<NIQVL
M:W,B\?*TH&XC@<$]A6M10!2U?1=/\06$ECJEA;:E92??MKR%98V^JL"#5'PY
MX)\.^#EE70- TO0UE_U@TVSCMP^/78HS6W10!FZ'X;TGPS;SP:/I=EI,$\S7
M$L=C;I"LDK !I&"@98X&2>3@4NN^&])\46:6FLZ79:O:I(LRP7UNDR*XSA@K
M @,,G!Z\UHT4 9^N^'M*\4::^GZSIEGJ]A(0SVM];I/$Q!R"48$'!YZ5'K?A
M71?$VEKINL:18:KIRE6%G?6R30@K]T[&!'';CBM2B@#,O?"^C:EH/]AW>DV-
MUHOEI%_9LULCVVQ,;%\LC;A=JX&,# QTK-\/_#/P?X2OS?:'X4T/1KW88_M.
MGZ=#!)M.,KN10<' X]JZ6B@#/UWP]I7BC37T_6=,L]7L)"&>UOK=)XF(.02C
M @X//2H=>\(Z%XITV+3M:T73]7T^)U>.TO[6.>)& (#!&! (!(!QT)K6HH Y
M"S^#O@+39(Y+3P1X<M9(Y4G1H=)MT*R)G8X(3AER<'J,G%;FO>&='\56<=IK
M>DV.L6L<@F2"_MDG19 " X5P0&&3SUY-:=% &39^$="T]=46UT73[9=5=I-0
M$-K&@O&;.YI<#]X3DY+9SDU8T70]-\-Z9#IVD:?:Z7I\.?*M+*%88H\L6.U%
M  R23P.I-7J* .;OOAKX1U/6/[7O/"NB7>K;MWVZ?3H7GSZ^85W9_&K'B3P+
MX;\9>5_;_A_2M<\G_5_VE917&SZ;U./PK<HH R+GPCH5YX?.@W&BZ=/H9 4Z
M9):1M;8#!@/*(VX# 'IU&:6X\(Z%=:AIM]/HNGS7VFKLL;F2UC:2U7&,1,1E
M!CCY<5K44 9]CX>TK2]2U#4++3+.TO\ 4"C7EU!;HDMR4!"&1P,O@$@9)QDU
ME:9\-/"&BZM_:FG^%-$L-3SN^V6NG0QS9/4[U4']:Z6B@#F=?^&/@[Q7J!O]
M;\):'K%\5"&ZU#389Y2HZ#<ZDX'I5WPWX+\/>#8YX] T'3-#2<AI5TVSCMQ(
M0, L$49QD]?6MFB@#!F\ ^&+B7599?#FDRR:LH74'>QB)O .@F.W]X!_M9J;
M4/!N@:OH<&BWVAZ;>Z- J+#IUQ:1R6\8080+&1M 4<# X[5L44 9/B+PGH?C
M"SCM->T;3];M(W\U(-1M8[A%?!&X*X(!P2,^YIVL>%=%\1:2NE:KH]AJ>F+M
MQ97ELDL(V_=^1@5X[<<5J44 <]X;^'?A3P==2W.@>&-'T.YE3RY)M-L(K=W7
M(.TE%!(R <>U7]<\-Z3XFMX(-8TNRU:""9;B*.^MTF6.500LBA@<,,G!'(R:
MTJ* ,_7/#^E^)M/:QUC3;/5K)CN:VOH$FC)]2K CN:@\.^$-"\'V\EOH.B:=
MHD$AW/%IUI';JQ]2$ !/)_.M>B@##O/ OAK4;K4[F[\/:5=7&J1K#?S3643O
M=HN J2DKEU&U<!L@8'I5Y]"TV313H[Z=:MI'D?9?[/:!3;^3MV^7Y>-NS;QM
MQC'%7J* .0O/@[X"U!;=;KP1X<N5MXA!")M)MW$48)(1<IPH+$X'')K;3POH
ML?A_^PDTBP70_*,']F+;(+;RSU3RL;=OMC%:E% &'>>!_#FHZ+9Z/=^']+NM
M(LV5[:PFLHW@@900I2,KM4@$@8'&36=JOPB\"Z[J$]_J7@KP[J%]<-OFNKK2
MH)99&]69D))^M=;10!D7_@_0=4M=.MKW1-.O+;3722RAN+2-TM6081H@1A"H
MX!7&*LZSH>F^(]/>QU;3[75+*3[]M>0+-&V/56!!J]10!D>'?"&A>#[>2WT'
M1-.T2"0[GBTZTCMU8^I"  GD_G4-OX#\,VOAZ;08/#NDPZ%,2TNF1V,2VTA)
M!):(+M/(!Y'85NT4 9&F>$="T6^%[I^BZ=87@MDLQ<6MI''(($ "1;E .Q0!
MA>@P,"ETWPGH>C:K?:GI^C:?8ZE?'==WEM:QQS7!SG,CJ 7YYY)K6HH ****
M "BBB@ HHHH **** "BBB@ HHHH *\J\1_\ )TWP\_[$SQ+_ .EVA5ZK7E7B
M/_DZ;X>?]B9XE_\ 2[0J /5:*** /*O$?_)TWP\_[$SQ+_Z7:%7JM>5>(_\
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M!+?_ !NKM% %+SM1_P"?6U_\"6_^-T>=J/\ SZVO_@2W_P ;J[10!2\[4?\
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M )];7_P);_XW1YVH_P#/K:_^!+?_ !NKM% %+SM1_P"?6U_\"6_^-T>=J/\
MSZVO_@2W_P ;J[10!2\[4?\ GUM?_ EO_C='G:C_ ,^MK_X$M_\ &ZNT4 4O
M.U'_ )];7_P);_XW1YVH_P#/K:_^!+?_ !NKM% %+SM1_P"?6U_\"6_^-T>=
MJ/\ SZVO_@2W_P ;J[10!2\[4?\ GUM?_ EO_C='G:C_ ,^MK_X$M_\ &ZNT
M4 4O.U'_ )];7_P);_XW1YVH_P#/K:_^!+?_ !NKM% %+SM1_P"?6U_\"6_^
M-T>=J/\ SZVO_@2W_P ;J[10!2\[4?\ GUM?_ EO_C='G:C_ ,^MK_X$M_\
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M/,R)&_\ =C<L/S('\JDHH **** "O*O$?_)TWP\_[$SQ+_Z7:%7JM>5>(_\
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M[J9YKB2XEFF?&Z2261F=V. ,LQ. !T H V))4AC9Y'6-%Y+,< ?C57^VM/\
M^?\ M?\ O\O^-7:* *7]M:?_ ,_]K_W^7_&C^VM/_P"?^U_[_+_C5VB@"E_;
M6G_\_P#:_P#?Y?\ &C^VM/\ ^?\ M?\ O\O^-7:* *7]M:?_ ,_]K_W^7_&C
M^VM/_P"?^U_[_+_C5VB@"E_;6G_\_P#:_P#?Y?\ &C^VM/\ ^?\ M?\ O\O^
M-7:* *7]M:?_ ,_]K_W^7_&C^VM/_P"?^U_[_+_C5VB@"E_;6G_\_P#:_P#?
MY?\ &C^VM/\ ^?\ M?\ O\O^-7:* *7]M:?_ ,_]K_W^7_&C^VM/_P"?^U_[
M_+_C5VB@"E_;6G_\_P#:_P#?Y?\ &C^VM/\ ^?\ M?\ O\O^-7:* *7]M:?_
M ,_]K_W^7_&C^VM/_P"?^U_[_+_C5VB@"E_;6G_\_P#:_P#?Y?\ &C^VM/\
M^?\ M?\ O\O^-7:* *7]M:?_ ,_]K_W^7_&C^VM/_P"?^U_[_+_C5VB@"E_;
M6G_\_P#:_P#?Y?\ &C^VM/\ ^?\ M?\ O\O^-7:* *7]M:?_ ,_]K_W^7_&C
M^VM/_P"?^U_[_+_C5VB@"E_;6G_\_P#:_P#?Y?\ &C^VM/\ ^?\ M?\ O\O^
M-7:* *7]M:?_ ,_]K_W^7_&C^VM/_P"?^U_[_+_C5VB@"E_;6G_\_P#:_P#?
MY?\ &C^VM/\ ^?\ M?\ O\O^-7:* *7]M:?_ ,_]K_W^7_&C^VM/_P"?^U_[
M_+_C5VB@"E_;6G_\_P#:_P#?Y?\ &C^VM/\ ^?\ M?\ O\O^-7:* *7]M:?_
M ,_]K_W^7_&C^VM/_P"?^U_[_+_C5VB@"E_;6G_\_P#:_P#?Y?\ &C^VM/\
M^?\ M?\ O\O^-7:* *7]M:?_ ,_]K_W^7_&C^VM/_P"?^U_[_+_C5VB@"E_;
M6G_\_P#:_P#?Y?\ &C^VM/\ ^?\ M?\ O\O^-7:* *7]M:?_ ,_]K_W^7_&C
M^VM/_P"?^U_[_+_C5VB@"E_;6G_\_P#:_P#?Y?\ &C^VM/\ ^?\ M?\ O\O^
M-7:* *7]M:?_ ,_]K_W^7_&C^VM/_P"?^U_[_+_C5VB@"E_;6G_\_P#:_P#?
MY?\ &C^VM/\ ^?\ M?\ O\O^-7:* *7]M:?_ ,_]K_W^7_&C^VM/_P"?^U_[
M_+_C5VB@"E_;6G_\_P#:_P#?Y?\ &C^VM/\ ^?\ M?\ O\O^-7:* *7]M:?_
M ,_]K_W^7_&C^VM/_P"?^U_[_+_C5VB@"E_;6G_\_P#:_P#?Y?\ &C^VM/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MWS%_\11]@G_Z"5U_WS%_\10!=HJE]@G_ .@E=?\ ?,7_ ,11]@G_ .@E=?\
M?,7_ ,10!=HJE]@G_P"@E=?]\Q?_ !%'V"?_ *"5U_WS%_\ $4 7:*I?8)_^
M@E=?]\Q?_$4?8)_^@E=?]\Q?_$4 7:*I?8)_^@E=?]\Q?_$4?8)_^@E=?]\Q
M?_$4 7:*I?8)_P#H)77_ 'S%_P#$4?8)_P#H)77_ 'S%_P#$4 7:*I?8)_\
MH)77_?,7_P 11]@G_P"@E=?]\Q?_ !% %VBJ7V"?_H)77_?,7_Q%'V"?_H)7
M7_?,7_Q% %VBJ7V"?_H)77_?,7_Q%'V"?_H)77_?,7_Q% %VBJ7V"?\ Z"5U
M_P!\Q?\ Q%'V"?\ Z"5U_P!\Q?\ Q% %VBJ7V"?_ *"5U_WS%_\ $4?8)_\
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M_H)77_?,7_Q% %VBJ7V"?_H)77_?,7_Q%'V"?_H)77_?,7_Q% %VBJ7V"?\
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M_P"^8O\ XBC[!/\ ]!*Z_P"^8O\ XB@"[15+[!/_ -!*Z_[YB_\ B*/L$_\
MT$KK_OF+_P"(H NT52^P3_\ 02NO^^8O_B*LP1M#'M:5YS_>D"@_H * )***
M* "O*O$?_)TWP\_[$SQ+_P"EVA5ZK7E7B/\ Y.F^'G_8F>)?_2[0J /5:***
M /*O$?\ R=-\//\ L3/$O_I=H5>JUY5XC_Y.F^'G_8F>)?\ TNT*O5: "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@"[15+[?/_T#;K_OJ+_XNC[?/_T#;K_OJ+_XN@"[15+[?/\ ] VZ_P"^HO\
MXNC[?/\ ] VZ_P"^HO\ XN@"[15+[?/_ - VZ_[ZB_\ BZ/M\_\ T#;K_OJ+
M_P"+H NT52^WS_\ 0-NO^^HO_BZ/M\__ $#;K_OJ+_XN@"[15+[?/_T#;K_O
MJ+_XNC[?/_T#;K_OJ+_XN@"[15+[?/\ ] VZ_P"^HO\ XNC[?/\ ] VZ_P"^
MHO\ XN@"[15+[?/_ - VZ_[ZB_\ BZ/M\_\ T#;K_OJ+_P"+H NT52^WS_\
M0-NO^^HO_BZ/M\__ $#;K_OJ+_XN@"[15+[?/_T#;K_OJ+_XNC[?/_T#;K_O
MJ+_XN@"[15+[?/\ ] VZ_P"^HO\ XNC[?/\ ] VZ_P"^HO\ XN@"[15+[?/_
M - VZ_[ZB_\ BZ/M\_\ T#;K_OJ+_P"+H NT52^WS_\ 0-NO^^HO_BZ/M\__
M $#;K_OJ+_XN@"[15+[?/_T#;K_OJ+_XNC[?/_T#;K_OJ+_XN@"[15+[?/\
M] VZ_P"^HO\ XNC[?/\ ] VZ_P"^HO\ XN@"[15+[?/_ - VZ_[ZB_\ BZ/M
M\_\ T#;K_OJ+_P"+H NT52^WS_\ 0-NO^^HO_BZ/M\__ $#;K_OJ+_XN@"[1
M5+[?/_T#;K_OJ+_XNC[?/_T#;K_OJ+_XN@"[15+[?/\ ] VZ_P"^HO\ XNC[
M?/\ ] VZ_P"^HO\ XN@"[15+[?/_ - VZ_[ZB_\ BZ/M\_\ T#;K_OJ+_P"+
MH NT52^WS_\ 0-NO^^HO_BZ/M\__ $#;K_OJ+_XN@"[15+[?/_T#;K_OJ+_X
MNC[?/_T#;K_OJ+_XN@"[15+[?/\ ] VZ_P"^HO\ XNC[?/\ ] VZ_P"^HO\
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M_P!]1?\ Q='V^?\ Z!MU_P!]1?\ Q= %VBJ7V^?_ *!MU_WU%_\ %T?;Y_\
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M/C)*6MC D,2DG)(10 ,DD].]:%% !1110 4444 %%%% !1110 4444 %%%%
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M)-&DTV[RHV8!GP,G:.^!UQ3UF1Y'175G3&Y0>5STR.U #Z*16#*"#D'D$4M
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MJJ*D<9=RJJJ <LQ)).><#LZ* &21)-&R2(LB-P589!_"JO\ 8NG_ //A:_\
M?E?\*NT4 4O[%T__ )\+7_ORO^%']BZ?_P ^%K_WY7_"KM% %+^Q=/\ ^?"U
M_P"_*_X4?V+I_P#SX6O_ 'Y7_"KM% %+^Q=/_P"?"U_[\K_A1_8NG_\ /A:_
M]^5_PJ[10!2_L73_ /GPM?\ ORO^%']BZ?\ \^%K_P!^5_PJ[10!2_L73_\
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M?C[P[9:]X<U6TUO1KU/,M[ZQE$D4@]B.X/!!Y!!!P16Q0!2_L73_ /GPM?\
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M U/I?[27B.;]G[7_ (CZK\'/&&E:OI5U) G@SR/.U.[19DC6:-0H)0A]Y..
MCD;@ S=)XF^/EOX5UOX7Z7<>#_%%S<>.Y/+C:UT_S$TD^6CG[:V[$6/,P<9^
MY(?X: )_CCXX^)'@G2M-E^&_PTC^)-]<3/'=02Z]!I2VB!<K(6E!W@GC"\C'
MOQ_.=\6)/%$GQ.\4MXU2XC\7'4ISJJ79S*MSO/F!O?=FOZ.?#OQLTSQ)\9O%
MOPWAT77;;4_#=G;7L^IW-B4T^X290RK#+GYV&[!&!RK8)VG'\S= 'Z4_\$O/
M"?[0/BSX8^+;?X>^/;#P'X.34DQ=:IHXU%GNC'^]^SJY"#"B+?GKN2OU8^&O
MA_Q%X7\#Z7I?BSQ2WC7Q#;JXN]=:QBLC=,79E/DQ?*@52J<==N3DDU^1W_!'
MGXJZEX#\<>+= LO!&N>)[7Q1?:3:76K:9$6MM&5%O2);EL$*K;CC)'"/SD '
M]5?#OQ#\4ZM\9/%WA*]\!7VE^&-)L[:XT[Q=+<JUOJDDB@R1+&!E2A)&<G[I
MR%RNX \KTW_@G7\$(=>.M:SH&I>,-6\_STNO$FM7=X4;.0 ID"D#'\0/O7TO
M7@>F>*OV@O%7[/.L:C_PAGAOP=\8!=O%8:3J-\;JP,*SH/,=XF/)B\S W8)"
MDX#8'5>*/#OQ7U;Q=\,]1T?Q5H^A:)8^8WC'2/L7G?VCNC3"6\C*60*X?!RI
MP026P5(!ZE5/5M9T_0-/EOM4OK;3;*+'F7-W,L4:9.!EF( R2!^-<)X=^%^O
MZ3\4_''B74?'VK:SX<\0V]O!9>%YD"0:0R)MD>&16SESD\!2,\EB 1RNA_L>
M^ K/X GX/>()-:\;^$FN&NG;Q!J+O=N_G><O[V+RRNU@.%P#SD'<<@'I&O?%
M+PEX7\:>'_".JZ_96'B7Q )3I>F328FNA&I9RH]@#UQGH,FN9\/_ +0GAOQ?
MXP^)/A/0;75-2\2> XXVU&Q%J8_/>2-Y(XX&8@.6V8YP/F'4'-=;)\._"\VJ
M:!J<OA[3)]3\/Q-#I-_-:H]Q8QLFQEAD(+("O! /..:Z':-Q..>F: /!+KXN
M?%[QO^SSH/C/P'\,8])\=ZA=H+GPCXRG:W>UMQ.\<K,Q\LAMJAUR <-G:2-I
M[?7/#_Q(NOC7X7UC2_%6FV?PTM]/GBUGPY)8A[J[NB&\J6.?;E54E. 5^X<A
MMPV^BT4 >1^'?V>TLD^*]EXB\8^(O&.A^/[B=I-*U2[81:7;31NDEM:E"&C3
M;(5RI! 1.X+'1T+]G'X=Z)\,_"O@)_#5IJ_AKPQ+'<:7;:NOVLP3H6*S!GR=
M^7?G_:(&!Q7I=% #/)0RB78OFA2H?'(!P2,^G _*O+?CI^RW\,?VE/[$_P"%
MC^&?^$C_ +%\_P"P?Z?=6OD^=Y?F_P"HE3=GRH_O9QMXQDY]5HH ^5?^'7'[
M,7_1,_\ ROZI_P#)-?55%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7E7B/_DZ;X>?]B9X
ME_\ 2[0J]5KRKQ'_ ,G3?#S_ +$SQ+_Z7:%0!ZK1110!Y5XC_P"3IOAY_P!B
M9XE_]+M"KU6O*O$?_)TWP\_[$SQ+_P"EVA5ZK0!XC^TM'#9KX=UFWU#6-'\2
MV'VI=%O+#2CJ5O+/*J(UI- %8DS)N5#P 58[L@*W,ZA!=K\3OA+?R>$;K1=6
MM]'NX-:DT?0[EK2TN)[6WC@C\Z.)E*H591AF$87!( S7TI10!\(W/PW\8:GX
M/T*UM?#&LPS^&] %IK5M)92QF\<:K%,\4)*@7.4CDE_=E@<CG<P!^E_@1IFH
M17GQ UBXM+RPTS6O$4UYI]O?6TEM*T?E1HTIBD"NF]D/# $[<XY%>KUF^)M%
M/B3PYJNDB_O-*-_:2VHO]/=4N;;>A7S8F964.N=RDJ0"!D'I0!_+37V+_P $
MTM>^,OA7XFZWK7PJT%_&>FV4$;>(/"R:O;6'VZ)DF2"3]\?F\IV+909!(4D!
M^?N3_ARK\$/^AI^('_@PL?\ Y#KT[]G/_@FW\._V8/B9;>-_"'BGQG-J,=O-
M:2VFI7MI);7,,BX*2*ELC$!@CC##YHU)R 00#Y=\5:#;^(M:\37?QF^$/[05
M]9ZSJMQJC6-EYFH:78-*,&-/LUP@\M< +D-@*HZ9SU/@?X@?L4>%_ >G?#_4
M[8>'+6VU&'5OL_BSP]J4%U->PAE2>693@LH=Q@L%PS#;@D5^E55K_3K35;5K
M:]M8;RW;[T-Q&'0_4$8H \.\._'KX%>.?%%KXETSXA_#>_\ $\5L;*#4'FMD
MU!("Q8Q*SRB4(22=O3)/K7L.EWAU6W-UIVIZ;>0R'<9K6+>K' &=RR<\ ?D*
MX+Q-^RC\&/&6]M8^%?A"[E;[T_\ 8UNDI_[:*H;]:\SU+_@FG^S[<7+7>F>$
M+SPS?'_EZT+6KVV<?0"4J/\ OF@#Z5\K4?\ GZM?_ 9O_CE'E:C_ ,_5K_X#
M-_\ '*^8/^&#;G0?F\(_'_XO>'<?<MIO$(OK5/I%)'_6C_A0G[3?AGG0OVE;
M778%^Y9^)?!UJ?SFB;>?RH ^G_*U'_GZM?\ P&;_ ..4>5J/_/U:_P#@,W_Q
MROF#^U_VR_"/_'SH'PI\?VR]/[-O+S3;IQ_M>:#&#]*/^&L?C+X7X\9?LM>+
M8%7[TOA35[36]P]52/:?PZT ?3_E:C_S]6O_ (#-_P#'*/*U'_GZM?\ P&;_
M ..5\PK_ ,%)/A7I#!?&>B^._APV<,/%7A6ZAV?7RA)7?>$_VVO@-XV:-=+^
M*_A?S)/N17U^MF['T"S[#GVQ0![!Y6H_\_5K_P" S?\ QRCRM1_Y^K7_ ,!F
M_P#CE+I6L6&NV:7FFWMOJ%H_W;BUE66-OHRD@U<H I>5J/\ S]6O_@,W_P <
MH\K4?^?JU_\  9O_ (Y5VN;\+_$;PWXUUGQ+I.AZO!J.H^&[U=/U6WBSFUG,
M:R!#D8/RN.5R,AESN5@ #7\K4?\ GZM?_ 9O_CE'E:C_ ,_5K_X#-_\ '*NT
M4 4O*U'_ )^K7_P&;_XY1Y6H_P#/U:_^ S?_ !RKM% %+RM1_P"?JU_\!F_^
M.4>5J/\ S]6O_@,W_P <J[10!2\K4?\ GZM?_ 9O_CE'E:C_ ,_5K_X#-_\
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M )_[7_O\O^-7:* *7]M:?_S_ -K_ -_E_P :/[:T_P#Y_P"U_P"_R_XU=HH
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2,H=2K
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M_A_6K7=Y&HZ7H-K;7$.Y2C;)$C#+E693@\AB.AKT"J7V"?\ Z"5U_P!\Q?\
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M^P3_ /02NO\ OF+_ .(H NT52^P3_P#02NO^^8O_ (BC[!/_ -!*Z_[YB_\
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M]@G_ .@E=?\ ?,7_ ,10!=HJE]@G_P"@E=?]\Q?_ !%'V"?_ *"5U_WS%_\
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M^6+[3>[$"#[1*2\@ ' "EMHQ@84<"@#T"BBB@ HHHH **** "BBB@ HHK/\
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MC_\ ':/^&L/@A_T63X?_ /A46/\ \=KU6B@#RK_AK#X(?]%D^'__ (5%C_\
M':/^&L/@A_T63X?_ /A46/\ \=KU6B@#RK_AK#X(?]%D^'__ (5%C_\ ':/^
M&L/@A_T63X?_ /A46/\ \=KU6B@#RK_AK#X(?]%D^'__ (5%C_\ ':/^&L/@
MA_T63X?_ /A46/\ \=KU6B@#RK_AK#X(?]%D^'__ (5%C_\ ':/^&L/@A_T6
M3X?_ /A46/\ \=KU6B@#RK_AK#X(?]%D^'__ (5%C_\ ':/^&L/@A_T63X?_
M /A46/\ \=KU6B@#RK_AK#X(?]%D^'__ (5%C_\ ':/^&L/@A_T63X?_ /A4
M6/\ \=KU6B@#RK_AK#X(?]%D^'__ (5%C_\ ':/^&L/@A_T63X?_ /A46/\
M\=KU6B@#RK_AK#X(?]%D^'__ (5%C_\ ':/^&L/@A_T63X?_ /A46/\ \=KU
M6B@#RK_AK#X(?]%D^'__ (5%C_\ ':/^&L/@A_T63X?_ /A46/\ \=KU6B@#
MRK_AK#X(?]%D^'__ (5%C_\ ':/^&L/@A_T63X?_ /A46/\ \=KU6B@#RK_A
MK#X(?]%D^'__ (5%C_\ ':/^&L/@A_T63X?_ /A46/\ \=KU6B@#RK_AK#X(
M?]%D^'__ (5%C_\ ':/^&L/@A_T63X?_ /A46/\ \=KU6B@#RK_AK#X(?]%D
M^'__ (5%C_\ ':/^&L/@A_T63X?_ /A46/\ \=KU6B@#RK_AK#X(?]%D^'__
M (5%C_\ ':/^&L/@A_T63X?_ /A46/\ \=KU6B@#RK_AK#X(?]%D^'__ (5%
MC_\ ':/^&L/@A_T63X?_ /A46/\ \=KU6B@#RK_AK#X(?]%D^'__ (5%C_\
M':/^&L/@A_T63X?_ /A46/\ \=KU6B@#RK_AK#X(?]%D^'__ (5%C_\ ':/^
M&L/@A_T63X?_ /A46/\ \=KU6B@#RK_AK#X(?]%D^'__ (5%C_\ ':/^&L/@
MA_T63X?_ /A46/\ \=KU6B@#RK_AK#X(?]%D^'__ (5%C_\ ':/^&L/@A_T6
M3X?_ /A46/\ \=KU6B@#RK_AK#X(?]%D^'__ (5%C_\ ':/^&L/@A_T63X?_
M /A46/\ \=KU6B@#RK_AK#X(?]%D^'__ (5%C_\ ':/^&L/@A_T63X?_ /A4
M6/\ \=KU6B@#RK_AK#X(?]%D^'__ (5%C_\ ':/^&L/@A_T63X?_ /A46/\
M\=KU6B@#RK_AK#X(?]%D^'__ (5%C_\ ':/^&L/@A_T63X?_ /A46/\ \=KU
M6B@#RK_AK#X(?]%D^'__ (5%C_\ ':/^&L/@A_T63X?_ /A46/\ \=KU6B@#
MRK_AK#X(?]%D^'__ (5%C_\ ':/^&L/@A_T63X?_ /A46/\ \=KU6B@#RK_A
MK#X(?]%D^'__ (5%C_\ ':/^&L/@A_T63X?_ /A46/\ \=KU6B@#RK_AK#X(
M?]%D^'__ (5%C_\ ':/^&L/@A_T63X?_ /A46/\ \=KU6B@#RK_AK#X(?]%D
M^'__ (5%C_\ ':/^&L/@A_T63X?_ /A46/\ \=KU6B@#RK_AK#X(?]%D^'__
M (5%C_\ ':/^&L/@A_T63X?_ /A46/\ \=KU6B@#RK_AK#X(?]%D^'__ (5%
MC_\ ':/^&L/@A_T63X?_ /A46/\ \=KU6B@#RK_AK#X(?]%D^'__ (5%C_\
M':/^&L/@A_T63X?_ /A46/\ \=KU6B@#RK_AK#X(?]%D^'__ (5%C_\ ':/^
M&L/@A_T63X?_ /A46/\ \=KU6B@#RK_AK#X(?]%D^'__ (5%C_\ ':/^&L/@
MA_T63X?_ /A46/\ \=KU6B@#RK_AK#X(?]%D^'__ (5%C_\ ':/^&L/@A_T6
M3X?_ /A46/\ \=KU6B@#RK_AK#X(?]%D^'__ (5%C_\ ':/^&L/@A_T63X?_
M /A46/\ \=KU6B@#RK_AK#X(?]%D^'__ (5%C_\ ':/^&L/@A_T63X?_ /A4
M6/\ \=KU6B@#RK_AK#X(?]%D^'__ (5%C_\ ':/^&L/@A_T63X?_ /A46/\
M\=KU6B@#RK_AK#X(?]%D^'__ (5%C_\ ':/^&L/@A_T63X?_ /A46/\ \=KU
M6B@#RK_AK#X(?]%D^'__ (5%C_\ ':/^&L/@A_T63X?_ /A46/\ \=KU6B@#
MRK_AK#X(?]%D^'__ (5%C_\ ':Y72?BQX(^*'[4W@K_A#?&7A_Q;]A\&>(OM
B?]A:I!>_9]]]HFSS/*=MN[8^,XSM;'0U[_10 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
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MVFM! (.XC':%4(<$9L07^^VW7[;IIIMF*ZRP0A"]Y$* !198(/GYFRS\ >J
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MJ2Q.=PIQ@-QF\$S83)Z+\1:?(_=W&7-;YP)YPC_/P9RAZ+OFL2#F%RR:=YH
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MK +KZF7Y 0@'ZIR;D8Q<)MQA'IAR>H+"G[<H2QXD%E"GOU\6LTRY!_Y=F?]
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M.>N"7 /L8IE=OO322]M>8ZNMMHJN3V$WZLH/X'3/9999)OJ<"G_>*BES'^P
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M/F]]\T_$-<0IQ7GPK^P$=D<)<+6Y]ZO-^QN+U-@<?X>KE(?(CV4'].WB*?(
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M"10"$$$_K^M9#I2"WU-0</G+7WX'0]D",TZ"702UKA>J%U72&VO/2>$SLE2
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M$V=AJL(?G?V'2"2)I4CV$@=]'A@P M(YD@"!I--K29+_*@I_C FG)Q<02.3
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M.8&J4K\$*O<EC>2>5:<&24*>>=9%X9=<>^ZY9TO8Y.YG 2N&6 =N<I.;#!(
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M\'TUXS/F]./ 9B$*?PK 04M!\^Y[IZ0$2>62\!@=#$A$ >,C=\T[XFTK%?X
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M5[_:%@TH"NA?W_G.=]H.98% 8+/QC6]\HWG_^]^?W<??_.8WF[___>_K?L1
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M H% (! (! *!0& #$84_@4 @$ @$ H% (! (! *!0" 0" 0"@4 @$ @$ H%
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MW8\6"$P"P:_<&C_]Z4^_[D>;B0]_^,/9Y[[6M:ZU[D?;Z?">][PGJZ<0?X$
M,C^W/E[QBE=,?B\!@IQ<N/[UKS_YO0*!$AQ]]-'9]3]U,P )+;FU_U__]5^3
MWB<0V,JXPA6ND-TGG_O<Y];]:&O!G__\Y^9ZU[M>]46GWN &-VAN=*,;-7OL
ML4=STYO>M+GUK6_=W/&.=VSN?O>[-_OMMU_SB$<\HCGLL,.:9SWK6<VK7O6J
M-J'W*U_Y2O.SG_VL^=.?_K10<O.7OO2E4<^]CNN((XZH?C\\S^]___NV>8_
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M[IPTA+@@I/'8)/*Z%-94"J1:4XY&UZW1_'AW!&EZ=^-@SE[\XA<WKW[UJ]N
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M?RG%?+NY(70?'4AN\6G(HT4X1+;K4![EV/'S/L9H%G^PR//F_&"R<LK&-H%
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M:_ZJ]<2_2+9[TM?DO;UKCR)2\^_"AB%?).W1@6."OZ7"'WO ?F;/LB7M#T%
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M].TIV&?A3P)=YM2-Z/0?<XEK'V+KL,78(>)E^7U\!S;3F$(<]L?IIY]^3/S
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M3EPU!^PAMH2$@?X>LQ_L,=]5L0_GE_[4Z=HI/@)>DOC))\Z@PH'H*B51#DT
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M]*< [J8WO6D7;#%/0^!^ FX* W.BRIPPPATI+?AO+2%-K!-C,3:7/]M'QB0
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M,6/.OQ%[+ 7_Z&4V/YLM6K]3^#]<"*[3[^+*<[_-&K.N4I)<WRYW^;/$$=]
M(B6;QCH2\+9O)!GP1Z+Q6IMCX!M']\&AFCMK/_'^UO%0WM_W*L&^>^][W]O]
MCOOA<?/ ,CZ3;\;G\MTE:?N.]IQQ>4]_Q^]F8TO2[G-/YEB2 -M6(LZ4A".R
MQ?N9 _Y4;GM9AWPC^X5_0C981VF/D&OF5Y,(^\!^2(WDS*$YRFW"=(VUX\1"
MTN_R3>T3X\9)X--QS^OVLN_)EY4(1N;F/%[B%-R#OM\$C7YR'6(\T;M:UV/U
MT1"_V3I3I*W0QYJ,>  R@#XD%\BR_KI.^LAWQ+U+D.%_]F,WOJ?Q>S=S*VE@
MB46>9'4T]][7.DC[W+ZQ/LD9ZX8<\E[V7>(,R%?%$3@W.C/B#"3I^+DIL02P
M#J/Q2F#$^^/K4I,0WS5]/UQ<DJ5)+OE^$A+I!@4M$4J^OV2LL2@U#5#T1Z[:
M1VGL=*YWC<:>> 3\B)_!2^;W)(/(%C&G.;X?7T0'7\\BT_+">=_8WYDG,H4N
M]2Y]'>"_QD_7DMEL)G8?VP /ZSY\U2' -45S2!^.!?\GNI>8A(0[^B-Q7\9I
MCQN[-8/_\U[6/SO!?K OO!?]$ND$,57V,!M@"+<3(=DCU@@.S[S3E7@T,53R
M3VX"G9C6BS'2B_8'>>\=\)7V<U^_VN-TKN^H(0\[< H.K?"'/9'D$[LL<?SL
MM!+';VX3QV]OT/76,%F9<_R^.[L,GSTUN31*_G'AQB3P\B]2TC 9*(_"V*T%
MW[YOB]%9; ^R./=KDMQ0""8V+Q9I_UNW_#,_G[@E-IAGIV?TX_')3Z-#\V>P
M=ZP_R7A39),YE!A,IKA/=&JR^?(>WE,Q</(ETW[UW9(='>U7\VCLY!D?=VP1
MD 8$T??R36K"]XR>X^_'@$Z.[D-FTR$X;3PCN4-NR)^A-ZTE?IR]T;>+S+GU
M03[E:S?%O=@8ON,F?LX8<CO/6*+QVKMC;<8INCS'H17^L$4E/LN1*LVG;TWG
M2S:VS_O?.?E9= [N+#H-W7<F3^DFOM:F(B#^0_1]2C%<OOV0[TLW[P-++_P!
M>T_AF^]*7N:<!'^;34\&I@+U(9#3H8" +<5'SF4KFP4W*1XSAJ<S7CD49#^>
MQ/ARCL [6(^>36^QB?IK-_%S;&ARBL_-CJ;3V%3I?D.;094*?\0>[!&Y6:E@
M(ODDXNO692D^R/Y@-^1[RCWH=T6Z4YLHB)/U]63B!-@P8S@!^YY\B#@!8V1O
M:FHW!:78OV_TZE>_NM/=_)Y4W&&.4UY#GQ/JV^>^,[V5-XE+\39R3FQF:J&;
M_<%6\AQCB_B]?MS=/":_KC].[V9_L+>L1>_G=\AJ<CB:%^M[+.@ _"O>4#X4
M.R@?,]N*7+ V<&I\NWXNA#7K.[-K_ R;LJ_ODT]A/2O.L]_'\B X.KZ#[YO[
M+.D9YEL!FW7)7DAY+7V^C3UBG?!7?7/C8A^2;=9Q-*]+*?S!5^&DHYQ!^T]C
MEEWS2^0(.12=QF=,Y,,0?K5VX0^?Q3WM)?9G'B=*W!Q;L>3/]_T#O(TU9MWX
M';9/R>YNA3\-M=$*?V8@)<DS!/.D"YN:02;01CE14KFP8,PPCACS0RL92_#1
M=%=@:.1$JDOPC_'PBE>\HJL<'I*XPG@F9!E%A \EGM_7LR0?2X(;:MR4"G]2
MI3)!2+D*V)GCN<IG2N%/ZD:"K$74(,W[QJ@_(YF1;Q*Y&!]+.DZQCZ&%/X"P
M4)7:-P;\F3+;1"RG)%CSG1.5R+3<8*]=^&.M"M;X+GUBT%@8FXPTWQ.!,N8X
M4?L P6!_,?;R8(M[DP'6ZQ LL?#'?"C*XJQ&1HUW1L@X5<=<#'&L[0=$/R/8
MN^4%C\E)]%TD$@XEL$N%/ZE#&D<,R2SI*IUH-02>C[#@H'*0<H-8$&V,G-L5
M/O[QCW=CBQ(5$1E3 T(1EE#X W18*<!,%W,<MX%=%_XH%BXE7K,=$$$-G\$V
M"W\X?KZ% &9D-),5B-<A2>!D'=F$U)ES'+B]Z!YD,ALE)T,YSX(O4[K,184_
M29>3L9*<=&ZC<^=VM=%U)'H6DK(V:A7^L!W8$0*4 A&YKC!'["@.O804A,98
M^S =B6V.$<9#[8M=%/ZD#CCL-,0A/\A:'&H7>">^"%W.-\GGCPUBC4G*&+N^
M$#2Z6+$][*^I1X7[/7O'&.RCW":POQ Y"H+'WK^4_).ZWO$7=5BTQB0S#;V_
M]>+]V6J1'ZCP0Y+AF/'ZV6BLQGFH&%KX \FO>=SC'G=,0I3OY5L*. T-FM0L
M_/&][3T$]J[]?O8.W;,T>[@&!'L0N=$WL@ZF)/=&D) ;)=GUU^*0+H%\J*@0
MWL6OJ\5-V N2"DNR:]LG>BVM\ <4W$6G0-)A_-XQP>U#A8!(]$WXX;51*ORI
MY?\+\J7"]GQ]C?7_/=O^$YB/DI44D @FLN_&C-4^3*<">E<ZJ!^\-';!5<^N
MU75R#HR5[RP9&J?K_Z?X/>F]R42)I +#?5_%>[/3G"XS1N:Y)SN=?Q<5^PCH
MLO7,I_T\Y-[IQ'&):/AL05;?J%10.H;_<U])QI+F<U_->!4<"3ZR7?D>0^;:
MSUB#YD&04I+BNO'6*OQ)O#]_J1;O[UWXV0HH\N9#GF=O\&W8@4._)Z3UQ^;'
MO2I>ZQ=X>(YB%DD%YGT3^"CFVOJ*DMQ\7_$A#4>&RIWD7SEAQ7I.76I+>G-L
MHJPYL \D>,S9R^!W\9>X!/Y>OI?-BX20L?8+_R]ZUQH=/_LP%[Z-9!7QOCSN
MP/[FX^*?<$-CX@[>67(&CD]25Y\_=V__;T]-383:%DJ\;.(,)-!)[L6GX::'
M<@;\%P4.D@8EYT4^B7]38#MFO90*?Y)<8H.+*]%=8WSQ$G91^)-X!/%@";(X
MMJ'RP_OA3<PC6RN7_]:>.1G;7(L\-(\*)_-[IG5!%FJ<:%V,M5N,V^]X#C^!
M73X$NRC\25WA)4/CJ?T<V3_4'\=#>1\ZG6Z/^$:)?.3HV"9OUC4]R*:ROLWA
ME#6>[ >R5Z*3=9XWS<%KT<MC[W]HA3]D&SLF<?Q3_>_$\?,[Y!HH%LLY2(G&
M8T[!2"@5_OA.9"E[U#IU[Z%[D8SA0XF%Y':I^TKB5.SFS_(2\)13;&JRB3V>
MVS7>R?X:>E)R2E*/XB<N'!!.@Z^! QPR#VF_VE-T86F_\OVLWZ'%JD>E\"?Y
MZ6PQ=A-Y,=1' =^ S2/!F<V5SZW\#_;6V")@/GHT7OIH'SBDPA_^!@XH*I@C
M!_A)_!@V\) ]E/:YO<G/)#<B_TB!@>3UL8V-WOK6MX;?.N?^EX9UA3\*Z10^
M;N/2]'H*V''R[!1JL=GSO#!%%WQ^]EHD_Q,OP^Y)A:A]FTJ#$/%'WW.L'^MY
M?"LV223[\08*$<EHN8!3;'_/\'O6O?RQH;'X4N%/LNOI)-]%XRGVQ=!Q^5E%
M3OS)*+E>3LG81G;I/<6+YG("B5_A6^ OQ+5R3D"AAJ*AL395*?:?3N;@2RF0
M\AY\S:$VC_=D;XCK*0S+?1LV/UTXQD:SEA7\\$$B?D]N!-]?_,B:&L/OL9WD
MN-&3Z_B],84_OINXLT*>/)[O_IZE*$GL*/D]0]=LRL75 %GA1W^O>@X]*>=A
MB,UG7IUD)%X3S:MB'>^=3F@?,D;C2\U?R1)%[.G$EVA>EU+X8_V4>$'^V[Z:
MRO %K)5H7.P+O.TFU"K\L4Y]+QQ>%%^G(\1>V9MC_7EZ37T 69^XL6C,K?"G
MH39:X4\%$/Q.ZA$PCAS12%@(<C"(:W1BI<P<>Q]UW238*4M&YYS3*E(@C<$9
M*0O)*TZ6&&)\EPI_D%H2MJ<8GNLPI/ G=6P3G&84<53['?((90%E]U*1RC!8
M4D?-=1A3^ ,,5.19OHX%9DL=^,P?YS!/@.%<(&VCY)=:A3^>C;P6Y,SOP[A#
M-*[K"CD&Y!]"CX'??X[U(>&$<[$)2RO\(8-4Z$>GBI@_P2..]1SY8=X<QZV(
M(9(?R%&&_9 ]52K\,7XRJ$92'GF:$V\NY(I$CB5!\GF)Q)<\7#,Q<RF%/\9!
M'T7C2 D3V\"N"W\4*I824"7TUBSJ.G2L*_PAW]AHZRZ!.@ZC "M"D#Q".@M^
M(Y[S#JZNE&2ELX,$EGU"T#=UN^Q?;*JQMDJI\ <Y5CL0<FB%/V2/9('\%)"T
M'I!<"/HAB5_;P"X*?ZP/275.E9J;H&<]E>P"I(B@ZQ)L;;)?4E\^1D4"DK_&
MH)3\XWT5:=1X7P&5B*SRW<;<_W@O_$FP5@4B!0=RG6R>)9"Q<3>1?[4*?_C:
MC@LO^?T"V37\?K*.;Q7I!'[:>>>==^1._V$/1"<ZNR2C2F 3')H*\\HGY9N6
M=*U+D$-'^TT@-TJ\TY2.:.O@O:/G>+XBL6UBB84_[!?<7S0F28ZZ5!YU+*'P
M)_G_4Y+@<M3P_P79K8N(?_-W$KFF%.5'8&L*NN8^BO^G;Y90_+,-X!453N7S
M2PZQP8<@=2!7P!_9N7R#TFGR8\!&U#FTQ-4,Y?]2 G742,?WEF0S-5&G#^M<
M@DC>""A=M0I_:O/^^"Z)(5%!K6<9]]Q&:PFX4_&"O!!!8J,XP;JB3WJ#C1$5
M[!JG]3NU V\?XAQ1(6.ZEF*[F4MS%LE*_,T8[*+PAPTG>)_' M+W%W<;<@+T
M$%C39)1DX=S.EQRUE&02*!7^L*5Q]V)G<SD#R5GB+1%GH&#1B7=#"R!*A3]I
MW=4J\D_81>&/.>!?U"CXEPB5WU^\2UQO"-)) *5Y%@^7Q+VO OE=%/Y8I_A"
M10YS_'%S::^;^\@WE10I::N&WI@+W* 3CO(Q*M8>$B?MX] *?[8%"6;121K\
MC+'?O&2'\J/GVH]DKW48W9]-37;CTN9 HIW$N4B>Z"*_"7PB37,B3I=\(Z=?
M_.(7SY*AB3-4M!7M5W8CWWF('WA4"G_(*,7<0XNSUH%O&^E3\5^VV1BTPI_Q
M2(7OZ82SR(:R;N?P#RDW2YY#Y"OAWL4TQO ^1['P9YO7V+V?@QS$J;N/$S+R
M[XA3QW^(?;$#Y8:);>#;\J(<?(3OA.NS]J;X$GQ>G(,BA<A6._744SL?<E^\
M6:GP!Y]<J_DP_1S%'A0[+>4D65R74]SS,5HOXDYC4(K]DQ]\Z"&G"V\"76_M
MY,_ 16E&- 3>F<R,UJ9](P=5GLI<\#?9)25^;VCACSVB"$V.3'X/.;2*]C2;
MK '[5DPACWFRK>QGG%H)<J44I$?%J>85;T''SEG[;$4%:U%SBW0MA:NQ)DN<
MX+IYW#;,(=LM&E<Z1& 3:A3^D+%D;71RDV\K'UI3^[G^_#K_P-4*?QIJHQ7^
M5 0!P! M)<NY=.5A@-1,QI9L1!B6GJ<K;RU()(H"'2[=I!GNFU J_)% IX"C
M-DJ%/Q)E5;\S)!0T(='[@01&B_ES5";G7\++'"&_+XPM_ 'KDY.6.P;F2 )D
M'^;D)2]YR3''71(N$J)+SE.MPA]!7(HSNH_@. /6]\LO^V;HQ0!(ES4N@)\_
MBX,J*7 3EE;X(S L 2VZ#\>[5M$4"'R49!5G7D> 32@5_CB*$QE< XC8DTXZ
M*?S& D5+ F.V5+DO>:.F$[^4PA\R1V I&@>C7.>2;6#7A3^*3TJ=W!U!.[:[
MWU'&NL*?FA?BP)X3<!$8HG_F=+S5M8=-*+'#]Y9L0&^R(P7T!+>0$@HW!%-*
MERZJ4:*_)+BQ0?6($+2O7OC"%TYZSW4XM,(?,A51&-T'X8,$VR=V4?@CH#^T
MH^H0*+0CLZ-G2<"8JG/9GI).$$%L#XD""&/'+SN*6=*>P.O0_:7X/Q\?NW=L
M@E<I^0=I6"L13\)2?A)MDE]CBM):X<^%X?OPJ06*<W+76D NK^O"7:OPAP\C
M@2*Z#[\U]]/F@-]?.GF0WT]W'37H,D8VT)]1MTD^DX0ULDG0>9.=S59#\BH$
MT4PA[]X;7;BU(4&3=21^[8)DLJ,T7DE)V\02"W\44;+;HC'QB?!:1QU+*/R1
MT%_3_Y<\E#^#_Z^;]Q#H1"O)*1JKI@V21&MQ4J[G/>]Y8>&_P%6M J-:H$-Q
MO62G)&T-2LR7#M 2?"3N);]GG4WF,I?Y.PNBG7SRR8/&0B;?]*8W#;^3N:NI
MVYP4PV^,GC64_Y/T7DJT\LY#U^<0X%CHJM)^&X-2X8^"M9J\/UD<!6M=_#;-
M5&KN.SXQOR]_EN0=IXZ5H%-_J:D+_[]F4Q<^:<0-N.;Z&_2?=6W=D6F*)J?N
M99Q6/KZ4-#\&NRC\D3A3XIQ\>]^P9MQ!D@%;(G^6^,[<Q+R:*!7^B,.1)[5@
MK3E%+7J6N,709Y4*4G ?M0H$^]A%X4_-D_[85-$S)*8-@1BCDSVB>["G-"C9
M)W91^"/958RT%O!9.@U'S[*^IA;$B._XWI+3R!Q<Q5.>\I2ND):O*[G.J4PZ
M,F_BRR3\1?L3_\3>&X-#+OS).?YG/_O9'<>O^(&,P4&.X?BCTPGX&6,+*4J%
M/WC=N3%#OZ]A271_^JI&XJJ82Y3 SU[ ?VV"TPGD?41C5'3AI+1:$#,H^:U7
MO.(5NSVV"4>E\,=:'WM:7 FX*$V4\V?(W2&+QV ?A3]T7VFOYPG*=&CI9_?E
MWY-MD?_MPEU*VJ\%^5<EVU*<@Z\Q%$>Q\(?,<QK]-JZ:G(*XE+@Y?R"/3\EU
MX$N+L^4Q:#R\/2!':&YAL\8I4<,T%SE--^P3I<(?,JU6SH?O$!5]D#MS\QQQ
M C@=ZP:_-X<3T'PF'Z.U,;:Y;RGVSS;7]+4&R$-V0_Z,U !]".@;/$4T5CEI
M-9H0)>!);G_[VX?/&EKX@Y=8%[MWPLX<'B3GVQ2_DW7YLS1NDD=0 ET4-0-R
MX2!K%2>!]1[E"KB64O@3G9J<KGW&"_@.>--H7.+M3HG;A!J%/VSVJ'&%"[\L
M5Z,6O*^"R^A9K?"GH39:X<\6X#CZDD!%UM4&Q5JJVE4045.(<[1+#OU01Z]4
M^"-A<1L5]J7"'T&W**F:PE8-SW ]"ITRIQ3^  7,R,J=,]^9$<\YX(0( />K
M55/G7_M@'6H5_@B81 F.^[ATQMZ$I17^<.RCTRQ<"/Z:W<,$LZ/@KDM@>DA
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M[6X;[W%4"G^<ZEBS&25^)7J.QKYCL(_"'SDR9-C<:U^G=GINR:^@\VN<ZI3
M%J.KHF>1IV.: QS%PA\-QPX)OB<_#9]7\OM<>'5-%)S&4<LG=BIRB9L3G]EW
M0]52X4_M4[]*\:,Q\TR6.ZT9+X5[H7MWP>\YJ6\,UL7^:^HCA4[1<\2$AD!A
M>,EN9@?7YO<48D7/&EKXHX%FJ:G,+B]V\;IB#/E!Z_9\S<,8Q(9+>5M+*?P1
M>RR=2F0^]@4Y1IJS1N,B-X;8RC4*?\1Y2CZ2V$[-$XKM0\6HT;-:X4]#;;3"
MGRU@UX4_@C EXXB0K"F@W$O7F>A9QB#I<!-*A3^*&+:!4N&/CCL2$R102\KI
M*T%D# -6$$/R-3+O$$_[@:F%/PD,E?P81W/%R,^K5-,1>.LZ'2;4+/R)CF]T
M21Y&C$05Y]NXAAR1OK3"'TE[)0-'LE_-@ 4RF"$3/8L3Z'C?32@5_BPM\6=7
M0%B6CHFLF?0'2RC\8: HPI#4G8^!\T=6;:L@9M>%/_2.DZPB@@8I(KA4J\OU
MH6-=X8_$S'V"W81(453<MS.L5R0?7<IV<OJ:I'0% !*.$0B"LXA(>V\=0271
M.S]U+UVU"G^V@4,K_-%QJF1OT!FU3U@8BUT4_NC85+.P0)"UE-!+SFTJZK5'
M!!3)_GZ W?[2"8AL<,H/.2!X)&#L1 ^!*>\A,"OYD*XL[3&V<NF$E5J%/U.2
M?]:A%?[$J%'X ^9&IRC)L7D')>2]SE0" ?U 4JW"'PG$);]?<7W-9&_Z2P??
MDMTG>?=X@* +WU9B#WF""Y%XP 87>,89D$&*P12BZ'AL#6@(@8LA3P5V=",G
M3ZP?04TGY>3S2@</#>J;_U+PU(G%Y%L-D(\"/=%SK'=-)+:))1;^D*4Z]D9C
MTI $AW34L83"'R?>U,1<_U_A<:E06!(T7G%7O-0^&ABEHDE\3QX8)ML4#?!?
M)<29"S)18P7^ 'N0?.3KK_-[R*.233^T\,?O2T:,[J&0T3O4 EN3K(Z>-93_
MHS]*C8YP8S7]#]Q"J6"G5N'/DY_\Y&KC!<5EI<0)R8BZ[N]JWZWSD<B'4B*"
MHI*:B0@Z&)?L@Z%)@WPEG5%SKA@OP)_!.4M.==I(M)<W<1C^7I?-:(Q++/S!
M09:2'L5 V/F[6F>U_<8Y*!7^:*97LW$,;JQT\K*DTTV-YQ)*A3_VX#:PB\*?
MF@FW-0I_2MV%Z=V:^G4*=E'X(S9@O=:"?<1OC)[%UG)2_#J0^7Q8OFD>.\(A
MZW0LT9]-S=X5 W:""]M"/-#O;^++^)P*$J,Q'L7"'QR) BJQZXCC]PYL/W*I
MS_&SL89R_'ZNU$F\5N%/+5]A7>%/+<PI_&'WEPH2<3DU92C>J,01D*/LJDW8
M1>'/.GZG9N%/31QRX<^A@QXHQ1CLK9J-1\FE-[[QC>&S\"QC>/M6^+-?L(4D
MZ>/%-S5/X"/SVW#+_-@:^DG>6HDC8%/4XLNGHE3X(V99$W,*?]@I<OC$-7);
MPGY4^(#SH;?F\'MRZJ(QBK&,08W8_Q#,+?RQ+THR51R[9J.$=:>H#2W\$=,J
MK2-<?72R_;:N=7-SZJFG%O/D:N]YX[C&-:X1/FLIA3_V8VF=R9G8!Z=$MO/'
M(UZ#3Z78;\CI7#4*?]@:)=V$NZV9=\<_*.7MM,*?AMIHA3];P*X+?P@H%8C1
M\TXXX80NF;06!'5*R6^<)L&035A*X4^:%\8E DZ@1L+4Y2]_^0L%Y"B<RU[V
MLIW1I<@* 7I()P'-+?P!A"_RNG2?9.PS;H<JQ%J%/XPLSD=T'P%R27E+*MI:
M6N$/IZRTIQVG.F1/#\5+7O*2U76O>]WP63IC,_HVH17^7!B.%2T9J (1-1V:
M?1;^)#G-T8QD&ODCJ*HX9UO8=>$/Z*:B*T=4;""9@UY":BQ)QNT#2R[\$9R)
MDD3H)D18C8XS.NZ4DGM:X<]G4(/\0U[2U=%]=,S4N6.?V$7A#W]# 50MV)^2
MI:)G*<P7*%\'28A1(2C21'"XAFP42-1]+!IC*_PY+-0J_$F0M&$-\']R<ID/
MXC0KR8A0J_#G36]ZTUJ_?VCBVQ#P$20)E>:KIH]P/('<X^OF77RM(<4!0YLN
M\.-+B<1D "*\A@PD2R.9PC:@0VMVHXNPQ,(?)T,[82L:D^(#)] ==;3"GV/A
M1-I+7>I2X3WXBGC$HPPV!DXG?W<^BHY^-7@)@6N%C:6]-P0X!4DST3U\/[9E
M#=G)CF(C.)TM>M90_H\=P<Z([B$9 A]4PY]T#Z?32J*,GK74PI]G/>M9JZM<
MY2KAL\P]'[!FA]>I4/!6.NG/228?_>A'JSP'9R>QM)3T,*3PQWSQP_+?96](
M9JZQE\D+Q2'1&)=8^"-QVZF.T7/$BQ2&'X^<7"F1Z%:WNM5H/WD=\/ULONA9
M$@J'-&&#5OBS'G/]?SY!Z;18,8--12K;QBX*?R0LU2Q2P5^4XK&:36Q*>F<K
M1SI2\OOK7__Z*O'M=7D)1['P1Q%[%*.YW_WNU]F8-6P.S5Y*1=^M\.?_KB&%
M/QKVE/2WV(.$Y5J0[%DZG8[-/J3A);LV:O2C:5RM)EP?_. 'BXTY6^%/0P[)
M@F*;)?N /5\+;)I[W.,>X;,4%CLY?2A:X<_N0?_QF>2D2(K/_5&^,%F&OQ 7
MO]*5KG1,XQP_PQ80CY@C\SRC%,L[Y913N@84^\0A%/Z(>44RTSW)^!J<@&+J
M4B'J42W\82N4=-J5KWSESBZIQ>_)QRO%W8<6_C@9]WK7NUYXC^M<YSI=GNT2
M^#:%UU>XPA7"<8HIR.NH!?Y-E(_@6DKA#\CG+G$(QL\NW56NLU@GN1%QHO0
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MB=8"4_/&H@M_$C@DG"E%.1)-= !$NK:1]IPKSBBY11X*)-'O'*_T.-,^ QE
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MZ?>^?C\B>UJ_/Z'-__<L2Q%Q$_0L>2<H01[3P0+7?$*!O:8ME>8R)>=*\A/
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MW;0SO_>"%[R@_ISCCS^^^M[WOA?\7B 0"*Q#B,*?0" 0" 0"@4 @$ @$ H%
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M9R(4ER4Y <EIWO+U9W3HGC_MM>'.@82"TAYCD/BW99F+<5@-A3_.E6*[-N>
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M1B0M^/E%)@$AKMJN#W5F!-V'@* *HZ[D("%4=#.=M*O'/.$\M27$DT^(O5E
M0(6S6OI>L@9YLHR0%-A6L".Q"PG<%5'XLS) )NKT42(8!(?(FR&241"[)Y]\
M<BU?\^]!$$E*170L SC/;<6/ M8Z^2P3!)5VV&&'XGBMJ_5=)B#>VSJ!VG.S
M2@*DN]TX)5&OI-L0)@HBEB71%Q95^*/K\2A2>UZ/X(LN,Q*3ND(!@QO]1@7W
MYO%P)-U:*G&T"R2Y2W9O"SA)#!PJD, .;NL&;LV'+/B<!/3.J,[$0P94R,>V
MFS0E^(X+*JR6PA^V '*XS190 #.4+7#BB2<6BPC8 ORP9;(%^(:E];5G$/?+
M!+9 &_%O/\[C=H\^X-.V%3O:<[-(^ 4Z_O###Z^#&"5;P!Y<5%?V-BRJ\(>N
ML,\7;0NPO?G5??WV>1;^ -V$)RM]'YMD5(,?-YTM<H[S9RA.B>]7DO<>MV\O
MB[R?! H%V&YX,\G,;K''\0B&:G2A^4+I%FT%(&Y>'F7;.GL/>, #BO.&HQ5H
M729$X<]H:&ZB6VOI,_D*0]ZH_O6O?[U8@.C19$WAV3A$X<]TB,*??SWK4N&/
MVTQ+7&?2=WV36X:"V$VIFZQ'W*]KH[TNP"&T\?;B QKUC<.0A3\2NDN?-51S
M 3Z%PH/2=T3ASYI/%/X,"YR*N#:?5BQ /#B/8SOW[##^AWVZJ.+#:;'++KNT
M\G6:H UU(Q;@P]H*M?&G71&%/XN!W"S\NYB='(Z\H$!<&\<KD37?4V0V^U>N
MT5 WMT?AS]J?I4';D$GLFO\J%"A]U]9;;]VY>5H4_OP+> BW6BP#!TB'N:UP
M&<"^T;BP-%8)X5UC?RL1&@:3FZ.::,_C<=85'731^VS&MG.-KQNJ\8'/T:BI
M]#U=?7^Q$3YSZ3-P?T<===0@8P5%$FUQKF4M_/GL9S];W?6N=RU^EULA[<]E
M /]%?F]IG/3TD#G&BK<T3RM]5]?"GV.//;987$]_>Q=QL6D+=146M?$CRUCX
ML^VVVQ;CA'RL+A<V! *!Y484_G3$D(4_"0PF1KT.EWFG0TX'12GP/U3A#](7
ML5=*=N+X<]2'</H5R^A64$I&M.%>]:I7U<F6XR X6"I,$009ZB86I#/RL#0G
MC&8&XDH.U(^"H)_.ZR7G0'?/(3N3]$6Z9I?CD(_-6NG^.10838+>I0(P<\.X
MY&S-,SE*8,49Z=J%UME62%CJF$H^2R[M$GSJ X%[9[1T=HSC12]ZT=(EE"5(
M6FDKV!%(B,*?U0F%&)+*2^=$L,A5M=,D_)*9NCIMM=56:WV^H,H#'_C F17A
M]87WY/BV%:9(U!HJ&6XH"+#?][[W+8Y7]Z0^YW8>4&S=EOR$F)_%>;:N^^RS
M3]&XMP?M\66XU2_'O M_Z%@!Y*<^]:EK$;KF"?EC_[-GAWY<M2ZA+K]]A;TK
M44TGF5'VE[&3,Y*#\V"MY@$2,!5OSV+L[#*D<J[WC7V;;;:I2<@N!67F0 >M
MDOU)]@BX35N8QHX\^."#6\_@+.RBOA P$:@M!=W9(@I'ADA<</L" K)$ZK&S
M$93CYGNU%/Z 8(."OY(MH.A?=Z=I;0$)IZ5D9FLMF6!9@GKVU]%'']T:7) 4
MB6A?)HPB_OU]EV3?>8),UX6O-%Y[81;='>U?"?DE'\T>Q,4,F3PT%.9=^$/N
M2;!\\I.?7+0%[*=9V0+GG'-.[;N7; $WK; ANW(Q\[[Q1_>_-O]7XB:9T@:^
MV"SFLZT1B0>7VO9[0W4CW'WWW6L^M:1C%<H,>=/ ,D+BGQN4\O=/MFT;S,MI
MIYU6#&ZR6=APSL*R-"M@EY5LMD<\XA&#WF8S+PQ=^(,W%Y\HV5<26"0H#G%S
M.Q[2[1YM1=R"U5UNNIAWX4_;39_TP=![/ I__H4H_!D6_"A<?VF/\0L5!D]2
MO#(MT@WOI0[$DM ES@]Q X[F/7C=TO>(X^KXV\7&'K+PAPXJ)2F*]PUA?VB&
MU];8,0I_UGRB\&=ZI$*SM[[UK;6>EDB>YP:P&R4@LQ'YTD/E""P29(MF(:4\
M"-S@*:><,LAYQOVU<:1D99^$S2C\F2\TWY"?M.NNNZ[5Z(U_(KZGD$%!N3/!
M3F/3:FZ4-QY.-[6ZC1<W.<W>BL*?M3]+\14],037('YRM[O=K2@;^%?XSZXR
M<,C"GY+=05XO^TUK= Q?4FY1B0-4],+GGQ4'Z-:</&?.VFZZZ:9U<Y5%YF,!
MN>X6AI*?+6=%+L%J@SE_][O?7<>?<U]=7I4;3>GH6>P)N0Z*$O+S;6_RJ<8U
MI-;8P)XMR0?[3&/0:6TDOX]3;6L\V=7W]SERLDJY3\9O_KO<VCP.<NKP3FVW
M"RUKX8^SQ_8MW>1J/RC,)N\7S8T:IU@&>9^/$P^(#V3'3XNO?>UK=?Y,6R%>
MU\(?3>]*G^'WAXBYRRV0']YVDWW?PI]24RV//-&AUMZ82S?=);GAO"]ZGP4"
M@<D1A3\=,8O"GP2.NQL[)+OE@42=F]HZPWGZ%/X DIX!P<#*#5D*4->\U/6C
MCZ-A7S!6#SWTT#I)(G\/QALC5D"XZPTJJM)+9!2" Q$UE"/$6)$<Z,:44B#7
MWPM^(L>0)D,H/82*SA_(&,D3XSISJ/B6N*? @P,]Q!@$(XXYYIBBT\^H6K2C
M:7PJ_4M&.L(*@3(4O*L "Z/5>N?&H+."3''6.0Z2SB0GV3N3DF/6D''I//AN
M)*X;F9QI2>R,+(E(72&(KO,"XS _V_XLL*203?*)G^V;G.#G_9Z$8@1 J5+>
MGP5L%%?T[2ZG<Z#D)/+)VKJ5AQQR3NSY2?>C>?;[BI"0>(*4#-N20\QAL09=
MK\B&=;7PQ[[GX)8>9.RR@KY%"DMRS?<O@\BM&TB7/DD1YH+#])K7O&8MG>4[
M..P2POH$<3ESSIK J+$,(?.=89_GY@=.;ZFK$2=5UP?RJ,]W"G ?=-!!-0&A
MF))LFW;,?M]Z.4=N)FKK)LUN(9/[R#0)0>P1GXT0&B* 9KQT.6)"1_-2X6HB
M:A#W0^M8\E+0OY2$("CD%H1E#8C.L_#'/M$E6A>GTOZW/K.ZC2F![:"@V!73
M^1C\G:3L4G<XL@#)7O(+)+JQ'V:M)^CV_?;;KTCPL0OX$%UNJD%.*T0C,W-9
MK$A%,B(;N:^M8HZLKR!.Z0R:)\T)%I&05$)*7BP1Z.QS05I)L7WU@'GC*PG"
MYHGE279*6B*+NGSN:BK\ ?Z<H)JS5+(%))'S_?O: N>??WY]?O,DYF0+/.<Y
MS^FU]YSG6=D";"')26VV 'NH:S%? ON"3STK6X#_H3E%:3_C4=AO?62&VPG8
M GS\6=@";+]29TZV )^2KAG:%K"V[+A28$-A&Q]K66V!>1;^V"?6J%10GO;_
MK+M9L@5P9Z5.[8K%^!5=DE2'+/RQ?^T/\T/FX"GX).8*-T<VEG0KOQJ'PK;I
MVG%V2#SA"4]HG8-9WP*&IRO=]H,CEVB\B/D8!;PSGH7,&ZHKNG>T]OD<\$G&
M)<$F'@[O5;*%G$=)>!)D\<U#%-@T^2&Z!3_6!7ZVQ/W@%?C"*ZW :^C"'Z#[
MV4$E^YY>DFPG49<_T3?>8)_@&TJ)L?ZLL$:Q+1NO"^9=^,,&+-GD_"KS,61P
M/0I__H4H_!D>['*)9!)>2_;FQAMO7/OY9YUUUM3^"[G*%NJBKW!*;D0NW7Q-
M'^% Z6RV39\Q&8,$IN3CY9]-_K G^8Y=$UZ'+/R11%=*5B1O^#I=8[!->&=^
MJ!A36V*0)PI_UGRB\&<RD!/6C5WB+.5Q8#:UQ'=^#1T]1!'?,D)<R1YJ:["(
M[]5,KF\##[8SVU\2<>E6H=2<IN\-A%'X,WNPE<EBL6IGHZESR7PVESTC67J4
MS\F'H@]P9OD>L-]PPY/D T$4_I3WDC.KV1QNE-W4U^[ 19'38B\ENT,LE&_:
MA]L;JO"'S,:7Y9^#2S_DD$.6MB&&<>'7VSA ,=59<X!B?3CH-@Z0'ERTCA/7
MP,V4XLN+O-US%I #Q'<H<9SX<T7T7;F%24'WN]&E--^:R_)!1LEE^T434.]0
M:C+"_K7G\.U=[0<_IZF"\RQ^[G/;"AOZ^/[D()W&UBTE)M-/XAER OD,7?RJ
M%(,1 U6DE0HEV^3=LA;^@/=5>$A/M34K%.\V)OS1$+$=>XN.2KE(77(B4EZI
MO5':M_CQO?;:JXXC.&-=QDD^XV?=<"?_5Y-VG]UV0V77PA_^NV+<_/<U3M58
M=1).G ZD?_?>>^]:EI?.77KZRDMV0\E6%Q\:\B9!>>)M_*3WH2<51)(;0^ET
M<RV_E$^R; VG X'5A"C\Z8A9%OXD2(([\, #1Y*J^=.W\ =29P/?Q4G, ZP$
M.V4H^9'RDI" 0! 0%32A$/V_(#JCD1)WA7")7$<",Z9<<4M)]'%R*;(WO.$-
M=;)O,[#G.Y#M#" )<3K:ZI8@L$"1EYXN!@MCB5&I"SE'J]3UP=HP/CD$@HY'
M''%$;6A)C)*8ITN*.6+42)QFJ' 0%#,8G_7B&.OD:KZ2X3+. $@)SQ2Q ($Y
M17B8>W-$"4M@D_QL;20](DV-QWH9BS440-+)FI,F.2,/F"+;D0I]"A]F"484
M,CQ/FC)NG6QTRA@:' 7SI4#$^2@EMWH8G@J0!)@1@Q(WW8"#\)*8IHA(T-PC
MF,L!>^YSGUL[SAP#@49)LHS8?*]Y/\%:Z]L'#'5$K3W!J2L9;CZ;0V;^G'&&
M]/.>][RZ*,@X]]]___H\^;._]^]D'*>IU&G+0X8P]#E7XYS1-C@;^>=RT)P3
M>U[W"F=>8@_G$&'M[#?GVKC]6<>BIS_]Z?7/<IS]OKDH&>'F7K&-SV.P]S7V
MU]7"'_/4-LZ^P;]Y@QXB[^DV'?ES0\B^<S8YTO0DV4K&"["0JTA;<E^"$QVI
M4#(GB.PK^L*9)X/[.N*''WYXO5^-C;-LG,ZB<VE,9#ER.\G\I'^,D?Z1_.K?
MO:.SH1L>AZU$ I%E=(P;,!2B3N)$DF])/Y-=$J D!W(@%4N:*^,Y^>23Z_DS
M5G-)7_HS&TLBFO=V$X/S2%=Z]YSH2#;*=MMM5^OL23H'(W/39PE*T<D^CVX7
M&%6(:#S&19\VQYOF5X*SG_-^"GWH@9+M0&9*?K)^]DV7HHB^,"XRO22?%9)R
MJ!==S#L*\RK\0=;:,Z7;%^@(MM$0-U]V 9+,'BH5\9"AB!ZV>@+R2_<^.C'_
M>7_'=NMRF^808"=) BDEX#M/[(@N\T@6L\_9I0)F>8";+!&8)$<E'),A[#/R
MCJPC.\A :VINR#G)@#E!QM963,2F<5:6K0.=LXE<94.:TYS4]&<)5+OLLDMM
M9_$KFK*4C"*K%(4IO+9WV*8E\A5)S'] L/5)4%UMA3]@_SE7 AELQ9(M8-[9
M[>85J9QL ?-N_NE,^HT]*EA>L@7HL;3W^MH"='V;+6!,D]@"[.DV6X"\M7_H
MJDF"C9)Q2K: 8KMI; 'C*MD"_#")#@(.D]@"_)O<%O!Y_ BV@.2'DBW KFO:
M M:AJRU@#20=SN+V/>.B4TJV@,8L70O]%H5Y%?[083B<-EO &N'EY@&V -E"
M=Y5L 5Q7TQ8H853ACS/BS'=]V(QN:#$>OH%S4=(E2;XI5G;&R=&^7-^06%3A
M#PZ/?Y7K;?(/3[KHI(T2DJUE?_%WZ17V!5^.W%6LE.1TTBN)5_3_[#!S2I[3
M*VR*O/ I-7WJD[A"/TJT\3LXN)S'2KJ0G-YIIYUJWL>^XZ>3Q9+XZ!)C-4YC
M]PY)1O.?Z4ZVO@0*,B7=TM0U^(__\%W&EZ^Y(EJ\D,^G0S2M,#]M_'3?)+59
M8!:%/\"NI6_PW[H7EVX*Q>>3'>;)GL.;LX53O(&]I9A*HB-;@)V&$\YM%V?-
MK:,^@]SN(X/F7?C#3E&XD;]':M*$(V9'V*?XS5'QC7$)2%'X\R]$X<_L8$\K
MMMMAAQWJI)=<+O+)Q9W8UGAZ2<=L'G*4'<U?23Y]\@'8WG01.4JWLU]Q?PH&
MNX#\28DX;)D\Z2MUE%8$1-;Y/G8Y'6(L] <98)SX!T7\]'RI,%5\Q$TX?/"^
MQ35#%OX 6Y$/1Q?E<M+:6",R'V^2_+#DTY"]]C;_"]? ]\7-\+W,']TFIEL:
M;Q3^K/E$X4]_L)?9=J4DM^3+X.K)D#:=.,WC+,S"+Y\49!@;R#Y@*^5^/3E+
MMN&$<*#-,YUS@VQ?<1[QW%+B)&YPYYUWKG]_DGC!:BS\(4/[^,Z3/'R8<< 1
M6$L\6MY@D ].M[*A%7[VX77%H^@XW#,NI*DODGX4%Z,+NR:(1^'/VI_%!A'+
MH$<3G^^LX0SQ^?C;YIGE7[-SQ%E20]B23.0?RTOB_TXBMX8J_.%O*0HHW3CH
MS^(1\F3PX&2W&%&;#&9?S ,X0'JWQ &R9>0 S),#M-[V16DL<EH6W:Q.?@^[
MLE2(*V=*LX^5#ER>VT)+Q;:X+/[!O.*'?"HYB:5B#[RL8I!QR?<*-^A]LJ?D
MMSB;8J.X$[:^^$WBK/S7GYT#>9Y^SL_3"W*5_%N;3\T?Z@O<'[Z(/L07Y?*.
M;K(N[!TRCTTD[L9V)4_(%;J*7,5GTI/&ZW-\GC@S^Z@T7C_?!_,L_$G L[ %
M\6#B:OG\6!>Y /@,<\/'PQ_PI>D3^J7I9_LL^YG?SN[F[YD_OC;_2"PZ?8<"
MDZY0/$('6P<V:RF?EA\O;]#^9M,DKLO:TY5TGKD4A\"3>3?VJ;'A ZU_/O?V
M1U?=3U?BC7U^'MMP3KP_7<5F\9EL ?YQXK\3+RFN:O_Q]9P/GY5X;V>HU-S5
MT[?P1\Z:<UCBPWV7[Y=O10Z/XPR[V(?DACQGYZ+4&)+=8 ]:C\3GV$=\!QR"
MN6IR"GB>Q.EH#$FV>!^Q4N<Y\91#^OZ!0&!-1.%/1\RC\ ?,K^IDA'X*1(YZ
M)BG\:8+Q*L#*Z42L,_PX^6V$VZB',2;HJYB ,2@)1X> :0QDCJ2$4 %;BA59
MS7BEY)!_E%%RHD>-C7+N\YT*7R@K1@%%BA1@Y#(&1E7P=IDC#B92DW-L_1BB
MXY*5W$[0-,;,L_TQZ5C,%V.$T84$I-P1#;/N8# )""0&%P,C=U92$M.LP#CB
MR#*0&7?(+-7@' C[KRT1ILN3DA<8.?:T! :&$*.(49DZ94\*YTX1$$.,(6C<
MR%Z!V''GI>UAS#+ )9@SR!GJR&3?,ZTC+ E5X1%R0_!,<(T1S7F<9IZ;>Q[Y
M;.S.'GDG0<!-6LCJ21.5HO!G[6?9"W^:\![VKXZ59+VD$K*QSQEQECEC]A8=
MQ7GF%$Y30.D\2"I*Q8%MY.PDYU=2:/,,<,X4^TR3K)>*)24[27Y&7CIO;=?Q
M=IU7.EY @VTBZ*Z(5I+ M%U-R$6%E8AH)(ESQ_&<5#:F^26OZ"KS2V<KRB4'
MS.^L"F\DKR)12O: 8.#0'81G@7D4_I@'Y&")T*47Z?=Y=V6WA]DW$@[S,3D[
MR%:D"3M=8*Y$ +,A$"GS#E:SS>R]W#;S&*?$Z3[%V<8O:.G,\(&<RTGL+&<8
M0<B^161+V$%.3ROCY@7C9'.RRYU?@6$ZH)3(/^XA[Q&;*=&'G$;*3C(/J['P
MIXF2+5!*8!NGL]@_R1:0B"'Q>)(NRPD*B]@"].!0MH!W(O.2KDJV0-)5TYP3
M!&^R!216LV'HQ6EM ?K99[$%),4F6X#_/(TMP(<IV0*3G+>NML"LY) @=JD)
MBX<\-E?++@/G4?BCV$]PI&0+6#?[8=ZV /F*:[0'\S'1@7@H"4IM&%7X,XE\
MH,-Q7N2$X!V_@1SBG]//](FS0V>3;\MP@]0B"G\4+@N.Y78*'TAPN&\W[GE!
M,H"":DF4^!:)!*7$@*Z/][=/\%EX'/)9D'2:1@?.A,[4YE'@66$2NXY>GH87
M2LUU<$SV-%W-_F?/=@4YBCNB@R33XE(%,?%LYL&Y(5_HO5%<K>#XHC&KPI\F
MV/?B&Q(1V%=X HD9D]@S]BE[B&YE:X@13-.!<MZ%/X /T-57@KV]AU-EZ]N3
M=#A.*241C)J+<8EI4?CS+T3AS^QA7[,S^3U\6#XX&3NMS"9+R55G1))L7]BC
M[&_Q-/K)FAO3)'X)'X\])*["CN2C:70RJ0TT=.%/ IFH,%>"#1Z@KW[WGN)=
M=)L8F,1/.EF\I^WG^R *?_Z%*/SY/WC?267$$(]"0QS9,@)WP-YDN^-7Q,#%
M62;)!< -RD50/#%$S I68^'//!YKV0:Z5(X.WBN7W_XL1L!OP6E,P^W0V_2%
M GNR,;?+?1?_1K.[<39G%/ZL_5F:[^&8W7RHF,?8V1#LFJ[G-S4]%"^2E"S/
M2H+N-+'%H0I_$M@'WM4^$K.5(\>&H-/) ?&"<3[Q/))_Y=A(,B]Q@,:IH& 1
M'"#^'(>2CXGM++^._%\DS!N;-[\M@^UG/LFAE0H^G;U:BOE8$WF!\[[-F9^N
MT*.4L$LF*Y+KPC'R3=C;?!7%AOPR36LEW5M+GY7.9>)_^>_.HJ)#Q5 I3H3S
M3;>W*F#(QX6SX&], [)2 P.R7-P>]T?NX7WP(^;#.--XG6/G5GXD_84+Q@TI
M],'1\EE\IN*#?+QR7G& ?;"(PI\FS+_WH@.\)QY7<:4YF":/A9PQO_:%_2%N
M)#=Q$KE#+Z5\6H5%]K'X 1VIJ(@-:I_9+Q[?38[PR\7.V#::GK%WQ4;('OM8
M+H?]F(]=W%\A4Q^P67VV/497V>]].4E<G?E2Q"3F*Y^6[G ^K$GI=R:Y(2TU
M=\<)I;GD ]CSULP9[L(9]N'^O(-YIY<TE<<EX$YP,=/FP%IK^3WB#WQE[Z2
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MBW1-<O.9QQ7!@4 @$ @$ H% (! (! *!U0T<4\X[Z4@8" 0"@4 @$ @$ H%
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M H% (! (! *!0" 0" 0"@4!@"1&%/X% (! (! *!0" 0" 0"@4 @$ @$ H%
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M)+I< M(,@B(!(R(V(2)#.X ( @UTM!$1(2 SR)".-+0=Z&ZU&2)M(S1#@XB
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M*$GG48]Z5"<;E\)Z4TNT<MGE>Y])[Q@K_+&+YY*,[4[(9ID*^T@BOB ?FTO
MMR\/C$L&K81<23>2\NAMYYQS3A?$%;!=I^.Y:B?LN5J+8,8*?UJ#_YO8-O@W
MEA#A6G(GVW5)P%,+?R3%C14L& <20R11'L5U[KGGCK;3A@-C<UXRVI*[7'+6
MC*WMAU+XH\B\=N*&2S\N6?S0"I_,<.?U_K>:LE/H$H4_DLS'3N&A)RRIJ[/?
M:R=<N/:=_-MGF\*? KO1SK7\2\,$-;)$,I$"C:%]N53AC_5_;/,%R6U+R@+K
MH]/%:\^BRTW1]8^B\$=2U5B?\-,<E0QWL>/68=Y)HG+R%[_FPQ[VL*Y@RZZ]
M] _M]2ZUN>OO_)N?*7H)6X#,H\.\]*4O[9*P):@N.;\/!>]DPZG:=Y[JV]LU
M$HW'UFH)OTOJY^S3JZZZ:G1^VEAG*BG\6<]8X<_2IR:,K?W\3%,@#\;6?3+C
M*&7A$J=4;\.ZPA^;XATGR#XG0#CM;W@:1O_R;T]^\I,73=9D4X^MK^;@DCK'
M',8*?\BT)>%?J3W'*713D? K_F$S1@G]].:^S\':X>_8X1)ZR0,Q0GY@S[=!
MQ":?0^WD0U=KX<22L;\QK&%CLFH*YL38>JM ?ZE-'D&G%V.O/6MJX0^]KW9"
M6EFSC]+GH)CF$-"OXN7TX.':I4_N=:][=9L,;!,3=/J+;S3T]_LSNYQM/34F
M*!8X%C=P@M62,7OCU\9@M6<M5?BS9*$JQC8R=1WE^%YG#QP7WU]AK/!G2M'0
M5.C-8VO\4C@)LO8,1:^;X&\X%#M_RF:U8X4_2VZ !1N1U9[SH0]]J.D^*?P)
M(8000@@A3"&%/Q-95_C3FOR_*\8*?R3=[8+3L?#'#D>U2>.2?+S4CF5S.8K"
MGY;3#C8AD&!'_EJ;.8WLW+X.02S.V^'QR=K)<6J,NK^@XMRD)L&?L1--3G+A
MC[%L=]Z;W>QFH[+O*"Y)<?JM)6"9PI]_3#X>"WB\ZUWO6JP8U'W<K_8<S]>.
M32C\J25 */Q9*BE*.\<2^E+X<_C8\4NR7>T][!:ZQ"YG!<FB H^U9]D]O26I
M-X4_^X&M8G=(R3=VU.W+%__/;ADF77@WB>#?\1W?T7V?;8/"=(_::8$N"<1+
MGW#4RG$I_-%/DFZ'\Y\N3J>WLZO=]16KS%W7)*4H"*^U\Z06_ECWQG0$22]+
ML<2)/Q(>Z .U>RCHG[K+^J[A*QC[+H++2R9N^,ZU73E=AU+XPXX@3ZYSG>N<
MTD9KC&)+0>^C3'[WK'>\XQVKV]WN=M7Q;SQ)^)MB,RY1^&-<C"7$\4TL69##
M?A\[7>BD%?X4V/#DF35WJ-=(?'*")IVOL%3ACS$T5DS*=["D++!^/>4I3ZD^
MRSM>=MEE&^]Q%(4_DHG&"DXE02]9>+U+)/G9M(F>*,%4<M&K7_WJU9577MF]
MHP0L2;]WNM.=.IV2_*OIU'Q7"H&,A9-T*A#=><Q.MGD"7^J^>=_[WC>JG]/A
MEM3/V:=\X[5GT6OMACZ5%/ZLY[@4_E@#:B=^N&P2M]1.X\>!DU#XP\ZARUI'
M)7CV?0[T3'J71-2A+'32'1^63="V70.L06,G8Y.YBC'WR7$I_'%2#M_"4%?V
M_13RZ&<_LTWA+EUG[%2$DUCXHRUCFT#LXL0?IT[4GC6U\$=<XT8WNE'U'C:6
M.70?[M+8-$)1#WD\)JN/XK+QCPU4I\0$;30P9F_8*&')$W_XH'9]XL^4V%\+
M"A;'BH^GG'A\%/#C'P??7R&%/ZON9\:*RMB[3G$Z)%+X$T(((8000CB)I/!G
M(BG\.973L?!'\LC8[KP<VE=???6B)P^TLNO"'^^M#Y<(2 J6</Z,G:9SW>M>
MMPM^KD-PY,8WOO$IORN8LD22I39*E'*RS1)S_[@4_DAHD4142];CN#K__/.[
M>;[TQ4DOJ6OX3..:DWZJ4RN%/_\8 ![;V=MX7JI0PGTDP]6>0\&P@]LFG!A4
MF\=V 6QUB*Y[AN*16CM/Y\*?X[+;M+77=ZJ]A^*:G_JIGUID]SYKFW%2DWTN
M>H^Q-)44_APMOA\]S!P9ZD/:3C=0V&-=)UL4OP@D#PN#!*WL[O?&-[YQ]NDG
M"AJMH[7D<OJ-1-<E3U!LY;@4_EQXX875HK^G/_WIBP2ZZ.R77W[Y:##MI!;^
M*$P;)J+U9:KQNRT2V<PS=E/M.5,+?\P3IT/6Y)(=).TT>PA)XY(4%-V,O:ND
MP"4*+*QU$@S& LF'4O@#\I-^/]R@P44V2L1R(MN223AC2+ G_^F;-3M>6\R+
MJ3O@+U'X8XT9*Q"YRUWNTHVI)?0TB5(2(L?6]I-:^%-@JT@&')[R9 Q*9J,G
M&ZM+%?X8:^>==U[U/F3W4K+ ^F4,?=$7?5'U6?P43L[=Q%CACP2@I>P$\X*L
MKLT]]IZ3</:]@<[2^#X*LQ0(.;FTILLH$.)W.2DX+>>;O_F;J^.)[MMR:NJN
M<%+XF!^;_<<.7.(D%&NU-46"?^U9UA R9RK'L?!G3"=Z\8M?O+@/XK@4_OSX
MC__XJ!YBC7*?)4\D.&2.<^&/]8K_Z4$/>E GV_IM5]@C-L2^5"AB@PK%^A+$
MASX'_@JQ .-B[AJH@)GOH^9SL+[2PY<\6:65XU+XXUO6"N1MAO9G?_9G6[>/
M3L#_,U:4<!(+?^BZ8GJU8D<;']"MK<E+M).N-5:$,;7P1ULNO?32JKW$;_*0
MASRDT^M.!\AG^M 99YQQ2E^0;V)WNX@)BC76BN,4-]K4Z8_^Z(_6MMNIFC;T
MJ<E#]R4/EHAG&P=.^!K;&/10"W_$I,=.T^%;6OIY<[ 6'@??7R&%/_^XJ<+7
M?,W75'5;O@_M/R0[_[@5_M#E:O=98OT,(8000@@AG!Q2^#.1%/Z<RNE8^ ,)
MR(XYKSFO[1[YS&<^L]M5;1^[=^ZZ\,?%D>,D'D')N>_(T2H0;M>LVOTE04G0
MV100=@1X+9F,TU1BP=R LM_CR-6&L1W*YLS]0R_\\=X<=M_XC=]XR@[4OHLD
M-+)P5\4"[FN7Y#O<X0ZG..HY>.W,;%?$3:3PYQ_[4E*%!)::\U41A623N8EG
M@FN<HK6343S/<SEWIXP5@6AR<]A.W_S>][[W5LY,B3MV!!/('3MZ_J07_KSB
M%:_H=E0<WN>A#WWH001VIF <6:=]J]K:),@K*$]NSY%/UC+%( ]^\(.KP7AZ
MKN!F:W)>"G]VC^\M &R<"_(.URX%D)(*?O '?_"4(AZ_*Y'CK6]]:[=#^_#;
MEU. %,-(W&G5>11/2!ZH!<PE#R@NH@OM8W?GXU[X<]%%%VVU<R![UMK@-*':
M]RG722W\@80UISJ.)6([P<#]6F6J>6+LLP?'BAI<4PM_(% L,;QV/_+J%K>X
M17?Z$UFPM([J?G2>*8G )?FN9B->[WK7ZX+S?F:._:0=DAPDO:P[C?.0"G_@
M727]EX+,X7@KW\_)!VP,8VZ)I%??C(XCX8P.:.P,;0M_5DQB<P'RI&7L+%'X
MXWG6+OZ#L6(D.F?+J:=]]"-[_:YWO>OHNNXZZ84_T-?\,[6D2_.5?CEV<HZK
MI? '[-5ULD!AD*2/N;* /NJT #L?UW0UFSRP\Z:,:>OQ,''9Q3^W1!%H0?(S
MGT>MZ+0D5$K<5#RR-/J9#-_4WWZ&[%AZ'3'VAH5G+O89?]9)0-_2JVH)A8(.
M"K8/!?.'7<?7,&PK^<!&9JO-G9]\%_PPM0UMR&+RAEW;,LZ.8^'/,Y[QC.H.
MX'3XI9.GCTOA#^C?[(6:;XI-PA8C%W:QH9@Q?2BG"AVWPA]]1W:PCVY_^]M_
MTO<K&X=\W==]7>=S'F[N4?P5BG7%I,9. 5(L-,=.\#OT_^&)QB[M<O*/S5&6
M*&ILY;@4_NBC6N'/%5=<L54QC7FL[[5OK$C =1(+?V#,&?>UC;Z*#2CN:Q.(
M5MU+^XQ],K/F[R[7U,(?6)OHU[7[F:?N];K7O:[KYUWY'/9IEVD#6]::6HL)
MLH?$Q'<9$^2;M=;68H+DR::Y(J;)SUJ;S^P=/H=?^[5?:Y:'VF8SB=>\YC7=
M&CYV:J_K4 M_8(UB/]9\#VS4YSSG.=UF9[OXQGP34W20X^+[0PI__A%CWCHZ
M9N?SQSE5:A>%R+[9%#N_<-P*?^1(U&P&]L0N; 7]*7Y6N^2UA!!"""&$$ Z3
M%/Y,)(4_IW*Z%OY (,<.Q4ZKD9 X=)@)&!L7=E 5:/CU7__U+J%(@BDG5TDH
MX)3P_Q)Z.(XE='%<<X8X*4. G'-D:N+[49SXHUB' [8$K27L<S;8W9:SWON1
M$\59YMTXXP0O?^S'?JQSRG_)EWS)*7U6=KQ[_.,?/ZFX ^[MR/>AD]2].'0?
M_O"'KW[HAWYH]<$/?K#K0\Y#;=+OI7V22[3OMW_[MU<_^[,_NWKA"U^X>L #
M'O!/25@*&,9V*S])A3\$/X=EK9"#0ULQD(2=H\ N71SUM60IR6L2F=8YMU+X
M\_\QEQ[WN,=U.Z35YIR A<1T,M <,!?,JR*C^G/8O]N-TH[I"AIJ]_,<R6RM
M@4MS\[+++COEI!6RYD8WNE$7G/%L<H2<T:8B9_R7DY=<)D/-=W+!SIH<I'04
M 6]RI]:?)[WPAVRF!PP#7YSO=DM[T8M>U 77)*Q(<N*$-FZL1</K*';E7X<$
M1 FZ3FD9R@?C3S*T\2X8*Y@G8&5LD6_D?@DT"=A)PB/S[?1.EM<2):SE@O1T
MP#F)B">M\,=\U%^[O 3PIN";6I/L1$E&]-NI_9(+[!@I"7%*,-#8(./((8DW
MP\ *7<\N=I+(6^:!=@H^DXLWN<E-J@'L,\\\LQNWYOR[W_WN[I0',M>8*V.W
MR#KCEZR3E&!NNS<]TZZ(GC%5;SXNA3_6DD<^\I&GS$_?6$* 0*3D WU!U^WK
MH&5MH'M;&\B$'_[A'^X2#OTN(]A]Z'BUQ$3722[\ ?EH#=#NFLZEC^A=3H@S
MMJP5DD'TI;7"?^D]UF=S]X(++EA]U5=]5;?>Z%M)KQ+M:VWU#BV4A+LR1X?M
M-;?H_N:IGZ'SD;76#6.#WC"<3\:'>69-,$;( #JH.25I5]NM 8*V_CL%X^U-
M;WI39R,.UUWKE(0*]W+_=[WK7=T[*4K4%FW2/NTL.HVQ(\'D48]Z5*<7>D])
M$&,ZXJ$5_A3TN?E,5DD:HN_5=N,U%V]WN]MUA;@2$(PKW])Z3=[1\8R]W_B-
MW^B^K_'XCG>\HTLJ(U<4;[ #G()22_@IZ\,#'_C 3A[,39!;HO"G0.<BOVO%
M2<8,_95.^Y:WO*7K0_-\J*N3?=8FLE!!*?N<K6(M*Z<KU?K;=3H4_A2\:TEH
MJ\F\L:NU\ ?FL+%[SWO>LYH$0UY)$C9N)85ND@5DTRM?^<JN8+6V\0E[AY^F
M%,)/A6UE<XWA?*'W\)V156R?OIU0LQ%<F^:3<<IO9'[3W8;ZIF]B3>8;E/!E
MWAOS_#CZH;_&%S^:O[.6T9OTH?;Y/;: Y$TGT-BTAF_'!B/KX'\@.[PWV_/Y
MSW]^)UOH9M[/>F*>25KJ%PF5]A1[5'O]O'XCQ^AYPR1QA4#NO8M"IZ/&^[.Y
M:K:V<46'V,>F2.O0[V2E349J-J"_8R<KMN6;Y7^A*Y0Q6.:GL>?=;2#!?VOL
M*EJH;6A"=Y%$/J=P_3@6_O"!\W,."ZS8US9<,,?) S+9!@OK9,NF$S>.4^$/
MR! G=%M;C+7A>"'/^;'HH<:5/BKV89$_?5EH+!J;^HG\Y^>@+^E?!<;B"A(R
MZ0+6GGT4@ Q95_BCC;OV.8@33(&^98VV3@Z3D,EUN@D=S?HXQ>=@W?"S?D?R
M\G =].[F!UNDY>1AW]_:)P9B X>ASD<6D]'\(^P*8\HWL&X/?0YE;36>K&=T
M,V.<CY4,TQ=B!U,X+H4_Y@N=;!@D]XUM@.:]C0-SRUI0DHS[/AK?BY[ =C.^
MZ!'\@70;W_DVM[E-U39QG=3"'Y2-]>AD-M8;^ME*X9PU]Y)++NEBK?0U8]1<
M8?-98^EBQ4:7\,Z/3U;J7V/;N*RUMZ7P![ZG]8A?C/XVM!=\2W.,O<DWS0]B
M_%C;C8UBH]5\#KZ/GZ-[ESFEF) /A>YI0RLVX3X@ ]C&-7^6F"#;V7<X"OAP
MSSGGG*JM)FG?1H_K-@HIL6)Z?6TS/'J)]S1FQ(#9:^:WN4MW,>ZT@9YHK18#
M<R_SCFSEQS(&QT[B..3"'[!5S",ZS5C!/E^66*$XMO=A8[&!:CYJ?];G9* U
M@S^"GU"<D:YG+EG7S%-S:@K%]\=O7>1HOXU]WQ^_Q[Y\?RG\^?]8!\7.;*#
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M7_S%7ZSVYTDO_($ #">X!'IR6S_5=GC;=-FY]Q"0A,#Y+8 D(&7]' :0_5D
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M0@@AA!!"""$<("G\"2&$$$(((8000@@AA!!"""&$$$(((8000@@AA!!"".$
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M*;*#S)(<;7XXA;COLZ(;FFN*MIS6;(Y9:UOFC)]_WO.>MS;AR-K(QSMU#10
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M.1P[+:3P9_VU[\(?CMN6HD5("/NR+_NRIN>T.*G-6<X53CV!346A=O>T@YM
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MZ(L%0QS:"'%HQTQH1@5D3#XBS&7AM1,,8)A\8L>TR*([G<C<<\^=Q#*('A'
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M642%3+)@8*OS>S")VQ1HUP@T$ "0W]3Y/1$4]:*IPM^F&']8_*KSG>1<Y3B
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MQ%9$/N1,B+?98*+,PZDGQ&'J3YGC\O/D6=0U^@K:ZZ#&BW7,"^2(( 89"^J
M,J"L&0?1MAD7T:YY5[PCWA?C$/I0\E_>#XOW?*]VN72TCZ\S%O!9Q!?>'WDX
M<0<!$G&(^D><XCM1__A>Q"GR ,:>&(=9N"C'6-0'OF.="QG]]N4Y<6!88X!.
M\ [*/HIWP!B;LFW-P5K? ?6,15#&3X@S)TV:E!96!M'^)X?^?YC4,2X@AZ"N
MT_]CLB"^\+[+G*',%^@#R!4P=]+^.L67NFF-&3PCHD.>@YA!#L.SE7U665_Y
M>YZ7[T*?Q3,3/RD#RHQZUC0C<R_&]N&(ZIE#8TZC4Q]>CJ7*/ISR8!$>4P9M
MF/<^J++@,VF?[ I.^?/.>(9R;J:L5_1E;!Z#X(3=7COEG]'8$!% UA$/:%O$
M1 QP]&M\IPLOO#!]1[XK%VVJ_+X(Y4IA21U]6#061/MUZDKD\Z/?:=!S^Y$Y
M@KI/%&C"'$$9/ZH^0QWK?F4Y<'_B KEJ.<?>.F];YA^T%_Z.-D.\)U<D!R8'
M9 Q"N1!C!KENQ6?SW6G7W)MG+?O'LET3<XEMY%&T:^(8O].NC5'^D7I>=7Y@
M6)3S>3PK:R;DB.3K[>;S,)+0_["I#/6O4_XX.<2"4>3YW).^C/R,/+WL<\L^
MJ&Q3Y$<(F1A/,0;@WM2SL>5(GQ;Y#DT[=:$;Y?Q"/W/W.>."8;7W0??_W2C'
ME)0?<TOD<C?>>&-J[\3*=CDZN2IUDWI(S""7Y7=9%QA/.3KU*%+N8V-+ZT7Y
M40_I'\DE*0?*E7I&O: /;YH^@^>)YN:MWY_V4<=WHHRBZT#EQ3-4J6O<,]I7
M\3Z'4:^I*]&<G;I7UWQ:J04HQ^Z,5YES9KV/<6@Y%FR=\RLU%?1/Y(/EG!_K
MA(R5>#[B]7A8GZC#^%OVY\SGEOH&<BO*K36>EFNEY-*LE9;]^2 I^T_>+S&;
M^S)_Q-AVK :C->Z3RQ/SRWF(<BVA7?Y1UW.6:_3<A]R(9V4>B;K(LS!.IPQ;
M\Z1RO$X_Q=PHWXOOQP9:@]+X='ON*OE)'1J@UKZ=-DS?7JXOTK>/73-J[=O+
M.6/:?=FWE_/&@XR!?#[/RSB1=TR;&:LQ*\<C/!_C%LJ4>#[V?4;[]ZIK@:.F
MRKH ;;F)ZP)5S<_C95V@;(_19QU&[D@](E9%\XY.\:"*\:>5<GZ"\B)VT^_0
M[EOG)ZC7Q ?B!/&">%#.3_3+J-?[2@:M":3_CN;<(G6C\4=$I";J,/Z(B(B(
MB(B(B(B(B(B(B(B(B(P7AG'BGXB(R.1*O\8?$9DX:/P1$:D)C3\B(B(B(B(B
M(B(B(B(B(B(B,I'0^",B(E(=C3\BDHO&'Q&1FM#X(R(B(B(B(B(B(B(B(B(B
M(B(3"8T_(B(BU='X(R*Y:/P1$:F)%U]\L;CBBBNRK_ONNV_4CRPB(B(B(B(B
M(B(B(B(B(B(B4IDWWG@CI)?Y]:]_/>I'%A$1:0S777==J!]%QR\B$Q.-/R(B
M(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(-1../B(B(B(B(B(B(B(B(B(B(B(B(
MB(B(B(B(2 /1^",B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B+20#3^R&3#O_[U
MK^*O?_UK\<(++Q3///-,\?CCCQ<//?10<?_]]Q?WW'-/<====Q5WW'%'NNZ\
M\\[BWGOO+1Y\\,'BL<<>2S__E[_\I7CCC3>*__[WOZ/^*ND97G_]]>*YYYXK
MGGCBB?0]6K\#SW_WW7>GY__M;W];_.$/?TC?_3__^<_(GOD?__A'\=)++Q5_
M^M.?BB>??+)X]-%'BP<>>*"X[[[[TK/RS+_YS6_2\_,]^/M)DR:E[_?'/_ZQ
M>/755U-\&064V]___O=4!WB6W__^]\4CCSR2GI]ZTOK\9=E3KQY^^.'TL[RG
MUUY[;63/+](TB*5[[KEG]G7((8>,^I%%9 R1-KS??ON-^G%%.O+O?_\[Y9GD
MR^3-Y,_DU>1TK7DU>1_C@F>??3;]/+\W$6$<0EY+3LQXJK6\RER8_^?O^7=^
MCI]OPA@*R,=Y?[Q'WC?OM<SERW$(^3WCD-_][G?%\\\_G\8!37E^$1$1D?'"
MY9=?'AHWDH])/N2GS+?_^<]_+IY^^NF4V[)&,':NNLQOR7O)<<NY:G+B=@M]
M5>!S(N_ZP ,/K.6^(F>??7:H[K$F)2(B(B(B(B(B(C(YH_%GP+ X\^M?_[K8
M<,,-BT]\XA/%AS_\X?"U_?;;C_IK-();;[VU..:88XKO?>][Q=>__O5BK;76
M*I9>>NEBWGGG+6::::945A_XP >*][WO?:EB3S'%%,6[WO6NXAWO>$?Q]K>_
MO7C;V][V9IWES_S=.]_YSO1S_/S[W__^8MIIIRT^_>E/%XLNNFBQ_OKK%WOM
MM5=QQAEG)!/(/__YS]J_$PMX+,1==MEEQ0$'')#JR6*++5;,...,Q3333%.\
M][WO3>V+[]'Z'<8^_Y133IF^^W3335=\X0M?*-9>>^VTT''..><43SWU5"V&
ME--..ZTX[+##BN]\YSO%IIMN6JR\\LJIG&:???9T7YZ7,N29W_.>]Q3O?O>[
MT_.-+7_^R\7?\[WX?OS.U%-/77SD(Q])G[?\\LL76VVU57'HH8>F163*J!\Q
MWLLOOUR<?/+)R5RPRRZ[%!MMM%'QI2]]J5AHH86*SWWN<\7'/O:QXH,?_&#V
M\_/__#T_P\]2Y\KRGV>>>5+9T&Y_\I.?%#?>>&,R%"DFE(D$1L2QN4*WZ^,?
M__BH'WFH(#Z_\,(+LR\$UC+QN.JJJT+U! -TG;3F3;TN\A"145*:51"_'7_\
M\<6WOO6M8M555RWFGGONU,>09U)/R9O)[WKEU?P\O\<XXRM?^4JQVVZ[%;_X
MQ2^2Z7L08X)10)G1'UUPP05I?+7NNNL6"RZX8!JSDM>6XY!NY57F\>31G_SD
M)XN%%UXXC:$P UYTT47)%#2H')B8A_B1L1KCDS766*.8;[[YLMYWZSB$/)XQ
MX*<^]:EBR2673.,<QB!77WUU\>*++YK#BTA'R-6JS/'-///,Q3>_^<T4P_KE
MA!-."-U[__WWK^&;RT2"?I!Y+?(JYNQRZQK]\>JKKU[<<LLMM?6EY'IGG756
MFC?-?0Z>F7G>;;?=-IDBI%YVVFFGT-S/SW[VLU$_<J,H-_YB<ZPSSSRS^,$/
M?E!LN>66:<Z:O):\G/GVJ:::JNM:1VM^SK\S5UW.M7_H0Q\J/O.9SZ0Y?/+E
M;WSC&VE^_-QSSTV&H5Q8XXJ\:^X;A;*(S(%<=]UUX7M(',QDD??"Y@IUPC@U
M4O<NN>226N\O(B(B(B(B(B(BTC0T_@P %FT0"9UZZJG%$DLLD19C(I/38Z^-
M-]YXU%^I$6#6Z*<<^[U8M$;(Q@+&*Z^\4GGAF@;&PMIWO_O=)";$/#+H9T=8
M@EGJ^NNOKR16Y+N.LNQ9N)QCCCF*;W_[VVE'PZB1"='\*)\?X>$BBRQ2''30
M0<E$-LJ3F42&@<:?[K!;9:1\-MMLLU$_LHP 3,"1>L(NP'6B\4>:#OD4ITRR
M,<"7O_SE9#Z)U-NJ%T9OQ@3GG7?>N#-W,PY!@+OCCCLF\_N@RXMQ,#G\KKON
MFG8C[V?'<<J9_((-$^@79YAAAH&_:R9+,#,APN2$HXEZ"I2(M.=7O_I57S%F
M^NFG3T9)3))58;.1R#TQ2HI4@;R+.44VNL%\D%OG,"$LL\PRJ?^NLE$!_3_Y
M%H:1.>><,_N^F" P_FR]]=;)5"&#0>-/#'))3N-A0X$MMM@B;5(0:4^#N'+G
MJ(=A_,$P$KG'7'/-%;Z'Q"%WB+P7<I,ZT?@C(B(B(B(B(B(B\E8T_M0(BS?L
MV+GOOOL6L\PR2VU"*HT__T<GXP_&&19S$:^Q>]UJJZU6;++))FD'518F]MY[
M[V*???9)1AM$;OP;)\KP\PA5H^^)G^>DF!MNN"&T:,U"VA577%&LN.**:>>]
MW/MQ&@TG&['C'[N-\WWX7NS0QX([NU/GFLMX=G8,9&?LR+-W,_[P7=CAF\5*
M%O/766>=M+#.XB^G#E'VK<_,8@WOB5T+68B/M@=V+*1-//_\\]G/W\GXP_W9
MY1MQ->5"O5AOO?723J"<#%0^/R<_4?;;;+--VAV14Y78-33Z_)0_[Y//?>FE
ME[*?7V2\H?&G.QI_) >-/R*=03"W\\X[I_XCIZ[R,Q_]Z$>+Q1=?/)VP6>:I
MY*B[[[Y[,LASL@\G3T;R=,SU!Q]\<,I+FVP 8@Q__OGGIS%,9%,*<GS&+N3&
MY/+DQ1CQR8E76&&%].^YGX7PEQ-U$&)%3?"OOOIJ<>RQQZ;WDQN;&".RNSDG
M%&RWW7;I/9/38T*B7^59R.=SGY^303E5E=-\-?&+"/1K_.%BDQ.$RXCAV6 F
MBL8?&3;T@6S(P]PJ\W.1NLY<(&-A# 0Y]^'T[Q_^\(?%9S_[V>S[,$^'J8XY
MX,<??WP()3*QT?B3QS///%,<?OCAZ;2J=HMQO2Y^A_E_#.F<I(5IB!-.]]AC
MCY2?<WHG>2[Y[@X[[)#^?:VUUBJ66FJIU,>P<4$G@U%N7LNZ%VM>N1=M-XK&
MGV8R:N,/X]A(W7OLL<=JO;^(B(B(B(B(B(A(T]#X4P-OO/%&<=MMMQ6;;KII
M,>VTTW:<]&9!%.$4/Q>9+-?X\W\@V.*$'';89A(?\PH[1S_[[+-)9(Z1)2*X
MX[VQ\,;)3"R<17?88W&)G9]S^-O?_I9,+PC&<C^?W;%9$,<@TNU[L6". .V+
M7_QB6DC/70C'-,3)5#EEQL]@KF+!$&'DCW_\XR1RF31I4A(:O_[ZZZ%3>/B\
MUUY[+94?[S(BNN-"D(E!)Y<''G@@+?S3_E@8/?KHHXNKKKHJ+011OI1A1,#'
M=WWYY9>+FV^^.;U7=IB//#]Q J'I1(7W<=%%%V5?M--6J#^\-\0F+/X===11
MJ1YAUN)]8#Q#H(KY#W'G_OOOG\2BG-;UT$,/%7__^]\'*LXEMB!(ONFFFXIS
MSSTWW1M1, )C1,K$,@2S6VVU57I6VA0+\RRD?O_[WR^.//+(XK333DMUE.<E
M?HPW@>F@C3]E#*%NW'___<6--]Z8A,1GGGEF<?SQQR=!Q0$''/"F0!G3)^5.
M6;>6/?5D^^VW?]/H=^"!!Z;Z1/]"^1.C:.M5ZPM"I79U&B-AI'R677;94)O)
M[9LZE2UUCM/)KKWVVE2FE GEB7@*80_MK+4<^7_^GG^GKA]WW''%+W_YR^+V
MVV\O_O2G/_5UPL-8:/>1LN =C/U^+[SP0LK;SCKKK-2?$8]Y?NI'^9VH+]0=
MVO*@H9S;/3O];J2>L&MPI&QZ]=O]&G_X_*>??KJX[KKK4JZ%\(<Z0KRC[5'6
MU!WZ901*AQYZ:''**:<4UUQS3<KM^HW3Q$WJ,L] G,"P39R@?5-'RSC!^Q\;
M)Z@#G>($I_>5<>+JJZ].N5 _)T&V@]@6>9?TJZV4[9@^A.^,P(X32X@]?!?:
M+U?YO1"*(<ZAS[KSSCO[BGO# $/W<LLMEVU@P?QQP@DG)'-.KWI/'TYYDF=B
M#L_Y?-H*IG#B2I4383K%@$Y7]/1.3#,85C#>Y+;I^>>?/]5O<OQN4,_8P9\Q
M6B2/9WS+[_:"=DR^SB8(N3&)SV><<^NMMW85%O/9U(D33SPQ;0B1^_R,6Q!6
MDD\V">H>;1?!)'TE]8K<EYR24[%^]*,?I9RX-#\1BXEYQ+C6F%?FI<0+\BAB
M,S&$^$"^A8B:>M'D&-$)\I)(6^.$B5;XWL0'<IR?_O2G*7;2AY7Y V5)7T*_
M0C[/J6#WWGMOREE[E5=Y @#Y)W62_HEWP#LJ^R+>2SFVH1^[^.*+4_NH,\^2
M&'48?\J+^2A.#*?=1C9I&;7QA[I-/T,^1 Y'?D3[H XC2*>-=!H[D%<=<L@A
M:?S&][[CCCM27.[G=#5RODLOO32KC=/>HANR//SPP\7EEU_>\[-[]4'MX$0^
M\K:<9Z>/'G7;Y]T_\<03*9><>NJIL^L@\Y9L'$1NUJZ,Z)\Y!8M8RH9!N9]+
M7HA!Z+###@MM%-2-<NZ/>L5[9TQSQ!%'I).Z&#\0EUO'#M1SXC;S/O2WU&_B
M]0477)#J!#E^E5./.D&_$>G7J+^M\ X9QY!;\XR,<?ANO-.R_RG;+/T/><!8
MAF'\H=RB^3)])'UPKUQVT# ?0GT@?XR,KTO#/+&4<J=.TUZJY%_48W(1YD'N
MNNNN-,?#N'R5559)<W&Y\XU\3N0=L/E9)QC/M/L=VDND/K%92N29F*<M8=Z2
MN8K<W^4]5#'HCH7Q)FTQ4HYL-#@,'GWTT;;/L.:::X;>"_$P\E[&SON/A7H;
M^;QH'T#_&_G\L?6 .$,_01PE+V,,1?Y3SGOQ7_Z_'".PEL%)=#GK$^1$]+57
M7GEEZC>[C1&8\R&G(I>@S@SCM%KBPA_^\(<T%T(NQS,R]T<9\$S,.97E4)8%
MZS7TH?0WE,?IIY^><DCJ7]4X)R(B(B(B(B(B,M'0^%,1)B 1@K!8@A"ID^&"
MA4=V0F9"DX4T?@\!2&2R7.//X&%1F5WW(N\%$P_"A%ZPF(5X,+*CWZRSSIHF
MZ",3W4R,8\S)-?]P??[SGZ]ET:H?B"DLL$3*GG:UX((+CO2Y2UBD85$C\OR(
M>C;??/-1/_K(0#00*2^,,RR@L7C&B5(SS3132+PZ]J(M+K+((LDLA"BZ'\$,
M(B>,=PC!V4T3X6C41-CK0AS 8CQ]#8MFB V)64TV PW:^(/(L<XR[A5O$&EP
MHAE".19;<^,F[VI8S]EZD7/D@.@(L1!B7L0H&(P05T7ZD9P+(1BB>!9Y?_[S
MGR=3$6*'*GSM:U\+W9MW@-@&$2(G![)+;F[\H!S:B9OJ)K*#=9U7+_- U/A#
MNT! 23M!N#K55%-5?C8,RAB?B/D([*KD*@B]AE66U!5.],.,@H@*,2;]0U5.
M/OGDT/TY%1(Q",8I3C+!/!XYM6;L13\VYYQS)B$??5Q4N#IHB''4N=SO0]R)
MFF40QG$Z3J3<$)YA+(B8X0%C4N0^Q+1<>'>(!B.G_"#&C9I:&!=39W+O01S^
MTI>^U/6], ["9!+Y7.H]^5CD?9-/(53B]*;<^S .1,14M2\;!(BFAA7SB!&?
M_O2GTX[SB)HQ##;-"-6.+W_YRZ'OB:F#>$Z.Q+BYR@[]97EAID/@AG"1_(LZ
MREP"IG]R?'*EJB=&\USDJ9B[&",HEAL>4>,/^4*O_IG^C9/*R$%S!)O#-/X0
M\XC+S(-B<F/^B?RG[K$#&ZO0!V.HP-C.W%BN68+-@1CKY[8G<AW:30[,2<PS
MSSQ9G\VI<^2PN;&1L4JWC:1:+_I0/KM. TD_E!NSL $$8ZW<]TR^S]P.1ATV
M%")_8IQ/W8H8B8BQU)=(>;>#>2'&QM1O1-2,9Z)FC9R+-DZNSJ96;$)!G<TQ
M0[<CVO[IAS R86(BCV%#J]PQ [DD??Y8!F'\(7]E#84ZQ5Q]SLE2O"?R,]X;
M8G+ZV%&/89@[8HXP<EH\&P]@$,#(W;0Y/\HS\JX_]*$/=?PL-OJHLUWE7O0/
M)?1IF W(\7)C#1N*8=BH"FV=-I"[ =HTTTR3\E#&IL, 8\HHW@OC]6ZLN^ZZ
MH<_#^!*!S?0BGX\1D?9-6YUOOOG2VGB5[TV=8JX4HS3S5_1#C!&84V"# 9Z+
MN%:U'Z*_67[YY5-?4\<)Q<QQL89';&:NCKZLZG?O=)%3,L[D-&9,3FS@T\_<
MFHB(B(B(B(B(R.2*QI\@?'\6 IEXG&VVV3I.O#)QR\(! AQV/6I%XT^S8"&-
M';DB.SVSB,_.59R8TPMVJ_OH1S\:>N<LWE;9E9 =#:-"6Q82AK$#6"=8]&)1
M-O=Y:7.<WL,N8J.&!1,68]EA+??Y62Q?=-%%AR(F;RI1XP^+7/T(F'M]-@MU
MG B1"YTDNT)BWL+8&1'3UG4A!F#Q#B$4)INF"?Q&9?QA@1"1$#$7 39QG85(
M!"V<1L""+/_E__DW?H:%=&)Z[K-R#XP:F+T0*'6CB<8?ZLJ33SZ9=BJ.FC-(
M&GE7L\PRRYMEBD"<LN3O<]LIGX-YDU,$HH*6J/&'7&RZZ:8+B6W*B]_1^)/W
M6?QL]/2^W(L82YWCU(I(7>ED_$$L6<8)Q(;MX@2BSC).S####"E.1 RG_"SC
M!$388T^,R"%J_*%-]6.TZG8A%OGJ5[^:A/U-Z6LP.D7B-D*7J%B$?H:Z$"TO
M#(9CQWZ]&*3Q!U%.U)!\SCGGA)X?&$M@/(O<AUR&OJ@3&/[(T2*?27O%@!B%
M_CPR'N$B=G-R7%-H9_PA-C-7@XB>?AH1%1M,$//HOUMC'G_'=R*W)3^."/FY
M!SD%1F)VE&\J4>,/?44_FPVTNXA=F$1GGWWVVC^;BW=-NQ^UV'FB$#7^K+32
M2FFG> R9O=H8)A!,\YPRU:W_';3QA]P+LP]Y.X+I' %^>9%#D(>3QY4QA__R
M_QB&<L6B? YS*/09C-M[Y8,(?G--H_21G%#4*T] ,+O""BN$\@]$[]=??WW/
MC48P*)"3YN3>_ P[^C>QC9>G/[$Q#N\Z=RS!F(L^BO81'9MB(N9]1PW>)=0E
M\BI.!:<?BQC+Z[KH"\@%,3QA HK,ST;;/WD 8Y0J<UB\3_J7L=1E_,$\5@KI
M:;\Y\:$4B&^RR2;)L$5\&.7\=BL(]WFOD3$UF[#DQ(Q1,;D9?Z"<'\-HFE/G
MB%?DS&>??79XLP?F!3@)Y0,?^$#6L[(I ;%IF/%>XT_>Q1BA;M,S^07&,F)T
MW9_-Q9P61MMH?.'G&5\S%TONEGL_V@KWQ!!,FV&\26[ G\EY<C<]H+\BE]QT
MTTW36DQ38KR(B(B(B(B(B,BHT?B3"3LILCLK"^_L0-YI,I)%2G8DNO322SL:
M-S3^- .$Z1AEUEQSS>S=))FT9K=!3">YQIS55ELM++ACX3^Z@ 2(UIA4C]P+
M@=>P=ZMF<1U1) *UB"  @2 +NI,F31KJ\XZ%(,DS8/Y"%)PKT&"A J$-YL&)
M3-3X4UX(V599996TRRB+>.P R@D'+.YC'J#=L%,N"[:(%G/K%3_',SWSS#,]
MGYT3@H@9$<$3GX_Y@'>/()+G1#S%_:@+B+FNN.**)!!'N!+939S/1CC((ER3
MQ &#-OX\]]QSZ50+=DG'_(0X@G>#: ?!"/=G<9R^FT5!8DXIF.._Q%?*BQV!
M$1;S+EA W'WWW9,9*.>9B>OT]P@6.H&  &'+V O1>J1\$">T^YQ.%SLPM@.S
M*O4L5UC&=^3>F)QNOOGFM!LV9DW*M2Q3_LO_\_>4(W69'9)SRI%G0*3-,^48
M:2%J_&F]$%4A-.2]88ZB_AQ^^.'%44<=E01__!DQ$[$=X=4&&VPPE/X&X7B[
M]QCMSQ&11.I)KSRCRJZBY<[=Q%3$&^S.R0E/3SWU5*H?CS[Z:&IKB-00]T5$
M9^3?M/=<N"<&S?WWW[\X_?334YS@?99Q@CK;*T[P;\0)=L:FKV%'8$Y>PX"<
M\\R8X3#-1(T@4>-/>=$W+;[XXJD.T]\@'F27?)Z=>(09"D,B_1&"NEQ#''6!
M_A?S3Q,@SD1,.>0/B COOOONGL)0<FG:)#O'1\2]Y86AC/XHPB"-/Y13U/A8
M94=IV@PY6>0^")H0V7:"_I5X$OE,<B+::Q1R L3XD7LA#F9NH"F0"Q)[Z0MH
M_^0"M'_$ZI0)AASJ/]^5^%;&O/(J8QYC7&(DO\OF&/2%N:=08!@BYE9Y!\,@
M:OSAHOVP$S>GN1$_&7\P[J!/(Y^_Z::;4AY#?E%52$V\83,.YB8X483Q 9^/
M 9$=Q3&E(0:.Q&SRF::<!C(Y$S7^D!, XM_CCS\^B1][O4MR#H2XG<8<@S3^
M$#]HTSQ#3E[(W#"F)MH$)ZDQ9B/V=!H[D)\P=[KMMMNF.IY3MQ&0(H0F3G6"
M^U"^N:?/($ZG_75J,_P].65D#J"\R+<>?OCACN8MQE?,%>3&#_H=QKI-A_R9
M>=.HF#KGXCUPJCK]7#\"8.H@8PO$]9%Q#V,TYH28S^14N <??##EV=1GXC9U
MG[$'8V+RDLAGD[/2'NAG<HBV_]:+/(QY,PQMVVRS31H_T'89%S,^QCC/W!LG
M97/B"*)K<J6Q]&/\H?Y35KQ/GB5'[$[^Q7B'V%2>EM24S0E:8=XB>E(@8\ F
MFOI*ZC3^D&^VFZ/@O4;NP3Q[9 ZDTR9B93S(G0]DS$??G&MXIS^DC>74"?(]
MYN$PP@W[U"?&^^W*#4-*Y+U@U(F\%^:)NM$TXT_YGMC0:*^]]DKUBKF6,H=G
M',7)R9BF,2=6'2-@>F;>DGR3M0/ZFG)>C;DIQ@_4Q<CZ!_.>.?6*N,JXA[J8
M,P;ALQDSLB;#F(FR8+Z=\2?CS-8Q)[&$7)AQ#WT.N6/.\S._MO+**Z=^5T1$
M1$1$1$1$9**C\:<+3$8B6L&HP\D*G79D9?(64=*WO_WM+(&HQI_AP[MD$0?!
M/;M;,4G,8FVN\)G%VMUVVRT)!J,F&81"4?$L"P158.(^5YA57H@:J^Z.F0MQ
M Q'A99==ELHQ5]A N2$@6VJII9*X(R)TK!.$'@B(V0&=1?C<'3+Y&4Y 6'WU
MU9,AI=?I(!.%J/$'80>B"<0/N0OZB.0BHF $Y2S*=0/S9U1 BX#I_///#RW>
MLX"U\,(+AW;X(TXASFR*^6?0QI]N$ >)TP@)V'$841AMCQB$>(T%]TX7@CH6
M^W.?FWX$LU 4=@>-E \FIW[!>$ [RA6R(T1',%=5>$)_B9$MYU[D5Y@I$/[T
M(FK\H1_AY!86MQ%C53'5CHI<T4EYU=W'1$_\H1W33^:*4ZA;B,MR[T%,1!!0
M!_W$"806M(W<YT;PA" C0M3XPUB,7"-R*@\B"T2+N?? )(^XL"D08]9??_VT
M8W*DKI)7DL=1EXA1&- 8YR':07!8Q>S3>O'[B'XB8"C $)I[14XOBAH(N:K&
M280]T?A,G.L$8J'H;L?$^RKB3WX'HV+D7N2#;/ P'N"=,MY#G,A[0FB%X38G
MYO$>$ 3GE@OY [EO$XD:?^C7$"3GB#HQE^::#,J+7;,1"N:,Q>^[[[[4G^1^
M-F.0)I^^-+E0U?A30N[+:>(8X7O%2S8<H1\>F^\-ROC#_,<66VR1?3(5IXG1
M7JK.+7$Z1J[PDV<BM^IF5"77HVQS=Z=GS@_#QM@\EOX!T6VG]L><#^^5>9].
M^0CSC^TV&<$<P[_E;A3$SW8S/#41C#D8=-9::ZV^3G&FSZ6,V;R!307ZA5P*
MXTXD[V,!A=P9TV<NK"G01B,GHU*G5EUUU:SO6<7X0^[%^@4B\CKFCZ+&'S;8
M8 R(T#[GA"?>$>8LC$>,-<E;AFV&J,+\\\\?7@O .-9$$U-)G<:?3C#O&[D'
MN7]=4*^8CZ6=Y\SY$]/66&.-GJ85S!K;;;==UKB&.,,8M]=G#AMRA\A[J7O>
MH&G&'_)L-EJ@'^\%!IT<<W/KQ1B$-;0<$S_F'#;*R_ULS-R]3+/$(<8VN:?@
MD9>MO?;:E3=_8%X.LVG.O8BK;+A WB@B(B(B(B(B(C*1T?C3 80P[,K$[HR=
M%FJ8X&?7(\1_D9V1-?X,!X3G&'T0^[*[/Y/LN>(QS#/++;=<VMTP9W?P;G0S
MC76ZF+2OLI#)XG54X,?N>'6?^,," 8NQEU]^>5I0IIWD+D*41KH--]RP..VT
MT[).8:D;@B +<RSB8%+A5*+<Q0[B(3OWLL,9NV%2#O)6HL8?=NGO=JI*.Q"Z
M(>:-W(>=TKN!T""W'I07)U[DG@[6"N)M%OHB]Z+>-66']4$;?THS)[$2HPX[
M;=)7$F\16'"2&3&?6(Z8A/Z:.$Q\J7**2:<+ 1*BG"BC,/Y03L3[W'M2=H@H
M,&I6N7@/W4Y(;-<7Y0B%H\8?1-F(FIHLH.G$>#+^T/=Q"DL$\AP,\Y'O2-O.
MA7=.+,*T>>JIIZ:=6#?::*.4WV'B'&:<&"OT[474^$-_%SUEAMR6,HG<YP<_
M^$'H'H,&P0H&I@,//#"9Q,F!HZ?;]+JH%Y$=>C$]U"%(K0M$,='ZC#$D"NV-
MG#UR'\J5OJ(3F#4C0EDN<J$J9@?J$J=.1.Y%W".F-(5RHP6,[.R<S68+B.00
MLLT]]]QIMVGR+4X3P%3/\S,VILW4&?/XS":9!%N)&G_8@3KW9 V$?Y1SY/,9
M)^0(!DMXAY$=O<?#J2#CG7Z-/T ^1+^!H:'7)BX(X)E;X62Z<HPY*.,/&Z^P
MBWSNYY+WTP;Z&3M$YK(0KG(:0C?(=9A+P"2<\YGD4V/%UHS;NIT^AS&2#6HX
M(:5;>>VRRR[)=-GZWMF4(?<4(384HI\=CV,:H(\B9XN>?,O%^^/4&?*"NL"D
MC9DD\AR8Q*N<!LL8C>>/W(N^.F?C@&C[7V"!!5+<JM,X$S7^Y%SD*(LMME@R
M[W&J3Y4YM5'#::FYIK[R(A=M\FE]D[OQIX18C3DM9SZ+\0Q]&$:3=NV*_IW3
M,W/&J-QOCSWV>$M?T10T_KSU8BTX=\Q)KL^8//+Y;!X76:MCC!<9(_0R?=)G
MSS///-G/2_W&H%XU!^3J=0KFV#X"TYV(B(B(B(B(B,A$1N-/!VZZZ::N$XPL
MN+-;]":;;)(6>B,7PN3(9"^3PYT^BQTUY?]@0AP1.#M$L>LY0H!<PPT-8:&%
M%DHF%82KF#7J.A4 D634C'/**:=4.F6!G:K9R3QRKZVVVJJ671X1X5-VG'Z!
M&"7W.5AP0."".!N3%N]PV(NZ+,ZQHS6FO.VWWSX9?7(%&(C;V*$7,3H+/P@!
MJIZ0,5&(&G].//'$L# !00R&O\A]>AE_EEEFF;"@N-VNP3FP,!@5_=,7-^54
MJ4$9?XCS-]YX8VIO_$[T)(!!7)P8$644QA_ZQB:45Z>+ON"$$T[H^3VBQA\,
MI$TY"2O*>#+^8(JL4LZ<1!7YCI@J>H'(DU/?$(>PRWL3ZCV[!D>(&G\XC3":
MM])/DJ-&[M,TXT\K?'_: /TN>0/BI/766R^)>!"18/+BU"+ZRM+<Q3B!,0#B
M2D2]B(XQ!F#>1NQ%7L!8BWJ76T:<WM.4OA@0/$<W(.B5#[6#\N?DDLA]B!O=
M3LVC'-GQ.O*9G+A"'8B"V2ER AD78TV$WJ,&<2#FWA566"&-.2-&M4%=Y!Q-
M)&K\N>ZZZT(B^\AIHUR,&R.?'S%P<VG\&3QU&']*$'L3O_B97B>CT'=Q^@MU
M-'>']/+*-?Y@5&A"#M7IHA]GHY9>L#$&F\JTF_QN]YGTF^4II&S&@?"U4TZ\
M]-)+I].Z:<?T@QAY.IU@0ED>=]QQ;\YU'7/,,=GSA(P),'B/AU-.>H%)*OJN
M(\;_7&Z]]=;P*8]L'E!ETR3,Q<SQ1NY%7\Z<?R^BQA].VZE[OG(0QA_:"_D[
MIP)S8M1X-/XPOQS=S >#7^2D\V$S48P_0)_,&@L&M)SGX.38@P\^^,WVQ3O$
M8$A?G3.OPMK?22>=U%CCE\:?MU[D:Y%VBBDF\OF<N!KY_%R#<WGUFKNCWXH:
M%X=]8387$1$1$1$1$1&9R&C\Z0 [Y8YZ C/GPK0Q$6'RFYVU.(WGR"./3+L\
M(>[,$3HAW,>4@CF%G9 ON^RR))@:U"(ZHC5V(8^([EA8BIYP0MM<>^VU0XO7
MB(?8-3.ZJ$A9468( ]F-CK+,71!@ 9=WQ2D9AQUV6'J'PQ9E<S_*]X(++D@[
MZR+FR"DW%NOXGNRVC! 1X<;##S^<%D0DGZCQ!P%T%3  1N[32^B*D ?1<.0S
M?_C#'Z:3N*(0ER*GI7 MOOCBE>XU" 9A_.&[L>MMKJ"5MHIP@I,@.'T,L12F
M3OH.%M.)F<2RUHN_I^PCSSY>C#\(XR+B]66773:)YQ%R#^MZZJFG>GZ/J/&'
MSQVOC#?C3Q6BXK]>QA]R$_*2W#C!&&;AA1=.(AW,RXBP<^)$]/3.01M_Z%>K
MP"[:D?LTV?C3#?)<KK'OLO4J?Z:$=X_1E-UG<^H3[07#<4X<&R;49P2SD?;,
M)A71W)8- !COY-Z#,B7_YI3=3O .$%U'3OWAA%&$LA$C'._]OOON2^\Z]S[$
M#L3Y54Y'JI,''WPP">%RC>F(PAB#85BZ_OKKDV"=O@/#.>.C=C$/ >/..^\<
MBA63B_&'&! A:OQY[+''0I\?%1!K_!D\=1I_2FASY"28#'K-(3$VC8X9<XT_
MG$C5[:2;L1>G6_ [PQP[E :=7F T)_;ES/DP7\4<(SDAQIY.YB=R4DX8;YU'
MQ)Q +D ?T>YW, 5Q2A'U)M?(ASD(X\/D,N?4%.,/<P,8OB//0=YR\\TWA^_%
MW".&LLB]B/?,)?5B4"=^18@:?Y@_X<H]J9,<ECE8C/FTGY=>>FG<F."...*(
M=!)8) _'Q(ZAFSZ\:0:@B63\*:'_8).XG,W!^!F,ID\\\41:5UQTT45[_@Y]
M#'T-&Q V&8T_;[T8HT:(&G\XX2]"W<8?QH34R]S/P[#.)AK#S $QOXN(B(B(
MB(B(B$QD-/YT8'(S_IQYYIG% @LLD'T=>^RQ R[A. C*,(FP>+#66FNE4U9R
MS31,@+/@PF+-I9=>FDYWJ>M$GQQ8]$%$%]DM"],"(K2<!7X6HMCMO9/ H-W%
MXCFGZ^0N)"(*N_KJJ]-.YA@,.NUD.O9B(9==UCG1!Z,/X@C$9<.$,F31Y)>_
M_&7:X1)A'R+EG.=''(*H [$Y1A\$=IPF, HNNNBB4#MFT:6)C%?C#V)>=E./
MF.L0H"*4IHWFB!-82#_GG'.2L"%RNA!F.G8<'&9<Z\8@C#_L>)@;=[AFG776
M)"S*A=U[V=$SNN!;Q?AS_OGGA^(U K+HPN]8V.V:NIB[((P0AWCY^../URZL
M(=%\X8474A^$"0H#92X3R?@S^^RSAT1"B+CK% 6.1^,/(LU(G$"D34Z8"_T_
MN1!Y4.2Y-?X,#NH0[[#*#NQCH0^EO\;8M<XZZV2;?>GK=]EEE_0L501ZU(](
M?A<U^1%C$<5%\HJ--MHHJ]_A^])/1,18"-PX:37'](#1CC87$9_3SS'FRVG;
MU!N$=N1WD7C':5)LGC!J."DOYQ2+\L(4%3$K8;K^V<]^EG*J2*RH8OS9?__]
M0^V >A%%XT]O%EQPP>QWL,022X0_'S#I1MYUM \=)H,P_I20NW-*".:$Z*FS
MW:Y<X7]IILX]R1F!-Z>X/?GDDP,9.V!DO>NNNXHSSC@CS:]%81Z'.IMCYF4<
MA$BWTYP1^0%S,^UR#[X_[:C3?>C/.&DPYYTBI&6SFJ:> %&%IAA_RGD7ZFWN
M<S#_S(8!;"J2,R?(N.S11Q]-&\A$^FI^=O/--\^:RQB/QA_R"F($\VML-((I
MCU/@<\:>_ QK 9MLLDF:4R$N--T$1"Z!D3,R_U/6>XS7S%.2T];Q/<G;R0,?
M>>21-$^RWW[[I;FFW/'+,(P_Q-!(>V%^()I/16$-@_K&*52]GH=Q#OE:SJ8[
MC"$WW733--?9=/;>>^_0AG;$FCHWIM'XTYVZC3_$!.;6B+<YGT=.@SFV[CG)
M\EG8F(<Y!\9_S"%'P.@;&7=4G5L3$1$1$1$1$1$9-AI_.L "+I.L@[@PU40F
M8S&Y=/HLQ  Y''[XX:%[[KGGG@,NX3@86R*"^]:+BHXP_I.?_&2M%\*#7!#>
M''KHH<7TTT^?+=Q :+#DDDNFDXDPG7!B XL7+/XC"N7TBY566BD)!W(%NGPF
MBX?LL)V[N,?/11<1RHOG0AA1=]E3+KG<?__](2%PZ\6B'>5;]_-3GZ.P*!YY
M=DXS:B+CU?@#F!58P(SLK$P;8+?ZE5=>.<561)J(BFG+++:?=MIIQ2&''%)L
MO/'&:7$XLIA*+&&A'E%ODP0/@S#^('R)+,82]S'EL%LJ,8!%9T13Y8D=])\(
M'C"#(G@@ID0$!N55Q?A#WX'X(_<>U GZ#@RD&VRP0;'EEENF&,*NMV.O;HN@
M[$)-/X+@.O>$/.HZW_'[W_]^$CNPP(U(!\$(N5)Y.@"+NP@BV(&7_(3%5<34
M&"[)>Q *(&K@1(B99YXY]0OE#MJ(?W*92,8?C+:(07*_*_T[0D-._T,LAL"[
M71WARA$0CD?C#T*AB"F'77G9H?[TTT\O'GC@@21R;8T3U&?B*_%ZGWWV22<R
M5HD3&G\&!R<PDN.16W'*&T;SK;?>NMAKK[V2 9H^]ZRSSDJY,^\1D39QB5C)
MO]'_(ECD]%#$7 B<<_-T?I:^&U-[/Z+<R&EL7!%3:PDQFYB2*^#FHESI=RC+
MDTXZ*?4!E!__)2?E\S@=+F<';"YB"@) ^I.((8'VR.[?;'B!"#KG7KQ#=E@G
M%^1^B.?+.H#0]YACCDF[[R/@S6W3])NSS39;ZK/H3YL [R-'A%A>C(>WV&*+
M)%A')$F]*$_Z0<2,@/;>>^]-;0:A\IQSSEEI_%W%^$._%;D'SQA%XT]OQF/?
M/TH&:?P!YF$XU8:^BE,@HFVQW141_B.T9"R%^2AW[$#L);<BQZ"_9?,>C)(8
M"1D[E*>)E6,'<B_^'6,.&S 1JX\^^N@T;J:/98S&=Z?_*L<.4=%G"9L\($SM
MI_PH!TX$ZG;2+F,@-O*(M*=V9<GI;,/>-&?0-,7X ]1'XOPRRRP3,M>1B] _
MTI^2:S*.8,Q)CL%8FSP! S(Y$B:RW,^EOE#7.>F',4@.X]7XTPHY"/,'Y&K,
M;3'_FMM&B#>LF1"GZC+'#(+2R,Y<!G/KD=C SQ+_,&%CDMI^^^U3?*4<,4)2
M]^B+.+FZ7"^@3O+O]!VL)V"4HC[.,LLLJ4Z.G7/,+;=A&'^8MV-\%XF5W(>Y
M0HSYS)5UF@=A3:8JE!'S FR.T.DDN,A%3L<\Y'@YG9'^/-)_LO$=]8TU*\J,
M<5RG.<Q;;[VUY_TU_G2G;N-/"9NB,(^;NT[!N)'^D?4HY@_(NQCOL)9"_"#W
M([<E[A,7J?_$;DZAI4PY\9)XSHG<? 9S.]0[YJ7+>0 V2(IP^^VWA\J&G$!$
M1$1$1$1$1&0\H/%G!"#XCDPXLMC=+Y.#\8>%@GX75NJ^<A8GQH+ BLEOA'2Y
M.WWV>]'0V;6*12X$7='=R/GY49?UV"NR^,^I$J-^WK$7.\E'T?@38Q#&GQ(6
MX1 U(@*/B(3KN%A I?XCL,#04O=N>G4P".,/"^V(PEC(CQKY$$L@TF*!OKSX
M_];WQB(BIX%MN.&&H<^N8OSAN["HR2)FKH@Y]T((T@M$?-1WQ$J(*2.GT5&6
ME-O8\BS+M"Q7KEQ!B\:?]K 0CA@$H7;=,89%]UZ,1_$O;8M=X!$G1.-$NWK=
M&B<H#_(IS%51X8G&G\%!/E5GV^AV42<0&")*Q#1$_:U#8#@,XT\) FL$RXLL
MLDBV8:>?BW9#6T1,A0DT<MK,6)B'8$?L???=-PF ZNX_VUW$ ,S;O'.$YIQ
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M75<D,5L@I6.Z[22!RQ@8(B\YQ<9J32[XLZ0)@1G%2F.272P\*."V>.(=N_.
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M=L^\ZX+^O2]^G\*?$.JD\&<#V.S"'PD13@VI/4_%I$7L*:I'W4/B8BVHXI)
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M4$VP*=<J%OZX) 8+""TR=L@7;5C3M^:QOE?</C00-D7ACV<)!M=V.G:1^6R
M9>X*N-EL5N$/'<#?H0\D!)H;=J*N^:N2;^R89%POHN.&L(S"'_#9Z7")'S7_
MC%\CR>9E+WM9VV8;-2;-"3;GIS_]Z=:?<AJ1G?R625_AC\L"V:(VA8TG'OC
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MP-K]G6XP+QQ.N_10Z@*@ E$<1$ZT_C<.C(?9,<NH9(0^_.$/;PU=1H'@XVS
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M/1/Q0\<RSV"?>6:P$3C3P9ZC7[P[VT BEMU"+L9KT9RP#026.-ES=0P[1@)
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M?W>^\YT'^VJICG8"A,Z[J>_AKY*W<SK:MD2.^$->B)<LE<W&@3]I7Z?V&]F
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MQU]Q-*? 7-5T$/),1=4WNM&-DD8GP@E91N<HQ%FBQZQ?)[F4ZJ)C(?[8<ZE
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M@A$9CXN?D<B4^)!,X3PS)GR?)(MB&4F4*0CF^AD_2\E(;KB')+*"*/<V]N9
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M84S':RK(Z."7>Z_@EUN+QHN/OR2>+N[C)""Q;[(Z-/H(,8-@ T_%#,CQ<<S
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M&>86]G3B3\>^P8&4%&%WU1"KO^ +OF!SYSO?>0CRS.G8X[D"=P(.-;:+@(7
MA.X\+8A''2>B$W_*8>W_Q5_\Q= Y\-N__=N'@'$-@6T7%T)?*?9!_!&8KWE&
M+_[;#Q"L:N8%>:TE.O&GHZ.CH^-DQ+&=^-,+?W:#3OPY$9WXTW&RH>6)/T[#
M2.V/QSSF,3MX\]VBG_BS#LAYIM:4YC$='? ]W_,]R36B,WYK_.1/_F0_\><4
MAH+OU%K[UF_]UN;/ZL2?CHYI=/__1$P1?]A-*?T5KIO=[&9#S@+Q7?,_.79-
MK8VGQM;JT7)UCOY=/O[B%[_XT!3S1W[D1X83#YQR4%* _]2G/G7RW4JO2U[R
MDMGO]RTMGJ&6< KJ8O[XC_]X\_"'/WP80\7>J7I!8X94Y;WD8N]ZU[L.A DD
MAL<^]K%#7M2XF%.%^IJ_/^I1CQI.'];,]/:WO_T0E] P/#4WBNS5'SBUJ2./
M=[SC'<EY-A<=\S!%_+GRE:^\50YI@$\.6=_V$%(;PL0VLIQ_5_=+#B &(9*\
M_.4OKSXPP1Y&_B#/XF>HP[87U00MA;H@\G5,B/$-,4%&8;Z:[Q:GC2%I.B@A
M-7Z:$[<\T8CLIZ?IA/A99&+\G6JKS']+8M44-!,5!R-[K:]<\S.ZC?Y$V/FN
M[_JN0?Z2PV+E:FG(9W*:O$;2(K_)<?O O1%EU7(C>%D_\9JUIM7&=W0< IWX
MLP6.([.A&7,EQ3\V.8%!6/@]['C%:"]ZT8LV+WSA"X>.6(3$#_[@#VZ^YFN^
M)BMX4D)3]WLGVZR9*8CP@]&H2T!IP2PABQ'__=___</8&"-C9=RP>BEDXWF9
MRURFF(7)&& H,\AK"MV-K3E31%9*]O&L:U_[VIM[W_O>@Q+009P3)!CI2#B,
M6EVK,)A+3SC">M8A'>&L$X Z.CJ6$G_"Q2C7*:&6 -2)/QV' N?TO//.V]SR
MEK?,.K&IBVUZJUO=:CA66U>0;7 $K9/]G"98JO\Y<@@5NA$J5N_Z>K?HQ)]I
M\-$$7ZQC/D,<>"BQQP72Z F)=L$T=CF[^'G/>]Y@V[+Q!5"0XW7+>?K3GSX4
M_4B6"WP(YB#A.X&+?3RV>VN(/T[N<CI1Z67_UJ(3?]:)0Q-_=$^K67MO?.,;
MFSZ_HZ.CHZ.CHQ?^[ J=^',B.O&GHR./DXGXT[$.=.)/QS;LD_C3<6JC$W\Z
M.M:#[O^?B"GB#S+.7"C@EL=VH@^BA.)Q1<X*H*]SG>L,C353M6QR\W+T\H.*
MK'<-A>NY[U=SN4M\X ,?&$X^S34'U2#>J8$/>]C#-J]ZU:N&$RU;-=4Q-W*=
M3B55<TA/J*%4-]B)/QW[QA3QYXE/?.*L>Y)!00XAW2#<(_6XGQH#M0UJS%)R
MZ*(7O>CFCG>\X[ _2NI^ ,E&#6^JOLA>UC1[R>DT_-NO^[JO.Z&&6:/@,\XX
MXX0:<[433O&:VZ@;C)E:CA1Q2GW'1S_ZT=GWCD&VF1_O/7Z.9_/A7_&*5PSU
M(N9F_/_-'Q+.KF*K" V:N-!=B)?Q.)@/M976RUEGG374G*@#;W%RFGNXEWE0
MTRZFCFSK0 \G#'5T' *=^#,!AA7R1>GI/@3L(Q[QB&)F*)+,N>>>FV1'YBX*
M"%/P[__^[ZN_YPUO>,-@A)9>BL-KP+!UVDXLV*<NA!D$GQ(%I!#K\8]__'""
M4.G]"5ADJ9+3DA2:<22PZ4OOKVB0PBIAS6*U,I"P\DOO[[C5/_B#/UC5Z0&4
MV>M>][K-;__V;P]%GPHYD;/,/<.)$X*HA?5J?#@_W_B-WSBL<TZC.7<Q@K"[
M=9N@#+_S.[]S('_=[W[W&Y+1.M$IV.9X'M-I5^"=:_::8MH QJ7??]G+7C:<
M,L:!-YX8\<8+D]@X&E/CB^!VW_O>=V"EDR?O>M>[LNN1<?O>][YWV-N*=17J
M.AD#,0UCWIRXM^=(?NM,H>N^N74"AF"H=;S6KK G,UH1?X*Q>]O;WG;H9E)J
MX!Z2^&.](>'^R9_\R= )0< %H9(QSV"W3@7D[0EK>"QCL/;M$QV..8R.1J9'
M."%O?O.;A_4\Q[EB'PB&E>QO\E$PK&;?"'3J++#MWKZ%;B^%>52D3,:6O#NY
MPAE: ^A!NH=,2CEQN0N9@?PT!RE;PU@C[B 7EY)SV85?_=5?/00B=#I:2OBQ
M!JU%:Y(^<%\%%H[,99<@4Y#)CJ,->I0NH%?);FO<GF8?LC,484@H.7;\W>]^
M]^+.'N1$C4X3S!B#O?M7?_57P[<AI;"M?9=N+XCB8=^&/6N.4]@U\2><DH/H
M4O.]OLGZVE?WDA00Q;U+K:YPM#$;@(Y_V]O>ULS>$O3XN[_[NR'P38ZP-=@U
MI4"HJ)F#J6Z< G>IWT'RJQDK^ZOFG<B& ':7=5+ZNP*7+3KRZ#2D>UCI<P6I
M6@2^2F"MI=[AQW[LQZKFA3ZHF1=-&:; QZZY'U)<#:S5FONS>P($LQT7;G\@
MY9&E?(0;W>A&21_!J<&.K*=3$&A]6ZZ;E'\G1YS8*['(]K=O=>>*?02^&]N+
MW\:7$#CEK[+5=N4CT-]T %^$_VD_W?_^]Q_V)?U'GWA/>M(XT"GC]R7GV(SW
MN<]]AN8LU@'Y%/S,?:W[M>'UKW_]H+^,AU.'V1[L:P%JMK-QY<L;QZ"KQ_8'
M'YX^E\AXZ$,?NGGF,Y\YR#MK;4GRXE"P?B51^1Q\!?84F?2]W_N]PYJWEL9K
M+-@MQLE>- [VK7&P5L67EG9P\RXIV7#..>?\[\^P0W6\>\M;WC+()#%)[V)O
MC.5#F#LVI62]/:RKF?D7TVJ9J([!+K"'%120&1(BFB&) 1D_XSA>8\8YQ".,
MOQ@1OP?YF+VBR. 8"/=DBX(!#8D4*Y+=UA1;]]:WOO7@P_IV\Q*^/<3)[#U[
MS%ZT)\DO/HL.=,]__O.'-583)\S9 RW&T3W8P4[-"W$FWVC^?$>8V[&.LF=\
M$]G#1Z ?QTG;71?^D%%\>G*0W\0_%GM3;$IG!-\KM=_)/;+27M.XRCUV$2<3
M&WSG.]\YQ%ZM?SJ=;@\^E/$,^]HX>V_[1<Q#S,1^B^70L1-_['WVK?UD3=_K
M7O?:W.YVMSM!UIF[;_F6;QD:@8@#V3MGGWWV$$\X__SS/VVN=DW\D2,2>V/3
M*=QA8[%?R #O;4\$'S_8+F2#=P^VEOEDRUD/?.LE$)]*R8(QV$;&F:RQSHWS
M6*>$][7VZ$;Q?^-L'6G@)D9EG'>!4!SB_11\B9NS"=FM=%M*5]LOY(ZU0O=X
M3SX_N[=%O"3 W 0?F*X3MZ2/Q>W%=$)^9#S?WM7[F7,RDWRYV]WN-L1UK''W
MX4?3H:7(Y?]\[Q3HE?AWO%MJ?XBQU?@T+KKPD-"H+_5>UD M<C$C_E  .9/R
MK\PS.WJL^ZT+^XM=1+^8>[:H^-32/1_ )O%^UH>Q$+?C3](;]K"]8[['[^7/
MWHV<M(;) =] 7UK?9)J\+CV8 OLO'B/[-;6F%)G6KBEQK"DHPDK]'CD50*:P
M_YT:;UQT="?SS 6Y,8Y9:N+IO[XAA;>__>W)YXWS?BW@75//4735 NP/^X),
MD%>G-ZP5-E+PB<:Z(,BR8+N2M?2<<6)WT+]REJF8:2KV=]6K7C6Y1LQ)[1K9
M)CM]7^KW[-U68^D=S TYP/<BX]GWY.@XEQ5L /:+/<F69M.)J;(AR(,6L0MZ
M/?Y>,9(Q^!AL<3ZGY_/%Q%/(@?&>\,[^SC:EZ\@&_H[W]=UKJFD(<?/QE3MM
M_G*7NUSU6MMV$GT)\2?8.&( 8MGV7FSKCFVPX-?[#K&<EK$YNBOUG6-Y;W[5
M&HAA\P&M;WN?#6L=!]N<['1Y]W&,<QO89WP9LH@<$7-B5_$C<S&$$*^DV_C=
M8CKTJ3$EZY>.2XG^;P&^7^HYI47..5AC]H(Y(Y,T?;,&^9$IOYV<(GO5_9#G
MQI)?,VY.3<ZEWI6-7H,2_Y_\\SQY1K%,\TONA#SCV,[V+>PM<HO^HI/8+>2Q
M=74,,<M=$7^F8(VPG\0YR!UDDU2^G;ZW-W<YCH<@_I 1?&"-#5.-R-40L!6M
MUWVN(6M_WXU'C86X2\IF4!O3RD<9PW?*J9(?\7/%#L6XIB#&M\WVKX%8.WE)
MQ_MF-A0_7=V&V!Q[C9RDC\:U&W$.34Q7'9]OL+Z0/G89@V^)71!_ML&XJ'4D
M ]D[ZM#C9_LW,D)<J&0<V0#L*<U*XWNIJ3#/<_8TVYQ='[\C.R@T]V='J^\>
M_W_^#CDRQZX7:U/[DJIG4D,M+]<JU\D6$S<@]\?/T3R9SO4-8 [$>\C.\<^%
MT]#,9:OU'N0$&R9%YC+';!JU#OL@J8YA/>PJ%MK1L0V=^#,!3FP-28,0KRV8
MDX"3:*\I<#+> D2(,#7@+-8\1V*L%+[[P0]^\%#L77I_#IO@7HVAZF<91E-'
M?,87A<(AG2JZ$%#AP*:,A]PEF%!3. _V#X,PY2SE+L>N8JRNQ0!D^-2LHR77
M^$A93CJ'8BU%Z%,0P*KY3D$)B3Q!.F2OE.%9.E[6%C:\0%LHXE6 H4C OS,N
M2XO;X\OO*1(65!1('!>U=NP6M<7<3B'9-L\, $$[@<EM<FR?Q!\RAFR56."(
MG7[ZZ8/Q7GH*2\UZ]IXZ#G#2)0P5@)9 -QP_7WIJGV^00"P!AU80NV2?VO,*
M!"3]2D 6D*4E[TSV*L8Z))DA!;K0^N LTX^E\^WT$\$6!9%TO@"Q8(M[U!!^
M!!K,I4#!7.?9[Y'/ B/6. )"KH/)TLL:]8T2UG0HVW8?)WX)PDMNVUM(V*6G
M0!ICP8D4=D'\\9X(4HHPKG&-:Q3I7^\8"#,(>BV+,>; _E><7R,C%57P)=B7
M:TQTY)*ON6LJP2JXVGI?E5QC>U5B3O%.Z0FRUJ']NJ0S#WGOR.G2!A8"U;6^
MY1*P(0\Q+X+O4S!N-?>3Z*J!A$G-_<V+9*8"*[IBJ8]PS6M><RC2(K>L+T%M
M13R"S4M]!,T_Q$,DY"4OEH!MZKLEZNENOC\_O70]EU[N&?Q,A;6:3K3LB+5V
MI'2S-6:\V<>*,Q3R2%1)9+$ES+%_HV,E/./ OSG22(5/2\\H\EI+'",%=H "
M2(4R;#SZ/4[N6M_B@DX8"XD["7")/7N*K(W'TN\8!^-H_TKLS2D&R<4*Q93X
M#)JPB"58QVQ=M@ =?Z4K76E(-$IT>-?0)$$"QDG4\3?Z/3K*/"/7+=4'; NV
MKL(O<I(O&^]A?V8SLONN=:UK#>/I/;V#>(/WMX[(IO'O&6O?Z[L4>B!$KLV6
MD=Q#4+1>C&MLH_D&]KGY"(7SOMM<^B[S)FE,-NN>E^NX6I-,ROFM<\>.?X!L
M%FQH<QG+:'\W?_9!*$[SG;Y//-6WA1BL,0F=^,2)^6JI]YU+_/&^=).B.\5-
M]G/*_R+3[&ES8\^$N0G%:YH_V$/C.?5G,D*\C7^I4&YNMT@^)OWG'7.Q0?O7
M.X1W]&[V3I#-01[X-N-O?LR3)*PBE=2XKIGXH\!%,2%_Q[Y)G6IJWOB<9#)9
M8A^%.3/7]I!Y<I'SUB 2G;WJSZDQF4O\D7M@3](K]K&YBM_9WB ;[ U%:=[!
M.@O[G_Y-Z5C[Q3Y1?,_>(JMK8Q+Q/</%G[4_V)XZ>08]$71ZV,-L ?_UW@IC
M4[(EQ([]CN(8^WD)C*F"33:L=6[L4KK:GJ;_0N&G,67C&4_CEK)9O+_O4+"L
M +SV)%F%C_9\B.>[WU@66G/BF>QXNBZ0?(RC*Y M^"C>_1*7N$1R3.G]4BB4
M2LTQ.3 %X]O2SHZO;22-7<-Z2+T7?Z@6YC)U+WI1T34?)OA7UD/0^V1TD-MA
M_NTE:\=>B_6HWQ/?9U.++\RQJ9'1Y(CH FLQ?H9]87_088$T&6P2:S60E.@_
M[Y(JKJ$#4Z!W=[FFZ,$I**I+_9[O4=2J -CW!EMM;$>/[99@NYAW=JLBLQ3$
M0%//R_W\7(A#IIXC]S<'BD'$!^A%) +?&,LR%[G+YV>+L=.M#7K+%0C3YL1Z
M2JUGNCQ&;>RO]M*=>@HY&T"<>"[8+>0=\D/*!W+Y-WJ>[ \V 'E@W<DAB=W$
MO\.68%-8LPKP$<WF% "G["C/XA,@^B!NT(O!1O=?>W_LKX5FG\&>3^E7-JR]
MI"B/'#HTD+]WN=80NJ>0(_X@J%@S"HH1%-@!8[^>K1C[]>P&.F9LKX7+[X78
MG$)G32CF('?BG[6G<5WP 4,<D;[R[MYKK.="',*_BS,A$TQ!K%CLQ+CX=K(D
M]M>"3O7\*;L_);_(*3I18\0Y_EI._\NOM$2N_FG.?/(5^"9BO\8G5YL4V]'!
MY@]R*10M6Y_&7SV5HMI<?-_ZK,$4\4?A+C(<>YT\(G-"G)O.(DOII!!/\F=^
M82HG&6(4YE(Q,_+:6G$(XL\8\EGV+!LP-S?6P*YBOOLF_M"I\G%T;>J9WD?]
MR#$T(6H!LD-M"%D0CP692F<MS?^,81WQ=^SG^'GVK 8>VXKXY<E3<T>NS0$[
M,KX7_4)>LO&<Q!1LXN!#A9@VV7GE*U_Y?^-S\3W$2_PN'URL8ZWKZA#$GS'D
MZ?@H[.;4.Y#U[/:2\:-GV VI.@HQ(R2BFOB:9XH!Q[71=*:<2'@G]@8?*[:7
MQ3AK22)B8WXO14ST'O9 J[4D/DW7IWP238KB'*JQXV/S@>)W8\^I>QL3A^?
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M7RM&VCR1!"^A3O@BK<R3^4IS9QXE-2/..7Y(HU7I7)V"W!QRQ)#WR\E-X^=
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M_.'4ZUZS2B>*! (;!8)VNE"ETP9T@')ZA83>"-P% H% (!!8%?0M_ D$ H%
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MX<NIDCD1ST:T;A4A"TQ[7Y*(V>HEFYXM8_Z236_/*()#XND\J^B&#'4O:T!
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M_=5'/M@7 N7[[[]_7730]+O292_SO7*[U+V:=I;Q\K6=OH1;QJ6UV?Y]"W\
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M H% (! (! *!0" 0" 0"@4 @$ @$ H% (! (! *!P HB"G\"@4 @$ @$ H%
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MC.SC*U_YRG7"Q@UN<(-ZGLRG>36GU[WN=>O?FT-SF:_=*USA"M7M;G>[NJ
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MP7 !@<"R$(4_@<!Y@:=-?*VN_?Q\=DA?/Y^O0L9K<I'[G<G/QROA@J,3Z6S
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MF,01C@)R3"#&Y=]^YG?^QM^.G5RYBH4__Q][]P%TW575#7P^41E'1 2E"(B
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ME_\?\CUWO?#'[Y5X4ATW*7NK%-@GQJ&_SL5]AM;X)F-1FX3WGQ>GK&.5I>F
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M6_VSBR[!ORD@5 4$G5;PY"<_>7:/>]RCZ^0OP.KY2#:^JZ ;8IXY07+B5"'
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M"2Y=DUH0*'<-1<8HS#*/BJ;J?<N&1NZ47%)4OTE[V;.BA@$N3KSUM0O@]RD
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M4S'S1S_ZT;D!L7F%/^2QXJ1-^75C"#=9^+,8B(=#A X)D):Z3'+ J:_1L\A
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M*78*>?^RE[UL]N$/?[@KJIA2M&&OU-^='([>^?SG/_\H>[E_#9TXLPCV,1_
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M1(ZMLLHJH3''SV^WW78I-L_Z@G^F;9N07_PN_<=WP&[B5"MDWD,?^M#>G3C
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M'[VI/O?Y/LPE=&?L^YQ8UV:S@+X6_K"^<S$ND''(*+Y36W\>LA*? W'?4IT
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MY#F+I? 'F=%VUTYT8!(>(L]C3#8%D1G372< =WGUQ>_/7$-'8/,:3HM =I.
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MZC"G^.Y?__K7TVZ7R'1D 6O&))M>#,Y_3IW#+B?@39^V+0[MZ_J_6 I_V+R
M[T,B),D1Z-*L*8SUB'QA_A+(9==.?"<D9I#H,FE $7\"]A5)2.B=^$^ZDAE<
M^"*8HXQ;YCIZ+1NQ''C@@4E&XD/K"]@9K$W8P_C<L_Y-X687?<'WYKNSD0K?
MD3G,CHCXJ4I/H1Z$Y!ST18H?6&<([$;T#;X/B1/LRLINHMC9)"L@WZ<9_(\6
M_C!>6-](BN*T!!)B*;)DG8X4KM$WZ-OL[DS_XT?!G](F(=#"G]',HO '6/O8
M\9C$3N8OOAN*2? 14&C<1J\H+?S)((?1(8D;H7M1D,F<PN_"_")!.&J_1^-^
MC&&2N-A9&YV9^8R?D7Y =YBTP).VD[Q$L2@^.'1=DNZP>]A-F+5NG"^Y"6(6
MG%#!/;"?2)9AS8BT%SF&GX3?Y;W1:T@JQG_(;M>1]^Q3X4\&?QXGS[ ;/?%;
MUA!\_1%_'M^.=9@3_-"OD*4YIE.ZLWJ^EEKA3X9YSL[TZ/?H8:RYZ&41_2 7
M#"!CD!/HA>B'Z(G$D"+OT,?"GPSSFCE(X1HZ'WX1=$OL9'0JQF/4O[!4"G_J
MH(O1CQ3KDRC)F*G;E),FW"%G^1[(%-9-; !T(V*,G!I ; O_=%^8M/"'_F+,
ML68P;Y&C^+KP;[*&$$O%=\?\I)^)L=(GK"/HN)RJP48[V"[(',;Y+,%G1W)^
MV_?'#B,V- GD$Y$;T';L,<[8$#0*_@[\E!'=DF]XRBFG3"7Y-H/?AUA;9&,;
MUCEB6NBN45A_T?<I8$ G0.=!'\.W0!NZ*B9@7J#O(;=)3&6#.M8K?*5]D@G0
M9OUG3. ?),Y#;ASZ<IOU'!N#C3*P/="]D9F3%D;A$V">X2?!7L9WA,V+KC;)
M!AC(>^(G%'WS38DEL$83WV5<M?$EGG'&&<E_A%W..*1HB7XD9ZN+C4F8[]@$
MY/C@@\/?@0Z&O=%V'*)3(\,YA8=QC5^5^]-N^B>?>A>1<26%/W58VYG'^"%X
M)[XQ\HHUJ*NU'1\):SLG;;".$2]%_\?.(=;0QO>!WXE3R]AP GF<[9%(VQC#
MQ!/(*>*$&_+=D(7T2>0^?2W\J</ZP,FZ%'PA\Y$368>;="ZCMQ"S8/R2$XOM
MBVW'-VH;%[#PYZ:@NY-W$I%EY'LB7Z89QV>-('8;R<?![J(?A^5&1@M_N _S
M%ML5&4:.%FMKFU-]D"/($^0*\B52?)JQ\*?YLO!'IH&%/P7PSB@VD6L:C@46
M(SX.]\;YB_".M*EMLE&7T(9(F]L:""A/_"[/HZ\(@)&D29(-BC,%.R2FHM01
M^$&AQC#&:8:#B( 401$<]SCP",X0<&?1[EMRWR#1<1$E.A<B\-TB]XX6B?#M
MICF/HX4_)!DUM9%QAK.4)$'&(,8I#B/&)V.5,<L81=%B]\!KKKDFM76:CC+@
M^_ ,GD70@X0I$MLYSO:DDTY*;42Y82[13O[,'./?^!E^EGF(<L@[<J\N=\?G
MGI'O.^W^:J(NF^C'Z'SEBO09/\NZ@8,(0Q8'%^,))TS^5HPG$I-(2,&9A"*.
MW!PF?_LD ]H6MTU;%HQ[-M^$\=IF+6^;=#0/LLS(X[W-^Y;H ;.:^[0_\IPV
M^D*>L^@<)#GA%"(0DN=LEJW\/[H,IT&0Q#*JKZ8Y9TO>AW:U'>^3%(/.DEG,
M:_HQ<L])B@PBSXD6C70]_YL8''?H5$O%#H ^V0)MY_ L]8%L7_.-"4JB?R-;
M2?)!9T)'8EPP/NHZ+G(XZ[C\/'H68RWK4-,\ 6H6?H%IRH(N8"WGW;&#F-O8
M1<QK[!&^$=^+/[.&HO_R?="'>:^F;T-?1MZW2UG NV3YB!Z.W"%(BQQ"'A%4
MSN./__+_C$N2,MAAE"3P;&/1)WR++MLWB[5\5G-^&-D&1PX@\QE3]&W6P9K6
M"L8;]A.Z&L%_BA(81UW/_\6P_L^2Z%QNL@OH<\88":04W2!?\/7D<<#%&& -
M0%?@^S/_ALF7KJG+#,8K2=FT@X1RVCDH,[)N0WMY%]8LDM.0GR2_3&/<SH+Z
M6LA[Y#4<GP9!O5%K>/93T1\$?Z^\\LHTA[,,G49?9#F#?YK^YYO1AKJ=Q[<C
M0(O\(>&$$VZR[VP0VCDMV="%/,B^0W9!9XSR37@WOD>>1[POLI1_8T,DOD%7
M^G87LF 4T_8-1-?:Z)B-W)NK2[+/HZU>T84.,*G]WH6/,/=#CEOA_T%^85MD
MOVU]W>'/_!US)MNJZ"OH@-@@O -SMVM?>YWZO$9?I:WU]3&O.<@V=%GF-7)L
M6,QB5OZ!65'WYQ$S04=$7V<MRGU4]^>Q_G JU:AW6PRR8-KQOF'/9#Z@GZ&G
MY?A:?0WBFS!^T06PI]"I>';3MXCF!RPUWWV)73"K^3[M]7\4=1T=.P)=+OL@
M&6MUG7101R>)$9F +HM.BQSA7::EEW9-=)Z/DP%<C$7Z@#YE?-(7C O6\#[V
M250W'Y097;S3/-K ,]OX)&?Q#1DK49V==^G*GU;WI7%O[._++[\\%4NQ]C#W
M<VPBRP;T!'R9R ;\4=B%^"30$[&5ZOI>W^FB\#>OY_7\!G0K^JW>9UFWROD-
MP];SKLER'YE-C)9\G;HO,=OYN9W9EYAE?HXE3-,G4U_GF0_H1K25-8JQ2%NP
MTVDO]GEN;[;7Z_YGQB*%6=PCZ_?3FLN#^DE>&V:]QB,/LG^$,8U]4X\O-JWM
M]%E>V[$'6-O1"V:UMF>YC)V8[9&<8U:?,_@0^7=^;I0^%Y6A"Y%Z7  9,CB7
MA\4%\C?./L5IS.5I^O[J+)2X0+2=N:VS\M>W\6\-:UN;PI]!LCQ =K/N(+OJ
M.8(YAHJ<8$T8)P\BS,,/T$34EH_Z^Z*QNX7D*Y"%@X4_(B(=T47ACXB(B(B(
MB(B(B(B(B(B(B(C(0F$6)_Z)B(@L5KHH_!&1I8&%/R(B'6'ACXB(B(B(B(B(
MB(B(B(B(B(@L)2S\$1$1:8^%/R)2BH4_(B(=8>&/B(B(B(B(B(B(B(B(B(B(
MB"PE+/P1$1%ICX4_(E**A3\B(AUQW7775=_][G>+KTLNN63>3181$1$1$1$1
M$1$1$1$1$1$1:<V___WO4+[,V6>?/>\FBXB(](;33S\]M(Z2QR\B2Q,+?T1$
M1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1ZB(4_(B(B(B(B(B(B(B(B(B(B(B(B
M(B(B(B(B(CW$PA\1$1$1$1$1$1$1$1$1$1$1$1$1$1$1$1&1'F+ACRP:_OWO
M?U=__O.?J]_][G?5BA4KJLLNNZPZ__SSJW/..:?Z\8]_7)UYYIG5Z:>?GJXS
MSC@C_=UYYYU777KII>GGK[WVVNJ?__QG];___6_>KY+:<,,--U2__O6OJ\LO
MOSR]1WZ''_WH1ZG]9Y]]=K5LV;+TGK_\Y2^KZZ^_OOKO?_\[M_;^_>]_K_[P
MAS^D-O_L9S^K+K[XXM2^G_SD)ZFMM)FVT_^\!]_E@@LN2.]W]=57IV_WG__\
M9R[MI]_H;\8 ;;GBBBNJBRZZZ,;VGW7663>VG__R_^>>>V[Z&7Z6=_[+7_Z2
MY*.(5$F6[KGGGL77OOON.^\FB\@ D3G\CG>\8][-%1D*^N6?_O2GI"^C-Z/_
MUW73K-NA]V$77'755>GGYZ67SAOT>O1:=.+ERY<W]A?_S]_S[_S<7__ZUU[8
M4)"_-]^1[\EWS;I\MD.PJ[!#?OK3GU:_^<UOJK_][6^]:;^(B(C(0N$;W_A&
MR&Y$AY1RLK_]][___4UB'>BR=5]UUF_Q5:/C9E\U.G%3H*\-W"?RK??::Z].
MGBMRQ!%'A,8>\T1$1$1$1$1$1$1D,6/ASY0AB>@[W_E.]=SG/K=:<\TUJU56
M625\[;333O-^C5[PPQ_^L/K(1SY2O>UM;ZM>\8I75$]_^M.K1S_ZT=4#'_C
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M_E"G(G4YLI6KIQ!\UY2^AIG4(P$FS%X>#:@DL)D$F.CY8FR0&T!<ZF7B#XD
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M<72X5WUBI:QVYXU5/B/7A<DP(M>%YS2#:5KB#QOC?E8^).&>_HYG+8SAR[Z
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MNW:"0'+&7;?==EOQQ!-/=&PGZ"]ZU>>#ZSL<]9YZ&=E/D\<6E&FN"]>9\DA
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ME50(?HDB()/5?R+[(CB48VR":.(/JZ0P"W#59)]67_K2ET(!BDLOO70*PB,
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MHJK74T\]U?9<K[?>>K7OZ^:;;V[;WO1B7^H] DBNO/+*%#2P_?;;IY?2'_C
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MYZGDAWO[V]\^.>*((YHXY3.?^<RFR.>>][QGX\]CN]%1V\_R'/G:@?J(PI]
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M%/Y<AJ["'\F 8[N& 2=*E^$O4#=664A)MB6AKPM67ZR7PA_&B.!4?I)#.D$
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MM? O.L&RBTW'8!&%/X):77:_!,1:Q55L=G9Y*:C8U^Y?2ZQ"X0]?^I#F(M/
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M1NABD-:&I+RNCI",B9K.8H'F+L/)&/IT38O"G\O05?C#H*@5/,H=E>FB1-9
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MJ-+-G(@IH4$'>XT;!-&=D"M(J#!*D,>ZLWM6-7E_$84_3E+OX@%LV-IV?UZ
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M#MW+47N"94.#$@P "342EAA)7<<2KX7Q/P91^/-GX"N*)?*C$-&;X BG<NK
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M%2_8,^8WW^MD5I)E::^CE[37)7=. [EK3<EA=(5G]97QUCK)>+10HF%\GOY
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M4B&&PD7O0:;W[5XM29L-H@BCQ)?IV)*]\%)[CTQ0,.K]V+1]>)2". F=)1O
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M_ZD%OH,N.WVWW7:KEH!N/^%1I>(?E^*C/OZK4N(O_P!=L-8X%<*5GN$4FE7
M*A3^D&WFJ0;(';9C_@S%J/P_?<!GP)8NT8=YP1-KZE+X>LEVYW-T\L\RT-5L
MP:4H:I5._YR&L84_^+43NDKWP'^<HEA+ON./7?(=7Z7#=\%WG_C$)VZP9L;(
M+B=[-?>Q=NB-76,.UMIWNXC"'W& 6K8I?6"__?8KZ@-.N.X#=F&7'J_HIQ:O
MLVYTOJYBFBC\Z0;Z[^)OUGH,K N>0!:)[9Q]]MG-J5T*=JQ)'SU:<:7BX'QL
M"E'QB"%81.&/ E8G%97FE%_MQ!-/K"HS^<+8]/FSG++YUK>^M=I[!0*!0" 0
M" 0"@4 @$ @$ H% 8'40A3]3('%&M[A20$!2@J23588@J !-:?RZ,XXY!2"'
MI,JNPAT)33KOS4+7]WVW9O*.Y/S2<Q3K],6WO_WM)HETQQUW;+I-=B53NFPR
MB:62G20WZ>J[UUY[-:</*%P1F%1T@9[,X[P%934*?P2%2O<0K!*XJH6NA!]7
MW\(?B>(^VS7ODLE*EW?I>W7=.Y\;-#4+784_N^ZZ:_5D;+!G['%%/4ZHT;E]
MAQUV:+H =B6$C;W,Q2&''#)HG.NM\$>A1=?\"4C7[/0KZ;:+QNUW10BST%7X
M(X&C%IQ>T\7[5QF++OQ!?S4[5"O>*G4Q=NVYYYY53_# 2R0NE)Y%SW"ZQ"QT
M%?[X;BT9KQ-WZ1GX;ZUG..6H](Q:"4LUL.S"'S11H_ @0:)]Z3E]BPN=)E4Z
M%6(9^H*BYV5 (6#7'-!)QYSFN C@/UTGW$AZK'FRAT11^E+I673^/LT,N@I_
M)&'62B;M*D[JHQOT@7&6[B_!KB^Z"G\4+=6D.?Q&XF#I69IX2"KM ^^,3TIP
M)YO8RVPWQ4Y=]#?VPA<>^]C'#GK?KL*?6LG6"2]YR4N*SWGUJU\]U_W0O\*<
M/.D<;U(L.<MF]6X2/YV4FA=R:L1@7)I\K!J<ZM3E*Y#T6K.9C(3:+MW0:;A]
M3IPLR33[J*9<5XQ=&J/F"JN 52C\H<N/.04JQ^M>][KB<PXZZ*!>WV?C7^,:
MU^CD8V-UJ;X\4X&8TU.7 ?I2Z41>E^8@JW+*V"R,+?RA_W?I(&R FGY#_%%Q
M:.E9^"K^.@W61($N7Y@""^O716]HB^_$Y^YTISM-[GO?^TYVWWWWIA'5BU_\
MXJ;!DP)(/@0%&?2%>>S+113^*-RMJ0\XN:_T''[&/G#J2'Y26+H4<]0\^9PN
M43HMUA6%/]U0#--UXL^0HERZ@L9 &D*QWYP,E?9>7SX_]'*J]M!W+=VG9N$/
M6NN*T2Q29KIGGT9E@4 @$ @$ H% (! (! *!0" 06'^(PI\IT#%+9^Z24UU
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M/[(+^L6?9 H[HC2V32&-/YM#T8\"X]H;,!2R:W"Q5A3HT(=#,M5G$?NI\:=
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MB4'WJJ"W%"';YT46=?>X/Y>YLS8E;16(2[ KDE4 54X_5"11>QXR:A6<P*J
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M <0JAE!46CM%DEY8U\_;9>@!29S^6SV+'I L5(BQKCVBL4KAXU "96SC#QM
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M%GRDY(R; (93/!@U8X*W^[WQAS$R%(SE',R9-)F"8OTA8TU@84Y'PAX8.JV
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MR!VZ;$A&#+WUH^CH*0PU_HB_S_FF1GI)?JMV+>,D/K0(A4%#LM5A&7/:Z.3
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MB2YYUS<*%-]P&,<4O.[WQA\RDT%9>P:%)6,+;>;&N Z]:IOQXR3;N?!VA:&
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M0ZSQ^[[O^ZISH\CR#6]XPUJRPKRJM:@UU+BF,7$@ZYB]G<:?\QEJ_/%A7S@
M;-T< ']?/4OM&OP+C01CXSYS-/X4.>*PN5H<E1R[^]WOOK;_-Q<:Z1W T+]/
M;P*?JZ[&F-"S<G8UN4*G.J#-VCV<BH;E5FIKA-TSMP[8#XT_L.:\P;TF>^0-
MU3V1P]O2D9MD/S;^F#][W6%AY&]__L@ -D3_(#FZ0LY2[9S#U/IZG@^C7D<-
MUU0]3_ZH)7"82LUV+S'.=6(ZZ[!?&G]J=83D.1V\#F2^NB)OF!^*X1W4QI]R
MKPZ,K^4UU$&I=5;KL(INM/;%@=FVB_S@L8T_OL\^==A%39>S2QU6;W\?3KK\
M()#&GSU@TXT_*$Z( JC:"70,?@XMIYI"':, _(S$K1-0!$EJC06$E5<#^[FQ
M03!&HT!@33@)#BH4\WJO,<EP_\X \4R^T^DJ LWN=<B93>//^9]=:OPQCQ2(
M$[/ZAB CDG*5E/*6G#%*AA#30"!(3M$I$.)X#25/QS;^<$3L8:=D2,A[[3"C
M38!L:K&)9S8'3I 2!.PWP[E?@0B%!LMX][O?W;YYHC]V3BZ4F!:(8A2X'D=J
M%P+6-:Q[B0<G_?6-#>.A4,9ICPP2!N24 C7/S/GU>X*R'(0QKTBVWESOR"./
MK 9.%+?=^<YW;M>G[QZS#IQ>[QZ\086C4PL*6+-D[Y2 61I_SF>H\<>:*KK!
M?G.*JD+@,>/#"56\H'%586 MP&)]"/;;LU.,X4TT_L ]29PK4NJO.<Y(7V>2
MO;>][6WW_2F8]KT@;+]PEKRT)KIRDU$L\3=EWW'H-$5W99;_KSE,]CO[9IU@
M\)R-/QS%FJW$7I0<(B.-A?6_CH.7QI^O,]3X8P]:?SYTOP0DW3XF:*MPARU"
MK[&#^\$X'[:@MPLZ07CL7/HY^]\I3 )U-3N/;F1_\T'&%!]93VPI=H_&B)HC
MRG:AZZ<TR/&]!'SZ=I" FT)!)VS1O6Q6^V\=F9;&G_,9:OPQ!]:& !_=S69F
M\XQY;;.Y\7Q.H2>W:\4-9!:[W8$34V3IIAI_8'VQ&=BTM;<?L)L$HQ7DVF-C
M=([QMHY//?74UM:H^31L4@D#SSIVG[.[O'777NG;!O[,'M7,JD%8 'A*D6'Q
M=9RVJCA*HH.<'H- J,)7P?Q^P+04.RD&58S#EQ(/F*JGK!\VH%,^-6LI_#-G
M&KO)WS&_;UR<D%0KI+-^%:N33\9Y3#++/G$ODB">D2U1]E-M_4YM_#$?QQQS
M3-7WL!?8I.YUS%CZ&;ZY-\PYQ$ AJOL<BCWL<N,/Z%MR14-W7S=9<]Z*PX:F
MGQ7V>O95_'][2-R#+I1$L_\T./KO(KRI3].Z@@IKE5RE)]E84Q.E[H/<(7_,
MG;76MTF<QL=FV 6L-0ES]U1KA..7&1L'%9 =8V($]CZ;W&$-8@S\'GYB;6_X
M3'T#,;DDV:4!J+]__=E^4>Q,/IA'ZV*J;4(&B4.Q <6E%$+Z3CIB6:R/O2B.
M*SZLP)QLIG]7:0*Q_LAY^Z=_*KV]PX9D*R[#O#G0RA[LRU3?0[:(>7E._O[4
M0D?[E<STK&+"8]^:<1 ;?ZQW8VP_*<15A,^6'Q,C%J>WOA46#>4)R'OKGY\\
M95TOT_WR!7/I?CIF5=U/=BON&=+]9/I>ZOY=:?RQI\B0_AN0W3==S0=3N#^F
MH*/$:^U/S>OV.I_6=PW%\>=J_"'WK6/[0MR 7J ?QA3(D5O6$OU##]6*,.PS
M!3/TV-CU:CS(=F]#HT?ZWRGVR/X4SR$/Q\0,2O[!O'CK9VWO6K\*M.R%=6.
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MG9K;W_[VS:_]VJ]5==)SG_O<;=_^GO"'?_B'U>=]RUO>LNU;"R&$G26-/^'
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M,)TT_H0#3QI_0@@A[ 5I_ G+6-3X(WD5]C]I_ EA?W,0&G\4>UWK6M>Z4,)
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MRG^=ZURG][EF/V?L8H.U:8NY G&;)AC;=.&/H 8[8R'<V%>741L1_!8T7#8
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M'#X&B1\V4VC=R]QNS&+:=@A_M,OK7>]Z@[[/NG/@G<(<6?L1HQ4+EB AF8T
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MZ"=B<^Q9ZV16:ROF@#8"$[^98HPV;O!Y?)\XU**YI-\3TQ*CGLJW9TOX:G+
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M+M./ ;>__>V7*E,((8000@@AA!!"""&$$$(((8000@@AA'!1(L*?D6RZ\*=
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M.6VS=:^]1?@#MM$)?K_W>[_7GTXX^UGO^W:WNUTO^!T:WZ82_A IUH+B<A&
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M-OS)3                *!)R_ '                ^-]U^%-57T0
M            C^TGH./P1Y(D29(D29(D29(D29(D29(D2=*<%JTQSJ]?62=$
,     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>image_1.jpg
<TEXT>
begin 644 image_1.jpg
MB5!.1PT*&@H    -24A$4@  #08   *#" (   !]V*%:  "  $E$051X7NS=
M>9AE97TG\.H&FFX;:'80!003%3&""[@F+NR*SXRCDQ@Q" Z:&8W#",HH)!A1
M7'"$B N):'#!Q#PX)HH:15"#F#C)F $,BQ(5(P*155F:AE[FICK=Y]:WSGON
MK5OW5)WJ_GS^\)'[OM_?^]ZWSCWW5M>OJR<F            8 %:-TW.
M        @ 4A&^*TQ $          +! 94-<?TM<C@           $"75!UO
MA;:WIC$           #HCJKCK=#VUC0&            W5%UO!7:WIK&
M        H#NJCK="VUO3&            '1'U?%6:'MK&@,          (#N
MJ#K>"FUO36,           #0'57'6Z'MK6D,            NJ/J>"NTO36-
M 0          0'=4'6^%MK>F,0           .B.JN.MT/;6- 8
M  #=476\%=K>FL8           "@.ZJ.MT+;6],8            =$?5\59H
M>VL: P          @.ZH.MX*;6]-8P           - =5<=;H>VM:0P
M      "ZH^IX*[2]-8T!          ! =U0=;X6VMZ8Q            Z(ZJ
MXZW0]M8T!@           -U1=;P5VMZ:Q@           * [JHZW0MM;TQ@
M          !T1]7Q5FA[:QH#          " [J@ZW@IM;TUC
MT!U5QUNA[:UI#            +JCZG@KM+TUC0$          $!W5!UOA;:W
MIC$           #HCJKCK=#VUC0&            W5%UO!7:WIK&
M    H#NJCK="VUO3&            '1'U?%6:'MK&@,          (#NJ#K>
M"FUO36,           #0'57'6Z'MK6D,            NJ/J>"NTO36- 0
M        0'=4'6^%MK>F,0           .B.JN.MT/;6- 8           #=
M476\%=K>FL8           "@.ZJ.MT+;6],8            =$?5\59H>VL:
M P          @.ZH.MX*;6]-8PO.O_S+OWSZTY\^Y9137O2B%SWI24]Z^,,?
MOLTVVVPY:=MMM]UUUUWWWGOO_???_]!##WWE*U]YZJFG?NA#'[KDDDMNNNFF
M+ 0          $#W5!UOA;:WIK&%XN:;;S[CC#/VWW__ZLG,T';;;?>TISWM
MU:]^]<<^]K%KK[UV[=JUN4:C+->:7'@.EUYP\J2&/JN,C54NUII<N$YF!OG]
MW__]+#%SIYYZ:M8=)$L49*PUN7"=S)3U#B3#P\E"=3(S*2?-J]P<
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M&LZ7OO2EK#6<+%20L=;DPG4R,\@+7O""+#%(EJB3F4DY:5[EY@
M!AG8?M TUDU_\1=_46VZ3;EP629;DPO/X=(+3I[4T&>5L;'*Q5J3"]?)S'".
M//+(+#2<0PXY)&L-)PL59*PUN7"=S SAZU__>E9IE/DZF9F4D^95;@X
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MUENWWGKKK#*T+%>0L=;DPG4R,YQ]]MEGU:I56:L@PW4R,RDGS:O<'
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MZ%.?^E16K'/^^>=G<H:R8D'&"C+6CEQU)DXYY90L5R=C=3(SJJQ;D#$
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M>]WKU@V]AV%DK"!C[<A5Z_SW__[?\Z&IOO:UKV7=/CF[3F9&E74+,@8
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M W7Z*S?(6#MRU8*,U>E-N__^^Q_YR$?F0)^]]MJKU,Z;4^MD9E19MR!C
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M4^MDIB!C!1EK1ZY:)S,;K%FSYL ##\S9?5:L6''[[;?GHW6R]*BR;D'&
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MUZ9<>YH,U,G,N.5Z=3)3D+$VY=K39*!.9@K>][[W97)H66M46;<@8P
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M7'N:#-3)S+CE>G4R4Y"Q-N7:TV2@3F:&</SQQV>51ID?5=8MR!@
M0 L&=BPTC770???=]Y=_^9?''W_\KKON6FU]'+;;;KLWO_G-=]]]=RXYA*S5
MIEQ[YK)B0<;:D:L69&PD6;1-N?8&.:]-N?8T&:B3F7'+]>IDIB!C;<JUI\E
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M- 8           #=476\%=K>FL8           "@.ZJ.MT+;6],8
M    =$?5\59H>VL: P          @.ZH.MX*;6]-8P           - =5<=;
MH>VM:0P           "ZH^IX*[2]-8T!          ! =U0=;X6VMZ8Q
M        Z(ZJXZW0]M8T!@           -U1=;P5VMZ:Q@           * [
MJHZW0MM;TQ@           !T1]7Q5FA[:QH#          " [J@ZW@IM;TUC
M            T!U5QUNA[:UI#            +JCZG@KM+TUC0$
M $!W5!UOA;:WIC$           #HCJKCK=#VUC0&            W5%UO!7:
MWIK&            H#NJCK="VUO3&            '1'U?%6:'MK&@,
M     (#NJ#K>"FUO36,           #0'57'6Z'MK6D,            NJ/J
M>"NTO36- 0          0'=4'6^%MK>F,0           .B.JN.MT/;6- 8
M          #=476\%=K>FL8           "@.ZJ.MT+;6],8
M=$?5\59H>VL: P          @.ZH.MX*;6]-8P           - =5<=;H>VM
M:0P           "ZH^IX*[2]-8T!          ! =U0=;X6VMZ8Q
M    Z(ZJXZW0]M8T!@           -U1=;P5VMZ:Q@           * [JHZW
M0MM;TQ@           !T1]7Q5FA[:QH#          " [J@ZW@IM;TUC
M        T!U5QUNA[:UI#            +JCZG@KM+TUC0$          $!W
M5!UOA;:WIC$           #HCJKCK=#VUC0&            W5%UO!7:WIK&
M            H#NJCK="VUO3&            '1'U?%6:'MK&@,
M (#NJ#K>"FUO36,           #0'57'6Z'MK6D,            NJ/J>"NT
MO36- 0          0'=4'6^%MK>F,0           .B.JN.MT/;6- 8
M      #=476\%=K>FL8           "@.ZJ.MT+;6],8            =$?5
M\59H>VL: P          @.ZH.MX*;6]-8P           - =5<=;H>VM:0P
M          "ZH^IX*[2]-8T!          ! =U0=;X6VMZ8Q
MZ(ZJXZW0]M8T!@           -U1=;P5VMZ:Q@           * [JHZW0MM;
MTQ@           !T1]7Q5FA[:QH#          " [J@ZW@IM;TUC
M    T!U5QUNA[:UI#            +JCZG@KM+TUC0$          $!W5!UO
MA;:WIC$           #HCJKCK=#VUC0&            W5%UO!7:WIK&
M        H#NJCK="VUO3&            '1'U?%6:'MK&@,          (#N
MJ#K>"FUO36,           #0'57'6Z'MK6D,            NJ/J>"NTO36-
M 0          0'=4'6^%MK>F,0           .B.JN.MT/;6- 8
M  #=476\%=K>FL8           "@.ZJ.MT+;6],8            =$?5\59H
M>VL: P          @.ZH.MX*;6]-8P           - =5<=;H>VM:0P
M      "ZH^IX*[2]-8T!          ! =U0=;X6VMZ8Q            Z(ZJ
MXZW0]M8T!@           -U1=;P5VMZ:Q@           * [JHZW0MM;TQ@
M          !T1]7Q5FA[:QH#          " [J@ZW@IM;TUC
MT!U5QUNA[:UI#            +JCZG@KM+TUC0$          $!W5!UOA;:W
MIC$           #HCJKCK=#VUC0&            W5%UO!7:WIK&
M    H#NJCK="VUO3&            '1'U?%6:'MK&@,          (#NJ#K>
M"FUO36,           #0'57'6Z'MK6D,            NJ/J>"NTO36- 0
M        0'=4'6^%MK>F,0           .B.JN.MT/;6- 8           #=
M476\%=K>FL8           "@.ZJ.MT+;6],8            =$?5\59H>VL:
M P          @.ZH.MX*;6]-8P           - =5<=;H>VM:0P
M  "ZH^IX*[2]-8T!          ! =U0=;X6VMZ8Q            Z(ZJXZW0
M]M8T!@           -U1=;P5VMZ:Q@           * [JHZW0MM;TQ@
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MS!?/E2I5@L\B!\.SA$[]0>/H%0#MHWO(XK[YFTE_6\<]K!]VV&$H<@!B%L=
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M9-X&W:F=39G0^O%RU%%'X>X9^_KKKU&G"L\AR>]I;Q&^__Y[=,=8W;IU4><
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M,-JU:U<<:Q%OO/$&ZF)E\N3)N,NP.\!0+9=8]"7G31[/0??%%U]$71@3)DQ
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MG9PE/!#8X"[E4HV^!+P5^"3-LWJO7+D2=<*L6+$"W87%X%DAE0UPGGN/?:6
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M3M0)H#(/?I@0@RZZ=.D"1YWS"W*G3IT*KEB4$Q8MH]C:H'UT#UD\7XPZ<.!
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MJ-.!FEIDPICNOE,A],*='^^__SZX8F*G#]J(6:D'H[1 D4(6+%A0L6)%B.>
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M,TO*ZD\PM% *H' 62C:&]'R5U=L&U6'Z+&@F;!A 6J\^V: Z3"^/LA*G'3A
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MTKG !%&*B (@M,\';3.0XG#S*FR"2 X\)>BD( C"2-:O7W_NN>=BP?('[8E
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MTGT2W4D[)(A\!$\#L1,!;<2L,A*&?J [:8>$R6!C4W/K -N 6L$%)HA21!0
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M'_OMM]^8,6/@THY&16^D 0V'$'26>TW4$E-#'Q/]$^7$(O?#;/\IK3MI;'"
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M\-V[=P>7OGW[HI$ Q><K?H5#HR+,=M$TH7P)Z&PF&S=N;-BP(7HJ6H,.:)H
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MLV%1H(/>LK'GSHX^8EX9"4<_4$Y D JIN/GH.=W) V$S@>GVPX8RD$1_$W;
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M]^[=P>OHHX]&HR+Z]>L'7CUZ]$ C+VSHHK9ASQ+0V4P\EX#R-8A&R:#M$.*
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M$K7"U!HV;(@.C'W]]==HIQH<,BS.4%!.0+!^_?KHP]C:M6O13AB>-Y0+^X_
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MZ6"0D1/4EG,'5(D2JH.IN?-L@*6XN:"<@*#GNVMN_F@M$'8 J"6G%A4;\NF
M/GKSD >#D X#Y>0$42M,+06;LF>))MKN/$?4O"C06B[#J!6FIB<#:.0%^HAY
M920<_4 Y 4$]:;2YD/)H/MW)@W$(OVDQ-I2!))ZOD&@3=L A!6;!,U3]V=96
M\.@OD"('=!-V] 2UPM0\_PC[GCU[T$X8[HMR83$HQ-1E,(^V>K,$> M\[#;
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M.3YV&^ 3*RF$&S%L=!-V] 2UY-2*6;5JU>3)D_OW[^_W_=6=.W?>O7LWNKE
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MG"!JA:F977$V$*G#I^]@D$E ,)1(.7<#+BQ*J&;G+C6;"\H)"-K0_-%:(.P
M4$M.+2HVY-,!??3F(0\&(1T&RLD)HE:86@HV9?WMSH9%@=9A$QT,:H6I>69
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MT>,U4G&4GT-4H38PSWYB=DN-@=J<9.(N$S]02T#-L^:UK3@;$._P-AP,+*]
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M\9R[ 1<6)53C<Y>.S074F,"+9RQH_N@@%K8?J"6G%@/C^71 -^UY<+"DR/U
M+0&U%&S*^MN=\46!#@(3'0!J":A9<F=''S&OC#4+F0I)DGBG.WG4UH_Q,I!'
M?Q/.Q*VWDLYVU(('8R:6HHR$HR>H):"V>/%BS^_S^].?_H2F@?SQCW]$B1QH
MF@#&+X.21*TW2X"8\;'; )]822'<B&&CF["C)Z@EIR;"6V^]!2,>=MAA:.3B
MA!-. /O''W\<C:( :DS%*[_]]MLHRAB_B:%=('/GSBW^KEH'-/6B7[]^Z,98
MITZ=XOUI:A$LF9J-&S=Z?C5ZU.^3N/+**U&"L29-FH0>(]!'+&P_4$M.382H
M2U()Q>4Z:M0H- KCG'/. 9$\:*H:(TF3(6K GG]HK'[]^C+W(G&4]Q:%0& L
M8K&EK%\Y*)\O4&-R0:*6G)HX-G0Y],D1-9*1(T>B!&.-&C7:M&D3FM;$>,$7
MLVO7KN;-FX/411==E/'Z8JH6+5IP>Y00PVP7=<#ALZ!18MBY!- B"J@EH+9A
MPX:&#1NB6_14>*Y!!S2UDJB'$!LN5NB30\G<B?3/C%<,:.&#V?Y3O/99J=U)
M5:$V, NWU!BHS4E&8IEX@EIB:F97G''$.WQQ<XC:43/2!P/+*U 0\9R[ 1<6
M)50;YJXX!E9JFPNH,;$7-][\T4<L;#]02TXM!L;SZ8">VO/@8$F1^X%:8FHI
MV)0UMSOCBP)]Q";:#]024+/DSHX^8EX9:Q8R%9(D\4YW\JBM'^-EH 3-33@3
MM]Y*.MM1"QZ,F5B*,A*.GJ"6F-KIIY^.;HRU:M7JXX\_1E,?5JQ8T;)E2Y3(
M@=8)4+PHHFZ1&>G+H Q1Z\T2(&9\[#; )U92"#=BV.@F[.@):H6I\6U2\C/1
MQ?_&<?CPX6CDXK+++@/[H4.'HE$40(V%O;((>_?N;=^^/<@>??31:.?/5U]]
MU:%#!U#(@]9>>'Z["6? @ ';MV]':Q78,S777W\]>C)6ITZ=%UYX 4U]>.:9
M9SS_M=GHT:/1M CT$0[;$]0*4]._))50?%%LUJQ9I"]<O>>>>T#!#5K7I.22
MIC_@!0L6>*Z( P\\<-6J56@=A;???KM___[XTYHH[RT*@<!86+$5DZ9^Y:!\
MOD"-R06)6G)JXICM<@[HDZ.JJDJ\I<R>/9O7)THP=NVUUZ*I%V8+WI,KKK@"
MI/;==]]UZ]85_RKAJJNN0F=AS'91!QP["QHEAIU+ "VB@%IB:M=<<PVZ15R#
MLV;-\ER##FB= /H/(39<K- G1Z2YD^R?Z"86><9T_TG!G505R@.S<$N-BO*<
M@!H37B:>H):8FMD5)XG.#F_#P<"&"M29<S?@P@1"S6/#W*5@<P$U)O;B&=/-
M'WV$P_8$M>34XF$VGP[H:2(/&9N*W!/4$E,KZ4W907^[,[LHT$=LHOU +3$U
M&^[LZ"/FE;%I(9=S(9DZW<FCO'[,EH$2]#=A'"FLWO*8RK;^@@=C)IPB=!-V
M] 2UQ-06+5KDF>0N7;I\^>67:%T$M^G<N3,ZNT"'!#![&=1?;Y8 ,>-CMP$^
ML9)"N!'#1C=A1T]0*TS-L3GQQ!-GSYX=]0\><QY__/'B+XKDIT:T<S%MVC2P
MKUV[]FNOO89VPH :"WME06Z^^6;498S_$.V\6+Y\>:=.G=#9!3KX\(M?_ (]
ML_#YVKAQ(UH'PO=^[H4_K8D]4[-ERY9V[=JA<_9?<K_[[KMH7<3KK[]>OWY]
M=&:L8\>.(A__1S?AL#U!K3 UQT;GDE2"Y^'RE%-.$?P^'L_EY@8=:N+8E%#2
MG"$T!SQJU"AP<6C9LN7<N7/16H %"Q:<>>:9C@@^JXGRWJ(0"(R%O4LQ:>I7
M#LKG"]287)"H):<FCMDNYX ^+IHT:;)PX4)T*&+^_/F-&S=&Y^S7IXE\Q5'&
M=,%[PE\*Y1CS_&^V>-="YR@8[*(.-8?]+VB4&'8N ;2( FJ)J6W8L&&__?9#
M3\::-FWZ_OOOHW41\^;-*_ZPIAMT2 !G(,V'$,\"T'FQ0A\7VOHG>HI%[F"V
M_Y3ZG505R@.S<$N-BO*<@!H3J,\ 4$M8S>R*D\$90D^'M^%@8$,%.F9Z<NX&
M7)A J'ELF+M,Z6\NH,:$7]QL\T<WX; ]02TYM7B8S:<#.IO(0\:F(O<$M835
M2G=3SJ.YW9E=%.@FEV34$E.SX<Z./F)>&9L6<CD7DF.C_W0GC_+Z,5L&JM#<
MA'&8L'K+8RK;CIG.@@=C)IPB=!-V] 2UA-6NO?9:],S"3R9//ODD6KMXXHDG
M6K1HD;<?/'BPR_N_H$\"F+T,.C8ZZ\T2(&9\[#; )U92"#=BV.@F[.@):H6I
MN2T[=.APPPTW+%NV#(V\X+O%====5UQ\O7KU0M.:;-Z\>9]]]@&OJJHJOC,]
M]]QSGWSRR;9MVR*M!)!B8:\LR*I5JWA4*)W]BA$>(5KGV+%CQSWWW-.D29.\
M_8477NCR_B_HYL/6K5N_][WOH7.6YLV;3YHT:<^>/>A3$Q[JHX\^FO_*7'Q<
M$ZNFYOGGGR^N+D[=NG5__>M?^X6Q=^_>.^ZXP_._XZFHJ!#LC.@9)>QB4"M,
MS6VI9TDJ@<](CQX]8&B6_0J0X.^,G3]__K'''NMV.??<<]W_UP'=:N*V+(FD
MN<?2%C!O%_QD XX.E9650X<._?###]''BW7KUDV<./'PPP]W*Z!1393W%H5
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ME<F7@S-?/*I[[[WW^../Y\<RMS%?7.O7KW?_Q $'JPE:9[$Y:3AD%@T!\PM
MP'&MLK+RN...&S-FS$LOO?3!!Q_PB> !\/]=OGSYFV^^R0/@+8Z?ECR_&1A'
M*D)M;U$(#AEWT'3TJSQJYPOM_"U%0"TYM4@8['(.Z,,8/X?P&Y3[)UVZ=.&K
MF*]9YXC"_Y?_,_\)_[G;S,W%%U^,(X5AJN#]X*E&T2(F3)B ;M$QV$4S7@7
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M?N5&X7RAG;^E"*@EIQ854UW. 7UR7OP>5>7U%PE#&31HT/;MVVL.$@']!1_
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M:T0:-6IT]=57KUJU"@<@"(*("S8:X8:/;LD[6@)&7PKQ8\3",:.;L"-!$/:
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M1A(1+,1>$0L_%;N22.R%&$5C-"B""A84$03%",0:1:.(7:.HH%%!12P@HHB
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M_KC;2JX]OOON.Y3Z8%0QIC_&8K!:AS(<O"7MFT*[+&HJEVE;C83G0]4M6K1
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M>O7JA;HH3)X\.9(AB$76%82YB9(?.1UBL!#[[+,/ZI3IV+$CV@DQ?OQXU#E
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MJI91I0STLI 3.2;L -595Q#F)DI^.G7JA,%"?/311ZA3QO,7QX)?2HEJ(>0
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M5V4;! PD]!:"KAG(_/GS]]]___),JR&GS-MOOUW]#1SN+QL5"4S8 4H#Q2F
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MSUU<RE]G-&&%%ILM6[;LLLLNF%)R-&_>//0HS81*M,$8M2@_LFT8V:9N@])
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MRC'$_4CX P\\ #+)QQ]_#+( *EA7,F?1HP-FQ0)%J;-Z]>K6K5MCMEP,&#
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M/%_C<<<==Z"NF&#R65<0YB9*?DXZZ20,%F+,F#&H4^8?__@'V@G1HT</U#E
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M&;95'=:O7W_  0<49KF<:M6JG7GFF9,F3=JZ=2M&^O#--]\,'#APM]UV0Z_
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MA!!"""$5@M#]?M U RG/;DEEFY * _9 ]D%"++!C9-<U,!_9Y<1 L&A8. :
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MV%'&MF;-&@UJ8F1"G,2/EY9+7+#)TGED)@$     J J1U_MA;0 @"D\9/'4
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MW)C#UK3ZQ.G3I_?ITT?;#'SK6]^:,V=.@SZRHD,I2<^>/:=,F:*EXUBX<.&
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M5>4AF8KLAVW;J5 C*D='%G]LUAZ ECREU_H5S,GF6<(J97I?R+TJ<4^"&AW
M?=WH>Q5SP047:*B?2BWX)GY! 0    "H;G*IJ,W> &VQ4F&X,8>M:77<"_*X
ME]^OO/**5G&<TOXBN5+>>.,-^<ZD33;9Q/ ;,O;88P]O8DZ?/GV6+U^NH2G)
MN,<OO_S2]ZMKSCOO/ T-Y?O+%)TZ=8K\RU'-J??DDT]JJ)G%BQ>W;]]>R\7_
MV."""R[0$O4TM#R2K%MO5E[&AW_&*]EU^.&':W^.<^>==VJ<@<,..TSJA+_?
MFJ+B-^Y'CARI00W=>NNMWGAWV4R?/EW>-1XS9HRF-73%%5=XXUU[[[VW!C4D
M\8[QH:%IQHE!M%R=C!=\6K3[JIB<QGYL6G):J>PT2KQC-N;:4A-WWGEGR>K?
MO[\&&2@^$_7KUT^#BM@VU3DEORXJ_I*,8XXY1H.B?/#!!\6_>'7111=I7#E)
M[X[96JKU2W0R?!K<9IMM)&7:M&D:E"KISC&>J"!:KE[):[+6KZ9&Q*&US*H5
M/S\X97ZEJIV9C3.$EC,K:.?57Q4?DJG(?MBVG0HUHG)T9#''9N<!Z-CTE%X.
ME^ET   _<$E$053K5]#)\%G"-JF_+^2D=!73H4.'R/56V07?E"\H      #5
M3:X3M=D;H"U6*@PWYK UK<ZP8<,TSL!66VTE=6Z__78-LMO @0/E+IC\1L#S
MSS\O64[==A/W=@U-2?8]WGSSS=J?XVR\\<9Q?RUHP8(%Q5]#XA@L%4VH<^21
M1VJ<,=][U*-'CV7+EFEHJ"5+EG3KUDT+U='0LBEMW=8&S&J6AW_V*_FMM][2
M_AQG]]UW-WRS6/SK7_^24KUZ]=*@\KCXXHNEZ\C?X3KZZ*.]\3OMM)-[HWO?
MO3<.&C1(TQHZZ*"#O/&.P1OE$N\8'QJ:9IP81,O5R7+!ITAZ=QK_Y%3!L6G#
M::7BTRCQCL&8<S3-++'XZQ!<[[WWGL:%FC9MFI9PG%&C1FE<0Q9.M9/L=9$[
M;U*M18L6<;\)YKSSSI,B-34U<^?.U;ARD@$X9FNIUB_1R?!IL/A'R5>L6*%!
MJ9+N'..)"J+EZB19D[5^-34B#JUE4"W[5ZJU)8TSG)8S*^A[4JOXU5\5'Y*I
MR'C8%IX*-:)R=&0QQV;G 6C54WJM7T$GPV<)"Z7[OE"*5S&17[I6V07?E"\H
M      #53:X3M=D;H"U6*@PWYK UK>Y=_ADS9FB<@5_]ZE=2ZN233]8@NXT=
M.U;N0N1;&*[CCS]>LAR#G25)9-]C__[]M3_'^>UO?ZMQ!H8/'ZZ%2OJB*:?4
MG_3*<7O4<HYSS377:)R!XN_-RM&XLBEMW=;ZS6K&AW_V*_D7O_B%]N<X3SSQ
MA,89^\YWOB/5WGKK+0TJ@^>>>T[Z;=VZ=<B'7NO6K>O<N;,W_MQSSZTM^DON
M3ITZK5V[5I/KK5RY<H,--O#&NR(_%99XQ_C0T#3CQ"!:+O,%GR+IW6G\DU,%
MQZ8-IY6*3Z,$.P9CSM$TL\3Y\^<7_T*3X<\SY16O6+>F6UGC&K)PJIUDKXMJ
M_<9P^>67:U"P5:M6;;SQQE)AP( !&E=F,@#';"W5^B5F^338JE4K2?GRRR\U
M*%72G6,\44&T7)V$:U++)1NDUC*HEOTKU=J2QAE.RYD5M/#JK[H/R51D/&P+
M3X4:43DZLIACL_  ="Q[2J_U*YCELX2%4GQ?R$GU*F;????5N(8JN^";\@4%
M     *"ZR46B-GL#M,5*A>'&'+:F.<Y!!QVD06;^\I>_2*F]]MI+@^Q6_(=]
M/_O9SS2HH=6K5_M^PW^27Y0(EWV/"Q8L*/X9+->''WZHH0:*OX;$J?L2D46+
M%FFHAR;4_0S$NG7K-,[,PH4+?>]1:5]D,FO6+"U41^/*IH1UFR-93K:'?_8K
M>?WZ]3UZ])#N.G?NO&;-&@TU-G+D2"EXTTTW:5 9K%JUJDV;-M)UR*<4;[[Y
MI@3GWFE]YIEGY/:0WXAY]MEG)=@=@SL2C6M(4ASC0T/3C!.#:+EL%WRZI'>G
MD4].%1R;-IQ6;)A&"7:BQIRG:<:)Q=^'$>OEP=JU:]UXJ1"YW\7.J8YUQWW]
M[__^K]3LU:N7><T__>E/DNYZ_/''-:[,= 3&:TG3LGT:+%Y1#SSP@ :E2KIS
MC"<JB)9+8TUJQ62#U%I1U;)_I9JC_46-,Y*6,RAHY]5?=1^2J<ARV':>"C6B
M<G1D<<9FYP%HVU-ZK5_!+)\E+)3B^T).JE<Q[GH+V9YKPX)OLA<4     (#J
M)A>)VNP-T!8K%88;<]B:YCB777:9!IEYYYUWI-0VVVRC079;N'"AW(7]]MM/
M@QHJ_JXFUV:;;6;^[DE<V??XP ,/:'^.L^NNNVJ<L9UVVDG+.<[X\>,USD.C
M'>>G/_VI!AE[Z*&'M)SC]._?7^.,R:]/YFA0V92P;G,DR\GV\,]^)4^>/%G[
M<YPA0X9H7!POOOABN@7-'7SPP=)UR)\R7W/--=[(EBU;YGX&9<6*%:U;M_8V
M777559I<[\(++_1&NK[__>]K4!%)<8P/#4TS3@RBY;)=\.F2WIU&/CE5<&S:
M<%JQ81HEV(D:<YZF&2>Z+QXTTW'^_O>_:UR IYYZ2I,=YY%''M&XANR<ZB2O
MBW)6K5K5I4L7*6N^IVW???>5W-Z]>Y?OG!Y$QN 8KR5-R_9IL/AK)K?<<LOP
MCV\3DNX<XXD*HN726)-:,=D@M594M>Q?J>9HEU'CC*3E# K:>?57W8=D*K(<
MMIVG0HVH'!U9G+'9>0#:]I1>ZU<PRV<)"Z7XOE#J5S$//_RPQM6S8<$WV0L*
M     $!UDXM$;?8&:(N5"L.-.6Q-<YQGGGE&@\Q\_OGG4JI'CQX:9+?UZ]?+
M7>C;MZ\&-73555=)BNN$$T[0N/1DWV/Q/AC7+W[Q"XTS-FS8,"WG.,.'#]<X
M#XUVG-&C1VN0L8LNNDC+.<[99Y^M<<9\?^] @\JFA'6;(UE.MH=_]BMYS)@Q
MVI_CW'###1H7QYPY<Z1@9G]07CR!N^VVFP;5.^200[R1WC?'#SSP0&_3][[W
M/4]> \4_:'+UU5=K4!%)<8P/#4TS3@RBY;)=\.F2WIU&/CE5<&S:<%JQ81HE
MV(D:<YZF&2>N7KVZ>!?7\<<?KW$!CCON.,GMVK6K6U/C&K)SJI.\+LH[__SS
MI>P11QRA07[>??==271=>>65&E=^.@CCM:1IV3X-7GSQQ9+BU'T>_]QSSVEH
M2K0SXXD*HN726)-:,=D@M594M>(76DZ97ZGF:)=1XXRDY0P*VGGU5]V'9"JR
M'+:=IT*-J!P=69RQV7D VO:47NM7,,MG"0NE^+Y0ZE<QO_G-;S2NG@T+OLE>
M4       JIM<)&JS-T!;K%08;LQA:UJIWT[O6KY\N91JTZ:-!F5KYLR9]]QS
MS]EGGWWXX8?OL,,./7KT:->N78L6+62<(3IV[*A%&QH\>+#FE/FKZ;/OL?A'
M!%QCQX[5.&-WW'&'EHOZ60&-=IP77GA!@XP=>>216LYQ[KKK+HTSYLZ&EC,^
M!HMEL&YS-"W;PS_[E3QTZ%#M+_&O7Q7?\<TVVTR#RN/UUU^7KH-^D>2;;[YI
MV[:M-_*22R[)M\J/:VRPP08K5ZXL)-?[ZJNOFC=O[HUTO?'&&QI71%(<XT-#
MTXP3@VBY;!=\NJ1WIY%/3A4<FS:<5FR81@EVHL:<IVG&B:ZSSCI+<MTEMV3)
M$HTKXCZMN<]XDGO..>=H7!$[ISK)ZZ*\&3-FR&]7N<_\'W_\L<85.?/,,[U9
M3MW7D<Z;-T_CRD^&X1BO)4W+]FEPVK1I[DE<LG)VVVVW,6/&F#P*L6@WQA,5
M1,NEL2:U8K)!:JVH:MF_4LW1+J/&&4G+&12T\^JON@_)5&0Y;#M/A1I1.3JR
M.&.S\P"T[2F]UJ]@EL\2&:C@^T*I7\4<==11&E?/A@5?VU0O*       U4TN
M$K79&Z M5BH,-^:P-<UQDORRAM8R'D:ZYLV;-W+DR&VWW59'$U^K5JVT>D/%
M7YOD>O'%%S4N/=GWV*]?/^W/<5Y]]56-,_;**Z]HN:A?1M!HQYDY<Z8&&=ME
MEUVTG..\_OKK&F?,G0TM%W_Q9[EN<S0MV\,_^Y7\W>]^5_NKFZO6=5K5:UFO
M1;WF=6KJ-:NGM>JT;]]>.RZ/=>O6=>K427I_Z*&'-*ZV=N+$B1+FG>=)DR9)
MZX0)$SS9__'((X](F-N[R6^'2983M3#R-,TX,8B6RW;!ITO[3MR[ELMV<JK@
MV+3AM&+#-&ITU)CS-,TXT35ERA1-=IS?__[W&E?D=[_[G:8YSM2I4S6NB)U3
MG>1UD=?WOO<]J1SRQ1XY7W_]=<>.'25K\.#!&I<)&89CO)8T+=NG0=<))YR@
M.0WML,,.PX8-&S=NW)PY<S0Y/JUN,,)P6BZ--:D5DPU2:T55R_Z5:HYV&37.
M2%K.H*"=5W_5?4BF);-AVWDJU(C*T9'%&9N=!Z!M3^FU?@4S?I8H$QO>%TK]
M*B;D^^QM6/"U3?6" @    !0W>0B49N] =IBI<)P8PY;TQS'9(M#$*UE/(RT
MK%RY\L(++VS3IHV.(P'MHZ%--ME$$QSG@P\^T+CT9-]CCQX]M#_'F3U[ML89
M^_###[6<X_3LV5/C/#3:<>;/GZ]!QGSO49)/!6;-FJ7EHE:.5_;K-D=SLCW\
MLU_)??KTT?[*H'GSYMIQV0P:-$AZ/^.,,S2HMO8WO_F--Z9=NW;>7_%8NW:M
M;&5P5Z,G^S^*?P EY$^]O23+B5H8>9IFG!A$RV6[X-.E?2?N7<ME.SE5<&S:
M<%JQ81HU.FK,>9IFG)BS\\X[2_J^^^ZK047VV6<?R>K7KY\&^;%SJI.\+O)Z
MX($'I+)[OEZS9HW&>=QUUUV2XIHX<:+&94+'8;R6-"W;IT'7XL6+M]EF&TT+
MT+5KUZ.//OK66V^=/GVZ%C*C%0U&&$[+I;$FM6*R06JMJ&K9OU+-T2ZCQAE)
MRQD4]#VI5?SJK[H/R;1D-FP[3X4:43DZLCACL_, M.TIO=:O8,;/$JFSYWVA
MU*]BW%.JQM6S8<'G-,$+"@    ! =9.+1&WV!FB+E0K#C3EL33-.]*6UDE6+
MZ\,//]QNN^UT!(EI-PVU;]]>$QSGBR^^T+CT9-^C_.1BSH(%"S3.F#M:+1?U
MQXL:[3BK5JW2(&.^]VCAPH4:9VS^_/E:+FKEY%5DW>9HCEE6$*T552W[E5S\
M'39EHAV7S2VWW")=;[WUUAI4]"[M88<=)@'R8R7]^_>7 -?VVV_OC7&-&3-&
M@_Q(EF,\/YIFG!A$RR4KJ+6258M+^T[<NY9+5E!K156K@F/3AM.*#=.HH:'!
M7IIFG)ASXXTW:G[4CV?Y?EHV:M0HC?-CYU0G>5WDM7KUZN[=NTOQ\>/':YS'
M'GOL(?'N"QL-RHJ,Q F=1B]-,T[TI;7,JGW\\<?%DQG)G>TKK[SRDT\^T7*A
MM(K9"$-HN336I%9,-DBM%54M^U>J.=IEU#@C:3F#@KXGM8I?_6E$'%K+K%J6
MAV2*LAFVG:="C:@<'5F<L=EY -KVE%Z;=D&ME:Q:":QZ7RCUJYB0]6;#@L]I
M@A<4     (#J%GF%&-9FH<)P8PY;TXP3?6FM9-5BF3%C1K=NW;3[-&A/#35O
MWEP3TGB[,(0E/7[SS3<:9\P=K99SG!8M6FB<AT9'/2[ALKE'&N2G4NLV1W/,
MLH)HK:AJOH]"65=RJU:MM+_RT([+9MJT:=JWX\A'64N7+G4/+F_ #3?<X UP
MC1X]VAO@/C1???65-^#SSS_W!N2\__[[WI@@FF8\/YIFG!A$RR4KJ+6258M+
M^T[<NY9+5E!K156K@F/3]PDMX].*#=.HH:'!7IIFG)@S?_[\EBU;2H7APX=K
MG,?%%U\L\6X%PV] :=13;>+""R^4XH<<<H@&U9L\>;($N]S3BL9E18=B/#.:
M9ISH2VL95W./_4LNN63##3?4_"CN C[]]-/__>]_:\4 FF\\PB!:+G'!VK1K
M:JVH:KY/[&5]I9JC74:-,Y*6,RCH>]]3/ZEE>?6GM8RK979(IBN#85?]J3 A
M'5F<L57? 9BC%1/7U'+)"FJM9-7BLNU]H2S7FPT+/J<)7E       *I;Y!5B
M6)N%"L.-.6Q-,T[TI;6253.W8L6*;;?=5ONNT[QY\_[]^Y]]]MEWWGGGA D3
MIDV;-F_>O.7+EZ]>O7K]^O5:*/Y=\'W[IJP?EEC28Y*WJ-Q<+1?U%I5&1STN
MX;*Y1QI4I(+K-D=SS+*":*VH:KZ/0EE7<DU-C?97'MIQ.?7LV5-Z_\,?_N -
M>/SQQR5@ZM2IW@#7N^^^*S$//_RP-^#/?_ZS!)C\\DB.)#K&\Z-IQHE!M%RR
M@EHK6;6XM._$O6NY9 6U5E2U*C@V?9_0,CZMV#"-&AH:[*5IQHEY\FV7KMZ]
M>_N>,5WN[;UZ]9+X08,&:5R 1CW5)N;,F2/WL5FS9K-FS=*X.J>>>JHWTM6V
M;=O%BQ=K7%9D,([QS&B:<:(OK16SVH(%"T:.'+GUUEMKE2@;;KCAN''CM)P?
MS8PYPF):+G'!VK1K:JVH:KY/[&5]I9JC74:-,Y*6,RCH>]]3/ZEE>?6GM6)6
MR^"0+(>R#KOJ3X4)Z<CBC*WZ#L <K9BXII9+5E!K):L6BX7O"V6YWFQ8\'E-
M[8("     %#=(J\0P]HL5!ANS&%KFG&B+ZV5K)JY$2-&:,=U7XQ_^>67SYLW
M3Z.#K5V[5JM$W87L?U(G^QY3_R&#N+^D4)OVTO*]1ZG_-H0&%:G@NLW1'+.L
M(%HKJIHE*UF^#JW1.?'$$^4>_?=__[<WX-QSS_6V=NW:U?<MW1X]>GC#SCSS
M3&_K3W_Z4V^K4]1+"$ETHA9&GJ89)P;1<LD*:JUDU>+2OA/WKN62%=1:4=6J
MX-CTO0L9GU9\QY#Q-&KW46/.TS3CQ+SQX\=K"<=Y[KGG-*[.A D3--1Q'GGD
M$8T+T*BGVM"AAQXJ]2^XX (-JOLBTN*S^="A0S4N0S(8QWAF-,TXT9?6*K7:
MY,F3K[ONN@$#!G3JU$DK!KOVVFNU4!'-*76$>5HN<<':M&MJK:AJQ6O;*?,K
MU1SM,FJ<D;2<04'?9[E&??6GM4JM5KY#LJS*,6S?15)EI\(D=&1QQN8[MXWZ
M ,S1BHEK:KED!;56LFJQ6/B^4.I7,2'KS88%G]?4+B@      -5-KCJUV1N@
M+58J##?FL#7-.-&7UDI6S="R9<N*?Q-DBRVV>/?==S4TBN];)QK4T*:;;JH)
MCO/!!Q]H7'JR[U'VRN3,GCU;XXS-G#E3RT5]Z91&1STNX7SOT9PY<S3.V*Q9
ML[1<U @KNVYS-,<L*XC6BJJ6_4KV_2V2M]YZ2^,:E;OOOEOND1Q*.^VTD[=U
M\.#!WM:\$TXXP1NVW7;;>5N+__I9OHLNA"0Z40LC3].,$X-HN60%M5:R:G%I
MWXE[UW+)"FJMJ&I5<&S:<%JQ81JU^Z@QYVF:<6+>ZM6KNW3I(D6&#!FB<75.
M.NDDB>S:M:M;0>,"-.JI-O3PPP]+??=>%W]CQVVWW29AKC?>>$/"LJ2C,9X9
M33-.]*6UDE6KK?LFDFG3IMUUUUU#AP[=<LLMM7I#S9HU>^RQQ[1$0YJ3>(1:
M+G'!VE1KEK!1(/M7JCG:9=0X(VDY@X*^)[5&??6GM9)5JRW#(9F-%(?=%$Z%
M2>C(XHRM^@[ '*V8N*:62U90:R6K9L[.]X52OXK99)---*Z>#0L^KZE=4
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M6].,$WUIK635# T9,D0Z+?D'FYY[[CDIY43=A>...TX3'.>FFV[2N/1DW^/
M@0.U/\>Y\\X[-<[8[W[W.RWG.(,&#=(X#XV.>ES"'7GDD5K.<>ZZZRZ-,S9V
M[%@M%S7"RJ[;',TQRPJBM:*J9;^2CS[Z:.W/<:ZZZBJ-:VR*O^/AYIMOSC6-
M&S=.FH+^WKIX:]V]]]Z;:[KCCCND::NMMFJ8'49RG:B%D:=IQHE!M%RR@EHK
M6;6XM._$O6NY9 6U5E2U*C@V;3BMV#"-VGW4F/,TS3C1:\J4*5K%<?[XQS]*
MV!_^\ <-<IRI4Z=*6(A&/=7FBG_&ZX ##O &3)HT20*<9,L^%3H@XYG1-.-$
M7UHK6;40<^;,.?744V7[>\[]]]^OT1X:G7B$6BYQ0=<&&VP@-;_^^FL-,C-C
MQ@PIY42-,/M7JCG:9=0X(VDY@X+5=_6GM9)5"U'R(5E9)0R[B9P*2Z8CBS.V
MZCL <[1BXII:+EE!K96LFCD[WQ=*\G+.]RKFJ*..TKAZ-BQXKR9U00$
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MQ$$''22EG*@19O]*-<>&A\;WM:73F*_^M%:R:B;B'I*6,!^V#:?"U ^6%,G
MG#A+KOH.P)S4'R^IYB0;I-9*5LV<G>\+.:E>Q;CK;=&B11I:SX8%+YK.!04
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M#TT+D/$K5:L>FJJY^M-:4=6\D=D<DJGP]IC9L"MX*DS]8$F1C,J)NB^^JN8
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MEOU*=N?_\LLO3_)6;S'M(T.''GJHCJ9.^_;MS=^/7K-FC1NO)>H<=MAA&FU
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MA>7+EX\>/?K;W_ZV5@SF#GNGG7:Z]-)+ITV;IN4,9-SCNG7KW G<<\\]M6B
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M.PT"          ! I<EG.MK,EC@     F#9M6N'2J-[HT:,U#@
M )4FG^EH,UOB     .#TTT\O7!K5:=>NW>+%BS4.            E28?ZV@S
M6^(     -''SY\]OV[9MX=*HSFFGG:9Q            L(!\K*/-;(D#
MT,2==]YYA>NB.LV:-7O__?<U#@           !:03W:TF2UQ     )JRM]]^
MNV7+EH7KHCI''WVTQ@$          , .\LF.-K,E#@   $"3]=EGGVVUU5:%
MBZ(Z-34U;[_]MH8"          # #O+ACC:S)0X   ! 4[-\^?*I4Z>.'#ER
MXXTW+EP1U1LZ=*@F            P!KRX8XVLR4.    0%-0N/()U:U;MX4+
M%VHR            K"&?[V@S6^(     - 6%*Y]@-34U?__[WS43
M    -I&/>+29+7$     FH+"E4^ FIJ:.^^\4],           !@&?F41YO9
M$@<   "@*2A<^?C9<<<=)TV:I#D           "PCWS0H\ULB0,   #0%!2N
M?.JT;MVZ6[=N_?OW/_/,,Y][[KGUZ]=K @           *PDG_MH,UOB
M              "-16''6\"VM[ V                  #L4=CQ%K#M+:P-
M                  ![%':\!6Q["VL#                 , >A1UO =O>
MPMH                  +!'8<=;P+:WL#8                  .Q1V/$6
ML.TMK T                  'L4=KP%;'L+:P,                 P!Z%
M'6\!V]["V@                  L$=AQUO MK>P-@
M[%'8\1:P[2VL#0                  >Q1VO 5L>PMK P
M  # 'H4=;P';WL+:                  "P1V''6\"VM[ V
M      #L4=CQ%K#M+:P-                  ![%':\!6Q["VL#
M         , >A1UO =O>PMH                  +!'8<=;P+:WL#8
M             .Q1V/$6L.TMK T                  'L4=KP%;'L+:P,
M                P!Z%'6\!V]["V@                  L$=AQUO MK>P
M-@                  [%'8\1:P[2VL#0                  >Q1VO 5L
M>PMK P                # 'H4=;P';WL+:                  "P1V''
M6\"VM[ V                  #L4=CQ%K#M+:P-                  ![
M%':\!6Q["VL#                 , >A1UO =O>PMH
M +!'8<=;P+:WL#8                  .Q1V/$6L.TMK T
M     'L4=KP%;'L+:P,                 P!Z%'6\!V]["V@
M        L$=AQUO MK>P-@                  [%'8\1:P[2VL#0
M            >Q1VO 5L>PMK P                # 'H4=;P';WL+:
M              "P1V''6\"VM[ V                  #L4=CQ%K#M+:P-
M                  ![%':\!6Q["VL#                 , >A1UO =O>
MPMH                  +!'8<=;P+:WL#8                  .Q1V/$6
ML.TMK T                  'L4=KP%;'L+:P,                 P!Z%
M'6\!V]["V@                  L$=AQUO MK>P-@
M[%'8\1:P[2VL#0                  >Q1VO 5L>PMK P
M  # 'H4=;P';WL+:                  "P1V''6\"VM[ V
M      #L4=CQ%K#M+:P-                  ![%':\!6Q["VL#
M         , >A1UO =O>PMH                  +!'8<=;P+:WL#8
M             .Q1V/$6L.TMK T                  'L4=KP%;'L+:P,
M                P!Z%'6\!V]["V@                  L$=AQUO MK>P
M-@                  [%'8\1:P[2VL#0                  >Q1VO 5L
M>PMK P                # 'H4=;P';WL+:                  "P1V''
M6\"VM[ V                  #L4=CQ%K#M+:P-                  ![
M%':\!6Q["VL#                 , >A1UO =O>PMH
M +!'8<=;P+:WL#8                  .Q1V/$6L.TMK T
M     'L4=KP%;'L+:P,                 P!Z%'6\!V]["V@
M        L$=AQUO MK>P-@                  [%'8\1:P[2VL#0
M            >Q1VO 5L>PMK P                # 'H4=;P';WL+:
M              "P1V''6\"VM[ V                  #L4=CQ%K#M+:P-
M                  ![%':\!6Q["VL#                 , >A1UO =O>
MPMH                  +!'8<=;P+:WL#8                  .Q1V/$6
ML.TMK T                  'L4=KP%;'L+:P,                 P!Z%
M'6\!V]["V@                  L$=AQUO MK>P-@
M[%'8\1:P[2VL#0                  >Q1VO 5L>PMK P
M  # 'H4=;P';WL+:                  "P1V''6\"VM[ V
M      #L4=CQ%K#M+:P-                  ![%':\!6Q["VL#
M         , >A1UO =O>PMH                  +!'8<=;P+:WL#8
M             .Q1V/$6L.TMK T                  'L4=KP%;'L+:P,
M                P!Z%'6\!V]["V@                  L$=AQUO MK>P
M-@           .#_VK5C&P8"& 9B^T^=E (>D6M]0):61S@  ( =*=Y*]G9M
M            L"/%6\G>K@T           !VI'@KV=NU 0          P(X4
M;R5[NS8           #8D>*M9&_7!@           #M2O)7L[=H
M  !@1XJWDKU=&P           .Q(\5:RMVL#          " '2G>2O9V;0
M         + CQ5O)WJX-            =J1X*]G;M0$          ,".%&\E
M>[LV            V)'BK61OUP8            [4KR5[.W:
M8$>*MY*]71L           #L2/%6LK=K P          @!TIWDKV=FT
M      "P(\5;R=ZN#0           ':D>"O9V[4!          # CA1O)7N[
M-@           -B1XJUD;]<&            .U*\E>SMV@           &!'
MBK>2O5T;            [$CQ5K*W:P,          ( =*=Y*]G9M
M    L"/%6\G>K@T           !VI'@KV=NU 0          P(X4;R5[NS8
M          #8D>*M9&_7!@           #M2O)7L[=H           !@1XJW
MDKU=&P           .Q(\5:RM\<#            O,,SB)/$ 0
M\%+/($X2!P          P$L]@SA)'            "_U#.(D<0
M +S4,XC[?'Z<            X(TD<0           /P)21P           !_
6X@MLOZ5I'!U3+0    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137039037416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 11, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AVADEL PHARMACEUTICALS PLC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1341933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10 Earlsfort Terrace<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">D02 T380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">901-5201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 390,167,685<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,032,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of either (a)&#160;a definitive proxy statement involving the election of directors or (b)&#160;an amendment to this Form&#160;10-K, either of which will be filed within 120 days after December&#160;31, 2021, are incorporated by reference into Part&#160;III of this Form 10-K.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001012477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=avdl_AmericanDepositarySharesMember', window );">American Depositary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American Depositary Shares*<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AVDL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=avdl_OrdinaryShareNominalValue001PerShareMember', window );">Ordinary Share, Nominal Value $0.01 Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary Shares, nominal value $0.01 per share**<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AVDL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=avdl_AmericanDepositarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=avdl_AmericanDepositarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=avdl_OrdinaryShareNominalValue001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=avdl_OrdinaryShareNominalValue001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137041333896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Deloitte and Touche LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">St. Louis, Missouri<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">34<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Audit Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137037535544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of (Loss) Income - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 22,334,000<span></span>
</td>
<td class="nump">$ 59,215,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,742,000<span></span>
</td>
<td class="nump">12,125,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">17,104,000<span></span>
</td>
<td class="nump">20,442,000<span></span>
</td>
<td class="nump">32,917,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">68,495,000<span></span>
</td>
<td class="nump">32,405,000<span></span>
</td>
<td class="nump">30,183,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible asset amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">406,000<span></span>
</td>
<td class="nump">816,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Changes in fair value of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,327,000<span></span>
</td>
<td class="nump">845,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of Hospital Products</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(45,760,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_RestructuringCostsNet', window );">Restructuring (income) costs</a></td>
<td class="num">(53,000)<span></span>
</td>
<td class="num">(43,000)<span></span>
</td>
<td class="nump">6,441,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">85,546,000<span></span>
</td>
<td class="nump">16,519,000<span></span>
</td>
<td class="nump">83,327,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating (loss) income</a></td>
<td class="num">(85,546,000)<span></span>
</td>
<td class="nump">5,815,000<span></span>
</td>
<td class="num">(24,112,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment and other income (expense), net</a></td>
<td class="nump">2,126,000<span></span>
</td>
<td class="num">(832,000)<span></span>
</td>
<td class="nump">1,069,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(9,942,000)<span></span>
</td>
<td class="num">(12,994,000)<span></span>
</td>
<td class="num">(12,483,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount', window );">Gain from release of certain liabilities</a></td>
<td class="nump">217,000<span></span>
</td>
<td class="nump">3,364,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeconsolidationGainOrLossAmount', window );">Loss on deconsolidation of subsidiary</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,678,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense - changes in fair value of contingent consideration payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(435,000)<span></span>
</td>
<td class="num">(378,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(93,145,000)<span></span>
</td>
<td class="num">(5,082,000)<span></span>
</td>
<td class="num">(38,582,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="num">(15,816,000)<span></span>
</td>
<td class="num">(12,110,000)<span></span>
</td>
<td class="num">(5,356,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (77,329,000)<span></span>
</td>
<td class="nump">$ 7,028,000<span></span>
</td>
<td class="num">$ (33,226,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings (loss) per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss) per share - basic (in usd per share)</a></td>
<td class="num">$ (1.32)<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="num">$ (0.89)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss) per share - diluted (in usd per share)</a></td>
<td class="num">$ (1.32)<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="num">$ (0.89)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>Weighted average number of shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of shares outstanding - basic (in shares)</a></td>
<td class="nump">58,535<span></span>
</td>
<td class="nump">52,996<span></span>
</td>
<td class="nump">37,403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of shares outstanding - diluted (in shares)</a></td>
<td class="nump">58,535<span></span>
</td>
<td class="nump">54,941<span></span>
</td>
<td class="nump">37,403<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_RestructuringCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring Costs, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_RestructuringCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeconsolidationGainOrLossAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from deconsolidation of subsidiary and derecognition of group of assets constituting transfer of business or nonprofit activity, excluding conveyance of oil and gas mineral rights and transfer of good or service in contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeconsolidationGainOrLossAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from remeasurement to fair value of retained investment in former subsidiary and group of assets constituting business or nonprofit activity deconsolidated and derecognized, excluding conveyance of oil and gas mineral rights and transfer of product or service in contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137037548232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive (Loss) Income - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (77,329)<span></span>
</td>
<td class="nump">$ 7,028<span></span>
</td>
<td class="num">$ (33,226)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive (loss) income, net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation (loss) gain</a></td>
<td class="num">(1,228)<span></span>
</td>
<td class="nump">1,111<span></span>
</td>
<td class="num">(117)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Net other comprehensive (loss) income, net of income tax benefit (expense) of $214, $(202), $(43), respectively</a></td>
<td class="num">(1,661)<span></span>
</td>
<td class="nump">644<span></span>
</td>
<td class="nump">727<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive (loss) income, net of tax</a></td>
<td class="num">(2,889)<span></span>
</td>
<td class="nump">1,755<span></span>
</td>
<td class="nump">610<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive (loss) income</a></td>
<td class="num">$ (80,218)<span></span>
</td>
<td class="nump">$ 8,783<span></span>
</td>
<td class="num">$ (32,616)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137040264664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive (Loss) Income (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Unrealized gain (loss) on marketable securities, tax</a></td>
<td class="nump">$ 214<span></span>
</td>
<td class="num">$ (202)<span></span>
</td>
<td class="num">$ (43)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137037609224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 50,708<span></span>
</td>
<td class="nump">$ 71,722<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">106,513<span></span>
</td>
<td class="nump">149,680<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent', window );">Research and development tax credit receivable</a></td>
<td class="nump">2,443<span></span>
</td>
<td class="nump">3,326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">32,826<span></span>
</td>
<td class="nump">38,726<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">192,490<span></span>
</td>
<td class="nump">263,454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">285<span></span>
</td>
<td class="nump">359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">2,652<span></span>
</td>
<td class="nump">2,604<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">16,836<span></span>
</td>
<td class="nump">16,836<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent', window );">Research and development tax credit receivable</a></td>
<td class="nump">1,225<span></span>
</td>
<td class="nump">3,445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">33,777<span></span>
</td>
<td class="nump">24,939<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">247,265<span></span>
</td>
<td class="nump">311,637<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liability</a></td>
<td class="nump">900<span></span>
</td>
<td class="nump">474<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">7,679<span></span>
</td>
<td class="nump">2,934<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">7,151<span></span>
</td>
<td class="nump">6,501<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">5,270<span></span>
</td>
<td class="nump">5,200<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">21,000<span></span>
</td>
<td class="nump">15,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">142,397<span></span>
</td>
<td class="nump">128,210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liability</a></td>
<td class="nump">1,707<span></span>
</td>
<td class="nump">1,840<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">3,917<span></span>
</td>
<td class="nump">4,212<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">169,021<span></span>
</td>
<td class="nump">149,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred shares, nominal value of $0.01 per share; 50,000 shares authorized; 488 issued and outstanding at December 31, 2021 and 2020, respectively</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares, nominal value of $0.01 per share; 500,000 shares authorized;&#160;58,620 and 58,396 issued and outstanding at December 31, 2021 and 2020, respectively</a></td>
<td class="nump">586<span></span>
</td>
<td class="nump">583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">549,349<span></span>
</td>
<td class="nump">566,916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(447,756)<span></span>
</td>
<td class="num">(384,187)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(23,940)<span></span>
</td>
<td class="num">(21,051)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">78,244<span></span>
</td>
<td class="nump">162,266<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 247,265<span></span>
</td>
<td class="nump">$ 311,637<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Tax Credit Receivable, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The non current portion of tax credit receivable on research and development as on the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137037553576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Feb. 29, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred shares, nominal value (in usd per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred shares, shares authorized (in shares)</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares, shares issued (in shares)</a></td>
<td class="nump">488,000<span></span>
</td>
<td class="nump">488,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred shares, shares outstanding (in shares)</a></td>
<td class="nump">488,000<span></span>
</td>
<td class="nump">488,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, nominal value (in usd per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized (in shares)</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, shares issued (in shares)</a></td>
<td class="nump">58,620,000<span></span>
</td>
<td class="nump">58,396,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, shares outstanding (in shares)</a></td>
<td class="nump">58,620,000<span></span>
</td>
<td class="nump">58,396,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137034383400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Shareholders' Equity - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Ordinary shares</div></th>
<th class="th"><div>Preferred shares</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th">
<div>Additional paid-in capital </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Accumulated deficit</div></th>
<th class="th">
<div>Accumulated deficit </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Accumulated other comprehensive loss</div></th>
<th class="th"><div>Treasury Shares</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,720<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,407<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2018</a></td>
<td class="nump">$ 2,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 427<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 433,756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (357,989)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (23,416)<span></span>
</td>
<td class="num">$ (49,998)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">(33,226)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33,226)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Vesting of restricted shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Vesting of restricted shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan', window );">Employee share purchase plan share issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee share purchase plan share issuance</a></td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,927<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,407<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2019</a></td>
<td class="num">$ (29,199)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 429<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">434,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(391,215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,806)<span></span>
</td>
<td class="num">$ (49,998)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible Enumeration]</a></td>
<td class="text">Accounting Standards Update 2020-06 [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="nump">$ 7,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">1,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">2,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">February 2020 private placement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,680<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">February 2020 private placement</a></td>
<td class="nump">60,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">60,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_StockIssuedDuringPeriodSharesPublicOffering', window );">May 2020 public offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_StockIssuedDuringPeriodValuePublicOffering', window );">May 2020 public offering</a></td>
<td class="nump">116,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Vesting of restricted shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Vesting of restricted shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan', window );">Employee share purchase plan share issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee share purchase plan share issuance</a></td>
<td class="nump">144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">2,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Retirement of treasury shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,407)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,407)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Retirement of treasury shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (54)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49,944)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (49,998)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,396<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">162,266<span></span>
</td>
<td class="num">$ (12,939)<span></span>
</td>
<td class="nump">$ 583<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">566,916<span></span>
</td>
<td class="num">$ (26,699)<span></span>
</td>
<td class="num">(384,187)<span></span>
</td>
<td class="nump">$ 13,760<span></span>
</td>
<td class="num">(21,051)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">(77,329)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(77,329)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">$ (2,889)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,889)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Vesting of restricted shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Vesting of restricted shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan', window );">Employee share purchase plan share issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee share purchase plan share issuance</a></td>
<td class="nump">94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">8,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,620<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">$ 78,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 586<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 549,349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (447,756)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (23,940)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_StockIssuedDuringPeriodSharesPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Public Offering</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_StockIssuedDuringPeriodSharesPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_StockIssuedDuringPeriodValuePublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value Public Offering</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_StockIssuedDuringPeriodValuePublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S65<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124359872&amp;loc=SL124427846-239511<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(1)<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(2)<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(01)<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 25<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109244457&amp;loc=d3e16649-113920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockRetiredCostMethodAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockRetiredCostMethodAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesRetired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common and preferred stock retired from treasury during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesRetired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137037854728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (77,329)<span></span>
</td>
<td class="nump">$ 7,028<span></span>
</td>
<td class="num">$ (33,226)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net (loss) income to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">815<span></span>
</td>
<td class="nump">1,690<span></span>
</td>
<td class="nump">2,486<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_AcquisitionRelatedContingentConsiderationRemeasurement', window );">Remeasurement of acquisition-related contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,327<span></span>
</td>
<td class="nump">845<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_FinancingRelatedContingentConsiderationRemeasurement', window );">Remeasurement of financing-related contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">435<span></span>
</td>
<td class="nump">378<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and debt issuance costs</a></td>
<td class="nump">1,248<span></span>
</td>
<td class="nump">6,524<span></span>
</td>
<td class="nump">5,995<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Changes in deferred tax</a></td>
<td class="num">(15,666)<span></span>
</td>
<td class="num">(7,431)<span></span>
</td>
<td class="num">(6,334)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">8,872<span></span>
</td>
<td class="nump">2,999<span></span>
</td>
<td class="nump">519<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of Hospital Products</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(45,760)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_NoncashGainLossDeconsolidationOfSubsidiary', window );">Loss on deconsolidation of subsidiary</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount', window );">Gain from release of certain liabilities</a></td>
<td class="num">(217)<span></span>
</td>
<td class="num">(3,364)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other adjustments</a></td>
<td class="nump">1,272<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Net changes in assets and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,281<span></span>
</td>
<td class="nump">2,471<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,352)<span></span>
</td>
<td class="nump">1,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(439)<span></span>
</td>
<td class="nump">1,863<span></span>
</td>
<td class="num">(1,187)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable', window );">Research and development tax credit receivable</a></td>
<td class="nump">2,796<span></span>
</td>
<td class="nump">2,213<span></span>
</td>
<td class="num">(1,014)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable &amp; other current liabilities</a></td>
<td class="nump">4,232<span></span>
</td>
<td class="num">(2,788)<span></span>
</td>
<td class="nump">4,641<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(114)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">895<span></span>
</td>
<td class="num">(13,226)<span></span>
</td>
<td class="nump">357<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue', window );">Earn-out payments for contingent consideration in excess of acquisition-date fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,323)<span></span>
</td>
<td class="num">(10,988)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRoyalties', window );">Royalty payments for contingent consideration payable in excess of original fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(866)<span></span>
</td>
<td class="num">(1,748)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet', window );">Other assets and liabilities</a></td>
<td class="num">(3,789)<span></span>
</td>
<td class="num">(3,126)<span></span>
</td>
<td class="num">(4,057)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(77,310)<span></span>
</td>
<td class="num">(48,734)<span></span>
</td>
<td class="num">(38,325)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(26)<span></span>
</td>
<td class="num">(98)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from disposal of property and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from the disposition of the Hospital Products</a></td>
<td class="nump">16,500<span></span>
</td>
<td class="nump">25,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from sales of marketable securities</a></td>
<td class="nump">102,224<span></span>
</td>
<td class="nump">36,284<span></span>
</td>
<td class="nump">63,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities</a></td>
<td class="num">(61,769)<span></span>
</td>
<td class="num">(131,407)<span></span>
</td>
<td class="num">(24,648)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">56,929<span></span>
</td>
<td class="num">(69,721)<span></span>
</td>
<td class="nump">38,723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from the February 2020 private placement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">60,570<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from the May 2020 public offering</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">116,924<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from issuance of ordinary shares</a></td>
<td class="nump">263<span></span>
</td>
<td class="nump">2,189<span></span>
</td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(145)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">263<span></span>
</td>
<td class="nump">179,683<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of foreign currency exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(896)<span></span>
</td>
<td class="nump">720<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents</a></td>
<td class="num">(21,014)<span></span>
</td>
<td class="nump">61,948<span></span>
</td>
<td class="nump">449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at January 1</a></td>
<td class="nump">71,722<span></span>
</td>
<td class="nump">9,774<span></span>
</td>
<td class="nump">9,325<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at December 31</a></td>
<td class="nump">50,708<span></span>
</td>
<td class="nump">71,722<span></span>
</td>
<td class="nump">9,774<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid (refund), net</a></td>
<td class="nump">76<span></span>
</td>
<td class="num">(1,701)<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">$ 6,469<span></span>
</td>
<td class="nump">$ 6,469<span></span>
</td>
<td class="nump">$ 6,469<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AcquisitionRelatedContingentConsiderationRemeasurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the remeasurement of acquisition related contingent considerations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AcquisitionRelatedContingentConsiderationRemeasurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the Earn Out Payment In Excess Of Acquisition Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_FinancingRelatedContingentConsiderationRemeasurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the remeasurement of financing related contingent considerations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_FinancingRelatedContingentConsiderationRemeasurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in research and development tax credit receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_NoncashGainLossDeconsolidationOfSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncash Gain (Loss) Deconsolidation Of Subsidiary</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_NoncashGainLossDeconsolidationOfSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from remeasurement to fair value of retained investment in former subsidiary and group of assets constituting business or nonprofit activity deconsolidated and derecognized, excluding conveyance of oil and gas mineral rights and transfer of product or service in contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123371682&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating assets after deduction of noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137041294984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Avadel Pharmaceuticals plc (Nasdaq: AVDL) (&#8220;Avadel,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221;) is a biopharmaceutical company. The Company is registered as an Irish public limited company. The Company&#8217;s headquarters are in Dublin, Ireland with operations in St. Louis, Missouri, United States (&#8220;U.S&#8221;).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s lead product candidate, FT218, is an investigational once-nightly, extended-release formulation of sodium oxybate for the treatment of excessive daytime sleepiness (&#8220;EDS&#8221;) or cataplexy in adults with narcolepsy. The Company is primarily focused on the development and potential United States (&#8220;U.S.&#8221;) Food and Drug Administration (&#8220;FDA&#8221;) approval of FT218. In December 2020, the Company submitted a New Drug Application (&#8220;NDA&#8221;) to the FDA for FT218 to treat excessive daytime sleepiness or cataplexy in adults with narcolepsy. In February 2021, the NDA for FT218 was accepted by the FDA and was assigned a Prescription Drug User Fee Act (&#8220;PDUFA&#8221;) target action date of October 15, 2021. On October 15, 2021, the Company announced that the FDA informed us that the review of the Company&#8217;s NDA for FT218 was ongoing beyond its previously assigned target action date. As of the date of this Annual Report, the FDA&#8217;s review of the Company&#8217;s NDA for FT218 remains ongoing. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside of the Company&#8217;s lead product candidate, the Company continues to evaluate opportunities to expand its product portfolio. As of the date of this Annual Report, the Company does not have any approved or commercialized products in its portfolio. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (&#8220;U.S. GAAP&#8221;). The consolidated financial statements include the accounts of the Company and all subsidiaries. All intercompany accounts and transactions have been eliminated.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s results of operations for the period January 1, 2019 through February 6, 2019 include the results of Avadel Specialty Pharmaceuticals, LLC (&#8220;Specialty Pharma&#8221;) prior to its February 6, 2019 voluntary petition for reorganization under Chapter 11 of the U.S. Bankruptcy Code. See&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 3: Subsidiary Bankruptcy and Deconsolidation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications are made to prior year amounts whenever necessary to conform with the current year presentation. Certain reclassifications have been made to the Consolidated Statements of Cash Flows for the fiscal year ended December 31, 2019 and balances within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 14: Other Assets and Liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the year ended December 31, 2020 to condense line items of the same nature into a single line. This change does not affect previously reported net cash flows used in operating activities in the Consolidated Statements of Cash Flows. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Out of Period Adjustments </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the Company determined that 0.50% of additional interest expense (the &#8220;Additional Interest&#8221;), as defined in the indenture dated as of February 16, 2018 among Avadel Finance Cayman Ltd, Avadel Pharmaceuticals PLC, and The Bank of New York Mellon as trustee (the &#8220;Indenture&#8221;), was owed on its long term 4.50% exchangeable unsecured senior notes due 2023 (the &#8220;2023 Notes&#8221;) from a period of February 17, 2019 through December 31, 2021, totaling $817, $773, and $635 for the years ended December 31, 2021, 2020 and 2019, respectively. At December 31, 2020, the Company&#8217;s accrued interest was understated by $1,408. The Additional Interest resulted from not removing a restrictive legend from the 2023 Notes 365 days following their original issuance on February 16, 2018.  The restrictive legend was removed in March 2022 and the Additional Interest is no longer applicable following the date of removal of the restrictive legend. The Company identified and recorded an out of period adjustment for cumulative amount of the Additional Interest in 2021 of $1,408. Management assessed the materiality of the impact of the out of period adjustment on its financial statements, both quantitatively and qualitatively, and determined that it was not material for any quarterly or annual period.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 Notes were issued on February 16, 2018 (the &#8220;Original Issuance&#8221;) with a restrictive legend which remained in place until March 14, 2022. Per the terms of the Indenture, if the restrictive legend on the 2023 Notes was not removed on the 365th day following the original issuance of the 2023 Notes, the Company owed Additional Interest, payable on each of the semi-annual interest payment dates of February 1 and August 1 beginning August 1, 2019 and each of the semi-annual payment dates thereafter until the restrictive legend was removed. The non-payment of the Additional Interest expense on the semi-annual </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payment dates, which was first due beginning August 1, 2019, is defined as an &#8220;Event of Default&#8221; in the Indenture, causing the Company to be in technical default of its 2023 Notes until the default was cured. The Additional Interest was paid to the trustee on March 10, 2022, which under the terms of the indenture, management believes cured the Event of Default for all periods. Additionally, on March 14, 2022, the restrictive legend on the 2023 Notes was removed and the Company is not subject to the Additional Interest after that date. Had the Company identified and been unable to cure the technical default prior to the issuance of its financial statements for fiscal years 2020 and 2019, it could have resulted in the reclassification of the long-term principal balance of 2023 Notes reported in those periods. As a result of curing the technical default, the Company classified the 2023 Notes as long-term at December 31, 2021 and 2020. The Indenture is included as Exhibit 4.2 to this Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to June 30, 2020, revenue included sales of pharmaceutical products, licensing fees, and, if any, milestone payments for research and development (&#8220;R&amp;D&#8221;) achievements.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine the appropriate revenue recognition, the Company performs the following five steps: (i) Identify the contract(s) with a customer&#894; (ii) Identify the performance obligations in the contract; (iii) Determine the transaction price&#894; (iv) Allocate the transaction price to the performance obligations in the contract&#894; and (v) Recognize revenue when (or as) the entity satisfies a performance obligation. The Company applies the five-step model to contracts only when the Company and its customer&#8217;s rights and obligations under the contract can be determined, the contract has commercial substance, and it is probable that the Company will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. The Company identifies the promised goods or services in the contract to determine if they are separate performance obligations or if they should be bundled with other goods and services into a single performance obligation. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Sales &#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to June 30, 2020, the Company sold products primarily through wholesalers and considered these wholesalers to be the Company&#8217;s customers. Revenue from product sales is recognized when the customer obtains control of the Company&#8217;s product, which occurs typically upon receipt by the customer. The Company&#8217;s gross product sales were subject to a variety of price adjustments in arriving at reported net product sales. These adjustments included estimates of product returns, chargebacks, payment discounts, rebates, and other sales allowances and are estimated based on analysis of historical data for the product or comparable products, future expectations for such products and other judgments and analysis.   &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development (&#8220;R&amp;D&#8221;). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> R&amp;D expenses consist primarily of costs related to outside services, personnel expenses, clinical studies and other R&amp;D expenses. Outside services and clinical studies costs relate primarily to services performed by clinical research organizations and related clinical or development manufacturing costs, materials and supplies, filing fees, regulatory support, and other third-party fees. Personnel expenses relate primarily to salaries, benefits and share-based compensation. Other R&amp;D expenses primarily include overhead allocations consisting of various support and facilities-related costs. R&amp;D expenditures are charged to operations as incurred. Raw materials used in the production of pre-clinical and clinical products are expensed as R&amp;D costs.  &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes refundable R&amp;D tax credits received for spending on innovative R&amp;D as an offset of R&amp;D expenses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising Expenses.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expenses the costs of advertising as incurred. Branded advertising expenses were $0, $312 and $372 for the years ended December&#160;31, 2021, 2020 and 2019, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-based Compensation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for share-based compensation based on the estimated grant-date fair value. The fair value of stock options is estimated using Black-Scholes option-pricing valuation models (&#8220;Black-Scholes model&#8221;). As required by the Black-Scholes model, estimates are made of the underlying volatility of Avadel stock, a risk-free rate and an expected term of the option or warrant. The Company estimates the expected term using a simplified method, as the Company does not have enough historical exercise data for a majority of such options upon which to estimate an expected term. The Company recognizes compensation cost, net of an estimated forfeiture rate, using the accelerated method over the requisite service period of the award.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, the Company determines deferred tax assets and liabilities on the basis of the differences between the financial statement and tax bases of assets and liabilities by using enacted tax rates in effect for the year in which </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes deferred tax assets to the extent that the Company believes that these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the Company determines that it would be able to realize its deferred tax assets in the future in excess of their net recorded amount, the Company would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records uncertain tax positions on the basis of a two-step process in which (1) the Company determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes interest and penalties related to unrecognized tax benefits in the income tax expense line in the consolidated statements of (loss) income. Accrued interest and penalties are included on the related tax liability line in the consolidated balance sheets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Cash and cash equivalents consist of cash on hand, cash on deposit and fixed term deposits which are highly liquid investments with original maturities of less than three months.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Securities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s marketable securities are considered to be available for sale and are carried at fair value, with unrealized gains and losses, net of taxes, reported as a component of accumulated other comprehensive (loss) income (&#8220;AOCI&#8221;) in shareholders&#8217; equity, with the exception of unrealized gains and losses on equity instruments and allowances for expected credit losses, if any, which are reported in earnings in the current period. The cost of securities sold is based upon the specific identification method.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For available-for-sale debt securities in an unrealized loss position, the Company assesses whether it intends to sell or if it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security&#8217;s amortized cost basis is written down to fair value. If the criteria are not met, the Company evaluates whether the decline in fair value has resulted from a credit loss or other factors. In making this assessment, management considers, among other factors, the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and adverse conditions specifically related to the security. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of the cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded for the credit loss, limited by the amount that the fair value is less than the amortized costs basis.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allowance for Credit Losses.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts owed to the Company are presented net of an allowance that includes as assessment of expected credit losses.  An allowance for credit losses is established based on expected losses. Expected losses are estimated by reviewing individual accounts, considering aging, financial condition of the debtor, payment history, current and forecast economic conditions and other relevant factors.  To the extent that the Company identifies that any individual customer's credit quality has deteriorated, the Company establishes allowances based on the individual risk characteristics of that customer. The Company makes concerted efforts to collect all outstanding balances due from customers; however, amounts are written off against the allowance when the related balances are no longer deemed collectible </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Property and equipment is stated at historical cost less accumulated depreciation. Depreciation and amortization are computed using the straight-line method over the following estimated useful lives:  </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:77.639%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.161%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software, office and computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements, furniture, fixtures and fittings</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5-10 years</span></div></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Goodwill represents the excess of the acquisition consideration over the fair value of assets acquired and liabilities assumed. The Company has determined that it operates in a single segment and have a single reporting unit associated with the development and commercialization of pharmaceutical products.  The Company tests goodwill for impairment annually and when events or changes in circumstances indicate that the carrying value may not be recoverable. The Company determined that no impairment of goodwill existed at December 31, 2021 and 2020. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Assets. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets include fixed assets and intangible assets. Prior to the sale of the Company&#8217;s portfolio of sterile injectable drugs used in the hospital setting (&#8220;Hospital Products&#8221;) on June 30, 2020, intangible assets consisted primarily of purchased licenses and intangible assets recognized as part of the &#201;clat Pharmaceuticals acquisition. Acquired in-process research and development (&#8220;IPR&amp;D&#8221;) had an indefinite life and was not amortized until completion and development of the project, at which time the IPR&amp;D became an amortizable asset, for which amortization of such intangible assets was computed using the straight-line method over the estimated useful life of the assets.  &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets are reviewed for impairment whenever conditions indicate that the carrying value of the assets may not be fully recoverable. Such impairment tests are based on a comparison of the pretax undiscounted cash flows expected to be generated by the asset to the recorded value of the asset or other market-based value approaches. If impairment is indicated, the asset value is written down to its market value if readily determinable or its estimated fair value based on discounted cash flows. Any significant changes in business or market conditions that vary from current expectations could have an impact on the fair value of these assets and any potential associated impairment.  On June 30, 2020, the Company transferred its remaining intangible asset to Exela Sterile Medicines LLC (&#8220;Exela Buyer&#8221;) as part of the disposition of the Hospital Products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lease Obligations. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if a contract is a lease at the inception of the arrangement. Right-of-use assets and operating lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. The Company reviews all options to extend, terminate, or purchase its right-of-use assets at the inception of the lease and will include these options in the lease term when they are reasonably certain of being exercised. Short term leases with an initial term of 12 months or less are not recorded on the balance sheet and the associated lease payments are recognized in the consolidated statements of (loss) income on a straight-line basis over the lease term. The Company&#8217;s lease contracts do not provide a readily determinable implicit rate. The Company&#8217;s estimated incremental borrowing rate is based on information available at the inception of the lease. The Company&#8217;s lease agreements may contain variable costs such as common area maintenance, insurance, real estate taxes or other costs. Variable lease costs are expensed as incurred on the consolidated statements of (loss) income.</span></div>Use of Estimates. The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, including marketable securities and contingent liabilities at the date of the consolidated financial statements and the reported amounts of sales and expenses during the periods presented. These estimates and assumptions are based on the best information available to management at the balance sheet dates and depending on the nature of the estimate can require significant judgments. Changes to these estimates and judgments can have and have had a material impact on the Company&#8217;s consolidated statements of (loss) income and balance sheets.  Actual results could differ from those estimates under different assumptions or&#160;conditions.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137042626216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Newly Issued Accounting Standards<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract', window );"><strong>Accounting Changes and Error Corrections [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Newly Issued Accounting Standards</a></td>
<td class="text">Newly Issued Accounting Standards&#160;<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Guidance</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. The FASB&#8217;s amendments primarily impact ASC 740, Income Taxes, and may impact both interim and annual reporting periods. ASU 2019-12 is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years and early adoption is permitted. The Company adopted the provisions of ASU 2019-12 on January 1, 2021. Adoption of ASU 2019-12 did not have any impact on the Company&#8217;s consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging- Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to reduce the complexity associated with applying U.S. GAAP principles for certain financial instruments with characteristics of liabilities and equity. The amendments in this ASU reduce the number of accounting models for convertible instruments and expand the existing disclosure requirements over earnings per share as it relates to convertible instruments. Convertible debt will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The update also requires the if-converted method to be used for convertible instruments and the effect of potential share settlement be included in the diluted earnings per share calculation when an instrument may be settled in cash or shares. This ASU will be effective for the Company&#8217;s fiscal year beginning January 1, 2022 and interim periods therein. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The amendments may be adopted through either a modified retrospective method, or a fully retrospective method.</span></div>The Company elected to early adopt ASU 2020-06 as of January 1, 2021 using a modified retrospective method. The Company&#8217;s 4.50% exchangeable senior notes due 2023 (the &#8220;2023 Notes&#8221;) are a convertible instrument with a cash-conversion feature that is accounted for within the scope of Subtopic 470-20. The Company calculated the cumulative-effect adjustment as of January 1, 2021 by comparing (i) the historical amortization schedule for the 2023 Notes through December 31, 2020 and (ii) an updated amortization schedule wherein the conversion feature within the 2023 Notes would not be separated as an equity component and subsequently recognized as non-cash interest expense under ASC 835-30. The adoption resulted in a $26,699 decrease in additional paid-in capital, a $12,939 increase in long-term debt, and a $13,760 increase to the opening balance of retained earnings.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (c)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137042619704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsidiary Bankruptcy and Deconsolidation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReorganizationsAbstract', window );"><strong>Reorganizations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReorganizationUnderChapter11OfUSBankruptcyCodeDisclosureTextBlock', window );">Subsidiary Bankruptcy and Deconsolidation</a></td>
<td class="text">Subsidiary Bankruptcy and Deconsolidation<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 6, 2019, the Company deconsolidated Specialty Pharma effective with the filing of the Chapter 11 bankruptcy and recorded a non-cash charge of approximately&#160;$2,678&#160;for the&#160;year ended&#160;December 31, 2019. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized a non-cash gain of $217 and $3,364 from the release of certain liabilities that had been retained following the deconsolidation of Specialty Pharma. These gains are included in "Gain from release of certain liabilities" within non-operating (loss) income for the years ended December 31, 2021 and 2020.</span></div>On October 26, 2021, the U.S. Bankruptcy Court for the District of Delaware issued the Final Decree and Order, dismissing the bankruptcy case and dissolving Specialty Pharma.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReorganizationUnderChapter11OfUSBankruptcyCodeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the description and amounts of reorganization under Chapter 11 of the US Bankruptcy Code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -URI http://asc.fasb.org/topic&amp;trid=2209115<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReorganizationUnderChapter11OfUSBankruptcyCodeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReorganizationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReorganizationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137042733400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition of the Hospital Products<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Disposition of the Hospital Products</a></td>
<td class="text">Disposition of the Hospital Products<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2020 (the &#8220;Closing Date&#8221;), the Company announced the sale of its Hospital Products, which included its three FDA-approved commercial products, Akovaz, Bloxiverz and Vazculep, as well as Nouress, to the Exela Buyer pursuant to an Asset Purchase Agreement (the &#8220;Transaction&#8221;).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Transaction, the Exela Buyer agreed to pay a total aggregate consideration amount of $42,000, of which $14,500 was paid on the Closing Date and an additional $27,500 was paid in <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzQwNg_d7d1bf58-ccde-4c16-a6b6-573abd462bd2">ten</span> equal monthly installments following the Closing Date. During the year ended December 31, 2020, the Company collected four installment payments, totaling $11,000. The Company collected the remaining six installment payments, totaling $16,500 during 2021. In connection with the sale of the Hospital Products, the parties also agreed to cause the dismissal of the pending civil litigation related to Nouress in the District Court for the District of Delaware.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was party to a Membership Interest Purchase Agreement, dated March 13, 2012, by and among the Company, Avadel Legacy, Breaking Stick Holdings, LLC, Deerfield Private Design International II, L.P. (&#8220;Deerfield International&#8221;), Deerfield Private Design Fund II, L.P. (&#8220;Deerfield Fund&#8221;) and Horizon Sant&#233; FLML, Sarl (&#8220;Horizon&#8221;) (the &#8220;Deerfield MIPA&#8221;) and a Royalty Agreement, dated February 4, 2013, by and among the Company, Avadel Legacy, the Deerfield Fund and Horizon (the &#8220;Deerfield Royalty Agreement&#8221;). In connection with the closing of the sale of the Hospital Products, the Deerfield MIPA (with respect to certain sections thereof) and the Royalty Agreement were assigned to the Exela Buyer. Pursuant to the Purchase Agreement, the Exela Buyer assumed and will pay, perform, satisfy and discharge the liabilities and obligations of Avadel Legacy under the Deerfield Royalty Agreement for obligations that arise after the Closing Date.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was also party to a Royalty Agreement, dated December 3, 2013, by and between the Company, Avadel Legacy and Broadfin Healthcare Master Fund, Ltd. (the &#8220;Broadfin Royalty Agreement&#8221;). In connection with the closing of the sale of the Hospital Products, the Broadfin Royalty Agreement was assigned to the Exela Buyer and the Exela Buyer assumed and shall pay, perform, satisfy and discharge the liabilities and obligations of Avadel Legacy under the Broadfin Royalty Agreement for obligations that arise after the Closing Date.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a net gain on the sale of the Hospital Products of $45,760 during the year ended December 31, 2020 which has been recorded on the consolidated statements of (loss) income. The $45,760 gain represents the aggregate consideration of $42,000, less transaction fees of $2,928, plus the assets and liabilities either transferred to the Exela Buyer or eliminated by the Company due to the sale of the Hospital Products, which are listed below.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,922)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(407)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,095)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term contingent consideration payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net liabilities disposed of</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,688&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aggregate consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less transaction fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,928)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net gain on the sale of the Hospital Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,760&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the disposition of the Hospital Products, the Company entered into a separate and distinct agreement with the Exela Buyer, whereby the Exela Buyer assumed all future returns of the Hospital Products in exchange for cash consideration paid by the Company. The Company recorded a $518 gain from this transaction, which is recorded in &#8220;Selling, general and administrative expenses&#8221; for the year ended December 31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated various qualitative and quantitative factors related to the disposition of the Hospital Products and determined that it did not meet the criteria for presentation as a discontinued operation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma condensed combined statements of (loss) income for the years ended December 31, 2020 and 2019 included below is being provided for information purposes only and are not necessarily indicative of the results of operations that would have resulted if the Transaction had actually occurred on the date indicated. The pro forma adjustments are based on available information and assumptions that the Company believes are attributable to the sale.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:39.575%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.001%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Pro Forma Condensed Combined Statement of (Loss) Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pro Forma Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notes</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pro Forma</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,175)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,392)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,783)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,968)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,082)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,348)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,430)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:39.575%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.001%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Pro Forma Condensed Combined Statement of (Loss) Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pro Forma Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notes</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pro Forma</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59,273)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,112)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,181)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67,293)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38,582)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42,803)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(e)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(81,385)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjustments to the pro forma unaudited condensed combined statements of (loss) income</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) This adjustment reflects Product sales attributable to the Hospital Products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) This adjustment reflects the following estimated expenses attributable to the Hospital Products:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cost of products of $3,540.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">R&amp;D expenses of $322.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Selling, general and administrative expenses of $797.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Intangible asset amortization on acquired development technology for Vazculep of $406.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in fair value of related party contingent consideration of $3,327. The Company will no longer be responsible for these payments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) This amount reflects the adjustments noted in (a) and (b) above, as well as estimated Changes in fair value of related party payable of $435 attributable to the Hospital Products. The Company will no longer be responsible for these payments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) This adjustment reflects the following estimated expenses attributable to the Hospital Products:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cost of products of $11,368.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">R&amp;D expenses of $1,960.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Selling, general and administrative expenses of $1,102.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Intangible asset amortization on acquired development technology for Vazculep of $816.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in fair value of related party contingent consideration of $845. The Company will no longer be responsible for these payments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) This amount reflects the adjustments noted in (a) and (d) above, as well as the reversal of estimated Changes in fair value of related party payable of $378 attributable to the Hospital Products. The Company will no longer be responsible for these payments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137040130680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text">Revenue Recognition <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to June 30, 2020, the Company generated revenue primarily from the sale of pharmaceutical products to customers. On June 30, 2020, the Company sold the Hospital Products. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4: Disposition of the Hospital Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Sales and Services</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to June 30, 2020, the Company sold products primarily through wholesalers and considered these wholesalers to be its customers. Revenue from product sales was recognized when the customer obtained control of the Company&#8217;s product and its performance obligations were met, which occurred typically upon receipt of delivery to the customer. As is customary in the pharmaceutical industry, the Company&#8217;s gross product sales were subject to a variety of price adjustments in arriving at reported net product sales. These adjustments included estimates for product returns, chargebacks, payment discounts, rebates, and other sales allowances and are estimated when the product is delivered based on analysis of historical data for the product or comparable products, as well as future expectations for such products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reserves to reduce Gross Revenues to Net Revenues</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from product sales were recorded at the net selling price, which included estimated reserves to reduce gross product sales to net product sales resulting from product returns, chargebacks, payment discounts, rebates, and other sales allowances that are offered within contracts between the Company and its customers and end users. These reserves were based on the amounts earned or to be claimed on the related sales and were classified as reductions of accounts receivable if the amount was payable to the customer, except in the case of the estimated reserve for future expired product returns, which were classified as a liability. The reserves were classified as a liability if the amount is payable to a party other than a customer. Where appropriate, these estimated reserves took into consideration relevant factors such as the Company&#8217;s historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns. Overall, these reserves reflected the Company&#8217;s best estimates to reduce gross selling price to net selling price to which it expected to be entitled based on the terms of its contracts. The actual selling price ultimately received may differ from the Company&#8217;s estimates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Returns</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with industry practice, the Company maintained a returns policy that generally offered customers a right of return for product that has been purchased from the Company. The Company estimated the amount of product returns and records this estimate as a reduction of revenue in the period the related product revenue was recognized. The Company estimated product return liabilities based on analysis of historical data for the product or comparable products, as well as future expectations for such products and other judgments and analysis.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chargebacks, Discounts and Rebates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chargebacks, discounts and rebates represent the estimated obligations resulting from contractual commitments to sell products to its customers or end users at prices lower than the list prices charged to the Company&#8217;s wholesale customers. Customers charged the Company for the difference between the gross selling price they pay for the product and the ultimate contractual price agreed to between the Company and these end users. These reserves were established in the same period that the related revenue was recognized, resulting in a reduction of product revenue and accounts receivable. Chargebacks, discounts and rebates were estimated at the time of sale to the customer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s primary source of revenue was from the sale of pharmaceutical products, which are equally affected by the same economic factors as it relates to the nature, amount, timing, and uncertainty of revenue and cash flows. For further detail about the Company&#8217;s revenues by product, see&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note&#160;21: Company Operations by Product, Customer and Geography.  </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not recognize revenue in advance of invoicing its customers and therefore has no related contract assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A receivable is recognized in the period the Company sells its products and when the Company&#8217;s right to consideration is unconditional. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no material deferred contract costs at&#160;December&#160;31, 2021 and 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transaction Price Allocated to the Remaining Performance Obligation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For product sales, the Company generally satisfies its performance obligations within the same period the product is delivered. Product sales recognized in 2020 and 2019 from performance obligations satisfied (or partially satisfied) in previous periods were immaterial. No product sales were recognized in 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected certain of the practical expedients from the disclosure requirement for remaining performance obligations for specific situations in which an entity need not estimate variable consideration to recognize revenue. Accordingly, the Company applies the practical expedient in ASC 606 to its stand-alone contracts and does not disclose information about variable consideration from remaining performance obligations for which it recognizes revenue.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137042635016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to measure certain assets and liabilities at fair value, either upon initial recognition or for subsequent accounting or reporting. For example, the Company uses fair value extensively when accounting for and reporting certain financial instruments, when measuring certain contingent consideration liabilities and in the initial recognition of net assets acquired in a business combination. Fair value is estimated by applying the hierarchy described below, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;defines fair value as a market-based measurement that should be determined based on the assumptions that marketplace participants would use in pricing an asset or liability. When estimating fair value, depending on the nature and complexity of the asset or liability, the Company may generally use one or each of the following techniques:&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Income approach, which is based on the present value of a future stream of net cash flows. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a basis for considering the assumptions used in these techniques, the standard establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value as follows: &#160;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 - Quoted prices for identical assets or liabilities in active markets. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 - Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are directly or indirectly observable, or inputs that are derived principally from, or corroborated by, observable market data by correlation or other means. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 - Unobservable inputs that reflect estimates and assumptions. </span></div><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial instruments measured at fair value on a recurring basis classified in the fair value hierarchy (Level 1, 2 or 3) based on the inputs used for valuation in the accompanying consolidated balance sheets:</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,098&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,415&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,672&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,008&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A review of fair value hierarchy classifications is conducted on a quarterly basis.&#160; Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. During the fiscal year ended December&#160;31, 2021, there were no transfers in and out of&#160;Level&#160;1, 2, or 3. During the&#160;twelve months ended December&#160;31, 2021, 2020 and 2019, the Company did not recognize any allowances for credit losses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s financial instruments, such as cash and cash equivalents and accounts payable, are reflected in the balance sheet at carrying value, which approximates fair value due to their short-term nature.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the fair value of its&#160;$143,750&#160;aggregate principal amount of&#160;the 2023 Notes based on interest rates that would be currently available to the Company for issuance of similar types of debt instruments with similar terms and remaining maturities or recent trading prices obtained from brokers (a Level 2 input). The estimated fair value of the 2023 Notes at&#160;December&#160;31, 2021 is&#160;$153,273. See&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note&#160;11:&#160;Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;for additional information regarding the Company&#8217;s debt obligations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137040127176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock', window );">Marketable Securities</a></td>
<td class="text">Marketable Securities&#160;<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in available-for-sale debt securities that are recorded at fair market value. The change in the fair value of available-for-sale debt investments is recorded as accumulated other comprehensive loss in shareholders&#8217; equity, net of income tax effects. As of December&#160;31, 2021, the Company considered any decreases in fair value on its marketable securities to be driven by factors other than credit risk, including market risk.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the Company&#8217;s available-for-sale securities&#8217; adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category as of&#160;December&#160;31, 2021 and 2020, respectively:</span></div><div style="margin-bottom:15pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:44.861%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.675%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.675%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.675%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.678%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,046)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,812&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">948&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,247)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,513&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:44.861%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.675%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.675%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.675%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.678%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147,903&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,815&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149,680&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines realized gains or losses on the sale of marketable securities on a specific identification method. The Company reflects these gains and losses as a component of investment and other income in the accompanying consolidated statements of (loss) income.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized gross realized gains of&#160;$174, $474 and $483 for the&#160;twelve months ended December&#160;31, 2021, 2020 and 2019, respectively. These realized gains were offset by realized losses of $275, $912 and $151&#160;for the twelve-months ended December&#160;31, 2021, 2020 and 2019, respectively. </span></div><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated fair value of the Company&#8217;s investments in marketable debt securities, accounted for as available-for-sale securities and classified by the contractual maturity date of the securities as of December&#160;31, 2021:</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:33.554%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.240%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Debt Securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 1 Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1-5 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5-10 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 10 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,819&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,671&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,730&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,415&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified its investment in available-for-sale marketable securities as current assets in the consolidated balance sheets as the securities need to be available for use, if required, to fund current operations. There are no restrictions on the sale of any securities in the Company&#8217;s investment portfolio. </span></div>Total gross unrealized losses of the Company&#8217;s available-for-sale debt securities at December&#160;31, 2021 were immaterial and have been in an unrealized loss position for less than one year. The unrealized losses are driven by factors other than credit risk. The Company does not intend to sell the investments and it is not more likely than not that it will be required to sell the investments before recovery of their amortized cost bases.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137042750344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, net</a></td>
<td class="text">Property and Equipment, net<div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal categories of property and equipment, net at December&#160;31, 2021 and 2020, respectively, are as&#160;follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.103%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Property and Equipment, net:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Software, office and computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,443&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Furniture, fixtures and fittings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less - accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(465)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,384)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Depreciation expense for the years ended December&#160;31, 2021, 2020 and 2019 was $97, $287 and $459, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137042608264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill and Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s goodwill is $16,836 at December&#160;31, 2021 and 2020.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded amortization expense related to an amortizable intangible asset that was assumed by the Exela Buyer as part of the disposition of the Hospital Products on June 30, 2020 of $406 and $816 for the years ended December&#160;31, 2020 and 2019, respectively. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4: Disposition of the Hospital Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. There was no amortization expense recorded during the year ended December&#160;31, 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No impairment loss related to goodwill or intangible assets was recognized during the years ended December&#160;31, 2021 or 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137040130680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases office space and a production suite. All leased facilities are classified as operating leases with remaining lease terms between&#160;<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90ZXh0cmVnaW9uOjIyMGM2MjEzZTI4YTQ4YTU5NDMyYzkzOTY1NjcxODAyXzY2OQ_ea03d613-a2cf-479a-bdb9-ee92938c3329">two</span>&#160;and&#160;four years. The Company determines if a contract is a lease at the inception of the arrangement. The Company reviews all options to extend, terminate, or purchase its right-of-use assets at the inception of the lease and will include these options in the lease term when they are reasonably certain of being exercised. The Company&#8217;s lease agreements do not contain any material residual value guarantees or material variable lease payments. For the Company&#8217;s leased production suite, contract consideration was allocated to lease and non-lease components on the basis of relative standalone price. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease costs, which are included in selling, general and administrative expenses in the consolidated statements of (loss) income of years ended December&#160;31, 2021, 2020 and 2019 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Lease cost:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sublease income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(110)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(336)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(276)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">797&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,239&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable lease costs were immaterial for the years ended December&#160;31, 2021, 2020 and 2019.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Represents sublease income received for office subleases.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2021 and 2020, the Company reduced its operating lease liabilities by $578 and $769 for cash paid. During the year ended December&#160;31, 2021, the Company remeasured its production suite lease liability. During the year ended December&#160;31, 2021, the Company did not enter into any new operating or finance leases.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company&#8217;s operating leases have a weighted-average remaining lease term of 2.9 years and a weighted-average discount rate of 4.9%. The Company&#8217;s lease contracts do not provide a readily determinable implicit rate. The Company&#8217;s estimated incremental borrowing rate is based on information available at the inception of the lease.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of the Company&#8217;s operating lease liabilities were as follows:</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:80.076%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.989%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,013&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,607&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137040098280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-Term Debt</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><div style="margin-bottom:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt is summarized as follows:</span></div><div style="margin-bottom:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:58.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.487%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.490%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of 4.50% exchangeable senior notes due 2023 </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: unamortized debt discount and issuance costs, net </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,353)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,540)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142,397&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: current maturities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142,397&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity component:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity component of exchangeable notes, net of issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26,699)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2021, 2020 and 2019, the total interest expense was $9,942, $12,994 and $12,464, respectively, with coupon interest expense of $6,469 for each period and the amortization of debt issuance costs and debt discount of $1,248, $6,525 and $5,995, respectively. Current period interest expense also included $2,225 of additional interest expense owed as a result of not removing a restrictive legend from the 2023 Notes 365 days following original issuance of the 2023 Notes on February 16, 2018. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1: Background and Basis of Presentation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further details.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 2: Newly Issued Accounting Standards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company elected to early adopt ASU 2020-06 as of January 1, 2021 using a modified retrospective method. The adoption resulted in a $12,939 increase in long-term debt and a $26,699 decrease in the equity component of the 2023 Notes.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 16, 2018, Avadel Finance Cayman Limited, a Cayman Islands exempted company and an indirect wholly-owned subsidiary of the Company (the &#8220;Issuer&#8221;), issued $125,000 aggregate principal amount of 4.50% exchangeable senior notes due 2023 (the &#8220;2023 Notes&#8221;) in a private placement (the &#8220;Offering&#8221;) to qualified institutional buyers pursuant to Rule 144A under the Securities Act. In connection with the Offering, the Issuer granted the initial purchasers of the 2023 Notes a 30-day option to purchase up to an additional $18,750 aggregate principal amount of the 2023 Notes, which was fully exercised on February 16, 2018. Net proceeds received by the Company, after issuance costs and discounts, were approximately $137,560.  The 2023 Notes are the Company&#8217;s senior unsecured obligations and rank equally in right of payment with all of the Company&#8217;s existing and future senior unsecured indebtedness and effectively junior to any of the Company&#8217;s existing and future secured indebtedness, to the extent of the value of the assets securing such indebtedness.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 Notes will be exchangeable at the option of the holders at an initial exchange rate of 92.6956 ADSs per $1 principal amount of 2023 Notes, which is equivalent to an initial exchange price of approximately $10.79 per ADS. Such initial exchange price represents a premium of approximately 20% to the $8.99 per ADS closing price on The Nasdaq Global Market on February 13, 2018.  Upon the exchange of any 2023 Notes, the Issuer will pay or cause to be delivered, as the case may be, cash, ADSs or a combination of cash and ADSs, at the Issuer&#8217;s election. Holders of the 2023 Notes may convert their 2023 Notes, at their option, only under the following circumstances prior to the close of business on the business day immediately preceding August 1, 2022, under the circumstances and during the periods set forth below and regardless of the conditions described below, on or after August 1, 2022 and prior to the close of business on the business day immediately preceding the maturity date:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prior to the close of business on the business day immediately preceding August 1, 2022, a holder of the 2023 Notes may surrender all or any portion of its 2023 Notes for exchange at any time during the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzIzMjM_cdb5c14c-1181-4685-9a23-0a0887188621">five</span> business day period immediately after any <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzIzNjg_cdf18a29-792e-43e1-baa4-c68eb2cf6a76">five</span> consecutive trading day period (the &#8220;Measurement Period&#8221;) in which the trading price per $1 principal amount of 2023 Notes, as determined following a request by a holder of the 2023 Notes, for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the ADSs and the exchange rate on each such trading day.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If a transaction or event that constitutes a fundamental change or a make-whole fundamental change occurs prior to the close of business on the business day immediately preceding August 1, 2022, regardless of whether a holder of the 2023 Notes has the right to require the Company to repurchase the 2023 Notes, or if Avadel is a party to a merger </span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">event that occurs prior to the close of business on the business day immediately preceding August 1, 2022, all or any portion of a the holder&#8217;s 2023 Notes may be surrendered for exchange at any time from or after the date that is 95 scheduled trading days prior to the anticipated effective date of the transaction (or, if later, the earlier of (x) the business day after the Company gives notice of such transaction and (y) the actual effective date of such transaction) until 35 trading days after the actual effective date of such transaction or, if such transaction also constitutes a fundamental change, until the related fundamental change repurchase date. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prior to the close of business on the business day immediately preceding August 1, 2022, a holder of the 2023 Notes may surrender all or any portion of its 2023 Notes for exchange at any time during any calendar quarter commencing after the calendar quarter ending on June 30, 2018 (and only during such calendar quarter), if the last reported sale price of the ADSs for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the exchange price on each applicable trading day. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If the Company calls the 2023 Notes for redemption pursuant to Article 16 to the Indenture prior to the close of business on the business day immediately preceding August 1, 2022, then a holder of the 2023 Notes may surrender all or any portion of its 2023 Notes for exchange at any time prior to the close of business on the second business day prior to the redemption date, even if the 2023 Notes are not otherwise exchangeable at such time. After that time, the right to exchange shall expire, unless the Company defaults in the payment of the redemption price, in which case a holder of the 2023 Notes may exchange its 2023 Notes until the redemption price has been paid or duly provided for.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considered the guidance in ASC 815-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Embedded Derivatives</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to determine if this instrument contains an embedded feature that should be separately accounted for as a derivative. ASC 815 provides for an exception to this rule when convertible notes, as host instruments, are deemed to be conventional, as defined by ASC 815-40. The Company determined that this exception applies due, in part, to its ability to settle the 2023 Notes in cash, ADSs or a combination of cash and ADSs, at the Company&#8217;s option. The Company have therefore applied the guidance provided by ASC 470-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and Other Options, </span>as amended by ASU 2020-06.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137040127176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingent Consideration Payable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_LongTermContingentConsideraionPayableTextBlock', window );">Contingent Consideration Payable</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Consideration Payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the sale of the Hospital Products on June 30, 2020, the Company computed the fair value of the contingent consideration using several significant assumptions and when those assumptions changed, due to underlying market conditions, the fair value of these liabilities changed as well. Prior to the sale of the Hospital Products, these changes had a material impact on the Company&#8217;s consolidated statements of (loss) income and balance sheets. As part of the sale of the Hospital Products on June 30, 2020, the Exela Buyer assumed and will pay, perform, satisfy and discharge the liabilities and obligations of Avadel Legacy and the Company under the Deerfield Royalty Agreement and the Broadfin Royalty Agreement. As of December&#160;31, 2021 and 2020, the balance of the contingent consideration payable is $0.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes to the contingent consideration payables, a recurring Level 3 measurement, for the twelve-month periods ended&#160;December 31, 2020&#160;and&#160;2019:</span></div><div><span><br/></span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:78.665%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent Consideration Payable:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of related party payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,736)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,327&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of contingent consideration payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,189)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Disposition of the Hospital Products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,900)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1) Fair value adjustments are reported as changes in fair value of contingent consideration and other expense - changes in fair value of contingent consideration payable in the consolidated statements of (loss) income.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_LongTermContingentConsideraionPayableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_LongTermContingentConsideraionPayableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137042750344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of loss before income taxes for the years ended twelve months ended December 31, are as follows:&#160;</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:48.679%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.909%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Loss Before Income Taxes:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,631)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,205)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,134)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(56,687)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(212)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total loss before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93,145)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,082)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38,582)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax benefit consists of the following for the years ended December 31:&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:48.679%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.909%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Income Tax Benefit:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. - Federal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,810)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. - State</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,790)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,256)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. - Federal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,876)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,093)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. - State</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,876)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,453)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,816)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,110)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,356)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The reconciliation between income taxes at the statutory rate and the Company&#8217;s benefit for income taxes is as follows for the years ended December 31:&#160;</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:48.679%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.909%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Reconciliation to Effective Income Tax Rate:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit - at statutory tax rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,642)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(636)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,823)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Differences in international tax rates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,950)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,218)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nondeductible changes in fair value of contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intercompany asset transfer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,190)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in valuation allowances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nondeductible share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hospital Products sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,328)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized tax benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(261)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State and local taxes (net of federal)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in U.S. tax law</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,124)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nondeductible interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Orphan drug and R&amp;D tax credit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,524)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,793)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(378)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit - at effective income tax rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,816)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,110)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,356)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the income tax benefit increased by $3,706 when compared to the same period in 2020. The increase in the income tax benefit in 2021 was primarily driven by the additional tax benefit from an increase in the net operating losses in the U.S. in 2021, when compared to the same period in 2020. This was partially offset by the nonrecurring nature of tax benefits recognized in 2020 from the sale of the Company&#8217;s Hospital Products and passage of the Coronavirus Aid, Relief and Economic Security Act (the &#8220;CARES Act&#8221;) in the U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the income tax benefit increased by $6,754 when compared to the same period in 2019. The increase in the income tax benefit in 2020 was primarily driven by the tax benefits from the sale of the Company&#8217;s Hospital Products and passage of the CARES Act in the U.S. The Company recorded additional tax benefit in 2020 from the Orphan Drug and R&amp;D tax credit in the U.S. Tax benefit from the intercompany asset transfer recorded in 2019 did not recur, resulting in a partial offset of tax benefits described above.  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unrecognized Tax Benefits</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company or one of its subsidiaries files income tax returns in Ireland, France, U.S. and various states. The Company is no longer subject to Irish, French, U.S. Federal, and state and local examinations for years before 2017. During 2020, the Company completed the 2015 through 2017 U.S. Federal Tax Audit. Completion of the audit resulted in an assessment of $1,937 for the 2015 through 2017 U.S. Federal Tax Returns compared to the IRS Claims of $50,695 made on July 2, 2019 and the updated IRS Claims of $9,302 on October 2, 2019 made as part of the Specialty Pharma bankruptcy proceedings, which at this time does not include interest and penalties.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the Company&#8217;s unrecognized tax benefits for the twelve months ended </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:48.679%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.909%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Unrecognized Tax Benefit Activity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at January 1: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increases for tax positions of prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Statute of limitations expiration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,266)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,322)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,143&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,143&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,465&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects that within the next twelve months the unrecognized tax benefits could decrease by an immaterial amount and the interest could increase by an immaterial amount.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021, 2020 and 2019, there are $2,483, $2,483 and $3,806 of unrecognized tax benefits that if recognized would affect the annual effective tax rate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes interest and penalties accrued related to unrecognized tax benefits in income tax expense.  During the years ended December&#160;31, 2021, 2020 and 2019, the Company recognized approximately $239, $203 and $555 in interest and penalties. The Company had approximately $1,777 and $1,475 for the payment of interest and penalties accrued at December&#160;31, 2021 and 2020, respectively. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Tax Assets (Liabilities)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income tax provisions reflect the effect of temporary differences between consolidated financial statement and tax reporting of income and expense items.  The net deferred tax assets (liabilities) at December&#160;31, 2021 and 2020 resulted from the following temporary differences:&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:48.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.353%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Net Deferred Tax Assets and Liabilities: </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Orphan drug and R&amp;D tax credit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,964&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,153&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,845&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(925)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(890)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(965)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: valuation allowances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,025)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,624)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred tax assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,128&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,256&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At December 31, 2021, the Company had $124,720 of net operating losses in Ireland that do not have an expiration date and $74,406 of net operating losses in the U.S.  Of the $74,406 of net operating losses in the U.S., $10,365 were acquired due to the acquisition of FSC Therapeutics and FSC Laboratories, Inc., (collectively &#8220;FSC&#8221;) and $64,041 are due to the losses at US Holdings.&#160;The portion due to the acquisition of FSC will expire in 2034 through 2035. A valuation allowance is recorded if, based on the weight of available evidence, it is more likely than not that a deferred tax asset will not be realized. This assessment is based on an evaluation of the level of historical taxable income and projections for future taxable income.  For the year ended December 31, 2021, the Company recorded $4,045 of valuation allowances related to Irish net operating losses. The U.S. net operating losses are subject to an annual limitation as a result of the FSC acquisition under Internal Revenue Code Section 382 and will not be fully utilized before they expire.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a valuation allowance against all of its net operating losses in Ireland and France as of December 31, 2021 and 2020. The Company intends to continue maintaining a full valuation allowance on the Irish net operating losses until there is sufficient evidence to support the reversal of all or some portion of these allowances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company believes it is more likely than not that it will be able to realize the deferred tax assets in the U.S., the Company continues to monitor any unfavorable changes that could ultimately impact its assessment of the realizability of the Company&#8217;s U.S. deferred tax assets.  If the Company experiences an ownership change under Internal Revenue Code Section 382, the U.S. net operating losses could also be limited in their utilization.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, the Company has unremitted earnings of $3,916 outside of Ireland as measured on a U.S. GAAP basis.  Whereas the measure of earnings for purposes of taxation of a distribution may be different for tax purposes, these earnings, which are considered to be invested indefinitely, would become subject to income tax if they were remitted as dividends or if the Company were to sell its stock in the subsidiaries, net of any prior income taxes paid. It is not practicable to estimate the amount of deferred tax liability on such earnings, if any.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">R&amp;D Tax Credits Receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The French and Irish governments provide tax credits to companies for spending on innovative R&amp;D.  These credits are recorded as an offset of R&amp;D expenses and are credited against income taxes payable in years after being incurred or, if not so utilized, are recoverable in cash after a specified period of time, which may differ depending on the tax credit regime.  As of December 31, 2021, the Company&#8217;s net research tax credit receivable amounts to $3,668 and represents a French gross research </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tax credit of $3,139 and an Irish gross research tax credit of $529.  As of December 31, 2020, the Company&#8217;s net research tax credit receivable amounts to $6,771 and represents a French gross research tax credit of $6,396 and an Irish gross research tax credit of $375. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 CARES Act</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CARES Act, enacted on March 27, 2020, includes significant business tax provisions. In particular, the CARES Act modified the rules associated with net operating losses. Under the temporary provisions of the CARES Act, net operating loss carryforwards and carrybacks may offset 100% of taxable income for taxable years beginning before 2021. In addition, net operating losses arising in 2018, 2019 and 2020 taxable years may be carried back to each of the preceding five years to generate a refund. During the twelve months ended December 31, 2020, the income tax benefit includes a discrete tax benefit of $9,124 as a result of the Company&#8217;s ability under the CARES Act to carry back net operating losses incurred to periods when the statutory U.S. Federal tax rate was 35% versus the Company&#8217;s current U.S. Federal tax rate of 21%. During the twelve months ended December 31, 2020, the Company received $3,351 in cash tax refunds from carryback claims related to the CARES Act from the carryback of 2018 tax losses. The Company filed refund claims for $18,753 associated with the carryback of 2019 tax losses and a $10,273 refund claim associated with the carryback of 2020 tax losses.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137042677000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Assets and Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">Other Assets and Liabilities</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Assets and Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various other assets and liabilities are summarized for the years ended December 31, as follows:&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prepaid Expenses and Other Current Assets: </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax receivable (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid and other expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee from Armistice</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivable from Exela (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term deposit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,826&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,726&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:14pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Non-Current Assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use assets at contract manufacturing organizations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee from Armistice</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,777&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,939&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued Expenses:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,697&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,781&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued outsourced contract costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,048&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer allowances</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued restructuring (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,151&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,501&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:1pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:61.895%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.667%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Current Liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee to Deerfield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due to Exela</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,270&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,200&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:61.895%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.667%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Non-Current Liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax liabilities and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee to Deerfield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,917&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,212&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137042692536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingent Liabilities and Commitments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Contingent Liabilities and Commitments</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Liabilities and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to potential liabilities generally incidental to its business arising out of present and future lawsuits and claims related to product liability, personal injury, contract, commercial, intellectual property, tax, employment, compliance and other matters that arise in the ordinary course of business. The Company accrues for potential liabilities when it is probable that future costs (including legal fees and expenses) will be incurred and such costs can be reasonably estimated. At December 31, 2021, there were no contingent liabilities with respect to any litigation, arbitration or administrative or other proceeding that are reasonably likely to have a material adverse effect on the Company&#8217;s consolidated financial position, results of operations, cash flows or liquidity. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">First Complaint</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 12, 2021, Jazz Pharmaceuticals, Inc. (&#8220;Jazz&#8221;) filed a formal complaint (the &#8220;First Complaint&#8221;) initiating a lawsuit in the United States District Court for the District of Delaware (the &#8220;Court&#8221;) against Avadel Pharmaceuticals plc, Avadel US Holdings, Inc., Avadel Management Corporation, Avadel Legacy Pharmaceuticals, LLC, Avadel Specialty Pharmaceuticals, LLC, and Avadel CNS Pharmaceuticals, LLC (collectively, the &#8220;Avadel Parties&#8221;). In the First Complaint, Jazz alleges the sodium oxybate product (&#8220;Proposed Product&#8221;) described in the NDA owned by Avadel CNS Pharmaceuticals, LLC will infringe at least one claim of US Patent No. 8731963, 10758488, 10813885, 10959956 and/or 10966931 (collectively, the &#8220;patents-in-suit&#8221;). The First Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 3, 2021, the Avadel Parties timely filed their Answer and Counterclaims (the &#8220;Avadel Answer&#8221;) with the Court in response to the First Complaint. The Avadel Answer generally denies the allegations set forth in the First Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patents-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of each patent-in-suit, and ii) a declaratory judgment of invalidity of each patent-in-suit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 18, 2021, Jazz filed its Answer (&#8220;Jazz Answer&#8221;) with the Court in response to the Avadel Answer. The Jazz Answer generally denies the allegations set forth in the Avadel Answer and sets forth a single affirmative defense asserting that Avadel has failed to state a claim for which relief can be granted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 21, 2021, the Court issued an oral order requiring the parties to i) confer regarding proposed dates to be included in the Court&#8217;s scheduling order for the case, and ii) submit a proposed order, including a proposal for the length and timing of trial, to the Court by no later than July 21, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 30, 2021, the Court issued a scheduling order establishing timing for litigation events including i) a claim construction hearing date of August 2, 2022, and ii) a trial date of October 30, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 18, 2021, consistent with the scheduling order, Jazz filed a status update with the Court indicating that Jazz did not intend to file a preliminary injunction with the Court at this time. Jazz further indicated that it would provide the Court with an </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">update regarding whether preliminary injunction proceedings may be necessary after receiving further information regarding the FDA&#8217;s action on Avadel&#8217;s NDA.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2022, the Court entered an agreed order dismissing this case with respect to Avadel Pharmaceuticals plc, Avadel US Holdings, Inc., Avadel Specialty Pharmaceuticals, LLC, Avadel Legacy Pharmaceuticals, LLC, and Avadel Management Corporation.  A corresponding order was entered in the two below cases on the same day.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Second Complaint</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 4, 2021, Jazz filed another formal complaint (the &#8220;Second Complaint&#8221;) initiating a lawsuit in the Court against the Avadel Parties. In the Second Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS Pharmaceuticals, LLC will infringe at least one claim of US Patent No. 11077079. The Second Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 9, 2021, the Avadel Parties timely filed their Answer and Counterclaims (the &#8220;Second Avadel Answer&#8221;) with the Court in response to the Second Complaint. The Second Avadel Answer generally denies the allegations set forth in the Second Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patent-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of the patent-in-suit, and ii) a declaratory judgment of invalidity of the patent-in-suit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 22, 2021, the Court issued an oral order stating that this case should proceed on the same schedule as the case filed on May 12, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Third Complaint</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 10, 2021, Jazz filed another formal complaint (the &#8220;Third Complaint&#8221;) initiating a lawsuit in the Court against the Avadel Parties. In the Third Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS Pharmaceuticals, LLC will infringe at least one claim of US Patent No. 11147782. The Third Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses.  This case will proceed on the same schedule as the cases associated with the First and Second Complaints above.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 7, 2022, Avadel CNS Pharmaceuticals LLC timely filed its Answer and Counterclaims (the &#8220;Third Avadel Answer&#8221;) with the Court in response to the Third Complaint. The Third Avadel Answer generally denies the allegations set forth in the Third Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patent-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of the patent-in-suit, and ii) a declaratory judgment of invalidity/unenforceability of the patent-in-suit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2021, the Court entered a revised schedule for the First, Second and Third Complaints, setting a new claim construction date of August 31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Material Commitments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, the Company has one commitment with its primary contract manufacturer related to facility upgrades and the purchase and validation of equipment to be used in the manufacture of FT218. The total cost of this commitment is estimated to be approximately $5,500 and is expected to be completed during the year ending December 31, 2022. The Company has incurred approximately $3,348 of this commitment during the year ended December 31, 2021. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has a commitment with another contract manufacturer that commences in the first quarter of 2022 and will continue until FDA approval of the contract manufacturer. The commitment will be approximately $3,000 per year.   </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deerfield Guarantee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company&#8217;s February 2018 divestiture of its pediatric assets, including four pediatric commercial stage assets &#8211; Karbinal&#8482; ER, Cefaclor, Flexichamber&#8482; and AcipHex&#174; Sprinkle&#8482; (&#8220;FSC products&#8221;), to Cerecor, Inc. (&#8220;Cerecor&#8221;), the Company guaranteed to Deerfield a quarterly royalty payment of 15% on net sales of the FSC products through February 6, 2026 (&#8220;FSC Product Royalties&#8221;), in an aggregate amount of up to approximately $10,300. Given the Company&#8217;s explicit </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">guarantee to Deerfield, the Company recorded the guarantee in accordance with ASC 460. The balance of this guarantee liability was $1,054 at December&#160;31, 2021. This liability is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Armistice Guarantee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company&#8217;s February 2018 divestiture of the pediatric assets, Armistice Capital Master Fund, Ltd., the majority shareholder of Cerecor, guaranteed to the Company the FSC Product Royalties. The Company recorded the guarantee in accordance with ASC 460. The balance of this guarantee asset was $1,050 at December&#160;31, 2021. This asset is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s guarantee to Deerfield and the guarantee received by the Company from Armistice largely offset and when combined are not material.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137042690088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Costs<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring Costs</a></td>
<td class="text">Restructuring Costs&#160;<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019 French Restructuring</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2019, the Company initiated a plan to discontinue all French R&amp;D activities, which resulted in the redundancy and reduction of its entire workforce at its V&#233;nissieux, France site (&#8220;2019 French Restructuring&#8221;). This reduction was part of an effort to align the Company&#8217;s cost structure with its ongoing and future planned projects. The discontinuation of R&amp;D activities and elimination of the workforce in France was completed during the year ended December 31, 2020.  Restructuring charges associated with this plan recognized during the years ended December 31, 2021 and 2020 were immaterial. Restructuring charges associated with this plan of $4,855 of were recognized during the year ended December 31, 2019.  Included in the 2019 French Restructuring charges of $4,855 were charges for employee severance, benefits and other costs of $4,339, charges related to fixed asset impairment of $629, charges related to the early termination penalty related to the office and copier lease terminations of $887, partially offset by a benefit of $1,000 related to the reversal of the French retirement indemnity obligation. At December 31, 2021, there are no future expected retirement indemnity benefits to be paid. The Company does not expect to incur any additional expenses related to the 2019 French Restructuring. The following table sets forth activities for the Company&#8217;s cost reduction plan obligations for the years ended&#160;December&#160;31, 2021 and 2020:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.560%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.915%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019 French Restructuring Obligation:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of restructuring accrual at January 1,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,922&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Benefit) charges for employee severance, benefits and other costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,813)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency impact</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of restructuring accrual at December 31, </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2019 French Restructuring liability of&#160;$41 is included in the consolidated balance sheet in accrued expenses at&#160;December 31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019 Corporate Restructuring</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2019, the Company announced a plan to reduce its corporate workforce by more than&#160;50%&#160;(the &#8220;2019 Corporate Restructuring&#8221;). The reduction in workforce is primarily a result of the exit of Noctiva during the first quarter of 2019 (see&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note&#160;3: Subsidiary Bankruptcy and Deconsolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), as well as an effort to better align the Company&#8217;s remaining cost structure at its U.S. and Ireland locations with its ongoing and future planned projects. The reduction in workforce was completed during the year ended December 31, 2020.  Restructuring income associated with this plan for the years ended December 31, 2021 and 2020 were immaterial. Restructuring charges associated with this plan of $1,755 were recognized during the year ended December 31, 2019. Included in the 2019 Corporate Restructuring charges of $1,755 for the year ended December 31, 2019 were charges for employee severance, benefit and other costs of $3,406, charges related to the early termination penalty related to the office lease termination of $288, the write-off of $125 of property, plant and equipment, net, partially offset by a benefit of $2,064 related to share based compensation forfeitures related to the employees affected by the global reduction in workforce. The Company does not expect to incur any additional expenses related to the 2019 Corporate Restructuring.</span></div>During the years ended December 31, 2021, 2020 and 2019, the Company paid $272, $1,014, and $2,326 respectively, and has no remaining obligation for the 2019 Corporate Restructuring plan as of December 31, 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137042691656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Instruments and Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_EquityTransactionsDisclosureTextBlock', window );">Equity Instruments and Transactions</a></td>
<td class="text">Equity Instruments and Transactions<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capital Shares</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has 500,000 shares of authorized ordinary shares with a nominal value of $0.01 per ordinary share. As of December&#160;31, 2021, the Company had 58,620 ordinary shares issued and outstanding, respectively. The Board of Directors is authorized to issue preferred shares in series, and with respect to each series, to fix its designation, relative rights (including voting, dividend, conversion, sinking fund, and redemption rights), preferences (including dividends and liquidation) and limitations. The Company has 50,000 shares of authorized preferred shares, $0.01 nominal value, of which 488 are currently issued and outstanding as of December 31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shelf Registration Statement on Form S-3</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the Company filed with the SEC a new shelf registration statement on Form S-3 (the 2020 Shelf Registration Statement) (File No. 333-236258) that allows issuance and sale by the Company, from time to time, of:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">up to $250,000 in aggregate of ordinary shares, nominal value US$0.01 per share (the &#8220;Ordinary Shares&#8221;), each of which may be represented by American Depositary Shares (&#8220;ADSs&#8221;), preferred shares, nominal value US$0.01 per share (the &#8220;Preferred Shares&#8221;), debt securities (the &#8220;Debt Securities&#8221;), warrants to purchase Ordinary Shares, ADSs, Preferred Shares and/or Debt Securities (the &#8220;Warrants&#8221;), and/or units consisting of Ordinary Shares, ADSs, Preferred Shares, one or more Debt Securities or Warrants in one or more series, in any combination, pursuant to the terms of the 2020 Shelf Registration Statement, the base prospectus contained in the 2020 Shelf Registration Statement (the &#8220;Base Prospectus&#8221;), and any amendments or supplements thereto (together, the &#8220;Securities&#8221;); including</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">up to $50,000 of ADSs that may be issued and sold from time to time pursuant to the terms of an Open Market Sale Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">SM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, entered into with Jefferies LLC on February 4, 2020 (the &#8220;Sales Agreement&#8221;), the 2020 Shelf Registration Statement, the Base Prospectus and the terms of the sales agreement prospectus contained in the 2020 Shelf Registration Statement.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transactions costs associated with the 2020 Shelf Registration Statement totaled $428 of which $214 was charged against additional paid-in capital during the twelve months ended December 31, 2020 as a result of the May 2020 Public Offering, discussed below. The remaining costs of $214 are recorded as a prepaid asset at December 31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">February 2020 Private Placement</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 21, 2020, the Company announced that it entered into a definitive agreement for the sale of its ADSs and Series A Non-Voting Convertible Preferred Shares (&#8220;Series A Preferred&#8221;) in a private placement to a group of institutional accredited investors. The private placement resulted in gross proceeds of approximately $65,000 before deducting placement agent and other offering expenses, which resulted in net proceeds of $60,570.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the private placement, the Company issued 8,680 ADSs and 488 shares of Series A Preferred at a price of $7.09 per share, priced at-the-market under Nasdaq rules. Each share of non-voting Series A Preferred is convertible into one ADS, provided that conversion will be prohibited if, as a result, the holder and its affiliates would own more than 9.99% of the total number of Avadel ADSs outstanding. The closing of the private placement occurred on February 25, 2020.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Issuance costs of $4,430 have been recorded as a reduction of additional paid-in capital.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">May 2020 Public Offering</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the shelf registration statement described above, on April 28, 2020, the Company announced the pricing of an underwritten public offering of 11,630 Ordinary Shares, in the form of ADSs at a price to the public of $10.75 per ADS. Each ADS represents the right to receive one Ordinary Share. All of the ADSs were offered by the Company and the gross proceeds to the Company from the offering were approximately $125,000, before deducting underwriting discounts and commissions and offering expenses, which resulted in net proceeds of $116,924. The offering closed on May 1, 2020.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Retirement of Treasury Shares</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company retired all of its 5,407 treasury shares, or $49,998 previously repurchased ordinary shares. As a result, the Company reduced additional paid-in capital by $49,944 and ordinary shares by $54 during the twelve months ended December 31, 2020. The portion allocated to additional paid-in capital is determined pro rata by applying a percentage, determined by dividing the number of shares to be retired by the number of shares issued and outstanding as of the retirement date, to the balance of additional paid-in capital as of the retirement date. Based on this calculation, the entirety of the excess of repurchase price over par of $49,944 was allocated to additional paid-in capital.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_EquityTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Transactions Disclosure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_EquityTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137042760264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text">Share-Based Compensation&#160;<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense included in the Company&#8217;s consolidated statements of (loss) income for all share-based compensation arrangements was as follows for the periods ended December&#160;31, 2021, 2020 and 2019, respectively:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:48.679%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.909%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-based Compensation Expense:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(421)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,064)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,872&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,999&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company expects $18,429 of unrecognized expense related to granted, but non-vested share-based compensation arrangements to be incurred in future periods. This expense is expected to be recognized over a weighted average period of 3.2 years.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The excess tax benefit related to share-based compensation recorded by the Company was not material for the years ended December&#160;31, 2021, 2020 and 2019. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon exercise of stock options, or upon the issuance of restricted share awards or performance share unit awards, the Company issues new shares.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021, there were 1,336 shares authorized for stock option grants, restricted share award grants, and performance share unit award grants in subsequent periods.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inducement Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the Board of Directors approved the Avadel Pharmaceuticals plc 2021 Inducement Plan (the &#8220;Inducement Plan&#8221;), which allows the Company to grant equity awards to induce highly-qualified prospective officers and employees who are not currently employed by the Company to accept employment and provide them with a proprietary interest in the Company. The maximum number of shares reserved and available for issuance under the Plan is 1,500 shares. As of December 31, 2021, the Company had not issued any shares under this Inducement Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Determining the Fair Value of Stock Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the total fair value of stock options on the grant date using the Black-Scholes option-pricing model and recognizes each grant&#8217;s fair value as compensation expense over the period that the option vests. Options are granted to employees of the Company and become exercisable ratably over four years following the grant date and expire ten years after the grant date. Prior to 2021, the Company issued stock options to its Board of Directors as compensation for services rendered that are exercisable ratably over three years following the grant date, and expire ten years after the grant date. In 2021, the Company issued stock options to its Board of Directors as compensation for services rendered and are exercisable one year following the grant date and expire ten years after the grant date.  </span></div><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions under the Black-Scholes option-pricing model for stock option grants as of December&#160;31, 2021, 2020 and 2019, are as follows: &#160;&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:48.679%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.909%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Option Assumptions: </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock option grants:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.20</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.08</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.25</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected term</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The expected term of the options represents the period of time between the grant date and the time the options are either exercised or forfeited, including an estimate of future forfeitures for outstanding options. Given the limited historical data, the simplified method has been used to calculate the expected life.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The expected volatility is calculated based on an average of the historical volatility of the Company&#8217;s stock price for a period approximating the expected term.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-free interest rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant and a maturity that approximates the expected term.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected dividend yield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The Company has not distributed any dividends since its inception and have no plan to distribute dividends in the foreseeable future.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the combined stock option activity and other data for the Company&#8217;s stock option plans for the year ended December&#160;31, 2021 is as follows: &#160;&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:34.782%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.194%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.194%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.194%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.196%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Stock Option Activity and Other Data: </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number&#160;of Stock<br/>Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options outstanding, January 1, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,898&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,857&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(234)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options outstanding, December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,403&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.83 years</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,204&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options exercisable, December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.88 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value of options exercisable at December&#160;31, 2021, 2020 and 2019 was $6,291, $1,841, and $572, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average grant date fair value of options granted during the years ended December&#160;31, 2021, 2020 and 2019 was $5.36, $4.63 and $1.24 per share, respectively.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Share Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted share awards represent Company shares issued free of charge to employees of the Company as compensation for services rendered. The Company measures the total fair value of restricted share awards on the grant date using the Company&#8217;s stock price at the time of the grant. Restricted share awards granted from 2017-2020 vest over a three-year period; two-thirds (2/3) vesting on the second anniversary of the grant date and the remaining one-third (1/3) vesting on the third anniversary of the grant date.&#160; In 2021, restricted share awards granted to employees vest over a four-year period; one-fourth (1/4) on each anniversary of the grant date. In 2018, the Company issued restricted share awards to its Board of Directors vesting over a three-year period; one-third (1/3) vesting on each of the three anniversaries of the grant date. Compensation expense for such awards granted during and after 2017 is recognized over the applicable vesting period.&#160; </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company&#8217;s restricted share awards as of December&#160;31, 2021, and changes during the year then ended, is reflected in the table below.&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:48.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.353%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Share Activity and Other Data: </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Restricted Share Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date<br/>Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested restricted share awards outstanding, January 1, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.08&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested restricted share awards outstanding, December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average grant date fair value of restricted share awards granted during the years ended December&#160;31, 2021, 2020 and 2019 was $8.22, $7.69 and $2.47, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Share Units Awards</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance share units awards (&#8220;PSUs&#8221;) represent Company shares issued free of charge to employees of the Company as compensation for achieving various results. The Company measures the total fair value of performance share unit awards on the grant date using the Company&#8217;s stock price at the time of the grant. In 2020, the Company granted performance share awards, of which 50% vest upon the achievement of certain regulatory milestones related to FT218 and the other 50% vest one year following achievement of those milestones (&#8220;2020 PSU awards&#8221;). The Company has not yet recognized any share-based compensation expense related to the 2020 PSU awards as the regulatory milestones have not yet been met; however, in the event the performance conditions are met before a certain date, approximately 100% of the outstanding shares, or $1,786 of compensation expense will be recognized by the Company for the 2020 PSU awards outstanding as of December&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the Company granted performance share awards of which 50% vest upon achievement of certain corporate objectives and the second 50% vests one year following achievement of those objectives (&#8220;2021 PSU awards&#8221;).  The Company has not yet recognized any share-based compensation expense related to the 2021 PSU awards as the objectives have not yet been met; however, in the event the performance conditions are met and exceeded, approximately 150% of the outstanding shares, or $3,509 of compensation expense will be recognized by the Company for the 2021 PSU awards outstanding as of December&#160;31, 2021.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company&#8217;s performance share units awards as of December&#160;31, 2021, and changes during the year then ended, is reflected in the table below. </span></div><div><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:48.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.353%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Performance Unit Share Activity and Other Data</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Performance Share Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date<br/>Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested performance share awards outstanding, January 1, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested performance share awards outstanding, December 31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average grant date fair value of performance share awards granted during the years ended December 31, 2021 and 2020 was $8.20 and $7.09 per share, respectively. There were no performance share awards granted during the year ended December 31, 2019. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Share Purchase Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, the Board of Directors approved the Avadel Pharmaceuticals plc 2017 Avadel Employee Share Purchase Plan (&#8220;ESPP&#8221;).  The total number of Company ordinary shares, nominal value $0.01 per share, or ADSs representing such ordinary shares (collectively, &#8220;Shares&#8221;) which may be issued under the ESPP is 1,000. The purchase price at which a share will be issued or sold for a given offering period will be established by the Compensation Committee of the Board (&#8220;Committee&#8221;) (and may differ among participants, as determined by the Committee in its sole discretion) but will in no event be less than 85% of the lesser of: (a) the fair market value of a Share on the offering date; or (b) the fair market value of a Share on the purchase date.  During the years ended December&#160;31, 2021 and 2020, the Company issued 17 and 49 ordinary shares to employees, respectively.  Expense related to the ESPP for the years ended December&#160;31, 2021, 2020 and 2019 was immaterial.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137042611560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net (Loss) Income Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net (Loss) Income Per Share</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net (Loss) Income Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net (loss) income per share is calculated by dividing net (loss) income by the weighted average number of shares outstanding during each period. Diluted net (loss) income per share is calculated by dividing net (loss) income - diluted by the diluted number of shares outstanding during each period. Except where the result would be anti-dilutive to net (loss) income, diluted net (loss) income per share would be calculated assuming the impact of the conversion of the 2023 Notes, the conversion of the Company&#8217;s preferred shares, the exercise of outstanding equity compensation awards, and ordinary shares expected to be issued under the Company&#8217;s ESPP.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a choice to settle the conversion obligation under the 2023 Notes in cash, shares or any combination of the two. The Company utilizes the if-converted method to reflect the impact of the conversion of the 2023 Notes, unless the result is anti-dilutive. This method assumes the conversion of the 2023 Notes into shares of the Company&#8217;s ordinary shares and reflects the elimination of the interest expense related to the 2023 Notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dilutive effect of the stock options, restricted stock units, preferred shares and ordinary shares expected to be issued under the Company&#8217;s ESPP has been calculated using the treasury stock method. The dilutive effect of the PSUs will be calculated using the treasury stock method, if and when the contingent vesting condition is achieved.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted net (loss) income per share, together with the related shares outstanding in thousands for the years ended December&#160;31, 2021, 2020 and 2019, is as follows: &#160;&#160;</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:55.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.832%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net (Loss) Income Per Share: </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77,329)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,226)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive securities&#8212;employee and director equity awards outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,535&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,941&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,403&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income per share - basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.89)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income per share - diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Potential ordinary shares of 15,327, 14,915, and 16,740 were excluded from the calculation of weighted average shares for the years ended December&#160;31, 2021, 2020 and 2019, respectively, because either their effect was considered to be anti-dilutive or they were related to shares from PSUs for which the contingent vesting condition had not been achieved. For the years ended December&#160;31, 2021 and 2019, the effects of dilutive securities were entirely excluded from the calculation of net (loss) income per share as a net loss was reported in these periods.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137040136472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Loss<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Comprehensive Loss</a></td>
<td class="text">Comprehensive Loss<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of accumulated other comprehensive loss for the year ended December 31, net of immaterial tax effects:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:49.047%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.782%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.782%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,627)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,738)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,621)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive (loss) income </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,228)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,855)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,627)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,738)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized (loss) gain on marketable securities, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive (loss) income, net of income tax benefit (expense) of  $214, $(202), $(43),  respectively</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,661)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">727&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,576&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss at December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,940)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,051)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,806)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137042674840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Company Operations by Product, Customer and Geographic Area<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Company Operations by Product, Customer and Geographic Area</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Operations by Product, Customer and Geographic Area</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that it operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer based technology. The Company&#8217;s Chief Operating Decision Maker is the CEO. The CEO reviews profit and loss information on a consolidated basis to assess performance and make overall operating decisions as well as resource allocations. All products are included in one segment because the Company&#8217;s products have similar economic and other characteristics, including the nature of the products and production processes, type of customers, distribution methods and regulatory environment.&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2020, the Company sold the Hospital Products. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4: Disposition of the Hospital Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company had no revenue during the twelve months ended December&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of total revenues by product for the twelve months ended December 31, 2020 and 2019:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.839%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Revenue by Product: </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bloxiverz</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vazculep</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Akovaz</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,334&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,215&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of total revenues by significant customer for the twelve months ended December 31, 2020 and 2019:&#160;</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.839%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue by Significant Customer:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">McKesson Corporation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cardinal Health</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AmerisourceBergen </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">QuVa Pharma</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Others</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,334&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,215&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All revenue earned during the years ended December 31, 2020 and 2019 was generated in the U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concentration of credit risk with respect to accounts receivable was limited due to the high credit quality comprising a significant portion of the Company&#8217;s customers. Management periodically monitors the creditworthiness of the Company&#8217;s customers and believes that it has adequately provided for any exposure to potential credit loss. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, the Company is working with contract manufacturing organizations for the manufacture of FT218. Additionally, the Company purchases raw materials used in FT218 from a limited number of suppliers, including a single supplier for certain key ingredients.</span></div><div><span><br/></span></div><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-monetary long-lived assets primarily consist of property and equipment, goodwill, intangible assets and operating right-of use-assets.&#160;The following table summarizes non-monetary long-lived assets by geographic region as of December&#160;31, 2021, 2020, and 2019:</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:48.679%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.909%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-lived Assets by Geographic Region: </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,424&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,817&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,422&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,482&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,694&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137042635016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">Related Party Transactions<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4: Disposition of the Hospital Products, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prior to June 30, 2020,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company was party to a Membership Interest Purchase Agreement by and among the Company, Avadel Legacy, Breaking Stick Holdings, LLC, Deerfield Private Design International II, L.P. (&#8220;Deerfield International&#8221;), Deerfield Private Design Fund II, L.P. (&#8220;Deerfield Fund&#8221;) and Horizon Sant&#233; FLML, Sarl (&#8220;Horizon&#8221;) (the &#8220;Deerfield MIPA&#8221;) and a Royalty Agreement by and among the Company, Avadel Legacy, the Deerfield Fund and Horizon (the &#8220;Deerfield Royalty Agreement&#8221;). In connection with the closing of the sale of the Hospital Products, the Deerfield MIPA (with respect to certain sections thereof) and the Royalty Agreement were assigned to the Exela Buyer. Pursuant to the Purchase Agreement, the Exela Buyer assumed and will pay, perform, satisfy and discharge the liabilities and obligations of Avadel Legacy under the Deerfield Royalty Agreement for obligations that arise after the Closing Date.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to June 30, 2020, the Company was also party to a Royalty Agreement by and between itself, Avadel Legacy and Broadfin Healthcare Master Fund, Ltd. (the &#8220;Broadfin Royalty Agreement&#8221;). In connection with the closing of the sale of the Hospital Products, the Broadfin Royalty Agreement was assigned to the Exela Buyer and the Exela Buyer assumed and shall pay, perform, satisfy and discharge the liabilities and obligations of Avadel Legacy under the Broadfin Royalty Agreement for obligations that arise after the Closing Date.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 12: Contingent Consideration Payable </span>for a summary of payments made for and changes to the fair value of the related party payable for the year ended December 31, 2019. Deerfield and Broadfin disposed of their 2023 Notes and ordinary shares in the Company during the year ended December 31, 2020 and are no longer considered related parties for the years ended December 31, 2021 and 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137042735688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subsequent Events</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span>On March 16, 2022, Avadel Finance Cayman Limited, a Cayman Islands exempted company and an indirect wholly-owned subsidiary of the Company (the &#8220;Issuer&#8221;), executed an agreement to exchange $117,375 of its 2023 Notes due February 1, 2023  (the &#8220;February 2023 Notes&#8221;) for a new series of its Exchangeable Senior Notes due October 2, 2023 (the &#8220;October 2023 Notes&#8221;) (the &#8220;Exchange&#8221;). The remaining $26,375 aggregate principal amount of the February 2023 Notes will maintain a maturity date of February 1, 2023. Taking into consideration the Exchange and the maturity date of the October 2023 Notes and based on the Company&#8217;s current plans, the Company has sufficient cash on hand and available liquidity to satisfy its obligations and fund working capital needs for at least twelve months following the date of issuance of the Consolidated Financial Statements. The Company has a recent history of generating losses from operations including during 2021 and expects to continue generating losses over the next twelve months. Similar to other businesses in the Company&#8217;s industry and at its stage of development, the Company will continue in the medium term to rely on external sources of capital to fund its business.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137038761784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_NatureOfBusinessPolicyPolicyTextBlock', window );">Nature of Operations</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Avadel Pharmaceuticals plc (Nasdaq: AVDL) (&#8220;Avadel,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221;) is a biopharmaceutical company. The Company is registered as an Irish public limited company. The Company&#8217;s headquarters are in Dublin, Ireland with operations in St. Louis, Missouri, United States (&#8220;U.S&#8221;).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s lead product candidate, FT218, is an investigational once-nightly, extended-release formulation of sodium oxybate for the treatment of excessive daytime sleepiness (&#8220;EDS&#8221;) or cataplexy in adults with narcolepsy. The Company is primarily focused on the development and potential United States (&#8220;U.S.&#8221;) Food and Drug Administration (&#8220;FDA&#8221;) approval of FT218. In December 2020, the Company submitted a New Drug Application (&#8220;NDA&#8221;) to the FDA for FT218 to treat excessive daytime sleepiness or cataplexy in adults with narcolepsy. In February 2021, the NDA for FT218 was accepted by the FDA and was assigned a Prescription Drug User Fee Act (&#8220;PDUFA&#8221;) target action date of October 15, 2021. On October 15, 2021, the Company announced that the FDA informed us that the review of the Company&#8217;s NDA for FT218 was ongoing beyond its previously assigned target action date. As of the date of this Annual Report, the FDA&#8217;s review of the Company&#8217;s NDA for FT218 remains ongoing. </span></div>Outside of the Company&#8217;s lead product candidate, the Company continues to evaluate opportunities to expand its product portfolio. As of the date of this Annual Report, the Company does not have any approved or commercialized products in its portfolio.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (&#8220;U.S. GAAP&#8221;). The consolidated financial statements include the accounts of the Company and all subsidiaries. All intercompany accounts and transactions have been eliminated.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s results of operations for the period January 1, 2019 through February 6, 2019 include the results of Avadel Specialty Pharmaceuticals, LLC (&#8220;Specialty Pharma&#8221;) prior to its February 6, 2019 voluntary petition for reorganization under Chapter 11 of the U.S. Bankruptcy Code. See&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 3: Subsidiary Bankruptcy and Deconsolidation.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text">Reclassifications<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications are made to prior year amounts whenever necessary to conform with the current year presentation. Certain reclassifications have been made to the Consolidated Statements of Cash Flows for the fiscal year ended December 31, 2019 and balances within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 14: Other Assets and Liabilities </span>for the year ended December 31, 2020 to condense line items of the same nature into a single line. This change does not affect previously reported net cash flows used in operating activities in the Consolidated Statements of Cash Flows.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to June 30, 2020, revenue included sales of pharmaceutical products, licensing fees, and, if any, milestone payments for research and development (&#8220;R&amp;D&#8221;) achievements.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine the appropriate revenue recognition, the Company performs the following five steps: (i) Identify the contract(s) with a customer&#894; (ii) Identify the performance obligations in the contract; (iii) Determine the transaction price&#894; (iv) Allocate the transaction price to the performance obligations in the contract&#894; and (v) Recognize revenue when (or as) the entity satisfies a performance obligation. The Company applies the five-step model to contracts only when the Company and its customer&#8217;s rights and obligations under the contract can be determined, the contract has commercial substance, and it is probable that the Company will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. The Company identifies the promised goods or services in the contract to determine if they are separate performance obligations or if they should be bundled with other goods and services into a single performance obligation. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Sales &#160;</span></div>Prior to June 30, 2020, the Company sold products primarily through wholesalers and considered these wholesalers to be the Company&#8217;s customers. Revenue from product sales is recognized when the customer obtains control of the Company&#8217;s product, which occurs typically upon receipt by the customer. The Company&#8217;s gross product sales were subject to a variety of price adjustments in arriving at reported net product sales. These adjustments included estimates of product returns, chargebacks, payment discounts, rebates, and other sales allowances and are estimated based on analysis of historical data for the product or comparable products, future expectations for such products and other judgments and analysis.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development (&#8220;R&amp;D&#8221;)</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development (&#8220;R&amp;D&#8221;). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> R&amp;D expenses consist primarily of costs related to outside services, personnel expenses, clinical studies and other R&amp;D expenses. Outside services and clinical studies costs relate primarily to services performed by clinical research organizations and related clinical or development manufacturing costs, materials and supplies, filing fees, regulatory support, and other third-party fees. Personnel expenses relate primarily to salaries, benefits and share-based compensation. Other R&amp;D expenses primarily include overhead allocations consisting of various support and facilities-related costs. R&amp;D expenditures are charged to operations as incurred. Raw materials used in the production of pre-clinical and clinical products are expensed as R&amp;D costs.  &#160;</span>The Company recognizes refundable R&amp;D tax credits received for spending on innovative R&amp;D as an offset of R&amp;D expenses.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Expenses</a></td>
<td class="text">Advertising Expenses.  The Company expenses the costs of advertising as incurred. Branded advertising expenses were $0, $312 and $372 for the years ended December&#160;31, 2021, 2020 and 2019, respectively.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-based Compensation</a></td>
<td class="text">Share-based Compensation. The Company accounts for share-based compensation based on the estimated grant-date fair value. The fair value of stock options is estimated using Black-Scholes option-pricing valuation models (&#8220;Black-Scholes model&#8221;). As required by the Black-Scholes model, estimates are made of the underlying volatility of Avadel stock, a risk-free rate and an expected term of the option or warrant. The Company estimates the expected term using a simplified method, as the Company does not have enough historical exercise data for a majority of such options upon which to estimate an expected term. The Company recognizes compensation cost, net of an estimated forfeiture rate, using the accelerated method over the requisite service period of the award.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, the Company determines deferred tax assets and liabilities on the basis of the differences between the financial statement and tax bases of assets and liabilities by using enacted tax rates in effect for the year in which </span><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes deferred tax assets to the extent that the Company believes that these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the Company determines that it would be able to realize its deferred tax assets in the future in excess of their net recorded amount, the Company would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records uncertain tax positions on the basis of a two-step process in which (1) the Company determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes interest and penalties related to unrecognized tax benefits in the income tax expense line in the consolidated statements of (loss) income. Accrued interest and penalties are included on the related tax liability line in the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">Cash and Cash Equivalents.  Cash and cash equivalents consist of cash on hand, cash on deposit and fixed term deposits which are highly liquid investments with original maturities of less than three months.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Securities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s marketable securities are considered to be available for sale and are carried at fair value, with unrealized gains and losses, net of taxes, reported as a component of accumulated other comprehensive (loss) income (&#8220;AOCI&#8221;) in shareholders&#8217; equity, with the exception of unrealized gains and losses on equity instruments and allowances for expected credit losses, if any, which are reported in earnings in the current period. The cost of securities sold is based upon the specific identification method.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span>For available-for-sale debt securities in an unrealized loss position, the Company assesses whether it intends to sell or if it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security&#8217;s amortized cost basis is written down to fair value. If the criteria are not met, the Company evaluates whether the decline in fair value has resulted from a credit loss or other factors. In making this assessment, management considers, among other factors, the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and adverse conditions specifically related to the security. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of the cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded for the credit loss, limited by the amount that the fair value is less than the amortized costs basis.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts', window );">Allowance for Credit Losses</a></td>
<td class="text">Allowance for Credit Losses.  Amounts owed to the Company are presented net of an allowance that includes as assessment of expected credit losses.  An allowance for credit losses is established based on expected losses. Expected losses are estimated by reviewing individual accounts, considering aging, financial condition of the debtor, payment history, current and forecast economic conditions and other relevant factors.  To the extent that the Company identifies that any individual customer's credit quality has deteriorated, the Company establishes allowances based on the individual risk characteristics of that customer. The Company makes concerted efforts to collect all outstanding balances due from customers; however, amounts are written off against the allowance when the related balances are no longer deemed collectible<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Property and equipment is stated at historical cost less accumulated depreciation. Depreciation and amortization are computed using the straight-line method over the following estimated useful lives:  </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:77.639%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.161%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software, office and computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements, furniture, fixtures and fittings</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5-10 years</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill</a></td>
<td class="text">Goodwill.  Goodwill represents the excess of the acquisition consideration over the fair value of assets acquired and liabilities assumed. The Company has determined that it operates in a single segment and have a single reporting unit associated with the development and commercialization of pharmaceutical products.  The Company tests goodwill for impairment annually and when events or changes in circumstances indicate that the carrying value may not be recoverable. The Company determined that no impairment of goodwill existed at December 31, 2021 and 2020.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long-Lived Assets</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Assets. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets include fixed assets and intangible assets. Prior to the sale of the Company&#8217;s portfolio of sterile injectable drugs used in the hospital setting (&#8220;Hospital Products&#8221;) on June 30, 2020, intangible assets consisted primarily of purchased licenses and intangible assets recognized as part of the &#201;clat Pharmaceuticals acquisition. Acquired in-process research and development (&#8220;IPR&amp;D&#8221;) had an indefinite life and was not amortized until completion and development of the project, at which time the IPR&amp;D became an amortizable asset, for which amortization of such intangible assets was computed using the straight-line method over the estimated useful life of the assets.  &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets are reviewed for impairment whenever conditions indicate that the carrying value of the assets may not be fully recoverable. Such impairment tests are based on a comparison of the pretax undiscounted cash flows expected to be generated by the asset to the recorded value of the asset or other market-based value approaches. If impairment is indicated, the asset value is written down to its market value if readily determinable or its estimated fair value based on discounted cash flows. Any significant changes in business or market conditions that vary from current expectations could have an impact on the fair value of these assets and any potential associated impairment.  On June 30, 2020, the Company transferred its remaining intangible asset to Exela Sterile Medicines LLC (&#8220;Exela Buyer&#8221;) as part of the disposition of the Hospital Products.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Lease Obligations</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lease Obligations. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if a contract is a lease at the inception of the arrangement. Right-of-use assets and operating lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. The Company reviews all options to extend, terminate, or purchase its right-of-use assets at the inception of the lease and will include these options in the lease term when they are reasonably certain of being exercised. Short term leases with an initial term of 12 months or less are not recorded on the balance sheet and the associated lease payments are recognized in the consolidated statements of (loss) income on a straight-line basis over the lease term. The Company&#8217;s lease contracts do not provide a readily determinable implicit rate. The Company&#8217;s estimated incremental borrowing rate is based on information available at the inception of the lease. The Company&#8217;s lease agreements may contain variable costs such as common area maintenance, insurance, real estate taxes or other costs. Variable lease costs are expensed as incurred on the consolidated statements of (loss) income.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">Use of Estimates. The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, including marketable securities and contingent liabilities at the date of the consolidated financial statements and the reported amounts of sales and expenses during the periods presented. These estimates and assumptions are based on the best information available to management at the balance sheet dates and depending on the nature of the estimate can require significant judgments. Changes to these estimates and judgments can have and have had a material impact on the Company&#8217;s consolidated statements of (loss) income and balance sheets.  Actual results could differ from those estimates under different assumptions or&#160;conditions.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Guidance</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Guidance</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. The FASB&#8217;s amendments primarily impact ASC 740, Income Taxes, and may impact both interim and annual reporting periods. ASU 2019-12 is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years and early adoption is permitted. The Company adopted the provisions of ASU 2019-12 on January 1, 2021. Adoption of ASU 2019-12 did not have any impact on the Company&#8217;s consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging- Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to reduce the complexity associated with applying U.S. GAAP principles for certain financial instruments with characteristics of liabilities and equity. The amendments in this ASU reduce the number of accounting models for convertible instruments and expand the existing disclosure requirements over earnings per share as it relates to convertible instruments. Convertible debt will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The update also requires the if-converted method to be used for convertible instruments and the effect of potential share settlement be included in the diluted earnings per share calculation when an instrument may be settled in cash or shares. This ASU will be effective for the Company&#8217;s fiscal year beginning January 1, 2022 and interim periods therein. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The amendments may be adopted through either a modified retrospective method, or a fully retrospective method.</span></div>The Company elected to early adopt ASU 2020-06 as of January 1, 2021 using a modified retrospective method. The Company&#8217;s 4.50% exchangeable senior notes due 2023 (the &#8220;2023 Notes&#8221;) are a convertible instrument with a cash-conversion feature that is accounted for within the scope of Subtopic 470-20. The Company calculated the cumulative-effect adjustment as of January 1, 2021 by comparing (i) the historical amortization schedule for the 2023 Notes through December 31, 2020 and (ii) an updated amortization schedule wherein the conversion feature within the 2023 Notes would not be separated as an equity component and subsequently recognized as non-cash interest expense under ASC 835-30. The adoption resulted in a $26,699 decrease in additional paid-in capital, a $12,939 increase in long-term debt, and a $13,760 increase to the opening balance of retained earnings.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_NatureOfBusinessPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for nature of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_NatureOfBusinessPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for charging off uncollectible financing receivables, including, but not limited to, factors and methodologies used in estimating the allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (a,b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137042671240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment Useful Life</a></td>
<td class="text">Property and equipment is stated at historical cost less accumulated depreciation. Depreciation and amortization are computed using the straight-line method over the following estimated useful lives:  <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:77.639%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.161%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software, office and computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements, furniture, fixtures and fittings</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5-10 years</span></div></td></tr></table><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal categories of property and equipment, net at December&#160;31, 2021 and 2020, respectively, are as&#160;follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.103%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Property and Equipment, net:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Software, office and computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,443&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Furniture, fixtures and fittings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less - accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(465)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,384)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137040434072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition of the Hospital Business - (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Schedule of Assets and Liabilities either Transferred Or Eliminated Representing the Aggregate Consideration of Disposal Group</a></td>
<td class="text">The $45,760 gain represents the aggregate consideration of $42,000, less transaction fees of $2,928, plus the assets and liabilities either transferred to the Exela Buyer or eliminated by the Company due to the sale of the Hospital Products, which are listed below.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,922)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(407)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,095)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term contingent consideration payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net liabilities disposed of</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,688&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aggregate consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less transaction fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,928)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net gain on the sale of the Hospital Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,760&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock', window );">Schedule of Error Corrections and Prior Period Adjustments</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma condensed combined statements of (loss) income for the years ended December 31, 2020 and 2019 included below is being provided for information purposes only and are not necessarily indicative of the results of operations that would have resulted if the Transaction had actually occurred on the date indicated. The pro forma adjustments are based on available information and assumptions that the Company believes are attributable to the sale.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:39.575%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.001%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Pro Forma Condensed Combined Statement of (Loss) Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pro Forma Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notes</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pro Forma</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,175)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,392)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,783)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,968)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,082)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,348)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,430)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:39.575%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.001%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unaudited Pro Forma Condensed Combined Statement of (Loss) Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pro Forma Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notes</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pro Forma</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59,273)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,112)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,181)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67,293)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38,582)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42,803)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(e)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(81,385)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjustments to the pro forma unaudited condensed combined statements of (loss) income</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) This adjustment reflects Product sales attributable to the Hospital Products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) This adjustment reflects the following estimated expenses attributable to the Hospital Products:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cost of products of $3,540.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">R&amp;D expenses of $322.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Selling, general and administrative expenses of $797.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Intangible asset amortization on acquired development technology for Vazculep of $406.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in fair value of related party contingent consideration of $3,327. The Company will no longer be responsible for these payments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) This amount reflects the adjustments noted in (a) and (b) above, as well as estimated Changes in fair value of related party payable of $435 attributable to the Hospital Products. The Company will no longer be responsible for these payments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) This adjustment reflects the following estimated expenses attributable to the Hospital Products:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cost of products of $11,368.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">R&amp;D expenses of $1,960.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Selling, general and administrative expenses of $1,102.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Intangible asset amortization on acquired development technology for Vazculep of $816.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in fair value of related party contingent consideration of $845. The Company will no longer be responsible for these payments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) This amount reflects the adjustments noted in (a) and (d) above, as well as the reversal of estimated Changes in fair value of related party payable of $378 attributable to the Hospital Products. The Company will no longer be responsible for these payments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137040431800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial instruments measured at fair value on a recurring basis classified in the fair value hierarchy (Level 1, 2 or 3) based on the inputs used for valuation in the accompanying consolidated balance sheets:</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,098&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,415&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,672&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,008&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137041292408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Available-for-sale Securities</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the Company&#8217;s available-for-sale securities&#8217; adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category as of&#160;December&#160;31, 2021 and 2020, respectively:</span></div><div style="margin-bottom:15pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:44.861%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.675%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.675%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.675%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.678%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,046)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,812&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">948&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,247)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,513&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:44.861%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.675%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.675%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.675%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.678%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147,903&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,815&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149,680&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Investments Classified by Contractual Maturity Date</a></td>
<td class="text"><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated fair value of the Company&#8217;s investments in marketable debt securities, accounted for as available-for-sale securities and classified by the contractual maturity date of the securities as of December&#160;31, 2021:</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:33.554%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.240%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Debt Securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 1 Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1-5 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5-10 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 10 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government securities - U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fixed-income securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,819&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,671&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,730&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,195&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,415&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137040433480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text">Property and equipment is stated at historical cost less accumulated depreciation. Depreciation and amortization are computed using the straight-line method over the following estimated useful lives:  <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:77.639%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.161%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software, office and computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements, furniture, fixtures and fittings</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5-10 years</span></div></td></tr></table><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal categories of property and equipment, net at December&#160;31, 2021 and 2020, respectively, are as&#160;follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.103%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Property and Equipment, net:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Software, office and computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,443&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Furniture, fixtures and fittings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less - accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(465)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,384)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137040971864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of Lease Costs</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease costs, which are included in selling, general and administrative expenses in the consolidated statements of (loss) income of years ended December&#160;31, 2021, 2020 and 2019 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Lease cost:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sublease income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(110)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(336)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(276)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">797&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,239&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable lease costs were immaterial for the years ended December&#160;31, 2021, 2020 and 2019.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Represents sublease income received for office subleases.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Maturities of Operating Lease Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of the Company&#8217;s operating lease liabilities were as follows:</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:80.076%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.989%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,013&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,607&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137042620984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt Instruments</a></td>
<td class="text"><div style="margin-bottom:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt is summarized as follows:</span></div><div style="margin-bottom:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:58.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.487%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.490%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of 4.50% exchangeable senior notes due 2023 </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: unamortized debt discount and issuance costs, net </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,353)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,540)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of liability component</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142,397&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: current maturities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142,397&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity component:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity component of exchangeable notes, net of issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26,699)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137040426200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingent Consideration Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Schedule of Related Party Transactions</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes to the contingent consideration payables, a recurring Level 3 measurement, for the twelve-month periods ended&#160;December 31, 2020&#160;and&#160;2019:</span></div><div><span><br/></span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:78.665%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent Consideration Payable:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of related party payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,736)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,327&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of contingent consideration payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,189)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Disposition of the Hospital Products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,900)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1) Fair value adjustments are reported as changes in fair value of contingent consideration and other expense - changes in fair value of contingent consideration payable in the consolidated statements of (loss) income.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137040991512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_ScheduleOfComponentsOfIncomeBeforeIncomeTaxTableTextBlock', window );">Schedule Of Components Of Loss Before Income Tax</a></td>
<td class="text"><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of loss before income taxes for the years ended twelve months ended December 31, are as follows:&#160;</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:48.679%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.909%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Loss Before Income Taxes:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,631)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,205)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,134)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(56,687)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(212)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total loss before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93,145)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,082)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38,582)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_ScheduleOfIncomeTaxPaymentsTableTextBlock', window );">Schedule Of Income Tax (Benefit) Provision</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax benefit consists of the following for the years ended December 31:&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:48.679%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.909%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Income Tax Benefit:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. - Federal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,810)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. - State</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,790)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,256)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. - Federal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,876)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,093)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. - State</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,876)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,453)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,816)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,110)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,356)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text">The reconciliation between income taxes at the statutory rate and the Company&#8217;s benefit for income taxes is as follows for the years ended December 31:&#160;<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:48.679%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.909%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Reconciliation to Effective Income Tax Rate:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit - at statutory tax rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,642)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(636)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,823)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Differences in international tax rates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,950)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,218)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nondeductible changes in fair value of contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intercompany asset transfer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,190)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in valuation allowances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nondeductible share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hospital Products sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,328)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized tax benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(261)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State and local taxes (net of federal)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in U.S. tax law</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,124)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nondeductible interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Orphan drug and R&amp;D tax credit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,524)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,793)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(378)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit - at effective income tax rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,816)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,110)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,356)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Summary of Unrecognized Tax Benefits</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the Company&#8217;s unrecognized tax benefits for the twelve months ended </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:48.679%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.909%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Unrecognized Tax Benefit Activity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at January 1: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increases for tax positions of prior years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Statute of limitations expiration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,266)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,322)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,143&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,143&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,465&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text">The net deferred tax assets (liabilities) at December&#160;31, 2021 and 2020 resulted from the following temporary differences:&#160;<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:48.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.353%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Net Deferred Tax Assets and Liabilities: </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Orphan drug and R&amp;D tax credit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,964&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,153&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,845&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(925)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(890)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(965)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: valuation allowances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,025)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,624)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred tax assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,128&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,256&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_ScheduleOfComponentsOfIncomeBeforeIncomeTaxTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of income before income tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_ScheduleOfComponentsOfIncomeBeforeIncomeTaxTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_ScheduleOfIncomeTaxPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of scheduled payments of income tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_ScheduleOfIncomeTaxPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=124434304&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137041003272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Assets and Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock', window );">Schedule of Prepaid Expenses and Other Current Assets</a></td>
<td class="text"><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various other assets and liabilities are summarized for the years ended December 31, as follows:&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prepaid Expenses and Other Current Assets: </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax receivable (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid and other expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee from Armistice</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivable from Exela (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term deposit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,826&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,726&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock', window );">Schedule of Other Non-Current Assets</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Non-Current Assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use assets at contract manufacturing organizations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee from Armistice</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,777&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,939&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued Expenses:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,697&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,781&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued outsourced contract costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,048&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer allowances</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued restructuring (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,151&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,501&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Schedule of Other Current Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:61.895%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.667%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Current Liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,695&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee to Deerfield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Due to Exela</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,270&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,200&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Schedule of Other Non-Current Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:61.895%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.667%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Non-Current Liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax liabilities and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee to Deerfield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,917&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,212&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of prepaid expenses and other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137042746936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Costs (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring and Related Costs</a></td>
<td class="text">The following table sets forth activities for the Company&#8217;s cost reduction plan obligations for the years ended&#160;December&#160;31, 2021 and 2020:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.560%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.915%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019 French Restructuring Obligation:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of restructuring accrual at January 1,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,922&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Benefit) charges for employee severance, benefits and other costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,813)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency impact</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of restructuring accrual at December 31, </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137044428776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense included in the Company&#8217;s consolidated statements of (loss) income for all share-based compensation arrangements was as follows for the periods ended December&#160;31, 2021, 2020 and 2019, respectively:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:48.679%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.909%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-based Compensation Expense:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(421)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,064)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,872&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,999&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_ScheduleOfShareBasedPaymentAwardStockOptionsAndWarrantGrantsValuationAssumptionsTableTextBlock', window );">Schedule of Share Based Payment Award Stock Options and Warrant Grants Valuation Assumptions</a></td>
<td class="text"><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions under the Black-Scholes option-pricing model for stock option grants as of December&#160;31, 2021, 2020 and 2019, are as follows: &#160;&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:48.679%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.909%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Option Assumptions: </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock option grants:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.20</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.08</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.25</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Share-based Compensation, Stock Options, Activity</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the combined stock option activity and other data for the Company&#8217;s stock option plans for the year ended December&#160;31, 2021 is as follows: &#160;&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:34.782%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.194%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.194%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.194%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.196%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Stock Option Activity and Other Data: </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number&#160;of Stock<br/>Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options outstanding, January 1, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,898&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,857&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(234)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options outstanding, December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,403&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.83 years</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,204&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options exercisable, December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.88 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award</a></td>
<td class="text">A summary of the Company&#8217;s restricted share awards as of December&#160;31, 2021, and changes during the year then ended, is reflected in the table below.&#160;<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:48.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.353%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Share Activity and Other Data: </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Restricted Share Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date<br/>Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested restricted share awards outstanding, January 1, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.08&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested restricted share awards outstanding, December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company&#8217;s performance share units awards as of December&#160;31, 2021, and changes during the year then ended, is reflected in the table below. </span></div><div><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:48.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.353%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Performance Unit Share Activity and Other Data</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Performance Share Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date<br/>Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested performance share awards outstanding, January 1, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-vested performance share awards outstanding, December 31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_ScheduleOfShareBasedPaymentAwardStockOptionsAndWarrantGrantsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options and Warrants grants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_ScheduleOfShareBasedPaymentAwardStockOptionsAndWarrantGrantsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137042672680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net (Loss) Income Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share Reconciliation</a></td>
<td class="text"><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted net (loss) income per share, together with the related shares outstanding in thousands for the years ended December&#160;31, 2021, 2020 and 2019, is as follows: &#160;&#160;</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:55.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.832%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net (Loss) Income Per Share: </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77,329)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,226)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive securities&#8212;employee and director equity awards outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,535&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,941&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,403&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income per share - basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.89)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income per share - diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137042762088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Loss (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of accumulated other comprehensive loss for the year ended December 31, net of immaterial tax effects:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:49.047%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.782%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.782%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,627)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,738)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,621)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive (loss) income </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,228)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,855)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,627)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,738)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized (loss) gain on marketable securities, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive (loss) income, net of income tax benefit (expense) of  $214, $(202), $(43),  respectively</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,661)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">727&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,576&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss at December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,940)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,051)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,806)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137039247624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Company Operations by Product, Customer and Geographic Area (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Revenue from External Customers by Product and Services</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of total revenues by product for the twelve months ended December 31, 2020 and 2019:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.839%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Revenue by Product: </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bloxiverz</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vazculep</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Akovaz</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,334&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,215&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock', window );">Schedule of Revenue by Major Customers by Reporting Segments</a></td>
<td class="text"><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of total revenues by significant customer for the twelve months ended December 31, 2020 and 2019:&#160;</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.839%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue by Significant Customer:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">McKesson Corporation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cardinal Health</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AmerisourceBergen </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">QuVa Pharma</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Others</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,334&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,215&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Revenue from External Customers by Geographic Areas</a></td>
<td class="text">All revenue earned during the years ended December 31, 2020 and 2019 was generated in the U.S.Concentration of credit risk with respect to accounts receivable was limited due to the high credit quality comprising a significant portion of the Company&#8217;s customers. Management periodically monitors the creditworthiness of the Company&#8217;s customers and believes that it has adequately provided for any exposure to potential credit loss.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock', window );">Long-lived Assets by Geographic Areas</a></td>
<td class="text">The following table summarizes non-monetary long-lived assets by geographic region as of December&#160;31, 2021, 2020, and 2019:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:48.679%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.909%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-lived Assets by Geographic Region: </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,424&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,817&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,422&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,482&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,694&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137034847928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense, debt</a></td>
<td class="nump">$ 9,942,000<span></span>
</td>
<td class="nump">$ 12,994,000<span></span>
</td>
<td class="nump">$ 12,464,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Operating expenses</a></td>
<td class="nump">85,546,000<span></span>
</td>
<td class="nump">16,519,000<span></span>
</td>
<td class="nump">83,327,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_AdvertisingMember', window );">Advertising</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Operating expenses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">312,000<span></span>
</td>
<td class="nump">372,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member', window );">4.50% Exchangeable Senior Notes Due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_DebtInstrumentAdditionalInterestExpensePercentage', window );">Debt instrument, additional interest expense, percentage</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_AdditionalInterestExpenseDebt', window );">Additional interest expense</a></td>
<td class="nump">$ 817,000<span></span>
</td>
<td class="nump">$ 773,000<span></span>
</td>
<td class="nump">$ 635,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member', window );">4.50% Exchangeable Senior Notes Due 2023 | Pro Forma Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense, debt</a></td>
<td class="nump">$ 1,408,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AdditionalInterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional Interest Expense, Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AdditionalInterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DebtInstrumentAdditionalInterestExpensePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Additional Interest Expense, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DebtInstrumentAdditionalInterestExpensePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_AdvertisingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_AdvertisingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137039268184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Property and Equipment Useful Lives (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember', window );">Software, office and computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life (in years)</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=avdl_LeaseholdImprovementsFurnitureFixturesAndFittingsMember', window );">Leasehold improvements, furniture, fixtures and fittings | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life (in years)</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=avdl_LeaseholdImprovementsFurnitureFixturesAndFittingsMember', window );">Leasehold improvements, furniture, fixtures and fittings | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life (in years)</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=avdl_LeaseholdImprovementsFurnitureFixturesAndFittingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=avdl_LeaseholdImprovementsFurnitureFixturesAndFittingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137034736488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Newly Issued Accounting Standards (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; (deficit) equity</a></td>
<td class="nump">$ 78,244<span></span>
</td>
<td class="nump">$ 162,266<span></span>
</td>
<td class="num">$ (29,199)<span></span>
</td>
<td class="nump">$ 2,780<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; (deficit) equity</a></td>
<td class="nump">549,349<span></span>
</td>
<td class="nump">566,916<span></span>
</td>
<td class="nump">434,391<span></span>
</td>
<td class="nump">433,756<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; (deficit) equity</a></td>
<td class="num">(447,756)<span></span>
</td>
<td class="num">(384,187)<span></span>
</td>
<td class="num">$ (391,215)<span></span>
</td>
<td class="num">$ (357,989)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; (deficit) equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,939)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; (deficit) equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,699)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; (deficit) equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 142,397<span></span>
</td>
<td class="nump">$ 128,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member', window );">4.50 Percent Exchangeable Senior Notes Due 2023 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137039200776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsidiary Bankruptcy and Deconsolidation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeconsolidationGainOrLossAmount', window );">Charge for deconsolidation of subsidiary</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,678<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount', window );">Gain from release of certain liabilities</a></td>
<td class="nump">$ 217<span></span>
</td>
<td class="nump">$ 3,364<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=avdl_SpecialtyPharmaMember', window );">Specialty Pharma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeconsolidationGainOrLossAmount', window );">Charge for deconsolidation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,678<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionContingentConsiderationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeconsolidationGainOrLossAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from deconsolidation of subsidiary and derecognition of group of assets constituting transfer of business or nonprofit activity, excluding conveyance of oil and gas mineral rights and transfer of good or service in contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeconsolidationGainOrLossAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from remeasurement to fair value of retained investment in former subsidiary and group of assets constituting business or nonprofit activity deconsolidated and derecognized, excluding conveyance of oil and gas mineral rights and transfer of product or service in contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=avdl_SpecialtyPharmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=avdl_SpecialtyPharmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137034824088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition of the Hospital Business Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from the disposition of the Hospital Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,500<span></span>
</td>
<td class="nump">$ 25,500<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Gain (loss) on disposition of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=avdl_BloxiverzVazculepAkovazandNouressMember', window );">The Business | Disposal Group, Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Aggregate consideration</a></td>
<td class="nump">$ 42,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration', window );">Initial cash consideration</a></td>
<td class="nump">14,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments', window );">Additional consideration paid in monthly installments</a></td>
<td class="nump">$ 27,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm', window );">Payment installment term (in months)</a></td>
<td class="text">10 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from the disposition of the Hospital Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,500<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Net gain on the sale of the Hospital Products</a></td>
<td class="nump">$ 45,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold', window );">Transaction fees</a></td>
<td class="nump">$ 2,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Additional Consideration Paid In Monthly Installments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Initial Cash Consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Payment Installment Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=avdl_BloxiverzVazculepAkovazandNouressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=avdl_BloxiverzVazculepAkovazandNouressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137034744136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition of the Hospital Business Components of Consideration and Assets and Liabilities Either Transferred or Eliminated (Details) - The Business - Disposal Group, Disposed of by Sale, Not Discontinued Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">$ (134)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1', window );">Inventories</a></td>
<td class="num">(4,922)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1', window );">Goodwill</a></td>
<td class="num">(1,654)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets, net</a></td>
<td class="num">(407)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="num">(1,095)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining', window );">Total long-term contingent consideration payable</a></td>
<td class="nump">14,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Net liabilities disposed of</a></td>
<td class="nump">6,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Aggregate consideration</a></td>
<td class="nump">42,000<span></span>
</td>
<td class="nump">$ 42,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold', window );">Less transaction fees</a></td>
<td class="num">(2,928)<span></span>
</td>
<td class="num">(2,928)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Net gain on the sale of the Hospital Products</a></td>
<td class="nump">$ 45,760<span></span>
</td>
<td class="nump">$ 45,760<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts of material contingent liabilities, for example, but not limited to, product or environmental liabilities or litigation, that remain with the entity despite the disposal of the disposal group that is classified as a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.Z.5.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872618&amp;loc=d3e7384-122677<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14472-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14453-108349<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14394-108349<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as goodwill attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2510-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=avdl_BloxiverzVazculepAkovazandNouressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=avdl_BloxiverzVazculepAkovazandNouressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137038616104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition of the Hospital Business - Unaudited Pro Forma Condensed Combined Statement of Income (Loss) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 22,334,000<span></span>
</td>
<td class="nump">$ 59,215,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expense</a></td>
<td class="nump">85,546,000<span></span>
</td>
<td class="nump">16,519,000<span></span>
</td>
<td class="nump">83,327,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(85,546,000)<span></span>
</td>
<td class="nump">5,815,000<span></span>
</td>
<td class="num">(24,112,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,742,000<span></span>
</td>
<td class="nump">12,125,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">17,104,000<span></span>
</td>
<td class="nump">20,442,000<span></span>
</td>
<td class="nump">32,917,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">68,495,000<span></span>
</td>
<td class="nump">32,405,000<span></span>
</td>
<td class="nump">30,183,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible asset amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">406,000<span></span>
</td>
<td class="nump">816,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Changes in fair value of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,327,000<span></span>
</td>
<td class="nump">845,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense - changes in fair value of contingent consideration payable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">435,000<span></span>
</td>
<td class="nump">378,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ProFormaMember', window );">Pro Forma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">159,000<span></span>
</td>
<td class="num">(58,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,127,000<span></span>
</td>
<td class="nump">67,235,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,968,000)<span></span>
</td>
<td class="num">(67,293,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,430,000)<span></span>
</td>
<td class="num">(81,385,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,334,000<span></span>
</td>
<td class="nump">59,215,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,519,000<span></span>
</td>
<td class="nump">83,327,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,815,000<span></span>
</td>
<td class="num">(24,112,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,082,000)<span></span>
</td>
<td class="num">(38,582,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Pro Forma Adjustments | Pro Forma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,175,000)<span></span>
</td>
<td class="num">(59,273,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,392,000)<span></span>
</td>
<td class="num">(16,092,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,783,000)<span></span>
</td>
<td class="num">(43,181,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,348,000)<span></span>
</td>
<td class="num">(42,803,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Pro Forma Adjustments | Pro Forma | Disposal Group, Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,540,000<span></span>
</td>
<td class="nump">11,368,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">322,000<span></span>
</td>
<td class="nump">1,960,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">797,000<span></span>
</td>
<td class="nump">1,102,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible asset amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">406,000<span></span>
</td>
<td class="nump">816,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Changes in fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,327,000<span></span>
</td>
<td class="nump">845,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense - changes in fair value of contingent consideration payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 435,000<span></span>
</td>
<td class="nump">$ 378,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ProFormaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ProFormaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137038625240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Measured on Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">$ 106,513<span></span>
</td>
<td class="nump">$ 149,680<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Mutual and money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">78,098<span></span>
</td>
<td class="nump">104,672<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">16,479<span></span>
</td>
<td class="nump">22,155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Government securities - U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">9,471<span></span>
</td>
<td class="nump">18,999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember', window );">Other fixed-income securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">2,465<span></span>
</td>
<td class="nump">3,854<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">78,098<span></span>
</td>
<td class="nump">104,672<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 1 | Mutual and money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">78,098<span></span>
</td>
<td class="nump">104,672<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 1 | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 1 | Government securities - U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 1 | Other fixed-income securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">28,415<span></span>
</td>
<td class="nump">45,008<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 2 | Mutual and money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 2 | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">16,479<span></span>
</td>
<td class="nump">22,155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 2 | Government securities - U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">9,471<span></span>
</td>
<td class="nump">18,999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 2 | Other fixed-income securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">2,465<span></span>
</td>
<td class="nump">3,854<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 3 | Mutual and money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 3 | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 3 | Government securities - U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 3 | Other fixed-income securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137034820920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details) - Senior Notes - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 142,397<span></span>
</td>
<td class="nump">$ 128,210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Estimate of Fair Value Measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">153,273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member', window );">4.50% Exchangeable Senior Notes Due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">$ 143,750<span></span>
</td>
<td class="nump">$ 143,750<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137127919176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_MarketableSecuritiesRealizedGain', window );">Marketable securities, realized gains</a></td>
<td class="nump">$ 174<span></span>
</td>
<td class="nump">$ 474<span></span>
</td>
<td class="nump">$ 483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_MarketableSecuritiesRealizedLoss', window );">Marketable securities, realized loss</a></td>
<td class="nump">$ 275<span></span>
</td>
<td class="nump">$ 912<span></span>
</td>
<td class="nump">$ 151<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_MarketableSecuritiesRealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Marketable Securities, Realized Gain</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_MarketableSecuritiesRealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_MarketableSecuritiesRealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Marketable Securities, Realized Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_MarketableSecuritiesRealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137037813240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities - Summary of Marketable Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="nump">$ 106,812<span></span>
</td>
<td class="nump">$ 147,903<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">948<span></span>
</td>
<td class="nump">1,815<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(1,247)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">106,513<span></span>
</td>
<td class="nump">149,680<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Mutual and money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="nump">78,331<span></span>
</td>
<td class="nump">103,404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">813<span></span>
</td>
<td class="nump">1,288<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(1,046)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">78,098<span></span>
</td>
<td class="nump">104,672<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="nump">16,478<span></span>
</td>
<td class="nump">21,811<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(93)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">16,479<span></span>
</td>
<td class="nump">22,155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Government securities - U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="nump">9,530<span></span>
</td>
<td class="nump">18,849<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(98)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">9,471<span></span>
</td>
<td class="nump">18,999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember', window );">Other fixed-income securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="nump">2,473<span></span>
</td>
<td class="nump">3,839<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 2,465<span></span>
</td>
<td class="nump">$ 3,854<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137038509096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities - Schedule of Maturities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 106,513<span></span>
</td>
<td class="nump">$ 149,680<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Less than 1 Year</a></td>
<td class="nump">5,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">1-5 Years</a></td>
<td class="nump">10,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">5-10 Years</a></td>
<td class="nump">318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Greater than 10 Years</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">16,479<span></span>
</td>
<td class="nump">22,155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Government securities - U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Less than 1 Year</a></td>
<td class="nump">1,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">1-5 Years</a></td>
<td class="nump">5,938<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">5-10 Years</a></td>
<td class="nump">807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Greater than 10 Years</a></td>
<td class="nump">1,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">9,471<span></span>
</td>
<td class="nump">18,999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember', window );">Other fixed-income securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Less than 1 Year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">1-5 Years</a></td>
<td class="nump">1,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">5-10 Years</a></td>
<td class="nump">605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Greater than 10 Years</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,465<span></span>
</td>
<td class="nump">$ 3,854<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Less than 1 Year</a></td>
<td class="nump">6,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">1-5 Years</a></td>
<td class="nump">18,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">5-10 Years</a></td>
<td class="nump">1,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Greater than 10 Years</a></td>
<td class="nump">1,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 28,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_FixedIncomeSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137038766136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less - accumulated depreciation</a></td>
<td class="num">$ (465)<span></span>
</td>
<td class="num">$ (1,384)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">285<span></span>
</td>
<td class="nump">359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">287<span></span>
</td>
<td class="nump">$ 459<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember', window );">Software, office and computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">448<span></span>
</td>
<td class="nump">1,443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture, fixtures and fittings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 302<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137034733528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 16,836,000<span></span>
</td>
<td class="nump">$ 16,836,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible asset amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">406,000<span></span>
</td>
<td class="nump">$ 816,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment loss related to goodwill or intangible assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137034345080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease, payments</a></td>
<td class="nump">$ 578<span></span>
</td>
<td class="nump">$ 769<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating lease, weighted average remaining lease term (in years)</a></td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating lease, weighted average discount rate, percent</a></td>
<td class="nump">4.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term of contract</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term of contract</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137041298312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Components of lease costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">$ 821<span></span>
</td>
<td class="nump">$ 1,133<span></span>
</td>
<td class="nump">$ 1,515<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="num">(110)<span></span>
</td>
<td class="num">(336)<span></span>
</td>
<td class="num">(276)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 711<span></span>
</td>
<td class="nump">$ 797<span></span>
</td>
<td class="nump">$ 1,239<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137040804472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturities of operating lease liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 974<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">1,013<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">614<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">2,807<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: interest</a></td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 2,607<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137037712280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Schedule of Long-Term Debt Instruments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current maturities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 142,397<span></span>
</td>
<td class="nump">128,210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member', window );">4.50% Exchangeable Senior Notes Due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less: unamortized debt discount and issuance costs, net</a></td>
<td class="num">$ (1,353)<span></span>
</td>
<td class="num">(15,540)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">142,397<span></span>
</td>
<td class="nump">128,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent', window );">Equity component of exchangeable notes, net of issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(26,699)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.50% Exchangeable Senior Notes Due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal amount of 4.50% exchangeable senior notes due 2023</a></td>
<td class="nump">$ 143,750<span></span>
</td>
<td class="nump">$ 143,750<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137033830504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Narrative (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 16, 2018 </div>
<div>USD ($) </div>
<div>day </div>
<div>$ / shares </div>
<div>Rate</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense, debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,942<span></span>
</td>
<td class="nump">$ 12,994<span></span>
</td>
<td class="nump">$ 12,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_CouponInterestExpense', window );">Coupon interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,469<span></span>
</td>
<td class="nump">6,469<span></span>
</td>
<td class="nump">6,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,248<span></span>
</td>
<td class="nump">6,524<span></span>
</td>
<td class="nump">5,995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; (deficit) equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,244<span></span>
</td>
<td class="nump">162,266<span></span>
</td>
<td class="num">(29,199)<span></span>
</td>
<td class="nump">$ 2,780<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_AmericanDepositorySharesConversionRatio', window );">ADSs, conversion ratio | Rate</a></td>
<td class="nump">9269.56%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; (deficit) equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">549,349<span></span>
</td>
<td class="nump">566,916<span></span>
</td>
<td class="nump">434,391<span></span>
</td>
<td class="nump">$ 433,756<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; (deficit) equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,939)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; (deficit) equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,699)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,248<span></span>
</td>
<td class="nump">6,525<span></span>
</td>
<td class="nump">5,995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,397<span></span>
</td>
<td class="nump">128,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member', window );">4.50% Exchangeable Senior Notes Due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_AdditionalInterestExpenseDebt', window );">Additional interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 817<span></span>
</td>
<td class="nump">$ 773<span></span>
</td>
<td class="nump">$ 635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member', window );">4.50% Exchangeable Senior Notes Due 2023 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_DebtInstrumentOptiontoIncreaseFaceAmount', window );">Option to increase aggregate principal amount</a></td>
<td class="nump">$ 18,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from loans or conditional grants</a></td>
<td class="nump">$ 137,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_AmericanDepositarySharesOptionPricePerShare', window );">ADS, option price per share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 10.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_AmericanDepositarySharesPremiumPercentage', window );">ADS premium percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_AmericanDepositarySharesPurchasedPricePerShare', window );">ADS purchased, price per share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 8.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member', window );">4.50% Exchangeable Senior Notes Due 2023 | Convertible Debt | Debt Instrument, Redemption, Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted', window );">Number of business days</a></td>
<td class="text">5 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays', window );">Consecutive business days</a></td>
<td class="text">5 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay', window );">Percentage of product of the last reported sale price of the American Depositary Shares and the exchange rate on each such trading day</a></td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member', window );">4.50% Exchangeable Senior Notes Due 2023 | Convertible Debt | Debt Instrument, Redemption, Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays', window );">Scheduled threshold trading days</a></td>
<td class="text">95 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | day</a></td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member', window );">4.50% Exchangeable Senior Notes Due 2023 | Convertible Debt | Debt Instrument, Redemption, Period Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | day</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days | day</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Threshold percentage of stock price trigger</a></td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member', window );">4.50% Exchangeable Senior Notes Due 2023 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_AdditionalInterestExpenseDebt', window );">Additional interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AdditionalInterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional Interest Expense, Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AdditionalInterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AmericanDepositarySharesOptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>American Depositary Shares, Option Price Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AmericanDepositarySharesOptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AmericanDepositarySharesPremiumPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>American Depositary Shares, Premium Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AmericanDepositarySharesPremiumPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AmericanDepositarySharesPurchasedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>American Depositary Shares Purchased, Price Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AmericanDepositarySharesPurchasedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AmericanDepositorySharesConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>American Depository Shares, Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AmericanDepositorySharesConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_CouponInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Coupon Interest Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_CouponInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Business Day Period During Which Debt Can Be Converted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Percentage of Product Of The Last Reported Sale Price Of The American Depositary Shares And The Exchange Rate On Each Such Trading Day</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Scheduled Threshold Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Threshold Consecutive Business Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DebtInstrumentOptiontoIncreaseFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Option to Increase Face Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DebtInstrumentOptiontoIncreaseFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137042639816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingent Consideration Payable - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Contingent consideration payable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3),(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137041780056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingent Consideration Payable - Payable Balance (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward', window );"><strong>Business Combination, Changes in Related Party Payable [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized', window );">Related party payable, beginning balance</a></td>
<td class="nump">$ 17,327<span></span>
</td>
<td class="nump">$ 28,840<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments of related party payable</a></td>
<td class="num">(6,189)<span></span>
</td>
<td class="num">(12,736)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Fair value adjustments</a></td>
<td class="nump">3,762<span></span>
</td>
<td class="nump">1,223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax', window );">Disposition of the Hospital Products</a></td>
<td class="num">(14,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized', window );">Related party payable, ending balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17,327<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Changes in Related Party Payable [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount, measured at acquisition-date fair value, of all liabilities assumed that arise from contingencies and were recognized by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137034847832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income (Loss) Before Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total loss before income taxes</a></td>
<td class="num">$ (93,145)<span></span>
</td>
<td class="num">$ (5,082)<span></span>
</td>
<td class="num">$ (38,582)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total loss before income taxes</a></td>
<td class="num">(36,631)<span></span>
</td>
<td class="num">(27,205)<span></span>
</td>
<td class="num">(50,134)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total loss before income taxes</a></td>
<td class="num">(56,687)<span></span>
</td>
<td class="nump">22,335<span></span>
</td>
<td class="nump">10,401<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_FR', window );">France</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total loss before income taxes</a></td>
<td class="nump">$ 173<span></span>
</td>
<td class="num">$ (212)<span></span>
</td>
<td class="nump">$ 1,151<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137034744888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income Tax Provision (Benefit) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">U.S. - Federal</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (12,810)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">U.S. - State</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="nump">60<span></span>
</td>
<td class="num">(12,790)<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Ireland</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,256)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">U.S. - Federal</a></td>
<td class="num">(15,876)<span></span>
</td>
<td class="nump">680<span></span>
</td>
<td class="num">(4,093)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">U.S. - State</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(104)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred</a></td>
<td class="num">(15,876)<span></span>
</td>
<td class="nump">680<span></span>
</td>
<td class="num">(5,453)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="num">$ (15,816)<span></span>
</td>
<td class="num">$ (12,110)<span></span>
</td>
<td class="num">$ (5,356)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137034717624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Tax Rate (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Effective Income Tax Rate Reconciliation, Amount [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income tax benefit - at statutory tax rate</a></td>
<td class="num">$ (11,642)<span></span>
</td>
<td class="num">$ (636)<span></span>
</td>
<td class="num">$ (4,823)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Differences in international tax rates</a></td>
<td class="num">(8,950)<span></span>
</td>
<td class="nump">1,755<span></span>
</td>
<td class="num">(1,218)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther', window );">Nondeductible changes in fair value of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">988<span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount', window );">Intercompany asset transfer</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,190)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowances</a></td>
<td class="nump">4,296<span></span>
</td>
<td class="nump">4,231<span></span>
</td>
<td class="nump">7,379<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Nondeductible share-based compensation</a></td>
<td class="nump">645<span></span>
</td>
<td class="nump">1,060<span></span>
</td>
<td class="nump">1,039<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Hospital Products sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(9,328)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxContingencies', window );">Unrealized tax benefits</a></td>
<td class="nump">239<span></span>
</td>
<td class="num">(274)<span></span>
</td>
<td class="num">(261)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State and local taxes (net of federal)</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount', window );">Change in U.S. tax law</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(9,124)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount', window );">Nondeductible interest expense</a></td>
<td class="nump">2,173<span></span>
</td>
<td class="nump">1,728<span></span>
</td>
<td class="nump">982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit', window );">Orphan drug and R&amp;D tax credit</a></td>
<td class="num">(1,524)<span></span>
</td>
<td class="num">(2,793)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems', window );">Other</a></td>
<td class="num">(1,113)<span></span>
</td>
<td class="nump">263<span></span>
</td>
<td class="num">(378)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="num">$ (15,816)<span></span>
</td>
<td class="num">$ (12,110)<span></span>
</td>
<td class="num">$ (5,356)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Amount, Orphan Drug and Research And Development Tax Credit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Intercompany Asset Transfer, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Interest Expense, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherReconcilingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137033668120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Oct. 02, 2019</div></th>
<th class="th"><div>Jul. 02, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_IncreaseDecreaseInIncomeTaxBenefit', window );">Increase (decrease) in income tax benefit</a></td>
<td class="nump">$ 3,706<span></span>
</td>
<td class="nump">$ 6,754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_DeferredTaxAssetsAmortizationofIntangibleAssets', window );">Amortization</a></td>
<td class="nump">3,429<span></span>
</td>
<td class="nump">3,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax expense (benefit)</a></td>
<td class="num">(15,876)<span></span>
</td>
<td class="nump">680<span></span>
</td>
<td class="num">$ (5,453)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits</a></td>
<td class="nump">2,483<span></span>
</td>
<td class="nump">2,483<span></span>
</td>
<td class="nump">3,806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Income tax penalties and interest expense</a></td>
<td class="nump">239<span></span>
</td>
<td class="nump">203<span></span>
</td>
<td class="nump">$ 555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Income tax penalties and interest accrued</a></td>
<td class="nump">1,777<span></span>
</td>
<td class="nump">1,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarnings', window );">Unremitted earnings</a></td>
<td class="nump">3,916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Deferred tax assets, tax credit carryforwards, research</a></td>
<td class="nump">3,668<span></span>
</td>
<td class="nump">6,771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit', window );">CARES Act, change in tax rate, deferred tax liability, income tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_CARESActProceedsFromIncomeTaxRefunds', window );">CARES Act, cash tax refunds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=us-gaap_TaxYear2019Member', window );">Tax Year 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_CARESActCashRefundClaims', window );">CARES Act, cash refund claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=us-gaap_TaxYear2020Member', window );">Tax Year 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_CARESActCashRefundClaims', window );">CARES Act, cash refund claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">124,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsValuationAllowance', window );">Operating loss carryforwards, valuation allowance (decrease)</a></td>
<td class="nump">4,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Gross research tax credit</a></td>
<td class="nump">529<span></span>
</td>
<td class="nump">375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">74,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_FR', window );">France</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Gross research tax credit</a></td>
<td class="nump">3,139<span></span>
</td>
<td class="nump">6,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember', window );">Internal Revenue Service (IRS) | Speciality Pharama</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied', window );">Bankruptcy claims, amount of filed claims likely to be denied</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,937<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,302<span></span>
</td>
<td class="nump">$ 50,695<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=avdl_FscHoldingsLlcMember', window );">FSC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">10,365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=avdl_U.S.HoldingsMember', window );">U.S. Holdings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 64,041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_CARESActCashRefundClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>CARES Act, Cash Refund Claims</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_CARESActCashRefundClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_CARESActProceedsFromIncomeTaxRefunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>CARES Act, Proceeds From Income Tax Refunds</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_CARESActProceedsFromIncomeTaxRefunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Coronavirus Aid, Relief And Economic Security Act (CARES Act), Change in Tax Rate, Deferred Tax Liability, Income Tax Benefit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DeferredTaxAssetsAmortizationofIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Amortization of Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DeferredTaxAssetsAmortizationofIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_IncreaseDecreaseInIncomeTaxBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Income Tax Benefit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_IncreaseDecreaseInIncomeTaxBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of bankruptcy claim filed with bankruptcy court that are likely to be denied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The earnings that is allocated to common stock and participating securities to the extent that each security may share in earnings as if all of the earnings for the period had been distributed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2814-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_TaxYear2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_TaxYear2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_TaxYear2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_TaxYear2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=avdl_SpecialityPharamaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=avdl_SpecialityPharamaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=avdl_FscHoldingsLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=avdl_FscHoldingsLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=avdl_U.S.HoldingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=avdl_U.S.HoldingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137038864632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Unrecognized Tax Benefit (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Unrecognized Tax Benefit Activity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Beginning balance</a></td>
<td class="nump">$ 3,143<span></span>
</td>
<td class="nump">$ 6,465<span></span>
</td>
<td class="nump">$ 5,315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease', window );">Increases for tax positions of prior years</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,416<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Statute of limitations expiration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,266)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,322)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Ending balance</a></td>
<td class="nump">$ 3,143<span></span>
</td>
<td class="nump">$ 3,143<span></span>
</td>
<td class="nump">$ 6,465<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137038262408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 35,990<span></span>
</td>
<td class="nump">$ 31,302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch', window );">Orphan drug and R&amp;D tax credit</a></td>
<td class="nump">4,964<span></span>
</td>
<td class="nump">2,793<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share-based compensation</a></td>
<td class="nump">4,108<span></span>
</td>
<td class="nump">2,626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_DeferredTaxAssetsAmortizationofIntangibleAssets', window );">Amortization</a></td>
<td class="nump">3,429<span></span>
</td>
<td class="nump">3,701<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">662<span></span>
</td>
<td class="nump">423<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Gross deferred tax assets</a></td>
<td class="nump">49,153<span></span>
</td>
<td class="nump">40,845<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNetAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(925)<span></span>
</td>
<td class="num">(890)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses', window );">Prepaid expenses</a></td>
<td class="num">(75)<span></span>
</td>
<td class="num">(75)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Gross deferred tax liabilities</a></td>
<td class="num">(1,000)<span></span>
</td>
<td class="num">(965)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowances</a></td>
<td class="num">(24,025)<span></span>
</td>
<td class="num">(21,624)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 24,128<span></span>
</td>
<td class="nump">$ 18,256<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DeferredTaxAssetsAmortizationofIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Amortization of Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DeferredTaxAssetsAmortizationofIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Tax Credit Carryforwards, Orphan Drug And Research</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137034508232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income tax receivable (see Note 13)</a></td>
<td class="nump">$ 29,097<span></span>
</td>
<td class="nump">$ 18,615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid and other expenses</a></td>
<td class="nump">3,179<span></span>
</td>
<td class="nump">1,018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_GuaranteeCurrent', window );">Guarantee from Armistice</a></td>
<td class="nump">279<span></span>
</td>
<td class="nump">318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other</a></td>
<td class="nump">271<span></span>
</td>
<td class="nump">798<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_ShortTermNoteReceivable', window );">Receivable from Exela (see Note 4)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">16,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term deposit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,477<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total</a></td>
<td class="nump">$ 32,826<span></span>
</td>
<td class="nump">$ 38,726<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_GuaranteeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Guarantee, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_GuaranteeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_ShortTermNoteReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Short Term Note Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_ShortTermNoteReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137040976152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets and Liabilities - Other Non-Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred tax assets (see Note 13)</a></td>
<td class="nump">$ 24,128<span></span>
</td>
<td class="nump">$ 18,256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent', window );">Right of use assets at contract manufacturing organizations</a></td>
<td class="nump">8,549<span></span>
</td>
<td class="nump">5,201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_GuaranteeNoncurrent', window );">Guarantee from Armistice</a></td>
<td class="nump">771<span></span>
</td>
<td class="nump">1,050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_OtherNoncurrentReceivables', window );">Other</a></td>
<td class="nump">329<span></span>
</td>
<td class="nump">432<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Total</a></td>
<td class="nump">$ 33,777<span></span>
</td>
<td class="nump">$ 24,939<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_GuaranteeNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Guarantee, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_GuaranteeNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right-Of-Use Asset, Contract Manufacturing, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_OtherNoncurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of other noncurrent receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_OtherNoncurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137041422632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets and Liabilities - Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued compensation</a></td>
<td class="nump">$ 3,167<span></span>
</td>
<td class="nump">$ 1,697<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">2,678<span></span>
</td>
<td class="nump">2,781<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_AccruedOutsourceContractCosts', window );">Accrued outsourced contract costs</a></td>
<td class="nump">1,048<span></span>
</td>
<td class="nump">473<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_AccruedTradeDiscountsAndRebates', window );">Customer allowances</a></td>
<td class="nump">217<span></span>
</td>
<td class="nump">1,030<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveCurrent', window );">Accrued restructuring (see Note 16)</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">520<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 7,151<span></span>
</td>
<td class="nump">$ 6,501<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AccruedOutsourceContractCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Outsource Contract Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AccruedOutsourceContractCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AccruedTradeDiscountsAndRebates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for accrued discounts and rebates</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AccruedTradeDiscountsAndRebates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137041371416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets and Liabilities - Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_AccruedInterestCurrent', window );">Accrued interest</a></td>
<td class="nump">$ 4,920<span></span>
</td>
<td class="nump">$ 2,695<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_OtherGuarantorObligationsCurrentCarryingValue', window );">Guarantee to Deerfield</a></td>
<td class="nump">280<span></span>
</td>
<td class="nump">319<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_OtherLiabilitiesMiscellaneousCurrent', window );">Other</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Due to Exela</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,026<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">$ 5,270<span></span>
</td>
<td class="nump">$ 5,200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AccruedInterestCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Interest, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AccruedInterestCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_OtherGuarantorObligationsCurrentCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Guarantor Obligations, Current Carrying Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_OtherGuarantorObligationsCurrentCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_OtherLiabilitiesMiscellaneousCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Liabilities, Miscellaneous, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_OtherLiabilitiesMiscellaneousCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToAffiliateCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToAffiliateCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137039003048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets and Liabilities - Other Non-Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities', window );">Tax liabilities and other</a></td>
<td class="nump">$ 3,143<span></span>
</td>
<td class="nump">$ 3,159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuarantyLiabilities', window );">Guarantee to Deerfield</a></td>
<td class="nump">774<span></span>
</td>
<td class="nump">1,053<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Total</a></td>
<td class="nump">$ 3,917<span></span>
</td>
<td class="nump">$ 4,212<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Liabilities And Other Noncurrent Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuarantyLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents a non-contingent liability for the fair value of an obligation to stand ready to perform over the term of a guaranty issued in the event that specified triggering events or conditions occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123422226&amp;loc=d3e11019-110243<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123422226&amp;loc=d3e11049-110243<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuarantyLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137038515352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingent Liabilities and Commitments - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2018</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Purchase obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_CostsIncurredPurchaseObligation', window );">Costs incurred, purchase obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_ContractualObligationAnnualAmount', window );">Contractual obligation, annual amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuarantyLiabilities', window );">Guarantee to Deerfield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">774<span></span>
</td>
<td class="nump">$ 1,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_CostsIncurredPurchaseObligation', window );">Costs incurred, purchase obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale | 2016 MIPA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuarantyLiabilities', window );">Guarantee to Deerfield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale | Cerecor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuarantyAssets', window );">Guaranty assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=avdl_FSCMember', window );">FSC | Discontinued Operations, Disposed of by Sale | 2016 MIPA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_PercentageOfRoyaltyPayableOnNetSales', window );">Percentage of royalty payable on net sales</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_RoyaltyPayableonNetSalesMaximum', window );">Royalty payable on net sales, maximum</a></td>
<td class="nump">$ 10,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_ContractualObligationAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual Obligation, Annual Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_ContractualObligationAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_CostsIncurredPurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs Incurred, Purchase Obligation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_CostsIncurredPurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_PercentageOfRoyaltyPayableOnNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of royalty that has to be paid by the company as per the royalty agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_PercentageOfRoyaltyPayableOnNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_RoyaltyPayableonNetSalesMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalty Payable on Net Sales, Maximum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_RoyaltyPayableonNetSalesMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuarantyAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the contractual right to receive fees, as compensation in exchange for providing a guarantee to a third party, over life of the guarantee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuarantyAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuarantyLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents a non-contingent liability for the fair value of an obligation to stand ready to perform over the term of a guaranty issued in the event that specified triggering events or conditions occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123422226&amp;loc=d3e11019-110243<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123422226&amp;loc=d3e11049-110243<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuarantyLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=avdl_A2016MIPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=avdl_A2016MIPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=avdl_CerecorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=avdl_CerecorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=avdl_FSCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=avdl_FSCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137038142824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Costs - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember', window );">2019 French Restructuring Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Operating lease, impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">629<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Fixed asset impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve</a></td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">$ 248<span></span>
</td>
<td class="nump">1,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for restructuring</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">1,813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember', window );">2019 French Restructuring Obligation | Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve</a></td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember', window );">2019 French Restructuring Obligation | Employee Severance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment', window );">(Benefit) charges for employee severance, benefits and other costs</a></td>
<td class="num">(122)<span></span>
</td>
<td class="nump">172<span></span>
</td>
<td class="nump">4,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember', window );">2019 French Restructuring Obligation | Retirement Indemnity Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=avdl_TwoThousandNineteenCorporateRestructuringObligationsMember', window );">2019 Corporate Restructuring Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Fixed asset impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisposals', window );">Write-off of property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation', window );">Share-based compensation forfeitures related to the employees affected by the global reduction in workforce</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=avdl_TwoThousandNineteenCorporateRestructuringObligationsMember', window );">2019 Corporate Restructuring Obligations | Employee Severance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment', window );">(Benefit) charges for employee severance, benefits and other costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent', window );">Percent reduction in workforce</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for restructuring</a></td>
<td class="nump">$ 272<span></span>
</td>
<td class="nump">$ 1,014<span></span>
</td>
<td class="nump">$ 2,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring And Related Costs, Expected Number Of Positions Eliminated, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring Charges Before Gain (Loss) Due to Curtailment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_RestructuringChargesBeforeGainLossDuetoCurtailment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for employee benefit and equity-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeBenefitsAndShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123399704&amp;loc=SL77918431-209957<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisposals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisposals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=avdl_RetirementIndemnityObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=avdl_RetirementIndemnityObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=avdl_TwoThousandNineteenCorporateRestructuringObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=avdl_TwoThousandNineteenCorporateRestructuringObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137038292232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Costs - Severance Obligation (Details) - 2019 French Restructuring Obligation - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance of accrued costs</a></td>
<td class="nump">$ 248<span></span>
</td>
<td class="nump">$ 1,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(77)<span></span>
</td>
<td class="num">(1,813)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Foreign currency impact</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance of accrued costs</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="nump">$ 1,922<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Severance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment', window );">(Benefit) charges for employee severance, benefits and other costs</a></td>
<td class="num">$ (122)<span></span>
</td>
<td class="nump">$ 172<span></span>
</td>
<td class="nump">$ 4,339<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring Charges Before Gain (Loss) Due to Curtailment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_RestructuringChargesBeforeGainLossDuetoCurtailment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137033222136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Instruments and Transactions (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 28, 2020</div></th>
<th class="th"><div>Feb. 21, 2020</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Feb. 29, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, nominal value (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,620,000<span></span>
</td>
<td class="nump">58,396,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, shares outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,620,000<span></span>
</td>
<td class="nump">58,396,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred shares, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred shares, nominal value (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares, shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">488,000<span></span>
</td>
<td class="nump">488,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred shares, shares outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">488,000<span></span>
</td>
<td class="nump">488,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration', window );">Maximum aggregate offering price of securities under shelf registration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration', window );">Maximum aggregate offering price of ADSs under shelf registration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 428,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,826,000<span></span>
</td>
<td class="nump">$ 38,726,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">February 2020 private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,570,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from the February 2020 private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">60,570,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock', window );">Maximum threshold percentage for trigger of convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Retirement of treasury shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,407,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Retirement of treasury shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Securities Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">February 2020 private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from the February 2020 private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,570,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Securities Purchase Agreement | American Depositary Receipts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during period, new issues (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,680,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Securities Purchase Agreement | Series A Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during period, new issues (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">488,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued, price per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=avdl_PublicOfferingMember', window );">Public Offering | American Depositary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Public offering, shares issued</a></td>
<td class="nump">11,630,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Public offering, price per share (in dollars per share)</a></td>
<td class="nump">$ 10.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avdl_SaleOfStockConsiderationReceivedOnTransactionGross', window );">Public offering, proceeds</a></td>
<td class="nump">$ 125,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds from public offering</a></td>
<td class="nump">$ 116,924,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Charges against additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 214,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">February 2020 private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,478,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance costs recorded as a reduction to additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,430,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Retirement of treasury shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,944,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,944,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Retirement of treasury shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,407,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Retirement of treasury shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,998,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,998,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">February 2020 private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during period, new issues (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,680,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Retirement of treasury shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,407,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Retirement of treasury shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum Aggregate Offering Price of American Depositary Shares Under Shelf Registration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum Aggregate Offering Price of Securities Under Shelf Registration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum Threshold Percentage For Trigger Of Convertible Preferred Stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_SaleOfStockConsiderationReceivedOnTransactionGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Consideration Received On Transaction, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_SaleOfStockConsiderationReceivedOnTransactionGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockRetiredCostMethodAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockRetiredCostMethodAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesRetired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common and preferred stock retired from treasury during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesRetired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=sic_Z8880">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=sic_Z8880</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=avdl_PublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=avdl_PublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=avdl_AmericanDepositarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=avdl_AmericanDepositarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137038518344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Stock-based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 8,872<span></span>
</td>
<td class="nump">$ 2,999<span></span>
</td>
<td class="nump">$ 519<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">758<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="nump">429<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">8,114<span></span>
</td>
<td class="nump">3,281<span></span>
</td>
<td class="nump">2,154<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember', window );">Restructuring costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (421)<span></span>
</td>
<td class="num">$ (2,064)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137032453944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1">48 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Feb. 29, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, nominal value (in usd or euro per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 18,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Weighted average period for unrecognized expense (in years)</a></td>
<td class="text">3 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value of options exercised</a></td>
<td class="nump">$ 6,291<span></span>
</td>
<td class="nump">$ 1,841<span></span>
</td>
<td class="nump">$ 572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Grant date fair value of options granted (in usd per share)</a></td>
<td class="nump">$ 5.36<span></span>
</td>
<td class="nump">$ 4.63<span></span>
</td>
<td class="nump">$ 1.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 8,872<span></span>
</td>
<td class="nump">$ 2,999<span></span>
</td>
<td class="nump">$ 519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan', window );">Employee share purchase plan share issuance (in shares)</a></td>
<td class="nump">17,000<span></span>
</td>
<td class="nump">49,000<span></span>
</td>
<td class="nump">54,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=avdl_RestrictedShareAwardsGrantedToEmployeesMember', window );">Restricted Share Awards Granted To Employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=avdl_RestrictedShareAwardsGrantsBeginningIn2018Member', window );">Restricted Share Awards, Grants Beginning In 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="nump">1,336,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Option | Board of Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">285,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant fair value of free share awards</a></td>
<td class="nump">$ 8.20<span></span>
</td>
<td class="nump">$ 7.09<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 1,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares | Share-based Payment Arrangement, Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">17,000<span></span>
</td>
<td class="nump">49,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=avdl_A2017AvadelEmployeeSharePurchasePlanMember', window );">2017 Avadel Employee Share Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, nominal value (in usd or euro per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for issuance under ESPP</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of common stock, percentage</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=avdl_InducementPlanMember', window );">Inducement Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of shares reserved and available for issuance (in shares)</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember', window );">2/3 vesting at second anniversary of grant date | Restricted Share Awards Granted From 2017-2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember', window );">1/3 vesting at third anniversary of grant date | Restricted Share Awards Granted From 2017-2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember', window );">1/4 vesting at each anniversary of grant date | Restricted Share Awards Granted To Employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=avdl_SharebasedCompensationAwardTrancheFourMember', window );">1/3 vesting at third anniversary of grant date | Restricted Share Awards, Grants Beginning In 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=avdl_VestOneYearFollowingAchievementOfMilestonesMember', window );">Vest One Year Following Achievement Of Milestones | Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=avdl_VestUponTheAchievementOfCertainRegulatoryMilestonesMember', window );">Vest Upon The Achievement Of Certain Regulatory Milestones | Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=avdl_VestUponAchievementOfCertainCorporateObjectivesMember', window );">Vest Upon Achievement Of Certain Corporate Objectives | Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 3,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=avdl_VestOneYearFollowingAchievementOfCertainCorporateObjectivesMember', window );">Vest One Year Following Achievement Of Certain Corporate Objectives | Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=avdl_VestUponAchievementOfCertainCorporateObjectivesBeingMetAndExceededMember', window );">Vest Upon Achievement Of Certain Corporate Objectives Being Met And Exceeded | Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">150.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 25<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109244457&amp;loc=d3e16649-113920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=avdl_RestrictedShareAwardsGrantedToEmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=avdl_RestrictedShareAwardsGrantedToEmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=avdl_RestrictedShareAwardsGrantsBeginningIn2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=avdl_RestrictedShareAwardsGrantsBeginningIn2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=avdl_A2017AvadelEmployeeSharePurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=avdl_A2017AvadelEmployeeSharePurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=avdl_InducementPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=avdl_InducementPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=avdl_RestrictedShareAwardsGrantedFrom20172020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=avdl_RestrictedShareAwardsGrantedFrom20172020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=avdl_SharebasedCompensationAwardTrancheFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=avdl_SharebasedCompensationAwardTrancheFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=avdl_VestOneYearFollowingAchievementOfMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=avdl_VestOneYearFollowingAchievementOfMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=avdl_VestUponTheAchievementOfCertainRegulatoryMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=avdl_VestUponTheAchievementOfCertainRegulatoryMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=avdl_VestUponAchievementOfCertainCorporateObjectivesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=avdl_VestUponAchievementOfCertainCorporateObjectivesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=avdl_VestOneYearFollowingAchievementOfCertainCorporateObjectivesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=avdl_VestOneYearFollowingAchievementOfCertainCorporateObjectivesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=avdl_VestUponAchievementOfCertainCorporateObjectivesBeingMetAndExceededMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=avdl_VestUponAchievementOfCertainCorporateObjectivesBeingMetAndExceededMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137038894472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Fair Value Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">3 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years 2 months 12 days<span></span>
</td>
<td class="text">6 years 29 days<span></span>
</td>
<td class="text">6 years 3 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">73.91%<span></span>
</td>
<td class="nump">75.76%<span></span>
</td>
<td class="nump">56.48%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">0.72%<span></span>
</td>
<td class="nump">2.52%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137034849848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Stock Options (Details)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Stock Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options outstanding, beginning balance (in shares) | shares</a></td>
<td class="nump">5,898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares) | shares</a></td>
<td class="nump">2,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="num">(48)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(234)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired (in shares) | shares</a></td>
<td class="num">(70)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options outstanding, ending balance (in shares) | shares</a></td>
<td class="nump">8,403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Stock options exercisable (in shares) | shares</a></td>
<td class="nump">3,256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Stock Options, Outstanding, Weighted Average Exercise Price [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Stock options outstanding, beginning balance (in usd per share) | $ / shares</a></td>
<td class="nump">$ 7.02<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in usd per share) | $ / shares</a></td>
<td class="nump">8.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in usd per share) | $ / shares</a></td>
<td class="nump">3.54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in usd per share) | $ / shares</a></td>
<td class="nump">7.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired (in usd per share) | $ / shares</a></td>
<td class="nump">12.62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Stock options outstanding, ending balance (in usd per share) | $ / shares</a></td>
<td class="nump">7.39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Stock options exercisable (in usd per share) | $ / shares</a></td>
<td class="nump">$ 7.88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Stock options outstanding, Weighted Average Remaining Contractual Life (in years)</a></td>
<td class="text">7 years 9 months 29 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Stock options exercisable, Weighted Average Remaining Contractual Life (in years)</a></td>
<td class="text">5 years 10 months 17 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Stock options outstanding, Aggregate Intrinsic Value | $</a></td>
<td class="nump">$ 12,204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Stock options exercisable, Aggregate Intrinsic Value | $</a></td>
<td class="nump">$ 6,291<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137034755016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Restricted Stock and Performance Unit Share Activity (Details) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=avdl_FreeShareAwardMember', window );">Free Share Award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Free Share Activity and Other Data, Nonvested [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, beginning balance (in shares)</a></td>
<td class="nump">347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(160)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, ending balance (in shares)</a></td>
<td class="nump">274<span></span>
</td>
<td class="nump">347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Free Share Activity and Other Data, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested free share award, beginning balance (in usd per share)</a></td>
<td class="nump">$ 5.87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in usd per share)</a></td>
<td class="nump">8.22<span></span>
</td>
<td class="nump">$ 7.69<span></span>
</td>
<td class="nump">$ 2.47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in usd per share)</a></td>
<td class="nump">5.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in usd per share)</a></td>
<td class="nump">7.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested free share award, ending balance (in usd per share)</a></td>
<td class="nump">$ 7.14<span></span>
</td>
<td class="nump">$ 5.87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Free Share Activity and Other Data, Nonvested [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, beginning balance (in shares)</a></td>
<td class="nump">257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, ending balance (in shares)</a></td>
<td class="nump">535<span></span>
</td>
<td class="nump">257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Free Share Activity and Other Data, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested free share award, beginning balance (in usd per share)</a></td>
<td class="nump">$ 7.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in usd per share)</a></td>
<td class="nump">8.20<span></span>
</td>
<td class="nump">$ 7.09<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in usd per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in usd per share)</a></td>
<td class="nump">5.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested free share award, ending balance (in usd per share)</a></td>
<td class="nump">$ 7.71<span></span>
</td>
<td class="nump">$ 7.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=avdl_FreeShareAwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=avdl_FreeShareAwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137040883528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net (Loss) Income Per Share - Reconciliation of basic and diluted EPS (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (77,329)<span></span>
</td>
<td class="nump">$ 7,028<span></span>
</td>
<td class="num">$ (33,226)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted Average Number of Shares Outstanding, Diluted [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic shares (in shares)</a></td>
<td class="nump">58,535<span></span>
</td>
<td class="nump">52,996<span></span>
</td>
<td class="nump">37,403<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive securities&#8212;employee and director equity awards outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,945<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted shares (in shares)</a></td>
<td class="nump">58,535<span></span>
</td>
<td class="nump">54,941<span></span>
</td>
<td class="nump">37,403<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss) per share - basic (in usd per share)</a></td>
<td class="num">$ (1.32)<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="num">$ (0.89)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss) per share - diluted (in usd per share)</a></td>
<td class="num">$ (1.32)<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="num">$ (0.89)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137040967688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net (Loss) Income Per Share - Narrative (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share</a></td>
<td class="nump">15,327<span></span>
</td>
<td class="nump">14,915<span></span>
</td>
<td class="nump">16,740<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137038164072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Loss (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 162,266<span></span>
</td>
<td class="num">$ (29,199)<span></span>
</td>
<td class="nump">$ 2,780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Net other comprehensive (loss) income</a></td>
<td class="num">(80,218)<span></span>
</td>
<td class="nump">8,783<span></span>
</td>
<td class="num">(32,616)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">78,244<span></span>
</td>
<td class="nump">162,266<span></span>
</td>
<td class="num">(29,199)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Unrealized gain (loss) on marketable securities, tax</a></td>
<td class="nump">214<span></span>
</td>
<td class="num">(202)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign currency translation adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(22,627)<span></span>
</td>
<td class="num">(23,738)<span></span>
</td>
<td class="num">(23,621)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Net other comprehensive (loss) income</a></td>
<td class="num">(1,228)<span></span>
</td>
<td class="nump">1,111<span></span>
</td>
<td class="num">(117)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(23,855)<span></span>
</td>
<td class="num">(22,627)<span></span>
</td>
<td class="num">(23,738)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Unrealized gain (loss) on marketable securities, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">1,576<span></span>
</td>
<td class="nump">932<span></span>
</td>
<td class="nump">205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Net other comprehensive (loss) income</a></td>
<td class="num">(1,661)<span></span>
</td>
<td class="nump">644<span></span>
</td>
<td class="nump">727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(85)<span></span>
</td>
<td class="nump">1,576<span></span>
</td>
<td class="nump">932<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated other comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(21,051)<span></span>
</td>
<td class="num">(22,806)<span></span>
</td>
<td class="num">(23,416)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">$ (23,940)<span></span>
</td>
<td class="num">$ (21,051)<span></span>
</td>
<td class="num">$ (22,806)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137033643016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Company Operations by Product, Customer and Geographic Area - Revenue by Product (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 22,334,000<span></span>
</td>
<td class="nump">$ 59,215,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">22,334,000<span></span>
</td>
<td class="nump">59,215,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=avdl_BloxiverzMember', window );">Bloxiverz</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,201,000<span></span>
</td>
<td class="nump">7,479,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,201,000<span></span>
</td>
<td class="nump">7,479,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=avdl_VazculepMember', window );">Vazculep</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,429,000<span></span>
</td>
<td class="nump">33,152,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,429,000<span></span>
</td>
<td class="nump">33,152,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=avdl_AkovazMember', window );">Akovaz</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,545,000<span></span>
</td>
<td class="nump">18,642,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,545,000<span></span>
</td>
<td class="nump">18,642,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=avdl_OtherProductsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">159,000<span></span>
</td>
<td class="num">(58,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 159,000<span></span>
</td>
<td class="num">$ (58,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=avdl_BloxiverzMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=avdl_BloxiverzMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=avdl_VazculepMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=avdl_VazculepMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=avdl_AkovazMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=avdl_AkovazMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=avdl_OtherProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=avdl_OtherProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137040220600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Company Operations by Product, Customer and Geographic Area - Revenue by Significant Customer (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 22,334,000<span></span>
</td>
<td class="nump">$ 59,215,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=avdl_CustomerMember', window );">McKesson Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,758,000<span></span>
</td>
<td class="nump">14,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=avdl_CustomerBMember', window );">Cardinal Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,155,000<span></span>
</td>
<td class="nump">15,088,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=avdl_CustomerCMember', window );">AmerisourceBergen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,155,000<span></span>
</td>
<td class="nump">12,059,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=avdl_CustomerDMember', window );">QuVa Pharma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,117,000<span></span>
</td>
<td class="nump">3,252,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=avdl_OtherCustomersMember', window );">Others</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,149,000<span></span>
</td>
<td class="nump">$ 13,916,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=avdl_CustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=avdl_CustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=avdl_CustomerBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=avdl_CustomerBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=avdl_CustomerCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=avdl_CustomerCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=avdl_CustomerDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=avdl_CustomerDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=avdl_OtherCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=avdl_OtherCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137040652408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Company Operations by Product, Customer and Geographic Area - Data by Geographic Region (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasLongLivedAssetsAbstract', window );"><strong>Long-lived Assets by Geographic Region:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 29,422<span></span>
</td>
<td class="nump">$ 26,482<span></span>
</td>
<td class="nump">$ 29,694<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasLongLivedAssetsAbstract', window );"><strong>Long-lived Assets by Geographic Region:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">19,605<span></span>
</td>
<td class="nump">20,424<span></span>
</td>
<td class="nump">22,254<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_FR', window );">France</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasLongLivedAssetsAbstract', window );"><strong>Long-lived Assets by Geographic Region:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicAreasLongLivedAssetsAbstract', window );"><strong>Long-lived Assets by Geographic Region:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 9,817<span></span>
</td>
<td class="nump">$ 6,047<span></span>
</td>
<td class="nump">$ 7,244<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicAreasLongLivedAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicAreasLongLivedAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140137038613144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details) - Convertible Debt - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 16, 2022</div></th>
<th class="th"><div>Feb. 16, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member', window );">4.50% Exchangeable Senior Notes Due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | 4.50% Exchangeable Senior Notes Due October 2, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="nump">$ 117,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | 4.50% Exchangeable Senior Notes Due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="nump">$ 26,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>avdl-20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:avdl="http://www.avadel.com/20211231"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:sic="http://xbrl.sec.gov/sic/2021"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="avdl-20211231.xsd" xlink:type="simple"/>
    <context id="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3840421dd70d40aba8c9dc8a0052f33e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">avdl:AmericanDepositarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i370907e69e7f449e958e11d58db5bf21_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">avdl:OrdinaryShareNominalValue001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia143361add2b4e9c93fd4b3b2019fefd_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie534be6ccea84023a1ded40a74cfac08_I20220311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2022-03-11</instant>
        </period>
    </context>
    <context id="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib45086ff0e0a4835b7367935d02327f4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib3742cf8102b48d39bc674ec35e7f8d0_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i812a792161364ad492b0f6fe55adf3f4_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6fb14a7aef624d6b8b4c8f13072f3c9f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i26cf650e64fc419d90c5273bbc7ac968_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ic6fbbd5528b2439293da3c165945acb2_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i394f53cfcde141e98500d79a19551b90_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ie19b226220734349af34ea12f273148b_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i62c97ced29404b4b822be5a8b268125c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie148f975b2854da787567794ba46c657_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia8606a26085a4a74842150a8d122fa0d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3e4d19794fda42f0b37baafb371b84eb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifb598c0f14344aae992296441052f63c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i197afee9fd6b4ccaa43ec6478392822f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i899ea66e7b964d058e1797ec8ba84773_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i54c88094c4ef4380afaf16c83eff800a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i67e12346ebfb4c079f8ca4ba96c5d37c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib7eb97deba3549d6b376ab774b0445a5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie73b28a1c0c648e5a6641e1c909996f0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4cf266a805904fcb95e5e2c230b341cd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iecf586fe05cc4a8796842f7e0739adcd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if771595121ea48de8b53daa551326307_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9de1c77df78b4ba98727acf8dec79f60_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i222f8cd80d79448189c83644ac3d2355_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id0877df49af64182b24f4e10a6ba5e3e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic789417b0e004065ba225a51e910fb39_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i00d4167fc12941e6afffad25855327d4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia20446b447fa4a8ab7a66e1764ce6493_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i82fc7bbe97ac467ba08500fce8cb112e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaddacdf3080a4469857cc1c79a9583e3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i965ba5cfda524be99b22224e377b7879_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i27057cf80d054326a72f1357eef1f0c2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifdaa54a433dd430a83d91856c8287945_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia03de445d5514be7925f47534612a3c6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2aea8b8d433e4423879f52b4780b5b0f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic1271ce9577746e28ccd19f9aebc5938_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i71e818e3e9d648c6b90862da8ce42be5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibcc16b22124640c1b74cb0fad033cc0d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5c79a087deb04cc1aee09bf57361d370_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4880683abd4349769692521b4246f81c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5f3ba7983a1d4e8d8ca3d4d571f7417f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic954e2aba16348f4beeb6795e6fad4fa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i79b00d255f634de49f2fc2b349447e88_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i10196011707944b18724021dfce2ca7e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic562d9c206fb48efa5bb76601ca9f47a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0a1f89fa820b46799ce79a937450f547_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1f8c561814cb4f708a96e8a38bb166f0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5309d5e8acaa431c9c274770bb06176c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i99ac7af65eda496da535e06c493274b8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iaf9cbe9d47d34e1390ad1c335c52c141_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:AdvertisingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4b913b3f3b0f4f44964bcbdf8ad62c1b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:AdvertisingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iaa9feaab286342789251faa80710001c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:AdvertisingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i78886c225d1047eeaaea9dd1a3216a79_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">avdl:SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i66c72f9a21ad431c99a6a9e5043d92a7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">avdl:LeaseholdImprovementsFurnitureFixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie09e5d490621464e9ce04e340e7c04df_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">avdl:LeaseholdImprovementsFurnitureFixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8ffb01488f3a42119218fd36f48c1d40_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i85c848bffc1542ceb9f02559b91119f8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">avdl:SpecialtyPharmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i394c910852974a2b9a5ecd7ffb761fce_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:BloxiverzVazculepAkovazandNouressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6d1b0f4826d84816aa9460ece5298de4_D20200630-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:BloxiverzVazculepAkovazandNouressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-30</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i0756957a1e1d4fce943a2b692ad6e709_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:BloxiverzVazculepAkovazandNouressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1c9923703844411eb3e5ce7edba6c8ed_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:BloxiverzVazculepAkovazandNouressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic759888cdbc54a9a9b75a3bc35604e1c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:BloxiverzVazculepAkovazandNouressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9d9561d07a174b4d928f303fd47bd68b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i38080e480d2448d89a3f5285f946f2e5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibaeb39fd6c394110b9fd0a0d5423884f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib89e2680daf342f19590ad40660e7d7c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i76d9d41ce856419e9dfc0d9e14013a83_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i452c804743a24cfe918d651e2bd94b98_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9ead4e892b78440b941a75e56c9490b1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i116a6b04235e4b1c93dc94865613041c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0083fb6ccd404e979fe21e48af0fa1f5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id52d7d2aa62b4b4da464b12866a6c924_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i83bc9cfa1af3440280eb8de38f8166dd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic01169ef9e0a4955a3206600ff07ada7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id2b2742f57824ceda1edb68f0ff8c8f3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5d1044cc5fce464b8bc7a7bfef8cde56_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i18e72e8a73fd4634a6d3d9497623275a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if3c0427547534f92a024aa31e44c88b7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i293bd7a5c8b64a69aac7ebd06bdbcd7d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if5fb86d740e0439ca6608ab69d36eb11_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6bfe961a6b074629ab468b545ec27937_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia0630338310348249f7dc7b831142ee2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7eb59743d34e40129c556f867c6c573c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic5f30bb744514756aea4f12be8815603_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id5979606d5744565bf77ff486631a39e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6913fac34a90404fa88993860b66d7e2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic28f71d280c5400baa92f1e72d94daf9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id88486af4378447498d419d174a87a1f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifa70138b99c048b89b45f15ed355b484_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie16c2dc1e48343529c36da1c15195964_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia4b3eeee3d8446c7b5e89621aa4d248c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib17fcae9927b47b188df8b1fa2c25721_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i68cd10c5610845ebabca121f25b49d60_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9d79f4c0bc9b455887433f737f576ca8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7a771a5f8997450bbbff5c44c4e92027_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6b4d5f4b3fec4948b3a7c8a60e155623_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2c7e425e645c4dc79f2d64d4e4939081_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id14aee310c1d455eba4dc5a754e72eee_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i440d19b8d2524ebdaf59efde284e3f22_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib15012d3c7954901bf95432b698ea122_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1789d52ed2dd4776b2edfab82bbba9d2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia43fd9d7d0184bf48d0ca7e30b92fe15_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i26a649c3c54c4610811b4ccf08d404fc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia2ad46fe0b3942418942545c861a553b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4de00269e1884c6ba19491a6f480f8c0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i12fe5967822c4c7c815ef3f9bfcf263a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7a1d5321937c496998a92b6d7b15b2ec_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id0135ceeb3a74418aebc3bea16187547_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i90001ac5605243f1919453ac916355e5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i85699a651b9645bdaa89df0e755480d9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idcf68fc36aa144f6aed0720b51cae4de_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1e1399e88a8a4132b1ab0865edb594ab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9e74df425db74915b7e617e549e87b1f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">avdl:SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i79bb42f554984d2286d06ea284888cfd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">avdl:SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id8c3aa61520d40aebe11479c3ccbff53_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i82ff4d5bf5de4a8ba5b7fb4b53054871_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i91742d6730614741949177cbcf4302d6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8f6fe7015e8f450194b70a8556bf0935_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icfaa054052d14e7a8ca1f2c58126ec2e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4dc9b8e4c33d47f78a2c32f6fc5be381_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1b007cff8b974e868c3993f562d9feaf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifd8ea8ce80304018bd5b1979eb26d074_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i33e06b7a13eb4e85be3a4f81119b68c1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id9ebe4ca9019413ebb51803e053e035d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibf503e36fd6a429f84871178d6090bcd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7d1ea1ea40054379a04b6e20ee96f982_I20180216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-02-16</instant>
        </period>
    </context>
    <context id="id653d0c0a8b74c299e04291165d88344_D20180216-20180216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-16</startDate>
            <endDate>2018-02-16</endDate>
        </period>
    </context>
    <context id="i483626a1ca994a1ab8f44a4dd0abd7f7_D20180216-20180216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2018-02-16</startDate>
            <endDate>2018-02-16</endDate>
        </period>
    </context>
    <context id="i911b1d37c6734cba9182382fa4082eed_D20180216-20180216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-16</startDate>
            <endDate>2018-02-16</endDate>
        </period>
    </context>
    <context id="i0cf2ba3d017445f7b369d02baa194a26_D20180216-20180216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-16</startDate>
            <endDate>2018-02-16</endDate>
        </period>
    </context>
    <context id="ic9d6fffe305c44aeb5282edb28b92265_D20180216-20180216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-16</startDate>
            <endDate>2018-02-16</endDate>
        </period>
    </context>
    <context id="i74b20dd17dcf4f36b4f73cfd680e44c9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1798461a2fc34d85ace6dea31e0f8881_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i08b7b375f4d048c9ab8e6d5fd7ea7ea5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie59a27f48eeb44b5bb24636fb8639702_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i13a6499a4aea49bfbc0d46162aaf1ebe_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia4590886cb1c49159327f4cd498c421f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i537c662c0452407d996503d13075eee0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia3e2739e702347078b4ee9a8124ae398_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i64421d34a1204f448424959b78e8a9d8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idaf12fbafde84863931c23859cbdb5da_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">avdl:SpecialityPharamaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia27d598a536e49f8a6849f6207c5e949_I20190702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">avdl:SpecialityPharamaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-02</instant>
        </period>
    </context>
    <context id="i7cf4dc7580ba45efa635d0308b128ae0_I20191002">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">avdl:SpecialityPharamaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-02</instant>
        </period>
    </context>
    <context id="i0729539c1221405f81e7676478827e0e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib32f28d9fbb54bab90164eb85e585915_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i94f0c3f367384e14bdd26826dd6b02fd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">avdl:FscHoldingsLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if8fc76361f664419bb4b6bec6e9f55d1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">avdl:U.S.HoldingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i965546c452da46f2b76a6fe33a65e75c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8b27235b791c489ba62df9bcd96969e8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8aae7fedfa0841069d9766ab4280c0ce_D20180201-20180228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:FSCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:A2016MIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-01</startDate>
            <endDate>2018-02-28</endDate>
        </period>
    </context>
    <context id="ie92e7a337b354b108b7bcc24805f0ef5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:A2016MIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5adac7e213d040e6be9c9156b4e7a03d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:CerecorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia9dabd3a46c348c4af8ae3e2b161a78b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3109188b67084c50b94dbbece93b1abd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5b6255d17e27499c84e9416e2247c6d2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">avdl:RetirementIndemnityObligationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5abec81499e34146bd019b20912a78d9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">avdl:RetirementIndemnityObligationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9fe6439ac97147e2bef805733848150d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia076dc0709334bbeaf09ce17301fb2b2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1c3cd06d5ae74e7ca62b8e96948d1fbe_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib7cf514ecb0a4781b0ac7b4a71edab2e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5987a3d29dec46bbb4bf5192b6d19fa6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i08f7c0e44e0a42769d59e55ba48a1a37_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ice4e909fcef6444cab32b6676fcfd8a6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iee22e31315ba4f7e8c83a112021555d6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i27fed9afac844925a080e2a721c7438b_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateRestructuringObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i91f93d16ae9742dd81fc60061f927f11_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateRestructuringObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7326c61f55a843b198262a29c6c921c5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateRestructuringObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iba84066aae6641519638f5dc4a7827a7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateRestructuringObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i18f1d74601ab46d1bf4daa3efd8b638b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:TwoThousandNineteenCorporateRestructuringObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic33e6a0dbfbb440fb29af7e8c03ab9d7_I20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2020-02-29</instant>
        </period>
    </context>
    <context id="i2787db7d87db4fbbb4a9524ed6ef5ca7_D20200201-20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-02-29</endDate>
        </period>
    </context>
    <context id="idaf43fbfb3db4fd9b03a187560479d16_D20200221-20200221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-21</startDate>
            <endDate>2020-02-21</endDate>
        </period>
    </context>
    <context id="i69fc50e94a814273a65f41128688da91_D20200221-20200221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sic:Z8880</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-21</startDate>
            <endDate>2020-02-21</endDate>
        </period>
    </context>
    <context id="i72449ec228e943259a39bc04a30d454e_D20200221-20200221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-21</startDate>
            <endDate>2020-02-21</endDate>
        </period>
    </context>
    <context id="ifc5a6d80e8124b0a8bd28950f9fab4f6_I20200221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-21</instant>
        </period>
    </context>
    <context id="i0dd0849c19e5445a8e3c4ff75cf420fe_D20200221-20200221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2020-02-21</startDate>
            <endDate>2020-02-21</endDate>
        </period>
    </context>
    <context id="i03c965967c7441e5b5bcfced0e7683c0_D20200221-20200221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-21</startDate>
            <endDate>2020-02-21</endDate>
        </period>
    </context>
    <context id="ief992a6b46384fde9bd18e611b58d86a_D20200428-20200428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">avdl:AmericanDepositarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-28</startDate>
            <endDate>2020-04-28</endDate>
        </period>
    </context>
    <context id="i0872a3688509439e8994fb7fcb662949_I20200428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">avdl:AmericanDepositarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-28</instant>
        </period>
    </context>
    <context id="icd0f3157ccaf401eb75302e497df671d_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="i25009cefa3684002b043b7c8af74ee8a_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="iae6e5465f9294b758b40203ccdae2d14_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="i5b077651731849bb9b0eddf0ad66d964_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="iebf3233476024b80bd208d93e82c7650_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9c016d73d5464ed1853cdbc6f93adae3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1d53c3a9d81648dfa5f09b49ada455d1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id1229a210a7f49d4bbb9220069f8160e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7d793592e3a9425abb3183a775c1d08e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i455e8146c8434385aa9ae98f6c5ed465_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iaea59e16245b4fe5ba425b805b97b872_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i430f2e5a391247ff991d3a3d8de0d7d8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i62b6ae12248b41dd9329f8af33aa447e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2880bd052c594c028d8ff7cb30be355f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">avdl:InducementPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i17b0b84673264785a47fb9c2393d8d97_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i12defb4ee11f4638be647bb1b2e8d3cd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3404683becd24bbaa99d0f9b831bc219_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i80fe8f6ade7440249243d34649acec04_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibc32436cac984c44acb451d8f53084cb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i542cb65bcac94725a2e85b1f9d50115f_D20170101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i43f3e0d370bf48618c4b4ffce4f20c85_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avdl:RestrictedShareAwardsGrantedToEmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i543086e15a0649c38d2ae050067cfe92_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avdl:RestrictedShareAwardsGrantsBeginningIn2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i9385e38dbc52477281fcde7e0e8243bf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avdl:FreeShareAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i60cd02301b0744718ab6232fc8397080_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avdl:FreeShareAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifa8fa276a1de4b9ea652bbce418a979a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avdl:FreeShareAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id51962221b6045adacaa762297fcce4c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avdl:FreeShareAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie4e4adc9bd9a43e4b7a14bed4eafeaaa_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avdl:FreeShareAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8ada9b293d7f49f393204ff4cdec742a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">avdl:VestUponTheAchievementOfCertainRegulatoryMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia69e39054ae948c9a9472b1618aee17c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">avdl:VestOneYearFollowingAchievementOfMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibcd77640185c41ca9d2ac2883e957c10_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8244f7a6941e41b6b0fc0fa1f31f090c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">avdl:VestUponAchievementOfCertainCorporateObjectivesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i213dddfe6eca46e9b836e9ed09ef1520_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">avdl:VestOneYearFollowingAchievementOfCertainCorporateObjectivesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4518f66a522647cd984ba59be675f8ce_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">avdl:VestUponAchievementOfCertainCorporateObjectivesBeingMetAndExceededMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i08ccab8f43964d778b6f1aa5700dd88f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie7b206dec3ef4b5d9ee30dd96c6c7208_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ice6e75c4e53f421694026f9bdc2f0a37_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1ea3506d4ee445e483ed272a81e24e72_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ief179786cb524ebfa29b22addb7be488_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">avdl:A2017AvadelEmployeeSharePurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifdf6a4240ce9425b9403a1273967c137_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">avdl:A2017AvadelEmployeeSharePurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icf6ce914e29a4f3d86cdf8ae44d7a965_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iebe32eeb9dbe40dbb43d30c6ba5c778b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ief750bd091b4462594bc83d332433361_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avdl:RestrictedShareAwardsGrantedFrom20172020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3e7e7087a91147f6a6c45f3da7e17949_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avdl:RestrictedShareAwardsGrantedFrom20172020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6def031541f3454daffd8bd55988af5e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avdl:RestrictedShareAwardsGrantedToEmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i97ce66e51f7346639c2f4447e25ce6b6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avdl:RestrictedShareAwardsGrantsBeginningIn2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">avdl:SharebasedCompensationAwardTrancheFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8998385242564cbfaaaf6433c863849d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ief47867d77194fa783312c489f06e3d5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i79413685d8144e178e42b28c2e99365b_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ieeed97785c574074863094742c31cea8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i474a662d5a374ab8b341858690d4bd8e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ica4213e299f9427b901f343c8c2b93e9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie6899b6aea474e37acddcb73ba8cdaef_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i00f270d697454afeb8bada6c69682df2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5a4d131f2ecc46778f5ed88f6d27c807_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i56a9ae7f277b43dc8ec524cd0712a41c_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i4eec0f5944eb41a387ea1b80154c9f6b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i575efbeda86d4caba5c559924eae6606_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5143455b68ee4952a8f2f5bd2395cc6b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7de80df209214ad6aec995ee651920e0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7560f23c3ff844359638f73f581206cd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:BloxiverzMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic58ebe2ec1a34491b83d98083867b7c2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:BloxiverzMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i15b58b8fae3c434ca88a14dfad44f1f9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:VazculepMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic8c719f27eb049d5b2f929f14a52769d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:VazculepMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic69cf75cdcb0443f8394a9f9f2b8481e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:AkovazMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i633dae8062544ae688cd05721bcc4684_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:AkovazMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id56837453cdf432dba648aaa4d2c9cf8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:OtherProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3fb31d32e89a42278408412283fc7bc7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:OtherProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i961305f8256144a0921c3dcb9f63da7a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">avdl:CustomerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia55f30e804be44cea8352288a384a9c3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">avdl:CustomerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i94e3ccf5ec9740e58837d91fdc1f7e3f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">avdl:CustomerBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6393bb62733a46eeb7ef3712baca37c8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">avdl:CustomerBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6170920a302f4c30b265cb1c3c9b5e4c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">avdl:CustomerCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibd0191dbbea742a0ad131c24b89d15dc_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">avdl:CustomerCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0359dc3ae57641d8a06f346eb996b112_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">avdl:CustomerDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5eca0785abb64ad4a7ba38ca114bffbd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">avdl:CustomerDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4efcd62648ae4318a25132f75b187f91_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">avdl:OtherCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i791518d5395c46a5a1dcb85211cb3fc0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">avdl:OtherCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i202d7516b2bd4304ad55b1aafeb6d3d5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i27b63bdbcab14d6eb97ff7f6e4f0a10c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie28cee2136b144d498b35733e7331556_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0bcaec4506f44e42ab5e37d5e0a7f18d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i78d0a8066299410fae55ee22a1483399_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia1133dde1f8446e48e8886c74d1845df_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ica869e44a5d747338f8da7c47e19f318_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6708f8d915264e56880479e22149d123_I20220316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-16</instant>
        </period>
    </context>
    <context id="i360019dcf2b1493e9e2047d365cd0d6f_I20220316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-16</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="rate">
        <measure>utr:Rate</measure>
    </unit>
    <unit id="day">
        <measure>avdl:day</measure>
    </unit>
    <unit id="segment">
        <measure>avdl:segment</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl80L2ZyYWc6MDliOTZkNWMzY2FkNGU0MWE2YjM3N2IxYjYwOTY2ZDQvdGFibGU6ZTA3YjAwYTYxZDRjNGYzMWE2YmM3ZDdiNDUxMTMxZTkvdGFibGVyYW5nZTplMDdiMDBhNjFkNGM0ZjMxYTZiYzdkN2I0NTExMzFlOV80LTEtMS0xLTIzNDU4_739c444b-a96f-4570-b728-a7bd003389ee">0001012477</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl80L2ZyYWc6MDliOTZkNWMzY2FkNGU0MWE2YjM3N2IxYjYwOTY2ZDQvdGFibGU6ZTA3YjAwYTYxZDRjNGYzMWE2YmM3ZDdiNDUxMTMxZTkvdGFibGVyYW5nZTplMDdiMDBhNjFkNGM0ZjMxYTZiYzdkN2I0NTExMzFlOV81LTEtMS0xLTIzNDU4_2ffbb74f-e386-4799-8da9-24a0a46fb1be">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl80L2ZyYWc6MDliOTZkNWMzY2FkNGU0MWE2YjM3N2IxYjYwOTY2ZDQvdGFibGU6ZTA3YjAwYTYxZDRjNGYzMWE2YmM3ZDdiNDUxMTMxZTkvdGFibGVyYW5nZTplMDdiMDBhNjFkNGM0ZjMxYTZiYzdkN2I0NTExMzFlOV82LTEtMS0xLTIzNDU4_e0416590-edc0-4873-99ae-58fd6a1be46d">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl80L2ZyYWc6MDliOTZkNWMzY2FkNGU0MWE2YjM3N2IxYjYwOTY2ZDQvdGFibGU6ZTA3YjAwYTYxZDRjNGYzMWE2YmM3ZDdiNDUxMTMxZTkvdGFibGVyYW5nZTplMDdiMDBhNjFkNGM0ZjMxYTZiYzdkN2I0NTExMzFlOV83LTEtMS0xLTIzNDU4_c04c4da7-6c3a-4203-81ff-af7c5b6e45d5">2021</dei:DocumentFiscalYearFocus>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMTktMC0xLTEtMzUzMDQ_f56fced8-8277-4fc5-853a-d6b09d65d5dd">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate202006Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <avdl:DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm
      contextRef="i6d1b0f4826d84816aa9460ece5298de4_D20200630-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzQwNg_d7d1bf58-ccde-4c16-a6b6-573abd462bd2">P10M</avdl:DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i91742d6730614741949177cbcf4302d6_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90ZXh0cmVnaW9uOjIyMGM2MjEzZTI4YTQ4YTU5NDMyYzkzOTY1NjcxODAyXzY2OQ_ea03d613-a2cf-479a-bdb9-ee92938c3329">P2Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <avdl:DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted
      contextRef="i911b1d37c6734cba9182382fa4082eed_D20180216-20180216"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzIzMjM_cdb5c14c-1181-4685-9a23-0a0887188621">P5D</avdl:DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted>
    <avdl:DebtInstrumentConvertibleThresholdConsecutiveBusinessDays
      contextRef="i911b1d37c6734cba9182382fa4082eed_D20180216-20180216"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzIzNjg_cdf18a29-792e-43e1-baa4-c68eb2cf6a76">P5D</avdl:DebtInstrumentConvertibleThresholdConsecutiveBusinessDays>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="ief750bd091b4462594bc83d332433361_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTQvZnJhZzo5OWYwMTc3ZjI0YWU0ZDZkOTgxZjA5OWNkNGNkZTY0ZS90ZXh0cmVnaW9uOjk5ZjAxNzdmMjRhZTRkNmQ5ODFmMDk5Y2Q0Y2RlNjRlXzEyNjQ0MzgzNzIwMTM3_4aef4419-c0e6-40b5-8d2b-bcc54c123d28"
      unitRef="number">0.67</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i3e7e7087a91147f6a6c45f3da7e17949_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTQvZnJhZzo5OWYwMTc3ZjI0YWU0ZDZkOTgxZjA5OWNkNGNkZTY0ZS90ZXh0cmVnaW9uOjk5ZjAxNzdmMjRhZTRkNmQ5ODFmMDk5Y2Q0Y2RlNjRlXzEyNjQ0MzgzNzIwMTQ2_f728c597-c404-441b-a75d-65c390a30101"
      unitRef="number">0.33</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i6def031541f3454daffd8bd55988af5e_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTQvZnJhZzo5OWYwMTc3ZjI0YWU0ZDZkOTgxZjA5OWNkNGNkZTY0ZS90ZXh0cmVnaW9uOjk5ZjAxNzdmMjRhZTRkNmQ5ODFmMDk5Y2Q0Y2RlNjRlXzEyNjQ0MzgzNzIwMTU1_1f474040-349b-4bdd-8b5f-15354086971f"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i97ce66e51f7346639c2f4447e25ce6b6_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTQvZnJhZzo5OWYwMTc3ZjI0YWU0ZDZkOTgxZjA5OWNkNGNkZTY0ZS90ZXh0cmVnaW9uOjk5ZjAxNzdmMjRhZTRkNmQ5ODFmMDk5Y2Q0Y2RlNjRlXzEyNjQ0MzgzNzIwMTY2_54032740-53b5-4848-8dfb-efc3e6bfc418"
      unitRef="number">0.33</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <dei:DocumentType
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDM2_763c8d76-e419-41a9-9626-4547e8caa7e5">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDM3_6fca0d8d-787b-4513-bb2d-4ad7325d9e67">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl8yMDE_418155ac-bb00-45dc-b6b3-184439c0c4c2">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl8yMDE_4e7639b6-d6f7-4d03-8778-1803cf241b2b">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDI5_fe4bd0ba-53a2-4e14-a8fb-e0bf5140487c">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDMw_c665f155-bb53-406b-8d48-e999de70183b">001-37977</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDM4_fe2b1500-7aee-4896-811d-476d74541490">AVADEL PHARMACEUTICALS PLC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6YzBhNzgyOTdjNjY2NDM0Mzk5NGIxZDMzOTk0ODNjNjEvdGFibGVyYW5nZTpjMGE3ODI5N2M2NjY0MzQzOTk0YjFkMzM5OTQ4M2M2MV8wLTAtMS0xLTIzNDU4_fce14099-05be-407a-9905-9a405aa497fe">L2</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6YzBhNzgyOTdjNjY2NDM0Mzk5NGIxZDMzOTk0ODNjNjEvdGFibGVyYW5nZTpjMGE3ODI5N2M2NjY0MzQzOTk0YjFkMzM5OTQ4M2M2MV8wLTItMS0xLTIzNDU4_df999b46-6d4c-47c5-ae3e-0e9ec8d52344">98-1341933</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6YzBhNzgyOTdjNjY2NDM0Mzk5NGIxZDMzOTk0ODNjNjEvdGFibGVyYW5nZTpjMGE3ODI5N2M2NjY0MzQzOTk0YjFkMzM5OTQ4M2M2MV8zLTAtMS0xLTIzNDU4L3RleHRyZWdpb246MTBlNTUyZmNmOWUzNGExOWFiZTM5MTY0NzRmNzFlNmJfNA_f91d6332-1096-4607-a2fd-062c59cd1e9f">10 Earlsfort Terrace</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6YzBhNzgyOTdjNjY2NDM0Mzk5NGIxZDMzOTk0ODNjNjEvdGFibGVyYW5nZTpjMGE3ODI5N2M2NjY0MzQzOTk0YjFkMzM5OTQ4M2M2MV8zLTAtMS0xLTIzNDU4L3RleHRyZWdpb246MTBlNTUyZmNmOWUzNGExOWFiZTM5MTY0NzRmNzFlNmJfNw_8d2452ec-ffc9-4480-81a4-6f2c120e1049">Dublin 2</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6YzBhNzgyOTdjNjY2NDM0Mzk5NGIxZDMzOTk0ODNjNjEvdGFibGVyYW5nZTpjMGE3ODI5N2M2NjY0MzQzOTk0YjFkMzM5OTQ4M2M2MV8zLTAtMS0xLTIzNDU4L3RleHRyZWdpb246MTBlNTUyZmNmOWUzNGExOWFiZTM5MTY0NzRmNzFlNmJfMTE_b47aeb3c-c44f-4800-ad22-052de252da05">IE</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6YzBhNzgyOTdjNjY2NDM0Mzk5NGIxZDMzOTk0ODNjNjEvdGFibGVyYW5nZTpjMGE3ODI5N2M2NjY0MzQzOTk0YjFkMzM5OTQ4M2M2MV8zLTAtMS0xLTIzNDU4L3RleHRyZWdpb246MTBlNTUyZmNmOWUzNGExOWFiZTM5MTY0NzRmNzFlNmJfMTQ_d5b87581-67c2-4278-a59f-d93d6585d4be">D02 T380</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6YzBhNzgyOTdjNjY2NDM0Mzk5NGIxZDMzOTk0ODNjNjEvdGFibGVyYW5nZTpjMGE3ODI5N2M2NjY0MzQzOTk0YjFkMzM5OTQ4M2M2MV82LTAtMS0xLTIzNDU4L3RleHRyZWdpb246MmQ3MjViNDVhNGVjNDNiZDllNGUwM2I4OWM2Mjk2NGFfNjE_c44a6b89-a880-4ffc-9dea-48c841e65ebf">1</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6YzBhNzgyOTdjNjY2NDM0Mzk5NGIxZDMzOTk0ODNjNjEvdGFibGVyYW5nZTpjMGE3ODI5N2M2NjY0MzQzOTk0YjFkMzM5OTQ4M2M2MV82LTAtMS0xLTIzNDU4L3RleHRyZWdpb246MmQ3MjViNDVhNGVjNDNiZDllNGUwM2I4OWM2Mjk2NGFfNjQ_6129414b-ba1f-469c-bbf5-d1b84421cd0a">901-5201</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i3840421dd70d40aba8c9dc8a0052f33e_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6OGI4ZWM3OWU3Njg1NGRmZGFjZDIzOTFkZDU3OTVkZDUvdGFibGVyYW5nZTo4YjhlYzc5ZTc2ODU0ZGZkYWNkMjM5MWRkNTc5NWRkNV8xLTAtMS0xLTIzNDU4_c0230a3e-bbb7-4ec0-baf0-795cd07a730f">American Depositary Shares*</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i3840421dd70d40aba8c9dc8a0052f33e_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6OGI4ZWM3OWU3Njg1NGRmZGFjZDIzOTFkZDU3OTVkZDUvdGFibGVyYW5nZTo4YjhlYzc5ZTc2ODU0ZGZkYWNkMjM5MWRkNTc5NWRkNV8xLTEtMS0xLTIzNDU4_66d75bb5-17e5-437e-956a-c93da44a8704">AVDL</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i3840421dd70d40aba8c9dc8a0052f33e_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6OGI4ZWM3OWU3Njg1NGRmZGFjZDIzOTFkZDU3OTVkZDUvdGFibGVyYW5nZTo4YjhlYzc5ZTc2ODU0ZGZkYWNkMjM5MWRkNTc5NWRkNV8xLTItMS0xLTIzNDU4_30c69c1b-e71e-438f-9b61-49113535d566">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i370907e69e7f449e958e11d58db5bf21_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6OGI4ZWM3OWU3Njg1NGRmZGFjZDIzOTFkZDU3OTVkZDUvdGFibGVyYW5nZTo4YjhlYzc5ZTc2ODU0ZGZkYWNkMjM5MWRkNTc5NWRkNV8yLTAtMS0xLTIzNDU4_72d14d56-6a7b-4550-b46a-f2a006a2c390">Ordinary Shares, nominal value $0.01 per share**</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i370907e69e7f449e958e11d58db5bf21_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6OGI4ZWM3OWU3Njg1NGRmZGFjZDIzOTFkZDU3OTVkZDUvdGFibGVyYW5nZTo4YjhlYzc5ZTc2ODU0ZGZkYWNkMjM5MWRkNTc5NWRkNV8yLTEtMS0xLTIzNDU4_287fd018-5636-44f8-b5f1-82e2f8afda8e">AVDL</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i370907e69e7f449e958e11d58db5bf21_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGFibGU6OGI4ZWM3OWU3Njg1NGRmZGFjZDIzOTFkZDU3OTVkZDUvdGFibGVyYW5nZTo4YjhlYzc5ZTc2ODU0ZGZkYWNkMjM5MWRkNTc5NWRkNV8yLTItMS0xLTIzNDU4_b3ddd837-267c-45a2-bfde-976471fff22e">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDQz_0a99b907-3d16-439f-9676-b1d5bf54a3df">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDM5_980bdedf-ba46-4a99-942b-1b04ca608500">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDQw_4674a3c5-6559-4519-a257-6bfc90fefb86">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDQ0_9bc9c3fe-7658-4d1f-85b8-0642706fd2f7">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDQ1_d5177634-d44b-4f71-a614-5a933e6cf1fb">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDMx_1aaea427-3287-4a4e-87a7-d6086c452a3b">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDMy_21f2c496-6281-4516-b44d-0d220bf26e66">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDM0_7a4b251e-e3fd-4b4b-a0a9-97c31fa61884">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDMz_2a45192c-9bd4-45fa-9469-374221bc94f3">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="ia143361add2b4e9c93fd4b3b2019fefd_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl8yOTk2_08fd7379-a736-4cf9-b5ce-9b0d70fcb8b1"
      unitRef="usd">390167685</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ie534be6ccea84023a1ded40a74cfac08_I20220311"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl8zNzQ0_b0aab1e8-fb6e-4d15-9453-22d2ba3487a3"
      unitRef="shares">59032237</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xL2ZyYWc6MTQ0OTM2OWVjYzYwNDRiMGJmZjlkNzRkODRmOGQxZTYvdGV4dHJlZ2lvbjoxNDQ5MzY5ZWNjNjA0NGIwYmZmOWQ3NGQ4NGY4ZDFlNl80MDM1_978a36cb-23a1-4808-bb00-07da830c63cb">Portions of either (a)&#160;a definitive proxy statement involving the election of directors or (b)&#160;an amendment to this Form&#160;10-K, either of which will be filed within 120 days after December&#160;31, 2021, are incorporated by reference into Part&#160;III of this Form 10-K.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMy0yLTEtMS0yMzQ1OA_ce6ddac4-757d-4aee-8653-11d5445ef62f"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMy00LTEtMS0yMzQ1OA_ffe5aad9-edf6-4690-a8ff-742d7d6f07bf"
      unitRef="usd">22334000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMy02LTEtMS0yMzQ1OA_33532a69-b006-452f-98bd-6cd2c9dbc2a4"
      unitRef="usd">59215000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfNy0yLTEtMS0yMzQ1OA_7adca47e-ca0c-4776-8920-85ab5617bbaa"
      unitRef="usd">0</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfNy00LTEtMS0yMzQ1OA_40740739-f5cd-4056-b6fd-6619d1dc995b"
      unitRef="usd">5742000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfNy02LTEtMS0yMzQ1OA_49702d03-62ee-40e3-8ee3-35f14dc62a70"
      unitRef="usd">12125000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfOC0yLTEtMS0yMzQ1OA_6afcbe0c-a1d0-4283-9fba-79e40811b4ff"
      unitRef="usd">17104000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfOC00LTEtMS0yMzQ1OA_4e2aec7c-7d62-44e5-b627-e53bfaf7f2fc"
      unitRef="usd">20442000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfOC02LTEtMS0yMzQ1OA_820ce2d8-2319-4197-81ae-22ba52a554a4"
      unitRef="usd">32917000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfOS0yLTEtMS0yMzQ1OA_4a34d226-fc16-4e3f-80e3-75a4adcc56c0"
      unitRef="usd">68495000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfOS00LTEtMS0yMzQ1OA_b1407bc1-0a7a-4142-9ede-8c992832077d"
      unitRef="usd">32405000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfOS02LTEtMS0yMzQ1OA_254f1f5d-d214-4964-898c-f3f432757d8e"
      unitRef="usd">30183000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTAtMi0xLTEtMjM0NTg_80fcc84d-2729-4da2-8a13-aeb27235ca7a"
      unitRef="usd">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTAtNC0xLTEtMjM0NTg_3360190a-10d9-4377-96f0-73184268acd3"
      unitRef="usd">406000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTAtNi0xLTEtMjM0NTg_eeddfe63-7dab-4537-95d9-c0a3ac94bcd2"
      unitRef="usd">816000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTEtMi0xLTEtMjM0NTg_e1fdd64d-e5b9-4edb-b794-5ee02b23a55e"
      unitRef="usd">0</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTEtNC0xLTEtMjM0NTg_f2b5248c-a05d-4e10-9af4-312334ffcaec"
      unitRef="usd">3327000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTEtNi0xLTEtMjM0NTg_4a650525-9436-413d-9d1b-2f1244342950"
      unitRef="usd">845000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTItMi0xLTEtMjM0NTg_75deae66-5902-40e7-8211-f85aa3b2b35a"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTItNC0xLTEtMjM0NTg_aed9c5f6-97b9-436f-abea-c70f22717781"
      unitRef="usd">45760000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTItNi0xLTEtMjM0NTg_a70af2fc-5a0e-437d-8f56-84a0f888a2da"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <avdl:RestructuringCostsNet
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTQtMi0xLTEtMjM0NTg_436f44ba-a482-4536-864c-c740dbad18a4"
      unitRef="usd">-53000</avdl:RestructuringCostsNet>
    <avdl:RestructuringCostsNet
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTQtNC0xLTEtMjM0NTg_1d72ade6-07d1-4338-8ad2-6c313867f52e"
      unitRef="usd">-43000</avdl:RestructuringCostsNet>
    <avdl:RestructuringCostsNet
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTQtNi0xLTEtMjM0NTg_25a7882b-3fd3-49d1-890a-316a0874e1e6"
      unitRef="usd">6441000</avdl:RestructuringCostsNet>
    <us-gaap:CostsAndExpenses
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTUtMi0xLTEtMjM0NTg_6876690e-2e98-4ffa-b7f0-4cf89313009e"
      unitRef="usd">85546000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTUtNC0xLTEtMjM0NTg_9f15243f-4362-4d77-b0f7-96c04763a59e"
      unitRef="usd">16519000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTUtNi0xLTEtMjM0NTg_aa0bb5b5-f15a-4c3f-b4ff-3dfba559b37c"
      unitRef="usd">83327000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTYtMi0xLTEtMjM0NTg_b38245f7-b0dd-4634-8479-9a81fac14932"
      unitRef="usd">-85546000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTYtNC0xLTEtMjM0NTg_946098b7-a0f3-4b88-ab8c-0959e3fdd008"
      unitRef="usd">5815000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTYtNi0xLTEtMjM0NTg_434201af-7e25-42ff-8ef2-55b3d28bdb81"
      unitRef="usd">-24112000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeNet
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTctMi0xLTEtMjM0NTg_773ca4e0-eb6f-4cdd-a472-6a57946c6e4d"
      unitRef="usd">2126000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTctNC0xLTEtMjM0NTg_4fccb353-6615-47bc-8258-9dd85d7bb7f3"
      unitRef="usd">-832000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTctNi0xLTEtMjM0NTg_041558f7-51ec-414c-a915-bf651e4d85d5"
      unitRef="usd">1069000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InterestExpense
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTgtMi0xLTEtMjM0NTg_846f874f-2f82-4390-8e0e-be7e08739a51"
      unitRef="usd">9942000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTgtNC0xLTEtMjM0NTg_81417cfb-cf51-4ab5-b056-daef5495a492"
      unitRef="usd">12994000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTgtNi0xLTEtMjM0NTg_3ad503ec-0695-4732-9749-9956d7210f83"
      unitRef="usd">12483000</us-gaap:InterestExpense>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTktMi0xLTEtMjM0NTg_13afc7dc-7200-4499-9e99-20c42ae4c09f"
      unitRef="usd">217000</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTktNC0xLTEtMjM0NTg_f5d17358-3ec8-4f2e-b033-7a1561f49bfa"
      unitRef="usd">3364000</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMTktNi0xLTEtMjM0NTg_56714497-8409-43c9-aaa1-2357ba17be3f"
      unitRef="usd">0</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjAtMi0xLTEtMjM0NTg_6f866395-7888-4874-88e1-352c02bf4621"
      unitRef="usd">0</us-gaap:DeconsolidationGainOrLossAmount>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjAtNC0xLTEtMjM0NTg_cb707196-398e-4f56-8c80-71d1a3cab185"
      unitRef="usd">0</us-gaap:DeconsolidationGainOrLossAmount>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjAtNi0xLTEtMjM0NTg_de073e68-da20-4bdb-9779-a0c4c78d0371"
      unitRef="usd">-2678000</us-gaap:DeconsolidationGainOrLossAmount>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjEtMi0xLTEtMjM0NTg_0c5c5640-161c-4b6c-acbe-b4470d144ac4"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjEtNC0xLTEtMjM0NTg_c4507cc6-c396-4664-9803-5ab80bd8ba59"
      unitRef="usd">-435000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjEtNi0xLTEtMjM0NTg_aadfc264-8f17-42c3-ae2a-fe4adcaa45ee"
      unitRef="usd">-378000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjItMi0xLTEtMjM0NTg_ac665b0a-be52-4e39-8eaf-cdbf1c10ecd0"
      unitRef="usd">-93145000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjItNC0xLTEtMjM0NTg_728aeca4-8dda-45bb-b4eb-a0508c64cb34"
      unitRef="usd">-5082000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjItNi0xLTEtMjM0NTg_fb4821b0-ea0a-4221-8164-e82826983234"
      unitRef="usd">-38582000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjMtMi0xLTEtMjM0NTg_9c9e7f84-a770-40c3-a716-e14c8584458a"
      unitRef="usd">-15816000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjMtNC0xLTEtMjM0NTg_85aa433b-4220-4ddc-8ff4-63968b905370"
      unitRef="usd">-12110000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjMtNi0xLTEtMjM0NTg_f623a896-1d5b-492b-bf31-1cb72f8f39dd"
      unitRef="usd">-5356000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjYtMi0xLTEtMjM0NTg_dd26b39b-1540-4eae-b115-f67cd63ee33a"
      unitRef="usd">-77329000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjYtNC0xLTEtMjM0NTg_0f9fcf0d-8446-4cf1-bc54-2e8fde1f3da7"
      unitRef="usd">7028000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMjYtNi0xLTEtMjM0NTg_45f57a9f-0ae8-4a44-bb6e-e32e333683dd"
      unitRef="usd">-33226000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMzEtMi0xLTEtMjM0NTg_1c4adb6e-fa25-47b5-a3fa-6180e3d0f685"
      unitRef="usdPerShare">-1.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMzEtNC0xLTEtMjM0NTg_7e2d926c-8d3f-448d-9dd1-07e105f99428"
      unitRef="usdPerShare">0.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMzEtNi0xLTEtMjM0NTg_4fa46bda-3e09-45ae-a2a7-0e47919b8a80"
      unitRef="usdPerShare">-0.89</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMzYtMi0xLTEtMjM0NTg_016f5f54-5669-4d64-8542-8a26bea8dfb4"
      unitRef="usdPerShare">-1.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMzYtNC0xLTEtMjM0NTg_bed05b4f-0b12-45f6-b24b-7c69a2c4e2ff"
      unitRef="usdPerShare">0.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMzYtNi0xLTEtMjM0NTg_fd935f7d-3d0a-43ea-bcf6-baca83bc3d0e"
      unitRef="usdPerShare">-0.89</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMzgtMi0xLTEtMjM0NTg_e8f41144-ea9c-42a0-b62f-c4518d60c2cd"
      unitRef="shares">58535000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMzgtNC0xLTEtMjM0NTg_cad0d07d-beb2-4319-a354-535f4ed7eeac"
      unitRef="shares">52996000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMzgtNi0xLTEtMjM0NTg_411037d4-eb31-46d2-a8a8-021d35b42b65"
      unitRef="shares">37403000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMzktMi0xLTEtMjM0NTg_61c2a76f-59ab-46d8-8c81-97a3976afeaf"
      unitRef="shares">58535000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMzktNC0xLTEtMjM0NTg_0faa45a1-0703-404b-8f78-1337e98ce046"
      unitRef="shares">54941000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83My9mcmFnOmM3NWIyNjg0ZDM5YTQxZGE4MDNiMTU2YTNjZTc4Y2QzL3RhYmxlOjA0OWFjODNmNTEyNTQ0N2NhMDJmM2Y0MmU5MDNhODNhL3RhYmxlcmFuZ2U6MDQ5YWM4M2Y1MTI1NDQ3Y2EwMmYzZjQyZTkwM2E4M2FfMzktNi0xLTEtMjM0NTg_00ec8023-14f8-4c3d-8b45-2cc7551d593a"
      unitRef="shares">37403000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfMi0yLTEtMS0yMzQ1OA_b448c81c-8357-44f2-b591-87512d106943"
      unitRef="usd">-77329000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfMi00LTEtMS0yMzQ1OA_f7f059ff-d616-4d9b-84d5-1feb0d7ec0d6"
      unitRef="usd">7028000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfMi02LTEtMS0yMzQ1OA_356ed94d-08cb-4707-ac16-f6d7c5c7e10b"
      unitRef="usd">-33226000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNC0yLTEtMS0yMzQ1OA_4e97cd06-b268-41e2-9185-2c0ca71b1197"
      unitRef="usd">-1228000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNC00LTEtMS0yMzQ1OA_30221201-bda0-4872-9e88-0db967e5c657"
      unitRef="usd">1111000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNC02LTEtMS0yMzQ1OA_bf9018c7-025d-4490-afc6-4cc36019e953"
      unitRef="usd">-117000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNS0wLTEtMS0yMzQ1OC90ZXh0cmVnaW9uOmQzZmE2NzZjNzc4MTQyMzViZGVlODhlNjZhYWMzM2NkXzQz_356cbfd1-ecad-402e-8027-f15cd072ced3"
      unitRef="usd">214000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNS0wLTEtMS0yMzQ1OC90ZXh0cmVnaW9uOmQzZmE2NzZjNzc4MTQyMzViZGVlODhlNjZhYWMzM2NkXzQ3_b99f0d85-5126-478d-a598-f9e623f03aab"
      unitRef="usd">-202000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNS0wLTEtMS0yMzQ1OC90ZXh0cmVnaW9uOmQzZmE2NzZjNzc4MTQyMzViZGVlODhlNjZhYWMzM2NkXzUx_eee60a6e-bed3-4cdf-aa34-b03e70b6349d"
      unitRef="usd">-43000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNS0yLTEtMS0yMzQ1OA_00355a43-b136-4aa2-a97e-1fa0d0e174b4"
      unitRef="usd">-1661000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNS00LTEtMS0yMzQ1OA_d0f4d08a-ade7-44db-81ae-7a9f4c3098d4"
      unitRef="usd">644000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNS02LTEtMS0yMzQ1OA_ffb721bf-4fa8-42b1-94ae-d97862624f2f"
      unitRef="usd">727000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNi0yLTEtMS0yMzQ1OA_39a120f9-8844-443e-aeb3-2b7aa5994539"
      unitRef="usd">-2889000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNi00LTEtMS0yMzQ1OA_0ecab2ce-9c0a-4974-a7ed-20dfe7650ce9"
      unitRef="usd">1755000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNi02LTEtMS0yMzQ1OA_1ff8210f-0ca0-4cec-ae37-404ceee0e068"
      unitRef="usd">610000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNy0yLTEtMS0yMzQ1OA_0ebceecf-8895-4678-9cf6-1dc7a7ff1c2f"
      unitRef="usd">-80218000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNy00LTEtMS0yMzQ1OA_009f2dc2-5c37-4c92-b23e-860af4a164f9"
      unitRef="usd">8783000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83Ni9mcmFnOmFhMGRmZmNiNjdiYzQzNjNhNjE0ZjUxYjljMmY5NGU1L3RhYmxlOjg1MjBkYWJjNTgyMjQ2MjA4MDFiY2QyNDMyYzBkMTI4L3RhYmxlcmFuZ2U6ODUyMGRhYmM1ODIyNDYyMDgwMWJjZDI0MzJjMGQxMjhfNy02LTEtMS0yMzQ1OA_80a1546a-9011-4f97-af62-52bdb0a2bced"
      unitRef="usd">-32616000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfNC0yLTEtMS0yMzQ1OA_7fb436cf-fc08-4f7f-a9dd-0ef40a9898aa"
      unitRef="usd">50708000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfNC00LTEtMS0yMzQ1OA_59de3b20-306e-4d3b-ad0e-998bb04d4bea"
      unitRef="usd">71722000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfNS0yLTEtMS0yMzQ1OA_0cbd972b-39d2-497d-95fa-7f385fa90d6d"
      unitRef="usd">106513000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfNS00LTEtMS0yMzQ1OA_1d403aa8-7be5-4cac-9d5b-ba9a63caa039"
      unitRef="usd">149680000</us-gaap:MarketableSecuritiesCurrent>
    <avdl:ResearchAndDevelopmentTaxCreditReceivableCurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfOC0yLTEtMS0yMzQ1OA_a80069a1-c602-4aad-a763-4147c8d289cd"
      unitRef="usd">2443000</avdl:ResearchAndDevelopmentTaxCreditReceivableCurrent>
    <avdl:ResearchAndDevelopmentTaxCreditReceivableCurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfOC00LTEtMS0yMzQ1OA_64ed633f-4531-496f-bd17-004de84b8ede"
      unitRef="usd">3326000</avdl:ResearchAndDevelopmentTaxCreditReceivableCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfOS0yLTEtMS0yMzQ1OA_d9b2ce67-f8a4-4f01-a321-e13cad5c5e99"
      unitRef="usd">32826000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfOS00LTEtMS0yMzQ1OA_36e2410b-59bf-43c1-9391-84a72a28ef63"
      unitRef="usd">38726000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTAtMi0xLTEtMjM0NTg_29c97992-e664-4b27-81b9-aafe047390f7"
      unitRef="usd">192490000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTAtNC0xLTEtMjM0NTg_a1d68f31-1efd-4c59-99a5-ebb130a649ca"
      unitRef="usd">263454000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTEtMi0xLTEtMjM0NTg_96397f94-e6a1-4dbd-976f-8ec6f78e3e7f"
      unitRef="usd">285000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTEtNC0xLTEtMjM0NTg_6fa776b4-dd2f-4247-bfbe-9be54e00b338"
      unitRef="usd">359000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTItMi0xLTEtMjM0NTg_f2108093-7edc-49a1-b721-6d300d778f7e"
      unitRef="usd">2652000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTItNC0xLTEtMjM0NTg_496ad562-1ba8-451b-9187-89ba7736e767"
      unitRef="usd">2604000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTMtMi0xLTEtMjM0NTg_60ccc910-65f6-4295-8cd3-d73b18f5462a"
      unitRef="usd">16836000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTMtNC0xLTEtMjM0NTg_a2c21d25-ed9c-4fb8-a114-04e394d6ebc4"
      unitRef="usd">16836000</us-gaap:Goodwill>
    <avdl:ResearchAndDevelopmentTaxCreditReceivableNonCurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTUtMi0xLTEtMjM0NTg_d1c7e07f-0ee2-49be-80cf-74545c0b7a32"
      unitRef="usd">1225000</avdl:ResearchAndDevelopmentTaxCreditReceivableNonCurrent>
    <avdl:ResearchAndDevelopmentTaxCreditReceivableNonCurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTUtNC0xLTEtMjM0NTg_fc274dbf-2056-4be0-bb7b-a114bd4b5bd4"
      unitRef="usd">3445000</avdl:ResearchAndDevelopmentTaxCreditReceivableNonCurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTYtMi0xLTEtMjM0NTg_88b32373-d378-48a9-b0e4-4236672c2f9b"
      unitRef="usd">33777000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTYtNC0xLTEtMjM0NTg_9eed8edd-b106-4d12-bdf9-1d06f5690b9e"
      unitRef="usd">24939000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTctMi0xLTEtMjM0NTg_8e4aca89-babf-4a45-8cab-18e05a38734b"
      unitRef="usd">247265000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMTctNC0xLTEtMjM0NTg_01363df4-93fa-4bde-969c-f31daa46362b"
      unitRef="usd">311637000</us-gaap:Assets>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMjMtMi0xLTEtMjM0NTg_25cfd72c-0710-440d-9ec1-7c00ad3e6128"
      unitRef="usd">900000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMjMtNC0xLTEtMjM0NTg_35c2bad9-3f20-4f5f-821f-9b44bd06530e"
      unitRef="usd">474000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMjQtMi0xLTEtMjM0NTg_4862be8c-39ae-4856-adaf-e0e95dbe6c95"
      unitRef="usd">7679000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMjQtNC0xLTEtMjM0NTg_fe179210-e5bf-45a3-972d-65f94b4bf274"
      unitRef="usd">2934000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMjUtMi0xLTEtMjM0NTg_7026adba-6ecb-4569-b022-73ba143dc61f"
      unitRef="usd">7151000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMjUtNC0xLTEtMjM0NTg_11b7d5bc-6bd5-45a8-87ba-86992660313b"
      unitRef="usd">6501000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMjctMi0xLTEtMjM0NTg_3dc101b0-2490-404c-b2aa-cd791e356dae"
      unitRef="usd">5270000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMjctNC0xLTEtMjM0NTg_afa0597d-2dcd-4a37-b21d-102c0bfe0877"
      unitRef="usd">5200000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMjgtMi0xLTEtMjM0NTg_4871dc5e-8983-4f55-ab7e-fcbe63c4d904"
      unitRef="usd">21000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMjgtNC0xLTEtMjM0NTg_f900d332-e276-416a-b7b7-40bc279245db"
      unitRef="usd">15109000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMjktMi0xLTEtMjM0NTg_180d1672-f9cb-4073-964d-3b4890e5a0c2"
      unitRef="usd">142397000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMjktNC0xLTEtMjM0NTg_a101ccab-d8d7-41aa-ac36-298df062f28f"
      unitRef="usd">128210000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzEtMi0xLTEtMjM0NTg_55331d22-2b6c-4c10-9e85-0800a3be447e"
      unitRef="usd">1707000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzEtNC0xLTEtMjM0NTg_20bad181-868b-49d4-b583-6789aa47df93"
      unitRef="usd">1840000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzItMi0xLTEtMjM0NTg_25020244-e3e6-4142-baad-23bc1a803cfe"
      unitRef="usd">3917000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzItNC0xLTEtMjM0NTg_6303ec4d-943a-4549-9c92-f8b9f37da2bf"
      unitRef="usd">4212000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzMtMi0xLTEtMjM0NTg_86c6508e-8e94-48b5-a490-7838072034d8"
      unitRef="usd">169021000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzMtNC0xLTEtMjM0NTg_2208c218-9973-4a60-bd04-8c2cc651e5d3"
      unitRef="usd">149371000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzYtMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo4N2EwOTlkNmU0MGQ0NjkxOTc5OTczYzExZGNlZmU5Yl8zOQ_76d23339-9c73-41ba-8c72-2fd2c48ef5cb"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzYtMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo4N2EwOTlkNmU0MGQ0NjkxOTc5OTczYzExZGNlZmU5Yl8zOQ_c4704952-904f-4f4b-9286-888cd4d16168"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzYtMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo4N2EwOTlkNmU0MGQ0NjkxOTc5OTczYzExZGNlZmU5Yl81Mw_2f82829e-4cd6-4316-9ede-7be8e4c334b4"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzYtMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo4N2EwOTlkNmU0MGQ0NjkxOTc5OTczYzExZGNlZmU5Yl81Mw_8ed5a6ab-277d-499d-a2d3-342ffbea2b3a"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzYtMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo4N2EwOTlkNmU0MGQ0NjkxOTc5OTczYzExZGNlZmU5Yl83NQ_35d1f159-81be-4f1b-80b9-52818ff5f30f"
      unitRef="shares">488000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzYtMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo4N2EwOTlkNmU0MGQ0NjkxOTc5OTczYzExZGNlZmU5Yl83NQ_54e90d3b-13bf-460e-9ba5-1c79a6cf535c"
      unitRef="shares">488000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzYtMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo4N2EwOTlkNmU0MGQ0NjkxOTc5OTczYzExZGNlZmU5Yl83NQ_bfbff1c3-6010-47cd-a2ce-626b503f7516"
      unitRef="shares">488000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzYtMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo4N2EwOTlkNmU0MGQ0NjkxOTc5OTczYzExZGNlZmU5Yl83NQ_c4b04cf3-eedf-4648-9862-bf5f567f016e"
      unitRef="shares">488000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzYtMi0xLTEtMjM0NTg_7893b29e-2989-442b-962a-820ef66f7db8"
      unitRef="usd">5000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzYtNC0xLTEtMjM0NTg_7e26b15c-8d28-4aca-a108-5ab9d1eba42a"
      unitRef="usd">5000</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzctMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo5MTVhZDQyODE3ZmM0MWUxODMyMzBkNmRiMDkwZGQ2OF8zOA_7497b81e-2537-4ba4-bb1a-0316481773cb"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzctMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo5MTVhZDQyODE3ZmM0MWUxODMyMzBkNmRiMDkwZGQ2OF8zOA_b0d9e9e9-f35c-4919-9413-4c54dcd87691"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzctMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo5MTVhZDQyODE3ZmM0MWUxODMyMzBkNmRiMDkwZGQ2OF81Mg_305646c4-e9b4-4646-afe0-9d7fff2bfad4"
      unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzctMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo5MTVhZDQyODE3ZmM0MWUxODMyMzBkNmRiMDkwZGQ2OF81Mg_85d9458f-da1d-4f99-b52a-81bcb01fe419"
      unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzctMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo5MTVhZDQyODE3ZmM0MWUxODMyMzBkNmRiMDkwZGQ2OF83NA_31e2ea49-3098-450d-93cd-2dfe381d3b81"
      unitRef="shares">58620000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzctMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo5MTVhZDQyODE3ZmM0MWUxODMyMzBkNmRiMDkwZGQ2OF83NA_6a8b3dec-1381-485e-924f-89d9488e311d"
      unitRef="shares">58620000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzctMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo5MTVhZDQyODE3ZmM0MWUxODMyMzBkNmRiMDkwZGQ2OF8xMjY_1a17f8fe-aef1-46f0-800f-fefea375add0"
      unitRef="shares">58396000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzctMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo5MTVhZDQyODE3ZmM0MWUxODMyMzBkNmRiMDkwZGQ2OF8xMjY_ea5c1ae1-e8c0-4062-b987-9a2078a5ea69"
      unitRef="shares">58396000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzctMi0xLTEtMjM0NTg_16ebfa0f-1f16-43a5-ae0c-e14c541372e4"
      unitRef="usd">586000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzctNC0xLTEtMjM0NTg_236772d7-5031-4927-aff8-397013135b7f"
      unitRef="usd">583000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzktMi0xLTEtMjM0NTg_4b5dfae4-e5d5-4e99-b1af-836d378a007a"
      unitRef="usd">549349000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfMzktNC0xLTEtMjM0NTg_2716d762-7a00-4317-9965-e8dac9bccd29"
      unitRef="usd">566916000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfNDAtMi0xLTEtMjM0NTg_c548942f-9f3e-4a0f-9aef-504ad0112abb"
      unitRef="usd">-447756000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfNDAtNC0xLTEtMjM0NTg_f844eb67-3141-48fe-8b68-b7a66f85e38a"
      unitRef="usd">-384187000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfNDEtMi0xLTEtMjM0NTg_9ef2ad61-edd0-4ae0-b02c-5fb709411d27"
      unitRef="usd">-23940000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfNDEtNC0xLTEtMjM0NTg_277f4a7c-0747-4670-8e0d-4ebb08027a0b"
      unitRef="usd">-21051000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfNDItMi0xLTEtMjM0NTg_aaa7893b-7440-4732-8a93-6ba95d801727"
      unitRef="usd">78244000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfNDItNC0xLTEtMjM0NTg_5c8ee24d-badf-4336-93b9-b3af274423b6"
      unitRef="usd">162266000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfNDMtMi0xLTEtMjM0NTg_2d62ffee-4e6e-4d9d-83f1-9865c7d87c81"
      unitRef="usd">247265000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl83OS9mcmFnOjE1MzVlNjU2YmE5MjQwMDc5MTZiYTgyNmU4ZjYzOTliL3RhYmxlOjY2ZjU5YzhhYjNiMjRhMWM4MmVmZmRmN2ZmNDA2YjE0L3RhYmxlcmFuZ2U6NjZmNTljOGFiM2IyNGExYzgyZWZmZGY3ZmY0MDZiMTRfNDMtNC0xLTEtMjM0NTg_12d4c109-2efc-4659-9d19-bf253b69ff38"
      unitRef="usd">311637000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="ib3742cf8102b48d39bc674ec35e7f8d0_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjEtMi0xLTEtMjM0NTg_cf77c001-a6f8-402d-80c3-05c992a8b6d8"
      unitRef="shares">42720000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ib3742cf8102b48d39bc674ec35e7f8d0_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjEtNC0xLTEtMjM0NTg_da4210af-62e9-4e59-b926-7d8f2d40e5c2"
      unitRef="usd">427000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i812a792161364ad492b0f6fe55adf3f4_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjEtNi0xLTEtMjM0NTg_fd63465b-1cf9-4e52-8cb8-d85ca27e4ed8"
      unitRef="shares">0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i812a792161364ad492b0f6fe55adf3f4_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjEtOC0xLTEtMjM0NTg_b88a71cc-412d-4510-9fb3-0d12ec795bc2"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6fb14a7aef624d6b8b4c8f13072f3c9f_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjEtMTAtMS0xLTIzNDU4_f5f9c88d-7095-4186-a7ae-219385f2d788"
      unitRef="usd">433756000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i26cf650e64fc419d90c5273bbc7ac968_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjEtMTItMS0xLTIzNDU4_5f0659a6-00e5-4c22-98df-662f94dc5b1c"
      unitRef="usd">-357989000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic6fbbd5528b2439293da3c165945acb2_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjEtMTQtMS0xLTIzNDU4_10bf4123-a516-49ce-aeff-b497abfc5e29"
      unitRef="usd">-23416000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i394f53cfcde141e98500d79a19551b90_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjEtMTYtMS0xLTIzNDU4_dac78ca4-f4b2-4a49-be5c-6c7824429de7"
      unitRef="shares">5407000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i394f53cfcde141e98500d79a19551b90_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjEtMTgtMS0xLTIzNDU4_f3daa9da-b619-4e6e-a93b-72bdbbc37527"
      unitRef="usd">-49998000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie19b226220734349af34ea12f273148b_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjEtMjAtMS0xLTIzNDU4_0e140469-f263-4166-8276-f2255e5ecc42"
      unitRef="usd">2780000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i62c97ced29404b4b822be5a8b268125c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjItMTItMS0xLTIzNDU4_5b6bc122-44e1-407a-a04e-95a28690365c"
      unitRef="usd">-33226000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjItMjAtMS0xLTIzNDU4_d0e72a95-95da-44ce-b40a-96910dfda636"
      unitRef="usd">-33226000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie148f975b2854da787567794ba46c657_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjMtMTQtMS0xLTIzNDU4_ea3b4699-b824-4165-86ff-3afbe08f56fc"
      unitRef="usd">610000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjMtMjAtMS0xLTIzNDU4_e426013b-62dd-476b-ac3f-6820d21ffc3d"
      unitRef="usd">610000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="ia8606a26085a4a74842150a8d122fa0d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjQtMi0xLTEtMjM0NTg_2a5c69db-612e-484f-8e17-72885ab22d64"
      unitRef="shares">153000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="ia8606a26085a4a74842150a8d122fa0d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjQtNC0xLTEtMjM0NTg_ff8b55ea-83e5-491e-a418-8f28000a52e3"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="i3e4d19794fda42f0b37baafb371b84eb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjQtMTAtMS0xLTIzNDU4_893e7650-f7a1-4e9b-9188-57ed1b5723b2"
      unitRef="usd">-2000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjQtMjAtMS0xLTIzNDU4_53e8203d-49f1-41b1-be18-75aef580198d"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
      contextRef="ia8606a26085a4a74842150a8d122fa0d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjUtMi0xLTEtMjM0NTg_5f714701-25a2-4dc6-a40b-60de478fc2fd"
      unitRef="shares">54000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i3e4d19794fda42f0b37baafb371b84eb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjUtMTAtMS0xLTIzNDU4_9682c2ea-eabf-4e17-9b06-212623301d3e"
      unitRef="usd">118000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjUtMjAtMS0xLTIzNDU4_c384e1a7-a938-4ce5-9f9e-b05da75f9a11"
      unitRef="usd">118000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3e4d19794fda42f0b37baafb371b84eb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjYtMTAtMS0xLTIzNDU4_5bbce8ef-4c54-414c-9e1b-bac4046ec811"
      unitRef="usd">519000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjYtMjAtMS0xLTIzNDU4_b7130681-9afe-4b87-a5e0-515f6f29f5bb"
      unitRef="usd">519000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesOutstanding
      contextRef="ifb598c0f14344aae992296441052f63c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjctMi0xLTEtMjM0NTg_4b895522-8f6b-48bc-b19e-c328190505ca"
      unitRef="shares">42927000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ifb598c0f14344aae992296441052f63c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjctNC0xLTEtMjM0NTg_dd85e058-0ceb-4c5a-b859-81d6ec450b89"
      unitRef="usd">429000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i197afee9fd6b4ccaa43ec6478392822f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjctNi0xLTEtMjM0NTg_397f806a-c902-4abd-9313-ac39938fa11b"
      unitRef="shares">0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i197afee9fd6b4ccaa43ec6478392822f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjctOC0xLTEtMjM0NTg_61eb10cb-2910-409a-844a-8ad5ad5b55e1"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i899ea66e7b964d058e1797ec8ba84773_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjctMTAtMS0xLTIzNDU4_bcb8b4d1-a98c-4486-9631-ab135ab20de7"
      unitRef="usd">434391000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i54c88094c4ef4380afaf16c83eff800a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjctMTItMS0xLTIzNDU4_6111f895-27fc-4790-8821-884e711587fd"
      unitRef="usd">-391215000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i67e12346ebfb4c079f8ca4ba96c5d37c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjctMTQtMS0xLTIzNDU4_1b839dc9-8f2c-4b6b-a90b-a85187eb6ede"
      unitRef="usd">-22806000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="ib7eb97deba3549d6b376ab774b0445a5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjctMTYtMS0xLTIzNDU4_a9d6d88e-fd30-48f3-a7aa-b1b24fb9acd4"
      unitRef="shares">5407000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ib7eb97deba3549d6b376ab774b0445a5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjctMTgtMS0xLTIzNDU4_89429366-290c-43d6-af24-02eda645bc22"
      unitRef="usd">-49998000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie73b28a1c0c648e5a6641e1c909996f0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjctMjAtMS0xLTIzNDU4_3973befe-ba91-4abb-806d-c70da01e6eeb"
      unitRef="usd">-29199000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i4cf266a805904fcb95e5e2c230b341cd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjgtMTItMS0xLTIzNDU4_f1c178c6-dde6-48f6-b335-202cb8c7c378"
      unitRef="usd">7028000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjgtMjAtMS0xLTIzNDU4_205f860f-42c9-4a0d-8dbf-802137fcb769"
      unitRef="usd">7028000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iecf586fe05cc4a8796842f7e0739adcd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjktMTQtMS0xLTIzNDU4_3f7543d0-55cb-4f64-afda-1a9fc6a19f02"
      unitRef="usd">1755000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjktMjAtMS0xLTIzNDU4_9ee41f16-d2a6-4162-b238-f053715c916a"
      unitRef="usd">1755000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="if771595121ea48de8b53daa551326307_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzAtMi0xLTEtMjM0NTg_ab88b597-71b2-4365-9d13-02f88dd4b53d"
      unitRef="shares">403000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if771595121ea48de8b53daa551326307_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzAtNC0xLTEtMjM0NTg_b675826a-0dba-4e0c-9a62-ba4daac31671"
      unitRef="usd">4000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i9de1c77df78b4ba98727acf8dec79f60_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzAtMTAtMS0xLTIzNDU4_ede1dfd2-022e-4b49-bbfb-72bd5b1ee002"
      unitRef="usd">2041000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzAtMjAtMS0xLTIzNDU4_434129f6-4f4f-43d9-b486-4b74039e41e7"
      unitRef="usd">2045000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="if771595121ea48de8b53daa551326307_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzEtMi0xLTEtMjM0NTg_42253f97-dde7-48e3-895e-6200c3d19232"
      unitRef="shares">8680000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="if771595121ea48de8b53daa551326307_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzEtNC0xLTEtMjM0NTg_8ff04560-c6f5-4f7c-b495-285589274750"
      unitRef="usd">87000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i222f8cd80d79448189c83644ac3d2355_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzEtNi0xLTEtMjM0NTg_b021d85d-ba01-4229-a03b-62dd2db9b89a"
      unitRef="shares">488000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i222f8cd80d79448189c83644ac3d2355_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzEtOC0xLTEtMjM0NTg_592efd99-1be1-4525-b24f-335b3620aa07"
      unitRef="usd">5000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i9de1c77df78b4ba98727acf8dec79f60_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzEtMTAtMS0xLTIzNDU4_af47c164-6cc0-4e66-8dd4-47f25b6fff6d"
      unitRef="usd">60478000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzEtMjAtMS0xLTIzNDU4_67dac234-ea55-409d-8211-08350f3efe21"
      unitRef="usd">60570000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <avdl:StockIssuedDuringPeriodSharesPublicOffering
      contextRef="if771595121ea48de8b53daa551326307_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzItMi0xLTEtMjM0NTg_e1e522f4-cadc-482c-bf7b-99094d612bf4"
      unitRef="shares">11630000</avdl:StockIssuedDuringPeriodSharesPublicOffering>
    <avdl:StockIssuedDuringPeriodValuePublicOffering
      contextRef="if771595121ea48de8b53daa551326307_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzItNC0xLTEtMjM0NTg_dd665211-52a2-4ce7-870f-b3236149149f"
      unitRef="usd">116000</avdl:StockIssuedDuringPeriodValuePublicOffering>
    <avdl:StockIssuedDuringPeriodValuePublicOffering
      contextRef="i9de1c77df78b4ba98727acf8dec79f60_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzItMTAtMS0xLTIzNDU4_b848fe7e-1450-49a9-a329-e075a00de473"
      unitRef="usd">116808000</avdl:StockIssuedDuringPeriodValuePublicOffering>
    <avdl:StockIssuedDuringPeriodValuePublicOffering
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzItMjAtMS0xLTIzNDU4_20a72140-4281-4b6d-9862-c825cce68768"
      unitRef="usd">116924000</avdl:StockIssuedDuringPeriodValuePublicOffering>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="if771595121ea48de8b53daa551326307_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzMtMi0xLTEtMjM0NTg_ff51d3e7-726f-4741-90fa-66f26a9fed10"
      unitRef="shares">114000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="if771595121ea48de8b53daa551326307_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzMtNC0xLTEtMjM0NTg_352de33c-dc80-40ad-a249-a19cd9f72b3a"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="i9de1c77df78b4ba98727acf8dec79f60_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzMtMTAtMS0xLTIzNDU4_610a63ae-4e62-41fa-8822-eb9611561448"
      unitRef="usd">-1000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzMtMjAtMS0xLTIzNDU4_b7522cb5-1f18-48d2-b1b6-890b27d5a8b3"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
      contextRef="if771595121ea48de8b53daa551326307_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzQtMi0xLTEtMjM0NTg_2046ba69-fb87-41dc-b1d2-5280dbc1d32e"
      unitRef="shares">49000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i9de1c77df78b4ba98727acf8dec79f60_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzQtMTAtMS0xLTIzNDU4_183178ad-a578-4924-83f6-274b837708dd"
      unitRef="usd">144000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzQtMjAtMS0xLTIzNDU4_3eafc07f-1d15-4898-b48a-eac8995daf69"
      unitRef="usd">144000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9de1c77df78b4ba98727acf8dec79f60_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzUtMTAtMS0xLTIzNDU4_8096d08b-9f19-4396-8cac-1105a997fcfd"
      unitRef="usd">2999000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzUtMjAtMS0xLTIzNDU4_b65d5411-ea12-43ab-9cd0-5723f4ddd4c1"
      unitRef="usd">2999000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="if771595121ea48de8b53daa551326307_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzYtMi0xLTEtMjM0NTg_6b1ae154-0454-4063-8f42-4c248c3146ef"
      unitRef="shares">5407000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="if771595121ea48de8b53daa551326307_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzYtNC0xLTEtMjM0NTg_1efb8ce2-6c88-46b6-9f3e-9f31f58514df"
      unitRef="usd">54000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i9de1c77df78b4ba98727acf8dec79f60_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzYtMTAtMS0xLTIzNDU4_ad39ebc4-42f4-4e2c-94f5-27631e3e757e"
      unitRef="usd">49944000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="id0877df49af64182b24f4e10a6ba5e3e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzYtMTYtMS0xLTIzNDU4_455d4a0d-62c0-4abb-9869-5aaf3c9beeb6"
      unitRef="shares">5407000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="id0877df49af64182b24f4e10a6ba5e3e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzYtMTgtMS0xLTIzNDU4_c7928ac5-74d5-4fae-9c27-5b170a8fdd8f"
      unitRef="usd">49998000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzYtMjAtMS0xLTIzNDU4_dbfd6284-7096-4850-bf8a-aca783894f62"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:SharesOutstanding
      contextRef="ic789417b0e004065ba225a51e910fb39_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzctMi0xLTEtMjM0NTg_90729378-a0a5-4322-b90a-3dab00b090b3"
      unitRef="shares">58396000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ic789417b0e004065ba225a51e910fb39_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzctNC0xLTEtMjM0NTg_5bd5fc90-d64d-45d7-b300-31e5ed7c2fed"
      unitRef="usd">583000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i00d4167fc12941e6afffad25855327d4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzctNi0xLTEtMjM0NTg_e6af9374-05c5-4d0e-95bf-1e0807faddc3"
      unitRef="shares">488000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i00d4167fc12941e6afffad25855327d4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzctOC0xLTEtMjM0NTg_c1c80bfe-7769-4cfe-9a06-d2bf6a2fde74"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia20446b447fa4a8ab7a66e1764ce6493_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzctMTAtMS0xLTIzNDU4_586df6a8-9abe-46fc-8a4f-8456031f9e12"
      unitRef="usd">566916000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i82fc7bbe97ac467ba08500fce8cb112e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzctMTItMS0xLTIzNDU4_e61c25d5-1a3d-40c5-b0e9-295578c41703"
      unitRef="usd">-384187000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaddacdf3080a4469857cc1c79a9583e3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzctMTQtMS0xLTIzNDU4_1517edbe-9b91-4ba3-bc34-61bb911c9413"
      unitRef="usd">-21051000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i965ba5cfda524be99b22224e377b7879_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzctMTYtMS0xLTIzNDU4_05b13cb8-11ba-4b39-bd03-34b6c24e8680"
      unitRef="shares">0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i965ba5cfda524be99b22224e377b7879_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzctMTgtMS0xLTIzNDU4_fa2ca4bb-c9d4-4dd5-9d01-fd6152eac32b"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMzctMjAtMS0xLTIzNDU4_6efddad6-6b19-4f1c-9266-8d1200d0372d"
      unitRef="usd">162266000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i27057cf80d054326a72f1357eef1f0c2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMTktMTAtMS0xLTI0NTky_ae035a2a-2593-4fbe-823a-f4b9b6bc0c87"
      unitRef="usd">-26699000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifdaa54a433dd430a83d91856c8287945_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMTktMTItMS0xLTI0NTky_9ee64294-ae39-499f-a30b-0289f49ff15f"
      unitRef="usd">13760000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia03de445d5514be7925f47534612a3c6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMTktMjAtMS0xLTM1MzAw_c49be4b6-614a-4b13-8248-010cbb75fa87"
      unitRef="usd">-12939000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i2aea8b8d433e4423879f52b4780b5b0f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjAtMTItMS0xLTI0NTky_778106cc-e8f7-4bbe-888f-fc5aac11201d"
      unitRef="usd">-77329000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjAtMjAtMS0xLTM1Mjc5_4bf73bd0-f927-43ba-b7dc-83d933d62d89"
      unitRef="usd">-77329000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic1271ce9577746e28ccd19f9aebc5938_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjEtMTQtMS0xLTI0NTky_852851b4-082b-4ba2-8148-d92bb676e1bc"
      unitRef="usd">-2889000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjEtMjAtMS0xLTM1Mjgx_11303af7-bf21-44b8-bc8b-c341f2820d4a"
      unitRef="usd">-2889000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i71e818e3e9d648c6b90862da8ce42be5_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjItMi0xLTEtMjQ1ODQ_e09f782b-8f5c-4b88-bfe3-6d8d225f632a"
      unitRef="shares">48000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i71e818e3e9d648c6b90862da8ce42be5_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjItNC0xLTEtMjQ1ODQ_7566a8ab-33fd-41db-9d54-0e9cd3898347"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ibcc16b22124640c1b74cb0fad033cc0d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjItMTAtMS0xLTI0NTky_ba5de53f-4ad8-4358-92ad-d4c2e607d968"
      unitRef="usd">168000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjItMjAtMS0xLTM1Mjg0_4c6091d5-9ea4-4092-8967-96985f3900d9"
      unitRef="usd">169000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="i71e818e3e9d648c6b90862da8ce42be5_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjMtMi0xLTEtMjQ1ODQ_8071e643-e25b-48d2-8bc7-64c06fbf4e88"
      unitRef="shares">159000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="i71e818e3e9d648c6b90862da8ce42be5_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjMtNC0xLTEtMjQ1ODQ_d00209c5-df21-44b2-956a-766b22dc665f"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="ibcc16b22124640c1b74cb0fad033cc0d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjMtMTAtMS0xLTI0NTky_d9993a88-d609-4ec7-a3eb-e6cef17234f3"
      unitRef="usd">-2000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjMtMjAtMS0xLTM1Mjg3_688ec7a4-3375-4581-a6be-7085dbecccee"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
      contextRef="i71e818e3e9d648c6b90862da8ce42be5_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjQtMi0xLTEtMjQ1ODQ_d84f9906-2743-49a2-81f5-3f1e5e622580"
      unitRef="shares">17000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ibcc16b22124640c1b74cb0fad033cc0d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjQtMTAtMS0xLTI0NTky_b859bb54-10d8-4481-8d6e-2e22a63b61a1"
      unitRef="usd">94000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjQtMjAtMS0xLTM1Mjky_5fece827-a3df-4f70-a27c-a1af6591010b"
      unitRef="usd">94000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ibcc16b22124640c1b74cb0fad033cc0d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjUtMTAtMS0xLTI0NTky_02e43429-0ee9-4915-88e0-1c700d600ac1"
      unitRef="usd">8872000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjUtMjAtMS0xLTM1Mjk1_bb84e222-2aec-431d-90d6-0c46f15f6a80"
      unitRef="usd">8872000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesOutstanding
      contextRef="i5c79a087deb04cc1aee09bf57361d370_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjYtMi0xLTEtMzUyOTg_46cfd133-efa7-4811-9f8a-6df5b33232fb"
      unitRef="shares">58620000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i5c79a087deb04cc1aee09bf57361d370_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjYtNC0xLTEtMzUyOTg_7305ec82-9c5c-4661-9b1a-28935311c2d5"
      unitRef="usd">586000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i4880683abd4349769692521b4246f81c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjYtNi0xLTEtMzUyOTg_c56575a0-28e2-41df-90fb-c49e2478ec53"
      unitRef="shares">488000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i4880683abd4349769692521b4246f81c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjYtOC0xLTEtMzUyOTg_2d446223-26ff-44f0-8b1b-e9a6fa145eca"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5f3ba7983a1d4e8d8ca3d4d571f7417f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjYtMTAtMS0xLTM1Mjk4_f50d7d08-7755-42d1-ab0a-370f6dec9ff7"
      unitRef="usd">549349000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic954e2aba16348f4beeb6795e6fad4fa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjYtMTItMS0xLTM1Mjk4_c5c0992f-8dd3-4aae-8bdb-9179b0c0f09b"
      unitRef="usd">-447756000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i79b00d255f634de49f2fc2b349447e88_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjYtMTQtMS0xLTM1Mjk4_642230ab-d177-447f-9de8-3f7f11e49771"
      unitRef="usd">-23940000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i10196011707944b18724021dfce2ca7e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjYtMTYtMS0xLTM1Mjk4_c8b9819d-357e-46b6-bc7a-76b1e3728705"
      unitRef="shares">0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i10196011707944b18724021dfce2ca7e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjYtMTgtMS0xLTM1Mjk4_f898261f-6f9e-4546-810b-a1583fb5e69c"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84Mi9mcmFnOjgzOWFiNzM3YjFkYjRiYTI5M2MzYTkxOTY2ZDBkOTkwL3RhYmxlOmVjNDViZDZhZDgxOTQ1YWNhNjU4ZGU5Zjk2NzYxMjEyL3RhYmxlcmFuZ2U6ZWM0NWJkNmFkODE5NDVhY2E2NThkZTlmOTY3NjEyMTJfMjYtMjAtMS0xLTM1Mjk4_fe784ce4-79fd-48e2-acaf-cc35c3874042"
      unitRef="usd">78244000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMy0yLTEtMS0yMzQ1OA_7529f3ef-b65c-4bbc-8c1a-9cdb744ba979"
      unitRef="usd">-77329000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMy00LTEtMS0yMzQ1OA_b3645de4-d511-49a0-909c-4e8cd0ee1bac"
      unitRef="usd">7028000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMy02LTEtMS0yMzQ1OA_614e1022-910a-4760-b50c-5b992ff2753c"
      unitRef="usd">-33226000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNS0yLTEtMS0yMzQ1OA_28b5d2a5-1844-4dd5-94aa-21269ce1a2e4"
      unitRef="usd">815000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNS00LTEtMS0yMzQ1OA_d605a65d-dbe4-4991-9931-53a69884c88e"
      unitRef="usd">1690000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNS02LTEtMS0yMzQ1OA_ed4acaae-3e25-4c88-9897-9f3c38150408"
      unitRef="usd">2486000</us-gaap:DepreciationAndAmortization>
    <avdl:AcquisitionRelatedContingentConsiderationRemeasurement
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNy0yLTEtMS0yMzQ1OA_5471299e-a347-4b27-bf12-332790b532bf"
      unitRef="usd">0</avdl:AcquisitionRelatedContingentConsiderationRemeasurement>
    <avdl:AcquisitionRelatedContingentConsiderationRemeasurement
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNy00LTEtMS0yMzQ1OA_20f73b7c-f07b-4ca5-af58-afa47450a5a8"
      unitRef="usd">3327000</avdl:AcquisitionRelatedContingentConsiderationRemeasurement>
    <avdl:AcquisitionRelatedContingentConsiderationRemeasurement
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNy02LTEtMS0yMzQ1OA_77015d3d-9a8c-408f-b36c-34fa88bcef4d"
      unitRef="usd">845000</avdl:AcquisitionRelatedContingentConsiderationRemeasurement>
    <avdl:FinancingRelatedContingentConsiderationRemeasurement
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfOC0yLTEtMS0yMzQ1OA_67042c5b-613c-4686-83be-8e0fcea01b21"
      unitRef="usd">0</avdl:FinancingRelatedContingentConsiderationRemeasurement>
    <avdl:FinancingRelatedContingentConsiderationRemeasurement
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfOC00LTEtMS0yMzQ1OA_d30f0560-13d7-4c10-abb9-fc2c771316e1"
      unitRef="usd">435000</avdl:FinancingRelatedContingentConsiderationRemeasurement>
    <avdl:FinancingRelatedContingentConsiderationRemeasurement
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfOC02LTEtMS0yMzQ1OA_b452cd1c-5f5f-459c-91b5-676782b16f81"
      unitRef="usd">378000</avdl:FinancingRelatedContingentConsiderationRemeasurement>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfOS0yLTEtMS0yMzQ1OA_ab9e9c2a-f864-43f2-9d84-a3aa9728b420"
      unitRef="usd">1248000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfOS00LTEtMS0yMzQ1OA_f2a8543d-088f-4431-abf3-27a305fbfc26"
      unitRef="usd">6524000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfOS02LTEtMS0yMzQ1OA_72269872-3d61-410c-b58a-ad327dc33c51"
      unitRef="usd">5995000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTAtMi0xLTEtMjM0NTg_157ff166-0262-4553-80e8-0d793f54cdd4"
      unitRef="usd">15666000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTAtNC0xLTEtMjM0NTg_146d7a54-e2f3-4bbf-bea7-29d87a5fe365"
      unitRef="usd">7431000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTAtNi0xLTEtMjM0NTg_8aae3329-ec61-46d7-b5cb-d11054c1aea0"
      unitRef="usd">6334000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:ShareBasedCompensation
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTEtMi0xLTEtMjM0NTg_5589d76c-c09e-4a9a-ab27-bc7edfb5bad9"
      unitRef="usd">8872000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTEtNC0xLTEtMjM0NTg_8b8dec5e-0f38-4fd6-be02-1cffcd3af039"
      unitRef="usd">2999000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTEtNi0xLTEtMjM0NTg_87ee0b92-b186-43f2-96e7-7a1680c88233"
      unitRef="usd">519000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTItMi0xLTEtMjM0NTg_0b61f000-6c19-46ca-9969-d9fcd926f7e9"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTItNC0xLTEtMjM0NTg_6a27a9c2-5fb8-4078-a49a-d5c03af1ec23"
      unitRef="usd">45760000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTItNi0xLTEtMjM0NTg_c76bf524-0e06-46d9-8869-5014c010cecf"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <avdl:NoncashGainLossDeconsolidationOfSubsidiary
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTMtMi0xLTEtMjM0NTg_ddba6c23-8bf8-44a9-8d60-b76f4ce34993"
      unitRef="usd">0</avdl:NoncashGainLossDeconsolidationOfSubsidiary>
    <avdl:NoncashGainLossDeconsolidationOfSubsidiary
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTMtNC0xLTEtMjM0NTg_dd8c4fd8-337c-4b90-aa5a-26910743b3e1"
      unitRef="usd">0</avdl:NoncashGainLossDeconsolidationOfSubsidiary>
    <avdl:NoncashGainLossDeconsolidationOfSubsidiary
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTMtNi0xLTEtMjM0NTg_f9dd2478-1ec4-4463-a67f-1a91647d6080"
      unitRef="usd">-1750000</avdl:NoncashGainLossDeconsolidationOfSubsidiary>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTQtMi0xLTEtMjM0NTg_2cf8e67e-d4ef-4a76-a2af-995c2c906772"
      unitRef="usd">217000</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTQtNC0xLTEtMjM0NTg_bc6ce927-08ae-49e3-8b11-afe28c904668"
      unitRef="usd">3364000</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTQtNi0xLTEtMjM0NTg_a47de877-2d59-440f-ac9f-c975326af44f"
      unitRef="usd">0</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTUtMi0xLTEtMjM0NTg_7c7ff703-914e-46b5-ab63-820b1f155281"
      unitRef="usd">1272000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTUtNC0xLTEtMjM0NTg_3663981e-0b92-4012-ac05-411c566f63a6"
      unitRef="usd">142000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTUtNi0xLTEtMjM0NTg_7cc963fb-9392-4b20-a38d-d22c63fa468d"
      unitRef="usd">-254000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTctMi0xLTEtMjM0NTg_79356780-4ae9-4454-8119-6af3d0d8646f"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTctNC0xLTEtMjM0NTg_824c522c-47ef-4a41-a2b9-d1b7eca34df8"
      unitRef="usd">-8281000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTctNi0xLTEtMjM0NTg_aee9dadd-9850-4b65-8b47-1a4a2a7b038e"
      unitRef="usd">-2471000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTgtMi0xLTEtMjM0NTg_2735c54a-23d4-439a-82b2-18adfc2ff19e"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTgtNC0xLTEtMjM0NTg_11d065ff-cb36-4664-8d78-163c22296acd"
      unitRef="usd">1352000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTgtNi0xLTEtMjM0NTg_14f8b4a9-82cd-400b-a65c-36a4f8832248"
      unitRef="usd">-1155000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTktMi0xLTEtMjM0NTg_9fca10fd-5e28-40a5-8f98-7edc15a3216b"
      unitRef="usd">439000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTktNC0xLTEtMjM0NTg_5f59a3ba-4371-47ee-9377-faf330a06b62"
      unitRef="usd">-1863000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMTktNi0xLTEtMjM0NTg_9e009eb2-cade-486b-a0fe-89460c9dfcae"
      unitRef="usd">1187000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjAtMi0xLTEtMjM0NTg_e0858ddc-c06f-4479-852f-5ccdeabafb88"
      unitRef="usd">-2796000</avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable>
    <avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjAtNC0xLTEtMjM0NTg_52135520-8ebf-4a56-bd2e-863230cbae8b"
      unitRef="usd">-2213000</avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable>
    <avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjAtNi0xLTEtMjM0NTg_4c517845-bc71-4fad-821a-8fd9bcfb77ae"
      unitRef="usd">1014000</avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjEtMi0xLTEtMjM0NTg_b2531d71-2126-4111-b981-11d82e469395"
      unitRef="usd">4232000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjEtNC0xLTEtMjM0NTg_f3dd659d-ac22-4108-a556-cf06047c57cb"
      unitRef="usd">-2788000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjEtNi0xLTEtMjM0NTg_e5f8bdd9-8170-4094-8a99-9a3a0f1862ba"
      unitRef="usd">4641000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjItMi0xLTEtMjM0NTg_c3837345-1173-47e2-8a12-469110bffd1b"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjItNC0xLTEtMjM0NTg_f4dd7ff1-17c4-4a6d-8e17-d1d7b81048c4"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjItNi0xLTEtMjM0NTg_f6b752a4-4baa-484a-83aa-76f11b125933"
      unitRef="usd">-114000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjMtMi0xLTEtMjM0NTg_8b3f0931-a047-40fd-b1f3-a69d69b24455"
      unitRef="usd">895000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjMtNC0xLTEtMjM0NTg_99086e70-79f2-49d1-8e67-1710193aea39"
      unitRef="usd">-13226000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjMtNi0xLTEtMjM0NTg_cda934d9-a34a-4446-8f86-c84f08a17609"
      unitRef="usd">357000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <avdl:EarnOutPaymentInExcessOfAcquisitionDateFairValue
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjUtMi0xLTEtMjM0NTg_161eeb80-90ce-4ac1-b440-227f91ee1c74"
      unitRef="usd">0</avdl:EarnOutPaymentInExcessOfAcquisitionDateFairValue>
    <avdl:EarnOutPaymentInExcessOfAcquisitionDateFairValue
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjUtNC0xLTEtMjM0NTg_b89ed304-3ed1-4fda-9edb-2c7f75728930"
      unitRef="usd">5323000</avdl:EarnOutPaymentInExcessOfAcquisitionDateFairValue>
    <avdl:EarnOutPaymentInExcessOfAcquisitionDateFairValue
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjUtNi0xLTEtMjM0NTg_07269ef3-e151-49e0-97ea-b2087bf4cf0d"
      unitRef="usd">10988000</avdl:EarnOutPaymentInExcessOfAcquisitionDateFairValue>
    <us-gaap:PaymentsForRoyalties
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjYtMi0xLTEtMjM0NTg_f88c99d0-a5e9-4fe3-bcda-12a584f80499"
      unitRef="usd">0</us-gaap:PaymentsForRoyalties>
    <us-gaap:PaymentsForRoyalties
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjYtNC0xLTEtMjM0NTg_a7edd175-f2b7-45c8-82ba-b30d29ef0502"
      unitRef="usd">866000</us-gaap:PaymentsForRoyalties>
    <us-gaap:PaymentsForRoyalties
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjYtNi0xLTEtMjM0NTg_ca71c5cc-c247-409b-96d0-5152b5125eea"
      unitRef="usd">1748000</us-gaap:PaymentsForRoyalties>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjctMi0xLTEtMjM0NTg_e8cf5a56-cb18-4501-a3c7-34a5200f55c0"
      unitRef="usd">3789000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjctNC0xLTEtMjM0NTg_d23e4586-0bea-4fbd-a611-ffa729dfe946"
      unitRef="usd">3126000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjctNi0xLTEtMjM0NTg_1e296f14-c048-47ae-9d5a-71b6b2f82230"
      unitRef="usd">4057000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjgtMi0xLTEtMjM0NTg_528b653f-7453-48ca-a5b5-0d8487f6f2dd"
      unitRef="usd">-77310000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjgtNC0xLTEtMjM0NTg_d51ae1e1-ba67-4f09-8d9b-d60766464e6e"
      unitRef="usd">-48734000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMjgtNi0xLTEtMjM0NTg_3c13b621-9fe4-4a6c-a55d-50ba49bc769e"
      unitRef="usd">-38325000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzEtMi0xLTEtMjM0NTg_29caa413-473a-4895-bdfa-c6f5ac20c0fd"
      unitRef="usd">26000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzEtNC0xLTEtMjM0NTg_61624a7b-5d7f-4e6f-828f-11fedfa2212e"
      unitRef="usd">98000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzEtNi0xLTEtMjM0NTg_f4f8e1a3-1c09-4109-8b4b-deb5b187e180"
      unitRef="usd">29000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzItMi0xLTEtMjM0NTg_f7d0156f-037f-4589-8ce6-8dcf29a34ec5"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzItNC0xLTEtMjM0NTg_4cc96a27-cf4a-494b-836b-e3dcc7cfc430"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzItNi0xLTEtMjM0NTg_bba32e31-7ff2-4a01-a301-a27d6f7cf583"
      unitRef="usd">154000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzMtMi0xLTEtMjM0NTg_281b5d9c-66af-4651-ae75-ac08ab143a5b"
      unitRef="usd">16500000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzMtNC0xLTEtMjM0NTg_84d60592-e5ed-46bc-83c4-2fb33987ba4d"
      unitRef="usd">25500000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzMtNi0xLTEtMjM0NTg_ad6e502a-aa96-4537-a6db-b9843b2be7c0"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzUtMi0xLTEtMjM0NTg_20e40bbb-dc44-412f-9221-a25e4373b781"
      unitRef="usd">102224000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzUtNC0xLTEtMjM0NTg_8eb0d6c1-845f-411b-b9a1-46aa000292ff"
      unitRef="usd">36284000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzUtNi0xLTEtMjM0NTg_9564ec5f-a0a0-4d75-b4f5-fab13fdad236"
      unitRef="usd">63246000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzYtMi0xLTEtMjM0NTg_6b055bd8-e2fe-48f6-a649-311d3f41dfd0"
      unitRef="usd">61769000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzYtNC0xLTEtMjM0NTg_443d6f7c-81f7-4059-9c54-ec054e4f7c4e"
      unitRef="usd">131407000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzYtNi0xLTEtMjM0NTg_59be688b-32c4-44ad-877a-9d638c9c0042"
      unitRef="usd">24648000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzctMi0xLTEtMjM0NTg_6c5b0618-3a6d-4191-b30a-f214c4dd6d87"
      unitRef="usd">56929000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzctNC0xLTEtMjM0NTg_0b783e92-555c-490d-896c-9415461eba16"
      unitRef="usd">-69721000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfMzctNi0xLTEtMjM0NTg_022ff384-3b7f-4817-a775-adf3e6331afb"
      unitRef="usd">38723000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDQtMi0xLTEtMjM0NTg_c697e5da-5692-4f44-8a04-b5ff1552b48a"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDQtNC0xLTEtMjM0NTg_9c35d3cc-51c9-4de9-a102-839a2a49e1cd"
      unitRef="usd">60570000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDQtNi0xLTEtMjM0NTg_7c3db41a-a987-4e40-8df7-98563ac893b4"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDUtMi0xLTEtMjM0NTg_f791055e-29cb-477b-9cfb-f759ef687257"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDUtNC0xLTEtMjM0NTg_2e91e061-b6d7-4a44-a915-286b61c617b1"
      unitRef="usd">116924000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDUtNi0xLTEtMjM0NTg_ca2ee0c1-dd18-4948-ad95-cf48785af4f2"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDYtMi0xLTEtMjM0NTg_58f9b0f2-246b-4005-9ffd-c00be0e31dbc"
      unitRef="usd">263000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDYtNC0xLTEtMjM0NTg_69fd470b-a438-441f-ab35-4924db4fbb67"
      unitRef="usd">2189000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDYtNi0xLTEtMjM0NTg_2764fd36-4c47-4f01-95f7-b0552d94877b"
      unitRef="usd">118000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDgtMi0xLTEtMjM0NTg_2bc6452c-bdcb-4f1b-b86c-68d5b5d2434a"
      unitRef="usd">0</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDgtNC0xLTEtMjM0NTg_a499681a-b183-48aa-94e9-50ffeb78c589"
      unitRef="usd">0</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDgtNi0xLTEtMjM0NTg_c87f879c-c232-46fa-a67c-525af893e26c"
      unitRef="usd">-145000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDktMi0xLTEtMjM0NTg_4b98ad75-eb59-4663-ba8f-588a9745fbe6"
      unitRef="usd">263000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDktNC0xLTEtMjM0NTg_791a6e03-d508-41f5-8597-ffaadbc95f40"
      unitRef="usd">179683000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNDktNi0xLTEtMjM0NTg_eff41dc0-ccca-45d9-8112-831ff268c142"
      unitRef="usd">-27000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTAtMi0xLTEtMjM0NTg_97118263-501d-4f70-8590-32b0f132efc7"
      unitRef="usd">-896000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTAtNC0xLTEtMjM0NTg_1b00ad80-772d-4e73-a57f-b63e5c2af31b"
      unitRef="usd">720000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTAtNi0xLTEtMjM0NTg_755ee13e-0e73-4032-981c-8a7dc31ba41b"
      unitRef="usd">78000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTEtMi0xLTEtMjM0NTg_93e320e1-487d-426d-9e85-252ce29c0e99"
      unitRef="usd">-21014000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTEtNC0xLTEtMjM0NTg_09395f47-c903-4493-a90f-a607600f2646"
      unitRef="usd">61948000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTEtNi0xLTEtMjM0NTg_fc934aa3-20f0-43ed-942a-e6d3ded09b7a"
      unitRef="usd">449000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTItMi0xLTEtMjM0NTg_9435fab4-aa12-46a4-ac54-4b9abe1e3a9a"
      unitRef="usd">71722000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie73b28a1c0c648e5a6641e1c909996f0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTItNC0xLTEtMjM0NTg_dbd2296a-f135-44f6-a687-0a36febe9966"
      unitRef="usd">9774000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie19b226220734349af34ea12f273148b_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTItNi0xLTEtMjM0NTg_23c18a23-843e-4b72-b03f-19c6ea7ccd06"
      unitRef="usd">9325000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTMtMi0xLTEtMjM0NTg_adb29c19-1bec-419d-8269-f9f9822768bb"
      unitRef="usd">50708000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTMtNC0xLTEtMjM0NTg_ffb118a6-e97d-4c68-afe7-841ce767df75"
      unitRef="usd">71722000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie73b28a1c0c648e5a6641e1c909996f0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTMtNi0xLTEtMjM0NTg_f828cec0-39fe-4741-bb51-e14708465891"
      unitRef="usd">9774000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTYtMi0xLTEtMjM0NTg_3e9a9b3d-a871-4498-ab2b-02935385bd19"
      unitRef="usd">76000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTYtNC0xLTEtMjM0NTg_31eb9807-e3a5-4529-83c9-9fff03b71bcc"
      unitRef="usd">-1701000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTYtNi0xLTEtMjM0NTg_64cca4f4-cdec-4a17-9fde-9b7316ab3b67"
      unitRef="usd">140000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTctMi0xLTEtMjM0NTg_074f9d4d-15b7-44ce-956d-9a7e68be6a6f"
      unitRef="usd">6469000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTctNC0xLTEtMjM0NTg_aa0a19c7-aec5-47cb-a6c3-bebf2bb3b34a"
      unitRef="usd">6469000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl84NS9mcmFnOjQyMWVmNDhlYWEzMDRmN2M4ZjZjZWM0NDNiMzEyNDAyL3RhYmxlOjE3ZjlkOWNlNDUwMTQxNDI4ZDNmN2E1YzFjMGFkZTE0L3RhYmxlcmFuZ2U6MTdmOWQ5Y2U0NTAxNDE0MjhkM2Y3YTVjMWMwYWRlMTRfNTctNi0xLTEtMjM0NTg_20c80961-580b-43cf-bd10-ba030102cf8b"
      unitRef="usd">6469000</us-gaap:InterestPaidNet>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyMjI_6dc75914-9f77-4b96-81ec-c6b9b1bb3f7f">Summary of Significant Accounting Policies&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nature of Operations.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Avadel Pharmaceuticals plc (Nasdaq: AVDL) (&#x201c;Avadel,&#x201d; the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;our,&#x201d; or &#x201c;us&#x201d;) is a biopharmaceutical company. The Company is registered as an Irish public limited company. The Company&#x2019;s headquarters are in Dublin, Ireland with operations in St. Louis, Missouri, United States (&#x201c;U.S&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s lead product candidate, FT218, is an investigational once-nightly, extended-release formulation of sodium oxybate for the treatment of excessive daytime sleepiness (&#x201c;EDS&#x201d;) or cataplexy in adults with narcolepsy. The Company is primarily focused on the development and potential United States (&#x201c;U.S.&#x201d;) Food and Drug Administration (&#x201c;FDA&#x201d;) approval of FT218. In December 2020, the Company submitted a New Drug Application (&#x201c;NDA&#x201d;) to the FDA for FT218 to treat excessive daytime sleepiness or cataplexy in adults with narcolepsy. In February 2021, the NDA for FT218 was accepted by the FDA and was assigned a Prescription Drug User Fee Act (&#x201c;PDUFA&#x201d;) target action date of October 15, 2021. On October 15, 2021, the Company announced that the FDA informed us that the review of the Company&#x2019;s NDA for FT218 was ongoing beyond its previously assigned target action date. As of the date of this Annual Report, the FDA&#x2019;s review of the Company&#x2019;s NDA for FT218 remains ongoing. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outside of the Company&#x2019;s lead product candidate, the Company continues to evaluate opportunities to expand its product portfolio. As of the date of this Annual Report, the Company does not have any approved or commercialized products in its portfolio. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (&#x201c;U.S. GAAP&#x201d;). The consolidated financial statements include the accounts of the Company and all subsidiaries. All intercompany accounts and transactions have been eliminated.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s results of operations for the period January 1, 2019 through February 6, 2019 include the results of Avadel Specialty Pharmaceuticals, LLC (&#x201c;Specialty Pharma&#x201d;) prior to its February 6, 2019 voluntary petition for reorganization under Chapter 11 of the U.S. Bankruptcy Code. See&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 3: Subsidiary Bankruptcy and Deconsolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain reclassifications are made to prior year amounts whenever necessary to conform with the current year presentation. Certain reclassifications have been made to the Consolidated Statements of Cash Flows for the fiscal year ended December 31, 2019 and balances within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 14: Other Assets and Liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for the year ended December 31, 2020 to condense line items of the same nature into a single line. This change does not affect previously reported net cash flows used in operating activities in the Consolidated Statements of Cash Flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Out of Period Adjustments &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2021, the Company determined that 0.50% of additional interest expense (the &#x201c;Additional Interest&#x201d;), as defined in the indenture dated as of February 16, 2018 among Avadel Finance Cayman Ltd, Avadel Pharmaceuticals PLC, and The Bank of New York Mellon as trustee (the &#x201c;Indenture&#x201d;), was owed on its long term 4.50% exchangeable unsecured senior notes due 2023 (the &#x201c;2023 Notes&#x201d;) from a period of February 17, 2019 through December 31, 2021, totaling $817, $773, and $635 for the years ended December 31, 2021, 2020 and 2019, respectively. At December 31, 2020, the Company&#x2019;s accrued interest was understated by $1,408. The Additional Interest resulted from not removing a restrictive legend from the 2023 Notes 365 days following their original issuance on February 16, 2018.  The restrictive legend was removed in March 2022 and the Additional Interest is no longer applicable following the date of removal of the restrictive legend. The Company identified and recorded an out of period adjustment for cumulative amount of the Additional Interest in 2021 of $1,408. Management assessed the materiality of the impact of the out of period adjustment on its financial statements, both quantitatively and qualitatively, and determined that it was not material for any quarterly or annual period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2023 Notes were issued on February 16, 2018 (the &#x201c;Original Issuance&#x201d;) with a restrictive legend which remained in place until March 14, 2022. Per the terms of the Indenture, if the restrictive legend on the 2023 Notes was not removed on the 365th day following the original issuance of the 2023 Notes, the Company owed Additional Interest, payable on each of the semi-annual interest payment dates of February 1 and August 1 beginning August 1, 2019 and each of the semi-annual payment dates thereafter until the restrictive legend was removed. The non-payment of the Additional Interest expense on the semi-annual &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;payment dates, which was first due beginning August 1, 2019, is defined as an &#x201c;Event of Default&#x201d; in the Indenture, causing the Company to be in technical default of its 2023 Notes until the default was cured. The Additional Interest was paid to the trustee on March 10, 2022, which under the terms of the indenture, management believes cured the Event of Default for all periods. Additionally, on March 14, 2022, the restrictive legend on the 2023 Notes was removed and the Company is not subject to the Additional Interest after that date. Had the Company identified and been unable to cure the technical default prior to the issuance of its financial statements for fiscal years 2020 and 2019, it could have resulted in the reclassification of the long-term principal balance of 2023 Notes reported in those periods. As a result of curing the technical default, the Company classified the 2023 Notes as long-term at December 31, 2021 and 2020. The Indenture is included as Exhibit 4.2 to this Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to June 30, 2020, revenue included sales of pharmaceutical products, licensing fees, and, if any, milestone payments for research and development (&#x201c;R&amp;amp;D&#x201d;) achievements.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To determine the appropriate revenue recognition, the Company performs the following five steps: (i) Identify the contract(s) with a customer&#x37e; (ii) Identify the performance obligations in the contract; (iii) Determine the transaction price&#x37e; (iv) Allocate the transaction price to the performance obligations in the contract&#x37e; and (v) Recognize revenue when (or as) the entity satisfies a performance obligation. The Company applies the five-step model to contracts only when the Company and its customer&#x2019;s rights and obligations under the contract can be determined, the contract has commercial substance, and it is probable that the Company will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. The Company identifies the promised goods or services in the contract to determine if they are separate performance obligations or if they should be bundled with other goods and services into a single performance obligation. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Sales &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to June 30, 2020, the Company sold products primarily through wholesalers and considered these wholesalers to be the Company&#x2019;s customers. Revenue from product sales is recognized when the customer obtains control of the Company&#x2019;s product, which occurs typically upon receipt by the customer. The Company&#x2019;s gross product sales were subject to a variety of price adjustments in arriving at reported net product sales. These adjustments included estimates of product returns, chargebacks, payment discounts, rebates, and other sales allowances and are estimated based on analysis of historical data for the product or comparable products, future expectations for such products and other judgments and analysis.   &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development (&#x201c;R&amp;amp;D&#x201d;). &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; R&amp;amp;D expenses consist primarily of costs related to outside services, personnel expenses, clinical studies and other R&amp;amp;D expenses. Outside services and clinical studies costs relate primarily to services performed by clinical research organizations and related clinical or development manufacturing costs, materials and supplies, filing fees, regulatory support, and other third-party fees. Personnel expenses relate primarily to salaries, benefits and share-based compensation. Other R&amp;amp;D expenses primarily include overhead allocations consisting of various support and facilities-related costs. R&amp;amp;D expenditures are charged to operations as incurred. Raw materials used in the production of pre-clinical and clinical products are expensed as R&amp;amp;D costs.  &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes refundable R&amp;amp;D tax credits received for spending on innovative R&amp;amp;D as an offset of R&amp;amp;D expenses. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Advertising Expenses.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company expenses the costs of advertising as incurred. Branded advertising expenses were $0, $312 and $372 for the years ended December&#160;31, 2021, 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-based Compensation. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for share-based compensation based on the estimated grant-date fair value. The fair value of stock options is estimated using Black-Scholes option-pricing valuation models (&#x201c;Black-Scholes model&#x201d;). As required by the Black-Scholes model, estimates are made of the underlying volatility of Avadel stock, a risk-free rate and an expected term of the option or warrant. The Company estimates the expected term using a simplified method, as the Company does not have enough historical exercise data for a majority of such options upon which to estimate an expected term. The Company recognizes compensation cost, net of an estimated forfeiture rate, using the accelerated method over the requisite service period of the award.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, the Company determines deferred tax assets and liabilities on the basis of the differences between the financial statement and tax bases of assets and liabilities by using enacted tax rates in effect for the year in which &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes deferred tax assets to the extent that the Company believes that these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the Company determines that it would be able to realize its deferred tax assets in the future in excess of their net recorded amount, the Company would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records uncertain tax positions on the basis of a two-step process in which (1) the Company determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes interest and penalties related to unrecognized tax benefits in the income tax expense line in the consolidated statements of (loss) income. Accrued interest and penalties are included on the related tax liability line in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  Cash and cash equivalents consist of cash on hand, cash on deposit and fixed term deposits which are highly liquid investments with original maturities of less than three months.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Marketable Securities. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s marketable securities are considered to be available for sale and are carried at fair value, with unrealized gains and losses, net of taxes, reported as a component of accumulated other comprehensive (loss) income (&#x201c;AOCI&#x201d;) in shareholders&#x2019; equity, with the exception of unrealized gains and losses on equity instruments and allowances for expected credit losses, if any, which are reported in earnings in the current period. The cost of securities sold is based upon the specific identification method.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For available-for-sale debt securities in an unrealized loss position, the Company assesses whether it intends to sell or if it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security&#x2019;s amortized cost basis is written down to fair value. If the criteria are not met, the Company evaluates whether the decline in fair value has resulted from a credit loss or other factors. In making this assessment, management considers, among other factors, the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and adverse conditions specifically related to the security. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of the cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded for the credit loss, limited by the amount that the fair value is less than the amortized costs basis.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Allowance for Credit Losses.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts owed to the Company are presented net of an allowance that includes as assessment of expected credit losses.  An allowance for credit losses is established based on expected losses. Expected losses are estimated by reviewing individual accounts, considering aging, financial condition of the debtor, payment history, current and forecast economic conditions and other relevant factors.  To the extent that the Company identifies that any individual customer's credit quality has deteriorated, the Company establishes allowances based on the individual risk characteristics of that customer. The Company makes concerted efforts to collect all outstanding balances due from customers; however, amounts are written off against the allowance when the related balances are no longer deemed collectible &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  Property and equipment is stated at historical cost less accumulated depreciation. Depreciation and amortization are computed using the straight-line method over the following estimated useful lives:  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software, office and computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements, furniture, fixtures and fittings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5-10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  Goodwill represents the excess of the acquisition consideration over the fair value of assets acquired and liabilities assumed. The Company has determined that it operates in a single segment and have a single reporting unit associated with the development and commercialization of pharmaceutical products.  The Company tests goodwill for impairment annually and when events or changes in circumstances indicate that the carrying value may not be recoverable. The Company determined that no impairment of goodwill existed at December 31, 2021 and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Lived Assets. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-lived assets include fixed assets and intangible assets. Prior to the sale of the Company&#x2019;s portfolio of sterile injectable drugs used in the hospital setting (&#x201c;Hospital Products&#x201d;) on June 30, 2020, intangible assets consisted primarily of purchased licenses and intangible assets recognized as part of the &#xc9;clat Pharmaceuticals acquisition. Acquired in-process research and development (&#x201c;IPR&amp;amp;D&#x201d;) had an indefinite life and was not amortized until completion and development of the project, at which time the IPR&amp;amp;D became an amortizable asset, for which amortization of such intangible assets was computed using the straight-line method over the estimated useful life of the assets.  &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-lived assets are reviewed for impairment whenever conditions indicate that the carrying value of the assets may not be fully recoverable. Such impairment tests are based on a comparison of the pretax undiscounted cash flows expected to be generated by the asset to the recorded value of the asset or other market-based value approaches. If impairment is indicated, the asset value is written down to its market value if readily determinable or its estimated fair value based on discounted cash flows. Any significant changes in business or market conditions that vary from current expectations could have an impact on the fair value of these assets and any potential associated impairment.  On June 30, 2020, the Company transferred its remaining intangible asset to Exela Sterile Medicines LLC (&#x201c;Exela Buyer&#x201d;) as part of the disposition of the Hospital Products.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lease Obligations. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if a contract is a lease at the inception of the arrangement. Right-of-use assets and operating lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. The Company reviews all options to extend, terminate, or purchase its right-of-use assets at the inception of the lease and will include these options in the lease term when they are reasonably certain of being exercised. Short term leases with an initial term of 12 months or less are not recorded on the balance sheet and the associated lease payments are recognized in the consolidated statements of (loss) income on a straight-line basis over the lease term. The Company&#x2019;s lease contracts do not provide a readily determinable implicit rate. The Company&#x2019;s estimated incremental borrowing rate is based on information available at the inception of the lease. The Company&#x2019;s lease agreements may contain variable costs such as common area maintenance, insurance, real estate taxes or other costs. Variable lease costs are expensed as incurred on the consolidated statements of (loss) income.&lt;/span&gt;&lt;/div&gt;Use of Estimates. The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, including marketable securities and contingent liabilities at the date of the consolidated financial statements and the reported amounts of sales and expenses during the periods presented. These estimates and assumptions are based on the best information available to management at the balance sheet dates and depending on the nature of the estimate can require significant judgments. Changes to these estimates and judgments can have and have had a material impact on the Company&#x2019;s consolidated statements of (loss) income and balance sheets.  Actual results could differ from those estimates under different assumptions or&#160;conditions.</us-gaap:SignificantAccountingPoliciesTextBlock>
    <avdl:NatureOfBusinessPolicyPolicyTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyODg_2e27f442-605b-43e9-b120-31662a996db5">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nature of Operations.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Avadel Pharmaceuticals plc (Nasdaq: AVDL) (&#x201c;Avadel,&#x201d; the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;our,&#x201d; or &#x201c;us&#x201d;) is a biopharmaceutical company. The Company is registered as an Irish public limited company. The Company&#x2019;s headquarters are in Dublin, Ireland with operations in St. Louis, Missouri, United States (&#x201c;U.S&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s lead product candidate, FT218, is an investigational once-nightly, extended-release formulation of sodium oxybate for the treatment of excessive daytime sleepiness (&#x201c;EDS&#x201d;) or cataplexy in adults with narcolepsy. The Company is primarily focused on the development and potential United States (&#x201c;U.S.&#x201d;) Food and Drug Administration (&#x201c;FDA&#x201d;) approval of FT218. In December 2020, the Company submitted a New Drug Application (&#x201c;NDA&#x201d;) to the FDA for FT218 to treat excessive daytime sleepiness or cataplexy in adults with narcolepsy. In February 2021, the NDA for FT218 was accepted by the FDA and was assigned a Prescription Drug User Fee Act (&#x201c;PDUFA&#x201d;) target action date of October 15, 2021. On October 15, 2021, the Company announced that the FDA informed us that the review of the Company&#x2019;s NDA for FT218 was ongoing beyond its previously assigned target action date. As of the date of this Annual Report, the FDA&#x2019;s review of the Company&#x2019;s NDA for FT218 remains ongoing. &lt;/span&gt;&lt;/div&gt;Outside of the Company&#x2019;s lead product candidate, the Company continues to evaluate opportunities to expand its product portfolio. As of the date of this Annual Report, the Company does not have any approved or commercialized products in its portfolio.</avdl:NatureOfBusinessPolicyPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyMTg_ed8c6693-5c90-4b21-ae40-60fe2ecf78ff">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (&#x201c;U.S. GAAP&#x201d;). The consolidated financial statements include the accounts of the Company and all subsidiaries. All intercompany accounts and transactions have been eliminated.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s results of operations for the period January 1, 2019 through February 6, 2019 include the results of Avadel Specialty Pharmaceuticals, LLC (&#x201c;Specialty Pharma&#x201d;) prior to its February 6, 2019 voluntary petition for reorganization under Chapter 11 of the U.S. Bankruptcy Code. See&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 3: Subsidiary Bankruptcy and Deconsolidation.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyNzY_8d1e7e9f-28db-419a-aa68-234252984277">Reclassifications&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain reclassifications are made to prior year amounts whenever necessary to conform with the current year presentation. Certain reclassifications have been made to the Consolidated Statements of Cash Flows for the fiscal year ended December 31, 2019 and balances within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 14: Other Assets and Liabilities &lt;/span&gt;for the year ended December 31, 2020 to condense line items of the same nature into a single line. This change does not affect previously reported net cash flows used in operating activities in the Consolidated Statements of Cash Flows.</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <avdl:DebtInstrumentAdditionalInterestExpensePercentage
      contextRef="ic562d9c206fb48efa5bb76601ca9f47a_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMTA0NDUzNjA1Mjc2ODc_8f3bcb5c-7576-4bf5-83dc-294ef33552e0"
      unitRef="number">0.0050</avdl:DebtInstrumentAdditionalInterestExpensePercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0a1f89fa820b46799ce79a937450f547_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMTA0NDUzNjA1Mjc2OTQ_6328c307-48ec-4c68-afb4-8003e0916c82"
      unitRef="number">0.0450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <avdl:AdditionalInterestExpenseDebt
      contextRef="ic562d9c206fb48efa5bb76601ca9f47a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMTA0NDUzNjA1Mjc3MDE_77bb6140-0da3-49f7-ba89-1d73496e285f"
      unitRef="usd">817000</avdl:AdditionalInterestExpenseDebt>
    <avdl:AdditionalInterestExpenseDebt
      contextRef="i1f8c561814cb4f708a96e8a38bb166f0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMTA0NDUzNjA1Mjc3MTA_8610802e-7eaf-4d79-b8ed-6aec9ad7f79b"
      unitRef="usd">773000</avdl:AdditionalInterestExpenseDebt>
    <avdl:AdditionalInterestExpenseDebt
      contextRef="i5309d5e8acaa431c9c274770bb06176c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMTA0NDUzNjA1Mjc3MTk_4f9e8615-168c-4e41-9a50-8f33bb670584"
      unitRef="usd">635000</avdl:AdditionalInterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i99ac7af65eda496da535e06c493274b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjc0ODc3OTEzNDk0Nw_1fd3a4fa-6349-4d1a-b237-db0618749f6d"
      unitRef="usd">1408000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i99ac7af65eda496da535e06c493274b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMTA0NDUzNjA1Mjc3Mjg_d016d7d1-7fd3-4df9-9816-ef1c3f191d1a"
      unitRef="usd">1408000</us-gaap:InterestExpenseDebt>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEzMTM_15fbc60d-3e6d-4a8c-8a88-8242ecb30f33">&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to June 30, 2020, revenue included sales of pharmaceutical products, licensing fees, and, if any, milestone payments for research and development (&#x201c;R&amp;amp;D&#x201d;) achievements.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To determine the appropriate revenue recognition, the Company performs the following five steps: (i) Identify the contract(s) with a customer&#x37e; (ii) Identify the performance obligations in the contract; (iii) Determine the transaction price&#x37e; (iv) Allocate the transaction price to the performance obligations in the contract&#x37e; and (v) Recognize revenue when (or as) the entity satisfies a performance obligation. The Company applies the five-step model to contracts only when the Company and its customer&#x2019;s rights and obligations under the contract can be determined, the contract has commercial substance, and it is probable that the Company will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. The Company identifies the promised goods or services in the contract to determine if they are separate performance obligations or if they should be bundled with other goods and services into a single performance obligation. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Sales &#160;&lt;/span&gt;&lt;/div&gt;Prior to June 30, 2020, the Company sold products primarily through wholesalers and considered these wholesalers to be the Company&#x2019;s customers. Revenue from product sales is recognized when the customer obtains control of the Company&#x2019;s product, which occurs typically upon receipt by the customer. The Company&#x2019;s gross product sales were subject to a variety of price adjustments in arriving at reported net product sales. These adjustments included estimates of product returns, chargebacks, payment discounts, rebates, and other sales allowances and are estimated based on analysis of historical data for the product or comparable products, future expectations for such products and other judgments and analysis.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyMDM_6bcd848e-e92a-45f2-aef8-4f524a599d8b">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development (&#x201c;R&amp;amp;D&#x201d;). &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; R&amp;amp;D expenses consist primarily of costs related to outside services, personnel expenses, clinical studies and other R&amp;amp;D expenses. Outside services and clinical studies costs relate primarily to services performed by clinical research organizations and related clinical or development manufacturing costs, materials and supplies, filing fees, regulatory support, and other third-party fees. Personnel expenses relate primarily to salaries, benefits and share-based compensation. Other R&amp;amp;D expenses primarily include overhead allocations consisting of various support and facilities-related costs. R&amp;amp;D expenditures are charged to operations as incurred. Raw materials used in the production of pre-clinical and clinical products are expensed as R&amp;amp;D costs.  &#160;&lt;/span&gt;The Company recognizes refundable R&amp;amp;D tax credits received for spending on innovative R&amp;amp;D as an offset of R&amp;amp;D expenses.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyMzE_4a698fb8-e20d-4e3c-8b03-c0c97c443b8a">Advertising Expenses.  The Company expenses the costs of advertising as incurred. Branded advertising expenses were $0, $312 and $372 for the years ended December&#160;31, 2021, 2020 and 2019, respectively.</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:CostsAndExpenses
      contextRef="iaf9cbe9d47d34e1390ad1c335c52c141_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfNzAyMw_4b92a0a9-2383-480c-b1da-457a1b16c271"
      unitRef="usd">0</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i4b913b3f3b0f4f44964bcbdf8ad62c1b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfNzAyNw_f034581a-0154-47f6-8823-0bf7ca7a62f3"
      unitRef="usd">312000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="iaa9feaab286342789251faa80710001c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfNzAzNA_81014fdd-169d-44ca-8662-db04f2e28587"
      unitRef="usd">372000</us-gaap:CostsAndExpenses>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyNTA_f4d116c5-a8e4-48ca-b8dd-9768b4a86f43">Share-based Compensation. The Company accounts for share-based compensation based on the estimated grant-date fair value. The fair value of stock options is estimated using Black-Scholes option-pricing valuation models (&#x201c;Black-Scholes model&#x201d;). As required by the Black-Scholes model, estimates are made of the underlying volatility of Avadel stock, a risk-free rate and an expected term of the option or warrant. The Company estimates the expected term using a simplified method, as the Company does not have enough historical exercise data for a majority of such options upon which to estimate an expected term. The Company recognizes compensation cost, net of an estimated forfeiture rate, using the accelerated method over the requisite service period of the award.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyMTU_53bd4a8a-7d07-4470-960c-9cce6811f88a">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, the Company determines deferred tax assets and liabilities on the basis of the differences between the financial statement and tax bases of assets and liabilities by using enacted tax rates in effect for the year in which &lt;/span&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes deferred tax assets to the extent that the Company believes that these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the Company determines that it would be able to realize its deferred tax assets in the future in excess of their net recorded amount, the Company would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records uncertain tax positions on the basis of a two-step process in which (1) the Company determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes interest and penalties related to unrecognized tax benefits in the income tax expense line in the consolidated statements of (loss) income. Accrued interest and penalties are included on the related tax liability line in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyMjE_2880bdaf-e1d0-47b7-b6f5-1c1085706135">Cash and Cash Equivalents.  Cash and cash equivalents consist of cash on hand, cash on deposit and fixed term deposits which are highly liquid investments with original maturities of less than three months.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyOTk_a6e89a6a-261b-48c6-890b-b0601853d65a">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Marketable Securities. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s marketable securities are considered to be available for sale and are carried at fair value, with unrealized gains and losses, net of taxes, reported as a component of accumulated other comprehensive (loss) income (&#x201c;AOCI&#x201d;) in shareholders&#x2019; equity, with the exception of unrealized gains and losses on equity instruments and allowances for expected credit losses, if any, which are reported in earnings in the current period. The cost of securities sold is based upon the specific identification method.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;For available-for-sale debt securities in an unrealized loss position, the Company assesses whether it intends to sell or if it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security&#x2019;s amortized cost basis is written down to fair value. If the criteria are not met, the Company evaluates whether the decline in fair value has resulted from a credit loss or other factors. In making this assessment, management considers, among other factors, the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and adverse conditions specifically related to the security. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of the cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded for the credit loss, limited by the amount that the fair value is less than the amortized costs basis.</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyMTY_7382f6f4-2e8b-4ac6-aa22-96c42bb383a3">Allowance for Credit Losses.  Amounts owed to the Company are presented net of an allowance that includes as assessment of expected credit losses.  An allowance for credit losses is established based on expected losses. Expected losses are estimated by reviewing individual accounts, considering aging, financial condition of the debtor, payment history, current and forecast economic conditions and other relevant factors.  To the extent that the Company identifies that any individual customer's credit quality has deteriorated, the Company establishes allowances based on the individual risk characteristics of that customer. The Company makes concerted efforts to collect all outstanding balances due from customers; however, amounts are written off against the allowance when the related balances are no longer deemed collectible</us-gaap:FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyMTI_51712042-c533-4d6f-82b6-e20fb688821a">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  Property and equipment is stated at historical cost less accumulated depreciation. Depreciation and amortization are computed using the straight-line method over the following estimated useful lives:  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software, office and computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements, furniture, fixtures and fittings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5-10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyOTM_9c5434b8-64f5-40c4-b957-ed5ba2310bf5">Property and equipment is stated at historical cost less accumulated depreciation. Depreciation and amortization are computed using the straight-line method over the following estimated useful lives:  &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software, office and computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements, furniture, fixtures and fittings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5-10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The principal categories of property and equipment, net at December&#160;31, 2021 and 2020, respectively, are as&#160;follows:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.103%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Property and Equipment, net:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Software, office and computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures and fittings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less - accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(465)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,384)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i78886c225d1047eeaaea9dd1a3216a79_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RhYmxlOmI4ODRmZDJmNGNhMTQ4Yzk4OGVmMDUyMTM4ZDI5YzcxL3RhYmxlcmFuZ2U6Yjg4NGZkMmY0Y2ExNDhjOTg4ZWYwNTIxMzhkMjljNzFfMS0xLTEtMS0yMzQ1OA_ed3ab7a3-cca1-4194-8a2e-59b629bbbec3">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i66c72f9a21ad431c99a6a9e5043d92a7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RhYmxlOmI4ODRmZDJmNGNhMTQ4Yzk4OGVmMDUyMTM4ZDI5YzcxL3RhYmxlcmFuZ2U6Yjg4NGZkMmY0Y2ExNDhjOTg4ZWYwNTIxMzhkMjljNzFfMi0xLTEtMS0yMzQ1OC90ZXh0cmVnaW9uOmQyY2JmMzY2NjUwNTQ0ZGU5MGQ4ODVhZDU5ZDFmOTk1XzQ_a9854735-69fb-48d9-aed3-e47623351b19">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ie09e5d490621464e9ce04e340e7c04df_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RhYmxlOmI4ODRmZDJmNGNhMTQ4Yzk4OGVmMDUyMTM4ZDI5YzcxL3RhYmxlcmFuZ2U6Yjg4NGZkMmY0Y2ExNDhjOTg4ZWYwNTIxMzhkMjljNzFfMi0xLTEtMS0yMzQ1OC90ZXh0cmVnaW9uOmQyY2JmMzY2NjUwNTQ0ZGU5MGQ4ODVhZDU5ZDFmOTk1Xzc_1347a9fd-e041-438c-82cb-edee4b9cf5b8">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyNDc_1be128e4-af83-4f9c-b90c-e91cb4f40a0f">Goodwill.  Goodwill represents the excess of the acquisition consideration over the fair value of assets acquired and liabilities assumed. The Company has determined that it operates in a single segment and have a single reporting unit associated with the development and commercialization of pharmaceutical products.  The Company tests goodwill for impairment annually and when events or changes in circumstances indicate that the carrying value may not be recoverable. The Company determined that no impairment of goodwill existed at December 31, 2021 and 2020.</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjc0ODc3OTExNzkyOQ_1bf89cf3-cf81-44d8-b6b2-ffcdb97fb356"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjc0ODc3OTExNzkyOQ_d8a6a29f-cb96-4519-9ca8-3f19f1121f87"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyNjA_a9395b5e-cf90-4508-b988-04417047c7bb">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Lived Assets. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-lived assets include fixed assets and intangible assets. Prior to the sale of the Company&#x2019;s portfolio of sterile injectable drugs used in the hospital setting (&#x201c;Hospital Products&#x201d;) on June 30, 2020, intangible assets consisted primarily of purchased licenses and intangible assets recognized as part of the &#xc9;clat Pharmaceuticals acquisition. Acquired in-process research and development (&#x201c;IPR&amp;amp;D&#x201d;) had an indefinite life and was not amortized until completion and development of the project, at which time the IPR&amp;amp;D became an amortizable asset, for which amortization of such intangible assets was computed using the straight-line method over the estimated useful life of the assets.  &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-lived assets are reviewed for impairment whenever conditions indicate that the carrying value of the assets may not be fully recoverable. Such impairment tests are based on a comparison of the pretax undiscounted cash flows expected to be generated by the asset to the recorded value of the asset or other market-based value approaches. If impairment is indicated, the asset value is written down to its market value if readily determinable or its estimated fair value based on discounted cash flows. Any significant changes in business or market conditions that vary from current expectations could have an impact on the fair value of these assets and any potential associated impairment.  On June 30, 2020, the Company transferred its remaining intangible asset to Exela Sterile Medicines LLC (&#x201c;Exela Buyer&#x201d;) as part of the disposition of the Hospital Products.&lt;/span&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjExOTU_aa8873f3-530a-4dfc-a91e-4bb3e5bbc6ae">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lease Obligations. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if a contract is a lease at the inception of the arrangement. Right-of-use assets and operating lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. The Company reviews all options to extend, terminate, or purchase its right-of-use assets at the inception of the lease and will include these options in the lease term when they are reasonably certain of being exercised. Short term leases with an initial term of 12 months or less are not recorded on the balance sheet and the associated lease payments are recognized in the consolidated statements of (loss) income on a straight-line basis over the lease term. The Company&#x2019;s lease contracts do not provide a readily determinable implicit rate. The Company&#x2019;s estimated incremental borrowing rate is based on information available at the inception of the lease. The Company&#x2019;s lease agreements may contain variable costs such as common area maintenance, insurance, real estate taxes or other costs. Variable lease costs are expensed as incurred on the consolidated statements of (loss) income.&lt;/span&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85MS9mcmFnOmNjMTg5NTM0Yjc2NDQ5Mjk4YzQ5NDcxZGIzYjAwOGI2L3RleHRyZWdpb246Y2MxODk1MzRiNzY0NDkyOThjNDk0NzFkYjNiMDA4YjZfMjEyNjQ_cac652ec-8579-4324-a85d-59f4c14b7686">Use of Estimates. The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, including marketable securities and contingent liabilities at the date of the consolidated financial statements and the reported amounts of sales and expenses during the periods presented. These estimates and assumptions are based on the best information available to management at the balance sheet dates and depending on the nature of the estimate can require significant judgments. Changes to these estimates and judgments can have and have had a material impact on the Company&#x2019;s consolidated statements of (loss) income and balance sheets.  Actual results could differ from those estimates under different assumptions or&#160;conditions.</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85NC9mcmFnOmE0MDc4MDQ4YTIyODQxMTE5YTc4OTRlOTk3ZDk0OTljL3RleHRyZWdpb246YTQwNzgwNDhhMjI4NDExMTlhNzg5NGU5OTdkOTQ5OWNfMzEwNQ_6eddb116-3adf-4821-ab1c-af7dd2c53021">Newly Issued Accounting Standards&#160;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Guidance&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. The FASB&#x2019;s amendments primarily impact ASC 740, Income Taxes, and may impact both interim and annual reporting periods. ASU 2019-12 is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years and early adoption is permitted. The Company adopted the provisions of ASU 2019-12 on January 1, 2021. Adoption of ASU 2019-12 did not have any impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging- Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to reduce the complexity associated with applying U.S. GAAP principles for certain financial instruments with characteristics of liabilities and equity. The amendments in this ASU reduce the number of accounting models for convertible instruments and expand the existing disclosure requirements over earnings per share as it relates to convertible instruments. Convertible debt will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The update also requires the if-converted method to be used for convertible instruments and the effect of potential share settlement be included in the diluted earnings per share calculation when an instrument may be settled in cash or shares. This ASU will be effective for the Company&#x2019;s fiscal year beginning January 1, 2022 and interim periods therein. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The amendments may be adopted through either a modified retrospective method, or a fully retrospective method.&lt;/span&gt;&lt;/div&gt;The Company elected to early adopt ASU 2020-06 as of January 1, 2021 using a modified retrospective method. The Company&#x2019;s 4.50% exchangeable senior notes due 2023 (the &#x201c;2023 Notes&#x201d;) are a convertible instrument with a cash-conversion feature that is accounted for within the scope of Subtopic 470-20. The Company calculated the cumulative-effect adjustment as of January 1, 2021 by comparing (i) the historical amortization schedule for the 2023 Notes through December 31, 2020 and (ii) an updated amortization schedule wherein the conversion feature within the 2023 Notes would not be separated as an equity component and subsequently recognized as non-cash interest expense under ASC 835-30. The adoption resulted in a $26,699 decrease in additional paid-in capital, a $12,939 increase in long-term debt, and a $13,760 increase to the opening balance of retained earnings.</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85NC9mcmFnOmE0MDc4MDQ4YTIyODQxMTE5YTc4OTRlOTk3ZDk0OTljL3RleHRyZWdpb246YTQwNzgwNDhhMjI4NDExMTlhNzg5NGU5OTdkOTQ5OWNfMzEwOA_48792386-6df4-4f36-89d6-f3df534a42d1">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Guidance&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. The FASB&#x2019;s amendments primarily impact ASC 740, Income Taxes, and may impact both interim and annual reporting periods. ASU 2019-12 is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years and early adoption is permitted. The Company adopted the provisions of ASU 2019-12 on January 1, 2021. Adoption of ASU 2019-12 did not have any impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging- Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to reduce the complexity associated with applying U.S. GAAP principles for certain financial instruments with characteristics of liabilities and equity. The amendments in this ASU reduce the number of accounting models for convertible instruments and expand the existing disclosure requirements over earnings per share as it relates to convertible instruments. Convertible debt will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The update also requires the if-converted method to be used for convertible instruments and the effect of potential share settlement be included in the diluted earnings per share calculation when an instrument may be settled in cash or shares. This ASU will be effective for the Company&#x2019;s fiscal year beginning January 1, 2022 and interim periods therein. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The amendments may be adopted through either a modified retrospective method, or a fully retrospective method.&lt;/span&gt;&lt;/div&gt;The Company elected to early adopt ASU 2020-06 as of January 1, 2021 using a modified retrospective method. The Company&#x2019;s 4.50% exchangeable senior notes due 2023 (the &#x201c;2023 Notes&#x201d;) are a convertible instrument with a cash-conversion feature that is accounted for within the scope of Subtopic 470-20. The Company calculated the cumulative-effect adjustment as of January 1, 2021 by comparing (i) the historical amortization schedule for the 2023 Notes through December 31, 2020 and (ii) an updated amortization schedule wherein the conversion feature within the 2023 Notes would not be separated as an equity component and subsequently recognized as non-cash interest expense under ASC 835-30. The adoption resulted in a $26,699 decrease in additional paid-in capital, a $12,939 increase in long-term debt, and a $13,760 increase to the opening balance of retained earnings.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8ffb01488f3a42119218fd36f48c1d40_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85NC9mcmFnOmE0MDc4MDQ4YTIyODQxMTE5YTc4OTRlOTk3ZDk0OTljL3RleHRyZWdpb246YTQwNzgwNDhhMjI4NDExMTlhNzg5NGU5OTdkOTQ5OWNfMjc0ODc3OTA3ODgyNA_28a36894-385e-4787-a43d-2f549c541bf1"
      unitRef="number">0.0450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:StockholdersEquity
      contextRef="i27057cf80d054326a72f1357eef1f0c2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85NC9mcmFnOmE0MDc4MDQ4YTIyODQxMTE5YTc4OTRlOTk3ZDk0OTljL3RleHRyZWdpb246YTQwNzgwNDhhMjI4NDExMTlhNzg5NGU5OTdkOTQ5OWNfMjc0ODc3OTA3ODgzMQ_5712682b-e2aa-43fb-991f-f3d231967eaa"
      unitRef="usd">-26699000</us-gaap:StockholdersEquity>
    <us-gaap:LongTermDebt
      contextRef="ia03de445d5514be7925f47534612a3c6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85NC9mcmFnOmE0MDc4MDQ4YTIyODQxMTE5YTc4OTRlOTk3ZDk0OTljL3RleHRyZWdpb246YTQwNzgwNDhhMjI4NDExMTlhNzg5NGU5OTdkOTQ5OWNfMjc0ODc3OTA3ODg0Mw_59fba576-a9f3-46ac-8de1-e88836cc7de1"
      unitRef="usd">12939000</us-gaap:LongTermDebt>
    <us-gaap:StockholdersEquity
      contextRef="ifdaa54a433dd430a83d91856c8287945_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85NC9mcmFnOmE0MDc4MDQ4YTIyODQxMTE5YTc4OTRlOTk3ZDk0OTljL3RleHRyZWdpb246YTQwNzgwNDhhMjI4NDExMTlhNzg5NGU5OTdkOTQ5OWNfMjc0ODc3OTA3ODg1NQ_d8be8e18-f250-49ff-997a-8bb0bc3fdffb"
      unitRef="usd">13760000</us-gaap:StockholdersEquity>
    <us-gaap:ReorganizationUnderChapter11OfUSBankruptcyCodeDisclosureTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85Ny9mcmFnOjY4NmZkNTA2OTY5NzRkNzFiZGM4N2JmYjk3NTZmOWQ1L3RleHRyZWdpb246Njg2ZmQ1MDY5Njk3NGQ3MWJkYzg3YmZiOTc1NmY5ZDVfNjE4Ng_887b2594-d0cd-4076-a6e1-0fa9c44c2ed3">Subsidiary Bankruptcy and Deconsolidation&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 6, 2019, the Company deconsolidated Specialty Pharma effective with the filing of the Chapter 11 bankruptcy and recorded a non-cash charge of approximately&#160;$2,678&#160;for the&#160;year ended&#160;December 31, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized a non-cash gain of $217 and $3,364 from the release of certain liabilities that had been retained following the deconsolidation of Specialty Pharma. These gains are included in "Gain from release of certain liabilities" within non-operating (loss) income for the years ended December 31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;On October 26, 2021, the U.S. Bankruptcy Court for the District of Delaware issued the Final Decree and Order, dismissing the bankruptcy case and dissolving Specialty Pharma.</us-gaap:ReorganizationUnderChapter11OfUSBankruptcyCodeDisclosureTextBlock>
    <us-gaap:DeconsolidationGainOrLossAmount
      contextRef="i85c848bffc1542ceb9f02559b91119f8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85Ny9mcmFnOjY4NmZkNTA2OTY5NzRkNzFiZGM4N2JmYjk3NTZmOWQ1L3RleHRyZWdpb246Njg2ZmQ1MDY5Njk3NGQ3MWJkYzg3YmZiOTc1NmY5ZDVfMTUwMw_85210919-872b-4a89-8758-0f8876133e9b"
      unitRef="usd">-2678000</us-gaap:DeconsolidationGainOrLossAmount>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85Ny9mcmFnOjY4NmZkNTA2OTY5NzRkNzFiZGM4N2JmYjk3NTZmOWQ1L3RleHRyZWdpb246Njg2ZmQ1MDY5Njk3NGQ3MWJkYzg3YmZiOTc1NmY5ZDVfMTY0OTI2NzQ0ODEzNg_13afc7dc-7200-4499-9e99-20c42ae4c09f"
      unitRef="usd">217000</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl85Ny9mcmFnOjY4NmZkNTA2OTY5NzRkNzFiZGM4N2JmYjk3NTZmOWQ1L3RleHRyZWdpb246Njg2ZmQ1MDY5Njk3NGQ3MWJkYzg3YmZiOTc1NmY5ZDVfNDk3MQ_2810091e-99f7-4a4f-b4bd-46372bf1d059"
      unitRef="usd">3364000</us-gaap:DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4Xzc2MjA_7d688c82-d4bc-4534-b68b-e6bf9f5280b6">Disposition of the Hospital Products&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 30, 2020 (the &#x201c;Closing Date&#x201d;), the Company announced the sale of its Hospital Products, which included its three FDA-approved commercial products, Akovaz, Bloxiverz and Vazculep, as well as Nouress, to the Exela Buyer pursuant to an Asset Purchase Agreement (the &#x201c;Transaction&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Transaction, the Exela Buyer agreed to pay a total aggregate consideration amount of $42,000, of which $14,500 was paid on the Closing Date and an additional $27,500 was paid in &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzQwNg_d7d1bf58-ccde-4c16-a6b6-573abd462bd2"&gt;ten&lt;/span&gt; equal monthly installments following the Closing Date. During the year ended December 31, 2020, the Company collected four installment payments, totaling $11,000. The Company collected the remaining six installment payments, totaling $16,500 during 2021. In connection with the sale of the Hospital Products, the parties also agreed to cause the dismissal of the pending civil litigation related to Nouress in the District Court for the District of Delaware.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company was party to a Membership Interest Purchase Agreement, dated March 13, 2012, by and among the Company, Avadel Legacy, Breaking Stick Holdings, LLC, Deerfield Private Design International II, L.P. (&#x201c;Deerfield International&#x201d;), Deerfield Private Design Fund II, L.P. (&#x201c;Deerfield Fund&#x201d;) and Horizon Sant&#xe9; FLML, Sarl (&#x201c;Horizon&#x201d;) (the &#x201c;Deerfield MIPA&#x201d;) and a Royalty Agreement, dated February 4, 2013, by and among the Company, Avadel Legacy, the Deerfield Fund and Horizon (the &#x201c;Deerfield Royalty Agreement&#x201d;). In connection with the closing of the sale of the Hospital Products, the Deerfield MIPA (with respect to certain sections thereof) and the Royalty Agreement were assigned to the Exela Buyer. Pursuant to the Purchase Agreement, the Exela Buyer assumed and will pay, perform, satisfy and discharge the liabilities and obligations of Avadel Legacy under the Deerfield Royalty Agreement for obligations that arise after the Closing Date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company was also party to a Royalty Agreement, dated December 3, 2013, by and between the Company, Avadel Legacy and Broadfin Healthcare Master Fund, Ltd. (the &#x201c;Broadfin Royalty Agreement&#x201d;). In connection with the closing of the sale of the Hospital Products, the Broadfin Royalty Agreement was assigned to the Exela Buyer and the Exela Buyer assumed and shall pay, perform, satisfy and discharge the liabilities and obligations of Avadel Legacy under the Broadfin Royalty Agreement for obligations that arise after the Closing Date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded a net gain on the sale of the Hospital Products of $45,760 during the year ended December 31, 2020 which has been recorded on the consolidated statements of (loss) income. The $45,760 gain represents the aggregate consideration of $42,000, less transaction fees of $2,928, plus the assets and liabilities either transferred to the Exela Buyer or eliminated by the Company due to the sale of the Hospital Products, which are listed below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,922)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,654)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term contingent consideration payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net liabilities disposed of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Aggregate consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less transaction fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,928)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net gain on the sale of the Hospital Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to the disposition of the Hospital Products, the Company entered into a separate and distinct agreement with the Exela Buyer, whereby the Exela Buyer assumed all future returns of the Hospital Products in exchange for cash consideration paid by the Company. The Company recorded a $518 gain from this transaction, which is recorded in &#x201c;Selling, general and administrative expenses&#x201d; for the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluated various qualitative and quantitative factors related to the disposition of the Hospital Products and determined that it did not meet the criteria for presentation as a discontinued operation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited pro forma condensed combined statements of (loss) income for the years ended December 31, 2020 and 2019 included below is being provided for information purposes only and are not necessarily indicative of the results of operations that would have resulted if the Transaction had actually occurred on the date indicated. The pro forma adjustments are based on available information and assumptions that the Company believes are attributable to the sale.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.001%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unaudited Pro Forma Condensed Combined Statement of (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pro Forma Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pro Forma&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Product sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13,783)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,968)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,082)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13,348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.001%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unaudited Pro Forma Condensed Combined Statement of (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pro Forma Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pro Forma&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Product sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(59,273)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;83,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,092)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,112)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(67,293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38,582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(42,803)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(e)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(81,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Adjustments to the pro forma unaudited condensed combined statements of (loss) income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) This adjustment reflects Product sales attributable to the Hospital Products.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b) This adjustment reflects the following estimated expenses attributable to the Hospital Products:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Cost of products of $3,540.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;R&amp;amp;D expenses of $322.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Selling, general and administrative expenses of $797.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Intangible asset amortization on acquired development technology for Vazculep of $406.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Changes in fair value of related party contingent consideration of $3,327. The Company will no longer be responsible for these payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c) This amount reflects the adjustments noted in (a) and (b) above, as well as estimated Changes in fair value of related party payable of $435 attributable to the Hospital Products. The Company will no longer be responsible for these payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(d) This adjustment reflects the following estimated expenses attributable to the Hospital Products:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Cost of products of $11,368.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;R&amp;amp;D expenses of $1,960.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Selling, general and administrative expenses of $1,102.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Intangible asset amortization on acquired development technology for Vazculep of $816.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Changes in fair value of related party contingent consideration of $845. The Company will no longer be responsible for these payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(e) This amount reflects the adjustments noted in (a) and (d) above, as well as the reversal of estimated Changes in fair value of related party payable of $378 attributable to the Hospital Products. The Company will no longer be responsible for these payments.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i394c910852974a2b9a5ecd7ffb761fce_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzMyMw_84e2c138-480a-45ec-a79d-aef59d4493d0"
      unitRef="usd">42000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <avdl:DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration
      contextRef="i394c910852974a2b9a5ecd7ffb761fce_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzMzNg_3b8ac63c-dcd7-495a-8bc0-3ed52795a51d"
      unitRef="usd">14500000</avdl:DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration>
    <avdl:DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments
      contextRef="i394c910852974a2b9a5ecd7ffb761fce_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzM4Ng_f25f95f3-6ada-4cf2-8d4f-c5b42184da52"
      unitRef="usd">27500000</avdl:DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i0756957a1e1d4fce943a2b692ad6e709_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzUyNw_02fb9dbf-cb73-4411-b80f-ecebb706a86a"
      unitRef="usd">11000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i1c9923703844411eb3e5ce7edba6c8ed_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzY1Mg_7c89975b-4ab3-4d4f-b29b-69152789ea73"
      unitRef="usd">16500000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i0756957a1e1d4fce943a2b692ad6e709_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzIzOTg_94f3abaa-e98b-4c46-9f06-a130c4a3f137"
      unitRef="usd">45760000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4Xzc2MjE_ab2dd2e5-5802-4e90-a6d9-8bd546681715">The $45,760 gain represents the aggregate consideration of $42,000, less transaction fees of $2,928, plus the assets and liabilities either transferred to the Exela Buyer or eliminated by the Company due to the sale of the Hospital Products, which are listed below.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,922)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,654)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term contingent consideration payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net liabilities disposed of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Aggregate consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less transaction fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,928)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net gain on the sale of the Hospital Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i0756957a1e1d4fce943a2b692ad6e709_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzI1MTc_2f5e86e4-cbed-4160-94cd-e26b368ffaa7"
      unitRef="usd">45760000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="ic759888cdbc54a9a9b75a3bc35604e1c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzI1Njc_83556bc0-c3aa-4750-b123-06957409724a"
      unitRef="usd">42000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
      contextRef="i0756957a1e1d4fce943a2b692ad6e709_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzI1OTY_a753398b-428c-4685-803e-5a37bf0b87d9"
      unitRef="usd">2928000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets
      contextRef="i394c910852974a2b9a5ecd7ffb761fce_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo4MTQyNzRlZWRjNTQ0NTM3OTgzMWY4YjI5MzZjMTNjNi90YWJsZXJhbmdlOjgxNDI3NGVlZGM1NDQ1Mzc5ODMxZjhiMjkzNmMxM2M2XzEtMi0xLTEtMjM0NTg_9ff507bf-570b-4a8e-a3d2-fe10bb09b0f5"
      unitRef="usd">134000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1
      contextRef="i394c910852974a2b9a5ecd7ffb761fce_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo4MTQyNzRlZWRjNTQ0NTM3OTgzMWY4YjI5MzZjMTNjNi90YWJsZXJhbmdlOjgxNDI3NGVlZGM1NDQ1Mzc5ODMxZjhiMjkzNmMxM2M2XzItMi0xLTEtMjM0NTg_aca67ac0-028e-4bab-b5f4-bb7000329e74"
      unitRef="usd">4922000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1
      contextRef="i394c910852974a2b9a5ecd7ffb761fce_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo4MTQyNzRlZWRjNTQ0NTM3OTgzMWY4YjI5MzZjMTNjNi90YWJsZXJhbmdlOjgxNDI3NGVlZGM1NDQ1Mzc5ODMxZjhiMjkzNmMxM2M2XzMtMi0xLTEtMjM0NTg_8208bd27-a68e-44fb-8293-cb985d6bf0b4"
      unitRef="usd">1654000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="i394c910852974a2b9a5ecd7ffb761fce_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo4MTQyNzRlZWRjNTQ0NTM3OTgzMWY4YjI5MzZjMTNjNi90YWJsZXJhbmdlOjgxNDI3NGVlZGM1NDQ1Mzc5ODMxZjhiMjkzNmMxM2M2XzQtMi0xLTEtMjM0NTg_1796a0a7-651d-403d-96f4-2ffbe01016ec"
      unitRef="usd">407000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets
      contextRef="i394c910852974a2b9a5ecd7ffb761fce_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo4MTQyNzRlZWRjNTQ0NTM3OTgzMWY4YjI5MzZjMTNjNi90YWJsZXJhbmdlOjgxNDI3NGVlZGM1NDQ1Mzc5ODMxZjhiMjkzNmMxM2M2XzUtMi0xLTEtMjM0NTg_ddc2a379-c563-4787-b1e9-a6b47916ee1c"
      unitRef="usd">1095000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets>
    <us-gaap:DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining
      contextRef="i394c910852974a2b9a5ecd7ffb761fce_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo4MTQyNzRlZWRjNTQ0NTM3OTgzMWY4YjI5MzZjMTNjNi90YWJsZXJhbmdlOjgxNDI3NGVlZGM1NDQ1Mzc5ODMxZjhiMjkzNmMxM2M2XzYtMi0xLTEtMjM0NTg_89f61009-d996-48ca-a284-ab21a235ad8a"
      unitRef="usd">14900000</us-gaap:DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i394c910852974a2b9a5ecd7ffb761fce_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo4MTQyNzRlZWRjNTQ0NTM3OTgzMWY4YjI5MzZjMTNjNi90YWJsZXJhbmdlOjgxNDI3NGVlZGM1NDQ1Mzc5ODMxZjhiMjkzNmMxM2M2XzctMi0xLTEtMjM0NTg_db152de5-d190-436d-8d91-129295eaa880"
      unitRef="usd">6688000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i394c910852974a2b9a5ecd7ffb761fce_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo4MTQyNzRlZWRjNTQ0NTM3OTgzMWY4YjI5MzZjMTNjNi90YWJsZXJhbmdlOjgxNDI3NGVlZGM1NDQ1Mzc5ODMxZjhiMjkzNmMxM2M2XzgtMi0xLTEtMjM0NTg_c6224b40-7109-49b6-b78a-9e580b3fe47a"
      unitRef="usd">42000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
      contextRef="i6d1b0f4826d84816aa9460ece5298de4_D20200630-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo4MTQyNzRlZWRjNTQ0NTM3OTgzMWY4YjI5MzZjMTNjNi90YWJsZXJhbmdlOjgxNDI3NGVlZGM1NDQ1Mzc5ODMxZjhiMjkzNmMxM2M2XzktMi0xLTEtMjM0NTg_bb2765cc-41e3-48b9-8b27-c7792844eab0"
      unitRef="usd">2928000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i6d1b0f4826d84816aa9460ece5298de4_D20200630-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo4MTQyNzRlZWRjNTQ0NTM3OTgzMWY4YjI5MzZjMTNjNi90YWJsZXJhbmdlOjgxNDI3NGVlZGM1NDQ1Mzc5ODMxZjhiMjkzNmMxM2M2XzEwLTItMS0xLTIzNDU4_e726f84e-a30f-46be-840e-1fa37993f389"
      unitRef="usd">45760000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="i9d9561d07a174b4d928f303fd47bd68b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzI3NDg3NzkwODYwNzM_f1205975-9a69-42f2-b46b-5f2468fb214e"
      unitRef="usd">518000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4Xzc2MjI_938eca30-6ada-4d34-938a-bf86181835eb">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited pro forma condensed combined statements of (loss) income for the years ended December 31, 2020 and 2019 included below is being provided for information purposes only and are not necessarily indicative of the results of operations that would have resulted if the Transaction had actually occurred on the date indicated. The pro forma adjustments are based on available information and assumptions that the Company believes are attributable to the sale.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.001%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unaudited Pro Forma Condensed Combined Statement of (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pro Forma Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pro Forma&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Product sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13,783)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,968)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,082)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13,348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.996%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.001%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unaudited Pro Forma Condensed Combined Statement of (Loss) Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As Reported&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pro Forma Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pro Forma&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Product sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(59,273)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;83,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,092)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,112)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(67,293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38,582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(42,803)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(e)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(81,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Adjustments to the pro forma unaudited condensed combined statements of (loss) income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) This adjustment reflects Product sales attributable to the Hospital Products.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b) This adjustment reflects the following estimated expenses attributable to the Hospital Products:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Cost of products of $3,540.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;R&amp;amp;D expenses of $322.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Selling, general and administrative expenses of $797.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Intangible asset amortization on acquired development technology for Vazculep of $406.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Changes in fair value of related party contingent consideration of $3,327. The Company will no longer be responsible for these payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c) This amount reflects the adjustments noted in (a) and (b) above, as well as estimated Changes in fair value of related party payable of $435 attributable to the Hospital Products. The Company will no longer be responsible for these payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(d) This adjustment reflects the following estimated expenses attributable to the Hospital Products:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Cost of products of $11,368.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;R&amp;amp;D expenses of $1,960.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Selling, general and administrative expenses of $1,102.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Intangible asset amortization on acquired development technology for Vazculep of $816.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Changes in fair value of related party contingent consideration of $845. The Company will no longer be responsible for these payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(e) This amount reflects the adjustments noted in (a) and (d) above, as well as the reversal of estimated Changes in fair value of related party payable of $378 attributable to the Hospital Products. The Company will no longer be responsible for these payments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i38080e480d2448d89a3f5285f946f2e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo2OTllZmVkNDY2YTQ0YzA1YTI5ODJjMDU3MmE4NzkyZi90YWJsZXJhbmdlOjY5OWVmZWQ0NjZhNDRjMDVhMjk4MmMwNTcyYTg3OTJmXzUtMi0xLTEtMjM0NTg_a57bc86f-155f-475a-9388-8f2072404cf3"
      unitRef="usd">22334000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibaeb39fd6c394110b9fd0a0d5423884f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo2OTllZmVkNDY2YTQ0YzA1YTI5ODJjMDU3MmE4NzkyZi90YWJsZXJhbmdlOjY5OWVmZWQ0NjZhNDRjMDVhMjk4MmMwNTcyYTg3OTJmXzUtNC0xLTEtMjM0NTg_bb524c65-2041-4ac5-a816-03566b5dc5da"
      unitRef="usd">-22175000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib89e2680daf342f19590ad40660e7d7c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo2OTllZmVkNDY2YTQ0YzA1YTI5ODJjMDU3MmE4NzkyZi90YWJsZXJhbmdlOjY5OWVmZWQ0NjZhNDRjMDVhMjk4MmMwNTcyYTg3OTJmXzUtOC0xLTEtMjM0NTg_b9f1cfd3-00fd-4ce4-9e43-eab3edfc9c0a"
      unitRef="usd">159000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostsAndExpenses
      contextRef="i38080e480d2448d89a3f5285f946f2e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo2OTllZmVkNDY2YTQ0YzA1YTI5ODJjMDU3MmE4NzkyZi90YWJsZXJhbmdlOjY5OWVmZWQ0NjZhNDRjMDVhMjk4MmMwNTcyYTg3OTJmXzYtMi0xLTEtMjM0NTg_f3e36680-98c6-4012-8a22-5aa8bd6a22c5"
      unitRef="usd">16519000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ibaeb39fd6c394110b9fd0a0d5423884f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo2OTllZmVkNDY2YTQ0YzA1YTI5ODJjMDU3MmE4NzkyZi90YWJsZXJhbmdlOjY5OWVmZWQ0NjZhNDRjMDVhMjk4MmMwNTcyYTg3OTJmXzYtNC0xLTEtMjM0NTg_71125783-a68f-46b6-887b-6a4e9e69a9e1"
      unitRef="usd">-8392000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ib89e2680daf342f19590ad40660e7d7c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo2OTllZmVkNDY2YTQ0YzA1YTI5ODJjMDU3MmE4NzkyZi90YWJsZXJhbmdlOjY5OWVmZWQ0NjZhNDRjMDVhMjk4MmMwNTcyYTg3OTJmXzYtOC0xLTEtMjM0NTg_a27b15e5-66fc-42bd-8fcd-2d9f0c8027ae"
      unitRef="usd">8127000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i38080e480d2448d89a3f5285f946f2e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo2OTllZmVkNDY2YTQ0YzA1YTI5ODJjMDU3MmE4NzkyZi90YWJsZXJhbmdlOjY5OWVmZWQ0NjZhNDRjMDVhMjk4MmMwNTcyYTg3OTJmXzctMi0xLTEtMjM0NTg_7f44b87d-0a91-4261-b949-b64a3806adbd"
      unitRef="usd">5815000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibaeb39fd6c394110b9fd0a0d5423884f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo2OTllZmVkNDY2YTQ0YzA1YTI5ODJjMDU3MmE4NzkyZi90YWJsZXJhbmdlOjY5OWVmZWQ0NjZhNDRjMDVhMjk4MmMwNTcyYTg3OTJmXzctNC0xLTEtMjM0NTg_5d9967c5-48d8-4350-b4e5-f13252595f37"
      unitRef="usd">-13783000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib89e2680daf342f19590ad40660e7d7c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo2OTllZmVkNDY2YTQ0YzA1YTI5ODJjMDU3MmE4NzkyZi90YWJsZXJhbmdlOjY5OWVmZWQ0NjZhNDRjMDVhMjk4MmMwNTcyYTg3OTJmXzctOC0xLTEtMjM0NTg_7b79ed3b-a7ac-4acb-b863-61d77736b6f4"
      unitRef="usd">-7968000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i38080e480d2448d89a3f5285f946f2e5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo2OTllZmVkNDY2YTQ0YzA1YTI5ODJjMDU3MmE4NzkyZi90YWJsZXJhbmdlOjY5OWVmZWQ0NjZhNDRjMDVhMjk4MmMwNTcyYTg3OTJmXzgtMi0xLTEtMjM0NTg_b0d0e2a7-3e6d-4e4e-8df0-e89ae8108a2f"
      unitRef="usd">-5082000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ibaeb39fd6c394110b9fd0a0d5423884f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo2OTllZmVkNDY2YTQ0YzA1YTI5ODJjMDU3MmE4NzkyZi90YWJsZXJhbmdlOjY5OWVmZWQ0NjZhNDRjMDVhMjk4MmMwNTcyYTg3OTJmXzgtNC0xLTEtMjM0NTg_ba621074-7536-4880-a4cc-718d4becb94e"
      unitRef="usd">-13348000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ib89e2680daf342f19590ad40660e7d7c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTo2OTllZmVkNDY2YTQ0YzA1YTI5ODJjMDU3MmE4NzkyZi90YWJsZXJhbmdlOjY5OWVmZWQ0NjZhNDRjMDVhMjk4MmMwNTcyYTg3OTJmXzgtOC0xLTEtMjM0NTg_56cc471e-bafc-4542-a848-b63c59843a7f"
      unitRef="usd">-18430000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i76d9d41ce856419e9dfc0d9e14013a83_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTplMjc5YTY2NmIzNGQ0MjRkOTY3ZWU4YmQ0YWQ2MGE3ZC90YWJsZXJhbmdlOmUyNzlhNjY2YjM0ZDQyNGQ5NjdlZThiZDRhZDYwYTdkXzUtMi0xLTEtMjM0NTg_23154092-f5c6-4378-8042-a5ac1e0e1447"
      unitRef="usd">59215000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i452c804743a24cfe918d651e2bd94b98_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTplMjc5YTY2NmIzNGQ0MjRkOTY3ZWU4YmQ0YWQ2MGE3ZC90YWJsZXJhbmdlOmUyNzlhNjY2YjM0ZDQyNGQ5NjdlZThiZDRhZDYwYTdkXzUtNC0xLTEtMjM0NTg_36c62c2d-b7d9-4736-a600-671cd62794dd"
      unitRef="usd">-59273000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ead4e892b78440b941a75e56c9490b1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTplMjc5YTY2NmIzNGQ0MjRkOTY3ZWU4YmQ0YWQ2MGE3ZC90YWJsZXJhbmdlOmUyNzlhNjY2YjM0ZDQyNGQ5NjdlZThiZDRhZDYwYTdkXzUtOC0xLTEtMjM0NTg_f5b1c4e9-cc84-4cf2-bece-d190fd3af35b"
      unitRef="usd">-58000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostsAndExpenses
      contextRef="i76d9d41ce856419e9dfc0d9e14013a83_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTplMjc5YTY2NmIzNGQ0MjRkOTY3ZWU4YmQ0YWQ2MGE3ZC90YWJsZXJhbmdlOmUyNzlhNjY2YjM0ZDQyNGQ5NjdlZThiZDRhZDYwYTdkXzYtMi0xLTEtMjM0NTg_2ebd0221-897a-4e33-90f7-a24e9859e528"
      unitRef="usd">83327000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i452c804743a24cfe918d651e2bd94b98_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTplMjc5YTY2NmIzNGQ0MjRkOTY3ZWU4YmQ0YWQ2MGE3ZC90YWJsZXJhbmdlOmUyNzlhNjY2YjM0ZDQyNGQ5NjdlZThiZDRhZDYwYTdkXzYtNC0xLTEtMjM0NTg_3bfb671d-ee1d-4d0c-90c6-d994aea90cc0"
      unitRef="usd">-16092000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i9ead4e892b78440b941a75e56c9490b1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTplMjc5YTY2NmIzNGQ0MjRkOTY3ZWU4YmQ0YWQ2MGE3ZC90YWJsZXJhbmdlOmUyNzlhNjY2YjM0ZDQyNGQ5NjdlZThiZDRhZDYwYTdkXzYtOC0xLTEtMjM0NTg_1816a4ca-391a-4e62-9272-d7835ca27df9"
      unitRef="usd">67235000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i76d9d41ce856419e9dfc0d9e14013a83_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTplMjc5YTY2NmIzNGQ0MjRkOTY3ZWU4YmQ0YWQ2MGE3ZC90YWJsZXJhbmdlOmUyNzlhNjY2YjM0ZDQyNGQ5NjdlZThiZDRhZDYwYTdkXzctMi0xLTEtMjM0NTg_bf315316-8d03-4f6d-b070-ee686bf154a3"
      unitRef="usd">-24112000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i452c804743a24cfe918d651e2bd94b98_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTplMjc5YTY2NmIzNGQ0MjRkOTY3ZWU4YmQ0YWQ2MGE3ZC90YWJsZXJhbmdlOmUyNzlhNjY2YjM0ZDQyNGQ5NjdlZThiZDRhZDYwYTdkXzctNC0xLTEtMjM0NTg_0fa32a5a-c1e3-4df9-a852-af5a2b18def4"
      unitRef="usd">-43181000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9ead4e892b78440b941a75e56c9490b1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTplMjc5YTY2NmIzNGQ0MjRkOTY3ZWU4YmQ0YWQ2MGE3ZC90YWJsZXJhbmdlOmUyNzlhNjY2YjM0ZDQyNGQ5NjdlZThiZDRhZDYwYTdkXzctOC0xLTEtMjM0NTg_6032cc34-465d-46fc-8268-724a53d19083"
      unitRef="usd">-67293000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i76d9d41ce856419e9dfc0d9e14013a83_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTplMjc5YTY2NmIzNGQ0MjRkOTY3ZWU4YmQ0YWQ2MGE3ZC90YWJsZXJhbmdlOmUyNzlhNjY2YjM0ZDQyNGQ5NjdlZThiZDRhZDYwYTdkXzgtMi0xLTEtMjM0NTg_e652864e-dcc8-495c-8afe-d77b65ece15b"
      unitRef="usd">-38582000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i452c804743a24cfe918d651e2bd94b98_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTplMjc5YTY2NmIzNGQ0MjRkOTY3ZWU4YmQ0YWQ2MGE3ZC90YWJsZXJhbmdlOmUyNzlhNjY2YjM0ZDQyNGQ5NjdlZThiZDRhZDYwYTdkXzgtNC0xLTEtMjM0NTg_5c8ae484-e78b-44bb-9feb-cbb14aa4f2ee"
      unitRef="usd">-42803000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i9ead4e892b78440b941a75e56c9490b1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90YWJsZTplMjc5YTY2NmIzNGQ0MjRkOTY3ZWU4YmQ0YWQ2MGE3ZC90YWJsZXJhbmdlOmUyNzlhNjY2YjM0ZDQyNGQ5NjdlZThiZDRhZDYwYTdkXzgtOC0xLTEtMjM0NTg_52299e48-8ec6-455c-aeff-c56725c4ca8c"
      unitRef="usd">-81385000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i116a6b04235e4b1c93dc94865613041c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzY0MDU_b5dbff94-7265-4633-88f0-3fb77a90c63b"
      unitRef="usd">3540000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i116a6b04235e4b1c93dc94865613041c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzY0MjU_db0f5a7e-432d-455e-861b-b59a4c7de368"
      unitRef="usd">322000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i116a6b04235e4b1c93dc94865613041c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzY0Nzc_3e81876e-5281-43df-8835-0564ba4c5673"
      unitRef="usd">797000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i116a6b04235e4b1c93dc94865613041c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzY1NjI_49b65ee7-789d-4122-91ce-e424ff9c5b66"
      unitRef="usd">406000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i116a6b04235e4b1c93dc94865613041c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzY2MzM_9f5f1c3d-a05d-4755-8326-eb5ac0baba84"
      unitRef="usd">3327000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i116a6b04235e4b1c93dc94865613041c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzY4NDA_30393194-74a3-460a-a380-486af0ebd5be"
      unitRef="usd">-435000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i0083fb6ccd404e979fe21e48af0fa1f5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzcwNjc_bf92b0a4-7f99-4bcb-92dc-1feade9dc882"
      unitRef="usd">11368000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i0083fb6ccd404e979fe21e48af0fa1f5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzcwODc_bfb3a7f0-1965-4622-8e02-714c84b42b0a"
      unitRef="usd">1960000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i0083fb6ccd404e979fe21e48af0fa1f5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzcxMzk_4e963aff-0033-4dcb-af99-a7676ac8274c"
      unitRef="usd">1102000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i0083fb6ccd404e979fe21e48af0fa1f5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzcyMjQ_07ca2c8e-153d-4c3a-8be8-1011bfb79afc"
      unitRef="usd">816000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i0083fb6ccd404e979fe21e48af0fa1f5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4XzcyOTU_b6553579-6db9-4318-8c20-d18a71d7a4cf"
      unitRef="usd">845000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i0083fb6ccd404e979fe21e48af0fa1f5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDAvZnJhZzo2Y2JiYjk5NmI4YzA0MDcwOGJhM2NmYmQ0YTczMzhlOC90ZXh0cmVnaW9uOjZjYmJiOTk2YjhjMDQwNzA4YmEzY2ZiZDRhNzMzOGU4Xzc1MTg_9e8d6495-cd09-405b-8dcc-d082bf5c1ddf"
      unitRef="usd">-378000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDMvZnJhZzo4NWM2YTdhYjQxZWE0ODRmYTgyNWEwM2MxNGRjOTVhMi90ZXh0cmVnaW9uOjg1YzZhN2FiNDFlYTQ4NGZhODI1YTAzYzE0ZGM5NWEyXzc1NjY_95507b19-43a9-4e09-8927-b9b463dfb4cd">Revenue Recognition &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to June 30, 2020, the Company generated revenue primarily from the sale of pharmaceutical products to customers. On June 30, 2020, the Company sold the Hospital Products. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 4: Disposition of the Hospital Products&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Product Sales and Services&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to June 30, 2020, the Company sold products primarily through wholesalers and considered these wholesalers to be its customers. Revenue from product sales was recognized when the customer obtained control of the Company&#x2019;s product and its performance obligations were met, which occurred typically upon receipt of delivery to the customer. As is customary in the pharmaceutical industry, the Company&#x2019;s gross product sales were subject to a variety of price adjustments in arriving at reported net product sales. These adjustments included estimates for product returns, chargebacks, payment discounts, rebates, and other sales allowances and are estimated when the product is delivered based on analysis of historical data for the product or comparable products, as well as future expectations for such products.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reserves to reduce Gross Revenues to Net Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from product sales were recorded at the net selling price, which included estimated reserves to reduce gross product sales to net product sales resulting from product returns, chargebacks, payment discounts, rebates, and other sales allowances that are offered within contracts between the Company and its customers and end users. These reserves were based on the amounts earned or to be claimed on the related sales and were classified as reductions of accounts receivable if the amount was payable to the customer, except in the case of the estimated reserve for future expired product returns, which were classified as a liability. The reserves were classified as a liability if the amount is payable to a party other than a customer. Where appropriate, these estimated reserves took into consideration relevant factors such as the Company&#x2019;s historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns. Overall, these reserves reflected the Company&#x2019;s best estimates to reduce gross selling price to net selling price to which it expected to be entitled based on the terms of its contracts. The actual selling price ultimately received may differ from the Company&#x2019;s estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Returns&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consistent with industry practice, the Company maintained a returns policy that generally offered customers a right of return for product that has been purchased from the Company. The Company estimated the amount of product returns and records this estimate as a reduction of revenue in the period the related product revenue was recognized. The Company estimated product return liabilities based on analysis of historical data for the product or comparable products, as well as future expectations for such products and other judgments and analysis.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Chargebacks, Discounts and Rebates&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Chargebacks, discounts and rebates represent the estimated obligations resulting from contractual commitments to sell products to its customers or end users at prices lower than the list prices charged to the Company&#x2019;s wholesale customers. Customers charged the Company for the difference between the gross selling price they pay for the product and the ultimate contractual price agreed to between the Company and these end users. These reserves were established in the same period that the related revenue was recognized, resulting in a reduction of product revenue and accounts receivable. Chargebacks, discounts and rebates were estimated at the time of sale to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation of revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s primary source of revenue was from the sale of pharmaceutical products, which are equally affected by the same economic factors as it relates to the nature, amount, timing, and uncertainty of revenue and cash flows. For further detail about the Company&#x2019;s revenues by product, see&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note&#160;21: Company Operations by Product, Customer and Geography.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not recognize revenue in advance of invoicing its customers and therefore has no related contract assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A receivable is recognized in the period the Company sells its products and when the Company&#x2019;s right to consideration is unconditional. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no material deferred contract costs at&#160;December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Transaction Price Allocated to the Remaining Performance Obligation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For product sales, the Company generally satisfies its performance obligations within the same period the product is delivered. Product sales recognized in 2020 and 2019 from performance obligations satisfied (or partially satisfied) in previous periods were immaterial. No product sales were recognized in 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has elected certain of the practical expedients from the disclosure requirement for remaining performance obligations for specific situations in which an entity need not estimate variable consideration to recognize revenue. Accordingly, the Company applies the practical expedient in ASC 606 to its stand-alone contracts and does not disclose information about variable consideration from remaining performance obligations for which it recognizes revenue.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90ZXh0cmVnaW9uOjdkMjY0YTc1ZjA0NDQxZTc5YjM3Mjk5YzVjYWIyZmY4XzM1MjU_a6e98840-f226-4aad-be9e-abb5693c0d0e">Fair Value Measurements&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to measure certain assets and liabilities at fair value, either upon initial recognition or for subsequent accounting or reporting. For example, the Company uses fair value extensively when accounting for and reporting certain financial instruments, when measuring certain contingent consideration liabilities and in the initial recognition of net assets acquired in a business combination. Fair value is estimated by applying the hierarchy described below, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#160;defines fair value as a market-based measurement that should be determined based on the assumptions that marketplace participants would use in pricing an asset or liability. When estimating fair value, depending on the nature and complexity of the asset or liability, the Company may generally use one or each of the following techniques:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Income approach, which is based on the present value of a future stream of net cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a basis for considering the assumptions used in these techniques, the standard establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value as follows: &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 - Quoted prices for identical assets or liabilities in active markets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 - Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are directly or indirectly observable, or inputs that are derived principally from, or corroborated by, observable market data by correlation or other means. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 - Unobservable inputs that reflect estimates and assumptions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial instruments measured at fair value on a recurring basis classified in the fair value hierarchy (Level 1, 2 or 3) based on the inputs used for valuation in the accompanying consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Marketable securities (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Note &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mutual and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government securities - U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other fixed-income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A review of fair value hierarchy classifications is conducted on a quarterly basis.&#160; Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. During the fiscal year ended December&#160;31, 2021, there were no transfers in and out of&#160;Level&#160;1, 2, or 3. During the&#160;twelve months ended December&#160;31, 2021, 2020 and 2019, the Company did not recognize any allowances for credit losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of the Company&#x2019;s financial instruments, such as cash and cash equivalents and accounts payable, are reflected in the balance sheet at carrying value, which approximates fair value due to their short-term nature.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates the fair value of its&#160;$143,750&#160;aggregate principal amount of&#160;the 2023 Notes based on interest rates that would be currently available to the Company for issuance of similar types of debt instruments with similar terms and remaining maturities or recent trading prices obtained from brokers (a Level 2 input). The estimated fair value of the 2023 Notes at&#160;December&#160;31, 2021 is&#160;$153,273. See&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note&#160;11:&#160;Long-Term Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;for additional information regarding the Company&#x2019;s debt obligations.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90ZXh0cmVnaW9uOjdkMjY0YTc1ZjA0NDQxZTc5YjM3Mjk5YzVjYWIyZmY4XzM1Mjg_9aa0553e-a1b2-4da2-898f-e271870c457b">&lt;div style="margin-bottom:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial instruments measured at fair value on a recurring basis classified in the fair value hierarchy (Level 1, 2 or 3) based on the inputs used for valuation in the accompanying consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Marketable securities (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Note &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mutual and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government securities - U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other fixed-income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id52d7d2aa62b4b4da464b12866a6c924_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzUtMi0xLTEtMjM0NTg_5d3ae8b0-dc1e-4273-b2f6-286bc992fb8c"
      unitRef="usd">78098000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i83bc9cfa1af3440280eb8de38f8166dd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzQtNC0xLTEtMzU0MDk_9566bb4f-ead7-4d6d-82b0-1ecdc366dbdb"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic01169ef9e0a4955a3206600ff07ada7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzQtNi0xLTEtMzU0MTE_7021f1e9-54c9-4f37-a7c6-e0c1e53f6940"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id2b2742f57824ceda1edb68f0ff8c8f3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzUtOC0xLTEtMjM0NTg_8e97e13e-dad4-414c-b7ef-360c44acf58d"
      unitRef="usd">104672000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5d1044cc5fce464b8bc7a7bfef8cde56_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzQtMTAtMS0xLTM1NDEz_70d57282-824e-47c7-8ca5-d1c829451ec8"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i18e72e8a73fd4634a6d3d9497623275a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzQtMTItMS0xLTM1NDEz_c0496971-c298-4d82-852c-b9f9d8100d7a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if3c0427547534f92a024aa31e44c88b7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzUtMi0xLTEtMzU0MDc_30437142-ade8-488c-87ab-90488949ad32"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i293bd7a5c8b64a69aac7ebd06bdbcd7d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzYtNC0xLTEtMjM0NTg_b4993319-f8a6-4c3f-a3cd-fc522d944504"
      unitRef="usd">16479000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if5fb86d740e0439ca6608ab69d36eb11_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzUtNi0xLTEtMzU0MDM_4c722301-8f6c-4e09-8614-a6a5a9b716e6"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6bfe961a6b074629ab468b545ec27937_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzUtOC0xLTEtMzU0MTM_1c703845-881c-4f7a-a593-0c785ff8d625"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia0630338310348249f7dc7b831142ee2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzYtMTAtMS0xLTIzNDU4_1732a93c-1e92-4381-935b-6b0b2fbbcef5"
      unitRef="usd">22155000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7eb59743d34e40129c556f867c6c573c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzUtMTItMS0xLTM1NDEz_54cd5dcc-ac6b-4d3d-aaa9-4193820824f4"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic5f30bb744514756aea4f12be8815603_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzYtMi0xLTEtMzU0MDc_5f4ef673-225b-4339-a20a-4af84926cbfb"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id5979606d5744565bf77ff486631a39e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzctNC0xLTEtMjM0NTg_30f31629-d69c-4401-8132-11800a93f919"
      unitRef="usd">9471000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6913fac34a90404fa88993860b66d7e2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzYtNi0xLTEtMzU0MDM_44a5ad52-6f1f-4a39-9f5f-1080a79ab7df"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic28f71d280c5400baa92f1e72d94daf9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzYtOC0xLTEtMzU0MTM_6c2ae31a-fed7-4980-b4d1-d83bf6478b0e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id88486af4378447498d419d174a87a1f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzctMTAtMS0xLTIzNDU4_055c928c-322d-40b7-b59b-2a82443d5d62"
      unitRef="usd">18999000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifa70138b99c048b89b45f15ed355b484_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzYtMTItMS0xLTM1NDEz_250f9838-3325-46c8-bf0e-3583bfd971ec"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie16c2dc1e48343529c36da1c15195964_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzctMi0xLTEtMzU0MDc_cc5a56a0-0741-4850-b602-a7df95e5d57e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia4b3eeee3d8446c7b5e89621aa4d248c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzktNC0xLTEtMjM0NTg_eb4f7099-c3c5-4ac7-a391-b79a78748a0a"
      unitRef="usd">2465000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib17fcae9927b47b188df8b1fa2c25721_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzctNi0xLTEtMzU0MDM_c8caefac-9470-4bd0-960d-94e8f65dcf63"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i68cd10c5610845ebabca121f25b49d60_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzctOC0xLTEtMzU0MTM_c93bbe2e-8ebe-4c23-8d5c-efc22b2178be"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9d79f4c0bc9b455887433f737f576ca8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzktMTAtMS0xLTIzNDU4_ed85794b-eaf4-45e5-8ddc-786873c96f9e"
      unitRef="usd">3854000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7a771a5f8997450bbbff5c44c4e92027_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzctMTItMS0xLTM1NDEz_d41257ac-0940-46e0-91bd-974429acd332"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6b4d5f4b3fec4948b3a7c8a60e155623_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzEwLTItMS0xLTIzNDU4_baa7ca7b-99ad-4ab2-bd30-aa3ebd881a7f"
      unitRef="usd">78098000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2c7e425e645c4dc79f2d64d4e4939081_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzEwLTQtMS0xLTIzNDU4_5010315e-3ad2-4fc9-b665-a47e88b9e8f8"
      unitRef="usd">28415000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id14aee310c1d455eba4dc5a754e72eee_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzgtNi0xLTEtMzU0MDM_5a468e6e-22e2-4078-a391-30b017289452"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i440d19b8d2524ebdaf59efde284e3f22_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzEwLTgtMS0xLTIzNDU4_6637d2b0-1594-4c48-80b1-fb8d96c7217e"
      unitRef="usd">104672000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib15012d3c7954901bf95432b698ea122_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzEwLTEwLTEtMS0yMzQ1OA_eeeca103-cfc3-4d67-b389-05c3f553a68e"
      unitRef="usd">45008000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1789d52ed2dd4776b2edfab82bbba9d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90YWJsZTo0YjE3MDliZWZkOWE0NzU3OTgwZGVlMDJhMWZiMTY3Ni90YWJsZXJhbmdlOjRiMTcwOWJlZmQ5YTQ3NTc5ODBkZWUwMmExZmIxNjc2XzgtMTItMS0xLTM1NDEz_6abb1c69-4261-4f55-b32d-5456d8348792"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia43fd9d7d0184bf48d0ca7e30b92fe15_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90ZXh0cmVnaW9uOjdkMjY0YTc1ZjA0NDQxZTc5YjM3Mjk5YzVjYWIyZmY4XzMwMjY_343af6f3-79c4-4b99-a4b6-80d6f3f3cace"
      unitRef="usd">143750000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebt
      contextRef="i26a649c3c54c4610811b4ccf08d404fc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDYvZnJhZzo3ZDI2NGE3NWYwNDQ0MWU3OWIzNzI5OWM1Y2FiMmZmOC90ZXh0cmVnaW9uOjdkMjY0YTc1ZjA0NDQxZTc5YjM3Mjk5YzVjYWIyZmY4XzEwOTk1MTE2MzE4Nzk_5d01a518-1d90-4d6d-9206-05d1394b872c"
      unitRef="usd">153273000</us-gaap:LongTermDebt>
    <us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90ZXh0cmVnaW9uOmY1MmNhOTdkN2UxNTQ5OTZiOGNmNGEyZGU0NDU5MTIzXzIyOTU_b912afa5-a5da-48bd-a98b-d8e6a9ddfaf9">Marketable Securities&#160;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has investments in available-for-sale debt securities that are recorded at fair market value. The change in the fair value of available-for-sale debt investments is recorded as accumulated other comprehensive loss in shareholders&#x2019; equity, net of income tax effects. As of December&#160;31, 2021, the Company considered any decreases in fair value on its marketable securities to be driven by factors other than credit risk, including market risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables show the Company&#x2019;s available-for-sale securities&#x2019; adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category as of&#160;December&#160;31, 2021 and 2020, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:15pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.861%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.678%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable Securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mutual and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,046)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government securities - U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other fixed-income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.861%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.678%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable Securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mutual and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government securities - U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other fixed-income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;147,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines realized gains or losses on the sale of marketable securities on a specific identification method. The Company reflects these gains and losses as a component of investment and other income in the accompanying consolidated statements of (loss) income.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized gross realized gains of&#160;$174, $474 and $483 for the&#160;twelve months ended December&#160;31, 2021, 2020 and 2019, respectively. These realized gains were offset by realized losses of $275, $912 and $151&#160;for the twelve-months ended December&#160;31, 2021, 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the estimated fair value of the Company&#x2019;s investments in marketable debt securities, accounted for as available-for-sale securities and classified by the contractual maturity date of the securities as of December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable Debt Securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less than 1 Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1-5 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;5-10 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Greater than 10 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government securities - U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other fixed-income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has classified its investment in available-for-sale marketable securities as current assets in the consolidated balance sheets as the securities need to be available for use, if required, to fund current operations. There are no restrictions on the sale of any securities in the Company&#x2019;s investment portfolio. &lt;/span&gt;&lt;/div&gt;Total gross unrealized losses of the Company&#x2019;s available-for-sale debt securities at December&#160;31, 2021 were immaterial and have been in an unrealized loss position for less than one year. The unrealized losses are driven by factors other than credit risk. The Company does not intend to sell the investments and it is not more likely than not that it will be required to sell the investments before recovery of their amortized cost bases.</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90ZXh0cmVnaW9uOmY1MmNhOTdkN2UxNTQ5OTZiOGNmNGEyZGU0NDU5MTIzXzIyOTc_75c14b07-733a-4c3d-89ee-6892c73ad50b">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables show the Company&#x2019;s available-for-sale securities&#x2019; adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category as of&#160;December&#160;31, 2021 and 2020, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:15pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.861%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.678%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable Securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mutual and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,046)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government securities - U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other fixed-income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.861%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.678%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable Securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mutual and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government securities - U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other fixed-income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;147,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia2ad46fe0b3942418942545c861a553b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzQtMi0xLTEtMjM0NTg_68e96d05-e350-4da9-b1dd-11409f5b61dd"
      unitRef="usd">78331000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia2ad46fe0b3942418942545c861a553b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzQtNC0xLTEtMjM0NTg_59149036-cd8c-4c36-a44d-cc6db01ec605"
      unitRef="usd">813000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia2ad46fe0b3942418942545c861a553b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzQtNi0xLTEtMjM0NTg_94e11361-3f3a-4b8b-bb8d-af6419d22daf"
      unitRef="usd">1046000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia2ad46fe0b3942418942545c861a553b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzQtOC0xLTEtMjM0NTg_258c3902-85b6-484f-82ee-2f02b85acad4"
      unitRef="usd">78098000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i4de00269e1884c6ba19491a6f480f8c0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzUtMi0xLTEtMjM0NTg_dd14cb5f-3d20-40b2-8616-8482b22eb342"
      unitRef="usd">16478000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4de00269e1884c6ba19491a6f480f8c0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzUtNC0xLTEtMjM0NTg_664f2c3e-5283-479d-b377-83753d3351e2"
      unitRef="usd">94000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4de00269e1884c6ba19491a6f480f8c0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzUtNi0xLTEtMjM0NTg_ff30de67-c2f9-4e0a-b6c1-020837934541"
      unitRef="usd">93000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4de00269e1884c6ba19491a6f480f8c0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzUtOC0xLTEtMjM0NTg_e1457d03-74fa-4b7b-b9e2-0eeb67eccc87"
      unitRef="usd">16479000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i12fe5967822c4c7c815ef3f9bfcf263a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzYtMi0xLTEtMjM0NTg_91b9da36-73cb-4ffe-9928-0e101ab12790"
      unitRef="usd">9530000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i12fe5967822c4c7c815ef3f9bfcf263a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzYtNC0xLTEtMjM0NTg_97b6a0d5-e82e-41b1-a0d7-ff9181fabc18"
      unitRef="usd">39000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i12fe5967822c4c7c815ef3f9bfcf263a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzYtNi0xLTEtMjM0NTg_d109318a-5305-42bf-ba4f-f827117bd537"
      unitRef="usd">98000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i12fe5967822c4c7c815ef3f9bfcf263a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzYtOC0xLTEtMjM0NTg_42154716-5578-49ab-a8c5-f36b26822c96"
      unitRef="usd">9471000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7a1d5321937c496998a92b6d7b15b2ec_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzgtMi0xLTEtMjM0NTg_b8519e7b-3c01-4123-b6b7-585e34dc6a75"
      unitRef="usd">2473000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7a1d5321937c496998a92b6d7b15b2ec_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzgtNC0xLTEtMjM0NTg_f96508f2-d041-45ab-a07c-2dab01ae1ed0"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7a1d5321937c496998a92b6d7b15b2ec_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzgtNi0xLTEtMjM0NTg_a0da1600-7eeb-46ae-beb4-65ee5c0f02c0"
      unitRef="usd">10000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7a1d5321937c496998a92b6d7b15b2ec_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzgtOC0xLTEtMjM0NTg_5110762c-9c2f-4088-b70a-c5a9bc256eba"
      unitRef="usd">2465000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzExLTItMS0xLTIzNDU4_22d28f20-0f54-4fab-91b7-03509ce6e0b6"
      unitRef="usd">106812000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzExLTQtMS0xLTIzNDU4_b21f22e1-78c2-46fc-b089-c3e30b8240ef"
      unitRef="usd">948000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzExLTYtMS0xLTIzNDU4_66ae2c1e-cfc3-42f8-a9d1-0082829c1519"
      unitRef="usd">1247000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTplYzg4OTc4YjI4Y2M0ZjM3YmUwODQ2ZDcwNTUyZTcxMC90YWJsZXJhbmdlOmVjODg5NzhiMjhjYzRmMzdiZTA4NDZkNzA1NTJlNzEwXzExLTgtMS0xLTIzNDU4_89b91537-3220-4311-a7a3-6e2ea3dab657"
      unitRef="usd">106513000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id0135ceeb3a74418aebc3bea16187547_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzQtMi0xLTEtMjM0NTg_7abf2d3f-4618-4718-8435-fee3c12cfc58"
      unitRef="usd">103404000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id0135ceeb3a74418aebc3bea16187547_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzQtNC0xLTEtMjM0NTg_cf3e4ee7-c056-42c4-bb00-4763e60ac260"
      unitRef="usd">1288000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id0135ceeb3a74418aebc3bea16187547_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzQtNi0xLTEtMjM0NTg_0a4e97a7-6d98-4303-8ca1-4feda2fcb9bb"
      unitRef="usd">20000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id0135ceeb3a74418aebc3bea16187547_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzQtOC0xLTEtMjM0NTg_0a17840a-eaf2-472a-a13d-7c6599f2b95e"
      unitRef="usd">104672000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i90001ac5605243f1919453ac916355e5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzUtMi0xLTEtMjM0NTg_68970d14-dd91-434d-a81b-b1257f43b6db"
      unitRef="usd">21811000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i90001ac5605243f1919453ac916355e5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzUtNC0xLTEtMjM0NTg_d05663e1-3ac0-461d-ad4d-bde885b83592"
      unitRef="usd">350000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i90001ac5605243f1919453ac916355e5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzUtNi0xLTEtMjM0NTg_cd96191e-9292-42a3-b6d8-5a4c6f3d434b"
      unitRef="usd">6000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i90001ac5605243f1919453ac916355e5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzUtOC0xLTEtMjM0NTg_faa25d20-b092-4fc9-bf5a-c97b8401238a"
      unitRef="usd">22155000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i85699a651b9645bdaa89df0e755480d9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzYtMi0xLTEtMjM0NTg_256a89af-d5c6-4b78-9dd6-15f7fd70e41e"
      unitRef="usd">18849000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i85699a651b9645bdaa89df0e755480d9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzYtNC0xLTEtMjM0NTg_2706ae39-82f3-4cd3-a518-07e9f29aa846"
      unitRef="usd">155000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i85699a651b9645bdaa89df0e755480d9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzYtNi0xLTEtMjM0NTg_90933001-aeb0-4dea-a051-8dd855ed6385"
      unitRef="usd">5000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i85699a651b9645bdaa89df0e755480d9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzYtOC0xLTEtMjM0NTg_ada2d680-ab05-472d-bde8-29dedf36e989"
      unitRef="usd">18999000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="idcf68fc36aa144f6aed0720b51cae4de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzgtMi0xLTEtMjM0NTg_1380c7b6-426c-43af-9caf-76d81bcff33d"
      unitRef="usd">3839000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="idcf68fc36aa144f6aed0720b51cae4de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzgtNC0xLTEtMjM0NTg_bff8bafe-d821-4946-86ba-d2163e15a2ac"
      unitRef="usd">22000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="idcf68fc36aa144f6aed0720b51cae4de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzgtNi0xLTEtMjM0NTg_deed5f24-bd30-4f65-a278-a6c5b4cde5b0"
      unitRef="usd">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idcf68fc36aa144f6aed0720b51cae4de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzgtOC0xLTEtMjM0NTg_3d84773f-68c8-4ab8-929a-601c76498c4e"
      unitRef="usd">3854000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzEwLTItMS0xLTIzNDU4_d500fa14-2b51-424b-b10a-dbe1e1c379d8"
      unitRef="usd">147903000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzEwLTQtMS0xLTIzNDU4_304503b0-0833-46f2-b27f-4cf618771724"
      unitRef="usd">1815000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzEwLTYtMS0xLTIzNDU4_75ff4704-a603-46a8-a6b1-19788e7f56f9"
      unitRef="usd">38000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTozNjA3NjJmMGE2Mjc0YjEzYTEwNWQ5ZmUzM2MzZTE2MC90YWJsZXJhbmdlOjM2MDc2MmYwYTYyNzRiMTNhMTA1ZDlmZTMzYzNlMTYwXzEwLTgtMS0xLTIzNDU4_0253bd0a-2c45-4c76-bbbc-11c363da2eb7"
      unitRef="usd">149680000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <avdl:MarketableSecuritiesRealizedGain
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90ZXh0cmVnaW9uOmY1MmNhOTdkN2UxNTQ5OTZiOGNmNGEyZGU0NDU5MTIzXzExMzU_392c231a-414e-44b2-9a0b-445d97f41597"
      unitRef="usd">174000</avdl:MarketableSecuritiesRealizedGain>
    <avdl:MarketableSecuritiesRealizedGain
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90ZXh0cmVnaW9uOmY1MmNhOTdkN2UxNTQ5OTZiOGNmNGEyZGU0NDU5MTIzXzExMzk_415e1be3-5e65-429e-a572-0e9dbad0dd31"
      unitRef="usd">474000</avdl:MarketableSecuritiesRealizedGain>
    <avdl:MarketableSecuritiesRealizedGain
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90ZXh0cmVnaW9uOmY1MmNhOTdkN2UxNTQ5OTZiOGNmNGEyZGU0NDU5MTIzXzExNDc_dc39741c-4420-4a69-9a16-43aac1de91d4"
      unitRef="usd">483000</avdl:MarketableSecuritiesRealizedGain>
    <avdl:MarketableSecuritiesRealizedLoss
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90ZXh0cmVnaW9uOmY1MmNhOTdkN2UxNTQ5OTZiOGNmNGEyZGU0NDU5MTIzXzEyNjM_28ee4e87-c87d-4531-a394-88c4a3cb3ed2"
      unitRef="usd">275000</avdl:MarketableSecuritiesRealizedLoss>
    <avdl:MarketableSecuritiesRealizedLoss
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90ZXh0cmVnaW9uOmY1MmNhOTdkN2UxNTQ5OTZiOGNmNGEyZGU0NDU5MTIzXzEyNjc_b54f02d5-f2d9-4947-938f-79a13781309d"
      unitRef="usd">912000</avdl:MarketableSecuritiesRealizedLoss>
    <avdl:MarketableSecuritiesRealizedLoss
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90ZXh0cmVnaW9uOmY1MmNhOTdkN2UxNTQ5OTZiOGNmNGEyZGU0NDU5MTIzXzEyNzU_76fefd71-c990-4be9-bb07-4378b15837d4"
      unitRef="usd">151000</avdl:MarketableSecuritiesRealizedLoss>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90ZXh0cmVnaW9uOmY1MmNhOTdkN2UxNTQ5OTZiOGNmNGEyZGU0NDU5MTIzXzIyOTg_84d0e660-46cd-489e-941d-d7cf2dc93eda">&lt;div style="margin-bottom:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the estimated fair value of the Company&#x2019;s investments in marketable debt securities, accounted for as available-for-sale securities and classified by the contractual maturity date of the securities as of December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable Debt Securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less than 1 Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1-5 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;5-10 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Greater than 10 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government securities - U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other fixed-income securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i4de00269e1884c6ba19491a6f480f8c0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzUtMi0xLTEtMjM0NTg_df79ba26-b1cd-4fc3-acf4-a04233d74279"
      unitRef="usd">5288000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i4de00269e1884c6ba19491a6f480f8c0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzUtNC0xLTEtMjM0NTg_e5f86828-7d85-4178-bc32-898d308d4608"
      unitRef="usd">10873000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i4de00269e1884c6ba19491a6f480f8c0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzUtNi0xLTEtMjM0NTg_f7981bf0-a470-43b5-a7a2-d518ae7aab74"
      unitRef="usd">318000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i4de00269e1884c6ba19491a6f480f8c0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzUtOC0xLTEtMjM0NTg_917146df-b60b-4532-8df1-9a849caca7a2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i293bd7a5c8b64a69aac7ebd06bdbcd7d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzUtMTAtMS0xLTIzNDU4_b4993319-f8a6-4c3f-a3cd-fc522d944504"
      unitRef="usd">16479000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i12fe5967822c4c7c815ef3f9bfcf263a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzYtMi0xLTEtMjM0NTg_8aabfe0c-fc5a-489d-899b-73bfd8245d58"
      unitRef="usd">1531000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i12fe5967822c4c7c815ef3f9bfcf263a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzYtNC0xLTEtMjM0NTg_bd9eba6b-f31d-43fa-afc8-aff0cc26b73f"
      unitRef="usd">5938000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i12fe5967822c4c7c815ef3f9bfcf263a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzYtNi0xLTEtMjM0NTg_e04629c7-ab37-4049-a78f-5c684a94465e"
      unitRef="usd">807000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i12fe5967822c4c7c815ef3f9bfcf263a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzYtOC0xLTEtMjM0NTg_6ccb2e91-974b-459b-ba41-7b28404b5dd9"
      unitRef="usd">1195000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id5979606d5744565bf77ff486631a39e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzYtMTAtMS0xLTIzNDU4_30f31629-d69c-4401-8132-11800a93f919"
      unitRef="usd">9471000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i7a1d5321937c496998a92b6d7b15b2ec_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzgtMi0xLTEtMjM0NTg_fcd73689-3f42-456b-a6aa-c9738c0f57a5"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i7a1d5321937c496998a92b6d7b15b2ec_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzgtNC0xLTEtMjM0NTg_f2bb54b5-12a2-4520-a862-8f0c355a2ca7"
      unitRef="usd">1860000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i7a1d5321937c496998a92b6d7b15b2ec_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzgtNi0xLTEtMjM0NTg_48af3f45-4768-43e2-a635-deea3b3b4a29"
      unitRef="usd">605000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i7a1d5321937c496998a92b6d7b15b2ec_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzgtOC0xLTEtMjM0NTg_59fec777-6090-45be-a8c1-68ae9700274b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia4b3eeee3d8446c7b5e89621aa4d248c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzgtMTAtMS0xLTIzNDU4_eb4f7099-c3c5-4ac7-a391-b79a78748a0a"
      unitRef="usd">2465000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i1e1399e88a8a4132b1ab0865edb594ab_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzExLTItMS0xLTIzNDU4_59be3d81-f1b4-42ef-8893-957e8831f87c"
      unitRef="usd">6819000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i1e1399e88a8a4132b1ab0865edb594ab_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzExLTQtMS0xLTIzNDU4_0b24974e-388b-44f2-84c8-ffaed7925649"
      unitRef="usd">18671000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i1e1399e88a8a4132b1ab0865edb594ab_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzExLTYtMS0xLTIzNDU4_5d68bdd7-b6b0-4559-93e1-b2abcd996a35"
      unitRef="usd">1730000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i1e1399e88a8a4132b1ab0865edb594ab_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzExLTgtMS0xLTIzNDU4_dea83521-96a9-44b2-bf40-76aa187867db"
      unitRef="usd">1195000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1e1399e88a8a4132b1ab0865edb594ab_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMDkvZnJhZzpmNTJjYTk3ZDdlMTU0OTk2YjhjZjRhMmRlNDQ1OTEyMy90YWJsZTpmN2ExODEzNmQ5NzA0NmZhOTgxYjIyYzUyNjBhMmFlZi90YWJsZXJhbmdlOmY3YTE4MTM2ZDk3MDQ2ZmE5ODFiMjJjNTI2MGEyYWVmXzExLTEwLTEtMS0yMzQ1OA_db3742f0-9966-46e6-adba-37bffbcb94dc"
      unitRef="usd">28415000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTUvZnJhZzpjZmQ4ZDM1ZjU0MWY0NjA2OWNmZTA2NDM4YzQ2YTM5My90ZXh0cmVnaW9uOmNmZDhkMzVmNTQxZjQ2MDY5Y2ZlMDY0MzhjNDZhMzkzXzIzNw_e6a35345-5256-4a66-962b-65d9a166b511">Property and Equipment, net&lt;div style="margin-bottom:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The principal categories of property and equipment, net at December&#160;31, 2021 and 2020, respectively, are as&#160;follows:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.103%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Property and Equipment, net:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Software, office and computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures and fittings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less - accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(465)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,384)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Depreciation expense for the years ended December&#160;31, 2021, 2020 and 2019 was $97, $287 and $459, respectively.</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9e74df425db74915b7e617e549e87b1f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTUvZnJhZzpjZmQ4ZDM1ZjU0MWY0NjA2OWNmZTA2NDM4YzQ2YTM5My90YWJsZTo4NzA4ZWVhNzgyNDE0NzlmOGNkNTg3N2ZkN2QzMjU2MC90YWJsZXJhbmdlOjg3MDhlZWE3ODI0MTQ3OWY4Y2Q1ODc3ZmQ3ZDMyNTYwXzMtMi0xLTEtMjM0NTg_168153a5-276b-4e3d-aa0f-2c01f00368e1"
      unitRef="usd">448000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i79bb42f554984d2286d06ea284888cfd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTUvZnJhZzpjZmQ4ZDM1ZjU0MWY0NjA2OWNmZTA2NDM4YzQ2YTM5My90YWJsZTo4NzA4ZWVhNzgyNDE0NzlmOGNkNTg3N2ZkN2QzMjU2MC90YWJsZXJhbmdlOjg3MDhlZWE3ODI0MTQ3OWY4Y2Q1ODc3ZmQ3ZDMyNTYwXzMtNC0xLTEtMjM0NTg_4e2f6a8a-bd86-44c2-a301-73a6b4486995"
      unitRef="usd">1443000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id8c3aa61520d40aebe11479c3ccbff53_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTUvZnJhZzpjZmQ4ZDM1ZjU0MWY0NjA2OWNmZTA2NDM4YzQ2YTM5My90YWJsZTo4NzA4ZWVhNzgyNDE0NzlmOGNkNTg3N2ZkN2QzMjU2MC90YWJsZXJhbmdlOjg3MDhlZWE3ODI0MTQ3OWY4Y2Q1ODc3ZmQ3ZDMyNTYwXzQtMi0xLTEtMjM0NTg_675a6c05-e094-4231-b3db-76444beb67d8"
      unitRef="usd">302000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i82ff4d5bf5de4a8ba5b7fb4b53054871_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTUvZnJhZzpjZmQ4ZDM1ZjU0MWY0NjA2OWNmZTA2NDM4YzQ2YTM5My90YWJsZTo4NzA4ZWVhNzgyNDE0NzlmOGNkNTg3N2ZkN2QzMjU2MC90YWJsZXJhbmdlOjg3MDhlZWE3ODI0MTQ3OWY4Y2Q1ODc3ZmQ3ZDMyNTYwXzQtNC0xLTEtMjM0NTg_ef73df3c-706b-4234-a02c-a03c5e80afa7"
      unitRef="usd">300000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTUvZnJhZzpjZmQ4ZDM1ZjU0MWY0NjA2OWNmZTA2NDM4YzQ2YTM5My90YWJsZTo4NzA4ZWVhNzgyNDE0NzlmOGNkNTg3N2ZkN2QzMjU2MC90YWJsZXJhbmdlOjg3MDhlZWE3ODI0MTQ3OWY4Y2Q1ODc3ZmQ3ZDMyNTYwXzUtMi0xLTEtMjM0NTg_e035fa2b-61a1-44b2-8e02-de9fb11702c4"
      unitRef="usd">465000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTUvZnJhZzpjZmQ4ZDM1ZjU0MWY0NjA2OWNmZTA2NDM4YzQ2YTM5My90YWJsZTo4NzA4ZWVhNzgyNDE0NzlmOGNkNTg3N2ZkN2QzMjU2MC90YWJsZXJhbmdlOjg3MDhlZWE3ODI0MTQ3OWY4Y2Q1ODc3ZmQ3ZDMyNTYwXzUtNC0xLTEtMjM0NTg_7757eb1f-9734-440e-8366-091587fe8f2c"
      unitRef="usd">1384000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTUvZnJhZzpjZmQ4ZDM1ZjU0MWY0NjA2OWNmZTA2NDM4YzQ2YTM5My90YWJsZTo4NzA4ZWVhNzgyNDE0NzlmOGNkNTg3N2ZkN2QzMjU2MC90YWJsZXJhbmdlOjg3MDhlZWE3ODI0MTQ3OWY4Y2Q1ODc3ZmQ3ZDMyNTYwXzYtMi0xLTEtMjM0NTg_a0aa8e81-7de7-4937-935e-98d35db555c0"
      unitRef="usd">285000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTUvZnJhZzpjZmQ4ZDM1ZjU0MWY0NjA2OWNmZTA2NDM4YzQ2YTM5My90YWJsZTo4NzA4ZWVhNzgyNDE0NzlmOGNkNTg3N2ZkN2QzMjU2MC90YWJsZXJhbmdlOjg3MDhlZWE3ODI0MTQ3OWY4Y2Q1ODc3ZmQ3ZDMyNTYwXzYtNC0xLTEtMjM0NTg_7479778c-c27e-497c-8afe-e39aaebca726"
      unitRef="usd">359000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTUvZnJhZzpjZmQ4ZDM1ZjU0MWY0NjA2OWNmZTA2NDM4YzQ2YTM5My90ZXh0cmVnaW9uOmNmZDhkMzVmNTQxZjQ2MDY5Y2ZlMDY0MzhjNDZhMzkzXzIwNg_2420bd66-1dd2-4db2-a6b9-78d1b34ef77d"
      unitRef="usd">97000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTUvZnJhZzpjZmQ4ZDM1ZjU0MWY0NjA2OWNmZTA2NDM4YzQ2YTM5My90ZXh0cmVnaW9uOmNmZDhkMzVmNTQxZjQ2MDY5Y2ZlMDY0MzhjNDZhMzkzXzIxMA_7caaf042-6997-41b6-b9f6-e2a0cee5bf14"
      unitRef="usd">287000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTUvZnJhZzpjZmQ4ZDM1ZjU0MWY0NjA2OWNmZTA2NDM4YzQ2YTM5My90ZXh0cmVnaW9uOmNmZDhkMzVmNTQxZjQ2MDY5Y2ZlMDY0MzhjNDZhMzkzXzIxNw_61796f57-08ef-485c-af60-2f6c1c3d44b5"
      unitRef="usd">459000</us-gaap:Depreciation>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTgvZnJhZzozMjJhMmZjMTRkOWE0YjRiOTZhMjY0NzU1ODdiOGY3NC90ZXh0cmVnaW9uOjMyMmEyZmMxNGQ5YTRiNGI5NmEyNjQ3NTU4N2I4Zjc0XzEwMDA_7ea73267-8ea4-4f63-b767-01c78458b330">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill and Intangible Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;div style="margin-bottom:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s goodwill is $16,836 at December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded amortization expense related to an amortizable intangible asset that was assumed by the Exela Buyer as part of the disposition of the Hospital Products on June 30, 2020 of $406 and $816 for the years ended December&#160;31, 2020 and 2019, respectively. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 4: Disposition of the Hospital Products&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. There was no amortization expense recorded during the year ended December&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No impairment loss related to goodwill or intangible assets was recognized during the years ended December&#160;31, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:Goodwill
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTgvZnJhZzozMjJhMmZjMTRkOWE0YjRiOTZhMjY0NzU1ODdiOGY3NC90ZXh0cmVnaW9uOjMyMmEyZmMxNGQ5YTRiNGI5NmEyNjQ3NTU4N2I4Zjc0XzEwOTk1MTE2MzEyMDM_328c75d0-5af3-42e8-bb96-531582c3125c"
      unitRef="usd">16836000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTgvZnJhZzozMjJhMmZjMTRkOWE0YjRiOTZhMjY0NzU1ODdiOGY3NC90ZXh0cmVnaW9uOjMyMmEyZmMxNGQ5YTRiNGI5NmEyNjQ3NTU4N2I4Zjc0XzEwOTk1MTE2MzEyMDM_a082465c-723c-4cc8-ad27-1ddb79afca47"
      unitRef="usd">16836000</us-gaap:Goodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTgvZnJhZzozMjJhMmZjMTRkOWE0YjRiOTZhMjY0NzU1ODdiOGY3NC90ZXh0cmVnaW9uOjMyMmEyZmMxNGQ5YTRiNGI5NmEyNjQ3NTU4N2I4Zjc0XzEwOTk1MTE2MzEwMTU_3360190a-10d9-4377-96f0-73184268acd3"
      unitRef="usd">406000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTgvZnJhZzozMjJhMmZjMTRkOWE0YjRiOTZhMjY0NzU1ODdiOGY3NC90ZXh0cmVnaW9uOjMyMmEyZmMxNGQ5YTRiNGI5NmEyNjQ3NTU4N2I4Zjc0XzI3NDg3NzkwNzI4MDc_c8954a32-7c7d-4848-9483-20aa75d4f9fe"
      unitRef="usd">816000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AssetImpairmentCharges
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTgvZnJhZzozMjJhMmZjMTRkOWE0YjRiOTZhMjY0NzU1ODdiOGY3NC90ZXh0cmVnaW9uOjMyMmEyZmMxNGQ5YTRiNGI5NmEyNjQ3NTU4N2I4Zjc0Xzg3MA_02e4adb8-9e37-4a1e-835a-0af79eba848c"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMTgvZnJhZzozMjJhMmZjMTRkOWE0YjRiOTZhMjY0NzU1ODdiOGY3NC90ZXh0cmVnaW9uOjMyMmEyZmMxNGQ5YTRiNGI5NmEyNjQ3NTU4N2I4Zjc0Xzg3MA_4014854c-243b-4f05-ab28-ecf6d18d3a71"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90ZXh0cmVnaW9uOjIyMGM2MjEzZTI4YTQ4YTU5NDMyYzkzOTY1NjcxODAyXzI0OTI_39b2119a-4c2d-446e-bd25-4be61b01919c">Leases&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases office space and a production suite. All leased facilities are classified as operating leases with remaining lease terms between&#160;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90ZXh0cmVnaW9uOjIyMGM2MjEzZTI4YTQ4YTU5NDMyYzkzOTY1NjcxODAyXzY2OQ_ea03d613-a2cf-479a-bdb9-ee92938c3329"&gt;two&lt;/span&gt;&#160;and&#160;four years. The Company determines if a contract is a lease at the inception of the arrangement. The Company reviews all options to extend, terminate, or purchase its right-of-use assets at the inception of the lease and will include these options in the lease term when they are reasonably certain of being exercised. The Company&#x2019;s lease agreements do not contain any material residual value guarantees or material variable lease payments. For the Company&#x2019;s leased production suite, contract consideration was allocated to lease and non-lease components on the basis of relative standalone price. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease costs, which are included in selling, general and administrative expenses in the consolidated statements of (loss) income of years ended December&#160;31, 2021, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sublease income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(336)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Variable lease costs were immaterial for the years ended December&#160;31, 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Represents sublease income received for office subleases.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2021 and 2020, the Company reduced its operating lease liabilities by $578 and $769 for cash paid. During the year ended December&#160;31, 2021, the Company remeasured its production suite lease liability. During the year ended December&#160;31, 2021, the Company did not enter into any new operating or finance leases.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company&#x2019;s operating leases have a weighted-average remaining lease term of 2.9 years and a weighted-average discount rate of 4.9%. The Company&#x2019;s lease contracts do not provide a readily determinable implicit rate. The Company&#x2019;s estimated incremental borrowing rate is based on information available at the inception of the lease.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of the Company&#x2019;s operating lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i8f6fe7015e8f450194b70a8556bf0935_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90ZXh0cmVnaW9uOjIyMGM2MjEzZTI4YTQ4YTU5NDMyYzkzOTY1NjcxODAyXzY3Ng_bfc293fa-9e4f-413e-8072-1bf2b1c02d29">P4Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90ZXh0cmVnaW9uOjIyMGM2MjEzZTI4YTQ4YTU5NDMyYzkzOTY1NjcxODAyXzI0ODk_2afd4db6-8ca4-4d39-8546-c5020be4e7ee">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease costs, which are included in selling, general and administrative expenses in the consolidated statements of (loss) income of years ended December&#160;31, 2021, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sublease income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(336)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Variable lease costs were immaterial for the years ended December&#160;31, 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Represents sublease income received for office subleases.&lt;/span&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTowNTJjNmZmZTNiMjc0NjQ1YTAxYjFkNTdkZmRmYmVhYy90YWJsZXJhbmdlOjA1MmM2ZmZlM2IyNzQ2NDVhMDFiMWQ1N2RmZGZiZWFjXzItNC0xLTEtMjM0NTg_2ce2fe79-9352-42c6-8f09-423411c00b16"
      unitRef="usd">821000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTowNTJjNmZmZTNiMjc0NjQ1YTAxYjFkNTdkZmRmYmVhYy90YWJsZXJhbmdlOjA1MmM2ZmZlM2IyNzQ2NDVhMDFiMWQ1N2RmZGZiZWFjXzItNi0xLTEtMjM0NTg_21115ecc-d373-401f-a9b8-a5ad27505403"
      unitRef="usd">1133000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTowNTJjNmZmZTNiMjc0NjQ1YTAxYjFkNTdkZmRmYmVhYy90YWJsZXJhbmdlOjA1MmM2ZmZlM2IyNzQ2NDVhMDFiMWQ1N2RmZGZiZWFjXzItOC0xLTEtMzU0MzA_ec46aee8-5290-464e-b823-88485124f300"
      unitRef="usd">1515000</us-gaap:OperatingLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTowNTJjNmZmZTNiMjc0NjQ1YTAxYjFkNTdkZmRmYmVhYy90YWJsZXJhbmdlOjA1MmM2ZmZlM2IyNzQ2NDVhMDFiMWQ1N2RmZGZiZWFjXzUtNC0xLTEtMjM0NTg_178d987e-2bb9-46f6-b344-674a3e2f7095"
      unitRef="usd">110000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTowNTJjNmZmZTNiMjc0NjQ1YTAxYjFkNTdkZmRmYmVhYy90YWJsZXJhbmdlOjA1MmM2ZmZlM2IyNzQ2NDVhMDFiMWQ1N2RmZGZiZWFjXzUtNi0xLTEtMjM0NTg_0180d9c5-5c59-4c77-a43d-f1647ce61c97"
      unitRef="usd">336000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTowNTJjNmZmZTNiMjc0NjQ1YTAxYjFkNTdkZmRmYmVhYy90YWJsZXJhbmdlOjA1MmM2ZmZlM2IyNzQ2NDVhMDFiMWQ1N2RmZGZiZWFjXzUtOC0xLTEtMzU0MzA_b0a04e42-3a57-4b1c-a19a-a9d0dad9151b"
      unitRef="usd">276000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTowNTJjNmZmZTNiMjc0NjQ1YTAxYjFkNTdkZmRmYmVhYy90YWJsZXJhbmdlOjA1MmM2ZmZlM2IyNzQ2NDVhMDFiMWQ1N2RmZGZiZWFjXzYtNC0xLTEtMjM0NTg_712146c3-ac22-4312-8339-fba551d32504"
      unitRef="usd">711000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTowNTJjNmZmZTNiMjc0NjQ1YTAxYjFkNTdkZmRmYmVhYy90YWJsZXJhbmdlOjA1MmM2ZmZlM2IyNzQ2NDVhMDFiMWQ1N2RmZGZiZWFjXzYtNi0xLTEtMjM0NTg_37544d6a-5597-4850-b504-0c38c3194a73"
      unitRef="usd">797000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTowNTJjNmZmZTNiMjc0NjQ1YTAxYjFkNTdkZmRmYmVhYy90YWJsZXJhbmdlOjA1MmM2ZmZlM2IyNzQ2NDVhMDFiMWQ1N2RmZGZiZWFjXzYtOC0xLTEtMzU0MzA_3d6ffc71-fd48-479e-b902-e9835ef55435"
      unitRef="usd">1239000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90ZXh0cmVnaW9uOjIyMGM2MjEzZTI4YTQ4YTU5NDMyYzkzOTY1NjcxODAyXzE1ODU_cceb753e-b088-474b-b7ce-7b54e5378cf0"
      unitRef="usd">578000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90ZXh0cmVnaW9uOjIyMGM2MjEzZTI4YTQ4YTU5NDMyYzkzOTY1NjcxODAyXzE1OTI_bf1a09c1-ede5-4d10-a623-3a10c86524e7"
      unitRef="usd">769000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90ZXh0cmVnaW9uOjIyMGM2MjEzZTI4YTQ4YTU5NDMyYzkzOTY1NjcxODAyXzIxNzQ_2da67e4d-ebdb-4ceb-8c28-18d2de309b60">P2Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90ZXh0cmVnaW9uOjIyMGM2MjEzZTI4YTQ4YTU5NDMyYzkzOTY1NjcxODAyXzIyMTc_ad557ecb-00d7-4d02-bf0f-16515d51d118"
      unitRef="number">0.049</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90ZXh0cmVnaW9uOjIyMGM2MjEzZTI4YTQ4YTU5NDMyYzkzOTY1NjcxODAyXzI0OTA_6c9d33c9-1aef-4331-b00f-7c527924fadb">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of the Company&#x2019;s operating lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTo5NDIxYTM4YjUyMWQ0MDU1YTJiNzhlMDk0NzYxZDEzZi90YWJsZXJhbmdlOjk0MjFhMzhiNTIxZDQwNTVhMmI3OGUwOTQ3NjFkMTNmXzItMi0xLTEtMjM0NTg_3452e3aa-5854-4d0f-a91d-0b2ada64d8f0"
      unitRef="usd">974000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTo5NDIxYTM4YjUyMWQ0MDU1YTJiNzhlMDk0NzYxZDEzZi90YWJsZXJhbmdlOjk0MjFhMzhiNTIxZDQwNTVhMmI3OGUwOTQ3NjFkMTNmXzMtMi0xLTEtMjM0NTg_0b011777-73e5-4213-aa68-0aab7132f45d"
      unitRef="usd">1013000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTo5NDIxYTM4YjUyMWQ0MDU1YTJiNzhlMDk0NzYxZDEzZi90YWJsZXJhbmdlOjk0MjFhMzhiNTIxZDQwNTVhMmI3OGUwOTQ3NjFkMTNmXzQtMi0xLTEtMjM0NTg_7e4087f3-f210-4dcf-a5d0-112ca7999811"
      unitRef="usd">614000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTo5NDIxYTM4YjUyMWQ0MDU1YTJiNzhlMDk0NzYxZDEzZi90YWJsZXJhbmdlOjk0MjFhMzhiNTIxZDQwNTVhMmI3OGUwOTQ3NjFkMTNmXzUtMi0xLTEtMjM0NTg_12f3f871-4db3-47e4-a6c9-7660f9bb549a"
      unitRef="usd">206000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTo5NDIxYTM4YjUyMWQ0MDU1YTJiNzhlMDk0NzYxZDEzZi90YWJsZXJhbmdlOjk0MjFhMzhiNTIxZDQwNTVhMmI3OGUwOTQ3NjFkMTNmXzYtMi0xLTEtMjM0NTg_41cab1ff-566e-453f-ab6f-6d7c6b0d80ad"
      unitRef="usd">0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTo5NDIxYTM4YjUyMWQ0MDU1YTJiNzhlMDk0NzYxZDEzZi90YWJsZXJhbmdlOjk0MjFhMzhiNTIxZDQwNTVhMmI3OGUwOTQ3NjFkMTNmXzctMi0xLTEtMjM0NTg_71610252-49ee-4b56-9a16-96c3b9ced333"
      unitRef="usd">0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTo5NDIxYTM4YjUyMWQ0MDU1YTJiNzhlMDk0NzYxZDEzZi90YWJsZXJhbmdlOjk0MjFhMzhiNTIxZDQwNTVhMmI3OGUwOTQ3NjFkMTNmXzgtMi0xLTEtMjM0NTg_41dd560b-74c4-47a3-9c9e-9aa096cbb33c"
      unitRef="usd">2807000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTo5NDIxYTM4YjUyMWQ0MDU1YTJiNzhlMDk0NzYxZDEzZi90YWJsZXJhbmdlOjk0MjFhMzhiNTIxZDQwNTVhMmI3OGUwOTQ3NjFkMTNmXzktMi0xLTEtMjM0NTg_a6035422-5373-456a-8aa0-0bd79cc12d0e"
      unitRef="usd">200000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjEvZnJhZzoyMjBjNjIxM2UyOGE0OGE1OTQzMmM5Mzk2NTY3MTgwMi90YWJsZTo5NDIxYTM4YjUyMWQ0MDU1YTJiNzhlMDk0NzYxZDEzZi90YWJsZXJhbmdlOjk0MjFhMzhiNTIxZDQwNTVhMmI3OGUwOTQ3NjFkMTNmXzEwLTItMS0xLTIzNDU4_3f919674-bf7e-42e5-af87-bc8e37c5c928"
      unitRef="usd">2607000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzY2NTY_40b37fa1-14e6-46aa-89cf-e3c9a553bf38">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Long-Term Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;div style="margin-bottom:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.487%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Principal amount of 4.50% exchangeable senior notes due 2023 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt discount and issuance costs, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,353)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,540)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net carrying amount of liability component&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;142,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;142,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity component:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity component of exchangeable notes, net of issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2021, 2020 and 2019, the total interest expense was $9,942, $12,994 and $12,464, respectively, with coupon interest expense of $6,469 for each period and the amortization of debt issuance costs and debt discount of $1,248, $6,525 and $5,995, respectively. Current period interest expense also included $2,225 of additional interest expense owed as a result of not removing a restrictive legend from the 2023 Notes 365 days following original issuance of the 2023 Notes on February 16, 2018. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 1: Background and Basis of Presentation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for further details.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As described in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 2: Newly Issued Accounting Standards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company elected to early adopt ASU 2020-06 as of January 1, 2021 using a modified retrospective method. The adoption resulted in a $12,939 increase in long-term debt and a $26,699 decrease in the equity component of the 2023 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2023 Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 16, 2018, Avadel Finance Cayman Limited, a Cayman Islands exempted company and an indirect wholly-owned subsidiary of the Company (the &#x201c;Issuer&#x201d;), issued $125,000 aggregate principal amount of 4.50% exchangeable senior notes due 2023 (the &#x201c;2023 Notes&#x201d;) in a private placement (the &#x201c;Offering&#x201d;) to qualified institutional buyers pursuant to Rule 144A under the Securities Act. In connection with the Offering, the Issuer granted the initial purchasers of the 2023 Notes a 30-day option to purchase up to an additional $18,750 aggregate principal amount of the 2023 Notes, which was fully exercised on February 16, 2018. Net proceeds received by the Company, after issuance costs and discounts, were approximately $137,560.  The 2023 Notes are the Company&#x2019;s senior unsecured obligations and rank equally in right of payment with all of the Company&#x2019;s existing and future senior unsecured indebtedness and effectively junior to any of the Company&#x2019;s existing and future secured indebtedness, to the extent of the value of the assets securing such indebtedness.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2023 Notes will be exchangeable at the option of the holders at an initial exchange rate of 92.6956 ADSs per $1 principal amount of 2023 Notes, which is equivalent to an initial exchange price of approximately $10.79 per ADS. Such initial exchange price represents a premium of approximately 20% to the $8.99 per ADS closing price on The Nasdaq Global Market on February 13, 2018.  Upon the exchange of any 2023 Notes, the Issuer will pay or cause to be delivered, as the case may be, cash, ADSs or a combination of cash and ADSs, at the Issuer&#x2019;s election. Holders of the 2023 Notes may convert their 2023 Notes, at their option, only under the following circumstances prior to the close of business on the business day immediately preceding August 1, 2022, under the circumstances and during the periods set forth below and regardless of the conditions described below, on or after August 1, 2022 and prior to the close of business on the business day immediately preceding the maturity date:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Prior to the close of business on the business day immediately preceding August 1, 2022, a holder of the 2023 Notes may surrender all or any portion of its 2023 Notes for exchange at any time during the &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzIzMjM_cdb5c14c-1181-4685-9a23-0a0887188621"&gt;five&lt;/span&gt; business day period immediately after any &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzIzNjg_cdf18a29-792e-43e1-baa4-c68eb2cf6a76"&gt;five&lt;/span&gt; consecutive trading day period (the &#x201c;Measurement Period&#x201d;) in which the trading price per $1 principal amount of 2023 Notes, as determined following a request by a holder of the 2023 Notes, for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the ADSs and the exchange rate on each such trading day.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;If a transaction or event that constitutes a fundamental change or a make-whole fundamental change occurs prior to the close of business on the business day immediately preceding August 1, 2022, regardless of whether a holder of the 2023 Notes has the right to require the Company to repurchase the 2023 Notes, or if Avadel is a party to a merger &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;event that occurs prior to the close of business on the business day immediately preceding August 1, 2022, all or any portion of a the holder&#x2019;s 2023 Notes may be surrendered for exchange at any time from or after the date that is 95 scheduled trading days prior to the anticipated effective date of the transaction (or, if later, the earlier of (x) the business day after the Company gives notice of such transaction and (y) the actual effective date of such transaction) until 35 trading days after the actual effective date of such transaction or, if such transaction also constitutes a fundamental change, until the related fundamental change repurchase date. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Prior to the close of business on the business day immediately preceding August 1, 2022, a holder of the 2023 Notes may surrender all or any portion of its 2023 Notes for exchange at any time during any calendar quarter commencing after the calendar quarter ending on June 30, 2018 (and only during such calendar quarter), if the last reported sale price of the ADSs for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the exchange price on each applicable trading day. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;If the Company calls the 2023 Notes for redemption pursuant to Article 16 to the Indenture prior to the close of business on the business day immediately preceding August 1, 2022, then a holder of the 2023 Notes may surrender all or any portion of its 2023 Notes for exchange at any time prior to the close of business on the second business day prior to the redemption date, even if the 2023 Notes are not otherwise exchangeable at such time. After that time, the right to exchange shall expire, unless the Company defaults in the payment of the redemption price, in which case a holder of the 2023 Notes may exchange its 2023 Notes until the redemption price has been paid or duly provided for.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considered the guidance in ASC 815-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Embedded Derivatives&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to determine if this instrument contains an embedded feature that should be separately accounted for as a derivative. ASC 815 provides for an exception to this rule when convertible notes, as host instruments, are deemed to be conventional, as defined by ASC 815-40. The Company determined that this exception applies due, in part, to its ability to settle the 2023 Notes in cash, ADSs or a combination of cash and ADSs, at the Company&#x2019;s option. The Company have therefore applied the guidance provided by ASC 470-20, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt with Conversion and Other Options, &lt;/span&gt;as amended by ASU 2020-06.</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzY2NTk_2f8595f7-702b-4585-9e44-3465cd0c2351">&lt;div style="margin-bottom:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.487%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Principal amount of 4.50% exchangeable senior notes due 2023 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt discount and issuance costs, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,353)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,540)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net carrying amount of liability component&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;142,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;142,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity component:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity component of exchangeable notes, net of issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0a1f89fa820b46799ce79a937450f547_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90YWJsZTpkZTE0ODFlODlhYzQ0OTk4ODk5MTBkOGUwMWM5NWUzYi90YWJsZXJhbmdlOmRlMTQ4MWU4OWFjNDQ5OTg4OTkxMGQ4ZTAxYzk1ZTNiXzEtMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo1YzEyM2RhN2U1M2U0NWNiYjVhOTgzOTg5ZGM2MmZjNF8yNA_2d1025a5-30cd-485e-a94f-933327a9806b"
      unitRef="number">0.0450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia43fd9d7d0184bf48d0ca7e30b92fe15_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90YWJsZTpkZTE0ODFlODlhYzQ0OTk4ODk5MTBkOGUwMWM5NWUzYi90YWJsZXJhbmdlOmRlMTQ4MWU4OWFjNDQ5OTg4OTkxMGQ4ZTAxYzk1ZTNiXzEtMi0xLTEtMjM0NTg_ba03a3e0-2254-4f5e-ac12-215a4f593078"
      unitRef="usd">143750000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="icfaa054052d14e7a8ca1f2c58126ec2e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90YWJsZTpkZTE0ODFlODlhYzQ0OTk4ODk5MTBkOGUwMWM5NWUzYi90YWJsZXJhbmdlOmRlMTQ4MWU4OWFjNDQ5OTg4OTkxMGQ4ZTAxYzk1ZTNiXzEtNC0xLTEtMjM0NTg_5410f60f-df2b-4882-8fbc-eb3c8c63c84f"
      unitRef="usd">143750000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i4dc9b8e4c33d47f78a2c32f6fc5be381_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90YWJsZTpkZTE0ODFlODlhYzQ0OTk4ODk5MTBkOGUwMWM5NWUzYi90YWJsZXJhbmdlOmRlMTQ4MWU4OWFjNDQ5OTg4OTkxMGQ4ZTAxYzk1ZTNiXzItMi0xLTEtMjM0NTg_aa6e38a1-42a8-46fa-9f94-cf5a5de0f351"
      unitRef="usd">1353000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i1b007cff8b974e868c3993f562d9feaf_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90YWJsZTpkZTE0ODFlODlhYzQ0OTk4ODk5MTBkOGUwMWM5NWUzYi90YWJsZXJhbmdlOmRlMTQ4MWU4OWFjNDQ5OTg4OTkxMGQ4ZTAxYzk1ZTNiXzItNC0xLTEtMjM0NTg_00513137-ccc2-4f83-b619-b5afb77ad7e6"
      unitRef="usd">15540000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="i4dc9b8e4c33d47f78a2c32f6fc5be381_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90YWJsZTpkZTE0ODFlODlhYzQ0OTk4ODk5MTBkOGUwMWM5NWUzYi90YWJsZXJhbmdlOmRlMTQ4MWU4OWFjNDQ5OTg4OTkxMGQ4ZTAxYzk1ZTNiXzMtMi0xLTEtMjM0NTg_88571dd3-282b-4535-8bc2-4a20f2bf7927"
      unitRef="usd">142397000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i1b007cff8b974e868c3993f562d9feaf_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90YWJsZTpkZTE0ODFlODlhYzQ0OTk4ODk5MTBkOGUwMWM5NWUzYi90YWJsZXJhbmdlOmRlMTQ4MWU4OWFjNDQ5OTg4OTkxMGQ4ZTAxYzk1ZTNiXzMtNC0xLTEtMjM0NTg_08cc14dc-a90c-4651-9e96-768b6a3b130d"
      unitRef="usd">128210000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90YWJsZTpkZTE0ODFlODlhYzQ0OTk4ODk5MTBkOGUwMWM5NWUzYi90YWJsZXJhbmdlOmRlMTQ4MWU4OWFjNDQ5OTg4OTkxMGQ4ZTAxYzk1ZTNiXzQtMi0xLTEtMjM0NTg_ed7b67ca-ae93-4b04-98d4-e8aaa4db984a"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90YWJsZTpkZTE0ODFlODlhYzQ0OTk4ODk5MTBkOGUwMWM5NWUzYi90YWJsZXJhbmdlOmRlMTQ4MWU4OWFjNDQ5OTg4OTkxMGQ4ZTAxYzk1ZTNiXzQtNC0xLTEtMjM0NTg_da2895a6-6efe-45d8-85ac-9914d890bca9"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90YWJsZTpkZTE0ODFlODlhYzQ0OTk4ODk5MTBkOGUwMWM5NWUzYi90YWJsZXJhbmdlOmRlMTQ4MWU4OWFjNDQ5OTg4OTkxMGQ4ZTAxYzk1ZTNiXzUtMi0xLTEtMjM0NTg_f25b6cb7-30bf-4491-9a32-a2b9144bb376"
      unitRef="usd">142397000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90YWJsZTpkZTE0ODFlODlhYzQ0OTk4ODk5MTBkOGUwMWM5NWUzYi90YWJsZXJhbmdlOmRlMTQ4MWU4OWFjNDQ5OTg4OTkxMGQ4ZTAxYzk1ZTNiXzUtNC0xLTEtMjM0NTg_e55cef84-5e25-4cff-8a74-866ed0ba8f6e"
      unitRef="usd">128210000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="i4dc9b8e4c33d47f78a2c32f6fc5be381_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90YWJsZTpkZTE0ODFlODlhYzQ0OTk4ODk5MTBkOGUwMWM5NWUzYi90YWJsZXJhbmdlOmRlMTQ4MWU4OWFjNDQ5OTg4OTkxMGQ4ZTAxYzk1ZTNiXzgtMi0xLTEtMjM0NTg_92e819a0-aa67-4a81-bb16-b5db3a824e46"
      unitRef="usd">0</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="i1b007cff8b974e868c3993f562d9feaf_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90YWJsZTpkZTE0ODFlODlhYzQ0OTk4ODk5MTBkOGUwMWM5NWUzYi90YWJsZXJhbmdlOmRlMTQ4MWU4OWFjNDQ5OTg4OTkxMGQ4ZTAxYzk1ZTNiXzgtNC0xLTEtMjM0NTg_ef50000d-e57d-43fe-9f6b-4a48961da6e9"
      unitRef="usd">26699000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:InterestExpenseDebt
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzEwOTk1MTE2Mzc3Nzk_97222a18-451b-4425-ad56-9dbcc32f6b59"
      unitRef="usd">9942000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzEwOTk1MTE2Mzc3OTY_5cb22e30-48d5-4d6f-9c99-7fd46524049d"
      unitRef="usd">12994000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzEwOTk1MTE2Mzc4MTE_5864a938-2b4e-4dba-8de9-acdfad611ed5"
      unitRef="usd">12464000</us-gaap:InterestExpenseDebt>
    <avdl:CouponInterestExpense
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzEwOTk1MTE2Mzc4MjI_2caaa098-ea9e-48c4-90c5-4a1753c26cc8"
      unitRef="usd">6469000</avdl:CouponInterestExpense>
    <avdl:CouponInterestExpense
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzEwOTk1MTE2Mzc4MjI_db5784c0-eb27-49a8-9a30-c42a3e42acfc"
      unitRef="usd">6469000</avdl:CouponInterestExpense>
    <avdl:CouponInterestExpense
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzEwOTk1MTE2Mzc4MjI_e0dd0764-46d8-413b-af5a-b3b281cf37bd"
      unitRef="usd">6469000</avdl:CouponInterestExpense>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ifd8ea8ce80304018bd5b1979eb26d074_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzEwOTk1MTE2Mzc4Mzg_9dd596d8-87b8-4060-96ac-6bbf0f71d37d"
      unitRef="usd">1248000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i33e06b7a13eb4e85be3a4f81119b68c1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzEwOTk1MTE2Mzc4NDc_adc9d5b5-c7a6-45d0-b9c4-d4e3798bb241"
      unitRef="usd">6525000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="id9ebe4ca9019413ebb51803e053e035d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzEwOTk1MTE2Mzc4NTc_45ba64e8-1e21-42f7-b4d5-4acd79e01dc1"
      unitRef="usd">5995000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <avdl:AdditionalInterestExpenseDebt
      contextRef="ibf503e36fd6a429f84871178d6090bcd_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzI3NDg3NzkwODI3NjA_c0870ca2-a2e8-46aa-b693-c34b87b2c346"
      unitRef="usd">2225000</avdl:AdditionalInterestExpenseDebt>
    <us-gaap:LongTermDebt
      contextRef="ia03de445d5514be7925f47534612a3c6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzI3NDg3NzkwODE3NjU_7d24d454-3cfb-4d74-ae58-b583c7237599"
      unitRef="usd">12939000</us-gaap:LongTermDebt>
    <us-gaap:StockholdersEquity
      contextRef="i27057cf80d054326a72f1357eef1f0c2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzI3NDg3NzkwODE3Nzc_569dd9b4-b13e-4f6f-9572-71e4e7f1711e"
      unitRef="usd">-26699000</us-gaap:StockholdersEquity>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i7d1ea1ea40054379a04b6e20ee96f982_I20180216"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzI1Mg_0a9468c0-fc52-45a2-8522-8c5c513cc876"
      unitRef="usd">125000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7d1ea1ea40054379a04b6e20ee96f982_I20180216"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzI4NQ_7e45c9b4-c2d8-40f2-9672-a04142947eef"
      unitRef="number">0.0450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <avdl:DebtInstrumentOptiontoIncreaseFaceAmount
      contextRef="i7d1ea1ea40054379a04b6e20ee96f982_I20180216"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzYwNQ_ddc14f86-6b4a-43b4-8326-d6ae69b8d32c"
      unitRef="usd">18750000</avdl:DebtInstrumentOptiontoIncreaseFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="id653d0c0a8b74c299e04291165d88344_D20180216-20180216"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzc5NQ_e1add4b4-e311-41c9-ac23-daa197a0c10c"
      unitRef="usd">137560000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <avdl:AmericanDepositorySharesConversionRatio
      contextRef="i483626a1ca994a1ab8f44a4dd0abd7f7_D20180216-20180216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzEyMzA_863fb765-23db-4f66-8666-aab8d3c9b5f8"
      unitRef="rate">92.6956</avdl:AmericanDepositorySharesConversionRatio>
    <avdl:AmericanDepositarySharesOptionPricePerShare
      contextRef="i7d1ea1ea40054379a04b6e20ee96f982_I20180216"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzEzNDM_f673fbf6-f752-4def-b29e-7a1bb1e4b78c"
      unitRef="usdPerShare">10.79</avdl:AmericanDepositarySharesOptionPricePerShare>
    <avdl:AmericanDepositarySharesPremiumPercentage
      contextRef="i7d1ea1ea40054379a04b6e20ee96f982_I20180216"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzE0MjE_b369ec26-2cc1-4f49-adbb-a7e3c6d0a42c"
      unitRef="number">0.20</avdl:AmericanDepositarySharesPremiumPercentage>
    <avdl:AmericanDepositarySharesPurchasedPricePerShare
      contextRef="i7d1ea1ea40054379a04b6e20ee96f982_I20180216"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzE0MzE_18ba0084-811f-4102-9cd8-4489186d0c5f"
      unitRef="usdPerShare">8.99</avdl:AmericanDepositarySharesPurchasedPricePerShare>
    <avdl:DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay
      contextRef="i911b1d37c6734cba9182382fa4082eed_D20180216-20180216"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzI2MjE_fe25cbc8-3904-4edf-96b5-179455e1fc44"
      unitRef="number">0.98</avdl:DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay>
    <avdl:DebtInstrumentConvertibleScheduledThresholdTradingDays
      contextRef="i0cf2ba3d017445f7b369d02baa194a26_D20180216-20180216"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzMzMDk_3d3c6b13-a8c3-442a-bec2-36709bbd01f1">P95D</avdl:DebtInstrumentConvertibleScheduledThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i0cf2ba3d017445f7b369d02baa194a26_D20180216-20180216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzM1NTc_7f8db574-9470-4302-aac7-1b20ea74b468"
      unitRef="day">35</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="ic9d6fffe305c44aeb5282edb28b92265_D20180216-20180216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzQxMjQ_3c67bd76-0bd2-467d-ae53-a426c9ce49f3"
      unitRef="day">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="ic9d6fffe305c44aeb5282edb28b92265_D20180216-20180216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzQxOTA_9c49ea99-64d5-43ca-87e7-c9296bd69e70"
      unitRef="day">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="ic9d6fffe305c44aeb5282edb28b92265_D20180216-20180216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjQvZnJhZzo3ZmRmYWFjMDNmZjU0NWRiOGZlNDg5MDU5YTQzMzdiYy90ZXh0cmVnaW9uOjdmZGZhYWMwM2ZmNTQ1ZGI4ZmU0ODkwNTlhNDMzN2JjXzQzMzk_00f79741-b968-4513-bce5-36b978422080"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <avdl:LongTermContingentConsideraionPayableTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjcvZnJhZzpmNWUxYzhmMWZkOGI0YWU4YmUxZGQ5YTk3N2M0MTVhMy90ZXh0cmVnaW9uOmY1ZTFjOGYxZmQ4YjRhZThiZTFkZDlhOTc3YzQxNWEzXzUyNTY_b540913b-3a7e-47e7-889b-d127c2fbe99c">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contingent Consideration Payable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;div style="margin-bottom:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the sale of the Hospital Products on June 30, 2020, the Company computed the fair value of the contingent consideration using several significant assumptions and when those assumptions changed, due to underlying market conditions, the fair value of these liabilities changed as well. Prior to the sale of the Hospital Products, these changes had a material impact on the Company&#x2019;s consolidated statements of (loss) income and balance sheets. As part of the sale of the Hospital Products on June 30, 2020, the Exela Buyer assumed and will pay, perform, satisfy and discharge the liabilities and obligations of Avadel Legacy and the Company under the Deerfield Royalty Agreement and the Broadfin Royalty Agreement. As of December&#160;31, 2021 and 2020, the balance of the contingent consideration payable is $0.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes to the contingent consideration payables, a recurring Level 3 measurement, for the twelve-month periods ended&#160;December 31, 2020&#160;and&#160;2019:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.665%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Payable:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments of related party payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,736)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value adjustments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments of contingent consideration payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,189)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value adjustments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Disposition of the Hospital Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1) Fair value adjustments are reported as changes in fair value of contingent consideration and other expense - changes in fair value of contingent consideration payable in the consolidated statements of (loss) income.</avdl:LongTermContingentConsideraionPayableTextBlock>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjcvZnJhZzpmNWUxYzhmMWZkOGI0YWU4YmUxZGQ5YTk3N2M0MTVhMy90ZXh0cmVnaW9uOmY1ZTFjOGYxZmQ4YjRhZThiZTFkZDlhOTc3YzQxNWEzXzI3NDg3NzkwODYwMjk_bbf4ead9-13e8-4919-a518-6daad028b557"
      unitRef="usd">0</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjcvZnJhZzpmNWUxYzhmMWZkOGI0YWU4YmUxZGQ5YTk3N2M0MTVhMy90ZXh0cmVnaW9uOmY1ZTFjOGYxZmQ4YjRhZThiZTFkZDlhOTc3YzQxNWEzXzI3NDg3NzkwODYwMjk_d5acf9c3-4993-41d1-bc1b-18dd1d38c527"
      unitRef="usd">0</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjcvZnJhZzpmNWUxYzhmMWZkOGI0YWU4YmUxZGQ5YTk3N2M0MTVhMy90ZXh0cmVnaW9uOmY1ZTFjOGYxZmQ4YjRhZThiZTFkZDlhOTc3YzQxNWEzXzUyNjU_67a8b4cd-6208-4893-8db6-426401a9f314">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes to the contingent consideration payables, a recurring Level 3 measurement, for the twelve-month periods ended&#160;December 31, 2020&#160;and&#160;2019:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.665%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Contingent Consideration Payable:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments of related party payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,736)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value adjustments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments of contingent consideration payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,189)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value adjustments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Disposition of the Hospital Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(14,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1) Fair value adjustments are reported as changes in fair value of contingent consideration and other expense - changes in fair value of contingent consideration payable in the consolidated statements of (loss) income.</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
      contextRef="ie19b226220734349af34ea12f273148b_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjcvZnJhZzpmNWUxYzhmMWZkOGI0YWU4YmUxZGQ5YTk3N2M0MTVhMy90YWJsZTplY2Q5ODIxYTcyYjc0ZDRiOTViYjRlZGIyYTYzYTRiNi90YWJsZXJhbmdlOmVjZDk4MjFhNzJiNzRkNGI5NWJiNGVkYjJhNjNhNGI2XzctMi0xLTEtMjM0NTg_dfc3aabc-b218-45d5-aa95-efdff39f152b"
      unitRef="usd">28840000</us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjcvZnJhZzpmNWUxYzhmMWZkOGI0YWU4YmUxZGQ5YTk3N2M0MTVhMy90YWJsZTplY2Q5ODIxYTcyYjc0ZDRiOTViYjRlZGIyYTYzYTRiNi90YWJsZXJhbmdlOmVjZDk4MjFhNzJiNzRkNGI5NWJiNGVkYjJhNjNhNGI2XzgtMi0xLTEtMjM0NTg_77d61aa3-a186-4b68-87d2-ea2b708db3e2"
      unitRef="usd">12736000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjcvZnJhZzpmNWUxYzhmMWZkOGI0YWU4YmUxZGQ5YTk3N2M0MTVhMy90YWJsZTplY2Q5ODIxYTcyYjc0ZDRiOTViYjRlZGIyYTYzYTRiNi90YWJsZXJhbmdlOmVjZDk4MjFhNzJiNzRkNGI5NWJiNGVkYjJhNjNhNGI2XzktMi0xLTEtMjM0NTg_c7c607e9-67ba-419d-bf25-9ab8fcf64065"
      unitRef="usd">1223000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
      contextRef="ie73b28a1c0c648e5a6641e1c909996f0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjcvZnJhZzpmNWUxYzhmMWZkOGI0YWU4YmUxZGQ5YTk3N2M0MTVhMy90YWJsZTplY2Q5ODIxYTcyYjc0ZDRiOTViYjRlZGIyYTYzYTRiNi90YWJsZXJhbmdlOmVjZDk4MjFhNzJiNzRkNGI5NWJiNGVkYjJhNjNhNGI2XzEwLTItMS0xLTIzNDU4_281f893b-0a00-45b7-a335-a14768939f5b"
      unitRef="usd">17327000</us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjcvZnJhZzpmNWUxYzhmMWZkOGI0YWU4YmUxZGQ5YTk3N2M0MTVhMy90YWJsZTplY2Q5ODIxYTcyYjc0ZDRiOTViYjRlZGIyYTYzYTRiNi90YWJsZXJhbmdlOmVjZDk4MjFhNzJiNzRkNGI5NWJiNGVkYjJhNjNhNGI2XzExLTItMS0xLTIzNDU4_f57eef26-974d-4def-bdfd-04eb4e2154aa"
      unitRef="usd">6189000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjcvZnJhZzpmNWUxYzhmMWZkOGI0YWU4YmUxZGQ5YTk3N2M0MTVhMy90YWJsZTplY2Q5ODIxYTcyYjc0ZDRiOTViYjRlZGIyYTYzYTRiNi90YWJsZXJhbmdlOmVjZDk4MjFhNzJiNzRkNGI5NWJiNGVkYjJhNjNhNGI2XzEyLTItMS0xLTIzNDU4_8cd4b2ea-8b5e-4eb2-97a3-97f078a91cc4"
      unitRef="usd">3762000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjcvZnJhZzpmNWUxYzhmMWZkOGI0YWU4YmUxZGQ5YTk3N2M0MTVhMy90YWJsZTplY2Q5ODIxYTcyYjc0ZDRiOTViYjRlZGIyYTYzYTRiNi90YWJsZXJhbmdlOmVjZDk4MjFhNzJiNzRkNGI5NWJiNGVkYjJhNjNhNGI2XzEzLTItMS0xLTIzNDU4_ac7d6249-96f3-432b-a0c0-17954a7d2fb6"
      unitRef="usd">14900000</us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax>
    <us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMjcvZnJhZzpmNWUxYzhmMWZkOGI0YWU4YmUxZGQ5YTk3N2M0MTVhMy90YWJsZTplY2Q5ODIxYTcyYjc0ZDRiOTViYjRlZGIyYTYzYTRiNi90YWJsZXJhbmdlOmVjZDk4MjFhNzJiNzRkNGI5NWJiNGVkYjJhNjNhNGI2XzE0LTItMS0xLTIzNDU4_ad2b70d5-6069-4005-8e95-80ccba699bd4"
      unitRef="usd">0</us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzk2NTk_54a8239a-6937-480b-a87f-34b995a5ac8e">Income Taxes&lt;div style="margin-bottom:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of loss before income taxes for the years ended twelve months ended December 31, are as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Loss Before Income Taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,631)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27,205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50,134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(56,687)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(93,145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,082)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38,582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax benefit consists of the following for the years ended December 31:&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Income Tax Benefit:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. - Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,810)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. - State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,790)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. - Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,876)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,093)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. - State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,876)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,453)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,816)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;The reconciliation between income taxes at the statutory rate and the Company&#x2019;s benefit for income taxes is as follows for the years ended December 31:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Reconciliation to Effective Income Tax Rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax benefit - at statutory tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,642)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,823)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Differences in international tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,950)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nondeductible changes in fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intercompany asset transfer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in valuation allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nondeductible share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Hospital Products sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(261)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State and local taxes (net of federal)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in U.S. tax law&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nondeductible interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Orphan drug and R&amp;amp;D tax credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,793)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(378)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax benefit - at effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,816)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2021, the income tax benefit increased by $3,706 when compared to the same period in 2020. The increase in the income tax benefit in 2021 was primarily driven by the additional tax benefit from an increase in the net operating losses in the U.S. in 2021, when compared to the same period in 2020. This was partially offset by the nonrecurring nature of tax benefits recognized in 2020 from the sale of the Company&#x2019;s Hospital Products and passage of the Coronavirus Aid, Relief and Economic Security Act (the &#x201c;CARES Act&#x201d;) in the U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, the income tax benefit increased by $6,754 when compared to the same period in 2019. The increase in the income tax benefit in 2020 was primarily driven by the tax benefits from the sale of the Company&#x2019;s Hospital Products and passage of the CARES Act in the U.S. The Company recorded additional tax benefit in 2020 from the Orphan Drug and R&amp;amp;D tax credit in the U.S. Tax benefit from the intercompany asset transfer recorded in 2019 did not recur, resulting in a partial offset of tax benefits described above.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Unrecognized Tax Benefits&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company or one of its subsidiaries files income tax returns in Ireland, France, U.S. and various states. The Company is no longer subject to Irish, French, U.S. Federal, and state and local examinations for years before 2017. During 2020, the Company completed the 2015 through 2017 U.S. Federal Tax Audit. Completion of the audit resulted in an assessment of $1,937 for the 2015 through 2017 U.S. Federal Tax Returns compared to the IRS Claims of $50,695 made on July 2, 2019 and the updated IRS Claims of $9,302 on October 2, 2019 made as part of the Specialty Pharma bankruptcy proceedings, which at this time does not include interest and penalties.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the Company&#x2019;s unrecognized tax benefits for the twelve months ended &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Unrecognized Tax Benefit Activity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at January 1: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increases for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Statute of limitations expiration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,266)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,322)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company expects that within the next twelve months the unrecognized tax benefits could decrease by an immaterial amount and the interest could increase by an immaterial amount.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2021, 2020 and 2019, there are $2,483, $2,483 and $3,806 of unrecognized tax benefits that if recognized would affect the annual effective tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes interest and penalties accrued related to unrecognized tax benefits in income tax expense.  During the years ended December&#160;31, 2021, 2020 and 2019, the Company recognized approximately $239, $203 and $555 in interest and penalties. The Company had approximately $1,777 and $1,475 for the payment of interest and penalties accrued at December&#160;31, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Tax Assets (Liabilities)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income tax provisions reflect the effect of temporary differences between consolidated financial statement and tax reporting of income and expense items.  The net deferred tax assets (liabilities) at December&#160;31, 2021 and 2020 resulted from the following temporary differences:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.353%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Net Deferred Tax Assets and Liabilities: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Orphan drug and R&amp;amp;D tax credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(925)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(890)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(965)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: valuation allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,025)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21,624)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;At December 31, 2021, the Company had $124,720 of net operating losses in Ireland that do not have an expiration date and $74,406 of net operating losses in the U.S.  Of the $74,406 of net operating losses in the U.S., $10,365 were acquired due to the acquisition of FSC Therapeutics and FSC Laboratories, Inc., (collectively &#x201c;FSC&#x201d;) and $64,041 are due to the losses at US Holdings.&#160;The portion due to the acquisition of FSC will expire in 2034 through 2035. A valuation allowance is recorded if, based on the weight of available evidence, it is more likely than not that a deferred tax asset will not be realized. This assessment is based on an evaluation of the level of historical taxable income and projections for future taxable income.  For the year ended December 31, 2021, the Company recorded $4,045 of valuation allowances related to Irish net operating losses. The U.S. net operating losses are subject to an annual limitation as a result of the FSC acquisition under Internal Revenue Code Section 382 and will not be fully utilized before they expire.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded a valuation allowance against all of its net operating losses in Ireland and France as of December 31, 2021 and 2020. The Company intends to continue maintaining a full valuation allowance on the Irish net operating losses until there is sufficient evidence to support the reversal of all or some portion of these allowances.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the Company believes it is more likely than not that it will be able to realize the deferred tax assets in the U.S., the Company continues to monitor any unfavorable changes that could ultimately impact its assessment of the realizability of the Company&#x2019;s U.S. deferred tax assets.  If the Company experiences an ownership change under Internal Revenue Code Section 382, the U.S. net operating losses could also be limited in their utilization.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2021, the Company has unremitted earnings of $3,916 outside of Ireland as measured on a U.S. GAAP basis.  Whereas the measure of earnings for purposes of taxation of a distribution may be different for tax purposes, these earnings, which are considered to be invested indefinitely, would become subject to income tax if they were remitted as dividends or if the Company were to sell its stock in the subsidiaries, net of any prior income taxes paid. It is not practicable to estimate the amount of deferred tax liability on such earnings, if any.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;R&amp;amp;D Tax Credits Receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The French and Irish governments provide tax credits to companies for spending on innovative R&amp;amp;D.  These credits are recorded as an offset of R&amp;amp;D expenses and are credited against income taxes payable in years after being incurred or, if not so utilized, are recoverable in cash after a specified period of time, which may differ depending on the tax credit regime.  As of December 31, 2021, the Company&#x2019;s net research tax credit receivable amounts to $3,668 and represents a French gross research &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;tax credit of $3,139 and an Irish gross research tax credit of $529.  As of December 31, 2020, the Company&#x2019;s net research tax credit receivable amounts to $6,771 and represents a French gross research tax credit of $6,396 and an Irish gross research tax credit of $375. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2020 CARES Act&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The CARES Act, enacted on March 27, 2020, includes significant business tax provisions. In particular, the CARES Act modified the rules associated with net operating losses. Under the temporary provisions of the CARES Act, net operating loss carryforwards and carrybacks may offset 100% of taxable income for taxable years beginning before 2021. In addition, net operating losses arising in 2018, 2019 and 2020 taxable years may be carried back to each of the preceding five years to generate a refund. During the twelve months ended December 31, 2020, the income tax benefit includes a discrete tax benefit of $9,124 as a result of the Company&#x2019;s ability under the CARES Act to carry back net operating losses incurred to periods when the statutory U.S. Federal tax rate was 35% versus the Company&#x2019;s current U.S. Federal tax rate of 21%. During the twelve months ended December 31, 2020, the Company received $3,351 in cash tax refunds from carryback claims related to the CARES Act from the carryback of 2018 tax losses. The Company filed refund claims for $18,753 associated with the carryback of 2019 tax losses and a $10,273 refund claim associated with the carryback of 2020 tax losses.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <avdl:ScheduleOfComponentsOfIncomeBeforeIncomeTaxTableTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzk2NjQ_79dfd548-d73b-4d51-a193-e36fc53b609d">&lt;div style="margin-bottom:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of loss before income taxes for the years ended twelve months ended December 31, are as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Loss Before Income Taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,631)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27,205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50,134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(56,687)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(93,145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,082)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38,582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</avdl:ScheduleOfComponentsOfIncomeBeforeIncomeTaxTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i74b20dd17dcf4f36b4f73cfd680e44c9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmMGNjY2E5MDlmZWI0NDY0YmU3NmRjODZlNGZlYWU1NC90YWJsZXJhbmdlOmYwY2NjYTkwOWZlYjQ0NjRiZTc2ZGM4NmU0ZmVhZTU0XzItMi0xLTEtMjM0NTg_eb8ed09a-00bb-40a9-aa27-2b9f7696d985"
      unitRef="usd">-36631000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i1798461a2fc34d85ace6dea31e0f8881_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmMGNjY2E5MDlmZWI0NDY0YmU3NmRjODZlNGZlYWU1NC90YWJsZXJhbmdlOmYwY2NjYTkwOWZlYjQ0NjRiZTc2ZGM4NmU0ZmVhZTU0XzItNC0xLTEtMjM0NTg_a52e9510-9596-4e0f-8750-7735eacbb47e"
      unitRef="usd">-27205000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i08b7b375f4d048c9ab8e6d5fd7ea7ea5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmMGNjY2E5MDlmZWI0NDY0YmU3NmRjODZlNGZlYWU1NC90YWJsZXJhbmdlOmYwY2NjYTkwOWZlYjQ0NjRiZTc2ZGM4NmU0ZmVhZTU0XzItNi0xLTEtMjM0NTg_0da6217c-8bbe-46ef-8bb7-8c71b4327fd3"
      unitRef="usd">-50134000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie59a27f48eeb44b5bb24636fb8639702_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmMGNjY2E5MDlmZWI0NDY0YmU3NmRjODZlNGZlYWU1NC90YWJsZXJhbmdlOmYwY2NjYTkwOWZlYjQ0NjRiZTc2ZGM4NmU0ZmVhZTU0XzMtMi0xLTEtMjM0NTg_c9f2f103-05f9-4f5f-b935-7da5b500f29b"
      unitRef="usd">-56687000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i13a6499a4aea49bfbc0d46162aaf1ebe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmMGNjY2E5MDlmZWI0NDY0YmU3NmRjODZlNGZlYWU1NC90YWJsZXJhbmdlOmYwY2NjYTkwOWZlYjQ0NjRiZTc2ZGM4NmU0ZmVhZTU0XzMtNC0xLTEtMjM0NTg_423be182-f373-44eb-9a37-6ae7e608cdd3"
      unitRef="usd">22335000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia4590886cb1c49159327f4cd498c421f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmMGNjY2E5MDlmZWI0NDY0YmU3NmRjODZlNGZlYWU1NC90YWJsZXJhbmdlOmYwY2NjYTkwOWZlYjQ0NjRiZTc2ZGM4NmU0ZmVhZTU0XzMtNi0xLTEtMjM0NTg_eaa1c740-3a80-4117-bf13-018e3ac189ea"
      unitRef="usd">10401000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i537c662c0452407d996503d13075eee0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmMGNjY2E5MDlmZWI0NDY0YmU3NmRjODZlNGZlYWU1NC90YWJsZXJhbmdlOmYwY2NjYTkwOWZlYjQ0NjRiZTc2ZGM4NmU0ZmVhZTU0XzQtMi0xLTEtMjM0NTg_831316d5-4397-4935-8bfd-6199845d6ee1"
      unitRef="usd">173000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia3e2739e702347078b4ee9a8124ae398_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmMGNjY2E5MDlmZWI0NDY0YmU3NmRjODZlNGZlYWU1NC90YWJsZXJhbmdlOmYwY2NjYTkwOWZlYjQ0NjRiZTc2ZGM4NmU0ZmVhZTU0XzQtNC0xLTEtMjM0NTg_526e4709-9948-4401-a8a9-521b2e589c53"
      unitRef="usd">-212000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i64421d34a1204f448424959b78e8a9d8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmMGNjY2E5MDlmZWI0NDY0YmU3NmRjODZlNGZlYWU1NC90YWJsZXJhbmdlOmYwY2NjYTkwOWZlYjQ0NjRiZTc2ZGM4NmU0ZmVhZTU0XzQtNi0xLTEtMjM0NTg_a557dcee-b23b-461c-9d5e-b942169601be"
      unitRef="usd">1151000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmMGNjY2E5MDlmZWI0NDY0YmU3NmRjODZlNGZlYWU1NC90YWJsZXJhbmdlOmYwY2NjYTkwOWZlYjQ0NjRiZTc2ZGM4NmU0ZmVhZTU0XzUtMi0xLTEtMjM0NTg_f338323e-cc49-4c96-b5d3-a62cffa1a720"
      unitRef="usd">-93145000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmMGNjY2E5MDlmZWI0NDY0YmU3NmRjODZlNGZlYWU1NC90YWJsZXJhbmdlOmYwY2NjYTkwOWZlYjQ0NjRiZTc2ZGM4NmU0ZmVhZTU0XzUtNC0xLTEtMjM0NTg_3df1b8a9-9723-4844-93fb-21c428b378e0"
      unitRef="usd">-5082000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmMGNjY2E5MDlmZWI0NDY0YmU3NmRjODZlNGZlYWU1NC90YWJsZXJhbmdlOmYwY2NjYTkwOWZlYjQ0NjRiZTc2ZGM4NmU0ZmVhZTU0XzUtNi0xLTEtMjM0NTg_50b3e3a7-c7df-49ca-97e7-45206328c69a"
      unitRef="usd">-38582000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <avdl:ScheduleOfIncomeTaxPaymentsTableTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzk2Njc_dfdb8586-a903-4cb6-b197-1bb97c8f67d2">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax benefit consists of the following for the years ended December 31:&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Income Tax Benefit:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. - Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,810)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. - State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,790)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. - Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,876)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,093)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. - State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,876)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,453)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,816)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</avdl:ScheduleOfIncomeTaxPaymentsTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzMtMi0xLTEtMjM0NTg_858e5c04-66da-4ca4-93f6-b75e10063d73"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzMtNC0xLTEtMjM0NTg_caea17cb-e44f-4819-ae3d-9df4525fa8f7"
      unitRef="usd">-12810000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzMtNi0xLTEtMjM0NTg_0f6b0a25-4579-4439-b2f1-71742d028198"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzQtMi0xLTEtMjM0NTg_f0aa2a6b-c5bb-4cd9-9c22-4a53898ac96b"
      unitRef="usd">60000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzQtNC0xLTEtMjM0NTg_1fdecbc1-4465-4fbf-9d1e-5cac9e8ad1d9"
      unitRef="usd">20000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzQtNi0xLTEtMjM0NTg_569813cd-e6a0-401b-8351-a57da88c440b"
      unitRef="usd">97000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzYtMi0xLTEtMjM0NTg_c860094b-c44e-463a-a7ce-5f0009edbd09"
      unitRef="usd">60000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzYtNC0xLTEtMjM0NTg_e853cf8a-dcb3-4fd6-86f7-e1266fac0beb"
      unitRef="usd">-12790000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzYtNi0xLTEtMjM0NTg_be445f21-0b07-4bea-8b52-84de95b001c1"
      unitRef="usd">97000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzktMi0xLTEtMjM0NTg_152373fc-c353-491c-87ee-0ccda8c283d5"
      unitRef="usd">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzktNC0xLTEtMjM0NTg_969c04a6-f6d4-4a20-9571-d0e1a6dcf899"
      unitRef="usd">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzktNi0xLTEtMjM0NTg_98f27f90-575f-4bb6-ad31-86a31629f25e"
      unitRef="usd">-1256000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzEwLTItMS0xLTIzNDU4_64b70ae8-eadf-4f63-b215-385493a51beb"
      unitRef="usd">-15876000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzEwLTQtMS0xLTIzNDU4_444e5730-8e17-4bee-9385-d18658141668"
      unitRef="usd">680000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzEwLTYtMS0xLTIzNDU4_2d3f94e4-c369-454a-80c5-a437afcdd654"
      unitRef="usd">-4093000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzExLTItMS0xLTIzNDU4_cd30d3fb-cd81-488b-8887-aad71ad939a4"
      unitRef="usd">0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzExLTQtMS0xLTIzNDU4_93aa1492-b66a-494c-93fc-015c41c0de25"
      unitRef="usd">0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzExLTYtMS0xLTIzNDU4_7a30fe29-02e5-4e12-bd57-e3b2196dc42a"
      unitRef="usd">-104000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzEzLTItMS0xLTIzNDU4_093b25f4-40f0-4186-86a8-1a3339ea7ef6"
      unitRef="usd">-15876000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzEzLTQtMS0xLTIzNDU4_49e15acd-478d-4f3e-a686-7a07b64c3c8d"
      unitRef="usd">680000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzEzLTYtMS0xLTIzNDU4_4e1bf8e7-95ff-4a53-8b21-d65273eac532"
      unitRef="usd">-5453000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzE1LTItMS0xLTIzNDU4_a4cdf218-96a1-4b41-b82a-1d7720ba6625"
      unitRef="usd">-15816000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzE1LTQtMS0xLTIzNDU4_da36ab78-b73d-41c8-b917-6364d139fbc9"
      unitRef="usd">-12110000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTo1ZGQ2YWI5YTU1NjI0NWM5ODdkZTBjMjRjYzgxZGNmNy90YWJsZXJhbmdlOjVkZDZhYjlhNTU2MjQ1Yzk4N2RlMGMyNGNjODFkY2Y3XzE1LTYtMS0xLTIzNDU4_13263a2f-a707-4285-bf91-1c628703b302"
      unitRef="usd">-5356000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzk2Nzc_54d7b0e8-39fa-4e1b-a907-3b610cf074a2">The reconciliation between income taxes at the statutory rate and the Company&#x2019;s benefit for income taxes is as follows for the years ended December 31:&#160;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Reconciliation to Effective Income Tax Rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax benefit - at statutory tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,642)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,823)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Differences in international tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,950)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nondeductible changes in fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intercompany asset transfer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in valuation allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nondeductible share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Hospital Products sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(261)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State and local taxes (net of federal)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in U.S. tax law&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nondeductible interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Orphan drug and R&amp;amp;D tax credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,793)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(378)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax benefit - at effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,816)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzE3LTItMS0xLTIzNDU4_a962862e-fdc2-403f-9560-f2da7a413a1f"
      unitRef="usd">-11642000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzE3LTQtMS0xLTIzNDU4_23b9864b-11b6-4388-b344-b98d93849de0"
      unitRef="usd">-636000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzE3LTYtMS0xLTIzNDU4_46f9982f-c4bd-41f6-940e-b9b368b9bd2f"
      unitRef="usd">-4823000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzE4LTItMS0xLTIzNDU4_e5bcde47-2c71-4b89-bb6f-fcec7f1c7f6d"
      unitRef="usd">-8950000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzE4LTQtMS0xLTIzNDU4_9e8f62ea-4ebb-43ba-8904-7fa862b90ec8"
      unitRef="usd">1755000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzE4LTYtMS0xLTIzNDU4_bd2ab610-04a8-454e-a7ab-edaec4628662"
      unitRef="usd">-1218000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzE5LTItMS0xLTIzNDU4_240321fd-152d-40f4-9593-68f343e2d3df"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzE5LTQtMS0xLTIzNDU4_45ef7a7b-4683-4527-ae21-8270de6bbd22"
      unitRef="usd">988000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzE5LTYtMS0xLTIzNDU4_1ac9caac-822d-4d68-9bfc-bba02ca37c40"
      unitRef="usd">121000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <avdl:EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzIwLTItMS0xLTIzNDU4_fa93fd8b-59ba-4730-9274-c482e4a3054a"
      unitRef="usd">0</avdl:EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount>
    <avdl:EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzIwLTQtMS0xLTIzNDU4_ad3f1a4e-8056-4a45-b952-c42124407862"
      unitRef="usd">0</avdl:EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount>
    <avdl:EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzIwLTYtMS0xLTIzNDU4_763c8ead-702d-4308-825a-29711434880b"
      unitRef="usd">-8190000</avdl:EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzIxLTItMS0xLTIzNDU4_380137d8-7294-4008-b468-4d3317b1a022"
      unitRef="usd">4296000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzIxLTQtMS0xLTIzNDU4_de6a00f8-ca75-4b43-b8a7-265b97882b1c"
      unitRef="usd">4231000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzIxLTYtMS0xLTIzNDU4_2c78f2be-d206-42b8-872a-0e61b9ef4c4d"
      unitRef="usd">7379000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzIyLTItMS0xLTIzNDU4_0f58dcc1-2c27-4f16-96d5-f1da84444d4d"
      unitRef="usd">645000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzIyLTQtMS0xLTIzNDU4_aa3283a8-c038-4aa5-9fa0-1f58d70435f9"
      unitRef="usd">1060000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzIyLTYtMS0xLTIzNDU4_7c1ffa1a-c542-4d2f-ad41-b4ced4e2c08e"
      unitRef="usd">1039000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzIzLTItMS0xLTIzNDU4_47ed4a70-7435-43d7-9ded-74c68dbd306d"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzIzLTQtMS0xLTIzNDU4_0e793610-7954-487c-92fb-c540a09d1dd8"
      unitRef="usd">-9328000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzIzLTYtMS0xLTIzNDU4_fec715e2-621c-492b-8fb8-6bb1f9b6fef7"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI0LTItMS0xLTIzNDU4_9dde6212-16c8-4342-802a-940142841fbd"
      unitRef="usd">239000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI0LTQtMS0xLTIzNDU4_f5b67a15-69ba-4454-9c9d-384adc10abcf"
      unitRef="usd">-274000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI0LTYtMS0xLTIzNDU4_e5cb07fc-74f0-4f2a-b326-b44588a71616"
      unitRef="usd">-261000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI1LTItMS0xLTIzNDU4_72b9dff1-efb9-4446-95d7-0f82c262dd79"
      unitRef="usd">60000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI1LTQtMS0xLTIzNDU4_c690732d-22c5-4faa-a9c9-f31870336ede"
      unitRef="usd">20000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI1LTYtMS0xLTIzNDU4_f4f92c2a-88aa-4a60-a4b9-c1532d0a9686"
      unitRef="usd">-7000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI2LTItMS0xLTIzNDU4_61955442-abe0-4903-b41f-0b4b9d736f65"
      unitRef="usd">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI2LTQtMS0xLTIzNDU4_82011bf7-5efd-4f22-b7f3-afaaa78a4283"
      unitRef="usd">-9124000</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI2LTYtMS0xLTIzNDU4_fd054c73-0a17-472c-bd4f-09b5d8fdd650"
      unitRef="usd">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount>
    <avdl:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI3LTItMS0xLTIzNDU4_bc19b7ef-c9c8-4eb8-a187-f17cbfd2ba5f"
      unitRef="usd">2173000</avdl:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount>
    <avdl:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI3LTQtMS0xLTIzNDU4_2a11e517-0c61-4820-9aac-03db064c5133"
      unitRef="usd">1728000</avdl:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount>
    <avdl:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI3LTYtMS0xLTIzNDU4_422a1cbf-4782-4839-92e9-9670298e821d"
      unitRef="usd">982000</avdl:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount>
    <avdl:EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI4LTItMS0xLTIzNDU4_6f9d65f5-0e8c-440c-83c3-8d27094cb151"
      unitRef="usd">1524000</avdl:EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit>
    <avdl:EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI4LTQtMS0xLTIzNDU4_c92d3f59-9537-4320-8279-03884e3f51c3"
      unitRef="usd">2793000</avdl:EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit>
    <avdl:EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI4LTYtMS0xLTIzNDU4_b60b16c2-850d-4a36-b311-1f46fbcd383c"
      unitRef="usd">0</avdl:EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI5LTItMS0xLTIzNDU4_2308ce82-5b63-4dab-9a44-b8d8730ec07c"
      unitRef="usd">-1113000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI5LTQtMS0xLTIzNDU4_68187f8e-291e-44e1-836a-fd387cc0e71d"
      unitRef="usd">263000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzI5LTYtMS0xLTIzNDU4_00e386d8-752b-4875-be08-7262e5cd6234"
      unitRef="usd">-378000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzMwLTItMS0xLTIzNDU4_5db7dd14-dd07-46d8-b711-3a4f33832c3f"
      unitRef="usd">-15816000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzMwLTQtMS0xLTIzNDU4_179228d0-6960-443d-a0b4-af46ef628394"
      unitRef="usd">-12110000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTplNTk5MmZhMDc0ZGM0Y2QzYjAxYTk5N2Q1ZmUxMWU5My90YWJsZXJhbmdlOmU1OTkyZmEwNzRkYzRjZDNiMDFhOTk3ZDVmZTExZTkzXzMwLTYtMS0xLTIzNDU4_5b8a4f41-96de-400e-8382-5354c5b00a84"
      unitRef="usd">-5356000</us-gaap:IncomeTaxExpenseBenefit>
    <avdl:IncreaseDecreaseInIncomeTaxBenefit
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzI3NDg3NzkwODgxMTM_96894e1e-3eec-4aa7-b503-539119b56bef"
      unitRef="usd">3706000</avdl:IncreaseDecreaseInIncomeTaxBenefit>
    <avdl:IncreaseDecreaseInIncomeTaxBenefit
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzQ1NQ_ebc45505-f911-4843-bb3a-6b6114bdbe79"
      unitRef="usd">6754000</avdl:IncreaseDecreaseInIncomeTaxBenefit>
    <us-gaap:BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied
      contextRef="idaf12fbafde84863931c23859cbdb5da_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzIzMTM_0ae7d7f8-3e2b-4de2-9a31-0103511d61b6"
      unitRef="usd">1937000</us-gaap:BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied>
    <us-gaap:BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied
      contextRef="ia27d598a536e49f8a6849f6207c5e949_I20190702"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzIzOTc_f3547371-4aa8-4250-807a-a3ebf684b9fb"
      unitRef="usd">50695000</us-gaap:BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied>
    <us-gaap:BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied
      contextRef="i7cf4dc7580ba45efa635d0308b128ae0_I20191002"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzI0NTE_3f148bad-4825-46fb-812b-dfa01ca7eece"
      unitRef="usd">9302000</us-gaap:BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzk2Njg_f909a677-fe43-4b27-82a2-cf062fd0238e">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the Company&#x2019;s unrecognized tax benefits for the twelve months ended &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Unrecognized Tax Benefit Activity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at January 1: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increases for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Statute of limitations expiration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,266)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,322)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzItMi0xLTEtMjM0NTg_d3343f3c-acdb-4820-8d3b-dc61edef6951"
      unitRef="usd">3143000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ie73b28a1c0c648e5a6641e1c909996f0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzItNC0xLTEtMjM0NTg_12391580-c3e8-446f-8997-c7dd4b46bb38"
      unitRef="usd">6465000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ie19b226220734349af34ea12f273148b_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzItNi0xLTEtMjM0NTg_a9793635-ed03-4085-93d2-2c07433e7622"
      unitRef="usd">5315000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzQtMi0xLTEtMjM0NTg_f51f9660-b920-437a-85e3-29f7a60c8207"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzQtNC0xLTEtMjM0NTg_11f9cc77-e59f-49b6-9647-c71e61fab413"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzQtNi0xLTEtMjM0NTg_2745f4d3-1560-4f7f-80e7-c813959e35b2"
      unitRef="usd">2416000</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzUtMi0xLTEtMjM0NTg_d6c03053-c801-44e4-aff5-5b9ee636ec45"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzUtNC0xLTEtMjM0NTg_b4969714-2464-4253-be85-bc3fb0b1163a"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzUtNi0xLTEtMjM0NTg_f5d16c0a-2ebf-46e2-b115-ed6afc640bb6"
      unitRef="usd">1266000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzYtMi0xLTEtMjM0NTg_1d8d363d-a9c3-4d90-98aa-7b4561c686d2"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzYtNC0xLTEtMjM0NTg_c47e1742-9685-4dc3-8941-2e530077a200"
      unitRef="usd">3322000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzYtNi0xLTEtMjM0NTg_404739db-8ea9-43ff-8cc6-02a08473297e"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzctMi0xLTEtMjM0NTg_c98d8b21-05b4-419b-88de-a70a88e61747"
      unitRef="usd">3143000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzctNC0xLTEtMjM0NTg_dbd8d282-e97f-4dd0-ad81-7225d2883e5a"
      unitRef="usd">3143000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ie73b28a1c0c648e5a6641e1c909996f0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpmZDIyM2U5YzViOTc0ZTZhOTlmNzRjOTliNTNhZjUyOS90YWJsZXJhbmdlOmZkMjIzZTljNWI5NzRlNmE5OWY3NGM5OWI1M2FmNTI5XzctNi0xLTEtMjM0NTg_77d06cca-546d-44b3-8b18-a10aae2767c5"
      unitRef="usd">6465000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzMxMjU_b99711b8-d6f5-435a-beab-d2f50980d622"
      unitRef="usd">2483000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzMxMjk_9c2cd5a8-6509-479d-b904-7376642286b6"
      unitRef="usd">2483000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="ie73b28a1c0c648e5a6641e1c909996f0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzMxMzY_a9432cf4-1213-4d3f-9001-4c080c103e2c"
      unitRef="usd">3806000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzM0MjY_a7870a2a-9003-414d-bf7f-ec2e4794ce65"
      unitRef="usd">239000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzM0MzA_b1f7288f-6105-4a83-99f4-6878ef0a6620"
      unitRef="usd">203000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzM0Mzc_105805ee-7b43-4901-8753-8afab4d5f176"
      unitRef="usd">555000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzM0OTg_e42a465f-0070-406d-bb17-731200e84b25"
      unitRef="usd">1777000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzM1MDU_3b7cb2c6-d5ac-436f-977f-dd19235972ce"
      unitRef="usd">1475000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzk2NzA_6b7a8011-70a2-427a-b994-624f54aa7f5c">The net deferred tax assets (liabilities) at December&#160;31, 2021 and 2020 resulted from the following temporary differences:&#160;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.353%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Net Deferred Tax Assets and Liabilities: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Orphan drug and R&amp;amp;D tax credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(925)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(890)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(965)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: valuation allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,025)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21,624)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzMtMi0xLTEtMjM0NTg_fc51cdb7-8406-4958-9621-d240e83b3e68"
      unitRef="usd">35990000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzMtNC0xLTEtMjM0NTg_83c89ac4-fade-430a-bb90-411b917104a2"
      unitRef="usd">31302000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <avdl:DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzQtMi0xLTEtMjM0NTg_695aff11-0eda-488b-a122-473e345074bb"
      unitRef="usd">4964000</avdl:DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch>
    <avdl:DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzQtNC0xLTEtMjM0NTg_b0545bb0-801f-4d8c-9465-6b9733690188"
      unitRef="usd">2793000</avdl:DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzUtMi0xLTEtMjM0NTg_8c17ad9f-7682-497e-9509-f0854f99ed60"
      unitRef="usd">4108000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzUtNC0xLTEtMjM0NTg_76512127-a8bc-4732-8cc9-52948affd19b"
      unitRef="usd">2626000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <avdl:DeferredTaxAssetsAmortizationofIntangibleAssets
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzYtMi0xLTEtMjM0NTg_f868f16c-6ee9-4b31-9fcc-9bb9affd6661"
      unitRef="usd">3429000</avdl:DeferredTaxAssetsAmortizationofIntangibleAssets>
    <avdl:DeferredTaxAssetsAmortizationofIntangibleAssets
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzYtNC0xLTEtMjM0NTg_1ca50cb7-34e3-41b8-80e0-48987dc833ff"
      unitRef="usd">3701000</avdl:DeferredTaxAssetsAmortizationofIntangibleAssets>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzktMi0xLTEtMjM0NTg_40e82c63-ff2c-457e-9d29-75ef067c85c8"
      unitRef="usd">662000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzktNC0xLTEtMjM0NTg_9d127948-fdfa-420d-b8e0-ec0a7d97b5d8"
      unitRef="usd">423000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzEwLTItMS0xLTIzNDU4_b82966c9-1bd0-442d-95a2-bb4af705d400"
      unitRef="usd">49153000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzEwLTQtMS0xLTIzNDU4_65f58952-b4b9-4c9a-a0a5-3078aa75be88"
      unitRef="usd">40845000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzEzLTItMS0xLTIzNDU4_f880c218-c808-441f-adb5-917969cdd638"
      unitRef="usd">925000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzEzLTQtMS0xLTIzNDU4_91206e64-4136-4cd8-a2da-4b919f02c5d3"
      unitRef="usd">890000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesPrepaidExpenses
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzE0LTItMS0xLTIzNDU4_372a6a76-2270-411c-a9bf-7c9f1900f3b1"
      unitRef="usd">75000</us-gaap:DeferredTaxLiabilitiesPrepaidExpenses>
    <us-gaap:DeferredTaxLiabilitiesPrepaidExpenses
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzE0LTQtMS0xLTIzNDU4_932fc991-9a72-4328-afdf-e97183943bcf"
      unitRef="usd">75000</us-gaap:DeferredTaxLiabilitiesPrepaidExpenses>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzE2LTItMS0xLTIzNDU4_8d8c78d6-713a-4313-be04-9ef9940e7729"
      unitRef="usd">1000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzE2LTQtMS0xLTIzNDU4_f44ea2a8-98fe-420e-a237-a42477625f24"
      unitRef="usd">965000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzE4LTItMS0xLTIzNDU4_833edfff-a927-4340-94d2-79b2bea5c961"
      unitRef="usd">24025000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzE4LTQtMS0xLTIzNDU4_73ef55b0-d69d-4ce0-a78c-7c07f1683d6d"
      unitRef="usd">21624000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzIwLTItMS0xLTIzNDU4_3d267d72-5314-4569-8ab5-3288e65710ef"
      unitRef="usd">24128000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90YWJsZTpiZTVlOTM2Zjk1NjI0OWRmODUwNzZkYzIyYmEwOWFjMC90YWJsZXJhbmdlOmJlNWU5MzZmOTU2MjQ5ZGY4NTA3NmRjMjJiYTA5YWMwXzIwLTQtMS0xLTIzNDU4_970cf692-6b2d-4777-80f2-c1e5160a7f1d"
      unitRef="usd">18256000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i0729539c1221405f81e7676478827e0e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzM5NDU_cc70dd95-7d3e-42b9-be80-43d422b4ea20"
      unitRef="usd">124720000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ib32f28d9fbb54bab90164eb85e585915_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzQwMjM_d0b9dd13-7e6c-4602-b489-6f4dc17793a1"
      unitRef="usd">74406000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ib32f28d9fbb54bab90164eb85e585915_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzQwNzA_aa24cb80-8d84-4d20-8871-05fb7c53383d"
      unitRef="usd">74406000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i94f0c3f367384e14bdd26826dd6b02fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzQxMTA_2473f84e-bc75-43b8-a67b-838395ece606"
      unitRef="usd">10365000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="if8fc76361f664419bb4b6bec6e9f55d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzQxNjE_c6f5e162-e8c9-4968-8396-05f77ead22d0"
      unitRef="usd">64041000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwardsValuationAllowance
      contextRef="i0729539c1221405f81e7676478827e0e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzQ3NDI_eb2606a4-b19f-4068-8fd4-17123903de68"
      unitRef="usd">4045000</us-gaap:OperatingLossCarryforwardsValuationAllowance>
    <us-gaap:UndistributedEarnings
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzYxNjg_1ff0d9e0-ce27-4e07-a16a-c0765deb46d0"
      unitRef="usd">3916000</us-gaap:UndistributedEarnings>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzcxMjk_e7159647-0fe9-4802-8289-20e852236d6f"
      unitRef="usd">3668000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="i537c662c0452407d996503d13075eee0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzcxODU_91de440f-f225-4288-a180-2feb4bada006"
      unitRef="usd">3139000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="i74b20dd17dcf4f36b4f73cfd680e44c9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzcyMzA_8ba80bba-47a3-45fc-a51f-4a2c28bdaf86"
      unitRef="usd">529000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzczMTA_68301e87-fdfa-4b11-98b7-56c1d355a6cb"
      unitRef="usd">6771000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="ia3e2739e702347078b4ee9a8124ae398_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzczNjY_aff7cb81-c5ad-421c-b0ba-64c87b32598e"
      unitRef="usd">6396000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="i1798461a2fc34d85ace6dea31e0f8881_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzc0MTE_5c1dfd2b-5764-452e-9532-877e60b24798"
      unitRef="usd">375000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <avdl:CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzgzNjM_8f9ca21a-d201-4875-8964-ed7250831aee"
      unitRef="usd">9124000</avdl:CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit>
    <avdl:CARESActProceedsFromIncomeTaxRefunds
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzg2MjE_00c4536c-4dd0-46aa-b5a9-3ca642ba5751"
      unitRef="usd">3351000</avdl:CARESActProceedsFromIncomeTaxRefunds>
    <avdl:CARESActCashRefundClaims
      contextRef="i965546c452da46f2b76a6fe33a65e75c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzg3Njc_70926fed-941e-4ca0-9d12-41f3e6102e49"
      unitRef="usd">18753000</avdl:CARESActCashRefundClaims>
    <avdl:CARESActCashRefundClaims
      contextRef="i8b27235b791c489ba62df9bcd96969e8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzAvZnJhZzpmNmFjYTk3NzlmZWQ0N2JhYTQwMDEyODI4ZjcxOTM3Zi90ZXh0cmVnaW9uOmY2YWNhOTc3OWZlZDQ3YmFhNDAwMTI4MjhmNzE5MzdmXzI3NDg3NzkwODgxMjQ_8309e2b6-ecf3-48b1-a6bc-a4f91e53288f"
      unitRef="usd">10273000</avdl:CARESActCashRefundClaims>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90ZXh0cmVnaW9uOjAzOTBjZmU3ZTJmMTQ4ZTRiNTJjMTdmNjVhMjI3MjUzXzE3Nw_3cc87812-daf2-4a1c-b114-b4fb0732c4ac">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Assets and Liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;div style="margin-bottom:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Various other assets and liabilities are summarized for the years ended December 31, as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Prepaid Expenses and Other Current Assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax receivable (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Note 13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid and other expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee from Armistice&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receivable from Exela (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Note 4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Short-term deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:14pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Non-Current Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Note 13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right of use assets at contract manufacturing organizations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee from Armistice&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrued Expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued outsourced contract costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued restructuring (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Note 16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.895%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Current Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee to Deerfield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Due to Exela&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.895%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Non-Current Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax liabilities and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee to Deerfield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90ZXh0cmVnaW9uOjAzOTBjZmU3ZTJmMTQ4ZTRiNTJjMTdmNjVhMjI3MjUzXzE3Mg_563e9443-b77a-4a0b-ab2f-e86295e8f5d4">&lt;div style="margin-bottom:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Various other assets and liabilities are summarized for the years ended December 31, as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Prepaid Expenses and Other Current Assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax receivable (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Note 13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid and other expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee from Armistice&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Receivable from Exela (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Note 4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Short-term deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock>
    <us-gaap:IncomeTaxesReceivable
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzItMi0xLTEtMjM0NTg_08ba54cf-6172-40d1-ae1d-74416d9012bb"
      unitRef="usd">29097000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzItNC0xLTEtMjM0NTg_b1a8969f-2ce7-4baf-930a-cf0c5ca2d779"
      unitRef="usd">18615000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzMtMi0xLTEtMjM0NTg_582af7e3-282d-4d5d-a117-69c756a7f134"
      unitRef="usd">3179000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzMtNC0xLTEtMjM0NTg_5fa58070-e1ce-4f8a-9539-94fa7b496ba9"
      unitRef="usd">1018000</us-gaap:PrepaidExpenseCurrent>
    <avdl:GuaranteeCurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzQtMi0xLTEtMzY1NjA_8f238f80-9c4b-49df-8e4c-808330c803bc"
      unitRef="usd">279000</avdl:GuaranteeCurrent>
    <avdl:GuaranteeCurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzQtNC0xLTEtMzY1NjA_3d8351c5-7031-4353-baa2-97646413c1ee"
      unitRef="usd">318000</avdl:GuaranteeCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzQtMi0xLTEtMjc5OTc_07127373-710e-4b64-bcaa-100f47d936cf"
      unitRef="usd">271000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzQtNC0xLTEtMjc5OTc_d41d1dba-c063-49cd-a044-47b97f638802"
      unitRef="usd">798000</us-gaap:OtherAssetsCurrent>
    <avdl:ShortTermNoteReceivable
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzYtMi0xLTEtMjM0NTg_75e516a8-540a-4a83-a42c-6aac634972cc"
      unitRef="usd">0</avdl:ShortTermNoteReceivable>
    <avdl:ShortTermNoteReceivable
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzYtNC0xLTEtMjM0NTg_89183f91-748c-48f2-bfbe-7959a2b79930"
      unitRef="usd">16500000</avdl:ShortTermNoteReceivable>
    <us-gaap:ShortTermInvestments
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzctMi0xLTEtMjM0NTg_9e17fced-0ca2-4cd9-ada3-c7f0c9dfa8ed"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzctNC0xLTEtMjM0NTg_65701f63-c518-4744-89d8-0510a436f50b"
      unitRef="usd">1477000</us-gaap:ShortTermInvestments>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzktMi0xLTEtMjM0NTg_7b37e79f-b82e-455e-b8c6-8391256cfec2"
      unitRef="usd">32826000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTphY2NlYWI2ZGY1ZjI0YzdiODAxMWY3ZTUzNDc2MDRmZi90YWJsZXJhbmdlOmFjY2VhYjZkZjVmMjRjN2I4MDExZjdlNTM0NzYwNGZmXzktNC0xLTEtMjM0NTg_c9c1c1dc-0b93-4c87-bcb1-4b7cc251cee1"
      unitRef="usd">38726000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90ZXh0cmVnaW9uOjAzOTBjZmU3ZTJmMTQ4ZTRiNTJjMTdmNjVhMjI3MjUzXzE4MA_9e6514c3-2efa-4917-91d0-6642f1bb665c">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Non-Current Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Note 13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right of use assets at contract manufacturing organizations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee from Armistice&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTo5YjE3NmUxMzM4MzM0ZjUzOWJjNWNmZDM0NjcwOTIxOS90YWJsZXJhbmdlOjliMTc2ZTEzMzgzMzRmNTM5YmM1Y2ZkMzQ2NzA5MjE5XzItMi0xLTEtMjM0NTg_d162d295-a0a8-40b8-bb5c-39e12fae0d17"
      unitRef="usd">24128000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTo5YjE3NmUxMzM4MzM0ZjUzOWJjNWNmZDM0NjcwOTIxOS90YWJsZXJhbmdlOjliMTc2ZTEzMzgzMzRmNTM5YmM1Y2ZkMzQ2NzA5MjE5XzItNC0xLTEtMjM0NTg_0e06bfbc-afcf-4b83-946d-82ba65d800dc"
      unitRef="usd">18256000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTo5YjE3NmUxMzM4MzM0ZjUzOWJjNWNmZDM0NjcwOTIxOS90YWJsZXJhbmdlOjliMTc2ZTEzMzgzMzRmNTM5YmM1Y2ZkMzQ2NzA5MjE5XzMtMi0xLTEtMjgwMTk_346b8c5c-1d42-428e-b69b-8be990400d22"
      unitRef="usd">8549000</avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent>
    <avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTo5YjE3NmUxMzM4MzM0ZjUzOWJjNWNmZDM0NjcwOTIxOS90YWJsZXJhbmdlOjliMTc2ZTEzMzgzMzRmNTM5YmM1Y2ZkMzQ2NzA5MjE5XzMtNC0xLTEtMjgwMTk_6ffa2e10-ac72-4b96-9841-f52cb37f6872"
      unitRef="usd">5201000</avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent>
    <avdl:GuaranteeNoncurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTo5YjE3NmUxMzM4MzM0ZjUzOWJjNWNmZDM0NjcwOTIxOS90YWJsZXJhbmdlOjliMTc2ZTEzMzgzMzRmNTM5YmM1Y2ZkMzQ2NzA5MjE5XzQtMi0xLTEtMjM0NTg_8c9a05db-a98d-4090-9836-dc67a252991c"
      unitRef="usd">771000</avdl:GuaranteeNoncurrent>
    <avdl:GuaranteeNoncurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTo5YjE3NmUxMzM4MzM0ZjUzOWJjNWNmZDM0NjcwOTIxOS90YWJsZXJhbmdlOjliMTc2ZTEzMzgzMzRmNTM5YmM1Y2ZkMzQ2NzA5MjE5XzQtNC0xLTEtMjM0NTg_65755ec6-1e1d-441d-aeac-4f59ff02f5de"
      unitRef="usd">1050000</avdl:GuaranteeNoncurrent>
    <avdl:OtherNoncurrentReceivables
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTo5YjE3NmUxMzM4MzM0ZjUzOWJjNWNmZDM0NjcwOTIxOS90YWJsZXJhbmdlOjliMTc2ZTEzMzgzMzRmNTM5YmM1Y2ZkMzQ2NzA5MjE5XzYtMi0xLTEtMjM0NTg_d7448485-85da-456f-a591-16db7680c099"
      unitRef="usd">329000</avdl:OtherNoncurrentReceivables>
    <avdl:OtherNoncurrentReceivables
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTo5YjE3NmUxMzM4MzM0ZjUzOWJjNWNmZDM0NjcwOTIxOS90YWJsZXJhbmdlOjliMTc2ZTEzMzgzMzRmNTM5YmM1Y2ZkMzQ2NzA5MjE5XzYtNC0xLTEtMjM0NTg_3a6b5660-495c-4644-91c6-7f7a6c2461ce"
      unitRef="usd">432000</avdl:OtherNoncurrentReceivables>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTo5YjE3NmUxMzM4MzM0ZjUzOWJjNWNmZDM0NjcwOTIxOS90YWJsZXJhbmdlOjliMTc2ZTEzMzgzMzRmNTM5YmM1Y2ZkMzQ2NzA5MjE5XzctMi0xLTEtMjM0NTg_6387fe30-e86f-47ef-8454-3ee88d291266"
      unitRef="usd">33777000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTo5YjE3NmUxMzM4MzM0ZjUzOWJjNWNmZDM0NjcwOTIxOS90YWJsZXJhbmdlOjliMTc2ZTEzMzgzMzRmNTM5YmM1Y2ZkMzQ2NzA5MjE5XzctNC0xLTEtMjM0NTg_0f653f6e-2118-49f1-abc8-e17bba05fc48"
      unitRef="usd">24939000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90ZXh0cmVnaW9uOjAzOTBjZmU3ZTJmMTQ4ZTRiNTJjMTdmNjVhMjI3MjUzXzE4Ng_c703ddec-93af-4b90-b451-5e9dac07d7b2">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrued Expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued outsourced contract costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued restructuring (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Note 16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedSalariesCurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpmZWU3NTAxM2MzNzc0ZjI4YmVmOTU1ZjdjMWU5NmYyMy90YWJsZXJhbmdlOmZlZTc1MDEzYzM3NzRmMjhiZWY5NTVmN2MxZTk2ZjIzXzQtMi0xLTEtMjgxMTI_2d4567de-3887-4052-bb6a-a59facf97ec2"
      unitRef="usd">3167000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpmZWU3NTAxM2MzNzc0ZjI4YmVmOTU1ZjdjMWU5NmYyMy90YWJsZXJhbmdlOmZlZTc1MDEzYzM3NzRmMjhiZWY5NTVmN2MxZTk2ZjIzXzQtNC0xLTEtMjgxMTI_a3506c95-cc22-4f37-8a60-7150225ecdb0"
      unitRef="usd">1697000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpmZWU3NTAxM2MzNzc0ZjI4YmVmOTU1ZjdjMWU5NmYyMy90YWJsZXJhbmdlOmZlZTc1MDEzYzM3NzRmMjhiZWY5NTVmN2MxZTk2ZjIzXzQtMi0xLTEtMjgyMDI_73c3eec8-0ffc-4604-89ce-812dbd90dffd"
      unitRef="usd">2678000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpmZWU3NTAxM2MzNzc0ZjI4YmVmOTU1ZjdjMWU5NmYyMy90YWJsZXJhbmdlOmZlZTc1MDEzYzM3NzRmMjhiZWY5NTVmN2MxZTk2ZjIzXzQtNC0xLTEtMjgyMDI_b4944020-46fd-43c6-9e0c-71d35d3e5000"
      unitRef="usd">2781000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <avdl:AccruedOutsourceContractCosts
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpmZWU3NTAxM2MzNzc0ZjI4YmVmOTU1ZjdjMWU5NmYyMy90YWJsZXJhbmdlOmZlZTc1MDEzYzM3NzRmMjhiZWY5NTVmN2MxZTk2ZjIzXzQtMi0xLTEtMjgyMTQ_d699ff64-03e4-447a-be2a-701d769b0a20"
      unitRef="usd">1048000</avdl:AccruedOutsourceContractCosts>
    <avdl:AccruedOutsourceContractCosts
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpmZWU3NTAxM2MzNzc0ZjI4YmVmOTU1ZjdjMWU5NmYyMy90YWJsZXJhbmdlOmZlZTc1MDEzYzM3NzRmMjhiZWY5NTVmN2MxZTk2ZjIzXzQtNC0xLTEtMjgyMTQ_40f4f5be-0b6e-4a0e-8770-7f538e987b8f"
      unitRef="usd">473000</avdl:AccruedOutsourceContractCosts>
    <avdl:AccruedTradeDiscountsAndRebates
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpmZWU3NTAxM2MzNzc0ZjI4YmVmOTU1ZjdjMWU5NmYyMy90YWJsZXJhbmdlOmZlZTc1MDEzYzM3NzRmMjhiZWY5NTVmN2MxZTk2ZjIzXzQtMi0xLTEtMjgxODk_39822c3c-bbfe-4070-bd7f-f238b3fc36b6"
      unitRef="usd">217000</avdl:AccruedTradeDiscountsAndRebates>
    <avdl:AccruedTradeDiscountsAndRebates
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpmZWU3NTAxM2MzNzc0ZjI4YmVmOTU1ZjdjMWU5NmYyMy90YWJsZXJhbmdlOmZlZTc1MDEzYzM3NzRmMjhiZWY5NTVmN2MxZTk2ZjIzXzQtNC0xLTEtMjgxODk_87ef3d72-3208-4528-a17f-88f51bfa41fd"
      unitRef="usd">1030000</avdl:AccruedTradeDiscountsAndRebates>
    <us-gaap:RestructuringReserveCurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpmZWU3NTAxM2MzNzc0ZjI4YmVmOTU1ZjdjMWU5NmYyMy90YWJsZXJhbmdlOmZlZTc1MDEzYzM3NzRmMjhiZWY5NTVmN2MxZTk2ZjIzXzctMi0xLTEtMjgxMjM_0272ab0f-e66c-4620-99ab-c90652f835ac"
      unitRef="usd">41000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:RestructuringReserveCurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpmZWU3NTAxM2MzNzc0ZjI4YmVmOTU1ZjdjMWU5NmYyMy90YWJsZXJhbmdlOmZlZTc1MDEzYzM3NzRmMjhiZWY5NTVmN2MxZTk2ZjIzXzctNC0xLTEtMjgxMjM_8c1b9502-29c9-4d9a-b712-d1f88d7521f8"
      unitRef="usd">520000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpmZWU3NTAxM2MzNzc0ZjI4YmVmOTU1ZjdjMWU5NmYyMy90YWJsZXJhbmdlOmZlZTc1MDEzYzM3NzRmMjhiZWY5NTVmN2MxZTk2ZjIzXzktMi0xLTEtMjM0NTg_2ee73a12-d984-49de-b280-2ebfd72ec7b3"
      unitRef="usd">7151000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpmZWU3NTAxM2MzNzc0ZjI4YmVmOTU1ZjdjMWU5NmYyMy90YWJsZXJhbmdlOmZlZTc1MDEzYzM3NzRmMjhiZWY5NTVmN2MxZTk2ZjIzXzktNC0xLTEtMjM0NTg_07b36073-ec78-45ac-914e-60176078c056"
      unitRef="usd">6501000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90ZXh0cmVnaW9uOjAzOTBjZmU3ZTJmMTQ4ZTRiNTJjMTdmNjVhMjI3MjUzXzE4NQ_49d89d49-ffd3-478c-9bb1-83fd513dfaff">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.895%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Current Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee to Deerfield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Due to Exela&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <avdl:AccruedInterestCurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpkMDc3MjUyMGMzMjM0ODQxOWM5M2QxMjg0MjA3ZTkyOS90YWJsZXJhbmdlOmQwNzcyNTIwYzMyMzQ4NDE5YzkzZDEyODQyMDdlOTI5XzItMi0xLTEtMjM0NTg_f1012d09-77ab-4243-ab0f-67afc904d332"
      unitRef="usd">4920000</avdl:AccruedInterestCurrent>
    <avdl:AccruedInterestCurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpkMDc3MjUyMGMzMjM0ODQxOWM5M2QxMjg0MjA3ZTkyOS90YWJsZXJhbmdlOmQwNzcyNTIwYzMyMzQ4NDE5YzkzZDEyODQyMDdlOTI5XzItNC0xLTEtMjM0NTg_4b322d8b-82c2-4c99-bf84-c43a38206c10"
      unitRef="usd">2695000</avdl:AccruedInterestCurrent>
    <avdl:OtherGuarantorObligationsCurrentCarryingValue
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpkMDc3MjUyMGMzMjM0ODQxOWM5M2QxMjg0MjA3ZTkyOS90YWJsZXJhbmdlOmQwNzcyNTIwYzMyMzQ4NDE5YzkzZDEyODQyMDdlOTI5XzQtMi0xLTEtMjM0NTg_5006a3f4-ab5a-4ad5-887c-7ecb4f58e00d"
      unitRef="usd">280000</avdl:OtherGuarantorObligationsCurrentCarryingValue>
    <avdl:OtherGuarantorObligationsCurrentCarryingValue
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpkMDc3MjUyMGMzMjM0ODQxOWM5M2QxMjg0MjA3ZTkyOS90YWJsZXJhbmdlOmQwNzcyNTIwYzMyMzQ4NDE5YzkzZDEyODQyMDdlOTI5XzQtNC0xLTEtMjM0NTg_a5fcf8a4-f5f5-40e1-9419-1196a039f9ec"
      unitRef="usd">319000</avdl:OtherGuarantorObligationsCurrentCarryingValue>
    <avdl:OtherLiabilitiesMiscellaneousCurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpkMDc3MjUyMGMzMjM0ODQxOWM5M2QxMjg0MjA3ZTkyOS90YWJsZXJhbmdlOmQwNzcyNTIwYzMyMzQ4NDE5YzkzZDEyODQyMDdlOTI5XzUtMi0xLTEtMjM0NTg_04285021-e69c-4121-8349-fc7e0ab580c1"
      unitRef="usd">70000</avdl:OtherLiabilitiesMiscellaneousCurrent>
    <avdl:OtherLiabilitiesMiscellaneousCurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpkMDc3MjUyMGMzMjM0ODQxOWM5M2QxMjg0MjA3ZTkyOS90YWJsZXJhbmdlOmQwNzcyNTIwYzMyMzQ4NDE5YzkzZDEyODQyMDdlOTI5XzUtNC0xLTEtMjM0NTg_35a6671f-3e50-4fa3-8f93-6fe544380b2d"
      unitRef="usd">160000</avdl:OtherLiabilitiesMiscellaneousCurrent>
    <us-gaap:DueToAffiliateCurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpkMDc3MjUyMGMzMjM0ODQxOWM5M2QxMjg0MjA3ZTkyOS90YWJsZXJhbmdlOmQwNzcyNTIwYzMyMzQ4NDE5YzkzZDEyODQyMDdlOTI5XzYtMi0xLTEtMjgwMzA_5639cc57-71a4-473e-86e7-3748448a1b31"
      unitRef="usd">0</us-gaap:DueToAffiliateCurrent>
    <us-gaap:DueToAffiliateCurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpkMDc3MjUyMGMzMjM0ODQxOWM5M2QxMjg0MjA3ZTkyOS90YWJsZXJhbmdlOmQwNzcyNTIwYzMyMzQ4NDE5YzkzZDEyODQyMDdlOTI5XzYtNC0xLTEtMjgwMzA_643843de-a8a3-4cba-9ff2-0b85133ab4a3"
      unitRef="usd">2026000</us-gaap:DueToAffiliateCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpkMDc3MjUyMGMzMjM0ODQxOWM5M2QxMjg0MjA3ZTkyOS90YWJsZXJhbmdlOmQwNzcyNTIwYzMyMzQ4NDE5YzkzZDEyODQyMDdlOTI5XzYtMi0xLTEtMjM0NTg_19591353-4490-4bbb-b9ee-a7ba1ed6e7e0"
      unitRef="usd">5270000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZTpkMDc3MjUyMGMzMjM0ODQxOWM5M2QxMjg0MjA3ZTkyOS90YWJsZXJhbmdlOmQwNzcyNTIwYzMyMzQ4NDE5YzkzZDEyODQyMDdlOTI5XzYtNC0xLTEtMjM0NTg_4d43dc4b-ec60-4195-b73f-681e4e5734f5"
      unitRef="usd">5200000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90ZXh0cmVnaW9uOjAzOTBjZmU3ZTJmMTQ4ZTRiNTJjMTdmNjVhMjI3MjUzXzE4Nw_c02ee994-d9e9-47c9-8c88-f073416540ab">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.895%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Non-Current Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax liabilities and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee to Deerfield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <avdl:TaxLiabilitiesAndOtherNoncurrentLiabilities
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZToyNjY2YWI5YjdiN2I0NThmOTM3ZGJjYWU1YWUzNGVlNC90YWJsZXJhbmdlOjI2NjZhYjliN2I3YjQ1OGY5MzdkYmNhZTVhZTM0ZWU0XzQtMi0xLTEtMjM0NTg_7db8b6db-9336-4c2d-a7d5-2ed0c7c76e53"
      unitRef="usd">3143000</avdl:TaxLiabilitiesAndOtherNoncurrentLiabilities>
    <avdl:TaxLiabilitiesAndOtherNoncurrentLiabilities
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZToyNjY2YWI5YjdiN2I0NThmOTM3ZGJjYWU1YWUzNGVlNC90YWJsZXJhbmdlOjI2NjZhYjliN2I3YjQ1OGY5MzdkYmNhZTVhZTM0ZWU0XzQtNC0xLTEtMjM0NTg_5d5e7772-fb88-4134-8811-2cb9290e14cb"
      unitRef="usd">3159000</avdl:TaxLiabilitiesAndOtherNoncurrentLiabilities>
    <us-gaap:GuarantyLiabilities
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZToyNjY2YWI5YjdiN2I0NThmOTM3ZGJjYWU1YWUzNGVlNC90YWJsZXJhbmdlOjI2NjZhYjliN2I3YjQ1OGY5MzdkYmNhZTVhZTM0ZWU0XzUtMi0xLTEtMjM0NTg_a0a94eb0-d455-4356-b35f-fc8cc6d35a64"
      unitRef="usd">774000</us-gaap:GuarantyLiabilities>
    <us-gaap:GuarantyLiabilities
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZToyNjY2YWI5YjdiN2I0NThmOTM3ZGJjYWU1YWUzNGVlNC90YWJsZXJhbmdlOjI2NjZhYjliN2I3YjQ1OGY5MzdkYmNhZTVhZTM0ZWU0XzUtNC0xLTEtMjM0NTg_ea451530-3bcf-43fd-bbbc-66c1adae91bc"
      unitRef="usd">1053000</us-gaap:GuarantyLiabilities>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZToyNjY2YWI5YjdiN2I0NThmOTM3ZGJjYWU1YWUzNGVlNC90YWJsZXJhbmdlOjI2NjZhYjliN2I3YjQ1OGY5MzdkYmNhZTVhZTM0ZWU0XzctMi0xLTEtMjM0NTg_fd4ec3f6-85e0-427c-a3a7-a9aa85ba1fdc"
      unitRef="usd">3917000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzYvZnJhZzowMzkwY2ZlN2UyZjE0OGU0YjUyYzE3ZjY1YTIyNzI1My90YWJsZToyNjY2YWI5YjdiN2I0NThmOTM3ZGJjYWU1YWUzNGVlNC90YWJsZXJhbmdlOjI2NjZhYjliN2I3YjQ1OGY5MzdkYmNhZTVhZTM0ZWU0XzctNC0xLTEtMjM0NTg_7cfbb992-2ae7-4a2a-b431-9548a6545167"
      unitRef="usd">4212000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzkvZnJhZzplMGJkMGJiMTkwN2M0M2M5YmU3NjdjMWVhNDI0YmNlYi90ZXh0cmVnaW9uOmUwYmQwYmIxOTA3YzQzYzliZTc2N2MxZWE0MjRiY2ViXzE5NzA_3e26e529-a84f-47f5-a7a7-6c997de057b9">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contingent Liabilities and Commitments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to potential liabilities generally incidental to its business arising out of present and future lawsuits and claims related to product liability, personal injury, contract, commercial, intellectual property, tax, employment, compliance and other matters that arise in the ordinary course of business. The Company accrues for potential liabilities when it is probable that future costs (including legal fees and expenses) will be incurred and such costs can be reasonably estimated. At December 31, 2021, there were no contingent liabilities with respect to any litigation, arbitration or administrative or other proceeding that are reasonably likely to have a material adverse effect on the Company&#x2019;s consolidated financial position, results of operations, cash flows or liquidity. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;First Complaint&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 12, 2021, Jazz Pharmaceuticals, Inc. (&#x201c;Jazz&#x201d;) filed a formal complaint (the &#x201c;First Complaint&#x201d;) initiating a lawsuit in the United States District Court for the District of Delaware (the &#x201c;Court&#x201d;) against Avadel Pharmaceuticals plc, Avadel US Holdings, Inc., Avadel Management Corporation, Avadel Legacy Pharmaceuticals, LLC, Avadel Specialty Pharmaceuticals, LLC, and Avadel CNS Pharmaceuticals, LLC (collectively, the &#x201c;Avadel Parties&#x201d;). In the First Complaint, Jazz alleges the sodium oxybate product (&#x201c;Proposed Product&#x201d;) described in the NDA owned by Avadel CNS Pharmaceuticals, LLC will infringe at least one claim of US Patent No. 8731963, 10758488, 10813885, 10959956 and/or 10966931 (collectively, the &#x201c;patents-in-suit&#x201d;). The First Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#x2019; fees, costs and expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 3, 2021, the Avadel Parties timely filed their Answer and Counterclaims (the &#x201c;Avadel Answer&#x201d;) with the Court in response to the First Complaint. The Avadel Answer generally denies the allegations set forth in the First Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patents-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of each patent-in-suit, and ii) a declaratory judgment of invalidity of each patent-in-suit.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 18, 2021, Jazz filed its Answer (&#x201c;Jazz Answer&#x201d;) with the Court in response to the Avadel Answer. The Jazz Answer generally denies the allegations set forth in the Avadel Answer and sets forth a single affirmative defense asserting that Avadel has failed to state a claim for which relief can be granted.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 21, 2021, the Court issued an oral order requiring the parties to i) confer regarding proposed dates to be included in the Court&#x2019;s scheduling order for the case, and ii) submit a proposed order, including a proposal for the length and timing of trial, to the Court by no later than July 21, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 30, 2021, the Court issued a scheduling order establishing timing for litigation events including i) a claim construction hearing date of August 2, 2022, and ii) a trial date of October 30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 18, 2021, consistent with the scheduling order, Jazz filed a status update with the Court indicating that Jazz did not intend to file a preliminary injunction with the Court at this time. Jazz further indicated that it would provide the Court with an &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;update regarding whether preliminary injunction proceedings may be necessary after receiving further information regarding the FDA&#x2019;s action on Avadel&#x2019;s NDA.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 4, 2022, the Court entered an agreed order dismissing this case with respect to Avadel Pharmaceuticals plc, Avadel US Holdings, Inc., Avadel Specialty Pharmaceuticals, LLC, Avadel Legacy Pharmaceuticals, LLC, and Avadel Management Corporation.  A corresponding order was entered in the two below cases on the same day.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Second Complaint&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 4, 2021, Jazz filed another formal complaint (the &#x201c;Second Complaint&#x201d;) initiating a lawsuit in the Court against the Avadel Parties. In the Second Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS Pharmaceuticals, LLC will infringe at least one claim of US Patent No. 11077079. The Second Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#x2019; fees, costs and expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 9, 2021, the Avadel Parties timely filed their Answer and Counterclaims (the &#x201c;Second Avadel Answer&#x201d;) with the Court in response to the Second Complaint. The Second Avadel Answer generally denies the allegations set forth in the Second Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patent-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of the patent-in-suit, and ii) a declaratory judgment of invalidity of the patent-in-suit.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 22, 2021, the Court issued an oral order stating that this case should proceed on the same schedule as the case filed on May 12, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Third Complaint&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 10, 2021, Jazz filed another formal complaint (the &#x201c;Third Complaint&#x201d;) initiating a lawsuit in the Court against the Avadel Parties. In the Third Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS Pharmaceuticals, LLC will infringe at least one claim of US Patent No. 11147782. The Third Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#x2019; fees, costs and expenses.  This case will proceed on the same schedule as the cases associated with the First and Second Complaints above.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 7, 2022, Avadel CNS Pharmaceuticals LLC timely filed its Answer and Counterclaims (the &#x201c;Third Avadel Answer&#x201d;) with the Court in response to the Third Complaint. The Third Avadel Answer generally denies the allegations set forth in the Third Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patent-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of the patent-in-suit, and ii) a declaratory judgment of invalidity/unenforceability of the patent-in-suit.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 21, 2021, the Court entered a revised schedule for the First, Second and Third Complaints, setting a new claim construction date of August 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Material Commitments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2021, the Company has one commitment with its primary contract manufacturer related to facility upgrades and the purchase and validation of equipment to be used in the manufacture of FT218. The total cost of this commitment is estimated to be approximately $5,500 and is expected to be completed during the year ending December 31, 2022. The Company has incurred approximately $3,348 of this commitment during the year ended December 31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has a commitment with another contract manufacturer that commences in the first quarter of 2022 and will continue until FDA approval of the contract manufacturer. The commitment will be approximately $3,000 per year.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deerfield Guarantee&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Company&#x2019;s February 2018 divestiture of its pediatric assets, including four pediatric commercial stage assets &#x2013; Karbinal&#x2122; ER, Cefaclor, Flexichamber&#x2122; and AcipHex&#xae; Sprinkle&#x2122; (&#x201c;FSC products&#x201d;), to Cerecor, Inc. (&#x201c;Cerecor&#x201d;), the Company guaranteed to Deerfield a quarterly royalty payment of 15% on net sales of the FSC products through February 6, 2026 (&#x201c;FSC Product Royalties&#x201d;), in an aggregate amount of up to approximately $10,300. Given the Company&#x2019;s explicit &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;guarantee to Deerfield, the Company recorded the guarantee in accordance with ASC 460. The balance of this guarantee liability was $1,054 at December&#160;31, 2021. This liability is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Armistice Guarantee&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Company&#x2019;s February 2018 divestiture of the pediatric assets, Armistice Capital Master Fund, Ltd., the majority shareholder of Cerecor, guaranteed to the Company the FSC Product Royalties. The Company recorded the guarantee in accordance with ASC 460. The balance of this guarantee asset was $1,050 at December&#160;31, 2021. This asset is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the Company&#x2019;s guarantee to Deerfield and the guarantee received by the Company from Armistice largely offset and when combined are not material.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:PurchaseObligation
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzkvZnJhZzplMGJkMGJiMTkwN2M0M2M5YmU3NjdjMWVhNDI0YmNlYi90ZXh0cmVnaW9uOmUwYmQwYmIxOTA3YzQzYzliZTc2N2MxZWE0MjRiY2ViXzE0Mjc_c6cbbd41-d9ce-4cf2-8ee7-693fbecc10f9"
      unitRef="usd">5500000</us-gaap:PurchaseObligation>
    <avdl:CostsIncurredPurchaseObligation
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzkvZnJhZzplMGJkMGJiMTkwN2M0M2M5YmU3NjdjMWVhNDI0YmNlYi90ZXh0cmVnaW9uOmUwYmQwYmIxOTA3YzQzYzliZTc2N2MxZWE0MjRiY2ViXzEwOTk1MTE2NDU4Mjc_68272543-67a2-4e9d-9dbc-00837820018c"
      unitRef="usd">3348000</avdl:CostsIncurredPurchaseObligation>
    <avdl:ContractualObligationAnnualAmount
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzkvZnJhZzplMGJkMGJiMTkwN2M0M2M5YmU3NjdjMWVhNDI0YmNlYi90ZXh0cmVnaW9uOmUwYmQwYmIxOTA3YzQzYzliZTc2N2MxZWE0MjRiY2ViXzI3NDg3NzkwOTc2OTk_80a65fc6-20e5-467a-812e-be8866474b8e"
      unitRef="usd">3000000</avdl:ContractualObligationAnnualAmount>
    <avdl:PercentageOfRoyaltyPayableOnNetSales
      contextRef="i8aae7fedfa0841069d9766ab4280c0ce_D20180201-20180228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzkvZnJhZzplMGJkMGJiMTkwN2M0M2M5YmU3NjdjMWVhNDI0YmNlYi90ZXh0cmVnaW9uOmUwYmQwYmIxOTA3YzQzYzliZTc2N2MxZWE0MjRiY2ViXzEwNDQ1MzYwNDkxNTY2_debeac1e-543c-4484-bc6a-9a05dd871da7"
      unitRef="number">0.15</avdl:PercentageOfRoyaltyPayableOnNetSales>
    <avdl:RoyaltyPayableonNetSalesMaximum
      contextRef="i8aae7fedfa0841069d9766ab4280c0ce_D20180201-20180228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzkvZnJhZzplMGJkMGJiMTkwN2M0M2M5YmU3NjdjMWVhNDI0YmNlYi90ZXh0cmVnaW9uOmUwYmQwYmIxOTA3YzQzYzliZTc2N2MxZWE0MjRiY2ViXzEwNDQ1MzYwNDkxNTcx_21bf3e38-af02-4bd8-b30e-beae9faf7d59"
      unitRef="usd">10300000</avdl:RoyaltyPayableonNetSalesMaximum>
    <us-gaap:GuarantyLiabilities
      contextRef="ie92e7a337b354b108b7bcc24805f0ef5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzkvZnJhZzplMGJkMGJiMTkwN2M0M2M5YmU3NjdjMWVhNDI0YmNlYi90ZXh0cmVnaW9uOmUwYmQwYmIxOTA3YzQzYzliZTc2N2MxZWE0MjRiY2ViXzE2NDkyNjc0NTk0MzQ_6bbaa099-e372-4a42-b155-72b12897e008"
      unitRef="usd">1054000</us-gaap:GuarantyLiabilities>
    <us-gaap:GuarantyAssets
      contextRef="i5adac7e213d040e6be9c9156b4e7a03d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xMzkvZnJhZzplMGJkMGJiMTkwN2M0M2M5YmU3NjdjMWVhNDI0YmNlYi90ZXh0cmVnaW9uOmUwYmQwYmIxOTA3YzQzYzliZTc2N2MxZWE0MjRiY2ViXzE2NDkyNjc0NTk0MjM_c8eff4e3-ef13-477a-88cd-9ad7a16e4c33"
      unitRef="usd">1050000</us-gaap:GuarantyAssets>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzI4ODE_f1eab408-aa21-41d6-9fb4-8951da353c23">Restructuring Costs&#160;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2019 French Restructuring&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2019, the Company initiated a plan to discontinue all French R&amp;amp;D activities, which resulted in the redundancy and reduction of its entire workforce at its V&#xe9;nissieux, France site (&#x201c;2019 French Restructuring&#x201d;). This reduction was part of an effort to align the Company&#x2019;s cost structure with its ongoing and future planned projects. The discontinuation of R&amp;amp;D activities and elimination of the workforce in France was completed during the year ended December 31, 2020.  Restructuring charges associated with this plan recognized during the years ended December 31, 2021 and 2020 were immaterial. Restructuring charges associated with this plan of $4,855 of were recognized during the year ended December 31, 2019.  Included in the 2019 French Restructuring charges of $4,855 were charges for employee severance, benefits and other costs of $4,339, charges related to fixed asset impairment of $629, charges related to the early termination penalty related to the office and copier lease terminations of $887, partially offset by a benefit of $1,000 related to the reversal of the French retirement indemnity obligation. At December 31, 2021, there are no future expected retirement indemnity benefits to be paid. The Company does not expect to incur any additional expenses related to the 2019 French Restructuring. The following table sets forth activities for the Company&#x2019;s cost reduction plan obligations for the years ended&#160;December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.915%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019 French Restructuring Obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance of restructuring accrual at January 1,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(Benefit) charges for employee severance, benefits and other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,813)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance of restructuring accrual at December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2019 French Restructuring liability of&#160;$41 is included in the consolidated balance sheet in accrued expenses at&#160;December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2019 Corporate Restructuring&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2019, the Company announced a plan to reduce its corporate workforce by more than&#160;50%&#160;(the &#x201c;2019 Corporate Restructuring&#x201d;). The reduction in workforce is primarily a result of the exit of Noctiva during the first quarter of 2019 (see&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note&#160;3: Subsidiary Bankruptcy and Deconsolidation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), as well as an effort to better align the Company&#x2019;s remaining cost structure at its U.S. and Ireland locations with its ongoing and future planned projects. The reduction in workforce was completed during the year ended December 31, 2020.  Restructuring income associated with this plan for the years ended December 31, 2021 and 2020 were immaterial. Restructuring charges associated with this plan of $1,755 were recognized during the year ended December 31, 2019. Included in the 2019 Corporate Restructuring charges of $1,755 for the year ended December 31, 2019 were charges for employee severance, benefit and other costs of $3,406, charges related to the early termination penalty related to the office lease termination of $288, the write-off of $125 of property, plant and equipment, net, partially offset by a benefit of $2,064 related to share based compensation forfeitures related to the employees affected by the global reduction in workforce. The Company does not expect to incur any additional expenses related to the 2019 Corporate Restructuring.&lt;/span&gt;&lt;/div&gt;During the years ended December 31, 2021, 2020 and 2019, the Company paid $272, $1,014, and $2,326 respectively, and has no remaining obligation for the 2019 Corporate Restructuring plan as of December 31, 2021.</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringCharges
      contextRef="ia9dabd3a46c348c4af8ae3e2b161a78b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc1OTU1_4715d3bb-ce6a-4ae6-bc9a-d8ad89180282"
      unitRef="usd">4855000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia9dabd3a46c348c4af8ae3e2b161a78b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc1OTY2_36f61b8c-aab5-4edc-a4ae-18c66f7a02fa"
      unitRef="usd">4855000</us-gaap:RestructuringCharges>
    <avdl:RestructuringChargesBeforeGainLossDuetoCurtailment
      contextRef="i3109188b67084c50b94dbbece93b1abd_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc2MDk5_ccadf170-9390-457a-bb61-4b0d613c5fc8"
      unitRef="usd">4339000</avdl:RestructuringChargesBeforeGainLossDuetoCurtailment>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="ia9dabd3a46c348c4af8ae3e2b161a78b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc1OTc3_ca9ef2aa-482e-41ba-9fa4-2fb08be3486c"
      unitRef="usd">629000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="ia9dabd3a46c348c4af8ae3e2b161a78b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc1OTg2_4393bfe1-783b-445e-94e7-1ff98cb4ceed"
      unitRef="usd">887000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:RestructuringCharges
      contextRef="i5b6255d17e27499c84e9416e2247c6d2_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc1OTk1_b2e9ee1e-2cb5-42dd-82cd-60611db298ce"
      unitRef="usd">1000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i5abec81499e34146bd019b20912a78d9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc2MTEz_ef26da72-b6a2-4029-8975-6fc80d926ac4"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzI4Nzk_e5a32d62-06ef-4610-a928-dfc00197a6c3">The following table sets forth activities for the Company&#x2019;s cost reduction plan obligations for the years ended&#160;December&#160;31, 2021 and 2020:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.915%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019 French Restructuring Obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance of restructuring accrual at January 1,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(Benefit) charges for employee severance, benefits and other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,813)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance of restructuring accrual at December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i9fe6439ac97147e2bef805733848150d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90YWJsZTo2MjQ2ZWFjYjAxMDk0ZDZiOTkyYWFiMDk3NTE3NzExNi90YWJsZXJhbmdlOjYyNDZlYWNiMDEwOTRkNmI5OTJhYWIwOTc1MTc3MTE2XzItMi0xLTEtMjM0NTg_1e48e679-3692-4fb9-a165-3c8c5d7e34a7"
      unitRef="usd">248000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ia076dc0709334bbeaf09ce17301fb2b2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90YWJsZTo2MjQ2ZWFjYjAxMDk0ZDZiOTkyYWFiMDk3NTE3NzExNi90YWJsZXJhbmdlOjYyNDZlYWNiMDEwOTRkNmI5OTJhYWIwOTc1MTc3MTE2XzItNC0xLTEtMjM0NTg_a8d2ad95-3fa4-4ed7-ba76-433a6cfcf34f"
      unitRef="usd">1922000</us-gaap:RestructuringReserve>
    <avdl:RestructuringChargesBeforeGainLossDuetoCurtailment
      contextRef="i1c3cd06d5ae74e7ca62b8e96948d1fbe_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90YWJsZTo2MjQ2ZWFjYjAxMDk0ZDZiOTkyYWFiMDk3NTE3NzExNi90YWJsZXJhbmdlOjYyNDZlYWNiMDEwOTRkNmI5OTJhYWIwOTc1MTc3MTE2XzMtMi0xLTEtMjM0NTg_c0a890d6-e234-4541-b5db-048bafc91b45"
      unitRef="usd">-122000</avdl:RestructuringChargesBeforeGainLossDuetoCurtailment>
    <avdl:RestructuringChargesBeforeGainLossDuetoCurtailment
      contextRef="ib7cf514ecb0a4781b0ac7b4a71edab2e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90YWJsZTo2MjQ2ZWFjYjAxMDk0ZDZiOTkyYWFiMDk3NTE3NzExNi90YWJsZXJhbmdlOjYyNDZlYWNiMDEwOTRkNmI5OTJhYWIwOTc1MTc3MTE2XzMtNC0xLTEtMjM0NTg_31a36dcd-8b66-4865-b6e8-0b5c1b4abf5d"
      unitRef="usd">172000</avdl:RestructuringChargesBeforeGainLossDuetoCurtailment>
    <us-gaap:PaymentsForRestructuring
      contextRef="i5987a3d29dec46bbb4bf5192b6d19fa6_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90YWJsZTo2MjQ2ZWFjYjAxMDk0ZDZiOTkyYWFiMDk3NTE3NzExNi90YWJsZXJhbmdlOjYyNDZlYWNiMDEwOTRkNmI5OTJhYWIwOTc1MTc3MTE2XzQtMi0xLTEtMjM0NTg_789547ba-ebbf-4701-906a-6cbe4dd1bf33"
      unitRef="usd">77000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i08f7c0e44e0a42769d59e55ba48a1a37_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90YWJsZTo2MjQ2ZWFjYjAxMDk0ZDZiOTkyYWFiMDk3NTE3NzExNi90YWJsZXJhbmdlOjYyNDZlYWNiMDEwOTRkNmI5OTJhYWIwOTc1MTc3MTE2XzQtNC0xLTEtMjM0NTg_5f9f6f2b-d4d5-489a-a525-377408530278"
      unitRef="usd">1813000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="i5987a3d29dec46bbb4bf5192b6d19fa6_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90YWJsZTo2MjQ2ZWFjYjAxMDk0ZDZiOTkyYWFiMDk3NTE3NzExNi90YWJsZXJhbmdlOjYyNDZlYWNiMDEwOTRkNmI5OTJhYWIwOTc1MTc3MTE2XzUtMi0xLTEtMjM0NTg_dcb0f12d-9e3c-47d1-8c3e-b950f425b553"
      unitRef="usd">-8000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="i08f7c0e44e0a42769d59e55ba48a1a37_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90YWJsZTo2MjQ2ZWFjYjAxMDk0ZDZiOTkyYWFiMDk3NTE3NzExNi90YWJsZXJhbmdlOjYyNDZlYWNiMDEwOTRkNmI5OTJhYWIwOTc1MTc3MTE2XzUtNC0xLTEtMjM0NTg_7133b87a-870b-49a4-bb15-b129253c2c68"
      unitRef="usd">-33000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="ice4e909fcef6444cab32b6676fcfd8a6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90YWJsZTo2MjQ2ZWFjYjAxMDk0ZDZiOTkyYWFiMDk3NTE3NzExNi90YWJsZXJhbmdlOjYyNDZlYWNiMDEwOTRkNmI5OTJhYWIwOTc1MTc3MTE2XzYtMi0xLTEtMjM0NTg_4371099d-0748-4f0d-aa83-038945c9426d"
      unitRef="usd">41000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i9fe6439ac97147e2bef805733848150d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90YWJsZTo2MjQ2ZWFjYjAxMDk0ZDZiOTkyYWFiMDk3NTE3NzExNi90YWJsZXJhbmdlOjYyNDZlYWNiMDEwOTRkNmI5OTJhYWIwOTc1MTc3MTE2XzYtNC0xLTEtMjM0NTg_0916ef36-66c5-4acd-b0ed-5e1110dfc7fd"
      unitRef="usd">248000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="iee22e31315ba4f7e8c83a112021555d6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzExNjE_59f43a4c-17ba-456a-9edf-f4bfc6e8a28a"
      unitRef="usd">41000</us-gaap:RestructuringReserve>
    <avdl:RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent
      contextRef="i27fed9afac844925a080e2a721c7438b_I20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEzOTM_d1c12ea1-0e15-4ca2-8ad7-12bf82696c8e"
      unitRef="number">0.50</avdl:RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent>
    <us-gaap:RestructuringCharges
      contextRef="i91f93d16ae9742dd81fc60061f927f11_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc2MDA2_343a285c-9305-44e5-9b74-af8efca4cba2"
      unitRef="usd">1755000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i91f93d16ae9742dd81fc60061f927f11_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc2MDE3_f445598b-c398-4855-9678-77eaa979b6fb"
      unitRef="usd">1755000</us-gaap:RestructuringCharges>
    <avdl:RestructuringChargesBeforeGainLossDuetoCurtailment
      contextRef="i7326c61f55a843b198262a29c6c921c5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc2MDI4_03e11b63-68e6-45be-8afc-523f4ad027dd"
      unitRef="usd">3406000</avdl:RestructuringChargesBeforeGainLossDuetoCurtailment>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i91f93d16ae9742dd81fc60061f927f11_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc2MDM5_65e203b3-f109-413e-8159-fe9500b31c47"
      unitRef="usd">288000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:PropertyPlantAndEquipmentDisposals
      contextRef="i91f93d16ae9742dd81fc60061f927f11_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc2MDQ4_25ebdc99-fadc-4204-9a47-9fa02e5e3248"
      unitRef="usd">125000</us-gaap:PropertyPlantAndEquipmentDisposals>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="i91f93d16ae9742dd81fc60061f927f11_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc2MDU3_8186bd7d-86f9-4e37-8659-20b93a874d50"
      unitRef="usd">2064000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:PaymentsForRestructuring
      contextRef="iba84066aae6641519638f5dc4a7827a7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc2MDY4_27bc6480-ae65-4af8-b3c5-33ed058310b1"
      unitRef="usd">272000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i18f1d74601ab46d1bf4daa3efd8b638b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc2MDc3_f1fd6d4a-4e73-461c-b279-11bec8c93e32"
      unitRef="usd">1014000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i7326c61f55a843b198262a29c6c921c5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDUvZnJhZzphZDhmNjhiMGZjYjY0ZjExODdiZTRiM2U2MTExOTc2OC90ZXh0cmVnaW9uOmFkOGY2OGIwZmNiNjRmMTE4N2JlNGIzZTYxMTE5NzY4XzEwNDQ1MzYwNDc2MDg4_75e93bfc-203a-4b31-a1ed-b2bfd381dfc9"
      unitRef="usd">2326000</us-gaap:PaymentsForRestructuring>
    <avdl:EquityTransactionsDisclosureTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzQ3MTA_f0eb216d-ac55-4c61-8481-60a0de3d3fe3">Equity Instruments and Transactions&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Capital Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has 500,000 shares of authorized ordinary shares with a nominal value of $0.01 per ordinary share. As of December&#160;31, 2021, the Company had 58,620 ordinary shares issued and outstanding, respectively. The Board of Directors is authorized to issue preferred shares in series, and with respect to each series, to fix its designation, relative rights (including voting, dividend, conversion, sinking fund, and redemption rights), preferences (including dividends and liquidation) and limitations. The Company has 50,000 shares of authorized preferred shares, $0.01 nominal value, of which 488 are currently issued and outstanding as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shelf Registration Statement on Form S-3&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2020, the Company filed with the SEC a new shelf registration statement on Form S-3 (the 2020 Shelf Registration Statement) (File No. 333-236258) that allows issuance and sale by the Company, from time to time, of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt"&gt;up to $250,000 in aggregate of ordinary shares, nominal value US$0.01 per share (the &#x201c;Ordinary Shares&#x201d;), each of which may be represented by American Depositary Shares (&#x201c;ADSs&#x201d;), preferred shares, nominal value US$0.01 per share (the &#x201c;Preferred Shares&#x201d;), debt securities (the &#x201c;Debt Securities&#x201d;), warrants to purchase Ordinary Shares, ADSs, Preferred Shares and/or Debt Securities (the &#x201c;Warrants&#x201d;), and/or units consisting of Ordinary Shares, ADSs, Preferred Shares, one or more Debt Securities or Warrants in one or more series, in any combination, pursuant to the terms of the 2020 Shelf Registration Statement, the base prospectus contained in the 2020 Shelf Registration Statement (the &#x201c;Base Prospectus&#x201d;), and any amendments or supplements thereto (together, the &#x201c;Securities&#x201d;); including&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;b.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;up to $50,000 of ADSs that may be issued and sold from time to time pursuant to the terms of an Open Market Sale Agreement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline"&gt;SM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, entered into with Jefferies LLC on February 4, 2020 (the &#x201c;Sales Agreement&#x201d;), the 2020 Shelf Registration Statement, the Base Prospectus and the terms of the sales agreement prospectus contained in the 2020 Shelf Registration Statement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transactions costs associated with the 2020 Shelf Registration Statement totaled $428 of which $214 was charged against additional paid-in capital during the twelve months ended December 31, 2020 as a result of the May 2020 Public Offering, discussed below. The remaining costs of $214 are recorded as a prepaid asset at December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;February 2020 Private Placement&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 21, 2020, the Company announced that it entered into a definitive agreement for the sale of its ADSs and Series A Non-Voting Convertible Preferred Shares (&#x201c;Series A Preferred&#x201d;) in a private placement to a group of institutional accredited investors. The private placement resulted in gross proceeds of approximately $65,000 before deducting placement agent and other offering expenses, which resulted in net proceeds of $60,570.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the terms of the private placement, the Company issued 8,680 ADSs and 488 shares of Series A Preferred at a price of $7.09 per share, priced at-the-market under Nasdaq rules. Each share of non-voting Series A Preferred is convertible into one ADS, provided that conversion will be prohibited if, as a result, the holder and its affiliates would own more than 9.99% of the total number of Avadel ADSs outstanding. The closing of the private placement occurred on February 25, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Issuance costs of $4,430 have been recorded as a reduction of additional paid-in capital.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;May 2020 Public Offering&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the shelf registration statement described above, on April 28, 2020, the Company announced the pricing of an underwritten public offering of 11,630 Ordinary Shares, in the form of ADSs at a price to the public of $10.75 per ADS. Each ADS represents the right to receive one Ordinary Share. All of the ADSs were offered by the Company and the gross proceeds to the Company from the offering were approximately $125,000, before deducting underwriting discounts and commissions and offering expenses, which resulted in net proceeds of $116,924. The offering closed on May 1, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Retirement of Treasury Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the Company retired all of its 5,407 treasury shares, or $49,998 previously repurchased ordinary shares. As a result, the Company reduced additional paid-in capital by $49,944 and ordinary shares by $54 during the twelve months ended December 31, 2020. The portion allocated to additional paid-in capital is determined pro rata by applying a percentage, determined by dividing the number of shares to be retired by the number of shares issued and outstanding as of the retirement date, to the balance of additional paid-in capital as of the retirement date. Based on this calculation, the entirety of the excess of repurchase price over par of $49,944 was allocated to additional paid-in capital.&lt;/span&gt;&lt;/div&gt;</avdl:EquityTransactionsDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzc1_59b156cf-041d-455c-bf13-5afdecef47c7"
      unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzEzOQ_915677c9-a5a6-4758-8a6f-f9a658dce9e2"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzE3OQ_31e2ea49-3098-450d-93cd-2dfe381d3b81"
      unitRef="shares">58620000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzE3OQ_6a8b3dec-1381-485e-924f-89d9488e311d"
      unitRef="shares">58620000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzUzNw_7dbb3441-14d9-44a2-b02e-ca286d940f63"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzU3OQ_6de77cd7-c0e2-42f8-bcb4-8d2193a8f284"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzYwNg_947d22a4-8bbe-4548-b985-624a85cdabb1"
      unitRef="shares">488000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzYwNg_b1c6f3c6-e5b4-4657-bf58-f811a098cd35"
      unitRef="shares">488000</us-gaap:PreferredStockSharesIssued>
    <avdl:MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration
      contextRef="ic33e6a0dbfbb440fb29af7e8c03ab9d7_I20200229"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzkzMA_a9a9c775-753d-42cf-8c8e-47766cf0ab42"
      unitRef="usd">250000</avdl:MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ic33e6a0dbfbb440fb29af7e8c03ab9d7_I20200229"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzk4Mg_12b29ace-7248-4ee4-9369-a5c31b597740"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ic33e6a0dbfbb440fb29af7e8c03ab9d7_I20200229"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzExMjc_0e103f71-993e-4fdc-af7e-f0b431ca5020"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <avdl:MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration
      contextRef="ic33e6a0dbfbb440fb29af7e8c03ab9d7_I20200229"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzE3MDk_2161e23d-9104-4bfc-9fe5-b8019944ed61"
      unitRef="usd">50000</avdl:MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i2787db7d87db4fbbb4a9524ed6ef5ca7_D20200201-20200229"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzIxNDY_193a62ef-b770-404f-b12e-a173b6340917"
      unitRef="usd">428000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i9de1c77df78b4ba98727acf8dec79f60_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzIxNTg_3eeaadc6-caa9-439a-8df5-7ada8194e58d"
      unitRef="usd">214000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i5f3ba7983a1d4e8d8ca3d4d571f7417f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzIzNDI_f094cddd-f3b4-4694-9799-db4c63fc8a2a"
      unitRef="usd">214000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="idaf43fbfb3db4fd9b03a187560479d16_D20200221-20200221"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzI3NTI_deaefb59-e834-40b6-a4c7-6e6394d8ab16"
      unitRef="usd">65000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="idaf43fbfb3db4fd9b03a187560479d16_D20200221-20200221"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzI4NTE_ed869973-e15c-4613-9a5c-4827edbf8389"
      unitRef="usd">60570000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i69fc50e94a814273a65f41128688da91_D20200221-20200221"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzI5MTQ_b7444824-b913-4cd7-89fc-5df55b1a60b6"
      unitRef="shares">8680000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i72449ec228e943259a39bc04a30d454e_D20200221-20200221"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzI5MjY_114e07e0-f638-4d9a-bf72-d79e53768bcd"
      unitRef="shares">488000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="ifc5a6d80e8124b0a8bd28950f9fab4f6_I20200221"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzI5NzI_ee711576-42a4-4ec9-9bd5-de65d087e56b"
      unitRef="usdPerShare">7.09</us-gaap:SharesIssuedPricePerShare>
    <avdl:MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock
      contextRef="i0dd0849c19e5445a8e3c4ff75cf420fe_D20200221-20200221"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzMyMTE_abeaaa70-3db6-4be8-8461-3478cc48f54f"
      unitRef="number">0.0999</avdl:MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="i03c965967c7441e5b5bcfced0e7683c0_D20200221-20200221"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzMzNDk_3c6a1677-9631-42cc-aa6e-94dafe49e99b"
      unitRef="usd">4430000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ief992a6b46384fde9bd18e611b58d86a_D20200428-20200428"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzM1OTU_f42b1a8f-2e8f-40a8-a139-7a41fd582d8d"
      unitRef="shares">11630000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i0872a3688509439e8994fb7fcb662949_I20200428"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzM2NjM_c87f5643-8d28-493e-bb97-535cc6079351"
      unitRef="usdPerShare">10.75</us-gaap:SaleOfStockPricePerShare>
    <avdl:SaleOfStockConsiderationReceivedOnTransactionGross
      contextRef="ief992a6b46384fde9bd18e611b58d86a_D20200428-20200428"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzM4Mzc_dea70cc7-99dc-4fe3-98c7-0c7c895fd7c4"
      unitRef="usd">125000000</avdl:SaleOfStockConsiderationReceivedOnTransactionGross>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="ief992a6b46384fde9bd18e611b58d86a_D20200428-20200428"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzM5NTQ_aa875c87-c9ed-43b1-bfd0-1a59b468792d"
      unitRef="usd">116924000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="icd0f3157ccaf401eb75302e497df671d_D20200801-20200831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzQwNzM_ea91e8fa-931e-46be-96ea-93010fee10ec"
      unitRef="shares">5407000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i25009cefa3684002b043b7c8af74ee8a_D20200801-20200831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzQwOTY_3a2f9e72-f617-4faa-9412-a1c4af67b195"
      unitRef="usd">49998000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="iae6e5465f9294b758b40203ccdae2d14_D20200801-20200831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzQxOTM_a9002138-4346-4f67-93c4-a760261cb185"
      unitRef="usd">49944000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i5b077651731849bb9b0eddf0ad66d964_D20200801-20200831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzQyMTk_67028ac7-c9ee-4251-8a19-192fa7dae170"
      unitRef="usd">54000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="iae6e5465f9294b758b40203ccdae2d14_D20200801-20200831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNDgvZnJhZzozNmFkZDU4YmI1NDU0MDc2OTkyODVkYjViMjIwZmFmMy90ZXh0cmVnaW9uOjM2YWRkNThiYjU0NTQwNzY5OTI4NWRiNWIyMjBmYWYzXzQ2NjM_d3a3a672-1141-400e-959d-d0cdc9a3aa6c"
      unitRef="usd">49944000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzY3MTI_6d7d1af5-3b10-4d7c-92e3-47d8d19f3585">Share-Based Compensation&#160;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation expense included in the Company&#x2019;s consolidated statements of (loss) income for all share-based compensation arrangements was as follows for the periods ended December&#160;31, 2021, 2020 and 2019, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Share-based Compensation Expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restructuring costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,064)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company expects $18,429 of unrecognized expense related to granted, but non-vested share-based compensation arrangements to be incurred in future periods. This expense is expected to be recognized over a weighted average period of 3.2 years.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The excess tax benefit related to share-based compensation recorded by the Company was not material for the years ended December&#160;31, 2021, 2020 and 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon exercise of stock options, or upon the issuance of restricted share awards or performance share unit awards, the Company issues new shares.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2021, there were 1,336 shares authorized for stock option grants, restricted share award grants, and performance share unit award grants in subsequent periods.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inducement Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, the Board of Directors approved the Avadel Pharmaceuticals plc 2021 Inducement Plan (the &#x201c;Inducement Plan&#x201d;), which allows the Company to grant equity awards to induce highly-qualified prospective officers and employees who are not currently employed by the Company to accept employment and provide them with a proprietary interest in the Company. The maximum number of shares reserved and available for issuance under the Plan is 1,500 shares. As of December 31, 2021, the Company had not issued any shares under this Inducement Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Determining the Fair Value of Stock Options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures the total fair value of stock options on the grant date using the Black-Scholes option-pricing model and recognizes each grant&#x2019;s fair value as compensation expense over the period that the option vests. Options are granted to employees of the Company and become exercisable ratably over four years following the grant date and expire ten years after the grant date. Prior to 2021, the Company issued stock options to its Board of Directors as compensation for services rendered that are exercisable ratably over three years following the grant date, and expire ten years after the grant date. In 2021, the Company issued stock options to its Board of Directors as compensation for services rendered and are exercisable one year following the grant date and expire ten years after the grant date.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average assumptions under the Black-Scholes option-pricing model for stock option grants as of December&#160;31, 2021, 2020 and 2019, are as follows: &#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Option Assumptions: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock option grants:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.08&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.25&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected term&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The expected term of the options represents the period of time between the grant date and the time the options are either exercised or forfeited, including an estimate of future forfeitures for outstanding options. Given the limited historical data, the simplified method has been used to calculate the expected life.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The expected volatility is calculated based on an average of the historical volatility of the Company&#x2019;s stock price for a period approximating the expected term.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk-free interest rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant and a maturity that approximates the expected term.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected dividend yield&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The Company has not distributed any dividends since its inception and have no plan to distribute dividends in the foreseeable future.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the combined stock option activity and other data for the Company&#x2019;s stock option plans for the year ended December&#160;31, 2021 is as follows: &#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Stock Option Activity and Other Data: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number&#160;of Stock&lt;br/&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise Price per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock options outstanding, January 1, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(234)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock options outstanding, December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.83 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock options exercisable, December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.88 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate intrinsic value of options exercisable at December&#160;31, 2021, 2020 and 2019 was $6,291, $1,841, and $572, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average grant date fair value of options granted during the years ended December&#160;31, 2021, 2020 and 2019 was $5.36, $4.63 and $1.24 per share, respectively.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Share Awards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted share awards represent Company shares issued free of charge to employees of the Company as compensation for services rendered. The Company measures the total fair value of restricted share awards on the grant date using the Company&#x2019;s stock price at the time of the grant. Restricted share awards granted from 2017-2020 vest over a three-year period; two-thirds (2/3) vesting on the second anniversary of the grant date and the remaining one-third (1/3) vesting on the third anniversary of the grant date.&#160; In 2021, restricted share awards granted to employees vest over a four-year period; one-fourth (1/4) on each anniversary of the grant date. In 2018, the Company issued restricted share awards to its Board of Directors vesting over a three-year period; one-third (1/3) vesting on each of the three anniversaries of the grant date. Compensation expense for such awards granted during and after 2017 is recognized over the applicable vesting period.&#160; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the Company&#x2019;s restricted share awards as of December&#160;31, 2021, and changes during the year then ended, is reflected in the table below.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.353%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Share Activity and Other Data: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of Restricted Share Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-vested restricted share awards outstanding, January 1, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-vested restricted share awards outstanding, December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average grant date fair value of restricted share awards granted during the years ended December&#160;31, 2021, 2020 and 2019 was $8.22, $7.69 and $2.47, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance Share Units Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Performance share units awards (&#x201c;PSUs&#x201d;) represent Company shares issued free of charge to employees of the Company as compensation for achieving various results. The Company measures the total fair value of performance share unit awards on the grant date using the Company&#x2019;s stock price at the time of the grant. In 2020, the Company granted performance share awards, of which 50% vest upon the achievement of certain regulatory milestones related to FT218 and the other 50% vest one year following achievement of those milestones (&#x201c;2020 PSU awards&#x201d;). The Company has not yet recognized any share-based compensation expense related to the 2020 PSU awards as the regulatory milestones have not yet been met; however, in the event the performance conditions are met before a certain date, approximately 100% of the outstanding shares, or $1,786 of compensation expense will be recognized by the Company for the 2020 PSU awards outstanding as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2021, the Company granted performance share awards of which 50% vest upon achievement of certain corporate objectives and the second 50% vests one year following achievement of those objectives (&#x201c;2021 PSU awards&#x201d;).  The Company has not yet recognized any share-based compensation expense related to the 2021 PSU awards as the objectives have not yet been met; however, in the event the performance conditions are met and exceeded, approximately 150% of the outstanding shares, or $3,509 of compensation expense will be recognized by the Company for the 2021 PSU awards outstanding as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the Company&#x2019;s performance share units awards as of December&#160;31, 2021, and changes during the year then ended, is reflected in the table below. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.353%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Performance Unit Share Activity and Other Data&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of Performance Share Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-vested performance share awards outstanding, January 1, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-vested performance share awards outstanding, December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average grant date fair value of performance share awards granted during the years ended December 31, 2021 and 2020 was $8.20 and $7.09 per share, respectively. There were no performance share awards granted during the year ended December 31, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Share Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2017, the Board of Directors approved the Avadel Pharmaceuticals plc 2017 Avadel Employee Share Purchase Plan (&#x201c;ESPP&#x201d;).  The total number of Company ordinary shares, nominal value $0.01 per share, or ADSs representing such ordinary shares (collectively, &#x201c;Shares&#x201d;) which may be issued under the ESPP is 1,000. The purchase price at which a share will be issued or sold for a given offering period will be established by the Compensation Committee of the Board (&#x201c;Committee&#x201d;) (and may differ among participants, as determined by the Committee in its sole discretion) but will in no event be less than 85% of the lesser of: (a) the fair market value of a Share on the offering date; or (b) the fair market value of a Share on the purchase date.  During the years ended December&#160;31, 2021 and 2020, the Company issued 17 and 49 ordinary shares to employees, respectively.  Expense related to the ESPP for the years ended December&#160;31, 2021, 2020 and 2019 was immaterial.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzY3MTM_e737449b-b507-4a2b-8871-fe7440c72474">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation expense included in the Company&#x2019;s consolidated statements of (loss) income for all share-based compensation arrangements was as follows for the periods ended December&#160;31, 2021, 2020 and 2019, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Share-based Compensation Expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restructuring costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,064)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iebf3233476024b80bd208d93e82c7650_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpiNmZhMDc4NzQ2OTI0ZTM0ODZiOGI4MDhhM2YzM2VhYy90YWJsZXJhbmdlOmI2ZmEwNzg3NDY5MjRlMzQ4NmI4YjgwOGEzZjMzZWFjXzMtMi0xLTEtMjM0NTg_ef9d4cff-9621-4b69-8b08-ab00b245262b"
      unitRef="usd">758000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9c016d73d5464ed1853cdbc6f93adae3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpiNmZhMDc4NzQ2OTI0ZTM0ODZiOGI4MDhhM2YzM2VhYy90YWJsZXJhbmdlOmI2ZmEwNzg3NDY5MjRlMzQ4NmI4YjgwOGEzZjMzZWFjXzMtNC0xLTEtMjM0NTg_22509fa8-39b8-4d48-bcc9-319f2030b591"
      unitRef="usd">139000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1d53c3a9d81648dfa5f09b49ada455d1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpiNmZhMDc4NzQ2OTI0ZTM0ODZiOGI4MDhhM2YzM2VhYy90YWJsZXJhbmdlOmI2ZmEwNzg3NDY5MjRlMzQ4NmI4YjgwOGEzZjMzZWFjXzMtNi0xLTEtMjM0NTg_49882d5a-4aeb-4b33-9527-6f4aaf13cc0f"
      unitRef="usd">429000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id1229a210a7f49d4bbb9220069f8160e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpiNmZhMDc4NzQ2OTI0ZTM0ODZiOGI4MDhhM2YzM2VhYy90YWJsZXJhbmdlOmI2ZmEwNzg3NDY5MjRlMzQ4NmI4YjgwOGEzZjMzZWFjXzQtMi0xLTEtMjM0NTg_d648dc40-354a-4fe7-ae8f-4ff9d3cf26cd"
      unitRef="usd">8114000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9d9561d07a174b4d928f303fd47bd68b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpiNmZhMDc4NzQ2OTI0ZTM0ODZiOGI4MDhhM2YzM2VhYy90YWJsZXJhbmdlOmI2ZmEwNzg3NDY5MjRlMzQ4NmI4YjgwOGEzZjMzZWFjXzQtNC0xLTEtMjM0NTg_8d7c341b-5877-4c52-91d4-b5aa71f8c945"
      unitRef="usd">3281000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7d793592e3a9425abb3183a775c1d08e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpiNmZhMDc4NzQ2OTI0ZTM0ODZiOGI4MDhhM2YzM2VhYy90YWJsZXJhbmdlOmI2ZmEwNzg3NDY5MjRlMzQ4NmI4YjgwOGEzZjMzZWFjXzQtNi0xLTEtMjM0NTg_2893c087-ebff-4059-943e-4816102bd3f6"
      unitRef="usd">2154000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i455e8146c8434385aa9ae98f6c5ed465_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpiNmZhMDc4NzQ2OTI0ZTM0ODZiOGI4MDhhM2YzM2VhYy90YWJsZXJhbmdlOmI2ZmEwNzg3NDY5MjRlMzQ4NmI4YjgwOGEzZjMzZWFjXzUtMi0xLTEtMjM0NTg_180a2b8c-2dfd-40d9-9caa-264b4913d748"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iaea59e16245b4fe5ba425b805b97b872_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpiNmZhMDc4NzQ2OTI0ZTM0ODZiOGI4MDhhM2YzM2VhYy90YWJsZXJhbmdlOmI2ZmEwNzg3NDY5MjRlMzQ4NmI4YjgwOGEzZjMzZWFjXzUtNC0xLTEtMjM0NTg_031874ca-82e7-4047-b371-5428e117592f"
      unitRef="usd">-421000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i430f2e5a391247ff991d3a3d8de0d7d8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpiNmZhMDc4NzQ2OTI0ZTM0ODZiOGI4MDhhM2YzM2VhYy90YWJsZXJhbmdlOmI2ZmEwNzg3NDY5MjRlMzQ4NmI4YjgwOGEzZjMzZWFjXzUtNi0xLTEtMjM0NTg_ccea8c75-bda1-402f-ae46-2725683cd29a"
      unitRef="usd">-2064000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpiNmZhMDc4NzQ2OTI0ZTM0ODZiOGI4MDhhM2YzM2VhYy90YWJsZXJhbmdlOmI2ZmEwNzg3NDY5MjRlMzQ4NmI4YjgwOGEzZjMzZWFjXzYtMi0xLTEtMjM0NTg_5f2fee78-e485-4d15-8dae-47025519530a"
      unitRef="usd">8872000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpiNmZhMDc4NzQ2OTI0ZTM0ODZiOGI4MDhhM2YzM2VhYy90YWJsZXJhbmdlOmI2ZmEwNzg3NDY5MjRlMzQ4NmI4YjgwOGEzZjMzZWFjXzYtNC0xLTEtMjM0NTg_569f1a22-acb6-4464-a2bd-9b8790425606"
      unitRef="usd">2999000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpiNmZhMDc4NzQ2OTI0ZTM0ODZiOGI4MDhhM2YzM2VhYy90YWJsZXJhbmdlOmI2ZmEwNzg3NDY5MjRlMzQ4NmI4YjgwOGEzZjMzZWFjXzYtNi0xLTEtMjM0NTg_654864b6-4a8f-4967-b062-79cfb435330d"
      unitRef="usd">519000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI5Mw_4e225793-0c5b-41c1-8f48-dce502a019fc"
      unitRef="usd">18429000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzUwMw_36155214-fd9c-42ca-8f41-1dac7399e22b">P3Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i62b6ae12248b41dd9329f8af33aa447e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzgxNg_503a8afa-3268-42a5-ab22-1debf9c83058"
      unitRef="shares">1336000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i2880bd052c594c028d8ff7cb30be355f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI3NDg3NzkwODEwMzc_ac04c126-3f17-445f-beab-6612cfebff1a"
      unitRef="shares">1500000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i17b0b84673264785a47fb9c2393d8d97_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzEzMTI_46cfb4bf-5ceb-4273-9a8b-aeae92173448">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i17b0b84673264785a47fb9c2393d8d97_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzEzNTE_b59fa27e-5032-47f8-a710-5bc0c6b41592">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i12defb4ee11f4638be647bb1b2e8d3cd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzE1MTk_19a67a67-e9ac-4cad-9969-e53c8072fd7b">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i12defb4ee11f4638be647bb1b2e8d3cd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzE1NTk_a335fdfd-5ffa-4464-9173-c8445e8ff6c4">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <avdl:ScheduleOfShareBasedPaymentAwardStockOptionsAndWarrantGrantsValuationAssumptionsTableTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzY3MDc_0209e136-7e0b-44e8-b810-7ca48caaf229">&lt;div style="margin-bottom:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average assumptions under the Black-Scholes option-pricing model for stock option grants as of December&#160;31, 2021, 2020 and 2019, are as follows: &#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Option Assumptions: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock option grants:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.08&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.25&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</avdl:ScheduleOfShareBasedPaymentAwardStockOptionsAndWarrantGrantsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i3404683becd24bbaa99d0f9b831bc219_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTphYjk3OTNhMjRjZDY0YzQ1ODUwODFmZjE5ZjlhZGE0Mi90YWJsZXJhbmdlOmFiOTc5M2EyNGNkNjRjNDU4NTA4MWZmMTlmOWFkYTQyXzMtMi0xLTEtMjM0NTg_28b08c1c-2d92-4779-beab-6e5c024cca67">P6Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i80fe8f6ade7440249243d34649acec04_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTphYjk3OTNhMjRjZDY0YzQ1ODUwODFmZjE5ZjlhZGE0Mi90YWJsZXJhbmdlOmFiOTc5M2EyNGNkNjRjNDU4NTA4MWZmMTlmOWFkYTQyXzMtNC0xLTEtMjM0NTg_2471c7bc-fa49-40c6-82a8-1554f34a2441">P6Y29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ibc32436cac984c44acb451d8f53084cb_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTphYjk3OTNhMjRjZDY0YzQ1ODUwODFmZjE5ZjlhZGE0Mi90YWJsZXJhbmdlOmFiOTc5M2EyNGNkNjRjNDU4NTA4MWZmMTlmOWFkYTQyXzMtNi0xLTEtMjM0NTg_96caf1a3-1c6a-4d9e-ba19-4207919acd2c">P6Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i3404683becd24bbaa99d0f9b831bc219_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTphYjk3OTNhMjRjZDY0YzQ1ODUwODFmZjE5ZjlhZGE0Mi90YWJsZXJhbmdlOmFiOTc5M2EyNGNkNjRjNDU4NTA4MWZmMTlmOWFkYTQyXzQtMi0xLTEtMjM0NTg_2065d0c3-8dc4-4334-831c-937604c95c7c"
      unitRef="number">0.7391</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i80fe8f6ade7440249243d34649acec04_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTphYjk3OTNhMjRjZDY0YzQ1ODUwODFmZjE5ZjlhZGE0Mi90YWJsZXJhbmdlOmFiOTc5M2EyNGNkNjRjNDU4NTA4MWZmMTlmOWFkYTQyXzQtNC0xLTEtMjM0NTg_dccf0fda-74d2-42ff-837d-eb4a3a4b8d9c"
      unitRef="number">0.7576</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ibc32436cac984c44acb451d8f53084cb_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTphYjk3OTNhMjRjZDY0YzQ1ODUwODFmZjE5ZjlhZGE0Mi90YWJsZXJhbmdlOmFiOTc5M2EyNGNkNjRjNDU4NTA4MWZmMTlmOWFkYTQyXzQtNi0xLTEtMjM0NTg_9f76281e-1d5c-4ec3-b17d-e73ed6c6fce4"
      unitRef="number">0.5648</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i3404683becd24bbaa99d0f9b831bc219_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTphYjk3OTNhMjRjZDY0YzQ1ODUwODFmZjE5ZjlhZGE0Mi90YWJsZXJhbmdlOmFiOTc5M2EyNGNkNjRjNDU4NTA4MWZmMTlmOWFkYTQyXzUtMi0xLTEtMjM0NTg_ea6b7a90-078f-4264-ab15-110e33c804b7"
      unitRef="number">0.0110</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i80fe8f6ade7440249243d34649acec04_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTphYjk3OTNhMjRjZDY0YzQ1ODUwODFmZjE5ZjlhZGE0Mi90YWJsZXJhbmdlOmFiOTc5M2EyNGNkNjRjNDU4NTA4MWZmMTlmOWFkYTQyXzUtNC0xLTEtMjM0NTg_691ba2a2-41f4-4b47-97c3-4bab81ebb7ac"
      unitRef="number">0.0072</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ibc32436cac984c44acb451d8f53084cb_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTphYjk3OTNhMjRjZDY0YzQ1ODUwODFmZjE5ZjlhZGE0Mi90YWJsZXJhbmdlOmFiOTc5M2EyNGNkNjRjNDU4NTA4MWZmMTlmOWFkYTQyXzUtNi0xLTEtMjM0NTg_98456917-bb26-4e7c-925f-f12ff941e5d4"
      unitRef="number">0.0252</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i3404683becd24bbaa99d0f9b831bc219_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTphYjk3OTNhMjRjZDY0YzQ1ODUwODFmZjE5ZjlhZGE0Mi90YWJsZXJhbmdlOmFiOTc5M2EyNGNkNjRjNDU4NTA4MWZmMTlmOWFkYTQyXzYtMi0xLTEtMjM0NTg_787eadb0-09bb-4e9a-a150-835114521f82"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i80fe8f6ade7440249243d34649acec04_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTphYjk3OTNhMjRjZDY0YzQ1ODUwODFmZjE5ZjlhZGE0Mi90YWJsZXJhbmdlOmFiOTc5M2EyNGNkNjRjNDU4NTA4MWZmMTlmOWFkYTQyXzYtNC0xLTEtMjM0NTg_bf1ef104-63b5-4efe-96b0-b98f910ae7e0"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ibc32436cac984c44acb451d8f53084cb_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTphYjk3OTNhMjRjZDY0YzQ1ODUwODFmZjE5ZjlhZGE0Mi90YWJsZXJhbmdlOmFiOTc5M2EyNGNkNjRjNDU4NTA4MWZmMTlmOWFkYTQyXzYtNi0xLTEtMjM0NTg_c91ea152-4a88-443e-aadc-cf5532666fd5"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzY3MTg_6f003fb4-e020-4829-a0ca-16e3713ce719">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the combined stock option activity and other data for the Company&#x2019;s stock option plans for the year ended December&#160;31, 2021 is as follows: &#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Stock Option Activity and Other Data: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number&#160;of Stock&lt;br/&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise Price per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock options outstanding, January 1, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(234)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock options outstanding, December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.83 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock options exercisable, December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.88 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzItMi0xLTEtMjM0NTg_7695dcd5-89ec-4fdb-838b-b0680ddd1018"
      unitRef="shares">5898000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzItNC0xLTEtMjM0NTg_1147b6e4-5949-4df0-8593-c052d6190c26"
      unitRef="usdPerShare">7.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzMtMi0xLTEtMjM0NTg_0e5907e1-d5e5-40b3-9ee1-d1a1ff3e8ffa"
      unitRef="shares">2857000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzMtNC0xLTEtMjM0NTg_e164a6bf-4922-49de-b2f4-e8b41ea70b09"
      unitRef="usdPerShare">8.20</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzQtMi0xLTEtMjM0NTg_4b18d396-1ddb-4434-9389-7702b30d2fd8"
      unitRef="shares">48000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzQtNC0xLTEtMjM0NTg_8832665b-1a3b-4523-acf4-ddb234604b79"
      unitRef="usdPerShare">3.54</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzUtMi0xLTEtMjM0NTg_842cf09f-758a-4a38-b684-778d38a88002"
      unitRef="shares">234000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzUtNC0xLTEtMjM0NTg_54de7362-6ec1-4cb2-b10e-c80fc7346ac9"
      unitRef="usdPerShare">7.13</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzYtMi0xLTEtMjM0NTg_9c309d8b-74dd-49dc-85f2-9e5c2e14891e"
      unitRef="shares">70000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzYtNC0xLTEtMjM0NTg_952b000d-0f8f-425c-82a3-6bd438ed911f"
      unitRef="usdPerShare">12.62</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzctMi0xLTEtMjM0NTg_8e715c7b-2e0a-45a0-94c4-abe6ff0b8bc4"
      unitRef="shares">8403000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzctNC0xLTEtMjM0NTg_10ccc2ba-3797-4cb5-ae8d-9103d9e5b99b"
      unitRef="usdPerShare">7.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzctNi0xLTEtMjM0NTg_48796160-93b6-4aa8-97f2-12ab4b209066">P7Y9M29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzctOC0xLTEtMjM0NTg_18c295ac-5249-4bcf-a181-ed466ff75a81"
      unitRef="usd">12204000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzgtMi0xLTEtMjM0NTg_5a33f89e-bbd4-467e-a12b-f2041fc7826d"
      unitRef="shares">3256000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzgtNC0xLTEtMjM0NTg_40b2981c-a6d3-4423-b99b-693e9ae62b42"
      unitRef="usdPerShare">7.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzgtNi0xLTEtMjM0NTg_44e341ff-c2e9-40cc-ba2a-2147390139de">P5Y10M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTpmNzY2OWIyOTk5MDM0MWYzOWE0ZWM5M2FhNzE3ZGIyYi90YWJsZXJhbmdlOmY3NjY5YjI5OTkwMzQxZjM5YTRlYzkzYWE3MTdkYjJiXzgtOC0xLTEtMjM0NTg_c530deac-1cf6-4183-9102-b56874422494"
      unitRef="usd">6291000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI4MTM_0ca6e638-5be1-47bb-b23a-c19ee85f6c93"
      unitRef="usd">6291000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI4MTc_24092a61-9446-493f-85e8-4752db8b559e"
      unitRef="usd">1841000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI4MjU_618dd3ff-6c8e-4633-a79a-0c23d2fea425"
      unitRef="usd">572000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI5NDg_3b50a7af-bac7-415f-94b3-f1571e7584c1"
      unitRef="usdPerShare">5.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI5NTI_7c5147f5-dad3-4ce8-95c7-16965eab9fd4"
      unitRef="usdPerShare">4.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI5NTk_0a8e8b4d-29d1-4105-a78e-b72033aa122a"
      unitRef="usdPerShare">1.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i542cb65bcac94725a2e85b1f9d50115f_D20170101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzY3MTA_fc1deddf-878d-4dd8-980b-e3c0be50c5a7">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i43f3e0d370bf48618c4b4ffce4f20c85_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI3NDg3NzkwODEwMjA_86b05f2f-f184-494a-a6b8-21aa555999fd">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i543086e15a0649c38d2ae050067cfe92_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI3NDg3NzkwODEwMzU_e00f91ab-d904-4bd5-a0ff-f32f402d2c87">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzY3Mjg_8248d45c-f15d-4e8c-b7e8-e535abb9a8e9">A summary of the Company&#x2019;s restricted share awards as of December&#160;31, 2021, and changes during the year then ended, is reflected in the table below.&#160;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.353%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Share Activity and Other Data: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of Restricted Share Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-vested restricted share awards outstanding, January 1, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-vested restricted share awards outstanding, December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the Company&#x2019;s performance share units awards as of December&#160;31, 2021, and changes during the year then ended, is reflected in the table below. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.353%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Performance Unit Share Activity and Other Data&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of Performance Share Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-vested performance share awards outstanding, January 1, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-vested performance share awards outstanding, December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i9385e38dbc52477281fcde7e0e8243bf_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4NDVjN2U0ZmQ2ZWE0MTczOTczYWQ0MmQzM2YwODgwZi90YWJsZXJhbmdlOjg0NWM3ZTRmZDZlYTQxNzM5NzNhZDQyZDMzZjA4ODBmXzItMi0xLTEtMjM0NTg_e981d79f-9f89-48fe-bb86-2473a87f157c"
      unitRef="shares">347000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i9385e38dbc52477281fcde7e0e8243bf_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4NDVjN2U0ZmQ2ZWE0MTczOTczYWQ0MmQzM2YwODgwZi90YWJsZXJhbmdlOjg0NWM3ZTRmZDZlYTQxNzM5NzNhZDQyZDMzZjA4ODBmXzItNC0xLTEtMjM0NTg_dbae645c-c3a7-4569-b4dd-7467247af10d"
      unitRef="usdPerShare">5.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i60cd02301b0744718ab6232fc8397080_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4NDVjN2U0ZmQ2ZWE0MTczOTczYWQ0MmQzM2YwODgwZi90YWJsZXJhbmdlOjg0NWM3ZTRmZDZlYTQxNzM5NzNhZDQyZDMzZjA4ODBmXzMtMi0xLTEtMjM0NTg_86079eb5-0d78-448a-9cb4-35458aeb061d"
      unitRef="shares">99000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i60cd02301b0744718ab6232fc8397080_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4NDVjN2U0ZmQ2ZWE0MTczOTczYWQ0MmQzM2YwODgwZi90YWJsZXJhbmdlOjg0NWM3ZTRmZDZlYTQxNzM5NzNhZDQyZDMzZjA4ODBmXzMtNC0xLTEtMjM0NTg_93a94a5f-ea8d-4fc9-af53-99821e71ff3a"
      unitRef="usdPerShare">8.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i60cd02301b0744718ab6232fc8397080_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4NDVjN2U0ZmQ2ZWE0MTczOTczYWQ0MmQzM2YwODgwZi90YWJsZXJhbmdlOjg0NWM3ZTRmZDZlYTQxNzM5NzNhZDQyZDMzZjA4ODBmXzQtMi0xLTEtMjM0NTg_e6828f88-3dd2-4d2e-a4fd-71406f4b5ed0"
      unitRef="shares">160000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i60cd02301b0744718ab6232fc8397080_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4NDVjN2U0ZmQ2ZWE0MTczOTczYWQ0MmQzM2YwODgwZi90YWJsZXJhbmdlOjg0NWM3ZTRmZDZlYTQxNzM5NzNhZDQyZDMzZjA4ODBmXzQtNC0xLTEtMjM0NTg_22220313-22d3-45f3-9dbe-db69c980a6ff"
      unitRef="usdPerShare">5.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i60cd02301b0744718ab6232fc8397080_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4NDVjN2U0ZmQ2ZWE0MTczOTczYWQ0MmQzM2YwODgwZi90YWJsZXJhbmdlOjg0NWM3ZTRmZDZlYTQxNzM5NzNhZDQyZDMzZjA4ODBmXzUtMi0xLTEtMjM0NTg_215429c5-73e5-44dc-853d-f0b6affdb606"
      unitRef="shares">12000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i60cd02301b0744718ab6232fc8397080_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4NDVjN2U0ZmQ2ZWE0MTczOTczYWQ0MmQzM2YwODgwZi90YWJsZXJhbmdlOjg0NWM3ZTRmZDZlYTQxNzM5NzNhZDQyZDMzZjA4ODBmXzUtNC0xLTEtMjM0NTg_9f77f3dd-74fe-4221-a90f-e76fea095baf"
      unitRef="usdPerShare">7.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ifa8fa276a1de4b9ea652bbce418a979a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4NDVjN2U0ZmQ2ZWE0MTczOTczYWQ0MmQzM2YwODgwZi90YWJsZXJhbmdlOjg0NWM3ZTRmZDZlYTQxNzM5NzNhZDQyZDMzZjA4ODBmXzYtMi0xLTEtMjM0NTg_0740ea53-1b15-44c7-b648-0bde3d58c677"
      unitRef="shares">274000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ifa8fa276a1de4b9ea652bbce418a979a_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4NDVjN2U0ZmQ2ZWE0MTczOTczYWQ0MmQzM2YwODgwZi90YWJsZXJhbmdlOjg0NWM3ZTRmZDZlYTQxNzM5NzNhZDQyZDMzZjA4ODBmXzYtNC0xLTEtMjM0NTg_4872316c-a51f-4565-b3ed-37942e80c7c8"
      unitRef="usdPerShare">7.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i60cd02301b0744718ab6232fc8397080_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzQ1MDM_2225d828-b4fd-4388-ae12-cd9734716a3f"
      unitRef="usdPerShare">8.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="id51962221b6045adacaa762297fcce4c_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzQ1MDc_835a7201-c86f-4ee4-a255-b5eebda0d908"
      unitRef="usdPerShare">7.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie4e4adc9bd9a43e4b7a14bed4eafeaaa_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzQ1MTQ_a668a760-83cf-4488-ad1c-be1343eecfff"
      unitRef="usdPerShare">2.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i8ada9b293d7f49f393204ff4cdec742a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzQ5NDE_24f3192b-7267-4367-a5d3-b4774437b5a2"
      unitRef="number">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="ia69e39054ae948c9a9472b1618aee17c_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzUwMzQ_8a50ac3a-e47f-4975-9a98-670047a78eb0"
      unitRef="number">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ia69e39054ae948c9a9472b1618aee17c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzUwNDI_fb25ab9f-0ec6-46c6-aafe-6fa2c417a902">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="ibcd77640185c41ca9d2ac2883e957c10_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzUzMTg_752b0169-876a-4474-8ef3-7e90e369fce2"
      unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibcd77640185c41ca9d2ac2883e957c10_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzUzNTE_3f30315b-3786-4855-a9b3-94152c50b7e7"
      unitRef="usd">1786000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i8244f7a6941e41b6b0fc0fa1f31f090c_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI3NDg3NzkwODA5NjQ_50fc8e9e-7302-4e30-b28e-4953c17aa872"
      unitRef="number">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i213dddfe6eca46e9b836e9ed09ef1520_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI3NDg3NzkwODA5Njk_e2dabece-d91d-460b-afd9-894faaea0a77"
      unitRef="number">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i213dddfe6eca46e9b836e9ed09ef1520_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI3NDg3NzkwODA5ODU_eb23ac4a-00c4-45b8-aee7-fc2b25254ad6">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i4518f66a522647cd984ba59be675f8ce_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI3NDg3NzkwODA5OTE_a9676c57-89ad-42a4-8f4c-c73164962bc3"
      unitRef="number">1.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8244f7a6941e41b6b0fc0fa1f31f090c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzI3NDg3NzkwODA5OTc_8fe7b038-0658-4c76-8575-330017246331"
      unitRef="usd">3509000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i08ccab8f43964d778b6f1aa5700dd88f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4ODA1OTVjMGU2MGQ0MGJmYmQ5ZjgzYmUwZjM0NjA2Zi90YWJsZXJhbmdlOjg4MDU5NWMwZTYwZDQwYmZiZDlmODNiZTBmMzQ2MDZmXzItMi0xLTEtMjM0NTg_c6e2f256-eb1e-4dfc-b4ee-e914e511db43"
      unitRef="shares">257000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i08ccab8f43964d778b6f1aa5700dd88f_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4ODA1OTVjMGU2MGQ0MGJmYmQ5ZjgzYmUwZjM0NjA2Zi90YWJsZXJhbmdlOjg4MDU5NWMwZTYwZDQwYmZiZDlmODNiZTBmMzQ2MDZmXzItNC0xLTEtMjM0NTg_e2660426-bafb-46a7-847b-12d742d7f5eb"
      unitRef="usdPerShare">7.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ibcd77640185c41ca9d2ac2883e957c10_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4ODA1OTVjMGU2MGQ0MGJmYmQ5ZjgzYmUwZjM0NjA2Zi90YWJsZXJhbmdlOjg4MDU5NWMwZTYwZDQwYmZiZDlmODNiZTBmMzQ2MDZmXzMtMi0xLTEtMjM0NTg_7a4fc997-6286-46eb-b616-95a0da42c9f1"
      unitRef="shares">285000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ibcd77640185c41ca9d2ac2883e957c10_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4ODA1OTVjMGU2MGQ0MGJmYmQ5ZjgzYmUwZjM0NjA2Zi90YWJsZXJhbmdlOjg4MDU5NWMwZTYwZDQwYmZiZDlmODNiZTBmMzQ2MDZmXzMtNC0xLTEtMjM0NTg_c82d73c9-c50c-441b-9804-ccf4af00571b"
      unitRef="usdPerShare">8.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ibcd77640185c41ca9d2ac2883e957c10_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4ODA1OTVjMGU2MGQ0MGJmYmQ5ZjgzYmUwZjM0NjA2Zi90YWJsZXJhbmdlOjg4MDU5NWMwZTYwZDQwYmZiZDlmODNiZTBmMzQ2MDZmXzQtMi0xLTEtMjM0NTg_5150a4a4-05eb-4d7d-9f82-b06367820390"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ibcd77640185c41ca9d2ac2883e957c10_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4ODA1OTVjMGU2MGQ0MGJmYmQ5ZjgzYmUwZjM0NjA2Zi90YWJsZXJhbmdlOjg4MDU5NWMwZTYwZDQwYmZiZDlmODNiZTBmMzQ2MDZmXzQtNC0xLTEtMjM0NTg_f5071bc0-9f64-47e7-afa6-effcf34022d1"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ibcd77640185c41ca9d2ac2883e957c10_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4ODA1OTVjMGU2MGQ0MGJmYmQ5ZjgzYmUwZjM0NjA2Zi90YWJsZXJhbmdlOjg4MDU5NWMwZTYwZDQwYmZiZDlmODNiZTBmMzQ2MDZmXzUtMi0xLTEtMjM0NTg_a463089a-d338-42e9-ae00-f45c1004dacd"
      unitRef="shares">7000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ibcd77640185c41ca9d2ac2883e957c10_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4ODA1OTVjMGU2MGQ0MGJmYmQ5ZjgzYmUwZjM0NjA2Zi90YWJsZXJhbmdlOjg4MDU5NWMwZTYwZDQwYmZiZDlmODNiZTBmMzQ2MDZmXzUtNC0xLTEtMjM0NTg_b6bb62a9-bbaa-4381-a480-e645854e768c"
      unitRef="usdPerShare">5.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ie7b206dec3ef4b5d9ee30dd96c6c7208_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4ODA1OTVjMGU2MGQ0MGJmYmQ5ZjgzYmUwZjM0NjA2Zi90YWJsZXJhbmdlOjg4MDU5NWMwZTYwZDQwYmZiZDlmODNiZTBmMzQ2MDZmXzYtMi0xLTEtMjM0NTg_da94160f-8b54-45ee-864f-0fec98d4600e"
      unitRef="shares">535000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ie7b206dec3ef4b5d9ee30dd96c6c7208_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90YWJsZTo4ODA1OTVjMGU2MGQ0MGJmYmQ5ZjgzYmUwZjM0NjA2Zi90YWJsZXJhbmdlOjg4MDU5NWMwZTYwZDQwYmZiZDlmODNiZTBmMzQ2MDZmXzYtNC0xLTEtMjM0NTg_4ae95a6a-db3a-4eec-b081-cd04e1e9d7eb"
      unitRef="usdPerShare">7.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ibcd77640185c41ca9d2ac2883e957c10_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzEwNDQ1MzYwNDc1Mzgx_0583ece1-4228-49ea-a0fe-7ff236e380f3"
      unitRef="usdPerShare">8.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ice6e75c4e53f421694026f9bdc2f0a37_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzU3MzI_845069c6-d43c-4bb6-a1a2-6f60c554784d"
      unitRef="usdPerShare">7.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i1ea3506d4ee445e483ed272a81e24e72_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzEwNDQ1MzYwNDc1Mzkx_8f0ba6e7-e74a-4934-8362-d5d969de4399"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ief179786cb524ebfa29b22addb7be488_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzU5NjQ_7efabbeb-ee89-4d1c-95c2-171ffe989fda"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ief179786cb524ebfa29b22addb7be488_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzYwODM_afde9817-fe69-41a8-bb03-fd8abc1058b3"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="ifdf6a4240ce9425b9403a1273967c137_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzYzNzc_0f2900bb-a059-4747-836a-49d071a695aa"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="icf6ce914e29a4f3d86cdf8ae44d7a965_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzY1NzM_e55c5424-bcb1-4f36-a1e9-483a83f09d2c"
      unitRef="shares">17000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="iebe32eeb9dbe40dbb43d30c6ba5c778b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTEvZnJhZzoyY2U4YjJlNWVhYWE0NjE1OTAwZGFhZmViZmQ1YzQwZi90ZXh0cmVnaW9uOjJjZThiMmU1ZWFhYTQ2MTU5MDBkYWFmZWJmZDVjNDBmXzY1ODA_350667d7-8de7-404e-8711-984d02090820"
      unitRef="shares">49000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90ZXh0cmVnaW9uOjc4NDIyM2U0ZmE3YjQ5YzY5NWQ5ZTAyZjRlOTIzMTk3XzIxNzk_e4e786ef-5713-4efb-8a67-5f640b2acb43">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net (Loss) Income Per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net (loss) income per share is calculated by dividing net (loss) income by the weighted average number of shares outstanding during each period. Diluted net (loss) income per share is calculated by dividing net (loss) income - diluted by the diluted number of shares outstanding during each period. Except where the result would be anti-dilutive to net (loss) income, diluted net (loss) income per share would be calculated assuming the impact of the conversion of the 2023 Notes, the conversion of the Company&#x2019;s preferred shares, the exercise of outstanding equity compensation awards, and ordinary shares expected to be issued under the Company&#x2019;s ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a choice to settle the conversion obligation under the 2023 Notes in cash, shares or any combination of the two. The Company utilizes the if-converted method to reflect the impact of the conversion of the 2023 Notes, unless the result is anti-dilutive. This method assumes the conversion of the 2023 Notes into shares of the Company&#x2019;s ordinary shares and reflects the elimination of the interest expense related to the 2023 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The dilutive effect of the stock options, restricted stock units, preferred shares and ordinary shares expected to be issued under the Company&#x2019;s ESPP has been calculated using the treasury stock method. The dilutive effect of the PSUs will be calculated using the treasury stock method, if and when the contingent vesting condition is achieved.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of basic and diluted net (loss) income per share, together with the related shares outstanding in thousands for the years ended December&#160;31, 2021, 2020 and 2019, is as follows: &#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.832%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net (Loss) Income Per Share: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(77,329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities&#x2014;employee and director equity awards outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net (loss) income per share - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net (loss) income per share - diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Potential ordinary shares of 15,327, 14,915, and 16,740 were excluded from the calculation of weighted average shares for the years ended December&#160;31, 2021, 2020 and 2019, respectively, because either their effect was considered to be anti-dilutive or they were related to shares from PSUs for which the contingent vesting condition had not been achieved. For the years ended December&#160;31, 2021 and 2019, the effects of dilutive securities were entirely excluded from the calculation of net (loss) income per share as a net loss was reported in these periods.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90ZXh0cmVnaW9uOjc4NDIyM2U0ZmE3YjQ5YzY5NWQ5ZTAyZjRlOTIzMTk3XzIxODQ_0d526f14-c0c8-4f78-b24d-fc2876591322">&lt;div style="margin-bottom:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of basic and diluted net (loss) income per share, together with the related shares outstanding in thousands for the years ended December&#160;31, 2021, 2020 and 2019, is as follows: &#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.832%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net (Loss) Income Per Share: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(77,329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities&#x2014;employee and director equity awards outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net (loss) income per share - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net (loss) income per share - diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i2aea8b8d433e4423879f52b4780b5b0f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzUtMi0xLTEtMjM0NTg_778106cc-e8f7-4bbe-888f-fc5aac11201d"
      unitRef="usd">-77329000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzUtNC0xLTEtMjM0NTg_b3645de4-d511-49a0-909c-4e8cd0ee1bac"
      unitRef="usd">7028000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzUtNi0xLTEtMjM0NTg_614e1022-910a-4760-b50c-5b992ff2753c"
      unitRef="usd">-33226000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzgtMi0xLTEtMjM0NTg_e8f41144-ea9c-42a0-b62f-c4518d60c2cd"
      unitRef="shares">58535000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzgtNC0xLTEtMjM0NTg_cad0d07d-beb2-4319-a354-535f4ed7eeac"
      unitRef="shares">52996000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzgtNi0xLTEtMjM0NTg_411037d4-eb31-46d2-a8a8-021d35b42b65"
      unitRef="shares">37403000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzktMi0xLTEtMjM0NTg_68b81a78-4fb8-4f72-b3ef-229dc18f875d"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzktNC0xLTEtMjM0NTg_8f0aa73f-e614-4644-9100-e2baa0f97eb5"
      unitRef="shares">1945000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzktNi0xLTEtMjM0NTg_dd650455-01fc-4008-b9c2-e13273dab3f6"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzEwLTItMS0xLTIzNDU4_61c2a76f-59ab-46d8-8c81-97a3976afeaf"
      unitRef="shares">58535000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzEwLTQtMS0xLTIzNDU4_0faa45a1-0703-404b-8f78-1337e98ce046"
      unitRef="shares">54941000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzEwLTYtMS0xLTIzNDU4_00ec8023-14f8-4c3d-8b45-2cc7551d593a"
      unitRef="shares">37403000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzE1LTItMS0xLTIzNDU4_07f2d98c-c8d3-4aed-b152-b3c4062c5d66"
      unitRef="usdPerShare">-1.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzE1LTQtMS0xLTIzNDU4_d6b19ec2-df0c-47a2-aafa-a215f9c8d221"
      unitRef="usdPerShare">0.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzE1LTYtMS0xLTIzNDU4_8c3e9d9f-6d98-4901-aea8-19150bea09d9"
      unitRef="usdPerShare">-0.89</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzIwLTItMS0xLTIzNDU4_21a64914-e97c-4e0c-8716-bb6ba21be68b"
      unitRef="usdPerShare">-1.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzIwLTQtMS0xLTIzNDU4_ce3253ce-128e-4f92-9a66-a7197df1241e"
      unitRef="usdPerShare">0.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90YWJsZTpkNjBiZWU0MjAzMTM0YzdjYjg4MWFiNjc4YTM2MzBlMC90YWJsZXJhbmdlOmQ2MGJlZTQyMDMxMzRjN2NiODgxYWI2NzhhMzYzMGUwXzIwLTYtMS0xLTIzNDU4_b959136c-29d4-4d13-9c6e-56430f5de7a3"
      unitRef="usdPerShare">-0.89</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90ZXh0cmVnaW9uOjc4NDIyM2U0ZmE3YjQ5YzY5NWQ5ZTAyZjRlOTIzMTk3XzE2ODA_e8e9eddf-80cd-40c5-a85e-3bf13ed27424"
      unitRef="shares">15327000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90ZXh0cmVnaW9uOjc4NDIyM2U0ZmE3YjQ5YzY5NWQ5ZTAyZjRlOTIzMTk3XzE2ODQ_4da1c54e-72c7-49ed-aa21-d04661d167bf"
      unitRef="shares">14915000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNTcvZnJhZzo3ODQyMjNlNGZhN2I0OWM2OTVkOWUwMmY0ZTkyMzE5Ny90ZXh0cmVnaW9uOjc4NDIyM2U0ZmE3YjQ5YzY5NWQ5ZTAyZjRlOTIzMTk3XzE2OTI_5eb3deee-5128-4dea-8a65-6a3253bfaa7d"
      unitRef="shares">16740000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90ZXh0cmVnaW9uOmZkZGMxYmUwNjBhOTQ2OWM4MjNkMjFhYWNjYjYzMmYzXzE4Ng_dbbd60b8-84b0-4ddf-b162-044ee1eda6a3">Comprehensive Loss&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of accumulated other comprehensive loss for the year ended December 31, net of immaterial tax effects:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,738)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,621)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net other comprehensive (loss) income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,855)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,738)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized (loss) gain on marketable securities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net other comprehensive (loss) income, net of income tax benefit (expense) of  $214, $(202), $(43),  respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,661)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,940)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21,051)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90ZXh0cmVnaW9uOmZkZGMxYmUwNjBhOTQ2OWM4MjNkMjFhYWNjYjYzMmYzXzE4MQ_c07edcac-5dfc-476e-8b4f-c073b27288a0">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of accumulated other comprehensive loss for the year ended December 31, net of immaterial tax effects:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,738)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,621)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net other comprehensive (loss) income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,855)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,738)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized (loss) gain on marketable securities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net other comprehensive (loss) income, net of income tax benefit (expense) of  $214, $(202), $(43),  respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,661)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss at December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,940)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21,051)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i8998385242564cbfaaaf6433c863849d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzMtMi0xLTEtMjM0NTg_14ac88f1-bc2e-4eb4-9637-6d9fb5c059d3"
      unitRef="usd">-22627000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ief47867d77194fa783312c489f06e3d5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzMtNC0xLTEtMjM0NTg_a216b64e-5675-413e-b1b0-6843d7500feb"
      unitRef="usd">-23738000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i79413685d8144e178e42b28c2e99365b_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzMtNi0xLTEtMjM0NTg_a785d45b-1d11-4b77-9499-e106f8f6ded2"
      unitRef="usd">-23621000</us-gaap:StockholdersEquity>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ieeed97785c574074863094742c31cea8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzQtMi0xLTEtMjM0NTg_acf59f55-f6d6-4436-95a2-a27b854289a9"
      unitRef="usd">-1228000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i474a662d5a374ab8b341858690d4bd8e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzQtNC0xLTEtMjM0NTg_f914cbe7-dbcf-49e0-8ac7-f2cc4e60ccc1"
      unitRef="usd">1111000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ica4213e299f9427b901f343c8c2b93e9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzQtNi0xLTEtMjM0NTg_92252c4d-9c2e-435d-abba-c58019ea878a"
      unitRef="usd">-117000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="ie6899b6aea474e37acddcb73ba8cdaef_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzUtMi0xLTEtMjM0NTg_4416f9ac-f091-43e1-ae38-0b15126b2c53"
      unitRef="usd">-23855000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8998385242564cbfaaaf6433c863849d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzUtNC0xLTEtMjM0NTg_8bb55b2a-5f3f-41b8-8dd7-f58da50ea1f4"
      unitRef="usd">-22627000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ief47867d77194fa783312c489f06e3d5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzUtNi0xLTEtMjM0NTg_757e3d7b-023f-41b3-80a5-0b1a0fc16b4f"
      unitRef="usd">-23738000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i00f270d697454afeb8bada6c69682df2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzgtMi0xLTEtMjM0NTg_f4513820-95f4-4073-9cfc-a98a40250f81"
      unitRef="usd">1576000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5a4d131f2ecc46778f5ed88f6d27c807_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzgtNC0xLTEtMjM0NTg_7a61893b-424b-4205-bfb3-7f2698dd3e7c"
      unitRef="usd">932000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i56a9ae7f277b43dc8ec524cd0712a41c_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzgtNi0xLTEtMjM0NTg_ca70ad19-aa66-4980-8457-08ffab9b6cfe"
      unitRef="usd">205000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzktMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo3NjU4ZWU2OTZkNjc0OTc4YWY3ZmRjYWVhMGJhNjNhZl80Mw_5ca0fd2f-6a4b-4d79-816f-0efb1c5d33be"
      unitRef="usd">214000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzktMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo3NjU4ZWU2OTZkNjc0OTc4YWY3ZmRjYWVhMGJhNjNhZl80Nw_0b070220-c250-427b-a428-3f5fd9823323"
      unitRef="usd">-202000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzktMC0xLTEtMjM0NTgvdGV4dHJlZ2lvbjo3NjU4ZWU2OTZkNjc0OTc4YWY3ZmRjYWVhMGJhNjNhZl81MQ_b1092bf9-89a4-45e5-807a-886247dc7a36"
      unitRef="usd">-43000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i4eec0f5944eb41a387ea1b80154c9f6b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzktMi0xLTEtMjM0NTg_9a895574-dc29-4200-88ab-3f4d5462b1b2"
      unitRef="usd">-1661000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i575efbeda86d4caba5c559924eae6606_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzktNC0xLTEtMjM0NTg_a9f10c7f-d08d-405c-9130-29555b70f714"
      unitRef="usd">644000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5143455b68ee4952a8f2f5bd2395cc6b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzktNi0xLTEtMjM0NTg_a2321b31-bd68-4694-b3f7-3a0051c1c850"
      unitRef="usd">727000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i7de80df209214ad6aec995ee651920e0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzEwLTItMS0xLTIzNDU4_4a83e10d-5af5-4622-9ac9-ec666e03466f"
      unitRef="usd">-85000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i00f270d697454afeb8bada6c69682df2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzEwLTQtMS0xLTIzNDU4_b860751d-bb3e-4a3e-9517-97f395892b02"
      unitRef="usd">1576000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5a4d131f2ecc46778f5ed88f6d27c807_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzEwLTYtMS0xLTIzNDU4_59f64b20-3a8a-497f-bffb-f5448df1de6b"
      unitRef="usd">932000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i79b00d255f634de49f2fc2b349447e88_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzExLTItMS0xLTIzNDU4_74ce3037-b911-4f1b-b8fc-73b917822de9"
      unitRef="usd">-23940000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaddacdf3080a4469857cc1c79a9583e3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzExLTQtMS0xLTIzNDU4_559ddac1-95ab-4b2a-a841-1fec65766993"
      unitRef="usd">-21051000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i67e12346ebfb4c079f8ca4ba96c5d37c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjAvZnJhZzpmZGRjMWJlMDYwYTk0NjljODIzZDIxYWFjY2I2MzJmMy90YWJsZTo1MmMwZTNhNjRhYmM0OWY3OWNkNzVjZWRhMmZiODc0MS90YWJsZXJhbmdlOjUyYzBlM2E2NGFiYzQ5Zjc5Y2Q3NWNlZGEyZmI4NzQxXzExLTYtMS0xLTIzNDU4_f6539c0b-e473-4b6d-b39b-f607b2c32a18"
      unitRef="usd">-22806000</us-gaap:StockholdersEquity>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90ZXh0cmVnaW9uOjhmYTZlOTI4OTY0NjQ3NGM4MjI5NmVjYjA4ZGFmMDU1XzE5NjI_23a32fa0-ef73-4a1c-86bf-a9c970b1be9e">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Company Operations by Product, Customer and Geographic Area&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has determined that it operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer based technology. The Company&#x2019;s Chief Operating Decision Maker is the CEO. The CEO reviews profit and loss information on a consolidated basis to assess performance and make overall operating decisions as well as resource allocations. All products are included in one segment because the Company&#x2019;s products have similar economic and other characteristics, including the nature of the products and production processes, type of customers, distribution methods and regulatory environment.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 30, 2020, the Company sold the Hospital Products. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 4: Disposition of the Hospital Products&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company had no revenue during the twelve months ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a summary of total revenues by product for the twelve months ended December 31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Revenue by Product: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Bloxiverz&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vazculep&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Akovaz&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Product sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a summary of total revenues by significant customer for the twelve months ended December 31, 2020 and 2019:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Revenue by Significant Customer:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cardinal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AmerisourceBergen &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;QuVa Pharma&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Others&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Product sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All revenue earned during the years ended December 31, 2020 and 2019 was generated in the U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Concentration of credit risk with respect to accounts receivable was limited due to the high credit quality comprising a significant portion of the Company&#x2019;s customers. Management periodically monitors the creditworthiness of the Company&#x2019;s customers and believes that it has adequately provided for any exposure to potential credit loss. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Currently, the Company is working with contract manufacturing organizations for the manufacture of FT218. Additionally, the Company purchases raw materials used in FT218 from a limited number of suppliers, including a single supplier for certain key ingredients.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-monetary long-lived assets primarily consist of property and equipment, goodwill, intangible assets and operating right-of use-assets.&#160;The following table summarizes non-monetary long-lived assets by geographic region as of December&#160;31, 2021, 2020, and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-lived Assets by Geographic Region: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90ZXh0cmVnaW9uOjhmYTZlOTI4OTY0NjQ3NGM4MjI5NmVjYjA4ZGFmMDU1XzExMw_92f1435e-8c78-4936-a864-9fbfb23effec"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90ZXh0cmVnaW9uOjhmYTZlOTI4OTY0NjQ3NGM4MjI5NmVjYjA4ZGFmMDU1XzExMw_d9f993c8-4982-4477-9383-2a42d9899f1d"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90ZXh0cmVnaW9uOjhmYTZlOTI4OTY0NjQ3NGM4MjI5NmVjYjA4ZGFmMDU1XzUzOA_39ce0faf-4675-4867-8e37-3613a01e7e70"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90ZXh0cmVnaW9uOjhmYTZlOTI4OTY0NjQ3NGM4MjI5NmVjYjA4ZGFmMDU1XzUzOA_98c7e6ca-b7a2-4ce1-adec-5cbb6cf107b5"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90ZXh0cmVnaW9uOjhmYTZlOTI4OTY0NjQ3NGM4MjI5NmVjYjA4ZGFmMDU1XzI3NDg3NzkwNzI4OTM_dbbda1a3-ee3b-4834-a2d7-527a4dbe175e"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90ZXh0cmVnaW9uOjhmYTZlOTI4OTY0NjQ3NGM4MjI5NmVjYjA4ZGFmMDU1XzE5NTk_530a8348-5978-453b-a0fe-7467e4321848">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a summary of total revenues by product for the twelve months ended December 31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Revenue by Product: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Bloxiverz&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vazculep&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Akovaz&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Product sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7560f23c3ff844359638f73f581206cd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZToxNGE0Y2JhZGE1NjM0NmEwODEzMTI0ZWU4NTJhNzc0ZC90YWJsZXJhbmdlOjE0YTRjYmFkYTU2MzQ2YTA4MTMxMjRlZTg1MmE3NzRkXzItNC0xLTEtMjM0NTg_d5e60891-82d2-41f6-9349-e840ecbc629b"
      unitRef="usd">2201000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic58ebe2ec1a34491b83d98083867b7c2_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZToxNGE0Y2JhZGE1NjM0NmEwODEzMTI0ZWU4NTJhNzc0ZC90YWJsZXJhbmdlOjE0YTRjYmFkYTU2MzQ2YTA4MTMxMjRlZTg1MmE3NzRkXzItNi0xLTEtMjM0NTg_f56667a0-eb3e-40c9-8669-873e31fbc1fc"
      unitRef="usd">7479000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i15b58b8fae3c434ca88a14dfad44f1f9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZToxNGE0Y2JhZGE1NjM0NmEwODEzMTI0ZWU4NTJhNzc0ZC90YWJsZXJhbmdlOjE0YTRjYmFkYTU2MzQ2YTA4MTMxMjRlZTg1MmE3NzRkXzMtNC0xLTEtMjM0NTg_b780c621-798d-42f6-a93f-1358435413c7"
      unitRef="usd">10429000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8c719f27eb049d5b2f929f14a52769d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZToxNGE0Y2JhZGE1NjM0NmEwODEzMTI0ZWU4NTJhNzc0ZC90YWJsZXJhbmdlOjE0YTRjYmFkYTU2MzQ2YTA4MTMxMjRlZTg1MmE3NzRkXzMtNi0xLTEtMjM0NTg_b6624df3-5712-4cae-aa02-132181795c93"
      unitRef="usd">33152000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic69cf75cdcb0443f8394a9f9f2b8481e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZToxNGE0Y2JhZGE1NjM0NmEwODEzMTI0ZWU4NTJhNzc0ZC90YWJsZXJhbmdlOjE0YTRjYmFkYTU2MzQ2YTA4MTMxMjRlZTg1MmE3NzRkXzQtNC0xLTEtMjM0NTg_a6651dd4-0b38-441e-887a-d215b7d5eb0d"
      unitRef="usd">9545000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i633dae8062544ae688cd05721bcc4684_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZToxNGE0Y2JhZGE1NjM0NmEwODEzMTI0ZWU4NTJhNzc0ZC90YWJsZXJhbmdlOjE0YTRjYmFkYTU2MzQ2YTA4MTMxMjRlZTg1MmE3NzRkXzQtNi0xLTEtMjM0NTg_b1887aa5-597b-48d8-ab1a-0489bbb2e298"
      unitRef="usd">18642000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id56837453cdf432dba648aaa4d2c9cf8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZToxNGE0Y2JhZGE1NjM0NmEwODEzMTI0ZWU4NTJhNzc0ZC90YWJsZXJhbmdlOjE0YTRjYmFkYTU2MzQ2YTA4MTMxMjRlZTg1MmE3NzRkXzUtNC0xLTEtMjM0NTg_7e74e2ce-c3a4-4cc8-bf49-b72aa646abcc"
      unitRef="usd">159000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3fb31d32e89a42278408412283fc7bc7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZToxNGE0Y2JhZGE1NjM0NmEwODEzMTI0ZWU4NTJhNzc0ZC90YWJsZXJhbmdlOjE0YTRjYmFkYTU2MzQ2YTA4MTMxMjRlZTg1MmE3NzRkXzUtNi0xLTEtMjM0NTg_4efa9266-9187-43ae-a573-79dc17cd38de"
      unitRef="usd">-58000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZToxNGE0Y2JhZGE1NjM0NmEwODEzMTI0ZWU4NTJhNzc0ZC90YWJsZXJhbmdlOjE0YTRjYmFkYTU2MzQ2YTA4MTMxMjRlZTg1MmE3NzRkXzYtNC0xLTEtMjM0NTg_b08d8037-2b33-4b31-aca3-ec744c9a61f5"
      unitRef="usd">22334000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZToxNGE0Y2JhZGE1NjM0NmEwODEzMTI0ZWU4NTJhNzc0ZC90YWJsZXJhbmdlOjE0YTRjYmFkYTU2MzQ2YTA4MTMxMjRlZTg1MmE3NzRkXzYtNi0xLTEtMjM0NTg_8ccde1e1-eadd-4010-b2ca-0aa952f54dae"
      unitRef="usd">59215000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90ZXh0cmVnaW9uOjhmYTZlOTI4OTY0NjQ3NGM4MjI5NmVjYjA4ZGFmMDU1XzE5NjQ_23b2a950-c65d-473b-af61-4b05f2b7dc70">&lt;div style="margin-bottom:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a summary of total revenues by significant customer for the twelve months ended December 31, 2020 and 2019:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Revenue by Significant Customer:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cardinal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AmerisourceBergen &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;QuVa Pharma&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Others&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Product sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i961305f8256144a0921c3dcb9f63da7a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTpkOTM3ZTk5MDRmZTk0OGE1YmJhZDc5N2QyODViNDE4Yi90YWJsZXJhbmdlOmQ5MzdlOTkwNGZlOTQ4YTViYmFkNzk3ZDI4NWI0MThiXzItNC0xLTEtMjM0NTg_8175f3de-98c9-478a-b638-5272142ca4d0"
      unitRef="usd">5758000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia55f30e804be44cea8352288a384a9c3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTpkOTM3ZTk5MDRmZTk0OGE1YmJhZDc5N2QyODViNDE4Yi90YWJsZXJhbmdlOmQ5MzdlOTkwNGZlOTQ4YTViYmFkNzk3ZDI4NWI0MThiXzItNi0xLTEtMjM0NTg_d8e84c4e-7fd4-47e2-9c44-0d7f3506e3cd"
      unitRef="usd">14900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i94e3ccf5ec9740e58837d91fdc1f7e3f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTpkOTM3ZTk5MDRmZTk0OGE1YmJhZDc5N2QyODViNDE4Yi90YWJsZXJhbmdlOmQ5MzdlOTkwNGZlOTQ4YTViYmFkNzk3ZDI4NWI0MThiXzMtNC0xLTEtMjM0NTg_3044e1b4-619d-4d37-8fda-d6045d676724"
      unitRef="usd">5155000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6393bb62733a46eeb7ef3712baca37c8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTpkOTM3ZTk5MDRmZTk0OGE1YmJhZDc5N2QyODViNDE4Yi90YWJsZXJhbmdlOmQ5MzdlOTkwNGZlOTQ4YTViYmFkNzk3ZDI4NWI0MThiXzMtNi0xLTEtMjM0NTg_8109c318-ed2c-4f94-8194-c7e5c8957640"
      unitRef="usd">15088000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6170920a302f4c30b265cb1c3c9b5e4c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTpkOTM3ZTk5MDRmZTk0OGE1YmJhZDc5N2QyODViNDE4Yi90YWJsZXJhbmdlOmQ5MzdlOTkwNGZlOTQ4YTViYmFkNzk3ZDI4NWI0MThiXzQtNC0xLTEtMjM0NTg_1cd155d1-7ddd-4fe3-a1e6-16b332ab5f59"
      unitRef="usd">3155000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd0191dbbea742a0ad131c24b89d15dc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTpkOTM3ZTk5MDRmZTk0OGE1YmJhZDc5N2QyODViNDE4Yi90YWJsZXJhbmdlOmQ5MzdlOTkwNGZlOTQ4YTViYmFkNzk3ZDI4NWI0MThiXzQtNi0xLTEtMjM0NTg_161d7c20-09fb-4eb3-b638-d98b73e56766"
      unitRef="usd">12059000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0359dc3ae57641d8a06f346eb996b112_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTpkOTM3ZTk5MDRmZTk0OGE1YmJhZDc5N2QyODViNDE4Yi90YWJsZXJhbmdlOmQ5MzdlOTkwNGZlOTQ4YTViYmFkNzk3ZDI4NWI0MThiXzUtNC0xLTEtMjM0NTg_f653dc10-2e1e-4c23-9533-a2879b1a5966"
      unitRef="usd">3117000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5eca0785abb64ad4a7ba38ca114bffbd_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTpkOTM3ZTk5MDRmZTk0OGE1YmJhZDc5N2QyODViNDE4Yi90YWJsZXJhbmdlOmQ5MzdlOTkwNGZlOTQ4YTViYmFkNzk3ZDI4NWI0MThiXzUtNi0xLTEtMjM0NTg_597102ea-796f-45f1-82c5-2ce9ab3bc30a"
      unitRef="usd">3252000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4efcd62648ae4318a25132f75b187f91_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTpkOTM3ZTk5MDRmZTk0OGE1YmJhZDc5N2QyODViNDE4Yi90YWJsZXJhbmdlOmQ5MzdlOTkwNGZlOTQ4YTViYmFkNzk3ZDI4NWI0MThiXzYtNC0xLTEtMjM0NTg_eab71262-ff12-48e1-9dfa-48af3352172e"
      unitRef="usd">5149000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i791518d5395c46a5a1dcb85211cb3fc0_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTpkOTM3ZTk5MDRmZTk0OGE1YmJhZDc5N2QyODViNDE4Yi90YWJsZXJhbmdlOmQ5MzdlOTkwNGZlOTQ4YTViYmFkNzk3ZDI4NWI0MThiXzYtNi0xLTEtMjM0NTg_df41f641-5ca9-4bf1-aabc-b8d2317fc46f"
      unitRef="usd">13916000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTpkOTM3ZTk5MDRmZTk0OGE1YmJhZDc5N2QyODViNDE4Yi90YWJsZXJhbmdlOmQ5MzdlOTkwNGZlOTQ4YTViYmFkNzk3ZDI4NWI0MThiXzctNC0xLTEtMjM0NTg_a3a7af8c-9a6a-4091-8828-46ef921876b9"
      unitRef="usd">22334000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if48b5c38480f48da93d58a7d57caf6de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTpkOTM3ZTk5MDRmZTk0OGE1YmJhZDc5N2QyODViNDE4Yi90YWJsZXJhbmdlOmQ5MzdlOTkwNGZlOTQ4YTViYmFkNzk3ZDI4NWI0MThiXzctNi0xLTEtMjM0NTg_06253144-2dfe-4c75-82eb-7583623e51b8"
      unitRef="usd">59215000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90ZXh0cmVnaW9uOjhmYTZlOTI4OTY0NjQ3NGM4MjI5NmVjYjA4ZGFmMDU1XzE5NjY_5077a918-932d-4514-acdf-86d963841b60">All revenue earned during the years ended December 31, 2020 and 2019 was generated in the U.S.Concentration of credit risk with respect to accounts receivable was limited due to the high credit quality comprising a significant portion of the Company&#x2019;s customers. Management periodically monitors the creditworthiness of the Company&#x2019;s customers and believes that it has adequately provided for any exposure to potential credit loss.</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90ZXh0cmVnaW9uOjhmYTZlOTI4OTY0NjQ3NGM4MjI5NmVjYjA4ZGFmMDU1XzE5NTY_b99d48ac-97ae-409b-bb13-2a2e1b411bfb">The following table summarizes non-monetary long-lived assets by geographic region as of December&#160;31, 2021, 2020, and 2019:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-lived Assets by Geographic Region: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:NoncurrentAssets
      contextRef="ib32f28d9fbb54bab90164eb85e585915_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTo2ZGYzOTdkMWZjZGY0YjU0ODRkNmJkZTRhNmI0ZDM0ZS90YWJsZXJhbmdlOjZkZjM5N2QxZmNkZjRiNTQ4NGQ2YmRlNGE2YjRkMzRlXzItMi0xLTEtMjM0NTg_e7f09211-67bd-4293-a1fd-74feb554e4f0"
      unitRef="usd">19605000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i202d7516b2bd4304ad55b1aafeb6d3d5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTo2ZGYzOTdkMWZjZGY0YjU0ODRkNmJkZTRhNmI0ZDM0ZS90YWJsZXJhbmdlOjZkZjM5N2QxZmNkZjRiNTQ4NGQ2YmRlNGE2YjRkMzRlXzItNC0xLTEtMjM0NTg_dc2ff938-b6d2-407c-82ba-833d1b3e8f6d"
      unitRef="usd">20424000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i27b63bdbcab14d6eb97ff7f6e4f0a10c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTo2ZGYzOTdkMWZjZGY0YjU0ODRkNmJkZTRhNmI0ZDM0ZS90YWJsZXJhbmdlOjZkZjM5N2QxZmNkZjRiNTQ4NGQ2YmRlNGE2YjRkMzRlXzItNi0xLTEtMjM0NTg_7ded04a6-7805-44d5-8e23-36fb82b49cb3"
      unitRef="usd">22254000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ie28cee2136b144d498b35733e7331556_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTo2ZGYzOTdkMWZjZGY0YjU0ODRkNmJkZTRhNmI0ZDM0ZS90YWJsZXJhbmdlOjZkZjM5N2QxZmNkZjRiNTQ4NGQ2YmRlNGE2YjRkMzRlXzMtMi0xLTEtMjM0NTg_8f7b18ea-1821-4862-bf56-372f9a559780"
      unitRef="usd">0</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i0bcaec4506f44e42ab5e37d5e0a7f18d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTo2ZGYzOTdkMWZjZGY0YjU0ODRkNmJkZTRhNmI0ZDM0ZS90YWJsZXJhbmdlOjZkZjM5N2QxZmNkZjRiNTQ4NGQ2YmRlNGE2YjRkMzRlXzMtNC0xLTEtMjM0NTg_b0101290-dbe2-48a9-91a6-768dabbb7394"
      unitRef="usd">11000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i78d0a8066299410fae55ee22a1483399_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTo2ZGYzOTdkMWZjZGY0YjU0ODRkNmJkZTRhNmI0ZDM0ZS90YWJsZXJhbmdlOjZkZjM5N2QxZmNkZjRiNTQ4NGQ2YmRlNGE2YjRkMzRlXzMtNi0xLTEtMjM0NTg_fd2efca5-303f-4a9d-8476-452e2686bf72"
      unitRef="usd">196000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i0729539c1221405f81e7676478827e0e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTo2ZGYzOTdkMWZjZGY0YjU0ODRkNmJkZTRhNmI0ZDM0ZS90YWJsZXJhbmdlOjZkZjM5N2QxZmNkZjRiNTQ4NGQ2YmRlNGE2YjRkMzRlXzQtMi0xLTEtMjM0NTg_95396a0d-9e39-4521-9eae-25b5a27bf80b"
      unitRef="usd">9817000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ia1133dde1f8446e48e8886c74d1845df_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTo2ZGYzOTdkMWZjZGY0YjU0ODRkNmJkZTRhNmI0ZDM0ZS90YWJsZXJhbmdlOjZkZjM5N2QxZmNkZjRiNTQ4NGQ2YmRlNGE2YjRkMzRlXzQtNC0xLTEtMjM0NTg_d80106c8-384b-44e9-8dd7-5d7464cc379e"
      unitRef="usd">6047000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ica869e44a5d747338f8da7c47e19f318_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTo2ZGYzOTdkMWZjZGY0YjU0ODRkNmJkZTRhNmI0ZDM0ZS90YWJsZXJhbmdlOjZkZjM5N2QxZmNkZjRiNTQ4NGQ2YmRlNGE2YjRkMzRlXzQtNi0xLTEtMjM0NTg_bed57d4a-a6b3-4cf3-8387-fcaf20321c83"
      unitRef="usd">7244000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ib45086ff0e0a4835b7367935d02327f4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTo2ZGYzOTdkMWZjZGY0YjU0ODRkNmJkZTRhNmI0ZDM0ZS90YWJsZXJhbmdlOjZkZjM5N2QxZmNkZjRiNTQ4NGQ2YmRlNGE2YjRkMzRlXzUtMi0xLTEtMjM0NTg_cb5d4bdc-8ddc-44d3-9fad-85663769d658"
      unitRef="usd">29422000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i99065b4abdc2484fbd3a2b99ef88c50e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTo2ZGYzOTdkMWZjZGY0YjU0ODRkNmJkZTRhNmI0ZDM0ZS90YWJsZXJhbmdlOjZkZjM5N2QxZmNkZjRiNTQ4NGQ2YmRlNGE2YjRkMzRlXzUtNC0xLTEtMjM0NTg_26c8938b-4875-411c-a256-dd295bd6ceb6"
      unitRef="usd">26482000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ie73b28a1c0c648e5a6641e1c909996f0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjMvZnJhZzo4ZmE2ZTkyODk2NDY0NzRjODIyOTZlY2IwOGRhZjA1NS90YWJsZTo2ZGYzOTdkMWZjZGY0YjU0ODRkNmJkZTRhNmI0ZDM0ZS90YWJsZXJhbmdlOjZkZjM5N2QxZmNkZjRiNTQ4NGQ2YmRlNGE2YjRkMzRlXzUtNi0xLTEtMjM0NTg_190e4dd4-7514-414e-b4e1-64b566896aff"
      unitRef="usd">29694000</us-gaap:NoncurrentAssets>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjYvZnJhZzpjMmEwNGI3YjJjNzE0NjZkODNkODU0M2NkOTI3N2ZiZi90ZXh0cmVnaW9uOmMyYTA0YjdiMmM3MTQ2NmQ4M2Q4NTQzY2Q5Mjc3ZmJmXzIyNDA_41c950de-327b-45f3-9cc2-ac5046ccd55a">Related Party Transactions&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As noted in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 4: Disposition of the Hospital Products, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;prior to June 30, 2020,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company was party to a Membership Interest Purchase Agreement by and among the Company, Avadel Legacy, Breaking Stick Holdings, LLC, Deerfield Private Design International II, L.P. (&#x201c;Deerfield International&#x201d;), Deerfield Private Design Fund II, L.P. (&#x201c;Deerfield Fund&#x201d;) and Horizon Sant&#xe9; FLML, Sarl (&#x201c;Horizon&#x201d;) (the &#x201c;Deerfield MIPA&#x201d;) and a Royalty Agreement by and among the Company, Avadel Legacy, the Deerfield Fund and Horizon (the &#x201c;Deerfield Royalty Agreement&#x201d;). In connection with the closing of the sale of the Hospital Products, the Deerfield MIPA (with respect to certain sections thereof) and the Royalty Agreement were assigned to the Exela Buyer. Pursuant to the Purchase Agreement, the Exela Buyer assumed and will pay, perform, satisfy and discharge the liabilities and obligations of Avadel Legacy under the Deerfield Royalty Agreement for obligations that arise after the Closing Date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to June 30, 2020, the Company was also party to a Royalty Agreement by and between itself, Avadel Legacy and Broadfin Healthcare Master Fund, Ltd. (the &#x201c;Broadfin Royalty Agreement&#x201d;). In connection with the closing of the sale of the Hospital Products, the Broadfin Royalty Agreement was assigned to the Exela Buyer and the Exela Buyer assumed and shall pay, perform, satisfy and discharge the liabilities and obligations of Avadel Legacy under the Broadfin Royalty Agreement for obligations that arise after the Closing Date.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 12: Contingent Consideration Payable &lt;/span&gt;for a summary of payments made for and changes to the fair value of the related party payable for the year ended December 31, 2019. Deerfield and Broadfin disposed of their 2023 Notes and ordinary shares in the Company during the year ended December 31, 2020 and are no longer considered related parties for the years ended December 31, 2021 and 2020.</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjkvZnJhZzo4MGUzNzJjYzEzNGQ0YWQxYWRhNzE4NGVmOWMyZWE5MS90ZXh0cmVnaW9uOjgwZTM3MmNjMTM0ZDRhZDFhZGE3MTg0ZWY5YzJlYTkxXzQy_695ee507-1bf1-4f6e-8166-aa18ee6e3cdf">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Subsequent Events&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;On March 16, 2022, Avadel Finance Cayman Limited, a Cayman Islands exempted company and an indirect wholly-owned subsidiary of the Company (the &#x201c;Issuer&#x201d;), executed an agreement to exchange $117,375 of its 2023 Notes due February 1, 2023  (the &#x201c;February 2023 Notes&#x201d;) for a new series of its Exchangeable Senior Notes due October 2, 2023 (the &#x201c;October 2023 Notes&#x201d;) (the &#x201c;Exchange&#x201d;). The remaining $26,375 aggregate principal amount of the February 2023 Notes will maintain a maturity date of February 1, 2023. Taking into consideration the Exchange and the maturity date of the October 2023 Notes and based on the Company&#x2019;s current plans, the Company has sufficient cash on hand and available liquidity to satisfy its obligations and fund working capital needs for at least twelve months following the date of issuance of the Consolidated Financial Statements. The Company has a recent history of generating losses from operations including during 2021 and expects to continue generating losses over the next twelve months. Similar to other businesses in the Company&#x2019;s industry and at its stage of development, the Company will continue in the medium term to rely on external sources of capital to fund its business.</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i6708f8d915264e56880479e22149d123_I20220316"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjkvZnJhZzo4MGUzNzJjYzEzNGQ0YWQxYWRhNzE4NGVmOWMyZWE5MS90ZXh0cmVnaW9uOjgwZTM3MmNjMTM0ZDRhZDFhZGE3MTg0ZWY5YzJlYTkxXzI3NDg3NzkwNzYxNTI_40aab02a-f8b8-4c72-918b-9d019ca30e05"
      unitRef="usd">117375000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i360019dcf2b1493e9e2047d365cd0d6f_I20220316"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xNjkvZnJhZzo4MGUzNzJjYzEzNGQ0YWQxYWRhNzE4NGVmOWMyZWE5MS90ZXh0cmVnaW9uOjgwZTM3MmNjMTM0ZDRhZDFhZGE3MTg0ZWY5YzJlYTkxXzI3NDg3NzkwNzYxNjU_a5890e0c-80c7-4fb5-84df-67f439e9a3b6"
      unitRef="usd">26375000</us-gaap:DebtInstrumentFaceAmount>
    <dei:AuditorName
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xOTkvZnJhZzozMzcwMmJkMmM1N2Q0OTFlYWI2YzNjZWE1ZmVlMzFlYS90ZXh0cmVnaW9uOjMzNzAyYmQyYzU3ZDQ5MWVhYjZjM2NlYTVmZWUzMWVhXzI3NDg3NzkwNzAxMzM_8bf666ae-7148-4fff-8af8-5ee02ae00339">Deloitte and Touche LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xOTkvZnJhZzozMzcwMmJkMmM1N2Q0OTFlYWI2YzNjZWE1ZmVlMzFlYS90ZXh0cmVnaW9uOjMzNzAyYmQyYzU3ZDQ5MWVhYjZjM2NlYTVmZWUzMWVhXzI3NDg3NzkwNzAxMzQ_97f1c227-5c83-41b3-8335-7814d073bb4a">St. Louis, Missouri</dei:AuditorLocation>
    <dei:AuditorFirmId
      contextRef="i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU2YmI5NWJiNGVkOTRmNmFiYjliZTRkMTg2ZTIxZGZiL3NlYzo1NmJiOTViYjRlZDk0ZjZhYmI5YmU0ZDE4NmUyMWRmYl8xOTkvZnJhZzozMzcwMmJkMmM1N2Q0OTFlYWI2YzNjZWE1ZmVlMzFlYS90ZXh0cmVnaW9uOjMzNzAyYmQyYzU3ZDQ5MWVhYjZjM2NlYTVmZWUzMWVhXzI3NDg3NzkwNzAxMzY_02ae8c73-7b35-4ecf-93fd-c31f6661b8c2">34</dei:AuditorFirmId>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>135
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M%YQ%7-D7X/E,2K.YL V4YZ;G_P)02P,$%     @ 0X!P5,P](><< @  < 4
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MNM!QNL")8,7AQRJ0,CTIV*X*.,A#9N"(V')#FS?X$A,$LW GN4(1OH"UNF^
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MSL"\$<#W*R'T\XNYL3W<T"_^!U!+ P04    " !#@'!4%>"(@^0"  "7"@
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M0T7R;XB0>!;0WY;R',@5$R37"=F *A#7==M3^!@X'_9SL)T$K0!W8KN_"4U
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M[3&HO<=X;.=,S7[!H&ES7->?!@!:^AX'L+;E8$]VXSX4:P9<K/>T1*QM#-A
M8_![G3,SR3S4FQ\[IFMWR_C,SOC[],W,I*X@\/4T&$)U#6ZYBSWJQMS2@6%P
M\\VYV0T\XQ$\ #,[, #40\ULZ[FPG1OM'1CDTG&CL7.E&A"])SX%8-)SW6\
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M7IX^$= ^KCYV.P_'3%9=!P"K04F_ H,BG:8C@<;3P><73M^0Y<=&_1ZMVF6
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MW]FV\?D&A"[@$G.CG5&R$%R_:>PI'#O%^19ZT4&G+T G*5P;[2L'[W6!Q3Y
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M57/W<R8X0DT+\'RB 'Y]00I6WU=/_@M02P,$%     @ 0X!P5,XF)0<!"0
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MY@/G[QT^<5R;O3$X)4NE[MWD.IL$D2.$ E/K$!C]ON,Y"N& B,:W%C/H4KK
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M3W,>JDOLP/RI^-UM"/=:4(DZ]XW60*IJ:9MNU*UVO7S6M+!']^8AN&$ZY]*
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M_G0<@6TN2LV'-Q5?3E;&TU6'AP6I!VTPH/]K8_S^(P3H;JOG_P%02P,$%
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M6 ?[YS/%-XLI1K^4TTFTE,-4SV8,<H8[&8]S;:</G.HP=5/QO+01NSG#>QM
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M)\*XMS+=#UMM^$W(>65MM>:O*R6!!EJ ^XNJLNT/.J![-?;]_P!02P,$%
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M@]H9T/I:4=&'B7,P_B M_@%02P,$%     @ 0X!P5.P^_IM3#   B"<  !D
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M_9&@OG&Z#"_F<^WPFA\NE\0S,GX"QG.-^M?<> ?MEYK3?P!02P,$%     @
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M=E^%U^;6/+S9/S&]Y-* P 6YQMW1L ,ZO(/#P*K*OSWGRM)+UG\6]*\#:F=
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MFEU/1@G8KGMW&V]VL6-NC*?^&Y<-?7AHPP62UX9:1[\)!LY?Z/(?4$L#!!0
M   ( $. <%356-:QO@8  $8/   9    >&PO=V]R:W-H965T<R]S:&5E=#,P
M+GAM;+U787/;N!']*SMJI]/.T))(4;;DLSUC.TES;5.[<2[]T.D'B(1$C$&
M!X!2Y%_?MR IRW>)TYGK](M$@MB'W;>+M\#%SKI'7TD9Z$NMC;\<52$TYY.)
M+RI9"S^VC33XLK:N%@&O;C/QC9.BC$:UGF33Z>FD%LJ,KB[BV+V[NK!MT,K(
M>T>^K6OA]C=2V]WE*!T- Q_5I@H\,+FZ:,1&/LCP4W/O\#8YH)2JEL8K:\C)
M]>7H.CV_R7E^G/!9R9T_>B:.9&7M([_\6%Z.INR0U+((C"#PMY6W4FL&@AL_
M]YBCPY)L>/P\H+^+L2.6E?#RUNI_JC)4EZ/%B$JY%JT.'^WNO>SCF3->8;6/
MO[3KYIY.1U2T/MBZ-X8'M3+=O_C2\W!DL/B60=8;9-'O;J'HY1L1Q-6%LSMR
M/!MH_!!#C=9P3AE.RD-P^*I@%ZYN;=T(LZ>[1CK!/'E:[>G>V;(M0D*WT0/I
M2)B2_BSMQHFF4@5=HP N)@$.,,RDZ!>[Z1;+OK%8FM$':T+EZ:TI9?D28 +/
M#^YG@_LWV:N(;V0QIEF:4#;-TE?P9@<Z9A%O]@V\![E!Q07Z*!OK@C(;^M?U
MR@>'XOGW*_#Y 3Z/\/G_A^U7%^/M?.X;4<C+$?:KEVXK1[_% _I421KL*^%1
M_$$ZU*0L*50BD ID(ZSTI Q9(\EW?":8(#%_"Q%H(L&,7]@:2Q5*:/44?2&[
MIJ82V&R%;(,JA*:F\\PG0"QT6W)*"M20LUK+\L1A>V-/,CP\C48'D[A;2[@!
MQSR/-D[) .6AQNH]!]E-"+*HC-5VLQ\?A_B'WRVR].P'3[>5DNN!,"R/FE-1
MDSZ(1X H'X.[?7O7F[^]@UIM63YXT;7J@M76,RN=C,98(4D<BK=:E>"L9'<8
MS)+P7F(V5HS332$C1(WUR&[AA]8]T^Q/V?OC84<[Z!O_(^&V=6RHM2VZ3(_I
M6C\S2L+)GE2L_3)?M)*%:#M>?\7' : 26UBH6FGA2"(46X-^]M1R/JA *K%Q
MI%,>>7F10L8U(K1P 3GGMV>W8-^_,$UX+"3S@1K:-W%ZT1<IADI .[5JX]1:
MALJ6'8*3FU:+8)%M:;;*6<-QC>G.T%]:!#J;1LV8)L<A$G)1QH'WUC<JH/[Z
MG0'N'J2DO]L@*3^G-\HWUJNA9K]J0>-?;)B2C.7*D*;%7FC=P$- SD!DW2FC
M9&7D&I/U"AP.VM:!K5'U=A<-Q4HS:=C7ADD;NFITQ[(?_4IQ?_=\PM[]UTM.
M(X_9-%V>0PX[KY^EXKR;PI_I1MLO:*WNB7Y/68(A_)\E^=F2/HNGHM6RH72:
MY-F29K,DG6=T_6BWXHF6R3R?4[I(3O.,[F+)I/,E_7&^^-.P#'FA$0)PLV0V
MR_$P7R99.O]-;'BU,6H->4&A#[7TOZ#FX0AW$-)CGCX4?T4EHV1NK4-[Z60
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MA8NN=#P!W]<6NZU_X04.5^>K_P!02P,$%     @ 0X!P5'A\AG\2!   ^ H
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M\"$"T\Q9S<;I*LPV*^UX4@K+@D=3,EZ!Y;GF4-J-=] -N]._ %!+ P04
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MIJ#8 (84(7)7\<=T\MZ5MMLJ=[M?8FIZR^?7 JI;H&A+WYC;PG@/%%2EWK<
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MINF+:RO_,J/%0XQN3E-;:?%_-8CQ10Q/YMG_A>$/'<8G1]\E"FG7]/7%01$
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M:J= _PM%K=$+SL'P-*^_ U!+ P04    " !#@'!45YQNG)X$   E"P  &0
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M)C<D+RF7L*5YQ6"Q!\57)5_RE)8:>'LID%+-5D+N@2K#%EX_*Q9,MB5@(^'
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MEE3ZBAJ3/^W04QSHR4SY- "[$8ZKS>3 J_'IM(3]<'3[X@M3AA!: H'?&95
M!I$=*(@&Q&N&-]@=&L/7CH?9NIC^7=P]B)HN()X;CTV-!<28ED__@UEXAW80
MU Z"H9(@AM@;HTV2Z%T:<LB#E3WR8.1%[<QK03%RDA@T,38IL:TP1KGJ-:EZ
MX,=NB+UQK!6&G:=+P>3*/M 4V,NO7S'M;/L&O*B?/B_N]0,2;V=E)"AG2]SJ
MG8^QX&7]**L-+3;V(;00&I]5=KC&=RR3Q@'7ET+H@V$2M"_C^3]02P,$%
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MJLEP2ODR7;_I-DXWX8]?:4<=(RPK:M%HO #=EUJ[W<8;Z)O^\A=02P,$%
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MNP.T/U>4T6;A M3_#^-_4$L#!!0    ( $. <%2/OUHZ_@(  )P&   9
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MCZ2PH"4W#W+U%6H]'<N72*[=+UE5OKV>1Y)2&YG78,P@9Z)ZTM?Z'#8 0?<
M(*P!X2Z@?0 0U8#H5$"[!K3=R512W#G$U-#10,D54=8;V>S"':9#HWPF;-EG
M1N%;AC@SFI5SS5*&%2=C*IY469CDC5"1DA@2*;3D+*6N0N<Q&,JXOB ?R.,L
M)N=G%^2,,$&^9;+4B- #WV!&EM=/ZNCC*GIX('H0DGLI3*;))Y%"NDW@HY1&
M3[C6,PZ/,F+65R0*+DG8"H,]"4U.A[?VP..3X<''(VJBICJ1XXL.\(U+C1:M
MR4WR7#+-;"$NR02/C(DE"&.76#Y058E^WJ$WN360ZU]'HK>;Z&T7O7T@^B2C
M:@D$>PM^2=N702ZP4:QOSKZZ5\P=QVQ;S\L(C_-ELQ!_]8C?>X3=7K]QVM+4
M:31UCFKZ@IV0+)3,L6=QP(9AI22@C+5S1N>,XRG#WKO<>9]/T-M1]=XGBKKM
M'6&54W>O]"U5W495]ZBJ60$)H]R\D2G6+*='BM]K*'O_X>KUF^C]?W7UXOXI
MU\;?:)DY8"P[>C1)9"E,U6T::S/=;EQ3W[&/<>I50^H/334R[U$"$YIP6"!E
MZZJ'*:EJ#%4;(PO7F.?28)MWRPPG-RCK@.\74IKUQ@9H_@N,?@-02P,$%
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M!&4WX/I62O,ZL6U(VW;._P502P,$%     @ 0X!P5".91A,Z!@  AQT  !D
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MB>*+_.&>,5>*I_GAG$53)DR _GS&N7H],<\+E<^'C?X'4$L#!!0    ( $.
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MHS84_2L6VH==:29@F\]5$BF;T6XK==31IK-]J/K@!&="!W!JFV2VO[Z&,$#
M>"+E95X2/LZ]G.OK<S">'AE_%CM*)7C)TES,K)V4^\^V+38[FA$Q87N:JSM;
MQC,BU2E_LL6>4Q)705EJ(\?Q[8PDN36?5M<>^'S*"IDF.7W@0!191OC/+S1E
MQYD%K=<+WY.GG2POV//IGCS1%96/^P>NSNPF2YQD-!<)RP&GVYFU@)^7V"D#
M*L2/A!Y%YQB4I:P9>RY/?HUGEE,RHBG=R#(%47\'NJ1I6F92//ZMDUK-,\O
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MW>M4M->I74)+,K^AP1FW=1[:N,-)MTJ_5NGWJ@P^R9]_X'(R:JDZ-''&+9O
M/\BP=TSYJ%8^ZE6^HK'80(8&@,8Q#I'.<TBSO!"([1+>TW;CVM/X^WM\4CN;
M](;U2 5,0=[9/%T%FAQDW_/&K0H=VMB>YW:GW[9V.['5J_2F8 2+0E4@QN]J
MP+7<& N!R9KW),-N;/?V]^?>=G;NG/^:_8JNV=BNY;32WVEDM=)O-L[$#+&U
MOEMPV= %$>7A4J_6]Y=+?6JWUA?J7J//VAU->2FZAVR-"0<IBB6E=3Z2BEAY
MSR@G@N;ZY'VF0I[C>IC(NQEBRD!^CRD5VXER4-_VYO\ 4$L#!!0    ( $.
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M#DH30.,S(?2F80BJ1]/H-U!+ P04    " !#@'!4U4>/")0"   B!P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6R-5=%NFS 4_14+]:&5UH(A(6V5
M(#5ATR:U6M6TV\.T!P=N@E6PF6V:[N]G&\(((5%?P-><<WS/O>)ZNN7B568
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MTO]RN]W/4%T59EL5__H%=-$[(W+];\_*=+LRK5=F RN_*P!::(/$%R!(+<Z
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M'G8M#_M[GL,?Z'7S!F"7.B,Z0.S8M2CL[U'?57ISW.TVYSZS7,/!_H[SS24
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M@.^7$H+=?+!_*=C^J^7Z_U!+ P04    " !#@'!4L;A?-OD!  !Q!   &0
M 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6R-5,%NVS ,_17!V*$%MLBQFZXH
M' -M@F$[; @:=#T,.\@V$PN5)4]BXO;O2\F.D0)-UXM%4GQ/Y#.EK#/VT=4
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MV*_X;!3N,O0SP[$4AHDE"$-PJ%D&BKK\3ND[G7,@5\UH1#D5*9#S"1C*N+[
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M[]^?[81 $R=%Z@O$SLQX=C>V=WR@[(TG  )]Y!GA$RL18G=GVWR=0(YYC^Z
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M@4TJ;M!U! *G&;^1T-=EA*ZO;M 52@EZ2>B>8Q+SL2VD*Z5MKTL'L\*!U^+
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MP/MW9^ =8!GXMLS7!<GB8M@7$HV*V8_J)U]73T8=3X8(?,DSL2S 31;3>#]
M7Z:QRP5M<[E&UH@3&ET #,\!<A T !H?[^X8W"='N\/0X'YC=_\:B0O@H$[W
M6[O[YW72Y;[')=[5!2[CX6/JXJ]?Y5TP%30M_K;$=G>QW3*VVQU;BF!!P?N8
M5D=GJI98]4A!7L CS>B<"5-15:&],K22S><1#AQ_V']N+G3;R \\=V>TA]K;
MH?:LJ*_2G OVO7PA3, J;[\)S$7A 3"#4>! ,S!_!\RW IO0.>6<QDT"Z8ML
M/8KAFLDS$V*_!>8#] ;!(9EM,W_@[-M,_!;A'SS7P^;$@EUB@36QAXS3*%]D
M[+M,KE$61K$)6BB1.\ 'J1QC-&D;X4&CPO92&>Q2&;Q5\MNED0M#$L'D:R5U
M4ZZ9H)P68KMBIM0&;=3XL+ ,-LYA8H/6(GF>9\XKW.45_L^\2!3Q]:&\5WF%
M+<PP"(*#Q Q&;M"!&CJZZSEOEE;*A)"%10G/6+8P=S"G70LA[*@%V.BY\+@W
M5O%&BH**XKP\EFHH^R^(".>OLOMN"(_E'<FC!!DMC0AA&Z'O#PY(-%CY0="A
M.Q#I/) UC_'5_<T,7$7B'$1+DBVHDG&5!R>"GJL!3Z>9,/+($B9>SX\3^G']
M[";F$*(.$8>ZKT%\-&92+"NX=+XVSS#C.MH>O]CK8DYW0&AO@;*O@C_EHK[5
MKJ'N3M [><.&NL5 >X\Y9*UB#$0)8:F9MW;7@(.@JR- W1*@O2<TB#L<TO8C
M:F6&@],3I_41V@7RQXDS")Z#@@[BD%8\9%>\*:>)%&;;F*WU"\&34X:TJB"[
MJOPFOZ?EE[/4$"G+(,F+8E\033*(VF(AM2) 3@=M6BZ072Z^6H"<@V>2K*LO
M))+(;W221<VAU@BTK2>NXW;T,Z3U!-GUY!>NT&T;1:.7&#&X+0Q>:U(U&.&N
MOHNT2B'[$/UP,;NP%8D6).2?O@2URB"[ROQ4";;GQL!UNP9'I/4)V4?'6Z[*
MRI:6%B,4GIPTK!4&VQ7FAVH0&R8KV)IJ#58^#CLHQ5J_L'W^FJKA5.UQW--G
MFJTIF%'^S-2[.[V?G8%_P6Q%(T;4M +NEH23E-@8TLJ&T>GY;WRQVZ7JFF1/
M?+T2T6O=7LX!2?-U)DMY#N8LH=NV(V>Q)YJ\ I'+^4M.:1DSSN?C^GG-#P88
MXH,!_<9@%6('[5O=&JP\QP\[! 5KX<-VX;N=C6WD:6'"IQ^?L%8K;!^??D9/
ML&&"<K#?Q9C6-OS&5[648/ I3^+V1\]^1*U0^/03%-:BA>T3U$]Q%[8W@&2;
M/1S;^XU]TY3R1;G#+<.KEZ;:=MQ=W>VB7Y5[QP?7K^''2;47KL-46_-?"%^P
M3+YR="Y#.A>!Q,2KW>[J1.2K<G?V,1<B3\O#)24QY<I WI_GN=B>J ?L_N<P
M^@]02P,$%     @ 0X!P5,RUEYKT @  W@@  !D   !X;"]W;W)K<VAE971S
M+W-H965T-S0N>&ULC59=;]HP%/TK5M2'5EH;\D%@%2"59M/Z4*DJ[?8P[<%-
M+F#5L3/[4NA^_6PGI% @\ *V<\ZY]]CQO1DLI7K5<P DJX(+/?3FB.6U[^ML
M#@755[($89Y,I2HHFJF:^;I40'-'*K@?=CJ)7U FO-' K3VHT4 ND#,!#XKH
M15%0]3X&+I=#+_#6"X]L-D>[X(\&)9W!!/"Y?%!FYC<J.2M :"8%43 =>C?!
M==JW> ?XR6"I-\;$.GF1\M5.[O*AU[$) 8<,K0(U?V]P"YQ;(9/&WUK3:T):
MXN9XK?[=>3=>7JB&6\E_L1SG0Z_OD1RF=,'Q42Y_0.VG:_4RR;7[)<L*V^MZ
M)%MHE$5--AD43%3_=%7OPP8A2 X0PIH0?B;$!PA138A.)<0U(78[4UEQ^Y!2
MI*.!DDNB+-JHV8';3,<V]IFPQSY!99XRP\/1G<AD >2)KD"32_(L%&1R)M@_
MR.TB&8. *4-RG@)2QO6%!4U2<GYV0<X($^1I+A>:BEP/?#3Y6%4_JV./J]CA
M@=A!2.ZEP+DFWT0.^;: ;XPT;L*UFW'8JIA"=D6BX L).V&P)Z';T^F=/?3T
M9'KPM<5-U)Q-Y/2B WH'#^/&7A:&[^3WH^2<F NPI"K_TQ(R;D+&+F1\(.08
M9DP()F;F,G$J,MAWJI5$UTG8LO(VBH(X&OAOFSN]"TKBI+L-2G=!W2CX &U9
MZ#86NJT6S!MMZI\VK[,IB@3-MI52,UMD-)%34BIFEM^!JKUO;*6=;&34^63L
M*"+=181QD.QWE32NDE97$Z2X0+ .."N8F3E#L"J9<N-]9I*C9HXBTEW$91 F
M!]ST&C>]=C> R,%T#]Q["+VC>>\B+J,H##_EWJ:SE7>_R;O?FK>I4T?N1O^4
MNW$**-T%;5V@*G]_H_(7H&:N@VJ2R87 JFPVJTV3OG&]Z=/ZV#3OJM=^R%2=
M_YXJ4Q,TX3 UDITKVRM5U4VK"<K2]9<7B:9;N>'<?(" L@#S?"HEKB<V0/-)
M,_H/4$L#!!0    ( $. <%2XP5>_7P,  #,+   9    >&PO=V]R:W-H965T
M<R]S:&5E=#<U+GAM;)V6;6_;-A#'OPHA%$4++)%(/=C*; -MC*T%NBU(VNXU
M(YTMHI2HD73L]M./E!1%D6@A[1M;I.[^_!VI.][J*.0W50!H="IYI=9>H75]
MY?LJ*Z"DZE+44)DW.R%+JLU0[GU52Z!YXU1RGP1!XI>45=YFU<S=R,U*'#1G
M%=Q(I YE2>7W]\#%<>UA[W'BENT+;2?\S:JF>[@#_:6^D6;D]RHY*Z%23%1(
MPF[MO<-7USBR#HW%5P9'-7A&-I1[(;[9P<=\[066"#ADVDI0\_< U\"Y53(<
M_W6B7K^F=1P^/ZK_T01O@KFG"JX%_Y?ENEA[2P_EL*,'KF_%\0-T <56+Q-<
M-;_HV-HFL8>R@]*B[)P-0<FJ]I^>NHT8.)A W0ZD<R O=0@[A[ )M"5KPMI2
M33<K*8Y(6FNC9A^:O6F\332LLL=XIZ5YRXR?WGRL,E$"^DQ/H- %VL(.I(2\
MFWBS!4T95V_-JR]W6_3FU5OT"K$*?2[$0=$J5RM?&PJKY6?=BN_;%<F9%;>0
M7:(0_X9(0+##_?KE[L%S=]_$WF\ Z3> -'KA6;TN8DU/B"H%6EW-R(:];-C(
M1F=D_S89:')-4LVJ/>)"*911*;^;Q#M2Z=ZW5C%N%&WZ/6S".$U-D _#[7%8
MX3 @O=4SW*C'C69Q_Y%U02N4R\,>F6-%MZ]I6?^^;38E,[O#M NXU4P&*%&:
M1"/>J1%9I*$;-^YQXUG<NX)*N+#IFR/S_9J:IJBM"B[(> J)@^4(<FI$$I*X
M(9,>,IF%?%<*J=F/LV#)9,TP(ND(S&&T"+ ;;-&#+>8/6Q<@742+R6))0D9
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MARH*&ZJ2R6X<!?H8_H+Y,\D%HK!1/N<Z5 %X>;25$\FVYG18,:G.&C-,U=<
M<"U0SS=,O>1JH@^<^OMB\A=02P,$%     @ 0X!P5!(U@D*] @  ,0<  !D
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M/Y HB,(]]-G[Z<$NW3>M&?H3#?V)G%Y\L#_CHN=,%USJ1@'Y?;70J,R?^.=
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ME<3.FHG]U"9Z[5+&2HIEW??HK))'6?-N^']9RJ;L>.O<]MQN37E*$F;-)/P
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M"K27DA,LLJJJ&8#E56F[ 09HMNA?0(;Q'#OE6=WJ7,QM^NIQ AKF@G;F6AM
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M/)/V%VW+6,]!T5HJGI=@K2!/6?%/7\I"U "X?09 2@ Y! 1G 'X)\-\+"$I
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MA G0SQ><J]W$O*!JH ?_ %!+ P04    " !#@'!4&8)<36L(  !3,@  &0
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MWE+YR'8?H$JHK?D21H7Y1;MR;;?OH&0K),LKL%*0DZ)\XI?*B"- V#X#""M
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M,//+M>[IJ3 WZ-^7G*O#P#@H_DLP^0]02P,$%     @ 0X!P5"%8X<U^!
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M=LV2D!RH((PB#IN9=>N^BUQ' TS$5P)[T6@C+67-V$_=^9C,+$>O"#*(I:;
MZN\)[B#+-)-:QZ^*U*KGU,!F^\#^P8A78M98P!W+OI%$IC-K;*$$-KC(Y /;
M_P.5H*'FBUDFS"_:5[&.A>)"2)978+6"G-#R'_^NC&@ W-$K *\">&U \ K
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MIIN##T2MJ="(064IPZO)*$"JFRV=863CNVTEC>U=OZSM. ;E'.QY):79&2[
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M/8'.3-]E1AP*';U*1ISKG?K!ASI]0M/Z]/V]UC@8_M9VYYZC4S'AQI0C(VY
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M$+@.4/>7C,G]B1Z@VJB9_ =02P,$%     @ 0X!P5''E7S-O P  V@P  !D
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M6!.(YB9H)HJO;#/-N-*MV0X+?7NB, ?T_H+K;-N)Z<_=?9S^!5!+ P04
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MU!B1TD7$GH]4"Z?FT')ZJ41@Q624.B)F=00R:5;B^V(S.WMQMPJ1: %CYIW
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M3[C3*(J3\-K'K"G+4SCWW5Q866Q?^-Z^K/[Q+U!+ P04    " !#@'!4%#8
M'+X"  !W.   &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSS=J];N)
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M]<X">F?JG07TSM0["^B=J7<6T#M3[RR@=Z;>64#O/#GL+:!WIMY90.]"O8N
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M4$L! A0#%     @ 0X!P5-VY:)#N    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ 0X!P5)E<G",0!@  G"<
M !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    " !#@'!4 6U=G^\&  !#'0  &               @($-"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ 0X!P5,P](><< @  < 4
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M965T-BYX;6Q02P$"% ,4    " !#@'!4%>"(@^0"  "7"@  &
M    @($<)   >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @
M0X!P5)U^_E *"   HBD  !@              ("!-B<  'AL+W=O<FMS:&5E
M=',O<VAE970X+GAM;%!+ 0(4 Q0    ( $. <%2?PVRI1@D  /8H   8
M          " @78O  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4
M    " !#@'!4-AI,/^0:  "!3@  &0              @('R.   >&PO=V]R
M:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( $. <%1QM]::J 4  $L-
M   9              " @0U4  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL
M4$L! A0#%     @ 0X!P5+^+M0[T @  L@8  !D              ("![%D
M 'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " !#@'!49P$M
MULL)  !K'0  &0              @($770  >&PO=V]R:W-H965T<R]S:&5E
M=#$S+GAM;%!+ 0(4 Q0    ( $. <%3.)B4' 0D  %(9   9
M  " @1EG  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @
M0X!P5!35'68+"   .10  !D              ("!47   'AL+W=O<FMS:&5E
M=',O<VAE970Q-2YX;6Q02P$"% ,4    " !#@'!41C5"0DH&  "N#P  &0
M            @(&3>   >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4
M Q0    ( $. <%2(;_>5G@(  ,P%   9              " @11_  !X;"]W
M;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ 0X!P5&I-0?[N @
M[08  !D              ("!Z8$  'AL+W=O<FMS:&5E=',O<VAE970Q."YX
M;6Q02P$"% ,4    " !#@'!4^P0 @(0$  "Y"@  &0              @($.
MA0  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( $. <%0"
MH33B%PL  + >   9              " @<F)  !X;"]W;W)K<VAE971S+W-H
M965T,C N>&UL4$L! A0#%     @ 0X!P5** L^D6!   XPD  !D
M     ("!%Y4  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $. <%3+BTTR]0@  / 7   9              "
M@43   !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ 0X!P
M5%/D=_DI#0  Y2H  !D              ("!<,D  'AL+W=O<FMS:&5E=',O
M<VAE970R-RYX;6Q02P$"% ,4    " !#@'!4$<K#8L$$  "8#   &0
M        @('0U@  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0
M   ( $. <%1@_.QU.0,  $X'   9              " @<C;  !X;"]W;W)K
M<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ 0X!P5-58UK&^!@  1@\
M !D              ("!.-\  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q0
M2P$"% ,4    " !#@'!4>'R&?Q($  #X"@  &0              @($MY@
M>&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( $. <%2BZ<F!
MZ $  &<$   9              " @7;J  !X;"]W;W)K<VAE971S+W-H965T
M,S(N>&UL4$L! A0#%     @ 0X!P5%W?PU*@&0  ADT  !D
M ("!E>P  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " !#
M@'!4N9=5'CX#   -!P  &0              @(%L!@$ >&PO=V]R:W-H965T
M<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( $. <%2>$];.S@8   (3   9
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M970S.2YX;6Q02P$"% ,4    " !#@'!4S5S"^MP"   K!@  &0
M    @(%N( $ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    (
M $. <%2/OUHZ_@(  )P&   9              " @8$C 0!X;"]W;W)K<VAE
M971S+W-H965T-#$N>&UL4$L! A0#%     @ 0X!P5$JYTN_C!@  Y!$  !D
M             ("!MB8! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"
M% ,4    " !#@'!4S7&_"'D$  #G"P  &0              @('0+0$ >&PO
M=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( $. <%3R@W\,Y (
M $ &   9              " @8 R 0!X;"]W;W)K<VAE971S+W-H965T-#0N
M>&UL4$L! A0#%     @ 0X!P5!M_=;;J!0  @1   !D              ("!
MFS4! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    " !#@'!4
MX4*)(!<#  #2!@  &0              @(&\.P$ >&PO=V]R:W-H965T<R]S
M:&5E=#0V+GAM;%!+ 0(4 Q0    ( $. <%34 AT=40,  &L'   9
M      " @0H_ 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%
M  @ 0X!P5#W( F'E!   &@P  !D              ("!DD(! 'AL+W=O<FMS
M:&5E=',O<VAE970T."YX;6Q02P$"% ,4    " !#@'!4"*8H^ZP#  #K#
M&0              @(&N1P$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+
M 0(4 Q0    ( $. <%3UJ6;<L@(  'D(   9              " @9%+ 0!X
M;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ 0X!P5%7H=\PD
M!   =Q(  !D              ("!>DX! 'AL+W=O<FMS:&5E=',O<VAE970U
M,2YX;6Q02P$"% ,4    " !#@'!40J<^9-("   7"   &0
M@('54@$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( $.
M<%3#TVR4V0,  *4-   9              " @=Y5 0!X;"]W;W)K<VAE971S
M+W-H965T-3,N>&UL4$L! A0#%     @ 0X!P5/3QW@FZ P  @@H  !D
M         ("![ED! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"% ,4
M    " !#@'!4(YE&$SH&  "''0  &0              @('?70$ >&PO=V]R
M:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( $. <%0ACM55+P4  "LF
M   9              " @5!D 0!X;"]W;W)K<VAE971S+W-H965T-38N>&UL
M4$L! A0#%     @ 0X!P5+@+FJBK @  [ <  !D              ("!MFD!
M 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    " !#@'!4IM-1
M^H4"  "B!@  &0              @(&8; $ >&PO=V]R:W-H965T<R]S:&5E
M=#4X+GAM;%!+ 0(4 Q0    ( $. <%21OPSY9@0  "<4   9
M  " @51O 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @
M0X!P5$4(OXH"!   C!$  !D              ("!\7,! 'AL+W=O<FMS:&5E
M=',O<VAE970V,"YX;6Q02P$"% ,4    " !#@'!4L5Y56A8#  #Y"0  &0
M            @($J> $ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4
M Q0    ( $. <%2E!58:DP(  ",'   9              " @7=[ 0!X;"]W
M;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ 0X!P5%RXF0/H @
M0 D  !D              ("!07X! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX
M;6Q02P$"% ,4    " !#@'!4U4>/")0"   B!P  &0              @(%@
M@0$ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( $. <%2.
M!.9:C0(  &H'   9              " @2N$ 0!X;"]W;W)K<VAE971S+W-H
M965T-C4N>&UL4$L! A0#%     @ 0X!P5,7=7[]6 P  ! L  !D
M     ("![X8! 'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $. <%1:%[D!)0,  ",+   9              "
M@7": 0!X;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @ 0X!P
M5&SS;3^N!   BQ   !D              ("!S)T! 'AL+W=O<FMS:&5E=',O
M<VAE970W,BYX;6Q02P$"% ,4    " !#@'!4Y0TLWLH%  !_&   &0
M        @(&QH@$ >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0
M   ( $. <%3,M9>:] (  -X(   9              " @;*H 0!X;"]W;W)K
M<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @ 0X!P5+C!5[]? P  ,PL
M !D              ("!W:L! 'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6Q0
M2P$"% ,4    " !#@'!4S\\G^N\"  !K"   &0              @(%SKP$
M>&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    ( $. <%02-8)"
MO0(  #$'   9              " @9FR 0!X;"]W;W)K<VAE971S+W-H965T
M-S<N>&UL4$L! A0#%     @ 0X!P5/7/U ;! @  NP<  !D
M ("!C;4! 'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q02P$"% ,4    " !#
M@'!4&CMM5ID"   (!P  &0              @(&%N $ >&PO=V]R:W-H965T
M<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( $. <%3!EFL:5P(  - %   9
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M970X-"YX;6Q02P$"% ,4    " !#@'!4G>(4%RH#  !,"P  &0
M    @(&KT0$ >&PO=V]R:W-H965T<R]S:&5E=#@U+GAM;%!+ 0(4 Q0    (
M $. <%09@EQ-:P@  %,R   9              " @0S5 0!X;"]W;W)K<VAE
M971S+W-H965T.#8N>&UL4$L! A0#%     @ 0X!P5(T.MI4- P  O0H  !D
M             ("!KMT! 'AL+W=O<FMS:&5E=',O<VAE970X-RYX;6Q02P$"
M% ,4    " !#@'!4-O1"718$   Q$   &0              @('RX $ >&PO
M=V]R:W-H965T<R]S:&5E=#@X+GAM;%!+ 0(4 Q0    ( $. <%0A6.'-?@0
M ,H3   9              " @3_E 0!X;"]W;W)K<VAE971S+W-H965T.#DN
M>&UL4$L! A0#%     @ 0X!P5%P?AIR5 P   @L  !D              ("!
M].D! 'AL+W=O<FMS:&5E=',O<VAE970Y,"YX;6Q02P$"% ,4    " !#@'!4
MG*"<,W4"  #L!0  &0              @(' [0$ >&PO=V]R:W-H965T<R]S
M:&5E=#DQ+GAM;%!+ 0(4 Q0    ( $. <%2YL* V*@0  $81   9
M      " @6SP 0!X;"]W;W)K<VAE971S+W-H965T.3(N>&UL4$L! A0#%
M  @ 0X!P5"FET*KE P  M!$  !D              ("!S?0! 'AL+W=O<FMS
M:&5E=',O<VAE970Y,RYX;6Q02P$"% ,4    " !#@'!4<>5?,V\#  #:#
M&0              @('I^ $ >&PO=V]R:W-H965T<R]S:&5E=#DT+GAM;%!+
M 0(4 Q0    ( $. <%0<@MSDRP(  *\)   9              " @8_\ 0!X
M;"]W;W)K<VAE971S+W-H965T.34N>&UL4$L! A0#%     @ 0X!P5"?"_9:&
M @  FP<  !D              ("!D?\! 'AL+W=O<FMS:&5E=',O<VAE970Y
M-BYX;6Q02P$"% ,4    " !#@'!4\N][JP8#   M$   #0
M@ %. @( >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( $. <%27BKL<P    !,"
M   +              "  7\% @!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( $.
M<%2K&?XX\ 8  # _   /              "  6@& @!X;"]W;W)K8F]O:RYX
M;6Q02P$"% ,4    " !#@'!4%#8 '+X"  !W.   &@              @ &%
M#0( >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !#@'!4
M1OT@>DP"  ">-@  $P              @ %[$ ( 6T-O;G1E;G1?5'EP97-=
:+GAM;%!+!08     : !H (\<  #X$@(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>273</ContextCount>
  <ElementCount>520</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>97</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1001003 - Statement - Consolidated Statements of (Loss) Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ConsolidatedStatementsofLossIncome</Role>
      <ShortName>Consolidated Statements of (Loss) Income</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1002004 - Statement - Consolidated Statements of Comprehensive (Loss) Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ConsolidatedStatementsofComprehensiveLossIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive (Loss) Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1003005 - Statement - Consolidated Statements of Comprehensive (Loss) Income (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ConsolidatedStatementsofComprehensiveLossIncomeParenthetical</Role>
      <ShortName>Consolidated Statements of Comprehensive (Loss) Income (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1004006 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1005007 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1006008 - Statement - Consolidated Statements of Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity</Role>
      <ShortName>Consolidated Statements of Shareholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>1007009 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2106102 - Disclosure - Newly Issued Accounting Standards</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/NewlyIssuedAccountingStandards</Role>
      <ShortName>Newly Issued Accounting Standards</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - Subsidiary Bankruptcy and Deconsolidation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/SubsidiaryBankruptcyandDeconsolidation</Role>
      <ShortName>Subsidiary Bankruptcy and Deconsolidation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2110104 - Disclosure - Disposition of the Hospital Products</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/DispositionoftheHospitalProducts</Role>
      <ShortName>Disposition of the Hospital Products</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2115105 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2116106 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2120107 - Disclosure - Marketable Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/MarketableSecurities</Role>
      <ShortName>Marketable Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2125108 - Disclosure - Property and Equipment, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/PropertyandEquipmentnet</Role>
      <ShortName>Property and Equipment, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2128109 - Disclosure - Goodwill and Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/GoodwillandIntangibleAssets</Role>
      <ShortName>Goodwill and Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2130110 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2135111 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2139112 - Disclosure - Contingent Consideration Payable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ContingentConsiderationPayable</Role>
      <ShortName>Contingent Consideration Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2143113 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2151114 - Disclosure - Other Assets and Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilities</Role>
      <ShortName>Other Assets and Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2158115 - Disclosure - Contingent Liabilities and Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ContingentLiabilitiesandCommitments</Role>
      <ShortName>Contingent Liabilities and Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2160116 - Disclosure - Restructuring Costs</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/RestructuringCosts</Role>
      <ShortName>Restructuring Costs</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2164117 - Disclosure - Equity Instruments and Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/EquityInstrumentsandTransactions</Role>
      <ShortName>Equity Instruments and Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2166118 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2173119 - Disclosure - Net (Loss) Income Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/NetLossIncomePerShare</Role>
      <ShortName>Net (Loss) Income Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2177120 - Disclosure - Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ComprehensiveLoss</Role>
      <ShortName>Comprehensive Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2180121 - Disclosure - Company Operations by Product, Customer and Geographic Area</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicArea</Role>
      <ShortName>Company Operations by Product, Customer and Geographic Area</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2185122 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2186123 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.avadel.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2311302 - Disclosure - Disposition of the Hospital Business - (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/DispositionoftheHospitalBusinessTables</Role>
      <ShortName>Disposition of the Hospital Business - (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2317303 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/FairValueMeasurements</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2321304 - Disclosure - Marketable Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/MarketableSecuritiesTables</Role>
      <ShortName>Marketable Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/MarketableSecurities</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2326305 - Disclosure - Property and Equipment, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/PropertyandEquipmentnetTables</Role>
      <ShortName>Property and Equipment, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/PropertyandEquipmentnet</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2331306 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/Leases</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2336307 - Disclosure - Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/LongTermDebtTables</Role>
      <ShortName>Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/LongTermDebt</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2340308 - Disclosure - Contingent Consideration Payable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ContingentConsiderationPayableTables</Role>
      <ShortName>Contingent Consideration Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/ContingentConsiderationPayable</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2344309 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/IncomeTaxes</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2352310 - Disclosure - Other Assets and Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilitiesTables</Role>
      <ShortName>Other Assets and Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/OtherAssetsandLiabilities</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2361311 - Disclosure - Restructuring Costs (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/RestructuringCostsTables</Role>
      <ShortName>Restructuring Costs (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/RestructuringCosts</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2367312 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/ShareBasedCompensation</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2374313 - Disclosure - Net (Loss) Income Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/NetLossIncomePerShareTables</Role>
      <ShortName>Net (Loss) Income Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/NetLossIncomePerShare</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2378314 - Disclosure - Comprehensive Loss (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ComprehensiveLossTables</Role>
      <ShortName>Comprehensive Loss (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/ComprehensiveLoss</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2381315 - Disclosure - Company Operations by Product, Customer and Geographic Area (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaTables</Role>
      <ShortName>Company Operations by Product, Customer and Geographic Area (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicArea</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment Useful Lives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Property and Equipment Useful Lives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Newly Issued Accounting Standards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails</Role>
      <ShortName>Newly Issued Accounting Standards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.avadel.com/role/NewlyIssuedAccountingStandards</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - Subsidiary Bankruptcy and Deconsolidation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/SubsidiaryBankruptcyandDeconsolidationDetails</Role>
      <ShortName>Subsidiary Bankruptcy and Deconsolidation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.avadel.com/role/SubsidiaryBankruptcyandDeconsolidation</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2412405 - Disclosure - Disposition of the Hospital Business Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/DispositionoftheHospitalBusinessNarrativeDetails</Role>
      <ShortName>Disposition of the Hospital Business Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.avadel.com/role/DispositionoftheHospitalBusinessTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2413406 - Disclosure - Disposition of the Hospital Business Components of Consideration and Assets and Liabilities Either Transferred or Eliminated (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails</Role>
      <ShortName>Disposition of the Hospital Business Components of Consideration and Assets and Liabilities Either Transferred or Eliminated (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2414407 - Disclosure - Disposition of the Hospital Business - Unaudited Pro Forma Condensed Combined Statement of Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails</Role>
      <ShortName>Disposition of the Hospital Business - Unaudited Pro Forma Condensed Combined Statement of Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2418408 - Disclosure - Fair Value Measurements - Measured on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Measured on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2419409 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2422410 - Disclosure - Marketable Securities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails</Role>
      <ShortName>Marketable Securities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2423411 - Disclosure - Marketable Securities - Summary of Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails</Role>
      <ShortName>Marketable Securities - Summary of Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2424412 - Disclosure - Marketable Securities - Schedule of Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails</Role>
      <ShortName>Marketable Securities - Schedule of Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2427413 - Disclosure - Property and Equipment, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/PropertyandEquipmentnetDetails</Role>
      <ShortName>Property and Equipment, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.avadel.com/role/PropertyandEquipmentnetTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2429414 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/GoodwillandIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2432415 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2433416 - Disclosure - Leases - Components of lease costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/LeasesComponentsofleasecostsDetails</Role>
      <ShortName>Leases - Components of lease costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2434417 - Disclosure - Leases - Maturities of operating lease liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails</Role>
      <ShortName>Leases - Maturities of operating lease liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2437418 - Disclosure - Long-Term Debt - Schedule of Long-Term Debt Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails</Role>
      <ShortName>Long-Term Debt - Schedule of Long-Term Debt Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2438419 - Disclosure - Long-Term Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/LongTermDebtNarrativeDetails</Role>
      <ShortName>Long-Term Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2441420 - Disclosure - Contingent Consideration Payable - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ContingentConsiderationPayableNarrativeDetails</Role>
      <ShortName>Contingent Consideration Payable - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2442421 - Disclosure - Contingent Consideration Payable - Payable Balance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ContingentConsiderationPayablePayableBalanceDetails</Role>
      <ShortName>Contingent Consideration Payable - Payable Balance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2445422 - Disclosure - Income Taxes - Income (Loss) Before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Income (Loss) Before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2446423 - Disclosure - Income Taxes - Income Tax Provision (Benefit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails</Role>
      <ShortName>Income Taxes - Income Tax Provision (Benefit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2447424 - Disclosure - Income Taxes - Reconciliation of Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails</Role>
      <ShortName>Income Taxes - Reconciliation of Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2448425 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2449426 - Disclosure - Income Taxes - Unrecognized Tax Benefit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/IncomeTaxesUnrecognizedTaxBenefitDetails</Role>
      <ShortName>Income Taxes - Unrecognized Tax Benefit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2450427 - Disclosure - Income Taxes - Deferred Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails</Role>
      <ShortName>Income Taxes - Deferred Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2453428 - Disclosure - Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails</Role>
      <ShortName>Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2454429 - Disclosure - Other Assets and Liabilities - Other Non-Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails</Role>
      <ShortName>Other Assets and Liabilities - Other Non-Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2455430 - Disclosure - Other Assets and Liabilities - Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails</Role>
      <ShortName>Other Assets and Liabilities - Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2456431 - Disclosure - Other Assets and Liabilities - Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Other Assets and Liabilities - Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2457432 - Disclosure - Other Assets and Liabilities - Other Non-Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails</Role>
      <ShortName>Other Assets and Liabilities - Other Non-Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>2459433 - Disclosure - Contingent Liabilities and Commitments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ContingentLiabilitiesandCommitmentsNarrativeDetails</Role>
      <ShortName>Contingent Liabilities and Commitments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>2462434 - Disclosure - Restructuring Costs - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/RestructuringCostsNarrativeDetails</Role>
      <ShortName>Restructuring Costs - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>2463435 - Disclosure - Restructuring Costs - Severance Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails</Role>
      <ShortName>Restructuring Costs - Severance Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>2465436 - Disclosure - Equity Instruments and Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails</Role>
      <ShortName>Equity Instruments and Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.avadel.com/role/EquityInstrumentsandTransactions</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>2468437 - Disclosure - Share-Based Compensation - Stock-based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ShareBasedCompensationStockbasedCompensationExpenseDetails</Role>
      <ShortName>Share-Based Compensation - Stock-based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>2469438 - Disclosure - Share-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails</Role>
      <ShortName>Share-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>2470439 - Disclosure - Share-Based Compensation - Fair Value Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ShareBasedCompensationFairValueAssumptionsDetails</Role>
      <ShortName>Share-Based Compensation - Fair Value Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>2471440 - Disclosure - Share-Based Compensation - Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ShareBasedCompensationStockOptionsDetails</Role>
      <ShortName>Share-Based Compensation - Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>2472441 - Disclosure - Share-Based Compensation - Restricted Stock and Performance Unit Share Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails</Role>
      <ShortName>Share-Based Compensation - Restricted Stock and Performance Unit Share Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>2475442 - Disclosure - Net (Loss) Income Per Share - Reconciliation of basic and diluted EPS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/NetLossIncomePerShareReconciliationofbasicanddilutedEPSDetails</Role>
      <ShortName>Net (Loss) Income Per Share - Reconciliation of basic and diluted EPS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.avadel.com/role/NetLossIncomePerShareTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>2476443 - Disclosure - Net (Loss) Income Per Share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/NetLossIncomePerShareNarrativeDetails</Role>
      <ShortName>Net (Loss) Income Per Share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.avadel.com/role/NetLossIncomePerShareTables</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>2479444 - Disclosure - Comprehensive Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ComprehensiveLossDetails</Role>
      <ShortName>Comprehensive Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.avadel.com/role/ComprehensiveLossTables</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>2482445 - Disclosure - Company Operations by Product, Customer and Geographic Area - Revenue by Product (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebyProductDetails</Role>
      <ShortName>Company Operations by Product, Customer and Geographic Area - Revenue by Product (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>2483446 - Disclosure - Company Operations by Product, Customer and Geographic Area - Revenue by Significant Customer (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebySignificantCustomerDetails</Role>
      <ShortName>Company Operations by Product, Customer and Geographic Area - Revenue by Significant Customer (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>2484447 - Disclosure - Company Operations by Product, Customer and Geographic Area - Data by Geographic Region (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaDatabyGeographicRegionDetails</Role>
      <ShortName>Company Operations by Product, Customer and Geographic Area - Data by Geographic Region (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="avdl-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>2487448 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.avadel.com/role/SubsequentEvents</ParentRole>
      <Position>96</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="avdl-20211231.htm">avdl-20211231.htm</File>
    <File>a123121ex-1020.htm</File>
    <File>a123121ex-1021.htm</File>
    <File>a123121ex-211.htm</File>
    <File>a123121ex-231.htm</File>
    <File>a123121ex-311.htm</File>
    <File>a123121ex-312.htm</File>
    <File>a123121ex-321.htm</File>
    <File>a123121ex-322.htm</File>
    <File>avdl-20211231.xsd</File>
    <File>avdl-20211231_cal.xml</File>
    <File>avdl-20211231_def.xml</File>
    <File>avdl-20211231_lab.xml</File>
    <File>avdl-20211231_pre.xml</File>
    <File>ex1022avadel-formofexchang.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>avdl-20211231_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1058">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="40">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>141
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "avdl-20211231.htm": {
   "axisCustom": 0,
   "axisStandard": 36,
   "contextCount": 273,
   "dts": {
    "calculationLink": {
     "local": [
      "avdl-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "avdl-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "avdl-20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "avdl-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "avdl-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "avdl-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd"
     ]
    }
   },
   "elementCount": 703,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 6,
    "http://www.avadel.com/20211231": 3,
    "http://xbrl.sec.gov/dei/2021q4": 4,
    "total": 13
   },
   "keyCustom": 64,
   "keyStandard": 456,
   "memberCustom": 40,
   "memberStandard": 56,
   "nsprefix": "avdl",
   "nsuri": "http://www.avadel.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.avadel.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.avadel.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106102 - Disclosure - Newly Issued Accounting Standards",
     "role": "http://www.avadel.com/role/NewlyIssuedAccountingStandards",
     "shortName": "Newly Issued Accounting Standards",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReorganizationUnderChapter11OfUSBankruptcyCodeDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - Subsidiary Bankruptcy and Deconsolidation",
     "role": "http://www.avadel.com/role/SubsidiaryBankruptcyandDeconsolidation",
     "shortName": "Subsidiary Bankruptcy and Deconsolidation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReorganizationUnderChapter11OfUSBankruptcyCodeDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110104 - Disclosure - Disposition of the Hospital Products",
     "role": "http://www.avadel.com/role/DispositionoftheHospitalProducts",
     "shortName": "Disposition of the Hospital Products",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115105 - Disclosure - Revenue Recognition",
     "role": "http://www.avadel.com/role/RevenueRecognition",
     "shortName": "Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116106 - Disclosure - Fair Value Measurements",
     "role": "http://www.avadel.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2120107 - Disclosure - Marketable Securities",
     "role": "http://www.avadel.com/role/MarketableSecurities",
     "shortName": "Marketable Securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2125108 - Disclosure - Property and Equipment, net",
     "role": "http://www.avadel.com/role/PropertyandEquipmentnet",
     "shortName": "Property and Equipment, net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128109 - Disclosure - Goodwill and Intangible Assets",
     "role": "http://www.avadel.com/role/GoodwillandIntangibleAssets",
     "shortName": "Goodwill and Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130110 - Disclosure - Leases",
     "role": "http://www.avadel.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0002002 - Document - Audit Information",
     "role": "http://www.avadel.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135111 - Disclosure - Long-Term Debt",
     "role": "http://www.avadel.com/role/LongTermDebt",
     "shortName": "Long-Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "avdl:LongTermContingentConsideraionPayableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2139112 - Disclosure - Contingent Consideration Payable",
     "role": "http://www.avadel.com/role/ContingentConsiderationPayable",
     "shortName": "Contingent Consideration Payable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "avdl:LongTermContingentConsideraionPayableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143113 - Disclosure - Income Taxes",
     "role": "http://www.avadel.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2151114 - Disclosure - Other Assets and Liabilities",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilities",
     "shortName": "Other Assets and Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2158115 - Disclosure - Contingent Liabilities and Commitments",
     "role": "http://www.avadel.com/role/ContingentLiabilitiesandCommitments",
     "shortName": "Contingent Liabilities and Commitments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2160116 - Disclosure - Restructuring Costs",
     "role": "http://www.avadel.com/role/RestructuringCosts",
     "shortName": "Restructuring Costs",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "avdl:EquityTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2164117 - Disclosure - Equity Instruments and Transactions",
     "role": "http://www.avadel.com/role/EquityInstrumentsandTransactions",
     "shortName": "Equity Instruments and Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "avdl:EquityTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2166118 - Disclosure - Share-Based Compensation",
     "role": "http://www.avadel.com/role/ShareBasedCompensation",
     "shortName": "Share-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "if4bd641a9e3147d19bc0538e00bcf2c3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2173119 - Disclosure - Net (Loss) Income Per Share",
     "role": "http://www.avadel.com/role/NetLossIncomePerShare",
     "shortName": "Net (Loss) Income Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2177120 - Disclosure - Comprehensive Loss",
     "role": "http://www.avadel.com/role/ComprehensiveLoss",
     "shortName": "Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001003 - Statement - Consolidated Statements of (Loss) Income",
     "role": "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome",
     "shortName": "Consolidated Statements of (Loss) Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "avdl:RestructuringCostsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2180121 - Disclosure - Company Operations by Product, Customer and Geographic Area",
     "role": "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicArea",
     "shortName": "Company Operations by Product, Customer and Geographic Area",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2185122 - Disclosure - Related Party Transactions",
     "role": "http://www.avadel.com/role/RelatedPartyTransactions",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2186123 - Disclosure - Subsequent Events",
     "role": "http://www.avadel.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "avdl:NatureOfBusinessPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "avdl:NatureOfBusinessPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311302 - Disclosure - Disposition of the Hospital Business - (Tables)",
     "role": "http://www.avadel.com/role/DispositionoftheHospitalBusinessTables",
     "shortName": "Disposition of the Hospital Business - (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317303 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.avadel.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2321304 - Disclosure - Marketable Securities (Tables)",
     "role": "http://www.avadel.com/role/MarketableSecuritiesTables",
     "shortName": "Marketable Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2326305 - Disclosure - Property and Equipment, net (Tables)",
     "role": "http://www.avadel.com/role/PropertyandEquipmentnetTables",
     "shortName": "Property and Equipment, net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2331306 - Disclosure - Leases (Tables)",
     "role": "http://www.avadel.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002004 - Statement - Consolidated Statements of Comprehensive (Loss) Income",
     "role": "http://www.avadel.com/role/ConsolidatedStatementsofComprehensiveLossIncome",
     "shortName": "Consolidated Statements of Comprehensive (Loss) Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336307 - Disclosure - Long-Term Debt (Tables)",
     "role": "http://www.avadel.com/role/LongTermDebtTables",
     "shortName": "Long-Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2340308 - Disclosure - Contingent Consideration Payable (Tables)",
     "role": "http://www.avadel.com/role/ContingentConsiderationPayableTables",
     "shortName": "Contingent Consideration Payable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "avdl:ScheduleOfComponentsOfIncomeBeforeIncomeTaxTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2344309 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.avadel.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "avdl:ScheduleOfComponentsOfIncomeBeforeIncomeTaxTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2352310 - Disclosure - Other Assets and Liabilities (Tables)",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilitiesTables",
     "shortName": "Other Assets and Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2361311 - Disclosure - Restructuring Costs (Tables)",
     "role": "http://www.avadel.com/role/RestructuringCostsTables",
     "shortName": "Restructuring Costs (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2367312 - Disclosure - Share-Based Compensation (Tables)",
     "role": "http://www.avadel.com/role/ShareBasedCompensationTables",
     "shortName": "Share-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2374313 - Disclosure - Net (Loss) Income Per Share (Tables)",
     "role": "http://www.avadel.com/role/NetLossIncomePerShareTables",
     "shortName": "Net (Loss) Income Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2378314 - Disclosure - Comprehensive Loss (Tables)",
     "role": "http://www.avadel.com/role/ComprehensiveLossTables",
     "shortName": "Comprehensive Loss (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2381315 - Disclosure - Company Operations by Product, Customer and Geographic Area (Tables)",
     "role": "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaTables",
     "shortName": "Company Operations by Product, Customer and Geographic Area (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003005 - Statement - Consolidated Statements of Comprehensive (Loss) Income (Parenthetical)",
     "role": "http://www.avadel.com/role/ConsolidatedStatementsofComprehensiveLossIncomeParenthetical",
     "shortName": "Consolidated Statements of Comprehensive (Loss) Income (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i78886c225d1047eeaaea9dd1a3216a79_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment Useful Lives (Details)",
     "role": "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails",
     "shortName": "Summary of Significant Accounting Policies - Property and Equipment Useful Lives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i78886c225d1047eeaaea9dd1a3216a79_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Newly Issued Accounting Standards (Details)",
     "role": "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails",
     "shortName": "Newly Issued Accounting Standards (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i8ffb01488f3a42119218fd36f48c1d40_I20201231",
      "decimals": "4",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeconsolidationGainOrLossAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409404 - Disclosure - Subsidiary Bankruptcy and Deconsolidation (Details)",
     "role": "http://www.avadel.com/role/SubsidiaryBankruptcyandDeconsolidationDetails",
     "shortName": "Subsidiary Bankruptcy and Deconsolidation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i85c848bffc1542ceb9f02559b91119f8_D20190101-20191231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DeconsolidationGainOrLossAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412405 - Disclosure - Disposition of the Hospital Business Narrative (Details)",
     "role": "http://www.avadel.com/role/DispositionoftheHospitalBusinessNarrativeDetails",
     "shortName": "Disposition of the Hospital Business Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i9d9561d07a174b4d928f303fd47bd68b_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GainLossOnDispositionOfAssets1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i394c910852974a2b9a5ecd7ffb761fce_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413406 - Disclosure - Disposition of the Hospital Business Components of Consideration and Assets and Liabilities Either Transferred or Eliminated (Details)",
     "role": "http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails",
     "shortName": "Disposition of the Hospital Business Components of Consideration and Assets and Liabilities Either Transferred or Eliminated (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i394c910852974a2b9a5ecd7ffb761fce_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414407 - Disclosure - Disposition of the Hospital Business - Unaudited Pro Forma Condensed Combined Statement of Income (Loss) (Details)",
     "role": "http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails",
     "shortName": "Disposition of the Hospital Business - Unaudited Pro Forma Condensed Combined Statement of Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib89e2680daf342f19590ad40660e7d7c_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418408 - Disclosure - Fair Value Measurements - Measured on Recurring Basis (Details)",
     "role": "http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails",
     "shortName": "Fair Value Measurements - Measured on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i6b4d5f4b3fec4948b3a7c8a60e155623_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i4dc9b8e4c33d47f78a2c32f6fc5be381_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419409 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "role": "http://www.avadel.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i26a649c3c54c4610811b4ccf08d404fc_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "avdl:MarketableSecuritiesRealizedGain",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422410 - Disclosure - Marketable Securities - Narrative (Details)",
     "role": "http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails",
     "shortName": "Marketable Securities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "avdl:MarketableSecuritiesRealizedGain",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423411 - Disclosure - Marketable Securities - Summary of Marketable Securities (Details)",
     "role": "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails",
     "shortName": "Marketable Securities - Summary of Marketable Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004006 - Statement - Consolidated Balance Sheets",
     "role": "http://www.avadel.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424412 - Disclosure - Marketable Securities - Schedule of Maturities (Details)",
     "role": "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails",
     "shortName": "Marketable Securities - Schedule of Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i4de00269e1884c6ba19491a6f480f8c0_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427413 - Disclosure - Property and Equipment, net (Details)",
     "role": "http://www.avadel.com/role/PropertyandEquipmentnetDetails",
     "shortName": "Property and Equipment, net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429414 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)",
     "role": "http://www.avadel.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
     "shortName": "Goodwill and Intangible Assets - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432415 - Disclosure - Leases - Narrative (Details)",
     "role": "http://www.avadel.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433416 - Disclosure - Leases - Components of lease costs (Details)",
     "role": "http://www.avadel.com/role/LeasesComponentsofleasecostsDetails",
     "shortName": "Leases - Components of lease costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434417 - Disclosure - Leases - Maturities of operating lease liabilities (Details)",
     "role": "http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails",
     "shortName": "Leases - Maturities of operating lease liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437418 - Disclosure - Long-Term Debt - Schedule of Long-Term Debt Instruments (Details)",
     "role": "http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails",
     "shortName": "Long-Term Debt - Schedule of Long-Term Debt Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438419 - Disclosure - Long-Term Debt - Narrative (Details)",
     "role": "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
     "shortName": "Long-Term Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "avdl:CouponInterestExpense",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "avdl:CouponInterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DueToRelatedPartiesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441420 - Disclosure - Contingent Consideration Payable - Narrative (Details)",
     "role": "http://www.avadel.com/role/ContingentConsiderationPayableNarrativeDetails",
     "shortName": "Contingent Consideration Payable - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DueToRelatedPartiesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ie73b28a1c0c648e5a6641e1c909996f0_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442421 - Disclosure - Contingent Consideration Payable - Payable Balance (Details)",
     "role": "http://www.avadel.com/role/ContingentConsiderationPayablePayableBalanceDetails",
     "shortName": "Contingent Consideration Payable - Payable Balance (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ie19b226220734349af34ea12f273148b_I20181231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005007 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.avadel.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445422 - Disclosure - Income Taxes - Income (Loss) Before Income Taxes (Details)",
     "role": "http://www.avadel.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails",
     "shortName": "Income Taxes - Income (Loss) Before Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "avdl:ScheduleOfComponentsOfIncomeBeforeIncomeTaxTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i74b20dd17dcf4f36b4f73cfd680e44c9_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "avdl:ScheduleOfIncomeTaxPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446423 - Disclosure - Income Taxes - Income Tax Provision (Benefit) (Details)",
     "role": "http://www.avadel.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails",
     "shortName": "Income Taxes - Income Tax Provision (Benefit) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "avdl:ScheduleOfIncomeTaxPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447424 - Disclosure - Income Taxes - Reconciliation of Tax Rate (Details)",
     "role": "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails",
     "shortName": "Income Taxes - Reconciliation of Tax Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "avdl:IncreaseDecreaseInIncomeTaxBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448425 - Disclosure - Income Taxes - Additional Information (Details)",
     "role": "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails",
     "shortName": "Income Taxes - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "avdl:IncreaseDecreaseInIncomeTaxBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i99065b4abdc2484fbd3a2b99ef88c50e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449426 - Disclosure - Income Taxes - Unrecognized Tax Benefit (Details)",
     "role": "http://www.avadel.com/role/IncomeTaxesUnrecognizedTaxBenefitDetails",
     "shortName": "Income Taxes - Unrecognized Tax Benefit (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ie19b226220734349af34ea12f273148b_I20181231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450427 - Disclosure - Income Taxes - Deferred Taxes (Details)",
     "role": "http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails",
     "shortName": "Income Taxes - Deferred Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxesReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453428 - Disclosure - Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details)",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails",
     "shortName": "Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxesReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsLiabilitiesNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454429 - Disclosure - Other Assets and Liabilities - Other Non-Current Assets (Details)",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails",
     "shortName": "Other Assets and Liabilities - Other Non-Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455430 - Disclosure - Other Assets and Liabilities - Accrued Expenses (Details)",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails",
     "shortName": "Other Assets and Liabilities - Accrued Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "avdl:AccruedInterestCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456431 - Disclosure - Other Assets and Liabilities - Other Current Liabilities (Details)",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails",
     "shortName": "Other Assets and Liabilities - Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "avdl:AccruedInterestCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib3742cf8102b48d39bc674ec35e7f8d0_I20181231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006008 - Statement - Consolidated Statements of Shareholders' Equity",
     "role": "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity",
     "shortName": "Consolidated Statements of Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib3742cf8102b48d39bc674ec35e7f8d0_I20181231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "avdl:TaxLiabilitiesAndOtherNoncurrentLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457432 - Disclosure - Other Assets and Liabilities - Other Non-Current Liabilities (Details)",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails",
     "shortName": "Other Assets and Liabilities - Other Non-Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "avdl:TaxLiabilitiesAndOtherNoncurrentLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459433 - Disclosure - Contingent Liabilities and Commitments - Narrative (Details)",
     "role": "http://www.avadel.com/role/ContingentLiabilitiesandCommitmentsNarrativeDetails",
     "shortName": "Contingent Liabilities and Commitments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ia9dabd3a46c348c4af8ae3e2b161a78b_D20190101-20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462434 - Disclosure - Restructuring Costs - Narrative (Details)",
     "role": "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
     "shortName": "Restructuring Costs - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ia9dabd3a46c348c4af8ae3e2b161a78b_D20190101-20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i9fe6439ac97147e2bef805733848150d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2463435 - Disclosure - Restructuring Costs - Severance Obligation (Details)",
     "role": "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails",
     "shortName": "Restructuring Costs - Severance Obligation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i5987a3d29dec46bbb4bf5192b6d19fa6_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserveTranslationAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2465436 - Disclosure - Equity Instruments and Transactions (Details)",
     "role": "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails",
     "shortName": "Equity Instruments and Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ic33e6a0dbfbb440fb29af7e8c03ab9d7_I20200229",
      "decimals": "0",
      "lang": "en-US",
      "name": "avdl:MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468437 - Disclosure - Share-Based Compensation - Stock-based Compensation Expense (Details)",
     "role": "http://www.avadel.com/role/ShareBasedCompensationStockbasedCompensationExpenseDetails",
     "shortName": "Share-Based Compensation - Stock-based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "iebf3233476024b80bd208d93e82c7650_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2469438 - Disclosure - Share-Based Compensation - Narrative (Details)",
     "role": "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails",
     "shortName": "Share-Based Compensation - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2470439 - Disclosure - Share-Based Compensation - Fair Value Assumptions (Details)",
     "role": "http://www.avadel.com/role/ShareBasedCompensationFairValueAssumptionsDetails",
     "shortName": "Share-Based Compensation - Fair Value Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "avdl:ScheduleOfShareBasedPaymentAwardStockOptionsAndWarrantGrantsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i3404683becd24bbaa99d0f9b831bc219_D20210101-20211231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i99065b4abdc2484fbd3a2b99ef88c50e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2471440 - Disclosure - Share-Based Compensation - Stock Options (Details)",
     "role": "http://www.avadel.com/role/ShareBasedCompensationStockOptionsDetails",
     "shortName": "Share-Based Compensation - Stock Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i99065b4abdc2484fbd3a2b99ef88c50e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i9385e38dbc52477281fcde7e0e8243bf_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2472441 - Disclosure - Share-Based Compensation - Restricted Stock and Performance Unit Share Activity (Details)",
     "role": "http://www.avadel.com/role/ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails",
     "shortName": "Share-Based Compensation - Restricted Stock and Performance Unit Share Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i60cd02301b0744718ab6232fc8397080_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007009 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2475442 - Disclosure - Net (Loss) Income Per Share - Reconciliation of basic and diluted EPS (Details)",
     "role": "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofbasicanddilutedEPSDetails",
     "shortName": "Net (Loss) Income Per Share - Reconciliation of basic and diluted EPS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2476443 - Disclosure - Net (Loss) Income Per Share - Narrative (Details)",
     "role": "http://www.avadel.com/role/NetLossIncomePerShareNarrativeDetails",
     "shortName": "Net (Loss) Income Per Share - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i99065b4abdc2484fbd3a2b99ef88c50e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2479444 - Disclosure - Comprehensive Loss (Details)",
     "role": "http://www.avadel.com/role/ComprehensiveLossDetails",
     "shortName": "Comprehensive Loss (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i79413685d8144e178e42b28c2e99365b_I20181231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2482445 - Disclosure - Company Operations by Product, Customer and Geographic Area - Revenue by Product (Details)",
     "role": "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebyProductDetails",
     "shortName": "Company Operations by Product, Customer and Geographic Area - Revenue by Product (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i92daecbb51c2421fb1ccd70006b8713c_D20210101-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2483446 - Disclosure - Company Operations by Product, Customer and Geographic Area - Revenue by Significant Customer (Details)",
     "role": "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebySignificantCustomerDetails",
     "shortName": "Company Operations by Product, Customer and Geographic Area - Revenue by Significant Customer (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i961305f8256144a0921c3dcb9f63da7a_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2484447 - Disclosure - Company Operations by Product, Customer and Geographic Area - Data by Geographic Region (Details)",
     "role": "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaDatabyGeographicRegionDetails",
     "shortName": "Company Operations by Product, Customer and Geographic Area - Data by Geographic Region (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "ib45086ff0e0a4835b7367935d02327f4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i7d1ea1ea40054379a04b6e20ee96f982_I20180216",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2487448 - Disclosure - Subsequent Events (Details)",
     "role": "http://www.avadel.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20211231.htm",
      "contextRef": "i6708f8d915264e56880479e22149d123_I20220316",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 97,
   "tag": {
    "avdl_A2016MIPAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2016 MIPA [Member]",
        "label": "2016 MIPA [Member]",
        "terseLabel": "2016 MIPA"
       }
      }
     },
     "localname": "A2016MIPAMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ContingentLiabilitiesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_A2017AvadelEmployeeSharePurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2017 Avadel Employee Share Purchase Plan [Member]",
        "label": "2017 Avadel Employee Share Purchase Plan [Member]",
        "terseLabel": "2017 Avadel Employee Share Purchase Plan"
       }
      }
     },
     "localname": "A2017AvadelEmployeeSharePurchasePlanMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_A450PercentExchangeableSeniorNotesDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four Point Fifty Percent Exchangeable Senior Notes Due 2023 [Member]",
        "label": "4.50 Percent Exchangeable Senior Notes Due 2023 [Member]",
        "terseLabel": "4.50 Percent Exchangeable Senior Notes Due 2023"
       }
      }
     },
     "localname": "A450PercentExchangeableSeniorNotesDue2023Member",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.50 Percent Exchangeable Senior Notes Due October 2 2023",
        "label": "4.50 Percent Exchangeable Senior Notes Due October 2 2023 [Member]",
        "terseLabel": "4.50% Exchangeable Senior Notes Due October 2, 2023"
       }
      }
     },
     "localname": "A450PercentExchangeableSeniorNotesDueOctober22023Member",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_AccruedInterestCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Interest, Current",
        "label": "Accrued Interest, Current",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "AccruedInterestCurrent",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_AccruedOutsourceContractCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Outsource Contract Costs",
        "label": "Accrued Outsource Contract Costs",
        "terseLabel": "Accrued outsourced contract costs"
       }
      }
     },
     "localname": "AccruedOutsourceContractCosts",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_AccruedTradeDiscountsAndRebates": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for accrued discounts and rebates",
        "label": "Accrued trade discounts and rebates",
        "terseLabel": "Customer allowances"
       }
      }
     },
     "localname": "AccruedTradeDiscountsAndRebates",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_AcquisitionRelatedContingentConsiderationRemeasurement": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the remeasurement of acquisition related contingent considerations",
        "label": "Acquisition Related Contingent Consideration Remeasurement",
        "verboseLabel": "Remeasurement of acquisition-related contingent consideration"
       }
      }
     },
     "localname": "AcquisitionRelatedContingentConsiderationRemeasurement",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_AdditionalInterestExpenseDebt": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Interest Expense, Debt",
        "label": "Additional Interest Expense, Debt",
        "terseLabel": "Additional interest expense"
       }
      }
     },
     "localname": "AdditionalInterestExpenseDebt",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_AkovazMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Akovaz [Member]",
        "label": "Akovaz [Member]",
        "terseLabel": "Akovaz"
       }
      }
     },
     "localname": "AkovazMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_AmericanDepositarySharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depositary Shares [Member]",
        "label": "American Depositary Shares [Member]",
        "terseLabel": "American Depositary Shares"
       }
      }
     },
     "localname": "AmericanDepositarySharesMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/CoverPage",
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_AmericanDepositarySharesOptionPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depositary Shares, Option Price Per Share",
        "label": "American Depositary Shares, Option Price Per Share",
        "terseLabel": "ADS, option price per share (in dollars per share)"
       }
      }
     },
     "localname": "AmericanDepositarySharesOptionPricePerShare",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "avdl_AmericanDepositarySharesPremiumPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depositary Shares, Premium Percentage",
        "label": "American Depositary Shares, Premium Percentage",
        "terseLabel": "ADS premium percentage"
       }
      }
     },
     "localname": "AmericanDepositarySharesPremiumPercentage",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "avdl_AmericanDepositarySharesPurchasedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depositary Shares Purchased, Price Per Share",
        "label": "American Depositary Shares Purchased, Price Per Share",
        "verboseLabel": "ADS purchased, price per share (in dollars per share)"
       }
      }
     },
     "localname": "AmericanDepositarySharesPurchasedPricePerShare",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "avdl_AmericanDepositorySharesConversionRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depository Shares, Conversion Ratio",
        "label": "American Depository Shares, Conversion Ratio",
        "terseLabel": "ADSs, conversion ratio"
       }
      }
     },
     "localname": "AmericanDepositorySharesConversionRatio",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "avdl_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information [Abstract]",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://www.avadel.com/20211231",
     "xbrltype": "stringItemType"
    },
    "avdl_BloxiverzMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bloxiverz [Member]",
        "terseLabel": "Bloxiverz"
       }
      }
     },
     "localname": "BloxiverzMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_BloxiverzVazculepAkovazandNouressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bloxiverz, Vazculep, Akovaz and Nouress [Member]",
        "label": "Bloxiverz, Vazculep, Akovaz and Nouress [Member]",
        "terseLabel": "The Business"
       }
      }
     },
     "localname": "BloxiverzVazculepAkovazandNouressMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_BusinessCombinationChangesinRelatedPartyPayableRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Changes in Related Party Payable [Roll Forward]",
        "label": "Business Combination, Changes in Related Party Payable [Roll Forward]",
        "terseLabel": "Business Combination, Changes in Related Party Payable [Roll Forward]"
       }
      }
     },
     "localname": "BusinessCombinationChangesinRelatedPartyPayableRollForward",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ContingentConsiderationPayablePayableBalanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "avdl_CARESActCashRefundClaims": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CARES Act, Cash Refund Claims",
        "label": "CARES Act, Cash Refund Claims",
        "terseLabel": "CARES Act, cash refund claims"
       }
      }
     },
     "localname": "CARESActCashRefundClaims",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_CARESActProceedsFromIncomeTaxRefunds": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CARES Act, Proceeds From Income Tax Refunds",
        "label": "CARES Act, Proceeds From Income Tax Refunds",
        "terseLabel": "CARES Act, cash tax refunds"
       }
      }
     },
     "localname": "CARESActProceedsFromIncomeTaxRefunds",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_CerecorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cerecor [Member]",
        "label": "Cerecor [Member]",
        "terseLabel": "Cerecor"
       }
      }
     },
     "localname": "CerecorMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ContingentLiabilitiesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_ContractualObligationAnnualAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual Obligation, Annual Amount",
        "label": "Contractual Obligation, Annual Amount",
        "terseLabel": "Contractual obligation, annual amount"
       }
      }
     },
     "localname": "ContractualObligationAnnualAmount",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ContingentLiabilitiesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coronavirus Aid, Relief And Economic Security Act (CARES Act), Change in Tax Rate, Deferred Tax Liability, Income Tax Benefit",
        "label": "Coronavirus Aid, Relief And Economic Security Act (CARES Act), Change in Tax Rate, Deferred Tax Liability, Income Tax Benefit",
        "terseLabel": "CARES Act, change in tax rate, deferred tax liability, income tax benefit"
       }
      }
     },
     "localname": "CoronavirusAidReliefAndEconomicSecurityActCARESActChangeinTaxRateDeferredTaxLiabilityIncomeTaxBenefit",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_CostsIncurredPurchaseObligation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs Incurred, Purchase Obligation",
        "label": "Costs Incurred, Purchase Obligation",
        "terseLabel": "Costs incurred, purchase obligation"
       }
      }
     },
     "localname": "CostsIncurredPurchaseObligation",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ContingentLiabilitiesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_CouponInterestExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coupon Interest Expense",
        "label": "Coupon Interest Expense",
        "terseLabel": "Coupon interest expense"
       }
      }
     },
     "localname": "CouponInterestExpense",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_CustomerBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer B [Member]",
        "terseLabel": "Cardinal Health"
       }
      }
     },
     "localname": "CustomerBMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebySignificantCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_CustomerCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer C [Member]",
        "terseLabel": "AmerisourceBergen"
       }
      }
     },
     "localname": "CustomerCMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebySignificantCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_CustomerDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer D",
        "label": "Customer D [Member]",
        "terseLabel": "QuVa Pharma"
       }
      }
     },
     "localname": "CustomerDMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebySignificantCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_CustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer A [Member]",
        "terseLabel": "McKesson Corporation"
       }
      }
     },
     "localname": "CustomerMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebySignificantCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_DebtInstrumentAdditionalInterestExpensePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Additional Interest Expense, Percentage",
        "label": "Debt Instrument, Additional Interest Expense, Percentage",
        "terseLabel": "Debt instrument, additional interest expense, percentage"
       }
      }
     },
     "localname": "DebtInstrumentAdditionalInterestExpensePercentage",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "avdl_DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Business Day Period During Which Debt Can Be Converted",
        "label": "Debt Instrument, Convertible, Business Day Period During Which Debt Can Be Converted",
        "terseLabel": "Number of business days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleBusinessDayPeriodDuringWhichDebtCanBeConverted",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "avdl_DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Percentage of Product Of The Last Reported Sale Price Of The American Depositary Shares And The Exchange Rate On Each Such Trading Day",
        "label": "Debt Instrument, Convertible, Percentage of Product Of The Last Reported Sale Price Of The American Depositary Shares And The Exchange Rate On Each Such Trading Day",
        "terseLabel": "Percentage of product of the last reported sale price of the American Depositary Shares and the exchange rate on each such trading day"
       }
      }
     },
     "localname": "DebtInstrumentConvertiblePercentageOfProductOfTheLastReportedSalePriceOfTheAmericanDepositarySharesAndTheExchangeRateOnEachSuchTradingDay",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "avdl_DebtInstrumentConvertibleScheduledThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Scheduled Threshold Trading Days",
        "label": "Debt Instrument, Convertible, Scheduled Threshold Trading Days",
        "terseLabel": "Scheduled threshold trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleScheduledThresholdTradingDays",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "avdl_DebtInstrumentConvertibleThresholdConsecutiveBusinessDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Threshold Consecutive Business Days",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Business Days",
        "terseLabel": "Consecutive business days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveBusinessDays",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "avdl_DebtInstrumentOptiontoIncreaseFaceAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Option to Increase Face Amount",
        "label": "Debt Instrument, Option to Increase Face Amount",
        "terseLabel": "Option to increase aggregate principal amount"
       }
      }
     },
     "localname": "DebtInstrumentOptiontoIncreaseFaceAmount",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_DeferredTaxAssetsAmortizationofIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Amortization of Intangible Assets",
        "label": "Deferred Tax Assets, Amortization of Intangible Assets",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "DeferredTaxAssetsAmortizationofIntangibleAssets",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Tax Credit Carryforwards, Orphan Drug And Research",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Orphan Drug And Research",
        "terseLabel": "Orphan drug and R&amp;D tax credit"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsOrphanDrugAndResearch",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Additional Consideration Paid In Monthly Installments",
        "label": "Disposal Group, Including Discontinued Operation, Additional Consideration Paid In Monthly Installments",
        "terseLabel": "Additional consideration paid in monthly installments"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAdditionalConsiderationPaidInMonthlyInstallments",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Initial Cash Consideration",
        "label": "Disposal Group, Including Discontinued Operation, Initial Cash Consideration",
        "terseLabel": "Initial cash consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInitialCashConsideration",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Payment Installment Term",
        "label": "Disposal Group, Including Discontinued Operation, Payment Installment Term",
        "terseLabel": "Payment installment term (in months)"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPaymentInstallmentTerm",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "avdl_EarnOutPaymentInExcessOfAcquisitionDateFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the Earn Out Payment In Excess Of Acquisition Date Fair Value",
        "label": "Earn Out Payment In Excess Of Acquisition Date Fair Value",
        "negatedTerseLabel": "Earn-out payments for contingent consideration in excess of acquisition-date fair value"
       }
      }
     },
     "localname": "EarnOutPaymentInExcessOfAcquisitionDateFairValue",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Amount, Orphan Drug and Research And Development Tax Credit",
        "label": "Effective Income Tax Rate Reconciliation, Amount, Orphan Drug and Research And Development Tax Credit",
        "negatedTerseLabel": "Orphan drug and R&amp;D tax credit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAmountOrphanDrugAndResearchAndDevelopmentTaxCredit",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Intercompany Asset Transfer, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Intercompany Asset Transfer, Amount",
        "verboseLabel": "Intercompany asset transfer"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationIntercompanyAssetTransferAmount",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Interest Expense, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Interest Expense, Amount",
        "terseLabel": "Nondeductible interest expense"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestExpenseAmount",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_EquityTransactionsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Transactions Disclosure",
        "label": "Equity Transactions Disclosure [Text Block]",
        "terseLabel": "Equity Instruments and Transactions"
       }
      }
     },
     "localname": "EquityTransactionsDisclosureTextBlock",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/EquityInstrumentsandTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "avdl_FSCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "FSC [Member]",
        "label": "FSC [Member]",
        "terseLabel": "FSC"
       }
      }
     },
     "localname": "FSCMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ContingentLiabilitiesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_FinancingRelatedContingentConsiderationRemeasurement": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the remeasurement of financing related contingent considerations",
        "label": "Financing Related Contingent Consideration Remeasurement",
        "terseLabel": "Remeasurement of financing-related contingent consideration"
       }
      }
     },
     "localname": "FinancingRelatedContingentConsiderationRemeasurement",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_FourPointFiftyPercentExchangeableSeniorNotesDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four Point Fifty Percent Exchangeable Senior Notes Due 2023 [Member]",
        "label": "Four Point Fifty Percent Exchangeable Senior Notes Due 2023 [Member]",
        "terseLabel": "4.50% Exchangeable Senior Notes Due 2023"
       }
      }
     },
     "localname": "FourPointFiftyPercentExchangeableSeniorNotesDue2023Member",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_FreeShareAwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Free Share Award [Member]",
        "terseLabel": "Free Share Award"
       }
      }
     },
     "localname": "FreeShareAwardMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_FscHoldingsLlcMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FSC Holdings, LLC [Member]",
        "terseLabel": "FSC"
       }
      }
     },
     "localname": "FscHoldingsLlcMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_GuaranteeCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee, Current",
        "label": "Guarantee, Current",
        "verboseLabel": "Guarantee from Armistice"
       }
      }
     },
     "localname": "GuaranteeCurrent",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_GuaranteeNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee, Noncurrent",
        "label": "Guarantee, Noncurrent",
        "terseLabel": "Guarantee from Armistice"
       }
      }
     },
     "localname": "GuaranteeNoncurrent",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_IncomeTaxesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes [Line Items]",
        "terseLabel": "Income Taxes [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxesLineItems",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.avadel.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "avdl_IncomeTaxesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes [Table]",
        "terseLabel": "Income Taxes [Table]"
       }
      }
     },
     "localname": "IncomeTaxesTable",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.avadel.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "avdl_IncreaseDecreaseInIncomeTaxBenefit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Income Tax Benefit",
        "label": "Increase (Decrease) In Income Tax Benefit",
        "terseLabel": "Increase (decrease) in income tax benefit"
       }
      }
     },
     "localname": "IncreaseDecreaseInIncomeTaxBenefit",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in research and development tax credit receivable.",
        "label": "Increase (Decrease) In Research and Development Tax Credit Receivable",
        "negatedLabel": "Research and development tax credit receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_InducementPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inducement Plan",
        "label": "Inducement Plan [Member]",
        "terseLabel": "Inducement Plan"
       }
      }
     },
     "localname": "InducementPlanMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_LeaseholdImprovementsFurnitureFixturesAndFittingsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leasehold Improvements, Furniture, Fixtures And Fittings [Member]",
        "label": "Leasehold Improvements, Furniture, Fixtures And Fittings [Member]",
        "terseLabel": "Leasehold improvements, furniture, fixtures and fittings"
       }
      }
     },
     "localname": "LeaseholdImprovementsFurnitureFixturesAndFittingsMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_LongTermContingentConsideraionPayableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Contingent Consideraion Payable [Text Block]",
        "terseLabel": "Contingent Consideration Payable"
       }
      }
     },
     "localname": "LongTermContingentConsideraionPayableTextBlock",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ContingentConsiderationPayable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "avdl_MarketableSecuritiesRealizedGain": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable Securities, Realized Gain",
        "label": "Marketable Securities, Realized Gain",
        "terseLabel": "Marketable securities, realized gains"
       }
      }
     },
     "localname": "MarketableSecuritiesRealizedGain",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_MarketableSecuritiesRealizedLoss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable Securities, Realized Loss",
        "label": "Marketable Securities, Realized Loss",
        "terseLabel": "Marketable securities, realized loss"
       }
      }
     },
     "localname": "MarketableSecuritiesRealizedLoss",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum Aggregate Offering Price of American Depositary Shares Under Shelf Registration",
        "label": "Maximum Aggregate Offering Price of American Depositary Shares Under Shelf Registration",
        "terseLabel": "Maximum aggregate offering price of ADSs under shelf registration"
       }
      }
     },
     "localname": "MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum Aggregate Offering Price of Securities Under Shelf Registration",
        "label": "Maximum Aggregate Offering Price of Securities Under Shelf Registration",
        "terseLabel": "Maximum aggregate offering price of securities under shelf registration"
       }
      }
     },
     "localname": "MaximumAggregateOfferingPriceofSecuritiesUnderShelfRegistration",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum Threshold Percentage For Trigger Of Convertible Preferred Stock",
        "label": "Maximum Threshold Percentage For Trigger Of Convertible Preferred Stock",
        "terseLabel": "Maximum threshold percentage for trigger of convertible preferred stock"
       }
      }
     },
     "localname": "MaximumThresholdPercentageForTriggerOfConvertiblePreferredStock",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "avdl_NatureOfBusinessPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for nature of business.",
        "label": "Nature Of Business Policy [Policy Text Block]",
        "terseLabel": "Nature of Operations"
       }
      }
     },
     "localname": "NatureOfBusinessPolicyPolicyTextBlock",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "avdl_NoncashGainLossDeconsolidationOfSubsidiary": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Gain (Loss) Deconsolidation Of Subsidiary",
        "label": "Noncash Gain (Loss) Deconsolidation Of Subsidiary",
        "negatedTerseLabel": "Loss on deconsolidation of subsidiary"
       }
      }
     },
     "localname": "NoncashGainLossDeconsolidationOfSubsidiary",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Right-Of-Use Asset, Contract Manufacturing, Noncurrent",
        "label": "Operating Lease, Right-Of-Use Asset, Contract Manufacturing, Noncurrent",
        "terseLabel": "Right of use assets at contract manufacturing organizations"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_OrdinaryShareNominalValue001PerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ordinary Share, Nominal Value $0.01 Per Share",
        "label": "Ordinary Share, Nominal Value $0.01 Per Share [Member]",
        "terseLabel": "Ordinary Share, Nominal Value $0.01 Per Share"
       }
      }
     },
     "localname": "OrdinaryShareNominalValue001PerShareMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_OtherCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Customers [Member]",
        "terseLabel": "Others"
       }
      }
     },
     "localname": "OtherCustomersMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebySignificantCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_OtherGuarantorObligationsCurrentCarryingValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Guarantor Obligations, Current Carrying Value",
        "label": "Other Guarantor Obligations, Current Carrying Value",
        "terseLabel": "Guarantee to Deerfield"
       }
      }
     },
     "localname": "OtherGuarantorObligationsCurrentCarryingValue",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_OtherLiabilitiesMiscellaneousCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Liabilities, Miscellaneous, Current",
        "label": "Other Liabilities, Miscellaneous, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherLiabilitiesMiscellaneousCurrent",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_OtherNoncurrentReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of other noncurrent receivables.",
        "label": "Other Noncurrent Receivables",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncurrentReceivables",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_OtherProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Products [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherProductsMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_PercentageOfRoyaltyPayableOnNetSales": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of royalty that has to be paid by the company as per the royalty agreement.",
        "label": "Percentage Of Royalty Payable On Net Sales",
        "terseLabel": "Percentage of royalty payable on net sales"
       }
      }
     },
     "localname": "PercentageOfRoyaltyPayableOnNetSales",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ContingentLiabilitiesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "avdl_PublicOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public Offering [Member]",
        "label": "Public Offering [Member]",
        "terseLabel": "Public Offering"
       }
      }
     },
     "localname": "PublicOfferingMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Tax Credit Receivable, Current",
        "label": "Research And Development Tax Credit Receivable, Current",
        "verboseLabel": "Research and development tax credit receivable"
       }
      }
     },
     "localname": "ResearchAndDevelopmentTaxCreditReceivableCurrent",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The non current portion of tax credit receivable on research and development as on the balance sheet date.",
        "label": "Research and Development Tax Credit Receivable Non Current",
        "terseLabel": "Research and development tax credit receivable"
       }
      }
     },
     "localname": "ResearchAndDevelopmentTaxCreditReceivableNonCurrent",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_RestrictedShareAwardsGrantedFrom20172020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Share Awards Granted From 2017-2020",
        "label": "Restricted Share Awards Granted From 2017-2020 [Member]",
        "terseLabel": "Restricted Share Awards Granted From 2017-2020"
       }
      }
     },
     "localname": "RestrictedShareAwardsGrantedFrom20172020Member",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_RestrictedShareAwardsGrantedToEmployeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Share Awards Granted To Employees",
        "label": "Restricted Share Awards Granted To Employees [Member]",
        "terseLabel": "Restricted Share Awards Granted To Employees"
       }
      }
     },
     "localname": "RestrictedShareAwardsGrantedToEmployeesMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_RestrictedShareAwardsGrantsBeginningIn2018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Share Awards, Grants Beginning In 2018",
        "label": "Restricted Share Awards, Grants Beginning In 2018 [Member]",
        "terseLabel": "Restricted Share Awards, Grants Beginning In 2018"
       }
      }
     },
     "localname": "RestrictedShareAwardsGrantsBeginningIn2018Member",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring And Related Costs, Expected Number Of Positions Eliminated, Percent",
        "label": "Restructuring And Related Costs, Expected Number Of Positions Eliminated, Percent",
        "terseLabel": "Percent reduction in workforce"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "avdl_RestructuringChargesBeforeGainLossDuetoCurtailment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Charges Before Gain (Loss) Due to Curtailment",
        "label": "Restructuring Charges Before Gain (Loss) Due to Curtailment",
        "terseLabel": "(Benefit) charges for employee severance, benefits and other costs"
       }
      }
     },
     "localname": "RestructuringChargesBeforeGainLossDuetoCurtailment",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_RestructuringCostsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome": {
       "order": 7.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Costs, Net",
        "label": "Restructuring Costs, Net",
        "terseLabel": "Restructuring (income) costs"
       }
      }
     },
     "localname": "RestructuringCostsNet",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_RetirementIndemnityObligationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retirement Indemnity Obligation [Member]",
        "label": "Retirement Indemnity Obligation [Member]",
        "terseLabel": "Retirement Indemnity Obligation"
       }
      }
     },
     "localname": "RetirementIndemnityObligationMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_RoyaltyPayableonNetSalesMaximum": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty Payable on Net Sales, Maximum",
        "label": "Royalty Payable on Net Sales, Maximum",
        "terseLabel": "Royalty payable on net sales, maximum"
       }
      }
     },
     "localname": "RoyaltyPayableonNetSalesMaximum",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ContingentLiabilitiesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_SaleOfStockConsiderationReceivedOnTransactionGross": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Consideration Received On Transaction, Gross",
        "label": "Sale Of Stock, Consideration Received On Transaction, Gross",
        "terseLabel": "Public offering, proceeds"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransactionGross",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_ScheduleOfComponentsOfIncomeBeforeIncomeTaxTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of income before income tax.",
        "label": "Schedule Of Components Of Income Before Income Tax [Table Text Block]",
        "verboseLabel": "Schedule Of Components Of Loss Before Income Tax"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeBeforeIncomeTaxTableTextBlock",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "avdl_ScheduleOfIncomeTaxPaymentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of scheduled payments of income tax.",
        "label": "Schedule Of Income Tax Payments [Table Text Block]",
        "terseLabel": "Schedule Of Income Tax (Benefit) Provision"
       }
      }
     },
     "localname": "ScheduleOfIncomeTaxPaymentsTableTextBlock",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of prepaid expenses and other current assets.",
        "label": "Schedule Of Prepaid Expenses and Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule of Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "avdl_ScheduleOfShareBasedPaymentAwardStockOptionsAndWarrantGrantsValuationAssumptionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options and Warrants grants.",
        "label": "Schedule Of Share Based Payment Award Stock Options And Warrant Grants Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Share Based Payment Award Stock Options and Warrant Grants Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsAndWarrantGrantsValuationAssumptionsTableTextBlock",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "avdl_SharebasedCompensationAwardTrancheFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Award, Tranche Four [Member]",
        "label": "Share-based Compensation Award, Tranche Four [Member]",
        "terseLabel": "1/3 vesting at third anniversary of grant date"
       }
      }
     },
     "localname": "SharebasedCompensationAwardTrancheFourMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_ShortTermNoteReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short Term Note Receivable",
        "label": "Short Term Note Receivable",
        "terseLabel": "Receivable from Exela (see Note 4)"
       }
      }
     },
     "localname": "ShortTermNoteReceivable",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Software and Software Development Costs, Office Equipment, and Computer Equipment [Member]",
        "label": "Software and Software Development Costs, Office Equipment, and Computer Equipment [Member]",
        "terseLabel": "Software, office and computer equipment"
       }
      }
     },
     "localname": "SoftwareandSoftwareDevelopmentCostsOfficeEquipmentandComputerEquipmentMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/PropertyandEquipmentnetDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_SpecialityPharamaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Speciality Pharama [Member]",
        "label": "Speciality Pharama [Member]",
        "terseLabel": "Speciality Pharama"
       }
      }
     },
     "localname": "SpecialityPharamaMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_SpecialtyPharmaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specialty Pharma [Member]",
        "label": "Specialty Pharma [Member]",
        "terseLabel": "Specialty Pharma"
       }
      }
     },
     "localname": "SpecialtyPharmaMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/SubsidiaryBankruptcyandDeconsolidationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_StockIssuedDuringPeriodSharesPublicOffering": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Shares, Public Offering",
        "label": "Stock Issued During Period, Shares, Public Offering",
        "terseLabel": "May 2020 public offering (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesPublicOffering",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "avdl_StockIssuedDuringPeriodValuePublicOffering": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value Public Offering",
        "label": "Stock Issued During Period, Value Public Offering",
        "terseLabel": "May 2020 public offering"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValuePublicOffering",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Liabilities And Other Noncurrent Liabilities",
        "label": "Tax Liabilities And Other Noncurrent Liabilities",
        "terseLabel": "Tax liabilities and other"
       }
      }
     },
     "localname": "TaxLiabilitiesAndOtherNoncurrentLiabilities",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_TwoThousandNineteenCorporateFrenchRestructuringObligationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Nineteen Corporate French Restructuring Obligation [Member]",
        "label": "Two Thousand Nineteen Corporate French Restructuring Obligation [Member]",
        "terseLabel": "2019 French Restructuring Obligation"
       }
      }
     },
     "localname": "TwoThousandNineteenCorporateFrenchRestructuringObligationMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_TwoThousandNineteenCorporateRestructuringObligationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Nineteen Corporate Restructuring Obligations [Member]",
        "label": "Two Thousand Nineteen Corporate Restructuring Obligations [Member]",
        "terseLabel": "2019 Corporate Restructuring Obligations"
       }
      }
     },
     "localname": "TwoThousandNineteenCorporateRestructuringObligationsMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_U.S.HoldingsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. Holdings [Member]",
        "label": "U.S. Holdings [Member]",
        "terseLabel": "U.S. Holdings"
       }
      }
     },
     "localname": "U.S.HoldingsMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_VazculepMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vazculep [Member]",
        "terseLabel": "Vazculep"
       }
      }
     },
     "localname": "VazculepMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_VestOneYearFollowingAchievementOfCertainCorporateObjectivesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vest One Year Following Achievement Of Certain Corporate Objectives",
        "label": "Vest One Year Following Achievement Of Certain Corporate Objectives [Member]",
        "terseLabel": "Vest One Year Following Achievement Of Certain Corporate Objectives"
       }
      }
     },
     "localname": "VestOneYearFollowingAchievementOfCertainCorporateObjectivesMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_VestOneYearFollowingAchievementOfMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vest One Year Following Achievement Of Milestones",
        "label": "Vest One Year Following Achievement Of Milestones [Member]",
        "terseLabel": "Vest One Year Following Achievement Of Milestones"
       }
      }
     },
     "localname": "VestOneYearFollowingAchievementOfMilestonesMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_VestUponAchievementOfCertainCorporateObjectivesBeingMetAndExceededMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vest Upon Achievement Of Certain Corporate Objectives Being Met And Exceeded",
        "label": "Vest Upon Achievement Of Certain Corporate Objectives Being Met And Exceeded [Member]",
        "terseLabel": "Vest Upon Achievement Of Certain Corporate Objectives Being Met And Exceeded"
       }
      }
     },
     "localname": "VestUponAchievementOfCertainCorporateObjectivesBeingMetAndExceededMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_VestUponAchievementOfCertainCorporateObjectivesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vest Upon Achievement Of Certain Corporate Objectives",
        "label": "Vest Upon Achievement Of Certain Corporate Objectives [Member]",
        "terseLabel": "Vest Upon Achievement Of Certain Corporate Objectives"
       }
      }
     },
     "localname": "VestUponAchievementOfCertainCorporateObjectivesMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_VestUponTheAchievementOfCertainRegulatoryMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vest Upon The Achievement Of Certain Regulatory Milestones",
        "label": "Vest Upon The Achievement Of Certain Regulatory Milestones [Member]",
        "terseLabel": "Vest Upon The Achievement Of Certain Regulatory Milestones"
       }
      }
     },
     "localname": "VestUponTheAchievementOfCertainRegulatoryMilestonesMember",
     "nsuri": "http://www.avadel.com/20211231",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_FR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FRANCE",
        "terseLabel": "France"
       }
      }
     },
     "localname": "FR",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaDatabyGeographicRegionDetails",
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.avadel.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_IE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "IRELAND",
        "terseLabel": "Ireland"
       }
      }
     },
     "localname": "IE",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaDatabyGeographicRegionDetails",
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.avadel.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "U.S."
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaDatabyGeographicRegionDetails",
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.avadel.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r783",
      "r784",
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r783",
      "r784",
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r783",
      "r784",
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r783",
      "r784",
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r794"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r783",
      "r784",
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r782"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.avadel.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "sic_Z8880": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "8880 American Depositary Receipts [Member]",
        "terseLabel": "American Depositary Receipts"
       }
      }
     },
     "localname": "Z8880",
     "nsuri": "http://xbrl.sec.gov/sic/2021",
     "presentation": [
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r154",
      "r166",
      "r173",
      "r265",
      "r486",
      "r487",
      "r488",
      "r529",
      "r530",
      "r569",
      "r572",
      "r575",
      "r576",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r154",
      "r166",
      "r173",
      "r265",
      "r486",
      "r487",
      "r488",
      "r529",
      "r530",
      "r569",
      "r572",
      "r575",
      "r576",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r154",
      "r166",
      "r173",
      "r265",
      "r486",
      "r487",
      "r488",
      "r529",
      "r530",
      "r569",
      "r572",
      "r575",
      "r576",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "terseLabel": "Board of Directors"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SubsidiaryBankruptcyandDeconsolidationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r234",
      "r421",
      "r425",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebySignificantCustomerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r358",
      "r389",
      "r441",
      "r444",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r685",
      "r743",
      "r747",
      "r776",
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LeasesNarrativeDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r358",
      "r389",
      "r441",
      "r444",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r685",
      "r743",
      "r747",
      "r776",
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LeasesNarrativeDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r234",
      "r421",
      "r425",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebySignificantCustomerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProFormaMember": {
     "auth_ref": [
      "r173",
      "r330",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pro Forma [Member]",
        "terseLabel": "Pro Forma"
       }
      }
     },
     "localname": "ProFormaMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r228",
      "r421",
      "r423",
      "r688",
      "r742",
      "r744"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebyProductDetails",
      "http://www.avadel.com/role/ContingentLiabilitiesandCommitmentsNarrativeDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r228",
      "r421",
      "r423",
      "r688",
      "r742",
      "r744"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebyProductDetails",
      "http://www.avadel.com/role/ContingentLiabilitiesandCommitmentsNarrativeDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r358",
      "r389",
      "r431",
      "r441",
      "r444",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r685",
      "r743",
      "r747",
      "r776",
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LeasesNarrativeDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r358",
      "r389",
      "r431",
      "r441",
      "r444",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r685",
      "r743",
      "r747",
      "r776",
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LeasesNarrativeDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAdjustmentMember": {
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r157",
      "r158",
      "r163",
      "r164",
      "r166",
      "r168",
      "r169",
      "r171",
      "r172",
      "r190",
      "r575",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Adjustment [Member]",
        "terseLabel": "Pro Forma Adjustments"
       }
      }
     },
     "localname": "RestatementAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r3",
      "r151",
      "r152",
      "r153",
      "r157",
      "r158",
      "r163",
      "r164",
      "r165",
      "r166",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r190",
      "r268",
      "r269",
      "r490",
      "r530",
      "r570",
      "r575",
      "r576",
      "r577",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r799",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r3",
      "r151",
      "r152",
      "r153",
      "r157",
      "r158",
      "r163",
      "r164",
      "r165",
      "r166",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r190",
      "r268",
      "r269",
      "r490",
      "r530",
      "r570",
      "r575",
      "r576",
      "r577",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r799",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Revision of Prior Period [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "auth_ref": [
      "r3",
      "r151",
      "r153",
      "r157",
      "r158",
      "r163",
      "r164",
      "r165",
      "r166",
      "r168",
      "r169",
      "r171",
      "r172",
      "r190",
      "r268",
      "r269",
      "r490",
      "r530",
      "r570",
      "r575",
      "r576",
      "r577",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r799",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previously Reported [Member]",
        "terseLabel": "As Reported"
       }
      }
     },
     "localname": "ScenarioPreviouslyReportedMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r167",
      "r173",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario, Unspecified [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SubsidiaryBankruptcyandDeconsolidationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r229",
      "r230",
      "r421",
      "r424",
      "r745",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaDatabyGeographicRegionDetails",
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.avadel.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r229",
      "r230",
      "r421",
      "r424",
      "r745",
      "r762",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaDatabyGeographicRegionDetails",
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.avadel.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r167",
      "r173",
      "r330",
      "r442",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r236",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Relationship to Entity [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Changes and Error Corrections [Abstract]",
        "terseLabel": "Accounting Changes and Error Corrections [Abstract]"
       }
      }
     },
     "localname": "AccountingChangesAndErrorCorrectionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r157",
      "r158",
      "r159",
      "r161",
      "r239",
      "r240",
      "r262",
      "r263",
      "r264",
      "r265",
      "r268",
      "r269",
      "r340",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r490",
      "r529",
      "r530",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r574",
      "r575",
      "r576",
      "r577",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r599",
      "r600",
      "r635",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible Enumeration]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r65",
      "r649"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "totalLabel": "Total",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets",
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "terseLabel": "Accrued Liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r36",
      "r37",
      "r69"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Salaries, Current",
        "verboseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r63",
      "r299"
     ],
     "calculation": {
      "http://www.avadel.com/role/PropertyandEquipmentnetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less - accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/PropertyandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r84",
      "r85",
      "r86",
      "r91",
      "r99",
      "r100",
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]",
        "terseLabel": "Unrealized gain (loss) on marketable securities, net"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r54",
      "r88",
      "r90",
      "r91",
      "r729",
      "r755",
      "r759"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r99",
      "r100",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r87",
      "r91",
      "r99",
      "r100",
      "r101",
      "r151",
      "r152",
      "r153",
      "r555",
      "r750",
      "r751",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveLossDetails",
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r82",
      "r91",
      "r99",
      "r100",
      "r101",
      "r555",
      "r606",
      "r607",
      "r608",
      "r609",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r486",
      "r487",
      "r488",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r446",
      "r449",
      "r493",
      "r494"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "verboseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "auth_ref": [
      "r394",
      "r401"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "terseLabel": "Issuance costs recorded as a reduction to additional paid-in capital"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net (loss) income to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising Expenses"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingMember": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Announcement promoting product, service, or event.",
        "label": "Advertising [Member]",
        "terseLabel": "Advertising"
       }
      }
     },
     "localname": "AdvertisingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r449",
      "r478",
      "r492"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.avadel.com/role/ShareBasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r133",
      "r371",
      "r380",
      "r381",
      "r616"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt discount and debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r133",
      "r288",
      "r290"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Intangible asset amortization"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails",
      "http://www.avadel.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "verboseLabel": "Antidilutive securities excluded from computation of earnings per share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/NetLossIncomePerShareNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r133",
      "r295"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Impairment loss related to goodwill or intangible assets"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r143",
      "r212",
      "r217",
      "r224",
      "r261",
      "r341",
      "r342",
      "r343",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r352",
      "r353",
      "r552",
      "r558",
      "r589",
      "r643",
      "r649",
      "r697",
      "r727"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r32",
      "r34",
      "r81",
      "r143",
      "r261",
      "r341",
      "r342",
      "r343",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r352",
      "r353",
      "r552",
      "r558",
      "r589",
      "r643",
      "r649"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r578"
     ],
     "calculation": {
      "http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r247"
     ],
     "calculation": {
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r248"
     ],
     "calculation": {
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r245",
      "r275"
     ],
     "calculation": {
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Adjusted Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r249",
      "r252",
      "r718"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "5-10 Years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r249",
      "r251",
      "r717"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "1-5 Years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "auth_ref": [
      "r249",
      "r253",
      "r719"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Greater than 10 Years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r249",
      "r250",
      "r716"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Less than 1 Year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r243",
      "r246",
      "r275",
      "r704"
     ],
     "calculation": {
      "http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      },
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Fair Value",
        "verboseLabel": "Marketable securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]",
        "terseLabel": "Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r450",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.avadel.com/role/ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r560",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of bankruptcy claim filed with bankruptcy court that are likely to be denied.",
        "label": "Bankruptcy Claims, Amount of Filed Claims Likely to be Denied",
        "terseLabel": "Bankruptcy claims, amount of filed claims likely to be denied"
       }
      }
     },
     "localname": "BankruptcyClaimsAmountOfFiledClaimsLikelyToBeDenied",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r440",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r440",
      "r443",
      "r545",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionContingentConsiderationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition, Contingent Consideration [Line Items]",
        "terseLabel": "Business Acquisition, Contingent Consideration [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SubsidiaryBankruptcyandDeconsolidationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r544"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "verboseLabel": "Changes in fair value of contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized": {
     "auth_ref": [
      "r547"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount, measured at acquisition-date fair value, of all liabilities assumed that arise from contingencies and were recognized by the entity.",
        "label": "Business Combination, Liabilities Arising from Contingencies, Amount Recognized",
        "periodEndLabel": "Related party payable, ending balance",
        "periodStartLabel": "Related party payable, beginning balance"
       }
      }
     },
     "localname": "BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ContingentConsiderationPayablePayableBalanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r29",
      "r60",
      "r135"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r39",
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).",
        "label": "Cash, Cash Equivalents, and Marketable Securities [Text Block]",
        "verboseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "CashCashEquivalentsAndMarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r128",
      "r135",
      "r138"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at December 31",
        "periodStartLabel": "Cash and cash equivalents at January 1"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r128",
      "r603"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r141",
      "r143",
      "r178",
      "r179",
      "r180",
      "r183",
      "r186",
      "r194",
      "r195",
      "r196",
      "r261",
      "r341",
      "r346",
      "r347",
      "r348",
      "r352",
      "r353",
      "r387",
      "r388",
      "r391",
      "r392",
      "r589",
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CoverPage",
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r326",
      "r327",
      "r328",
      "r335",
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Contingent Liabilities and Commitments"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ContingentLiabilitiesandCommitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Number of shares reserved and available for issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r151",
      "r152",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Ordinary shares",
        "verboseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails",
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Ordinary shares, nominal value (in usd per share)",
        "verboseLabel": "Ordinary shares, nominal value (in usd or euro per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails",
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Ordinary shares, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Ordinary shares, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r51",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Ordinary shares, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r51",
      "r649"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Ordinary shares, nominal value of $0.01 per share; 500,000 shares authorized;\u00a058,620 and 58,396 issued and outstanding at December 31, 2021 and 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r94",
      "r96",
      "r97",
      "r106",
      "r711",
      "r738"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofComprehensiveLossIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "terseLabel": "Net other comprehensive (loss) income",
        "totalLabel": "Total comprehensive (loss) income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveLossDetails",
      "http://www.avadel.com/role/ConsolidatedStatementsofComprehensiveLossIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r105",
      "r115",
      "r710",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r354",
      "r355",
      "r356",
      "r358",
      "r362",
      "r363",
      "r364",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r378",
      "r379",
      "r380",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible Debt"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r432",
      "r439",
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r110",
      "r688"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "verboseLabel": "Cost of products"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldAmortization": {
     "auth_ref": [
      "r108"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.",
        "label": "Cost, Amortization",
        "terseLabel": "Charges against additional paid-in capital"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "terseLabel": "Operating expenses",
        "totalLabel": "Total operating expenses",
        "verboseLabel": "Total operating expense"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "verboseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Federal, State and Local, Tax Expense (Benefit) [Abstract]",
        "verboseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r144",
      "r523",
      "r536"
     ],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "verboseLabel": "U.S. - Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r144",
      "r523",
      "r536",
      "r538"
     ],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r144",
      "r523",
      "r536"
     ],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "verboseLabel": "U.S. - State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r43",
      "r45",
      "r46",
      "r142",
      "r149",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r378",
      "r379",
      "r380",
      "r381",
      "r617",
      "r698",
      "r700",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r46",
      "r374",
      "r700",
      "r725"
     ],
     "calculation": {
      "http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Long-term debt, gross",
        "verboseLabel": "Principal amount of 4.50% exchangeable senior notes due 2023"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": {
     "auth_ref": [
      "r373"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.",
        "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component",
        "negatedTerseLabel": "Equity component of exchangeable notes, net of issuance costs"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Threshold percentage of stock price trigger"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Threshold trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r355",
      "r378",
      "r379",
      "r615",
      "r617",
      "r618"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "verboseLabel": "Debt instrument, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r72",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r73",
      "r142",
      "r149",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r378",
      "r379",
      "r380",
      "r381",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period One"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": {
     "auth_ref": [
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Three [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Three"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Two"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r73",
      "r142",
      "r149",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r378",
      "r379",
      "r380",
      "r381",
      "r395",
      "r398",
      "r399",
      "r400",
      "r614",
      "r615",
      "r617",
      "r618",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r362",
      "r375",
      "r378",
      "r379",
      "r616"
     ],
     "calculation": {
      "http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "negatedTerseLabel": "Less: unamortized debt discount and issuance costs, net"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "verboseLabel": "Schedule of Available-for-sale Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesMember": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions.",
        "label": "Debt Securities [Member]",
        "terseLabel": "Debt Securities"
       }
      }
     },
     "localname": "DebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeconsolidationGainOrLossAmount": {
     "auth_ref": [
      "r556"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from deconsolidation of subsidiary and derecognition of group of assets constituting transfer of business or nonprofit activity, excluding conveyance of oil and gas mineral rights and transfer of good or service in contract with customer.",
        "label": "Deconsolidation, Gain (Loss), Amount",
        "negatedLabel": "Charge for deconsolidation of subsidiary",
        "terseLabel": "Loss on deconsolidation of subsidiary"
       }
      }
     },
     "localname": "DeconsolidationGainOrLossAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome",
      "http://www.avadel.com/role/SubsidiaryBankruptcyandDeconsolidationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount": {
     "auth_ref": [
      "r557"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from remeasurement to fair value of retained investment in former subsidiary and group of assets constituting business or nonprofit activity deconsolidated and derecognized, excluding conveyance of oil and gas mineral rights and transfer of product or service in contract with customer.",
        "label": "Deconsolidation, Revaluation of Retained Investment, Gain (Loss), Amount",
        "negatedTerseLabel": "Gain from release of certain liabilities",
        "terseLabel": "Gain from release of certain liabilities"
       }
      }
     },
     "localname": "DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome",
      "http://www.avadel.com/role/SubsidiaryBankruptcyandDeconsolidationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r144",
      "r524",
      "r536"
     ],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "U.S. - Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r144",
      "r524",
      "r536"
     ],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Ireland"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r133",
      "r144",
      "r524",
      "r536",
      "r537",
      "r538"
     ],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income tax expense (benefit)",
        "totalLabel": "Total deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.avadel.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r47",
      "r48",
      "r514",
      "r699",
      "r724"
     ],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Gross deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r144",
      "r524",
      "r536"
     ],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "U.S. - State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r515"
     ],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Gross deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r517"
     ],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "terseLabel": "Deferred tax assets (see Note 13)",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails",
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net [Abstract]",
        "verboseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r521",
      "r522"
     ],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "verboseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r521",
      "r522"
     ],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r520",
      "r521",
      "r522"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "verboseLabel": "Deferred tax assets, tax credit carryforwards, research"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r521",
      "r522"
     ],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r516"
     ],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Less: valuation allowances"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Net [Abstract]",
        "verboseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r521",
      "r522"
     ],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPrepaidExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.",
        "label": "Deferred Tax Liabilities, Prepaid Expenses",
        "negatedTerseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPrepaidExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesDeferredTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r133",
      "r297"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "verboseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/PropertyandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r133",
      "r297"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "verboseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "auth_ref": [
      "r450",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of share-based payment arrangement.",
        "label": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]",
        "terseLabel": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining": {
     "auth_ref": [
      "r27",
      "r329",
      "r331",
      "r332",
      "r333",
      "r334",
      "r338"
     ],
     "calculation": {
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts of material contingent liabilities, for example, but not limited to, product or environmental liabilities or litigation, that remain with the entity despite the disposal of the disposal group that is classified as a component of the entity.",
        "label": "Discontinued Operation, Amounts of Material Contingent Liabilities Remaining",
        "terseLabel": "Total long-term contingent consideration payable"
       }
      }
     },
     "localname": "DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax": {
     "auth_ref": [
      "r10",
      "r11",
      "r12",
      "r23"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.",
        "label": "Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax",
        "negatedTerseLabel": "Disposition of the Hospital Products"
       }
      }
     },
     "localname": "DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ContingentConsiderationPayablePayableBalanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsDisposedOfBySaleMember": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of by sale and representing a strategic shift that has or will have a major effect on operations and financial results.",
        "label": "Discontinued Operations, Disposed of by Sale [Member]",
        "terseLabel": "Discontinued Operations, Disposed of by Sale"
       }
      }
     },
     "localname": "DiscontinuedOperationsDisposedOfBySaleMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ContingentLiabilitiesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ContingentLiabilitiesandCommitmentsNarrativeDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessNarrativeDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ContingentLiabilitiesandCommitmentsNarrativeDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessNarrativeDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r296",
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessNarrativeDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Aggregate consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": {
     "auth_ref": [
      "r19",
      "r26"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold",
        "negatedTerseLabel": "Less transaction fees",
        "terseLabel": "Transaction fees"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1": {
     "auth_ref": [
      "r7",
      "r8",
      "r20",
      "r303"
     ],
     "calculation": {
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Goodwill",
        "negatedLabel": "Goodwill"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwill1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets": {
     "auth_ref": [
      "r7",
      "r8",
      "r20",
      "r303"
     ],
     "calculation": {
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets",
        "negatedTerseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1": {
     "auth_ref": [
      "r7",
      "r8",
      "r20",
      "r303"
     ],
     "calculation": {
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventory1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets": {
     "auth_ref": [
      "r7",
      "r8",
      "r20",
      "r294",
      "r303"
     ],
     "calculation": {
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent",
        "negatedTerseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets": {
     "auth_ref": [
      "r7",
      "r8",
      "r20",
      "r303"
     ],
     "calculation": {
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "auth_ref": [
      "r133",
      "r296",
      "r301"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal",
        "terseLabel": "Net gain on the sale of the Hospital Products"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r28",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Disposition of the Hospital Products"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalProducts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r440",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ContingentLiabilitiesandCommitmentsNarrativeDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DueToAffiliateCurrent": {
     "auth_ref": [
      "r42",
      "r147",
      "r639",
      "r761"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due to Affiliate, Current",
        "terseLabel": "Due to Exela"
       }
      }
     },
     "localname": "DueToAffiliateCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r147",
      "r344",
      "r346",
      "r347",
      "r351",
      "r352",
      "r353",
      "r639",
      "r706",
      "r734"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.",
        "label": "Due to Related Parties",
        "terseLabel": "Contingent consideration payable"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ContingentConsiderationPayableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings (loss) per share"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r107",
      "r163",
      "r164",
      "r166",
      "r167",
      "r168",
      "r176",
      "r178",
      "r183",
      "r185",
      "r186",
      "r190",
      "r191",
      "r576",
      "r577",
      "r712",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net income (loss) per share - basic (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome",
      "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofbasicanddilutedEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]",
        "terseLabel": "Weighted average number of shares outstanding"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r107",
      "r163",
      "r164",
      "r166",
      "r167",
      "r168",
      "r178",
      "r183",
      "r185",
      "r186",
      "r190",
      "r191",
      "r576",
      "r577",
      "r712",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net income (loss) per share - diluted (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome",
      "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofbasicanddilutedEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r187",
      "r188",
      "r189",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Net (Loss) Income Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/NetLossIncomePerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r603"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "verboseLabel": "Effect of foreign currency exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount": {
     "auth_ref": [
      "r503"
     ],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to Tax Cuts and Jobs Act.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Amount",
        "verboseLabel": "Change in U.S. tax law"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeBenefitsAndShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for employee benefit and equity-based compensation.",
        "label": "Employee Benefits and Share-based Compensation",
        "terseLabel": "Share-based compensation forfeitures related to the employees affected by the global reduction in workforce"
       }
      }
     },
     "localname": "EmployeeBenefitsAndShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r479"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "verboseLabel": "Unrecognized compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee Severance"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Option"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationFairValueAssumptionsDetails",
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r99",
      "r100",
      "r101",
      "r151",
      "r152",
      "r153",
      "r158",
      "r169",
      "r172",
      "r193",
      "r265",
      "r394",
      "r401",
      "r486",
      "r487",
      "r488",
      "r529",
      "r530",
      "r575",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r611",
      "r750",
      "r751",
      "r752",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveLossDetails",
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails",
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Error Corrections and Prior Period Adjustments Restatement [Line Items]",
        "terseLabel": "Error Corrections and Prior Period Adjustments Restatement [Line Items]"
       }
      }
     },
     "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r364",
      "r378",
      "r379",
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Estimate of Fair Value Measurement"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r578",
      "r579",
      "r580",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r364",
      "r378",
      "r379",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r579",
      "r658",
      "r659",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r364",
      "r378",
      "r379",
      "r578",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r578",
      "r579",
      "r581",
      "r582",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r364",
      "r378",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r364",
      "r432",
      "r433",
      "r438",
      "r439",
      "r579",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r364",
      "r378",
      "r379",
      "r432",
      "r433",
      "r438",
      "r439",
      "r579",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r364",
      "r378",
      "r379",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r579",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r364",
      "r378",
      "r379",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r658",
      "r659",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r583",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r254",
      "r255",
      "r257",
      "r258",
      "r259",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r276",
      "r277",
      "r278",
      "r279",
      "r372",
      "r393",
      "r564",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for charging off uncollectible financing receivables, including, but not limited to, factors and methodologies used in estimating the allowance for credit loss.",
        "label": "Financing Receivable, Allowance for Credit Losses, Policy for Uncollectible Amounts [Policy Text Block]",
        "terseLabel": "Allowance for Credit Losses"
       }
      }
     },
     "localname": "FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FixedIncomeSecuritiesMember": {
     "auth_ref": [
      "r432",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment that provides a return in the form of fixed periodic payments and eventual return of principal at maturity.",
        "label": "Fixed Income Securities [Member]",
        "terseLabel": "Other fixed-income securities"
       }
      }
     },
     "localname": "FixedIncomeSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture, fixtures and fittings"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/PropertyandEquipmentnetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "auth_ref": [
      "r133"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.",
        "label": "Gain (Loss) on Disposition of Assets",
        "terseLabel": "Gain (loss) on disposition of assets"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r133",
      "r556"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 21.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome": {
       "order": 6.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedTerseLabel": "Gain on sale of Hospital Products"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeographicAreasLongLivedAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographic Areas, Long-Lived Assets [Abstract]",
        "verboseLabel": "Long-lived Assets by Geographic Region:"
       }
      }
     },
     "localname": "GeographicAreasLongLivedAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaDatabyGeographicRegionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r282",
      "r284",
      "r649",
      "r696"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets",
      "http://www.avadel.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "verboseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/GoodwillandIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r286",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r133",
      "r283",
      "r285",
      "r287"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment loss"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GranteeStatusAxis": {
     "auth_ref": [
      "r445",
      "r447",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of recipient to whom award is granted.",
        "label": "Grantee Status [Axis]",
        "terseLabel": "Grantee Status [Axis]"
       }
      }
     },
     "localname": "GranteeStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GranteeStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of recipient to whom award is granted.",
        "label": "Grantee Status [Domain]",
        "terseLabel": "Grantee Status [Domain]"
       }
      }
     },
     "localname": "GranteeStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GuarantyAssets": {
     "auth_ref": [
      "r705"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the contractual right to receive fees, as compensation in exchange for providing a guarantee to a third party, over life of the guarantee.",
        "label": "Guaranty Assets",
        "terseLabel": "Guaranty assets"
       }
      }
     },
     "localname": "GuarantyAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ContingentLiabilitiesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuarantyLiabilities": {
     "auth_ref": [
      "r336",
      "r337",
      "r707",
      "r733"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents a non-contingent liability for the fair value of an obligation to stand ready to perform over the term of a guaranty issued in the event that specified triggering events or conditions occur.",
        "label": "Guaranty Liabilities",
        "terseLabel": "Guarantee to Deerfield"
       }
      }
     },
     "localname": "GuarantyLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ContingentLiabilitiesandCommitmentsNarrativeDetails",
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r133",
      "r291"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-lived",
        "terseLabel": "Fixed asset impairment"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r293",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r103",
      "r212",
      "r216",
      "r220",
      "r223",
      "r226",
      "r695",
      "r708",
      "r714",
      "r740"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Total loss before income taxes",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome",
      "http://www.avadel.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r212",
      "r216",
      "r220",
      "r223",
      "r226"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "terseLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r440",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ContingentLiabilitiesandCommitmentsNarrativeDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ContingentLiabilitiesandCommitmentsNarrativeDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r8",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r21",
      "r24",
      "r25",
      "r26",
      "r304",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ContingentLiabilitiesandCommitmentsNarrativeDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r302",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessNarrativeDetails",
      "http://www.avadel.com/role/ShareBasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessNarrativeDetails",
      "http://www.avadel.com/role/ShareBasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r145",
      "r504",
      "r512",
      "r519",
      "r534",
      "r539",
      "r541",
      "r542",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "verboseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r146",
      "r171",
      "r172",
      "r211",
      "r502",
      "r535",
      "r540",
      "r741"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.avadel.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax benefit",
        "totalLabel": "Income tax benefit"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome",
      "http://www.avadel.com/role/IncomeTaxesIncomeTaxProvisionBenefitDetails",
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Amount [Abstract]",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Amount [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r98",
      "r500",
      "r501",
      "r512",
      "r513",
      "r518",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r503"
     ],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Change in valuation allowances"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r503"
     ],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Differences in international tax rates"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r503"
     ],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Income tax benefit - at statutory tax rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther": {
     "auth_ref": [
      "r503"
     ],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount",
        "terseLabel": "Nondeductible changes in fair value of contingent consideration"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r503"
     ],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount",
        "terseLabel": "Nondeductible share-based compensation"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r503"
     ],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Hospital Products sale"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": {
     "auth_ref": [
      "r503"
     ],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherReconcilingItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r503"
     ],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State and local taxes (net of federal)"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxContingencies": {
     "auth_ref": [
      "r503"
     ],
     "calculation": {
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Amount",
        "terseLabel": "Unrealized tax benefits"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesReconciliationofTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r503"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "terseLabel": "Gross research tax credit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r137"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "verboseLabel": "Income taxes paid (refund), net"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r79",
      "r705",
      "r735"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "verboseLabel": "Income tax receivable (see Note 13)"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable &amp; other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r132",
      "r686"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "verboseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Changes in deferred tax"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Net changes in assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating assets after deduction of noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net",
        "negatedLabel": "Other assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r102",
      "r210",
      "r613",
      "r616",
      "r713"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r113",
      "r369",
      "r377",
      "r380",
      "r381"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense, debt"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r126",
      "r129",
      "r137"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "verboseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.",
        "label": "Internal Revenue Service (IRS) [Member]",
        "terseLabel": "Internal Revenue Service (IRS)"
       }
      }
     },
     "localname": "InternalRevenueServiceIRSMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r112",
      "r113"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Net",
        "terseLabel": "Investment and other income (expense), net"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Investments Classified by Contractual Maturity Date"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r631",
      "r633"
     ],
     "calculation": {
      "http://www.avadel.com/role/LeasesComponentsofleasecostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LeasesComponentsofleasecostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Components of Lease Costs"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Lease Obligations"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Maturities of Operating Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r632"
     ],
     "calculation": {
      "http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r632"
     ],
     "calculation": {
      "http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r632"
     ],
     "calculation": {
      "http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r632"
     ],
     "calculation": {
      "http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r632"
     ],
     "calculation": {
      "http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r632"
     ],
     "calculation": {
      "http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r632"
     ],
     "calculation": {
      "http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r632"
     ],
     "calculation": {
      "http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Operating lease, term of contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r67",
      "r143",
      "r218",
      "r261",
      "r341",
      "r342",
      "r343",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r352",
      "r353",
      "r553",
      "r558",
      "r559",
      "r589",
      "r643",
      "r644"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r57",
      "r143",
      "r261",
      "r589",
      "r649",
      "r701",
      "r731"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r71",
      "r143",
      "r261",
      "r341",
      "r342",
      "r343",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r352",
      "r353",
      "r553",
      "r558",
      "r559",
      "r589",
      "r643",
      "r644",
      "r649"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.",
        "label": "Liabilities, Fair Value Adjustment",
        "terseLabel": "Fair value adjustments"
       }
      }
     },
     "localname": "LiabilitiesFairValueAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ContingentConsiderationPayablePayableBalanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r7",
      "r8",
      "r20",
      "r22",
      "r26",
      "r303"
     ],
     "calculation": {
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "totalLabel": "Net liabilities disposed of"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessComponentsofConsiderationandAssetsandLiabilitiesEitherTransferredorEliminatedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.",
        "label": "Long-lived Assets by Geographic Areas [Table Text Block]",
        "terseLabel": "Long-lived Assets by Geographic Areas"
       }
      }
     },
     "localname": "LongLivedAssetsByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r46",
      "r363",
      "r376",
      "r378",
      "r379",
      "r700",
      "r728"
     ],
     "calculation": {
      "http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term debt",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "negatedTerseLabel": "Less: current maturities"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets",
      "http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt [Text Block]",
        "verboseLabel": "Long-Term Debt"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r73",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r30",
      "r68"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "verboseLabel": "Marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Mutual and money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r128",
      "r131",
      "r134"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r26",
      "r92",
      "r95",
      "r101",
      "r104",
      "r134",
      "r143",
      "r157",
      "r163",
      "r164",
      "r166",
      "r167",
      "r171",
      "r172",
      "r181",
      "r212",
      "r216",
      "r220",
      "r223",
      "r226",
      "r261",
      "r341",
      "r342",
      "r343",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r352",
      "r353",
      "r577",
      "r589",
      "r709",
      "r736"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.avadel.com/role/ConsolidatedStatementsofComprehensiveLossIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net (loss) income",
        "verboseLabel": "Net (loss) income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.avadel.com/role/ConsolidatedStatementsofComprehensiveLossIncome",
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome",
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofbasicanddilutedEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r5",
      "r155",
      "r156",
      "r159",
      "r160",
      "r173",
      "r174",
      "r175",
      "r241",
      "r242",
      "r266",
      "r267",
      "r426",
      "r427",
      "r428",
      "r429",
      "r489",
      "r531",
      "r532",
      "r533",
      "r573",
      "r596",
      "r597",
      "r598",
      "r636",
      "r692",
      "r693",
      "r694",
      "r754",
      "r755",
      "r756",
      "r757",
      "r759",
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "Newly Issued Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/NewlyIssuedAccountingStandards"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r154",
      "r157",
      "r158",
      "r159",
      "r161",
      "r162",
      "r166",
      "r173",
      "r190",
      "r239",
      "r240",
      "r262",
      "r263",
      "r264",
      "r265",
      "r268",
      "r269",
      "r340",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r490",
      "r527",
      "r528",
      "r529",
      "r530",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r574",
      "r575",
      "r576",
      "r577",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r599",
      "r600",
      "r635",
      "r689",
      "r690",
      "r691",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Guidance"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r230"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets",
        "terseLabel": "Long-lived assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaDatabyGeographicRegionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebyProductDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebyProductDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r212",
      "r216",
      "r220",
      "r223",
      "r226"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating income (loss)",
        "totalLabel": "Operating (loss) income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r626",
      "r633"
     ],
     "calculation": {
      "http://www.avadel.com/role/LeasesComponentsofleasecostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease costs"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LeasesComponentsofleasecostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "auth_ref": [
      "r619"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease.",
        "label": "Operating Lease, Impairment Loss",
        "terseLabel": "Operating lease, impairment loss"
       }
      }
     },
     "localname": "OperatingLeaseImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r621"
     ],
     "calculation": {
      "http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LeasesMaturitiesofoperatingleaseliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r621"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r621"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r622",
      "r628"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating lease, payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r620"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r630",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating lease, weighted average discount rate, percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r629",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating lease, weighted average remaining lease term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r520"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsValuationAllowance": {
     "auth_ref": [
      "r516"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Operating Loss Carryforwards, Valuation Allowance",
        "terseLabel": "Operating loss carryforwards, valuation allowance (decrease)"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityEquityAxis": {
     "auth_ref": [
      "r383",
      "r562",
      "r563",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of options indexed to an issuer's equity.",
        "label": "Option Indexed to Issuer's Equity [Axis]",
        "terseLabel": "Option Indexed to Issuer's Equity [Axis]"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityEquityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationFairValueAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding.",
        "label": "Option Indexed to Issuer's Equity, Type [Domain]",
        "terseLabel": "Option Indexed to Issuer's Equity, Type [Domain]"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationFairValueAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r36",
      "r37",
      "r38",
      "r69"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Accrued professional fees"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r80",
      "r649"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "totalLabel": "Total",
        "verboseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets",
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r83",
      "r88",
      "r601",
      "r602",
      "r604"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofComprehensiveLossIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "verboseLabel": "Foreign currency translation (loss) gain"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofComprehensiveLossIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r93",
      "r96",
      "r550",
      "r551",
      "r554"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofComprehensiveLossIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Total other comprehensive (loss) income, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofComprehensiveLossIncome",
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "verboseLabel": "Other comprehensive (loss) income, net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofComprehensiveLossIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r84",
      "r88"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofComprehensiveLossIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Net other comprehensive (loss) income, net of income tax benefit (expense) of $214, $(202), $(43), respectively"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofComprehensiveLossIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax": {
     "auth_ref": [
      "r85",
      "r89"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax",
        "terseLabel": "Unrealized gain (loss) on marketable securities, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveLossDetails",
      "http://www.avadel.com/role/ConsolidatedStatementsofComprehensiveLossIncomeParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other current liabilities.",
        "label": "Other Current Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Current Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r35",
      "r36",
      "r69",
      "r649"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities",
        "totalLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets",
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities Disclosure [Abstract]",
        "terseLabel": "Other Liabilities Disclosure [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other liabilities.",
        "label": "Other Liabilities Disclosure [Text Block]",
        "verboseLabel": "Other Assets and Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets",
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "verboseLabel": "Schedule of Other Non-Current Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other expense - changes in fair value of contingent consideration payable",
        "terseLabel": "Other expense - changes in fair value of contingent consideration payable"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other adjustments"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r127",
      "r311"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Payments",
        "terseLabel": "Payments for restructuring"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRoyalties": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for royalties during the current period.",
        "label": "Payments for Royalties",
        "negatedTerseLabel": "Royalty payments for contingent consideration payable in excess of original fair value"
       }
      }
     },
     "localname": "PaymentsForRoyalties",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r125"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "terseLabel": "Transaction costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r120",
      "r548"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "negatedTerseLabel": "Payments of related party payable"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ContingentConsiderationPayablePayableBalanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r244"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.avadel.com/role/ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r450",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]",
        "terseLabel": "Preferred shares"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r50",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred shares, nominal value (in usd per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred shares, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r50",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred shares, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred shares, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r50",
      "r649"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred shares, nominal value of $0.01 per share; 50,000 shares authorized; 488 issued and outstanding at December 31, 2021 and 2020, respectively"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r32",
      "r58",
      "r59"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets",
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails",
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r31",
      "r33",
      "r280",
      "r281"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "verboseLabel": "Prepaid and other expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PrivatePlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.",
        "label": "Private Placement [Member]",
        "terseLabel": "Securities Purchase Agreement"
       }
      }
     },
     "localname": "PrivatePlacementMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from the disposition of the Hospital Products"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from Issuance Initial Public Offering",
        "terseLabel": "Proceeds from the May 2020 public offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r123"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "verboseLabel": "Proceeds from loans or conditional grants"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.",
        "label": "Proceeds from Issuance of Private Placement",
        "terseLabel": "Proceeds from the February 2020 private placement"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r122",
      "r481"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "verboseLabel": "Proceeds from issuance of ordinary shares"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r124",
      "r125"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing activities, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r116",
      "r117",
      "r244"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-sale",
        "verboseLabel": "Proceeds from sales of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from disposal of property and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r63",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/PropertyandEquipmentnetDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r307",
      "r764",
      "r765",
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/PropertyandEquipmentnet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisposals": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Disposals",
        "terseLabel": "Write-off of property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisposals",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r62",
      "r298"
     ],
     "calculation": {
      "http://www.avadel.com/role/PropertyandEquipmentnetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "verboseLabel": "Total property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/PropertyandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/PropertyandEquipmentnetDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r40",
      "r41",
      "r300",
      "r649",
      "r721",
      "r732"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.avadel.com/role/PropertyandEquipmentnetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets",
      "http://www.avadel.com/role/PropertyandEquipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r61",
      "r300",
      "r764",
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r40",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property and Equipment Useful Life",
        "verboseLabel": "Schedule of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/PropertyandEquipmentnetTables",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r40",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/PropertyandEquipmentnetDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, plant and equipment, useful life (in years)"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_PurchaseObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.",
        "label": "Purchase Obligation",
        "terseLabel": "Purchase obligation"
       }
      }
     },
     "localname": "PurchaseObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ContingentLiabilitiesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Unrecognized Tax Benefit Activity [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesUnrecognizedTaxBenefitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r637",
      "r638",
      "r639",
      "r641",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "verboseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReorganizationUnderChapter11OfUSBankruptcyCodeDisclosureTextBlock": {
     "auth_ref": [
      "r645",
      "r646",
      "r647",
      "r648",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the description and amounts of reorganization under Chapter 11 of the US Bankruptcy Code.",
        "label": "Reorganization under Chapter 11 of US Bankruptcy Code Disclosure [Text Block]",
        "terseLabel": "Subsidiary Bankruptcy and Deconsolidation"
       }
      }
     },
     "localname": "ReorganizationUnderChapter11OfUSBankruptcyCodeDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SubsidiaryBankruptcyandDeconsolidation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReorganizationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reorganizations [Abstract]",
        "terseLabel": "Reorganizations [Abstract]"
       }
      }
     },
     "localname": "ReorganizationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r498",
      "r687",
      "r778"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "verboseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development (\u201cR&amp;D\u201d)"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r309",
      "r311",
      "r314",
      "r324",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring Costs"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCosts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r133",
      "r308",
      "r317",
      "r320"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring costs"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringChargesMember": {
     "auth_ref": [
      "r317",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about restructuring charges have been included.",
        "label": "Restructuring Charges [Member]",
        "terseLabel": "Restructuring costs"
       }
      }
     },
     "localname": "RestructuringChargesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r310",
      "r311",
      "r320",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r311",
      "r318"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending balance of accrued costs",
        "periodStartLabel": "Beginning balance of accrued costs",
        "terseLabel": "Restructuring reserve"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveCurrent": {
     "auth_ref": [
      "r45",
      "r311",
      "r321"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Current",
        "terseLabel": "Accrued restructuring (see Note 16)"
       }
      }
     },
     "localname": "RestructuringReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveTranslationAdjustment": {
     "auth_ref": [
      "r311",
      "r321"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.",
        "label": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency impact"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r53",
      "r401",
      "r490",
      "r649",
      "r730",
      "r754",
      "r759"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r151",
      "r152",
      "r153",
      "r158",
      "r169",
      "r172",
      "r265",
      "r486",
      "r487",
      "r488",
      "r529",
      "r530",
      "r575",
      "r750",
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r208",
      "r209",
      "r215",
      "r221",
      "r222",
      "r228",
      "r229",
      "r234",
      "r420",
      "r421",
      "r688"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Product sales",
        "verboseLabel": "Product sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebyProductDetails",
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebySignificantCustomerDetails",
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r140",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r422",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Revenue from External Customers by Geographic Areas"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues [Abstract]"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Net proceeds from public offering"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Public offering, shares issued"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Public offering, price per share (in dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r91",
      "r610",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable": {
     "auth_ref": [
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information about a contingent payment arrangement including the terms that will result in payment and the accounting treatment that will be followed if such contingency occurs, including the potential impact on earnings per share if the contingency is to be settled in shares of common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]",
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SubsidiaryBankruptcyandDeconsolidationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Capitalization, Long-term Debt [Line Items]",
        "terseLabel": "Schedule of Capitalization, Long-term Debt [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfCapitalizationLongtermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCapitalizationLongtermDebtTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning the long-term debt component of the capitalization of the entity. The table may be detailed by subsidiary (legal entity) and include information by type of debt detailed by instrument.",
        "label": "Schedule of Capitalization, Long-term Debt [Table]",
        "terseLabel": "Schedule of Capitalization, Long-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfCapitalizationLongtermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r73",
      "r149",
      "r378",
      "r380",
      "r395",
      "r398",
      "r399",
      "r400",
      "r614",
      "r615",
      "r618",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt Instruments"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "verboseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r8",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r21",
      "r24",
      "r25",
      "r26",
      "r304",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Schedule of Assets and Liabilities either Transferred Or Eliminated Representing the Aggregate Consideration of Disposal Group"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Schedule of Earnings Per Share Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/NetLossIncomePerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "verboseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r449",
      "r477",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Revenue from External Customers by Product and Services"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable": {
     "auth_ref": [
      "r163",
      "r164",
      "r165",
      "r168",
      "r169",
      "r171",
      "r172",
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of prior period adjustments to correct an error in previously issued financial statements. The disclosure may include, but is not limited to: (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustment (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. This table can be used to disclose the amounts as previously reported and the effect of the correction or other adjustment on per line item or per share amount basis. This table uses as its line items financial statement line items that are affected by prior period adjustments.",
        "label": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]",
        "terseLabel": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]"
       }
      }
     },
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock": {
     "auth_ref": [
      "r170",
      "r171",
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.",
        "label": "Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]",
        "terseLabel": "Schedule of Error Corrections and Prior Period Adjustments"
       }
      }
     },
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r578",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of noncurrent assets.",
        "label": "Schedule of Other Assets, Noncurrent [Table Text Block]",
        "terseLabel": "Schedule of Other Non-Current Assets"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r63",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/PropertyandEquipmentnetDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.",
        "label": "Schedule of Related Party Transactions [Table Text Block]",
        "terseLabel": "Schedule of Related Party Transactions"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ContingentConsiderationPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r310",
      "r311",
      "r312",
      "r313",
      "r320",
      "r321",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r315",
      "r316",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.",
        "label": "Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]",
        "terseLabel": "Schedule of Revenue by Major Customers by Reporting Segments"
       }
      }
     },
     "localname": "ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r212",
      "r213",
      "r219",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaDatabyGeographicRegionDetails",
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebyProductDetails",
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebySignificantCustomerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r450",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationFairValueAssumptionsDetails",
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.avadel.com/role/ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails",
      "http://www.avadel.com/role/ShareBasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r456",
      "r466",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Share-based Compensation, Stock Options, Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r75",
      "r141",
      "r194",
      "r195",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r511",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Summary of Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r204",
      "r206",
      "r207",
      "r212",
      "r214",
      "r220",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r233",
      "r234",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Company Operations by Product, Customer and Geographic Area"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicArea"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaDatabyGeographicRegionDetails",
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebyProductDetails",
      "http://www.avadel.com/role/CompanyOperationsbyProductCustomerandGeographicAreaRevenuebySignificantCustomerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "verboseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome",
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessUnauditedProFormaCondensedCombinedStatementofIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/DispositionoftheHospitalBusinessNarrativeDetails",
      "http://www.avadel.com/role/ShareBasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofLongTermDebtInstrumentsDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series A preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series A Preferred Stock [Member]",
        "terseLabel": "Series A Preferred Stock"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Forfeited (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.avadel.com/role/ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in usd per share)",
        "verboseLabel": "Weighted average grant fair value of free share awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.avadel.com/role/ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding, ending balance (in shares)",
        "periodStartLabel": "Outstanding, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "verboseLabel": "Free Share Activity and Other Data, Nonvested [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Nonvested free share award, ending balance (in usd per share)",
        "periodStartLabel": "Nonvested free share award, beginning balance (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "verboseLabel": "Free Share Activity and Other Data, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Vested (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "verboseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "verboseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "verboseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationFairValueAssumptionsDetails",
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.avadel.com/role/ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails",
      "http://www.avadel.com/role/ShareBasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for issuance under ESPP"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r468"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period",
        "negatedTerseLabel": "Expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Grant date fair value of options granted (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r480"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Stock options outstanding, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r458",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Stock options outstanding, ending balance (in shares)",
        "periodStartLabel": "Stock options outstanding, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Stock Options, Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Stock options outstanding, ending balance (in usd per share)",
        "periodStartLabel": "Stock options outstanding, beginning balance (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Stock Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "verboseLabel": "Stock options exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "verboseLabel": "Stock options exercisable (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r448",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.avadel.com/role/ShareBasedCompensationRestrictedStockandPerformanceUnitShareActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Exercised (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Expired (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "verboseLabel": "Forfeited (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Granted (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche One [Member]",
        "terseLabel": "2/3 vesting at second anniversary of grant date"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche Three [Member]",
        "terseLabel": "1/4 vesting at each anniversary of grant date"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche Two [Member]",
        "terseLabel": "1/3 vesting at third anniversary of grant date"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r450",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedPaymentArrangementEmployeeMember": {
     "auth_ref": [
      "r447",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.",
        "label": "Share-based Payment Arrangement, Employee [Member]",
        "terseLabel": "Share-based Payment Arrangement, Employee"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementEmployeeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Vesting percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Expiration period (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r472",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Weighted average period for unrecognized expense (in years)",
        "verboseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationFairValueAssumptionsDetails",
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r480"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "verboseLabel": "Stock options exercisable, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Stock options exercisable, Weighted Average Remaining Contractual Life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Stock options outstanding, Weighted Average Remaining Contractual Life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Purchase price of common stock, percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Shares issued, price per share (in dollars per share)"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r44",
      "r702",
      "r703",
      "r726"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term Investments",
        "terseLabel": "Short-term deposit"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r139",
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r49",
      "r50",
      "r51",
      "r141",
      "r143",
      "r178",
      "r179",
      "r180",
      "r183",
      "r186",
      "r194",
      "r195",
      "r196",
      "r261",
      "r341",
      "r346",
      "r347",
      "r348",
      "r352",
      "r353",
      "r387",
      "r388",
      "r391",
      "r392",
      "r394",
      "r589",
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/CoverPage",
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r78",
      "r99",
      "r100",
      "r101",
      "r151",
      "r152",
      "r153",
      "r158",
      "r169",
      "r172",
      "r193",
      "r265",
      "r394",
      "r401",
      "r486",
      "r487",
      "r488",
      "r529",
      "r530",
      "r575",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r611",
      "r750",
      "r751",
      "r752",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveLossDetails",
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails",
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r193",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan": {
     "auth_ref": [
      "r50",
      "r51",
      "r394",
      "r401",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Ownership Plan",
        "terseLabel": "Employee share purchase plan share issuance (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r50",
      "r51",
      "r394",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Stock issued during period, new issues (in shares)",
        "verboseLabel": "February 2020 private placement (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Shares, Other",
        "verboseLabel": "Vesting of restricted shares (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r50",
      "r51",
      "r394",
      "r401",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.avadel.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r50",
      "r51",
      "r394",
      "r401"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Employee share purchase plan share issuance"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r50",
      "r51",
      "r394",
      "r401"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "February 2020 private placement"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Value, Other",
        "verboseLabel": "Vesting of restricted shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r78",
      "r394",
      "r401"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r51",
      "r55",
      "r56",
      "r143",
      "r238",
      "r261",
      "r589",
      "r649"
     ],
     "calculation": {
      "http://www.avadel.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Total shareholders\u2019 (deficit) equity",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveLossDetails",
      "http://www.avadel.com/role/ConsolidatedBalanceSheets",
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/NewlyIssuedAccountingStandardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Shareholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r627",
      "r633"
     ],
     "calculation": {
      "http://www.avadel.com/role/LeasesComponentsofleasecostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "negatedTerseLabel": "Sublease income"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/LeasesComponentsofleasecostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r612",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r612",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r612",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r612",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r651",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "verboseLabel": "Supplemental disclosures of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about the period subject to enacted tax laws.",
        "label": "Tax Period [Axis]",
        "terseLabel": "Tax Period [Axis]"
       }
      }
     },
     "localname": "TaxPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified tax period.",
        "label": "Tax Period [Domain]",
        "terseLabel": "Tax Period [Domain]"
       }
      }
     },
     "localname": "TaxPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxYear2019Member": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified as tax year 2019.",
        "label": "Tax Year 2019 [Member]",
        "terseLabel": "Tax Year 2019"
       }
      }
     },
     "localname": "TaxYear2019Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxYear2020Member": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified as tax year 2020.",
        "label": "Tax Year 2020 [Member]",
        "terseLabel": "Tax Year 2020"
       }
      }
     },
     "localname": "TaxYear2020Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r254",
      "r255",
      "r257",
      "r258",
      "r259",
      "r372",
      "r393",
      "r564",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r77",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Shares"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockRetiredCostMethodAmount": {
     "auth_ref": [
      "r51",
      "r394",
      "r402"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.",
        "label": "Treasury Stock, Retired, Cost Method, Amount",
        "negatedTerseLabel": "Retirement of treasury shares",
        "terseLabel": "Retirement of treasury shares"
       }
      }
     },
     "localname": "TreasuryStockRetiredCostMethodAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockSharesRetired": {
     "auth_ref": [
      "r51",
      "r394",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common and preferred stock retired from treasury during the period.",
        "label": "Treasury Stock, Shares, Retired",
        "negatedTerseLabel": "Retirement of treasury shares (in shares)",
        "terseLabel": "Retirement of treasury shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesRetired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.avadel.com/role/EquityInstrumentsandTransactionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r310",
      "r311",
      "r320",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r148",
      "r432",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "Government securities - U.S."
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementsMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/MarketableSecuritiesScheduleofMaturitiesDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UndistributedEarnings": {
     "auth_ref": [
      "r182",
      "r184"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The earnings that is allocated to common stock and participating securities to the extent that each security may share in earnings as if all of the earnings for the period had been distributed.",
        "label": "Undistributed Earnings, Basic",
        "terseLabel": "Unremitted earnings"
       }
      }
     },
     "localname": "UndistributedEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r499",
      "r507"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesUnrecognizedTaxBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r508"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesUnrecognizedTaxBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r505"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Income tax penalties and interest accrued"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r505"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Income tax penalties and interest expense"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.",
        "label": "Unrecognized Tax Benefits, Period Increase (Decrease)",
        "terseLabel": "Increases for tax positions of prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesUnrecognizedTaxBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r509"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Statute of limitations expiration"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesUnrecognizedTaxBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r510"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r186"
     ],
     "calculation": {
      "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofbasicanddilutedEPSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Effect of dilutive securities\u2014employee and director equity awards outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofbasicanddilutedEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r177",
      "r186"
     ],
     "calculation": {
      "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofbasicanddilutedEPSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Diluted shares (in shares)",
        "verboseLabel": "Weighted average number of shares outstanding - diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome",
      "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofbasicanddilutedEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofbasicanddilutedEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r176",
      "r186"
     ],
     "calculation": {
      "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofbasicanddilutedEPSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic shares (in shares)",
        "verboseLabel": "Weighted average number of shares outstanding - basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.avadel.com/role/ConsolidatedStatementsofLossIncome",
      "http://www.avadel.com/role/NetLossIncomePerShareReconciliationofbasicanddilutedEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "66",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2814-109256"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a,b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Z.5.Q2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=26872618&loc=d3e7384-122677"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2510-110228"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(c))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123422226&loc=d3e11019-110243"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123422226&loc=d3e11049-110243"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "63",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=117411753&loc=d3e23176-110880"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=SL116886442-113899"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4549-113899"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "40",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109244457&loc=d3e16649-113920"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "c",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90193-114008"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90198-114008"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123399704&loc=SL77918431-209957"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "852",
   "URI": "http://asc.fasb.org/topic&trid=2209115"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.2)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(3),(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62652-112803"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r779": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r780": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r781": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r782": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r783": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r784": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r785": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r786": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r787": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r788": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r789": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r790": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r791": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r792": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r793": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r794": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r795": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>142
<FILENAME>0001012477-22-000004-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001012477-22-000004-xbrl.zip
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MG5E#G &KT0]U9C>OS$8O-VB?",L^P.+E,*VVP#=D&S;)@)DH)V>L;Y(14&6
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M8%!E^ ]=^>KH/V7[\_3U^PI02P,$%     @ 0X!P5#/SY;6)!   "B8  !$
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M9^^*3;K+4.M<#M:FYGTAO47!]BM6UO9Q4:/FEP_0%VCKBFJD:@$_KPARSN2
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M]-Q'"%M1\>[,<\@+#^FIK9_UZ@=C^!]02P,$%     @ 0X!P5-FL*SP;"
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M-0/8PPJ$0J'X0RS%=&C"N"*S6(0QT;G]6<Z?<<6+1:P!$Z$3= FVX9@)$\-
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MOD_8^@5-\>N_YW%?%IW^&U!+ P04    " !#@'!4]COK3N$$   T&   $0
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MG8J&0*Z"Y//F$9$9*TFR">WBI*ZLDD="6F1"^LI>FT7,C\1(C+"!6I!"2&>
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M!>H DTQT.@@-U";T51K/!_>%P0SY0&F2AQU]#/0102ICB- 6A1$5-N+0UWS
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M!]7*9Z#7N^[@YK[;J3R#6(RJ<3.7Q?Z0;B0?M1.>20H%\!0+X=%==<39PNK
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MIJ,]]W0X&3UV"'5[!([!HX/A_C[8)^G!PZ=/4G ,'CT;[![L#_8/GJRIQR\
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M1B#>9RXMEK@A<;?"0'AGSG(R(^'>.4AQ4=.PNV>Y&'JUHRC*![<BETD*HL*
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MY".-TP6;4;D<7LI$XW:HDFZCAR586; ?TIH$ ES ]QV P504\:U=K\-E!<)
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MS]_RW5^[K&U2WA([R2'8I&Q[T!9+RG1.406_WVQI;<*?H-]!/T%7/RW) EN
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M8T"V-#^(SZ;A72/V12LQ>>G&E+9%T,,N&?E-.YJCL8?\J+W<NWKS-^;F$B=
MNEN/,*(/<:(OG^%/G4T8K$6:[''<Y4WTQ L,=Q!L+F+)8F9._*Y!2D9ZM=.:
M\EQ4=L3O^!L<0.QU3%6E^I*G+W][95X3)#ZAK>E7&FE7M,S>HP&-#'9WN?8A
MYQ'*LFJI($W#,#0\-OCAT[8)7X@[(8[#^GLJ6F;D5A46*V&:P; >ZYNN#WDG
M.>RDP?J3!3(Z7[%UV8!J\+WST@]J)^FA4KQ=8O5MNVSRS%DT0Y^LNG 1MLLQ
M3R?"4W 2VS)7=AOW<:&@++T-7C&IBKSZU!4)*4,&]):KP FW3B3H60AS3J*&
MQ]UJ9;C1\.DW!'A_WNHWOCQ20^]'ZM:JQBL4(4F9EC!OL#-\BH;V<@V6(@'C
M6*,B/>!0(.@@4=UX5L*K35?]RA3TY":)CO!U1\%X @Y8V7X6CRYO."//GS9I
M0;>>IO-YFLQ668W7M<M532<0IAP#>%-78C(+#0QLOL8(6+=,1[#C]40AZ*.M
M*]"293/G@ ;== @+4U9TRWP,HC+/0-W 6<IR'(U.1+,V2'_X)%M*=*:?/"V(
MR UT6&$ZN/8TOOMQBQF*_GM_TDUACG-,ZN_O[NX/NJ\R(W52K)C"Q03 <%?9
MC<0%K;#?,6Z$B 7XZ (S,-X@F^0U?)OB!1G'#05^ O>E@J7]G4<H#A\FX'W4
M38(ENO6GY9=OW?FDN/5;8V/M/1X$.\O: F)U$0F 5;!]9A59%\$2>CPPUA!>
M".J!2^Y;QJDP#VPH$-.C\$;L(FL3H;&S-7(^U<BYDYN6E,KO9-6@]<#[ N'1
MR4'HVK&D.'6H4,-9?'=\]G[X]@U_I^5'9'0G(&^S:HY&R0 ,F!9$RW $M\H&
M#/H:54.C=YIEFZUXA[A2/MO?VS>2;59I5ZH,)0U*9X2\H7'4!'IV(CSAVP^\
M Q#>"J'A^CH8Z6ZL$!\D1VF99ND ?#B$.G@!C/<Y;-'/*O*4VZ85*2'5:7 #
M_NL\;[#12-HHZIP'2MS_: /RMF11^6\XQDLN+&/1P)X@1I//T:1<)+@\W!A%
M^#@Z<\V3[ \='(!#<#F+9/\)2YN=Y+1WZIXE5#8460UF/6?P$>9\:5)3\2\)
M]2$3)0N=N3EEFRD)@.@E1)F.B9O \M]3PD$F')FMF4X(^T?E<])SI,XH/B#I
M<%D\.-4UMMV@1\YJAUMSR#[U"J=S 6=QZ<\Z#>K'! \J.-,J[RY 5<&CR-]<
MXDNI>_?Z]_>A*,'O!R$-QX$Q,<O0CE%_>_3SR? DYB["MP(1Z#Y@7;57R^ER
MF8X_-+)=J@M"5*+MA5EVS+P,DL<)5X ^ >T(_RJ:ZNO.*Y:3%<5E\]<S\Q3!
MJ$:(LA MA5M&#]GZOA%RBBF'WI P&)D\EV" T$N 2):R0^P@Q1@C=%D$F=E4
MXYS>E2R7CH5"B$P_%*)(;^;X1J$LT\N'^R6FUM)D;^?@'X/D' 0/H9X?[>S_
M W?K&'M2.8(V(3(:3**=Q_A%_N>?')#@"YMJ#G8N 2$/=I[] [$GL" UW94F
MW94M[ [0*,_^(:N/U^D^[)=6<N1XMA !+*YC%O:N1QAWY^H.JYN3,OFOM)3(
MCLH?M!FF!+C-O$ /?.7(<SXM0TW;FE4<3-_0T>4##)EOY4-ML/7 M9E2BIB
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MMWZ'ET&O5U4RXZ%DC&ASRHVI&(0GSGTDYTH86LG/FL24<P,.2Q(%++:&DXA
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MGQR*^_S)U_9&W2$M*UXPH4=/,8V/WAU\V!*?$O5'\BSS:0T[W')ACM.VX:W
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MJ2VH+43JZTXG)& L(L8"RPP([=_(:^79>[HG"K'#T6%B ZD7O^2UQSA=D-A
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MU9T5/W%!<-.+TSO@X)2%O^%L;C;,2Q&L3%\TI$0'U3M48 1,C6O2F>U(N*$
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M3)B+NQF3W]N'5W^#Q?!@J=ORV\/3$T, T(!T:>=)]7$UXD@#!KPY_-P;!Y.
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M<M6,]-M"L""?<4TJ/!SQC9^3D&H?]-/ J8[Y%UG/O";S5"S%RA9B7EC[H3J
MG\DVFYH:YE1B8V/^"64[1R3/[OI9ENS\L;%#7?W%8E^38_[P*]J"9.%H[,,?
MHBWXM>FV._B'; N>VGYZP;9 T\]B=)%((WX#</-T\W 96V>6(S$47]KSQ#M6
M'H%OW)MPZJ^F=;V4A>MOAG@WT="9/7[]*A(!1A!=G:S;R.$GI;'DF51<9J\I
MIZ4K(,7Z!'<6DKU[7).>0RN)PZJJPVK7YRT%J1#EZ@KQRNWAK+$GF'KFL6?R
MW]ZMM%H?#B%_9HRT1%(')/5XED@5M/MZAU?K#2QG$WMS:=/'8%%MGV5*$JXK
M(!$JUH$-+'G\)*\IN$YS*<,AR%S3C\/^"#^NRMPOP4??\!+$@:LGP]<X&1ZX
M(Y>/VF 3SG:TI5O+72@<^S'AXL*[DA'F[-UE'0OM"Z3N,!<3!![!//7TI:G+
MWX$HNFI'5BTLK7AS:NX@F&U8&$OEAX_FG5^+4 SA1XJ25;:8$4.J"Y*NSE<.
M5_@K@Q(I$Y.Y;+$6L*QJY N\6AQB<\>O0-TIA=K)I+0D;@[&G%04WG7,KQI=
M6AR\E^)3AJ7/6>#PPVKV'P\?,>\/8QUI!T(]:%&' VE9-\DV'L&B$-5_WJP[
M<</LVU!O1/C(1G'+"RWLJ,WLT7?).DO2!ZF/1VGX1EV\6PW._W)E0_8EMKF%
MH0O$7_7(5>TJ6#69&D#=H;Y63HWTE2/FUK%E S,QB-'6&819.-SZA_4E#!B?
ME'))>*)2,829I"/Y'AVB"5,2.QHWR%_%,$7D 9:QAN2T6))5UI:5=TIBTF3(
M@GKLV/A('1OQ''H$D^@COQ_I,-OWE0GY2Q/I+79;HER3N2MP<8UWTYLWAW\/
M%_\?T'!:!=<AV ,Z%Q21YZYT*2W$M4O1LXU[B'?X:H;0>\G)63K?Z32O]NFZ
M)A('9V.-:$4DU,ATE;#.A2K=LLO_Z,%7#[*8&+6&;D;D$?E0W9#;Y'2YX7<\
MSP_\?(\>Q/ !XEM?\9\?Z1.CO_S%/Y\].7GX_8S2""0%0&<KR7*K41R[$66A
M'_X/:VB/OB+>J*:6O+!GUV4%3\8-6;BW/A+.1WI#[H35HOJCR<L25=RVX*-U
MHZ_XZ/U72XZ[_;WL=NV7Y^W^E=ON9UM"$X0'_35_&^8:XL*;LEBYC?\(5EOB
M).Q I)^N2'FK$\=UNN6X"=",T/ZP,^ &VX3C,OI,EY$8#PNI'S]_S91B[3GS
M88( AWQE=I77R,M+RF^-5$PP\YOB;2GL<=2V4^P1E<V+:G%..2Y5QI,P6IP*
MSW)($.HMR:.O@_7:^<18TC$(;P766@Z,%9JCWAJHO&VE?4PB%24.FXJ7D<4#
MEA.JIVH\@8+V#S&]?O^4<(A'#^X>'.)H3SZ&/2'OB+T.C<I? 8\>3H=?F4LV
M&SM[.)G&-9"1TT?.D=9E:%9-\/R0,/9%1L&*X#22_*]^U(/0HFHI[92"YQ)A
MKXM".!$@7$SJQ\%M?1A9.EA:E1VJG,'',"KKFDE_W6U89N_)F<&]3D,H1?9G
M0@LKG-/KDM(Y]AYTCH.P*W92:*&%2QA\S][32:Y=OAA3XO0HH)ME+C='EQL^
MX%(7O3,/G.3HE0:]I&2(C]@%JSM-R6Z4:F2 TZ&.!$WD_0_>VNEW:DJ]OXP^
M0 /GT02\#Q- #_;5]S^0(7C$;L7W5[L5-?$0UY?1I3Q;4FJ'RC,O<333]$=(
M*Y-WM_L"J>$FWS'+XLN\V<]^E):L&!PY6BF*V(Y^Z.>Y: BJ"DZPV:,'NF:N
MKN[HR<'F2Z*3QW5%FBQ+8)S.TB($-)=^/GUU.GOXUV^_^3(RY% F5%*;C_-E
M"(7S!<%7,@_LBAEO#6GX*QI6:^^3$.46;Q=$B1"^<CJ3S"38.=M23%Y,=FN[
MB@K_,7"&09%SU)X8L95">^\TAO&Z#H/&R8/P9T4%S)HK>K>+AKBB#^,9RK$>
M<68W,G81^N$&9XH<,$W9:A- 'SWE&CV-C3#$V7OGCJ"'9 A+F"Y%:I[E>\$3
MY"L2@-5 )BUX&?Y!P(1A 5$[$W$@$K.%3X=Q05I\F4NL(O#$#SHJ>F^7OIRO
M]U-=3!-69J*!^EK7C*HP4@K4W@Z\U$4 02DG\QT7\_$%>7!]V26-7;VSA@G1
M(PO_!#,TO\ ))D9;)9()D:TCO!7<NR5#@Z!0\5'2:\N$V8.-S2>,PC93_Y,N
MTY] 8#.8#[:=_?SS:]_/E"OIB,B\0'@,A"[S?(]48\M]EK(J1]=;< >K\UQ3
M[<MZ2WXEOSK37R*+3[3F IZV*8Y5K3&Z,"+2 *ULQ-X%H]RPRT>_7H<86-Q*
MB=.!V.3AU3=6KY%:W,D+Y^[AB&)]%J)[RD&1^$ZDA8>0'^P?IIQZ7/'"?WWP
M]>P9!(UYO;Q4?$@)"K*Z64:IZ B%; IL.!LVPD5F=!UJ*V%$')2AZB71EP@R
M,C(N?Q7M=W@3VV13%*:G>%^J/ 'ZB1S!U'=IXE\7N[V<:58:YC-G+/']"STR
M?5ERM@\TZJ$K&SO/2B5)6/*P*S=<KQ%1B](-(:<U;**EWI]7^3)'-=$]WC=Z
M1W+3Y+SA'_$%N3HN]]6@H63!;DX>2PNK>?)T6S6-"H?E'[Z6&7_X_:/OU/2^
MKH')>JW,(&<+-00>:<K6C NRNKG;0M\NW%" %',J^&,EJSA&^.Q, #_/?7SR
M$LM=45Q$%2^[S2ZK-#.N-U=;2$-D99T)O)-H]#1/JJ?V/HZ/^+_!./RB,:@^
M%0"]9XM_=26G@H(CTUJ_HC[,Z>S9RG?[9,ET*W.NGV?DS!PM/V]U%(4-..VL
MQF5AG4K:$D3 MLX(#5SC<EJ,M\7[2!8OQB)B\IY1LJK<SGZ"V_^*EDVR<["E
MZ95_HCZH\)M?\@0;\_RG7Q0:@]V\D<7$VRD: XX!QIJE>/'$:B?U6RL;XC))
M(0S/>HJGK;T84,MP(.D:&R.=TE$,5WOA4-0I&_SCVIJB<;<G[A1$#WI3"JJ2
M8(OB':X;D@&WLT#GA6IMX8@M]_GIGQ?!^W.8E0M9D#&<4/^*%B2=%66$TP\7
M')NT?G?UN'6F(]^'M-'Z4\V1VR:<6IMG7%S5C;%V6C64&XFO$K@C!X,83MH=
MA3F&1\.J?V)"CEXM4O/9<MF#];VKX!VI*:(!,5J!6!8L7=I\?HAI.IA]1[A/
MR1K*IOFW'7W%X)QNN(= W)-='4[!DWIU(O04$?Z<#ZYFS3WE6RC0%%=*! Y?
M=7BBG,Y>$JN]*+LSX!JPL$PP)EL(C8F#5'K=Q)Q:C&"]ZJKHJ?(!O!-L5'X0
M,(4 JST%.VLU+*'*A2;1LMO.:M>/G*@T8L 97Y?F,[X-2W5#2;[U>=*XQ*>&
MH]53;(<!5>ED4/(Y9=@2((ZL&<<%YI\<;5)H[NXQ(TSB7OE6W(N7, 9*LRX_
M;.PQM@:OT:M!1$-1B[#G5$=:,$&>N+T'/G1]:Q=RJ+1(?;!DH\$D*$!'P)RC
M_^E/$&1;BX(4;GM=;5]]_>#'A'(PJA)YR1'*L9>,K@+<&T$FYF+D;*2$=KA-
M(V0/G#AA\\ EN-IVNF^J$PG9DCR/)%WTG:\U/"F%@Y(A:8INLS^'K?&XWH1M
M4N:4J,\U590/.Z()5:8K-.;)KQ@1+$SRGPVG0C[6AKF?$&/\7V CO\<W 9(<
MORDUJII<RY2W::[1Z\<OGK3J'+%]9DNF^,9@Q>4U%,\89D!5^Y:T#K5SBEQE
M"5!R]CPD FRICQS$HF$ P[D7^S'*ECX1NX!</V%OZ>>4N"IRY'K#\.62MI$G
M,2WYE&*#_3%$X7:8N]84.8N1-A&LS8W0MJ/3KS!0""=W3263M"Q--76L\41(
M*[K*(4=UT\#NNU%[K:-F5S&QEUX ED*'PQE?DJ3.JCW)PYML-M13Q\#H?/92
MZ9GIY5X588L 3OZTFOT8 L39%^5I<1I,*&6!B@@(QLM\F=GD".39@^J_E00Y
MY=RG;[_SM\]GETW)%&Y$+D\HIE)/]A2)&GX0.VO8@WJ(,?BI"3OPP%/ZR+<L
MI;\/.XR%(FEXY!'&^C,D6HJ>M&92)=;1W60R%T#@,F.6LCTAX.$TJZM754L?
M+TE,42CG!%DSY .BF6+:B*X9LERDJ5Q#-[_WT^;/B4QX>/>0"1\?*6S &\GI
MC";1F4^!.] <7>(N1]N@]PG10>!H2'PB;%E(#MSY6./\K7JD#MEV@ 'GPZ]W
M9'";68E6,>-N&Y+R&#Q .2.XPIU2A"/!3!?9U&";,NFS77! JL7!N:BY<'XR
MN7$.24C_HN'K8>M39L>G:!#A*7.=!OA(-'2;-VI_PI/<"\=S@H^B"Y>8/4:J
M8A/.+R'WOL>TL6?[V=E%OJ3B$&VQ8&7HW$#*O 30058(U3Y:\8H(]X#CA529
M"F+Z>Q$.DO6FGJ,O,,DH$;DH>BFH7$(\WE71-=SA>E$VM3"U@T]",YVT=*L0
MVG*K -%)K,DI43X,92[B%C9(K:Z%4J\6;G3N>:0^X4JB!?OSAJD6\,2CCTIG
M(K&3=IZT;UYP IU46)D0*>[YL+>"*1)2JA7%A%H)..^V !UF\GO9='5')1L6
M)@UNJ )'\BAWH6\$1H O:-#%(>:IFOV32-^=5_VL(C'IYH!Z$$W,LL[H?^AE
M&4OH?Q?, GTHNJ'T\5Q[T)!,M=?"4-3;;5?9\$<"=.K89C.U@CPY+1>3_Y(8
MG7R>RT)X.OA6&'\4E Q,0]P9_$593TS)"#X'?)LDOJCOJB"TS^P>;\;?BAG3
MFVRWY5XH]6LB]0.3>3C!Z@,(+,)*O!2N8DQ*;VMA]S)'(R]&WETVX$VA;C [
M0S0=_?7#>WI7U+L-/Q3-"0-JVWT48J$C6.$PO$+H>Q>RSHJ&/F>S@:C$TD9N
MEYW.?HODHOB /4 C?:,_Q9=GIN5U74LG$ 7?1,K"&Y6:*:S!&HS"I-Q<K<$;
M@O.TWH,I=8E1@ACEW3[/)AF7QI?84QG(V9-B2YF!70BHVSL] %<?;[ UEHZ1
ML/PAK.,YA?\4_;PMM]PC_.VW<:%E!"N(?!F(GBE8/6'6OE] N;?J+4YP&CF]
M@A#]):WU='J)H. \1&6Z4->D$A&V(BRYYQI.KHZ'5G%9K367S9))@]A-5D\R
M)X=8\[.F7:.4[8K&S%S+7=9+0).C1SN3[,ABK^ZQ45%9:7?=$/% [S2E5$J^
M8\5V5R82]J3P:CGTS/,]W@7GO(N*,]FQL40.W?-Q NUW7:J?RX9\0H03+0[8
MI__J[*!]1C$&I73N>-NG>!YEFYYJ[&VQE5Z6G'PW@\R&W;PP4$/):)RJ*P/!
M7TICD"X8;Q'A1'4 *AQJ8<'OI!F#@+Y1"YFBPMYC&>T?[5 ^1J.;RETBQ&BD
M.Q(;A$*Y"VP*H?[(/6,OB\I?0$$9#2K$&3PO#G7%)Q"K6[.[=QH&O'9@NGU#
M#9-ATQ=YHR^SS _LF)$W!. >#PV5.>C8I>OI@))4_,Z<*+EAO X]\J9<[;VJ
M3;<#!Q#4E'G(C&,M\=ZX'5P<BLN"C_H_U4'ZF%R@JHT9AA^UE^=.C\)-@\7+
M0KF3P^\Y="S"X<B!SN!<G!^B'\MDM$UQ+F3^U@.URQ=O@M7'IGI3(5V:[]W'
M&V+%KUQ VM2;@@D%-SM1B2\J8>(V:&S*Y^X%H9)'O,^"2R\DCBOWJE62SHXT
M5+=6D^9 VZWOE ])-,?.Q1L1&:>V=U4JM_0,I.(/=SEB8I[8+%$HB4TK28Q!
M#\36-:7?$P]"G01(7\<I[7E3_HIXA,N"E^5L7E>=**6<AWN?<."?#@&O3@YW
MR36$D8<QC._LRBM)<B%!#D2-BSVEY.LX:/0*PBT5-1KN]+J\I5'].>[9W\)X
MT3E]IU__VFWI13D B.1>DR3<79S7!$N]9,@TM:M:OB8LM*VB&X(?A,<LQ2_A
ME>W7/-^,E=C)^;^(-</@!Q0.;*QKW$4VGOHO7O(B7_2V1[XA?#)')R48!U>X
MW#D:'U0D#\X&0\%!9)M?C-ST=!91?+95\W#/IBR$G*\&![SBOY-A<\?3I:PE
MG[KW6RV,?(7,OFW$=E\OWL2:FU71-\4:IP@;*_<#U;U>>'DK3CC<]7Z(VSI&
M83&'>?I;B ME*SOHX)T>B)OD[KB_,OKPOGF C@JXV@/?XS=KW)G5Z R@E*MP
M)FX 4Z@DS%^4.SX%PWE8M^W)JJL6$G%31 !6(TJC0N$P_#*$ .?E+HVN;5GZ
M^P[TS-+3',CN@AC-&F9."GN1DHO""1UB)@W\A2QW5:")$RV?G.?@\YBFROI$
M4VE=%FM:AX.Y1.D<*<>:KE#3DZ!/)+5*E-HG5 ?3BEE?'@<H99,^QYI79#+
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M1<E)B*MZ'*]J6U1^9A,N3TFUN<=>W.%)P3=E$"[;A#TXMN$/3WBE8$3L$=;
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MTN =ODM).E)-6 *<<T<_7BZ\ 2JRXYX_^AETP_' B-T2D@[:"';:,0V$,X&
M\FO=!83(HJR[Q!=U&+E%C(:(^7)S[?%^GVW1TZK59@ZA1)"6R4T??2V!U/C9
M/6R]8Q3&@3]Q:^T:]YGC4CW9G4(0IXF"UPAYB^#KBYHV/?;:#C=:J6R,]B80
M0NK*$!JP5[1W. )9$R#K7S];(.MGLU_,"U?A';_,U3Y3L,6[I>60KLW2LUF8
MJ$CN@MME&E:L#3M"UK[D.J?"4>L$O68[H3TDS;@A5ED%CU^;.X+ANRCKC;&L
MN_*H1B_"ZI//J?U/FJ3Y_LG6F^9E0SM[Y&;SVF?NS/-]URX)Y#BYG,3;1:'Y
M(L0CFDURO[.$T8IV.R*===VPR<J$)5 [<[AAWM![DDI>#4Z_]$A"8)-!"R:<
M3I2DHCBD;/EL'LE493,+ZL-B">?^9BL+!D&;A5AU?]:2.#7Q :FC!S^9;_38
MXU"+NF!P\'-S[;Q ]=N[DF'Q-KNZ8;#BOEC#YW,P9UUD\4_,%0';3!W(>K_P
MN%5=G2A-WZ(PZ4]Q=8(C$5[WG*1ZF"*$ =4Y05ZY'0E"+7(T"["YU[4ZZW6M
M>DVEA!HAYCDHA@VC4%=5X83K1-^ &.*B<M"H;MD-GM66=WC@.?(F>_MRU^L@
MU^\QOP=U8C]+MIO+U=G8Q_(N88 5$83AO3P/:]8$!Z2MW9W/;IM+4M]1*>H<
M.2-#$Y5Q?]MP;^H&TTU'5B#9C3Z/ZV,/V6%"(1'M13"1B"9&=A1W0+J=U!\H
M,434F)KU01^\9WHH"ZU(C#>761_9?6L=NVT?.4V.!H%IC5H6A$)O"(=6"0T]
MYX(UC%$>/R909\FJJ51>JK^32"V^ 3\'-290?M#K;[0P@M3Q.&SE51:2S7VF
MU4"4*>(C5^1)D\%5$1V5LO."M=3O["?>$ L]E *Z9P>I>+!6B$XC+(8JW"VF
M%Y.)*=D""M/+0@;"#!=V((5Q6]91]:1RPDB#Q\DF7AY7:M_]49+EY>5E!$PP
MS >V]RPAF%B"5W[$/H/<X#N$XQ_[23%N]V$AN,SPWX^9X0_]BB^'E*HB3J[,
M^[YOI9$$FU.2M!H*R]/"W ^*IUZ0AN5$A6M+O"L!Y+1MO2C1+*[.?+B7W?\T
MM1%7'1I)C#@:0*E,XW.\9<.7Y'^4HCOA4,-:MV[!I\##4J.G06UVU#.XQWZ
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MYH[S(*TXSXE/.R\.M2S^5*T.AK$M]+?:RG4DN_L<J09 -AUN M".Y<>K@LQ
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MU:Z_HDBO<;:5XT>JLV!#1 (:]2;H-CX)+S%&"O-!\$[-KR?SPPF:8!&]ISU
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MA0M)+B>RL[*J%*?"#LNCW34['!P$]?K0#;;GCE+^D$IZ=1@*31X8 EAJY>Z
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M'=KU'ZE[8?2<Z2REWVE8C+DL&.^."EJ^8_^HY&2=OZL4:\<?KPU_8EJUZV1
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M:A)'O/J +6LR6%M:/V^IX5.S$;J.DW@<Q:\-<QQRTVZN^7+0(T2K=[=15N:
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ME("?M"H)2Q'6)=?R21TRDY$W"3#^9.!!99;Q,B6/!%0+D%/.F/*DBS_9)>(
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M3/8/^+S\8>RY:..Z#4?2\G>D;.;/']HY0KI#BG6QX>+1Q]5#4)Q?G&>_:_.
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M(>_%-]Q&RL&,&0A]$S ]IPN?/05W.!?J2$? ZQX#E^P((Q2):%H,>+GJ1(9
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ME'#A8,7*2B+/?VZ'F;6_VP:+WD2J!"*L"2.<W/0^@+[LC:"2WW@KZ#$?R8A
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M#6.GN(!UA0R?;";7,OQ:[$\=%XU\8[ZUS*8T[(O['4#=/37F\ \-NF/W]?!
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MSU)&:*^@$U5?.4L('K3\HCA-S(>>F%@<BHUS0)SE%5"IJ>^GRL.G>?G@(=C
M#_2*LTDC0;1KC*BSGJU8W;]L!)1<UATX8AK1O)5_?TE[\32C'WA&C[0QJ<Y
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MI=;#?NW0F:>B?E+4_^*C*^I_=!MDT &>0 M]8"L(0CG(A;.N3[X1KL)9Z)&
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M61?>D5AOI4[MWI,6:KD&2I13\:@VNW(&-^!@-9OVC=K:>!)J&5S&_M4[+AT
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MJNS4WYR$/\"6\33E<D_&UPY8QUW)FHS;7,5:VN,IN['.<2F:2.GF7U5YN36
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M4QY\I'E ]Q\38/'\HP58G';-+]\UQA1<6[B8^Z-_K3Q<9&*#6ZDR<PY4>.J
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M9=KQ;F AP[!WN>TC=Y57LQ $'VO+Y5XUH9:%$MS\3MX*7O$!&^X76.(3&K+
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M-J_&+UH\Z S?B_%2-="FE[@)@W:1D^+%VI1>G8W@F='Q3>9(G*@W,1!YI2'
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MXCW@9LE ,9I41/*L'7FM5R)X]@3)&6%CW@MP8N6"H&OQ;%GRSI+\I.IFET)
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M)[&@ ,!0HRQ5G6#MKP2=B#*WZ&GLYBD>KUY"KT69P?%<J)*E(!L5?>ZI=+C
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M@D<O9$^S6Q>&'[P4?89H:EFNI7EV =9<-5K!KW@VA7>%>4EO'S<VI6[#WFC
M3B.I.A2YG'8M"OYE93U* 0N?X*G0-TM>O5 KIT')_YKB5^2P1V"%XJ$<PS=Z
MVT^'VLHICEAQD61T <PEW-0S)O:L1)&X,6#F*1N7_+7ZX4V4E..4S5XG&;V?
MOO1&#B\O('S#G"BB%XJ/WUPGT>3R->5]DZA0W@SY9OEQCSZ:$Y#B,W?0ZYO^
MRH]!X[SC9YZS^J4W??.FR5IFSW?M;K)K3W:)&J%H+LLS?J<G=VH#-IOL>GQP
MB]?PAS>X>_+6)V\Y@AWRSRXWYV]8TTHMW[+767_($;?J:7; 7[H#?W!6E-J[
M#!688Q[R40 JC6/I:^S);40TW,T=.2)];)-(Q582_/+%?0$UD17A)6F>QZ"P
MIOF8X&'?K=^BYU9>:%C-&T08MYLJP!BRU@G4K+/@Y[9QYB-NW$/<@2OGMELG
ML>"KO--2?X1X=VN_ED:KU1SDDP[MQ<.2]'V+C9U_Y:/R^#;MW/,J6&KI*E%#
M5_FA=H(_&.#:_PC5[H28+%^WS$VAS[:OH*0CN=TA.=O477>/4%_OWS/9D?$.
MD/&!HSO.!@7?6TS!>QI>[S_7+MF;Q]8?.S8Y)_VW=IXK]><#Q..SS3=?_H>-
MQF^.Z3?KS:M*KX:'PP)1E",MF&DO259H>:$A4?Y#BZ8%!I(QJ#R#\37>\AV+
MS7$L2A^P,%X?8M2]J,+46LE$&G221XB]B/ZAGG9^F=2OU:[A:U&17/$,)Y#F
MU[S00E@@4BWLXC1*8)(*R3&:<C4TOBKE%!N7L?/WY[8U:']W=LL*-#EY4X=!
MXI)/< Z7L*_PT;C@QJ?C0TTD,\" +)PD5P0M3;LL'\-YP-Q$E%[.<S'HOE9F
MB#Q1UQ;FVC@O$QSU-<7^88?J&#1&R!I?E!%LL_X*"\#$G$Y6?V7!&_-$A&OT
MAT9[0YK_7E8^F#&[X$8 )//-8#%,]S5+K]FL?/%3.V$@R8RY79S?@-4GT:4?
M;%>,>*<"VMUDNU2!'7IR%Z.<#QW6W]$8]@]$]?=U2_8ZK'_&4_CCA:[]PC->
MH%X*RNAA!*I/4DX*4A2["'\7X7_2"/_S"R!W ?<NX-Z]L@N./X2*6]WX%XT;
MG[5O_"Y.WD5[<&G]@>X.=[][1$=RNT-RCJV[9D=R'<D](LGU=7/X-/U7NL#V
MVBE;EM5[FHRM+KI=!=]HQ-=8WIR$-YME.Q7O7D<E5J'OLU\H]GVX&/M.LE;L
MFX0*!;^1<G\\^CTN$A@,O]K31-1;O; 9]8:G1JR +<))-$K7J9&>_Z:4->'3
M^7)Z#N^BJ+,(1Z=LFH67&@P/G,/+LAFNCF$:XWS"81S<*A70SF,1,\>0/):4
M-[XA*ONQ;#ZK)YUD&LST&\<*=7JG^ UK\$7R 1;#4_4\O>([K&O"85TO+5L'
M<A-GU!XOIT:-<N[CE&69&KNQP.;$)CF2,CSSTM.!Q'JT6U7\74R@=:SS4['P
M:RJ18&XVE[!Y(8BCB=XXE21K[CLMFT>48<!B+. O>]H'?L%279OP\#(#!KB8
MT6-)5DX+EH5\C6GYA NX.=^MCS511?F[B'475^TFVT6L=^S)70S@=1'K+F+=
M1:S?GF17O)Q0.BKJ1:(YMVQ1=2!#U:]T+>/K=*EZKF'7+E[=Q:N[>'47K]ZS
M2.[S>.7SBE?/W??"QR,Q\0_XAO=]%\?9XSB.K5MV?^?#.!W%[0[%'0SNT &A
MH[6.UNXDW8;>IDW'MH_B]CM([7A>[VER5W8U2+TK\.8W:*&D>U(,]B5I(!0@
M;8=Y!4DLC_6*W^8"OLFRUTEE5[P/4<7A]EGRLN4Q92J5YJT Y=*7+-6LY^JJ
M9;$RO!JV*-/":5'P+)P1)OK2B*T.%*-C?/3EP#2U% .<6LDGDY33VQMPY$P+
M6/:MF(XG,%Z8LF1$,.D7&9P557W7H7!1":ZKV21HY,-ZU H6I]&746-1%@[;
MD-*@V&4+" 5+OZ>%C$*+J":'E8E \>)@S@-'6+NBX"X0V$VV"['N[).[&''J
M0JQ=B+4+L8*R*U4I&4[M JE=(+4+I':!U.W;KRZ0VKVR"Z2N&TB5MSI?^U;O
M @I['% X&.I#MPM?;=.1[#.U6;8^'#YZV]>.W)XGN3FZZ>T1VOI>1DMMIPN6
M[ENPU+*7:)H4K"1M@^)O+\55T I=EK?4P\+7!+(RC#OF6,')TYFN)64S>%B%
M &5?YO<\**:LF.%7'>U3/N%E#TL%1#&J"":6U%AYFDU*C1587#D=YUD]4G,%
M?=WM#VG6G&&!J4"BQJGARUKMF>'QB <3F%\Y;11MXBB6;KL#L0_#X>"F^*UV
MR_)[VA%%7B<U*/;<K%E:YG7U[4M;MVV/8IG /CA/EBY9Z346ZK:[86<Y!FE'
M^175T^('DR*A66 P%V:MQ44^6K7GFM/WM(C-L'0X3?-K'"0'#DWH_6J'%.[V
MDN_#AE9_MOJX)UAF?,9YU>SY@:B<1EQ6[[Z<[G&VFO5:.YN.1CA76-(9<&,2
M@Q""4SH,J1P8E_\9C-,PJ0&6GH)+D6,PXLVF0 Q4#YZ1S4S<%,/A9%2C7$[@
M#QBF;]1Q ^M\9L5$.SG1M1/X5!N(XP-V/,RR*7SK"Q\#.]#)Y<5(LTSC_XC4
MXVE!:081G[ D!7;\W(CEWT; \RS&!)-%24D;2^SEZ9[MZ]KU90(L"O-IMUN7
M>03$X[3V*!^KT0[/?B4F,\Q^3]M:Z@+R^@#KT<XY;.LQ+/^YD]!2LNHR,[K,
MC&ZRNS_9+C.CR\SH,C.ZS(PN,T,L[A<&>A/96F#V4AXO*$TAS __GB8L2%*1
ML-JE;'0I&UW*1I>RL7W[U:5L=*_L4C;6TV_7O>Z[5([G'>VT+7_G8YT=O>T.
MO3FZTW\:,.:.XIXGQ1TXNN7ZNYP]M-^Y' =#I^=U?<?W)X_#@\6>38.2_S7%
M# ,)0HXQO;01@<6_U07;NG;-FV'6+,^,D)67=6'X2]!41.X#72'WD0)291[<
MXA&;7+*)=LDB+> \@X?Q 8Q25BD).$;$ZQ"F"@M?L8BGVAF\,F'I9*9]OF3%
MB(5\2C19ZMJ'#T<8SFQD+EC#+@+912"[R>[!9+L(9!>!["*0702RBT"J*C)"
MUSEGW[N&T%V0L0LR=D'&;=RO+LC8O;(+,JY;%TXW^H1]UP*>\3CI@+2?N[/=
M\O2!U=]E;WM';KM$;K9N669';EMT)OM,;H[NFSLMW/8\E.B8O4<_GNT():[M
M(=H1U?(S+] V9!<4E4.@95 Q$39:@31/[LN-9"_=J=T@>,OOW=Q]?M=I^QF>
MJ>T,>DYWJ.L\N@O'>7]AGKU9_QUS7QXQA\5>,O.MG>=)1FDN.J6A) LNF7:_
M]Y>DPFK7ESQKM8W [Y8,OEGA*:QH_;#R)2+7!ML]U#WKZ\8/A'-28X<TOTII
M."Q;> OUJH#I,,*]D+T6Y&>_]LYZZIWZ1JM)2C%'!AS"TA2A-N(2WB3GF.59
M@<T;"GQGQB;30N"+U/-M5,C-DX0\%M<6ZM4X+VF]KPEH!G:B3H;!\'_CBS*5
MQJR_PH(R3Z>3U5]9<*(_$?49OFFT-Z3Y[V51RZP+;@1PP-\,%L-T7[/TFLW*
M%S^U5C5*,F-N%^<W8'7*T_:R:+L1"9)BG7Q6LK2"L#E"&LYF__/_!K;EORFU
M?^7E&%$^M,]%'DU#1!K*(J#=LI2*L?A2 3QUE1334CM,(EW[PM.$Q_3HNS#/
M\E$2:F>B(\E,.PPGV@%^#5]BFV^.#K^\.\._TN_6FU=-%EM)Z>T4L&'[#EHO
M.2V)_ODB\?I!,/2"P.71T(W[#'X+N!M9@SZWK2@._MNW7OS8ZQ_NJ!?B1W#4
M8AZ8"UA0&N!K,#=Y@4^]>/LA^6N:1'@&>#)'3)SL%U[F4[!URENNF_:2+?>1
MUTPC+D.<6;8++]Z>@@9RE<#H"&0DUD>K_K44+7&.6'FY_3?K[UR[9%><<C^S
M7"LX7&93+EAW+#B2V+?4R@2!J)KLC. VB^R;9]J_IQG7'%.U5H)W(&112(FR
MP*UPV<$K")(,.';Q E1YKV@+EYQ3%F<\I7L*OJ30;/")$!:$2J 6P;S3?$P-
MDW(A%ZH7X33'!8?KD.BU'A^NTQ'8X C"D[)I%E[B5]^?V]9 UQ+9T^B*1SWM
ML ;\HBS>$9O!U2WNX8(E9>O>#R75PV?E=$PH/6N^2*_@TM3<(^VBR*\GEW6J
M+4QFLHB!1K.ZY"FL&C.*<9B5K9I>6IZO@Q@4.;_729K"M:]-47DJ88/*&)EW
M)@8J./!S(=&)Q/-<?(6()IH6*C=X<LU3^,L()GXYGZNLIFD_4M[O4_#1>TE3
MEBWV0*EEL!.X10M;02<&Q_Z5V )W%LDT3KX34-1HE$S$IM-F2UPH[2!Y59%7
MXR$=/DA>M0#^<+ :(TX0%CP$3XDT\#&;T5>).1>F@9A@Q@0QM.YM0C@!Y,&9
M8E'0H+,P&<,7I219;[H[34$;WC#J_CQJ;/\3 9K]D+5XRPG,7?OVTZ@ZRY>\
M6MBB_,LSWB![8 V4U'3;) 1QB&*\8,!9,(]I##_ %58T,3GA;UB!,=.FXXL"
MQ'M9W0!C4"@ND?3Q#U>L67.!,EG<=#""$MU2HVV\J+ICA($[R063EI,*2JXQ
M=?@-&)7Z]T5RV+F6?I[NR0Z!^"Q=Y]6C:)>F'']OW @*LW.I^".Y0]<_FK/S
MW0-UQQTLF^62T9<A@MY%2CR!WD7PC41';(&*6"8:3BZG(!+4I%1D8>TPB),"
M#O>O*9C]\ QL'VXTG1C)[$H?0I3-5'M_?"@5#R&"E=JQ\#9!/JT)"I5AX=1@
MQ_#:H[/I:=JSDM4(-JD=%@4F-Y.DWNG%WXAKJ52=ILJWEKI#A -7^0V:BNC<
MJO>';D^[PWN<C=[CZ+;C"G>#4D9T@7XZ0J\8R&5=*,RNH_L>&#*GF?:1@5R6
M.+NX+%D ]Y[@/#D8?3/87^U#,D+(3U!DU%].RA1>A)*3C\8"#93\(/1Z\@Q&
MH&@#ZUU?YFDZ,_)KK+\KIT$)]K2$RVVX3UK^C9.RG&)%H'!NZ/B.<(KO@''9
M1<&YNBSX]Y"R[V%)EJ\[OJ>AKZ^Q*]&T@3$LMY3,)0;VSK6&!"/V#K_W3HY&
M-L89SQ"JMA[F-)SD>#*V'*4YX>JSZLV59Z;YF'J!^E!((C!'&%A]</HO[3XM
M@EW (B] ##642@%;?1-N,E$)#D7%D*PZ<PT!6NGRG-N([055EK"W1@5[^U1J
M(LT)*7H+=\EV$'NZJME]=_64^C1-:POP@7?;(M_48U<YFCZ@5;F?5_0:9@O9
MU,(-EL=Q M<6S#$4I@937C\T-LHI$":IZDI-E9#Z>0"+K R2ET/?)9F/JBN0
M)II%I)^+ 6MOPMS7+'W@./3%@,,ESS/MWZ!W-J\>'&!^(=Z6R6':<"&'S=>2
MLI[43-\"L?+L1<U1<]//U%:KL(#V/LVO[R!^GGY=.V!9GP+MD_,ZQDT6D8PJ
MQ* #C5^AIP-;=605/^!OB)E!3G(=&WP4/$Z%BT-:URTV:C / FI4;].I34I)
M'2Y4*%1$,BH<#=267S^5\%I^J!N%Y59&Y78';6/8<YQ!A][03?;!)MOO<#$Z
MM(O]P&OH("R6U82*++Z?M /8$OJY79*QBT2]?*V?^$2HK >_8ICI)'N%F1Y7
M"9+#S[/[PG'8B6/O@"NV'[ABY_;FA[ KGBU%;0N"Q4X -CR/5SXO6(K:E5W[
M+7ZH*+DKNW[:LE[?UYVNRG^KSF2?R<T=Z+[C=N2V16>RS^1F#W3/[U EMO>
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M-L84O35I+>))\MTB\^Z/W-OT9@)]"Q[,JLX7K<MIES?BQ@N A(7L5R4W0.#
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M%SH#=V#"CQ$;.I$W8'[D^2&+^Q%'J64-I=2RAIW4VG:I9<])+<?Q')OUAT8
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MW\9I-G+:W ;=,,^0(RKUO4_35-.D$5\G$WA;N,;$SSC76!CF(YC-#,VG+)_
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MH$('$YFQ(=9F-.*:/KM+'_=#7+>D/Q'7B\;UM")5(D7%>08A.2V>I<K@(]5
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M!$BTQH@HURR)"L99)&+'N<<"SGO8DA&<MP'GS&'F0I*:10V2\**_+-/@<C;
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M=1RDB1"#+S=\;$9,I*.Q:\"9/M?'M\L$/.D<*&:JT4IH);026@FMU"4K+3+
MNQ;W3\:3PW0T&>\.U\K*U2MP!R_<(&X>/7?'@XD[:)1((T2>7](AK])_3P;C
MP22]3J-/@Y#.9/NK%(8?CIIW:10\=OIM3\6_F0T4$Y8$%\P"2<F"L%2",8D
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M)Z516F2.Q6 1%:*3\U8T/!O1L![N46L>W)T<F#,/@(998G1,M-:2L,P(PL&
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MFI=?-"FI<>?2W?YP:I'TQN?SCG<G>O/F94W'\Y?5YBBP!*YKX/7EPK._#7I
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MU=JF+^!#^6<A;83^70]7A2QR3<Z(90(JQ$E.8\7R0@AM"R%%6K L=ADKEN-
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MWDUW*DP1]49#M;-C^3W2<(Q=SZY@M6':P=L,GA"0EA"FJC_X%NIJJM^%?-'
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MEMB96PCRM <)M'.QK&H,ZG270P1+5VYCH^3B6%:#X2K(4MF4)/AR021BM\T
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MW:6[Y>TJL%#\>/E2SLY(IF40V#YY._!R&YOXO/K\N/%A(_IS:^OM%,:[@2D
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M "U7,KN<S^K7Y _8 U$M@!W;[Z=5G*P>7805*+W!*,PVJG%7R[15#6P,\BA
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M85R%,-#93Q67.D\U,7 TA(D,$U(Z)JDU&2W@GUEB7FPFK),M(0P/IX@IZKI
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M _=KW:NWL,KHS/K61SS<('/FXCT;T7QT:!F5+P2)PNRQ*<@J*-T.=L.A'NO
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MB!,=SJ_FZ:;KQ6E2.XW: )$8[?%49LWN*I29_*DSV6I"#K\WDY.HQ,E>]65
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M4(&3T4PCQJA 7'J-7,(1,9$%=3"*1+^*<OIUQ?]OUT6FFG7?:>J77NX&E-,
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MB"YNAGLA>G$W@&##B+8(Q+! G+J$G.4))4T5(<H%P< TN6+'\SG'8[QL,*\
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M$W5.@+V""+49]A0CJR5%.F'/A+#46U57N) /E3ZX@+Z OC@B'QS7"^*<:YM
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MA.S7/_$D<)^8ZM0.J_^Y#:'<Y3#.]YAEMC_/GDGN<0CGM'VP#R.*70#;F(1
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MTJ($?[6[C]_=X(32W&,4'56(&ZMS'!PCSZEE$7[XY.?:W85!?+6[C]_=B$/
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M7"OTUCDM*!5(M/ ?O#K@D3(6<R<CQ3$:F8PN\ AL<TKD//D^GZV/;Z%+[R/
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MT,$9&1; <TYF:X9M52Y$NET[EJPG1P8F>@'O"/J=S"*88WBP]CRJY8.3M0R
MZ@E'P4EQG\>@#3>"IVN;,D:0\2IFB#[OM].U)C>'04H;A+<;>]F )'MQGF?(
MC<T$O%1&[=(M/.N-2J!>N<WR,LW:8 1#-!VR=K[QT[;*^8J_ 2?NM-T<!LJ5
M&#AN#WX 0U-VGQV 67&A_24-ZOB-'@.=%Q8DG^)<W,BJWX(N)R4%/"FYZ'$/
M2&0W,8Q!<M>33LUT;J^X;M(J4):, 8-S4+IDVD&:V]UN[XM)@;5QUW< H8,,
M"^/S35;;,84O24:,@U+IQK(PKGV2GRL#2#X[G5'1^P6EO*SB!SEB *=%X">
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M2&FP/,%+6F#%B G /O0665'V854NT:(+-%Y&&DV080HS*4R?5+M4EFLR8*K
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M,OC!24CZ '>^;+0'C<'(G@8W3$M.Y[TA:$C;=.:RFT"A0M]T.G T(*F'(^
M.+H]'#3L: #7'X"2]=N#U,>\-QHV>K%QW@^#I(=)]^)H"*C;Z)B+P2B=DSYS
M'=,^&S1R3Z'@\[W[/3^"QQC?^7*K<1[Z@UX7;M;NGH[Z\$&2Z,1ITD]GH"(.
M'G4K%VKO=. 51G H7 9.2V</S=>M1C@[[_0ND][G<\[AZET7I@E;#>"K0[A-
M8WABAODE EP/?@L-(#?MKNE?PGFC/GP,;S5^V^W&[!B:7"-WD-CO-2-X<1)
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ML',4<;"4"(^,*](BL" HI?XA@0WV@7D6PU+U?!>UL@6V!<>.!QR!D$7FE(V
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M?];N5MM?OX2[.:\+HW)M<(&N-[(K0?LI0YLGE&H##IV1D8,'8:W5%%B5T!'
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M,>*:&F2QMXC(R'+?1T7NI7Y<&)['C4;__/0T2^-4L9KOGCKXUFTZWH:M!K]
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M--YH;&5*N4"#15V@>6:_GD47_DUG>V\WNKD>XCK >11^3<K"4R(X-5X@Q:)
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M(;P*E"'HZ\TD_?-$8YE<KMT =_?9O:;#\E;I@[7ZTUVF <\\8(EA1H1#3&F
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M_+ 2>9O0\:VFJ2=HLHU*U*\V7/3VO \M:17B</"CU1N*,V:=>;#2?BO$WK5
MY&UQW;(9E^7;C*AT#IN97ZL0=\P-OCAJ^:.?RS0>V=#H= >EP.2U8&/CXX-?
M>>1E"X'1XFWZ=]!'5 ,![8'F7_Y\1.X3#"XT9/,7\N=%]_7B6;<0<2T4]6(_
M5BK&6;AT(L)Z$9'NZ=KA/]'D>ZR8:O4,3LNEC;-NOQCB#X6EP#A4ZGI5O6;D
MPDJ;#]]<8EV_F].5.R^9T'QZI9@4$<S0[1X9_9E;7, EQ**0-SC'8S \20N_
MN0BY@Y:1DI#< 8S(RO"JH^L]MF>  LCUHCU!-L%;?K#M"WO97_GG;1'%5@>-
M=?YXO]T]@(^59'P-P]W>V=T"7__P,LXS?<0;K^FYSZQ!FZ.$7CR*, M\CR5[
M?!9>7ABQV>.-:NX_.]W_].=Q\]N_VLW-O8N]W1.\?=P^WMG\?+6_^1G2^(_'
M>_0SI/__.FV.S_VG^R?[GYH_X/X7V\>_'>WL?J$0-W"((TZ:QQ^/]KYM'^\=
M0_I_NG<%<S_?/CP(#F)Z[#32W&&8^B&5<$12A#F/D<1@(098J6:Y\Q@V<@3E
M+)<TX6BYBIP::67PT1,F)77$^3BN37NKYQN9LG\R21_UVJFI\$\?^G(:QAO>
MGY^6NLX[.=:88EGY)1=+R_@5S*OYY<!C%8.W'HF0#^ K&?-1D83@[\Q11;6V
M^#XIXX6ISV3)[U+]-X=XE63O4?=B*"U_>M;MP%Q=Q&;VQCX:W2(8];<\H(BI
M1N/>L1BPD<._''S!O5JGD+5 DVT;'OIC& %^N#-.J2:X?$Y!W#6[O;C@,"?B
M,8+#W*QAKIY%%E?,7Q:7KRG],%G<NK&S-_9ANM-O1W!X9(YI%)-,8W(6?8@R
MP]N5GJV%A]_SZ]?"PV_GD;.A]K)0O7[L]N#73L.?]WJQXR\;@Q[<K"J_V6ON
MKY<#\87;4O!@Z9?Z_9_FJ',E63:+[7:_14A0\@I0P]FV[?A:U[O>N/1@Q4IM
MC&9:4$Z%Y#XO?-DD.6->2Z:Y"0>?[UK8OF.CTE^#KC\YZK9A1NQO%0S>2[(2
M^<AR4;F!J4N:I\V+_=WMH^WC/^$93;SS;8_M?-L^V;[Z^WC_VY]'S=/]ULZF
MQ\V_QC8P'7^]W,L;F^@6W?X$[W/U1>P?>[%'O[#M;]OM_4];E_NGG_GVU9<?
M_W/5G.!R)MQZK1-!SM.(>'0<&<E4/H23G/!8F, @?*2K<LI^B'H[]P*Y;8U(
M!2+%Q)66*BA%#$]6:<8(]5R;A&5D061$FDDZMT:DYT6D<;)I2XETDN<ME$H@
M3EA$CCB,I.8L*(%QB@X0B:TJ-BGM72/2 KEMC4@%(BD#1BRU")IP'HG2D5-'
M-<RWQC I7(%(ND:DQ4&DL1@))A$1N'"(!$(0=THAPXU!D6"9=-ZC%VB!2)).
M,CR^IJ+W7)BTJ%B*P\G3U@UO;]9Z;9[LY2.QG"GNBC$8!9[BA>)8<4@ L>&*
M4\^(CU8_8#/\'7 W;1]*'.RD7?NCQKWYX=Z7B=S0^B1,$@(!Q$G$.9/(B$P1
M0Y73@E-MK,FR'Y0^)1!;/&:8M^W4,_@TN*^5D@9A&?S+:<<XT4)+@P-W0<>9
MSR_4KOQ"KCR>5"5#N'=1H>!\RJ<:,-+6*Y2H]SQ*[+TGV94)F1='=>W/"SA)
M>\LI)-34F&0XH+C!)#'./"0CSK!H'G#6Y#&3=.V\LSGOV#QL*!74\X!,4:-E
M(B#KG$5>:!@DB*V4MN"\Y"D%V@4E1EKXQ;-RR:QA![<V([[&$MK3"/07K6-G
MKAT]_/7?#)I'J8UQTN8MWCPR97T(WBGFK/;!QE0LOLV2:=6%I><$]J\3"1;G
M1"9C/4K8$ #VF"GOF$;8$4&H=-0+5A26M)@\:SIS86EA5$-JH*N!KMYE\):!
M;D) UCDA'+5() ;I)\G'IT* ]%/H8 6.EB0^OUT&-=#50+<X[UUO7GC+0#<6
MT2FA8)R40YB60,>0QE;DB,[BY(ET/,UO\\)RB#P]M#KW0O>8UP[_NI%S/[@P
M6VEH\4\T?.WT(K3B*H;A4O2A;74:, ><VMY)K(Z57O.1%&=8GZ-T](2N7NBI
M]<'G >H>6\@>>S;UMX4O&\_ES$4M<#++&RZT7\Z0(V"<J,)!&L4%MRDZ[6RP
MTDLC-0V)WET,J5.#ETL-#B>*O8D+PC3%R(C$$<<J,\4FCZS1EF,J<-+%$KQ0
M\NTMP==8]":Q2-C,>$P2C=YSJ91.(@:=M\12Y356=]<K?HY%-=S,!#?C)5=E
M)=&&.<0ISS^P0"XYAE2BTN@06%1^9=U,$>FHP:8&FX4$&VF-C6"_2CG.@M?1
M"\I]P(I0RXF_^QQ%#3;S!INQV,9;A6T@!MFLQ,&-QDASH1#6*5EGG/0I9A*2
MR57LUP.;.=6B'HP;(YQCU2U0_OX'RHOS%0M\<N*&6ZT\2)%YU5SLQ-0:-'Z)
M/\[@FOB/_'GC/V=PY[FSY]]%+7A3A?MO<'KH]T^VU<ET4#N=&WKLC5ZK#Q]M
MPJ^=PS\*HMYZZ^*LP' R:-Z.0KZ'3W_S\-__:N_3]G=WW&7;QU_Y_K>O=&=W
M_V3[V..=7<_WH"W[IW\>[WW[^ZCYZ5_0QNVC_;;&S8L#X2U.@28D;0YB@C)(
M$YD0CME<1&#,95PA? H3^W_.LO V!Z;^.U;@:JM\6U:Y?7& '5:80B;O(6M'
M>1\ULIQJQ))(P6C*&&4%X]CD"M_,9OED;8#:+-^#69+FEP-'L*$N 40:RQ$7
M42!(P2W26E+ -*\LDROK?%(6#:SREC3 &"7X<RP2W'<2XZ''W1<NEYG%LWF,
M'B=A>*9<(99I%2UQ&A/!O4G2U<<E%]]]QX]I6&V$4!P%3TVNN$ 2I*V#:8$'
MP0O6;9H+O%(NR"GQVJGG7*!0 N+2&*R6@7OKK/!"&$-YM%%*+.=[7++VUIF\
M=8)FQB2"O4HH8)V%P(1'AC",*/BP< HG1?C*NN23J<72JXC6#CMT6,(9A]&6
M.D9N!+4ZT21<H,P([\M)>";IK=IAY^BPXVP$E%'B&$&0J6O$I>'(L:00LQ@+
MXHG7 J^LJRD;R%_/8>>ZIV7Q][O-\S3D$]=XWNO>^9E??Z&Q?"::K1 U#HE"
M$DRX#=)&;XR(40IB*(YX+J<A:PR? <.W+OZ]^_FV7#*WFD6" Q(V"0!QFL7;
MO4'12RDC9ES*M+*NGW+:<58/6/#%ZAK(W@*0U?O[WB"V?1F3@M<2*T$"<HY%
MQ"W\,((H9%2"?$(;ZC"=[P:_&N-JC%N<]Z[W#2XGC.W=AC%ADN2.8DBLM44<
MT NYE!Q*@G,=$@E1NGEN''RI0XQS.72F%IX+=>,A6HJ+0U=4"2,RZ-_0/<_G
MX88]]%XGA?GWST+/&K,Q:3N, Q4B2<9#Y";1Y*ECW'"NHM8UX=%B32X_)O)_
MQ7UDF"GD3*;23L0AIY-'BL$?E*8T1%.<CS<<S^U\_!Q\:#F80FHPK<'TP6 *
M+V5]2 QK;#F71@OE/?'*6$A6660UJ=+"@>E8P4$(D\>09%9NAWCF5[*:$T12
M]%(H*8W)^Q#)*A9SV'%2@VD-IC68W@&F4D5 2BZC2XY[K$S2WG)GC<R[U)6O
MB9L6#DS'RAY)"F8\=BARQ0!,94".&8>2Q,I1SZ@ENJ"HTWBR?+N$8%I41?Y9
M4-!<[_0MWVK[_!3\Q9>_9RMO=<X+$=Y;9YA&GI:5>5OILO+2]?_K>O]<O[V'
M.%]7F*60SAGA'(_!\"0M_.8B#T3+2$E([H!(MC)Z5?6T4]L[;'6&_37&[G'[
M^7-#"8)_)JU-BR-4.[M;#4JN98F?MPT34%6TX5K;YM8(SN&\U1@HQ<.LP/QG
M/.N"974.-UM]W^[VSWMQ%Q[S6QL@Z]7AIUG!3Y?OGV[!O4XN=S9/Z/;F'MZ^
M^C/#S^7.[GX;H.=BY].?1_O'&V0;H&3_?XZP/_V[8[^9\YWCH],]^,[.[F>^
MLPO7'0.$?&KRYC&T^_3OX[WC#;[_Z>-I<_,K 2@1V\>?#RBSC":+44P9/2SQ
M2$N7D#7>*.R(BR:64P8X4PP;&<6#88P0J:R)GL,H6":#,)*X%#RA2:TT(H#Z
M6?:UWGE\)>O..]ILY[*Q<Q9[!0CT&^ZR\4>O&\[]8+7Q.[A>%XRM83NA\2EV
M#WOV[ @L;Z,7[6LZQ%@I>AS8"G@90[?*<'\Z*+<'T1F):?(Z", QIJ3QQ$A.
M&,G$C8;$E<6#L>D]MGL4&\/!/K)]B%(&L7<*7PN-P9$=-%J#1K>P 7ADJ].X
M,S;JEQ@QW\.>G[<_CF,1#*:+O9U4@E&>QBITZM\*E* [? Z6+F ^[<?.=9R$
MWQ]0_6A>'!B:"&<B(NV51MPP"2FCY,@D"%PI@] D^GM6\EYZ<"O4Z1S68_OS
ML0TF0<+O\[!JBCC/,H5,,T0MI\%H8Q()*^O=3IP(7R?^T*@&>A5\/\)0?8_M
M[EG^0X'SOGL*0.I;^9Q@"9W=U#@[LC P/IX7(6?CK)PA^JOYT'C[/(>KA='T
MNNUV#*@7V]'V8[X]S!C%1=>7-!Q\$C)+8@M^@;^>]5IQ8'N7C;-N^S)/-N47
M!M$?=0 =#R_7&B/H]7_^0U.B?NTW?C]JQ=2X-J&\XM7JY]8V[0G<I-4O7N[W
MK9WJ\JV=1B]^;\6+XJ'Y<'M^V6*]K-4IS:YXUT[#YE<I0O)BF0V:DV_6;=A^
M/\*WX8G%UXNML'"+4WA>HPO1N&VW*Q#-[0E5>_IP7>,BPF?PWU[L=\][^<(V
MA%/EC+O6V&C?]&C#]F+5J?#L18+BVEL?YJU?KW8V#B#9C#C9A'@A<ZRE0CHR
MA9@DS&(2551X@9"XGF9G&5P#TVN4WB*G+$"QS\(>T,U(P-A(GPA63LP(Q0T7
MO3TO(7,"ZJZQX<A^CXU^"^)#VVM$L(WN*2!K!J%J+P"@--P80D2(-?TM=,[W
M[=@!)',9SO-O-X@#UU>_9".$?_J8H0ZFA\NSXNN^R@/@3P%NW6NY\^*KIW%P
MU WE'7KQ,.]+Z *0Q\[W5J_;R>^U-A:JCV?^"Q,@[W0:_SKOQ ;#JXV\,K(Z
M.A*Y0!.*/_QWMW_6&L ,6.5(@-Y_Q1OQV6=J>7''#_FY+?^ =]GN#F*#?VA
M G_6[;>&<_C4]K]F&G=K8@?C#G=/=G,GF,'C4/@GA$&0]WWL=4]_SY$,M.!;
M:W T3(&W?E2>M%%$ 3%,'+A.K1\0^ES%7O<=X^-GMKUYR+:O3BZVK_+WFP?!
MN6")92C&3%>G&4>6!H4$598'%XD2D$9WNI/0V"M'I!$*(HK"? <02 $$GL(
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M<+'= HS)M["#!C3["-[,A@BM'T1XQ%FO^[V5,283;L%M&O$'..]YKWCEL^X
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M88?F5%^^>^]9*6%1U?*&%4XE-R@EF3( P1*5A@,%!!)HD>7BWB-AJER2:%S
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MD-*CZ*^*,%T-_5+HMHW(5:E!$6P>ZS-G43J.A&H%,QU'DXAR5OX>OU'XO:8
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M+: 8"0A9KBU.A>6@Y_EJ?BWU.\ILDMD2#L+5'S[UL?PV>PM6:I3@AC*2GR<
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M\<^O^O?!OG7T[7-X].G/7\?GIX.CP<?P^\\H_'%^^NOP_$+_<;Y__>/3C_#
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M5NZB[",A(GO[3A+WP@![P9%(&:64C-@5^C[PD8=WZ%/Z]YAFR%GYO:^4!L"
MZ'U-4F2:C+M;PZRL\=91MH&5!L.(CBC\97B3>V2+;[2 P?QHC')8/VBKG +?
M^HP."5ZTB&XX4T_%E-E-T#RNO),,!F&&W-V99)2&,43]EOQ#.6<4&59.([[
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MT\(DLH H9QWEA$3^[?A7BXGN"<58SF>,/2=I/$KBE@"',%4J,1Q$#S(2P7/
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MM#7-7M ;]:V7!#?PG_YH$&W]?U!+ P04    " !#@'!4;-OYZE89   <(@$
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MGEEBK5V/KD[VK*=H&A"'@(6Z1/YW%BU#F]O *VROIX'*^U2*6/*>=FX6J<N
MC0Q9V,@M[ -Q6P+1'"EU(.4]\,(2FR3-:.QD3P11+6D@T*@;SO&_:+ D(?+
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M"XBW26P$4E[OJZX@13]B/D828-#!HG/$"ED4O6/$!1Z(%E0(D8P.1C;9LZ\
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M?#^G!>/9Y'0\GWY[-LFT=L@<BA6%H<JT=L@H&:2BF?/@04>/-JT)WG<,]^X
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MCB8P'_BD1/8F,&V38CIFRR)Y?\PZ[1+ZH+3HZS#QTF,?"*^[&G(-K3WLCY'
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MU&]CW2:5?E]P.A_.AN./JY4G:\$)1KT!@*).#3DS**HVX0X\@4W>V3;W3MZ
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MJ"XQJ;EQP&-Q=L^N4FL!W9,;< SZV8:4OO,&WD_*_$^8(H4P9U\^QR\XFBQ
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M"6&Q>&.3'>STQ.ZU-Q<?>LFWSX8$%04S1=%L08$]JW,$0ZT5KSI,LLU=I[<
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M6:GI)EK7(48%+&G)"PJ1K&A3O7[8Y+W]308[6[M!7L_[^23]\6DRHD^;+3-
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MYNH4$W4.D24)CAPOZQCX4IC(RMJ"P8G<YHCI3E@/T[OIGY$&G0BO83K+Q=L
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MKU"PZ#Z>=6/8!HBJ6I*/,1W9#=U.:9LGSFXD7L/7\!A95EPEB2N>!X7VCM9
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MG$MM%,W$Z9(O'A@0GZTFALL<7/26FCK5A9KA.X(+I%_6/;IP[UYM-2RN.Y_
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M4GA#@L/#;=8Q*F:!>5?IEJJ'T?V8W#\ERG38H+BK,?Z"?SB['>!_PO#Z<_$
M?8.)OX;%+U_Y&=P>AP?2 ',Z4Z*RS40ZP4D0D1-(6F@5 QZ*Z^2K]3S0GY/E
MA(C484_FUL-=5DAZ.RJWIHO PT57QD^?_6BK( ;>YRP 5-DL-9$:]\[ @L%O
M008>#,^5#J9]C?#G3#D%ZE3H(]W7.)]?*R!;R[U"BG- T]/I2%SRE&0K0K!:
M<&K/>P[]W(Z.-<FZ)5^-WMU=.7>_^>%-B85_,YXL1CDH&7K>E<L+I@,.#%<6
MJS0GU!I&M0-N9,73?(41_9PDQZ!&C?;C!WLMWL\G\3/^<-&(J306O(O;6'8>
M'#A@$$0**&]14IFC)([:1)B)7,L4J<@5]Y(J8_HQ>7]\>O384'TY46_#.,H?
MO?MS!)/IY^'7]S=^-'!1>,Z=)YP+M!6I8"A.[T@IEP$V.FXV.Y;VT0)Y-^ ?
MC[,]*+9&S_:#Y]K]FY /Q<B:WC5_'= 0O(J&$N$X&E5*16(#>!(-* ZXU>"/
M3FL5?FHX/QZ9CTZ*&MWF&V;+.\,M2*])EED1::TCGE,@6:3LC$I4T#I)YA=<
MY* -&2NHK4IK^LZ2F9$=P6<F2%P418IX(O5! $DQ4:]4SCE4BDS\ :L<M%HF
MCZ+R4ZERL%KFETFS2:L(@A(I2A]WB@:V4Y02<-8';GVF(5:A[#T0YU_%8"\6
MC+O11H6@[164=6Y\ S!5JQ0\@'.<J@0'*V>[DEM(MKJZO1594<L(2(O;</:E
MZ[&UI/B4#&[!+.@Z8<8]J/F9J@)UM+R/0&ME8#Q>TQ:+%JYKN/:]&ZTSUG4V
M,08NB&&ESI0UN'YQ8+B2)2X,!.X4JW?J:P:R?_.YA3J;^8-;ZZ)&]8!GH7[Z
M<[S.0W92^YS1!$NAA J4^I\6'%&2)9TX]UST>OVW#>1ET^8P71QEM?F$#%AS
M/$:I&2LQBBJ79B+.$V>#(2)KJPQ0[FT=JW,OF!=.G0/UT6'.U*(2[0Z7U3VD
M;\;SR0HHEX'9$%@YY2%:ER3QBANB)?(_ :Z/::,(VX[:OON\]1QY4%>T'686
M+8"6\>(.^%_@)V_&-S?C/XLU%C\/X=OB]/4N_S:\P3\9CVY+8'AA+$@5"=,)
M;34-GI22&J3LCH&%))UN1H2]7WVV;*@KY [3?6[1_O%U//KT&1Z ? F3&8KA
M US/;\J___X(M0+O."1.#"UFDY:,>!0-$5I"8EEYV.SI\@0U#H)PUA2I+_0.
M4VD>H-X&^>5X\G4\\3-X%_X)L=19N47,;/1^49LGEUPV1&PU'OFLT90+X%*Q
M_6BRU^O/GB+UA-UACDJS=>]9]!F%$C/UA'K@N#7Z0&QBC@C*%.=*2\-8-YO-
M1=.F/R5TF,]Q".E?P*+UV>QJE%[_%0$2I'4C-&D<UPI(E-&6@MZE#(WV1 A#
M+?Z9H)!K+#H[$9TUH7I7285\AQ)+4IKP+9R/X% ,)C/"3"@Q)3D3ZYTA3,D@
M/(,,O(X/]CZ*'_LZYF!]5*@ELL:R[LG8 $W5"YF'>(YS(W.X?G8HNH5P:S2B
M?8@J4BUEDI)$31.1*27B)6YZF@8:F2V)*'4<97VH^IE;F5J:WD>FG;>NXI29
MJT7QR=O0PK*0W<:_(M35OB1=5%&)1-(BZ(I*1SS%;<HJ9;E(,2L(C4R%YN_L
MWQAHHYIQ?;EVW5SX[2C-EYV.[P&B EA*+I1"/@C(1$J<@TB,22EGCYM6H(T4
MO>WIYZO2UK*JL#HO;0S\X\6:)( J+R'@T*(AD@5%@DJX)MD0DW.%3G6LM0<P
M?FQS[7"-5*B.=;@@[H8Q2AL3J,F8JEI]-49U'-NQ!5GV3?#J2]/]7>6V&UMT
MD(65ACA1YKCC%.TW$8D$L,8I&5VE8O'GP]YGS.$3)^\^"J[5IV!8JH ^[%(K
M E"722KI.1*T*$5P2VD+26DH;A]5)_EJ*YP33 "HKNEM30U:J:EKD_P>HB*(
M98GE1;(MI#<HT'*P0"73]45&2"+18$FFN9P>&"<^<DX,!\:CB#B*9LV%]WMO
M_]3I0%/C?L3<]1G]*:B?QNOCY?I:@BHJ0>$A$C_C'&"E4[+')1FR5(EKL&(S
MY^, 0CQZ[47SH9V0NXY/VHUT^@*NAZ/1<'3]=H3\M>NH"4U-*/51@_$9SZC)
MDR 1=I11::\EHXZW9,3V-U\P*3H0=87SWL/LX$45DQ6PI+5AR7)"J7)$E@SA
MD*+'(PH P^$+1NL$5.^$]-/XZ$A=-9S^,,GCR9=28GF9=K[N_<4IE88' HNK
M21XC<<I$HBVBS<;C:BBJL&@'H)\<ZD15-;H.K!N0+:LL%6&-1T4\B\,BC<$:
M*2S1I52\S-D3BTS'KW"X H3SL5*<_E.P?FS'97<:JU!H?0/3:MXT 575$[D5
MUG%<B1VJ;W.7ZDSV%7:J[>"\<BE8G'U<9[LR^&C*>'@3.ACK5?"5K)W^"/&,
M=ZYO/NPC\@H\N%>@:9VV%JV5,I3:#09-*$L3<3HRHD+42=F( ZT3J? (2O]6
M2@<JVMV:XP#Y5D@+7![-%XU.YTM.*P8R" K%=DI$(I6)U6CV*!Y,$C&7:_8J
M"G\$Y<<V)-IIID);BP> 5G.A":2JIL,64,<Q'%JJZRGEMY!UA2UB&[3$<HPJ
M)2*4U;C[!4&<Q*^$=AXI+AE+=:J+]:;^9\R$^MK?1\15+X_7J]S=(KCVOZR=
M=X:KK(4G6NM2T)1I8DM3,T<CB!!3=+5.I8TQ]F]*M%;ISKO>3O71H84QG<P&
MGX:SLHV^':7AMV&:^YO%U'""&2>#+9T(2B?':$I[IN+_3PXA<F%R:D(0?,,]
M<N!WF\38">''M"RZT4B':5Q; ?WG</;Y ]PLY%&*<GX:OQ[-T Q?39HF4/>Q
M. XCT=,@^[5 .E+K4R2IH),.]ZA#('NE07II2&(V$&DL;L\R)V(=2TE;[0 J
MKD''H,\."^;X[-E'%1VSYM5P A%_O8Y.H-+CMLL)\PDWY) "\=H%$@*>^,O1
MWK-&A48;D>+AN_NS2*JK:-R)?'=:(O_[[QLB^A6_7?QB\?,B@@^0_V?Y_,>'
MM[?B^O///__F%XD$?XOC+W]?2&K[)KRM%?4KF/GAS?0AN.D0#:V-C@V/K_SW
M?\G?[T;S<)2K-SV@085QP5\S&*6BT6'Z/_]KJ)B2%LT,5+:0#O4535*>)FVB
MD$SI'9=Y3[WN2 TZ?KTM,IHA*LE*P?D,NC2\C<0%I+9QB3I%C99P8KVW;[$?
MK;[X\RW:=?8IEV(1Y>1"I(B2!$\U"3HP&AV/4E2JDUMM3"=X-=XMNSNK--XM
M/?JK@/>\8)\:V3_&9=.\P:WR@Y_!P$M&D:(:=SAO2F4=W"@#EP1P^W3.> ]P
M8OU,FP_NQYP*)T288^2$[#/$#\/I?[^9 +P=S6 "T]EB@$9&2&@[$LN3)#**
M2+P!1O D$1E^%;,Y4H)(VZ']G ]')4N-:*L:$_Y5.6*A/;T8H(T!Y[C3Q 3C
MB92"$FNX(S;C?RXD+EFO!3*[&]K/V7!4LM3(>NW,68VG166=3*3D<N.T#K&$
M<W.B$B@MG0O"UFG@\B/VSVC%Z:.H_%3Z9RQ#Q]^.$OQ5DE46O<,FTV40T/+C
MPB\:$Z!\$R.*AM(U*3GBE0DDJ1PX:)V#JM.1O1F^\[_;VHL[X^HZK&!V/X6R
MQ+:O ]H;H*P:7=,,YW$";FIH>@\RM533\4B5E#8Z"4W0N@8B66EW+G@F6AMG
M60 PN?_EJS:9G@G?.1TN[:.=&G'@.U.I--6&IV*"1L0D ^<X=A=)5 8@.".\
MK!/5<T*9;S5TV#B7;1\%'._R;"-SU(_2O<RJ/_"=RPS04KRS7"]V?:UVV.LK
M7;AU((O-J[CD<DA.4%/288&AVBT2C?&D/0/-=YP?#@-R]$NZ4D&6*ZD(V)Q+
M"PM*@K61>* &O$C.IA-S'79[27<(@N5B]':$"I\O3.UWL\\P^?39CY:+R?3W
M\>@;T@'2A_'-S9OQI/RC0=(II*#QS B&$YF\(4[B5RYX[AFN6<&<F%OJH'&>
MI8]JGUG0F8^J/HU.Z8*O^6A_GR_K5B0%V6A)I$AX0C44=WBJ&?$>$J/:F1#K
M)'#W-L0SFBH]<+7_:74 T4[I>O#9@2ZK?[P=H2$R'*<!*L,Z:1,)NB12&HHG
M*\@<U[PH!$2:9#ZQ>)P]1_AS/AUE/K6@V2G=+SX[SG\L]'$[S@S"AY H8=J6
MXKRZW*CB631YEZDTJ53$.+/I]'"$/Z?34:93"YH=HRSOP>-$+608WA]J3#X8
M'S+)23(BO?=HA4M)E TB<"M9CHWR!4YH1CT:Y,])=91)U8YL%:K$]&?>@LS@
MDTHD:V=1(4&B+B@GPD7\L>$QLCIU7(]TCCI)7?PG#*\_X^>K;S#QU[ PF5[Y
M&=S&J=R?0C);9DSPQ/B$\\C+0*PM6<[)\"!\=)*=FV5QD"#.:*T\&U=2-2*>
MU<FXN3@&@<6@(@/"0:(,DJ$$M[&2JR=!."&"S&>[?#X[^C.:@:<P!4YP.N_%
MW[.:PP_=#@T$P976HD02@"_5PY(AU@=<G;7* ?4H30QG-I'W%,'/V7R:L[DF
MD\_8P_:\()3V@=/L"0\NE=+#CM@8+(E4:^J3,13.[4IU3Q'\G-*G.:5K,OD<
MO7SS"4R?EP+3* (-E(B2D"1+/7%G;2"<.><SRH+;BKG-1Q__S\E\FI.Y&H?/
MTZ_XO RB*%FUI2]HJ10O1<@D1(\*E31EPX%S=6(9VM7.S,=,";,V:RNEPXG$
M2FY;SL2GQ$GI^,(LY8[7<EW\@"EAK?Q^1U'YJ:2$/6S.QY1P2FI!C'90$I.*
MOX)Z8LNB$;BCD=>Q 2ZL,>Q>3'BR,>P^&CF7EII-QO2S,>QP_\:P>Y&EC]Z:
MAVCZ7%@<M)-"TTAH,;:D4AF'Y2-1QBLC(BU7[C\X>_=J#'MRY-U'P5VW<BR%
M0Y8Y*P7?*D'*1&<XBT B!$5DXN5LQC7A413/A>?1;9B4._KS;7OZ"9Y_JRMM
MW*7$*\3[[^K9Q7F(0G%);-0X2%UJ(R-08GB6$"U#4Z-.,/%EMU<[A#M=JFKG
M(M)A4F,1UP0^EQ7Z&_PZGK8I_+GS6:W3#9NAW,@=C)P*!BE0[Y),25@E+.)-
M:'(+#C0.=CZUY1$JQOF7^8V?05HX+AZ\YNT(![5XV=UIU> NEXU/1)H8\8-@
MQ,LD2+E8THJZB/CKG++V1-KZ</GNY=NKV6PR#/-9.1=]&K_'J3&:_0ZS=_F3
M_^N^]Y$FR[PO;0*80LD =R2HC%.&>LTBTRG+.FZK/4#VO\Y5Y=:CDV<E==7(
MA"MIOI_'-^DV/7V0H[=.!T,42P9'[A)QCBL2/*B<T7PTFPW..^L5N8GE"#RI
MI;I'S1];R;U.0[?-&;$>]( Y:B./N-M&NV@,(HFG69#$,NYA@<=@ZT2=/ 'J
M<KG1E2:J=)E]1%OG($C'2],84YK<,4-"L>^E+A>^G%I3*S+[F>7B@+HX.W:&
M/T83\#?#?T/Z#WS=<'3]"]*E;!?O1A\ASB?(.YA>3893_-4K_'9TO;PQ+PJC
MJ'''!1 EBP<SLH"G\=(-T-)DLE8^Y#K;<87!7/BV?6SU5UC4&\IOZ6S/G@&U
M7A+C2]T8!0EE%TH;#QJ"X/C#5.<TO _*OB[3^C48:ZGI5&['GFZ.ZU*F/+A,
MC#(E;@CW,PMXP.=19!5!&2%^H.[D]<BP5P/R?9326Y_I)J!^-B#?6WV-&DX?
M(OO>B!&L4=8")0D76]Q=(1);@A SEYXJ$;RD=;)NSZ4!>?=\V$?D=4V;3Q,_
MFBY;4EVE?\ZGLR*%=4]+1:7PE*+>P!$I)"5. ",YV1R,$7@6J]-PMAF^4VE5
MOI<R=ULO76FB@J?K'DH\3=_9]&\7(7$%Y]JL7^%-.N>HF29HP.-Q5BA3"BH&
M0JU00:-)%U.=)65?I!?&H>ZU<YR#U9KV@7$G$XK!<+3+5,"%ERE4>D@A!LVI
MD'7<J8TA7AA_.M3'3@]:QQ>)?O3]'9X0EDT5P_?WDW&:Q]E+7#\1-RZIZ1<8
M7T_\U\_#>(4SXP-\@]$<;O^PY=5C1V_OY+*RAB0VKC>]4$HY7D*XJ72EL;5Q
M/!B=/047(QMTB*/EJ7EY^/X 7\>3V7!T_7:TN!I?R77E=Y":9>%9*:U#-9$^
M:&(SVGDQ>*,9]]KK2@71&J!KN\RNY/H&5Y"7X]%LXN.L-"!=Z^'U7_%F7CQR
M5],IX/\+EUN4R5.+.X-62I=( 4:"*!'\UN!G&T.D=;P)!X ]0L!'UYS:7(EK
MJZS&)>A=O/)NZ;SXOOKETO&2K M1R4"$*#X_H+B-6),)-UQR7$FD"95\5ON#
M[2T!H3:W:BOJV.[2T@EYM8.\FWR$R;=A7,9T1DC!*2$)GI($GM[1VG4J&P*2
MRJBYUIXV6N0;]9O>AN $4@GJ:'S<H>0[[CF^PC.]&J45HNFZCT@#4/NX0?>A
MQ6,X_;H_N]'48[5W).;>.&"TL+E40]$IZW+II$BP/!#GA8[2(=-5HPWH%'6_
MP]/9H^KWD6[7,>LO;L9_X:EU\N_5B54E$#*7/FV!XWI&\4@<1#!$2^&2]V@D
M;29([ A7WWAP?\9GA[(>=R2H#LW(!99_^']'W*>^KJ!89G4 GDEB4.Q8+8@+
MF9?+?Q8R<S8FVDAG#Y][]BIK(::NI]G5?X^_^35UP%/*O-0D)<G1*BT)"MHS
MPADR*'@K\F:[U1WZNO_4L]?6P2+J,/1L 63ATUL/<)U3DH5U5D0BLF6E4*LD
M@8I 0!GE,T#.UC92V9:'G[WFV@IL9WF6$_%\?AQ>CX9Y&/WH]H^/Y 5] LE1
M/:)-);3A'<W&&T=+UG5F,CL1.'/*>9FB25EPV<H[^@2F'CRE0)/G(@421;$1
MM [$JH!V;N(BQBRI]G6N@D_64TIE+O'()$91FASDLKJP3)Q,&;3)/FNH(I#+
M\93NPZE./*5[J.Q$/*4\YI!!E:K=5*'=@!N0Y1%W(:N-Q-\$R>JT$3UW3VD;
M;M56U"EX2G_S_QQ/UK-E&>44T2!5W'@2.,X1F9(I0;B.T$QC"C(H)1O54FSD
M%'G\_G/RDNZE[7%G4N_8/U:RCM_E!YC6SKL&H#KWD>Z$T[^/M*V>QK6$W!L#
MC N"62=)=A(93IDB-N5,M' !-\X4G6Z4F72*FG_"0]J+XO>1;=>.FS64=4!/
M2A[PM$*"<XY(5ZH-. V$<V"<LA(?+YX[ &YY;K\N@(XD/>Y&3%T[1]=07JRP
M(&0CI4@$:,A$"EK*>N' J/$9LG;9.;:7REY<F,X.$52M:?9RW59<.9V,-\2X
M19O)+(FST9-(D3X6N!-1[:6TEQ>FM$,$U;6C]'9,*RP,]UYIC"7<%BR.6N+!
M4SQ2.)&R94K;_6;:JPM3VB&"ZK!V]9VS]G;'7@&*@7-!;2!(&)SZU"9BH\+C
MOJ;2)9,C#;J1YK8]_>S5UUID.ZL6']?!_<K/?/A^][,/<(W_L%_7]M,8CN'4
MWD,J&^YL'8V.D26&VZ4,G@<)W%L.DFKG/;A#W-E/H^G!D<T9Y=I&1R(P-.6T
M09Z+<BNDG<LF:LW]^8;\/I3U]-?QZ/K7X3=(Q0LZFUZ%Z<)1.@!J%&0TBJC0
MEL@@(G'.RU(MQ8D<(YYIZCCSF^$[47?U/LS9="E64$P%#_7OXU&<3TI9EB6N
M@6 XY[V+9-D=7>'@0]"&0' I)>JS=+P*43:1]$^)&AH;=RCN&A5J#_"$&N&#
M9R80Y;5&R%23D(PBW$CAN!86]]*?%Q0=KR:U%74*%Q2W&=EW$]'?+!QR0F9G
MC'!$<3P82@!-'-A,P,42B1&-X(UR2QNY)G?".*?KBKUT/^Y:!QW[K%<CNP]I
M=2!J JKS6XN=</J_M>A(7>-:LNZ-"$Q$B>NH(,X&62[Z3>E#@\?CK#VG^*7+
MC:JBGR(!GKB\Z%/_^XBX0[W'\7PTFWP?_/%Q8"AWS)A,O"WAKP8L<5(!<3QI
M):0WQCREY"G$OUV/O_U]]<2EGE??+-2\4/#=^_KU^G0D^'$KJ75XPE@C>/-A
M0*DR-#-&(A.*2!=9N4O!#]XG (&_RD^%&>RGMS<?+D%O>TJMPGQ[^WK %'/<
M.V1.E D1^$0<A4BH"=P:70(>GZICNI_>WKZ^!+WM*;4^*B9\G(<I_&M>*AU]
M*_6-6GA'=SVJM9.S$<;-T%L.>-I.("+-$K]Q-*MRA91C$MKI,-CUT)9'YH=/
MO7>\4SJ*6/)S*>5XO .<JED$(M $5YPGKGFEQK0[$+5U#KR",+OKCO?&1[CZ
M4F@^D,:!ECC(9-' D"9*8EDJE8JXS=Q$ERNU[-R%Z CNPRY8L'G([T3@-<)8
M'PYV54I121:RLD1GAZLDA+)*)HU6AO+642IRJA2GN@5-;WZ>&FIO+=YC.V]V
M#63=8DEE8#$Y2S(X% Y%X808$M&,4:%RXC[5J8>^ ]#1'#FM%?T,<PX1> VO
M\F-8*].J";"Z+?AV03M24=(N%/@\*5I(OU=ZX$(93:*.0,2U$S<\08*AAH@4
M)$X$G42H5!R_7UH\5YJT5U;L(_3Z;%AGSW+)C/*&!,<+*/ $T7CB2I.EG&RL
M=0VY%<[1[<M#U?4T"0Z0=07K\J'5NPK MMDRJQ!"U(@H W&0%.%6"9> N1QM
M#P>,B[(56HJY0G>4AXCN-<1K@JNJE; +V7&,A+::>Y((+<5>84/8B2]YRAW%
M[4]0/&C)$%CIMLX)Y3H$':4/E3K?]DN'9XR#OMBPC[0[KS4B%7V/:V59_?Z*
MGTMSS;+^?831<#SY?3R#Z:LYO(NS,6Y?')4FUE6.C7),@"+4&]S)O"^E'V@D
M43#<%AU* IJ5D3D00/]V0C?J&_<L^ZX39MZ,YY/W8Q3AFV&>?7\6_3W462D9
M2JJ728J5(LJ,N,@\2=DEG:-2P<A&C#D8PB5PIA_Y5]AK2HS?#"9?BDANCUD0
MHY$\)@*Z%-86TA-+0R1>2N.-]GC.JM.#;!N:B[$_6XNZPS2279A6\Z )JJKV
MYW9<Q[$^V^OM&2*T$'H/*\(Z^,DQ1U/V!%SI!P-2$RM!H *]UZ7;J*?]K E'
MM#S[8L(^LJ[ @)?CT3>8S(:XX!5@:R=)5%$8W)ER9I9(5K(4*3B"6Z;7U@M8
M7$Q7(,!6./T;#5WHZE'CUK:"WFE''A@^\4A+"PD!I"]_?UV"#Z8%Z^O1_,LJ
M^^G7X736()!B#R:4%TXWJ5  [!=CT<% ;J,MVLVFPI5W^2J-OY;W_/: 99W.
MDZTO:M^VIMR_#T?7'V=^E/PD3?_XFORL6+"4ZHJC:?;FWE>!I[2YI<=,<^'M
M.Y-7/RX?@I_"__T?_Q]02P,$%     @ 0X!P5"T>J[>E<@  F:8  !0   !A
M=F1L+3(P,C$Q,C,Q7V<Q+FIP9^R[!U13W]8ONB%4Z4@1$()2E:9(;P&4+E(4
M$!"B D*D2PL8"$5Z$Q!0D*)4I8E4Z;V(= 0$*0D="21("1"2R_^\=^_]G^\[
MWWOG?N.>\;[[QG\E<XRUQMISKC7W7G/.WUQ[;=(T:1%@UM?6TP;(R,B EV<_
M@#0+W 1 Y.1__,\*Q=F?DH:2DH*"\APU-14-_3EZ>KIS='0,C*S,#(PLC'1T
MS!S,+.?9V-G9Z9DX+W"P76!E8V?[0P@9Z(R'@I*6DI*6C8&.@>U_N9#: !8:
M,A?R/!#998"<A0S$0D;J L  0$9)]K<"_-^%C/QLCE34-+3GZ,XNJ&$&R,E
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M3BMPPQ3+_OC9Z#D.01F4$.X/U?ZFV3^G6.A_2K/_H=C_U&L&H >1G3T\$ L
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M&?7;G*'JQ]CY)*H:GY+> DN=$AOM2_6MUM[G!R_TL"SWK)J$M"LLFJ>RD86
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MT.4CADN5RS/I*/1JQ;0("<A-G3K]S4D"6-0YG3Y"'^800RV@A]^@!"WPG^J
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MR'/A9KE>HYJQ+=?24@RZIKHF_G$HC?'56S%R'XLO M0 XP19&QR)CF@N1SS
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MOU"04#71P%CB>2DJ/+*[]='"@1%F3I)NH6IGMG7@MTGM]O2;GALU7B,68B2
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M[N%S%YBF[F$EFQ<C1O8K6&#&2-?.3T^OZYSFU&Z>#VF06Z-P"'B4J0($=I,
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M8?;!J!R<8SSHB[=%-XOXJO%VWY7/\CG]=,_N=?YX@*,Q5OE^HDJV0-T7Q=G
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M\+?BCO6G%( Q?X+DQQL+QX@2>;9D-16R'(G@K"%>MEJ_K(WX^IV.X4SC; H
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M:"5'I@JY=!@!'H=SK#IGC_KI_E:LX4I>5N'X:ON*Z<SDC* 9&CUGT?7=7Z:
M+AL&2@D1N>+/S^W^7Y5,!RXUK#SK!"%XZ,Z I%I;GOG6]J<=X=NG550X?NE=
MO]JC*_H^??P?6OGWG^6)+1&<YR5=11(TJ)[:"+Q9@FJ:3="<9&U0^7'DSZ99
M*C:B &JDC0[W'R5+?[O?+AM(+J8 %$ B91NY48_=FM3:'KJ#,]H**Z\WO^X%
M0<8;8A3""Z>+/-4E^&S3G8U>RW0*=']C?I58>NX,VVHN%PW>K\7@;/!D%CN)
M+1<:[VT0VG"6]V>/-XK3%%*I'/[#Q.Z"D\&TZ!>1LV?43[Z2*!FB )@*M6FW
M_2W" ]2S'9,^(GA_+&UQP7TR4]'V1A\_LF#E(ZL>]E=IH9,-"TG#_Y.9E8M
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M VY'%WY![)D[MM STIK;2JV\YGS;2-Q<W??8+]X:'K\=XL]/.VQ/>&L8]KK
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M%P&&[4#> 9J]KN-=QN@8/J;Y_&-153?SIM5YO4>X44UUI7!*:2;2*..0)9A
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MD[EL3*1","&Q2L,L"6(9N]"C]<QC8\25X,!\(?0+*L&Q.R..6T%K4UCN#_L
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MK7-ZJHS9O( DL/<GQTEZIZH[R9M.S]2I^:#"U>8>67*+DCN>7W\ DI(H2Z(
M"*0Y-7MWG)@DUGI /EA86!>60*90HO]'$L*<:C6X##XUOM[+#EKAFX05(S[H
MR.]/RRXS8\G! ^$],.&&A-J=-CTP"\N1+@*,2X@>T!RQG\\S@J8-;0/&JF^R
MVLR-)":<]3>Y7L^;@F!_+]</^GK]B]O-^F'9</,,I6E6Y$4.4V0."VLN3 L%
M8YRG2$0TQM0GW"*HD!,-P.B('23)R',&[3AS_ EYXY0D4S&BC7S=Z=:$ZW>T
M W]J]4"C'^@H.'BJTG6XCY'!Y"GA%!*;K@/7,M_IRD$\ZP^?;L=06]?U[UY5
M=Q0SEA6(H(S!/*<91"*6D-"(F_#>-*(*<YD+I[:+KA),S>#=E6U=*E#5W4>6
MC<2.Y7^=9\*.IP?%=V N[FOF4BMP YI+6AUV)70#EAKSQB]L 5QG*<:M8>L+
MTE$96N\'N;=0^+5<E(^;Q[9>::(*F<0H@XI*4U",$L@2SF&<HR23$A%<6/':
MT9.GQE>M</:M$@YQZF>=J[0?F$U:N0)69CVK[=4]$0Z?.EHOA)/*='L@G+[
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MZZWXGTVSZWPO*[XJZP1=S>>*4U._F7*!(8HP@2R5"D9)$DN18"40<>N:ZB;
MU RUUT([[@*=\;<CX"%1'9AI7\M[4[,N7;4Q@& O/_C'U^6\Y"]@D$X4OA &
M;J3J*,3(_53](#INJ^KY'%_.DTJN5E+4A0?J!AI56WGE7U+,8AQ)EJ,4BD(@
MB(2BD @<0Y''19HJG%/E=(#</]S4^&PG+:AJ26_:/P'=B0Q^*A?MOSIF+E]
MWI;;0N$Y,)/MH:PEO6D:YU1@+VQ(MK(!)3 W]0XY,A/9J'_,.U9W!:V^-V,B
M3HB2&.*8(=-V'D."(P8S5$0HIQF*LWSV5)/A;VNZ6MN1S)G17+Z&UV,.&'4A
M[\N%:6 $6'/:'Z0JWDP*+#%+&)2$"X@RJHF;%PB2&!$6)YAP_9!&RP\+,3*N
MVQ&'0U6/$!Q2.T8. -+ 5'RV^-_@]?L&H=YS8TVAIMXYLKUTN6]=B8;!]1.;
M9HD_KTP3+9*2C&!!(:)(DZP)I,991&%!N!0%9BJ1\6R]7-.Y'0V<'L;)=ML-
M-MQ;7@L%Q-;J,!5G:']+41=,[;C@>J0&IH*M@#4-W+;]<&LA0Y9:Z ,A<!6%
MDT.-7""A3]WCV@>]5WL<%!Y64V@JR:V7GQ9-W<V/^CUHRBG,>)9SO;G3>SFB
MR0 E60RQXIH;<H$H1103P:U/$&U'G=H.K^V!LUZ:4X6F[BV]OU_596K TTK_
M8_ED#N1KX1T.'JUGP>)$<@AL!^>55Y5>]CAOY09&\+;6RQ# .B1L# 'P2+D;
MH8!V.R]V!:SW(-GZ8>.=,+OJ=W#T['RS!\D?YH1_*^\?UE_4[U73(]O$W)G3
MD%_I8J/TGW6)41,3VM9>40AIHR]',,HIA@A%*:21-@HCDK!(1JG4-UD3_S62
M3&TQJ*4WQY8;LPS4RS&@:\!;+<!C5PT]6?=4&_ N!QW7SYW%<C'6C Q]R/RZ
MO$6M"?RBH-:EL57K F+-U!SHTT1 NS04O7YB'):;L29HI"5HZ(ER6YI"@-N[
M7%TUP'A+6 @<#I:U( ]T6^KJYC"KE]G';S.,(\J50%"*3$&4QC%D+,>0B 3G
MF!=<X,AFS=H_<FJ+S\>5O:>R TS_@N"G[L#,_O';[>>[#]=_[\?*]30I;B]N
M? GM7^JON_ZR.X\:Y1,]%GW[K9WXC6_G\;OEX^-RT3G.^;)95VM:>\9GF$>,
M4&T$4IDBB&1,(2D8AHE0<6;2'61F903:#3>UCZV1&#0BOSJ1[(CMVHV\%_'^
M+S4\C@-_Q=="Z-&AW :9*_N4]PXQ<K=R&W6/>Y9;W16F";#9Z>[+*]YR;6YN
MYJ:^<^W$-&<<=&Y..'ZFY:))^OI.?\SB(J,\E0)FD?$[8JF7\IQ%D LN]0]Q
MB@FZIA6PEU13(ZB]F,#(Z7AH$6:B[,XX1H=_#-?EI5;,';6:XQ+P:L)NMDF[
M6KGANOA>A?6@O7S])'O3CKY7@7FIK^]U#P_=L]U(\RM=;Z4Q_:B_RX4I([EO
M.SS+$:=8D0@FA>00981 G.O-5\Y4G":<YIEPJMMPG3A3(^B?]8R9-M[K![H
M<5176;V2I1WGQX^>AT/];7GY=>/U&]#J]G)3MUKG-5>;Q-K?M"$TE[M?@_?Z
M-]NF['6MW#@:H^^Z"_PCM5VW$FDB7===X+-ONN[T5/=F;'<-ZYN,X+H<8Q/F
M_47=BJ:;XNV/LII)*2*": [3@L<0F1Q?+)1^RS,<IX6@.<X*VQYM-@-.C5GW
M,H-&Z)NV':(YF=D*#OYA1+<LXV4-?3^E#@'HP*09!$NG3G$N %W=0,YJL-'Z
MRKFHWFTWYW2?GRE8UW#=M'YY_1>Y>I8SE$<2$TD@1T1 1.,4TKA(88H+E<9%
MG##I9."=&F1JY'(@(U@U0KJ9;2>QC%E12(0PY"+%IF*M@HQA#!F1228PYU)X
M!+)?B^@;1K$;@J&<KTQ36X^66B=!9DBA+$DB&)D85L2XA$Q@"@O*64P8B14C
MKC'M82 >.Z!]"'3M]A/7XC7P@G?X?7^[\'T[F_-]V@<UTD\.-*KIW:?J:X.Z
M]UJ?ZN"/^JOB=/%>/BVK4M/72^/*;JNX$)(0D1 *>5Z8BI*(FO:' @J%$"4Y
M$G$2VY<'[QUK:NO75EJP%[<]='&I=-T/;S\1! 9M8#XXC]?E&CK.P+G4" \&
MX%A%PJ\ TK%,N!4T_77"^Q\Q8J%P*UT.*X7;W>+9O*SM'K3OAK8K9J-X3'E"
M,RB08*:6A39>!:.048FDT.8KP\BM-M'YP5S>[W'*#;4"@OE>9L>B0CW0VEE6
M8> :F$\[0NXZ' Y2P><R&F';B9T?;MS.81?5/FH2=OD.S_*H)H3@4U7I/<;[
MVK!K_!*U#_2S_+/^337+,R1RFA;:%LM331N<F^3"&&)4I)QD489S)R>"U:A3
ML\H^2K;:F!51OUV121MZKM.'YOKJ1^L89#?<[3@E.)H#TTLM+V@$!HW$K</R
M9GNLH\5N+@B8HN@$4]A2J%8CCUL)U06,HT*H3C=[5F/<12(OJZKN$:V6JS_I
M2E1FF*92SGR^_-,X2F9"1(S1!$..S5XQSQ-(,"L@(DKR+$V3(G(J8.,R^-1H
M:A^I;PHI MZ5_@8\;^4'=*L ^$G()FW)L;:-TQ394=E0P _,:)WL"(/YW2'F
M.]'!3O: 11 ]$ M;Z=!%@''+&7I <U2ST.<9[F?&QK>FK0EC1]1GE)&0B<@D
MATF2UX5="HASCF%!$1,R+22S*_Q\XME3XZMO\KFLS,>Q5* NB[8]O'0]_'V-
MX>5SWBN0&=S#[0>*TRGN&?6O/K!]_=S1SF;/*-0]ACUWB6?PW3[$[_N*+JKY
MJPI^K<LPCF06ISF%:6Z^9L)3B-,BA8DJ.%94<,G=@J&MAIW:A_[Q=9?C]5YV
M0'?".X;7V<V G?41'M>A'=^=".4MO'=;>#ME0\\590[FT_5#,&S$F]W0XT:V
M.<%Q%,'F=G> H)&O^NUJ6QYJ5HHH3S.8Y!&!*"*F?%^1PPB3(B$TI8HX53T^
M,\[42.KP:-G(Z=E-\ARN=DP4 *W!+11WH*X[B3^&8;C#^,Y8;W<>?ZQP[Y'\
MB<L]?<)'68TLI2F740%Y2B5$,>40JQ1!04BA#9LLDBAQ#WRZ*O'Q+:.>O*L!
MGT!6Q;G "899C$RS$)Q EA$%N:"12**<1)ERC78*@.OHH4X!(;5TFD\XZ_:W
MM@YUT S;BXJ'=7F_35[M126/7-F!LV??EQ6?+ZO-2GY1IHJ_7%2UU?9-UG;<
MG0GCJ\=\1RLIOM*7NL>A*>=?5_.?B53QE-6EV%D,D<((8AIE4'%!<)HIA=+$
M[8#^2HFF=XI?"PMK:4%7(<>2GU=.E!W+C C^&)P$68UZ*R>X7>EMR;UL.E,,
MTI(B$'YAZX]>*=.XA4K# 'A4T3308WU[NB[*Y>KS<KT+RC-E3@I*$<P85Q#)
M+(<D-760:5I@'G%MH%JE4YT=86K[U$9 4$OHVH7U-7B6!M,UD Q-3ATT!O!J
MG54]<,/4UZ.,W!OUC)+';5#/7>CW->]R+C\MGK0=]HM\EO.T?34E3E'&N?Z:
MXR*""-$8$L'T9UXD5+"(<UPX><Y[QIK:%U[+!E*WC[L/2[O//!!" W_PW13P
M1M ;T (VP/=O@4E0)N@;;U1.L%#\-3O8W.(9UBRK2LJZ,&'5M$';6^.HX#@A
M"L$\,]NF6&/*1); F$F:BCP6'.4N/-$SUO1XPI1__L+FY;U/.[X^5.T8(Q!6
M S-&(^5-4[ZT&K:1G@4B8>.:>\8;-[#YLN)'D<T6MUS12?VN7?Q0C'/"A("4
M\Q2B0D80<Z6M"99'""LLE=T1_*F'3XT1ZN22YG'OY.I>6GI&3N+63P'7HC'P
M-[_KI7XW5"_UNU-6P(5>ZG=CKN1]TI[LI?[ZFJ"MX)I^OZ;-KUS0>5U]92$^
M+?1'(:OU;9/J/,OS1""6%3"..(4HU88_X4CIM5RH.,XQ2F.K*L !9)G:E]WV
MWS9MCIZV4M?ECLI6[FV^>)!>:%:S96<CC#0' _/)V9YJ-]O.Z.8?OQ[,S%8;
M<'MA9D*U7W/!=(P6;5;R3*&-FPMPEJW>G![I'8)HBDF;\W]C/9DA]LF>HB@*
MF<(XSP1$BIK&D%$&(\EQ'.$\X]+)*7I^J*GQY%Y2L!75)G_1%6 [[@L#V\#4
MYHF83X#@!3!"!P6>&V[L0, +:I\(_KMTAV<O\/8PYHO:I7&9"(SZR&96)(4D
M.#>)GGJ'A%B10IKD!"8H)XAFN(@B)\KH&VQJI%''6&I\33BR1[F=7ESMF"(4
M6@-SQ59,DYRPS^6LPWCN>G%S[_%M 4C8#M]] X[;W]M"]:/NWC;W!,T3;\)G
M]@G+.!)IC)6$+&.9*6O)($&$PY1@*7B!:$YBM_ 5NX&G%Z5R(5O\BH WNYDH
M,%&1R8:51$\"(@6"6.^K819S3A42N9 J0,K^%?,PRC%Y34]EDVHNFECEIS;5
M?"'_;'Y3#3X9=O0?'N*!%X*^1/YM#..(F?QG@!HCE?_UT%/(Y3\#AV4R_[F[
M_9:/SQOC5/RBOLFGY:I.0_I-WM=KU4PDB8P+E.L-*L<0<<4@Q1)#HDP,=(Q0
M2A,7HCH_U-3(J9'46%&KG:R@:H5UXZ$>?.VX)PQJ _/-'K"]F."W2X YT\ME
M+()22L]PH]+(9;5?4X?%'7YT<4>K!_/_'_[8:+MI;IYXNQ"_TM4_93O,MI;[
M_K!:FHTJQ0*F7"80"4$@8R2!299E4<Q%E,6.I<T\I)B>';H7M]-7P8U<?&;#
MCG4&1GCHXT4M^0TP_P4=!6YJM_])V <*DKX"Q:!$YB/'J QW!5"OJ>^:1WER
M8E/W[:/4M]#Y=_KCPP\3=BW;LX99PF3&442@(BS5QI3F/TQ3$^O <,S3),]$
M[LA__2-.C^M^_^MO?P40M ([DMP%>"T)+1QD0Y-76]:Q%;4^N6R%!3^UXI[?
M#+MSE!TP8?GHPICC<H\= $<\8WG;M4763/S5MLCDRRQ-<:R2F$.L-V!Z3\85
MQ$4<F5.!@I,$I]*M*]B9<::V(?NJ'V:^"5,DK:Z^/Z]C*SOE8GT+I!W":\<E
M 4 ;F$..FL+OA!RBOME)% 8J978XUAM5+3NI\/D"9:<O]W3W\P<I-G/Y137]
M9O]>"OEIH9:KQS;-ZUDN-O*C%O[##_UE+NA\&S]6O7OYNEJ*#:\-HM_DZKGD
MW8T!95F:<:+-E#C-M'$B(DB*F$&1D%PIB2)<.-45&4S2J9%3JPDP;PS8Z@)V
MR@#V EIUF@9XK3Z._NS!YMW2!3Z%V1R8->TGLCJ82;U[K/>3@^PA!P<^K!=^
M,&G'==P/#?J1KW_P 3U"]7^E/\K'S>/M_?U*WM.U%D[)^AQBI8=8JG.M$GY?
MZ.?_]B#GZIN\+TUH3-V0(Q,THJG@D"I3:X\C!&G!"(RR@F F:8Q3JTR@\*)-
M;4%IE0-TJYVV>!OUS'%UTW[J]OUO%=@8=4!E] &KCD(.:05AY[A_+7G;F1MX
M\=A.VDXQL-4,?-U-VODN+K5^H%80?)O"5#ITTWFS*1VI^<[84^N6\3((^KWY
M,F%''"_;9A"D#G)UAAG!;>D6LIR];S^,.G*R;"P(<Q(XRV/)4)[DD+&4FQZ.
M K(B8E#FD8PX2A/,K7JW]0TRM>5T*R?8"]H>4]N1:R^@_2M>*)@&7KL\$++F
M*!L(3FQ!*LG_>K]\_@]]>[W[^ .9'V'S8TU%O0\>A51L5-O2@]6U'C;Z0:')
M.\TF][)Z)_7&0?Y,RX6IC?]^(]?+N\UJ3<NY&7V69I%(,IE +&@"4:$-<2*Q
M@$F,D) \C8K4*I3<<_RIT</N3 7P1GR@I0?R\6F^?)$F[.=9KDRP[@U@;?)0
MO?E?KA_TJNX0CNX[718V];"3,+C7I5NOMI4>-.(#(S_XR6CP%Z!U,"6R.UH,
M"[R#!3SL!(QDY@XQ$6ZFK#^,O?:JQV/',TK]=3ZP/*]XS-4'$:O5<G6W7*UD
MG:)CW%!U9XPF7'5?%;W3X:'VE\Z*F*HH0A$L$J&-42RIJ0T30<XQ39.(")Q*
MSQ,'3Y&FMC9M-3([S%HGT%&J7H8.>I!T&@MT-&O=TX[9E0'FU_ED8819&W@Q
M&V?"KCE$N!+CH4X+?,5ZJV.!*V'L\?]?^V3/(+;EX^-R4:<<U$7"9HK%12%X
M!N,XPQ!ERI3Z8Z;^.9(LCE,E7!/&7@\QO3"U+RM1+HSGKFIS9!;+Q]*< >[B
M3OZ_Z*]1;!*5FDO^"V11=!-%47L'H)OUPW)EB@W\U__^7W$>_5>&;_(DJK]\
M_6-*\FW.4[V'V%>W!G0-WDM>EW@!:7QCLM/B^B*3IG8#],.?S!OQ+.?G8SCL
M9M:.EJ^9K8%)MA&MR7#=-29M$F4"QL6=T3]L(-SK0<:-?#NCXE&HV[GKKNZ"
M_D6]+ZNG947G/Z^6FZ=/"S[?F*_!5#%>FAQ[/:5M'(W>@J$\4CC."BAR;2HB
M@F.("8\AI2E35,8\8VBV7J[IW(Z0? 5QLA)WX@SW/7R6!YW3@:A5T1RS5-Y-
MU-UFQHY2QL![:$]I*S6HQ:ZK"S6"@Z[D8"?Z/O*N+T;QFO;L7D@.U;S=39BW
M:NWN!5E/XW>_YUW1 JBNW=ZM[MZI]__NY:B\^ZUIBVKR(=8OGQ;&3=#4(C .
MS.\/=/'EJ38T/R\7S]JFE.+OLKQ_T'_>&L?GO?Q9/WK]7IN:NP*R,TZU=8@P
M@TCFF2;BG$ L&8>*Z7T[DE%*4^K9=>B-57.AFO$:'>WD!VIE7-(&!4"-ZL8I
M?:H)TJ82>RO5IW'/6[]B!>%Y*AF#&8]-9TZJ(!8*PTRF,4X2CBG&7NV7_NU>
ML.$[/O6]7O*X&]2__;MEZ9>:@*@3LGRZ;6:Z@!STFF%MT,OK=C3-N]0  SK(
M@!H:L-;8@!:<&["#YP9L 0(M0J"&"!B,P+[2?. 67!.9\_!=O]Y:L?$;C;VU
MQN>\?5.2S<\.U:*5VO!]50SOY76A^BA/<<)$##/S'R1D!EE6",A(1@@IDBRG
M3DDE=L-.[1BGEKKI&%_GL7ET1;/$VVYI"X_BP(O/#L"]R#>@;10P:,, -Z2"
M4K;ET*.2JAL<KVG/\6[/*IIR5:=-:'V:X,JV7CZF1815G$*5$@Y12BEDFH\@
MSV.:$2DBECDU+#HSSM2HIR-F&X_L6#SS#)QV1!, I(&9Y1B? =H478 A;*',
M,V.-6R.S7^&C\I@7+O=TE6U8)?_8Z/7VP_,N)H%2SO.<)S#!/(.(QACB#&,H
M299QI#(D$K<LUQ.#3(T#]C*"6DC/@)!3<%INI:\$:>BMK2L^[OO*'@#"[O-.
M#33NOJM'U:-]4-^UU_0B.\R][R0[\S3A>292&$>U6]&<'IH:_%3*C#.94TFP
M>SNR<\--C0@:\7S:D)T%U/+D+QA, U/!MAG9JP(:0Q4(L\-E@)9D9X=\@ZYD
ME]0_W9CLXEW>73LVCYNZ5W+M6S$.FI5\D(NJ?)9-UQ 33/M9KK^H[_3'+$8Y
MUYI+B.-$$TK"];8B9P)F49$7::P8X](M3,I1@NE%4744V&5)=%0 <RV]<Z</
MITFQ(Z4!@1Z8I;H(-Q[T ]FW/8^:<'U3Z7EM?"=:AZ#M0GS "]U#Q$F&L1N+
M^ !THMN(UV/<<T:;PA,?'N7J7K/JSZOEG^L',QI=O,P4DFF.N8 1(:9F/960
MX8+#0HHT30F-<V15=NS".%.SEQI1P596T @+6FGMLT?[H.WGJH" #<Q)GE@Y
MY9%:(.&=2MKW[-&R22T4[":4VESND5-Z^\_E,_U7Z^CC61YGI"!0)4A!%"<<
M,AK',&=%D>H-%)<.95NZ3Y[:Q][(YI!2> !3_V=\E?)#&Q.U6)>]GA< <,B6
M] 5BI#Q(6T#<<AM/*=V;M7APPWCYB*?D/,@T/'F!WV:K3EHLN;9MZN#R[4E-
M'DN:QBF,91I!)"6&K,@S2!2F.)(QQM3II.;D*%-CG[V035Z#VP;I-)!VVZ"K
MX1F8GUXC,\#Y3"\$0;<LIT<:=6/2J^SK[4?_Q>Z;C$]<K6XWHM3S<;M>UREL
MFLL_SNG]K,@CK 0N(%8D,O7A3'9'BB'E*5))6B0LRVSW&.>'F=IW_^GNXS?0
MB@HZL@(CK/T.HP?7RQN,,&@-3 -^0#EM+R[CX+V[Z'GT:)N+R^IU]Q865_ML
M+9(H+FZ?J9#S#VV%E?K$]ZM^31YH);_J.6]7KT02$<6D@'FL4KWQ$ 4DHM ;
M#R(CD2DB%+)J/^4X[M0(P@@.&LG!5O0F4@%LA0=&>A>[W7X2;+8U@T [,)O8
MHNJU+;*'UV73- C,(VVIPL'MN.ER!JU_2V;_N!$W;,XZ'F[GW&^_MF!,[<B^
MK2JY-O'*O&FDL3]29AFA(A,"(E08CU.10D8C N,HR;*4<%QDPJ\L3/_ 4V/^
M;BV1YI1'"PVW[6$:-7QKNER8 KN=XQ# #LS[QY@V4M=9)ZW<(Y5SM\-LH'HK
M%P9_HZHJ=I"<KYUB>;\??QWD^-[-:565JN1-YL:/LIIIMN(,:YX22$F(DH1"
M9OSF-$JQBE@2\<*I-<^%\:;&5H>9\>!08/ /([)CP.$EP.U(*B", W/350@Z
M$Y$E+D'YY]*8H]*.)0"OV<;V-D^2D4IJUA(?ERM9WB^: _[CGG=")7E$"Z;)
M)=-[8XD4Q F.8)02(A"C.4J=6C/;#3LUROFTDOKOYVO^7(.P);D$QVUHCFD%
M!JW$VU"A@9L,NN$4EG/LAAZ7>IS@.&(@M[O=G?2_R'LZ;V(+ZH6VH$0F&8T@
MU?8-1(SI#1GA!"9I6A"EHBC#5G4Z3SQ[:I12BP?:6!87H^44;I<][U>@,3!1
MN #AY&0_H[*W9_WU\T9SIY]1I.M#/W>)^R?9>N(_ZQF;94D1B9@(B"F233]U
MPO,<DBR33$1%3I75^?BKYT[M4]R>]1C9[+_!+E"7OS]/]0?^]JPT=_KH3NCI
M_<%UGS7:QW9"@>Z'=NK7[A_9W?)9KFZ9Z;_";3I['%P_H?>GEDN3=BM9(.(^
MJ:WW6W3XM-'>HY-*=-^DTQ?XUM2MZJ9\K6%6S7*2T%207(.!,HAX)"'5K&U:
M..=Q7A21BIP*6+X>P(G"1RA,^=V, 9:[7"K9RNE:P/85C*E2,1<\A42C"9&*
M(XACQB%3>E^,XRQ)[:+1@\ XPDKX)32 !<6LD$1!52 .42:1-NB1@+S0]GQ&
M$5&<NM9V]H=PG*RD,^_BE4C:N0FN06?PM:)J&]I\N/1N>910/JUVX!+*KP89
MN83R:16/2RB?N<XW<+:O'^S/<GF_HD\/);]=25K5IUG[L[TD)RAGL81)1DP5
MY81"JA<?2#0#<,EPGL;<+;S66Y:I$:U% ^B]/J!6R#5.UW_>[*AFI-D8F)4\
M)F+04]L J 8.(_:79^1@XZN!.PY)OOZ1?JS[*UW]4Z[-$W^3?+.J:S\WQ:MF
M(D,)2R6!119G)F8E@23E!2R*@N-4,<FU1>5 JN>'FAIG[B4%>U'=6+$'5SO2
M"X/6P)QV$JAQJMA=QB<H._4,-RKY7%;[-;=8W.$9_+;MU5.?&']1=39%?4B0
MYI@2)2(8BT@S1R$0Q*GF$(4RQ#(4LYBZ-4$[-]+4B*.6S\1AM5D]'A$BYU&U
MXXT@6 V]07."R3T>[1($80/0SHXV;L39):6/0LPNWN =4W;<(>+VT93'U*/\
MJ@==E=J\J2^YU\-WFDY\DX^T-'7_9SPF-$%*0(PTZ @3!"FE'&)*(RR15#%*
M'0//KA9J:F33>'_FR\4]U,,] KZ3WOQ8E:)5$SS1%T/_SI%JUT^C'66-/3D#
ML]NYKCFM1H;WMCJ!O5+=ICI@IU;0V+A@((<.H+M>L+&C[()!>2(4+]RS/8]X
M:/5PNQ#F#U.;_9G.357VUU6Y,X9$$N,$JC@B$$4RA32-">1,[PXY$4H*JX[K
M3J-.C8*-M+6CN?ZA([>C"]X*<4N_?&@<A[8%ST$XSC;2":ZP3GZKD<?U_+N
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MM]9&PK8DT;;M%D:R8#F!2.AM&DI1"IG*!4QRDF6X($7&G-9FI]&G]O&VPM^
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M($@,$_VON?Y%+JE5T5:W8:>VO!M1ZUJ:$NR$K4\H/]_^S2^'S@Y].T((C^G
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M)J,$B8SI#;"@U'0Z5IIL8PQQHG"2,E84&7'+)CHYSM2X]I68-NX=)UCM6"$
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MY(Z]>JQ0MR.9X$@.3#8[".L?.B+? +H&6ZF; -B K7Y<4 K;_L=JY'%; KF
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MN;K%AP1_1(_X6>"!T02TJHSD"O?%=" ON+,X;^0 ]X7MO._;^XE^[-IXT_5
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M_@0J]/:?):#("A&G!*4D=?*_6HX[M>W"OZZJY_F:+G;MWRIJF][C"KG=)R8
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M<;3NMP_M_++B_]D$$+W;E":XH/8_-#5(WO]X7JQ>I*PO>OCG4M/KT_SY4;]
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M?]G+[] ;C?I?BUK&O]/YTI27N2_GE=YV[-?N_2SUE_\;_36C&8F9A RD1:$
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MUR+?U:V-FY=\*[;^-NL!!U81M9D .[/(,ZQC[-0^Z2^9*;FQ_#XW_J$ZG#I
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MDW)S9>X!0T^K6/=P[)SK=]\PE)]^SH<M0K4X>M?R7TTOH3>TFE<S2+&,"UH
MKF0"8$930#*2 Y$+E#&1Q_H/EWQ#5P&<MATC)!$V!])UG8R>7",_V-MM/D(B
M&OQ@XFKKX9IP&PWZ(;^Y%;$M;D%;$E\5XE5;$]M"=*U%L?5S;HVV>TN?YYH3
MYO]5LZTY@E_+\H<9_M-\*>NDK1F&"4ZA@@!C10&4$ /&$P12R;@L8J2)S\V_
MZC+ZU+PJ^]%;A^+?174$@]$@JM?M7T:)J-;"U1_K-#^63MI0J(?VW'H&_(;
M. ?@ D7"V4CP2J%O#N!<CG5S>8@;]57E>O8'_8]5^59;)]K:+*LZD H+K+6.
M!2!"2@ IDH!B'H.")SA'$A9Q9M62_?SCIT9>G7!.<6D7D.MGG=OQ"$PKME!8
MTT6_QGU\H._<XP+]KV,>N/#H419ZOUK=2KYRU3 KY<#Y:TR?=O-7_I1[QDG,
M1 *S#!0BQ@"2) 88*@0X+7)"H%09Y2[&B<V@4UO6AR<6=7OBSN&BQ;[!#K&:
M 3OSPS>N@>G!!Z3.EH8+1EX-#*N!1[4K7* X-B><[AUPBO1O^OE_/J^6WY[D
M/7^:RY]UD45MO,AR3>?++_+[9F%F^N6/^4)?NEINJ[TQ;62H%*>F"KC29,4Q
M($F& -6#Y$4FN.16B4JWB3$U^C**1$:32*L2[>D2/6B3O]$FVJD3[?1Q."H8
M/FD6!S^C3$5@QAL^"T.RYH=/A\/AS"C3,M+Y2X!%XG:H<C.8O><FPY\^WM'(
MS0@<G'[<_K1A5O6?E<DIJ];S'W0MJQDDJ6E%F  ",=,;8/U=(E ID**49)Q!
M02EQL9\/'S^U3XV6KDZ[[.1S,X>/H+,S?(<#$ICPC[&XBQY7BSE_B?YJ_QLD
MS?0\'%ZMV:,A1K5;SZMW;*%>N.KFU'E:+K7)6SW*LFM6->?FF'2^V)A('G/
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MWPQ0X#4^ !NGA=ZK_\V+_/S31UO@O<KM+^[^"X>7V?ZF;YTEI@L]$1!(HBB
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M?KIE'DWN->C-=9J.M.-E5TU'YR-C=*+2>:@+N0NZOC<U;IOCV&[WEV8H9;3
M@.0\!U#(5.^U:0Y4D11QB@6';LT"K$>>FMUX.2MA)_L-SC?;^;#UR@5 .;B[
MS@_ MU6HM $K7-G*WM%?KY:E#2B]!2ZM'N!&94+.9^]: ZEIF?U^*4PHTDS2
M)!.DR$!2<*PI"^: 8!P#@06E),9IS*WVT1='F!HU=4*V[>BC]Z9'GI;3CH,N
M ]G/-5[@";WU<D7&FCRN:G^&)"K)?_^^^OD_];TU/_P#FK^"YJ\U*5Q^ZBB+
M_ZI2W2*_?N$PNT2;3EQ*47W0(KV;_]04,M<$H@VFKI.JK&9I@3,!$P($R2F
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ME=,??5_'PBM9]PPW*C5?5_N8B"WN<*QA4ZX-NW]8E3]H6_%!D4QPL[%7%&<
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MV!$+:FH=[^\=X%K>I?U %OI>>P6M$(G)MP'Q>[WKF&_<J]9MQL^N/1:O](\
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M#?Y#6Q:[+H/=P180W,"GVFX?M*2?]SH[H/L.M!SY.ZQZ(N?UI'*E8=1CJB=
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M19 PC"%-BHPAEDABUX![&!E3$Q\'9 +6T@F$)M3!:-!_32QL,:,@'5CR&![
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MAQ[OA!G&^]$Y-'"H'J?5[W3U-[DV>NA7R3>KVA3X1=*Y<33_9HQ.><$)QYQ
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M>J:O( F+2 (S+A.(D,"P8(F6$&F*]+VER.,TZA'Y,9"LB0:&F.J?_PDV>VZ
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MVD;#NZ\;I,SR5*M52G%($F4LOUFD1013,!98:)E XHPZE9 ]G6!J N'#<O$
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MJJ[;>/AW$\;S<;G^;[G^LJO-/,M252#$."29J7N/C=J3*/T/3A!C),I5ZE@
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MYD9M,X3"=39>L9P/+]6Z]LKMX/!4XK'[<W,D!]"F9GE3W/Z:?K>:I(*&.U&
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MLRMKV*87V\0*YZU)-0(<:8&!_(Y0@H0<LK9")>%:E2/M1NBPGF K/==06*-
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MY0U]NYKHX).H5B)/F38J,@:1T4G $AF)UCL>;)NF5+=I&4DV<(^W)_NQ>01
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M)Q:YQB0-H$^YCFDLX!338 5M/,\MHR]'4HX/4SKL/?3@&K)',8[3KOPU+/_
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M>IN588T5O3N(<BP3,D^_?)EUK RS<U:^F9?%\F0CS'.FIH(YF^)!,D=,%5I
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M*<!:VD\HT''91EGO2NG @T;;@+"IN$8 Q_?X%>>G6'.-[FI">'.S!9UI<\D
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M;7FU6D]/PAI7DV!$]*:V\.',@0K%070L@S *K3*6<=VF:\UU.K:#S5.[D#B
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M+L#L(]^;J?$',7O@6^X7IR>GLZZ;]JM2R.>ETWJZR&_+L[S8S)_N&K<9*;/
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M95B[!C7AYY$6^+2,E%W0?5-+CQ$Q(S!,VK.ENQ[GA8ZV[!)D;^I4-Y\@.E>
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M71Z([J&J+G=!S C,J"-5)$5F32@V0Q?M558:"-%UQ1S6":^""6U:V?QWU>5
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M)VDY+A=:&"87BV&R'.%B;,^*]68YT@,=62V$-FX,GNU-(CG$6D5=(I?D$H0
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MB>L$ED,!8AO@!M).IX!;WJS;=368S<[+7,A+U][6AC.& 7C.9+3@?:;_[=8
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MQ;PJD5D'T@N#GL?&N8Z_<*G"/MAK5ZJPCXH[\"*K9_'@+B-*R%([8!F\8CJ
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M @L^2>9U-A&E"BJV"82:VZC;&&;[FK@JS7>!%D%6+ H?:+N.DD$$S1"+,ZD
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MQ<A4$N3+* X,A*'_2*$174IW9G</FQ6[E:9QTPU:@7!@772 JJV2NKTIP1+
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M_8J?L)9HWETN8I*,\;5])\D(R=;GI%D4 9FP&10M$N,;I:+O2^FX^0>G0][
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MR%OPM!2#KL?]6B(Q' VSSLJ:=L&)Z1. ;F_">_+C6^"RK28[J@:_<Z\P"4F
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M5@V!]7&!WV%Z':14DRQL=MPQ24)CVLK,8DUHSMX9FWP*5C9WJK:3U\T!R<G
M=HQ^^KDL?=2^[ Z'D[IVE'1(CD64M)(\,/K7LB*BK-T5;< V^65/4=7-045#
MI!VMC:,!UL(UNW(P-Q3\$PATP%BS<DA:Y&@D%F6MHA5Y5<6H2XJG<?4/[,+0
M#&XGN^ Z4BN][:-73-U?H1,A#0B$S)P-A6F35^DLM#)-U$&8DH0XT07J?<+&
M/?@Z&<2.T,9@(>:@>1PK=_.*-YCENUO4 1D<VQ\V0.[&CI0.E+6Q>MN=EVP"
MEBN@/))G3GMB'4:6"%B9,^DB2"71R(<UKT,UX'F6MJ,;$6U]PQ>2[VOZU7].
MN#69V%=,UL!$<Q59<(:SDD/BVGL=>)O&O#L0-V[8.#!V'O4A&E@Y QY,G,8T
MK1KU#VN@UH]L::8V47TZ8P7%:P^!0KG:_TP73H#3!#T9,"5,@#FU*09K9ZRN
MAL6F;Y@OS_!#>1#+OIKEU:O?7"[JFKV^."4=W*X20V&,JX79*?DZZ\%JVKZ=
M8D5B#L6&J/1NMX3'4-&]K=H'.O<'^9Y*-QW<(M[R>L< _#F?I2L6;_G*2J>(
MVK%LC:PNHZ<] "3+&6100J:2VUP)[4KAN*=@C?#85$U=P6_=/O7AQG/+&48A
M7#UX$5;5>,C4K"?)&68?A(A%.F@30>Y.X[CG%2>#X*"JZ@"$=VWZ=J:X%121
MZ\30)V)*\EC'WGA6#-:A$BISVS!L>HZ\<<\Q&D-O> 7U@KI;$[Z=+X-6AI(%
M*[%8IK51#(J3]&WF6"=*<-&FV&)7"L?-\3D%]H96TXL+71\XPK#)$3ZBA&J0
M][8,@@_F_W21LM4<%'K+O*B!AP=7:_XL4RD7E77)3K>YR&E_K'>G_.T3)IS^
M6$T\)$?"122W(@5.]M[JS$+QBDD(+D&,"6.;#7DC.=V'P_O@8VM'U(,5T$46
MT?U5O%Z\$VZX %-J/[J,M3F!8+199%9TT2B=!</;'#%M)*?[,/88'!VO@/%3
M^O^XA 7,+O"&?&>D#K&F^LI:CF.1O(M0(W"1-9:4N0CRN0UPXY.[#R</@<+Q
M,NS"E-SQ%&YXD.3N"8NL*,'K%'>*/\A",FD$FE@P&]?P8ND>+=U'@\<8D2-%
M/W:KV<_?YHN++[@X_W-^@7=VTYAX5IPV4E%JSS1K:\^T6DI \4J4PCC,NYF1
M+2_H/DH[V)H,(=$.#@1NV'@W^X'+BU5OF(D3(22G++/*0VT#8UA(*3*;E*]%
MR(3W-HU3-E$S;AU&8[-RM/@[@-!]_^KZNNJ^K>1*"^7J;*F(JVF/A0&91Y:L
M$ $X]URV0=0.Q(TS0VX4Y_=XY;RPQ*SK@[3F9T9/OJCE(='N')[N5$@X3P%4
M<+59A6>:4VP5>/(L>LTQ<J.2:I-&WOY4Z-DDQV"#BC$S6T1BVFA-J]:M;@9L
M,$EZ"VT,W1 IIV.>%.V#F;TS3_=0RMB>^FT/F-J_[]/TZ[>+#^6OY56]^)OY
M;"6M?\#LLM"?EPOZQ=M[@@GGDH):#,SFG&J3#L5\"(5%JRB\C2GEM-O@B&.H
MZ/XPZ1"HG58W8X/PYJCD#OTZ965K7;"'4$]+2B#Z01/]&*1S$!VW.V%KP\.[
M/W0Z&#+'2G)L)#RXB;P-=)<$Z&PCQ;9D2[&.)>"A,J29"2[7)-K,Q;/^U#/O
MZ/Y(Z7!3,HQ<.PC_-N:&34!&I!VW'HDIBBFR,,RCH.A%H1.2NZ!3F_KHC>1T
M?PQUC/=SO )>6%"W3@6[OA=O$<YM>47+0&X7KDX7PI7HC%!*,A^-8KIV%_&(
MP(3.Q5010J/V&>U#N+6@/\,9+.@%UZ<@@*!% 62JMA+0F"0#+Q23]42W9/3<
MMVGNMIF>[@.V?1#RT&0-H(*.+N0>9:9>\R-1\R -9Z)X<OF%+"R <RRA T-^
M7TRRY>7<-KJZ#]".@=: *AG;]UYS\>'R8CF_7"2\CC!K2\+E)(L$.I*CD-1J
M9"(:<AF<8LJD8$H0GE;+3N[WDZ_I/C([!"L#2[<3G'Q9D*=1);3JV[_JW1KA
M@@(*GVH)(W&@'.=D5CUG@ I(6([G2-1(M=LE[S,OZCY:.Q8K@TBX@Y#M$Y)
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M6SS<SKW31H6HB6ICZRUZ,!",5!!#C!D1.5-M9M\^2<[(,!I.W=O=3R?+O@,
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MF^OZW__^B$N-P0O, BRK8:51' *)$J11F'G1 ;?7#C\#JZ-(&'?3XH#P:J^
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M^XX)BW,B:+(/@11?UYGQ/@<&Q<D8G9&"N<LVP&'.0?Y2[_.[4<-!2.SG!G2
MFOW7,+FN;41O9O.56*Y$4C;X>I_%321)D!]SV@A@SG)F?!U W+#XT8"C_4SL
MI38-=(&37@Z]8XI"=R-'YY.T7OQZUX)$Z2[]JRN/'*/,D=0C)1W_28%G+@.W
M21B5$Y.EX2G6A*?];.9?+0--L=*#U53:Z]T8YM<W\[N[@;5/^';<R-^G]*V?
M)[_5>1)7/LD@A \@ZJ@154?L>/(6]$?+T24O;&@SD^](@O?#^XN]_S^#EGL
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MR[<X=4_JPDWZ_#4'V(H<J2NB[BS,L'%QC&-$V."2AV)/)%VH?"?^T:3*%&6
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MJ-N"G2G=5.OD((7?)S<R+>MU^$IEHRC[:(_!"]U@E):AQ5RMJ5.ODR&JD?L
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M&Z[;8:MX<L=IS5QXY=4]5(OK+IDF^)/[()'&E6%NJ?4V^]YM-F<R?LDGV2J
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M)*O3NU@QI!6O7XGB<Y=>4H%TXCM@)&#]$'MS$18F,\R<NW1@2H)=02R9(=H
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MPZ.P"IJ09RJM1IJJ<Z$R+:49,*5\4V>@*-)3R*$YKD'"U72^@3LVD+M:Z,#
M;MSU7(/%/%MCC'FH !X9U3!++W+S+HD,XOO,A(F]BW&9HH0?9']L2K.NBQ2:
M.-(F8B7>;]6YI%;H'4QFI"1@U5UP;%KTFCH'R<:QB:^J(E844250=C*D2H96
M!/IFEC?:B.M2(B]6@%27RO#0[&>B[688J\Y?ULZ/VH8$&;=>BU-WIEA/U1&:
M CDU&O-QE8PT'H+73,D]7#]0M/&#Y.#C)%*P6!USNU*&<GI!HM[DM;5*%L_=
MUN;4V_@Q*8:L6,>28AC&*C3DN1'^SBYM0%IIKO\N>A4B?JY 5CF6=6!/,J$<
M#0B1),[ ZRH>57W::D*:Q;\[XC/F# [=,<+#1-^_"](8%N+T]+!E.I*+T%4P
MPOY-*Q4_FI<$%ENF<R^W66ND+)ECJ:L[::(8HG$;&@SII*08L:"28XFA\29)
M::RP77>?7 2L;'<-*UO#RM:PLA^#_VQ)C$4+-GG)&2,0 )L[W-U8'?CE $:I
M$T0YL1'=86L?,)Z#],N$55QG9=-19.P+1Z1?*$^!/_T*AG* =0OX&,TCX8B"
MJ8+A"R:$K*%>IJRC^<E(NN6.29-AM@V\V=PU?%\*G$;N*+[&1&TZ _+L1P>5
M'C%@'VFS$]/FJ>D2K7'@<*X.)3G.S&?!YM-&5JE/F35[ZI0FEWR<()!QTYGC
MLI$+EH8>"I4)P57N5T=W(M'8D&*J]119P+J:69H^*26*)OEWCDM;/[D-+L8\
M\F0U9L+;IM3IR10?5,:33HXX-'4W:GJ\( 'KB5<PK<R*X4\IZ*>FRIS.8@PP
MAT9F'<V<IOV1O@H4S9"M%Q@V6!*_Q^,+6DH2J(K,E<K199Q!9JHWK;4'<_5!
MI<(XG$9U78H4<.,^P9HI<O3CQ TW[19*E0HU_+/BY4RK3J-(<JFT?J8'O:GZ
MJ\&V<=4^L>01M97'06K.HG!YF>_J %V1^Y83!X2J>,' ROR@(.UW<^^-CCBA
M"54'%OJA-/VUGLPT;\@1MA^SH'DNS9QC10,'LMPTKFX^JY-9K:<L1W=8Y:#@
M(<="O< XBW@-4EW<:T]CEHAGBO6G.KTF/,3J%D 23B_@XG[57&^ZL,Q2]Z6X
MQ*3^Q5/#,@:J<X"OP;D9_2JV9:'>"2MA S_W K=HJ=;T@F8Y:I[FT'%B;RD5
M'F(Y@R7P T05@1'@F$WI%#O2*87\[M0-*!L/'A=.*0<555/.**Z)-6#XD.JE
MN2"3?I:1*5 P_XTE*7@EGA4HO;W!BHB@*A;@ !]+8"KP/;%6S 3?+-IT?+RU
M[4<Z@8"?4X231E\*<&+I*8.E9ZT"4K'AI1QQQ/823.E?WD>-&Z4.4Z-4 1&H
MJ/_7O4\<@P#3%&<PFW_G5E>46J4T0Y#*>3YJ9(AQSSLWX'I$ZYX.G32L9"SZ
M,/A>WL2V6%"33KI:IQ'#F$?LNR/W1IIL"XB(WQ1!-1OS!1H@2Z(Y6I !XM"R
M6L4 ^&>Y(&#62=%TY*&>-%@?#MCCKV]L>KO*=BW"EN,8'1G4J.#G,2-"(K,\
MP6Y=BKPOT=UKQ8:RGY1#4K \*N?$J.>2GV+GR#?G<$(V5$=;#4LN>/ILZ@\5
MVZS:(47710[Z(\1$XXO(J:K)SE1W._>9U<XFO:SR3F:,7'$3%AGD.O@4DBPH
M7).52P6;R3I^IQ^[93X2,^SI)BUI16/(E,V8]'$2-X\O->'$VH<7OF=:HMJ>
M-JN4*PX*%*3E2QL9:4H:OTA7;$E\0H^'WDZW#@GBE<;C6ZQUX;H_(_2%',S%
M##T9IZH)4)7#4H;VU-0?IJKLX'%QI^DJP>%Z!#T,.KB5Z<:H8T\EZ!CIJ\S.
MFC@$[%<$'WGTX-G/G669PR-H\<%L+JP',R4-,13ZO*"8K:,IF3M];7&.@/5.
MG8",HJA8MO.D?<LA+!UFRD,3L=%W-Y$\*R5/DF/$ *YG<VT@"QM=F64CU1.X
M1J>5AZWUE!M0D]GY.&/GB9[=NASX3=/"3#;Y\F\UZANRC=84/7(-4@RQ8.BS
MPI(H(SX6,PLLH1Y9=KG-"=& G)AGJBB1#JZ:"37&XW&<9,S5@Q6=L)'^SG'1
MIIR ZN7*+GB=JU<&I$3I/0>ZN3I%%?XU0IOFFJI"ZAX_7Y.+Q#.XSNG:-=;K
MG.XZI[O.Z3Y'JI!'Q"#M-"JG3BTN)6W2Z*9/#1!2+MY&JPNT7,II0F*@T@3X
MV""! T.E$Q7C>3B<29^SXKL92%@ #U14KFB+3G:.:0R+%5X:!<8V6@-\G103
MT"+8:X)*4(>706EZL-PSHWZ/"G;KIST4<5SBTC,,,Y)$1#T;6PD;UAJXI35C
M9':.\P0;SZ0L8E_4X8XQ:>-(?U><WMH2CB+"02Q[9KLN+&<P8+"@P3US;V0#
MU+O.U]!8;S]?*,G^?/+7#@>SFBU8%14[LO6 9L>O5R^.CM=@+/"62GIF!ER*
M:\B,QZLZJ ?0%3#$$9BUGP=]H$ +8'O:L9;'R9B5W&E0HH5I/2NUPBFO<DL3
M=K&*? W[;#JY4F Q9X?R)\Q[4^U+[LT]O$(:2^0V!_'%^\6U7*>U8$OCFN7<
M=FERT_/@2D#RHJ)(Y6^I!5 %AE$C$RH@$B2)O(L]:CJCF$$IGXUEO2H1FU6G
M842@"L8?Z_U/>0HW"-5 Z]NU(/^$4J#55WF)28@E$7U^9Q)B*I1,I1WF[?BD
MFCRAFA@CEZYUHFG.L&1NO!&%5%10?J@KD?%8,RT6)UU:$,FD2.;=P8%4H(?H
M]"P>^"*COZ.617"O<S!G[%=9I'_G,'W#@ (:W/F.07>#_$$FRGX3="H-=86+
M:0 ^I>^W/8")[%N) *;"RZ5.KE@,<Y"ZE)O2X1NJ<=D'N=7?"\OK9)H5;#7U
MG-76D96I2@+5A2$H.GI8*21[6W*P#G=FJ<4]9I-F)81?XDZ(G@6L-]!N"-I
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MO-[-Z]W\?'9S6SBQM2Y9ZY*U+ODN7?)F$/L/\)_;;!3^^O\!4$L! A0#%
M  @ 0X!P5"#G9S Q0   8:L! !(              ( !     &$Q,C,Q,C%E
M>"TQ,#(P+FAT;5!+ 0(4 Q0    ( $. <%3EB.EP\@$   $6   2
M      "  6%   !A,3(S,3(Q97@M,3 R,2YH=&U02P$"% ,4    " !#@'!4
M,_/EM8D$   *)@  $0              @ &#0@  83$R,S$R,65X+3(Q,2YH
M=&U02P$"% ,4    " !#@'!4/&Z](#4#  "["   $0              @ $[
M1P  83$R,S$R,65X+3(S,2YH=&U02P$"% ,4    " !#@'!4V:PK/!L(
M)0  $0              @ &?2@  83$R,S$R,65X+3,Q,2YH=&U02P$"% ,4
M    " !#@'!4-_J'LC,(  "T)   $0              @ 'I4@  83$R,S$R
M,65X+3,Q,BYH=&U02P$"% ,4    " !#@'!4]COK3N$$   T&   $0
M        @ %+6P  83$R,S$R,65X+3,R,2YH=&U02P$"% ,4    " !#@'!4
M]V]I$.L$  !2&   $0              @ %;8   83$R,S$R,65X+3,R,BYH
M=&U02P$"% ,4    " !#@'!4TAT_/?4\!  3[R< $0              @ %U
M90  879D;"TR,#(Q,3(S,2YH=&U02P$"% ,4    " !#@'!4;-OYZE89   <
M(@$ $0              @ &9H@0 879D;"TR,#(Q,3(S,2YX<V102P$"% ,4
M    " !#@'!4K/=8!C(K  !YL@$ %0              @ $>O 0 879D;"TR
M,#(Q,3(S,5]C86PN>&UL4$L! A0#%     @ 0X!P5$;V%]>GAP  F.8% !4
M             ( !@^<$ &%V9&PM,C R,3$R,S%?9&5F+GAM;%!+ 0(4 Q0
M   ( $. <%0M'JNWI7(  )FF   4              "  5UO!0!A=F1L+3(P
M,C$Q,C,Q7V<Q+FIP9U!+ 0(4 Q0    ( $. <%3CY"P7FTX! &G5#0 5
M          "  33B!0!A=F1L+3(P,C$Q,C,Q7VQA8BYX;6Q02P$"% ,4
M" !#@'!4G'7B./[5  !\TPD %0              @ $",0< 879D;"TR,#(Q
M,3(S,5]P<F4N>&UL4$L! A0#%     @ 0X!P5"R_C$GJ0@  ^#T" !X
M         ( !,P<( &5X,3 R,F%V861E;"UF;W)M;V9E>&-H86YG+FAT;5!+
4!08     $  0 !($  !92@@    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
